,Number of reads used to calculate differential expression,,,,,,,,,,,,,,,,,,Results 3 DAI,,,,,,,Results 7 DAI,,,,,,,Results 14 DAI,,,,,,,Results 21 DAI,,,,,,,Results 28 DAI,,,,,,,Gene annotations,,,,,,,
Gene ID,Con1,Con2,Con3,3dai1,3dai2,3dai3,7dai1,7dai2,7dai3,14dai1,14dai2,14dai3,21dai1,21dai2,21dai3,28dai1,28dai2,28dai3,3_bm,3_0s,3_lfc,3_SE,3_stat,3_pval,3_padj,7_bm,7_0s,7_lfc,7_SE,7_stat,7_pval,7_padj,14_bm,14_0s,14_lfc,14_SE,14_stat,14_pval,14_padj,21_bm,21_0s,21_lfc,21_SE,21_stat,21_pval,21_padj,28_bm,28_0s,28_lfc,28_SE,28_stat,28_pval,28_padj,SignalP,SMURF,EffectorP.prediction,Description,GO.Names.list,InterPro.IDs,TC_DB.ID,Transporter.family
RL4_JR_00001,1488,1425,1555,3,2,6,0,0,0,0,0,0,0,4,3,0,1,2,87.00880172,1,1.925082465,0.451911978,4.259861567,2.05E-05,0.000213668,5.711971597,0,0.951541965,1.231630466,0.772587226,0.439766707,0.60104221,14.80746984,0,-1.699271907,1.187950208,-1.43042351,0.152595505,0.265839875,62.03359232,1,1.416028286,0.56087854,2.524661197,0.011580988,0.054460062,33.17681676,1,0.43982727,0.833601031,0.527623232,0.597760865,0.70845473,N,-,,phosphotransferase enzyme family,P:phosphorylation; F:transferase activity; F:kinase activity,G3DSA:3.90.1200.10 (GENE3D); IPR002575 (PFAM); PTHR21310 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_00002,4815,5137,5627,0,0,10,0,0,1,1,0,1,0,0,0,0,0,0,100.5835211,1,-0.1008683,0.545272964,-0.184986799,0.85323939,0.926866435,29.26130599,1,0.069624492,1.108938829,0.06278479,0.949937878,0.973599757,69.18715687,1,-1.676133978,1.027837744,-1.630737913,0.102945633,0.197959713,59.55135633,0,-3.923247892,1.186877486,-3.305520526,0.000948002,0.007083776,50.91119908,0,-3.583680356,1.190693172,-3.009742931,0.002614689,0.01062775,N,-,,hypothetical protein SPBR_05962,F:ATP binding; F:protein kinase activity; P:protein phosphorylation,G3DSA:1.10.510.10 (GENE3D); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_00003,266,388,303,0,0,1,0,0,0,0,0,0,0,1,0,0,2,0,7.676561128,1,0.895749804,1.175778592,0.761835443,0.446158224,0.634878561,1.228877941,0,3.168234102,1.393699125,2.273255428,0.023010792,0.064270208,3.186462957,0,0.517284174,1.224177231,0.422556604,0.672618794,0.774873995,7.687760443,1,1.04053618,1.168301699,0.890639962,0.373122354,0.518794813,10.85579728,1,2.09788035,1.002541525,2.092562051,0.036388267,0.087409539,N,-,,efflux pump antibiotic resistance,P:transmembrane transport; C:integral component of membrane; F:transporter activity,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23502 (PANTHER); PTHR23502:SF60 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.86, the major facilitator superfamily (mfs).
RL4_JR_00004,19,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.107742422,0,5.111862662,3.916657681,1.305159419,0.191838569,NA,0.035922547,0,8.265523575,2.957241237,2.795011604,0.005189785,0.021136506,0.090622017,0,5.654091023,1.901038436,2.974211839,0.002937422,0.013425942,0.104350953,0,5.233604409,2.756136928,1.898891291,0.057578771,0.133834953,0.086801426,0,5.609724771,1.61014838,3.483980012,0.000494016,0.002680555,Y,-,,ubiquitin-conjugating enzyme family,,no IPS match,,
RL4_JR_00005,3,34,16,0,0,0,0,0,0,0,0,0,0,4,1,0,0,5,0.217803895,0,4.096842266,3.22913978,1.268710104,0.204544478,NA,0.068244858,0,7.338786377,2.559964527,2.866753152,0.004147063,0.018371529,0.178116731,0,4.67910724,1.699229464,2.753664139,0.005893221,0.021453783,25.8872601,1,7.184083651,1.024614577,7.011498579,2.36E-12,1.06E-10,37.00312301,1,7.755003964,1.854261843,4.182259369,2.89E-05,0.000245163,N,-,,cytochrome P450 oxidoreductase,"P:aromatic compound catabolic process; F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor; P:oxidation-reduction process; F:2 iron, 2 sulfur cluster binding",IPR001663 (PRINTS); IPR017941 (G3DSA:2.102.10.GENE3D); IPR015879 (G3DSA:3.90.380.GENE3D); IPR015879 (PFAM); IPR017941 (PFAM); PTHR21266 (PANTHER); PTHR21266:SF2 (PANTHER); IPR017941 (PROSITE_PROFILES); IPR017941 (SUPERFAMILY); SSF55961 (SUPERFAMILY),,
RL4_JR_00006,7,54,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.302616563,0,3.622476943,2.879049129,1.258219912,0.208312236,NA,0.095718636,0,6.850984494,2.425031994,2.825110972,0.004726424,0.019923787,0.247800654,0,4.203102955,1.658783871,2.533846048,0.011281829,0.035707308,0.28594967,0,3.779647727,2.051934114,1.841992733,0.065476213,0.144590328,0.24198901,0,4.134410742,1.544768062,2.676395794,0.00744187,0.024785835,N,-,,Amino acid polyamine transporter I,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PFAM); PTHR11785:SF369 (PANTHER); IPR002293 (PANTHER),2.A.3.4.1, the amino acid-polyamine-organocation (apc) family.
RL4_JR_00007,5,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0.070355367,0,5.727575862,3.921913603,1.460403375,0.144179246,NA,0.022758145,0,8.923897389,3.921737306,2.275495958,0.022876195,0.063966053,0.05808194,0,6.296994923,2.399843671,2.623918799,0.008692451,0.029265836,0.066960678,0,5.873958035,3.921967327,1.497707029,0.134209385,0.244621066,14.78687252,1,8.198729147,2.504208177,3.273980663,0.001060439,0.005005567,N,-,,cytochrome P450,F:oxidoreductase activity; F:metal ion binding; P:metabolic process,IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_00008,14257,5830,15503,0,0,3,2,0,0,0,0,0,1,3,0,0,0,0,151.9888027,1,-3.013188718,1.003550687,-3.002527681,0.002677476,0.013181249,89.57343898,1,-0.306583899,1.042900868,-0.293972235,0.76877912,0.859938363,116.7817621,0,-4.678692758,1.249402999,-3.744742697,0.000180579,0.001652082,156.0594752,1,-2.412551142,0.859944343,-2.805473588,0.00502427,0.028117634,115.605746,0,-4.766856288,1.265254696,-3.767507287,0.000164886,0.001060033,N,-,,Zn(2)-C6 fungal-type DNA-binding domain partial,"P:regulation of transcription, DNA-templated; F:binding",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR021858 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00009,3747,1277,2431,0,0,6,0,0,0,0,0,0,3,12,0,0,0,0,52.38822866,1,0.154102016,0.846203511,0.182109876,0.855496499,0.92758379,9.553145911,0,0.209545217,1.314205627,0.159446294,0.873317268,0.927275505,24.59891613,0,-2.431557604,1.257764525,-1.933237546,0.053206942,0.118667257,104.4359873,1,1.620281995,0.661365796,2.44990292,0.014289474,0.06441715,24.12296536,0,-2.506154508,1.265639462,-1.980148836,0.047686807,0.107991259,N,-,,NAD(P)-binding domain,,IPR016040 (G3DSA:3.40.50.GENE3D); IPR008030 (PFAM); PTHR14194 (PANTHER); PTHR14194:SF75 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_00010,488,788,405,0,0,16,0,0,0,0,0,0,16,27,1,6,2,8,67.91194668,1,3.403817794,0.992025368,3.431180194,0.000600961,0.003902237,2.180446249,0,2.340992027,1.378733763,1.69792899,0.089521165,0.185606971,5.63032439,0,-0.304017483,1.247551868,-0.243691257,0.807469945,0.874032474,273.4387504,1,5.386667288,0.608462865,8.852910504,8.53E-19,7.13E-17,168.3030499,1,4.65209883,0.686767933,6.77390222,1.25E-11,1.06E-09,N,-,,Aromatic-ring hydroxylase partial,F:oxidoreductase activity; C:membrane,PR00420 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR002938 (PFAM); PTHR13789 (PANTHER); PTHR13789:SF188 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_00011,19,40,38,0,0,0,0,0,0,0,0,0,0,7,2,0,0,9,0.391073951,0,3.252255665,2.286134397,1.422600381,0.154852033,NA,0.123334075,0,6.484769061,2.049763,3.163667732,0.001557945,0.015023052,0.321896292,0,3.824504163,1.355652301,2.821154186,0.00478512,0.018341568,47.72320706,1,7.24203993,0.622751894,11.62909339,2.93E-31,5.21E-29,66.60813313,1,7.734874309,1.725825691,4.481839822,7.40E-06,7.82E-05,N,-, Effector probability:0.695,Yer057p UK114 family,P:biological_process; C:cellular_component; F:molecular_function,IPR006175 (PFAM); IPR013813 (G3DSA:3.30.1330.GENE3D); PTHR11803:SF18 (PANTHER); IPR006175 (PANTHER); IPR013813 (SUPERFAMILY),,
RL4_JR_00012,2,10,10,0,0,0,0,0,0,0,0,0,0,1,2,0,0,1,0.088966974,0,5.388359216,3.918744352,1.375021877,0.169124662,NA,0.02774448,0,8.636633687,2.83973425,3.041352791,0.002355177,0.015193819,0.07290031,0,5.966926956,1.712093866,3.485163445,0.000491837,0.00334859,23.3663349,1,7.887964219,0.966724352,8.159476069,3.36E-16,2.37E-14,7.438118444,1,6.82697585,1.243952017,5.488134397,4.06E-08,1.17E-06,N,-,,Fungal specific transcription factor domain-containing,P:metabolic process; F:binding,IPR001138 (SMART); IPR007219 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00013,682,616,419,0,0,5,0,0,0,0,0,0,0,7,0,0,5,4,25.9914456,1,2.095787092,0.741548967,2.826228861,0.00470996,0.02072484,2.225392332,0,2.311566571,1.350031094,1.712232096,0.086853905,0.181552057,5.727083831,0,-0.328634338,1.22631905,-0.26798437,0.78871135,0.860304413,34.6849134,1,2.690024792,0.6681913,4.025830313,5.68E-05,0.000661499,54.35910312,1,3.387201021,0.560968486,6.038130668,1.56E-09,8.87E-08,N,-, Effector probability:0.9,stress responsive A B barrel domain-containing,,IPR013097 (SMART); IPR013097 (PFAM); G3DSA:3.30.70.900 (GENE3D); IPR013097 (PROSITE_PROFILES); IPR011008 (SUPERFAMILY),,
RL4_JR_00014,674,580,441,0,0,7,0,0,0,0,0,0,2,5,6,0,0,1,33.53019057,1,2.585868328,0.648014153,3.990450386,6.59E-05,0.000590138,2.192147141,0,2.333274008,1.339954104,1.741308901,0.081629447,0.172892501,5.64592681,0,-0.308057029,1.219232048,-0.252664806,0.800527246,0.869026146,103.0046083,1,3.7451591,0.493765015,7.5849017,3.33E-14,1.91E-12,12.88680941,1,0.558335816,1.137540416,0.490827234,0.623548646,0.729077515,N,-,,aldehyde dehydrogenase,F:aldehyde dehydrogenase (NAD) activity; F:retinal dehydrogenase activity; P:oxidation-reduction process,IPR015590 (PFAM); IPR016162 (G3DSA:3.40.605.GENE3D); IPR016163 (G3DSA:3.40.309.GENE3D); PTHR11699:SF211 (PANTHER); PTHR11699 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_00015,168,709,134,0,0,20,0,0,0,0,0,0,2,13,1,0,2,1,80.55014323,1,4.25870821,1.925279577,2.211994695,0.026967031,0.083395392,1.330877274,0,3.053244621,1.681507381,1.815778305,0.069404387,0.152719826,3.432268106,0,0.410033074,1.425973397,0.28754609,0.773694217,0.8487247,84.37002392,1,4.478610949,0.858282897,5.218105785,1.81E-07,3.84E-06,18.42709473,1,2.513121438,1.115760856,2.252383586,0.024298042,0.063702143,N,-,,salicylate hydroxylase,F:FAD binding; F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR003953 (PFAM); PTHR13789 (PANTHER); PTHR13789:SF188 (PANTHER); SSF54373 (SUPERFAMILY); IPR023753 (SUPERFAMILY),3.D.7.1.4, the h2:heterodisulfide oxidoreductase (hho) family
RL4_JR_00016,348,852,204,0,0,4,0,0,0,0,0,0,1,11,1,3,2,10,21.03363541,1,1.91123673,1.066575161,1.791938158,0.073142873,0.17635192,1.844608692,0,2.582307069,1.543979355,1.672501034,0.094425564,0.193616642,4.747494532,0,-0.057991279,1.348301898,-0.043010604,0.965693081,0.979803304,68.55065145,1,3.72957595,0.793129637,4.702353533,2.57E-06,4.23E-05,134.0686761,1,4.713493007,0.805521563,5.851479619,4.87E-09,2.43E-07,N,-,,Amino acid polyamine transporter partial,P:transmembrane transport; C:membrane; C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transport; P:amino acid transmembrane transport,IPR002293 (PFAM); IPR002293 (PIRSF); IPR002293 (PANTHER); PTHR11785:SF217 (PANTHER),2.A.3.4.1, the amino acid-polyamine-organocation (apc) family.
RL4_JR_00017,2,3,3,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0.032158513,0,6.856435058,3.93981678,1.740292872,0.081807605,NA,0.010193076,0,10.08155358,3.266297165,3.086538998,0.002025014,0.015023052,0.026533125,0,7.425284889,1.857672284,3.997090851,6.41E-05,0.000871421,9.342883716,1,7.956018387,1.273971703,6.245051099,4.24E-10,1.46E-08,0.026220723,0,7.343296924,1.395022181,5.263928434,1.41E-07,2.99E-06,N,-,,MFS monocarboxylate,P:transmembrane transport; C:membrane; C:integral component of membrane; F:molecular_function,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11360 (PANTHER); PTHR11360:SF125 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.13.4, the major facilitator superfamily (mfs).
RL4_JR_00018,19,26,27,0,0,0,0,0,0,2,4,15,0,1,9,0,0,0,0.289097189,0,3.688069068,2.537774594,1.453268969,0.146149089,NA,0.091733166,0,6.911857075,2.130361621,3.244452494,0.001176766,0.015023052,151.2314958,1,9.427226107,0.461940815,20.40786569,1.42E-92,2.88E-89,91.00455308,1,8.304316371,1.398796519,5.936757964,2.91E-09,8.92E-08,0.235811581,0,4.171854811,1.255579563,3.322652688,0.000891659,0.004352962,N,-,,alpha-D-xyloside xylohydrolase,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:carbohydrate binding",IPR013785 (G3DSA:3.20.20.GENE3D); IPR000322 (PFAM); IPR025887 (PFAM); PTHR22762 (PANTHER); PTHR22762 (PANTHER); PTHR22762:SF38 (PANTHER); PTHR22762:SF38 (PANTHER); IPR017853 (SUPERFAMILY); IPR011013 (SUPERFAMILY); SSF51011 (SUPERFAMILY); SSF117125 (SUPERFAMILY),,
RL4_JR_00019,2,0,0,0,0,0,0,0,0,0,5,67,0,0,4,0,0,2,0.00781203,0,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,0,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,474.6365905,1,16.12485426,2.910297097,5.54062136,3.01E-08,1.16E-06,38.54880116,1,12.27450117,3.915554676,3.134805204,0.001719683,0.011717218,14.73730051,1,11.35168021,3.743633924,3.032262354,0.002427281,0.009966028,N,-,,mfs sugar,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,IPR003663 (PRINTS); IPR005828 (PFAM); IPR003663 (TIGRFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF65 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.119, the major facilitator superfamily (mfs).
RL4_JR_00020,24,28,47,0,0,0,0,0,0,0,0,12,0,2,0,0,0,0,0.394699212,0,3.238759357,2.248162538,1.440625089,0.149690629,NA,0.124436855,0,6.471673613,2.024721319,3.196328084,0.001391887,0.015023052,78.31046153,1,7.952506138,1.658458126,4.795120246,1.63E-06,4.13E-05,8.399061916,1,5.088096068,1.072007873,4.746323416,2.07E-06,3.48E-05,0.324126412,0,3.712271019,1.280676448,2.898679854,0.003747373,0.01415752,Y,-,,glycoside hydrolase family 3,P:glucan catabolic process; F:beta-glucosidase activity,IPR001764 (PRINTS); IPR026891 (SMART); IPR026891 (PFAM); IPR001764 (PFAM); IPR002772 (G3DSA:3.40.50.GENE3D); IPR001764 (G3DSA:3.20.20.GENE3D); IPR002772 (PFAM); IPR026892 (PANTHER); PTHR30620:SF16 (PANTHER); IPR026892 (PANTHER); PTHR30620:SF16 (PANTHER); IPR017853 (SUPERFAMILY); IPR002772 (SUPERFAMILY),,
RL4_JR_00021,23,4,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.172741011,0,4.430641902,3.338715312,1.327049924,0.184492168,NA,0.055921295,0,7.625812244,2.521027415,3.024882712,0.002487296,0.015349618,0.144332368,0,4.980273745,1.591673689,3.128953992,0.001754298,0.008920397,0.166411698,0,4.559495228,2.161884143,2.109037731,0.034941325,0.099498352,0.142090279,0,4.899213352,1.423727557,3.441117176,0.000579318,0.003061373,N,-,,Pisatin demethylase,F:oxidoreductase activity; F:metal ion binding; C:membrane; P:metabolic process,IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305 (PANTHER); PTHR24305:SF89 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_00022,444,657,438,0,0,28,1,0,2,8,29,130,4,18,9,2,23,1,113.1359277,1,4.213667102,1.232174717,3.41969937,0.000626904,0.004049312,43.05367799,1,4.667257548,0.89181139,5.233458107,1.66E-07,1.87E-05,1165.977288,1,7.833118548,0.726340791,10.78435721,4.08E-27,1.03E-24,202.1001387,1,5.073668438,0.396333473,12.80151384,1.61E-37,4.07E-35,133.2482437,1,4.851293176,0.594815913,8.155957279,3.46E-16,5.57E-14,Y,-,,catalase peroxidase HPI,P:response to oxidative stress; F:metal ion binding; F:catalase activity; P:cellular oxidant detoxification; P:oxidation-reduction process; F:heme binding; P:hydrogen peroxide catabolic process,IPR000763 (PRINTS); IPR002016 (PRINTS); G3DSA:1.10.420.10 (GENE3D); G3DSA:1.10.520.10 (GENE3D); G3DSA:1.10.420.10 (GENE3D); G3DSA:1.10.520.10 (GENE3D); IPR002016 (PFAM); PTHR30555:SF0 (PANTHER); PTHR30555 (PANTHER); PTHR30555 (PANTHER); PTHR30555:SF0 (PANTHER); IPR002016 (PROSITE_PROFILES); IPR010255 (SUPERFAMILY); IPR010255 (SUPERFAMILY),,
RL4_JR_00023,9,17,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.142077112,0,4.713080285,3.478329476,1.354983856,0.175422701,NA,0.045306151,0,7.930088296,2.489795173,3.185036417,0.001447358,0.015023052,0.117210423,0,5.283861644,1.479380452,3.571671937,0.00035471,0.002636622,0.135215323,0,4.860016,2.12364315,2.288527618,0.022106814,0.080442001,0.114875037,0,5.210585653,1.309854051,3.977989494,6.95E-05,0.000514771,N,-,,vitamin b6 transporter bsu1,P:transmembrane transport; C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00024,12,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.071929436,0,5.694794066,3.921573911,1.45217053,0.146454195,NA,0.023893797,0,8.854098021,3.073514507,2.880773134,0.003967011,0.018038671,0.060402148,0,6.23986042,1.906507024,3.272928104,0.001064395,0.006053899,0.069563484,0,5.818707613,3.002013997,1.938267983,0.052590536,0.126308286,0.05796782,0,6.190703391,1.533331926,4.03741896,5.40E-05,0.000415789,N,-,,---NA---,,no IPS match,,
RL4_JR_00025,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.004235441,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001340044,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003452355,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003983613,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003339785,0,10.24113992,1.835951848,5.578109216,2.43E-08,8.07E-07,N,-,,alpha-mannosidase,P:carbohydrate metabolic process; F:metal ion binding; F:mannosidase activity; P:transport; P:single-organism process,IPR015341 (SMART); IPR015341 (PFAM); IPR027291 (G3DSA:3.20.110.GENE3D); IPR000602 (PFAM); IPR015341 (G3DSA:1.20.1270.GENE3D); IPR011682 (PFAM); PTHR11607 (PANTHER); PTHR11607:SF15 (PANTHER); IPR011013 (SUPERFAMILY); IPR011330 (SUPERFAMILY); IPR028995 (SUPERFAMILY),,
RL4_JR_00026,0,7,2,0,0,4,0,0,2,0,1,1,3,33,0,0,13,1,15.31162377,1,8.876668935,2.306210441,3.849028161,0.000118587,0.000986173,18.76884027,1,11.28854027,2.242602572,5.033678466,4.81E-07,4.47E-05,14.3722061,1,8.999991049,1.740058768,5.172233958,2.31E-07,7.46E-06,160.3544288,1,12.18048416,2.0452415,5.955523668,2.59E-09,8.03E-08,57.58240887,1,11.03421275,1.862011118,5.925965019,3.10E-09,1.63E-07,N,-,,sodium phosphate,F:inorganic phosphate transmembrane transporter activity; P:transmembrane transport; P:phosphate ion transport; C:integral component of membrane,IPR001204 (PFAM); IPR001204 (PANTHER); PTHR11101:SF57 (PANTHER),2.A.20.2.1, the inorganic phosphate transporter (pit) family.
RL4_JR_00027,7659,12388,10488,1,0,7,0,0,0,0,0,8,8,7,1,0,13,0,159.8740513,1,-1.403665645,0.652348234,-2.151712186,0.03142003,0.094029568,39.07187266,0,-1.822538263,1.215188808,-1.499798427,0.133666625,0.252279243,153.5307449,1,-0.865844637,1.321397165,-0.655249353,0.512307224,0.643418724,229.3772107,1,-0.132004399,0.488479397,-0.270235346,0.786979201,0.862075561,150.3111654,1,-0.515186841,0.729316159,-0.706397129,0.479941206,0.609176972,N,-,,OPT oligopeptide transporter,P:transmembrane transport; C:integral component of membrane,IPR004813 (TIGRFAM); IPR004813 (PFAM); PTHR22601 (PANTHER); PTHR22601:SF4 (PANTHER),2.A.67.1.3, the oligopeptide transporter (opt) family.
RL4_JR_00028,13,7,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.107586653,0,5.113928303,3.890314475,1.314528256,0.188668496,NA,0.034913204,0,8.306039872,2.612369247,3.179504536,0.001475271,0.015023052,0.089666769,0,5.668657121,1.516587408,3.737771454,0.000185659,0.001681223,0.103369324,0,5.246959757,2.320108849,2.26151448,0.023727417,0.083109543,0.087555538,0,5.596379761,1.309213385,4.274612393,1.91E-05,0.000173402,N,-,,fumarylacetoacetase,P:metabolic process; F:hydrolase activity,IPR011234 (PFAM); IPR011234 (G3DSA:3.90.850.GENE3D); IPR005959 (PTHR11820:PANTHER); PTHR11820 (PANTHER); IPR011234 (SUPERFAMILY),,
RL4_JR_00029,25,104,93,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.898981203,0,2.051450944,1.860927231,1.102381066,0.27029604,NA,0.281311497,0,5.295171231,1.887181711,2.805861885,0.00501822,0.020690191,0.737265504,0,2.628827396,1.407935514,1.867150428,0.061880584,0.133485119,0.851193204,0,2.205337563,1.533299106,1.438295734,0.150350162,0.266601644,0.732480139,0,2.535883535,1.382962221,1.833660744,0.066704369,0.13974379,N,-,,Phenylacetate 2-hydroxylase,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24281:SF2 (PANTHER); PTHR24281 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_00030,18,20,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0.248138368,0,3.908418379,2.703117813,1.445892724,0.148207293,NA,0.07885548,0,7.130035997,2.188909689,3.257345898,0.001124593,0.015023052,0.205117058,0,4.474082676,1.341968566,3.333969803,0.00085616,0.00508075,0.236667206,0,4.051770848,1.697611646,2.386747793,0.016998148,0.070796482,14.93370715,1,6.08311034,1.000761258,6.078483044,1.21E-09,6.98E-08,N,-,,fungal specific transcription factor domain-containing,F:binding,IPR007219 (SMART); IPR007219 (PFAM),,
RL4_JR_00031,1919,2244,3344,0,0,2,0,0,0,3,0,0,0,6,0,0,0,0,37.6119783,1,-1.296466281,1.051355262,-1.233138149,0.217524227,0.385308794,9.473376534,0,0.221571718,1.235859652,0.179285502,0.85771353,0.916475916,57.9543165,1,-0.005281008,0.875509935,-0.006031923,0.995187251,0.998095149,52.62665351,1,0.378751518,0.687000372,0.551311955,0.581419845,0.70747217,24.57143948,0,-2.53267691,1.223129656,-2.070652852,0.038391249,0.091182594,N,-,,methylthioribose-1-phosphate isomerase,C:nucleus; C:cytoplasm; P:L-methionine biosynthetic process from S-adenosylmethionine; P:L-methionine biosynthetic process from methylthioadenosine; F:S-methyl-5-thioribose-1-phosphate isomerase activity,IPR011559 (TIGRFAM); IPR000649 (PFAM); IPR005251 (TIGRFAM); IPR027363 (G3DSA:1.20.120.GENE3D); G3DSA:3.40.50.10470 (GENE3D); PTHR10233:SF6 (PANTHER); PTHR10233 (PANTHER); SSF100950 (SUPERFAMILY),,
RL4_JR_00032,5742,5264,4015,0,0,5,1,0,0,0,2,0,0,5,0,0,8,0,79.39488237,1,-1.018476487,0.720122953,-1.414309157,0.157271149,0.306721979,41.72116679,1,0.115216009,1.13314197,0.101678353,0.919011985,0.955641561,65.71790349,1,-1.631096008,1.047686031,-1.556855737,0.11950474,0.221078225,77.7543947,1,-0.873936081,0.715121623,-1.222080347,0.221677244,0.357079482,79.84910198,1,0.029439128,0.595572976,0.049429925,0.96057668,0.973947415,N,-,,tmem1 family,C:cytoplasmic part; P:Golgi vesicle transport,IPR022233 (PFAM); PTHR13251 (PANTHER),,
RL4_JR_00033,4474,5609,5121,0,7,36,0,0,1,3,5,7,9,11,5,0,9,5,254.640675,1,1.75625547,0.793945572,2.212060286,0.0269625,0.083395392,28.84774003,1,0.099222887,1.118670382,0.088697161,0.929322589,0.960445502,168.423279,1,1.256996923,0.421758758,2.980369462,0.002879009,0.013212642,234.3834463,1,1.508904615,0.354578051,4.25549357,2.09E-05,0.000272159,121.3155908,1,0.858426534,0.453023748,1.894881975,0.05810804,0.125419719,N,-,,Proteasome component PRE3,"C:endoplasmic reticulum membrane; C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; F:threonine-type endopeptidase activity; C:proteasome core complex, beta-subunit complex; C:proteasome storage granule; P:proteasomal ubiquitin-independent protein catabolic process",IPR000243 (PRINTS); IPR001353 (PFAM); IPR017905 (G3DSA:1.20.120.GENE3D); IPR017905 (PFAM); IPR029055 (G3DSA:3.60.20.GENE3D); PTHR11599:SF4 (PANTHER); PTHR11599 (PANTHER); IPR017905 (PROSITE_PROFILES); IPR023333 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY); IPR017905 (SUPERFAMILY),,
RL4_JR_00034,7351,4890,4059,3,1,6,0,0,0,2,1,2,3,1,2,0,0,0,126.2910972,1,-0.088503344,0.577557987,-0.153237157,0.878211256,0.940772371,21.10831384,0,-0.934194896,1.244945391,-0.750390261,0.453019695,0.612511594,97.2198988,1,-0.418827498,0.716721945,-0.584365389,0.558974508,0.68511597,113.7517489,1,-0.601435524,0.680593953,-0.883692135,0.376862427,0.522380758,52.95278418,0,-3.640438413,1.216749392,-2.99193773,0.002772128,0.01112264,N,-,,cyclin-dependent kinase complex component,C:intracellular organelle,IPR013922 (PFAM); PTHR15615:SF9 (PANTHER); PTHR15615 (PANTHER),,
RL4_JR_00035,887,919,763,0,0,2,0,0,0,0,0,1,4,2,1,0,1,1,17.95459395,1,0.255737007,1.019293291,0.25089639,0.801894216,0.899966022,3.30675888,0,1.74016965,1.279677146,1.359850534,0.173877227,0.309802023,15.04568738,1,0.055557363,1.197169936,0.046407249,0.962985659,0.978252741,64.76555085,1,2.232536683,0.582876848,3.830203053,0.000128038,0.001320143,19.61320423,1,0.695340548,0.974002715,0.71390001,0.475289011,0.605397061,N,-, Effector probability:0.654,Fe-Mn family superoxide dismutase,F:metal ion binding; P:removal of superoxide radicals; P:oxidation-reduction process; F:superoxide dismutase activity,IPR001189 (PRINTS); IPR019832 (PFAM); IPR019831 (PFAM); G3DSA:1.10.287.990 (GENE3D); IPR001189 (PIRSF); PTHR11404:SF6 (PANTHER); IPR001189 (PANTHER); IPR019831 (SUPERFAMILY); IPR019832 (SUPERFAMILY),,
RL4_JR_00036,404,681,551,0,0,1,0,0,0,0,0,0,0,6,0,0,51,0,10.41882863,1,0.120298682,1.184402533,0.101569085,0.919098719,0.961445874,2.095303273,0,2.398381883,1.340967253,1.788546199,0.073687929,0.159817703,5.444183776,0,-0.255603669,1.226195606,-0.208452606,0.834875585,0.893825473,30.35127068,1,2.557728177,0.695880995,3.675525262,0.000237361,0.002217044,202.2534096,1,5.234238144,2.016815802,2.595298063,0.009450892,0.030034615,Y,-,,tripeptidyl-peptidase 1,P:proteolysis; F:serine-type endopeptidase activity,IPR015500 (PRINTS); IPR015366 (SMART); IPR000209 (G3DSA:3.40.50.GENE3D); IPR015366 (PFAM); IPR000209 (PFAM); PTHR14218 (PANTHER); PTHR14218:SF18 (PANTHER); IPR030400 (PROSITE_PROFILES); IPR009020 (SUPERFAMILY); IPR000209 (SUPERFAMILY),,
RL4_JR_00037,6799,5727,6110,1,6,4,0,0,3,2,0,2,0,13,3,0,7,1,147.9208268,1,-0.12304487,0.463593581,-0.265415388,0.790689484,0.892347509,52.02254078,1,1.067836,0.859281515,1.242707984,0.213975461,0.360629787,96.93279518,1,-0.93451153,0.740090916,-1.262698283,0.206697631,0.333483158,152.3313863,1,0.50408795,0.418176037,1.205444372,0.2280318,0.364167505,95.13932859,1,-0.232750206,0.542737552,-0.428844854,0.668036135,0.764364998,Y,-,,Allergen Asp f 15,C:integral component of membrane,IPR010829 (PFAM); PTHR38850:SF2 (PANTHER); PTHR38850 (PANTHER),,
RL4_JR_00038,3439,2776,3078,0,0,1,0,0,0,0,0,2,0,2,0,0,1,2,40.95172735,1,-2.369216745,1.139357799,-2.079431719,0.037577688,0.107753524,11.90577356,0,-0.108049546,1.216027103,-0.088854554,0.929197501,0.960445502,43.79757384,1,-0.935895711,1.032516678,-0.906421883,0.364712595,0.508868565,43.54775702,1,-1.451529919,1.015444958,-1.429452091,0.152874335,0.26980103,48.87501661,1,-0.61364402,0.83636505,-0.733703566,0.463129425,0.594244763,N,-,,c2 domain containing,,IPR000008 (SMART); IPR000008 (G3DSA:2.60.40.GENE3D); IPR000008 (PFAM); IPR000008 (PROSITE_PROFILES); IPR000008 (SUPERFAMILY),,
RL4_JR_00039,4109,4870,7132,0,0,0,0,0,0,3,0,0,2,2,0,0,2,0,64.34895321,0,-4.110184186,1.219905895,-3.369263319,0.000753694,0.004726084,20.33885755,0,-0.880695442,1.216516432,-0.723948661,0.469097254,0.627722748,86.32826605,1,-1.107678064,0.874897741,-1.266065748,0.205489544,0.331904299,87.95055433,1,-1.23063775,0.780229929,-1.577275755,0.114732089,0.216947588,60.45842904,1,-1.978808449,1.013411913,-1.952620078,0.05086463,0.113687501,N,-, Effector probability:0.857,Cytochrome c oxidase-assembly factor cox-23,C:mitochondrion,IPR010625 (PFAM); IPR009069 (G3DSA:1.10.810.GENE3D); PTHR21588 (PANTHER); PTHR21588:SF4 (PANTHER); IPR009069 (SUPERFAMILY),,
RL4_JR_00040,5143,4886,6965,0,0,5,0,0,0,1,0,0,3,6,0,0,5,2,86.9003401,1,-1.176773454,0.703828939,-1.671959461,0.094532316,0.212493042,21.54629019,0,-0.96389156,1.202230846,-0.801752478,0.422696153,0.585837854,67.15787057,1,-2.658869322,1.196452477,-2.222294135,0.026263434,0.069170398,116.7221117,1,-0.158138798,0.533646338,-0.296336332,0.766973242,0.848514432,89.54738952,1,-0.298912427,0.610934392,-0.489270912,0.624649912,0.729562851,N,-,,n-acetyltransferase b complex non catalytic subunit,F:transferase activity,IPR019183 (PFAM); PTHR22767 (PANTHER); PTHR22767:SF3 (PANTHER); PTHR22767:SF3 (PANTHER); PTHR22767 (PANTHER); PTHR22767:SF3 (PANTHER),,
RL4_JR_00041,400,581,452,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.776981293,0,-0.632390385,1.228541767,-0.514748788,0.606728576,0.773215364,1.840394143,0,2.58555627,1.342890632,1.925366227,0.054183558,0.125761516,4.771643996,0,-0.065301793,1.218083378,-0.053610281,0.957245665,0.975063398,5.504936657,0,-0.487713925,1.219607868,-0.399894046,0.689234557,0.789885077,4.693687582,0,-0.144352988,1.217173656,-0.118596872,0.905594744,0.939654312,N,-,,Increased loss of mitochondrial DNA 1,C:integral component of membrane,IPR018815 (PFAM),,
RL4_JR_00042,4567,5401,6791,0,0,0,2,0,0,0,0,0,1,3,0,0,6,0,67.06382901,0,-4.169794917,1.204939997,-3.46058304,0.000539007,0.003572071,65.88783015,1,0.723759314,0.981012368,0.737767776,0.460655578,0.619141649,55.39549745,0,-3.602729497,1.198809894,-3.005255058,0.002653582,0.012402986,85.2692453,1,-1.307988996,0.763298432,-1.713601053,0.08660202,0.175685324,78.00142794,1,-0.538323425,0.672143588,-0.800905394,0.423186417,0.558537291,N,-,,prenyltransferase and squalene oxidase,F:catalytic activity,IPR008930 (G3DSA:1.50.10.GENE3D); IPR001330 (PFAM); PTHR11774:SF4 (PANTHER); PTHR11774:SF4 (PANTHER); PTHR11774 (PANTHER); PTHR11774 (PANTHER); IPR008930 (SUPERFAMILY),,
RL4_JR_00043,10303,12244,18581,3,2,15,0,0,0,5,1,3,4,11,2,0,7,0,267.6923322,1,-0.516977785,0.518485787,-0.997091527,0.318720085,0.507454391,51.8569821,0,-2.2309735,1.210421238,-1.8431381,0.06530885,0.145382929,218.2064834,1,-0.870925645,0.569945038,-1.528087072,0.126490921,0.23102906,257.050508,1,-0.534852813,0.468995278,-1.140422597,0.254110283,0.393700518,161.6653186,1,-1.677994526,0.715420823,-2.345465035,0.019003361,0.052499053,N,-,,t-complex 1 subunit beta,C:nucleus; C:chaperonin-containing T-complex; F:ATP binding; F:unfolded protein binding; P:protein folding,IPR017998 (PRINTS); IPR027409 (G3DSA:3.50.7.GENE3D); IPR002423 (PFAM); IPR012716 (TIGRFAM); IPR027410 (G3DSA:3.30.260.GENE3D); IPR027413 (G3DSA:1.10.560.GENE3D); PTHR11353:SF23 (PANTHER); PTHR11353 (PANTHER); SSF54849 (SUPERFAMILY); SSF48592 (SUPERFAMILY); IPR027409 (SUPERFAMILY),,
RL4_JR_00044,38172,38800,55783,1,4,16,0,0,0,0,4,3,6,20,0,0,21,2,633.0792553,1,-2.146298551,0.489374707,-4.38579788,1.16E-05,0.000131345,168.0887539,0,-3.927569056,1.19993352,-3.273155545,0.001063539,0.015023052,488.8777149,1,-2.966064986,0.606293784,-4.89212501,9.98E-07,2.71E-05,641.5283164,1,-1.731739353,0.521353158,-3.321624362,0.000894951,0.00672209,529.7516186,1,-1.878935006,0.732191839,-2.566178571,0.010282588,0.032131745,N,-,,eukaryotic translation initiation factor 3 subunit B,"C:multi-eIF complex; C:cytoplasmic stress granule; P:RNA phosphodiester bond hydrolysis; F:ribonuclease activity; F:protein kinase activity; P:mRNA processing; C:eukaryotic 48S preinitiation complex; P:regulation of translational initiation; P:protein phosphorylation; F:translation initiation factor activity; F:ATP binding; P:formation of translation preinitiation complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:eukaryotic 43S preinitiation complex; C:eukaryotic translation initiation factor 3 complex, eIF3e; P:proteolysis; C:cytosol; F:translation initiation factor binding",IPR000504 (SMART); IPR000504 (PFAM); IPR013979 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR011400 (PIRSF); IPR015943 (G3DSA:2.130.10.GENE3D); IPR011400 (PANTHER); PTHR14068:SF0 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); SSF82171 (SUPERFAMILY),,
RL4_JR_00045,11768,16783,15345,2,13,27,0,0,1,0,6,4,5,41,5,0,10,1,403.9521288,1,0.451451134,0.458701765,0.984193148,0.325020554,0.514258666,65.49716617,1,-1.428084065,1.11864154,-1.276623488,0.201735205,0.346095551,218.8568082,1,-0.867252126,0.525078988,-1.651660315,0.098603817,0.192047911,427.4417979,1,0.746310728,0.491152171,1.519510188,0.128634126,0.236803731,189.7600078,1,-1.10642003,0.577221629,-1.916802791,0.05526299,0.120928847,N,-,,fatty acid desaturase,"F:oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water; P:lipid metabolic process; C:integral component of membrane; P:oxidation-reduction process",IPR005804 (PFAM); IPR021863 (PFAM); PTHR32100:SF0 (PANTHER); PTHR32100 (PANTHER),,
RL4_JR_00046,637,460,718,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,15.23243869,1,-0.003946216,1.155376254,-0.003415524,0.997274811,0.999337107,2.305269376,0,2.260529258,1.30976324,1.725906781,0.084364185,0.17723833,5.986920542,0,-0.393036245,1.210049128,-0.324810155,0.745324758,0.829558911,6.906626507,0,-0.815372665,1.209841304,-0.673950098,0.50034304,0.638192653,5.914931534,0,-0.478203821,1.215091808,-0.393553654,0.693910604,0.783172987,N,-,,HET-domain-containing partial,P:biological_process; C:cellular_component; F:molecular_function,IPR010730 (PFAM); PTHR33112 (PANTHER); PTHR33112:SF6 (PANTHER),,
RL4_JR_00047,7405,5913,5548,9,5,5,0,0,2,3,0,1,4,6,3,1,15,1,225.2264075,1,0.788569363,0.493475751,1.597990097,0.110045181,0.237185888,43.04653115,1,0.497366384,1.006967079,0.493925168,0.621359029,0.750703759,102.3822125,1,-0.944478907,0.753156012,-1.254028238,0.209831742,0.337356925,162.5008172,1,0.24233169,0.457888755,0.529237042,0.596641023,0.719593849,142.7383029,1,0.749927238,0.485318468,1.54522708,0.122291346,0.222218213,N,-,,tbc1 domain family member 14,C:Golgi apparatus,IPR000195 (SMART); G3DSA:1.10.8.270 (GENE3D); IPR000195 (PFAM); PTHR22957:SF286 (PANTHER); PTHR22957:SF286 (PANTHER); PTHR22957 (PANTHER); PTHR22957 (PANTHER); IPR000195 (PROSITE_PROFILES); IPR000195 (SUPERFAMILY); IPR000195 (SUPERFAMILY),8.A.87.1.2, the tbc1 domain (tbc1) family.
RL4_JR_00048,3925,5539,9727,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,86.59785821,1,-3.401498313,1.221592391,-2.784478961,0.00536138,0.023007963,24.01875233,0,-1.120611504,1.246999814,-0.898646087,0.368841202,0.533192038,63.04519846,0,-3.789345935,1.240029864,-3.055850543,0.002244231,0.01081933,72.78098582,0,-4.212685206,1.248708436,-3.373633977,0.000741829,0.005751166,62.9283101,0,-3.889414625,1.255923896,-3.096855341,0.001955853,0.008320593,N,-,,methyltransferase BUD23,"P:ribosomal small subunit export from nucleus; C:cytoplasm; P:cellular bud site selection; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA (guanine-N7)-methylation; C:nucleolus; F:rRNA (guanine) methyltransferase activity",IPR013216 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR022238 (PFAM); PTHR12734:SF0 (PANTHER); PTHR12734:SF0 (PANTHER); PTHR12734 (PANTHER); PTHR12734 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_00049,4856,5174,8375,0,5,4,4,0,0,0,3,1,1,2,0,0,4,0,128.7020726,1,-0.389748735,0.603945313,-0.645337792,0.518708307,0.703044088,112.4423969,1,1.608313162,0.774592239,2.076335239,0.037862956,0.094986169,90.62572174,1,-0.912669115,0.777209529,-1.174289661,0.240279023,0.373324866,87.27055732,1,-1.849336775,0.890699708,-2.076274146,0.037868603,0.103618225,75.64909771,1,-1.255805975,0.81922977,-1.532910571,0.125297891,0.226139241,N,-,,transmembrane adaptor Erv26,P:fungal-type cell wall organization; P:protein retention in Golgi apparatus; C:nuclear membrane; P:ER to Golgi vesicle-mediated transport; C:integral component of Golgi membrane; C:integral component of endoplasmic reticulum membrane; P:protein glycosylation; C:ER to Golgi transport vesicle; F:COPII adaptor activity,IPR007277 (PFAM); IPR007277 (PANTHER); PTHR13144:SF0 (PANTHER),,
RL4_JR_00050,327,251,424,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,28.01588339,1,2.246638019,0.873421228,2.572227407,0.010104649,0.038146104,1.268002012,0,3.122858745,1.382054094,2.259577797,0.023847467,0.066187019,3.300420372,0,0.465993345,1.223008841,0.381022057,0.703186882,0.798280331,3.807947364,0,0.043500358,1.227765299,0.035430516,0.971736452,0.984375345,3.268388173,0,0.377603115,1.227616722,0.307590397,0.758394028,0.831572399,N,-,,het-s domain containing,F:ATP binding; C:membrane; C:integral component of membrane; F:protein kinase activity; P:phosphorylation; F:protein serine/threonine kinase activity; P:protein phosphorylation; F:kinase activity,G3DSA:1.10.510.10 (GENE3D); PTHR37542 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.C.104.2.4, the heterokaryon incompatibility prion/amyloid protein (het-s) family
RL4_JR_00051,319,177,456,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13.83035935,1,0.942180323,1.21125712,0.77785328,0.436655514,0.62673552,45.81929674,1,4.91852799,1.034922662,4.752556078,2.01E-06,0.000166649,3.119789169,0,0.547201654,1.266504859,0.432056498,0.665700351,0.76988238,3.599879727,0,0.124587673,1.281365068,0.097230427,0.922543405,0.954067965,3.101222685,0,0.45332212,1.275232133,0.35548204,0.722228497,0.804639473,N,-,,hypothetical protein CMQ_223,,no IPS match,,
RL4_JR_00052,5,14,5,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,30.64665766,1,8.705241624,0.953653375,9.128307883,6.96E-20,9.01E-18,0.03127473,0,8.465103727,2.730142358,3.100608912,0.001931232,0.015023052,0.080844295,0,5.820637764,1.63029614,3.570294759,0.00035658,0.002644698,0.093267196,0,5.396073946,2.49995412,2.15846919,0.030891371,0.094084527,0.079034042,0,5.751246264,1.38336723,4.157425547,3.22E-05,0.000267113,Y,-,,gpi anchored,"P:cellular aromatic compound metabolic process; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:ferric iron binding; P:oxidation-reduction process",IPR015889 (G3DSA:2.60.130.GENE3D); IPR000627 (PFAM); PTHR34315:SF2 (PANTHER); PTHR34315 (PANTHER); IPR015889 (SUPERFAMILY),,
RL4_JR_00053,186,92,203,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,1.903830155,0,0.968480701,1.376817256,0.703419932,0.481794088,NA,0.608653104,0,4.181715605,1.563963024,2.673794419,0.007499841,0.027306976,1.580954134,0,1.527734331,1.272478852,1.20059703,0.229907554,0.361067321,1.823719827,0,1.105588841,1.303588252,0.848112001,0.396375598,0.54047871,20.86658417,1,4.291789765,0.801597858,5.354043453,8.60E-08,2.01E-06,N,-,,major facilitator superfamily transporter,P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane; P:anion transport,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF203 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_00054,3585,4120,6108,2,3,1,0,0,0,0,0,0,0,2,0,0,0,0,103.1321046,1,-0.505857742,0.675176654,-0.749222798,0.45372293,0.642728193,17.43869592,0,-0.658753961,1.218101024,-0.540804045,0.588642654,0.726083469,45.53609303,0,-3.319984371,1.208361174,-2.747509968,0.006004968,0.021766667,60.57473785,1,-2.029022574,1.044319984,-1.942912714,0.052026705,0.125807414,45.20461031,0,-3.412172269,1.218793085,-2.799632122,0.005116088,0.018245997,N,-, Effector probability:0.865,phosphoribosylglycinamide formyltransferase,C:nucleus; F:phosphoribosylglycinamide formyltransferase activity; P:adenine biosynthetic process; C:cytoplasm; P:'de novo' IMP biosynthetic process,IPR002376 (PFAM); IPR004607 (TIGRFAM); IPR002376 (G3DSA:3.40.50.GENE3D); PTHR10520 (PANTHER); IPR004607 (HAMAP); IPR002376 (SUPERFAMILY),,
RL4_JR_00055,4465,2444,3396,0,5,28,0,0,0,0,0,1,1,0,3,0,1,6,187.9385745,1,1.973641604,0.752647942,2.622264,0.008734774,0.033932517,13.20232678,0,-0.257194305,1.245074283,-0.206569446,0.836346124,0.901927921,40.57854172,1,-1.940081,1.213536723,-1.598699869,0.109887307,0.207982631,77.51760126,1,-0.519210187,0.786090137,-0.660497012,0.508934935,0.644211184,81.52169218,1,0.519564216,0.652914044,0.795762047,0.426170355,0.560823349,N,-,,cytochrome c peroxidase,F:peroxidase activity; P:response to oxidative stress; F:metal ion binding; P:cellular oxidant detoxification; P:oxidation-reduction process; F:heme binding,IPR002207 (PRINTS); IPR002016 (PRINTS); G3DSA:1.10.420.10 (GENE3D); IPR002016 (PFAM); G3DSA:1.10.520.10 (GENE3D); PTHR31356:SF3 (PANTHER); PTHR31356 (PANTHER); IPR002016 (PROSITE_PROFILES); IPR010255 (SUPERFAMILY),9.A.61.3.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_00056,153,86,104,0,0,0,0,0,0,5,0,0,0,0,0,0,6,0,1.365393742,0,1.448187388,1.407536562,1.028880831,0.303535677,NA,0.440977953,0,4.646822469,1.623595555,2.862056658,0.004209017,0.018435165,56.48626942,1,5.494422474,1.548475992,3.548277469,0.00038776,0.002821807,1.310261888,0,1.582895341,1.301245102,1.216446723,0.223814794,0.359193871,24.27687649,1,5.066464547,0.700095047,7.23682387,4.59E-13,5.23E-11,N,-,,---NA---,,no IPS match,,
RL4_JR_00057,42,46,54,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.568405791,0,2.712669164,1.857323502,1.460525946,0.144145582,NA,0.18076816,0,5.933235224,1.854628747,3.199149821,0.001378335,0.015023052,0.46996184,0,3.278124615,1.270108866,2.580979239,0.009852051,0.032310386,0.542232022,0,2.85573195,1.384834837,2.062146238,0.039193815,0.106077888,0.464243899,0,3.193768935,1.231923416,2.59250607,0.00952795,0.030182207,N,-,,predicted protein,F:arylformamidase activity; P:tryptophan catabolic process to kynurenine,G3DSA:3.50.30.50 (GENE3D); IPR007325 (PFAM); PTHR34861:SF3 (PANTHER); PTHR34861 (PANTHER); SSF102198 (SUPERFAMILY),,
RL4_JR_00058,200,282,276,0,0,30,0,0,0,0,0,9,0,1,0,0,0,0,117.6031089,1,5.332970919,1.252878497,4.256574706,2.08E-05,0.000216151,0.967171658,0,3.513663028,1.419269185,2.475684716,0.013298095,0.041828254,61.00365047,1,4.621869987,1.407718781,3.283233874,0.001026235,0.00587315,6.913588671,1,1.381741491,1.164780534,1.186267671,0.23551661,0.372894444,2.48298299,0,0.774404137,1.221876419,0.633782701,0.526222644,0.650153053,N,-,,Anhydro-N-acetylmuramic acid kinase,"F:ATP binding; P:carbohydrate metabolic process; F:sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity; P:pentose-phosphate shunt; P:peptidoglycan turnover; P:amino sugar metabolic process; P:phosphorylation; F:phosphotransferase activity, alcohol group as acceptor; F:kinase activity",G3DSA:3.30.420.40 (GENE3D); IPR005338 (PFAM); PTHR30605:SF0 (PANTHER); PTHR30605:SF0 (PANTHER); PTHR30605 (PANTHER); PTHR30605 (PANTHER); SSF53067 (SUPERFAMILY),,
RL4_JR_00059,660,522,1233,0,0,6,0,0,3,0,0,1,0,0,0,0,0,0,32.48429912,1,1.808354612,0.793271479,2.279616324,0.022630454,0.072684741,31.15591629,1,4.009719606,0.936350775,4.282283639,1.85E-05,0.00110794,14.40964395,1,0.166738084,1.239471188,0.134523566,0.892988578,0.933245423,9.130681227,0,-1.218062436,1.25236746,-0.972607861,0.330748234,0.477312696,7.889422006,0,-0.893698361,1.264042712,-0.707015952,0.479556565,0.608841407,N,-,,Transaldolase,"F:ATP binding; P:carbohydrate metabolic process; F:sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity; P:pentose-phosphate shunt; P:peptidoglycan turnover; P:amino sugar metabolic process; F:phosphotransferase activity, alcohol group as acceptor; C:intracellular part",IPR001585 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR10683:SF18 (PANTHER); IPR001585 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_00060,313,242,261,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,18.53446886,1,2.903314785,0.749904139,3.871581225,0.000108132,0.000913186,1.046974516,0,3.399346193,1.405573829,2.41847573,0.015585685,0.047546204,2.705759622,0,0.752981108,1.213422115,0.620543419,0.534900077,0.663897013,3.120593453,0,0.331004049,1.217027514,0.271977457,0.785639353,0.861446659,2.657662795,0,0.675833051,1.20492449,0.560892451,0.574870856,0.689663477,N,-,,sugar transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,IPR003663 (PRINTS); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); IPR003663 (TIGRFAM); PTHR23500 (PANTHER); PTHR23500:SF161 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.57, the major facilitator superfamily (mfs).
RL4_JR_00061,3434,3596,6445,0,0,8,0,0,0,1,3,0,0,2,0,0,1,0,84.19927578,1,-0.309247499,0.754817387,-0.40969843,0.682027182,0.82588359,16.92822865,0,-0.615898346,1.232194068,-0.499838753,0.617188621,0.748255267,78.89179893,1,-0.444728756,0.78878404,-0.563815612,0.572879626,0.696189513,59.1448417,1,-1.996597741,1.061888357,-1.880233197,0.060076303,0.136875015,47.94611882,1,-2.449013122,1.16526951,-2.101670988,0.035582107,0.085880532,N,-,,methyltransferase type 11,C:integral component of membrane; F:methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR013216 (PFAM); PTHR10108:SF792 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_00062,27,23,40,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.358079677,0,3.379193547,2.319759375,1.456700028,0.145199202,NA,0.113572109,0,6.603550007,2.048895798,3.222979916,0.001268644,0.015023052,0.296195221,0,3.943162922,1.325556659,2.974722277,0.002932539,0.013415737,0.341786948,0,3.521211095,1.558644423,2.259149709,0.023874074,0.0833822,0.29388824,0,3.853024654,1.264126831,3.047973162,0.002303905,0.009568948,N,-,,hypothetical protein SPBR_03034,P:RNA phosphodiester bond hydrolysis; F:RNA binding; F:ribonuclease activity,no IPS match,,
RL4_JR_00063,662,788,813,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.077792724,0,-1.284532662,1.198320967,-1.071943742,0.283745301,0.466974817,2.889085358,0,1.934903314,1.276355314,1.515959774,0.129529524,0.246741118,7.50385652,0,-0.718619325,1.198006474,-0.599845945,0.54860891,0.676012245,8.657484848,0,-1.141093413,1.196263502,-0.953881324,0.340143718,0.487329156,7.402104669,0,-0.801619307,1.201275401,-0.667306852,0.50457615,0.631968521,N,-,,hypothetical protein SPBR_09104,"F:DNA binding; P:biological_process; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:catalytic activity; P:metabolic process; P:regulation of transcription, DNA-templated; C:cellular_component; F:molecular_function; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR022085 (PFAM),,
RL4_JR_00064,12,4,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.087094262,0,5.418622327,3.918997902,1.382655072,0.166770654,NA,0.028390249,0,8.604360711,2.757128296,3.120769072,0.001803794,0.015023052,0.072807439,0,5.968368443,1.616059233,3.693161934,0.000221483,0.001876396,0.083919162,0,5.547486293,2.55659147,2.169875929,0.030016246,0.092263052,0.071080772,0,5.895565545,1.355096663,4.350660514,1.36E-05,0.000130014,N,-,,hypothetical protein OIDMADRAFT_205291,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00065,10,6,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.103273328,0,5.172901819,3.917084657,1.320599954,0.186634788,NA,0.033068488,0,8.383719556,2.614205396,3.206985789,0.001341336,0.015023052,0.08573679,0,5.731644026,1.498105229,3.825928857,0.00013028,0.001356816,0.098894896,0,5.31044324,2.331938373,2.277265686,0.022770365,0.081236766,0.084592808,0,5.647684298,1.299318399,4.346651524,1.38E-05,0.000132037,N,-, Effector probability:0.587,hypothetical protein TGAM01_07443,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00066,5,1,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.047045835,0,6.3065725,3.92937252,1.604982085,0.108497747,NA,0.015021455,0,9.52117425,3.187070481,2.987437619,0.002813267,0.015349618,0.039135215,0,6.860806128,1.884520736,3.64061058,0.000271992,0.002152971,0.045148079,0,6.441071201,3.324035121,1.937726578,0.05265659,0.126338381,0.038907381,0,6.766098536,1.432899259,4.721963874,2.34E-06,2.96E-05,N,-,,RNA interference and silencing,F:nucleic acid binding,IPR003165 (SMART); IPR014811 (SMART); IPR032474 (PFAM); IPR003165 (PFAM); IPR003100 (PFAM); IPR014811 (PFAM); IPR032472 (PFAM); G3DSA:3.40.50.2300 (GENE3D); G3DSA:2.170.260.10 (GENE3D); IPR012337 (G3DSA:3.30.420.GENE3D); PTHR22891:SF55 (PANTHER); PTHR22891:SF55 (PANTHER); PTHR22891 (PANTHER); PTHR22891:SF55 (PANTHER); PTHR22891 (PANTHER); PTHR22891 (PANTHER); IPR003100 (PROSITE_PROFILES); IPR003165 (PROSITE_PROFILES); IPR012337 (SUPERFAMILY); IPR003100 (SUPERFAMILY),,
RL4_JR_00067,5972,4939,5774,5,3,3,0,0,0,0,1,6,0,0,2,0,0,0,152.4618479,1,0.05175978,0.463713585,0.111620149,0.911124595,0.956734502,21.33420781,0,-0.949569973,1.201128064,-0.790565138,0.429197797,0.591725227,102.0901119,1,0.021159769,0.573093528,0.036922017,0.970547185,0.98297516,83.00534803,1,-2.279582272,1.011426613,-2.253828644,0.02420695,0.084138472,54.39537764,0,-3.679212386,1.188928235,-3.094562209,0.001971036,0.008378144,N,-,,dihydrodipicolinate synthase,P:metabolic process; F:lyase activity,IPR002220 (PRINTS); IPR002220 (SMART); IPR002220 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); IPR002220 (PANTHER); PTHR12128:SF26 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_00068,1404,986,1677,0,4,9,0,0,0,0,0,0,0,1,0,0,2,1,82.57452845,1,2.262491999,0.507193774,4.460803967,8.17E-06,9.72E-05,5.153918786,0,1.099792362,1.260487151,0.872513742,0.382928174,0.54738017,13.39903082,0,-1.555191788,1.209224411,-1.286106842,0.198405777,0.323612064,19.46980371,1,-1.031639968,1.161730194,-0.888020277,0.374529844,0.520180339,28.34129968,1,0.564568781,0.876023782,0.644467414,0.519272382,0.644167899,N,-,,chromatin organization chromo domain containing,C:nucleus,IPR000953 (SMART); G3DSA:2.40.50.40 (GENE3D); IPR023780 (PFAM); IPR000953 (PROSITE_PROFILES); IPR016197 (SUPERFAMILY),,
RL4_JR_00069,4505,4467,6420,2,4,0,0,0,0,1,1,4,4,4,0,0,3,2,113.5974851,1,-0.6384151,0.664184798,-0.961201012,0.336451108,0.526612198,19.49656987,0,-0.819677124,1.205463647,-0.679968347,0.496524503,0.65168841,95.69573592,1,-0.075908809,0.630747533,-0.120347374,0.904207978,0.941112528,111.8986114,1,-0.164737858,0.563983671,-0.292096857,0.77021257,0.850611068,76.61441766,1,-0.626791542,0.702931958,-0.89168167,0.372563581,0.508795017,N,-,,presequence translocase-associated motor subunit,P:protein import into mitochondrial matrix; C:integral component of membrane; C:presequence translocase-associated import motor,IPR013875 (PFAM); PTHR28021 (PANTHER); PTHR28021:SF1 (PANTHER),,
RL4_JR_00070,1402,1482,2004,0,0,3,0,0,0,0,3,0,0,4,0,0,0,0,30.98444497,1,-0.098621244,0.872668028,-0.113011181,0.910021691,0.956202596,6.19761648,0,0.833743983,1.235246825,0.674961446,0.49970026,0.653811326,39.67071787,1,0.585481717,0.860751142,0.680198595,0.496378722,0.62934649,34.67216716,1,0.457477027,0.76376437,0.598976654,0.549188453,0.678750073,15.98095572,0,-1.912040529,1.208395455,-1.582297021,0.11358178,0.21020207,N,-,,molybdenum cofactor biosynthetic,F:nucleotide binding; P:mycelium development; C:cytoplasm; P:growth of unicellular organism as a thread of attached cells; F:adenylyltransferase activity; P:cellular protein modification process; F:small protein activating enzyme activity; F:sulfurtransferase activity; P:tRNA wobble uridine modification; P:single-organism cellular process; P:tRNA thio-modification,IPR001763 (SMART); IPR001763 (G3DSA:3.40.250.GENE3D); IPR000594 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR001763 (PFAM); PTHR10953 (PANTHER); IPR028885 (HAMAP); IPR001763 (PROSITE_PROFILES); IPR000594 (SUPERFAMILY),3.A.25.2.1, the symbiont-specific erad-like machinery (selma) family.
RL4_JR_00071,2417,2283,4152,0,9,0,0,0,0,0,0,0,0,3,0,0,0,0,107.3114659,1,0.984813609,1.209839362,0.81400361,0.415642883,0.606911516,11.13390655,0,-0.011440314,1.239130343,-0.009232535,0.992633608,0.996447484,29.10030586,0,-2.674036728,1.216723248,-2.197736201,0.02796791,0.072527439,45.61894819,1,-0.822109597,0.907837068,-0.905569542,0.365163736,0.511380751,28.93655485,0,-2.768599793,1.229981839,-2.250927375,0.024390138,0.063910492,N,-,,hypothetical protein CMQ_213,F:DNA binding; F:recombinase activity; P:DNA recombination,PF15341 (PFAM),,
RL4_JR_00072,3580,2611,2067,0,6,5,0,0,0,0,2,2,0,1,3,0,1,3,100.2158658,1,1.048394152,0.568672362,1.843582036,0.065244076,0.162126461,10.69283551,0,0.046990281,1.25845216,0.037339744,0.970214117,0.984659342,56.1770805,1,0.221281543,0.783985623,0.282252042,0.777750256,0.852525317,64.61675788,1,-0.244616379,0.789375502,-0.309885952,0.756647686,0.840950365,52.8089395,1,-0.013848874,0.779031143,-0.017777048,0.985816715,0.990315928,N,-,,ulp1 protease family,P:proteolysis; F:cysteine-type peptidase activity,G3DSA:3.30.310.130 (GENE3D); IPR003653 (PFAM); PTHR12606 (PANTHER); IPR003653 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY),,
RL4_JR_00073,735,992,952,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,10.7662892,0,-1.530637549,1.206669784,-1.268480879,0.204626275,0.369615521,3.422202143,0,1.690596047,1.273407605,1.327615793,0.184305065,0.323821535,8.8921232,0,-0.963488491,1.203762771,-0.800397315,0.423480636,0.564566494,19.89495567,1,-0.435391661,1.15241419,-0.377808313,0.705572998,0.802352684,8.771841905,0,-1.046567624,1.207807676,-0.866501882,0.386214995,0.52250492,N,-,,methyltransferase- family,F:methyltransferase activity; P:methylation,PF13649 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_00074,1228,1304,916,0,3,2,0,0,0,0,0,1,2,0,2,0,1,3,45.54121621,1,1.162682502,0.700638061,1.659462378,0.097022656,0.216555629,4.456686037,0,1.309623723,1.279559747,1.023495563,0.306073597,0.467634256,17.9958692,1,-0.372277387,1.207289872,-0.308357914,0.757810002,0.837105124,51.15452882,1,1.024877794,0.765262839,1.339249395,0.180489497,0.306004045,37.21266412,1,1.235350153,0.762405521,1.620332118,0.105160953,0.198315263,N,-,,glutathione s-transferase,P:transmembrane transport; C:membrane; C:integral component of membrane; F:transferase activity; P:transport; F:transporter activity,no IPS match,,
RL4_JR_00075,176,154,136,0,0,10,0,0,0,0,0,0,4,7,1,0,2,0,40.05294271,1,4.942033628,0.571532448,8.646986965,5.29E-18,5.26E-16,0.600171561,0,4.202180989,1.517261506,2.769582548,0.005612818,0.022181435,1.549200296,0,1.557762387,1.2282367,1.268291679,0.204693808,0.330988677,76.75210976,1,5.445791608,0.473177768,11.50897607,1.19E-30,2.01E-28,9.239928502,1,3.149198207,0.984704866,3.198113785,0.001383297,0.006224836,N,-,,D-lactate dehydrogenase,"F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:NAD binding; P:oxidation-reduction process",IPR006139 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR006140 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10996:SF161 (PANTHER); PTHR10996 (PANTHER); SSF52283 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_00076,6435,4207,5261,0,0,9,0,0,0,0,0,0,0,1,0,0,1,1,97.73365139,1,-0.320664885,0.630920193,-0.508249519,0.611278367,0.776912733,20.37281819,0,-0.883046107,1.219154198,-0.724310434,0.468875172,0.627722748,52.64276372,0,-3.529186411,1.201888119,-2.936368499,0.003320796,0.014617277,64.72271812,1,-3.004782135,1.156517839,-2.598128654,0.009373337,0.046160036,62.95395623,1,-1.928823083,0.983858018,-1.960468937,0.049941005,0.112018759,N,-,,DUF221 domain,"F:calcium activated cation channel activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:NAD binding; C:fungal-type vacuole membrane; P:cation transmembrane transport; C:integral component of membrane; P:oxidation-reduction process",IPR032880 (PFAM); IPR003864 (PFAM); IPR027815 (PFAM); PTHR13018 (PANTHER); PTHR13018:SF52 (PANTHER); PTHR13018 (PANTHER),1.A.17.5.11, the calcium-dependent chloride channel (ca-clc) family.
RL4_JR_00077,378,207,185,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.071019759,0,0.278866589,1.312980681,0.212391997,0.831801229,0.916417221,0.998167232,0,3.468287471,1.49512612,2.319729035,0.02035554,0.058318363,2.560388921,0,0.832723725,1.266343519,0.657581227,0.510807261,0.642331724,2.951454855,0,0.411453045,1.283320048,0.320616081,0.748501349,0.83446115,2.496404744,0,0.766087346,1.254731481,0.610558799,0.541491706,0.663673105,N,-,,DNA mismatch repair,F:ATP binding; C:integral component of membrane; P:mismatch repair; F:mismatched DNA binding,PTHR11361 (PANTHER); PTHR11361:SF21 (PANTHER),,
RL4_JR_00078,572,322,260,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,4.606866352,0,-0.306168522,1.288834982,-0.237554479,0.812226661,0.904593187,1.498911235,0,2.881715004,1.444625854,1.994782937,0.046066559,0.110457176,3.841437386,0,0.247434933,1.263340555,0.195857667,0.844721573,0.900472602,8.439551774,1,0.769166287,1.210894914,0.635204821,0.52529484,0.659386344,3.741254377,0,0.182508831,1.255978551,0.14531206,0.884464493,0.923883524,N,-,,DNA mismatch repair MSH4,F:ATP binding; P:mismatch repair; F:mismatched DNA binding,IPR000432 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000432 (PFAM); PTHR11361 (PANTHER); IPR027417 (SUPERFAMILY); IPR007696 (SUPERFAMILY),,
RL4_JR_00079,8,3,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.063354708,0,5.877664906,3.923570906,1.498039681,0.134122941,NA,0.020540813,0,9.071092856,2.904921297,3.122663897,0.001792223,0.015023052,0.052860606,0,6.429788012,1.668644145,3.853300915,0.000116536,0.001275471,0.060941837,0,6.008952288,2.846103937,2.111290529,0.034747348,0.099426657,0.051790991,0,6.352000109,1.352356758,4.696985521,2.64E-06,3.29E-05,N,-, Effector probability:0.753,dna mismatch repair,F:ATP binding; C:integral component of membrane; P:mismatch repair; F:mismatched DNA binding,G3DSA:1.10.1420.10 (GENE3D); IPR007696 (PFAM); PTHR11361:SF21 (PANTHER); PTHR11361 (PANTHER); IPR007696 (SUPERFAMILY),,
RL4_JR_00080,9,7,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.188963927,0,4.301193374,3.226508659,1.333079755,0.182505632,NA,0.058753592,0,7.553531608,2.474029335,3.053129363,0.002264683,0.015081,0.155632047,0,4.870349115,1.581903295,3.078790676,0.002078427,0.010155401,0.179739929,0,4.447953516,2.109681692,2.108352901,0.035000475,0.099498352,0.157159776,0,4.756406807,1.448325282,3.284073589,0.001023182,0.004875161,,,,,,,,
RL4_JR_00081,2363,2471,2623,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,29.87306775,0,-3.003046991,1.185267616,-2.533644681,0.011288313,0.041764198,9.52891607,0,0.213214387,1.212448579,0.175854375,0.86040835,0.918192232,48.24911143,1,-0.02963707,0.845596653,-0.035048707,0.972040902,0.983799069,28.51804873,0,-2.860974273,1.185527044,-2.413250957,0.015810929,0.067575203,24.36228481,0,-2.520334632,1.189863341,-2.118171512,0.034160545,0.083223176,N,-,,vacuolar calcium ion transporter,P:transmembrane transport; P:mycelium development; C:integral component of membrane,IPR004837 (PFAM); PTHR31503 (PANTHER); PTHR31503 (PANTHER); PTHR31503:SF18 (PANTHER),2.A.19.2.2, the ca(2+):cation antiporter (caca) family.
RL4_JR_00082,5795,13678,17599,0,0,0,0,0,0,0,0,0,2,1,0,0,0,0,148.8527775,0,-5.320069671,1.307037067,-4.070328077,4.69E-05,0.000443793,46.61177934,0,-2.077119019,1.262730023,-1.644943085,0.099981549,0.202483641,122.3386674,0,-4.745751055,1.262107608,-3.76017942,0.000169792,0.001597555,163.8779536,1,-2.814862008,0.963449934,-2.921648452,0.003481843,0.020971838,121.9323045,0,-4.843714613,1.284976236,-3.769497425,0.000163577,0.001052901,N,-,,wd repeat-containing,C:nucleolus; P:ribosomal large subunit assembly,IPR001632 (PRINTS); IPR020472 (PRINTS); IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR19848 (PANTHER); PTHR19848:SF0 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR011047 (SUPERFAMILY),8.A.92.1.4,The G-Protein αβγ Complex (GPC) Family
RL4_JR_00083,24158,9899,11338,10,20,2,0,0,3,10,5,4,0,2,7,0,9,9,448.7734428,1,0.536696705,0.902233638,0.594853353,0.551941501,0.731439045,86.89919108,1,-0.289549983,0.969957827,-0.298518116,0.765307751,0.857951607,326.507203,1,0.128529199,0.583675589,0.22020657,0.82571028,0.887599103,249.0506227,1,-1.366268412,0.790326534,-1.728739141,0.083855793,0.171592543,247.8596923,1,-0.358888782,0.615151876,-0.583414919,0.559614017,0.678086635,N,-,,glycosyltransferase family 20,P:trehalose biosynthetic process; F:transferase activity,IPR003337 (TIGRFAM); IPR006379 (TIGRFAM); IPR003337 (PFAM); IPR023214 (G3DSA:3.40.50.GENE3D); G3DSA:3.40.50.2000 (GENE3D); IPR001830 (PFAM); G3DSA:3.40.50.2000 (GENE3D); PTHR10788:SF15 (PANTHER); PTHR10788 (PANTHER); SSF53756 (SUPERFAMILY); IPR023214 (SUPERFAMILY),,
RL4_JR_00084,8597,8356,11059,1,5,15,8,0,1,1,0,3,2,1,0,0,12,0,219.2751666,1,0.156011321,0.408148058,0.382241979,0.702281887,0.839159299,223.4617804,1,2.288431213,0.672269566,3.404038097,0.000663975,0.015023052,123.122346,1,-1.522788056,0.746412508,-2.040142736,0.041336111,0.098144182,129.4251291,1,-2.443113614,0.854065108,-2.86057069,0.004228793,0.024593065,137.8321588,1,-0.41718073,0.637069157,-0.654843709,0.512568386,0.638597884,N,-,,branched-chain-amino-acid aminotransferase 1,F:branched-chain-amino-acid transaminase activity; P:branched-chain amino acid metabolic process,G3DSA:3.30.470.10 (GENE3D); G3DSA:3.20.10.10 (GENE3D); IPR001544 (PFAM); IPR005786 (PIRSF); PTHR11825:SF2 (PANTHER); IPR001544 (PANTHER); IPR001544 (PANTHER); PTHR11825:SF2 (PANTHER); IPR001544 (SUPERFAMILY),,
RL4_JR_00085,3594,4824,5245,0,0,9,0,0,0,3,0,2,0,2,0,0,0,0,89.18784971,1,-0.136825163,0.664209383,-0.205997034,0.836793228,0.918937779,17.38672747,0,-0.654415689,1.210903253,-0.540435983,0.588896398,0.726219462,91.46691875,1,-0.155545496,0.685089166,-0.227044162,0.820389402,0.884215978,60.24832319,1,-2.01452929,1.031552969,-1.952909206,0.050830355,0.124389486,44.74456042,0,-3.397404695,1.206343815,-2.816282267,0.004858296,0.017499199,N,-,,acetylornithine deacetylase,P:metabolic process; F:hydrolase activity,IPR011650 (G3DSA:3.30.70.GENE3D); IPR011650 (PFAM); IPR023210 (PFAM); G3DSA:3.40.630.10 (GENE3D); IPR023210 (G3DSA:3.20.20.GENE3D); IPR002933 (PFAM); PTHR11014 (PANTHER); PTHR11014:SF79 (PANTHER); IPR023210 (SUPERFAMILY); SSF53187 (SUPERFAMILY); IPR011650 (SUPERFAMILY),8.A.5.1.6, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_00086,1307,1148,1048,0,0,0,5,0,0,0,0,0,0,1,0,0,0,0,14.03374358,0,-1.913100559,1.193025773,-1.603570185,0.108808827,0.235391783,116.0667005,1,4.603470702,1.401577044,3.284493509,0.001021659,0.015023052,11.64033897,0,-1.351988674,1.198161565,-1.128385948,0.25915696,0.395732286,17.43641429,1,-0.827068178,1.148334471,-0.720232823,0.471381658,0.61238766,11.41904214,0,-1.427206793,1.19413648,-1.195178958,0.232017118,0.359605855,N,-,,CAMK CAMKL kinase,F:nucleotide binding; F:protein kinase activity; P:phosphorylation,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24343:SF196 (PANTHER); PTHR24343 (PANTHER); PTHR24343 (PANTHER); PTHR24343:SF196 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.3, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_00087,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_00088,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.012021509,0,8.275938237,3.994557068,2.071803731,0.038283749,NA,0.003842866,0,11.4894157,3.940199092,2.915948011,0.003546096,0.016928889,0.009954621,0,8.839817482,2.38250595,3.710302374,0.000207012,0.001791132,0.011482935,0,8.417149062,3.994556965,2.107154594,0.035104181,0.099498352,0.009795195,0,8.760474239,1.567861258,5.587531547,2.30E-08,8.07E-07,N,-, Effector probability:0.964,mfs multidrug transporter,,no IPS match,,
RL4_JR_00089,4,3,3,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0.039970542,0,6.542410055,3.93337371,1.663307516,0.096250895,NA,0.012864123,0,9.746451341,3.124569951,3.119293693,0.001812852,0.015023052,0.0331946,0,7.102326488,1.761343441,4.032334821,5.52E-05,0.000782296,18.66281302,1,8.436296797,1.127765805,7.480539632,7.40E-14,4.07E-12,0.032550447,0,7.025142538,1.365856389,5.143397649,2.70E-07,4.90E-06,Y,-,,ferric-chelate reductase,F:catalytic activity; P:metabolic process,G3DSA:3.40.50.80 (GENE3D); IPR013121 (PFAM); IPR013112 (PFAM); IPR013130 (PFAM); PTHR32361 (PANTHER); PTHR32361:SF9 (PANTHER); SSF52343 (SUPERFAMILY),5.B.1.5.3, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_00090,22550,23158,29861,5,19,55,0,0,0,0,3,2,0,47,3,0,27,5,714.5669264,1,0.516309591,0.456538531,1.130922267,0.25808781,0.437093701,96.00551075,0,-3.11954135,1.189735809,-2.622045438,0.008740378,0.030448151,286.289136,1,-2.634605297,0.678033307,-3.885657637,0.000102053,0.001175928,505.6284288,1,-0.32360926,0.922103076,-0.350946947,0.72562815,0.817330628,388.0313186,1,-0.539397581,0.612697168,-0.880365716,0.378661223,0.514416327,N,-,,isocitrate dehydrogenase subunit 1,F:magnesium ion binding; F:isocitrate dehydrogenase (NAD+) activity; F:NAD binding; C:mitochondrion; P:tricarboxylic acid cycle,IPR024084 (SMART); IPR024084 (PFAM); IPR024084 (G3DSA:3.40.718.GENE3D); IPR004434 (TIGRFAM); PTHR11835:SF42 (PANTHER); IPR001804 (PANTHER); SSF53659 (SUPERFAMILY),,
RL4_JR_00091,831,949,984,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14.90185825,1,-0.625077122,1.145235003,-0.545806861,0.585198706,0.758426055,3.530144039,0,1.64579373,1.260085053,1.306097336,0.191519459,0.333257687,9.164911655,0,-1.007109807,1.194496486,-0.843124964,0.399158558,0.541337072,10.57356767,0,-1.429537984,1.192380492,-1.19889414,0.230569111,0.367292676,9.037355428,0,-1.089603816,1.197518866,-0.909884468,0.362883442,0.499771099,N,-,,alanine racemase domain-containing,C:membrane,IPR026956 (SMART); IPR001608 (PFAM); IPR029066 (G3DSA:3.20.20.GENE3D); IPR026956 (PFAM); PTHR28004 (PANTHER); PTHR28004:SF2 (PANTHER); IPR029066 (SUPERFAMILY),,
RL4_JR_00092,1861,2221,2520,0,0,3,0,0,0,1,1,0,0,3,0,0,0,0,37.90940425,1,-0.533679534,0.867548946,-0.615157838,0.538450489,0.721175355,8.403240611,0,0.39454611,1.22166564,0.322957524,0.74672741,0.844699916,40.77138315,1,-0.433197987,1.03439952,-0.418791751,0.675368334,0.777157196,37.25572587,1,-0.38459343,0.863181023,-0.44555362,0.655919719,0.765378259,21.59965129,0,-2.346685014,1.201966646,-1.95237116,0.050894155,0.113728385,N,-,,ste ste20 ysk kinase,F:nucleotide binding; P:phosphorylation; F:kinase activity,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24361 (PANTHER); PTHR24361:SF426 (PANTHER); PTHR24361:SF426 (PANTHER); PTHR24361 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_00093,3365,2905,3431,1,1,10,0,0,0,1,0,0,0,3,0,0,0,0,95.02118734,1,0.912854618,0.445635469,2.048433489,0.040517543,0.113627403,12.39186717,0,-0.165799678,1.208198645,-0.137228823,0.890849929,0.938703205,43.1885218,1,-1.854583066,1.187363904,-1.561933169,0.118303734,0.219641848,49.08445701,1,-0.931216917,0.84834427,-1.097687519,0.272340962,0.414342936,31.64170591,0,-2.897554989,1.189412121,-2.436123644,0.014845609,0.043230311,N,-,,UBX domain (Ubx5),P:proteasome-mediated ubiquitin-dependent protein catabolic process; F:ubiquitin binding,IPR006577 (SMART); IPR012336 (G3DSA:3.40.30.GENE3D); IPR001012 (PFAM); PF14555 (PFAM); G3DSA:1.10.8.10 (GENE3D); G3DSA:3.10.20.90 (GENE3D); PF13899 (PFAM); PTHR23322:SF6 (PANTHER); PTHR23322 (PANTHER); IPR001012 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR029071 (SUPERFAMILY),,
RL4_JR_00094,58,15,47,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4.290996873,1,3.914990649,1.323215754,2.958694102,0.003089456,0.014764958,0.152424067,0,6.179245805,2.063165991,2.995030857,0.002744171,0.015349618,0.394029941,0,3.531853242,1.421063588,2.485359046,0.012942083,0.03960872,0.454368407,0,3.11048233,1.635840715,1.901457949,0.057242055,0.133205197,0.388314518,0,3.450007252,1.358380403,2.539794629,0.011091758,0.034155732,N,-,,---NA---,,no IPS match,,
RL4_JR_00095,29144,11266,25053,8,8,9,0,0,0,1,0,5,0,0,3,0,0,4,437.7312497,1,-0.614869221,0.546470563,-1.125164396,0.260519377,0.440115361,83.2637706,0,-2.914102672,1.247147708,-2.336613902,0.019459269,0.056244066,258.9851984,1,-2.187158025,0.741176832,-2.950926054,0.003168228,0.014086577,277.34026,1,-3.5569636,0.948574285,-3.749799731,0.000176976,0.001731286,241.7627923,1,-2.905132964,0.898128593,-3.234651459,0.001217913,0.005620497,N,-,,proteasome component,C:membrane; C:intracellular part,IPR011989 (G3DSA:1.25.10.GENE3D); IPR024372 (PFAM); IPR024372 (PTHR23346:PANTHER); IPR026827 (PANTHER); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_00096,7383,2908,4279,0,3,5,0,0,2,0,0,0,0,0,0,0,6,3,100.8806657,1,-0.269679354,0.694910983,-0.388077553,0.697958643,0.836852823,37.50901429,1,0.843079589,1.081621368,0.779459073,0.435709337,0.597339304,48.20125249,0,-3.402017824,1.24560578,-2.731215509,0.006310119,0.022658635,55.56680628,0,-3.823339212,1.253713962,-3.049610459,0.002291384,0.014766632,92.41819609,1,0.26415243,0.653741745,0.404062356,0.686166866,0.777553388,N,-,,c6 transcription,F:binding,IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00097,293,435,330,0,3,3,0,0,0,0,0,0,3,1,0,0,0,0,39.75333672,1,3.117505701,0.660020269,4.72334843,2.32E-06,3.19E-05,1.359436219,0,3.022570881,1.383195452,2.185208805,0.02887354,0.076926501,3.524284809,0,0.371903563,1.224779281,0.303649456,0.761394969,0.839530977,36.01427108,1,2.706132298,0.771168686,3.50913146,0.000449573,0.003841285,3.465991885,0,0.293141421,1.221874643,0.239911208,0.810399092,0.871697738,N,-,,diaminopropionate ammonia-lyase,P:metabolic process; F:hydrolase activity,IPR001926 (PFAM); IPR002933 (PFAM); G3DSA:3.40.630.10 (GENE3D); G3DSA:3.40.50.1100 (GENE3D); IPR011650 (G3DSA:3.30.70.GENE3D); IPR011650 (PFAM); PTHR11014:SF101 (PANTHER); PTHR11014 (PANTHER); SSF53187 (SUPERFAMILY); IPR011650 (SUPERFAMILY); IPR001926 (SUPERFAMILY),,
RL4_JR_00098,145,423,220,0,0,4,0,0,0,5,12,7,11,47,7,1,5,20,18.48579103,1,2.802317908,0.966851351,2.898395815,0.003750769,0.017138015,1.017295353,0,3.440851604,1.541410939,2.232274027,0.025596857,0.069741962,197.5976581,1,6.205362318,0.542957025,11.42882775,3.00E-30,9.75E-28,361.4741241,1,6.9294513,0.556023055,12.46252513,1.20E-35,2.57E-33,185.2328109,1,6.17281027,0.796062983,7.754173225,8.89E-15,1.25E-12,N,-,,Isoflavone reductase IRL,,IPR008030 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR14194 (PANTHER); PTHR14194:SF75 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_00099,330,348,373,1,0,1,0,0,0,1,2,1,1,4,1,0,0,3,18.09409541,1,1.559252986,1.007939535,1.546970757,0.121870297,0.255192181,1.342460601,0,3.040641711,1.352121901,2.248792589,0.024525695,0.067458991,36.73818813,1,3.213299844,0.738263162,4.352512772,1.35E-05,0.000243187,39.01269498,1,3.277389086,0.609769225,5.37480239,7.67E-08,1.78E-06,25.53048019,1,2.53666373,0.839702152,3.020908929,0.002520171,0.010280716,N,-,,transcriptional activator Mut3p,"F:DNA binding; C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_00100,7,10,18,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,15.41375305,1,7.388954734,0.88021248,8.39451258,4.68E-17,4.06E-15,0.043760489,0,7.978989689,2.503257316,3.187442872,0.001435368,0.015023052,0.114926229,0,5.308444619,1.493126703,3.555253956,0.000377614,0.002775444,0.132677827,0,4.886348579,2.15051342,2.272177674,0.023075781,0.082008524,0.114781743,0,5.211076566,1.331960204,3.912336531,9.14E-05,0.000644508,N,-,,flavin-containing monooxygenase,"F:NADP binding; F:flavin adenine dinucleotide binding; P:oxidation-reduction process; F:N,N-dimethylaniline monooxygenase activity",PR00411 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR020946 (PFAM); PTHR23023 (PANTHER); PTHR23023:SF123 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_00101,35,34,49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.470838128,0,2.984294828,2.036501564,1.46540267,0.14281109,NA,0.149502472,0,6.207100819,1.930393537,3.215458765,0.001302362,0.015023052,0.38936078,0,3.549044359,1.290399056,2.750346368,0.00595323,0.021648887,0.449269127,0,3.126861208,1.446094698,2.162279699,0.030596624,0.093564124,0.385559703,0,3.461514877,1.245063466,2.780191509,0.005432685,0.019172511,N,-,,glycerol proton symporter of the plasma subject to glucose-induced inactivation,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR003663 (PRINTS); IPR003663 (TIGRFAM); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF107 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.38, the major facilitator superfamily (mfs).
RL4_JR_00102,175,211,183,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,6.10583431,1,1.651127672,1.161927587,1.421024589,0.155309611,0.304351623,0.730081618,0,3.919449272,1.465791145,2.67394798,0.007496408,0.027304297,1.891715633,0,1.269600407,1.220317628,1.040385206,0.298160972,0.438938735,6.193854711,1,1.793844298,1.157335297,1.549978042,0.121146786,0.225897426,1.860715765,0,1.190617274,1.210284346,0.983750041,0.325238429,0.461412843,N,-,,fungal specific transcription factor,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (PFAM); PTHR31313:SF43 (PANTHER); PTHR31313 (PANTHER),,
RL4_JR_00103,52,113,93,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.042562572,0,1.837728033,1.590565951,1.155392539,0.247929716,NA,0.329431018,0,5.067460896,1.721097793,2.944318978,0.003236662,0.016208996,0.858266599,0,2.409774244,1.299522373,1.854353795,0.063688561,0.136635513,0.990495231,0,1.986789071,1.369717748,1.450509839,0.146916397,0.26193494,0.847989486,0,2.32472561,1.278552368,1.818248253,0.069026198,0.143420943,N,-,,short-chain dehydrogenase,,IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24320 (PANTHER); PTHR24320:SF99 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_00104,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.007760107,0,8.901087564,4.041366561,2.202494486,0.027630398,NA,0.002334598,0,12.18995876,4.048442383,3.01102439,0.002603679,0.015349618,0.006343058,0,9.480780804,4.042868098,2.345063102,0.01902386,0.053738157,0.007335717,0,9.055356819,4.042572319,2.23999872,0.025091006,0.08557795,0.006581095,0,9.341867313,1.819064456,5.135533973,2.81E-07,4.95E-06,,,,,,,,
RL4_JR_00105,21,57,60,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.556249653,0,2.743961592,2.055930804,1.334656588,0.181988768,NA,0.174466455,0,5.984312586,1.966893896,3.042519272,0.002346068,0.015170793,0.457021433,0,3.318603714,1.376505454,2.410890349,0.015913632,0.046671382,0.527598194,0,2.895304761,1.548086013,1.870247994,0.061449388,0.138414917,0.454262716,0,3.225517093,1.332201117,2.421193806,0.015469627,0.044560448,Y,-, Effector probability:0.569,---NA---,,no IPS match,,
RL4_JR_00106,417,524,458,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,5.625243722,0,-0.593985486,1.211576293,-0.490258426,0.623951042,0.784434058,1.793719315,0,2.622606758,1.329431757,1.972727629,0.048526602,0.115166769,11.1492445,1,0.933636741,1.199255789,0.778513433,0.436266391,0.576600645,5.365012712,0,-0.450579684,1.206548492,-0.373445151,0.70881716,0.804932004,4.576865764,0,-0.107992611,1.205307705,-0.089597545,0.928607035,0.953564527,Y,-,,"1,3-beta-glucanosyltransferase gel2","P:fungal-type cell wall organization; P:carbohydrate metabolic process; C:fungal-type cell wall; F:1,3-beta-glucanosyltransferase activity; C:plasma membrane; C:anchored component of membrane",IPR004886 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR31468 (PANTHER); PTHR31468:SF4 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_00107,36,39,29,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,23.32964364,1,6.423218772,0.666826269,9.632522097,5.83E-22,9.91E-20,0.134192231,0,6.363352097,1.984932515,3.205827931,0.001346745,0.015023052,0.346522708,0,3.718875922,1.302727789,2.854683805,0.00430797,0.016970383,0.399661491,0,3.296299969,1.487098006,2.216599011,0.026650505,0.086792012,0.339612542,0,3.644469677,1.239467868,2.940350269,0.003278414,0.012700876,N,-,,MFS general substrate transporter,P:transmembrane transport; C:membrane; C:integral component of membrane; F:transporter activity,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); PTHR23502:SF56 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.33, the major facilitator superfamily (mfs).
RL4_JR_00108,765,1201,784,7,15,1,0,0,0,2,0,0,0,0,0,0,0,1,205.5448156,1,4.072493523,0.880726241,4.624017466,3.76E-06,4.88E-05,3.54623079,0,1.639292145,1.305963516,1.25523579,0.209393177,0.354902501,31.32074058,1,0.833376132,1.057562776,0.788015757,0.430687489,0.571240684,10.59099003,0,-1.431809991,1.224610834,-1.16919592,0.242324704,0.380747615,16.37747631,1,-0.145718676,1.151017455,-0.126599884,0.899257089,0.934802672,N,-,,aminotransferase class-V,F:catalytic activity,IPR015421 (G3DSA:3.40.640.GENE3D); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR000192 (PFAM); PTHR11601:SF22 (PANTHER); PTHR11601 (PANTHER); PTHR11601 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_00109,154,145,303,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2.391321393,0,0.639683307,1.34953527,0.47400266,0.63549801,0.791837971,0.753668627,0,3.873292489,1.508548501,2.567562452,0.010241634,0.034134283,1.974498241,0,1.207023501,1.267018908,0.952648373,0.34076826,0.484201805,11.59129673,1,1.739218193,1.194773728,1.455688347,0.145478793,0.260057071,1.96869353,0,1.109052121,1.272757059,0.871377702,0.383547957,0.519590991,N,-,,---NA---,,no IPS match,,
RL4_JR_00110,400,1424,722,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.39507254,0,-1.480051963,1.347162752,-1.098643769,0.271923478,0.453650662,3.285222143,0,1.74955662,1.427188993,1.22587592,0.220245372,0.368007345,8.538291716,0,-0.904875322,1.30372112,-0.69407123,0.48763754,0.62239567,9.853444567,0,-1.32773045,1.317523344,-1.007747192,0.313575843,0.459672132,8.397574386,0,-0.983691314,1.317212228,-0.746797891,0.455185569,0.587148126,N,-,,homoserine acetyltransferase family,"F:transferase activity, transferring acyl groups",IPR000073 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR008220 (PIRSF); PTHR10992 (PANTHER); PTHR10992:SF903 (PANTHER); PTHR10992:SF903 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_00111,30078,27099,28687,1,3,5,0,0,0,2,1,13,4,19,6,0,5,5,396.7569316,1,-2.630439175,0.501914657,-5.240809643,1.60E-07,3.03E-06,109.9700334,0,-3.315443031,1.191848007,-2.781766645,0.00540639,0.021724287,399.1853855,1,-1.177752325,0.455589634,-2.585116597,0.009734607,0.03203939,499.6954898,1,-0.819790249,0.316556802,-2.589709788,0.009605687,0.047052533,336.2236071,1,-2.095827294,0.498068272,-4.207911666,2.58E-05,0.000222875,N,-,,trna selenocysteine-associated 1,F:nucleotide binding; F:nucleic acid binding,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR24012 (PANTHER); PTHR24012 (PANTHER); PTHR24012:SF333 (PANTHER); PTHR24012:SF333 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY),9.A.60.1.1, the small nuclear rna exporter (snrna-e).
RL4_JR_00112,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.011718044,0,8.30924678,3.99658426,2.0790871,0.037609346,NA,0.004006569,0,11.4341231,3.991291091,2.864768027,0.004173148,0.018371529,0.009992212,0,8.834284459,3.994251091,2.211749902,0.02698395,0.070608817,0.011494389,0,8.415706565,3.9944702,2.106839241,0.035131517,0.099498352,0.009494587,0,8.783878684,1.912952289,4.591791826,4.39E-06,5.09E-05,Y,-,,hypothetical protein NECHADRAFT_75598,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_00113,1779,1142,2380,0,0,2,0,0,0,2,0,0,0,6,0,0,0,2,28.65730873,1,-0.789609525,1.0639794,-0.742128583,0.458009433,0.64633125,6.684398199,0,0.724654357,1.268491439,0.571272564,0.567814896,0.709257839,39.55617956,1,-0.088575023,1.061738056,-0.083424554,0.933513966,0.960456848,44.1644912,1,0.86474986,0.716915138,1.206209514,0.227736717,0.363811022,32.00679842,1,-0.313255017,1.017655828,-0.307820196,0.758219153,0.831470695,N,-,,hypothetical protein CMQ_4166,,no IPS match,,
RL4_JR_00114,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,phenylacetate 2-hydroxylase,F:oxidoreductase activity; F:binding,IPR002401 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24281 (PANTHER); PTHR24281:SF2 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_00115,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.00781203,0,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,0,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,0,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,0.007662926,0,9.0007212,4.037607722,2.229221316,0.025799183,0.085851084,0.006329724,0,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,Y,-, Effector probability:0.817,hypothetical protein AK830_g11410,,IPR029167 (PFAM),,
RL4_JR_00116,957,726,828,3,5,0,0,0,0,0,0,2,0,0,0,0,0,0,80.27239065,1,2.403160452,0.583488574,4.11860756,3.81E-05,0.00036887,3.217491429,0,1.779612223,1.279311861,1.3910699,0.164204231,0.296799148,21.31741695,1,0.951140051,1.037914919,0.916395009,0.359459752,0.503298072,9.595800321,0,-1.289617146,1.19745338,-1.076966476,0.281495243,0.425080232,8.178030541,0,-0.945642837,1.197779746,-0.789496433,0.429821914,0.564308464,N,-,,fungal specific transcription factor domain containing,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; C:cytosol; P:regulation of transcription, DNA-templated; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); IPR001138 (PFAM); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00117,17,19,28,0,0,12,0,0,0,0,0,0,0,0,0,0,0,1,46.07816384,1,7.872738211,0.810787462,9.709990073,2.73E-22,4.96E-20,0.08084911,0,7.093836333,2.187685758,3.242621253,0.001184355,0.015023052,0.211020082,0,4.432534296,1.355479104,3.270086779,0.001075145,0.006101327,0.243523563,0,4.010382185,1.705843957,2.35096661,0.018724714,0.074406487,7.574879299,1,5.282490526,1.160767062,4.550861837,5.34E-06,5.99E-05,Y,-,,multicopper oxidase,F:copper ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR011706 (PFAM); IPR001117 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); IPR011707 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); PTHR11709 (PANTHER); PTHR11709:SF87 (PANTHER); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY),2.A.108.1.5, the iron/lead transporter (ilt) family.
RL4_JR_00118,85,141,109,0,0,23,0,0,0,0,0,0,0,0,0,0,5,0,89.1788738,1,6.168258491,1.14163421,5.403007755,6.55E-08,1.35E-06,0.429701304,0,4.684169074,1.615575352,2.899381368,0.003738998,0.017456706,1.115591318,0,2.031594998,1.259565295,1.612933451,0.106758967,0.203584061,1.287160426,0,1.608912934,1.29899642,1.2385815,0.215500523,0.350287814,20.4012711,1,4.835899819,0.748143697,6.46386495,1.02E-10,7.38E-09,Y,-,,hypothetical protein AK830_g11181,,no IPS match,,
RL4_JR_00119,1001,886,941,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.31365179,0,-1.602337677,1.185489845,-1.351624971,0.176495318,0.331848984,3.622566322,0,1.608537274,1.261448242,1.275151227,0.20225572,0.346694734,9.37726289,0,-1.040156501,1.192239562,-0.872439176,0.382968836,0.526575648,10.81623085,0,-1.4622867,1.189403941,-1.229428161,0.218911317,0.35401327,9.223481986,0,-1.119141634,1.190621995,-0.93996385,0.347236104,0.484598973,N,-,,nucleoside-diphosphate-sugar epimerase,P:biological_process; C:cellular_component; F:molecular_function,IPR016040 (G3DSA:3.40.50.GENE3D); PTHR14097:SF8 (PANTHER); PTHR14097 (PANTHER); PTHR14097:SF8 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_00120,26839,15851,15312,9,18,14,0,0,1,1,8,13,7,9,15,0,26,2,519.6111771,1,0.263403179,0.473805376,0.555931174,0.578257906,0.753221778,84.33739304,1,-1.847910299,1.148174463,-1.609433373,0.107521613,0.21398619,350.9766026,1,-0.179754025,0.491109864,-0.366015912,0.714353202,0.806823049,467.9585699,1,0.054543516,0.519927151,0.104906074,0.916450339,0.949649157,303.3704343,1,-0.451372262,0.766384901,-0.588962884,0.555886172,0.675266645,Y,-,,IRE kinase,F:nucleotide binding; P:RNA phosphodiester bond hydrolysis; F:ribonuclease activity; P:protein phosphorylation; F:kinase activity,IPR018997 (SMART); IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR010513 (PFAM); IPR000719 (PFAM); IPR027295 (G3DSA:2.140.10.GENE3D); G3DSA:3.30.200.20 (GENE3D); PTHR13954:SF6 (PANTHER); PTHR13954 (PANTHER); IPR010513 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR011047 (SUPERFAMILY),8.A.104.1.2, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_00121,1361,1139,1506,0,0,0,0,0,1,0,0,0,3,0,0,0,0,0,15.98361384,0,-2.101008709,1.189560739,-1.766205491,0.07736138,0.18335681,14.48047256,1,2.030845815,1.124037223,1.806742493,0.070802439,0.155188888,13.2416879,0,-1.538137178,1.193768734,-1.288471656,0.197581829,0.322676338,43.21255087,1,0.371245531,0.849066195,0.437239797,0.661937451,0.76991576,13.06695738,0,-1.621655724,1.198413601,-1.353168658,0.176001756,0.292709884,N,-,,gliotoxin biosynthesis,P:mycelium development,PR01217 (PRINTS); IPR013024 (G3DSA:3.10.490.GENE3D),,
RL4_JR_00122,5677,5896,6768,0,1,3,0,0,3,0,2,2,2,3,1,0,6,1,92.87259529,1,-1.579713686,0.74329376,-2.125288508,0.033562547,0.098703409,51.5186342,1,1.106592917,0.844918848,1.309703198,0.190296261,0.331585257,89.41197917,1,-0.914498049,0.738396368,-1.238492072,0.21553366,0.344173939,110.3572483,1,-0.840147655,0.608794581,-1.380018287,0.167581014,0.288623265,90.45742149,1,-0.408760036,0.586779926,-0.696615576,0.486043405,0.61445742,N,-,,glycerol-3-phosphate dehydrogenase [NAD+],P:carbohydrate metabolic process; C:glycerol-3-phosphate dehydrogenase complex; F:NAD binding; P:glycerol-3-phosphate catabolic process; P:oxidation-reduction process; F:glycerol-3-phosphate dehydrogenase [NAD+] activity,IPR006168 (PRINTS); IPR006109 (PFAM); IPR013328 (G3DSA:1.10.1040.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011128 (PFAM); PTHR11728 (PANTHER); PTHR11728 (PANTHER); PTHR11728:SF8 (PANTHER); PTHR11728 (PANTHER); PTHR11728:SF8 (PANTHER); IPR008927 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_00123,2243,1615,1532,0,1,0,0,0,0,0,0,0,0,0,3,0,6,0,29.5557963,1,-1.580352459,1.156372659,-1.366646337,0.171736186,0.32543504,6.948052054,0,0.668957741,1.257787029,0.531852949,0.594827847,0.730616088,17.90517861,0,-1.973287141,1.207211836,-1.634582334,0.102136633,0.196621273,49.55252026,1,-0.040219493,0.870604531,-0.046197202,0.963153073,0.978772417,40.69687195,1,1.11738923,0.65703149,1.70066313,0.089006262,0.174886165,N,-,,gp46 recombination endonuclease subunit,P:nucleic acid phosphodiester bond hydrolysis; F:endonuclease activity; C:membrane; C:integral component of membrane; F:hydrolase activity,IPR029052 (G3DSA:3.60.21.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PF13476 (PFAM); IPR029052 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_00124,5992,6482,4701,0,7,5,0,0,0,0,5,2,1,14,2,0,1,1,144.2627524,1,0.119828394,0.529053042,0.226495993,0.820815675,0.909688124,22.1760943,0,-1.005381383,1.219987822,-0.824091327,0.409887668,0.573763376,109.4575812,1,-0.025586913,0.602056221,-0.042499209,0.966100742,0.979942282,150.7675813,1,0.648012489,0.478380211,1.35459719,0.175545929,0.299377216,67.30722718,1,-2.04552219,0.981102238,-2.084922559,0.037076331,0.088746536,N,-,,glycogen debranching enzyme,"C:nucleus; P:glycogen biosynthetic process; C:cytoplasm; P:glycogen catabolic process; F:amylo-alpha-1,6-glucosidase activity; F:4-alpha-glucanotransferase activity",IPR029436 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); IPR032788 (PFAM); IPR032790 (PFAM); IPR032792 (PFAM); IPR006421 (TIGRFAM); PTHR10569:SF2 (PANTHER); IPR010401 (PANTHER); IPR010401 (PANTHER); PTHR10569:SF2 (PANTHER); IPR017853 (SUPERFAMILY); IPR008928 (SUPERFAMILY),,
RL4_JR_00125,4164,3098,5195,1,1,9,0,0,4,0,4,1,4,4,0,0,3,0,101.9853935,1,0.386297365,0.54418587,0.709862909,0.477789153,0.666975344,53.29094522,1,2.059268016,0.782794505,2.630662328,0.008521866,0.02979964,78.91126471,1,-0.027485997,0.695399576,-0.039525472,0.968471445,0.981461953,100.6453892,1,0.143969761,0.578931903,0.248681684,0.803607018,0.874424616,52.20114217,1,-1.070836034,0.879164992,-1.218014871,0.223218322,0.349858438,N,-,,integral membrane,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00126,507,387,447,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,5.353849035,0,-0.523083938,1.201588726,-0.435326935,0.663325136,0.811913948,1.717490057,0,2.685247088,1.335303613,2.010963696,0.044329292,0.107293422,4.44241845,0,0.037600591,1.205017164,0.031203365,0.975107356,0.985851408,5.123742908,0,-0.384436014,1.204034032,-0.31928999,0.749506623,0.835076998,19.09892754,1,1.646224587,0.974117935,1.689964354,0.091034774,0.177905248,N,-,,---NA---,,no IPS match,,
RL4_JR_00127,1148,1153,852,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16.49192788,1,-0.819421302,1.159178802,-0.706898109,0.479629799,0.668401077,4.072790373,0,1.439579049,1.28149658,1.123357698,0.261285608,0.417545457,10.50639383,0,-1.204074556,1.208165545,-0.996613884,0.318951964,0.461625401,12.11664134,0,-1.625968707,1.20741773,-1.346649686,0.178093084,0.302752262,10.28758067,0,-1.276626044,1.203976747,-1.060341114,0.288989441,0.423446902,N,-,,MFS multidrug transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF44 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.3.65, the major facilitator superfamily (mfs).
RL4_JR_00128,2350,2550,2175,0,0,0,0,0,0,0,1,0,1,2,1,0,0,1,28.41862552,0,-2.930998728,1.192167602,-2.458545865,0.013950096,0.049545007,9.094467701,0,0.280574127,1.226285531,0.228799998,0.819024368,0.890745101,31.37177572,1,-1.40549719,1.193073442,-1.178047504,0.238777669,0.371562422,54.11047186,1,-0.056666537,0.745987968,-0.075961731,0.939449545,0.964307242,30.47630476,1,-1.510234219,1.120319023,-1.348039432,0.1776457,0.294805252,N,-,,c6 zinc finger domain containing,"F:DNA binding; C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PTHR31845:SF14 (PANTHER); PTHR31845 (PANTHER); PTHR31845 (PANTHER); PTHR31845:SF14 (PANTHER),,
RL4_JR_00129,653,697,477,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,7.353515533,0,-0.980581511,1.221324947,-0.802883387,0.422042139,0.61394789,2.362909092,0,2.225054159,1.330094357,1.672854371,0.094355968,0.193569337,6.094081856,0,-0.418213092,1.217801857,-0.343416369,0.731285247,0.818772636,7.028092459,0,-0.840117506,1.218366607,-0.6895441,0.490480931,0.630143205,9.824612178,1,0.438820953,1.14024544,0.384847804,0.700350179,0.788069078,N,-,,Transcription fungi,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:phosphorylation; F:kinase activity; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31001:SF54 (PANTHER); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00130,1108,1296,927,0,2,4,0,0,0,0,0,0,0,1,0,0,0,0,44.7082732,1,1.448149434,0.649046775,2.231194253,0.025668265,0.080350498,4.298543202,0,1.361742225,1.276299032,1.066946061,0.285996194,0.44563631,11.10471572,0,-1.283972861,1.207934822,-1.062948792,0.287805174,0.427290227,16.81971706,1,-0.75989086,1.159345312,-0.655448253,0.512179193,0.647175131,10.88536654,0,-1.358069383,1.205305336,-1.126743027,0.259851145,0.391691654,N,-,,HC-toxin efflux carrier TOXA,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF68 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_00131,1744,2801,2795,3,0,0,0,0,0,0,0,0,0,1,3,0,0,2,59.71639907,1,-0.593141406,0.900592223,-0.658612623,0.510144555,0.696096331,9.345217294,0,0.241272719,1.241638595,0.194317992,0.845926898,0.9080034,24.34327444,0,-2.41645861,1.212316014,-1.993258013,0.046233202,0.106450974,61.00927892,1,-0.074781017,0.781014715,-0.095748538,0.92372029,0.954938528,38.80230921,1,-0.800127379,1.001857575,-0.798643838,0.424496961,0.559712427,N,-,,glutathione s-transferase,F:transferase activity,IPR010987 (G3DSA:1.20.1050.GENE3D); IPR004045 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR11260:SF314 (PANTHER); PTHR11260 (PANTHER); IPR004045 (PROSITE_PROFILES); IPR010987 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR010987 (SUPERFAMILY),1.A.12.2.1, the intracellular chloride channel (clic) family.
RL4_JR_00132,1515,1736,4196,0,2,0,4,0,0,0,0,0,1,0,1,0,0,0,45.57129406,1,-1.177796857,1.124176909,-1.047697073,0.294778197,0.479904316,98.49519894,1,3.226716979,1.397568771,2.308807298,0.020954277,0.059729426,24.34709028,0,-2.416745934,1.262366608,-1.914456481,0.055561855,0.122524116,47.05810411,1,-1.037865895,1.104707482,-0.939493859,0.347477244,0.494668839,24.3997707,0,-2.522570958,1.285832288,-1.961819579,0.049783493,0.111746384,N,-, Effector probability:0.796,RNA recognition domain-containing,F:organic cyclic compound binding; F:heterocyclic compound binding,IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),9.A.60.1.1, the small nuclear rna exporter (snrna-e).
RL4_JR_00133,160331,184232,185880,0,0,34,0,0,0,0,0,0,0,4,0,0,2,0,2257.614185,1,-3.960051267,1.389827213,-2.849311937,0.00438139,0.019457474,677.9823493,0,-5.939583898,1.202619632,-4.938871562,7.86E-07,6.98E-05,1759.578427,0,-8.592020649,1.207036974,-7.118274614,1.09E-12,8.85E-11,2046.039256,1,-6.317501593,0.77471909,-8.1545707,3.50E-16,2.45E-14,1742.088878,1,-7.024439748,1.031987758,-6.806708407,9.99E-12,8.59E-10,Y,-,,clock-controlled 6,,no IPS match,,
RL4_JR_00134,101,112,111,0,0,3,3,0,0,0,1,0,0,1,0,0,5,0,12.75522449,1,3.820016229,0.861423802,4.434537586,9.23E-06,0.000108152,67.35022591,1,6.957853862,0.847767687,8.207264759,2.26E-16,8.18E-14,8.918071445,1,3.046718897,1.197875183,2.543436028,0.010976816,0.035245569,5.251862904,1,2.609016065,1.156119953,2.256700144,0.024026818,0.08365596,20.36163622,1,4.926721672,0.689930287,7.140897808,9.27E-13,9.68E-11,N,-,,monooxygenase fad-binding,F:FAD binding; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity,PR00420 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR002938 (PFAM); PTHR13789:SF234 (PANTHER); PTHR13789 (PANTHER); PTHR13789:SF234 (PANTHER); PTHR13789 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_00135,38,42,50,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0.520319754,0,2.840188062,1.936441267,1.466704986,0.142456326,NA,0.165396694,0,6.061431141,1.887957073,3.210576781,0.001324689,0.015023052,0.430143357,0,3.405804963,1.276820219,2.667411522,0.007643801,0.02640254,0.496300282,0,2.983414761,1.408317349,2.118425057,0.034139086,0.098985751,23.58827722,1,6.487085923,0.665489702,9.747838173,1.88E-22,5.45E-20,Y,-,,integral membrane,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,PTHR33048 (PANTHER),9.B.313.1.2, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_00136,4,8,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.107708388,0,5.112317972,3.916660799,1.305274629,0.19179935,NA,0.033571934,0,8.361068224,2.673701081,3.127151454,0.00176509,0.015023052,0.088514721,0,5.684980699,1.597156118,3.559439578,0.000371647,0.002740389,0.102212635,0,5.262651344,2.413577883,2.180435684,0.029225181,0.090879902,0.088735943,0,5.583075164,1.382954551,4.037063374,5.41E-05,0.000415789,,,,,,,,
RL4_JR_00137,1041,322,732,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.270172454,0,-1.150382395,1.304948522,-0.881553851,0.378018121,0.569821107,2.676236814,0,2.045307363,1.416432349,1.44398521,0.148743136,0.274840821,6.900514845,0,-0.597794894,1.281806919,-0.466368909,0.640951462,0.74991247,7.956148982,0,-1.019327896,1.292003316,-0.788951455,0.43014038,0.572596811,6.778713157,0,-0.674890124,1.290133055,-0.523116682,0.600893057,0.710171846,N,-,,hypothetical protein ACRE_043650,,no IPS match,,
RL4_JR_00138,1427,983,1605,0,3,1,0,0,0,0,0,0,1,0,0,0,0,0,43.81373941,1,0.646580031,0.765419168,0.844739796,0.398256135,0.590351919,5.09657014,0,1.115946597,1.259616923,0.885941255,0.375649184,0.540259317,13.23693062,0,-1.537626381,1.207355087,-1.273549429,0.202823144,0.328646209,24.58256896,1,-1.008636018,1.158215642,-0.87085339,0.383834209,0.529111146,13.08059598,0,-1.623174527,1.214459465,-1.33654072,0.1813726,0.299380107,N,-,,Catalyzes late reaction in the cephamycin biosynthetic pathway,,PTHR34598:SF3 (PANTHER); PTHR34598:SF3 (PANTHER); PTHR34598 (PANTHER),,
RL4_JR_00139,238,169,214,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.475752475,0,0.589594937,1.250354896,0.471542071,0.637253684,0.793091617,0.794123996,0,3.798097091,1.455185583,2.6100431,0.009053082,0.031306898,2.054870586,0,1.149781668,1.221387022,0.941373739,0.346513366,0.49022604,2.370040591,0,0.72776028,1.230573814,0.591399127,0.554253025,0.683284047,2.021838074,0,1.070280131,1.212960981,0.882369794,0.377576865,0.513287561,N,-,,Neutral alkaline non-lysosomal ceramidase,,IPR010730 (PFAM); PTHR33112:SF6 (PANTHER); PTHR33112:SF6 (PANTHER); PTHR33112 (PANTHER); PTHR33112 (PANTHER); PTHR33112 (PANTHER); PTHR33112:SF6 (PANTHER),,
RL4_JR_00140,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_00141,8,5,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.075705644,0,5.620914543,3.920835969,1.433601045,0.151686145,NA,0.024388201,0,8.82339091,2.771310154,3.18383379,0.001453384,0.015023052,0.062936845,0,6.178740024,1.566457845,3.944402363,8.00E-05,0.001012726,0.072576923,0,5.757050328,2.615371033,2.201236558,0.027719282,0.088451852,0.061761109,0,6.100586805,1.313701258,4.643815911,3.42E-06,4.12E-05,,,,,,,,
RL4_JR_00142,1030,1283,1303,0,0,5,0,0,0,0,0,0,0,2,0,0,1,0,33.6057451,1,1.056598744,0.690804635,1.529518898,0.126135858,0.261503514,4.615856336,0,1.258916926,1.248762484,1.008131604,0.313391287,0.475230279,11.99253254,0,-1.395054356,1.197416622,-1.165053441,0.243997362,0.377942058,21.85977882,1,-0.093871831,1.021757295,-0.091872925,0.926799003,0.956926461,15.69287162,1,-0.548815811,1.131325128,-0.485108832,0.627599148,0.731488589,N,-,,o-methyltransferase,F:O-methyltransferase activity; C:integral component of membrane; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR001077 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); PTHR11746 (PANTHER); PTHR11746:SF87 (PANTHER); IPR016461 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY); IPR011991 (SUPERFAMILY),,
RL4_JR_00143,1,7,6,0,0,4,0,0,0,0,0,0,0,2,0,0,1,0,15.33104999,1,8.647727041,1.012780597,8.538598649,1.36E-17,1.29E-15,0.017719627,0,9.283528721,3.127944429,2.967932753,0.002998099,0.01558642,0.046526393,0,6.615349589,1.874839435,3.528488609,0.00041794,0.002974018,8.07690019,1,7.885607307,1.165657506,6.764943619,1.33E-11,5.53E-10,3.906822327,1,7.453788478,1.268810419,5.874627421,4.24E-09,2.16E-07,N,-,,integral membrane,C:membrane; F:methyltransferase activity,PTHR33048 (PANTHER),9.B.313.1.2, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_00144,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.008141456,0,8.841220392,4.035983802,2.190598582,0.028480854,NA,0.002675567,0,12.01934062,4.032893235,2.980327006,0.002879408,0.015349618,0.006783092,0,9.399044527,3.291065204,2.855927776,0.004291127,0.016940088,0.007815077,0,8.97609272,4.035428601,2.224322026,0.026126786,0.086108719,0.006504647,0,9.346543544,1.704039324,5.484934187,4.14E-08,1.17E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_00145,1,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.027186335,0,7.09661823,3.945773956,1.798536436,0.07209204,NA,0.008339319,0,10.36686958,3.947335555,2.626295493,0.008631985,0.030149395,0.022359912,0,7.666868789,2.77222115,2.765605042,0.00568173,0.02087907,0.025838613,0,7.244826043,3.945961686,1.836010235,0.066356143,0.145897057,0.022908147,0,7.535214489,1.793030449,4.202502245,2.64E-05,0.000226893,N,-,,Heterokaryon incompatibility,C:membrane; C:integral component of membrane,IPR010730 (PFAM); PTHR24148:SF30 (PANTHER); PTHR24148 (PANTHER),,
RL4_JR_00146,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.016941764,0,7.786237146,3.969489371,1.961521097,0.049818266,NA,0.005360177,0,11.01327471,3.970079784,2.774068863,0.005535996,0.021974647,0.013809418,0,8.370946466,3.970412799,2.108331524,0.035002323,0.086240817,0.015934454,0,7.948319201,3.970395183,2.001896243,0.045295892,0.115278131,0.013359141,0,8.321812604,2.097869539,3.966792239,7.28E-05,0.000534084,N,-, Effector probability:0.574,---NA---,,no IPS match,,
RL4_JR_00147,56,47,23,0,1,3,0,0,0,0,0,1,0,0,0,0,0,0,19.97283154,1,5.565974799,0.854647599,6.512596308,7.39E-11,2.61E-09,0.164619251,0,6.068689553,1.985593711,3.05636018,0.002240419,0.015045494,6.920460118,1,4.398585454,1.256359423,3.501056604,0.000463417,0.003200299,0.486152512,0,3.013750541,1.535357872,1.962897769,0.049658054,0.122392356,0.409884783,0,3.372422623,1.292862385,2.60849311,0.009094184,0.029101964,N,-,,kinase-like domain,C:integral component of membrane; F:protein kinase activity; P:protein phosphorylation,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); PTHR21310 (PANTHER); PTHR21310:SF16 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_00148,9,18,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.177352979,0,4.393034374,3.165749521,1.387675919,0.165235752,NA,0.055984589,0,7.624209719,2.376757494,3.207819787,0.001337453,0.015023052,0.14603501,0,4.96489577,1.432530571,3.465821862,0.000528613,0.003525482,0.168541802,0,4.54172773,1.960302506,2.316850443,0.02051188,0.077696516,0.144539202,0,4.879212661,1.299413843,3.75493357,0.000173387,0.001104813,,,,,,,,
RL4_JR_00149,4352,2963,3398,2,0,8,0,0,0,0,3,2,1,3,0,0,1,3,93.41216712,1,0.490051981,0.530954134,0.922964809,0.356025545,0.546875615,13.74923017,0,-0.315740297,1.227022303,-0.257322378,0.796929919,0.876986805,72.02790715,1,0.178547971,0.688176076,0.259451001,0.795287284,0.865100297,62.28838779,1,-0.66590111,0.765490104,-0.869901658,0.384354149,0.529683648,60.80753623,1,-0.396731556,0.757437911,-0.52378096,0.600430898,0.710067867,N,-,,---NA---,,no IPS match,,
RL4_JR_00150,659,567,942,0,0,2,0,0,0,0,1,1,0,0,0,0,0,0,16.26767686,1,0.503880115,1.041139693,0.483969748,0.628407339,0.787961211,2.739510635,0,2.011502434,1.296599947,1.55136705,0.120813747,0.23489757,21.48171777,1,1.172929278,1.050004222,1.117071011,0.263963964,0.401498073,8.238765602,0,-1.069808614,1.213807807,-0.881365738,0.378119896,0.523801333,7.078998163,0,-0.737322982,1.223024318,-0.602868619,0.546596094,0.667378701,N,-,,het domain containing,,no IPS match,,
RL4_JR_00151,7,7,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.095790724,0,5.281489435,3.917890237,1.348044257,0.177644148,NA,0.030401963,0,8.50483176,2.644191548,3.216420446,0.001298005,0.015023052,0.079196933,0,5.846257675,1.50286186,3.890083202,0.00010021,0.001162113,0.09138412,0,5.424458169,2.389196636,2.270410935,0.023182662,0.082218611,0.078438007,0,5.75943817,1.299738536,4.43122829,9.37E-06,9.48E-05,N,-,,F-box domain,,no IPS match,,
RL4_JR_00152,96,103,104,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.214753398,0,1.617074149,1.380999276,1.170944965,0.241620899,NA,0.387633885,0,4.832776341,1.608230979,3.005026272,0.002655579,0.015349618,1.00518231,0,2.181666777,1.230910965,1.772400149,0.076328157,0.157222027,1.159589917,0,1.759287021,1.262931351,1.393018725,0.163614128,0.283857616,0.990041592,0,2.100917785,1.212453609,1.732781996,0.083134424,0.166271526,N,-,,g- coupled receptor,F:transmembrane signaling receptor activity; P:signal transduction; C:membrane,G3DSA:1.20.1070.10 (GENE3D); IPR000832 (PFAM); PTHR23112:SF19 (PANTHER); PTHR23112:SF19 (PANTHER); PTHR23112 (PANTHER); PTHR23112 (PANTHER); IPR017981 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY),9.A.14.6.5, the g-protein-coupled receptor (gpcr) family.
RL4_JR_00153,256,445,356,0,0,3,0,0,0,0,0,0,0,1,0,0,1,0,15.72167174,1,2.069990602,0.923257515,2.242051182,0.024958065,0.078682981,1.353772085,0,3.0285591,1.396210077,2.169128523,0.030072928,0.079229093,3.518030835,0,0.374387438,1.235680451,0.302980789,0.761904502,0.839862516,8.07090827,1,0.896521737,1.181654658,0.758700295,0.448031861,0.590083275,7.328379754,1,1.219745114,1.16150368,1.050143134,0.29365231,0.428604532,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF3 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_00154,1841,1611,2063,0,2,1,0,0,0,1,0,0,0,3,2,0,0,0,41.85762488,1,-0.247051684,0.846028432,-0.292013453,0.770276338,0.879607274,7.025647476,0,0.65286591,1.224847493,0.533018122,0.594021036,0.730241955,29.3064798,1,-1.03806607,1.189630095,-0.87259567,0.382883502,0.526554368,52.34345025,1,0.628695166,0.666382324,0.943445142,0.345453263,0.492098067,17.99530483,0,-2.083341139,1.195638816,-1.742450238,0.081429692,0.163489119,N,-,,pyridine nucleotide-disulfide oxidoreductase,F:monooxygenase activity,IPR023753 (G3DSA:3.50.50.GENE3D); PF13454 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR23023:SF110 (PANTHER); PTHR23023:SF110 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_00155,9707,13685,16394,0,4,9,0,0,0,0,0,1,0,5,0,0,3,1,225.8947805,1,-1.056031991,0.547784057,-1.927825349,0.053876854,0.140738832,50.43913051,0,-2.190970198,1.207453196,-1.814538406,0.069594876,0.153005936,138.0697182,1,-3.888918687,1.208733019,-3.217351248,0.001293801,0.007053549,171.8965733,1,-2.279423998,0.729082528,-3.126427957,0.001769439,0.011957765,149.3186066,1,-2.339684012,0.802609576,-2.915096059,0.003555791,0.013560219,N,-,,C2H2 finger domain-containing,F:catalytic activity; F:metal ion binding; C:cytoplasmic part,IPR015880 (SMART); PF13920 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR22938 (PANTHER); PTHR22938:SF0 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),,
RL4_JR_00156,1838,2007,2569,0,1,0,0,0,0,0,1,0,0,5,0,0,2,1,33.65776852,1,-1.832415434,1.150826332,-1.592260608,0.11132616,0.239125544,8.142951796,0,0.4399182,1.222788661,0.359766339,0.719021878,0.824074798,29.04139222,1,-1.255166548,1.195520667,-1.049891134,0.293768168,0.434366721,44.51801027,1,0.38228112,0.688852635,0.554953412,0.578926527,0.705285896,36.05993899,1,-0.094329929,0.858953087,-0.109819652,0.912552406,0.943489544,N,-,,swib mdm2 domain,F:DNA binding,IPR019835 (SMART); IPR014876 (PFAM); IPR003121 (G3DSA:1.10.245.GENE3D); IPR009057 (G3DSA:1.10.10.GENE3D); IPR003121 (PFAM); PTHR13844:SF4 (PANTHER); PTHR13844 (PANTHER); PTHR13844:SF4 (PANTHER); SSF109715 (SUPERFAMILY); IPR003121 (SUPERFAMILY),,
RL4_JR_00157,532,565,777,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,7.485825518,0,-1.006562253,1.211165796,-0.831068923,0.405934695,0.597656603,2.374614738,0,2.217743918,1.297904211,1.708711551,0.087504393,0.182509679,29.71570124,1,1.968928147,0.863645447,2.27978756,0.022620291,0.06134686,7.139005931,0,-0.863070744,1.20717531,-0.714950626,0.474639553,0.615408563,6.127440759,0,-0.529009508,1.215477817,-0.435227612,0.663397222,0.760346035,N,-,,---NA---,,no IPS match,,
RL4_JR_00158,13,12,26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202484872,0,4.201609859,2.999739487,1.40065825,0.161316293,NA,0.06379211,0,7.435375148,2.319565781,3.205503034,0.001348266,0.015023052,0.167187594,0,4.767535019,1.423315874,3.349597308,0.000809291,0.004862471,0.192976699,0,4.345742827,1.88626994,2.303881716,0.021229284,0.07902445,0.166774866,0,4.670843645,1.311444109,3.561603283,0.000368597,0.002089611,Y,-, Effector probability:0.827,hypothetical protein CMQ_291,C:cellular_component; F:molecular_function,IPR011058 (G3DSA:2.30.60.GENE3D); IPR011058 (PFAM); IPR011058 (SUPERFAMILY),,
RL4_JR_00159,129,98,138,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,16.72861207,1,4.062562696,0.758714161,5.354536536,8.58E-08,1.71E-06,0.464694101,0,4.571116563,1.567963412,2.915320937,0.003553229,0.016941021,1.205666852,0,1.918747849,1.233263181,1.555829995,0.119748523,0.221430877,1.390817317,0,1.496601377,1.259294757,1.188444063,0.234658505,0.371934466,1.189661732,0,1.835463304,1.220742171,1.503563445,0.132693809,0.235995928,N,-,,hypothetical protein CMQ_7409,C:membrane; F:binding,PTHR33048 (PANTHER); PTHR33048:SF2 (PANTHER),9.B.313.1.2, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_00160,392,443,466,0,0,40,0,0,0,0,0,0,0,1,0,0,0,0,157.9577188,1,4.938409065,1.368401179,3.608889806,0.00030751,0.00222006,1.661126056,0,2.733355274,1.327006981,2.059789672,0.039418652,0.097965428,4.31297458,0,0.080323682,1.2013129,0.066863248,0.946690572,0.968795648,8.987484448,1,0.6048935,1.146736934,0.527491077,0.597852611,0.720454379,4.253545982,0,-0.002315091,1.202061688,-0.001925934,0.998463328,0.998660594,Y,-,,fad binding domain-containing,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; P:oxidation-reduction process",IPR016169 (G3DSA:3.30.465.GENE3D); IPR006094 (PFAM); IPR016167 (G3DSA:3.30.43.GENE3D); PTHR13878:SF56 (PANTHER); PTHR13878 (PANTHER); IPR016166 (PROSITE_PROFILES); PS51257 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY),,
RL4_JR_00161,3330,3105,1996,0,0,2,0,0,0,0,0,0,0,5,0,0,0,0,41.53976805,1,-1.476083872,1.056361425,-1.397328449,0.162314824,0.312745474,10.93805829,0,0.014283687,1.258352515,0.011351101,0.990943326,0.995269731,28.14128767,0,-2.625580581,1.217858991,-2.155898673,0.031091578,0.078988993,52.5068781,1,-0.065631153,0.748107172,-0.087729613,0.930091583,0.958393779,27.47695714,0,-2.693948114,1.214727369,-2.217738878,0.026572642,0.068617189,Y,-,,hrq family 2,C:membrane; C:integral component of membrane,IPR021848 (PFAM),,
RL4_JR_00162,208,264,246,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.885100642,0,0.369268056,1.243783701,0.296890895,0.766549808,0.877722899,0.918716071,0,3.587851257,1.420871363,2.525106318,0.011566329,0.03757201,2.384411082,0,0.93552951,1.216384657,0.769106635,0.44183001,0.581600184,2.750911443,0,0.513066035,1.222673008,0.419626532,0.674758303,0.778389861,2.349469329,0,0.854140988,1.211576084,0.704983368,0.480820587,0.609709223,N,-,,kinase-like domain partial,F:ATP binding; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,G3DSA:1.10.510.10 (GENE3D); PTHR11909:SF149 (PANTHER); PTHR11909 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_00163,422,345,649,2,0,0,0,0,0,0,0,0,0,5,0,0,0,0,25.75844651,1,1.173680354,1.045675365,1.122413698,0.261686583,0.441082468,1.783483184,0,2.630689373,1.35261102,1.944897191,0.051787353,0.121228397,4.654955771,0,-0.03006211,1.229414426,-0.024452381,0.980491767,0.989482211,25.42960486,1,2.533586829,0.741603833,3.416361561,0.000634639,0.005079622,4.623363081,0,-0.122721428,1.239495399,-0.099009184,0.921130978,0.949617349,N,-,,aig2 family,P:glutathione biosynthetic process; F:gamma-glutamylcyclotransferase activity,IPR013024 (G3DSA:3.10.490.GENE3D); IPR013024 (SUPERFAMILY),,
RL4_JR_00164,170,109,195,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1.882295991,0,0.984904289,1.326261987,0.742616691,0.45771378,NA,0.600727091,0,4.200634843,1.528999755,2.747309036,0.006008649,0.023329322,1.560980134,0,1.546042166,1.24573082,1.241072422,0.214578996,0.343351291,5.81238312,1,2.068409803,1.179472561,1.753673524,0.079486465,0.165699085,1.543719927,0,1.459626459,1.240084904,1.177037519,0.239180531,0.368207827,N,-,,swim zinc finger domain,F:ligase activity,IPR022025 (PFAM),,
RL4_JR_00165,348,789,361,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,29.01307878,1,2.416865945,0.86401088,2.797263324,0.005153751,0.022281029,1.943451891,0,2.506980387,1.432208986,1.750429171,0.080044286,0.170247587,5.02792626,0,-0.140779292,1.278313436,-0.11012893,0.912307124,0.946547439,5.80051707,0,-0.563185652,1.289791874,-0.436648473,0.662366303,0.770034001,4.924350263,0,-0.213610569,1.280804798,-0.166778396,0.867544418,0.912043114,Y,-,,aromatic compound dioxygenase,"C:nucleus; F:DNA binding; F:zinc ion binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:iron ion binding; P:transcription, DNA-templated; P:oxidation-reduction process; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR015889 (G3DSA:2.60.130.GENE3D); PTHR34315:SF1 (PANTHER); PTHR34315 (PANTHER); IPR015889 (SUPERFAMILY),,
RL4_JR_00166,2855,1283,2417,0,1,5,0,0,0,0,1,0,0,0,0,0,5,0,53.06672756,1,0.442149413,0.725363268,0.609555835,0.542156075,0.723618138,8.353557367,0,0.403116197,1.281680279,0.314521651,0.753124875,0.84917026,29.44717484,1,-1.282503302,1.230110048,-1.042592331,0.297137143,0.438004722,24.91501698,0,-2.666167036,1.236148914,-2.156833215,0.031018662,0.094200346,40.57655775,1,0.533234262,0.787283229,0.677309312,0.498209724,0.62608582,N,-,,bZIP transcription factor,,IPR019357 (PFAM); PTHR21614 (PANTHER),,
RL4_JR_00167,2183,1393,1025,0,0,0,0,0,0,0,6,0,0,1,0,0,0,0,18.40385437,0,-2.304274109,1.242942161,-1.853886835,0.063755352,0.159349313,5.978610158,0,0.885766753,1.312013843,0.675119975,0.499599544,0.653811326,62.38872776,1,1.645567813,1.374070332,1.197586306,0.23107811,0.362405346,21.68440058,1,-1.226737517,1.194704272,-1.026812698,0.304508669,0.450226383,14.93402622,0,-1.814368502,1.237094031,-1.466637504,0.142474692,0.249067112,N,-,,trk family potassium uptake,C:membrane; P:transport,IPR004773 (TIGRFAM); IPR003445 (PFAM); PTHR31064 (PANTHER); PTHR31064 (PANTHER); PTHR31064:SF5 (PANTHER),2.A.38.2.3, the k(+) transporter (trk) family.
RL4_JR_00168,8490,3392,4989,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,92.97188312,1,-1.757443559,0.944212404,-1.861279889,0.062704662,0.157786746,21.70767684,0,-0.974607841,1.27067342,-0.767001045,0.443080894,0.60418494,55.81110378,0,-3.613498496,1.244353523,-2.903916314,0.003685267,0.015684377,64.34048433,0,-4.034841636,1.252523221,-3.221370725,0.00127579,0.009096742,54.61477304,0,-3.685022138,1.246274678,-2.956829825,0.003108196,0.012183695,N,-,,efflux pump antibiotic resistance,P:transmembrane transport; C:integral component of membrane,PR01036 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501 (PANTHER); PTHR23501:SF77 (PANTHER); PTHR23501:SF77 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.65, the major facilitator superfamily (mfs).
RL4_JR_00169,891,403,538,1,6,1,0,0,3,0,17,2,4,6,6,3,14,5,69.21928422,1,2.91976953,0.726957189,4.016425691,5.91E-05,0.000539794,30.49368391,1,4.35714382,0.956168587,4.556878232,5.19E-06,0.000380818,152.3931148,1,4.607861981,1.313139194,3.509043064,0.000449722,0.003130151,126.1228394,1,3.976168075,0.525521068,7.566144005,3.84E-14,2.20E-12,144.8856768,1,4.575133712,0.485560115,9.422383692,4.41E-21,1.12E-18,Y,-,,hypothetical protein F503_03409,,no IPS match,,
RL4_JR_00170,21159,14828,18142,0,0,9,0,0,0,0,5,1,0,4,0,0,0,4,250.2093998,1,-2.091041049,0.633692286,-3.299773559,0.000967629,0.005775351,69.30565074,0,-2.649379517,1.201880519,-2.20436181,0.027498909,0.073831289,224.9180122,1,-1.890240155,0.636005607,-2.972049514,0.00295819,0.013478269,222.7275879,1,-3.015985219,0.765911645,-3.937771725,8.22E-05,0.000902165,205.6467091,1,-2.712830086,0.765282709,-3.544873098,0.000392802,0.002209479,N,-,,helicase swr1,F:organic cyclic compound binding; F:heterocyclic compound binding; F:helicase activity,IPR001650 (SMART); IPR014001 (SMART); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000330 (PFAM); PTHR10799 (PANTHER); PTHR10799 (PANTHER); PTHR10799:SF638 (PANTHER); PTHR10799:SF638 (PANTHER); PTHR10799 (PANTHER); PTHR10799:SF638 (PANTHER); IPR014012 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_00171,6791,8356,10580,1,0,18,0,0,0,1,0,0,3,9,2,0,8,6,181.7673897,1,-0.172818743,0.821147731,-0.21045999,0.833308676,0.917055467,32.61697216,0,-1.562060839,1.203306702,-1.29814023,0.194239152,0.336716681,96.09167326,1,-3.25898835,1.201609558,-2.712185776,0.006684112,0.023702259,181.4241431,1,-0.127228056,0.462337876,-0.27518415,0.783174763,0.860328141,159.2910151,1,0.097845007,0.498244748,0.196379404,0.844313216,0.895617738,N,-, Effector probability:0.569,NADH:ubiquinone oxidoreductase subunit,C:mitochondrion; C:integral component of membrane; F:NADH dehydrogenase (ubiquinone) activity; P:oxidation-reduction process,IPR008699 (PFAM); PTHR12840:SF1 (PANTHER); IPR008699 (PANTHER),,
RL4_JR_00172,28,21,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.264273583,0,3.817539906,2.646629233,1.442415831,0.1491851,NA,0.085379661,0,7.015786436,2.184249077,3.211990112,0.001318189,0.015023052,0.21967608,0,4.376283556,1.359134268,3.219905244,0.00128233,0.007010146,0.253290443,0,3.954150788,1.695832318,2.331687365,0.019717144,0.076371876,0.214690939,0,4.304625505,1.260592577,3.414763489,0.000638374,0.003331721,N,-, Effector probability:0.634,FAD NAD(P)-binding domain-containing,"F:NADP binding; F:oxidoreductase activity; F:flavin adenine dinucleotide binding; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:N,N-dimethylaniline monooxygenase activity",IPR023753 (G3DSA:3.50.50.GENE3D); PTHR23023 (PANTHER); PTHR23023:SF91 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_00173,15,14,23,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0.207127624,0,4.168956043,2.936472914,1.419715477,0.155690531,NA,0.065641347,0,7.394410396,2.280189898,3.242892359,0.001183229,0.015023052,6.669972194,1,5.692072526,1.227711627,4.636326969,3.55E-06,7.85E-05,28.1344024,1,6.655182509,0.888454792,7.490738491,6.85E-14,3.79E-12,0.169912519,0,4.643841922,1.275302,3.641366455,0.000271195,0.001615204,N,-, Effector probability:0.566,FAD NAD(P)-binding domain-containing,F:nucleotide binding; F:coenzyme binding; F:oxidoreductase activity,IPR023753 (G3DSA:3.50.50.GENE3D); PF13738 (PFAM); PTHR23023:SF91 (PANTHER); PTHR23023:SF91 (PANTHER); PTHR23023 (PANTHER); PTHR23023 (PANTHER); PS51257 (PROSITE_PROFILES); IPR023753 (SUPERFAMILY),,
RL4_JR_00174,66,56,55,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.70838461,0,2.395057019,1.676989146,1.428188742,0.15323754,NA,0.227388455,0,5.602386411,1.783223884,3.141717908,0.001679598,0.015023052,0.587594607,0,2.956342137,1.258998609,2.348169503,0.018865934,0.053576076,0.677691131,0,2.534217268,1.340620922,1.890330985,0.058713707,0.135146692,0.576888991,0,2.879473866,1.221555653,2.357218731,0.018412398,0.051173629,N,-, Effector probability:0.651,hypothetical protein SPI_05248,,no IPS match,,
RL4_JR_00175,1363,1472,2137,0,0,5,0,0,0,0,0,2,2,1,0,0,3,0,38.94291087,1,0.584072733,0.72100768,0.81007838,0.417895129,0.609327697,6.287381435,0,0.812984772,1.242383335,0.654375143,0.512870145,0.663590899,29.39668428,1,-0.03054184,1.048717192,-0.029123047,0.976766455,0.98690455,41.56049744,1,0.058264073,0.87039465,0.066939834,0.946629601,0.968827831,27.84337811,1,0.247654769,0.883858455,0.280197318,0.779326124,0.848003977,N,-,,kinase-like domain,F:nutrient reservoir activity,G3DSA:3.30.200.20 (GENE3D); IPR025213 (PFAM); IPR011009 (SUPERFAMILY),,
RL4_JR_00176,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,integral membrane family,C:integral component of membrane,PTHR33048 (PANTHER),2.A.1.7.25, the major facilitator superfamily (mfs).
RL4_JR_00177,4,3,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3.870164595,1,7.109386415,1.293552872,5.49601533,3.88E-08,8.50E-07,0.01636602,0,9.397785321,2.992839876,3.140089584,0.001688962,0.015023052,0.042709187,0,6.735791415,1.692976898,3.978667058,6.93E-05,0.000910129,0.049283843,0,6.314993111,3.049577816,2.070776183,0.038379717,0.104573368,0.042422089,0,6.645173693,1.353290221,4.910383295,9.09E-07,1.33E-05,Y,-,,tyrosinase central domain containing,F:oxidoreductase activity; F:metal ion binding; P:oxidation-reduction process,IPR008922 (G3DSA:1.10.1280.GENE3D); IPR002227 (PFAM); PTHR11474 (PANTHER); PTHR11474:SF31 (PANTHER); IPR008922 (SUPERFAMILY),,
RL4_JR_00178,2,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.045575612,0,6.354442004,3.930132953,1.616851664,0.105910304,NA,0.014558699,0,9.569249634,3.303198713,2.896964568,0.003767923,0.017533671,0.03745184,0,6.932702189,2.024248727,3.424827243,0.00061519,0.003931937,0.043199693,0,6.506850385,3.481949349,1.868737806,0.061659301,0.138795115,0.036338554,0,6.874125335,1.54392739,4.452363098,8.49E-06,8.72E-05,N,-,,pantothenate transporter,C:membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662 (PANTHER); PTHR11662:SF173 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.18, the major facilitator superfamily (mfs).
RL4_JR_00179,2475,2088,2760,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29.21993477,0,-2.971306458,1.188406823,-2.50024352,0.012410796,0.045159356,9.32517775,0,0.244364339,1.21713374,0.200770327,0.840878166,0.904694812,24.20551102,0,-2.408347311,1.191513946,-2.021249788,0.043253914,0.101194742,27.92394523,0,-2.830688998,1.190308558,-2.378113624,0.017401463,0.071914209,23.88841663,0,-2.492035164,1.196266957,-2.08317646,0.037235142,0.089042469,N,-,,Sterigmatocystin biosynthesis regulatory,"F:nucleic acid binding; C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00180,144,275,165,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.367421229,0,0.654648276,1.353589253,0.483638796,0.628642237,0.787961211,0.75343184,0,3.874070019,1.524214256,2.541683366,0.011032006,0.036218122,1.952325947,0,1.224185474,1.26751365,0.965816403,0.334136059,0.477593317,2.252421025,0,0.801652692,1.291333229,0.620794597,0.534734778,0.667018557,1.91712144,0,1.147565559,1.258606613,0.911774614,0.361887376,0.498789775,N,-,,DNA repair RAD50,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF12 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_00181,41,58,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.464002989,0,3.005679487,2.265159316,1.326917478,0.184535982,NA,0.149988496,0,6.203052622,2.093861107,2.962494791,0.00305157,0.015695116,0.384369723,0,3.569650088,1.440975,2.47724637,0.013240047,0.040301335,0.443157446,0,3.147516187,1.66705014,1.888075296,0.059015843,0.135526289,0.372825108,0,3.509870769,1.363479294,2.574201739,0.010047167,0.031523882,N,-,,GDSL-like Lipase Acylhydrolase family,"P:carbohydrate metabolic process; C:membrane; C:integral component of membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:hydrolase activity",IPR013830 (G3DSA:3.40.50.GENE3D); PF13517 (PFAM); IPR013830 (G3DSA:3.40.50.GENE3D); IPR013830 (PFAM); PTHR30383:SF4 (PANTHER); PTHR30383 (PANTHER); SSF69318 (SUPERFAMILY); IPR013830 (SUPERFAMILY); IPR013830 (SUPERFAMILY); SSF69318 (SUPERFAMILY),1.C.107.1.4, the import subunit a of the insecticidal toxin complex (itc-a) family.
RL4_JR_00182,301,209,461,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.849622222,0,-0.047278217,1.28388095,-0.036824456,0.970624974,0.984504494,1.220186628,0,3.178259554,1.42251389,2.23425555,0.025466263,0.069511891,3.18616889,0,0.516804849,1.249760229,0.4135232,0.679223328,0.779555263,3.676728313,0,0.09409355,1.260741947,0.074633473,0.940506341,0.965068758,3.167581032,0,0.422812343,1.258339114,0.336008266,0.736864633,0.815789213,N,-,,kinesin light,P:biological_process; F:microtubule motor activity; C:kinesin complex; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_00183,9,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.060211392,0,5.951458697,3.9244509,1.516507366,0.129391109,NA,0.019887228,0,9.119069408,3.11807976,2.924578623,0.003449229,0.016643092,0.050409936,0,6.501364368,1.894887719,3.43100243,0.000601355,0.003867929,0.058069094,0,6.079381628,3.122639096,1.946872962,0.051549967,0.125437014,0.048473234,0,6.448713867,1.479460533,4.358827914,1.31E-05,0.000126331,N,-, Effector probability:0.823,related to RF2,"F:chitinase activity; P:carbohydrate metabolic process; F:chitin binding; P:chitin catabolic process; P:metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:hydrolase activity, acting on glycosyl bonds; F:hydrolase activity",IPR029226 (PFAM),,
RL4_JR_00184,983,884,838,0,1,0,0,0,0,0,0,5,0,3,0,0,1,0,18.84535322,1,-0.590308113,1.14154698,-0.517112413,0.605077689,0.772371113,3.475614996,0,1.668305969,1.271510634,1.312066077,0.189497841,0.330421558,41.47740244,1,2.15631665,0.674506011,3.196882777,0.001389214,0.007457264,22.3962723,1,0.90237297,0.857256398,1.052629028,0.292511048,0.437147507,12.68144419,1,-0.124413146,1.12104481,-0.110979637,0.911632495,0.943212652,N,-,,glycosyl hydrolase family 2,"F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR006101 (PRINTS); IPR004199 (SMART); IPR006104 (PFAM); IPR013812 (G3DSA:2.60.40.GENE3D); IPR014718 (G3DSA:2.70.98.GENE3D); IPR032312 (PFAM); IPR013812 (G3DSA:2.60.40.GENE3D); IPR008979 (G3DSA:2.60.120.GENE3D); IPR006102 (PFAM); IPR006103 (PFAM); IPR004199 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR10066 (PANTHER); PTHR10066:SF72 (PANTHER); PTHR10066:SF72 (PANTHER); PTHR10066 (PANTHER); IPR011013 (SUPERFAMILY); IPR008979 (SUPERFAMILY); IPR017853 (SUPERFAMILY); IPR006102 (SUPERFAMILY); IPR006102 (SUPERFAMILY),,
RL4_JR_00185,181,167,183,0,0,1,0,0,0,0,4,8,1,0,3,0,4,0,5.94291099,1,1.757900922,1.14882143,1.53017769,0.125972752,0.261231752,0.679132814,0,4.023772245,1.470839986,2.735696801,0.006224835,0.023876729,85.12151471,1,5.769251144,0.453870598,12.71122468,5.12E-37,1.99E-34,40.2480964,1,3.698443262,0.737400183,5.015517144,5.29E-07,1.03E-05,17.17489712,1,3.903384448,0.752785053,5.185257639,2.16E-07,4.29E-06,Y,-,,2-aminoadipate transaminase,,PTHR40616 (PANTHER); PTHR40616:SF1 (PANTHER),,
RL4_JR_00186,12,23,8,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0.175327749,0,4.409771336,3.233943829,1.363589342,0.172696848,NA,0.056185686,0,7.61978919,2.436545699,3.12729172,0.001764248,0.015023052,66.56465537,1,8.7712727,1.798878939,4.875966086,1.08E-06,2.89E-05,0.166943535,0,4.556100959,2.04406309,2.228943413,0.02581767,0.085851084,0.141117787,0,4.912914466,1.343527289,3.656728454,0.000255455,0.00153675,N,-,,membrane,F:peroxidase activity; P:response to oxidative stress; F:metal ion binding; C:integral component of membrane; P:cellular oxidant detoxification; P:oxidation-reduction process; F:heme binding,PTHR23294 (PANTHER); PTHR23294 (PANTHER); PTHR23294:SF22 (PANTHER); PTHR23294:SF22 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.58.5, the major facilitator superfamily (mfs).
RL4_JR_00187,197,271,196,0,0,9,0,0,0,0,0,0,0,0,3,0,0,0,37.04476494,1,4.231799768,0.64969579,6.513509606,7.34E-11,2.61E-09,0.855040664,0,3.691547918,1.455964865,2.535464974,0.011229816,0.036678992,2.213363001,0,1.043132969,1.231589016,0.846981384,0.397005498,0.539356369,31.4591114,1,2.976046896,0.872336648,3.411580729,0.000645874,0.005145139,2.173506967,0,0.966433034,1.222250033,0.790699945,0.429119108,0.56380954,N,-,,glucokinase,"F:transferase activity, transferring phosphorus-containing groups; P:organic substance metabolic process; P:phosphate-containing compound metabolic process",PR00475 (PRINTS); G3DSA:3.40.367.20 (GENE3D); IPR022672 (PFAM); IPR022673 (PFAM); G3DSA:3.30.420.40 (GENE3D); IPR001312 (PANTHER); PTHR19443:SF16 (PANTHER); IPR001312 (PROSITE_PROFILES); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_00188,1091,1053,944,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.38415194,0,-1.732615747,1.191539537,-1.45409841,0.145919024,0.291516455,3.970052671,0,1.476419119,1.263405147,1.168603059,0.242563595,0.394921781,10.26308703,0,-1.170288199,1.196123421,-0.978400872,0.327876097,0.470900832,11.83732956,0,-1.5923274,1.193916103,-1.333701251,0.182301785,0.308559942,10.07593537,0,-1.246638693,1.192337176,-1.045542081,0.295772502,0.430705679,N,-,,fungal transcriptional regulatory,"P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00189,9,12,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140300173,0,4.731037413,3.460737375,1.367060513,0.171606339,NA,0.044442427,0,7.957210845,2.458836124,3.236169653,0.001211454,0.015023052,0.115806296,0,5.298820435,1.433150596,3.697322842,0.000217885,0.001855231,0.133636547,0,4.876331821,2.080123961,2.344250589,0.019065357,0.075082357,0.114628848,0,5.213061252,1.283200888,4.062544922,4.85E-05,0.000379516,,,,,,,,
RL4_JR_00190,39,78,80,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.793103248,0,2.232196147,1.725546606,1.293616839,0.195797803,NA,0.249992783,0,5.465450936,1.796390537,3.042462552,0.00234651,0.015170793,0.652904729,0,2.804052536,1.307759317,2.144165596,0.032019621,0.080738889,0.75357758,0,2.38101716,1.40399861,1.695882848,0.089908069,0.180834167,0.647176675,0,2.714724848,1.280866874,2.119443404,0.034053012,0.083021128,N,-, Effector probability:0.563,glycoside hydrolase family 51,P:L-arabinose metabolic process; P:carbohydrate metabolic process; F:alpha-L-arabinofuranosidase activity; F:hydrolase activity,IPR017853 (SUPERFAMILY),,
RL4_JR_00191,640,628,575,0,0,23,0,0,0,0,5,5,0,0,3,0,1,0,95.21747667,1,3.724629566,1.107147832,3.364166428,0.000767752,0.004803162,2.36747957,0,2.222226825,1.299069286,1.710629947,0.087149447,0.181994368,77.83186245,1,3.711474575,0.491633415,7.549272415,4.38E-14,3.99E-12,35.96871789,1,1.484465436,0.848420439,1.74968137,0.08017331,0.166680213,9.875497439,1,0.427981615,1.121675567,0.381555619,0.702791009,0.789762371,N,-,,hexose transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,IPR003663 (PRINTS); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500 (PANTHER); PTHR23500:SF145 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.83, the major facilitator superfamily (mfs).
RL4_JR_00192,150,322,157,0,3,1,0,0,0,0,0,0,0,0,0,0,2,0,30.40781475,1,3.324202037,0.870969331,3.816669448,0.000135265,0.001105705,0.815088659,0,3.760613252,1.546459517,2.431756674,0.015025798,0.04620022,2.109198801,0,1.112681112,1.290000138,0.862543405,0.388388558,0.532292644,2.433296771,0,0.69021575,1.31797906,0.523692501,0.600492432,0.722511474,9.787827508,1,2.676551805,1.071236198,2.498563632,0.012469775,0.037509351,N,-,,Aromatic amino acid aminotransferase,F:pyridoxal phosphate binding; F:transaminase activity; P:biosynthetic process,IPR015421 (G3DSA:3.40.640.GENE3D); IPR004839 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); PTHR11751 (PANTHER); PTHR11751 (PANTHER); PTHR11751 (PANTHER); PTHR11751:SF377 (PANTHER); PTHR11751:SF377 (PANTHER); PTHR11751:SF377 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_00193,5,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.118337558,0,4.976904677,3.807079975,1.307276104,0.191118957,NA,0.037456716,0,8.204511675,2.628682747,3.121149437,0.001801466,0.015023052,0.097263591,0,5.55302571,1.57858062,3.517733361,0.000435249,0.003057922,0.112237998,0,5.128759307,2.336165006,2.195375453,0.028136676,0.089221375,0.095585255,0,5.476921484,1.368359066,4.002547008,6.27E-05,0.000469982,N,-,,pyruvate decarboxylase,F:magnesium ion binding; F:thiamine pyrophosphate binding; F:carboxy-lyase activity,IPR029061 (G3DSA:3.40.50.GENE3D); IPR012001 (PFAM); IPR012000 (PFAM); IPR029035 (G3DSA:3.40.50.GENE3D); PTHR18968 (PANTHER); IPR012110 (PTHR18968:PANTHER); IPR029035 (SUPERFAMILY); IPR029061 (SUPERFAMILY),,
RL4_JR_00194,15,14,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.195487464,0,4.252422554,2.998570533,1.418149917,0.156147,NA,0.062139449,0,7.473633366,2.29734619,3.253159406,0.001141295,0.015023052,0.161724603,0,4.816435141,1.374940346,3.503013898,0.000460025,0.003185199,0.186599702,0,4.394540178,1.840698414,2.387430849,0.016966594,0.070752375,0.160040876,0,4.730074646,1.265553753,3.737553333,0.00018582,0.001168587,N,-,,Pyruvate decarboxylase,F:magnesium ion binding; F:thiamine pyrophosphate binding; F:carboxy-lyase activity,IPR029061 (G3DSA:3.40.50.GENE3D); IPR011766 (PFAM); IPR012110 (PTHR18968:PANTHER); PTHR18968 (PANTHER); IPR029061 (SUPERFAMILY),,
RL4_JR_00195,77,134,85,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.198116778,0,1.637170071,1.493674807,1.096068612,0.27304875,NA,0.381621629,0,4.855428203,1.666562226,2.91343949,0.003574711,0.016958421,0.988662241,0,2.206056271,1.277446768,1.726926183,0.084180921,0.169231066,1.140594827,0,1.783434927,1.329449859,1.341483408,0.179763553,0.305130926,0.970922151,0,2.12930953,1.254618874,1.697176389,0.089663318,0.175870029,N,-,,fungal specific transcription factor domain-containing,"F:metal ion binding; P:metabolic process; P:regulation of transcription, DNA-templated",PTHR31944 (PANTHER); PTHR31944:SF75 (PANTHER),,
RL4_JR_00196,168,113,139,0,0,5,0,0,0,0,0,0,0,1,0,0,0,0,20.7669122,1,4.170479608,0.695302976,5.998075306,2.00E-09,5.20E-08,0.538047464,0,4.359751738,1.545680623,2.820603216,0.004793345,0.02009869,1.39052245,0,1.713237085,1.2356266,1.386533023,0.165584204,0.2824081,5.615254582,1,2.236964541,1.16686804,1.91706728,0.055229385,0.130227648,1.366478684,0,1.635336411,1.220175022,1.340247408,0.180164923,0.297775032,N,-,,Mg2+ transporter -like Zinc transport,P:transmembrane transport; C:membrane; C:integral component of membrane; F:metal ion transmembrane transporter activity; P:metal ion transport,G3DSA:1.20.58.340 (GENE3D),,
RL4_JR_00197,269,216,315,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.187790051,0,0.224872657,1.232866294,0.182398252,0.855270198,0.92758379,1.01640451,0,3.441979027,1.403457594,2.452499485,0.014186758,0.044102693,2.640708538,0,0.787727635,1.215706439,0.647958758,0.517011625,0.64780021,3.046499472,0,0.365372828,1.220667398,0.299322181,0.764694232,0.846640689,2.609264006,0,0.702517272,1.21576397,0.57784018,0.563372025,0.680766411,N,-,,Hydroxycinnamoyl-Coenzyme A shikimate quinate hydroxycinnamoyltransferase,F:transferase activity,IPR003480 (PFAM); IPR023213 (G3DSA:3.30.559.GENE3D); IPR023213 (G3DSA:3.30.559.GENE3D); PTHR31642:SF13 (PANTHER); PTHR31642 (PANTHER); PTHR31642:SF13 (PANTHER); PTHR31642 (PANTHER); PTHR31642 (PANTHER); PTHR31642:SF13 (PANTHER); PTHR31642 (PANTHER),,
RL4_JR_00198,73,35,54,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,27.37277965,1,5.946258251,0.712531524,8.34525639,7.11E-17,5.98E-15,0.207428891,0,5.734862899,1.860225707,3.082885521,0.00205004,0.015023052,0.535238793,0,3.090357366,1.308245369,2.362215407,0.018166083,0.052011716,0.617187632,0,2.668813285,1.424633152,1.873333693,0.06102232,0.137947378,0.525616989,0,3.013163188,1.264654935,2.382597105,0.017190997,0.048430397,Y,-,,glycoside hydrolase family 18,F:hydrolase activity,IPR029226 (PFAM); PTHR11177 (PANTHER); PTHR11177:SF218 (PANTHER),,
RL4_JR_00199,434,225,144,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,7.025466233,1,1.156380998,1.268529736,0.911591558,0.361983768,0.553215358,1.049218053,0,3.39634909,1.55450058,2.184849033,0.028899917,0.076939759,2.679019893,0,0.767415088,1.30915078,0.58619305,0.557745792,0.68401416,3.087339644,0,0.346545312,1.33538572,0.259509523,0.795242135,0.868121468,32.06078228,1,3.446474622,0.89894832,3.833896284,0.000126129,0.000842388,Y,-, Effector probability:0.633,glycoside hydrolase family 18,"P:metabolic process; F:hydrolase activity, acting on glycosyl bonds",IPR029226 (PFAM); PTHR11177:SF218 (PANTHER); PTHR11177 (PANTHER),,
RL4_JR_00200,13991,11859,12806,0,1,0,0,0,0,0,0,2,0,0,0,0,0,0,162.5752377,1,-4.424986153,1.13987449,-3.881994193,0.000103603,0.000885022,49.5253213,0,-2.164565507,1.195866047,-1.810040107,0.070289568,0.154298635,141.1538836,1,-2.992442871,1.031002091,-2.902460525,0.003702438,0.015732205,147.818267,0,-5.234860682,1.18837512,-4.405057455,1.06E-05,0.000147898,126.0248515,0,-4.891355033,1.18892473,-4.114099832,3.89E-05,0.000313837,N,-,,kelch repeat,,PF13418 (PFAM); IPR015915 (G3DSA:2.120.10.GENE3D); PTHR23244:SF276 (PANTHER); PTHR23244 (PANTHER); IPR011043 (SUPERFAMILY); SSF117281 (SUPERFAMILY),,
RL4_JR_00201,5937,4233,5356,3,5,0,0,0,0,0,0,2,0,0,0,0,0,0,132.1469176,1,-0.152612607,0.646366018,-0.236108648,0.813348364,0.904930541,19.85346226,0,-0.845795565,1.211256251,-0.698279629,0.485002336,0.641324072,64.37257909,1,-1.675752988,1.039564686,-1.611975677,0.106967233,0.203827642,59.25508181,0,-3.916065923,1.196298614,-3.273485297,0.001062299,0.007765905,50.55127021,0,-3.573482193,1.196318924,-2.987064837,0.0028167,0.011261782,N,-,,fungal specific transcription factor,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR007219 (PFAM); PTHR31944:SF82 (PANTHER); PTHR31944 (PANTHER),,
RL4_JR_00202,2333,1651,2267,0,2,0,0,0,3,1,0,5,1,0,0,0,0,0,40.92177878,1,-0.994318352,1.014263425,-0.980335411,0.32692058,0.51636362,36.1101437,1,2.642415246,0.87414404,3.022860221,0.002503979,0.015349618,64.22395362,1,1.21844325,0.631507936,1.929418746,0.053678898,0.119412254,33.14305059,1,-1.651644243,1.149899186,-1.436338301,0.1509061,0.267213058,20.35728012,0,-2.26129646,1.201631099,-1.881855806,0.059855596,0.128452292,N,-,,fad dependent oxidoreductase superfamily,F:oxidoreductase activity; P:single-organism metabolic process,IPR006076 (PFAM); G3DSA:3.30.9.10 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR023209 (PIRSF); IPR023209 (PANTHER); PTHR11530:SF3 (PANTHER); SSF51971 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_00203,467,191,274,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.696212763,0,0.01143511,1.310981037,0.008722559,0.993040493,0.997382756,1.199477715,0,3.203164924,1.477570172,2.167859763,0.030169358,0.079379839,3.083852945,0,0.564192846,1.271766801,0.443629167,0.657310715,0.762706439,3.555156651,0,0.142837472,1.287024042,0.110982753,0.911630023,0.946206129,3.017499641,0,0.492621316,1.266781961,0.388876169,0.697367752,0.785728517,N,-,,zinc finger transcription factor 1,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31313 (PANTHER); PTHR31313:SF6 (PANTHER); IPR001138 (SUPERFAMILY),,
RL4_JR_00204,6041,5062,6188,7,2,1,0,0,0,0,2,6,0,0,2,0,0,0,159.3421568,1,0.117120341,0.70487371,0.166157908,0.868032683,0.93607543,22.07444621,0,-0.998788092,1.199077305,-0.832963886,0.404865097,0.569059419,111.900549,1,0.16393638,0.538197049,0.304602895,0.760668615,0.83907268,85.27819679,1,-2.330233548,1.011285341,-2.304229532,0.021209762,0.078980817,56.38683337,0,-3.731081364,1.190311165,-3.134542861,0.001721221,0.007476346,N,-,,homocysteine s-methyltransferase,F:transferase activity,IPR003726 (G3DSA:3.20.20.GENE3D); IPR003726 (PFAM); PTHR21091:SF119 (PANTHER); PTHR21091 (PANTHER); PTHR21091:SF119 (PANTHER); PTHR21091 (PANTHER); IPR003726 (PROSITE_PROFILES); IPR003726 (SUPERFAMILY),,
RL4_JR_00205,2433,2708,3319,5,0,3,0,0,0,0,2,2,1,1,0,0,0,0,95.63328333,1,0.578863141,0.571250691,1.013325937,0.310904503,0.498988576,10.75243341,0,0.038889549,1.213009896,0.032060372,0.974423905,0.986927705,56.66235774,1,0.201857637,0.74830381,0.269753588,0.787349831,0.859513661,45.60705145,1,-1.305387306,1.018874341,-1.281205398,0.200121531,0.330921199,27.66557533,0,-2.70378207,1.201341307,-2.250636062,0.024408597,0.063942315,N,-,,biotin lipoate A B ligase,F:catalytic activity; P:primary metabolic process; P:cellular metabolic process; P:organic substance metabolic process,IPR004143 (PFAM); G3DSA:3.90.1550.10 (GENE3D); IPR029068 (G3DSA:3.10.180.GENE3D); PTHR39175 (PANTHER); PTHR39175:SF1 (PANTHER); PD006086 (PRODOM); IPR004143 (PROSITE_PROFILES); SSF55681 (SUPERFAMILY); IPR029068 (SUPERFAMILY),,
RL4_JR_00206,439,460,668,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.254919016,0,-0.747416369,1.220276881,-0.612497361,0.540208743,0.722314906,1.982470838,0,2.47812026,1.319745911,1.87772528,0.060418757,0.136814016,5.168858127,0,-0.181073038,1.213254927,-0.149245664,0.881359789,0.92609097,5.964603885,0,-0.603804374,1.214104981,-0.497324682,0.618960109,0.736996867,5.123761446,0,-0.270926297,1.221615517,-0.221777059,0.824487439,0.882165837,N,-,,hypothetical protein F503_02511,F:nucleic acid binding; P:DNA integration; C:cellular_component,no IPS match,,
RL4_JR_00207,2300,1991,2761,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,43.40364003,1,-0.207922425,0.752261047,-0.276396638,0.782243438,0.887681454,8.962644222,0,0.30155522,1.219309895,0.247316307,0.804663439,0.881986339,23.29092516,0,-2.352789975,1.19381513,-1.970816013,0.048744924,0.111022186,26.87069653,0,-2.775226622,1.192935895,-2.3263837,0.01999809,0.076714457,23.01389712,0,-2.438221695,1.200227569,-2.031466163,0.042207729,0.09808429,N,-,,hypothetical protein F503_03412,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00208,7120,5325,4839,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,69.14012712,0,-4.21378564,1.205342115,-3.495925005,0.000472421,0.003214357,22.2932206,0,-1.012987796,1.223731566,-0.827785949,0.407791733,0.571619987,57.44566579,0,-3.655125695,1.204798452,-3.033806766,0.002414891,0.011510523,70.25311405,1,-3.130758315,1.15993055,-2.699091179,0.006952912,0.036343953,56.24113465,0,-3.727358518,1.200442562,-3.104986975,0.001902874,0.008122513,N,-,,Nitrosoguanidine resistance SNG1,C:integral component of membrane,IPR022703 (PFAM); PTHR34814 (PANTHER),9.B.316.1.2,The Nitrosoguanidine Resistance or DUF3533 (NGR) Family
RL4_JR_00209,410,329,432,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.671109218,0,-0.326340594,1.205003048,-0.270821385,0.786528412,0.889944352,1.492712267,0,2.887560941,1.344868036,2.147096119,0.03178563,0.082814453,3.871527444,0,0.235886548,1.204942259,0.195765852,0.844793439,0.900472602,4.466023525,0,-0.186375623,1.204624533,-0.154716775,0.877044605,0.92394929,3.817899366,0,0.153356421,1.205021327,0.127264487,0.898731067,0.934447736,N,-,,aldo-keto reductase (AKR13) puatative,P:biological_process; F:oxidoreductase activity; P:oxidation-reduction process,IPR023210 (G3DSA:3.20.20.GENE3D); IPR023210 (PFAM); IPR001395 (PANTHER); PTHR11732:SF245 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.6, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_00210,11738,11147,13518,0,5,10,0,0,0,0,0,5,2,11,4,0,0,2,223.7479936,1,-0.672209702,0.416571462,-1.613671994,0.106598592,0.232211298,46.39339334,0,-2.070339334,1.189512708,-1.740493666,0.081772371,0.173086563,152.945984,1,-1.586372262,0.667555083,-2.376391558,0.017482899,0.050412097,240.2543033,1,-0.33844444,0.383259933,-0.883067628,0.377199733,0.522669673,133.5903305,1,-3.120067727,0.972740141,-3.20750383,0.001338923,0.00606559,N,-,,glutaminyl-tRNA synthetase,F:ATP binding; F:RNA binding; F:oxidoreductase activity; C:mitochondrion; C:cytosol; P:oxidation-reduction process; F:glutamine-tRNA ligase activity; P:glutaminyl-tRNA aminoacylation,IPR000924 (PRINTS); IPR020056 (G3DSA:2.40.240.GENE3D); G3DSA:3.90.800.10 (GENE3D); IPR020058 (PFAM); IPR004514 (TIGRFAM); IPR014729 (G3DSA:3.40.50.GENE3D); IPR020056 (G3DSA:2.40.240.GENE3D); IPR020061 (G3DSA:1.10.1160.GENE3D); IPR020059 (PFAM); PTHR11451 (PANTHER); PTHR11451:SF29 (PANTHER); PTHR11451 (PANTHER); PTHR11451:SF29 (PANTHER); IPR011035 (SUPERFAMILY); SSF52374 (SUPERFAMILY),,
RL4_JR_00211,283,241,182,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.832313192,0,0.395785465,1.267247263,0.312319053,0.754798061,0.871570076,0.913352139,0,3.596411351,1.458350815,2.466081078,0.013660041,0.042767379,2.351834356,0,0.955494395,1.234624167,0.773915189,0.438980947,0.579054476,2.711905138,0,0.53373706,1.245228628,0.428625755,0.6681956,0.773816819,2.299423893,0,0.884780454,1.220848181,0.724726029,0.468620124,0.599997313,N,-,,rna drb0094 family,P:biological_process; C:cellular_component; F:ligase activity; F:molecular_function,IPR021122 (PFAM); SSF56091 (SUPERFAMILY),,
RL4_JR_00212,280,207,188,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,2.699870471,0,0.464756979,1.262051953,0.368255029,0.712683081,0.845313838,0.870787864,0,3.665235666,1.460186602,2.510114571,0.0120692,0.038905872,2.243491264,0,1.023415973,1.231343187,0.831137885,0.40589574,0.548124379,2.58697504,0,0.6016737,1.241734025,0.484543137,0.628000458,0.744032838,9.917191258,1,2.612892904,0.99634635,2.622474508,0.00872938,0.028157047,N,-,,Ca2+ regulator and membrane fusion Fig1,C:membrane,PS51257 (PROSITE_PROFILES),1.A.81.4.1, the low affinity ca(2+) channel (lacc) family.
RL4_JR_00213,36452,26673,29040,28,32,39,0,0,9,4,0,12,1,15,0,0,4,11,1055.108527,1,0.850722509,0.321862511,2.643123944,0.008214496,0.032452901,202.7309197,1,0.228026738,0.627010763,0.363672765,0.716102383,0.822092358,427.8626246,1,-1.272684433,0.509530863,-2.4977573,0.012498173,0.038436058,421.9201116,1,-1.982863638,0.610801528,-3.246330516,0.00116903,0.008424507,396.4676301,1,-1.539633705,0.607917851,-2.53263447,0.011320894,0.034661037,N,-,,pyruvate carboxylase,F:DNA binding; F:ATP binding; P:gluconeogenesis; F:pyruvate carboxylase activity; F:metal ion binding; F:biotin binding; C:cytosol; F:biotin carboxylase activity; P:pyruvate metabolic process,IPR005482 (SMART); IPR005481 (PFAM); IPR000891 (PFAM); IPR005930 (TIGRFAM); IPR013816 (G3DSA:3.30.470.GENE3D); IPR003379 (PFAM); IPR013815 (G3DSA:3.30.1490.GENE3D); IPR005479 (PFAM); G3DSA:3.10.600.10 (GENE3D); IPR000089 (PFAM); IPR005482 (PFAM); G3DSA:2.40.50.100 (GENE3D); IPR013785 (G3DSA:3.20.20.GENE3D); IPR005930 (PIRSF); IPR016185 (G3DSA:3.40.50.GENE3D); IPR009057 (G3DSA:1.10.10.GENE3D); PTHR18866 (PANTHER); PTHR18866:SF110 (PANTHER); IPR011764 (PROSITE_PROFILES); IPR000891 (PROSITE_PROFILES); IPR000089 (PROSITE_PROFILES); IPR011761 (PROSITE_PROFILES); SSF51569 (SUPERFAMILY); SSF89000 (SUPERFAMILY); IPR016185 (SUPERFAMILY); IPR011054 (SUPERFAMILY); IPR011053 (SUPERFAMILY); SSF56059 (SUPERFAMILY),3.B.1.1.6, the na(+)-transporting carboxylic acid decarboxylase (nat-dc) family.
RL4_JR_00214,11852,13946,17947,4,0,13,0,0,0,2,0,7,2,13,0,0,4,2,264.8995194,1,-0.826142011,0.524748174,-1.574359002,0.115404476,0.245750383,55.46639482,0,-2.328044978,1.197694534,-1.943771899,0.051922964,0.121433512,212.1729667,1,-1.007351235,0.548388654,-1.836929389,0.06622032,0.140552486,237.5682068,1,-0.881685067,0.505464152,-1.744307808,0.081105431,0.167864368,173.3151613,1,-1.884395525,0.6644027,-2.836224966,0.004565028,0.016590419,N,-, Effector probability:0.847,UPF0041 domain-containing,C:integral component of mitochondrial inner membrane; P:pyruvate transmembrane transport; P:mitochondrial pyruvate transport; F:pyruvate transmembrane transporter activity,IPR005336 (PFAM); PTHR14154 (PANTHER); PTHR14154:SF3 (PANTHER),2.A.105.1.1, the mitochondrial pyruvate carrier (mpc) family.
RL4_JR_00215,5570,6009,10991,2,1,16,0,0,0,0,0,0,0,1,0,0,0,1,179.0906489,1,0.181008077,0.638812979,0.283350657,0.776908049,0.884950554,28.32097483,0,-1.358322056,1.227508989,-1.106567909,0.268480788,0.425823832,74.1556805,0,-4.023519035,1.224348803,-3.286252273,0.0010153,0.005820442,89.60380211,1,-3.502110972,1.184545899,-2.956500864,0.003111514,0.019174726,81.2289449,1,-3.177237571,1.169278331,-2.717263707,0.006582414,0.022500655,N,-,,small nuclear ribonucleo B and B,"C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP; C:cytosol; C:viral nucleocapsid; P:mitochondrial pyruvate transport; C:U2-type prespliceosome; C:U2 snRNP; C:U1 snRNP; C:mitochondrial inner membrane; P:mRNA splicing, via spliceosome",IPR001163 (SMART); G3DSA:2.30.30.100 (GENE3D); G3DSA:2.30.30.100 (GENE3D); IPR001163 (PFAM); PTHR10701 (PANTHER); IPR010920 (SUPERFAMILY); IPR010920 (SUPERFAMILY),,
RL4_JR_00216,22724,20732,30389,0,0,32,0,0,0,3,0,2,2,25,0,1,9,6,416.6741098,1,-1.183320447,1.325325635,-0.892852606,0.371936111,0.564053172,93.60327869,0,-3.082985135,1.193935205,-2.58220473,0.009817133,0.033197402,289.8489039,1,-2.584074366,0.684758942,-3.773699337,0.000160845,0.00154683,400.0312262,1,-1.046513488,0.725919335,-1.441638813,0.149404293,0.265622207,336.1178077,1,-1.213759148,0.468968823,-2.588144642,0.009649445,0.030493331,N,-,,60S ribosomal L11,F:structural constituent of ribosome; C:ribosome; P:translation,IPR002132 (PIRSF); IPR031310 (PFAM); IPR031309 (PFAM); IPR022803 (G3DSA:3.30.1440.GENE3D); PTHR11994 (PANTHER); IPR022803 (SUPERFAMILY),,
RL4_JR_00217,4337,4098,4791,0,0,13,0,3,0,1,0,0,1,0,1,0,7,2,102.5277598,1,0.279848788,0.786404777,0.355858454,0.721946571,0.852030818,131.8837193,1,2.438683647,1.591011675,1.532788027,0.125328092,0.240944149,54.85793683,1,-2.30170517,1.186344179,-1.940166446,0.052359465,0.117301886,69.46216391,1,-1.946615946,1.007779161,-1.931589797,0.053410156,0.127223158,84.93218093,1,0.431687712,0.517292321,0.834514054,0.403991371,0.540916773,N,-,,phosphatidylinositol transfer sfh5,C:integral component of membrane; C:endoplasmic reticulum; C:organelle part; P:transport,IPR001251 (SMART); IPR001251 (PFAM); IPR001251 (G3DSA:3.40.525.GENE3D); PTHR23324 (PANTHER); PTHR23324:SF60 (PANTHER); IPR001251 (PROSITE_PROFILES); IPR011074 (SUPERFAMILY); IPR001251 (SUPERFAMILY),,
RL4_JR_00218,132,191,215,3,2,7,0,0,0,0,0,0,0,0,0,0,0,0,75.1049938,1,5.093241652,0.514938443,9.890971859,4.56E-23,9.29E-21,0.683206816,0,4.015049799,1.491174448,2.692541979,0.007090961,0.026156963,1.780935774,0,1.356266091,1.238519804,1.095070169,0.273485897,0.412510611,2.05521285,0,0.933482959,1.256381959,0.742992966,0.457485939,0.599539882,1.763128505,0,1.268387861,1.236206512,1.026032341,0.30487634,0.439987513,N,-,,alpha-ketoglutarate-dependent taurine dioxygenase,F:dioxygenase activity; F:ATP binding; C:cytoplasm; P:oxidation-reduction process; F:glutamine-tRNA ligase activity; P:glutaminyl-tRNA aminoacylation,IPR003819 (PFAM); G3DSA:3.60.130.10 (GENE3D); PTHR30468 (PANTHER); PTHR30468:SF9 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_00219,97,113,136,0,3,2,0,0,0,0,0,0,0,1,0,0,2,0,33.05266155,1,4.483754898,0.684302902,6.552295609,5.67E-11,2.07E-09,0.439723425,0,4.650773933,1.577797938,2.947635957,0.003202139,0.016125399,1.144525522,0,1.994008981,1.235479528,1.613955501,0.106537079,0.203275798,5.332217122,1,2.517262756,1.163243262,2.164003728,0.030464063,0.093257059,8.852973193,1,3.569763797,0.998436584,3.575353562,0.000349755,0.001992835,N,-,,major facilitator superfamily transporter,P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane; P:anion transport,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662 (PANTHER); PTHR11662:SF242 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_00220,1539,1415,2178,0,0,6,0,0,0,0,0,2,0,0,3,0,0,1,43.3665854,1,0.799105112,0.664607668,1.202371189,0.229219747,0.401368254,6.493910256,0,0.766359924,1.238870345,0.618595744,0.536182706,0.683703874,29.91614251,1,-0.074819445,1.045640797,-0.071553678,0.942957105,0.966146922,48.42788397,1,0.034676737,0.86485433,0.040095466,0.968017017,0.981982997,24.12881688,1,-1.043024658,1.141167881,-0.91399756,0.360718128,0.4980596,N,-,,bem46 family,C:integral component of membrane; C:endoplasmic reticulum,IPR022742 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR12277 (PANTHER); IPR029058 (SUPERFAMILY),1.C.57.3.4, the clostridial cytotoxin (cct) family.
RL4_JR_00221,7610,6334,8883,0,5,2,0,0,0,1,1,1,1,0,3,0,7,3,138.7063083,1,-1.054774869,0.590663369,-1.785746205,0.07414036,0.178155246,29.02028955,0,-1.393494941,1.198516272,-1.162683373,0.24495799,0.397987925,100.7984979,1,-1.636984734,0.854300511,-1.916169677,0.055343502,0.122149032,125.1893479,1,-1.709294222,0.74611402,-2.290928969,0.021967522,0.080296448,123.5889404,1,-0.212089697,0.5236184,-0.405046303,0.685443476,0.776907555,N,-,,lyar-type c2hc zinc finger,,IPR014898 (PFAM); PTHR13100:SF10 (PANTHER); PTHR13100 (PANTHER); PTHR13100:SF10 (PANTHER); PTHR13100 (PANTHER); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY),2.A.47.1.19, the divalent anion:na(+) symporter (dass) family.
RL4_JR_00222,1093,1025,1186,0,0,3,0,0,0,0,0,0,0,7,0,0,0,0,24.6680062,1,0.481179473,0.843417195,0.570511813,0.568330613,0.744973184,4.217688895,0,1.389063186,1.246470881,1.11439682,0.265108987,0.422122568,10.94059261,0,-1.262691117,1.189928043,-1.061149138,0.28862213,0.428070677,40.70219001,1,1.834176633,0.568303196,3.227461408,0.001248939,0.008949403,10.78506359,0,-1.34473995,1.192648061,-1.127524535,0.259520773,0.391368458,N,-,,peroxisome biosynthesis peroxin-10,P:cellular process,IPR001841 (SMART); PF13923 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR006845 (PFAM); IPR025654 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),3.A.20.1.2, the peroxisomal protein importer (ppi) family.
RL4_JR_00223,368,288,459,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.438164952,0,-0.252545146,1.225888177,-0.206009937,0.836783149,0.918937779,1.413195566,0,2.96647212,1.36173747,2.178446423,0.029372817,0.077891447,3.675721231,0,0.310648213,1.216658275,0.25532906,0.798468957,0.867691536,4.240806094,0,-0.11180667,1.219246067,-0.091701481,0.926935221,0.956926461,3.63688874,0,0.223475967,1.221004356,0.183026347,0.854777346,0.903216513,N,-,,exs family,C:Golgi apparatus; P:single-organism cellular process; C:plasma membrane,IPR004342 (PFAM); PTHR10783:SF55 (PANTHER); PTHR10783 (PANTHER); IPR004342 (PROSITE_PROFILES),2.A.94.1.2, the phosphate permease (pho1) family.
RL4_JR_00224,41,30,72,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.566573678,0,2.71714278,1.960477546,1.385959654,0.165759224,NA,0.179003317,0,5.947084923,1.911533412,3.111159286,0.001863544,0.015023052,0.468480953,0,3.281696511,1.332396328,2.463003269,0.013777866,0.041501671,0.540684193,0,2.859368522,1.478889829,1.933456074,0.053180039,0.126962485,0.466872327,0,3.185151121,1.296027509,2.457626168,0.013985867,0.041080878,N,-,,hypothetical protein HMPREF1624_03190,,no IPS match,,
RL4_JR_00225,939,1111,1415,1,0,1,0,0,0,1,3,2,1,0,0,0,2,0,27.74751553,1,-0.159356794,1.027137217,-0.155146549,0.876705786,0.939966455,4.394573655,0,1.329734207,1.255402984,1.059209054,0.289504583,0.448891756,59.04718343,1,2.079571373,0.630694864,3.297270186,0.000976295,0.005641561,22.52582438,1,-0.80039611,1.153895088,-0.693647211,0.487903479,0.628022212,19.05950309,1,0.243337657,1.000331822,0.243256939,0.807806361,0.870395546,N,-,,protoporphyrinogen oxidase,C:nucleus; P:porphyrin-containing compound biosynthetic process; F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:heme biosynthetic process; C:cytosol; F:oxygen-dependent protoporphyrinogen oxidase activity; P:oxidation-reduction process; C:mitochondrial inner membrane,G3DSA:1.10.3110.10 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR027418 (G3DSA:3.90.660.GENE3D); IPR002937 (PFAM); PTHR10742 (PANTHER); PTHR10742:SF276 (PANTHER); PTHR10742 (PANTHER); PTHR10742:SF276 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_00226,7156,4235,4623,0,5,0,0,0,1,0,4,0,0,2,0,0,0,0,103.8766517,1,-0.906555739,0.81562461,-1.111486494,0.266359,0.446467377,30.00707737,1,0.013390043,1.150566044,0.011637787,0.990714599,0.995138749,84.48930983,1,-0.716970699,0.786592409,-0.91148947,0.362037531,0.505972938,69.26823877,1,-2.25356401,1.053092015,-2.139949764,0.032358827,0.096277732,52.00394548,0,-3.614357485,1.212483662,-2.980953557,0.002873524,0.011423018,N,-,,F-box domain-containing,C:cellular_component; F:molecular_function,IPR015943 (G3DSA:2.130.10.GENE3D); G3DSA:1.20.1280.50 (GENE3D); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY); SSF82171 (SUPERFAMILY),,
RL4_JR_00227,25546,24202,30043,13,20,29,0,0,0,0,2,4,0,8,1,0,7,7,720.6479477,1,0.289747154,0.258115603,1.122548,0.261629511,0.441077402,101.6181925,0,-3.201504863,1.187548705,-2.695893525,0.00702001,0.025989957,305.6040034,1,-2.454144702,0.616841767,-3.978564414,6.93E-05,0.000910129,346.2114285,1,-2.405771066,0.520011901,-4.626376937,3.72E-06,5.90E-05,339.1191183,1,-1.510193543,0.464760459,-3.249401954,0.001156479,0.005371263,N,-,,valyl-tRNA synthetase,F:valine-tRNA ligase activity; F:ATP binding; P:valyl-tRNA aminoacylation; P:regulation of translational fidelity; C:mitochondrion; F:aminoacyl-tRNA editing activity,IPR002303 (PRINTS); IPR002300 (PFAM); IPR013155 (PFAM); IPR009008 (G3DSA:3.90.740.GENE3D); IPR014729 (G3DSA:3.40.50.GENE3D); IPR002303 (TIGRFAM); IPR009080 (G3DSA:1.10.730.GENE3D); PTHR11946 (PANTHER); PTHR11946 (PANTHER); IPR002303 (PTHR11946:PANTHER); PTHR11946 (PANTHER); IPR002303 (PTHR11946:PANTHER); IPR002303 (PTHR11946:PANTHER); IPR002303 (HAMAP); IPR009008 (SUPERFAMILY); IPR009080 (SUPERFAMILY); SSF52374 (SUPERFAMILY),,
RL4_JR_00228,37,17,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.263085685,0,3.823966539,2.747981898,1.391554486,0.164057349,NA,0.086202696,0,7.002115013,2.270580491,3.083843554,0.00204345,0.015023052,0.219985652,0,4.374110697,1.458580658,2.998881599,0.002709726,0.012576077,0.253499866,0,3.952932821,1.828371297,2.16199676,0.030618426,0.093602525,0.21336282,0,4.312885593,1.341016777,3.216130974,0.001299315,0.005923263,N,-,,beta-lactamase family,,IPR001466 (PFAM); IPR012338 (G3DSA:3.40.710.GENE3D); PTHR22935:SF54 (PANTHER); PTHR22935 (PANTHER); PTHR22935 (PANTHER); IPR012338 (SUPERFAMILY),,
RL4_JR_00229,5,3,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.063276824,0,5.87940758,3.923591175,1.498476095,0.134009599,NA,0.020036142,0,9.105709955,2.902766052,3.136907967,0.001707397,0.015023052,0.052382982,0,6.440646237,1.663008368,3.872888652,0.000107553,0.001219335,0.060451023,0,6.020182964,2.848341685,2.113574714,0.034551607,0.099426657,0.052168047,0,6.346281664,1.356006076,4.680127749,2.87E-06,3.54E-05,N,-,,tyrosinase central domain containing,"P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:snoRNA binding; F:catalytic activity; F:oxidoreductase activity; F:metal ion binding; P:metabolic process; C:membrane; C:integral component of membrane; P:nucleoside metabolic process; P:RNA processing; P:oxidation-reduction process",IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR002110 (PFAM); PTHR24198 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_00230,1707,2341,1956,9,8,20,0,0,0,0,0,0,0,3,1,1,0,0,255.2124748,1,3.243441305,0.35043435,9.255489092,2.13E-20,2.95E-18,7.700018581,0,0.520683274,1.238093863,0.420552342,0.674082001,0.79196908,19.97104119,0,-2.130789179,1.201751346,-1.773069934,0.076217119,0.157025258,44.71032663,1,0.164513842,0.76386076,0.215371505,0.829477684,0.893358319,35.68203798,1,-1.274411817,1.132296805,-1.125510389,0.260372817,0.392186072,N,-,,methyltransferase type 12,F:methyltransferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_00231,868,1490,1439,7,0,14,0,0,2,1,0,0,0,9,1,1,3,2,139.201922,1,3.029367765,0.625960532,4.839550755,1.30E-06,1.91E-05,23.59276878,1,2.817514795,1.029204359,2.737565936,0.006189571,0.02380351,23.66890348,1,-0.504426842,1.216538131,-0.414641209,0.678404576,0.778792145,60.27892006,1,2.054285999,0.604032961,3.400950164,0.000671521,0.005311834,54.79592612,1,1.67243745,0.675774407,2.474845796,0.013329371,0.039564416,N,-,,pisatin demethylase (cytochrome P450),"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; F:methyltransferase activity; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding; P:methylation",IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24305:SF77 (PANTHER); PTHR24305:SF77 (PANTHER); PTHR24305 (PANTHER); PTHR24305 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_00232,65,56,83,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.813120088,0,2.196018861,1.599367379,1.373054678,0.169735349,NA,0.25873731,0,5.415832801,1.736526273,3.11877389,0.001816053,0.015023052,0.673066683,0,2.759507755,1.257581696,2.19429701,0.028214064,0.072997492,0.776559701,0,2.337303785,1.326812081,1.761593687,0.078137971,0.163561497,0.665859459,0,2.672946027,1.233652955,2.166692032,0.030258345,0.075639823,N,-,,MFS general substrate transporter,P:biological_process; P:transmembrane transport; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function; F:transporter activity,G3DSA:1.20.1250.20 (GENE3D); PTHR23502:SF51 (PANTHER); PTHR23502 (PANTHER); PTHR23502:SF51 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.2.43, the major facilitator superfamily (mfs).
RL4_JR_00233,15,25,31,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.284757902,0,3.70986629,2.591494076,1.431554996,0.152271217,NA,0.089720226,0,6.943663309,2.163184057,3.209927185,0.001327686,0.015023052,0.234587322,0,4.28030421,1.369731243,3.124922668,0.001778518,0.009016383,0.270765892,0,3.857549756,1.690309038,2.282156499,0.022480102,0.080827783,0.232974537,0,4.189471515,1.287667091,3.253536215,0.001139782,0.005308322,N,-,,uncharacterized protein LW94_2826,,no IPS match,,
RL4_JR_00234,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.015572136,0,7.899458556,3.974566037,1.987502153,0.046866778,NA,0.005005645,0,11.10559461,3.974227246,2.79440352,0.005199555,0.021136506,0.013004533,0,8.449602389,2.844306081,2.970707845,0.002971143,0.013488722,0.014998643,0,8.029635455,3.97405316,2.020515361,0.043329958,0.113246213,0.012910819,0,8.3508871,1.560789616,5.350424565,8.77E-08,2.01E-06,N,-,,glycoside hydrolase family 18,P:metabolic process; F:hydrolase activity,no IPS match,,
RL4_JR_00235,254,531,262,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8.076274841,1,0.749461916,1.24076812,0.604030604,0.545823296,0.725807082,1.356618707,0,3.02560242,1.460006089,2.072321782,0.038235442,0.095583884,3.510148118,0,0.377723924,1.274218692,0.296435711,0.766897357,0.843462123,4.049469281,0,-0.044680906,1.288744081,-0.034670115,0.972342791,0.984640718,3.439424416,0,0.304201632,1.272479368,0.239062133,0.811057404,0.87212789,N,-,,siderochrome-iron transporter,P:transmembrane transport; F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF50 (PANTHER); PTHR23501 (PANTHER); PTHR23501:SF50 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.16.7, the major facilitator superfamily (mfs).
RL4_JR_00236,50596,243594,177486,0,5,14,0,0,0,0,0,0,0,3,0,0,0,0,2011.522292,1,-4.259953653,0.921740465,-4.621641138,3.81E-06,4.92E-05,601.1781105,0,-5.766125213,1.350509365,-4.269592914,1.96E-05,0.001159177,1572.396837,0,-8.429750567,1.367862271,-6.162718825,7.15E-10,3.77E-08,1827.269318,1,-6.699631028,1.160679202,-5.772164277,7.83E-09,2.18E-07,1557.707132,0,-8.518977985,1.445772655,-5.89233581,3.81E-09,1.97E-07,Y,-,,---NA---,,no IPS match,,
RL4_JR_00237,40,40,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.422659568,0,3.140183631,2.166902734,1.44915763,0.147293567,NA,0.136205171,0,6.341969026,2.001808483,3.168119768,0.001534283,0.015023052,0.350611895,0,3.702120599,1.323426112,2.797376117,0.005151952,0.019346573,0.404299524,0,3.279734171,1.515927932,2.163515891,0.030501523,0.093329682,0.342449586,0,3.63208448,1.254204284,2.895927343,0.003780399,0.014261007,Y,-,,SFI1 like,,IPR001938 (SUPERFAMILY),,
RL4_JR_00238,2045,2689,4561,0,7,11,0,0,0,0,2,0,0,12,0,0,0,0,135.1487999,1,1.508834882,0.607505837,2.483654954,0.013004174,0.046734826,11.65857525,0,-0.077865577,1.254946595,-0.062046925,0.950525463,0.973667236,46.24601007,1,-0.919311204,1.077257423,-0.853381174,0.393447958,0.536618825,83.41543829,1,0.634070938,1.362045828,0.465528344,0.641553144,0.75421654,30.46101285,0,-2.842663165,1.246861443,-2.279854896,0.022616296,0.060180777,N,-,,6-phosphogluconate dehydrogenase,F:oxidoreductase activity,IPR013328 (G3DSA:1.10.1040.GENE3D); IPR015814 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR028939 (PFAM); PTHR22981 (PANTHER); PTHR22981:SF63 (PANTHER); IPR016040 (SUPERFAMILY); IPR008927 (SUPERFAMILY),,
RL4_JR_00239,1217,1353,1259,0,0,9,0,0,0,1,0,0,1,3,0,0,0,0,49.73614397,1,1.804239216,0.53446787,3.375767406,0.000736101,0.004641112,4.908041082,0,1.170406168,1.244649282,0.940350173,0.347037972,0.509902504,23.78748296,1,-0.517853413,1.190599049,-0.43495198,0.663597284,0.768043172,36.01758413,1,0.822344938,0.742395802,1.107690716,0.26799541,0.409392506,12.51316604,0,-1.559102601,1.192721549,-1.307180709,0.191151345,0.311308891,N,-,,rna binding domain-containing,F:organic cyclic compound binding; F:heterocyclic compound binding,IPR000504 (SMART); IPR025715 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); IPR025715 (PFAM); PTHR19965:SF30 (PANTHER); PTHR19965:SF30 (PANTHER); PTHR19965 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_00240,243,302,288,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,3.345720161,0,0.155566889,1.2306337,0.126412018,0.89940579,0.950926961,1.065407625,0,3.3741313,1.39427713,2.419986118,0.0155211,0.047434067,2.765380576,0,0.721649675,1.212344954,0.595251107,0.551675633,0.678964759,7.202028156,1,1.245803544,1.15428337,1.079287441,0.28045961,0.423814397,6.585890023,1,1.569469191,1.134033461,1.383970795,0.166367397,0.280044871,N,-,,---NA---,,no IPS match,,
RL4_JR_00241,89120,102711,122162,17,45,43,0,0,7,0,0,5,1,19,0,0,20,0,1952.890168,1,-0.867945844,0.390624249,-2.221945633,0.02628698,0.081901495,464.908641,1,-1.824940415,0.628199112,-2.905035011,0.00367212,0.017256186,1071.364083,1,-4.712401577,0.714845728,-6.592193801,4.33E-11,2.73E-09,1284.22627,1,-3.572242965,0.786372475,-4.542685658,5.55E-06,8.48E-05,1104.275779,1,-3.502482426,1.087689408,-3.220112655,0.001281402,0.005873336,N,-,,ATP-dependent RNA helicase eIF4A,F:translation initiation factor activity; F:ATP binding; P:mycelium development; C:cytosol; F:helicase activity; P:translational initiation,IPR014001 (SMART); IPR001650 (SMART); IPR011545 (PFAM); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24031 (PANTHER); PTHR24031:SF84 (PANTHER); IPR014014 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_00242,8676,11027,14205,0,0,0,0,0,0,0,0,0,0,0,0,0,5,1,135.7089507,0,-5.186702865,1.217792362,-4.259102804,2.05E-05,0.00021412,42.94515084,0,-1.958928876,1.204722262,-1.626041899,0.103940742,0.208574045,112.0181597,0,-4.618609861,1.205243949,-3.832095456,0.000127056,0.00133713,129.2710076,0,-5.041442246,1.207883286,-4.173782604,3.00E-05,0.000377274,137.6965474,1,-1.544849963,0.68409951,-2.258224047,0.023931695,0.062920906,N,-,,F-box domain-containing,P:mycelium development,IPR003347 (SMART); PF13621 (PFAM); G3DSA:2.60.120.650 (GENE3D); IPR001810 (PFAM); G3DSA:1.20.1280.50 (GENE3D); PTHR12480:SF21 (PANTHER); PTHR12480 (PANTHER); IPR001810 (PROSITE_PROFILES); IPR003347 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY); IPR001810 (SUPERFAMILY),,
RL4_JR_00243,3603,4060,3335,4,9,13,0,0,0,0,2,1,2,1,0,0,2,0,206.2030282,1,1.867053185,0.360272629,5.182334245,2.19E-07,4.00E-06,14.14541192,0,-0.356705209,1.216824229,-0.2931444,0.76941178,0.860424124,58.77891503,1,-0.598104248,0.857824262,-0.697234007,0.48565636,0.621119882,64.84666089,1,-1.102945103,0.857372223,-1.286425047,0.198294762,0.328644789,43.6575739,1,-1.412344091,0.975215957,-1.448237266,0.147550706,0.255944988,N,-,,ccch zinc finger and smr domain-containing,C:membrane; F:binding,IPR000571 (SMART); IPR013899 (SMART); PF14608 (PFAM); IPR002625 (PFAM); IPR013899 (PFAM); PTHR13119 (PANTHER); IPR002625 (PROSITE_PROFILES); IPR000571 (PROSITE_PROFILES); IPR000571 (PROSITE_PROFILES); IPR002625 (SUPERFAMILY); IPR000571 (SUPERFAMILY),,
RL4_JR_00244,268,221,229,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.871376655,0,0.37588692,1.228011493,0.306093975,0.759533095,0.873023023,0.921381473,0,3.583706749,1.423083536,2.518268717,0.011793331,0.03810153,2.381888074,0,0.936959594,1.212969385,0.772451147,0.43984727,0.579895008,2.747150262,0,0.514932583,1.217749012,0.422856087,0.672400263,0.777330003,2.339810986,0,0.85962915,1.203116138,0.714502218,0.474916685,0.605075052,N,-,,tlg2-vesicle of,C:membrane,IPR032816 (PFAM); PTHR12677:SF23 (PANTHER); IPR015414 (PANTHER),9.B.27.5.2, the deda or ydjx-z (deda) family.
RL4_JR_00245,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein SPBR_01692,,no IPS match,,
RL4_JR_00246,8746,7357,12886,0,0,0,0,0,0,0,1,0,0,0,3,0,3,0,115.3205126,0,-4.951849417,1.219644607,-4.060075687,4.91E-05,0.000461598,36.58100779,0,-1.727537571,1.210579615,-1.427033423,0.153570261,0.281499128,103.2408868,1,-3.42512372,1.208481299,-2.834238084,0.00459351,0.01778382,138.9872971,1,-2.445634811,0.879730135,-2.779982988,0.005436175,0.029929999,106.2342869,1,-2.299624216,0.896197593,-2.565979013,0.010288505,0.032131745,N,-,,hypothetical protein CMQ_7766,,IPR011989 (G3DSA:1.25.10.GENE3D),,
RL4_JR_00247,4300,4213,4022,0,0,9,0,0,0,3,0,4,8,4,0,0,3,0,84.61233641,1,0.102975296,0.525519259,0.195949614,0.844649603,0.92194962,16.08323286,0,-0.541934975,1.206312321,-0.449249308,0.653251822,0.77645796,100.8277165,1,0.442163225,0.568642489,0.777576832,0.436818523,0.577029062,138.5548649,1,0.729238434,0.458865665,1.589219872,0.112010762,0.213174138,52.4956118,1,-1.058289734,0.833519395,-1.269664197,0.204204271,0.326578463,N,-,,proline iminopeptidase,P:proteolysis; F:peptidase activity,IPR002410 (PRINTS); IPR000073 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR10992 (PANTHER); PTHR10992:SF749 (PANTHER); PTHR10992:SF749 (PANTHER); PTHR10992 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_00248,3906,4327,3865,0,5,11,0,0,0,0,0,0,0,0,0,0,0,0,130.6347767,1,0.990948629,0.424746692,2.333034367,0.019646342,0.064548874,15.5265358,0,-0.491113802,1.208834218,-0.406270599,0.684543785,0.799648263,40.20615735,0,-3.140315248,1.190920304,-2.636881106,0.008367215,0.028359453,46.37906304,0,-3.562539337,1.190338378,-2.992879506,0.002763588,0.017379709,39.53116861,0,-3.218682968,1.18962737,-2.705622826,0.006817643,0.023101953,N,-, Effector probability:0.76,cytosine deaminase,P:cytosine metabolic process; C:nucleus; P:cytidine metabolic process; F:zinc ion binding; C:cytoplasm; F:cytosine deaminase activity; P:pyrimidine-containing compound salvage,G3DSA:3.40.140.10 (GENE3D); IPR002125 (PFAM); PTHR11079 (PANTHER); PTHR11079:SF63 (PANTHER); IPR002125 (PROSITE_PROFILES); IPR016193 (SUPERFAMILY),,
RL4_JR_00249,31370,16633,15634,2,26,7,0,0,4,0,5,5,1,18,0,0,10,1,508.7644109,1,-0.006826054,0.873350309,-0.007815941,0.993763845,0.997603551,119.9481212,1,-0.380194794,0.870675989,-0.436666221,0.66235343,0.78367521,283.2004066,1,-1.42681822,0.607803282,-2.347500025,0.018899872,0.053627327,325.3165923,1,-1.330002929,0.768795741,-1.729982177,0.08363346,0.171345362,252.2476369,1,-1.696563817,0.683292791,-2.482923629,0.013030902,0.038857867,N,-,,phd finger and bah domain containing,F:binding,IPR001965 (SMART); IPR001025 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR001025 (PFAM); PTHR10629 (PANTHER); PTHR10629:SF35 (PANTHER); IPR001025 (PROSITE_PROFILES); IPR019787 (PROSITE_PROFILES); IPR000949 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY); IPR011011 (SUPERFAMILY); IPR009057 (SUPERFAMILY),,
RL4_JR_00250,685,579,586,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.401651769,0,-0.990185019,1.193573725,-0.829596864,0.406766751,0.598341715,2.37475624,0,2.217790643,1.300930234,1.704772927,0.088236783,0.183772163,6.138984279,0,-0.428945072,1.199453646,-0.357617048,0.720629919,0.8109015,7.080429446,0,-0.850956279,1.19722715,-0.71077262,0.47722515,0.617890619,6.029927099,0,-0.506024529,1.195152379,-0.4233975,0.672005269,0.766394835,N,-,,DNA polymerase theta subunit,F:organic cyclic compound binding; F:heterocyclic compound binding; F:hydrolase activity,IPR001650 (SMART); IPR014001 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011545 (PFAM); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_00251,209,190,182,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.327260603,0,0.679100937,1.246387553,0.544855358,0.585853002,0.758426055,0.746181177,0,3.887993141,1.460411495,2.662258654,0.007761821,0.027959129,1.929289723,0,1.241115489,1.215857283,1.020773989,0.307361531,0.448699082,2.225212576,0,0.81902034,1.224279027,0.668981762,0.503507112,0.640533925,1.894895042,0,1.163994366,1.203357991,0.967288517,0.333399823,0.470084,N,-,,dead deah box helicase,F:nucleic acid binding; F:ATP binding; F:DNA-directed DNA polymerase activity; P:DNA biosynthetic process; F:helicase activity,G3DSA:1.10.150.20 (GENE3D); SSF158702 (SUPERFAMILY),,
RL4_JR_00252,1981,1967,2022,0,1,0,1,0,0,1,0,0,2,0,0,0,0,0,31.92452182,1,-1.73306224,1.136234437,-1.525268188,0.127192219,0.2630789,29.95371146,1,1.454545376,1.110235145,1.3101237,0.190153992,0.331394405,30.87178853,1,-1.156741218,1.18640302,-0.974998545,0.329560982,0.472588581,41.46683851,1,-0.802113138,1.007019242,-0.796522156,0.425728603,0.568367894,19.49243664,0,-2.198609529,1.187772104,-1.851036509,0.064164301,0.135799237,N,-,,hypothetical protein CSUB01_03061,,G3DSA:3.30.710.10 (GENE3D); IPR000210 (PFAM); PTHR26379:SF149 (PANTHER); PTHR26379 (PANTHER); IPR000210 (PROSITE_PROFILES); IPR011333 (SUPERFAMILY),,
RL4_JR_00253,7247,5010,7174,0,0,2,0,0,0,0,0,1,1,2,0,0,8,0,84.99905936,1,-2.654257234,1.026641929,-2.585377781,0.009727235,0.037114141,24.76636184,0,-1.164800876,1.209529412,-0.963019886,0.335537544,0.498724085,70.68543112,1,-2.853441931,1.19894427,-2.379962106,0.017314418,0.0500403,91.3731753,1,-1.927611593,0.867857843,-2.221114447,0.026343211,0.08636862,94.15875363,1,-0.349815468,0.607518217,-0.575810664,0.564743165,0.68217902,N,-,,hypothetical protein SPI_00102,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR004827 (PFAM); IPR021833 (PFAM),,
RL4_JR_00254,21320,12541,11631,0,3,7,0,0,0,0,3,4,0,0,0,0,0,0,232.2820576,1,-1.619740859,0.613582846,-2.639807923,0.008295303,0.032755605,58.85570372,0,-2.413582894,1.235519261,-1.953496777,0.050760759,0.119260678,200.7191722,1,-1.445756807,0.649249625,-2.226811924,0.025959846,0.068567045,174.3061514,0,-5.472657015,1.230331243,-4.448116754,8.66E-06,0.000126019,147.6314668,0,-5.119646203,1.226956005,-4.172640406,3.01E-05,0.000254045,N,-,,short-chain dehydrogenase,F:hydrolase activity,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24320 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_00255,227321,131991,154138,12,33,33,5,0,4,3,2,18,0,4,3,0,20,0,2556.153749,1,-2.013299486,0.426156043,-4.724324621,2.31E-06,3.18E-05,809.4651072,1,-2.083523053,0.643502118,-3.237787408,0.001204605,0.015023052,1867.552458,1,-3.295430955,0.637872646,-5.166283546,2.39E-07,7.63E-06,2007.081716,1,-5.432871704,0.669234036,-8.118044525,4.74E-16,3.24E-14,1744.670358,1,-4.224233857,1.168995176,-3.613559701,0.000302022,0.001758465,N,-,,chaperone dnaj 2,C:nucleus; F:ATP binding; F:heat shock protein binding; P:response to heat; F:metal ion binding; P:negative regulation of cellular response to heat; F:unfolded protein binding; P:microtubule cytoskeleton organization; P:protein folding,IPR001623 (PRINTS); IPR001623 (SMART); IPR002939 (PFAM); G3DSA:2.60.260.20 (GENE3D); IPR001305 (PFAM); IPR001623 (PFAM); G3DSA:2.60.260.20 (GENE3D); IPR001623 (G3DSA:1.10.287.GENE3D); IPR001305 (G3DSA:2.10.230.GENE3D); PTHR24078 (PANTHER); PTHR24078:SF239 (PANTHER); IPR001305 (PROSITE_PROFILES); IPR001623 (PROSITE_PROFILES); IPR012724 (HAMAP); IPR008971 (SUPERFAMILY); IPR001305 (SUPERFAMILY); IPR001623 (SUPERFAMILY); IPR008971 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_00256,3388,3387,5835,0,1,0,0,0,0,0,0,0,1,5,0,0,6,0,58.22925431,1,-2.798731776,1.177519497,-2.376802918,0.017463416,0.058797584,15.87467283,0,-0.523196027,1.226419873,-0.426604328,0.669667544,0.788825193,41.4835345,0,-3.18552267,1.213554524,-2.624952243,0.008666112,0.029216024,77.24565641,1,-0.34032428,0.68195137,-0.499044792,0.617747829,0.735846679,64.39796449,1,-0.161255469,0.722833581,-0.22308796,0.823467049,0.881446651,N,-,,tRNA methyltransferase,P:metabolic process,IPR015943 (G3DSA:2.130.10.GENE3D); PTHR16288:SF0 (PANTHER); PTHR16288 (PANTHER); PTHR16288 (PANTHER); PTHR16288:SF0 (PANTHER); IPR028884 (HAMAP); IPR011047 (SUPERFAMILY),,
RL4_JR_00257,49091,51568,74118,5,11,85,4,0,7,0,4,1,3,35,3,0,28,5,1160.760475,1,-0.541942393,0.689907689,-0.785528849,0.432143562,0.62297706,376.0809618,1,-0.269836824,0.515409176,-0.523539038,0.600599192,0.735335897,614.4782164,1,-3.840608918,0.706229475,-5.43818837,5.38E-08,1.95E-06,862.6198985,1,-1.618220623,0.60014366,-2.696388768,0.00700958,0.036583506,716.4035212,1,-1.753810633,0.699126477,-2.508574188,0.012121951,0.036702977,N,-,,60S acidic ribosomal P0,"F:structural constituent of ribosome; P:cytoplasmic translation; C:cytosolic large ribosomal subunit; F:large ribosomal subunit rRNA binding; P:ribosomal large subunit assembly; C:preribosome, large subunit precursor",PF00428 (PFAM); IPR001790 (PFAM); IPR030670 (PIRSF); PTHR21141:SF3 (PANTHER); PTHR21141 (PANTHER); SSF160369 (SUPERFAMILY),,
RL4_JR_00258,7452,4926,5512,0,0,1,0,0,0,2,3,8,2,0,3,0,4,3,75.17681281,1,-3.312806979,1.158217692,-2.8602628,0.004232901,0.018911284,22.98752904,0,-1.057244808,1.221235494,-0.865717393,0.38664516,0.551278876,156.9671449,1,0.806402661,0.476618324,1.691925427,0.090660193,0.180004667,115.922965,1,-1.003700474,0.697609393,-1.438771445,0.150215289,0.266419964,95.71243194,1,-0.350545791,0.604136077,-0.580243101,0.561750692,0.67969954,N,-,,DNA mismatch repair,F:ATP binding; P:mismatch repair; F:mismatched DNA binding,IPR007696 (SMART); IPR000432 (SMART); IPR007696 (PFAM); IPR007695 (PFAM); IPR007860 (G3DSA:3.30.420.GENE3D); IPR016151 (G3DSA:3.40.1170.GENE3D); PIRSF037677 (PIRSF); IPR007860 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.1420.10 (GENE3D); IPR000432 (PFAM); PTHR11361:SF86 (PANTHER); PTHR11361 (PANTHER); PTHR11361:SF86 (PANTHER); PTHR11361 (PANTHER); PTHR11361:SF86 (PANTHER); IPR007860 (SUPERFAMILY); IPR016151 (SUPERFAMILY); IPR007696 (SUPERFAMILY); IPR016151 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_00259,15454,8816,5332,5,3,0,0,0,1,3,31,41,3,2,12,0,52,17,192.7488399,1,-0.865616176,0.934917882,-0.925874018,0.354511455,0.545268562,48.05560553,1,-0.897241658,1.204031099,-0.745198075,0.456151986,0.615704814,641.6096414,1,2.48187434,0.665411158,3.729835772,0.000191605,0.001713457,265.4713788,1,0.309979317,0.791837186,0.391468502,0.695450967,0.794655348,421.8596336,1,1.854241524,0.806060546,2.300374995,0.021426984,0.057747215,N,-,,hypothetical protein CMQ_7843,,no IPS match,,
RL4_JR_00260,4541,6260,4214,6,8,29,0,0,3,0,3,12,1,5,2,0,8,1,295.8128701,1,2.040141533,0.406765069,5.015527851,5.29E-07,8.75E-06,47.50797377,1,1.34939351,0.897068247,1.504226144,0.132523148,0.250681986,151.6151271,1,1.203010358,0.523635503,2.297419391,0.021594857,0.059104171,106.4332258,1,-0.162940989,0.588738788,-0.276762789,0.781962255,0.859631519,87.39483296,1,0.190448428,0.5865708,0.324681058,0.745422472,0.822336297,N,-,,glycoside hydrolase family 38,F:alpha-mannosidase activity; F:zinc ion binding; P:mannose metabolic process; F:carbohydrate binding,IPR015341 (SMART); IPR000602 (PFAM); IPR015341 (PFAM); IPR011682 (PFAM); IPR015341 (G3DSA:1.20.1270.GENE3D); IPR027291 (G3DSA:3.20.110.GENE3D); PTHR11607:SF15 (PANTHER); PTHR11607 (PANTHER); PTHR11607 (PANTHER); PTHR11607:SF15 (PANTHER); IPR028995 (SUPERFAMILY); IPR011013 (SUPERFAMILY); IPR011330 (SUPERFAMILY),,
RL4_JR_00261,289,161,365,0,0,0,0,0,0,0,0,3,0,3,0,0,0,1,3.226963752,0,0.207225198,1.301796086,0.159184069,0.873523855,0.939103212,1.027777506,0,3.425863854,1.458386684,2.349077849,0.018819972,0.054897911,22.17221925,1,3.153905073,0.913167508,3.453807814,0.000552731,0.003645505,15.12218733,1,2.606790204,0.935534231,2.786418837,0.005329396,0.029454223,10.01888583,1,1.622976396,1.177697854,1.378092344,0.168174779,0.282523584,Y,-,,NAK kinase,"F:ATP binding; P:vacuolar protein processing; P:regulation of vacuole fusion, non-autophagic; C:cytoplasm; F:protein serine/threonine kinase activity; P:protein phosphorylation",IPR000719 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); PTHR22967 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.2.2, the pock size-determining protein (psdp) family.
RL4_JR_00262,278,153,257,0,0,1,0,0,0,0,0,3,0,5,0,0,0,0,6.549622195,1,1.392492355,1.186121554,1.173987903,0.240399871,0.415146409,0.876298082,0,3.655992044,1.467059061,2.492055119,0.012700633,0.040413645,21.76543716,1,3.39801132,0.891897165,3.809868954,0.00013904,0.001411881,22.67521991,1,3.571916007,0.740947926,4.820738252,1.43E-06,2.54E-05,2.236489539,0,0.924741992,1.238373477,0.746739178,0.455221016,0.587148126,N,-,,alpha- -mannosyltransferase,"P:biological_process; F:transferase activity, transferring glycosyl groups; C:membrane; C:integral component of membrane; P:protein glycosylation; F:transferase activity; C:cellular_component; F:molecular_function",IPR022751 (PFAM); IPR029044 (G3DSA:3.90.550.GENE3D); PTHR31646 (PANTHER); IPR029044 (SUPERFAMILY),,
RL4_JR_00263,474,497,417,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,5.574447468,0,-0.580921683,1.206175519,-0.481622843,0.630073896,0.789333974,1.785803673,0,2.629022417,1.333054035,1.972179932,0.04858907,0.115260971,4.617117249,0,-0.017777896,1.205616392,-0.014745898,0.988234902,0.994620753,21.37181892,1,2.268975986,0.75697827,2.997412311,0.002722822,0.017160269,4.532176259,0,-0.093947869,1.199692305,-0.078309971,0.937581486,0.959665644,N,-,,metallo ase,F:hydrolase activity,IPR024080 (G3DSA:1.20.1050.GENE3D); IPR001567 (PFAM); IPR024077 (G3DSA:1.10.1370.GENE3D); IPR024079 (G3DSA:3.40.390.GENE3D); PTHR11804 (PANTHER); PTHR11804:SF40 (PANTHER); SSF55486 (SUPERFAMILY),,
RL4_JR_00264,2938,1835,2438,0,0,3,0,0,0,0,0,0,0,3,0,0,0,0,40.16313753,1,-0.657422942,0.878020655,-0.748755668,0.454004484,0.643015379,9.228623433,0,0.259411474,1.242239185,0.208825705,0.834584304,0.900795727,23.85296428,0,-2.387138536,1.205462177,-1.980268301,0.047673389,0.109121725,39.54377251,1,-0.520709723,0.882858272,-0.589799903,0.555324808,0.684188815,23.44922586,0,-2.465298651,1.20699189,-2.042514676,0.041100505,0.096144427,N,-,,rhodanese-like domain-containing,F:phosphoprotein phosphatase activity; P:regulation of protein kinase activity; P:mitotic cell cycle process; P:protein dephosphorylation; P:positive regulation of cell cycle; C:intracellular part; P:regulation of G2/M transition of mitotic cell cycle,IPR000751 (PRINTS); IPR001763 (SMART); IPR001763 (G3DSA:3.40.250.GENE3D); IPR001763 (PFAM); PTHR10828:SF17 (PANTHER); PTHR10828 (PANTHER); IPR001763 (PROSITE_PROFILES); IPR001763 (SUPERFAMILY),,
RL4_JR_00265,2923,2511,3414,0,1,2,0,0,0,0,0,0,0,1,0,0,0,0,50.94620972,1,-0.935190503,0.853643384,-1.095528321,0.273285245,0.455363772,11.25374447,0,-0.026846035,1.212114628,-0.022148099,0.982329818,0.990676395,29.23220726,0,-2.680565018,1.192255972,-2.24831335,0.024556216,0.065526392,37.73587671,1,-2.155865441,1.144464287,-1.883733258,0.059601065,0.136354635,28.87102211,0,-2.765340051,1.197775461,-2.308729926,0.020958573,0.056724284,N,-,,cwfj domain-containing,F:enzyme activator activity; C:intracellular part,IPR006767 (PFAM); IPR006768 (PFAM); IPR011146 (G3DSA:3.30.428.GENE3D); PTHR12072:SF4 (PANTHER); PTHR12072 (PANTHER),,
RL4_JR_00266,1467,1072,2579,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,20.27717407,0,-2.444186801,1.251201479,-1.953471797,0.050763716,0.13445792,6.406204445,0,0.785959837,1.288908215,0.609787281,0.542002728,0.688782374,23.26522198,1,-0.916827933,1.235737289,-0.741927868,0.45813104,0.596082592,23.36218485,1,-1.357839337,1.19678949,-1.134568233,0.25655627,0.395859834,16.70942461,0,-1.976376203,1.256707361,-1.572662232,0.115797049,0.213326988,N,-,,set domain containing,P:peptidyl-lysine methylation; F:transferase activity; C:intracellular part,G3DSA:3.90.1410.10 (GENE3D); IPR001214 (PFAM); PTHR13271 (PANTHER); PTHR13271:SF25 (PANTHER); IPR001214 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY),,
RL4_JR_00267,248,93,243,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.305440646,0,0.69236335,1.39757898,0.495401949,0.620316419,0.781840501,0.739487551,0,3.900834349,1.568888398,2.486368281,0.012905433,0.040923809,1.917773357,0,1.24921951,1.296786203,0.963319557,0.335387182,0.4785708,2.211968489,0,0.827220421,1.329239215,0.622326224,0.533727381,0.666418761,1.895088892,0,1.1637401,1.294479562,0.899002298,0.368651437,0.504930887,,,,,,,,
RL4_JR_00268,61834,45513,81464,10,1,1,0,0,0,0,0,2,1,5,3,0,6,0,862.8591252,1,-2.8634996,1.004777036,-2.849885595,0.004373496,0.019432995,238.6630298,0,-4.43331684,1.214719453,-3.649663164,0.000262584,0.010760645,634.4427249,1,-5.278812648,1.067448785,-4.945260813,7.60E-07,2.13E-05,775.2953642,1,-3.614479948,0.575780246,-6.277533784,3.44E-10,1.20E-08,638.9241102,1,-4.102960766,0.787830516,-5.207923125,1.91E-07,3.89E-06,N,-,,U3 small nucleolar RNA-associated 20,"P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:mycelium development; C:nuclear lumen; C:preribosome; P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",IPR011430 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR17695:SF11 (PANTHER); PTHR17695 (PANTHER); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_00269,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_00270,86,52,133,0,0,0,0,0,0,0,0,5,0,0,4,0,0,0,1.072207301,0,1.796840895,1.578148226,1.138575493,0.254880255,NA,0.339788081,0,5.022546942,1.715865123,2.927122227,0.003421144,0.016584684,33.38144422,1,5.461247093,0.769841727,7.093986856,1.30E-12,1.03E-10,39.56561712,1,5.089336778,1.481122098,3.436135876,0.000590075,0.004783066,0.883489798,0,2.264834865,1.290504048,1.755000202,0.079259273,0.160243638,N,-,,Hexose transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,IPR003663 (PRINTS); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); IPR003663 (TIGRFAM); PTHR23500:SF50 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.39, the major facilitator superfamily (mfs).
RL4_JR_00271,2904,3013,3042,1,4,5,0,0,0,0,0,0,0,0,0,0,1,1,97.10621019,1,0.782512476,0.47956639,1.631708338,0.102740943,0.226163144,11.46683638,0,-0.053855984,1.209134183,-0.044540949,0.964473212,0.981342768,29.72219641,0,-2.704452705,1.18700544,-2.278382739,0.022703784,0.061490933,34.28682144,0,-3.126728177,1.18538094,-2.637741228,0.008346024,0.042020634,40.48939935,1,-1.107946396,0.965760406,-1.147226982,0.251287823,0.382025406,N,-,,cullin family,F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; C:cullin-RING ubiquitin ligase complex; F:ligase activity; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process,IPR019559 (SMART); IPR016158 (SMART); IPR001373 (PFAM); G3DSA:1.20.1310.10 (GENE3D); G3DSA:1.20.1310.10 (GENE3D); IPR019559 (PFAM); G3DSA:4.10.1030.10 (GENE3D); G3DSA:1.20.1310.10 (GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); G3DSA:1.20.1310.10 (GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); PTHR11932:SF23 (PANTHER); PTHR11932 (PANTHER); PTHR11932:SF23 (PANTHER); PTHR11932 (PANTHER); PTHR11932 (PANTHER); PTHR11932:SF23 (PANTHER); IPR016158 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY); IPR016159 (SUPERFAMILY); IPR016158 (SUPERFAMILY),,
RL4_JR_00272,3042,2690,4427,0,0,0,0,0,0,2,0,0,0,0,4,0,1,0,40.45242959,0,-3.440527537,1.209033461,-2.8456843,0.004431611,0.019659097,12.83501375,0,-0.21655428,1.221899578,-0.177227559,0.859329649,0.917815206,55.59926544,1,-1.038116901,1.045524928,-0.992914538,0.320751604,0.463302788,77.1499782,1,-0.503912934,0.775553359,-0.649746311,0.515856104,0.650522239,37.03932256,1,-2.037536753,1.145937164,-1.778052774,0.075395188,0.153411631,N,-, Effector probability:0.618,DNL zinc finger domain containing partial,F:binding; P:cellular process,IPR007853 (PFAM); IPR024158 (PANTHER); PTHR20922:SF13 (PANTHER); IPR007853 (PROSITE_PROFILES),,
RL4_JR_00273,3,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.019478151,0,7.57718263,3.961086708,1.912905015,0.055760213,NA,0.006341168,0,10.76585697,3.960170739,2.718533538,0.006557201,0.024747198,0.01633527,0,8.122024615,2.743094565,2.960898512,0.00306743,0.013767301,0.018830106,0,7.702177146,3.960482763,1.944757144,0.051804214,0.125559168,0.016075682,0,8.032689633,1.553673371,5.170127636,2.34E-07,4.41E-06,Y,-, Effector probability:0.623,clock-controlled pheromone CCG-4,F:pheromone activity; P:response to pheromone; C:extracellular region; F:mating pheromone activity,no IPS match,,
RL4_JR_00274,1313,1262,1774,0,1,2,0,0,0,0,0,0,0,1,0,0,0,0,33.00417254,1,0.086969951,0.863255942,0.100746426,0.919751757,0.961596159,5.515466389,0,1.001973981,1.239468578,0.808389982,0.418866117,0.58273871,14.35642191,0,-1.654750841,1.198602093,-1.380567288,0.167412047,0.28466018,20.57640014,1,-1.13061662,1.150088609,-0.983069141,0.325573411,0.472132739,14.20770431,0,-1.742370444,1.207058076,-1.44348518,0.148883844,0.25759551,N,-,,mitochondrial FMP32,C:mitochondrion; C:integral component of membrane,IPR024461 (PFAM); PTHR14360 (PANTHER); PTHR14360:SF1 (PANTHER),,
RL4_JR_00275,20905,18418,14140,10,1,35,2,0,3,2,8,8,2,38,1,0,19,1,456.8406919,1,0.212677758,0.694357102,0.306294496,0.75938043,0.873023023,141.8651314,1,0.282871538,0.722258769,0.391648465,0.695317973,0.807240395,314.9334901,1,-0.310215509,0.436683992,-0.710389011,0.477462936,0.613898243,386.0306138,1,-0.056275433,0.767954578,-0.073279638,0.941583595,0.965812369,254.917614,1,-0.750673261,0.713448973,-1.052175123,0.292719211,0.427489111,N,-,,clathrin heavy chain,C:clathrin coat of trans-Golgi network vesicle; C:clathrin coat of coated pit; F:structural molecule activity; P:intracellular protein transport; P:endocytosis,IPR000547 (SMART); IPR016341 (PIRSF); IPR011990 (G3DSA:1.25.40.GENE3D); IPR015348 (PFAM); IPR022365 (PFAM); IPR016025 (G3DSA:2.130.10.GENE3D); PF13838 (PFAM); IPR000547 (PFAM); PTHR10292 (PANTHER); IPR000547 (PROSITE_PROFILES); IPR000547 (PROSITE_PROFILES); IPR000547 (PROSITE_PROFILES); IPR000547 (PROSITE_PROFILES); IPR000547 (PROSITE_PROFILES); IPR000547 (PROSITE_PROFILES); IPR000547 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR001473 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_00276,1847,2628,1373,2,0,8,0,0,0,0,0,3,0,9,0,0,12,0,74.35161935,1,1.29150106,0.645987304,1.999266939,0.045579479,0.12414129,7.591049032,0,0.54127449,1.285001439,0.421224812,0.673590927,0.791880066,39.07536771,1,0.283746593,0.910623552,0.31159593,0.755347628,0.83547901,58.68591143,1,1.187873407,0.707135471,1.679838526,0.092988737,0.185373294,65.46680605,1,1.538652721,1.27687536,1.205014028,0.228197887,0.355571499,N,-,,dipeptidyl aminopeptidase b,C:membrane; F:serine-type peptidase activity; C:vacuole,IPR029058 (G3DSA:3.40.50.GENE3D); IPR001375 (PFAM); IPR002469 (PFAM); IPR002469 (G3DSA:2.140.10.GENE3D); PTHR11731:SF125 (PANTHER); PTHR11731 (PANTHER); IPR029058 (SUPERFAMILY); SSF82171 (SUPERFAMILY),8.A.51.1.1, the dipeptidyl-aminopeptidase-like protein 6 beta subunit of kv4 channels (dpp6) family.
RL4_JR_00277,183,347,322,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,27.46425417,1,2.496005617,0.920430138,2.711781715,0.006692265,0.027643289,1.085266398,0,3.347440784,1.439062544,2.32612599,0.02001183,0.057561736,2.828724288,0,0.688906638,1.249634374,0.551286562,0.581437249,0.703114036,3.264522014,0,0.266019721,1.262320074,0.210738724,0.833091156,0.895250261,2.79763156,0,0.602235318,1.252049506,0.480999605,0.630516779,0.733959806,N,-, Effector probability:0.647,upf0145 domain-containing,,IPR002765 (PFAM); IPR002765 (G3DSA:3.30.110.GENE3D); PTHR34068 (PANTHER); IPR002765 (SUPERFAMILY),,
RL4_JR_00278,6,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.052373401,0,6.152792007,3.927092664,1.566754985,0.117171973,NA,0.017047958,0,9.341134867,3.037162897,3.075612071,0.00210071,0.015023052,0.043589254,0,6.711642742,1.756749632,3.820489054,0.000133187,0.001376714,0.050242563,0,6.288262322,3.091669559,2.033937393,0.041957908,0.111128512,0.042269194,0,6.647922329,1.37353153,4.84002164,1.30E-06,1.80E-05,,,,,,,,
RL4_JR_00279,51662,45651,59598,14,24,104,2,0,8,14,14,16,20,65,17,0,19,4,1356.675791,1,0.267598519,0.430166751,0.622080898,0.533888674,0.71706681,319.3911398,1,-0.278592407,0.518009239,-0.537813587,0.590705751,0.72783002,887.4537787,1,-0.530652796,0.302791685,-1.752534242,0.079681987,0.162216055,1209.192403,1,0.084018325,0.270468893,0.310639511,0.756074687,0.840405775,614.8898165,1,-1.982933696,0.576312351,-3.440727397,0.000580153,0.003064187,N,-,,atp synthase subunit alpha,"C:proton-transporting ATP synthase complex, catalytic core F(1); F:ATP binding; P:ATP hydrolysis coupled proton transport; F:proton-transporting ATPase activity, rotational mechanism; C:mitochondrial inner membrane; P:ATP synthesis coupled proton transport; F:proton-transporting ATP synthase activity, rotational mechanism",IPR027417 (G3DSA:3.40.50.GENE3D); IPR005294 (TIGRFAM); G3DSA:1.20.150.20 (GENE3D); IPR000793 (PFAM); IPR023366 (G3DSA:2.40.30.GENE3D); IPR000194 (PFAM); IPR004100 (PFAM); IPR005294 (PIRSF); PTHR15184 (PANTHER); IPR005294 (PTHR15184:PANTHER); IPR005294 (HAMAP); IPR004100 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR000793 (SUPERFAMILY),3.A.2.1.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_00280,1816,2116,1980,1,8,3,0,0,0,4,0,0,1,3,0,0,1,1,109.3400553,1,1.698856912,0.50123591,3.389335998,0.000700621,0.004444531,7.572095851,0,0.544850961,1.226240954,0.444326182,0.656806775,0.779022372,63.91336857,1,0.950983915,1.180473029,0.805595631,0.420476045,0.561685577,43.99665349,1,0.194901904,0.744811896,0.261679365,0.793568651,0.866752677,30.55568047,1,-0.509263346,0.972420333,-0.523707011,0.600482339,0.710067867,N,-,,carbohydrate kinase,F:nucleotide binding; F:ATP-dependent NAD(P)H-hydrate dehydratase activity; P:nicotinamide nucleotide metabolic process; C:cytosol; P:phosphorylation; F:kinase activity; F:ADP-dependent NAD(P)H-hydrate dehydratase activity,IPR000631 (TIGRFAM); IPR029056 (G3DSA:3.40.1190.GENE3D); IPR000631 (PFAM); PTHR12592 (PANTHER); PTHR12592:SF0 (PANTHER); IPR000631 (HAMAP); IPR000631 (PROSITE_PROFILES); IPR029056 (SUPERFAMILY),,
RL4_JR_00281,6727,10702,5878,1,5,7,0,0,0,0,0,0,2,0,0,0,0,0,171.2562764,1,-0.24677109,0.572302523,-0.431189939,0.666330269,0.814617734,30.18660124,0,-1.450299017,1.241320703,-1.16835159,0.242664973,0.394959778,77.99521511,0,-4.096305875,1.227148211,-3.338069386,0.000843627,0.005021092,108.5910881,1,-2.741878523,1.064897897,-2.574780673,0.010030367,0.048661938,76.37424804,0,-4.16879051,1.227572429,-3.395962969,0.000683876,0.003521997,N,-,,hypothetical protein CMQ_8012,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_00282,5658,5874,11068,2,6,5,0,0,0,0,2,4,2,0,1,0,2,0,177.2078953,1,-0.110397571,0.570235449,-0.193599979,0.846489115,0.922969553,28.34747695,0,-1.359671652,1.228367581,-1.106893142,0.268340131,0.425791684,115.9077844,1,-0.64166342,0.683399024,-0.938929377,0.347767005,0.49138774,113.9338373,1,-2.06625582,0.901154224,-2.292899225,0.021853807,0.080257454,81.66553989,1,-2.475415443,1.040591375,-2.378854469,0.017366531,0.048775624,N,-,,prohibitin-2,P:mitochondrion inheritance; C:integral component of membrane; P:negative regulation of proteolysis; P:protein folding; P:replicative cell aging; C:mitochondrial inner membrane,IPR000163 (PRINTS); IPR001107 (SMART); IPR001107 (PFAM); IPR000163 (PANTHER); PTHR23222:SF1 (PANTHER); IPR001107 (SUPERFAMILY),8.A.21.2.3, the stomatin/podocin/band 7/nephrosis.2/spfh (stomatin) family.
RL4_JR_00283,778,738,818,3,0,6,0,0,0,0,3,0,0,2,2,0,0,0,62.44593173,1,2.56892949,0.497424148,5.164464771,2.41E-07,4.32E-06,2.982840329,0,1.888840991,1.269848679,1.487453601,0.136895049,0.257316934,31.26235262,1,1.646820916,0.845666049,1.947365533,0.051490927,0.115869601,36.21483859,1,1.547539757,0.733452343,2.109939074,0.034863604,0.099498352,7.618692157,0,-0.843316194,1.192545843,-0.707156206,0.479469411,0.608807096,N,-,,hypothetical protein CMQ_7963,,IPR028094 (SMART); IPR028094 (PFAM); PTHR41391 (PANTHER),,
RL4_JR_00284,24834,18811,15341,1,1,8,0,0,0,1,0,4,2,4,0,0,0,2,284.8226721,1,-2.005377695,0.580898946,-3.452197163,0.000556041,0.003667461,76.28148884,0,-2.787732302,1.218099038,-2.288592483,0.022103041,0.062406411,233.3771128,1,-2.29529421,0.714302871,-3.21333471,0.001312033,0.007126084,261.0258092,1,-2.552513281,0.666545653,-3.829465046,0.000128422,0.001321417,206.6321481,1,-3.79859775,0.995358051,-3.816312878,0.000135461,0.000894677,N,-,,adenylate cyclase,P:signal transduction; F:phosphorus-oxygen lyase activity; P:cyclic nucleotide biosynthetic process,IPR001932 (SMART); IPR000159 (SMART); SM00364 (SMART); IPR013716 (SMART); IPR001054 (SMART); IPR003591 (SMART); IPR013716 (PFAM); IPR001932 (PFAM); IPR001054 (G3DSA:3.30.70.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR001611 (PFAM); IPR001054 (PFAM); IPR001932 (G3DSA:3.60.40.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR23155 (PANTHER); PTHR23155 (PANTHER); PTHR23155:SF526 (PANTHER); PTHR23155:SF526 (PANTHER); IPR001611 (PROSITE_PROFILES); IPR001932 (PROSITE_PROFILES); IPR001054 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR000159 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001932 (SUPERFAMILY); IPR032675 (SUPERFAMILY); IPR029787 (SUPERFAMILY); IPR032675 (SUPERFAMILY),8.A.43.1.12, the neat-domain containing methaemoglobin heme sequestration (n-mhs) family.
RL4_JR_00285,10016,10560,10504,0,1,16,0,0,0,0,0,2,4,8,0,0,2,0,193.7119705,1,-0.552034371,0.719331733,-0.76742669,0.442827865,0.632124186,39.78877675,0,-1.848757813,1.192984802,-1.549691002,0.121215699,0.235543349,116.1287348,1,-2.678348911,1.028287101,-2.604670337,0.00919627,0.030616845,188.3118478,1,-0.615489096,0.444448576,-1.384837594,0.166102133,0.286895956,109.2523743,1,-2.90876216,0.969454429,-3.000411441,0.002696151,0.010888924,N,-,,GTP1 OBG domain-containing,,IPR022024 (PFAM); PTHR34693:SF3 (PANTHER); PTHR34693 (PANTHER),,
RL4_JR_00286,1405,1904,1495,3,0,8,0,0,1,0,0,3,1,11,0,0,0,0,80.09743121,1,1.775225074,0.530173562,3.34838476,0.000812841,0.005038872,15.55152905,1,1.754896712,1.139234492,1.540417468,0.123458626,0.238346026,35.49060374,1,0.587159177,0.870246609,0.674704355,0.499863617,0.632623313,71.89118992,1,1.976523994,0.540504347,3.65681424,0.000255369,0.002365612,15.72495102,0,-1.888715004,1.205258605,-1.567062036,0.117100192,0.215179572,N,-,,autophagy-related 22,C:integral component of fungal-type vacuolar membrane; F:transporter activity; P:amino acid transmembrane export from vacuole,IPR024671 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11360 (PANTHER); PTHR11360:SF136 (PANTHER); PTHR11360:SF136 (PANTHER); IPR020846 (SUPERFAMILY),9.A.15.1.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_00287,15181,14828,15330,0,3,4,0,0,3,0,0,4,6,7,5,0,7,0,220.8861423,1,-2.073907484,0.563280328,-3.68183901,0.000231558,0.0017475,86.17513615,1,-0.204672842,0.844371018,-0.242396811,0.808472705,0.883636834,176.3699068,1,-2.225578709,0.738168246,-3.015001963,0.002569776,0.012089411,305.593869,1,-0.549742508,0.366598339,-1.499577191,0.13372396,0.243881298,175.0359516,1,-1.716995778,0.581341533,-2.953506122,0.003141864,0.012291163,N,-,,bah domain-containing,F:chromatin binding,IPR013083 (G3DSA:3.30.40.GENE3D); IPR001025 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY),,
RL4_JR_00288,75,140,102,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.281678301,0,1.53988152,1.471598462,1.046400604,0.295376114,NA,0.406834934,0,4.763064679,1.645965009,2.893782463,0.003806318,0.017621649,1.056630888,0,2.109957553,1.274751248,1.655191596,0.097885639,0.190965585,1.219187173,0,1.687199852,1.322584873,1.275683615,0.202067383,0.33343094,1.040570446,0,2.029383657,1.25650803,1.61509804,0.106289465,0.200033613,Y,-,,"alpha-1,6-mannosyltransferase subunit",F:mannosyltransferase activity; P:protein glycosylation,IPR005599 (PFAM); IPR005599 (PANTHER); PTHR22760:SF1 (PANTHER),,
RL4_JR_00289,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein BBAD15_g5720,,no IPS match,,
RL4_JR_00290,1938,1919,2579,0,0,9,0,0,0,0,1,0,0,6,0,0,11,3,60.07131068,1,1.026025452,0.575608593,1.782505447,0.074666844,0.179103826,8.170253216,0,0.435087455,1.221479198,0.356197187,0.721692898,0.825815876,29.10237403,1,-1.259329416,1.194199963,-1.054538148,0.291636605,0.431719402,48.59886532,1,0.636914645,0.634510696,1.003788667,0.315480488,0.461731476,85.59122152,1,2.063668523,0.479165341,4.306798397,1.66E-05,0.000153206,N,-,,transport YOS1,C:endoplasmic reticulum membrane; P:ER to Golgi vesicle-mediated transport; C:integral component of Golgi membrane; C:ER to Golgi transport vesicle,IPR013880 (PFAM); IPR013880 (PANTHER),,
RL4_JR_00291,4892,4441,3119,0,4,0,0,0,2,0,2,2,1,4,0,0,0,2,82.06020885,1,-0.949193619,0.802060312,-1.183444193,0.236633152,0.410967464,34.88244676,1,1.07935534,1.030872481,1.047030899,0.295085327,0.454758478,70.20126506,1,-0.372136966,0.776503662,-0.479246892,0.631762999,0.742508544,73.2334143,1,-0.587528435,0.720123659,-0.815871591,0.414573582,0.55818584,55.30868062,1,-1.561249712,0.987684878,-1.580716427,0.113942891,0.210565109,N,-,,ubiquitin carboxyl-terminal hydrolase,P:localization; C:cytoplasm; P:proteolysis; P:cellular protein metabolic process; F:hydrolase activity,G3DSA:2.20.210.10 (GENE3D); IPR001394 (PFAM); PTHR24006 (PANTHER); PTHR24006:SF469 (PANTHER); IPR003903 (PROSITE_PROFILES); IPR028889 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_00292,14370,15852,16364,3,6,14,0,1,1,12,9,12,15,25,2,0,28,9,318.479438,1,-0.410789696,0.354290892,-1.159470101,0.246264617,0.42248024,107.2499355,1,-0.776088994,0.975743971,-0.795381798,0.426391445,0.589206035,435.8996074,1,0.800675538,0.311484545,2.570514496,0.010154758,0.03307811,437.4714683,1,0.586147463,0.357876203,1.637849787,0.101453033,0.197845138,326.6522325,1,0.467628955,0.487534623,0.95917076,0.337472728,0.474571024,N,-,,mitochondrial phosphate carrier 2,F:inorganic phosphate transmembrane transporter activity; P:transmembrane transport; P:phosphate ion transport; C:mitochondrion; C:integral component of membrane,IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); PTHR24089:SF50 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.4.6, the mitochondrial carrier (mc) family.
RL4_JR_00293,3545,4276,5866,1,4,5,0,0,0,1,4,3,0,8,0,0,11,1,115.9165984,1,0.176921873,0.549648388,0.321881909,0.747542159,0.868106609,17.31183547,0,-0.648215585,1.215166369,-0.533437726,0.593730608,0.730194921,107.1119591,1,0.510800923,0.570845363,0.894814877,0.370886056,0.515263792,84.22483017,1,-0.100853531,0.627506414,-0.160721116,0.872313058,0.921169139,94.63408774,1,0.669742533,0.593894313,1.12771333,0.259441006,0.391335504,N,-,,cystathionine beta-synthase,,G3DSA:3.10.580.10 (GENE3D); PTHR42115 (PANTHER); IPR000644 (PROSITE_PROFILES); IPR000644 (PROSITE_PROFILES); SSF54631 (SUPERFAMILY),,
RL4_JR_00294,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.651,hypothetical protein CMQ_7798,,IPR012674 (G3DSA:2.40.128.GENE3D); PTHR38115 (PANTHER); PTHR38115:SF1 (PANTHER); IPR011038 (SUPERFAMILY),,
RL4_JR_00295,3060,2319,2541,0,5,7,0,0,0,0,2,0,0,7,3,0,6,0,98.41411627,1,1.217263373,0.464085263,2.62293046,0.008717706,0.033894644,10.16037044,0,0.120664077,1.226809984,0.098355962,0.921649642,0.956814121,41.94284842,1,-0.701257975,1.036128346,-0.67680609,0.498528994,0.631440952,87.26927558,1,1.086649116,0.506521123,2.145318462,0.031927393,0.09552744,48.95393561,1,0.579147714,0.631129066,0.917637524,0.358808666,0.496134819,N,-,,NAD dependent epimerase dehydratase family,F:coenzyme binding; F:catalytic activity,IPR001509 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10366 (PANTHER); PTHR10366:SF3 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_00296,3953,6518,5608,0,0,13,0,0,1,1,0,1,2,6,4,0,1,0,114.4476212,1,-0.0632522,0.884525261,-0.071509772,0.942992048,0.971842636,29.93850733,1,0.019167477,1.137141257,0.016855845,0.986551618,0.993421755,71.02350398,1,-1.724527102,1.054646888,-1.635170141,0.102013386,0.196532541,142.9155158,1,0.353197789,0.5101733,0.692309436,0.488743026,0.62894295,56.59334662,1,-2.706069647,1.147363504,-2.358511177,0.018348407,0.051037809,N,-,,f-actin capping beta subunit,F:actin filament binding; F:ATP binding; P:barbed-end actin filament capping; C:cytoplasm; F:helicase activity; C:F-actin capping protein complex; P:actin cytoskeleton organization,IPR001698 (PRINTS); IPR001698 (PFAM); IPR001698 (PANTHER); SSF90096 (SUPERFAMILY),,
RL4_JR_00297,4317,5027,6078,0,3,0,0,0,0,0,0,1,0,4,0,0,0,0,85.76717056,1,-1.710830229,0.86623385,-1.975021213,0.048265741,0.129523656,19.5966999,0,-0.82705158,1.202660913,-0.687684759,0.49165132,0.647348742,57.50906534,1,-2.521954305,1.195613124,-2.109339764,0.034915265,0.086194133,74.90564685,1,-1.201439179,0.762016119,-1.576658484,0.114874128,0.21708625,50.45175825,0,-3.570602782,1.201996865,-2.970559146,0.002972582,0.011729302,N,-,,chromodomain-helicase-dna-binding 3,F:DNA binding; F:ATP binding; P:barbed-end actin filament capping; F:actin binding; C:cytoplasm; F:helicase activity; P:chromatin silencing; C:F-actin capping protein complex; P:actin cytoskeleton organization,IPR001650 (SMART); IPR014001 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR000330 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10799:SF635 (PANTHER); PTHR10799 (PANTHER); PTHR10799:SF635 (PANTHER); PTHR10799:SF635 (PANTHER); PTHR10799 (PANTHER); PTHR10799 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_00298,771,1276,1163,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,12.92846225,0,-1.794705118,1.225818923,-1.464086648,0.143170275,0.287044262,4.097153648,0,1.430890841,1.282777955,1.115462606,0.264652234,0.421594258,10.66169106,0,-1.225336661,1.217608164,-1.006347278,0.314248545,0.456711255,24.33763255,1,0.631131063,0.899952363,0.701293857,0.483119647,0.623298936,10.52858148,0,-1.309946097,1.224498974,-1.069781294,0.284717764,0.418945991,N,-, Effector probability:0.652,vacuolar atpase assembly integral membrane vma21,C:endoplasmic reticulum membrane; P:vacuolar proton-transporting V-type ATPase complex assembly; C:integral component of membrane; C:COPII vesicle coat; C:endoplasmic reticulum-Golgi intermediate compartment membrane,IPR019013 (PFAM); IPR019013 (PANTHER),,
RL4_JR_00299,16711,15028,13438,1,7,5,0,0,1,6,21,51,23,58,24,0,23,27,266.2927936,1,-1.152660856,0.463982511,-2.484276515,0.012981496,0.046674295,67.52083984,1,-1.479119753,1.117892611,-1.323132239,0.185791405,0.325698061,712.7184686,1,1.945192148,0.483971264,4.01923067,5.84E-05,0.000814222,851.2830725,1,1.975325452,0.243600024,8.108888593,5.11E-16,3.46E-14,434.9571085,1,1.055620928,0.664458772,1.588692893,0.112129744,0.208085348,N,-,,DUF2406 domain,,IPR018809 (PFAM); PTHR28186 (PANTHER),,
RL4_JR_00300,25915,28046,42695,6,10,37,2,0,0,6,1,3,3,26,2,0,8,3,667.4503651,1,-0.367319751,0.424721883,-0.864847717,0.387122377,0.579954069,166.6545887,1,-1.78537078,0.994908833,-1.794506914,0.072732296,0.158185711,412.3082956,1,-1.941738505,0.553320653,-3.509246391,0.000449378,0.003130151,519.1246622,1,-1.099160528,0.549378743,-2.000733632,0.045421103,0.115440701,369.1556879,1,-2.206475714,0.589065404,-3.745722795,0.000179875,0.001136142,N,-,,60S ribosomal l33,F:structural constituent of ribosome; P:cytoplasmic translation; P:ribosomal large subunit biogenesis; C:cytosolic large ribosomal subunit,IPR001780 (PFAM); IPR001780 (PANTHER); IPR001780 (PRODOM); IPR009000 (SUPERFAMILY),,
RL4_JR_00301,38049,27722,34679,1,8,22,0,0,1,6,0,6,10,20,4,0,5,2,558.7457813,1,-1.175000385,0.43147322,-2.723228997,0.006464723,0.026812003,137.8233553,1,-2.622696834,1.118813973,-2.344175972,0.019069172,0.055369523,437.8351562,1,-1.763902744,0.492496874,-3.581551143,0.00034156,0.002572884,595.3102982,1,-0.80997329,0.338425758,-2.393355918,0.016695037,0.070052735,361.1519142,1,-2.857967026,0.611250832,-4.675604314,2.93E-06,3.60E-05,N,-,,glucose-6-phosphate 1-dehydrogenase,"F:NADP binding; P:pentose-phosphate shunt, oxidative branch; C:cytoplasm; C:mediator complex; P:NADPH regeneration; P:response to hydrogen peroxide; P:glucose metabolic process; F:RNA polymerase II transcription cofactor activity; F:glucose-6-phosphate dehydrogenase activity; P:regulation of transcription from RNA polymerase II promoter",IPR001282 (PRINTS); IPR001282 (TIGRFAM); IPR022675 (PFAM); G3DSA:3.30.360.10 (GENE3D); IPR001282 (PIRSF); IPR022674 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR001282 (PANTHER); IPR016040 (SUPERFAMILY); SSF55347 (SUPERFAMILY),,
RL4_JR_00302,13504,10999,11169,0,1,8,0,0,0,1,0,6,8,2,2,0,0,1,181.227313,1,-1.401344415,0.534734441,-2.620636165,0.008776587,0.034062512,45.81161474,0,-2.052109062,1.20213049,-1.707060156,0.087810872,0.182998074,168.4359136,1,-1.079006166,0.585923353,-1.84154832,0.065541246,0.139486983,238.3140292,1,-0.696927366,0.514429144,-1.354758716,0.175494444,0.299377216,123.5902075,1,-3.8403836,1.121046244,-3.425713812,0.000613186,0.003215178,N,-,,mediator of RNA polymerase II transcription subunit 14,C:nucleus; P:mycelium development; P:regulation of transcription from RNA polymerase II promoter,IPR013947 (PFAM); PTHR12809 (PANTHER),,
RL4_JR_00303,15,18,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.173628695,0,4.423679982,3.180653738,1.390808414,0.164283531,NA,0.055826634,0,7.628894651,2.380647631,3.204545919,0.001352757,0.015023052,0.14381873,0,4.988457497,1.425600355,3.499197709,0.00046666,0.003218304,0.165855573,0,4.565278218,1.95783476,2.331799553,0.019711239,0.076371876,0.140494543,0,4.918175129,1.283164991,3.832847032,0.000126669,0.000844875,N,-,,---NA---,,no IPS match,,
RL4_JR_00304,285,330,423,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.152172332,0,-0.156211598,1.229721437,-0.127030068,0.8989166,0.950562931,1.316606228,0,3.068614374,1.364542352,2.248823109,0.024523753,0.067458991,3.430093889,0,0.410551527,1.215088081,0.337877997,0.735455129,0.822007919,3.958063518,0,-0.012134221,1.218062433,-0.009961904,0.992051682,0.995065735,3.39601645,0,0.322504341,1.219774127,0.264396771,0.791474199,0.85808719,N,-,,dynactin subunit,P:single-organism cellular process,PF04912 (PFAM); PTHR15346 (PANTHER); PTHR15346 (PANTHER); IPR028133 (PTHR15346:PANTHER); IPR028133 (PTHR15346:PANTHER),,
RL4_JR_00305,18226,23755,34564,0,4,23,0,0,0,3,2,1,0,24,0,0,14,5,425.7813357,1,-1.19806728,0.754719701,-1.587433426,0.112414514,0.241019081,96.52052343,0,-3.127259669,1.210356462,-2.583750959,0.009773234,0.033129495,307.7320438,1,-2.357311769,0.66661119,-3.536261922,0.000405832,0.002913932,387.516956,1,-1.529466393,1.748530645,-0.874715234,0.381728869,0.527213859,341.6287872,1,-1.151870723,0.567461678,-2.029865219,0.042370241,0.098366948,N,-,,40S ribosomal S28,F:structural constituent of ribosome; C:ribosome; P:translation,IPR000289 (PFAM); G3DSA:2.40.50.140 (GENE3D); IPR000289 (PANTHER); IPR000289 (PRODOM); IPR000289 (HAMAP); IPR012340 (SUPERFAMILY),,
RL4_JR_00306,1624,2585,2407,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26.6312716,0,-2.83732503,1.217609727,-2.330241757,0.019793377,0.064927371,8.442592885,0,0.38782628,1.243645869,0.311846233,0.755157386,0.850718204,21.96732412,0,-2.268280274,1.210627918,-1.873639488,0.060980131,0.131966556,25.34847199,0,-2.690985725,1.211894943,-2.220477724,0.026386356,0.08636862,21.69342892,0,-2.352929777,1.217633668,-1.932379039,0.053312739,0.117524817,N,-,,molybdopterin synthase sulfur carrier subunit,F:nucleotide binding; F:structural constituent of ribosome; C:cytosol; C:ribosome; F:molybdopterin synthase activity; P:Mo-molybdopterin cofactor biosynthetic process; C:molybdopterin synthase complex; P:translation,IPR003749 (PFAM); IPR012675 (G3DSA:3.10.20.GENE3D); PTHR33359:SF1 (PANTHER); PTHR33359 (PANTHER); IPR016155 (SUPERFAMILY),,
RL4_JR_00307,1931,2721,3270,0,1,0,0,0,0,0,0,0,0,1,2,0,0,0,39.76505022,1,-2.138302131,1.170093907,-1.827461983,0.067630337,0.166678017,10.04222372,0,0.137469331,1.233230025,0.111470957,0.911242895,0.950652603,26.19641024,0,-2.522334032,1.209233276,-2.085895321,0.036988106,0.089800381,53.5140216,1,-0.613542233,0.878751131,-0.698197944,0.485053412,0.625227982,25.95899489,0,-2.611919505,1.219140725,-2.14242659,0.03215917,0.079533854,N,-,,conserved oligomeric golgi complex component 4,F:nucleotide binding; C:intracellular membrane-bounded organelle; P:autophagy; C:membrane; P:calcium ion transport; P:intra-Golgi vesicle-mediated transport; F:hydrolase activity,IPR013167 (SMART); IPR013167 (PFAM); PTHR24016:SF0 (PANTHER); PTHR24016 (PANTHER),,
RL4_JR_00308,261,301,262,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,3.310911599,0,0.170696335,1.227364749,0.139075475,0.889390508,0.945730939,1.057757217,0,3.384572138,1.398323382,2.42045022,0.015501302,0.047388757,2.739421735,0,0.735381782,1.211653569,0.606924125,0.543901267,0.671519076,12.4723248,1,1.263442643,1.148497363,1.10008319,0.271295877,0.413001166,2.693427839,0,0.656943048,1.204677112,0.545327077,0.585528585,0.698371648,N,-,,---NA---,,no IPS match,,
RL4_JR_00309,8715,7423,7076,2,2,4,0,0,0,0,0,1,0,2,0,0,8,2,144.3610496,1,-0.908906257,0.544633686,-1.66883959,0.095149174,0.213483764,29.84604095,0,-1.433926005,1.205984845,-1.189008312,0.234436396,0.384846773,83.59467494,1,-3.117787575,1.193659308,-2.611957662,0.00900254,0.030115605,96.93850607,1,-2.777595892,1.020968782,-2.720549288,0.006517356,0.034603159,121.2721703,1,-0.23360929,0.501760673,-0.465579114,0.641516796,0.743005898,N,-,,calcium-transporting p-type atpase,F:ATP binding; F:metal ion binding; C:integral component of membrane; P:calcium ion transmembrane transport; F:calcium-transporting ATPase activity,PR00121 (PRINTS); PR00119 (PRINTS); IPR004014 (SMART); IPR006068 (PFAM); IPR008250 (PFAM); IPR023298 (G3DSA:1.20.1110.GENE3D); PF00702 (PFAM); IPR004014 (PFAM); IPR001757 (TIGRFAM); IPR023298 (G3DSA:1.20.1110.GENE3D); IPR006413 (PTHR24093:PANTHER); PTHR24093 (PANTHER); SSF81653 (SUPERFAMILY); SSF81665 (SUPERFAMILY); IPR023214 (SUPERFAMILY); IPR023299 (SUPERFAMILY),3.A.3.2.6, the p-type atpase (p-atpase) superfamily.
RL4_JR_00310,12941,11497,16132,0,2,12,0,0,0,0,0,2,0,2,0,0,2,6,223.6785227,1,-1.010876501,0.517216244,-1.954456214,0.050647288,0.134236705,51.52036329,0,-2.221573836,1.194006413,-1.86060461,0.062800033,0.141195455,146.9553629,1,-3.05786926,1.037362882,-2.947733443,0.00320113,0.014201681,162.5756356,1,-3.575679488,1.022011146,-3.498669759,0.000467585,0.003951838,184.3510886,1,-1.302629048,0.585205999,-2.225932493,0.026018704,0.067462067,N,-,,double-strand-break repair rad21,"P:mitotic chromosome condensation; C:nuclear rDNA heterochromatin; C:nuclear mitotic cohesin complex; P:establishment of mitotic sister chromatid cohesion; P:protein acetylation; F:chromatin binding; P:DNA unwinding involved in DNA replication; C:chromosome, centromeric outer repeat region; P:replication-born double-strand break repair via sister chromatid exchange; C:mitochondrion; P:apoptotic process; C:horsetail nucleus leading edge; C:nuclear subtelomeric heterochromatin",IPR006909 (PFAM); IPR006910 (PFAM); IPR023093 (G3DSA:1.10.10.GENE3D); PTHR12585:SF29 (PANTHER); PTHR12585 (PANTHER); IPR011991 (SUPERFAMILY),,
RL4_JR_00311,1332,2074,2305,0,0,5,0,0,0,5,0,1,0,5,0,0,0,1,42.02340891,1,0.352945002,0.756182475,0.46674581,0.64068175,0.79572677,7.24879306,0,0.607740906,1.251465599,0.485623342,0.627234244,0.754918551,80.75575785,1,1.401916563,0.666089338,2.104697499,0.035317648,0.086785406,41.87787742,1,0.514502462,0.736612828,0.698470679,0.484882888,0.625087757,26.09250844,1,-1.200514608,1.153218411,-1.04101235,0.297869817,0.433261298,N,-,,tubulin-specific chaperone,P:tubulin complex assembly; F:beta-tubulin binding; P:post-chaperonin tubulin folding pathway,IPR004226 (PFAM); G3DSA:1.20.58.90 (GENE3D); IPR004226 (PRODOM); IPR004226 (SUPERFAMILY),,
RL4_JR_00312,1512,1709,3691,0,0,2,0,0,0,0,0,1,0,1,2,0,0,1,35.1026478,1,-1.195243943,1.115019713,-1.07194871,0.28374307,0.466974817,8.617947846,0,0.358092643,1.28653925,0.278337908,0.780752979,0.867485783,29.14099532,1,-1.350228843,1.244825229,-1.084673424,0.278066322,0.416996511,49.42139004,1,-0.385341718,0.936087355,-0.411651451,0.680594914,0.782675574,30.00386082,1,-1.466083265,1.196348461,-1.225465083,0.220400038,0.346460237,N,-,,tho complex subunit 7,P:RNA metabolic process; P:gene expression; C:THO complex,IPR008501 (PFAM); PTHR23405 (PANTHER); PTHR23405:SF5 (PANTHER),,
RL4_JR_00313,1378,1210,1224,2,0,2,0,0,0,3,1,0,0,2,1,0,1,0,43.02439164,1,0.696242491,0.734036066,0.948512645,0.342868538,0.532988098,4.890578519,0,1.175554059,1.247824391,0.942082931,0.346150183,0.509334753,53.70197503,1,1.361072916,0.739321463,1.840975791,0.065625106,0.139606762,32.24784797,1,0.41923893,0.849798346,0.49333931,0.621772857,0.739336485,16.29048608,1,-0.619073583,1.118933477,-0.553271125,0.58007777,0.692768038,N,-,,rna polymerase ii transcription factor siii subunit a,"C:nucleus; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:molecular_function",IPR010684 (PFAM); PTHR15141 (PANTHER); PTHR15141:SF53 (PANTHER),,
RL4_JR_00314,3234,3730,4543,2,3,0,0,0,0,0,0,0,0,0,0,0,1,0,90.21843407,1,-0.522066216,0.69154497,-0.754927355,0.450292571,0.639089561,14.6204868,0,-0.404436422,1.207518131,-0.334931967,0.737676408,0.837268513,38.05714302,0,-3.061135501,1.195406124,-2.560749389,0.010444667,0.033821634,43.91291048,0,-3.483778091,1.195815044,-2.913308467,0.003576211,0.021456214,41.50205629,1,-2.218584847,1.132735297,-1.958608382,0.050158667,0.112407372,N,-,,nedd8,P:protein neddylation; F:protein tag,IPR019956 (PRINTS); IPR000626 (SMART); IPR000626 (PFAM); G3DSA:3.10.20.90 (GENE3D); PTHR10666 (PANTHER); IPR000626 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY),3.A.16.1.3, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_00315,4656,3765,5312,0,0,1,0,0,0,0,0,1,0,0,0,0,2,0,58.56223771,1,-2.92971391,1.147043852,-2.554142899,0.010644956,0.039817309,17.46415532,0,-0.660833006,1.205797861,-0.548046259,0.58366014,0.722242616,51.85192256,1,-2.352392859,1.193783026,-1.970536361,0.048776932,0.111070099,52.32126062,0,-3.736548857,1.193913705,-3.129664098,0.001750063,0.01186831,52.51034951,1,-1.733042625,0.983740274,-1.761687175,0.078122166,0.158292361,N,-,,NF-X1 type zinc finger,P:ascospore formation; P:hyphal growth; F:organic cyclic compound binding; F:heterocyclic compound binding; P:mycelium development,IPR000967 (SMART); IPR001374 (SMART); IPR001374 (PFAM); IPR000967 (PFAM); IPR001374 (G3DSA:3.30.1370.GENE3D); PTHR12360 (PANTHER); PTHR12360 (PANTHER); PTHR12360:SF1 (PANTHER); IPR001374 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR001374 (SUPERFAMILY); SSF57850 (SUPERFAMILY),,
RL4_JR_00316,1526,2192,2391,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.52187294,0,-2.718292119,1.21251174,-2.241868701,0.024969859,0.078682981,7.766397486,0,0.508242917,1.239123806,0.410163145,0.681686274,0.797944718,20.23339208,0,-2.149689661,1.207040733,-1.780958672,0.074919203,0.154887075,23.34874277,0,-2.572459841,1.207711118,-2.130029112,0.03316921,0.097485704,20.01808805,0,-2.236976827,1.215625756,-1.840185448,0.065741016,0.138470519,N,-,,rna recognition domain-containing,F:nucleic acid binding; C:nucleus; P:mRNA 3'-end processing,IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR025742 (PFAM); IPR026896 (PFAM); PTHR23139:SF8 (PANTHER); PTHR23139 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_00317,6966,5000,6802,0,0,5,0,0,0,0,1,1,1,7,0,0,3,3,93.87139664,1,-1.309792366,0.691874134,-1.893107868,0.058343526,0.149252583,23.94344409,0,-1.116046039,1.207214754,-0.924480119,0.355236398,0.519385067,76.37812517,1,-1.944707057,1.038544128,-1.872531945,0.061133047,0.132161214,108.9501954,1,-0.496266145,0.567614571,-0.874301279,0.381954203,0.527453124,94.8057236,1,-0.636426401,0.635452984,-1.001531848,0.316569751,0.451934391,N,-,,Mg2+ transporter,C:cytoplasm; P:magnesium ion transport; C:integral component of membrane; F:magnesium ion transmembrane transporter activity; P:magnesium ion transmembrane transport,G3DSA:1.20.58.340 (GENE3D); G3DSA:3.30.460.20 (GENE3D); IPR002523 (PFAM); G3DSA:1.20.58.340 (GENE3D); PTHR21535:SF51 (PANTHER); PTHR21535 (PANTHER); PTHR21535:SF51 (PANTHER); SSF144083 (SUPERFAMILY); SSF143865 (SUPERFAMILY),1.A.35.2.3, the cora metal ion transporter (mit) family.
RL4_JR_00318,2208,2279,2579,3,7,7,0,0,0,2,0,19,14,20,18,0,3,12,141.2805579,1,1.905829012,0.388547785,4.905005468,9.34E-07,1.44E-05,9.013260347,0,0.293460741,1.213286822,0.24187252,0.808878944,0.883777832,169.0174543,1,2.671957307,1.170499498,2.28274964,0.02244512,0.061005155,411.0365465,1,3.723633122,0.293041425,12.70684895,5.42E-37,1.31E-34,123.0531401,1,2.188980395,0.603024461,3.630002654,0.000283418,0.001671293,N,-, Effector probability:0.693,hypothetical protein CMQ_153,F:RNA polymerase I regulatory region DNA binding; C:RNA polymerase I core factor complex; P:transcription of nuclear large rRNA transcript from RNA polymerase I promoter; F:RNA polymerase I transcription factor binding,IPR011250 (G3DSA:2.40.160.GENE3D); IPR020915 (PFAM); PTHR28221 (PANTHER),,
RL4_JR_00319,3503,3466,4632,1,0,11,0,0,2,1,1,0,3,7,0,0,1,0,98.40467169,1,0.573382603,0.541185225,1.059494192,0.289374773,0.474135248,33.48698586,1,1.226565467,0.987027852,1.24268577,0.21398365,0.360629787,57.23690439,1,-1.243392076,1.033832215,-1.202702003,0.229091658,0.36003166,100.2362556,1,0.540330307,0.504259191,1.071532888,0.283929891,0.428050945,41.76455964,1,-2.228462643,1.130666503,-1.97092833,0.048732074,0.109793558,N,-,,Mob1 partial,P:phosphorylation; F:kinase activity,IPR005301 (SMART); IPR005301 (PFAM); IPR005301 (G3DSA:1.20.140.GENE3D); PTHR22599:SF20 (PANTHER); PTHR22599:SF20 (PANTHER); IPR005301 (PANTHER); IPR005301 (PANTHER); IPR005301 (SUPERFAMILY),,
RL4_JR_00320,4986,5076,6448,3,6,0,0,0,0,0,0,2,0,10,0,0,11,0,144.2499187,1,0.018765279,0.730540085,0.025686858,0.979507106,0.989942886,20.98772774,0,-0.925987978,1.197725376,-0.773122116,0.439450113,0.600771751,67.57869265,1,-1.761773272,1.034051283,-1.703758121,0.088426285,0.176225927,103.0907292,1,-0.026427355,0.533457963,-0.049539714,0.960489189,0.977676992,96.41609562,1,0.283756048,0.582476102,0.487154833,0.626148611,0.730334456,N,-,,lipid acyl hydrolase,P:cellular macromolecule metabolic process; C:membrane; P:primary metabolic process; F:hydrolase activity,IPR007149 (PFAM); IPR002641 (PFAM); IPR021771 (PFAM); PTHR14226 (PANTHER); PTHR14226:SF33 (PANTHER); IPR016035 (SUPERFAMILY),,
RL4_JR_00321,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_00322,215,244,294,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.013976484,0,0.306017898,1.239251576,0.246937671,0.804956461,0.901630269,0.957294213,0,3.52842574,1.408277474,2.505490435,0.012228171,0.039243355,2.490912547,0,0.872147417,1.214912619,0.717868432,0.472838414,0.609422801,2.874116614,0,0.449570653,1.22052174,0.368343011,0.712617485,0.807888482,2.462773938,0,0.786109788,1.21531164,0.646838031,0.517736776,0.643121685,N,-,,---NA---,,no IPS match,,
RL4_JR_00323,18,67,50,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.548085486,0,2.765384828,2.126019157,1.30073373,0.193349613,NA,0.172187335,0,6.003432106,2.014497955,2.980113278,0.002881418,0.015349618,0.449837476,0,3.341898881,1.414681656,2.362297459,0.018162063,0.052011716,0.519261356,0,2.918504555,1.604322665,1.819150611,0.068888455,0.149005685,0.445260507,0,3.254427991,1.363528965,2.386768506,0.01699719,0.048044822,N,-,,---NA---,,no IPS match,,
RL4_JR_00324,5634,12262,15838,4,0,0,0,0,0,0,0,1,0,6,0,0,10,0,175.6552036,1,-2.096205614,1.085075787,-1.931851801,0.0533778,0.139816319,42.44364367,0,-1.941974931,1.255338768,-1.546972802,0.121869804,0.23649658,117.827555,1,-3.647903755,1.252044527,-2.913557527,0.00357336,0.015397444,152.5946008,1,-1.87730421,0.816983841,-2.297847417,0.021570475,0.079756744,149.5043285,1,-1.045195893,0.838857544,-1.245975435,0.212773414,0.33708822,N,-,,ribosome biogenesis ERB1,"P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:ribonucleoprotein complex binding; C:PeBoW complex; P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:nucleoplasm; C:preribosome, large subunit precursor",IPR012953 (SMART); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR012953 (PFAM); IPR001680 (PFAM); PTHR17605 (PANTHER); IPR028598 (HAMAP); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),8.A.92.1.2,The G-Protein αβγ Complex (GPC) Family
RL4_JR_00325,1902,2375,2262,0,1,6,0,0,0,0,2,0,1,3,0,0,0,3,57.18654278,1,0.686443906,0.596602164,1.150589031,0.249901348,0.427041306,8.363200654,0,0.401475483,1.22463981,0.327831482,0.743039083,0.841562224,37.39433,1,-0.426806045,1.034954864,-0.412390975,0.680052877,0.779980547,46.39225126,1,0.047899431,0.750765058,0.063800827,0.94912882,0.970207017,43.49123249,1,-0.098085706,0.845730724,-0.115977466,0.907670401,0.94065126,N,-,,fungal transcriptional regulatory,"C:nucleus; F:zinc ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00326,1271,1508,1100,0,3,10,0,0,0,0,0,0,1,0,0,0,0,1,77.83556578,1,2.294191827,0.50896102,4.507598299,6.56E-06,8.02E-05,5.002265594,0,1.143001745,1.265342914,0.903313823,0.366359362,0.530893266,12.92819957,0,-1.50333779,1.205752941,-1.246804166,0.212469313,0.340677751,24.22398933,1,-0.974335831,1.156163354,-0.842731979,0.399378358,0.543581916,20.04402366,1,-0.641911631,1.131572958,-0.567273746,0.570528211,0.686435905,N,-,,pH-response regulator palc,C:membrane; C:cell part,IPR004328 (SMART); IPR004328 (G3DSA:1.25.40.GENE3D); PTHR40463 (PANTHER); IPR004328 (PROSITE_PROFILES),,
RL4_JR_00327,239,272,274,0,0,0,0,0,0,0,2,0,0,0,4,0,5,1,3.148712122,0,0.243071756,1.225316071,0.198374739,0.84275188,0.920863894,1.003522019,0,3.460459158,1.398786933,2.473900117,0.013364706,0.041985583,18.29001269,1,2.63268969,1.033644396,2.546997499,0.010865421,0.034976637,41.54539397,1,3.500183304,1.320339191,2.650972817,0.00802603,0.040677432,29.23459748,1,3.920241597,0.627628552,6.246117368,4.21E-10,2.63E-08,N,-,,"alpha-1,3-glucosyltransferase","C:endoplasmic reticulum membrane; F:transferase activity, transferring hexosyl groups; C:integral component of membrane; P:single-organism cellular process; P:carbohydrate derivative biosynthetic process; P:primary metabolic process; P:cellular metabolic process; P:single-organism metabolic process",IPR004856 (PFAM); IPR004856 (PANTHER); PTHR12413:SF1 (PANTHER); PTHR12413:SF1 (PANTHER); IPR004856 (PANTHER),,
RL4_JR_00328,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_00329,104,53,64,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.879027328,0,2.083542372,1.621132025,1.285239166,0.198708721,NA,0.284623894,0,5.278505642,1.763543538,2.993124654,0.002761369,0.015349618,0.732349318,0,2.638340007,1.293596903,2.039537974,0.041396365,0.098241163,0.844346616,0,2.216849789,1.371328175,1.616571314,0.105970848,0.2049188,0.716749326,0,2.56584429,1.258339216,2.039072022,0.04144284,0.096728621,Y,-,,extracellular serine-rich,C:membrane,IPR008972 (G3DSA:2.60.40.GENE3D); PTHR34883 (PANTHER); PTHR34883:SF3 (PANTHER); IPR008972 (SUPERFAMILY),,
RL4_JR_00330,2806,2731,3304,6,0,14,0,1,0,0,1,2,2,4,0,0,2,0,149.1988973,1,1.774257797,0.39561176,4.484845945,7.30E-06,8.84E-05,49.59973641,1,0.893494536,1.105067685,0.808542814,0.41877817,0.58273871,50.09359037,1,-0.275895998,0.847973511,-0.325359218,0.744909217,0.829278746,68.41982324,1,0.206641831,0.61035387,0.338560696,0.734940695,0.823149839,36.59459714,1,-1.096653019,0.975255268,-1.124477924,0.260810331,0.392669829,N,-,,copii-coated vesicle 4 erv29,"C:endoplasmic reticulum membrane; F:transferase activity, transferring hexosyl groups; C:integral component of membrane",IPR002995 (PFAM); PTHR23427 (PANTHER); PTHR23427:SF1 (PANTHER),9.B.214.1.3,The ER to Golgi Transport Factor (ER/G-TF) Family
RL4_JR_00331,1121,879,871,1,0,1,2,0,0,0,0,0,2,0,0,0,3,0,25.36503888,1,0.111986457,1.014434195,0.110393023,0.912097686,0.956904954,48.31552645,1,3.260245314,0.993545057,3.281426736,0.001032834,0.015023052,9.530777836,0,-1.063555516,1.201671794,-0.885063228,0.376122531,0.519915962,29.6159038,1,0.262250387,1.02096613,0.256864924,0.797283049,0.869318422,20.93115568,1,1.062524321,0.850911516,1.248689553,0.211778644,0.335722368,N,-,,ibr domain-containing,F:ubiquitin-protein transferase activity; F:metal ion binding; P:protein ubiquitination,IPR002867 (PFAM); IPR031127 (PANTHER); SSF57850 (SUPERFAMILY),,
RL4_JR_00332,1924,3182,2957,1,0,12,0,0,1,2,1,1,0,5,1,0,0,1,88.35367366,1,1.094673709,0.681004277,1.607440285,0.107957819,0.234171733,19.66383343,1,1.017980265,1.143033692,0.890595152,0.373146401,0.537726064,63.25360853,1,0.281739662,0.773298024,0.364335164,0.715607744,0.807655511,60.58667553,1,0.295316725,0.675932509,0.436902681,0.662181928,0.770023202,33.81202589,1,-1.699250896,1.149099782,-1.478767051,0.139202585,0.244918788,N,-,,fumarylacetoacetate hydrolase,P:metabolic process; F:hydrolase activity,IPR011234 (PFAM); IPR011234 (G3DSA:3.90.850.GENE3D); PTHR11820 (PANTHER); PTHR11820:SF6 (PANTHER); IPR011234 (SUPERFAMILY),,
RL4_JR_00333,634,429,918,0,3,0,0,0,0,0,0,0,0,1,0,0,2,0,31.88568479,1,1.295214155,0.910269763,1.422890452,0.154767914,0.303654797,2.493181285,0,2.147418205,1.335341928,1.608141076,0.107804285,0.214464421,6.504211154,0,-0.512601597,1.234380384,-0.415270368,0.677943991,0.778511525,11.5167999,1,0.009125754,1.186110601,0.007693848,0.993861258,0.99563127,14.18108447,1,1.041406593,1.041011715,1.000379321,0.317126974,0.452240931,N,-,,Complex 1 LYR,,IPR008011 (PFAM); PTHR13166:SF16 (PANTHER); PTHR13166 (PANTHER),,
RL4_JR_00334,154,151,213,0,2,5,0,0,0,0,4,1,0,1,6,0,5,0,37.18055086,1,4.366197789,0.595745805,7.328961036,2.32E-13,1.21E-11,0.656651961,0,4.072214552,1.483556919,2.744899437,0.006052944,0.023430607,39.58036198,1,4.557832994,0.682405268,6.679070648,2.40E-11,1.57E-09,63.79612027,1,4.600184702,0.616169809,7.465774259,8.28E-14,4.44E-12,20.99526138,1,4.229344505,0.719224716,5.880421533,4.09E-09,2.09E-07,N,-,,hexose transporter,C:integral component of plasma membrane; P:proton transport; F:sugar:proton symporter activity; P:glucose import; F:glucose transmembrane transporter activity; P:glucose transmembrane transport,IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF102 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.83, the major facilitator superfamily (mfs).
RL4_JR_00335,1627,1545,2653,2,2,1,0,0,0,4,2,0,0,6,0,0,4,0,63.16215655,1,0.463335006,0.718179793,0.645151827,0.5188288,0.70309059,7.340109163,0,0.589634981,1.247119234,0.4727976,0.636357586,0.762454011,79.13293097,1,1.373230884,0.655809239,2.093948671,0.036264553,0.088489355,46.18883035,1,0.745609067,0.689377091,1.081569255,0.279443972,0.422849182,34.48116424,1,0.405713273,0.818425839,0.495723929,0.620089202,0.726414806,N,-,,ferric reductase like transmembrane component,F:oxidoreductase activity; C:membrane; F:superoxide-generating NADPH oxidase activity; C:integral component of membrane; P:oxidation-reduction process; P:superoxide anion generation,IPR000778 (PRINTS); G3DSA:3.40.50.80 (GENE3D); IPR013112 (PFAM); IPR013130 (PFAM); IPR013121 (PFAM); PTHR11972 (PANTHER); IPR029648 (PTHR11972:PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY),5.B.1.5.4, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_00336,844,823,893,0,0,3,0,0,0,0,0,1,0,4,4,0,3,1,21.7029938,1,0.848168907,0.843162645,1.00593748,0.314445646,0.502595528,3.272436049,0,1.755165302,1.262976469,1.389705465,0.164618335,0.297176169,14.98333843,1,0.065932606,1.188273956,0.055486031,0.955751258,0.97422732,64.37515707,1,2.41489195,0.528085911,4.572914937,4.81E-06,7.40E-05,27.30533831,1,1.644160861,0.741643792,2.21691448,0.026628936,0.068709984,N,-,,like family,C:membrane,IPR006976 (PFAM); PTHR28008:SF1 (PANTHER); PTHR28008 (PANTHER),2.A.128.1.18,the multidrug resistance exporter vanz (vanz) family
RL4_JR_00337,3452,2236,3074,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,34.88129324,0,-3.226784588,1.199734646,-2.6895819,0.007154159,0.029022192,11.19484233,0,-0.019243499,1.231304759,-0.015628543,0.987530735,0.993830963,28.96644985,0,-2.667357313,1.202339162,-2.218473287,0.026522579,0.069725939,52.0330998,1,-1.336769954,1.028229216,-1.300069997,0.19357698,0.322839084,28.50800712,0,-2.747115382,1.204455611,-2.280794208,0.022560627,0.060128021,N,-,,transcriptional activator SPT7,,IPR001487 (PRINTS); IPR001487 (SMART); IPR006565 (PFAM); IPR001487 (PFAM); IPR001487 (G3DSA:1.20.920.GENE3D); PTHR22880 (PANTHER); PTHR22880 (PANTHER); PTHR22880:SF168 (PANTHER); PTHR22880:SF168 (PANTHER); PTHR22880 (PANTHER); IPR001487 (PROSITE_PROFILES); IPR001487 (SUPERFAMILY),,
RL4_JR_00338,40023,38598,54584,3,25,9,3,0,3,0,1,0,5,9,1,0,7,2,796.4150425,1,-1.025297381,0.729184398,-1.406087931,0.159698016,0.309163838,263.9618975,1,-0.730895379,0.636179037,-1.148883155,0.250604164,0.404692941,447.5177808,1,-5.629510876,1.20144242,-4.68562686,2.79E-06,6.38E-05,599.6134513,1,-2.389777546,0.447557687,-5.339596698,9.32E-08,2.12E-06,476.9422758,1,-2.944363374,0.598876371,-4.916479458,8.81E-07,1.30E-05,N,-,,serine hydroxymethyltransferase,F:pyridoxal phosphate binding; C:cytoplasm; P:L-serine metabolic process; F:glycine hydroxymethyltransferase activity; P:tetrahydrofolate interconversion; F:methyltransferase activity; P:glycine metabolic process; P:methylation,IPR015422 (G3DSA:3.90.1150.GENE3D); IPR001085 (PIRSF); IPR001085 (PFAM); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR11680:SF5 (PANTHER); IPR001085 (PANTHER); IPR001085 (HAMAP); IPR015424 (SUPERFAMILY),,
RL4_JR_00339,25845,26723,29500,1,31,48,0,0,1,5,15,29,21,23,9,0,14,4,770.2660761,1,0.446310568,0.786280235,0.567622774,0.57029114,0.746300147,114.1404844,1,-2.327498623,1.103699709,-2.10881511,0.034960544,0.089158636,633.3579158,1,0.485270561,0.345364988,1.405094838,0.159993079,0.275240657,688.2217709,1,0.193618163,0.309447254,0.625690356,0.53151806,0.66464374,351.6255371,1,-1.267537729,0.455325489,-2.783805782,0.005372519,0.018991407,Y,-,,vacuolar protease a,F:aspartic-type endopeptidase activity; P:cellular response to starvation; P:proteolysis involved in cellular protein catabolic process; P:lysosomal microautophagy,IPR001461 (PRINTS); IPR033121 (PFAM); IPR021109 (G3DSA:2.40.70.GENE3D); IPR021109 (G3DSA:2.40.70.GENE3D); PTHR13683:SF307 (PANTHER); IPR001461 (PANTHER); IPR033121 (PROSITE_PROFILES); IPR021109 (SUPERFAMILY),8.A.32.1.4,The β-Amyloid Cleaving Enzyme (BACE1) Family
RL4_JR_00340,11869,11872,13058,1,3,2,0,0,0,0,8,1,5,3,1,0,1,0,189.0422317,1,-1.985033043,0.606564482,-3.27258371,0.001065693,0.006232204,47.00292123,0,-2.089157337,1.189216705,-1.756750749,0.078960303,0.16861523,191.1751407,1,-0.748213334,0.51094515,-1.464371143,0.143092568,0.253085125,208.8953703,1,-1.25208959,0.499395221,-2.5072118,0.012168777,0.056699893,124.0421848,1,-3.892409834,1.11957838,-3.476674705,0.000507673,0.002742899,N,-,,hypothetical protein CMQ_1935,,no IPS match,,
RL4_JR_00341,737,615,964,5,1,4,0,0,0,1,0,2,0,1,5,0,0,3,82.83505844,1,2.778100709,0.531484488,5.22705887,1.72E-07,3.24E-06,2.93368414,0,1.912727169,1.285042169,1.488454788,0.136630997,0.256868305,31.7027564,1,1.663377959,0.864837008,1.923342715,0.054437024,0.120621673,60.99753699,1,2.200942713,0.646342533,3.405226488,0.000661092,0.005237525,29.65501533,1,1.415126974,0.865007991,1.635969827,0.101845902,0.193650659,N,-,,DUF155 domain containing,C:mitochondrial inner membrane,IPR003734 (PFAM); PTHR16255:SF1 (PANTHER); PTHR16255 (PANTHER); PTHR16255 (PANTHER); PTHR16255:SF1 (PANTHER),,
RL4_JR_00342,3338,3056,3384,2,3,0,0,0,1,0,2,0,4,5,0,0,8,0,83.2729905,1,-0.330557852,0.654350419,-0.505169466,0.613439815,0.778295802,21.88185432,1,0.738484647,1.113828097,0.66301492,0.507320998,0.659781444,48.08677765,1,-1.00486747,1.02594315,-0.979457263,0.327354095,0.470423401,94.68238558,1,0.648819018,0.499951651,1.297763526,0.194368607,0.323787783,62.79019194,1,0.691489077,0.541544473,1.27688327,0.201643461,0.32372505,N,-,,tubulin-specific chaperone c,F:tubulin binding; P:tubulin complex assembly; C:cytoplasm; P:post-chaperonin tubulin folding pathway,IPR006599 (SMART); IPR031925 (PFAM); IPR012945 (PFAM); IPR027684 (PANTHER); IPR017901 (PROSITE_PROFILES),,
RL4_JR_00343,861,827,1104,0,1,1,0,0,0,0,0,0,3,3,0,0,0,2,22.97804736,1,0.153926477,1.014536886,0.151720928,0.87940705,0.941268208,3.546800256,0,1.638947268,1.260554837,1.30017927,0.193539534,0.335964185,9.224230005,0,-1.016587956,1.197532139,-0.848902441,0.395935581,0.538666083,50.61421726,1,1.879038523,0.61984716,3.031454597,0.002433785,0.015556866,23.85068397,1,0.588376551,0.980712049,0.599948325,0.548540675,0.668750672,N,-,,Mediator subunit Med9,F:hydrolase activity,IPR011425 (PFAM),,
RL4_JR_00344,27865,29114,30012,64,143,31,1,0,16,4,2,8,17,26,6,0,8,10,2256.606342,1,2.446035363,0.752538639,3.250378432,0.001152515,0.006616622,283.6302784,1,1.139289117,0.575972572,1.978026686,0.047925696,0.114034767,400.4625031,1,-1.354974746,0.423276024,-3.20116111,0.00136875,0.007371434,653.2439351,1,-0.057362736,0.279459325,-0.205263273,0.837366437,0.898239408,388.7184438,1,-1.2631766,0.431823695,-2.925213724,0.003442197,0.013226659,N,-,,"2,3-bisphosphoglycerate-independent phosphoglycerate mutase",C:cytoplasm; F:phosphoglycerate mutase activity; F:manganese ion binding; P:glucose catabolic process,IPR011258 (G3DSA:3.40.1450.GENE3D); IPR006124 (PFAM); IPR005995 (PIRSF); IPR017849 (G3DSA:3.40.720.GENE3D); IPR005995 (TIGRFAM); IPR011258 (PFAM); PTHR31637:SF0 (PANTHER); PTHR31637 (PANTHER); IPR005995 (HAMAP); IPR017850 (SUPERFAMILY); IPR011258 (SUPERFAMILY),,
RL4_JR_00345,113521,56995,75339,8,20,12,0,0,0,1,22,17,0,12,10,0,14,12,1263.681081,1,-1.815414713,0.54099449,-3.355699081,0.000791647,0.004922449,315.9288921,0,-4.837936041,1.243373984,-3.890974159,9.98E-05,0.004858685,1107.909035,1,-1.427553221,0.633356871,-2.253947633,0.024199463,0.064796445,1082.822261,1,-2.705864308,0.659003793,-4.105992006,4.03E-05,0.000484104,939.9692635,1,-2.318293456,0.616514553,-3.760322356,0.000169695,0.001085288,N,-,,frequency clock,"C:nucleus; P:prenylcysteine catabolic process; P:rhythmic process; C:cytoplasm; F:oxidoreductase activity; P:transcription, DNA-templated; F:oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor; P:regulation of transcription, DNA-templated; P:oxidation-reduction process; P:circadian rhythm",IPR018554 (PFAM),,
RL4_JR_00346,1352,2218,2782,0,4,2,0,0,0,0,0,0,1,5,0,0,0,2,65.14706079,1,0.576538103,0.719927353,0.800828168,0.423231129,0.61472463,8.025271611,0,0.460916957,1.26172355,0.365307406,0.714881951,0.821124522,20.9836729,0,-2.202236302,1.225668952,-1.796762738,0.072373294,0.150949162,53.58998181,1,0.632429466,0.703732705,0.89867852,0.368823921,0.514910028,35.5718113,1,-0.581220154,1.022701924,-0.568318237,0.569818898,0.686041423,N,-,,prefoldin subunit,C:nucleus; C:prefoldin complex; C:cytosol; P:protein folding,IPR004127 (PFAM); IPR016655 (PIRSF); IPR009053 (G3DSA:1.10.287.GENE3D); IPR016655 (PANTHER); IPR009053 (SUPERFAMILY),,
RL4_JR_00347,9044,11001,13348,2,0,48,0,0,0,3,1,1,0,6,0,0,2,5,337.1323503,1,0.665817838,1.128336268,0.59008813,0.555131566,0.733713606,42.40140676,0,-1.940542847,1.1986613,-1.618925085,0.105463383,0.21084152,157.9877609,1,-1.439369722,0.682319526,-2.109524448,0.034899338,0.086175829,151.5035864,1,-1.754084674,0.652712463,-2.687377329,0.007201555,0.037411875,153.8347176,1,-1.224678641,0.62167076,-1.969979482,0.048840722,0.109964935,N,-,,sec14 cytosolic factor,C:cell pole; P:regulation of filamentous growth; C:nucleus; C:prospore membrane; C:cell division site; C:growing cell tip; P:phospholipid transport; P:ascospore-type prospore-specific spindle pole body remodeling; F:phosphatidylinositol transporter activity; F:phosphatidylcholine transporter activity; P:Golgi vesicle transport,IPR001071 (PRINTS); IPR001251 (SMART); IPR011074 (SMART); IPR011074 (PFAM); G3DSA:1.10.8.20 (GENE3D); IPR001251 (G3DSA:3.40.525.GENE3D); IPR001251 (PFAM); PTHR23324:SF56 (PANTHER); PTHR23324 (PANTHER); IPR001251 (PROSITE_PROFILES); IPR011074 (SUPERFAMILY); IPR001251 (SUPERFAMILY),,
RL4_JR_00348,497,634,603,0,0,3,0,0,0,0,0,0,1,0,0,0,0,0,18.42189284,1,1.390610756,0.86988147,1.598620967,0.109904848,0.237008657,2.217224408,0,2.316777196,1.304580986,1.775878401,0.075752962,0.163351401,5.756601182,0,-0.33613949,1.204016451,-0.279181808,0.780105304,0.854227641,15.95383308,1,0.191685473,1.149392664,0.166771095,0.867550163,0.918150455,5.674560504,0,-0.418157678,1.205660011,-0.346828853,0.7287199,0.809655627,N,-,,kinetochore,,IPR013950 (PFAM); PTHR31749 (PANTHER); PTHR31749:SF3 (PANTHER); PTHR31749 (PANTHER); PTHR31749:SF3 (PANTHER),,
RL4_JR_00349,2705,2460,2371,4,2,0,0,0,0,0,4,1,1,0,0,0,3,2,86.46626664,1,0.332168025,0.613867127,0.541107368,0.58843358,0.760205163,9.676765084,0,0.191032905,1.221788293,0.156355161,0.875753079,0.928925357,62.89271888,1,0.688120936,0.66894676,1.028663232,0.303637953,0.44499575,38.17255546,1,-1.928758398,1.141702037,-1.689371076,0.09114834,0.182675563,50.89128991,1,0.413516596,0.663096496,0.62361451,0.532880779,0.656217209,N,-,,hypothetical protein F503_07625,,no IPS match,,
RL4_JR_00350,4282,3468,5210,0,0,8,0,0,0,0,4,2,3,4,0,0,3,0,82.17757399,1,-0.14662871,0.606027567,-0.24195056,0.808818472,0.902858546,16.44761205,0,-0.574325143,1.209568394,-0.474818246,0.634916527,0.761358261,87.12796881,1,0.174309823,0.628946711,0.277145615,0.781668297,0.854911984,93.31419033,1,-0.116839433,0.592237271,-0.197284836,0.843604645,0.902334358,53.85967467,1,-1.121578668,0.865040766,-1.296561632,0.194782061,0.315588304,N,-,,26S protease regulatory subunit 6B,"F:ATP binding; F:identical protein binding; C:proteasome regulatory particle, base subcomplex; P:proteasome regulatory particle assembly; C:cytosol; C:CENP-A containing chromatin; C:nuclear periphery; F:peptidase activity; P:ubiquitin-dependent protein catabolic process; P:positive regulation of RNA polymerase II transcriptional preinitiation complex assembly",IPR003593 (SMART); G3DSA:1.10.8.60 (GENE3D); IPR005937 (TIGRFAM); IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23073 (PANTHER); PTHR23073:SF8 (PANTHER); IPR027417 (SUPERFAMILY),3.A.16.1.1, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_00351,3843,3002,3979,1,6,3,0,0,1,0,0,1,3,0,0,0,0,0,112.7461225,1,0.539097502,0.498998198,1.080359616,0.279982072,0.463211061,23.17847416,1,0.59566432,1.119471015,0.532094456,0.594660577,0.73056856,42.28223847,1,-2.010484322,1.192179146,-1.686394473,0.091719845,0.181645484,69.21432797,1,-1.059726148,0.852002065,-1.243807018,0.213570597,0.347988782,35.28168923,0,-3.054650602,1.195552346,-2.55501201,0.010618413,0.032978968,N,-,,hypothetical protein SPSK_00492,,PF11704 (PFAM); IPR021713 (PANTHER); PTHR31441:SF2 (PANTHER); PTHR31441:SF2 (PANTHER); IPR021713 (PANTHER); IPR021713 (PANTHER); PTHR31441:SF2 (PANTHER),,
RL4_JR_00352,2123,2275,3321,3,3,0,0,0,0,0,0,1,0,0,0,0,0,0,85.04022293,1,0.383702916,0.681494675,0.563031422,0.573413488,0.749424421,9.760516735,0,0.178496056,1.226361136,0.145549341,0.884277162,0.934426328,31.95664264,1,-1.519324449,1.203189781,-1.262747135,0.206680069,0.333483158,29.37787443,0,-2.903896035,1.204902709,-2.410066816,0.015949599,0.068052968,25.24492212,0,-2.571690411,1.214452499,-2.117571839,0.034211345,0.083326887,N,-,,-tyrosine phosphatase 2,F:hydrolase activity,IPR000242 (PRINTS); IPR003595 (SMART); IPR000242 (SMART); IPR029021 (G3DSA:3.90.190.GENE3D); IPR000242 (PFAM); PTHR19134:SF81 (PANTHER); PTHR19134:SF81 (PANTHER); PTHR19134 (PANTHER); IPR000242 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES); IPR029021 (SUPERFAMILY),,
RL4_JR_00353,3001,3164,5696,0,0,0,0,0,0,0,0,0,4,3,1,0,0,2,47.22366974,0,-3.663790831,1.233092334,-2.971221805,0.002966175,0.01426772,14.89674094,0,-0.431468094,1.236248671,-0.349014001,0.727078799,0.8296124,38.98382161,0,-3.095859052,1.22071201,-2.536109275,0.011209175,0.035707308,103.9136094,1,0.25171553,0.616553743,0.408262107,0.683081256,0.784502558,53.53876129,1,-1.47949626,1.020090546,-1.45035778,0.146958774,0.255268071,N,-,,rrna processing,C:membrane,IPR000408 (PRINTS); IPR009091 (G3DSA:2.130.10.GENE3D); PF13540 (PFAM); PTHR22870 (PANTHER); PTHR22870:SF169 (PANTHER); PTHR22870:SF169 (PANTHER); PTHR22870 (PANTHER); PTHR22870 (PANTHER); PTHR22870:SF169 (PANTHER); IPR000408 (PROSITE_PROFILES); IPR000408 (PROSITE_PROFILES); IPR009091 (SUPERFAMILY),,
RL4_JR_00354,7,43,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.244386551,0,3.930814789,3.058133141,1.285364177,0.198665053,NA,0.077476253,0,7.15613045,2.479903625,2.88564861,0.00390608,0.017801595,0.200310167,0,4.510375713,1.658855435,2.718968524,0.006548584,0.023311485,0.231126347,0,4.086816973,2.112996952,1.934132924,0.053096787,0.126853461,0.195379729,0,4.443353059,1.523321066,2.916885454,0.003535456,0.013497922,N,-,,---NA---,,no IPS match,,
RL4_JR_00355,2242,2149,2345,0,0,7,1,0,0,0,0,0,2,1,0,0,0,0,53.68785036,1,0.668000117,0.560276717,1.192268208,0.233156096,0.406689637,30.92320868,1,1.281819053,1.108637315,1.156211357,0.247594716,0.400920447,22.32385832,0,-2.291532037,1.18650731,-1.931325679,0.05344279,0.119083633,48.38817442,1,-0.395074546,0.841633308,-0.469414105,0.638773668,0.752394531,21.98915343,0,-2.372497324,1.188143918,-1.99680972,0.045845857,0.104877837,N,-,,sec34-like family,C:cis-Golgi network; C:membrane; P:intracellular protein transport,IPR007265 (PFAM); IPR007265 (PANTHER),,
RL4_JR_00356,1264,2204,1988,0,0,11,0,0,0,0,0,0,2,3,1,0,3,1,63.9897537,1,1.337264167,0.795894911,1.680201931,0.092918034,0.209688885,6.962149369,0,0.665979069,1.26108794,0.528098833,0.597430741,0.732888923,18.12404098,0,-1.990821348,1.21854144,-1.633774022,0.102306309,0.19691047,61.20913761,1,0.908599384,0.668497989,1.359165472,0.17409416,0.297402289,36.84997339,1,0.524038035,0.804925058,0.651039534,0.515020967,0.640927641,N,-,,carrier ymc1,P:transmembrane transport; F:structural constituent of ribosome; C:integral component of membrane; P:translation,IPR002067 (PRINTS); IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089:SF35 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.8.12, the mitochondrial carrier (mc) family.
RL4_JR_00357,1,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.024017057,0,7.277353383,3.950950707,1.841924621,0.065486177,NA,0.007517509,0,10.51930317,3.508544607,2.998195646,0.002715833,0.015349618,0.019750033,0,7.848844754,2.050648851,3.827493308,0.000129455,0.00135673,0.022802265,0,7.426944679,3.951205681,1.879665418,0.060153691,0.136951133,0.019716075,0,7.757103381,1.450896594,5.346420561,8.97E-08,2.04E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_00358,456,681,592,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.02783294,1,0.05072636,1.165827626,0.043511029,0.965294173,0.982724897,2.212609743,0,2.319787711,1.320222135,1.757119237,0.078897487,0.168516642,5.747414801,0,-0.333813409,1.215183302,-0.274702103,0.783545115,0.85661605,6.631360106,0,-0.756369101,1.215968085,-0.622030389,0.533921886,0.666497237,5.66557504,0,-0.415867776,1.217689663,-0.341521973,0.732710666,0.812599079,N,-,,RINT-1 family,F:catalytic activity; P:nucleobase-containing compound metabolic process; C:intracellular,IPR007528 (PFAM); PTHR13520 (PANTHER); PTHR13520:SF0 (PANTHER); IPR007528 (PROSITE_PROFILES),,
RL4_JR_00359,7423,9476,14954,2,0,7,0,0,0,0,0,1,0,1,0,0,1,0,174.0123087,1,-1.267279199,0.652737032,-1.941485065,0.052199469,0.137501863,40.06763904,0,-1.858876686,1.221229609,-1.522135291,0.127975185,0.244546879,111.3643524,1,-3.561627162,1.220830375,-2.917380855,0.003529845,0.01530456,125.0504138,1,-4.001804236,1.181105003,-3.388186677,0.000703564,0.00552644,108.20796,1,-3.692366699,1.16983592,-3.156311612,0.001597781,0.007045962,N,-,,exosome complex exonuclease RRP6,F:3'-5' exonuclease activity; P:nucleic acid phosphodiester bond hydrolysis; P:localization; F:organic cyclic compound binding; F:heterocyclic compound binding; P:nuclear polyadenylation-dependent ncRNA catabolic process; P:nuclear-transcribed mRNA catabolic process; P:snRNA 3'-end processing; C:nuclear lumen; C:exosome (RNase complex),IPR002562 (SMART); IPR002121 (SMART); IPR002121 (PFAM); IPR002562 (PFAM); IPR012588 (PFAM); IPR012337 (G3DSA:3.30.420.GENE3D); PTHR12124:SF47 (PANTHER); PTHR12124 (PANTHER); IPR002121 (PROSITE_PROFILES); IPR012337 (SUPERFAMILY); IPR010997 (SUPERFAMILY),,
RL4_JR_00360,129,110,136,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.49746168,0,1.315050637,1.317241697,0.998336631,0.318116151,NA,0.478440033,0,4.529091505,1.553272374,2.915838574,0.00354734,0.016928889,1.240752049,0,1.87753574,1.225188521,1.532446402,0.125412314,0.229473029,1.431284962,0,1.455338361,1.247002716,1.167069119,0.243182457,0.381385127,1.22315806,0,1.795500521,1.212090938,1.481324928,0.138520009,0.244042994,Y,-,,carbohydrate-binding module family 19,,no IPS match,,
RL4_JR_00361,190,175,124,0,0,1,0,0,0,3,0,0,0,0,0,0,0,0,5.783025506,1,1.868967914,1.183610203,1.57904005,0.114326871,0.24396511,0.633002221,0,4.125394896,1.530207305,2.695971246,0.007018372,0.025989957,34.84022678,1,3.917564284,0.87453709,4.479586204,7.48E-06,0.000148171,1.879924792,0,1.062441542,1.264561348,0.840166073,0.400815278,0.544756744,1.593814127,0,1.413598592,1.225305974,1.153669877,0.248635538,0.378903495,N,-,,DNA (cytosine-5-)-methyltransferase,F:methyltransferase activity; F:chromatin binding; F:transferase activity; P:methylation,IPR001525 (PRINTS); IPR029063 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10629:SF11 (PANTHER); PTHR10629 (PANTHER); IPR001525 (PROSITE_PROFILES); IPR001025 (PROSITE_PROFILES); IPR001025 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_00362,5152,5640,9649,0,3,3,0,0,0,0,2,0,0,5,0,0,4,0,116.9363504,1,-1.138301564,0.702051266,-1.621393793,0.104933211,0.229559873,25.70173431,0,-1.218319775,1.222576526,-0.996518213,0.318998422,0.480992407,82.91924863,1,-2.057101742,1.063900517,-1.933547084,0.053168839,0.118632921,97.65638384,1,-1.329152426,0.756553549,-1.75685175,0.078943082,0.164939889,82.33439435,1,-1.417841388,0.837153946,-1.693644753,0.090332809,0.17690903,N,-,,prefoldin subunit,F:methyltransferase activity; F:chromatin binding; P:methylation,no IPS match,,
RL4_JR_00363,2966,2628,3121,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,34.82562547,0,-3.224477831,1.183313311,-2.72495695,0.006430987,0.026702485,11.12593846,0,-0.010337661,1.209534591,-0.008546809,0.993180716,0.996480454,50.99006647,1,-0.833250726,1.026291632,-0.811904433,0.416846471,0.558516896,37.29202992,1,-2.13632963,1.138470135,-1.876491587,0.060587809,0.137522773,28.43373565,0,-2.743325511,1.189931744,-2.30544779,0.021141508,0.057127773,N,-,,histone acetyltransferase,"F:transferase activity, transferring acyl groups other than amino-acyl groups; C:nuclear lumen; P:chromatin organization; C:chromosomal part",IPR002717 (PFAM); IPR016181 (G3DSA:3.40.630.GENE3D); G3DSA:3.30.60.60 (GENE3D); PTHR10615 (PANTHER); PTHR10615:SF114 (PANTHER); PTHR10615 (PANTHER); PTHR10615 (PANTHER); PTHR10615:SF114 (PANTHER); PTHR10615 (PANTHER); PTHR10615:SF114 (PANTHER); IPR002717 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_00364,64044,70192,101859,15,42,162,0,0,14,22,8,8,36,117,30,0,85,38,2048.680719,1,0.253878966,0.544800338,0.466003687,0.641212862,0.795954736,429.7924305,1,-0.653296891,0.710408769,-0.91960702,0.357778157,0.521962736,1136.963424,1,-1.181657701,0.576005914,-2.051468003,0.040221393,0.096060717,1992.260343,1,0.307977619,0.327618268,0.9400502,0.347191812,0.494418719,1380.322496,1,-0.311705763,0.99280091,-0.313966033,0.753546837,0.828237931,N,-,,F0 subunit DCCD-binding site,"F:hydrogen ion transmembrane transporter activity; P:ATP hydrolysis coupled proton transport; C:proton-transporting ATP synthase complex, coupling factor F(o); C:integral component of membrane; P:ATP synthesis coupled proton transport",IPR000454 (PRINTS); IPR000454 (G3DSA:1.20.20.GENE3D); IPR002379 (PFAM); PTHR10031 (PANTHER); PTHR10031:SF13 (PANTHER); IPR002379 (SUPERFAMILY),3.A.2.1.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_00365,19866,8050,8886,2,5,4,0,0,0,0,0,0,0,4,0,0,2,0,221.6259167,1,-1.032449665,0.656747593,-1.572064634,0.115935562,0.246495262,47.6914785,0,-2.11013442,1.273237443,-1.657298434,0.097459154,0.198552529,122.1420862,0,-4.743427061,1.257320474,-3.772647594,0.000161524,0.00155121,156.8228773,1,-2.542281505,0.90224923,-2.817715351,0.004836667,0.027342965,126.7193,1,-3.171832703,1.071777528,-2.959413331,0.003082254,0.012105439,N,-,,n-acetylglucosaminyl transferase component GPI1,P:GPI anchor biosynthetic process; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; C:integral component of membrane; F:phosphatidylinositol N-acetylglucosaminyltransferase activity,IPR007720 (PFAM); PTHR21329:SF3 (PANTHER); PTHR21329 (PANTHER),,
RL4_JR_00366,2690,1133,1179,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.88051739,0,-2.415655293,1.270473453,-1.901381951,0.057252002,0.147013482,6.487072984,0,0.767987955,1.338976411,0.573563469,0.566263238,0.708231372,16.61043348,0,-1.865024372,1.260146031,-1.480006543,0.1388715,0.247654583,19.14447494,0,-2.286036167,1.266577012,-1.804893146,0.071091405,0.152759014,16.17701149,0,-1.929713266,1.263147045,-1.52770279,0.126586347,0.227653066,N,-,,phosphatidylinositol class Q,C:nucleus; P:GPI anchor biosynthetic process; C:mitochondrial intermembrane space; F:protein disulfide oxidoreductase activity; C:integral component of membrane; F:phosphatidylinositol N-acetylglucosaminyltransferase activity; P:glycerol ether metabolic process; C:cytosol; P:cell redox homeostasis; P:oxidation-reduction process; P:mitochondrial respiratory chain complex assembly,no IPS match,,
RL4_JR_00367,11637,6398,7998,0,0,0,0,0,0,0,0,1,0,1,0,0,0,1,103.5853126,0,-4.79701991,1.222947494,-3.92250684,8.76E-05,0.000762159,33.45114415,0,-1.598457754,1.230941338,-1.298565338,0.19409314,0.336547007,92.7125754,1,-3.279067779,1.215956963,-2.696697234,0.007003091,0.024549617,103.4210148,1,-3.717354255,1.174381394,-3.165372232,0.001548847,0.010704486,91.88073166,1,-3.375746137,1.147366496,-2.942169001,0.00325922,0.012648372,N,-,,mitochondrial distribution morphology,C:nucleus; C:mitochondrial intermembrane space; C:cytosol; P:mitochondrial respiratory chain complex assembly,IPR007918 (PFAM); PTHR21329 (PANTHER),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_00368,25367,15979,17804,0,3,27,0,0,1,0,2,3,1,16,3,0,2,6,362.973793,1,-0.748104181,0.828973193,-0.902446771,0.366819586,0.558513285,85.45193835,1,-1.868022669,1.132254407,-1.64982592,0.098978546,0.200934785,231.3040129,1,-2.294733474,0.706077778,-3.249972658,0.001154161,0.006473533,328.5529657,1,-0.915379395,0.48976605,-1.869013575,0.061620926,0.138739576,244.1483792,1,-1.831165321,0.612655963,-2.988896594,0.002799869,0.011200581,N,-,,26s proteasome non-atpase regulatory subunit 3,"P:regulation of catalytic activity; P:regulation of protein catabolic process; C:proteasome regulatory particle, lid subcomplex; F:enzyme regulator activity",SM00753 (SMART); IPR000717 (SMART); IPR011991 (G3DSA:1.10.10.GENE3D); IPR000717 (PFAM); IPR013586 (PFAM); PTHR10758 (PANTHER); PTHR10758:SF2 (PANTHER); IPR011991 (SUPERFAMILY),,
RL4_JR_00369,7934,6264,8423,0,0,5,0,0,2,0,2,2,0,0,4,0,9,0,109.2955829,1,-1.573988982,0.682687774,-2.305576636,0.0211343,0.068827792,47.57936367,1,0.257571684,0.988539427,0.260557826,0.794433516,0.875623764,103.4488001,1,-1.215802118,0.746108269,-1.629525056,0.103201915,0.198294969,124.7876924,1,-1.696613032,0.746247873,-2.273524781,0.022994574,0.081863596,108.4915342,1,-0.400229233,0.572031478,-0.699662953,0.484137818,0.612507235,N,-,,transcription initiation factor tfiid subunit,"F:translation initiation factor activity; C:transcription factor TFIID complex; C:peptidase complex; F:protein heterodimerization activity; C:SAGA-type complex; P:transcription from RNA polymerase II promoter; P:DNA-templated transcription, initiation; F:transcription factor binding; P:chromatin organization; P:translational initiation",IPR003228 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); PTHR12264 (PANTHER); IPR003228 (PRODOM); IPR009072 (SUPERFAMILY),,
RL4_JR_00370,1315,1478,2167,6,3,12,1,0,0,0,0,0,2,11,0,0,1,5,150.0496713,1,2.705928077,0.44042827,6.143856473,8.05E-10,2.27E-08,28.57822987,1,1.744170708,1.125302932,1.549956602,0.121151933,0.235464644,16.35520289,0,-1.842775463,1.208997959,-1.524217183,0.127454467,0.232400819,81.62640605,1,2.070378785,0.52954233,3.909751248,9.24E-05,0.001001934,56.91657546,1,1.324744343,0.67676195,1.957474622,0.050291693,0.112655617,N,-,,hypothetical protein F503_07645,,no IPS match,,
RL4_JR_00371,641,759,1398,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,14.96132371,1,-0.636808041,1.20494851,-0.528493986,0.59715652,0.766940002,3.505048143,0,1.655963073,1.316492931,1.257859449,0.208442591,0.35388156,15.68787027,1,-0.049294772,1.233841974,-0.039952257,0.968131189,0.981231383,10.60719644,0,-1.434269436,1.244025757,-1.152925836,0.248940827,0.388071727,9.163759069,0,-1.109690687,1.256684866,-0.883030199,0.377219955,0.513137948,N,-,,DASH complex subunit Spc34,C:spindle microtubule; C:DASH complex; P:attachment of spindle microtubules to kinetochore,IPR013966 (PFAM),,
RL4_JR_00372,2334,2015,2954,2,3,4,0,0,0,5,0,0,1,0,0,0,5,1,88.54805013,1,0.942960308,0.530465581,1.777608844,0.07546812,0.180336533,9.265501819,0,0.25359983,1.221429939,0.20762536,0.835521502,0.901326723,79.44905696,1,1.088566688,1.551302469,0.701711439,0.482859138,0.618714835,37.11673603,1,-1.874238129,1.149140514,-1.630991254,0.102892165,0.200150465,50.50489675,1,0.692308895,0.649456705,1.065981596,0.286431961,0.420978895,N,-, Effector probability:0.737,DSBA-like thioredoxin domain-containing,F:protein disulfide oxidoreductase activity; P:oxidation-reduction process,IPR012336 (G3DSA:3.40.30.GENE3D); IPR001853 (PFAM); PTHR31290 (PANTHER); PTHR31290:SF4 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_00373,816,549,1127,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,9.885385323,0,-1.407789416,1.234680213,-1.1402057,0.254200613,0.432125152,31.27670537,1,3.967362797,0.90945714,4.362341691,1.29E-05,0.000814047,8.187537441,0,-0.844623219,1.227664965,-0.687991629,0.491458053,0.625222585,9.447154064,0,-1.267229658,1.230023492,-1.030248338,0.302893444,0.448624359,8.124516677,0,-0.936088632,1.239257003,-0.755362794,0.450031331,0.582011397,N,-,,ring finger domain containing,P:response to organic substance; F:metal ion binding; C:intracellular membrane-bounded organelle; C:cytoplasmic part; P:single-organism cellular process; P:response to endoplasmic reticulum stress; P:ubiquitin-dependent protein catabolic process; P:protein ubiquitination,IPR001841 (SMART); IPR001841 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR22937:SF39 (PANTHER); PTHR22937 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),3.A.20.1.5, the peroxisomal protein importer (ppi) family.
RL4_JR_00374,127,149,169,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,17.05708918,1,3.767596958,0.762692643,4.939862722,7.82E-07,1.23E-05,0.566551582,0,4.285193582,1.513413004,2.831476649,0.004633362,0.019672352,1.47339286,0,1.629734933,1.225540726,1.329808875,0.183581251,0.304984671,1.700022286,0,1.20719716,1.243224466,0.971021076,0.331537783,0.478179495,1.455668029,0,1.54483478,1.21834818,1.267974792,0.204806953,0.32738718,N,-,,DNA replication regulator sld2,,IPR021110 (PFAM); PTHR28124 (PANTHER),,
RL4_JR_00375,316,376,430,2,3,25,0,2,4,2,7,2,5,5,2,1,5,2,144.1202015,1,5.14204233,0.544165145,9.449415094,3.41E-21,4.96E-19,115.613754,1,6.149238321,0.625389941,9.832646677,8.14E-23,4.34E-20,93.75253669,1,4.583094993,0.482544005,9.497776262,2.14E-21,3.62E-19,90.17560179,1,4.206188237,0.466176003,9.022747219,1.83E-19,1.70E-17,53.72931036,1,3.831957344,0.562887974,6.807673144,9.92E-12,8.59E-10,N,-,,factor-induced 1,C:integral component of membrane; P:cell morphogenesis involved in conjugation with cellular fusion,IPR016509 (PIRSF); IPR033481 (PFAM); IPR033481 (PTHR28092:PANTHER); PTHR28092 (PANTHER),1.A.81.3.1, the low affinity ca(2+) channel (lacc) family.
RL4_JR_00376,4901,5039,3457,0,0,12,0,0,3,0,0,3,5,8,0,0,5,0,99.72175719,1,0.140067295,0.812960199,0.17229293,0.863207242,0.932574881,45.46892268,1,1.508061725,0.900423817,1.674835445,0.093966522,0.193023485,64.18053243,1,-0.898304774,0.881031161,-1.019606132,0.307915296,0.449118925,130.1852525,1,0.695339679,0.502292846,1.384331243,0.166257052,0.287065595,63.01826865,1,-0.458112103,0.711035581,-0.644288577,0.519388321,0.644167899,N,-,,glycosyl hydrolase family 47,F:hydrolase activity,IPR001382 (PRINTS); IPR001382 (G3DSA:1.50.10.GENE3D); IPR001382 (PFAM); PTHR11742 (PANTHER); PTHR11742 (PANTHER); PTHR11742:SF49 (PANTHER); PTHR11742:SF49 (PANTHER); PTHR11742 (PANTHER); IPR001382 (SUPERFAMILY),,
RL4_JR_00377,7615,5372,4464,0,3,8,0,0,0,0,1,1,0,4,0,0,2,0,124.3964595,1,-0.103771469,0.566798086,-0.183083661,0.854732375,0.92758379,22.5795494,0,-1.031400101,1.237124072,-0.833707891,0.40444561,0.568729912,72.40901452,1,-1.851756564,1.06080756,-1.745610263,0.080878698,0.164190081,82.9962357,1,-1.415972646,0.808553522,-1.751241701,0.079904285,0.166296174,64.4518274,1,-2.080200473,1.001724639,-2.076619054,0.037836733,0.090098053,N,-,,map kinase kinase kinase,P:signal transduction; P:response to chemical; F:protein kinase activity; P:phosphorylation; C:intracellular,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); PTHR24361:SF424 (PANTHER); PTHR24361:SF424 (PANTHER); PTHR24361 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_00378,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_00379,1343,1185,1042,0,0,17,0,0,0,0,0,1,4,0,3,0,0,0,79.2232073,1,2.42754088,0.94475174,2.56950136,0.010184499,0.038411995,4.597885647,0,1.264611014,1.263504778,1.00087553,0.316886988,0.478664392,18.36768645,1,-0.418236857,1.1980218,-0.349106216,0.72700957,0.815370617,79.84306454,1,1.813607094,0.598523829,3.030133481,0.002444457,0.015615221,11.63680595,0,-1.454456596,1.195974692,-1.216126567,0.223936712,0.350579711,N,-,,glycoside hydrolase family 5,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR001547 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR31308:SF2 (PANTHER); PTHR31308:SF2 (PANTHER); PTHR31308 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_00380,300,290,278,0,2,10,0,0,0,0,0,1,0,0,0,0,0,0,57.68452826,1,4.38442371,0.45583023,9.618545296,6.68E-22,1.11E-19,1.113778921,0,3.310113482,1.386335748,2.38767087,0.016955519,0.050729657,9.380822054,1,1.623965273,1.194449691,1.35959286,0.173958799,0.293013159,3.324351471,0,0.239899154,1.207697021,0.198641836,0.842542925,0.901625458,2.832768587,0,0.584002573,1.198516465,0.487271214,0.626066145,0.730334456,N,-,,eukaryotic and archaeal DNA primase small subunit,"F:DNA primase activity; P:DNA replication initiation; C:nuclear chromatin; C:alpha DNA polymerase:primase complex; P:lagging strand elongation; C:primosome complex; P:DNA replication, synthesis of RNA primer",G3DSA:3.90.920.10 (GENE3D); IPR002755 (PFAM); IPR014052 (TIGRFAM); IPR014052 (PANTHER); SSF56747 (SUPERFAMILY),,
RL4_JR_00381,2466,2255,4807,0,0,8,0,0,0,2,1,1,0,0,0,0,0,0,68.38299961,1,0.172703272,0.789944539,0.218627085,0.826940552,0.913003252,11.92640694,0,-0.110638518,1.255677207,-0.088110636,0.929788743,0.960711748,67.72586421,1,0.064631725,0.800361558,0.08075316,0.935638259,0.961430162,36.06283148,0,-3.19966843,1.236750273,-2.587158055,0.009677119,0.04731088,31.15342771,0,-2.875099046,1.247686395,-2.304344311,0.021203323,0.057279522,N,-,,tRNA (guanine-N(1)-)-methyltransferase,F:methyltransferase activity; P:methylation,IPR016009 (PFAM); IPR007356 (PANTHER); PTHR13563:SF13 (PANTHER); IPR028564 (PROSITE_PROFILES),,
RL4_JR_00382,226,133,163,0,0,0,0,0,0,0,2,0,0,3,0,0,0,0,2.078521698,0,0.841922438,1.304765125,0.645267429,0.518753896,NA,0.670323869,0,4.042649529,1.517876375,2.663358884,0.007736485,0.027939221,17.4147961,1,3.223900857,1.057616049,3.048271498,0.002301619,0.011053885,14.0283566,1,3.257432953,0.900038979,3.619213202,0.0002955,0.002683353,1.695809536,0,1.323835491,1.230528119,1.075827095,0.282004592,0.415739152,N,-,,DNA mismatch repair msh-2,F:ATPase activity; P:reciprocal meiotic recombination; F:double-strand/single-strand DNA junction binding; P:interstrand cross-link repair; P:removal of nonhomologous ends; C:nuclear chromosome; F:heteroduplex DNA loop binding; P:meiotic gene conversion; F:Y-form DNA binding; P:meiotic mismatch repair; F:four-way junction DNA binding; F:damaged DNA binding; P:postreplication repair; P:mitotic recombination; P:negative regulation of reciprocal meiotic recombination; F:ATP binding; P:maintenance of DNA repeat elements; C:MutSalpha complex; P:chromatin silencing at silent mating-type cassette; C:MutSbeta complex; F:guanine/thymine mispair binding; F:single base insertion or deletion binding,IPR007696 (SMART); IPR000432 (SMART); IPR000432 (PFAM); IPR007696 (PFAM); IPR007860 (PFAM); G3DSA:1.10.1420.10 (GENE3D); IPR007860 (G3DSA:3.30.420.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR007861 (PFAM); IPR011184 (PIRSF); IPR007695 (PFAM); PTHR11361 (PANTHER); IPR032642 (PTHR11361:PANTHER); IPR027417 (SUPERFAMILY); IPR007696 (SUPERFAMILY),,
RL4_JR_00383,18,21,26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.260133916,0,3.840309954,2.653067597,1.447497967,0.147757505,NA,0.082530123,0,7.064283802,2.171708165,3.252869752,0.001142459,0.015023052,0.21491247,0,4.406674468,1.341501062,3.284883325,0.001020246,0.005842179,0.247986536,0,3.984337573,1.67984244,2.371851953,0.017699181,0.072435007,0.212657245,0,4.32061832,1.257192614,3.436719459,0.000588805,0.003106645,N,-,,"hypothetical protein AM506_21650, partial",,no IPS match,,
RL4_JR_00384,8218,10196,11441,2,4,11,0,0,3,6,7,1,2,8,1,0,2,2,213.8512006,1,-0.219379666,0.436173469,-0.502964259,0.614989401,0.778967874,66.12917754,1,0.400920265,0.854477123,0.46919953,0.638927021,0.764175743,226.6770571,1,0.22643666,0.46027189,0.491962825,0.622745624,0.73583995,174.4203768,1,-0.697707319,0.493624241,-1.41343812,0.157526944,0.27597968,120.160484,1,-1.897651242,0.768025687,-2.470817413,0.013480463,0.03988594,N,-, Effector probability:0.86,nadh-ubiquinone oxidoreductase 213 kda subunit,C:integral component of membrane,IPR003397 (PFAM); PTHR21382:SF1 (PANTHER); PTHR21382 (PANTHER),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_00385,9381,7275,5692,4,2,15,0,0,0,0,2,0,4,5,4,0,4,4,203.1004357,1,0.459775245,0.474531154,0.968904235,0.332592972,0.522188889,28.92163068,0,-1.388534775,1.229799577,-1.129074039,0.258866602,0.414793058,90.09979531,1,-2.203613602,1.057013646,-2.084754167,0.037091621,0.090008526,181.649338,1,0.025690339,0.49822391,0.051563842,0.958876231,0.976481804,117.6203906,1,-0.474320732,0.588820989,-0.805543179,0.4205063,0.55640699,N,-,,ubiquitin carboxyl-terminal hydrolase,F:thiol-dependent ubiquitinyl hydrolase activity; P:ubiquitin-dependent protein catabolic process,IPR001394 (PFAM); IPR025305 (PFAM); PTHR24006 (PANTHER); IPR028889 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY),,
RL4_JR_00386,111756,188150,276001,71,151,25,8,10,18,17,50,74,19,79,62,3,42,104,4323.951104,1,-0.195184811,0.864938041,-0.225663344,0.82146327,0.90986066,1454.225477,1,-0.091061932,0.525886775,-0.173158818,0.862526593,0.919734062,2958.37973,1,-0.824436283,0.502186942,-1.641691996,0.100653851,0.194841222,3281.274603,1,-1.009941523,0.565107898,-1.787165824,0.073910691,0.156951709,2866.494924,1,-0.94211275,0.979787284,-0.961548252,0.336276577,0.473336198,N,-,,xylulose-5-phosphate phosphoketolase,F:aldehyde-lyase activity; P:carbohydrate metabolic process,IPR005593 (PIRSF); IPR005593 (PFAM); IPR029061 (G3DSA:3.40.50.GENE3D); IPR018969 (PFAM); IPR018970 (PFAM); PTHR31273:SF0 (PANTHER); PTHR31273 (PANTHER); IPR029061 (SUPERFAMILY); IPR029061 (SUPERFAMILY),,
RL4_JR_00387,110,197,125,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.749050188,0,1.091390977,1.390663681,0.784798648,0.432571633,NA,0.556808642,0,4.310370643,1.575305592,2.736212367,0.00621509,0.023865381,1.442936067,0,1.660457779,1.267198964,1.310337071,0.190081832,0.313061406,1.664715093,0,1.23789432,1.299447992,0.952630907,0.340777112,0.487762276,1.417390975,0,1.583363416,1.253048128,1.263609418,0.206370251,0.329366141,N,-, Effector probability:0.836,---NA---,,no IPS match,,
RL4_JR_00388,7676,6493,6319,2,4,5,0,0,0,3,0,3,0,4,3,0,6,0,153.2653457,1,-0.264919497,0.472502819,-0.56067284,0.575020586,0.750296858,26.32854587,0,-1.253012997,1.206237347,-1.038778147,0.298907927,0.45911169,120.7299229,1,-0.485910033,0.619338209,-0.784563307,0.432709651,0.57324686,123.4053165,1,-0.784371134,0.580066869,-1.352208127,0.176308745,0.300273514,89.9348916,1,-0.7881547,0.624053539,-1.262960069,0.20660353,0.329428099,N,-,,chitin synthase activator,C:cell part,IPR006597 (SMART); IPR006597 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR11102 (PANTHER); PTHR11102:SF60 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); SSF81901 (SUPERFAMILY),,
RL4_JR_00389,165,244,126,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5.985380679,1,1.725496573,1.220437153,1.413834845,0.1574104,0.306762878,0.694411787,0,3.991820246,1.544013622,2.585352998,0.009727934,0.033020172,1.791558804,0,1.348273365,1.268244753,1.063101867,0.287735758,0.427290227,2.066343259,0,0.926118222,1.294118124,0.715636544,0.474215803,0.61509544,1.751718851,0,1.277634745,1.253497815,1.019255662,0.308081607,0.443401034,N,-,,dna mismatch repair msh3,F:nucleotide binding; F:DNA binding; P:DNA repair,IPR007696 (SMART); IPR000432 (SMART); IPR016151 (G3DSA:3.40.1170.GENE3D); IPR007695 (PFAM); IPR007696 (PFAM); IPR007860 (PFAM); G3DSA:1.10.1420.10 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000432 (PFAM); PTHR11361:SF84 (PANTHER); PTHR11361 (PANTHER); IPR016151 (SUPERFAMILY); IPR007696 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_00390,8,15,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.141340375,0,4.720499932,3.469958308,1.360390965,0.173706236,NA,0.044792438,0,7.946166275,2.474678198,3.210989729,0.001322787,0.015023052,0.116489564,0,5.291637723,1.456846448,3.632254949,0.000280955,0.002210804,0.134420207,0,4.868223224,2.103286404,2.314579325,0.020635965,0.077838716,0.114902246,0,5.210587924,1.296665264,4.018452617,5.86E-05,0.000442311,N,-,,Uncharacterised protein,,no IPS match,,
RL4_JR_00391,56,82,61,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.802726251,0,2.214867087,1.639870408,1.350635438,0.176812243,NA,0.255878167,0,5.432096732,1.759120159,3.0879623,0.00201534,0.015023052,0.663077627,0,2.782405112,1.271699219,2.187942771,0.028673771,0.073978914,0.7649576,0,2.359727667,1.348799676,1.749501953,0.080204292,0.166680717,0.651818071,0,2.704366127,1.238747681,2.183145259,0.029025114,0.073301011,N,-,,hypothetical protein CMQ_81,P:biological_process; F:catalytic activity; P:protein geranylgeranylation; F:Rab geranylgeranyltransferase activity,no IPS match,,
RL4_JR_00392,1694,2027,3064,0,5,4,0,0,0,0,0,5,0,1,5,0,1,6,82.4153575,1,1.047774578,0.603860362,1.735127263,0.082718266,0.193208479,8.55525047,0,0.368636596,1.242919336,0.296589316,0.766780068,0.858841192,54.85142151,1,0.82349127,0.72105989,1.142056688,0.253430457,0.38910069,77.99161193,1,0.686338504,0.690284436,0.994283614,0.320084811,0.46624904,70.26670683,1,1.120451788,0.675160643,1.659533624,0.097008311,0.186448206,N,-,,geranylgeranyltransferase beta subunit,C:Rab-protein geranylgeranyltransferase complex; P:protein geranylgeranylation; F:Rab geranylgeranyltransferase activity,IPR008930 (G3DSA:1.50.10.GENE3D); IPR001330 (PFAM); PTHR11774 (PANTHER); IPR026873 (PTHR11774:PANTHER); IPR008930 (SUPERFAMILY),,
RL4_JR_00393,1938,1616,1670,1,3,0,0,0,0,0,0,0,1,0,0,0,1,0,54.98975999,1,0.25550157,0.735694468,0.347293042,0.728371178,0.856411891,6.703144841,0,0.720717031,1.23611941,0.583048066,0.559860944,0.703352671,17.33042713,0,-1.92622298,1.192994278,-1.614612086,0.106394726,0.203080734,29.30048476,1,-1.39869004,1.14306189,-1.223634566,0.221090114,0.35654818,20.88634591,1,-1.073061967,1.11991896,-0.958160371,0.337981897,0.475155055,N,-,,Rho GTPase activator,P:signal transduction,IPR000198 (SMART); IPR000198 (G3DSA:1.10.555.GENE3D); IPR000198 (PFAM); PTHR23176:SF29 (PANTHER); PTHR23176 (PANTHER); IPR000198 (PROSITE_PROFILES); IPR008936 (SUPERFAMILY),9.A.1.1.1, the non abc multidrug exporter (n-mde) family.
RL4_JR_00394,1214,1807,2219,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.00518234,0,-2.494988294,1.22507125,-2.036606682,0.041689473,0.116353992,6.633021813,0,0.735798755,1.256250072,0.585710418,0.558070132,0.702061382,17.31954259,0,-1.925376509,1.216782077,-1.582351143,0.113569432,0.21296109,19.98876344,0,-2.348326461,1.218430783,-1.92733678,0.053937673,0.127956639,17.17885955,0,-2.016308761,1.228558678,-1.641198583,0.1007562,0.192149102,N,-,,---NA---,,no IPS match,,
RL4_JR_00395,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,ribosome biogenesis,C:nuclear lumen; P:ribosome biogenesis,IPR007023 (PFAM); IPR007023 (PANTHER),,
RL4_JR_00396,9393,14902,18985,0,0,4,1,0,0,0,1,0,0,0,2,0,6,0,188.7427681,1,-2.899500757,0.864825289,-3.352701168,0.000800271,0.004972283,76.98697657,1,-1.37899168,1.133082028,-1.217027229,0.223593856,0.372484696,150.7870445,1,-4.008527807,1.222479604,-3.279014058,0.001041704,0.005950158,184.2576008,1,-3.620592513,1.059048865,-3.418720921,0.000629162,0.005039768,165.1312888,1,-1.9710837,0.763515835,-2.5815885,0.009834677,0.030943476,N,-,,atp-dependent rrna helicase rrp3,"F:nucleic acid binding; C:nucleus; F:ATP binding; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:cytosol; F:ATP-dependent RNA helicase activity",IPR001650 (SMART); IPR014001 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24031 (PANTHER); PTHR24031:SF78 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_00397,1177,1325,2351,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,23.14989812,1,-1.430772217,1.191023957,-1.201295918,0.229636433,0.401925343,6.091789683,0,0.858558828,1.272179355,0.674872473,0.49975679,0.653811326,15.95091226,0,-1.80666911,1.227254169,-1.472123018,0.140987661,0.250238268,18.4110549,0,-2.229760329,1.230165872,-1.812568841,0.069898347,0.150626918,15.88633542,0,-1.903479696,1.243337516,-1.530943666,0.125783316,0.226732433,Y,-,,lpxtg-domain-containing,C:membrane,IPR013320 (G3DSA:2.60.120.GENE3D),,
RL4_JR_00398,11013,8974,8285,0,0,5,6,0,0,0,4,0,0,2,0,0,2,1,132.2648004,1,-1.912433608,0.698921201,-2.736264982,0.006214096,0.025917484,170.2761121,1,1.870390438,1.56015312,1.198850558,0.23058606,0.380677875,125.3108107,1,-1.54003168,0.756979587,-2.034442813,0.041906969,0.099173949,116.3562336,1,-3.065471202,1.027592355,-2.983158824,0.002852899,0.017830619,107.174603,1,-2.226748601,0.847516767,-2.627379998,0.008604519,0.027851902,N,-,,leucine permease transcriptional regulator,P:cellular process,IPR005062 (PFAM); PTHR12436 (PANTHER); PTHR12436:SF3 (PANTHER); PTHR12436 (PANTHER); PTHR12436 (PANTHER); PTHR12436:SF3 (PANTHER),3.A.22.1.1, the transcription-coupled trex/tap nuclear mrna export complex (trex) family.
RL4_JR_00399,7516,11003,15006,10,0,2,0,3,0,1,0,0,0,0,0,0,0,1,242.4749859,1,-0.42198738,1.055098122,-0.399950839,0.689192726,0.831135544,157.3063137,1,1.121889443,1.611628583,0.696121585,0.48635269,0.642442362,121.6820278,1,-3.638589479,1.219740826,-2.983084113,0.002853596,0.013113846,127.6688581,0,-5.023448981,1.225460091,-4.099235069,4.15E-05,0.000497274,117.2782025,1,-3.75134257,1.165650124,-3.218240615,0.001289796,0.005901121,N,-,,low-temperature viability ltv1,"P:ribosomal small subunit export from nucleus; C:nucleus; C:late endosome membrane; P:ribosomal small subunit biogenesis; P:response to osmotic stress; C:cytosol; P:cellular response to oxidative stress; C:preribosome, small subunit precursor",IPR007307 (PFAM); PTHR21531 (PANTHER),,
RL4_JR_00400,13982,18179,23414,6,9,2,0,0,0,2,3,0,1,3,4,0,9,0,362.5779729,1,-0.79476141,0.677558549,-1.172978204,0.240804546,0.415587791,70.36509078,0,-2.671286815,1.202092149,-2.222198038,0.026269925,0.071192552,229.2577627,1,-2.169177937,0.70011574,-3.098313339,0.001946255,0.009635153,271.757031,1,-1.992619203,0.583954279,-3.41228633,0.000644204,0.005139926,216.7547596,1,-1.794170468,0.691080029,-2.596183354,0.009426575,0.029966741,N,-,,ribosome biogenesis GTPase,F:GTP binding; C:cytoplasm; P:ribosome biogenesis; P:sexual reproduction; P:cellular process,IPR023179 (G3DSA:1.10.1580.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR006073 (PFAM); PTHR11089:SF7 (PANTHER); PTHR11089 (PANTHER); PTHR11089 (PANTHER); PTHR11089:SF7 (PANTHER); PTHR11089 (PANTHER); PTHR11089:SF7 (PANTHER); IPR030378 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_00401,4963,5320,5648,0,1,10,0,0,0,0,2,1,0,3,0,0,1,0,110.0283042,1,0.040790778,0.490818836,0.083107605,0.933765979,0.967199448,20.35014209,0,-0.881443866,1.196620985,-0.736610737,0.461359104,0.619840304,74.99443105,1,-1.126337753,0.846863492,-1.330010992,0.18351465,0.304973664,72.95920359,1,-1.649246232,0.849204592,-1.942107058,0.052124141,0.125807414,55.92041657,1,-2.6854016,1.119315129,-2.39914706,0.016433313,0.046698652,N,-,,exocyst complex component sec8,P:exocytosis,IPR007191 (PFAM); PTHR14146 (PANTHER),1.F.2.1.1, the octameric exocyst (exocyst) family.
RL4_JR_00402,2456,2054,2719,0,0,5,0,0,1,0,1,3,1,4,0,0,0,0,47.93540277,1,0.078281279,0.672299598,0.116438086,0.907305352,0.955051208,18.58494472,1,1.179624226,1.11917014,1.054016886,0.291875186,0.451007035,51.23397684,1,0.428125174,0.74407022,0.575382756,0.565032464,0.68953576,52.92394132,1,0.2290751,0.672239061,0.340764339,0.733280998,0.82192739,23.5798191,0,-2.473278224,1.196353041,-2.067348132,0.038701362,0.091725489,N,-,,glucan synthesis regulatory,C:cell division site; P:negative regulation of G0 to G1 transition; C:cellular_component; F:molecular_function; P:cell wall biogenesis,IPR018958 (SMART); IPR018958 (PFAM); IPR009203 (PIRSF); IPR018958 (G3DSA:3.40.1580.GENE3D); PTHR14289:SF21 (PANTHER); PTHR14289:SF21 (PANTHER); PTHR14289 (PANTHER); SSF160631 (SUPERFAMILY),,
RL4_JR_00403,3670,3498,4065,0,0,3,0,0,2,0,3,0,0,5,4,0,4,0,56.37872565,1,-1.285204157,0.844709349,-1.521475,0.12814068,0.264570818,33.09104096,1,1.268236813,0.981145453,1.292608357,0.196146548,0.339325817,60.72129795,1,-0.618993453,0.845327965,-0.732252425,0.464014511,0.601264932,101.5050728,1,0.450219689,0.50137666,0.897966987,0.36920315,0.514987936,52.11583138,1,-0.497655013,0.7460975,-0.667010697,0.504765301,0.63203243,N,-,,upf0220 domain containing,C:fungal-type vacuole membrane; C:integral component of membrane; C:Vps55/Vps68 complex; C:Golgi apparatus; P:protein targeting to vacuole; P:late endosome to vacuole transport via multivesicular body sorting pathway,IPR007919 (PFAM); PTHR13180:SF0 (PANTHER); IPR007919 (PANTHER),9.B.199.1.4, the 4 tms pf05225 (pf0225) family.
RL4_JR_00404,8673,6109,5311,2,0,0,0,0,0,0,3,1,1,4,0,0,3,2,100.4888655,1,-2.663763241,1.042334056,-2.555575369,0.01060124,0.039701965,25.96884784,0,-1.233168498,1.231025361,-1.001740936,0.31646873,0.478175322,96.84953198,1,-1.053767485,0.77836983,-1.353813374,0.175795926,0.295142805,102.4047892,1,-1.275242583,0.723092958,-1.76359425,0.077800316,0.16312647,91.64027353,1,-1.004853474,0.708197067,-1.41888963,0.155931196,0.266195138,N,-,,phosphoinositide-specific phospholipase c,F:phosphatidylinositol phospholipase C activity; P:lipid catabolic process; P:cellular response to UV; C:cytosol; F:signal transducer activity; P:intracellular signal transduction,IPR001192 (PRINTS); IPR001711 (SMART); IPR000008 (SMART); IPR000909 (SMART); IPR000008 (G3DSA:2.60.40.GENE3D); IPR000909 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR000008 (PFAM); IPR017946 (G3DSA:3.20.20.GENE3D); IPR001711 (PFAM); IPR001192 (PANTHER); PTHR10336:SF36 (PANTHER); IPR001192 (PANTHER); PTHR10336:SF36 (PANTHER); IPR000909 (PROSITE_PROFILES); IPR001711 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY); IPR017946 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR000008 (SUPERFAMILY),,
RL4_JR_00405,613,393,599,0,0,0,0,0,0,0,0,1,0,3,0,0,0,1,6.383067354,0,-0.776838859,1.216096417,-0.638797095,0.522954938,0.707155045,2.044525256,0,2.433727206,1.330752879,1.828834823,0.067424357,0.149108442,11.79699614,1,0.745046744,1.207743416,0.61689158,0.537306241,0.666057106,18.14605857,1,1.649005119,0.884240974,1.864882047,0.062197939,0.139635064,12.58911947,1,0.639124348,1.142110932,0.559599186,0.57575286,0.689963038,N,-,,palmitoyltransferase PFA3,"F:transferase activity, transferring acyl groups; C:membrane; C:vacuole",IPR001594 (PFAM); PTHR22883 (PANTHER); PTHR22883:SF40 (PANTHER); PTHR22883 (PANTHER); PTHR22883:SF40 (PANTHER); IPR001594 (PROSITE_PROFILES),8.A.114.1.6, the huntington-interacting protein 14 (hip14) family.
RL4_JR_00406,38,66,86,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0.76165226,0,2.290488602,1.749990598,1.308857662,0.19058257,NA,0.239580525,0,5.526720048,1.807256861,3.058071139,0.002227667,0.015045494,7.125907916,1,3.823075489,1.239553343,3.084236358,0.002040754,0.010000287,0.723949905,0,2.438680258,1.41121959,1.728065764,0.083976435,0.17176998,0.623677675,0,2.767988351,1.284740359,2.154511868,0.031200052,0.077610944,N,-,,dhhc zinc finger membrane,F:nucleic acid binding; F:zinc ion binding; F:metal ion binding; C:membrane; C:integral component of membrane; F:transferase activity,IPR015880 (SMART),,
RL4_JR_00407,1799,1346,1771,0,0,2,0,0,0,0,0,0,1,0,4,0,6,0,27.23650653,1,-0.6681156,1.01377225,-0.659039149,0.50987063,0.696038253,6.273592434,0,0.816220781,1.238772641,0.658894743,0.509963362,0.661383713,16.25564337,0,-1.833951342,1.196040469,-1.533352249,0.125189087,0.229188847,66.60392766,1,0.837374233,0.67624095,1.238277914,0.21561303,0.350414435,39.17971175,1,1.259150839,0.641367978,1.963226856,0.04961982,0.111471196,N,-,,ubiquitin-conjugating enzyme,F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; C:cytoplasm; C:membrane; C:integral component of membrane; P:protein ubiquitination,SM00212 (SMART); IPR000608 (PFAM); IPR016135 (G3DSA:3.10.110.GENE3D); PTHR24067:SF54 (PANTHER); PTHR24067 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_00408,25254,17458,23652,0,0,0,0,0,0,1,0,1,3,8,0,0,0,0,264.3558492,0,-6.148675341,1.201273391,-5.118464611,3.08E-07,5.36E-06,84.73075274,0,-2.939297267,1.200339046,-2.448722531,0.014336384,0.044472228,236.9673658,1,-3.762664378,1.041935621,-3.611225398,0.000304754,0.002352599,313.087384,1,-1.852236557,0.504046968,-3.674730083,0.000238101,0.002220436,216.0594301,0,-5.66907091,1.205252297,-4.703638337,2.56E-06,3.20E-05,N,-,,TFIIIC transcription initiation factor complex subunit,"F:translation initiation factor activity; F:DNA binding; F:metal ion binding; P:regulation of transcription, DNA-templated; P:translational initiation",IPR007309 (PFAM),,
RL4_JR_00409,11856,14962,17887,0,0,2,0,0,0,0,0,2,0,0,1,0,0,0,186.7200026,1,-3.871785152,1.042722084,-3.713151579,0.000204694,0.00156945,56.7631838,0,-2.361381783,1.198313847,-1.970587078,0.048771126,0.115503354,160.869955,1,-3.202450477,1.045785854,-3.062243062,0.00219685,0.010616185,180.2709184,1,-4.490956792,1.155246328,-3.887445199,0.000101305,0.001080867,146.3504962,0,-5.107062557,1.211250785,-4.216354383,2.48E-05,0.000215968,N,-,,urease accessory,,PTHR40644:SF1 (PANTHER); PTHR40644 (PANTHER),,
RL4_JR_00410,15041,11892,16604,0,1,4,2,0,0,0,0,0,0,0,0,0,0,0,196.8269809,1,-2.509460011,0.684815182,-3.664433961,0.000247886,0.001849512,100.0290331,1,-0.658842001,0.979744989,-0.672462742,0.501289152,0.655223243,143.8130867,0,-4.97907527,1.194479763,-4.168404876,3.07E-05,0.000480478,165.9032884,0,-5.401390761,1.194496473,-4.521897623,6.13E-06,9.28E-05,141.9556691,0,-5.063083098,1.200974652,-4.215811791,2.49E-05,0.000216302,N,-,,Altered inheritance of mitochondria 6,P:lipid metabolic process; C:integral component of membrane; F:phosphoric diester hydrolase activity,PTHR31571:SF4 (PANTHER); PTHR31571 (PANTHER); IPR017946 (SUPERFAMILY),,
RL4_JR_00411,5055,2548,8329,1,3,3,0,0,0,0,0,0,0,4,0,0,0,0,108.4051759,1,-0.508198125,0.748764606,-0.678715474,0.49731816,0.684284288,19.88793711,0,-0.848341259,1.280082908,-0.662723683,0.507507539,0.659781444,52.04914143,0,-3.512842833,1.26143278,-2.784803827,0.005356012,0.019915224,76.11423791,1,-1.319847237,0.913794935,-1.444358233,0.148638233,0.264538954,51.91512125,0,-3.611870321,1.278908284,-2.824182442,0.004740139,0.017134563,N,-,,cyanate hydratase,F:cyanate hydratase activity; F:sequence-specific DNA binding; P:cyanate metabolic process,IPR008076 (PRINTS); IPR003712 (SMART); IPR001387 (SMART); IPR008076 (TIGRFAM); IPR010982 (G3DSA:1.10.260.GENE3D); IPR003712 (PFAM); IPR008076 (PIRSF); IPR003712 (G3DSA:3.30.1160.GENE3D); PTHR34186 (PANTHER); PTHR34186:SF2 (PANTHER); IPR001387 (PROSITE_PROFILES); IPR003712 (SUPERFAMILY); IPR010982 (SUPERFAMILY),,
RL4_JR_00412,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.723,hypothetical protein SPBR_00964,,G3DSA:3.30.70.900 (GENE3D); IPR011008 (SUPERFAMILY),,
RL4_JR_00413,10,5,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.083517673,0,5.479205755,3.919521691,1.397927142,0.162134947,NA,0.027059247,0,8.673602176,2.738175188,3.167657867,0.001536723,0.015023052,0.069598319,0,6.033716615,1.569067253,3.845416187,0.000120348,0.001297917,0.080239849,0,5.612259043,2.542894879,2.20703541,0.027311586,0.087982757,0.068090833,0,5.958561202,1.320919501,4.510919248,6.45E-06,7.00E-05,N,-,,MFS general substrate transporter,C:integral component of membrane; P:transport,IPR010573 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF70 (PANTHER); PTHR23501:SF70 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.3.47, the major facilitator superfamily (mfs).
RL4_JR_00414,10221,18103,20056,4,0,2,3,0,0,0,0,0,0,2,0,0,0,0,242.3144775,1,-2.298746137,0.757597911,-3.034256172,0.002411296,0.012166961,128.2562371,1,-0.205184191,0.891543133,-0.230144996,0.817979101,0.890086483,160.1496259,0,-5.134289132,1.225291161,-4.190260484,2.79E-05,0.000443537,192.8624825,1,-3.853706356,1.068818547,-3.605575865,0.000311461,0.002802811,158.8034096,0,-5.224876477,1.240194223,-4.212950182,2.52E-05,0.000218499,N,-,,rRNA processing,C:nuclear lumen; C:intracellular non-membrane-bounded organelle; P:ribosome biogenesis; P:cellular process,IPR008610 (PFAM); PTHR13028:SF0 (PANTHER); IPR008610 (PANTHER),,
RL4_JR_00415,15188,8807,8207,0,4,8,0,0,0,0,2,2,0,9,0,0,0,2,191.0586153,1,-0.857296336,0.587804249,-1.458472507,0.144710348,0.289420545,41.6657186,0,-1.915258612,1.241256993,-1.542999252,0.122830957,0.237542023,135.7042549,1,-1.742091294,0.800100884,-2.177339543,0.029455243,0.075514023,159.4823529,1,-1.260471681,0.704692177,-1.788684083,0.073665708,0.156661477,119.2179098,1,-2.912686456,1.011903674,-2.878422651,0.003996693,0.014888342,N,-,,MYND finger,C:intracellular organelle,IPR002893 (PFAM); PTHR12197 (PANTHER); PTHR12197:SF168 (PANTHER); PTHR12197 (PANTHER); IPR002893 (PROSITE_PROFILES); SSF144232 (SUPERFAMILY),,
RL4_JR_00416,86,80,99,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.058877838,0,1.815077911,1.435673843,1.264268984,0.206133498,NA,0.337621143,0,5.031998498,1.646730802,3.055750516,0.00224498,0.015045494,0.876613138,0,2.378681717,1.236694451,1.923419092,0.054427438,0.120621673,1.011312884,0,1.956415833,1.277981056,1.530864502,0.125802884,0.232776718,0.865125171,0,2.295301938,1.217889248,1.88465572,0.059476334,0.127800909,N,-,,---NA---,,no IPS match,,
RL4_JR_00417,1140,1430,871,0,0,1,0,0,0,0,0,1,0,4,0,0,4,0,17.70761796,1,-0.952706656,1.176996239,-0.809438998,0.418262678,0.60964569,4.455477099,0,1.310014434,1.293556526,1.01272299,0.311192493,0.472984319,17.99504219,1,-0.372172662,1.21667459,-0.305893347,0.759685852,0.838628237,29.30549244,1,0.922599654,0.804959848,1.146143694,0.251735701,0.391283999,26.69204543,1,1.175341751,0.800191021,1.468826467,0.141879863,0.248449259,N,-,,variant SH3 domain-containing,C:cell division site; C:cytoplasm; C:cellular bud neck; P:cytokinesis,IPR002931 (SMART); IPR001452 (SMART); G3DSA:2.30.30.40 (GENE3D); IPR002931 (PFAM); IPR011511 (PFAM); PTHR14167 (PANTHER); PTHR14167:SF26 (PANTHER); IPR001452 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY); IPR001452 (SUPERFAMILY),8.A.34.1.1, the endophilin (endophilin) family.
RL4_JR_00418,518,528,486,0,0,2,0,0,0,4,0,0,0,0,0,0,0,1,13.78244226,1,1.006505457,1.012182421,0.994391363,0.320032372,0.508536051,1.966651705,0,2.489833648,1.314906157,1.893544748,0.058285463,0.133317093,49.36946828,1,2.896664909,1.174599306,2.466087707,0.013659788,0.041256473,5.870624978,0,-0.580516211,1.197519108,-0.484765719,0.627842543,0.743932796,12.36749671,1,0.697743727,1.120578373,0.622663924,0.533505394,0.656746762,N,-,,STE STE20 YSK kinase,F:ATP binding; F:protein kinase activity; P:protein phosphorylation,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24361 (PANTHER); PTHR24361:SF367 (PANTHER); PTHR24361 (PANTHER); PTHR24361:SF367 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_00419,1097,1221,1176,0,0,3,0,0,0,0,0,0,0,0,1,0,0,0,25.47497618,1,0.390839659,0.852559157,0.458431132,0.64664273,0.79868454,4.474006646,0,1.303978057,1.247617291,1.045174723,0.295942224,0.455792289,11.59886176,0,-1.346847091,1.192461447,-1.129468038,0.258700445,0.395094782,23.01579309,1,-0.819810808,1.141286258,-0.718321808,0.472558887,0.613575113,11.41941548,0,-1.427137046,1.193201118,-1.196057416,0.231674154,0.359284499,N,-,,rai1,P:RNA metabolic process; P:gene expression,IPR013961 (PFAM); PTHR12395:SF9 (PANTHER); PTHR12395 (PANTHER),,
RL4_JR_00420,6288,9390,12056,2,6,2,0,0,0,1,1,0,0,8,0,0,7,0,186.9383265,1,-0.720783346,0.636388237,-1.132615759,0.257375648,0.436249851,35.05374334,0,-1.666002773,1.219103336,-1.36658044,0.171756852,0.307213793,110.5101875,1,-2.494509083,1.059558549,-2.354290931,0.01855808,0.052924507,137.8107759,1,-1.157134258,0.675078818,-1.714072826,0.086515352,0.175579863,117.9558274,1,-1.114265495,0.719174055,-1.549368316,0.121293206,0.2211586,N,-,,50S ribosomal subunit,F:structural constituent of ribosome; C:mitochondrion; C:cytosolic large ribosomal subunit; P:ribosomal large subunit assembly; P:translation,IPR031309 (PFAM); IPR031310 (PFAM); IPR022803 (G3DSA:3.30.1440.GENE3D); PTHR11994:SF4 (PANTHER); PTHR11994 (PANTHER); IPR022803 (SUPERFAMILY),,
RL4_JR_00421,296553,266367,216678,19,14,6,0,0,3,3,1,7,1,1,1,0,30,1,3453.539324,1,-3.321258206,0.69712716,-4.764207158,1.90E-06,2.68E-05,1034.060674,1,-4.362650683,0.92258094,-4.728745734,2.26E-06,0.000181482,2681.078049,1,-4.881382541,0.559825642,-8.719469375,2.80E-18,3.88E-16,3015.038411,1,-7.239502078,0.890156933,-8.132837938,4.19E-16,2.89E-14,2664.328764,1,-4.211163986,1.094351401,-3.848091193,0.000119042,0.000801928,N,-,,hsp70 nucleotide exchange factor fes1,C:nucleus; P:cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process; C:cytosolic ribosome; P:cytoplasmic translation; P:regulation of catalytic activity; F:adenyl-nucleotide exchange factor activity,IPR011989 (G3DSA:1.25.10.GENE3D); IPR013918 (PFAM); PTHR19316 (PANTHER); PTHR19316:SF22 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_00422,89025,76628,85374,32,32,163,0,2,2,11,32,20,14,79,17,0,37,18,2204.381962,1,0.286446094,0.392841603,0.729164354,0.465901133,0.654186135,416.6656602,1,-2.232821537,0.759719304,-2.939008561,0.00329264,0.016299299,1334.551353,1,-0.714923101,0.339609739,-2.105131327,0.035279878,0.086732656,1570.579108,1,-0.592295821,0.380176543,-1.55794941,0.119245241,0.223460682,1094.018681,1,-1.451055424,0.675902802,-2.146840375,0.031805992,0.078827114,N,-,,actin,P:DNA repair; C:NuA4 histone acetyltransferase complex; P:actomyosin contractile ring contraction; C:Swr1 complex; P:histone exchange; P:chronological cell aging; F:ATP binding; C:cellular bud neck contractile ring; C:prospore membrane; C:cell tip; C:Ino80 complex; P:histone acetylation; P:regulation of endocytosis; P:mitotic actomyosin contractile ring assembly; F:structural constituent of cytoskeleton; C:actin filament; P:endocytosis; P:protein secretion; P:regulation of transcription from RNA polymerase II promoter; P:vacuole inheritance; C:actin filament bundle; P:establishment or maintenance of cell polarity regulating cell shape; P:establishment of cell polarity; P:cellular response to oxidative stress; P:ascospore wall assembly; C:actin cortical patch,IPR004000 (PRINTS); IPR004000 (SMART); G3DSA:3.30.420.40 (GENE3D); IPR004000 (PFAM); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.90.640.10 (GENE3D); PTHR11937:SF244 (PANTHER); IPR004000 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_00423,1827,1632,1836,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.17230678,0,-2.506502798,1.1824552,-2.119744408,0.034027606,0.099855111,6.770114154,0,0.706350838,1.226350368,0.575978004,0.564630049,0.707237391,17.5424268,0,-1.943810638,1.188218775,-1.635902982,0.101859894,0.196455392,20.23552827,0,-2.366030843,1.185757885,-1.995374329,0.046002069,0.116384544,17.27417797,0,-2.024347341,1.189328378,-1.70209286,0.088737962,0.174574784,N,-,,peptidyl-tRNA hydrolase domain,P:translational termination; F:translation release factor activity; C:mitochondrial large ribosomal subunit; C:mitochondrial inner membrane; F:hydrolase activity,IPR014720 (G3DSA:3.30.160.GENE3D); IPR000352 (PFAM); PTHR11075 (PANTHER); SSF75620 (SUPERFAMILY),,
RL4_JR_00424,28070,29727,17490,3,4,6,0,0,1,3,1,1,2,6,7,0,8,0,388.5588424,1,-1.891996635,0.537467659,-3.520205547,0.000431212,0.002974107,107.1182522,1,-2.230739169,1.147949631,-1.943237847,0.051987427,0.121556188,299.143631,1,-2.613218688,0.724189222,-3.608474979,0.000308002,0.002371266,400.2619444,1,-1.507826339,0.522115393,-2.887917801,0.003878012,0.022894969,276.5554394,1,-2.37999567,0.707838527,-3.362342651,0.000772842,0.003881459,N,-,,hypothetical protein CMQ_201,C:integral component of membrane,IPR024512 (PFAM); PD585641 (PRODOM),,
RL4_JR_00425,1962,1826,3518,0,0,2,0,0,0,0,0,0,0,2,0,0,3,0,36.68465183,1,-1.258568078,1.069882129,-1.176361437,0.239450475,0.41410549,9.173775645,0,0.26792432,1.252185433,0.21396537,0.830574062,0.898616571,23.996345,0,-2.395827562,1.222453098,-1.959852337,0.050013052,0.113146846,35.71811078,1,-1.112581807,1.062589201,-1.047047914,0.29507748,0.439620289,35.46566063,1,-0.324114309,0.919564888,-0.35246486,0.724489668,0.806271476,N,-,,elongator complex 2,C:intracellular part,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR22847 (PANTHER); PTHR22847:SF485 (PANTHER); PTHR22847 (PANTHER); PTHR22847:SF485 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_00426,797,1223,1050,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.36709423,0,-1.730627882,1.217560197,-1.421389995,0.155203413,0.30421659,3.928950096,0,1.491389403,1.278392866,1.166612739,0.243366797,0.395974717,10.20693265,0,-1.162416746,1.211835036,-0.959220283,0.337447785,0.480698096,11.77688666,0,-1.584989762,1.21207435,-1.307667109,0.190986244,0.319890111,10.06202741,0,-1.244548433,1.216191432,-1.023316232,0.306158351,0.441323079,N,-,,ubiquitin-related modifier 1,C:cytosol; P:cell budding; P:cellular response to oxidative stress; F:protein tag; P:invasive growth in response to glucose limitation; P:tRNA wobble position uridine thiolation; P:protein urmylation,IPR015221 (PFAM); IPR015221 (PIRSF); IPR012675 (G3DSA:3.10.20.GENE3D); PTHR14986 (PANTHER); IPR015221 (PTHR14986:PANTHER); IPR016155 (SUPERFAMILY),,
RL4_JR_00427,351,312,307,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,11.52075297,1,1.668413268,1.012473294,1.647859038,0.099381601,0.220433687,1.245223249,0,3.149174819,1.372989175,2.293663255,0.021809849,0.061759084,11.06284634,1,1.463992955,1.194754982,1.225349948,0.220443397,0.349861882,3.71376348,0,0.080047444,1.206726614,0.066334365,0.947111624,0.969106756,3.163077711,0,0.424787817,1.198505217,0.354431346,0.723015647,0.804984982,N,-,,c2h2 transcription factor,P:response to carbohydrate; F:sequence-specific DNA binding; C:intracellular part; P:cellular process; P:regulation of transcription from RNA polymerase II promoter,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY),,
RL4_JR_00428,1217,1243,1752,0,0,3,0,0,0,0,0,0,0,0,3,0,0,1,28.27178838,1,0.115759239,0.87520776,0.132264868,0.894774794,0.948391329,5.336114748,0,1.049659795,1.243650849,0.844014859,0.398661103,0.562639108,13.90130277,0,-1.608269395,1.201423702,-1.338636313,0.180689098,0.30161524,44.94646367,1,0.313931615,0.860852579,0.364675234,0.715353848,0.809359449,21.13351496,1,-0.759493455,1.138718433,-0.666972127,0.504789937,0.63203243,N,-,,mitochondrial folate carrier,P:FAD transport; P:transmembrane transport; F:structural constituent of ribosome; C:mitochondrion; C:integral component of membrane; P:translation,IPR002067 (PRINTS); IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089 (PANTHER); PTHR24089:SF62 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.10.1, the mitochondrial carrier (mc) family.
RL4_JR_00429,2714,3257,4492,2,0,0,2,0,0,0,0,3,0,0,0,0,4,0,61.9556818,1,-1.72477979,1.037973299,-1.661680307,0.096576892,0.215855968,57.85643025,1,1.415177653,0.989608087,1.430038488,0.152705973,0.280270146,54.02664702,1,-0.525284263,0.876962527,-0.598981424,0.549185272,0.676475447,39.84923969,0,-3.343693733,1.2075984,-2.768878903,0.005624954,0.030751268,49.69039865,1,-0.431981903,0.801994204,-0.538634694,0.590138943,0.701968609,N,-, Effector probability:0.592,TOM7 family,C:integral component of mitochondrial outer membrane; F:protein channel activity; P:protein import into mitochondrial outer membrane; P:protein import into mitochondrial matrix; C:endoplasmic reticulum; C:mitochondrial outer membrane translocase complex,IPR012621 (PFAM); PTHR12504 (PANTHER),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_00430,3136,4081,6612,0,0,1,0,0,0,2,1,0,0,0,0,0,1,0,59.00756396,1,-2.944496865,1.196078618,-2.461792077,0.013824478,0.049163075,17.37510313,0,-0.653482688,1.237253204,-0.528172152,0.597379856,0.732888923,75.48733446,1,-0.886291165,0.894142399,-0.991219258,0.321578529,0.464209169,52.52447428,0,-3.742122331,1.230256471,-3.041741636,0.002352137,0.015092133,49.17230718,1,-2.489007603,1.17101789,-2.125507752,0.033544268,0.082077263,N,-,,splicing factor 3b subunit 4,"F:nucleotide binding; F:RNA binding; C:U2-type prespliceosome; C:U2 snRNP; P:mRNA splicing, via spliceosome",IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR24012:SF453 (PANTHER); PTHR24012 (PANTHER); PTHR24012:SF453 (PANTHER); PTHR24012 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),9.A.60.1.1, the small nuclear rna exporter (snrna-e).
RL4_JR_00431,10581,7239,13033,2,5,4,0,0,5,2,2,6,2,2,2,0,6,1,198.0142079,1,-0.810385736,0.539452114,-1.502238502,0.133035525,0.2715296,85.93797389,1,1.059354833,0.720721659,1.469852918,0.141601593,0.264055145,178.3869581,1,-0.343227829,0.536326688,-0.639960375,0.522198361,0.652361328,163.0995653,1,-1.554535751,0.654184099,-2.37629706,0.017487378,0.072063371,131.0785173,1,-1.196827419,0.659430318,-1.814941453,0.069532907,0.1441779,N,-,,CMGC GSK kinase,F:ATP binding; F:protein serine/threonine kinase activity; P:protein phosphorylation,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24057 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_00432,8878,9195,10648,0,2,4,0,0,0,3,0,1,0,5,0,0,4,1,146.2317557,1,-1.642263901,0.617401749,-2.65995991,0.007814995,0.031237007,36.60788228,0,-1.728574705,1.190661051,-1.451777316,0.146563533,0.272199773,134.7938142,1,-1.551922942,0.737738115,-2.103623101,0.035411337,0.086952311,129.758352,1,-1.769390058,0.669786556,-2.641722264,0.008248567,0.041612724,116.6523498,1,-1.532141776,0.681206982,-2.249157477,0.024502479,0.064121891,N,-,,cap binding,"C:commitment complex; C:polysome; C:nuclear cap binding complex; P:mRNA cis splicing, via spliceosome; C:mitotic spindle; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; F:RNA cap binding; P:response to osmotic stress; C:cytosol; F:mRNA binding; P:mRNA transport",IPR015174 (PFAM); IPR015172 (PFAM); IPR016021 (G3DSA:1.25.40.GENE3D); IPR016021 (G3DSA:1.25.40.GENE3D); IPR016021 (G3DSA:1.25.40.GENE3D); IPR027159 (PANTHER); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY),9.A.60.1.1, the small nuclear rna exporter (snrna-e).
RL4_JR_00433,2242,2501,2410,0,3,3,0,0,0,0,0,0,0,7,0,0,1,0,64.18709175,1,0.367708372,0.614055328,0.59881961,0.549293184,0.729286139,9.158884361,0,0.270369937,1.217692762,0.22203461,0.824286941,0.89413981,23.74523651,0,-2.380533396,1.189828674,-2.000736281,0.045420817,0.105130397,55.47381326,1,0.707454117,0.578614571,1.222669031,0.221454729,0.356942099,27.23917912,1,-1.530463495,1.120231585,-1.366202771,0.171875328,0.287073193,N,-,,centromere kinetochore,P:mitotic spindle assembly checkpoint; P:ascospore formation; P:ER to Golgi vesicle-mediated transport; C:RZZ complex; P:pathogenesis,PTHR12205:SF0 (PANTHER); PTHR12205 (PANTHER); PTHR12205:SF0 (PANTHER),,
RL4_JR_00434,7095,8393,8980,0,2,8,0,0,0,0,3,1,1,1,0,0,3,3,144.6727942,1,-0.70914498,0.521319302,-1.360289129,0.173738447,0.328244153,31.20487405,0,-1.498187895,1.195647045,-1.253035252,0.210192878,0.355977552,111.1151466,1,-1.330456125,0.745167789,-1.785445029,0.07418916,0.153793636,106.8799213,1,-2.840475305,1.017077959,-2.792780318,0.005225717,0.028974265,113.7126947,1,-1.025047548,0.632100519,-1.621652755,0.10487772,0.19791529,N,-,,zinc metalloprotease,F:zinc ion binding; C:cytoplasm; C:integral component of membrane; P:protein processing; F:metalloendopeptidase activity,IPR011237 (G3DSA:3.30.830.GENE3D); IPR011765 (PFAM); IPR007863 (PFAM); PTHR11851 (PANTHER); PTHR11851:SF68 (PANTHER); IPR011249 (SUPERFAMILY); IPR011249 (SUPERFAMILY); IPR011249 (SUPERFAMILY); IPR011249 (SUPERFAMILY),,
RL4_JR_00435,22701,22275,25762,2,3,9,0,0,1,0,0,3,1,3,5,0,4,0,361.5009155,1,-1.722127972,0.420297473,-4.097402633,4.18E-05,0.000400609,99.6177189,1,-2.112105768,1.102337785,-1.916024105,0.055362028,0.128056317,253.7133929,1,-3.279091737,0.849633607,-3.859418588,0.000113657,0.001251467,339.7278551,1,-2.190466884,0.504203037,-4.344414301,1.40E-05,0.000191207,246.4524805,1,-3.161208338,0.759972815,-4.159633443,3.19E-05,0.000265196,N,-,,ornithine decarboxylase,P:pantothenate biosynthetic process; C:cytoplasm; C:integral component of membrane; P:putrescine biosynthetic process from ornithine; F:ornithine decarboxylase activity,IPR002433 (PRINTS); IPR000183 (PRINTS); IPR029066 (G3DSA:3.20.20.GENE3D); IPR022644 (PFAM); IPR009006 (G3DSA:2.40.37.GENE3D); IPR022643 (PFAM); PTHR11482:SF6 (PANTHER); PTHR11482 (PANTHER); IPR009006 (SUPERFAMILY); IPR029066 (SUPERFAMILY),,
RL4_JR_00436,8506,9844,15134,5,2,5,0,0,0,0,0,0,0,3,0,0,3,0,219.0788088,1,-0.797667443,0.549042252,-1.45283435,0.146269752,0.291986546,42.21726068,0,-1.934272809,1.211461132,-1.596644546,0.110344963,0.218659303,110.3141494,0,-4.596499369,1.212286875,-3.791593776,0.000149684,0.001477113,139.3492489,1,-2.741547719,0.902022963,-3.039332512,0.00237103,0.015187455,121.1779167,1,-2.515792416,0.905948646,-2.776970224,0.005486821,0.019323151,N,-,,mitochondrial presequence protease,C:mitochondrial intermembrane space; F:zinc ion binding; P:protein processing; F:metalloendopeptidase activity; P:proteolysis involved in cellular protein catabolic process,IPR013578 (SMART); IPR011765 (PFAM); IPR013578 (PFAM); IPR011237 (G3DSA:3.30.830.GENE3D); IPR007863 (PFAM); IPR011237 (G3DSA:3.30.830.GENE3D); PTHR11851 (PANTHER); PTHR11851:SF150 (PANTHER); IPR011249 (SUPERFAMILY); IPR011249 (SUPERFAMILY); IPR011249 (SUPERFAMILY); IPR011249 (SUPERFAMILY),,
RL4_JR_00437,7560,7128,8598,1,0,0,0,0,1,0,0,1,1,5,2,0,2,1,103.1457576,1,-3.693259384,1.140473728,-3.238355511,0.001202209,0.006825067,39.06339084,1,-0.508429907,1.106792202,-0.459372506,0.645966689,0.770501393,83.55629615,1,-3.117100555,1.187309622,-2.625347675,0.008656053,0.029191832,137.5380804,1,-0.774284408,0.531731068,-1.456157924,0.145348968,0.259918457,91.11103161,1,-1.949170393,0.842028051,-2.314852089,0.020621028,0.055962861,N,-,,muscle-derived (neurite-outgrowth-promoting),F:syntaxin binding,IPR026183 (PFAM); IPR026183 (PANTHER); PTHR16127:SF13 (PANTHER),,
RL4_JR_00438,1225,1064,857,0,4,2,0,0,0,0,0,1,3,0,0,0,0,0,52.29419523,1,1.569906803,0.641746598,2.446303273,0.014432954,0.051015614,4.06219822,0,1.443332578,1.28249778,1.125407467,0.260416408,0.416485208,16.97019169,1,-0.237490955,1.205049724,-0.197079797,0.843765093,0.899755404,40.01226082,1,0.728265223,0.867472855,0.839525086,0.401174718,0.545147499,10.25048691,0,-1.271457933,1.203439019,-1.056520449,0.290730503,0.42538242,N,-,,hypothetical protein CMQ_37,,no IPS match,,
RL4_JR_00439,181,165,138,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,9.578391601,1,2.662316847,1.029888412,2.585053696,0.009736383,0.037116549,0.623924261,0,4.146194798,1.511307062,2.743449628,0.006079738,0.023479246,1.61017294,0,1.502122428,1.229148563,1.222083703,0.221675975,0.351432442,1.856955505,0,1.080124649,1.24511381,0.867490699,0.385673206,0.530995541,1.578000179,0,1.427977128,1.21192444,1.178272408,0.238688024,0.367561406,N,-,,2-nitropropane dioxygenase,F:dioxygenase activity; F:nitronate monooxygenase activity; P:oxidation-reduction process,IPR013785 (G3DSA:3.20.20.GENE3D); IPR004136 (PFAM); PTHR32332 (PANTHER); PTHR32332:SF23 (PANTHER); SSF51412 (SUPERFAMILY),,
RL4_JR_00440,1009,1382,1785,4,0,11,0,0,1,5,3,0,0,0,0,0,5,0,98.98598949,1,2.398370322,0.552293453,4.342565189,1.41E-05,0.00015631,14.66167563,1,1.978950485,1.14372754,1.73026391,0.083583134,0.175975874,92.67186295,1,2.273732421,0.592553517,3.837176485,0.000124457,0.00132508,15.91842726,0,-2.019856163,1.215521551,-1.661719746,0.09656898,0.190931639,32.98523487,1,1.190938453,0.753364229,1.580826919,0.113917618,0.210565109,N,-,,hypothetical protein F503_08792,,PTHR38117:SF1 (PANTHER); PTHR38117 (PANTHER),,
RL4_JR_00441,89,79,72,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.961599002,0,1.954193123,1.489998708,1.311540146,0.18967534,NA,0.308770589,0,5.161025125,1.687592476,3.058217668,0.002226578,0.015045494,0.79752171,0,2.515748255,1.246768161,2.017815608,0.043610469,0.101871801,0.919791485,0,2.093620555,1.297694247,1.613338858,0.106670909,0.205879327,0.78243519,0,2.43992437,1.217210324,2.004521587,0.045014217,0.103395859,Y,-,,hypothetical protein CMQ_218,,IPR027796 (PFAM),,
RL4_JR_00442,1515,1504,1041,15,0,1,0,0,0,0,0,1,4,4,0,0,2,4,171.1258538,1,3.18383107,1.284845071,2.477988313,0.013212547,0.047316927,5.253902403,0,1.072202335,1.276158112,0.840179853,0.400807553,0.564412297,20.03870281,1,-0.608256664,1.209831849,-0.502761326,0.615132088,0.729910602,68.90967994,1,1.74526339,0.588299221,2.966625361,0.003010876,0.018679607,50.42627613,1,1.58542695,0.644749315,2.458981985,0.013933161,0.040962037,N,-,,peroxisome biosynthesis pas1,F:nucleotide binding; F:ATPase activity; C:peroxisome; P:protein targeting to peroxisome,IPR003593 (SMART); IPR003959 (PFAM); IPR015342 (PFAM); G3DSA:1.10.8.60 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR029067 (G3DSA:3.10.330.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR025653 (PTHR23077:PANTHER); PTHR23077 (PANTHER); IPR025653 (PTHR23077:PANTHER); IPR025653 (PTHR23077:PANTHER); PTHR23077 (PANTHER); IPR025653 (PTHR23077:PANTHER); PTHR23077 (PANTHER); PTHR23077 (PANTHER); IPR027417 (SUPERFAMILY); IPR029067 (SUPERFAMILY); IPR009010 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.20.1.5, the peroxisomal protein importer (ppi) family.
RL4_JR_00443,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_00444,2545,2584,2927,1,5,10,0,0,0,0,0,0,0,4,0,0,3,0,120.5436361,1,1.60346874,0.396169875,4.047427229,5.18E-05,0.000482801,10.27826523,0,0.103987206,1.209281558,0.085990897,0.931473654,0.96158861,26.68067583,0,-2.548761307,1.187355268,-2.146586937,0.031826181,0.080351186,46.82690484,1,-0.2509498,0.738192958,-0.339951495,0.733893056,0.822321221,37.89761895,1,-0.426069623,0.842268276,-0.505859754,0.612955107,0.720391231,N,-,,dna replication licensing factor mcm7,P:cell division; C:nucleus; F:DNA binding; F:ATP binding; P:DNA replication initiation; F:DNA helicase activity; P:DNA duplex unwinding; C:MCM complex,IPR001208 (PRINTS); IPR008050 (PRINTS); IPR003593 (SMART); IPR031327 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR033762 (PFAM); G3DSA:2.40.50.140 (GENE3D); IPR027925 (PFAM); IPR001208 (PFAM); PTHR11630 (PANTHER); PTHR11630 (PANTHER); IPR008050 (PTHR11630:PANTHER); IPR008050 (PTHR11630:PANTHER); IPR008050 (PTHR11630:PANTHER); PTHR11630 (PANTHER); IPR001208 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR012340 (SUPERFAMILY),,
RL4_JR_00445,897,1143,1645,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,14.72749216,0,-1.982790862,1.225630133,-1.617772612,0.105711611,0.230648655,4.64984192,0,1.248251822,1.271279491,0.981886227,0.326155902,0.48850992,12.1508778,0,-1.414089647,1.217980771,-1.161011471,0.245637235,0.379958955,22.04689588,1,-0.126213946,1.051616834,-0.120018948,0.904468138,0.941301299,12.06920656,0,-1.507003336,1.230778997,-1.224430494,0.220789872,0.346965303,N,-,,hypothetical protein VP1G_10917,,no IPS match,,
RL4_JR_00446,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003906015,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,0,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,N,-,,mitochondrial ribosomal,C:ribosome,IPR017082 (PIRSF); IPR019368 (PFAM); PTHR12810:SF0 (PANTHER); PTHR12810 (PANTHER),,
RL4_JR_00447,16394,12344,17658,4,1,1,0,0,0,0,0,1,0,5,0,0,2,0,236.9216058,1,-2.268084323,0.640198541,-3.542782713,0.000395929,0.002748925,59.04824062,0,-2.418314019,1.197774985,-2.01900528,0.043486671,0.105658205,159.721563,1,-4.108714777,1.19663315,-3.433562555,0.000595705,0.003842254,196.8117148,1,-2.473514583,0.692365921,-3.572553918,0.000353517,0.003110021,158.936619,1,-3.490843022,0.990716721,-3.523553149,0.000425802,0.002372725,N,-,,centromere microtubule-binding cbf5,C:endoplasmic reticulum; C:membrane part,PF04511 (PFAM); IPR007599 (PANTHER); SSF144091 (SUPERFAMILY),3.A.16.1.4, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_00448,738,783,941,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,27.92560879,1,0.341589601,1.010483084,0.338045838,0.735328645,0.860348933,3.133299196,0,1.817800203,1.266979515,1.434751061,0.151358048,0.278604503,8.145686494,0,-0.837145154,1.196285673,-0.699786993,0.484060339,0.620018582,13.40983199,1,-0.312631191,1.145450946,-0.27293285,0.784904834,0.861035561,8.047125347,0,-0.922199009,1.201836917,-0.767324581,0.442888557,0.576233184,Y,-,,exo-alpha-sialidase neuraminidase,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00449,4736,3176,3394,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.11954791,0,-3.598038573,1.202775398,-2.991446765,0.002776589,0.013537964,14.54283125,0,-0.396692509,1.231638604,-0.322085154,0.747388185,0.845164027,37.50321895,0,-3.03995151,1.204549564,-2.523724718,0.011611882,0.03622764,43.24647709,0,-3.46169103,1.205530155,-2.871509283,0.004085168,0.02388125,36.76406352,0,-3.114043629,1.202468286,-2.589709571,0.009605693,0.03038352,N,-,,hypothetical protein F503_08805,,no IPS match,,
RL4_JR_00450,1991,2709,2318,0,2,2,0,0,1,0,1,0,2,4,0,0,6,0,51.90200891,1,-0.194187441,0.765326344,-0.253731551,0.799702957,0.898371898,18.37356839,1,1.212296639,1.131168292,1.071720847,0.283845434,0.443228864,31.1784941,1,-1.39362119,1.199327169,-1.162002517,0.245234442,0.379451856,61.59303297,1,0.526107907,0.637685391,0.825027379,0.409356047,0.553146934,46.13942209,1,0.72885997,0.655000373,1.112762681,0.265810367,0.398182251,N,-,,carbon-nitrogen family,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; P:nitrogen compound metabolic process",IPR003010 (G3DSA:3.60.110.GENE3D); IPR003010 (PFAM); PTHR11750 (PANTHER); IPR003010 (PROSITE_PROFILES); IPR003010 (SUPERFAMILY),,
RL4_JR_00451,823,992,738,1,3,3,0,0,0,0,0,2,0,2,1,0,1,0,55.83109024,1,2.082234351,0.600284236,3.468747349,0.000522891,0.003490789,3.289926141,0,1.747535112,1.288946646,1.355785453,0.175167441,0.3112243,21.50398686,1,0.917194676,1.047027648,0.875998526,0.381030835,0.524837575,27.47037903,1,0.988362816,0.870156549,1.135844829,0.256021512,0.395335947,12.2067083,1,-0.045455827,1.133734266,-0.040093899,0.968018266,0.979139355,Y,-,,centromere microtubule binding cbf5,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00452,2702,2068,4374,0,1,3,2,0,0,0,0,1,3,2,0,0,0,0,55.75008514,1,-0.589283236,0.822011865,-0.716879234,0.473448616,0.662796526,56.10935018,1,1.63741988,1.011688536,1.618501961,0.105554465,0.210942209,36.51012219,1,-1.756718185,1.222498348,-1.436990233,0.150720769,0.263176451,70.59391382,1,-0.065222645,0.738103056,-0.088365229,0.929586396,0.958118474,29.85098828,0,-2.813492583,1.237782818,-2.273009886,0.023025584,0.060918223,N,-,,hydroxyacylglutathione hydrolase,C:intracellular organelle part; P:cellular process,IPR007174 (PFAM); IPR007174 (PANTHER),,
RL4_JR_00453,7192,7913,7565,0,17,1,0,0,0,0,1,3,1,6,1,0,4,3,230.9504043,1,0.602394317,1.213921565,0.496238254,0.619726325,0.781764585,29.03947019,0,-1.394406891,1.196717024,-1.165193494,0.243940679,0.396526023,102.6049232,1,-1.22620558,0.740552439,-1.655798449,0.097762642,0.190813377,129.8426445,1,-0.748803485,0.538044694,-1.391712423,0.164009499,0.28434866,111.6210004,1,-0.694324677,0.574586613,-1.20838993,0.226897311,0.354112825,N,-, Effector probability:0.639,hydroxyacylglutathione hydrolase,F:hydroxyacylglutathione hydrolase activity; P:methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,IPR001279 (SMART); IPR001279 (G3DSA:3.60.15.GENE3D); IPR001279 (PFAM); IPR032282 (PFAM); PTHR11935:SF94 (PANTHER); PTHR11935 (PANTHER); IPR001279 (SUPERFAMILY),,
RL4_JR_00454,464,450,712,0,0,1,0,0,1,1,2,1,1,0,0,4,0,0,10.29949121,1,0.14713778,1.169794955,0.12578083,0.899905417,0.951246544,11.43238232,1,3.341862303,1.143368721,2.922821169,0.003468757,0.0167035,38.61179543,1,2.593788899,0.763072422,3.399138567,0.000675985,0.004214081,15.49420647,1,0.296185402,1.161782195,0.254940559,0.798769009,0.870563641,69.41374933,1,3.38395501,1.81088952,1.86867005,0.061668733,0.131483229,N,-,,hypothetical protein HMPREF1624_07851,,no IPS match,,
RL4_JR_00455,1824,2495,2889,0,0,1,0,0,0,0,0,2,2,0,0,0,0,0,32.72002445,1,-2.009249164,1.164776563,-1.725008237,0.084525988,0.19578734,9.151731766,0,0.271436358,1.231146333,0.220474488,0.825501639,0.895132796,36.84890267,1,-0.571074092,1.04931839,-0.544233378,0.586280886,0.7068644,46.14867987,1,-1.054773684,1.03200846,-1.022059145,0.306752908,0.452487354,23.61186457,0,-2.475192416,1.214172681,-2.038583519,0.041491611,0.096797826,N,-,,pfkB family kinase,"P:phosphorylation; F:phosphotransferase activity, alcohol group as acceptor; F:kinase activity",IPR029056 (G3DSA:3.40.1190.GENE3D); IPR011611 (PFAM); PTHR10584 (PANTHER); PTHR10584:SF177 (PANTHER); IPR029056 (SUPERFAMILY),,
RL4_JR_00456,4777,4662,6144,2,17,11,0,0,2,1,6,1,4,1,2,0,0,1,260.5506693,1,1.654398905,0.539873952,3.064416978,0.002180947,0.011232428,38.55609153,1,0.800958853,0.984291274,0.813741698,0.415792941,0.579496407,116.1181823,1,0.328778176,0.546029903,0.602124854,0.547091032,0.674306015,119.9410498,1,-0.346909404,0.578973954,-0.599179638,0.5490531,0.678750073,58.27123476,1,-2.648081056,1.127739264,-2.348132357,0.018867815,0.052218196,N,-,,arginine biosynthesis,F:glutamate N-acetyltransferase activity; P:arginine biosynthetic process; P:ornithine biosynthetic process; C:mitochondrial matrix; F:acetyl-CoA:L-glutamate N-acetyltransferase activity,IPR002813 (TIGRFAM); IPR016117 (G3DSA:3.60.70.GENE3D); IPR002813 (PFAM); PTHR23100:SF0 (PANTHER); IPR002813 (PANTHER); PD004193 (PRODOM); IPR016117 (SUPERFAMILY),,
RL4_JR_00457,40784,45871,56041,1,0,12,0,0,0,0,0,2,3,10,0,0,13,0,626.9169038,1,-3.026626611,0.6536874,-4.630082532,3.66E-06,4.76E-05,181.3537556,0,-4.037149733,1.195594325,-3.376688605,0.000733641,0.015023052,484.9368666,1,-4.876294967,1.044097118,-4.670346159,3.01E-06,6.83E-05,612.597856,1,-2.733023508,0.481025889,-5.681655748,1.33E-08,3.62E-07,516.8675652,1,-2.791122003,0.822415005,-3.39381211,0.00068927,0.003546166,N,-,,centromere microtubule-binding cbf5,P:pseudouridine synthesis; F:RNA binding; C:intracellular ribonucleoprotein complex; P:mycelium development; C:viral nucleocapsid; P:RNA processing; F:pseudouridine synthase activity,IPR002478 (SMART); IPR012960 (SMART); IPR002478 (PFAM); IPR004521 (TIGRFAM); IPR002501 (PFAM); IPR004802 (TIGRFAM); IPR012960 (PFAM); IPR015947 (G3DSA:2.30.130.GENE3D); IPR032819 (PFAM); IPR004802 (PANTHER); IPR002478 (PROSITE_PROFILES); IPR020103 (SUPERFAMILY); IPR015947 (SUPERFAMILY),,
RL4_JR_00458,848,598,1119,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.18687398,0,-1.451139593,1.223288469,-1.186261155,0.235519182,0.409498185,3.240077837,0,1.769403754,1.297259072,1.363955583,0.172581545,0.308090018,8.43791417,0,-0.888079755,1.219411167,-0.728285733,0.466438694,0.603479277,9.735615079,0,-1.310625161,1.22060216,-1.073752942,0.282933426,0.426739303,8.363117366,0,-0.977848597,1.229460188,-0.795347916,0.426411148,0.560994397,N,-,,ribosome assembly 3,"P:ribosomal large subunit assembly; C:preribosome, large subunit precursor",IPR028217 (PFAM); PTHR28127 (PANTHER),,
RL4_JR_00459,14055,8161,6416,8,18,2,7,0,0,0,16,16,0,6,10,0,0,4,346.7011778,1,0.976617744,0.857594647,1.138787127,0.254791952,0.432859797,193.3795296,1,2.066176354,1.584088562,1.304331339,0.192120635,0.333787344,324.8038519,1,1.327883807,0.633956131,2.094598887,0.036206664,0.088369399,230.3168378,1,0.053959684,0.698814388,0.077216047,0.938451676,0.963869266,122.3122199,1,-1.740601105,0.84096581,-2.069764412,0.038474412,0.091337261,Y,-,,integral membrane,C:membrane,IPR018825 (PFAM); IPR018827 (PFAM); PTHR31685:SF3 (PANTHER); PTHR31685:SF3 (PANTHER); PTHR31685 (PANTHER); PTHR31685:SF3 (PANTHER); PTHR31685 (PANTHER),9.B.57.1.3, the conidiation and conidial germination protein (ccgp) family.
RL4_JR_00460,26,19,27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.286791205,0,3.699486784,2.536956425,1.458238205,0.144774896,NA,0.091701519,0,6.912344954,2.13016524,3.244980635,0.001174586,0.015023052,0.237825188,0,4.260309095,1.330110555,3.202973677,0.001360164,0.007332429,0.274338873,0,3.838545994,1.628757773,2.356732264,0.018436534,0.074086903,0.234587119,0,4.177349875,1.250696103,3.340019901,0.000837724,0.004141085,N,-,,---NA---,,no IPS match,,
RL4_JR_00461,529,382,550,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,36.36668079,1,3.025473656,0.579194312,5.223590065,1.75E-07,3.28E-06,1.860403166,0,2.569872111,1.328189603,1.934868414,0.053006445,0.123454035,4.825100389,0,-0.081773243,1.208865509,-0.067644616,0.946068539,0.968354856,5.565906437,0,-0.504004406,1.208640203,-0.417001193,0.676677535,0.779715494,4.759811189,0,-0.164782773,1.210883713,-0.136084721,0.891754306,0.929009712,N,-,,metallo-beta-lactamase superfamily,F:zinc ion binding; P:antibiotic catabolic process; F:beta-lactamase activity,IPR001279 (SMART); IPR001279 (G3DSA:3.60.15.GENE3D); IPR001279 (PFAM); PTHR23131 (PANTHER); PTHR23131:SF0 (PANTHER); IPR001279 (SUPERFAMILY),,
RL4_JR_00462,1329,1449,1336,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,26.57736228,1,-1.197957261,1.141933789,-1.049060175,0.294150424,0.479169161,5.276145949,0,1.066072799,1.241680055,0.858572862,0.390576216,0.555020701,24.73615929,1,-0.621647193,1.190438035,-0.522200379,0.601530822,0.719634049,15.76452919,0,-2.005684168,1.190278286,-1.685054824,0.091977995,0.183828898,13.44162215,0,-1.662372396,1.191744949,-1.394906181,0.163044133,0.275872635,N,-,,ubiquitin carboxyl-terminal hydrolase 22 27 51,P:protein deubiquitination; F:zinc ion binding; F:thiol-dependent ubiquitinyl hydrolase activity; P:ubiquitin-dependent protein catabolic process,IPR001607 (PFAM); IPR001394 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR24006 (PANTHER); IPR028889 (PROSITE_PROFILES); IPR001607 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY); SSF57850 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_00463,3136,2819,5143,0,0,2,0,0,0,1,0,0,0,2,0,0,0,0,51.78119285,1,-1.857925917,1.058713779,-1.75488971,0.079278175,0.18687205,13.96920486,0,-0.338722062,1.230829253,-0.275198255,0.783163928,0.869113614,47.55853826,1,-2.03864193,1.213777264,-1.679584872,0.093038113,0.183466665,50.13224648,1,-1.712899215,1.052531835,-1.627408462,0.103650376,0.201161597,36.26314822,0,-3.094213525,1.226553264,-2.522689895,0.011646105,0.035570683,N,-,,n-6 adenine-specific DNA methyltransferase 2,C:cytoplasm; P:peptidyl-lysine methylation; F:protein-lysine N-methyltransferase activity,IPR019369 (PFAM); PTHR13200 (PANTHER); PTHR13200:SF0 (PANTHER),,
RL4_JR_00464,13837,16710,21365,6,7,7,0,0,0,4,8,2,5,12,0,0,4,5,350.9120258,1,-0.674317226,0.445576255,-1.513359876,0.130188271,0.267342615,65.81111897,0,-2.574759917,1.197414129,-2.150266858,0.031534112,0.082381535,291.5570877,1,-0.582849657,0.469382938,-1.241735927,0.21433401,0.343015731,292.6463195,1,-0.889542511,0.456124792,-1.950217411,0.051150211,0.124884468,222.1721267,1,-1.520615255,0.577780236,-2.631822898,0.008492812,0.027561426,N,-,,NADH-ubiquinone oxidoreductase 40 kDa subunit,F:nucleic acid binding; F:methyltransferase activity; P:methylation,IPR016040 (G3DSA:3.40.50.GENE3D); IPR001509 (PFAM); PTHR12126:SF7 (PANTHER); PTHR12126 (PANTHER); IPR016040 (SUPERFAMILY),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_00465,3732,4452,4290,5,1,15,0,0,0,1,0,0,3,6,3,0,6,0,165.6941104,1,1.326412374,0.409545591,3.238741673,0.001200583,0.00682058,15.95776247,0,-0.530655055,1.205638666,-0.440144356,0.659832558,0.781423324,52.47603828,1,-2.220965167,1.191379592,-1.864196082,0.062294173,0.1341843,128.6813616,1,0.715299392,0.453967269,1.575662918,0.115103508,0.217267527,63.95965253,1,-0.083766414,0.63297287,-0.132338079,0.89471689,0.931517584,N,-,,26s proteasome regulatory subunit rpn9,"C:nucleus; P:mycelium development; F:structural molecule activity; C:proteasome regulatory particle, lid subcomplex; P:proteasome assembly; C:proteasome storage granule; P:ubiquitin-dependent protein catabolic process",SM00753 (SMART); IPR000717 (SMART); IPR000717 (PFAM); PTHR10539 (PANTHER); IPR011991 (SUPERFAMILY),,
RL4_JR_00466,2248,3094,3215,0,0,4,0,0,0,0,0,0,3,1,8,0,5,0,49.633763,1,-0.515434085,0.782902611,-0.658362966,0.510304927,0.696096331,10.90121955,0,0.019085017,1.222769923,0.015608019,0.987547108,0.993830963,28.36554807,0,-2.637079325,1.201188285,-2.195392145,0.02813548,0.072831399,141.7612575,1,1.498010377,0.623834089,2.401296119,0.01633711,0.069156321,47.32969441,1,0.179908894,0.716254508,0.251180121,0.801674853,0.866085989,N,-,,GPI transamidase component GAA1,P:proteolysis; F:serine-type endopeptidase activity; P:attachment of GPI anchor to protein; C:GPI-anchor transamidase complex,IPR007246 (PFAM); IPR007246 (PIRSF); PTHR13304:SF0 (PANTHER); IPR007246 (PANTHER); SSF53187 (SUPERFAMILY),,
RL4_JR_00467,2166,1723,2707,0,0,11,0,0,0,0,0,2,1,13,5,0,7,2,68.2654902,1,1.141766356,0.69837722,1.634884879,0.102073183,0.225057575,8.361518138,0,0.401701537,1.230453551,0.326466234,0.744071633,0.842341981,34.7455788,1,-0.436703039,1.044052304,-0.418276974,0.675744623,0.777270581,134.7309427,1,2.262917,0.422287535,5.358711337,8.38E-08,1.93E-06,63.27177414,1,1.411543812,0.564221663,2.501754019,0.012357975,0.037272714,N,-,,rhomboid 2,P:proteolysis; F:serine-type endopeptidase activity; C:GPI-anchor transamidase complex,IPR022764 (G3DSA:1.20.1540.GENE3D); IPR022764 (PFAM); PTHR12917:SF21 (PANTHER); PTHR12917 (PANTHER); SSF144091 (SUPERFAMILY),9.B.104.4.3, the rhomboid protease (rhomboid) family.
RL4_JR_00468,103117,95507,116594,40,42,132,0,0,10,7,33,16,25,34,10,0,52,16,2502.770675,1,0.008217781,0.223955427,0.036693826,0.970729132,0.984504494,495.584446,1,-1.380671863,0.59136072,-2.334737187,0.019557154,0.056462498,1483.248331,1,-1.225991885,0.446978764,-2.742841459,0.006091009,0.022031215,1668.755734,1,-1.389917786,0.321091617,-4.328726477,1.50E-05,0.000203278,1347.577682,1,-1.600215331,0.81061648,-1.974072045,0.048373552,0.10922886,N,-,,aconitate hydratase,"F:metal ion binding; F:double-stranded DNA binding; C:cytosol; P:tricarboxylic acid cycle; F:4 iron, 4 sulfur cluster binding; C:mitochondrial nucleoid; F:single-stranded DNA binding; F:aconitate hydratase activity; P:mitochondrial genome maintenance",IPR001030 (PRINTS); IPR001030 (PFAM); IPR015928 (G3DSA:3.20.19.GENE3D); IPR015931 (G3DSA:3.30.499.GENE3D); IPR000573 (PFAM); IPR015932 (G3DSA:3.40.1060.GENE3D); IPR015931 (G3DSA:3.30.499.GENE3D); IPR006248 (TIGRFAM); IPR015937 (PANTHER); PTHR11670:SF30 (PANTHER); IPR001030 (SUPERFAMILY); IPR015928 (SUPERFAMILY),,
RL4_JR_00469,5218,7797,9911,0,0,0,0,0,0,0,0,2,0,0,3,0,0,0,91.86052789,0,-4.623702173,1.23394637,-3.747085193,0.000178901,0.001403343,28.98618644,0,-1.391802833,1.220278567,-1.140561565,0.254052419,0.408891491,88.72828553,1,-2.241523908,1.064799002,-2.105114584,0.035281335,0.086732656,116.3108065,1,-2.099149938,0.893897741,-2.348311044,0.018858765,0.074617037,75.16717279,0,-4.145805921,1.227619113,-3.377110927,0.000732515,0.003726992,N,-,,zinc finger,"F:nucleic acid binding; C:nucleus; P:ribosomal large subunit export from nucleus; F:zinc ion binding; C:cytoplasm; P:cellular bud site selection; F:ribosomal large subunit binding; C:preribosome, large subunit precursor",IPR003604 (SMART); IPR022755 (PFAM); PTHR20863:SF2 (PANTHER); PTHR20863 (PANTHER); SSF57667 (SUPERFAMILY),,
RL4_JR_00470,3502,3229,4076,0,2,13,0,0,0,0,2,7,8,3,3,0,8,4,108.8316532,1,1.01812622,0.466684284,2.181616683,0.029137835,0.088366712,13.76191614,0,-0.317113474,1.203741852,-0.263439768,0.792211643,0.874170527,96.91610502,1,1.010708716,0.512134868,1.973520608,0.048436279,0.110543032,156.6698115,1,1.205272782,0.440639575,2.735280377,0.006232716,0.033430132,95.62601262,1,1.136439618,0.469266557,2.421735794,0.015446576,0.044506712,N,-,,cbs domain containing,P:regulation of mitotic metaphase/anaphase transition; P:positive regulation of cellular process; C:cytoplasm; P:negative regulation of metabolic process,IPR000644 (SMART); IPR016711 (PIRSF); IPR000644 (PFAM); G3DSA:3.10.580.10 (GENE3D); PTHR13780 (PANTHER); PTHR13780 (PANTHER); IPR016711 (PTHR13780:PANTHER); IPR016711 (PTHR13780:PANTHER); IPR000644 (PROSITE_PROFILES); IPR000644 (PROSITE_PROFILES); IPR000644 (PROSITE_PROFILES); SSF54631 (SUPERFAMILY); SSF54631 (SUPERFAMILY),,
RL4_JR_00471,32566,32676,39130,1,3,16,0,0,0,4,0,7,2,11,3,1,5,4,512.6196411,1,-1.856571401,0.450088074,-4.124906895,3.71E-05,0.000359344,132.956347,0,-3.589295951,1.188841966,-3.019153137,0.002534824,0.015349618,435.1509274,1,-1.961194807,0.481027462,-4.077095303,4.56E-05,0.000669408,490.1251354,1,-1.954146765,0.405023048,-4.824779167,1.40E-06,2.50E-05,405.7463387,1,-2.372027758,0.518993704,-4.570436483,4.87E-06,5.55E-05,N,-,,importin subunit beta-3,P:mRNA export from nucleus; P:regulation of protein desumoylation; C:nuclear membrane; P:regulation of mitotic nuclear division; P:protein import into nucleus; C:cytosol; F:protein transporter activity; C:nuclear periphery; F:Ran GTPase binding; F:nuclear localization sequence binding,SM01349 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); PF13513 (PFAM); PTHR10527:SF5 (PANTHER); PTHR10527 (PANTHER); IPR001494 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_00472,1670,1650,1676,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,42.92581523,1,0.875833157,0.604608107,1.448596448,0.147450314,0.29331862,6.397789942,0,0.787971972,1.228861223,0.641221285,0.521378923,0.67125381,16.57419879,0,-1.861836414,1.188266836,-1.56685044,0.117149654,0.218063815,19.11883626,0,-2.284048848,1.185730527,-1.926279872,0.054069437,0.128179127,16.31092314,0,-1.941534446,1.18807971,-1.634178607,0.102221353,0.194145789,N,-,,importin subunit beta-3,P:mRNA export from nucleus; P:regulation of protein desumoylation; C:nuclear membrane; P:regulation of mitotic nuclear division; P:protein import into nucleus; C:cytosol; F:protein transporter activity; C:nuclear periphery; F:Ran GTPase binding; F:nuclear localization sequence binding,no IPS match,,
RL4_JR_00473,3569,2311,2021,6,1,0,0,0,0,0,0,7,3,6,2,0,2,1,99.97256443,1,0.867971702,0.944184242,0.919282132,0.357948021,0.549208192,10.22243575,0,0.111891512,1.264406049,0.088493338,0.929484579,0.960514845,71.76658361,1,0.915788446,1.224777143,0.747718433,0.45463001,0.593867373,101.5702615,1,1.240930885,0.542979674,2.285409462,0.02228883,0.080484515,40.75039015,1,-0.389314308,0.879409364,-0.442699753,0.657982921,0.756280745,N,-,,white collar 1,"F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR001610 (SMART); IPR000679 (SMART); IPR000014 (SMART); G3DSA:3.30.450.20 (GENE3D); G3DSA:3.30.450.20 (GENE3D); IPR013655 (PFAM); IPR013654 (PFAM); G3DSA:3.30.450.20 (GENE3D); IPR000014 (PFAM); IPR000679 (PFAM); IPR013088 (G3DSA:3.30.50.GENE3D); IPR000014 (TIGRFAM); PTHR23244 (PANTHER); PTHR23244:SF6 (PANTHER); IPR000014 (PROSITE_PROFILES); IPR000014 (PROSITE_PROFILES); IPR000679 (PROSITE_PROFILES); IPR000014 (SUPERFAMILY); SSF57716 (SUPERFAMILY); IPR000014 (SUPERFAMILY); IPR000014 (SUPERFAMILY),1.A.1.4.12, the voltage-gated ion channel (vic) superfamily.
RL4_JR_00474,253,195,266,0,2,1,0,0,0,0,0,0,1,3,0,0,1,0,22.68503299,1,2.705058315,0.852985932,3.171281277,0.001517681,0.008281768,0.909697551,0,3.6020288,1.422215386,2.532688674,0.011319144,0.036911202,2.359512374,0,0.950223696,1.215358587,0.781846367,0.434304868,0.57481188,24.06884592,1,3.24929794,0.752006692,4.320836473,1.55E-05,0.000209284,6.187789576,1,1.796706228,1.135951392,1.581675273,0.11372372,0.21034941,N,-,,hypothetical protein SPSK_00495,,no IPS match,,
RL4_JR_00475,14,11,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.112914219,0,5.044390045,3.916206202,1.288080807,0.197717836,NA,0.036939707,0,8.225223278,2.701548222,3.044633152,0.002329643,0.015159195,0.094120808,0,5.600404875,1.64442526,3.405691344,0.000659967,0.004137158,0.108463808,0,5.178076716,2.432841104,2.12840728,0.03330333,0.097823098,0.090917351,0,5.543853524,1.39817144,3.965074213,7.34E-05,0.000536779,N,-,,RTA1 domain,C:integral component of membrane; P:response to stress,IPR007568 (PFAM); PTHR31465:SF16 (PANTHER); PTHR31465 (PANTHER),9.A.26.1.1, the lipid-translocating exporter (lte) family.
RL4_JR_00476,9,7,33,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.192843981,0,4.271868776,3.209813716,1.330877476,0.18322933,NA,0.059920892,0,7.525143953,2.472324674,3.043752316,0.002336474,0.015160123,0.158803576,0,4.841277774,1.587295444,3.050016802,0.002288286,0.011000287,0.183407787,0,4.418807497,2.107811639,2.096395814,0.036047093,0.100959199,0.160450324,0,4.726504177,1.455330839,3.247718009,0.001163345,0.005400673,N,-,,fungal trichothecene efflux pump,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR010573 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF2 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.47, the major facilitator superfamily (mfs).
RL4_JR_00477,29,13,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.257576389,0,3.854401274,2.701012992,1.427020635,0.153573947,NA,0.082998626,0,7.056262782,2.214229971,3.186779547,0.001438664,0.015023052,0.214417156,0,4.409688918,1.387669461,3.177766061,0.001484144,0.007833931,0.247260148,0,3.988407847,1.744274663,2.286570992,0.022220876,0.080442001,0.210880804,0,4.329902424,1.287339035,3.363451511,0.000769744,0.003871661,N,-,,hypothetical protein SPI_05396,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding; C:cellular_component",IPR021833 (PFAM); PTHR37012 (PANTHER); PTHR37012:SF2 (PANTHER),,
RL4_JR_00478,28,30,42,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.399393887,0,3.221729944,2.198456564,1.465450806,0.142797965,NA,0.126622539,0,6.446710892,1.996428901,3.229121202,0.001241713,0.015023052,0.330035498,0,3.787548265,1.305519956,2.901179907,0.003717604,0.01574077,0.380839422,0,3.365290518,1.502636241,2.239590945,0.025117491,0.085598989,0.327012694,0,3.699389021,1.251336073,2.956351295,0.003113023,0.01219613,N,-,,carnitinyl- dehydratase,F:catalytic activity; P:metabolic process,IPR001753 (PFAM); IPR029045 (G3DSA:3.90.226.GENE3D); PTHR11941 (PANTHER); PTHR11941:SF68 (PANTHER); IPR029045 (SUPERFAMILY),,
RL4_JR_00479,95,140,100,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.35203849,0,1.462784971,1.409334996,1.037925671,0.299304661,NA,0.431210798,0,4.679159455,1.611091882,2.904340532,0.003680276,0.01727818,1.116902574,0,2.030035761,1.253917143,1.618955266,0.105456889,0.201708963,1.28848072,0,1.607516293,1.29084285,1.245323002,0.213013044,0.347359811,1.097286595,0,1.952728665,1.234267826,1.582094765,0.113627939,0.210249064,N,-,,acyl- dehydrogenase domain-containing,F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; P:oxidation-reduction process,G3DSA:1.20.140.10 (GENE3D); IPR009075 (PFAM); IPR006091 (PFAM); G3DSA:2.40.110.10 (GENE3D); IPR013786 (G3DSA:1.10.540.GENE3D); IPR013786 (PFAM); PTHR10909 (PANTHER); PTHR10909:SF319 (PANTHER); IPR009075 (SUPERFAMILY); IPR009100 (SUPERFAMILY),,
RL4_JR_00480,111,107,112,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1.321325811,0,1.495706117,1.347527746,1.109963132,0.267014914,NA,22.73425961,1,5.634111848,1.118805267,5.035828857,4.76E-07,4.46E-05,1.094325018,0,2.059020788,1.22675113,1.678433985,0.093262408,0.18380156,1.262339185,0,1.636758777,1.253384006,1.30587176,0.191596172,0.320699494,1.077198045,0,1.978979314,1.209140276,1.636682983,0.101696726,0.193439668,N,-,,acyl- synthetases amp-acid ligases ii,F:catalytic activity; P:metabolic process,G3DSA:2.30.38.10 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR025110 (PFAM); G3DSA:3.30.300.30 (GENE3D); IPR000873 (PFAM); G3DSA:3.40.50.980 (GENE3D); PTHR24096 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.7, the fatty acid transporter (fat) family.
RL4_JR_00481,223,398,453,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.31441101,0,-0.211411794,1.282977674,-0.16478213,0.86911547,0.936747787,1.359945773,0,3.021888508,1.406606776,2.148353442,0.031685688,0.082660448,3.553494164,0,0.359694045,1.247721326,0.288280754,0.773131838,0.848291615,4.101434268,0,-0.063343776,1.257212227,-0.050384314,0.959816136,0.977090124,3.525616817,0,0.268501546,1.255374977,0.21388155,0.830639428,0.885752945,N,-,,Thiolase,F:catalytic activity,PTHR18919:SF94 (PANTHER); PTHR18919:SF94 (PANTHER); PTHR18919 (PANTHER); PTHR18919 (PANTHER); IPR016039 (SUPERFAMILY); IPR016039 (SUPERFAMILY),,
RL4_JR_00482,3580,5202,4687,4,1,6,4,0,2,8,0,1,0,1,1,0,9,2,125.3850098,1,0.330969869,0.526936271,0.628102272,0.529936945,0.713874769,125.2279164,1,2.586062882,0.646426764,4.00055045,6.32E-05,0.003349021,139.8067573,1,1.014311999,1.374165129,0.73812963,0.46043568,0.598256421,65.27752008,1,-1.98220287,1.031538478,-1.921598575,0.054656288,0.129323877,93.60235762,1,0.642494149,0.537350851,1.195669734,0.231825467,0.359405643,N,-,,response regulator,"C:nucleus; F:transcription factor activity, sequence-specific DNA binding; P:phosphorelay signal transduction system; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding; P:response to stress; F:phosphorelay response regulator activity",IPR000232 (PRINTS); IPR001789 (SMART); IPR000232 (SMART); IPR011991 (G3DSA:1.10.10.GENE3D); IPR001789 (PFAM); G3DSA:3.40.50.2300 (GENE3D); IPR014402 (PIRSF); IPR000232 (PFAM); IPR027725 (PANTHER); PTHR10015:SF136 (PANTHER); IPR001789 (PROSITE_PROFILES); IPR011006 (SUPERFAMILY); IPR011991 (SUPERFAMILY),9.B.238.3.1,The Uncharacterized Bacterial 5 TMS Protein-1 (UBP1) Family
RL4_JR_00483,10471,9406,9546,1,5,0,3,0,1,4,3,1,0,8,0,0,8,5,167.8934224,1,-1.641147534,0.612024105,-2.681508,0.007329116,0.02959947,114.0460018,1,0.858074395,0.748982359,1.145653678,0.251938478,0.406458602,171.931976,1,-0.586163643,0.535768926,-1.094060545,0.273928425,0.41256343,144.6951998,1,-1.143948195,0.546292759,-2.094020424,0.036258161,0.101052846,163.676571,1,-0.18103543,0.434788179,-0.416376154,0.677134775,0.770682283,N,-,,translation initiation factor eIF-2B subunit epsilon,P:biological regulation; C:protein complex; C:cytoplasmic part; P:biosynthetic process,IPR003307 (SMART); IPR029044 (G3DSA:3.90.550.GENE3D); IPR003307 (PFAM); IPR005835 (PFAM); G3DSA:2.160.10.10 (GENE3D); IPR001451 (PFAM); IPR016021 (G3DSA:1.25.40.GENE3D); PTHR22572:SF7 (PANTHER); PTHR22572 (PANTHER); PTHR22572 (PANTHER); PTHR22572 (PANTHER); PTHR22572:SF7 (PANTHER); PTHR22572:SF7 (PANTHER); IPR003307 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR029044 (SUPERFAMILY),,
RL4_JR_00484,8502,8865,10613,0,0,7,0,0,0,0,0,1,1,2,4,0,4,2,138.6650062,1,-1.418145627,0.599410933,-2.365898832,0.017986359,0.060136676,35.62265555,0,-1.6892225,1.191649652,-1.417549611,0.156322301,0.285509622,99.08122148,1,-3.3818975,1.189657272,-2.842749404,0.004472622,0.017435821,162.6933945,1,-1.210912048,0.571481547,-2.118899648,0.034098949,0.098954387,121.6105487,1,-1.228260865,0.631728151,-1.944287054,0.051860845,0.115144041,N,-,,nuclear envelope pore membrane,P:nuclear pore organization; F:protein anchor; P:protein import into nucleus; C:integral component of membrane; C:nuclear pore transmembrane ring; P:spindle pole body duplication; C:nuclear envelope lumen,PTHR28206:SF1 (PANTHER); PTHR28206 (PANTHER); PTHR28206 (PANTHER),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_00485,612,756,888,0,0,5,0,0,0,0,0,0,0,5,0,0,0,0,28.13073133,1,1.730521921,0.70462493,2.455947623,0.014051364,0.049864033,2.866975232,0,1.94594059,1.282368884,1.51745774,0.129151155,0.246214696,7.464708996,0,-0.711166416,1.2049553,-0.590201493,0.555055572,0.681881156,28.67146614,1,1.882847172,0.696699276,2.702524943,0.006881502,0.036082449,7.383779492,0,-0.798057414,1.211999575,-0.658463444,0.51024038,0.636778484,N,-,,ubiquitin carboxyl-terminal hydrolase,F:cysteine-type peptidase activity,IPR001578 (G3DSA:3.40.532.GENE3D); IPR001578 (PFAM); IPR001578 (PANTHER); PTHR10589:SF29 (PANTHER); SSF54001 (SUPERFAMILY),,
RL4_JR_00486,5323,5985,7485,0,0,6,0,0,0,4,0,0,1,5,0,0,10,1,98.09435415,1,-1.07570028,0.660166705,-1.62943734,0.10322047,0.226912582,23.86638846,0,-1.111422532,1.199733277,-0.926391351,0.354242637,0.518306443,106.4106911,1,-0.924339203,0.749661639,-1.23300854,0.217572578,0.346446175,101.0609317,1,-0.898950759,0.634298859,-1.417235339,0.156414133,0.274422647,107.4357664,1,0.139585469,0.54986358,0.253854728,0.799607791,0.86477557,N,-,,f-box domain-containing,F:DNA binding,IPR011722 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); IPR011722 (PFAM); IPR032698 (PFAM); PTHR31350 (PANTHER); IPR001810 (PROSITE_PROFILES); IPR011722 (SUPERFAMILY); IPR001810 (SUPERFAMILY),,
RL4_JR_00487,2419,2175,3317,0,0,4,0,0,1,0,0,0,0,1,0,0,0,0,46.8050866,1,-0.385752815,0.773419704,-0.49876259,0.617946645,0.780493688,19.39572065,1,1.057345865,1.125165361,0.939724863,0.347358708,0.510299687,26.08588628,0,-2.516285457,1.200234198,-2.096495384,0.036038269,0.088064551,34.11054289,1,-1.992407732,1.153721995,-1.726939195,0.084178584,0.172004328,25.83458061,0,-2.6050128,1.209159424,-2.154399783,0.031208834,0.077610944,N,-,,phosphatidylserine synthase,C:endoplasmic reticulum membrane; P:phosphatidylserine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:transmembrane transport; P:mycelium development; C:integral component of membrane; P:negative regulation of phosphatidylinositol biosynthetic process; C:cytosol; P:fungal-type cell wall organization or biogenesis; C:mitochondrial outer membrane; P:negative regulation of G0 to G1 transition; F:CDP-diacylglycerol-serine O-phosphatidyltransferase activity,IPR004533 (TIGRFAM); IPR016271 (PIRSF); IPR000462 (PFAM); PTHR15362 (PANTHER); PTHR15362:SF2 (PANTHER),,
RL4_JR_00488,2102,2164,1750,0,2,7,0,0,0,0,2,0,0,0,0,0,2,0,66.91616033,1,1.169172591,0.53804125,2.173016645,0.029779065,0.089810576,7.749898758,0,0.511395887,1.238402778,0.412947949,0.67964475,0.796222703,35.70820775,1,-0.310025692,1.038231805,-0.298609319,0.765238154,0.842180032,23.0930272,0,-2.556482605,1.196830793,-2.136043474,0.03267587,0.096851051,27.35936512,1,-0.541124292,0.976867139,-0.553938474,0.579620954,0.692385813,N,-,,zinc metallo ase,P:proteolysis; F:metallopeptidase activity,IPR001229 (SMART); IPR024079 (G3DSA:3.40.390.GENE3D); IPR021917 (PFAM); IPR001229 (G3DSA:2.100.10.GENE3D); PTHR21054:SF2 (PANTHER); PTHR21054 (PANTHER); IPR001229 (PROSITE_PROFILES); IPR001229 (SUPERFAMILY),,
RL4_JR_00489,286,357,316,0,3,2,0,0,3,0,0,2,0,1,0,0,2,0,35.52275557,1,3.007252991,0.680331201,4.420277928,9.86E-06,0.000114717,29.36490997,1,5.342488946,0.871593183,6.129567156,8.81E-10,1.56E-07,16.1847506,1,2.33521197,1.040897604,2.243459837,0.024867177,0.066251395,7.688579846,1,1.041071275,1.154811891,0.901507235,0.367318689,0.513688084,10.8583383,1,2.102279774,0.986287543,2.131507984,0.033047315,0.081116138,Y,-,,beta-glucosidase M,"P:polysaccharide catabolic process; C:membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR001764 (PRINTS); IPR026891 (SMART); IPR001764 (G3DSA:3.20.20.GENE3D); IPR001764 (PFAM); IPR002772 (PFAM); IPR026891 (PFAM); IPR002772 (G3DSA:3.40.50.GENE3D); PTHR30620:SF32 (PANTHER); IPR026892 (PANTHER); IPR026892 (PANTHER); IPR017853 (SUPERFAMILY); IPR002772 (SUPERFAMILY),,
RL4_JR_00490,1282,965,1212,0,1,9,0,2,0,4,0,0,0,3,0,0,0,2,56.17444735,1,2.122378365,0.504441843,4.207379688,2.58E-05,0.00026149,81.09173259,1,2.992698232,0.982744005,3.045246998,0.002324893,0.015159195,55.72536052,1,1.73599991,1.201213265,1.44520541,0.148400197,0.260067478,25.23633149,1,0.550720006,0.860697931,0.639852829,0.522268283,0.657007434,25.99936045,1,0.279650297,0.974596955,0.286939432,0.774158697,0.843851383,N,-,,nrm1,,IPR013734 (PFAM); PTHR40468 (PANTHER),,
RL4_JR_00491,1677,1919,1579,0,0,6,0,0,2,0,0,0,0,0,0,0,1,0,43.71612581,1,0.792940585,0.640041894,1.238888567,0.215386768,0.383568054,25.41150781,1,2.366632543,1.003906307,2.357423723,0.018402235,0.053834517,17.218559,0,-1.916809902,1.19702933,-1.60130571,0.109309225,0.207198389,19.86146628,0,-2.33898073,1.195720752,-1.956126233,0.050450286,0.123921717,20.77283199,1,-1.063713805,1.125021479,-0.94550533,0.344400951,0.481438579,N,-,,hypothetical protein SPSK_00450,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00492,1598,2346,1746,0,3,15,0,0,0,0,7,2,0,5,0,7,6,0,104.2614162,1,2.094201207,0.583719447,3.58768449,0.000333628,0.002368785,7.316013943,0,0.594496776,1.251167857,0.475153492,0.634677574,0.761161896,86.8574424,1,1.929874904,0.562975043,3.427993707,0.00060806,0.003898667,41.93025669,1,0.521820358,0.720677011,0.724069659,0.469022971,0.610079339,153.9751862,1,2.511010632,0.728389153,3.447347644,0.00056612,0.003001027,N,-,,hypothetical protein CMQ_325,,no IPS match,,
RL4_JR_00493,11981,7928,9500,1,9,0,0,0,0,3,0,0,2,3,0,0,6,1,199.3935446,1,-0.592440187,1.002497242,-0.590964406,0.55454427,0.733272058,37.71411507,0,-1.771506846,1.212724517,-1.460766086,0.144079646,0.268280754,130.6153102,1,-1.988446529,0.864946733,-2.298923682,0.021509273,0.058885853,142.990799,1,-1.791486942,0.694411907,-2.579862072,0.009883978,0.048136258,126.1849321,1,-1.100181035,0.615509954,-1.787430127,0.073867996,0.151032605,N,-,,metacaspase partial,,IPR029030 (G3DSA:3.40.50.GENE3D); PF00656 (PFAM); PTHR31773 (PANTHER); PTHR31773:SF9 (PANTHER); IPR029030 (SUPERFAMILY),,
RL4_JR_00494,134,125,93,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.413681077,0,1.398331801,1.374549681,1.017301754,0.309009902,NA,0.455024443,0,4.60166396,1.598819958,2.878162695,0.003999988,0.018131607,1.172815303,0,1.959508094,1.247521568,1.570720815,0.116247512,0.21697821,1.352478573,0,1.537527163,1.279446565,1.201712682,0.229474866,0.365894963,1.147585609,0,1.887464458,1.223491027,1.542687619,0.122906587,0.223055959,N,-,,microtubule associated,C:new mitotic spindle pole body; P:mitotic sister chromatid segregation; C:gamma-tubulin complex; C:horsetail nucleus leading edge,IPR012943 (PFAM); IPR019528 (PFAM); PTHR18937 (PANTHER),,
RL4_JR_00495,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein TOPH_02114,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00496,379,432,398,0,0,8,0,0,0,0,2,0,0,1,0,0,0,2,35.40278252,1,3.3045272,0.55941912,5.907068746,3.48E-09,8.71E-08,1.549647422,0,2.833620892,1.340529911,2.113806539,0.034531794,0.088354606,19.70196223,1,2.007823904,1.033911321,1.941969165,0.052140833,0.116967382,8.644441314,1,0.708057691,1.148440222,0.616538569,0.537539125,0.669191557,18.68287869,1,1.790080649,0.972516991,1.840667737,0.065670265,0.13837907,N,-,,DNA repair and recombination rad54,C:nucleus; F:ATP binding; P:DNA geometric change; P:chromatin remodeling; P:heteroduplex formation; F:DNA translocase activity; P:telomere maintenance via recombination; P:positive regulation of endodeoxyribonuclease activity,IPR014001 (SMART); IPR001650 (SMART); IPR013967 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR000330 (PFAM); PTHR10799 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_00497,5202,5999,5022,0,0,4,0,0,0,0,3,3,1,3,0,0,0,2,80.48734341,1,-1.427808703,0.763218631,-1.870772862,0.061376571,0.155114642,20.84849277,0,-0.916322959,1.208167674,-0.758440222,0.448187487,0.608851663,96.98967833,1,-0.163193707,0.622810183,-0.262028001,0.793299854,0.863866594,83.59598391,1,-1.266432351,0.753146727,-1.681521417,0.09266168,0.185012722,67.75508521,1,-1.956409999,0.971209077,-2.014406625,0.043966859,0.101427307,Y,-,,UDP-glucose:glyco glucosyltransferase,"F:transferase activity, transferring glycosyl groups; P:carbohydrate derivative metabolic process; P:primary metabolic process; P:cellular metabolic process",IPR009448 (PFAM); IPR029044 (G3DSA:3.90.550.GENE3D); PTHR11226:SF0 (PANTHER); IPR009448 (PANTHER); IPR029044 (SUPERFAMILY),,
RL4_JR_00498,17958,13774,12634,0,6,21,0,0,2,0,3,1,5,9,3,0,12,2,305.754161,1,-0.294856977,0.580770454,-0.507699685,0.611663969,0.776912733,75.94587591,1,-0.73781824,1.00631471,-0.733188368,0.463443549,0.622227829,177.4628316,1,-2.194417409,0.764435984,-2.870635939,0.00409647,0.016595704,281.5869084,1,-0.615625529,0.428435258,-1.436916121,0.150741829,0.267062295,205.4669735,1,-0.755249101,0.514728743,-1.467275943,0.142301005,0.248928417,N,-,,coatomer subunit alpha,"P:ER to Golgi vesicle-mediated transport; F:ubiquitin binding; P:retrograde vesicle-mediated transport, Golgi to ER; F:structural molecule activity; C:Golgi membrane; P:intracellular protein transport; C:COPI vesicle coat",IPR020472 (PRINTS); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR010714 (PFAM); IPR001680 (PFAM); IPR016391 (PIRSF); IPR006692 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR19876 (PANTHER); PTHR19876:SF1 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR011044 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_00499,4018,4003,4556,0,3,16,0,0,0,1,0,2,0,0,0,0,0,1,135.4536016,1,1.089791394,0.482829257,2.257094775,0.024002153,0.07613634,16.04854386,0,-0.538856373,1.199047212,-0.4494038,0.653140391,0.77645796,65.71961467,1,-0.783217782,0.845454908,-0.926386226,0.3542453,0.497693507,48.05198624,0,-3.613725904,1.185200126,-3.049042796,0.002295718,0.01477695,48.44279646,1,-2.340314913,1.118714558,-2.091967872,0.03644139,0.087516383,N,-,,GANP Nin1 mts3 eIF-3 p25 family,"C:proteasome regulatory particle, lid subcomplex; C:proteasome storage granule; P:ubiquitin-dependent protein catabolic process",IPR033464 (PFAM); IPR006746 (PANTHER),,
RL4_JR_00500,4131,3639,4553,2,0,9,0,0,0,0,2,3,2,6,0,0,0,5,103.7121115,1,0.441037294,0.471707413,0.93498063,0.349798282,0.539953526,15.70818001,0,-0.507938798,1.202020021,-0.422570996,0.672608291,0.791000479,75.94449142,1,-0.019251466,0.6655724,-0.028924676,0.976924665,0.986965903,89.71796429,1,0.135890409,0.537655547,0.252746223,0.800464326,0.871998489,77.03681397,1,-0.26724202,0.67505959,-0.395879155,0.692194179,0.781845835,N,-,,SPG20,C:microtubule organizing center; P:microtubule nucleation; C:spindle pole; F:gamma-tubulin binding,IPR009686 (PFAM); PTHR21068 (PANTHER); PTHR21068:SF20 (PANTHER); PTHR21068 (PANTHER),,
RL4_JR_00501,399,321,196,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,7.497120834,1,0.962096106,1.208558564,0.796069082,0.425991884,0.616614937,1.191818541,0,3.212501647,1.459373738,2.201287829,0.027715654,0.074354055,3.058789639,0,0.576262965,1.257143894,0.458390617,0.646671831,0.754302779,13.16167852,1,1.110223951,1.192974709,0.930634944,0.352042432,0.498591359,2.979798393,0,0.510871832,1.246151103,0.40995978,0.681835452,0.774069455,N,-,,c6 zinc finger domain containing,F:binding,IPR007219 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31313 (PANTHER); PTHR31313:SF6 (PANTHER); PTHR31313:SF6 (PANTHER); PTHR31313 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00502,9591,7571,7393,1,0,1,0,0,0,0,1,5,6,0,0,0,2,1,112.0982637,1,-2.984411958,1.018758454,-2.92945982,0.003395517,0.015865194,31.58431959,0,-1.515598092,1.209569115,-1.253006606,0.210203302,0.355977552,121.8666195,1,-0.766604974,0.631982922,-1.213015332,0.225123959,0.355451491,149.8975756,1,-0.818794468,1.640071577,-0.49924313,0.617608114,0.735846679,95.05328187,1,-2.022824173,0.845821785,-2.391548916,0.016777448,0.047529844,N,-,,exportin 1,C:nuclear envelope; P:RNA import into nucleus; P:mRNA-binding (hnRNP) protein import into nucleus; P:tRNA transport; C:cytosol; F:Ran GTPase binding; F:nuclear localization sequence binding,IPR001494 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR013598 (PFAM); PTHR12363 (PANTHER); PTHR12363:SF33 (PANTHER); IPR016024 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_00503,1121,1093,1607,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.24322538,0,-2.032505996,1.204230166,-1.687805249,0.09144862,0.207347926,4.83763952,0,1.191140399,1.250275375,0.952702439,0.340740857,0.503868365,12.6038271,0,-1.466929031,1.203113277,-1.219277569,0.222738859,0.352786016,14.54340805,0,-1.889597099,1.2025582,-1.571314469,0.116109622,0.218795982,12.48610563,0,-1.556016952,1.21269145,-1.283110351,0.199453418,0.321212956,N,-,,5-formyltetrahydrofolate cyclo-ligase,P:folic acid-containing compound metabolic process; F:ligase activity,IPR002698 (PFAM); IPR024185 (G3DSA:3.40.50.GENE3D); IPR002698 (PTHR23407:PANTHER); PTHR23407 (PANTHER); SSF100950 (SUPERFAMILY),,
RL4_JR_00504,2171,1723,1656,0,1,0,0,0,0,0,0,2,1,1,0,0,0,0,30.21311748,1,-1.624767732,1.147142276,-1.416361131,0.156669798,0.306208005,7.141364261,0,0.629365248,1.244216917,0.505832415,0.612974301,0.745467485,31.42895543,1,-0.197155231,1.041169312,-0.189359433,0.849811117,0.904107582,34.57970044,1,-0.702211462,1.022889182,-0.686498082,0.492399073,0.631400787,18.07451247,0,-2.089724253,1.196043782,-1.747197121,0.080603151,0.162087014,N,-,,sodium bile acid transporter family,C:membrane,IPR016833 (PIRSF); IPR016833 (PFAM); IPR016833 (PANTHER); PTHR18640:SF5 (PANTHER),2.A.28.3.7, the bile acid:na(+) symporter (bass) family.
RL4_JR_00505,6148,5088,3729,0,2,2,0,0,0,0,2,7,0,2,0,0,0,0,83.69018196,1,-1.282196434,0.789220378,-1.624636756,0.10423998,0.228623805,19.38179952,0,-0.81107839,1.237058628,-0.655650728,0.512048878,0.66300933,111.0466421,1,0.505995955,0.577377791,0.876368928,0.380829505,0.524703035,65.52508087,1,-2.161400723,1.05033997,-2.0578106,0.039608318,0.106832454,48.72085178,0,-3.520266558,1.208443442,-2.913058597,0.003579074,0.013638738,N,-,,sexual differentiation process isp4,P:mycelium development; C:membrane,IPR004813 (TIGRFAM); IPR004813 (PFAM); PTHR22601 (PANTHER); PTHR22601:SF18 (PANTHER),2.A.67.1.5, the oligopeptide transporter (opt) family.
RL4_JR_00506,46,44,47,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.548398595,0,2.764364961,1.877085831,1.472689695,0.140834726,NA,0.175259069,0,5.977983094,1.865658063,3.20422226,0.001354279,0.015023052,0.454179376,0,3.327695016,1.267419446,2.62556727,0.008650471,0.02918273,0.52391564,0,2.905418498,1.385172734,2.097513492,0.035948144,0.10074037,0.447189944,0,3.247322911,1.224739711,2.651439225,0.008014954,0.026228638,N,-,,Ph signal transduction,C:membrane; C:integral component of membrane,PS51257 (PROSITE_PROFILES),,
RL4_JR_00507,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_00508,4714,4918,10410,0,0,0,0,0,0,0,0,1,0,4,0,0,1,0,79.63420813,0,-4.417658521,1.262562336,-3.4989627,0.000467072,0.003183269,25.03757804,0,-1.180548734,1.244221111,-0.948825513,0.342709363,0.505818632,72.19412529,1,-2.886961373,1.237039661,-2.333766219,0.019607967,0.054842592,91.88168607,1,-1.62774958,0.862896939,-1.886377742,0.05924407,0.135865506,69.45935933,1,-3.023993563,1.187647294,-2.546205072,0.010890119,0.033642998,N,-,,"N2,N2-dimethylguanosine tRNA methyltransferase",C:nuclear envelope; F:methyltransferase activity; P:tRNA methylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR002905 (PFAM); IPR002905 (PANTHER); PTHR10631:SF3 (PANTHER); IPR002905 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),9.B.178.1.2, the mdmd complementing protein 1 (mcp1) family.
RL4_JR_00509,2294,2357,2599,0,0,6,0,0,0,0,4,0,0,0,0,0,0,0,51.93891453,1,0.334462562,0.610833747,0.547550891,0.584000318,0.757436342,9.255984762,0,0.255131661,1.212562424,0.210407032,0.833350005,0.900231456,55.392569,1,0.426904006,0.736553843,0.579596468,0.562186776,0.6875737,27.71151724,0,-2.819608792,1.185555531,-2.378301749,0.017392587,0.071906876,23.68420066,0,-2.479613713,1.190760372,-2.082378429,0.037307917,0.08915333,N,-,,diacylglycerol kinase catalytic domain-containing,P:phosphorylation; F:kinase activity,IPR001206 (SMART); IPR001206 (PFAM); PTHR12358 (PANTHER); PTHR12358:SF36 (PANTHER); IPR001206 (PROSITE_PROFILES); IPR016064 (SUPERFAMILY),,
RL4_JR_00510,1772,1409,1306,0,1,1,0,0,0,0,0,1,0,0,0,4,0,1,29.78522431,1,-0.533354701,1.018373026,-0.523732156,0.600464847,0.768889063,5.779161947,0,0.934712428,1.256699553,0.743783529,0.457007446,0.616366339,21.40718379,1,-0.747220073,1.200268491,-0.622544105,0.533584152,0.66306689,17.19248708,0,-2.13084087,1.200796436,-1.774522981,0.075976684,0.160263318,86.07631375,1,1.991636658,1.330705724,1.496677005,0.134477322,0.238455847,N,-,,set domain-containing 5,F:nucleotide binding; F:ATPase activity; F:ATP binding; C:cytoplasm; P:vacuole organization; P:intracellular protein transport,IPR001214 (SMART); G3DSA:2.170.270.10 (GENE3D); IPR001214 (PFAM); PTHR12197:SF177 (PANTHER); PTHR12197 (PANTHER); IPR001214 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY),,
RL4_JR_00511,9893,10312,13762,9,2,1,0,0,0,4,9,19,10,6,9,0,5,1,246.1424419,1,-0.463386215,0.849804658,-0.545285567,0.585557129,0.758426055,43.09523735,0,-1.963965359,1.195377716,-1.642966346,0.100389897,0.203107442,350.5407851,1,1.169172887,0.356912743,3.275794738,0.001053651,0.006006286,333.370507,1,0.489190494,0.440309417,1.11101529,0.266561768,0.407571414,137.7025257,1,-1.531664418,0.65760359,-2.329160668,0.019850556,0.054291431,N,-,,Major facilitator superfamily general substrate transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF20 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.3.52, the major facilitator superfamily (mfs).
RL4_JR_00512,5324,3921,4667,1,4,3,0,0,0,0,7,1,0,1,2,0,1,1,109.0725253,1,-0.157140834,0.546357253,-0.287615535,0.773641052,0.882461368,17.81242365,0,-0.689281596,1.212109658,-0.568662737,0.56958504,0.710542245,107.4705309,1,0.485107805,0.557559599,0.870055516,0.384270066,0.528097849,76.41851036,1,-1.434518065,0.856928121,-1.674023794,0.094125923,0.187197991,56.52803054,1,-1.737983539,0.974431253,-1.783587639,0.074490696,0.151876418,N,-,,DNA-binding creA,F:DNA binding; F:metal ion binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_00513,1144,1188,2056,0,0,5,0,0,0,0,0,1,1,0,0,0,0,0,36.57034404,1,0.740254357,0.763082894,0.970083804,0.332004721,0.521767389,5.5197781,0,1.000812816,1.266692119,0.790099505,0.429469659,0.59173823,20.93115729,1,-0.700572163,1.217437467,-0.57544817,0.564988234,0.68953576,25.96910974,1,-1.132232508,1.173215939,-0.965067444,0.334511032,0.481302288,14.35363288,0,-1.757110148,1.234476367,-1.423364753,0.154630445,0.264733387,N,-,,rad55,F:DNA binding; P:DNA repair; F:catalytic activity; P:DNA recombination; C:intracellular organelle part,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR013632 (PFAM); PTHR22942:SF29 (PANTHER); PTHR22942 (PANTHER); PTHR22942 (PANTHER); IPR020588 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_00514,535,456,611,0,0,13,0,0,0,0,1,0,0,1,0,0,0,1,56.03299224,1,3.355687343,0.740527062,4.531485093,5.86E-06,7.25E-05,2.038784824,0,2.437770648,1.307156736,1.864941349,0.062189626,0.140243029,13.13698588,1,0.746143491,1.194475254,0.624662159,0.532192814,0.661825335,10.11901011,1,0.30889099,1.147844741,0.269105201,0.787848728,0.86284136,12.59215326,1,0.635987948,1.129489579,0.563075534,0.573383451,0.688672294,Y,-,,prp 4 c domain-containing,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00515,388,604,721,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,6.871258606,0,-0.882853516,1.244383734,-0.709470473,0.478032569,0.667102415,2.169192374,0,2.348286022,1.335230739,1.758711775,0.078626476,0.168150685,13.50718418,1,0.648825512,1.219586323,0.532004582,0.594722822,0.714062364,6.537236095,0,-0.735912073,1.232125731,-0.597270274,0.550326947,0.679519554,12.98316696,1,0.538309641,1.162408361,0.463098563,0.64329372,0.744723178,N,-,,hypothetical protein SPSK_00576,,no IPS match,,
RL4_JR_00516,1522,1446,2060,3,0,0,0,0,0,0,0,0,0,6,2,0,0,0,50.2584019,1,-0.082405772,0.860513358,-0.095763502,0.923708406,0.963140743,6.375006422,0,0.793030611,1.233802518,0.642753277,0.520384205,0.67065558,16.59483653,0,-1.863778909,1.198526796,-1.555058189,0.119932212,0.221730042,62.48767812,1,1.422510933,0.560972326,2.535795205,0.011219232,0.05325585,16.42477758,0,-1.951574463,1.207157417,-1.616669405,0.105949661,0.199579595,N,-,,TFIID associated,,IPR001487 (PRINTS); IPR001487 (SMART); IPR001487 (G3DSA:1.20.920.GENE3D); G3DSA:3.30.710.10 (GENE3D); IPR000210 (PFAM); IPR001487 (PFAM); PTHR22880 (PANTHER); IPR001487 (PROSITE_PROFILES); IPR000210 (PROSITE_PROFILES); IPR001487 (SUPERFAMILY); IPR011333 (SUPERFAMILY),,
RL4_JR_00517,1405,1248,2285,0,0,1,0,0,0,0,0,0,0,9,0,0,6,0,23.458257,1,-1.452719135,1.176450441,-1.234832412,0.216892882,0.384996487,6.216063805,0,0.829428602,1.259170716,0.658710207,0.510081878,0.661420544,16.23516812,0,-1.832169464,1.21739195,-1.504995546,0.132325222,0.238765405,54.84010489,1,1.496642211,0.652924925,2.292211789,0.021893425,0.080273303,39.2967985,1,1.191409747,0.724731909,1.643931682,0.100190315,0.191431978,N,-,,import inner membrane translocase subunit tim-21,C:membrane part,IPR013261 (PFAM); IPR013261 (PANTHER),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_00518,7445,8000,8962,7,0,3,0,0,1,0,1,0,1,4,0,0,4,1,179.6500511,1,-0.513784003,0.652194848,-0.787776851,0.430827244,0.622068789,40.50322109,1,-0.576772342,1.106963717,-0.52103997,0.602338928,0.736693406,88.68238166,1,-3.186211015,1.188478882,-2.680915128,0.007342113,0.02554349,118.6241163,1,-1.527413725,0.667662961,-2.28770175,0.022154896,0.080442001,102.5781959,1,-1.297320474,0.680303981,-1.90697175,0.056524246,0.122971205,N,-,,arf gtpase-activating,"P:ER to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to ER; F:GTPase activator activity; C:Golgi membrane; P:COPI coating of Golgi vesicle; C:endoplasmic reticulum-Golgi intermediate compartment; P:positive regulation of GTPase activity; C:COPI vesicle coat",IPR001164 (PRINTS); IPR001164 (SMART); IPR001164 (PFAM); PTHR23180:SF16 (PANTHER); PTHR23180 (PANTHER); IPR001164 (PROSITE_PROFILES); SSF57863 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_00519,649,348,275,0,0,58,0,2,9,0,7,4,6,12,0,5,14,10,226.5520776,1,5.467101697,2.155435574,2.536425474,0.011199058,0.041509274,162.732844,1,6.709334563,0.676674119,9.915163551,3.58E-23,2.41E-20,85.1309152,1,4.357155688,0.616556352,7.066922064,1.58E-12,1.22E-10,108.8942341,1,4.503012917,0.602849928,7.469542102,8.05E-14,4.38E-12,211.947845,1,5.591935985,0.48272144,11.58418815,4.96E-31,2.79E-28,N,-,,2-nitropropane dioxygenase,F:dioxygenase activity; F:nitronate monooxygenase activity; P:oxidation-reduction process,IPR004136 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR32332 (PANTHER); PTHR32332:SF23 (PANTHER); PTHR32332 (PANTHER); PTHR32332:SF23 (PANTHER); SSF51412 (SUPERFAMILY),,
RL4_JR_00520,3394,4636,9909,0,1,2,0,0,0,0,0,0,1,10,0,0,6,0,86.98720138,1,-1.97830533,0.997488646,-1.983286063,0.047335485,0.127741611,22.31197816,0,-1.014270942,1.27010021,-0.798575525,0.424536584,0.587525198,58.73631916,0,-3.687214352,1.259536913,-2.927436515,0.003417688,0.014889386,117.2449739,1,-0.13173876,0.738160041,-0.178469103,0.858354584,0.911754109,81.99403592,1,-0.754423606,0.85458261,-0.882797751,0.377345556,0.513149248,N,-,,folic acid synthesis,P:folic acid-containing compound biosynthetic process; F:2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase activity; C:cytosol; P:phosphorylation; F:dihydropteroate synthase activity; F:kinase activity,IPR000489 (PFAM); IPR000550 (PFAM); IPR000489 (G3DSA:3.20.20.GENE3D); IPR006390 (TIGRFAM); IPR000550 (G3DSA:3.30.70.GENE3D); IPR000550 (TIGRFAM); PTHR20941:SF1 (PANTHER); PTHR20941 (PANTHER); IPR000489 (PROSITE_PROFILES); IPR000550 (SUPERFAMILY); IPR011005 (SUPERFAMILY),,
RL4_JR_00521,1571,1656,1719,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,27.45715913,1,-0.681015406,1.006681366,-0.676495492,0.498726107,0.685758905,6.323807285,0,0.804738375,1.227553498,0.655562773,0.512105485,0.66300933,16.40154569,0,-1.846748617,1.188741064,-1.553533123,0.120295822,0.222239946,22.93272914,1,-1.32158886,1.138795629,-1.160514517,0.245839387,0.384537169,16.15913404,0,-1.928022903,1.190841437,-1.619042505,0.105438118,0.198726907,N,-,,calcium proton exchanger,C:integral component of membrane; P:calcium ion transmembrane transport; F:calcium:proton antiporter activity,IPR004837 (PFAM); IPR004798 (TIGRFAM); PTHR31503:SF14 (PANTHER); PTHR31503 (PANTHER),2.A.19.2.4, the ca(2+):cation antiporter (caca) family.
RL4_JR_00522,14059,19275,19393,0,0,4,0,0,0,0,0,1,2,0,0,0,0,0,227.0728787,1,-3.146536523,0.794581215,-3.959993599,7.50E-05,0.000662466,67.24290423,0,-2.605796075,1.198265896,-2.174639271,0.029657159,0.07843997,181.3751639,1,-4.299406792,1.200973746,-3.579934037,0.000343681,0.002585012,220.4059995,1,-3.931805717,1.027263102,-3.827457358,0.000129474,0.001330886,172.682746,0,-5.345758389,1.209070553,-4.421378368,9.81E-06,9.88E-05,N,-,,nitrate reductase,F:nitrate reductase (NADPH) activity; F:molybdenum ion binding; P:oxidation-reduction process; P:nitric oxide biosynthetic process; F:heme binding; F:molybdopterin cofactor binding; P:nitrate assimilation,IPR008335 (PRINTS); IPR001199 (PRINTS); IPR001834 (PRINTS); IPR001199 (SMART); IPR012137 (PIRSF); IPR005066 (PFAM); G3DSA:2.40.30.10 (GENE3D); IPR008333 (PFAM); IPR001199 (PFAM); IPR001199 (G3DSA:3.10.120.GENE3D); IPR001433 (PFAM); IPR000572 (PFAM); IPR000572 (G3DSA:3.90.420.GENE3D); IPR005066 (G3DSA:2.60.40.GENE3D); G3DSA:3.40.50.80 (GENE3D); PTHR19370 (PANTHER); PTHR19370:SF95 (PANTHER); IPR001199 (PROSITE_PROFILES); IPR017927 (PROSITE_PROFILES); IPR014756 (SUPERFAMILY); IPR001199 (SUPERFAMILY); IPR017938 (SUPERFAMILY); SSF52343 (SUPERFAMILY); IPR000572 (SUPERFAMILY),,
RL4_JR_00523,20863,20540,12849,1,6,1,0,0,0,0,3,4,4,7,0,0,4,0,280.2866253,1,-1.992760853,0.715797777,-2.783971838,0.00536977,0.023031851,70.38615317,0,-2.671688946,1.224489312,-2.181880169,0.029118378,0.077399218,230.6753316,1,-1.703345168,0.635469237,-2.680452599,0.007352268,0.025561249,274.2177309,1,-1.572775403,0.557359105,-2.821834949,0.004774975,0.027084939,192.3500967,1,-2.806786321,0.812137037,-3.456050142,0.000548153,0.00292108,N,-,,MIF4G domain-containing,"C:polysome; F:RNA binding; C:cytoplasm; P:nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay",IPR003890 (SMART); IPR003890 (PFAM); IPR007193 (PFAM); IPR016021 (G3DSA:1.25.40.GENE3D); PTHR12839 (PANTHER); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_00524,3007,3411,2232,0,0,5,0,0,0,0,0,3,0,1,5,0,4,0,53.94552451,1,-0.239100306,0.73770873,-0.324112073,0.745853187,0.866885639,11.19222045,0,-0.018856526,1.245243144,-0.015142847,0.987918218,0.99400678,48.36655991,1,-0.268652399,0.88297747,-0.304257366,0.760931823,0.839271574,85.48398601,1,0.309919283,0.678920376,0.456488411,0.648038803,0.758717955,43.69539289,1,-0.143789343,0.78384938,-0.183440017,0.85445278,0.903057392,N,-,,chitin synthase d,C:integral component of membrane; F:chitin synthase activity,IPR029044 (G3DSA:3.90.550.GENE3D); PF03142 (PFAM); IPR004835 (PANTHER); PTHR22914:SF21 (PANTHER); IPR029044 (SUPERFAMILY),4.D.1.1.12, the putative vectorial glycosyl polymerization (vgp) family.
RL4_JR_00525,364073,236113,288060,9,22,56,0,0,4,2,6,11,2,10,7,0,26,8,4020.455445,1,-2.82515406,0.367468457,-7.688153934,1.49E-14,9.37E-13,1176.396216,1,-4.156904684,0.851387722,-4.882504852,1.05E-06,9.14E-05,3082.051742,1,-4.301367861,0.484399681,-8.879790865,6.70E-19,9.55E-17,3518.265891,1,-4.767466695,0.478457689,-9.964238846,2.19E-23,2.49E-21,3047.980512,1,-4.00108668,0.728548634,-5.491859419,3.98E-08,1.17E-06,N,-,,Heat shock hsp88,C:nucleus; F:ATP binding; P:mycelium development; C:cytosol,IPR013126 (PRINTS); IPR013126 (PFAM); G3DSA:3.90.640.10 (GENE3D); IPR029047 (G3DSA:2.60.34.GENE3D); IPR029048 (G3DSA:1.20.1270.GENE3D); G3DSA:3.30.30.30 (GENE3D); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); PTHR19375:SF78 (PANTHER); PTHR19375 (PANTHER); PTHR19375:SF78 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY); IPR029047 (SUPERFAMILY); IPR029048 (SUPERFAMILY),1.A.33.1.3, the cation channel-forming heat shock protein-70 (hsp70) family.
RL4_JR_00526,28009,28931,29401,3,7,11,0,0,0,0,2,2,2,15,0,0,32,2,474.2876273,1,-1.416367046,0.354024756,-4.000757069,6.31E-05,0.000569245,110.4952486,0,-3.322317233,1.189537616,-2.792948443,0.005223002,0.021180778,315.100206,1,-3.152456454,0.740151403,-4.259204859,2.05E-05,0.000343873,409.2024306,1,-1.681067296,0.461283135,-3.644328542,0.000268091,0.002460942,420.281452,1,-0.816394417,0.819652857,-0.99602461,0.319238188,0.454611344,N,-,,eukaryotic translation initiation factor 5B,F:GTP binding; F:translation initiation factor activity; F:GTPase activity; P:translational initiation,IPR000795 (PRINTS); G3DSA:2.40.30.10 (GENE3D); IPR023115 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PF00009 (PFAM); IPR004161 (PFAM); IPR005225 (TIGRFAM); G3DSA:2.40.30.10 (GENE3D); IPR023115 (G3DSA:3.40.50.GENE3D); PTHR23115 (PANTHER); PTHR23115:SF186 (PANTHER); PTHR23115:SF186 (PANTHER); PTHR23115 (PANTHER); PTHR23115:SF186 (PANTHER); IPR000795 (PROSITE_PROFILES); IPR023115 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR009000 (SUPERFAMILY),,
RL4_JR_00527,9328,8235,5892,0,0,3,0,0,0,1,0,0,1,4,0,0,5,0,105.6310992,1,-2.386096929,0.905688426,-2.6345671,0.008424465,0.033137313,30.37075017,0,-1.459067245,1.227410809,-1.188735861,0.234543624,0.384960364,89.25589032,1,-3.138036473,1.210921735,-2.591444502,0.009557396,0.031548442,115.5145856,1,-1.500879379,0.720506404,-2.083089577,0.037243059,0.102636357,95.71555042,1,-1.270796692,0.721838596,-1.760499782,0.078323104,0.158604287,N,-,,thermotolerance,,IPR015943 (G3DSA:2.130.10.GENE3D); PF10433 (PFAM); IPR017986 (SUPERFAMILY),,
RL4_JR_00528,2555,2726,2871,0,2,0,0,0,2,0,0,5,0,3,0,0,0,1,48.68556545,1,-1.391298107,1.005425382,-1.383790515,0.166422608,0.318031304,29.17366333,1,1.72774811,0.983923605,1.755977904,0.079092182,0.168825614,59.52027694,1,0.570502743,0.66550086,0.857253201,0.391304966,0.534769368,43.21390438,1,-0.682010125,0.847873663,-0.804377061,0.421179245,0.56415397,34.00312477,1,-1.715385436,1.118937985,-1.533047818,0.125264073,0.226139241,N,-,,gtpase-activating gyp10,C:intracellular membrane-bounded organelle; C:cytoplasmic part,IPR000195 (SMART); G3DSA:1.10.8.270 (GENE3D); IPR000195 (PFAM); PTHR20913 (PANTHER); PTHR20913:SF7 (PANTHER); PTHR20913 (PANTHER); PTHR20913:SF7 (PANTHER); IPR000195 (PROSITE_PROFILES); IPR000195 (SUPERFAMILY); IPR000195 (SUPERFAMILY),,
RL4_JR_00529,1764,1739,2177,0,0,1,0,0,0,0,0,0,0,5,0,0,2,0,26.52107213,1,-1.659588576,1.142914443,-1.452067201,0.146482921,0.292320858,7.227409958,0,0.612006897,1.222102505,0.500781967,0.616524578,0.747987748,18.78348371,0,-2.042480284,1.191357661,-1.714414026,0.086452714,0.173042167,41.72907312,1,0.567872929,0.673361016,0.843340964,0.399037779,0.543346219,26.27529673,1,-0.460476417,0.980580173,-0.469595888,0.638643763,0.740355862,N,-,,vps52 sac2 family,,IPR007258 (PFAM); IPR007258 (PANTHER),,
RL4_JR_00530,39578,68141,87734,3,9,76,6,0,0,5,10,0,10,38,0,0,26,3,1176.109364,1,-0.949069194,0.803709248,-1.180861359,0.237657804,0.411899802,380.452478,1,-0.888796547,1.578585207,-0.563033622,0.573411989,0.713294354,779.1012985,1,-2.324737643,0.712388225,-3.263301611,0.001101223,0.006228367,990.4479498,1,-1.547478251,0.817938944,-1.891923917,0.058501119,0.135014457,763.9985009,1,-2.173756163,0.825953166,-2.63181528,0.008493003,0.027561426,N,-,,eukaryotic translation initiation factor 5A-2,F:translation initiation factor activity; P:positive regulation of translational termination; F:translation elongation factor activity; F:ribosome binding; P:translational frameshifting; P:translational initiation; P:positive regulation of translational elongation,IPR020189 (SMART); G3DSA:2.40.50.140 (GENE3D); IPR001884 (PIRSF); IPR020189 (PFAM); IPR014722 (G3DSA:2.30.30.GENE3D); IPR001884 (TIGRFAM); IPR001884 (PANTHER); IPR012340 (SUPERFAMILY); IPR008991 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_00531,3971,4115,5482,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,54.21007715,0,-3.862835681,1.19800848,-3.224380916,0.001262454,0.007102825,17.21677831,0,-0.640268125,1.203895833,-0.531830169,0.594843625,0.730616088,44.81911861,0,-3.297092252,1.195076734,-2.758895859,0.005799701,0.021216598,55.72609712,1,-2.772905363,1.148837918,-2.413661073,0.015793146,0.067556497,44.34966546,0,-3.384625995,1.20221629,-2.815322019,0.004872838,0.017536514,N,-,,RNA polymerase 1 specific transcription initiation factor,C:nucleus; P:cellular nitrogen compound biosynthetic process; C:intracellular non-membrane-bounded organelle; P:gene expression; C:macromolecular complex; P:primary metabolic process; P:cellular macromolecule biosynthetic process,IPR021752 (PFAM); IPR033599 (PTHR31576:PANTHER); PTHR31576 (PANTHER),,
RL4_JR_00532,2239,2221,2497,3,0,4,0,0,0,0,1,0,0,2,3,0,2,2,73.31128023,1,0.634309477,0.562888751,1.126882488,0.259792168,0.439250675,8.881220467,0,0.314759409,1.213661559,0.259346938,0.795367567,0.876220125,30.88747161,1,-1.375594117,1.186390181,-1.159478676,0.246261123,0.380458967,63.51392373,1,0.297275266,0.658904954,0.451165626,0.651870182,0.761970168,45.17232875,1,0.207706855,0.741066198,0.280281108,0.779261844,0.848003977,N,-,,yip1 domain family,C:integral component of membrane; C:endoplasmic reticulum,IPR006977 (PFAM); PTHR12822:SF2 (PANTHER); PTHR12822 (PANTHER),9.B.135.2.4, the membrane trafficking yip (yip) family.
RL4_JR_00533,1652,2419,4377,0,4,2,0,0,0,0,0,0,0,3,0,0,0,0,73.35887394,1,0.185804021,0.78140355,0.237782412,0.812049861,0.904593187,10.55711969,0,0.065308353,1.278686821,0.051074549,0.959266116,0.978272787,27.73540618,0,-2.604711498,1.246955106,-2.088857479,0.036720554,0.089322175,44.05491842,1,-0.783693568,0.966136532,-0.811162338,0.417272451,0.560915594,27.71001925,0,-2.706106437,1.266413531,-2.13682685,0.032612077,0.080338877,N,-,,rhodanese domain containing,,IPR001763 (SMART); IPR001763 (PFAM); IPR001763 (G3DSA:3.40.250.GENE3D); PTHR12231:SF151 (PANTHER); PTHR12231 (PANTHER); IPR001763 (PROSITE_PROFILES); IPR001763 (SUPERFAMILY),9.B.102.4.1, the yede/yeee (yede/yeee) family.
RL4_JR_00534,5039,10527,8671,3,30,74,0,0,1,7,4,5,5,20,1,5,4,6,650.9856995,1,2.522769333,0.730777945,3.452169501,0.000556098,0.003667461,40.33655993,1,-0.572698204,1.155912427,-0.495451204,0.620281658,0.750106518,221.9822638,1,0.720807794,0.511167793,1.410119739,0.15850433,0.273000652,229.4746207,1,0.700672895,0.546362796,1.282431563,0.199691298,0.330371633,219.3974026,1,0.53901106,0.603335768,0.893384892,0.37165109,0.5079675,N,-,,rab GDP-dissociation inhibitor,F:Rab GDP-dissociation inhibitor activity; P:vesicle-mediated transport; C:cell division site; F:oxidoreductase activity; P:small GTPase mediated signal transduction; P:protein transport; P:regulation of catalytic activity; C:cytosol; P:oxidation-reduction process; F:transferase activity,IPR018203 (PRINTS); IPR000806 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); G3DSA:3.30.519.10 (GENE3D); IPR018203 (PFAM); PTHR11787 (PANTHER); PTHR11787:SF8 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_00535,4040,3342,7078,0,4,4,0,0,0,0,1,0,0,0,1,0,8,1,104.7128812,1,-0.219774061,0.65908835,-0.333451594,0.738793423,0.862613513,18.13608486,0,-0.715326327,1.2384536,-0.577596389,0.563536645,0.706217398,55.28499337,1,-2.417349798,1.225152184,-1.973101652,0.048483982,0.110602036,64.38873314,1,-2.847592138,1.185104052,-2.402820355,0.016269178,0.069049765,85.48787158,1,0.193754459,0.672616842,0.288060672,0.773300297,0.843259613,N,-,,50S ribosomal l4,F:structural constituent of ribosome; C:mitochondrial ribosome; P:translation,IPR010729 (PFAM); PTHR21183:SF18 (PANTHER); IPR010729 (PANTHER),,
RL4_JR_00536,445,328,538,0,0,3,0,0,0,2,0,0,0,0,0,0,0,0,16.67053163,1,1.80083894,0.882711353,2.0401221,0.041338166,0.115492041,1.66184925,0,2.732650332,1.345950873,2.030274943,0.0423286,0.103585253,26.46080302,1,1.913530269,1.044002211,1.832879519,0.06682049,0.141584479,4.984934103,0,-0.345018535,1.218540958,-0.283140696,0.777068986,0.856035631,4.274127791,0,-0.009465047,1.221878741,-0.007746307,0.993819403,0.995368843,N,-, Effector probability:0.677,hypothetical protein SPBR_08014,C:integral component of membrane,no IPS match,,
RL4_JR_00537,33282,36140,34025,1,17,7,0,0,0,3,4,1,1,3,3,0,4,2,588.0550234,1,-1.282231738,0.731975055,-1.751742399,0.079818113,0.18781545,132.5954318,0,-3.585364299,1.193967575,-3.00289922,0.00267421,0.015349618,414.6135066,1,-2.402002519,0.543899796,-4.416259274,1.00E-05,0.000188276,446.5383119,1,-3.111766869,0.572742281,-5.433101363,5.54E-08,1.32E-06,368.1667748,1,-3.114204633,0.631003158,-4.935323367,8.00E-07,1.20E-05,N,-,,c2h2 transcription factor,F:nucleic acid binding; F:metal ion binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_00538,890,1077,850,0,0,3,0,0,0,0,0,3,6,1,0,0,1,0,22.79163022,1,0.686334035,0.872858905,0.786305817,0.431688346,0.622540838,3.624047456,0,1.607977363,1.276124,1.260047897,0.207652084,0.352883151,28.87454064,1,1.358904625,0.865363787,1.570327584,0.11633892,0.217108798,70.70321989,1,2.140697929,0.613247766,3.490755361,0.000481657,0.004060598,13.07117713,1,-0.18739573,1.130576087,-0.165752427,0.868351786,0.912797117,N,-,,spc97 spc98 family,C:microtubule cytoskeleton; C:cytoskeletal part,IPR007259 (PFAM); IPR007259 (PANTHER); PTHR19302:SF35 (PANTHER); IPR007259 (PANTHER); PTHR19302:SF35 (PANTHER),,
RL4_JR_00539,695,788,1134,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,10.45218833,0,-1.488111971,1.217352193,-1.222416963,0.221549988,0.390955389,3.307860674,0,1.739529037,1.281053836,1.357889097,0.174498878,0.310636236,8.631831678,0,-0.920815686,1.212060816,-0.759710795,0.447427475,0.586907975,17.98448193,1,0.371907267,1.04060945,0.357393705,0.720797089,0.813518061,8.562810864,0,-1.011820476,1.22272253,-0.82751438,0.407945575,0.543909527,N,-,,ct20 family,"C:H4/H2A histone acetyltransferase complex; P:regulation of transcription, DNA-templated",IPR012423 (PFAM); PTHR13581 (PANTHER); IPR012423 (PTHR13581:PANTHER),,
RL4_JR_00540,1215,1437,1743,2,0,2,0,0,0,0,0,1,1,3,2,0,3,0,45.36290403,1,0.494235751,0.758934781,0.651222956,0.514902574,0.700329309,5.582906572,0,0.984456041,1.239974148,0.793932714,0.427234603,0.590129456,21.03458731,1,-0.710822097,1.197864305,-0.593407862,0.552908228,0.679738058,57.39035727,1,1.224220744,0.628220762,1.948711055,0.051329941,0.125142223,25.96161031,1,0.432736258,0.868404376,0.498311927,0.618264203,0.724696116,Y,-,,tat pathway signal sequence,C:nucleus,IPR018812 (PFAM); PTHR10335:SF8 (PANTHER); PTHR10335 (PANTHER); PTHR10335 (PANTHER),,
RL4_JR_00541,2432,2119,1875,7,1,4,0,0,1,0,2,0,0,2,3,0,5,5,119.491312,1,1.597046083,0.513946161,3.107419032,0.001887287,0.009971817,17.65479448,1,1.332174051,1.135416618,1.173290958,0.240679147,0.392611495,37.0484362,1,-0.403526823,1.038408636,-0.388601181,0.697571193,0.794042136,61.56565968,1,0.413540112,0.680691179,0.607529706,0.543499435,0.673981306,77.07383175,1,1.645508287,0.497579433,3.307026331,0.00094292,0.004554899,N,-,,hypothetical protein CMQ_4073,P:biological_process; P:peroxisome inheritance; C:extrinsic component of intraperoxisomal membrane; C:cellular_component; F:molecular_function,IPR024758 (PFAM),,
RL4_JR_00542,553,611,642,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.23887492,0,-0.957955275,1.195523339,-0.801285299,0.4229665,0.614654739,2.306717358,0,2.259680021,1.292177337,1.748738317,0.080336263,0.170794401,5.987407944,0,-0.392923501,1.196638257,-0.328356125,0.742642413,0.827028026,6.907552005,0,-0.815325763,1.194395096,-0.682626516,0.494842875,0.633651714,5.903309077,0,-0.475207402,1.198367429,-0.396545659,0.691702532,0.781552074,N,-,,MFS multidrug,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF68 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_00543,616,493,661,0,0,0,0,0,0,0,0,0,2,0,0,0,0,2,7.058892814,0,-0.922017135,1.197286871,-0.770088738,0.441247256,0.631411026,2.254908791,0,2.292423489,1.300288458,1.763011487,0.077898552,0.166925349,5.850125604,0,-0.359655175,1.200842645,-0.299502334,0.764556791,0.841802388,25.37308985,1,0.962156228,1.015859151,0.947135464,0.343569756,0.49036422,20.50209192,1,1.24661369,0.977720235,1.275020855,0.20230186,0.324455531,N,-,,transmembrane,C:integral component of membrane,PF07264 (PFAM); PTHR38421:SF1 (PANTHER); PTHR38421 (PANTHER),,
RL4_JR_00544,9293,6375,5999,0,0,4,2,0,0,0,0,0,0,0,0,0,5,0,101.8501878,1,-1.857849959,0.797868629,-2.328516113,0.019884715,0.065148394,72.58021439,1,0.349137864,1.005345662,0.347281416,0.728379911,0.830722418,71.98730367,0,-3.980675722,1.209734941,-3.290535462,0.000999969,0.005752094,83.00480517,0,-4.402298181,1.212238849,-3.631543557,0.000281731,0.002578206,89.74486822,1,-1.151542074,0.718913074,-1.601782072,0.109203809,0.204039226,N,-,,formamidase,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; P:cellular nitrogen compound biosynthetic process; C:integral component of membrane",G3DSA:2.60.120.580 (GENE3D); IPR004304 (PFAM); PTHR31891:SF1 (PANTHER); PTHR31891 (PANTHER); SSF141130 (SUPERFAMILY),,
RL4_JR_00545,4758,2593,5117,0,3,7,0,0,0,0,0,4,0,8,0,0,0,1,100.1818054,1,0.262476365,0.59881926,0.438323184,0.661152022,0.810238699,15.8022236,0,-0.516563314,1.242261967,-0.415824784,0.677538222,0.794306449,67.02324908,1,-0.372826996,0.801559946,-0.465126779,0.64184067,0.750692577,79.42074762,1,-0.006033333,0.686575633,-0.008787572,0.992988622,0.995249435,47.92169438,1,-2.314449964,1.158017107,-1.998631929,0.045648193,0.104543758,N,-,,ubiquitin thioesterase OTU1,P:proteolysis; F:peptidase activity,PTHR13312:SF0 (PANTHER); PTHR13312 (PANTHER); IPR003323 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_00546,14050,11359,12060,6,3,12,0,0,0,3,0,1,4,1,0,0,2,5,280.0285306,1,-0.211139951,0.363828825,-0.580327716,0.56169364,0.738722669,48.06328987,0,-2.121333455,1.19993797,-1.767869264,0.077082762,0.165654293,163.9694812,1,-1.935306958,0.74451775,-2.5994101,0.009338414,0.03096695,184.5769479,1,-2.118232596,0.671784611,-3.15314248,0.001615229,0.011083378,166.6354357,1,-1.397295224,0.58038512,-2.407531094,0.016060794,0.045871804,N,-,,Chromatin structure-remodeling complex subunit RSC1,C:nucleus; F:chromatin binding; C:RSC complex,IPR001487 (PRINTS); IPR001025 (SMART); IPR001487 (SMART); IPR001487 (G3DSA:1.20.920.GENE3D); IPR001025 (PFAM); IPR001487 (PFAM); IPR001487 (G3DSA:1.20.920.GENE3D); PTHR16062 (PANTHER); IPR001487 (PROSITE_PROFILES); IPR001025 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); IPR001487 (SUPERFAMILY); IPR001487 (SUPERFAMILY),,
RL4_JR_00547,4009,3490,6269,0,7,12,0,0,0,0,0,2,0,7,1,0,2,1,156.6584863,1,1.030805731,0.522475871,1.972925042,0.048504103,0.12981974,17.34866509,0,-0.651289091,1.223142835,-0.53247182,0.594399254,0.730459253,58.28142443,1,-1.498299258,1.058927838,-1.414921022,0.157091654,0.271352312,89.97335219,1,-0.074799698,0.619676218,-0.120707712,0.90392255,0.94125928,60.05878206,1,-1.200286703,0.888856353,-1.350371968,0.176896698,0.293860388,N,-,,orotate phosphoribosyltransferase,P:nucleoside metabolic process; P:pyrimidine nucleotide biosynthetic process; F:orotate phosphoribosyltransferase activity,IPR029057 (G3DSA:3.40.50.GENE3D); IPR000836 (PFAM); IPR004467 (TIGRFAM); PTHR19278 (PANTHER); IPR023031 (HAMAP); IPR029057 (SUPERFAMILY),,
RL4_JR_00548,1243,1742,2390,0,0,6,3,0,2,0,0,0,2,0,0,0,4,2,44.41796557,1,0.678303675,0.734371951,0.923651393,0.355667847,0.546634946,92.47706556,1,3.65778958,0.708740758,5.160969702,2.46E-07,2.59E-05,17.73406239,0,-1.959516102,1.219388361,-1.606966382,0.108061743,0.205410643,39.09267752,1,-0.616332116,1.049106386,-0.587482951,0.556879397,0.68577036,47.78935165,1,1.129512171,0.694473499,1.626429479,0.103858324,0.196517573,N,-, Effector probability:0.648,polyamine acetyltransferase,F:N-acetyltransferase activity,IPR016181 (G3DSA:3.40.630.GENE3D); IPR000182 (PFAM); PTHR10908 (PANTHER); PTHR10908:SF0 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_00549,46862,43347,51266,15,15,67,0,0,6,4,5,7,0,42,0,0,19,1,1092.527594,1,-0.037544671,0.327122709,-0.114772438,0.908625496,0.955724256,236.786316,1,-0.869699585,0.636151301,-1.367126946,0.171585519,0.307015842,597.311716,1,-1.859087659,0.402007797,-4.624506472,3.75E-06,8.19E-05,708.7508467,1,-1.649511812,1.984971189,-0.83100038,0.405973415,0.549602999,542.4903149,1,-2.185985313,0.767549036,-2.848007373,0.004399391,0.016144918,N,-,,cytochrome p450 61,F:iron ion binding; C:integral component of membrane; P:ergosterol biosynthetic process; F:C-22 sterol desaturase activity; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding,IPR001128 (PRINTS); IPR002403 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24286:SF0 (PANTHER); PTHR24286 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_00550,600,500,628,0,1,27,0,0,0,0,0,0,3,9,2,0,0,5,118.0090841,1,4.158924871,0.952991271,4.364074465,1.28E-05,0.000143849,2.204399856,0,2.325121209,1.299566461,1.789151443,0.073590429,0.159674668,5.716339832,0,-0.326243484,1.198140901,-0.272291417,0.785397955,0.857937947,89.90576117,1,3.778939406,0.423036372,8.932894797,4.15E-19,3.65E-17,42.46270073,1,2.56737871,0.67547162,3.800868361,0.00014419,0.000945877,Y,-,,phosphatidylethanolamine-binding pebp,C:membrane,IPR008914 (PFAM); IPR008914 (G3DSA:3.90.280.GENE3D); PTHR11362 (PANTHER); IPR008914 (SUPERFAMILY),,
RL4_JR_00551,384,388,454,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,16.733485,1,1.338505177,1.008892415,1.326707543,0.184605445,0.342085955,1.562731853,0,2.821426138,1.331787197,2.118526252,0.034130524,0.087549205,4.058390834,0,0.167969643,1.200372949,0.139931213,0.88871434,0.930823916,13.99439793,1,0.694854485,1.142308492,0.608289696,0.542995354,0.673918602,4.005052325,0,0.084471298,1.201804653,0.070287045,0.943965193,0.964444761,N,-,,---NA---,,no IPS match,,
RL4_JR_00552,2898,2913,4485,3,0,0,0,0,0,0,0,1,0,2,0,0,0,0,71.25559965,1,-1.089483763,0.882645375,-1.234339175,0.217076544,0.384996487,13.00923162,0,-0.236006483,1.219871086,-0.19346838,0.846592167,0.908621134,40.43222599,1,-1.933910012,1.203810151,-1.606490867,0.1081661,0.205563964,47.18136714,1,-1.601506016,1.037052219,-1.544286765,0.122518877,0.227866208,33.65867059,0,-2.986682245,1.214555537,-2.459074249,0.013929581,0.040962037,N,-,,rhomboid family membrane,C:membrane,no IPS match,,
RL4_JR_00553,4453,4302,5272,0,0,8,0,0,0,0,0,0,1,7,6,0,0,0,86.6184237,1,-0.223233745,0.555047577,-0.402188486,0.687545315,0.829851172,17.86595586,0,-0.693642868,1.19794769,-0.579026007,0.562571625,0.705532151,46.40410313,0,-3.347226602,1.188218776,-2.817012044,0.004847271,0.018525394,148.7410504,1,0.773505029,0.418642432,1.847650813,0.064652874,0.143127905,45.80865391,0,-3.431326571,1.192698688,-2.87694336,0.004015477,0.014925367,N,-,,Rhomboid family,C:membrane; F:peptidase activity,IPR022764 (G3DSA:1.20.1540.GENE3D); IPR022764 (PFAM); PTHR22936:SF4 (PANTHER); PTHR22936:SF4 (PANTHER); IPR002610 (PANTHER); SSF144091 (SUPERFAMILY),9.B.104.1.11, the rhomboid protease (rhomboid) family.
RL4_JR_00554,15723,16985,21137,0,0,5,0,0,0,0,0,0,0,1,0,0,7,0,234.4586941,1,-2.843423378,0.702878306,-4.045399259,5.22E-05,0.000484683,68.43228348,0,-2.63110456,1.190104709,-2.210817704,0.027048463,0.07284959,178.0440324,0,-5.287108559,1.194371964,-4.426685084,9.57E-06,0.000181761,209.4428797,1,-4.76278284,1.147148541,-4.151844919,3.30E-05,0.000408225,203.063433,1,-2.010188776,0.637848794,-3.151513015,0.001624269,0.007131711,N,-,,mitochondrial mRNA processing,P:mitochondrial RNA metabolic process; C:mitochondrion; P:RNA processing; P:organelle organization,IPR013943 (PFAM); PTHR31014 (PANTHER),,
RL4_JR_00555,5999,3625,3907,1,0,1,0,0,0,4,0,3,0,0,0,0,3,0,67.82894212,1,-2.118804497,1.041609445,-2.034164061,0.041935057,0.116799656,17.43010127,0,-0.657969323,1.238942028,-0.531073535,0.595367823,0.731171208,108.6631807,1,0.351046182,0.621964184,0.564415429,0.572471441,0.695929499,51.75586883,0,-3.720831685,1.215680779,-3.060697964,0.002208217,0.014332179,55.53050596,1,-1.184257643,0.878643995,-1.347824203,0.177714931,0.294805252,N,-,,Cohesin loading factor,C:nucleus; P:mitotic sister chromatid cohesion; C:cytoplasmic part,IPR019440 (PFAM),,
RL4_JR_00556,2536,1821,2242,0,0,0,0,0,0,0,4,0,0,12,1,0,6,0,26.31747128,0,-2.820373439,1.192094832,-2.365896876,0.017986454,0.060136676,8.444191873,0,0.387571196,1.232623419,0.314427902,0.753196067,0.84917026,53.21590949,1,0.564315608,0.75261729,0.749804204,0.453372637,0.592786333,82.96843133,1,1.647310491,0.512160658,3.216394044,0.001298125,0.009223517,44.64846106,1,0.836028248,0.640353059,1.30557391,0.191697497,0.311879304,N,-,,alpha beta hydrolase fold family,F:hydrolase activity,IPR000073 (PFAM); IPR012020 (PIRSF); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR10794 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_00557,6756,9449,9577,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,107.3875434,1,-3.850687006,1.165473167,-3.303968821,0.000953264,0.005715136,32.86409596,0,-1.572929745,1.205086099,-1.305242627,0.191810243,0.333648957,85.49749228,0,-4.228820541,1.201426132,-3.519833996,0.000431817,0.003042251,98.653608,0,-4.651477501,1.203463786,-3.865074759,0.000111055,0.00116401,84.45301325,0,-4.313849954,1.207316608,-3.573089218,0.000352794,0.002007397,N,-,,60s ribosomal subunit assembly export loc1,,PTHR28028 (PANTHER),,
RL4_JR_00558,2352,3486,3924,0,0,6,0,0,1,0,0,1,6,3,0,0,0,3,62.08834704,1,-0.172485378,0.712883312,-0.241954574,0.808815362,0.902858546,21.7715891,1,0.749586186,1.135141527,0.660346017,0.509031806,0.661016052,38.81261483,1,-1.863311023,1.208552224,-1.541771209,0.123129201,0.226194888,105.1995167,1,0.704071459,0.585313469,1.20289639,0.229016417,0.365394142,54.09481183,1,-0.658777111,0.87738979,-0.750837449,0.452750489,0.584714594,N,-, Effector probability:0.728,imidazoleglycerol-phosphate dehydratase,C:nucleus; F:imidazoleglycerol-phosphate dehydratase activity; C:cytosol; P:histidine biosynthetic process,IPR000807 (PFAM); G3DSA:3.30.230.40 (GENE3D); G3DSA:3.30.230.40 (GENE3D); PTHR23133 (PANTHER); IPR000807 (PTHR23133:PANTHER); IPR000807 (HAMAP); IPR020568 (SUPERFAMILY); IPR020568 (SUPERFAMILY),,
RL4_JR_00559,1140,1383,1682,1,8,2,0,0,0,0,2,1,0,5,2,0,0,1,98.62020123,1,2.139634725,0.616909449,3.468312456,0.000523738,0.00349146,5.339174701,0,1.048852674,1.244268588,0.842947161,0.399257996,0.563324426,36.09081872,1,0.797255224,0.862569614,0.924279282,0.355340927,0.49894443,55.37505296,1,1.489406581,0.596909402,2.495197052,0.01258872,0.058201274,21.12705219,1,-0.758937685,1.13795062,-0.666933759,0.504814446,0.63203243,N,-,,imidazoleglycerol-phosphate dehydratase,C:membrane,PTHR39153 (PANTHER),,
RL4_JR_00560,643,855,999,0,2,0,0,0,0,0,0,0,0,1,0,0,0,0,26.02929507,1,0.330547243,1.030112367,0.320884647,0.748297809,0.868242572,3.170611033,0,1.800705271,1.281696682,1.4049387,0.160039507,0.290464388,8.261784674,0,-0.857520363,1.209398244,-0.709047138,0.478295226,0.614656114,13.54539894,1,-0.334210431,1.160303396,-0.288037105,0.773318336,0.853017557,8.177779733,0,-0.945411834,1.217548264,-0.776488178,0.437460798,0.57201655,N,-,,replication factor c subunit 4,C:nucleus; C:Elg1 RFC-like complex; F:DNA binding; F:ATP binding; P:UV-damage excision repair; P:leading strand elongation; C:cytosol; C:DNA replication factor C complex; C:Rad17 RFC-like complex,IPR003593 (SMART); IPR013748 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.20.272.10 (GENE3D); IPR003959 (PFAM); G3DSA:1.10.8.60 (GENE3D); PTHR11669 (PANTHER); PTHR11669:SF5 (PANTHER); IPR027417 (SUPERFAMILY); IPR008921 (SUPERFAMILY),,
RL4_JR_00561,3857,3858,4459,0,2,3,0,0,0,1,0,0,0,3,0,0,3,0,76.18290238,1,-0.661394678,0.663527399,-0.996785783,0.3188685,0.507576434,15.52599021,0,-0.491104205,1.199655038,-0.409371185,0.682267282,0.798006594,51.37767024,1,-2.182224766,1.186902312,-1.838588351,0.065975756,0.14014657,58.53647889,1,-1.258818152,0.847944501,-1.484552526,0.137662399,0.249469574,51.34592333,1,-1.021685691,0.842360087,-1.212884735,0.225173893,0.351997169,N,-,,atp nad kinase,F:NAD+ kinase activity; P:NAD metabolic process; P:phosphorylation; P:NADP biosynthetic process,IPR002504 (PFAM); IPR017437 (G3DSA:2.60.200.GENE3D); IPR017438 (G3DSA:3.40.50.GENE3D); PTHR20275:SF11 (PANTHER); IPR002504 (PANTHER); IPR002504 (PANTHER); IPR016064 (SUPERFAMILY),,
RL4_JR_00562,600,1591,1353,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18.1504617,1,-1.001733111,1.237325934,-0.809595179,0.41817288,0.609623723,4.512679952,0,1.291517637,1.342015877,0.962371355,0.335863098,0.498841713,11.7822172,0,-1.369528214,1.261823091,-1.085356754,0.277763678,0.416789607,13.59941925,0,-1.792628256,1.269173732,-1.412437251,0.157821255,0.276316826,11.66462643,0,-1.457798538,1.276207069,-1.142289973,0.253333508,0.384353572,Y,-,,hypothetical protein SPSK_04448,,no IPS match,,
RL4_JR_00563,293,405,327,0,0,20,0,0,0,0,0,0,1,0,1,0,2,0,80.49967127,1,4.396910494,1.046658042,4.200904514,2.66E-05,0.000268417,1.315732997,0,3.069706384,1.378017937,2.227624402,0.025905572,0.070361595,3.411199586,0,0.418947979,1.218616107,0.343789957,0.731004254,0.818660074,22.88292277,1,1.748472445,1.027825607,1.701137268,0.088917214,0.179483013,11.07699805,1,2.001556881,0.99641426,2.008759772,0.044562616,0.102428261,N,-,,kinesin-II 85 kDa subunit,F:ATP binding; F:microtubule motor activity; P:plus-end-directed vesicle transport along microtubule; C:microtubule; F:microtubule binding,IPR001752 (PRINTS); IPR001752 (SMART); IPR001752 (PFAM); IPR001752 (G3DSA:3.40.850.GENE3D); IPR032923 (PTHR24115:PANTHER); IPR027640 (PANTHER); IPR027640 (PANTHER); IPR001752 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_00564,1044,1021,1143,0,5,0,0,0,0,0,2,0,0,2,0,0,0,0,52.88779613,1,1.278060882,0.657708744,1.943201903,0.051991768,0.137043246,4.096694219,0,1.431059694,1.247749585,1.146912579,0.251417753,0.405812549,26.31312843,1,0.603392237,1.027016552,0.587519487,0.556854867,0.683345294,20.28285524,1,0.086052722,1.009536179,0.085239859,0.932070703,0.959944651,10.47513266,0,-1.302655492,1.192294566,-1.092561796,0.274586244,0.407455364,N,-,,eukaryotic initiation factor 4E,F:translation initiation factor activity; C:cytoplasm; P:translational initiation,IPR001040 (PFAM); IPR023398 (G3DSA:3.30.760.GENE3D); PTHR11960:SF6 (PANTHER); IPR001040 (PANTHER); IPR023398 (SUPERFAMILY),,
RL4_JR_00565,602,734,1245,0,1,7,0,0,0,0,0,1,0,0,0,0,2,0,45.03090438,1,2.154892097,0.67983537,3.169726367,0.001525826,0.008315087,3.240864856,0,1.769021579,1.312316938,1.348013981,0.177653886,0.315044426,14.98641871,1,0.06525791,1.227732621,0.053153194,0.957609849,0.975121084,9.796996722,0,-1.31964079,1.237086189,-1.066733103,0.286092374,0.430413862,16.17445241,1,0.651670775,1.046475971,0.622728847,0.533462723,0.656746762,N,-,,ef-hand superfamily Ca2+-modulated,,IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (SUPERFAMILY),8.A.82.1.7, the calmodulin calcium binding protein (calmodulin) family.
RL4_JR_00566,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_00567,1379,1522,1559,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,73.95262141,1,1.543341317,0.979976527,1.5748758,0.115285116,0.245560306,5.701053056,0,0.954300789,1.232977495,0.773980703,0.438942203,0.600320629,14.79198399,0,-1.69772722,1.190569117,-1.425979555,0.153874244,0.267488633,17.06483854,0,-2.120097522,1.188438811,-1.783934942,0.074434237,0.157699655,14.57746167,0,-1.779400115,1.193175099,-1.491315161,0.13587877,0.240519677,N,-,,DASH complex subunit ASK1,C:mitotic spindle; P:mycelium development; C:condensed nuclear chromosome kinetochore,IPR013964 (PFAM); PTHR28200 (PANTHER),,
RL4_JR_00568,1651,1892,2142,4,1,0,0,0,0,0,0,0,0,0,1,0,0,0,71.04493823,1,0.493477891,0.68389316,0.721571614,0.470557897,0.659569325,7.240667126,0,0.60937303,1.224354131,0.497709784,0.618688611,0.749246308,18.82431713,0,-2.045565681,1.193470961,-1.713963512,0.086535427,0.173173486,31.35457946,1,-1.518400208,1.144448837,-1.326752371,0.184590611,0.311652482,18.59241392,0,-2.13038754,1.199495461,-1.776069698,0.07572143,0.153982623,N,-,,---NA---,,no IPS match,,
RL4_JR_00569,211,94,104,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.625826128,0,1.196343333,1.442820494,0.829169905,0.407008272,NA,0.529158646,0,4.383875633,1.637911653,2.676503109,0.007439488,0.027136034,1.357145895,0,1.748445186,1.297694185,1.34734763,0.177868299,0.297839672,1.56435566,0,1.327244675,1.341247397,0.989559926,0.322389266,0.468723624,1.323942676,0,1.6808843,1.276721224,1.316563293,0.18798505,0.307338709,N,-,,fad binding,F:oxidoreductase activity; F:protein heterodimerization activity; C:membrane; C:integral component of membrane; C:FANCM-MHF complex; P:oxidation-reduction process,IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (PFAM); IPR023753 (SUPERFAMILY),,
RL4_JR_00570,42061,16937,15395,15,13,15,0,0,1,3,2,2,5,10,3,0,9,0,608.1503705,1,0.030473259,0.591743248,0.051497434,0.958929147,0.978906038,106.2188997,1,-2.221531571,1.206201247,-1.841758642,0.065510462,0.145735582,309.2857036,1,-2.096001324,0.72294665,-2.899247578,0.003740594,0.015764501,400.6753794,1,-1.291731563,0.594801316,-2.171702597,0.029878103,0.092062527,275.0860114,1,-2.308164261,0.875084446,-2.637647456,0.008348332,0.027187798,N,-,,NADP-dependent malic enzyme,F:oxaloacetate decarboxylase activity; P:malate metabolic process; F:metal ion binding; F:NAD binding; F:malate dehydrogenase (decarboxylating) (NAD+) activity; P:oxidation-reduction process; F:malate dehydrogenase (decarboxylating) (NADP+) activity,IPR001891 (PRINTS); IPR012301 (SMART); IPR012302 (SMART); IPR001891 (PIRSF); IPR012302 (PFAM); IPR012301 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR012301 (G3DSA:3.40.50.GENE3D); PTHR23406:SF2 (PANTHER); PTHR23406 (PANTHER); IPR016040 (SUPERFAMILY); SSF53223 (SUPERFAMILY),,
RL4_JR_00571,5455,3080,3304,3,1,4,0,0,0,0,2,0,0,6,0,0,1,0,100.6525968,1,0.081871679,0.614936692,0.133138386,0.894083938,0.94830577,15.2693712,0,-0.467027517,1.251361527,-0.3732155,0.708988061,0.81688983,54.96708245,1,-1.281695492,1.065806716,-1.202559031,0.22914701,0.360062754,69.35829381,1,-0.308701411,0.718512238,-0.42963974,0.667457725,0.773316107,42.28336646,1,-2.249573071,1.149928668,-1.956271839,0.05043314,0.112897533,N,-,,gas2 domain containing,P:cell cycle arrest; C:membrane; C:integral component of membrane,IPR003108 (PFAM); IPR003108 (G3DSA:3.30.920.GENE3D); IPR003108 (PROSITE_PROFILES); IPR003108 (SUPERFAMILY),,
RL4_JR_00572,20935,12320,18555,3,16,9,0,0,2,4,7,1,0,3,4,0,9,3,398.6725352,1,-0.133452132,0.558523803,-0.238937232,0.811154254,0.904262969,84.88488281,1,-0.948781464,1.010031956,-0.939357868,0.347547037,0.510399093,276.7891306,1,-0.790297872,0.520067567,-1.519606146,0.128609992,0.234097009,247.9228131,1,-2.092830566,0.622031422,-3.364509399,0.000766799,0.005913052,225.2999304,1,-1.169373238,0.546175266,-2.14102196,0.032272267,0.0797162,N,-,,cutinase transcription factor 1 beta,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR007219 (PFAM); PTHR19444 (PANTHER); PTHR19444:SF21 (PANTHER); PTHR19444:SF21 (PANTHER),,
RL4_JR_00573,6283,3471,5539,3,0,3,0,0,0,0,0,0,1,0,2,0,1,0,102.3860737,1,-0.698083198,0.674759064,-1.034566612,0.300871353,0.486655879,19.50805538,0,-0.820485986,1.231957842,-0.666001675,0.50541003,0.658738131,50.47724382,0,-3.468595146,1.213312516,-2.858781312,0.004252718,0.016940088,86.79930815,1,-1.524579287,0.882862476,-1.726859311,0.084192933,0.172004328,53.56410202,1,-2.620794842,1.147880873,-2.283159257,0.022420989,0.059834611,N,-,,cutinase transcription factor 1 beta,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR19444:SF21 (PANTHER); PTHR19444 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00574,163,149,132,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1.779928172,0,1.065935227,1.292974224,0.824405628,0.409709118,NA,0.571440343,0,4.272946733,1.524256662,2.80329871,0.00505828,0.020783007,12.54593785,1,2.589847652,1.199267775,2.159524092,0.03080953,0.078377364,5.713832343,1,2.152137498,1.159333324,1.856357834,0.063402571,0.141398905,1.44785281,0,1.552166686,1.209303434,1.283521276,0.199309511,0.321134436,N,-,,---NA---,,no IPS match,,
RL4_JR_00575,7290,9092,17469,1,2,5,0,0,0,0,0,0,0,0,0,0,0,0,179.9425146,1,-1.481613127,0.688759705,-2.151132124,0.031465773,0.094062943,42.31119509,0,-1.937477454,1.239274307,-1.563396774,0.117959298,0.230454356,111.0733228,0,-4.60639227,1.239765722,-3.715534467,0.000202775,0.00177279,128.2241971,0,-5.029713904,1.24871227,-4.027920623,5.63E-05,0.000656403,110.9197471,0,-4.707152452,1.260589023,-3.734089671,0.000188395,0.001184049,N,-, Effector probability:0.574,hypothetical protein F503_08845,C:membrane,no IPS match,,
RL4_JR_00576,4301,4539,3801,0,2,1,0,0,0,3,0,0,3,8,2,0,3,2,70.61132545,1,-1.44962629,0.857103534,-1.691308264,0.090777943,0.206285921,16.26344964,0,-0.55800468,1.213513836,-0.459825561,0.645641435,0.770294979,75.26067491,1,-0.783222643,0.854077982,-0.917038794,0.359122312,0.502940142,127.8023475,1,0.794172286,0.448279871,1.771599257,0.076461103,0.161083785,67.59130645,1,-0.335964233,0.67161872,-0.500230596,0.616912717,0.723698443,N,-,,required for hyphal anastomosis,C:nuclear envelope; P:positive regulation of macroautophagy; P:asymmetric protein localization to old mitotic spindle pole body; P:negative regulation of septation initiation signaling; C:endoplasmic reticulum; C:Golgi trans cisterna; P:intra-S DNA damage checkpoint; C:fungal-type vacuole; C:old mitotic spindle pole body; P:re-entry into mitotic cell cycle after pheromone arrest,IPR021819 (SMART); IPR012486 (SMART); IPR012486 (PFAM); IPR021819 (PFAM); PTHR13239 (PANTHER); PTHR13239:SF4 (PANTHER); PTHR13239:SF4 (PANTHER); PTHR13239:SF4 (PANTHER); PTHR13239 (PANTHER); PTHR13239 (PANTHER),,
RL4_JR_00577,1727,1405,2243,0,0,7,0,0,0,3,0,3,0,0,4,0,0,0,48.12931913,1,0.943516833,0.631939199,1.493050018,0.135424094,0.274709429,6.807462611,0,0.698339828,1.239006937,0.563628666,0.573006873,0.713053304,70.42263502,1,1.457141488,0.635047563,2.29453914,0.02175955,0.059442439,58.98205825,1,0.742684249,1.352825568,0.548987443,0.583014068,0.708560489,17.53881332,0,-2.046269883,1.21216754,-1.688108134,0.091390473,0.178359395,N,-,,RING finger,F:ubiquitin-protein transferase activity; C:nucleus; F:zinc ion binding; P:regulation of translational termination; F:metal ion binding; C:cytosol; F:ligase activity; P:protein ubiquitination,IPR002867 (SMART); IPR016135 (G3DSA:3.10.110.GENE3D); IPR002867 (PFAM); IPR006575 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR11685:SF100 (PANTHER); PTHR11685:SF100 (PANTHER); IPR031127 (PANTHER); IPR031127 (PANTHER); IPR006575 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); SSF57850 (SUPERFAMILY); IPR016135 (SUPERFAMILY),,
RL4_JR_00578,3680,3554,2930,0,0,22,0,0,0,4,0,3,1,1,0,0,4,0,124.8036339,1,1.2019516,1.104655433,1.088078295,0.276560545,0.459788246,13.09742868,0,-0.245648765,1.223364492,-0.200797691,0.840856769,0.904694812,97.59550012,1,0.750809935,0.58656548,1.280010434,0.200541466,0.326044934,52.32822614,1,-1.577995044,1.022399605,-1.543422978,0.122728182,0.228129767,48.59973658,1,-0.356707665,0.753480493,-0.473413271,0.635918364,0.738549373,N,-,,NDT80 like DNA-binding family,"F:DNA binding; F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated",IPR024061 (G3DSA:2.60.40.GENE3D); IPR024061 (PFAM); PTHR35144 (PANTHER); PTHR35144:SF1 (PANTHER); IPR024061 (PROSITE_PROFILES); IPR008967 (SUPERFAMILY),,
RL4_JR_00579,2755,2820,6060,0,1,0,0,0,0,1,0,0,0,5,0,0,0,0,54.22826386,1,-2.675037646,1.211641659,-2.207779524,0.027259646,0.083981946,14.532124,0,-0.395717325,1.257800787,-0.314610492,0.753057412,0.84917026,49.2012719,1,-2.102163023,1.237012672,-1.699386813,0.089246325,0.17761545,64.07463312,1,-0.543075287,0.807037027,-0.67292487,0.500995089,0.63867258,38.07810756,0,-3.164668623,1.255547154,-2.520549399,0.011717179,0.035712353,N,-,,hypothetical protein SPBR_07385,,IPR018555 (PFAM),,
RL4_JR_00580,1336,1256,2008,0,3,0,0,0,0,0,0,0,0,3,0,0,0,2,42.35967508,1,0.049017267,0.876856455,0.05590113,0.95542057,0.977466894,5.811291176,0,0.926578628,1.248378252,0.742225865,0.4579505,0.616898451,15.15445254,0,-1.732795865,1.207569559,-1.43494497,0.151302779,0.264056083,29.52207724,1,0.131952914,0.884519777,0.149180287,0.881411374,0.92661179,29.76141632,1,-0.122831852,0.998041665,-0.12307287,0.902049395,0.93703192,N,-,,dolichyl pyrophosphate phosphatase,F:nucleotide binding; P:mycelium development; C:integral component of membrane; F:nucleoside-triphosphatase activity; P:single-organism cellular process; C:intracellular organelle part,IPR000326 (SMART); IPR000326 (G3DSA:1.20.144.GENE3D); IPR000326 (PFAM); PTHR11247:SF1 (PANTHER); PTHR11247 (PANTHER); IPR000326 (SUPERFAMILY),,
RL4_JR_00581,33,25,35,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,19.46335585,1,6.346857239,0.703681069,9.019508291,1.89E-19,2.27E-17,0.118428839,0,6.543348104,2.022932029,3.234586239,0.001218191,0.015023052,0.307226708,0,3.890971788,1.304751399,2.982155675,0.002862264,0.013147714,0.354403662,0,3.4691095,1.518092089,2.285177246,0.022302437,0.080484515,0.303104246,0,3.807848233,1.242924117,3.063620844,0.002186759,0.009134048,N,-,,hypothetical protein F503_08858,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00582,765,897,909,0,0,24,0,0,0,0,0,3,1,7,1,0,0,0,101.9595539,1,3.294279547,1.134038931,2.904908692,0.003673603,0.016867004,3.284769776,0,1.749731818,1.266449224,1.381604399,0.167093203,0.300664498,28.0238949,1,1.49924351,0.854337347,1.754861255,0.079283043,0.161533815,56.86712174,1,2.556243442,0.517549939,4.939124227,7.85E-07,1.48E-05,8.408014628,0,-0.985458476,1.198815953,-0.822026495,0.411061818,0.547123577,N,-,,emopamil binding,F:cholestenol delta-isomerase activity; C:integral component of membrane; P:sterol metabolic process,IPR007905 (PFAM); PTHR14207:SF1 (PANTHER); IPR007905 (PANTHER); PTHR14207:SF1 (PANTHER); IPR033118 (PROSITE_PROFILES),,
RL4_JR_00583,18167,31567,26508,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,307.5131932,0,-6.366829242,1.238363358,-5.141325606,2.73E-07,4.84E-06,97.50638975,0,-3.141906934,1.214683309,-2.586605834,0.00969264,0.032933502,253.5608705,0,-5.797195997,1.219035353,-4.755560191,1.98E-06,4.82E-05,292.5845063,0,-6.219885054,1.22130838,-5.092804696,3.53E-07,7.09E-06,257.5143712,1,-4.938669252,1.160880645,-4.254243771,2.10E-05,0.000186953,N,-,,glucose-repressible,C:cellular_component; F:molecular_function,IPR020100 (PFAM); PTHR38789 (PANTHER); IPR020100 (PRODOM),,
RL4_JR_00584,961,574,583,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.446894482,0,-1.180834763,1.229088175,-0.960740479,0.336682672,0.526684035,2.733158501,0,2.015014734,1.337441204,1.506619302,0.131908267,0.250032861,7.031491382,0,-0.624814175,1.227776684,-0.508898876,0.610823108,0.726691779,8.106991637,0,-1.046331717,1.229476917,-0.851038114,0.394748181,0.539302875,6.876858495,0,-0.695666974,1.224489697,-0.568128075,0.569948006,0.686041423,,,,,,,,
RL4_JR_00585,9742,5600,5263,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,82.19158678,0,-4.463257757,1.235371484,-3.612887148,0.000302807,0.002197772,26.65840922,0,-1.270982651,1.247092772,-1.019156457,0.308128695,0.469654137,68.47298451,0,-3.908470276,1.226520747,-3.186632013,0.001439398,0.007649587,78.93828796,0,-4.329830465,1.231782761,-3.515092599,0.000439601,0.003771997,66.85303639,0,-3.976721862,1.223698504,-3.249756251,0.00115504,0.005367038,N,-,,hypothetical protein CMQ_3400,,no IPS match,,
RL4_JR_00586,115,134,109,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,33.48017093,1,4.129756131,0.756024946,5.46246014,4.70E-08,1.00E-06,0.460386689,0,4.584697965,1.575551254,2.90990087,0.003615434,0.017053643,1.191346952,0,1.936863377,1.234653151,1.568751009,0.116705968,0.217593226,1.374219027,0,1.514517198,1.261475255,1.200592079,0.229909475,0.366530221,1.170160054,0,1.859779277,1.215573364,1.529960538,0.126026497,0.227089924,N,-,,14-3-3 domain,F:protein domain specific binding,G3DSA:1.20.190.20 (GENE3D); IPR000308 (PANTHER); PTHR18860:SF38 (PANTHER); IPR023410 (SUPERFAMILY),8.A.98.1.6, the 14-3-3 protein (14-3-3) family.
RL4_JR_00587,6903,4770,4509,5,6,0,0,0,0,0,0,2,0,1,13,0,0,0,163.0490072,1,0.446921098,0.830991663,0.537816585,0.590703681,0.761657227,20.87447884,0,-0.918124535,1.229642562,-0.74665969,0.455269008,0.614922991,66.75770047,1,-1.744877794,1.055048531,-1.653836523,0.098160733,0.1913421,191.2590871,1,1.025251335,1.549499441,0.661666153,0.508185201,0.643896278,52.61489806,0,-3.63120675,1.204759158,-3.014052,0.002577836,0.010490591,N,-,,sterol regulatory element-binding cleavage-activating,P:SREBP signaling pathway; C:endoplasmic reticulum; C:membrane part; P:primary metabolic process; C:intracellular organelle part; P:organic substance metabolic process,IPR000731 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR030225 (PTHR10796:PANTHER); PTHR10796 (PANTHER); IPR000731 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),2.A.6.6.4, the resistance-nodulation-cell division (rnd) superfamily.
RL4_JR_00588,1506,1654,2158,0,0,0,0,0,0,0,0,0,0,0,0,0,3,2,21.26103291,0,-2.512490829,1.200011807,-2.093721756,0.036284774,0.104907334,6.746762557,0,0.711267895,1.231334992,0.577639634,0.563507442,0.706217398,17.57044433,0,-1.946164003,1.198701937,-1.623559571,0.10446984,0.200199254,20.27431847,0,-2.368831429,1.198057786,-1.977226355,0.04801605,0.119764935,43.7038666,1,0.90648228,0.697579227,1.29946857,0.193783173,0.314532643,N,-,,phospholipase a2,,IPR003347 (SMART); G3DSA:2.60.120.650 (GENE3D); PF13621 (PFAM); PTHR12461:SF2 (PANTHER); PTHR12461:SF2 (PANTHER); PTHR12461 (PANTHER); PTHR12461 (PANTHER); PTHR12461 (PANTHER); IPR003347 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_00589,18450,24610,28688,0,0,2,0,0,1,0,0,0,0,4,0,0,0,1,295.2482557,1,-4.558608144,1.050914198,-4.337754836,1.44E-05,0.000158905,100.4849307,1,-2.127023999,1.116743039,-1.904667344,0.056823327,0.130630414,237.399372,0,-5.702185283,1.205407479,-4.730504316,2.24E-06,5.34E-05,289.9970951,1,-3.432554958,0.78203947,-4.389234929,1.14E-05,0.000157339,242.3485346,1,-4.85084737,1.148155574,-4.224904256,2.39E-05,0.00020851,N,-,,et-dependent rrna methyltransferase spb1,"P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:rRNA (uridine-2'-O-)-methyltransferase activity; F:rRNA (guanosine-2'-O-)-methyltransferase activity; C:nucleolus; C:mitotic spindle pole body; P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:preribosome, large subunit precursor; P:enzyme-directed rRNA 2'-O-methylation",IPR029063 (G3DSA:3.40.50.GENE3D); IPR012920 (PFAM); IPR002877 (PFAM); IPR024576 (PFAM); IPR015507 (PANTHER); IPR028589 (PTHR10920:PANTHER); IPR015507 (HAMAP); IPR028589 (HAMAP); IPR029063 (SUPERFAMILY),,
RL4_JR_00590,155,209,180,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,6.007602972,1,1.713849603,1.171255593,1.463258415,0.143396682,0.287356947,0.697189169,0,3.985940827,1.480281467,2.692691164,0.007087789,0.026156963,1.808681593,0,1.33433314,1.227161328,1.087333108,0.276889622,0.415909574,10.10984279,1,2.630860459,1.03478343,2.542426158,0.011008586,0.052428002,1.780867308,0,1.253967848,1.218285259,1.02928919,0.303343801,0.438575916,N,-,,WD repeat,"C:nucleus; P:regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; F:protein complex binding; F:protein binding, bridging; C:Cul4-RING E3 ubiquitin ligase complex; P:premeiotic DNA replication",IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22852 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),3.A.20.1.2, the peroxisomal protein importer (ppi) family.
RL4_JR_00591,2619,2803,3030,1,1,0,0,0,0,2,0,1,0,1,1,0,2,0,51.933845,1,-1.442304626,1.006235973,-1.433366192,0.151753215,0.299535793,10.79079543,0,0.033789086,1.208896017,0.027950366,0.977701738,0.988344851,56.64858657,1,-0.20683214,0.845955098,-0.244495412,0.806847155,0.873732013,45.96115401,1,-1.307151109,1.009842978,-1.294410258,0.195523749,0.325230485,35.34162244,1,-1.031756997,0.97276228,-1.060646592,0.28885054,0.423365912,N,-,,thiamine-repressible mitochondrial transport THI74,C:intracellular membrane-bounded organelle; C:membrane; C:cytoplasmic part,IPR009262 (PFAM); IPR025016 (PFAM); PTHR23051 (PANTHER); PTHR23051 (PANTHER); PTHR23051:SF0 (PANTHER); PTHR23051:SF0 (PANTHER); SSF103481 (SUPERFAMILY); SSF103481 (SUPERFAMILY),2.A.7.24.5, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_00592,7806,6135,6659,0,0,17,0,0,1,0,0,1,1,3,0,0,5,0,147.2274738,1,-0.107029285,0.973052457,-0.109993335,0.912414661,0.956988186,35.79787249,1,-0.341299381,1.120241518,-0.304665892,0.76062063,0.85506464,74.79787458,1,-2.943011644,1.192894587,-2.467117945,0.013620549,0.041187107,100.1191695,1,-1.604951684,0.749552381,-2.141213509,0.032256824,0.096106406,86.40893102,1,-1.05541988,0.679142154,-1.55404855,0.120172836,0.219487597,N,-, Effector probability:0.652,ras rab7,"P:small GTPase mediated signal transduction; C:fungal-type vacuole membrane; P:protein transport; C:late endosome; C:phagocytic vesicle; P:vacuole fusion, non-autophagic; P:phagosome-lysosome fusion; P:vacuolar acidification; C:mitochondrial outer membrane; P:retrograde transport, endosome to Golgi; C:plasma membrane; C:lysosome; F:GTP binding; P:vacuole inheritance; P:piecemeal microautophagy of nucleus; F:GTPase activity; C:integral component of membrane; P:positive regulation of vacuole fusion, non-autophagic; C:cytosol; P:regulation of endocytosis; P:protein localization to vacuole",PR00449 (PRINTS); SM00176 (SMART); SM00175 (SMART); SM00173 (SMART); SM00174 (SMART); IPR001806 (PFAM); IPR005225 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24073 (PANTHER); PTHR24073:SF540 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_00593,1403,957,1701,1,1,0,0,0,0,0,0,0,6,2,0,0,1,0,34.2089159,1,-0.355971061,1.0321077,-0.344897205,0.730171652,0.857701992,5.141737164,0,1.103202766,1.265117801,0.872015844,0.383199734,0.547691007,13.3716985,0,-1.552245011,1.212492559,-1.280209927,0.200471315,0.326035598,79.32366244,1,1.827395717,0.615407818,2.969406083,0.00298376,0.018534092,17.09423311,1,-0.711957316,1.151915025,-0.618064093,0.53653309,0.659661805,N,-,,atpase associated with various cellular activities aaa_3,,G3DSA:1.10.8.300 (GENE3D),,
RL4_JR_00594,11517,11583,13666,5,4,19,0,0,0,2,2,0,7,13,0,0,6,0,301.9893397,1,0.200118553,0.337789645,0.592435427,0.553559049,0.732622322,46.85526227,0,-2.084631251,1.189099666,-1.753117346,0.079581867,0.169519264,159.5167361,1,-1.90872093,0.73767941,-2.587466728,0.009668453,0.031873468,257.7306184,1,-0.125622877,0.3691236,-0.340327405,0.733609981,0.822114119,143.2662867,1,-1.64548248,0.638346174,-2.577727488,0.00994524,0.031242802,N,-,,guanosine-diphosphatase,C:integral component of membrane; F:hydrolase activity,IPR000407 (PFAM); IPR000407 (PANTHER); PTHR11782:SF30 (PANTHER); IPR000407 (PANTHER); PTHR11782:SF30 (PANTHER),,
RL4_JR_00595,841,464,390,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,6.763423896,0,-0.860136482,1.268363195,-0.678146831,0.4976786,0.684433921,2.200202121,0,2.32797205,1.397638917,1.66564627,0.09578389,0.196021943,5.639938811,0,-0.306629746,1.255119346,-0.244303258,0.80699596,0.87379969,10.51271006,1,0.215347772,1.206411252,0.178502788,0.858328132,0.911754109,5.494622987,0,-0.37194296,1.251005125,-0.297315297,0.766225804,0.837168045,N,-,,oxidoreductase fad-binding domain-containing,F:oxidoreductase activity; P:metabolic process,IPR012349 (G3DSA:2.30.110.GENE3D); G3DSA:3.40.50.80 (GENE3D); PTHR30212:SF3 (PANTHER); PTHR30212 (PANTHER); PTHR30212:SF3 (PANTHER); PTHR30212 (PANTHER); PTHR30212 (PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY),,
RL4_JR_00596,5913,6116,6879,0,0,13,0,0,0,0,0,0,0,10,2,0,6,1,125.3323106,1,-0.247207994,0.804309589,-0.307354279,0.758573725,0.872779853,24.12250954,0,-1.126794929,1.193571359,-0.944053257,0.345142434,0.508371903,62.62619775,0,-3.779716948,1.187289699,-3.183483317,0.001455145,0.007721115,131.6368696,1,0.088390253,0.451042677,0.195968713,0.844634655,0.902768487,92.30433249,1,-0.450498928,0.583318649,-0.772303317,0.439934801,0.573938907,N,-,,heterochromatin one,C:nucleus,IPR000953 (SMART); G3DSA:2.40.50.40 (GENE3D); IPR023780 (PFAM); G3DSA:2.40.50.40 (GENE3D); PTHR22812 (PANTHER); IPR000953 (PROSITE_PROFILES); IPR016197 (SUPERFAMILY); IPR016197 (SUPERFAMILY),,
RL4_JR_00597,2274,2299,2464,2,0,4,0,0,0,0,0,1,0,10,0,0,1,1,63.58495015,1,0.391376811,0.60408289,0.64788594,0.517058725,0.702091392,8.993966344,0,0.2965709,1.214027698,0.244286766,0.807008733,0.883358844,29.82444006,1,-1.3930624,1.186229288,-1.174361833,0.240250126,0.373324866,67.02455893,1,1.2408708,0.491097767,2.526728654,0.011513042,0.054268876,34.20899304,1,-0.759345936,0.967012619,-0.785249253,0.432307443,0.566910097,N,-,,hypothetical protein CMQ_3935,,no IPS match,,
RL4_JR_00598,28494,30482,40343,0,3,16,0,0,0,7,0,4,1,1,0,0,5,5,482.0629326,1,-1.959635031,0.595735301,-3.289439164,0.001003873,0.005938791,125.993974,0,-3.511703242,1.194630783,-2.939572034,0.003286659,0.016287065,431.5745206,1,-1.848511879,0.524238684,-3.526088282,0.000421746,0.002992123,391.89848,1,-4.856760192,1.025711308,-4.735016718,2.19E-06,3.67E-05,380.8635805,1,-2.314009876,0.556209715,-4.160319056,3.18E-05,0.000264618,N,-,,lysyl-tRNA synthetase,F:nucleic acid binding; F:ATP binding; P:mycelium development; C:cytoplasm; F:lysine-tRNA ligase activity; P:lysyl-tRNA aminoacylation,IPR018149 (PRINTS); G3DSA:3.30.930.10 (GENE3D); IPR004365 (PFAM); IPR004364 (PFAM); G3DSA:2.40.50.140 (GENE3D); PTHR22594:SF35 (PANTHER); IPR018150 (PANTHER); IPR006195 (PROSITE_PROFILES); SSF55681 (SUPERFAMILY); IPR012340 (SUPERFAMILY),9.B.111.1.5,The 6 TMS Lysyl tRNA Synthetase (LysS) Family
RL4_JR_00599,4102,3692,4886,0,7,5,0,0,0,1,3,12,1,5,0,0,2,8,125.7813137,1,0.559755462,0.46880761,1.193998244,0.232478655,0.405855097,16.12918282,0,-0.546112326,1.202360188,-0.454200274,0.649684686,0.773568803,154.4885396,1,1.59763425,0.421117458,3.793797242,0.000148361,0.001471112,77.71552568,1,-0.323466833,0.620714734,-0.521119954,0.602283211,0.723726266,108.0353214,1,0.712163983,0.538191141,1.323254748,0.185750675,0.304644072,N,-,,cytochrome c oxidase assembly cox15,"F:oxidoreductase activity, acting on the CH-CH group of donors; C:integral component of membrane; P:heme a biosynthetic process; P:oxidation-reduction process",IPR003780 (PFAM); PTHR23289:SF2 (PANTHER); PTHR23289 (PANTHER); IPR023754 (HAMAP),,
RL4_JR_00600,379,249,526,0,4,0,0,0,0,0,0,0,0,0,0,0,0,1,36.6164168,1,2.517813472,0.825762412,3.049077356,0.002295454,0.011674758,1.453833647,0,2.925528128,1.392702579,2.100612272,0.035675016,0.090592702,3.790209961,0,0.266396147,1.241256115,0.214618195,0.830065007,0.890398191,4.37333777,0,-0.156190793,1.248562619,-0.125096483,0.900447167,0.938855288,11.12740267,1,1.118012501,1.169908946,0.955640612,0.339253836,0.476546211,N,-,,g2-specific serine threonine kinase,F:ATP binding; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,G3DSA:1.10.510.10 (GENE3D); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_00601,2164,1481,2008,0,11,2,0,0,1,0,0,1,1,0,0,0,1,0,118.264946,1,2.04565623,0.892680873,2.291587388,0.021929464,0.070992288,16.59717693,1,1.529376713,1.135013603,1.347452321,0.177834599,0.315298969,25.1878157,1,-1.073398651,1.199120193,-0.895155179,0.370704141,0.515263792,30.86834372,1,-1.506697022,1.151708019,-1.308228299,0.190795886,0.319729949,22.2629388,1,-1.186221342,1.132801399,-1.047157378,0.295027,0.429929242,N,-,,hypothetical protein SPSK_01205,,no IPS match,,
RL4_JR_00602,1371,1352,1592,0,1,0,0,0,0,0,0,1,1,1,0,0,5,0,25.2686336,1,-1.262282541,1.139109296,-1.108131191,0.267805162,0.44824672,5.501082242,0,1.005787541,1.23207037,0.816339363,0.414306067,0.578054047,20.78183129,1,-0.685525375,1.18847686,-0.576810031,0.564067793,0.688940202,29.80186638,1,-0.335609706,1.009802657,-0.332351776,0.739623648,0.826839951,33.39564576,1,1.195440529,0.68040357,1.756958049,0.07892496,0.159695288,N,-,,hypothetical protein HMPREF1624_06733,,PTHR42106 (PANTHER); PTHR42106:SF1 (PANTHER),,
RL4_JR_00603,91,139,134,0,0,0,0,0,0,0,0,0,0,1,5,0,0,0,1.464100803,0,1.347813299,1.38366301,0.974090721,0.330011497,NA,0.464216836,0,4.572625013,1.581615994,2.891109492,0.003838843,0.017678241,1.207959259,0,1.916541184,1.248230559,1.535406396,0.124684034,0.228553532,53.58188936,1,4.875152879,0.666565716,7.313836818,2.60E-13,1.34E-11,1.193165975,0,1.831899814,1.23665133,1.481338975,0.138516268,0.244042994,N,-,,"carboxy-cis,cis-muconate cyclase","P:beta-ketoadipate pathway; F:carboxy-cis,cis-muconate cyclase activity",IPR015943 (G3DSA:2.130.10.GENE3D); IPR019405 (PFAM); PTHR30344 (PANTHER); PTHR30344:SF4 (PANTHER); SSF75011 (SUPERFAMILY),,
RL4_JR_00604,2487,2618,3123,0,0,5,0,0,0,1,0,0,2,0,0,0,3,0,52.01281956,1,-0.115900342,0.677271274,-0.171128389,0.864122814,0.93296902,10.47515704,0,0.076592547,1.210165399,0.063290974,0.949534803,0.973285192,38.29647785,1,-1.616198945,1.189793227,-1.358386406,0.174341106,0.29325746,50.03720325,1,-1.258165071,1.012569539,-1.242546831,0.214034873,0.348562557,38.47255695,1,-0.461619206,0.850871212,-0.542525355,0.587456646,0.70009399,N,-,,duf21 and cbs domain,C:fungal-type vacuole membrane; C:integral component of membrane; P:cellular manganese ion homeostasis; P:cellular metabolic process; P:mitochondrion organization; F:hydrolase activity,G3DSA:3.10.580.10 (GENE3D); IPR002550 (PFAM); IPR000644 (PFAM); PTHR12064:SF29 (PANTHER); PTHR12064 (PANTHER); IPR000644 (PROSITE_PROFILES); IPR000644 (PROSITE_PROFILES); SSF54631 (SUPERFAMILY),1.A.112.1.1, the cyclin m mg2+ exporter (cnnm) family.
RL4_JR_00605,1872,1197,1166,1,9,0,0,0,2,1,0,0,0,0,0,0,0,1,99.06252278,1,2.19985664,0.994059606,2.213002749,0.026897456,0.083306548,24.22232837,1,2.636719337,1.040892733,2.533132621,0.011304817,0.036876365,25.1355963,1,-0.663290508,1.213982434,-0.546375705,0.584807707,0.706009208,16.21760718,0,-2.046653116,1.217910769,-1.680462286,0.092867406,0.185260573,21.12460875,1,-0.757811707,1.143209645,-0.662880785,0.507406909,0.634258636,N,-,,translation initiation factor eif-2b subunit family,P:biological regulation; F:catalytic activity; C:membrane; P:organonitrogen compound biosynthetic process; P:primary metabolic process; P:cellular biosynthetic process,IPR000649 (PFAM); IPR000086 (PFAM); IPR015797 (G3DSA:3.90.79.GENE3D); G3DSA:3.40.50.10470 (GENE3D); PTHR10233:SF20 (PANTHER); PTHR10233 (PANTHER); PTHR10233 (PANTHER); PTHR10233:SF20 (PANTHER); IPR000086 (PROSITE_PROFILES); SSF100950 (SUPERFAMILY); IPR015797 (SUPERFAMILY),,
RL4_JR_00606,30,19,44,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.368376171,0,3.338223753,2.326275828,1.435007712,0.1512849,NA,0.116887698,0,6.561958775,2.064087181,3.179109311,0.001477284,0.015023052,0.305064131,0,3.900350387,1.353466731,2.881748253,0.003954756,0.016305678,0.352018317,0,3.478519881,1.592342087,2.184530516,0.028923287,0.090433452,0.303185875,0,3.807694387,1.290605598,2.950316033,0.00317449,0.012386017,N,-,,Zinc C2H2-type DNA-binding partial,"F:nucleic acid binding; F:DNA binding; C:nucleus; F:transcription factor activity, sequence-specific DNA binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated",no IPS match,,
RL4_JR_00607,2065,1544,1877,0,0,5,0,0,0,0,1,1,0,10,0,0,4,0,40.98107113,1,0.474976563,0.674259032,0.70444227,0.48115739,0.669500594,7.01790404,0,0.654490438,1.235875663,0.529576281,0.596405743,0.732008029,32.5030643,1,-0.172117417,1.035440443,-0.166226284,0.867978875,0.916215007,61.06312212,1,1.556487676,0.539233616,2.886481164,0.003895761,0.022972963,33.31056924,1,0.53299079,0.757227983,0.703870964,0.481513135,0.610254272,N,-,,hypothetical protein F503_08879,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00608,1050,888,873,0,0,0,0,0,0,2,0,0,0,2,0,0,2,0,11.24967377,0,-1.594129382,1.191328044,-1.338111185,0.180860195,0.338020039,3.611310695,0,1.613048417,1.270998668,1.269118889,0.204398664,0.349185364,31.47167979,1,0.798060151,1.032605208,0.772860862,0.43960473,0.579650727,18.78570169,1,0.269667443,1.019511683,0.264506476,0.791389675,0.865128532,16.88255394,1,0.559861143,0.974033406,0.574786388,0.565435773,0.682834381,N,-,,PUA-like domain,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_00609,38687,24830,18895,2,4,12,0,0,1,3,3,6,4,18,7,0,4,4,427.5854813,1,-1.638452534,0.535930897,-3.057208576,0.002234088,0.011421445,116.3753604,1,-2.362402513,1.163187021,-2.030973928,0.042257639,0.103497469,370.235478,1,-1.508863161,0.552709518,-2.729938803,0.006334608,0.022701442,493.349765,1,-0.792088567,0.466317497,-1.698603573,0.089393903,0.180157895,312.4448709,1,-2.359349471,0.652174922,-3.617663594,0.000297274,0.001736817,N,-,,E3 ubiquitin- ligase UPL3,P:mycelium development; F:transferase activity,IPR000569 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); G3DSA:3.30.2160.10 (GENE3D); IPR000569 (PFAM); PTHR11254 (PANTHER); PTHR11254:SF338 (PANTHER); PTHR11254 (PANTHER); PTHR11254:SF338 (PANTHER); PTHR11254:SF338 (PANTHER); PTHR11254 (PANTHER); IPR000569 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR000569 (SUPERFAMILY),8.A.30.1.1, the nedd4-family interacting protein-2 (nedd4) family.
RL4_JR_00610,1088,1626,1647,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,29.35569911,1,-0.49765017,1.038185785,-0.479345968,0.631692526,0.790633265,5.554502751,0,0.991840968,1.255446695,0.790030331,0.429510055,0.59173823,14.4608789,0,-1.665088077,1.209322311,-1.376877001,0.168550279,0.28592544,16.68695009,0,-2.087816096,1.209649435,-1.725967901,0.084353188,0.17222747,18.15392831,1,-0.822652149,1.147214097,-0.717086855,0.473320506,0.603725136,N,-,,2-oxoisovalerate dehydrogenase alpha subunit,"F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor; C:integral component of membrane; F:methyltransferase activity; P:oxidation-reduction process; P:methylation",IPR001017 (PFAM); IPR029061 (G3DSA:3.40.50.GENE3D); PTHR11516:SF1 (PANTHER); PTHR11516 (PANTHER); IPR029061 (SUPERFAMILY),,
RL4_JR_00611,2933,2633,4370,0,0,6,0,0,0,0,0,0,1,6,0,0,0,1,62.47541416,1,-0.172044321,0.691717448,-0.248720517,0.803576977,0.901349047,12.54652315,0,-0.183759073,1.223674849,-0.150169854,0.880630609,0.931815077,32.71868367,0,-2.843115439,1.206220172,-2.357045176,0.018421006,0.052622534,71.13687181,1,0.224117939,0.626357012,0.357811815,0.720484148,0.813255519,39.82137333,1,-1.995299257,1.145834192,-1.741350774,0.081622111,0.163745567,N,-,,ubiquinone menaquinone biosynthesis methyltransferase,"F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor; C:mitochondrial matrix; C:integral component of membrane; F:2-hexaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity; C:extrinsic component of mitochondrial inner membrane; P:aerobic respiration; P:ubiquinone biosynthetic process; P:methylation",IPR029063 (G3DSA:3.40.50.GENE3D); IPR004033 (TIGRFAM); IPR004033 (PFAM); PTHR10108 (PANTHER); PTHR10108:SF821 (PANTHER); IPR004033 (HAMAP); IPR004033 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_00612,9240,8203,11386,0,0,7,0,0,0,0,1,2,3,13,2,0,4,1,141.7430643,1,-1.467844158,0.61271761,-2.395629133,0.016591869,0.056534712,36.6234847,0,-1.72920389,1.195559066,-1.446355884,0.148077409,0.274060986,116.0471353,1,-1.979959227,0.856018652,-2.312986081,0.020723404,0.057120541,209.2005499,1,0.05879563,0.403116205,0.145852808,0.884037587,0.928610911,116.913387,1,-1.542784633,0.696451547,-2.215207419,0.026745831,0.068945383,N,-,,Ser Thr phosphatase family,F:hydrolase activity,IPR018829 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); PTHR31987:SF11 (PANTHER); PTHR31987 (PANTHER); PTHR31987:SF11 (PANTHER); PTHR31987 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_00613,9583,7605,7054,0,0,9,0,0,0,0,3,3,1,11,0,0,2,9,131.3787504,1,-0.929997414,0.624359005,-1.489523506,0.136349568,0.276289065,31.22348246,0,-1.499019455,1.212854243,-1.235943613,0.216479524,0.363323784,123.5706664,1,-0.743110174,0.633177316,-1.173620969,0.240546878,0.373683688,146.3251005,1,-0.346161608,0.528493909,-0.654996402,0.512470071,0.647461875,152.9499032,1,-0.05518878,0.566160642,-0.097479012,0.922346001,0.950025763,N,-,,telomere silencing,C:cell part,IPR013941 (SMART); IPR013941 (PFAM); PTHR28089 (PANTHER),,
RL4_JR_00614,8077,8221,9813,0,9,17,0,0,6,1,2,1,3,6,3,0,12,0,241.4499568,1,0.561092758,0.399631,1.404027111,0.160310777,0.310141058,89.5296065,1,1.587579411,0.614650297,2.582898631,0.00979741,0.033178116,119.6610307,1,-1.419124874,0.738683244,-1.921154818,0.054712192,0.121125352,180.6008897,1,-0.347025367,0.445789576,-0.778451059,0.436303148,0.578064561,131.6355373,1,-0.290945129,0.604820724,-0.481043584,0.630485523,0.733959806,N,-,,Dihydrolipoamide succinyltransferase,F:dihydrolipoyllysine-residue succinyltransferase activity; C:mitochondrial oxoglutarate dehydrogenase complex; P:tricarboxylic acid cycle; P:2-oxoglutarate metabolic process; C:mitochondrial nucleoid; P:mitochondrial genome maintenance,IPR006255 (TIGRFAM); IPR000089 (PFAM); IPR001078 (PFAM); IPR023213 (G3DSA:3.30.559.GENE3D); G3DSA:2.40.50.100 (GENE3D); PTHR23151:SF8 (PANTHER); PTHR23151 (PANTHER); IPR000089 (PROSITE_PROFILES); SSF52777 (SUPERFAMILY); IPR011053 (SUPERFAMILY),,
RL4_JR_00615,19230,21184,22612,7,7,43,0,0,3,8,2,6,13,33,14,0,12,16,543.2982569,1,0.303965273,0.430459107,0.706142043,0.480099808,0.6689418,108.6002628,1,-0.676268834,0.844828359,-0.800480745,0.423432315,0.586478092,352.1375751,1,-0.676833135,0.411880908,-1.643273873,0.100326281,0.194467408,629.3413722,1,0.694977822,0.247734513,2.805333068,0.005026461,0.028117634,370.1903653,1,-0.177695724,0.506558651,-0.350790029,0.725745878,0.807225861,N,-,,dihydrolipoyl dehydrogenase,C:mitochondrial oxoglutarate dehydrogenase complex; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; P:leucine catabolic process; P:valine catabolic process; P:L-serine biosynthetic process; F:glycine dehydrogenase (decarboxylating) activity; P:isoleucine catabolic process; P:cell redox homeostasis; C:glycine cleavage complex; P:glycine catabolic process; F:dihydrolipoyl dehydrogenase activity; P:2-oxoglutarate metabolic process; P:hydrogen peroxide metabolic process; C:mitochondrial nucleoid; C:mitochondrial pyruvate dehydrogenase complex; F:RNA binding; F:flavin adenine dinucleotide binding; F:pyruvate dehydrogenase activity; P:oxidation-reduction process; P:pyruvate metabolic process,PR00411 (PRINTS); PR00368 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR006258 (TIGRFAM); IPR004099 (PFAM); PIRSF000350 (PIRSF); IPR004099 (G3DSA:3.30.390.GENE3D); IPR023753 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR22912:SF151 (PANTHER); PTHR22912 (PANTHER); IPR016156 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_00616,7325,7262,7652,3,2,10,0,0,0,4,1,0,0,0,2,0,2,0,173.4613804,1,0.046747675,0.398511024,0.117305852,0.906617688,0.954593069,28.44628107,0,-1.364636586,1.193539399,-1.143352777,0.252892151,0.407359552,125.8600926,1,-0.860813611,0.659316335,-1.305615477,0.191683354,0.315186338,104.3314897,1,-2.698896685,1.006955731,-2.680253561,0.007356641,0.037974382,80.33647691,1,-2.424178398,0.966603128,-2.507935603,0.01214388,0.03675838,N,-,,mitochondrial rna-splicing mrs3,P:transmembrane transport; C:integral component of membrane,IPR002067 (PRINTS); IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089:SF51 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.5.1, the mitochondrial carrier (mc) family.
RL4_JR_00617,9513,8265,12039,7,0,7,0,0,0,1,0,4,0,8,3,0,5,2,216.0632212,1,-0.427564766,0.504631758,-0.847280734,0.396838663,0.589048364,37.83341165,0,-1.776097643,1.197849147,-1.482738997,0.138143769,0.259230855,135.4659685,1,-1.292877959,0.680991134,-1.898523922,0.0576271,0.126089638,174.5291796,1,-0.69058651,0.49448309,-1.396582661,0.162539107,0.282622096,131.3592097,1,-1.109326269,0.612031381,-1.812531683,0.069904083,0.144740049,N,-,,and tpr domain-containing,,IPR001623 (PRINTS); IPR001623 (SMART); IPR019734 (SMART); IPR019734 (PFAM); IPR001623 (G3DSA:1.10.287.GENE3D); IPR001623 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR24078 (PANTHER); PTHR24078:SF170 (PANTHER); PTHR24078:SF170 (PANTHER); PTHR24078 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR001623 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR001623 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_00618,2560,2010,2756,4,2,0,0,0,2,0,0,7,1,4,0,0,0,2,85.48776654,1,0.402396032,0.629769705,0.63895743,0.522850626,0.707148923,28.08662994,1,1.882615819,0.994425212,1.893169839,0.058335287,0.133379213,69.69778494,1,1.202557755,0.590156775,2.037692026,0.041580742,0.098563201,53.28284525,1,0.207962527,0.67789534,0.306776747,0.759013309,0.842585668,38.61473526,1,-0.802773261,0.976684568,-0.821937079,0.411112709,0.547123577,N,-,,hypothetical protein CMQ_1956,,PTHR31570 (PANTHER),,
RL4_JR_00619,10284,9045,9249,4,1,1,0,0,0,1,0,7,3,10,0,0,2,0,166.4557669,1,-1.605607282,0.609597377,-2.633881547,0.008441493,0.033156332,36.65156954,0,-1.730267539,1.19819046,-1.444067197,0.148720074,0.274840821,151.3744363,1,-0.565375579,0.543059115,-1.041093988,0.29783193,0.438543842,177.4112532,1,-0.393427994,0.440035826,-0.894081733,0.371278162,0.517153858,100.9111456,1,-2.784440637,0.96757888,-2.877740198,0.004005349,0.014898661,Y,-,,vacuole morphology and inheritance,C:PAS complex; P:regulation of lipid kinase activity,IPR032878 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR021841 (PFAM); PTHR16023:SF0 (PANTHER); PTHR16023:SF0 (PANTHER); IPR026825 (PANTHER); IPR026825 (PANTHER); PTHR16023:SF0 (PANTHER); IPR026825 (PANTHER); IPR021133 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),9.B.149.1.7, the m50 peptidase (m50-p) family.
RL4_JR_00620,3566,3614,6870,3,0,0,0,0,0,1,6,5,4,9,2,0,2,4,86.08778892,1,-1.471309325,0.94035205,-1.564636697,0.117668119,0.248881648,17.62474066,0,-0.67406823,1.23613208,-0.545304374,0.585544196,0.723873486,136.7640542,1,1.05178693,0.535392642,1.964515103,0.049470387,0.112144692,145.8818913,1,0.852996766,0.511063559,1.669062001,0.095105093,0.18866361,83.1449567,1,-0.19739514,0.714434104,-0.276295797,0.782320884,0.850896868,N,-,,fatty acid desaturase,C:membrane; P:lipid metabolic process,IPR001199 (SMART); IPR001199 (PFAM); IPR012171 (PIRSF); IPR005804 (PFAM); IPR001199 (G3DSA:3.10.120.GENE3D); PTHR19353 (PANTHER); PTHR19353:SF20 (PANTHER); PTHR19353 (PANTHER); PTHR19353:SF20 (PANTHER); IPR001199 (PROSITE_PROFILES); IPR001199 (SUPERFAMILY),,
RL4_JR_00621,1192,1497,2686,0,0,2,0,0,0,0,0,0,0,0,0,0,5,2,29.05535596,1,-0.827739046,1.092310729,-0.757787161,0.44857841,0.637655108,6.733355364,0,0.71410486,1.280013503,0.557888537,0.5769205,0.716426119,17.65714054,0,-1.953265727,1.235847062,-1.580507643,0.113990658,0.213592711,20.38244091,0,-2.376499102,1.240170425,-1.916268162,0.055330971,0.130436806,51.64423403,1,1.32474335,0.699678547,1.893359967,0.058310015,0.125701038,N,-,,wd-40 repeat-containing,C:cytoplasm,IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22850:SF121 (PANTHER); PTHR22850 (PANTHER); IPR017986 (SUPERFAMILY),,
RL4_JR_00622,1422,1304,2388,0,0,6,0,0,0,3,0,2,0,0,5,0,1,0,43.25425891,1,0.765950581,0.723288487,1.05898351,0.28960729,0.474325691,6.434041991,0,0.779704046,1.25910214,0.619254008,0.535749038,0.68340917,63.01921108,1,1.279527788,0.711607233,1.798081481,0.072164097,0.150605919,67.57824104,1,1.2099341,1.566482476,0.772389171,0.439883966,0.581743097,20.57387711,1,-1.049554666,1.163341973,-0.902189288,0.366956324,0.503446177,N,-, Effector probability:0.855,n-terminal acetyltransferase c complex catalytic subunit mak3,C:NatC complex; C:nucleus; P:regulation of protein localization; C:cytosol; P:N-terminal protein amino acid acetylation; F:peptide alpha-N-acetyltransferase activity,IPR000182 (PFAM); IPR016181 (G3DSA:3.40.630.GENE3D); PTHR23091:SF66 (PANTHER); PTHR23091 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_00623,10386,7467,10807,5,4,8,0,0,1,4,0,0,5,3,12,0,0,3,227.0413961,1,-0.103631329,0.41837348,-0.247700521,0.804366129,0.901630269,45.87041813,1,-0.807267265,1.119636572,-0.721008303,0.470904406,0.629157127,138.9264224,1,-1.528348124,0.754251849,-2.02631008,0.042733019,0.100377978,283.3972741,1,0.527636822,0.590643823,0.893324879,0.371683219,0.517433327,115.4658382,1,-2.216215968,0.85731143,-2.585076894,0.009735728,0.030698925,N,-,,phospholipid:diacylglycerol acyltransferase,C:lipid particle; P:lipid storage; C:perinuclear endoplasmic reticulum; F:O-acyltransferase activity; C:integral component of membrane; P:triglyceride biosynthetic process; F:phospholipid:diacylglycerol acyltransferase activity; P:ceramide metabolic process,IPR029058 (G3DSA:3.40.50.GENE3D); IPR003386 (PFAM); PTHR11440 (PANTHER); PTHR11440:SF4 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_00624,7744,6482,8569,10,5,4,0,1,0,0,2,0,3,1,3,0,4,1,246.928963,1,0.59727416,0.562038129,1.062693311,0.287921055,0.472132657,67.36688557,1,-0.471866436,1.107145166,-0.426201054,0.66996135,0.789052394,91.03415053,1,-2.222268978,1.031777164,-2.153826481,0.031253782,0.079281707,147.7767522,1,-0.900597381,0.573890056,-1.569285565,0.116581414,0.219402755,97.16151046,1,-1.197918981,0.684964048,-1.748878623,0.080312003,0.161690224,N,-,,cysteine protease ATG4,P:autophagosome assembly; P:protein delipidation; C:nucleus; P:piecemeal microautophagy of nucleus; P:late nucleophagy; F:cysteine-type endopeptidase activity; C:cytosol; P:protein processing; P:C-terminal protein lipidation; P:mitophagy; P:protein targeting to membrane; P:CVT pathway,IPR005078 (PFAM); IPR005078 (PANTHER); PTHR22624:SF34 (PANTHER); IPR005078 (PANTHER); PTHR22624:SF34 (PANTHER); PTHR22624:SF34 (PANTHER); SSF54001 (SUPERFAMILY),9.A.15.2.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_00625,10618,11041,15868,1,3,0,0,0,0,0,1,1,2,5,0,1,3,0,183.9019978,1,-2.545649825,0.776830755,-3.276968388,0.001049281,0.006153872,47.49871597,0,-2.104326452,1.199448158,-1.754412175,0.079359907,0.169254314,138.1507336,1,-2.942258266,1.044144483,-2.817865068,0.004834412,0.018497199,181.5496015,1,-1.668351729,0.60445831,-2.760077414,0.005778767,0.031440092,150.2999605,1,-2.23396187,0.785412156,-2.84431792,0.004450662,0.016275514,N,-,,g-patch domain-containing,C:preribosome; P:RNA processing,IPR000467 (SMART); IPR001374 (G3DSA:3.30.1370.GENE3D); IPR000467 (PFAM); IPR001374 (PFAM); PTHR23106 (PANTHER); IPR001374 (PROSITE_PROFILES); IPR000467 (PROSITE_PROFILES); IPR001374 (SUPERFAMILY),,
RL4_JR_00626,25694,36120,31749,10,14,152,0,0,1,6,6,11,18,62,16,3,23,12,1169.748679,1,1.102667944,0.737851035,1.494431656,0.135062833,0.274158395,129.1564712,1,-2.522077521,1.121023215,-2.249799547,0.024461673,0.067356108,495.9356378,1,-0.746996661,0.391670685,-1.907205948,0.056493924,0.124066048,929.2883795,1,0.717764171,0.316738862,2.266107061,0.023444829,0.082854762,531.6753607,1,-0.340656462,0.385286425,-0.884164195,0.376607583,0.51263662,N,-,,histone h2b,F:DNA binding; F:protein heterodimerization activity; C:nuclear nucleosome; P:nucleosome assembly,IPR000558 (PRINTS); IPR000558 (SMART); IPR009072 (G3DSA:1.10.20.GENE3D); IPR007125 (PFAM); IPR000558 (PANTHER); IPR009072 (SUPERFAMILY),,
RL4_JR_00627,20053,28466,26789,6,10,137,0,0,6,14,6,17,20,42,8,2,12,10,966.4714528,1,1.161459766,0.836393994,1.388651489,0.164938752,0.316307085,152.4690966,1,0.014297558,0.6674222,0.02142206,0.982908976,0.99097747,562.5441218,1,0.281408157,0.391732769,0.718367673,0.472530614,0.609103633,720.3024345,1,0.614215313,0.346762043,1.77128762,0.076512885,0.161125824,398.7168078,1,-0.641254609,0.426692953,-1.5028479,0.132878271,0.236240999,N,-, Effector probability:0.757,histone H2A,F:DNA binding; P:DNA repair; P:nucleocytoplasmic transport; F:protein heterodimerization activity; F:structural constituent of nuclear pore; C:nucleosome; C:nuclear pore,IPR002119 (PRINTS); IPR002119 (SMART); IPR032454 (PFAM); IPR007125 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); PTHR23430 (PANTHER); IPR009072 (SUPERFAMILY),,
RL4_JR_00628,5262,4904,5759,4,4,3,0,0,1,3,2,0,0,0,2,0,7,0,147.426899,1,0.112561603,0.459223871,0.2451127,0.80636917,0.901743694,29.70013804,1,0.038139443,1.108782929,0.034397574,0.972560118,0.98570677,101.6174038,1,-0.37883166,0.660032176,-0.573959382,0.565995288,0.690461055,80.09056483,1,-2.214212405,1.0081383,-2.196337947,0.028067764,0.089114489,79.00582457,1,-0.209074002,0.583592584,-0.358253356,0.720153721,0.802858008,N,-,,complex 1,"C:mitochondrial respiratory chain complex I; P:mitochondrial electron transport, NADH to ubiquinone",IPR008011 (PFAM); IPR033034 (PTHR12868:PANTHER); PTHR12868 (PANTHER),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_00629,22178,24880,29564,34,38,50,0,0,9,2,6,11,8,48,8,0,14,1,1144.250103,1,1.407583778,0.306645966,4.590256958,4.43E-06,5.66E-05,181.8766284,1,0.56555582,0.560987959,1.008142529,0.313386043,0.475230279,394.2105698,1,-0.744656183,0.397570692,-1.873015791,0.061066205,0.132073116,636.6596949,1,0.338424418,0.401322849,0.843272241,0.399076204,0.543346219,311.978902,1,-1.571489909,0.632405169,-2.484941594,0.012957269,0.038699808,N,-,,pyruvate dehydrogenase e1 component beta subunit,C:mitochondrial pyruvate dehydrogenase complex; P:arginine biosynthetic process; P:acetyl-CoA biosynthetic process from pyruvate; F:pyruvate dehydrogenase (acetyl-transferring) activity; P:glutamine biosynthetic process; P:oxidation-reduction process; C:mitochondrial nucleoid,IPR005475 (SMART); IPR005475 (PFAM); IPR029061 (G3DSA:3.40.50.GENE3D); IPR009014 (G3DSA:3.40.50.GENE3D); IPR033248 (PFAM); IPR027110 (PTHR11624:PANTHER); IPR033247 (PANTHER); IPR029061 (SUPERFAMILY); IPR009014 (SUPERFAMILY),,
RL4_JR_00630,6249,7230,10301,0,8,41,1,0,4,3,0,1,1,11,1,0,9,7,315.6410731,1,1.288017066,0.860165573,1.497405972,0.134287655,0.27324764,89.88469747,1,1.469018492,0.69604799,2.110513231,0.034814173,0.08885251,118.1529089,1,-1.263602702,0.765320521,-1.651076466,0.098722962,0.192138535,153.6019678,1,-0.18627177,0.522185095,-0.356715983,0.721304439,0.813999938,164.1230199,1,0.397650808,0.499381258,0.796287009,0.425865234,0.560717009,N,-,,sterol 24-c-methyltransferase,F:sterol 24-C-methyltransferase activity; P:sterol biosynthetic process; P:methylation,IPR013216 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR013705 (PFAM); PTHR10108 (PANTHER); PTHR10108 (PANTHER); PTHR10108:SF878 (PANTHER); IPR030384 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_00631,7510,6720,11016,1,5,7,0,0,0,0,0,0,0,14,3,0,1,0,177.3848735,1,-0.332463752,0.501408201,-0.66306006,0.507292089,0.693730287,31.89384354,0,-1.529725031,1.207328264,-1.267033232,0.205143408,0.349961587,83.15122293,0,-4.188701607,1.205166561,-3.4756205,0.000509673,0.003430075,181.0173858,1,0.093431482,0.50363028,0.185516015,0.852824321,0.907897583,86.32067885,1,-3.351037453,1.146735474,-2.922241031,0.003475225,0.013323231,N,-,,Pre-mRNA-splicing factor slt-11,"F:nucleotide binding; F:nucleic acid binding; C:spliceosomal complex; C:Prp19 complex; P:mRNA splicing, via spliceosome",IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR14089 (PANTHER); PTHR14089:SF6 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_00632,1225,1761,2366,0,2,1,0,0,1,0,2,0,0,3,0,0,0,0,41.2624921,1,-0.194749963,0.903622921,-0.215521274,0.829360928,0.914685203,16.1362262,1,1.62339732,1.149534739,1.412221193,0.157884842,0.287487769,33.34951427,1,-0.128765566,1.062464333,-0.121195189,0.903536434,0.940606978,32.42160291,1,-0.103064072,0.910003038,-0.113256844,0.909826931,0.944820274,17.5437534,0,-2.046637376,1.233180369,-1.659641548,0.096986585,0.18644184,N,-, Effector probability:0.658,Mitochondrial zinc maintenance mitochondrial,C:mitochondrion; P:cellular process,PTHR13166:SF2 (PANTHER); PTHR13166 (PANTHER),,
RL4_JR_00633,38818,38657,46102,4,8,31,0,0,1,3,1,0,3,18,13,2,12,3,716.948979,1,-1.006935007,0.373672265,-2.694700951,0.007045183,0.028679942,166.8378144,1,-2.915579746,1.106447957,-2.63508078,0.008411726,0.029563713,450.0169769,1,-3.651379429,0.743746187,-4.909442889,9.13E-07,2.50E-05,697.2239724,1,-1.084556276,0.335193223,-3.235615166,0.001213809,0.008728563,504.1331443,1,-1.88984762,0.442872186,-4.267252899,1.98E-05,0.000178105,N,-,,like subfamily C member 2,C:polysome; P:ribosomal subunit export from nucleus; P:regulation of translational fidelity; C:mitochondrion; P:rRNA processing; C:nucleolus; C:ribosome,IPR001623 (SMART); IPR001623 (PFAM); IPR032003 (PFAM); IPR001623 (G3DSA:1.10.287.GENE3D); PTHR24078 (PANTHER); PTHR24078:SF193 (PANTHER); IPR001623 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_00634,8367,7391,7896,0,0,5,0,0,0,0,1,0,0,1,2,0,7,0,113.7154413,1,-1.628526591,0.662107796,-2.459609447,0.013908828,0.049419956,30.29558286,0,-1.455501287,1.196990416,-1.21596737,0.223997352,0.373020795,86.26998745,1,-3.142493103,1.187501869,-2.646305816,0.008137621,0.02777656,113.744306,1,-2.206158387,0.845180157,-2.610281807,0.009046766,0.04490123,104.1706676,1,-0.772686908,0.575943706,-1.341601445,0.179725257,0.297193897,N,-,,"N2,N2-dimethylguanosine tRNA partial",C:membrane; C:integral component of membrane; F:methyltransferase activity; F:transferase activity; P:methylation,IPR012472 (PFAM); PTHR38409 (PANTHER); PTHR38409:SF1 (PANTHER),9.B.178.1.4, the mdmd complementing protein 1 (mcp1) family.
RL4_JR_00635,2824,2488,3716,2,0,0,0,0,0,0,0,0,0,1,0,0,1,0,56.11736784,1,-1.519920305,1.020836207,-1.488897331,0.136514406,0.276486345,11.44323104,0,-0.050956003,1.216695469,-0.041880655,0.966593838,0.982682143,29.7808619,0,-2.707394084,1.197998746,-2.25993065,0.023825555,0.064015372,38.37263196,1,-2.183308495,1.151391024,-1.896235467,0.057928915,0.134453018,33.33516672,1,-1.866027517,1.136378443,-1.642082819,0.100572842,0.192003213,N,-,,c2h2 finger domain containing,F:binding,IPR003604 (SMART); IPR022755 (PFAM); PTHR17614 (PANTHER); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_00636,18791,15546,16329,15,15,7,0,0,1,3,8,8,11,11,8,1,22,8,500.4616988,1,0.475373023,0.580325392,0.819149102,0.41270135,0.603696901,74.36753286,1,-1.639310824,1.112388161,-1.473685969,0.140566162,0.26265658,315.9896117,1,-0.137627986,0.381543232,-0.360714001,0.718313257,0.809604225,417.4634141,1,0.06856647,0.339332077,0.202063036,0.839867445,0.900048463,325.0031153,1,0.222656255,0.374152997,0.595094139,0.551780546,0.67181073,N,-,,CMGC SRPK kinase,F:ATP binding; F:protein serine/threonine kinase activity; P:protein phosphorylation,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); PTHR24055:SF0 (PANTHER); PTHR24055 (PANTHER); PTHR24055:SF0 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_00637,6677,6627,10184,0,0,8,0,0,0,0,0,3,1,16,3,0,12,1,124.2116231,1,-1.058385136,0.674667124,-1.568751608,0.116705828,0.247616683,29.68553572,0,-1.42621002,1.205834357,-1.182757824,0.23690514,0.387642067,96.91313671,1,-1.689133577,0.873762897,-1.933171553,0.053215068,0.118667257,191.7390855,1,0.437951466,0.466809088,0.938181105,0.348151347,0.495227612,130.467391,1,-0.016875368,0.602752695,-0.027997167,0.97766441,0.985232852,N,-,,transcription factor IWS1,"P:regulation of transcription elongation from RNA polymerase II promoter; P:transcription from RNA polymerase II promoter; C:chromosome, centromeric region; C:nucleolus; P:chromatin silencing at telomere; P:translational elongation; F:transcription factor activity, core RNA polymerase II binding; C:chromosome, telomeric region; F:DNA binding; F:transcription factor activity, RNA polymerase II transcription factor binding; P:chromatin silencing at centromere; C:mitotic spindle; F:translation elongation factor activity; P:chromatin organization involved in regulation of transcription; P:poly(A)+ mRNA export from nucleus",IPR017923 (G3DSA:1.20.930.GENE3D); IPR017923 (PFAM); PTHR22908:SF63 (PANTHER); PTHR22908 (PANTHER); IPR017923 (PROSITE_PROFILES); IPR017923 (SUPERFAMILY),,
RL4_JR_00638,6653,5792,6993,2,5,9,0,0,0,0,0,2,2,6,0,0,6,1,172.199946,1,0.343499345,0.388976875,0.883084233,0.377190762,0.568784147,24.80969446,0,-1.16731596,1.196033631,-0.975989244,0.329069794,0.491927996,77.33140072,1,-1.997689168,1.028884132,-1.94160752,0.052184632,0.117039701,116.9072085,1,-0.521072385,0.534718917,-0.974479055,0.329818734,0.476582657,93.9393625,1,-0.486913992,0.581152991,-0.837841325,0.402119826,0.539338089,N,-,,nitrogen assimilation transcription factor nira,F:binding,IPR007219 (SMART); IPR001138 (SMART); IPR018767 (SMART); IPR018767 (PFAM); IPR007219 (PFAM); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31313 (PANTHER); PTHR31313 (PANTHER); PTHR31313:SF4 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),9.A.34.1.1, the nuclear pore complex biogenesis (npc-b) family.
RL4_JR_00639,10,28,28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.266293992,0,3.806666082,2.734553063,1.392061516,0.163903771,NA,0.083560845,0,7.046320394,2.247462978,3.135233133,0.001717176,0.015023052,0.218776113,0,4.381503253,1.439121724,3.044567516,0.002330151,0.011175012,0.252555842,0,3.958178794,1.809034524,2.188006222,0.028669149,0.089868463,0.217297939,0,4.290236958,1.340744417,3.19989172,0.001374792,0.006197583,,,,,,,,
RL4_JR_00640,136,195,215,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.191340489,0,0.765960778,1.302320757,0.588150634,0.556431189,0.734525185,0.693909085,0,3.992635524,1.485824223,2.687151994,0.007206415,0.026501193,1.808068141,0,1.334477448,1.23608557,1.079599569,0.280320533,0.419592324,2.086473157,0,0.911722656,1.252843975,0.727722425,0.46678352,0.608260379,1.789147095,0,1.247255879,1.233483281,1.011165614,0.311937171,0.447296962,N,-,,kinase-like domain,F:ATP binding; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,G3DSA:1.10.510.10 (GENE3D); IPR011009 (SUPERFAMILY),,
RL4_JR_00641,8,15,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.114180001,0,5.028490663,3.852764019,1.305164458,0.191836854,NA,0.036621343,0,8.237494238,2.638339012,3.122227356,0.001794883,0.015023052,0.094288861,0,5.598608997,1.575285635,3.554027837,0.000379379,0.002783213,0.108745199,0,5.174540053,2.350701539,2.201274797,0.027716576,0.088451852,0.091868414,0,5.532693034,1.355420139,4.081902634,4.47E-05,0.000353059,Y,-,,carbonic anhydrase,F:zinc ion binding; F:helicase activity; F:carbonate dehydratase activity,SSF63829 (SUPERFAMILY),,
RL4_JR_00642,22,44,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.330492533,0,3.495237907,2.522321135,1.385722801,0.165831563,NA,0.105852939,0,6.705832546,2.179292104,3.07706917,0.002090468,0.015023052,0.272752754,0,4.064972534,1.434157423,2.834397722,0.004591215,0.017781738,0.314589058,0,3.641957872,1.733111274,2.101398754,0.035605977,0.100197476,0.265935732,0,3.998086226,1.33934439,2.985106935,0.002834792,0.011311262,N,-,,allantoin transport,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR001248 (PFAM); PTHR30618:SF9 (PANTHER); PTHR30618 (PANTHER),2.A.39.3.1, the nucleobase:cation symporter-1 (ncs1) family.
RL4_JR_00643,66,282,91,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.805276218,0,1.045714202,1.653447491,0.63244476,0.527096294,NA,0.572261202,0,4.270911865,1.763799766,2.42142671,0.015459718,0.047318798,1.482001778,0,1.621844763,1.408429032,1.151527501,0.249515288,0.384138196,1.710030677,0,1.199097002,1.482750887,0.808697545,0.418689141,0.561936578,1.450140172,0,1.550298818,1.397810026,1.109091214,0.267390835,0.399606229,N,-,,alpha-ketoglutarate dependent xanthine dioxygenase,F:dioxygenase activity; P:oxidation-reduction process,G3DSA:3.60.130.10 (GENE3D); IPR003819 (PFAM); PTHR37995 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_00644,171,474,159,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3.292456086,0,0.17874364,1.444209818,0.123765701,0.90150079,0.952214332,1.049155952,0,3.396414199,1.583526117,2.144842552,0.031965438,0.083203273,2.710245229,0,0.750865401,1.337440361,0.561419726,0.57451144,0.697488166,12.76188702,1,1.292594348,1.268796887,1.018755927,0.308318854,0.45393753,2.647446703,0,0.681772434,1.335364463,0.510551578,0.60966509,0.717607421,N,-,,Cyclopropane-fatty-acyl-phospholipid synthase,C:membrane; C:integral component of membrane; P:lipid biosynthetic process,IPR029063 (G3DSA:3.40.50.GENE3D); IPR003333 (PIRSF); IPR029063 (PFAM); PTHR10108:SF795 (PANTHER); PTHR10108:SF795 (PANTHER); PTHR10108 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_00645,11,9,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.158686199,0,4.553217627,3.314541537,1.373709629,0.169531846,NA,0.050097136,0,7.78398711,2.427304846,3.206843641,0.001341999,0.015023052,0.131139881,0,5.117685985,1.452806133,3.522621408,0.000427301,0.003016735,0.151355782,0,4.69621702,2.035276007,2.307410398,0.021031952,0.078549803,0.130682501,0,5.022467442,1.312495063,3.826656256,0.000129896,0.000865259,N,-,,aryl-alcohol dehydrogenase,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; P:oxidation-reduction process",IPR007867 (PFAM); IPR012132 (PIRSF); IPR000172 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR11552:SF128 (PANTHER); PTHR11552 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_00646,1358,1931,1995,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,21.22371122,0,-2.509879644,1.209402327,-2.075305783,0.037958204,0.108501411,6.730027587,0,0.714886614,1.242166488,0.57551594,0.564942413,0.707364127,17.51683819,0,-1.94168026,1.205072556,-1.611255896,0.107123959,0.204011092,29.52512832,1,-1.413156409,1.157228507,-1.221155891,0.222027001,0.357224782,17.31165045,0,-2.027406929,1.212366356,-1.67227251,0.094470598,0.182924996,N,-, Effector probability:0.708,major facilitator superfamily transporter multidrug resistance,,G3DSA:2.80.10.50 (GENE3D); PTHR39697:SF1 (PANTHER); PTHR39697 (PANTHER),,
RL4_JR_00647,6852,6546,9893,0,1,2,0,0,0,0,2,1,1,10,0,0,4,0,108.5218121,1,-2.336161366,0.879901791,-2.65502513,0.00793025,0.031519399,29.47102461,0,-1.415746131,1.203251115,-1.176600722,0.239354909,0.391296424,98.98192114,1,-1.668372423,0.865987268,-1.926555373,0.054035065,0.120019964,138.0441895,1,-0.393970078,0.541080198,-0.728117716,0.46654153,0.608166818,91.54339912,1,-1.578627028,0.792881583,-1.990999742,0.046480916,0.105947607,N,-,,two-component response regulator ssk1p,P:positive regulation of cellular process; C:cell part; P:intracellular signal transduction,IPR001789 (SMART); IPR001789 (PFAM); G3DSA:3.40.50.2300 (GENE3D); PTHR24423:SF477 (PANTHER); PTHR24423 (PANTHER); IPR001789 (PROSITE_PROFILES); IPR011006 (SUPERFAMILY),9.B.238.3.1,The Uncharacterized Bacterial 5 TMS Protein-1 (UBP1) Family
RL4_JR_00648,16096,19221,28395,1,0,8,0,0,0,6,1,3,0,4,5,0,5,0,295.0685358,1,-2.30837548,0.655373032,-3.522231414,0.00042793,0.002956017,80.39903012,0,-2.863606565,1.204884345,-2.376665093,0.017469942,0.051765442,303.7838928,1,-1.339478964,0.556898166,-2.405249371,0.016161433,0.047233935,306.611878,1,-2.021928685,0.581516017,-3.476995689,0.000507066,0.004232517,227.8734088,1,-2.753935427,0.776909655,-3.544730602,0.000393015,0.002209479,N,-,,Ribosomal mitochondrial,C:ribosome,IPR021036 (PFAM); PTHR28158 (PANTHER),,
RL4_JR_00649,3872,4927,5930,0,0,2,0,0,0,0,0,4,0,0,0,0,0,0,66.63793153,1,-2.268298202,1.038700983,-2.18378363,0.028978151,0.088003551,18.69562741,0,-0.759143089,1.209376604,-0.627714383,0.530191061,0.678542663,74.70846455,1,-0.608629747,0.765271085,-0.795312614,0.426431678,0.567377678,56.2130888,0,-3.840028193,1.202546767,-3.193246447,0.001406828,0.00985382,48.22241502,0,-3.50540067,1.208381621,-2.900905317,0.003720863,0.014078377,N,-,,transcription factor partial,"F:DNA binding; C:nucleus; F:zinc ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (G3DSA:4.10.240.GENE3D),,
RL4_JR_00650,2965,2254,3275,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,37.65374659,1,-2.235669182,1.148402314,-1.946764783,0.051562941,0.136088797,10.80319051,0,0.032105136,1.220179885,0.026311806,0.979008639,0.989243725,34.54273357,1,-1.658903469,1.196083707,-1.386945963,0.165458241,0.282288377,32.35158905,0,-3.043010413,1.196368054,-2.543540346,0.010973538,0.052334939,35.0537208,1,-1.768972354,1.13081514,-1.564333808,0.117739197,0.21607401,N,-,,tRNA-specific adenosine deaminase,F:catalytic activity; C:membrane,G3DSA:3.40.140.10 (GENE3D); IPR002125 (PFAM); PTHR11079 (PANTHER); PTHR11079:SF92 (PANTHER); IPR002125 (PROSITE_PROFILES); IPR016193 (SUPERFAMILY),,
RL4_JR_00651,1551,1242,1283,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.29675518,0,-2.128883545,1.190244636,-1.788610073,0.073677634,0.177199924,5.233376085,0,1.077818112,1.2510731,0.861514896,0.38895452,0.553501496,13.5228695,0,-1.568314661,1.196387409,-1.310875264,0.189899909,0.312863577,15.59610953,0,-1.990273028,1.194455541,-1.666259613,0.095661717,0.189544987,13.27848699,0,-1.644874503,1.193837395,-1.377804472,0.168263665,0.282626013,N,-,,duf636 domain,F:carbon-sulfur lyase activity; P:metabolic process,IPR006913 (PFAM); IPR006913 (G3DSA:3.90.1590.GENE3D); IPR011057 (SUPERFAMILY); IPR011057 (SUPERFAMILY),,
RL4_JR_00652,211,219,262,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,2.768304691,0,0.428652272,1.234609079,0.34719676,0.728443505,0.856411891,0.881097442,0,3.648105023,1.418700895,2.571440559,0.01012764,0.033880684,2.289791804,0,0.993601035,1.211344507,0.820246452,0.412075626,0.554296234,30.57862808,1,2.901853563,0.849720321,3.415069044,0.000637658,0.005091713,2.261322338,0,0.909186737,1.209393996,0.751770507,0.452189081,0.584130447,N,-,,coiled-coil domain-containing,,IPR018613 (PFAM),,
RL4_JR_00653,4253,3343,3038,0,3,0,0,0,2,1,0,4,2,6,0,0,0,0,66.58934068,1,-1.175515504,0.864516559,-1.359737407,0.173913036,0.328421886,32.46312779,1,1.319799229,1.015173,1.300073219,0.193575875,0.335969652,72.40686879,1,0.182686612,0.69066133,0.264509686,0.791387202,0.862340333,83.44944786,1,0.326259519,0.57443398,0.567966956,0.570057406,0.696828593,34.62174432,0,-3.027421753,1.197448678,-2.528226727,0.011464029,0.03505687,N,-,,hypothetical protein F503_04929,,no IPS match,,
RL4_JR_00654,4493,3253,2150,5,0,0,0,0,3,0,0,2,4,0,0,0,0,0,89.99654515,1,0.051646745,1.061283884,0.048664402,0.961186746,0.980415288,41.00505033,1,1.911490077,0.950328873,2.011398507,0.044283381,0.107207936,46.01176496,1,-1.047808078,1.082733264,-0.9677435,0.333172488,0.476552453,75.30841953,1,-0.170513261,1.414335695,-0.120560671,0.904039021,0.94125928,32.1587244,0,-2.920945386,1.229647171,-2.375433746,0.017528339,0.049148278,N,-,,hypothetical protein SPSK_05803,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_00655,3214,3567,4544,2,1,9,0,0,0,0,0,0,1,3,0,0,0,0,107.8005498,1,0.670919484,0.494326313,1.357240079,0.17470494,0.329535931,14.37651644,0,-0.380165642,1.207969994,-0.314714474,0.752978453,0.84917026,37.43096601,0,-3.037208619,1.19576584,-2.53996938,0.011086217,0.035529239,64.53765088,1,-0.740197469,0.756410941,-0.978565259,0.327794832,0.474538558,37.03712891,0,-3.12466909,1.203185549,-2.596996858,0.009404278,0.029905251,N,-, Effector probability:0.718,Glucosamine 6-phosphate N-acetyltransferase,C:nucleus; C:cytoplasm; F:glucosamine 6-phosphate N-acetyltransferase activity; P:UDP-N-acetylglucosamine biosynthetic process,IPR000182 (PFAM); IPR016181 (G3DSA:3.40.630.GENE3D); PTHR13355 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_00656,3947,3392,4429,0,0,0,0,0,0,0,3,2,1,8,0,0,2,0,46.96841272,0,-3.656005758,1.188071234,-3.077261408,0.00208912,0.010848531,14.98670775,0,-0.440113329,1.204380601,-0.365427116,0.714792603,0.821124522,75.42986516,1,0.049351218,0.668472203,0.073826881,0.941148137,0.965074824,86.28511802,1,0.354644885,0.522264199,0.679052645,0.497104506,0.635588349,46.11516888,1,-1.508542849,0.97733298,-1.543530076,0.122702216,0.222804867,N,-,,syntaxin 5,P:ER to Golgi vesicle-mediated transport; C:cis-Golgi network; P:vesicle docking; C:integral component of membrane; F:SNAP receptor activity; C:SNARE complex; C:Golgi membrane; P:intra-Golgi vesicle-mediated transport; F:SNARE binding; P:intracellular protein transport; P:vesicle fusion with Golgi apparatus,IPR000727 (SMART); IPR000727 (PFAM); G3DSA:1.20.58.70 (GENE3D); IPR021538 (PFAM); PTHR19957 (PANTHER); PTHR19957 (PANTHER); PTHR19957:SF3 (PANTHER); IPR000727 (PROSITE_PROFILES); IPR010989 (SUPERFAMILY),8.A.91.1.2, the syntaxin (syntaxin) family.
RL4_JR_00657,1060,1204,1055,0,4,3,0,0,0,0,0,0,0,0,0,0,0,0,56.829469,1,1.701136122,0.579819901,2.933904338,0.003347274,0.015702736,4.260568333,0,1.374519161,1.256623823,1.093819117,0.274034318,0.432102206,11.03317944,0,-1.274668642,1.196044208,-1.065737064,0.286542518,0.426042427,12.72721211,0,-1.696891926,1.194109917,-1.421051698,0.155301731,0.272896567,10.84738299,0,-1.35299905,1.194944553,-1.132269314,0.257521227,0.389106465,N,-,,sorbitol dehydrogenase,F:zinc ion binding; P:mycelium development; F:oxidoreductase activity; P:oxidation-reduction process,IPR011032 (G3DSA:3.90.180.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013149 (PFAM); IPR013154 (PFAM); IPR002085 (PANTHER); PTHR11695:SF451 (PANTHER); PTHR11695:SF451 (PANTHER); IPR002085 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_00658,1481,2020,2020,0,0,11,0,0,0,0,0,5,0,3,0,0,0,2,64.18219945,1,1.379891668,0.706865116,1.952128683,0.050922929,0.134835849,7.042743339,0,0.649372418,1.236196685,0.525298625,0.599375613,0.734489099,50.80673166,1,1.122264091,0.69141663,1.623137254,0.104560067,0.200281668,33.1651344,1,-0.134857899,0.873384116,-0.154408464,0.877287681,0.924109214,32.81140386,1,-0.396218304,0.985456248,-0.40206585,0.687635565,0.778520641,N,-,,alcohol dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR020471 (PRINTS); IPR023210 (G3DSA:3.20.20.GENE3D); IPR023210 (PFAM); IPR020471 (PIRSF); PTHR11732:SF256 (PANTHER); IPR001395 (PANTHER); PTHR11732:SF256 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.5, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_00659,2641,2381,1910,0,0,3,0,0,0,0,3,0,0,2,0,0,0,0,39.26693382,1,-0.609378735,0.874012023,-0.697220082,0.485665073,0.673589878,8.947303172,0,0.304119176,1.242178014,0.24482737,0.806590101,0.883358844,46.60304423,1,0.070293058,0.867043241,0.081072148,0.935384575,0.961430162,34.63266358,1,-1.041705137,1.031714399,-1.009683627,0.312646889,0.458708847,22.59537547,0,-2.411763497,1.19870392,-2.011975982,0.044222469,0.101854526,N,-,,lipase,P:lipid metabolic process; F:hydrolase activity,IPR002921 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR21493:SF122 (PANTHER); PTHR21493:SF122 (PANTHER); PTHR21493 (PANTHER); PTHR21493 (PANTHER); PTHR21493 (PANTHER); PTHR21493:SF122 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_00660,1077,1158,877,7,0,1,0,0,0,0,2,1,0,8,5,0,4,1,86.79032206,1,2.348091542,0.924493813,2.539867232,0.011089456,0.041196621,4.013850933,0,1.46060498,1.275896939,1.14476721,0.252305602,0.406837341,32.5511216,1,1.22108762,0.864985996,1.411684843,0.158042778,0.272483836,92.2253499,1,2.810641715,0.475817605,5.906972939,3.48E-09,1.06E-07,32.96946619,1,1.672438612,0.687489521,2.432675059,0.014987745,0.043526112,N,-,,pigment biosynthesis Ayg1,,IPR029058 (G3DSA:3.40.50.GENE3D); IPR010520 (PFAM); G3DSA:1.20.1440.110 (GENE3D); PTHR10992 (PANTHER); PTHR10992:SF807 (PANTHER); IPR029058 (SUPERFAMILY),8.A.51.1.3, the dipeptidyl-aminopeptidase-like protein 6 beta subunit of kv4 channels (dpp6) family.
RL4_JR_00661,823,1093,852,2,0,3,0,0,0,0,0,3,0,0,0,0,5,0,42.73618088,1,1.467091579,0.696312967,2.106942782,0.03512254,0.102186048,3.558342712,0,1.634365662,1.280712777,1.276137547,0.201906901,0.346272729,28.71296198,1,1.382525717,0.870240441,1.588670959,0.112134699,0.210923711,10.632399,0,-1.437430912,1.206078143,-1.191822371,0.233330902,0.370580062,28.36129176,1,1.816122966,0.706307252,2.571293101,0.010131954,0.031711292,N,-,,2-deoxy-d-gluconate 3-dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); SM00822 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); PTHR24322:SF486 (PANTHER); IPR002347 (PANTHER); PTHR24322:SF486 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_00662,135,184,140,0,0,2,0,0,0,0,4,0,0,0,0,0,0,0,9.486948409,1,2.725839926,1.04613465,2.605630095,0.009170544,0.035422963,0.590285634,0,4.22612247,1.525440782,2.770427092,0.005598283,0.022135087,32.90075104,1,4.402184541,0.765824017,5.748297834,9.01E-09,3.83E-07,1.763732572,0,1.154513597,1.257062717,0.918421635,0.358398168,0.504347665,1.502453534,0,1.499235678,1.223097262,1.225769793,0.220285318,0.346387458,N,-,,xylosidase arabinosidase,"P:carbohydrate metabolic process; F:xylan 1,4-beta-xylosidase activity",IPR006710 (PFAM); IPR023296 (G3DSA:2.115.10.GENE3D); IPR006710 (PANTHER); IPR006710 (PANTHER); PTHR22925:SF30 (PANTHER); PTHR22925:SF30 (PANTHER); IPR023296 (SUPERFAMILY),,
RL4_JR_00663,12,45,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.31118804,0,3.582100093,2.639262237,1.357235383,0.174706431,NA,0.098506949,0,6.809426238,2.243322924,3.035419541,0.002402013,0.015281694,0.255583852,0,4.158464962,1.484672433,2.800930947,0.005095542,0.019201401,0.294929473,0,3.734958864,1.819395965,2.052856517,0.040086495,0.107602271,0.250789086,0,4.083190738,1.386251598,2.945490375,0.003224432,0.012541838,N,-,,hypothetical protein SPI_03588,"C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated",no IPS match,8.A.23.1.4, the basigin (basigin) family.
RL4_JR_00664,92,135,162,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1.559706547,0,1.256450211,1.382720699,0.908679686,0.36351923,NA,0.492876561,0,4.486108024,1.570918331,2.855723265,0.004293892,0.01864555,1.286283392,0,1.825594598,1.253099272,1.456863505,0.145154062,0.25561991,10.79674185,1,2.355306775,1.172047958,2.009565189,0.044477229,0.114413603,1.275107026,0,1.735976921,1.246630859,1.392534854,0.163760495,0.276540644,N,-, Effector probability:0.576,shikimate kinase,F:ATP binding; P:D-gluconate catabolic process; P:phosphorylation; F:gluconokinase activity,IPR006001 (TIGRFAM); IPR031322 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11603 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_00665,114,94,226,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,9.357416986,1,2.800654226,1.118141852,2.504739647,0.012254156,0.044669081,0.54202341,0,4.348822596,1.595668143,2.725392881,0.006422501,0.024347775,1.420990935,0,1.681475677,1.289270599,1.304206951,0.192163031,0.315821189,5.651770588,1,2.200578733,1.220877106,1.802457202,0.071473502,0.153482335,1.418397837,0,1.582010138,1.29007479,1.226293352,0.220088302,0.346185189,N,-, Effector probability:0.971,---NA---,,no IPS match,,
RL4_JR_00666,970,1075,1533,0,5,0,5,0,0,0,0,0,0,1,1,0,4,0,54.34068566,1,1.1977757,0.73882315,1.621194056,0.104976027,0.229559873,116.0849461,1,4.597313063,1.398161379,3.288113328,0.001008612,0.015023052,11.80405025,0,-1.372333077,1.207638284,-1.136377585,0.255798573,0.39172663,27.26860326,1,-0.059994617,1.03225082,-0.058120193,0.95365289,0.972674072,27.14673752,1,1.118097722,0.800329833,1.397046163,0.16239969,0.274920057,N,-,,DUF858 domain containing,C:nucleus; P:cytoplasmic translation; C:cytosol; F:N-terminal protein N-methyltransferase activity; P:N-terminal peptidyl-proline dimethylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR008576 (PFAM); IPR008576 (PIRSF); IPR008576 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_00667,105,67,159,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.310834584,0,1.506935523,1.481760612,1.016989863,0.309158252,NA,0.415613462,0,4.731972281,1.649686646,2.868406732,0.004125448,0.018371529,1.08530828,0,2.07015512,1.286547746,1.60907757,0.107599381,0.204762431,1.252395207,0,1.647650328,1.337713332,1.23169164,0.218064294,0.35309467,1.079273193,0,1.976079202,1.278367073,1.54578387,0.122156774,0.222071424,N,-,,short chain dehydrogenase,,IPR002347 (PRINTS); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR016040 (SUPERFAMILY),,
RL4_JR_00668,128,140,119,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.554657991,0,1.26123819,1.322218264,0.953880478,0.340144146,NA,0.497461747,0,4.47295163,1.552780718,2.880607401,0.003969097,0.018040054,1.287075953,0,1.825298868,1.229117595,1.485048196,0.137531057,0.245870462,1.484608312,0,1.40301155,1.251222977,1.121312169,0.262155007,0.40259661,1.264247449,0,1.74811753,1.211345677,1.443120294,0.148986587,0.257685206,N,-,,hypothetical protein SPSK_01793,P:proteolysis; F:cysteine-type peptidase activity,no IPS match,,
RL4_JR_00669,11,11,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.108956281,0,5.095886337,3.89260031,1.309121392,0.190493234,NA,0.035267736,0,8.291823163,2.627671741,3.15557801,0.001601804,0.015023052,0.090471654,0,5.657604833,1.53913994,3.675822248,0.000237085,0.001965084,0.104305135,0,5.23443572,2.340030655,2.236909037,0.025292286,0.085851084,0.08800386,0,5.591888399,1.319916026,4.236548606,2.27E-05,0.000200365,N,-,,family inorganic phosphate transporter,C:cytoplasm,IPR011629 (SMART); IPR011629 (G3DSA:3.30.1220.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011629 (PFAM); IPR003495 (PFAM); PTHR13748:SF4 (PANTHER); PTHR13748 (PANTHER); PTHR13748 (PANTHER); PTHR13748:SF4 (PANTHER); PTHR13748:SF4 (PANTHER); PTHR13748 (PANTHER); PTHR13748 (PANTHER); IPR011629 (SUPERFAMILY); IPR027417 (SUPERFAMILY),9.B.10.1.1, the putative tripartite zn(2+) transporter (tzt) family.
RL4_JR_00670,30797,38668,37137,0,0,1,0,0,2,0,0,0,0,3,0,0,0,0,431.9816678,1,-5.89776291,1.157747136,-5.094171884,3.50E-07,6.03E-06,155.054049,1,-1.98457729,0.990206069,-2.004206349,0.045047961,0.108651469,353.8534331,0,-6.278016551,1.197760669,-5.2414616,1.59E-07,5.32E-06,420.2839558,1,-4.404021534,0.867884616,-5.074432075,3.89E-07,7.75E-06,348.8121397,0,-6.360086413,1.206186603,-5.272887623,1.34E-07,2.91E-06,N,-,,siderochrome-iron transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501:SF50 (PANTHER); PTHR23501:SF50 (PANTHER); PTHR23501 (PANTHER); PTHR23501 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.16.7, the major facilitator superfamily (mfs).
RL4_JR_00671,4028,3075,4449,3,10,3,0,0,5,2,2,8,1,5,1,0,0,1,167.7727783,1,1.267600623,0.566377692,2.238083596,0.025215604,0.079265733,61.58625052,1,2.487345001,0.695248571,3.577634105,0.000346718,0.013498012,127.9580936,1,1.331688465,0.470368773,2.83115832,0.004637976,0.01790698,83.00653836,1,0.035988767,0.590068219,0.060990859,0.951366489,0.971282538,45.02303577,1,-2.212794961,1.129942266,-1.958325685,0.050191809,0.112456752,N,-,,GDP GTP exchange factor,C:cell part,IPR009449 (PFAM); PTHR14430 (PANTHER); PTHR14430:SF0 (PANTHER); PTHR14430:SF0 (PANTHER); PTHR14430 (PANTHER); SSF144284 (SUPERFAMILY),,
RL4_JR_00672,117,130,103,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.407256565,0,1.404961536,1.357098957,1.035268304,0.300543628,NA,0.450693763,0,4.615414953,1.584026259,2.913723764,0.003571458,0.016958421,1.165169834,0,1.968951506,1.236725967,1.592067733,0.111369486,0.210079332,1.343940349,0,1.546676835,1.265038159,1.222632553,0.221468512,0.356942099,1.143387353,0,1.893079456,1.215944681,1.55687959,0.119499076,0.218438011,N,-,,f-box domain-containing,,IPR032675 (G3DSA:3.80.10.GENE3D); SSF52047 (SUPERFAMILY),,
RL4_JR_00673,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_00674,2179,2055,2212,0,0,2,0,0,1,3,0,0,0,6,1,0,0,0,33.43482341,1,-1.059218083,1.001557962,-1.057570429,0.29025133,0.474999067,17.62452415,1,1.33881216,1.116966406,1.198614527,0.230677867,0.380714393,54.57764226,1,0.186626,0.843185803,0.221334371,0.824832089,0.886824596,58.35319994,1,0.87694286,0.563135422,1.557250398,0.119411047,0.22366081,21.03818448,0,-2.308722442,1.18758574,-1.944046955,0.051889789,0.115154092,N,-,,gat domain-containing,P:intracellular protein transport; C:intracellular,IPR004152 (G3DSA:1.20.58.GENE3D); IPR008942 (G3DSA:1.25.40.GENE3D); IPR004152 (PFAM); IPR004152 (PROSITE_PROFILES); IPR002014 (PROSITE_PROFILES); SSF89009 (SUPERFAMILY); IPR008942 (SUPERFAMILY),,
RL4_JR_00675,2046,1757,1493,0,0,10,0,0,0,0,0,0,10,6,6,0,2,4,59.41183479,1,1.396281378,0.614780446,2.271187035,0.023135658,0.073986945,6.829715597,0,0.693750241,1.250505881,0.554775672,0.579048109,0.718187105,17.61556809,0,-1.949727226,1.202072522,-1.621971379,0.104809476,0.200698154,195.3183949,1,2.934664413,0.432815063,6.780411923,1.20E-11,5.01E-10,54.43911109,1,1.199466826,0.626436232,1.914746889,0.055524791,0.121370575,N,-,,indole-diterpene biosynthesis,C:membrane; C:integral component of membrane,IPR029058 (G3DSA:3.40.50.GENE3D); IPR008547 (PFAM); IPR008547 (PANTHER); PTHR12265:SF14 (PANTHER),,
RL4_JR_00676,1353,754,1149,0,0,4,0,0,0,0,0,0,2,5,0,0,2,0,28.21075743,1,0.885813426,0.796034661,1.112782483,0.265801861,0.445808302,4.158582873,0,1.409424104,1.291256989,1.091513243,0.275047108,0.433176727,10.75364963,0,-1.237841236,1.21802329,-1.016270581,0.309500554,0.450781702,51.08445688,1,1.849177591,0.630170441,2.934408648,0.003341839,0.020283689,18.30216707,1,0.339110483,1.011651944,0.335204697,0.737470679,0.816282285,N,-,,thioesterase family,,IPR029069 (G3DSA:3.10.129.GENE3D); PF13622 (PFAM); PTHR38110 (PANTHER); PTHR38110:SF1 (PANTHER); IPR029069 (SUPERFAMILY); IPR029069 (SUPERFAMILY),,
RL4_JR_00677,32524,29657,47610,10,9,35,0,0,0,4,0,4,5,20,0,0,11,0,743.7731936,1,-0.460791677,0.368527018,-1.250360637,0.211167837,0.37861697,138.7533592,0,-3.650870912,1.20316105,-3.034399187,0.002410153,0.015304622,431.9867456,1,-2.473493084,0.585728133,-4.222937133,2.41E-05,0.000391233,544.176362,1,-1.539571107,0.548705772,-2.805822694,0.00501883,0.028117634,401.110848,1,-2.585121535,0.773160347,-3.343577494,0.000827056,0.004104873,N,-,,40S ribosomal S9,F:structural constituent of ribosome; C:small ribosomal subunit; F:rRNA binding; P:translation,IPR001912 (SMART); IPR002942 (SMART); IPR005710 (TIGRFAM); IPR002942 (G3DSA:3.10.290.GENE3D); IPR001912 (PFAM); IPR002942 (PFAM); PTHR11831:SF10 (PANTHER); IPR022801 (PANTHER); IPR002942 (PROSITE_PROFILES); SSF55174 (SUPERFAMILY),,
RL4_JR_00678,36662,33215,47487,7,3,35,0,0,4,3,0,5,4,4,2,0,7,10,696.2718894,1,-0.949804543,0.529537523,-1.79364918,0.072869182,0.175978719,186.4183038,1,-1.168936104,0.766614227,-1.524803562,0.127308101,0.243686195,453.0914634,1,-2.58539415,0.564918933,-4.576575506,4.73E-06,9.97E-05,519.5263993,1,-2.758073506,0.510082567,-5.407111881,6.40E-08,1.52E-06,483.8979775,1,-1.771312557,0.526488333,-3.364390902,0.000767128,0.003861982,N,-, Effector probability:0.559,60s ribosomal l21,F:structural constituent of ribosome; C:ribosome; P:translation,IPR001147 (G3DSA:2.30.30.GENE3D); IPR001147 (PFAM); IPR001147 (PANTHER); IPR008991 (SUPERFAMILY),,
RL4_JR_00679,9852,7553,5371,2,4,8,0,0,1,0,0,8,8,4,0,0,9,6,174.0317726,1,-0.094671237,0.519598813,-0.182200641,0.85542527,0.92758379,38.92705396,1,-0.50548549,1.156498282,-0.437082785,0.662051311,0.783564396,127.9142032,1,-0.450355047,1.355855108,-0.332155733,0.739771668,0.825101726,178.0803583,1,-0.066837326,0.619288614,-0.107925972,0.914054415,0.947849339,153.0168845,1,0.366630857,0.509566884,0.719495062,0.471835944,0.602894867,N,-,,nuclear migration,P:cortical protein anchoring; C:cell cortex; F:phospholipid binding,IPR001849 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); IPR024774 (PFAM); PTHR28190 (PANTHER); PTHR28190:SF1 (PANTHER); IPR001849 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY),,
RL4_JR_00680,1678,1128,2023,0,0,1,0,0,0,0,0,1,1,1,0,0,0,0,22.99977213,1,-1.418056908,1.166646899,-1.215497945,0.224176232,0.394484405,6.114023921,0,0.853340827,1.257937006,0.67836531,0.497540098,0.652429184,22.39796922,1,-0.840213894,1.210234243,-0.694257247,0.487520897,0.622368828,31.66664308,1,-0.488948935,1.039856251,-0.470208199,0.638206277,0.752251287,15.7346941,0,-1.889684579,1.221575509,-1.546924087,0.121881552,0.221831874,N,-,,pre-mrna splicing factor cwc24,"F:zinc ion binding; C:spliceosomal complex; P:mRNA splicing, via spliceosome",IPR000571 (SMART); IPR001841 (SMART); PF13920 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR000571 (G3DSA:4.10.1000.GENE3D); IPR000571 (PFAM); PTHR12930 (PANTHER); PTHR12930:SF0 (PANTHER); IPR000571 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR000571 (SUPERFAMILY),3.A.20.1.3, the peroxisomal protein importer (ppi) family.
RL4_JR_00681,721,649,1287,0,0,0,0,0,0,0,0,1,0,3,0,0,0,0,10.55866656,0,-1.502794039,1.241814632,-1.210159714,0.226217613,0.397733468,3.334914923,0,1.727747016,1.308073504,1.320833279,0.186556961,0.326544391,15.22253052,1,0.025637435,1.225570991,0.020918768,0.983310456,0.991734913,22.10314816,1,0.908310141,0.922074888,0.985071986,0.324588713,0.471177163,8.684320894,0,-1.032182977,1.245887235,-0.82847223,0.407403115,0.543656685,N,-,,hypothetical protein CMQ_5266,C:membrane,no IPS match,,
RL4_JR_00682,5716,6021,10497,1,2,0,0,0,0,0,0,0,3,2,0,0,0,1,114.6429065,1,-2.190809587,0.908227016,-2.412182801,0.015857329,0.054607044,27.95539592,0,-1.339578858,1.221102625,-1.097023976,0.272630911,0.430375871,73.11666102,0,-4.003163266,1.21812584,-3.286329813,0.001015021,0.005820442,120.3474643,1,-1.352451359,0.727526164,-1.858972814,0.063030992,0.140725203,80.10556174,1,-3.15659688,1.161484001,-2.717727388,0.006573197,0.022484332,N,-,,mitochondrial carrier rim2,P:transmembrane transport; C:integral component of membrane,IPR002067 (PRINTS); IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089 (PANTHER); PTHR24089:SF88 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.10.4, the mitochondrial carrier (mc) family.
RL4_JR_00683,1774,1456,2789,1,0,0,0,0,0,0,0,0,0,1,2,0,0,2,33.98290443,1,-1.728656867,1.177187585,-1.468463386,0.141978395,0.285059925,7.575919829,0,0.544017955,1.253596443,0.433965777,0.664313293,0.785076375,19.78075054,0,-2.117129081,1.217966558,-1.738248942,0.082166959,0.166310092,46.10897098,1,-0.204585956,0.889927523,-0.229890582,0.818176795,0.885330774,34.3855006,1,-0.501589043,1.013364121,-0.494974148,0.620618369,0.726698391,N,-,,pre-mrna-splicing factor slu7,"F:metal ion binding; C:spliceosomal complex; P:mRNA splicing, via spliceosome",IPR007627 (PFAM); IPR021715 (PFAM); IPR001878 (G3DSA:4.10.60.GENE3D); PTHR12942 (PANTHER); PTHR12942:SF2 (PANTHER); PTHR12942:SF2 (PANTHER); PTHR12942 (PANTHER); IPR001878 (PROSITE_PROFILES); IPR001878 (SUPERFAMILY),,
RL4_JR_00684,562,619,462,2,5,4,0,0,0,0,0,0,0,0,0,0,2,3,82.06507543,1,3.390103445,0.505241092,6.709872767,1.95E-11,7.71E-10,2.119343557,0,2.381991698,1.32721908,1.794723821,0.072697713,0.158178284,5.474128183,0,-0.263412804,1.211350191,-0.217453884,0.827854642,0.888802071,6.313689585,0,-0.685442013,1.211143424,-0.565946196,0.571430357,0.698169707,35.18374012,1,2.616898282,0.684020003,3.825762799,0.000130368,0.000867833,N,-,,ph domain-containing,C:membrane,PTHR13466:SF0 (PANTHER); PTHR13466 (PANTHER),,
RL4_JR_00685,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_00686,3962,3397,4598,0,2,7,0,0,0,4,5,2,5,3,1,0,10,0,90.45403857,1,0.195132689,0.524532179,0.372012809,0.709883312,0.843587482,15.21071439,0,-0.461525329,1.205139945,-0.382964095,0.701746386,0.811594712,135.9989436,1,1.178281962,0.472033017,2.496185477,0.012553694,0.038548256,113.8087854,1,0.383205052,0.517324438,0.740744152,0.458848583,0.600854002,77.61972873,1,0.656995063,0.558278704,1.176822719,0.239266273,0.368283827,N,-, Effector probability:0.556,sorting nexin-3,C:pre-autophagosomal structure; C:Golgi membrane; P:endocytosis; C:nucleus; C:late endosome membrane; P:vesicle organization; P:mycelium development; P:autophagy; C:cytosol; P:late endosome to Golgi transport; F:phosphatidylinositol-3-phosphate binding; C:extrinsic component of membrane; P:CVT pathway,IPR001683 (SMART); IPR001683 (G3DSA:3.30.1520.GENE3D); IPR001683 (PFAM); PTHR10555 (PANTHER); IPR001683 (PROSITE_PROFILES); IPR001683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_00687,3375,3602,5222,0,1,10,0,0,0,0,0,1,0,5,0,0,4,0,94.8961622,1,0.351422444,0.596423288,0.589216502,0.555716049,0.73388089,15.42986609,0,-0.482189493,1.213751983,-0.397271848,0.691167005,0.804455699,46.73707682,1,-2.179758512,1.202114904,-1.813269685,0.069790237,0.14643655,66.49166076,1,-0.557911708,0.711087123,-0.784589806,0.432694109,0.574938038,55.33669814,1,-0.647667119,0.794268204,-0.81542622,0.414828381,0.550890815,N,-,,pre-mrna-splicing factor sap114,"F:RNA binding; C:catalytic step 2 spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; C:U2-type prespliceosome; C:U2 snRNP; P:mRNA 3'-splice site recognition",IPR000061 (SMART); IPR000061 (PFAM); IPR022030 (PFAM); PTHR15316:SF1 (PANTHER); PTHR15316:SF1 (PANTHER); PTHR15316 (PANTHER); IPR000061 (PROSITE_PROFILES); IPR000061 (PROSITE_PROFILES); IPR000061 (SUPERFAMILY); IPR000061 (SUPERFAMILY),,
RL4_JR_00688,31,33,45,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.435458414,0,3.097013355,2.110872339,1.467172267,0.142329199,NA,0.138151139,0,6.321025146,1.960515656,3.224164585,0.001263408,0.015023052,0.35989936,0,3.662658907,1.296166546,2.825762567,0.004716821,0.018129498,0.415288227,0,3.240381643,1.470017398,2.204315165,0.027502187,0.088148036,0.356398279,0,3.575198582,1.246715965,2.867692949,0.004134766,0.015312548,N,-,,---NA---,,no IPS match,,
RL4_JR_00689,3380,3009,1920,1,0,0,0,0,0,0,1,0,2,3,0,0,6,2,43.46183784,1,-2.209942854,1.179273287,-1.873987037,0.060932212,0.154230526,10.78747547,0,0.034282557,1.263452322,0.027134033,0.97835283,0.988904269,35.57832583,1,-1.642824787,1.219565748,-1.347057172,0.17796182,0.297946993,62.6386236,1,0.017097642,0.731343588,0.023378398,0.981348436,0.98847522,64.95868414,1,0.909518763,0.609286846,1.492759558,0.135500137,0.239975317,N,-,,histone-lysine n-methyltransferase,F:methyltransferase activity; P:methylation,IPR001214 (SMART); IPR003616 (SMART); IPR006560 (SMART); IPR001214 (PFAM); G3DSA:2.170.270.10 (GENE3D); PTHR22884 (PANTHER); PTHR22884:SF363 (PANTHER); PTHR22884:SF363 (PANTHER); IPR001214 (PROSITE_PROFILES); IPR006560 (PROSITE_PROFILES); IPR003616 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY),,
RL4_JR_00690,4295,4741,6543,0,0,10,0,0,0,0,0,0,0,6,0,0,5,3,100.4292876,1,-0.222362377,0.70479277,-0.315500366,0.752381773,0.870775614,19.72685991,0,-0.836616684,1.207388561,-0.692914204,0.488363395,0.644368416,51.42444374,0,-3.495424793,1.20069918,-2.911157807,0.003600921,0.015473567,83.4107716,1,-0.65681413,0.659977625,-0.995206663,0.319635762,0.465924573,92.35619187,1,0.021313099,0.590241789,0.036109099,0.971195367,0.980367224,N,-,,small nuclear ribonucleo,P:mRNA metabolic process; C:viral nucleocapsid; C:spliceosomal snRNP complex; P:RNA processing,IPR001163 (SMART); G3DSA:2.30.30.100 (GENE3D); IPR001163 (PFAM); PTHR10553:SF5 (PANTHER); PTHR10553 (PANTHER); IPR010920 (SUPERFAMILY),,
RL4_JR_00691,6026,4818,4033,0,0,8,0,0,0,1,0,1,0,3,1,0,4,0,90.14068648,1,-0.384878511,0.646191711,-0.595610411,0.55143552,0.730887242,19.21191275,0,-0.798377888,1.227311021,-0.650509833,0.515362952,0.665710031,67.06396117,1,-1.614002362,1.047875616,-1.540261399,0.123496649,0.226705362,78.74396835,1,-1.147741072,0.775277996,-1.480425188,0.138759812,0.250927505,63.87546574,1,-0.914367327,0.771851922,-1.184640864,0.236159473,0.364832875,N,-,,pab-dependent poly -specific ribonuclease subunit pan3,F:ATP binding; C:PAN complex; P:mRNA processing; P:nuclear-transcribed mRNA poly(A) tail shortening; F:poly(A) RNA binding,G3DSA:3.30.200.20 (GENE3D); PTHR12272 (PANTHER); IPR030844 (HAMAP); IPR011009 (SUPERFAMILY),,
RL4_JR_00692,1843,1710,1938,3,2,5,0,0,0,0,2,1,6,2,0,0,0,0,87.27004421,1,1.492921479,0.472115193,3.162197493,0.001565833,0.008510372,7.015070488,0,0.655066509,1.223114907,0.535572337,0.592254152,0.729116581,40.37315833,1,0.411618496,0.844681174,0.487306346,0.626041251,0.738228873,84.8784496,1,1.327804781,0.530334813,2.503710388,0.012289859,0.057070971,17.92095486,0,-2.077361162,1.189734,-1.746071948,0.080798451,0.162414992,N,-,,UBX domain-containing,P:protein processing; F:molecular_function,IPR006577 (SMART); G3DSA:3.10.20.90 (GENE3D); PF14555 (PFAM); IPR001012 (PFAM); G3DSA:1.10.8.10 (GENE3D); PTHR23322 (PANTHER); PTHR23322:SF1 (PANTHER); PTHR23322:SF1 (PANTHER); IPR012336 (SUPERFAMILY); IPR029071 (SUPERFAMILY),,
RL4_JR_00693,402,971,621,0,0,15,0,0,0,0,0,0,0,0,0,0,1,0,65.37065276,1,3.070171412,1.003124018,3.060610012,0.002208866,0.011319051,2.562955972,0,2.107740786,1.379467321,1.527938179,0.126527888,0.242651626,6.660712151,0,-0.546576278,1.260677958,-0.433557416,0.664609864,0.768796876,7.686076896,0,-0.96932129,1.268267844,-0.764287524,0.444695919,0.586880367,10.41917177,1,0.297736845,1.196212555,0.248899615,0.803438433,0.867528435,N,-,,imp-specific 5 -nucleotidase 1,F:magnesium ion binding; P:nicotinic acid riboside biosynthetic process; C:nucleus; P:inosine salvage; P:nicotinamide riboside biosynthetic process; F:IMP 5'-nucleotidase activity; C:cytosol; P:dephosphorylation; P:nucleotide metabolic process,IPR009453 (PIRSF); IPR009453 (PFAM); PTHR28213 (PANTHER); PTHR28213 (PANTHER); PTHR28213:SF1 (PANTHER); PTHR28213:SF1 (PANTHER),,
RL4_JR_00694,95381,43324,39279,18,15,18,4,1,4,0,11,10,8,2,0,0,3,6,1078.52286,1,-0.983587135,0.554774865,-1.772948267,0.07623728,0.181483434,396.3876183,1,-0.538270096,0.700117298,-0.768828448,0.441995159,0.603191991,743.0932705,1,-1.894265564,0.669035371,-2.831338442,0.004635364,0.01790478,764.6259726,1,-3.156198555,0.87417104,-3.610504592,0.000305602,0.002767638,631.5845118,1,-3.246159629,0.756374246,-4.291737388,1.77E-05,0.000162,N,-,,HAL kinase,F:kinase activity,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); PTHR24343 (PANTHER); PTHR24343:SF191 (PANTHER); PTHR24343 (PANTHER); PTHR24343:SF191 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.C.104.2.4, the heterokaryon incompatibility prion/amyloid protein (het-s) family
RL4_JR_00695,7636,8800,7510,0,4,22,0,0,0,0,3,2,6,3,1,0,5,1,212.286101,1,0.466198056,0.641700666,0.72650393,0.467529899,0.656021485,30.75686015,0,-1.477295596,1.202684514,-1.228331769,0.21932245,0.366999808,116.158769,1,-0.984950959,0.674669219,-1.459902024,0.144317003,0.254736389,169.4021145,1,-0.46408061,0.503749064,-0.921253543,0.35691807,0.502893885,104.9371735,1,-1.011743005,0.627600933,-1.612080149,0.1069445,0.200879177,N,-,,glycosyltransferase family 39,P:fungal-type cell wall organization; P:filamentous growth; P:cell wall mannoprotein biosynthetic process; P:multicellular organism development; C:integral component of membrane; P:regulation of endoplasmic reticulum unfolded protein response; C:dolichyl-phosphate-mannose-protein mannosyltransferase complex; P:protein O-linked mannosylation; P:chain elongation of O-linked mannose residue; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity,IPR016093 (SMART); G3DSA:2.80.10.50 (GENE3D); IPR003342 (PFAM); IPR016093 (PFAM); IPR032421 (PFAM); IPR027004 (PTHR10050:PANTHER); IPR027005 (PANTHER); IPR016093 (PROSITE_PROFILES); IPR016093 (PROSITE_PROFILES); IPR016093 (PROSITE_PROFILES); IPR016093 (SUPERFAMILY),9.B.142.5.4, the integral membrane glycosyltransferase family 39 (gt39) family.
RL4_JR_00696,3107,2414,3020,0,1,2,0,0,1,0,0,0,1,2,0,0,0,0,49.72533764,1,-0.883516491,0.849225144,-1.040379571,0.298163589,0.483796307,20.28814323,1,0.934554293,1.122017822,0.83292286,0.404888236,0.569059419,28.26060206,0,-2.631771,1.192130664,-2.207619583,0.027270803,0.071212176,49.93317376,1,-0.741638007,0.853758829,-0.868673894,0.385025524,0.530291378,27.83292188,0,-2.712534737,1.193838503,-2.272111956,0.023079749,0.061013697,N,-,,autophagy 3,P:autophagosome assembly; P:piecemeal microautophagy of nucleus; P:late nucleophagy; F:metal ion binding; C:cytosol; P:C-terminal protein lipidation; F:Atg8 ligase activity; P:mitophagy; P:protein targeting to membrane; P:CVT pathway,IPR007134 (PFAM); IPR019461 (PFAM); IPR007135 (PFAM); PTHR12866:SF2 (PANTHER); PTHR12866:SF2 (PANTHER); PTHR12866 (PANTHER),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_00697,2107,1671,1783,0,2,7,0,0,0,0,2,2,1,4,0,0,0,0,64.9756597,1,1.301912113,0.515816495,2.523983096,0.011603351,0.042689911,7.134455489,0,0.630748087,1.236094186,0.510275102,0.609858743,0.742928174,47.12497712,1,0.803629199,0.746380254,1.076702116,0.281613367,0.420881861,46.62792133,1,0.601651597,0.675962654,0.890066328,0.373430272,0.519151655,18.11619199,0,-2.093049143,1.192707642,-1.754871915,0.079281219,0.160256008,N,-,,palmitoyltransferase pfa5,F:transferase activity,IPR001594 (PFAM); PTHR22883:SF97 (PANTHER); PTHR22883 (PANTHER); PTHR22883 (PANTHER); PTHR22883:SF97 (PANTHER); PTHR22883 (PANTHER); IPR001594 (PROSITE_PROFILES),8.A.114.1.3, the huntington-interacting protein 14 (hip14) family.
RL4_JR_00698,5000,5899,7099,1,1,3,0,0,0,1,1,12,8,2,1,0,0,1,101.5905905,1,-1.228175668,0.69199824,-1.774824843,0.075926813,0.181167283,22.86919319,0,-1.049843979,1.201234235,-0.873971078,0.382134005,0.54655368,156.4315548,1,0.878525803,0.489863311,1.793410088,0.072907376,0.151859584,160.8513698,1,0.176545718,0.55461155,0.318323191,0.750239795,0.835479314,66.25078626,1,-2.85725869,1.132424859,-2.52313314,0.011631435,0.035536597,N,-,,phosphoglycerate mutase,C:nucleus; C:cytoplasm; P:phosphate-containing compound metabolic process,IPR013078 (SMART); IPR013078 (PFAM); IPR029033 (G3DSA:3.40.50.GENE3D); PTHR23029 (PANTHER); PTHR23029 (PANTHER); PTHR23029:SF48 (PANTHER); PTHR23029:SF48 (PANTHER); PTHR23029:SF48 (PANTHER); IPR029033 (SUPERFAMILY),,
RL4_JR_00699,19831,10898,12872,0,1,0,0,0,0,2,1,3,2,2,2,0,1,3,181.5721887,1,-4.587373843,1.181660687,-3.882141375,0.000103541,0.000885022,56.11403563,0,-2.344765612,1.228271865,-1.90899562,0.056262657,0.12966544,193.9786636,1,-1.575435923,0.667653396,-2.359661364,0.018291624,0.052311977,212.5261161,1,-2.054958648,0.67179995,-3.058884786,0.002221626,0.014400743,167.4722811,1,-2.406326018,0.797324805,-3.017999694,0.002544492,0.010371569,N,-,,c6 zinc finger domain containing,"C:nucleus; F:zinc ion binding; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00700,6633,4550,4098,0,2,2,0,0,0,0,0,6,3,2,3,0,1,1,84.7376715,1,-1.307134676,0.785019432,-1.665098495,0.095893107,0.214503967,19.7393179,0,-0.837454584,1.235520682,-0.677815108,0.497888931,0.652642619,89.79031701,1,-0.104200113,0.675805053,-0.154186644,0.877462572,0.92304978,123.436249,1,-0.108064244,0.592961252,-0.182245035,0.855390432,0.909846425,60.89923856,1,-1.869879143,0.9923927,-1.884212917,0.059536181,0.12788677,N,-,,transcription factor,,PTHR39609 (PANTHER); PTHR39609:SF1 (PANTHER),,
RL4_JR_00701,1084,970,977,0,0,3,0,0,0,0,0,0,0,1,0,0,2,0,23.58897166,1,0.602891835,0.845844763,0.712768892,0.475988778,0.665258943,3.88800122,0,1.506532045,1.259672125,1.195971567,0.231707655,0.381791451,10.0578869,0,-1.1412084,1.193123281,-0.956488251,0.338825617,0.482118138,15.61249686,1,-0.61600926,1.142159753,-0.539337215,0.589654195,0.713847808,17.60623859,1,0.451726263,0.969687193,0.465847405,0.64132473,0.742868424,N,-,,DNA polymerase eta subunit,F:binding,IPR002110 (SMART); IPR001126 (PFAM); IPR017961 (G3DSA:3.30.1490.GENE3D); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); G3DSA:1.10.150.20 (GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR017961 (PFAM); G3DSA:3.30.70.270 (GENE3D); IPR002110 (PFAM); PTHR11076 (PANTHER); PTHR11076 (PANTHER); PTHR11076:SF11 (PANTHER); PTHR11076:SF11 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR001126 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY); SSF56672 (SUPERFAMILY); IPR017961 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_00702,569,761,935,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.073542946,0,-1.283968608,1.220897636,-1.051659509,0.292955795,0.477986674,2.871111023,0,1.943841841,1.293266217,1.503048495,0.132826539,0.251068203,7.487810936,0,-0.715635271,1.213738905,-0.589612204,0.555450668,0.682200966,8.641079924,0,-1.138459006,1.214412721,-0.937456424,0.348523829,0.495547336,7.419045076,0,-0.804935707,1.222903431,-0.658216901,0.510398766,0.636819163,N,-,,hypothetical protein FPOA_06481,,no IPS match,,
RL4_JR_00703,116,155,152,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5.517913083,1,2.079002335,1.172941402,1.772469052,0.076316728,0.181619565,0.540057006,0,4.354328952,1.532084489,2.842094534,0.00448182,0.019176787,1.403552884,0,1.700026839,1.232140542,1.37973452,0.1676684,0.284811222,1.619424281,0,1.277437003,1.253404403,1.01917386,0.308120434,0.453777367,1.384953949,0,1.616779892,1.222331755,1.322701374,0.185934707,0.304823333,N,-,,"putative cyclase, partial",F:arylformamidase activity; P:tryptophan catabolic process to kynurenine,G3DSA:3.50.30.50 (GENE3D); IPR007325 (PFAM); PTHR34861 (PANTHER); PTHR34861:SF3 (PANTHER); SSF102198 (SUPERFAMILY),,
RL4_JR_00704,207,344,298,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.421792688,0,0.123139551,1.27086729,0.096894107,0.922810489,0.962640224,1.085283639,0,3.3474547,1.42032901,2.356816398,0.018432358,0.053893982,2.822188219,0,0.692322976,1.234968961,0.560599495,0.575070596,0.69783228,3.25649769,0,0.26963679,1.244132041,0.216726827,0.82842124,0.892774047,2.784595757,0,0.608992602,1.234320038,0.493383064,0.621741947,0.727593298,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF276 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_00705,189,331,248,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.102421022,0,0.264539547,1.290406727,0.20500478,0.83756839,0.918937779,0.985458688,0,3.486697966,1.447984995,2.407965537,0.016041695,0.048571355,2.558777887,0,0.833783867,1.243666982,0.670423738,0.502587706,0.634834428,2.952351463,0,0.411171995,1.256132033,0.327331828,0.743416922,0.829889342,2.519683655,0,0.753233221,1.240170644,0.607362563,0.543610327,0.665424643,N,-,,CAIB BAIF family enzyme,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:transferase activity",IPR025496 (PFAM); IPR010839 (PFAM); IPR023606 (G3DSA:3.40.50.GENE3D); IPR023606 (G3DSA:3.40.50.GENE3D); IPR003673 (PFAM); IPR023606 (SUPERFAMILY); IPR023606 (SUPERFAMILY),,
RL4_JR_00706,203,181,253,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.541189331,0,0.551997271,1.249020445,0.441944144,0.658529626,0.807862359,0.808985887,0,3.771257448,1.439341547,2.620126861,0.008789706,0.030594706,2.103412673,0,1.115897247,1.217747839,0.916361508,0.359477317,0.503298072,2.426789216,0,0.693480388,1.226052561,0.56562044,0.57165183,0.69835603,2.079476672,0,1.030015944,1.216262255,0.846869941,0.397067618,0.533905662,Y,-,,glucose-dependent insulinotropic receptor,F:nucleic acid binding; P:nucleic acid phosphodiester bond hydrolysis; F:calcium ion binding; F:nuclease activity; C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00707,154,111,169,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.72738925,0,1.108847459,1.312564693,0.844794519,0.398225575,NA,0.551689029,0,4.323524113,1.531667608,2.822756119,0.004761278,0.019997366,1.432133292,0,1.670376292,1.233795434,1.3538519,0.175783632,0.295142805,1.652094479,0,1.248194774,1.254797224,0.994738234,0.319863594,0.466165954,1.414207467,0,1.586035795,1.225235536,1.294474205,0.195501674,0.316553011,N,-,,Major facilitator superfamily transporter,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00708,66,109,152,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,25.33960639,1,3.897163548,0.937944188,4.155005808,3.25E-05,0.000319714,0.41163882,0,4.745868715,1.649431918,2.877274693,0.004011262,0.018157671,1.078207717,0,2.08001529,1.287662439,1.615342054,0.106236641,0.203008636,1.244604902,0,1.656930277,1.340034195,1.236483579,0.216278866,0.350989504,1.073080717,0,1.984832529,1.280060219,1.550577465,0.121002976,0.220788454,N,-, Effector probability:0.641,hypothetical protein TGAM01_08376,C:membrane; C:integral component of membrane,PTHR35896 (PANTHER); PTHR35896:SF3 (PANTHER),,
RL4_JR_00709,311,209,298,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.256233677,0,0.194191371,1.236896254,0.156998916,0.875245703,0.939754467,1.043272085,0,3.404385904,1.411735177,2.411490455,0.015887468,0.04826319,2.702517024,0,0.754450816,1.220816103,0.617988913,0.536582647,0.665404547,3.11718204,0,0.332360955,1.226535345,0.270975441,0.786409921,0.861704567,2.662870414,0,0.673038037,1.217471726,0.552816154,0.580389306,0.692975759,N,-,,hypothetical protein VE03_09865,C:membrane; C:integral component of membrane,IPR021765 (PFAM); PTHR33365:SF3 (PANTHER); PTHR33365 (PANTHER),,
RL4_JR_00710,336,283,323,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,27.79468625,1,2.305208897,0.843123039,2.734131071,0.006254514,0.026072727,1.20500591,0,3.196498326,1.372802563,2.32844723,0.019888368,0.057239142,3.120547916,0,0.547132313,1.204749504,0.45414612,0.64972366,0.756678055,3.599452474,0,0.124975705,1.205308254,0.103687754,0.917417145,0.950144337,3.071399765,0,0.467208472,1.200044051,0.389326101,0.69703493,0.785728517,N,-,,Ankyrin repeat domain,,IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR002110 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24198 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),8.A.28.1.2, the ankyrin (ankyrin) family.
RL4_JR_00711,734,931,990,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.6514633,0,-1.515212766,1.203565719,-1.25893646,0.208053283,0.37434907,3.383481298,0,1.706990207,1.269160291,1.344976059,0.178632966,0.316222283,8.798716941,0,-0.948309682,1.201444441,-0.789307978,0.429932025,0.57038813,10.15221785,0,-1.370899564,1.200374653,-1.14205974,0.253429189,0.393131689,8.689990945,0,-1.033050447,1.206833178,-0.856001032,0.391997208,0.528442368,N,-,,Di-copper centre-containing,F:metal ion binding; F:oxidoreductase activity; P:metabolic process; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity,IPR002227 (PFAM); IPR008922 (G3DSA:1.10.1280.GENE3D); PTHR11474 (PANTHER); PTHR11474:SF37 (PANTHER); IPR008922 (SUPERFAMILY),,
RL4_JR_00712,123,78,106,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.222089876,0,1.608138828,1.410177003,1.140380835,0.254127674,NA,0.392526505,0,4.814668728,1.629437166,2.95480478,0.00312867,0.015941545,1.015146408,0,2.16702998,1.249429175,1.734416023,0.082844294,0.167241403,1.170784802,0,1.745147519,1.288427312,1.354478831,0.175583663,0.299391139,0.998579334,0,2.087762193,1.229085518,1.698630537,0.089388819,0.175535646,Y,-,,---NA---,,no IPS match,,
RL4_JR_00713,305,269,288,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.448123521,0,0.111833231,1.21040446,0.092393274,0.926385583,0.964699207,1.103988602,0,3.322828392,1.385732905,2.397885178,0.016490033,0.049602413,2.857958582,0,0.674030941,1.205374257,0.559188101,0.576033353,0.698330939,3.296531486,0,0.251884852,1.206625366,0.208751497,0.834642237,0.896217086,2.811362882,0,0.59485856,1.198918032,0.496162827,0.619779536,0.726136056,N,-,,thimet oligopeptidase,F:metal ion binding; P:proteolysis; F:peptidase activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:hydrolase activity,IPR024080 (G3DSA:1.20.1050.GENE3D); IPR024077 (G3DSA:1.10.1370.GENE3D); IPR024079 (G3DSA:3.40.390.GENE3D); IPR001567 (PFAM); PTHR11804 (PANTHER); PTHR11804:SF40 (PANTHER); SSF55486 (SUPERFAMILY),,
RL4_JR_00714,133,135,195,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.847894913,0,1.011679824,1.309609073,0.772505204,0.439815266,NA,0.586153883,0,4.236043554,1.512063559,2.801498343,0.00508659,0.020861615,1.527504076,0,1.577375407,1.232813309,1.27949252,0.200723672,0.32627015,1.762604792,0,1.154803468,1.252191773,0.922225726,0.356410847,0.502528871,1.513454443,0,1.488521565,1.229530864,1.210641887,0.226032684,0.353012636,N,-,,fungal specific transcription factor domain-containing,F:binding,IPR001138 (SMART); IPR007219 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31313:SF19 (PANTHER); PTHR31313 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00715,28564,18055,23326,16,5,9,0,0,0,0,0,2,1,13,4,0,1,2,514.0118464,1,-0.33999462,0.601899859,-0.56486908,0.572162816,0.748269358,89.57080106,0,-3.019436839,1.2080746,-2.499379457,0.012441102,0.039725183,244.4479911,1,-3.850364265,1.052384021,-3.658706507,0.000253491,0.002046529,366.9265687,1,-1.245953509,0.454082685,-2.743891254,0.006071565,0.032681868,246.0477638,1,-3.516292461,0.868538483,-4.048516592,5.15E-05,0.000400519,N,-,,importin-beta domain-containing,C:nuclear envelope; C:cytosol; P:intracellular protein transport; F:Ran GTPase binding,IPR001494 (SMART); IPR013713 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR001494 (PFAM); PTHR10997 (PANTHER); PTHR10997:SF18 (PANTHER); IPR001494 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_00716,2866,2840,3729,0,2,6,0,0,0,0,0,0,1,5,2,0,1,5,76.62358545,1,0.367094853,0.556801023,0.659292705,0.509707826,0.69594038,11.98619343,0,-0.117824862,1.209008025,-0.097455814,0.922364422,0.957297304,31.17721154,0,-2.773487838,1.192812455,-2.325166733,0.020063046,0.055743746,84.61265557,1,0.528218506,0.546894211,0.965851339,0.334118575,0.480874281,71.51389942,1,0.380238271,0.637017245,0.596904203,0.550571341,0.67079882,N,-,,ARP2 3 complex 20 kDa subunit,F:actin binding; P:actin filament polymerization; F:structural molecule activity; P:Arp2/3 complex-mediated actin nucleation; P:actin cortical patch assembly; C:actin cortical patch; C:Arp2/3 protein complex,G3DSA:3.30.1460.20 (GENE3D); IPR008384 (PIRSF); IPR008384 (PFAM); PTHR22629:SF0 (PANTHER); IPR008384 (PANTHER); PTHR22629:SF0 (PANTHER); IPR008384 (PANTHER); SSF69645 (SUPERFAMILY),,
RL4_JR_00717,8270,5694,7306,3,16,30,0,0,2,4,0,2,1,6,0,0,3,4,357.6817372,1,1.764835731,0.386839128,4.562195506,5.06E-06,6.35E-05,45.96040103,1,0.335735666,1.00213675,0.335019812,0.737610141,0.837268513,127.6515007,1,-0.524344709,0.630171603,-0.832066546,0.405371384,0.547708513,114.5480636,1,-0.866281399,0.602349555,-1.438170562,0.150385666,0.266617906,110.2744362,1,-0.587490456,0.597202695,-0.983737114,0.325244786,0.461412843,N,-,,ubiquitin carboxyl-terminal hydrolase,F:thiol-dependent ubiquitin-specific protease activity; P:protein deubiquitination; C:proteasome regulatory particle; P:negative regulation of proteasomal protein catabolic process; C:nucleoplasm; P:ubiquitin-dependent protein catabolic process,IPR000626 (SMART); G3DSA:3.10.20.90 (GENE3D); IPR001394 (PFAM); IPR000626 (PFAM); PTHR24006:SF432 (PANTHER); PTHR24006 (PANTHER); PTHR24006 (PANTHER); PTHR24006:SF432 (PANTHER); PTHR24006 (PANTHER); PTHR24006:SF432 (PANTHER); IPR000626 (PROSITE_PROFILES); IPR028889 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY); IPR029071 (SUPERFAMILY),,
RL4_JR_00718,23,15,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.21545081,0,4.1121455,2.882439828,1.42661972,0.153689537,NA,0.069494481,0,7.312669405,2.265781112,3.227438594,0.001249038,0.015023052,0.179136738,0,4.670002882,1.375341726,3.39552185,0.000684979,0.004254434,0.206563588,0,4.248160358,1.795683586,2.365762204,0.017992997,0.073252552,0.175537369,0,4.594611226,1.263714627,3.635798088,0.000277121,0.00164181,,,,,,,,
RL4_JR_00719,4,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.032210436,0,6.854185942,3.939765511,1.739744643,0.081903867,NA,0.010529524,0,10.03691075,3.358540727,2.988473734,0.002803746,0.015349618,0.026851541,0,7.411129599,1.969847227,3.762286484,0.000168367,0.001588581,0.030944551,0,6.987498434,3.770565646,1.853169813,0.063858023,0.142111804,0.025969352,0,7.348903313,1.426327007,5.152327117,2.57E-07,4.73E-06,N,-,,hypothetical protein SPI_03476,,no IPS match,,
RL4_JR_00720,43,36,37,0,0,3,0,0,0,0,0,1,0,0,0,0,0,0,11.91965817,1,5.301485725,0.873781535,6.067289719,1.30E-09,3.46E-08,0.148859154,0,6.213588674,1.93379401,3.213159542,0.001312833,0.015023052,6.883586041,1,4.52895836,1.209090933,3.74575496,0.000179852,0.001649296,0.443873759,0,3.144641774,1.4367005,2.188794237,0.028611799,0.089799895,0.378071601,0,3.489015552,1.229972606,2.836661187,0.004558796,0.016585631,N,-, Effector probability:0.778,hypothetical protein F503_03634,,no IPS match,,
RL4_JR_00721,2178,1640,2147,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,63.83452847,1,0.406501755,0.675538335,0.601744911,0.54734395,0.727566273,7.612633182,0,0.53711767,1.230648083,0.436451068,0.662509494,0.783763818,19.72547993,0,-2.113061231,1.194958179,-1.768313962,0.077008431,0.158269053,22.75294468,0,-2.53522993,1.193629719,-2.12396683,0.033672917,0.098281432,19.43512315,0,-2.194416807,1.197768443,-1.83208768,0.066938359,0.140089062,N,-,,MFS general substrate transporter,P:transmembrane transport; C:integral component of membrane; F:binding,G3DSA:1.20.1250.20 (GENE3D); IPR001138 (PFAM); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR23502:SF17 (PANTHER); PTHR23502 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR020846 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.2.31, the major facilitator superfamily (mfs).
RL4_JR_00722,26,17,38,0,0,5,0,0,0,0,0,5,0,2,1,0,3,4,19.41377037,1,6.503464297,0.778998261,8.348496553,6.91E-17,5.94E-15,0.101861722,0,6.760458029,2.11509985,3.196283159,0.001392104,0.015023052,32.75947232,1,7.212242164,0.740010959,9.746128863,1.92E-22,3.40E-20,17.96517893,1,5.979001616,0.906079878,6.598757748,4.15E-11,1.67E-09,41.30765219,1,7.448304415,0.660572434,11.27553018,1.73E-29,8.77E-27,N,-,,GPR1 FUN34 -class plasma membrane,C:integral component of membrane,IPR000791 (PFAM); PTHR31123 (PANTHER); IPR030186 (PTHR31123:PANTHER),2.A.96.2.1, the acetate uptake transporter (acetr) family.
RL4_JR_00723,151,152,211,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.052286531,0,0.860337166,1.284327355,0.669873738,0.502938283,NA,0.651650837,0,4.083245543,1.484947354,2.749757783,0.005963933,0.023186611,1.696891837,0,1.425710434,1.226182362,1.162723,0.244941907,0.379057148,1.957978291,0,1.003174889,1.240923498,0.808409938,0.418854633,0.562024147,1.679847071,0,1.338021736,1.223612147,1.093501515,0.274173664,0.406961345,N,-,,het domain-containing,,IPR010730 (PFAM); PTHR10622:SF10 (PANTHER); PTHR10622 (PANTHER),,
RL4_JR_00724,153,279,254,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,2.764841873,0,0.430662809,1.309518301,0.328871165,0.74225307,0.864302105,0.874701356,0,3.65863609,1.468721889,2.491033951,0.012737195,0.04050452,24.41834813,1,2.84570593,1.062239213,2.678969006,0.007384923,0.025630771,2.629278037,0,0.578251183,1.265547851,0.456917676,0.647730219,0.758592494,2.251823067,0,0.915401632,1.248591057,0.733147676,0.463468365,0.594528974,N,-,,Dimeric alpha-beta barrel,,G3DSA:3.30.70.900 (GENE3D); IPR009799 (PFAM); IPR011008 (SUPERFAMILY),,
RL4_JR_00725,2246,2234,2538,0,0,4,2,0,0,1,0,0,0,0,0,0,0,2,43.35667552,1,-0.195247255,0.736170871,-0.265220022,0.790839972,0.892347509,53.57963758,1,1.964607945,0.97314672,2.018819881,0.043505944,0.105679665,34.31272154,1,-1.3879573,1.186511383,-1.169780012,0.242089509,0.375446414,26.81388319,0,-2.772123636,1.185390668,-2.338573866,0.019357499,0.075643466,37.65174108,1,-0.74830476,0.96797568,-0.773061529,0.439485967,0.573437693,N,-,,Mediator subunit Med1,C:mediator complex; F:RNA polymerase II transcription cofactor activity; P:regulation of transcription from RNA polymerase II promoter,IPR019680 (PFAM); PTHR35041 (PANTHER); PTHR35041:SF2 (PANTHER); PTHR35041:SF2 (PANTHER); PTHR35041:SF2 (PANTHER); PTHR35041 (PANTHER); PTHR35041 (PANTHER),,
RL4_JR_00726,1733,1360,1097,0,0,5,0,0,0,1,0,2,0,1,0,0,5,0,35.87851147,1,0.824500317,0.723369141,1.139805764,0.254367232,0.43222826,5.417448844,0,1.027970152,1.277018943,0.804976432,0.42083328,0.584317485,38.01398812,1,0.794072143,0.876924935,0.905518946,0.365190527,0.509114418,20.09286871,1,-1.088707589,1.165538296,-0.934081354,0.350261929,0.496903746,32.93922315,1,1.219919985,0.715261174,1.705558792,0.088090257,0.173591642,N,-,,mitosis inhibitor kinase SWE1,C:intracellular organelle; P:peptidyl-tyrosine phosphorylation; P:regulation of protein kinase activity; P:negative regulation of organelle organization; P:regulation of meiotic nuclear division; P:mitotic DNA damage checkpoint; P:protein autophosphorylation; F:protein kinase activity; P:signal transduction involved in mitotic cell cycle checkpoint; P:peptidyl-serine phosphorylation; P:negative regulation of G2/M transition of mitotic cell cycle,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR11042 (PANTHER); PTHR11042:SF95 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_00727,2055,2151,2010,0,0,1,0,0,0,0,0,2,3,1,0,0,5,0,28.75475525,1,-1.794647475,1.140358239,-1.573757627,0.115543494,0.245918033,7.973206398,0,0.470395475,1.224276166,0.384223338,0.700812922,0.810791081,33.64291895,1,-0.358206113,1.030506462,-0.347602005,0.7281391,0.816444816,55.76319188,1,0.138893523,0.737785078,0.188257431,0.850674854,0.906544879,39.60434878,1,0.676340716,0.669106026,1.010812473,0.312106192,0.447475955,N,-,,Spc97 Spc98 family,C:nucleus; C:equatorial microtubule organizing center; P:microtubule nucleation; P:establishment or maintenance of cell polarity regulating cell shape; C:cytosol; F:gamma-tubulin binding; C:gamma-tubulin complex; P:cytoplasmic microtubule organization; C:mitotic spindle pole body; C:microtubule; P:mitotic spindle assembly,IPR007259 (PFAM); PTHR19302:SF14 (PANTHER); IPR007259 (PANTHER); IPR007259 (PANTHER); PTHR19302:SF14 (PANTHER),,
RL4_JR_00728,478,343,716,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.097949544,0,-0.710852491,1.250952483,-0.568248995,0.569865907,0.745983002,1.933801438,0,2.513950308,1.356751279,1.852919063,0.06389396,0.142956381,5.047064792,0,-0.146719843,1.236216427,-0.118684593,0.905525243,0.941902555,5.82400537,0,-0.569428914,1.240823705,-0.458912021,0.646297346,0.757555062,5.014382474,0,-0.239871489,1.247282034,-0.192315357,0.84749519,0.898240218,N,-,,transcriptional co-activator,C:SLIK (SAGA-like) complex; F:transcription coactivator activity; C:Ada2/Gcn5/Ada3 transcription activator complex; P:transcription from RNA polymerase II promoter; P:histone acetylation; P:regulation of nucleic acid-templated transcription; C:SAGA complex,IPR024738 (PFAM); PTHR21277:SF5 (PANTHER); PTHR21277 (PANTHER),,
RL4_JR_00729,754,633,501,0,5,2,0,0,0,0,0,1,0,1,0,0,0,0,55.25781425,1,2.543546079,0.617665905,4.117996573,3.82E-05,0.000369411,2.440049283,0,2.178701038,1.32705894,1.641751525,0.100641509,0.203494477,12.78438532,1,0.498894755,1.209774607,0.412386532,0.680056133,0.779980547,11.25973572,1,0.061119521,1.165206621,0.052453805,0.958167103,0.976274862,6.148954458,0,-0.534212038,1.210015705,-0.441491821,0.658856981,0.75668409,N,-,,mediator of replication checkpoint 1,P:single-organism cellular process,IPR018564 (PFAM); IPR024146 (PANTHER); PTHR14396:SF10 (PANTHER),,
RL4_JR_00730,1101,984,1158,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,12.96129806,0,-1.798588858,1.184974608,-1.517829029,0.129057505,0.265920943,4.140746892,0,1.415626933,1.249001811,1.13340663,0.257043531,0.412394139,10.73688916,0,-1.235584786,1.190638516,-1.037749719,0.299386591,0.440354883,12.38569654,0,-1.657871682,1.187905171,-1.395626286,0.162827062,0.283025581,22.16292302,1,0.888252722,0.842620328,1.054155345,0.291811801,0.426594641,N,-,,hypothetical protein FIBSPDRAFT_966862,,G3DSA:2.40.10.10 (GENE3D); IPR009003 (SUPERFAMILY),,
RL4_JR_00731,803,553,809,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.617691936,0,-1.20986759,1.204522081,-1.004437867,0.315167605,0.503256474,2.757814548,0,2.001968739,1.295780102,1.54499111,0.122348414,0.237106122,7.149501031,0,-0.649005115,1.207194059,-0.53761457,0.590843169,0.710415231,8.246900553,0,-1.071190748,1.206424848,-0.887905077,0.374591814,0.52019505,7.050338509,0,-0.731558043,1.210470192,-0.604358577,0.545605269,0.666697242,N,-,,methionyl-tRNA formyltransferase,,no IPS match,,
RL4_JR_00732,1096,991,1320,4,0,3,0,0,0,0,0,9,1,0,3,0,0,0,65.31709937,1,1.679664409,0.577468574,2.908668083,0.00362972,0.016738986,4.332552061,0,1.350260313,1.247954814,1.081978528,0.279262069,0.438382547,69.7467867,1,2.461653181,1.385290728,1.776993905,0.075569243,0.155944356,51.20673761,1,1.027752197,0.741203241,1.386599707,0.165563858,0.286259231,11.12193884,0,-1.389116848,1.200943421,-1.156688003,0.247399853,0.37764556,N,-,,methionyl-trna formyltransferase,P:metabolic process,IPR002376 (PFAM); IPR002376 (G3DSA:3.40.50.GENE3D); PTHR11138 (PANTHER); PTHR11138:SF0 (PANTHER); IPR002376 (SUPERFAMILY),,
RL4_JR_00733,200678,90980,109358,8,34,6,0,0,5,1,8,45,2,2,13,0,33,7,1969.285053,1,-2.104683891,0.849965909,-2.476198007,0.013278991,0.04753401,564.4736463,1,-2.76299048,0.863690009,-3.199053424,0.001378796,0.015023052,1695.589646,1,-1.827779948,0.863580049,-2.116514793,0.034301048,0.08511368,1684.335577,1,-3.418396326,0.880350126,-3.882996348,0.000103177,0.00109504,1477.775646,1,-2.710165641,0.827776077,-3.274032333,0.001060245,0.005005567,N,-,,stf2,,no IPS match,,
RL4_JR_00734,10189,7744,10255,0,2,7,0,0,0,0,0,1,2,2,0,0,9,0,155.1377167,1,-1.043343532,0.528471583,-1.974266102,0.048351493,0.129668469,35.95560045,0,-1.702631657,1.200035497,-1.418817745,0.155952158,0.284987857,99.69467827,1,-3.391427618,1.193320733,-2.842008461,0.00448303,0.017459535,134.149477,1,-2.042772988,0.748307268,-2.729858543,0.006336151,0.033747252,126.5994636,1,-0.720418805,0.576166993,-1.250364589,0.211166394,0.334856655,Y,-,,pheromone processing carboxypeptidase kex1,C:trans-Golgi network; P:apoptotic process; C:integral component of membrane; F:serine-type carboxypeptidase activity; P:proteolysis involved in cellular protein catabolic process,IPR001563 (PRINTS); IPR029058 (G3DSA:3.40.50.GENE3D); IPR001563 (PFAM); IPR001563 (PANTHER); PTHR11802:SF50 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_00735,4486,4047,6331,0,0,1,0,0,0,1,0,0,0,0,0,0,0,2,63.04638393,1,-3.044144115,1.160289112,-2.623608274,0.008700379,0.033862717,18.80448676,0,-0.767535631,1.209986353,-0.634334122,0.525862792,0.674538485,60.06230136,1,-2.46374224,1.201449138,-2.050642148,0.040301809,0.096184703,56.5308385,0,-3.848184186,1.202961673,-3.198925013,0.00137941,0.00970572,63.27710969,1,-1.817716805,0.991644987,-1.833031809,0.066797841,0.139852799,N,-,,DUF431 domain-containing,F:carboxypeptidase activity; F:protein-arginine omega-N monomethyltransferase activity; P:proteolysis; P:peptidyl-arginine omega-N-methylation,IPR007364 (PFAM); PTHR35517 (PANTHER); PTHR35517:SF1 (PANTHER),,
RL4_JR_00736,8429,8991,12220,0,0,3,0,0,0,0,0,2,0,1,0,0,10,0,129.8745628,1,-2.70482261,0.88359026,-3.061172959,0.002204717,0.01131166,37.56985779,0,-1.766016228,1.198310007,-1.473755721,0.140547374,0.26265658,110.8684546,1,-2.606094641,1.041747166,-2.501657528,0.012361344,0.038119477,116.9448886,1,-3.899978369,1.152783684,-3.383096433,0.000716735,0.00558226,135.5204799,1,-0.714817585,0.631419584,-1.132080163,0.257600734,0.389168521,N,-,,dihydroorotate oxidase,"F:oxidoreductase activity, acting on the CH-CH group of donors; P:single-organism metabolic process",IPR013785 (G3DSA:3.20.20.GENE3D); IPR005720 (PFAM); SSF51395 (SUPERFAMILY),,
RL4_JR_00737,2767,2105,3104,0,1,5,0,0,0,0,0,1,0,6,0,0,2,0,58.87012748,1,0.196340404,0.634873642,0.309259026,0.757124497,0.872432934,10.13948219,0,0.123575009,1.222465625,0.101086694,0.919481641,0.955641561,32.82651531,1,-1.567802724,1.19679402,-1.310002138,0.190195112,0.313146092,54.44172601,1,0.321711389,0.64364066,0.499830743,0.617194262,0.735706605,33.72235244,1,-0.95029022,0.989038322,-0.960822447,0.33664145,0.473665187,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:membrane; P:basic amino acid transport; F:transporter activity,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF6 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.48.1, the major facilitator superfamily (mfs).
RL4_JR_00738,2833,2885,3032,0,0,7,0,0,6,0,3,1,0,1,0,0,2,0,61.77918638,1,0.283555048,0.567142132,0.499971757,0.617094964,0.779780161,67.46019167,1,3.156085775,0.618834046,5.100051936,3.40E-07,3.44E-05,59.03972107,1,0.153124671,0.735256551,0.208260193,0.835025812,0.893825473,37.47979459,1,-2.144300277,1.137249918,-1.88551368,0.059360519,0.136101734,36.29934643,1,-1.079230922,0.967886476,-1.115038745,0.264833819,0.39701546,N,-,,l-fucose permease,C:membrane,G3DSA:1.20.1250.20 (GENE3D); PTHR23514 (PANTHER); PTHR23514 (PANTHER); PTHR23514:SF5 (PANTHER); PTHR23514:SF5 (PANTHER); PTHR23514 (PANTHER); PTHR23514:SF5 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.7.25, the major facilitator superfamily (mfs).
RL4_JR_00739,1735,1395,1136,0,0,1,0,0,0,0,0,0,2,1,0,0,0,0,20.91167044,1,-1.251262684,1.160933008,-1.077807828,0.281119525,0.46433956,5.512546105,0,1.002864377,1.272124876,0.788337997,0.430499028,0.592697383,14.19772061,0,-1.638531777,1.210377167,-1.353736522,0.175820452,0.295142805,39.00753733,1,0.268875262,0.874985462,0.307291119,0.758621795,0.842312279,13.8880983,0,-1.709614667,1.206567491,-1.416924191,0.156505093,0.266779609,N,-,,fungal specific transcription factor domain-containing,F:binding,IPR007219 (SMART); IPR007219 (PFAM); PTHR31944 (PANTHER); PTHR31944:SF32 (PANTHER); PTHR31944:SF32 (PANTHER); PTHR31944:SF32 (PANTHER); PTHR31944 (PANTHER),,
RL4_JR_00740,863,791,573,0,0,1,0,0,0,0,0,0,0,0,4,0,0,0,12.76294911,1,-0.317184681,1.166969431,-0.271802048,0.785774231,0.889847237,2.881393821,0,1.938844694,1.316052174,1.473227834,0.140689612,0.26279023,7.422524781,0,-0.702769942,1.216592464,-0.57765436,0.563497498,0.688492478,47.10041202,1,2.004347197,1.375997581,1.456650233,0.145212954,0.259766989,7.258529929,0,-0.773507939,1.211193957,-0.638632594,0.523061972,0.647424055,N,-,,pentafunctional arom polypeptide,F:3-dehydroquinate dehydratase activity,IPR013785 (G3DSA:3.20.20.GENE3D); IPR001381 (TIGRFAM); IPR001381 (PFAM); PTHR21090 (PANTHER); PTHR21090 (PANTHER); PTHR21090:SF4 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_00741,302,419,471,0,0,10,4,0,0,2,0,2,7,12,7,0,6,7,42.96731033,1,3.502942204,0.673318384,5.202504915,1.97E-07,3.64E-06,90.76218163,1,5.526604461,0.759960423,7.272226673,3.54E-13,9.94E-11,39.08364542,1,3.036829812,0.762083205,3.984905835,6.75E-05,0.00090065,185.3257114,1,5.245433908,0.378367747,13.863322,1.06E-43,3.57E-41,78.62661812,1,4.449187848,0.50494993,8.811146574,1.24E-18,2.51E-16,N,-,,aryl-alcohol dehydrogenase Aad14,F:oxidoreductase activity; P:oxidation-reduction process,IPR023210 (PFAM); IPR023210 (G3DSA:3.20.20.GENE3D); PTHR11732:SF259 (PANTHER); IPR001395 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.6, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_00742,1136,1560,1855,0,1,5,0,0,0,0,0,1,1,0,0,0,0,0,45.34491537,1,0.977471282,0.672247914,1.45403394,0.145936897,0.291516455,5.772963188,0,0.936157338,1.251145137,0.7482404,0.454315167,0.613962366,21.55130994,1,-0.761195724,1.20693447,-0.630685213,0.528246369,0.657644644,26.68312273,1,-1.194149423,1.161014624,-1.028539519,0.303696111,0.449221786,14.90931406,0,-1.811880075,1.218803214,-1.486605921,0.137118923,0.242418211,N,-,,amidohydrolase,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; C:integral component of membrane",G3DSA:3.20.20.140 (GENE3D); IPR011059 (G3DSA:2.30.40.GENE3D); IPR013108 (PFAM); PTHR22642:SF2 (PANTHER); PTHR22642 (PANTHER); IPR011059 (SUPERFAMILY); IPR032466 (SUPERFAMILY),,
RL4_JR_00743,73,103,102,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,1.117154951,0,1.73796044,1.456322453,1.193389855,0.232716726,NA,0.354582255,0,4.961302681,1.646668636,3.012933247,0.002587358,0.015349618,7.4209653,1,3.267842541,1.209945482,2.700818004,0.006916918,0.024323333,1.064130548,0,1.883227384,1.295298731,1.453894256,0.145975625,0.260716742,4.77120435,1,3.150378359,1.149788004,2.73996454,0.006144581,0.021190016,Y,-,,hypothetical protein HMPREF1624_06866,,no IPS match,,
RL4_JR_00744,2069,2114,2721,0,1,9,0,0,1,0,0,0,1,4,2,0,1,0,69.97000328,1,1.105087715,0.526823853,2.097641759,0.035936803,0.104072574,18.15083452,1,1.2493775,1.117760068,1.11775106,0.263673329,0.420431858,22.81930331,0,-2.323261257,1.193499862,-1.946595329,0.051583269,0.115973577,70.95808671,1,0.790539981,0.578809201,1.365804103,0.172000458,0.294720704,26.42252133,1,-1.479985016,1.130583075,-1.309045792,0.19051884,0.31057812,N,-,,spx domain-containing,C:membrane,PTHR10783 (PANTHER); PTHR10783:SF51 (PANTHER); IPR004331 (PROSITE_PROFILES),4.E.1.1.3, the vacuolar (acidocalcisome) polyphosphate polymerase (v-ppp) family.
RL4_JR_00745,19681,23480,30113,3,0,3,0,0,1,0,0,0,0,12,0,0,7,3,334.8142311,1,-2.971335965,0.662765279,-4.483240234,7.35E-06,8.89E-05,102.2781112,1,-2.154920766,1.113787765,-1.934767856,0.053018789,0.123454379,242.1177778,0,-5.730580238,1.203047262,-4.763387455,1.90E-06,4.69E-05,327.5315462,1,-2.059745408,0.655703324,-3.141276446,0.001682132,0.011500057,288.9142733,1,-1.917609631,0.567346265,-3.379963438,0.000724955,0.003695955,N,-,,u3 small nucleolar ribonucleo mpp10,C:intracellular ribonucleoprotein complex; P:ribosome biogenesis; C:nucleolus,IPR012173 (PFAM); PTHR17039:SF0 (PANTHER); IPR012173 (PANTHER); PTHR17039:SF0 (PANTHER); IPR012173 (PANTHER); IPR012173 (PANTHER); PTHR17039:SF0 (PANTHER),,
RL4_JR_00746,45958,35618,41340,9,11,23,0,0,1,1,11,5,0,10,9,0,5,6,757.2983684,1,-0.885575313,0.281925964,-3.141162661,0.001682785,0.009031687,166.7423764,1,-2.915575482,1.117821054,-2.608266746,0.009100201,0.031419274,536.9872441,1,-1.579984414,0.438286762,-3.604910185,0.000312261,0.002398581,596.4374343,1,-1.916062356,0.433054779,-4.42452652,9.67E-06,0.000137254,463.9340321,1,-2.469658687,0.510393375,-4.838735779,1.31E-06,1.80E-05,N,-,,delta-aminolevulinic acid dehydratase,F:porphobilinogen synthase activity; F:zinc ion binding; P:mycelium development; P:heme biosynthetic process; C:cytosol,IPR001731 (PRINTS); IPR001731 (SMART); IPR001731 (PIRSF); IPR013785 (G3DSA:3.20.20.GENE3D); IPR001731 (PFAM); IPR001731 (PANTHER); PTHR11458:SF2 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_00747,1060,1287,1443,0,0,4,0,0,0,0,0,1,4,6,0,0,0,0,30.46452088,1,0.674104894,0.763687164,0.882697688,0.377399632,0.568993937,4.824704099,0,1.195049465,1.245742109,0.959307272,0.337403973,0.500396046,19.04901115,1,-0.498896399,1.196317267,-0.417026831,0.676658783,0.777846431,75.79957539,1,2.161755577,0.506105432,4.271354227,1.94E-05,0.000254487,12.40131759,0,-1.546146456,1.204714899,-1.283412745,0.199347511,0.321144558,N,-,,tyrosine phosphatase,F:phosphatase activity; P:dephosphorylation,IPR029021 (G3DSA:3.90.190.GENE3D); IPR026893 (PFAM); PTHR31126:SF17 (PANTHER); PTHR31126 (PANTHER); IPR029021 (SUPERFAMILY),,
RL4_JR_00748,5470,6498,9244,0,0,5,0,0,0,0,0,1,0,1,0,0,2,0,103.8477795,1,-1.530323987,0.751677367,-2.035878761,0.041762531,0.116398609,26.80343234,0,-1.278866596,1.210552126,-1.056432489,0.290770669,0.449821292,76.46887986,1,-2.977904533,1.207331855,-2.46651699,0.013643426,0.04121935,84.76089431,1,-3.416793974,1.164452439,-2.93424949,0.003343553,0.020283689,77.15261319,1,-2.374693201,1.010765896,-2.349399806,0.018803704,0.052132394,N,-,,u3 small nucleolar ribonucleo imp3,C:small-subunit processome; F:snoRNA binding; P:ribosomal small subunit biogenesis; C:Mpp10 complex; C:viral nucleocapsid; P:rRNA processing; C:ribosome; F:rRNA binding,IPR001912 (SMART); IPR002942 (SMART); IPR001912 (PFAM); IPR002942 (G3DSA:3.10.290.GENE3D); IPR002942 (PFAM); IPR022801 (PANTHER); PTHR11831:SF1 (PANTHER); IPR002942 (PROSITE_PROFILES); SSF55174 (SUPERFAMILY),,
RL4_JR_00749,2746,2903,4398,0,0,2,0,0,0,0,0,0,0,4,2,0,2,0,47.72298441,1,-1.712399313,1.042923236,-1.641922678,0.100606029,0.222604824,12.69127663,0,-0.200308404,1.221709461,-0.16395748,0.869764617,0.924869293,33.11677436,0,-2.860554093,1.205627089,-2.372669061,0.017660079,0.050821672,73.53379033,1,0.017872339,0.653509676,0.027348239,0.978181982,0.986659949,40.57900742,1,-1.294168879,1.007343796,-1.284734054,0.198885234,0.320603883,N,-, Effector probability:0.779,transcription initiation factor IIA,F:translation initiation factor activity; P:RNA polymerase II transcriptional preinitiation complex assembly; C:cytosol; C:transcription factor TFIIA complex; P:translational initiation; P:regulation of transcription from RNA polymerase II promoter,IPR015871 (PFAM); IPR015872 (G3DSA:1.10.287.GENE3D); IPR015872 (PFAM); IPR009088 (G3DSA:2.30.18.GENE3D); IPR003194 (PIRSF); IPR003194 (PANTHER); PTHR10966:SF0 (PANTHER); IPR015872 (PRODOM); IPR009088 (SUPERFAMILY); IPR009083 (SUPERFAMILY),,
RL4_JR_00750,2232,2564,5257,0,1,0,0,0,0,0,0,1,0,1,0,0,4,0,47.98546238,1,-2.465379601,1.214358836,-2.030190358,0.042337194,0.117558484,12.55325282,0,-0.184537028,1.265241209,-0.145851263,0.884038806,0.934346956,39.45750373,1,-1.891853665,1.239047729,-1.526861008,0.126795577,0.231460228,42.05933005,1,-2.33357085,1.202371444,-1.940806945,0.052281698,0.125826526,48.36773271,1,-0.422367203,0.886764638,-0.47630136,0.633859697,0.737088484,N,-,,pentatricopeptide repeat,P:RNA processing,IPR002885 (TIGRFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24015 (PANTHER),,
RL4_JR_00751,2087,2433,4014,1,1,3,0,0,0,0,0,1,1,2,0,0,3,0,63.56236609,1,-0.150434728,0.740868346,-0.203051904,0.839094463,0.919330195,10.73310324,0,0.041453629,1.243026185,0.033348959,0.973396312,0.986356739,34.58007777,1,-1.660811727,1.218241427,-1.363286201,0.172792329,0.291632519,49.74662115,1,-0.741603517,0.901124446,-0.822975695,0.410521815,0.554352278,39.52062961,1,-0.547770628,0.914103767,-0.599243377,0.549010601,0.669242997,N,-, Effector probability:0.708,Sm-like ribonucleo,"F:U6 snRNA binding; C:U4/U6 x U5 tri-snRNP complex; P:cytoplasmic mRNA processing body assembly; C:cytoplasmic mRNA processing body; C:cytosol; C:viral nucleocapsid; C:nucleolus; C:U6 snRNP; C:small nucleolar ribonucleoprotein complex; P:mRNA splicing, via spliceosome",IPR001163 (SMART); G3DSA:2.30.30.100 (GENE3D); IPR001163 (PFAM); IPR027141 (PANTHER); IPR010920 (SUPERFAMILY),,
RL4_JR_00752,8830,10517,9242,0,2,27,1,0,2,0,0,1,5,17,2,0,0,5,234.0149046,1,0.202880727,0.870130031,0.233161389,0.815636087,0.906040195,77.74311247,1,0.464776619,0.852369535,0.545275963,0.585563733,0.723873486,101.5288266,1,-3.419513156,1.193144059,-2.865968388,0.004157358,0.016775244,243.6547287,1,0.467879247,0.369716468,1.265508269,0.205689186,0.337646402,130.3089217,1,-1.477552154,0.683275462,-2.162454583,0.030583154,0.076269566,N,-,,bin amphiphysin rvs domain for vesicular trafficking,C:cytoplasm; P:RNA processing,IPR004148 (SMART); IPR027267 (G3DSA:1.20.1270.GENE3D); IPR018859 (PFAM); PTHR10663 (PANTHER); PTHR10663:SF191 (PANTHER); SSF103657 (SUPERFAMILY),8.A.34.1.4, the endophilin (endophilin) family.
RL4_JR_00753,1677,1558,2237,1,4,6,0,0,0,0,0,0,4,0,0,0,3,1,86.84607422,1,1.632723871,0.493984931,3.305209873,0.000949053,0.005705508,6.938709412,0,0.670792297,1.230497702,0.545139008,0.585657916,0.723901505,18.05912515,0,-1.985768042,1.198055023,-1.65749319,0.097419805,0.190327692,58.08589808,1,0.358640585,0.753554561,0.475931809,0.63412296,0.749007813,36.81890651,1,0.537770711,0.770863481,0.697621205,0.485414117,0.613815153,N,-,,acetylglutamate synthase,"F:transferase activity, transferring acyl groups; C:mitochondrion; P:cellular amino acid biosynthetic process",IPR006855 (PFAM); IPR011190 (PIRSF); PTHR23342 (PANTHER); PTHR23342 (PANTHER); PTHR23342 (PANTHER); PTHR23342:SF4 (PANTHER); PTHR23342:SF4 (PANTHER); IPR006855 (PROSITE_PROFILES),,
RL4_JR_00754,2862,3426,3118,1,0,1,0,0,0,0,0,2,2,0,0,0,0,0,51.67155891,1,-1.606492399,1.015514786,-1.581948802,0.113661259,0.242989662,12.05289738,0,-0.125765506,1.214237649,-0.103575693,0.917506078,0.954372266,44.24663009,1,-0.957229252,1.03457412,-0.925239896,0.354841135,0.498392293,54.67442234,1,-1.454588632,1.015823981,-1.431929801,0.152163912,0.269063851,30.75986699,0,-2.856729397,1.193594005,-2.393384506,0.016693736,0.047319171,N,-,,hypothetical protein PDE_03727,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_00755,555,572,563,3,0,2,0,0,0,0,0,0,0,0,0,0,0,0,44.60817805,1,2.193362069,0.660181623,3.322361593,0.000892589,0.005446331,2.164910043,0,2.351246519,1.300309451,1.808220742,0.070572152,0.154784685,5.608876795,0,-0.298618089,1.196067992,-0.249666483,0.80284528,0.870422534,6.470093199,0,-0.720846864,1.193450926,-0.604002098,0.545842247,0.675877798,5.519433925,0,-0.378241435,1.19399946,-0.316785264,0.751406546,0.827057386,N,-,,hypothetical protein CMQ_3851,,IPR014942 (PFAM); SSF81301 (SUPERFAMILY),,
RL4_JR_00756,291,374,316,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,3.946802123,0,-0.082737117,1.227819352,-0.067385416,0.946274879,0.973563316,1.258680291,0,3.133659288,1.377136693,2.275488921,0.022876617,0.063966053,3.262628301,0,0.483190727,1.213888654,0.398051934,0.690591904,0.788234779,27.04602771,1,2.386222615,0.860643077,2.772604205,0.005560971,0.030484479,3.209867594,0,0.403899575,1.209788781,0.333859581,0.738485521,0.817087302,N,-,,6-phosphogluconate dehydrogenase,F:oxidoreductase activity,IPR016040 (G3DSA:3.40.50.GENE3D); IPR013328 (G3DSA:1.10.1040.GENE3D); IPR006115 (PFAM); IPR015815 (PIRSF); IPR029154 (PFAM); PTHR22981 (PANTHER); PTHR22981:SF75 (PANTHER); IPR008927 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_00757,4990,5690,5665,0,0,9,0,0,0,0,0,0,2,2,6,0,0,1,99.93816073,1,-0.312016514,0.560280682,-0.556893222,0.577600386,0.752605646,20.90186164,0,-0.920030207,1.19905443,-0.767296449,0.442905279,0.604026844,54.23098801,0,-3.572044496,1.189452545,-3.003099629,0.002672449,0.012468146,147.0235956,1,0.096661688,0.492870193,0.196119971,0.844516265,0.902753677,60.80247742,1,-2.71949463,1.1203163,-2.427434671,0.015206025,0.043942428,N,-,,cytosolic phospholipase a2 zeta,C:membrane; P:lipid catabolic process; F:phospholipase activity,IPR002642 (SMART); IPR002642 (PFAM); G3DSA:3.40.1090.10 (GENE3D); PTHR10728:SF37 (PANTHER); PTHR10728 (PANTHER); IPR002642 (PROSITE_PROFILES); IPR016035 (SUPERFAMILY),,
RL4_JR_00758,7064,8129,13184,0,0,1,0,0,0,0,5,1,1,3,0,0,0,0,116.995166,1,-3.980119505,1.188045976,-3.350139293,0.000807709,0.005010869,35.71702715,0,-1.69305608,1.21723801,-1.390899779,0.16425582,0.296821637,139.1195075,1,-0.952394429,0.673669266,-1.413741842,0.157437715,0.27171828,129.1523246,1,-2.073210353,0.799211595,-2.594069413,0.009484734,0.04657271,92.88827903,0,-4.451204266,1.230472394,-3.617475927,0.00029749,0.001737074,N,-,,54s ribosomal l3,"P:RNA phosphodiester bond hydrolysis, endonucleolytic; C:nucleus; F:ribonuclease III activity; F:structural constituent of ribosome; P:primary miRNA processing; F:double-stranded RNA binding; P:pre-miRNA processing; P:mitochondrial translation; P:production of siRNA involved in RNA interference; C:mitochondrial large ribosomal subunit",IPR014720 (SMART); IPR000999 (SMART); IPR000999 (G3DSA:1.10.1520.GENE3D); IPR014720 (G3DSA:3.30.160.GENE3D); PTHR11207 (PANTHER); PTHR11207:SF5 (PANTHER); PTHR11207 (PANTHER); IPR000999 (PROSITE_PROFILES); IPR000999 (SUPERFAMILY); SSF54768 (SUPERFAMILY),,
RL4_JR_00759,5335,6911,8471,0,1,5,5,0,0,4,1,1,1,6,1,0,0,1,110.0805496,1,-1.209556899,0.675048436,-1.79180757,0.073163796,0.17635192,137.8337242,1,2.05989598,1.398823898,1.472591356,0.140861257,0.262991976,127.1163644,1,-0.477424807,0.639184839,-0.746927614,0.455107257,0.594056971,122.0591163,1,-0.631548364,0.580536254,-1.08787067,0.276652206,0.419452468,75.20550893,1,-3.059733054,1.14165163,-2.680093448,0.007360161,0.02457027,N,-,,hypothetical protein F503_05715,C:integral component of membrane,PTHR34286 (PANTHER),,
RL4_JR_00760,125,81,164,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.467651322,0,1.343905558,1.405999592,0.955836378,0.339154906,NA,0.466921039,0,4.564102302,1.598969711,2.854401976,0.004311794,0.018715255,1.216113632,0,1.906066785,1.263799481,1.508203488,0.131502455,0.237822589,1.403134351,0,1.48372612,1.301309544,1.140179235,0.254211637,0.393742209,1.205780168,0,1.816119053,1.256014992,1.445937401,0.148194761,0.256886141,N,-, Effector probability:0.565,---NA---,,no IPS match,,
RL4_JR_00761,4794,3967,4480,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,52.91006859,0,-3.827840093,1.184748983,-3.230929209,0.001233885,0.006970937,16.94795347,0,-0.61750557,1.205730607,-0.512142237,0.608551466,0.741710166,50.37022772,1,-2.304437051,1.189062239,-1.938028957,0.05261969,0.117676549,50.60303434,0,-3.688343661,1.18811193,-3.104373896,0.001906822,0.012752029,43.16293025,0,-3.345527969,1.188356925,-2.815255162,0.004873852,0.017536514,N,-,,hypothetical protein CMQ_2713,,G3DSA:1.20.5.170 (GENE3D); PTHR42070 (PANTHER),,
RL4_JR_00762,3431,2953,4500,0,0,7,0,0,0,2,1,0,2,0,3,0,3,1,70.09891149,1,-0.074313836,0.630193709,-0.117922212,0.906129294,0.954325172,13.79217669,0,-0.320308788,1.213481483,-0.26395853,0.791811874,0.873824661,65.87737662,1,-0.557264554,0.860015247,-0.647970551,0.517003998,0.64780021,88.94510956,1,-0.293584308,0.686367641,-0.427736231,0.668843169,0.774411164,54.47558421,1,-0.454776683,0.774472702,-0.58720815,0.557063919,0.676291629,N,-,,serine threonine- phosphatase pp2a catalytic subunit,F:protein serine/threonine phosphatase activity; P:signal transduction involved in meiotic recombination checkpoint; P:negative regulation of glucose mediated signaling pathway; P:protein dephosphorylation; P:double-strand break repair via homologous recombination; C:cytosol; P:negative regulation of DNA damage checkpoint; P:positive regulation of double-strand break repair via nonhomologous end joining; C:protein phosphatase 4 complex,IPR006186 (PRINTS); IPR006186 (SMART); IPR004843 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); PTHR11668:SF278 (PANTHER); PTHR11668 (PANTHER); PTHR11668 (PANTHER); PTHR11668:SF278 (PANTHER); PTHR11668 (PANTHER); PTHR11668:SF278 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_00763,9992,9204,9918,1,3,8,0,0,3,1,0,0,5,5,0,0,6,4,181.1384411,1,-0.660648222,0.435859331,-1.515737248,0.129585805,0.266421623,65.39127503,1,0.433660975,0.846603279,0.512236352,0.608485605,0.741710166,107.5814074,1,-3.441843602,1.186054329,-2.90192744,0.003708744,0.01574077,177.9462498,1,-0.770990979,0.476390811,-1.618400191,0.105576381,0.204295015,147.6234923,1,-0.541019755,0.484967291,-1.115579887,0.264602006,0.396826018,Y,-,,alpha- -mannosyltransferase,"P:mitochondrial respiratory chain complex IV assembly; F:transferase activity, transferring glycosyl groups; C:mitochondrial matrix; F:transferase activity",PTHR40020 (PANTHER); PTHR40020:SF1 (PANTHER); PTHR40020:SF1 (PANTHER); PTHR40020 (PANTHER),,
RL4_JR_00764,99,86,97,1,0,0,0,0,0,0,0,0,0,1,2,0,0,0,11.19267181,1,2.674118084,1.14600839,2.333419291,0.01962615,0.0645203,0.36068861,0,4.936713325,1.630279103,3.028139977,0.002460641,0.015349618,0.934283791,0,2.286988098,1.233481796,1.854091488,0.063726072,0.136687024,24.35984512,1,4.186183132,0.853177407,4.90657992,9.27E-07,1.71E-05,0.919725996,0,2.206787691,1.212662193,1.819787657,0.068791348,0.1430504,Y,-,,hypothetical protein SPI_04110,,no IPS match,,
RL4_JR_00765,1878,1034,1889,0,0,22,0,0,0,0,0,1,1,0,0,0,0,0,103.0525482,1,2.296959015,1.122512083,2.046266628,0.040730145,0.114066778,6.098746298,0,0.856975092,1.273280296,0.673045122,0.500918585,0.654908023,22.31461043,1,-0.832603727,1.21774866,-0.683723788,0.494149599,0.627353627,27.55539489,1,-1.263444757,1.173259482,-1.076867288,0.281539559,0.425080232,15.61279336,0,-1.878481998,1.227872243,-1.52986763,0.126049497,0.227090954,Y,-,,hypothetical protein SPI_04111,,no IPS match,,
RL4_JR_00766,185,117,65,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1.470362809,0,1.341509734,1.518696355,0.883329791,0.377058112,NA,22.79162569,1,5.47209792,1.209139235,4.525614391,6.02E-06,0.000420379,1.226261249,0,1.895053198,1.323657754,1.431679143,0.152235668,0.265363964,1.413314253,0,1.473941437,1.38053845,1.067656925,0.285675296,0.429850255,1.190139969,0,1.834734134,1.296759628,1.414860622,0.157109366,0.267324715,N,-,,hsp70 family chaperone,,G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); PTHR19375:SF175 (PANTHER); PTHR19375 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_00767,129,130,154,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,13.10767314,1,3.473724993,0.858731531,4.045181605,5.23E-05,0.000484683,0.526252301,0,4.391657149,1.526581959,2.87679094,0.004017417,0.018157671,1.366886663,0,1.737908041,1.221948629,1.422243128,0.154955683,0.268717254,1.576978681,0,1.315528219,1.23997285,1.060933084,0.288720313,0.433208827,1.349183621,0,1.654287679,1.212398885,1.364474761,0.172418192,0.287600362,N,-,,---NA---,,no IPS match,,
RL4_JR_00768,472,376,512,0,2,0,0,0,0,0,0,0,0,2,0,0,0,0,21.44300429,1,1.20166266,1.010464291,1.189218333,0.234353762,0.408026312,1.731880713,0,2.673146887,1.328067171,2.012810004,0.044134621,0.10700135,4.494016138,0,0.020771622,1.204490783,0.017245148,0.986241044,0.993502919,13.20740902,1,1.32198318,1.022398558,1.293021366,0.19600367,0.325771082,4.434334528,0,-0.062566177,1.206307099,-0.051865878,0.958635563,0.972856077,N,-,,hypothetical protein F503_05720,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_00769,3281,3122,3123,6,15,2,0,0,0,3,5,6,1,0,2,0,4,3,226.3372665,1,2.231605815,0.748964911,2.979586602,0.002886376,0.013941944,12.21094464,0,-0.144554497,1.210443777,-0.119422727,0.904940456,0.946577132,143.0282557,1,1.836577875,0.413498881,4.441554646,8.93E-06,0.000170601,65.04542894,1,-0.888990387,0.843159361,-1.054356304,0.29171982,0.436272336,68.62570117,1,0.56041886,0.562769091,0.99582381,0.319335759,0.454622407,N,-,,pyridoxamine 5 -phosphate oxidase,F:pyridoxamine-phosphate oxidase activity; P:organic substance biosynthetic process; P:cellular biosynthetic process; P:single-organism metabolic process,IPR019576 (PFAM); IPR011576 (PFAM); IPR000659 (TIGRFAM); IPR012349 (G3DSA:2.30.110.GENE3D); PTHR10851 (PANTHER); IPR000659 (PTHR10851:PANTHER); IPR012349 (SUPERFAMILY),2.A.7.2.4, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_00770,1841,796,1867,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.80644388,0,-2.256753612,1.253409474,-1.800491905,0.071783001,0.174080178,5.704720855,0,0.953325336,1.31117857,0.727075135,0.46717993,0.626050741,14.80120613,0,-1.698731075,1.244575835,-1.364907648,0.172282078,0.291036836,17.07257149,0,-2.120860982,1.249154212,-1.697837595,0.089538418,0.180375509,14.62843252,0,-1.78452535,1.256196325,-1.420578388,0.155439365,0.265624232,N,-,,heterokaryon incompatibility partial,P:transmembrane transport; C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00771,1613,792,1803,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.65060734,0,-2.159940738,1.244467757,-1.735634151,0.082628544,0.19314718,5.320154258,0,1.054000824,1.302008286,0.80951929,0.418216512,0.582201559,13.82501078,0,-1.600313942,1.237280395,-1.293412511,0.195868425,0.320511815,15.9483205,0,-2.022600949,1.240855687,-1.630004979,0.103100445,0.200478587,13.68288976,0,-1.688119936,1.248963078,-1.351617167,0.176497816,0.293342151,N,-,,isochorismatase hydrolase,F:catalytic activity; P:metabolic process; C:cellular_component; F:hydrolase activity,IPR000868 (G3DSA:3.40.50.GENE3D); IPR000868 (PFAM); PTHR11080 (PANTHER); PTHR11080:SF13 (PANTHER); IPR000868 (SUPERFAMILY),,
RL4_JR_00772,78,22,93,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.758693816,0,2.295809311,1.911764661,1.200884898,0.229795853,NA,0.242210603,0,5.510937907,1.920964302,2.868839313,0.00411981,0.018371529,0.630701503,0,2.853186748,1.403317718,2.033172326,0.042035116,0.099361082,0.727604447,0,2.431131824,1.542919153,1.575670261,0.115101815,0.217267527,0.626355443,0,2.760802375,1.371482287,2.013006221,0.044113975,0.101650887,N,-,,elongation factor 1-gamma,"C:nucleus; F:DNA binding; F:zinc ion binding; F:translation elongation factor activity; P:transcription, DNA-templated; P:translational elongation",IPR010987 (G3DSA:1.20.1050.GENE3D); IPR004046 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR11260 (PANTHER); PTHR11260:SF143 (PANTHER); IPR004045 (PROSITE_PROFILES); IPR010987 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR010987 (SUPERFAMILY),,
RL4_JR_00773,139,48,37,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.8897992,0,2.066002055,1.843601279,1.12063388,0.262443737,NA,0.293149903,0,5.236059958,1.906432815,2.746522151,0.006023082,0.023358481,0.746032062,0,2.611855179,1.413175835,1.848216701,0.064571,0.13813549,0.859497585,0,2.191326096,1.536017326,1.426628502,0.153687004,0.270708164,0.721975794,0,2.555511152,1.369943506,1.865413531,0.062123462,0.132365331,N,-,,dihydrodipicolinate synthase,P:metabolic process; F:lyase activity,IPR002220 (PRINTS); IPR002220 (SMART); IPR002220 (PIRSF); IPR002220 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR12128:SF23 (PANTHER); IPR002220 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_00774,28,11,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.214159066,0,4.120725484,2.943139126,1.400112366,0.161479673,NA,0.069644621,0,7.309593734,2.318449348,3.152794233,0.001617158,0.015023052,0.178809477,0,4.672294815,1.439560522,3.245639723,0.00117187,0.006551086,0.206118592,0,4.251149143,1.878435844,2.263132465,0.023627525,0.083034578,0.174711992,0,4.600588224,1.312719665,3.504623528,0.000457253,0.002516136,N,-,,Aspartate aminotransferase,F:pyridoxal phosphate binding; F:L-phenylalanine:2-oxoglutarate aminotransferase activity; P:cellular amino acid metabolic process; P:biosynthetic process; F:L-aspartate:2-oxoglutarate aminotransferase activity,IPR000796 (PRINTS); IPR015421 (G3DSA:3.40.640.GENE3D); IPR004839 (PFAM); IPR000796 (PANTHER); IPR015424 (SUPERFAMILY),9.A.70.1.1, the aspartate amino transferase (aat) family.
RL4_JR_00775,0,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.045523689,0,6.356049428,3.930158926,1.617249976,0.105824333,NA,0.014222251,0,9.601523177,3.930685298,2.442709718,0.014577457,0.045068105,0.037133423,0,6.942039266,2.508790783,2.767085766,0.005655987,0.020792017,0.042872483,0,6.517226643,3.930483171,1.658123533,0.097292535,0.192062179,0.036589925,0,6.864117219,1.743378449,3.937250241,8.24E-05,0.000589759,N,-, Effector probability:0.668,---NA---,,no IPS match,,
RL4_JR_00776,247,212,239,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2.790031908,0,0.41730757,1.224356745,0.340838217,0.733225378,0.859100276,0.892948083,0,3.628892125,1.420508676,2.554642704,0.010629685,0.035207352,2.312586693,0,0.979433115,1.209327086,0.809899263,0.417998076,0.55924574,6.679103738,1,1.504129853,1.148595753,1.309538059,0.190352155,0.319234043,2.276196287,0,0.899478669,1.202062628,0.748279373,0.454291664,0.586173454,N,-,,C6 zinc finger domain,F:binding,IPR001138 (SMART); IPR007219 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31944 (PANTHER); PTHR31944:SF80 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00777,6,1,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.06259201,0,5.894793533,3.92377119,1.502328563,0.133012276,NA,0.019858876,0,9.118229424,3.086219786,2.954497754,0.003131784,0.015941545,0.051980539,0,6.451370571,1.863456422,3.462045312,0.000536087,0.003561249,0.059983117,0,6.031112141,3.072529143,1.962914543,0.049656105,0.122392356,0.051943886,0,6.350958414,1.478540113,4.295425168,1.74E-05,0.000159763,N,-,,monocarboxylate permease mch4,P:ion transmembrane transport; C:integral component of fungal-type vacuolar membrane; F:transporter activity,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11360:SF125 (PANTHER); PTHR11360 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.13.4, the major facilitator superfamily (mfs).
RL4_JR_00778,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.012376897,0,8.237661038,3.992283311,2.063395906,0.039075029,NA,0.004015611,0,11.43115744,3.991119401,2.864148198,0.004181323,0.018371529,0.010235446,0,8.805715205,3.038577053,2.897973312,0.003755825,0.015764501,0.01179869,0,8.381441139,3.992433907,2.099331219,0.035787713,0.10034633,0.009844433,0,8.758432769,1.618956569,5.409924478,6.31E-08,1.56E-06,Y,-,,major allergen Asp f 2 partial,C:fungal-type cell wall; P:proteolysis; C:fungal-type vacuole; F:metallopeptidase activity,IPR029482 (PFAM); IPR024079 (G3DSA:3.40.390.GENE3D); PTHR39399 (PANTHER); SSF55486 (SUPERFAMILY),2.A.5.1.15, the zinc (zn(2+))-iron (fe(2+)) permease (zip) family.
RL4_JR_00779,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.695,Peptidoglycan-binding Lysin subgroup,F:chitin binding; C:membrane; P:proteolysis; C:integral component of membrane; F:serine-type endopeptidase activity; C:GPI-anchor transamidase complex; F:metallopeptidase activity,no IPS match,,
RL4_JR_00780,2,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.031447737,0,6.88746135,3.940532175,1.747850555,0.080489909,NA,0.009847587,0,10.12878004,3.400277852,2.978809521,0.002893706,0.015349618,0.025971474,0,7.450461189,2.009824406,3.707020956,0.000209712,0.001805374,0.029985831,0,7.031138171,3.838400574,1.831788537,0.066982932,0.146670023,0.026122247,0,7.345137159,1.461013394,5.027426298,4.97E-07,7.98E-06,N,-,,phosphotransferase enzyme family,P:phosphorylation; F:transferase activity; F:kinase activity,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); IPR011009 (SUPERFAMILY),,
RL4_JR_00781,13,6,7,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0.103351212,0,5.171826213,3.917076976,1.32032795,0.186725548,NA,0.03357316,0,8.36245445,2.640830034,3.166600782,0.001542319,0.015023052,0.086214414,0,5.724952241,1.53714433,3.724407741,0.000195774,0.001734522,4.110973851,1,6.246616241,1.237527042,5.047660399,4.47E-07,8.79E-06,0.084215753,0,5.651985494,1.319531838,4.283326353,1.84E-05,0.000167796,N,-,,hypothetical protein PFICI_11808,,IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (SUPERFAMILY),,
RL4_JR_00782,140,117,198,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,13.26630092,1,3.32057564,0.895548492,3.70786805,0.000209012,0.001599546,0.574883648,0,4.264028464,1.526433426,2.793458523,0.005214772,0.021155879,1.498191442,0,1.605210385,1.241075576,1.293402606,0.195871849,0.320511815,1.728723567,0,1.182715192,1.263718566,0.93590078,0.349324275,0.495990505,1.485363985,0,1.515415458,1.237848774,1.224233113,0.220864301,0.347028406,N,-,,fungal fucose-specific lectin,P:biological_process; C:membrane; C:integral component of membrane; F:carbohydrate binding; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_00783,2465,1710,1856,0,1,0,0,0,1,1,1,0,0,6,2,0,6,0,32.08243576,1,-1.740921035,1.151550409,-1.511806189,0.130583175,0.26790913,17.12861001,1,1.426431152,1.141936872,1.249133106,0.211616394,0.357533156,38.91309994,1,-0.303231348,1.042049632,-0.290995111,0.771055059,0.846655251,66.40417875,1,1.148688863,0.573971758,2.001298579,0.045360223,0.115366053,42.78288835,1,0.960283377,0.649850784,1.477698267,0.139488558,0.245279898,N,-,,P-loop containing nucleoside triphosphate hydrolase,C:membrane; C:integral component of membrane; F:hydrolase activity,IPR027417 (G3DSA:3.40.50.GENE3D); PF05729 (PFAM); PTHR10039 (PANTHER); PTHR10039:SF5 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_00784,15,3,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.152777665,0,4.60777964,3.536490825,1.302924246,0.192600626,NA,0.048566263,0,7.828669098,2.602427494,3.008217949,0.002627846,0.015349618,0.126920232,0,5.164841481,1.639218473,3.150795068,0.001628267,0.00842339,0.146447813,0,4.743583651,2.278130721,2.082226278,0.037321806,0.102797412,0.126593786,0,5.066854578,1.457134242,3.4772737,0.00050654,0.002739702,N,-,,F-box cyclin-like,F:oxidoreductase activity; F:3-hydroxyacyl-CoA dehydrogenase activity; P:oxidation-reduction process; P:fatty acid metabolic process,no IPS match,,
RL4_JR_00785,2,3,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.055438833,0,6.070182866,3.925964172,1.546163592,0.122065064,NA,0.017196872,0,9.325093967,3.062843706,3.044586947,0.002330001,0.015159195,0.0455623,0,6.641157849,1.81490804,3.659225538,0.000252979,0.002044019,0.052624492,0,6.219985665,3.101454869,2.00550578,0.044909003,0.115085715,0.045964008,0,6.532481827,1.447193787,4.51389571,6.36E-06,6.91E-05,N,-,,F-box cyclin-like,P:biological_process; C:cellular_component; F:molecular_function,PTHR11177 (PANTHER); PTHR11177:SF194 (PANTHER),,
RL4_JR_00786,49,17,41,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0.422479409,0,3.140479039,2.244426846,1.399234305,0.161742732,NA,0.136080652,0,6.34288804,2.054537287,3.087258665,0.002020117,0.015023052,0.351928841,0,3.694801909,1.382301062,2.672935737,0.007519065,0.02600718,19.67641443,1,5.062222384,1.095133728,4.622469617,3.79E-06,5.98E-05,0.346767044,0,3.613084741,1.31592281,2.74566617,0.006038818,0.020889316,N,-,,kinesin light chain 1,P:biological_process; F:microtubule motor activity; C:kinesin complex; F:ADP binding,IPR019734 (SMART); PF13424 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR002182 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR010730 (PFAM); IPR011990 (PFAM); PTHR10622 (PANTHER); PTHR10622 (PANTHER); PTHR10622:SF11 (PANTHER); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_00787,11,7,8,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0.103654677,0,5.167647346,3.917047189,1.319271149,0.18707848,NA,0.033409457,0,8.369331141,2.609705976,3.207001561,0.001341263,0.015023052,26.08110884,1,8.534376004,0.815428195,10.46612817,1.24E-25,2.78E-23,0.099374256,0,5.30373628,2.323100851,2.283041771,0.022427908,0.080726669,0.084516361,0,5.648375408,1.294532028,4.363256596,1.28E-05,0.000124037,Y,-,,hypothetical protein PFICI_10433,,no IPS match,1.C.105.2.5, the bacillus thuringiensis vegetative insecticidal protein-3 (vip3) family.
RL4_JR_00788,519,745,842,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,8.44963019,0,-1.181150594,1.224012304,-0.964982615,0.33455352,0.524560372,2.674335332,0,2.046286653,1.301737479,1.571965689,0.115958509,0.227599772,26.46728321,1,1.782497643,0.879546199,2.026610593,0.042702252,0.100377978,8.044658127,0,-1.035240504,1.216568271,-0.850951425,0.394796337,0.539302875,6.901344486,0,-0.700563554,1.223802263,-0.572448324,0.567018286,0.683860995,N,-,,HET-domain-containing partial,,IPR010730 (PFAM); PTHR33112 (PANTHER); PTHR33112:SF6 (PANTHER),,
RL4_JR_00789,2,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.019807577,0,7.554471241,3.960244045,1.907577199,0.056445884,NA,0.006345689,0,10.76483733,3.598854133,2.991184674,0.002778974,0.015349618,0.016456887,0,8.11166391,2.107222176,3.849458308,0.000118379,0.001287296,0.018982256,0,7.691271347,3.960080967,1.942200529,0.052112829,0.125807414,0.016250605,0,8.025401699,1.467255338,5.469669453,4.51E-08,1.22E-06,N,-,,hypothetical protein VE02_09051,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_00790,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003906015,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,0,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,,,,,,,,
RL4_JR_00791,302,286,410,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.981774481,0,-0.095897181,1.225539436,-0.078248955,0.937630021,0.969307326,1.265173289,0,3.126095074,1.368182061,2.284853137,0.022321441,0.062812795,3.293582944,0,0.469030583,1.213385884,0.386546925,0.699091657,0.795222511,3.80023724,0,0.046463746,1.216156318,0.038205406,0.969523911,0.982920757,3.260091438,0,0.381353734,1.217529934,0.313219186,0.754114143,0.828494542,N,-,,---NA---,,no IPS match,,
RL4_JR_00792,48543,37935,55831,0,2,4,2,0,0,0,0,2,0,7,1,0,4,0,598.2028585,1,-3.952169626,0.644305667,-6.133997926,8.57E-10,2.39E-08,225.460145,1,-2.35742187,0.989310506,-2.382893799,0.017177149,0.051170242,482.7161497,1,-4.870177354,1.046975689,-4.651662313,3.29E-06,7.39E-05,579.6056929,1,-3.425901222,0.581850645,-5.887939197,3.91E-09,1.18E-07,479.483359,1,-4.196042474,0.808640442,-5.189008927,2.11E-07,4.23E-06,N,-,,pyrABCN,F:aspartate carbamoyltransferase activity; F:dihydroorotase activity; P:glutamine metabolic process; P:negative regulation of pyrimidine nucleobase metabolic process; F:carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; F:ATP binding; P:'de novo' pyrimidine nucleobase biosynthetic process; F:GMP synthase (glutamine-hydrolyzing) activity; F:metal ion binding; C:mitochondrion; C:integral component of membrane; C:cytosol; F:amino acid binding,IPR006130 (PRINTS); IPR002082 (PRINTS); IPR005483 (PRINTS); PR00099 (PRINTS); IPR011607 (SMART); IPR002474 (SMART); IPR005480 (SMART); IPR002474 (G3DSA:3.50.30.GENE3D); IPR013815 (G3DSA:3.30.1490.GENE3D); IPR006131 (PFAM); IPR029062 (G3DSA:3.40.50.GENE3D); IPR005480 (PFAM); IPR006130 (G3DSA:3.40.50.GENE3D); IPR002082 (TIGRFAM); IPR005480 (G3DSA:1.10.1030.GENE3D); G3DSA:3.20.20.140 (GENE3D); IPR013816 (G3DSA:3.30.470.GENE3D); IPR011607 (G3DSA:3.40.50.GENE3D); IPR005479 (PFAM); IPR002474 (PFAM); IPR013816 (G3DSA:3.30.470.GENE3D); IPR006275 (TIGRFAM); IPR006130 (G3DSA:3.40.50.GENE3D); IPR016185 (G3DSA:3.40.50.GENE3D); IPR017926 (PFAM); IPR006274 (TIGRFAM); IPR006132 (PFAM); IPR011607 (PFAM); PTHR11405 (PANTHER); PTHR11405 (PANTHER); PTHR11405:SF46 (PANTHER); PTHR11405:SF46 (PANTHER); IPR011761 (PROSITE_PROFILES); IPR006274 (HAMAP); IPR017926 (PROSITE_PROFILES); IPR011761 (PROSITE_PROFILES); IPR011607 (SUPERFAMILY); IPR006130 (SUPERFAMILY); IPR029062 (SUPERFAMILY); SSF56059 (SUPERFAMILY); SSF56059 (SUPERFAMILY); IPR002474 (SUPERFAMILY); IPR005480 (SUPERFAMILY); IPR032466 (SUPERFAMILY); IPR016185 (SUPERFAMILY); IPR016185 (SUPERFAMILY),,
RL4_JR_00793,2821,2729,2479,0,4,1,0,0,0,0,0,0,0,3,4,0,0,0,68.05509685,1,-0.048336868,0.667773946,-0.072385077,0.942295461,0.971716138,10.31822596,0,0.098438251,1.221090927,0.080615004,0.935748133,0.964339006,26.67970568,0,-2.548627807,1.191642915,-2.138751277,0.032455817,0.081696344,81.34836219,1,0.575976372,0.575200778,1.001348388,0.316658407,0.462917466,26.19961746,0,-2.625263802,1.188475743,-2.208933432,0.027179271,0.069721339,N,-,,integral membrane channel,C:membrane; P:transport,PTHR35859:SF2 (PANTHER); PTHR35859 (PANTHER); PTHR35859:SF2 (PANTHER); PTHR35859 (PANTHER); PTHR35859:SF2 (PANTHER); PTHR35859 (PANTHER),1.A.4.4.1, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_00794,132,250,255,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2.563867824,0,0.539485072,1.334267635,0.404330479,0.685969716,0.828896683,0.80896139,0,3.771311775,1.492243629,2.527276178,0.011495107,0.037388648,15.10895186,1,2.919903736,1.079949153,2.703741863,0.006856353,0.024194394,2.436960378,0,0.687759117,1.279879131,0.537362553,0.591017205,0.71485476,2.091797736,0,1.021746125,1.260154517,0.810810192,0.417474681,0.55340811,N,-,,hypothetical protein SPI_04119,,no IPS match,,
RL4_JR_00795,3811,4800,4184,0,2,2,0,0,0,0,0,0,3,4,1,0,4,1,75.10744265,1,-1.059389589,0.758538878,-1.396618709,0.162528261,0.313082775,16.40587044,0,-0.570599588,1.211131772,-0.471129238,0.637548447,0.763317547,42.53441879,0,-3.221538551,1.195207454,-2.695380237,0.007030835,0.024629817,102.6878063,1,0.090916986,0.552210868,0.16464179,0.869225936,0.91953598,64.66753791,1,-0.369028716,0.68496745,-0.538753653,0.590056847,0.701953422,N,-,,hypothetical protein CMQ_3150,,no IPS match,,
RL4_JR_00796,476,463,605,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,6.167704526,0,-0.727174185,1.202601266,-0.604667736,0.54539979,0.725807082,1.962365474,0,2.492870562,1.309044281,1.904343954,0.056865403,0.13066779,5.102646135,0,-0.162451499,1.201888644,-0.135163519,0.89248259,0.932936886,5.887243789,0,-0.584967087,1.200688216,-0.48719316,0.626121452,0.742849742,12.4090616,1,0.687918296,1.131630472,0.607900116,0.543253722,0.665268982,N,-,,tor signaling pathway regulator,C:intracellular part; P:regulation of cellular metabolic process,IPR007304 (PFAM); PTHR10933:SF9 (PANTHER); IPR007304 (PANTHER); IPR007304 (PANTHER); PTHR10933:SF9 (PANTHER),,
RL4_JR_00797,339,382,222,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.803449348,0,-0.029419285,1.270502036,-0.023155638,0.981526125,0.991069033,1.223779626,0,3.174315753,1.430385326,2.219203242,0.026472901,0.071646711,3.15199879,0,0.533048443,1.242405837,0.429045346,0.667890225,0.771671122,3.634870909,0,0.111191144,1.251172567,0.088869551,0.929185583,0.958045216,3.079187798,0,0.463688204,1.232649718,0.376171914,0.706789094,0.792759452,N,-,,RNase3 domain-containing,"P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:positive regulation of termination of RNA polymerase II transcription; F:zinc ion binding; P:co-transcriptional gene silencing by RNA interference machinery; F:double-stranded DNA binding; P:regulation of chromatin silencing at centromere; P:chromatin silencing at centromere outer repeat region; F:euchromatin binding; F:ATP binding; C:chromosome, centromeric outer repeat region; F:ribonuclease III activity; F:double-stranded RNA binding; P:regulation of histone H3-K9 methylation; C:nuclear pericentric heterochromatin; C:nuclear euchromatin; C:cytosol; C:nuclear periphery; P:production of siRNA involved in RNA interference; P:establishment of chromatin silencing at silent mating-type cassette; P:heterochromatin organization involved in chromatin silencing; P:cellular protein localization",IPR000999 (SMART); IPR001650 (SMART); IPR014001 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000999 (G3DSA:1.10.1520.GENE3D); IPR000999 (G3DSA:1.10.1520.GENE3D); IPR005034 (PFAM); IPR006935 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000999 (PFAM); IPR001650 (PFAM); PTHR14950 (PANTHER); PTHR14950:SF28 (PANTHER); PTHR14950 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR005034 (PROSITE_PROFILES); IPR000999 (PROSITE_PROFILES); IPR000999 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR000999 (SUPERFAMILY); IPR000999 (SUPERFAMILY); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_00798,1022,629,553,5,2,0,0,0,2,0,0,0,0,4,0,0,0,0,75.14877741,1,2.604656419,0.810152204,3.215021085,0.001304349,0.007288276,21.61043422,1,3.567012389,1.061409691,3.360636726,0.00077763,0.015023052,7.329399977,0,-0.684650712,1.234320036,-0.55467844,0.579114626,0.701142845,24.49612645,1,1.560108032,0.825843053,1.889109592,0.058877145,0.135361285,7.154886854,0,-0.752830206,1.230607729,-0.611754817,0.540699988,0.663104091,N,-,,hypothetical protein SPBR_09023,,no IPS match,,
RL4_JR_00799,335,136,209,3,7,0,0,0,0,0,0,0,0,1,0,0,0,0,88.96243836,1,4.866375695,0.88651611,5.489325733,4.03E-08,8.80E-07,0.873611786,0,3.660500561,1.525849817,2.398991382,0.016440302,0.049526409,2.248166748,0,1.020133249,1.277824544,0.798335933,0.424675571,0.565732217,6.603482122,1,1.541165034,1.218045556,1.265277006,0.205772046,0.337672928,2.202164055,0,0.946986602,1.269556505,0.745919223,0.455716212,0.587442953,N,-,,PREDICTED: protein TsetseEP-like,,PR01217 (PRINTS),,
RL4_JR_00800,48,40,41,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0.51598854,0,2.85223391,1.936151085,1.473146353,0.140711577,NA,0.165566144,0,6.060128869,1.894351601,3.199051785,0.001378804,0.015023052,6.926735262,1,4.375636999,1.208091262,3.621942427,0.000292399,0.002280624,0.493636962,0,2.991345412,1.407893621,2.124695622,0.033612019,0.098223396,0.420417243,0,3.33585774,1.227736913,2.717078637,0.006586096,0.022505643,N,-,,ubiquitin carboxyl-terminal family 1,F:thiol-dependent ubiquitin-specific protease activity; C:intracellular; P:ubiquitin-dependent protein catabolic process,IPR001578 (PRINTS); IPR001578 (PFAM); IPR001578 (G3DSA:3.40.532.GENE3D); PTHR10589:SF26 (PANTHER); IPR001578 (PANTHER); SSF54001 (SUPERFAMILY),,
RL4_JR_00801,530,719,1287,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.10909862,0,-1.439958363,1.269232412,-1.134511182,0.256580186,0.435263289,3.173633097,0,1.799260171,1.33607873,1.346672266,0.178085808,0.315633786,8.329291528,0,-0.869333357,1.24904373,-0.695999136,0.486429371,0.621558873,9.615427221,0,-1.292640347,1.25484984,-1.030115561,0.302955761,0.448651029,8.313617184,0,-0.969218688,1.267118321,-0.764899909,0.444331148,0.577214531,N,-,,mitochondrial ATP-dependent RNA helicase,P:RNA metabolic process; F:helicase activity,IPR001650 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR022192 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR12131 (PANTHER); PTHR12131:SF1 (PANTHER); PTHR12131:SF1 (PANTHER); PTHR12131 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_00802,2153,713,1468,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,24.76254539,1,-0.517368102,1.124470228,-0.460099422,0.645444859,0.79800127,5.544428011,0,0.994479537,1.347451069,0.73804501,0.460487098,0.618997398,14.28841061,0,-1.647826435,1.264652659,-1.302987365,0.192579075,0.316333479,16.47387261,0,-2.06932916,1.271736973,-1.62716757,0.103701513,0.201222273,14.0257389,0,-1.723842725,1.273825185,-1.353280454,0.175966051,0.292698582,N,-,,fungal transcriptional regulatory,F:metal ion binding,IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31845 (PANTHER),,
RL4_JR_00803,975,795,1222,0,0,4,0,0,1,0,0,0,0,0,0,0,0,1,27.19118082,1,1.021872739,0.767222948,1.331911073,0.182889412,0.340331164,13.17247247,1,2.457368842,1.13382914,2.167318473,0.030210579,0.079446994,9.867699129,0,-1.113890776,1.203624693,-0.925446929,0.354733478,0.498310216,11.38477216,0,-1.536380488,1.202773258,-1.277365021,0.201473408,0.332667687,17.12740435,1,-0.26347624,1.138651347,-0.231393254,0.817009306,0.876944686,N,-,,general amino acid permease agp3,C:integral component of plasma membrane; F:L-amino acid transmembrane transporter activity; P:regulation of anion transmembrane transport; P:L-alpha-amino acid transmembrane transport; F:catalytic activity; F:antiporter activity; P:L-amino acid transport; P:ion transmembrane transport; C:vacuole; P:chloride transport; F:voltage-gated chloride channel activity,IPR002293 (PIRSF); IPR004841 (PFAM); IPR002293 (PANTHER); PTHR11785:SF212 (PANTHER),2.A.3.10.14, the amino acid-polyamine-organocation (apc) family.
RL4_JR_00804,4377,3730,4677,0,2,0,0,0,3,2,4,0,0,5,1,0,4,0,67.06208355,1,-2.035170092,1.005614417,-2.023807593,0.042989953,0.119046855,44.43909586,1,1.622494948,0.852762887,1.902633162,0.057088429,0.131150494,95.80098478,1,0.201661244,0.610974985,0.33006465,0.741351113,0.826492974,78.47699116,1,-0.333204962,0.614845392,-0.541932927,0.587864713,0.712829966,57.14203419,1,-0.686238294,0.751500175,-0.913157863,0.361159522,0.498533082,N,-,,voltage gated chloride channel,"P:ion transmembrane transport; C:endoplasmic reticulum; C:fungal-type vacuole; F:hydrolase activity, hydrolyzing O-glycosyl compounds; P:chloride transport; P:amino acid transport; C:plasma membrane; C:Golgi medial cisterna; F:voltage-gated chloride channel activity; P:cellular iron ion homeostasis; P:carbohydrate metabolic process; P:regulation of anion transmembrane transport; C:endosome; P:cellular copper ion homeostasis; C:integral component of membrane",IPR001807 (PRINTS); IPR001807 (PFAM); G3DSA:3.10.580.10 (GENE3D); IPR000644 (PFAM); IPR014743 (G3DSA:1.10.3080.GENE3D); PTHR11689 (PANTHER); PTHR11689:SF93 (PANTHER); PTHR11689 (PANTHER); PTHR11689:SF93 (PANTHER); IPR000644 (PROSITE_PROFILES); IPR000644 (PROSITE_PROFILES); SSF54631 (SUPERFAMILY); IPR014743 (SUPERFAMILY),2.A.49.1.2, the chloride carrier/channel (clc) family.
RL4_JR_00805,379,379,372,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,12.1660994,1,1.44795195,1.009757501,1.433960083,0.151583654,0.299423596,1.448275303,0,2.931225477,1.346205056,2.177398951,0.029450814,0.078047344,10.24933358,1,1.24387102,1.192352482,1.043207473,0.296852213,0.437811529,4.326357342,0,-0.140203346,1.199783488,-0.116857206,0.906973211,0.943114281,3.689345052,0,0.20289774,1.196241495,0.169612692,0.865314741,0.910077049,N,-,,aromatic-l-amino-acid decarboxylase,F:pyridoxal phosphate binding; P:cellular amino acid metabolic process; F:carboxy-lyase activity,IPR010977 (PRINTS); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR002129 (PFAM); G3DSA:1.20.1340.10 (GENE3D); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR11999:SF70 (PANTHER); PTHR11999 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_00806,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein VP1G_10850,,no IPS match,,
RL4_JR_00807,30656,26516,29710,1,2,41,0,0,0,0,4,4,3,13,3,0,1,1,529.9724546,1,-0.828770356,0.886958165,-0.93439622,0.350099547,0.54021413,111.1548672,0,-3.330905916,1.19184745,-2.794741824,0.005194118,0.021136506,345.2426267,1,-2.163753302,0.540157471,-4.005782421,6.18E-05,0.000851754,441.052199,1,-1.443064071,0.372085639,-3.878311659,0.000105184,0.001110518,294.5679484,1,-4.382895632,0.973631345,-4.50159668,6.74E-06,7.23E-05,N,-,,lysophospholipase NTE1,C:endoplasmic reticulum membrane; F:lysophospholipase activity; P:phosphatidylcholine metabolic process; P:lipid catabolic process; C:integral component of membrane,IPR000595 (SMART); IPR014710 (G3DSA:2.60.120.GENE3D); IPR014710 (G3DSA:2.60.120.GENE3D); IPR014710 (G3DSA:2.60.120.GENE3D); IPR000595 (PFAM); G3DSA:3.40.1090.10 (GENE3D); IPR002641 (PFAM); PTHR14226 (PANTHER); PTHR14226 (PANTHER); PTHR14226 (PANTHER); PTHR14226:SF29 (PANTHER); PTHR14226:SF29 (PANTHER); PTHR14226:SF29 (PANTHER); IPR000595 (PROSITE_PROFILES); IPR000595 (PROSITE_PROFILES); IPR016035 (SUPERFAMILY); IPR018490 (SUPERFAMILY); IPR018490 (SUPERFAMILY); IPR018490 (SUPERFAMILY),1.A.1.24.1, the voltage-gated ion channel (vic) superfamily.
RL4_JR_00808,14801,16347,19589,0,4,23,1,0,0,0,3,0,1,2,2,0,3,0,322.9232888,1,-0.580347332,0.677626996,-0.85644069,0.391754066,0.584169031,86.8508981,1,-1.625012141,1.104716579,-1.470976512,0.141297469,0.263633729,191.3898542,1,-2.792914806,0.856036887,-3.26261035,0.001103912,0.006240091,230.2853042,1,-2.563879708,0.672675218,-3.811467465,0.000138144,0.001404328,177.4787368,1,-3.093057837,0.863327948,-3.582714823,0.000340042,0.001944056,N,-,,eukaryotic translation initiation factor 2 subunit alpha,C:nucleus; C:multi-eIF complex; F:translation initiation factor activity; P:formation of translation preinitiation complex; P:mitotic G1 DNA damage checkpoint; P:regulation of cytoplasmic translational initiation in response to stress; F:ribosome binding; C:cytosol; C:ribosome; C:eukaryotic translation initiation factor 2B complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 2 complex,IPR022967 (SMART); IPR011488 (PFAM); IPR024055 (G3DSA:3.30.70.GENE3D); IPR003029 (PFAM); G3DSA:2.40.50.140 (GENE3D); IPR024054 (G3DSA:1.10.150.GENE3D); PTHR10602 (PANTHER); PTHR10602:SF0 (PANTHER); IPR003029 (PROSITE_PROFILES); IPR024054 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR024055 (SUPERFAMILY),,
RL4_JR_00809,744,823,1390,0,0,3,0,0,0,0,0,3,1,6,1,0,3,0,23.24077882,1,0.603514209,0.922591256,0.654151234,0.513014376,0.698576411,3.719031455,0,1.570481261,1.291629345,1.215891592,0.224026222,0.373020795,29.22398066,1,1.29682903,0.896111682,1.447173445,0.147848352,0.259442303,54.24452532,1,2.170238297,0.615066894,3.528458969,0.000417987,0.003614104,21.2587688,1,0.980394873,0.917486976,1.068565439,0.285265529,0.41956907,N,-,,mitochondrial inner membrane protease subunit 2,P:proteolysis; F:serine-type peptidase activity; C:membrane part,IPR000223 (PRINTS); IPR028360 (G3DSA:2.10.109.GENE3D); PTHR12383:SF3 (PANTHER); IPR000223 (PANTHER); IPR015927 (SUPERFAMILY),,
RL4_JR_00810,475,636,470,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,6.372722622,0,-0.773979776,1.222246941,-0.633243374,0.526574726,0.710518791,2.03527219,0,2.440369264,1.332621829,1.831254157,0.067062617,0.148566701,5.268416307,0,-0.208159898,1.215264374,-0.171287748,0.863997514,0.91367006,6.077416585,0,-0.630422018,1.215937412,-0.518465845,0.604133284,0.725076667,9.034505974,1,0.643995686,1.140055905,0.564880795,0.572154847,0.687686114,N,-,,2OG-Fe(II) oxygenase family,F:oxidoreductase activity; P:oxidation-reduction process,IPR005123 (PFAM); PTHR33099 (PANTHER); PTHR33099:SF2 (PANTHER); IPR005123 (PROSITE_PROFILES),,
RL4_JR_00811,3352,3789,5390,0,0,1,0,0,0,1,3,0,1,0,0,0,0,0,53.87308919,1,-2.801671044,1.165195239,-2.404464892,0.016196162,0.055446197,15.84584358,0,-0.520566579,1.215189503,-0.428383045,0.668372267,0.788584227,75.93901973,1,-0.349297517,0.763898569,-0.457256409,0.647486758,0.754854437,57.0189987,1,-2.651871075,1.159205066,-2.287663463,0.022157127,0.080442001,40.9991154,0,-3.2712936,1.213772911,-2.695144677,0.007035807,0.023722128,N,-,,solute carrier family 25 member 38,P:transmembrane transport; C:integral component of membrane,IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089 (PANTHER); PTHR24089:SF279 (PANTHER); PTHR24089:SF279 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.18.6, the mitochondrial carrier (mc) family.
RL4_JR_00812,3231,2994,5708,0,0,3,0,0,0,1,0,1,0,0,6,0,0,0,58.90425047,1,-1.409812865,0.929962665,-1.515988672,0.129522217,0.266358015,14.99011135,0,-0.440482267,1.235390219,-0.356553144,0.72142636,0.825815876,56.76976726,1,-1.276470861,1.063785348,-1.199932733,0.230165466,0.36127057,103.0542388,1,0.281766226,1.70163292,0.165585787,0.868482933,0.918849498,39.00743188,0,-3.199457609,1.233119524,-2.594604615,0.009469979,0.030057535,N,-,,Ribonuclease T2,,no IPS match,,
RL4_JR_00813,9411,11579,15232,6,1,27,0,0,6,0,15,27,3,8,11,0,22,2,316.4059105,1,0.327547742,0.622563332,0.526127584,0.598799564,0.768219741,102.1366571,1,1.092799179,0.65443598,1.669833585,0.094952294,0.19447736,412.739356,1,1.349940471,0.644396691,2.094890446,0.036180732,0.088348706,304.0706126,1,0.14322935,0.454979525,0.314803946,0.752910516,0.837900524,218.2402668,1,0.068511334,0.684636023,0.100069718,0.920288976,0.949065582,N,-,,squalene monooxygenase,P:organic cyclic compound metabolic process; C:membrane; F:binding; P:primary metabolic process; F:monooxygenase activity; P:cellular metabolic process; P:single-organism metabolic process,PR00420 (PRINTS); IPR013698 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR006076 (PFAM); PTHR10835:SF0 (PANTHER); PTHR10835 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_00814,20358,12103,13155,0,4,1,0,0,0,0,0,1,0,6,1,0,7,0,217.6813522,1,-2.509443169,0.740200544,-3.39022065,0.000698364,0.00443366,58.76295518,0,-2.411309302,1.223790169,-1.97036172,0.04879693,0.115510412,157.8111924,1,-4.090602517,1.2153662,-3.365736612,0.000763396,0.004641812,208.1700906,1,-1.996393482,0.649710605,-3.072742641,0.002121013,0.013846073,175.1625876,1,-1.791874532,0.680484608,-2.633233009,0.00845763,0.02748187,N,-,,suppressor of mek1,P:regulation of cellular process; P:cellular process,IPR006887 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR23318 (PANTHER); PTHR23318 (PANTHER); PTHR23318:SF0 (PANTHER); PTHR23318:SF0 (PANTHER); PTHR23318:SF0 (PANTHER); PTHR23318 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_00815,460,448,415,0,0,0,0,0,0,0,0,0,3,1,0,0,4,0,5.304466541,0,-0.509360051,1.199749774,-0.424555238,0.67116093,0.817535882,1.699109588,0,2.700801979,1.332261899,2.027230517,0.042638844,0.104078887,4.394978499,0,0.053304305,1.201719258,0.044356703,0.964620073,0.979323468,37.01768036,1,2.372150171,0.740529045,3.203318203,0.001358538,0.009572161,19.75978035,1,2.588279376,0.747844235,3.460987268,0.000538198,0.002875598,N,-,,dolichyl-phosphate beta-glucosyltransferase,C:endoplasmic reticulum membrane; P:GPI anchor biosynthetic process; F:dolichyl-phosphate beta-D-mannosyltransferase activity; P:protein N-linked glycosylation; P:dolichol metabolic process; P:protein O-linked mannosylation; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity,IPR029044 (G3DSA:3.90.550.GENE3D); IPR001173 (PFAM); PTHR10859 (PANTHER); PTHR10859 (PANTHER); PTHR10859:SF91 (PANTHER); PTHR10859:SF91 (PANTHER); IPR029044 (SUPERFAMILY),4.D.2.1.6, the glycosyl transferase 2 (gt2) family.
RL4_JR_00816,10521,18416,33274,4,0,10,0,0,0,0,0,1,2,2,2,0,4,2,326.6469511,1,-1.61679839,0.763825305,-2.116712263,0.034284275,0.100436013,77.57000616,0,-2.811923,1.253880814,-2.242575984,0.02492417,0.068387762,210.6494382,1,-4.522709952,1.264645784,-3.576266186,0.000348537,0.002610322,281.6356455,1,-2.524300124,0.756686698,-3.335991145,0.000849959,0.006480592,234.4657912,1,-2.439421451,0.813839275,-2.997424093,0.002722717,0.010969958,N,-, Effector probability:0.722,snrnp and snornp,"C:box C/D snoRNP complex; C:small-subunit processome; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:RNA binding; C:U4/U6 x U5 tri-snRNP complex; C:viral nucleocapsid; C:ribosome; P:mRNA splicing, via spliceosome",IPR018492 (PRINTS); IPR002415 (PRINTS); IPR029064 (G3DSA:3.30.1330.GENE3D); IPR004038 (PFAM); PTHR23105:SF49 (PANTHER); PTHR23105 (PANTHER); IPR029064 (SUPERFAMILY),,
RL4_JR_00817,281,334,336,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,43.86655579,1,3.04949243,0.679626635,4.487011359,7.22E-06,8.78E-05,1.215069279,0,3.184485869,1.370692661,2.323267615,0.02016478,0.057857293,3.15465733,0,0.531579279,1.207760993,0.440136154,0.659838498,0.765113384,3.639568446,0,0.109130451,1.209384414,0.090236363,0.928099389,0.957315232,3.110438511,0,0.449289904,1.206212497,0.372479894,0.709535579,0.794676225,N,-,,hypothetical protein CMQ_2778,,no IPS match,,
RL4_JR_00818,643,624,978,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.949174902,0,-1.264199092,1.216567946,-1.039152064,0.29873402,0.484314812,2.836547554,0,1.961282855,1.291404029,1.518721338,0.128832653,0.245767832,7.397688667,0,-0.698277764,1.212148586,-0.576066146,0.564570473,0.689138108,8.536571059,0,-1.121016582,1.212545541,-0.924515034,0.355218228,0.501475817,7.337187838,0,-0.788982417,1.222309658,-0.645484891,0.518613006,0.643657353,N,-, Effector probability:0.721,aaa family ATPase,F:nucleotide binding,no IPS match,,
RL4_JR_00819,963,944,1550,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17.59238518,1,-0.940493869,1.17035816,-0.803594918,0.421630959,0.613568563,4.360424235,0,1.34095408,1.268488209,1.057127745,0.29045329,0.44960517,11.38239264,0,-1.319881463,1.213478434,-1.087684318,0.276734493,0.415799942,13.13541054,0,-1.742697614,1.214167362,-1.435302634,0.151200877,0.267501115,11.30086819,0,-1.412126443,1.225522652,-1.152264661,0.249212334,0.379611085,N,-,,aaa family ATPase,F:nucleotide binding,IPR003593 (SMART); IPR003959 (PFAM); G3DSA:1.10.8.60 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23077 (PANTHER); PTHR23077:SF27 (PANTHER); IPR027417 (SUPERFAMILY),3.A.16.1.1, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_00820,827,690,1106,0,0,3,0,0,0,0,0,5,0,0,0,0,0,0,21.89972924,1,0.7999843,0.880589315,0.908464691,0.363632761,0.555275613,3.320141022,0,1.734193374,1.277997656,1.35696131,0.174793504,0.310875773,41.13802045,1,2.20338966,0.696293219,3.164456583,0.001553728,0.008104043,9.973964635,0,-1.345528128,1.207609774,-1.114207716,0.265190086,0.40608736,8.561138387,0,-1.011590347,1.216703815,-0.831418736,0.405737118,0.542648639,N,-,,hypothetical protein HMPREF1624_06067,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00821,2334,1863,2089,0,0,3,0,0,0,0,3,2,2,1,0,0,7,0,36.56835834,1,-0.448335627,0.848617086,-0.528313222,0.597281956,0.766980355,8.052101275,0,0.456175941,1.2281507,0.371433197,0.710314903,0.817953066,57.35735798,1,0.950317945,0.670229814,1.417898645,0.156220358,0.270363743,46.66238385,1,-0.292241916,0.850363408,-0.343667088,0.731096665,0.820569087,47.50651179,1,1.134358922,0.583924062,1.942648019,0.052058701,0.11546426,N,-, Effector probability:0.824,GTP-binding ypt2,P:small GTPase mediated signal transduction; P:Golgi to plasma membrane transport; P:exocytosis; P:membrane addition at site of cytokinesis; F:GTP binding; C:nucleus; C:incipient cellular bud site; P:vesicle fusion; F:GTPase activity; P:autophagy; P:ascospore-type prospore assembly; C:cytosol; C:transport vesicle,PR00449 (PRINTS); SM00176 (SMART); SM00174 (SMART); SM00173 (SMART); SM00175 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001806 (PFAM); IPR005225 (TIGRFAM); PTHR24073:SF380 (PANTHER); PTHR24073 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_00822,5061,4297,5254,0,2,20,0,0,0,2,4,5,8,1,2,0,1,0,150.7451614,1,0.899190161,0.703103461,1.278887405,0.200936708,0.36484346,18.65024231,0,-0.755606658,1.200682219,-0.62931444,0.52914322,0.677544297,134.3603313,1,0.874167991,0.462919814,1.88837886,0.058975107,0.128400857,153.559838,1,0.52318443,0.566895235,0.922894387,0.356062246,0.502247178,51.51749703,1,-2.557998381,1.120026776,-2.283872524,0.022379024,0.059754118,N,-,,atp synthase regulation nca2,C:integral component of membrane,IPR013946 (PFAM); PTHR28234:SF1 (PANTHER); PTHR28234 (PANTHER),,
RL4_JR_00823,14890,17802,18032,9,34,33,0,0,4,8,34,45,2,15,13,0,57,3,692.4698384,1,1.258921902,0.418066271,3.011297466,0.002601339,0.012900743,102.3043954,1,0.040715379,0.752516839,0.054105605,0.956851027,0.977320494,815.9061305,1,1.982653176,0.391204057,5.06807928,4.02E-07,1.20E-05,398.162649,1,0.030535084,0.375404274,0.081339202,0.935172198,0.962317601,408.0617978,1,0.654368545,0.959617162,0.681905838,0.495298494,0.623433273,N,-,,methylsterol monooxygenase,C:endoplasmic reticulum membrane; F:C-4 methylsterol oxidase activity; F:iron ion binding; C:integral component of membrane; P:ergosterol biosynthetic process; P:oxidation-reduction process; P:fatty acid biosynthetic process; C:plasma membrane,IPR006694 (PFAM); PTHR11863 (PANTHER); PTHR11863:SF22 (PANTHER),,
RL4_JR_00824,305,295,306,0,0,1,0,0,0,0,0,2,0,0,0,0,0,0,7.446639843,1,0.98620638,1.143901007,0.862143117,0.388608767,0.58138095,1.159841136,0,3.251621741,1.375189903,2.36448925,0.018054951,0.053079354,16.00227333,1,2.42225648,1.031813603,2.347571765,0.018896233,0.053627327,3.466126887,0,0.179553706,1.203554842,0.149186144,0.881406753,0.92661179,2.957427154,0,0.521900286,1.197897173,0.435680372,0.663068648,0.760055481,N,-, Effector probability:0.81,pterin-4-alpha-carbinolamine dehydratase,P:ascospore formation; C:nucleus; P:tetrahydrobiopterin biosynthetic process; C:cytosol; F:4-alpha-hydroxytetrahydrobiopterin dehydratase activity; C:ascospore-type prospore,IPR001533 (PFAM); IPR001533 (G3DSA:3.30.1360.GENE3D); IPR001533 (PANTHER); PTHR12599:SF0 (PANTHER); IPR001533 (SUPERFAMILY),,
RL4_JR_00825,6598,5606,4446,0,0,4,0,0,1,0,0,1,3,3,0,0,0,3,82.04070097,1,-1.476493206,0.787132645,-1.875787029,0.06068453,0.153877893,30.89244402,1,-0.046379229,1.139150924,-0.040713858,0.967524013,0.983216586,61.92945469,1,-2.641808691,1.205280502,-2.191862132,0.028389463,0.073338843,103.8909928,1,-0.705094057,0.649752839,-1.085172722,0.277845163,0.421009021,76.33082726,1,-1.434926884,0.853536008,-1.681155651,0.092732685,0.180180088,N,-,,bzip transcription factor,"F:transcription factor activity, sequence-specific DNA binding; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR004827 (SMART); IPR004827 (PFAM); G3DSA:1.20.5.170 (GENE3D); PTHR19304:SF26 (PANTHER); PTHR19304 (PANTHER); SSF57959 (SUPERFAMILY),,
RL4_JR_00826,2937,2871,2373,0,0,5,0,0,0,0,0,0,0,0,2,0,7,0,51.93205281,1,-0.120501968,0.689069417,-0.174876384,0.861176767,0.931390702,10.53969919,0,0.067805322,1.228451437,0.055195769,0.955982499,0.976729066,27.22012345,0,-2.577554921,1.196844815,-2.153625005,0.031269592,0.079301941,50.66435852,1,-1.251943343,1.020597026,-1.226677435,0.219943852,0.355274777,53.71594273,1,0.746511133,0.591393067,1.262292668,0.206843494,0.329555784,N,-,,chromatin remodeling complex subunit,"P:DNA repair; C:mitotic spindle; F:ATP-dependent 3'-5' DNA helicase activity; C:DASH complex; P:DNA duplex unwinding; P:attachment of spindle microtubules to kinetochore; C:cytosol; P:regulation of transcription, DNA-templated; C:Ino80 complex; P:nucleosome mobilization",IPR004000 (SMART); G3DSA:3.90.640.10 (GENE3D); IPR004000 (PFAM); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR027664 (PTHR11937:PANTHER); IPR004000 (PANTHER); IPR027664 (PTHR11937:PANTHER); IPR004000 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_00827,383,333,323,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.15966277,0,-0.158752961,1.208212529,-0.131394897,0.895462925,0.94860497,1.334777703,0,3.048985947,1.366387632,2.231420921,0.02565326,0.069858031,3.44971029,0,0.402646494,1.206948083,0.333607137,0.738676032,0.824242935,3.978711917,0,-0.019366863,1.207277525,-0.016041765,0.987201072,0.992494375,3.387137552,0,0.326028883,1.199229126,0.271865381,0.785725531,0.853682906,N,-,,chromatin remodeling complex subunit,"P:DNA repair; F:ATP-dependent 3'-5' DNA helicase activity; P:DNA duplex unwinding; C:cytosol; P:regulation of transcription, DNA-templated; C:Ino80 complex; P:nucleosome mobilization",no IPS match,,
RL4_JR_00828,4831,8886,7892,13,7,36,0,0,0,8,3,7,9,6,1,0,3,8,411.5160127,1,1.918307855,0.460377646,4.166813641,3.09E-05,0.00030693,27.57186991,0,-1.319611553,1.228416618,-1.07423779,0.282716119,0.442022329,229.378023,1,1.051406235,0.480621418,2.187597547,0.028698931,0.074024962,200.3701365,1,0.411397492,0.547815025,0.750978841,0.45266539,0.594770653,141.4412721,1,0.083712364,0.623801122,0.1341972,0.89324664,0.930178158,N,-, Effector probability:0.856,profilin,"P:positive regulation of formin-nucleated actin cable assembly; P:sequestering of actin monomers; C:medial cortex; P:plasma membrane fusion involved in cytogamy; P:intracellular transport; F:guanyl-nucleotide exchange factor activity; P:actin filament polymerization; P:mitotic actomyosin contractile ring assembly; P:positive regulation of GTPase activity; F:actin monomer binding; C:nucleus; F:phosphatidylinositol-4,5-bisphosphate binding; F:proline-rich region binding; C:mating projection; C:cell cortex of cell tip; P:actin cortical patch organization; C:actin cytoskeleton; C:cytosol; C:extrinsic component of plasma membrane",IPR005455 (PRINTS); IPR005455 (PRINTS); IPR005455 (SMART); IPR005455 (PFAM); G3DSA:3.30.450.30 (GENE3D); IPR005455 (PANTHER); IPR005455 (SUPERFAMILY),,
RL4_JR_00829,846,1051,877,1,0,4,0,0,0,0,0,0,0,5,0,0,0,0,36.49832268,1,1.451078621,0.687614047,2.11030974,0.034831685,0.101629788,3.56196037,0,1.632894853,1.272845034,1.282870113,0.199537585,0.343197865,9.227659264,0,-1.01684072,1.201441014,-0.846350931,0.397357004,0.539511107,30.70284805,1,1.581489755,0.690978605,2.288768051,0.022092833,0.080442001,9.073397878,0,-1.095344417,1.201026188,-0.912007105,0.361764977,0.498789775,N,-,,Got1-like family,"P:ER to Golgi vesicle-mediated transport; C:integral component of membrane; C:cytosol; C:Golgi membrane; C:endoplasmic reticulum; C:ER to Golgi transport vesicle; C:Golgi cis cisterna; P:retrograde transport, endosome to Golgi; P:Golgi to endosome transport",IPR007305 (PFAM); PTHR21493 (PANTHER),,
RL4_JR_00830,7047,6333,4527,0,7,3,0,0,1,0,0,3,1,0,0,0,2,0,139.4402803,1,-0.157007531,0.618105896,-0.254013968,0.799484767,0.898250479,32.56085722,1,-0.154545857,1.144667138,-0.135013797,0.892600965,0.939851798,79.18917729,1,-1.317095037,0.884400393,-1.489251981,0.136421027,0.244317439,78.14520607,1,-3.179898346,1.166220508,-2.726669892,0.006397701,0.034057161,66.07102381,1,-2.118133759,0.99392588,-2.131078183,0.033082702,0.081146636,N,-,,dead deah box DNA helicase,F:nucleic acid binding; P:regulation of translation; F:ATP binding; P:cytoplasmic translation; C:cytosol; F:helicase activity,IPR001650 (SMART); IPR003593 (SMART); IPR004179 (SMART); IPR014001 (SMART); PIRSF039073 (PIRSF); IPR004179 (PFAM); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000008 (G3DSA:2.60.40.GENE3D); IPR011545 (PFAM); G3DSA:1.10.3380.10 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24031:SF336 (PANTHER); PTHR24031 (PANTHER); PTHR24031 (PANTHER); PTHR24031:SF336 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY); IPR027417 (SUPERFAMILY); SSF158702 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); SSF158702 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR014756 (SUPERFAMILY),,
RL4_JR_00831,687,482,812,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,7.875518064,0,-1.079928897,1.216002919,-0.888097289,0.374488421,0.56638423,2.511252631,0,2.137043262,1.30846679,1.633242263,0.102418054,0.206426831,6.527532934,0,-0.517758103,1.214283453,-0.42638982,0.669823818,0.772709245,17.1659024,1,0.011427524,1.160980415,0.009842995,0.992146553,0.995065735,21.18693217,1,1.095692913,0.997249592,1.098714827,0.271892473,0.404423577,N,-,,D111 G- partial,F:nucleic acid binding,IPR000467 (SMART); IPR000467 (PFAM); PTHR20923:SF1 (PANTHER); PTHR20923 (PANTHER); IPR000467 (PROSITE_PROFILES),,
RL4_JR_00832,569,601,1027,1,0,3,0,0,0,0,0,0,0,3,0,0,0,1,30.2738622,1,1.473288066,0.80419927,1.831993786,0.066952346,0.165514316,2.76409549,0,1.998588727,1.31120808,1.524234603,0.127450117,0.2438658,7.227214885,0,-0.664632611,1.225740965,-0.542229256,0.587660583,0.707793725,20.37590915,1,1.18658022,0.909435756,1.304743312,0.191980268,0.321023982,14.55289519,1,0.183098037,1.164234108,0.157269088,0.875032781,0.916625828,N,-,,Retinol dehydrogenase 13,C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:endomembrane system,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24320 (PANTHER); PTHR24320:SF54 (PANTHER); PTHR24320:SF54 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_00833,361,514,462,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,13.01678048,1,1.186966274,1.039898213,1.141425439,0.253692924,0.431351995,1.710198776,0,2.691370574,1.341664471,2.005993772,0.044856912,0.108285635,4.442152783,0,0.037851403,1.214641962,0.031162601,0.975139865,0.985851408,9.136874214,1,0.561365346,1.161494962,0.483312769,0.628873675,0.74489307,4.379397818,0,-0.044345128,1.215730223,-0.036476125,0.970902715,0.98031006,N,-,,---NA---,,no IPS match,,
RL4_JR_00834,2231,2234,1961,0,0,2,0,0,0,0,0,0,1,0,0,0,3,2,33.42218674,1,-1.063304421,1.013023227,-1.049634789,0.293886056,0.478945557,8.262284467,0,0.419025799,1.229439933,0.340826573,0.733234144,0.833535041,21.36280319,0,-2.227968106,1.19329037,-1.867079599,0.061890473,0.133485119,33.95232337,1,-1.700354056,1.144173108,-1.486098601,0.137253042,0.248869458,47.2872293,1,0.641586457,0.667217167,0.961585655,0.33625778,0.473336198,N,-, Effector probability:0.757,synaptobrevin,"P:vesicle fusion; C:fungal-type vacuole membrane; C:integral component of membrane; F:SNAP receptor activity; C:SNARE complex; P:vacuole fusion, non-autophagic",IPR001388 (PRINTS); IPR010908 (SMART); IPR010908 (PFAM); IPR001388 (PFAM); IPR010908 (G3DSA:3.30.450.GENE3D); IPR001388 (G3DSA:1.10.3840.GENE3D); PTHR21136 (PANTHER); PTHR21136:SF86 (PANTHER); IPR001388 (PROSITE_PROFILES); IPR010908 (PROSITE_PROFILES); SSF58038 (SUPERFAMILY); IPR011012 (SUPERFAMILY),1.F.1.1.2, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_00835,1101,887,1288,0,4,1,0,0,0,0,0,0,3,0,0,0,2,0,48.91392542,1,1.259335186,0.678287239,1.85663995,0.063362396,0.158773787,4.162511511,0,1.408017879,1.256913104,1.120218951,0.26262047,0.419149227,10.81430955,0,-1.246027955,1.1995648,-1.038733343,0.29892877,0.439749326,40.41290673,1,0.670015567,0.856051006,0.782681829,0.433813976,0.57585057,18.40619933,1,0.332101849,0.990921369,0.335144503,0.737516084,0.816282285,N,-,,cbf nf-y family transcription factor,C:nucleus; F:protein heterodimerization activity,IPR003958 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); PTHR10252 (PANTHER); PTHR10252:SF44 (PANTHER); IPR009072 (SUPERFAMILY),,
RL4_JR_00836,1062,1239,1459,4,0,9,0,0,0,0,0,1,1,5,2,3,4,0,89.68533503,1,2.389586171,0.477359626,5.005840546,5.56E-07,9.13E-06,4.781729814,0,1.207947471,1.245132879,0.97013539,0.331979011,0.49518001,18.94070407,1,-0.48641957,1.195987014,-0.406709742,0.684221185,0.783160574,62.99689246,1,1.852675352,0.551369362,3.360134749,0.000779045,0.00599379,75.81673918,1,1.920882977,0.601442887,3.193791161,0.001404177,0.006307581,N,-,,peroxisome biogenesis factor 7,"C:nucleus; C:peroxisome; F:peroxisome matrix targeting signal-2 binding; P:protein import into peroxisome matrix, docking; C:cytosol",IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22850 (PANTHER); PTHR22850:SF124 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),3.A.20.1.5, the peroxisomal protein importer (ppi) family.
RL4_JR_00837,6525,8160,6301,3,0,40,0,0,0,0,2,0,2,16,0,0,19,0,267.4344073,1,1.186412115,0.998073545,1.188702096,0.234556916,0.408260149,27.00420095,0,-1.289569373,1.211058237,-1.064828539,0.286953528,0.446509394,85.57400488,1,-2.113428972,1.042186412,-2.027879992,0.042572498,0.10020095,163.4277014,1,0.366267443,0.536924584,0.682158079,0.495138999,0.633950729,141.9872913,1,0.241994606,1.513437572,0.159897316,0.872961963,0.915931593,N,-,,cell division control 3,F:GTP binding; P:cell division,IPR016491 (PIRSF); IPR030379 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR18884:SF75 (PANTHER); IPR016491 (PANTHER); IPR030379 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_00838,5931,6902,11832,0,0,2,0,0,2,0,3,2,0,3,0,0,0,0,105.9454869,1,-3.022933975,1.083788002,-2.789229968,0.005283353,0.02271769,49.7385821,1,0.140073624,1.023133699,0.136906471,0.891104724,0.93877623,117.6346418,1,-1.018831774,0.725906846,-1.40352964,0.16045896,0.275757343,105.6521723,1,-2.309370656,0.923378094,-2.501002212,0.012384241,0.057439503,80.75575344,0,-4.249272466,1.23685598,-3.435543455,0.000591367,0.00311529,N,-,,30S ribosomal subunit,C:intracellular organelle; F:RNA binding; C:cytoplasmic part,IPR002942 (SMART); IPR002942 (PFAM); IPR002942 (G3DSA:3.10.290.GENE3D); IPR022801 (PANTHER); PTHR11831:SF4 (PANTHER); PTHR11831:SF4 (PANTHER); IPR022801 (PANTHER); IPR002942 (PROSITE_PROFILES); SSF55174 (SUPERFAMILY),,
RL4_JR_00839,10488,15868,18157,3,1,1,0,0,2,1,0,3,0,8,0,0,4,0,220.6491603,1,-2.457439874,0.742449392,-3.309908933,0.000933263,0.005636714,75.22256432,1,-0.718753412,1.004408253,-0.715598871,0.474239071,0.631528467,177.8663706,1,-2.19727239,0.780446929,-2.815402698,0.004871615,0.018604386,202.0863729,1,-1.826439308,0.653719914,-2.793917195,0.005207381,0.028890265,161.3774008,1,-2.536404163,0.824951382,-3.074610477,0.002107776,0.008851612,N,-,,la domain-containing,F:nucleotide binding; C:nucleus; F:RNA binding; C:intracellular ribonucleoprotein complex; P:RNA processing,IPR002344 (PRINTS); IPR000504 (SMART); IPR006630 (SMART); IPR011991 (G3DSA:1.10.10.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR006630 (PFAM); IPR000504 (PFAM); PTHR22792:SF70 (PANTHER); PTHR22792:SF70 (PANTHER); PTHR22792 (PANTHER); PTHR22792 (PANTHER); IPR006630 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR011991 (SUPERFAMILY),,
RL4_JR_00840,1293,732,1658,0,0,2,0,0,0,0,0,2,0,1,0,0,0,1,22.2210562,1,-0.267653541,1.077713146,-0.24835323,0.803861117,0.901349047,4.643125824,0,1.250350818,1.300729562,0.961268856,0.336417003,0.499444544,25.0896279,1,0.401796654,1.07963432,0.372159949,0.709773764,0.803385445,17.96298417,1,-0.885417341,1.189139446,-0.744586637,0.456521649,0.598586078,19.35810275,1,-0.553761105,1.173704651,-0.471806177,0.637065141,0.739118203,N,-,,MFS multidrug transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502:SF60 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.86, the major facilitator superfamily (mfs).
RL4_JR_00841,149,247,300,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,26.82254438,1,2.792459305,0.91803966,3.041763258,0.002351968,0.011917612,0.880173616,0,3.649548691,1.467919644,2.486204681,0.012911368,0.040929805,2.300470131,0,0.986933806,1.252850378,0.787750735,0.430842523,0.571371457,2.655198036,0,0.563916105,1.269828248,0.444088487,0.65697861,0.766260618,2.283655674,0,0.895096397,1.256565708,0.712335528,0.476257028,0.606172522,Y,-,,"galacturan 1,4-alpha-galacturonidase C","P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR012334 (G3DSA:2.160.20.GENE3D); IPR000743 (PFAM); PTHR31736 (PANTHER); PTHR31736:SF10 (PANTHER); IPR011050 (SUPERFAMILY),,
RL4_JR_00842,5692,4388,4412,0,1,10,0,0,0,0,0,1,2,5,0,0,0,0,104.1326119,1,0.149296671,0.529949224,0.281718821,0.778159122,0.885757236,18.63203546,0,-0.754167974,1.216279269,-0.620061522,0.535217284,0.683038102,54.59900699,1,-2.437179977,1.196869715,-2.036295134,0.041720728,0.098848737,94.15384863,1,-0.299579259,0.593191903,-0.505029245,0.613538296,0.732713144,47.18726886,0,-3.474137236,1.19349295,-2.910898833,0.003603907,0.013728201,N,-,,fungal specific transcription factor,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR007219 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); PTHR31313 (PANTHER); PTHR31313:SF41 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00843,471,348,539,0,0,2,0,0,0,0,0,1,0,4,0,0,1,0,13.04212299,1,1.183582562,1.029842744,1.149284751,0.250438584,0.427718985,1.724541033,0,2.679245658,1.337788995,2.00274159,0.045205032,0.108944128,10.97838376,1,0.987058991,1.20387525,0.81990139,0.412272324,0.554442748,21.21424484,1,2.302869375,0.770839622,2.987481843,0.00281286,0.017623891,8.287036144,1,0.868662362,1.143193086,0.759856207,0.447340541,0.579716239,N,-,,bis(5 -adenosyl)-triphosphatase,P:nucleoside catabolic process; F:pyrophosphatase activity,IPR001310 (PFAM); IPR011146 (G3DSA:3.30.428.GENE3D); PTHR23089:SF19 (PANTHER); IPR001310 (PANTHER); IPR011146 (PROSITE_PROFILES); IPR011146 (SUPERFAMILY),,
RL4_JR_00844,1084,882,951,0,3,0,0,0,2,2,4,1,0,3,0,1,1,0,35.69008802,1,0.676242496,0.84448729,0.800772852,0.423263158,0.61472463,22.49685292,1,3.199139546,1.00116497,3.195416982,0.001396289,0.015023052,69.68217722,1,2.551430876,0.573847908,4.446179622,8.74E-06,0.000169206,23.18975084,1,0.79620983,0.856494442,0.929614707,0.35257061,0.499043207,29.39111759,1,0.515818819,0.969493402,0.53204985,0.59469147,0.70586087,N,-,,amino acid transporter,C:membrane,IPR013057 (PFAM); PTHR22950:SF332 (PANTHER); PTHR22950 (PANTHER); PTHR22950:SF332 (PANTHER),2.A.18.7.3, the amino acid/auxin permease (aaap) family.
RL4_JR_00845,978,1838,1158,0,0,0,0,0,0,0,0,3,2,11,0,0,0,1,16.09792494,0,-2.111022062,1.244878996,-1.695764864,0.089930419,0.204930826,5.120875241,0,1.109167029,1.29929985,0.853665171,0.393290537,0.557469097,32.77171827,1,0.844362063,0.91053732,0.927322851,0.353758934,0.497079173,78.06843478,1,2.327299011,0.604243154,3.851593514,0.000117352,0.001223672,20.40969993,1,-0.676618019,1.164755865,-0.580909734,0.561301292,0.679399352,N,-,,major facilitator superfamily MFS-1,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23507 (PANTHER); PTHR23507:SF7 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.11.4, the major facilitator superfamily (mfs).
RL4_JR_00846,75,91,132,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1.190543288,0,1.645998941,1.458910353,1.128238577,0.259219176,NA,0.376191749,0,4.875799572,1.63814439,2.976416245,0.002916387,0.01539889,0.982611388,0,2.21380139,1.260456681,1.75634865,0.079028895,0.161210666,5.145614003,1,2.73538652,1.183448413,2.311369461,0.020812456,0.078120428,0.975637392,0,2.122135726,1.249968214,1.697751753,0.089554626,0.175724919,N,-,,---NA---,,no IPS match,,
RL4_JR_00847,27,21,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.411689648,0,3.177845237,2.265419759,1.402762214,0.160687758,NA,0.129568808,0,6.413210664,2.048993558,3.129932077,0.001748467,0.015023052,0.340034977,0,3.743727965,1.377224732,2.718313053,0.006561572,0.023349511,0.392505454,0,3.321387427,1.60121067,2.074297586,0.038051682,0.103895617,0.339857429,0,3.643388946,1.322986508,2.753912397,0.005888753,0.020482179,N,-,,---NA---,,no IPS match,,
RL4_JR_00848,7960,3696,4355,11,10,6,0,0,2,0,5,3,0,1,0,0,7,0,277.37528,1,1.651642726,0.610227546,2.706601394,0.006797582,0.027993273,39.42428065,1,0.707702317,1.067886017,0.662713348,0.50751416,0.659781444,111.7955962,1,0.260712443,0.641539537,0.406385621,0.684459283,0.783173847,65.20699332,1,-3.018843454,1.19741818,-2.521127125,0.011697958,0.054808804,78.89023348,1,-0.312475116,0.731607131,-0.427107805,0.669300809,0.765007013,N,-,,riboflavin transporter mch5,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11360:SF118 (PANTHER); PTHR11360 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.13.19, the major facilitator superfamily (mfs).
RL4_JR_00849,4877,5318,9609,0,2,2,0,0,0,0,0,0,1,3,0,0,0,1,102.5145022,1,-1.676085678,0.825279144,-2.030931824,0.042261911,0.117469393,24.85627927,0,-1.170065279,1.228623984,-0.952337977,0.340925604,0.503905086,65.07884947,0,-3.835153571,1.223745539,-3.133946925,0.00172472,0.008805381,96.46238369,1,-1.55616095,0.813083279,-1.913901061,0.055632799,0.130813304,72.18036715,1,-2.9889772,1.167818385,-2.559453797,0.010483679,0.032580494,N,-,,diphthamide biosynthesis 2,P:lipid transport; P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine; C:cytoplasm; F:lipid transporter activity; C:integral component of membrane,IPR010014 (TIGRFAM); IPR016435 (PFAM); IPR016435 (TIGRFAM); IPR010014 (PTHR10762:PANTHER); IPR016435 (PANTHER),,
RL4_JR_00850,572,529,980,2,2,0,0,0,0,0,0,1,0,0,0,0,0,0,44.4282197,1,1.660704209,0.799129694,2.078141034,0.037696371,0.107866361,2.616755818,0,2.07761225,1.318236854,1.576053835,0.115013397,0.226095475,13.33830871,1,0.376637936,1.220693206,0.308544304,0.757668193,0.837039807,7.89342961,0,-1.008018872,1.230243772,-0.81936515,0.412578112,0.556461088,6.801784117,0,-0.679675701,1.24062084,-0.547851268,0.583794032,0.696631064,N,-,,oligosaccharide translocation rft1,P:lipid transport; C:membrane part; P:cellular process,IPR007594 (PFAM); IPR007594 (PANTHER),2.A.66.3.1, the multidrug/oligosaccharidyl-lipid/polysaccharide (mop) flippase superfamily.
RL4_JR_00851,28643,34418,45440,0,2,5,0,1,2,1,0,2,0,4,3,0,11,0,469.0780378,1,-3.36412863,0.639161871,-5.263343733,1.41E-07,2.72E-06,194.5100715,1,-1.437860201,0.866162501,-1.660035155,0.096907381,0.197801272,382.4071754,1,-3.889302063,0.875267437,-4.443558503,8.85E-06,0.00016966,458.4722963,1,-3.184085281,0.613858121,-5.187005224,2.14E-07,4.47E-06,397.5882474,1,-2.567143394,0.767064956,-3.346709265,0.000817769,0.004068754,N,-,,atp-dependent rna helicase dbp-3,"F:nucleic acid binding; F:ATP binding; P:RNA secondary structure unwinding; C:nucleolus; P:ribosomal large subunit assembly; C:preribosome, large subunit precursor; F:ATP-dependent RNA helicase activity; P:endonucleolytic cleavage in ITS1 upstream of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",IPR014001 (SMART); IPR001650 (SMART); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24031:SF215 (PANTHER); PTHR24031 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_00852,271,195,349,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,10.87568742,1,1.914133102,1.050460893,1.822184067,0.068427061,0.168090324,1.030622803,0,3.421888502,1.420608187,2.408748966,0.016007304,0.048481727,2.682702556,0,0.76490825,1.231639255,0.621048937,0.534567425,0.663897013,3.095213698,0,0.342449057,1.240515926,0.276053737,0.782506793,0.860060929,2.657336854,0,0.676177546,1.234753691,0.547621401,0.583951892,0.696737321,N,-,,zinc-finger transcription factor,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR021858 (PFAM),,
RL4_JR_00853,57,35,83,3,0,3,0,0,0,0,0,0,0,0,0,0,0,0,42.34467911,1,5.758137917,0.70975485,8.112854624,4.94E-16,3.72E-14,0.219912199,0,5.650237597,1.838162373,3.073851189,0.002113148,0.015045494,0.573921341,0,2.989012797,1.314204717,2.274389034,0.022942606,0.062005057,0.662252112,0,2.566812588,1.426207098,1.79974745,0.071900525,0.154137797,0.570405071,0,2.895985867,1.284880211,2.253895609,0.024202736,0.06349142,N,-, Effector probability:0.552,short chain dehydrogenase ( ),F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); IPR002347 (PANTHER); PTHR24322:SF344 (PANTHER); IPR002347 (PANTHER); PTHR24322:SF344 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_00854,7851,3624,6487,24,15,13,0,0,1,0,0,2,0,0,0,0,0,0,482.5470761,1,2.476931477,0.609812919,4.061789113,4.87E-05,0.000459282,32.29234473,1,-0.138993783,1.161291665,-0.119688953,0.904729552,0.94652946,72.23212553,1,-1.890292684,1.078701249,-1.75237832,0.079708777,0.162237969,68.31082945,0,-4.121237575,1.233633312,-3.340731427,0.00083558,0.006389916,58.29649642,0,-3.779136929,1.232072136,-3.067301678,0.002160007,0.009033488,N,-,,maltose permease mal61,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR003663 (TIGRFAM); IPR005828 (PFAM); PTHR23500:SF69 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.11, the major facilitator superfamily (mfs).
RL4_JR_00855,2671,1759,2460,0,1,4,0,0,0,0,0,0,0,0,0,0,0,0,50.7123792,1,0.149234216,0.69131283,0.215870746,0.829088501,0.914632047,8.79587599,0,0.328687381,1.237109178,0.265689874,0.790478063,0.87373468,22.77105215,0,-2.320188885,1.202110208,-1.93009665,0.053594864,0.119277731,26.26394568,0,-2.742242894,1.201889091,-2.281610604,0.02251234,0.080886247,22.42277602,0,-2.40071824,1.205041627,-1.992228473,0.046345996,0.105687659,N,-,,arca,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR021858 (PFAM); PTHR37534 (PANTHER); PTHR37534:SF1 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00856,336,616,422,0,0,5,0,0,0,6,0,0,0,1,0,0,0,4,24.65160465,1,2.379125844,0.78620935,3.026071672,0.002477536,0.012415071,1.766803231,0,2.644429478,1.378476579,1.918370989,0.055063987,0.127445216,71.00407349,1,3.776745312,1.681506705,2.246048322,0.024700913,0.065877777,9.300701878,1,0.514277887,1.18875285,0.432619688,0.665291084,0.771685885,33.97125403,1,2.606314782,0.812483709,3.207836357,0.001337376,0.006061293,N,-,,inositol oxygenase,F:inositol oxygenase activity; C:cytoplasm; F:iron ion binding; P:inositol catabolic process; P:oxidation-reduction process,IPR007828 (PFAM); PTHR12588:SF0 (PANTHER); IPR007828 (PANTHER); SSF109604 (SUPERFAMILY),,
RL4_JR_00857,257,302,323,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7.354760127,1,1.022517994,1.155372181,0.885011783,0.376150276,0.567659088,1.124960422,0,3.295628608,1.381155222,2.386139194,0.017026305,0.050877602,2.923014414,0,0.641525231,1.209296176,0.530494716,0.595768972,0.714979264,3.37245554,0,0.219025121,1.211901543,0.180728478,0.856580705,0.910465716,2.884831573,0,0.557920811,1.20861451,0.46162015,0.644353742,0.745694552,N,-,,MEI5,,no IPS match,,
RL4_JR_00858,17,19,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.232236805,0,4.003971291,2.780683117,1.439923617,0.149889011,NA,0.073845315,0,7.224765874,2.217270333,3.258405512,0.001120402,0.015023052,0.191990908,0,4.569606122,1.348379493,3.38896145,0.000701579,0.004336253,0.221516413,0,4.14725036,1.732057174,2.394407311,0.01664725,0.069939175,0.189650622,0,4.485686775,1.254906875,3.574517651,0.000350874,0.001998088,N,-,,---NA---,,no IPS match,,
RL4_JR_00859,7,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.040048427,0,6.539679192,3.933323561,1.662634434,0.096385634,NA,0.013368794,0,9.692075144,3.932229642,2.464778516,0.013709797,0.042883363,0.033672224,0,7.082952623,2.521469773,2.809057121,0.004968683,0.018847114,0.038771083,0,6.662108255,3.932980377,1.693908338,0.090282702,0.181335521,0.032173391,0,7.03898856,1.680362782,4.188969571,2.80E-05,0.000238827,N,-,,monooxygenase,"F:NADP binding; F:flavin adenine dinucleotide binding; C:integral component of membrane; P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; F:N,N-dimethylaniline monooxygenase activity",IPR020946 (PFAM); PF13450 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR23023 (PANTHER); PTHR23023:SF139 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_00860,47,121,87,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.033635707,0,1.85016512,1.642079196,1.126721004,0.259860459,NA,0.32646996,0,5.080521222,1.752622086,2.898811593,0.003745799,0.017473407,0.850202575,0,2.423490272,1.322853684,1.832016875,0.066948907,0.141797224,0.981199673,0,2.00045272,1.403013358,1.425825855,0.153918616,0.270983479,0.839140172,0,2.339841904,1.299949571,1.79994821,0.071868816,0.147810637,N,-,,aldehyde dehydrogenase,"F:NADP binding; F:flavin adenine dinucleotide binding; P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; F:N,N-dimethylaniline monooxygenase activity",IPR016162 (G3DSA:3.40.605.GENE3D); IPR015590 (PFAM); IPR016163 (G3DSA:3.40.309.GENE3D); PTHR11699 (PANTHER); PTHR11699:SF196 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_00861,17,53,44,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4.280156869,1,3.952223821,1.312321232,3.011628346,0.002598505,0.012900743,0.145087398,0,6.250447072,2.044925509,3.056564674,0.002238892,0.015045494,0.379144601,0,3.588490298,1.399890585,2.563407696,0.010365026,0.033602892,0.437652154,0,3.165134284,1.613424109,1.961749714,0.049791631,0.122632027,0.375595366,0,3.500096871,1.341050125,2.609967224,0.00905509,0.029008788,N,-,,alcohol dehydrogenase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR013149 (PFAM); IPR013154 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); PTHR11695:SF484 (PANTHER); IPR002085 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_00862,101,244,162,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,2.056523759,0,0.857715926,1.416670246,0.605445007,0.544883354,NA,0.65096108,0,4.084924265,1.576891112,2.590492288,0.009583877,0.032673628,23.83253672,1,3.287651307,1.089555866,3.017423346,0.002549335,0.01200999,1.953172516,0,1.007235568,1.325753818,0.759745553,0.447406694,0.589535759,1.66762738,0,1.348756851,1.283502254,1.050841046,0.293331601,0.428211381,N,-,,3-oxoacyl-[acyl-carrier- ] reductase,,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_00863,19,37,36,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.370607521,0,3.329791238,2.32411016,1.432716613,0.15193884,NA,0.116979345,0,6.561083809,2.061324182,3.18294612,0.001457847,0.015023052,0.305196171,0,3.901327894,1.349901654,2.890083054,0.003851401,0.016036854,0.352234398,0,3.478285362,1.587783955,2.190654057,0.028476836,0.089620303,0.302164146,0,3.81425053,1.283719002,2.971250347,0.002965899,0.011716632,Y,-,,"2,3-bisphosphoglycerate-independent phosphoglycerate mutase",,no IPS match,,
RL4_JR_00864,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.012706323,0,8.20293094,3.990270723,2.055732934,0.039808266,NA,0.004020132,0,11.42967648,3.991033794,2.863838561,0.004185413,0.018371529,0.010357064,0,8.787173804,3.991470463,2.201487869,0.027701505,0.072039566,0.01195084,0,8.36455496,3.991447685,2.095619339,0.036115972,0.100959199,0.010019356,0,8.741909568,1.949319774,4.484594926,7.31E-06,7.74E-05,N,-,,metallo-beta-lactamase superfamily,,IPR001279 (SMART); IPR001279 (PFAM); IPR001279 (G3DSA:3.60.15.GENE3D); PTHR11935 (PANTHER); PTHR11935 (PANTHER); PTHR11935:SF100 (PANTHER); PTHR11935:SF100 (PANTHER); IPR001279 (SUPERFAMILY),,
RL4_JR_00865,34,8,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.228768884,0,4.025445819,2.945886449,1.366463334,0.171793582,NA,0.074804927,0,7.206439253,2.360948592,3.052349076,0.002270579,0.0150814,0.191608366,0,4.572336379,1.513187865,3.021658106,0.002513943,0.011881961,0.220824388,0,4.15162657,1.9474272,2.131852,0.033019015,0.097241379,0.186972356,0,4.503018315,1.382241703,3.257764764,0.001122935,0.005239499,N,-,,c6 zinc finger domain containing,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_00866,39,94,81,0,0,127,0,0,0,0,0,0,0,0,0,0,2,0,485.8210948,1,9.13857467,2.421715509,3.773595468,NA,NA,0.272600788,0,5.340610845,1.793529974,2.977709279,0.002904113,0.015363307,0.711313931,0,2.680654736,1.323096647,2.02604605,0.042760066,0.100394923,0.820983254,0,2.25754443,1.418012822,1.592047967,0.111373927,0.212451359,8.424975154,1,4.231848847,1.072029047,3.947513231,7.90E-05,0.000569881,N,-,,short chain dehydrogenase reductase family,,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); PTHR24322:SF633 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_00867,11,8,14,0,0,8,0,0,0,0,0,1,0,0,0,0,1,0,30.67960158,1,8.434125681,0.6981282,12.08105571,1.33E-33,7.75E-31,0.041753297,0,8.047120654,2.493906366,3.226713225,0.001252209,0.015023052,6.607391356,1,6.347146929,1.237403287,5.129408495,2.91E-07,9.05E-06,0.125365019,0,4.968216048,2.13467165,2.327391216,0.019944453,0.076714457,3.968135114,1,6.229630852,1.180439166,5.277384071,1.31E-07,2.86E-06,N,-,,integral membrane partial,C:integral component of membrane,PTHR33048 (PANTHER),2.A.1.7.25, the major facilitator superfamily (mfs).
RL4_JR_00868,2,3,4,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0.036038566,0,6.691887793,3.936267545,1.700059185,0.089119794,NA,0.011360376,0,9.924477985,3.208780189,3.092913008,0.001982022,0.015023052,23.55859532,1,9.666447794,0.994768759,9.717281231,2.54E-22,4.37E-20,0.0342852,0,6.838770256,3.522579786,1.941409612,0.052208613,0.125807414,0.02951127,0,7.172883508,1.387887465,5.168202531,2.36E-07,4.41E-06,Y,-,,Glucarate dehydratase,,no IPS match,,
RL4_JR_00869,11,7,37,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.216176223,0,4.107087383,3.083175193,1.332096662,0.182828427,NA,0.067261135,0,7.358510516,2.431287272,3.026590317,0.002473289,0.015349618,0.178151166,0,4.675564319,1.57919912,2.960718671,0.003069222,0.013767301,0.205742147,0,4.253035923,2.055369161,2.069232138,0.038524308,0.104882662,0.179942238,0,4.560918559,1.459623717,3.124722151,0.001779731,0.007674521,Y,-,,glycoside hydrolase family 92,F:catalytic activity; C:membrane; F:binding,IPR014718 (G3DSA:2.70.98.GENE3D); G3DSA:1.20.1610.10 (GENE3D); IPR012939 (PFAM); G3DSA:1.20.1050.60 (GENE3D); G3DSA:3.30.2080.10 (GENE3D); PTHR12143 (PANTHER); PTHR12143 (PANTHER); PTHR12143:SF22 (PANTHER); PTHR12143:SF22 (PANTHER); IPR008928 (SUPERFAMILY),1.C.96.1.3," the haemolytic lectin, cel-iii (cel-iii) family"
RL4_JR_00870,197,130,238,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.243544946,0,0.731613315,1.302083078,0.561879136,0.574198369,0.749991058,0.715121009,0,3.949146405,1.492328108,2.646299017,0.008137785,0.028983342,1.859785233,0,1.293382791,1.242375434,1.041056315,0.297849413,0.438543842,2.145618275,0,0.871060274,1.26008107,0.6912732,0.48939387,0.629460485,1.840800238,0,1.205758039,1.24031725,0.972136797,0.330982498,0.467783053,N,-, Effector probability:0.554,transporter protein,,no IPS match,,
RL4_JR_00871,5376,5655,13798,0,2,45,0,0,0,0,0,38,0,1,2,0,6,0,286.342308,1,0.99927016,1.151818293,0.867558856,0.385635879,0.578863195,30.86411667,0,-1.482376076,1.26010476,-1.176391141,0.23943861,0.391296424,328.1417202,1,1.614602066,2.192468168,0.736431247,0.461468295,0.599026203,117.0165465,1,-2.222166357,0.954047065,-2.32919993,0.019848477,0.07655841,104.4669731,1,-1.220132965,0.852721013,-1.430870058,0.15246746,0.262141822,N,-,,high-affinity glucose transporter rgt2,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,IPR003663 (PRINTS); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); IPR003663 (TIGRFAM); PTHR23500 (PANTHER); PTHR23500:SF84 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.68, the major facilitator superfamily (mfs).
RL4_JR_00872,23,19,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.263433001,0,3.822083562,2.627466326,1.454665098,0.145761999,NA,0.084193052,0,7.035627751,2.161288378,3.255293381,0.001132753,0.015023052,0.218318389,0,4.384044773,1.33213875,3.290982094,0.000998383,0.005746234,0.251840908,0,3.962085743,1.660557224,2.385997716,0.017032857,0.070824507,0.21522089,0,4.301965088,1.247797918,3.447645669,0.000565495,0.003000757,N,-,,aaa family ATPase,F:nucleotide binding,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003959 (PFAM); PTHR23077:SF47 (PANTHER); PTHR23077 (PANTHER); IPR027417 (SUPERFAMILY),3.A.16.1.3, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_00873,0,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.024701871,0,7.238701169,3.949789044,1.832680452,0.066850106,NA,0.007694775,0,10.48756637,3.950855392,2.654505246,0.00794248,0.02841517,0.020152476,0,7.824018738,2.683596837,2.915497078,0.003551224,0.015351236,0.023270171,0,7.399037905,3.950359032,1.873003908,0.061067845,0.137947378,0.019940236,0,7.746134954,1.600920209,4.838551548,1.31E-06,1.80E-05,N,-,,paxneb superfamily,C:nucleus; C:Elongator holoenzyme complex; C:cytosol,no IPS match,,
RL4_JR_00874,102,158,194,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.820343546,0,1.033511074,1.365803536,0.756705519,0.449226307,NA,0.574406382,0,4.265251693,1.544273898,2.761978751,0.005745222,0.022566214,1.500483848,0,1.603375254,1.256602271,1.275960812,0.201969372,0.327472442,1.731784686,0,1.180445223,1.284773895,0.918796084,0.358202241,0.50414202,1.488868228,0,1.512325475,1.253708883,1.206281216,0.227709078,0.35496131,N,-,,benzoate 4-monooxygenase cytochrome P450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305:SF94 (PANTHER); PTHR24305 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_00875,22,7,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.150500893,0,4.62959205,3.441741033,1.345130853,0.178582981,NA,0.049267511,0,7.809151871,2.513103201,3.107374129,0.001887573,0.015023052,0.125986461,0,5.177623813,1.537629696,3.367276157,0.000759146,0.004624306,0.145188209,0,4.756739124,2.15143695,2.21095911,0.027038669,0.087339591,0.122620392,0,5.110467868,1.359595523,3.75881487,0.00017072,0.001090562,Y,-,,Pre-mRNA-splicing regulator WTAP,P:cell adhesion,no IPS match,8.A.28.1.1, the ankyrin (ankyrin) family.
RL4_JR_00876,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,regulator of G- signaling 3- partial,,no IPS match,,
RL4_JR_00877,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.012021509,0,8.275938237,3.994557068,2.071803731,0.038283749,NA,0.003842866,0,11.4894157,3.940199092,2.915948011,0.003546096,0.016928889,0.009954621,0,8.839817482,2.38250595,3.710302374,0.000207012,0.001791132,0.011482935,0,8.417149062,3.994556965,2.107154594,0.035104181,0.099498352,0.009795195,0,8.760474239,1.567861258,5.587531547,2.30E-08,8.07E-07,N,-,,C immunoglobulin-A-binding beta partial,F:zinc ion binding; F:metal ion binding; F:helicase activity,no IPS match,3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_00878,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.035128172,0,6.727520446,3.937002433,1.708792555,0.087489382,NA,0.011851484,0,9.86545478,3.935469214,2.506805223,0.012182782,0.039159773,0.029817427,0,7.256480674,2.728853436,2.659168345,0.007833381,0.026937891,0.034319564,0,6.837337772,3.936353153,1.736972651,0.082391998,0.169591174,0.028609445,0,7.205940358,1.872474392,3.848351885,0.000118915,0.000801609,Y,-,,hypothetical protein SPSK_06470,,no IPS match,,
RL4_JR_00879,10,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.071877513,0,5.695819613,3.921584421,1.452428152,0.146382593,NA,0.02355735,0,8.874230252,2.873442435,3.08836194,0.002012632,0.015023052,0.060083732,0,6.247280626,1.683855068,3.710105902,0.000207173,0.001791132,0.069236274,0,5.825382506,2.759673988,2.110895175,0.034781323,0.099426657,0.058219191,0,6.183716455,1.37275385,4.504606893,6.65E-06,7.15E-05,N,-,,cytochrome P450,"F:iron ion binding; F:metal ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR002401 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24279 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_00880,677,490,458,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.496802567,0,-0.802097855,1.216620239,-0.659283669,0.509713627,0.69594038,2.095393825,0,2.39837701,1.339913034,1.789949758,0.073461989,0.159498552,5.399123108,0,-0.243652732,1.217103872,-0.200190581,0.841331533,0.89782233,6.225750277,0,-0.665360529,1.217538848,-0.546479917,0.584736089,0.709886439,5.286177234,0,-0.316160195,1.211109962,-0.26104995,0.794053988,0.860467656,N,-,,carotenoid cleavage dioxygenase 1,"F:dioxygenase activity; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; P:oxidation-reduction process",IPR004294 (PFAM); PTHR10543:SF24 (PANTHER); IPR004294 (PANTHER); PTHR10543:SF24 (PANTHER); IPR004294 (PANTHER); IPR004294 (PANTHER),,
RL4_JR_00881,1351,510,531,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13.31596314,1,-0.408962006,1.249652747,-0.327260519,0.743470851,0.865102725,3.107550132,0,1.829798541,1.417548991,1.290818556,0.196766602,0.340107846,7.944608681,0,-0.800977455,1.284560018,-0.623542259,0.532928241,0.662414428,9.155582377,0,-1.221830855,1.294512067,-0.943854357,0.345244079,0.491991034,7.726300023,0,-0.863663329,1.286879003,-0.671130174,0.502137606,0.629771245,N,-,,methyltransferase type 12,"F:DNA binding; C:nucleus; F:zinc ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:methyltransferase activity; F:transferase activity; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter; P:methylation",IPR007219 (PFAM); PTHR31845:SF14 (PANTHER); PTHR31845 (PANTHER),,
RL4_JR_00882,2381,2459,1639,0,0,5,0,0,0,2,0,1,0,2,0,0,0,0,45.16734772,1,0.181781327,0.734344462,0.247542313,0.804488549,0.901630269,8.388252513,0,0.397206865,1.257143942,0.315959734,0.752033071,0.848613869,50.25666422,1,0.174605078,0.875667064,0.199396649,0.841952482,0.898291718,32.95321541,1,-0.953418277,1.045203376,-0.91218446,0.361671623,0.507754463,21.14127619,0,-2.315779455,1.208864365,-1.915665248,0.055407719,0.121140823,N,-,,cytochrome P450,F:oxidoreductase activity; F:binding,IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR003097 (PFAM); IPR023173 (G3DSA:1.20.990.GENE3D); IPR008254 (PFAM); G3DSA:2.40.30.10 (GENE3D); IPR001433 (PFAM); IPR029039 (G3DSA:3.40.50.GENE3D); IPR001128 (PFAM); IPR023206 (PIRSF); G3DSA:3.40.50.80 (GENE3D); PTHR19384 (PANTHER); PTHR19384:SF70 (PANTHER); IPR017927 (PROSITE_PROFILES); IPR008254 (PROSITE_PROFILES); IPR017938 (SUPERFAMILY); IPR029039 (SUPERFAMILY); IPR001128 (SUPERFAMILY); SSF52343 (SUPERFAMILY),,
RL4_JR_00883,607,808,1105,0,2,0,0,0,0,4,0,2,0,6,0,0,0,0,26.10089846,1,0.329435931,1.045254034,0.315173078,0.752630245,0.870775614,3.183283845,0,1.794913944,1.295005443,1.386028107,0.165738321,0.298824953,65.59320566,1,2.566313538,0.658260602,3.898628492,9.67E-05,0.001136179,33.66697012,1,1.947339484,0.693698896,2.80718262,0.00499769,0.028065231,8.25567282,0,-0.959107256,1.231921791,-0.778545573,0.436247451,0.571041428,N,-,,mitotic spindle checkpoint component mad2,P:mitotic spindle assembly checkpoint; P:chromosome decondensation; C:mitotic spindle microtubule; C:nuclear chromatin; C:condensed nuclear chromosome kinetochore; C:mitotic checkpoint complex; C:nuclear periphery; F:anaphase-promoting complex binding; P:mitotic DNA integrity checkpoint; P:mitotic cell cycle checkpoint inhibiting CAR assembly; C:nuclear pore,IPR003511 (G3DSA:3.30.900.GENE3D); IPR003511 (PFAM); PTHR11842 (PANTHER); IPR027097 (PTHR11842:PANTHER); IPR003511 (PROSITE_PROFILES); IPR003511 (SUPERFAMILY),,
RL4_JR_00884,2417,3123,2589,4,0,8,0,0,0,3,0,1,1,0,0,0,4,0,103.5234624,1,1.159346992,0.501199106,2.31314657,0.020714582,0.067541791,10.43505492,0,0.082182851,1.225798598,0.067044334,0.946546409,0.971385497,66.75187181,1,0.267901882,0.752607318,0.355965024,0.721866759,0.811659159,40.50982292,1,-2.040006599,1.150901663,-1.772529023,0.076306782,0.160859081,42.04099149,1,-0.04594188,0.765638007,-0.060004702,0.95215189,0.96889828,N,-,,ubiquitin carboxyl-terminal hydrolase 14,F:thiol-dependent ubiquitin-specific protease activity; P:protein deubiquitination; F:zinc ion binding; P:ubiquitin-dependent protein catabolic process,IPR015940 (SMART); IPR001607 (SMART); IPR016652 (PIRSF); G3DSA:1.10.8.10 (GENE3D); IPR001394 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR015940 (PFAM); IPR001607 (PFAM); PTHR24006 (PANTHER); PTHR24006:SF22 (PANTHER); PTHR24006 (PANTHER); PTHR24006:SF22 (PANTHER); IPR015940 (PROSITE_PROFILES); IPR028889 (PROSITE_PROFILES); IPR015940 (PROSITE_PROFILES); IPR001607 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY); SSF57850 (SUPERFAMILY); SSF57850 (SUPERFAMILY); IPR009060 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_00885,11,10,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.120241053,0,4.953608973,3.684245538,1.34453823,0.178774403,NA,0.038596889,0,8.161138748,2.52706793,3.229489264,0.001240115,0.015023052,0.099705416,0,5.515851142,1.450294481,3.803262865,0.000142803,0.001422967,0.114992954,0,5.093310824,2.186340183,2.329605824,0.019826994,0.076540006,0.097826264,0,5.439357552,1.279278386,4.251895141,2.12E-05,0.000188427,N,-, Effector probability:0.809,---NA---,,no IPS match,,
RL4_JR_00886,6137,5261,6055,0,2,1,0,0,0,0,2,1,0,0,1,0,0,0,89.58639726,1,-1.911177184,0.842448857,-2.26859728,0.023292827,0.074290953,22.31407442,0,-1.014355043,1.198833148,-0.846118615,0.397486577,0.561686323,79.99183992,1,-1.256828817,0.847221333,-1.483471637,0.137949147,0.246459528,76.31564662,1,-3.137261281,1.139372456,-2.753499319,0.005896189,0.031992989,56.9176346,0,-3.744600138,1.187786265,-3.152587504,0.001618303,0.007111684,N,-,,hypothetical protein SPI_09347,C:membrane; C:integral component of membrane; C:cellular_component,no IPS match,,
RL4_JR_00887,6713,7211,6467,0,12,2,3,0,0,2,5,7,4,3,0,0,7,0,185.6137686,1,0.306814367,0.946499986,0.324156759,0.745819358,0.866885639,93.11303199,1,0.97930267,0.847071571,1.156103809,0.247638698,0.400927528,174.6103646,1,0.731062181,0.425093869,1.719766467,0.0854749,0.171316149,127.4503187,1,-0.770299714,0.5739722,-1.342050563,0.179579602,0.304972068,93.63263184,1,-0.566534057,0.58326959,-0.97130738,0.331395235,0.4679903,N,-,,aif-like mitochondrial oxidoreductase,"F:oxidoreductase activity; F:metal ion binding; F:flavin adenine dinucleotide binding; C:cytosol; P:cell redox homeostasis; P:oxidation-reduction process; F:2 iron, 2 sulfur cluster binding",PR00411 (PRINTS); PR00368 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR004099 (G3DSA:3.30.390.GENE3D); IPR023753 (PFAM); IPR017941 (G3DSA:2.102.10.GENE3D); IPR017941 (PFAM); PTHR22912:SF180 (PANTHER); PTHR22912 (PANTHER); IPR017941 (PROSITE_PROFILES); IPR017941 (SUPERFAMILY); IPR016156 (SUPERFAMILY); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),5.B.14.1.1, the flavin-based extracellular electron transfer (f-eet) family.
RL4_JR_00888,30,38,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.410049018,0,3.183864061,2.164189395,1.471157778,0.141248453,NA,0.130675545,0,6.401515742,1.98400502,3.22656227,0.00125287,0.015023052,0.338943576,0,3.750359317,1.29699847,2.891568036,0.003833246,0.016016484,0.39102839,0,3.327653065,1.483619406,2.24292905,0.02490139,0.085379809,0.333736321,0,3.670332523,1.238820412,2.962764003,0.003048902,0.011997721,,,,,,,,
RL4_JR_00889,4250,3893,3350,0,0,4,0,0,0,0,0,1,0,0,2,0,0,0,61.36152922,1,-0.923918327,0.758267384,-1.218459803,0.223049291,0.393264776,14.80321749,0,-0.422279781,1.219668919,-0.346224925,0.729173684,0.83104407,44.71900461,1,-2.105445037,1.195757664,-1.760762319,0.07827864,0.160067249,63.3498202,1,-1.741501118,1.020692184,-1.706196192,0.087971557,0.177928889,37.47578245,0,-3.141686155,1.191891829,-2.635881948,0.008391892,0.027294542,N,-,,c6 zinc finger domain containing,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31944 (PANTHER); PTHR31944:SF80 (PANTHER); PTHR31944 (PANTHER); PTHR31944:SF80 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00890,551,820,862,0,0,0,0,0,1,0,8,29,4,20,4,0,30,0,8.969881812,0,-1.267323878,1.222963538,-1.036272823,0.300074881,0.486005734,12.21948405,1,2.873876179,1.145915614,2.507930029,0.012144071,0.039072565,258.6069905,1,5.112154351,1.156060469,4.422047536,9.78E-06,0.000184515,164.5613597,1,4.337335743,0.40948335,10.59221515,3.24E-26,4.31E-24,123.1349854,1,4.059658189,1.778982846,2.282010869,0.022488699,0.059967889,Y,-,,alpha-n-arabinofuranosidase a precursor,P:L-arabinose metabolic process; F:alpha-L-arabinofuranosidase activity; C:extracellular region,IPR010720 (SMART); IPR013781 (G3DSA:3.20.20.GENE3D); IPR010720 (PFAM); PTHR31776:SF0 (PANTHER); PTHR31776 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_00891,10,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.083873061,0,5.473169478,3.919468514,1.396406033,0.162592259,NA,0.027231992,0,8.664692331,2.739196218,3.163224407,0.00156032,0.015023052,0.069879144,0,6.028874472,1.572054705,3.835028421,0.00012555,0.001330959,0.080555604,0,5.606809253,2.542742044,2.205024795,0.027452355,0.088070176,0.068140071,0,5.957991141,1.321301006,4.509185352,6.51E-06,7.04E-05,N,-,,tetrahydroxynaphthalene reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); SM00822 (SMART); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24322:SF416 (PANTHER); IPR002347 (PANTHER); PTHR24322:SF416 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_00892,2,1,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.043087897,0,6.43325575,3.931440899,1.636360794,0.1017641,NA,0.013349484,0,9.68956465,3.307247417,2.929797329,0.003391831,0.016488617,0.035486061,0,7.000235053,2.007905814,3.486336364,0.000489685,0.003336184,0.040989406,0,6.580024414,3.515659895,1.871632812,0.061257421,0.138205949,0.03599389,0,6.883467456,1.538725637,4.47348591,7.70E-06,8.06E-05,N,-,,hypothetical protein VFPFJ_07627,F:phosphoenolpyruvate carboxykinase (ATP) activity; P:gluconeogenesis; P:biological_process; F:phosphoenolpyruvate carboxykinase activity; F:ATP binding; F:purine nucleotide binding; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_00893,489,664,707,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,47.51620221,1,2.120671606,0.722385074,2.935652578,0.003328469,0.015654862,2.368140667,0,2.221733414,1.303541734,1.704382265,0.088309695,0.183857298,6.163364944,0,-0.434739208,1.209705967,-0.359375931,0.719313878,0.810138358,7.111880668,0,-0.857409782,1.209748372,-0.708750515,0.478479311,0.619039487,6.091652103,0,-0.52049938,1.215331349,-0.428277754,0.668448913,0.76457809,N,-,,S-adenosyl-L-methionine-dependent methyltransferase,F:methyltransferase activity,no IPS match,,
RL4_JR_00894,1280,1986,2129,0,0,0,0,0,0,0,0,0,0,0,0,0,10,0,21.67191847,0,-2.540045028,1.220445346,-2.081244388,0.037411543,0.107503827,6.855977309,0,0.688124983,1.251770792,0.549721233,0.582510591,0.721156091,17.87190508,0,-1.970641875,1.213189234,-1.624348304,0.104301493,0.200047993,20.62459958,0,-2.393477841,1.214374724,-1.970954924,0.048729032,0.120926826,56.29476958,1,1.721387156,0.655228304,2.627156283,0.008610178,0.027861314,N,-,,S-adenosyl-L-methionine-dependent partial,F:methyltransferase activity; F:transferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF852 (PANTHER); PTHR10108 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_00895,1629,1756,1696,0,12,7,0,0,0,0,0,2,2,4,3,0,1,0,143.2322933,1,2.58645359,0.608757523,4.248741895,2.15E-05,0.000222559,6.508424157,0,0.763238833,1.229530883,0.62075613,0.534760092,0.682663848,29.86448474,1,-0.066448171,1.029961978,-0.064515169,0.948560029,0.970218401,83.03410545,1,1.597732549,0.505115786,3.163101594,0.001560978,0.010766285,20.46152766,1,-1.03648,1.119565331,-0.925787867,0.354556234,0.491966817,N,-,,Biotin synthase,"F:metal ion binding; F:biotin synthase activity; F:4 iron, 4 sulfur cluster binding; P:biotin biosynthetic process; F:2 iron, 2 sulfur cluster binding",IPR010722 (SMART); IPR006638 (SMART); IPR002684 (TIGRFAM); IPR013785 (G3DSA:3.20.20.GENE3D); IPR010722 (PFAM); IPR007197 (PFAM); PTHR22976 (PANTHER); PTHR22976:SF19 (PANTHER); IPR002684 (HAMAP); SSF102114 (SUPERFAMILY),,
RL4_JR_00896,673,435,926,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,15.70120199,1,0.589814262,1.070928052,0.550750595,0.581804656,0.755334732,2.562645345,0,2.107781378,1.332950011,1.581290641,0.113811598,0.224386638,6.680196264,0,-0.551110086,1.233372074,-0.44683198,0.654996379,0.760903329,7.707883373,0,-0.973706813,1.236720438,-0.787329766,0.431088849,0.573355028,6.629805818,0,-0.64277987,1.244788227,-0.516376887,0.605591205,0.713951967,N,-,,C2H2 and C2HC zinc finger,P:biological_process; C:cellular_component; F:molecular_function,PTHR40788:SF2 (PANTHER); PTHR40788 (PANTHER),,
RL4_JR_00897,4568,3993,7087,4,9,13,0,0,0,0,2,1,1,6,0,0,0,2,224.246518,1,1.376759628,0.42528533,3.23726104,0.00120683,0.006837025,19.72411549,0,-0.836421333,1.219660509,-0.68578209,0.492850532,0.648379657,73.66134573,1,-1.092570858,0.88045529,-1.240915774,0.214636865,0.343351291,92.78459946,1,-0.438087888,0.641228954,-0.683200416,0.49448021,0.633347517,65.84393389,1,-1.884574493,1.005434554,-1.874388031,0.060876962,0.13017513,N,-,,kinase domain-containing,F:ATP binding; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24362 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_00898,219,306,298,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.307718104,0,0.17202298,1.247764389,0.137864954,0.890347149,0.946008341,1.050388239,0,3.394587742,1.40486573,2.4163076,0.01567881,0.04780148,2.730967593,0,0.739659885,1.221016053,0.605774087,0.544664779,0.672059308,3.151097936,0,0.317049997,1.227210881,0.258350053,0.79613676,0.868817061,2.695662263,0,0.655822487,1.220080876,0.537523782,0.590905862,0.702550711,N,-,,gcn5-related n-acetyltransferase,P:biological_process; F:transferase activity; C:cellular_component; F:N-acetyltransferase activity,IPR000182 (PFAM); IPR016181 (G3DSA:3.40.630.GENE3D); PTHR21471:SF44 (PANTHER); PTHR21471 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_00899,85,78,80,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.972779928,0,1.937490318,1.471158647,1.316982585,0.187844462,NA,0.311426846,0,5.148606928,1.674861131,3.074050041,0.00211174,0.015045494,0.80611864,0,2.500057774,1.23931666,2.017287313,0.043665539,0.101950222,0.929824886,0,2.077848879,1.286228249,1.615458904,0.106211353,0.205266262,0.792760336,0,2.421168133,1.21358851,1.995048662,0.046037573,0.105233074,N,-,,multidrug efflux pump,C:integral component of membrane,no IPS match,,
RL4_JR_00900,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein S7711_11078,F:metal ion binding,no IPS match,,
RL4_JR_00901,6821,6344,6709,0,0,8,0,0,0,2,1,0,0,4,4,0,0,3,110.092274,1,-0.708203736,0.532666754,-1.329543716,0.183668653,0.341547498,25.44225372,0,-1.203618836,1.19638094,-1.006049825,0.314391603,0.47631669,95.88141761,1,-1.440174348,0.843688002,-1.706998731,0.087822288,0.175263719,130.6016064,1,-0.542276956,0.527895175,-1.027243629,0.304305759,0.450057816,86.94786202,1,-1.707908212,0.830885794,-2.055527035,0.039828127,0.093781346,N,-,,pre-mrna-splicing factor 38b,,no IPS match,,
RL4_JR_00902,1593,1277,1334,0,0,1,0,0,0,0,0,1,0,0,2,0,0,0,20.62548486,1,-1.225759034,1.142391493,-1.072976332,0.283281736,0.466588411,5.395901862,0,1.033693579,1.248630569,0.827861823,0.407748758,0.571619987,20.44407385,1,-0.650903492,1.194145237,-0.545079,0.585699185,0.70641155,35.35408734,1,-0.290145788,1.016042916,-0.285564501,0.775211696,0.854454433,13.69612161,0,-1.689549139,1.193402939,-1.415740722,0.156851431,0.267135532,Y,-,,PLC-like TIM beta alpha-barrel domain,P:lipid metabolic process; F:phosphoric diester hydrolase activity,IPR017946 (G3DSA:3.20.20.GENE3D); PTHR13593:SF41 (PANTHER); PTHR13593 (PANTHER); IPR017946 (SUPERFAMILY),,
RL4_JR_00903,845,700,970,5,0,4,0,0,0,0,0,0,0,1,0,0,0,0,75.63007477,1,2.486331012,0.525535594,4.731042083,2.23E-06,3.08E-05,3.198828184,0,1.787934632,1.270873857,1.406854522,0.159470531,0.289847499,8.30750429,0,-0.865593343,1.198614973,-0.722161296,0.470195316,0.606711366,13.59552652,1,-0.341117647,1.147996129,-0.297141809,0.766358246,0.847926701,8.203989301,0,-0.950132992,1.203681143,-0.78935605,0.429903936,0.564342973,N,-,,Mg2+ transporter zinc transport,P:transmembrane transport; C:membrane; P:lipid metabolic process; C:integral component of membrane; F:metal ion transmembrane transporter activity; P:metal ion transport; F:phosphoric diester hydrolase activity,G3DSA:1.20.58.340 (GENE3D); PTHR21535:SF52 (PANTHER); PTHR21535 (PANTHER); PTHR21535 (PANTHER),,
RL4_JR_00904,2901,1965,2566,3,0,6,0,0,0,0,0,0,2,4,2,0,0,0,82.71762055,1,0.895632803,0.536993731,1.667864541,0.09534262,0.213741439,9.502829117,0,0.217166939,1.232869821,0.176147502,0.860178063,0.918156865,24.58448882,0,-2.430723164,1.199928566,-2.025723225,0.042793155,0.100426033,82.29605399,1,0.88312699,0.559830039,1.577491253,0.114682533,0.216947588,24.18748812,0,-2.510016198,1.20144359,-2.089166915,0.036692701,0.087973856,N,-,,bromodomain associated,F:protein heterodimerization activity; F:molecular_function,IPR019473 (PFAM); IPR006565 (PFAM); PTHR12321 (PANTHER); PTHR12321:SF47 (PANTHER),,
RL4_JR_00905,35325,31678,52498,6,14,42,0,0,7,0,4,1,4,33,6,0,17,0,808.7585228,1,-0.43988591,0.413208137,-1.064562553,0.287073933,0.470995681,216.5580861,1,-0.440978371,0.652809321,-0.675508693,0.49935263,0.653789591,431.3914982,1,-3.289737124,0.710485536,-4.630266144,3.65E-06,8.04E-05,681.5377514,1,-0.874532058,0.466101919,-1.876267876,0.060618506,0.137553198,455.9727432,1,-2.253636756,0.925681131,-2.434571345,0.01490944,0.043366298,N,-,,g- beta subunit,F:protein kinase C binding; F:GDP-dissociation inhibitor activity; P:G-protein coupled receptor signaling pathway; C:cytosolic small ribosomal subunit; P:conjugation with cellular fusion; P:invasive growth in response to glucose limitation; F:signal transducer activity; P:regulation of eIF2 alpha phosphorylation by amino acid starvation; P:positive regulation of protein autophosphorylation; F:G-protein alpha-subunit binding; F:ribosome binding; P:regulation of catalytic activity; P:glucose mediated signaling pathway; P:negative regulation of translation; P:positive regulation of conjugation with cellular fusion; P:regulation of fungal-type cell wall biogenesis; P:cellular protein localization; P:intracellular signal transduction,IPR020472 (PRINTS); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR19868:SF0 (PANTHER); PTHR19868 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),8.A.92.1.4,The G-Protein αβγ Complex (GPC) Family
RL4_JR_00906,5517,3335,3947,7,1,1,0,0,0,1,0,0,2,3,0,0,0,0,133.2754727,1,0.448792983,0.808170221,0.555319871,0.578675889,0.753405347,16.4444583,0,-0.573994413,1.234440418,-0.46498349,0.64194328,0.766967644,53.47728966,1,-2.255463019,1.209177925,-1.8652863,0.062141284,0.133940465,79.55986718,1,-0.593421897,0.710524163,-0.835188905,0.403611356,0.547063585,41.58651951,0,-3.291858761,1.208341715,-2.724278009,0.006444224,0.022110391,Y,-,,membrane dipeptidase,F:metal ion binding; F:dipeptidase activity; P:proteolysis; F:metallopeptidase activity,IPR008257 (PFAM); G3DSA:3.20.20.140 (GENE3D); PTHR10443:SF12 (PANTHER); IPR008257 (PANTHER); IPR008257 (PROSITE_PROFILES); IPR032466 (SUPERFAMILY),,
RL4_JR_00907,529,369,621,0,0,0,0,0,0,0,0,7,4,0,4,0,0,0,6.0386727,0,-0.69681465,1.221791605,-0.570322015,0.568459312,0.744978484,1.925860838,0,2.519943072,1.334170546,1.888771326,0.058922477,0.134357582,50.49652937,1,3.319510401,1.151379831,2.88307152,0.00393818,0.016253622,81.56474113,1,3.335074518,0.625455779,5.33223072,9.70E-08,2.18E-06,4.950022852,0,-0.221279082,1.223100928,-0.180916454,0.856433154,0.904494178,Y,-,,DUF1237 domain-containing,F:catalytic activity,IPR008313 (SMART); IPR012341 (G3DSA:1.50.10.GENE3D); IPR008313 (PFAM); IPR008313 (PIRSF); PTHR31047:SF1 (PANTHER); PTHR31047 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_00908,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.008141456,0,8.841220392,4.035983802,2.190598582,0.028480854,NA,0.002675567,0,12.01934062,4.032893235,2.980327006,0.002879408,0.015349618,0.006783092,0,9.399044527,3.291065204,2.855927776,0.004291127,0.016940088,0.007815077,0,8.97609272,4.035428601,2.224322026,0.026126786,0.086108719,0.006504647,0,9.346543544,1.704039324,5.484934187,4.14E-08,1.17E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_00909,278,391,206,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.541220563,0,0.073687992,1.29471101,0.056914625,0.954613204,0.977334789,1.135696326,0,3.282080201,1.453338946,2.258303343,0.023926754,0.066316157,2.929150547,0,0.638862258,1.253406633,0.509700716,0.610261152,0.726258834,3.378318444,0,0.216812918,1.265733559,0.17129428,0.863992378,0.915629352,2.863540512,0,0.568526335,1.244882813,0.456690645,0.647893416,0.748336851,Y,-,,Methylglyoxal reductase (NADPH-dependent),F:coenzyme binding; F:methylglyoxal reductase (NADPH-dependent) activity; P:oxidation-reduction process; F:transferase activity,IPR002575 (PFAM); IPR000058 (G3DSA:4.10.1110.GENE3D); G3DSA:3.90.1200.10 (GENE3D); G3DSA:3.90.1200.10 (GENE3D); PTHR21310 (PANTHER); PTHR21310:SF3 (PANTHER); SSF118310 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR011009 (SUPERFAMILY),,
RL4_JR_00910,12,10,9,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,15.39836264,1,7.60400845,0.815258483,9.327113553,1.09E-20,1.53E-18,0.039932412,0,8.112102212,2.514404563,3.226251786,0.00125423,0.015023052,0.103036153,0,5.468437969,1.448588023,3.77501255,0.00016,0.00154377,0.118824418,0,5.046022537,2.164476405,2.331290156,0.019738065,0.07639446,0.100991126,0,5.39285731,1.279420657,4.215077566,2.50E-05,0.000216635,N,-,,methyltransferase type 11,F:methyltransferase activity; F:transferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_00911,665,1049,508,0,0,17,0,0,0,0,0,0,0,1,0,0,0,0,73.92696081,1,3.065088583,1.032039997,2.969931971,0.002978657,0.014310886,2.886817181,0,1.936127868,1.359983095,1.423641128,0.154550384,0.282885892,7.447596899,0,-0.707616928,1.247794814,-0.567093981,0.570650332,0.694555383,12.60159371,1,-0.186210985,1.201581881,-0.154971532,0.87684376,0.92394929,7.279666228,0,-0.777600275,1.247750142,-0.623201912,0.533151845,0.65647117,N,-,,major facilitator superfamily transporter,C:membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23502:SF50 (PANTHER); PTHR23502 (PANTHER); PTHR23502:SF50 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.33, the major facilitator superfamily (mfs).
RL4_JR_00912,389,1262,522,0,0,3,0,0,0,0,0,0,0,0,0,0,3,0,20.34561593,1,0.931442525,1.08536051,0.858187225,0.390789089,0.58357265,2.819984392,0,1.969883531,1.44637877,1.361941679,0.173216291,0.308950714,7.308066359,0,-0.680383503,1.308042052,-0.520154151,0.602956139,0.720646888,8.432381425,0,-1.10301314,1.322842412,-0.833820515,0.404382133,0.54800754,18.74521324,1,1.363402016,1.032382175,1.32063692,0.186622456,0.305604459,N,-,,general amidase,"F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",PIRSF001221 (PIRSF); IPR023631 (PFAM); IPR023631 (G3DSA:3.90.1300.GENE3D); IPR000120 (PANTHER); PTHR11895:SF45 (PANTHER); IPR023631 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_00913,383,707,461,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,10.09771899,1,0.191190443,1.201986275,0.159062085,0.87361996,0.939103212,1.997041504,0,2.467712172,1.369720264,1.801617627,0.071605586,0.156542493,5.178561897,0,-0.183381416,1.240515896,-0.147826736,0.882479509,0.926627206,5.974747807,0,-0.605886711,1.245507294,-0.486457778,0.626642634,0.743380981,12.45579819,1,0.681016509,1.164877239,0.584625131,0.558799806,0.677748926,N,-,,GNAT family N-acetyltransferase,F:transferase activity,IPR000182 (PFAM); IPR016181 (G3DSA:3.40.630.GENE3D); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_00914,684,931,459,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,8.395854247,0,-1.171843259,1.259880904,-0.930122248,0.352307793,0.542812168,2.69686925,0,2.034332775,1.361520107,1.494162858,0.135133058,0.254667066,6.948098146,0,-0.607448117,1.244662105,-0.488042589,0.625519675,0.737987985,12.02460006,1,-0.085623113,1.197399997,-0.071507527,0.942993834,0.966671314,6.784467121,0,-0.675981314,1.242684918,-0.54396839,0.586463225,0.699050266,N,-,,C6 finger domain-containing,"C:nucleus; F:zinc ion binding; P:metabolic process; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter; F:hydrolase activity",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR021858 (PFAM); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00915,937,1378,1037,1,5,23,0,0,0,3,0,12,1,3,0,0,7,0,151.4627222,1,3.525238041,0.549221979,6.418603363,1.38E-10,4.64E-09,4.308455284,0,1.358391241,1.276675358,1.064006783,0.287325627,0.446854501,122.361872,1,3.397469607,0.522756239,6.499146933,8.08E-11,4.78E-09,34.23010023,1,0.998810694,0.776911926,1.285616375,0.198576979,0.328904827,38.0037475,1,1.988234497,0.644561611,3.084630645,0.002038051,0.008605198,N,-,,mandelate racemase muconate lactonizing enzyme domain-containing,P:cellular amino acid catabolic process; F:catalytic activity,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR013342 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013341 (PFAM); IPR029065 (G3DSA:3.20.20.GENE3D); IPR029017 (G3DSA:3.30.390.GENE3D); IPR029065 (PFAM); PF13561 (PFAM); PTHR13794:SF50 (PANTHER); IPR001354 (PANTHER); IPR029065 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR029017 (SUPERFAMILY),,
RL4_JR_00916,1223,1206,917,1,0,4,0,0,0,0,1,3,0,1,3,0,3,0,38.78258575,1,1.179398879,0.694989845,1.6970016,0.089696358,0.204568882,4.319851396,0,1.354611731,1.275474975,1.06204493,0.288215289,0.447715646,38.48448586,1,1.524068498,0.762087583,1.999860033,0.04551538,0.105253017,45.7709852,1,1.042246639,0.760876623,1.369797163,0.170750228,0.29318719,22.49744659,1,0.83543932,0.858236315,0.973437393,0.330335962,0.467130114,N,-,,c6 transcription factor,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR007219 (SMART); IPR007219 (PFAM); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR19444 (PANTHER); PTHR19444:SF23 (PANTHER); PTHR19444 (PANTHER); PTHR19444:SF23 (PANTHER); PTHR19444 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00917,328,289,301,0,1,0,0,0,0,0,0,0,0,2,0,0,0,0,11.68323745,1,0.970123643,1.141020495,0.850224555,0.395200252,0.587578578,1.176681406,0,3.230839164,1.377745768,2.34501839,0.019026141,0.055260431,3.044842506,0,0.582684884,1.205133296,0.483502436,0.62873903,0.740071381,11.53518585,1,1.886663382,1.017291408,1.854594826,0.063654108,0.141803705,2.993727535,0,0.504176717,1.198362614,0.420721333,0.673958581,0.768103403,N,-,,---NA---,,no IPS match,,
RL4_JR_00918,962,1020,1137,2,0,2,0,0,0,0,2,0,0,1,0,0,0,0,40.25719104,1,0.985577057,0.73785607,1.33573077,0.181637288,0.338928865,3.978837484,0,1.47316179,1.249806673,1.178711733,0.238512982,0.390146801,26.01752646,1,0.644151164,1.029233735,0.625855082,0.531409999,0.661025867,15.93109636,1,-0.65514518,1.141296063,-0.574036134,0.565943349,0.693381681,10.19253089,0,-1.263170172,1.195843136,-1.056300893,0.290830768,0.425406173,N,-,,alternative oxidase,F:alternative oxidase activity; F:metal ion binding; F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process; C:respiratory chain,no IPS match,,
RL4_JR_00919,915,1093,947,0,3,5,0,0,0,0,0,3,5,6,0,0,11,0,55.00089884,1,2.044799051,0.553899782,3.691640828,0.000222812,0.001692458,3.792104265,0,1.542563963,1.265028552,1.21939063,0.222695965,0.371232099,29.32068507,1,1.293772295,0.858786465,1.506512209,0.131935735,0.238265677,81.96420087,1,2.659631446,0.48345832,5.501263162,3.77E-08,9.36E-07,52.12827519,1,2.8059602,0.53522016,5.242628007,1.58E-07,3.33E-06,N,-,,allantoate permease,P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane; P:anion transport,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF148 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.36, the major facilitator superfamily (mfs).
RL4_JR_00920,1457,1641,1906,0,0,2,0,0,0,0,0,0,1,1,0,0,2,1,27.6739118,1,-0.701474812,1.017793791,-0.689211133,0.490690412,0.678598471,6.369741944,0,0.794254784,1.229129765,0.646192784,0.518154512,0.668548117,16.56313227,0,-1.860957987,1.194014413,-1.558572465,0.119097604,0.220589855,32.43434402,1,-0.549090881,1.01635529,-0.540254856,0.589021286,0.713548759,31.45013211,1,0.265071579,0.85187168,0.311163741,0.755676146,0.829850432,N,-,,unsaturated rhamnogalacturonyl hydrolase,"P:metabolic process; F:hydrolase activity, acting on glycosyl bonds",IPR010905 (PFAM); IPR012341 (G3DSA:1.50.10.GENE3D); PTHR33886:SF2 (PANTHER); PTHR33886 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_00921,3088,3465,3472,0,0,9,4,0,0,1,5,0,0,9,0,0,4,6,74.57610723,1,0.408449299,0.543344717,0.751731426,0.452212588,0.641256786,102.0677885,1,2.424090358,0.741364664,3.26976787,0.001076358,0.015023052,83.5440766,1,0.545618398,0.612386945,0.890970002,0.372945264,0.516935631,74.4738763,1,0.568583079,0.526604478,1.079715617,0.280268837,0.423667062,92.40528636,1,1.008221501,0.495034071,2.036670927,0.04168303,0.097177222,N,-,,major facilitator superfamily transporter,"C:membrane; P:metabolic process; F:hydrolase activity, acting on glycosyl bonds",G3DSA:3.30.200.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); IPR010440 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR23504:SF6 (PANTHER); PTHR23504:SF6 (PANTHER); PTHR23504 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR020846 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR032675 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.2.96, the major facilitator superfamily (mfs).
RL4_JR_00922,41771,31320,26343,3,0,6,0,0,0,0,8,3,0,6,2,0,13,2,451.1318164,1,-2.862487246,0.589389106,-4.856701993,1.19E-06,1.76E-05,128.5064821,0,-3.540173701,1.220769191,-2.899953348,0.003732182,0.017432924,413.0434646,1,-1.914545598,0.557607806,-3.433498556,0.000595845,0.003842254,424.7733116,1,-2.911865949,0.605782254,-4.806786478,1.53E-06,2.68E-05,388.4023603,1,-1.885766363,0.589225251,-3.200416749,0.00137229,0.006196135,N,-,,u4 u6 snrna-associated-splicing factor prp24,C:nucleus; F:RNA binding; P:RNA processing,IPR000504 (SMART); IPR003107 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR031766 (PFAM); PTHR24012 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY),,
RL4_JR_00923,880,1118,990,0,0,5,0,0,0,0,0,1,0,3,0,0,5,1,31.10653841,1,1.327131243,0.69409371,1.912034677,0.055871746,0.144241046,3.829055927,0,1.528560794,1.265042994,1.208307387,0.226929048,0.376738695,16.42932787,1,-0.160980848,1.197413729,-0.134440456,0.893054293,0.933245423,23.49131161,1,0.752615337,0.865913536,0.869157607,0.384760931,0.530099936,36.44476448,1,1.985296,0.63596749,3.121694162,0.001798136,0.007737412,Y,-,,cfem domain containing,P:mycelium development; C:membrane,IPR008427 (PFAM),9.B.87.1.15, the selenoprotein p receptor (selp-receptor) family.
RL4_JR_00924,5618,6267,9991,2,0,5,0,0,1,0,1,2,2,2,0,0,2,1,126.4766091,1,-1.04511346,0.65834237,-1.587492325,0.112401184,0.241019081,36.94207478,1,-0.40338947,1.131585817,-0.356481553,0.721479964,0.825815876,92.87516384,1,-1.583124247,0.884299925,-1.790257132,0.073412584,0.152554299,109.7837472,1,-1.669812987,0.786436708,-2.123264302,0.03373171,0.098396303,86.67304676,1,-1.871769638,0.893455646,-2.094977682,0.036172977,0.087057615,N,-,,mitochondrial large ribosomal subunit,C:large ribosomal subunit,IPR001063 (PFAM); IPR001063 (G3DSA:3.90.470.GENE3D); IPR005727 (PANTHER); IPR005727 (PANTHER); PTHR13501:SF2 (PANTHER); IPR001063 (SUPERFAMILY),,
RL4_JR_00925,1139,1535,1670,0,2,0,0,0,0,3,1,0,0,1,0,0,2,0,33.45029413,1,-0.471601138,1.026912671,-0.459241717,0.646060596,0.798449075,5.527518296,0,0.998857671,1.246981752,0.801020279,0.423119906,0.586205816,55.44244603,1,1.18370928,0.75619698,1.565345155,0.117502001,0.218554153,20.61579476,1,-1.134314456,1.15589419,-0.981330701,0.326429688,0.473018014,21.94763409,1,-0.08349807,0.998729398,-0.083604297,0.93337105,0.956395178,N,-,,hypothetical protein SPSK_02771,C:mitochondrial inner membrane peptidase complex,IPR024645 (PFAM),,
RL4_JR_00926,995,1083,1439,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,14.05686415,0,-1.915568052,1.202762494,-1.592640327,0.111240901,0.239005339,4.459856895,0,1.308456674,1.251637447,1.045395915,0.295840024,0.455713396,11.61681379,0,-1.349259973,1.201366722,-1.123104168,0.261393256,0.398425975,41.48572435,1,1.712764041,0.610235234,2.806727547,0.005004755,0.028089327,11.50112316,0,-1.437448086,1.210125567,-1.187850356,0.234892371,0.36331886,N,-,,cytochrome c oxidase family,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00927,52632,18250,26679,7,5,8,0,0,0,0,0,0,0,4,2,0,3,0,527.4507168,1,-1.535935404,0.600506779,-2.557731996,0.010535725,0.039495346,125.8894344,0,-3.510493221,1.275461193,-2.752332443,0.005917242,0.023080664,322.9220537,0,-6.146051274,1.270011773,-4.839365591,1.30E-06,3.40E-05,407.530229,1,-3.290827053,0.780506634,-4.216270447,2.48E-05,0.000317927,326.8942314,1,-4.083598264,1.001101197,-4.079106364,4.52E-05,0.000356775,N,-,,isochorismatase family family,F:catalytic activity; P:metabolic process,IPR027450 (G3DSA:2.60.120.GENE3D); IPR000868 (PFAM); IPR027450 (PFAM); IPR010987 (G3DSA:1.20.1050.GENE3D); IPR000868 (G3DSA:3.40.50.GENE3D); PTHR11080 (PANTHER); PTHR11080:SF33 (PANTHER); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY); IPR010987 (SUPERFAMILY); IPR000868 (SUPERFAMILY),,
RL4_JR_00928,589,721,421,4,1,3,0,0,0,0,0,0,0,0,0,0,0,0,66.71513891,1,2.874963439,0.623648428,4.609910503,4.03E-06,5.20E-05,2.244227915,0,2.299405896,1.353673399,1.698641561,0.089386741,0.185442219,5.786165557,0,-0.343400014,1.230955994,-0.278970179,0.78026771,0.854227641,6.673085475,0,-0.765331744,1.233625197,-0.620392439,0.534999449,0.667217372,5.657409502,0,-0.413887299,1.226514537,-0.337449974,0.735777717,0.815376169,N,-,,short-chain oxidoreductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); SM00822 (SMART); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_00929,2466,2667,3184,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,33.28224365,0,-3.159010413,1.192041963,-2.650083229,0.008047194,0.031914931,10.58397847,0,0.061679304,1.210920858,0.050935867,0.959376625,0.978272787,46.43212457,1,-0.7662333,1.031017122,-0.743181935,0.457371539,0.595499424,31.75114619,0,-3.015953965,1.190880185,-2.532541898,0.011323884,0.053626904,27.18886067,0,-2.678705636,1.197711191,-2.236520504,0.025317696,0.0659994,N,-,,hypothetical protein SPI_04783,,no IPS match,,
RL4_JR_00930,24441,23884,19881,6,10,4,0,0,4,0,0,0,0,1,0,0,0,0,429.5331784,1,-0.958287022,0.533619264,-1.79582539,0.072522291,0.175497863,125.3684614,1,-0.416580447,0.780495329,-0.533738553,0.593522432,0.730056393,226.9157526,0,-5.637017323,1.197921138,-4.705666461,2.53E-06,5.90E-05,265.7216949,1,-5.112286225,1.150209818,-4.444655352,8.80E-06,0.000127698,222.5392028,0,-5.711699408,1.196407695,-4.774041017,1.81E-06,2.38E-05,Y,-,,hypothetical protein CMQ_2567,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00931,2559,3834,4313,5,13,12,0,0,0,0,0,0,2,3,0,0,3,4,243.2499449,1,2.174720179,0.446226994,4.873573785,1.10E-06,1.64E-05,13.58989446,0,-0.298973351,1.227264653,-0.243609518,0.807533256,0.883373135,35.43848861,0,-2.958267979,1.209942133,-2.444966497,0.01448656,0.043173957,71.55665841,1,-0.335787787,0.712465463,-0.47130395,0.637423695,0.751755708,76.139299,1,0.394567965,0.635995163,0.6203946,0.534998027,0.658344071,N,-,,annexin anxc4,F:calcium ion binding; F:calcium-dependent phospholipid binding,IPR018502 (G3DSA:1.10.220.GENE3D); IPR018502 (G3DSA:1.10.220.GENE3D); IPR018502 (G3DSA:1.10.220.GENE3D); PTHR10502 (PANTHER); PTHR10502:SF107 (PANTHER); SSF47874 (SUPERFAMILY),1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_00932,2420,2481,3670,0,4,0,0,0,0,0,1,0,0,0,0,0,1,0,66.24098515,1,-0.418272911,0.780058965,-0.536206787,0.591815644,0.76236688,10.84060362,0,0.027082655,1.221945177,0.02216356,0.982317485,0.990676395,36.10815082,1,-1.670235137,1.201754711,-1.389830321,0.164580408,0.281359685,32.61652592,0,-3.054768051,1.203400413,-2.538446903,0.01113457,0.052903575,31.88181871,1,-1.793577774,1.143150047,-1.568978438,0.116652963,0.214591434,N,-,,splicing factor 3B subunit 5,C:cytosol; C:U2 snRNP; P:spliceosomal complex assembly,IPR017089 (PIRSF); IPR009846 (PFAM); IPR009846 (PANTHER); PTHR20978:SF0 (PANTHER),,
RL4_JR_00933,5746,6192,8168,5,0,2,0,0,0,0,0,0,0,0,0,0,1,0,138.3260118,1,-0.832562388,0.626714132,-1.328456382,0.184027384,0.341748534,25.50596925,0,-1.207281322,1.199824874,-1.006214613,0.314312344,0.476267896,66.42044456,0,-3.864590556,1.196677954,-3.229432399,0.001240362,0.006858233,76.64118873,0,-4.28724847,1.197730544,-3.579476611,0.000344283,0.00304582,69.60297609,1,-3.023238985,1.134576392,-2.664641187,0.007707051,0.02549294,N,-,,complex 1,,no IPS match,,
RL4_JR_00934,22216,12130,12683,0,4,8,0,3,0,1,7,0,7,4,0,0,0,0,249.9515766,1,-1.401698082,0.587775752,-2.384749759,0.017090742,0.057877242,175.7370971,1,0.608457433,1.631938793,0.372843292,0.70926508,0.817115995,222.0679508,1,-1.257122016,0.66067358,-1.902788388,0.057068163,0.12513712,261.1926814,1,-1.255263204,0.61745434,-2.032965229,0.042056036,0.111266623,152.5561875,0,-5.166986599,1.228442949,-4.206126629,2.60E-05,0.00022443,N,-,,GATA zinc finger,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:binding",IPR000679 (PRINTS); IPR000679 (SMART); IPR000679 (PFAM); IPR013860 (PFAM); IPR013088 (G3DSA:3.30.50.GENE3D); PTHR10071 (PANTHER); PTHR10071:SF143 (PANTHER); IPR000679 (PROSITE_PROFILES); SSF57716 (SUPERFAMILY),,
RL4_JR_00935,688,784,548,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,15.771301,1,0.590445737,1.03954239,0.567986204,0.570044335,0.746096854,2.609114486,0,2.082048564,1.315652903,1.582521164,0.113530645,0.223876327,6.736191065,0,-0.562743193,1.213862697,-0.463597073,0.642936452,0.751279852,7.769185983,0,-0.984748565,1.213880513,-0.811240113,0.417227794,0.560915594,6.599036861,0,-0.636003884,1.209505991,-0.525837729,0.599000958,0.709154325,N,-,,enoyl- hydratase isomerase,F:catalytic activity; P:metabolic process,IPR029045 (G3DSA:3.90.226.GENE3D); IPR001753 (PFAM); IPR014748 (G3DSA:1.10.12.GENE3D); PTHR11941:SF28 (PANTHER); PTHR11941:SF28 (PANTHER); PTHR11941 (PANTHER); IPR029045 (SUPERFAMILY),,
RL4_JR_00936,1258,1191,843,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,13.22906189,0,-1.827879892,1.213460571,-1.506336453,0.131980825,0.270043959,4.260113899,0,1.374706479,1.288729747,1.066714322,0.286100858,0.445673522,10.97542063,0,-1.267099265,1.213729373,-1.043971822,0.296498427,0.43747132,12.65646888,0,-1.688873164,1.213620249,-1.391599362,0.164043752,0.284359355,32.8294686,1,0.905685733,0.859247804,1.054044862,0.291862378,0.426597626,N,-,,P-loop containing nucleoside triphosphate hydrolase,C:membrane; C:integral component of membrane,IPR031352 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10039:SF5 (PANTHER); PTHR10039 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_00937,87,185,154,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1.720908101,0,1.114707506,1.420366838,0.784802543,0.432569349,NA,0.543862758,0,4.344195219,1.588925204,2.734046391,0.006256123,0.023932153,1.4168752,0,1.686473985,1.278766959,1.318828245,0.187226539,0.309314864,1.63515597,0,1.263548407,1.316020289,0.960128364,0.336990615,0.484044542,16.13091838,1,3.319954365,1.034007054,3.210765683,0.001323818,0.006007916,N,-,,alcohol dehydrogenase,F:catalytic activity,IPR001509 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10366 (PANTHER); PTHR10366:SF475 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_00938,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_00939,312,452,417,0,0,6,0,0,0,0,0,0,0,1,0,0,0,0,27.66240158,1,2.89822829,0.675869919,4.28814511,1.80E-05,0.000192387,1.509146942,0,2.871791018,1.357596785,2.115349012,0.034400212,0.088107021,3.922181872,0,0.217437794,1.217686746,0.178566281,0.858278272,0.909674333,8.537094859,1,0.740766634,1.163675966,0.636574662,0.524401934,0.65867381,3.869178247,0,0.134377292,1.21887419,0.110247057,0.912213444,0.943388651,N,-,,mage,C:intracellular organelle; F:organic cyclic compound binding; F:heterocyclic compound binding,IPR002190 (SMART); IPR002190 (PFAM); PTHR11736:SF14 (PANTHER); PTHR11736 (PANTHER),,
RL4_JR_00940,603,666,1025,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,12.97173924,1,-0.351162225,1.174589568,-0.298965898,0.764966066,0.877161421,2.894271547,0,1.932212023,1.296759852,1.490030726,0.136216157,0.256135973,23.24444705,1,1.095504158,1.05445893,1.038925393,0.298839436,0.439681797,8.723013639,0,-1.152155141,1.218819013,-0.945304535,0.344503424,0.49137262,7.505520064,0,-0.821689955,1.229153812,-0.668500514,0.503814154,0.631248399,N,-,,phosphatidylinositol n-acetylglucosaminyltransferase subunit c,"F:transferase activity, transferring glycosyl groups",IPR009450 (PFAM); IPR009450 (PANTHER),,
RL4_JR_00941,1012,1397,1171,0,0,3,0,0,0,3,2,1,5,0,4,0,2,0,25.86900229,1,0.335066647,0.881464631,0.380124891,0.70385271,0.839727461,4.590498453,0,1.266898486,1.261947982,1.003922906,0.315415775,0.477272893,67.30212104,1,2.037513494,0.631565995,3.226129192,0.001254767,0.006907701,98.84008094,1,2.286900365,0.617980892,3.700600446,0.00021509,0.002041036,19.44282303,1,0.198127605,0.992330613,0.199658866,0.841747386,0.893457625,N,-,,AGC NDR kinase,P:maintenance of endoplasmic reticulum location involved in endoplasmic reticulum polarization at cell division site; C:medial cortex; P:positive regulation of nuclear migration during mitotic telophase; F:protein serine/threonine kinase activity; P:positive regulation of mitotic spindle elongation; C:mitotic spindle pole body; P:mitotic cytokinesis checkpoint; P:negative regulation of protein localization to microtubule; F:ATP binding; P:cytoplasmic sequestering of protein; C:cytosol; C:Sid2-Mob1 complex; P:negative regulation of protein homooligomerization; P:peptidyl-serine phosphorylation; P:septation initiation signaling,IPR000719 (SMART); IPR000961 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR017892 (PFAM); IPR000719 (PFAM); PTHR24356 (PANTHER); PTHR24356:SF185 (PANTHER); IPR000961 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_00942,325,375,442,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4.572728786,0,-0.295345387,1.216605431,-0.242761852,0.80818989,0.902685257,1.452507824,0,2.926924717,1.346257633,2.17411931,0.029696176,0.078481643,14.84892341,1,1.232627943,1.196828944,1.029911542,0.303051532,0.444586829,4.360273959,0,-0.151695493,1.208994126,-0.125472482,0.900149509,0.938768454,3.735421677,0,0.185081998,1.211487799,0.152772482,0.878577699,0.919251752,Y,-,,hypothetical protein SPI_03726,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_00943,1960,2519,2181,2,4,4,0,0,0,0,6,1,0,6,7,0,0,1,94.23270777,1,1.223559032,0.515163185,2.375090201,0.017544662,0.059046763,8.539076113,0,0.371465622,1.229346307,0.302165159,0.762526163,0.856065863,75.69834518,1,1.349398129,0.591159124,2.28263098,0.022452115,0.061005155,117.0605099,1,1.747450754,0.470660901,3.712759549,0.000205012,0.00196195,29.15821845,1,-1.424095457,1.127626397,-1.262914261,0.206619994,0.329428099,N,-,,rna polymerase ii mediator complex component srb4,"C:nucleoplasm part; F:transcription factor activity, protein binding; C:protein complex; P:regulation of transcription from RNA polymerase II promoter",IPR019313 (PFAM); PTHR13114 (PANTHER),,
RL4_JR_00944,4975,9529,10042,51,82,25,0,6,6,13,21,14,6,24,5,0,3,9,1364.383148,1,3.668773499,0.726165923,5.052252364,4.37E-07,7.34E-06,317.4219511,1,2.88059142,0.669720071,4.301187235,1.70E-05,0.001041703,480.9107008,1,2.280154577,0.415595951,5.486469665,4.10E-08,1.52E-06,294.1821517,1,1.182317293,0.453540125,2.606863714,0.009137572,0.045218924,158.4846567,1,0.041239129,0.673341234,0.061245513,0.951163684,0.968281952,N,-,,6-phosphofructokinase,F:ATP binding; C:cytoplasm; F:metal ion binding; C:integral component of membrane; P:fructose 6-phosphate metabolic process; P:glycolytic process through fructose-6-phosphate; F:6-phosphofructokinase activity,IPR022953 (PRINTS); IPR000023 (PFAM); IPR009161 (TIGRFAM); IPR009161 (PIRSF); G3DSA:3.40.50.450 (GENE3D); PTHR13697:SF4 (PANTHER); PTHR13697 (PANTHER); IPR009161 (HAMAP); IPR000023 (SUPERFAMILY); IPR000023 (SUPERFAMILY),,
RL4_JR_00945,28903,14446,9171,2,6,2,0,0,0,3,2,8,6,29,4,0,20,24,285.493287,1,-1.58394232,0.772374665,-2.050743494,0.040291933,0.113228243,68.66420348,0,-2.635960477,1.285822919,-2.050018271,0.040362648,0.099768186,276.1128497,1,-0.766556959,0.638558043,-1.20044993,0.229964647,0.361067321,412.6767814,1,0.140832857,0.599313438,0.23499032,0.814216247,0.882459805,423.880524,1,0.654471674,0.805077281,0.812930248,0.416258051,0.552301502,N,-,,c6 zinc finger domain containing,"C:nucleus; F:zinc ion binding; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31001:SF39 (PANTHER); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_00946,61,22,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.366367086,0,3.346214197,2.593475609,1.290243172,0.196966241,NA,0.121453574,0,6.507526129,2.281305671,2.852544581,0.004337073,0.018768641,0.307670529,0,3.890016031,1.563813883,2.487518543,0.012863775,0.039392878,0.354369475,0,3.469678906,1.877293574,1.848234583,0.064568414,0.143028991,0.296146797,0,3.840654952,1.462038145,2.626918432,0.008616199,0.027871888,N,-,,---NA---,,no IPS match,,
RL4_JR_00947,805123,741961,1012445,124,204,442,4,11,38,50,56,100,41,252,45,3,242,41,14785.66662,1,-1.153752291,0.2225367,-5.184548384,2.17E-07,3.98E-06,4118.67435,1,-1.921930097,0.540522384,-3.555690113,0.000376988,0.014296025,10096.74279,1,-2.360932414,0.30330016,-7.784144957,7.02E-15,6.83E-13,11580.30071,1,-2.401875801,0.500912765,-4.794998185,1.63E-06,2.82E-05,9641.901256,1,-2.683394062,0.974660064,-2.753158933,0.005902323,0.020515285,N,-,,translation elongation factor 1-alpha,F:GTP binding; F:translation elongation factor activity; C:cytoplasm; F:GTPase activity; P:translational elongation,IPR000795 (PRINTS); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:2.40.30.10 (GENE3D); IPR004161 (PFAM); IPR004539 (TIGRFAM); G3DSA:2.40.30.10 (GENE3D); IPR004160 (PFAM); PF00009 (PFAM); PTHR23115 (PANTHER); PTHR23115:SF153 (PANTHER); IPR000795 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR009001 (SUPERFAMILY); IPR009000 (SUPERFAMILY),,
RL4_JR_00948,2209,2549,5253,1,0,4,0,0,0,0,0,0,0,1,2,0,0,3,65.14602495,1,-0.427930493,0.810925651,-0.5277062,0.59770327,0.767400578,12.49776593,0,-0.178146053,1.266526969,-0.140657134,0.888140811,0.936726194,32.81769234,0,-2.847458909,1.241739987,-2.293120089,0.021841092,0.059616936,61.16734987,1,-0.922291281,0.931026501,-0.990617647,0.321872317,0.468240979,54.88599535,1,-0.658511729,0.941394573,-0.699506612,0.484235482,0.612554255,N,-,,histone-lysine N-methyltransferase 1,C:mitochondrial inner membrane,IPR032741 (PFAM),,
RL4_JR_00949,839,953,1833,0,3,1,0,0,0,0,0,2,1,1,1,0,0,0,42.27459164,1,0.818609459,0.837768644,0.977130697,0.328504452,0.51776262,4.537225449,0,1.283597685,1.301826699,0.985997357,0.32413441,0.486273676,24.89546116,1,0.423823492,1.08550628,0.390438544,0.696212291,0.792941077,36.6933046,1,0.534494669,0.912808249,0.585549779,0.558178105,0.686951904,11.86970828,0,-1.482973833,1.257032286,-1.179742039,0.238102828,0.366981066,N,-,,complex i intermediate-associated 30,"C:mitochondrial respiratory chain complex I; P:mitochondrial electron transport, NADH to ubiquinone; P:protein complex assembly; F:unfolded protein binding; P:protein folding",IPR013857 (PFAM); PTHR13194 (PANTHER); PTHR13194:SF18 (PANTHER); IPR008979 (SUPERFAMILY),,
RL4_JR_00950,217,229,240,1,3,0,0,0,3,0,0,1,0,0,0,0,0,0,36.84447549,1,3.18109064,0.736361087,4.320014588,1.56E-05,0.000169031,29.01251848,1,5.837367275,0.858402161,6.800270945,1.04E-11,2.32E-09,8.773259137,1,1.965305374,1.194003992,1.645978898,0.099768104,0.193606646,2.623960989,0,0.581112438,1.213282927,0.478958721,0.631967995,0.747334262,2.241317319,0,0.922019988,1.203272181,0.766260538,0.443521294,0.5766859,Y,-,,glycosyl hydrolase family 76,"F:mannan endo-1,6-alpha-mannosidase activity; P:carbohydrate catabolic process; C:integral component of membrane; C:endoplasmic reticulum",IPR012341 (G3DSA:1.50.10.GENE3D); IPR005198 (PFAM); IPR014480 (PIRSF); PTHR12145 (PANTHER); PTHR12145:SF23 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_00951,25130,30063,37344,4,3,11,0,0,2,2,2,1,1,7,0,0,9,0,476.6808526,1,-1.755842451,0.439730659,-3.992995295,6.52E-05,0.0005849,136.1961907,1,-1.769892222,0.990583079,-1.7867176,0.073983143,0.16031251,350.2517714,1,-2.913715127,0.687500146,-4.238130196,2.25E-05,0.00036923,390.4099257,1,-2.809805584,0.584562192,-4.80668374,1.53E-06,2.68E-05,337.5639779,1,-2.526448632,0.68798265,-3.672256317,0.000240418,0.001457626,N,-,,nucleolar GTP-binding,"F:GTP binding; P:ribosomal subunit export from nucleus; P:ribosomal large subunit biogenesis; C:integral component of membrane; P:ferrous iron transmembrane transport; F:ferrous iron transmembrane transporter activity; P:rRNA processing; C:nucleolus; P:assembly of large subunit precursor of preribosome; C:preribosome, large subunit precursor",IPR010674 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR012973 (PFAM); IPR024926 (PIRSF); PTHR11702 (PANTHER); PTHR11702:SF4 (PANTHER); PTHR11702:SF4 (PANTHER); IPR031167 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_00952,965,1197,989,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.6765,0,-1.766229494,1.201240676,-1.470337734,0.141470306,0.284545059,4.047271579,0,1.448617026,1.265500765,1.144698657,0.252334008,0.406837341,10.48327201,0,-1.200902257,1.200970167,-0.999943454,0.317337874,0.460060886,12.09325916,0,-1.623176899,1.199655064,-1.353036342,0.176044021,0.2998731,10.30616645,0,-1.279147271,1.200606091,-1.065417942,0.286686841,0.42123121,N,-,,carbon-nitrogen hydrolase,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:transferase activity, transferring acyl groups; P:nitrogen compound metabolic process",IPR003010 (PFAM); IPR003010 (G3DSA:3.60.110.GENE3D); PTHR23088:SF5 (PANTHER); PTHR23088:SF5 (PANTHER); PTHR23088 (PANTHER); IPR003010 (PROSITE_PROFILES); IPR003010 (SUPERFAMILY),,
RL4_JR_00953,679,873,617,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,32.77409525,1,1.116499826,0.876252377,1.274176089,0.202601017,0.367048434,2.796902353,0,1.9817652,1.307604411,1.515569375,0.129628276,0.246775477,7.23230949,0,-0.6652789,1.213232771,-0.548352234,0.583450068,0.704706334,8.342326638,0,-1.087443619,1.213296552,-0.896271911,0.370107557,0.515736171,7.094841767,0,-0.740479693,1.210879491,-0.611522202,0.540853924,0.663126406,N,-, Effector probability:0.793,Carbon-nitrogen hydrolase,F:transferase activity; F:hydrolase activity,IPR003010 (PFAM); IPR003010 (G3DSA:3.60.110.GENE3D); PTHR23088:SF5 (PANTHER); PTHR23088 (PANTHER); PTHR23088 (PANTHER); PTHR23088:SF5 (PANTHER); IPR003010 (PROSITE_PROFILES); IPR003010 (SUPERFAMILY),,
RL4_JR_00954,1016,816,1494,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.22143062,0,-1.827258884,1.220877228,-1.496677014,0.13447732,0.27351433,4.194312554,0,1.396991081,1.277013616,1.093951594,0.273976209,0.43209523,10.93941471,0,-1.262628369,1.216801101,-1.037662087,0.299427402,0.440354883,12.6231755,0,-1.685327206,1.217787263,-1.383925795,0.166381177,0.287150978,10.85684271,0,-1.35431933,1.228563094,-1.102360422,0.270305011,0.402713101,N,-,,tRNA (uracil-O(2)-)-methyltransferase,F:transferase activity,IPR011671 (PFAM); PTHR21210 (PANTHER); PTHR21210:SF0 (PANTHER),,
RL4_JR_00955,1422,915,1424,0,0,5,0,0,0,0,0,0,0,0,0,0,5,1,34.04774702,1,1.000245251,0.709546694,1.409696161,0.158629419,0.307898834,4.787488362,0,1.206224682,1.266496075,0.952410912,0.340888628,0.503905086,12.41147007,0,-1.444715296,1.208276812,-1.195682381,0.231820529,0.363080297,14.3163772,0,-1.866879598,1.207900387,-1.545557579,0.122211453,0.227377979,38.91024099,1,1.646784562,0.663075555,2.483554927,0.013007827,0.038816461,N,-,,"hydroxyquinol 1,2-dioxygenase","F:ferric iron binding; C:integral component of membrane; F:catechol 1,2-dioxygenase activity; P:oxidation-reduction process; P:catechol-containing compound metabolic process",IPR007535 (PFAM); IPR015889 (G3DSA:2.60.130.GENE3D); IPR000627 (PFAM); PTHR33711:SF6 (PANTHER); PTHR33711 (PANTHER); IPR015889 (SUPERFAMILY),,
RL4_JR_00956,16409,6103,6347,0,11,3,0,0,2,7,4,6,2,6,10,0,10,6,214.1364405,1,-0.226162532,0.969585325,-0.233256967,0.815561872,0.906040195,56.25886176,1,-0.167875446,1.112995597,-0.150832084,0.880108176,0.931615043,243.7076286,1,0.565462226,0.587209709,0.962964708,0.335565235,0.478648074,249.509276,1,0.246601027,0.670552419,0.367758015,0.713053677,0.808136381,175.9983073,1,0.068142174,0.646899672,0.105336542,0.916108768,0.946417202,Y,-,,transient receptor potential ion channel,F:dioxygenase activity; C:membrane; P:metabolic process,IPR032800 (SMART); IPR010308 (PFAM); IPR032800 (PFAM); PTHR31145 (PANTHER); PTHR31145 (PANTHER); PTHR31145:SF7 (PANTHER),1.A.4.9.3, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_00957,5226,6460,4930,0,0,0,0,0,0,0,3,1,2,12,0,0,0,1,66.90244563,0,-4.166283474,1.204555444,-3.45877269,0.000542643,0.003590332,21.39091414,0,-0.953378386,1.214776,-0.78481826,0.432560133,0.594109228,85.37190478,1,-0.78036741,0.75850128,-1.028828073,0.303560472,0.444946608,130.6035015,1,0.424158554,0.498805128,0.850349225,0.395130957,0.539444041,61.70246715,1,-2.742184796,1.127705136,-2.431650533,0.015030201,0.04359232,N,-,,WD repeat,F:zinc ion binding; C:Seh1-associated complex; C:fungal-type vacuole membrane; C:extrinsic component of fungal-type vacuolar membrane,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR22850 (PANTHER); IPR025651 (PTHR22850:PANTHER); IPR025651 (PTHR22850:PANTHER); PTHR22850 (PANTHER); IPR025651 (PTHR22850:PANTHER); PTHR22850 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),3.A.20.1.2, the peroxisomal protein importer (ppi) family.
RL4_JR_00958,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_00959,4179,4447,4222,2,0,4,0,0,0,0,4,0,0,4,2,0,2,1,86.94476953,1,-0.481291171,0.613119265,-0.784987846,0.432460695,0.623162171,16.46866474,0,-0.576105888,1.204245788,-0.478395601,0.632368664,0.759112383,74.03382124,1,-0.401635114,0.739902185,-0.542821906,0.587252429,0.707526311,84.5294332,1,-0.337375472,0.611392431,-0.551814931,0.581075156,0.707283423,57.05723244,1,-1.090713519,0.834748136,-1.306637861,0.191335732,0.311408822,N,-,,phosphatidylinositol 3,"C:phosphatidylinositol 3-kinase complex, class III, type II; C:phosphatidylinositol 3-kinase complex, class III, type I; P:ascospore-type prospore membrane assembly; C:pre-autophagosomal structure; C:fungal-type vacuole membrane; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol phosphorylation; F:protein kinase activity; P:positive regulation of ascospore formation; P:protein phosphorylation; P:protein localization to prospore membrane; P:positive regulation of transcription elongation from RNA polymerase II promoter; C:peroxisome; C:endosome; C:prospore membrane; P:phosphatidylinositol-mediated signaling; C:nucleus-vacuole junction; P:pexophagy; C:cytosol; P:protein localization to vacuole; F:1-phosphatidylinositol-3-kinase activity",IPR001263 (SMART); IPR000403 (SMART); IPR002420 (SMART); IPR001263 (G3DSA:1.25.40.GENE3D); IPR000403 (PFAM); G3DSA:3.30.1010.10 (GENE3D); IPR000008 (G3DSA:2.60.40.GENE3D); IPR000403 (G3DSA:1.10.1070.GENE3D); IPR002420 (PFAM); IPR001263 (PFAM); IPR015433 (PANTHER); IPR001263 (PROSITE_PROFILES); IPR000403 (PROSITE_PROFILES); IPR002420 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR011009 (SUPERFAMILY),,
RL4_JR_00960,725,828,891,0,0,0,0,0,0,0,0,0,0,3,1,0,0,0,9.795933458,0,-1.394410175,1.195398893,-1.166481066,0.24342,0.418596197,3.11787442,0,1.824945801,1.268439415,1.438733124,0.150226151,0.277125769,8.099166411,0,-0.828793518,1.195974299,-0.692986061,0.488318299,0.623028918,31.0143535,1,1.472671392,0.744208663,1.978842044,0.047833793,0.119594863,7.991745102,0,-0.912209248,1.1998005,-0.760300773,0.44707482,0.579446051,N,-,,nuclear qri2,C:intracellular organelle,IPR014854 (PFAM); IPR029225 (PFAM); PTHR16140:SF0 (PANTHER); IPR027786 (PANTHER); PTHR16140:SF0 (PANTHER); PTHR16140:SF0 (PANTHER); IPR027786 (PANTHER); IPR027786 (PANTHER),,
RL4_JR_00961,1211,1261,1393,0,0,0,1,0,0,0,0,0,2,0,0,0,0,2,15.47598941,0,-2.054236641,1.187216481,-1.730296601,0.083577297,0.194141112,27.24505628,1,2.085564308,1.108970443,1.880631104,0.060022118,0.136190064,12.80488179,0,-1.48965653,1.189994825,-1.251817654,0.210636316,0.338328107,33.39709787,1,-0.17228935,1.008796699,-0.170786988,0.864391261,0.915860351,27.35882077,1,0.112706181,0.969734731,0.116223724,0.907475235,0.94064156,N,-,,alpha beta hydrolase fold family,F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR000073 (PFAM); PTHR10992:SF817 (PANTHER); PTHR10992 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_00962,1134,989,974,0,0,3,0,0,0,5,3,0,0,0,0,0,0,0,23.85310562,1,0.569692465,0.849656802,0.670497151,0.502540922,0.68914588,3.976736317,0,1.473982368,1.262036833,1.167939263,0.242831265,0.395166892,89.15931969,1,2.670266757,0.542738721,4.919985721,8.66E-07,2.37E-05,11.85716696,0,-1.594801061,1.192727748,-1.337104015,0.181188687,0.306909991,10.09699461,0,-1.249699041,1.19172676,-1.048645615,0.294341253,0.429238829,N,-,,hypothetical protein SPI_05666,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00963,5538,4549,5579,0,0,6,0,0,0,0,0,2,2,6,0,0,3,0,85.45667227,1,-0.776794691,0.615532034,-1.261989056,0.206952724,0.372862263,20.00435021,0,-0.856723397,1.201445187,-0.71307739,0.47579787,0.633221309,64.84180997,1,-1.686842576,1.0311359,-1.635907136,0.101859024,0.196455392,102.4971439,1,-0.212095483,0.540238674,-0.392595891,0.694617975,0.793972341,62.65926148,1,-1.383237095,0.842941597,-1.640964333,0.100804819,0.192149102,N,-,,related to apopolysialoglyco,,no IPS match,,
RL4_JR_00964,4528,3754,6019,0,0,1,0,0,0,0,1,0,2,0,0,0,0,1,60.75887567,1,-2.987259242,1.159249319,-2.57689109,0.009969336,0.037810246,18.10374844,0,-0.71274338,1.211708691,-0.588213475,0.556389014,0.701079248,54.9741139,1,-2.407870501,1.201363595,-2.004281227,0.045039944,0.104535624,73.00472216,1,-2.038954583,1.029226289,-1.981055677,0.04758503,0.119227525,54.03934061,1,-2.520726225,1.139027524,-2.213051197,0.026894116,0.069146847,N,-,,iron-sulfur cluster biosynthesis,,IPR008011 (PFAM); PTHR13166 (PANTHER); PTHR13166:SF7 (PANTHER),,
RL4_JR_00965,2249,1978,2166,0,0,8,0,0,0,1,0,4,0,6,0,0,0,1,56.11495638,1,0.933292623,0.528341365,1.766457605,0.077319108,0.18335681,8.182568927,0,0.432984929,1.221378154,0.354505218,0.722960294,0.826338946,58.25403419,1,0.92579374,0.663761481,1.394768703,0.1630856,0.27932306,48.51065808,1,0.66003578,0.611383117,1.079578028,0.28033013,0.423696457,28.21668158,1,-1.362583806,1.116476904,-1.220431699,0.222301267,0.348907197,N,-,,palmitoyltransferase erf2,C:endoplasmic reticulum membrane; F:metal ion binding; F:palmitoyltransferase activity; C:integral component of membrane; P:cellular process,IPR001594 (PFAM); PTHR22883 (PANTHER); PTHR22883:SF43 (PANTHER); IPR001594 (PROSITE_PROFILES),8.A.114.1.5, the huntington-interacting protein 14 (hip14) family.
RL4_JR_00966,11487,13134,15924,12,16,29,0,0,3,10,10,12,9,23,2,0,14,7,521.9670834,1,1.130339827,0.294021571,3.844411216,0.000120842,0.001000844,79.66505473,1,-0.035752785,0.849151597,-0.042104125,0.966415692,0.982682143,401.2211132,1,0.956525013,0.330854408,2.891075314,0.003839261,0.016016484,350.0872664,1,0.455799183,0.364320326,1.251094574,0.210899975,0.344586996,238.2240872,1,-0.011994209,0.441639804,-0.02715835,0.978333435,0.98545197,N,-, Effector probability:0.853,hypothetical protein CMQ_2762,C:mitochondrion; C:integral component of membrane,PTHR40466 (PANTHER); PD968187 (PRODOM),,
RL4_JR_00967,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.008470882,0,8.791019641,4.031633903,2.180510397,0.029219649,NA,0.002680088,0,12.01721297,4.032710343,2.979934573,0.0028831,0.015349618,0.006904709,0,9.374372631,4.033343739,2.324218623,0.02011378,0.055743746,0.007967227,0,8.951770626,4.033311655,2.219459191,0.026455501,0.08636862,0.006679571,0,9.335361424,1.822923296,5.121093929,3.04E-07,5.22E-06,,,,,,,,
RL4_JR_00968,165,140,156,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32.03883224,1,3.340625795,0.845474637,3.951183926,7.78E-05,0.00068437,0.590066173,0,4.226599754,1.50552308,2.807396187,0.004994377,0.020659657,1.527659805,0,1.577634238,1.219179563,1.294013028,0.195660921,0.320477457,1.762083207,0,1.155499856,1.23309026,0.937076461,0.348719229,0.49556133,1.503097607,0,1.498109375,1.206447877,1.241752258,0.214327982,0.339126555,N,-,,ferric reductase like transmembrane component,F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process,IPR013121 (PFAM); G3DSA:3.40.50.80 (GENE3D); IPR013112 (PFAM); IPR013130 (PFAM); PTHR32361:SF12 (PANTHER); PTHR32361 (PANTHER); PTHR32361:SF12 (PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY),5.B.1.5.4, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_00969,3919,4766,5512,0,0,4,0,0,0,0,0,5,1,3,0,0,5,0,72.1548537,1,-1.236748158,0.773152406,-1.599617551,0.109683453,0.236844258,18.05471881,0,-0.70881164,1.204921996,-0.588263507,0.556355436,0.701079248,79.48221397,1,-0.235010804,0.685372317,-0.342895093,0.731677383,0.819051507,75.56567182,1,-1.068662481,0.757682393,-1.410435943,0.158410998,0.277061903,65.76068768,1,-0.543219073,0.706951687,-0.768396318,0.442251767,0.57592272,N,-,,duf1690 domain-containing,,IPR012471 (PFAM),,
RL4_JR_00970,1761,1901,3902,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,30.07003364,0,-3.012617121,1.253685599,-2.403008477,0.016260811,0.055644166,9.454081714,0,0.224502888,1.270604867,0.176689775,0.859752073,0.918156865,24.80366057,0,-2.443554616,1.237849376,-1.974032272,0.048378073,0.110435088,32.64362714,1,-1.923105267,1.197534119,-1.605887662,0.108298595,0.208147926,24.7619704,0,-2.543828917,1.256201586,-2.025016483,0.042865672,0.099248783,N,-,,trna wybutosine-synthesizing,P:metabolic process; F:transferase activity,IPR003827 (PFAM); IPR003827 (G3DSA:3.30.1960.GENE3D); PTHR23245:SF31 (PANTHER); PTHR23245 (PANTHER); PTHR23245 (PANTHER); PTHR23245:SF31 (PANTHER); PTHR23245 (PANTHER); IPR003827 (SUPERFAMILY),,
RL4_JR_00971,26031,19034,22766,0,2,3,1,0,2,1,0,0,1,10,14,0,3,3,298.1040644,1,-3.138401993,0.681189792,-4.607235795,4.08E-06,5.25E-05,127.9151563,1,-0.780552143,0.863229551,-0.904223149,0.365877088,0.530270315,235.6875516,1,-4.660544817,1.197013728,-3.893476496,9.88E-05,0.001152571,443.3855106,1,-0.560251774,0.553632449,-1.011956173,0.311559009,0.457646305,254.5446678,1,-2.489779001,0.637178406,-3.907506874,9.33E-05,0.000654778,N,-,,importin subunit beta-1,"P:regulation of protein desumoylation; F:Ran guanyl-nucleotide exchange factor activity; F:protein transporter activity; P:nuclear pore complex assembly; F:Ran GTPase binding; P:protein import into nucleus, docking; P:protein targeting to membrane; P:phosphatidylcholine biosynthetic process; F:nuclear localization sequence binding; P:positive regulation of GTPase activity; C:nuclear pore; P:translation; P:ribosomal protein import into nucleus; C:mitotic spindle midzone; C:nuclear exosome (RNase complex); C:nuclear membrane; P:mycelium development; C:cytoplasm; P:protein import into nucleus, translocation; P:NLS-bearing protein import into nucleus; C:nuclear periphery",IPR001494 (SMART); IPR001494 (PFAM); IPR000357 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR10527 (PANTHER); IPR001494 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_00972,828,708,1037,0,0,0,0,0,1,0,2,0,0,0,3,0,3,0,10.25648783,0,-1.460963019,1.200607807,-1.21685284,0.223660212,0.393916236,12.64361637,1,2.674132821,1.131257751,2.36385812,0.018085737,0.053138994,24.17692015,1,0.927270753,1.038762418,0.892668754,0.372034588,0.516150846,38.70227259,1,1.021105871,0.85700234,1.191485511,0.233463041,0.370677951,19.97897866,1,1.208841966,0.868390661,1.392048557,0.163907695,0.276594235,Y,-,,glycosyl hydrolase,P:carbohydrate metabolic process; F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process; F:carbohydrate binding; F:hydrolase activity,IPR014718 (G3DSA:2.70.98.GENE3D); IPR005887 (TIGRFAM); G3DSA:3.30.2080.10 (GENE3D); IPR012939 (PFAM); G3DSA:1.20.1050.60 (GENE3D); G3DSA:1.20.1610.10 (GENE3D); PTHR12143 (PANTHER); PTHR12143:SF22 (PANTHER); IPR008928 (SUPERFAMILY),1.C.96.1.3," the haemolytic lectin, cel-iii (cel-iii) family"
RL4_JR_00973,1699,1522,2160,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,21.46357565,0,-2.526237706,1.195276399,-2.1135176,0.03455649,0.101056224,6.829967291,0,0.693587937,1.22991884,0.563929842,0.57280188,0.712885851,24.26264187,1,-1.000203356,1.195318511,-0.836767227,0.402723422,0.544809244,33.81914411,1,-0.649925519,1.019897828,-0.637245713,0.523964806,0.658288083,17.56783661,0,-2.048646384,1.204179734,-1.701279573,0.088890502,0.174760453,N,-,,DUF300 domain,C:integral component of membrane,IPR005178 (PFAM); IPR005178 (PANTHER); PTHR23423:SF10 (PANTHER),2.A.82.1.3, the organic solute transporter (ost) family.
RL4_JR_00974,6714,9177,5216,3,2,4,0,0,0,3,0,8,0,1,4,0,1,2,146.8225418,1,-0.587312034,0.60496379,-0.970821798,0.331637026,0.521390414,27.35292004,0,-1.308080297,1.236975831,-1.057482503,0.290291436,0.449560881,155.7873417,1,0.311078537,0.570369289,0.54539847,0.585479493,0.706264822,123.9663399,1,-1.252234545,0.741461453,-1.688873427,0.091243689,0.182811372,87.65309633,1,-1.794216837,0.881907506,-2.034472804,0.041903948,0.097579916,N,-,,fermentation associated,F:nucleotide binding; C:membrane; P:cellular metabolic process,PTHR32085 (PANTHER); IPR029636 (PTHR32085:PANTHER),8.A.6.1.1, the auxiliary nutrient transporter (ant) family.
RL4_JR_00975,169255,161936,219786,20,34,49,1,0,4,11,14,6,12,44,7,0,23,15,2860.525014,1,-1.754616001,0.270416751,-6.488562545,8.67E-11,3.03E-09,759.4275263,1,-3.075258822,0.704545796,-4.364881373,1.27E-05,0.000809708,2090.425817,1,-2.807610858,0.432915454,-6.485356056,8.85E-11,5.15E-09,2455.432705,1,-2.48214148,0.390753316,-6.352195566,2.12E-10,7.57E-09,1998.991089,1,-3.03595491,0.669924368,-4.53178755,5.85E-06,6.47E-05,N,-,,elongation factor 2,F:GTP binding; F:translation elongation factor activity; F:metal ion binding; F:GTPase activity; C:integral component of membrane; P:translational elongation,IPR000795 (PRINTS); IPR005517 (SMART); IPR000640 (SMART); G3DSA:2.40.30.10 (GENE3D); G3DSA:3.90.1430.10 (GENE3D); IPR005517 (PFAM); IPR005225 (TIGRFAM); IPR014721 (G3DSA:3.30.230.GENE3D); IPR004161 (PFAM); PF00009 (PFAM); IPR000640 (G3DSA:3.30.70.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.70.870 (GENE3D); IPR009022 (PFAM); IPR000640 (PFAM); PTHR23115:SF187 (PANTHER); PTHR23115:SF187 (PANTHER); PTHR23115:SF187 (PANTHER); PTHR23115 (PANTHER); PTHR23115 (PANTHER); PTHR23115 (PANTHER); PTHR23115:SF187 (PANTHER); IPR000795 (PROSITE_PROFILES); IPR009022 (SUPERFAMILY); IPR020568 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR009022 (SUPERFAMILY); IPR009000 (SUPERFAMILY),,
RL4_JR_00976,3728,4786,4571,3,0,1,0,0,0,0,0,0,0,7,0,0,1,0,86.58281157,1,-1.063847581,0.759688319,-1.400373751,0.161401426,0.311500552,16.7280062,0,-0.598668698,1.208265906,-0.495477605,0.620263026,0.750106518,43.43701639,0,-3.251848711,1.195004819,-2.721201337,0.006504513,0.023203556,78.19616614,1,-0.185331351,0.604505231,-0.306583535,0.759160388,0.842633077,46.68444679,1,-2.404315797,1.12810555,-2.131286205,0.033065571,0.081141276,N,-,,ccch zinc finger and rrm domain-containing,F:organic cyclic compound binding; F:heterocyclic compound binding,IPR000504 (SMART); IPR002483 (G3DSA:1.20.1390.GENE3D); IPR002483 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR14398:SF0 (PANTHER); PTHR14398 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000571 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_00977,8493,9719,11749,0,9,8,0,0,0,0,1,2,0,2,3,0,8,4,222.5643479,1,-0.186917126,0.474880043,-0.393609142,0.69386963,0.8342798,38.08108546,0,-1.785506126,1.195541872,-1.493470172,0.135314157,0.254913436,119.9441092,1,-2.038271784,0.858280312,-2.374832273,0.017556926,0.050595925,151.2800534,1,-1.801682386,0.678534634,-2.655254862,0.007924851,0.040321164,158.3454171,1,-0.349736676,0.499253265,-0.700519556,0.483602897,0.61210648,N,-,,methylenetetrahydrofolate reductase 1,P:methionine biosynthetic process; C:mitochondrion; P:tetrahydrofolate interconversion; P:oxidation-reduction process; F:methylenetetrahydrofolate reductase (NAD(P)H) activity,IPR029041 (G3DSA:3.20.20.GENE3D); IPR003171 (PFAM); IPR004621 (TIGRFAM); PTHR21091 (PANTHER); PTHR21091:SF120 (PANTHER); PTHR21091:SF120 (PANTHER); PTHR21091 (PANTHER); IPR029041 (SUPERFAMILY),,
RL4_JR_00978,913,638,820,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,9.450046642,0,-1.342855931,1.198874131,-1.120097512,0.262672211,0.442286872,3.031466134,0,1.865512183,1.287820031,1.44858143,0.14745451,0.273114451,15.68718263,1,0.179057643,1.199522136,0.149274146,0.881337315,0.92609097,13.05890323,1,-0.258233616,1.15316877,-0.223933931,0.822808713,0.888675731,7.718551121,0,-0.862218401,1.204175616,-0.7160238,0.473976653,0.604257569,N,-,,hypothetical protein F503_02948,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_00979,16788,13842,13427,0,2,7,0,0,0,0,5,3,0,1,0,0,3,4,219.0487572,1,-1.695226984,0.532822948,-3.181595297,0.001464663,0.008062566,56.6429798,0,-2.358293539,1.202307689,-1.961472558,0.049823923,0.117529189,204.9990449,1,-1.18746885,0.553928197,-2.143723424,0.032055054,0.08080811,172.7237032,1,-4.478742365,1.148096932,-3.901014139,9.58E-05,0.00103509,184.5867439,1,-1.640438899,0.583405512,-2.811833047,0.004926006,0.017686459,N,-,,homeobox and c2h2 transcription factor,F:binding,IPR015880 (SMART); IPR001356 (SMART); IPR009057 (G3DSA:1.10.10.GENE3D); IPR009057 (G3DSA:1.10.10.GENE3D); IPR008422 (PFAM); PTHR11850:SF121 (PANTHER); PTHR11850 (PANTHER); PTHR11850 (PANTHER); PTHR11850:SF121 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR001356 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY),,
RL4_JR_00980,5110,4266,4280,0,0,6,0,0,0,0,0,0,0,2,0,0,2,0,77.54607884,1,-0.587621184,0.623321646,-0.942725457,0.345821349,0.535334072,17.53719212,0,-0.666798608,1.210831359,-0.550694862,0.581842868,0.720707563,45.32195586,0,-3.313135909,1.192163016,-2.779096368,0.005451035,0.020177799,60.29448175,1,-2.009933586,1.018169959,-1.974064907,0.048374363,0.120430397,52.22458436,1,-1.718975359,0.969824335,-1.772460535,0.076318141,0.155164895,N,-,,homeobox and c2h2 transcription factor,"F:DNA binding; C:nucleus; F:metal ion binding; P:regulation of transcription, DNA-templated",no IPS match,,
RL4_JR_00981,3609,4857,6352,3,0,11,0,0,0,0,0,0,0,0,0,0,6,0,131.514626,1,0.446951777,0.571771825,0.78169605,0.434393224,0.625005277,18.74318202,0,-0.762815609,1.219123146,-0.625708413,0.531506214,0.679796045,48.93426911,0,-3.423805748,1.210024488,-2.829534263,0.004661581,0.017978607,56.47439725,0,-3.846721895,1.213067969,-3.171068722,0.001518792,0.010503941,71.70809643,1,-0.387673765,0.709177683,-0.546652517,0.584617482,0.697449276,N,-,,u2 small nuclear ribonucleo a,"C:cytoplasm; C:viral nucleocapsid; C:U2-type prespliceosome; C:U2 snRNP; P:mRNA splicing, via spliceosome",IPR032675 (G3DSA:3.80.10.GENE3D); PF14580 (PFAM); PTHR10552 (PANTHER); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY),8.A.43.1.12, the neat-domain containing methaemoglobin heme sequestration (n-mhs) family.
RL4_JR_00982,1938,1704,1493,4,0,3,0,0,5,0,0,0,0,5,0,0,0,2,72.29708254,1,1.086414328,0.588414525,1.846341791,0.064842593,0.161423826,53.50727016,1,3.62369642,0.717058967,5.05355429,4.34E-07,4.14E-05,17.07287368,0,-1.904578677,1.198899083,-1.588606334,0.112149297,0.210923711,39.74750615,1,0.693585713,0.691499588,1.003016813,0.315852749,0.46201629,31.46825521,1,-0.292548718,0.971939076,-0.300994914,0.763418373,0.834731212,N,-,,coupling of ubiquitin conjugation to ER degradation 1,F:nucleotide binding; C:membrane; C:integral component of membrane,PTHR15486 (PANTHER); IPR003892 (PROSITE_PROFILES),,
RL4_JR_00983,7244,10712,12881,3,2,0,0,0,0,4,0,4,0,1,0,0,0,2,169.8605249,1,-1.859059605,0.765105536,-2.429808068,0.01510682,0.05278006,39.06506365,0,-1.822308729,1.213555001,-1.501628461,0.133193089,0.251573138,172.23682,1,-0.645355628,0.594003334,-1.086451189,0.277279425,0.416309788,121.6848579,1,-3.96042887,1.170360752,-3.383938552,0.00071454,0.005576309,115.8185545,1,-2.866147094,1.00965282,-2.838745196,0.004529131,0.016518092,N,-,,pentatricopeptide repeat,F:nucleotide binding; C:mitochondrion; P:regulation of mitochondrial translation,IPR000504 (SMART); IPR002885 (PFAM); IPR002885 (TIGRFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR24015 (PANTHER); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_00984,797,866,515,0,1,8,0,0,0,0,1,0,1,1,0,0,0,0,47.33777045,1,2.55478606,0.634567419,4.026027786,5.67E-05,0.000522324,2.82604925,0,1.966832324,1.334622759,1.473699074,0.140562632,0.26265658,15.12063759,1,0.287510477,1.221184691,0.235435704,0.813870577,0.879140943,21.71628696,1,0.639951762,1.052300746,0.608145308,0.543091104,0.673940833,7.109281165,0,-0.743487157,1.223982686,-0.60743274,0.543563766,0.665424643,N,-,,dna polymerase alpha catalytic subunit,"P:nucleic acid phosphodiester bond hydrolysis; C:site of double-strand break; P:lagging strand elongation; P:synthesis of RNA primer involved in mitotic DNA replication; P:gene conversion at mating-type locus, DNA repair synthesis; P:RNA-dependent DNA biosynthetic process; P:mitotic DNA replication initiation; F:chromatin binding; C:nuclear chromosome, telomeric region; P:premeiotic DNA replication; F:nucleoside binding; F:single-stranded DNA binding; F:nucleotide binding; F:DNA replication origin binding; F:3'-5' exonuclease activity; F:DNA-directed DNA polymerase activity; C:nuclear chromatin; C:alpha DNA polymerase:primase complex",IPR006172 (PRINTS); IPR006172 (SMART); IPR006134 (PFAM); G3DSA:1.10.287.690 (GENE3D); IPR023211 (G3DSA:3.90.1600.GENE3D); IPR006133 (PFAM); IPR015088 (PFAM); IPR024647 (PFAM); TIGR00592 (TIGRFAM); IPR012337 (G3DSA:3.30.420.GENE3D); PTHR10322 (PANTHER); IPR029702 (PTHR10322:PANTHER); PTHR10322 (PANTHER); IPR029702 (PTHR10322:PANTHER); SSF56672 (SUPERFAMILY); IPR012337 (SUPERFAMILY),,
RL4_JR_00985,63707,51293,56905,11,10,18,0,0,1,2,0,6,0,8,9,0,5,9,946.4376248,1,-1.486991871,0.294681339,-5.04610124,4.51E-07,7.55E-06,229.6207805,1,-3.400667637,1.11919377,-3.038497648,0.00237761,0.015223444,630.8811245,1,-3.150627903,0.562755673,-5.598571551,2.16E-08,8.55E-07,775.9522537,1,-2.540485069,0.466043684,-5.451173696,5.00E-08,1.21E-06,645.7721331,1,-2.580281755,0.528542396,-4.881882274,1.05E-06,1.52E-05,N,-,,eukaryotic translation initiation factor subunit,F:RNA binding,IPR003890 (SMART); IPR022745 (PFAM); IPR003890 (PFAM); IPR016021 (G3DSA:1.25.40.GENE3D); PTHR23253 (PANTHER); PTHR23253 (PANTHER); PTHR23253 (PANTHER); PTHR23253:SF9 (PANTHER); PTHR23253 (PANTHER); PTHR23253:SF9 (PANTHER); PTHR23253:SF9 (PANTHER); IPR016024 (SUPERFAMILY); IPR022745 (SUPERFAMILY),,
RL4_JR_00986,2825,2558,2357,0,0,6,0,0,0,0,2,1,0,4,0,0,3,0,53.92535913,1,0.229592001,0.623050066,0.368496874,0.712502776,0.845222865,9.952009994,0,0.150574204,1.224875877,0.122930174,0.902162392,0.944820251,47.90040957,1,-0.088789155,0.854065817,-0.103960554,0.917200652,0.950516972,45.70546134,1,-0.205786222,0.751386837,-0.273875202,0.784180529,0.860779256,36.82133388,1,-0.364404777,0.839404525,-0.43412296,0.664199153,0.760834532,N,-,,voltage gated chloride channel,F:ion channel activity; P:ion transport; P:transmembrane transport; C:membrane,IPR001807 (PRINTS); IPR000644 (SMART); IPR001807 (PFAM); G3DSA:3.10.580.10 (GENE3D); IPR014743 (G3DSA:1.10.3080.GENE3D); PTHR11689:SF65 (PANTHER); PTHR11689 (PANTHER); PTHR11689 (PANTHER); PTHR11689:SF65 (PANTHER); IPR000644 (PROSITE_PROFILES); IPR000644 (PROSITE_PROFILES); SSF54631 (SUPERFAMILY); IPR014743 (SUPERFAMILY),2.A.49.2.3, the chloride carrier/channel (clc) family.
RL4_JR_00987,6292,6127,4849,0,0,5,0,0,0,0,0,2,0,1,0,0,4,0,88.43434064,1,-1.21025159,0.705653137,-1.715080012,0.086330558,0.19872593,22.27379585,0,-1.011723332,1.216151622,-0.83190559,0.405462236,0.569419986,70.48578504,1,-1.838869617,1.043577534,-1.762082411,0.078055375,0.159739764,70.31219914,1,-3.131611462,1.153563611,-2.714728023,0.006633022,0.035088478,71.77418475,1,-1.124854099,0.759314655,-1.48140707,0.138498132,0.244042994,N,-,,intron-binding aquarius,"C:spliceosomal complex; F:helicase activity; P:mRNA splicing, via spliceosome",IPR026300 (PIRSF); PF13087 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PF13086 (PFAM); IPR032174 (PFAM); PTHR10887 (PANTHER); PTHR10887:SF356 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_00988,2960,3466,3763,0,0,3,3,0,0,0,0,0,6,10,0,0,2,0,52.29814494,1,-1.157470426,0.862336283,-1.342249478,0.179515119,0.336627744,79.92597132,1,1.983543418,0.840795883,2.359125988,0.018318036,0.053665747,33.75930676,0,-2.888232275,1.191865806,-2.423286465,0.015380793,0.045402292,134.9399658,1,1.405506062,0.414854966,3.387945609,0.000704182,0.005527012,41.04708939,1,-1.305318346,0.980350553,-1.331481215,0.183030722,0.30157625,N,-,,guanylate kinase,C:nucleus; P:phosphorylation; F:kinase activity,IPR008145 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR021861 (PFAM); IPR008145 (PFAM); G3DSA:3.30.63.10 (GENE3D); PTHR13265 (PANTHER); PTHR13265:SF0 (PANTHER); IPR008144 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),8.A.24.1.8, the ezrin/radixin/moesin-binding phosphoprotein 50 (ebp50) family.
RL4_JR_00989,974,1070,1633,2,1,0,0,0,0,2,6,0,3,0,0,0,4,0,42.81336002,1,0.385834018,0.880904657,0.437997478,0.661388111,0.810272445,4.640846387,0,1.251040498,1.264022698,0.989729457,0.322306373,0.484480077,81.31501571,1,2.431736316,0.588271376,4.133698177,3.57E-05,0.000546745,41.9207233,1,0.525398193,0.877076341,0.599033595,0.549150482,0.678750073,27.47175279,1,1.071115512,0.813282472,1.317027661,0.187829353,0.307148451,N,-,,insig domain-containing,C:membrane; C:integral component of membrane,IPR025929 (PFAM); PTHR15301:SF3 (PANTHER); PTHR15301 (PANTHER); PTHR15301 (PANTHER); PTHR15301:SF3 (PANTHER),,
RL4_JR_00990,9543,15008,15756,0,3,3,0,0,0,0,0,0,0,2,2,0,1,3,197.4607592,1,-2.129834352,0.690004273,-3.086697337,0.002023936,0.010584145,51.2482462,0,-2.213922376,1.211356214,-1.827639426,0.067603685,0.149407095,133.5687738,0,-4.872451023,1.211867778,-4.020612738,5.80E-05,0.000811695,181.4342451,1,-2.559263439,0.783144701,-3.267931758,0.001083365,0.007897098,158.1286353,1,-2.307303377,0.798984252,-2.887795811,0.003879516,0.014553576,N,-,,wd domain-containing,P:ribosomal large subunit biogenesis; P:rRNA processing,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR017986 (SUPERFAMILY),,
RL4_JR_00991,49914,31767,32750,0,3,1,1,0,0,3,11,2,4,12,0,0,6,5,484.4327576,1,-4.180128967,0.794664887,-5.260241188,1.44E-07,2.76E-06,169.7714271,1,-2.808268407,1.141814173,-2.459479373,0.013913869,0.043374249,512.2689594,1,-1.536208277,0.530688044,-2.89474823,0.003794628,0.015900997,523.3015849,1,-2.159444143,0.520762331,-4.146698048,3.37E-05,0.000414971,431.8219613,1,-2.385426511,0.556639495,-4.285406498,1.82E-05,0.000166383,N,-,,myb and hsa domain containing,C:nucleus; P:cellular process,IPR001005 (SMART); IPR014012 (SMART); PF13921 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); IPR014012 (PFAM); IPR017877 (PROSITE_PROFILES); IPR014012 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY),,
RL4_JR_00992,3246,2162,2956,0,0,2,0,0,0,0,0,1,0,1,5,0,0,0,40.94249305,1,-1.437304753,1.023995697,-1.40362382,0.160430898,0.310141058,10.68281999,0,0.048296853,1.230025774,0.039264911,0.968679182,0.983743421,34.14933633,1,-1.63849498,1.200017357,-1.365392734,0.172129646,0.290827861,84.07970188,1,0.346405386,0.647440626,0.535038075,0.592623529,0.715942397,27.22061679,0,-2.680448318,1.202982278,-2.228169415,0.02586922,0.067160474,N,-,,pre-mRNA-splicing factor SPP2,P:primary metabolic process; P:organic substance metabolic process,IPR026822 (PFAM); PTHR15818 (PANTHER); PTHR15818 (PANTHER); PTHR15818:SF2 (PANTHER),,
RL4_JR_00993,1116,1768,1381,0,1,24,0,0,0,0,2,0,2,2,0,0,5,2,116.8611455,1,2.699909135,0.935082112,2.887349786,0.003885021,0.017646992,5.47168207,0,1.013560283,1.266613523,0.800212745,0.423587547,0.586532579,29.88667426,1,0.18598965,1.054162389,0.176433585,0.859953321,0.910782239,43.03196289,1,0.672971166,0.777925655,0.865084166,0.386992595,0.5321136,48.01462184,1,1.684289234,0.627670421,2.683397493,0.007287831,0.024385093,N,-,,alpha amylase,P:carbohydrate metabolic process; F:hydrolase activity,IPR006047 (SMART); G3DSA:3.90.400.10 (GENE3D); IPR006047 (PFAM); IPR013780 (G3DSA:2.60.40.GENE3D); IPR013781 (G3DSA:3.20.20.GENE3D); IPR015902 (PANTHER); IPR015902 (PANTHER); PTHR10357:SF136 (PANTHER); PTHR10357:SF136 (PANTHER); SSF51011 (SUPERFAMILY); IPR017853 (SUPERFAMILY),8.A.9.1.2, the rbat transport accessory protein (rbat) family.
RL4_JR_00994,10559,13369,20904,11,12,48,0,0,6,5,4,6,15,38,5,0,30,3,569.1069523,1,1.171364416,0.434681982,2.694761839,0.007043896,0.028679942,112.6894379,1,0.76101773,0.698356099,1.089727334,0.275833272,0.434212189,273.3356027,1,-0.273994297,0.488292479,-0.561127416,0.57471068,0.697521862,510.6870261,1,1.04762344,0.443572065,2.361788585,0.018187011,0.073598514,284.7655005,1,0.132939361,0.766250197,0.173493412,0.862263606,0.908180765,N,-,,cyclopropane-fatty-acyl-phospholipid synthase,C:integral component of membrane,IPR029063 (G3DSA:3.40.50.GENE3D); IPR029063 (PFAM); PTHR10108 (PANTHER); PTHR10108 (PANTHER); PTHR10108:SF90 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_00995,14735,11575,9422,4,2,20,0,0,0,3,1,2,0,1,6,0,2,12,275.7910039,1,0.033904111,0.494062867,0.068623071,0.945289654,0.973081766,46.18823736,0,-2.063919134,1.220755235,-1.690690381,0.090895952,0.187995266,172.9719476,1,-1.282518844,0.648703838,-1.977048337,0.048036167,0.109852756,198.9487923,1,-1.467038749,0.672230231,-2.182345694,0.029084029,0.090552212,212.4026934,1,-0.207379892,0.749203436,-0.276800509,0.781933291,0.85056667,N,-,,actin cytoskeleton-regulatory complex pan1,C:endosome; P:cellular bud site selection; F:calcium ion binding; C:membrane; P:cell budding; P:endocytosis; C:actin cortical patch,PR01217 (PRINTS); IPR000261 (SMART); IPR002048 (SMART); IPR000261 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR11216 (PANTHER); PTHR11216 (PANTHER); IPR026812 (PTHR11216:PANTHER); PTHR11216 (PANTHER); IPR026812 (PTHR11216:PANTHER); IPR026812 (PTHR11216:PANTHER); IPR026812 (PTHR11216:PANTHER); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR000261 (PROSITE_PROFILES); IPR000261 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY); IPR011992 (SUPERFAMILY),1.A.14.3.14, the calcium transporter a (cata) (formerly the testis-enhanced gene transfer (tegt) family.
RL4_JR_00996,4858,5171,5535,2,0,6,0,0,0,0,0,0,0,15,0,0,3,3,105.3950307,1,-0.348242581,0.539250633,-0.645789842,0.518415467,0.702893668,19.87834078,0,-0.847603427,1.19669603,-0.70828632,0.478767471,0.636052545,51.58725992,0,-3.499955199,1.187147474,-2.948205909,0.003196241,0.014186209,119.6879313,1,0.16030908,1.425896869,0.112426841,0.910484974,0.945309718,84.53617371,1,-0.370223231,0.615981389,-0.601029897,0.547820074,0.668344061,N,-,,forkhead box l2,"C:nucleus; F:transcription factor activity, sequence-specific DNA binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR001766 (PRINTS); IPR001766 (SMART); IPR011991 (G3DSA:1.10.10.GENE3D); IPR001766 (PFAM); PTHR11829:SF220 (PANTHER); PTHR11829:SF220 (PANTHER); PTHR11829 (PANTHER); PTHR11829 (PANTHER); IPR001766 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY),,
RL4_JR_00997,5446,5824,6136,0,0,0,0,0,0,2,0,4,0,0,1,0,0,0,69.74737266,0,-4.226376261,1.187615305,-3.558708147,0.000372683,0.002614231,22.24022403,0,-1.009574416,1.1956321,-0.844385507,0.398454019,0.562503707,105.8411119,1,-0.254153199,0.608268295,-0.417830752,0.676070865,0.777523735,76.20797649,1,-3.134940079,1.139126142,-2.752057005,0.005922221,0.032065502,56.87754828,0,-3.743556974,1.189177272,-3.14802264,0.00164379,0.00720169,N,-, Effector probability:0.717,duf1649 domain,C:nucleus; C:pre-autophagosomal structure; C:cytosol; P:macroautophagy,IPR012445 (PFAM); IPR012445 (PANTHER); PTHR13292:SF0 (PANTHER),9.A.15.2.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_00998,1586,1326,1520,0,6,10,0,0,0,0,0,0,2,0,4,0,0,0,103.9551108,1,2.467920665,0.392834298,6.282345203,3.34E-10,1.02E-08,5.66933302,0,0.96235506,1.237395304,0.777726453,0.436730294,0.598346513,14.68109547,0,-1.686928606,1.191005086,-1.416390766,0.156661126,0.270834063,74.09978767,1,1.238049785,0.610911385,2.02656198,0.042707228,0.11240205,14.44965888,0,-1.766792373,1.191398885,-1.482956208,0.138086046,0.243490285,N,-,,Peroxisomal biogenesis factor 3,C:peroxisomal membrane; P:peroxisome organization; C:integral component of membrane,IPR006966 (PFAM); PTHR28080:SF1 (PANTHER); PTHR28080:SF1 (PANTHER); PTHR28080 (PANTHER); PTHR28080 (PANTHER),9.A.17.1.2, the integral membrane peroxisomal protein importer-2 (ppi2) family.
RL4_JR_00999,1450,2403,2340,0,0,8,0,0,0,0,0,1,0,3,0,0,10,4,55.46924232,1,0.830313455,0.705101689,1.177579729,0.238964195,0.413373602,7.888114781,0,0.485821894,1.250831298,0.388399215,0.697720625,0.808324158,27.04568788,1,-1.210059449,1.213402463,-0.997244925,0.318645639,0.461379928,35.74579766,1,-0.316479028,0.90165791,-0.350996785,0.72559076,0.817330628,88.3817337,1,2.102615239,0.527345036,3.987171765,6.69E-05,0.000496709,N,-, Effector probability:0.66,transport particle subunit bet5,C:TRAPPI protein complex; C:TRAPPII protein complex; C:TRAPPIII protein complex; F:Rab guanyl-nucleotide exchange factor activity; P:transport; P:positive regulation of GTPase activity,IPR007233 (SMART); G3DSA:3.30.450.70 (GENE3D); IPR007233 (PFAM); IPR007233 (PANTHER); PTHR23249:SF16 (PANTHER); IPR011012 (SUPERFAMILY),,
RL4_JR_01000,1813,1623,1661,0,3,0,0,0,0,0,0,0,0,4,0,0,0,0,44.43087251,1,-0.133360755,0.841041559,-0.15856619,0.874010669,0.939103212,6.535079068,0,0.757348241,1.232329728,0.614566235,0.538841219,0.685970421,16.9097077,0,-1.890757452,1.19014626,-1.588676548,0.112133436,0.210923711,35.55051262,1,0.405476205,0.741209276,0.547046857,0.584346541,0.709753926,16.62396602,0,-1.969008432,1.188278762,-1.657025688,0.097514282,0.187278472,N,-,,camkk meta kinase,F:ATP binding; F:protein serine/threonine kinase activity; P:protein phosphorylation,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24347:SF256 (PANTHER); IPR020636 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.2, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_01001,1029,1118,982,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.56472472,0,-1.753445645,1.193012921,-1.469762493,0.141626091,0.284718001,4.018710477,0,1.458837565,1.260160078,1.157660516,0.247002603,0.400153705,10.40150247,0,-1.189603349,1.195739932,-0.994867962,0.319800487,0.462511477,11.99809233,0,-1.611771091,1.193639338,-1.350299911,0.176919801,0.301111613,10.22184076,0,-1.267319854,1.193649984,-1.061718151,0.288363657,0.422774692,N,-,,CAMKK META kinase,F:nucleotide binding; F:protein kinase activity; P:phosphorylation,no IPS match,,
RL4_JR_01002,13871,11141,11879,0,4,1,0,0,0,0,0,8,2,5,0,0,2,1,183.3175919,1,-2.241726059,0.671293303,-3.339413707,0.000839554,0.005184772,47.32082045,0,-2.098873249,1.200300413,-1.748623283,0.080356159,0.170794401,174.3277952,1,-1.127898281,1.266427639,-0.890614075,0.373136246,0.517129548,179.7806257,1,-1.641900723,0.58004774,-2.830630322,0.004645638,0.026455054,135.2833215,1,-2.6100403,0.841990892,-3.099843863,0.001936227,0.008254441,N,-,,serine threonine- kinase hal4,C:nucleus; F:ATP binding; P:cellular response to cation stress; P:G1/S transition of mitotic cell cycle; P:protein dephosphorylation; C:cytosol; F:protein serine/threonine kinase activity; P:protein phosphorylation; P:cellular cation homeostasis; P:cellular protein localization; P:intracellular signal transduction,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); PTHR24343:SF124 (PANTHER); PTHR24343 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.C.104.2.4, the heterokaryon incompatibility prion/amyloid protein (het-s) family
RL4_JR_01003,3686,2490,2779,0,0,3,0,0,0,0,0,0,0,3,0,0,1,1,47.18214868,1,-0.970402666,0.873268554,-1.111230517,0.266469139,0.446560237,11.50337267,0,-0.058441543,1.234384167,-0.047344696,0.962238506,0.979659843,29.68713933,0,-2.702780073,1.202764989,-2.247138966,0.024631147,0.065709021,46.26971347,1,-0.833931148,0.878583915,-0.949176434,0.342530885,0.489499365,40.3521999,1,-1.100286448,0.982648297,-1.119715418,0.262835053,0.394896114,N,-,,hypothetical protein SPSK_03297,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_01004,4441,8630,9306,0,0,9,0,0,0,0,0,2,0,0,0,0,1,0,124.3732296,1,-0.965489347,0.841687093,-1.147088218,0.251345163,0.428521178,28.35852571,0,-1.360209159,1.237625297,-1.099047638,0.271747288,0.429315756,87.09733897,1,-2.214136466,1.082321782,-2.045728455,0.040783095,0.097195869,85.52720173,0,-4.445492396,1.238631555,-3.589035317,0.000331904,0.002953011,77.35987046,1,-3.187177794,1.175484725,-2.711373212,0.006700516,0.022811945,N,-,,dna-directed rna polymerase i and iii 14 kda polypeptide,F:RNA polymerase III activity; F:DNA binding; C:DNA-directed RNA polymerase I complex; F:RNA polymerase I activity; P:transcription from RNA polymerase I promoter; F:protein dimerization activity; P:tRNA transcription from RNA polymerase III promoter; C:DNA-directed RNA polymerase III complex,G3DSA:3.30.1360.10 (GENE3D); IPR009025 (PFAM); PTHR13946:SF28 (PANTHER); PTHR13946 (PANTHER); IPR009025 (SUPERFAMILY),,
RL4_JR_01005,1105,1398,1538,0,0,0,0,0,0,0,0,0,4,4,1,0,3,0,16.204815,0,-2.120624809,1.201862938,-1.764448127,0.077656561,0.184002971,5.144440965,0,1.102477188,1.245161653,0.885408882,0.375936143,0.540515006,13.38466793,0,-1.553540674,1.199933909,-1.294688535,0.195427697,0.320147249,78.37472715,1,1.936196908,0.530015931,3.653091908,0.000259101,0.002391433,24.80866161,1,0.554235884,0.866596904,0.639554424,0.522462321,0.646769898,N,-,,histone acetyltransferase type b catalytic subunit,"C:chromosome, telomeric region; F:histone acetyltransferase activity; F:histone binding; P:histone acetylation; P:chromatin silencing at telomere; C:histone acetyltransferase complex",IPR019467 (G3DSA:3.90.360.GENE3D); IPR016181 (G3DSA:3.40.630.GENE3D); IPR013523 (G3DSA:1.10.10.GENE3D); IPR019467 (PFAM); IPR017380 (PIRSF); IPR017380 (PANTHER); IPR016181 (SUPERFAMILY),,
RL4_JR_01006,734,1036,1541,0,1,0,2,0,0,0,0,0,0,0,0,0,1,0,21.24422008,1,-0.873150478,1.191585366,-0.73276368,0.463702577,0.651702566,48.79115642,1,3.100288733,1.012365482,3.062420429,0.002195548,0.015045494,10.90872668,0,-1.258510553,1.230267483,-1.022956852,0.306328247,0.448030507,12.59148719,0,-1.681632457,1.233235006,-1.363594488,0.172695228,0.295711006,14.71429575,1,-0.427607795,1.175745633,-0.363690736,0.716088962,0.799735356,N,-,,zip zinc transporter,P:transmembrane transport; C:integral component of membrane; F:metal ion transmembrane transporter activity; P:metal ion transport,IPR003689 (PFAM); PTHR16133 (PANTHER); PTHR16133 (PANTHER); PTHR16133:SF0 (PANTHER); PTHR16133:SF0 (PANTHER),2.A.5.6.1, the zinc (zn(2+))-iron (fe(2+)) permease (zip) family.
RL4_JR_01007,2047,1424,1551,0,0,0,0,0,0,0,0,2,0,0,0,0,3,0,20.04484309,0,-2.427554978,1.198509489,-2.025478314,0.042818273,0.118651995,6.452519778,0,0.775691242,1.253469346,0.61883543,0.536024779,0.683588612,29.65067946,1,-0.051934181,1.045857349,-0.049657041,0.960395691,0.976994169,19.20451894,0,-2.290557015,1.202479103,-1.904862221,0.056797983,0.132530408,27.91957333,1,0.253107009,0.859047086,0.294636944,0.768271237,0.839131205,N,-,,F-box and WD-40 domain-containing CDC4,,IPR001680 (SMART); IPR001810 (SMART); IPR001810 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); G3DSA:1.20.1280.50 (GENE3D); PTHR22844:SF201 (PANTHER); PTHR22844 (PANTHER); IPR001810 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY); IPR017986 (SUPERFAMILY),,
RL4_JR_01008,2204,1826,1939,8,6,4,0,0,0,0,0,4,0,0,1,0,4,0,167.7240734,1,2.35749815,0.467874181,5.038743839,4.69E-07,7.83E-06,7.653806752,0,0.529372018,1.229786861,0.430458346,0.666862261,0.787353296,45.78947101,1,0.697550909,0.744967173,0.936351203,0.349092393,0.492779056,32.46588486,1,-1.590610905,1.142299331,-1.392464184,0.16378188,0.284099972,34.89631848,1,0.417544955,0.74523058,0.560289616,0.575281909,0.689663477,N,-,,f-box wd repeat-containing 7,,IPR020472 (PRINTS); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR22844 (PANTHER); PTHR22844:SF201 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_01009,8678,14979,17370,14,58,47,0,1,8,5,17,69,7,32,6,0,17,1,949.7100256,1,2.248833694,0.561318565,4.0063412,6.17E-05,0.000559595,165.3025212,1,1.456752522,0.62737948,2.32196393,0.020234878,0.058038378,772.7992986,1,2.256107124,0.666988979,3.382525342,0.000718227,0.004420258,407.9990751,1,0.772665692,0.446846221,1.729153469,0.083781632,0.171510113,207.6427195,1,-0.52296469,0.743039935,-0.703817743,0.481546283,0.610254272,N,-,,pyruvate dehydrogenase E1 component subunit alpha,C:mitochondrial pyruvate dehydrogenase complex; P:acetyl-CoA biosynthetic process from pyruvate; F:pyruvate dehydrogenase (acetyl-transferring) activity; P:oxidation-reduction process; C:mitochondrial nucleoid,IPR017597 (TIGRFAM); IPR001017 (PFAM); IPR029061 (G3DSA:3.40.50.GENE3D); PTHR11516:SF40 (PANTHER); PTHR11516 (PANTHER); IPR029061 (SUPERFAMILY),,
RL4_JR_01010,7530,6393,4999,0,0,11,0,0,0,1,0,0,0,4,0,0,1,0,117.8899456,1,-0.432341344,0.765606136,-0.564704649,0.572274671,0.748295683,24.45872009,0,-1.146729148,1.22458688,-0.936421226,0.349056353,0.511976295,74.07581236,1,-2.826610836,1.206451812,-2.342912338,0.019133878,0.053975652,88.7001349,1,-1.521019223,0.787416876,-1.931656876,0.053401871,0.127223158,65.49264209,1,-2.929953158,1.132445633,-2.587279311,0.009673714,0.030528351,N,-,,DNA ligase,P:DNA ligation involved in DNA repair; F:DNA binding; F:ATP binding; F:DNA ligase (ATP) activity; P:DNA replication; P:DNA recombination; P:DNA biosynthetic process,IPR012309 (PFAM); IPR000977 (TIGRFAM); G3DSA:3.30.470.30 (GENE3D); IPR012310 (PFAM); G3DSA:3.30.1490.70 (GENE3D); G3DSA:2.40.50.140 (GENE3D); IPR012308 (G3DSA:1.10.3260.GENE3D); IPR012308 (PFAM); PTHR10459:SF10 (PANTHER); PTHR10459 (PANTHER); PTHR10459:SF10 (PANTHER); PTHR10459 (PANTHER); IPR012310 (PROSITE_PROFILES); SSF56091 (SUPERFAMILY); IPR012308 (SUPERFAMILY); IPR012340 (SUPERFAMILY),,
RL4_JR_01011,2268,1336,2246,0,0,3,0,0,2,0,0,0,0,3,0,0,0,3,34.68765228,1,-0.360987903,0.894567461,-0.40353346,0.686555825,0.829274862,26.19814483,1,2.197056902,1.025542082,2.142337151,0.032166361,0.083591248,19.28971188,0,-2.080839991,1.21278248,-1.715756969,0.086206533,0.17261767,34.28464027,1,-0.221738219,0.895984618,-0.24747994,0.804536815,0.875158501,41.1268864,1,0.089583502,0.875385888,0.102336013,0.918489971,0.948055725,N,-,,DUF1941 family,P:biological_process; F:molecular_function,IPR008709 (PFAM); IPR008709 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_01012,2996,2447,2525,0,9,24,0,0,0,2,0,0,0,17,0,0,2,1,195.6001074,1,2.498896379,0.544607574,4.588434867,4.47E-06,5.70E-05,10.22774582,0,0.111134964,1.223429446,0.090838883,0.927620614,0.959733049,48.57488109,1,-0.704461616,1.031898105,-0.68268525,0.494805752,0.627824719,98.68530647,1,1.279903687,1.508913405,0.848228721,0.396310605,0.54047871,41.04957084,1,-0.398511766,0.838353296,-0.475350628,0.634537079,0.737622035,N,-,,RNA recognition domain-containing,"F:nucleotide binding; C:nucleus; P:chromatin remodeling; C:cytoplasmic mRNA processing body; C:cytosol; F:poly(U) RNA binding; P:mRNA splicing, via spliceosome; P:negative regulation of induction of conjugation with cellular fusion by negative regulation of transcription from RNA polymerase II promoter",IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR018835 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR14089:SF17 (PANTHER); PTHR14089 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY),,
RL4_JR_01013,13421,15493,17233,4,13,21,0,0,0,3,0,1,5,9,3,0,9,7,409.489996,1,0.328793139,0.331467271,0.991932439,0.321230484,0.509744853,58.80142721,0,-2.412269605,1.190880287,-2.025618889,0.042803854,0.104400148,192.552801,1,-2.233842546,0.744913215,-2.9987957,0.00271049,0.012576077,287.9198719,1,-0.669357893,0.396476078,-1.688268044,0.091359787,0.182927066,237.2281324,1,-0.54386269,0.445855675,-1.219817803,0.222533951,0.349110049,N,-,,asparaginyl-tRNA synthetase,F:nucleic acid binding; F:ATP binding; F:asparagine-tRNA ligase activity; C:cytosol; P:asparaginyl-tRNA aminoacylation,IPR002312 (PRINTS); G3DSA:2.40.50.140 (GENE3D); IPR004365 (PFAM); IPR004364 (PFAM); IPR004522 (TIGRFAM); G3DSA:3.30.930.10 (GENE3D); IPR004522 (PTHR22594:PANTHER); IPR018150 (PANTHER); IPR006195 (PROSITE_PROFILES); IPR012340 (SUPERFAMILY); SSF55681 (SUPERFAMILY),,
RL4_JR_01014,2643,6277,5016,0,3,11,0,0,0,0,0,1,0,11,0,0,0,0,122.4062794,1,0.449079341,0.685308321,0.655295328,0.512277628,0.697828027,17.79641759,0,-0.688000359,1.262841965,-0.544803212,0.585888869,0.724098551,52.88069059,1,-2.384698049,1.240932624,-1.921698248,0.054643738,0.12100351,97.65714582,1,-0.075476692,1.340455731,-0.056306739,0.95509745,0.973755078,45.8339491,0,-3.432112104,1.251496779,-2.742405863,0.006099093,0.021054659,Y,-,,mitochondrial precursor,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines; F:metal ion binding",IPR006035 (PRINTS); IPR006035 (PFAM); IPR023696 (G3DSA:3.40.800.GENE3D); IPR006035 (PANTHER); PTHR11358:SF36 (PANTHER); IPR006035 (PROSITE_PROFILES); SSF52768 (SUPERFAMILY),,
RL4_JR_01015,7612,6866,7520,0,2,6,3,0,2,0,2,4,0,5,1,0,2,0,126.9226996,1,-0.841416437,0.52613806,-1.599231269,0.109769225,0.236924722,113.8376435,1,1.594116355,0.670407232,2.377832875,0.017414717,0.051657324,114.5881954,1,-0.595465835,0.60721977,-0.98064303,0.326768807,0.469782363,113.7921076,1,-1.114880638,0.607213284,-1.836061014,0.066348633,0.145897057,79.48788512,1,-2.407136081,0.966333957,-2.490998131,0.012738479,0.038195046,N,-, Effector probability:0.667,cell division control 42,F:GTP binding; P:cell division; P:small GTPase mediated signal transduction; C:intracellular,PR00449 (PRINTS); SM00174 (SMART); SM00173 (SMART); SM00175 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); IPR001806 (PFAM); PTHR24072 (PANTHER); PS51420 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_01016,971,734,1125,0,0,5,0,0,0,0,0,1,0,0,0,0,0,0,30.35938357,1,1.417888755,0.696281686,2.036372325,0.041712982,0.116365787,3.593596978,0,1.62003862,1.271503467,1.274112625,0.202623505,0.346913923,15.83487724,1,-0.072226509,1.201024122,-0.060137434,0.952046176,0.972469277,10.77066363,0,-1.456381535,1.203269874,-1.210353194,0.226143394,0.361836578,9.226349497,0,-1.119577188,1.210534285,-0.924862024,0.355037683,0.492297527,N,-,,hypothetical protein CMQ_3154,P:biological_process; C:cellular_component; F:molecular_function,PTHR31996 (PANTHER); PTHR31996:SF2 (PANTHER),,
RL4_JR_01017,660,595,871,0,0,8,0,0,1,0,0,2,5,8,0,0,1,1,39.0260148,1,2.473011851,0.590359043,4.18899631,2.80E-05,0.000281156,12.07405183,1,2.95054534,1.132603677,2.605099559,0.009184757,0.031632565,20.01230531,1,1.196087036,1.042087549,1.147779797,0.251059479,0.386106723,86.7477573,1,3.373049945,0.46567255,7.243394402,4.38E-13,2.18E-11,18.16806922,1,0.969084607,0.99075764,0.978124788,0.32801261,0.464428426,N,-,,histidine acid phosphatase,C:mitochondrion; P:dephosphorylation; F:acid phosphatase activity,IPR000560 (PFAM); IPR029033 (G3DSA:3.40.50.GENE3D); PTHR11567:SF129 (PANTHER); PTHR11567:SF129 (PANTHER); PTHR11567 (PANTHER); IPR029033 (SUPERFAMILY),,
RL4_JR_01018,3180,3596,5240,1,0,8,0,0,0,0,0,0,0,0,0,0,0,0,88.59704701,1,0.122539178,0.613407951,0.199767835,0.841662158,0.92016616,15.1824102,0,-0.458865435,1.218220004,-0.376668774,0.706419771,0.81522984,39.62522346,0,-3.119398543,1.205994954,-2.586576779,0.009693457,0.031924711,45.72870451,0,-3.542242379,1.208111849,-2.932048372,0.003367343,0.02038837,39.31659842,0,-3.210839419,1.216252156,-2.639945511,0.008291936,0.027038921,Y,-,,pentatricopeptide repeat,P:biological_process; F:transferase activity; C:cellular_component,IPR002885 (PFAM); IPR002885 (PFAM); IPR002885 (TIGRFAM); PTHR24015 (PANTHER); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES),,
RL4_JR_01019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_01020,816,1068,1459,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,13.37175696,0,-1.843456634,1.223783771,-1.506358131,0.131975263,0.270043959,4.22404358,0,1.386813602,1.274098085,1.088466907,0.276389038,0.434884167,11.03225709,0,-1.274753402,1.216461988,-1.047918813,0.294676014,0.435391121,20.7555547,1,0.014370684,1.048763858,0.013702497,0.989067331,0.99348281,10.950327,0,-1.366637981,1.228344976,-1.112584826,0.26588678,0.398182251,N,-,,mis12 domain-containing,"C:nucleus; C:condensed chromosome, centromeric region; P:mitotic nuclear division; C:kinetochore",IPR008685 (PFAM); PTHR14527 (PANTHER),,
RL4_JR_01021,2753,4221,3617,0,0,0,0,0,0,0,0,2,0,0,1,0,3,0,42.66520844,0,-3.517275657,1.213566849,-2.898295764,0.003751966,0.017138015,13.55514276,0,-0.295241706,1.226959771,-0.240628677,0.809842922,0.884275087,48.2107946,1,-1.133666627,1.051785125,-1.077850029,0.281100689,0.420301783,50.26477868,1,-2.419921912,1.161144856,-2.084082705,0.037152645,0.102470861,46.29361654,1,-0.842751375,0.876520631,-0.961473519,0.336314134,0.473336198,N,-,,gmp synthase,P:receptor-mediated endocytosis; C:actin cortical patch,no IPS match,,
RL4_JR_01022,30520,41659,54471,11,4,51,0,1,0,2,0,3,2,23,1,0,20,3,844.5119451,1,-0.541647454,0.609742527,-0.888321596,0.374367786,0.56638423,198.504862,1,-2.930038995,1.13129437,-2.589988134,0.009597924,0.032699491,459.8682653,1,-3.372042475,0.717710124,-4.698334833,2.62E-06,6.08E-05,603.2078646,1,-1.799844583,0.637984515,-2.821141486,0.004785309,0.027100416,514.2702906,1,-1.763515433,0.68572941,-2.571736616,0.010118984,0.031700097,N,-,,translationally-controlled tumor,P:cytoplasmic translation; C:mitochondrion; C:cytosol; P:cellular response to oxidative stress,IPR018105 (PRINTS); IPR011323 (G3DSA:2.170.150.GENE3D); IPR018105 (PFAM); IPR018105 (PANTHER); IPR011057 (SUPERFAMILY),,
RL4_JR_01023,15500,14119,16014,9,26,3,0,0,6,2,6,38,7,12,8,0,23,13,492.7858048,1,0.732860375,0.831647801,0.881214829,0.378201555,0.569992293,114.5851974,1,0.770517517,0.62341,1.235972341,0.216468845,0.363323784,467.308692,1,1.117866819,0.659184336,1.695833408,0.089917434,0.178810469,364.7765996,1,0.026844263,0.310903297,0.086342806,0.931193911,0.959334387,333.4482504,1,0.574951419,0.393770539,1.460117919,0.144257669,0.251612213,N,-,,sphinganine hydroxylase,C:endoplasmic reticulum membrane; F:iron ion binding; F:sphingosine hydroxylase activity; C:integral component of membrane; P:oxidation-reduction process; P:fatty acid biosynthetic process; P:sphingolipid metabolic process,IPR006694 (PFAM); PTHR11863:SF3 (PANTHER); PTHR11863 (PANTHER),,
RL4_JR_01024,2997,2206,2266,0,0,4,0,0,4,0,2,4,0,0,0,0,0,0,45.11612577,1,-0.298467795,0.760777258,-0.392319554,0.694822117,0.835178847,47.11805092,1,2.769774981,0.791908541,3.497594527,0.000469474,0.015023052,66.46565743,1,0.953837851,0.633971844,1.504542924,0.13244163,0.238881001,28.58211339,0,-2.864212278,1.199570538,-2.387698086,0.016954263,0.070747485,24.30903889,0,-2.517254213,1.197676854,-2.101780797,0.035572482,0.085877773,N,-,,hypothetical protein SPBR_01479,,PTHR40625 (PANTHER); PTHR40625:SF1 (PANTHER),,
RL4_JR_01025,1407,1474,1805,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,18.74229923,0,-2.330572822,1.19222124,-1.95481572,0.050604825,0.134167749,5.961281195,0,0.889860323,1.230563588,0.723132337,0.469598584,0.627909758,15.49972777,0,-1.765255203,1.193197695,-1.479432294,0.139024814,0.247804798,36.83075013,1,-0.444782541,1.013701858,-0.438770569,0.660827787,0.768890065,15.3152428,0,-1.850649548,1.199774518,-1.542497795,0.122952673,0.223099609,N,-,,binuclear zinc transcription factor,"F:transition metal ion binding; P:metabolic process; P:regulation of transcription, DNA-templated",IPR006620 (SMART); IPR007219 (SMART); IPR001138 (SMART); IPR001138 (PFAM); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31313:SF44 (PANTHER); PTHR31313 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_01026,485,112,527,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.413574675,0,-0.24444432,1.432709715,-0.170616781,0.864525102,0.933156362,1.41298035,0,2.966690372,1.565935183,1.894516711,0.058156458,0.133120686,3.673467061,0,0.311663401,1.351437251,0.230616257,0.817612937,0.881899997,4.237385676,0,-0.110510605,1.38084471,-0.080031161,0.936212473,0.962839135,3.643132638,0,0.220952116,1.366092158,0.161740271,0.87151039,0.914876165,N,-,,hypothetical protein SPI_02531,,IPR022036 (PFAM); PTHR35020 (PANTHER); PTHR35020:SF2 (PANTHER),,
RL4_JR_01027,13926,7416,14606,3,0,8,0,0,1,2,2,2,3,8,4,0,0,1,203.2217728,1,-1.127330584,0.604952872,-1.863501499,0.062391742,0.157158618,54.96439749,1,-1.13016398,1.144741827,-0.987265384,0.323512556,0.485700696,169.133224,1,-1.280490297,0.669908686,-1.911440058,0.055948053,0.123161141,235.0428146,1,-0.478457707,0.498529911,-0.959737213,0.337187489,0.484121289,124.2689404,1,-3.840793783,1.163095096,-3.302218189,0.000959234,0.004620479,N,-,,nitrate reductase,"F:cytochrome-b5 reductase activity, acting on NAD(P)H; C:integral component of membrane; C:endoplasmic reticulum; P:oxidation-reduction process",IPR001834 (PRINTS); IPR001709 (PRINTS); G3DSA:2.40.30.10 (GENE3D); IPR001433 (PFAM); IPR008333 (PFAM); G3DSA:3.40.50.80 (GENE3D); PTHR19370 (PANTHER); PTHR19370:SF115 (PANTHER); IPR017927 (PROSITE_PROFILES); IPR017938 (SUPERFAMILY); SSF52343 (SUPERFAMILY),5.B.1.2.4, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_01028,1159,1050,1323,1,6,4,0,0,0,0,0,0,0,3,0,0,0,0,87.50793011,1,2.279222859,0.467270068,4.877742047,1.07E-06,1.61E-05,4.499254519,0,1.295808399,1.244076723,1.041582384,0.297605339,0.457388589,11.68122961,0,-1.35724216,1.192092135,-1.13853797,0.254895913,0.390698899,25.51080094,1,0.525876991,0.851899064,0.617299647,0.5370371,0.668737011,11.52824414,0,-1.440885029,1.196751567,-1.203996776,0.228590825,0.355964641,N,-,,pbn1,P:proteolysis; C:endoplasmic reticulum part; P:cellular protein metabolic process; P:single-organism cellular process; C:membrane part; P:single-organism metabolic process,IPR013233 (SMART); IPR013233 (PFAM); PTHR28533 (PANTHER); PTHR28533:SF1 (PANTHER),,
RL4_JR_01029,3946,4469,2700,0,3,1,0,0,0,0,4,1,0,9,0,2,1,2,72.66639669,1,-0.829276011,0.800557961,-1.035872543,0.300261609,0.486039926,14.41033939,0,-0.383471468,1.246566998,-0.307622028,0.758369957,0.853672231,75.00537704,1,0.115439486,0.717758315,0.160833367,0.872224645,0.91916335,78.92923302,1,0.294713421,0.665179765,0.443058307,0.657723561,0.766715365,86.93977131,1,-0.080958177,0.711631657,-0.113764159,0.909424751,0.941987274,N,-,,homeobox domain containing,F:DNA binding,IPR001356 (SMART); IPR001356 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); IPR001763 (G3DSA:3.40.250.GENE3D); IPR001763 (PFAM); IPR001356 (PROSITE_PROFILES); IPR001763 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY); IPR001763 (SUPERFAMILY),1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_01030,221,121,149,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.953845585,0,0.93116517,1.33094712,0.69962597,0.48416092,NA,0.631223535,0,4.129367585,1.54327853,2.67571116,0.007457088,0.027180643,1.626385647,0,1.487261004,1.254358802,1.185674307,0.235750945,0.368210824,1.87528148,0,1.065642679,1.278116258,0.833760366,0.404416033,0.54800754,1.593840137,0,1.413274854,1.239326315,1.140357336,0.25413746,0.38508557,N,-, Effector probability:0.74,---NA---,,no IPS match,,
RL4_JR_01031,113,53,47,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.848220555,0,2.135056371,1.723361226,1.238890802,0.215385941,NA,0.276799515,0,5.318827417,1.825742307,2.91324104,0.003576984,0.016958421,0.708409958,0,2.686535926,1.337438219,2.008717778,0.044567072,0.103651973,0.816476193,0,2.265417584,1.436320998,1.577236277,0.114741169,0.216947588,0.689293779,0,2.622227445,1.295431335,2.024211839,0.04294836,0.0994175,N,-,,homeobox domain-containing,"F:DNA binding; C:nucleus; P:regulation of transcription, DNA-templated",IPR001356 (SMART); IPR008422 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); PTHR11850 (PANTHER); IPR001356 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY),,
RL4_JR_01032,2491,3196,4621,0,0,7,0,0,0,0,0,0,0,3,3,0,0,0,67.92595624,1,-0.063376802,0.717395233,-0.088342938,0.929604113,0.965954701,13.00365889,0,-0.235383352,1.231509176,-0.191134063,0.848420561,0.90981992,33.98622724,0,-2.897927345,1.21409389,-2.386905468,0.01699086,0.049288098,80.16559479,1,0.002995657,0.670777338,0.004465949,0.9964367,0.997331935,33.76324537,0,-2.991150628,1.22612931,-2.439506669,0.014707331,0.042839968,N,-,,nuclear pore complex an-nup82,C:nuclear envelope,IPR015943 (G3DSA:2.130.10.GENE3D); PTHR13257 (PANTHER); PTHR13257 (PANTHER); PTHR13257:SF0 (PANTHER); PTHR13257:SF0 (PANTHER); IPR017986 (SUPERFAMILY),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_01033,948,999,1960,0,0,1,0,0,0,0,0,0,3,4,0,0,2,0,19.35756608,1,-1.116325981,1.200491623,-0.929890687,0.352427685,0.542882375,4.892686501,0,1.174784144,1.293286404,0.908371217,0.363682128,0.528223633,12.822638,0,-1.491745554,1.235479233,-1.207422605,0.227269434,0.358168704,58.78401093,1,1.61457031,0.668228242,2.416195857,0.015683623,0.067144473,20.50727928,1,0.052360995,1.053469548,0.049703378,0.960358765,0.973947415,N,-,,nuclear cap-binding subunit 2,"F:nucleotide binding; C:nucleus; C:nuclear cap binding complex; P:mRNA cis splicing, via spliceosome; C:mitotic spindle; F:RNA cap binding; C:cytosol",IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR18847:SF0 (PANTHER); IPR027157 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),9.A.60.1.1, the small nuclear rna exporter (snrna-e).
RL4_JR_01034,2228,3481,6637,1,0,8,0,0,0,0,0,1,0,1,0,0,0,0,89.81187971,1,-0.006184102,0.797464994,-0.007754701,0.993812706,0.997603551,15.38760414,0,-0.478229669,1.279167412,-0.373860109,0.708508396,0.816705946,46.98670001,1,-2.188666996,1.255503608,-1.743258228,0.081288518,0.164823745,50.75862223,1,-2.631856306,1.222726261,-2.152449317,0.031361983,0.094731527,40.51646915,0,-3.25421147,1.277667051,-2.546994905,0.010865502,0.033591819,N,-,,ribosomal subunit L31,F:structural constituent of ribosome; P:mitochondrial translation; C:mitochondrial large ribosomal subunit,IPR016340 (PFAM); IPR016340 (PIRSF); PTHR28271:SF1 (PANTHER); PTHR28271 (PANTHER),,
RL4_JR_01035,1743,1597,2010,0,0,0,0,0,0,0,0,0,0,6,2,0,0,0,21.37109038,0,-2.520005495,1.187136008,-2.122760558,0.033773922,0.099289244,6.814138734,0,0.69696341,1.224563822,0.569152377,0.569252736,0.710390358,17.69365853,0,-1.956256157,1.190385584,-1.643380249,0.100304284,0.194462001,63.7525642,1,1.340051691,0.538060261,2.490523439,0.012755508,0.058864868,17.46399232,0,-2.040093497,1.195516997,-1.706452942,0.087923781,0.173364806,N,-,,anaphase-promoting complex subunit 3,F:DNA binding; F:ubiquitin-protein transferase activity; C:cell division site; C:anaphase-promoting complex; P:mitotic sister chromatid segregation; P:anaphase-promoting complex-dependent catabolic process; P:positive regulation of mitotic metaphase/anaphase transition; P:mitotic G1 cell cycle arrest in response to nitrogen starvation; P:protein ubiquitination,IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR001440 (PFAM); PF13432 (PFAM); PF12895 (PFAM); IPR019734 (PFAM); PTHR12558:SF13 (PANTHER); PTHR12558:SF13 (PANTHER); PTHR12558 (PANTHER); PTHR12558 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY),3.A.20.1.2, the peroxisomal protein importer (ppi) family.
RL4_JR_01036,29579,37072,29013,11,14,81,3,0,0,4,8,20,8,56,7,2,19,12,917.2878968,1,0.520131636,0.491679105,1.057868091,0.290115584,0.474999067,189.98409,1,-1.231013823,0.869442615,-1.415865523,0.156814881,0.286133838,555.5194439,1,-0.349221174,0.395162086,-0.8837416,0.376835718,0.520617469,734.021,1,0.084180934,0.488436776,0.172347657,0.86316422,0.915373674,506.6803752,1,-0.562694364,0.38364063,-1.466722551,0.142451546,0.249067112,N,-,,Histone H4,"C:nucleus; F:DNA binding; P:mycelium development; F:protein heterodimerization activity; P:DNA-templated transcription, initiation; C:nucleosome; P:nucleosome assembly",IPR001951 (PRINTS); IPR001951 (SMART); IPR009072 (G3DSA:1.10.20.GENE3D); PF15511 (PFAM); PTHR10484 (PANTHER); IPR009072 (SUPERFAMILY),,
RL4_JR_01037,728,750,1287,0,1,0,0,3,0,1,4,1,0,0,4,0,1,0,19.02391429,1,-0.609791463,1.178497454,-0.517431294,0.604855119,0.772207834,118.4871321,1,4.706529335,1.568519528,3.000618895,0.002694315,0.015349618,58.03637273,1,2.416787375,0.660730748,3.657749216,0.00025444,0.002052549,49.03868717,1,1.715806261,1.401051276,1.224656292,0.220704749,0.356060481,12.90432892,1,-0.163686746,1.165595476,-0.140431865,0.888318783,0.926762254,N,-, Effector probability:0.776,trafficking particle complex subunit 2,F:identical protein binding; P:ER to Golgi vesicle-mediated transport; P:protein complex assembly; C:TRAPPI protein complex; C:TRAPPII protein complex; C:TRAPPIII protein complex,IPR006722 (PFAM); G3DSA:3.30.450.70 (GENE3D); IPR006722 (PANTHER); IPR011012 (SUPERFAMILY),,
RL4_JR_01038,1234,944,2465,0,0,0,0,0,0,0,1,0,2,4,0,0,0,0,18.38261009,0,-2.302668783,1.26795859,-1.816044152,0.0693636,0.169828405,5.790429797,0,0.931750305,1.30916178,0.711715174,0.476641169,0.633893301,23.02993507,1,-0.774086577,1.246406628,-0.621054606,0.534563696,0.663897013,52.20071273,1,1.122387245,0.738731109,1.519344768,0.128675737,0.236826079,15.16939679,0,-1.836874225,1.271497298,-1.444654446,0.148554971,0.257246295,N,-,,duf788 domain containing,P:vacuolar protein processing; C:integral component of membrane; C:endoplasmic reticulum; C:vacuole,IPR008506 (PFAM); IPR008506 (PANTHER); PTHR13505:SF7 (PANTHER),9.B.26.1.4, the regulator of er stress and autophagy tmem208 (tmem208) family.
RL4_JR_01039,3017,3095,2734,1,0,0,0,0,0,1,2,0,4,5,0,0,0,0,45.56656582,1,-2.302274262,1.143030725,-2.014184057,0.043990213,0.120913799,11.36810594,0,-0.041359919,1.218279169,-0.033949459,0.972917453,0.98597021,56.16074397,1,-0.276528259,0.851352948,-0.324810361,0.745324602,0.829558911,91.22373893,1,0.78816417,0.516663979,1.525486975,0.12713768,0.234646192,28.88138147,0,-2.765843462,1.189087458,-2.326021894,0.020017383,0.054526769,N,-,,phosphatidylinositol 4-kinase,C:nucleus; C:trans-Golgi network; P:phosphatidylinositol-mediated signaling; P:phosphatidylinositol phosphorylation; F:1-phosphatidylinositol 4-kinase activity,IPR000403 (SMART); IPR001263 (G3DSA:1.25.40.GENE3D); IPR000403 (PFAM); G3DSA:3.30.1010.10 (GENE3D); IPR021601 (PFAM); IPR000403 (G3DSA:1.10.1070.GENE3D); IPR015433 (PANTHER); IPR015433 (PANTHER); PTHR10048:SF22 (PANTHER); PTHR10048:SF22 (PANTHER); IPR001263 (PROSITE_PROFILES); IPR000403 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR011009 (SUPERFAMILY),,
RL4_JR_01040,4011,4202,4038,0,0,1,0,0,0,0,0,1,0,3,0,0,1,0,52.950558,1,-2.773100329,1.139824079,-2.432919589,0.014977627,0.052463495,15.70120298,0,-0.507257371,1.204606293,-0.421098058,0.673683479,0.791896897,47.17174797,1,-2.195183304,1.187764921,-1.848163104,0.064578751,0.13813549,58.9527189,1,-1.272541943,0.849601647,-1.497810117,0.134182591,0.244616265,43.87580638,1,-2.305540982,1.116285844,-2.065367929,0.038888201,0.091974546,N,-,,dna polymerase epsilon subunit c,"P:negative regulation of transcription from RNA polymerase II promoter; P:RNA polymerase II transcriptional preinitiation complex assembly; F:transcription coactivator activity; F:transcription corepressor activity; F:protein heterodimerization activity; C:negative cofactor 2 complex; F:RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly; F:chromatin binding; P:positive regulation of transcription from RNA polymerase II promoter in response to heat stress; F:core promoter binding",IPR009072 (G3DSA:1.10.20.GENE3D); IPR003958 (PFAM); PTHR10252:SF5 (PANTHER); PTHR10252 (PANTHER); IPR009072 (SUPERFAMILY),,
RL4_JR_01041,718,728,1102,0,0,0,0,0,2,0,0,0,0,0,2,0,3,0,10.1637385,0,-1.447779323,1.213838449,-1.19272818,0.232975846,0.406462136,21.97794684,1,3.412035583,1.006894618,3.388671985,0.00070232,0.015023052,8.399808431,0,-0.881534536,1.210049061,-0.7285114,0.466300592,0.603385226,28.96361014,1,0.44995028,1.031057783,0.436396764,0.662548887,0.770083497,19.91152511,1,1.211338542,0.887028695,1.365613704,0.172060243,0.287334646,N,-,,synaptobrevin,C:membrane; C:integral component of membrane,IPR019150 (PFAM); PTHR13050 (PANTHER),,
RL4_JR_01042,2276,1454,2753,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,25.7302078,0,-2.787807101,1.217775841,-2.289261296,0.022064175,0.07131519,8.201649572,0,0.429554492,1.251803028,0.343148628,0.73148665,0.832296298,21.33170085,0,-2.226018711,1.215226828,-1.831772193,0.066985368,0.141844774,33.92246448,1,-1.695793532,1.169364182,-1.450184261,0.147007143,0.262050585,21.11815136,0,-2.31421479,1.225080339,-1.889031042,0.058887669,0.126670417,N,-,,brct domain containing,,IPR001357 (G3DSA:3.40.50.GENE3D); IPR001357 (PROSITE_PROFILES); IPR001357 (SUPERFAMILY),,
RL4_JR_01043,7998,6118,12156,3,0,3,0,0,0,2,0,6,0,6,0,0,1,0,145.9704145,1,-1.473913716,0.700019567,-2.105532166,0.03524501,0.102432773,33.06959337,0,-1.581948874,1.221128058,-1.295481554,0.195154161,0.338013418,147.4462165,1,-0.435232478,0.610538061,-0.712867069,0.475928019,0.612702856,123.6718042,1,-1.442623899,0.713930521,-2.020678282,0.043313079,0.113246213,89.605805,1,-3.408583524,1.162690824,-2.931633633,0.003371843,0.013010635,N,-,,anthranilate synthase component 2,F:indole-3-glycerol-phosphate synthase activity; P:tryptophan biosynthetic process; P:glutamine metabolic process; P:cellular amino acid biosynthetic process; F:transferase activity; F:phosphoribosylanthranilate isomerase activity; F:anthranilate synthase activity,PR00097 (PRINTS); PR00096 (PRINTS); IPR001240 (PFAM); IPR016302 (PIRSF); IPR029062 (G3DSA:3.40.50.GENE3D); IPR013785 (G3DSA:3.20.20.GENE3D); IPR006221 (TIGRFAM); IPR013785 (G3DSA:3.20.20.GENE3D); IPR017926 (PFAM); IPR013798 (PFAM); PTHR11922:SF7 (PANTHER); PTHR11922 (PANTHER); IPR001240 (HAMAP); IPR017926 (PROSITE_PROFILES); IPR029062 (SUPERFAMILY); IPR011060 (SUPERFAMILY); IPR011060 (SUPERFAMILY),,
RL4_JR_01044,4326,5385,7049,0,0,4,0,0,1,0,0,0,0,3,0,0,3,0,82.32998172,1,-1.490903284,0.800626508,-1.862170773,0.062579023,0.157519182,30.60046564,1,-0.025631878,1.124297459,-0.022798129,0.981811301,0.990676395,55.35580662,0,-3.601695535,1.204649622,-2.989828303,0.002791343,0.012892381,75.91616593,1,-1.738161104,0.886391963,-1.960939603,0.049886069,0.122834739,66.45261379,1,-1.506546392,0.882928408,-1.706306398,0.087951047,0.173384804,N,-,,mitochondrial import inner membrane translocase subunit TIM9,F:metal ion binding; C:mitochondrial intermembrane space protein transporter complex; F:protein transporter activity; P:protein import into mitochondrial inner membrane; F:unfolded protein binding; C:mitochondrial inner membrane protein insertion complex,IPR004217 (PFAM); IPR004217 (G3DSA:1.10.287.GENE3D); PTHR10898 (PANTHER); IPR004217 (SUPERFAMILY),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_01045,3,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.028304421,0,7.040982679,3.944305359,1.785100807,0.074244967,NA,0.009194001,0,10.23263417,3.417489009,2.994196657,0.002751685,0.015349618,0.023520804,0,7.602821568,1.997858148,3.805486178,0.000141526,0.001415819,0.027113088,0,7.178283977,3.944203294,1.819957908,0.068765415,0.148866758,0.02280449,0,7.539230421,1.431110837,5.268096799,1.38E-07,2.93E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_01046,3958,3771,4036,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,63.11200226,1,-1.921840555,1.001056715,-1.919811862,0.054881668,0.14261292,15.05052663,0,-0.446207125,1.202438327,-0.371085248,0.710574038,0.818065333,46.84514159,1,-2.134695196,1.18551484,-1.800648228,0.071758343,0.150099475,44.9906138,0,-3.518728019,1.183974612,-2.971962392,0.002959029,0.01842569,38.40150446,0,-3.17687295,1.185947902,-2.678762654,0.007389475,0.024643754,N,-,,nucleoporin,P:nuclear pore organization; P:protein import into nucleus; F:structural constituent of nuclear pore; P:mRNA export from nucleus in response to heat stress; C:nuclear pore inner ring,IPR018864 (PFAM); PTHR31431:SF1 (PANTHER); PTHR31431 (PANTHER); PTHR31431 (PANTHER); PTHR31431 (PANTHER); PTHR31431:SF1 (PANTHER); PTHR31431:SF1 (PANTHER); PTHR31431 (PANTHER); PTHR31431:SF1 (PANTHER); PTHR31431:SF1 (PANTHER),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_01047,434,288,331,0,0,0,0,0,0,0,1,0,0,0,0,0,2,0,4.199315101,0,-0.172656982,1.225768217,-0.140856142,0.88798359,0.945379342,1.35192579,0,3.030554636,1.383871817,2.189909932,0.02853077,0.07617738,11.33255772,1,1.347699376,1.207021846,1.116549283,0.264187087,0.401596107,4.024196798,0,-0.035917955,1.222860042,-0.02937209,0.976567832,0.985736391,11.14565093,1,1.972431659,0.994542024,1.983256223,0.047338817,0.107443514,N,-,,---NA---,,no IPS match,,
RL4_JR_01048,5001,3751,3673,1,4,2,0,0,0,0,0,3,4,4,0,0,4,0,99.41553068,1,-0.17584969,0.595325555,-0.295384077,0.767700495,0.877998908,15.99294674,0,-0.533814983,1.223812221,-0.43619027,0.662698687,0.783763818,60.75202379,1,-0.779494234,0.86852892,-0.897487943,0.369458604,0.514073517,100.8711431,1,0.13629065,0.567122916,0.240319419,0.810082642,0.879014762,55.88333401,1,-0.648500889,0.762277431,-0.850741295,0.394913078,0.531573374,N,-,,Rho GTPase activator,P:signal transduction,IPR000198 (SMART); IPR000198 (PFAM); IPR000198 (G3DSA:1.10.555.GENE3D); PTHR15228 (PANTHER); PTHR15228:SF25 (PANTHER); IPR000198 (PROSITE_PROFILES); IPR008936 (SUPERFAMILY),9.A.1.1.1, the non abc multidrug exporter (n-mde) family.
RL4_JR_01049,159,151,192,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.005578194,0,0.893564774,1.268590785,0.704375898,0.481198712,NA,0.638816293,0,4.111994054,1.48320631,2.772368231,0.005565004,0.02203794,1.659826328,0,1.457671553,1.21851214,1.19627167,0.23159056,0.362944711,1.914957075,0,1.035294665,1.230941022,0.84105952,0.400314591,0.544343975,1.639305781,0,1.373207698,1.212760824,1.13229886,0.257508809,0.389106465,N,-,,Serine family S28,C:membrane; P:proteolysis; C:integral component of membrane; F:serine-type peptidase activity,no IPS match,,
RL4_JR_01050,4489,2443,3219,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,40.3711746,0,-3.437627441,1.216772665,-2.825201074,0.004725095,0.020780231,13.02642732,0,-0.237838666,1.248323936,-0.1905264,0.848896658,0.910129432,33.59493341,0,-2.881197294,1.215903195,-2.369594312,0.017807613,0.051202576,38.7382418,0,-3.30288204,1.218334415,-2.710981483,0.006708437,0.035376525,47.68940493,1,-1.255247967,0.998641041,-1.256956119,0.208769526,0.331850351,N,-,,mfs transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662 (PANTHER); PTHR11662:SF211 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_01051,697,798,738,1,2,2,0,0,0,0,1,2,1,6,0,2,0,5,42.68857684,1,1.789171762,0.66882734,2.675087658,0.007470971,0.030038533,2.861681666,0,1.948691662,1.279659142,1.522820881,0.127803524,0.244403415,28.25752075,1,1.703075351,0.85303739,1.996483825,0.045881285,0.105857367,41.93812804,1,2.394259009,0.578678353,4.137460811,3.51E-05,0.00042787,76.17664865,1,2.713095583,0.585243049,4.635844184,3.55E-06,4.25E-05,N,-,,GPI mannosyltransferase 3,"F:transferase activity, transferring glycosyl groups; C:membrane; P:single-organism metabolic process",IPR005599 (PFAM); PTHR22760:SF4 (PANTHER); IPR005599 (PANTHER); PTHR22760:SF4 (PANTHER); IPR005599 (PANTHER),,
RL4_JR_01052,6309,5274,4890,4,10,16,0,0,3,0,0,8,2,3,0,0,0,1,247.4138004,1,1.486196388,0.338830018,4.386259502,1.15E-05,0.000131345,49.3369894,1,1.230784459,0.875814924,1.405301994,0.159931496,0.290439542,106.7199799,1,0.034101534,1.254622666,0.027180709,0.978315602,0.988075334,93.77740294,1,-0.958438614,0.682075672,-1.405179298,0.159967968,0.278917803,61.03740567,1,-2.725696875,1.12118044,-2.431095636,0.015053241,0.043617343,N,-,,ornithine aminotransferase,F:pyridoxal phosphate binding; F:ornithine-oxo-acid transaminase activity,IPR015421 (G3DSA:3.40.640.GENE3D); IPR010164 (TIGRFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR005814 (PIRSF); IPR005814 (PFAM); IPR010164 (PTHR11986:PANTHER); IPR005814 (PANTHER); IPR015424 (SUPERFAMILY),9.B.313.1.2, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_01053,2176,980,976,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,16.43715248,0,-2.141265223,1.264983229,-1.692722223,0.090508353,0.205902718,24.11575097,1,2.643789796,1.100113561,2.403197169,0.016252422,0.04908622,13.72640392,0,-1.589883323,1.256180536,-1.265648748,0.205638865,0.332092498,15.82103477,0,-2.010948463,1.261746868,-1.59378122,0.110985045,0.212023317,13.37130404,0,-1.654919427,1.25797819,-1.315539045,0.188328804,0.30765233,N,-,,---NA---,,PS51257 (PROSITE_PROFILES),,
RL4_JR_01054,22529,10715,10974,4,4,3,0,0,0,0,2,1,5,13,2,0,14,5,259.7186825,1,-1.245631832,0.633807414,-1.965315967,0.049377679,0.131512603,57.25651498,0,-2.373842596,1.254008799,-1.893003142,0.058357452,0.133384998,169.0191769,1,-2.608754648,0.924674112,-2.82126926,0.004783403,0.018341568,287.2370761,1,-0.440060947,0.530234468,-0.829936517,0.406574677,0.550196285,234.0723741,1,-0.353394717,0.587537565,-0.601484463,0.547517357,0.66806619,N,-,,ULK ULK kinase,P:entry into host; P:late nucleophagy; C:pre-autophagosomal structure; P:protein autophosphorylation; F:protein serine/threonine kinase activity; P:mitophagy; P:pathogenesis; P:autophagosome assembly; F:ATP binding; P:piecemeal microautophagy of nucleus; P:spore germination; P:autophagic cell death; C:cytosol; C:extrinsic component of autophagosome membrane; P:CVT pathway,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR022708 (PFAM); PTHR24348 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.A.15.1.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_01055,574,586,572,0,0,0,0,0,0,0,0,0,0,7,1,0,0,1,6.943411469,0,-0.897778893,1.192266656,-0.753001762,0.451448855,0.640285077,2.219551293,0,2.315289291,1.298621642,1.782882108,0.074605496,0.161392783,5.749037527,0,-0.334218822,1.196005437,-0.279445905,0.779902647,0.854146949,44.34807386,1,2.956782695,0.537161235,5.504460304,3.70E-08,9.23E-07,13.02142362,1,0.520306303,1.119487553,0.464771851,0.642094848,0.743590339,N,-,,zeta toxin family,F:ATP binding; P:phosphorylation; F:kinase activity,IPR027417 (G3DSA:3.40.50.GENE3D); IPR010488 (PFAM); IPR027417 (SUPERFAMILY),,
RL4_JR_01056,1456,1830,1850,0,3,30,0,0,0,0,0,2,0,5,0,0,0,2,159.2031084,1,2.883793709,0.837137198,3.444828058,0.000571423,0.00375815,6.556306006,0,0.752632518,1.232910329,0.610451953,0.541562462,0.688395736,30.03215692,1,-0.082603852,1.037542095,-0.079614941,0.936543512,0.961911993,39.71210163,1,0.700012175,0.685975808,1.020461898,0.307509451,0.453177957,31.53833003,1,-0.294713192,0.978599284,-0.301158193,0.763293868,0.834731212,N,-,,3-phytase A,C:membrane; F:phosphatase activity,IPR000560 (PFAM); IPR029033 (G3DSA:3.40.50.GENE3D); PTHR20963 (PANTHER); PTHR20963:SF24 (PANTHER); IPR029033 (SUPERFAMILY),,
RL4_JR_01057,3180,3814,3401,0,2,0,0,0,0,1,0,0,0,4,0,0,0,0,57.79141286,1,-1.740006603,1.014851881,-1.714542423,0.086429153,0.198840673,13.32787653,0,-0.270830394,1.212932192,-0.223285684,0.823313168,0.893527365,45.61537982,1,-1.959596337,1.192754742,-1.642916409,0.100400229,0.194571065,55.89829337,1,-0.633386638,0.753571671,-0.840512804,0.400620926,0.544686012,33.99335479,0,-3.000936165,1.193505386,-2.514388456,0.011923902,0.03621496,N,-,,acid phosphatase,,no IPS match,,
RL4_JR_01058,26,40,52,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.472736801,0,2.978563117,2.083037363,1.429913438,0.152741865,NA,0.149024927,0,6.211657174,1.956744595,3.174485414,0.001501024,0.015023052,0.38961286,0,3.548378128,1.321762612,2.684580497,0.007262089,0.025308569,0.449691214,0,3.12561721,1.494085474,2.091993574,0.036439091,0.101330896,0.386986297,0,3.456807797,1.275060329,2.711093522,0.006706171,0.022815853,N,-, Effector probability:0.586,---NA---,,no IPS match,,
RL4_JR_01059,3128,3434,5526,0,0,2,2,1,0,0,0,1,2,2,2,0,1,0,55.84080143,1,-1.984572518,1.058052293,-1.875684719,0.060698585,0.153877893,98.18935338,1,1.787718506,0.864964079,2.066812425,0.038751832,0.096588536,46.29853401,1,-2.163948216,1.212088143,-1.785305985,0.074211699,0.153801277,91.85140866,1,-0.200383471,0.661537073,-0.302905883,0.761961588,0.844685058,43.41261264,1,-2.291777265,1.156049403,-1.982421564,0.047432078,0.107606944,N,-,,translocation sec62,P:protein transport; C:integral component of endoplasmic reticulum membrane; F:protein transporter activity,IPR004728 (PFAM); IPR011553 (TIGRFAM); PTHR12443:SF9 (PANTHER); IPR004728 (PANTHER),1.A.15.1.1, the non-selective cation channel-2 (nscc2) family.
RL4_JR_01060,503,529,528,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,6.253941931,0,-0.746906293,1.194450517,-0.625313717,0.531765179,0.71562856,1.99698547,0,2.467722649,1.307336067,1.887596244,0.059080175,0.1345656,18.17368971,1,1.637679759,1.031173301,1.588171219,0.112247627,0.210990527,5.971186694,0,-0.605094288,1.194440224,-0.506592357,0.612440872,0.732022646,5.096081162,0,-0.263088554,1.195364043,-0.220090738,0.825800488,0.883104134,N,-,,gcn5-related n-acetyltransferase,"F:transferase activity, transferring acyl groups other than amino-acyl groups",IPR016181 (G3DSA:3.40.630.GENE3D); IPR016181 (SUPERFAMILY),,
RL4_JR_01061,3125,3335,2701,0,4,2,0,0,0,0,0,1,0,1,0,0,6,0,76.48912838,1,0.022026473,0.631126568,0.034900247,0.972159284,0.985446749,11.79543216,0,-0.094592759,1.22358794,-0.077307691,0.938378773,0.9662533,36.98718908,1,-1.779347382,1.195637717,-1.488199441,0.136698305,0.244684165,39.1771468,1,-2.216404584,1.148847639,-1.929241537,0.053700884,0.127664111,53.07936108,1,0.365490766,0.630600895,0.579591258,0.562190289,0.679879117,N,-,,phospholipase D,F:catalytic activity,IPR001736 (SMART); IPR025202 (PFAM); G3DSA:3.30.870.10 (GENE3D); IPR015679 (PANTHER); IPR015679 (PANTHER); PTHR18896:SF68 (PANTHER); IPR015679 (PANTHER); PTHR18896:SF68 (PANTHER); IPR015679 (PANTHER); PTHR18896:SF68 (PANTHER); PTHR18896:SF68 (PANTHER); IPR001736 (PROSITE_PROFILES); SSF56024 (SUPERFAMILY),,
RL4_JR_01062,9443,8675,10129,0,5,8,0,0,0,0,6,12,6,9,0,0,6,2,183.5270708,1,-0.50103491,0.426531484,-1.174672748,0.240125666,0.414854973,36.05980159,0,-1.70680181,1.191554261,-1.432416354,0.152024701,0.279475849,218.5683221,1,0.613258286,0.387007542,1.584615854,0.113053641,0.21211176,199.867982,1,-0.148229758,0.400450541,-0.370157466,0.711265166,0.806987876,130.0825713,1,-0.829344355,0.545411331,-1.520585121,0.128363983,0.229951402,Y,-,,disulfide isomerase,C:cell; C:integral component of membrane; P:cell redox homeostasis; F:isomerase activity,IPR013766 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR18929 (PANTHER); PTHR18929:SF43 (PANTHER); IPR013766 (PROSITE_PROFILES); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY),8.A.88.1.3, the calciquestrin (casq) family.
RL4_JR_01063,846,759,822,0,2,0,0,0,0,0,0,0,1,1,0,0,0,0,25.72884429,1,0.356325347,1.001518803,0.35578498,0.722001599,0.852030818,3.106466025,0,1.830268691,1.270176432,1.440956267,0.149597038,0.276116196,8.045137642,0,-0.819123696,1.192422235,-0.686940978,0.492119923,0.625791319,22.60381452,1,0.492807608,1.009544213,0.488148614,0.625444579,0.742358135,7.917200467,0,-0.898809958,1.191386098,-0.754423742,0.45059482,0.582665716,N,-,,tyrosyl-DNA phosphodiesterase,P:DNA repair; C:nucleus; F:phosphoric diester hydrolase activity,IPR027415 (G3DSA:3.30.870.GENE3D); G3DSA:3.30.870.10 (GENE3D); IPR010347 (PFAM); PTHR12415:SF0 (PANTHER); IPR010347 (PANTHER); SSF56024 (SUPERFAMILY); SSF56024 (SUPERFAMILY),,
RL4_JR_01064,2650,8384,6728,1,3,20,2,0,0,0,7,7,1,21,0,0,3,6,182.4326955,1,0.759374762,0.760569697,0.998428895,0.318071428,0.506703126,67.25144414,1,0.702145007,1.067854352,0.657528815,0.510840949,0.66215035,159.5009174,1,0.868243015,0.645780067,1.34448717,0.178790903,0.298890208,161.7849609,1,0.554456188,1.316558038,0.421140711,0.673652335,0.777823001,114.3009674,1,0.052205184,0.746366341,0.069945791,0.944236806,0.964624928,N,-, Effector probability:0.607,acyl binding,C:nucleus; F:fatty-acyl-CoA binding; C:cytosol,IPR000582 (PRINTS); IPR000582 (PFAM); IPR014352 (G3DSA:1.20.80.GENE3D); PTHR23310 (PANTHER); IPR000582 (PROSITE_PROFILES); IPR000582 (SUPERFAMILY),,
RL4_JR_01065,438,588,512,0,0,16,0,1,1,6,0,0,0,5,0,0,3,6,67.28472343,1,3.573328423,0.91124576,3.921366308,8.80E-05,0.000764961,49.68496631,1,4.143651403,0.992400596,4.175381817,2.97E-05,0.001654484,71.53258038,1,3.6158927,1.645145792,2.197916268,0.027955073,0.072512724,25.95642976,1,2.428930021,0.697662247,3.4815271,0.000498563,0.004184614,60.80928309,1,3.569495808,0.54191618,6.586804263,4.49E-11,3.35E-09,N,-,,fad binding,F:oxidoreductase activity; P:oxidation-reduction process; C:cellular_component,IPR000103 (PRINTS); PR00368 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR22912 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_01066,1157,1293,1238,2,4,6,0,0,0,2,0,2,0,0,0,0,4,3,89.88174461,1,2.326259378,0.452499433,5.14091115,2.73E-07,4.84E-06,4.722993763,0,1.225844548,1.245052661,0.984572449,0.324834128,0.48705594,47.38134637,1,1.400927665,0.739617621,1.894124242,0.058208521,0.127032348,14.12462371,0,-1.847229761,1.190218352,-1.552009141,0.120660036,0.225357642,49.59238461,1,1.925674988,0.573298288,3.358940763,0.000782418,0.003915959,N,-,,actin cytoskeleton-regulatory complex END3,F:actin binding; F:calcium ion binding; C:mating projection tip; P:actin filament organization; C:endosome membrane; P:endocytosis; P:ascospore wall assembly; C:plasma membrane; C:actin cortical patch,IPR000261 (SMART); IPR002048 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR025604 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); IPR000261 (PFAM); PTHR11216 (PANTHER); PTHR11216:SF74 (PANTHER); IPR000261 (PROSITE_PROFILES); IPR000261 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY); IPR011992 (SUPERFAMILY),,
RL4_JR_01067,39,11,46,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.377406882,0,3.30319298,2.432380511,1.358008323,0.174461043,NA,0.120521652,0,6.517811278,2.154534809,3.025159422,0.002485021,0.015349618,0.313764987,0,3.860009383,1.451396205,2.65951459,0.007825334,0.026919362,0.361968294,0,3.438311218,1.726192243,1.991847219,0.046387824,0.117038802,0.311532448,0,3.768076828,1.37759203,2.735263231,0.006233041,0.02146583,N,-,,cytoskeletal adaptor,F:calcium ion binding; P:actin filament organization; P:endocytosis,no IPS match,,
RL4_JR_01068,1978,1629,2029,0,4,4,0,0,0,0,0,0,0,1,0,0,1,1,69.81297887,1,1.133830838,0.53292883,2.127546448,0.033374706,0.098257255,7.193046764,0,0.618910961,1.226693516,0.504535936,0.613884816,0.745857893,18.64711616,0,-2.031955987,1.191067966,-1.705994994,0.088009012,0.17556714,25.52161316,1,-1.506911897,1.141775914,-1.319796536,0.186902958,0.314902143,29.60314954,1,-0.436434386,0.972561371,-0.448747399,0.653613888,0.752797249,N,-,,dual specificity phosphatase,P:protein dephosphorylation; F:phosphatase activity; P:dephosphorylation; C:cellular_component; F:protein tyrosine/serine/threonine phosphatase activity,IPR020422 (SMART); IPR029021 (G3DSA:3.90.190.GENE3D); IPR000340 (PFAM); IPR024950 (PANTHER); PTHR10159:SF298 (PANTHER); IPR000387 (PROSITE_PROFILES); IPR029021 (SUPERFAMILY),,
RL4_JR_01069,2109,1577,1962,1,0,6,0,0,0,0,0,0,0,4,0,0,0,0,55.50642701,1,0.919803342,0.578894793,1.588895519,0.112083983,0.240436796,7.220108948,0,0.613504979,1.234074181,0.497137845,0.619091848,0.749395801,18.69142785,0,-2.035360886,1.195129162,-1.703046792,0.088559312,0.176403624,37.60540485,1,0.252724569,0.75392493,0.335211848,0.737465285,0.82515593,18.3975899,0,-2.115277716,1.196506964,-1.767877481,0.077081388,0.15637128,N,-,,spo7,C:endomembrane system; C:membrane part; P:cellular process,IPR005605 (PFAM); PTHR28249 (PANTHER),,
RL4_JR_01070,4106,3540,2906,0,3,0,0,0,0,0,5,1,1,14,1,0,5,3,66.33737137,1,-1.164499514,0.86767813,-1.342086972,0.179567798,0.336627744,13.61958573,0,-0.302049899,1.230539935,-0.245461273,0.806099291,0.883061574,80.82735617,1,0.460985566,0.641652447,0.718434985,0.472489122,0.609103633,115.6025606,1,1.237740143,0.508755083,2.43288015,0.014979258,0.065631958,75.7792296,1,0.59696611,0.560768712,1.064549604,0.287079796,0.421625026,N,-,,alpha beta hydrolase,C:endoplasmic reticulum; C:Golgi apparatus; F:carboxylic ester hydrolase activity,IPR000073 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR10992 (PANTHER); PTHR10992:SF702 (PANTHER); PTHR10992 (PANTHER); PTHR10992:SF702 (PANTHER); PTHR10992 (PANTHER); PTHR10992:SF702 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_01071,20,49,42,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.448619149,0,3.054246068,2.187940897,1.395945418,0.162730932,NA,0.141399193,0,6.287610768,2.016934036,3.117410216,0.001824475,0.015023052,0.368984337,0,3.627697143,1.364422177,2.658779083,0.007842437,0.026950723,0.425876373,0,3.204483155,1.567412107,2.044442008,0.040909901,0.109060755,0.365149716,0,3.540898974,1.306491477,2.710235034,0.006723555,0.022859634,Y,-,,kelch repeat,C:membrane; C:integral component of membrane,IPR015915 (G3DSA:2.120.10.GENE3D); PF13854 (PFAM); PTHR23244:SF300 (PANTHER); PTHR23244 (PANTHER); PTHR23244:SF300 (PANTHER); PTHR23244 (PANTHER); PTHR23244:SF300 (PANTHER); PTHR23244 (PANTHER); SSF117281 (SUPERFAMILY),,
RL4_JR_01072,23,13,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.214740034,0,4.1168584,2.891855533,1.423604448,0.154561007,NA,0.069148992,0,7.319720311,2.271269208,3.222744483,0.001269688,0.015023052,0.178575087,0,4.673904779,1.381771354,3.38254572,0.000718173,0.004420258,0.205932078,0,4.252398479,1.805807565,2.354845866,0.01853039,0.074216851,0.175438894,0,4.595282986,1.270040716,3.618217059,0.00029664,0.00173511,Y,-,,glyco x,C:membrane; C:integral component of membrane; F:carbohydrate binding,PTHR38122:SF1 (PANTHER); PTHR38122 (PANTHER),,
RL4_JR_01073,5800,6291,7831,0,4,17,0,0,2,0,8,1,4,19,1,0,10,3,176.6406638,1,0.54316841,0.521365475,1.041818908,0.297495646,0.483363768,44.07449738,1,0.446320204,0.98414031,0.453512777,0.650179545,0.773702958,135.1157236,1,0.139239747,0.533484817,0.261000393,0.794092204,0.864308552,199.110922,1,0.944878076,0.412625887,2.289914678,0.022026263,0.080406536,125.8368802,1,0.333095099,0.489536735,0.68042922,0.496232724,0.624453932,N,-,,Ras small monomeric GTPase,F:GTP binding; P:small GTPase mediated signal transduction; C:intracellular; C:plasma membrane,PR00449 (PRINTS); SM00173 (SMART); SM00174 (SMART); SM00175 (SMART); IPR005225 (TIGRFAM); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR020849 (PANTHER); IPR020849 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_01074,1542,2270,1991,0,0,5,0,0,3,3,0,0,0,3,0,0,0,1,42.45548172,1,0.346787231,0.724469996,0.478677148,0.632168326,0.790864775,35.56105765,1,2.741006421,0.882142701,3.107214305,0.001888594,0.015023052,52.49731097,1,0.348731893,0.866404906,0.402504523,0.687312761,0.785455964,34.28838913,1,-0.214231825,0.881915412,-0.242916522,0.808070066,0.877489212,26.3784955,1,-1.225218847,1.1382023,-1.076450862,0.281725666,0.415457397,N,-,,molybdopterin binding domain,C:nucleus; C:cytoplasm,IPR001453 (SMART); IPR001453 (PFAM); IPR001453 (G3DSA:3.40.980.GENE3D); PTHR23293 (PANTHER); PTHR23293:SF5 (PANTHER); IPR001453 (SUPERFAMILY),,
RL4_JR_01075,1526,1845,1985,0,0,9,0,0,1,0,0,0,0,4,0,0,4,4,55.84385827,1,1.285425805,0.575522921,2.233491939,0.025516521,0.080062993,16.20604136,1,1.610683168,1.122281859,1.435185961,0.151234113,0.278427009,17.74778426,0,-1.960586215,1.195122275,-1.640490063,0.100903313,0.195212142,36.52363098,1,0.326717885,0.75445137,0.433053604,0.664975828,0.771499972,62.42730459,1,1.58075525,0.559203779,2.826796436,0.004701621,0.01700747,N,-,,gmf family,C:nucleus; F:actin binding; C:cytosol; P:actin filament debranching; P:actin cortical patch assembly; C:actin cortical patch; P:negative regulation of Arp2/3 complex-mediated actin nucleation; F:Arp2/3 complex binding,IPR002108 (SMART); IPR011171 (PIRSF); IPR002108 (PFAM); IPR029006 (G3DSA:3.40.20.GENE3D); IPR011171 (PANTHER); IPR002108 (PROSITE_PROFILES); SSF55753 (SUPERFAMILY),,
RL4_JR_01076,2615,2404,2723,0,2,0,0,0,0,0,0,1,6,1,0,0,2,0,46.98186641,1,-1.31712061,1.000761666,-1.316118168,0.188134384,0.346925928,9.892414862,0,0.159202711,1.212053989,0.131349521,0.895498819,0.941970775,32.14414469,1,-1.52987012,1.186141588,-1.289787101,0.197124588,0.322249205,89.46864756,1,0.644372385,0.564958968,1.140564928,0.254051019,0.393700518,32.98619059,1,-0.901678236,0.968453726,-0.931049374,0.351828024,0.489030476,N,-,,cytosolic fe-s cluster assembly factor nbp35,"F:ATP binding; C:cytoplasm; F:metal ion binding; F:4 iron, 4 sulfur cluster binding; P:iron-sulfur cluster assembly",IPR033756 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR019591 (PANTHER); IPR028601 (HAMAP); IPR019591 (HAMAP); IPR027417 (SUPERFAMILY),3.A.1.132.3, the atp-binding cassette (abc) superfamily.
RL4_JR_01077,1195,1082,1114,2,1,4,0,0,0,0,0,0,1,1,0,0,0,0,56.98788247,1,1.670009146,0.559548082,2.984567725,0.002839793,0.013773504,4.346249224,0,1.345782727,1.250821314,1.075919248,0.281963373,0.441112872,11.24876192,0,-1.302663695,1.191293575,-1.093486712,0.27418016,0.412696988,26.29871695,1,0.009368793,1.010198246,0.009274212,0.992600355,0.995155817,11.06132788,0,-1.381269943,1.189403286,-1.161313374,0.245514483,0.375608404,N,-,,hypothetical protein SPSK_01654,,IPR029178 (PFAM); PTHR28244 (PANTHER),,
RL4_JR_01078,595,554,748,0,0,0,0,0,0,3,0,3,0,3,0,0,0,0,7.572793051,0,-1.023298843,1.199740198,-0.852933697,0.393696073,0.585918576,2.410160531,0,2.196333636,1.290522971,1.70189426,0.088775192,0.184475979,58.97285086,1,2.953858521,0.618724329,4.774110832,1.81E-06,4.51E-05,19.26496489,1,1.419038113,0.861187187,1.647769654,0.099399948,0.194864898,6.194663562,0,-0.544788684,1.206275283,-0.451628821,0.651536404,0.751718435,N,-,,d-glycerate 3-kinase,F:GTP binding; P:SRP-dependent cotranslational protein targeting to membrane; P:phosphorylation; F:kinase activity; C:intracellular,IPR027417 (G3DSA:3.40.50.GENE3D); IPR000897 (PFAM); PTHR10285 (PANTHER); PTHR10285:SF78 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_01079,4553,5873,3891,1,0,83,3,1,2,9,1,13,13,66,22,7,30,20,384.7614547,1,2.530829607,1.398253525,1.809993368,0.070296816,0.171393133,142.5213269,1,2.504928744,0.668380475,3.747758704,0.000178422,0.007886398,239.737302,1,1.972047545,0.490597759,4.019683153,5.83E-05,0.000813781,652.9125909,1,3.477131827,0.364895999,9.52910374,1.59E-21,1.66E-19,422.1275652,1,3.009940933,0.347924701,8.651127445,5.10E-18,1.01E-15,N,-,,peroxisomal hydratase-dehydrogenase-epimerase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); SM00822 (SMART); IPR029069 (G3DSA:3.10.129.GENE3D); IPR029069 (G3DSA:3.10.129.GENE3D); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002539 (PFAM); PTHR13078 (PANTHER); IPR016040 (SUPERFAMILY); IPR029069 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR029069 (SUPERFAMILY),,
RL4_JR_01080,3962,3201,4109,0,0,7,0,0,0,0,0,2,2,0,0,0,2,1,71.70629388,1,-0.087971988,0.581212601,-0.151359395,0.879692218,0.941301297,14.37725641,0,-0.380206207,1.207859589,-0.314776826,0.752931108,0.84917026,50.27664653,1,-1.211366832,1.032495487,-1.17324177,0.240698866,0.37380508,61.62756637,1,-1.710606703,1.013531614,-1.687768472,0.091455682,0.183037909,51.83725303,1,-0.900837757,0.843931069,-1.067430493,0.285777485,0.420077967,N,-,,ring finger,C:membrane,PTHR22770 (PANTHER); PTHR22770:SF33 (PANTHER); PTHR22770:SF33 (PANTHER); PTHR22770 (PANTHER); SSF57850 (SUPERFAMILY),,
RL4_JR_01081,1201,984,1742,0,0,4,0,0,0,0,0,1,4,0,0,0,1,0,30.89206626,1,0.613115104,0.797626014,0.768674908,0.442086324,0.631839564,4.956001955,0,1.156256156,1.263885567,0.91484244,0.360274351,0.524478208,19.42086886,1,-0.541134703,1.21046022,-0.447048729,0.654839877,0.760885908,52.15993761,1,1.163717475,1.334760175,0.871855107,0.383287427,0.528565442,16.6800176,1,-0.666279056,1.154952915,-0.576888501,0.564014779,0.68146177,N,-,,hypothetical protein CMQ_2962,P:biological_process; C:cellular_component; F:molecular_function,IPR032675 (G3DSA:3.80.10.GENE3D); IPR001810 (PROSITE_PROFILES),,
RL4_JR_01082,74,100,107,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.127754909,0,1.724299743,1.449165883,1.189856705,0.234102718,NA,0.357734142,0,4.948505771,1.641490714,3.014641343,0.002572833,0.015349618,0.931063615,0,2.292009488,1.248498069,1.835813403,0.066385259,0.140780133,1.074350462,0,1.869352783,1.292289958,1.446542838,0.148025006,0.263586561,0.92026691,0,2.206618185,1.232275114,1.790686316,0.073343647,0.150112073,Y,-,,hypothetical protein CFIO01_08482,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_01083,12969,12667,13054,3,5,23,0,1,0,0,0,4,1,10,2,0,0,0,313.0311138,1,0.234119165,0.350561525,0.667840445,0.504235447,0.690888944,87.86850389,1,-1.243257129,1.104434175,-1.125695997,0.260294219,0.416394083,154.3233779,1,-1.996689297,0.737697237,-2.70665145,0.006796557,0.024050453,216.7296171,1,-0.821677833,0.426326463,-1.927344194,0.053936749,0.127956639,126.3049646,0,-4.894549796,1.18703002,-4.123358058,3.73E-05,0.000303172,N,-,,threonyl-tRNA synthetase,F:ATP binding; P:cytoplasmic translation; F:threonine-tRNA ligase activity; C:cytosol; P:threonyl-tRNA aminoacylation,IPR002320 (PRINTS); IPR012947 (SMART); IPR004095 (PFAM); G3DSA:3.30.54.20 (GENE3D); IPR002314 (PFAM); IPR012947 (PFAM); IPR002320 (TIGRFAM); IPR004154 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.980.10 (GENE3D); G3DSA:3.30.930.10 (GENE3D); IPR012675 (G3DSA:3.10.20.GENE3D); IPR004154 (PFAM); PTHR11451:SF33 (PANTHER); PTHR11451 (PANTHER); PTHR11451 (PANTHER); IPR002320 (HAMAP); IPR006195 (PROSITE_PROFILES); IPR018163 (SUPERFAMILY); IPR004154 (SUPERFAMILY); SSF55681 (SUPERFAMILY); IPR012676 (SUPERFAMILY),,
RL4_JR_01084,3138,3449,4513,0,0,7,0,0,0,1,0,0,0,3,1,0,6,0,71.10566864,1,-0.107642111,0.630508861,-0.170722598,0.864441893,0.933156362,14.0807052,0,-0.350175114,1.209523858,-0.289514847,0.77218742,0.8619831,47.74211978,1,-2.045869317,1.196687631,-1.709610146,0.087337988,0.17450361,63.98570786,1,-0.71103649,0.758620407,-0.937275722,0.348616748,0.495547336,59.46371185,1,0.062104636,0.664689473,0.09343406,0.925558733,0.951785717,N,-,,small nuclear ribonucleo sm d2,P:RNA splicing; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP; C:viral nucleocapsid; C:U2-type prespliceosome; C:U1 snRNP,IPR001163 (SMART); IPR001163 (PFAM); G3DSA:2.30.30.100 (GENE3D); IPR027248 (PANTHER); IPR010920 (SUPERFAMILY),,
RL4_JR_01085,7583,5752,7525,1,4,2,0,0,0,0,4,1,5,3,1,0,4,3,132.9219439,1,-0.927599837,0.578951459,-1.60220658,0.109109936,0.235918064,26.61913238,0,-1.26887748,1.202475768,-1.055220832,0.291324339,0.450471274,106.8512668,1,-0.775291196,0.674645313,-1.149183402,0.250480364,0.385448123,147.7997446,1,-0.41854977,0.52130554,-0.802887632,0.422039685,0.565007512,105.5095636,1,-0.572617056,0.589545973,-0.971284824,0.331406464,0.4679903,N,-,,las seventeen-binding,,IPR007461 (PFAM); PTHR15629:SF8 (PANTHER); PTHR15629 (PANTHER),,
RL4_JR_01086,9987,8202,6058,0,3,9,0,0,0,0,0,0,1,7,0,0,6,0,155.6511838,1,-0.468887914,0.55680011,-0.842111749,0.399725405,0.591445963,31.40041012,0,-1.50716992,1.229422596,-1.225916885,0.220229954,0.368007345,80.79340722,0,-4.147163642,1.213197075,-3.4183759,0.00062996,0.003996829,130.5516894,1,-0.910191306,0.620752258,-1.466271439,0.142574353,0.256413646,102.0977483,1,-1.071593825,0.683378647,-1.568082103,0.116861973,0.214858811,N,-,,at hook domain-containing,P:positive regulation of maintenance of mitotic sister chromatid cohesion; P:mitotic chromosome condensation; C:nuclear mitotic cohesin complex; P:establishment of mitotic sister chromatid cohesion; F:chromatin binding; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; C:nuclear chromatin; C:2-micrometer circle DNA; P:replication-born double-strand break repair via sister chromatid exchange; P:rDNA condensation; P:regulation of gene expression; C:cytosol; P:tRNA gene clustering; P:establishment of protein localization to chromatin; P:negative regulation of G0 to G1 transition; P:cohesin loading; C:SMC loading complex; P:attachment of mitotic spindle microtubules to kinetochore,IPR011989 (G3DSA:1.25.10.GENE3D); IPR024986 (PFAM); IPR026003 (PFAM); IPR033031 (PANTHER); PTHR21704:SF18 (PANTHER); IPR033031 (PANTHER); PTHR21704:SF18 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_01087,2471,2420,5187,0,0,1,0,0,0,0,0,0,2,0,0,0,0,0,43.84592048,1,-2.481780323,1.206853114,-2.056406281,0.039743371,0.112295893,12.59776555,0,-0.189645093,1.258905667,-0.150642815,0.880257485,0.931615043,33.03567083,0,-2.857014679,1.235434648,-2.312558323,0.020746935,0.057154278,56.75760393,1,-1.496413888,1.07596953,-1.390758611,0.164298638,0.284557596,32.97072463,0,-2.95689249,1.252730277,-2.360358447,0.018257285,0.050812261,N,-, Effector probability:0.946,transcription factor s-ii,"F:nucleic acid binding; F:zinc ion binding; F:DNA-directed RNA polymerase activity; P:transcription, DNA-templated; C:nucleolus",IPR001222 (SMART); IPR001222 (PFAM); IPR012164 (PIRSF); G3DSA:2.20.25.10 (GENE3D); PTHR11239:SF14 (PANTHER); PTHR11239 (PANTHER); IPR001222 (PROSITE_PROFILES); SSF57783 (SUPERFAMILY),,
RL4_JR_01088,11006,17090,24505,0,0,4,0,0,1,4,0,1,6,5,1,0,2,1,225.7282094,1,-3.191235857,0.888012121,-3.593685019,0.000326034,0.002318906,75.58335207,1,-1.668270545,1.141376417,-1.461630466,0.143842501,0.267937761,224.1558253,1,-2.053652068,0.746863473,-2.74970211,0.005964946,0.021675922,285.6967295,1,-1.308650685,0.57516644,-2.275255639,0.022890599,0.081550779,187.6308264,1,-3.147282553,0.928892627,-3.38820921,0.000703506,0.003608407,N,-,,deoxyhypusine hydroxylase,C:nucleus; C:cytoplasm; F:metal ion binding; F:deoxyhypusine monooxygenase activity; P:oxidation-reduction process; P:microtubule cytoskeleton organization; P:peptidyl-lysine modification to peptidyl-hypusine,IPR004155 (SMART); PF13646 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR12697 (PANTHER); IPR027517 (HAMAP); IPR021133 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),,
RL4_JR_01089,815,834,1071,4,0,0,0,0,0,0,0,0,0,0,1,0,2,0,51.13275,1,1.223593261,0.750616943,1.630116763,0.103076821,0.226657873,3.456225627,0,1.676270153,1.261772726,1.328504031,0.184011653,0.323643084,8.990522117,0,-0.979545052,1.197625925,-0.817905685,0.413411044,0.555605125,20.00853693,1,-0.452260832,1.145960516,-0.394656557,0.693096368,0.792770077,16.60999132,1,0.598560745,0.988469892,0.605542718,0.54481845,0.666298684,N,-,,ras-like GTP-binding,F:GTP binding; P:small GTPase mediated signal transduction; C:intracellular,PR00449 (PRINTS); SM00174 (SMART); SM00175 (SMART); SM00173 (SMART); IPR005225 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001806 (PFAM); PTHR24073:SF353 (PANTHER); PTHR24073 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_01090,905,916,1582,0,0,4,0,0,0,0,0,2,2,3,0,0,0,0,28.82706736,1,0.806150214,0.817115312,0.986580721,0.323848225,0.513299751,4.282796234,0,1.366861374,1.278433759,1.06916871,0.284993655,0.44455321,24.1914989,1,0.516838817,1.063537491,0.48596201,0.626994101,0.739048583,43.57831314,1,1.32579376,0.72012365,1.841064045,0.065612174,0.144768461,11.12908971,0,-1.390026417,1.233851648,-1.126574997,0.259922215,0.391739284,N,-,,nuclear pore,,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR11024 (PANTHER); PTHR11024:SF3 (PANTHER); PTHR11024:SF3 (PANTHER); PTHR11024 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_01091,1822,1743,2033,0,0,0,0,0,0,0,0,0,0,3,0,0,1,1,22.38728118,0,-2.586972179,1.18439128,-2.184220892,0.02894602,0.088003551,7.142139386,0,0.629154935,1.221321538,0.515142749,0.606453272,0.739669842,18.5337757,0,-2.02314693,1.187988686,-1.70300185,0.088567722,0.176403624,33.41588456,1,-0.137096626,0.846613902,-0.161935241,0.871356851,0.920927778,29.50332875,1,-0.428674553,0.970063008,-0.441903824,0.658558804,0.756523151,N,-, Effector probability:0.625,Thioredoxin-like fold,,IPR012336 (G3DSA:3.40.30.GENE3D); IPR032801 (PFAM); PTHR42336 (PANTHER); PTHR42336:SF2 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_01092,1566,1524,1996,1,4,2,0,0,2,0,0,0,0,0,0,0,4,0,70.05919316,1,1.106455274,0.580202977,1.907014127,0.056518758,0.14563488,25.22071109,1,2.414339979,0.988480633,2.442475753,0.014586909,0.04506981,16.80769476,0,-1.882154816,1.193812807,-1.576591242,0.114889609,0.214958862,19.39214346,0,-2.304677177,1.192431478,-1.932754393,0.053266461,0.127056344,32.05608246,1,0.632327175,0.766885215,0.824539531,0.409633064,0.545584685,N,-,,mtDNA inheritance,F:GTPase activity; C:cytoplasmic part; P:cellular process,IPR003008 (G3DSA:3.40.50.GENE3D); IPR019605 (PFAM); IPR029209 (PFAM); PTHR13391 (PANTHER); IPR003008 (SUPERFAMILY),,
RL4_JR_01093,1027,1096,1712,0,0,4,0,0,0,0,0,0,0,2,0,0,0,0,30.57038749,1,0.641445602,0.800537391,0.801268759,0.422976073,0.614654739,4.838686899,0,1.190812144,1.262269134,0.943390052,0.34548143,0.508670028,12.63410542,0,-1.470379302,1.212785928,-1.212398057,0.225360044,0.355657847,22.60350276,1,-0.179352937,1.044408082,-0.171726876,0.863652256,0.915373674,12.54413542,0,-1.562699546,1.224988927,-1.27568463,0.202067024,0.324133178,N,-,,dnaj domain cwf23,C:nucleus,IPR001623 (SMART); IPR001623 (PFAM); IPR001623 (G3DSA:1.10.287.GENE3D); IPR001623 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_01094,574,638,530,0,0,22,0,0,0,0,0,2,0,0,0,0,0,0,91.00887781,1,3.748752503,1.088266549,3.444700662,0.000571692,0.00375815,2.240207021,0,2.301955485,1.309373967,1.758058083,0.078737627,0.168281727,18.79282175,1,1.472802962,1.039445016,1.416912814,0.15650842,0.270668131,6.684770165,0,-0.767848591,1.202041483,-0.638787098,0.522961442,0.657598684,5.691404067,0,-0.422498973,1.199439012,-0.352247149,0.72465292,0.806275914,N,-,,wd repeat-containing slp1,P:cell division; F:ubiquitin-protein transferase activator activity; P:regulation of meiotic nuclear division; P:regulation of catalytic activity; P:positive regulation of protein catabolic process; P:positive regulation of mitotic metaphase/anaphase transition; C:mitotic checkpoint complex; F:anaphase-promoting complex binding,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR024977 (PFAM); IPR001680 (PFAM); PTHR19918:SF8 (PANTHER); PTHR19918:SF8 (PANTHER); IPR033010 (PANTHER); IPR033010 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_01095,5681,5238,5208,2,3,1,0,0,0,3,0,6,2,2,1,0,7,1,112.5622868,1,-0.787911438,0.605769097,-1.300679485,0.193368187,0.354414215,20.68555241,0,-0.905006227,1.202427738,-0.75264916,0.451660768,0.611669528,125.7250275,1,0.438544183,0.508987888,0.861600429,0.388907435,0.532643245,98.01790934,1,-0.917316239,0.662916278,-1.383758809,0.16643232,0.287172331,86.99978383,1,-0.020339513,0.535445417,-0.037986156,0.96969872,0.980130145,N,-,,transcription factor tfiia complex subunit,C:nucleus; P:transcription initiation from RNA polymerase II promoter,IPR004855 (SMART); IPR004855 (PFAM); IPR013028 (G3DSA:1.10.287.GENE3D); IPR009088 (G3DSA:2.30.18.GENE3D); PTHR12694:SF8 (PANTHER); IPR004855 (PANTHER); IPR009083 (SUPERFAMILY); IPR009088 (SUPERFAMILY),,
RL4_JR_01096,14,26,43,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.39701121,1,4.450074792,1.245788433,3.572095129,0.000354137,0.002492707,0.103732338,0,6.734087419,2.147665862,3.135537767,0.001715393,0.015023052,0.272767288,0,4.062274828,1.409753014,2.881550731,0.003957235,0.016305678,0.314932342,0,3.639337427,1.701607449,2.138764396,0.032454754,0.096393191,0.27263603,0,3.96222833,1.337570616,2.962257306,0.003053925,0.012011124,N,-,,serine threonine kinase domain,F:kinase activity,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); PTHR24361 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.3, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_01097,726,691,1079,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,9.949034069,0,-1.417001231,1.213252648,-1.167935824,0.242832652,0.41776229,3.155076152,0,1.807749775,1.28195973,1.410145524,0.158496717,0.288336408,8.225772043,0,-0.851343303,1.209998022,-0.703590656,0.481687732,0.617904128,21.52670272,1,1.014505095,0.882713401,1.149302927,0.250431091,0.389734829,8.155982309,0,-0.941619727,1.219995829,-0.771822086,0.440219809,0.574162767,N,-,,major royal jelly,,no IPS match,,
RL4_JR_01098,27384,21406,23880,0,1,10,0,0,0,0,0,1,4,14,4,0,9,0,336.4774993,1,-2.169699323,0.522257619,-4.154461792,3.26E-05,0.00032009,93.13205546,0,-3.075682526,1.19683478,-2.569847216,0.010174338,0.033977118,247.3448553,1,-4.761183993,1.194360429,-3.986387925,6.71E-05,0.000899585,409.7349117,1,-0.974582982,0.367358174,-2.652950309,0.007979162,0.040505848,271.4811248,1,-2.095144909,0.587022754,-3.569103405,0.000358205,0.002035256,N,-,,aaa family ATPase,F:ATP binding,PR00830 (PRINTS); IPR003593 (SMART); G3DSA:1.10.8.60 (GENE3D); IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001487 (G3DSA:1.20.920.GENE3D); PTHR23069:SF0 (PANTHER); PTHR23069:SF0 (PANTHER); PTHR23069:SF0 (PANTHER); PTHR23069 (PANTHER); PTHR23069:SF0 (PANTHER); PTHR23069 (PANTHER); PTHR23069 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.16.1.1, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_01099,15413,4476,5899,2,0,0,0,1,0,0,0,0,0,1,0,0,0,0,122.1804012,1,-2.904590948,1.188566118,-2.443777341,0.014534394,0.051285287,71.80419486,1,-0.649538888,1.224719105,-0.530357439,0.595864129,0.731514459,85.49824107,0,-4.228834451,1.291601316,-3.274102,0.001059983,0.006035586,102.53328,1,-3.709759497,1.263222803,-2.93674203,0.003316799,0.020169723,83.13983944,0,-4.291260999,1.298442572,-3.304929376,0.000950003,0.004580373,N,-,,midasin,F:nucleotide binding; C:nucleus; F:catalytic activity; P:ribosome biogenesis; P:cellular process,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR012099 (PIRSF); IPR011704 (PFAM); PTHR22908 (PANTHER); IPR012099 (PTHR22908:PANTHER); PTHR22908 (PANTHER); IPR002035 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.D.4.10.1, the proton-translocating cytochrome oxidase (cox) superfamily.
RL4_JR_01100,4732,1230,1380,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29.04732807,0,-2.962687806,1.356740439,-2.183680623,0.028985725,0.088003551,9.578822614,0,0.205692364,1.403557127,0.14655076,0.883486621,0.934062686,24.38415454,0,-2.418882924,1.321845474,-1.829928666,0.067260606,0.142308543,28.09197275,0,-2.839267505,1.339523809,-2.119609585,0.034038983,0.0989162,23.6250193,0,-2.476059691,1.332781672,-1.857813431,0.063195513,0.134141419,N,-,,---NA---,,no IPS match,,
RL4_JR_01101,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_01102,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_01103,3286,3429,5601,1,0,1,0,0,1,0,0,0,0,1,0,0,6,0,62.97458791,1,-1.982457305,1.047564357,-1.892444404,0.058431795,0.14943153,24.90014598,1,0.424903639,1.13380746,0.374758197,0.707840306,0.816545331,40.54666039,0,-3.152566634,1.210964981,-2.603350786,0.009231744,0.030693798,50.80526115,1,-2.629890923,1.167760746,-2.252080259,0.024317201,0.084347946,63.44543142,1,-0.121936438,0.714358191,-0.170693694,0.864464622,0.909749953,N,-,,54s ribosomal l12,F:structural constituent of ribosome; C:ribosome; P:aerobic respiration; C:mitochondrial nucleoid; P:translation,IPR013823 (PFAM); IPR014719 (G3DSA:3.30.1390.GENE3D); IPR013823 (PRODOM); IPR014719 (SUPERFAMILY); IPR008932 (SUPERFAMILY),,
RL4_JR_01104,761,780,1190,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,14.71193866,1,-0.601737693,1.166041949,-0.516051497,0.605818443,0.772712141,3.450653604,0,1.678554661,1.277052202,1.314397844,0.188712356,0.329335597,9.001647124,0,-0.981357509,1.210750928,-0.810536243,0.417632043,0.559026223,10.38771338,0,-1.404133038,1.210986192,-1.159495498,0.246254271,0.384891092,16.65031551,1,0.584312082,1.011111562,0.577890813,0.563337838,0.680766411,N,-,,"hypothetical protein BABINDRAFT_24811, partial",,no IPS match,,
RL4_JR_01105,1013,1107,1590,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,26.27037274,1,0.29197533,0.887517761,0.328979703,0.742171029,0.864302105,4.692319555,0,1.235137238,1.256243261,0.983199096,0.32550946,0.487644473,12.23852445,0,-1.4244806,1.207159711,-1.180026626,0.237989625,0.370849156,14.12302703,0,-1.847261162,1.207130199,-1.530291566,0.125944575,0.232879985,12.1351182,0,-1.514867966,1.21776531,-1.243973657,0.213509258,0.338095283,N,-,,CTD kinase subunit gamma,C:CTDK-1 complex; C:cytosol; P:phosphorylation; F:kinase activity,IPR024637 (PFAM); IPR024638 (PFAM); PTHR28291 (PANTHER); IPR006569 (PROSITE_PROFILES),,
RL4_JR_01106,2864,3362,3505,0,0,3,0,0,0,4,1,0,4,3,1,0,0,1,50.48162789,1,-1.090637591,0.860177816,-1.267921087,0.204826133,0.36968398,12.4215504,0,-0.169256939,1.208712413,-0.140030777,0.888635673,0.937052848,84.38516027,1,0.337591078,0.668850577,0.504733179,0.613746254,0.72889317,96.1411769,1,0.498503217,0.541649784,0.920342317,0.357393902,0.503354188,39.19137772,1,-1.971146765,1.124010867,-1.753672337,0.079486668,0.160543091,N,-,,nadh-ubiquinone oxidoreductase kda subunit,P:biological_process,PF13233 (PFAM); IPR016488 (PIRSF); PTHR12964:SF0 (PANTHER); PTHR12964 (PANTHER),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_01107,1606,1870,2310,0,0,4,0,0,0,0,0,0,0,3,0,0,0,0,38.43047335,1,0.062371224,0.769096013,0.081096798,0.935364972,0.968241015,7.347193886,0,0.588278986,1.228446028,0.478880613,0.632023564,0.758788105,19.13129904,0,-2.068926825,1.198445805,-1.72634158,0.084285979,0.169341388,34.11020418,1,-0.195364952,0.868498552,-0.224945628,0.822021572,0.888202467,18.92933183,0,-2.156303257,1.206700053,-1.786942208,0.07394683,0.151163265,N,-,,cell cycle control cwf14,"P:cellular bud site selection; C:U2-type spliceosomal complex; C:U2 snRNP; P:mRNA splicing, via spliceosome",IPR001748 (PRINTS); IPR001748 (PFAM); IPR001748 (PANTHER),,
RL4_JR_01108,3685,3280,5097,2,1,5,3,0,0,0,0,0,6,2,0,0,2,1,95.2961651,1,0.028792166,0.576141659,0.049974109,0.96014302,0.979840726,82.20215455,1,1.761117093,0.850990616,2.069490614,0.038500071,0.096096133,39.76277305,0,-3.124410718,1.200502097,-2.60258664,0.009252343,0.030752044,109.7770423,1,0.237269082,0.585894002,0.404969297,0.685500079,0.786836017,54.47549015,1,-1.005285645,0.868150125,-1.15796291,0.246879173,0.377021361,N,-,,c2h2 type zinc finger domain containing,F:metal ion binding,IPR015880 (SMART); PTHR21354:SF0 (PANTHER); PTHR21354 (PANTHER),,
RL4_JR_01109,31011,11475,13886,0,4,2,3,0,0,0,0,0,2,3,0,0,4,1,263.2871435,1,-2.538393959,0.82118564,-3.091132914,0.001993944,0.010447393,139.9377139,1,-0.383596887,0.980160872,-0.391361151,0.695530304,0.807240395,186.9451117,0,-5.357480929,1.266427052,-4.230390467,2.33E-05,0.000380933,246.1206466,1,-2.743605137,0.815142314,-3.365798943,0.000763223,0.005894091,204.9697479,1,-2.552649649,0.835902549,-3.053764641,0.002259893,0.009408477,N,-,,transcription termination factor 2,F:metal ion binding,IPR001650 (SMART); IPR014001 (SMART); IPR000330 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); PTHR10799 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_01110,57097,63296,38755,19,35,11,0,0,9,6,11,1,5,92,5,0,54,6,1155.080079,1,-0.349719729,0.678474851,-0.515449804,0.606238737,0.772991246,290.7195429,1,-0.642824437,0.713510467,-0.900932035,0.367624457,0.532117777,690.7991848,1,-1.799755534,0.589034536,-3.055432956,0.002247358,0.010824099,1076.863564,1,-0.354793297,0.796518177,-0.445430258,0.65600885,0.765394054,772.286192,1,-0.931226884,0.904088554,-1.030017336,0.303001868,0.438277937,N,-,,acyl- desaturase,F:stearoyl-CoA 9-desaturase activity; P:unsaturated fatty acid biosynthetic process; P:mycelium development; F:metal ion binding; C:integral component of membrane; P:oxidation-reduction process; F:heme binding,IPR001199 (PRINTS); IPR015876 (PRINTS); IPR001199 (SMART); IPR009160 (PIRSF); IPR005804 (PFAM); IPR001199 (G3DSA:3.10.120.GENE3D); IPR001199 (PFAM); IPR015876 (PANTHER); PTHR11351:SF38 (PANTHER); IPR001199 (PROSITE_PROFILES); IPR001199 (SUPERFAMILY),,
RL4_JR_01111,1616,1278,1068,2,6,5,0,0,0,0,0,6,3,4,2,2,0,2,103.153163,1,2.370593381,0.489311668,4.844751388,1.27E-06,1.86E-05,5.117457342,0,1.110156573,1.274850538,0.870813119,0.383856201,0.548171732,52.17417145,1,1.848293288,0.659944467,2.800680028,0.005099505,0.019201401,78.45369598,1,1.964073356,0.549736534,3.572753916,0.000353247,0.003110021,59.67767842,1,1.082199197,0.76004581,1.423860486,0.154486862,0.264621803,N,-,,serine threonine kinase,F:protein kinase activity; P:phosphorylation,G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); PTHR24362 (PANTHER); PTHR24362:SF266 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_01112,24943,15762,20811,9,4,11,0,0,0,2,7,3,0,0,1,0,4,0,409.5674053,1,-0.678464829,0.417910294,-1.623470008,0.10448897,0.228715056,78.72639308,0,-2.833256133,1.207383805,-2.346607698,0.01894519,0.05515359,300.0341951,1,-1.068862064,0.495897363,-2.155409856,0.031129776,0.079026542,244.3249854,1,-4.950341642,1.159059196,-4.270999842,1.95E-05,0.000254562,215.5045795,1,-2.973041736,0.792760019,-3.750241767,0.000176664,0.001120071,N,-,,ATP-dependent protease La,F:ATP binding; P:oxidation-dependent protein catabolic process; P:misfolded or incompletely synthesized protein catabolic process; C:mitochondrial matrix; P:chaperone-mediated protein complex assembly; F:serine-type endopeptidase activity; P:regulation of mitochondrial DNA replication; P:cellular response to oxidative stress; F:sequence-specific DNA binding; F:ATP-dependent peptidase activity,PR00830 (PRINTS); IPR003593 (SMART); IPR003111 (SMART); IPR003111 (PFAM); IPR003959 (PFAM); IPR008269 (PFAM); G3DSA:1.10.8.60 (GENE3D); IPR004815 (TIGRFAM); IPR014721 (G3DSA:3.30.230.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027065 (PANTHER); PTHR10046:SF50 (PANTHER); IPR027503 (HAMAP); IPR020568 (SUPERFAMILY); IPR015947 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.29.1.1, the mitochondrial inner membrane i-aaa protease complex (mimp) familly.
RL4_JR_01113,1043,821,1246,2,4,2,0,0,0,0,0,2,0,9,0,0,0,3,72.19415558,1,2.030100636,0.561869832,3.613115564,0.00030254,0.002197772,3.947581689,0,1.484494799,1.263332392,1.175062721,0.239969624,0.391832962,23.25753318,1,0.647413589,1.042738011,0.620878478,0.534679583,0.663897013,47.94120748,1,2.225924383,0.570872418,3.899162602,9.65E-05,0.001040815,32.23939332,1,0.987007774,0.858857267,1.149210483,0.250469199,0.381181518,N,-,,hypothetical protein SPI_07671,P:biological_process; C:cellular_component; F:molecular_function,PTHR21678 (PANTHER),,
RL4_JR_01114,9,11,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.178745318,0,4.381520326,3.193534948,1.371996987,0.170064376,NA,0.055942674,0,7.624594655,2.406251837,3.168660294,0.001531433,0.015023052,0.147240761,0,4.950706933,1.479435765,3.346348013,0.000818836,0.004905586,0.169999375,0,4.528599064,2.010703849,2.252245683,0.024306751,0.084347946,0.147485085,0,4.848714202,1.349139623,3.593930619,0.000325727,0.001874919,N,-,,---NA---,,no IPS match,,
RL4_JR_01115,4,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.027619607,0,7.074815476,3.945191743,1.793275444,0.072928892,NA,0.009016735,0,10.25926285,3.442963153,2.979777126,0.002884582,0.015349618,0.023118361,0,7.622664632,2.025730144,3.762922053,0.00016794,0.001587507,0.026645183,0,7.202363964,3.944830361,1.825772798,0.067884492,0.147894085,0.022580329,0,7.544996427,1.445169607,5.220838018,1.78E-07,3.69E-06,N,-,,conserved fungal,F:nucleic acid binding; P:nucleic acid phosphodiester bond hydrolysis; F:nuclease activity,IPR018828 (PFAM); PTHR28133:SF1 (PANTHER); PTHR28133 (PANTHER),,
RL4_JR_01116,711,751,776,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,8.968914154,0,-1.267112347,1.189933591,-1.064859717,0.286939417,0.4709921,2.861754286,0,1.948633994,1.27367552,1.52992969,0.126034133,0.242025707,7.421978949,0,-0.70277385,1.193132464,-0.589015781,0.555850687,0.682526666,12.57371023,1,-0.177739328,1.141127419,-0.155757653,0.876224051,0.923604291,7.311860605,0,-0.783951394,1.194029163,-0.65655967,0.511464088,0.637912526,N,-,,mediator-rna polymerase ii transcription subunit 21,P:negative regulation of transcription from RNA polymerase II promoter; C:core mediator complex; C:mediator complex; C:cytosol; F:RNA polymerase II transcription corepressor activity; F:RNA polymerase II transcription coactivator activity; P:positive regulation of transcription from RNA polymerase II promoter; F:RNA polymerase II repressing transcription factor binding,IPR021384 (PFAM); PTHR13381 (PANTHER); SSF140718 (SUPERFAMILY),,
RL4_JR_01117,3470,3166,3293,5,2,2,0,0,0,1,0,0,0,5,0,0,0,0,113.7244696,1,0.503052472,0.500745891,1.004606291,0.315086467,0.503225411,12.72076132,0,-0.203568888,1.209290949,-0.168337395,0.866317857,0.922091327,44.00164272,1,-1.890603053,1.186971916,-1.592795102,0.111206164,0.20992694,58.0434956,1,-0.235756474,0.664913762,-0.354566994,0.722914006,0.815271142,32.39160484,0,-2.931346066,1.185791223,-2.472059169,0.013433728,0.039770905,N,-,,pyrimidine 5`-nucleotidase,P:metabolic process; C:cytosol; F:hydrolase activity,IPR006439 (TIGRFAM); IPR023214 (G3DSA:3.40.50.GENE3D); IPR010237 (TIGRFAM); IPR023214 (PFAM); PTHR12725:SF76 (PANTHER); PTHR12725 (PANTHER); IPR023214 (SUPERFAMILY),,
RL4_JR_01118,9145,7920,11344,0,0,0,0,0,0,1,4,0,1,6,0,0,0,2,113.2805236,0,-4.926103464,1.198224875,-4.111167751,3.94E-05,0.00038006,36.06835095,0,-1.707169429,1.197299668,-1.425849747,0.153911718,0.282022883,136.2219044,1,-1.211329724,0.677400574,-1.788202977,0.073743266,0.153081162,141.5789294,1,-1.275531651,0.593051543,-2.150793916,0.03149247,0.094938713,107.4527055,1,-2.755859789,0.983308269,-2.802640713,0.00506861,0.018108566,N,-,,hypothetical protein CMQ_3075,P:mycelium development; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_01119,15470,8484,6631,7,13,7,0,0,4,3,1,1,2,3,1,0,5,4,323.4072235,1,0.649545359,0.599562084,1.083366303,0.278645866,0.461937203,77.28408899,1,0.66459392,0.882172101,0.753360846,0.451233104,0.611429917,149.398341,1,-1.297672278,0.758557789,-1.710709846,0.087134689,0.174200552,157.6858622,1,-1.576337196,0.724301635,-2.176354601,0.029528756,0.091437919,147.8793967,1,-0.77565627,0.646545292,-1.199693633,0.230258347,0.357845858,N,-,,kh domain-containing,F:RNA binding,IPR004087 (SMART); IPR004088 (G3DSA:3.30.1370.GENE3D); IPR004088 (PFAM); PTHR10627 (PANTHER); PTHR10627:SF42 (PANTHER); IPR004088 (PROSITE_PROFILES); IPR004088 (PROSITE_PROFILES); IPR004088 (SUPERFAMILY); IPR004088 (SUPERFAMILY),,
RL4_JR_01120,767,605,722,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.359753702,0,-1.165987528,1.191732678,-0.978396876,0.327878073,0.517290234,2.677862978,0,2.044450331,1.287390349,1.588057836,0.112273262,0.22165593,6.9331939,0,-0.604599616,1.197942359,-0.50469842,0.613770671,0.72889317,7.997012107,0,-1.026725986,1.195697175,-0.85868396,0.390514902,0.535187247,6.823794673,0,-0.684451308,1.197466375,-0.571582904,0.56760458,0.684329171,N,-,,hypothetical protein CMQ_2685,,no IPS match,,
RL4_JR_01121,1885,1477,2427,2,0,4,2,0,2,3,2,0,0,3,0,0,1,0,58.44041584,1,0.674311446,0.648850833,1.039239547,0.298693342,0.484314812,70.71065547,1,3.208695154,0.761481517,4.213753167,2.51E-05,0.001428236,67.97075047,1,1.100724703,0.688857277,1.597899507,0.110065344,0.208223143,34.04276173,1,-0.197542869,0.880416697,-0.224374288,0.822466076,0.888452899,22.7453225,1,-1.224367915,1.144096754,-1.070161166,0.284546771,0.418877008,N,-,,dead deah box helicase,F:DNA binding; F:ATP binding; C:cytoplasm; F:hydrolase activity,IPR014001 (SMART); IPR001650 (SMART); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR006935 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24031 (PANTHER); PTHR24031:SF311 (PANTHER); PTHR24031:SF311 (PANTHER); PTHR24031:SF311 (PANTHER); PTHR24031 (PANTHER); PTHR24031 (PANTHER); PTHR24031 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.17.1.1, the phage t7 injectisome (t7 injectisome) family.
RL4_JR_01122,3539,2923,3815,0,0,1,0,0,0,0,0,0,0,3,0,0,0,0,44.82453797,1,-2.512496375,1.14128032,-2.201471743,0.027702645,0.084961721,13.09661189,0,-0.245618395,1.208833877,-0.203186227,0.838989477,0.90362327,33.97809459,0,-2.897595283,1.190688378,-2.433546288,0.014951724,0.044390396,51.23129424,1,-1.016297049,0.855138756,-1.188458647,0.234652763,0.371934466,33.5160783,0,-2.980578769,1.194385644,-2.495491121,0.01257829,0.037790857,N,-,,DNA-binding,F:DNA binding,no IPS match,,
RL4_JR_01123,104,104,145,0,3,0,0,0,0,0,0,1,0,0,0,0,5,0,25.43969738,1,3.736654545,0.863155047,4.32906528,1.50E-05,0.000164235,0.447517383,0,4.625389936,1.574263101,2.938130185,0.003301983,0.016310876,7.664046257,1,2.929118692,1.205164725,2.430471645,0.015079186,0.044703273,1.344607427,0,1.545339219,1.265387701,1.221237743,0.221996018,0.357224782,20.45629114,1,4.782825644,0.720047878,6.642371692,3.09E-11,2.39E-09,N,-,,duf455 domain-containing,P:nucleic acid metabolic process; F:catalytic activity,IPR007012 (PFAM); IPR007547 (PFAM); IPR009097 (G3DSA:3.90.1140.GENE3D); G3DSA:1.10.1410.10 (GENE3D); PF13563 (PFAM); IPR014492 (PANTHER); PTHR10682:SF23 (PANTHER); IPR011068 (SUPERFAMILY); SSF81631 (SUPERFAMILY),,
RL4_JR_01124,3007,2192,2347,0,0,1,2,0,0,1,2,0,0,3,0,0,0,1,33.95451238,1,-2.068572861,1.148176308,-1.801616047,0.071605835,0.17396081,54.31673466,1,1.867942298,0.993904353,1.879398448,0.060190108,0.136510032,51.7825787,1,-0.042218995,0.860256946,-0.049077192,0.96085778,0.977080773,40.89651838,1,-0.582918589,0.870056779,-0.669977642,0.502872043,0.63996725,31.92595026,1,-1.597041772,1.125738166,-1.418661835,0.155997629,0.266263654,N,-,,hypothetical protein F503_04436,,PTHR37848 (PANTHER),,
RL4_JR_01125,13238,10163,10945,5,1,12,0,2,3,0,2,1,2,8,6,5,16,4,241.3793842,1,-0.32625573,0.407859166,-0.799922514,0.423755692,0.615124366,148.8819844,1,0.947536984,0.696246743,1.360921245,0.173538579,0.309362011,136.0756237,1,-2.236114143,0.857700653,-2.607103231,0.009131183,0.030449306,239.8800277,1,-0.32544192,0.415583605,-0.783096148,0.433570653,0.575800481,283.2085882,1,0.546791214,0.371926375,1.470159825,0.141518473,0.247987978,Y,-,,multispanning membrane,P:cellular copper ion homeostasis; C:integral component of membrane; P:pseudohyphal growth; P:vacuolar transport; P:invasive growth in response to glucose limitation; C:intracellular,IPR004000 (SMART); G3DSA:3.30.420.40 (GENE3D); IPR004000 (PFAM); IPR004240 (PFAM); PTHR10766:SF1 (PANTHER); IPR004240 (PANTHER); IPR004240 (PANTHER); PTHR10766:SF1 (PANTHER); IPR004240 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY); IPR020846 (SUPERFAMILY),8.A.68.1.10, the endomembrane protein-70 (emp70) family.
RL4_JR_01126,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_01127,4282,2906,4468,0,1,5,0,0,0,0,0,0,0,0,0,0,0,0,73.47272092,1,-0.357382787,0.650287007,-0.549577008,0.582609533,0.755872864,14.82837121,0,-0.424790126,1.220491348,-0.348048454,0.727803795,0.830252453,38.46515077,0,-3.076535008,1.201533983,-2.56050603,0.010451985,0.033828611,44.370697,0,-3.498757313,1.202484059,-2.909608062,0.003618823,0.021655188,37.95952206,0,-3.160192746,1.206265083,-2.619816152,0.008797718,0.028341361,N,-,,arrestin,,PTHR11188:SF78 (PANTHER); PTHR11188:SF78 (PANTHER); PTHR11188 (PANTHER); PTHR11188 (PANTHER); PTHR11188:SF78 (PANTHER); PTHR11188:SF78 (PANTHER); PTHR11188 (PANTHER); PTHR11188 (PANTHER),,
RL4_JR_01128,2222,2222,3461,0,1,1,0,0,1,0,0,0,2,6,2,0,0,1,43.3478595,1,-1.344524556,1.034903761,-1.299178346,0.193882731,0.355038231,19.36369576,1,1.061543264,1.130617478,0.938905762,0.347779131,0.510564209,26.0486919,0,-2.514219731,1.205765167,-2.085165338,0.037054295,0.089939507,92.02418864,1,1.105444749,0.529755956,2.086705656,0.03691475,0.102009236,33.2073969,1,-1.666599319,1.145460899,-1.454959588,0.14568045,0.253526049,Y,-,,zip zinc transporter,P:transmembrane transport; C:integral component of membrane; F:metal ion transmembrane transporter activity; P:metal ion transport,IPR003689 (PFAM); PTHR16950 (PANTHER),2.A.5.4.18, the zinc (zn(2+))-iron (fe(2+)) permease (zip) family.
RL4_JR_01129,1654,2150,2217,0,5,3,0,0,0,0,0,0,0,5,6,0,0,0,75.6751171,1,1.047090566,0.573930326,1.824421045,0.068088443,0.167514549,7.677952525,0,0.524785801,1.229224953,0.426924136,0.669434585,0.788825193,19.96288149,0,-2.13025414,1.198181461,-1.777906109,0.075419277,0.15569836,100.903299,1,1.653860561,0.497847489,3.322022499,0.000893675,0.006718958,19.71036417,0,-2.214621719,1.20393301,-1.839489159,0.065843271,0.138541795,N,-,,phosphatidylinositol phospholipase c,P:lipid metabolic process; F:lyase activity; F:phosphoric diester hydrolase activity,IPR000909 (SMART); IPR017946 (G3DSA:3.20.20.GENE3D); PTHR13593 (PANTHER); PTHR13593:SF37 (PANTHER); IPR000909 (PROSITE_PROFILES); SSF89372 (SUPERFAMILY); IPR017946 (SUPERFAMILY),,
RL4_JR_01130,22479,18442,19050,58,95,38,0,0,14,12,48,69,23,85,47,5,101,28,1729.68642,1,2.623019967,0.608531347,4.310410594,1.63E-05,0.000176308,208.271246,1,1.335650449,0.666434283,2.00417428,0.045051395,0.108651469,1156.67224,1,2.291128567,0.429114279,5.339203748,9.34E-08,3.24E-06,1237.491454,1,2.134953573,0.304366528,7.014416423,2.31E-12,1.04E-10,871.6922319,1,1.86074321,0.535185343,3.476820194,0.000507398,0.002742875,Y,-,,"glucan 1,3-beta-glucosidase","P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR013781 (G3DSA:3.20.20.GENE3D); PTHR16631 (PANTHER); PTHR16631:SF13 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_01131,12273,14484,22781,1,2,0,0,0,1,0,0,1,0,6,0,0,9,0,223.7617585,1,-3.348632823,0.908958382,-3.684033163,0.000229572,0.001737339,71.77088096,1,-1.581676309,1.127565853,-1.402735197,0.160695818,0.291484844,169.6313772,1,-4.199126288,1.216485109,-3.45185178,0.000556753,0.003664871,212.3492142,1,-2.357480057,0.708492968,-3.327457241,0.000876424,0.006637096,196.9225869,1,-1.652128103,0.726900418,-2.272839666,0.023035844,0.060929446,N,-,,methyltransferase,C:nucleus; F:tRNA (cytosine-5-)-methyltransferase activity; C:cytoplasm; F:tRNA binding; P:tRNA methylation,IPR023267 (PRINTS); IPR023270 (PRINTS); IPR029063 (G3DSA:3.40.50.GENE3D); IPR001678 (PFAM); PTHR22808:SF1 (PANTHER); PTHR22808:SF1 (PANTHER); PTHR22808 (PANTHER); PTHR22808 (PANTHER); IPR001678 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_01132,2911,2344,4332,0,2,3,0,0,3,3,2,0,0,6,1,0,0,2,65.5825878,1,-0.317296682,0.725460555,-0.437372755,0.661841039,0.810583876,40.22119956,1,2.033520343,0.890559775,2.283418139,0.02240575,0.062980005,80.42304107,1,0.382967248,0.705174375,0.543081628,0.587073601,0.707479245,70.08495489,1,0.268689082,0.643548085,0.417512053,0.67630391,0.77948836,46.026993,1,-1.176244389,1.006640908,-1.16848459,0.242611352,0.37201877,N,-,,GTP-binding,F:binding,IPR006073 (PRINTS); IPR006169 (G3DSA:2.70.210.GENE3D); IPR006169 (PFAM); IPR006073 (PFAM); IPR014100 (PIRSF); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11702 (PANTHER); PTHR11702 (PANTHER); PTHR11702:SF31 (PANTHER); IPR031167 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR006169 (SUPERFAMILY),9.A.8.1.1, the ferrous iron uptake (feob) family.
RL4_JR_01133,1119,820,958,1,1,7,0,0,0,1,0,0,1,2,2,0,2,4,56.3663499,1,2.243193339,0.521965622,4.297588279,1.73E-05,0.000185441,3.711559223,0,1.573519647,1.272169195,1.236879224,0.216131924,0.362920925,20.6663355,1,-0.111736264,1.196555864,-0.093381569,0.925600432,0.956010343,47.67379037,1,1.566132979,0.676107582,2.31639612,0.02053665,0.077761251,46.61546214,1,2.070197613,0.624180175,3.316666718,0.000910982,0.004428082,N,-,,serine threonine partial,,no IPS match,,
RL4_JR_01134,12898,13648,17600,5,1,5,0,0,0,0,1,2,0,0,3,0,6,0,253.903729,1,-1.354918593,0.503593287,-2.690501696,0.007134467,0.02898555,56.05896601,0,-2.343376562,1.192391546,-1.965274385,0.049382489,0.116651003,166.736924,1,-2.596286316,0.85867347,-3.023601411,0.002497853,0.011833535,197.2467287,1,-3.082596048,0.855668976,-3.602556751,0.000315103,0.002823782,167.4786318,1,-1.93205426,0.668854038,-2.888603718,0.003869564,0.014535326,N,-,,dna-directed rna polymerases ii 24 kda polypeptide,"F:RNA polymerase III activity; F:DNA binding; C:DNA-directed RNA polymerase I complex; F:RNA polymerase II activity; F:RNA polymerase I activity; P:transcription, RNA-templated; P:transcription from RNA polymerase I promoter; C:cytosol; P:transcription from RNA polymerase II promoter; P:tRNA transcription from RNA polymerase III promoter; C:DNA-directed RNA polymerase III complex; C:DNA-directed RNA polymerase II, core complex",IPR000783 (G3DSA:3.90.940.GENE3D); IPR000783 (PFAM); IPR014381 (PIRSF); IPR005571 (PFAM); IPR005571 (G3DSA:3.40.1340.GENE3D); PTHR10535 (PANTHER); IPR000783 (PRODOM); IPR005571 (SUPERFAMILY); IPR000783 (SUPERFAMILY),,
RL4_JR_01135,13599,13832,16660,1,5,22,0,0,0,0,0,1,7,7,0,0,17,6,310.468384,1,-0.18424431,0.472410526,-0.3900089,0.696529966,0.836027421,56.14447456,0,-2.345567425,1.188519893,-1.973519702,0.048436382,0.114979611,152.3840701,1,-4.037916123,1.189591376,-3.394372392,0.000687861,0.004269714,261.5789104,1,-0.879396188,0.426795042,-2.060464864,0.039354121,0.106369589,253.8774109,1,-0.027064352,0.431259717,-0.062756503,0.949960403,0.967446095,N,-,,nuclear segregation,C:polysome; F:RNA binding; P:mRNA metabolic process; P:intracellular mRNA localization; P:regulation of mitotic nuclear division; C:nuclear outer membrane-endoplasmic reticulum membrane network; C:cytosol; C:endoplasmic reticulum; P:meiotic nuclear division,IPR006153 (PFAM); PTHR32468 (PANTHER); PTHR32468:SF4 (PANTHER),2.A.37.2.7, the monovalent cation:proton antiporter-2 (cpa2) family.
RL4_JR_01136,9642,8246,6156,0,1,28,0,0,2,0,3,3,4,0,1,0,8,3,211.4024852,1,0.385539392,1.007355384,0.382724308,0.701924189,0.839140905,49.87013727,1,0.133702407,1.02400264,0.13056842,0.896116726,0.942291035,123.132106,1,-0.739175364,0.653047002,-1.131886927,0.257681975,0.394126059,139.2555304,1,-1.417459668,0.716768534,-1.977569606,0.047977281,0.119764935,131.2928225,1,-0.164447742,0.527824744,-0.31155747,0.75537686,0.829611897,N,-,,pth11-like integral membrane,C:membrane,PTHR33048 (PANTHER); PTHR33048:SF19 (PANTHER),9.B.313.1.3, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_01137,19820,7948,11264,4,8,15,0,0,8,0,6,2,3,2,1,0,2,0,316.4061894,1,0.086659641,0.50861128,0.17038482,0.864707509,0.933229774,125.2976989,1,1.215444351,0.769442838,1.579642165,0.114188837,0.22498037,189.2338756,1,-1.018298993,0.677180235,-1.503734074,0.132649852,0.239086185,194.5113759,1,-1.873507636,0.726931397,-2.577282594,0.00995805,0.048403868,134.0579802,1,-3.253821295,1.05805148,-3.075295823,0.002102939,0.00883496,N,-,,zn 2cys6 transcription factor,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR012349 (G3DSA:2.30.110.GENE3D); IPR007219 (PFAM); IPR024624 (PFAM); PTHR31944 (PANTHER); PTHR31944:SF55 (PANTHER); IPR012349 (SUPERFAMILY),,
RL4_JR_01138,9271,3301,4922,0,1,2,0,0,0,0,0,0,0,2,0,0,0,0,84.93871042,1,-1.93249608,0.977132312,-1.97772201,0.047960076,0.128872957,22.55056732,0,-1.029565998,1.285588317,-0.800852018,0.423217321,0.586260534,57.88575281,0,-3.66615302,1.257576969,-2.915251401,0.003554021,0.015355889,74.74777801,1,-2.402927049,1.117464856,-2.150337914,0.031528495,0.094951224,56.56214327,0,-3.735565924,1.260292957,-2.964045703,0.003036232,0.011959517,N,-, Effector probability:0.566,zn 2cys6 transcription factor,F:organic cyclic compound binding; F:heterocyclic compound binding; F:metal ion binding; P:metabolic process,no IPS match,,
RL4_JR_01139,6359,3577,4652,10,16,6,0,0,2,0,0,0,0,3,1,0,3,0,309.7655019,1,2.041214511,0.602044343,3.390472041,0.000697724,0.004433045,37.47333076,1,0.864489806,1.030502659,0.838901092,0.401524815,0.565183449,48.28318314,0,-3.404470651,1.213010989,-2.806628038,0.005006301,0.018936713,77.34658555,1,-1.116755453,0.791061813,-1.411717054,0.15803329,0.276544601,58.96100454,1,-1.294363189,0.882050755,-1.467447516,0.142254357,0.248889815,N,-,,ring finger domain,F:zinc ion binding; F:metal ion binding,IPR001841 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001841 (PFAM); PTHR22763:SF39 (PANTHER); PTHR22763 (PANTHER); PTHR22763:SF39 (PANTHER); PTHR22763:SF39 (PANTHER); PTHR22763 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),8.A.112.1.6, the respiratory supercomplex factor (rcf) family.
RL4_JR_01140,1509,1517,1802,0,7,0,0,0,0,1,5,2,4,2,5,0,0,2,75.38207909,1,1.432743708,0.981396258,1.459903373,0.144316632,0.288845703,6.151624553,0,0.844530279,1.227349327,0.688092836,0.491394322,0.647220992,79.26066842,1,2.014495365,0.534576978,3.768391546,0.000164303,0.001566292,111.8829648,1,1.996723269,0.468339953,4.263405794,2.01E-05,0.000263034,30.50276865,1,-0.206669539,0.972111019,-0.2125987,0.831639985,0.886550118,N,-, Effector probability:0.773,Mitochondria fission 1,C:integral component of membrane; C:mitochondrial outer membrane; P:mitochondrial fission,IPR028061 (PFAM); IPR016543 (PIRSF); IPR028058 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR016543 (PANTHER); IPR011990 (SUPERFAMILY),,
RL4_JR_01141,298,540,543,0,0,1,0,0,0,3,0,0,4,0,3,0,1,0,9.376553447,1,0.367219158,1.199816937,0.306062656,0.759556941,0.873023023,1.755453205,0,2.653632597,1.369793188,1.937250542,0.052714725,0.122859416,37.78892648,1,2.437357614,0.890578861,2.736824014,0.006203547,0.022346633,71.43949353,1,3.291479641,0.689923752,4.770787539,1.84E-06,3.14E-05,8.393915947,1,0.832322103,1.172293027,0.709994928,0.477707282,0.607331269,N,-,,kinetochore spc24,C:Ndc80 complex; C:NMS complex; C:condensed nuclear chromosome kinetochore; C:cytosol; C:mitotic spindle pole body,IPR013252 (PFAM); PTHR22142:SF2 (PANTHER); PTHR22142 (PANTHER); SSF143026 (SUPERFAMILY),,
RL4_JR_01142,507,549,733,1,0,4,1,0,0,0,0,0,0,0,0,0,0,0,32.48926456,1,2.091275808,0.692330427,3.02063253,0.002522473,0.012601552,24.58031909,1,3.208127299,1.118107515,2.869247596,0.004114496,0.018371529,5.908757198,0,-0.374035138,1.206779767,-0.30994482,0.756602918,0.836319243,6.81809577,0,-0.796707525,1.206427644,-0.660385667,0.509006367,0.644211184,5.850098551,0,-0.462176651,1.21426764,-0.380621731,0.703483954,0.79010261,N,-,,cut9 interacting,C:intracellular part,IPR001130 (PFAM); G3DSA:3.20.20.140 (GENE3D); IPR001130 (PANTHER); IPR001130 (PANTHER); PTHR10060:SF24 (PANTHER); PTHR10060:SF24 (PANTHER); PTHR10060:SF24 (PANTHER); IPR032466 (SUPERFAMILY),,
RL4_JR_01143,9445,8395,12278,0,5,4,0,0,0,0,1,1,1,21,7,0,9,0,175.4129783,1,-1.104986415,0.545865363,-2.024283807,0.042940959,0.118951559,38.19578633,0,-1.789851898,1.198026015,-1.49400086,0.135175394,0.254699431,113.7230595,1,-2.624592193,1.038758873,-2.526661636,0.011515239,0.035948281,275.6671784,1,0.63698477,0.403470329,1.578764841,0.114390006,0.216526231,133.0757839,1,-0.849955423,0.615307944,-1.381349667,0.167171474,0.281117949,Y,-,,hypothetical protein CMQ_3250,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_01144,3813,3510,4785,0,4,0,0,0,0,1,5,4,4,7,2,0,0,0,80.36659209,1,-0.941317815,0.751555392,-1.252492929,0.210390303,0.377713206,15.38143139,0,-0.47763792,1.204481115,-0.396550775,0.691698758,0.804755728,116.2733667,1,1.008370326,0.494122413,2.040729786,0.041277693,0.098080566,130.743306,1,0.876336137,0.443974158,1.973844924,0.048399379,0.120463056,39.53553555,0,-3.218859795,1.198916406,-2.68480753,0.007257158,0.02430656,N,-,,hypothetical protein CMQ_3128,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_01145,10718,14556,26196,2,7,35,0,0,3,0,2,7,5,32,2,0,10,0,415.0086193,1,0.125184496,0.666950495,0.187696833,0.851114313,0.925661987,92.53407793,1,-0.397011146,0.922020388,-0.430588251,0.666767786,0.787333589,230.2097473,1,-1.278731571,0.649804949,-1.967869855,0.049083014,0.111532106,389.3370379,1,0.111084973,0.613346497,0.181112916,0.856278947,0.910313349,207.3394461,1,-1.6409092,0.821511784,-1.997426248,0.045778899,0.104819392,N,-,,isocitrate dehydrogenase subunit 2,F:magnesium ion binding; F:isocitrate dehydrogenase (NAD+) activity; F:NAD binding; P:tricarboxylic acid cycle; C:mitochondrial isocitrate dehydrogenase complex (NAD+),IPR024084 (SMART); IPR024084 (G3DSA:3.40.718.GENE3D); IPR004434 (TIGRFAM); IPR024084 (PFAM); IPR001804 (PANTHER); PTHR11835:SF34 (PANTHER); SSF53659 (SUPERFAMILY),,
RL4_JR_01146,5146,6005,4118,3,0,8,0,0,3,0,0,1,0,2,0,0,0,1,122.2567563,1,0.101220572,0.547278107,0.184952715,0.853266124,0.926866435,47.86219327,1,1.325095181,0.893662472,1.482769191,0.138135744,0.259230855,57.43045222,1,-2.519674124,1.205921517,-2.089418,0.036670112,0.089220913,66.76572523,1,-2.187855567,1.040140286,-2.103423544,0.035428762,0.099858856,57.25775132,1,-2.61815047,1.132553507,-2.311723422,0.02079293,0.056334312,N,-,,exocyst complex component sec5,C:incipient cellular bud site; C:cellular bud tip; C:cellular bud neck; P:Golgi to plasma membrane transport; P:exocyst assembly; P:endoplasmic reticulum inheritance; C:exocyst,PF15469 (PFAM); IPR029175 (PANTHER),1.F.2.1.1, the octameric exocyst (exocyst) family.
RL4_JR_01147,19368,25531,27428,0,4,10,0,0,0,0,0,0,2,2,0,0,5,0,360.4348868,1,-1.809775761,0.506248107,-3.574879069,0.00035039,0.002470427,92.0957619,0,-3.05955097,1.196014396,-2.558122192,0.010523911,0.034959968,239.6404806,0,-5.7157392,1.201125733,-4.758651859,1.95E-06,4.77E-05,303.1631412,1,-3.405021528,0.761029452,-4.474230949,7.67E-06,0.000113177,256.1209235,1,-2.910127239,0.733444851,-3.967751954,7.26E-05,0.000533871,N,-,,zn 2cys6 transcription factor,F:oxidoreductase activity; P:oxidation-reduction process,PTHR35392:SF2 (PANTHER); PTHR35392:SF2 (PANTHER); PTHR35392 (PANTHER); PTHR35392 (PANTHER); PTHR35392:SF2 (PANTHER); PTHR35392 (PANTHER),,
RL4_JR_01148,2755,4161,3690,3,4,1,0,0,0,0,0,0,3,1,1,0,3,0,108.7572858,1,0.320205259,0.62032861,0.516186507,0.605724153,0.772712141,13.562624,0,-0.296041227,1.224996952,-0.241666909,0.809038272,0.883777832,35.24437042,0,-2.950311889,1.205170461,-2.448045304,0.014363359,0.042920499,82.24956572,1,-0.282262309,0.698339017,-0.404190948,0.68607231,0.787047602,46.33976912,1,-0.843978744,0.875122775,-0.964411815,0.334839501,0.471802465,N,-,,short chain dehydrogenase reductase,F:oxidoreductase activity; C:cytosol; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); PTHR24322:SF340 (PANTHER); IPR002347 (PANTHER); PTHR24322:SF340 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_01149,477,448,671,0,2,0,0,0,0,0,0,0,0,0,3,0,0,3,22.3844146,1,0.979095648,1.023203234,0.956892644,0.338621445,0.528415732,2.020642084,0,2.450612764,1.315490909,1.862888407,0.062477968,0.140672755,5.263512472,0,-0.20727797,1.210440771,-0.171241728,0.864033698,0.91367006,34.97925337,1,1.716443622,0.862849008,1.989274608,0.046670901,0.117606488,27.31027661,1,1.951218538,0.865682957,2.253964366,0.02419841,0.06349142,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,PR01036 (PRINTS); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_01150,315,337,273,0,0,3,0,0,0,0,0,3,1,2,0,0,3,1,15.17265454,1,2.298435425,0.868124126,2.647588467,0.008106815,0.032120152,1.190957346,0,3.213488114,1.388162152,2.314922727,0.020617161,0.058917817,22.57465214,1,2.96715545,0.863635478,3.435657201,0.000591118,0.003821509,20.88615662,1,2.456231229,0.862376635,2.848211709,0.004396567,0.025364808,21.96785113,1,3.10841848,0.754685094,4.118828506,3.81E-05,0.000308451,N,-,,fungal specific transcription factor domain-containing,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR001138 (SMART); IPR001138 (PFAM); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31944 (PANTHER); PTHR31944:SF68 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_01151,1778,2603,2099,1,0,8,0,0,0,7,0,0,1,3,0,0,0,0,66.72777377,1,1.009271169,0.598705259,1.685756313,0.091842746,0.207988547,8.312856076,0,0.410198692,1.24107485,0.330518898,0.741007916,0.840102379,99.05546424,1,1.781124229,1.74653227,1.019806081,0.307820439,0.449045262,46.2275528,1,0.050504141,0.772557987,0.065372622,0.947877322,0.969713841,21.22744521,0,-2.321599886,1.208842939,-1.920514082,0.054792996,0.120035267,N,-,,NEDD8-activating enzyme E1 regulatory subunit,C:nucleus; F:NEDD8 activating enzyme activity; C:cytosol; P:protein neddylation,IPR000594 (PFAM); IPR030667 (PIRSF); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10953 (PANTHER); IPR000594 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_01152,22450,40973,44932,3,1,6,0,0,0,0,0,0,0,3,3,0,7,0,496.6848552,1,-2.83179318,0.628345991,-4.506741861,6.58E-06,8.04E-05,137.3372115,0,-3.636065027,1.226396605,-2.964836182,0.003028441,0.015659284,358.7315162,0,-6.297770469,1.232692328,-5.108955677,3.24E-07,9.96E-06,454.9817711,1,-3.393743892,0.706039032,-4.806736933,1.53E-06,2.68E-05,382.7668075,1,-3.133190523,0.799320702,-3.919816555,8.86E-05,0.000627003,N,-,,ribosome biogenesis BMS1,C:mitotic spindle; C:cytoplasm; P:ribosome biogenesis; C:nucleolus,IPR007034 (SMART); IPR012948 (SMART); IPR007034 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR012948 (PFAM); PTHR12858:SF2 (PANTHER); PTHR12858 (PANTHER); PTHR12858 (PANTHER); PTHR12858:SF2 (PANTHER); IPR030387 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_01153,3689,5167,5151,0,0,4,0,0,0,0,0,0,2,4,0,0,0,0,71.55418293,1,-1.230715687,0.788363071,-1.561102661,0.11849953,0.25018612,17.86351117,0,-0.693433025,1.2124236,-0.571939564,0.567362919,0.708900389,46.46195157,0,-3.348984801,1.200856946,-2.788829105,0.005289897,0.019725568,88.28162196,1,-0.469036965,0.643289117,-0.729123116,0.465926356,0.607690887,45.88145721,0,-3.433602211,1.205827654,-2.847506608,0.004406318,0.016158627,N,-,,fork head domain-containing,"C:M/G1 phase-specific MADS box-forkhead transcription factor complex; P:negative regulation of transcription from RNA polymerase II promoter; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; C:nuclear chromatin; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; P:transcription from RNA polymerase II promoter; P:positive regulation of transcription from RNA polymerase II promoter; P:positive regulation of induction of conjugation with cellular fusion; P:regulation of mitotic cell cycle",IPR001766 (PRINTS); IPR001766 (SMART); IPR000253 (SMART); IPR001766 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); IPR000253 (PFAM); IPR000253 (G3DSA:2.60.200.GENE3D); PTHR11829:SF128 (PANTHER); PTHR11829 (PANTHER); PTHR11829 (PANTHER); PTHR11829:SF128 (PANTHER); IPR000253 (PROSITE_PROFILES); IPR001766 (PROSITE_PROFILES); IPR008984 (SUPERFAMILY); IPR011991 (SUPERFAMILY),,
RL4_JR_01154,486,528,516,0,0,0,0,0,0,0,0,0,0,3,0,0,2,0,6.136743599,0,-0.719590687,1.196772176,-0.601276251,0.547656005,0.727769618,1.958933942,0,2.49547955,1.310314385,1.904489165,0.056846506,0.130654028,5.078090464,0,-0.155188222,1.198086686,-0.129530045,0.896938253,0.935951646,17.89281833,1,1.727816933,0.852904555,2.025803382,0.042784937,0.112548062,12.72052352,1,1.433625234,0.975119446,1.470204743,0.14150631,0.247987978,N,-,,duf1446 domain,,IPR010839 (PFAM); PTHR13943 (PANTHER); PTHR13943:SF46 (PANTHER); PTHR13943 (PANTHER); PTHR13943:SF46 (PANTHER),,
RL4_JR_01155,368,575,650,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,6.394826733,0,-0.779159362,1.24228805,-0.627197019,0.530530097,0.714327258,2.020742386,0,2.450571047,1.338790318,1.830436786,0.067184651,0.148672693,5.272309035,0,-0.209491763,1.226926529,-0.170745157,0.864424154,0.91375814,15.71994866,1,0.32051796,1.172039278,0.273470323,0.784491702,0.860934151,5.223901682,0,-0.298790507,1.235229207,-0.24189074,0.808864825,0.870911982,N,-,,nitrogen assimilation transcription factor nit-4,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (G3DSA:4.10.240.GENE3D),,
RL4_JR_01156,449,311,489,0,1,19,0,0,1,0,0,0,0,0,1,0,4,0,85.53101894,1,4.257819166,0.801488815,5.312387505,1.08E-07,2.13E-06,10.96577561,1,3.713593371,1.146965231,3.237755836,0.001204739,0.015023052,4.12006097,0,0.146069747,1.21628304,0.120095194,0.90440774,0.94122368,14.38809803,1,0.67492855,1.158032116,0.582823689,0.560011996,0.68857787,19.5109168,1,2.647955262,0.791387712,3.34596459,0.000819969,0.004075691,Y,-,,hypothetical protein SAPIO_CDS5889,F:nucleic acid binding; F:ATP binding; C:membrane; C:integral component of membrane; F:helicase activity; F:hydrolase activity,no IPS match,,
RL4_JR_01157,1391,1172,1056,0,0,4,0,0,0,0,5,3,0,0,3,0,0,0,29.76875541,1,0.745910057,0.757000292,0.985349762,0.324452297,0.513658421,4.660912372,0,1.244967248,1.264512079,0.984543579,0.324848316,0.48705594,70.73936642,1,2.416438826,0.557247535,4.336383162,1.45E-05,0.000258629,42.77747231,1,0.521127899,0.858377975,0.607107724,0.543779424,0.674065459,11.79136979,0,-1.473505521,1.197041582,-1.230956003,0.21833932,0.343914999,N,-, Effector probability:0.916,peptidylprolyl isomerase,F:isomerase activity,IPR004910 (PFAM); PTHR13848 (PANTHER),,
RL4_JR_01158,901,774,1041,4,0,50,0,0,0,1,11,6,4,13,3,0,12,2,242.0258339,1,4.46884902,1.030509071,4.336545058,1.45E-05,0.00015935,3.45565899,0,1.676520637,1.263233541,1.327166024,0.184453769,0.323952116,145.3096605,1,4.007542718,0.398247227,10.06295197,8.05E-24,1.57E-21,128.6592707,1,3.63480039,0.373760955,9.724933389,2.36E-22,2.54E-20,69.91939355,1,3.300524588,0.475840319,6.93620204,4.03E-12,3.71E-10,N,-,,ferric reductase like transmembrane component,F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process,IPR013112 (PFAM); IPR013130 (PFAM); G3DSA:3.40.50.80 (GENE3D); IPR013121 (PFAM); G3DSA:2.40.30.10 (GENE3D); PTHR11972:SF77 (PANTHER); PTHR11972 (PANTHER); PTHR11972 (PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY); IPR017938 (SUPERFAMILY),5.B.1.5.4, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_01159,295,350,320,0,0,1,0,0,0,0,0,1,0,2,0,0,2,0,7.694849702,1,0.890316345,1.154247987,0.771338877,0.440506095,0.630575315,1.236530521,0,3.159260765,1.371810015,2.302987098,0.021279569,0.060437746,9.704513861,1,1.470410616,1.197206045,1.228201796,0.219371225,0.348610668,11.72143729,1,1.809976414,1.022601716,1.76997201,0.076731804,0.161486076,10.87660575,1,2.095310736,0.982171222,2.133345683,0.032896379,0.080843651,N,-,,hypothetical protein CMQ_4168,,no IPS match,,
RL4_JR_01160,18378,21691,25915,10,2,9,0,0,1,0,1,0,3,12,0,0,11,3,415.2481441,1,-0.936207165,0.502401985,-1.863462314,0.06239725,0.157158618,93.24026347,1,-2.006888243,1.10896424,-1.809696084,0.07034293,0.154348827,226.1304495,1,-4.619305052,1.197710335,-3.85677982,0.000114891,0.001258823,327.9515951,1,-1.430649862,0.464119477,-3.082503392,0.002052674,0.013483584,280.4440064,1,-1.318716823,0.515138101,-2.559928726,0.010469363,0.03255599,N,-,,eukaryotic translation initiation factor 3 135 kda subunit,F:translation initiation factor activity; C:cytoplasm; P:intracellular distribution of mitochondria; P:translational initiation,IPR019734 (SMART); IPR011990 (PFAM); IPR028275 (PFAM); PF13424 (PFAM); IPR033646 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR025697 (PFAM); PTHR12601:SF6 (PANTHER); PTHR12601:SF6 (PANTHER); PTHR12601 (PANTHER); IPR027523 (HAMAP); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR023231 (SUPERFAMILY),,
RL4_JR_01161,1739,2574,3778,0,0,4,0,0,0,0,0,0,5,1,0,3,0,0,47.62764213,1,-0.471793706,0.856056001,-0.551124816,0.581548115,0.755334732,10.1818048,0,0.117537166,1.255394384,0.09362569,0.925406501,0.958747657,26.66054935,0,-2.547684894,1.227531145,-2.075454382,0.037944443,0.091660591,81.34682427,1,0.452831721,0.7309483,0.619512654,0.535578688,0.667577769,74.60660111,1,0.499375784,1.617018583,0.308825012,0.757454641,0.831082385,N,-,,folate-binding,C:mitochondrial matrix; C:mitochondrion; F:methyltransferase activity; F:transferase activity; P:iron-sulfur cluster assembly; P:methylation,IPR017703 (TIGRFAM); G3DSA:3.30.70.1400 (GENE3D); IPR006222 (PFAM); PTHR22602:SF0 (PANTHER); PTHR22602 (PANTHER); PS51257 (PROSITE_PROFILES); SSF103025 (SUPERFAMILY),,
RL4_JR_01162,7171,6926,7620,0,0,2,0,0,0,0,1,1,0,1,3,0,5,0,94.54781116,1,-2.812872692,1.004591072,-2.800017608,0.005109982,0.022152697,27.7530021,0,-1.329046061,1.192963213,-1.114071287,0.265248606,0.42227845,86.3044719,1,-2.157369979,1.025661708,-2.103393314,0.035431402,0.086980484,115.9324515,1,-1.665390432,0.731784111,-2.275794742,0.022858298,0.081464366,90.20322981,1,-1.128677198,0.670100747,-1.684339561,0.092116064,0.17932612,N,-,,poly(A) polymerase,"F:magnesium ion binding; F:ATP binding; F:RNA binding; C:mRNA cleavage and polyadenylation specificity factor complex; P:nuclear-transcribed mRNA catabolic process, meiosis-specific transcripts; C:cytosol; F:polynucleotide adenylyltransferase activity; C:Mmi1 nuclear focus complex; P:snoRNA polyadenylation; P:mRNA polyadenylation",IPR007012 (PFAM); IPR002934 (PFAM); IPR014492 (PIRSF); IPR007010 (G3DSA:3.30.70.GENE3D); G3DSA:3.30.460.10 (GENE3D); IPR007010 (PFAM); G3DSA:1.10.1410.10 (GENE3D); IPR014492 (PANTHER); PTHR10682:SF10 (PANTHER); SSF81301 (SUPERFAMILY); SSF81631 (SUPERFAMILY); IPR011068 (SUPERFAMILY),,
RL4_JR_01163,2887,2312,2398,0,0,5,0,0,0,3,0,0,4,0,4,0,1,0,49.46614183,1,0.002787807,0.673647114,0.004138379,0.996698061,0.999147552,9.753020838,0,0.179702432,1.226280519,0.146542679,0.883493001,0.934062686,58.4129637,1,-0.045432188,0.852976205,-0.053263137,0.957522251,0.975121084,104.8572765,1,0.92784745,0.565076073,1.641986794,0.100592741,0.19661309,28.60980924,1,-1.61280871,1.121056116,-1.438651185,0.150249376,0.259116834,N,-,,heat shock,F:GTP binding; F:nucleotide binding; C:membrane; C:integral component of membrane; F:hydrolase activity,IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR030379 (PFAM); IPR016491 (PANTHER); PTHR18884:SF72 (PANTHER); IPR030379 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_01164,29211,25208,29338,2,2,1,0,0,0,0,0,2,2,5,0,0,4,6,374.6681339,1,-3.427036732,0.661363194,-5.181777218,2.20E-07,4.00E-06,107.0380232,0,-3.276460008,1.190659932,-2.751801686,0.00592684,0.023100298,290.3649028,1,-4.106437457,1.031397549,-3.981430304,6.85E-05,0.000906552,358.6298998,1,-2.819319533,0.569556626,-4.950024995,7.42E-07,1.41E-05,332.8112338,1,-2.049265168,0.509399443,-4.022904214,5.75E-05,0.000435329,N,-,,pre-mrna-splicing factor 38b,F:zinc ion binding,IPR013083 (G3DSA:3.30.40.GENE3D),,
RL4_JR_01165,17447,21884,28788,4,16,46,0,0,4,0,1,2,6,31,0,0,14,2,616.6125573,1,0.404919536,0.493754405,0.820082883,0.412168859,0.603350719,123.7448587,1,-0.388715328,0.778959792,-0.499018476,0.617766368,0.748776336,245.8051066,1,-3.224729853,0.877508026,-3.674872202,0.000237969,0.001965084,439.848071,1,-0.410656009,0.678991195,-0.604803144,0.545309804,0.675466329,291.8119629,1,-1.284601405,0.609422815,-2.107898448,0.035039775,0.084854752,N,-,,40S ribosomal s12,F:structural constituent of ribosome; C:cytosolic small ribosomal subunit; P:cytoplasmic translation,IPR000530 (PRINTS); IPR029064 (G3DSA:3.30.1330.GENE3D); IPR004038 (PFAM); PTHR11843:SF0 (PANTHER); IPR000530 (PANTHER); IPR029064 (SUPERFAMILY),,
RL4_JR_01166,27823,33843,49197,3,7,30,0,0,0,1,8,1,3,22,3,0,21,1,643.7276549,1,-1.024905475,0.511082316,-2.005362821,0.044924273,0.122777964,139.9369937,0,-3.663124662,1.209199427,-3.029380085,0.002450562,0.015349618,445.8512772,1,-2.173155634,0.588551803,-3.692377837,0.000222167,0.001880618,566.9654481,1,-1.366383216,0.490634993,-2.784928173,0.005353958,0.029557702,451.406113,1,-1.752144877,0.831680961,-2.106751217,0.03513915,0.084993764,N,-, Effector probability:0.681,40s ribosomal s22,F:structural constituent of ribosome; C:ribosome; P:translation,IPR000630 (PFAM); G3DSA:3.30.1490.10 (GENE3D); G3DSA:3.30.1370.30 (GENE3D); IPR000630 (PANTHER); PTHR11758:SF16 (PANTHER); IPR000630 (SUPERFAMILY),,
RL4_JR_01167,314,302,383,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.991652277,0,-0.099420493,1.211865937,-0.082039185,0.934615554,0.967710837,1.271123194,0,3.119369343,1.360489283,2.292829046,0.021857849,0.061834865,3.303158178,0,0.464928541,1.205460719,0.385685351,0.699729713,0.795693992,3.81092044,0,0.042480785,1.206276517,0.035216457,0.97190714,0.984449759,3.262661567,0,0.38022125,1.2069312,0.315031421,0.752737797,0.827700934,N,-,,Phospholipase carboxylesterase,F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR003140 (PFAM); PTHR10655 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_01168,2064,1847,2182,0,0,5,0,0,1,0,1,0,0,3,0,0,0,0,43.44392004,1,0.332158216,0.658694884,0.504267187,0.614073632,0.778736623,17.15719084,1,1.42293588,1.117156349,1.273712387,0.202765365,0.346980731,28.01438035,1,-1.183510216,1.187266437,-0.996836244,0.318844002,0.461535127,35.30390534,1,-0.259460803,0.847101046,-0.306292625,0.759381854,0.842786504,19.88083357,0,-2.22710006,1.190899651,-1.870098843,0.061470093,0.131154069,N,-,,capsule-associated CAP1,C:integral component of membrane; F:transferase activity,IPR006598 (SMART); IPR006598 (PFAM); PTHR12203:SF26 (PANTHER); PTHR12203:SF26 (PANTHER); PTHR12203 (PANTHER); PTHR12203 (PANTHER),,
RL4_JR_01169,3043,3138,4062,0,0,4,0,0,0,2,0,0,0,0,0,0,3,2,56.21180933,1,-0.753570979,0.759168261,-0.992627087,0.32089172,0.509383973,13.01062482,0,-0.236141511,1.207538957,-0.195556019,0.844957688,0.907347943,55.9916429,1,-1.060777147,1.033010346,-1.026879499,0.304477209,0.445838482,39.05856199,0,-3.314792094,1.193210354,-2.77804503,0.005468704,0.030043748,59.78970355,1,-0.036829321,0.688985196,-0.053454445,0.957369827,0.971796603,N,-,,RNA polymerase ii- paf1,"P:regulation of histone H2B conserved C-terminal lysine ubiquitination; P:transcription elongation from RNA polymerase I promoter; P:rRNA processing; F:RNA polymerase II core binding; P:transcription elongation from RNA polymerase II promoter; P:negative regulation of transcription from RNA polymerase II promoter; P:positive regulation of transcription elongation from RNA polymerase II promoter; F:RNA polymerase II C-terminal domain phosphoserine binding; P:regulation of chromatin silencing at telomere; P:chromatin silencing at rDNA; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:positive regulation of transcription elongation from RNA polymerase I promoter; P:histone modification; C:Cdc73/Paf1 complex; C:cytosol; P:chromatin organization involved in regulation of transcription; P:regulation of histone H3-K4 methylation; P:positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues; F:chromatin binding; P:DNA-templated transcription, termination; P:regulation of transcription-coupled nucleotide-excision repair; F:transcription factor activity, RNA polymerase II core promoter sequence-specific; P:snoRNA transcription from an RNA polymerase II promoter; P:negative regulation of DNA recombination; F:transcription factor activity, TFIIF-class transcription factor binding; C:transcriptionally active chromatin; P:mRNA 3'-end processing; P:global genome nucleotide-excision repair; P:positive regulation of histone H3-K36 trimethylation; P:snoRNA 3'-end processing",IPR007133 (PFAM); IPR007133 (PANTHER),,
RL4_JR_01170,4624,4428,6263,0,1,6,2,0,0,0,1,0,0,1,1,0,5,1,92.03816895,1,-0.538903582,0.607922729,-0.886467238,0.375365801,0.567080408,64.04375802,1,0.852796882,0.978853649,0.871220005,0.383634039,0.548090739,58.39460472,1,-2.508941764,1.196044003,-2.097700218,0.035931636,0.087867604,71.97479549,1,-2.158608701,1.02278419,-2.110522163,0.034813404,0.099487925,76.69975466,1,-0.378891546,0.652388203,-0.580776208,0.561391292,0.679427066,N,-,,RER1,C:integral component of membrane,IPR004932 (PIRSF); IPR004932 (PFAM); IPR004932 (PANTHER),9.B.82.1.2, the endoplasmic reticulum retrieval protein1 (putative heavy metal transporter) (rer1) family.
RL4_JR_01171,812,1538,1290,0,1,0,0,0,1,0,2,0,1,0,4,0,1,6,22.70118728,1,-1.023938061,1.189586897,-0.860750958,0.389375221,0.582100614,14.02981134,1,2.161288948,1.165051834,1.855101108,0.06358179,0.142446851,27.79147947,1,0.416585597,1.068957741,0.389711942,0.696749565,0.793285267,61.82288745,1,1.348645982,0.751768117,1.793965388,0.072818693,0.155447875,60.00471214,1,2.019123316,0.686495344,2.941204678,0.003269384,0.012682956,N,-,,enoyl- hydratase,P:metabolic process; F:isomerase activity,IPR001753 (PFAM); IPR029045 (G3DSA:3.90.226.GENE3D); PTHR11941:SF54 (PANTHER); PTHR11941 (PANTHER); IPR029045 (SUPERFAMILY),,
RL4_JR_01172,5020,4693,7277,0,3,1,0,0,2,0,0,0,5,4,0,0,1,0,95.56919945,1,-1.434596541,0.773996602,-1.85349204,0.063811866,0.159441716,40.24471505,1,0.677786151,0.997382438,0.679564955,0.496779966,0.651854656,56.00141752,0,-3.618439073,1.202026957,-3.010281135,0.00261006,0.012233447,127.2277325,1,-0.124851822,0.550287198,-0.226884838,0.820513292,0.887195331,59.36707021,1,-2.779610324,1.141623823,-2.434786546,0.014900577,0.043352971,N,-,,ring finger domain-containing,F:zinc ion binding; F:metal ion binding; P:cysteine biosynthetic process from serine,IPR001452 (SMART); G3DSA:2.30.30.40 (GENE3D); PTHR16079:SF4 (PANTHER); PTHR16079:SF4 (PANTHER); PTHR16079:SF4 (PANTHER); PTHR16079 (PANTHER); PTHR16079 (PANTHER); PTHR16079 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY); SSF57850 (SUPERFAMILY),,
RL4_JR_01173,5777,4379,6114,0,0,9,0,0,0,0,2,2,0,2,2,0,1,0,99.20167503,1,-0.314632885,0.58245754,-0.540181668,0.589071754,0.760504468,20.72023782,0,-0.907465529,1.205826425,-0.752567293,0.451709978,0.611669528,82.43365105,1,-0.740356422,0.749980861,-0.987167088,0.323560734,0.466428715,89.29763727,1,-1.248014941,0.751288702,-1.661165592,0.096680194,0.191076901,56.88727158,1,-2.712688357,1.128504242,-2.403791014,0.016226046,0.04626548,N,-,,cysteine synthase,F:pyridoxal phosphate binding; C:cytoplasm; F:lyase activity; P:cysteine biosynthetic process from serine,G3DSA:3.40.50.1100 (GENE3D); G3DSA:3.40.50.1100 (GENE3D); IPR001926 (PFAM); PTHR10314:SF83 (PANTHER); PTHR10314 (PANTHER); IPR001926 (SUPERFAMILY),,
RL4_JR_01174,2746,3775,5861,0,0,2,0,0,0,0,0,0,0,2,2,0,4,0,57.09280707,1,-2.031627893,1.083496822,-1.875065853,0.060783665,0.154031293,15.56755389,0,-0.495004054,1.240512834,-0.399031788,0.689869782,0.803458973,40.76717454,0,-3.160378068,1.225143977,-2.579597278,0.009891559,0.032408462,74.35040172,1,-0.845535993,0.808867181,-1.045333539,0.295868842,0.440734445,56.02644252,1,-0.704169433,0.850211642,-0.828228406,0.40754116,0.543656685,N,-,,hypothetical protein CMQ_4282,,no IPS match,,
RL4_JR_01175,1900,1673,3214,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,47.10853892,1,-1.080394886,1.054869989,-1.024197196,0.305742143,0.492474619,8.531087492,0,0.372709478,1.251781531,0.297743231,0.765899145,0.858329401,30.14044776,1,-1.328109523,1.218322746,-1.090113048,0.275663349,0.414621267,25.73286199,0,-2.712792492,1.222741393,-2.218615078,0.026512923,0.086483036,22.17651854,0,-2.384741157,1.234341135,-1.931995208,0.053360097,0.117578016,N,-,,ribosomal l19,F:structural constituent of ribosome; C:mitochondrion; C:ribosome; P:translation,IPR001857 (PFAM); PTHR15680:SF9 (PANTHER); IPR001857 (PANTHER); IPR008991 (SUPERFAMILY),,
RL4_JR_01176,4249,2941,2705,3,3,0,0,0,0,1,0,0,0,7,2,0,0,5,93.77510127,1,0.03116614,0.688241068,0.045283755,0.963881136,0.981715225,12.77325195,0,-0.209500021,1.243571887,-0.168466354,0.866216411,0.922091327,43.95464813,1,-1.888542223,1.209451554,-1.561486457,0.118409017,0.219756716,85.26893708,1,0.580299057,0.578110967,1.003784895,0.315482306,0.461731476,68.99816584,1,0.081686264,0.709727048,0.115095323,0.908369567,0.941183163,N,-,,potassium transporter 1,P:cation transport; P:transmembrane transport; C:integral component of membrane; F:cation transmembrane transporter activity; P:single-organism cellular process,IPR004773 (TIGRFAM); IPR003445 (PFAM); PTHR31064 (PANTHER); PTHR31064 (PANTHER); PTHR31064:SF10 (PANTHER); PTHR31064:SF10 (PANTHER),2.A.38.2.2, the k(+) transporter (trk) family.
RL4_JR_01177,1159,1280,1392,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,15.34946997,0,-2.042375092,1.190460675,-1.715617438,0.086232085,0.198667424,4.888008317,0,1.176264364,1.239502703,0.948980879,0.342630337,0.505775744,12.69410666,0,-1.477111529,1.191977179,-1.23921125,0.215267275,0.343911298,23.95761621,1,-0.950232257,1.141285562,-0.832598158,0.405071398,0.548700302,12.52344253,0,-1.560288744,1.196189215,-1.304382889,0.192103066,0.312306286,N,-,,Zinc C6HC- partial,F:zinc ion binding; F:protein-arginine deiminase activity; F:metal ion binding; P:putrescine biosynthetic process,IPR000571 (SMART); IPR002867 (SMART); IPR001841 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR000571 (G3DSA:4.10.1000.GENE3D); IPR000571 (PFAM); IPR002867 (PFAM); PTHR22770:SF34 (PANTHER); PTHR22770 (PANTHER); IPR001841 (PROSITE_PROFILES); IPR000571 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); SSF57850 (SUPERFAMILY); IPR000571 (SUPERFAMILY),,
RL4_JR_01178,1665,1831,2303,0,0,0,0,0,0,0,0,0,1,4,2,0,0,1,23.19437007,0,-2.638044254,1.197024033,-2.203835664,0.027535903,0.084577523,7.365556934,0,0.584677753,1.225692557,0.477018278,0.633349106,0.760109041,19.17097001,0,-2.071925587,1.196194928,-1.732096951,0.083256302,0.167872297,66.7496482,1,1.041523465,0.583739499,1.784226467,0.074386873,0.157632292,26.32825863,1,-1.222537034,1.132352508,-1.079643508,0.280300959,0.413769822,N,-, Effector probability:0.729,zinc finger,F:zinc ion binding,IPR008913 (PFAM); PTHR28082:SF2 (PANTHER); PTHR28082 (PANTHER); IPR008913 (PROSITE_PROFILES); SSF161219 (SUPERFAMILY),,
RL4_JR_01179,3306,3774,3856,0,4,16,0,0,0,1,6,0,0,13,0,0,0,2,136.9966918,1,1.382134391,0.462317796,2.989576444,0.002793645,0.013581978,13.97367183,0,-0.339114573,1.205255204,-0.281363293,0.778431769,0.866015357,94.39778558,1,0.64350304,0.573634454,1.121799843,0.261947553,0.399030549,93.994882,1,0.481940266,1.413974947,0.340840739,0.733223479,0.82192739,50.4867059,1,-1.388406937,0.970389785,-1.430772417,0.152495451,0.262141822,N,-, Effector probability:0.573,proteasome component pre6,"P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:mitochondrion; C:nuclear outer membrane-endoplasmic reticulum membrane network; C:proteasome core complex, alpha-subunit complex; F:threonine-type endopeptidase activity; C:nuclear periphery; C:proteasome storage granule; P:proteasomal ubiquitin-independent protein catabolic process",IPR000426 (SMART); IPR000426 (PFAM); IPR029055 (G3DSA:3.60.20.GENE3D); IPR001353 (PFAM); PTHR11599:SF15 (PANTHER); PTHR11599 (PANTHER); IPR023332 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY),,
RL4_JR_01180,6330,5449,8772,0,10,18,0,0,0,0,1,6,1,3,11,0,3,9,230.6750507,1,0.973102754,0.533514763,1.823947191,0.068160056,0.167585817,25.99531069,0,-1.234701284,1.207149775,-1.022823604,0.306391255,0.467907708,114.5514608,1,-0.285019918,0.607196538,-0.469403068,0.638781556,0.748359076,205.4694858,1,0.560963441,0.67028141,0.836907354,0.402644646,0.546372283,144.9677257,1,0.295223089,0.584096375,0.505435579,0.613252935,0.720573978,N,-,,d-lactate dehydrogenase 2,F:D-lactate dehydrogenase (cytochrome) activity; F:flavin adenine dinucleotide binding; P:oxidation-reduction process,IPR006094 (PFAM); IPR016169 (G3DSA:3.30.465.GENE3D); IPR004113 (PFAM); IPR016171 (G3DSA:1.10.45.GENE3D); IPR016167 (G3DSA:3.30.43.GENE3D); PTHR11748:SF90 (PANTHER); PTHR11748 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016164 (SUPERFAMILY); IPR016166 (SUPERFAMILY),,
RL4_JR_01181,300,150,230,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2.699532864,0,0.464709678,1.29698574,0.358299759,0.720118998,0.850793742,77.54182507,1,5.370465149,1.019629846,5.267073313,1.39E-07,1.61E-05,2.246526021,0,1.02111933,1.251280534,0.81605947,0.414466123,0.556166931,2.590588384,0,0.599381038,1.267172365,0.473006715,0.636208388,0.750945434,2.207252369,0,0.94366537,1.244099513,0.758512772,0.44814407,0.580163497,N,-,,C6 zinc finger domain,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_01182,115,93,106,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.254373374,0,1.570630443,1.368645771,1.147579949,0.251142011,NA,0.401942982,0,4.780487959,1.60409415,2.980179162,0.002880798,0.015349618,1.040285829,0,2.13194015,1.232490027,1.729782882,0.083669074,0.168436211,1.199887299,0,1.709859106,1.263387692,1.353392246,0.175930353,0.299729905,1.023357216,0,2.05261707,1.212870215,1.692363325,0.090576721,0.177283838,N,-,,---NA---,,IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (SUPERFAMILY),,
RL4_JR_01183,1313,1016,1004,0,0,3,0,0,0,0,0,2,0,2,4,0,0,3,24.78304078,1,0.458044258,0.862771832,0.530898485,0.595489128,0.765762974,4.286995123,0,1.365604691,1.269350949,1.075829102,0.282003694,0.441112872,24.06253132,1,0.538777489,1.042294105,0.51691503,0.605215475,0.722130453,59.32490669,1,1.635287057,0.631170854,2.590878597,0.009573126,0.046938449,32.94885174,1,0.879750373,0.844003841,1.042353517,0.297247809,0.432480825,N,-,,alpha- sarcomeric (f-actin cross linking ),F:actin binding; F:calcium ion binding,IPR001715 (SMART); SM01184 (SMART); IPR001715 (PFAM); IPR014837 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); G3DSA:1.20.58.60 (GENE3D); G3DSA:1.20.58.60 (GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); PTHR11915 (PANTHER); IPR002048 (PROSITE_PROFILES); IPR001715 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR001715 (PROSITE_PROFILES); SSF46966 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR001715 (SUPERFAMILY); SSF46966 (SUPERFAMILY),8.A.66.1.3, the dystrophin (dystrophin) family.
RL4_JR_01184,1720,1217,1183,0,1,2,0,0,0,0,4,2,0,3,8,0,0,1,32.11021419,1,0.161536796,0.871931308,0.185263213,0.85302259,0.926866435,5.308848465,0,1.05717129,1.270428101,0.832137836,0.405331148,0.569419986,58.05162254,1,1.816359249,0.644304822,2.819099266,0.004815862,0.018440162,104.8942915,1,2.302116526,0.603443695,3.814964918,0.000136202,0.001387372,20.76628471,1,-0.721562732,1.133657271,-0.636491072,0.524456398,0.648366426,N,-,,vps9 domain,,IPR003123 (SMART); IPR003123 (PFAM); PTHR23101:SF65 (PANTHER); PTHR23101:SF65 (PANTHER); PTHR23101 (PANTHER); IPR003123 (PROSITE_PROFILES); SSF109993 (SUPERFAMILY),1.F.1.1.5, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_01185,119,133,174,0,0,1,0,0,0,0,0,0,2,3,2,0,0,0,5.521812597,1,2.07502233,1.172709305,1.769425996,0.076822811,0.18250451,0.540263187,0,4.353682571,1.528480036,2.848373855,0.004394327,0.018959667,1.407366936,0,1.695658509,1.232415964,1.375881649,0.168858277,0.286256062,51.55383834,1,4.821313896,0.589695222,8.175941934,2.94E-16,2.09E-14,1.393365304,0,1.607885956,1.226990865,1.310430258,0.190050323,0.310014423,N,-,,rhamnogalacturonate lyase C,F:hydrolase activity,IPR004843 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); PTHR12905 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_01186,1596,1402,2552,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,22.0739841,0,-2.566674176,1.22097817,-2.102145836,0.035540503,0.103071248,6.989184413,0,0.660310939,1.252818212,0.527060457,0.598151606,0.733358853,18.24979978,0,-2.000918636,1.215775436,-1.645796236,0.099805718,0.193606646,21.06041573,0,-2.423732346,1.217311068,-1.991054226,0.046474926,0.117229354,33.57311892,1,0.473140032,0.823840301,0.574310375,0.56575779,0.682834381,N,-,,hypothetical protein SPI_03610,,IPR003615 (PFAM),,
RL4_JR_01187,7735,3747,4509,6,3,8,0,1,1,0,4,4,0,2,4,0,1,2,178.5493714,1,0.76906342,0.524983258,1.464929422,0.142940175,0.286653379,68.32917295,1,0.763136535,1.037101811,0.735835699,0.461830693,0.620391543,110.3664354,1,0.258357956,0.627164102,0.411946339,0.680378755,0.780173804,107.6656549,1,-0.589344174,0.71253301,-0.827111398,0.408173925,0.551917867,70.42296953,1,-1.377712759,0.896087339,-1.53747598,0.124176793,0.224676559,N,-,,lipase atg15,P:autophagy; P:lipid metabolic process; C:endoplasmic reticulum; F:hydrolase activity,IPR002921 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR21493 (PANTHER); PTHR21493:SF140 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_01188,7011,6432,5203,26,48,19,3,0,5,6,18,9,2,13,35,0,16,21,793.5533642,1,3.240038686,0.601723728,5.384595178,7.26E-08,1.48E-06,137.8844707,1,2.476606081,0.589479569,4.201343376,2.65E-05,0.001500407,328.1406597,1,2.105397633,0.373612486,5.635244297,1.75E-08,7.11E-07,479.5789951,1,2.484372824,0.823165122,3.018073479,0.002543872,0.016192865,277.2348304,1,1.955788411,0.563678059,3.469690507,0.000521058,0.002800274,N,-,,alcohol dehydrogenase (NADP+),P:carbohydrate metabolic process; F:oxidoreductase activity; P:oxidation-reduction process,IPR020471 (PRINTS); IPR020471 (PIRSF); IPR023210 (PFAM); IPR023210 (G3DSA:3.20.20.GENE3D); PTHR11732:SF178 (PANTHER); IPR001395 (PANTHER); IPR001395 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.4, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_01189,8245,5471,6097,1,2,15,0,0,0,0,0,9,0,1,3,0,10,4,162.397799,1,0.3546425,0.517927711,0.684733588,0.49351205,0.681184578,25.45979298,0,-1.204615105,1.219646251,-0.987675815,0.323311443,0.485554624,124.1751695,1,-0.085315733,1.409469508,-0.060530386,0.951733216,0.972469277,108.6651371,1,-1.513453122,0.76683997,-1.973623156,0.048424609,0.120472854,132.4960204,1,0.461030337,0.47976703,0.960946267,0.336579186,0.473643399,N,-,,YL1 nuclear,"F:DNA binding; C:nucleus; P:chromatin remodeling; P:histone exchange; P:regulation of transcription, DNA-templated",IPR013272 (SMART); IPR013272 (PFAM); PF05764 (PFAM); IPR008895 (PANTHER),,
RL4_JR_01190,6738,8071,5007,3,3,8,0,0,5,1,0,5,1,14,5,0,3,2,164.7052988,1,0.103694116,0.504881807,0.205382953,0.837272938,0.918937779,72.55173164,1,1.645767391,0.748760219,2.197989889,0.027949826,0.074883045,109.7499567,1,-0.469204245,0.666591837,-0.703885374,0.481504161,0.617838799,189.9840329,1,0.704480729,0.469699746,1.499853334,0.133652398,0.243881298,91.06859745,1,-0.992887808,0.712259479,-1.393997325,0.163318412,0.27619825,N,-,,cell division control 25,C:endoplasmic reticulum membrane; P:cell division; C:nucleus; F:Ras guanyl-nucleotide exchange factor activity; C:cytosol; P:traversing start control point of mitotic cell cycle; P:Ras protein signal transduction; P:replicative cell aging; C:plasma membrane; P:positive regulation of GTPase activity,IPR001452 (PRINTS); IPR001452 (SMART); IPR001895 (SMART); IPR000651 (SMART); G3DSA:2.20.70.10 (GENE3D); IPR001895 (PFAM); IPR001895 (G3DSA:1.10.840.GENE3D); G3DSA:2.30.30.40 (GENE3D); IPR000651 (PFAM); IPR001452 (PFAM); PTHR23113 (PANTHER); PTHR23113:SF228 (PANTHER); PTHR23113 (PANTHER); PTHR23113:SF228 (PANTHER); IPR000651 (PROSITE_PROFILES); IPR001895 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR023578 (SUPERFAMILY); IPR001452 (SUPERFAMILY); IPR001202 (SUPERFAMILY),8.A.34.1.1, the endophilin (endophilin) family.
RL4_JR_01191,4246,3481,3840,0,0,4,0,0,0,0,0,3,0,0,2,0,1,1,61.50212956,1,-0.916219158,0.738980924,-1.239841421,0.215034054,0.383358351,14.81775384,0,-0.423716326,1.2099829,-0.35018373,0.726200816,0.828890918,57.83482684,1,-0.66891443,0.852392543,-0.784749275,0.432600586,0.573191504,63.49049617,1,-1.751461818,1.012562689,-1.729731736,0.083678216,0.171402374,48.92552081,1,-1.473345555,0.967570247,-1.522727223,0.127826964,0.229313964,N,-,,C2H2 finger domain,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated",IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007219 (PFAM); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_01192,4636,5757,5989,0,0,2,0,0,0,0,0,0,1,0,0,0,10,9,73.36646608,1,-2.418581124,1.025356175,-2.358771697,0.018335532,0.061103461,20.89707436,0,-0.919717042,1.202077658,-0.765106178,0.444208322,0.605559142,54.31079022,0,-3.574177462,1.194135934,-2.993107702,0.002761523,0.012771885,71.97539586,1,-3.046634111,1.14753293,-2.654942644,0.007932189,0.040338231,158.5012592,1,1.201305322,0.425418579,2.823819603,0.004745509,0.017141732,Y,-,,glycoside family 16,"P:carbohydrate metabolic process; C:integral component of membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR013320 (G3DSA:2.60.120.GENE3D); IPR000757 (PFAM); PTHR38121:SF2 (PANTHER); PTHR38121 (PANTHER); IPR000757 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),,
RL4_JR_01193,4513,4318,3584,0,2,1,0,0,0,0,2,4,0,0,0,0,0,2,69.66139653,1,-1.421735199,0.859997581,-1.653185114,0.098293195,0.218792875,15.99712685,0,-0.534182196,1.218645169,-0.438341045,0.661139077,0.782695875,82.98650309,1,0.218387562,0.628689724,0.347369384,0.728313831,0.816550301,47.63824048,0,-3.60119249,1.196602915,-3.009513386,0.002616665,0.016589692,55.22850884,1,-1.567833959,0.970849862,-1.614908772,0.106330452,0.200036386,N,-,,glucanase b,C:membrane; C:integral component of membrane; F:hydrolase activity,IPR032477 (PFAM); PTHR38165:SF1 (PANTHER); PTHR38165 (PANTHER),,
RL4_JR_01194,1370,1478,2241,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,24.12497559,1,-1.500250273,1.167064708,-1.285490224,0.198621031,0.361523956,6.426169482,0,0.781480036,1.245984235,0.627198975,0.530528815,0.678889085,16.77308658,0,-1.87917852,1.209234624,-1.554023084,0.12017891,0.222064481,27.37973203,1,-0.586693024,1.040984394,-0.563594447,0.573030167,0.699870982,16.64618075,0,-1.970882299,1.221047947,-1.614090834,0.106507725,0.200183909,N,-,,pre-mRNA-splicing factor cwc21,P:RNA splicing; C:spliceosomal complex; P:mRNA processing,IPR013170 (SMART); IPR013170 (PFAM),,
RL4_JR_01195,2364,2563,3388,4,0,3,0,0,1,0,0,0,0,0,1,0,0,1,84.95198979,1,0.400913452,0.604296564,0.663438244,0.507049919,0.693666747,19.92508225,1,0.98340695,1.120641759,0.87753909,0.380193896,0.544548269,27.46738785,0,-2.590713344,1.197414137,-2.163590077,0.030495824,0.077748607,41.3295688,1,-2.062987743,1.150171265,-1.793635265,0.072871404,0.155494829,34.55546414,1,-1.742016837,1.134599844,-1.535357903,0.124695938,0.225414457,N,-,,cell division cycle 123,F:magnesium ion binding; P:regulation of translation; C:nucleus; F:ATP binding; P:formation of cytoplasmic translation initiation complex; P:mycelium development; C:cytosol; P:cell cycle; P:regulation of mitotic cell cycle,IPR009772 (PFAM); PTHR15323 (PANTHER); IPR009772 (PTHR15323:PANTHER); IPR009772 (PTHR15323:PANTHER); IPR009772 (PTHR15323:PANTHER); PTHR15323 (PANTHER); PTHR15323 (PANTHER),,
RL4_JR_01196,2998,2374,2668,0,0,6,0,0,0,0,0,0,0,2,0,0,0,0,55.02847511,1,0.184421254,0.616063156,0.299354461,0.764669605,0.877161421,10.29951743,0,0.101034752,1.220927242,0.082752476,0.934048358,0.963755095,26.64307929,0,-2.546708973,1.192054169,-2.136403729,0.03264652,0.082087645,38.75284724,1,-1.242856344,1.016606059,-1.222554531,0.221497996,0.356942099,26.19608777,0,-2.625104611,1.19120344,-2.20374163,0.02754252,0.070456799,N,-,,hypothetical protein CMQ_4556,C:integral component of membrane,IPR022190 (PFAM),,
RL4_JR_01197,12522,14282,13137,4,6,17,0,0,1,0,0,3,8,10,5,0,29,3,313.611573,1,0.031098395,0.346436878,0.08976641,0.928472841,0.965640163,60.57530351,1,-1.295018779,1.110497917,-1.166160476,0.243549569,0.396208412,152.1745948,1,-2.460561017,0.854307263,-2.880182719,0.003974448,0.016348297,315.8466394,1,-0.009710986,0.351299102,-0.027643071,0.977946829,0.986585031,264.6091309,1,0.302326832,0.682161858,0.443189294,0.657628822,0.756167111,N,-,,guanine nucleotide-binding subunit alpha,P:nuclear migration involved in conjugation with cellular fusion; P:adaptation of signaling pathway by response to pheromone involved in conjugation with cellular fusion; P:inositol lipid-mediated signaling; P:karyogamy involved in conjugation with cellular fusion; F:signal transducer activity; P:pheromone-dependent signal transduction involved in conjugation with cellular fusion; F:GTP binding; F:G-protein coupled receptor binding; C:endosome; C:heterotrimeric G-protein complex; F:metal ion binding; F:GTPase activity; P:heterotrimeric G-protein complex cycle; F:G-protein beta/gamma-subunit complex binding; P:regulation of MAPK export from nucleus,IPR001019 (PRINTS); IPR002975 (PRINTS); IPR001019 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011025 (G3DSA:1.10.400.GENE3D); IPR001019 (PFAM); PTHR10218:SF214 (PANTHER); IPR001019 (PANTHER); IPR027417 (SUPERFAMILY); IPR011025 (SUPERFAMILY),8.A.92.1.3,The G-Protein αβγ Complex (GPC) Family
RL4_JR_01198,1169,1517,1769,0,0,2,0,0,0,0,0,0,0,0,0,0,2,0,25.49221754,1,-0.542350407,1.035153178,-0.523932514,0.600325479,0.76883364,5.659025819,0,0.964922091,1.245194693,0.774916643,0.438388917,0.599725993,14.74128852,0,-1.692839705,1.203782929,-1.406266582,0.159644979,0.274824991,17.01056345,0,-2.115570115,1.203513114,-1.757828884,0.078776629,0.164716097,22.30822802,1,-0.120142145,1.000266493,-0.120110137,0.904395902,0.938795214,N,-,,smr domain-containing,C:membrane,IPR002625 (SMART); IPR013899 (SMART); IPR013899 (PFAM); IPR002625 (PFAM); PTHR13308 (PANTHER); IPR002625 (PROSITE_PROFILES); IPR002625 (SUPERFAMILY),,
RL4_JR_01199,2947,4173,4158,0,1,5,0,0,0,2,1,1,1,2,0,0,5,0,72.42167853,1,-0.331967824,0.665355808,-0.498932781,0.617826739,0.780463075,14.38142101,0,-0.380624751,1.21763292,-0.312594005,0.754589133,0.850267306,73.89124242,1,-0.204320835,0.758006078,-0.269550392,0.78750617,0.85959164,60.50133853,1,-1.150017019,0.872499335,-1.318072086,0.187479518,0.315477833,56.24854767,1,-0.219564409,0.717561914,-0.30598671,0.759614765,0.83219415,N,-, Effector probability:0.552,duf543 domain,P:cristae formation; C:mitochondrial crista junction; C:MICOS complex,IPR007512 (PFAM); IPR007512 (PANTHER),,
RL4_JR_01200,4343,5616,8733,2,2,5,0,0,0,0,0,0,1,0,0,0,5,0,129.8783132,1,-0.429390324,0.610125026,-0.703774317,0.48157333,0.669850849,23.51988896,0,-1.090333422,1.226672456,-0.888854572,0.374081242,0.538766411,61.550778,0,-3.754738459,1.221069964,-3.074957675,0.002105324,0.010262062,80.35569087,1,-3.223949083,1.179770517,-2.732691685,0.006281911,0.033617518,80.54026018,1,-0.990218621,0.784103379,-1.262867433,0.206636826,0.329428099,N,-,,urb2 npa2 family,P:rRNA metabolic process; C:cytosol; P:ribosome biogenesis; C:nucleolus,IPR018849 (PFAM); PTHR15682 (PANTHER),,
RL4_JR_01201,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_01202,1149,2086,1952,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,30.96236845,1,-1.532690787,1.186452036,-1.291827011,0.196417059,0.358712865,6.60841623,0,0.741199173,1.268465081,0.584327613,0.558999918,0.70270705,17.21945332,0,-1.916964152,1.222980486,-1.567452771,0.117008897,0.217877152,29.50711289,1,-1.386245591,1.177245959,-1.177532682,0.238982961,0.377076902,17.02636742,0,-2.003436882,1.232508463,-1.625495436,0.104057035,0.196820004,N,-,,3-ketodihydrosphingosine reductase tsc10,C:endoplasmic reticulum membrane; C:lipid particle; F:3-dehydrosphinganine reductase activity; C:integral component of membrane; P:oxidation-reduction process; P:3-keto-sphinganine metabolic process; P:sphingolipid biosynthetic process,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24320 (PANTHER); PTHR24320:SF1 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_01203,15403,18675,23798,0,4,14,0,2,1,2,0,0,0,2,0,0,3,0,317.098976,1,-1.189106141,0.533833053,-2.227486916,0.025914749,0.080938945,159.4260193,1,-0.506995575,0.859038759,-0.590189406,0.555063674,0.700193732,213.3920846,1,-3.553880712,1.043692752,-3.405102417,0.000661392,0.004143525,228.7208773,1,-4.094912631,1.034103401,-3.959867676,7.50E-05,0.000835299,201.0089184,1,-3.295727647,0.886242884,-3.718763451,0.0002002,0.001246635,N,-,,sas10 utp3 family,"C:small-subunit processome; P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:nucleolus",IPR018972 (PFAM); PTHR13237:SF8 (PANTHER); PTHR13237 (PANTHER); PTHR13237 (PANTHER); PTHR13237:SF8 (PANTHER); PTHR13237 (PANTHER),,
RL4_JR_01204,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_01205,322,323,355,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.003203165,0,-0.103437768,1.204765149,-0.085857204,0.931579932,0.966629651,1.277263927,0,3.11246421,1.358512181,2.291083035,0.021958612,0.062069217,3.313500707,0,0.460603575,1.201570639,0.383334579,0.701471703,0.797227158,3.822527995,0,0.038265637,1.201248737,0.031854882,0.974587779,0.98517231,3.265980625,0,0.37877835,1.199652561,0.315740042,0.752199831,0.827378956,N,-,,oligomeric Golgi complex component,C:Golgi transport complex; P:intra-Golgi vesicle-mediated transport; F:methyltransferase activity; F:transferase activity; P:methylation,PF08700 (PFAM); PTHR31658:SF0 (PANTHER); PTHR31658:SF0 (PANTHER); IPR033370 (PANTHER); IPR033370 (PANTHER),,
RL4_JR_01206,2252,2862,2507,0,0,12,0,0,0,8,3,2,3,10,9,0,4,14,76.46811811,1,0.990629398,0.750468977,1.320013791,0.186830414,0.345067357,9.769223551,0,0.177299846,1.22396413,0.14485706,0.88482373,0.934426328,150.418719,1,2.090503413,0.468086475,4.466062419,7.97E-06,0.000156622,183.9951192,1,2.318737587,0.381031601,6.085420689,1.16E-09,3.78E-08,143.4940759,1,2.335513028,0.642110819,3.637242915,0.000275572,0.001633587,N,-,,dead deah box helicase,F:organic cyclic compound binding; F:heterocyclic compound binding; F:hydrolase activity,IPR014001 (SMART); IPR001650 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR018973 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR029045 (G3DSA:3.90.226.GENE3D); IPR011545 (PFAM); IPR001753 (PFAM); PTHR24031 (PANTHER); PTHR24031:SF122 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR029045 (SUPERFAMILY),,
RL4_JR_01207,9,1,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.089830267,0,5.373739002,3.918623748,1.37133324,0.170271098,NA,0.028534642,0,8.595588289,2.965673882,2.898359237,0.003751207,0.017473407,0.074658867,0,5.929840114,1.843638468,3.216379033,0.001298192,0.007073062,0.08614894,0,5.508942765,2.810708486,1.959983681,0.049997698,0.122989963,0.074600662,0,5.829328186,1.535768092,3.79570862,0.000147222,0.000959837,N,-,,hypothetical protein SPSK_02954,,no IPS match,,
RL4_JR_01208,7811,7223,9561,0,1,6,0,0,0,2,3,0,1,13,2,5,2,1,129.1211118,1,-1.211982034,0.589381227,-2.056363485,0.039747493,0.112295893,31.27145781,0,-1.501281626,1.194345569,-1.256990996,0.208756896,0.35406121,126.9445951,1,-1.002740506,0.669149013,-1.49853095,0.133995358,0.240953641,174.5030736,1,0.102768522,0.425474887,0.241538396,0.809137861,0.878366125,175.515839,1,-0.395552297,0.65879223,-0.600420405,0.548226092,0.668608671,N,-,,DEAD DEAH box helicase,P:intracellular transport; C:intracellular part,IPR000156 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); IPR000156 (PFAM); PTHR23138 (PANTHER); IPR000156 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_01209,4740,5759,5659,0,2,7,0,0,0,3,1,3,1,1,4,0,11,4,107.6137665,1,-0.255327933,0.537867499,-0.474704149,0.634997861,0.791837971,20.65344011,0,-0.902785395,1.201699351,-0.751257287,0.452497829,0.612160255,114.1666046,1,0.079586341,0.575401669,0.138314407,0.88999194,0.931320671,113.7241684,1,-0.633964478,0.619629778,-1.023134299,0.306244352,0.451934713,124.7843125,1,0.851768537,0.44758161,1.903046321,0.057034501,0.123762179,N,-,,yip1 domain-containing,C:integral component of membrane; C:endoplasmic reticulum,IPR013655 (PFAM); G3DSA:3.30.450.20 (GENE3D); IPR006977 (PFAM); PTHR21236:SF1 (PANTHER); PTHR21236:SF1 (PANTHER); PTHR21236 (PANTHER); PTHR21236 (PANTHER); IPR000014 (PROSITE_PROFILES); IPR000014 (SUPERFAMILY),9.B.135.1.2, the membrane trafficking yip (yip) family.
RL4_JR_01210,11947,11926,11733,0,0,4,0,0,6,0,0,0,0,0,0,0,5,0,157.9759104,1,-2.543767633,0.741143223,-3.432221404,0.000598659,0.003891519,101.904159,1,1.120878402,0.627769708,1.785492973,0.07418139,0.160612627,118.1766479,0,-4.69580311,1.187262196,-3.955152557,7.65E-05,0.000974016,136.3180464,0,-5.118002015,1.186251104,-4.314433931,1.60E-05,0.000215156,135.5515598,1,-1.841802439,0.669740957,-2.75002211,0.005959124,0.020670139,N,-,,wd domain-containing,,IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR10253 (PANTHER); PTHR10253:SF5 (PANTHER); PTHR10253 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_01211,1111,1340,1213,0,2,3,0,0,0,0,1,1,0,3,0,0,2,0,42.19749201,1,1.062833008,0.677057009,1.569783627,0.116465458,0.24733275,4.695359293,0,1.23431411,1.250040423,0.987419357,0.323437099,0.485659445,26.5153654,1,0.405192828,1.035055087,0.39146982,0.695449993,0.792251123,26.0786742,1,0.461905964,0.860281733,0.536924063,0.591320068,0.715057222,19.70397962,1,0.170737701,0.979574975,0.174297737,0.861631478,0.907870562,N,-,,nadh-ubiquinone oxidoreductase,"P:biological_process; P:respiratory electron transport chain; C:cellular_component; P:regulation of transcription from RNA polymerase I promoter; F:molecular_function; C:mitochondrial inner membrane; F:transcription factor activity, RNA polymerase I CORE element sequence-specific binding; F:RNA polymerase I CORE element sequence-specific DNA binding; C:RNA polymerase I core factor complex; P:transcription of nuclear large rRNA transcript from RNA polymerase I promoter; C:membrane; C:integral component of membrane; F:TBP-class protein binding; F:oxidoreductase activity, acting on NAD(P)H",no IPS match,,
RL4_JR_01212,10635,11648,11989,0,6,12,0,4,0,8,0,2,4,23,1,0,5,1,231.2762476,1,-0.335994104,0.400991595,-0.837908097,0.402082321,0.593806585,197.1502383,1,1.551929313,1.555968821,0.997403863,0.318568517,0.480487339,215.2162237,1,-0.456282165,0.510024724,-0.89462754,0.370986225,0.515263792,270.2735712,1,0.328003573,0.438844688,0.747425186,0.454806947,0.59702013,138.6786658,1,-1.527347862,0.624666417,-2.445061589,0.014482741,0.042319697,N,-,,nadh-ubiquinone oxidoreductase kda subunit,"P:respiratory electron transport chain; F:oxidoreductase activity, acting on NAD(P)H; C:mitochondrial inner membrane",IPR006806 (PFAM); PTHR12653 (PANTHER),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_01213,1017,1808,1170,0,0,5,0,0,0,0,0,0,0,10,0,0,0,0,35.26252639,1,0.838503112,0.785559584,1.067395943,0.28579308,0.469588703,5.14676691,0,1.10189275,1.292108375,0.852786633,0.393777638,0.558003255,13.33990572,0,-1.548599297,1.227660631,-1.261422952,0.207156503,0.334063785,55.50624685,1,1.876398818,0.694093848,2.703379123,0.006863841,0.036009759,13.10693718,0,-1.625986564,1.231595163,-1.320228118,0.186758867,0.305705176,N,-,,PBSP domain-containing,"P:biological_process; P:respiratory electron transport chain; F:oxidoreductase activity, acting on NAD(P)H; F:molecular_function; C:mitochondrial inner membrane",IPR007541 (PFAM); PTHR33321:SF2 (PANTHER); PTHR33321 (PANTHER),,
RL4_JR_01214,2535,3400,2129,0,4,0,0,0,0,0,0,2,1,5,0,0,4,0,64.60338504,1,-0.320744544,0.814201912,-0.39393735,0.693627294,0.834221928,10.42688123,0,0.08332867,1.250829984,0.066618702,0.946885257,0.971493333,39.93107557,1,-0.74892579,1.06037436,-0.706284327,0.480011338,0.616392033,60.43612239,1,0.285538137,0.678285831,0.420970222,0.673776826,0.777865055,41.8259139,1,-0.051764049,0.795413773,-0.06507814,0.948111785,0.96649782,N,-,,stu1,C:microtubule cytoskeleton; C:cytoskeletal part; P:single-organism cellular process,SM01349 (SMART); IPR024395 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR21567:SF9 (PANTHER); PTHR21567 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_01215,9512,6023,5155,4,6,7,0,0,0,0,2,0,0,4,1,0,1,0,197.7178359,1,0.395189731,0.496781657,0.795499845,0.426322801,0.616765634,26.79200926,0,-1.27819206,1.243460057,-1.02793174,0.303981938,0.464929764,84.5106629,1,-2.090703412,1.069310005,-1.955189236,0.050560739,0.114156315,105.0276284,1,-1.326298296,0.74652628,-1.776626399,0.075629729,0.159831144,71.04300381,1,-3.055805607,1.151602676,-2.653524232,0.007965605,0.02610089,N,-,,rho-type gtpase-activating,F:metal ion binding,IPR001781 (SMART); IPR000198 (SMART); IPR001781 (G3DSA:2.10.110.GENE3D); IPR000198 (G3DSA:1.10.555.GENE3D); IPR001781 (PFAM); IPR000198 (PFAM); PTHR23176 (PANTHER); PTHR23176 (PANTHER); PTHR23176:SF27 (PANTHER); IPR001781 (PROSITE_PROFILES); IPR000198 (PROSITE_PROFILES); IPR008936 (SUPERFAMILY),9.A.1.1.1, the non abc multidrug exporter (n-mde) family.
RL4_JR_01216,1180,2023,3888,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28.26304212,0,-2.923189447,1.298754436,-2.250763782,0.024400503,0.077184684,8.825285979,0,0.323806973,1.314800339,0.246278437,0.8054667,0.882734294,23.24528812,0,-2.349922332,1.269579213,-1.850945816,0.064177349,0.137451127,26.84060973,0,-2.773561794,1.279999395,-2.166846175,0.030246585,0.092802023,23.28457161,0,-2.455071597,1.293617133,-1.897834788,0.057717849,0.124790353,N,-,,hypothetical protein F503_02926,,no IPS match,,
RL4_JR_01217,2966,2667,3056,16,11,6,0,0,2,2,0,0,1,1,0,0,0,1,306.8071263,1,2.877786712,0.607294203,4.738702756,2.15E-06,2.99E-05,29.85945109,1,1.635322455,0.985030673,1.660174145,0.096879424,0.197784093,50.91855891,1,-0.829986697,1.025579727,-0.809285397,0.418351004,0.559570031,46.52124643,1,-1.346170492,1.007863886,-1.335666959,0.181658154,0.307609189,35.71558708,1,-1.805662418,1.117102091,-1.616380842,0.106011998,0.199622741,N,-,,hypothetical protein CMQ_4358,,IPR025261 (SMART); IPR025261 (PFAM); IPR033473 (PFAM); PTHR13199 (PANTHER),,
RL4_JR_01218,5000,4997,6687,3,0,2,0,0,0,0,2,1,6,2,0,0,1,6,104.4736872,1,-1.095355141,0.684302051,-1.600689548,0.109445697,0.2364363,21.17954609,0,-0.939120224,1.199791743,-0.782736028,0.433782141,0.59520714,77.29777651,1,-1.188849928,0.856520038,-1.388000134,0.165137004,0.281945854,127.4871755,1,-0.250578488,0.560106501,-0.447376504,0.654603237,0.764458798,102.570557,1,-0.20352305,0.614200811,-0.331362391,0.740370769,0.81813866,N,-,,coxi translation cya5,,IPR002885 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR24015 (PANTHER),,
RL4_JR_01219,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_01220,3970,3663,5026,0,0,3,0,0,0,0,0,0,0,3,0,0,0,2,61.97810912,1,-1.464952491,0.863353403,-1.696816721,0.089731316,0.204591414,16.07745438,0,-0.541488052,1.204009324,-0.449737425,0.652899783,0.776387977,41.80910637,0,-3.196805782,1.193036994,-2.679552938,0.007372055,0.025594883,60.27230526,1,-1.319195921,0.861368889,-1.531510991,0.125643152,0.232566164,56.06739879,1,-1.592794906,0.97900257,-1.626956817,0.103746269,0.196342239,N,-,,signal recognition particle,"F:RNA binding; P:SRP-dependent cotranslational protein targeting to membrane; C:endoplasmic reticulum; F:signal recognition particle binding; C:signal recognition particle, endoplasmic reticulum targeting",IPR026258 (PIRSF); IPR026258 (PFAM); PTHR12860 (PANTHER),3.A.5.9.1, the general secretory pathway (sec) family.
RL4_JR_01221,221797,149587,201811,12,17,8,7,0,6,1,14,1,3,15,5,0,9,2,2570.451663,1,-3.06355375,0.559054073,-5.479888081,4.26E-08,9.19E-07,944.6966644,1,-1.706769274,0.552648346,-3.088345936,0.00201274,0.015023052,2022.594533,1,-3.876657125,0.794067051,-4.882027429,1.05E-06,2.82E-05,2322.205024,1,-3.911691731,0.42834531,-9.132098886,6.72E-20,6.54E-18,1915.089869,1,-4.835133636,0.671805588,-7.197221518,6.15E-13,6.62E-11,N,-,,hsp70,F:ATP binding; P:mycelium development; F:unfolded protein binding; P:protein folding,IPR013126 (PRINTS); G3DSA:3.30.30.30 (GENE3D); IPR029048 (G3DSA:1.20.1270.GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR013126 (PFAM); G3DSA:3.30.420.40 (GENE3D); IPR029047 (G3DSA:2.60.34.GENE3D); G3DSA:3.90.640.10 (GENE3D); IPR012725 (TIGRFAM); PTHR19375:SF173 (PANTHER); PTHR19375 (PANTHER); IPR012725 (HAMAP); IPR029047 (SUPERFAMILY); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY); IPR029048 (SUPERFAMILY),1.A.33.1.2, the cation channel-forming heat shock protein-70 (hsp70) family.
RL4_JR_01222,6756,7298,7656,2,1,3,0,0,0,0,0,4,0,3,9,0,0,1,126.6014875,1,-1.229494404,0.612510097,-2.007304712,0.044717228,0.122335058,27.7392792,0,-1.328334261,1.19367214,-1.112813323,0.265788612,0.422872105,97.97390236,1,-1.163075337,0.739399095,-1.573000759,0.115718642,0.216230258,181.791225,1,0.039215508,0.572572342,0.068490049,0.945395541,0.968057261,78.31347881,1,-3.128627106,1.119245032,-2.795301312,0.005185136,0.018466235,N,-,,l-2-hydroxyglutarate mitochondrial precursor,,IPR015943 (G3DSA:2.130.10.GENE3D); IPR019417 (PFAM); SSF82171 (SUPERFAMILY),,
RL4_JR_01223,395,700,787,0,1,3,0,0,0,0,0,0,0,0,0,0,0,1,27.02707433,1,1.672155389,0.82675803,2.022545084,0.043120071,0.119250591,2.384227022,0,2.2119338,1.341007494,1.649456703,0.099054106,0.201047857,6.228282738,0,-0.449880561,1.237063621,-0.363668087,0.716105877,0.807881893,7.18856188,0,-0.872905226,1.241346229,-0.703192394,0.481935859,0.622159961,13.54311652,1,0.402989648,1.171740476,0.343923979,0.730903458,0.811269185,N,-,,fad dependent oxidoreductase,F:catalytic activity; P:metabolic process,IPR023753 (G3DSA:3.50.50.GENE3D); IPR006076 (PFAM); G3DSA:3.30.9.10 (GENE3D); PTHR13847:SF206 (PANTHER); PTHR13847 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_01224,812,1032,1623,0,0,1,0,0,0,1,0,1,0,2,0,0,2,0,17.65853966,1,-0.948522383,1.18884595,-0.797851381,0.424956741,0.616052962,4.361896973,0,1.34046511,1.28589656,1.042436189,0.297209496,0.456988381,28.98349818,1,0.503515906,1.064851729,0.472850719,0.636319686,0.746131631,21.19834753,1,-0.040952979,1.06308278,-0.03852285,0.969270813,0.98286099,19.07815643,1,0.228465064,1.037786144,0.220146574,0.825757003,0.883104134,N,-,,prp38 family,C:precatalytic spliceosome; C:cytosol,IPR005037 (PFAM); IPR005037 (PANTHER),,
RL4_JR_01225,27,57,34,0,0,0,0,0,0,0,0,1,1,1,0,0,5,0,0.478804355,0,2.960374232,2.109533787,1.403331035,0.160518148,NA,0.152129814,0,6.18230888,1.983006332,3.117644548,0.001823025,0.015023052,6.893279104,1,4.494969329,1.246256752,3.60677631,0.000310025,0.002383212,13.77907717,1,4.847628269,1.077007284,4.501017164,6.76E-06,0.000100698,19.69037607,1,6.309076126,0.804550385,7.841741484,4.44E-15,6.62E-13,N,-,,hypothetical protein SPSK_06619,C:membrane,no IPS match,,
RL4_JR_01226,1243,1066,1857,0,0,3,0,0,0,0,0,2,0,0,0,0,3,0,28.03107729,1,0.124482986,0.897650547,0.138676445,0.889705833,0.945788685,5.256216957,0,1.071407086,1.259898997,0.850391252,0.395107598,0.559105146,26.70731174,1,0.22617162,1.05577526,0.214223262,0.830372957,0.890497198,15.82025357,0,-2.011001347,1.213169576,-1.657642416,0.097389663,0.192113907,25.18628853,1,0.499256418,0.895743037,0.55736567,0.577277616,0.690890764,N,-,,cox1 assembly,C:mitochondrion; C:integral component of membrane; P:cellular process,IPR002994 (PFAM); PTHR23427:SF2 (PANTHER); PTHR23427 (PANTHER); IPR002994 (PROSITE_PROFILES),3.D.4.8.1, the proton-translocating cytochrome oxidase (cox) superfamily.
RL4_JR_01227,694,666,675,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,8.150614023,0,-1.129115868,1.188235925,-0.950245523,0.341987512,0.532125525,2.607249419,0,2.083025384,1.284031124,1.62225459,0.104748847,0.209746357,6.751581845,0,-0.566164364,1.193800235,-0.474253855,0.635318893,0.745321491,35.86904336,1,2.528970917,0.570933875,4.429533836,9.44E-06,0.000134294,6.641830903,0,-0.645360697,1.191629113,-0.541578492,0.588108912,0.700623925,N,-,,histone-fold domain containing,"C:chromosome, centromeric region",PF15511 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); IPR009072 (SUPERFAMILY),,
RL4_JR_01228,3459,2985,2631,0,1,8,0,0,0,0,0,0,7,7,0,0,2,0,74.92067432,1,0.561360066,0.548117024,1.024160975,0.305759248,0.492474619,11.69077049,0,-0.081735972,1.227792913,-0.066571464,0.946922864,0.971493333,30.17059118,0,-2.726044296,1.197728334,-2.276012196,0.02284528,0.061775003,128.0612342,1,1.397788245,0.45811914,3.051145704,0.002279699,0.014701882,37.29501915,1,-1.131615355,0.976237288,-1.159160144,0.246390914,0.376572116,N,-, Effector probability:0.745,rho gtpase,F:GTP binding; P:ascospore formation; P:developmental pigmentation; P:small GTPase mediated signal transduction; F:GTPase activity; C:fungal-type vacuole membrane; C:endomembrane system; P:conidium formation; P:pathogenesis; C:plasma membrane,PR00449 (PRINTS); SM00173 (SMART); SM00175 (SMART); SM00174 (SMART); IPR001806 (PFAM); IPR005225 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24072 (PANTHER); PS51420 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_01229,1209,2156,4330,1,0,0,0,0,0,0,0,0,0,0,0,0,4,0,40.71997703,1,-2.076549886,1.26594256,-1.640319199,0.100938816,0.223159582,9.55818828,0,0.208716674,1.322657657,0.157800979,0.874613627,0.928082695,25.2028585,0,-2.4665674,1.278189759,-1.929734911,0.053639692,0.119351262,29.10273613,0,-2.890295569,1.290389,-2.239863769,0.025099768,0.08557795,40.71710878,1,-0.080080046,0.96247041,-0.083202606,0.933690441,0.956553244,N,-,,DNA RNA DEAD DEAH box type,C:nucleus; F:molecular_function,IPR027417 (G3DSA:3.40.50.GENE3D); IPR032704 (PFAM); IPR032704 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_01230,608,908,894,0,0,7,0,0,0,0,0,0,4,6,1,0,5,1,36.41928243,1,2.063927911,0.66269456,3.114448248,0.001842893,0.009794345,3.072323644,0,1.846172373,1.290868425,1.430178581,0.152665771,0.280247178,7.995173111,0,-0.810113972,1.212636431,-0.668060064,0.504095253,0.636500417,80.17959488,1,2.956091148,0.512944294,5.762986713,8.26E-09,2.29E-07,34.5666745,1,2.275756809,0.670080698,3.396242895,0.000683177,0.003520187,Y,-,,pq loop repeat,C:integral component of membrane,PTHR16201:SF37 (PANTHER); PTHR16201 (PANTHER),,
RL4_JR_01231,473,520,594,0,0,3,0,0,1,0,0,0,0,1,0,0,0,2,17.81038772,1,1.529230847,0.858476691,1.781330656,0.074858449,0.179299832,11.40046381,1,3.36592194,1.127309893,2.985800055,0.002828375,0.015349618,5.254551312,0,-0.204651251,1.199848894,-0.170564187,0.86456646,0.91375814,10.07405707,1,0.319810408,1.146725373,0.278890147,0.78032913,0.858435079,19.91922415,1,1.400000775,0.977054141,1.432879425,0.151892298,0.261460306,N,-,,Ras small monomeric GTPase,F:GTP binding; C:cellular bud neck; P:small GTPase mediated signal transduction; F:GTPase activity; C:intracellular; C:plasma membrane,PR00449 (PRINTS); SM00175 (SMART); SM00176 (SMART); SM00174 (SMART); SM00173 (SMART); IPR005225 (TIGRFAM); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR020849 (PANTHER); PTHR24070:SF263 (PANTHER); IPR020849 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_01232,11947,7546,8920,8,6,15,0,2,0,4,5,10,21,34,24,2,10,9,299.0978436,1,0.675016067,0.377584883,1.787720052,0.073821185,0.177492846,113.1514596,1,-0.030893737,1.005749397,-0.030717132,0.975495128,0.987312443,242.6159116,1,0.692801723,0.422914091,1.638161833,0.101387939,0.195795624,671.7505539,1,2.330207273,0.329502411,7.071897488,1.53E-12,7.10E-11,229.3087772,1,0.593199359,0.423694535,1.400063749,0.161494229,0.273615976,Y,-,,hypothetical protein CMQ_4720,C:membrane; C:integral component of membrane,PTHR40622 (PANTHER),,
RL4_JR_01233,5175,4494,4959,0,0,8,0,0,0,0,0,0,0,3,0,0,0,0,89.03731437,1,-0.265953499,0.534188278,-0.497864723,0.618579393,0.781051028,18.72212737,0,-0.761137941,1.201886762,-0.633285901,0.526546959,0.675244941,48.47905885,0,-3.410305612,1.187431044,-2.872003078,0.00407879,0.016563847,67.95385467,1,-1.525355569,0.848819736,-1.797031224,0.072330663,0.154866027,47.70498182,0,-3.489868099,1.186599416,-2.94106676,0.00327084,0.012683745,N,-,,tata-binding -associated phospho,"F:RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly; F:chromatin binding; P:positive regulation of transcription from RNA polymerase II promoter in response to heat stress; P:negative regulation of tRNA transcription from RNA polymerase III promoter; P:regulation of RNA polymerase II transcriptional preinitiation complex assembly; F:core promoter binding; P:negative regulation of transcription from RNA polymerase II promoter; P:RNA polymerase II transcriptional preinitiation complex assembly; F:transcription coactivator activity; F:transcription corepressor activity; F:protein heterodimerization activity; C:negative cofactor 2 complex; C:cytosol",IPR003958 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); PTHR11064:SF8 (PANTHER); PTHR11064 (PANTHER); IPR009072 (SUPERFAMILY),,
RL4_JR_01234,5055,6482,7544,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,76.47015621,0,-4.359150061,1.207831523,-3.609071281,0.000307295,0.00222006,24.24334085,0,-1.134023027,1.20483929,-0.941223478,0.346590348,0.509540668,63.14105384,0,-3.791528852,1.200179648,-3.159134434,0.001582385,0.00822883,72.86015201,0,-4.214246361,1.20177999,-3.506670437,0.000453751,0.003859512,74.05236378,1,-1.688291862,0.871972665,-1.936175215,0.052846245,0.11681254,N,-, Effector probability:0.661,short-chain dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); SM00822 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24322:SF339 (PANTHER); IPR002347 (PANTHER); PTHR24322:SF339 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_01235,791,1132,1084,3,0,1,0,0,0,0,0,0,0,1,0,0,0,0,46.10479844,1,1.063958945,0.770955561,1.380052235,0.167570562,0.319551344,3.838681115,0,1.524904077,1.271070022,1.199701079,0.230255454,0.380389376,9.980615954,0,-1.130101234,1.207099671,-0.936212031,0.34916403,0.492808103,15.52768438,1,-0.606521413,1.15846491,-0.523556137,0.600587297,0.722511474,9.850996393,0,-1.213967878,1.212324943,-1.001355194,0.316655118,0.451934391,N,-,,fad dependent oxidoreductase superfamily,F:oxidoreductase activity; P:oxidation-reduction process,IPR006076 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13847:SF185 (PANTHER); PTHR13847 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_01236,14235,12239,14110,0,3,19,0,0,0,0,0,2,6,14,1,0,10,10,258.7701386,1,-0.498473144,0.607300526,-0.820801436,0.41175938,0.602967694,51.88256391,0,-2.231655135,1.192495601,-1.871415823,0.061287467,0.138471372,147.4141521,1,-3.060831596,1.029256619,-2.973827458,0.002941104,0.013430644,276.7209211,1,-0.198927502,0.355875931,-0.558979927,0.57617542,0.702901846,244.617281,1,-0.018906986,0.391318475,-0.048316108,0.961464317,0.97457908,N,-,,phosphatidylethanolamine N-methyltransferase,C:integral component of membrane; F:deoxyhypusine monooxygenase activity; P:phospholipid biosynthetic process; F:phosphatidylethanolamine N-methyltransferase activity; P:oxidation-reduction process; P:phosphatidylcholine biosynthetic process; P:peptidyl-lysine modification to peptidyl-hypusine; P:methylation,IPR007318 (PFAM); PTHR32138 (PANTHER); PTHR32138:SF0 (PANTHER); PTHR32138 (PANTHER); PTHR32138:SF0 (PANTHER); PTHR32138:SF0 (PANTHER); IPR016219 (PROSITE_PROFILES),,
RL4_JR_01237,14762,24315,31741,15,17,3,0,4,3,2,1,6,1,0,0,0,1,0,582.4103668,1,0.026454064,0.826095731,0.032023,0.974453709,0.987036672,270.8284638,1,0.527838507,0.696469118,0.757877836,0.44852412,0.609063744,302.7551786,1,-1.704766481,0.606611925,-2.810308223,0.004949408,0.018788077,279.1553782,1,-5.148285653,1.188249875,-4.332662484,1.47E-05,0.000200482,236.2323779,1,-4.848382062,1.183342955,-4.097190963,4.18E-05,0.000333403,N,-,,2-isopropylmalate synthase,F:2-isopropylmalate synthase activity; P:leucine biosynthetic process,IPR013709 (SMART); IPR000891 (PFAM); IPR013709 (PFAM); IPR005668 (TIGRFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR10277:SF28 (PANTHER); PTHR10277 (PANTHER); PTHR10277:SF28 (PANTHER); PTHR10277 (PANTHER); IPR000891 (PROSITE_PROFILES); IPR005668 (HAMAP); SSF89000 (SUPERFAMILY); IPR013709 (SUPERFAMILY); SSF51569 (SUPERFAMILY),,
RL4_JR_01238,1251,1136,972,0,0,1,0,0,0,0,0,9,1,0,0,0,2,2,17.2878513,1,-0.906685541,1.149220682,-0.78895686,0.430137221,0.621292395,4.327644411,0,1.352003184,1.267465502,1.066698211,0.286108135,0.445673522,69.65995025,1,2.471807559,1.39575586,1.770945501,0.076569765,0.157623485,22.19596999,1,-0.764183632,1.150017768,-0.664497239,0.506372115,0.642402915,33.40369297,1,1.260270707,0.748380122,1.683998105,0.092182035,0.179385567,N,-,,ferric reductase transmembrane component 7,F:ferric-chelate reductase activity; P:iron ion transport; C:integral component of membrane; P:oxidation-reduction process; C:plasma membrane; P:copper ion import,IPR013121 (PFAM); IPR013130 (PFAM); IPR013112 (PFAM); G3DSA:3.40.50.80 (GENE3D); G3DSA:2.40.30.10 (GENE3D); IPR030155 (PTHR11972:PANTHER); PTHR11972 (PANTHER); IPR030155 (PTHR11972:PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY); IPR017938 (SUPERFAMILY),5.B.1.5.4, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_01239,529,442,586,0,0,0,0,0,0,0,0,4,0,0,1,0,0,0,6.212058033,0,-0.737630289,1.198356492,-0.615534938,0.538201504,0.721078645,1.982828587,0,2.4779275,1.310461924,1.89088096,0.058640237,0.133804435,31.14134872,1,2.640163654,0.747201356,3.533403189,0.000410246,0.002937294,15.5722507,1,0.352522161,1.145030148,0.30787151,0.758180105,0.842098899,5.078658015,0,-0.258269636,1.203550508,-0.214589777,0.830087165,0.885461702,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662:SF240 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_01240,501,498,559,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,6.235112881,0,-0.742721849,1.193071269,-0.622529322,0.533593869,0.71706681,1.988959332,0,2.473501639,1.304633944,1.89593537,0.057968591,0.132780738,5.160856636,0,-0.178673349,1.195988514,-0.149393867,0.881242851,0.92609097,34.03485234,1,2.91644272,0.570940528,5.1081375,3.25E-07,6.58E-06,5.088225067,0,-0.260892618,1.197017634,-0.217952193,0.82746636,0.884325195,N,-,,xenobiotic compound family,F:oxidoreductase activity; P:metabolic process,IPR011251 (G3DSA:3.20.20.GENE3D); IPR011251 (PFAM); IPR016215 (TIGRFAM); IPR016215 (PIRSF); PTHR30011:SF30 (PANTHER); PTHR30011 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_01241,448,456,472,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,5.512640932,0,-0.5649372,1.19509449,-0.472713417,0.636417653,0.792413799,1.76033972,0,2.649686071,1.319569184,2.007993293,0.044644004,0.107874579,4.563405646,0,-0.001068167,1.19739887,-0.000892072,0.999288229,0.999593402,37.3569575,1,3.282379889,0.53935395,6.085762219,1.16E-09,3.78E-08,4.493938758,0,-0.081695057,1.195731449,-0.068322245,0.945529117,0.965166076,N,-,,phosphotransferase enzyme family,F:protein kinase activity; F:transferase activity; P:protein phosphorylation,G3DSA:3.90.1200.10 (GENE3D); IPR002575 (PFAM); PTHR21310 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_01242,3,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.035353752,0,6.718624434,3.936817271,1.706613229,0.087893965,NA,0.01118311,0,9.946128198,3.317750481,2.99785299,0.002718888,0.015349618,0.029302211,0,7.277205732,1.946856684,3.73792575,0.000185545,0.001681223,0.033817295,0,6.857818428,3.655808315,1.875869257,0.060673235,0.137615704,0.029287109,0,7.177634907,1.434494667,5.003598181,5.63E-07,8.78E-06,,,,,,,,
RL4_JR_01243,11324,10945,15582,3,1,8,0,0,0,3,0,2,3,5,0,0,4,0,219.8022521,1,-1.049230241,0.492816902,-2.129046785,0.03325039,0.097961965,47.97910347,0,-2.118842917,1.196224873,-1.771274754,0.076515024,0.164696333,171.1294753,1,-1.621303147,0.680924584,-2.381031885,0.017264218,0.049952255,192.1354465,1,-1.477469677,0.560582008,-2.635599532,0.008398879,0.042244734,139.1083029,1,-2.27565924,0.786981373,-2.891630373,0.003832485,0.014420892,N,-,,translation initiation factor 3 subunit G,"F:nucleotide binding; C:nucleus; C:multi-eIF complex; F:translation initiation factor activity; P:formation of translation preinitiation complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:eukaryotic 43S preinitiation complex; C:eukaryotic translation initiation factor 3 complex, eIF3e; C:cytosol; C:eukaryotic 48S preinitiation complex; P:regulation of translational initiation; P:translation reinitiation",IPR000504 (SMART); IPR017334 (PIRSF); IPR024675 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR10352:SF0 (PANTHER); IPR017334 (PANTHER); IPR017334 (HAMAP); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_01244,1793,1616,1470,0,4,0,0,0,0,0,0,0,0,5,0,0,0,0,51.59214001,1,0.356604953,0.743162323,0.479847998,0.631335481,0.790550246,6.276034143,0,0.815717935,1.243076912,0.65620874,0.511689826,0.66297924,16.21316443,0,-1.830035466,1.195621614,-1.530614238,0.125864761,0.230051424,38.75702527,1,0.774557479,0.682255694,1.135289138,0.256254192,0.395514282,15.90879571,0,-1.905571227,1.192037078,-1.598583855,0.109913099,0.204910722,N,-,,peptidase family m20 m25 m40,F:organic cyclic compound binding; F:heterocyclic compound binding,IPR011993 (G3DSA:2.30.29.GENE3D),,
RL4_JR_01245,813,621,1165,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.32606106,0,-1.47070094,1.22514434,-1.200430751,0.229972092,0.402167701,3.277851307,0,1.75266962,1.295878308,1.35249553,0.176216848,0.312759413,8.54663286,0,-0.906552067,1.220105394,-0.743011277,0.457474853,0.595500013,9.861858461,0,-1.329212792,1.221465929,-1.088211108,0.276501922,0.419413028,8.480527434,0,-0.997947276,1.231329929,-0.810462941,0.417674156,0.553527595,N,-,,glutamyl-tRNA amidotransferase,"F:nucleotide binding; C:nuclear part; C:cytoplasm; C:protein complex; P:single-organism cellular process; P:intracellular protein transport; P:organelle organization; F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor; P:translation",IPR023631 (G3DSA:3.90.1300.GENE3D); IPR023631 (PFAM); PTHR11895:SF7 (PANTHER); PTHR11895:SF7 (PANTHER); IPR000120 (PANTHER); IPR023631 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_01246,262,162,245,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.660130395,0,0.485896885,1.265033288,0.384098102,0.700905738,0.838793781,0.852982518,0,3.694908575,1.455867347,2.537943161,0.011150609,0.036511005,2.208959198,0,1.045352073,1.231589433,0.848782918,0.396002097,0.538666083,2.54781402,0,0.623325061,1.242703066,0.501588093,0.615957297,0.734837709,2.176423242,0,0.964013122,1.226342343,0.7860881,0.431815876,0.566412196,N,-,,calcium ion transporter,P:transmembrane transport; C:membrane,PTHR31503 (PANTHER); PTHR31503:SF0 (PANTHER),2.A.19.2.8, the ca(2+):cation antiporter (caca) family.
RL4_JR_01247,10744,7423,11873,1,8,7,0,0,3,1,2,1,3,1,3,0,7,0,220.3500243,1,-0.254957374,0.472287637,-0.539834953,0.58931086,0.760504468,66.29103981,1,0.385267694,0.871642986,0.442001714,0.658487965,0.780287425,132.3224778,1,-1.614861041,0.760807592,-2.122561682,0.033790599,0.084322411,175.1383258,1,-1.264883602,0.605399401,-2.089337386,0.036677363,0.101686282,124.8869255,1,-1.177113549,0.657064726,-1.791472746,0.073217464,0.149941386,N,-,,CHCH domain-containing,C:intracellular part,PTHR13523:SF2 (PANTHER); PTHR13523 (PANTHER),,
RL4_JR_01248,23319,15028,10961,0,10,16,0,0,0,2,11,4,0,15,0,0,3,1,338.461955,1,-0.40733392,0.664797985,-0.612718344,0.540062591,0.722267315,64.07601371,0,-2.536184203,1.244357116,-2.03814819,0.041535115,0.102167299,298.7220756,1,-0.264842993,0.547578158,-0.48366245,0.628625447,0.740026491,249.58885,1,-1.523153625,1.511657438,-1.007605021,0.313644117,0.459705658,179.0064979,1,-2.644667308,0.830278435,-3.185277608,0.001446152,0.006469218,N,-,,Rho guanyl nucleotide exchange factor,P:regulation of Rho protein signal transduction; F:Rho guanyl-nucleotide exchange factor activity; C:intracellular; P:intracellular signal transduction; P:positive regulation of GTPase activity,IPR000219 (SMART); IPR000591 (SMART); IPR001180 (SMART); IPR000219 (G3DSA:1.20.900.GENE3D); IPR000591 (PFAM); IPR000219 (PFAM); IPR001180 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); PF15405 (PFAM); PTHR12673 (PANTHER); PTHR12673 (PANTHER); PTHR12673:SF95 (PANTHER); IPR000219 (PROSITE_PROFILES); IPR000591 (PROSITE_PROFILES); IPR001180 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY); IPR000219 (SUPERFAMILY),,
RL4_JR_01249,2706,2876,3477,0,1,6,1,0,0,0,2,0,0,8,0,0,6,0,67.16319944,1,0.227521929,0.587151884,0.387500977,0.698385362,0.837070731,33.83848622,1,0.861114948,1.108826398,0.776600331,0.437394606,0.598795783,45.65528014,1,-0.892203555,1.031694364,-0.864794446,0.38715162,0.531028723,66.67066018,1,0.54856089,0.558724852,0.981808646,0.326194128,0.472884861,52.77378723,1,0.372182144,0.641882126,0.579829424,0.562029653,0.67987458,N,-,,vacuolar ATPase proteolipid subunit C,"C:vacuolar proton-transporting V-type ATPase, V0 domain; P:ATP hydrolysis coupled proton transport; C:integral component of membrane; C:endoplasmic reticulum; F:proton-transporting ATPase activity, rotational mechanism; P:vacuolar acidification; C:fungal-type vacuole",IPR000245 (PRINTS); G3DSA:1.20.120.610 (GENE3D); IPR002379 (PFAM); IPR011555 (TIGRFAM); PTHR10263:SF8 (PANTHER); PTHR10263 (PANTHER); IPR002379 (SUPERFAMILY),3.A.2.2.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_01250,1185,1249,925,0,0,3,0,0,0,0,0,1,1,1,0,0,4,0,24.96340445,1,0.430575733,0.877959963,0.490427527,0.623831402,0.784404528,4.336061809,0,1.349207505,1.274802455,1.058365944,0.289888639,0.449212003,17.69131177,1,-0.333539616,1.203654898,-0.277105686,0.781698956,0.854911984,26.23244054,1,0.017725049,1.029477599,0.017217518,0.986263087,0.99170625,26.40765266,1,1.230762619,0.76866494,1.601169191,0.109339451,0.204167903,N,-,,hypothetical protein CMQ_4721,,no IPS match,,
RL4_JR_01251,3464,3325,6405,6,7,2,0,0,3,1,0,0,0,1,0,0,0,0,176.5651882,1,1.088773017,0.670360901,1.624159486,0.104341775,0.228638249,44.69413845,1,1.571288824,0.905316415,1.73562392,0.082630354,0.174392085,54.40038113,1,-2.286565761,1.222073,-1.871054971,0.061337462,0.132546524,54.02192387,1,-2.726681918,1.181518755,-2.307777093,0.021011538,0.078502516,43.1438253,0,-3.344862214,1.236159552,-2.705849911,0.006812983,0.023096861,N,-, Effector probability:0.604,sco1,P:copper ion transport; P:cellular copper ion homeostasis; F:copper ion binding; C:integral component of membrane; C:mitochondrial inner membrane; P:respiratory chain complex IV assembly,IPR003782 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR017276 (PIRSF); PTHR12151:SF5 (PANTHER); IPR003782 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_01252,3019,3667,6934,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,54.2279109,0,-3.863308138,1.255581555,-3.076907369,0.002091603,0.010854514,17.03993901,0,-0.625384544,1.249905235,-0.500345567,0.616831774,0.748168653,44.70666219,0,-3.293462524,1.23521966,-2.66629704,0.00766919,0.02647627,51.60802748,0,-3.716730607,1.242499155,-2.991334514,0.00277761,0.017446219,44.6183678,0,-3.393342597,1.251610848,-2.711180238,0.006704417,0.022815853,N,-,,phd transcription factor,F:binding,IPR001965 (SMART); IPR019787 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR12321 (PANTHER); IPR019787 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY),,
RL4_JR_01253,3615,3266,5077,4,5,5,0,0,2,0,5,5,1,9,4,0,1,0,147.0570776,1,0.906037531,0.473477908,1.913579315,0.05567393,0.143866938,33.88800378,1,1.183461943,0.998227613,1.18556322,0.235794834,0.386199889,111.1263407,1,1.017836622,0.517766368,1.965822203,0.049319152,0.111902084,129.4406355,1,0.982588615,0.462917424,2.122600199,0.033787368,0.098501901,42.91536078,1,-2.272368908,1.140520503,-1.992396367,0.046327586,0.10567362,N,-,,kynurenine 3-monooxygenase,F:kynurenine 3-monooxygenase activity; F:FAD binding; P:tryptophan catabolic process; P:quinolinate biosynthetic process; P:'de novo' NAD biosynthetic process from tryptophan; C:integral component of membrane; P:anthranilate metabolic process; P:oxidation-reduction process; C:mitochondrial outer membrane,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789:SF205 (PANTHER); PTHR13789 (PANTHER); IPR027545 (HAMAP); IPR023753 (SUPERFAMILY),,
RL4_JR_01254,8009,7690,9131,5,0,15,0,0,0,0,4,3,3,0,2,0,4,1,206.8877059,1,0.267331489,0.404699721,0.660567514,0.508889708,0.695164474,31.65975333,0,-1.519068648,1.191380179,-1.275049455,0.202291738,0.34669776,133.0517656,1,-0.54469733,0.566384051,-0.961710218,0.336195188,0.479318418,142.0187587,1,-1.521927691,0.65996586,-2.306070334,0.021106703,0.078712841,103.8839472,1,-1.319059349,0.676444619,-1.949988678,0.051177469,0.114166986,N,-,,methionine aminopeptidase 1,P:protein initiator methionine removal; C:cytosolic ribosome; F:metal ion binding; P:proteolysis; F:metalloaminopeptidase activity,IPR001714 (PRINTS); IPR000994 (G3DSA:3.90.230.GENE3D); IPR000994 (PFAM); IPR002467 (TIGRFAM); IPR031615 (PFAM); PTHR10804:SF13 (PANTHER); PTHR10804 (PANTHER); IPR002467 (HAMAP); IPR000994 (SUPERFAMILY),,
RL4_JR_01255,5205,5385,6833,0,0,7,0,0,0,5,5,0,2,3,1,0,1,0,96.38093887,1,-0.741638936,0.609433168,-1.216932348,0.223629957,0.393916236,22.14369115,0,-1.003338006,1.197521941,-0.837845196,0.402117651,0.565814756,152.1632172,1,0.5099106,0.500447891,1.01890848,0.308246417,0.449342942,106.751582,1,-0.76310478,0.619135072,-1.232533601,0.217749823,0.352641868,60.80269804,1,-2.815449625,1.128559975,-2.494727518,0.012605389,0.03784981,Y,-,,integral membrane,C:integral component of membrane,IPR009637 (PFAM); PTHR21229:SF1 (PANTHER); IPR009637 (PANTHER),,
RL4_JR_01256,1250,833,1794,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19.19001047,1,-1.099925977,1.187365324,-0.926358514,0.354259696,0.545189701,4.879795483,0,1.178613165,1.287582764,0.915368858,0.359998021,0.524226726,12.72895595,0,-1.481180513,1.228126915,-1.20604841,0.227798825,0.35866801,14.6878168,0,-1.903845707,1.230615686,-1.547067642,0.121846936,0.226908262,12.64136106,0,-1.573878118,1.241563884,-1.267657782,0.204920188,0.32751648,N,-,,DUF185 domain-containing,,IPR003788 (PFAM); PTHR12049:SF7 (PANTHER); PTHR12049:SF7 (PANTHER); IPR003788 (PANTHER); IPR003788 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_01257,874,712,1140,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.85275177,0,-1.542481973,1.20769418,-1.277212392,0.201527273,0.365590281,3.452079753,0,1.677976967,1.275285193,1.315766054,0.188252576,0.328759934,8.984683864,0,-0.978658831,1.207210154,-0.810678097,0.417550555,0.559026223,10.36639008,0,-1.401198741,1.206800262,-1.161085877,0.245606978,0.384294645,8.895240801,0,-1.066826868,1.21568932,-0.877548935,0.380188552,0.51593742,N,-,,cyclin-dependent kinase G- partial,C:nucleus; F:ATP binding; F:protein kinase activity; P:protein phosphorylation,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24056:SF107 (PANTHER); PTHR24056 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_01258,2024,1545,2106,3,0,8,0,0,0,3,0,1,0,6,0,0,1,0,83.36544359,1,1.565802306,0.48490824,3.229069289,0.001241938,0.007006729,7.23179916,0,0.61114699,1.231627651,0.496210839,0.619745664,0.749868843,58.46322811,1,0.793323315,0.746384024,1.062888928,0.287832325,0.427290227,45.70360273,1,0.819081406,0.633271031,1.293413666,0.195868026,0.325749632,22.356078,1,-1.193214002,1.129233967,-1.056657909,0.290667741,0.42538242,Y,-,,hypothetical protein SPBR_04360,C:membrane,PTHR42028 (PANTHER); PTHR42028:SF1 (PANTHER),,
RL4_JR_01259,895,791,900,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,10.33816513,0,-1.472343963,1.185525492,-1.241933618,0.214261055,0.382733017,3.30583741,0,1.740514334,1.264674883,1.37625437,0.168742895,0.30303909,8.566198376,0,-0.909709298,1.191982338,-0.76319025,0.445349943,0.584788952,9.881270279,0,-1.331934519,1.189087434,-1.120131692,0.262657647,0.403123947,16.15688591,1,0.6796698,0.972056807,0.699207901,0.484422114,0.612713791,N,-,,RNA recognition motif containing,F:nucleotide binding; F:U6 snRNA binding; F:pre-mRNA binding; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome; C:Prp19 complex; P:spliceosomal snRNP assembly,IPR012677 (G3DSA:3.30.70.GENE3D); PTHR14089 (PANTHER); PTHR14089:SF16 (PANTHER); IPR012677 (SUPERFAMILY),,
RL4_JR_01260,6206,2705,2448,0,0,3,0,0,0,0,2,4,0,0,0,0,7,0,56.65162811,1,-1.378359513,1.007349018,-1.368303824,0.171216994,0.324980845,14.77062437,0,-0.419117211,1.306444543,-0.320807502,0.748356274,0.845975229,79.45393625,1,0.317336852,0.748001443,0.424246311,0.67138619,0.77398244,43.53265202,0,-3.471203149,1.270717513,-2.731687502,0.006301088,0.033666761,63.75426394,1,0.146544544,0.792879679,0.184825703,0.853365747,0.902476985,N,-,,short-chain dehydrogenase reductase sdr,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24322:SF512 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_01261,146,137,84,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,9.113565854,1,3.039437067,1.074595424,2.828447802,0.004677433,0.020615071,0.476625557,0,4.534792686,1.6168456,2.804715977,0.005036094,0.020746984,1.225668641,0,1.895950016,1.267738284,1.495537399,0.134774247,0.241983733,1.413248767,0,1.474149188,1.30547062,1.129209012,0.258809673,0.398668483,1.196026451,0,1.827824752,1.242705165,1.47084345,0.141333459,0.247835343,N,-,,---NA---,,no IPS match,,
RL4_JR_01262,103,84,50,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.952099241,0,1.968559437,1.606091821,1.225682997,0.220317991,NA,0.30848755,0,5.162489567,1.754740068,2.942025238,0.003260734,0.016208996,0.791640164,0,2.526674463,1.30009882,1.943448008,0.051962051,0.116592156,0.912657154,0,2.10500751,1.374845044,1.531087098,0.125747868,0.232717449,0.771050143,0,2.460952844,1.262112854,1.949867507,0.051191913,0.114166986,N,-,,predicted protein,,IPR032675 (G3DSA:3.80.10.GENE3D),,
RL4_JR_01263,5477,4557,5099,0,0,7,0,0,0,0,0,1,0,9,1,0,0,0,87.20841719,1,-0.507502169,0.571819305,-0.887521923,0.374797969,0.566747327,19.37330002,0,-0.810463863,1.203554402,-0.673391965,0.500697959,0.65470414,56.64518688,1,-2.497298068,1.189050767,-2.100245118,0.035707284,0.087445706,103.5802378,1,0.138922291,0.496842202,0.279610489,0.779776359,0.858084516,49.33185333,0,-3.538252161,1.187922299,-2.978521544,0.002896427,0.011491505,N,-,,mRNA-decapping enzyme 2,F:binding; F:hydrolase activity,IPR007722 (SMART); IPR007722 (PFAM); IPR015797 (G3DSA:3.90.79.GENE3D); IPR000086 (PFAM); PTHR23114:SF17 (PANTHER); PTHR23114:SF17 (PANTHER); PTHR23114 (PANTHER); PTHR23114 (PANTHER); IPR000086 (PROSITE_PROFILES); IPR015797 (SUPERFAMILY); IPR007722 (SUPERFAMILY),,
RL4_JR_01264,848,969,1814,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,14.45485969,0,-1.955866943,1.249837836,-1.56489657,0.117607163,0.248817229,4.548507177,0,1.28001627,1.297875649,0.98623953,0.324015585,0.486251334,11.9229504,0,-1.386793877,1.23636804,-1.121667524,0.26200383,0.399044803,13.76269721,0,-1.809970471,1.240228191,-1.459385042,0.144459161,0.258692784,19.2545936,1,-0.539881239,1.180730648,-0.457243352,0.647496142,0.748219406,N,-, Effector probability:0.617,ph domain-containing,C:membrane,IPR025187 (PFAM); PTHR35519 (PANTHER); PTHR35519:SF2 (PANTHER),,
RL4_JR_01265,4305,4443,4394,4,6,17,12,0,0,3,4,0,0,5,0,0,3,1,205.9200384,1,1.645792534,0.320379568,5.13700841,2.79E-07,4.92E-06,284.5750876,1,3.994250927,1.896877803,2.105697542,0.035230634,0.089666702,108.1951428,1,0.381131467,0.5651848,0.674348403,0.500089838,0.632784592,70.36815376,1,-0.641686974,0.665628396,-0.96403185,0.335029958,0.481892941,61.86915578,1,-0.71516965,0.737846019,-0.969266801,0.332412089,0.469083261,Y,-,,ribonucleoside-diphosphate reductase small subunit,"F:ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; P:deoxyribonucleoside diphosphate metabolic process; C:integral component of membrane; P:oxidation-reduction process",IPR000358 (PFAM); IPR012348 (G3DSA:1.10.620.GENE3D); PTHR23409:SF18 (PANTHER); IPR000358 (PANTHER); IPR009078 (SUPERFAMILY),,
RL4_JR_01266,1772,1542,3028,0,0,2,0,0,1,0,0,0,0,0,0,0,4,0,32.83841762,1,-1.05263174,1.067303321,-0.986253597,0.324008684,0.513304017,17.34603977,1,1.385601359,1.151938081,1.20284361,0.229036845,0.378870886,20.828987,0,-2.19161759,1.222134917,-1.793269761,0.0729298,0.151859584,24.03835969,0,-2.614523122,1.224895444,-2.134486771,0.032802955,0.097057254,36.16400521,1,0.271173449,0.840275621,0.322719644,0.746907574,0.823369413,N,-,,WD repeat,P:cellular process,PF05486 (PFAM); PTHR12834:SF12 (PANTHER); PTHR12834 (PANTHER); PTHR12834 (PANTHER),,
RL4_JR_01267,825,717,1376,0,0,0,0,0,0,0,0,0,1,2,0,0,7,0,11.59822684,0,-1.638273461,1.23295473,-1.328737724,0.183934515,0.341748534,3.66882196,0,1.590090081,1.29437942,1.228457481,0.219275281,0.366981547,9.587220375,0,-1.072287458,1.225014693,-0.875326201,0.381396442,0.525126829,28.39962367,1,0.809193708,0.899462809,0.899641097,0.368311279,0.514575714,36.55718047,1,2.143634964,0.713450469,3.004602362,0.002659283,0.010778717,N,-,,wd repeat containing 82,"C:Set1C/COMPASS complex; P:histone H3-K79 methylation; P:termination of RNA polymerase II transcription, poly(A)-coupled; C:mRNA cleavage and polyadenylation specificity factor complex; P:termination of RNA polymerase II transcription, exosome-dependent; P:telomere maintenance; P:mRNA 3'-end processing; P:snoRNA 3'-end processing; P:histone H3-K4 methylation",IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR19861:SF0 (PANTHER); PTHR19861 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),,
RL4_JR_01268,2396,2885,3698,1,2,4,0,0,0,0,0,0,0,1,0,0,0,2,77.28632715,1,0.260562899,0.610185904,0.427022155,0.669363191,0.816661642,11.38261328,0,-0.043289503,1.219529118,-0.0354969,0.971683518,0.98535224,29.66880362,0,-2.701924997,1.201421714,-2.248939708,0.024516332,0.065454469,38.24823882,1,-2.178317857,1.155554592,-1.885084333,0.059418453,0.136172892,44.1177057,1,-1.094059562,0.990681749,-1.104350173,0.269441266,0.401721811,N,-,,mitochondrial oxaloacetate transport,F:secondary active sulfate transmembrane transporter activity; C:integral component of membrane; P:sulfate transmembrane transport; F:oxaloacetate secondary active transmembrane transporter activity; P:oxaloacetate(2-) transmembrane transport; F:malonate(1-) transmembrane transporter activity; P:isopropylmalate transport; F:isopropylmalate transmembrane transporter activity; C:mitochondrial inner membrane,IPR002067 (PRINTS); IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); PTHR24089:SF95 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.15.1, the mitochondrial carrier (mc) family.
RL4_JR_01269,948,951,2278,6,0,0,0,0,0,0,3,0,4,2,0,0,4,2,76.96174743,1,1.782779492,1.822657521,0.978120942,0.328014511,0.517290234,5.199565538,0,1.087019528,1.319759132,0.823649939,0.410138492,0.573939565,37.19436189,1,0.826845753,0.937509182,0.881960164,0.37779835,0.521520384,61.04826652,1,1.372396593,0.754260771,1.819525349,0.068831319,0.148945738,43.84540584,1,1.474520503,0.76778134,1.920495363,0.054795358,0.120035267,N,-,,cytoplasmic trna 2-thiolation 2,C:cytoplasm; P:tRNA modification,IPR019407 (PFAM); PTHR20882 (PANTHER); SSF52402 (SUPERFAMILY),,
RL4_JR_01270,2714,1645,2264,0,5,4,0,0,0,3,0,0,5,2,0,0,1,0,81.67751141,1,1.084351971,0.560836624,1.93345428,0.05318026,0.13955837,8.471747803,0,0.382864493,1.247802657,0.306830965,0.758972038,0.853898657,55.1090408,1,0.167842343,0.870343684,0.192846051,0.847079537,0.902149509,79.84017458,1,0.896179106,0.621776469,1.441320396,0.149494188,0.265688722,25.39371795,1,-1.413450507,1.140171351,-1.239682532,0.215092841,0.339858772,N,-,,ph domain-containing,C:cell part,IPR001849 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); IPR001849 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); PTHR12752:SF9 (PANTHER); PTHR12752 (PANTHER); IPR001849 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR011993 (SUPERFAMILY),,
RL4_JR_01271,782,666,1045,0,0,3,0,0,0,1,0,2,1,1,0,0,2,1,21.38562473,1,0.874144099,0.878127857,0.995463352,0.31951096,0.508004368,3.156676169,0,1.807032359,1.279665319,1.412113255,0.157916617,0.287487769,32.2856035,1,1.557247873,0.865284109,1.799695449,0.07190874,0.150263646,22.80605723,1,0.462335624,1.028497415,0.449525315,0.653052751,0.762912092,23.2243981,1,1.269378747,0.870774364,1.45775852,0.144907115,0.25252746,N,-,,hypothetical protein CMQ_4762,,no IPS match,,
RL4_JR_01272,13748,13486,16982,2,4,5,0,3,0,0,3,1,0,5,2,0,11,1,247.9741157,1,-1.371831333,0.476477454,-2.879110692,0.003987983,0.018014379,171.2632066,1,0.70469765,1.597938199,0.441004321,0.659209869,0.780868612,176.2359583,1,-2.180807741,0.743367575,-2.933686933,0.003349619,0.014701072,208.0140467,1,-1.897452443,0.575335507,-3.297992945,0.000973786,0.007223137,194.2623249,1,-0.976639697,0.536444839,-1.820578045,0.068671023,0.142917596,N,-,,RNA recognition domain-containing,"F:nucleotide binding; C:nucleus; P:stress granule assembly; C:cytoplasmic stress granule; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; C:cytoplasmic mRNA processing body; F:mRNA binding; P:regulation of mRNA stability; F:poly(U) RNA binding",IPR003954 (SMART); IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR24012 (PANTHER); PTHR24012:SF379 (PANTHER); PTHR24012 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY),9.A.60.1.1, the small nuclear rna exporter (snrna-e).
RL4_JR_01273,4288,3488,3641,0,1,9,0,0,3,0,0,1,2,1,0,0,2,0,88.0265952,1,0.395986813,0.504426,0.785024589,0.432439152,0.623162171,42.78662161,1,1.76830361,0.8679395,2.037358146,0.041614165,0.102308157,44.370284,1,-2.09224977,1.191897264,-1.755394389,0.079191871,0.16144553,66.31495089,1,-1.153838298,0.852513017,-1.353455343,0.175910207,0.299729905,44.92205486,1,-1.460661281,0.970574228,-1.504945462,0.132338099,0.235564449,N,-,,dual specificity kinase YAK1,F:ATP binding; F:protein kinase activity; P:protein phosphorylation,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24058 (PANTHER); PTHR24058:SF17 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_01274,3364,3246,3812,0,2,9,0,0,0,0,0,0,0,2,0,0,0,0,92.066076,1,0.681146668,0.46743444,1.45720257,0.145060471,0.289978761,13.2922277,0,-0.267001753,1.20299089,-0.221948275,0.82435415,0.89413981,34.50081151,0,-2.919604801,1.186804452,-2.460055485,0.013891554,0.041769555,47.82490362,1,-1.61298544,1.00962321,-1.59761129,0.110129512,0.211004315,34.03110641,0,-3.002558718,1.190590487,-2.521907197,0.01167205,0.035606961,N,-,,CCR4-NOT transcription complex subunit 2,"C:membrane; C:intracellular part; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:regulation of transcription from RNA polymerase II promoter",IPR007282 (PFAM); PTHR23326:SF3 (PANTHER); PTHR23326:SF3 (PANTHER); PTHR23326 (PANTHER); PTHR23326 (PANTHER),,
RL4_JR_01275,1239,1716,2617,2,0,0,0,0,0,0,0,0,1,1,0,0,0,0,42.39239528,1,-0.794405646,1.067304173,-0.744310447,0.456688682,0.645248748,7.009050969,0,0.656223233,1.267101752,0.517893083,0.604532868,0.738454743,18.35091532,0,-2.008852095,1.227205538,-1.636932064,0.101644665,0.19619649,34.50570332,1,-0.695596834,1.060537994,-0.655890537,0.511894557,0.646896205,18.26369855,0,-2.104665972,1.242793552,-1.693496051,0.090361086,0.176930187,N,-,,COBW domain-containing 1,C:cytoplasm,IPR011629 (G3DSA:3.30.1220.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003495 (PFAM); PTHR13748:SF31 (PANTHER); PTHR13748 (PANTHER); IPR027417 (SUPERFAMILY); IPR011629 (SUPERFAMILY),9.B.10.1.1, the putative tripartite zn(2+) transporter (tzt) family.
RL4_JR_01276,2199,1812,2809,0,0,1,0,0,2,0,0,0,2,1,0,0,9,0,30.98156946,1,-1.919152633,1.154004842,-1.663036897,0.09630505,0.215307371,27.40104421,1,1.990612532,0.999759081,1.991092223,0.046470749,0.111305472,22.48878263,0,-2.302233212,1.200323951,-1.918009891,0.055109757,0.121765862,48.58283002,1,-0.399038672,0.863840996,-0.461935326,0.6441277,0.756034438,56.9991919,1,1.301767652,0.605040928,2.15153652,0.031433877,0.078102577,N,-,,mob1 family,,IPR005301 (SMART); IPR005301 (G3DSA:1.20.140.GENE3D); IPR005301 (PFAM); PTHR22599:SF1 (PANTHER); IPR005301 (PANTHER); IPR005301 (SUPERFAMILY),,
RL4_JR_01277,1750,2028,1305,0,1,0,0,0,0,0,0,0,0,0,2,0,0,0,28.49859608,1,-1.506244621,1.168472782,-1.289071209,0.197373332,0.359895315,6.57810046,0,0.747911942,1.267177711,0.590218669,0.555044057,0.700193732,16.9690105,0,-1.895748328,1.213545211,-1.56215715,0.118250972,0.219618686,38.84095289,1,-0.557215978,1.040356705,-0.535600891,0.592234413,0.715594648,16.60575783,0,-1.967383922,1.211446493,-1.623995722,0.104376722,0.197166848,N,-,,c6 zinc finger domain containing,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR021858 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D),,
RL4_JR_01278,632,859,709,0,0,3,0,0,0,0,0,0,1,1,0,0,0,1,20.31346473,1,1.03783015,0.881161737,1.177797568,0.238877319,0.413310958,2.822763678,0,1.968451701,1.294388381,1.520758166,0.128320536,0.245068013,7.319212553,0,-0.682559117,1.207553824,-0.565241154,0.571909748,0.6956914,21.76777476,1,0.630030718,1.027916856,0.612919921,0.539929291,0.670935698,14.56755201,1,0.174624962,1.13460318,0.153908402,0.877681959,0.918504376,N,-,,MOSC domain-containing,P:biological_process; F:pyridoxal phosphate binding; F:catalytic activity; F:molybdenum ion binding; C:membrane; C:integral component of membrane; C:cellular_component,IPR005303 (PFAM); IPR005302 (PFAM); PTHR14237 (PANTHER); PTHR14237 (PANTHER); PTHR14237:SF23 (PANTHER); PTHR14237:SF23 (PANTHER); IPR005302 (PROSITE_PROFILES); IPR011037 (SUPERFAMILY),,
RL4_JR_01279,1653,1998,1476,0,0,4,0,0,0,0,0,1,3,3,0,0,8,0,35.92022803,1,0.223214736,0.776928893,0.287303946,0.773879602,0.882486692,6.607961562,0,0.741369057,1.250623125,0.592799735,0.553315185,0.699120747,23.58342283,1,-0.943744578,1.202188334,-0.78502224,0.432440529,0.573115319,59.67799076,1,0.991912892,0.639925516,1.55004429,0.121130886,0.225897426,47.64554173,1,1.580465235,0.590273508,2.677513412,0.007417088,0.024719559,N,-,,condensin subunit,C:nucleus; F:ATP binding; P:mitotic chromosome condensation; C:condensin complex,IPR010935 (SMART); IPR010935 (PFAM); IPR003395 (PFAM); IPR024704 (PIRSF); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR18937 (PANTHER); IPR027120 (PTHR18937:PANTHER); IPR027417 (SUPERFAMILY); IPR010935 (SUPERFAMILY),,
RL4_JR_01280,23424,29807,33881,5,7,5,0,0,0,6,1,3,2,6,3,0,0,0,474.690838,1,-1.642479051,0.474479563,-3.461643405,0.000536888,0.003563818,110.7752543,0,-3.325980895,1.196504122,-2.779748798,0.005440096,0.021851053,382.1371684,1,-1.808398089,0.526226859,-3.436537036,0.000589202,0.003813989,404.358383,1,-2.215489372,0.496879656,-4.45880475,8.24E-06,0.00012059,285.1697509,0,-6.069457101,1.213714112,-5.000730438,5.71E-07,8.88E-06,N,-,,dead box RNA helicase,F:nucleic acid binding; F:ATP binding; P:RNA metabolic process; C:mitochondrion; F:helicase activity,IPR001650 (SMART); IPR014001 (SMART); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24031 (PANTHER); PTHR24031:SF232 (PANTHER); PTHR24031:SF232 (PANTHER); IPR014014 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_01281,2568,2614,4155,0,0,7,0,2,0,0,2,0,6,1,0,0,2,1,63.95358781,1,0.109589519,0.679309753,0.161324813,0.871837581,0.938895466,88.45430974,1,1.585616155,0.99084065,1.600273622,0.109537896,0.217187577,46.44141823,1,-0.929099844,1.050944636,-0.884061645,0.376662936,0.520449784,95.37750073,1,0.46629476,0.66183639,0.704546875,0.481092269,0.621511805,45.61634636,1,-0.640183056,0.881820723,-0.725978693,0.467851833,0.599316777,N,-,,hypothetical protein CMQ_4525,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_01282,2664,2423,2883,0,2,4,0,0,0,0,7,4,1,7,1,0,0,2,63.14875862,1,0.212928763,0.603852494,0.35261718,0.724375456,0.854214364,10.17008421,0,0.119253606,1.210947611,0.098479575,0.92155149,0.956810358,107.2773341,1,1.745423777,0.462021189,3.777800279,0.00015822,0.001535778,77.46241678,1,0.933284091,0.504965418,1.848213874,0.064571409,0.143028991,40.74111177,1,-0.930852646,0.967771039,-0.96185214,0.336123882,0.473282451,N,-,,domain-containing,,PTHR20932:SF15 (PANTHER); PTHR20932 (PANTHER),,
RL4_JR_01283,663,587,599,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,7.400043666,0,-0.989836501,1.190704412,-0.831303295,0.405802314,0.597569544,2.371269974,0,2.219902996,1.296545837,1.712166999,0.086865897,0.181552057,6.134556775,0,-0.42790543,1.196844905,-0.357527887,0.720696653,0.8109015,7.075688322,0,-0.849986686,1.194232603,-0.711742992,0.47662394,0.617507024,20.76076631,1,1.177256407,0.966997514,1.217434781,0.223438836,0.350149856,N,-,,Arv1-like family,P:regulation of plasma membrane sterol distribution; C:integral component of membrane; P:intracellular sterol transport; C:Golgi apparatus; C:cortical endoplasmic reticulum; P:membrane lipid biosynthetic process; P:sterol metabolic process; P:sphingolipid metabolic process,IPR007290 (PFAM); IPR007290 (PANTHER),9.A.19.1.1, the lipid intermediate transporter (arv1) family.
RL4_JR_01284,1579,1764,1972,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,55.30502421,1,0.229187874,0.743838747,0.308114997,0.75799483,0.87260239,6.774542943,0,0.705378426,1.225423317,0.575620209,0.564871918,0.707364127,17.60344273,0,-1.94882245,1.191949614,-1.634987274,0.102051715,0.196532541,20.30999111,0,-2.371320359,1.190397063,-1.992041507,0.046366504,0.11701417,17.37765826,0,-2.032905443,1.197280485,-1.697935838,0.089519872,0.175690775,N,-,,vacuolar ATP synthase subunit,"C:vacuolar proton-transporting V-type ATPase, V0 domain; P:ATP hydrolysis coupled proton transport; C:integral component of membrane; F:proton-transporting ATPase activity, rotational mechanism; P:vacuolar acidification",IPR008389 (PFAM); IPR008389 (PANTHER),3.A.2.2.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_01285,745,753,1458,5,5,6,0,0,0,5,0,15,5,2,10,0,0,0,125.0451559,1,3.151348959,0.533659958,5.905162855,3.52E-09,8.79E-08,3.705940236,0,1.575559052,1.305145355,1.207190483,0.227358795,0.377050291,162.5360317,1,4.006715425,0.615875961,6.505718164,7.73E-11,4.60E-09,162.1391922,1,3.607536055,0.659567897,5.469544636,4.51E-08,1.10E-06,9.670298874,0,-1.187322878,1.249802366,-0.950008506,0.342107931,0.479093057,N,-,,family,"C:integral component of membrane; P:regulation of transcription, DNA-templated",IPR029062 (G3DSA:3.40.50.GENE3D); IPR002818 (PFAM); IPR029062 (SUPERFAMILY),,
RL4_JR_01286,13458,10728,12421,0,2,15,0,0,3,0,3,9,1,9,0,0,0,0,219.4976619,1,-0.659080444,0.562043676,-1.172649871,0.240936241,0.415639217,74.98417539,1,0.098472998,0.854867444,0.115190955,0.908293768,0.948789395,203.2729707,1,-0.345835821,0.465975041,-0.742176704,0.457980281,0.595963029,185.2750645,1,-1.14099737,0.504254041,-2.262743134,0.023651528,0.083034578,119.2938221,0,-4.81216735,1.191795333,-4.037746427,5.40E-05,0.000415526,N,-,,tuberous sclerosis 1,P:methionine import into cell; C:cytoplasm; C:membrane; C:integral component of membrane; P:regulation of amino acid transmembrane transport; P:negative regulation of G1/S transition of mitotic cell cycle; C:TSC1-TSC2 complex,IPR007483 (PFAM); IPR007483 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_01287,1721,1433,1509,0,0,1,0,0,0,0,0,2,2,0,2,0,3,3,22.46519289,1,-1.375416251,1.139469637,-1.207067049,0.227406324,0.398792087,5.980173072,0,0.885365768,1.239779583,0.714131592,0.475145812,0.6325695,28.46272611,1,0.057933899,1.033041661,0.056080893,0.955277365,0.97422732,55.73236628,1,0.567610618,0.739091246,0.767984495,0.442496396,0.584587163,48.8761395,1,1.372457313,0.611471295,2.24451634,0.024799199,0.064848112,N,-,,hypothetical protein SMAC_00890,C:membrane,no IPS match,,
RL4_JR_01288,9176,7537,4458,0,0,5,0,0,0,5,2,0,1,9,0,0,0,0,104.1541584,1,-1.577562564,0.819367021,-1.925343006,0.054186461,0.141457007,27.55849275,0,-1.318882878,1.253911498,-1.051814965,0.292884452,0.451986038,141.7577693,1,-0.246327134,0.677258414,-0.363712179,0.716072948,0.807881893,126.9498728,1,-0.468778733,0.659209263,-0.711122794,0.477008146,0.617767649,68.88199774,0,-4.019847053,1.229024516,-3.270762299,0.00107258,0.005048756,N,-,,c6 zinc finger domain containing,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR007219 (PFAM); PTHR31001 (PANTHER); PTHR31001 (PANTHER); PTHR31001:SF11 (PANTHER); PTHR31001:SF11 (PANTHER),,
RL4_JR_01289,20995,11763,16967,0,0,9,0,0,0,0,0,0,4,0,0,0,5,9,232.0281238,1,-2.039440455,0.739797528,-2.756754891,0.005837809,0.024599612,63.60781307,0,-2.52561396,1.217528095,-2.074378382,0.038044183,0.095270466,164.3502072,0,-5.171645209,1.213595785,-4.261423179,2.03E-05,0.000342176,226.782432,1,-2.785609523,0.792937706,-3.513024418,0.000443037,0.003792494,247.154942,1,-0.785179423,0.556306146,-1.41141605,0.158121973,0.268937507,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23504 (PANTHER); PTHR23504:SF15 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.96, the major facilitator superfamily (mfs).
RL4_JR_01290,69,57,61,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.747618415,0,2.317261963,1.634657662,1.417582419,0.156312716,NA,0.239738864,0,5.526044533,1.7623834,3.135551852,0.001715311,0.015023052,0.620068347,0,2.878549543,1.254229569,2.295073895,0.02172889,0.059384459,0.715176284,0,2.456457494,1.328238073,1.849410541,0.064398554,0.142802314,0.609466648,0,2.80021849,1.220156066,2.294967479,0.021734988,0.058433686,N,-,,multidrug resistance,"F:nucleotide binding; F:ATPase activity; F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:membrane; C:integral component of membrane; P:transport",IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); PTHR24223:SF209 (PANTHER); PTHR24223 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.208.41, the atp-binding cassette (abc) superfamily.
RL4_JR_01291,5212,6199,7978,3,14,1,0,0,0,0,2,1,0,2,0,0,10,5,223.7251225,1,0.855818612,0.880336281,0.972149655,0.330976102,0.520752757,24.58039336,0,-1.153952978,1.204482263,-0.958048958,0.338038072,0.501011413,86.24806697,1,-1.406784339,0.865706187,-1.625013612,0.104159658,0.199869671,81.9493559,1,-2.516380706,1.032682104,-2.436742824,0.014820215,0.065631958,138.8833623,1,0.581152393,0.487576966,1.191919293,0.233292892,0.361144168,N,-,,DUF1014 domain,,IPR010422 (PFAM); PTHR21680 (PANTHER); IPR010422 (PTHR21680:PANTHER),,
RL4_JR_01292,991,1473,1224,0,0,10,0,0,0,0,0,2,0,3,3,0,3,0,53.04438959,1,1.858872014,0.684123175,2.717159836,0.00658448,0.02722564,4.726162681,0,1.224872818,1.266048626,0.967476915,0.333305676,0.496667433,25.26549636,1,0.387852656,1.050954969,0.369047835,0.712092071,0.805139616,55.09491933,1,1.471444846,0.647425839,2.272762003,0.023040526,0.081940754,23.66511931,1,0.680123889,0.87586052,0.776520774,0.43744156,0.57201655,N,-,,ubiquitin-conjugating enzyme,F:ligase activity,IPR000608 (PFAM); IPR016135 (G3DSA:3.10.110.GENE3D); PTHR24067 (PANTHER); PTHR24067:SF149 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),,
RL4_JR_01293,298,438,457,0,0,0,0,0,0,0,0,2,0,0,0,0,1,0,4.792299976,0,-0.362914111,1.238001984,-0.293145016,0.76941131,0.879039577,1.518380969,0,2.862948094,1.359146991,2.106430072,0.035167011,0.089527286,16.95154576,1,2.020689823,1.053933847,1.917283355,0.055201943,0.121916334,4.562809978,0,-0.217088517,1.224677713,-0.177261752,0.859302792,0.912474124,7.770270765,1,1.047403957,1.151628586,0.909498053,0.363087285,0.499771099,N,-,,mt-a70 family,F:nucleic acid binding; C:cytosol; F:methyltransferase activity; P:nucleobase-containing compound metabolic process; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR007757 (PFAM); PTHR12829 (PANTHER); PTHR12829:SF4 (PANTHER); IPR007757 (PROSITE_PROFILES),,
RL4_JR_01294,3764,3157,3407,0,0,4,0,0,0,0,0,0,0,1,0,0,1,2,56.56708443,1,-0.752133727,0.737097451,-1.020399306,0.307539123,0.494560254,13.23441683,0,-0.260680853,1.211832444,-0.215112951,0.829679257,0.897895161,34.24137755,0,-2.908677905,1.189556375,-2.445178695,0.014478039,0.043161268,43.50587653,1,-2.383433594,1.14117482,-2.08857885,0.036745651,0.101814152,52.25864514,1,-0.766942533,0.833931221,-0.919671207,0.357744603,0.495237094,N,-,,mitochondrial carrier leu5,F:structural constituent of ribosome; C:integral component of membrane; P:coenzyme A transmembrane transport; F:coenzyme A transmembrane transporter activity; C:mitochondrial inner membrane; P:translation,IPR002067 (PRINTS); IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089:SF0 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.12.4, the mitochondrial carrier (mc) family.
RL4_JR_01295,36,11,25,10,5,1,7,0,0,0,0,0,3,3,2,0,8,0,144.8070244,1,8.885884388,0.919568815,9.663098883,4.33E-22,7.54E-20,156.2752619,1,10.72869071,1.768592167,6.066232177,1.31E-09,2.25E-07,0.237170665,0,4.264208827,1.434520164,2.972568064,0.002953197,0.013463048,59.51558154,1,7.622457529,0.669931639,11.37796319,5.38E-30,8.65E-28,31.11722183,1,7.608291879,0.807005513,9.427806577,4.19E-21,1.09E-18,N,-,,inorganic phosphate transporter pho84,C:integral component of plasma membrane; F:inorganic phosphate transmembrane transporter activity; F:selenite:proton symporter activity; P:proton transport; P:phosphate ion transport; P:manganese ion transmembrane transport; F:manganese ion transmembrane transporter activity; P:plasma membrane selenite transport; P:polyphosphate metabolic process,IPR004738 (TIGRFAM); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR24064:SF296 (PANTHER); PTHR24064 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.9.2, the major facilitator superfamily (mfs).
RL4_JR_01296,2074,2436,4273,0,1,0,0,0,0,1,0,0,0,2,0,0,0,0,43.00820311,1,-2.276031609,1.192644769,-1.908390216,0.0563408,0.145222196,11.02209208,0,0.003122428,1.250411333,0.00249712,0.998007588,0.999073169,39.9398133,1,-1.700760623,1.224282876,-1.38918926,0.164775207,0.281487138,41.3464719,1,-1.382049276,1.068831336,-1.293047116,0.195994764,0.325771082,28.76015051,0,-2.759771774,1.241340891,-2.223218291,0.026201084,0.067848076,N,-,,dna-binding hgh1,F:DNA binding,IPR011989 (G3DSA:1.25.10.GENE3D); IPR007205 (PFAM); IPR007206 (PFAM); PTHR13387 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_01297,12867,18252,21604,0,0,5,0,0,0,0,0,0,0,7,0,0,0,1,230.4814046,1,-2.858401029,0.766560197,-3.728867009,0.000192343,0.001484514,66.86099412,0,-2.597588388,1.204585636,-2.156416539,0.031051154,0.08136158,174.3866843,0,-5.257160432,1.209842097,-4.345327746,1.39E-05,0.000250075,229.3298778,1,-2.231899421,0.656897075,-3.397639454,0.000679699,0.005359779,180.1345158,1,-4.406282761,1.152656326,-3.822720322,0.000131987,0.00087631,N,-,,rRNA processing,"F:snoRNA binding; C:cytoplasm; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:nucleolus; C:90S preribosome; C:preribosome, small subunit precursor",IPR007955 (PFAM); PTHR12821:SF0 (PANTHER); IPR007955 (PANTHER); PTHR12821:SF0 (PANTHER); IPR007955 (PANTHER),,
RL4_JR_01298,2580,3348,4219,0,2,4,0,0,0,1,0,3,0,5,1,0,3,0,71.92218764,1,-0.155593187,0.666233707,-0.233541451,0.815340986,0.906040195,12.85695287,0,-0.219002573,1.221456802,-0.179296208,0.857705124,0.916475916,64.09865009,1,-0.060588436,0.767312312,-0.078961898,0.93706293,0.962152647,68.39023239,1,-0.02135673,0.658904879,-0.032412464,0.974143123,0.985055494,44.81137243,1,-0.783090142,0.883222102,-0.886628789,0.375278789,0.511468265,N,-,,pol 2 transcription elongation factor subunit,"P:regulation of histone H2B conserved C-terminal lysine ubiquitination; P:positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues; P:transcription elongation from RNA polymerase I promoter; F:chromatin binding; P:regulation of transcription-coupled nucleotide-excision repair; P:translational elongation; F:RNA polymerase II core binding; P:transcription elongation from RNA polymerase II promoter; P:negative regulation of DNA recombination; P:positive regulation of transcription elongation from RNA polymerase II promoter; F:transcription factor activity, TFIIF-class transcription factor binding; F:translation elongation factor activity; F:RNA polymerase II C-terminal domain phosphoserine binding; P:positive regulation of transcription elongation from RNA polymerase I promoter; P:histone modification; C:Cdc73/Paf1 complex; C:transcriptionally active chromatin; P:recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex; C:cytosol; P:positive regulation of histone H3-K36 trimethylation",IPR031336 (PFAM); IPR007852 (PANTHER); PTHR12466:SF8 (PANTHER),,
RL4_JR_01299,9564,10472,12596,0,4,2,0,0,0,0,0,4,0,2,2,0,3,0,170.2614283,1,-1.804552765,0.631746362,-2.856451377,0.004284056,0.019087564,41.50918641,0,-1.909859602,1.192695392,-1.60129704,0.109311144,0.216780447,133.9517393,1,-1.751131708,0.748801207,-2.338580243,0.019357168,0.054466918,151.8546028,1,-2.254801735,0.746453006,-3.020688131,0.00252201,0.016070075,118.2723165,1,-2.454241545,0.859424495,-2.855680238,0.004294474,0.015817224,N,-,,developmental regulator flbA,F:GTPase activator activity; P:adaptation of signaling pathway by response to pheromone involved in conjugation with cellular fusion; C:intracellular; C:plasma membrane; P:intracellular signal transduction; P:positive regulation of GTPase activity,IPR016137 (SMART); IPR000591 (SMART); IPR000591 (PFAM); IPR016137 (PFAM); G3DSA:1.10.167.10 (GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); PTHR10845 (PANTHER); PTHR10845:SF180 (PANTHER); IPR000591 (PROSITE_PROFILES); IPR016137 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY); IPR016137 (SUPERFAMILY); IPR011991 (SUPERFAMILY),,
RL4_JR_01300,510,474,634,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,6.459620427,0,-0.793929072,1.201334629,-0.660872544,0.508694055,0.695052407,2.056365423,0,2.425368051,1.304973317,1.858557581,0.063089874,0.141689751,5.345841442,0,-0.22963433,1.201551494,-0.191114847,0.848435616,0.902928853,6.167701176,0,-0.652122571,1.200228064,-0.543332214,0.586901088,0.712002578,13.00441641,1,1.349251116,0.988297101,1.365228244,0.172181324,0.287394643,N,-,,NACHT and WD40 domain partial,,PTHR38117:SF3 (PANTHER); PTHR38117 (PANTHER),,
RL4_JR_01301,151,132,264,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2.173220535,0,0.777635644,1.342357884,0.579305752,0.562382885,0.739272894,0.686716814,0,4.007524071,1.513556105,2.647753894,0.008102849,0.028909777,1.795935787,0,1.343728276,1.258639922,1.067603413,0.285699443,0.425043522,6.084290653,1,1.864556918,1.195598766,1.559517266,0.118874001,0.222888752,1.787450383,0,1.248368554,1.261520715,0.98957436,0.322382207,0.458315059,N,-,,grf zinc finger domain-containing,P:DNA repair; F:oxidoreductase activity; P:oxidation-reduction process; P:DNA dealkylation,IPR027450 (G3DSA:2.60.120.GENE3D); IPR027450 (PFAM); IPR010666 (PFAM); PTHR31212:SF4 (PANTHER); IPR032854 (PANTHER); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_01302,1488,1649,2285,0,0,0,0,0,0,0,0,0,2,1,0,0,0,3,21.66231421,0,-2.539474131,1.206089693,-2.105543348,0.035244038,0.102432773,6.864269923,0,0.68634561,1.23611907,0.555242312,0.578728931,0.717879196,17.89601348,0,-1.972656181,1.203304622,-1.639365581,0.101137145,0.195477751,43.28737296,1,-0.068679638,0.867206747,-0.079196383,0.936876422,0.963171625,39.83197803,1,0.186073117,0.866905762,0.214640535,0.830047588,0.885461702,N,-,,origin recognition complex subunit 4,"C:origin recognition complex; F:DNA binding; P:macromolecular complex subunit organization; F:metal ion binding; C:nucleoplasm part; P:DNA-dependent DNA replication; C:protein-DNA complex; C:nuclear chromosome part; P:regulation of transcription, DNA-templated; P:single-organism cellular process",IPR003593 (SMART); IPR001965 (SMART); IPR032705 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PF13191 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR016527 (PTHR12087:PANTHER); PTHR12087 (PANTHER); IPR019787 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_01303,9535,19840,25240,7,0,8,0,0,0,0,0,0,1,0,0,0,8,0,320.2135221,1,-1.180967523,0.77342302,-1.526936092,0.126776904,0.262432373,68.78332119,0,-2.638480342,1.242156531,-2.124112602,0.033660729,0.086497563,180.3026867,0,-5.305289932,1.25039117,-4.24290419,2.21E-05,0.000364093,217.456903,1,-4.770986228,1.212068571,-3.936234586,8.28E-05,0.000906977,210.3760048,1,-2.003665389,0.829530867,-2.41541993,0.015717078,0.045055326,N,-,,ribosome biogenesis urb1,C:nucleus; P:rRNA processing,IPR021714 (PFAM); IPR032436 (PFAM); PTHR13500 (PANTHER),,
RL4_JR_01304,9496,11010,10247,0,4,28,0,0,0,0,2,5,2,3,1,0,5,0,262.4426426,1,0.314058541,0.760993501,0.412695432,0.679829772,0.824217283,39.39732868,0,-1.834494475,1.196514455,-1.533198757,0.12522689,0.240830292,150.3173542,1,-0.864598484,0.577034868,-1.498347035,0.13404311,0.240996704,158.1222845,1,-1.589543223,0.615450033,-2.582733184,0.00980211,0.047806532,119.8454857,1,-1.64195746,0.684017197,-2.40046225,0.01637438,0.046609669,N,-,,isopentenyl-diphosphate delta-isomerase,C:nucleus; F:isopentenyl-diphosphate delta-isomerase activity; P:farnesyl diphosphate biosynthetic process; F:hydrolase activity,IPR000086 (PFAM); IPR011876 (TIGRFAM); IPR015797 (G3DSA:3.90.79.GENE3D); IPR011876 (PIRSF); PTHR10885:SF0 (PANTHER); IPR011876 (PANTHER); IPR000086 (PROSITE_PROFILES); IPR015797 (SUPERFAMILY),,
RL4_JR_01305,279,361,283,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,15.54550742,1,1.739997905,1.028268181,1.69216352,0.0906148,0.206029972,1.186712565,0,3.218622129,1.392045651,2.312152713,0.020769269,0.05926883,3.073118387,0,0.569578988,1.218379741,0.467488886,0.640150142,0.749289074,3.545066593,0,0.147272781,1.222474041,0.12047109,0.904109979,0.94125928,10.38536936,1,1.428529609,1.134471478,1.259202754,0.207957107,0.330751761,N,-,,gcn5-related n-acetyltransferase,C:intracellular membrane-bounded organelle; C:cytoplasmic part,IPR000182 (PFAM); IPR016181 (G3DSA:3.40.630.GENE3D); PTHR21471:SF63 (PANTHER); PTHR21471 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_01306,688,646,450,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,14.8065649,1,0.769562029,1.046789856,0.73516382,0.462239731,0.650500556,2.309793071,0,2.257858788,1.338945423,1.686296357,0.091738732,0.189351438,5.948956291,0,-0.383464412,1.221384683,-0.313958754,0.753552366,0.834770123,6.859997208,0,-0.805219928,1.222404055,-0.658718306,0.510076676,0.645211768,5.815672841,0,-0.453774974,1.215134773,-0.373435922,0.708824028,0.794425867,N,-,,c6 zinc finger domain containing,"F:transcription factor activity, sequence-specific DNA binding; F:binding; P:regulation of transcription from RNA polymerase II promoter",PTHR31986:SF1 (PANTHER); PTHR31986 (PANTHER),,
RL4_JR_01307,7154,6760,14919,0,0,2,0,0,0,0,3,0,0,5,0,0,0,4,122.0988349,1,-3.253000235,1.111285998,-2.927239469,0.003419855,0.0159515,36.02796798,0,-1.705560685,1.238577116,-1.377032292,0.168502264,0.30272984,118.0109433,1,-1.962745052,0.919471026,-2.134645897,0.032789945,0.082311149,129.1182335,1,-1.850781042,0.804890318,-2.299420182,0.021481091,0.079552321,123.771992,1,-1.744537265,0.876668175,-1.989963039,0.046595007,0.10608825,N,-,,purine-cytosine permease fcy22,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR001248 (PFAM); IPR026030 (PIRSF); PTHR31806:SF5 (PANTHER); PTHR31806 (PANTHER),2.A.39.2.4, the nucleobase:cation symporter-1 (ncs1) family.
RL4_JR_01308,284,230,399,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,11.26870871,1,1.749622237,1.048804838,1.668205726,0.095274895,0.213696969,1.15325111,0,3.259686957,1.398422839,2.33097377,0.019754743,0.056951725,3.005411001,0,0.601051229,1.227757468,0.489552085,0.624450889,0.73700231,3.467842107,0,0.178461305,1.234530896,0.14455799,0.885059868,0.929358142,2.979899921,0,0.510947834,1.232984483,0.414399241,0.678581745,0.771461954,N,-,,riboflavin biosynthesis,C:nucleus; F:5-amino-6-(5-phosphoribosylamino)uracil reductase activity; P:riboflavin biosynthetic process; C:cytosol; P:oxidation-reduction process,IPR002734 (PFAM); IPR024072 (G3DSA:3.40.430.GENE3D); PTHR11079:SF3 (PANTHER); PTHR11079 (PANTHER); IPR024072 (SUPERFAMILY),,
RL4_JR_01309,2658,2179,2068,0,2,14,0,0,0,0,0,3,0,2,0,0,5,4,97.11517037,1,1.694397194,0.527921782,3.20956106,0.001329378,0.007407832,8.883751428,0,0.314393082,1.234067458,0.254761666,0.798907184,0.878017212,42.43070109,1,0.069736589,0.861413265,0.080956019,0.935476929,0.961430162,34.47263015,1,-1.029427315,1.02345998,-1.00583055,0.314497089,0.460755755,71.25906799,1,1.386600451,0.519231745,2.670484738,0.007574181,0.025176818,N,-, Effector probability:0.636,hypothetical protein HIM_00532,,no IPS match,,
RL4_JR_01310,522,810,815,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,16.26899825,1,0.499247476,1.052794088,0.474211892,0.635348814,0.791837971,2.733927691,0,2.014517499,1.304894097,1.543816854,0.122632707,0.237385401,7.119848172,0,-0.642843102,1.21759548,-0.527961144,0.597526305,0.716833311,17.52832159,1,-0.113428164,1.165554126,-0.097316942,0.922474702,0.954067965,7.039080333,0,-0.729064611,1.224512492,-0.59539173,0.551581652,0.671792978,N,-,,salicylate hydroxylase,F:FAD binding; F:oxidoreductase activity; C:membrane; P:oxidation-reduction process,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789 (PANTHER); PTHR13789:SF147 (PANTHER); SSF54373 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_01311,1396,1166,745,1,1,5,0,0,0,0,2,1,0,0,0,0,0,0,50.45021946,1,1.665199218,0.657673431,2.531954523,0.01134287,0.041871102,4.296519661,0,1.362430673,1.315414094,1.035742797,0.300322151,0.460406143,33.22260376,1,1.127451675,0.897995079,1.255520994,0.209289692,0.336752835,12.72617034,0,-1.696824998,1.232393737,-1.376852987,0.168557705,0.28995018,10.76379512,0,-1.341943374,1.227054372,-1.09362992,0.274117321,0.406961345,N,-,,DUF221 domain,C:integral component of membrane,IPR022257 (PFAM); IPR032880 (PFAM); IPR003864 (PFAM); IPR027815 (PFAM); PTHR13018:SF20 (PANTHER); PTHR13018 (PANTHER); PTHR13018:SF20 (PANTHER),1.A.17.5.8, the calcium-dependent chloride channel (ca-clc) family.
RL4_JR_01312,3745,3428,5781,0,5,0,0,0,0,1,0,2,2,2,2,0,8,0,91.62833611,1,-0.609555009,0.799417339,-0.762499109,0.445762174,0.634425649,16.34336223,0,-0.565171051,1.219650737,-0.463387619,0.643086552,0.76815224,66.71034267,1,-0.818418991,0.875960618,-0.934310258,0.350143874,0.49357513,95.12682362,1,-0.303845063,0.651770395,-0.466184205,0.641083655,0.75397801,73.20813329,1,0.189808543,0.661546547,0.286916384,0.774176345,0.843851383,N,-,,mitochondrial ribosomal,F:structural constituent of ribosome; P:mitochondrial translation; C:mitochondrial large ribosomal subunit,IPR013025 (PFAM); PTHR12059 (PANTHER); PTHR12059:SF5 (PANTHER); IPR012678 (SUPERFAMILY),,
RL4_JR_01313,12,3,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.133299514,0,4.804533788,3.704852392,1.296821919,0.194692467,NA,0.042225095,0,8.030362506,2.643644922,3.037610096,0.002384623,0.015223444,0.110584962,0,5.363242522,1.639994113,3.27028157,0.001074405,0.006100547,0.127617706,0,4.942076074,2.343474818,2.108866729,0.034956087,0.099498352,0.110518104,0,5.262890352,1.441728101,3.650404226,0.000261828,0.001569572,N,-,,hypothetical protein CMQ_4810,,no IPS match,,
RL4_JR_01314,2720,2331,2683,0,0,2,0,0,0,0,0,0,1,3,3,0,2,0,38.54446426,1,-1.320751432,1.003224259,-1.316506673,0.18800404,0.346874244,9.888129598,0,0.159831504,1.215194753,0.13152748,0.895358049,0.941970775,25.61625605,0,-2.490024177,1.188261641,-2.095518436,0.036124931,0.088246157,79.80113116,1,0.631508246,0.565107291,1.117501502,0.263779958,0.404417334,32.94307489,1,-0.899593463,0.96947478,-0.927918375,0.353449912,0.490768014,N,-,,hypothetical protein F503_02952,,no IPS match,,
RL4_JR_01315,152,109,148,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.629625218,0,1.192936254,1.313646173,0.908110782,0.363819694,NA,0.521824611,0,4.403865011,1.543208564,2.853706954,0.004321237,0.018725049,1.351964998,0,1.753625485,1.231393137,1.424098797,0.154417875,0.26806011,1.559439301,0,1.331561493,1.252927253,1.06276042,0.287890613,0.432220115,1.332096675,0,1.672225821,1.218945594,1.371862558,0.170106228,0.284917379,N,-,,---NA---,,no IPS match,,
RL4_JR_01316,622,569,638,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,15.32510728,1,-0.024216716,1.137164225,-0.021295707,0.983009768,0.991333724,2.337917402,0,2.240305864,1.291073801,1.735226803,0.082700641,0.174504041,6.059543803,0,-0.410258278,1.194182072,-0.34354751,0.731186605,0.818772636,6.989939764,0,-0.832509397,1.191239657,-0.698859706,0.484639711,0.624853823,5.968251397,0,-0.491106818,1.193980418,-0.411318989,0.680838648,0.773333106,N,-,,---NA---,,no IPS match,,
RL4_JR_01317,906,795,1362,0,3,0,0,0,0,0,0,2,0,3,7,0,0,0,36.22103593,1,0.641531383,0.88259272,0.726871374,0.467304755,0.65593121,3.865180586,0,1.514886643,1.27600502,1.187210567,0.235144574,0.385571582,23.07935834,1,0.669674262,1.055428096,0.634504866,0.525751392,0.6555058,91.11565769,1,2.570238358,0.589441554,4.360463457,1.30E-05,0.000178303,10.00422011,0,-1.236313095,1.225036379,-1.009205209,0.312876229,0.448262603,N,-,,dna mismatch repair,F:ATPase activity; C:MutLbeta complex; P:reciprocal meiotic recombination; P:meiotic heteroduplex formation; F:heteroduplex DNA loop binding; P:meiotic mismatch repair; C:mitotic spindle pole body; C:synaptonemal complex; F:single-stranded DNA binding; C:chiasma; F:ATP binding; C:MutLgamma complex; C:mitochondrion; C:cytosol; C:MutLalpha complex; F:dinucleotide insertion or deletion binding,IPR013507 (SMART); IPR032189 (PFAM); IPR013507 (PFAM); IPR002099 (TIGRFAM); IPR014721 (G3DSA:3.30.230.GENE3D); PF13589 (PFAM); IPR003594 (G3DSA:3.30.565.GENE3D); PTHR10073:SF40 (PANTHER); PTHR10073:SF40 (PANTHER); PTHR10073 (PANTHER); IPR003594 (SUPERFAMILY); IPR020568 (SUPERFAMILY),,
RL4_JR_01318,12697,10516,13530,7,4,17,0,0,0,0,0,1,4,6,0,0,10,1,314.0451529,1,0.225208941,0.32909102,0.684336331,0.493762811,0.681345908,46.84259975,0,-2.084238075,1.193888241,-1.745756431,0.080853285,0.171571687,128.0048516,1,-3.774114994,1.190341369,-3.170615666,0.001521163,0.007954675,201.4844845,1,-1.110800684,0.490605228,-2.264143595,0.023565284,0.082990784,165.7973868,1,-0.801925847,0.521229961,-1.538525999,0.123920057,0.224412551,N,-,,26S proteasome regulatory subunit rpn-1,"C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:proteasome regulatory particle, base subcomplex; P:regulation of catalytic activity; F:endopeptidase activity; P:regulation of protein catabolic process; C:proteasome storage granule; F:enzyme regulator activity",IPR016643 (PIRSF); IPR002015 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR016643 (PTHR10943:PANTHER); PTHR10943 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_01319,2844,4609,8769,3,0,0,0,0,0,0,0,0,0,2,0,0,0,0,94.85013141,1,-1.578380355,1.05190764,-1.500493289,0.133486671,0.27211001,20.21053813,0,-0.871559685,1.274589021,-0.683796636,0.494103591,0.649100136,53.195657,0,-3.544269049,1.260772908,-2.811187508,0.004935901,0.018765519,69.44378161,1,-2.285737239,1.123531402,-2.034422211,0.041909044,0.111051838,53.24874928,0,-3.64845238,1.280451655,-2.849348015,0.004380893,0.016098001,N,-,,rio1 family,"C:nucleus; F:ATP binding; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:cytosol; P:positive regulation of RNA import into nucleus; F:protein serine/threonine kinase activity; P:protein phosphorylation",IPR000687 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR015285 (PFAM); PF01163 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); IPR030484 (PTHR10593:PANTHER); PTHR10593 (PANTHER); IPR011991 (SUPERFAMILY); IPR011009 (SUPERFAMILY),,
RL4_JR_01320,1217,519,1037,0,3,0,0,0,0,0,0,0,3,0,0,0,0,0,35.00580745,1,0.826907525,0.931032547,0.888161782,0.374453734,0.56638423,3.531303843,0,1.645298219,1.339795018,1.228022345,0.21943858,0.367072766,9.134154799,0,-1.002373716,1.244674528,-0.805329982,0.420629284,0.561800907,38.47075426,1,0.974620307,0.923091126,1.05582242,0.291049353,0.435799276,8.997283584,0,-1.083348858,1.251880881,-0.86537695,0.386831928,0.522976747,N,-,,sporulation-specific 5,F:nucleotide binding; F:nucleic acid binding,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR24012:SF441 (PANTHER); PTHR24012 (PANTHER); PTHR24012 (PANTHER); PTHR24012:SF441 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY),,
RL4_JR_01321,144625,50925,95118,8,22,30,0,2,7,0,1,4,0,6,6,0,10,4,1520.962434,1,-1.62557871,0.516568295,-3.146880526,0.001650224,0.008892025,514.7445681,1,-1.361646493,0.728186705,-1.869913972,0.061495765,0.138849015,993.0264172,1,-4.622367561,0.827850036,-5.583580794,2.36E-08,9.17E-07,1187.75146,1,-3.790505966,0.714196525,-5.30737106,1.11E-07,2.46E-06,1008.854353,1,-3.512846167,0.719998855,-4.878960771,1.07E-06,1.53E-05,N,-,,nadph-cytochrome p450 reductase,C:endoplasmic reticulum membrane; F:FMN binding; F:NADPH-hemoprotein reductase activity; C:integral component of membrane; P:oxidation-reduction process,IPR001094 (PRINTS); IPR001709 (PRINTS); G3DSA:2.40.30.10 (GENE3D); IPR001433 (PFAM); IPR003097 (PFAM); IPR023208 (PIRSF); IPR023173 (G3DSA:1.20.990.GENE3D); G3DSA:3.40.50.80 (GENE3D); IPR008254 (PFAM); IPR029039 (G3DSA:3.40.50.GENE3D); PTHR19384:SF10 (PANTHER); PTHR19384 (PANTHER); PTHR19384 (PANTHER); IPR023208 (HAMAP); IPR008254 (PROSITE_PROFILES); IPR017927 (PROSITE_PROFILES); IPR029039 (SUPERFAMILY); SSF52343 (SUPERFAMILY); IPR017938 (SUPERFAMILY),,
RL4_JR_01322,91138,23365,25929,0,1,6,0,0,0,0,1,2,1,3,1,0,10,0,586.4748083,1,-3.888146143,0.966816413,-4.021597161,5.78E-05,0.000529262,183.2939388,0,-4.052493189,1.351439311,-2.998649777,0.002711788,0.015349618,487.2959958,1,-4.307603891,1.049232177,-4.105482073,4.03E-05,0.000605149,568.3552325,1,-4.068264819,0.916224608,-4.440248365,8.99E-06,0.000129414,490.3992558,1,-3.172152254,1.048763549,-3.024659138,0.002489135,0.010174602,N,-,,cell morphogenesis pag1,C:incipient cellular bud site; C:cellular bud; P:cell morphogenesis; C:mating projection tip; P:budding cell apical bud growth,IPR025481 (PFAM); IPR029473 (PFAM); IPR025614 (PFAM); PTHR12295:SF30 (PANTHER); PTHR12295 (PANTHER); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_01323,13692,7728,8229,3,1,3,0,0,0,5,1,6,9,10,13,0,9,4,167.8034795,1,-1.418929509,0.650243249,-2.182151849,0.029098328,0.088279716,38.24754897,0,-1.791766208,1.235657409,-1.450050957,0.14704431,0.272820997,200.5680487,1,-0.008765228,0.537227712,-0.016315666,0.986982559,0.994052072,362.6135427,1,1.03652442,0.468269305,2.213522025,0.026861676,0.087153604,160.4278317,1,-0.23951238,0.540547324,-0.443092344,0.657698943,0.756167111,N,-,,atp-dependent protease la,F:ATP binding; P:protein import into peroxisome matrix; P:misfolded or incompletely synthesized protein catabolic process; F:serine-type endopeptidase activity; P:protein processing; C:peroxisomal matrix; F:ATP-dependent peptidase activity,PR00830 (PRINTS); IPR003111 (SMART); IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR014721 (G3DSA:3.30.230.GENE3D); IPR008269 (PFAM); IPR003111 (PFAM); G3DSA:1.10.8.60 (GENE3D); IPR003959 (PFAM); IPR027065 (PANTHER); PTHR10046:SF24 (PANTHER); IPR027065 (PANTHER); IPR027065 (PANTHER); PTHR10046:SF24 (PANTHER); PTHR10046:SF24 (PANTHER); IPR027065 (PANTHER); IPR027501 (HAMAP); IPR015947 (SUPERFAMILY); IPR020568 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_01324,1960,3246,2944,0,5,8,0,0,0,0,0,1,0,2,0,0,0,0,103.4259693,1,1.248540181,0.546821132,2.283269811,0.02241448,0.072161535,10.40393751,0,0.086456601,1.240475275,0.069696352,0.944435346,0.970318166,33.57030228,1,-1.607905074,1.211620805,-1.327069548,0.184485677,0.30583478,39.26182832,1,-1.280337472,1.048533527,-1.221074424,0.222057842,0.357224782,26.73144468,0,-2.654216777,1.219510688,-2.176460448,0.029520848,0.074186792,N,-,,Replication factor A 2,F:DNA binding; P:DNA repair; P:chromosome organization; P:DNA replication; P:DNA recombination; C:nuclear chromosome; C:chromosomal part,IPR014892 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); G3DSA:2.40.50.140 (GENE3D); IPR004365 (PFAM); IPR014646 (PIRSF); PTHR13989:SF16 (PANTHER); PTHR13989 (PANTHER); IPR012340 (SUPERFAMILY); IPR011991 (SUPERFAMILY),,
RL4_JR_01325,5540,5072,5073,0,9,19,0,0,0,0,1,0,2,2,0,0,1,0,207.4486483,1,1.393246989,0.385620751,3.612997969,0.000302677,0.002197772,20.11721093,0,-0.864813146,1.202825838,-0.71898451,0.472150464,0.630239614,59.89475671,1,-2.551075405,1.188320887,-2.146790007,0.031810003,0.080344972,86.68594777,1,-1.202937336,0.73807229,-1.629836742,0.103136006,0.200487329,55.02621051,1,-2.660070827,1.114672869,-2.386413899,0.017013591,0.048050936,N,-,,Sec1 family superfamily,C:cell division site; F:antiporter activity; P:positive regulation of vesicle fusion; F:SNARE binding; C:plasma membrane; C:nucleus; C:cellular bud tip; P:drug transmembrane transport; C:prospore membrane; C:cell tip; C:cellular bud neck; P:vesicle docking involved in exocytosis; C:integral component of membrane; C:cytosol; F:drug transmembrane transporter activity,IPR027482 (G3DSA:3.40.50.GENE3D); G3DSA:3.90.830.10 (GENE3D); G3DSA:1.25.40.60 (GENE3D); IPR001619 (PIRSF); IPR001619 (PFAM); G3DSA:3.40.50.2060 (GENE3D); PTHR11679:SF30 (PANTHER); IPR001619 (PANTHER); IPR001619 (SUPERFAMILY),1.F.1.1.3, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_01326,3469,2735,4056,0,0,0,0,0,0,2,0,0,0,0,0,0,0,1,40.87139297,0,-3.455414409,1.196106765,-2.888884595,0.003866109,0.017590474,13.03251609,0,-0.238560102,1.214582109,-0.196413318,0.844286673,0.907028954,56.00020889,1,-1.059474414,1.036610171,-1.022056742,0.306754045,0.448232616,39.06336191,0,-3.314982244,1.19684794,-2.769760581,0.005609751,0.03068543,40.82516565,1,-2.041908165,1.1318822,-1.80399353,0.071232321,0.146799766,N,-,,mate efflux family,P:drug transmembrane transport; P:vesicle-mediated transport; C:membrane; F:drug transmembrane transporter activity,IPR002528 (TIGRFAM); IPR002528 (PFAM); PTHR11206:SF123 (PANTHER); PTHR11206 (PANTHER),2.A.66.1.5, the multidrug/oligosaccharidyl-lipid/polysaccharide (mop) flippase superfamily.
RL4_JR_01327,576,482,450,0,0,3,0,0,0,0,0,0,0,1,0,0,0,2,17.4930328,1,1.601557357,0.861353394,1.859349912,0.062977557,0.158125859,1.940447243,0,2.509203185,1.329167482,1.887800611,0.059052723,0.134533348,5.009727583,0,-0.135621105,1.206623978,-0.112397157,0.910508509,0.945337724,9.789148864,1,0.389056177,1.153203775,0.337369844,0.735838115,0.823808516,19.64445428,1,1.476176443,0.973484291,1.516384452,0.129422168,0.23156025,N,-,,duf202 domain-containing,C:integral component of membrane,IPR003807 (PFAM); PTHR34187:SF3 (PANTHER); PTHR34187 (PANTHER),9.B.51.1.5, the uncharacterized duf202/yidh (yidh) family.
RL4_JR_01328,3669,4708,4490,0,0,5,0,0,2,0,0,0,1,2,0,0,0,0,70.78583382,1,-0.783240257,0.700907344,-1.117466186,0.26379505,0.443353938,35.20726102,1,1.064743318,0.993564683,1.071639659,0.283881913,0.443228864,42.71432539,0,-3.227643118,1.19497598,-2.701010875,0.006912908,0.024317679,66.61661711,1,-1.339137463,0.861025503,-1.555281996,0.119878923,0.224208281,42.11014664,0,-3.309855163,1.197867458,-2.763123033,0.005725118,0.020023082,N,-,,glycosyltransferase 2,C:membrane,PTHR33604:SF1 (PANTHER); PTHR33604 (PANTHER),,
RL4_JR_01329,5490,5471,10440,0,0,0,0,0,4,0,0,0,0,0,1,0,3,0,85.12387612,0,-4.513834912,1.2419139,-3.634579588,0.000278434,0.002042686,64.36425808,1,1.273642048,0.812179692,1.568177659,0.116839677,0.22861999,70.28434227,0,-3.946167697,1.224072554,-3.223802122,0.001265008,0.006952736,90.75680749,1,-3.414916404,1.183352272,-2.885798662,0.003904218,0.023009436,81.58198144,1,-1.878178851,0.925307196,-2.029789521,0.042377939,0.098366948,N,-,,armadillo repeat,P:biological_process; C:nucleus; P:protein import into nucleus; P:ribosomal large subunit biogenesis; C:cytosol; F:molecular_function,IPR011989 (G3DSA:1.25.10.GENE3D); PTHR13347:SF1 (PANTHER); PTHR13347 (PANTHER); PTHR13347 (PANTHER); PTHR13347:SF1 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_01330,2823,3303,4576,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,54.60014566,1,-1.784862047,1.036377835,-1.722211714,0.085031174,0.196678286,13.53790883,0,-0.293468191,1.21889077,-0.240766603,0.809736015,0.884253743,35.31871511,0,-2.953412692,1.204452344,-2.452079326,0.014203335,0.042567957,40.75821549,0,-3.376233642,1.206101337,-2.799295165,0.00512143,0.028538513,35.02326201,0,-3.044010975,1.21431549,-2.506771098,0.012183959,0.036857658,N,-,,domain-containing,,IPR001623 (PRINTS); IPR001623 (SMART); IPR001623 (G3DSA:1.10.287.GENE3D); IPR001623 (PFAM); PTHR15606 (PANTHER); PTHR15606:SF4 (PANTHER); IPR001623 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_01331,442,881,671,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.061397922,0,-1.1132029,1.257309333,-0.885385061,0.375948987,0.567659088,2.554137886,0,2.112699133,1.34536309,1.570356099,0.11633229,0.227979756,6.641806184,0,-0.542489417,1.238986324,-0.437849399,0.661495459,0.766332535,7.664203125,0,-0.965219043,1.243259952,-0.776361405,0.437535626,0.579242706,6.549177274,0,-0.624987597,1.244945047,-0.502020229,0.615653292,0.722723429,N,-,,alpha beta hydrolase fold family,,IPR029058 (G3DSA:3.40.50.GENE3D); IPR029058 (SUPERFAMILY),,
RL4_JR_01332,14087,25247,28150,0,0,1,0,0,0,0,1,0,0,5,0,0,5,1,274.9982666,1,-5.241990829,1.207632781,-4.340715914,1.42E-05,0.000156991,85.50508183,0,-2.952428505,1.220070693,-2.419883145,0.015525495,0.047434067,231.2031964,1,-4.652444755,1.227676434,-3.789634327,0.000150869,0.001485798,277.8562634,1,-3.074767858,0.777550028,-3.9544309,7.67E-05,0.000851711,248.2000479,1,-2.570749136,0.745189131,-3.449794192,0.000561014,0.002980203,N,-,,atp-dependent rna helicase dbp10,C:nucleus; F:ATP binding; F:RNA binding; F:ATP-dependent RNA helicase activity,IPR012541 (SMART); IPR001650 (SMART); IPR014001 (SMART); IPR012541 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR011545 (PFAM); PTHR24031 (PANTHER); IPR033517 (PTHR24031:PANTHER); IPR033517 (PTHR24031:PANTHER); PTHR24031 (PANTHER); PTHR24031 (PANTHER); IPR033517 (PTHR24031:PANTHER); IPR012541 (PRODOM); IPR001650 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_01333,631,492,817,0,8,0,0,0,0,0,0,0,0,1,0,0,0,1,71.79954454,1,2.983888407,1.097302399,2.719294525,0.006542133,0.027064259,2.455700274,0,2.169299506,1.3055996,1.661535057,0.096606034,0.197265741,6.391392842,0,-0.487368343,1.212804844,-0.40185224,0.687792774,0.785915806,11.38581947,1,0.036022378,1.162306737,0.030992144,0.975275805,0.98517231,13.69406508,1,0.363176475,1.146068725,0.316888915,0.751327893,0.827057386,N,-,,developmental regulator,,no IPS match,,
RL4_JR_01334,4100,3577,2555,6,6,3,0,0,1,2,2,8,2,4,0,0,0,2,160.9869672,1,1.347353195,0.558664076,2.411741247,0.015876545,0.054650148,22.62999487,1,0.651822092,1.151908642,0.565862663,0.571487145,0.712016021,123.9241126,1,1.484365181,0.512109032,2.898533495,0.003749123,0.015764501,74.00064771,1,-0.027631202,0.66685021,-0.041435395,0.966948796,0.981390994,48.06066651,1,-1.276869533,0.988620259,-1.291567234,0.196507057,0.3178329,N,-,,revertant of glycogen synthase kinase mutation,F:catalytic activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR007751 (PFAM); PTHR12482 (PANTHER); PTHR12482 (PANTHER); IPR016445 (PTHR12482:PANTHER); IPR016445 (PTHR12482:PANTHER); PTHR12482 (PANTHER); PTHR12482 (PANTHER); IPR016445 (PTHR12482:PANTHER); IPR016445 (PTHR12482:PANTHER); PTHR12482 (PANTHER); IPR016445 (PTHR12482:PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_01335,10973,8163,6773,1,1,4,0,0,0,4,3,7,4,14,8,0,9,0,137.0639119,1,-1.503844713,0.668057937,-2.251069301,0.024381148,0.077153378,33.49959314,0,-1.600533217,1.226784411,-1.304657284,0.192009573,0.333787344,199.5104773,1,0.389109474,0.478477055,0.813224941,0.416089102,0.557723563,269.8968625,1,0.771508963,0.405157127,1.904221623,0.056881327,0.132584698,119.0223993,1,-0.637065666,0.627770273,-1.014806998,0.310197837,0.445769046,N,-,,ibr domain-containing,F:ubiquitin-protein transferase activity; F:zinc ion binding; F:metal ion binding; P:phosphorylation; F:kinase activity; F:ligase activity; P:protein ubiquitination,PTHR11685:SF126 (PANTHER); IPR031127 (PANTHER); PTHR11685:SF126 (PANTHER); SSF57850 (SUPERFAMILY),1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_01336,2072,1554,1631,0,1,4,0,0,0,0,0,0,0,5,1,0,0,2,44.28784671,1,0.539932205,0.678706831,0.795530825,0.426304787,0.616765634,6.753497532,0,0.709921518,1.245324941,0.5700693,0.568630696,0.709789112,17.4390103,0,-1.935244379,1.199025345,-1.614014573,0.106524265,0.203275798,49.8048292,1,0.935089543,0.634657629,1.473376354,0.140649583,0.253574969,31.8454745,1,-0.323566672,0.973988234,-0.332207989,0.739732212,0.818109082,N,-,,C6 zinc finger domain-containing,"C:nucleus; F:zinc ion binding; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31944 (PANTHER); PTHR31944:SF54 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_01337,2261,2180,3055,0,4,2,0,0,0,1,0,0,0,3,0,0,0,0,69.59593602,1,0.321936572,0.634107953,0.507699944,0.611663788,0.776912733,9.507013137,0,0.216472446,1.218745883,0.177619017,0.859022188,0.917583642,35.81593598,1,-1.478415238,1.195559934,-1.236588142,0.216240024,0.344870888,40.58728718,1,-0.565245866,0.866062738,-0.652661569,0.513974483,0.648860933,24.48910787,0,-2.527843158,1.20463282,-2.098434573,0.035866774,0.086382275,N,-,,hypothetical protein CMQ_3683,,PTHR28108:SF1 (PANTHER); PTHR28108 (PANTHER),,
RL4_JR_01338,864,1154,927,0,3,1,0,0,2,0,0,3,0,6,0,0,0,4,39.70823736,1,1.075231838,0.764052366,1.407275057,0.159345843,0.308714105,22.53951465,1,3.178768383,1.011650129,3.142161793,0.001677053,0.015023052,29.29798052,1,1.294151748,0.868757631,1.489657992,0.136314185,0.244212495,35.37710764,1,1.740121012,0.653639523,2.662202865,0.007763108,0.039637652,39.10083222,1,1.47616475,0.761349477,1.938879312,0.052516036,0.116198615,N,-,,abhydrolase domain-containing,C:membrane,IPR029058 (G3DSA:3.40.50.GENE3D); IPR000073 (PFAM); PTHR12277 (PANTHER); PTHR12277:SF50 (PANTHER); IPR029058 (SUPERFAMILY),1.C.57.3.4, the clostridial cytotoxin (cct) family.
RL4_JR_01339,2209,1993,2129,2,2,2,0,0,0,1,0,0,0,2,0,0,2,0,69.11834071,1,0.552760562,0.59957485,0.921920861,0.356569857,0.547505532,8.106058593,0,0.446541496,1.221352339,0.365612348,0.71465436,0.82111474,32.06031143,1,-1.2408583,1.187049711,-1.045329685,0.295870622,0.436837419,32.23509043,1,-0.895749907,1.009521431,-0.887301527,0.374916584,0.520503278,28.37401959,1,-0.610266037,0.966696073,-0.63129049,0.527850604,0.651380611,N,-,,abc transporter,C:membrane; C:integral component of membrane,PTHR37848 (PANTHER),,
RL4_JR_01340,2978,3378,4034,1,0,7,0,0,0,0,1,0,0,0,2,0,0,0,78.38680766,1,0.207878006,0.571782282,0.363561469,0.716185504,0.847992575,13.21274203,0,-0.258371114,1.207813088,-0.213916471,0.830612195,0.898616571,42.21790076,1,-1.952531282,1.193324027,-1.636212158,0.101795193,0.196449587,58.9334532,1,-1.591089788,1.017890692,-1.563124411,0.118023335,0.221518269,33.9808228,0,-3.00041284,1.200103891,-2.500127582,0.012414859,0.037410847,N,-,,glycylpeptide N-tetradecanoyltransferase,C:cytosol; P:replicative cell aging; F:glycylpeptide N-tetradecanoyltransferase activity; P:N-terminal protein myristoylation,IPR016181 (G3DSA:3.40.630.GENE3D); IPR022676 (PFAM); IPR016181 (G3DSA:3.40.630.GENE3D); IPR022677 (PFAM); PTHR11377:SF5 (PANTHER); IPR000903 (PANTHER); IPR000903 (PANTHER); PTHR11377:SF5 (PANTHER); IPR016181 (SUPERFAMILY); IPR016181 (SUPERFAMILY),,
RL4_JR_01341,195,341,315,3,0,0,0,0,0,0,0,2,0,3,0,0,9,1,33.62426482,1,2.51980927,0.907619067,2.776285075,0.005498397,0.023484778,1.085081316,0,3.347696553,1.426806354,2.346286546,0.018961524,0.05515359,15.82324431,1,2.502303131,1.067973733,2.343038086,0.01912743,0.053975652,15.29568731,1,2.540827698,0.912223037,2.785314113,0.005347589,0.029538647,44.9028439,1,4.439369093,0.615231274,7.215772805,5.36E-13,5.97E-11,N,-,,glycylpeptide n-tetradecanoyltransferase,F:transferase activity; F:hydrolase activity,IPR000073 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR10992:SF744 (PANTHER); PTHR10992 (PANTHER); PTHR10992:SF744 (PANTHER); PTHR10992 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_01342,2139,2276,3689,0,3,0,0,0,0,0,0,0,4,2,3,0,4,0,56.33872451,1,-0.754946623,0.895449609,-0.843092247,0.399176855,0.591013572,10.21279127,0,0.113142038,1.235435057,0.091580725,0.927031166,0.959634629,26.68177649,0,-2.548857057,1.212346271,-2.102416709,0.035516789,0.087147836,104.9710288,1,1.006271021,0.57383925,1.753576496,0.079503101,0.16569965,41.95196391,1,-0.07186658,0.818389147,-0.087814679,0.930023971,0.954398766,N,-,,ribosomal l36,F:structural constituent of ribosome; C:ribosome; P:translation,IPR000473 (PFAM); IPR000473 (TIGRFAM); IPR000473 (PANTHER); PD002101 (PRODOM); IPR000473 (SUPERFAMILY),,
RL4_JR_01343,422,602,858,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.527159533,0,-1.014448055,1.249689834,-0.811759868,0.416929434,0.608354556,2.371840066,0,2.219403913,1.333354201,1.664526884,0.096007183,0.196320143,6.205060461,0,-0.444582775,1.233452083,-0.360437816,0.718519751,0.809604225,7.162035205,0,-0.867655744,1.237239136,-0.701283785,0.483125931,0.623298936,6.16941232,0,-0.538839912,1.246181102,-0.432392941,0.665455848,0.762010213,N,-,,complex 1,,IPR008011 (PFAM); IPR026868 (PANTHER); PTHR13675:SF0 (PANTHER),,
RL4_JR_01344,667,685,1144,0,0,0,0,0,1,0,0,0,0,3,0,0,0,0,9.945370016,0,-1.416445204,1.227970625,-1.153484599,0.248711536,0.425632202,12.52267715,1,2.72712376,1.149652327,2.372129118,0.017685909,0.052191479,8.214693811,0,-0.849387716,1.220269737,-0.696065542,0.486387784,0.621558873,21.5151555,1,1.006048913,0.901614199,1.115830822,0.264494558,0.405267463,8.163102315,0,-0.942870079,1.232814028,-0.764811284,0.444383928,0.577214531,N,-,,gnat family acetyltransferase,C:membrane; F:transferase activity,IPR016181 (G3DSA:3.40.630.GENE3D); IPR000182 (PFAM); PTHR20531:SF1 (PANTHER); PTHR20531 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_01345,308,491,450,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.028678128,0,-0.432321356,1.242644909,-0.347904179,0.727912147,0.856109526,1.594587445,0,2.792330935,1.361486181,2.050943281,0.040272471,0.099647641,4.148161209,0,0.136602211,1.225024383,0.111509789,0.911212103,0.945874227,4.786581116,0,-0.286086056,1.228631487,-0.23284936,0.815878382,0.883693691,4.095358491,0,0.052402576,1.227922166,0.042675813,0.965959961,0.977936667,N,-, Effector probability:0.596,plac8 family,C:membrane,IPR006461 (TIGRFAM); IPR006461 (PFAM); PTHR15907 (PANTHER),1.A.87.3.2, the mechanosensitive calcium channel (mca) family.
RL4_JR_01346,5758,3275,5565,0,3,3,0,0,0,0,0,0,0,6,0,0,1,0,93.44043937,1,-0.646803619,0.672507676,-0.961778789,0.336160735,0.526372222,18.57460688,0,-0.749755659,1.230818876,-0.609151902,0.542423758,0.688970666,48.13440506,0,-3.400036793,1.21272728,-2.803628522,0.005053109,0.01907445,79.58905942,1,-0.588233827,0.697950661,-0.842801448,0.399339498,0.543581916,51.33350569,1,-2.554621696,1.14884605,-2.223641449,0.026172577,0.067808942,N,-,,ferrochelatase,C:nucleus; F:ferrochelatase activity; P:heme biosynthetic process; C:cytosol; C:mitochondrial inner membrane,G3DSA:3.40.50.1400 (GENE3D); IPR001015 (TIGRFAM); IPR001015 (PFAM); PTHR11108:SF1 (PANTHER); IPR001015 (PANTHER); IPR001015 (PANTHER); PTHR11108:SF1 (PANTHER); SSF53800 (SUPERFAMILY),,
RL4_JR_01347,534,649,626,0,0,3,0,0,0,0,0,0,1,0,0,0,1,0,18.71918823,1,1.333843912,0.863394722,1.544883097,0.122374543,0.255965569,2.313587308,0,2.255403109,1.297537882,1.738217544,0.082172489,0.173601454,6.004568945,0,-0.396984885,1.200821287,-0.330594477,0.740950819,0.826234837,16.23971216,1,0.130536702,1.146413664,0.11386527,0.909344597,0.944513135,9.77797546,1,0.4510777,1.129807276,0.399251899,0.689707606,0.779907249,N,-,,dsb repair complex subunit,"F:double-stranded DNA binding; P:DNA recombination; P:telomere maintenance; C:Ku70:Ku80 complex; F:ATP-dependent DNA helicase activity; P:double-strand break repair via nonhomologous end joining; F:damaged DNA binding; C:nuclear chromosome, telomeric region; F:nucleotide binding; P:cellular response to gamma radiation; P:cellular response to X-ray; F:telomeric DNA binding; P:DNA duplex unwinding",IPR006164 (SMART); IPR003034 (SMART); IPR006165 (PIRSF); IPR002035 (G3DSA:3.40.50.GENE3D); IPR006165 (TIGRFAM); IPR003034 (PFAM); IPR003034 (G3DSA:1.10.720.GENE3D); IPR005160 (PFAM); IPR006164 (PFAM); IPR016194 (G3DSA:2.40.290.GENE3D); IPR005160 (G3DSA:1.10.1600.GENE3D); IPR005161 (PFAM); IPR006165 (PTHR12604:PANTHER); PTHR12604 (PANTHER); PTHR12604 (PANTHER); IPR003034 (PROSITE_PROFILES); IPR016194 (SUPERFAMILY); IPR002035 (SUPERFAMILY); SSF68906 (SUPERFAMILY),,
RL4_JR_01348,1410,1071,1352,0,3,0,0,0,0,0,0,0,3,3,0,0,0,0,39.31984859,1,0.287927484,0.847826659,0.339606547,0.734152847,0.859641161,4.896463426,0,1.173780852,1.249635968,0.939298229,0.347577648,0.510399093,12.68171843,0,-1.475759559,1.195975175,-1.233938287,0.217225901,0.346002993,54.59932109,1,1.420275185,0.619570137,2.292355779,0.021885122,0.080273303,12.48818591,0,-1.556335471,1.197668528,-1.29947096,0.193782353,0.314532643,N,-,,atp-dependent dna helicase 2 subunit 1,"C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:helicase activity; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_01349,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,Y,-,,---NA---,,no IPS match,,
RL4_JR_01350,762,732,899,0,0,0,0,0,0,0,0,0,0,1,0,0,4,0,9.564894086,0,-1.360162397,1.191022147,-1.142012682,0.253448748,0.43102666,3.047982932,0,1.857636281,1.267791225,1.465254092,0.142851606,0.266288022,7.916349885,0,-0.795969671,1.194120702,-0.666573882,0.505044357,0.637063178,13.14457277,1,-0.271190661,1.142727642,-0.237318719,0.812409541,0.880973182,23.25669273,1,1.725813332,0.758294418,2.275914593,0.022851122,0.060646818,N,-,,transcription initiation factor IIA small partial,C:integral component of membrane,PTHR31965 (PANTHER); PTHR31965:SF1 (PANTHER); SSF103481 (SUPERFAMILY),2.A.7.2.4, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_01351,2935,2184,2194,0,5,4,2,0,0,0,0,0,0,0,0,0,0,0,84.55203969,1,0.932855969,0.537109099,1.736809095,0.082420873,0.192772214,54.03125986,1,1.912925314,0.996149886,1.92031876,0.054817648,0.127029358,24.27399071,0,-2.412333857,1.20038996,-2.009625152,0.044470877,0.103475789,27.99283737,0,-2.834153073,1.199882091,-2.362026314,0.018175352,0.073580744,23.80242274,0,-2.486869722,1.19777201,-2.076246316,0.037871176,0.090158865,N,-,,Ca2+:H+ antiporter,P:transmembrane transport; P:mycelium development; P:calcium ion transport; C:integral component of membrane; P:pathogenesis,IPR004837 (PFAM); PTHR31503:SF0 (PANTHER); PTHR31503 (PANTHER),2.A.19.2.8, the ca(2+):cation antiporter (caca) family.
RL4_JR_01352,8379,8128,6510,0,12,0,0,0,0,0,0,1,0,6,2,0,3,0,188.5348232,1,0.0286754,1.338851663,0.021417907,0.98291229,0.991333724,29.68134493,0,-1.425938691,1.211890583,-1.176623295,0.239345896,0.391296424,83.11437174,1,-3.108762669,1.198576942,-2.593711392,0.009494615,0.031394879,131.7004958,1,-0.786304221,0.567128593,-1.386465487,0.165604812,0.286281154,86.66722616,1,-1.942906044,0.85046834,-2.284513077,0.022341395,0.059685125,N,-,,vacuolar membrane-associated IML1,P:biological regulation; C:membrane; C:vacuole,IPR000591 (SMART); IPR027244 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); IPR000591 (PFAM); IPR027244 (PANTHER); IPR000591 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY),,
RL4_JR_01353,15486,15086,18415,4,4,4,2,0,0,0,0,2,1,10,0,0,1,2,283.4117641,1,-1.37742533,0.456202875,-3.019326277,0.002533375,0.012625092,107.0174208,1,-0.836661566,0.972125511,-0.860651795,0.38942985,0.553936051,175.0631903,1,-3.331085294,1.030831467,-3.231454803,0.001231618,0.006821062,236.4025902,1,-1.422724212,0.480190087,-2.962835451,0.003048195,0.018872784,178.5819949,1,-3.012798854,0.847128232,-3.556485004,0.00037585,0.002127155,N,-,,hypothetical protein CMQ_3941,,IPR027469 (G3DSA:1.20.1510.GENE3D); IPR002524 (PFAM); IPR002524 (TIGRFAM); IPR028084 (PFAM); PTHR11562:SF48 (PANTHER); IPR002524 (PANTHER); SSF161111 (SUPERFAMILY); SSF160240 (SUPERFAMILY),2.A.4.2.2, the cation diffusion facilitator (cdf) family.
RL4_JR_01354,13362,12587,16002,1,2,6,0,0,0,0,0,3,8,5,5,0,20,1,216.5892187,1,-1.60474771,0.518379742,-3.095699117,0.001963495,0.010314354,53.39151773,0,-2.273036086,1.189744822,-1.910524042,0.056065774,0.129316535,158.2071039,1,-2.524201076,0.852535541,-2.960816241,0.003068249,0.013767301,302.7633169,1,-0.392810267,0.397958092,-0.987064403,0.323611067,0.470094986,221.5583057,1,-0.340452056,0.705949653,-0.4822611,0.629620477,0.733253662,N,-,,cell lysis,C:endoplasmic reticulum part; C:membrane part,IPR003388 (PFAM); IPR003388 (PROSITE_PROFILES),8.A.102.1.4, the reticulon (reticulon) family.
RL4_JR_01355,5048,4757,5597,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,85.61259261,1,-1.725472535,0.843143446,-2.046475653,0.040709595,0.114048379,19.64968445,0,-0.830921477,1.196348619,-0.694547947,0.487338643,0.643470095,50.98746001,0,-3.483106888,1.1864621,-2.935708513,0.003327869,0.014638686,58.82027837,0,-3.905448868,1.185404866,-3.294611807,0.000985577,0.00728392,50.28077715,0,-3.565716799,1.1894011,-2.997909451,0.002718384,0.010961227,N,-,,PQ-loop repeat-containing 2,C:cytoplasm; C:membrane,IPR006603 (SMART); IPR006603 (PFAM); PTHR16201:SF35 (PANTHER); PTHR16201 (PANTHER),2.A.43.2.7, the lysosomal cystine transporter (lct) family.
RL4_JR_01356,16386,4591,8862,7,8,10,0,0,0,1,0,6,0,2,0,0,1,1,290.5579911,1,0.498029879,0.603617858,0.825074793,0.40932913,0.600702832,38.38063021,0,-1.796786556,1.29821409,-1.384044874,0.166344715,0.299598079,148.5956928,1,-0.858938515,0.776263262,-1.106504142,0.268508372,0.406651564,121.5988616,1,-3.181918765,1.148767158,-2.769855268,0.005608121,0.03068543,107.5792389,1,-2.821019324,1.087838627,-2.593233273,0.009507826,0.030149306,N,-,,NADH pyrophosphatase,F:NAD+ diphosphatase activity; C:nucleus; C:peroxisome; P:NADH metabolic process; F:metal ion binding; C:cytosol,IPR015376 (PFAM); IPR015797 (G3DSA:3.90.79.GENE3D); IPR015375 (PFAM); IPR000086 (PFAM); PTHR22769:SF7 (PANTHER); PTHR22769 (PANTHER); IPR000086 (PROSITE_PROFILES); IPR015797 (SUPERFAMILY),,
RL4_JR_01357,1256,1608,2656,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,22.02196549,0,-2.563227235,1.240309786,-2.066602443,0.03877163,0.110401033,6.932554765,0,0.67204826,1.269047644,0.529568975,0.59641081,0.732008029,51.36832827,1,0.453670633,0.89664916,0.505962257,0.612883145,0.728256609,20.9597999,0,-2.416793686,1.231940157,-1.961778478,0.04978828,0.122632027,18.08513575,0,-2.090495086,1.244839998,-1.679328339,0.093088071,0.18066318,N,-,,rna polymerase ii elongator complex subunit,C:intracellular part,IPR027417 (G3DSA:3.40.50.GENE3D); IPR013641 (PFAM); PTHR12435:SF2 (PANTHER); PTHR12435 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_01358,2104,2695,3988,0,0,9,0,0,3,1,0,3,0,3,0,0,2,0,69.47340656,1,0.451985486,0.742694142,0.608575537,0.542805823,0.72415534,39.21223696,1,2.157098136,0.894621616,2.411184905,0.015900785,0.048274668,59.52620846,1,0.148844404,0.784551173,0.189719179,0.849529191,0.903902631,45.45942021,1,-0.814865058,0.907168513,-0.898251037,0.36905173,0.514987936,36.50336609,1,-1.108887001,1.024660967,-1.082198929,0.279164144,0.412874227,N,-,,extracellular aldonolactonase,C:integral component of membrane,IPR015943 (G3DSA:2.130.10.GENE3D); IPR019405 (PFAM); PTHR30344 (PANTHER); PTHR30344:SF1 (PANTHER); IPR011048 (SUPERFAMILY),,
RL4_JR_01359,13,14,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.168275167,0,4.46873752,3.190752214,1.400527907,0.161355293,NA,0.053631907,0,7.686258135,2.361813634,3.254388079,0.001136369,0.015023052,0.139205483,0,5.03370605,1.38833582,3.62571215,0.000288166,0.002259794,0.160597485,0,4.611280922,1.929547429,2.389825124,0.016856397,0.070408836,0.137258415,0,4.952015202,1.263541114,3.919156366,8.89E-05,0.000628283,,,,,,,,
RL4_JR_01360,2284,1821,3258,0,3,0,7,2,14,25,25,30,2,13,1,0,1,0,53.30566797,1,-0.61938197,0.886341617,-0.698807275,0.484672481,0.672617182,373.4484364,1,5.370839867,0.426045492,12.60625911,1.95E-36,4.94E-33,692.0126876,1,4.764133002,0.328600794,14.49823947,1.24E-47,7.40E-45,108.3655675,1,1.796576743,0.504335562,3.562264645,0.000367669,0.003217505,27.89143361,1,-1.572644813,1.152303545,-1.364783455,0.17232112,0.287539329,Y,-,,minor extracellular protease vpr,F:peptidase activity,IPR015500 (PRINTS); IPR000209 (G3DSA:3.40.50.GENE3D); G3DSA:3.50.30.30 (GENE3D); IPR010435 (PFAM); IPR000209 (PFAM); PTHR10795:SF359 (PANTHER); IPR015500 (PANTHER); PTHR10795:SF359 (PANTHER); IPR015500 (PANTHER); IPR000209 (SUPERFAMILY); SSF52025 (SUPERFAMILY),1.B.12.9.2, the autotransporter-1 (at-1) family.
RL4_JR_01361,248,255,360,0,3,0,0,0,1,0,0,0,0,0,0,0,0,0,27.47592658,1,2.451130338,0.866085383,2.830125511,0.004652975,0.020551688,10.47171139,1,4.251897803,1.138981831,3.733069035,0.000189161,0.008182414,2.848123692,0,0.678675823,1.218281836,0.557076206,0.577475364,0.699827697,3.286453296,0,0.256036458,1.223464179,0.209271724,0.834236124,0.896099043,2.821128162,0,0.590041197,1.222085057,0.482815164,0.629226983,0.732879696,N,-,,GMC oxidoreductase,"F:oxidoreductase activity, acting on CH-OH group of donors",IPR023753 (G3DSA:3.50.50.GENE3D); IPR000172 (PFAM); IPR007867 (PFAM); IPR012132 (PIRSF); PTHR11552:SF128 (PANTHER); PTHR11552 (PANTHER); SSF54373 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_01362,7,6,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.095435337,0,5.286782925,3.917931075,1.3493813,0.177214524,NA,0.030229218,0,8.512810514,2.65782857,3.202919334,0.001360421,0.015023052,0.078916107,0,5.850556787,1.521421522,3.845454203,0.000120329,0.001297917,0.091068364,0,5.42926052,2.409551074,2.253224917,0.024244971,0.084186358,0.078388769,0,5.759892734,1.311559679,4.391636023,1.13E-05,0.000111455,N,-,,Enoyl-hydratase isomerase family,"F:transferase activity, transferring acyl groups",IPR003480 (PFAM); IPR023213 (G3DSA:3.30.559.GENE3D); IPR023213 (G3DSA:3.30.559.GENE3D); PTHR31642:SF31 (PANTHER); PTHR31642 (PANTHER),,
RL4_JR_01363,24,15,44,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.327998318,0,3.505684201,2.488723919,1.408627198,0.158945432,NA,0.103514383,0,6.737069611,2.1428867,3.143922453,0.001666996,0.015023052,0.271270289,0,4.069474526,1.401591109,2.903467708,0.00369055,0.015698795,0.313095084,0,3.64746879,1.690819507,2.157219487,0.030988567,0.094165438,0.270837561,0,3.970667817,1.329436487,2.986729984,0.002819787,0.011266906,N,-,,Pth11-like integral membrane,C:membrane,PTHR33048:SF27 (PANTHER); PTHR33048 (PANTHER),9.B.313.1.1, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_01364,81,151,128,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.452585629,0,1.359253176,1.429908628,0.950587436,0.341813849,NA,0.459938339,0,4.586007072,1.609125703,2.849999265,0.004371933,0.018894022,1.197050967,0,1.929746328,1.268419664,1.521378438,0.128164897,0.233412738,1.381360016,0,1.506910269,1.308481427,1.151648191,0.24946567,0.388590755,1.181851491,0,1.845658383,1.255716023,1.469805552,0.141614425,0.248060726,N,-,,benzoate 4-monooxygenase cytochrome P450,F:catalytic activity,IPR001128 (PRINTS); IPR002403 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305 (PANTHER); PTHR24305:SF38 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_01365,8314,5829,10728,0,4,3,0,0,0,0,0,0,0,0,0,0,0,0,142.2843711,1,-1.181212953,0.641311979,-1.841869468,0.065494246,0.16259953,31.43744262,0,-1.508922438,1.215974948,-1.240915728,0.214636882,0.361273267,81.83968736,0,-4.165764055,1.210939569,-3.440108953,0.00058148,0.003778501,94.42405173,0,-4.588283175,1.214439765,-3.778106835,0.000158025,0.001576359,81.08126602,0,-4.255084293,1.220118951,-3.487433983,0.000487679,0.002653279,N,-,,Major facilitator superfamily general substrate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); PTHR23502:SF34 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.33, the major facilitator superfamily (mfs).
RL4_JR_01366,1,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.052598981,0,6.146737788,3.927007759,1.565247172,0.117524965,NA,0.016379583,0,9.396716193,3.154537248,2.978793862,0.002893854,0.015349618,0.043074039,0,6.726018721,1.879354995,3.578897409,0.000345047,0.002591435,0.049740294,0,6.302230203,3.235884791,1.947606485,0.051462067,0.125322509,0.042946859,0,6.633844921,1.449850646,4.575536756,4.75E-06,5.44E-05,N,-, Effector probability:0.749,aconitase a isopropylmalate dehydratase,P:lysine biosynthetic process; F:lyase activity; F:iron-sulfur cluster binding,no IPS match,,
RL4_JR_01367,335,267,238,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3.362830416,0,0.14801529,1.2365431,0.119700874,0.904720108,0.953456484,1.083009246,0,3.350574541,1.41561306,2.366871737,0.017939149,0.052846351,9.291132539,1,1.669559219,1.207006049,1.383223573,0.166596324,0.283608741,3.220115239,0,0.285849582,1.227169202,0.232934123,0.815812561,0.883693691,2.735101803,0,0.634418145,1.210858181,0.523940916,0.600319635,0.710067867,N,PKS,,Acyl transferase acyl hydrolase lysophospholipase,F:catalytic activity; P:metabolic process,IPR020806 (SMART); SM00822 (SMART); IPR020807 (SMART); IPR020801 (SMART); IPR020841 (SMART); IPR020843 (SMART); IPR029063 (G3DSA:3.40.50.GENE3D); IPR032821 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.70.250 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); PF13602 (PFAM); IPR014030 (PFAM); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR014031 (PFAM); IPR001227 (G3DSA:3.40.366.GENE3D); IPR013968 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR014043 (PFAM); IPR020807 (PFAM); PTHR11712 (PANTHER); PTHR11712:SF270 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR016040 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR016035 (SUPERFAMILY); IPR011032 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR029063 (SUPERFAMILY); IPR016036 (SUPERFAMILY),,
RL4_JR_01368,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein BA78_8864,,no IPS match,,
RL4_JR_01369,400,301,316,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,4.063370533,0,-0.125104022,1.216622891,-0.102828923,0.918098749,0.961099653,1.306429089,0,3.079952244,1.378097959,2.234929834,0.025421956,0.0694149,3.373656773,0,0.434722687,1.213140396,0.358344911,0.720085212,0.810556225,23.94863686,1,3.032634135,0.693076671,4.375611333,1.21E-05,0.000167039,3.311033248,0,0.358723146,1.205655605,0.297533678,0.7660591,0.837166583,N,-,,C6 transcription factor,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PTHR31845:SF7 (PANTHER); PTHR31845 (PANTHER); PTHR31845:SF7 (PANTHER); PTHR31845 (PANTHER),,
RL4_JR_01370,302,247,230,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.11818268,0,0.256982214,1.233128955,0.208398491,0.834917834,0.917712165,1.002797706,0,3.461578246,1.419616206,2.438390202,0.01475284,0.045469812,2.588065885,0,0.817287144,1.218023599,0.670994507,0.502224029,0.63461259,2.984661818,0,0.395384174,1.223160464,0.323248001,0.746507431,0.832761102,2.537541265,0,0.74258271,1.206912769,0.615274549,0.538373422,0.660937905,N,-,,Major facilitator superfamily general substrate transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF44 (PANTHER); PTHR23501:SF44 (PANTHER); PTHR23501 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.3.65, the major facilitator superfamily (mfs).
RL4_JR_01371,84,107,124,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.262424051,0,1.561518946,1.40463167,1.111692823,0.266270247,NA,0.400313769,0,4.786237208,1.607761637,2.976956968,0.002911249,0.015387812,1.042453463,0,2.12883811,1.243308322,1.712236677,0.086853061,0.173706122,1.202903979,0,1.706206873,1.279510616,1.333483952,0.182373038,0.308628951,1.031233336,0,2.042276158,1.230867245,1.659217245,0.097072024,0.186535252,N,-,,Polyketide enoylreductase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process; C:cellular_component,IPR020843 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013149 (PFAM); IPR013154 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR002085 (PANTHER); PTHR11695:SF570 (PANTHER); IPR002085 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_01372,4,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.023384166,0,7.313912602,3.95207815,1.850649791,0.064219952,NA,0.007676691,0,10.49078673,3.950953353,2.655254516,0.007924859,0.028414957,0.019666007,0,7.855152288,2.683181743,2.927551333,0.003416427,0.014889386,0.022661569,0,7.435381089,3.951464833,1.881677151,0.059879864,0.136569486,0.019240544,0,7.773765358,1.580101908,4.919787338,8.66E-07,1.28E-05,N,-,,cytochrome P450 3A24,F:organic cyclic compound binding; F:heterocyclic compound binding; F:oxidoreductase activity,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_01373,432,258,321,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4.025639306,0,-0.111751983,1.239631148,-0.090149383,0.928168507,0.96556984,1.297380427,0,3.089961179,1.400887585,2.205716726,0.02740384,0.073595561,3.347646764,0,0.445781553,1.228388799,0.362899396,0.716680038,0.808250942,13.49563144,1,0.976244634,1.166820282,0.83667095,0.402777553,0.546372283,3.285150809,0,0.370016116,1.222729119,0.302614954,0.762183317,0.834101392,N,PKS,,polyketide synthase,F:catalytic activity,IPR020806 (SMART); IPR020801 (SMART); IPR020841 (SMART); IPR001227 (G3DSA:3.40.366.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.70.250 (GENE3D); IPR013120 (PFAM); IPR014043 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR014031 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR014030 (PFAM); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR009081 (PFAM); PTHR11712 (PANTHER); PTHR11712:SF265 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR016039 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR016035 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016036 (SUPERFAMILY),,
RL4_JR_01374,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_01375,17,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.099575004,0,5.225554086,3.917467722,1.333911204,0.182232959,NA,0.033078756,0,8.384543179,2.85633322,2.935421932,0.003330944,0.016382807,0.083679717,0,5.769111159,1.785549277,3.231000809,0.001233576,0.006824439,0.096372271,0,5.348323309,2.650657722,2.017734415,0.043618929,0.113446415,0.080422464,0,5.71884974,1.504420892,3.801362883,0.000143902,0.000945497,N,-,,Aromatic-ring hydroxylase partial,F:FAD binding; P:cellular response to drug; P:secondary metabolite biosynthetic process; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789:SF204 (PANTHER); PTHR13789 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_01376,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003880053,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,0,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-, Effector probability:0.829,c6 zinc finger domain containing partial,,IPR032710 (G3DSA:3.10.450.GENE3D); IPR009959 (PFAM); IPR032710 (SUPERFAMILY),,
RL4_JR_01377,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.008141456,0,8.841220392,4.035983802,2.190598582,0.028480854,NA,0.002675567,0,12.01934062,4.032893235,2.980327006,0.002879408,0.015349618,0.006783092,0,9.399044527,3.291065204,2.855927776,0.004291127,0.016940088,0.007815077,0,8.97609272,4.035428601,2.224322026,0.026126786,0.086108719,0.006504647,0,9.346543544,1.704039324,5.484934187,4.14E-08,1.17E-06,N,-,,Serine hydrolase FSH,P:secondary metabolite biosynthetic process,IPR029058 (G3DSA:3.40.50.GENE3D); IPR005645 (PFAM); PTHR22778 (PANTHER); PTHR22778:SF17 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_01378,16,1,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.155972904,0,4.577897363,3.770822993,1.214031359,0.224735749,NA,0.049556296,0,7.799553678,2.811206795,2.774450351,0.005529507,0.021974647,0.129689318,0,5.134162954,1.838644627,2.792362851,0.005232464,0.019569069,0.149647765,0,4.712466537,2.529334794,1.863124861,0.062444701,0.139909847,0.129660172,0,5.032604126,1.629480592,3.088471351,0.002011891,0.008526924,N,-,,Transcription fungi,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; C:membrane; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR007219 (PFAM); PTHR31313 (PANTHER); PTHR31313:SF42 (PANTHER),,
RL4_JR_01379,243,254,247,2,0,9,4,0,0,0,0,0,0,2,0,0,7,0,57.48104832,1,4.487303266,0.471952423,9.507956827,1.94E-21,2.94E-19,90.20080346,1,6.176051152,0.744485203,8.295733919,1.08E-16,4.05E-14,2.469634867,0,0.884851782,1.207963341,0.732515426,0.463854031,0.601133923,10.87202066,1,2.188804271,1.017584898,2.150979516,0.031477817,0.094938713,29.45388198,1,4.210962867,0.584679172,7.202176971,5.93E-13,6.45E-11,N,-,,GTPase activating,,IPR000195 (SMART); IPR000195 (PFAM); G3DSA:1.10.8.270 (GENE3D); PTHR22957 (PANTHER); PTHR22957:SF314 (PANTHER); PTHR22957 (PANTHER); PTHR22957 (PANTHER); PTHR22957 (PANTHER); PTHR22957:SF314 (PANTHER); PTHR22957:SF314 (PANTHER); PTHR22957:SF314 (PANTHER); IPR000195 (PROSITE_PROFILES); IPR000195 (SUPERFAMILY); IPR000195 (SUPERFAMILY),8.A.87.1.4, the tbc1 domain (tbc1) family.
RL4_JR_01380,19988,13003,16743,2,5,3,0,0,0,1,6,3,1,8,1,0,17,3,269.7476154,1,-1.63993637,0.530419611,-3.091771751,0.001989658,0.010431637,63.66312099,0,-2.526865667,1.207147843,-2.093252853,0.036326589,0.091878494,242.1906174,1,-1.031927065,0.523203592,-1.972324121,0.048572618,0.11075743,240.8334197,1,-1.588817225,0.53490461,-2.970281419,0.002975271,0.018515436,249.5056927,1,-0.488801917,0.544666453,-0.897433491,0.369487648,0.505661468,N,-,,glutamine repeat -1,"F:pyridoxamine-phosphate oxidase activity; P:pyridoxal phosphate biosynthetic process; P:pyridoxine biosynthetic process; F:oxidoreductase activity, acting on the CH-NH2 group of donors; F:FMN binding; F:oxidoreductase activity; P:oxidation-reduction process",no IPS match,,
RL4_JR_01381,105,45,92,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.957691307,0,1.95979087,1.612411908,1.215440583,0.224198098,NA,0.307923443,0,5.164813536,1.751250846,2.949214013,0.003185833,0.016079667,0.796864033,0,2.516056991,1.304552153,1.928674898,0.053771234,0.119523258,0.919009204,0,2.094329196,1.381426654,1.516062535,0.12950354,0.238101207,0.785331236,0,2.434284945,1.278552182,1.903938673,0.056918172,0.123589211,N,-,,heterokaryon incompatibility,,no IPS match,,
RL4_JR_01382,246,120,269,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.512866912,0,0.568054655,1.335553636,0.425332716,0.670594148,0.817535882,0.803347476,0,3.781320814,1.510844828,2.502785688,0.012322013,0.03948193,2.086785211,0,1.127326404,1.266875438,0.889847865,0.373547581,0.517557919,2.407227443,0,0.705141477,1.288986128,0.547051254,0.584343521,0.709753926,2.064487605,0,1.040258896,1.266164004,0.821583059,0.411314234,0.547319835,Y,-,,acetyl esterase,F:hydrolase activity,IPR013830 (G3DSA:3.40.50.GENE3D); IPR001087 (PFAM); PTHR22835:SF178 (PANTHER); PTHR22835:SF178 (PANTHER); PTHR22835 (PANTHER); PTHR22835 (PANTHER); IPR013830 (SUPERFAMILY),,
RL4_JR_01383,4291,4670,7051,4,11,13,0,0,1,0,2,0,0,3,2,0,0,0,241.9125158,1,1.460974151,0.418521555,3.490797864,0.00048158,0.00326578,29.59792537,1,0.043986294,1.126750811,0.039038174,0.968859953,0.983828295,68.4630675,1,-1.708147859,1.050639008,-1.625818047,0.103988368,0.199578813,92.21168591,1,-0.908572683,0.706321539,-1.286344296,0.19832293,0.328644789,52.37887119,0,-3.624689771,1.216577201,-2.979416159,0.002887983,0.011466989,N,-,,histidinol-phosphate aminotransferase,F:pyridoxal phosphate binding; P:histidine biosynthetic process; F:histidinol-phosphate transaminase activity,IPR015421 (G3DSA:3.40.640.GENE3D); IPR005861 (TIGRFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR004839 (PFAM); PTHR11751:SF424 (PANTHER); PTHR11751 (PANTHER); IPR005861 (HAMAP); IPR015424 (SUPERFAMILY),,
RL4_JR_01384,227,289,269,0,0,9,0,0,0,0,2,4,0,8,0,0,0,0,37.52142721,1,4.052270507,0.578483721,7.004986238,2.47E-12,1.15E-10,1.004439996,0,3.459150442,1.405950783,2.460363822,0.013879623,0.04329838,44.28780825,1,4.206091252,0.625290152,6.726623211,1.74E-11,1.16E-09,35.10036545,1,4.059903921,0.57488769,7.062081848,1.64E-12,7.58E-11,2.568778934,0,0.725377642,1.211026238,0.598977643,0.549187794,0.669378405,Y,-,,glycoside hydrolase family 76,F:hydrolase activity,IPR012341 (G3DSA:1.50.10.GENE3D); IPR005198 (PFAM); IPR014480 (PIRSF); PTHR12145 (PANTHER); PTHR12145:SF19 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_01385,138,122,163,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,9.325310332,1,2.865897091,1.022341657,2.803267451,0.00505877,0.021963515,0.538057349,0,4.359626755,1.524547526,2.859620105,0.004241488,0.018545287,1.397788223,0,1.705475207,1.224536599,1.392751518,0.163694944,0.280129752,1.612603667,0,1.283166089,1.242959767,1.032347243,0.301909477,0.447756475,1.380564025,0,1.620960043,1.216158947,1.33285213,0.182580334,0.301079134,N,-,,hypothetical protein CMQ_3337,,no IPS match,,
RL4_JR_01386,581,842,770,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.823277053,0,-1.243480424,1.215942529,-1.022647365,0.306474606,0.493105043,2.803076502,0,1.978514678,1.295269626,1.52749253,0.126638583,0.242817909,7.284118203,0,-0.675691716,1.210245536,-0.558309612,0.576632982,0.698890496,8.404533552,0,-1.098266718,1.210244248,-0.907475264,0.364155525,0.510533742,7.184605694,0,-0.758578982,1.214087112,-0.624814294,0.532092948,0.655507727,N,-,,large conductance mechanosensitive channel,F:ion channel activity; P:ion transmembrane transport; C:integral component of membrane,IPR001185 (PFAM); PTHR30266 (PANTHER); PTHR30266:SF2 (PANTHER); IPR001185 (SUPERFAMILY),1.A.22.1.1, the large conductance mechanosensitive ion channel (mscl) family.
RL4_JR_01387,5500,6881,7411,8,6,2,0,0,0,4,0,2,3,8,2,0,0,0,215.6029969,1,0.605241187,0.643291249,0.940850957,0.346781243,0.536311163,25.21707545,0,-1.190823016,1.200601235,-0.991855564,0.321267988,0.48326268,122.8563141,1,-0.424568707,0.624452923,-0.679905067,0.496564573,0.62934649,154.9668631,1,0.151384869,0.453887344,0.33352961,0.738734542,0.826169223,64.77405191,0,-3.931114009,1.200309284,-3.275084231,0.001056305,0.004994989,N,-,,sur7,C:membrane,IPR009571 (PFAM); PTHR28019:SF2 (PANTHER); PTHR28019 (PANTHER),,
RL4_JR_01388,6291,7920,7809,10,3,0,0,0,0,0,3,4,0,0,0,0,1,1,213.1007796,1,0.38814957,1.030175306,0.376780115,0.70633702,0.841334123,28.13036519,0,-1.348536336,1.199897389,-1.123876382,0.261065472,0.417325443,122.5866087,1,-0.380449089,0.582233397,-0.65343055,0.513478749,0.644490311,84.29625912,0,-4.424569347,1.195053391,-3.702403072,0.000213567,0.002028485,83.28315377,1,-2.407220842,0.979530629,-2.457524828,0.013989814,0.041080878,N,-,,hypothetical protein SPI_02499,C:membrane,no IPS match,,
RL4_JR_01389,1893,1721,1589,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,20.84868484,0,-2.484153558,1.189302709,-2.088747918,0.036730421,0.10591968,6.689199698,0,0.723734441,1.238387865,0.584416613,0.558940052,0.70270705,17.28614733,0,-1.922490396,1.194161597,-1.609908073,0.107417926,0.204490843,23.94857358,1,-1.397411494,1.144936709,-1.220514185,0.222270016,0.357389854,16.96753453,0,-1.998519403,1.190766716,-1.678346712,0.093279434,0.180929937,N,-,,ndt80 like dna-binding family,"F:DNA binding; F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated",IPR024061 (G3DSA:2.60.40.GENE3D); IPR024061 (PFAM); PTHR35144:SF2 (PANTHER); PTHR35144 (PANTHER); IPR024061 (PROSITE_PROFILES); IPR008967 (SUPERFAMILY),,
RL4_JR_01390,5702,4340,3813,5,0,8,0,0,0,0,0,3,4,1,7,0,0,5,136.3238013,1,0.52412687,0.507452118,1.032859755,0.301669535,0.487523785,17.88185633,0,-0.694873781,1.228965024,-0.565413797,0.571792342,0.712211091,65.56432144,1,-0.941156763,0.877028753,-1.07311962,0.283217449,0.422729289,161.8290748,1,0.781111637,0.601877157,1.297792462,0.194358661,0.323787783,81.91499681,1,-0.413425571,0.69882651,-0.591599725,0.554118658,0.673847155,N,-,,DNA topoisomerase 2,F:DNA binding; F:ATP binding; F:DNA topoisomerase type II (ATP-hydrolyzing) activity; P:DNA topological change,IPR001241 (PRINTS); IPR001154 (PRINTS); IPR002205 (SMART); IPR001241 (SMART); IPR003594 (SMART); IPR024946 (G3DSA:3.30.1360.GENE3D); IPR002205 (PFAM); IPR014721 (G3DSA:3.30.230.GENE3D); IPR006171 (PFAM); G3DSA:3.30.1490.30 (GENE3D); IPR013506 (PFAM); IPR003594 (PFAM); IPR013757 (G3DSA:1.10.268.GENE3D); IPR031660 (PFAM); IPR013758 (G3DSA:3.90.199.GENE3D); IPR013759 (G3DSA:3.40.50.GENE3D); IPR003594 (G3DSA:3.30.565.GENE3D); PTHR10169 (PANTHER); PTHR10169:SF38 (PANTHER); IPR006171 (PROSITE_PROFILES); IPR020568 (SUPERFAMILY); IPR013760 (SUPERFAMILY); IPR003594 (SUPERFAMILY),,
RL4_JR_01391,4398,3309,6407,2,1,2,0,0,0,0,0,0,0,1,0,0,0,0,91.83118961,1,-0.835717324,0.72774216,-1.148370082,0.250815819,0.428242349,17.78672289,0,-0.687259162,1.22763665,-0.559822943,0.575600213,0.715400952,46.39241003,0,-3.346871254,1.214788092,-2.755107064,0.005867293,0.021397866,57.54410837,1,-2.824294255,1.172433742,-2.408915877,0.015999985,0.068181756,46.05295111,0,-3.439008692,1.225428088,-2.80637332,0.005010261,0.017950086,N,-,,apses transcription factor xbp1,F:nucleic acid binding; F:DNA binding; F:methyltransferase activity; P:methylation,IPR003163 (G3DSA:3.10.260.GENE3D); PTHR11707 (PANTHER); PTHR11707:SF24 (PANTHER); PTHR11707 (PANTHER); PTHR11707 (PANTHER); PTHR11707:SF24 (PANTHER); PTHR11707:SF24 (PANTHER); IPR003163 (PROSITE_PROFILES); IPR003163 (SUPERFAMILY),,
RL4_JR_01392,1561,1114,2314,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,19.79401385,0,-2.409411346,1.229762046,-1.959250046,0.050083511,0.132915186,6.278691175,0,0.814974889,1.269721752,0.641853136,0.520968545,0.670966884,16.38412196,0,-1.845343465,1.22372711,-1.507969751,0.131562269,0.237847966,26.92925984,1,-0.561421532,1.061628741,-0.528830381,0.59692312,0.719676898,16.27519755,0,-1.938395184,1.237323795,-1.566603012,0.117207513,0.215337702,N,-,,tpr repeat,F:Hsp90 protein binding; P:protein folding; F:Hsp70 protein binding,IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR22904:SF342 (PANTHER); PTHR22904 (PANTHER); IPR013026 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_01393,10855,4640,9191,0,4,0,0,0,0,0,0,1,0,0,0,0,0,0,129.7543116,1,-1.849201824,0.900722973,-2.053019496,0.040070687,0.11276187,31.44355546,0,-1.509180965,1.249273935,-1.208046468,0.227029389,0.376843469,87.82233383,1,-3.194830911,1.234390958,-2.588183988,0.009648343,0.031817533,93.78578497,0,-4.578488023,1.243056859,-3.683249071,0.00023028,0.002160875,80.09460467,0,-4.237426891,1.242248496,-3.411094402,0.000647027,0.003363777,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR001958 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23504 (PANTHER); PTHR23504:SF2 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.96, the major facilitator superfamily (mfs).
RL4_JR_01394,2823,4162,3922,4,13,1,0,0,0,4,2,5,6,0,8,0,0,4,192.0838006,1,1.686285575,0.840267904,2.006842777,0.044766406,0.122408717,13.92559304,0,-0.334150954,1.22164359,-0.27352573,0.784449117,0.869397316,128.6696399,1,1.299626708,0.499966474,2.599427714,0.009337934,0.03096695,174.7372348,1,1.527155944,0.774318727,1.972257536,0.048580214,0.120758055,65.20206107,1,-0.403947006,0.775781401,-0.520696945,0.602577903,0.71149869,N,-,,inositol monophosphatase,F:magnesium ion binding; F:inositol monophosphate 1-phosphatase activity; P:inositol metabolic process; C:cytoplasm; P:signal transduction; P:phosphatidylinositol phosphorylation; P:inositol phosphate dephosphorylation,IPR000760 (PRINTS); IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); G3DSA:3.30.540.10 (GENE3D); PTHR20854:SF4 (PANTHER); IPR000760 (PANTHER); SSF56655 (SUPERFAMILY),,
RL4_JR_01395,3228,2725,3384,0,2,15,0,0,0,2,0,2,0,5,2,0,0,7,110.5788537,1,1.33714949,0.526193549,2.541174238,0.011048085,0.041061629,11.91282949,0,-0.108931985,1.209792808,-0.090041852,0.928253957,0.959733049,66.02917615,1,0.065596621,0.739142821,0.088746882,0.929283073,0.957758509,74.96385219,1,0.346960616,0.571118235,0.60751101,0.543511838,0.673981306,82.01070045,1,0.802800754,1.545965126,0.519287751,0.603560094,0.712160115,N,-,,acid phosphatase,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_01396,5883,6977,6290,1,3,18,3,0,0,4,0,5,9,17,0,0,3,2,179.7650045,1,0.67754552,0.484660081,1.397980866,0.162118813,0.312515425,91.48436551,1,1.07183284,0.846944046,1.265529695,0.205681511,0.35064342,140.4043274,1,0.194507508,0.519104399,0.374698247,0.707884896,0.801815472,225.4123936,1,1.165138036,0.38174419,3.052143468,0.002272135,0.014662437,88.93068762,1,-0.937990113,0.676367407,-1.386805607,0.165501047,0.278818319,N,-,,Ras family,P:small GTPase mediated signal transduction; P:protein localization to endosome; C:late endosome; C:mitochondrial outer membrane; P:endocytosis; P:protein targeting to vacuole; C:plasma membrane; P:Golgi to endosome transport; F:GTP binding; C:endocytic vesicle; P:vacuole inheritance; C:early endosome; F:GTPase activity; C:cytosol; P:multivesicular body assembly; P:late endosome to vacuole transport via multivesicular body sorting pathway,PR00449 (PRINTS); SM00174 (SMART); SM00175 (SMART); SM00173 (SMART); SM00176 (SMART); IPR005225 (TIGRFAM); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24073:SF132 (PANTHER); PTHR24073 (PANTHER); PTHR24073:SF132 (PANTHER); PTHR24073 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_01397,10447,15019,21066,0,1,4,0,0,0,0,0,0,2,0,0,0,0,0,209.4397713,1,-2.64882522,0.77507991,-3.417486617,0.000632022,0.004075917,58.6686585,0,-2.409019167,1.217085901,-1.979333722,0.047778445,0.113785806,153.4585554,0,-5.072722705,1.221915285,-4.151452042,3.30E-05,0.000512989,195.7488226,1,-3.72441745,1.056880474,-3.52397224,0.000425129,0.003666791,152.5422236,0,-5.16684415,1.238435594,-4.17207336,3.02E-05,0.000254254,N,-,,ribosome biogenesis kri1,C:nucleus; C:intracellular non-membrane-bounded organelle; C:intracellular organelle part,IPR024626 (PFAM); IPR018034 (PFAM); IPR018034 (PANTHER),,
RL4_JR_01398,11380,5719,4616,0,0,4,0,0,0,4,0,0,0,3,0,0,5,4,101.8574775,1,-1.92665789,0.919023684,-2.096418105,0.036045118,0.104349209,28.25021873,0,-1.35465583,1.277419566,-1.060462722,0.28893414,0.448350662,116.567523,1,-0.858168092,1.468986514,-0.584190586,0.559092095,0.685126409,95.34993472,1,-2.170590186,0.980564929,-2.213611891,0.026855489,0.087153604,119.0701509,1,-0.282777134,0.660015617,-0.428440065,0.66833076,0.764529313,N,-,,Zinc finger transcription factor 1,"F:transcription factor activity, sequence-specific DNA binding; F:metal ion binding; P:regulation of transcription, DNA-templated; C:intracellular part",IPR001138 (SMART); IPR007219 (SMART); IPR001138 (PFAM); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31313:SF29 (PANTHER); PTHR31313 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_01399,3001,2255,4680,0,0,0,0,0,0,0,0,2,6,2,2,0,0,1,39.4315196,0,-3.40365162,1.230383626,-2.766333645,0.00566905,0.024125253,12.4926648,0,-0.177551923,1.243710748,-0.14275982,0.886479871,0.935656856,45.62082381,1,-1.027748827,1.069826207,-0.960668958,0.336718644,0.479997121,120.8141899,1,0.915067755,0.601776964,1.520609479,0.128357867,0.23638112,39.79421484,1,-1.990695179,1.163814758,-1.710491438,0.087175035,0.172392038,N,-,,hypothetical protein MMYC01_206328,,PTHR42470 (PANTHER),,
RL4_JR_01400,710,674,581,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,49.8863616,1,2.95127173,0.600987536,4.910703723,9.08E-07,1.41E-05,2.529612014,0,2.126677073,1.301388308,1.634160273,0.102225202,0.206120217,6.534368744,0,-0.518897523,1.202512423,-0.431511154,0.666096744,0.770190401,7.536320014,0,-0.940877741,1.200816914,-0.783531386,0.43331513,0.575612135,6.409875517,0,-0.594113031,1.197163083,-0.496267417,0.619705751,0.726136056,N,-,,separin,C:intracellular organelle; F:peptidase activity,IPR005314 (PFAM); IPR005314 (PANTHER); IPR030397 (PROSITE_PROFILES),,
RL4_JR_01401,1299,1355,2386,0,0,0,0,0,0,1,0,0,1,2,0,0,0,0,20.07074313,0,-2.429403432,1.229322561,-1.976213167,0.048130639,0.129246134,6.3357803,0,0.801904885,1.262769227,0.635036765,0.525404437,0.674386325,27.64182138,1,-0.899979391,1.218292517,-0.738721923,0.460075871,0.59803151,36.46181951,1,0.019540588,0.899697083,0.021719074,0.982672048,0.989190158,16.48781133,0,-1.957096591,1.236156139,-1.583211481,0.113373271,0.209854546,N,-, Effector probability:0.585,hypothetical protein SPI_02511,C:membrane,no IPS match,,
RL4_JR_01402,2934,2760,4022,0,2,3,0,0,0,0,0,0,0,6,0,0,0,0,66.23155311,1,-0.336086547,0.690536824,-0.486703294,0.626468611,0.786271914,12.31182415,0,-0.156507886,1.213977717,-0.128921548,0.897419726,0.942779706,32.05677132,0,-2.813630746,1.197786353,-2.34902555,0.018822615,0.05350137,61.05794112,1,0.034472071,0.64749556,0.053239084,0.957541415,0.975755518,31.738095,0,-2.901922468,1.206030121,-2.406177439,0.016120433,0.046029155,N,-,,SIR2 family histone deacetylase,F:NAD+ binding,IPR029035 (G3DSA:3.40.50.GENE3D); IPR003000 (PFAM); IPR026591 (G3DSA:3.30.1600.GENE3D); PTHR11085:SF22 (PANTHER); IPR003000 (PANTHER); PTHR11085:SF22 (PANTHER); IPR003000 (PANTHER); IPR026590 (PROSITE_PROFILES); IPR029035 (SUPERFAMILY),,
RL4_JR_01403,5082,4549,4876,0,1,18,0,0,0,4,1,3,0,0,0,0,4,1,134.7806248,1,0.665086638,0.76266349,0.872057791,0.383176851,0.575682643,18.57474031,0,-0.749732254,1.201525348,-0.623983718,0.532638278,0.680985809,119.7150455,1,0.429913726,0.530907113,0.809772022,0.418071215,0.559269686,55.47743067,0,-3.821007195,1.18560774,-3.222825784,0.001269327,0.009068453,70.12885051,1,-0.536323594,0.662983265,-0.808954951,0.418541059,0.554313699,N,-,,cation efflux family,P:response to zinc ion; P:regulation of sequestering of zinc ion; C:integral component of membrane; F:zinc ion transmembrane transporter activity; P:zinc II ion transmembrane transport,IPR002524 (PFAM); IPR027470 (G3DSA:3.30.70.GENE3D); IPR002524 (TIGRFAM); IPR027469 (G3DSA:1.20.1510.GENE3D); PTHR11562:SF18 (PANTHER); IPR002524 (PANTHER); PTHR11562:SF18 (PANTHER); SSF161111 (SUPERFAMILY),2.A.4.1.6, the cation diffusion facilitator (cdf) family.
RL4_JR_01404,3282,2966,3005,0,9,20,0,0,0,0,14,24,2,1,2,0,1,0,185.5036316,1,2.188634877,0.404429697,5.411657194,6.24E-08,1.30E-06,11.86549197,0,-0.103150731,1.21307479,-0.085032458,0.932235586,0.962178913,296.4726897,1,3.193394506,0.542462974,5.886843266,3.94E-09,1.84E-07,77.31886393,1,-0.107854062,0.662035129,-0.162912899,0.870587014,0.920418891,34.0415117,1,-1.8986024,1.115474004,-1.70205885,0.088744337,0.174574784,N,-,,d-xylulose kinase,P:xylulose metabolic process; F:xylulokinase activity; C:cytoplasm; P:phosphorylation,IPR018484 (PFAM); G3DSA:3.30.420.40 (GENE3D); IPR018485 (PFAM); G3DSA:3.30.420.40 (GENE3D); PTHR10196:SF57 (PANTHER); PTHR10196 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_01405,434,774,894,0,1,3,0,0,0,0,0,0,0,1,1,0,0,0,27.90799726,1,1.511735591,0.831132261,1.818886911,0.068928685,0.169068014,2.660376707,0,2.053821611,1.334202577,1.539362648,0.123715787,0.238705909,6.953009334,0,-0.608689549,1.237804266,-0.491749435,0.622896486,0.735846444,21.67210988,1,0.704775223,1.063987557,0.662390474,0.507721007,0.643571757,6.900293442,0,-0.700354017,1.249679271,-0.56042701,0.575188213,0.689663477,N,-,,tldc domain containing 2,C:intracellular part,IPR006571 (SMART); IPR013902 (PFAM); IPR006571 (PFAM); PTHR23354 (PANTHER); PTHR23354 (PANTHER); PTHR23354:SF79 (PANTHER); PTHR23354 (PANTHER); PTHR23354:SF79 (PANTHER); PTHR23354:SF79 (PANTHER),,
RL4_JR_01406,3564,3406,5445,2,3,2,0,0,0,0,0,4,1,3,2,0,2,2,101.2720519,1,-0.153522859,0.620204642,-0.24753581,0.804493581,0.901630269,15.67993903,0,-0.5053867,1.216946967,-0.415290652,0.677929143,0.794672703,66.89337466,1,-0.358942315,0.772972338,-0.464366314,0.642385321,0.750895853,87.81261067,1,-0.266579431,0.647677499,-0.411592855,0.680637869,0.782675574,63.02395069,1,-0.630295384,0.785202855,-0.802716624,0.422138542,0.557910552,N,-,,mitochondrial hypoxia responsive domain-containing,P:mitochondrial respiratory chain complex IV assembly; C:integral component of mitochondrial inner membrane; C:mitochondrial respiratory chain supercomplex; P:mitochondrial respiratory chain supercomplex assembly,IPR007667 (PFAM); PTHR12297:SF3 (PANTHER); PTHR12297 (PANTHER); IPR007667 (PROSITE_PROFILES),8.A.112.1.2, the respiratory supercomplex factor (rcf) family.
RL4_JR_01407,13714,12708,17369,3,7,3,0,0,0,0,0,1,1,7,0,0,1,0,272.5063523,1,-1.04754013,0.489481017,-2.140103689,0.032346388,0.096122842,55.61946526,0,-2.332020868,1.192258157,-1.955969731,0.05046872,0.118801019,151.1352725,1,-4.025517792,1.193654577,-3.37243108,0.000745077,0.00455505,204.2688604,1,-1.711672764,0.558126015,-3.066821322,0.002163481,0.014077924,146.8589663,1,-4.144228251,1.132984462,-3.657797956,0.000254391,0.001531387,N,-,,threonine dehydratase,P:isoleucine biosynthetic process; F:pyridoxal phosphate binding; P:cellular amino acid biosynthetic process; F:L-threonine ammonia-lyase activity,IPR005787 (TIGRFAM); G3DSA:3.40.1020.10 (GENE3D); G3DSA:3.40.50.1100 (GENE3D); IPR001721 (PFAM); IPR001926 (PFAM); PTHR10314 (PANTHER); PTHR10314:SF30 (PANTHER); IPR001721 (PROSITE_PROFILES); IPR001721 (PROSITE_PROFILES); SSF55021 (SUPERFAMILY); IPR001926 (SUPERFAMILY),,
RL4_JR_01408,4901,6712,7907,5,4,0,0,0,0,0,0,0,1,11,2,0,1,2,160.6185613,1,-0.153431747,0.796044908,-0.192742577,0.847160577,0.923399489,24.76961006,0,-1.165006911,1.210242604,-0.962622624,0.33573694,0.498758712,64.57342691,0,-3.823890524,1.20551581,-3.171995335,0.001513954,0.007941593,147.2280754,1,0.223455969,0.493917595,0.452415487,0.650969692,0.761093318,82.53749377,1,-1.684844111,0.872739591,-1.930523295,0.053542032,0.117953236,N,-,,pre-mRNA-processing factor 17,C:catalytic step 2 spliceosome; C:Prp19 complex; P:spliceosomal complex assembly,IPR020472 (PRINTS); IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR032847 (PTHR22847:PANTHER); PTHR22847 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_01409,4074,4231,5950,0,3,11,0,0,0,0,2,1,4,2,2,0,2,0,122.9540438,1,0.522109861,0.506245589,1.031337107,0.302382763,0.488482887,18.05607835,0,-0.708942552,1.206968461,-0.587374546,0.556952185,0.701439594,69.23159339,1,-0.961207869,0.86360459,-1.113018481,0.265700492,0.403533121,118.8306174,1,-0.01934829,0.563077862,-0.034361661,0.972588756,0.984647651,54.32410895,1,-1.794311231,0.995410062,-1.802584984,0.071453417,0.147081444,N,-,,ER-derived vesicles ERV14,C:integral component of membrane; P:transport,IPR003377 (SMART); IPR003377 (PFAM); PTHR12290 (PANTHER),8.A.61.1.1," the endoplasmic reticulum-derived vesicle protein, erv14 (erv14) family."
RL4_JR_01410,3340,3558,5665,0,1,3,0,0,0,0,4,2,0,6,2,0,0,0,69.56207865,1,-1.046736928,0.79758875,-1.312376747,0.189393049,0.348931457,15.84127439,0,-0.520156031,1.221883699,-0.425700115,0.670326378,0.789233872,85.74417202,1,0.218509919,0.654390916,0.333913436,0.738444881,0.824075835,91.08929905,1,0.087776324,0.601303373,0.14597677,0.883939727,0.928610911,41.09454721,0,-3.27465117,1.221057139,-2.681816489,0.007322362,0.024468287,N,-,,peptidyl-prolyl cis-trans isomerase-like 2,C:nucleus; F:ubiquitin-protein transferase activity; F:peptidyl-prolyl cis-trans isomerase activity; P:protein peptidyl-prolyl isomerization; P:protein folding; P:protein ubiquitination,IPR002130 (PRINTS); IPR003613 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); IPR002130 (PFAM); IPR024936 (PANTHER); PTHR11071:SF269 (PANTHER); IPR003613 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); IPR029000 (SUPERFAMILY); SSF57850 (SUPERFAMILY),3.D.1.8.1, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_01411,5731,4634,5550,7,0,5,0,0,0,0,0,1,1,1,2,0,2,0,153.0970129,1,0.248197718,0.467122543,0.531333206,0.595187899,0.765616978,20.34215824,0,-0.880876763,1.202623193,-0.73246281,0.463886134,0.62273945,59.18738504,1,-2.568654613,1.189827769,-2.158845743,0.030862136,0.07846516,93.36921755,1,-1.211339452,0.739477445,-1.638101961,0.101400426,0.19781875,59.59800007,1,-1.940875353,0.971907793,-1.996974782,0.045827923,0.104860501,N,-,,c6 zinc finger domain containing,"P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR021858 (PFAM); PTHR38791 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_01412,260,228,292,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,3.114219984,0,0.258639011,1.221965591,0.211658179,0.832373717,0.916665376,0.993617449,0,3.474723394,1.399738223,2.482409452,0.013049723,0.041265009,2.579214989,0,0.821818524,1.20889995,0.679806897,0.496626739,0.62934649,10.99863521,1,2.124314086,1.019670493,2.083333881,0.0372208,0.10262198,2.545175077,0,0.738428725,1.20692327,0.611827399,0.54065196,0.663104091,N,-,,hypothetical protein CMQ_3877,C:membrane,PTHR42109:SF2 (PANTHER); PTHR42109 (PANTHER),,
RL4_JR_01413,38724,40958,56743,1,9,94,2,1,4,0,0,5,4,41,4,0,27,3,985.9981426,1,-0.269145217,0.975557502,-0.275888624,0.782633612,0.887825894,293.3122659,1,-0.543683616,0.599147683,-0.907428389,0.364180303,0.52857159,482.8367426,1,-3.503341797,0.706153574,-4.961161321,7.01E-07,1.98E-05,759.9210224,1,-0.99352694,0.565747543,-1.75613125,0.079066,0.164992426,572.3935042,1,-1.578554251,0.748750074,-2.108252546,0.03500915,0.084800872,N,-, Effector probability:0.625,60s ribosomal l10a,F:RNA binding; F:structural constituent of ribosome; C:large ribosomal subunit; P:translation,IPR028364 (PFAM); IPR016095 (G3DSA:3.40.50.GENE3D); IPR016094 (G3DSA:3.30.190.GENE3D); IPR002143 (PIRSF); PTHR23105 (PANTHER); PTHR23105:SF54 (PANTHER); IPR023674 (SUPERFAMILY),,
RL4_JR_01414,221,154,171,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.178976314,0,0.773886753,1.272526518,0.608149805,0.543088122,0.724232992,0.701125574,0,3.977839577,1.489400249,2.670766021,0.007567838,0.027481309,1.810086986,0,1.332934523,1.229078175,1.084499384,0.27814344,0.417050383,2.087433607,0,0.911069456,1.242525998,0.733239753,0.463412213,0.605160859,1.776445096,0,1.256864297,1.21581153,1.033765733,0.301245695,0.4365411,N,-,,integral membrane,C:membrane; C:integral component of membrane,PTHR33048 (PANTHER),9.B.313.1.2, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_01415,5494,4782,5380,4,3,9,2,0,0,0,5,2,6,10,5,0,2,0,161.2470277,1,0.656901847,0.383174403,1.714367771,0.086461204,0.198858331,64.64931354,1,0.806153221,0.975966145,0.826005313,0.408801078,0.572559085,104.0833396,1,0.120714891,0.56677373,0.212986038,0.831337853,0.890819689,203.9986785,1,1.20075853,0.345060571,3.479848559,0.000501697,0.004196995,58.78282288,1,-1.91637773,0.967230106,-1.98130488,0.047557093,0.107793949,N,-,,mucin-7 precursor,,no IPS match,,
RL4_JR_01416,7099,6683,10940,7,0,4,0,0,0,0,5,0,3,2,0,0,4,0,184.2137934,1,-0.393567539,0.683308619,-0.575973327,0.56463321,0.741611955,31.20664716,0,-1.498302188,1.208788639,-1.239507173,0.215157734,0.361765213,120.6283344,1,-1.011110851,0.705731876,-1.432712459,0.151940027,0.264894238,129.9083913,1,-1.512905698,0.703987802,-2.149051013,0.031630356,0.095116531,96.22787388,1,-1.674265213,0.809214782,-2.068999789,0.038546107,0.09142477,N,-,,Homoisocitrate dehydrogenase,F:magnesium ion binding; P:lysine biosynthetic process; F:NAD binding; F:homoisocitrate dehydrogenase activity; C:mitochondrion; P:oxidation-reduction process; F:3-isopropylmalate dehydrogenase activity,IPR024084 (SMART); IPR024084 (PFAM); IPR024084 (G3DSA:3.40.718.GENE3D); PTHR11835:SF48 (PANTHER); IPR001804 (PANTHER); SSF53659 (SUPERFAMILY),,
RL4_JR_01417,6971,13965,8630,32,44,48,0,0,1,4,6,4,4,8,0,0,1,2,977.6893822,1,2.8199535,0.45568534,6.188378803,6.08E-10,1.76E-08,47.47600306,1,-0.872331465,1.159525516,-0.75231761,0.45186008,0.6117842,216.1336493,1,0.210616847,0.524752399,0.401364239,0.688151975,0.786060091,183.3356799,1,-0.596730777,0.589411693,-1.01241761,0.311338422,0.45745197,115.6912869,1,-2.28105624,0.909585215,-2.507798282,0.0121486,0.036761677,N,-, Effector probability:0.67,minor allergen Alt a 7,"F:FMN binding; P:negative regulation of transcription, DNA-templated; F:oxidoreductase activity; P:oxidation-reduction process",IPR010089 (TIGRFAM); IPR029039 (G3DSA:3.40.50.GENE3D); IPR005025 (PFAM); PTHR30546 (PANTHER); IPR008254 (PROSITE_PROFILES); IPR029039 (SUPERFAMILY),,
RL4_JR_01418,14036,15484,22223,2,0,19,0,0,0,1,3,0,0,8,0,0,0,2,299.3160689,1,-0.982081396,0.764309171,-1.284926877,0.198817838,0.361801454,65.4355367,0,-2.566506972,1.199479761,-2.139683431,0.032380359,0.083947753,205.2862509,1,-2.394703932,0.765639216,-3.127718491,0.001761688,0.00895348,229.0642086,1,-2.012496019,0.619745764,-3.247292899,0.001165084,0.00840205,183.9920484,1,-3.613835889,1.002084035,-3.60632019,0.00031057,0.001797896,N,-,,argininosuccinate lyase,P:arginine biosynthetic process via ornithine; F:argininosuccinate lyase activity,PR00145 (PRINTS); IPR000362 (PRINTS); IPR029419 (PFAM); IPR024083 (G3DSA:1.10.275.GENE3D); G3DSA:1.10.40.30 (GENE3D); G3DSA:1.20.200.10 (GENE3D); IPR009049 (TIGRFAM); IPR022761 (PFAM); IPR009049 (PTHR11444:PANTHER); IPR000362 (PANTHER); IPR009049 (HAMAP); IPR008948 (SUPERFAMILY),,
RL4_JR_01419,5408,5316,6498,1,0,2,0,0,0,0,7,0,0,9,0,0,4,1,86.55439035,1,-1.897170542,0.851426031,-2.228227084,0.025865376,0.080844757,21.93129405,0,-0.989421129,1.195134655,-0.827874186,0.407741756,0.571619987,111.8746842,1,-0.025728068,1.265859486,-0.020324585,0.983784444,0.992114126,101.8354787,1,-0.208204519,0.52667196,-0.395321062,0.692605957,0.792477717,79.05947891,1,-0.793360055,0.680315293,-1.166165251,0.243547639,0.373115425,N,-,,YAP1-binding 2,C:cellular_component; F:molecular_function,IPR013877 (PFAM); PTHR28020 (PANTHER),,
RL4_JR_01420,68,76,123,0,0,13,0,0,0,0,0,0,0,1,0,0,1,0,50.7059497,1,5.886621225,0.84267208,6.985660687,2.84E-12,1.31E-10,0.336236732,0,5.037748152,1.675790789,3.006191575,0.002645423,0.015349618,0.878967148,0,2.37445819,1.270404489,1.869056832,0.061614908,0.133024157,5.026028833,1,2.895532437,1.189661167,2.433913553,0.014936562,0.065631958,4.734307334,1,3.207984574,1.172472455,2.736085236,0.006217492,0.021419566,Y,-,,lysine methyltransferase,P:biological_process; F:methyltransferase activity; F:transferase activity; F:molecular_function; P:methylation,IPR001214 (SMART); IPR001214 (PFAM); G3DSA:2.170.270.10 (GENE3D); PTHR12197 (PANTHER); IPR001214 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY),,
RL4_JR_01421,1293,1061,1416,1,0,0,0,0,0,0,0,0,0,4,0,0,0,3,25.10379887,1,-1.063418848,1.14231445,-0.930933551,0.351887938,0.542358171,4.80151393,0,1.202004477,1.245277126,0.965250588,0.334419315,0.497700827,12.4604765,0,-1.450413676,1.194692016,-1.214048187,0.224729324,0.354980227,30.42073571,1,0.840154776,0.749773515,1.120544749,0.262481694,0.402914972,34.3915504,1,0.700764772,0.84549133,0.828825498,0.407203158,0.543492219,N,-,,fungal zn binuclear cluster domain containing,"C:nucleus; F:zinc ion binding; P:porphyrin-containing compound biosynthetic process; F:oxidoreductase activity; F:oxygen-dependent protoporphyrinogen oxidase activity; P:regulation of transcription, DNA-templated; P:oxidation-reduction process; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_01422,15,3,9,0,0,5,0,0,0,0,0,0,0,0,0,0,2,0,19.19898649,1,8.01057523,0.948056972,8.449466083,2.93E-17,2.62E-15,0.034558672,0,8.320359163,2.718740199,3.060373023,0.002210615,0.015045494,0.088861883,0,5.680082269,1.645821391,3.451214269,0.00055807,0.003671153,0.102433513,0,5.259632742,2.466363434,2.132545702,0.032962012,0.097153424,7.808178583,1,7.233479299,1.11937578,6.462065223,1.03E-10,7.42E-09,N,-,,hypothetical protein SPI_08531,,no IPS match,,
RL4_JR_01423,160,101,236,0,0,3,0,0,0,0,0,0,0,0,1,0,3,0,13.42409618,1,3.171016319,0.951015277,3.334348455,0.000854995,0.005264187,0.624510775,0,4.144527069,1.551079422,2.672027627,0.007539444,0.027424114,1.630086617,0,1.483483567,1.271384216,1.166825534,0.243280833,0.376889848,11.51627819,1,2.015794393,1.193604833,1.688828947,0.091252215,0.182811372,13.20187252,1,3.547983352,0.942156106,3.765812619,0.000166008,0.001065843,N,-,,c2h2 transcription factor,F:nucleic acid binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D),,
RL4_JR_01424,13722,15478,21195,0,2,7,0,0,1,0,7,3,0,4,3,0,4,0,244.1423518,1,-1.912909382,0.582367593,-3.284711245,0.001020869,0.006010225,73.18672125,1,-1.612991976,1.113698331,-1.448320367,0.147527474,0.273114451,240.7574216,1,-1.054536102,0.531033301,-1.985819158,0.047053408,0.108069124,236.9261702,1,-2.076578572,0.604014729,-3.437960154,0.000586114,0.004758944,180.3067321,1,-2.700078815,0.803462356,-3.360554226,0.000777863,0.003896236,N,-,,elongation factor G,F:GTP binding; F:aspartic-type endopeptidase activity; F:translation elongation factor activity; F:GTPase activity; C:mitochondrion; P:proteolysis; P:mitochondrial translational elongation,IPR000795 (PRINTS); IPR000640 (SMART); IPR005517 (SMART); IPR004540 (TIGRFAM); IPR000640 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005517 (PFAM); IPR005225 (TIGRFAM); IPR004161 (PFAM); PF00009 (PFAM); IPR009022 (PFAM); G3DSA:2.40.30.10 (GENE3D); IPR014721 (G3DSA:3.30.230.GENE3D); G3DSA:3.30.70.870 (GENE3D); IPR000640 (G3DSA:3.30.70.GENE3D); PTHR23115:SF162 (PANTHER); PTHR23115 (PANTHER); PTHR23115:SF162 (PANTHER); PTHR23115:SF162 (PANTHER); PTHR23115 (PANTHER); IPR000795 (PROSITE_PROFILES); IPR004540 (HAMAP); IPR020568 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR009000 (SUPERFAMILY); IPR009022 (SUPERFAMILY); IPR009022 (SUPERFAMILY),,
RL4_JR_01425,433,394,599,0,0,0,0,0,0,2,0,4,0,3,0,0,1,1,5.684220135,0,-0.60946584,1.217598366,-0.500547518,0.616689606,0.779751055,1.805471139,0,2.613049498,1.327951198,1.967730066,0.049099105,0.116117088,52.83708486,1,3.361430658,0.633399621,5.306966642,1.11E-07,3.80E-06,17.46037882,1,1.824740081,0.876728432,2.081305925,0.037405913,0.102865591,15.88331974,1,1.545255098,0.996268439,1.55104291,0.120891401,0.220664402,Y,-,,aspartic-type endopeptidase,F:nucleotide binding; F:aspartic-type endopeptidase activity; P:protein catabolic process; P:proteolysis; C:integral component of membrane; P:translational elongation; C:intracellular,IPR001461 (PRINTS); IPR021109 (G3DSA:2.40.70.GENE3D); IPR033121 (PFAM); IPR021109 (G3DSA:2.40.70.GENE3D); IPR001461 (PANTHER); PTHR13683:SF326 (PANTHER); IPR033121 (PROSITE_PROFILES); IPR021109 (SUPERFAMILY),8.A.32.1.4,The β-Amyloid Cleaving Enzyme (BACE1) Family
RL4_JR_01426,1350,1082,1954,0,2,3,0,0,0,3,1,3,0,3,2,0,0,0,44.91340526,1,0.811959044,0.716372327,1.133431616,0.257033044,0.435850254,5.533786662,0,0.997169169,1.260239813,0.791253505,0.428796074,0.591721045,74.97822824,1,1.977831701,0.610338379,3.240549456,0.001192996,0.006654484,47.95507374,1,0.962044615,0.710764234,1.35353549,0.17588462,0.299729905,14.31594141,0,-1.753337995,1.225443919,-1.430777833,0.152493898,0.262141822,N,-,,aminotransferase class I and II,F:pyridoxal phosphate binding; F:transaminase activity; P:biosynthetic process,IPR015422 (G3DSA:3.90.1150.GENE3D); IPR004839 (PFAM); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR11751:SF388 (PANTHER); PTHR11751 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_01427,643,365,571,0,0,0,0,0,0,0,4,1,0,2,0,0,0,0,6.273013953,0,-0.751726533,1.227885815,-0.612212084,0.540397448,0.722359885,2.014385335,0,2.455167062,1.347531329,1.821974012,0.068458929,0.150934715,43.08330374,1,2.948597788,0.707409059,4.168165153,3.07E-05,0.000480478,14.03517312,1,1.096180776,1.050692133,1.043293978,0.296812159,0.441944575,5.132930627,0,-0.27370072,1.22595644,-0.223254849,0.823337166,0.881400804,N,-,,ABC transporter,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; C:integral component of membrane; C:plasma membrane",IPR003593 (SMART); IPR013525 (PFAM); IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR19241:SF269 (PANTHER); PTHR19241:SF269 (PANTHER); PTHR19241 (PANTHER); PTHR19241 (PANTHER); PTHR19241 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.1.204.9, the atp-binding cassette (abc) superfamily.
RL4_JR_01428,7013,7529,10937,1,0,3,0,0,0,0,0,0,0,6,0,0,1,0,123.2386858,1,-2.06023004,0.784399764,-2.626505177,0.008626668,0.033672898,32.22196762,0,-1.54449109,1.204351187,-1.282425845,0.199693303,0.343310848,84.03825057,0,-4.204005998,1.203234963,-3.493919414,0.000475985,0.003253794,121.0475723,1,-1.370933342,0.667409602,-2.054110904,0.039964959,0.107481332,87.18967538,1,-3.365992385,1.144532389,-2.940932399,0.003272259,0.01268439,N,-,,hypothetical protein CMQ_3493,,no IPS match,,
RL4_JR_01429,22055,28629,34757,3,0,4,0,0,1,0,0,1,0,3,0,0,3,0,387.7329179,1,-2.983278284,0.635536254,-4.694111887,2.68E-06,3.62E-05,117.769468,1,-2.377749906,1.118135388,-2.126531305,0.033459046,0.086198131,289.0284353,1,-4.99147634,1.206085477,-4.138575943,3.49E-05,0.000536876,338.0683063,1,-4.089572845,0.88610363,-4.615230892,3.93E-06,6.15E-05,291.3669141,1,-3.863363283,0.896454046,-4.309605494,1.64E-05,0.000151902,N,-,,nucleolar gtp-binding 2,"F:GTP binding; P:ribosomal large subunit export from nucleus; C:nucleolus; C:nucleoplasm; C:preribosome, large subunit precursor",IPR006073 (PRINTS); IPR027417 (G3DSA:3.40.50.GENE3D); IPR006073 (PFAM); IPR012971 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR023179 (G3DSA:1.10.1580.GENE3D); IPR024929 (PTHR11089:PANTHER); IPR024929 (PTHR11089:PANTHER); PTHR11089 (PANTHER); PTHR11089 (PANTHER); IPR030378 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_01430,14272,11399,12556,0,4,13,0,0,0,0,0,0,2,10,0,0,0,1,234.4260905,1,-0.592585444,0.421357487,-1.40637217,0.15961364,0.309073837,48.99235818,0,-2.148956964,1.198959564,-1.792351492,0.07307668,0.158832328,126.7113894,0,-4.796414693,1.191822071,-4.024438554,5.71E-05,0.00080305,204.8858955,1,-0.941796559,0.469895268,-2.004269087,0.045041243,0.11524958,131.9207251,1,-3.94025543,1.121023836,-3.514872123,0.000439966,0.002439995,N,-,,transcription initiation factor TFIID subunit 1,F:translation initiation factor activity; F:histone acetyltransferase activity; F:protein complex scaffold; P:RNA polymerase II transcriptional preinitiation complex assembly; C:transcription factor TFIID complex; C:cytosol; P:histone acetylation; F:chromatin binding; F:TBP-class protein binding; P:translational initiation,IPR022591 (PFAM); PTHR13900 (PANTHER),,
RL4_JR_01431,3822,2398,2851,0,1,2,0,0,0,0,0,2,0,0,2,0,8,0,51.79464214,1,-0.973868332,0.875365295,-1.112527921,0.265911232,0.445900068,11.6457653,0,-0.076195346,1.23906596,-0.061494181,0.950965649,0.973667236,43.04831907,1,-0.904935394,1.051592674,-0.860537941,0.389492579,0.532867955,53.92419051,1,-1.385617738,1.034208714,-1.339785403,0.180315123,0.305862057,60.37054472,1,0.74826207,0.612110981,1.222428763,0.221545528,0.348044758,N,-,,mads-box mef2 type transcription factor,F:binding,IPR002100 (PRINTS); IPR002100 (SMART); IPR002100 (PFAM); PTHR11945:SF141 (PANTHER); PTHR11945 (PANTHER); PTHR11945 (PANTHER); PTHR11945:SF141 (PANTHER); IPR002100 (PROSITE_PROFILES); IPR002100 (SUPERFAMILY),,
RL4_JR_01432,4688,6176,7054,0,1,1,0,0,0,0,0,0,0,0,0,0,2,0,83.66805765,1,-2.53304215,1.034279103,-2.449089557,0.014321783,0.050666569,22.77117374,0,-1.043641915,1.206892724,-0.864734615,0.387184466,0.551672461,59.30820356,0,-3.701180843,1.201123158,-3.081433255,0.002060067,0.010085161,68.43776873,0,-4.123907756,1.2028338,-3.428493409,0.000606941,0.004888847,66.39598111,1,-2.127094528,0.99676881,-2.133989856,0.032843611,0.080733567,N,-,,Actin-related 4,"P:DNA repair; P:chromatin remodeling; C:NuA4 histone acetyltransferase complex; P:regulation of transcription, DNA-templated; C:Ino80 complex; F:transferase activity",IPR004000 (SMART); IPR004000 (PFAM); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR027667 (PTHR11937:PANTHER); IPR004000 (PANTHER); IPR027667 (PTHR11937:PANTHER); IPR027667 (PTHR11937:PANTHER); IPR004000 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_01433,975,857,1783,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18.17482641,1,-1.001806953,1.195099799,-0.838262172,0.401883476,0.593717838,4.531847394,0,1.285310242,1.293776263,0.993456348,0.320487613,0.482661832,11.86097292,0,-1.379294312,1.232512448,-1.119091588,0.263101068,0.400305863,13.68942471,0,-1.802288986,1.235747157,-1.458460961,0.144713528,0.259056661,11.81498278,0,-1.476321131,1.248706335,-1.182280484,0.237094427,0.365942236,N,-,,pig-p domain containing,C:integral component of membrane; F:transferase activity,IPR013717 (PFAM); PTHR21726 (PANTHER),,
RL4_JR_01434,5690,4394,3408,11,0,13,0,0,0,0,9,6,0,9,3,0,0,2,214.4191703,1,1.52536391,0.75774135,2.013040347,0.044110385,0.121040202,17.46543625,0,-0.660877865,1.239922395,-0.532999378,0.594034011,0.730241955,154.5091815,1,1.399786008,0.499849771,2.800413425,0.00510372,0.019201401,116.8152311,1,0.533098983,0.539486252,0.988160461,0.323074069,0.469571723,58.62823896,1,-1.673162178,0.990470491,-1.689259996,0.091169616,0.178031314,N,-,,com1 regulatory,C:transcription elongation factor complex; P:transcription elongation from RNA polymerase II promoter,PTHR21497 (PANTHER); PTHR21497 (PANTHER); PTHR21497:SF34 (PANTHER); PTHR21497:SF34 (PANTHER); IPR011991 (SUPERFAMILY),,
RL4_JR_01435,1569,2567,2161,0,2,11,0,0,0,2,0,0,0,2,5,0,2,0,83.41005471,1,1.522018344,0.594391374,2.560633298,0.010448157,0.039207023,8.057862708,0,0.455129605,1.249403256,0.364277588,0.715650734,0.821667052,43.08176509,1,-0.359143198,1.051651216,-0.341504096,0.732724122,0.819951256,80.3633424,1,0.973094717,0.638055282,1.525094681,0.127235484,0.234783903,28.37084205,1,-0.624576739,1.009062098,-0.618967594,0.535937707,0.659099877,N,-, Effector probability:0.643,dynein light chain LC8-type,"C:peroxisome; P:actin filament-based process; C:cytoplasmic dynein complex; P:positive regulation of ATP-dependent microtubule motor activity, plus-end-directed; P:establishment of mitotic spindle localization; P:metabolic process; P:nuclear migration along microtubule; C:peroxisomal importomer complex; C:cytoplasmic microtubule; P:nuclear pore complex assembly; C:nuclear pore",IPR001372 (SMART); IPR001372 (PFAM); IPR001372 (G3DSA:3.30.740.GENE3D); IPR001372 (PANTHER); SSF54648 (SUPERFAMILY),,
RL4_JR_01436,21331,29091,33892,3,0,2,0,0,0,1,2,0,1,2,0,0,14,2,375.8683831,1,-3.421732822,0.727255522,-4.704993935,2.54E-06,3.45E-05,107.0333731,0,-3.276407114,1.201691451,-2.726496149,0.00640107,0.024293008,305.7257759,1,-3.518139665,0.873655379,-4.02691925,5.65E-05,0.000797952,339.2627372,1,-4.050232196,0.880644472,-4.599168363,4.24E-06,6.62E-05,344.9690744,1,-1.595413488,0.613266925,-2.601499321,0.009281725,0.029608527,N,-,,RNA recognition domain-containing,F:nucleotide binding; F:nucleic acid binding,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR24012:SF477 (PANTHER); PTHR24012:SF477 (PANTHER); PTHR24012 (PANTHER); PTHR24012:SF477 (PANTHER); PTHR24012 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY),,
RL4_JR_01437,6928,8123,6473,0,1,3,0,0,0,0,1,12,8,9,2,0,0,8,106.0467314,1,-1.825364269,0.765408389,-2.384823964,0.017087296,0.057877242,27.6936106,0,-1.325937025,1.208214804,-1.097434844,0.272451349,0.4301595,157.4758903,1,0.479575451,0.539860756,0.888331751,0.374362325,0.518332082,212.5183094,1,0.598642886,0.403695413,1.482907329,0.138099034,0.250045193,129.278838,1,-0.215558925,1.579117078,-0.13650598,0.891421297,0.928946134,N,-,,transcription factor,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated",IPR000818 (SMART); IPR000818 (PFAM); PTHR11795:SF383 (PANTHER); PTHR11795 (PANTHER); IPR000818 (PROSITE_PROFILES),,
RL4_JR_01438,1124,760,1020,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.56695024,0,-1.634453777,1.19990561,-1.362151959,0.173149934,0.327208051,3.710206743,0,1.574021146,1.276385649,1.233186183,0.217506309,0.364744676,9.602497689,0,-1.074504686,1.204456863,-0.892107239,0.372335455,0.516382772,11.07532632,0,-1.496550614,1.203293143,-1.243712409,0.213605427,0.347989534,9.451900343,0,-1.154475164,1.206001861,-0.957274778,0.338428582,0.475584927,Y,-,,hypothetical protein SPSK_09184,,no IPS match,,
RL4_JR_01439,1018,1777,1520,0,1,0,0,0,0,1,2,0,2,1,1,0,3,1,25.41050901,1,-1.269221491,1.180051424,-1.07556456,0.282122044,0.465147866,5.515115796,0,1.002129574,1.272664792,0.787426179,0.431032427,0.593028439,41.10216078,1,0.765029574,0.883019531,0.866378995,0.386282359,0.530154404,48.82586074,1,0.687881197,0.783870674,0.877544243,0.380191099,0.526094694,33.10535276,1,0.863033223,0.803668742,1.073866853,0.282882362,0.416911777,N,-, Effector probability:0.858,peptidyl-prolyl cis-trans isomerase,C:nucleus; F:peptidyl-prolyl cis-trans isomerase activity; P:protein peptidyl-prolyl isomerization; P:protein folding,IPR002130 (PRINTS); IPR024936 (PIRSF); IPR002130 (PFAM); IPR029000 (G3DSA:2.40.100.GENE3D); IPR024936 (PANTHER); IPR002130 (PROSITE_PROFILES); IPR029000 (SUPERFAMILY),3.D.1.8.1, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_01440,321,604,624,0,1,0,0,0,4,0,0,0,0,0,2,0,0,0,14.24331652,1,0.21400397,1.198716915,0.17852753,0.858308703,0.928904536,39.48073502,1,5.031859806,0.833883093,6.0342509,1.60E-09,2.69E-07,5.133422913,0,-0.170936168,1.241973506,-0.137632701,0.89053071,0.931343244,25.19531492,1,1.180936075,1.062814782,1.111140054,0.266508069,0.407571414,5.086452698,0,-0.260319329,1.250974089,-0.208093302,0.835156117,0.888417281,Y,-,,plc-like phosphodiesterase,P:lipid metabolic process; F:phosphoric diester hydrolase activity,IPR000909 (SMART); IPR017946 (G3DSA:3.20.20.GENE3D); PTHR13593:SF30 (PANTHER); PTHR13593 (PANTHER); PTHR13593:SF30 (PANTHER); IPR000909 (PROSITE_PROFILES); IPR017946 (SUPERFAMILY),,
RL4_JR_01441,129,135,190,0,1,0,0,0,0,0,0,1,0,2,0,0,0,0,9.822996665,1,1.990883166,1.162523767,1.712552657,0.086794869,0.199417297,0.574975294,0,4.263827506,1.515756087,2.813003716,0.004908108,0.020375016,7.997056485,1,2.566675242,1.206762796,2.126909489,0.033427604,0.08354013,9.75211593,1,2.900141407,1.03691073,2.796905581,0.005159461,0.028671537,1.484342256,0,1.516569132,1.228997876,1.233988407,0.217207224,0.342504773,Y,-,,Histidine phosphatase clade-2,C:integral component of membrane,IPR029033 (G3DSA:3.40.50.GENE3D); PTHR11567 (PANTHER); PTHR11567:SF36 (PANTHER); PTHR11567:SF36 (PANTHER); PTHR11567 (PANTHER); IPR029033 (SUPERFAMILY),,
RL4_JR_01442,6031,4640,7106,2,11,8,0,0,0,1,0,2,4,7,0,0,14,0,209.5718253,1,0.922267841,0.448683096,2.055499416,0.039830792,0.112388965,22.56717305,0,-1.03066454,1.2068814,-0.853989912,0.393110579,0.557292056,82.71093758,1,-1.277535221,0.862590968,-1.48104405,0.138594836,0.247213937,132.9855046,1,0.066720664,0.499441677,0.133590501,0.893726396,0.934639273,112.0140175,1,0.380555012,0.702417846,0.541778677,0.587970982,0.700542033,N,-,,ring finger domain,F:metal ion binding; C:membrane,IPR001841 (SMART); IPR001841 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR22765 (PANTHER); PTHR22765:SF5 (PANTHER); PTHR22765 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),8.A.112.1.6, the respiratory supercomplex factor (rcf) family.
RL4_JR_01443,1725,1434,2238,0,0,7,0,0,0,0,0,0,0,2,0,0,3,0,48.22493463,1,0.941556371,0.626133627,1.503762663,0.132642488,0.270998602,6.837816348,0,0.691922362,1.236866974,0.559415342,0.575878293,0.715507273,17.7940801,0,-1.964443462,1.201769326,-1.634626064,0.10212746,0.196621273,28.55361888,1,-0.666975248,1.030102947,-0.647484069,0.517318702,0.651798389,29.19449168,1,0.137334614,0.873965741,0.157139585,0.875134841,0.916625828,N,-,,GPALPP motifs-containing 1,,IPR022226 (PFAM),,
RL4_JR_01444,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_01445,1734,2313,2267,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,25.36568578,0,-2.767069792,1.201410644,-2.303184016,0.021268492,0.069154386,8.06158653,0,0.454453023,1.22948823,0.369627795,0.711659838,0.819035916,68.00843204,1,1.198790248,1.229826725,0.974763537,0.329677568,0.47263664,24.17288991,0,-2.622474328,1.19847155,-2.188182379,0.02865632,0.089856067,20.67246552,0,-2.283377595,1.203875679,-1.896688865,0.057869014,0.125037083,N,-,,gpi ethanolamine phosphate transferase,"C:membrane; P:metabolic process; F:transferase activity, transferring phosphorus-containing groups",IPR017849 (G3DSA:3.40.720.GENE3D); IPR002591 (PFAM); PTHR23071 (PANTHER); PTHR23071:SF1 (PANTHER); PTHR23071:SF1 (PANTHER); PTHR23071 (PANTHER); IPR017850 (SUPERFAMILY),9.A.6.1.2, the atp exporter (atp-e) family.
RL4_JR_01446,3194,4709,4985,7,13,21,0,0,3,1,4,4,7,16,1,0,6,0,306.5413826,1,2.297947476,0.372412815,6.170430722,6.81E-10,1.94E-08,44.53060338,1,1.599644193,0.879453042,1.818908022,0.068925464,0.151853303,111.1423557,1,0.757947859,0.546333222,1.387336205,0.165339268,0.282228081,188.2873624,1,1.60923869,0.429904932,3.743243149,0.00018166,0.001771975,65.40221199,1,-0.173780418,0.689709533,-0.251961745,0.801070633,0.865743833,N,-, Effector probability:0.697,hypothetical protein SPBR_02065,C:integral component of membrane,no IPS match,,
RL4_JR_01447,4953,4826,6293,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,64.20390553,0,-4.106938812,1.193082565,-3.442292203,0.000576807,0.00378872,20.42771306,0,-0.886970922,1.198284704,-0.740200488,0.459178352,0.617976769,53.11663667,0,-3.542138179,1.191622191,-2.972534588,0.002953519,0.013463048,65.29557623,1,-3.017571974,1.144729004,-2.636057934,0.008387541,0.042208674,63.72680255,1,-1.950462505,0.978912676,-1.992478546,0.046318577,0.10567362,N,-,,pumilio domain-containing,F:RNA binding,IPR001313 (SMART); IPR001313 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR12537:SF12 (PANTHER); PTHR12537 (PANTHER); PTHR12537 (PANTHER); PTHR12537:SF12 (PANTHER); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR033133 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),,
RL4_JR_01448,4382,1905,3174,1,0,0,0,0,0,1,0,0,2,1,0,0,0,5,47.56532456,1,-2.375456044,1.194476107,-1.988701181,0.046734196,0.12641166,12.11005414,0,-0.132613225,1.272324845,-0.104229062,0.916987572,0.954060707,42.30844401,1,-1.814490706,1.231648537,-1.473221175,0.140691407,0.2499257,58.65615845,1,-0.856531358,0.916520132,-0.934547238,0.350021681,0.496702105,67.50234174,1,0.308497636,1.392098917,0.221606117,0.82462052,0.882215,N,-,,moz represents a chromatin-associated acetyltransferase,C:mitochondrion; C:integral component of membrane; F:transferase activity,IPR024461 (PFAM); PTHR14360 (PANTHER); PTHR14360:SF12 (PANTHER),,
RL4_JR_01449,24667,8445,37228,0,0,4,0,0,0,0,0,1,0,7,1,0,1,3,291.8388075,1,-3.668843184,1.053520613,-3.4824598,0.00049683,0.0033497,87.71623724,0,-2.98926229,1.289456778,-2.318233803,0.020436618,0.058487877,235.8828453,1,-4.690840234,1.296452616,-3.618211862,0.000296646,0.002306635,302.4157486,1,-2.520502848,0.828797728,-3.041155594,0.00235672,0.015111964,254.7296359,1,-3.064791771,0.966752913,-3.170191401,0.001523386,0.006756145,Y,-,,esterase family,"F:hydrolase activity, acting on ester bonds",IPR013830 (G3DSA:3.40.50.GENE3D); IPR013830 (PFAM); PTHR37981 (PANTHER); PTHR37981:SF1 (PANTHER); IPR013830 (SUPERFAMILY),,
RL4_JR_01450,72379,38583,75917,5,0,4,0,0,0,5,6,19,3,25,8,0,56,26,806.2925078,1,-3.667424872,0.677690013,-5.411655481,6.24E-08,1.30E-06,236.9846063,0,-4.42313288,1.232932902,-3.587488723,0.000333878,0.01320123,840.9342274,1,-1.397420072,0.483064942,-2.892820306,0.003817997,0.01598569,914.7788101,1,-1.709581977,0.485239112,-3.523174318,0.000426411,0.003674391,1015.429608,1,-0.516096225,0.867989614,-0.594588019,0.552118891,0.672061045,N,-,,hypothetical protein CMQ_4531,P:mycelium development,PTHR36826 (PANTHER),,
RL4_JR_01451,654,344,522,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.03691324,0,-0.696357971,1.237283443,-0.562812001,0.573562907,0.749499631,1.9437375,0,2.506692157,1.363337976,1.838643243,0.065967677,0.146623808,5.021450251,0,-0.139225971,1.231446389,-0.113058897,0.909983861,0.94498683,5.790761988,0,-0.561047545,1.234512102,-0.454469052,0.649491262,0.759803469,4.936371793,0,-0.217388884,1.231639485,-0.176503666,0.859898269,0.906829494,N,-, Effector probability:0.661,poly polymerase,,IPR009288 (PFAM); IPR013024 (SUPERFAMILY),,
RL4_JR_01452,3140,8354,13684,0,0,0,0,0,0,0,0,1,0,4,0,0,0,0,100.7424111,0,-4.756856423,1.356088982,-3.507776027,0.000451869,0.003095172,31.36159399,0,-1.50543075,1.30424923,-1.154250825,0.248397351,0.401898655,89.19742131,1,-3.219016379,1.292718284,-2.490114373,0.012770199,0.03914184,111.5472271,1,-2.025761259,0.984498199,-2.057658674,0.03962291,0.106839404,82.86608522,0,-4.286487369,1.322236252,-3.241846805,0.001187578,0.005496994,N,-,,DEAD DEAH box helicase,"F:nucleic acid binding; F:ATPase activity; C:nucleus; F:ATP binding; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:helicase activity; P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",IPR001650 (SMART); IPR014001 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24031 (PANTHER); PTHR24031:SF302 (PANTHER); PTHR24031:SF302 (PANTHER); PTHR24031 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_01453,9379,5123,9369,0,1,9,0,0,0,0,10,0,2,10,0,0,0,0,137.0620081,1,-0.758286848,0.650183008,-1.166266788,0.243506597,0.418656863,30.32734392,0,-1.457042323,1.227747751,-1.186760327,0.235322172,0.385751572,157.0690877,1,0.010178642,1.688954644,0.006026593,0.995191504,0.998095149,149.4479236,1,-0.318456481,0.571695369,-0.557038763,0.577500945,0.704142229,77.62210182,0,-4.19218888,1.223832395,-3.42545997,0.000613759,0.003216518,N,-,,STE STE7 MKK kinase,C:nucleus; F:ATP binding; P:MAPK cascade; P:activation of MAPK activity; P:peptidyl-tyrosine phosphorylation; C:cell septum; F:protein tyrosine kinase activity; P:positive regulation of calcium-mediated signaling involved in cellular response to salt stress; F:MAP kinase kinase activity; C:cytosol; F:protein serine/threonine kinase activity,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); PTHR24361 (PANTHER); PTHR24361:SF351 (PANTHER); PTHR24361 (PANTHER); PTHR24361:SF351 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.3, the pock size-determining protein (psdp) family.
RL4_JR_01454,3141,3502,4297,0,2,1,0,0,0,0,0,0,0,1,0,0,0,0,63.61270234,1,-1.234818716,0.860980401,-1.434200727,0.15151499,0.299413458,13.90359747,0,-0.331903566,1.206927093,-0.274998852,0.78331712,0.869188324,36.18005148,0,-2.988167343,1.193987046,-2.502679869,0.012325698,0.038032723,45.75761553,1,-2.463859904,1.147190475,-2.147733927,0.031734899,0.095261147,35.7762427,0,-3.074696567,1.200737005,-2.560674448,0.01044692,0.032521052,N,-,,trna pseudouridine synthase d,P:pseudouridine synthesis; P:ncRNA metabolic process,PIRSF037016 (PIRSF); IPR001656 (TIGRFAM); IPR001656 (PFAM); PTHR13326:SF1 (PANTHER); IPR001656 (PANTHER); IPR001656 (PANTHER); PTHR13326:SF1 (PANTHER); IPR001656 (PANTHER); PTHR13326:SF1 (PANTHER); IPR011760 (PROSITE_PROFILES); IPR020103 (SUPERFAMILY),,
RL4_JR_01455,949,1683,1617,3,0,4,0,0,0,1,0,0,0,0,0,0,0,0,62.57940692,1,1.340218609,0.66467607,2.016348517,0.043763545,0.120453104,5.410228577,0,1.0298096,1.275843325,0.807159923,0.419574352,0.583369724,25.16952979,1,-0.666777957,1.218933247,-0.547017615,0.584366631,0.705729186,16.27140693,0,-2.051429445,1.224726482,-1.675010279,0.093932215,0.186849445,13.94512811,0,-1.715418175,1.232202145,-1.392156459,0.163875024,0.276585201,N,-,,peptidyl-prolyl cis-trans isomerase PIN4,F:isomerase activity,G3DSA:3.10.50.40 (GENE3D); PF13616 (PFAM); PTHR10657 (PANTHER); IPR000297 (PROSITE_PROFILES); SSF54534 (SUPERFAMILY),,
RL4_JR_01456,367,285,407,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.219789841,0,-0.179766515,1.215693121,-0.147871624,0.882444083,0.94282897,1.34714035,0,3.035572268,1.362043971,2.228688892,0.025834612,0.07020079,3.497113919,0,0.382556591,1.210530257,0.316023981,0.751984306,0.833671607,4.034295158,0,-0.039752981,1.211976603,-0.032800123,0.97383398,0.985021883,3.452596053,0,0.298458517,1.211682856,0.246317356,0.805436576,0.868932535,N,-,,hypothetical protein CMQ_4293,,no IPS match,,
RL4_JR_01457,5050,6210,6632,0,0,8,0,0,0,1,0,2,0,4,4,0,4,3,102.3084087,1,-0.624262465,0.609329047,-1.02450797,0.305595408,0.492413944,22.80759433,0,-1.045934286,1.200559531,-0.871205683,0.383641858,0.548090739,83.36037624,1,-1.293132769,0.856339056,-1.510070993,0.13102531,0.23721392,122.9998558,1,-0.387564511,0.551888278,-0.702251754,0.482522175,0.622814684,96.08413043,1,-0.358447729,0.596789034,-0.600627204,0.548088315,0.668521164,N,-,,coronin-6,"P:actin filament organization; C:Arp2/3 protein complex; F:microtubule binding; P:microtubule-based process; F:actin filament binding; C:endocytic vesicle; C:actomyosin contractile ring; C:growing cell tip; P:positive regulation of Arp2/3 complex-mediated actin nucleation; F:protein binding, bridging; C:actin cortical patch; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:actin cortical patch localization; C:actin fusion focus",IPR020472 (PRINTS); SM01167 (SMART); IPR001680 (SMART); IPR015048 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); PF16300 (PFAM); IPR001680 (PFAM); IPR015048 (PFAM); IPR015505 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),3.A.20.1.2, the peroxisomal protein importer (ppi) family.
RL4_JR_01458,11,5,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.122344168,0,4.928340423,3.719432729,1.32502475,0.185162942,NA,0.038900463,0,8.148924907,2.577709902,3.16130411,0.001570644,0.015023052,0.101472818,0,5.487400381,1.52911289,3.588616915,0.000332437,0.00252774,0.117082037,0,5.066553495,2.262039968,2.239816081,0.025102865,0.08557795,0.100870623,0,5.394406064,1.339579473,4.026939925,5.65E-05,0.000429856,,,,,,,,
RL4_JR_01459,52754,33711,35152,0,7,7,0,0,0,1,4,4,6,4,6,0,18,4,568.0312528,1,-2.493731638,0.53556194,-4.656289875,3.22E-06,4.25E-05,156.661317,0,-3.825984041,1.222576116,-3.129444449,0.001751372,0.015023052,472.0143941,1,-2.48501937,0.567912109,-4.375711189,1.21E-05,0.000220789,595.0808155,1,-2.030305294,0.507392749,-4.001447194,6.30E-05,0.000723532,494.1675503,1,-1.665647036,0.582818702,-2.857916245,0.004264329,0.015723356,N,-,,snf2 family atp-dependent chromatin-remodeling factor snf21,"C:nucleus; F:ATP binding; F:histone binding; P:regulation of transcription, DNA-templated; F:helicase activity",IPR001487 (PRINTS); IPR014001 (SMART); IPR014978 (SMART); IPR001650 (SMART); IPR001487 (SMART); IPR029295 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR014012 (PFAM); IPR029295 (PFAM); IPR000330 (PFAM); IPR001487 (G3DSA:1.20.920.GENE3D); IPR001487 (PFAM); IPR014978 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10799:SF640 (PANTHER); PTHR10799 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR014012 (PROSITE_PROFILES); IPR014978 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); IPR001487 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_01460,3074,2878,3296,0,1,6,0,0,0,0,1,2,7,2,1,0,0,0,67.90679411,1,0.214203348,0.561237677,0.381662452,0.702711754,0.839344435,11.80946335,0,-0.096351231,1.20650139,-0.079860025,0.936348584,0.964751666,51.46835182,1,-0.341537224,0.845006135,-0.404183129,0.686078059,0.784487719,118.1763438,1,0.908795078,0.482046346,1.885285688,0.059391277,0.136141427,30.18633289,0,-2.829606208,1.188736784,-2.380347143,0.017296335,0.048632434,N,-,,wd repeat-containing 70,,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR16017:SF0 (PANTHER); PTHR16017 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.15.2.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_01461,198,183,248,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6.329283765,1,1.515872967,1.157796455,1.309274149,0.190441503,0.350309308,0.799151864,0,3.788907192,1.440005294,2.631175876,0.008508999,0.029781496,2.077806051,0,1.133593573,1.216635794,0.931744388,0.351468641,0.494866881,2.397259836,0,0.711165253,1.224797488,0.580639053,0.561483746,0.689678871,2.053879195,0,1.04791283,1.214869007,0.862572692,0.38837245,0.524442659,N,-,,Ribonucleoside-diphosphate reductase large subunit,C:cellular_component; F:molecular_function,G3DSA:2.60.120.620 (GENE3D); SSF51197 (SUPERFAMILY),,
RL4_JR_01462,278,728,530,0,0,0,0,0,0,0,1,0,0,0,5,0,0,8,6.225701491,0,-0.740417091,1.30929294,-0.565509115,0.571727527,0.747937587,1.965496151,0,2.490632064,1.414164591,1.761203809,0.078203914,0.167429078,12.963133,1,0.794707085,1.255888777,0.632784606,0.526874311,0.656259292,54.08560507,1,2.935569759,1.652770119,1.776151278,0.075707986,0.159929764,63.97906867,1,3.580986299,1.677355903,2.134899512,0.032769219,0.080609413,N,-,,phytanoyl-dioxygenase family,F:dioxygenase activity; P:oxidation-reduction process,G3DSA:2.60.120.620 (GENE3D); IPR008775 (PFAM); SSF51197 (SUPERFAMILY),,
RL4_JR_01463,0,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.024701871,0,7.238701169,3.949789044,1.832680452,0.066850106,NA,0.007694775,0,10.48756637,3.950855392,2.654505246,0.00794248,0.02841517,0.020152476,0,7.824018738,2.683596837,2.915497078,0.003551224,0.015351236,0.023270171,0,7.399037905,3.950359032,1.873003908,0.061067845,0.137947378,0.019940236,0,7.746134954,1.600920209,4.838551548,1.31E-06,1.80E-05,N,-,,related to methyltransferase,F:transferase activity,no IPS match,,
RL4_JR_01464,67,41,142,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.986323648,0,1.917300026,1.719569772,1.114988212,0.264855473,NA,0.310178349,0,5.153963282,1.798519858,2.865669377,0.004161286,0.018371529,0.815063055,0,2.483131601,1.357874803,1.828689652,0.067446114,0.142581845,0.940872065,0,2.060215043,1.454719708,1.416228179,0.156708708,0.274844218,0.816234706,0,2.379167205,1.344488951,1.76956992,0.076798814,0.155922997,N,-,,methyltransferase type 11,P:metabolic process; F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108 (PANTHER); PTHR10108:SF854 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_01465,66,47,43,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.623705,0,2.578701436,1.805904194,1.427928151,0.15331254,NA,0.201320467,0,5.778129113,1.848342905,3.126113178,0.001771334,0.015023052,0.518465067,0,3.137019797,1.28604384,2.43927905,0.014716599,0.043769345,0.59782431,0,2.715159546,1.395078225,1.946241793,0.051625702,0.125559168,0.507344354,0,3.064349953,1.238723068,2.473797439,0.013368547,0.039639093,N,-,,methyltransferase type 11,P:metabolic process; F:transferase activity,no IPS match,,
RL4_JR_01466,944,1036,2606,0,0,1,0,0,0,0,0,0,1,5,2,0,3,0,22.00516779,1,-1.345968881,1.245400503,-1.080751836,0.279807518,0.463130502,5.691001345,0,0.956733957,1.33216584,0.718179319,0.472646728,0.630569418,14.98585995,0,-1.7166298,1.268484642,-1.35329175,0.175962444,0.295199858,65.94313975,1,1.560367852,0.700414157,2.22777886,0.025895265,0.08596379,26.60442124,1,0.307494343,1.00242843,0.306749424,0.759034107,0.831913871,N,-,,major facilitator superfamily transporter,F:allantoate transmembrane transporter activity; P:transmembrane transport; F:dipeptide transporter activity; P:allantoate transport; P:dipeptide transport; C:integral component of membrane; C:plasma membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662 (PANTHER); PTHR11662:SF230 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.4, the major facilitator superfamily (mfs).
RL4_JR_01467,260,230,369,0,2,3,0,0,0,0,0,1,0,0,0,0,0,0,30.89736881,1,3.164123781,0.69876646,4.528156344,5.95E-06,7.34E-05,1.086179578,0,3.346137411,1.400032625,2.390042454,0.016846425,0.050464492,9.32906044,1,1.649266212,1.208543744,1.364672334,0.172356059,0.291113236,3.265851242,0,0.265045975,1.230000857,0.215484382,0.829389687,0.893358319,2.805226804,0,0.598126873,1.227894161,0.487115984,0.626176139,0.730334456,Y,-,,Para-nitrobenzyl esterase,F:hydrolase activity,IPR002018 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR11559:SF232 (PANTHER); PTHR11559 (PANTHER); IPR029058 (SUPERFAMILY),8.A.117.1.3, the neuroligin (nlg) family.
RL4_JR_01468,9,0,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.07783472,0,5.58036684,3.920446681,1.423400774,0.154620008,NA,0.02486,0,8.794820867,3.920458201,2.243314535,0.024876539,0.068294094,0.064863454,0,6.133741557,2.318232757,2.645869591,0.008148122,0.02780303,0.07482961,0,5.712471232,3.920360222,1.457129169,0.145080728,0.259622194,0.064679782,0,6.035235457,1.770980997,3.407848795,0.000654772,0.003394554,N,-,,integral membrane,C:integral component of membrane,PTHR33048 (PANTHER),9.B.313.1.4, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_01469,156,149,120,0,0,1,0,0,0,0,0,0,1,0,0,0,2,0,5.524579321,1,2.073601085,1.168095581,1.775198125,0.075865179,0.18111077,0.54808409,0,4.333177343,1.54131477,2.81135134,0.004933388,0.02045709,1.414579314,0,1.6890325,1.233340811,1.369477508,0.170850061,0.289245153,10.94367603,1,2.218447734,1.156565436,1.918134214,0.055093995,0.13000344,9.107283572,1,3.280233962,0.987716608,3.321027444,0.000896867,0.004372066,N,-,,hypothetical protein FOMG_02051,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PTHR31263 (PANTHER); PTHR31263:SF12 (PANTHER); PTHR31263:SF12 (PANTHER); PTHR31263 (PANTHER),,
RL4_JR_01470,144,105,165,0,0,0,0,0,1,0,0,0,0,4,0,0,0,0,1.647396242,0,1.177255209,1.326321917,0.887608953,0.374751136,NA,9.904187017,1,5.307538013,1.149402025,4.617651526,3.88E-06,0.000290994,1.365425677,0,1.73914232,1.23669315,1.406284428,0.159639682,0.274824991,17.6215593,1,4.01526142,0.774625226,5.183489105,2.18E-07,4.55E-06,1.349357944,0,1.653785752,1.228237094,1.346471101,0.178150634,0.295216886,N,-,,hsp40 co-chaperone,C:membrane; C:integral component of membrane; C:cellular_component,IPR001623 (G3DSA:1.10.287.GENE3D); IPR001623 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY),,
RL4_JR_01471,341,355,362,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,16.0687919,1,1.548963774,1.007284733,1.537761591,0.124106918,0.258820625,1.353691373,0,3.028643152,1.352410251,2.239441137,0.025127227,0.068758528,3.509460762,0,0.37781723,1.201312324,0.314503749,0.753138469,0.834494239,4.048476435,0,-0.044479314,1.200604085,-0.037047446,0.970447176,0.983358259,3.456019968,0,0.297204933,1.198206931,0.248041407,0.804102369,0.867875119,N,-,,ctr copper transporter,C:membrane; C:integral component of membrane; F:copper ion transmembrane transporter activity; P:copper ion transmembrane transport,IPR007274 (PFAM); PTHR12483:SF36 (PANTHER); IPR007274 (PANTHER),1.A.56.3.2, the copper transporter (ctr) family.
RL4_JR_01472,2585,2291,2520,3,0,0,0,0,0,0,0,0,0,3,0,0,0,0,59.77426787,1,-0.66844318,0.839035021,-0.796680905,0.425636376,0.616319055,9.463962437,0,0.223092234,1.216096299,0.18344948,0.854445355,0.914045221,24.51155311,0,-2.426407572,1.1875949,-2.043127309,0.041039837,0.097578044,40.30855814,1,-0.540324891,0.846834369,-0.638052623,0.523439425,0.657965581,24.12479648,0,-2.506249314,1.187663602,-2.110235011,0.034838118,0.084548405,N,-,,transcriptional regulatory,F:binding,IPR001138 (SMART); IPR007219 (SMART); IPR001138 (PFAM); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31001 (PANTHER); PTHR31001:SF58 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_01473,12,11,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.132262563,0,4.816142198,3.537101679,1.361606941,0.173321963,NA,0.042439755,0,8.024182285,2.479960012,3.235609545,0.001213833,0.015023052,0.109660037,0,5.378511107,1.431895051,3.756218799,0.0001725,0.001606614,0.126475889,0,4.95599058,2.109520487,2.349344607,0.018806492,0.074526706,0.107621459,0,5.30177123,1.274071088,4.161283683,3.16E-05,0.000263937,N,-,,multidrug resistance Fnx1,P:transmembrane transport; C:integral component of membrane; F:transporter activity,PR01036 (PRINTS); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF83 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_01474,145,162,233,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.156566026,0,0.788857377,1.299316341,0.607132653,0.543762882,0.724484336,0.682718723,0,4.016020884,1.484915208,2.704545595,0.006839788,0.025509335,1.781204599,0,1.355759597,1.235013689,1.097768882,0.272305423,0.411036245,2.05551853,0,0.933045818,1.251743344,0.745397068,0.456031716,0.59823677,1.766647796,0,1.26538265,1.234954997,1.024638673,0.30553371,0.44067362,N,-,,hypothetical protein SPI_05576,,no IPS match,,
RL4_JR_01475,136,80,169,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1.52578231,0,1.287851129,1.406767324,0.91546847,0.359945748,NA,0.486108245,0,4.506015687,1.5979471,2.819877884,0.004804193,0.020121305,1.265157032,0,1.849067649,1.268419465,1.457773,0.144903123,0.255352344,5.471224265,1,2.37020951,1.197124014,1.979919776,0.047712544,0.119437894,1.253706605,0,1.759840152,1.260679,1.395946273,0.162730675,0.275434316,N,-, Effector probability:0.659,Glycoside family 2,F:hydrolase activity,no IPS match,,
RL4_JR_01476,87,82,81,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.001413775,0,1.895658176,1.458239082,1.299963909,0.193613339,NA,0.320625368,0,5.106622811,1.66685371,3.063629868,0.002186693,0.015045494,0.829761061,0,2.458430339,1.238656894,1.9847549,0.047171748,0.108267235,0.957090124,0,2.036198181,1.283506598,1.586433747,0.11264095,0.21395992,0.815739749,0,2.379991003,1.213142531,1.961839555,0.049781167,0.111746384,N,-,,---NA---,,no IPS match,,
RL4_JR_01477,14,6,22,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3.98401192,1,5.426963205,1.312084256,4.13613926,3.53E-05,0.000342615,0.052418172,0,7.718586427,2.46128476,3.135998951,0.001712698,0.015023052,0.137118087,0,5.053165271,1.511510247,3.343123397,0.000828411,0.004953827,0.158235048,0,4.631934877,2.085201799,2.221336505,0.026328178,0.08636862,0.136738827,0,4.956027229,1.361942849,3.638939205,0.000273763,0.001627435,N,-,,methyltransferase type 11,F:methyltransferase activity; F:transferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108:SF933 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_01478,12,6,28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.180926317,0,4.363879235,3.246311357,1.34425776,0.178865049,NA,0.056750921,0,7.603737458,2.464020162,3.085907158,0.002029322,0.015023052,0.149485787,0,4.928438564,1.552127416,3.175279628,0.001496922,0.007872642,0.172579272,0,4.506629631,2.093131689,2.153055948,0.031314282,0.094723687,0.150152387,0,4.821719385,1.412839162,3.412787185,0.000643021,0.003350793,Y,-, Effector probability:0.702,---NA---,,no IPS match,,
RL4_JR_01479,2,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.040629395,0,6.519518409,3.932956239,1.657663603,0.097385384,NA,0.012873165,0,9.745468895,3.165782515,3.078375994,0.002081321,0.015023052,0.033437834,0,7.093855841,1.819035928,3.899788746,9.63E-05,0.001133378,0.038584569,0,6.669085625,3.392387647,1.965897273,0.049310478,0.121802535,0.032900293,0,7.018393941,1.38996904,5.049316738,4.43E-07,7.16E-06,N,-,,ankyrin and het domain,,IPR010730 (PFAM); PTHR24148 (PANTHER),,
RL4_JR_01480,1,2,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.043417324,0,6.422584148,3.931259616,1.633721701,0.102317299,NA,0.013354005,0,9.689099612,3.307228345,2.929673613,0.003393182,0.016488617,0.035607679,0,6.996032967,2.008933431,3.482461319,0.000496827,0.003373492,0.041141557,0,6.574879128,3.513239179,1.871457875,0.061281644,0.138221573,0.036168813,0,6.878680684,1.541398496,4.462623195,8.10E-06,8.41E-05,N,-, Effector probability:0.601,feruloyl esterase,F:hydrolase activity,IPR011118 (PFAM),,
RL4_JR_01481,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.733,---NA---,,no IPS match,,
RL4_JR_01482,55,42,39,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,16.56429357,1,4.524984135,1.026201754,4.409448842,1.04E-05,0.000120092,0.175260295,0,5.978109372,1.887806353,3.166696288,0.001541813,0.015023052,0.451879069,0,3.335346571,1.285608962,2.594370971,0.009476418,0.031352697,0.521088715,0,2.913348601,1.413292425,2.061391224,0.039265731,0.106215744,0.442669754,0,3.261153193,1.23450305,2.641672853,0.00824977,0.026936124,N,-,,-like family domain-containing 1,,IPR008030 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR14194:SF53 (PANTHER); PTHR14194 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_01483,982,744,803,1,1,4,0,0,0,0,0,2,0,0,3,0,0,1,43.4522624,1,1.867122361,0.61826546,3.019936391,0.002528278,0.012615101,3.245817821,0,1.766979095,1.282452232,1.377812796,0.168261094,0.302350221,21.38353954,1,0.939279002,1.039918355,0.903223795,0.366407132,0.510529287,38.57744916,1,1.038081934,0.855323777,1.213671316,0.224873262,0.360373817,15.60048994,1,-0.020709699,1.125504099,-0.018400376,0.985319453,0.990209375,N,-,,Glycoside superfamily,"P:carbohydrate metabolic process; F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:heme binding",IPR001764 (PRINTS); IPR001764 (G3DSA:3.20.20.GENE3D); IPR002772 (G3DSA:3.40.50.GENE3D); IPR002772 (PFAM); IPR001764 (PFAM); PTHR30620:SF5 (PANTHER); PTHR30620:SF5 (PANTHER); IPR026892 (PANTHER); IPR026892 (PANTHER); IPR026892 (PANTHER); PTHR30620:SF5 (PANTHER); IPR002772 (SUPERFAMILY); IPR017853 (SUPERFAMILY),,
RL4_JR_01484,1930,1813,1524,0,1,3,0,0,0,2,10,0,4,0,0,0,0,1,40.59645226,1,0.213716093,0.752881694,0.283864112,0.77651452,0.884625815,6.786023663,0,0.703009525,1.244685745,0.564808851,0.572203786,0.712579568,118.0904574,1,2.514718973,1.079012668,2.330574096,0.019775829,0.055154405,57.45589672,1,0.402652428,0.753165791,0.534613273,0.592917304,0.716174225,24.54349448,1,-1.081775656,1.12296856,-0.963317847,0.335388039,0.472361093,N,-,,fungal specific transcription factor,"C:nucleus; F:zinc ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_01485,2731,2016,2109,2,22,11,0,0,3,0,1,2,7,1,11,0,1,0,265.7466011,1,3.107859499,0.667474285,4.656148664,3.22E-06,4.25E-05,36.94636473,1,2.493569053,0.883369102,2.82279406,0.004760714,0.019997366,43.58537435,1,0.084265537,0.862871039,0.097657162,0.922204533,0.954446809,201.4157868,1,2.619214811,0.707844227,3.700270075,0.00021537,0.002041781,26.17654608,1,-1.463955677,1.12683745,-1.299172011,0.193884904,0.314647324,N,-,,ATPase,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003593 (SMART); IPR010929 (PFAM); IPR003439 (PFAM); IPR029481 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR013525 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR19241:SF253 (PANTHER); PTHR19241 (PANTHER); PTHR19241:SF253 (PANTHER); PTHR19241 (PANTHER); PTHR19241:SF253 (PANTHER); PTHR19241 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.205.5, the atp-binding cassette (abc) superfamily.
RL4_JR_01486,17,9,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.170482128,0,4.449766917,3.199855871,1.390614795,0.164342267,NA,0.054608377,0,7.660053167,2.38324609,3.214125977,0.001308423,0.015023052,0.141609717,0,5.00766518,1.424133799,3.516288416,0.000437625,0.003070352,0.163340986,0,4.586465651,1.964681146,2.334458016,0.019571752,0.075954001,0.139800032,0,4.923121409,1.288449883,3.820964612,0.000132931,0.000879689,Y,-,,arylsulfotransferase (ASST) domain,F:transferase activity,PF14269 (PFAM); PTHR35340 (PANTHER); PTHR35340:SF4 (PANTHER),,
RL4_JR_01487,74,53,96,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4.704562484,1,3.015488112,1.195089667,2.523231683,0.011628176,0.042750185,0.281911776,0,5.292030214,1.726393854,3.065366691,0.002174033,0.015045494,0.733916132,0,2.634486466,1.270642546,2.073349797,0.038139737,0.092030342,0.846774187,0,2.212310237,1.339192905,1.651972788,0.098540098,0.193807011,0.72710098,0,2.545841649,1.249605206,2.037316776,0.041618308,0.097048679,N,-,,multidrug resistance fnx1,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501 (PANTHER); PTHR23501:SF81 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.48.2, the major facilitator superfamily (mfs).
RL4_JR_01488,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,ophD encodes a permease for phthalate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662:SF275 (PANTHER); PTHR11662 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.38, the major facilitator superfamily (mfs).
RL4_JR_01489,1057,1224,2266,0,0,2,0,0,0,0,1,0,0,6,0,0,0,0,25.74214615,1,-0.583386684,1.087399547,-0.536497082,0.591615052,0.76236688,5.696962016,0,0.955227807,1.284673366,0.743556948,0.457144557,0.616469119,22.77591958,1,-0.749743205,1.230567438,-0.609266247,0.542347976,0.670255238,41.30669525,1,1.06626456,0.74617037,1.428982713,0.153009202,0.26990949,14.88953711,0,-1.809991345,1.251865203,-1.445835654,0.148223303,0.256891637,N,-,,swr1-complex 5,C:intracellular part,IPR011421 (PFAM); IPR027124 (PANTHER); IPR011421 (PROSITE_PROFILES),,
RL4_JR_01490,90,95,158,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,1.36695666,0,1.446581349,1.420929238,1.018053053,0.308652744,NA,0.431934552,0,4.676428768,1.605576081,2.912617361,0.003584135,0.016976422,1.12884162,0,2.013546326,1.260158796,1.597851264,0.110076082,0.208223143,39.84393481,1,4.72641853,1.404329216,3.365605782,0.000763758,0.005894091,1.122023701,0,1.920313655,1.253738667,1.531669801,0.125603938,0.226586765,N,-, Effector probability:0.654,DSBA-like thioredoxin domain-containing,P:biological_process; F:protein disulfide oxidoreductase activity; P:oxidation-reduction process,IPR012336 (G3DSA:3.40.30.GENE3D); PTHR13887:SF19 (PANTHER); PTHR13887 (PANTHER); PTHR13887:SF19 (PANTHER); PTHR13887 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_01491,203,299,206,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.858608874,0,0.382656815,1.280183073,0.298907885,0.765010331,0.877161421,0.912248031,0,3.598116108,1.453023497,2.476295887,0.013275351,0.041782681,2.361728642,0,0.949516654,1.236605109,0.767841445,0.442581389,0.582135115,2.724466266,0,0.527154808,1.248241531,0.422317952,0.672792956,0.777330003,2.318915603,0,0.873004119,1.228373281,0.710699372,0.477270549,0.606973074,N,-, Effector probability:0.82,serine threonine kinase-43,C:linear element; P:meiotic recombination checkpoint; F:ATP binding; P:regulation of linear element assembly; P:reciprocal meiotic recombination; C:cytosol; F:protein serine/threonine kinase activity; P:protein phosphorylation,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24347:SF134 (PANTHER); IPR020636 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_01492,84419,103746,111756,42,72,117,13,5,14,13,31,16,14,89,29,0,94,13,2649.016313,1,0.263573569,0.247608287,1.064477981,0.287112224,0.470995681,995.2541481,1,0.595802789,0.403133504,1.47792923,0.139426722,0.26105758,1484.804282,1,-1.021658808,0.378130331,-2.7018695,0.006895082,0.024271839,1913.463753,1,-0.54930447,0.397829071,-1.380754976,0.167354311,0.28832098,1440.043953,1,-1.048173949,1.042125511,-1.005803944,0.31450989,0.449966459,N,-,,---NA---,,IPR007836 (PFAM),,
RL4_JR_01493,13182,18604,19440,0,2,16,0,0,1,0,2,0,0,3,1,0,1,0,282.8305841,1,-1.149233536,0.677461882,-1.696381105,0.08981373,0.204722103,74.60590658,1,-1.644965339,1.116997252,-1.47266731,0.140840765,0.262991976,185.4738335,1,-3.393940172,1.04744579,-3.240206038,0.001194434,0.006658056,217.5907073,1,-2.926043707,0.771662091,-3.791871783,0.000149516,0.001506319,171.6813574,1,-4.37603682,1.144733005,-3.822757622,0.000131967,0.00087631,N,-,,DNA-directed RNA polymerase I subunit RPA49,F:DNA binding; C:DNA-directed RNA polymerase I complex; F:RNA polymerase I activity; P:transcription from RNA polymerase I promoter,IPR009668 (PFAM); PTHR14440 (PANTHER),,
RL4_JR_01494,3897,1963,5370,1,4,41,0,0,0,9,32,135,2,0,2,0,18,0,243.038374,1,2.252611134,0.844895456,2.666141849,0.007672731,0.030758791,14.1034371,0,-0.352498642,1.2723054,-0.277055054,0.781737833,0.868102385,1264.72162,1,5.07207826,0.745522992,6.803382745,1.02E-11,7.14E-10,80.34254623,1,-0.578408718,0.841081021,-0.68769679,0.491643742,0.630868365,106.0493487,1,1.071822779,1.560948617,0.686648342,0.492304357,0.620688149,N,-,,alcohol dehydrogenase -like domain-containing,F:nucleotide binding; F:zinc ion binding; P:oxidation-reduction process; F:L-arabinitol 4-dehydrogenase activity; P:L-arabinose catabolic process to xylulose 5-phosphate,IPR016040 (G3DSA:3.40.50.GENE3D); IPR013154 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR013149 (PFAM); IPR002085 (PANTHER); PTHR11695:SF536 (PANTHER); IPR002085 (PANTHER); PTHR11695:SF536 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_01495,15740,18868,19999,3,0,7,0,0,3,1,3,0,0,12,1,0,6,2,275.9181287,1,-1.846894345,0.521145073,-3.543915964,0.000394231,0.00274217,97.785592,1,-0.470526752,0.849258295,-0.554044341,0.579548501,0.718631621,215.5911141,1,-2.482396992,0.747419698,-3.32128923,0.000896026,0.005274151,266.5978901,1,-1.39172305,0.497342279,-2.798320412,0.005136913,0.02859823,216.5318434,1,-1.797270315,0.574406773,-3.128915605,0.001754527,0.007585521,N,-,,F-type H+-transporting ATPase subunit g,"C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); P:cristae formation; F:structural molecule activity; F:proton-transporting ATPase activity, rotational mechanism; P:protein complex oligomerization; P:ATP synthesis coupled proton transport; P:protein oligomerization",IPR006808 (PFAM); PTHR12386:SF12 (PANTHER); IPR006808 (PANTHER),,
RL4_JR_01496,1560,2626,2223,0,0,2,0,0,0,0,0,0,0,3,0,0,0,0,33.47811771,1,-1.084774337,1.057544299,-1.025748367,0.30501021,0.491656449,8.197278157,0,0.430378824,1.251347129,0.343932402,0.730897123,0.831981493,21.31214213,0,-2.224582676,1.214589212,-1.831551486,0.06701827,0.14188477,36.626465,1,-0.368730074,0.901017807,-0.409237277,0.682365541,0.78412792,21.0223482,0,-2.307594381,1.220966285,-1.889973875,0.058761454,0.126479533,N,-,,S-adenosyl-L-methionine-dependent methyltransferase,C:cytoplasm; F:methyltransferase activity; F:transferase activity; F:S-adenosylmethionine-dependent methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108:SF800 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_01497,295,349,379,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,4.100983514,0,-0.138185589,1.217947117,-0.113457791,0.909667625,0.956076847,1.304061132,0,3.082485121,1.360067506,2.26642068,0.023425639,0.065230898,3.389448718,0,0.427912005,1.207848617,0.354276189,0.723131911,0.812540229,3.91068104,0,0.005386787,1.209149172,0.004455023,0.996445418,0.997331935,18.43289366,1,2.554788737,0.854566537,2.989572639,0.00279368,0.011189087,N,-,,---NA---,,no IPS match,,
RL4_JR_01498,13627,14294,21786,0,3,3,0,0,0,3,0,3,0,3,0,0,8,0,233.7855402,1,-2.421453486,0.671786248,-3.604499935,0.000312755,0.00224008,62.78454546,0,-2.506843574,1.201764243,-2.085969513,0.036981385,0.093255002,216.5369977,1,-1.749947804,0.647742416,-2.70161064,0.006900452,0.024282299,201.0958453,1,-3.30496933,0.888981251,-3.717704198,0.000201041,0.001929426,193.4386207,1,-1.766865248,0.6828542,-2.587470718,0.009668341,0.030524464,N,-,,tRNA-dihydrouridine synthase 3,F:oxidoreductase activity; F:binding; C:intracellular part; P:tRNA modification,IPR013785 (G3DSA:3.20.20.GENE3D); IPR001269 (PFAM); IPR001269 (PANTHER); PTHR11082:SF8 (PANTHER); PTHR11082:SF8 (PANTHER); IPR001269 (PANTHER); SSF51395 (SUPERFAMILY),,
RL4_JR_01499,880,1341,1150,0,3,0,0,0,0,0,0,1,2,3,0,0,2,0,37.60945908,1,0.48580486,0.882070266,0.550755284,0.581801441,0.755334732,4.314653646,0,1.356288916,1.272093949,1.066186123,0.286339514,0.445965311,17.70664758,1,-0.335586358,1.20773003,-0.277865375,0.781115704,0.854577953,43.5910475,1,1.326600873,0.701796439,1.890292967,0.058718789,0.135146692,18.76893175,1,0.279751069,1.003495543,0.278776593,0.780416279,0.849007717,N,-,,kelch domain-containing,,IPR006652 (SMART); PF13418 (PFAM); IPR006652 (PFAM); IPR015915 (G3DSA:2.120.10.GENE3D); IPR011498 (PFAM); PF13415 (PFAM); PTHR23244 (PANTHER); SSF117281 (SUPERFAMILY); IPR011043 (SUPERFAMILY),,
RL4_JR_01500,228626,75798,119756,14,13,3,0,5,5,0,5,0,4,4,4,0,12,1,1935.216551,1,-2.763565258,0.851367583,-3.246030636,0.001170262,0.00669965,785.2710804,1,-1.470484304,0.822101062,-1.788690433,0.073664685,0.15980153,1442.199141,1,-5.119122222,0.923946654,-5.54049544,3.02E-08,1.16E-06,1709.006629,1,-4.250540353,0.674815392,-6.298819506,3.00E-10,1.05E-08,1424.473545,1,-4.346120508,0.917770458,-4.735520164,2.18E-06,2.80E-05,N,-,,mitochondrial hypoxia responsive domain containing,P:mycelium development; C:integral component of membrane,IPR007667 (PFAM); PTHR28018:SF2 (PANTHER); PTHR28018 (PANTHER); IPR007667 (PROSITE_PROFILES),8.A.112.2.2, the respiratory supercomplex factor (rcf) family.
RL4_JR_01501,36943,22842,18718,8,3,4,0,0,3,2,0,0,1,3,0,0,7,4,433.5001874,1,-1.557033242,0.638281047,-2.439416381,0.014711007,0.051751787,129.9327137,1,-1.066663894,0.939400216,-1.135473333,0.256177049,0.411591126,283.4107571,1,-3.98828383,1.076749052,-3.70400496,0.000212222,0.001817713,322.5414456,1,-3.563048766,0.824419952,-4.321885657,1.55E-05,0.000208569,311.2850383,1,-1.87294841,0.594344911,-3.151281981,0.001625555,0.007134262,N,-,,c2h2 transcription factor,F:nucleic acid binding; C:nucleus; F:metal ion binding; P:regulation of cell size; C:cytosol; P:positive regulation of ribosomal protein gene transcription from RNA polymerase II promoter,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR23057 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_01502,190737,153059,237892,20,67,146,0,0,1,1,9,54,22,37,22,0,32,9,3611.822147,1,-0.821246637,0.440048728,-1.866262947,0.062004586,0.156362724,746.9091997,1,-5.145184694,1.131133328,-4.548698696,5.40E-06,0.000393073,2350.778383,1,-2.121393651,0.87601934,-2.421628787,0.015451125,0.045552472,2778.358717,1,-2.005077515,0.319292693,-6.279747571,3.39E-10,1.18E-08,2087.461946,1,-3.167511688,0.756974433,-4.184436817,2.86E-05,0.000243029,N,-,,hypothetical protein CMQ_3730,P:meiotic cell cycle,IPR001849 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); PF15406 (PFAM); PTHR42073 (PANTHER); IPR001849 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY),,
RL4_JR_01503,54041,31465,26320,0,6,16,0,4,0,3,0,1,4,5,1,0,5,2,555.6337211,1,-1.889093194,0.647817492,-2.916088584,0.003544498,0.016436672,298.4041747,1,-0.11071816,1.790121019,-0.061849539,0.950682653,0.973667236,411.8080366,1,-3.4886189,0.821335468,-4.247495736,2.16E-05,0.000359366,495.8808207,1,-2.705881483,0.608426606,-4.447342471,8.69E-06,0.000126293,396.7595202,1,-3.04060394,0.702096567,-4.330748909,1.49E-05,0.000139963,N,-,,histidine kinase group,"P:signal transduction; F:transferase activity, transferring phosphorus-containing groups; P:negative regulation of conidium formation",IPR004358 (PRINTS); IPR003661 (SMART); IPR003594 (SMART); IPR001789 (SMART); IPR001789 (PFAM); G3DSA:3.30.450.20 (GENE3D); IPR003661 (PFAM); G3DSA:3.40.50.2300 (GENE3D); IPR003594 (G3DSA:3.30.565.GENE3D); IPR003661 (G3DSA:1.10.287.GENE3D); IPR003594 (PFAM); PTHR24423 (PANTHER); PTHR24423 (PANTHER); PTHR24423 (PANTHER); PTHR24423:SF403 (PANTHER); PTHR24423:SF403 (PANTHER); PTHR24423:SF403 (PANTHER); PTHR24423 (PANTHER); PTHR24423 (PANTHER); PTHR24423:SF403 (PANTHER); PTHR24423:SF403 (PANTHER); IPR005467 (PROSITE_PROFILES); IPR001789 (PROSITE_PROFILES); IPR011006 (SUPERFAMILY); IPR000014 (SUPERFAMILY); IPR000014 (SUPERFAMILY); IPR003594 (SUPERFAMILY); IPR003661 (SUPERFAMILY),9.B.238.3.1,The Uncharacterized Bacterial 5 TMS Protein-1 (UBP1) Family
RL4_JR_01504,2984,2749,4017,0,0,5,0,0,0,0,0,0,0,0,0,0,4,0,57.97771936,1,-0.372195576,0.700425601,-0.531384883,0.595152095,0.765616978,12.35802332,0,-0.161909843,1.213658344,-0.133406443,0.89387195,0.940810219,32.16947464,0,-2.818694918,1.197368063,-2.35407558,0.018568835,0.052931295,37.11782639,0,-3.241279565,1.19765805,-2.70634808,0.00680277,0.035762226,47.28529047,1,-0.313858836,0.779577305,-0.4026013,0.687241553,0.778335652,N,-,,hypothetical protein F503_05198,C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,PTHR42075:SF1 (PANTHER); PTHR42075 (PANTHER),,
RL4_JR_01505,9656,7693,7024,3,10,8,0,0,0,3,0,1,2,3,1,0,6,0,238.3990033,1,0.455553641,0.420039292,1.084550064,0.278120982,0.461254517,31.40388056,0,-1.507330572,1.213664507,-1.241966427,0.214248949,0.360836583,120.7060699,1,-1.313317184,0.756174225,-1.736791787,0.082423929,0.16665865,133.7001654,1,-1.252916096,0.634959227,-1.973222914,0.048470171,0.120550351,102.528897,1,-1.05293707,0.645526667,-1.631128695,0.102863167,0.19507203,N,-,,succinate-semialdehyde dehydrogenase,F:aldehyde dehydrogenase (NAD) activity; F:succinate-semialdehyde dehydrogenase (NAD+) activity; F:succinate-semialdehyde dehydrogenase [NAD(P)+] activity; P:gamma-aminobutyric acid catabolic process; P:oxidation-reduction process,IPR010102 (TIGRFAM); IPR015590 (PFAM); IPR016163 (G3DSA:3.40.309.GENE3D); IPR016162 (G3DSA:3.40.605.GENE3D); PTHR11699:SF49 (PANTHER); PTHR11699 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_01506,4455,5608,10190,0,0,3,0,0,5,0,0,1,0,3,1,0,5,0,92.14705461,1,-2.198529607,0.974627375,-2.255764268,0.024085398,0.076335928,72.25231557,1,1.649610888,0.768000073,2.14793064,0.031719266,0.082726722,73.01585259,1,-2.904891674,1.233437307,-2.355119029,0.018516773,0.052836475,98.454798,1,-1.592801165,0.833319034,-1.911394196,0.055953942,0.131294012,85.66233415,1,-1.128281297,0.821505203,-1.373431711,0.169618177,0.284288039,N,-,,hypothetical protein F503_05196,,no IPS match,,
RL4_JR_01507,608,720,789,0,0,6,0,0,2,0,0,0,0,0,0,0,0,0,31.39706001,1,2.089620724,0.636660238,3.282159934,0.001030152,0.006050379,21.45495429,1,3.672877125,0.994036112,3.694913172,0.000219962,0.009238402,7.013119906,0,-0.621094226,1.199692751,-0.517711077,0.604659869,0.721713807,8.091671521,0,-1.043636028,1.198218809,-0.870989522,0.383759874,0.529080709,6.925123573,0,-0.705526193,1.204302971,-0.585837792,0.557984525,0.677003393,N,-,,ribosomal recycling factor,C:intracellular part,IPR023584 (G3DSA:1.10.132.GENE3D); IPR023584 (PFAM); IPR023584 (SUPERFAMILY),,
RL4_JR_01508,5,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.039996504,0,6.54149921,3.933356973,1.663083024,0.096295817,NA,0.013032346,0,9.728499922,3.165701449,3.073094567,0.002118513,0.015045494,0.033353808,0,7.096674078,1.817984811,3.903593712,9.48E-05,0.001128758,0.038443873,0,6.67411915,3.394815131,1.965974256,0.049301585,0.121802535,0.032424762,0,7.027757183,1.385158265,5.073613145,3.90E-07,6.47E-06,,,,,,,,
RL4_JR_01509,1968,2016,2899,5,0,2,0,0,0,2,0,0,3,0,3,0,5,0,85.43788493,1,0.721171822,0.634276268,1.136999535,0.25553848,0.43375479,8.713838945,0,0.342146279,1.2259715,0.279081756,0.780182083,0.867135505,44.84907033,1,-0.481652132,1.03990956,-0.463167328,0.643244433,0.751552988,83.04705833,1,0.650138409,0.642660415,1.011635996,0.311712128,0.457801755,41.80343147,1,0.493100278,0.721936449,0.683024494,0.494591365,0.622775472,N,-,,WD repeat,C:intracellular part,IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR14344 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR011047 (SUPERFAMILY); IPR017986 (SUPERFAMILY); SSF101908 (SUPERFAMILY),8.A.92.1.3,The G-Protein αβγ Complex (GPC) Family
RL4_JR_01510,2032,1627,2338,0,1,0,0,0,2,0,0,0,0,0,0,0,11,0,31.90977545,1,-1.731138126,1.146872367,-1.509442704,0.131185687,0.268762641,26.38030575,1,2.17342581,0.995908984,2.182353853,0.029083427,0.077326622,19.80007374,0,-2.118537115,1.196349561,-1.770834532,0.076588222,0.157629428,22.84232502,0,-2.540912923,1.195391644,-2.125590333,0.033537385,0.09814047,62.02402314,1,1.751381766,0.578113102,3.029479454,0.002449756,0.010044705,N,-,,integral membrane,C:membrane,IPR009571 (PFAM); PTHR28019 (PANTHER); PTHR28019:SF3 (PANTHER),1.H.1.4.3, the claudin tight junction (claudin1) family.
RL4_JR_01511,13526,7649,8157,0,3,0,0,0,0,0,0,2,0,1,0,0,5,0,140.9096181,1,-2.598695206,0.911331914,-2.85153539,0.004350864,0.019353517,37.83594311,0,-1.776156217,1.235447117,-1.437662684,0.150529786,0.277382577,110.3262396,1,-2.604577794,1.069444522,-2.435449189,0.014873313,0.044170556,116.2253387,1,-3.892440815,1.179017842,-3.301426556,0.000961945,0.00716154,114.4976178,1,-1.608485523,0.754398407,-2.132143319,0.032995066,0.081027176,N,-,,serine threonine- phosphatase pp-z,F:magnesium-dependent protein serine/threonine phosphatase activity; F:metal ion binding; F:cofactor binding; P:protein dephosphorylation,IPR006186 (PRINTS); IPR006186 (SMART); IPR031675 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); IPR004843 (PFAM); PTHR11668 (PANTHER); PTHR11668:SF276 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_01512,2075,1622,1085,0,2,2,0,0,0,0,0,0,0,2,0,0,3,1,42.84208393,1,0.363456141,0.806269932,0.450787169,0.65214295,0.80328887,6.211281722,0,0.830691849,1.294874968,0.641522826,0.521183055,0.671086997,15.95210775,0,-1.80662711,1.228321462,-1.470809691,0.141342591,0.250736357,26.41450969,1,-0.523681365,1.067061608,-0.490769569,0.623589436,0.740713636,34.50155722,1,0.727582655,0.802585707,0.906548234,0.364645747,0.500954978,N,-,,hypothetical protein SPSK_08550,,no IPS match,,
RL4_JR_01513,2364,3780,5076,0,0,1,0,0,0,0,0,0,1,1,0,0,3,0,48.75749087,1,-2.648118393,1.1968654,-2.212544863,0.02692904,0.083341088,14.14775438,0,-0.357026784,1.244883119,-0.286795426,0.774268966,0.863217367,37.02244439,0,-3.021362351,1.226042631,-2.464320796,0.013727319,0.041415838,56.0575412,1,-1.707974731,1.063458869,-1.60605622,0.108261558,0.208147926,48.39054863,1,-0.950788753,0.925204749,-1.027652261,0.304113432,0.439345691,N,-, Effector probability:0.755,dna-directed rna polymerases i ii iii subunit 10,"F:DNA binding; C:DNA-directed RNA polymerase I complex; F:zinc ion binding; F:RNA polymerase I activity; P:transcription, RNA-templated; P:transcription from RNA polymerase I promoter; P:transcription from RNA polymerase II promoter; P:tRNA transcription from RNA polymerase III promoter; C:DNA-directed RNA polymerase III complex; C:DNA-directed RNA polymerase II, core complex",IPR000268 (PIRSF); IPR009057 (G3DSA:1.10.10.GENE3D); IPR000268 (PFAM); PTHR23431:SF3 (PANTHER); PTHR23431 (PANTHER); IPR000268 (PRODOM); IPR023580 (SUPERFAMILY),,
RL4_JR_01514,12881,20960,20900,0,0,4,0,0,0,0,0,0,1,3,0,0,0,0,235.4555519,1,-3.227886987,0.837440925,-3.854465298,0.000115983,0.000969455,69.68675231,0,-2.657300443,1.209773931,-2.196526454,0.028054284,0.075103269,181.5495342,0,-5.315229745,1.214291291,-4.377227921,1.20E-05,0.000219655,230.8548852,1,-3.029473189,0.791685596,-3.82661148,0.000129919,0.001332759,179.5409316,0,-5.401947402,1.225601168,-4.40758996,1.05E-05,0.000104548,N,-,,WD domain containing,C:nucleolus,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR011042 (G3DSA:2.120.10.GENE3D); PTHR22847 (PANTHER); PTHR22847:SF492 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR011047 (SUPERFAMILY),,
RL4_JR_01515,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_01516,482,668,975,0,0,1,0,0,0,0,0,0,0,3,4,0,0,0,12.31357966,1,-0.244617463,1.193193906,-0.205010654,0.837563801,0.918937779,2.676988376,0,2.044800647,1.321780454,1.547004755,0.121862099,0.23649658,7.003828993,0,-0.619279402,1.231410456,-0.502902504,0.615032821,0.729878358,58.65988356,1,2.523174143,0.64985718,3.882659483,0.00010332,0.001095411,6.964723935,0,-0.713783706,1.244695742,-0.57346039,0.566333011,0.683365717,N,-,,isopenicillin N synthetase,F:dioxygenase activity; F:metal ion binding; P:oxidation-reduction process,IPR026992 (PFAM); IPR005123 (PFAM); IPR027443 (G3DSA:2.60.120.GENE3D); PTHR10209:SF187 (PANTHER); PTHR10209 (PANTHER); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_01517,11338,10423,12829,1,2,8,1,0,2,1,0,2,0,7,0,0,3,0,194.8436488,1,-1.041902608,0.468933991,-2.221853453,0.026293211,0.081901495,85.15374264,1,0.201132098,0.839477969,0.239591872,0.810646667,0.884675532,138.5027869,1,-2.241382551,0.84772845,-2.64398647,0.008193593,0.027883004,160.098404,1,-1.559289496,0.575802029,-2.708030568,0.006768379,0.03563694,124.4898301,1,-2.530203304,0.847999683,-2.983731425,0.002847566,0.011342095,N,-, Effector probability:0.688,family SERF,P:biological_process; F:metal ion binding; C:cellular_component; F:molecular_function,IPR007513 (PFAM); IPR026939 (G3DSA:4.10.1050.GENE3D); PF12907 (PFAM); PTHR33788 (PANTHER); PTHR33788:SF1 (PANTHER); IPR026939 (SUPERFAMILY),,
RL4_JR_01518,648,869,1160,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,18.72268383,1,-0.570121191,1.174778457,-0.485301027,0.627462827,0.787150814,3.383984443,0,1.706713003,1.288910683,1.324151491,0.185452738,0.325217015,8.837387504,0,-0.954724707,1.218386605,-0.783597508,0.433276319,0.57384739,14.21085203,1,-0.432265577,1.170723668,-0.369229383,0.711956757,0.807410636,8.770139183,0,-1.046321998,1.229732028,-0.850853661,0.394850649,0.531560008,N,-,,DUF1479 domain,P:DNA repair; F:catalytic activity,PTHR21521:SF0 (PANTHER); PTHR21521 (PANTHER),,
RL4_JR_01519,2270,3550,3387,1,0,5,0,0,0,1,3,3,0,2,2,0,10,2,66.20234277,1,-0.045652215,0.683736577,-0.066768718,0.946765827,0.973563316,11.74243666,0,-0.088149691,1.231285997,-0.071591565,0.942926953,0.969161923,84.65367565,1,0.881513776,0.606939642,1.452391167,0.146392871,0.257364559,62.55603075,1,-0.431745366,0.776326108,-0.556139181,0.578115712,0.704467636,83.52188683,1,1.289014639,0.551646934,2.336666006,0.019456557,0.053531969,N,-, Effector probability:0.658,B-cell receptor-associated 31-like containing,C:integral component of membrane; C:endoplasmic reticulum; P:intracellular protein transport,IPR008417 (PFAM); PTHR12701:SF18 (PANTHER); IPR008417 (PANTHER),3.A.5.8.1, the general secretory pathway (sec) family.
RL4_JR_01520,2461,2568,3991,0,0,1,0,0,0,0,0,0,2,0,0,0,0,0,39.79316183,1,-2.325290586,1.167162435,-1.992259616,0.04634258,0.125727559,11.38664697,0,-0.043818283,1.226378931,-0.035729808,0.971497803,0.98535224,29.72016316,0,-2.704440243,1.207314498,-2.240046192,0.025087924,0.066786785,52.92210555,1,-1.369688537,1.035841634,-1.322295313,0.186069833,0.313835925,29.49786944,0,-2.796312289,1.218383637,-2.295100003,0.021727394,0.058430243,N,-,,glucose-inducible sam-dependent methyltransferase,F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); IPR019410 (PFAM); PTHR14614:SF38 (PANTHER); PTHR14614 (PANTHER); PTHR14614:SF38 (PANTHER); PTHR14614 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_01521,4288,5451,4006,0,2,5,0,0,0,1,5,1,0,3,4,0,1,0,90.49289604,1,-0.386958722,0.6200593,-0.624067282,0.5325834,0.71613901,17.70750443,0,-0.680737801,1.221231181,-0.557419277,0.577240998,0.716736185,102.5896669,1,0.306092101,0.599585432,0.510506235,0.609696847,0.7259286,103.4133342,1,-0.195847943,0.605731579,-0.323324638,0.746449397,0.832761102,48.81856749,1,-2.474735726,1.131342666,-2.187432509,0.028710965,0.072636648,N,-,,golgi complex component,,IPR015943 (G3DSA:2.130.10.GENE3D); IPR025941 (PFAM); PTHR12616 (PANTHER); PTHR12616:SF1 (PANTHER); PTHR12616:SF1 (PANTHER); PTHR12616 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),,
RL4_JR_01522,409,412,701,0,0,3,0,0,0,0,0,0,4,0,0,5,0,1,17.51814084,1,1.567651472,0.912945562,1.71713576,0.08595437,0.198251554,1.9166039,0,2.526833029,1.340923215,1.884398003,0.05951116,0.135303675,5.007883453,0,-0.135457147,1.227071724,-0.11039057,0.912099631,0.946504374,43.02855136,1,2.535135716,1.35229514,1.874691139,0.060835227,0.137784371,92.46692947,1,3.926461867,1.452785565,2.702712611,0.006877618,0.023281182,N,-,,hypothetical protein SPBR_01759,C:plasma membrane,IPR029058 (G3DSA:3.40.50.GENE3D); IPR026195 (PANTHER); PTHR17384:SF5 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_01523,3922,4611,7750,0,0,4,0,0,0,0,0,3,2,1,0,0,0,0,80.19363773,1,-1.47260701,0.849097911,-1.734319435,0.082861421,0.193359117,20.46343422,0,-0.88950764,1.229345474,-0.723561976,0.469334692,0.627722748,73.05750728,1,-1.165675283,0.901470896,-1.293081439,0.195982894,0.320626926,84.45746312,1,-1.640349431,0.900874984,-1.82084025,0.068631144,0.14876693,53.31408241,0,-3.650221783,1.23399918,-2.958042309,0.003095996,0.012145278,N,-,,tyrosine phosphatase,C:integral component of membrane,IPR007482 (PFAM); IPR007482 (PANTHER); PTHR11035:SF3 (PANTHER),,
RL4_JR_01524,2506,3001,2743,2,0,4,0,0,0,0,1,0,0,4,0,0,1,0,68.5469601,1,0.153494388,0.626078073,0.245168126,0.806326255,0.901743694,10.57019518,0,0.063612641,1.217503802,0.052248412,0.958330758,0.977943738,35.24981112,1,-1.625633908,1.192260385,-1.36348899,0.172728452,0.291596273,47.66375867,1,-0.298226577,0.75168643,-0.396743329,0.691556745,0.791814095,30.84034768,1,-1.737419743,1.123642452,-1.546238966,0.122046866,0.222012645,N,-,,hypothetical protein SPBR_02041,,no IPS match,,
RL4_JR_01525,7420,11068,9829,0,0,0,3,0,0,0,3,0,0,0,0,0,1,0,113.9975359,0,-4.935176088,1.216191308,-4.057894555,4.95E-05,0.000464857,103.1502571,1,0.526608661,0.862426416,0.610612862,0.541455906,0.688346732,117.6265798,1,-1.957543307,0.872034985,-2.244799052,0.024781036,0.06607406,108.5714701,0,-4.789673173,1.20701774,-3.968187887,7.24E-05,0.000813835,96.65134775,1,-3.520860459,1.140721863,-3.086519662,0.002025146,0.008564995,N,-, Effector probability:0.814,hypothetical protein CMQ_4475,,no IPS match,,
RL4_JR_01526,161,125,46,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.33678097,0,1.478987708,1.619804265,0.913065695,0.361207991,NA,0.436220503,0,4.662650976,1.762336984,2.645720438,0.008151715,0.029019308,1.11368334,0,2.034080987,1.361618218,1.493870278,0.135209528,0.242612306,1.283538737,0,1.612965494,1.436814244,1.122598485,0.261608059,0.401937859,1.078381156,0,1.977126977,1.33181445,1.484536361,0.137666684,0.243131899,N,-,,stress response,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_01527,2306,3165,4287,0,0,3,0,0,0,0,0,1,0,2,0,0,0,5,50.50189145,1,-1.122185857,0.917621143,-1.222929381,0.22135637,0.390935521,12.32516781,0,-0.158068363,1.233447744,-0.12815165,0.898028962,0.94332183,38.70246016,1,-1.858405162,1.213408053,-1.531558289,0.125631472,0.229750192,45.1907756,1,-1.532573923,1.052019687,-1.456792056,0.145173789,0.25974282,68.80259662,1,0.247918729,1.361659876,0.182070966,0.855527034,0.903820035,N,-,,ADP-ribosylation factor 1,F:GTP binding; C:trans-Golgi network; P:small GTPase mediated signal transduction; F:GTPase activity; C:cytosol; P:Golgi to plasma membrane protein transport; P:endocytosis; P:protein targeting to vacuole,IPR006689 (PRINTS); SM00175 (SMART); SM00177 (SMART); SM00178 (SMART); IPR006689 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); PTHR11711 (PANTHER); IPR024156 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_01528,28194,30015,38401,8,6,63,0,0,8,1,0,0,2,12,0,0,26,1,755.4034307,1,-0.002087165,0.598171208,-0.003489244,0.997215991,0.999337107,197.7291227,1,0.07316247,0.583847302,0.125310967,0.90027737,0.944488746,330.3890982,1,-5.168073994,1.197236052,-4.316670873,1.58E-05,0.00027938,435.2054487,1,-2.096053796,0.486605416,-4.307501986,1.65E-05,0.000220254,423.5735066,1,-1.309458801,0.860328783,-1.522044625,0.127997899,0.229518151,N,-,,60S ribosomal L39,F:structural constituent of ribosome; P:cytoplasmic translation; C:cytosolic large ribosomal subunit,IPR023626 (G3DSA:1.10.1620.GENE3D); IPR000077 (PFAM); IPR000077 (PANTHER); PD007914 (PRODOM); IPR000077 (HAMAP); IPR023626 (SUPERFAMILY),,
RL4_JR_01529,10770,13501,14301,5,6,12,0,0,3,2,0,0,8,12,0,0,20,7,298.9493315,1,-0.119162362,0.382392506,-0.311623163,0.755326928,0.871701222,77.30475421,1,0.030114469,0.852350006,0.035331107,0.971815719,0.98535224,149.9782853,1,-2.97644748,1.03573575,-2.873751803,0.004056276,0.016545422,270.1388543,1,-0.197154588,0.408924907,-0.482129076,0.629714256,0.745539855,255.0032377,1,0.353552458,0.459679296,0.769128524,0.441817017,0.575578654,N,-,,S-phase kinase-associated 1,F:ubiquitin protein ligase activity; P:regulation of strand invasion; P:regulation of exit from mitosis; P:negative regulation of mitotic metaphase/anaphase transition; C:nuclear SCF ubiquitin ligase complex; P:vacuolar acidification; C:RAVE complex; F:DNA replication origin binding; P:nuclear envelope organization; P:G2/M transition of mitotic cell cycle; C:CBF3 complex; P:G1/S transition of mitotic cell cycle; C:cytosol; P:exit from mitosis; P:phosphorylation; F:ligase activity; P:septin ring assembly; P:regulation of protein complex assembly; P:protein neddylation; P:kinetochore assembly; P:cell separation after cytokinesis; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; F:kinase activity; C:single-stranded DNA-dependent ATP-dependent DNA helicase complex,IPR001232 (SMART); IPR016073 (PFAM); IPR016897 (PIRSF); G3DSA:3.30.710.10 (GENE3D); IPR016072 (PFAM); PTHR11165 (PANTHER); IPR011333 (SUPERFAMILY); IPR016072 (SUPERFAMILY),,
RL4_JR_01530,2038,1733,2106,2,3,5,0,0,0,0,1,1,0,4,0,0,0,3,86.72574403,1,1.396610262,0.477549071,2.924537697,0.003449683,0.016081436,7.502424782,0,0.558159349,1.223478939,0.456206749,0.648241313,0.772577248,33.79190956,1,-0.270341711,1.029121765,-0.262691666,0.792788241,0.863588137,38.48298627,1,0.203131288,0.741424467,0.273974352,0.784104332,0.860779256,41.2641862,1,0.054860162,0.837410232,0.065511693,0.947766597,0.966378328,N,-,,gpi mannosyltransferase 4,P:GPI anchor biosynthetic process; P:mannosylation; C:integral component of membrane; F:dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity; P:plasmid maintenance,IPR005599 (PFAM); IPR005599 (PANTHER); PTHR22760:SF3 (PANTHER),9.B.142.4.15, the integral membrane glycosyltransferase family 39 (gt39) family.
RL4_JR_01531,2123,3020,3944,0,2,2,0,0,0,0,0,1,0,0,3,0,8,0,60.04379176,1,-0.559961473,0.801390893,-0.698737006,0.484716403,0.672617182,11.48607704,0,-0.056345006,1.236079275,-0.045583651,0.9636421,0.980595691,36.50450938,1,-1.756415464,1.213735834,-1.447115109,0.147864687,0.259442303,63.53659588,1,-0.768491767,0.888769249,-0.864669618,0.38722015,0.532256858,60.6673587,1,0.682979093,0.68090483,1.003046333,0.315838506,0.451229699,N,-,,mitochondrial cytochrome c oxidase assembly factor,P:mitochondrial respiratory chain complex IV assembly; C:integral component of mitochondrial inner membrane; F:unfolded protein binding; P:aerobic respiration,IPR018625 (PFAM); PTHR33968 (PANTHER),,
RL4_JR_01532,3008,2430,4076,0,0,1,0,0,0,0,0,1,0,0,0,0,3,0,41.67506558,1,-2.398526568,1.161707147,-2.064656806,0.038955484,0.110704193,12.03147245,0,-0.12327818,1.224271864,-0.100695102,0.9197925,0.955670261,37.83396445,1,-1.818997074,1.204065646,-1.510712543,0.130861705,0.237129749,36.15541245,0,-3.203380216,1.206004319,-2.656192988,0.007902837,0.040269868,42.62946228,1,-0.684603229,0.882151829,-0.776060545,0.437713238,0.572146467,N,-,,duf28 domain containing,C:mitochondrion,IPR017856 (G3DSA:1.10.10.GENE3D); IPR026563 (G3DSA:3.30.1270.GENE3D); IPR002876 (PFAM); IPR026564 (G3DSA:3.30.70.GENE3D); IPR002876 (PANTHER); IPR029072 (SUPERFAMILY),,
RL4_JR_01533,18634,21775,16504,7,8,12,0,0,0,4,3,3,1,14,1,0,9,3,409.4090074,1,-0.42174835,0.380511318,-1.108372681,0.267700898,0.448164155,73.33070535,0,-2.730814379,1.203759305,-2.268571772,0.02329438,0.064918974,276.8879221,1,-1.219530725,0.513806903,-2.373519541,0.017619461,0.050719198,293.7827867,1,-1.192373574,0.50452883,-2.363340811,0.018111006,0.073513299,242.8463394,1,-1.289415466,0.502929832,-2.563807879,0.010353083,0.03229558,N,-,,HEAT repeat,C:intracellular organelle; P:localization; C:cytoplasmic part,IPR011989 (G3DSA:1.25.10.GENE3D); PTHR21663:SF0 (PANTHER); PTHR21663:SF0 (PANTHER); PTHR21663 (PANTHER); PTHR21663 (PANTHER); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_01534,1211,1986,1694,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,34.98879583,1,0.269591748,0.810335235,0.332691627,0.73936707,0.863035708,6.256051048,0,0.820273425,1.259973659,0.651024265,0.515030823,0.665365922,16.26246907,0,-1.834443294,1.213949459,-1.511136465,0.130753686,0.236976426,18.76471025,0,-2.257085076,1.214928833,-1.857792009,0.063198556,0.141037113,16.0396491,0,-1.917300852,1.220016243,-1.571537152,0.116057932,0.213718232,N,-,,uracil-5-carboxylate decarboxylase,P:regulation of quinolinate biosynthetic process; P:tryptophan metabolic process; F:aminocarboxymuconate-semialdehyde decarboxylase activity; F:hydrolase activity,G3DSA:3.20.20.140 (GENE3D); IPR006680 (PFAM); IPR032465 (PTHR21240:PANTHER); PTHR21240 (PANTHER); IPR032465 (PTHR21240:PANTHER); IPR032466 (SUPERFAMILY),,
RL4_JR_01535,26,43,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.341881151,0,3.446329413,2.473602694,1.393242909,0.163546348,NA,0.109854987,0,6.652306099,2.155674143,3.085951613,0.002029018,0.015023052,0.282623348,0,4.013645574,1.418640384,2.829219879,0.004666163,0.017989426,0.325931297,0,3.590834756,1.703051563,2.108470955,0.034990273,0.099498352,0.275255396,0,3.948107296,1.326149782,2.977120192,0.002909699,0.011530608,N,-,,alpha-galactosidase a,"P:phosphorylation; F:phosphotransferase activity, alcohol group as acceptor; F:kinase activity",IPR010440 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR011009 (SUPERFAMILY),,
RL4_JR_01536,117,86,143,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.376099289,0,1.436870739,1.380944635,1.040498441,0.298108388,NA,0.43842379,0,4.655002404,1.592414398,2.923235566,0.003464143,0.016689223,1.140127397,0,1.999194563,1.246141993,1.604307193,0.108646356,0.206173517,1.315375689,0,1.576945136,1.279420499,1.232546404,0.217745043,0.352641868,1.1280587,0,1.912244827,1.235528607,1.547713922,0.121691189,0.221724543,N,-,,F-box domain-containing,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated",IPR032675 (G3DSA:3.80.10.GENE3D); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY),,
RL4_JR_01537,1336,2096,2624,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,86.51377425,1,1.064003019,0.755500415,1.408342071,0.159029804,0.308309206,7.655984578,0,0.528877892,1.258004828,0.420410066,0.674185916,0.79196908,20.00809225,0,-2.13355548,1.221800979,-1.746238149,0.080769578,0.164034345,23.09294886,0,-2.556586247,1.224476076,-2.087902162,0.036806661,0.101849534,19.86284242,0,-2.225752782,1.234768043,-1.80256753,0.07145616,0.147081444,N,-,,Major facilitator superfamily general substrate transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR19444 (PANTHER); PTHR19444:SF28 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.58.5, the major facilitator superfamily (mfs).
RL4_JR_01538,1348,2418,3463,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,28.94322917,0,-2.957484967,1.263268375,-2.341137502,0.019225085,0.063394602,9.082869123,0,0.282313882,1.280731619,0.220431726,0.825534939,0.895132796,34.89061717,1,-1.423390366,1.240743116,-1.14720795,0.251295687,0.386409103,27.49898309,0,-2.808512631,1.250055796,-2.246709819,0.024658578,0.084922906,23.73700096,0,-2.482828576,1.261310853,-1.968450973,0.049016172,0.1103109,N,-,,hypothetical protein SPBR_01658,,no IPS match,,
RL4_JR_01539,98,85,66,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.19497519,1,4.254621773,0.871980251,4.879263918,1.06E-06,1.60E-05,0.321826766,0,5.101338268,1.694689175,3.010191099,0.002610834,0.015349618,0.829183298,0,2.459747216,1.260375587,1.951598588,0.050985881,0.114936776,0.956169185,0,2.037763609,1.314820049,1.549842209,0.121179393,0.225897426,0.811214377,0,2.387742137,1.228122957,1.944220751,0.051868836,0.115144041,N,-,,---NA---,,no IPS match,,
RL4_JR_01540,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.00781203,0,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,0,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,0,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,0.007662926,0,9.0007212,4.037607722,2.229221316,0.025799183,0.085851084,0.006329724,0,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,N,-,,hypothetical protein SPI_04992,P:biological_process; F:ATP binding; C:membrane; C:integral component of membrane; F:protein kinase activity; F:transferase activity; P:protein phosphorylation; C:cellular_component; F:molecular_function,G3DSA:3.90.1200.10 (GENE3D),,
RL4_JR_01541,9649,11862,11480,0,5,5,0,0,2,0,0,5,4,2,0,0,8,0,191.616351,1,-1.102410153,0.51619743,-2.135636658,0.032709041,0.09682161,60.93978664,1,-0.290484576,0.984949013,-0.294923465,0.768052346,0.859715247,141.9929313,1,-1.453169985,0.679020359,-2.140097814,0.032346863,0.081455429,171.6026664,1,-1.677744402,0.621811279,-2.698156916,0.006972457,0.036408522,138.8140588,1,-1.106410076,0.589934449,-1.875479687,0.060726761,0.129936276,N,-,,kelch domain-containing,,IPR000210 (SMART); IPR027443 (G3DSA:2.60.120.GENE3D); IPR015915 (G3DSA:2.120.10.GENE3D); IPR005123 (PFAM); G3DSA:3.30.710.10 (GENE3D); IPR000210 (PFAM); PF13854 (PFAM); IPR026992 (PFAM); PF13418 (PFAM); PTHR10209:SF136 (PANTHER); PTHR10209 (PANTHER); IPR000210 (PROSITE_PROFILES); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY); SSF117281 (SUPERFAMILY); IPR011333 (SUPERFAMILY),,
RL4_JR_01542,507,414,404,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,29.33174188,1,1.818300731,0.851051846,2.136533444,0.032635958,0.096675434,1.703477382,0,2.69710414,1.341578721,2.010395736,0.044389321,0.107413032,4.399256272,0,0.051829698,1.20717609,0.042934663,0.965753617,0.979803304,5.073582565,0,-0.370098783,1.206520074,-0.306748964,0.759034457,0.842585668,4.316637417,0,-0.023836974,1.200572359,-0.019854675,0.984159302,0.989343538,N,-,,hypothetical protein SPI_02785,,no IPS match,,
RL4_JR_01543,4193,3777,2436,0,10,9,0,0,0,0,0,0,0,0,0,0,1,0,156.2952367,1,1.488566787,0.598009771,2.489201448,0.01280304,0.046277004,13.50473606,0,-0.289831537,1.253575735,-0.231203851,0.817156439,0.889722807,34.73116889,0,-2.929133796,1.218708159,-2.403474347,0.016240106,0.047395456,40.04633603,0,-3.350746234,1.221645992,-2.742812776,0.006091541,0.032754566,37.76094549,1,-2.068628718,1.146395844,-1.804462855,0.071158777,0.146707925,N,-,,set domain-containing,,IPR001214 (SMART); G3DSA:2.170.270.10 (GENE3D); IPR001214 (PFAM); PTHR22884 (PANTHER); IPR001214 (PROSITE_PROFILES); IPR026489 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY),,
RL4_JR_01544,33955,25885,20398,12,5,6,6,0,0,0,18,10,3,0,1,0,16,2,505.154765,1,-0.933182039,0.604094761,-1.544761021,0.122404079,0.255965569,237.7166654,1,0.353289591,1.452577559,0.243215647,0.807838346,0.883444333,473.3129021,1,-0.316598205,0.614424391,-0.515276101,0.606360097,0.72314638,345.6022243,1,-3.490061626,0.787865098,-4.429770574,9.43E-06,0.000134294,337.5333667,1,-1.381005039,0.626356267,-2.204823537,0.02746648,0.070351153,N,-,,sphingolipid long chain base-responsive lsp1,P:response to heat; P:protein localization; C:mitochondrial outer membrane; P:endocytosis; F:protein kinase inhibitor activity; P:negative regulation of protein kinase activity; C:eisosome,IPR028245 (PFAM); PTHR31962:SF3 (PANTHER); PTHR31962 (PANTHER); PTHR31962:SF3 (PANTHER),,
RL4_JR_01545,1501,1203,1529,2,2,0,0,0,0,0,0,1,0,0,0,3,1,0,53.041744,1,0.564158535,0.736003659,0.766515937,0.443369373,0.632406938,5.401493819,0,1.032153404,1.240465182,0.832069629,0.405369644,0.569419986,20.50061996,1,-0.656854736,1.191908256,-0.551095047,0.581568521,0.703116832,16.15146859,0,-2.040868954,1.191368617,-1.713045757,0.086704122,0.175857219,65.73461269,1,0.960442575,0.747538473,1.284806884,0.198859776,0.320603883,N,-, Effector probability:0.848,lsm domain-containing,,IPR001163 (SMART); IPR001163 (PFAM); G3DSA:2.30.30.100 (GENE3D); IPR010920 (SUPERFAMILY),,
RL4_JR_01546,27,24,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.300234265,0,3.633485432,2.479148515,1.4656183,0.142752303,NA,0.096235365,0,6.842909961,2.106690015,3.248180753,0.001161455,0.015023052,0.24890311,0,4.195594617,1.318306676,3.18256343,0.001459775,0.007737574,0.287084829,0,3.773328921,1.596514073,2.3634799,0.018104209,0.073513299,0.244579265,0,4.117512664,1.240685359,3.318740432,0.000904244,0.00440167,N,-,,---NA---,,no IPS match,,
RL4_JR_01547,3298,2589,2926,3,1,4,0,0,0,1,1,4,0,7,0,0,0,2,88.68106115,1,0.492311974,0.536793816,0.917134213,0.359072315,0.550415623,11.28944706,0,-0.031364491,1.218856145,-0.025732726,0.979470521,0.989243725,74.11069176,1,0.724643514,0.61796086,1.172636588,0.240941571,0.374067238,61.76301124,1,0.400663122,0.588907618,0.680349701,0.496283061,0.63477337,43.4435323,1,-1.072851141,0.96888987,-1.107299368,0.268164517,0.400497879,N,-,,DNA excision repair,C:nucleus; F:DNA binding; P:nucleic acid phosphodiester bond hydrolysis; F:endonuclease activity; P:nucleotide-excision repair,IPR006084 (PRINTS); IPR001044 (PRINTS); IPR008918 (SMART); IPR006086 (SMART); IPR006085 (SMART); IPR029060 (G3DSA:3.40.50.GENE3D); IPR006086 (PFAM); G3DSA:1.10.150.20 (GENE3D); IPR006085 (PFAM); IPR006084 (PANTHER); PTHR11081:SF1 (PANTHER); IPR003903 (PROSITE_PROFILES); IPR020045 (SUPERFAMILY); IPR029060 (SUPERFAMILY),,
RL4_JR_01548,16553,11453,14248,0,0,7,0,0,1,1,0,2,2,3,3,0,3,0,195.1776466,1,-2.028586531,0.625839508,-3.24138458,0.001189506,0.0067718,63.46468177,1,-1.37501159,1.120618476,-1.227011351,0.219818325,0.3675865,163.9289063,1,-2.53148946,0.863235586,-2.9325592,0.003361808,0.014737519,220.8713311,1,-1.610116322,0.557406734,-2.888584267,0.003869803,0.022892827,149.1038522,1,-2.821476428,0.861395773,-3.275470483,0.001054861,0.004990874,N,-,,peroxisomal membrane,C:peroxisome; C:membrane; C:Pex17p-Pex14p docking complex,IPR001452 (SMART); IPR011511 (PFAM); IPR007223 (PFAM); G3DSA:2.30.30.40 (GENE3D); PTHR19332 (PANTHER); PTHR19332:SF3 (PANTHER); PTHR19332 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY),3.A.20.1.5, the peroxisomal protein importer (ppi) family.
RL4_JR_01549,8350,26428,10926,0,2,7,0,0,0,0,0,0,3,0,0,0,0,0,229.6930528,1,-1.909290682,0.840390985,-2.27190762,0.023092091,0.073882173,59.32021587,0,-2.424928685,1.293717379,-1.874388275,0.060876928,0.137666727,153.7026077,0,-5.075000985,1.290250078,-3.933346777,8.38E-05,0.001044458,205.2834736,1,-2.834633968,1.490148801,-1.902248934,0.057138618,0.133047826,150.6429663,0,-5.148767117,1.307157252,-3.938904145,8.19E-05,0.000587369,N,-,,NCS1 nucleoside transporter,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR026030 (PIRSF); IPR001248 (PFAM); PTHR31806:SF1 (PANTHER); PTHR31806 (PANTHER),2.A.39.2.4, the nucleobase:cation symporter-1 (ncs1) family.
RL4_JR_01550,42,63,72,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.710249249,0,2.391320303,1.7353231,1.378025973,0.168195269,NA,0.224560296,0,5.620220523,1.79941138,3.12336611,0.001787952,0.015023052,0.58573939,0,2.960476915,1.283065764,2.3073462,0.021035528,0.057760695,0.675974901,0,2.537703887,1.378399486,1.841051098,0.065614071,0.144768461,0.580250103,0,2.872224997,1.253966534,2.290511684,0.021991672,0.058953053,N,-,,hypothetical protein S7711_09913,,IPR012816 (PFAM); IPR012816 (TIGRFAM); PTHR11079 (PANTHER); PTHR11079:SF50 (PANTHER); SSF143990 (SUPERFAMILY),,
RL4_JR_01551,57,64,34,0,3,2,0,0,0,1,0,0,4,4,3,0,0,2,32.29311891,1,5.640722021,0.742810368,7.593757791,3.11E-14,1.84E-12,0.201575816,0,5.776418437,1.877546262,3.076578486,0.002093912,0.015023052,11.58861972,1,4.100607165,1.229870514,3.334177963,0.000855519,0.00508075,82.79932358,1,6.958751075,0.556195705,12.51133552,6.47E-36,1.42E-33,15.2369928,1,4.774838256,1.013800074,4.709842084,2.48E-06,3.12E-05,N,-,,Nitrilotriacetate monooxygenase component A pristinamycin IIA synthase subunit A,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity",IPR011251 (G3DSA:3.20.20.GENE3D); IPR016215 (PIRSF); IPR016215 (TIGRFAM); IPR011251 (PFAM); PTHR30011:SF30 (PANTHER); PTHR30011 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_01552,1009,1327,940,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,29.22910153,1,-0.068704763,1.03135403,-0.066616081,0.946887344,0.973563316,4.223042672,0,1.387299164,1.278750381,1.084886608,0.27797188,0.437035006,10.92322561,0,-1.260202796,1.210285119,-1.04124456,0.29776206,0.438543842,12.59998824,0,-1.682394977,1.210072159,-1.390326159,0.164429858,0.284736157,10.71835564,0,-1.335739057,1.209343453,-1.104515887,0.269369416,0.401700964,N,-,,Ntf2 partial,P:RNA processing; C:ribosome; C:exosome (RNase complex); P:RNA catabolic process,IPR009959 (PFAM); IPR032710 (G3DSA:3.10.450.GENE3D); IPR032710 (SUPERFAMILY),,
RL4_JR_01553,71,120,98,1,0,4,0,0,0,0,0,0,0,2,0,0,0,0,26.50540402,1,4.695879498,0.73252159,6.410568045,1.45E-10,4.85E-09,0.370022762,0,4.899865139,1.655270784,2.96015926,0.0030748,0.015771865,0.961574733,0,2.245886099,1.265407711,1.774832,0.075925631,0.156647868,9.132693899,1,3.532723666,1.058976775,3.335978418,0.000849998,0.006480592,0.947953102,0,2.163924148,1.246186572,1.73643674,0.082486641,0.16525074,N,-,,flavin-binding monooxygenase-like family,F:nucleotide binding; F:coenzyme binding; F:monooxygenase activity,IPR023753 (G3DSA:3.50.50.GENE3D); PF13450 (PFAM); PTHR23023:SF29 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_01554,25,17,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.255014041,0,3.868912848,2.672451712,1.447701686,0.147700498,NA,0.081849411,0,7.076422273,2.183301424,3.241156807,0.001190457,0.015023052,0.211732096,0,4.428274929,1.345189821,3.291933124,0.000995013,0.005730096,0.244200891,0,4.006527639,1.689898439,2.370868892,0.017746325,0.072500326,0.208289949,0,4.348361517,1.253788865,3.46817685,0.000524002,0.002811618,N,-,,kinesin light,C:integral component of plasma membrane; C:membrane; C:integral component of membrane,PTHR12231 (PANTHER),8.A.23.1.4, the basigin (basigin) family.
RL4_JR_01555,3,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.050518578,0,6.203571658,3.927818932,1.579393492,0.114245829,NA,0.015679562,0,9.458398181,3.928432548,2.407677379,0.016054361,0.048595169,0.041707502,0,6.769328364,2.483679161,2.725524484,0.006419941,0.022959612,0.048172973,0,6.347263641,3.927854352,1.615962068,0.106102515,0.20513423,0.042400061,0,6.645793481,1.794984517,3.702423848,0.000213549,0.001319212,N,-, Effector probability:0.64,---NA---,,no IPS match,,
RL4_JR_01556,578,363,418,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,21.06423782,1,1.764194348,0.876331209,2.013159328,0.04409787,0.121040202,1.746299462,0,2.661270445,1.360802971,1.955661842,0.050505003,0.1188308,4.504069938,0,0.017745309,1.221545115,0.014526937,0.988409589,0.994648201,5.193802179,0,-0.404000424,1.223294457,-0.330256073,0.741206481,0.827955455,4.417081248,0,-0.057071954,1.216934098,-0.046898146,0.962594405,0.975602438,N,-,,3-oxoacyl-(acyl-carrier- ) reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_01557,2211,1515,2227,0,0,52,0,0,0,1,5,6,0,0,1,0,2,0,222.2585731,1,3.112082625,1.478412649,2.105016234,0.035289895,0.102490197,7.582583866,0,0.542810502,1.238953815,0.438120046,0.661299264,0.78279396,108.9347731,1,2.288223546,0.476325963,4.803902633,1.56E-06,3.96E-05,32.31014451,1,-1.579518002,1.153325984,-1.369533007,0.170832725,0.29318719,27.10640561,1,-0.527825234,0.992377123,-0.531879688,0.594809326,0.70586087,N,-,,aminotriazole resistance,C:membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501:SF8 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.52, the major facilitator superfamily (mfs).
RL4_JR_01558,48,48,48,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0.577032442,0,2.690961274,1.834311171,1.467014603,0.142372083,NA,0.184457591,0,5.904208393,1.848198994,3.194573968,0.001400374,0.015023052,0.477821798,0,3.254651227,1.265035997,2.572773609,0.010088718,0.032905341,10.18646544,1,3.783001708,1.153886414,3.278487085,0.001043651,0.007668338,0.470169357,0,3.175122773,1.223538432,2.595033135,0.00945818,0.030039519,N,-, Effector probability:0.607,---NA---,,no IPS match,,
RL4_JR_01559,95,100,121,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.264101966,0,1.559540987,1.376466234,1.133003446,0.257212806,NA,0.402122317,0,4.779753605,1.597426307,2.992159064,0.002770119,0.015349618,1.045410503,0,2.124668924,1.232783549,1.723472807,0.084803059,0.170206376,1.206161205,0,1.702245799,1.264239856,1.346457945,0.178154874,0.302795118,1.032796681,0,2.039914808,1.219324714,1.672987339,0.094329789,0.182722233,N,-, Effector probability:0.562,---NA---,,no IPS match,,
RL4_JR_01560,358,295,331,0,0,5,0,0,0,1,0,3,0,0,0,0,0,0,23.02487553,1,2.958412997,0.66582314,4.443241483,8.86E-06,0.000104467,1.259806342,0,3.13234613,1.368873594,2.288265435,0.022122068,0.062425409,33.82680866,1,3.304877766,0.743173032,4.446982902,8.71E-06,0.000169206,3.760890892,0,0.061703645,1.205667165,0.051178009,0.959183675,0.97664267,3.207428537,0,0.404660677,1.200038839,0.337206317,0.735961376,0.815376169,N,-,,benzoate 4-monooxygenase cytochrome,F:oxidoreductase activity; F:metal ion binding; C:membrane,IPR002403 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24305 (PANTHER); PTHR24305:SF78 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_01561,340,461,452,0,5,4,0,0,0,0,0,0,0,0,2,0,4,1,60.35921344,1,3.471724717,0.55008551,6.311245534,2.77E-10,8.59E-09,1.599457459,0,2.787930804,1.34354984,2.075048295,0.037982059,0.095209114,4.157517221,0,0.133330191,1.212262774,0.109984563,0.912421618,0.946547439,24.06758436,1,1.460723051,1.024847375,1.42530789,0.15406822,0.271118496,26.91064974,1,2.974933094,0.702347061,4.235702344,2.28E-05,0.000200771,N,-,,L-lactate dehydrogenase,F:organic cyclic compound binding; F:heterocyclic compound binding; F:catalytic activity,IPR013785 (G3DSA:3.20.20.GENE3D); IPR000262 (PFAM); IPR012133 (PIRSF); PTHR10578:SF64 (PANTHER); PTHR10578 (PANTHER); IPR012133 (PROSITE_PROFILES); SSF51395 (SUPERFAMILY),,
RL4_JR_01562,160,159,163,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22.06157268,1,2.689646277,1.006775741,2.671544584,0.007550304,0.030327613,0.617020491,0,4.162160493,1.491808257,2.79001036,0.005270635,0.021322691,1.598801558,0,1.512097923,1.215995124,1.243506568,0.213681222,0.342295679,1.844289555,0,1.089824473,1.227949729,0.887515545,0.374801401,0.520414726,1.573763049,0,1.432081531,1.204526354,1.188916728,0.234472437,0.362780169,Y,-,,ferrooxidoreductase Fet3,F:metal ion binding; C:membrane,IPR008972 (G3DSA:2.60.40.GENE3D); IPR001117 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); IPR008972 (G3DSA:2.60.40.GENE3D); IPR011707 (PFAM); IPR011706 (PFAM); PTHR11709:SF105 (PANTHER); PTHR11709 (PANTHER); PTHR11709 (PANTHER); PTHR11709:SF105 (PANTHER); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY),2.A.108.1.1, the iron/lead transporter (ilt) family.
RL4_JR_01563,11494,11251,12458,0,4,4,0,0,0,0,0,0,0,0,3,0,0,2,188.2011059,1,-1.51268912,0.529867248,-2.854845483,0.004305777,0.01917387,44.96955311,0,-2.025354797,1.189599263,-1.702552162,0.088651909,0.184257623,116.6368432,0,-4.676895263,1.18572831,-3.944322847,8.00E-05,0.001012726,163.4585054,1,-2.774177651,0.841469163,-3.296826281,0.00097784,0.0072373,129.6774615,1,-3.074623459,0.967737001,-3.177127109,0.001487418,0.00662857,Y,-,,hypothetical protein SPBR_02144,,no IPS match,,
RL4_JR_01564,16,36,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.346893929,0,3.425203572,2.414494515,1.418600684,0.156015466,NA,0.109298133,0,6.659056204,2.105564365,3.162599214,0.001563674,0.015023052,0.285408546,0,3.998081916,1.375258401,2.907149605,0.003647387,0.015596838,0.329420679,0,3.574909509,1.641527829,2.177794031,0.029421374,0.091256615,0.282748679,0,3.910142646,1.302250305,3.002604515,0.0026768,0.010836707,N,-,,hypothetical protein SPI_08775,,no IPS match,,
RL4_JR_01565,13,14,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.199315594,0,4.224432488,2.993742939,1.411087249,0.158218889,NA,0.062970301,0,7.454269471,2.304509248,3.234645067,0.00121794,0.015023052,0.164577715,0,4.790772603,1.395273631,3.433572094,0.000595684,0.003842254,0.189940351,0,4.368814183,1.85824129,2.351047847,0.018720626,0.074406487,0.163582794,0,4.699073165,1.285097492,3.656588855,0.000255594,0.00153675,N,-,,toxin biosynthesis,C:membrane; C:integral component of membrane,IPR032805 (PFAM),,
RL4_JR_01566,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.015953485,0,7.867140353,3.973076766,1.980112848,0.04769085,NA,0.005346613,0,11.01668392,3.970228347,2.774823752,0.005523163,0.021974647,0.013444566,0,8.408299533,2.921098072,2.878472179,0.003996065,0.01637703,0.015478003,0,7.987409939,3.972128364,2.010864002,0.044339824,0.114176173,0.012834372,0,8.355328124,1.611812863,5.183807821,2.17E-07,4.29E-06,N,-, Effector probability:0.846,hypothetical protein SPI_08776,,no IPS match,,
RL4_JR_01567,2752,2516,3499,0,0,0,0,0,0,0,0,0,0,1,0,0,5,0,34.98202907,0,-3.230925899,1.193949997,-2.706081415,0.006808235,0.028022998,11.13129068,0,-0.011075282,1.212921606,-0.009131078,0.992714555,0.996447484,28.94949294,0,-2.666546174,1.194189346,-2.232934152,0.025553287,0.067702644,37.41238253,1,-2.142116374,1.146834159,-1.86785191,0.061782716,0.138918498,47.92890456,1,0.159234879,0.701089839,0.227124786,0.820326711,0.879573012,N,-,,hypothetical protein VP1G_10108,P:regulation of catalytic activity; F:protein phosphatase type 4 regulator activity; C:protein phosphatase 4 complex,IPR015267 (PFAM); PTHR16487:SF0 (PANTHER); IPR015267 (PANTHER); IPR015267 (PANTHER); PTHR16487:SF0 (PANTHER),,
RL4_JR_01568,5089,3190,4304,0,1,3,0,0,0,0,0,3,5,6,2,0,0,1,69.55430359,1,-1.037517045,0.770367712,-1.346781582,0.178050588,0.334223815,16.09527383,0,-0.54304277,1.2256489,-0.443065523,0.657718342,0.779649263,61.10959261,1,-0.793769282,0.874632018,-0.907546563,0.364117838,0.508178796,137.8939351,1,0.836478643,0.476850715,1.754172985,0.079400871,0.16555474,48.28790047,1,-2.331903456,1.134441777,-2.055551465,0.03982577,0.093781346,N,-,,apparatus membrane,C:integral component of membrane,PTHR34391:SF1 (PANTHER); PTHR34391 (PANTHER),,
RL4_JR_01569,3421,1649,2193,0,4,0,0,0,0,0,0,0,0,1,4,0,0,1,60.89618019,1,-0.126967187,0.841441527,-0.150892466,0.880060544,0.941454749,9.338444577,0,0.242353797,1.276855414,0.1898052,0.849461781,0.910253245,24.04254778,0,-2.398543208,1.228596525,-1.952262731,0.05090702,0.114810129,70.27275377,1,0.311007042,0.755577844,0.411614825,0.680621763,0.782675574,30.91595549,1,-1.530063513,1.159397032,-1.319706253,0.186933111,0.30586583,N,-,,regulator of gluconeogenesis,F:metal ion binding,IPR013144 (SMART); IPR006595 (SMART); IPR024964 (PFAM); IPR027370 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR027711 (PTHR12170:PANTHER); PTHR12170 (PANTHER); IPR027711 (PTHR12170:PANTHER); PTHR12170 (PANTHER); IPR006595 (PROSITE_PROFILES); IPR006594 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),,
RL4_JR_01570,2813,1885,1904,0,1,2,0,0,0,0,2,2,0,0,0,0,0,4,42.00628144,1,-0.518513148,0.876657772,-0.591465866,0.55420832,0.733063965,8.505347461,0,0.377186545,1.253003338,0.30102597,0.763394692,0.856565909,50.59903645,1,0.550712972,0.769924315,0.715281958,0.474434835,0.611091383,25.27061953,0,-2.686560992,1.20908043,-2.221986995,0.026284184,0.08636862,50.92539656,1,0.325994161,0.767875168,0.424540569,0.671171625,0.766134465,N,-,,sin3 complex subunit,,PTHR31011:SF2 (PANTHER); PTHR31011 (PANTHER); PTHR31011 (PANTHER); PTHR31011:SF2 (PANTHER),,
RL4_JR_01571,2315,2307,3403,0,0,3,0,0,0,0,0,0,1,0,0,0,0,0,43.47306998,1,-0.816374331,0.880895779,-0.92675473,0.354053894,0.544975786,10.15553712,0,0.121261374,1.222177461,0.099217485,0.920965592,0.956496381,26.46795191,0,-2.53725483,1.201246339,-2.112185275,0.034670561,0.085778289,39.85402175,1,-2.009057394,1.154453574,-1.740266944,0.081812156,0.16884388,26.22927368,0,-2.626879536,1.210791329,-2.169555954,0.030040501,0.075249895,N,-, Effector probability:0.941,mitochondrial import inner membrane translocase subunit tim10,F:metal ion binding; C:mitochondrial intermembrane space protein transporter complex; F:protein transporter activity; P:protein import into mitochondrial inner membrane; F:unfolded protein binding; C:mitochondrial inner membrane,IPR004217 (G3DSA:1.10.287.GENE3D); IPR004217 (PFAM); IPR027247 (PANTHER); IPR004217 (SUPERFAMILY),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_01572,1318,1190,2808,1,0,0,0,0,0,1,1,5,0,5,0,0,0,0,31.14885537,1,-1.542415539,1.214450967,-1.270051719,0.204066208,0.368883697,6.632648233,0,0.735839078,1.294842421,0.568284655,0.569841697,0.710687242,68.81048072,1,1.671245665,0.678247242,2.464065552,0.013737099,0.041415838,40.14765535,1,0.584901157,0.813010908,0.719425966,0.471878503,0.612927497,17.38549018,0,-2.03358919,1.265763271,-1.606610996,0.108139729,0.202474746,N,-,,lysyl-tRNA synthetase,F:nucleotide binding; P:tRNA aminoacylation for protein translation; F:aminoacyl-tRNA ligase activity,IPR018149 (PRINTS); IPR004365 (PFAM); IPR004364 (PFAM); G3DSA:3.30.930.10 (GENE3D); G3DSA:2.40.50.140 (GENE3D); PTHR22594:SF19 (PANTHER); IPR018150 (PANTHER); IPR006195 (PROSITE_PROFILES); SSF55681 (SUPERFAMILY); IPR012340 (SUPERFAMILY),9.B.111.1.5,The 6 TMS Lysyl tRNA Synthetase (LysS) Family
RL4_JR_01573,5552,5291,4014,0,0,0,0,0,0,0,0,1,3,7,0,0,1,0,59.67044695,0,-4.00125331,1.204570791,-3.32172533,0.000894627,0.005450611,19.19053698,0,-0.796767782,1.223686727,-0.651120719,0.514968563,0.665365922,55.98791136,1,-2.478226685,1.202837123,-2.060317758,0.039368173,0.094423925,113.0902818,1,0.16194357,0.532251012,0.304261648,0.760928561,0.843948043,52.31091204,1,-2.582489687,1.128742529,-2.287935133,0.022141299,0.059260019,N,-,,DNA repair RAD50,"F:ATPase activity; F:ATP binding; P:reciprocal meiotic recombination; C:membrane; P:mitotic recombination-dependent replication fork processing; P:double-strand break repair via homologous recombination; P:telomere maintenance; P:gene conversion at mating-type locus, DNA repair synthesis; C:Mre11 complex; P:intra-S DNA damage checkpoint; P:double-strand break repair via nonhomologous end joining; P:meiotic DNA double-strand break formation",IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PF13476 (PFAM); IPR004584 (TIGRFAM); IPR004584 (PANTHER); PTHR18867:SF12 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_01574,2361,1384,1808,0,3,0,0,0,0,0,5,4,3,8,0,0,7,0,46.12946602,1,-0.220724718,0.876944722,-0.251697413,0.801274957,0.899570577,7.118268174,0,0.634008276,1.260928077,0.502810816,0.615097288,0.746972376,83.58580351,1,1.96604176,0.559098278,3.516451107,0.000437357,0.003070352,81.22039767,1,1.711636371,0.537637672,3.183624324,0.001454436,0.010128039,45.06756208,1,1.268010987,0.649137583,1.953377867,0.050774837,0.113536931,N,-,,GATA zinc finger,F:binding,IPR000679 (SMART); IPR000014 (SMART); IPR013088 (G3DSA:3.30.50.GENE3D); IPR000679 (PFAM); G3DSA:3.30.450.20 (GENE3D); IPR000014 (TIGRFAM); IPR013655 (PFAM); PTHR10071 (PANTHER); IPR000679 (PROSITE_PROFILES); IPR000014 (PROSITE_PROFILES); SSF57716 (SUPERFAMILY); IPR000014 (SUPERFAMILY),,
RL4_JR_01575,1630,2823,2292,3,8,7,0,0,2,0,2,0,4,3,0,0,1,4,148.2235121,1,2.087210161,0.501474021,4.162150125,3.15E-05,0.000312197,27.39242248,1,1.981173196,1.028698095,1.925903437,0.054116432,0.125634524,38.13017019,1,-0.474300166,1.059877719,-0.447504611,0.65451076,0.760590786,75.18158699,1,0.837388445,0.637581901,1.31338177,0.189054337,0.317532506,55.45135128,1,0.603748116,0.727015285,0.830447623,0.406285749,0.5431487,N,-,,enoyl- hydratase isomerase,F:catalytic activity; P:metabolic process; C:cellular_component; F:molecular_function; F:isomerase activity,PTHR39477 (PANTHER); PTHR39477:SF1 (PANTHER),,
RL4_JR_01576,79,136,136,0,0,0,0,0,0,1,0,2,0,8,0,0,0,8,1.412282409,0,1.399782454,1.426307469,0.981403017,0.326394039,NA,0.446505024,0,4.628712319,1.607190639,2.88000204,0.003976726,0.018066616,25.23142744,1,4.376616382,0.887162668,4.933273839,8.09E-07,2.24E-05,33.43599088,1,5.151967727,0.665158156,7.745477794,9.52E-15,5.84E-13,60.07563251,1,5.716202951,1.624569921,3.518594601,0.000433839,0.002410879,N,-,,enoyl- hydratase isomerase,F:catalytic activity; P:metabolic process,IPR001753 (PFAM); IPR029045 (G3DSA:3.90.226.GENE3D); PTHR11941 (PANTHER); PTHR11941:SF74 (PANTHER); IPR029045 (SUPERFAMILY),,
RL4_JR_01577,844,1409,1717,0,4,0,0,0,0,0,0,4,0,2,1,0,6,1,47.96696885,1,0.736164562,0.849904661,0.866173109,0.386395238,0.579279004,5.01955648,0,1.137899639,1.284177769,0.886091993,0.375567957,0.540259317,39.11595715,1,1.270776156,0.805329137,1.577958747,0.114575087,0.214528978,32.80283987,1,0.355805764,0.908256586,0.391745868,0.695245996,0.794510802,43.55547066,1,1.735440818,0.689696493,2.516238427,0.011861491,0.036076178,N,-,,2OG-Fe(II) oxygenase,F:dioxygenase activity; F:metal ion binding; P:oxidation-reduction process,IPR027443 (G3DSA:2.60.120.GENE3D); IPR026992 (PFAM); IPR005123 (PFAM); PTHR10209:SF87 (PANTHER); PTHR10209 (PANTHER); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_01578,12298,16219,20487,0,0,2,0,0,0,0,3,0,0,0,1,0,0,2,203.8585492,1,-4.009208807,1.056466714,-3.794922029,0.00014769,0.001192925,62.0728985,0,-2.490391026,1.203108702,-2.069963438,0.038455768,0.096016105,185.4591507,1,-2.740600227,0.877334867,-3.123778992,0.001785445,0.009042444,196.5082589,1,-4.621207557,1.162790784,-3.974238203,7.06E-05,0.000796074,175.2338696,1,-3.535695538,1.004855659,-3.518610365,0.000433813,0.002410879,N,-,,atp-dependent rna helicase rok1,F:organic cyclic compound binding; F:heterocyclic compound binding,IPR014001 (SMART); IPR001650 (SMART); IPR001650 (PFAM); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24031:SF263 (PANTHER); PTHR24031:SF263 (PANTHER); PTHR24031:SF263 (PANTHER); PTHR24031 (PANTHER); PTHR24031:SF263 (PANTHER); PTHR24031 (PANTHER); PTHR24031 (PANTHER); PTHR24031 (PANTHER); PTHR24031 (PANTHER); PTHR24031:SF263 (PANTHER); PTHR24031 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_01579,7233,6800,9701,1,2,11,0,0,0,0,0,1,4,5,0,0,4,0,162.7833099,1,-0.193615834,0.480731737,-0.402752344,0.687130422,0.829723207,30.09610868,0,-1.446021825,1.198694463,-1.206330612,0.227690039,0.377329093,84.83296937,1,-3.140813428,1.196102314,-2.62587355,0.008642692,0.029166204,147.6904445,1,-0.62668695,0.531352,-1.179419575,0.238231144,0.376242448,92.96573195,1,-1.597797261,0.77997802,-2.048515753,0.04050949,0.095170005,N,-,,glycolate oxidase,"F:oxidoreductase activity, acting on CH-OH group of donors; P:transmembrane transport; F:flavin adenine dinucleotide binding; C:mitochondrion; C:integral component of membrane; P:oxidation-reduction process; P:cellular metabolic process; F:ligase activity",IPR016169 (G3DSA:3.30.465.GENE3D); IPR016171 (G3DSA:1.10.45.GENE3D); IPR006094 (PFAM); IPR016167 (G3DSA:3.30.43.GENE3D); IPR004113 (PFAM); PTHR11748:SF35 (PANTHER); PTHR11748 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY); IPR016164 (SUPERFAMILY),,
RL4_JR_01580,371,583,393,0,0,4,0,0,0,0,0,0,1,0,0,0,6,2,20.71747017,1,2.122314841,0.818253498,2.593713131,0.009494567,0.036381718,1.735473406,0,2.67026356,1.367832259,1.952186419,0.050916076,0.119520529,4.494837112,0,0.020951438,1.230176425,0.017031247,0.986411688,0.993575956,14.49765419,1,0.551689985,1.173104852,0.470281905,0.638153623,0.752251287,42.30862873,1,3.527428142,0.606790868,5.813251864,6.13E-09,3.01E-07,Y,-,,ca2+ h+-exchanging,P:calcium ion transport; P:cation transmembrane transport; C:integral component of membrane; F:cation transmembrane transporter activity; F:protein serine/threonine kinase activity; P:protein phosphorylation,IPR004837 (PFAM); PTHR31503 (PANTHER); PTHR31503:SF18 (PANTHER),2.A.19.2.2, the ca(2+):cation antiporter (caca) family.
RL4_JR_01581,229,339,281,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,3.420586901,0,0.123688288,1.253562432,0.098669428,0.921400744,0.961964073,1.08812084,0,3.343718454,1.40923199,2.372723922,0.017657457,0.052168352,2.82428667,0,0.691323883,1.225508237,0.564111984,0.572677922,0.696096925,3.258518221,0,0.268804289,1.232305259,0.218131252,0.827326848,0.892275707,10.50265586,1,2.270059224,1.003558062,2.26201085,0.023696733,0.062367929,N,-,,Vacuolar calcium ion transporter,P:transmembrane transport; F:organic cyclic compound binding; F:heterocyclic compound binding; C:integral component of membrane,PTHR31503 (PANTHER); PTHR31503:SF18 (PANTHER),2.A.19.2.8, the ca(2+):cation antiporter (caca) family.
RL4_JR_01582,1946,2457,1336,1,1,12,0,0,0,0,5,3,0,3,5,0,4,3,87.08947082,1,1.732651143,0.626045781,2.767610924,0.005646883,0.024056014,7.450928202,0,0.568157873,1.281187351,0.443461975,0.657431617,0.779491956,77.91222927,1,1.731996576,0.615777243,2.812699876,0.004912748,0.018726153,82.35521156,1,1.286753914,0.6400655,2.010347244,0.04439445,0.11425872,56.29944458,1,1.27557658,0.641991961,1.986904289,0.046933004,0.106665919,N,-,,CAMK CAMKL KIN4 kinase,F:nucleotide binding; F:protein kinase activity; P:phosphorylation,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); PTHR24343:SF98 (PANTHER); PTHR24343 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.2, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_01583,741,736,893,2,0,1,0,0,0,0,0,3,0,1,1,0,0,2,33.4258096,1,0.972181512,0.847018311,1.147769179,0.251063864,0.428310122,3.018293328,0,1.871756608,1.268405413,1.475676932,0.140030641,0.261994483,27.33738366,1,1.621014812,0.851387881,1.903967448,0.056914424,0.12488115,22.6933239,1,0.529541389,1.012440745,0.523034451,0.600950279,0.722602894,22.47267453,1,0.821194557,0.974490076,0.842691555,0.399400972,0.536686773,N,-,,gpi-anchored wall transfer 1,"C:endoplasmic reticulum membrane; P:GPI anchor biosynthetic process; F:transferase activity, transferring acyl groups; C:integral component of membrane",IPR009447 (PIRSF); IPR009447 (PFAM); IPR009447 (PANTHER),9.B.315.1.5, the glycoslyphosphatidylinositol (gpi) membrane anchoring protein gwt1 (gwt1) family.
RL4_JR_01584,554,725,621,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,15.65426618,1,-0.085211114,1.155312562,-0.073755897,0.941204621,0.971327931,2.436304628,0,2.180863206,1.30227867,1.674651714,0.094002587,0.193040004,6.317704988,0,-0.470264366,1.205983764,-0.389942535,0.69657904,0.793191768,7.288490381,0,-0.89264495,1.205214071,-0.740652612,0.458904099,0.600854002,6.218107963,0,-0.550136102,1.206141148,-0.456112539,0.648309054,0.748731512,N,-,,hypothetical protein CMQ_4435,,no IPS match,,
RL4_JR_01585,172,343,236,1,2,13,0,0,0,3,0,1,1,0,0,0,2,0,78.76709943,1,4.864754077,0.610466125,7.968917316,1.60E-15,1.15E-13,0.964827734,0,3.517229128,1.473018845,2.387769268,0.01695098,0.050729657,42.21421333,1,3.717217701,0.798448366,4.655551768,3.23E-06,7.29E-05,12.20327202,1,1.396763394,1.191745196,1.172031906,0.241184246,0.379703274,10.18754322,1,2.430590164,1.042579901,2.331322676,0.019736351,0.054052085,N,-,,glycosyltransferase family 2,C:integral component of membrane; F:transferase activity,IPR029044 (G3DSA:3.90.550.GENE3D); PF13641 (PFAM); PTHR10587:SF1 (PANTHER); PTHR10587 (PANTHER); IPR029044 (SUPERFAMILY),4.D.1.1.8, the putative vectorial glycosyl polymerization (vgp) family.
RL4_JR_01586,1395,1028,1319,0,5,3,0,0,0,0,0,0,1,0,1,0,0,1,66.42700647,1,1.736047392,0.546462133,3.176885068,0.00148866,0.008161619,4.780287806,0,1.208423206,1.253364095,0.964143788,0.334973842,0.498325283,12.37864567,0,-1.440864348,1.19772316,-1.203002827,0.228975226,0.359987151,33.22550182,1,-0.11744061,1.017630424,-0.115405954,0.90812336,0.943825602,19.55399954,1,-0.585965505,1.127320671,-0.519786002,0.603212737,0.711833212,N,-,,hypothetical protein SPI_08400,,no IPS match,,
RL4_JR_01587,820,686,833,0,2,16,1,0,0,2,0,1,6,3,0,0,4,2,86.45764358,1,3.383618307,0.5547296,6.099581321,1.06E-09,2.89E-08,25.2986538,1,2.810784385,1.114434914,2.522161098,0.011663628,0.037839501,36.38010646,1,1.648730817,0.847965346,1.944337496,0.051854766,0.116403026,76.83824729,1,2.731447804,0.512254819,5.332205193,9.70E-08,2.18E-06,37.80041926,1,2.359239452,0.618654642,3.813499956,0.000137013,0.000903747,N,-,,glutamyl-trna amidotransferase subunit a,F:catalytic activity,IPR023631 (PFAM); IPR023631 (G3DSA:3.90.1300.GENE3D); PTHR11895:SF44 (PANTHER); IPR000120 (PANTHER); IPR023631 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_01588,918,1055,953,2,0,3,0,0,0,0,0,0,1,0,0,0,0,0,43.33819091,1,1.392050244,0.672047774,2.071356083,0.038325532,0.109283358,3.752192953,0,1.557824228,1.262147958,1.234264349,0.217104416,0.364312152,9.722317969,0,-1.092195884,1.195926365,-0.913263488,0.36110398,0.505016811,20.52773076,1,-0.564770203,1.144277214,-0.493560647,0.621616499,0.73923738,9.564708705,0,-1.171430306,1.195502473,-0.979864394,0.327153061,0.463535508,N,-,,hypothetical protein FOC4_g10014425,,PTHR12864:SF22 (PANTHER); PTHR12864 (PANTHER),,
RL4_JR_01589,8338,10658,14748,0,6,5,0,0,4,0,0,0,0,2,1,0,0,0,202.0862349,1,-0.980121787,0.580624673,-1.688047086,0.091402191,0.20730027,80.14736194,1,0.625706715,0.781793529,0.800347779,0.423509328,0.586504504,111.340592,0,-4.609858192,1.210635704,-3.807799635,0.000140209,0.001415819,146.1561276,1,-2.725966503,0.888502726,-3.068045177,0.00215464,0.014029411,110.5130467,0,-4.701851542,1.223558407,-3.842768368,0.000121654,0.000816269,N,-,,isoleucyl-tRNA synthetase,P:isoleucyl-tRNA aminoacylation; F:ATP binding; F:isoleucine-tRNA ligase activity; P:regulation of translational fidelity; F:aminoacyl-tRNA editing activity; C:cytosol,IPR002301 (PRINTS); IPR009080 (G3DSA:1.10.730.GENE3D); IPR014729 (G3DSA:3.40.50.GENE3D); IPR013155 (PFAM); IPR002301 (TIGRFAM); IPR002300 (PFAM); IPR010663 (PFAM); IPR009008 (G3DSA:3.90.740.GENE3D); PTHR11946:SF82 (PANTHER); PTHR11946:SF82 (PANTHER); PTHR11946:SF82 (PANTHER); PTHR11946 (PANTHER); PTHR11946 (PANTHER); PTHR11946 (PANTHER); SSF52374 (SUPERFAMILY); IPR009008 (SUPERFAMILY); IPR009080 (SUPERFAMILY),,
RL4_JR_01590,612,896,1217,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,10.90746117,0,-1.549572173,1.239249014,-1.250412271,0.211148984,0.37861697,3.438622859,0,1.683601044,1.300811026,1.294270275,0.19557208,0.3384477,8.991471695,0,-0.979653331,1.227306337,-0.798214188,0.424746205,0.565732217,14.38954485,1,-0.45795552,1.180778408,-0.387842052,0.698132924,0.796730822,8.933939553,0,-1.073020947,1.240325127,-0.865112642,0.386976967,0.522976747,N,-,,hypothetical protein HMPREF1624_07015,,PTHR40635 (PANTHER); PTHR40635:SF1 (PANTHER); PTHR40635:SF1 (PANTHER); PTHR40635:SF1 (PANTHER); PTHR40635 (PANTHER),,
RL4_JR_01591,1631,2175,2406,0,0,0,0,0,1,0,0,0,0,0,3,0,0,4,24.9182028,0,-2.741424032,1.205669923,-2.273776578,0.022979423,0.073631632,17.27991883,1,1.399408907,1.128925208,1.239593994,0.215125603,0.361765213,20.57200239,0,-2.173637517,1.201959514,-1.808411591,0.070542465,0.147739329,52.64419652,1,-0.247645388,0.864523446,-0.286453061,0.774531139,0.853983207,49.80492202,1,0.406770014,0.772579894,0.526508672,0.598534829,0.70904003,N,-,,mitochondrial import receptor subunit,C:intracellular membrane-bounded organelle; C:membrane; C:cytoplasmic part; P:cellular process,IPR019564 (PFAM); PTHR12289:SF41 (PANTHER); PTHR12289:SF41 (PANTHER); PTHR12289 (PANTHER); PTHR12289 (PANTHER),,
RL4_JR_01592,1389,1598,2007,0,2,1,0,0,2,0,0,0,1,0,1,0,0,0,39.81976248,1,-0.102530249,0.864859969,-0.118551272,0.905630872,0.95392339,25.09632706,1,2.439776163,0.995162397,2.451636206,0.014220835,0.044195056,16.50851533,0,-1.856213823,1.199270055,-1.547786351,0.121673744,0.224294425,37.99665925,1,-0.530684134,1.021624783,-0.519451116,0.603446194,0.724521844,16.33709925,0,-1.943828827,1.207752819,-1.609459152,0.10751598,0.201741901,N,-,,GPI transamidase component,P:cell division; P:GPI anchor biosynthetic process; C:integral component of membrane,IPR009600 (PFAM); IPR009600 (PANTHER),,
RL4_JR_01593,17323,25010,30943,0,4,0,0,2,0,0,0,0,0,6,0,0,6,4,325.6932703,1,-3.464105735,0.856172338,-4.046037908,5.21E-05,0.000484683,169.4411936,1,-1.376863443,1.006378724,-1.368136478,0.17126936,0.306829817,242.1783711,0,-5.730939372,1.215278416,-4.715741921,2.41E-06,5.68E-05,303.5666782,1,-2.922572559,0.701545041,-4.165908655,3.10E-05,0.000387481,292.7975039,1,-1.907933621,0.596050023,-3.200962249,0.001369695,0.006190875,N,-,,pescadillo,"P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:ribonucleoprotein complex binding; C:PeBoW complex; P:cell cycle DNA replication; P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:nucleoplasm; C:preribosome, large subunit precursor",IPR001357 (SMART); IPR001357 (G3DSA:3.40.50.GENE3D); IPR010613 (PFAM); PTHR12221 (PANTHER); IPR001357 (PROSITE_PROFILES); IPR010613 (HAMAP); IPR001357 (SUPERFAMILY),,
RL4_JR_01594,1225,1426,1477,0,0,0,0,0,0,0,0,0,0,3,3,0,0,0,16.55544587,0,-2.151467195,1.192604466,-1.804007327,0.071230158,0.173202871,5.271019722,0,1.067436506,1.238133219,0.862133807,0.388613889,0.553251916,13.68755905,0,-1.585789401,1.19331229,-1.328897233,0.183881877,0.305183626,56.73222003,1,1.310345396,0.615168411,2.130059628,0.033166691,0.097485704,13.49962862,0,-1.668571955,1.197193265,-1.393736503,0.163397189,0.276285327,N,-,,RNA polymerase I specific transcription initiation factor,"F:translation initiation factor activity; F:metal ion binding; P:regulation of transcription, DNA-templated; P:translational initiation",IPR019622 (PFAM),,
RL4_JR_01595,11683,11965,12103,0,7,15,0,0,0,2,1,2,8,8,3,0,2,0,256.6204998,1,-0.113094078,0.369561798,-0.306022102,0.759587818,0.873023023,45.76436726,0,-2.05062213,1.191734936,-1.720703211,0.085304693,0.178880072,161.5858404,1,-1.553580273,0.661437537,-2.348793628,0.018834342,0.05350137,272.3156984,1,-0.130987575,0.361623227,-0.362221134,0.717186788,0.810694151,124.4821833,1,-3.11016818,0.968790871,-3.210360743,0.001325685,0.006013691,N,-,,MICOS complex subunit MIC60,C:integral component of mitochondrial inner membrane; P:biosynthetic process; P:single-organism process; P:cellular process,IPR019133 (PFAM); PTHR15415:SF7 (PANTHER); PTHR15415 (PANTHER),9.B.216.1.2," the micos complex component, mic60 (mic60) family."
RL4_JR_01596,8288,7340,7819,0,0,12,0,0,2,0,0,7,2,14,4,0,16,1,139.6219718,1,-0.619649981,0.744415819,-0.832397653,0.405184526,0.596960812,48.7889776,1,0.199576819,0.985243691,0.202565945,0.83947431,0.90380464,123.2347489,1,-0.473241216,0.573063379,-0.825809558,0.408912131,0.551095104,203.0017788,1,0.519097821,0.360117164,1.441469257,0.149452156,0.265660654,145.6072488,1,0.332768189,0.574226851,0.579506494,0.562247466,0.679879117,N,-, Effector probability:0.801,GTP-binding ypt5,P:small GTPase mediated signal transduction; P:protein localization to endosome; C:late endosome; P:endocytosis; P:protein targeting to vacuole; C:plasma membrane; P:Golgi to endosome transport; F:GTP binding; C:endocytic vesicle; C:early endosome; F:GTPase activity; C:cytosol; P:multivesicular body assembly; P:late endosome to vacuole transport via multivesicular body sorting pathway,PR00449 (PRINTS); SM00174 (SMART); SM00176 (SMART); SM00173 (SMART); SM00175 (SMART); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); PTHR24073:SF569 (PANTHER); PTHR24073 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_01597,2218,2824,2294,0,0,9,0,0,0,0,0,2,0,3,1,0,2,6,63.89225381,1,0.79500682,0.613453998,1.295951811,0.194992088,0.356749372,9.424259352,0,0.229175138,1.229825176,0.186347737,0.852172075,0.912278496,37.40997796,1,-0.602667584,1.041504534,-0.578650946,0.562824721,0.687919531,49.83202573,1,-0.123687724,0.759318583,-0.162893055,0.870602639,0.920418891,75.91371759,1,1.153794678,0.56455705,2.043716712,0.040981541,0.095939446,N,-,,phosphoinositide phosphatase,"F:phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; C:integral component of Golgi membrane; C:integral component of endoplasmic reticulum membrane; P:phosphatidylinositol-3-phosphate biosynthetic process; C:SPOTS complex; C:Golgi medial cisterna; P:phosphatidylinositol dephosphorylation",IPR002013 (PFAM); PTHR11200 (PANTHER); PTHR11200 (PANTHER); PTHR11200:SF170 (PANTHER); PTHR11200:SF170 (PANTHER); IPR002013 (PROSITE_PROFILES),,
RL4_JR_01598,3393,2914,2629,0,0,11,0,0,0,1,0,1,2,2,0,0,0,0,77.79993652,1,0.715163388,0.669440036,1.068300891,0.285384806,0.469105229,11.50514823,0,-0.058646444,1.226514859,-0.047815519,0.961863269,0.979638423,47.26802032,1,-0.877926695,1.037254279,-0.846394865,0.397332502,0.539511107,60.89891274,1,-0.392334733,0.752764507,-0.52119186,0.602233124,0.723726266,29.12136103,0,-2.777819263,1.192780867,-2.328859677,0.019866501,0.054320367,N,-,,upf0183 domain containing,C:membrane; C:integral component of membrane,PTHR38426 (PANTHER); PTHR38426:SF1 (PANTHER); PTHR38426 (PANTHER); PTHR38426:SF1 (PANTHER); PTHR38426:SF1 (PANTHER),1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_01599,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_01600,1135,1252,1650,1,0,7,0,0,0,0,0,0,0,0,0,0,0,2,52.93342751,1,1.567967928,0.581416549,2.6968065,0.007000794,0.028620751,5.119597728,0,1.109426452,1.244643539,0.891360793,0.372735644,0.537287125,13.33575754,0,-1.548331439,1.200836954,-1.289376908,0.197267085,0.322430089,15.38816099,0,-1.971016464,1.200094594,-1.642384254,0.100510396,0.196498892,27.93390388,1,0.058553196,0.987718508,0.059281258,0.952728089,0.969095027,N,-,,upf0183 domain containing,C:membrane,IPR005373 (PFAM); PTHR13465 (PANTHER),,
RL4_JR_01601,1527,1717,1168,0,0,7,0,0,0,0,0,1,1,4,8,0,0,0,44.49851647,1,1.193505129,0.656378415,1.818318673,0.06901544,0.169179075,5.703605084,0,0.95371271,1.267986722,0.752147237,0.451962519,0.6117842,21.21680737,1,-0.72861769,1.208059895,-0.603130435,0.546421921,0.67364534,119.4154625,1,2.40920416,0.533146151,4.518843766,6.22E-06,9.34E-05,14.41051534,0,-1.762821908,1.207607404,-1.459764078,0.144354924,0.251738479,N,-,,kinesin-ii 85 kda subunit,"F:ATP binding; P:chromosome segregation; C:kinesin complex; F:ATP-dependent microtubule motor activity, plus-end-directed; P:microtubule-based movement; F:microtubule binding; P:mitotic spindle assembly",IPR001752 (PRINTS); IPR001752 (SMART); IPR025901 (PFAM); IPR001752 (G3DSA:3.40.850.GENE3D); IPR001752 (PFAM); PTHR24115:SF105 (PANTHER); IPR027640 (PANTHER); IPR001752 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_01602,922,746,1810,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,13.78388121,0,-1.88732787,1.262863095,-1.494483351,0.13504933,0.274158395,4.343836849,0,1.346434933,1.317234699,1.02216783,0.306701474,0.468310804,11.38686378,0,-1.320441653,1.247174607,-1.058746422,0.28971528,0.42932192,17.15479638,1,-0.800262943,1.204171233,-0.664575702,0.506321914,0.642402915,11.3653737,0,-1.42035238,1.266048997,-1.121877893,0.261914362,0.393805006,N,-,,folylpolyglutamate synthase,P:biosynthetic process; P:cellular metabolic process,IPR013221 (G3DSA:3.40.1190.GENE3D); IPR004101 (G3DSA:3.90.190.GENE3D); IPR001645 (TIGRFAM); IPR023600 (PTHR11136:PANTHER); IPR001645 (PANTHER); IPR013221 (SUPERFAMILY); IPR004101 (SUPERFAMILY),,
RL4_JR_01603,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.024094941,0,7.272891949,3.950815046,1.840858624,0.065642279,NA,0.008022181,0,10.42999603,3.949140144,2.641080247,0.008264214,0.029217138,0.020227658,0,7.819061054,2.683739719,2.913494553,0.003574081,0.015397444,0.02329308,0,7.397610863,3.950316172,1.872662982,0.061114938,0.137968506,0.019339019,0,7.770086347,1.582891173,4.908793781,9.16E-07,1.34E-05,,,,,,,,
RL4_JR_01604,1779,1651,2161,0,2,1,0,0,0,0,0,0,1,0,1,0,0,5,42.16511483,1,-0.266042227,0.850260391,-0.312895003,0.754360434,0.871311401,7.110842133,0,0.635461439,1.224059281,0.519142699,0.603661234,0.737686709,18.4788931,0,-2.01890845,1.192267174,-1.693335599,0.090391606,0.179647549,40.26691158,1,-0.698654613,1.013221409,-0.68953795,0.4904848,0.630143205,55.0825754,1,0.878777378,0.683434865,1.285824623,0.198504275,0.320142686,N,-,,myosin-crossreactive antigen,F:catalytic activity; C:membrane; P:single-organism metabolic process,IPR023753 (G3DSA:3.50.50.GENE3D); IPR010354 (PFAM); PTHR37417:SF2 (PANTHER); PTHR37417 (PANTHER); PTHR37417:SF2 (PANTHER); PTHR37417 (PANTHER); PTHR37417 (PANTHER); PTHR37417:SF2 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_01605,1019,1527,1319,0,0,1,0,0,0,2,1,0,0,1,3,0,5,0,19.38409185,1,-1.116433104,1.166062189,-0.957438732,0.338345857,0.528272823,4.946813139,0,1.159033719,1.262726358,0.91788194,0.358680678,0.522684397,42.83194701,1,0.927776993,0.867363127,1.069652333,0.284775829,0.424168089,47.74258568,1,0.839998659,0.767531766,1.094415496,0.273772791,0.415834009,31.96775723,1,1.32137017,0.72350806,1.82633787,0.067799384,0.141569141,N,-,,d-isomer specific 2-hydroxyacid dehydrogenase,F:NAD binding; P:oxidation-reduction process,IPR016040 (G3DSA:3.40.50.GENE3D); IPR006140 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10996 (PANTHER); PTHR10996:SF127 (PANTHER); PTHR10996:SF127 (PANTHER); PTHR10996 (PANTHER); SSF52283 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_01606,3315,3013,3422,0,13,15,0,0,0,0,10,32,6,4,8,0,4,0,200.3973129,1,2.118407931,0.464529121,4.560333974,5.11E-06,6.39E-05,12.45931009,0,-0.173626252,1.206427677,-0.143917663,0.885565488,0.935081772,318.6854021,1,3.172160447,1.149557337,2.759462573,0.005789652,0.021191047,186.2575662,1,1.71882468,0.393151631,4.371912878,1.23E-05,0.000169663,47.25668741,1,-0.290121041,0.742013369,-0.390991663,0.695803398,0.784959266,N,-,,xylitol dehydrogenase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR013154 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR013149 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR11695:SF611 (PANTHER); IPR002085 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_01607,1752,1712,1080,7,4,14,0,0,0,0,4,28,3,1,0,0,8,1,174.2426722,1,3.076759624,0.442602911,6.951512399,3.61E-12,1.66E-10,5.894675232,0,0.906176807,1.283841813,0.705832134,0.480292536,0.637379431,228.5075122,1,3.842245859,1.271520465,3.021772724,0.002512992,0.011881961,49.44234399,1,0.61002248,0.789231426,0.772932324,0.439562434,0.581545752,53.06611308,1,1.915008958,0.594851189,3.219307606,0.001285006,0.005881863,N,-,,glycosyl hydrolase family 2,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR013781 (G3DSA:3.20.20.GENE3D); IPR013812 (G3DSA:2.60.40.GENE3D); IPR006102 (PFAM); IPR008979 (G3DSA:2.60.120.GENE3D); PTHR10066:SF68 (PANTHER); PTHR10066 (PANTHER); PTHR10066 (PANTHER); PTHR10066:SF68 (PANTHER); IPR006102 (SUPERFAMILY); IPR017853 (SUPERFAMILY); IPR008979 (SUPERFAMILY); IPR006102 (SUPERFAMILY),,
RL4_JR_01608,1736,1570,1931,0,0,5,0,0,0,0,1,4,2,0,0,0,2,0,40.01563662,1,0.547691795,0.663470627,0.825495166,0.409090526,0.600460689,6.676392241,0,0.726434834,1.225305284,0.59286028,0.553274662,0.699120747,51.16447457,1,1.213511505,0.6651328,1.824464985,0.068081805,0.143565965,38.61286037,1,-0.608083135,1.009509145,-0.602355251,0.54693769,0.676903082,24.8127822,1,-0.340186032,0.97525379,-0.348817954,0.727225983,0.808339344,N,-,,gtp-binding ypt4,F:GTP binding; C:nucleus; P:small GTPase mediated signal transduction; C:cytosol,PR00449 (PRINTS); SM00174 (SMART); SM00175 (SMART); SM00173 (SMART); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); PTHR24073:SF450 (PANTHER); PTHR24073:SF450 (PANTHER); PTHR24073 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_01609,264,364,185,0,0,6,0,0,0,0,0,2,0,0,2,0,0,0,26.20202168,1,3.365378742,0.769010846,4.376243537,1.21E-05,0.000136618,1.056304526,0,3.386640912,1.47055206,2.302972471,0.021280392,0.060437746,15.72017055,1,2.552510145,1.084641112,2.353322327,0.018606497,0.053017782,22.41066449,1,2.100110376,1.067587818,1.967154683,0.049165381,0.12177091,2.659956742,0,0.674914558,1.248870704,0.540419882,0.5889075,0.701162798,N,-, Effector probability:0.562,3-hydroxyacyl- dehydrogenase type-2,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); SM00822 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); IPR002347 (PANTHER); PTHR24322:SF424 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_01610,75,95,125,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.180324679,0,1.658476891,1.449331839,1.144304462,0.252497393,NA,0.373380831,0,4.886657726,1.634790525,2.989164453,0.002797415,0.015349618,0.974220103,0,2.22629712,1.254855735,1.77414587,0.076039025,0.156792172,1.124285307,0,1.803597163,1.299076886,1.388368297,0.165024925,0.285473666,0.965962701,0,2.136573742,1.242993572,1.718893637,0.085633741,0.170008162,N,-,,phd transcription factor,C:membrane,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); IPR011009 (SUPERFAMILY),,
RL4_JR_01611,737,663,741,0,0,1,0,0,0,0,0,0,3,0,0,0,0,0,12.38050375,1,-0.25242913,1.137790909,-0.22185898,0.824423664,0.911334452,2.73769853,0,2.012569705,1.278455623,1.574219447,0.115436725,0.226795522,7.093767399,0,-0.637593,1.193034583,-0.534429604,0.593044341,0.712385016,36.11960622,1,1.265634901,0.842982986,1.501376566,0.133258192,0.243385249,6.985076756,0,-0.718087409,1.19284868,-0.601993716,0.54717832,0.667893972,N,-,,Transcriptional regulatory moc3,"C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR021858 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_01612,178,185,152,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5.887149232,1,1.796043631,1.162140348,1.545461902,0.122234577,0.25575524,0.663060763,0,4.058409877,1.491884347,2.720324725,0.006521784,0.024659505,1.713629226,0,1.412321591,1.224211059,1.153658579,0.248640172,0.383230004,1.976483401,0,0.990171243,1.237401452,0.800202102,0.423593712,0.566562905,1.681368963,0,1.336636214,1.209251559,1.105341733,0.269011541,0.401397019,N,-,,aaa family ATPase,C:nucleus; F:DNA binding; F:ATP binding,IPR000641 (PRINTS); IPR003593 (SMART); IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PF13087 (PFAM); PF13086 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10887:SF368 (PANTHER); PTHR10887:SF368 (PANTHER); PTHR10887:SF368 (PANTHER); PTHR10887 (PANTHER); PTHR10887 (PANTHER); PTHR10887 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.24.5.1, the type vii or esx protein secretion system (t7ss) family.
RL4_JR_01613,0,0,1,0,0,2,0,0,0,0,3,0,1,73,8,0,9,3,7.640987839,1,11.20809083,2.995014191,3.742249658,0.00018238,0.001420856,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,23.53206219,1,12.7003739,3.576970922,3.550594672,0.000384362,0.002809588,379.244145,1,16.50816883,1.94818469,8.473615934,2.38E-17,1.81E-15,56.84456787,1,14.3936871,1.289018709,11.16639114,5.96E-29,2.74E-26,Y,-,,hypothetical protein GE21DRAFT_9447,,IPR027589 (TIGRFAM); PTHR38787:SF3 (PANTHER); PTHR38787 (PANTHER),,
RL4_JR_01614,58,22,36,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.459410481,0,3.019620637,2.148740533,1.405297937,0.159932702,NA,0.148964084,0,6.212566996,2.01337828,3.085643199,0.002031124,0.015023052,0.383309603,0,3.572049574,1.364061741,2.61868614,0.008826912,0.029659362,0.441907259,0,3.15079746,1.557508482,2.022972906,0.043075941,0.113019928,0.375496992,0,3.498007955,1.299260399,2.692307068,0.007095958,0.023877226,N,-,,---NA---,,IPR025676 (PFAM),,
RL4_JR_01615,19,20,1,0,0,11,0,0,2,6,6,5,2,8,4,0,11,0,42.16689598,1,8.119901129,1.992118698,4.076012709,4.58E-05,0.000434094,18.81046848,1,9.231859056,1.349167148,6.842635526,7.77E-12,1.79E-09,146.1068591,1,10.04442392,0.750759916,13.37900932,8.02E-41,3.69E-38,89.41451403,1,9.174471889,0.838435331,10.94237272,7.23E-28,1.06E-25,42.59611115,1,8.502939632,1.939294146,4.384553859,1.16E-05,0.000114694,Y,-,,hypothetical protein ASPCAL08112,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_01616,145,239,183,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,9.92580011,1,2.410062498,1.066393331,2.260012726,0.023820461,0.075790687,0.72753716,0,3.924478861,1.49508523,2.624919826,0.008666937,0.030230354,1.888459445,0,1.272091621,1.244452781,1.022209633,0.306681692,0.448232616,2.178863853,0,0.849495677,1.2625153,0.672859708,0.501036547,0.63867258,1.859283887,0,1.191806077,1.236691544,0.963705205,0.335193744,0.47221882,N,-,,Ankyrin repeat-containing domain,,IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24188:SF41 (PANTHER); PTHR24188 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),8.A.28.1.2, the ankyrin (ankyrin) family.
RL4_JR_01617,258,478,368,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,4.460152282,0,-0.259196822,1.270904175,-0.203946786,0.838395083,0.918937779,1.414672179,0,2.965078502,1.400022409,2.117879316,0.03418529,0.087645264,3.676678357,0,0.310751448,1.241353121,0.250332836,0.802329965,0.869979206,13.55472297,1,0.842147287,1.181580111,0.712729741,0.476013009,0.61687338,3.623873279,0,0.22887297,1.242612531,0.184186917,0.853866823,0.902725445,N,-,,ferric reductase transmembrane,F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process,IPR013130 (PFAM); PTHR11972:SF84 (PANTHER); PTHR11972 (PANTHER),,
RL4_JR_01618,1407,1038,822,0,0,2,0,0,0,1,0,0,0,5,0,0,0,0,20.71866227,1,-0.099857073,1.050640224,-0.095044023,0.92427986,0.963490302,4.229566807,0,1.385081593,1.301725345,1.064035204,0.287312752,0.446854501,21.94687314,1,-0.292329736,1.216205753,-0.240362073,0.810049578,0.876063661,32.59877971,1,1.310146308,0.741977965,1.76574827,0.077438091,0.162668188,10.62448825,0,-1.323177425,1.217245197,-1.087026203,0.27702523,0.41019018,N,-,,early growth response 1 (egr-1),F:binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); PF12874 (PFAM); IPR007219 (PFAM); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_01619,2,8,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.076616038,0,5.603946684,3.920671738,1.429333303,0.152908459,NA,0.023897092,0,8.851825101,2.889477277,3.063469359,0.002187866,0.015045494,0.062824072,0,6.181124832,1.71601513,3.602022339,0.000315751,0.002419883,0.072542559,0,5.757737579,2.768280125,2.079897019,0.03753498,0.102992322,0.062662934,0,6.087041146,1.410312281,4.316094546,1.59E-05,0.000148066,N,-,,gibberellin 3-beta hydroxylase,F:iron ion binding; F:oxidoreductase activity; P:oxidation-reduction process,PR00682 (PRINTS); IPR005123 (PFAM); IPR026992 (PFAM); IPR027443 (G3DSA:2.60.120.GENE3D); PTHR10209 (PANTHER); PTHR10209:SF172 (PANTHER); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_01620,351,553,470,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,28.44815854,1,2.661225028,0.698504491,3.809889645,0.000139029,0.001131933,1.75844366,0,2.651238354,1.350281493,1.963470852,0.049591488,0.11703545,4.56885947,0,-0.002715387,1.222502795,-0.002221171,0.998227764,0.999245831,5.271675234,0,-0.425311041,1.225100003,-0.347164345,0.728467855,0.819065026,4.504325202,0,-0.084929085,1.224328958,-0.069367864,0.944696808,0.964846347,N,-,,Major facilitator superfamily general substrate transporter,,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF165 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_01621,6,14,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.117652744,0,4.985195211,3.771049223,1.321965033,0.186179795,NA,0.03727945,0,8.21120441,2.587000481,3.174025081,0.001503407,0.015023052,0.096861148,0,5.558533868,1.521544025,3.653219214,0.000258973,0.002079177,0.111770093,0,5.134610101,2.278793994,2.253213812,0.024245671,0.084186358,0.095361094,0,5.480205274,1.324666427,4.137045494,3.52E-05,0.000287046,N,-,,"2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase",F:lyase activity,IPR005000 (PFAM); IPR015813 (G3DSA:3.20.20.GENE3D); PTHR30502:SF2 (PANTHER); PTHR30502 (PANTHER); IPR015813 (SUPERFAMILY),,
RL4_JR_01622,431,926,484,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,7.483456636,0,-1.005851814,1.288514245,-0.780629177,0.435020626,0.625797614,2.381464162,0,2.213737233,1.389188208,1.593547383,0.111037448,0.219816359,6.167448093,0,-0.435520655,1.261133955,-0.345340519,0.729838388,0.817716229,11.12701827,1,0.084705526,1.214613397,0.069738673,0.94440166,0.967428856,6.049321748,0,-0.510459806,1.264601439,-0.403652716,0.686468114,0.777807706,N,-, Effector probability:0.702,translation initiation inhibitor,P:biological_process; C:cellular_component; F:molecular_function,IPR013813 (G3DSA:3.30.1330.GENE3D); IPR006175 (PFAM); IPR006175 (PANTHER); PTHR11803:SF12 (PANTHER); IPR013813 (SUPERFAMILY),,
RL4_JR_01623,116,119,176,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.640004591,0,1.183863356,1.339425237,0.883859228,0.376772209,NA,0.519830599,0,4.409264931,1.542993142,2.857605009,0.004268514,0.018605318,1.355384819,0,1.749805451,1.23901129,1.412259489,0.15787357,0.272284842,1.564042795,0,1.327215362,1.26387208,1.050118428,0.293663667,0.438191544,1.343694819,0,1.660181952,1.234246364,1.345097706,0.178593684,0.295805832,N,-,,hypothetical protein VE00_04976,F:metal ion binding,no IPS match,,
RL4_JR_01624,8082,19380,13545,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,170.0251361,1,-4.537249417,1.233361652,-3.678766409,0.000234365,0.00176379,52.57482129,0,-2.250781127,1.247855207,-1.803719787,0.071275246,0.1560225,136.78401,0,-4.906761183,1.244836968,-3.941689804,8.09E-05,0.001022632,161.8610436,1,-4.38653807,1.207945588,-3.631403695,0.000281884,0.002578206,134.8739205,0,-4.989244869,1.257631576,-3.967175254,7.27E-05,0.000534084,N,PKS,,polyketide synthase,F:catalytic activity; P:metabolic process; F:binding,IPR020841 (SMART); IPR020807 (SMART); SM00822 (SMART); IPR020801 (SMART); IPR020843 (SMART); IPR020806 (SMART); PF13602 (PFAM); IPR014043 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013154 (PFAM); IPR009081 (PFAM); IPR001227 (G3DSA:3.40.366.GENE3D); IPR014031 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR014030 (PFAM); IPR020807 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR013968 (PFAM); G3DSA:3.30.70.250 (GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR032821 (PFAM); PTHR11712:SF262 (PANTHER); PTHR11712 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR009081 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016035 (SUPERFAMILY); IPR016036 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_01625,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein BN1723_002880,,no IPS match,,
RL4_JR_01626,1562,5015,3736,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,45.65636531,1,-2.548729578,1.261127796,-2.020992311,0.043280561,0.119567496,22.54600106,1,0.656631147,1.213086374,0.54128969,0.588307926,0.725759028,34.36500206,0,-2.913868032,1.272068769,-2.290652915,0.021983496,0.059924855,39.66568574,0,-3.336987636,1.284566077,-2.597754756,0.009383549,0.04618786,33.98602328,0,-3.000634942,1.287027195,-2.331446417,0.019729832,0.054052085,N,-,,duf341 domain containing,,IPR029058 (G3DSA:3.40.50.GENE3D); IPR005645 (PFAM); PTHR22778:SF4 (PANTHER); PTHR22778 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_01627,5,17,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.161373532,0,4.529252357,3.377273428,1.341097324,0.179888856,NA,0.050469752,0,7.773565238,2.497398084,3.112665653,0.001854059,0.015023052,0.132431236,0,5.105550158,1.539968643,3.315359817,0.000915252,0.005349893,0.152900195,0,4.682131806,2.137384789,2.190589093,0.028481541,0.089620303,0.131830515,0,5.012003009,1.378788591,3.635077228,0.000277897,0.001645445,N,-,,Levodione reductase,F:ligase activity,IPR002347 (PRINTS); IPR002347 (PRINTS); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_01628,10,3,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.117727378,0,4.983750576,3.870497591,1.287625288,0.197876432,NA,0.037219451,0,8.212290274,2.682988304,3.060874422,0.002206916,0.015045494,0.09758043,0,5.54344128,1.641404961,3.377253884,0.000732134,0.004492199,0.112619063,0,5.122416207,2.40962034,2.125818795,0.03351835,0.098116602,0.097607285,0,5.442195618,1.426985546,3.813770667,0.000136862,0.000903346,N,-,,FAD binding domain-containing,F:FAD binding; F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789 (PANTHER); PTHR13789:SF234 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_01629,25,16,31,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.28569908,0,3.704929162,2.566790929,1.443409013,0.148905287,NA,0.09101506,0,6.92299816,2.150200394,3.219699047,0.001283252,0.015023052,0.236823503,0,4.265752686,1.355070327,3.147993578,0.001643953,0.008489044,0.273228003,0,3.844177594,1.666288012,2.307030697,0.021053109,0.078592508,0.234565091,0,4.177591784,1.273733141,3.279801435,0.001038802,0.00492871,N,-, Effector probability:0.826,Outer membrane beta- partial,C:integral component of membrane,IPR011250 (G3DSA:2.40.160.GENE3D); IPR020915 (PFAM),,
RL4_JR_01630,9,9,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.127593849,0,4.867899316,3.603580028,1.350850898,0.1767432,NA,0.040422295,0,8.093793189,2.505797916,3.230026307,0.001237788,0.015023052,0.105449232,0,5.432996033,1.45271148,3.739900253,0.000184093,0.00167886,0.121685706,0,5.011250545,2.155189877,2.325201412,0.020061193,0.076851902,0.104609492,0,5.344032248,1.290940772,4.139641696,3.48E-05,0.000284921,N,-,,Flavin-binding monooxygenase-like family,,IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); PF13738 (PFAM); PTHR23023:SF130 (PANTHER); PTHR23023 (PANTHER); PTHR23023 (PANTHER); PTHR23023:SF130 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_01631,2,8,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.088256198,0,5.39977459,3.91883937,1.377901486,0.168233706,NA,0.02739899,0,8.654205265,2.846885473,3.039885288,0.002366683,0.015214845,0.072338659,0,5.976806514,1.719735303,3.475422354,0.00051005,0.003430075,0.083546134,0,5.553749136,2.676566635,2.074952689,0.03799092,0.103765326,0.072534576,0,5.874851281,1.442049431,4.07395971,4.62E-05,0.000364189,N,-,,flavin-containing monooxygenase 1,"F:NADP binding; F:oxidoreductase activity; F:flavin adenine dinucleotide binding; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity",no IPS match,,
RL4_JR_01632,226,244,170,0,3,2,4,0,0,0,0,1,0,0,0,0,2,0,34.24330205,1,3.5921761,0.699988606,5.131763676,2.87E-07,5.04E-06,90.07481708,1,6.676576427,1.219829693,5.473367688,4.42E-08,5.73E-06,8.633014055,1,2.057698384,1.212106678,1.697621522,0.089579218,0.178172889,2.461448278,0,0.673637652,1.244356879,0.541354063,0.588263564,0.713057414,9.8106309,1,2.684911416,0.996909139,2.693235835,0.00707622,0.023826646,N,PKS,,lovastatin nonaketide synthase,P:metabolic process; F:transferase activity,IPR020843 (SMART); SM00822 (SMART); IPR020841 (SMART); IPR020807 (SMART); IPR020801 (SMART); IPR016039 (G3DSA:3.40.47.GENE3D); IPR032821 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR014031 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR013968 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR020807 (PFAM); IPR001227 (G3DSA:3.40.366.GENE3D); G3DSA:3.30.70.250 (GENE3D); IPR014030 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR014043 (PFAM); PTHR11712 (PANTHER); PTHR11712:SF262 (PANTHER); IPR011032 (SUPERFAMILY); IPR016035 (SUPERFAMILY); IPR016036 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_01633,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_01634,104,223,228,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,2.23538106,0,0.737278579,1.38453794,0.532508758,0.594373678,0.764981461,154.0472339,1,7.574184841,1.781424043,4.251758514,2.12E-05,0.001226778,1.839380356,0,1.309769261,1.278839129,1.024186101,0.305747383,0.447374837,2.123089671,0,0.88667142,1.308071947,0.677846063,0.497869301,0.636125922,1.82416261,0,1.219272969,1.278570512,0.953622,0.340275015,0.477583106,N,-,,WW domain-containing oxidoreductase,,IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24320 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_01635,109,67,113,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.14797619,0,1.698352822,1.453366284,1.168564897,0.242578978,NA,0.36725979,0,4.910566676,1.652327105,2.971909535,0.002959539,0.01548137,0.952740891,0,2.258274537,1.259243074,1.793358712,0.072915585,0.151859584,1.098999578,0,1.836266391,1.305861742,1.406172133,0.159673017,0.278613464,0.940567458,0,2.174249,1.241518766,1.751281624,0.079897411,0.161115573,Y,-,,glucose-methanol-choline (gmc) oxidoreductase,,IPR007867 (PFAM); IPR000172 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR012132 (PIRSF); PTHR11552:SF117 (PANTHER); PTHR11552 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_01636,11,3,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.098353072,0,5.243145962,3.917598848,1.338357031,0.180780079,NA,0.031551178,0,8.451184393,2.726779363,3.09932828,0.0019396,0.015023052,0.081881992,0,5.797076967,1.622078163,3.573857968,0.00035176,0.002628851,0.094443377,0,5.376573698,2.493132782,2.156553288,0.031040488,0.094217518,0.081028862,0,5.708804855,1.375855323,4.149277005,3.34E-05,0.000275221,N,-,,Fungal transcriptional regulatory,"F:DNA binding; C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_01637,5,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.064342987,0,5.855762012,3.923318221,1.492553416,0.135554125,NA,0.020554377,0,9.070196174,2.852854508,3.179340604,0.001476105,0.015023052,0.053225458,0,6.421776604,1.600568976,4.012183604,6.02E-05,0.000835469,0.061398288,0,5.998628035,2.778711143,2.158780718,0.030867183,0.094078937,0.05231576,0,6.344295436,1.321605892,4.800444275,1.58E-06,2.11E-05,N,-,,Pc21g03980,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_01638,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.004235441,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001340044,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003452355,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003983613,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003339785,0,10.24113992,1.835951848,5.578109216,2.43E-08,8.07E-07,N,-,,pantothenate transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF197 (PANTHER); PTHR11662 (PANTHER); PTHR11662 (PANTHER); PTHR11662:SF197 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_01639,6,2,3,0,0,7,0,0,0,0,0,0,1,4,7,0,2,0,26.77342438,1,9.784045329,0.876612264,11.1612006,6.31E-29,2.83E-26,0.014195125,0,9.604540656,3.132499733,3.066094645,0.002168747,0.015045494,0.036403719,0,6.968265222,1.810711529,3.848357461,0.000118912,0.001291706,92.84757042,1,10.95073991,0.722110591,15.16490694,6.04E-52,3.22E-49,7.756611753,1,8.542664747,1.110021283,7.695946808,1.40E-14,1.92E-12,N,-,,"naringenin,2-oxoglutarate 3-dioxygenase",F:iron ion binding; F:naringenin 3-dioxygenase activity; P:oxidation-reduction process,PR00682 (PRINTS); IPR027443 (G3DSA:2.60.120.GENE3D); IPR026992 (PFAM); IPR005123 (PFAM); PTHR10209:SF161 (PANTHER); PTHR10209 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_01640,438,535,510,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,17.41128434,1,1.619777535,0.86454798,1.873554241,0.06099189,0.154238016,1.897205346,0,2.541662374,1.31776284,1.928770715,0.053759333,0.124948787,4.923352386,0,-0.110544937,1.203290682,-0.091868855,0.926802237,0.956468279,5.680021819,0,-0.532958606,1.202266427,-0.443294925,0.657552426,0.766683654,4.851173977,0,-0.191971861,1.203484587,-0.159513352,0.873264439,0.916059102,N,-,,stress responsive a b barrel domain containing,,IPR013097 (PFAM); G3DSA:3.30.70.900 (GENE3D); PTHR33178 (PANTHER); PTHR33178:SF2 (PANTHER); IPR013097 (PROSITE_PROFILES); IPR011008 (SUPERFAMILY),,
RL4_JR_01641,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.011995548,0,8.278788502,3.994728753,2.072428196,0.038225526,NA,0.003674643,0,11.54805534,3.998155187,2.888345949,0.003872737,0.017716233,0.009795413,0,8.859139625,3.047426446,2.90708891,0.003648095,0.015596838,0.01131933,0,8.43600951,3.995699254,2.111272389,0.034748906,0.099426657,0.00992088,0,8.755100215,1.62018887,5.403752846,6.53E-08,1.59E-06,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662:SF242 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_01642,3,2,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.066749566,0,5.802155369,3.922715664,1.479116986,0.139109051,NA,0.020694248,0,9.05786878,3.018679514,3.000606305,0.002694427,0.015349618,0.054955269,0,6.370280017,1.834276801,3.472910967,0.000514846,0.003454143,0.063475916,0,5.949263782,2.971176422,2.002325994,0.045249682,0.115278131,0.055660727,0,6.254485493,1.504905655,4.15606485,3.24E-05,0.000268141,N,-,,aminoglycoside phosphotransferase,,IPR015897 (SMART); G3DSA:3.90.1200.10 (GENE3D); IPR004119 (PFAM); PTHR11012 (PANTHER); IPR011009 (SUPERFAMILY),1.C.59.5.2, the clostridium perfringens enterotoxin (cpe) family
RL4_JR_01643,2,1,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.039207844,0,6.569353028,3.933873566,1.669945136,0.094930219,NA,0.012182185,0,9.821597089,3.332887603,2.94687318,0.003210048,0.016148008,0.032314532,0,7.135166909,2.005530639,3.557745152,0.000374052,0.002756115,0.037321548,0,6.715291015,3.602986518,1.863812418,0.062348051,0.139855449,0.032703342,0,7.02168735,1.510462425,4.648700447,3.34E-06,4.04E-05,N,-,,Integral membrane,C:integral component of membrane,no IPS match,,
RL4_JR_01644,1,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.019781616,0,7.556258757,3.960309894,1.907996838,0.056391625,NA,0.006177465,0,10.80099648,3.666590793,2.94578727,0.003221339,0.016157775,0.016297679,0,8.122821537,2.181397604,3.723677664,0.000196342,0.001734522,0.018818652,0,7.703057059,3.960515312,1.944963332,0.051779392,0.125559168,0.01637629,0,8.021846978,1.492011636,5.376531112,7.59E-08,1.81E-06,N,-, Effector probability:0.925,translation initiation,,IPR013813 (G3DSA:3.30.1330.GENE3D); IPR006175 (PANTHER); PTHR11803:SF12 (PANTHER); IPR013813 (SUPERFAMILY),,
RL4_JR_01645,2,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.023332243,0,7.316962966,3.952173502,1.85137696,0.064115341,NA,0.007340243,0,10.55232229,3.952867338,2.669536159,0.007595609,0.02755073,0.019347591,0,7.876007851,2.682888507,2.935644858,0.003328552,0.014638686,0.02233436,0,7.455347274,3.952084161,1.88643434,0.059236449,0.135865506,0.019491914,0,7.764036527,1.587461179,4.890851273,1.00E-06,1.45E-05,N,-,,Pre-mRNA-splicing factor SLU7,C:membrane; C:integral component of membrane,PTHR35896 (PANTHER); PTHR35896:SF3 (PANTHER),,
RL4_JR_01646,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.01164016,0,8.317974459,3.997123045,2.080990344,0.03743479,NA,0.003501898,0,11.6103591,4.002138943,2.901038485,0.003719282,0.017380689,0.009514587,0,8.898423346,3.998182413,2.22561715,0.026039836,0.068649449,0.011003575,0,8.472850999,3.997973129,2.11928663,0.034066251,0.0989162,0.009871642,0,8.75387984,1.939189559,4.514195015,6.36E-06,6.91E-05,Y,-,,hypothetical protein CFIO01_12333,C:membrane,PTHR35896 (PANTHER); PTHR35896:SF3 (PANTHER),,
RL4_JR_01647,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.027316142,0,7.090035941,3.945597266,1.796948716,0.072343762,NA,0.009180438,0,10.23403782,3.943784179,2.594979177,0.009459665,0.032349004,0.023155952,0,7.621026569,2.772153144,2.749136204,0.005975255,0.021690026,0.026656637,0,7.201741858,3.94481403,1.825622654,0.067907121,0.147894085,0.022279721,0,7.563746413,1.77582487,4.259286229,2.05E-05,0.000183431,Y,-,,---NA---,,no IPS match,,
RL4_JR_01648,61,90,76,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.914340653,0,2.027026529,1.557556391,1.301414537,0.1931166,NA,0.290785624,0,5.247535003,1.712266429,3.064672013,0.002179088,0.015045494,0.754923085,0,2.595011053,1.261858531,2.056499196,0.039734424,0.095167094,0.871001698,0,2.172319254,1.324268841,1.640391427,0.100923807,0.197078793,0.743718877,0,2.514069992,1.235695864,2.034537839,0.041897397,0.097579916,N,-,,ankyrin repeat-containing,,IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); PTHR24198 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),8.A.28.1.2, the ankyrin (ankyrin) family.
RL4_JR_01649,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.012376897,0,8.237661038,3.992283311,2.063395906,0.039075029,NA,0.004015611,0,11.43115744,3.991119401,2.864148198,0.004181323,0.018371529,0.010235446,0,8.805715205,3.038577053,2.897973312,0.003755825,0.015764501,0.01179869,0,8.381441139,3.992433907,2.099331219,0.035787713,0.10034633,0.009844433,0,8.758432769,1.618956569,5.409924478,6.31E-08,1.56E-06,N,-, Effector probability:0.611,hypothetical protein CFIO01_12336,C:membrane,IPR021765 (PFAM); PTHR33365 (PANTHER); PTHR33365:SF3 (PANTHER),,
RL4_JR_01650,251,520,415,0,0,5,0,0,0,0,0,0,0,1,0,0,0,0,23.88583068,1,2.577962847,0.810752512,3.17971614,0.001474194,0.008109557,1.516468434,0,2.864809592,1.40578397,2.037873281,0.041562607,0.102210085,3.947423954,0,0.208194064,1.250983977,0.166424245,0.867823095,0.916146091,8.566925606,1,0.729032182,1.199141854,0.607961585,0.543212952,0.673940833,3.896645957,0,0.124153073,1.255043814,0.098923298,0.921199171,0.949617349,N,-,,OPT superfamily oligopeptide transporter,C:membrane,IPR004813 (TIGRFAM); IPR004813 (PFAM); PTHR22601 (PANTHER); PTHR22601:SF25 (PANTHER),2.A.67.1.3, the oligopeptide transporter (opt) family.
RL4_JR_01651,2673,3545,2929,0,1,1,0,0,0,0,0,0,2,5,0,0,2,0,48.64877236,1,-1.568993535,1.02606255,-1.529140242,0.126229681,0.261631539,11.7393292,0,-0.087732484,1.223638242,-0.071698056,0.942842203,0.969161923,30.43106595,0,-2.73843868,1.199252864,-2.283453942,0.022403643,0.060938872,73.78904129,1,0.358538885,0.598838198,0.59872414,0.549356857,0.678750073,37.65830037,1,-1.152375198,0.985476224,-1.169358702,0.242259141,0.371647547,N,-,,tam domain-containingmethyltransferase,F:methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108:SF818 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY); IPR029063 (SUPERFAMILY),,
RL4_JR_01652,293,357,448,0,0,1,0,0,0,0,0,1,0,0,0,0,2,0,8.213332586,1,0.707874378,1.167930856,0.60609271,0.544453191,0.725048831,1.392654086,0,2.987602999,1.359801256,2.197087984,0.028014163,0.075015703,10.12797459,1,1.290897476,1.20536146,1.070962959,0.284186085,0.423476586,4.187969245,0,-0.093562094,1.219450145,-0.076724821,0.938842459,0.963977274,11.3148446,1,1.899732912,1.005023443,1.890237413,0.058726215,0.126479533,N,-,,O-methyltransferase B,F:O-methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); IPR001077 (PFAM); IPR016461 (PIRSF); PTHR11746:SF87 (PANTHER); PTHR11746 (PANTHER); IPR016461 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY); IPR029063 (SUPERFAMILY),,
RL4_JR_01653,1152,1651,1187,0,0,4,0,0,0,0,0,0,0,1,0,0,4,4,31.37228115,1,0.570358584,0.796474668,0.71610386,0.473927221,0.663172945,5.136519688,0,1.104776354,1.269205457,0.870447214,0.384056054,0.548372885,13.30145157,0,-1.544418443,1.211225399,-1.275087564,0.202278251,0.327868237,19.35612738,1,-1.020893607,1.163895178,-0.877135353,0.380413125,0.52625808,57.96987089,1,2.002838065,0.581048962,3.446935105,0.000566985,0.00300404,N,-,,peptidoglycan binding domain-containing,C:cellular_component; F:molecular_function,IPR018712 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR33840 (PANTHER); PTHR33840:SF1 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_01654,2793,2332,1994,0,0,6,0,0,1,1,2,0,1,10,3,0,20,2,51.43469761,1,0.327719817,0.653290472,0.501644874,0.615917348,0.77932821,18.56125634,1,1.18180174,1.141065415,1.035700253,0.300342004,0.460406143,50.43358082,1,0.038531386,0.864152087,0.044588662,0.96443518,0.979233954,105.6387742,1,1.702531539,0.466525788,3.649383553,0.00026287,0.002421804,115.1308755,1,2.376894669,0.588184259,4.041071536,5.32E-05,0.000411241,N,-,,cellular morphogenesis,F:catalytic activity; C:integral component of membrane,IPR024982 (PFAM); PTHR31778 (PANTHER); PTHR31778:SF2 (PANTHER); IPR011043 (SUPERFAMILY); IPR011043 (SUPERFAMILY),,
RL4_JR_01655,4509,5009,7335,0,0,0,0,0,0,0,7,0,1,5,1,0,9,2,67.28773626,0,-4.174613385,1.214143827,-3.438318667,0.000585338,0.003823249,21.29629468,0,-0.947059217,1.211382441,-0.781800351,0.434331915,0.595705643,110.4750484,1,0.00631129,1.420817926,0.004442012,0.996455799,0.998625867,103.1392197,1,-0.515940805,0.615204651,-0.838649064,0.401666269,0.545522599,104.6113058,1,0.303098373,0.567110924,0.534460475,0.593022989,0.70465412,N,-,,nuclease domain containing,,IPR016071 (SMART); IPR016071 (G3DSA:2.40.50.GENE3D); IPR016071 (PFAM); PTHR12302 (PANTHER); IPR016071 (PROSITE_PROFILES); IPR016071 (SUPERFAMILY),,
RL4_JR_01656,3521,4066,4286,2,2,0,3,0,1,3,0,2,1,7,3,0,0,1,83.75526874,1,-0.919394795,0.745542805,-1.233188475,0.217505454,0.385308794,91.46828645,1,2.168996302,0.74049298,2.929124731,0.00339918,0.016509836,85.56539382,1,0.041683637,0.667642042,0.062434111,0.950217131,0.971422623,111.707632,1,0.649657225,0.471128704,1.378937898,0.167913902,0.289045478,46.1918186,1,-2.258156237,1.123108598,-2.010630354,0.044364515,0.102065603,N,-,,Arp2 3 complex,,IPR007188 (PFAM); G3DSA:3.30.1460.20 (GENE3D); G3DSA:3.30.1460.20 (GENE3D); IPR007188 (PANTHER); PTHR12058:SF0 (PANTHER); SSF69645 (SUPERFAMILY); SSF69645 (SUPERFAMILY),,
RL4_JR_01657,10794,18952,23583,0,2,2,0,0,0,0,1,0,0,2,0,0,7,0,237.5922608,1,-3.116248973,0.848137789,-3.674224889,0.000238573,0.001793802,67.34057078,0,-2.607898873,1.224827977,-2.129196036,0.033238045,0.085803491,184.0181339,1,-4.310085304,1.230923429,-3.501505618,0.000462637,0.003197322,211.376535,1,-3.995102129,1.077854347,-3.706532464,0.000210116,0.002003228,202.0818641,1,-2.096107273,0.776369649,-2.69988307,0.006936385,0.023425917,N,-,,wd domain-containing,"C:small-subunit processome; P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:snoRNA binding; P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:integral component of membrane; C:viral nucleocapsid; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:Pwp2p-containing subcomplex of 90S preribosome",IPR020472 (PRINTS); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR007148 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR19853:SF0 (PANTHER); PTHR19853 (PANTHER); PTHR19853 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); SSF117289 (SUPERFAMILY); IPR011047 (SUPERFAMILY),8.A.92.1.3,The G-Protein αβγ Complex (GPC) Family
RL4_JR_01658,1418,1636,2356,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.60931623,0,-2.535938405,1.213445068,-2.089866671,0.036629778,0.105704185,6.836240976,0,0.692241997,1.243147958,0.556846024,0.577632636,0.717046546,17.84315983,0,-1.968387016,1.208767874,-1.62842433,0.103434942,0.19862962,20.59168061,0,-2.39123858,1.209434851,-1.977153691,0.04802426,0.119764935,17.70419316,0,-2.05977828,1.220343988,-1.687866946,0.091436773,0.178392058,N,-,,flavin-binding monooxygenase,"F:NADP binding; F:flavin adenine dinucleotide binding; P:oxidation-reduction process; F:N,N-dimethylaniline monooxygenase activity",IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR020946 (PFAM); PTHR23023 (PANTHER); PTHR23023:SF136 (PANTHER); PTHR23023:SF136 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_01659,20344,22581,31529,8,15,56,0,0,2,6,8,6,10,33,24,0,44,6,711.9524766,1,0.548544645,0.421717141,1.300740691,0.193347229,0.354414215,112.9903218,1,-1.452911944,0.992181328,-1.464361305,0.143095255,0.266643993,413.8692916,1,-0.592167043,0.410157475,-1.443755335,0.14880781,0.260735595,740.2970692,1,0.66346011,0.361426435,1.835671236,0.066406295,0.145975626,457.6058017,1,-0.033437682,0.781059857,-0.042810652,0.965852473,0.977925629,N,-, Effector probability:0.599,atp synthase subunit 4,"C:mitochondrial proton-transporting ATP synthase, stator stalk; F:proton-transporting ATPase activity, rotational mechanism; P:protein complex oligomerization; P:ATP synthesis coupled proton transport",IPR008688 (PFAM); IPR013837 (PANTHER); PTHR12733:SF3 (PANTHER); SSF161060 (SUPERFAMILY),3.A.2.1.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_01660,5794,8244,13501,0,0,2,0,0,0,0,0,0,0,3,0,0,4,0,117.5701338,1,-3.193179275,1.10717981,-2.884065666,0.003925769,0.017762852,34.54505173,0,-1.644919519,1.235283047,-1.331613449,0.182987243,0.322401545,90.57831597,0,-4.312118501,1.233516874,-3.495792065,0.000472657,0.003248593,116.5949266,1,-2.480183601,0.945091241,-2.624279533,0.008683249,0.04348066,105.7382256,1,-1.872580402,0.8769484,-2.13533704,0.032733489,0.080560666,N,-,,nucleolar complex 4,"C:nuclear part; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:90S preribosome",IPR005612 (PFAM); PTHR12455 (PANTHER); IPR027193 (PTHR12455:PANTHER),,
RL4_JR_01661,1244,1150,1089,0,0,2,0,0,0,0,0,1,0,3,0,0,0,1,21.59232551,1,-0.175801585,1.009001983,-0.174233141,0.861682241,0.931690354,4.473630377,0,1.304123047,1.254162609,1.039835695,0.298416243,0.458565236,18.06617293,1,-0.381116904,1.192026672,-0.319721792,0.749179239,0.832293494,25.37655781,1,0.538965677,0.854776155,0.630534291,0.528345075,0.661902237,18.72673323,1,-0.486245808,1.118349364,-0.434788826,0.663715716,0.760445316,N,-,,bZIP transcription factor,"F:DNA binding; C:nucleus; F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR004827 (SMART); G3DSA:1.20.5.170 (GENE3D); IPR004827 (PFAM); IPR004827 (PROSITE_PROFILES); SSF57959 (SUPERFAMILY),,
RL4_JR_01662,1641,1765,1860,0,2,2,2,0,0,0,0,2,5,4,3,0,0,1,44.75958292,1,0.226486731,0.737060392,0.307283817,0.758627352,0.872779853,51.35173651,1,2.37896358,0.975139529,2.439613522,0.014702982,0.045348304,30.45565554,1,-0.115966348,1.028969346,-0.11270146,0.910267244,0.945184161,111.6542634,1,1.973837714,0.443355546,4.452042456,8.51E-06,0.000124093,24.57416357,1,-1.084783742,1.120343513,-0.96825994,0.332914566,0.469595986,N,-,,cell cycle inhibitor Nif1,P:biological_process; C:cellular_component,IPR006597 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR006597 (PFAM); PTHR11102 (PANTHER); SSF81901 (SUPERFAMILY),,
RL4_JR_01663,222,226,290,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.949560434,0,0.337100408,1.235490493,0.272847431,0.784970497,0.88929167,0.937852884,0,3.558020551,1.409812255,2.523754875,0.011610886,0.03768047,2.439399209,0,0.902210026,1.213212184,0.743653944,0.457085859,0.595411379,2.814560381,0,0.479702132,1.218511241,0.393678873,0.693818141,0.793416386,2.411649648,0,0.816308825,1.21335931,0.672767595,0.501095156,0.62877537,N,-,,chitooligosaccharide deacetylase,,IPR002509 (PFAM); IPR002509 (G3DSA:3.20.20.GENE3D); PTHR10587 (PANTHER); PTHR10587:SF83 (PANTHER); IPR002509 (PROSITE_PROFILES); IPR011330 (SUPERFAMILY),,
RL4_JR_01664,336,356,359,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,4.213177141,0,-0.177072562,1.204910163,-0.146959141,0.883164271,0.942956711,10.72341458,1,3.954230115,1.130524714,3.497694535,0.000469298,0.015023052,3.486744843,0,0.387198805,1.201851669,0.322168547,0.747325011,0.830840372,13.65758371,1,0.914324227,1.141937789,0.800677791,0.423318203,0.566269891,3.4336638,0,0.306582011,1.198746493,0.255752165,0.798142212,0.86355951,N,-,,cystathionine gamma-synthase,F:pyridoxal phosphate binding; F:lyase activity; F:transferase activity,IPR015421 (G3DSA:3.40.640.GENE3D); IPR000277 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR000277 (PIRSF); IPR000277 (PANTHER); PTHR11808:SF35 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_01665,1079,673,1103,0,0,6,0,0,6,0,5,1,0,1,1,0,2,1,34.25606398,1,1.6417293,0.675541968,2.430240278,0.015088816,0.052739743,59.90178628,1,4.731025267,0.682537083,6.93152854,4.16E-12,1.03E-09,55.12904736,1,2.359173528,0.652083682,3.617899965,0.000297003,0.002307644,24.50764105,1,0.266968933,1.037183197,0.257398051,0.796871508,0.868963276,24.37859243,1,1.076949083,0.876244965,1.229050238,0.219052971,0.344878141,N,-,,hypothetical protein VFPBJ_02937,,no IPS match,,
RL4_JR_01666,13232,13043,18313,2,15,14,0,0,5,1,3,2,11,2,0,0,7,0,371.7250345,1,0.12916204,0.459406996,0.281149484,0.778595749,0.886006991,103.4194018,1,0.549987805,0.686218866,0.801475786,0.422856256,0.585920743,194.7779281,1,-1.604377186,0.627870202,-2.555268877,0.01061058,0.034254309,280.2837869,1,-0.724343222,0.822247446,-0.880930948,0.378355196,0.524055589,172.7218217,1,-1.746574942,0.650578805,-2.684647778,0.007260628,0.024310138,N,-,,pkhd-type hydroxylase tpa1,,IPR006620 (SMART); PF13661 (PFAM); IPR019601 (PFAM); PTHR12117 (PANTHER); IPR005123 (PROSITE_PROFILES),,
RL4_JR_01667,2619,3611,4631,0,6,12,0,0,0,0,0,4,1,1,0,0,0,2,137.3759607,1,1.273310223,0.526710379,2.417476991,0.015628522,0.053955769,13.74239716,0,-0.315087614,1.226617682,-0.25687516,0.797275147,0.877271337,61.87193603,1,-0.173254727,0.783055199,-0.221254808,0.824894036,0.886824596,54.72913668,1,-1.663346276,1.042357794,-1.595753671,0.110543801,0.211499618,50.31823488,1,-1.363115739,1.003809209,-1.35794305,0.174481756,0.290563779,N,-,,ribulose-phosphate 3-epimerase,P:carbohydrate metabolic process; F:metal ion binding; P:pentose-phosphate shunt; F:ribulose-phosphate 3-epimerase activity,IPR000056 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); IPR026019 (PIRSF); IPR000056 (PANTHER); IPR011060 (SUPERFAMILY),,
RL4_JR_01668,5107,3969,4865,0,2,11,0,0,1,0,0,0,1,2,0,0,1,1,113.6592876,1,0.479376001,0.460943939,1.039987645,0.298345641,0.4839737,27.19662518,1,0.227059702,1.118708164,0.202965983,0.83916162,0.903711485,46.14195885,0,-3.339040675,1.191485567,-2.802418063,0.00507211,0.019139038,70.55781765,1,-1.448981826,0.854284479,-1.696135025,0.089860312,0.180774023,56.65309354,1,-1.742083168,0.972163346,-1.791965491,0.073138494,0.149873963,N,-,,nonselective cation channel,C:integral component of membrane,IPR025337 (PFAM); PTHR35859 (PANTHER); PTHR35859:SF1 (PANTHER),1.A.4.4.1, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_01669,39,28,37,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4144889,0,3.168169086,2.148777806,1.47440516,0.140372536,NA,0.132796709,0,6.378212079,1.980300621,3.220830218,0.001278198,0.015023052,0.343911253,0,3.728444653,1.296787634,2.875138962,0.004038497,0.016505679,0.396678999,0,3.306588361,1.479944797,2.234264661,0.025465664,0.085851084,0.33869387,0,3.647440904,1.239306285,2.943131127,0.003249108,0.012613963,N,-, Effector probability:0.932,nonselective cation channel,F:nucleic acid binding; P:biological_process; C:membrane; C:integral component of membrane; F:methyltransferase activity; C:cellular_component; F:molecular_function; P:methylation,no IPS match,,
RL4_JR_01670,176,248,395,0,0,2,0,0,0,0,0,0,0,0,0,0,9,0,10.90757684,1,1.881343053,1.098841065,1.712115713,0.086875346,0.199417297,1.028466211,0,3.424853063,1.452164991,2.35844624,0.018351618,0.053748575,2.695147651,0,0.758359874,1.258775654,0.602458326,0.546869095,0.67411454,3.111077694,0,0.335203106,1.274523557,0.263002676,0.792548517,0.866114812,37.4298699,1,4.256788762,0.740263178,5.750372152,8.90E-09,4.27E-07,Y,-,,cell surface,C:integral component of membrane,IPR021476 (PFAM); PTHR34618 (PANTHER),,
RL4_JR_01671,2996,2848,2763,2,3,7,0,0,0,0,0,2,7,3,1,0,10,0,105.3765258,1,1.099431837,0.442371704,2.485312298,0.012943783,0.046661679,11.04292073,0,0.000503822,1.215049341,0.000414652,0.999669156,0.999866719,41.57159514,1,-0.826920709,1.02963279,-0.803121964,0.421904244,0.563206561,119.814601,1,1.148142897,0.46971172,2.4443565,0.01451108,0.065212907,66.69077511,1,1.18767106,0.494867142,2.399979628,0.016395984,0.046622318,N,-,,major facilitator superfamily transporter phosphate,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR24064 (PANTHER); PTHR24064:SF235 (PANTHER); PTHR24064:SF235 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.9.11, the major facilitator superfamily (mfs).
RL4_JR_01672,16512,13728,14609,7,3,35,0,0,0,0,2,0,10,8,2,0,4,1,407.4612577,1,0.443171771,0.500150358,0.886077085,0.37557599,0.567292896,57.50135808,0,-2.379995358,1.19656908,-1.989016262,0.046699408,0.111641806,164.4098507,1,-3.203225715,1.032090407,-3.103628996,0.001911629,0.00954777,316.0218457,1,-0.365386,0.38564694,-0.947462464,0.343403175,0.490333824,168.986013,1,-2.168445301,0.674138851,-3.216615238,0.001297124,0.005918605,N,-,,coatomer subunit beta,"C:nucleus; P:ER to Golgi vesicle-mediated transport; F:ubiquitin binding; F:catalytic activity; P:retrograde vesicle-mediated transport, Golgi to ER; F:structural molecule activity; C:cytosol; P:intracellular protein transport; P:late endosome to vacuole transport via multivesicular body sorting pathway; C:COPI vesicle coat",IPR020472 (PRINTS); IPR001680 (SMART); IPR006692 (PFAM); IPR016453 (PIRSF); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR19876 (PANTHER); PTHR19876:SF2 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR017986 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_01673,383,815,546,2,0,6,0,0,2,0,0,2,0,2,0,0,0,0,50.10844711,1,2.744805413,0.685296997,4.005278625,6.19E-05,0.000561492,20.99811207,1,3.913792482,1.066035388,3.671353245,0.00024127,0.009929821,18.81846216,1,1.454709796,1.089256868,1.335506655,0.181710579,0.302870909,14.7399223,1,0.921897636,1.086448115,0.848542718,0.396135793,0.540330716,5.730706142,0,-0.432378849,1.254412594,-0.34468631,0.730330211,0.810721783,N,-,,fmn-dependent dehydrogenase,F:FMN binding; F:oxidoreductase activity; F:metal ion binding; P:oxidation-reduction process; F:heme binding,IPR001199 (PRINTS); IPR001199 (SMART); IPR001199 (G3DSA:3.10.120.GENE3D); IPR001199 (PFAM); IPR000262 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR10578 (PANTHER); PTHR10578:SF69 (PANTHER); IPR001199 (PROSITE_PROFILES); IPR012133 (PROSITE_PROFILES); IPR001199 (SUPERFAMILY); SSF51395 (SUPERFAMILY),,
RL4_JR_01674,2173,4008,3042,3,2,11,0,0,4,0,0,0,0,4,0,0,2,0,125.486975,1,1.344847851,0.535070987,2.513400808,0.01195734,0.043743488,49.33816362,1,2.448660489,0.825623148,2.965833134,0.003018642,0.015636999,30.72252029,0,-2.75220728,1.221116446,-2.253845068,0.024205916,0.064796589,51.49606985,1,-0.505392091,0.819848529,-0.616445688,0.537600407,0.669191557,37.99402172,1,-1.180752336,1.021730013,-1.155640259,0.247828334,0.378014745,N,-,,hypothetical protein SPSK_07643,C:membrane,IPR022185 (PFAM); PTHR35895 (PANTHER),,
RL4_JR_01675,1671,2003,2103,0,0,7,1,2,0,0,0,0,0,1,0,0,0,0,49.90016861,1,0.853194622,0.600934216,1.419780401,0.155671623,0.304914549,106.3541748,1,2.812241784,0.843406126,3.334386244,0.000854879,0.015023052,19.15045359,0,-2.070315031,1.193780518,-1.734250979,0.082873561,0.167267132,26.10664693,1,-1.545777692,1.145334772,-1.349629584,0.17713483,0.30132563,18.89809598,0,-2.153907826,1.19864345,-1.796954571,0.072342832,0.148574275,N,-,,hcngp-like protein,"P:biological_process; C:nucleus; P:regulation of transcription, DNA-templated; C:cellular_component; F:molecular_function",IPR012479 (PFAM); IPR012479 (PANTHER),,
RL4_JR_01676,3195,3387,3596,0,1,16,0,0,1,5,0,2,2,0,0,0,5,1,109.8848163,1,1.071444247,0.697077248,1.537052384,0.124280482,0.25903939,22.38189656,1,0.682036126,1.112064375,0.613306335,0.539673805,0.686598574,102.0870398,1,0.753287117,0.565885433,1.331165415,0.183134589,0.304642553,57.54817492,1,-1.570019735,1.008577537,-1.556667363,0.119549481,0.223865082,59.92455998,1,0.228558788,0.617225477,0.370300313,0.711158741,0.795985214,N,-,,proteasome component pre4,"C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; F:threonine-type endopeptidase activity; C:proteasome core complex, beta-subunit complex; P:proteasome assembly; C:proteasome storage granule; P:proteasomal ubiquitin-independent protein catabolic process",IPR029055 (G3DSA:3.60.20.GENE3D); IPR016295 (PIRSF); IPR001353 (PFAM); PTHR11599:SF5 (PANTHER); PTHR11599:SF5 (PANTHER); PTHR11599 (PANTHER); IPR023333 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY),,
RL4_JR_01677,5011,5745,4649,8,6,17,0,0,0,0,3,0,0,12,2,0,1,0,255.4430957,1,1.628098155,0.345669805,4.709980829,2.48E-06,3.37E-05,19.81763403,0,-0.843161803,1.211413298,-0.696014981,0.486419448,0.642442362,74.79743012,1,-1.081680483,0.859522451,-1.258466817,0.208222981,0.335356261,126.5468215,1,0.550865015,0.477640111,1.153305602,0.248784972,0.387888488,54.20448176,1,-2.63736783,1.123401894,-2.347661905,0.018891661,0.052261766,N,-,,glucosamine-fructose-6-phosphate aminotransferase,P:carbohydrate metabolic process; F:glutamine-fructose-6-phosphate transaminase (isomerizing) activity; P:carbohydrate derivative biosynthetic process; F:carbohydrate binding,G3DSA:3.40.50.10490 (GENE3D); IPR001347 (PFAM); G3DSA:3.40.50.10490 (GENE3D); IPR005855 (TIGRFAM); IPR029055 (G3DSA:3.60.20.GENE3D); PF13522 (PFAM); IPR005855 (PTHR10937:PANTHER); IPR005855 (PTHR10937:PANTHER); PTHR10937 (PANTHER); PTHR10937 (PANTHER); IPR001347 (PROSITE_PROFILES); IPR001347 (PROSITE_PROFILES); IPR017932 (PROSITE_PROFILES); SSF53697 (SUPERFAMILY); IPR029055 (SUPERFAMILY),,
RL4_JR_01678,4358,3853,4485,8,1,11,0,0,2,0,0,2,2,3,2,0,1,0,181.280731,1,1.285985667,0.359737879,3.574785261,0.000350515,0.002470427,34.97586221,1,1.088864615,0.984090831,1.106467595,0.268524182,0.425823832,55.03904854,1,-1.383641782,1.027736463,-1.346300176,0.178205729,0.298256704,98.42659004,1,-0.084063088,0.562761846,-0.149375954,0.881256985,0.92661179,45.27930323,1,-2.355413649,1.117713555,-2.107349991,0.035087253,0.084924529,N,-,,26S protease subunit rpt4,"F:protein domain specific binding; C:proteasome regulatory particle, base subcomplex; P:nucleotide-excision repair; F:peptidase activity; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of RNA polymerase II transcriptional preinitiation complex assembly; P:positive regulation of transcription elongation from RNA polymerase II promoter; F:ATP binding; P:proteasome regulatory particle assembly; C:cytosolic proteasome complex; C:nuclear proteasome complex; F:TBP-class protein binding; P:ER-associated ubiquitin-dependent protein catabolic process; F:proteasome-activating ATPase activity",IPR003593 (SMART); IPR005937 (TIGRFAM); IPR003959 (PFAM); G3DSA:1.10.8.60 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23073 (PANTHER); PTHR23073:SF31 (PANTHER); IPR027417 (SUPERFAMILY),9.B.307.1.2, the ftsh aaa(+) zinc metaloprotease (ftsh) family.
RL4_JR_01679,3960,4206,3977,0,2,2,0,0,0,1,0,1,5,0,1,0,2,0,72.37041581,1,-0.980462439,0.739539603,-1.325774084,0.18491454,0.342303793,15.56724622,0,-0.494894875,1.205537938,-0.410517877,0.681426093,0.797755599,57.89221154,1,-1.319758162,1.028761582,-1.282861049,0.199540761,0.324939789,102.7113614,1,-0.217504194,0.612947069,-0.35484988,0.722702058,0.815213719,47.38756984,1,-1.552158109,0.967632425,-1.604078232,0.108696809,0.203354619,N,-,,GDSL-like lipase acylhydrolase,F:lysophospholipase activity; F:hydrolase activity,IPR013830 (PFAM); IPR013830 (G3DSA:3.40.50.GENE3D); PTHR30383:SF3 (PANTHER); PTHR30383 (PANTHER); IPR013830 (SUPERFAMILY),,
RL4_JR_01680,2469,2566,2159,8,3,5,0,0,0,0,1,0,12,4,0,0,7,2,152.5351811,1,1.861369079,0.465176416,4.001426157,6.30E-05,0.000569245,9.25615887,0,0.255153092,1.228054219,0.207770217,0.835408388,0.901326723,31.77262665,1,-1.429870539,1.194019392,-1.197527066,0.231101185,0.362405346,155.3942899,1,2.120484905,0.715260425,2.964633345,0.003030439,0.018789463,65.24294634,1,1.309124369,0.519092739,2.521946989,0.011670729,0.035606961,N,-,,PCI domain-containing,,SM00753 (SMART); IPR000717 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); IPR000717 (PFAM); PTHR10855:SF2 (PANTHER); PTHR10855 (PANTHER); IPR011991 (SUPERFAMILY),,
RL4_JR_01681,961,838,978,0,0,0,0,0,0,2,0,0,0,2,0,0,1,2,11.097672,0,-1.574655425,1.185670869,-1.328071277,0.184154561,0.341776417,3.54801335,0,1.638512775,1.259952954,1.300455521,0.193444891,0.335857494,31.33563701,1,0.816558708,1.027192238,0.794942444,0.426646983,0.56744273,18.63064591,1,0.29389323,1.011716502,0.290489707,0.771441624,0.851596865,27.64983453,1,1.127670159,0.837170521,1.347001753,0.177979668,0.295005194,N,-,,DNA cross-link repair pso2 snm1,P:DNA repair,IPR011084 (PFAM); IPR001279 (PFAM); IPR001279 (G3DSA:3.60.15.GENE3D); PTHR23240 (PANTHER); PTHR23240:SF6 (PANTHER); IPR001279 (SUPERFAMILY),,
RL4_JR_01682,2109,2005,4251,0,0,15,0,0,0,0,0,1,1,3,1,0,2,5,90.50225966,1,1.037631617,0.988228013,1.04999211,0.29372174,0.478945557,10.46559578,0,0.077861271,1.261882897,0.061702453,0.950799786,0.973667236,33.92739863,1,-1.626891961,1.231505162,-1.321059798,0.186481426,0.308436197,62.64208189,1,0.030275247,0.752756967,0.040219153,0.967918408,0.981981351,71.90757952,1,0.791630064,0.704650555,1.123436373,0.261252209,0.393159723,N,-,,U6 snRNA-associated Sm LSm2,"P:nucleocytoplasmic transport; C:U4/U6 x U5 tri-snRNP complex; C:cytoplasmic mRNA processing body; C:cytosol; C:viral nucleocapsid; F:structural constituent of nuclear pore; C:nucleolus; C:U6 snRNP; C:small nucleolar ribonucleoprotein complex; C:nuclear pore; P:mRNA splicing, via spliceosome",IPR001163 (SMART); IPR016654 (PIRSF); IPR001163 (PFAM); G3DSA:2.30.30.100 (GENE3D); IPR016654 (PANTHER); IPR010920 (SUPERFAMILY),,
RL4_JR_01683,9482,5159,5222,1,0,8,0,0,1,0,0,0,0,1,0,0,0,0,119.7629056,1,-0.63512789,0.676738556,-0.938512938,0.347980871,0.537860543,35.05091716,1,-0.303223464,1.164803002,-0.260321671,0.794615657,0.875623764,65.9544718,0,-3.85440786,1.227570979,-3.139865576,0.001690254,0.008664369,80.04653994,1,-3.3314421,1.18720843,-2.806113918,0.005014296,0.028117634,64.42241447,0,-3.923292579,1.225253779,-3.202024467,0.001364654,0.006171113,N,-,,CCAAT-binding complex subunit HAP2,"F:transcription factor activity, sequence-specific DNA binding; P:mycelium development; P:regulation of transcription, DNA-templated",IPR001289 (PRINTS); IPR001289 (SMART); IPR001289 (PFAM); PTHR12632:SF6 (PANTHER); IPR001289 (PANTHER); IPR001289 (PROSITE_PROFILES),,
RL4_JR_01684,1639,1349,1799,0,1,1,0,0,0,0,0,2,0,3,0,0,1,0,30.92446417,1,-0.622576246,1.009462047,-0.616740617,0.537405826,0.72036752,6.096613246,0,0.857486819,1.233816157,0.69498751,0.487063129,0.643190214,28.81935131,1,0.024677279,1.034012306,0.023865556,0.980959849,0.989758572,30.28690424,1,0.085367746,0.856953741,0.099617683,0.920647855,0.952540316,19.47281007,1,-0.948593777,1.127800121,-0.841100971,0.400291371,0.537455262,N,-,,hypothetical protein CMQ_611,C:membrane; C:integral component of membrane,PTHR42053 (PANTHER); PTHR42053:SF1 (PANTHER),,
RL4_JR_01685,330,284,677,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,16.57430793,1,1.778554995,0.978003249,1.818557348,0.06897899,0.169140547,1.611556743,0,2.776883816,1.409059703,1.970735385,0.048754151,0.115490174,4.226737138,0,0.109163348,1.262924411,0.086436961,0.931119066,0.958772317,4.878869152,0,-0.313964329,1.273593199,-0.246518535,0.805280859,0.875495903,4.220604187,0,0.008790391,1.278199891,0.006877165,0.99451286,0.995606045,N,-,,coiled-coil domain-containing mtmr15,,IPR014883 (SMART); IPR014883 (PFAM); IPR033315 (PANTHER); PTHR15749:SF4 (PANTHER),,
RL4_JR_01686,1810,2387,3229,0,5,0,0,0,0,1,1,4,1,1,3,0,0,1,69.75920723,1,0.1930351,0.809871523,0.238352744,0.811607516,0.904486774,9.385191414,0,0.235073902,1.237764448,0.189918124,0.84937329,0.910253245,69.41815253,1,0.971310681,0.654835849,1.483288799,0.137997697,0.246487065,70.51705639,1,0.250844157,0.710131204,0.353236353,0.723911257,0.81612309,31.69113123,1,-1.578035366,1.152406471,-1.369339209,0.170893267,0.285957408,N,-, Effector probability:0.659,dpy-30 domain-containing,C:Set1C/COMPASS complex; C:Lid2 complex; C:cytosol; P:histone H3-K4 methylation,IPR007858 (PFAM); PTHR23356 (PANTHER); PTHR23356:SF8 (PANTHER),,
RL4_JR_01687,30596,31031,46016,10,20,67,0,0,2,0,8,3,8,25,4,0,10,1,946.1821996,1,0.32375095,0.404356059,0.80065809,0.423329611,0.61472463,154.9161417,1,-1.985345773,0.995932117,-1.993454915,0.046211656,0.110763528,437.2182375,1,-2.012983953,0.53311614,-3.775882596,0.000159442,0.00154173,622.9520979,1,-0.83840499,0.381521715,-2.197528886,0.027982696,0.088928059,397.8576756,1,-2.441087425,0.641520222,-3.805160528,0.000141712,0.000932317,N,-,,40S ribosomal S13,"P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:structural constituent of ribosome; P:mycelium development; C:cytosolic small ribosomal subunit; F:small ribosomal subunit rRNA binding; P:translation",IPR012606 (SMART); IPR000589 (SMART); IPR012606 (PFAM); IPR000589 (PFAM); PTHR11885 (PANTHER); IPR009068 (SUPERFAMILY),,
RL4_JR_01688,7699,10053,14390,0,0,10,0,0,0,0,0,2,3,5,0,0,3,3,166.6708035,1,-1.332022413,0.807293809,-1.649984674,0.098946071,0.219646815,40.55109212,0,-1.876178103,1.214512256,-1.544799646,0.122394733,0.237106122,118.985635,1,-2.725958395,1.062565026,-2.565450894,0.010304181,0.033478666,170.3209222,1,-1.249261917,0.607341841,-2.05693373,0.039692601,0.106957809,138.9701769,1,-1.42441299,0.695097109,-2.049228767,0.04043975,0.095066745,N,-,,u2 snrnp auxilliary factor,"C:commitment complex; F:nucleotide binding; C:U2AF; P:mRNA cis splicing, via spliceosome; F:pre-mRNA branch point binding; C:U2-type prespliceosome; P:mRNA branch site recognition",IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR23139:SF9 (PANTHER); PTHR23139 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY),9.A.60.1.1, the small nuclear rna exporter (snrna-e).
RL4_JR_01689,254,316,509,4,0,0,0,0,0,0,1,0,0,2,0,0,0,0,44.56692725,1,2.71113979,0.877589169,3.089304066,0.00200626,0.010505179,1.356832128,0,3.025123792,1.395676964,2.167495681,0.030197079,0.079432128,11.39422313,1,1.322120108,1.225937541,1.078456336,0.280830158,0.419959308,12.12212967,1,1.641346846,1.068574097,1.53601594,0.124534471,0.230851615,3.534135812,0,0.264957969,1.252749085,0.211501227,0.832496175,0.886798924,N,-,,N-glycosylase DNA lyase,P:base-excision repair; C:intracellular membrane-bounded organelle; F:lyase activity,IPR003265 (SMART); IPR011257 (G3DSA:1.10.340.GENE3D); IPR012904 (PFAM); IPR023170 (G3DSA:1.10.1670.GENE3D); G3DSA:3.30.310.40 (GENE3D); IPR003265 (PFAM); PTHR10242:SF2 (PANTHER); PTHR10242 (PANTHER); PTHR10242 (PANTHER); PTHR10242:SF2 (PANTHER); SSF55945 (SUPERFAMILY); IPR011257 (SUPERFAMILY),,
RL4_JR_01690,18281,17628,21664,3,7,9,3,0,0,0,0,6,1,10,1,0,2,6,350.7596444,1,-0.964477596,0.377416602,-2.555472102,0.010604386,0.039701965,140.2610496,1,-0.513176408,0.840840135,-0.610313884,0.541653901,0.688425514,229.4477159,1,-1.988607488,0.619664731,-3.209166808,0.001331202,0.007207001,278.7900314,1,-1.521396248,0.457907038,-3.322500247,0.000892146,0.006718958,239.9309849,1,-1.814040729,0.569376004,-3.186015421,0.001442469,0.006456675,N,-,,U2 snRNP component prp10,C:U12-type spliceosomal complex; C:catalytic step 2 spliceosome; F:mRNA binding; C:U2-type prespliceosome; C:U2 snRNP; P:spliceosomal complex assembly,IPR011989 (G3DSA:1.25.10.GENE3D); IPR015016 (PFAM); PTHR12097 (PANTHER); IPR016024 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_01691,24186,25395,32505,9,5,36,0,0,4,2,1,3,0,13,0,0,5,0,596.2578732,1,-0.213044919,0.419987274,-0.507265176,0.61196877,0.776912733,141.7886952,1,-0.647936581,0.755749537,-0.857343007,0.391255347,0.555595766,320.7994379,1,-2.485402542,0.62471073,-3.978485437,6.94E-05,0.000910129,365.2060128,1,-2.133973383,0.66428552,-3.212433992,0.001316154,0.009325443,287.6211283,1,-3.084104875,0.723751701,-4.261274785,2.03E-05,0.000182128,N,-,,S-adenosylmethionine synthetase,C:nucleus; F:ATP binding; F:metal ion binding; C:cytosol; P:S-adenosylmethionine biosynthetic process; F:methionine adenosyltransferase activity; P:one-carbon metabolic process; P:methionine metabolic process,IPR022628 (PFAM); IPR022629 (PFAM); G3DSA:3.30.300.10 (GENE3D); G3DSA:3.30.300.10 (GENE3D); IPR002133 (PIRSF); IPR022630 (PFAM); G3DSA:3.30.300.10 (GENE3D); IPR002133 (TIGRFAM); IPR002133 (PANTHER); IPR002133 (HAMAP); IPR022636 (SUPERFAMILY); IPR022636 (SUPERFAMILY); IPR022636 (SUPERFAMILY),,
RL4_JR_01692,4981,3800,5499,0,5,6,0,0,0,0,0,1,1,7,3,0,1,0,119.8489028,1,0.248318687,0.493736477,0.502937698,0.615008075,0.778967874,18.16338684,0,-0.717465817,1.208313246,-0.593774685,0.552662823,0.698732639,53.64832049,1,-2.408430086,1.195809796,-2.014057833,0.044003462,0.102576801,120.6910392,1,0.385373119,0.487657351,0.790253892,0.429379509,0.571809486,50.41061891,1,-2.524922374,1.130743494,-2.232975372,0.025550569,0.06652083,N,-,,C2H2 finger domain-containing,F:binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PF12874 (PFAM); PTHR14596:SF27 (PANTHER); PTHR14596 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_01693,10,15,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.164672617,0,4.499997348,3.239353447,1.389165283,0.164782496,NA,0.052132681,0,7.727023197,2.387927543,3.235870042,0.001212726,0.015023052,0.135837155,0,5.068975495,1.413750741,3.585480345,0.000336458,0.002549367,0.156754567,0,4.646220383,1.972698304,2.355261508,0.018509674,0.074192579,0.134394161,0,4.983772795,1.280605741,3.891730793,9.95E-05,0.000691666,N,-,,ABC multidrug transporter,,IPR013525 (PFAM); PTHR19241 (PANTHER); PTHR19241:SF279 (PANTHER); PTHR19241:SF279 (PANTHER),3.A.1.205.26, the atp-binding cassette (abc) superfamily.
RL4_JR_01694,2,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.065686654,0,5.826486178,3.922986389,1.485217026,0.137486343,NA,0.020740685,0,9.057542805,2.994573611,3.024651914,0.002489194,0.015349618,0.053871136,0,6.406316401,1.793946234,3.571074919,0.000355519,0.002640701,0.062170494,0,5.981189048,2.949207178,2.028066761,0.042553435,0.11211385,0.052889767,0,6.332777667,1.445485431,4.381073328,1.18E-05,0.000115752,N,-, Effector probability:0.755,ABC multidrug,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR19241:SF279 (PANTHER); PTHR19241 (PANTHER); IPR027417 (SUPERFAMILY),3.A.1.205.7, the atp-binding cassette (abc) superfamily.
RL4_JR_01695,4,8,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.084428068,0,5.463794478,3.919386363,1.394043346,0.163304516,NA,0.026568139,0,8.699224271,2.745477917,3.168564649,0.001531937,0.015023052,0.069485547,0,6.035772722,1.579715748,3.820796703,0.000133021,0.001376714,0.080205485,0,5.6128793,2.556321234,2.195686217,0.02811441,0.089206645,0.068992658,0,5.947481064,1.333108376,4.46136351,8.14E-06,8.45E-05,N,-,,ATPase,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR010929 (PFAM); IPR013525 (PFAM); PTHR19241:SF279 (PANTHER); PTHR19241 (PANTHER); PTHR19241:SF279 (PANTHER); PTHR19241 (PANTHER),3.A.1.205.7, the atp-binding cassette (abc) superfamily.
RL4_JR_01696,10,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.076112954,0,5.613296335,3.920761995,1.431685051,0.152233977,NA,0.024897394,0,8.794438704,2.841464788,3.095037018,0.001967883,0.015023052,0.063536086,0,6.167051586,1.664399278,3.705271725,0.000211164,0.001813247,0.073219887,0,5.744776737,2.701495442,2.126517279,0.033460212,0.098027965,0.061558976,0,6.104208806,1.364476024,4.473665126,7.69E-06,8.06E-05,N,-,,ABC multidrug transporter,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); PTHR19241 (PANTHER); PTHR19241:SF279 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.1.205.26, the atp-binding cassette (abc) superfamily.
RL4_JR_01697,27,104,48,0,0,16,0,0,0,0,0,0,0,9,4,0,0,0,61.82905312,1,6.48424096,1.706939744,3.798752113,0.000145426,0.001175807,0.231454077,0,5.576869206,1.944685934,2.867748003,0.004134047,0.018371529,0.601208171,0,2.923754299,1.414768392,2.066595717,0.038772265,0.093259779,75.339234,1,6.836454846,0.740632186,9.230566774,2.69E-20,2.67E-18,0.590735227,0,2.84634418,1.372971189,2.073127391,0.038160425,0.090698194,N,-,,duf895 domain membrane,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR19444:SF24 (PANTHER); PTHR19444 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.58.5, the major facilitator superfamily (mfs).
RL4_JR_01698,6,5,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.075653721,0,5.62188959,3.920845465,1.433846256,0.151616142,NA,0.024051753,0,8.842772051,2.769222103,3.193233233,0.001406893,0.015023052,0.062618428,0,6.184712626,1.562635257,3.957873469,7.56E-05,0.000969085,0.072249713,0,5.763320111,2.615859017,2.203222756,0.027579052,0.088366425,0.062012479,0,6.097567222,1.315556543,4.634971606,3.57E-06,4.27E-05,N,-,,Cytochrome P450,F:oxidoreductase activity; F:metal ion binding; P:oxidation-reduction process,IPR016040 (G3DSA:3.40.50.GENE3D); IPR016040 (SUPERFAMILY),,
RL4_JR_01699,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein CMQ_6769,,IPR012816 (TIGRFAM); IPR012816 (PFAM); PTHR11079 (PANTHER); PTHR11079:SF10 (PANTHER); SSF143990 (SUPERFAMILY),,
RL4_JR_01700,261,205,327,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.15651272,0,0.239088773,1.245445343,0.191970506,0.847765309,0.923562004,1.00498743,0,3.458247234,1.411878815,2.449393814,0.01430969,0.044403028,2.61414509,0,0.802267385,1.222311822,0.656352471,0.511597364,0.643005799,3.016042318,0,0.379837818,1.229163552,0.309021381,0.757305263,0.841435035,2.58669404,0,0.715064818,1.224021707,0.584192922,0.559090523,0.677797219,N,-,,N-acetyltransferase family,"F:transferase activity, transferring acyl groups; F:acetyltransferase activity; P:metabolic process; F:transferase activity",IPR001447 (PRINTS); IPR001447 (PFAM); G3DSA:3.30.2140.10 (GENE3D); PTHR11786:SF0 (PANTHER); IPR001447 (PANTHER); SSF54001 (SUPERFAMILY),,
RL4_JR_01701,2784,1836,3851,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,33.59270037,0,-3.172464045,1.228282675,-2.582845226,0.009798927,0.037320097,10.67368673,0,0.049475457,1.250019137,0.03957976,0.968428164,0.983587184,40.82231969,1,-0.79808696,1.069243805,-0.746403165,0.455423908,0.594240449,32.10563017,0,-3.031993349,1.22471301,-2.475676608,0.013298397,0.060788385,27.61472046,0,-2.701158835,1.233484442,-2.189860482,0.028534357,0.072336095,N,-,,mitochondrial chaperone bcs1,F:nucleotide binding,IPR014851 (SMART); IPR003593 (SMART); IPR003959 (PFAM); IPR014851 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23070 (PANTHER); PTHR23070:SF11 (PANTHER); IPR027417 (SUPERFAMILY),3.A.28.1.1," the aaa-atpase, bcs1 (bcs1) family."
RL4_JR_01702,877,1235,1069,0,0,5,0,0,0,1,0,3,0,2,0,0,4,1,31.89689119,1,1.221575365,0.714051489,1.710766498,0.087124226,0.199819916,4.074051161,0,1.439077024,1.268579616,1.134400242,0.256626697,0.412056114,41.14126297,1,1.605380516,0.759833827,2.112804748,0.034617483,0.085730773,20.22407267,1,0.082870789,1.032859171,0.080234355,0.936050867,0.962770726,33.22544234,1,1.630281064,0.702123104,2.32193052,0.020236677,0.055005733,N,-,,ribonuclease e inhibitor rraa dimethylmenaquinone methyltransferase,"F:oxaloacetate decarboxylase activity; F:4-hydroxy-4-methyl-2-oxoglutarate aldolase activity; P:3,4-dihydroxybenzoate catabolic process; F:methyltransferase activity; P:methylation",IPR005493 (PFAM); IPR005493 (G3DSA:3.50.30.GENE3D); PTHR33254 (PANTHER); PTHR33254:SF6 (PANTHER); IPR005493 (SUPERFAMILY),,
RL4_JR_01703,454,1378,1472,0,0,2,0,0,0,1,0,0,4,0,0,0,0,0,20.95831483,1,-0.172266832,1.172553624,-0.146915952,0.883198361,0.942956711,4.171172784,0,1.405020361,1.379929965,1.018182369,0.308591296,0.469991138,22.00797504,1,-0.300503365,1.276759383,-0.235364133,0.813926122,0.879140943,49.87705659,1,1.445945565,1.556163915,0.929173046,0.352799414,0.499244454,10.88275744,0,-1.357710165,1.307613348,-1.038311644,0.299124989,0.434275956,N,-, Effector probability:0.742,DUF567 domain,P:biological_process; C:cellular_component; F:molecular_function,IPR007612 (PFAM); PTHR31087 (PANTHER); PTHR31087:SF11 (PANTHER); IPR025659 (SUPERFAMILY),,
RL4_JR_01704,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.791,---NA---,,no IPS match,,
RL4_JR_01705,3,4,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.055820182,0,6.060509136,3.925836179,1.543749882,0.122648937,NA,0.017537841,0,9.297779581,2.966257817,3.134514986,0.001721385,0.015023052,0.046002333,0,6.628866407,1.691453704,3.919035082,8.89E-05,0.001083112,0.053103852,0,6.207345942,2.981800204,2.081744422,0.037365821,0.102862679,0.04588756,0,6.53495445,1.360650987,4.802814617,1.56E-06,2.09E-05,N,-, Effector probability:0.783,---NA---,,no IPS match,,
RL4_JR_01706,7069,5098,6239,0,0,0,0,0,3,1,0,9,0,4,0,0,0,1,73.4115499,0,-4.300296569,1.193685271,-3.602538016,0.000315125,0.002249716,51.69082586,1,1.081993895,0.87012029,1.243499212,0.213683931,0.36036467,130.4908365,1,0.37905042,0.523430481,0.724165737,0.468963991,0.605817461,86.32319523,1,-1.45656194,0.76096763,-1.914091852,0.05560842,0.130813304,67.29384729,1,-2.884073278,1.124816142,-2.56403973,0.01034617,0.032291915,N,-,,hypothetical protein SPI_09297,,IPR003615 (PFAM),,
RL4_JR_01707,2694,1950,2124,0,4,8,0,0,0,2,3,3,0,13,2,0,0,1,89.61208268,1,1.430164795,0.477751579,2.993532324,0.002757683,0.0134913,8.69032891,0,0.346138059,1.237072095,0.279804273,0.779627673,0.866847621,87.60648478,1,1.525801097,0.553528033,2.756501943,0.005842327,0.02134526,97.30175406,1,1.818616491,0.490573412,3.70712404,0.000209626,0.002000439,29.39332827,1,-1.439971416,1.126097226,-1.278727434,0.200993055,0.322870805,N,-,,and nb-arc domain containing,P:riboflavin biosynthetic process; F:riboflavin kinase activity; P:phosphorylation; F:kinase activity,IPR015865 (PFAM); IPR023465 (G3DSA:2.40.30.GENE3D); PTHR22749:SF2 (PANTHER); IPR023468 (PANTHER); IPR015865 (SUPERFAMILY),,
RL4_JR_01708,19215,13388,14894,7,5,8,0,0,3,2,3,0,1,17,7,4,3,5,330.6042779,1,-0.570924586,0.411660497,-1.386882127,0.165477709,0.316968102,89.12403038,1,-0.293415275,0.875378228,-0.335186854,0.737484138,0.837238049,203.1258521,1,-1.95128818,0.687549769,-2.838031902,0.004539265,0.017654827,326.5395204,1,-0.211174699,0.408723529,-0.51666881,0.605387373,0.72590656,267.0438006,1,-0.848663094,0.527257767,-1.609579122,0.107489769,0.201730104,N,-,,F-box and WD-40 domain-containing MET30,C:nucleus; P:regulation of nucleobase-containing compound metabolic process; F:protein binding; P:G1/S transition of mitotic cell cycle; P:response to chemical; P:regulation of cellular macromolecule biosynthetic process; C:SCF ubiquitin ligase complex; P:protein ubiquitination,IPR020472 (PRINTS); IPR001810 (SMART); IPR001680 (SMART); G3DSA:1.20.1280.50 (GENE3D); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001810 (PFAM); PTHR22844:SF193 (PANTHER); PTHR22844:SF193 (PANTHER); PTHR22844 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001810 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_01709,278,222,273,0,0,4,0,0,0,0,4,2,3,16,3,0,12,0,18.35961016,1,2.986391558,0.743828646,4.014891838,5.95E-05,0.000542708,0.987437915,0,3.483759073,1.40585744,2.478031537,0.013210947,0.041631757,46.92751531,1,4.238806245,0.617401937,6.865553849,6.62E-12,4.79E-10,123.9788973,1,5.563852245,0.370830095,15.00377754,6.94E-51,3.34E-48,48.84601168,1,4.839914239,0.548146657,8.829597298,1.05E-18,2.17E-16,N,-,,succinate:fumarate antiporter,F:succinate:fumarate antiporter activity; P:fumarate transport; C:integral component of membrane; P:succinate transmembrane transport,IPR002067 (PRINTS); IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); PTHR24089 (PANTHER); PTHR24089:SF41 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.13.1, the mitochondrial carrier (mc) family.
RL4_JR_01710,2233,3656,4141,1,6,5,0,0,0,2,5,0,8,6,4,0,6,0,117.4930937,1,0.910221161,0.5697057,1.59770415,0.110108835,0.237205337,12.7152106,0,-0.202996599,1.238702877,-0.163878363,0.869826901,0.924869293,94.547434,1,0.789174448,0.634797859,1.243190154,0.21379777,0.342391962,175.4171475,1,1.706107244,0.48695941,3.503592305,0.000459028,0.003892507,56.06676346,1,0.161787111,0.726810233,0.222598835,0.823847744,0.881760931,N,-,,cofilin tropomyosin-type actin-binding,F:actin filament binding; P:sequestering of actin monomers; P:actin filament severing; P:actin filament depolymerization; P:actin cortical patch organization; P:phosphorylation; C:ribosome; F:kinase activity; F:actin monomer binding,IPR002108 (SMART); IPR002108 (PFAM); IPR029006 (G3DSA:3.40.20.GENE3D); IPR028458 (PANTHER); IPR002108 (PROSITE_PROFILES); IPR002108 (PROSITE_PROFILES); SSF55753 (SUPERFAMILY); SSF55753 (SUPERFAMILY),,
RL4_JR_01711,10936,14996,16231,1,0,2,0,0,1,0,0,0,0,7,0,0,0,2,186.9104689,1,-3.198888367,0.887200565,-3.605597756,0.000311435,0.002238492,63.02557918,1,-1.36298331,1.116918497,-1.220306865,0.222348568,0.370776311,139.6735387,0,-4.936927961,1.20243487,-4.105775775,4.03E-05,0.000605149,189.2532742,1,-1.891882684,0.63124407,-2.997070029,0.002725881,0.017163895,152.8341999,1,-3.324494179,0.994407736,-3.343190182,0.000828211,0.004108593,N,-,,ribosome biogenesis NSA2,"P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:actin binding; C:nucleolus; C:ribosome; P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:preribosome, large subunit precursor",IPR022309 (PFAM); PTHR12642:SF0 (PANTHER); PTHR12642 (PANTHER),,
RL4_JR_01712,234776,125110,65355,39,53,14,0,1,18,0,0,0,0,1,0,0,0,0,2571.06105,1,-0.979573568,0.837376988,-1.169811903,0.242076672,0.417028158,764.640508,1,-1.209803027,0.90201367,-1.341224714,0.179847505,0.317976671,1421.176511,0,-8.283872596,1.328159315,-6.237107627,4.46E-10,2.40E-08,1641.649947,1,-7.766316403,1.290817912,-6.016585554,1.78E-09,5.64E-08,1375.927952,0,-8.339962723,1.370624867,-6.084788715,1.17E-09,6.79E-08,N,-,,major facilitator superfamily transporter multidrug resistance,,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502:SF48 (PANTHER); PTHR23502 (PANTHER); PTHR23502 (PANTHER); PTHR23502:SF48 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.77, the major facilitator superfamily (mfs).
RL4_JR_01713,2454,3115,3584,3,5,5,0,0,0,0,0,0,1,5,0,0,1,3,126.02436,1,1.162504139,0.480058227,2.421589869,0.01545278,0.053575765,11.63521166,0,-0.074938033,1.217177698,-0.061567044,0.950907622,0.973667236,30.2944736,0,-2.732014153,1.199072829,-2.27843888,0.022700442,0.061490933,64.32717788,1,0.133351737,0.641990673,0.207716005,0.83545072,0.896749831,55.92031698,1,-0.175461992,0.767583522,-0.228590097,0.819187523,0.878771026,N,-,,dolichyl-phosphate mannosyltransferase polypeptide 3,"F:transferase activity, transferring glycosyl groups; C:integral component of membrane",IPR013174 (PFAM); PTHR16433:SF0 (PANTHER); PTHR16433 (PANTHER),,
RL4_JR_01714,1542,1491,1480,0,0,3,0,0,0,0,0,0,0,1,0,0,6,0,29.53625807,1,0.028489086,0.843902656,0.033758735,0.973069542,0.986246903,5.784985316,0,0.933240324,1.235316583,0.755466523,0.449969111,0.610370858,14.97732037,0,-1.715660994,1.189540363,-1.442289012,0.149220859,0.261142951,21.28770235,1,-1.190357468,1.139265615,-1.044846305,0.29609401,0.441004979,37.89306171,1,1.401817066,0.61148373,2.292484651,0.021877692,0.058740821,N,-,,hypothetical protein CMQ_7659,"P:biological_process; P:regulation of transcription, DNA-templated; C:cellular_component; F:molecular_function",no IPS match,,
RL4_JR_01715,2567,2466,3085,0,0,13,2,0,0,0,6,0,2,0,0,0,0,0,82.08250281,1,0.989412906,0.778473511,1.270965411,0.203740954,0.368459034,54.95774342,1,1.758942817,0.97417545,1.805570871,0.070985396,0.155488894,73.90545713,1,0.841990351,1.193713136,0.705354013,0.480589955,0.616978532,49.59883244,1,-1.238665007,1.011422013,-1.224676734,0.220697043,0.356060481,26.51145071,0,-2.642319059,1.195138579,-2.210889268,0.027043506,0.069443444,N,-,,oxidoreductase,,IPR019180 (PFAM); PTHR21193 (PANTHER); PTHR21193:SF3 (PANTHER); PTHR21193 (PANTHER),,
RL4_JR_01716,17646,21001,26048,2,3,4,0,0,0,0,0,0,0,2,0,0,1,4,318.3769846,1,-2.205567816,0.551328026,-4.000463808,6.32E-05,0.000569245,82.11471821,0,-2.894065696,1.194090104,-2.423657718,0.01536508,0.047057591,213.8890751,0,-5.551734457,1.200352721,-4.625085908,3.74E-06,8.19E-05,254.8334154,1,-4.254439027,1.029934944,-4.130784233,3.62E-05,0.00043996,245.0206468,1,-2.658421337,0.715970757,-3.713030612,0.000204792,0.001270539,N,-, Effector probability:0.661,hypoxanthine guanine phosphoribosyltransferase,F:magnesium ion binding; P:GMP salvage; P:mycelium development; P:IMP salvage; P:hypoxanthine metabolic process; P:guanine salvage; C:cytosol; P:adenine salvage; C:endoplasmic reticulum; F:hypoxanthine phosphoribosyltransferase activity; F:guanine phosphoribosyltransferase activity,IPR029057 (G3DSA:3.40.50.GENE3D); IPR000836 (PFAM); PTHR22573:SF57 (PANTHER); PTHR22573 (PANTHER); IPR029057 (SUPERFAMILY),,
RL4_JR_01717,611,1181,1470,0,0,2,0,0,0,0,0,0,0,2,1,0,1,2,20.72941714,1,-0.122933646,1.106428534,-0.111108528,0.911530286,0.956734502,4.11452662,0,1.424725404,1.319824077,1.079481295,0.280373228,0.439310715,10.77445885,0,-1.240595534,1.246240278,-0.995470582,0.319507445,0.46223112,30.09588408,1,0.636115589,0.932738561,0.681987017,0.49524716,0.63400904,29.30662847,1,0.901750895,0.928332231,0.97136657,0.33136577,0.4679903,N,-,,xenobiotic compound family,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:proteolysis; P:oxidation-reduction process; F:peptidase activity; F:monooxygenase activity",IPR016215 (TIGRFAM); IPR011251 (PFAM); IPR011251 (G3DSA:3.20.20.GENE3D); IPR016215 (PIRSF); PTHR30011:SF30 (PANTHER); PTHR30011 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_01718,2,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.024043018,0,7.275864843,3.950905398,1.841568985,0.065538221,NA,0.007685733,0,10.48932229,3.438867284,3.050225969,0.002286692,0.015101794,0.019909242,0,7.839781561,1.975830508,3.967841133,7.25E-05,0.000937752,0.02296587,0,7.41710638,3.950905352,1.877318163,0.0604745,0.137403188,0.01959039,0,7.76041061,1.430427943,5.425237004,5.79E-08,1.50E-06,N,-,,RTA1 like,C:membrane; C:integral component of membrane; P:response to stress,IPR007568 (PFAM); PTHR31465:SF1 (PANTHER); PTHR31465 (PANTHER),9.A.26.1.1, the lipid-translocating exporter (lte) family.
RL4_JR_01719,144,257,268,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,10.32793657,1,2.168785492,1.084622701,1.999575972,0.045546071,0.124103154,0.849542866,0,3.70069473,1.474723622,2.509415781,0.012093105,0.038967021,2.21685106,0,1.040469148,1.252381062,0.830792783,0.4060907,0.5481683,2.558505389,0,0.617528572,1.269862478,0.486295629,0.626757578,0.743397636,2.195931696,0,0.951646859,1.253530884,0.759173045,0.447749048,0.580090683,N,-,,acetyl- acetyltransferase,"F:transferase activity, transferring acyl groups other than amino-acyl groups; P:metabolic process",IPR020617 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR020616 (PFAM); IPR002155 (TIGRFAM); IPR002155 (PIRSF); IPR016039 (G3DSA:3.40.47.GENE3D); PTHR18919:SF98 (PANTHER); PTHR18919 (PANTHER); IPR016039 (SUPERFAMILY); IPR016039 (SUPERFAMILY),,
RL4_JR_01720,3487,2682,4764,1,1,4,0,0,0,2,0,1,0,8,0,0,0,0,76.8140055,1,-0.248536342,0.665157695,-0.373650255,0.708664539,0.842882935,13.81198102,0,-0.322382196,1.225685854,-0.263021879,0.792533716,0.874344631,64.62136295,1,-0.561106029,0.873602057,-0.642290187,0.520684785,0.650711364,73.61074555,1,0.220334909,0.636755088,0.346027717,0.729321885,0.819667453,35.66934677,0,-3.070401603,1.217904934,-2.521051945,0.011700458,0.035672127,N,-,,FAD-dependent oxidoreductase-like enzyme,,no IPS match,,
RL4_JR_01721,98,71,75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.974509766,0,1.934855444,1.493431025,1.295577373,0.195121129,NA,0.313571841,0,5.138743915,1.690549196,3.039689072,0.002368225,0.015214845,0.809394096,0,2.494164198,1.252647502,1.991114176,0.046468336,0.106919417,0.933409321,0,2.072260947,1.305181594,1.587718488,0.112350011,0.213543055,0.79407231,0,2.418289343,1.22339709,1.976700258,0.048075522,0.108749923,N,-, Effector probability:0.879,guanine-specific ribonuclease n1 t1,P:RNA phosphodiester bond hydrolysis; F:ribonuclease activity,IPR016191 (G3DSA:3.10.450.GENE3D); IPR016191 (SUPERFAMILY),,
RL4_JR_01722,999,991,1246,0,0,8,0,0,0,0,0,0,0,1,0,0,3,0,43.48240848,1,1.891239453,0.557299723,3.393576875,0.000689862,0.004407121,4.116626175,0,1.424017568,1.248925613,1.140194062,0.254205461,0.409030922,10.70041501,0,-1.230718428,1.194198276,-1.030581314,0.302737202,0.444190063,16.35713226,1,-0.706093674,1.144120395,-0.6171498,0.537135923,0.668777819,22.15305375,1,0.883265943,0.855212055,1.032803429,0.301695899,0.437130935,N,-,,Microcystin LR degradation,,IPR015995 (PFAM); IPR009197 (PIRSF); IPR010799 (PFAM),,
RL4_JR_01723,292,255,565,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.412823926,0,-0.24420149,1.29188571,-0.189027163,0.850071528,0.924897776,1.391208071,0,2.988998057,1.414461918,2.113169692,0.034586246,0.088449213,3.644839587,0,0.322814919,1.256593812,0.256896792,0.797258447,0.866685764,4.206948629,0,-0.100220478,1.267543304,-0.07906671,0.936979562,0.963171625,3.634944333,0,0.224312105,1.269334439,0.176716315,0.859731225,0.906747776,N,-,,DUF1338 domain,,IPR009770 (SMART); IPR009770 (PFAM); PTHR39479 (PANTHER); PTHR39479:SF2 (PANTHER),,
RL4_JR_01724,4178,4276,4008,0,0,2,2,0,0,0,0,0,0,0,0,0,0,0,57.6184374,1,-2.016542886,1.009023476,-1.998509384,0.045661464,0.124293033,60.61216824,1,1.133615601,0.979074232,1.157844385,0.246927547,0.400096147,41.38957644,0,-3.182170668,1.188641741,-2.677148681,0.007425168,0.025726351,47.74256047,0,-3.604344989,1.18765224,-3.034848811,0.002406563,0.015402307,40.69223037,0,-3.260454711,1.186557942,-2.747825956,0.005999184,0.020780617,N,-,,hypothetical protein CMQ_6597,P:biological_process; C:cellular_component; F:molecular_function,IPR022085 (PFAM),,
RL4_JR_01725,6,34,36,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.307123006,0,3.60087361,2.746991322,1.310842732,0.189910902,NA,0.095597412,0,6.852084046,2.318023518,2.956002816,0.003116542,0.015916638,0.251539524,0,4.180043539,1.554316116,2.689313645,0.007159911,0.025021381,0.290474537,0,3.756316552,1.922303252,1.954070748,0.050692851,0.124269498,0.251001582,0,4.081631934,1.457451172,2.800527395,0.005101918,0.018201873,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR010291 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23294 (PANTHER); PTHR23294:SF19 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.58.5, the major facilitator superfamily (mfs).
RL4_JR_01726,2,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0.00781203,0,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,0,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,0,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,4.019251067,1,9.900297128,3.251317242,3.045011111,0.002326717,0.014947977,0.006329724,0,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,N,-,,alkanesulfonate monooxygenase,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity",IPR016215 (PIRSF); IPR011251 (PFAM); IPR016215 (TIGRFAM); IPR011251 (G3DSA:3.20.20.GENE3D); PTHR30011:SF16 (PANTHER); PTHR30011 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_01727,751,490,548,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,31.16543069,1,1.402553629,0.867377281,1.617005263,0.105877145,0.230886327,2.299279466,0,2.264387829,1.328588934,1.704355479,0.088314696,0.183857298,5.931035275,0,-0.379296433,1.215518183,-0.312045051,0.755006286,0.835330027,6.839385799,0,-0.801061515,1.215628601,-0.65896896,0.509915701,0.645120139,5.81652631,0,-0.454099159,1.21200303,-0.374668337,0.707907143,0.793741546,N,-,,---NA---,,no IPS match,,
RL4_JR_01728,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.012350936,0,8.240449494,3.992446966,2.064009758,0.039016791,NA,0.003847388,0,11.48786319,3.994462804,2.875946969,0.004028174,0.018161447,0.010076238,0,8.824953261,3.04172355,2.901300239,0.003716176,0.01574077,0.011635085,0,8.399918427,3.993526077,2.103383893,0.035432225,0.099858856,0.009970118,0,8.753059774,1.62090679,5.400100629,6.66E-08,1.61E-06,N,-,,Zn2 Cys6 DNA-binding,"F:DNA binding; C:nucleus; F:zinc ion binding; P:proteolysis; P:regulation of transcription, DNA-templated; F:peptidase activity; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PTHR31845 (PANTHER); PTHR31845:SF14 (PANTHER),,
RL4_JR_01729,6,8,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.103880257,0,5.164549802,3.917025165,1.318487777,0.187340414,NA,0.032741083,0,8.397671435,2.622190363,3.202540728,0.00136221,0.015023052,0.085661608,0,5.73281062,1.512675648,3.789847894,0.00015074,0.001485798,0.098871987,0,5.310782877,2.346505097,2.263273532,0.023618833,0.083034578,0.085194025,0,5.641506692,1.313640015,4.294560632,1.75E-05,0.000160097,N,-,,hypothetical protein FGSG_04870,,no IPS match,,
RL4_JR_01730,24,27,20,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0.285702331,0,3.70514631,2.548074964,1.454096274,0.145919617,NA,0.091579731,0,6.914577987,2.13878216,3.23295103,0.001225186,0.015023052,0.236581846,0,4.269619219,1.336133251,3.195504054,0.001395868,0.007481085,18.89740259,1,5.600634692,1.038607293,5.392446912,6.95E-08,1.64E-06,0.231941845,0,4.19480629,1.249514156,3.357149872,0.000787504,0.003939466,N,-,,hypothetical protein FPOA_06815,,no IPS match,,
RL4_JR_01731,3,3,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.043824634,0,6.409485777,3.931038922,1.630481383,0.102999797,NA,0.013863198,0,9.637213424,3.082152025,3.126780686,0.001767317,0.015023052,0.03620692,0,6.97451837,1.741577292,4.00471366,6.21E-05,0.000852952,0.041784522,0,6.55323706,3.246406824,2.018612397,0.043527522,0.113446415,0.03596668,0,6.884945061,1.364876316,5.044372873,4.55E-07,7.32E-06,N,-,,hypothetical protein SPBR_09238,,no IPS match,,
RL4_JR_01732,17,12,8,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3.966821864,1,5.594246681,1.252380009,4.466892348,7.94E-06,9.49E-05,0.048122816,0,7.843207786,2.464655653,3.182273262,0.001461239,0.015023052,0.123423019,0,5.208524744,1.465067091,3.555144181,0.000377772,0.002775444,0.142281102,0,4.786271405,2.08070803,2.300308998,0.02143072,0.079482067,0.12020446,0,5.140596994,1.297909259,3.960675186,7.47E-05,0.000544797,N,-, Effector probability:0.579,hypothetical protein A1O3_03009,,no IPS match,,
RL4_JR_01733,63,76,64,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,12.27195755,1,4.485247733,0.875938731,5.120503952,3.05E-07,5.32E-06,0.260688462,0,5.405208994,1.737925433,3.11015012,0.001869923,0.015023052,0.675193247,0,2.756139043,1.255188805,2.195796388,0.02810652,0.072820364,0.778879736,0,2.333618293,1.322610157,1.764403729,0.077664031,0.163007527,0.663805038,0,2.677867106,1.223718235,2.188303671,0.02864749,0.072532091,N,-, Effector probability:0.62,homeobox domain containing,F:DNA binding; F:ATP binding; F:protein kinase activity; P:protein phosphorylation,no IPS match,1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_01734,55,23,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.393727078,0,3.242279913,2.325643552,1.3941431,0.163274396,NA,0.12878807,0,6.422770447,2.101125173,3.056824281,0.002236954,0.015045494,0.32919681,0,3.792241644,1.406179425,2.696840515,0.007000079,0.024547557,0.379378609,0,3.371179035,1.647368611,2.046402373,0.040716799,0.108690715,0.319983979,0,3.728617722,1.323616926,2.81699157,0.00484758,0.017479254,N,-,,2OG-Fe(II) oxygenase superfamily,F:oxidoreductase activity; F:metal ion binding,IPR005123 (PFAM); IPR026992 (PFAM); IPR027443 (G3DSA:2.60.120.GENE3D); PTHR10209 (PANTHER); PTHR10209:SF87 (PANTHER); PTHR10209:SF87 (PANTHER); PTHR10209 (PANTHER); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_01735,1,0,1,0,0,0,0,0,0,0,2,9,2,26,25,0,15,3,0.007786068,0,8.896911713,4.040984052,2.201669593,0.027688656,NA,0.002502822,0,12.10389348,4.040376809,2.995733828,0.002737853,0.015349618,74.18102641,1,13.52663698,1.660655436,8.145360372,3.78E-16,4.35E-14,363.8154377,1,15.53335096,1.262687349,12.30181879,8.86E-35,1.87E-32,80.01094684,1,13.95943508,1.175285009,11.87748927,1.55E-32,9.81E-30,Y,-,,Amidohydrolase family,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds",G3DSA:3.20.20.140 (GENE3D); IPR006680 (PFAM); IPR011059 (G3DSA:2.30.40.GENE3D); IPR011059 (G3DSA:2.30.40.GENE3D); PTHR11271:SF7 (PANTHER); PTHR11271 (PANTHER); PS51257 (PROSITE_PROFILES); IPR011059 (SUPERFAMILY); IPR011059 (SUPERFAMILY); IPR032466 (SUPERFAMILY),,
RL4_JR_01736,2406,2187,2994,2,1,2,0,0,1,0,2,0,0,3,0,0,0,0,66.05562125,1,0.036512128,0.673963586,0.054175223,0.95679556,0.978015059,19.01740172,1,1.113430497,1.11831318,0.995633886,0.319428064,0.481425084,40.74553817,1,-0.634064493,1.033798011,-0.61333499,0.539654862,0.668026381,40.94699527,1,-0.579865464,0.859837314,-0.674389742,0.500063563,0.638077325,24.77066799,0,-2.544342576,1.200236407,-2.119867854,0.034017191,0.082967481,N,-,,nuclear distribution nudE,P:mycelium development,IPR006964 (PFAM); IPR033494 (PANTHER); PTHR10921:SF1 (PANTHER),,
RL4_JR_01737,22584,28116,17225,0,8,27,0,1,2,3,5,0,8,7,0,0,3,1,441.312982,1,-0.612532693,0.725444766,-0.844354693,0.398471232,0.590351919,145.037831,1,-0.794473553,0.897015759,-0.885685168,0.375787203,0.54037762,299.3421296,1,-1.779887578,0.610209032,-2.916848957,0.00353587,0.015317562,364.2911482,1,-1.391126837,0.543038483,-2.561746322,0.010414736,0.05002334,241.0034233,1,-3.10699485,0.79957868,-3.885790016,0.000101998,0.000705896,N,-,,acetyl- carboxylase,F:ATP binding; F:acetyl-CoA carboxylase activity; F:metal ion binding; F:biotin carboxylase activity; P:fatty acid biosynthetic process,IPR005482 (SMART); IPR013537 (PFAM); IPR000089 (PFAM); IPR016185 (G3DSA:3.40.50.GENE3D); IPR005479 (PFAM); IPR005482 (PFAM); IPR013815 (G3DSA:3.30.1490.GENE3D); IPR005481 (PFAM); IPR029045 (G3DSA:3.90.226.GENE3D); IPR029045 (G3DSA:3.90.226.GENE3D); G3DSA:2.40.50.100 (GENE3D); IPR013816 (G3DSA:3.30.470.GENE3D); IPR000022 (PFAM); PTHR18866 (PANTHER); PTHR18866:SF6 (PANTHER); PTHR18866 (PANTHER); PTHR18866 (PANTHER); PTHR18866 (PANTHER); PTHR18866:SF6 (PANTHER); PTHR18866:SF6 (PANTHER); PTHR18866:SF6 (PANTHER); IPR011764 (PROSITE_PROFILES); IPR011763 (PROSITE_PROFILES); IPR011762 (PROSITE_PROFILES); IPR000089 (PROSITE_PROFILES); IPR011761 (PROSITE_PROFILES); IPR016185 (SUPERFAMILY); IPR029045 (SUPERFAMILY); SSF56059 (SUPERFAMILY); IPR029045 (SUPERFAMILY); IPR011053 (SUPERFAMILY); IPR011054 (SUPERFAMILY),3.B.1.1.5, the na(+)-transporting carboxylic acid decarboxylase (nat-dc) family.
RL4_JR_01738,199,263,212,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,2.713789255,0,0.457638325,1.259466115,0.363358982,0.716336739,0.847992575,0.865668145,0,3.67370051,1.44195951,2.547714055,0.010843131,0.035785514,16.58484666,1,2.844857027,1.045305248,2.721556245,0.006497533,0.023198876,2.587737478,0,0.601399538,1.232606413,0.487908818,0.625614428,0.742422186,2.205767169,0,0.945194851,1.215689313,0.777497047,0.436865576,0.571702722,N,-,,leucine-rich repeat-containing 40,P:biological_process; C:cellular_component,IPR003591 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR23155:SF419 (PANTHER); PTHR23155 (PANTHER); PTHR23155:SF419 (PANTHER); PTHR23155 (PANTHER); PTHR23155:SF419 (PANTHER); PTHR23155 (PANTHER); PTHR23155 (PANTHER); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY); IPR032675 (SUPERFAMILY),8.A.43.1.2, the neat-domain containing methaemoglobin heme sequestration (n-mhs) family.
RL4_JR_01739,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_01740,163,268,291,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6.719428035,1,1.305465991,1.198668206,1.089097037,0.276111097,0.459134596,0.916506173,0,3.591232321,1.450875814,2.47521689,0.013315528,0.041870077,2.391056135,0,0.931301843,1.243513687,0.748927698,0.453900785,0.593247037,2.759483678,0,0.508406051,1.257355416,0.404345537,0.685958644,0.787006376,2.368484308,0,0.842497777,1.245467278,0.676451154,0.498754249,0.626614564,N,-,,-ribulosamine 3- chloroplastic,P:phosphorylation; F:kinase activity,G3DSA:3.90.1200.10 (GENE3D); IPR016477 (PFAM); PTHR12149:SF8 (PANTHER); PTHR12149 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_01741,47,31,49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.505003982,0,2.88316418,1.977952752,1.457650683,0.144936852,NA,0.161508617,0,6.095741019,1.912894849,3.186657658,0.00143927,0.015023052,0.418972562,0,3.443309353,1.292627598,2.663806156,0.007726207,0.026650807,0.483295844,0,3.021502125,1.436759205,2.102998272,0.035465921,0.099858856,0.413518693,0,3.359587012,1.245994448,2.696309778,0.007011243,0.02364718,N,-,,Dual specificity phosphatase,F:phosphatase activity; P:dephosphorylation,IPR020422 (SMART); IPR029021 (G3DSA:3.90.190.GENE3D); IPR000340 (PFAM); IPR024950 (PANTHER); IPR000387 (PROSITE_PROFILES); IPR020422 (PROSITE_PROFILES); IPR029021 (SUPERFAMILY),,
RL4_JR_01742,19,23,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.233710279,0,3.994950036,2.7855525,1.434167921,0.151524349,NA,0.074872742,0,7.205206738,2.229134628,3.232288732,0.001228029,0.015023052,0.193432626,0,4.5603375,1.363378248,3.344880635,0.00082318,0.004925457,0.223106643,0,4.137359548,1.749225244,2.365252595,0.018017777,0.073323953,0.189596203,0,4.485949772,1.259384631,3.562017243,0.000368016,0.002088657,N,-,,-ribulosamine 3- chloroplastic,P:phosphorylation; F:kinase activity,G3DSA:3.90.1200.10 (GENE3D); IPR016477 (PFAM); IPR016477 (PIRSF); PTHR12149:SF8 (PANTHER); PTHR12149 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_01743,133,121,99,0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,20.88190137,1,4.112523258,0.760271324,5.40928367,6.33E-08,1.31E-06,0.455332539,0,4.600662476,1.588470613,2.896284287,0.003776101,0.017556495,1.174704322,0,1.95711507,1.239901919,1.578443456,0.114463769,0.214360191,1.354719805,0,1.535089159,1.268874281,1.209803983,0.226354118,0.362002123,1.15080489,0,1.883393887,1.217058493,1.547496605,0.121743542,0.221776748,N,-,,Vegetative incompatibility HET-E-1,,IPR001680 (SMART); G3DSA:1.20.1250.20 (GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR011701 (PFAM); IPR007751 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR23502 (PANTHER); PTHR23502:SF51 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR029058 (SUPERFAMILY); IPR020846 (SUPERFAMILY); IPR017986 (SUPERFAMILY); IPR027417 (SUPERFAMILY),2.A.1.2.36, the major facilitator superfamily (mfs).
RL4_JR_01744,4,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.027264219,0,7.09266555,3.945667758,1.797583067,0.072243104,NA,0.00884399,0,10.28583024,3.94513053,2.60722178,0.009128022,0.031480012,0.022837536,0,7.63887585,2.595985499,2.94257262,0.003254974,0.014386683,0.026329428,0,7.218834036,3.945265266,1.829746176,0.067287903,0.147083336,0.022531091,0,7.549319782,1.563189439,4.829433715,1.37E-06,1.88E-05,N,-,,60s ribosomal l36,"C:integral component of membrane; P:photosynthesis, light reaction",PTHR33048 (PANTHER),9.B.313.1.6, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_01745,6,2,17,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,11.55352956,1,7.392178959,1.205202838,6.133555886,8.59E-10,2.39E-08,0.030537314,0,8.497143622,2.848846741,2.982660843,0.002857545,0.015349618,0.080805126,0,5.814983583,1.768137088,3.288762858,0.001006288,0.005785154,0.093309597,0,5.393561246,2.653831754,2.032367439,0.042116472,0.111368315,0.081608051,0,5.701366948,1.513753077,3.766378437,0.000165633,0.001064106,N,-,,flavo involved in k+ transport,F:oxidoreductase activity,PR00411 (PRINTS); PR00368 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); PF13738 (PFAM); PTHR23023:SF100 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_01746,1,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.020137004,0,7.532070575,3.959425631,1.902313941,0.057130124,NA,0.00635021,0,10.76388836,3.598755407,2.991003039,0.002780627,0.015349618,0.016578504,0,8.1036955,2.10844956,3.843438162,0.000121323,0.001301133,0.019134407,0,7.680437669,3.959684783,1.939658859,0.052421163,0.126072273,0.016425528,0,8.020782431,1.468643254,5.461355174,4.73E-08,1.26E-06,N,-,,integral membrane,C:integral component of membrane; P:oxidation-reduction process,IPR006593 (SMART); PTHR23130 (PANTHER); PTHR23130:SF61 (PANTHER); IPR006593 (PROSITE_PROFILES),5.B.2.3.4, the eukaryotic cytochrome b561 (cytb561) family.
RL4_JR_01747,6,4,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3.878332013,1,6.901500559,1.271320139,5.428609481,5.68E-08,1.19E-06,0.019209811,0,9.16763723,2.895003388,3.166710363,0.001541738,0.015023052,0.049651487,0,6.520597687,1.626181743,4.009759495,6.08E-05,0.000841783,0.057262524,0,6.098921862,2.859605022,2.132784708,0.032942391,0.097138839,0.048801052,0,6.44077234,1.328958503,4.846481153,1.26E-06,1.76E-05,N,-,,P-type ATPase,F:nucleotide binding; F:ATP binding; F:metal ion binding; C:membrane; C:integral component of membrane; P:metal ion transport; F:hydrolase activity,PR00119 (PRINTS); IPR023299 (G3DSA:3.40.1110.GENE3D); IPR023214 (G3DSA:3.40.50.GENE3D); IPR001757 (TIGRFAM); G3DSA:3.30.70.100 (GENE3D); IPR006121 (PFAM); IPR008250 (PFAM); IPR008250 (G3DSA:2.70.150.GENE3D); PF00702 (PFAM); PTHR24093:SF50 (PANTHER); PTHR24093 (PANTHER); IPR006121 (PROSITE_PROFILES); IPR006121 (SUPERFAMILY); SSF81653 (SUPERFAMILY); IPR023214 (SUPERFAMILY),3.A.3.5.20, the p-type atpase (p-atpase) superfamily.
RL4_JR_01748,2,0,3,0,0,22,0,0,0,0,0,0,0,4,0,0,2,2,84.02763784,1,12.10465958,2.761445574,4.383450356,1.17E-05,0.000132541,0.006172944,0,10.80242385,3.961531915,2.726829944,0.006394599,0.024293008,0.016176062,0,8.134334048,2.743339398,2.965121287,0.003025636,0.013662596,16.06501907,1,10.01985246,1.88660968,5.311036285,1.09E-07,2.42E-06,22.46824352,1,10.65055958,1.014698959,10.49627527,8.99E-26,3.25E-23,N,-,,hypothetical protein FOWG_14410,C:membrane,no IPS match,,
RL4_JR_01749,0,0,0,1,0,27,0,0,0,0,0,0,0,0,0,0,0,0,113.1663184,1,15.65497964,3.923731225,3.989819573,6.61E-05,0.000590839,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.78,transcription factor cmr1,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; P:oxidation-reduction process",IPR025951 (PFAM); IPR025568 (PFAM),,
RL4_JR_01750,36,11,25,0,0,7,0,0,0,0,0,0,2,0,0,0,11,0,27.01408497,1,7.039290807,0.85197586,8.262312512,1.43E-16,1.15E-14,0.092001798,0,6.907701549,2.223950355,3.106050246,0.001896045,0.015023052,0.237170665,0,4.264208827,1.434520164,2.972568064,0.002953197,0.013463048,18.89798163,1,5.635660033,1.105505201,5.097814129,3.44E-07,6.92E-06,42.69882888,1,7.761332105,1.390082915,5.583359108,2.36E-08,8.07E-07,N,-,,a retinal short-chain dehydrogenase reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); SM00822 (SMART); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24320:SF34 (PANTHER); PTHR24320 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_01751,154,108,232,0,0,0,0,0,0,1,5,12,9,20,2,0,4,9,1.959126287,0,0.927209708,1.358999914,0.682273559,0.495065989,NA,0.621208748,0,4.15217724,1.539161012,2.697688681,0.00698227,0.025919592,129.8911814,1,6.428947186,0.498533994,12.89570474,4.76E-38,1.93E-35,185.183948,1,6.684597925,0.462726156,14.44612076,2.65E-47,1.03E-44,83.34300387,1,5.774918806,0.609500219,9.47484287,2.67E-21,7.31E-19,N,-,,heavy metal translocating p-type ATPase,F:nucleotide binding; F:ATP binding; F:metal ion binding; C:membrane; C:integral component of membrane; P:metal ion transport; F:hydrolase activity,G3DSA:1.20.5.170 (GENE3D); IPR021833 (PFAM); SSF57959 (SUPERFAMILY),,
RL4_JR_01752,791,715,859,0,0,0,0,0,0,0,3,1,0,3,0,0,2,0,9.450963883,0,-1.34292283,1.187888166,-1.130512845,0.258260189,0.437294857,3.017240383,0,1.872279244,1.26937557,1.474960829,0.140223075,0.262306036,37.85501374,1,2.042863835,0.737723382,2.769146112,0.005620342,0.020698562,21.06442572,1,1.104911859,0.849569069,1.300555657,0.193410594,0.322829255,15.43900412,1,0.806678887,0.975906792,0.826594193,0.40846711,0.544403075,N,-,,hypothetical protein LY89DRAFT_692397,C:membrane; C:integral component of membrane,IPR019378 (PFAM),,
RL4_JR_01753,676,522,659,0,0,6,0,0,0,2,0,5,2,3,0,0,18,0,30.31964474,1,2.298752838,0.618735225,3.715244817,0.000203007,0.001560916,2.37156686,0,2.219678104,1.298286457,1.709698266,0.087321684,0.182241254,60.77738012,1,3.196782192,0.578672169,5.52434066,3.31E-08,1.25E-06,37.74593114,1,2.197432224,0.672322919,3.268417844,0.001081506,0.007889226,75.54092784,1,3.67745574,1.492753582,2.463538379,0.013757317,0.040551042,N,-,,Acyltransferase 3,F:transferase activity,IPR002656 (PFAM); PTHR23028 (PANTHER); PTHR23028:SF58 (PANTHER); PTHR23028 (PANTHER); PTHR23028:SF58 (PANTHER),,
RL4_JR_01754,21,13,33,0,0,0,0,0,0,0,0,3,0,3,0,0,0,0,0.265128804,0,3.812689859,2.686023896,1.419454929,0.155766428,NA,0.083987434,0,7.038715,2.208773793,3.186707041,0.001439025,0.015023052,19.71568556,1,6.75940631,0.917104163,7.370380138,1.70E-13,1.50E-11,12.28805145,1,6.213225023,0.943772952,6.583389586,4.60E-11,1.84E-09,0.218467382,0,4.280485217,1.308340087,3.271691557,0.001069061,0.005034533,Y,-,,fibronectin type iii domain-containing,C:membrane; C:integral component of membrane,IPR013830 (PFAM); IPR013830 (G3DSA:3.40.50.GENE3D); IPR013830 (SUPERFAMILY),,
RL4_JR_01755,55,40,71,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14.54364938,1,4.231580453,1.03827161,4.075600654,4.59E-05,0.000434359,0.209933782,0,5.717326697,1.820849313,3.139923034,0.001689922,0.015023052,0.54646329,0,3.05987341,1.282936731,2.385054022,0.017076614,0.049480147,0.630492954,0,2.637812233,1.38543729,1.903956427,0.056915859,0.132629016,0.541287703,0,2.971575694,1.251404133,2.37459316,0.017568302,0.049219702,N,-,,alternative sulfate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662 (PANTHER); PTHR11662:SF217 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.43, the major facilitator superfamily (mfs).
RL4_JR_01756,0,5,3,0,0,2,4,0,0,0,0,0,0,1,0,0,0,0,7.669925152,1,8.487367264,1.344278436,6.313697396,2.72E-10,8.48E-09,89.25777934,1,13.09549786,2.571068237,5.093407351,3.52E-07,3.46E-05,0.02677636,0,7.413229196,2.562269014,2.893228289,0.00381304,0.015971544,4.042509783,1,7.93545383,1.388192494,5.71639298,1.09E-08,2.97E-07,0.026570569,0,7.328813904,1.622053555,4.518231768,6.24E-06,6.83E-05,N,-,,alpha-ketoglutarate-dependent sulfonate dioxygenase,,IPR003819 (PFAM); G3DSA:3.60.130.10 (GENE3D); PTHR30468 (PANTHER); PTHR30468:SF1 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_01757,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.076520265,0,5.605716893,3.920688782,1.429778594,0.152780575,NA,0.025406586,0,8.764944643,3.920178038,2.235853718,0.025361355,0.069286811,0.064135328,0,6.152966818,2.351357919,2.616771683,0.008876569,0.029766939,0.073862852,0,5.732065233,3.920545801,1.462057969,0.143725325,0.257834677,0.061356843,0,6.111075122,1.778672001,3.435751571,0.000590913,0.003114518,N,-,,hypothetical protein IQ07DRAFT_606115,,no IPS match,,
RL4_JR_01758,22,6,40,0,0,6,0,0,0,0,0,8,0,0,1,0,6,0,23.17787046,1,6.846584014,1.044950478,6.552065535,5.67E-11,2.07E-09,0.084113743,0,7.03632667,2.354480303,2.988483982,0.002803652,0.015349618,52.21071554,1,7.94543359,1.69678981,4.682626888,2.83E-06,6.46E-05,9.89019276,1,4.908363379,1.309792515,3.747435814,0.000178652,0.001745991,23.38450168,1,7.063347208,1.439883128,4.905500363,9.32E-07,1.36E-05,N,-,,sugar transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,IPR003663 (PRINTS); IPR003663 (TIGRFAM); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500 (PANTHER); PTHR23500:SF46 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.39, the major facilitator superfamily (mfs).
RL4_JR_01759,99,71,98,0,0,17,0,0,0,0,0,1,1,5,3,0,10,2,65.98307319,1,6.175358548,0.938696137,6.57865555,4.75E-11,1.75E-09,0.341755247,0,5.014455005,1.655776012,3.028462164,0.002458019,0.015349618,7.384403006,1,3.325053483,1.205907839,2.75730315,0.005828029,0.02130071,59.29766228,1,5.840546542,0.530783577,11.00363084,3.67E-28,5.47E-26,54.20924738,1,6.437625188,0.502732488,12.80526988,1.53E-37,1.41E-34,N,-,,glycoside hydrolase family 55,C:membrane; F:lyase activity; C:integral component of membrane; F:hydrolase activity,IPR024535 (PFAM); IPR012334 (G3DSA:2.160.20.GENE3D); PTHR31375:SF6 (PANTHER); PTHR31375 (PANTHER); PTHR31375:SF6 (PANTHER); IPR011050 (SUPERFAMILY); IPR011050 (SUPERFAMILY),,
RL4_JR_01760,6,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.03931169,0,6.565648311,3.933804284,1.669032783,0.095110883,NA,0.012855081,0,9.747348017,3.28134605,2.970533394,0.002972831,0.015526829,0.032951365,0,7.111040039,1.946326184,3.653570556,0.000258619,0.002077981,0.037975967,0,6.691091891,3.53588503,1.892338646,0.058445875,0.134982775,0.032200601,0,7.034092995,1.445232152,4.867102483,1.13E-06,1.61E-05,Y,-,,alpha beta-hydrolase,,IPR029058 (G3DSA:3.40.50.GENE3D); IPR022742 (PFAM); IPR029058 (SUPERFAMILY),,
RL4_JR_01761,42,27,27,0,0,0,1,0,0,0,0,0,0,0,3,0,0,0,0.38317097,0,3.281540694,2.248268214,1.459585949,0.144403903,NA,22.43568455,1,7.414205698,1.151825863,6.436915455,1.22E-10,2.47E-08,0.318735819,0,3.838803293,1.323926836,2.899558486,0.003736886,0.015764501,29.27336486,1,5.773953387,0.884353037,6.529014029,6.62E-11,2.58E-09,0.311943196,0,3.765532973,1.252570846,3.006243508,0.002644971,0.010733599,N,-,,Transcriptional regulatory moc3,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR38111 (PANTHER); PTHR38111:SF1 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_01762,70,38,97,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.810732969,0,2.200130721,1.717719802,1.280843778,0.200248544,NA,0.257636321,0,5.421853089,1.799713761,3.012619678,0.002590033,0.015349618,0.671979395,0,2.761565654,1.316145729,2.098221795,0.035885557,0.087797337,0.77536199,0,2.339345729,1.412848912,1.655764965,0.097769425,0.192703024,0.6676353,0,2.668860517,1.291891353,2.065855237,0.038842151,0.091945749,N,-,,hypothetical protein VFPFJ_06164,,no IPS match,,
RL4_JR_01763,45,30,37,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0.446395871,0,3.061180017,2.083252312,1.469423554,0.141717942,NA,0.143489936,0,6.266551408,1.958038403,3.200423137,0.00137226,0.015023052,0.370800385,0,3.620061704,1.297290719,2.790478381,0.005263021,0.019647061,0.427635004,0,3.198252577,1.46501712,2.183082049,0.029029768,0.090493422,15.0953334,1,5.233820341,0.992720713,5.272198187,1.35E-07,2.91E-06,N,-,,kinase-like domain,F:ATP binding; C:membrane; C:integral component of membrane; F:protein kinase activity; P:phosphorylation; F:protein serine/threonine kinase activity; P:protein phosphorylation; F:kinase activity,G3DSA:1.10.510.10 (GENE3D); IPR010440 (PFAM); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.1, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_01764,50,25,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.394308046,0,3.240172425,2.271932621,1.426174524,0.153817971,NA,0.128292441,0,6.428281773,2.061048215,3.118938085,0.001815041,0.015023052,0.32896242,0,3.793260974,1.365110928,2.778719952,0.005457355,0.020190971,0.379192095,0,3.371882042,1.589364108,2.121528998,0.03387731,0.098678874,0.320710881,0,3.725334803,1.28776126,2.892876901,0.003817309,0.014380596,Y,-,,endo-N-acetyl-beta-D-glucosaminidase precursor,F:hydrolase activity,IPR013781 (G3DSA:3.20.20.GENE3D); IPR001223 (PFAM); PTHR11177:SF160 (PANTHER); PTHR11177 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_01765,1759,1756,2021,0,0,9,0,0,0,0,0,2,0,5,2,0,8,2,56.51668738,1,1.29308391,0.516529956,2.503405456,0.012300454,0.044817822,7.061414413,0,0.645551772,1.22146254,0.52850722,0.597147337,0.732734313,31.32822752,1,-0.18619942,1.028180207,-0.181096094,0.85629215,0.908688308,60.47602045,1,1.101771414,0.565476988,1.948393016,0.051367955,0.125200274,63.69710825,1,1.834148525,0.497451415,3.687090777,0.000226832,0.00138521,N,-,,peptidase family M20 M25 M40,F:carboxypeptidase activity; C:membrane; P:proteolysis; F:metallopeptidase activity,IPR011650 (G3DSA:3.30.70.GENE3D); G3DSA:3.40.630.10 (GENE3D); IPR017141 (PIRSF); IPR002933 (PFAM); IPR011650 (PFAM); PTHR11014 (PANTHER); PTHR11014:SF16 (PANTHER); IPR011650 (SUPERFAMILY); SSF53187 (SUPERFAMILY),,
RL4_JR_01766,55,55,45,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4.440936366,1,3.528540812,1.178771238,2.99340593,0.002758825,0.0134913,0.199684664,0,5.78987621,1.832700756,3.159204356,0.001582005,0.015023052,0.515788852,0,3.144766436,1.270578414,2.475066789,0.013321126,0.040523762,0.59488284,0,2.722415637,1.372774113,1.98314902,0.047350786,0.118934932,0.505830247,0,3.069487156,1.226714973,2.502200776,0.012342391,0.037259006,N,-,,MFS transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF269 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.4, the major facilitator superfamily (mfs).
RL4_JR_01767,653,695,601,1,0,11,0,0,0,0,0,0,1,4,0,0,0,0,59.89562733,1,3.172534981,0.498679239,6.361874992,1.99E-10,6.48E-09,2.504974108,0,2.140786356,1.296287316,1.651475202,0.09864158,0.200451732,6.480446751,0,-0.506926347,1.200031895,-0.422427395,0.672713086,0.774894445,32.8335586,1,2.110996296,0.675468348,3.125233481,0.00177664,0.011992319,6.365424812,0,-0.583991811,1.19623022,-0.488193494,0.625412792,0.729888209,N,-,,carboxypeptidase S,F:metallocarboxypeptidase activity; P:proteolysis; C:integral component of membrane,G3DSA:3.40.630.10 (GENE3D); IPR002933 (PFAM); IPR011650 (PFAM); IPR011650 (G3DSA:3.30.70.GENE3D); IPR017141 (PIRSF); PTHR11014 (PANTHER); PTHR11014:SF16 (PANTHER); SSF53187 (SUPERFAMILY); IPR011650 (SUPERFAMILY),,
RL4_JR_01768,564,910,321,0,0,4,0,0,0,0,0,0,0,5,0,0,0,0,22.57695642,1,1.6272213,0.946020464,1.720069874,0.085419741,0.197434761,2.347378255,0,2.234572655,1.431505503,1.560994806,0.118524976,0.231336254,6.038239227,0,-0.404960755,1.284054937,-0.315376502,0.752475806,0.833942535,27.02135672,1,2.082010332,0.867042995,2.40127692,0.016337967,0.069156321,5.880452615,0,-0.469668377,1.284917528,-0.365524142,0.714720189,0.798823481,N,-,,OPT oligopeptide transporter,P:transmembrane transport; C:integral component of membrane,IPR004813 (PFAM); IPR004813 (TIGRFAM); PTHR22601 (PANTHER); PTHR22601:SF3 (PANTHER),2.A.67.1.6, the oligopeptide transporter (opt) family.
RL4_JR_01769,101,55,146,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.193944539,0,1.641674156,1.543188781,1.063819395,0.287410523,NA,0.37901595,0,4.864950704,1.69317377,2.873273133,0.004062427,0.018251171,0.989327199,0,2.203724783,1.304103953,1.689838282,0.091058898,0.180619177,1.141583835,0,1.781300879,1.366965641,1.303105818,0.192538638,0.321745124,0.983759204,0,2.109698605,1.292821884,1.63185558,0.102709913,0.194854389,N,-,,heterokaryon incompatibility,,IPR010730 (PFAM); PTHR33112:SF6 (PANTHER); PTHR33112 (PANTHER),,
RL4_JR_01770,1323,239,1067,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.31994488,0,-1.469781807,1.394051696,-1.054323747,0.29173472,0.476757181,3.332675912,0,1.728809983,1.490010096,1.160267294,0.245939996,0.399006995,8.615699543,0,-0.918048122,1.345545143,-0.682287121,0.495057415,0.628065322,9.93471421,0,-1.339721367,1.365489061,-0.98112933,0.326528969,0.473044185,8.496335525,0,-1.000676513,1.366264851,-0.732417665,0.46391368,0.594897802,N,-,,hypothetical protein PFICI_12526,P:metabolic process; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR001375 (PFAM); IPR013094 (PFAM); PTHR23024:SF169 (PANTHER); PTHR23024 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_01771,2930,2535,2412,1,0,6,0,0,0,0,0,0,0,5,0,0,0,2,64.51684171,1,0.434334163,0.579215334,0.749866479,0.453335125,0.642400156,10.12562036,0,0.125621102,1.225042756,0.10254426,0.918324684,0.955027479,26.1605068,0,-2.520293434,1.193547579,-2.11159863,0.03472089,0.085863255,50.22946221,1,0.08516313,0.680912755,0.125072014,0.900466539,0.938855288,40.4071732,1,-0.91251179,0.967302224,-0.943357481,0.345498084,0.482705685,N,-,,hypothetical protein BN14_07679,C:integral component of membrane; P:transport,IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); PTHR24089:SF112 (PANTHER); PTHR24089 (PANTHER); PTHR24089 (PANTHER); PTHR24089:SF112 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.9.3, the mitochondrial carrier (mc) family.
RL4_JR_01772,8,7,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.084176526,0,5.46803547,3.91942346,1.395112196,0.162982009,NA,0.027068289,0,8.673149337,2.710606404,3.199708126,0.001375668,0.015023052,0.069841554,0,6.029654598,1.531669627,3.936654805,8.26E-05,0.001035271,0.08054415,0,5.607022862,2.505696814,2.237710018,0.025239972,0.085851084,0.068440679,0,5.954283782,1.302034219,4.573062438,4.81E-06,5.49E-05,N,-,,xenobiotic compound family,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity",IPR016215 (PIRSF); IPR016215 (TIGRFAM); IPR011251 (G3DSA:3.20.20.GENE3D); IPR011251 (PFAM); PTHR30011 (PANTHER); PTHR30011:SF19 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_01773,1,1,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.031421776,0,6.888609831,3.94055895,1.74813013,0.080441497,NA,0.009679363,0,10.15254406,3.507654408,2.894396904,0.003798876,0.017606331,0.025812266,0,7.458756788,2.13401524,3.495175033,0.000473751,0.003250627,0.029822227,0,7.038792789,3.940767919,1.786147505,0.074075378,0.157153744,0.026247932,0,7.340866041,1.554023214,4.723781456,2.31E-06,2.94E-05,N,-,,sodium solute symporter,C:integral component of membrane; F:transporter activity,no IPS match,,
RL4_JR_01774,962,991,1021,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,11.91644279,0,-1.677072049,1.186703959,-1.413218551,0.157591474,0.306762878,3.804569493,0,1.537804732,1.253956287,1.226362312,0.220062362,0.3679338,9.863583692,0,-1.113081654,1.190692494,-0.934818738,0.349881721,0.493480433,19.40168815,1,0.193395318,1.010417375,0.191401418,0.84821111,0.904871719,9.713973613,0,-1.193797285,1.191450621,-1.001969586,0.316358282,0.451781045,N,-,,glycosyltranserase family 2,C:membrane; C:integral component of membrane,PF13704 (PFAM); PTHR21461 (PANTHER); PTHR21461:SF15 (PANTHER); PTHR21461:SF15 (PANTHER); PTHR21461 (PANTHER),,
RL4_JR_01775,539,528,500,0,0,9,2,0,0,0,0,0,0,4,0,0,0,0,40.64866657,1,3.110955093,0.517931758,6.006496119,1.90E-09,4.96E-08,46.63482849,1,4.127699137,0.982857154,4.199693841,2.67E-05,0.001502983,5.203875069,0,-0.190453709,1.198565896,-0.158901325,0.873746617,0.920384013,22.04878829,1,2.103862593,0.744918499,2.824285604,0.004738614,0.026923943,5.114541086,0,-0.268380182,1.194125315,-0.224750434,0.822173428,0.880902849,N,-,,triose-phosphate transporter,C:integral component of membrane,IPR004853 (PFAM); PTHR11132 (PANTHER); PTHR11132:SF128 (PANTHER),2.A.7.9.17, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_01776,3791,2445,1715,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.81764696,0,-3.094088872,1.245197805,-2.484817158,0.012961799,0.046674295,10.34129423,0,0.09521571,1.289596939,0.073833697,0.941142714,0.967934654,26.50700385,0,-2.539288092,1.238117566,-2.050926472,0.040274108,0.096141256,30.55538883,0,-2.960514836,1.242986814,-2.381774933,0.017229424,0.071407253,25.80705649,0,-2.603509411,1.23686065,-2.104933496,0.035297097,0.085355412,N,-,,Ankyrin repeat-containing,"F:hydrolase activity, acting on ester bonds; F:catalytic activity; P:nucleoside metabolic process",IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PF05729 (PFAM); IPR020683 (PFAM); PTHR24151 (PANTHER); PTHR24151 (PANTHER); PTHR24151:SF1 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY),8.A.28.1.1, the ankyrin (ankyrin) family.
RL4_JR_01777,29,19,31,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.314029463,0,3.568555498,2.448233468,1.457604246,0.144949659,NA,0.100377285,0,6.781875823,2.100533615,3.228644272,0.001243785,0.015023052,0.260503516,0,4.128655213,1.331988106,3.099618678,0.001937699,0.009606889,0.300504696,0,3.707016184,1.603354559,2.312037699,0.020775606,0.078120428,0.257243896,0,4.044231125,1.257610743,3.215805166,0.001300791,0.005927322,Y,-,,"extracellular endo-1,5-alpha-L-","P:arabinan catabolic process; P:hemicellulose catabolic process; C:extracellular region; F:arabinan endo-1,5-alpha-L-arabinosidase activity",IPR006710 (PFAM); IPR016840 (PIRSF); IPR023296 (G3DSA:2.115.10.GENE3D); IPR006710 (PANTHER); PTHR22925:SF41 (PANTHER); IPR023296 (SUPERFAMILY),,
RL4_JR_01778,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_01779,216,183,216,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,34.49738074,1,3.339750128,0.73576478,4.539154657,5.65E-06,7.04E-05,0.785837704,0,3.813221627,1.44364394,2.64138651,0.008256746,0.029217138,2.03627039,0,1.162935903,1.212228268,0.95933739,0.337388805,0.480681715,2.348854707,0,0.740749262,1.218904751,0.607717101,0.543375119,0.673981306,2.005549195,0,1.082104741,1.204763535,0.898188491,0.369085068,0.505202963,N,-,,D-amino-acid oxidase,F:oxidoreductase activity; P:oxidation-reduction process,IPR023753 (G3DSA:3.50.50.GENE3D); IPR006076 (PFAM); PTHR13847 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_01780,196,313,261,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,43.15459627,1,3.424170395,0.770522609,4.443958365,8.83E-06,0.000104421,0.985861445,0,3.486088299,1.432262249,2.433973459,0.01493409,0.045960128,2.561180544,0,0.832383105,1.233375057,0.67488239,0.49975049,0.632623313,2.95514882,0,0.409769964,1.243337931,0.329572479,0.74172302,0.82827237,2.524498673,0,0.750486627,1.230456953,0.609925138,0.541911399,0.664055782,N,-,,transcriptional regulator,F:organic cyclic compound binding; F:heterocyclic compound binding,IPR007396 (PFAM); IPR012349 (G3DSA:2.30.110.GENE3D); PTHR35802 (PANTHER); PTHR35802:SF1 (PANTHER); IPR012349 (SUPERFAMILY),,
RL4_JR_01781,135,156,169,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.843769819,0,1.01509068,1.288080569,0.788064586,0.430658928,NA,0.586616076,0,4.235008174,1.503926668,2.815967203,0.004863063,0.02028401,1.524205239,0,1.580903031,1.222070507,1.293626696,0.195794397,0.32049221,1.758559285,0,1.158413948,1.237615721,0.936004552,0.349270844,0.495990505,1.504365423,0,1.497352021,1.214070012,1.233332514,0.217451732,0.342730197,N,-,,O-methyltransferase,F:O-methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PF13578 (PFAM); PTHR10509:SF10 (PANTHER); PTHR10509 (PANTHER); IPR002935 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_01782,62,49,59,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.678632676,0,2.456897958,1.706445082,1.439775581,0.149930902,NA,0.217335251,0,5.667536633,1.794341528,3.1585607,0.001585503,0.015023052,0.562791293,0,3.018110372,1.259567612,2.396147966,0.0165684,0.048214569,0.649151417,0,2.596075231,1.346125343,1.928553864,0.053786271,0.127765932,0.554013236,0,2.937816516,1.224114927,2.399951549,0.016397242,0.046622318,N,-,,Cupin 1,F:nutrient reservoir activity,IPR006045 (PFAM); IPR014710 (G3DSA:2.60.120.GENE3D); PTHR36448:SF2 (PANTHER); PTHR36448 (PANTHER); PTHR36448 (PANTHER); IPR011051 (SUPERFAMILY),,
RL4_JR_01783,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.02328032,0,7.320019174,3.952269238,1.852105394,0.06401069,NA,0.007003795,0,10.61631824,3.954945293,2.684314813,0.007267863,0.026654099,0.019029174,0,7.901223933,3.905233982,2.023239573,0.043048454,0.100861501,0.02200715,0,7.475566337,3.952720027,1.8912461,0.0585915,0.135014457,0.019743285,0,7.750549064,2.275366972,3.406285298,0.000658533,0.003408819,N,-,,"hypothetical protein MYCTH_2071531, partial",,no IPS match,,
RL4_JR_01784,0,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.016230989,0,7.844051975,3.972032729,1.974820579,0.048288513,NA,0.005014687,0,11.10319729,3.974116214,2.793878359,0.005208006,0.021136905,0.013247767,0,8.426962998,2.842504877,2.964625696,0.003030514,0.013672426,0.015302944,0,8.002812168,3.972824045,2.014388777,0.043968732,0.113902079,0.013260666,0,8.337600113,1.56708315,5.32045802,1.04E-07,2.30E-06,Y,-,,hypothetical protein SPI_01585,,no IPS match,,
RL4_JR_01785,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,intracellular serine protease,P:proteolysis; C:membrane; C:integral component of membrane; F:serine-type endopeptidase activity; F:peptidase activity; C:cellular_component; F:hydrolase activity,IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (PFAM); IPR000209 (SUPERFAMILY),,
RL4_JR_01786,0,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.020111042,0,7.533833619,3.95948959,1.902728482,0.057075983,NA,0.006181986,0,10.80045294,3.961457679,2.726383522,0.006403255,0.024293008,0.016419296,0,8.115760534,2.742902141,2.958822487,0.003088169,0.013803367,0.018970802,0,7.692145024,3.960113045,1.942405415,0.05208804,0.125807414,0.016551213,0,8.01449721,1.56545604,5.119592634,3.06E-07,5.23E-06,N,-,,ankyrin repeat,,IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),,
RL4_JR_01787,29,16,44,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.351763833,0,3.40476559,2.401235117,1.417922621,0.156213357,NA,0.111532043,0,6.629560541,2.103962949,3.150987304,0.001627196,0.015023052,0.29137633,0,3.96647827,1.381259874,2.871637948,0.004083505,0.016566293,0.336236013,0,3.544644188,1.644007027,2.156100387,0.031075827,0.09426086,0.290001657,0,3.871770475,1.313225751,2.948290096,0.003195371,0.012448298,N,-,,udp-glucose 4-epimerase,F:coenzyme binding; F:UDP-glucose 4-epimerase activity; P:galactose metabolic process,IPR008089 (PRINTS); IPR001509 (PFAM); G3DSA:3.90.25.10 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10366:SF443 (PANTHER); PTHR10366 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_01788,169,145,228,1,5,18,0,0,0,0,0,0,2,7,0,0,0,1,121.0088713,1,5.989259025,0.462203398,12.95805925,2.12E-38,2.16E-35,0.686154031,0,4.008796007,1.480764157,2.707248138,0.006784353,0.025330586,1.786594619,0,1.351302932,1.230093073,1.098537144,0.271970007,0.410595167,48.76706266,1,4.795010094,0.549194666,8.730984454,2.52E-18,2.01E-16,9.134860793,1,2.201532688,1.145521924,1.921859933,0.054623385,0.11981196,N,-,,cell surface,P:biological_process; C:cellular_component; F:molecular_function,IPR021986 (PFAM); PTHR35040 (PANTHER); PTHR35040:SF2 (PANTHER),,
RL4_JR_01789,19,14,18,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0.203351416,0,4.195515758,2.944188819,1.425015859,0.154152617,NA,0.065146943,0,7.405664039,2.27905642,3.249443048,0.001156312,0.015023052,0.168704493,0,4.755960817,1.367353938,3.478222196,0.000504751,0.003404705,12.22935426,1,6.625363084,0.897497631,7.382039633,1.56E-13,8.18E-12,0.16611923,0,4.674973288,1.258624524,3.714351021,0.000203726,0.001265475,N,-,,spherulin 4-like cell surface,C:membrane,IPR021986 (PFAM); PTHR35040 (PANTHER); PTHR35040:SF1 (PANTHER),,
RL4_JR_01790,145,69,109,1,0,9,0,0,0,0,10,3,0,3,0,0,12,0,45.71389167,1,5.463363228,0.641873772,8.511585086,1.72E-17,1.56E-15,0.413349514,0,4.740104146,1.654945463,2.864205651,0.004180565,0.018371529,98.99270058,1,6.597778484,0.579926227,11.37692723,5.45E-30,1.62E-27,13.26499247,1,3.939140518,0.928229182,4.243715447,2.20E-05,0.000285747,47.37444808,1,5.727127496,1.287679273,4.44763507,8.68E-06,8.88E-05,N,-,,glycosyl group 1 family,C:membrane,PF13692 (PFAM); G3DSA:3.40.50.2000 (GENE3D); PTHR12526:SF393 (PANTHER); PTHR12526 (PANTHER); PTHR12526 (PANTHER); PTHR12526:SF393 (PANTHER); PTHR12526 (PANTHER); PTHR12526:SF393 (PANTHER); PTHR12526:SF393 (PANTHER); SSF53756 (SUPERFAMILY),2.A.66.6.1, the multidrug/oligosaccharidyl-lipid/polysaccharide (mop) flippase superfamily.
RL4_JR_01791,8,5,14,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0.10674607,0,5.125114818,3.916748856,1.308512495,0.190699539,NA,0.033726595,0,8.354589433,2.637112083,3.168082801,0.001534478,0.015023052,0.088309077,0,5.687524085,1.54761704,3.675020329,0.00023783,0.001965084,28.03871891,1,7.628523952,0.933894494,8.168507254,3.12E-16,2.21E-14,0.088085489,0,5.590982873,1.342243039,4.165402769,3.11E-05,0.000260073,N,-,,sterol glucosyltransferase,"F:transferase activity, transferring glycosyl groups; P:metabolic process",IPR004276 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR002213 (PFAM); PTHR11926:SF364 (PANTHER); IPR002213 (PANTHER); SSF53756 (SUPERFAMILY),,
RL4_JR_01792,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.00781203,0,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,0,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,0,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,0.007662926,0,9.0007212,4.037607722,2.229221316,0.025799183,0.085851084,0.006329724,0,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,N,-,,hypothetical protein TOPH_01974,,no IPS match,,
RL4_JR_01793,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003880053,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,0,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,transcription initiation factor,F:GTP binding; F:translation initiation factor activity; C:membrane; C:integral component of membrane; P:translational initiation,IPR006073 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (SUPERFAMILY),,
RL4_JR_01794,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.679,von Willebrand type A,"F:hydrolase activity, acting on ester bonds; C:membrane; C:integral component of membrane",no IPS match,,
RL4_JR_01795,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,integral membrane,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_01796,5,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.042810394,0,6.442299351,3.931595574,1.638596654,0.10129729,NA,0.013681411,0,9.655992964,3.931602703,2.45599408,0.014049547,0.043756137,0.03568286,0,6.995022953,2.447292178,2.858270466,0.004259572,0.016940088,0.041164466,0,6.574286727,3.931437036,1.672235029,0.094477986,0.187640173,0.035567596,0,6.896055327,1.640151902,4.204522348,2.62E-05,0.000225643,Y,-,,phosphoesterase superfamily,F:phosphatidylcholine phospholipase C activity; P:metabolic process,IPR007312 (PFAM); PTHR31956 (PANTHER); PTHR31956:SF1 (PANTHER); IPR017850 (SUPERFAMILY),,
RL4_JR_01797,24,37,50,0,0,27,3,0,0,0,0,0,0,0,0,0,0,0,103.5454135,1,7.969982626,1.243103397,6.411359379,1.44E-10,4.84E-09,67.07568206,1,8.545244635,0.881869901,9.689915289,3.33E-22,1.61E-19,0.366251264,0,3.637495224,1.330666951,2.733588011,0.006264838,0.02252316,0.42274173,0,3.214741955,1.519050777,2.116283408,0.034320711,0.099341681,0.364056122,0,3.544945193,1.280647936,2.768087227,0.005638636,0.019768418,Y,-,,rhamnogalacturonase B,P:polysaccharide catabolic process; F:rhamnogalacturonan endolyase activity; P:cell wall organization; C:extracellular region; F:carbohydrate binding,IPR029411 (PFAM); IPR008979 (G3DSA:2.60.120.GENE3D); IPR014766 (G3DSA:2.60.40.GENE3D); IPR016590 (PIRSF); IPR029413 (PFAM); IPR014718 (G3DSA:2.70.98.GENE3D); IPR015364 (PFAM); PTHR36574:SF1 (PANTHER); PTHR36574 (PANTHER); IPR011013 (SUPERFAMILY); IPR013784 (SUPERFAMILY); IPR008979 (SUPERFAMILY),,
RL4_JR_01798,129,271,86,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,13.44102671,1,3.100291348,1.074648376,2.884935592,0.003914937,0.017733515,0.635822177,0,4.119014317,1.661405063,2.479235442,0.013166436,0.04155618,1.638004675,0,1.477526965,1.341669073,1.101260359,0.270783359,0.40934907,1.889253817,0,1.055357574,1.39207113,0.758120438,0.448378886,0.590279056,1.596336115,0,1.411653358,1.327038181,1.063762428,0.287436336,0.421881921,N,-,,alpha beta hydrolase fold-1,C:membrane; C:integral component of membrane,IPR000073 (PRINTS); IPR000073 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR10992:SF827 (PANTHER); PTHR10992 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_01799,4047,12965,4461,0,2,22,0,0,0,0,0,0,1,1,0,0,3,0,188.0574913,1,0.318193471,1.001164774,0.317823279,0.750618992,0.870005683,27.98585616,0,-1.341096478,1.32362143,-1.013202452,0.310963469,0.472876759,72.38746108,0,-3.988664358,1.301458092,-3.064765883,0.002178404,0.010532076,96.83965068,1,-2.6705504,1.161566323,-2.299094203,0.021499591,0.07956263,82.3692527,1,-1.944882842,1.040373966,-1.869407449,0.061566149,0.131316043,N,-,,2OG-Fe(II)oxygenase superfamily,F:iron ion binding; F:oxidoreductase activity; P:oxidation-reduction process,PR00682 (PRINTS); IPR026992 (PFAM); IPR005123 (PFAM); IPR027443 (G3DSA:2.60.120.GENE3D); PTHR10209 (PANTHER); PTHR10209 (PANTHER); PTHR10209:SF146 (PANTHER); PTHR10209:SF146 (PANTHER); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_01800,2400,3557,2212,0,0,6,0,0,0,0,0,0,0,3,0,0,7,0,55.93390077,1,0.061571695,0.731449209,0.084177676,0.932915167,0.967054883,10.55385837,0,0.065860442,1.25318969,0.052554249,0.958087071,0.977939102,27.28921661,0,-2.581212922,1.217068785,-2.120843911,0.03393494,0.084536745,43.51329176,1,-0.728286589,0.907283399,-0.802711248,0.42214165,0.565069303,53.77772629,1,0.686041179,0.668219298,1.026670707,0.304575547,0.439855572,N,-,,c6 zinc finger domain,"F:zinc ion binding; P:positive regulation of pyrimidine-containing compound salvage; P:transcription from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:positive regulation of transcription from RNA polymerase II promoter; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter; C:nucleus; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; C:nuclear chromatin; F:iron ion binding; F:oxidoreductase activity; P:oxidation-reduction process",IPR001138 (SMART); IPR001138 (PROSITE_PROFILES),,
RL4_JR_01801,2290,3691,1686,0,1,89,0,0,0,0,0,0,0,0,0,0,0,0,378.9809794,1,3.509816653,1.436208489,2.443807205,0.014533191,0.051285287,9.97251735,0,0.147604162,1.291259516,0.114310222,0.908991879,0.949320657,25.71722674,0,-2.495619283,1.242506157,-2.008536753,0.044586285,0.10367284,29.66157713,0,-2.917653113,1.248351729,-2.337204366,0.01942856,0.075752271,25.12254491,0,-2.564678297,1.244800716,-2.060312356,0.039368689,0.09289396,N,-,,NCS1 nucleoside transporter,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR001248 (PFAM); PTHR30618 (PANTHER); PTHR30618:SF1 (PANTHER),2.A.39.3.3, the nucleobase:cation symporter-1 (ncs1) family.
RL4_JR_01802,490,551,254,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,16.68887051,1,1.750223915,0.97164838,1.801293503,0.071656631,0.17403239,1.689264651,0,2.709256762,1.429198973,1.895647011,0.058006736,0.132838051,4.339876951,0,0.071567794,1.262582348,0.056683664,0.954797187,0.974110281,5.004023991,0,-0.350068409,1.271988185,-0.275213569,0.783152163,0.860328141,4.226803219,0,0.006647499,1.256614806,0.005290005,0.995779206,0.996665131,Y,-,,L-amino-acid oxidase,F:oxidoreductase activity; P:oxidation-reduction process,G3DSA:3.90.660.10 (GENE3D); IPR002937 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR10742 (PANTHER); PTHR10742 (PANTHER); PTHR10742:SF292 (PANTHER); PTHR10742:SF292 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_01803,12,26,26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.257875032,0,3.852997531,2.724382339,1.414264612,0.157284223,NA,0.081217205,0,7.087410822,2.223979361,3.186815016,0.001438487,0.015023052,0.21218982,0,4.425637895,1.400980248,3.158958095,0.001583343,0.00822883,0.244915825,0,4.002501865,1.767215788,2.264863121,0.02352108,0.082950519,0.210366998,0,4.337130364,1.304713702,3.324200824,0.000886723,0.004335139,N,-,,Nipped-B B,,no IPS match,1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_01804,18,60,25,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4.239989958,1,4.082540573,1.350451469,3.023093141,0.002502052,0.012522541,0.133624545,0,6.369519641,2.115310471,3.01115119,0.002602592,0.015349618,0.346382768,0,3.719721874,1.442224636,2.579155688,0.009904214,0.032415756,0.399679604,0,3.296467384,1.687865199,1.953039489,0.050814916,0.124389486,0.339618323,0,3.645393468,1.367577751,2.66558407,0.007685471,0.025438181,N,-,,Pantothenate transporter liz1,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662:SF242 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.18, the major facilitator superfamily (mfs).
RL4_JR_01805,5547,5704,6146,0,0,0,0,0,0,0,0,0,5,8,2,0,5,0,69.67242775,0,-4.224830179,1.185773746,-3.562931118,0.000366737,0.002574733,22.22597956,0,-1.008650597,1.194916532,-0.844118037,0.39860345,0.56263619,57.66004707,0,-3.660513238,1.18628522,-3.085694045,0.002030777,0.009956215,164.4429208,1,0.555488952,0.396615972,1.400571311,0.161342305,0.280878755,76.13200902,1,-0.811033254,0.672380944,-1.206210945,0.227736165,0.35496131,N,-,,phosphotransferase enzyme family,F:catalytic activity,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); PTHR21310 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_01806,112,194,123,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1.736395787,0,1.101868,1.386423119,0.794755933,0.426755489,NA,0.553124957,0,4.319952105,1.573820326,2.74488265,0.006053254,0.023430607,1.432897419,0,1.670545392,1.264799975,1.32079809,0.186568697,0.308479746,10.96535784,1,2.202703905,1.184761673,1.859195783,0.062999392,0.140696731,1.407120249,0,1.593851318,1.250142704,1.274935504,0.202332071,0.324455531,N,-,,L-mandelate dehydrogenase,F:FMN binding; F:oxidoreductase activity; F:metal ion binding; C:membrane; P:oxidation-reduction process; F:heme binding,IPR001199 (PRINTS); IPR001199 (SMART); IPR001199 (G3DSA:3.10.120.GENE3D); IPR000262 (PFAM); IPR001199 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR10578 (PANTHER); PTHR10578:SF61 (PANTHER); IPR012133 (PROSITE_PROFILES); IPR001199 (PROSITE_PROFILES); IPR001199 (SUPERFAMILY); SSF51395 (SUPERFAMILY),,
RL4_JR_01807,140,172,150,0,0,15,0,0,0,0,0,0,3,8,7,0,4,3,59.13565433,1,5.252924718,0.857820368,6.123571918,9.15E-10,2.51E-08,0.592555713,0,4.220553245,1.510334105,2.79445007,0.005198807,0.021136506,1.535837546,0,1.570287165,1.225805736,1.281024488,0.200185065,0.325727033,129.2482613,1,6.069155799,0.402373779,15.08337798,2.08E-51,1.05E-48,39.04970481,1,4.920134114,0.588069274,8.366589325,5.93E-17,1.02E-14,N,-,,dibenzothiophene desulfurization enzyme A,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity",IPR011251 (PFAM); IPR016215 (TIGRFAM); IPR011251 (G3DSA:3.20.20.GENE3D); PTHR30011 (PANTHER); PTHR30011:SF16 (PANTHER); PTHR30011:SF16 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_01808,61,74,52,0,0,11,0,0,0,0,0,0,0,2,2,0,6,6,42.75754514,1,6.25929,0.715669245,8.746065367,2.21E-18,2.28E-16,0.241329736,0,5.516611448,1.778549027,3.101748316,0.001923814,0.015023052,0.623568715,0,2.871168906,1.271391874,2.258287915,0.023927715,0.064238714,28.01298068,1,5.185029343,0.768436216,6.747507774,1.50E-11,6.19E-10,67.96743563,1,7.005544764,0.493134455,14.20615551,8.39E-46,2.12E-42,N,-,,alcohol dehydrogenase -like domain-containing,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR016040 (G3DSA:3.40.50.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); PTHR11695:SF565 (PANTHER); IPR002085 (PANTHER); IPR002085 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_01809,0,5,1,0,0,20,0,0,0,0,0,0,0,1,3,0,0,0,76.39613512,1,11.60970156,2.937734184,3.951923773,7.75E-05,0.000682994,0.00786752,0,10.45694023,3.949934497,2.647370541,0.008112041,0.028922185,0.020433302,0,7.805751903,2.804066993,2.783725183,0.005373855,0.019945832,32.94102774,1,10.38328295,1.884801503,5.50895303,3.61E-08,9.02E-07,0.019989474,0,7.740939699,1.74385697,4.438976265,9.04E-06,9.18E-05,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23294 (PANTHER); PTHR23294:SF19 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.58.5, the major facilitator superfamily (mfs).
RL4_JR_01810,282,322,291,3,3,9,0,0,0,0,0,4,5,5,3,0,0,0,92.18785672,1,4.679555223,0.422203678,11.08364392,1.51E-28,6.14E-26,1.147795807,0,3.266703208,1.382811656,2.362363084,0.018158848,0.053280873,28.96877302,1,3.431839078,0.748750401,4.583422025,4.57E-06,9.69E-05,98.95566917,1,4.645352614,0.442063216,10.50834462,7.91E-26,1.04E-23,2.925451313,0,0.537722422,1.202942895,0.447005776,0.65487089,0.753730563,N,-,,flavin-binding monooxygenase,"F:NADP binding; F:flavin adenine dinucleotide binding; P:oxidation-reduction process; F:N,N-dimethylaniline monooxygenase activity",IPR023753 (G3DSA:3.50.50.GENE3D); IPR020946 (PFAM); PTHR23023:SF76 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_01811,280,456,392,1,0,4,0,0,0,0,0,3,5,0,1,0,0,0,29.885605,1,2.731799582,0.727902863,3.752972715,0.00017475,0.001377401,1.442587898,0,2.936871729,1.377585266,2.131898331,0.033015205,0.085337056,23.24631848,1,2.675512319,0.885807685,3.02042121,0.002524234,0.011919469,60.52375432,1,3.302818222,0.692378618,4.770248727,1.84E-06,3.15E-05,3.698998111,0,0.199275351,1.22950123,0.162078204,0.87124427,0.914876165,N,-,,short chain dehydrogenase reductase family oxidoreductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_01812,4095,1611,3489,0,0,3,0,0,0,0,0,1,0,2,0,0,0,0,47.81159387,1,-1.045445077,0.968888802,-1.07901451,0.280581259,0.463826122,11.70048528,0,-0.082991135,1.284584509,-0.064605431,0.948488161,0.97250801,36.76530984,1,-1.768903311,1.241720539,-1.424558308,0.154284919,0.267875239,42.92777692,1,-1.459217893,1.094445294,-1.333294502,0.182435177,0.308682515,29.82122492,0,-2.812076862,1.252592792,-2.245004826,0.024767823,0.064782797,N,-,,Plastidal glycolate glycerate translocator chloroplastic,C:integral component of membrane,IPR007300 (PFAM); PTHR30249:SF0 (PANTHER); PTHR30249 (PANTHER),2.A.122.2.6, the lrgb/cidb holin-like glycolate/glycerate transporter (lrgb/cidb/ggt) family.
RL4_JR_01813,1390,2785,2474,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,38.27997761,1,-0.596483418,0.94870121,-0.628736858,0.529521344,0.71343272,8.476298352,0,0.382073823,1.269087549,0.301061833,0.763367345,0.856565909,22.09089498,0,-2.276376326,1.229472218,-1.851506926,0.064096659,0.137336419,25.49437881,0,-2.69927024,1.233403265,-2.188473403,0.028635137,0.089817459,21.8412749,0,-2.362734025,1.239718972,-1.905862601,0.056668034,0.123178155,N,-,,aldehyde dehydrogenase (NAD+),"P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",IPR016163 (G3DSA:3.40.309.GENE3D); IPR015590 (PFAM); IPR016162 (G3DSA:3.40.605.GENE3D); PTHR11699:SF196 (PANTHER); PTHR11699 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_01814,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003906015,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,0,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,Y,-,,"alpha-1,3-glucanase mutanase",F:hydrolase activity,IPR024079 (G3DSA:3.40.390.GENE3D); IPR029463 (PFAM); IPR005197 (PFAM); IPR013830 (G3DSA:3.40.50.GENE3D); PTHR10566:SF52 (PANTHER); PTHR10566 (PANTHER); SSF55486 (SUPERFAMILY); IPR013830 (SUPERFAMILY),,
RL4_JR_01815,100,82,140,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.281115114,0,1.540084039,1.413529734,1.089530699,0.275919925,NA,0.406857823,0,4.762759073,1.613086462,2.952575193,0.003151353,0.016005016,1.06018086,0,2.104007746,1.251934739,1.680604971,0.09283967,0.183211559,1.223302786,0,1.681610043,1.290674195,1.302892743,0.192611382,0.321813571,1.051025259,0,2.014424992,1.241859672,1.622103559,0.104781176,0.197857033,N,-,,hypothetical protein VE03_05042,,IPR032675 (G3DSA:3.80.10.GENE3D); SSF52047 (SUPERFAMILY),,
RL4_JR_01816,963,915,1219,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,31.45947531,1,1.294334889,0.680682999,1.901523751,0.057233445,0.147012103,3.93518691,0,1.489036454,1.253694267,1.187718962,0.234944151,0.385406855,10.23249824,0,-1.166237013,1.196456167,-0.974742782,0.329687866,0.47263664,11.80582465,0,-1.58875262,1.194787744,-1.329736289,0.183605174,0.31029918,10.1148432,0,-1.252167485,1.203164115,-1.04072875,0.298001456,0.43332827,N,-,,hypothetical protein Z518_01442,C:membrane; C:integral component of membrane,IPR010730 (PFAM); PTHR24148 (PANTHER),,
RL4_JR_01817,1355,1387,1520,0,0,9,0,0,2,0,1,0,0,5,6,0,4,2,51.43187292,1,1.672822644,0.512924148,3.261345075,0.00110885,0.006392932,24.19969523,1,2.663783469,0.985280994,2.703577441,0.006859746,0.025536723,21.96525236,1,-0.669134719,1.187489436,-0.563486881,0.573103391,0.696196152,94.16169717,1,2.143887019,0.460378527,4.656791956,3.21E-06,5.16E-05,44.09541613,1,1.492255642,0.614753866,2.427403427,0.015207335,0.043942428,Y,-,,Piso0_004744 partial,,PTHR35204:SF1 (PANTHER); PTHR35204 (PANTHER),,
RL4_JR_01818,149,133,111,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.575995787,0,1.241488881,1.32922426,0.933995051,0.350306446,NA,0.506789029,0,4.446190498,1.561187279,2.847954604,0.00440012,0.018960415,1.30748272,0,1.802576707,1.236131756,1.458239947,0.144774416,0.25516995,1.507840878,0,1.38058008,1.26004392,1.095660285,0.273227469,0.415317238,1.281006678,0,1.728743581,1.215344298,1.422431145,0.154901127,0.265107152,N,-,,mfs general substrate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23502:SF2 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.86, the major facilitator superfamily (mfs).
RL4_JR_01819,2840,1883,1433,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,24.62853398,0,-2.724594608,1.2327659,-2.210147612,0.027094919,0.08363237,7.988928559,0,0.467566414,1.28719137,0.363245455,0.716421535,0.822365477,20.50487834,0,-2.168874295,1.229779973,-1.763627919,0.077794644,0.159431776,31.66171682,1,-0.887471077,1.071037858,-0.828608504,0.407325974,0.551065672,19.99237883,0,-2.235204877,1.228074798,-1.820088549,0.068745521,0.143013849,N,-,,Zn2 Cys6 DNA-binding,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; F:oxidoreductase activity; P:proteolysis; P:regulation of transcription, DNA-templated; P:oxidation-reduction process; F:peptidase activity; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR001138 (SMART); IPR001138 (PFAM); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31944:SF35 (PANTHER); PTHR31944 (PANTHER); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_01820,36716,21866,17645,7,8,5,0,0,0,0,1,1,1,4,2,0,0,0,458.1202554,1,-1.108292198,0.584945948,-1.894691642,0.058133266,0.148854734,98.93346677,0,-3.162862443,1.243041171,-2.544455098,0.010944838,0.036015492,268.0838576,1,-3.982108689,1.086333989,-3.665639417,0.000246721,0.002019246,337.130242,1,-2.688159052,0.672197263,-3.999062775,6.36E-05,0.000727556,247.2905353,0,-5.8638482,1.241952384,-4.721475858,2.34E-06,2.96E-05,N,-,,vegetative cell wall gp1,,no IPS match,,
RL4_JR_01821,537,450,435,1,0,0,0,0,0,0,0,0,0,3,0,0,0,0,15.75666487,1,0.338878794,1.144847748,0.296003372,0.767227506,0.877722899,1.827970941,0,2.595342443,1.331838645,1.948691347,0.051332296,0.120302268,4.721780552,0,-0.050234531,1.205153883,-0.041683084,0.966751339,0.980503963,17.48040458,1,1.827093976,0.863728248,2.115357441,0.034399494,0.099376683,4.633822524,0,-0.126111834,1.198899667,-0.105189648,0.916225325,0.946417202,N,-,,tam domain,F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108 (PANTHER); PTHR10108:SF879 (PANTHER); PTHR10108 (PANTHER); PTHR10108:SF879 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_01822,2190,2179,1970,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,29.24545747,1,-1.822867769,1.141635227,-1.59671647,0.110328923,0.237546411,8.144331285,0,0.439767544,1.227658387,0.358216544,0.720181268,0.824803245,21.06490722,0,-2.20771129,1.191883662,-1.852287569,0.06398454,0.137154241,28.30846713,1,-1.682596827,1.142938248,-1.472167749,0.140975584,0.254075015,20.69081885,0,-2.284699759,1.189194901,-1.921215569,0.054704536,0.11989256,N,-,,fad dependent oxidoreductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR006076 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13847 (PANTHER); PTHR13847:SF188 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_01823,17012,20289,12750,0,0,2,0,0,0,0,0,3,0,11,1,0,2,0,209.4897755,1,-4.052607447,1.062921756,-3.812705332,0.000137454,0.001120229,64.79113995,0,-2.552192975,1.219031862,-2.093622861,0.036293589,0.091817974,186.6405167,1,-2.804406662,0.890721787,-3.148465328,0.001641302,0.008482155,246.5323329,1,-1.446975826,0.5941009,-2.43557252,0.014868244,0.065631958,171.2770908,1,-3.609246573,1.006067826,-3.587478377,0.000333891,0.001916469,N,-,,ABC transporter,F:nucleotide binding; F:ATPase activity; C:membrane; P:transport,IPR003593 (SMART); G3DSA:1.20.1560.10 (GENE3D); IPR011527 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); PTHR24223:SF257 (PANTHER); PTHR24223 (PANTHER); IPR011527 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY),3.A.1.208.40, the atp-binding cassette (abc) superfamily.
RL4_JR_01824,7035,9944,6002,0,0,13,2,0,0,1,0,0,0,9,0,0,0,0,142.5253209,1,-0.591995301,0.90537493,-0.653867565,0.513197132,0.698708646,74.35072262,1,0.264710874,1.010513301,0.261956842,0.793354715,0.874836465,87.86745205,1,-3.112181695,1.21667143,-2.557947544,0.010529197,0.034056739,124.6861747,1,-0.757203783,0.669633897,-1.13077278,0.258150739,0.398016786,75.22549625,0,-4.146926378,1.216286805,-3.409497136,0.000650828,0.003378203,N,-,,ABC transporter,F:nucleotide binding; F:ATPase activity; C:membrane; P:transport,IPR003593 (SMART); IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24223 (PANTHER); PTHR24223:SF252 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.1.208.40, the atp-binding cassette (abc) superfamily.
RL4_JR_01825,3619,3337,3511,0,1,6,0,0,1,0,0,0,0,0,0,0,0,0,72.8138511,1,0.035337798,0.559884361,0.063116244,0.949673939,0.975256797,22.78193572,1,0.638107348,1.115147489,0.572217894,0.567174366,0.708827514,34.7096835,0,-2.928266438,1.186580537,-2.467819374,0.013593889,0.041118774,40.03723392,0,-3.350438486,1.184970156,-2.827445458,0.004692101,0.026674632,34.15161194,0,-3.007674967,1.185659651,-2.53671023,0.011189953,0.034387035,N,-,,HVA22 family TB2 DP1,C:membrane; C:integral component of membrane,IPR004345 (PFAM); IPR004345 (PANTHER); PTHR12300:SF40 (PANTHER),8.A.108.1.1, the curature-stabilizing protein yop1 (yop1) family.
RL4_JR_01826,2310,1850,3488,0,1,12,0,0,0,0,0,3,0,2,2,0,1,0,84.22485897,1,1.183729006,0.674393299,1.755250249,0.079216512,0.186830965,9.635679772,0,0.19706301,1.242316686,0.158625423,0.873963998,0.927670259,44.63935118,1,-0.071134854,0.889117509,-0.080006134,0.936232378,0.961689995,56.30760005,1,-0.149675675,0.786168014,-0.19038637,0.849006377,0.905529292,28.82739972,1,-1.628207102,1.158229294,-1.405772683,0.159791636,0.271291648,N,-,,mitochondrial genome maintenance mgm101,F:DNA binding; C:mitochondrial chromosome; P:recombinational repair; P:interstrand cross-link repair; P:DNA strand renaturation; P:mitochondrial genome maintenance,IPR009446 (PFAM); PTHR31404 (PANTHER); PTHR31404:SF0 (PANTHER),,
RL4_JR_01827,178,326,211,0,0,0,0,0,0,0,2,1,1,0,0,0,0,0,2.89471568,0,0.364534041,1.313790435,0.277467419,0.78142122,0.887242075,0.920877641,0,3.584518316,1.475654016,2.429104843,0.015136155,0.046472114,24.57219154,1,3.336749371,0.899543787,3.709379596,0.000207768,0.001794744,12.06684292,1,1.466040862,1.1869986,1.235082216,0.216799907,0.351553341,2.346420988,0,0.856010158,1.24905603,0.685325668,0.493138438,0.621445617,N,-,,CHCH domain-containing,C:nucleus; P:mitochondrial respiratory chain complex IV assembly; C:mitochondrial intermembrane space,IPR010625 (PFAM); PTHR13639:SF2 (PANTHER); PTHR13639 (PANTHER),,
RL4_JR_01828,1597,1741,1876,0,0,3,0,0,0,0,0,1,0,2,3,0,0,0,32.34645027,1,-0.184203841,0.85148092,-0.216333492,0.828727804,0.914481459,6.655700617,0,0.730925691,1.225200522,0.596576379,0.550790246,0.697061624,23.77825806,1,-0.960213037,1.188982362,-0.807592331,0.419325303,0.560799124,56.8642499,1,0.713919105,0.663454819,1.076062883,0.281899134,0.425484882,17.04191816,0,-2.00475848,1.193918041,-1.679142463,0.093124282,0.180698229,N,-,,biotin apo-,F:ligase activity,IPR019197 (PFAM); IPR004143 (PFAM); G3DSA:3.30.930.10 (GENE3D); IPR029062 (G3DSA:3.40.50.GENE3D); PTHR12835:SF5 (PANTHER); IPR004408 (PANTHER); IPR004143 (PROSITE_PROFILES); IPR029062 (SUPERFAMILY); SSF55681 (SUPERFAMILY); IPR029062 (SUPERFAMILY),,
RL4_JR_01829,360,259,204,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3.294675443,0,0.177542072,1.271540137,0.13962758,0.888954249,0.945636818,1.065988797,0,3.373456335,1.450786708,2.325260023,0.020058061,0.05766194,9.238950144,1,1.696768475,1.22399056,1.386259445,0.165667696,0.2824572,3.159325727,0,0.313346204,1.253278311,0.250021245,0.802570919,0.873670856,2.675626461,0,0.666121282,1.230858539,0.541184271,0.588380577,0.700689702,N,-,,---NA---,,no IPS match,,
RL4_JR_01830,4235,4730,6212,0,0,2,0,0,0,0,0,2,0,4,0,0,6,1,68.31560804,1,-2.305998495,1.031984416,-2.234528408,0.025448326,0.079910485,19.24561199,0,-0.800980963,1.204995713,-0.664716858,0.50623161,0.659214763,63.1343135,1,-1.641146116,1.041988117,-1.575014234,0.115253159,0.215479775,73.89982668,1,-1.180278789,0.767897278,-1.537026921,0.124286717,0.230518962,80.16995618,1,-0.157819209,0.622509006,-0.253521166,0.799865508,0.864869528,N,-, Effector probability:0.708,mitochondrial import inner membrane translocase subunit tim16,F:protein domain specific binding; P:protein import into mitochondrial matrix; C:presequence translocase-associated import motor,PF03656 (PFAM); IPR005341 (PANTHER); PTHR12388:SF0 (PANTHER),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_01831,1000,898,1411,5,2,4,0,0,0,0,0,3,0,0,0,0,2,0,94.80548007,1,2.412601797,0.520227868,4.637586617,3.53E-06,4.61E-05,4.185941967,0,1.399884598,1.262104041,1.109167353,0.267357994,0.424703069,30.40217808,1,1.139108412,0.871137991,1.307609613,0.191005755,0.31417421,12.58409615,0,-1.680857916,1.206055561,-1.393681991,0.163413657,0.283704265,18.52802323,1,0.311033248,1.004831343,0.309537765,0.75691249,0.830721105,N,-,,Golgi membrane,C:endoplasmic reticulum membrane; P:ER to Golgi vesicle-mediated transport; C:integral component of Golgi membrane; C:ER to Golgi transport vesicle; P:vesicle fusion with Golgi apparatus,IPR006977 (PFAM); PTHR21236:SF2 (PANTHER); PTHR21236 (PANTHER),9.B.135.1.1, the membrane trafficking yip (yip) family.
RL4_JR_01832,2278,2281,4354,0,0,2,0,0,0,0,0,0,4,2,0,0,4,0,43.08980279,1,-1.548547896,1.076223383,-1.438872189,0.150186738,0.29731216,11.18138319,0,-0.017580279,1.248566585,-0.014080369,0.988765862,0.994326358,29.27107756,0,-2.682473864,1.224527017,-2.1906204,0.028479274,0.073533325,79.05679232,1,0.254814335,0.697704196,0.365218293,0.714948464,0.809172054,44.59679276,1,-0.225979292,0.848449645,-0.266343788,0.789974453,0.856920006,N,-,,rcc1 domain-containing,,IPR000408 (PRINTS); IPR009091 (G3DSA:2.130.10.GENE3D); IPR000408 (PFAM); PF13540 (PFAM); PTHR22870 (PANTHER); PTHR22870:SF136 (PANTHER); PTHR22870:SF136 (PANTHER); PTHR22870 (PANTHER); IPR000408 (PROSITE_PROFILES); IPR000408 (PROSITE_PROFILES); IPR000408 (PROSITE_PROFILES); IPR000408 (PROSITE_PROFILES); IPR000408 (PROSITE_PROFILES); IPR000408 (PROSITE_PROFILES); IPR000408 (PROSITE_PROFILES); IPR009091 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_01833,526,461,650,0,2,0,0,0,0,0,0,0,0,1,0,0,4,0,22.54938894,1,0.936237105,1.013891482,0.923409577,0.355793803,0.546725531,2.078990007,0,2.409574914,1.306963758,1.843643253,0.065235148,0.145310341,5.404997093,0,-0.245532341,1.20375514,-0.203971998,0.838375381,0.895895331,10.24749148,1,0.278619713,1.151199049,0.242025663,0.808760278,0.878050377,20.78535712,1,2.264172917,0.775463601,2.919766854,0.003502933,0.013393958,N,-,,AAA family ATPase,F:nucleotide binding,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003959 (PFAM); PTHR23077 (PANTHER); PTHR23077:SF81 (PANTHER); IPR027417 (SUPERFAMILY),3.A.29.1.2, the mitochondrial inner membrane i-aaa protease complex (mimp) familly.
RL4_JR_01834,132,92,131,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,9.423667595,1,2.348132665,1.156481987,2.030410064,0.042314875,0.117536516,0.452489311,0,4.609531059,1.581281755,2.915059916,0.003556203,0.016947214,7.671477237,1,2.92012759,1.206399048,2.420532075,0.015497812,0.045663518,1.352735017,0,1.536671414,1.267127623,1.212720318,0.225236769,0.360785047,1.156083775,0,1.876653453,1.223864864,1.533382899,0.12518154,0.226130792,N,-,,---NA---,,no IPS match,,
RL4_JR_01835,10912,8442,11421,14,30,7,0,1,1,11,44,77,19,12,22,0,14,34,530.640861,1,1.698632001,0.701773249,2.420485539,0.015499796,0.053693135,86.9320094,1,-0.172933802,0.98186723,-0.176127482,0.860193791,0.918156865,1068.974488,1,3.272406867,0.469813586,6.965330438,3.28E-12,2.44E-10,554.3775799,1,1.830102528,0.498669113,3.669973693,0.000242575,0.002257423,404.7847892,1,1.650633338,0.84651364,1.949919363,0.051185731,0.114166986,N,-,,WD repeat containing 44,,no IPS match,,
RL4_JR_01836,5035,2398,3401,0,5,4,0,0,1,0,5,4,3,3,0,0,0,0,98.34427949,1,0.382032707,0.628888701,0.607472683,0.543537266,0.724420359,23.2863321,1,0.580883913,1.167798379,0.497417982,0.618894327,0.749246308,101.045128,1,0.994794054,0.597157121,1.665883263,0.095736668,0.187800431,81.29007184,1,-0.072756993,0.696610752,-0.104444258,0.916816802,0.949833922,35.13503821,0,-3.048653698,1.228681107,-2.481240804,0.013092589,0.038977496,N,-,,duf833 domain-containing,,IPR008551 (PFAM); IPR008551 (PANTHER); PTHR17985:SF8 (PANTHER); IPR008551 (PANTHER),,
RL4_JR_01837,1108,936,1250,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,32.23507337,1,1.211860692,0.672998024,1.800689822,0.071751783,0.174080178,4.193164964,0,1.397448326,1.251475987,1.116640143,0.26414822,0.420990125,10.88627198,0,-1.255580974,1.195048677,-1.050652578,0.293418183,0.433912604,12.5587463,0,-1.677946816,1.19308675,-1.406391292,0.159607965,0.278577942,32.84234685,1,0.895370764,0.845992631,1.058367095,0.289888115,0.424517958,N,-,,hypothetical protein CC77DRAFT_1062551,"P:biological_process; F:hydrogen ion transmembrane transporter activity; P:ATP hydrolysis coupled proton transport; C:membrane; C:integral component of membrane; C:proton-transporting V-type ATPase, V0 domain; C:cellular_component; F:molecular_function",IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); PTHR21310 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_01838,1487,1146,1773,0,2,0,0,0,2,0,0,0,0,0,0,0,0,0,33.56164618,1,-0.485596339,1.019525223,-0.476296543,0.633863128,0.791550676,24.34836035,1,2.61782223,1.003212113,2.609440413,0.009069044,0.031351387,14.53232553,0,-1.672325187,1.201974234,-1.391315338,0.164129825,0.280731601,16.76571957,0,-2.09474433,1.201220869,-1.743846102,0.081185929,0.167944123,14.36768469,0,-1.758558892,1.209381885,-1.454097266,0.145919342,0.253810914,N,-,,rna polymerase ii transcription factor b subunit 2,P:phosphorylation of RNA polymerase II C-terminal domain; F:translation initiation factor activity; C:cytoplasm; P:DNA duplex unwinding; C:core TFIIH complex; F:double-stranded DNA binding; P:nucleotide-excision repair; P:transcription from RNA polymerase II promoter; C:holo TFIIH complex; F:ATP-dependent DNA helicase activity; P:translational initiation; C:nucleotide-excision repair factor 3 complex,IPR004598 (PFAM); IPR004598 (TIGRFAM); IPR004598 (PANTHER),,
RL4_JR_01839,941,969,1105,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,23.89584123,1,0.03968076,1.007017359,0.039404246,0.968568095,0.984007287,3.845095672,0,1.522486189,1.251448217,1.216579454,0.223764264,0.372707237,9.984094853,0,-1.130696729,1.191710297,-0.948801678,0.342721488,0.486158378,11.51851174,0,-1.553120864,1.189261409,-1.305954143,0.191568152,0.320699494,9.85044222,0,-1.213926279,1.195713299,-1.015231895,0.3099953,0.445711788,N,-, Effector probability:0.745,acyl-coenzyme a thioesterase 13,C:nucleus; C:cytosol; F:isomerase activity,IPR029069 (G3DSA:3.10.129.GENE3D); IPR006683 (PFAM); IPR003736 (TIGRFAM); PTHR21660 (PANTHER); IPR029069 (SUPERFAMILY),,
RL4_JR_01840,1800,2791,2598,0,1,0,8,0,0,0,0,0,0,0,0,0,4,0,36.94244733,1,-2.004173111,1.168287541,-1.715479316,0.086257385,0.198669606,187.6718026,1,4.28199593,1.712815052,2.499975654,0.012420184,0.039670907,23.87048095,0,-2.388148623,1.208316799,-1.976425904,0.04810656,0.109964058,27.54399482,0,-2.810824837,1.209463371,-2.324026427,0.020124078,0.076947238,39.00907773,1,0.110139957,0.797159818,0.138165465,0.890109648,0.928122168,N,-,,forms a complex with the other RRN RRN6 and RRN11,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_01841,7497,6251,8397,0,1,1,0,2,2,0,0,0,5,3,0,0,5,1,100.1686229,1,-2.832127095,1.013065539,-2.795601061,0.00518033,0.022360388,123.6196524,1,1.272666798,0.748151392,1.701081908,0.088927608,0.184730712,73.18253444,0,-4.004465262,1.191702936,-3.360288156,0.000778612,0.004711697,143.0211498,1,-0.681963092,0.545098273,-1.251082833,0.210904258,0.344586996,98.90286061,1,-0.900546979,0.636349239,-1.415177271,0.157016527,0.267281832,N,-,,fungal specific transcription factor domain-containing,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR007219 (PFAM); PTHR31944 (PANTHER),,
RL4_JR_01842,6,3,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.055542679,0,6.067538165,3.925929095,1.545503757,0.122224461,NA,0.017869767,0,9.271776292,2.952016202,3.140828389,0.001684707,0.015023052,0.046199132,0,6.623717839,1.671165643,3.963531602,7.38E-05,0.000949998,0.053278911,0,6.202762499,2.961769202,2.094276115,0.036235391,0.101052846,0.045461266,0,6.541662675,1.344192082,4.86661301,1.14E-06,1.61E-05,,,,,,,,
RL4_JR_01843,137,68,94,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.187859032,0,1.649109768,1.477956662,1.115803874,0.264506095,NA,0.383815796,0,4.847094202,1.673231261,2.896846547,0.003769341,0.017533671,0.989194835,0,2.204493675,1.278451875,1.724346233,0.084645358,0.169939966,1.140574852,0,1.782919469,1.330131176,1.340408752,0.180112492,0.305620744,0.970002982,0,2.129525348,1.253974806,1.698220202,0.089466209,0.175619497,N,-,,hypothetical protein SPBR_04037,"P:RNA phosphodiester bond hydrolysis, endonucleolytic; F:nucleic acid binding; F:RNA-DNA hybrid ribonuclease activity; F:aspartic-type endopeptidase activity; P:proteolysis",no IPS match,,
RL4_JR_01844,954,1242,1336,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17.98906108,1,-0.980419972,1.156873788,-0.847473582,0.396731206,0.588996029,4.497935644,0,1.29623098,1.254030939,1.033651515,0.301299107,0.461663573,11.70251044,0,-1.359768696,1.201835972,-1.131409549,0.257882754,0.394262308,13.50312251,0,-1.782405131,1.201039564,-1.48405197,0.137795134,0.249572579,11.56346328,0,-1.4452177,1.208335303,-1.196040285,0.231680839,0.359284499,N,-, Effector probability:0.721,cytidine deoxycytidylate deaminase family,F:zinc ion binding; P:RNA modification; F:deaminase activity,IPR002125 (PFAM); G3DSA:3.40.140.10 (GENE3D); PTHR11079:SF67 (PANTHER); PTHR11079 (PANTHER); IPR002125 (PROSITE_PROFILES); IPR016193 (SUPERFAMILY),,
RL4_JR_01845,1647,1375,2388,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,21.5225052,0,-2.530186926,1.212883388,-2.086092488,0.036970246,0.106454303,6.829677826,0,0.693624972,1.246962206,0.5562518,0.578038732,0.717286753,17.80632304,0,-1.965433645,1.210146245,-1.624129029,0.104348274,0.20007991,24.55832216,1,-1.44229695,1.163953858,-1.239135847,0.215295194,0.35001025,17.66256017,0,-2.056407102,1.221511935,-1.683493254,0.092279644,0.179480847,N,-,,UPF0665 family c,P:biological_process; C:nucleus; C:cytosol; C:cellular_component; F:molecular_function,IPR029063 (G3DSA:3.40.50.GENE3D); IPR019410 (PFAM); PTHR14614 (PANTHER); PTHR14614:SF54 (PANTHER); PTHR14614 (PANTHER); PTHR14614:SF54 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_01846,2032,1662,2356,2,0,0,0,0,0,0,0,1,0,0,0,0,2,0,44.24845726,1,-0.948181335,1.012898849,-0.936106636,0.349218287,0.539364404,7.691093317,0,0.522293191,1.22686507,0.425713637,0.670316524,0.789233872,26.47672668,1,-1.169652575,1.194523534,-0.97917918,0.327491454,0.470553999,23.04777295,0,-2.553831125,1.194435441,-2.138107292,0.032508036,0.096494831,27.45532433,1,-0.551445537,0.98629665,-0.559107178,0.576088576,0.690120307,N,-,,rna polymerase,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_01847,79348,93586,44694,9,12,11,0,0,0,10,2,22,9,17,9,0,39,1,1108.44143,1,-2.010263133,0.527738511,-3.809203022,0.000139415,0.001133949,283.5517307,0,-4.681946323,1.258551382,-3.72010741,0.000199138,0.008540998,998.4856089,1,-1.434156659,0.640576469,-2.238853173,0.025165471,0.06690526,1079.485607,1,-1.842764765,0.465134587,-3.961788297,7.44E-05,0.000832215,868.6767358,1,-2.042268936,1.099157322,-1.858031508,0.06316454,0.134103789,N,-, Effector probability:0.91,copper resistance,,PTHR40620 (PANTHER),,
RL4_JR_01848,901,891,1013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,11.22359135,0,-1.590787525,1.187095771,-1.34006671,0.180223658,0.337139326,3.579759775,0,1.625650149,1.255850774,1.294461239,0.195506149,0.338391458,9.289801038,0,-1.026711917,1.191030673,-0.862036504,0.38866743,0.532468345,10.7170884,0,-1.449083116,1.18829137,-1.219467845,0.222666673,0.357913965,16.5260995,1,-0.174980941,1.121482393,-0.156026472,0.876012155,0.917325791,N,-,,hypothetical protein CMQ_7677,,PTHR39610 (PANTHER); PTHR39610 (PANTHER); PTHR39610:SF1 (PANTHER),1.G.20.2.1, the hantavirus gc envelope fusion glycoprotein (gc-efg) family.
RL4_JR_01849,5083,6905,5902,0,1,4,0,0,2,5,4,2,1,3,4,0,5,0,95.28441029,1,-1.249613058,0.706297109,-1.769245607,0.076852896,0.182522832,41.68799419,1,0.582941779,1.000317608,0.582756691,0.560057104,0.70351179,159.2062551,1,0.598660412,0.492806856,1.214797247,0.224443431,0.354653551,128.5180472,1,-0.374596242,0.562873231,-0.665507295,0.505726079,0.642146545,77.87170148,1,-0.875668348,0.704232792,-1.243435918,0.213707242,0.338355875,N,-,,vip1,F:organic cyclic compound binding; F:heterocyclic compound binding,IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_01850,4511,10870,15647,1,1,2,3,0,4,0,0,0,0,3,0,0,0,0,150.0830689,1,-2.319634093,0.919072369,-2.523886226,0.011606549,0.042689911,143.3054893,1,1.592934513,0.740294669,2.151757375,0.031416469,0.082148668,102.1769646,0,-4.485942721,1.272891843,-3.524213581,0.000424742,0.003004911,130.0113523,1,-2.691920049,1.019978458,-2.639193041,0.008310364,0.041882748,102.0673557,0,-4.587155533,1.29710403,-3.536459242,0.000405529,0.002269752,N,-,,Bud-site selection BUD22,,IPR015158 (PFAM); PTHR23325 (PANTHER),,
RL4_JR_01851,340,621,465,0,0,3,0,0,0,0,0,1,0,5,1,0,0,0,17.21814042,1,1.630869613,0.933063509,1.747865603,0.080487302,0.189092568,1.829039411,0,2.594465437,1.36839946,1.895985429,0.057961971,0.132780738,11.24985683,1,0.90270522,1.225089064,0.736848648,0.461214395,0.598862965,35.17530083,1,2.782140361,0.693327185,4.012738028,6.00E-05,0.000696091,4.680164379,0,-0.140191299,1.238760199,-0.113170651,0.909895263,0.942154971,N,-,,cell division control,P:regulation of kinase activity; P:mitotic spindle pole body duplication; F:identical protein binding; P:regulation of exit from mitosis; P:microtubule nucleation; F:structural constituent of cytoskeleton; C:mitotic spindle pole body; C:transcription export complex 2; C:nucleotide-excision repair factor 2 complex; P:cell division; P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:half bridge of spindle pole body; F:calcium ion binding; C:cytosol; P:regulation of mitotic sister chromatid segregation; P:cellular protein localization,IPR002048 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR002048 (PFAM); PTHR23050 (PANTHER); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY),1.I.1.1.1, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_01852,215,204,289,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.825158573,0,0.399192906,1.246149683,0.320341057,0.748709803,0.868473564,0.897855952,0,3.620871507,1.421821816,2.54664225,0.010876487,0.035860522,2.33696072,0,0.964004076,1.218387968,0.791212735,0.428819861,0.569285638,2.696432783,0,0.541481489,1.225617539,0.441802987,0.658631777,0.767304884,2.312729789,0,0.876687119,1.219324308,0.718994211,0.472144487,0.603212988,N,-,,---NA---,,no IPS match,,
RL4_JR_01853,13369,12493,12167,5,0,13,5,2,8,22,50,7,65,438,11,0,403,12,252.3095029,1,-0.483684528,0.399423835,-1.210955596,0.225912423,0.397282507,312.0579653,1,2.390782111,0.440905614,5.422435182,5.88E-08,7.44E-06,807.4258641,1,2.422085822,0.620687175,3.902264974,9.53E-05,0.001131048,2613.977997,1,4.090350018,0.846373003,4.832798308,1.35E-06,2.42E-05,1768.252776,1,3.736527218,1.469709483,2.542357697,0.011010743,0.033968242,N,-,,phosphoenolpyruvate carboxykinase,F:phosphoenolpyruvate carboxykinase (ATP) activity; F:ATP binding; P:gluconeogenesis; C:cytosol; P:phosphorylation; F:kinase activity,IPR013035 (G3DSA:3.90.228.GENE3D); IPR008210 (G3DSA:3.40.449.GENE3D); IPR001272 (PFAM); IPR001272 (PIRSF); IPR001272 (TIGRFAM); PTHR30031:SF0 (PANTHER); PTHR30031 (PANTHER); IPR001272 (HAMAP); IPR008210 (SUPERFAMILY); SSF53795 (SUPERFAMILY),,
RL4_JR_01854,1683,1349,1299,0,0,8,0,0,0,0,3,1,0,1,0,0,0,0,47.87605333,1,1.457352164,0.571259489,2.551121151,0.010737699,0.040145807,5.571726647,0,0.987444742,1.253898961,0.78749945,0.43098955,0.593028439,44.41029687,1,1.164226598,0.752467761,1.547211267,0.12181231,0.22450367,20.59838318,1,-1.132385911,1.150384801,-0.984354026,0.324941474,0.471486447,14.10625458,0,-1.732113235,1.196129224,-1.44809875,0.147589435,0.255968316,N,-,,hypothetical protein HMPREF1624_06464,C:integral component of membrane; P:single-organism metabolic process,no IPS match,,
RL4_JR_01855,3540,1734,1642,1,7,4,0,0,0,0,1,1,1,9,0,0,12,4,108.9530561,1,1.506058372,0.646105837,2.330977814,0.01975453,0.064826007,8.968093703,0,0.300751773,1.304242995,0.230594892,0.817629536,0.88999049,37.32653968,1,-0.518045637,1.091627825,-0.474562507,0.635098835,0.745217966,71.91014838,1,1.135113745,0.690262129,1.644467655,0.10007964,0.195921569,98.18624855,1,2.097043158,0.582007272,3.603121916,0.000314418,0.001814984,N,-,,fluconazole resistance 1,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); PTHR23502:SF9 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.77, the major facilitator superfamily (mfs).
RL4_JR_01856,2849,2354,4348,0,0,0,0,0,0,0,0,0,0,2,1,0,0,0,37.96893632,0,-3.349123725,1.219303699,-2.746751057,0.00601888,0.025245256,12.03478632,0,-0.123683663,1.23371353,-0.100253147,0.920143354,0.95583857,31.4059212,0,-2.784038782,1.213082661,-2.295011602,0.021732459,0.059384459,53.89957348,1,-0.900336815,0.89087323,-1.010622819,0.31219699,0.458257192,31.18584737,0,-2.876603983,1.224780872,-2.34866828,0.018840683,0.052192044,N,-,,nol1 nop2 sun family,F:transferase activity,IPR023267 (PRINTS); IPR029063 (G3DSA:3.40.50.GENE3D); IPR001678 (PFAM); PTHR22807:SF4 (PANTHER); PTHR22807 (PANTHER); IPR001678 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_01857,593,465,498,0,2,16,0,0,0,0,0,2,0,0,0,0,4,0,83.33512788,1,3.959899235,0.571369593,6.930538981,4.19E-12,1.91E-10,1.996400749,0,2.468164155,1.320881737,1.868573155,0.061682223,0.139207908,18.15735949,1,1.640353806,1.038504452,1.579534688,0.114213467,0.213931015,5.951031366,0,-0.600310185,1.202114726,-0.499378447,0.6175128,0.735838923,20.51059881,1,2.351851953,0.755875487,3.111427732,0.00186185,0.00797767,Y,-,,wsc domain containing,,IPR018535 (PFAM); PTHR32208:SF23 (PANTHER); PTHR32208 (PANTHER),,
RL4_JR_01858,5233,4411,3677,0,0,20,0,0,1,0,7,0,6,2,1,0,1,0,129.76074,1,0.698698941,1.065570672,0.65570399,0.512014601,0.697828027,26.57044911,1,0.277341578,1.136845074,0.243957233,0.807263943,0.883358844,99.22054079,1,0.332676601,1.425330196,0.233403181,0.815448344,0.880221669,124.6405399,1,0.263907872,0.560275119,0.471032647,0.637617422,0.751819773,47.25339546,1,-2.423391191,1.127966438,-2.148460371,0.031677201,0.078591439,Y,-,,integral membrane,P:proton transport; C:integral component of membrane; P:carbohydrate transport; F:sugar:proton symporter activity; C:Golgi membrane,IPR007271 (PFAM); IPR012404 (PIRSF); PTHR13146 (PANTHER); SSF103481 (SUPERFAMILY),2.A.7.12.13, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_01859,4947,5060,4794,0,0,3,0,0,0,4,0,1,0,0,0,0,14,4,70.81102439,1,-1.690139927,0.850236885,-1.987845925,0.046828733,0.12662539,18.9834887,0,-0.781125872,1.20269416,-0.649480057,0.516028133,0.666314167,99.92905423,1,-0.274878231,0.663979368,-0.413986103,0.678884285,0.779254478,56.69504525,0,-3.852299392,1.187333105,-3.244497586,0.00117658,0.008472883,131.8402125,1,1.244481353,0.398405854,3.123652274,0.001786214,0.007695923,N,-,,alpha-l-rhamnosidase c,,IPR021369 (PFAM); PTHR35872:SF1 (PANTHER); PTHR35872 (PANTHER),,
RL4_JR_01860,566,433,595,0,4,0,0,0,0,0,0,0,0,3,0,0,0,0,38.3938864,1,1.978840851,0.744826769,2.656779983,0.007889091,0.031456112,2.030688238,0,2.443523492,1.313788975,1.859905616,0.062898881,0.141323523,5.267126554,0,-0.208214291,1.204116211,-0.172918767,0.86271528,0.912943398,18.11065291,1,1.668285403,0.864333837,1.930140106,0.05358948,0.12754901,5.195314776,0,-0.291072125,1.206215256,-0.241310266,0.809314655,0.871047254,N,-, Effector probability:0.561,tRNA-intron endonuclease,P:RNA phosphodiester bond hydrolysis; C:tRNA-intron endonuclease complex; P:tRNA-type intron splice site recognition and cleavage; F:tRNA-intron endonuclease activity,IPR018593 (PFAM); PTHR28518 (PANTHER); IPR006677 (SUPERFAMILY),,
RL4_JR_01861,3598,3976,4883,2,3,3,2,0,0,3,1,3,1,0,6,0,1,0,105.4570218,1,0.004076881,0.556159776,0.007330414,0.994151229,0.997713653,60.45693842,1,1.145509721,0.976631598,1.172918963,0.240828304,0.392664964,101.7462481,1,0.460039114,0.577880408,0.796080137,0.425985459,0.566935294,114.6585775,1,0.053250204,0.62350454,0.085404677,0.931939675,0.959907346,44.59443945,1,-2.332300294,1.130213571,-2.063592541,0.039056365,0.092286044,N,-,,alcohol dehydrogenase -like domain-containing,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR011032 (G3DSA:3.90.180.GENE3D); IPR013154 (PFAM); IPR013149 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002085 (PANTHER); PTHR11695:SF559 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_01862,2090,1229,1260,0,1,3,0,0,0,0,1,0,2,3,2,0,0,0,37.72358295,1,0.409790733,0.796643346,0.514396731,0.606974644,0.77321973,5.908954589,0,0.902659582,1.286864278,0.701441168,0.483027738,0.639616816,23.04327462,1,-0.775232087,1.219252065,-0.635825938,0.52488988,0.654754207,67.45498674,1,1.401283462,0.632408904,2.215787054,0.02670609,0.086889189,14.86524791,0,-1.807725858,1.221113846,-1.480390927,0.13876895,0.24433019,N,-,,c2h2 type zinc finger domain containing,F:nucleic acid binding; F:metal ion binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_01863,2223,1666,1592,0,2,9,0,0,0,0,2,0,2,5,0,0,14,1,72.30359781,1,1.574280904,0.519397786,3.030973461,0.002437667,0.012275608,7.059721796,0,0.645954375,1.251553784,0.516121947,0.605769241,0.739515499,33.8908528,1,-0.172651551,1.044315376,-0.165325107,0.868688099,0.91677247,59.67574657,1,1.098735999,0.603638487,1.820188776,0.068730262,0.148866758,79.25110747,1,2.307556237,0.541484421,4.261537633,2.03E-05,0.000182075,N,-,,calpain-like protease,F:cysteine-type peptidase activity; C:intracellular,IPR022684 (PRINTS); IPR001300 (SMART); IPR022683 (SMART); G3DSA:2.60.120.380 (GENE3D); G3DSA:3.90.70.10 (GENE3D); IPR001300 (PFAM); IPR022682 (PFAM); IPR007330 (G3DSA:1.20.58.GENE3D); PTHR10183:SF308 (PANTHER); PTHR10183:SF308 (PANTHER); PTHR10183 (PANTHER); PTHR10183 (PANTHER); IPR001300 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY); IPR022682 (SUPERFAMILY); IPR022682 (SUPERFAMILY),,
RL4_JR_01864,1422,951,829,3,0,4,0,0,0,1,2,0,1,3,3,0,0,2,58.26912701,1,1.757751484,0.636833273,2.760143916,0.00577759,0.024472265,4.141186908,0,1.415540783,1.305200945,1.084538582,0.27812607,0.437141627,37.40460717,1,1.195251774,0.884218906,1.351760029,0.176452095,0.295810731,62.53029605,1,1.914962078,0.630072271,3.039273692,0.002371493,0.015187455,25.13540448,1,0.407561417,0.997790825,0.408463785,0.682933213,0.774756166,N,-,,peroxisomal adenine nucleotide transporter 1,P:fatty acid beta-oxidation; C:integral component of peroxisomal membrane; F:adenine nucleotide transmembrane transporter activity; P:transmembrane transport; F:structural constituent of ribosome; P:peroxisome organization; C:ribosome; P:ATP transport; P:translation,IPR002067 (PRINTS); IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); PTHR24089 (PANTHER); PTHR24089:SF310 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.17.1, the mitochondrial carrier (mc) family.
RL4_JR_01865,15188,16344,17127,5,15,56,0,0,4,0,2,1,0,14,0,0,11,0,579.3200005,1,1.058557197,0.463169804,2.285462455,0.022285725,0.071832062,99.69219112,1,0.105320195,0.74447545,0.141468997,0.88749945,0.93624486,183.5159573,1,-2.737612279,0.848163732,-3.227693164,0.001247928,0.006881274,242.2820846,1,-1.566315143,1.373355328,-1.140502469,0.254077025,0.393700518,201.4764767,1,-1.27643245,0.583330206,-2.188181645,0.028656374,0.072536446,N,-,,60s ribosomal l29,F:structural constituent of ribosome; P:cytoplasmic translation; C:cytosolic large ribosomal subunit,IPR002673 (PFAM); IPR002673 (PANTHER); IPR002673 (PRODOM),,
RL4_JR_01866,23696,20102,18695,7,4,23,3,0,0,0,1,1,4,10,2,0,13,5,440.5601466,1,-0.305451938,0.357115637,-0.855330618,0.392368142,0.584860095,147.342465,1,-0.622802946,0.863740814,-0.721053048,0.470876877,0.629157127,221.9578116,1,-3.687497789,1.039280787,-3.548124661,0.000387985,0.002821807,336.0750766,1,-1.215368409,0.420783382,-2.888346974,0.003872724,0.022892827,290.6621141,1,-0.843143227,0.43137758,-1.954536504,0.050637802,0.113305579,N,-,,SAM domain-containing,C:nucleus; F:RNA binding; C:cytoplasmic mRNA processing body; C:cytosol; F:flap-structured DNA binding; P:positive regulation of endodeoxyribonuclease activity; P:nuclear-transcribed mRNA poly(A) tail shortening,IPR001660 (SMART); IPR013761 (G3DSA:1.10.150.GENE3D); IPR001660 (PFAM); PTHR12515 (PANTHER); PTHR12515:SF5 (PANTHER); IPR001660 (PROSITE_PROFILES); IPR013761 (SUPERFAMILY),1.F.1.1.2, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_01867,9237,5894,3651,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,82.84673082,1,-2.650145687,1.119234615,-2.367819625,0.017893257,0.059898724,24.49625666,0,-1.148949102,1.276927181,-0.899776526,0.368239189,0.532702168,62.69344961,0,-3.781243529,1.249871644,-3.025305477,0.002483821,0.011772568,72.26199382,0,-4.202336326,1.25911111,-3.337542091,0.000845229,0.006453956,90.39425688,1,-1.123661694,0.858180104,-1.309354166,0.19041441,0.310508278,N,-,,RNA polymerase III transcription factor tfiiic,P:transcription initiation from RNA polymerase III promoter; C:intracellular part,IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR019734 (PFAM); PTHR23082 (PANTHER); IPR013026 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY),,
RL4_JR_01868,73572,37307,29899,0,0,0,0,0,0,0,0,0,0,0,2,0,2,1,561.3946347,0,-7.235198277,1.288155546,-5.616711662,1.95E-08,4.42E-07,183.151213,0,-4.051369807,1.273779764,-3.180588922,0.00146976,0.015023052,468.6715342,0,-6.683440427,1.264463745,-5.285592768,1.25E-07,4.21E-06,559.440941,1,-5.295996194,1.113949457,-4.754251783,1.99E-06,3.37E-05,470.9132462,1,-4.554938646,0.964219805,-4.723962963,2.31E-06,2.94E-05,N,-,,hypothetical protein CMQ_7693,F:catalytic activity; P:multicellular organism development; P:metabolic process; C:cellular_component; F:molecular_function,IPR001544 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_01869,37806,27136,27862,1,2,7,0,0,1,0,0,1,4,4,3,0,1,0,423.5252628,1,-2.615414774,0.530951235,-4.92590393,8.40E-07,1.32E-05,128.7560785,1,-2.517812594,1.128533149,-2.231048858,0.025677893,0.069906302,314.4688185,1,-5.115860451,1.204583958,-4.246993674,2.17E-05,0.000359581,437.3467719,1,-2.274536001,0.504570558,-4.507865081,6.55E-06,9.79E-05,305.8209628,1,-5.222921973,1.137316688,-4.592319826,4.38E-06,5.09E-05,N,-,,hypothetical protein CMQ_7150,P:biological_process; C:cellular_component,IPR024629 (PFAM); PTHR28184:SF1 (PANTHER); PTHR28184 (PANTHER),,
RL4_JR_01870,4220908,1967289,1517465,195,328,55,2,21,24,4,57,121,11,8,36,0,149,10,35507.19848,1,-2.679530859,0.903488297,-2.965761557,0.003019345,0.014463779,11119.47199,1,-3.277171421,0.917401684,-3.572231749,0.000353952,0.013674435,26940.87423,1,-4.320974553,0.929408476,-4.649166286,3.33E-06,7.46E-05,30056.417,1,-5.962442872,0.945814799,-6.304027888,2.90E-10,1.02E-08,25571.08028,1,-5.241009809,1.387074052,-3.778464316,0.000157798,0.001018947,N,-,,heat shock hsp98,C:nuclear envelope; F:ATPase activity; F:ATP binding; P:protein metabolic process; P:mycelium development; C:cytosol; P:protein refolding; P:protein unfolding; F:misfolded protein binding; P:cellular response to misfolded protein,IPR001270 (PRINTS); IPR003593 (SMART); IPR019489 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR004176 (PFAM); IPR003959 (PFAM); G3DSA:1.10.8.60 (GENE3D); G3DSA:1.10.8.60 (GENE3D); IPR004176 (G3DSA:1.10.1780.GENE3D); IPR003959 (PFAM); IPR019489 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11638:SF18 (PANTHER); PTHR11638 (PANTHER); PTHR11638:SF18 (PANTHER); PTHR11638 (PANTHER); IPR004176 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.9.1.2, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_01871,1135,867,836,6,0,0,0,0,0,0,2,2,0,0,0,0,0,1,71.74135824,1,2.176166193,1.080509321,2.014018899,0.044007549,0.12092071,3.653499161,0,1.596299652,1.283281772,1.243919837,0.213529068,0.360223538,38.1083695,1,1.77026173,0.757579146,2.33673503,0.019452966,0.054690871,10.86883313,0,-1.469257857,1.203898723,-1.220416493,0.222307028,0.35739261,16.60409551,1,-0.18599867,1.12861093,-0.164803179,0.869098901,0.913203235,N,-,,hypothetical protein CMQ_7221,,PTHR15263:SF1 (PANTHER); PTHR15263 (PANTHER),,
RL4_JR_01872,4506,4856,3601,0,0,13,0,0,0,0,2,4,0,2,1,0,8,0,101.7810772,1,0.275731154,0.832567698,0.331181662,0.740507271,0.863625206,16.72856602,0,-0.598683511,1.223134401,-0.489466661,0.624511352,0.753163816,84.87447066,1,0.151356267,0.638125161,0.237188996,0.812510172,0.87816647,67.47541872,1,-1.356100293,0.871362196,-1.556299205,0.11963696,0.223957056,73.21241327,1,0.247014004,0.586222037,0.421365947,0.673487881,0.767739788,N,-,,stress-activated map kinase-interacting,P:biological_process; C:TORC2 complex; C:cytosol; P:phosphorylation; C:cellular_component; F:kinase activity; P:positive regulation of mitotic cell cycle,IPR031313 (PFAM); IPR031567 (PFAM); IPR008828 (PANTHER),,
RL4_JR_01873,897,666,1209,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,11.0154835,0,-1.563949408,1.219454108,-1.282499602,0.199667444,0.36310455,3.501698401,0,1.657377131,1.287597763,1.287185469,0.198029651,0.341474638,9.121318016,0,-1.000429088,1.216303128,-0.82251625,0.410783142,0.552954199,26.5707023,1,1.262267463,0.794030416,1.589696613,0.111903207,0.21301372,9.041450285,0,-1.090354602,1.226517071,-0.888984449,0.374011438,0.510163227,N,-,,stress activated map kinase interacting,,IPR018800 (PFAM); PTHR13621 (PANTHER),,
RL4_JR_01874,646,840,741,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,16.59328337,1,0.456437993,1.027679676,0.444144224,0.656938314,0.806516594,2.853353739,0,1.952891013,1.287074807,1.517309641,0.129188525,0.246214696,7.401737068,0,-0.698755779,1.203463492,-0.58062067,0.561496138,0.687042168,8.53924354,0,-1.121159634,1.202413386,-0.932424445,0.351117217,0.49776037,7.288216289,0,-0.779238729,1.204579895,-0.646896675,0.517698818,0.643121685,N,-,,hypothetical protein CMQ_7733,,no IPS match,,
RL4_JR_01875,17756,23378,18063,0,4,3,0,0,1,0,0,4,4,4,0,0,1,0,281.9529096,1,-2.454444205,0.622735283,-3.941392552,8.10E-05,0.000709098,85.50458898,1,-1.86814218,1.120679881,-1.666972177,0.095519937,0.195521296,223.1319753,1,-2.626757366,0.769229986,-3.414788052,0.000638317,0.004031389,280.7083187,1,-2.120350074,0.572108377,-3.70620351,0.000210389,0.002003943,197.570488,1,-4.582378741,1.136327434,-4.032621764,5.52E-05,0.000421809,N,-,,ubiquitin carboxyl-terminal hydrolase,P:proteolysis; P:cellular protein metabolic process; F:hydrolase activity,IPR021905 (PFAM); IPR001394 (PFAM); G3DSA:2.20.210.10 (GENE3D); PTHR24006:SF492 (PANTHER); PTHR24006:SF492 (PANTHER); PTHR24006 (PANTHER); PTHR24006 (PANTHER); PTHR24006:SF492 (PANTHER); PTHR24006:SF492 (PANTHER); PTHR24006 (PANTHER); IPR028889 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY); IPR016024 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_01876,1432,1342,2160,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.6582903,0,-2.399468513,1.210350322,-1.982457862,0.047428019,0.127949001,6.232174674,0,0.825702917,1.245850536,0.66276242,0.507482725,0.659781444,16.25317822,0,-1.83376986,1.207672745,-1.518432761,0.128905338,0.234517391,18.7552385,0,-2.256503755,1.207997231,-1.867970966,0.061766118,0.138912027,16.12165706,0,-1.924702245,1.218885957,-1.579066716,0.114320755,0.211029653,N,-,,rnase p and rnase mrp subunit,P:ncRNA processing; C:intracellular ribonucleoprotein complex; F:ribonuclease activity,IPR013241 (PFAM); PTHR28272 (PANTHER); PTHR28272:SF1 (PANTHER),,
RL4_JR_01877,11,4,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.094828407,0,5.295865508,3.918001493,1.351675214,0.176479237,NA,0.030556624,0,8.497726466,2.698270897,3.149322952,0.001636492,0.015023052,0.078991289,0,5.849595606,1.572238131,3.720553197,0.000198787,0.001748495,0.091091274,0,5.428917346,2.461745615,2.205312081,0.027432203,0.088070176,0.077787553,0,5.766956969,1.335488547,4.318237685,1.57E-05,0.000147072,N,-,,tRNA pseudouridine synthase,,no IPS match,,
RL4_JR_01878,12500,17426,24953,0,0,7,0,0,0,0,1,0,0,0,0,0,1,0,246.1808292,1,-2.518271324,0.780968024,-3.22455113,0.001261703,0.007102825,69.17326581,0,-2.646642445,1.21423074,-2.179686577,0.029280702,0.077749021,188.7770733,1,-4.348541924,1.221293968,-3.560602148,0.000370005,0.002730273,208.8358066,0,-5.73340869,1.225628842,-4.677932252,2.90E-06,4.71E-05,183.7294426,1,-4.478046256,1.171587456,-3.822203995,0.000132264,0.000877572,N,-,,u3 small nucleolar rna-associated 10,"P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:preribosome; P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:nucleolus",IPR012954 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR022125 (PFAM); IPR012954 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR13457:SF2 (PANTHER); PTHR13457 (PANTHER); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_01879,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,Y,-,,---NA---,,no IPS match,,
RL4_JR_01880,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_01881,9132,15411,18178,0,0,1,0,0,0,0,3,0,0,0,2,0,2,0,175.292273,1,-4.58033217,1.201130521,-3.813350916,0.000137095,0.001118423,54.06658272,0,-2.291161138,1.221279235,-1.876033811,0.060650637,0.137277672,164.8014737,1,-2.543332849,0.900897526,-2.823110037,0.004756025,0.018259383,182.3252865,1,-3.602962461,1.060018144,-3.398963011,0.000676419,0.00534223,147.9075959,1,-3.397864941,1.039396366,-3.269075255,0.001078996,0.005069529,N,-,,nuclear export noc3,P:cellular component biogenesis; P:mycelium development; P:DNA-dependent DNA replication; C:macromolecular complex; C:nucleoplasm,IPR005612 (PFAM); IPR016903 (PIRSF); IPR011501 (PFAM); PTHR14428 (PANTHER); PTHR14428:SF5 (PANTHER); PTHR14428:SF5 (PANTHER); PTHR14428:SF5 (PANTHER); PTHR14428 (PANTHER),,
RL4_JR_01882,4815,4290,3968,0,1,24,0,0,0,0,0,6,0,9,2,0,4,0,152.0289746,1,1.100624872,0.911425679,1.20758598,0.227206555,0.398698876,16.8111765,0,-0.605795176,1.21283468,-0.499487017,0.617436331,0.748465933,82.42512585,1,0.141022035,0.627061111,0.224893607,0.822062043,0.884832342,105.4671212,1,0.48113497,0.488854286,0.984209371,0.325012579,0.471522047,58.06552541,1,-0.714236204,0.745515078,-0.958043942,0.338040601,0.475171607,N,-,,STE like transcription factor,"F:nucleic acid binding; C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:metal ion binding; P:regulation of transcription, DNA-templated",IPR003120 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR003120 (PFAM); PTHR14596 (PANTHER); PTHR14596:SF32 (PANTHER); IPR003120 (PRODOM),,
RL4_JR_01883,1256,1865,3695,0,0,6,0,0,0,1,0,0,1,0,0,0,2,0,50.05317261,1,0.256852688,0.875157651,0.29349305,0.769145311,0.879039577,8.48977001,0,0.37971809,1.303298909,0.291351499,0.770782505,0.861227565,33.41083204,1,-1.330883089,1.255952777,-1.059660135,0.289299245,0.428823654,35.10675972,1,-1.757552897,1.221074394,-1.439349564,0.150051506,0.266211933,30.08341077,1,-0.766516913,1.092828878,-0.701406166,0.483049575,0.611588964,N,-,,hypothetical protein SPBR_02931,"P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:nucleus; C:cytoplasm; C:nucleolus",no IPS match,,
RL4_JR_01884,1828,1815,3293,0,0,4,0,0,0,0,0,0,0,0,1,0,3,0,42.87875179,1,-0.226933784,0.828517952,-0.273903279,0.784158951,0.889113096,8.717432735,0,0.341535159,1.250047704,0.2732177,0.784685874,0.869397316,22.79845627,0,-2.321950652,1.219851766,-1.903469517,0.056979308,0.124996427,35.94771512,1,-1.791571138,1.175333103,-1.524309264,0.127431474,0.234974262,34.26445827,1,-0.247206584,0.914370884,-0.270357016,0.786885605,0.854393217,N,-,,phosphoribosylformimino-5-aminoimidazole carboxamide ribotide isomerase,F:1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino]imidazole-4-carboxamide isomerase activity; P:histidine biosynthetic process,IPR011858 (TIGRFAM); IPR013785 (G3DSA:3.20.20.GENE3D); IPR006062 (PFAM); PTHR21235 (PANTHER); PTHR21235:SF23 (PANTHER); IPR011060 (SUPERFAMILY),,
RL4_JR_01885,2313,2678,1869,0,1,19,0,0,0,0,0,0,0,10,0,0,0,3,108.1915932,1,1.774557305,0.820357573,2.163151001,0.030529568,0.091768685,8.85938543,0,0.318365824,1.245539487,0.255604762,0.798256041,0.87792752,22.87698837,0,-2.326761761,1.206113503,-1.929139965,0.053713489,0.119462953,66.5013998,1,1.160444485,0.612317811,1.895166962,0.058070286,0.134637427,44.51076063,1,-0.159574301,0.854472058,-0.186751924,0.851855143,0.901540015,N,-,,Bud site selection BUD4,P:septin ring disassembly; C:medial cortex; P:mitotic cytokinesis; C:cytosol; C:septin ring,IPR001849 (SMART); IPR012966 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR001849 (PFAM); PTHR36100 (PANTHER); IPR001849 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY),,
RL4_JR_01886,12701,23008,24714,2,0,4,0,0,0,0,0,0,0,5,0,0,7,3,278.3559025,1,-2.736777106,0.733278964,-3.732245491,0.00018978,0.001470303,76.64284781,0,-2.794569407,1.219763477,-2.291074836,0.021959086,0.062069217,200.1166355,0,-5.45570859,1.227027106,-4.446282045,8.74E-06,0.000169206,251.0237837,1,-2.914198856,0.774391191,-3.763212815,0.000167744,0.00165376,247.4814907,1,-1.668634909,0.628836838,-2.653526016,0.007965563,0.02610089,N,-,,atp-dependent rna helicase dbp9,F:nucleic acid binding; F:ATP binding; C:cytosol; F:helicase activity,IPR001650 (SMART); IPR014001 (SMART); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011545 (PFAM); PTHR24031:SF96 (PANTHER); PTHR24031 (PANTHER); PTHR24031:SF96 (PANTHER); PTHR24031 (PANTHER); IPR014014 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_01887,32,24,49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.416765672,0,3.160199243,2.190150581,1.44291414,0.149044659,NA,0.132095461,0,6.385534445,2.002939216,3.188081992,0.001432199,0.015023052,0.344845023,0,3.723649936,1.329681355,2.800407723,0.00510381,0.019201401,0.397938602,0,3.301665556,1.529328373,2.15889904,0.030858,0.094078937,0.342667263,0,3.631314822,1.27668938,2.84432132,0.004450614,0.016275514,N,-,,hypothetical protein CMQ_7731,,no IPS match,,
RL4_JR_01888,432,492,438,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9.289252655,1,0.393442756,1.150272695,0.342043029,0.732318511,0.858724992,1.747524765,0,2.660257416,1.328738927,2.00209188,0.045274851,0.109040004,4.526566625,0,0.010763636,1.203192886,0.008945894,0.992862304,0.997097309,5.221651862,0,-0.411487223,1.202088876,-0.34231015,0.732117498,0.821133092,4.451654618,0,-0.068005736,1.199818878,-0.056680002,0.954800105,0.970227926,N,-,,cas1 domain-containing,,IPR012419 (PFAM); PTHR13533 (PANTHER); PTHR13533:SF8 (PANTHER),,
RL4_JR_01889,144,138,94,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,5.330235905,1,2.246783541,1.189355611,1.889076337,0.058881601,0.150286455,0.486967547,0,4.503798321,1.592491846,2.828145295,0.004681855,0.019795212,1.254174812,0,1.86277004,1.253285346,1.486309599,0.137197249,0.245403701,9.46942432,1,3.152203173,1.054089288,2.990451767,0.002785651,0.017475042,1.225941986,0,1.792211897,1.229845175,1.457266274,0.145042893,0.25272058,Y,-,,Cas1p,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_01890,45222,49363,66724,10,20,74,1,0,2,2,0,0,5,56,10,3,21,5,1188.0337,1,-0.190342795,0.427434297,-0.445314745,0.656092314,0.805885182,245.4995187,1,-2.01552252,0.862435547,-2.337012343,0.019438542,0.05622542,554.7982493,1,-5.030066581,1.046970576,-4.804401093,1.55E-06,3.96E-05,982.206831,1,-0.665823687,0.52466061,-1.269055985,0.204421097,0.336126996,693.5149951,1,-1.561743069,0.462770503,-3.374767968,0.00073878,0.003749445,N,-,,40S ribosomal s18,F:RNA binding; F:structural constituent of ribosome; P:mycelium development; C:ribosome; P:translation,IPR001892 (PFAM); G3DSA:1.10.8.50 (GENE3D); IPR001892 (PIRSF); IPR027437 (G3DSA:4.10.910.GENE3D); PTHR10871 (PANTHER); IPR001892 (PROSITE_PROFILES); IPR010979 (SUPERFAMILY),,
RL4_JR_01891,1781,2467,2668,0,3,11,0,0,0,0,0,2,0,3,0,0,0,2,93.79189884,1,1.54754401,0.524863863,2.948467439,0.003193538,0.015164657,8.798809906,0,0.328184598,1.230846615,0.266633222,0.789751574,0.87326474,35.90810712,1,-0.512455217,1.047023227,-0.489440162,0.624530108,0.73700231,38.47202076,1,-0.461672056,0.879792681,-0.524750962,0.599756325,0.722146841,37.3860213,1,-0.718653217,0.990820159,-0.725311461,0.468260976,0.599689145,N,-,,upf0023 family,C:nucleus; F:RNA binding; C:cytoplasm; P:rRNA processing,IPR018978 (PFAM); IPR019783 (PFAM); IPR019783 (G3DSA:3.30.1250.GENE3D); PTHR10927 (PANTHER); PTHR10927 (PANTHER); IPR002140 (PTHR10927:PANTHER); IPR002140 (PTHR10927:PANTHER); IPR002140 (PTHR10927:PANTHER); IPR019783 (SUPERFAMILY); SSF109728 (SUPERFAMILY),,
RL4_JR_01892,18456,26197,21212,1,3,40,3,0,0,2,4,3,3,32,11,0,20,6,452.1868476,1,-0.404736876,0.833572627,-0.485544826,0.627289924,0.787054937,151.4499851,1,-0.689808028,0.868680751,-0.794086927,0.427144828,0.590085976,292.195915,1,-1.591626394,0.543118196,-2.930534098,0.003383799,0.014804484,515.1705669,1,0.133208448,0.425224919,0.313265854,0.75407869,0.838647488,337.1057706,1,-0.511899511,0.510816178,-1.002120788,0.316285259,0.451740478,Y,-,,carboxypeptidase y,P:phytochelatin biosynthetic process; P:mycelium development; F:serine-type carboxypeptidase activity; P:mature ribosome assembly; C:fungal-type vacuole; P:proteolysis involved in cellular protein catabolic process; P:protein catabolic process in the vacuole,IPR001563 (PRINTS); IPR008442 (PFAM); G3DSA:1.10.287.410 (GENE3D); IPR001563 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR11802:SF51 (PANTHER); IPR001563 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_01893,52352,34436,35658,7,9,0,0,0,3,1,2,2,3,1,1,0,0,2,631.2429543,1,-1.85423485,0.980169042,-1.891750066,0.058524289,0.149621169,185.8223101,1,-1.680000472,0.905130554,-1.856086356,0.06344125,0.142194937,446.0997954,1,-3.333266752,0.707157417,-4.713613506,2.43E-06,5.72E-05,510.1366371,1,-3.800261412,0.710797032,-5.346479009,8.97E-08,2.05E-06,412.761024,1,-4.847039296,1.002865698,-4.833188835,1.34E-06,1.85E-05,N,-,,3 5 -cyclic nucleotide phosphodiesterase,"P:signal transduction; F:3',5'-cyclic-nucleotide phosphodiesterase activity",IPR003607 (SMART); IPR002073 (G3DSA:1.10.1300.GENE3D); IPR002073 (PFAM); PTHR11347:SF123 (PANTHER); PTHR11347 (PANTHER); PTHR11347 (PANTHER); PTHR11347:SF123 (PANTHER); SSF109604 (SUPERFAMILY),,
RL4_JR_01894,32913,24599,32627,5,5,16,0,0,2,1,1,6,0,2,7,0,3,0,510.8150888,1,-1.18180607,0.353264453,-3.345386325,0.00082168,0.005082084,133.7624154,1,-1.740315412,0.992239229,-1.75392724,0.079442975,0.169307567,355.9318476,1,-2.219933304,0.559750266,-3.965935237,7.31E-05,0.00094287,419.2392366,1,-2.465274151,0.581062323,-4.242701778,2.21E-05,0.000286674,305.262787,1,-3.918995187,0.867271101,-4.518766024,6.22E-06,6.83E-05,N,-,,ubiquitin specific peptidase 11,P:proteolysis; P:cellular protein metabolic process; F:thiol-dependent ubiquitinyl hydrolase activity,IPR006615 (SMART); IPR006615 (G3DSA:3.30.2230.GENE3D); IPR006615 (PFAM); IPR001394 (PFAM); IPR028134 (PTHR24006:PANTHER); PTHR24006 (PANTHER); IPR028889 (PROSITE_PROFILES); IPR006615 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY); IPR006615 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_01895,22071,9002,10099,2,1,10,0,0,0,4,4,4,4,3,0,0,3,0,229.848143,1,-1.149455166,0.669975232,-1.715668148,0.086222798,0.198667424,53.32796296,0,-2.271295881,1.269288543,-1.789424393,0.073546494,0.159647782,238.2667943,1,-0.474204041,0.590233735,-0.803417381,0.421733532,0.563052918,206.7502431,1,-1.750130671,0.728674633,-2.401799914,0.016314629,0.069115323,144.7292665,1,-2.823713212,0.964399616,-2.927949332,0.003412056,0.013136807,N,-,,A-factor-processing enzyme,F:thiol-dependent ubiquitin-specific protease activity; P:protein deubiquitination; F:zinc ion binding; P:peptide catabolic process; C:mitochondrion; P:protein processing; F:metalloendopeptidase activity; P:ubiquitin-dependent protein catabolic process,IPR011237 (G3DSA:3.30.830.GENE3D); IPR011237 (G3DSA:3.30.830.GENE3D); IPR011237 (G3DSA:3.30.830.GENE3D); IPR011765 (PFAM); IPR011237 (G3DSA:3.30.830.GENE3D); IPR032632 (PFAM); IPR007863 (PFAM); PTHR11851:SF155 (PANTHER); PTHR11851 (PANTHER); PTHR11851:SF155 (PANTHER); PTHR11851 (PANTHER); IPR011249 (SUPERFAMILY); IPR011249 (SUPERFAMILY); IPR011249 (SUPERFAMILY); IPR011249 (SUPERFAMILY),,
RL4_JR_01896,4861,5188,6190,0,10,6,0,0,0,6,0,0,4,7,1,0,3,0,167.9907205,1,0.647076229,0.519930539,1.244543609,0.21329956,0.381430572,20.66970909,0,-0.903951373,1.197057431,-0.755144531,0.450162266,0.610461402,120.1532038,1,0.221291022,1.635169716,0.135332143,0.892349272,0.932893849,136.9612392,1,0.33001049,0.45376962,0.727264399,0.467064003,0.608547552,64.66129708,1,-1.443147826,0.85174432,-1.694343939,0.090199946,0.176683004,N,-,,NADH-ubiquinone oxidoreductase,,IPR019401 (G3DSA:2.60.260.GENE3D); IPR019401 (PFAM); PTHR13156 (PANTHER),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_01897,1087,885,1440,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17.40003412,1,-0.919582537,1.159802411,-0.792878621,0.427848544,0.618753487,4.318563582,0,1.354892574,1.262716485,1.072998246,0.283271903,0.442686151,11.24284694,0,-1.302099469,1.206904718,-1.078875117,0.280643403,0.419866087,12.97201436,0,-1.724660178,1.206595451,-1.429360749,0.152900574,0.26980103,11.13430354,0,-1.390730523,1.216092279,-1.143606079,0.252787039,0.383901121,Y,-,,hypothetical protein CMQ_7309,C:membrane,no IPS match,,
RL4_JR_01898,7967,11965,19724,0,5,3,0,0,0,0,0,0,0,7,0,0,10,0,209.8327364,1,-1.638246059,0.731273829,-2.240263489,0.025073822,0.07891676,49.69755081,0,-2.16960689,1.236923838,-1.754034341,0.079424623,0.169307567,130.3986445,0,-4.837804502,1.239451744,-3.903181003,9.49E-05,0.001128758,178.6151567,1,-1.885297835,0.75995312,-2.480808074,0.013108493,0.060164232,168.6831033,1,-1.257503688,0.80764212,-1.557006075,0.119469043,0.218438011,N,-,,nucleolar 4,F:nucleic acid binding,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR24012 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY),,
RL4_JR_01899,1612,2343,1684,0,2,19,2,0,0,0,0,1,1,4,0,0,0,0,111.3269202,1,2.189776207,0.729350371,3.002365247,0.002678905,0.013181249,51.88210719,1,2.292156031,1.002368649,2.286739548,0.02221103,0.062573576,25.29760297,1,-1.081709414,1.208430304,-0.895135955,0.370714416,0.515263792,47.04521735,1,0.558559453,0.711616971,0.784915868,0.432502898,0.574759396,18.46815671,0,-2.120709582,1.211599218,-1.75033918,0.080059804,0.161346639,N,-,,nuclear condensin complex subunit,P:mitotic chromosome condensation; C:condensin complex,IPR011989 (G3DSA:1.25.10.GENE3D); IPR025977 (PFAM); IPR027165 (PANTHER); PTHR14418:SF5 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_01900,2795,3573,4069,0,0,11,0,0,0,0,2,2,1,6,0,0,1,0,83.84257216,1,0.448774082,0.730178876,0.614608415,0.538813356,0.721500467,13.27050538,0,-0.264661026,1.214078934,-0.217993261,0.827434362,0.896520083,63.23301807,1,-0.103822404,0.756530381,-0.137234944,0.890845091,0.931513706,73.24870122,1,0.15772965,0.605307481,0.260577731,0.794418165,0.867409028,38.028616,1,-2.079176001,1.136323166,-1.829740044,0.06728882,0.140706176,N,-,,GPI ethanolamine phosphate transferase 2,F:mannose-ethanolamine phosphotransferase activity; P:metabolic process; C:integral component of membrane; C:cell part,IPR002591 (PFAM); IPR017849 (G3DSA:3.40.720.GENE3D); PTHR23072 (PANTHER); PTHR23072:SF0 (PANTHER); IPR017850 (SUPERFAMILY),9.A.6.1.2, the atp exporter (atp-e) family.
RL4_JR_01901,4838,5948,8563,4,0,1,1,0,3,0,0,0,2,3,0,0,0,0,121.3946067,1,-1.226312793,0.760190816,-1.613164441,0.106708787,0.232277207,74.87500903,1,1.451688215,0.774208824,1.875060281,0.060784431,0.137549745,63.80651467,0,-3.806664793,1.210939738,-3.143562535,0.001669047,0.008590461,104.2983197,1,-1.184498513,0.714578787,-1.657617795,0.097394636,0.192113907,63.35360418,0,-3.899130707,1.221098694,-3.193133139,0.00140738,0.006313737,N,-,,family UPF0642,P:biological_process; F:transferase activity; C:cellular_component; F:molecular_function,IPR019434 (PFAM); PTHR28219:SF1 (PANTHER); PTHR28219 (PANTHER),,
RL4_JR_01902,4371,3727,7046,0,1,3,0,0,0,0,0,0,6,0,0,0,7,6,79.66332307,1,-1.315942293,0.81049209,-1.623633727,0.104454003,0.228715056,19.05670643,0,-0.786760657,1.225925888,-0.641768532,0.521023485,0.670966884,49.77217139,0,-3.448318322,1.215714605,-2.836453808,0.004561758,0.017721886,113.3115809,1,-0.105497637,1.66770584,-0.06325914,0.949560152,0.970356938,120.6828521,1,0.759357466,0.551740522,1.376294538,0.168730463,0.283175193,N,-,,sumo ligase,P:regulation of DNA recombination; P:cellular process; F:SUMO transferase activity,IPR023321 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR004181 (PFAM); PTHR10782 (PANTHER); IPR027229 (PTHR10782:PANTHER); IPR023321 (PROSITE_PROFILES); IPR004181 (PROSITE_PROFILES),8.A.15.1.1, the k(+) channel accessory protein (kchap) family.
RL4_JR_01903,772,653,829,0,0,5,0,0,0,1,1,0,0,0,0,0,0,0,28.09052012,1,1.763007495,0.666615711,2.644713387,0.008176014,0.032331517,2.87376373,0,1.942560352,1.275974658,1.522412957,0.12790564,0.244460138,26.36786279,1,1.117528447,1.030209702,1.084758224,0.278028753,0.416996511,8.599843709,0,-1.131646559,1.193309844,-0.948325838,0.342963601,0.489913439,7.352017258,0,-0.791958285,1.198445449,-0.660821304,0.508726919,0.635594774,N,-,,bet3 family,C:nucleus; F:zinc ion binding; P:regulation of telomere maintenance via recombination; C:site of double-strand break; P:linear element assembly; P:reciprocal meiotic recombination; P:protein sumoylation; P:negative regulation of double-strand break repair via homologous recombination; F:SUMO ligase activity; P:regulation of reciprocal meiotic recombination,IPR007194 (PFAM); G3DSA:3.30.1380.20 (GENE3D); PTHR12817 (PANTHER); IPR024096 (SUPERFAMILY),,
RL4_JR_01904,4405,7959,6699,13,7,37,0,0,2,8,14,6,8,25,8,0,12,6,405.1154468,1,2.118035479,0.45651031,4.639622438,3.49E-06,4.58E-05,43.12525353,1,0.4852966,1.026411668,0.472808927,0.636349504,0.762454011,300.7490282,1,1.867677851,0.439512682,4.249428803,2.14E-05,0.000356865,325.0242688,1,1.826579789,0.38863985,4.699929221,2.60E-06,4.27E-05,153.0852871,1,0.831367003,0.517295338,1.607141881,0.108023248,0.202334345,N,-,,malate dehydrogenase,P:carbohydrate metabolic process; F:L-malate dehydrogenase activity; P:malate metabolic process; F:mRNA binding; P:tricarboxylic acid cycle; C:peroxisomal matrix,IPR001557 (PIRSF); IPR022383 (PFAM); IPR015955 (G3DSA:3.90.110.GENE3D); IPR010097 (TIGRFAM); IPR001236 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR11540:SF30 (PANTHER); IPR001557 (PANTHER); IPR016040 (SUPERFAMILY); IPR015955 (SUPERFAMILY),,
RL4_JR_01905,25230,24274,33783,17,13,65,2,0,2,8,0,0,3,22,3,0,11,0,855.8885088,1,0.700391898,0.367605158,1.905283108,0.05674328,0.145944797,169.0392635,1,-0.641334868,0.753714725,-0.850898685,0.394825635,0.558940571,363.5405998,1,-1.687123808,1.810569732,-0.931819293,0.351429922,0.494866881,462.3748986,1,-0.919686882,0.424901994,-2.164468264,0.03042843,0.093257059,314.5498789,1,-2.142622644,0.704912266,-3.039559313,0.002369245,0.009779295,N,-,,60S ribosomal l28,F:structural constituent of ribosome; C:cytosol; C:ribosome; P:translation,IPR029004 (PFAM); IPR002672 (PANTHER),,
RL4_JR_01906,2827,2096,2557,0,1,0,0,0,1,1,5,7,4,15,0,0,0,0,37.85121076,1,-2.051850253,1.143178763,-1.794863865,0.072675392,0.175617847,18.94760318,1,1.123301775,1.127534981,0.99624561,0.319130823,0.481120375,120.5376628,1,2.071277956,0.447790534,4.625551003,3.74E-06,8.19E-05,125.9828015,1,2.043871646,0.426683235,4.790138155,1.67E-06,2.88E-05,24.36118526,0,-2.520338966,1.195440848,-2.108292493,0.035005697,0.084800872,N,-, Effector probability:0.676,precursor,C:cytoplasm; C:integral component of membrane,IPR018559 (PFAM); PTHR28023 (PANTHER),,
RL4_JR_01907,11832,10796,10023,19,51,11,0,0,6,4,30,36,16,32,13,0,38,8,772.5939878,1,2.276041365,0.737573417,3.085850593,0.002029708,0.010593958,98.24024229,1,1.227187115,0.64631269,1.898751385,0.057597172,0.132049507,621.9923726,1,2.285337472,0.460555437,4.962133301,6.97E-07,1.98E-05,527.7296889,1,1.674179992,0.258930887,6.465740759,1.01E-10,3.84E-09,312.1083678,1,1.157573941,0.610095249,1.897365932,0.057779659,0.124870661,N,-,,C-5 sterol desaturase,F:iron ion binding; F:oxidoreductase activity; C:integral component of membrane; C:endoplasmic reticulum part; P:oxidation-reduction process; P:fatty acid biosynthetic process; P:sterol biosynthetic process,IPR006694 (PFAM); PTHR11863:SF33 (PANTHER); PTHR11863 (PANTHER),,
RL4_JR_01908,61,100,95,0,0,17,0,0,0,0,0,1,0,0,0,0,0,1,65.94583226,1,6.211627526,0.980974893,6.332096335,2.42E-10,7.65E-09,0.326364751,0,5.080929441,1.685787069,3.013980552,0.002578443,0.015349618,7.348438687,1,3.386088882,1.21989882,2.775712893,0.005508082,0.020352142,0.980527141,0,2.001300535,1.325087403,1.51031587,0.130962844,0.240086691,8.205122524,1,3.279531061,1.156218308,2.836428932,0.004562113,0.016585779,N,-,,tat pathway signal sequence,C:integral component of membrane,IPR021765 (PFAM); PTHR33365 (PANTHER); PTHR33365:SF5 (PANTHER),,
RL4_JR_01909,56,51,61,0,0,105,0,0,0,0,0,0,0,0,0,0,0,4,401.6195863,1,9.23167017,2.327839109,3.965768139,NA,NA,0.214336799,0,5.687541715,1.793290972,3.17156658,0.001516191,0.015023052,0.556054637,0,3.035446402,1.256560782,2.415678131,0.015705938,0.046155854,0.641465582,0,2.613253002,1.343086136,1.945707673,0.051689864,0.125559168,30.0102263,1,5.603210583,0.757387746,7.39807399,1.38E-13,1.77E-11,N,-,,spore germination,,no IPS match,,
RL4_JR_01910,283,169,303,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.996847886,0,0.31393339,1.271828321,0.246836295,0.80503492,0.901630269,0.958112168,0,3.527179482,1.444418607,2.441937168,0.014608689,0.045109564,2.487019847,0,0.874227774,1.238082789,0.706114148,0.480117154,0.616449723,2.868895823,0,0.452032335,1.249347856,0.361814632,0.717490557,0.810780345,2.457115599,0,0.789091427,1.237610149,0.637592887,0.523738727,0.647953887,N,-,,alpha beta-hydrolase,F:hydrolase activity,IPR000073 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR37017 (PANTHER); PTHR37017:SF4 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_01911,33972,30519,34048,5,4,19,0,0,1,0,1,0,3,26,4,0,2,4,548.9844611,1,-1.212458418,0.317453355,-3.819327776,0.000133816,0.001096054,135.3899652,1,-2.594261879,1.107900202,-2.341602497,0.019201153,0.055688845,334.3413969,1,-5.200148331,1.189062375,-4.373318374,1.22E-05,0.000222823,547.4008354,1,-0.938748212,0.403651223,-2.325641938,0.02003766,0.076819883,358.6631787,1,-3.020147151,0.625694635,-4.826870781,1.39E-06,1.89E-05,N,-,,WD domain-containing,,IPR020472 (PRINTS); IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22847 (PANTHER); PTHR22847:SF471 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),8.A.92.1.1,The G-Protein αβγ Complex (GPC) Family
RL4_JR_01912,710,772,1336,0,0,3,0,0,0,0,0,0,0,0,4,0,0,0,22.68244395,1,0.671984744,0.925581288,0.726013753,0.46783034,0.656217316,3.54224726,0,1.640739143,1.296974318,1.265051373,0.205852913,0.350722636,9.267203936,0,-1.023291647,1.226440287,-0.834359127,0.404078642,0.546399382,49.23708539,1,1.691776498,1.414115644,1.196349467,0.231560212,0.368523601,9.221537825,0,-1.118760277,1.24080012,-0.901644237,0.367245884,0.503748673,N,-,,ribonuclease mrp subunit rmp1,"P:nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay; C:ribonuclease MRP complex; F:rRNA primary transcript binding; P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",PTHR37792:SF1 (PANTHER); PTHR37792 (PANTHER),,
RL4_JR_01913,188,126,189,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.001326436,0,0.896460372,1.290656427,0.69457708,0.48732038,NA,0.640543462,0,4.108109937,1.503564087,2.732247979,0.006290378,0.024017805,1.660594256,0,1.456930764,1.232563488,1.182033038,0.237192592,0.369777918,1.915475595,0,1.034833798,1.249345386,0.828300813,0.407500163,0.551227675,1.637720511,0,1.374279968,1.22464946,1.122182317,0.26178493,0.393668857,N,-,,---NA---,,no IPS match,,
RL4_JR_01914,166,173,173,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.052378989,0,0.860477205,1.259220504,0.683341164,0.494391289,NA,0.65546724,0,4.07495589,1.478960669,2.755283475,0.00586413,0.022929887,1.698834235,0,1.424579846,1.215207448,1.172293544,0.241079223,0.374223559,1.959727506,0,1.002269284,1.225785249,0.817654874,0.413554284,0.557104983,1.67241469,0,1.344433179,1.204754378,1.11593965,0.264447968,0.39678952,N,-,,hypothetical protein A33O_20475,,no IPS match,,
RL4_JR_01915,1,5,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.052243594,0,6.156297049,3.927141982,1.567627827,0.116968014,NA,0.016206838,0,9.411448006,3.159956845,2.978347006,0.002898077,0.015349618,0.042793213,0,6.734147284,1.884518412,3.573404877,0.000352369,0.002628877,0.049424539,0,6.311098588,3.245286851,1.944696687,0.051811494,0.125559168,0.042897621,0,6.634748039,1.457566699,4.551934428,5.32E-06,5.97E-05,N,-,,kinase-like domain,F:ATP binding; F:protein kinase activity; P:phosphorylation; F:protein serine/threonine kinase activity; P:protein phosphorylation; F:kinase activity,G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_01916,395,527,522,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.800341133,0,-0.638293797,1.216530727,-0.524683662,0.599803117,0.76883364,1.84306509,0,2.583405529,1.325925472,1.948379139,0.051369614,0.12036186,4.7905702,0,-0.071156364,1.209395425,-0.05883631,0.953082487,0.972811039,5.527414295,0,-0.493722686,1.209631217,-0.408159677,0.68315645,0.784502558,4.72785319,0,-0.154814176,1.211989338,-0.127735593,0.898358222,0.934251951,N,-,,phosphoribosylformylglycinamidine cyclo-ligase,F:ATP binding; F:phosphoribosylamine-glycine ligase activity; F:metal ion binding; P:'de novo' IMP biosynthetic process; C:cytosol; P:purine nucleobase biosynthetic process; F:phosphoribosylformylglycinamidine cyclo-ligase activity,SM01209 (SMART); IPR020560 (SMART); IPR020560 (PFAM); IPR016188 (PFAM); IPR010918 (PFAM); IPR013816 (G3DSA:3.30.470.GENE3D); IPR020560 (G3DSA:3.90.600.GENE3D); IPR000115 (TIGRFAM); IPR010918 (G3DSA:3.90.650.GENE3D); IPR016188 (G3DSA:3.30.1330.GENE3D); IPR016185 (G3DSA:3.40.50.GENE3D); IPR020561 (PFAM); IPR004733 (TIGRFAM); IPR020562 (PFAM); IPR013815 (G3DSA:3.30.1490.GENE3D); PTHR10520 (PANTHER); PTHR10520:SF10 (PANTHER); IPR004733 (HAMAP); IPR011761 (PROSITE_PROFILES); IPR000115 (HAMAP); IPR010918 (SUPERFAMILY); SSF55326 (SUPERFAMILY); IPR016185 (SUPERFAMILY); SSF56059 (SUPERFAMILY); IPR011054 (SUPERFAMILY),,
RL4_JR_01917,2023,2202,1592,0,0,0,0,0,1,0,0,0,0,5,0,0,0,0,23.40535409,0,-2.651009125,1.204678789,-2.200594175,0.027764766,0.085088266,16.88944351,1,1.471551707,1.143887236,1.286448227,0.198286676,0.341591073,19.38924028,0,-2.088110409,1.204778948,-1.733189654,0.083061965,0.16761398,42.42013801,1,0.49783869,0.708988718,0.702181399,0.482566044,0.622814684,18.99527497,0,-2.161345205,1.202043675,-1.798058798,0.072167691,0.148304824,N,-,,Transmembrane amino acid transporter,F:L-amino acid transmembrane transporter activity; P:cation transport; F:neutral amino acid transmembrane transporter activity; P:neutral amino acid transport; P:carboxylic acid transport; C:fungal-type vacuole; C:vacuolar membrane; P:amino acid transmembrane transport,IPR013057 (PFAM); PTHR22950:SF60 (PANTHER); PTHR22950 (PANTHER); PTHR22950 (PANTHER),2.A.18.5.2, the amino acid/auxin permease (aaap) family.
RL4_JR_01918,120499,47704,60095,26,37,33,0,0,9,0,9,19,2,4,20,0,17,2,1589.976549,1,-0.427865866,0.52551867,-0.814178239,0.41554285,0.606874072,379.4105769,1,-1.240153404,0.831115625,-1.492155082,0.135658495,0.25541951,950.6972589,1,-1.896234396,0.734084496,-2.583128244,0.009790892,0.03218279,1099.518299,1,-1.989277963,0.907445227,-2.192174142,0.028366935,0.089498947,818.7893742,1,-2.9128936,0.813750526,-3.579590435,0.000344133,0.001963013,N,-,,RAN kinase,P:regulation of filamentous growth; C:intracellular organelle; F:ATP binding; P:regulation of cellular process; F:protein kinase activity; C:cytoplasmic part; P:protein phosphorylation; P:single-organism process,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24343:SF163 (PANTHER); PTHR24343:SF163 (PANTHER); PTHR24343 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_01919,1951,1951,3337,0,0,3,0,0,0,0,0,0,0,1,0,0,3,0,40.28738005,1,-0.681087025,0.910805359,-0.747785483,0.45458956,0.643397229,9.115309247,0,0.277150476,1.241472902,0.223243274,0.823346174,0.893527365,23.81720444,0,-2.385016846,1.214330381,-1.964059274,0.049523218,0.112212881,31.49844587,1,-1.862489532,1.170009765,-1.591858109,0.11141659,0.212475771,35.25273121,1,-0.303473235,0.903331694,-0.33594884,0.736909446,0.815789213,N,-,,enolase-phosphatase E1,"F:magnesium ion binding; C:nucleus; F:2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity; F:2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity; P:L-methionine biosynthetic process from S-adenosylmethionine; P:L-methionine biosynthetic process from methylthioadenosine; C:cytosol; P:dephosphorylation; F:acireductone synthase activity",IPR023943 (TIGRFAM); IPR023214 (G3DSA:3.40.50.GENE3D); PTHR20371 (PANTHER); IPR023214 (SUPERFAMILY),,
RL4_JR_01920,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.012706323,0,8.20293094,3.990270723,2.055732934,0.039808266,NA,0.004020132,0,11.42967648,3.991033794,2.863838561,0.004185413,0.018371529,0.010357064,0,8.787173804,3.991470463,2.201487869,0.027701505,0.072039566,0.01195084,0,8.36455496,3.991447685,2.095619339,0.036115972,0.100959199,0.010019356,0,8.741909568,1.949319774,4.484594926,7.31E-06,7.74E-05,,,,,,,,
RL4_JR_01921,271,204,429,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.587102867,0,0.054626408,1.28396389,0.042545128,0.966064137,0.982922264,1.136067139,0,3.281305946,1.426655966,2.299998055,0.02144833,0.060871715,2.967496072,0,0.619358931,1.247384031,0.496526263,0.619523163,0.733316088,3.424494885,0,0.196610504,1.258798898,0.156188971,0.87588407,0.923495388,2.95063872,0,0.525183856,1.255406801,0.418337591,0.675700309,0.769395595,N,-,,25S rRNA (adenine(2142)-N(1))-methyltransferase,P:rRNA methylation; C:nucleolus; F:rRNA (adenine) methyltransferase activity,IPR021867 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR21008:SF1 (PANTHER); PTHR21008 (PANTHER); PTHR21008 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_01922,27903,27667,39997,1,0,16,0,4,0,0,5,0,2,15,0,0,17,3,452.5241977,1,-2.18686812,0.791933048,-2.761430561,0.005754875,0.024401389,274.3719354,1,0.047040476,1.454476455,0.032341861,0.974199426,0.986927705,354.5203184,1,-2.964616212,0.699065679,-4.240826434,2.23E-05,0.000366145,442.6256347,1,-1.883671595,0.546887629,-3.444348517,0.000572437,0.004655364,400.0485794,1,-1.469147161,0.593980077,-2.473394676,0.013383625,0.03965736,N,-,,60S ribosomal L25,,IPR012677 (G3DSA:3.30.70.GENE3D); IPR013025 (PFAM); IPR005633 (PFAM); PTHR11620 (PANTHER); IPR013025 (HAMAP); IPR012678 (SUPERFAMILY),,
RL4_JR_01923,3651,4941,7341,0,0,5,0,0,0,0,0,0,0,0,0,0,11,0,82.76441537,1,-1.145023644,0.795128366,-1.440048794,0.149853595,0.296803706,20.06629664,0,-0.861228488,1.229007978,-0.700750934,0.483458464,0.640050727,52.5008001,0,-3.525302425,1.220285679,-2.888915674,0.003865727,0.016072535,60.59745411,0,-3.9483841,1.22519148,-3.222666958,0.001270031,0.009068453,94.67859249,1,0.222484226,0.729683932,0.304904927,0.760438563,0.832705529,N,-,,tim10 ddp family zinc finger,F:metal ion binding; C:mitochondrial intermembrane space protein transporter complex; C:cytosol; F:protein transporter activity; P:protein import into mitochondrial inner membrane; C:mitochondrial inner membrane,IPR004217 (PFAM); IPR004217 (G3DSA:1.10.287.GENE3D); PTHR21535:SF33 (PANTHER); PTHR21535 (PANTHER); IPR004217 (SUPERFAMILY),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_01924,40223,37929,30687,2,1,9,0,0,0,5,0,1,1,5,3,0,4,6,499.3327119,1,-2.604011943,0.505820951,-5.148090325,2.63E-07,4.69E-06,140.3661919,0,-3.667527552,1.208758792,-3.034126888,0.002412329,0.015308839,424.0899674,1,-2.86694492,0.649892311,-4.411415356,1.03E-05,0.000191474,476.0390475,1,-2.834355875,0.541249313,-5.236691869,1.63E-07,3.51E-06,414.5870532,1,-2.424132486,0.537477312,-4.510204306,6.48E-06,7.02E-05,N,-,,#NAME?,P:transmembrane transport; C:integral component of membrane; F:metal ion transmembrane transporter activity; P:metal ion transport,G3DSA:1.20.58.340 (GENE3D); IPR002523 (PFAM); G3DSA:3.30.460.20 (GENE3D); G3DSA:1.20.58.340 (GENE3D); PTHR21535:SF55 (PANTHER); PTHR21535 (PANTHER); SSF143865 (SUPERFAMILY); SSF144083 (SUPERFAMILY),1.A.35.2.3, the cora metal ion transporter (mit) family.
RL4_JR_01925,937,1003,1517,0,0,3,0,0,0,0,0,0,0,0,0,0,2,0,25.24978585,1,0.391325608,0.894298956,0.437578066,0.661692174,0.810523237,4.366242364,0,1.339036992,1.264356733,1.059065814,0.289569808,0.448924122,11.39482193,0,-1.321442444,1.210738559,-1.091435004,0.275081517,0.413807619,13.14978637,0,-1.744262672,1.211100653,-1.440229321,0.14980253,0.265947456,19.0281124,1,0.243054533,1.012946175,0.239948122,0.810370474,0.871697738,N,-,,Microsomal signal peptidase 12kDa subunit,C:integral component of membrane; P:signal peptide processing; F:peptidase activity; C:signal peptidase complex,IPR009542 (PFAM); PTHR13202:SF0 (PANTHER); IPR009542 (PANTHER),,
RL4_JR_01926,1757,2284,2121,3,0,18,0,0,0,0,0,0,0,5,0,0,1,2,123.6962683,1,2.176780784,0.621264421,3.503791158,0.000458685,0.003131859,7.883016594,0,0.486783755,1.229641947,0.395874389,0.692197695,0.804999435,20.46409614,0,-2.1659946,1.19724957,-1.809142099,0.07042893,0.147532069,43.66792216,1,0.432486609,0.69018074,0.626628046,0.53090308,0.66403875,38.75949011,1,-0.024319891,0.850230016,-0.028603896,0.977180505,0.984962928,N,-, Effector probability:0.895,RING-box 1,F:zinc ion binding; F:ligase activity,IPR013083 (G3DSA:3.30.40.GENE3D); IPR024766 (PFAM); PTHR11210:SF22 (PANTHER); PTHR11210 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),8.A.112.1.6, the respiratory supercomplex factor (rcf) family.
RL4_JR_01927,1968,1116,1609,0,1,3,0,0,0,0,2,0,0,0,0,0,0,0,38.12258291,1,0.38344267,0.781773217,0.490478136,0.623795598,0.784404528,6.001983213,0,0.880084033,1.269676139,0.693156314,0.48821146,0.644286363,31.19663582,1,0.058593413,1.055597033,0.055507368,0.955734261,0.97422732,17.88761618,0,-2.188120819,1.214706654,-1.801357399,0.071646566,0.153788739,15.25014006,0,-1.844597089,1.217119179,-1.515543523,0.129634817,0.231858775,N,-,,proteophosphoglycan 5,,no IPS match,,
RL4_JR_01928,564,724,500,0,1,6,0,0,0,0,0,0,0,0,0,0,0,0,38.13092779,1,2.531629635,0.63174684,4.007348316,6.14E-05,0.000557835,2.307076608,0,2.259537907,1.327138394,1.70256389,0.088649713,0.184257623,5.963804987,0,-0.38702624,1.216908692,-0.318040493,0.750454221,0.832887364,6.879010543,0,-0.80916966,1.217546721,-0.664590234,0.506312617,0.642402915,5.848260554,0,-0.461709593,1.213588542,-0.380449862,0.703611508,0.79015822,N,-,,tyrosyl-dna phosphodiesterase domain-containing,P:nucleic acid metabolic process; P:cellular macromolecule metabolic process; F:catalytic activity,IPR010347 (PFAM); G3DSA:3.30.870.10 (GENE3D); IPR027415 (G3DSA:3.30.870.GENE3D); PTHR12415:SF2 (PANTHER); IPR010347 (PANTHER); IPR003903 (PROSITE_PROFILES); IPR001736 (PROSITE_PROFILES); SSF56024 (SUPERFAMILY); SSF56024 (SUPERFAMILY),,
RL4_JR_01929,9515,8124,11710,1,1,2,2,0,0,0,0,0,0,1,0,0,5,0,142.7224757,1,-2.24227748,0.755692346,-2.967182999,0.00300542,0.014405534,81.88688363,1,-0.088133483,0.977919637,-0.090123441,0.928189122,0.959733049,96.87749792,0,-4.40912309,1.195102096,-3.689327551,0.000224848,0.001895385,115.7814569,1,-3.884799889,1.149084928,-3.380776994,0.000722812,0.005625265,115.0810688,1,-1.589012566,0.709974384,-2.238126617,0.025212799,0.065810671,N,-,,tRNA uridine 5-carboxymethylaminomethyl modification enzyme,F:oxidoreductase activity; F:flavin adenine dinucleotide binding; C:mitochondrion; P:oxidation-reduction process; P:mitochondrial tRNA wobble uridine modification,SM01228 (SMART); IPR002218 (PFAM); IPR026904 (PFAM); IPR004416 (TIGRFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR11806:SF0 (PANTHER); PTHR11806 (PANTHER); IPR004416 (HAMAP); IPR023753 (SUPERFAMILY),1.C.39.4.5, the membrane attack complex/perforin (macpf) family.
RL4_JR_01930,2824,3211,6118,0,4,4,0,0,1,0,1,1,0,2,2,0,0,0,95.68347324,1,0.026524063,0.678288461,0.039104399,0.968807154,0.984044596,24.59449838,1,0.451847317,1.157536626,0.390352501,0.696275906,0.807389704,54.23662361,1,-1.312265038,1.078965274,-1.216225462,0.223899047,0.354069658,73.34513743,1,-0.813550127,0.81999918,-0.992135293,0.321131532,0.467456774,39.79319085,0,-3.228226451,1.247438201,-2.587884873,0.009656725,0.030497299,N,-,,phosphatidyl synthase,C:integral component of membrane; P:phospholipid biosynthetic process; F:CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,IPR000462 (PFAM); PTHR14269 (PANTHER),4.F.1.1.7, the choline/ethanolaminephosphotransferase 1 (cept1) family.
RL4_JR_01931,2197,2941,2360,2,0,4,0,0,0,0,1,1,0,0,2,0,2,0,65.59981465,1,0.284095021,0.648416248,0.438136801,0.661287118,0.810270398,9.630040279,0,0.198008791,1.231657147,0.160766161,0.872277578,0.926463132,39.29750943,1,-0.631352405,1.042818618,-0.605428781,0.544894133,0.672089205,48.06024656,1,-1.123302505,1.026276028,-1.094542282,0.273717214,0.415811972,32.26227415,1,-0.866339354,0.987543011,-0.877267466,0.380341379,0.516059498,N,-,,vacuolar sorting-associated 45,"F:oxidoreductase activity; F:flavin adenine dinucleotide binding; C:membrane; P:vesicle docking involved in exocytosis; F:phosphotransferase activity, for other substituted phosphate groups; P:phospholipid biosynthetic process; P:oxidation-reduction process; P:tRNA wobble uridine modification",G3DSA:3.90.830.10 (GENE3D); IPR001619 (PFAM); IPR001619 (PIRSF); G3DSA:3.40.50.2060 (GENE3D); G3DSA:1.25.40.60 (GENE3D); IPR027482 (G3DSA:3.40.50.GENE3D); IPR001619 (PANTHER); PTHR11679:SF3 (PANTHER); IPR001619 (SUPERFAMILY),1.F.1.1.3, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_01932,1502,1810,2841,1,0,11,0,0,0,0,0,1,2,0,0,0,0,0,76.62567015,1,1.405211094,0.672632409,2.089121897,0.036696752,0.105860007,7.747732725,0,0.511666915,1.251686059,0.408782147,0.682699543,0.798230885,26.76057604,1,-1.189980441,1.216743337,-0.978004486,0.328072105,0.470987237,42.01011629,1,-0.808706822,1.048895768,-0.771007803,0.440702306,0.582597056,20.14707976,0,-2.246262874,1.232590504,-1.822391839,0.068395552,0.14246142,N,-,,mitochondrial outer membrane mmm1,P:mitochondrial outer membrane translocase complex assembly; P:protein import into mitochondrial outer membrane; P:mitochondrion-ER tethering; C:integral component of endoplasmic reticulum membrane; P:phospholipid transport; C:ERMES complex; P:mitochondrial genome maintenance,IPR019411 (PFAM); PTHR13466:SF5 (PANTHER); PTHR13466:SF5 (PANTHER); PTHR13466 (PANTHER); IPR027537 (HAMAP),9.A.58.1.1, the maintenance of mitochondrial morphology (mmm) family.
RL4_JR_01933,703,1089,1013,0,0,5,0,0,0,0,0,0,0,1,0,0,0,0,30.38158723,1,1.388454117,0.736376799,1.885521269,0.059359496,0.151235092,3.580654937,0,1.625290438,1.283893475,1.265907546,0.205546185,0.350495027,9.313881273,0,-1.030349942,1.213407477,-0.849137624,0.395804717,0.538592332,14.7588023,1,-0.507268548,1.165250416,-0.435330073,0.663322859,0.770577221,9.195248882,0,-1.114583273,1.219276271,-0.914135131,0.360645845,0.498027711,N,-,,prenyl ase rce1,C:membrane,IPR003675 (PFAM); PTHR13046 (PANTHER); PTHR13046:SF0 (PANTHER),9.B.1.2.2, the integral membrane caax protease (caax protease) family.
RL4_JR_01934,3892,2765,2239,0,1,4,0,0,0,0,0,0,3,3,0,0,1,0,58.8849852,1,-0.244584903,0.732168627,-0.334055427,0.738337734,0.862574715,11.51666099,0,-0.060090695,1.256495596,-0.04782404,0.961856478,0.979638423,29.61004298,0,-2.699000784,1.21711718,-2.217535689,0.026586507,0.069821478,74.11064423,1,0.201299107,0.674336095,0.298514507,0.765310505,0.847137736,32.78022142,1,-1.839283272,1.144887221,-1.606519173,0.108159886,0.202474746,N,-,,serine-rich,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_01935,1579,1339,2045,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,27.41066981,1,-0.68609726,1.026359562,-0.668476511,0.50382947,0.690448651,6.290237028,0,0.812343463,1.238528973,0.655893791,0.511892464,0.66300933,24.21067723,1,-0.882119295,1.199186596,-0.735598028,0.461975363,0.599389796,18.88470904,0,-2.26643969,1.200239071,-1.888323539,0.058982529,0.135480514,16.19845948,0,-1.931571953,1.209435278,-1.597085837,0.110246575,0.205343372,N,-,,mboat family,F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:1-acylglycerophosphocholine O-acyltransferase activity; P:glycerophospholipid biosynthetic process; C:integral component of membrane; C:endoplasmic reticulum; C:ribosome,IPR004299 (PFAM); PTHR13906 (PANTHER); PTHR13906:SF4 (PANTHER),2.A.50.2.4, the glycerol uptake (gup) or membrane-bound acyl transfeerase (mboat) family.
RL4_JR_01936,6449,6272,6138,0,0,15,0,0,0,0,2,6,2,8,2,0,1,0,132.8486516,1,-0.110409045,0.892594768,-0.123694479,0.901557183,0.952214332,24.18242809,0,-1.130343699,1.199142702,-0.942626509,0.345871976,0.509101905,117.2782623,1,0.035373852,0.535443402,0.066064596,0.947326397,0.969320437,142.195451,1,0.105541191,0.443520184,0.237962543,0.811910146,0.880525945,65.41524563,1,-2.926739277,1.114506634,-2.626040249,0.00863846,0.027918404,N,-,,GDP-mannose transporter,C:endoplasmic reticulum membrane; F:GDP-mannose transmembrane transporter activity; C:cytoplasmic vesicle membrane; C:integral component of membrane; P:protein glycosylation; P:carbohydrate transport; C:Golgi membrane; P:GDP-mannose transmembrane transport,IPR013657 (PFAM); TIGR00803 (TIGRFAM); PTHR11132:SF105 (PANTHER); PTHR11132 (PANTHER); SSF103481 (SUPERFAMILY),2.A.7.13.6, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_01937,315,371,351,0,0,3,0,0,0,0,0,1,0,0,0,0,1,0,15.6193037,1,2.13824539,0.86143894,2.482178702,0.013058177,0.046887592,1.327568187,0,3.056761844,1.359873269,2.247828465,0.02458713,0.067609598,9.941945451,1,1.367262482,1.196152688,1.143050127,0.253017779,0.388702883,3.972249767,0,-0.016987162,1.206922851,-0.01407477,0.988770329,0.993381581,7.251509776,1,1.254488024,1.129362681,1.11079288,0.266657512,0.398922475,N,-,,retinol dehydrogenase 8,F:oxidoreductase activity; P:oxidation-reduction process; C:cellular_component,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24322:SF405 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_01938,102,93,124,0,0,3,0,0,0,0,0,0,0,4,0,0,0,0,12.72909782,1,3.845406943,0.86511702,4.444955831,8.79E-06,0.000104088,0.405592567,0,4.767343586,1.596542443,2.986042499,0.002826134,0.015349618,1.054073769,0,2.11260185,1.233371325,1.712867656,0.08673689,0.173508056,17.26245229,1,4.399614686,0.758044294,5.80390186,6.48E-09,1.85E-07,1.041443862,0,2.027685713,1.220146352,1.661838115,0.096545238,0.185805081,N,-,,transcription factor bzip,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR004827 (SMART); IPR004827 (PFAM); G3DSA:1.20.5.170 (GENE3D); IPR004827 (PROSITE_PROFILES); SSF57959 (SUPERFAMILY),,
RL4_JR_01939,282,758,681,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10.77283073,1,0.040856732,1.249994418,0.032685531,0.973925362,0.986869097,2.187301751,0,2.336333914,1.408182915,1.659112527,0.097093119,0.198100495,5.715963918,0,-0.325980392,1.275598392,-0.255550958,0.798297591,0.867629072,6.597863144,0,-0.749146258,1.286335908,-0.582387736,0.56030554,0.688732984,5.66491121,0,-0.415736557,1.288336971,-0.322692406,0.746928204,0.823369413,N,-,,calcium homeostasis,P:biological_process; C:cellular_component,IPR005511 (PRINTS); IPR013658 (PFAM); IPR011042 (G3DSA:2.120.10.GENE3D); PTHR10907 (PANTHER); PTHR10907:SF59 (PANTHER); SSF63829 (SUPERFAMILY),,
RL4_JR_01940,5287,2987,3510,0,5,1,0,0,2,2,1,2,0,2,0,0,2,1,90.79053415,1,-0.26912645,0.70770981,-0.380277971,0.703739086,0.839727461,33.91796822,1,1.165788817,1.037630102,1.123510984,0.261220538,0.417507388,82.03425712,1,0.054271243,0.709561851,0.07648557,0.939032794,0.963531496,53.05335819,1,-1.810211852,1.053935637,-1.717573434,0.085874449,0.174827103,53.34494344,1,-0.964931317,0.877083031,-1.100159601,0.271262589,0.403605249,N,-,,lmbr1 domain-containing,C:cytoplasm; C:membrane,IPR006876 (PFAM); PTHR21355 (PANTHER); PTHR21355:SF0 (PANTHER),9.A.54.3.1, the lysosomal cobalamin (b12) transporter (l-b12t) family.
RL4_JR_01941,4698,10236,6696,2,2,85,0,0,0,2,5,9,8,11,1,0,3,2,448.4133291,1,2.079827206,1.083334004,1.919839309,0.0548782,0.14261292,27.80721504,0,-1.331862208,1.249554072,-1.065870008,0.286482408,0.445981996,192.0660478,1,0.804170793,0.523864169,1.535075006,0.124765405,0.228619902,211.5973459,1,0.636006624,0.540559139,1.176571772,0.23936647,0.377387964,97.4006484,1,-1.138132507,0.770514275,-1.477107621,0.139646791,0.245472875,N,-,,aldehyde dehydrogenase,F:aldehyde dehydrogenase (NAD) activity; P:oxidation-reduction process,IPR016163 (G3DSA:3.40.309.GENE3D); IPR015590 (PFAM); IPR016162 (G3DSA:3.40.605.GENE3D); PTHR11699 (PANTHER); PTHR11699:SF196 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_01942,664,619,782,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.249533555,0,-1.146768683,1.193123485,-0.961148362,0.336477576,0.526612198,2.629102669,0,2.070915335,1.280250916,1.617585513,0.105751953,0.211253458,6.828752677,0,-0.582785388,1.196066223,-0.487251774,0.626079919,0.738228873,7.878213488,0,-1.005215026,1.193866642,-0.841982673,0.399797652,0.544006347,6.742003711,0,-0.66694501,1.200378412,-0.5556123,0.578475921,0.691507521,N,-,,guanine nucleotide exchange factor,C:membrane; C:integral component of membrane,PTHR23284 (PANTHER); PTHR23284:SF0 (PANTHER); PTHR23284 (PANTHER),,
RL4_JR_01943,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_01944,4564,5373,8096,2,0,3,0,0,0,1,3,0,2,6,0,0,3,0,103.5833764,1,-1.225063979,0.732757618,-1.671854306,0.094553055,0.212493042,22.74583923,0,-1.042057542,1.216858227,-0.856350822,0.391803758,0.556218463,94.02656044,1,-0.871022855,0.774959169,-1.123959674,0.261030134,0.398112244,111.2797956,1,-0.437429797,0.605070503,-0.722940211,0.469716618,0.610667791,70.61097679,1,-1.619556557,0.898606752,-1.802297337,0.071498637,0.147138964,N,-,,hypothetical protein CMQ_7404,C:integral component of membrane,PTHR40978 (PANTHER); PTHR40978 (PANTHER); PTHR40978:SF1 (PANTHER); PTHR40978:SF1 (PANTHER),,
RL4_JR_01945,5899,5805,7015,7,1,13,0,0,2,3,0,4,2,10,0,0,2,1,202.9557602,1,0.782200789,0.375862046,2.081084796,0.037426145,0.10750792,42.60293655,1,0.534692846,0.979121395,0.546094538,0.585000954,0.723531238,121.1421002,1,-0.131343602,0.568254094,-0.231135338,0.817209662,0.881634879,130.1971177,1,0.100474373,0.455866655,0.220402988,0.825557319,0.890841719,76.22672293,1,-1.635136781,0.843739986,-1.93796289,0.05262775,0.116394926,N,-,,hypothetical protein CMQ_7320,C:integral component of membrane,PTHR40978:SF2 (PANTHER); PTHR40978 (PANTHER),,
RL4_JR_01946,45,40,27,0,0,3,0,0,0,0,0,0,0,0,0,0,1,0,11.90561143,1,5.32764493,0.91101817,5.848011712,4.97E-09,1.20E-07,0.145217385,0,6.249519659,1.976792797,3.161443965,0.00156989,0.015023052,0.373608639,0,3.610299184,1.317233468,2.740819507,0.006128616,0.022119826,0.430792556,0,3.188103378,1.493780418,2.134251688,0.032822184,0.097077583,4.225390675,1,4.468183684,1.158894696,3.855556246,0.000115467,0.000782007,Y,-,,chitin deacetylase,P:primary metabolic process; P:organic substance metabolic process; F:hydrolase activity,IPR001002 (SMART); IPR001002 (G3DSA:3.30.60.GENE3D); IPR001002 (PFAM); IPR002509 (G3DSA:3.20.20.GENE3D); IPR001002 (G3DSA:3.30.60.GENE3D); IPR002509 (PFAM); PTHR10587:SF92 (PANTHER); PTHR10587:SF92 (PANTHER); PTHR10587 (PANTHER); IPR001002 (PRODOM); IPR002509 (PROSITE_PROFILES); IPR001002 (PROSITE_PROFILES); IPR001002 (PROSITE_PROFILES); IPR011330 (SUPERFAMILY); IPR001002 (SUPERFAMILY); IPR001002 (SUPERFAMILY),9.B.87.1.15, the selenoprotein p receptor (selp-receptor) family.
RL4_JR_01947,2145,1426,764,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21.20105534,1,-1.279887309,1.231960679,-1.038902727,0.298849978,0.484406541,5.667416636,0,0.962888564,1.354691326,0.710780785,0.47722009,0.634496486,14.49053703,0,-1.668003117,1.265774439,-1.317772792,0.187579719,0.309746709,16.70136507,0,-2.089034902,1.272798173,-1.641293133,0.100736581,0.196827071,14.06514147,0,-1.727876895,1.266825741,-1.363942047,0.172585806,0.287785126,N,-,,Zinc C2H2,F:nucleic acid binding; F:metal ion binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR14596 (PANTHER); PTHR14596:SF31 (PANTHER); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_01948,7391,7343,9568,37,89,1207,5,0,18,16,54,133,3,254,54,0,254,5,5791.408759,1,5.877142892,0.919845439,6.389272201,1.67E-10,5.51E-09,311.2531143,1,3.552608652,0.426880015,8.3222651,8.63E-17,3.36E-14,1545.28459,1,4.202490064,0.545636102,7.702001485,1.34E-14,1.28E-12,1659.849639,1,4.087344952,0.931372957,4.388515813,1.14E-05,0.000157645,1096.802989,1,3.694261882,1.417101664,2.606913798,0.009136236,0.029208837,Y,-,,GPI anchored serine-rich,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_01949,7719,5766,5502,0,13,7,0,0,0,0,9,18,3,4,1,0,5,6,206.7816511,1,0.781816429,0.717453729,1.089709896,0.275840955,0.458872454,24.4580778,0,-1.146696681,1.218681413,-0.94093228,0.346739564,0.509591976,250.6298556,1,1.693794048,0.488521809,3.467182053,0.000525946,0.003510002,126.3435722,1,-0.475458981,0.567314954,-0.838086459,0.401982147,0.54580562,125.2869562,1,0.226470953,0.501495562,0.45159114,0.651563554,0.751718435,N,-,,lipid acyl hydrolase,C:cytoplasm; P:lipid catabolic process; C:integral component of membrane; F:triglyceride lipase activity,IPR021771 (PFAM); G3DSA:3.40.1090.10 (GENE3D); IPR002641 (PFAM); PTHR14226:SF35 (PANTHER); PTHR14226 (PANTHER); PTHR14226 (PANTHER); IPR016035 (SUPERFAMILY),,
RL4_JR_01950,10813,11021,14352,2,14,27,0,0,2,0,10,5,0,14,1,0,4,7,379.9745062,1,0.794529027,0.411134741,1.932527095,0.053294481,0.139709633,64.71984182,1,-0.412374101,0.979939307,-0.42081596,0.673889476,0.7919551,230.5047462,1,0.003571354,0.442569082,0.008069596,0.993561464,0.997409756,203.7716364,1,-0.647302217,0.529923558,-1.221501114,0.221896344,0.357224782,185.2559063,1,-0.693783762,0.518346067,-1.33845669,0.18074761,0.298494462,N,-,,small COPII coat GTPase,,IPR006689 (PRINTS); SM00178 (SMART); SM00177 (SMART); IPR006689 (PFAM); IPR005225 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11711 (PANTHER); PTHR11711:SF174 (PANTHER); IPR006687 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_01951,22147,15952,18615,0,3,1,0,0,6,8,2,9,5,18,8,0,4,15,254.1463905,1,-3.182603691,0.754722463,-4.216919261,2.48E-05,0.00025161,128.9548658,1,0.419729667,0.666042148,0.630184843,0.528573655,0.677243359,350.6102138,1,-0.278051897,0.418246494,-0.664803892,0.506175933,0.638013589,412.5313944,1,-0.113713029,0.340328571,-0.334127189,0.738283584,0.825980253,310.5464226,1,-0.471397481,0.726467316,-0.648890144,0.516409386,0.642035359,N,-,,gtp-binding sar1,,IPR018853 (PFAM); PTHR42046 (PANTHER),,
RL4_JR_01952,11827,12043,15440,5,9,35,0,0,3,1,0,5,0,11,7,0,0,2,413.1792145,1,0.826019594,0.378216262,2.183987515,0.028963166,0.088003551,78.09217161,1,0.011285835,0.845022172,0.013355667,0.989344036,0.994452863,173.5013932,1,-1.43242523,0.622994636,-2.299257727,0.021490309,0.058849847,261.4955658,1,-0.36765216,0.40450898,-0.908885039,0.363410812,0.509560237,143.1888831,1,-3.227090949,0.981650473,-3.287413429,0.001011123,0.004831344,N,-, Effector probability:0.614,ATP synthase delta mitochondrial,"C:mitochondrial proton-transporting ATP synthase complex, catalytic core F(1); F:proton-transporting ATPase activity, rotational mechanism; P:ATP synthesis coupled proton transport; F:proton-transporting ATP synthase activity, rotational mechanism",G3DSA:1.20.5.440 (GENE3D); IPR020546 (G3DSA:2.60.15.GENE3D); IPR020546 (PFAM); PTHR13822:SF7 (PANTHER); IPR001469 (PANTHER); IPR020546 (PRODOM); IPR020546 (SUPERFAMILY),3.A.2.1.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_01953,837,1038,1016,0,0,0,0,0,0,0,2,13,0,1,7,0,0,0,11.60785641,0,-1.639213432,1.198629247,-1.367573365,0.171445658,0.325117081,3.694774682,0,1.580040067,1.262113997,1.251899647,0.210606433,0.356302577,109.7631007,1,3.600849356,0.481266811,7.48202301,7.32E-14,6.62E-12,82.52704955,1,2.359062782,0.625299712,3.772691297,0.000161496,0.001604659,9.45888301,0,-1.155365415,1.201217584,-0.96182859,0.336135714,0.473282451,N,-, Effector probability:0.647,isochorismatase family,F:catalytic activity; P:metabolic process,IPR000868 (PFAM); IPR000868 (G3DSA:3.40.50.GENE3D); PTHR14119 (PANTHER); PTHR14119:SF3 (PANTHER); IPR000868 (SUPERFAMILY),,
RL4_JR_01954,4509,3845,4575,0,0,9,0,0,0,0,0,1,0,0,0,0,0,2,86.01572067,1,0.0724812,0.515377374,0.140637141,0.888156606,0.945379342,16.51473742,0,-0.580160695,1.20278664,-0.482347139,0.629559366,0.756547536,49.30107563,1,-2.268859832,1.187775155,-1.9101762,0.05611053,0.123345484,49.37351303,0,-3.652875055,1.18671505,-3.078139992,0.00208297,0.013632886,56.89706351,1,-1.628190581,0.96716351,-1.683469821,0.092284177,0.179480847,N,-,,ubiquitin carboxyl-terminal hydrolase 19,F:hydrolase activity,no IPS match,,
RL4_JR_01955,980,1293,986,0,5,9,0,0,0,0,0,0,0,0,0,0,5,0,87.54766783,1,2.681407399,0.488726787,5.486516124,4.10E-08,8.92E-07,4.192446765,0,1.39777996,1.272012339,1.098872957,0.271823484,0.429369118,10.85514451,0,-1.251189934,1.206404552,-1.037123021,0.299678528,0.440596197,12.52215443,0,-1.673459284,1.205770978,-1.387874907,0.16517514,0.285657594,29.96706554,1,1.580402947,0.706630908,2.236532437,0.025316915,0.0659994,N,-,,GDSL Lipase Acylhydrolase family,,IPR013830 (G3DSA:3.40.50.GENE3D); IPR013830 (PFAM); PTHR14209 (PANTHER); IPR013830 (SUPERFAMILY),,
RL4_JR_01956,1003,1139,1262,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,21.27563532,1,-0.145677783,1.016021382,-0.143380628,0.885989582,0.944154115,4.338971588,0,1.348147914,1.247125304,1.081004379,0.279695166,0.438821046,11.27543089,0,-1.306149508,1.194428005,-1.093535569,0.274158721,0.412696988,22.32139688,1,-0.779063567,1.143568337,-0.681256678,0.49570909,0.634304217,11.13104313,0,-1.390239068,1.199465356,-1.159048955,0.246436231,0.376572116,N,-,,3-oxo-5-alpha-steroid 4-dehydrogenase,P:polyprenol metabolic process,IPR001104 (PFAM); PTHR14624 (PANTHER); IPR001104 (PROSITE_PROFILES),,
RL4_JR_01957,671,637,881,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,8.737238877,0,-1.229632034,1.201243702,-1.023632451,0.306008912,0.492682199,2.778134749,0,1.991337176,1.280345,1.555312963,0.119871551,0.233469279,20.2256576,1,1.153604696,1.039076493,1.110221147,0.266903742,0.404935335,8.339856746,0,-1.087387219,1.200131804,-0.906056498,0.364905949,0.511189123,7.150038082,0,-0.751709334,1.208345725,-0.622097897,0.533877498,0.657124929,N,-,,Oxoglutarate iron-dependent oxygenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR027450 (G3DSA:2.60.120.GENE3D); IPR027450 (PFAM); IPR032862 (PTHR13069:PANTHER); IPR032862 (PTHR13069:PANTHER); PTHR13069 (PANTHER); PTHR13069 (PANTHER); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_01958,59011,40753,38458,0,3,13,3,0,0,0,2,3,4,14,7,0,10,8,625.9954389,1,-2.632230981,0.575342833,-4.575065216,4.76E-06,6.03E-05,245.2490501,1,-1.739789879,0.897345129,-1.938819105,0.052523369,0.122441626,494.3967272,1,-3.524202965,0.715501831,-4.925498181,8.41E-07,2.31E-05,690.3594595,1,-1.707862527,0.413799721,-4.127268438,3.67E-05,0.000445667,546.945067,1,-1.968388071,0.500425654,-3.933427582,8.37E-05,0.000597954,N,-,,ankyrin repeat,P:histone deacetylation; C:Set3 complex; P:negative regulation of meiotic nuclear division,IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); PTHR24149:SF1 (PANTHER); PTHR24149:SF1 (PANTHER); PTHR24149 (PANTHER); PTHR24149 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_01959,3110,3163,5464,0,1,8,0,0,0,0,0,0,0,1,0,0,2,0,85.30357476,1,0.13253118,0.649442755,0.204069072,0.838299523,0.918937779,14.7701595,0,-0.419156824,1.22939557,-0.340945449,0.733144649,0.833526917,38.60762486,0,-3.08187197,1.214740679,-2.537061632,0.011178727,0.035707308,48.56878585,1,-2.55951952,1.17213228,-2.183643915,0.028988424,0.090479045,46.10708505,1,-1.523712746,1.022869314,-1.489645574,0.136317452,0.241169702,N,-,,gtp-binding rbg1,,IPR006073 (PRINTS); IPR005225 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR006073 (PFAM); IPR004095 (PFAM); IPR031662 (PFAM); PTHR11702 (PANTHER); PTHR11702:SF26 (PANTHER); IPR031167 (PROSITE_PROFILES); IPR012676 (SUPERFAMILY); IPR027417 (SUPERFAMILY),9.A.8.1.9, the ferrous iron uptake (feob) family.
RL4_JR_01960,356,360,337,0,0,0,0,0,0,0,0,0,0,0,0,0,8,0,4.222878028,0,-0.180363563,1.20584718,-0.149574146,0.881100607,0.94187837,1.35124196,0,3.03128919,1.358370787,2.231562413,0.025643898,0.069851329,3.497395365,0,0.382892072,1.203639495,0.318111921,0.750400041,0.832887364,4.034169992,0,-0.039274297,1.203331912,-0.032637959,0.973963299,0.985054281,34.32221361,1,3.900173492,0.549832972,7.093378698,1.31E-12,1.31E-10,N,-,,centromere binding b,F:DNA binding,IPR009057 (G3DSA:1.10.10.GENE3D); IPR007889 (PFAM); IPR006600 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); IPR006600 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY); IPR009057 (SUPERFAMILY),,
RL4_JR_01961,14120,14562,19232,0,7,2,5,0,2,1,2,11,3,9,2,0,16,1,255.1585979,1,-1.70556822,0.622237419,-2.741024838,0.006124788,0.025597345,191.1374048,1,0.990722317,0.591182913,1.675830434,0.093771411,0.192682546,256.540018,1,-0.519092984,0.465227065,-1.115784148,0.264514541,0.401973163,265.961552,1,-1.01790738,0.440435189,-2.311139993,0.020825124,0.078120428,225.7396728,1,-0.755344067,0.651201926,-1.159922962,0.246080173,0.376272158,N,-,,mRNA processing,,IPR003114 (SMART); IPR003114 (PFAM); IPR032717 (PFAM); PTHR28069 (PANTHER); PTHR28069:SF1 (PANTHER); IPR003114 (PROSITE_PROFILES); SSF144232 (SUPERFAMILY),,
RL4_JR_01962,33473,39730,44941,7,1,11,0,0,0,2,3,4,3,13,0,0,8,8,593.8653457,1,-2.013339511,0.444837116,-4.526015115,6.01E-06,7.41E-05,150.4035136,0,-3.767180717,1.194523143,-3.15371095,0.001612087,0.015023052,462.8472919,1,-2.43075456,0.528114592,-4.602702891,4.17E-06,8.96E-05,531.4441956,1,-2.194155652,0.467578404,-4.69259408,2.70E-06,4.42E-05,476.3157641,1,-1.894073995,0.487309956,-3.886795194,0.000101576,0.000703462,N,-,,pre-mRNA-splicing factor RSE1,F:nucleic acid binding; C:U2-type prespliceosome; C:U2 snRNP; P:spliceosomal complex assembly,IPR015943 (G3DSA:2.130.10.GENE3D); PF10433 (PFAM); IPR004871 (PFAM); PTHR10644 (PANTHER); PTHR10644:SF1 (PANTHER); IPR017986 (SUPERFAMILY),,
RL4_JR_01963,2179,1718,2502,0,0,1,0,0,0,0,0,0,0,3,0,0,0,0,29.31414133,1,-1.827400048,1.148222494,-1.591503439,0.111496322,0.239428006,8.132883375,0,0.441715147,1.227407834,0.359876428,0.718939546,0.824074798,21.12398714,0,-2.211908721,1.196951321,-1.847952111,0.064609271,0.138165093,36.40435212,1,-0.336523467,0.865721272,-0.388720339,0.697483035,0.796078878,20.86693562,0,-2.296947074,1.203198742,-1.909033806,0.056257731,0.122470334,N,-,,thiamine biosynthetic bifunctional enzyme,C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_01964,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_01965,22,16,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.235180503,0,3.985724327,2.76507646,1.441451759,0.149457097,NA,0.075335499,0,7.196022026,2.214954695,3.24883486,0.001158787,0.015023052,0.195116001,0,4.546087367,1.350183013,3.367015673,0.000759864,0.004625893,0.22505503,0,4.124300718,1.728126799,2.386572976,0.017006232,0.070801027,0.19216503,0,4.46488428,1.254302209,3.559655917,0.000371341,0.002103989,N,-,,---NA---,,no IPS match,,
RL4_JR_01966,90,68,107,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.054717031,0,1.820642938,1.466765432,1.241263871,0.214508287,NA,0.3362211,0,5.037927572,1.661393311,3.032350941,0.002426569,0.015349618,0.873880065,0,2.382851984,1.250822805,1.905027615,0.056776482,0.124605484,1.008178241,0,1.960689823,1.298763279,1.509659116,0.131130429,0.240350396,0.864031576,0,2.296901757,1.233385378,1.86227419,0.062564452,0.133042176,N,-,,hydroxyethylthiazole kinase,"P:regulation of transcription, DNA-templated; C:intracellular part; F:kinase activity; P:cellular metabolic process",IPR000417 (PRINTS); IPR013785 (G3DSA:3.20.20.GENE3D); IPR003733 (PFAM); IPR000417 (PFAM); IPR029056 (G3DSA:3.40.1190.GENE3D); IPR003733 (TIGRFAM); PTHR20857:SF15 (PANTHER); PTHR20857 (PANTHER); IPR003733 (HAMAP); IPR000417 (HAMAP); IPR022998 (SUPERFAMILY); IPR029056 (SUPERFAMILY),,
RL4_JR_01967,4994,3230,3848,0,3,0,0,0,0,2,0,1,2,0,0,0,1,0,72.14793599,1,-1.348975364,0.869280965,-1.551828946,0.120703158,0.253591646,15.48971245,0,-0.487703903,1.227781251,-0.397223775,0.691202452,0.804455699,68.62755354,1,-0.71487315,0.867658006,-0.823911201,0.409990015,0.552253714,64.73985013,1,-1.799795993,1.031216973,-1.745312617,0.080930467,0.167639316,43.11539061,1,-2.279218104,1.133193525,-2.011322914,0.04429136,0.101943627,N,-,,trna processing endoribonuclease,F:catalytic activity; P:cellular metabolic process,IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31845:SF14 (PANTHER); PTHR31845 (PANTHER); IPR001138 (SUPERFAMILY),,
RL4_JR_01968,43262,27013,40269,0,14,13,0,0,0,0,1,0,0,3,2,0,4,1,601.4228149,1,-1.413614784,0.694262728,-2.03613809,0.041736491,0.116365787,140.9819861,0,-3.673850747,1.211450938,-3.032603823,0.002424537,0.015349618,372.9100726,1,-5.361235251,1.209567239,-4.432358184,9.32E-06,0.00017771,452.3724304,1,-3.698014235,0.707128767,-5.229619281,1.70E-07,3.63E-06,382.4505724,1,-3.493899234,0.736112768,-4.746418462,2.07E-06,2.67E-05,N,-,,5-aminolevulinate synthase,,IPR015421 (G3DSA:3.40.640.GENE3D); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR010961 (TIGRFAM); IPR004839 (PFAM); PTHR13693 (PANTHER); PTHR13693:SF57 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_01969,8387,5829,5480,0,2,1,0,0,1,0,3,2,0,5,0,5,6,3,98.54963039,1,-2.076941072,0.880678583,-2.35834175,0.018356785,0.061149306,34.78751212,1,-0.286654568,1.141752072,-0.251065511,0.80176346,0.879851993,101.9650033,1,-0.705596133,0.701281773,-1.006152107,0.314342406,0.45671678,95.51276882,1,-1.269062047,0.726886487,-1.745887522,0.080830499,0.167497209,189.4275282,1,0.606649669,0.498028874,1.218101403,0.223185441,0.349858438,N,-,,snf2 family helicase,F:ATP binding; F:helicase activity,IPR001650 (SMART); IPR014001 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000330 (PFAM); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10799 (PANTHER); PTHR10799:SF752 (PANTHER); PTHR10799 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_01970,2646,2340,3313,0,2,0,0,0,0,0,0,1,0,2,1,0,0,0,49.1211161,1,-1.404666544,1.014593863,-1.384461897,0.166217068,0.317712942,10.5367598,0,0.068114508,1.215416807,0.056042098,0.95530827,0.976324189,33.897649,1,-1.625338747,1.194254952,-1.360964628,0.173524868,0.292479206,49.26978252,1,-0.697936474,0.858772827,-0.812713738,0.416382203,0.56032294,27.09090671,0,-2.673521238,1.201805314,-2.224587632,0.026108934,0.067661365,N,-,,glutathione synthetase,F:nucleotide binding; F:metal ion binding; F:ligase activity,IPR014042 (G3DSA:1.10.1080.GENE3D); IPR005615 (PIRSF); IPR014049 (G3DSA:3.30.1490.GENE3D); IPR014709 (G3DSA:3.30.1490.GENE3D); IPR004887 (PFAM); IPR004887 (G3DSA:3.40.50.GENE3D); IPR005615 (TIGRFAM); IPR005615 (PFAM); IPR014049 (G3DSA:3.30.1490.GENE3D); IPR005615 (PANTHER); PTHR11130:SF0 (PANTHER); SSF56059 (SUPERFAMILY); IPR016185 (SUPERFAMILY),,
RL4_JR_01971,3450,5163,5928,0,0,11,0,0,2,4,0,1,0,11,3,0,1,2,100.3483823,1,-0.076050673,0.805050925,-0.09446691,0.924738267,0.963735642,37.20307784,1,0.892319974,1.012238088,0.881531711,0.378030098,0.542409926,98.89504715,1,-0.223548459,0.705807014,-0.316727454,0.751450415,0.833357798,128.5623316,1,0.632975565,0.522849065,1.210627706,0.226038121,0.3617253,66.25995787,1,-1.259625338,0.880436674,-1.430682497,0.152521232,0.262141822,N,-, Effector probability:0.575,ssdna binding,P:DNA replication; C:mitochondrial nucleoid; F:single-stranded DNA binding; P:mitochondrial genome maintenance,G3DSA:2.40.50.140 (GENE3D); IPR000424 (PFAM); IPR011344 (TIGRFAM); PTHR10302:SF0 (PANTHER); IPR011344 (PANTHER); IPR000424 (PROSITE_PROFILES); IPR012340 (SUPERFAMILY),,
RL4_JR_01972,358,204,203,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,13.11539734,1,1.243065031,1.184375482,1.049553161,0.293923601,0.478945557,0.988448024,0,3.482386308,1.473486732,2.363364551,0.018109845,0.053194386,2.540504637,0,0.84394093,1.251899918,0.674128114,0.500229867,0.632882676,10.95207248,1,2.125363233,1.071935176,1.982734852,0.047397054,0.11896902,2.482317999,0,0.774231534,1.240689127,0.624033464,0.532605608,0.65595813,N,-,,a-pheromone receptor,F:mating-type factor pheromone receptor activity; P:G-protein coupled receptor signaling pathway; C:membrane; C:integral component of membrane,IPR001499 (PRINTS); IPR001499 (PFAM); PTHR28097:SF1 (PANTHER); PTHR28097 (PANTHER),9.B.45.2.2, the fungal mating-type pheromone receptor (mat-pr) family.
RL4_JR_01973,2259,1303,1832,3,1,8,0,0,0,0,0,1,3,7,1,0,0,0,90.20537178,1,1.761266024,0.51544047,3.417011518,0.000633126,0.004079812,6.901516422,0,0.678611923,1.261664606,0.537870302,0.590666592,0.72783002,24.33152751,1,-1.005719468,1.210509596,-0.83082321,0.406073509,0.5481683,86.21864075,1,1.779043203,0.526410211,3.379575784,0.000725978,0.005645565,17.52944689,0,-2.045549417,1.214862073,-1.683770909,0.092225951,0.179436541,N,-,,pak-box p21-Rho-binding,,IPR000095 (PROSITE_PROFILES),,
RL4_JR_01974,20451,5884,8471,11,16,0,0,3,0,0,10,13,1,11,4,0,6,0,376.5521883,1,0.764755406,1.179234766,0.648518368,0.516649735,0.701970996,160.0933188,1,1.064118681,1.700616137,0.625725381,0.531495082,0.679796045,278.2097475,1,0.571495875,0.700922357,0.815348333,0.41487295,0.556535544,224.8481368,1,-0.446705672,0.670238463,-0.666487671,0.505099441,0.641672753,135.413335,1,-1.709838235,0.896863991,-1.906463245,0.05659013,0.123061655,N,-,,helix-loop-helix DNA-binding domain-containing,F:binding,IPR011598 (SMART); IPR011598 (G3DSA:4.10.280.GENE3D); IPR011598 (PFAM); PTHR12565 (PANTHER); PTHR12565 (PANTHER); PTHR12565:SF142 (PANTHER); PTHR12565 (PANTHER); PTHR12565:SF142 (PANTHER); PTHR12565:SF142 (PANTHER); IPR011598 (PROSITE_PROFILES); IPR011598 (SUPERFAMILY),,
RL4_JR_01975,454,494,401,0,0,0,0,0,2,0,0,0,0,0,0,0,2,0,5.421539996,0,-0.540779645,1.210114789,-0.446882932,0.654959588,0.805056549,20.49352165,1,4.302780064,1.010729689,4.257102675,2.07E-05,0.001211675,4.489400977,0,0.022708173,1.207809903,0.018801115,0.984999764,0.992746402,5.178200521,0,-0.399393289,1.207423318,-0.330781494,0.74080954,0.827891456,12.12728227,1,1.613683865,0.981291129,1.644449661,0.100083354,0.191300908,N,-,,histone H3-like centromeric cse-4,"C:CENP-A containing nucleosome; C:condensed nuclear chromosome, centromeric region; C:extrachromosomal circular DNA; F:protein heterodimerization activity; P:mitotic sister chromatid segregation; C:condensed chromosome kinetochore; C:nuclear nucleosome; P:2-micrometer plasmid partitioning; F:centromeric DNA binding",IPR000164 (PRINTS); IPR000164 (SMART); IPR007125 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); IPR000164 (PANTHER); IPR009072 (SUPERFAMILY),,
RL4_JR_01976,862,773,1222,2,2,0,0,0,0,0,1,0,0,2,0,0,0,0,47.53338451,1,1.165607768,0.764793478,1.524081731,0.127488296,0.26351641,3.613514705,0,1.612029746,1.271829389,1.267488988,0.204980499,0.349884082,17.25833758,1,-0.084428697,1.20409919,-0.070117726,0.944099958,0.966926452,18.88735361,1,0.248999923,1.035204904,0.240532016,0.809917846,0.878930139,9.33081425,0,-1.135776913,1.217491864,-0.932882549,0.350880614,0.488070643,N,-,,ER-associated proteolytic system,,PF04511 (PFAM); IPR007599 (PANTHER); SSF144091 (SUPERFAMILY),3.A.16.1.4, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_01977,3765,3782,4435,15,0,3,0,0,0,1,0,0,0,3,0,0,2,1,210.3687307,1,1.692372427,1.112399353,1.521371279,0.128166692,0.264570818,15.27326355,0,-0.467431997,1.200101903,-0.389493589,0.696911052,0.807663576,50.73274678,1,-2.158959012,1.187485923,-1.818092299,0.069050027,0.145335233,57.79320105,1,-1.236314191,0.849265016,-1.455746048,0.145462835,0.260057071,54.2269089,1,-0.991248164,0.841516851,-1.177930262,0.23882441,0.367715503,N,-,,"1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase",C:nucleus; C:cytoplasm; F:iron ion binding; P:L-methionine biosynthetic process from methylthioadenosine; F:acireductone dioxygenase [iron(II)-requiring] activity; P:oxidation-reduction process,IPR014710 (G3DSA:2.60.120.GENE3D); IPR004313 (PFAM); IPR004313 (PANTHER); IPR027496 (HAMAP); IPR011051 (SUPERFAMILY),,
RL4_JR_01978,5515,4916,7943,0,4,1,3,0,0,0,0,0,1,3,0,0,5,0,109.0414217,1,-1.208280814,0.715190975,-1.689451987,0.091132846,0.206804688,90.16060767,1,1.160075348,0.855117017,1.356627602,0.174899567,0.310966699,60.53224584,0,-3.73067748,1.203861371,-3.098926147,0.001942234,0.00962466,91.19479262,1,-1.43910277,0.773445414,-1.860639088,0.062795161,0.140415416,79.31209646,1,-0.929953405,0.734043996,-1.266890554,0.205194427,0.327747842,N,-,,hypothetical protein CMQ_7442,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_01979,4212,7580,5718,3,4,3,0,0,1,4,0,0,0,3,0,0,0,0,144.4351784,1,-0.116395249,0.595883237,-0.195332309,0.845132805,0.922353635,31.83593761,1,-0.108896646,1.146820593,-0.094955259,0.924350365,0.958732902,102.6126557,1,-0.575329994,1.342553705,-0.428534063,0.668262339,0.771875405,79.34149131,1,-1.829307333,0.915814612,-1.997464671,0.045774729,0.116070405,57.46132242,0,-3.758287656,1.223029373,-3.072933275,0.002119659,0.00888309,Y,-,,Ser Thr phosphatase family,"F:nucleotide binding; F:hydrolase activity, acting on ester bonds; F:metal ion binding; P:nucleotide catabolic process",IPR014485 (PIRSF); IPR008334 (G3DSA:3.90.780.GENE3D); IPR004843 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); IPR006179 (PANTHER); IPR006179 (PANTHER); PTHR11575:SF22 (PANTHER); PTHR11575:SF22 (PANTHER); PS51257 (PROSITE_PROFILES); IPR008334 (SUPERFAMILY); IPR029052 (SUPERFAMILY),,
RL4_JR_01980,4818,2991,5971,0,0,8,0,0,0,0,0,0,0,5,0,0,1,0,85.20361309,1,-0.317538206,0.726670319,-0.436976986,0.662128038,0.810691961,17.4125661,0,-0.656574833,1.233793471,-0.532159432,0.594615577,0.73056856,45.31068423,0,-3.312830713,1.217286341,-2.721488447,0.006498866,0.023198876,72.33370015,1,-0.756767952,0.752769345,-1.005311863,0.314746705,0.461054743,48.7459985,1,-2.474453854,1.158246159,-2.136379935,0.032648458,0.080390476,N,-,,RNA polymerase 2 transcription elongation factor,"F:translation elongation factor activity; P:histone modification; C:membrane; C:Cdc73/Paf1 complex; C:integral component of membrane; P:regulation of transcription, DNA-templated; P:translational elongation",no IPS match,,
RL4_JR_01981,19488,17182,17777,1,3,25,0,0,0,0,0,5,0,3,0,0,4,1,347.4290618,1,-0.561270944,0.614553301,-0.913299047,0.361085284,0.552456227,69.80239129,0,-2.659675312,1.192994539,-2.229411138,0.025786562,0.070107927,213.1016991,1,-2.172265578,0.671485638,-3.235014206,0.001216367,0.00674767,220.3522827,1,-3.424225019,0.851450701,-4.021636267,5.78E-05,0.000671075,200.3647157,1,-2.447690921,0.671168093,-3.646911924,0.000265411,0.00158823,N,-,,tetratricopeptide repeat 1,,IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR019734 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR019734 (PFAM); IPR031101 (PTHR14027:PANTHER); PTHR14027 (PANTHER); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); SSF81901 (SUPERFAMILY); IPR011990 (SUPERFAMILY),8.A.13.1.1, the tetratricopeptide repeat (tpr1) family.
RL4_JR_01982,4428,4291,3403,3,0,13,0,0,0,0,0,4,8,11,1,0,1,4,128.511223,1,0.928313342,0.503374668,1.844179697,0.065156956,0.162058064,15.63614503,0,-0.501252984,1.222659573,-0.409969377,0.681828411,0.797944718,66.35020298,1,-0.335871041,0.761893886,-0.440837035,0.65933098,0.764612468,174.8020113,1,1.481323868,0.410439446,3.609116719,0.000307241,0.002779999,72.86523872,1,-0.253422844,0.678891038,-0.373289423,0.708933047,0.794460111,N,-,,sorting nexin-41,C:integral component of membrane; F:phosphatidylinositol binding,IPR001683 (SMART); IPR001683 (G3DSA:3.30.1520.GENE3D); IPR001683 (PFAM); PTHR10555:SF139 (PANTHER); PTHR10555:SF139 (PANTHER); PTHR10555:SF139 (PANTHER); PTHR10555 (PANTHER); PTHR10555 (PANTHER); IPR001683 (PROSITE_PROFILES); IPR001683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_01983,1422,1097,1297,0,0,1,0,0,1,0,1,5,0,2,0,0,0,0,19.05161496,1,-1.083966298,1.141720053,-0.949415135,0.342409516,0.532554331,14.26169207,1,2.09365066,1.130914427,1.85129008,0.064127832,0.143384564,52.97364297,1,1.926880362,0.621078333,3.102475581,0.001919094,0.009561469,22.59875313,1,-0.1675356,1.018371699,-0.164513213,0.869327146,0.91953598,12.43201857,0,-1.549841427,1.195415664,-1.296487468,0.194807595,0.315588304,N,-,,general alpha-glucoside permease,C:membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PF13347 (PFAM); PTHR19432:SF35 (PANTHER); PTHR19432 (PANTHER); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.2.6.1, the glycoside-pentoside-hexuronide (gph):cation symporter family.
RL4_JR_01984,57,49,46,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.608661909,0,2.613958066,1.79774935,1.454016971,0.145941601,NA,0.195482745,0,5.820528091,1.837671647,3.167338463,0.001538412,0.015023052,0.504907729,0,3.175251055,1.269053641,2.502062129,0.012347226,0.038087541,0.582311943,0,2.753092519,1.373006712,2.005155908,0.044946382,0.115138395,0.495411807,0,3.099119853,1.225315406,2.529242542,0.0114309,0.03497669,Y,-,,carbohydrate-binding module family 1,"P:carbohydrate metabolic process; C:extracellular region; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:cellulose binding",PTHR34612 (PANTHER); PTHR34612:SF1 (PANTHER),,
RL4_JR_01985,16,20,21,0,1,0,0,0,0,0,0,1,0,1,0,0,0,0,8.238812256,1,4.980169032,1.176277335,4.233839149,2.30E-05,0.000235746,0.072682536,0,7.247705711,2.226883215,3.254641133,0.001135357,0.015023052,6.687674,1,5.554919856,1.220981747,4.549551925,5.38E-06,0.000111075,4.229588846,1,5.115953914,1.187202094,4.30925277,1.64E-05,0.000218806,0.186534998,0,4.509953788,1.257130573,3.587498295,0.000333866,0.001916469,Y,-,,hypothetical protein CMQ_7565,,no IPS match,,
RL4_JR_01986,4164,2611,2768,3,0,9,0,0,0,1,0,0,1,5,1,0,3,3,102.6264446,1,0.90711407,0.539536195,1.681284924,0.092707585,0.209395295,12.29105777,0,-0.153990871,1.245013569,-0.123686098,0.901563819,0.944583723,42.7320648,1,-1.833896719,1.210149676,-1.515429666,0.129663629,0.23551184,75.51355087,1,0.293561213,0.625738812,0.469143367,0.638967163,0.752534899,64.68496417,1,0.341899842,0.653065988,0.523530315,0.600605261,0.710067867,N,-,,sh3 domain,,IPR001452 (SMART); G3DSA:2.30.30.40 (GENE3D); PTHR13357:SF2 (PANTHER); PTHR13357 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY),,
RL4_JR_01987,11747,9942,9412,0,2,11,0,0,0,2,0,3,3,3,0,0,1,6,182.5361179,1,-0.702643035,0.487513764,-1.441278354,0.14950606,0.296324207,39.99772922,0,-1.85630939,1.20477693,-1.54079095,0.123367673,0.23824457,144.9360791,1,-1.355485918,0.676356565,-2.004099594,0.045059393,0.104556794,159.106729,1,-1.605106311,0.624083775,-2.571940457,0.010113028,0.049015994,149.4058623,1,-1.113545054,0.587489158,-1.895430818,0.058035349,0.125289533,N,-,,hypothetical protein CMQ_7223,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_01988,2486,1807,2256,1,2,0,0,0,0,0,0,0,1,0,0,0,1,0,52.20281051,1,-0.479915373,0.850521156,-0.564260359,0.572576955,0.748570961,8.374997289,0,0.39943828,1.231258496,0.324414639,0.745624139,0.843640457,21.67358686,0,-2.248914219,1.19617931,-1.880081188,0.060097014,0.130394305,34.31036172,1,-1.720895875,1.147495321,-1.499697509,0.133692776,0.243881298,25.1868502,1,-1.39851272,1.126950158,-1.240971227,0.214616378,0.339317744,N,-,,pumilio domain-containing,F:nucleotide binding; F:RNA binding,IPR001313 (SMART); IPR000504 (SMART); IPR000504 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR001313 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR12537:SF73 (PANTHER); PTHR12537:SF73 (PANTHER); PTHR12537 (PANTHER); PTHR12537 (PANTHER); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR033133 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR012677 (SUPERFAMILY),,
RL4_JR_01989,5634,3993,3451,2,2,12,2,0,0,0,0,0,0,4,0,0,4,0,134.282293,1,0.840634765,0.50029544,1.680276689,0.092903494,0.209688885,61.52727173,1,1.079763731,1.011275509,1.067724593,0.285644761,0.445294359,43.49557176,0,-3.253792515,1.211928384,-2.684805931,0.007257193,0.025306812,66.19716371,1,-0.993880296,0.799870518,-1.242551481,0.214033159,0.348562557,57.96441827,1,-0.735702231,0.787352093,-0.934400553,0.350097313,0.487516888,N,-,,phd-finger domain-containing,F:binding,IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR019787 (PFAM); PTHR24102 (PANTHER); PTHR24102:SF7 (PANTHER); PTHR24102 (PANTHER); PTHR24102:SF7 (PANTHER); PTHR24102 (PANTHER); IPR019787 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY); IPR011011 (SUPERFAMILY),,
RL4_JR_01990,8677,9585,12985,0,0,27,0,0,2,0,4,1,2,18,2,0,6,0,227.9726407,1,-0.163497988,1.230934442,-0.132824286,0.894332347,0.94830577,58.34716301,1,-0.200657867,0.989178801,-0.20285298,0.839249947,0.903711485,141.0445169,1,-1.356915422,0.687613424,-1.973369591,0.04845347,0.110557342,229.1593697,1,0.146483265,0.455477614,0.321603653,0.747752976,0.833902289,125.3643242,1,-1.445087232,0.684563,-2.110963101,0.034775484,0.084436876,N,-,,methionyl aminopeptidase,"F:DNA binding; P:ribosomal large subunit export from nucleus; P:ribosomal large subunit biogenesis; P:proteolysis; F:aminopeptidase activity; C:cytosolic large ribosomal subunit; C:nucleolus; C:nucleoplasm; C:preribosome, large subunit precursor",IPR000994 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); IPR000994 (G3DSA:3.90.230.GENE3D); PTHR10804 (PANTHER); PTHR10804:SF11 (PANTHER); PTHR10804:SF11 (PANTHER); PTHR10804 (PANTHER); PTHR10804 (PANTHER); PTHR10804:SF11 (PANTHER); PTHR10804:SF11 (PANTHER); IPR011991 (SUPERFAMILY); IPR000994 (SUPERFAMILY),,
RL4_JR_01991,3637,3257,4978,0,0,15,0,0,0,0,0,0,0,0,0,0,1,0,104.5942213,1,0.557998864,0.909331366,0.613636442,0.539455597,0.721704886,15.0326369,0,-0.444559162,1.212179044,-0.366743811,0.713810124,0.820892505,39.14608155,0,-3.101861076,1.199460299,-2.586047308,0.00970836,0.031963396,45.16825933,0,-3.524466452,1.200439805,-2.935979329,0.003324965,0.020207244,42.62916548,1,-2.261604635,1.138489346,-1.98649609,0.046978267,0.106720877,N,-,,swi-snf complex subunit,,IPR006939 (PFAM); PTHR10019:SF7 (PANTHER); PTHR10019:SF7 (PANTHER); IPR006939 (PANTHER); IPR006939 (PANTHER),,
RL4_JR_01992,7181,4994,5829,0,0,4,0,0,0,10,0,2,3,2,5,0,0,0,87.09193139,1,-1.568456869,0.765487824,-2.048963838,0.040465651,0.113520902,23.08675914,0,-1.063462254,1.21405219,-0.875960904,0.381051288,0.545390432,183.3432414,1,0.993067785,1.284827303,0.772919273,0.439570158,0.579650727,152.924247,1,-0.014047399,0.521017196,-0.026961489,0.978490451,0.986872777,58.58636433,0,-3.786299758,1.19731001,-3.162338682,0.001565074,0.006919924,N,-,,S-adenosylmethionine-dependent methyltransferase,,no IPS match,,
RL4_JR_01993,176,130,207,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2.041236983,0,0.867980669,1.290429642,0.672629209,0.501183215,NA,0.650888747,0,4.084946755,1.495696478,2.731133498,0.00631169,0.024071939,9.534485906,1,2.391622642,1.206739773,1.98188764,0.047491818,0.108804517,1.951453941,0,1.007917802,1.248145898,0.807532039,0.419360023,0.562312308,1.67233116,0,1.344240727,1.227277645,1.09530287,0.273383971,0.406283972,N,-,,---NA---,,no IPS match,,
RL4_JR_01994,10582,5609,6827,0,0,14,0,0,0,0,1,1,2,2,0,0,6,2,145.0389161,1,-0.491129091,0.933511159,-0.526109502,0.598812127,0.768219741,29.61796503,0,-1.422872614,1.237829517,-1.149489969,0.250354,0.404353469,90.60384296,1,-2.245672248,1.066806166,-2.105042434,0.035287614,0.086732656,114.576809,1,-1.749962494,0.799481851,-2.188870819,0.028606231,0.089799895,112.5821799,1,-0.562099866,0.625294733,-0.898935872,0.368686819,0.504930887,N,-,,heavy metal tolerance,F:ATP binding; F:phytochelatin transmembrane transporter ATPase activity; P:phytochelatin 2 import into vacuole; P:glutathione transmembrane import into vacuole; C:integral component of fungal-type vacuolar membrane; P:cadmium ion import into vacuole; P:cellular detoxification of cadmium ion,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.20.1560.10 (GENE3D); IPR003439 (PFAM); IPR011527 (PFAM); PTHR24221:SF264 (PANTHER); PTHR24221:SF264 (PANTHER); PTHR24221 (PANTHER); PTHR24221 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.210.2, the atp-binding cassette (abc) superfamily.
RL4_JR_01995,73703,51067,41484,3,2,31,0,0,2,1,0,17,1,12,1,0,2,23,829.7279225,1,-1.898100466,0.697422225,-2.721594464,0.006496781,0.026917594,234.0454609,1,-2.665751402,1.047467932,-2.544947985,0.010929402,0.035976392,674.9028695,1,-2.103752392,0.850284323,-2.474175208,0.013354419,0.040576271,705.0655623,1,-2.959070162,0.598140494,-4.947115585,7.53E-07,1.43E-05,717.4449597,1,-1.572354885,1.105912324,-1.421771736,0.155092527,0.26522954,N,-,,sphingosine n-acyltransferase lac1,P:plasma membrane organization; C:integral component of membrane; F:sphingosine N-acyltransferase activity; P:ceramide biosynthetic process; C:endoplasmic reticulum,IPR006634 (SMART); IPR006634 (PFAM); IPR013599 (PFAM); IPR016439 (PANTHER); PTHR12560:SF11 (PANTHER); IPR006634 (PROSITE_PROFILES),9.B.311.1.29,The 6-7 TMS TRAM-LAG (TRAM-LAG) Family
RL4_JR_01996,18069,12189,13882,5,0,2,0,0,0,2,0,1,3,8,0,0,8,3,234.0303969,1,-1.957569543,0.635801554,-3.078900218,0.002077663,0.010807743,56.6698131,0,-2.35898321,1.209664198,-1.950114102,0.051162521,0.119960364,174.9297091,1,-2.586279156,0.866646165,-2.984238853,0.002842848,0.013076324,228.733686,1,-1.271459514,0.513765649,-2.474784984,0.013331641,0.06085792,196.5546594,1,-1.034700983,0.519054792,-1.993433061,0.046214047,0.105550388,N,-,,pH signal transduction,C:membrane; P:response to pH; P:single-organism process; P:cellular process,IPR014844 (PFAM); PTHR35779:SF1 (PANTHER); PTHR35779 (PANTHER),9.B.213.1.2, the 7 tms ph sensor rim21/palh (rim21/palh) family.
RL4_JR_01997,46,74,61,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.729782574,0,2.352283773,1.712840019,1.373323689,0.169651741,NA,0.231802583,0,5.574591341,1.792633001,3.109722592,0.001872631,0.015023052,0.602151419,0,2.921267383,1.28048927,2.281368108,0.022526674,0.061158499,0.69477406,0,2.498460097,1.371238687,1.822046097,0.068447992,0.148587944,0.593451167,0,2.839863477,1.246845972,2.277637768,0.022748168,0.060464877,N,-,,peroxisomal short-chain alcohol dehydrogenase,,IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24320 (PANTHER); PTHR24320:SF39 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_01998,6713,5145,5135,3,4,0,0,0,0,2,1,19,2,1,5,0,11,0,130.1730895,1,-0.551048963,0.620073171,-0.888683769,0.374173057,0.56638423,21.85397532,0,-0.984280659,1.214733172,-0.810285486,0.417776115,0.581748499,209.8662652,1,1.539177658,0.603371431,2.550962109,0.0107426,0.03463953,135.8632997,1,-0.253293402,0.568064386,-0.445888543,0.655677758,0.765218707,97.79176896,1,0.264853914,0.561706116,0.471516877,0.63727167,0.739245495,N,-,,phosducin,C:cellular_component; F:molecular_function,IPR023196 (G3DSA:1.10.168.GENE3D); IPR012336 (G3DSA:3.40.30.GENE3D); IPR024253 (PFAM); PTHR21148 (PANTHER); PTHR21148:SF12 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_01999,6778,4773,5132,0,2,16,0,0,0,0,0,7,2,3,0,0,0,1,143.7202766,1,0.507240069,0.622222275,0.815207184,0.414953726,0.606309276,21.438786,0,-0.95661304,1.218210095,-0.785261134,0.432300478,0.594046354,100.821243,1,-0.151834541,1.180771613,-0.128589254,0.89768267,0.936474808,94.46619052,1,-0.975197285,0.691708382,-1.409838757,0.1585873,0.277259705,61.64480611,1,-2.740749165,1.127403479,-2.43102777,0.015056061,0.043617343,N,-,,guanine nucleotide-binding subunit beta,"C:heterotrimeric G-protein complex; C:mating projection; P:heterotrimeric G-protein complex cycle; P:regulation of transposition, RNA-mediated; P:invasive growth in response to glucose limitation; F:signal transducer activity; P:pheromone-dependent signal transduction involved in conjugation with cellular fusion",IPR001632 (PRINTS); IPR020472 (PRINTS); IPR001680 (SMART); PIRSF002394 (PIRSF); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); IPR016346 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),8.A.92.1.1,The G-Protein αβγ Complex (GPC) Family
RL4_JR_02000,3297,2321,3511,3,0,2,0,0,0,0,0,1,0,1,0,0,0,1,74.16465426,1,-0.218385564,0.689144519,-0.31689371,0.751324255,0.870021756,11.61184976,0,-0.072031651,1.223803437,-0.05885884,0.953064542,0.975027218,36.62832693,1,-1.762383578,1.199532761,-1.469225048,0.141771759,0.251277536,38.76773963,1,-2.199946091,1.153708147,-1.906848016,0.056540271,0.13231264,37.10478987,1,-1.871414149,1.134270804,-1.649883028,0.098966863,0.189448451,N,-,,acetoacetate- ligase,F:acetoacetate-CoA ligase activity; P:lipid metabolic process,G3DSA:3.30.300.30 (GENE3D); IPR005914 (TIGRFAM); G3DSA:3.40.50.980 (GENE3D); IPR032387 (PFAM); IPR000873 (PFAM); G3DSA:3.40.50.980 (GENE3D); PTHR24095 (PANTHER); PTHR24095:SF158 (PANTHER); PTHR24095:SF158 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.14, the fatty acid transporter (fat) family.
RL4_JR_02001,18145,13407,13384,8,6,10,0,0,0,9,5,7,3,31,11,0,17,16,346.359032,1,-0.229865981,0.389888978,-0.589567786,0.555480454,0.73388089,57.8221716,0,-2.388021483,1.208634587,-1.975801047,0.048177315,0.114442635,333.5055025,1,0.211759172,0.405553457,0.522148605,0.601566867,0.719634049,430.3049824,1,0.67077094,0.401915475,1.668935338,0.095130195,0.18867644,329.720486,1,0.511022009,0.46385825,1.101677095,0.270602078,0.402866203,N,-,,serine palmitoyltransferase 2,F:pyridoxal phosphate binding; F:transaminase activity; C:integral component of membrane; C:endoplasmic reticulum; P:biosynthetic process,IPR015421 (G3DSA:3.40.640.GENE3D); IPR004839 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); PTHR13693 (PANTHER); PTHR13693:SF3 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_02002,680,601,963,0,0,0,0,0,0,0,1,2,0,3,3,0,5,0,8.938081504,0,-1.262445236,1.21342541,-1.040397889,0.298155082,0.483796307,2.837631405,0,1.960738582,1.290349072,1.519541204,0.128626325,0.245513041,28.23437841,1,1.703716607,0.870364811,1.957474135,0.05029175,0.113638551,49.47231231,1,2.20099862,0.642952543,3.423267619,0.000618731,0.004971948,26.63079288,1,2.104169028,0.733916758,2.867040446,0.004143301,0.015338544,N,-,,transcription factor iiic,C:nucleus; F:molecular_function,IPR025451 (PFAM); PTHR14689 (PANTHER),,
RL4_JR_02003,5731,4482,4899,0,1,9,0,0,0,0,4,0,0,3,0,0,1,2,102.7541101,1,-0.012034257,0.510273368,-0.023583942,0.981184481,0.991024266,19.37855974,0,-0.810851178,1.209328852,-0.670496844,0.502541118,0.656351122,81.47108294,1,-0.633312691,0.747719673,-0.846992147,0.396999499,0.539356369,69.81627333,1,-1.579028956,0.86031487,-1.835408188,0.066445231,0.145997823,67.8186414,1,-1.314026826,0.838900568,-1.566367787,0.11726254,0.215399712,N,-,,kinase regulator ste50,F:SAM domain binding; P:cellular response to heat; P:regulation of protein kinase activity; C:cytoplasm; P:MAPK cascade involved in osmosensory signaling pathway; P:osmosensory signaling pathway via Sho1 osmosensor; F:protein kinase regulator activity; P:signal transduction involved in filamentous growth; F:kinase activity; P:pheromone-dependent signal transduction involved in conjugation with cellular fusion,IPR000159 (SMART); IPR001660 (SMART); IPR013761 (G3DSA:1.10.150.GENE3D); IPR000159 (PFAM); IPR001660 (PFAM); PTHR12844 (PANTHER); IPR001660 (PROSITE_PROFILES); IPR000159 (PROSITE_PROFILES); IPR013761 (SUPERFAMILY); IPR029071 (SUPERFAMILY),8.A.28.1.7, the ankyrin (ankyrin) family.
RL4_JR_02004,2200,1692,1950,0,0,2,0,0,0,0,2,0,0,1,0,0,2,0,30.96281063,1,-0.917765664,1.010412457,-0.908307947,0.363715545,0.555275613,7.481739037,0,0.562165278,1.232886886,0.45597474,0.648408143,0.772603048,35.03941447,1,-0.261231333,1.033891809,-0.252667959,0.800524809,0.869026146,26.33340483,1,-1.560537924,1.145264826,-1.362600062,0.173008589,0.296190511,26.75125246,1,-0.495319391,0.975480528,-0.507769635,0.611614907,0.719150033,N,-,,hypothetical protein SPSK_07370,,no IPS match,,
RL4_JR_02005,3187,3262,4790,1,6,0,0,0,0,0,0,0,0,11,3,0,0,1,102.9760531,1,0.159166103,0.776572655,0.204959706,0.837603606,0.918937779,14.21889947,0,-0.364275716,1.214374632,-0.299969801,0.764200191,0.857184656,37.06826413,0,-3.023173507,1.201341159,-2.516498735,0.011852733,0.03684282,115.8077848,1,1.029133738,0.486271486,2.116376895,0.034312766,0.099341681,44.1080032,1,-2.17536441,1.140025203,-1.90817221,0.056368962,0.122659734,N,-,,sodium hydrogen exchanger 3,F:sodium:proton antiporter activity; C:integral component of membrane; P:hydrogen ion transmembrane transport; P:sodium ion transmembrane transport; P:regulation of pH,IPR004709 (PRINTS); IPR006153 (PFAM); IPR004709 (TIGRFAM); PTHR10110:SF88 (PANTHER); IPR018422 (PANTHER),2.A.36.1.12, the monovalent cation:proton antiporter-1 (cpa1) family.
RL4_JR_02006,2251,1838,3260,0,4,2,0,0,0,0,0,0,0,0,0,6,0,0,68.90376595,1,0.366069923,0.671123034,0.545458738,0.585438052,0.758426055,9.274659153,0,0.252156731,1.237384402,0.203782051,0.83852382,0.903339516,24.1821018,0,-2.406959754,1.210109697,-1.989042612,0.0466965,0.107395585,27.90372327,0,-2.82964001,1.211522914,-2.335605855,0.019511793,0.075837584,120.1390351,1,1.892017523,2.005223251,0.943544576,0.345402426,0.482638637,N,-,,mRNA capping enzyme alpha,F:GTP binding; F:ATP binding; P:DNA repair; F:DNA ligase (ATP) activity; P:7-methylguanosine mRNA capping; P:DNA ligation; P:DNA recombination; F:mRNA guanylyltransferase activity; C:mRNA cap methyltransferase complex,IPR001339 (PFAM); G3DSA:2.40.50.140 (GENE3D); G3DSA:3.30.470.30 (GENE3D); IPR013846 (PFAM); PTHR10367:SF0 (PANTHER); PTHR10367 (PANTHER); PTHR10367:SF0 (PANTHER); PTHR10367 (PANTHER); IPR012310 (PROSITE_PROFILES); IPR012340 (SUPERFAMILY); SSF56091 (SUPERFAMILY),,
RL4_JR_02007,88,39,76,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.803795556,0,2.21254077,1.697739502,1.303227479,0.192497112,NA,0.258502497,0,5.417214061,1.79825766,3.012479346,0.002591231,0.015349618,0.668782908,0,2.768816943,1.307555274,2.117552503,0.034212984,0.084936796,0.771286916,0,2.347139408,1.400402984,1.676045705,0.09372924,0.186555644,0.658841107,0,2.687546523,1.275331807,2.107331212,0.03508888,0.084924529,N,-,,hypothetical protein CMQ_7503,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_02008,6550,5680,4709,0,0,11,0,0,0,0,0,1,0,1,0,0,5,0,109.9169662,1,-0.252331891,0.733634627,-0.34394763,0.730885671,0.858001443,21.85593919,0,-0.984402762,1.219393517,-0.807288827,0.419500099,0.583369724,62.85916568,1,-2.665805231,1.20108618,-2.219495384,0.026453041,0.069579264,69.00654125,1,-3.103060924,1.155661453,-2.685095116,0.007250917,0.037533503,74.49769421,1,-0.782822915,0.693169988,-1.129337577,0.258755455,0.390563354,N,-,,sister chromatid cohesion PDS5,P:attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation; P:regulation of histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore; P:mitotic chromosome condensation; P:protein localization to chromatin; P:mitotic sister chromatid cohesion; C:cytosol; F:methyltransferase activity; P:synapsis; C:condensed nuclear chromosome; P:double-strand break repair; P:methylation,IPR011989 (G3DSA:1.25.10.GENE3D); PTHR12663:SF0 (PANTHER); PTHR12663:SF0 (PANTHER); PTHR12663 (PANTHER); PTHR12663:SF0 (PANTHER); PTHR12663 (PANTHER); PTHR12663 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_02009,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_02010,1616,1663,3183,2,3,8,0,0,0,4,0,0,2,5,0,0,0,0,100.415404,1,1.611217429,0.55839473,2.885445265,0.003908604,0.017733515,8.10221221,0,0.447118303,1.262756043,0.354081301,0.723277955,0.826486731,65.498654,1,0.890755185,1.37376545,0.648404125,0.516723603,0.647658394,63.17366016,1,0.856312614,0.665081034,1.287531249,0.197909185,0.328066552,21.14229285,0,-2.315833506,1.244234452,-1.861251713,0.062708639,0.133303583,N,-,,s-adenosylmethionine-dependent methyltransferase,P:peptidyl-lysine methylation; F:transferase activity,IPR025714 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR12843:SF5 (PANTHER); IPR026635 (PANTHER); IPR026635 (HAMAP); IPR029063 (SUPERFAMILY),,
RL4_JR_02011,32381,14638,19996,4,0,6,0,0,0,0,4,7,0,1,1,0,0,0,329.237374,1,-2.112178264,0.650967397,-3.244675961,0.001175843,0.006717343,86.20245554,0,-2.964136471,1.239038628,-2.392287379,0.016743726,0.050231179,298.6690469,1,-1.372749972,0.596142106,-2.302722721,0.021294449,0.058392471,269.3681104,1,-4.28860859,1.074358082,-3.991786967,6.56E-05,0.000747006,217.1669669,0,-5.676447058,1.243876719,-4.563512584,5.03E-06,5.71E-05,N,-,,cell division cycle 37,,IPR013874 (SMART); IPR013873 (SMART); IPR013855 (SMART); IPR013855 (PFAM); IPR013874 (PFAM); IPR013873 (PFAM); PTHR12800:SF4 (PANTHER); IPR004918 (PANTHER); SSF101391 (SUPERFAMILY),,
RL4_JR_02012,50718,37986,31733,3,2,15,5,0,0,1,1,4,1,10,1,0,7,2,585.6131056,1,-2.061676408,0.495561188,-4.160286275,3.18E-05,0.000313924,267.239356,1,-0.710617187,0.792324788,-0.896876127,0.36978502,0.533973056,445.6194803,1,-3.061456251,0.665540034,-4.599958068,4.23E-06,9.06E-05,521.1012707,1,-2.657630606,0.55658865,-4.774855912,1.80E-06,3.09E-05,433.5542278,1,-2.794450735,0.602095374,-4.641209441,3.46E-06,4.17E-05,N,-,,tata-binding -associated factor mot1,"F:ATPase activity; F:DNA binding; F:ATP binding; P:negative regulation of transcription, DNA-templated; P:transcription of nuclear large rRNA transcript from RNA polymerase I promoter; C:mitochondrion; C:nuclear chromosome; F:helicase activity; F:TBP-class protein binding; P:rRNA processing; P:regulation of RNA polymerase II transcriptional preinitiation complex assembly",IPR001650 (SMART); IPR014001 (SMART); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011989 (G3DSA:1.25.10.GENE3D); IPR011989 (G3DSA:1.25.10.GENE3D); IPR000330 (PFAM); IPR022707 (PFAM); PTHR10799:SF753 (PANTHER); PTHR10799 (PANTHER); PTHR10799:SF753 (PANTHER); PTHR10799 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_02013,8730,9428,7585,1,1,7,0,0,0,1,0,1,0,9,0,0,3,2,148.2668187,1,-0.929710739,0.544180793,-1.708459305,0.087551151,0.200649312,33.1470176,0,-1.585264134,1.206909927,-1.313490011,0.189017885,0.329698265,103.2509002,1,-2.406493274,1.037416389,-2.319698531,0.020357191,0.056327107,134.9311799,1,-0.831903276,0.566142992,-1.469422544,0.141718216,0.255228912,110.388123,1,-1.363579446,0.678987252,-2.008254856,0.044616216,0.102528187,N,-,,chromosome segregation,C:nucleus; F:ATP binding; P:DNA repair; C:cohesin core heterodimer; P:mitotic sister chromatid cohesion; F:chromatin binding,IPR010935 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003395 (PFAM); IPR010935 (PFAM); IPR024704 (PIRSF); PTHR18937 (PANTHER); IPR029685 (PTHR18937:PANTHER); PTHR18937 (PANTHER); IPR029685 (PTHR18937:PANTHER); IPR027417 (SUPERFAMILY); IPR010935 (SUPERFAMILY),3.A.1.29.1, the atp-binding cassette (abc) superfamily.
RL4_JR_02014,703,302,333,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.317089359,0,-0.513082468,1.297064214,-0.395572141,0.692420693,0.832905929,1.732276724,0,2.672925326,1.443295718,1.851959576,0.064031628,0.143201091,4.440238488,0,0.038362314,1.272271472,0.030152617,0.975945338,0.986271771,5.117966695,0,-0.382755365,1.28289848,-0.298352029,0.765434498,0.847182367,4.329265585,0,-0.028084746,1.268895427,-0.022133224,0.982341684,0.988394073,N,-,,hypothetical protein SMAC_01908,,no IPS match,,
RL4_JR_02015,5,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.09751574,0,5.256061735,3.917696139,1.341620572,0.179719052,NA,0.03092924,0,8.480732859,2.685775695,3.157647481,0.001590478,0.015023052,0.080282644,0,5.82975527,1.567357969,3.71947914,0.000199634,0.001754423,0.092635686,0,5.405575741,2.442939389,2.212734285,0.02691597,0.087153604,0.078935567,0,5.753362153,1.336751383,4.303988181,1.68E-05,0.000154267,Y,-,,glycosyl hydrolase,F:hydrolase activity,IPR012341 (G3DSA:1.50.10.GENE3D); IPR005198 (PFAM); PTHR12145 (PANTHER); PTHR12145:SF14 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_02016,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.004235441,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001340044,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003452355,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003983613,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003339785,0,10.24113992,1.835951848,5.578109216,2.43E-08,8.07E-07,N,-,,cytochrome P450,,no IPS match,,
RL4_JR_02017,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.007760107,0,8.901087564,4.041366561,2.202494486,0.027630398,NA,0.002334598,0,12.18995876,4.048442383,3.01102439,0.002603679,0.015349618,0.006343058,0,9.480780804,4.042868098,2.345063102,0.01902386,0.053738157,0.007335717,0,9.055356819,4.042572319,2.23999872,0.025091006,0.08557795,0.006581095,0,9.341867313,1.819064456,5.135533973,2.81E-07,4.95E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_02018,4,3,1,0,0,12,0,0,0,0,0,0,0,0,0,0,0,0,45.85485715,1,10.61170512,1.730145691,6.133417075,8.60E-10,2.39E-08,0.010529524,0,10.03691075,3.358540727,2.988473734,0.002803746,0.015349618,0.026851541,0,7.411129599,1.969847227,3.762286484,0.000168367,0.001588581,0.030944551,0,6.987498434,3.770565646,1.853169813,0.063858023,0.142111804,0.025969352,0,7.348903313,1.426327007,5.152327117,2.57E-07,4.73E-06,Y,-,,subtilisin-like serine protease,F:hydrolase activity,IPR015500 (PRINTS); IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (PFAM); IPR010435 (PFAM); PTHR10795:SF363 (PANTHER); IPR015500 (PANTHER); IPR000209 (SUPERFAMILY),2.A.7.3.49, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_02019,70,36,39,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.577218994,0,2.690365405,1.916870758,1.403519456,0.160461994,NA,0.187252877,0,5.882638268,1.907023531,3.084722433,0.002037422,0.015023052,0.481126,0,3.244590759,1.322156405,2.454014326,0.014127135,0.042352123,0.554658981,0,2.823147319,1.458351534,1.935848286,0.052886285,0.126619446,0.470103975,0,3.174007135,1.268628454,2.501920184,0.012352177,0.037266326,N,-, Effector probability:0.749,---NA---,,no IPS match,,
RL4_JR_02020,3640,2505,3530,0,2,2,0,0,3,0,0,4,0,2,6,0,3,2,62.18162193,1,-0.64208576,0.755576546,-0.84979578,0.395438636,0.587825874,40.47436903,1,2.011584322,0.876077256,2.296126634,0.021668642,0.061436973,57.96246108,1,0.000624569,0.760666332,0.000821082,0.999344872,0.999593402,102.7079012,1,0.552806591,0.579739949,0.953542345,0.340315352,0.487371356,57.81447093,1,0.050334065,0.691948608,0.072742491,0.942011035,0.963323071,N,-,,hypothetical protein SPBR_02714,,PR00833 (PRINTS),,
RL4_JR_02021,5986,6130,7914,3,4,2,0,1,0,5,4,2,1,4,5,0,4,0,149.9251023,1,-0.482299686,0.534051677,-0.903095536,0.366475193,0.558513285,63.7827594,1,-0.282004573,1.106241352,-0.254921381,0.798783822,0.877976962,165.9194525,1,0.438771334,0.476700872,0.920433252,0.357346399,0.500730095,149.9171616,1,-0.212562321,0.498065383,-0.426775938,0.669542534,0.775103195,80.90128431,1,-1.347488642,0.769383931,-1.751386517,0.079879354,0.161115573,N,-,,NIPA 2,P:magnesium ion transport; C:membrane; C:integral component of membrane; F:magnesium ion transmembrane transporter activity; P:magnesium ion transmembrane transport,IPR008521 (PFAM); PTHR12570:SF6 (PANTHER); IPR008521 (PANTHER); SSF103481 (SUPERFAMILY),2.A.7.25.7, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_02022,287,250,248,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,3.142139741,0,0.245947515,1.220596408,0.20149782,0.840309334,0.919624667,1.007796378,0,3.45437793,1.40641893,2.456151476,0.014043395,0.043751075,2.605549414,0,0.807529676,1.210206996,0.667265747,0.504602401,0.636823075,31.26497947,1,2.716847839,0.8494749,3.198267352,0.00138256,0.009714382,2.559317543,0,0.730322246,1.200858021,0.608167022,0.543076705,0.665213118,N,-,,AMP-binding domain,F:catalytic activity; P:metabolic process; C:integral component of membrane,G3DSA:3.40.50.980 (GENE3D); IPR000873 (PFAM); IPR025110 (PFAM); G3DSA:3.40.50.980 (GENE3D); G3DSA:3.30.300.30 (GENE3D); G3DSA:2.30.38.10 (GENE3D); PTHR24095 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.6, the fatty acid transporter (fat) family.
RL4_JR_02023,806,1021,970,0,0,17,0,0,0,1,2,1,0,2,0,0,0,0,76.15170118,1,2.775771474,0.94596032,2.9343424,0.003342553,0.015692176,3.57689695,0,1.626823513,1.26623377,1.284773438,0.198871467,0.342343025,42.54045648,1,1.799605065,0.747337361,2.408022347,0.016039199,0.0469852,18.73642752,1,0.274716199,1.02312029,0.268508211,0.788308155,0.863157789,9.152630748,0,-1.107877841,1.202235253,-0.921515018,0.356781604,0.494174246,N,-,,glycosyl hydrolase family 1,P:carbohydrate metabolic process; F:strictosidine beta-glucosidase activity; F:beta-apiosyl-beta-glucosidase activity; F:glycosylceramidase activity; F:lactase activity; P:glycosyl compound metabolic process; F:scopolin beta-glucosidase activity,IPR001360 (PRINTS); IPR013781 (G3DSA:3.20.20.GENE3D); IPR001360 (PFAM); IPR001360 (PANTHER); PTHR10353:SF67 (PANTHER); IPR017853 (SUPERFAMILY),8.A.49.1.1, the klotho auxiliary protein (klotho) family.
RL4_JR_02024,43270,23110,23152,11,10,5,0,0,3,1,0,1,7,13,1,0,1,1,566.6383238,1,-0.860587325,0.640713024,-1.34317127,0.179216522,0.336180361,143.9175051,1,-1.254374561,0.943258575,-1.329831071,0.183573936,0.323097789,314.9008702,1,-4.198237104,1.080774874,-3.884469565,0.000102554,0.001177156,469.7387694,1,-1.373078707,0.524969069,-2.615542108,0.008908594,0.044258837,301.5348011,1,-4.414854574,1.031603634,-4.27960355,1.87E-05,0.000170015,N,-,,hypothetical protein CMQ_7085,,no IPS match,,
RL4_JR_02025,11079,5168,6470,2,2,0,0,0,0,0,2,3,0,1,0,0,2,3,126.418421,1,-1.748945826,0.83770385,-2.08778535,0.036817202,0.106085584,29.27403473,0,-1.406022334,1.252373926,-1.122685729,0.261570991,0.417803625,110.4449247,1,-0.921173303,0.744342644,-1.237566206,0.215876951,0.344559082,90.77872631,1,-3.522380306,1.194364816,-2.949166166,0.003186326,0.019540613,103.4308883,1,-1.15503774,0.752646529,-1.534635046,0.124873499,0.225695141,N,-,,sulfite exporter family,C:membrane; C:integral component of membrane,IPR025256 (PFAM); PTHR39469 (PANTHER); PTHR39469:SF1 (PANTHER),,
RL4_JR_02026,1477,1463,1846,0,0,0,0,0,0,0,0,0,0,1,1,0,1,4,19.1282126,0,-2.360008567,1.190840852,-1.98180014,0.047501614,0.128062844,6.087886596,0,0.859540213,1.229342592,0.699186881,0.484435248,0.640974324,15.82493616,0,-1.795226677,1.192540955,-1.505379474,0.132226543,0.238705692,31.90483676,1,-0.483411966,1.014111069,-0.476685425,0.633586143,0.748723121,48.95743522,1,1.085693398,0.680084769,1.596408929,0.110397524,0.205548902,N,-,,hypothetical protein F503_04226,C:membrane; C:integral component of membrane,PTHR42032 (PANTHER); PTHR42032:SF1 (PANTHER); PTHR42032 (PANTHER); PTHR42032:SF1 (PANTHER),,
RL4_JR_02027,57,78,107,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.968172954,0,1.944320052,1.563006703,1.243961429,0.213513759,NA,0.305549278,0,5.175855504,1.705267814,3.035215619,0.002403638,0.015282426,0.798489283,0,2.513198553,1.274701348,1.971597941,0.048655522,0.110868447,0.921576092,0,2.090404156,1.339380892,1.560724188,0.118588842,0.222477677,0.792988977,0,2.421317108,1.25832849,1.924232923,0.054325394,0.119263793,Y,-,,---NA---,,no IPS match,,
RL4_JR_02028,1650,1155,1473,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,27.11754065,1,-1.244124364,1.147067043,-1.084613469,0.278092887,0.461254517,5.470795888,0,1.013776863,1.251954177,0.809755566,0.418080675,0.582092516,14.15484816,0,-1.634287462,1.200071106,-1.361825524,0.173252955,0.292092075,20.33733123,1,-1.109658411,1.151185739,-0.963926474,0.33508279,0.481892941,13.92645105,0,-1.713606546,1.201285811,-1.426476971,0.15373071,0.263638793,N,-,,ras modification erf4,,IPR019383 (PFAM); PTHR13254 (PANTHER); PTHR13254 (PANTHER); PTHR13254:SF0 (PANTHER),,
RL4_JR_02029,2526,2132,2263,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,27.67711443,0,-2.892981942,1.184903044,-2.441534738,0.014624981,0.051538055,8.872103653,0,0.316271136,1.223250781,0.258549711,0.795982689,0.876314587,22.95103227,0,-2.331488167,1.190538255,-1.958347963,0.050189196,0.113494622,30.4832914,1,-1.806251823,1.141506538,-1.582340322,0.1135719,0.215336947,22.56137305,0,-2.409606784,1.1889413,-2.026682717,0.042694871,0.098921183,N,-,,trna exportin,"C:nuclear envelope; C:mitochondrion; C:cytosol; C:nuclear matrix; P:tRNA splicing, via endonucleolytic cleavage and ligation; F:Ran GTPase binding; P:tRNA re-export from nucleus",IPR013598 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR15952 (PANTHER); IPR016024 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_02030,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,Y,-,,---NA---,,no IPS match,,
RL4_JR_02031,5592,5832,7883,1,6,6,0,0,0,0,0,1,0,2,2,0,3,1,158.1674306,1,0.066426648,0.475565992,0.139679139,0.888913509,0.945636818,24.48520252,0,-1.148358922,1.200271612,-0.956749214,0.338693851,0.501574128,70.25951062,1,-2.843840554,1.196497092,-2.376805236,0.017463306,0.050384301,100.8654483,1,-1.494496642,0.755026299,-1.979396801,0.047771348,0.119535305,82.06201534,1,-1.283068434,0.772302336,-1.661355112,0.096642147,0.185956242,N,-,,FACT complex subunit pob-3,"P:DNA repair; C:FACT complex; P:transcription, DNA-templated; P:DNA-dependent DNA replication; P:chromatin silencing at centromere outer repeat region; P:positive regulation of RNA polymerase II transcriptional preinitiation complex assembly; F:DNA binding; C:chromosome, centromeric outer repeat region; C:nuclear chromatin; P:mitotic sister chromatid segregation; C:cytosol; C:replication fork protection complex; P:chromatin silencing at silent mating-type cassette; P:DNA replication-independent nucleosome organization; P:cellular protein localization",IPR000969 (PRINTS); IPR013719 (SMART); IPR024954 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR013719 (PFAM); PTHR13711 (PANTHER); PTHR13711:SF204 (PANTHER); IPR011993 (SUPERFAMILY),,
RL4_JR_02032,165,90,135,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.549489337,0,1.265641006,1.371265352,0.92297308,0.356021234,NA,0.498550683,0,4.46971382,1.58678103,2.816843494,0.004849815,0.02025158,1.288439967,0,1.82309067,1.256369723,1.451078163,0.146758096,0.257858203,1.485877508,0,1.401291178,1.288317706,1.087690693,0.276731678,0.419510142,1.267006846,0,1.744340511,1.240796542,1.405823156,0.159776644,0.271291648,N,-,,---NA---,,no IPS match,,
RL4_JR_02033,162,163,261,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,2.335845212,0,0.673583635,1.295611748,0.519896208,0.603135919,0.77127047,0.739447039,0,3.900845512,1.473690452,2.646991102,0.008121149,0.028934273,1.9300823,0,1.239886407,1.237317588,1.002076119,0.316306831,0.458978121,22.28527776,1,3.815652082,0.724580228,5.26601739,1.39E-07,3.04E-06,1.915925568,0,1.148286276,1.239130194,0.92668735,0.354088887,0.491520426,N,-,,cyclin-dependent kinase,P:phosphorylation; F:kinase activity,IPR013734 (PFAM),,
RL4_JR_02034,7261,6435,2871,2,5,8,0,0,0,0,0,0,2,3,0,0,2,0,157.4860579,1,0.464649867,0.603638783,0.769748201,0.441449272,0.631411026,21.67173346,0,-0.972197942,1.285855888,-0.756070685,0.449606817,0.610124708,55.50584406,0,-3.605560936,1.255372168,-2.872105203,0.004077472,0.016563847,94.64452519,1,-0.990550883,0.800370296,-1.237615748,0.215858572,0.350644641,61.63981578,1,-2.02575387,1.059184182,-1.912560539,0.055804336,0.121797564,N,-,,C2H2 type zinc finger domain,,no IPS match,,
RL4_JR_02035,6182,6616,6011,1,8,27,0,0,1,0,1,0,3,8,12,0,7,3,252.7389892,1,1.38855569,0.47804286,2.904667777,0.003676431,0.016867004,33.51713428,1,-0.210680214,1.115607995,-0.188847888,0.850212038,0.910767938,70.33841964,1,-2.814870323,1.190136968,-2.365165018,0.018022039,0.051701649,247.7421073,1,1.128918538,0.400157232,2.821187395,0.004784624,0.027100416,110.5608843,1,0.079310326,0.491479596,0.161370536,0.871801571,0.914998539,N,-,,aspartyl aminopeptidase,F:zinc ion binding; P:proteolysis; C:fungal-type vacuole lumen; F:aminopeptidase activity; C:ribosome; F:metallopeptidase activity,IPR001948 (PRINTS); IPR001948 (PFAM); IPR023358 (G3DSA:2.30.250.GENE3D); G3DSA:3.40.630.10 (GENE3D); PTHR28570:SF3 (PANTHER); PTHR28570 (PANTHER); SSF101821 (SUPERFAMILY); SSF53187 (SUPERFAMILY),,
RL4_JR_02036,2163,1467,2288,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33.60502731,1,-1.708285303,1.155099224,-1.478907844,0.139164947,0.280738782,7.525361891,0,0.553728714,1.241376571,0.446060226,0.655553743,0.778085716,19.52544714,0,-2.098374723,1.203917454,-1.742955645,0.081341363,0.164897869,22.52347563,0,-2.520618175,1.203728948,-2.094008106,0.036259258,0.101052846,19.27383456,0,-2.182387107,1.209851545,-1.803847022,0.071255292,0.146817223,N,-,,duf1740 domain containing,C:nucleus; P:regulation of heterochromatin domain assembly,IPR013633 (PFAM); PTHR13471 (PANTHER),,
RL4_JR_02037,1693,1259,1250,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,16.79537002,0,-2.172357792,1.198290528,-1.812880717,0.069850221,0.170661307,5.407280244,0,1.030664158,1.261118322,0.81726206,0.413778684,0.577692115,20.44859675,1,-0.651361214,1.201341054,-0.542195084,0.587684122,0.707793725,24.11003569,1,-0.315001398,1.030254984,-0.305750909,0.759794308,0.843151838,13.6760857,0,-1.68744295,1.200389306,-1.405746403,0.159799442,0.271291648,N,-,,voltage-gated chloride channel,P:regulation of anion transmembrane transport; P:ion transmembrane transport; C:integral component of membrane; P:chloride transport; F:voltage-gated chloride channel activity,IPR001807 (PRINTS); IPR014743 (G3DSA:1.10.3080.GENE3D); IPR001807 (PFAM); PTHR11689 (PANTHER); PTHR11689:SF24 (PANTHER); PTHR11689 (PANTHER); PTHR11689:SF24 (PANTHER); IPR014743 (SUPERFAMILY); SSF54631 (SUPERFAMILY),2.A.49.2.3, the chloride carrier/channel (clc) family.
RL4_JR_02038,4101,2869,3789,0,0,4,0,0,0,0,0,1,0,0,0,0,0,0,58.14578475,1,-0.819879995,0.758639471,-1.080724147,0.279819839,0.463130502,13.74446372,0,-0.315259769,1.219247555,-0.258569122,0.79596771,0.876314587,42.07981499,1,-2.002286029,1.196864073,-1.672943548,0.09433841,0.185633054,41.03933267,0,-3.386147845,1.197235141,-2.828306429,0.004679499,0.026617937,35.02882821,0,-3.04428423,1.198850655,-2.539335669,0.011106321,0.034179786,Y,-,,Sad1 UNC domain-containing,C:membrane; C:integral component of membrane,IPR012919 (PFAM); IPR008979 (G3DSA:2.60.120.GENE3D); PTHR12953:SF0 (PANTHER); PTHR12953 (PANTHER); IPR012919 (PROSITE_PROFILES); IPR008979 (SUPERFAMILY),,
RL4_JR_02039,101,120,100,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.290765757,0,1.529614991,1.380050537,1.10837607,0.267699435,NA,0.412423054,0,4.743408535,1.602473086,2.960055039,0.003075841,0.015771865,1.067839906,0,2.094749191,1.237207269,1.693127129,0.090431271,0.179691107,1.231797229,0,1.67234451,1.269251305,1.317583447,0.18764313,0.315595795,1.049480062,0,2.016875856,1.21682333,1.657492756,0.097419892,0.18713269,N,-,,meiosis mei2,F:organic cyclic compound binding; F:heterocyclic compound binding,IPR012677 (G3DSA:3.30.70.GENE3D); IPR007201 (PFAM); PTHR24012 (PANTHER); PTHR24012:SF353 (PANTHER); PTHR24012 (PANTHER); PTHR24012:SF353 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_02040,6356,6541,5763,5,10,14,0,0,0,2,0,4,8,2,0,0,3,0,258.779229,1,1.26819253,0.329736133,3.84608299,0.000120021,0.000995053,23.9809591,0,-1.118268967,1.204325252,-0.928543983,0.353125464,0.516927486,110.1644406,1,-0.358877002,0.617284662,-0.581380074,0.560984324,0.686747814,154.0687704,1,-0.044043579,0.558170219,-0.078907075,0.937106536,0.963171625,72.50643175,1,-1.635457521,0.838817186,-1.949718661,0.051209661,0.114181417,N,-,,NAD binding Rossmann fold oxidoreductase,F:oxidoreductase activity; P:metabolic process; C:membrane; C:integral component of membrane; P:oxidation-reduction process,IPR004104 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR000683 (PFAM); G3DSA:3.30.360.10 (GENE3D); PTHR22604 (PANTHER); PTHR22604:SF53 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02041,985,1762,1559,0,0,2,0,0,0,0,1,0,0,1,0,0,0,0,24.99638269,1,-0.51465074,1.067252462,-0.482220242,0.629649499,0.789044641,5.496467541,0,1.007008507,1.275389676,0.789569279,0.429779355,0.591867569,22.15120219,1,-0.687956508,1.218760029,-0.564472489,0.572432618,0.695929499,20.52289742,1,-1.127514965,1.176575037,-0.958302641,0.337910173,0.485021335,14.13205443,0,-1.73462654,1.230094706,-1.410156902,0.158493359,0.269433387,N,-,,myo-inositol 2-dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR000683 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.360.10 (GENE3D); PTHR22604 (PANTHER); PTHR22604 (PANTHER); PTHR22604:SF85 (PANTHER); PTHR22604:SF85 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02042,458,394,333,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,4.749776319,0,-0.350102057,1.218339664,-0.287359976,0.773836704,0.882486692,1.528357621,0,2.853633428,1.36514766,2.090347815,0.036586567,0.092466724,3.941824496,0,0.210316398,1.215017135,0.173097475,0.86257481,0.912943398,8.557338801,1,0.734634397,1.160211749,0.63318993,0.526609621,0.660583798,3.861134593,0,0.137073535,1.206489192,0.113613562,0.909544136,0.942014564,N,-,,siderophore iron transporter mira,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501:SF21 (PANTHER); PTHR23501 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.16.6, the major facilitator superfamily (mfs).
RL4_JR_02043,378,563,407,0,0,1,0,0,0,0,0,1,0,0,4,0,0,0,9.258762522,1,0.399686916,1.1779342,0.339311751,0.734374891,0.859668584,1.734363374,0,2.671179353,1.357410048,1.967849993,0.0490853,0.11611157,10.99223959,1,0.983234487,1.213395598,0.810316511,0.417758288,0.559026223,43.72502403,1,2.728762626,1.38014312,1.97715917,0.048023641,0.119764935,4.415869842,0,-0.056330484,1.221613748,-0.046111534,0.963221353,0.975749495,N,-,,MFS hexose transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF145 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.127, the major facilitator superfamily (mfs).
RL4_JR_02044,579,1031,750,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13.35691622,1,-0.411301937,1.189466837,-0.345786805,0.729502942,0.857173155,3.030327813,0,1.866078986,1.319501163,1.414230649,0.157294192,0.286695005,7.866521154,0,-0.78662217,1.228163733,-0.640486401,0.521856427,0.65201462,9.076416408,0,-1.209189241,1.230579576,-0.982617675,0.325795642,0.472387352,7.743684436,0,-0.86670618,1.232087922,-0.703445074,0.481778425,0.610284818,N,-,,Glycoside family 1,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR001360 (PRINTS); IPR001360 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); IPR001360 (PANTHER); IPR017853 (SUPERFAMILY),8.A.49.1.2, the klotho auxiliary protein (klotho) family.
RL4_JR_02045,204,220,325,0,0,125,0,0,0,0,0,0,0,3,3,0,8,0,480.308878,1,7.326401179,2.387110172,3.069150835,0.002146682,0.011090963,0.946628676,0,3.54452008,1.423333246,2.49029529,0.0127637,0.040550587,2.46973533,0,0.884297348,1.228122907,0.72003978,0.471500503,0.60808549,43.7906855,1,3.782752923,0.646716225,5.849169661,4.94E-09,1.45E-07,33.33409805,1,4.310607845,0.649967664,6.632034302,3.31E-11,2.54E-09,N,-,,choline transporter,,IPR002293 (PIRSF); IPR002293 (PFAM); IPR002293 (PANTHER); PTHR11785:SF373 (PANTHER),2.A.3.4.1, the amino acid-polyamine-organocation (apc) family.
RL4_JR_02046,3,5,8,0,0,33,0,0,0,0,0,0,0,0,0,0,0,0,126.0762141,1,10.98409275,2.020445901,5.436469616,5.43E-08,1.14E-06,0.020045184,0,9.105086071,2.902804386,3.136651617,0.001708891,0.015023052,0.052626217,0,6.43519728,1.665837588,3.863040026,0.000111985,0.001243128,0.060755323,0,6.013232261,2.846901695,2.112202284,0.034669103,0.099426657,0.052517893,0,6.340863232,1.359450275,4.664284784,3.10E-06,3.78E-05,Y,-,,hypothetical protein CMQ_1808,,PTHR40616 (PANTHER); PTHR40616:SF1 (PANTHER),,
RL4_JR_02047,449,697,632,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.158096784,0,-0.941735299,1.227805275,-0.767007048,0.443077325,0.63225902,2.271393757,0,2.281942551,1.320732127,1.727786054,0.084026589,0.176675764,5.906198476,0,-0.373164367,1.21789791,-0.306400367,0.759299829,0.838476381,6.814992012,0,-0.795809247,1.219130692,-0.652767789,0.513905992,0.648860933,5.828479468,0,-0.456770598,1.222014012,-0.373785074,0.708564225,0.794310538,N,-,,C6 transcription,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR001138 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_02048,2560,2475,2388,1,0,13,0,0,0,1,0,0,4,5,0,0,4,1,89.45424575,1,1.409008205,0.529886674,2.659074616,0.007835561,0.031288548,9.523058981,0,0.214129868,1.218843457,0.17568283,0.860543125,0.918239249,35.7148611,1,-1.472379683,1.188278504,-1.239086358,0.215313519,0.343930903,85.73384092,1,1.043374199,0.507034963,2.057795368,0.039609781,0.106832454,47.03347127,1,0.429928474,0.662412415,0.649034444,0.516316113,0.642035359,Y,-,,exocyst complex component,C:incipient cellular bud site; C:cellular bud tip; P:vesicle tethering involved in exocytosis; C:cellular bud neck; P:vesicle docking involved in exocytosis; P:Golgi to plasma membrane transport; F:Rab GTPase binding; C:exocyst,IPR007225 (PFAM); PTHR12702:SF0 (PANTHER); IPR007225 (PANTHER),1.F.2.1.2, the octameric exocyst (exocyst) family.
RL4_JR_02049,1197,1244,1386,0,1,0,0,0,0,0,0,0,2,2,0,0,0,0,23.33226841,1,-1.090464263,1.139575204,-0.956904169,0.338615627,0.528415732,4.883512811,0,1.177593103,1.238085905,0.951140061,0.341533281,0.504450586,12.67736074,0,-1.475223746,1.190162684,-1.239514368,0.215155071,0.343840559,41.27323723,1,0.834254029,0.735823436,1.13376931,0.256891328,0.396256047,12.50373173,0,-1.558029345,1.193981308,-1.304902627,0.191926007,0.312168806,N,-,,histone-like transcription factor and archaeal histone,"C:CCAAT-binding factor complex; F:transcription factor activity, sequence-specific DNA binding; F:protein heterodimerization activity; P:regulation of transcription, DNA-templated",IPR009072 (G3DSA:1.10.20.GENE3D); IPR003958 (PFAM); PTHR10252 (PANTHER); IPR027170 (PTHR10252:PANTHER); IPR009072 (SUPERFAMILY),,
RL4_JR_02050,8012,9227,10450,0,1,1,0,0,0,0,0,0,3,0,0,0,0,0,122.7506427,1,-3.160260515,1.019738072,-3.099090443,0.001941158,0.01022995,35.26307543,0,-1.674582087,1.19428701,-1.402160513,0.16086732,0.291661666,91.68322036,0,-4.329604477,1.192303062,-3.631295276,0.000282002,0.002216608,133.720403,1,-2.416997722,0.852323859,-2.835773864,0.00457148,0.026120901,90.55929579,0,-4.414566339,1.198157967,-3.684461032,0.000229187,0.001397903,N,-,,rrna-processing fcf2,,IPR014810 (PFAM); PTHR21686:SF12 (PANTHER); PTHR21686 (PANTHER),,
RL4_JR_02051,4738,6520,11707,5,2,1,0,0,2,1,0,1,1,6,6,0,4,0,161.7111805,1,-0.64101115,0.77869921,-0.82318197,0.41040452,0.601739769,47.48749376,1,0.239475343,1.048467864,0.228405039,0.819331373,0.890887545,92.98819317,1,-2.218819792,1.085674355,-2.043724974,0.040980725,0.09752991,178.2597522,1,0.000733975,0.588273263,0.001247677,0.999004498,0.999460773,90.73509917,1,-1.617317884,0.889766161,-1.817688685,0.069111728,0.143554993,N,-,,30s ribosomal s10,F:ATP binding; F:structural constituent of ribosome; C:mitochondrion; C:small ribosomal subunit; P:tryptophanyl-tRNA aminoacylation; F:tryptophan-tRNA ligase activity,IPR027486 (SMART); IPR027486 (G3DSA:3.30.70.GENE3D); IPR027486 (PFAM); IPR001848 (PANTHER); PTHR11700:SF9 (PANTHER); IPR027486 (SUPERFAMILY),,
RL4_JR_02052,824,713,1071,1,0,3,0,0,0,0,0,0,1,2,0,0,0,0,31.91498772,1,1.237239053,0.759413473,1.629203454,0.103269956,0.22696021,3.306099994,0,1.740317498,1.272627238,1.367499804,0.171468699,0.306901084,8.602763854,0,-0.91599356,1.20361295,-0.761036644,0.446635181,0.586020551,27.26116097,1,0.971760367,0.865110315,1.123279135,0.261318962,0.401678229,8.5132897,0,-1.003500215,1.211430906,-0.82835943,0.407466975,0.543656685,N,-,,tryptophanyl-tRNA synthetase,F:ATP binding; P:mitochondrial tryptophanyl-tRNA aminoacylation; F:structural constituent of ribosome; C:mitochondrion; C:ribosome; F:tryptophan-tRNA ligase activity,IPR002306 (PRINTS); IPR002306 (TIGRFAM); IPR014729 (G3DSA:3.40.50.GENE3D); IPR002305 (PFAM); G3DSA:1.10.240.10 (GENE3D); PTHR10055:SF10 (PANTHER); IPR002306 (PANTHER); SSF52374 (SUPERFAMILY),,
RL4_JR_02053,3898,4446,4893,0,1,1,1,0,0,0,1,1,1,5,2,0,0,1,64.87019763,1,-2.096082396,1.014632032,-2.065854744,0.038842197,0.110486957,39.18719478,1,0.311182473,1.108691457,0.28067545,0.778959341,0.866252081,58.19237009,1,-1.44343248,1.031961617,-1.398726906,0.161894892,0.277615421,99.23379588,1,0.037070757,0.541984717,0.068398159,0.945468687,0.968057261,50.65145237,1,-2.414801085,1.124271516,-2.147880695,0.031723234,0.078667095,N,-,,Importin 13,C:nuclear membrane; F:aminoacyl-tRNA ligase activity; C:cytosol; C:nuclear periphery,IPR011989 (G3DSA:1.25.10.GENE3D); PTHR12363 (PANTHER); PTHR12363:SF34 (PANTHER); IPR016024 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_02054,6459,9784,6985,3,5,13,0,0,1,0,2,3,6,4,0,0,2,2,213.6585984,1,0.430997728,0.453003477,0.95142256,0.341389913,0.531601242,39.26928346,1,-0.520646592,1.136683476,-0.458040081,0.646923645,0.771551919,112.6263249,1,-0.953986566,0.705174767,-1.352837071,0.176107687,0.29538009,161.263036,1,-0.420009888,0.562366509,-0.746861489,0.455147174,0.597325359,98.55482031,1,-1.537633003,0.782006439,-1.966266424,0.049267843,0.110779866,N,-,,Xaa-Pro aminopeptidase,C:nucleus; F:metal ion binding; P:negative regulation of transcription from RNA polymerase II promoter in response to iron; P:proteolysis; C:cytosol; F:aminopeptidase activity; F:metallopeptidase activity,IPR000994 (PFAM); IPR032416 (PFAM); PF16189 (PFAM); IPR000994 (G3DSA:3.90.230.GENE3D); IPR000587 (PFAM); IPR029149 (G3DSA:3.40.350.GENE3D); PTHR10804:SF87 (PANTHER); PTHR10804 (PANTHER); IPR028980 (SUPERFAMILY); IPR000994 (SUPERFAMILY),,
RL4_JR_02055,572,832,666,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.342242963,0,-1.162556123,1.21899391,-0.953701338,0.340234843,0.530308722,2.656257233,0,2.056164098,1.305799889,1.57463951,0.115339678,0.226648848,6.889779,0,-0.595327545,1.21287332,-0.490840664,0.623539147,0.736519697,7.948756984,0,-1.017765032,1.213115138,-0.838968207,0.401487151,0.545459267,6.780507144,0,-0.675061235,1.214121444,-0.556008,0.578205386,0.691347371,N,-,,fun14 family,C:integral component of mitochondrial outer membrane; P:mitophagy,no IPS match,,
RL4_JR_02056,679,606,654,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11.57497011,1,-0.109876755,1.138539028,-0.096506797,0.923118076,0.96277132,2.48230064,0,2.153867706,1.288561313,1.67152908,0.09461722,0.193906357,6.427877405,0,-0.495344008,1.194523181,-0.414679276,0.678376705,0.778792145,7.414412596,0,-0.917508721,1.191628845,-0.769961826,0.441322538,0.583340822,6.324869357,0,-0.574865037,1.192736034,-0.481971719,0.629826036,0.733408697,N,-, Effector probability:0.61,dihydrofolate reductase,F:NADP binding; P:nucleotide biosynthetic process; P:oxidation-reduction process; P:folic acid-containing compound metabolic process; F:dihydrofolate reductase activity; P:glycine biosynthetic process,IPR012259 (PRINTS); IPR024072 (G3DSA:3.40.430.GENE3D); IPR001796 (PFAM); PTHR22778:SF16 (PANTHER); PTHR22778 (PANTHER); IPR001796 (PROSITE_PROFILES); IPR024072 (SUPERFAMILY),,
RL4_JR_02057,1861,1356,1128,0,0,3,0,0,0,0,2,0,0,0,0,0,0,0,28.84471346,1,0.05616489,0.896288191,0.062663873,0.950034166,0.97550393,5.619221902,0,0.975209402,1.28067203,0.761482549,0.446368898,0.607522655,30.14330654,1,0.16020224,1.057456245,0.151497748,0.879583087,0.92489605,16.66947701,0,-2.086273365,1.216664784,-1.714747884,0.08639146,0.175433922,14.13029493,0,-1.734564653,1.213073882,-1.429892011,0.152748015,0.262353462,N,-,,mfs multidrug transporter,C:membrane,no IPS match,,
RL4_JR_02058,1900,1310,1070,0,0,0,0,0,0,0,1,0,0,0,3,0,1,3,17.12151298,0,-2.200076641,1.222531668,-1.799607076,0.071922703,0.174263561,5.541961918,0,0.995182723,1.291271886,0.770699598,0.44088501,0.602245354,22.08748474,1,-0.681501134,1.219446271,-0.558861141,0.576256492,0.698517807,45.32877574,1,0.311976188,0.893153955,0.349297214,0.72686619,0.817997129,39.86623454,1,0.936587081,0.784172168,1.194364093,0.232335576,0.359858912,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:3.40.50.80 (GENE3D); IPR013112 (PFAM); IPR013121 (PFAM); IPR011701 (PFAM); IPR013130 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23504:SF6 (PANTHER); PTHR23504 (PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY); IPR017938 (SUPERFAMILY); IPR020846 (SUPERFAMILY),5.B.1.5.1, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_02059,168,131,191,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32.14823318,1,3.2703312,0.856397501,3.81870708,0.000134153,0.001097713,0.622867819,0,4.148454654,1.498158326,2.76903621,0.005622239,0.022203784,1.617584343,0,1.494734319,1.226305024,1.218892764,0.222884897,0.352906896,1.866100116,0,1.0724789,1.241786888,0.863657775,0.387775916,0.532803793,1.597703288,0,1.410104828,1.220064119,1.155762887,0.247778157,0.377995155,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23512 (PANTHER); PTHR23512:SF3 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.53.4, the major facilitator superfamily (mfs).
RL4_JR_02060,619,573,689,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,7.51808764,0,-1.012806481,1.190761464,-0.850553626,0.395017359,0.587413711,2.39880327,0,2.203188986,1.287478121,1.711243827,0.087036111,0.181832718,6.225108992,0,-0.449227628,1.194954382,-0.375937052,0.706963694,0.801130562,11.19302874,1,0.075655851,1.14217874,0.066238189,0.947188193,0.969106756,10.00046956,1,0.398048079,1.125200014,0.35375762,0.723520537,0.805281459,N,-,,ATP-dependent RNA helicase Mrh4,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_02061,610,725,947,0,0,1,0,0,0,0,1,0,2,3,1,0,2,0,12.94632821,1,-0.346380802,1.163580374,-0.297685325,0.765943345,0.877722899,2.891633472,0,1.933559011,1.285608385,1.504003111,0.132580566,0.250743738,15.3811083,1,0.236433358,1.20386086,0.196395917,0.844300292,0.900136495,48.99335586,1,2.171723366,0.637696162,3.405576973,0.000660244,0.005234902,15.18913009,1,0.844158418,1.005257784,0.839743229,0.40105237,0.53819155,N,-,,type 2a phosphatase activator tip41,,IPR007303 (PFAM); PTHR21021 (PANTHER); PTHR21021:SF16 (PANTHER),,
RL4_JR_02062,12,10,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.147427388,0,4.659453818,3.381836147,1.377788164,0.168268701,NA,0.046936207,0,7.878418218,2.429753569,3.24247624,0.001184958,0.015023052,0.122065328,0,5.222150163,1.418173373,3.6823073,0.000231133,0.001935248,0.140831568,0,4.800487498,2.033855234,2.360289669,0.01826067,0.073778645,0.120734411,0,5.136227438,1.27673183,4.022949313,5.75E-05,0.000435329,N,-,,mitogen activated kinase kinase kinase 3,F:nucleotide binding; F:ATP binding; F:protein kinase activity; P:phosphorylation; F:protein serine/threonine kinase activity; P:protein phosphorylation; F:kinase activity,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24362 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_02063,273,307,233,0,0,7,0,0,0,0,0,0,2,0,0,0,0,0,30.00055213,1,3.663479571,0.621512638,5.894457078,3.76E-09,9.21E-08,1.047972082,0,3.398022365,1.413998267,2.403130501,0.016255385,0.04908622,2.708130366,0,0.752040015,1.220033598,0.616409266,0.537624439,0.666334289,21.74810252,1,2.080604671,1.02597403,2.027931127,0.042567278,0.112121147,2.65601902,0,0.677044129,1.210226127,0.559436054,0.575864162,0.690011321,N,-,,serine threonine- kinase,,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); IPR030616 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_02064,2035,2877,4582,0,0,11,0,0,0,0,0,3,0,2,0,0,0,0,79.91660128,1,0.513228344,0.866485193,0.592310577,0.553642635,0.732622322,11.9216616,0,-0.110054911,1.254084807,-0.087757152,0.930069694,0.960711748,50.73861936,1,-0.391629573,0.914359919,-0.428310083,0.668425379,0.771887594,44.0871866,1,-1.498986034,1.075989571,-1.3931232,0.163582539,0.283857616,31.12634536,0,-2.873833953,1.246095464,-2.306271098,0.021095489,0.05701864,N,-,,mitochondrial inner membrane protease ATP-23,C:mitochondrial intermembrane space; P:mitochondrial proton-transporting ATP synthase complex assembly; F:metal ion binding; P:mitochondrial protein processing; C:extrinsic component of mitochondrial inner membrane; F:metalloendopeptidase activity,IPR019165 (PFAM); PTHR21711:SF0 (PANTHER); PTHR21711 (PANTHER); PTHR21711:SF0 (PANTHER); PTHR21711 (PANTHER),,
RL4_JR_02065,6676,5995,8259,0,3,2,0,0,0,0,7,1,0,2,2,0,2,5,115.1808705,1,-1.430470757,0.679163623,-2.10622405,0.035184895,0.102330971,26.59024128,0,-1.267336921,1.197420091,-1.058389559,0.289877878,0.449212003,130.5260033,1,-0.100106779,0.553398737,-0.180894484,0.856450399,0.908688308,107.0471981,1,-1.611469448,0.747940246,-2.154543034,0.031197611,0.094516999,112.8757627,1,-0.553333644,0.600540503,-0.921392713,0.356845432,0.494195048,N,-,,glutamate 5-kinase,F:RNA binding; F:glutamate 5-kinase activity; C:cytoplasm; P:proline biosynthetic process; P:phosphorylation,IPR001057 (PRINTS); IPR002478 (SMART); IPR002478 (PFAM); IPR001048 (PFAM); IPR015947 (G3DSA:2.30.130.GENE3D); IPR001048 (G3DSA:3.40.1160.GENE3D); IPR005715 (TIGRFAM); PTHR11063 (PANTHER); PTHR11063:SF12 (PANTHER); IPR005715 (HAMAP); IPR002478 (PROSITE_PROFILES); IPR001048 (SUPERFAMILY); IPR015947 (SUPERFAMILY),,
RL4_JR_02066,73720,64566,79885,13,6,41,4,0,4,8,3,1,7,11,3,0,13,0,1206.846148,1,-1.326767707,0.382563696,-3.468096217,0.00052416,0.00349146,404.9875809,1,-1.035306604,0.55742686,-1.857295867,0.063269072,0.14193474,840.3917714,1,-2.819698106,0.538498146,-5.236226208,1.64E-07,5.46E-06,970.8875018,1,-2.602498081,0.368845225,-7.055799836,1.72E-12,7.90E-11,762.0025662,1,-3.42023052,0.860124815,-3.97643512,7.00E-05,0.000517558,N,-,,eukaryotic translation initiation factor 3 subunit A,F:translation initiation factor activity; P:formation of translation preinitiation complex; P:mycelium development; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; P:regulation of translational initiation; C:eukaryotic translation initiation factor 3 complex,SM00753 (SMART); IPR000717 (SMART); IPR000717 (PFAM); PTHR14005 (PANTHER); IPR027512 (HAMAP),,
RL4_JR_02067,1972,2517,2409,0,0,8,0,0,0,0,5,0,0,1,0,0,0,0,58.258746,1,0.760116654,0.595133189,1.277221081,0.201524207,0.365590281,8.818566527,0,0.324982655,1.223943557,0.265520949,0.790608174,0.87373468,62.11282139,1,0.818487912,0.680222634,1.203264741,0.228873889,0.359968813,30.42985931,1,-1.803752424,1.148139917,-1.571021439,0.116177669,0.218846307,22.57427666,0,-2.410348988,1.199425196,-2.009586755,0.044474944,0.10227318,N,-, Effector probability:0.732,Guanine nucleotide-binding subunit gamma,C:heterotrimeric G-protein complex; P:G-protein coupled receptor signaling pathway; F:signal transducer activity,SM01224 (SMART); IPR015898 (SMART); IPR015898 (PFAM); IPR015898 (G3DSA:4.10.260.GENE3D); PTHR28189 (PANTHER); IPR015898 (SUPERFAMILY),8.A.92.1.3,The G-Protein αβγ Complex (GPC) Family
RL4_JR_02068,1558,2134,1940,0,0,3,0,0,2,0,3,2,0,12,0,0,2,0,34.10696746,1,-0.315639439,0.878462823,-0.359308819,0.719364078,0.850271247,25.96208507,1,2.251994766,1.003546621,2.244036021,0.024830084,0.068203557,55.23573617,1,1.103304529,0.684280827,1.61235634,0.10688442,0.203732728,69.7251536,1,1.663220513,0.618391917,2.68958967,0.007153992,0.037222083,26.16269055,1,-0.455009999,0.990284348,-0.459474089,0.645893755,0.747069744,N,-,,---NA---,,no IPS match,,
RL4_JR_02069,294,412,449,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4.635514021,0,-0.314947374,1.235317277,-0.254952618,0.798759696,0.897559449,1.468859336,0,2.910776204,1.359270867,2.141424697,0.032239805,0.083674694,10.32435636,1,1.215047996,1.208244005,1.005631305,0.314592959,0.456884108,4.414567308,0,-0.169468126,1.22245237,-0.138629635,0.889742824,0.932233543,3.783916836,0,0.16650578,1.223582118,0.136080593,0.89175757,0.929009712,N,-,,seleno domain,,IPR011893 (TIGRFAM); IPR011893 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR36417 (PANTHER); PTHR36417:SF2 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_02070,21714,17801,21423,0,1,9,0,0,0,3,6,4,5,10,3,0,1,4,285.7097854,1,-2.018965382,0.505166819,-3.996631029,6.43E-05,0.000577262,77.86072606,0,-2.817304403,1.191486894,-2.364528236,0.018053051,0.053079354,307.9853259,1,-0.940714643,0.438194254,-2.146798217,0.031809349,0.080344972,348.2682904,1,-0.990565658,0.379564137,-2.60974513,0.00906097,0.044949693,231.9892112,1,-2.581956626,0.679523799,-3.799655921,0.000144897,0.000947728,N,-,,serine threonine- phosphatase PP1,,IPR006186 (PRINTS); IPR006186 (SMART); IPR029052 (G3DSA:3.60.21.GENE3D); IPR031675 (PFAM); IPR004843 (PFAM); PTHR11668 (PANTHER); PTHR11668:SF255 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_02071,35,34,37,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.424277488,0,3.134574405,2.116833145,1.480784828,0.138663921,NA,0.135494881,0,6.349217715,1.962672435,3.234985932,0.001216487,0.015023052,0.351302431,0,3.698187767,1.285208523,2.877500188,0.004008397,0.016402994,0.405254827,0,3.275901144,1.457697464,2.247312096,0.024620088,0.084922906,0.346073133,0,3.617220526,1.231254489,2.937833371,0.003305146,0.012783198,,,,,,,,
RL4_JR_02072,875,647,590,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,12.26587868,1,-0.23446422,1.161222215,-0.201911586,0.839985844,0.919624667,2.72429783,0,2.019709534,1.315700256,1.535083333,0.12476336,0.240132103,18.08925559,1,0.339562334,1.207128909,0.281297491,0.778482234,0.853052726,8.093964597,0,-1.043959719,1.213688016,-0.86015492,0.389703651,0.534408221,6.871518503,0,-0.694532595,1.208917888,-0.574507667,0.565624314,0.682834381,N,-,,3 HAT complex component NTO1,F:metal ion binding,IPR001965 (SMART); IPR019542 (PFAM); PF13832 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PF13831 (PFAM); PTHR13793:SF98 (PANTHER); PTHR13793 (PANTHER); PTHR13793 (PANTHER); PTHR13793:SF98 (PANTHER); PTHR13793 (PANTHER); IPR019787 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY),,
RL4_JR_02073,9174,7351,7947,4,0,10,0,0,0,0,1,0,0,4,0,0,17,2,176.2502828,1,-0.198863635,0.43518012,-0.456968565,0.64769364,0.799498368,31.37928051,0,-1.506206817,1.202518823,-1.252543236,0.210371984,0.356084486,88.98154615,1,-3.191531967,1.191817044,-2.677870721,0.007409181,0.025679749,109.6282084,1,-1.863574941,0.751244691,-2.480649732,0.013114317,0.060164232,160.0952655,1,0.46263459,0.527401906,0.877195523,0.380380448,0.516059498,N,-,,leucine rich repeat domain-containing,,IPR001611 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR15454:SF7 (PANTHER); PTHR15454 (PANTHER); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY),8.A.43.1.12, the neat-domain containing methaemoglobin heme sequestration (n-mhs) family.
RL4_JR_02074,947,637,728,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.221650797,0,-1.307489269,1.205012295,-1.085042264,0.277902937,0.461174158,2.968142347,0,1.895998847,1.300495687,1.457904756,0.144866798,0.269647246,7.662231112,0,-0.748788401,1.209223916,-0.619230558,0.535764484,0.664552761,8.836158258,0,-1.170623243,1.20843585,-0.968709463,0.33269017,0.479363593,7.520086281,0,-0.824661268,1.206975632,-0.683245996,0.494451413,0.622676686,N,-,,---NA---,,no IPS match,,
RL4_JR_02075,1583,2074,3632,2,0,0,0,0,0,0,0,0,1,3,0,0,0,0,49.1906064,1,-1.167456769,1.083421143,-1.07756506,0.281227902,0.464424539,9.133015442,0,0.274353245,1.267718138,0.216415019,0.82866426,0.897378751,23.95173384,0,-2.393124322,1.23475917,-1.938130431,0.052607312,0.117674862,48.99591274,1,-0.119013161,0.829035111,-0.143556237,0.8858509,0.929744,23.88795997,0,-2.491980446,1.252257125,-1.98999103,0.046591924,0.10608825,N,-,,hypothetical protein CMQ_7163,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_02076,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.012350936,0,8.240449494,3.992446966,2.064009758,0.039016791,NA,0.003847388,0,11.48786319,3.994462804,2.875946969,0.004028174,0.018161447,0.010076238,0,8.824953261,3.04172355,2.901300239,0.003716176,0.01574077,0.011635085,0,8.399918427,3.993526077,2.103383893,0.035432225,0.099858856,0.009970118,0,8.753059774,1.62090679,5.400100629,6.66E-08,1.61E-06,,,,,,,,
RL4_JR_02077,14044,12708,13709,0,8,0,0,0,0,0,0,0,0,7,0,0,1,0,225.9527167,1,-1.400477825,1.14062031,-1.227821224,0.219514087,0.388374738,51.7878727,0,-2.229014311,1.192118793,-1.869792108,0.061512693,0.138856261,134.1278864,0,-4.878476583,1.186828715,-4.110514449,3.95E-05,0.000594753,182.7966154,1,-1.783152587,0.569809039,-3.129386276,0.001751719,0.011871587,135.859967,1,-4.027545481,1.117191064,-3.605064174,0.000312076,0.00180455,N,-,,beta-ketoacyl synthase,"F:transferase activity, transferring acyl groups other than amino-acyl groups; P:mitochondrial respiratory chain complex III assembly; F:ribosome binding; P:positive regulation of mitochondrial translation; C:integral component of mitochondrial membrane; C:mitochondrial ribosome; P:fatty acid biosynthetic process",IPR021150 (PFAM); IPR007129 (PANTHER); PTHR12184:SF1 (PANTHER); IPR007129 (PANTHER); PTHR12184:SF1 (PANTHER); IPR006311 (PROSITE_PROFILES),,
RL4_JR_02078,1616,1299,2314,0,5,8,0,0,0,0,0,4,1,1,1,0,0,0,91.3914628,1,1.9132424,0.52339484,3.655447577,0.000256734,0.001907498,6.600053112,0,0.742964991,1.250658837,0.594058882,0.552472731,0.698732639,43.20093011,1,0.888125295,0.779179217,1.139821592,0.254360636,0.390135386,42.8129216,1,-0.007941042,0.877961889,-0.00904486,0.992783344,0.995240729,17.06712525,0,-2.006935541,1.223128764,-1.640821146,0.100834547,0.192160699,N,PKS-Like,,3-oxoacyl-(acyl-carrier- ) synthase 2,"F:transferase activity, transferring acyl groups other than amino-acyl groups; C:mitochondrion; P:fatty acid biosynthetic process",IPR020841 (SMART); IPR016039 (G3DSA:3.40.47.GENE3D); IPR017568 (PIRSF); IPR016039 (G3DSA:3.40.47.GENE3D); IPR017568 (TIGRFAM); IPR014030 (PFAM); IPR014031 (PFAM); PTHR11712:SF273 (PANTHER); PTHR11712 (PANTHER); IPR016039 (SUPERFAMILY); IPR016039 (SUPERFAMILY),,
RL4_JR_02079,1600,1867,1204,0,1,7,0,0,0,0,0,0,0,2,0,0,0,0,53.56877971,1,1.316129327,0.623572221,2.110628542,0.034804252,0.101586079,6.044127664,0,0.870051237,1.270753715,0.684673377,0.493550053,0.64896254,15.5932464,0,-1.773759675,1.213768718,-1.461365455,0.143915176,0.254230891,26.00702513,1,-0.482640678,1.046299537,-0.461283467,0.644595245,0.756260354,15.26097778,0,-1.845545395,1.211639488,-1.523180297,0.127713604,0.229180092,N,-,,opt family small oligopeptide transporter,P:transmembrane transport; C:integral component of membrane,IPR004813 (TIGRFAM); IPR004813 (PFAM); IPR004648 (TIGRFAM); PTHR22601 (PANTHER); PTHR22601:SF0 (PANTHER); PTHR22601:SF0 (PANTHER); PTHR22601 (PANTHER),2.A.67.1.2, the oligopeptide transporter (opt) family.
RL4_JR_02080,231,209,184,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.501426416,0,0.575018367,1.248776092,0.460465548,0.645182095,0.79800127,0.803358123,0,3.781501945,1.454742554,2.599430349,0.009337863,0.031996562,2.074503735,0,1.136493402,1.219827906,0.931683392,0.351500172,0.494866881,2.392529139,0,0.714488892,1.228270901,0.58170302,0.560766737,0.689132566,2.034559025,0,1.06137505,1.206492776,0.879719358,0.37901136,0.514753859,N,-,,fungal specific transcription factor,F:binding,IPR007219 (SMART); IPR007219 (PFAM); PTHR31944:SF35 (PANTHER); PTHR31944 (PANTHER); PTHR31944:SF35 (PANTHER); PTHR31944 (PANTHER); PTHR31944 (PANTHER); PTHR31944:SF35 (PANTHER),,
RL4_JR_02081,8648,9502,8851,7,6,7,0,0,2,1,3,8,6,8,12,0,14,2,253.6149055,1,0.234431474,0.386085054,0.60720163,0.54371711,0.724484336,53.37159416,1,-0.005343214,0.985340079,-0.005422711,0.995673324,0.997829394,176.2684314,1,0.09895032,0.454571611,0.217678178,0.827679868,0.888802071,307.0407207,1,0.803069507,0.381431511,2.10540945,0.035255682,0.099766288,157.007474,1,0.155273539,0.467685259,0.332004347,0.739885976,0.81813866,N,-,,filamentation,"F:transferase activity, transferring acyl groups; P:metabolic process; C:cellular_component",IPR019734 (SMART); IPR004167 (G3DSA:4.10.320.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR004167 (PFAM); G3DSA:2.40.50.100 (GENE3D); IPR000089 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR23151 (PANTHER); PTHR23151:SF44 (PANTHER); IPR000089 (PROSITE_PROFILES); IPR004167 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011053 (SUPERFAMILY),,
RL4_JR_02082,3710,4060,6889,0,0,0,0,0,0,0,0,0,0,0,0,0,14,0,58.41689306,0,-3.97066013,1.229882388,-3.228487673,0.001244466,0.007016141,18.43689436,0,-0.739059594,1.227179364,-0.602242521,0.547012715,0.69332115,48.22225811,0,-3.402673612,1.217263889,-2.795345892,0.005184421,0.019451514,55.656075,0,-3.825676435,1.221510524,-3.131922616,0.001736656,0.01179319,102.0172481,1,0.389147226,1.358907929,0.286367618,0.774596574,0.844173358,N,-,,Pre-rRNA-processing rix1,,IPR012583 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR016024 (SUPERFAMILY),,
RL4_JR_02083,6071,3935,5741,0,0,4,0,0,0,0,0,5,0,2,0,0,6,1,77.92947817,1,-1.378926946,0.777435276,-1.773687133,0.076114916,0.181424669,20.08249941,0,-0.862355856,1.217386671,-0.708366435,0.478717731,0.636052545,84.50733393,1,-0.386636641,0.69894845,-0.553169037,0.580147667,0.702141659,68.01668279,1,-2.215901488,1.03452607,-2.141948426,0.032197632,0.095995591,81.77566601,1,-0.202991403,0.621136762,-0.326806293,0.743814399,0.821009571,N,-,,ww domain-containing,"C:nucleus; P:mRNA cis splicing, via spliceosome; C:U2-type spliceosomal complex",IPR001202 (SMART); IPR001202 (PFAM); G3DSA:2.20.70.10 (GENE3D); IPR001202 (PROSITE_PROFILES); IPR001202 (SUPERFAMILY),,
RL4_JR_02084,223,150,209,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2.317288606,0,0.684986176,1.266045707,0.541043797,0.588477396,0.760205163,0.742793815,0,3.894474393,1.472321495,2.645124999,0.008166074,0.029019308,1.923457147,0,1.245031494,1.227099295,1.014613486,0.310290108,0.451801676,6.230128837,1,1.768697816,1.164254038,1.51916829,0.128720141,0.236832896,1.894456484,0,1.164166744,1.219444387,0.954669812,0.339744701,0.477103342,Y,-,,xylanase 3,P:metabolic process; F:hydrolase activity,IPR013320 (G3DSA:2.60.120.GENE3D); IPR000757 (PFAM); PTHR38121:SF1 (PANTHER); PTHR38121 (PANTHER); IPR000757 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),,
RL4_JR_02085,438,147,288,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11.46102575,1,1.070528377,1.234435738,0.867220824,0.385821029,0.578908948,1.118127792,0,3.304447019,1.513483492,2.183338659,0.02901088,0.077174277,2.879759374,0,0.662910129,1.292016972,0.513081595,0.607894245,0.724293437,3.320115243,0,0.241464532,1.313151022,0.183881768,0.854106208,0.908671362,2.82483575,0,0.587830126,1.290053711,0.455663296,0.64863212,0.748933768,Y,-,,acetylxylan esterase precursor,P:metabolic process; F:hydrolase activity,IPR000675 (SMART); IPR000675 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR33630:SF2 (PANTHER); PTHR33630 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_02086,8621,7191,5864,6,12,13,0,0,0,0,4,1,6,6,1,1,10,2,293.038336,1,1.187332137,0.383211097,3.098376188,0.001945843,0.010241409,27.99484487,0,-1.341544684,1.22041907,-1.099249198,0.271659385,0.429263102,110.0086004,1,-0.841171802,0.696005496,-1.208570631,0.226827845,0.357584102,172.7639413,1,0.043992884,0.484820651,0.090740533,0.927698763,0.957076935,139.9576409,1,0.228854179,0.484971962,0.471891567,0.637004188,0.739118203,N,-,,hypothetical protein SPI_06623,C:cell part,PTHR12751 (PANTHER),,
RL4_JR_02087,6265,8419,13049,0,3,2,0,0,0,0,0,1,0,0,1,0,1,0,142.4276631,1,-1.825324946,0.766733935,-2.380649745,0.017282135,0.058372252,34.88097159,0,-1.658881302,1.224934519,-1.354261209,0.175653057,0.31192285,97.81645709,1,-3.362053226,1.222931366,-2.749175727,0.005974535,0.021690026,115.0393263,1,-3.792708578,1.183099473,-3.205739386,0.001347159,0.009511847,94.74440364,1,-3.493185586,1.171472626,-2.981875555,0.002864884,0.011406588,N,-,,trna-dihydrouridine synthase 1,C:nucleus; F:tRNA dihydrouridine synthase activity; P:tRNA dihydrouridine synthesis; F:flavin adenine dinucleotide binding; C:mitochondrion; P:oxidation-reduction process,IPR013785 (G3DSA:3.20.20.GENE3D); IPR001269 (PFAM); IPR001269 (PANTHER); PTHR11082:SF5 (PANTHER); PTHR11082:SF5 (PANTHER); IPR001269 (PANTHER); SSF51395 (SUPERFAMILY),,
RL4_JR_02088,7303,10143,16936,0,0,2,0,0,2,0,4,5,0,4,0,0,7,0,144.8353959,1,-3.513336322,1.10854178,-3.169331447,0.0015279,0.008320836,61.87189815,1,-0.340854401,1.034231566,-0.329572615,0.741722918,0.840541802,176.9201412,1,-0.673546348,0.615447569,-1.094400859,0.273779207,0.412544975,146.552168,1,-2.404937938,0.85248677,-2.82108535,0.004786147,0.027100416,139.7408926,1,-1.464066049,0.781359239,-1.873742544,0.060965919,0.130310578,N,-,,pre-mRNA-splicing factor CWC22,F:RNA binding; C:U2-type spliceosomal complex,IPR003891 (SMART); IPR003890 (SMART); IPR003891 (PFAM); IPR016021 (G3DSA:1.25.40.GENE3D); PTHR18034:SF3 (PANTHER); PTHR18034 (PANTHER); IPR003891 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),,
RL4_JR_02089,2146,2090,2753,0,0,0,0,0,0,3,0,1,0,0,0,0,2,0,27.91616642,0,-2.905405382,1.19248655,-2.436426123,0.014833199,0.05206938,8.880299638,0,0.31486705,1.217146763,0.258692756,0.795872309,0.876314587,62.80309057,1,0.492051702,0.743861841,0.661482651,0.508302837,0.639945106,26.64568607,0,-2.763084609,1.192206054,-2.317623366,0.020469799,0.077654844,30.55189407,1,-0.761106031,0.984552102,-0.773047998,0.439493975,0.573437693,N,-,,dolichol phosphate-mannose biosynthesis regulatory,"F:transferase activity, transferring glycosyl groups; P:regulation of catalytic activity; C:integral component of endoplasmic reticulum membrane; P:dolichol metabolic process; F:enzyme regulator activity",IPR009914 (PFAM); PTHR15039 (PANTHER); PTHR15039:SF11 (PANTHER),,
RL4_JR_02090,7980,5799,5307,0,2,11,0,0,0,2,0,3,0,7,2,0,4,4,134.3471088,1,-0.040063946,0.551478569,-0.072648237,0.94208604,0.971622998,24.62324744,0,-1.156406499,1.224427541,-0.944446658,0.344941448,0.508149809,105.0669605,1,-0.65146744,0.69682545,-0.934907643,0.349835898,0.493480433,120.4930608,1,-0.362535111,0.567256548,-0.639102558,0.522756216,0.657422269,106.9900349,1,-0.2453127,0.574707372,-0.426848013,0.669490033,0.765007013,N,-,,Quino amine beta chain,,IPR015943 (G3DSA:2.130.10.GENE3D); IPR017986 (SUPERFAMILY),,
RL4_JR_02091,4672,3401,3242,0,0,1,0,0,0,0,0,0,0,1,0,0,0,2,49.051323,1,-2.654954719,1.156221926,-2.296232807,0.021662574,0.070267704,14.58143822,0,-0.400509919,1.231172919,-0.325307609,0.744948273,0.842969974,37.58475913,0,-3.04307281,1.203763891,-2.527964854,0.011472584,0.035826168,47.35165015,1,-2.518603055,1.158138751,-2.174698889,0.029652688,0.091669852,51.54377159,1,-1.425073303,0.979995401,-1.454163256,0.145901049,0.253810914,N,-,,phd finger domain-containing,P:cell division; P:chromatin organization; C:nucleus; F:zinc ion binding; F:metal ion binding; C:cellular_component; F:molecular_function,IPR001965 (SMART); IPR024610 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR10333:SF42 (PANTHER); IPR028651 (PANTHER); PTHR10333:SF42 (PANTHER); IPR019787 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY),,
RL4_JR_02092,747,662,1011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.644388961,0,-1.372169019,1.206950541,-1.136889186,0.255584613,0.43375479,3.06488451,0,1.849605831,1.279693655,1.445350474,0.148359467,0.274432479,7.979935265,0,-0.807580141,1.205970631,-0.669651582,0.503079924,0.63537689,9.207459865,0,-1.230171295,1.205423909,-1.020530027,0.307477156,0.453177957,7.901833413,0,-0.895963356,1.214395278,-0.737785606,0.460644742,0.59181494,N,-, Effector probability:0.855,hypothetical protein SPSK_07804,P:cell morphogenesis,no IPS match,,
RL4_JR_02093,1879,2236,2499,0,0,0,0,0,0,0,0,0,3,1,0,0,0,3,26.50610133,0,-2.830550755,1.195847204,-2.36698363,0.017933726,0.060009572,8.422867405,0,0.391184568,1.220995422,0.320381683,0.74867901,0.846203649,21.90357105,0,-2.264125738,1.194643692,-1.895230982,0.058061807,0.126794162,57.22104422,1,0.058088412,0.747248797,0.077736374,0.93803776,0.963639642,43.73407026,1,-0.111685421,0.849833201,-0.131420402,0.89544275,0.932081613,N,-,,hypothetical protein SPI_06616,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_02094,32728,25854,32092,8,2,3,0,0,0,0,4,1,0,3,0,0,10,1,469.856637,1,-1.980296444,0.605645735,-3.269727382,0.001076512,0.00628061,115.8154686,0,-3.390166461,1.194988188,-2.836987425,0.004554141,0.019409268,337.9168387,1,-2.896313631,0.676477335,-4.281464404,1.86E-05,0.000318593,358.1321429,1,-4.160930959,0.859171377,-4.842958074,1.28E-06,2.31E-05,341.4975103,1,-2.128548085,0.553404442,-3.846279361,0.000119925,0.000806703,N,-,,c2h2 finger domain containing,F:nucleic acid binding,IPR013087 (G3DSA:3.30.160.GENE3D); PTHR26374 (PANTHER); IPR007087 (PROSITE_PROFILES),,
RL4_JR_02095,676,570,621,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.464180532,0,-1.0024002,1.190425645,-0.84205192,0.399758892,0.591445963,2.391531607,0,2.20761575,1.295427971,1.704159396,0.088351313,0.183859372,6.188939971,0,-0.440699839,1.196955666,-0.368183928,0.712736094,0.805743707,7.138468797,0,-0.862801033,1.194387099,-0.722379732,0.470061044,0.611037113,6.086554434,0,-0.519497671,1.194415978,-0.434938648,0.663606961,0.760414268,N,-, Effector probability:0.835,---NA---,,no IPS match,,
RL4_JR_02096,566,913,903,0,0,4,0,0,0,0,0,1,0,0,0,0,0,0,24.85566581,1,1.3096532,0.81216647,1.612542807,0.106843873,0.232435283,3.033437587,0,1.864541017,1.301132666,1.433013763,0.151853904,0.279212574,14.39982069,1,0.168754484,1.214360036,0.138965775,0.889477194,0.930948735,9.117723318,0,-1.215827626,1.220889382,-0.995854042,0.319321068,0.465532874,7.811900331,0,-0.879360823,1.226943263,-0.716708628,0.473553901,0.60394675,N,-,,hypothetical protein CMQ_7742,,IPR022024 (PFAM),,
RL4_JR_02097,14924,21131,24476,0,0,14,0,0,2,0,1,0,0,4,0,0,1,0,296.2204101,1,-1.903651286,0.948614597,-2.006769969,0.044774162,0.122408717,95.575761,1,-1.160569383,0.998497664,-1.162315571,0.245107304,0.398080656,208.1289344,1,-4.495135594,1.208782926,-3.718728564,0.000200228,0.001758117,247.1793454,1,-3.193031996,0.79124448,-4.035455637,5.45E-05,0.000640112,202.2053818,1,-4.617774001,1.153383702,-4.00367544,6.24E-05,0.000468091,N,-,,ribosome biogenesis rlp24,"P:positive regulation of ATPase activity; P:ribosomal large subunit biogenesis; C:nucleolus; C:ribosome; P:assembly of large subunit precursor of preribosome; F:ATPase activator activity; C:preribosome, large subunit precursor",IPR011017 (SMART); IPR000988 (PFAM); IPR000988 (G3DSA:2.30.170.GENE3D); IPR024546 (PTHR10792:PANTHER); IPR000988 (PANTHER); SSF57716 (SUPERFAMILY),,
RL4_JR_02098,4392,4351,5482,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,56.85407347,0,-3.931539757,1.190938325,-3.301211887,0.000962682,0.005761963,18.09528395,0,-0.712053047,1.198837337,-0.593953012,0.552543541,0.698732639,47.03611464,0,-3.366744529,1.190197303,-2.828728079,0.004673339,0.017989689,54.26768776,0,-3.789236138,1.189918213,-3.184450912,0.001450289,0.010106109,65.06176824,1,-1.229404355,0.846088075,-1.453045364,0.146211159,0.254187498,N,-,,mitochondrial import inner membrane translocase subunit TIM14,P:protein import into mitochondrial matrix; P:positive regulation of ATPase activity; C:mitochondrion; C:integral component of membrane; F:protein transporter activity; F:ATPase activator activity,IPR001623 (SMART); IPR001623 (G3DSA:1.10.287.GENE3D); PTHR12763 (PANTHER); IPR001623 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_02099,729,1108,830,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,10.76079777,0,-1.529866449,1.22157757,-1.252369466,0.210435267,0.377713206,3.427223618,0,1.688522614,1.294086917,1.304798458,0.191961484,0.333787344,8.885685356,0,-0.962368179,1.215279924,-0.791890131,0.428424742,0.568984925,23.5751573,1,0.350682974,1.03923277,0.337444107,0.73578214,0.823808516,8.73882103,0,-1.041132895,1.217031082,-0.855469437,0.392291317,0.528747282,N,-,,QDE-2-interacting,F:nucleic acid binding; C:intracellular part; P:cellular process,PTHR28083 (PANTHER); PTHR28083:SF1 (PANTHER),,
RL4_JR_02100,713,985,718,0,2,4,0,0,0,0,0,0,3,0,0,0,3,0,41.03724403,1,1.907169428,0.657806557,2.899286133,0.003740134,0.017106769,3.110292305,0,1.828530173,1.298003321,1.408725343,0.158916398,0.288996008,8.052542698,0,-0.820294604,1.212617257,-0.676466213,0.498744691,0.631635132,37.22601391,1,1.110721124,0.871768367,1.274101202,0.202627553,0.334191883,19.49045538,1,1.292961355,0.873365596,1.480435412,0.138757086,0.24433019,N,-,,ku70 ku80 n-terminal alpha beta domain-containing,"F:nucleotide binding; F:telomeric DNA binding; P:DNA duplex unwinding; P:DNA recombination; C:cytosol; P:telomere maintenance; C:Ku70:Ku80 complex; F:ATP-dependent DNA helicase activity; P:double-strand break repair via nonhomologous end joining; F:damaged DNA binding; C:nuclear chromosome, telomeric region",IPR006164 (SMART); IPR014893 (G3DSA:1.25.40.GENE3D); IPR024193 (PIRSF); IPR006164 (PFAM); IPR016194 (G3DSA:2.40.290.GENE3D); IPR002035 (G3DSA:3.40.50.GENE3D); IPR014893 (PFAM); IPR005160 (G3DSA:1.10.1600.GENE3D); IPR005161 (PFAM); PTHR12604 (PANTHER); IPR024193 (PTHR12604:PANTHER); PTHR12604 (PANTHER); IPR024193 (PTHR12604:PANTHER); IPR002035 (SUPERFAMILY); IPR016194 (SUPERFAMILY); IPR014893 (SUPERFAMILY),,
RL4_JR_02101,1122,1190,1271,2,1,5,0,0,2,0,0,0,2,0,0,0,6,0,61.58789329,1,1.778834355,0.532947296,3.337730332,0.000844657,0.005212338,23.33387214,1,2.913145757,0.986911987,2.951778675,0.003159493,0.01603027,11.87640246,0,-1.381034198,1.190417785,-1.160125643,0.245997655,0.380225994,32.32578238,1,-0.063570525,1.00892279,-0.063008315,0.949759883,0.970365168,34.8708198,1,1.723822745,0.624283081,2.761283779,0.005757463,0.02011725,N,-,,hypothetical protein SPSK_07924,,IPR025423 (PFAM); PTHR23241 (PANTHER),9.A.55.2.1, the tmem205 (tmem205) family.
RL4_JR_02102,4494,3092,5041,5,6,0,0,1,0,0,0,0,0,0,0,0,4,0,148.5965358,1,0.808408182,0.822123475,0.983317234,0.325451331,0.514740588,54.36545413,1,0.388761318,1.123129516,0.346141128,0.729236656,0.83104407,41.63069115,0,-3.190631646,1.20348665,-2.651156659,0.008021662,0.027426988,48.02560211,0,-3.612953604,1.204927731,-2.998481579,0.002713286,0.017127192,56.57929935,1,-0.689343782,0.78980487,-0.872802648,0.382770656,0.518815648,N,-,,hypothetical protein SPBR_03288,,no IPS match,,
RL4_JR_02103,661,638,898,0,0,1,0,0,0,7,0,0,0,2,0,0,0,0,12.58692897,1,-0.28794316,1.154313783,-0.249449642,0.80301299,0.900849831,2.785963649,0,1.987269682,1.281867209,1.550292939,0.121071221,0.235352968,84.74214774,1,3.352726916,1.738153946,1.928901019,0.053743151,0.119502672,16.3910556,1,0.629447667,1.026468153,0.613216947,0.539732901,0.670856325,7.177668553,0,-0.757269204,1.210804528,-0.625426472,0.531691192,0.655230443,N,-,,DUF1295 domain-containing,C:membrane,IPR010721 (PFAM); PTHR32251:SF14 (PANTHER); PTHR32251 (PANTHER),9.B.115.1.5, the putative integral membrane steroid 5-reductase (sr) family.
RL4_JR_02104,1799,1442,1684,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,47.80928902,1,-0.076565328,0.842983393,-0.090826615,0.927630362,0.96537932,6.300681637,0,0.810025647,1.235408615,0.655674274,0.512033725,0.66300933,16.31114638,0,-1.838829594,1.192353309,-1.542185173,0.123028602,0.226092134,18.81384628,0,-2.260944783,1.190287776,-1.899494248,0.057499522,0.133681438,16.05083941,0,-1.91841131,1.192770392,-1.60836597,0.10775505,0.201965917,N,-,,dna topoisomerase iii,C:nucleus; F:DNA binding; P:mitotic DNA replication; C:site of double-strand break; C:mitochondrion; P:mitotic sister chromatid segregation; F:DNA topoisomerase type I activity; P:DNA topological change; C:RecQ helicase-Topo III complex; P:postreplication repair; P:maintenance of rDNA,IPR000380 (PRINTS); IPR003602 (SMART); IPR003601 (SMART); IPR006171 (SMART); IPR013497 (PFAM); IPR013824 (G3DSA:1.10.460.GENE3D); IPR006171 (PFAM); IPR013826 (G3DSA:1.10.290.GENE3D); IPR006171 (G3DSA:3.40.50.GENE3D); IPR000380 (PANTHER); PTHR11390:SF21 (PANTHER); IPR006171 (PROSITE_PROFILES); IPR023405 (SUPERFAMILY),3.A.7.7.1, the type iv (conjugal dna-protein transfer or virb) secretory pathway (ivsp) family.
RL4_JR_02105,6755,3408,5711,0,6,0,0,0,0,1,4,1,3,4,2,0,1,0,111.0392541,1,-0.515884709,0.980193776,-0.526308901,0.5986736,0.768219741,20.25477498,0,-0.874677221,1.239989594,-0.705390775,0.480567083,0.637439394,101.3179287,1,-0.108154415,0.670761462,-0.161241248,0.871903395,0.91895644,123.6585481,1,-0.0195415,0.583006482,-0.033518496,0.973261117,0.984893994,55.41348467,1,-2.674079514,1.155663903,-2.313890316,0.020673739,0.056083018,N,-,,Sin3 binding,C:cytoplasm,IPR018818 (PFAM); PTHR28164:SF1 (PANTHER); PTHR28164 (PANTHER),,
RL4_JR_02106,1380,1082,1414,0,0,22,0,0,0,9,3,12,12,25,2,0,23,6,99.46762871,1,2.605786408,1.088088368,2.394829763,0.016628084,0.056615987,4.94351077,0,1.159971249,1.24629284,0.930737313,0.351989463,0.515456792,213.9599589,1,3.925063203,0.365085316,10.75108483,5.86E-27,1.45E-24,246.0915097,1,4.056309499,0.34140208,11.88132627,1.48E-32,2.72E-30,145.6192247,1,3.742959848,0.462298407,8.096415199,5.66E-16,8.82E-14,N,-,,ph-response transcription factor pacc rim101,F:nucleic acid binding; P:response to abiotic stimulus; P:cellular component biogenesis; P:meiotic cell cycle process; P:cellular component organization; P:cellular response to stimulus; C:intracellular part; P:regulation of transcription from RNA polymerase II promoter,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY),,
RL4_JR_02107,12639,12882,16152,0,3,17,0,0,0,0,1,0,4,0,1,0,4,0,255.5454888,1,-0.632709361,0.572546189,-1.105080033,0.269124912,0.450178599,52.99634243,0,-2.262321568,1.190300616,-1.900630427,0.057350437,0.131632908,145.6399194,1,-3.955627414,1.191526009,-3.319799471,0.000900821,0.005296118,205.8703694,1,-2.2542854,0.670808901,-3.360547835,0.000777881,0.005989385,151.6148728,1,-2.404711811,0.770104502,-3.122578565,0.001792743,0.007719244,N,-,,wd tetratricopeptide repeat domain-containing,,G3DSA:2.170.270.10 (GENE3D); PTHR12197 (PANTHER); PTHR12197:SF128 (PANTHER); PTHR12197:SF128 (PANTHER); PTHR12197 (PANTHER); SSF82199 (SUPERFAMILY),,
RL4_JR_02108,4473,3580,3472,5,12,6,0,0,4,1,0,0,0,0,5,0,2,0,215.4656809,1,1.754741834,0.468688534,3.743940178,0.000181157,0.001414237,52.33826656,1,2.149029496,0.783128383,2.744159886,0.006066598,0.02345535,49.3393506,1,-2.107316128,1.196126333,-1.76178391,0.078105814,0.159810684,92.31069785,1,0.021264045,1.54435975,0.013768842,0.989014401,0.99348281,45.25871208,1,-1.475271148,0.975183333,-1.512814152,0.130326873,0.232562494,N,-,,4-nitrophenylphosphatase,P:4-nitrophenol catabolic process; F:phosphoprotein phosphatase activity; P:protein dephosphorylation; C:cytosol; F:alkaline phosphatase activity,IPR006357 (PFAM); PF13242 (PFAM); IPR006357 (PIRSF); IPR023215 (G3DSA:3.40.50.GENE3D); IPR023214 (G3DSA:3.40.50.GENE3D); PTHR19288:SF6 (PANTHER); PTHR19288 (PANTHER); PTHR19288:SF6 (PANTHER); IPR023214 (SUPERFAMILY),,
RL4_JR_02109,11906,7184,6643,0,1,4,0,2,0,0,0,0,1,2,0,0,1,1,125.9919567,1,-1.782474519,0.754437613,-2.362653304,0.018144635,0.060541486,109.9536668,1,0.124879762,1.031013768,0.121123273,0.903593395,0.945731811,85.52593947,0,-4.229297424,1.222526791,-3.459472181,0.000541235,0.003588386,115.9367051,1,-2.347755195,0.907445583,-2.587213205,0.00967557,0.04731088,94.75899465,1,-2.618908066,1.008041924,-2.598015027,0.009376439,0.029835464,N,-,,6-phosphogluconolactonase,C:nucleus; P:carbohydrate metabolic process; P:mycelium development; P:pentose-phosphate shunt; C:cytosol; F:6-phosphogluconolactonase activity,IPR006148 (PFAM); G3DSA:3.40.50.1360 (GENE3D); IPR005900 (TIGRFAM); PTHR11054:SF1 (PANTHER); PTHR11054 (PANTHER); PTHR11054 (PANTHER); SSF100950 (SUPERFAMILY),,
RL4_JR_02110,12,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.059578501,0,5.966391384,3.924634489,1.520241286,0.128450344,NA,0.02004641,0,9.107027569,3.923759247,2.320995503,0.020287087,0.058168209,0.05032591,0,6.502406857,2.479586791,2.62237518,0.008731925,0.029378933,0.057928398,0,6.082539977,3.924326801,1.549957556,0.121151704,0.225897426,0.047997702,0,6.463335231,1.836997167,3.51842417,0.000434118,0.002411104,N,-,,serine threonine kinase,F:transferase activity,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); PTHR24362 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.2, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_02111,39,30,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.376399142,0,3.307321706,2.26211875,1.462046016,0.143728601,NA,0.121469206,0,6.507097336,2.035300953,3.197118012,0.001388081,0.015023052,0.312757613,0,3.866490978,1.320681659,2.927647969,0.003415365,0.014889386,0.360631926,0,3.44441614,1.536803552,2.241285904,0.025007561,0.08557795,0.305886871,0,3.794198579,1.248037641,3.040131526,0.002364749,0.009764714,N,-, Effector probability:0.687,---NA---,,no IPS match,,
RL4_JR_02112,1759,1430,1792,1,0,4,1,0,1,0,1,1,1,4,1,0,8,0,45.21999514,1,0.626815503,0.663792537,0.94429429,0.345019283,0.535006141,38.04770548,1,2.452077787,0.984482174,2.490728478,0.01274815,0.040526625,30.82071034,1,-0.031454672,1.03139552,-0.030497196,0.975670529,0.986092487,54.00281658,1,1.034092089,0.614016953,1.684142569,0.092154119,0.184108219,47.12383209,1,1.648278905,0.562762333,2.928907655,0.003401555,0.013105305,N,-,,hypothetical protein SPI_06483,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_02113,59,51,43,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.613304661,0,2.603016974,1.804112005,1.442824484,0.14906992,NA,0.197331982,0,5.806993756,1.84317591,3.150536921,0.001629707,0.015023052,0.508959325,0,3.163908436,1.276181,2.479200392,0.01316773,0.040141554,0.586938522,0,2.741763804,1.382802917,1.982758187,0.047394447,0.11896902,0.49854946,0,3.089979377,1.229982845,2.512213394,0.011997652,0.036370126,N,-,,glutathione s-transferase,F:transferase activity,IPR012336 (G3DSA:3.40.30.GENE3D); IPR010987 (G3DSA:1.20.1050.GENE3D); IPR004045 (PFAM); PTHR11260:SF192 (PANTHER); PTHR11260 (PANTHER); IPR010987 (PROSITE_PROFILES); IPR004045 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR010987 (SUPERFAMILY),,
RL4_JR_02114,331,290,343,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11.86215318,1,0.90110357,1.140483945,0.790106318,0.429465681,0.620762052,1.231054588,0,3.165623417,1.366348367,2.316849417,0.020511936,0.058666803,3.191491293,0,0.514641138,1.20327649,0.42769982,0.668869681,0.772136448,3.681537619,0,0.092390765,1.203457057,0.076771135,0.938805614,0.963977274,3.144764901,0,0.433214046,1.200604906,0.360829815,0.718226673,0.801592269,N,-,,AGA1 A-agglutinin anchor subunit,,no IPS match,,
RL4_JR_02115,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_02116,633,472,691,3,0,0,0,0,0,0,0,1,0,0,0,0,0,0,37.34884213,1,1.399677532,0.856308917,1.634547422,0.102143957,0.225152771,2.284490734,0,2.273605111,1.305768593,1.741200641,0.081648415,0.172896497,12.42812757,1,0.582651722,1.200345669,0.485403278,0.627390308,0.73926579,6.840071842,0,-0.801396663,1.205279112,-0.664905461,0.506110963,0.642402915,5.853504727,0,-0.463148054,1.209974857,-0.382774941,0.701886643,0.78892121,N,-,,rRNA-processing efg1,P:biological_process,no IPS match,,
RL4_JR_02117,2098,2923,3959,0,0,4,0,0,0,0,0,0,0,2,0,0,0,0,51.21036003,1,-0.605527824,0.825229959,-0.733768591,0.463089787,0.651247454,11.34021417,0,-0.037910602,1.237404129,-0.030637203,0.975558872,0.987312443,29.63520249,0,-2.700285575,1.215746938,-2.221091817,0.026344743,0.069312417,42.22673927,1,-1.413401359,1.053755661,-1.341298948,0.179823411,0.305181368,29.42935072,0,-2.792948114,1.227778341,-2.274798325,0.022918031,0.060776601,N,-,,rRNA-processing efg1,"P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:nucleus; P:regulation of G1/S transition of mitotic cell cycle; P:rRNA processing; C:nucleolus",IPR019310 (PFAM); PTHR33911 (PANTHER),,
RL4_JR_02118,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,Y,-,,---NA---,,no IPS match,,
RL4_JR_02119,31,30,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.380071504,0,3.293300379,2.227268732,1.478627312,0.139239949,NA,0.121290715,0,6.508959846,2.006134087,3.244528812,0.001176451,0.015023052,0.314655477,0,3.857005248,1.294258072,2.980089775,0.002881639,0.01321872,0.362990945,0,3.434754913,1.496187775,2.295671018,0.021694699,0.07993407,0.310182901,0,3.7752117,1.234998237,3.056855942,0.002236717,0.009327333,N,-,,---NA---,,no IPS match,,
RL4_JR_02120,26,29,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.305865296,0,3.606768002,2.474943686,1.457313159,0.145029956,NA,0.098098165,0,6.815389825,2.112089496,3.226847082,0.001251623,0.015023052,0.253319559,0,4.171021755,1.331401069,3.132806375,0.001731436,0.008830684,0.292167858,0,3.748280067,1.610246022,2.327768562,0.019924396,0.076714457,0.248241687,0,4.096750344,1.248692329,3.280832476,0.001035012,0.004917643,N,-,,wd repeat domain-containing,C:cytoplasmic part,IPR031488 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR16453:SF9 (PANTHER); PTHR16453 (PANTHER); PTHR16453:SF9 (PANTHER); IPR017986 (SUPERFAMILY),,
RL4_JR_02121,699,946,856,0,2,0,0,0,0,0,1,0,1,0,0,0,0,0,26.07860941,1,0.319061772,1.022796637,0.311950353,0.755078254,0.871646866,3.200420554,0,1.787275331,1.279830633,1.396493633,0.162565897,0.294363507,16.15190512,1,0.096222885,1.200437717,0.080156499,0.936112788,0.961689995,18.8986442,1,-0.337387026,1.152730854,-0.292684997,0.769762939,0.850299995,8.188384185,0,-0.947259404,1.207142384,-0.78471224,0.432622305,0.567249525,N,-,,trna 2 -phosphotransferase 1,F:transferase activity,IPR002745 (PFAM); PTHR12684:SF2 (PANTHER); PTHR12684 (PANTHER); SSF56399 (SUPERFAMILY),,
RL4_JR_02122,10550,5012,5145,3,12,15,10,0,0,0,3,3,0,1,0,0,0,2,265.9952721,1,1.17093118,0.523224377,2.237914043,0.025226661,0.079265733,249.9307677,1,3.059298879,1.877050141,1.629843984,0.103134475,0.20737528,111.7850849,1,-0.529797557,0.71066787,-0.745492486,0.455974052,0.594619836,83.27052633,1,-3.392425254,1.204457316,-2.816559134,0.004854111,0.027365184,81.78913749,1,-2.263496734,1.029910073,-2.197761527,0.027966104,0.071162807,N,-,,lpxtg-motif cell wall anchor domain-containing,"P:biological_process; P:tRNA splicing, via endonucleolytic cleavage and ligation; F:transferase activity, transferring phosphorus-containing groups; C:cellular_component; F:molecular_function",no IPS match,1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_02123,4076,2306,2388,0,3,3,0,0,0,2,0,0,0,3,0,0,3,1,70.43945067,1,0.082448115,0.687372305,0.11994681,0.904525283,0.953456484,11.32124457,0,-0.035412912,1.263551219,-0.028026495,0.977641019,0.988344851,51.25079577,1,-0.828651832,1.063649948,-0.779064422,0.435941767,0.576397342,45.59686663,1,-0.826232788,0.917445779,-0.900579421,0.367811981,0.514306906,47.40644296,1,-0.142955381,0.799308305,-0.178848862,0.858056377,0.905736116,N,-,,tyrosine- phosphatase pmp1,F:MAP kinase phosphatase activity; P:regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion; P:protein dephosphorylation; P:cellular response to stimulus; C:intracellular part; F:protein tyrosine/serine/threonine phosphatase activity,IPR020422 (SMART); IPR000340 (PFAM); IPR029021 (G3DSA:3.90.190.GENE3D); PTHR10159:SF343 (PANTHER); IPR024950 (PANTHER); IPR024950 (PANTHER); IPR000387 (PROSITE_PROFILES); IPR020422 (PROSITE_PROFILES); IPR029021 (SUPERFAMILY),,
RL4_JR_02124,2878,2686,3606,0,2,3,0,0,1,0,0,1,0,0,0,0,1,0,64.08529146,1,-0.251471554,0.675544534,-0.37225015,0.709706611,0.843500368,21.03083779,1,0.839944728,1.11584903,0.752740474,0.451605883,0.611669528,36.79415271,1,-1.770309282,1.192004438,-1.485153263,0.137503229,0.245864128,34.95323388,0,-3.154597003,1.191916717,-2.646658913,0.00812913,0.041071578,33.80538654,1,-1.888291113,1.128966368,-1.672584026,0.094409214,0.182841103,N,-,,udp-glc gal endoplasmic reticulum nucleotide sugar transporter,F:UDP-galactose transmembrane transporter activity; P:UDP-glucose transport; P:UDP-galactose transmembrane transport; C:integral component of membrane; C:endoplasmic reticulum,IPR013657 (PFAM); PTHR10778:SF10 (PANTHER); PTHR10778 (PANTHER); PTHR10778 (PANTHER); SSF103481 (SUPERFAMILY),2.A.7.11.6, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_02125,24253,22719,27324,0,2,3,0,0,0,0,4,1,2,11,3,0,8,5,324.4520537,1,-3.270155698,0.667168645,-4.901542847,9.51E-07,1.45E-05,94.73018909,0,-3.100239037,1.186802939,-2.612261004,0.008994556,0.031125775,283.743859,1,-2.608472847,0.667229018,-3.909411574,9.25E-05,0.001112452,375.3066074,1,-1.459975073,0.396060334,-3.686244106,0.000227588,0.00214157,310.2566162,1,-1.52833236,0.464387355,-3.291072299,0.000998063,0.004777959,N,-,,kh domain RNA-binding,"P:3'-UTR-mediated mRNA stabilization; F:mRNA 3'-UTR AU-rich region binding; P:intracellular mRNA localization; P:negative regulation of MAPK cascade; C:cytoplasmic mRNA processing body; C:cytosol; P:telomere maintenance via telomerase; C:nuclear chromosome, telomeric region",IPR004087 (SMART); IPR004088 (PFAM); IPR004088 (G3DSA:3.30.1370.GENE3D); IPR004088 (G3DSA:3.30.1370.GENE3D); IPR004088 (G3DSA:3.30.1370.GENE3D); PTHR10288 (PANTHER); PTHR10288:SF102 (PANTHER); IPR004088 (PROSITE_PROFILES); IPR004088 (PROSITE_PROFILES); IPR004088 (PROSITE_PROFILES); IPR004088 (SUPERFAMILY); IPR004088 (SUPERFAMILY); IPR004088 (SUPERFAMILY),,
RL4_JR_02126,1530,1045,1185,0,0,0,0,0,0,3,3,1,0,1,0,0,0,3,15.00010175,0,-2.009328084,1.19972104,-1.674829412,0.093967706,0.211569999,4.82694608,0,1.194442126,1.26718863,0.942592206,0.345889528,0.509101905,75.69957906,1,2.194522188,0.592581643,3.703324622,0.000212792,0.001819872,18.38301497,1,-0.92598336,1.156017889,-0.801011272,0.42312512,0.566161205,34.32806971,1,0.712043722,0.85141062,0.836310594,0.402980195,0.540062802,N,-,,serine threonine- kinase ppk6,,PTHR42084 (PANTHER),,
RL4_JR_02127,1050,1139,1147,1,0,3,0,0,0,0,0,2,2,1,0,0,3,1,34.89692902,1,0.879600624,0.738295524,1.191393684,0.233499071,0.406939847,4.267501763,0,1.37214523,1.248017543,1.09945989,0.27156752,0.429247862,24.0647157,1,0.54144926,1.030086956,0.525634517,0.599142169,0.717921094,35.40352645,1,0.61845772,0.845657982,0.731333155,0.464575684,0.606397937,29.84847113,1,1.259928573,0.74456678,1.692163293,0.090614843,0.177289911,N,-,,WD repeat domain-containing,P:biological_process; C:cellular_component; F:molecular_function,IPR000195 (SMART); IPR000195 (PFAM); G3DSA:1.10.8.270 (GENE3D); PTHR22957:SF28 (PANTHER); PTHR22957 (PANTHER); PTHR22957 (PANTHER); PTHR22957 (PANTHER); PTHR22957:SF28 (PANTHER); PTHR22957:SF28 (PANTHER); PTHR22957 (PANTHER); IPR000195 (PROSITE_PROFILES); IPR000195 (SUPERFAMILY); IPR000195 (SUPERFAMILY),,
RL4_JR_02128,1831,1608,1448,1,1,5,0,0,1,0,0,0,1,0,0,0,1,0,56.74907835,1,1.129366795,0.581405886,1.942475682,0.052079541,0.137230264,15.66894577,1,1.727998204,1.135755722,1.521452342,0.128146362,0.244781558,16.24233996,0,-1.832632575,1.19745225,-1.530443135,0.125907079,0.230087232,28.04438475,1,-1.304450688,1.147779449,-1.136499428,0.255747605,0.395036943,19.79048583,1,-0.977308448,1.1230344,-0.870239102,0.384169751,0.520224519,N,-,,f-box domain containing,,IPR006553 (SMART); IPR001810 (SMART); IPR001611 (PFAM); IPR001810 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR24006 (PANTHER); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY); SSF52047 (SUPERFAMILY),,
RL4_JR_02129,5851,4585,4055,0,4,3,0,0,0,2,1,1,2,2,12,0,0,0,101.5033721,1,-0.416842212,0.606804632,-0.686946324,0.492116554,0.679825704,18.6916465,0,-0.758771173,1.224755598,-0.619528643,0.535568159,0.683264546,84.65940577,1,-0.568851947,0.759848149,-0.748638985,0.454074828,0.593351743,197.827048,1,1.224370165,0.716823394,1.708049954,0.087627074,0.177338422,47.1736942,0,-3.473717583,1.198647095,-2.898031955,0.003755123,0.01417622,N,-,,serine threonine- kinase ppk6,F:protein kinase activity; P:phosphorylation,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); PTHR22971:SF0 (PANTHER); PTHR22971 (PANTHER); PTHR22971:SF0 (PANTHER); PTHR22971 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.2, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_02130,1343,1023,1483,1,2,1,1,0,0,0,0,6,0,0,0,0,0,0,45.23692247,1,0.700220453,0.747824918,0.936342767,0.349096735,0.539278767,27.20747176,1,2.099045847,1.11967069,1.874699289,0.060834105,0.137600628,51.70071436,1,1.91106949,0.634291139,3.012921627,0.002587457,0.012155646,14.6603255,0,-1.901153678,1.198149271,-1.586741923,0.112571107,0.213882991,12.54689217,0,-1.563074705,1.204912299,-1.297251847,0.194544547,0.315510768,N,-,,phosphoglycerate mutase,C:membrane; C:integral component of membrane,IPR013078 (SMART); IPR029033 (G3DSA:3.40.50.GENE3D); IPR013078 (PFAM); PTHR16469 (PANTHER); PTHR16469 (PANTHER); PTHR16469:SF27 (PANTHER); IPR029033 (SUPERFAMILY),,
RL4_JR_02131,719,374,695,0,2,1,0,0,0,0,0,1,3,2,1,0,0,0,26.92792271,1,1.399172229,0.897752336,1.558528085,0.119108116,0.250821892,2.272690594,0,2.281078502,1.349424796,1.690408023,0.090949921,0.188068458,12.38892634,1,0.592277831,1.224576947,0.483659138,0.628627797,0.740026491,52.38911495,1,2.561161962,0.675510808,3.791444832,0.000149773,0.001507411,5.811546109,0,-0.452804776,1.238599282,-0.365578103,0.714679917,0.798823481,N,-,,hypothetical protein CMQ_7275,P:biological_process; C:cellular_component,no IPS match,,
RL4_JR_02132,1961,1957,3061,0,0,6,0,0,0,0,0,0,0,0,0,0,1,0,50.7366198,1,0.339520536,0.686426482,0.494620393,0.620868104,0.782245868,8.814530155,0,0.325563256,1.232407781,0.264168452,0.791650119,0.873795221,22.99588392,0,-2.334392398,1.206416701,-1.934980174,0.052992729,0.118327831,26.53674515,0,-2.757170098,1.207313668,-2.283723088,0.02238781,0.080726669,26.67515607,1,-1.497391632,1.14820878,-1.30411094,0.192195759,0.31240001,N,-,,Transcription factor Iwr1,,IPR013883 (PFAM); PTHR28063 (PANTHER),,
RL4_JR_02133,69,89,105,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.053874877,0,1.821999878,1.479709755,1.231322475,0.218202279,NA,0.333981443,0,5.047584157,1.661094888,3.038709103,0.002375942,0.015223444,0.870090971,0,2.389536937,1.2520465,1.908504944,0.056325985,0.123777788,1.004037681,0,1.96689536,1.301160704,1.511646759,0.13062375,0.239551796,0.861123866,0,2.302416218,1.235635342,1.863346037,0.062413597,0.132760015,N,-,,dienelactone hydrolase family,F:organic cyclic compound binding; F:heterocyclic compound binding; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR002925 (PFAM); PTHR17630:SF43 (PANTHER); PTHR17630 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_02134,3727,4616,8397,0,1,1,3,0,0,3,0,0,1,5,3,0,0,1,78.51800095,1,-2.423994078,1.086012952,-2.232012125,0.025614162,0.080232021,87.90063295,1,1.345546017,0.894170184,1.504798574,0.132375871,0.250597551,88.19101067,1,-1.138252623,0.907413798,-1.254392015,0.209699553,0.337284237,121.7432901,1,-0.1174065,0.617067783,-0.190265159,0.849101354,0.905535202,62.20810282,1,-2.745896455,1.178734481,-2.329529254,0.019831045,0.054252724,N,-,,atp-dependent rna helicase mrh-4,F:nucleic acid binding; F:ATP binding; P:RNA secondary structure unwinding; P:rRNA processing; F:ATP-dependent RNA helicase activity,IPR014001 (SMART); IPR001650 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR011545 (PFAM); PTHR24031:SF325 (PANTHER); PTHR24031 (PANTHER); PTHR24031:SF325 (PANTHER); PTHR24031 (PANTHER); PTHR24031 (PANTHER); IPR014014 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_02135,3424,4450,4233,0,15,23,7,0,0,4,4,2,1,12,0,0,19,6,256.6248039,1,2.147622708,0.682061578,3.148722602,0.001639858,0.008847857,171.6604653,1,3.329823739,1.533538353,2.171333852,0.029905945,0.078844193,128.8417647,1,1.018468803,0.500643886,2.034317869,0.041919557,0.099180554,103.8233782,1,0.764271676,0.514880466,1.4843672,0.137711531,0.249477412,157.1705104,1,1.927617331,0.444695269,4.334692686,1.46E-05,0.00013812,N,-,,coiled-coil domain-containing 55,C:cellular_component; F:molecular_function,IPR032640 (PFAM); IPR018612 (PFAM); PTHR31938 (PANTHER); IPR014756 (SUPERFAMILY),,
RL4_JR_02136,2090,2353,4432,0,2,1,0,0,0,2,0,0,0,0,2,0,1,0,55.16476619,1,-0.911428879,0.927724639,-0.982434702,0.325885737,0.515028254,11.11783736,0,-0.0093569,1.255869711,-0.007450534,0.994055389,0.997109171,51.28081781,1,-0.826080198,1.072299772,-0.770381771,0.441073463,0.58113323,52.9077177,1,-1.320438802,1.068289619,-1.236030734,0.21644714,0.351150023,32.91731886,1,-1.848567218,1.178956551,-1.567968909,0.116888388,0.214868361,N,-,,mitochondrial import inner membrane translocase subunit tim13,,IPR004217 (PFAM); IPR004217 (G3DSA:1.10.287.GENE3D); PTHR19338 (PANTHER); IPR004217 (SUPERFAMILY),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_02137,1849,2423,2607,3,0,7,0,0,0,2,2,3,0,9,0,0,8,1,84.52596111,1,1.137214792,0.536228581,2.120764973,0.033941586,0.09967439,8.759458282,0,0.334655797,1.225952796,0.272976087,0.784871597,0.869397316,80.11386054,1,1.31065206,0.586986887,2.232847257,0.025559019,0.067702644,62.40307075,1,1.068579691,0.577239996,1.851187891,0.064142527,0.14242173,60.77235805,1,1.328588931,0.568133223,2.338516526,0.019360469,0.053296561,N,-, Effector probability:0.643,mannose-binding 2,C:fungal-type vacuole membrane; C:integral component of membrane; C:endoplasmic reticulum; C:Golgi apparatus; F:carbohydrate binding,IPR013320 (G3DSA:2.60.120.GENE3D); IPR005052 (PFAM); PTHR12223 (PANTHER); PTHR12223:SF28 (PANTHER); IPR005052 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),,
RL4_JR_02138,3504,3265,3247,1,0,1,0,0,1,0,0,1,0,0,2,0,0,0,53.99784126,1,-1.693316006,1.003918646,-1.6867064,0.091659821,0.207751511,22.22370039,1,0.699261833,1.118173695,0.625360654,0.53173438,0.680001945,39.73952853,1,-1.904069045,1.187822606,-1.602991082,0.108936623,0.206608162,57.61205001,1,-1.547601882,1.009575342,-1.532923615,0.125294677,0.232005962,32.67848371,0,-2.944063976,1.185754951,-2.48286037,0.013033216,0.038857867,N,-,,camp-dependent kinase catalytic subunit,C:nucleus; F:ATP binding; P:negative regulation of induction of conjugation with cellular fusion; P:cellular age-dependent response to reactive oxygen species; C:cytosol; F:cAMP-dependent protein kinase activity; P:negative regulation of transcription by glucose; P:protein phosphorylation; P:signal transduction involved in regulation of aerobic respiration; C:vacuole; C:cAMP-dependent protein kinase complex,IPR000719 (SMART); IPR000961 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); PTHR24353 (PANTHER); IPR000961 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.1, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_02139,461,624,816,0,0,3,0,0,0,0,0,0,0,6,0,0,5,0,19.06537325,1,1.241971473,0.908850976,1.366529284,0.171772896,0.32543504,2.404379871,0,2.199766055,1.315211141,1.672557346,0.09441447,0.193616642,6.27770679,0,-0.461360337,1.221148496,-0.377808545,0.705572825,0.800091765,31.31458056,1,2.357326216,0.68780925,3.427296474,0.000609623,0.004906545,25.53079264,1,2.324799672,0.75642228,3.073415119,0.002116239,0.008876105,N,-,,Magnesium transport,P:transmembrane transport; C:integral component of membrane; F:metal ion transmembrane transporter activity; P:metal ion transport,G3DSA:1.20.58.340 (GENE3D); PTHR21535 (PANTHER); PTHR21535 (PANTHER); PTHR21535:SF43 (PANTHER); SSF144083 (SUPERFAMILY),,
RL4_JR_02140,7494,11876,7277,0,0,22,3,0,2,0,1,2,0,11,1,0,1,1,191.8151069,1,-0.212202862,1.160449105,-0.182862705,0.854905747,0.92758379,120.1100192,1,1.322269854,0.735588882,1.797566395,0.072245748,0.157445353,109.8803535,1,-1.890704046,0.893956048,-2.114985464,0.034431186,0.085352921,156.4761377,1,-0.556256916,0.620450458,-0.8965372,0.369965922,0.515623545,98.55210226,1,-2.682891148,1.009222762,-2.6583736,0.00785188,0.025845346,N,-,,3-isopropylmalate dehydrogenase leu2a,P:biological_process; F:zinc ion binding; F:metal ion binding,IPR001965 (SMART); IPR019787 (PFAM); IPR028012 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR28125:SF2 (PANTHER); PTHR28125 (PANTHER); PTHR28125:SF2 (PANTHER); PTHR28125 (PANTHER); IPR019787 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY); SSF53659 (SUPERFAMILY),,
RL4_JR_02141,2326,1636,2367,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,25.19865824,0,-2.757717377,1.196629883,-2.304570039,0.021190666,0.068956302,8.061736258,0,0.4544096,1.2343721,0.368130161,0.712776183,0.819947781,20.90235601,0,-2.196674863,1.199761291,-1.830926601,0.067111499,0.14205244,43.05854654,1,-0.869781876,1.022928547,-0.850286052,0.395166069,0.539444041,20.61408406,0,-2.279376099,1.204245732,-1.892783207,0.058386706,0.125833417,N,-,,hypothetical protein SPI_06659,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_02142,119,46,137,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.191213355,0,1.6449658,1.588830706,1.035331074,0.300514323,NA,0.380489276,0,4.859416609,1.72754197,2.81290799,0.00490957,0.020375016,0.989665516,0,2.203363048,1.327645747,1.659601631,0.09699462,0.189680033,1.141686926,0,1.781243122,1.399297413,1.272955345,0.203033888,0.334698489,0.981053729,0,2.113532164,1.312871319,1.609854777,0.107429564,0.201654492,N,-,,phosphotransferase enzyme family,P:phosphorylation; F:transferase activity; F:kinase activity,G3DSA:3.90.1200.10 (GENE3D); IPR002575 (PFAM); PTHR21310:SF18 (PANTHER); PTHR21310 (PANTHER); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_02143,6,60,15,0,2,0,0,0,0,0,0,0,1,4,0,0,0,2,16.35601551,1,5.390837877,1.398940193,3.853515615,0.000116434,0.000971234,0.105925275,0,6.704730802,2.415456786,2.775761024,0.005507267,0.021974647,0.274698631,0,4.054214133,1.673046757,2.423252139,0.015382246,0.045402292,25.6756424,1,6.540332873,1.076028719,6.078214048,1.22E-09,3.93E-08,14.99970529,1,5.882744965,1.699091425,3.462288654,0.000535602,0.002864751,Y,-,,Zinc-regulated transporter 1,P:transmembrane transport; C:membrane; C:integral component of membrane; F:metal ion transmembrane transporter activity; P:metal ion transport,IPR003689 (PFAM); PTHR11040 (PANTHER); PTHR11040:SF44 (PANTHER),2.A.5.1.15, the zinc (zn(2+))-iron (fe(2+)) permease (zip) family.
RL4_JR_02144,19,11,14,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0.175124879,0,4.411067996,3.152417135,1.399265328,0.161733433,NA,0.056457614,0,7.612326746,2.362568765,3.222055104,0.001272747,0.015023052,0.145661313,0,4.968010577,1.408317053,3.527622255,0.00041931,0.002979014,8.191143847,1,6.258358614,1.068535947,5.856947193,4.71E-09,1.40E-07,0.142937684,0,4.890581138,1.275498675,3.834250268,0.000125948,0.000841731,Y,-,,hypothetical protein FVEG_12048,,no IPS match,,
RL4_JR_02145,5789,5256,5539,0,0,6,0,0,0,1,0,0,0,6,0,0,0,0,89.2763367,1,-0.854804106,0.605854444,-1.410906719,0.158272121,0.307508978,21.24028575,0,-0.943192499,1.199690512,-0.786196514,0.431752368,0.5935349,66.06429751,1,-2.630420517,1.186995098,-2.216033176,0.02668923,0.070056485,87.50400877,1,-0.71642007,0.611872503,-1.170864954,0.241653064,0.380105216,54.10164113,0,-3.671394088,1.185197706,-3.097706037,0.001950248,0.008303725,N,-,,chromatin remodeling complex subunit,P:chromatin remodeling; F:ATP-dependent 3'-5' DNA helicase activity; P:DNA duplex unwinding; C:cytosol; F:mRNA binding; C:Ino80 complex; P:mitotic recombination; P:double-strand break repair,IPR004000 (SMART); IPR004000 (PFAM); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR027668 (PTHR11937:PANTHER); IPR004000 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_02146,6635,5281,4189,3,7,0,0,0,0,0,3,0,0,3,0,0,2,6,150.8042882,1,0.265904272,0.829276813,0.320645975,0.748478693,0.86832895,20.82778544,0,-0.914887768,1.231211661,-0.743079193,0.457433736,0.616486404,77.14575143,1,-1.145923971,0.879561593,-1.30283539,0.192630966,0.316333479,73.8586438,1,-1.695524119,0.894934721,-1.894578543,0.05814826,0.134694836,104.3343538,1,0.036327001,0.590595164,0.061509142,0.950953734,0.968191019,N,-,,phospholipase c,P:single-organism process,IPR001192 (PRINTS); IPR001711 (SMART); IPR000909 (SMART); IPR000008 (G3DSA:2.60.40.GENE3D); IPR017946 (G3DSA:3.20.20.GENE3D); IPR000909 (PFAM); IPR001711 (PFAM); IPR001192 (PANTHER); PTHR10336:SF82 (PANTHER); IPR001192 (PANTHER); PTHR10336:SF82 (PANTHER); PTHR10336:SF82 (PANTHER); IPR001192 (PANTHER); IPR001711 (PROSITE_PROFILES); IPR000909 (PROSITE_PROFILES); IPR017946 (SUPERFAMILY); IPR000008 (SUPERFAMILY),,
RL4_JR_02147,71913,65517,58576,52,117,11,0,0,5,11,0,18,13,13,5,2,23,7,2288.252371,1,0.92930511,0.923285563,1.006519703,0.314165638,0.50224638,299.1056788,1,-1.635245001,0.725271292,-2.254666658,0.02415426,0.066727462,890.233731,1,-1.461553916,0.721348421,-2.026141422,0.042750294,0.100394923,972.7614152,1,-1.840899098,0.37821273,-4.867364195,1.13E-06,2.06E-05,811.5550143,1,-1.703132804,0.416439557,-4.089747905,4.32E-05,0.000342665,Y,-,,hypothetical protein CMQ_7259,C:cell wall; F:structural constituent of cell wall,no IPS match,,
RL4_JR_02148,4499,4135,5734,2,2,2,0,0,1,2,0,3,2,12,0,0,2,0,101.1230216,1,-0.613799132,0.625760098,-0.980885701,0.326649109,0.516034747,27.62145748,1,0.19334243,1.114364847,0.173500116,0.862258337,0.919584753,89.08218932,1,-0.233099,0.674272992,-0.345704192,0.729565033,0.817500431,121.5050845,1,0.66875373,0.467816417,1.429521724,0.152854336,0.26980103,54.63779774,1,-1.8006249,0.985598381,-1.826935732,0.067709433,0.14141048,N,-,,1-acylglycerol-3-phosphate acyltransferase,F:1-acylglycerol-3-phosphate O-acyltransferase activity; C:intracellular organelle; C:integral component of membrane; P:phospholipid biosynthetic process,IPR002123 (SMART); G3DSA:3.40.1130.10 (GENE3D); IPR004552 (TIGRFAM); IPR002123 (PFAM); PTHR10434 (PANTHER); PTHR10434:SF11 (PANTHER); SSF69593 (SUPERFAMILY),,
RL4_JR_02149,2604,2468,2268,0,6,3,0,0,0,0,0,1,0,3,1,0,2,0,88.9407102,1,0.93065364,0.516875697,1.800536657,0.071775941,0.174080178,9.432365782,0,0.227942433,1.22388838,0.186244462,0.852253058,0.912278496,30.88541154,1,-1.457179574,1.191232483,-1.223253727,0.221233879,0.35089641,49.79743979,1,-0.117317856,0.74455909,-0.157566884,0.8747981,0.922643664,31.66792426,1,-0.824426856,0.968606892,-0.851147006,0.394687697,0.531411294,N,-,,duf2347 superfamily,,IPR028115 (PFAM); IPR018626 (PFAM); PTHR28153 (PANTHER),,
RL4_JR_02150,6093,17217,10570,17,37,8,0,0,1,4,4,12,20,40,13,0,4,8,635.7673722,1,1.83328894,0.81828948,2.240391677,0.025065506,0.07891676,52.92579781,1,-1.067238085,1.187827045,-0.898479361,0.368930043,0.533244309,266.8930223,1,0.475366004,0.559739592,0.849262784,0.395735085,0.538569969,602.6677931,1,1.855194266,0.477336637,3.886553266,0.000101678,0.001083543,185.9317011,1,-0.464178275,0.708965906,-0.654725808,0.512644306,0.638597884,N,-,,Potential stress response,P:filamentous growth of a population of unicellular organisms in response to biotic stimulus; P:cellular response to oxidative stress; P:filamentous growth of a population of unicellular organisms in response to starvation; P:cellular response to starvation; C:hyphal cell wall; C:cell surface,no IPS match,9.B.133.1.1, the ice nucleation protein secretion system (inp-ss) family.
RL4_JR_02151,31,31,21,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,11.78952793,1,5.765408799,0.903686549,6.379876747,1.77E-10,5.83E-09,0.107455869,0,6.683998398,2.085206805,3.205436689,0.001348577,0.015023052,0.276877954,0,4.042765934,1.333050873,3.032716918,0.002423628,0.011546736,0.319292401,0,3.620230039,1.586956242,2.281241249,0.022534175,0.080907954,0.270745568,0,3.971054868,1.252109543,3.171491576,0.001516583,0.006734824,Y,-,,---NA---,,no IPS match,,
RL4_JR_02152,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,peroxin 8,F:acetyltransferase activity; F:transferase activity,PTHR39214 (PANTHER),,
RL4_JR_02153,293,324,294,0,0,4,0,0,0,0,0,1,0,0,0,0,0,0,18.9316965,1,2.73858179,0.749460693,3.654069943,0.000258116,0.001916023,1.168668547,0,3.240707002,1.379710392,2.348831335,0.018832435,0.054904236,9.525631413,1,1.55330655,1.1959355,1.298821341,0.194005249,0.318125873,3.49165982,0,0.169113141,1.209019539,0.139876268,0.888757752,0.931638858,2.97681601,0,0.512584533,1.201397834,0.426656781,0.669629334,0.765007013,N,-,,integral membrane,C:integral component of membrane,IPR019334 (PFAM); PTHR22779:SF6 (PANTHER); PTHR22779 (PANTHER),8.A.70.1.5,The Endomembrane Morphogenesis TMEM170A (TMEM170A) Family
RL4_JR_02154,455,648,696,1,0,0,0,0,0,0,0,2,0,0,0,0,1,0,17.28768291,1,-0.002284462,1.165696303,-0.001959741,0.998436354,0.999539057,2.288451884,0,2.271108318,1.312117188,1.73087308,0.083474404,0.175880083,18.9574614,1,1.429189678,1.051564945,1.359107381,0.174112564,0.293199535,6.877526663,0,-0.809074849,1.215148705,-0.665823735,0.505523772,0.642050702,9.754949885,1,0.45526026,1.148693969,0.396328589,0.691862639,0.781558543,N,-,,galactoside O-acetyltransferase,F:acetyltransferase activity,IPR024688 (SMART); IPR001451 (PFAM); IPR024688 (PFAM); G3DSA:2.160.10.10 (GENE3D); PTHR23416 (PANTHER); PTHR23416 (PANTHER); PTHR23416:SF54 (PANTHER); IPR011004 (SUPERFAMILY),,
RL4_JR_02155,513,491,620,1,0,0,0,0,0,0,2,2,0,0,0,0,0,0,16.55438347,1,0.149251047,1.143237512,0.130551215,0.896130337,0.948632537,2.066810553,0,2.418073565,1.302139954,1.856999747,0.06331119,0.141997755,34.05351539,1,2.584086093,0.742148856,3.481897295,0.000497875,0.003376986,6.195566978,0,-0.658593432,1.197109602,-0.550152994,0.582214441,0.708134489,5.303548313,0,-0.320707303,1.202864875,-0.26661956,0.789762094,0.856781443,N,-,,isoprenylcysteine carboxyl methyltransferase,P:protein metabolic process; C:endoplasmic reticulum; F:methyltransferase activity; C:membrane part; C:intracellular organelle part; P:methylation,IPR007269 (PFAM); PTHR12714 (PANTHER); IPR025770 (PROSITE_PROFILES),9.B.115.1.8, the putative integral membrane steroid 5-reductase (sr) family.
RL4_JR_02156,2375,1953,2044,0,0,4,0,0,0,0,0,0,0,2,0,4,0,1,40.75364614,1,-0.057930061,0.740885226,-0.078190331,0.937676653,0.969307326,8.17493323,0,0.434344628,1.229033057,0.353403536,0.723785935,0.826880501,21.13555463,0,-2.212596174,1.192596292,-1.855276751,0.063556716,0.136468335,32.40000082,1,-0.908678981,1.016572904,-0.893865042,0.371394104,0.517169335,92.22999288,1,1.484807176,1.331166249,1.115418286,0.264671217,0.396830457,N,-,,mboat family,C:endoplasmic reticulum membrane; C:integral component of membrane; P:triglyceride biosynthetic process; F:diacylglycerol O-acyltransferase activity,IPR004299 (PFAM); IPR027251 (PTHR10408:PANTHER); IPR027251 (PTHR10408:PANTHER); IPR014371 (PANTHER),,
RL4_JR_02157,2189,1702,2013,0,0,0,0,0,0,0,0,2,1,3,0,0,0,0,23.56953445,0,-2.661287746,1.187438731,-2.241200052,0.025013119,0.078786498,7.553988576,0,0.548294181,1.230438857,0.445608636,0.655879971,0.778290395,32.54864513,1,-0.280611256,1.03410241,-0.271357317,0.786116227,0.858487625,43.8976126,1,0.200745126,0.745963739,0.269108424,0.787846248,0.86284136,19.23606995,0,-2.179574316,1.193603757,-1.82604512,0.067843466,0.141631978,N,-,,polyadenylation factor subunit 2,,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR22836 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),3.A.20.1.1, the peroxisomal protein importer (ppi) family.
RL4_JR_02158,2713,2385,4357,2,5,9,0,0,0,1,0,0,3,0,1,0,0,1,132.1522794,1,1.378804078,0.491128028,2.80742291,0.004993963,0.021763222,11.90520223,0,-0.108068335,1.234543302,-0.087537096,0.9302446,0.960711748,42.15849272,1,-1.807589306,1.213009415,-1.49016923,0.136179745,0.244058017,73.44862007,1,-0.390485413,0.785690983,-0.496996175,0.619191749,0.737046374,38.25405978,1,-1.922050347,1.155563197,-1.663301802,0.096252038,0.18554773,N,-,,mitochondrial nuclease,"F:nucleic acid binding; P:RNA phosphodiester bond hydrolysis, endonucleolytic; F:metal ion binding; P:DNA catabolic process, endonucleolytic; C:mitochondrion; P:apoptotic process; F:single-stranded DNA endodeoxyribonuclease activity; F:endoribonuclease activity; P:RNA catabolic process; P:cellular response to nitrogen starvation",IPR001604 (SMART); IPR020821 (SMART); IPR001604 (PFAM); IPR020821 (G3DSA:3.40.570.GENE3D); PTHR13966 (PANTHER); SSF54060 (SUPERFAMILY),,
RL4_JR_02159,843,1102,877,0,1,4,0,0,0,0,3,0,0,3,0,0,1,0,34.64737497,1,1.418216628,0.697631121,2.032903329,0.042062291,0.117036118,3.626296052,0,1.607072274,1.277111614,1.258364779,0.208259863,0.353633004,32.9226278,1,1.366860298,0.86492248,1.580326941,0.114032013,0.213630663,22.87134167,1,0.828108945,0.874655875,0.946782578,0.343749581,0.490551728,13.09476802,1,-0.191344547,1.13417213,-0.16870856,0.866025886,0.910635797,N,-,,zip zinc transporter,P:transmembrane transport; P:zinc II ion transport; C:endoplasmic reticulum; F:metal ion transmembrane transporter activity; C:membrane part; C:intracellular organelle part,IPR003689 (PFAM); PTHR11040 (PANTHER); PTHR11040 (PANTHER); PTHR11040:SF56 (PANTHER),2.A.5.5.3, the zinc (zn(2+))-iron (fe(2+)) permease (zip) family.
RL4_JR_02160,3313,4244,6445,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,55.92278268,0,-3.907703291,1.231153814,-3.174017127,0.001503448,0.008220597,17.63497895,0,-0.674899601,1.228814417,-0.549228258,0.582848815,0.721486572,46.12702978,0,-3.338581272,1.217784574,-2.741520417,0.006115556,0.02209632,57.25102806,1,-2.81660345,1.176231864,-2.394598833,0.016638559,0.069939175,45.86681567,0,-3.433152497,1.230013331,-2.791150641,0.005252102,0.018658784,N,-,,c2h2 transcription factor,F:nucleic acid binding; C:nucleus; F:metal ion binding; C:cytosol,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24375 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY),,
RL4_JR_02161,7856,10330,13103,0,0,2,0,0,0,0,2,0,0,3,0,0,1,0,132.9152052,1,-3.360940629,1.054192859,-3.188164859,0.001431789,0.007902932,39.62964737,0,-1.843013839,1.206883745,-1.527084813,0.126739923,0.242966193,119.0715661,1,-2.678183657,1.050304039,-2.549912746,0.010774988,0.034729698,131.3454138,1,-2.641602543,0.890404834,-2.966743264,0.003009722,0.018679607,106.3397186,1,-3.664786651,1.149301967,-3.1887065,0.001429109,0.006402535,N,-,,dna-directed rna polymerases i,"F:RNA polymerase III activity; F:DNA binding; C:DNA-directed RNA polymerase I complex; F:RNA polymerase II activity; F:RNA polymerase I activity; P:transcription, RNA-templated; P:transcription from RNA polymerase I promoter; C:cytosol; P:transcription from RNA polymerase II promoter; P:tRNA transcription from RNA polymerase III promoter; C:DNA-directed RNA polymerase III complex; C:DNA-directed RNA polymerase II, core complex",IPR006110 (SMART); IPR006111 (PIRSF); IPR028363 (PIRSF); IPR006110 (PFAM); IPR012293 (G3DSA:3.90.940.GENE3D); IPR006111 (PANTHER); IPR006110 (SUPERFAMILY),,
RL4_JR_02162,5977,5696,7549,2,3,20,0,0,0,0,0,0,1,2,0,0,4,2,197.294028,1,0.876844016,0.454366597,1.929816191,0.053629617,0.140272655,24.42725497,0,-1.144933347,1.19663381,-0.956795084,0.338670694,0.501574128,63.5143005,0,-3.800051295,1.192100435,-3.18769391,0.001434123,0.007639403,90.6154228,1,-1.910652228,0.85583075,-2.232511776,0.025581158,0.085851084,92.9532547,1,-0.687130208,0.636343375,-1.079810421,0.28022661,0.413769822,N,-,,translocation SEC63,C:integral component of membrane,IPR001623 (PRINTS); IPR001623 (SMART); IPR004179 (SMART); IPR000008 (G3DSA:2.60.40.GENE3D); G3DSA:1.10.3380.10 (GENE3D); IPR001623 (G3DSA:1.10.287.GENE3D); G3DSA:1.10.150.20 (GENE3D); IPR001623 (PFAM); PTHR24075:SF0 (PANTHER); PTHR24075:SF0 (PANTHER); PTHR24075 (PANTHER); PTHR24075 (PANTHER); IPR001623 (PROSITE_PROFILES); IPR014756 (SUPERFAMILY); SSF158702 (SUPERFAMILY); IPR001623 (SUPERFAMILY),3.A.5.8.1, the general secretory pathway (sec) family.
RL4_JR_02163,2900,2833,2226,0,3,5,0,0,0,0,0,0,4,2,6,0,0,0,75.08659389,1,0.612925597,0.567800475,1.079473554,0.280376677,0.463675842,10.26777017,0,0.105518511,1.234379162,0.085483062,0.93187736,0.961907265,26.49948193,0,-2.538844433,1.200313731,-2.115150704,0.034417105,0.085352921,133.6454219,1,1.459491466,0.507962313,2.873227851,0.00406301,0.023765438,25.96447073,0,-2.612259995,1.196617076,-2.183037538,0.029033046,0.073301011,N,-,,transcriptional regulatory,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR021858 (PFAM); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_02164,530,501,833,3,0,0,0,0,0,0,4,2,2,0,0,0,5,4,37.62031797,1,1.379077474,0.884277549,1.55955274,0.118865612,0.250557452,2.351549624,0,2.231792092,1.313346519,1.699317019,0.089259468,0.185216165,50.50612427,1,2.972138564,0.649768222,4.574151926,4.78E-06,0.000100447,25.70632455,1,0.90688746,1.037584995,0.874036791,0.382098218,0.527580043,54.85625542,1,3.261011399,0.580576997,5.61684568,1.94E-08,8.07E-07,N,-,,primary-amine oxidase,,IPR015798 (PFAM); IPR015800 (PFAM); IPR015798 (G3DSA:2.70.98.GENE3D); G3DSA:3.10.450.40 (GENE3D); G3DSA:3.10.450.40 (GENE3D); IPR015802 (PFAM); IPR000269 (PANTHER); PTHR10638:SF18 (PANTHER); IPR016182 (SUPERFAMILY); IPR016182 (SUPERFAMILY); IPR015798 (SUPERFAMILY),,
RL4_JR_02165,1017,949,697,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,10.6962478,0,-1.521261151,1.212262557,-1.254894117,0.2095172,0.376319092,3.443536459,0,1.68171313,1.298942178,1.294678977,0.195430995,0.338341047,8.874199928,0,-0.960492283,1.212867301,-0.79191869,0.428408089,0.568984925,10.23354448,0,-1.382285411,1.212583249,-1.139950936,0.254306742,0.393769042,20.26323972,1,1.161331438,0.86726417,1.339074619,0.180546382,0.298308114,N,-,,choline transport,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PIRSF); IPR002293 (PFAM); PTHR11785:SF369 (PANTHER); IPR002293 (PANTHER),2.A.3.4.2, the amino acid-polyamine-organocation (apc) family.
RL4_JR_02166,8336,7388,8236,1,1,2,0,0,3,1,0,0,2,5,0,0,3,0,121.5206943,1,-1.955618004,0.731503295,-2.673423371,0.007508143,0.030173117,58.78273129,1,0.713960118,0.849120635,0.840822952,0.400447127,0.564372852,90.46171888,1,-3.160138143,1.186693903,-2.662976641,0.007745279,0.026673712,130.2609679,1,-1.012782576,0.564646057,-1.793659167,0.072867587,0.155494829,89.73918094,1,-1.993710309,0.836627961,-2.383030931,0.017170752,0.048390496,N,-,,---NA---,,no IPS match,,
RL4_JR_02167,33527,27914,30094,1,5,1,0,0,1,2,3,1,2,4,2,3,1,4,419.8859326,1,-3.053461727,0.578252047,-5.280503097,1.29E-07,2.51E-06,126.6893413,1,-2.491467396,1.113427604,-2.237655495,0.02524353,0.069020801,355.6502395,1,-2.642188208,0.618040011,-4.27510867,1.91E-05,0.00032616,403.9780348,1,-2.744529652,0.540128479,-5.081253366,3.75E-07,7.50E-06,379.7579241,1,-2.392768645,0.594613518,-4.024073743,5.72E-05,0.000434145,N,-,,small glutamine-rich tetratricopeptide repeat-containing a,C:membrane; C:cytosol; C:endomembrane system; P:cellular process,IPR001623 (PRINTS); IPR019734 (SMART); IPR001623 (SMART); PF14559 (PFAM); IPR013105 (PFAM); PF13432 (PFAM); IPR001623 (G3DSA:1.10.287.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR001623 (PFAM); PTHR24074 (PANTHER); PTHR24074:SF8 (PANTHER); IPR001623 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY); IPR011990 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_02168,1660,1144,1203,0,0,7,0,0,0,0,0,0,2,1,4,0,0,0,42.72691055,1,1.370345773,0.622928475,2.199844488,0.02781793,0.08521918,5.154239841,0,1.099802703,1.268314756,0.86713704,0.385866928,0.550492607,13.29386678,0,-1.543686706,1.20678597,-1.279171904,0.200836528,0.326350943,76.50717535,1,1.635612532,0.607435128,2.692653843,0.007088582,0.0369197,13.03291421,0,-1.617954401,1.204610653,-1.343134728,0.179228352,0.296660246,N,-,,calcium-binding ef-hand,,IPR002048 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR23050 (PANTHER); PTHR23050:SF137 (PANTHER); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY),8.A.82.1.7, the calmodulin calcium binding protein (calmodulin) family.
RL4_JR_02169,10493,9729,9854,0,4,8,0,0,1,2,0,2,0,1,0,0,0,1,183.0154005,1,-0.712239359,0.443231207,-1.606925118,0.108070796,0.234354479,47.93206277,1,-0.885863529,1.111022062,-0.797341078,0.425252969,0.588114572,134.927066,1,-1.626242752,0.737150731,-2.206119704,0.027375619,0.071430611,119.1147825,1,-3.92651604,1.139310081,-3.446398048,0.000568113,0.004631355,105.4922102,1,-3.597286223,1.115261993,-3.22550777,0.001257494,0.005784702,N,-,,spindle pole body interacting,,PF08616 (PFAM); IPR012860 (PFAM),,
RL4_JR_02170,212739,26320,145900,0,1,9,0,0,0,0,0,2,0,0,0,0,0,2,1550.915379,1,-4.935936099,1.084197241,-4.552618205,5.30E-06,6.62E-05,489.6967718,0,-5.470220275,1.412133221,-3.873728197,0.000107183,0.005166218,1275.167226,1,-6.34763255,1.300379041,-4.881371006,1.05E-06,2.82E-05,1455.090877,0,-8.534059869,1.451302511,-5.880276376,4.10E-09,1.23E-07,1256.014615,1,-6.357427048,1.336127905,-4.758097652,1.95E-06,2.54E-05,N,-,,S-formylglutathione hydrolase,F:S-formylglutathione hydrolase activity; P:formaldehyde catabolic process; C:cytosol; F:carboxylic ester hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR000801 (PFAM); IPR014186 (TIGRFAM); IPR014186 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_02171,1236,356,1251,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,11.18959801,0,-1.586521528,1.324706335,-1.197640176,0.231057128,0.403719009,3.588053623,0,1.622270129,1.411237981,1.149536897,0.250334662,0.404353469,9.313412237,0,-1.030413725,1.295752159,-0.795224394,0.426482984,0.567377678,10.74234562,0,-1.452501441,1.307974551,-1.110496714,0.266785043,0.407789638,16.93827949,1,0.501936751,1.126726682,0.445482262,0.655971276,0.754653922,Y,-, Effector probability:0.902,hypothetical protein CMQ_7402,,no IPS match,,
RL4_JR_02172,846,126,662,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.406749384,0,-0.782035755,1.4580953,-0.536340632,0.591723154,0.76236688,2.071450209,0,2.414844236,1.578879446,1.529467143,0.126148678,0.24219972,5.352352572,0,-0.23127699,1.382495181,-0.167289545,0.86714223,0.915703067,6.17147534,0,-0.652878554,1.411446622,-0.462559862,0.643679885,0.755799471,5.276628793,0,-0.313474054,1.402276603,-0.22354652,0.823110182,0.881310793,N,-,,Acyl- N-acyltransferase,P:biological_process; C:cellular_component; F:N-acetyltransferase activity; F:molecular_function,IPR016181 (G3DSA:3.40.630.GENE3D); IPR016181 (SUPERFAMILY),,
RL4_JR_02173,376,566,572,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,6.085311721,0,-0.707523938,1.231237051,-0.574644775,0.565531564,0.74233411,1.928316834,0,2.518149446,1.333817828,1.887926067,0.059035877,0.134525246,5.020504474,0,-0.138823866,1.219195522,-0.113865138,0.909344702,0.944516853,25.06393945,1,1.195446021,1.035490737,1.154472926,0.248306332,0.387436588,4.962499808,0,-0.224706922,1.224335035,-0.183533849,0.854379162,0.903057392,N,-,,adp-ribosylation factor family,F:GTP binding; P:small GTPase mediated signal transduction; C:intracellular,IPR006689 (PRINTS); SM00178 (SMART); SM00177 (SMART); SM00175 (SMART); IPR005225 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR006689 (PFAM); PTHR11711 (PANTHER); PTHR11711:SF26 (PANTHER); IPR024156 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_02174,5166,4655,4106,0,1,4,0,0,0,0,3,1,0,6,5,0,3,2,79.11029127,1,-0.871601368,0.68142092,-1.279093937,0.200863978,0.364792595,17.93014852,0,-0.698761071,1.214737159,-0.575236433,0.565131406,0.707427664,76.32722066,1,-0.522356826,0.750748618,-0.695781268,0.486565822,0.621653679,125.6432373,1,0.424938713,0.487443675,0.871769879,0.38333393,0.528565442,71.71994432,1,-0.473610015,0.672141395,-0.704628547,0.481041428,0.60985116,N,-,,gelsolin domain containing,P:barbed-end actin filament capping; P:actin filament severing; F:actin binding; P:actin nucleation; F:calcium ion binding,IPR007122 (PRINTS); IPR007122 (SMART); IPR029006 (G3DSA:3.40.20.GENE3D); IPR007123 (PFAM); IPR029006 (G3DSA:3.40.20.GENE3D); IPR025118 (PFAM); IPR029006 (G3DSA:3.40.20.GENE3D); PTHR11977:SF16 (PANTHER); IPR007122 (PANTHER); SSF55753 (SUPERFAMILY); SSF55753 (SUPERFAMILY); SSF55753 (SUPERFAMILY),,
RL4_JR_02175,1683,1637,2296,2,0,1,0,0,0,0,2,0,2,0,0,0,0,0,46.36512277,1,-0.263841453,0.860751341,-0.306524591,0.759205259,0.873023023,7.121456692,0,0.633287217,1.228865106,0.515343152,0.60631325,0.739669842,34.2248929,1,-0.199178358,1.037892757,-0.191906492,0.847815452,0.902553485,40.01546321,1,-0.698533572,1.020773077,-0.684318178,0.493774271,0.632683434,18.34878858,0,-2.111383792,1.206404068,-1.750146445,0.080093047,0.161381513,N,-,,Mediator of RNA polymerase II transcription subunit 10,,IPR019145 (PFAM); PTHR13345 (PANTHER),,
RL4_JR_02176,2406,2183,1899,6,2,3,0,0,0,0,0,0,2,2,0,0,0,0,113.880154,1,1.447008758,0.505880601,2.860376058,0.004231389,0.018911284,8.355286209,0,0.402880421,1.235734994,0.326024935,0.744405489,0.842544153,21.57297731,0,-2.242104977,1.196973408,-1.873145186,0.061048339,0.132062689,51.52770057,1,0.068784829,0.751509841,0.091528846,0.927072386,0.956926461,21.15415935,0,-2.316679391,1.193289152,-1.941423323,0.052206952,0.11573742,N,-,,hypothetical protein CMQ_7456,,no IPS match,,
RL4_JR_02177,67953,50540,49500,0,5,4,2,0,0,0,0,1,0,3,1,0,3,0,726.872101,1,-3.58709724,0.560003168,-6.405494551,1.50E-10,4.99E-09,260.8837336,1,-2.602014853,1.005782155,-2.587056095,0.009679983,0.032912593,564.3050038,1,-5.972833336,1.208222844,-4.943486514,7.67E-07,2.15E-05,664.9202773,1,-4.64237129,0.77564779,-5.985153762,2.16E-09,6.76E-08,558.3183356,1,-4.823907406,0.884130264,-5.456104832,4.87E-08,1.30E-06,N,-,,bZIP transcription factor,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",G3DSA:1.20.5.170 (GENE3D); SSF57959 (SUPERFAMILY),,
RL4_JR_02178,603,875,767,3,0,4,0,0,0,0,1,2,3,2,0,0,0,0,54.50764407,1,2.259238596,0.615100211,3.672960202,0.000239757,0.001800168,2.873177569,0,1.942889538,1.294634966,1.500723825,0.133427008,0.251873961,28.3022371,1,1.690987514,0.870062054,1.943525185,0.051952735,0.116592156,44.56925682,1,1.93234681,0.693240618,2.787411411,0.005313098,0.029380184,7.354573934,0,-0.792313363,1.213313164,-0.653016374,0.513745723,0.639576471,N,-, Effector probability:0.856,zinc finger,F:DNA binding; F:metal ion binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); PF12874 (PFAM); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES),,
RL4_JR_02179,240,192,116,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.200734424,0,0.759767118,1.35383755,0.561195187,0.574664483,0.750296858,0.713220733,0,3.953281092,1.55079203,2.549201321,0.010796995,0.035644875,1.830126366,0,1.317383103,1.271174106,1.03635143,0.300038221,0.440868933,2.109876513,0,0.895900368,1.296888973,0.690807299,0.489686648,0.629677078,1.782509206,0,1.252109457,1.253059067,0.999242167,0.317677394,0.452962063,N,-,,NACHT and WD40 domain,P:proteolysis; F:serine-type endopeptidase activity,IPR001680 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR000209 (G3DSA:3.40.50.GENE3D); PF05729 (PFAM); PTHR22847 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR000209 (SUPERFAMILY); IPR027417 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_02180,149,178,168,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.987753676,0,0.906706413,1.277070324,0.709989415,0.4777107,NA,0.633627072,0,4.123843418,1.490493629,2.766763532,0.005661581,0.022298256,1.643615831,0,1.472322104,1.220981635,1.205851146,0.22787489,0.358731984,1.896171408,0,1.049891114,1.234380888,0.850540642,0.395024574,0.539396334,1.618858222,0,1.391540074,1.211020678,1.149063843,0.250529656,0.381216226,N,-,,hypothetical protein FOMG_09987,,no IPS match,,
RL4_JR_02181,34646,45793,62359,10,6,40,0,0,3,1,8,15,3,23,16,0,25,1,872.6941323,1,-0.867136327,0.48159333,-1.80055718,0.071772704,0.174080178,208.5624759,1,-1.866997727,0.89143636,-2.094370178,0.036227017,0.091718326,642.5584613,1,-1.354507931,0.489087571,-2.769458911,0.005614949,0.020686223,818.2583409,1,-0.990400325,0.485433478,-2.040239025,0.041326525,0.109882107,571.6627305,1,-1.940134792,0.906130627,-2.141120423,0.032264328,0.079716038,N,-,,telomere and ribosome associated,,IPR006861 (SMART),,
RL4_JR_02182,2802,2285,3110,0,1,0,0,0,3,0,2,0,2,2,0,0,0,3,40.69972824,1,-2.183355495,1.14339906,-1.909530601,0.056193678,0.144934564,38.57012528,1,2.262611938,0.859402678,2.632772733,0.0084691,0.029683219,42.77073821,1,-0.746187454,1.033254453,-0.722172019,0.470188724,0.606711366,57.89306498,1,-0.260338027,0.745709959,-0.349114323,0.727003484,0.818060711,48.82941206,1,-0.419186535,0.846181456,-0.495386105,0.620327601,0.726532358,N,-,,major facilitator superfamily transporter,C:membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23524 (PANTHER); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),,
RL4_JR_02183,1770,1974,3346,0,9,8,0,0,3,0,0,2,0,2,0,0,0,0,130.8966312,1,1.896683105,0.59968295,3.162809788,0.001562544,0.008498155,37.05059431,1,2.467347743,0.900102334,2.741185808,0.006121788,0.023596624,36.31975493,1,-0.542841455,1.066749447,-0.508874372,0.610840285,0.726691779,34.94117302,1,-1.069892406,1.058660334,-1.010609703,0.31220327,0.458257192,23.20471409,0,-2.450116308,1.234338497,-1.984963049,0.047148583,0.107059744,N,-,,tricarboxylate carrier,C:mitochondrial membrane; P:ion transmembrane transport; F:ion transmembrane transporter activity; C:integral component of membrane,IPR004686 (PFAM); IPR004686 (TIGRFAM); IPR004686 (PANTHER); PTHR11153:SF6 (PANTHER),2.A.54.1.4, the mitochondrial tricarboxylate carrier (mtc) family.
RL4_JR_02184,6693,4606,5095,0,0,2,0,0,0,0,0,3,1,2,2,0,0,0,73.0573781,1,-2.412796462,1.027705404,-2.347751069,0.018887139,0.062583787,21.0582891,0,-0.930779734,1.219137784,-0.763473782,0.445180893,0.606476581,73.84930856,1,-1.177805185,0.870315276,-1.353308642,0.175957049,0.295199858,99.28625654,1,-0.931724106,0.689217527,-1.351857823,0.176420802,0.300413828,53.33081304,0,-3.650706886,1.198854918,-3.045161539,0.002325554,0.00963036,N,-,,CMGC CLK kinase,F:nucleotide binding; F:protein kinase activity; P:protein phosphorylation; C:intracellular part,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); PTHR24058 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_02185,1057,971,1096,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.49380937,0,-1.745527019,1.184199512,-1.474014304,0.14047774,0.28296726,3.992190749,0,1.468346111,1.25083675,1.173891086,0.240438653,0.392282406,10.34882131,0,-1.18244309,1.190055888,-0.993602991,0.320416188,0.463023925,11.93791797,0,-1.604709558,1.18713082,-1.35175461,0.176453829,0.300419542,10.19463088,0,-1.263529243,1.191387893,-1.060552361,0.288893382,0.423367418,N,-,,hypothetical protein CMQ_7046,,no IPS match,,
RL4_JR_02186,5389,10799,14072,4,0,2,0,0,0,2,4,1,0,3,0,0,3,0,169.2867132,1,-1.590960409,0.819592784,-1.941159609,0.052238921,0.137561367,38.09450549,0,-1.786011957,1.248312586,-1.430740967,0.152504467,0.280103469,159.8716336,1,-0.800197726,0.679218777,-1.178114848,0.238750823,0.371562422,127.3156636,1,-2.633048602,0.968570282,-2.718489976,0.006558064,0.034764608,111.0079747,1,-2.404017588,0.968078699,-2.483287352,0.013017603,0.038834187,N,-,,tRNA processing endoribonuclease,P:tRNA 3'-end processing,IPR009799 (PFAM); IPR027794 (PFAM); IPR001279 (G3DSA:3.60.15.GENE3D); IPR001279 (G3DSA:3.60.15.GENE3D); G3DSA:3.30.70.900 (GENE3D); IPR001279 (PFAM); PTHR12553 (PANTHER); PTHR12553 (PANTHER); PTHR12553:SF49 (PANTHER); PTHR12553:SF49 (PANTHER); IPR001279 (SUPERFAMILY); IPR011008 (SUPERFAMILY); IPR001279 (SUPERFAMILY),,
RL4_JR_02187,59704,42148,46243,1,2,0,0,1,0,1,2,5,0,2,1,0,4,2,617.2309991,1,-4.963733825,0.86847832,-5.71543781,1.09E-08,2.55E-07,228.5315121,1,-3.177952353,1.131157954,-2.809468246,0.004962341,0.020543485,550.2787675,1,-2.940138141,0.575234009,-5.111203604,3.20E-07,9.91E-06,583.9262507,1,-4.863550292,0.875177745,-5.557214316,2.74E-08,7.04E-07,512.0581027,1,-3.635266298,0.663081633,-5.482381233,4.20E-08,1.17E-06,N,-,,"3 ,5 -cyclic-nucleotide phosphodiesterase","P:regulation of biological quality; P:negative regulation of phosphate metabolic process; P:regulation of reproductive process; P:cell communication; P:cellular response to stimulus; C:intracellular part; P:regulation of signal transduction; P:regulation of primary metabolic process; F:3',5'-cyclic-nucleotide phosphodiesterase activity",IPR000396 (PRINTS); IPR000396 (PFAM); IPR001279 (G3DSA:3.60.15.GENE3D); PTHR28283 (PANTHER); PTHR28283:SF1 (PANTHER); PTHR28283:SF1 (PANTHER); PTHR28283 (PANTHER); IPR001279 (SUPERFAMILY),,
RL4_JR_02188,381,420,579,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.513627768,0,-0.565395572,1.2222139,-0.462599527,0.643651448,0.797162367,1.7475191,0,2.660117931,1.3316539,1.997604581,0.045759546,0.109888049,4.555315102,0,0.001232361,1.21349751,0.001015544,0.999189713,0.999593402,5.256595092,0,-0.421492929,1.214731071,-0.346984562,0.728602917,0.819065026,4.513749302,0,-0.088025713,1.220813953,-0.072104118,0.942519049,0.963555535,N,-,,hypothetical protein SPBR_00265,,no IPS match,,
RL4_JR_02189,19833,17593,11602,4,5,6,0,0,0,1,8,2,0,9,2,0,4,4,300.2218917,1,-1.03670039,0.507595809,-2.042373815,0.041114465,0.114921924,63.60583215,0,-2.525555725,1.226651087,-2.058903099,0.039503522,0.098061542,250.4030236,1,-0.882666231,0.56362601,-1.566049501,0.117337029,0.218327529,244.0024755,1,-1.483913277,0.578681573,-2.564300205,0.010338408,0.049739341,204.6065703,1,-1.610947641,0.608936345,-2.64551074,0.00815677,0.026658261,N,-,,acyl- ligase,C:cell division site; C:mitotic spindle; P:metabolic process; F:ligase activity,IPR000873 (PFAM); G3DSA:2.30.38.10 (GENE3D); G3DSA:3.40.50.980 (GENE3D); G3DSA:3.40.50.980 (GENE3D); G3DSA:3.40.50.980 (GENE3D); PTHR22754:SF4 (PANTHER); PTHR22754:SF4 (PANTHER); PTHR22754 (PANTHER); PTHR22754 (PANTHER); SSF56801 (SUPERFAMILY); SSF56801 (SUPERFAMILY),4.C.1.1.4, the fatty acid transporter (fat) family.
RL4_JR_02190,2397,2395,3239,0,0,0,0,0,0,4,0,0,0,1,0,0,1,0,32.07409158,0,-3.105702567,1.196017788,-2.596702657,0.009412336,0.036117517,10.19153683,0,0.116168908,1.215332687,0.095586097,0.923849307,0.958507861,70.80468888,1,0.526491035,1.211095946,0.434722812,0.663763638,0.768081275,34.61655272,1,-2.01607038,1.14796935,-1.756205756,0.079053282,0.164992426,30.10357938,1,-1.69823055,1.133162702,-1.498664355,0.133960728,0.237581428,N,-,,actin patch,C:intracellular organelle; P:cellular process; F:hydrolase activity,IPR019236 (PFAM); IPR017210 (PIRSF); PTHR28208 (PANTHER); PTHR28208:SF3 (PANTHER),,
RL4_JR_02191,26561,43573,40035,0,2,5,0,0,0,0,3,0,0,0,0,0,9,1,478.7494901,1,-3.406546917,0.669364905,-5.089222471,3.60E-07,6.14E-06,140.5953974,0,-3.669888786,1.213773372,-3.02353707,0.002498384,0.015349618,389.3982113,1,-3.916316242,0.891294966,-4.393962036,1.11E-05,0.000204879,422.188191,0,-6.748918714,1.218885777,-5.536957472,3.08E-08,7.81E-07,403.4337434,1,-2.607005199,0.661311763,-3.942172731,8.07E-05,0.000580654,N,-,,atp-dependent rna helicase drs1,F:nucleotide binding; F:nucleic acid binding; C:nucleus; F:hydrolase activity,IPR001650 (SMART); IPR014001 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR011545 (PFAM); PTHR24031 (PANTHER); PTHR24031 (PANTHER); PTHR24031:SF337 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_02192,9,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.104668917,0,5.153764316,3.916948844,1.315759925,0.188254634,NA,0.033591244,0,8.361719343,2.605198789,3.20962814,0.001329068,0.015023052,0.086700883,0,5.718312181,1.490250785,3.837147573,0.000124472,0.00132508,0.099994312,0,5.295121094,2.315993314,2.286328316,0.022235059,0.080442001,0.084915445,0,5.644544057,1.292294627,4.367846107,1.25E-05,0.000121809,,,,,,,,
RL4_JR_02193,1203,1164,1311,0,1,2,0,0,0,0,0,2,0,3,0,0,1,0,30.36297299,1,0.329609319,0.84190929,0.391502176,0.695426081,0.835412453,4.696774977,0,1.233849265,1.240203508,0.994876451,0.319796357,0.481836667,25.18075812,1,0.40330373,1.027711605,0.392428895,0.69474134,0.791800216,26.08950295,1,0.468634232,0.845946729,0.553976056,0.579595233,0.706015608,15.86928271,1,-0.569405522,1.120728832,-0.508067166,0.61140624,0.718988175,N,-,,proline-rich -15,,PTHR32093 (PANTHER),,
RL4_JR_02194,822,854,1019,4,1,2,0,0,0,0,0,0,0,0,0,0,0,1,66.69027202,1,2.023846981,0.575047943,3.519440434,0.000432458,0.002979724,3.431675611,0,1.686575613,1.259696909,1.338874138,0.18061165,0.319134272,8.917964857,0,-0.96781659,1.194421168,-0.810280843,0.417778783,0.559026223,10.28901626,0,-1.390308259,1.192327082,-1.166046029,0.243595836,0.38185599,16.17224662,1,-0.117097867,1.126902064,-0.103911307,0.917239734,0.947271757,N,-,,PX domain-containing,F:protein binding; P:vesicle-mediated transport; P:organelle fusion; F:phosphatidylinositol binding; P:single-organism organelle organization; C:cytoplasmic part; C:membrane part; P:single-organism membrane fusion,IPR001683 (SMART); IPR000727 (SMART); IPR001683 (PFAM); IPR001683 (G3DSA:3.30.1520.GENE3D); G3DSA:1.20.5.110 (GENE3D); PTHR19957:SF130 (PANTHER); PTHR19957 (PANTHER); PTHR19957 (PANTHER); IPR000727 (PROSITE_PROFILES); IPR001683 (PROSITE_PROFILES); SSF58038 (SUPERFAMILY); IPR001683 (SUPERFAMILY),1.F.1.1.2, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_02195,12403,10540,15202,0,20,21,0,0,2,2,2,6,0,13,0,0,8,0,392.4645745,1,0.682128004,0.808161623,0.844048992,0.398642029,0.590436034,67.19096669,1,-0.489665668,0.984396334,-0.497427358,0.618887717,0.749246308,202.7308301,1,-0.648703463,0.503255078,-1.289015236,0.19739279,0.322531408,197.4183517,1,-1.296476576,1.327264977,-0.976803124,0.328666629,0.475324899,155.3623108,1,-1.333869971,0.617663392,-2.159541895,0.030808151,0.076755051,N,-,,microtubule associated,P:regulation of filamentous growth; P:positive regulation of ATPase activity; P:protein localization to microtubule; P:nuclear migration involved in conjugation with cellular fusion; P:karyogamy involved in conjugation with cellular fusion; C:astral microtubule; C:mitotic spindle pole body; F:ATPase activator activity; C:mitotic spindle midzone; C:nucleus; P:dynein-driven meiotic oscillatory nuclear movement; C:cell cortex of cell tip; F:microtubule plus-end binding; P:gamma-tubulin complex localization; C:cytosol; C:cortical microtubule; P:attachment of mitotic spindle microtubules to kinetochore; P:mitotic spindle assembly,IPR001715 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); IPR004953 (PFAM); IPR027328 (PANTHER); IPR004953 (PROSITE_PROFILES); IPR004953 (SUPERFAMILY); IPR001715 (SUPERFAMILY),,
RL4_JR_02196,0,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.020111042,0,7.533833619,3.95948959,1.902728482,0.057075983,NA,0.006181986,0,10.80045294,3.961457679,2.726383522,0.006403255,0.024293008,0.016419296,0,8.115760534,2.742902141,2.958822487,0.003088169,0.013803367,0.018970802,0,7.692145024,3.960113045,1.942405415,0.05208804,0.125807414,0.016551213,0,8.01449721,1.56545604,5.119592634,3.06E-07,5.23E-06,,,,,,,,
RL4_JR_02197,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.019504112,0,7.575372061,3.961019049,1.912480593,0.055814579,NA,0.006509392,0,10.7300969,3.9588721,2.710392412,0.006720365,0.025175252,0.016494478,0,8.109867811,2.851793459,2.843778109,0.004458208,0.017386326,0.018993711,0,7.690398192,3.960048927,1.941995752,0.052137615,0.125807414,0.015949996,0,8.040879118,1.654939983,4.858713428,1.18E-06,1.67E-05,N,-, Effector probability:0.671,Concanavalin A-like lectin glucanase,F:aspartic-type endopeptidase activity; P:proteolysis,no IPS match,,
RL4_JR_02198,4046,4680,4382,0,13,5,0,0,0,0,0,3,1,5,3,0,1,0,175.8524023,1,1.209271872,0.781311486,1.547746185,0.121683418,0.255059949,16.79003832,0,-0.603994134,1.205031988,-0.501226639,0.616211628,0.74787699,63.02702125,1,-0.852443278,0.853449965,-0.99882045,0.317881678,0.460540794,108.4940269,1,0.222797806,0.512985231,0.43431622,0.664058827,0.771073196,46.71494225,1,-2.404780443,1.12081345,-2.145567081,0.031907534,0.079008017,N,-,,metallopeptidase family M24,P:proteolysis; F:aminopeptidase activity; F:manganese ion binding; F:metallopeptidase activity,IPR007865 (SMART); IPR000994 (PFAM); IPR029149 (G3DSA:3.40.350.GENE3D); IPR007865 (PFAM); IPR000994 (G3DSA:3.90.230.GENE3D); PTHR10804 (PANTHER); PTHR10804:SF103 (PANTHER); IPR000994 (SUPERFAMILY); IPR028980 (SUPERFAMILY),,
RL4_JR_02199,602,505,1006,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,8.393652299,0,-1.171770052,1.242204607,-0.943298749,0.345528115,0.535286435,2.655010232,0,2.056674115,1.323173829,1.554349149,0.120101156,0.23385586,6.939101067,0,-0.605969371,1.231068637,-0.49223037,0.622556497,0.735702344,17.64341565,1,-0.075072447,1.179439087,-0.063650974,0.949248143,0.970207017,6.902129371,0,-0.700816718,1.24452567,-0.563119537,0.573353489,0.688672294,N,-,,cyclin-dependent kinase complex component,F:protein kinase binding; P:phosphorylation; F:kinase activity; P:regulation of cyclin-dependent protein serine/threonine kinase activity,IPR013922 (PFAM); PTHR15615 (PANTHER); PTHR15615:SF32 (PANTHER); PTHR15615:SF32 (PANTHER); PTHR15615 (PANTHER),,
RL4_JR_02200,496,1256,721,1,0,0,3,0,0,0,2,3,0,2,0,0,3,0,20.11997904,1,-0.471723353,1.234251856,-0.382193756,0.702317653,0.839159299,70.12282056,1,4.101229896,0.938060835,4.372029769,1.23E-05,0.000793621,43.45700152,1,2.257813297,0.775358354,2.911961011,0.003591675,0.015446947,17.57152639,1,0.403894849,1.113040952,0.362875102,0.716698187,0.810388391,19.71863373,1,1.206765732,0.969262411,1.245035109,0.213118845,0.337529846,N,-,,thiamine pyrophosphate enzyme,F:magnesium ion binding; F:thiamine pyrophosphate binding; F:catalytic activity; F:carbohydrate binding,IPR029061 (G3DSA:3.40.50.GENE3D); IPR011766 (PFAM); IPR029061 (G3DSA:3.40.50.GENE3D); IPR029035 (G3DSA:3.40.50.GENE3D); IPR012001 (PFAM); IPR012000 (PFAM); PTHR18968:SF135 (PANTHER); PTHR18968 (PANTHER); IPR029061 (SUPERFAMILY); IPR029035 (SUPERFAMILY); IPR029061 (SUPERFAMILY),,
RL4_JR_02201,187,79,158,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.678073036,0,1.150595006,1.416149864,0.812481105,0.416515625,NA,0.540039588,0,4.354344002,1.607506682,2.708756393,0.006753591,0.025262323,1.396685454,0,1.706635873,1.284518164,1.328619493,0.183973538,0.305238977,1.610710691,0,1.284856851,1.323445506,0.970842279,0.331626825,0.47818485,1.375578769,0,1.625814458,1.272666764,1.277486381,0.201430586,0.323522316,Y,-,,acetylxylan esterase A,F:acetylxylan esterase activity; C:extracellular region,IPR010126 (TIGRFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR010126 (PFAM); PTHR11731:SF134 (PANTHER); PTHR11731 (PANTHER); IPR029058 (SUPERFAMILY); IPR029058 (SUPERFAMILY),,
RL4_JR_02202,13312,20379,23354,0,0,1,0,0,0,0,0,0,0,0,2,6,1,0,232.7442422,1,-4.99633718,1.186804191,-4.20990861,2.55E-05,0.000259224,72.34834944,0,-2.711381327,1.208477888,-2.243633378,0.024856,0.068256221,188.7621963,0,-5.371439042,1.214756126,-4.421825029,9.79E-06,0.000184515,237.116229,1,-4.030014204,1.046073833,-3.852514111,0.000116911,0.001220336,287.0493313,1,-1.290937653,1.023848626,-1.26086769,0.207356521,0.330055773,N,-,,ribosomal large subunit biogenesis,"P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:cytosol; C:nucleolus; P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:preribosome, large subunit precursor",IPR029004 (PFAM); IPR006958 (PFAM); PTHR23405:SF4 (PANTHER); PTHR23405 (PANTHER); PTHR23405 (PANTHER); PTHR23405:SF4 (PANTHER),1.A.77.1.13, the mg(2+)/ca(2+) uniporter (mcu) family.
RL4_JR_02203,210,233,381,2,0,218,0,0,0,0,0,1,0,6,1,0,22,0,855.8608964,1,8.028795236,1.585767334,5.063034823,NA,NA,1.037431146,0,3.412343067,1.424482855,2.39549606,0.016597893,0.049882091,9.210938994,1,1.710841458,1.221107583,1.401057107,0.161196997,0.276650008,36.83505663,1,3.805977475,0.647400084,5.878864659,4.13E-09,1.24E-07,87.62827465,1,5.091257829,1.637232745,3.109672613,0.001872948,0.008015046,Y,-,,gegh 16,,IPR021476 (PFAM); PTHR34618:SF3 (PANTHER); PTHR34618 (PANTHER),,
RL4_JR_02204,18187,16257,17414,7,0,2,0,0,0,3,19,22,22,45,12,0,13,21,285.5561558,1,-1.64301706,0.796538259,-2.06269698,0.039141427,0.110989142,66.40160527,0,-2.58761847,1.1910951,-2.172470082,0.029820224,0.078686211,497.1284407,1,1.001440409,0.341499527,2.932479636,0.00336267,0.014737519,699.3312509,1,1.362619398,0.235556742,5.784675845,7.27E-09,2.04E-07,374.0179888,1,0.382825705,0.617752235,0.61970752,0.535450364,0.658740575,N,-,,carbohydrate-binding module family 21,,IPR005036 (PFAM); PTHR12307 (PANTHER); PTHR12307:SF18 (PANTHER); IPR005036 (PROSITE_PROFILES),,
RL4_JR_02205,57,67,35,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0.642219262,0,2.536694023,1.843552834,1.37598119,0.168827457,NA,0.206763248,0,5.739756888,1.869562886,3.07010635,0.002139826,0.015045494,16.2180904,1,4.926900501,1.075507885,4.580998958,4.63E-06,9.78E-05,0.613670545,0,2.677785071,1.433492055,1.868015286,0.06175994,0.138912027,0.51933192,0,3.031632654,1.263047051,2.400253143,0.016383737,0.046622318,N,-,,---NA---,,no IPS match,,
RL4_JR_02206,1347,976,1299,0,7,2,0,0,1,1,0,0,0,0,0,0,0,0,78.14337202,1,1.989228273,0.552160956,3.602623931,0.000315021,0.002249716,14.0017171,1,2.172295226,1.134088697,1.915454436,0.055434575,0.128194592,23.04580229,1,-0.431365385,1.196321071,-0.360576601,0.718415984,0.809604225,13.81353559,0,-1.815286423,1.197545924,-1.515838672,0.129560151,0.238162042,11.79712098,0,-1.474209227,1.201543673,-1.226929374,0.219849137,0.345970238,N,-,,kinase activator,,IPR007240 (PFAM); PTHR28005 (PANTHER),,
RL4_JR_02207,8,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.084531914,0,5.462044315,3.919371085,1.393602238,0.163437752,NA,0.027241034,0,8.664240159,2.723800602,3.18093775,0.001467992,0.015023052,0.070122379,0,6.024823835,1.551719139,3.882676758,0.000103313,0.001184529,0.080859905,0,5.601592295,2.521880211,2.221196816,0.026337634,0.08636862,0.068489917,0,5.953781473,1.310285218,4.543882041,5.52E-06,6.17E-05,N,-,,vacuolar iron transporter ccc1,P:autophagy; C:membrane; C:integral component of membrane; P:phosphorylation; F:kinase activity,IPR008217 (PFAM); PTHR31851:SF11 (PANTHER); PTHR31851:SF11 (PANTHER); PTHR31851 (PANTHER); PTHR31851 (PANTHER),2.A.89.1.1, the vacuolar iron transporter (vit) family.
RL4_JR_02208,52,57,81,0,2,0,0,1,0,0,0,0,0,3,0,0,0,0,16.77906939,1,4.049119578,1.031599161,3.925090025,8.67E-05,0.000754831,38.5762223,1,6.444105959,1.124491869,5.730682575,1.00E-08,1.49E-06,0.626876396,0,2.862122425,1.268431152,2.256427099,0.024043896,0.064465149,12.758163,1,4.727630033,0.887326976,5.3279458,9.93E-08,2.23E-06,0.621474941,0,2.772850148,1.243898277,2.229161499,0.025803161,0.067040546,N,-,,---NA---,,no IPS match,,
RL4_JR_02209,44,29,48,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.480935002,0,2.953610724,2.025936022,1.457899307,0.1448683,NA,0.15365466,0,6.167629179,1.932852522,3.190946598,0.001418075,0.015023052,0.398904113,0,3.514017642,1.298448482,2.70632042,0.006803337,0.024066031,0.460166369,0,3.092217132,1.454071543,2.126592152,0.033453985,0.098027965,0.394053989,0,3.429197243,1.249997462,2.743363366,0.006081335,0.021000518,N,-,,hypothetical protein SPBR_07905,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_02210,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.015953485,0,7.867140353,3.973076766,1.980112848,0.04769085,NA,0.005346613,0,11.01668392,3.970228347,2.774823752,0.005523163,0.021974647,0.013444566,0,8.408299533,2.921098072,2.878472179,0.003996065,0.01637703,0.015478003,0,7.987409939,3.972128364,2.010864002,0.044339824,0.114176173,0.012834372,0,8.355328124,1.611812863,5.183807821,2.17E-07,4.29E-06,N,-,,cycloheximide resistance,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); PTHR23502:SF4 (PANTHER); PTHR23502:SF4 (PANTHER); PTHR23502 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.2.33, the major facilitator superfamily (mfs).
RL4_JR_02211,5,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.036116451,0,6.688867936,3.936206087,1.699318528,0.089259183,NA,0.011865047,0,9.864558265,3.314974582,2.975756833,0.002922665,0.015423991,0.030182279,0,7.241923604,1.956978086,3.700564485,0.00021512,0.001836323,0.034776015,0,6.819019363,3.633971813,1.876464572,0.060591515,0.137522773,0.029134214,0,7.181351071,1.43229805,5.013866401,5.33E-07,8.42E-06,N,-,,salicylate hydroxylase,,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789:SF187 (PANTHER); PTHR13789 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_02212,1605,2068,1900,0,0,3,4,0,0,0,0,0,0,4,0,0,1,0,33.85580891,1,-0.294809658,0.869726838,-0.338968105,0.734633758,0.859848235,96.38017163,1,3.282791073,0.751820463,4.366456133,1.26E-05,0.000808982,18.51120758,0,-2.021290246,1.197226007,-1.688311342,0.091351479,0.18105763,37.40289442,1,0.262928584,0.759474761,0.346197921,0.729193977,0.819614677,22.09885566,1,-1.172972794,1.129899539,-1.038121313,0.29921358,0.434342293,N,-,,extradiol ring-cleavage dioxygenase,F:dioxygenase activity; P:cellular aromatic compound metabolic process; F:ferrous iron binding; P:oxidation-reduction process,IPR004183 (G3DSA:3.40.830.GENE3D); IPR004183 (PFAM); PTHR30096:SF4 (PANTHER); IPR014436 (PANTHER); IPR004183 (SUPERFAMILY),,
RL4_JR_02213,39,64,50,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.617405473,0,2.593532497,1.839859004,1.409636549,0.158647029,NA,0.196213188,0,5.815092127,1.853038953,3.138138094,0.001700248,0.015023052,0.509425894,0,3.162654662,1.292520115,2.44689009,0.014409477,0.043023708,0.587771242,0,2.73979437,1.408211136,1.945584934,0.051704618,0.125559168,0.501703257,0,3.082269365,1.251294861,2.463263824,0.013767857,0.0405703,N,-,,methyltransferase type 12,F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108:SF852 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_02214,3,4,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.051940129,0,6.164505167,3.927257941,1.569671577,0.116491537,NA,0.016370541,0,9.397405453,2.992854183,3.139947648,0.00168978,0.015023052,0.042830804,0,6.732538653,1.694588096,3.97296468,7.10E-05,0.000923699,0.049435993,0,6.310733005,3.048209506,2.070308157,0.038423496,0.104636337,0.042597013,0,6.642344925,1.354849392,4.902644503,9.46E-07,1.38E-05,N,-,,allantoate permease,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF242 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_02215,0,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.04093286,0,6.509090969,3.932768246,1.655091417,0.097905956,NA,0.012709462,0,9.763130057,3.933510723,2.482039772,0.013063269,0.041294945,0.033400243,0,7.093907348,2.486917965,2.852489486,0.004337825,0.017050402,0.038573114,0,6.669332897,3.933111544,1.695688725,0.089944845,0.18084987,0.033200902,0,7.005286476,1.655447835,4.231656429,2.32E-05,0.000203356,N,-,,Ribonuclease H,C:intracellular part,IPR012337 (G3DSA:3.30.420.GENE3D); IPR012337 (SUPERFAMILY),,
RL4_JR_02216,210,238,321,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.073795203,0,0.277600444,1.252559984,0.221626467,0.824604677,0.911402119,0.974093412,0,3.503284687,1.413003321,2.479318084,0.013163386,0.04155618,2.539176018,0,0.844361566,1.222637848,0.690606435,0.489812902,0.623992176,2.930089792,0,0.42166381,1.230178637,0.342766325,0.731774262,0.821133092,2.515755697,0,0.755375053,1.225654812,0.616303258,0.537694389,0.660377934,N,-, Effector probability:0.639,plasmid p 4b orf-3 family,F:metal ion binding,IPR002893 (PFAM); IPR024047 (G3DSA:3.10.290.GENE3D); IPR012912 (PFAM); SSF144232 (SUPERFAMILY); IPR024047 (SUPERFAMILY),,
RL4_JR_02217,3779,3503,6943,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,60.35534416,1,-2.979114077,1.192769544,-2.497644321,0.012502156,0.045390561,17.84567503,0,-0.692040057,1.235846608,-0.559972454,0.575498227,0.715400952,46.70038007,0,-3.356412944,1.223666404,-2.742915007,0.006089645,0.022031215,61.92281388,1,-2.075350294,1.067735031,-1.943694113,0.051932349,0.125762983,46.50555321,0,-3.453112089,1.237364483,-2.790699214,0.005259432,0.018671722,N,-,,serine threonine- kinase rio1,F:nucleotide binding; P:cellular macromolecule metabolic process; C:cytoplasm; F:protein kinase activity; P:phosphorylation; P:primary metabolic process,IPR000687 (SMART); IPR017407 (PIRSF); PF01163 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017407 (PTHR10593:PANTHER); PTHR10593 (PANTHER); IPR017407 (PTHR10593:PANTHER); PTHR10593 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_02218,5512,2213,3444,1,1,2,0,0,0,0,0,0,1,2,3,0,0,0,69.97848538,1,-0.834316353,0.837806799,-0.995833829,0.31933089,0.508004368,14.34709965,0,-0.377161243,1.279693502,-0.294727794,0.768201829,0.859715247,36.92183005,0,-3.017426526,1.241867273,-2.429749612,0.015109257,0.044730637,88.80816196,1,-0.065979176,0.721210243,-0.09148397,0.927108043,0.956926461,36.16831074,0,-3.090466062,1.24574124,-2.480825041,0.013107869,0.039011516,N,-, Effector probability:0.665,NADPH2 dehydrogenase,F:FMN binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR001155 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR22893:SF14 (PANTHER); PTHR22893 (PANTHER); SSF51395 (SUPERFAMILY),,
RL4_JR_02219,2,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.034972403,0,6.733719952,3.937132142,1.710310884,0.0872084,NA,0.010842141,0,9.989742612,3.938041173,2.536728839,0.011189359,0.036582263,0.028862178,0,7.299518476,2.596089798,2.811735743,0.004927497,0.01876118,0.033337935,0,6.877837922,3.937192266,1.746889016,0.080656592,0.167208843,0.029363557,0,7.175858118,1.736162342,4.13317231,3.58E-05,0.000291442,,,,,,,,
RL4_JR_02220,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein PDIP_12010,C:membrane; C:integral component of membrane,PTHR42109:SF2 (PANTHER); PTHR42109 (PANTHER),,
RL4_JR_02221,2,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.024398406,0,7.255705004,3.950296292,1.836749567,0.066246874,NA,0.007858478,0,10.45906412,3.503672134,2.985172048,0.002834189,0.015349618,0.020190067,0,7.823842655,2.055674641,3.805973231,0.000141248,0.001415819,0.023281625,0,7.398324204,3.950337591,1.872833406,0.061091393,0.137947378,0.019639628,0,7.759148925,1.450103779,5.350754226,8.76E-08,2.01E-06,N,-,,C6 finger domain,"P:regulation of transcription, DNA-templated",IPR021858 (PFAM); PTHR38791 (PANTHER),,
RL4_JR_02222,0,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.02046643,0,7.509973426,3.958630497,1.897114023,0.057812891,NA,0.006354731,0,10.76296664,3.960064592,2.717876537,0.006570235,0.024762936,0.016700122,0,8.094399799,2.742530175,2.951435091,0.00316301,0.014069558,0.019286557,0,7.669675312,3.959294103,1.937132002,0.05272921,0.126422133,0.016600451,0,8.012578593,1.566709906,5.114270715,3.15E-07,5.36E-06,N,-,,uncharacterized protein Y057_10567,F:GTP binding; F:metal ion binding,IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (SUPERFAMILY),,
RL4_JR_02223,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.007760107,0,8.901087564,4.041366561,2.202494486,0.027630398,NA,0.002334598,0,12.18995876,4.048442383,3.01102439,0.002603679,0.015349618,0.006343058,0,9.480780804,4.042868098,2.345063102,0.01902386,0.053738157,0.007335717,0,9.055356819,4.042572319,2.23999872,0.025091006,0.08557795,0.006581095,0,9.341867313,1.819064456,5.135533973,2.81E-07,4.95E-06,N,-,,uncharacterized protein Y057_10568,,IPR006073 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (SUPERFAMILY),,
RL4_JR_02224,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.004235441,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001340044,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003452355,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003983613,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003339785,0,10.24113992,1.835951848,5.578109216,2.43E-08,8.07E-07,N,-, Effector probability:0.797,hypothetical protein NECHADRAFT_90584,,no IPS match,,
RL4_JR_02225,2,5,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,11.48853097,1,9.100461076,1.083806456,8.396758506,4.59E-17,4.03E-15,0.010538566,0,10.03568073,3.395030033,2.955991738,0.003116654,0.015916638,0.027094776,0,7.400163553,2.021875483,3.660049105,0.000252167,0.002044019,0.031248852,0,6.973915455,3.802010328,1.834270518,0.066613848,0.146209671,0.026319198,0,7.339903947,1.463932978,5.013825126,5.34E-07,8.42E-06,N,-,,transcription factor,F:nucleic acid binding; F:metal ion binding,PTHR35391 (PANTHER); PTHR35391:SF1 (PANTHER),,
RL4_JR_02226,6,1,7,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3.873385796,1,7.010907575,1.394279228,5.028338251,4.95E-07,8.24E-06,0.017524277,0,9.298956951,3.127939805,2.972869534,0.002950298,0.015449001,0.045637481,0,6.639342479,1.866550324,3.557012309,0.000375097,0.002760077,0.052647401,0,6.219399886,3.177733933,1.957180814,0.050326214,0.123707918,0.045362791,0,6.54493583,1.447893145,4.520316884,6.17E-06,6.80E-05,N,-,,hypothetical protein,,IPR027417 (G3DSA:3.40.50.GENE3D),,
RL4_JR_02227,457,146,97,0,0,0,0,0,0,0,11,0,0,0,0,0,0,0,2.779788327,0,0.422616133,1.536727419,0.275010472,0.783308193,0.888395417,0.919208534,0,3.587190923,1.69195212,2.120149194,0.033993465,0.08724185,88.60642808,1,5.218505958,1.922717583,2.714130252,0.006645003,0.023580096,2.688368491,0,0.546128811,1.443658835,0.378294925,0.705211515,0.802298926,2.253133777,0,0.9140523,1.385544511,0.659706197,0.509442389,0.636146512,N,-,,3-hydroxyacyl- NAD binding,F:oxidoreductase activity; P:single-organism metabolic process,IPR000033 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011042 (G3DSA:2.120.10.GENE3D); IPR006108 (PFAM); IPR013328 (G3DSA:1.10.1040.GENE3D); IPR006176 (PFAM); PTHR23309:SF22 (PANTHER); PTHR23309 (PANTHER); PTHR23309:SF22 (PANTHER); PTHR23309 (PANTHER); SSF63825 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR008927 (SUPERFAMILY),9.B.87.1.14, the selenoprotein p receptor (selp-receptor) family.
RL4_JR_02228,50,66,82,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.793004224,0,2.232280154,1.645918254,1.35625214,0.175018958,NA,0.250937606,0,5.459979911,1.754927585,3.111228039,0.00186311,0.015023052,0.654457642,0,2.800276886,1.270233027,2.204537928,0.027486536,0.07164616,0.75525603,0,2.377618755,1.348482693,1.763180771,0.077870006,0.163236813,0.648493831,0,2.71164944,1.246175828,2.175976599,0.02955701,0.074259238,N,-, Effector probability:0.804,---NA---,,no IPS match,,
RL4_JR_02229,101,105,114,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.281554887,0,1.539804141,1.361579033,1.130895896,0.258098911,NA,0.408664582,0,4.756526575,1.59189845,2.987958545,0.002808476,0.015349618,1.060455995,0,2.104284216,1.228454127,1.712953028,0.086721182,0.173508056,1.223393043,0,1.6819192,1.257273831,1.337750901,0.180977652,0.306728947,1.045450948,0,2.022311027,1.212482892,1.667908916,0.095333809,0.184292067,N,-,,peptidase C14,C:mediator complex; P:DNA metabolic process; F:RNA polymerase II transcription cofactor activity; P:regulation of transcription from RNA polymerase II promoter,IPR029030 (G3DSA:3.40.50.GENE3D); PF00656 (PFAM); PTHR31773:SF9 (PANTHER); PTHR31773 (PANTHER); PTHR31773:SF9 (PANTHER); PTHR31773 (PANTHER),,
RL4_JR_02230,1080,1369,2429,0,5,0,0,0,0,0,0,0,1,0,4,0,1,0,59.49209475,1,0.857893136,0.907998584,0.944817703,0.344751952,0.534693237,6.112255223,0,0.853722072,1.284148832,0.664815519,0.506168496,0.659214763,16.02711362,0,-1.813534144,1.236067024,-1.467181075,0.142326804,0.252001349,66.35417952,1,0.97054375,0.779272087,1.24544914,0.2129667,0.347340179,19.84349273,1,-0.986659409,1.185264731,-0.832438006,0.405161757,0.541982136,N,-,,Mediator of RNA polymerase II transcription subunit 22,,IPR009332 (PFAM),,
RL4_JR_02231,5688,5388,9823,4,0,4,0,0,0,0,0,0,0,2,0,0,2,2,138.6874011,1,-0.72389784,0.644418771,-1.123334502,0.261295456,0.440848709,26.28299365,0,-1.250583701,1.220952133,-1.02426923,0.305708127,0.467146387,68.70044937,0,-3.91328615,1.216920355,-3.215729062,0.001301136,0.007082098,87.30962042,1,-2.628000446,1.057704787,-2.484625651,0.012968773,0.05963162,90.77158928,1,-1.383220985,0.810523134,-1.706578046,0.087900509,0.173352678,N,-,,tRNA pseudouridine synthase,P:pseudouridine synthesis; F:RNA binding; P:ncRNA metabolic process; F:pseudouridine synthase activity,IPR020094 (G3DSA:3.30.70.GENE3D); IPR020097 (PFAM); IPR001406 (TIGRFAM); IPR020095 (G3DSA:3.30.70.GENE3D); IPR001406 (PANTHER); PTHR11142:SF4 (PANTHER); IPR001406 (PANTHER); IPR020103 (SUPERFAMILY),,
RL4_JR_02232,499,575,629,9,0,0,0,0,1,1,0,0,0,1,0,0,0,2,97.41330273,1,3.682042017,1.949368342,1.888838522,0.058913469,0.150286455,11.54974531,1,3.263107109,1.128362098,2.891897128,0.003829233,0.017674189,16.71201852,1,0.654533215,1.193396665,0.548462414,0.583374431,0.70469905,10.52114889,1,0.217160675,1.147560728,0.189236761,0.849907257,0.905962809,20.30036792,1,1.298091504,0.977630487,1.3277936,0.184246302,0.30293826,N,-, Effector probability:0.844,gcn5-related n-acetyltransferase,F:transferase activity; F:N-acetyltransferase activity,IPR000182 (PFAM); IPR016181 (G3DSA:3.40.630.GENE3D); PTHR13256 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_02233,377,312,312,0,0,0,0,0,0,0,4,3,0,1,0,0,0,0,4.004601832,0,-0.104003585,1.211151038,-0.085871689,0.931568417,0.966629651,1.285783346,0,3.10293589,1.373544391,2.259072157,0.023878897,0.066239304,54.19039283,1,4.081871424,0.580129206,7.036141913,1.98E-12,1.49E-10,7.843308955,1,0.981604511,1.152019875,0.852072549,0.394173827,0.538888738,3.261816866,0,0.380377599,1.200975391,0.316723891,0.751453119,0.827057386,N,-,,Nitrogen assimilation transcription factor nit-4,F:binding,IPR007219 (SMART); IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); IPR001138 (PFAM); PTHR31313 (PANTHER); PTHR31313:SF19 (PANTHER); PTHR31313:SF19 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_02234,82,79,79,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.961417271,0,1.95446231,1.477730029,1.322611216,0.185964702,NA,0.307593022,0,5.166478392,1.677958044,3.079027161,0.002076777,0.015023052,0.796407254,0,2.517594618,1.239519,2.031106114,0.042244231,0.099669214,0.918646251,0,2.095329114,1.287327341,1.627658363,0.103597346,0.201119927,0.783314987,0,2.438574982,1.213693277,2.009218496,0.044513967,0.102339672,N,-,,D-tagatose 3-epimerase,,IPR013022 (PFAM); IPR013022 (G3DSA:3.20.20.GENE3D); PTHR12110 (PANTHER); PTHR12110:SF21 (PANTHER); IPR013022 (SUPERFAMILY),,
RL4_JR_02235,49,52,55,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.625040594,0,2.575663841,1.77021885,1.454997409,0.145669979,NA,0.199324386,0,5.792330749,1.818646569,3.184967793,0.001447701,0.015023052,0.517162656,0,3.140341307,1.260643666,2.491061821,0.012736196,0.039049438,0.596621803,0,2.717946581,1.35768876,2.001892231,0.045296323,0.115278131,0.509727193,0,3.058789177,1.224141267,2.498722377,0.012464191,0.037509351,N,-,,Alpha beta hydrolase fold-3,,IPR029058 (G3DSA:3.40.50.GENE3D); IPR013094 (PFAM); PTHR23024:SF169 (PANTHER); PTHR23024:SF169 (PANTHER); PTHR23024 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_02236,5,4,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3.862785838,1,7.341705145,1.321621392,5.555074387,2.77E-08,6.15E-07,0.014372391,0,9.587383754,3.110273247,3.08248922,0.002052772,0.015023052,0.036806162,0,6.95541204,1.783692342,3.899446041,9.64E-05,0.001133665,0.042427486,0,6.532069932,3.269434754,1.997920259,0.045725306,0.11600118,0.035764547,0,6.888631607,1.374806179,5.010620197,5.43E-07,8.54E-06,N,-,,sodium solute symporter,P:transmembrane transport; C:integral component of membrane; F:methyltransferase activity; F:transporter activity; P:methylation,IPR001734 (PFAM); IPR001734 (PANTHER); PTHR11819:SF131 (PANTHER); IPR001734 (PROSITE_PROFILES),2.A.21.6.1, the solute:sodium symporter (sss) family.
RL4_JR_02237,10,13,10,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3.951475308,1,5.757165221,1.227091161,4.691717618,2.71E-06,3.65E-05,0.042448797,0,8.023882013,2.484204275,3.229960633,0.001238073,0.015023052,0.109903271,0,5.37584799,1.439991197,3.733250592,0.000189024,0.001701051,0.12678019,0,4.95266481,2.117124232,2.339335942,0.019318054,0.075572463,0.107971305,0,5.298984333,1.279531681,4.141346721,3.45E-05,0.000283297,N,-,,xenobiotic compound family,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity",IPR016215 (PIRSF); IPR011251 (PFAM); IPR011251 (G3DSA:3.20.20.GENE3D); IPR016215 (TIGRFAM); PTHR30011 (PANTHER); PTHR30011:SF19 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_02238,17,21,17,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0.221307421,0,4.073594331,2.843703283,1.432496265,0.152001846,NA,0.070688907,0,7.288051923,2.244850236,3.246564874,0.001168068,0.015023052,15.86896508,1,6.466838864,1.060248393,6.099362101,1.06E-09,5.53E-08,0.211144348,0,4.216749153,1.767137841,2.386202737,0.017023364,0.070814115,0.179877455,0,4.562150078,1.256450399,3.630983032,0.000282344,0.001665927,N,-,,Puromycin N-acetyltransferase,F:transferase activity,IPR016181 (G3DSA:3.40.630.GENE3D); PTHR21471 (PANTHER); PTHR21471:SF61 (PANTHER); IPR016181 (SUPERFAMILY),,
RL4_JR_02239,1,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.023306281,0,7.318490338,3.952221322,1.851741019,0.064063021,NA,0.007172019,0,10.58400194,3.953884601,2.67686162,0.007431532,0.027132749,0.019188383,0,7.887106125,2.805984999,2.810815499,0.004941611,0.018765519,0.022170755,0,7.465424842,3.952399988,1.888833333,0.058914165,0.135415646,0.0196176,0,7.758757185,1.732270728,4.478951852,7.50E-06,7.90E-05,N,-,,class V Cysteine desulfurase,F:transaminase activity,IPR015422 (G3DSA:3.90.1150.GENE3D); IPR000192 (PFAM); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR11601:SF31 (PANTHER); PTHR11601 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_02240,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.035483559,0,6.713506645,3.936711262,1.705359169,0.088127459,NA,0.012024229,0,9.845157782,3.93506969,2.50190176,0.01235282,0.039545871,0.030098252,0,7.243938522,2.729142494,2.65429106,0.007947524,0.027228675,0.034635319,0,6.824549795,3.936093021,1.733838544,0.082946735,0.170352066,0.028658683,0,7.203999352,1.873470943,3.845268794,0.00012042,0.000809062,N,-, Effector probability:0.557,dicarboxylic amino acid permease,F:nucleotide binding; C:integral component of membrane; F:protein kinase activity; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR004841 (PFAM); PTHR11785:SF329 (PANTHER); IPR002293 (PANTHER),2.A.3.10.13, the amino acid-polyamine-organocation (apc) family.
RL4_JR_02241,220,218,182,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.488819116,0,0.582379805,1.251430713,0.465371194,0.641665659,0.796153376,0.798393168,0,3.790449218,1.455329668,2.604529614,0.009200047,0.031670173,2.062593759,0,1.144864219,1.220066551,0.938362107,0.348058353,0.491555982,2.378899848,0,0.722786964,1.228746743,0.588231032,0.556377231,0.685235308,2.023222513,0,1.069549378,1.206951637,0.88615761,0.375532603,0.511607589,N,-, Effector probability:0.584,transcription factor,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_02242,562,694,521,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.156084211,0,-0.941251684,1.2141,-0.775267016,0.438181896,0.628350836,2.288717522,0,2.271055542,1.31774566,1.723439972,0.084808992,0.177988102,5.920174988,0,-0.376437114,1.210645771,-0.310939106,0.755846914,0.835878435,6.828864237,0,-0.798612902,1.210386964,-0.659799656,0.509382404,0.644606529,5.810838769,0,-0.45244105,1.207378959,-0.374729944,0.70786132,0.793741546,N,-,,transcription factor,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR007219 (PFAM); PTHR31313 (PANTHER); PTHR31313:SF18 (PANTHER); PD016347 (PRODOM),,
RL4_JR_02243,3749,3339,2453,0,0,4,0,0,0,0,1,0,0,0,0,0,1,0,53.57777361,1,-0.677441264,0.791494687,-0.855901215,0.392052423,0.584496284,12.34466855,0,-0.160251236,1.242326296,-0.128992872,0.897363289,0.942779706,39.63706985,1,-1.839861022,1.207972313,-1.523098669,0.127734022,0.232753643,36.66269727,0,-3.223383978,1.210015397,-2.663919804,0.007723597,0.039495668,34.94886004,1,-1.942865849,1.135328884,-1.711280207,0.087029398,0.172171289,N,-,,Multidrug resistance 1A,F:nucleotide binding; F:ATPase activity; C:membrane; P:transport,IPR003593 (SMART); G3DSA:1.20.1560.10 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); IPR011527 (PFAM); PTHR24221 (PANTHER); PTHR24221:SF213 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR011527 (SUPERFAMILY); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.201.10, the atp-binding cassette (abc) superfamily.
RL4_JR_02244,774,623,562,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.842525212,0,-1.073627848,1.205435535,-0.890655548,0.373113989,0.565458652,2.524564557,0,2.129560459,1.312312661,1.622753878,0.104642029,0.209693425,6.51120679,0,-0.513830488,1.208689234,-0.425113812,0.67075371,0.773517548,7.508680061,0,-0.935644023,1.207777866,-0.774682207,0.438527467,0.580328141,6.379577246,0,-0.587355278,1.203142612,-0.488184254,0.625419337,0.729888209,N,-,,C6 zinc finger domain,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_02245,15,26,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.242432703,0,3.94213105,2.761288886,1.42764166,0.153395026,NA,0.07705268,0,7.163658962,2.225497892,3.218901707,0.001286826,0.015023052,0.199981328,0,4.512095181,1.376235234,3.27857845,0.001043314,0.005954063,0.230735206,0,4.088831001,1.753772312,2.331449171,0.019729687,0.076391237,0.196827752,0,4.433094564,1.274875107,3.47727753,0.000506533,0.002739702,N,-,,SPFH domain Band 7 family,,IPR001107 (PFAM); PTHR13806:SF20 (PANTHER); IPR027705 (PANTHER); IPR027705 (PANTHER); PTHR13806:SF20 (PANTHER); IPR001107 (SUPERFAMILY),,
RL4_JR_02246,4,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.048086037,0,6.275834862,3.928897297,1.59735274,0.110187101,NA,0.015371466,0,9.489257848,3.011312943,3.151202824,0.001625995,0.015023052,0.039818483,0,6.839745414,1.686120011,4.056499757,4.98E-05,0.000722512,0.04593174,0,6.417167193,3.108352057,2.064491755,0.038971115,0.105616311,0.03918078,0,6.760336148,1.344879849,5.026721275,4.99E-07,7.99E-06,N,-,,NAD dependent epimerase dehydratase family partial,C:cellular_component,no IPS match,,
RL4_JR_02247,8320,6225,4955,0,0,11,0,0,0,3,0,0,1,4,0,0,5,0,120.0934209,1,-0.492172207,0.797222608,-0.617358567,0.536998244,0.720057804,25.23729477,0,-1.191941264,1.233361088,-0.966417114,0.333835504,0.49728962,98.12752194,1,-1.393593827,0.88063828,-1.582481546,0.113539682,0.212944746,100.2086243,1,-1.234905639,0.72648973,-1.699825322,0.089163787,0.179801502,82.72915794,1,-1.005439608,0.727100735,-1.38280648,0.166724211,0.280481376,N,-,,ABC bile acid transporter,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003593 (SMART); IPR011527 (PFAM); G3DSA:1.20.1560.10 (GENE3D); IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24223 (PANTHER); PTHR24223 (PANTHER); PTHR24223:SF240 (PANTHER); PTHR24223:SF240 (PANTHER); PTHR24223 (PANTHER); PTHR24223:SF240 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY),3.A.1.208.12, the atp-binding cassette (abc) superfamily.
RL4_JR_02248,737,441,426,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.399465133,0,-0.780361588,1.24039484,-0.629123536,0.529268183,0.713209421,2.072509474,0,2.414219925,1.36925183,1.763167207,0.077872293,0.166925349,5.328313036,0,-0.224641451,1.234741947,-0.181933927,0.855634579,0.908489196,6.14306954,0,-0.646108338,1.237973811,-0.521907921,0.601734443,0.723267068,5.207121968,0,-0.29443194,1.229734412,-0.239427259,0.810774295,0.872008682,N,-, Effector probability:0.696,---NA---,,no IPS match,,
RL4_JR_02249,205,158,321,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,18.735682,1,2.225986555,1.054260336,2.111420186,0.034736212,0.101460084,0.860212266,0,3.682578861,1.467689212,2.509099904,0.012103925,0.038980568,2.24633397,0,1.020953467,1.249814572,0.816883952,0.41399475,0.556020542,2.592243398,0,0.598254662,1.266177575,0.472488752,0.636577968,0.751206519,2.232748565,0,0.927394821,1.254533281,0.739234929,0.459764354,0.591322954,N,-,,CFEM domain-containing,,IPR001578 (PFAM); IPR001578 (G3DSA:3.40.532.GENE3D); SSF54001 (SUPERFAMILY),,
RL4_JR_02250,774,646,1015,0,0,4,0,0,0,0,1,5,0,1,0,0,0,0,24.97182009,1,1.315728669,0.77289573,1.702336574,0.088692292,0.20273234,3.084172124,0,1.840557788,1.281478484,1.436276777,0.150923599,0.277956454,48.36394219,1,2.575540603,0.638369144,4.034563114,5.47E-05,0.000778936,13.27343113,1,-0.292422012,1.157285777,-0.252679172,0.800516144,0.871998489,7.947010318,0,-0.904201508,1.215162786,-0.744099077,0.456816537,0.58838156,N,-,,hypothetical protein F503_05926,C:integral component of membrane,no IPS match,,
RL4_JR_02251,13596,10403,9929,0,6,0,0,0,0,1,2,1,1,1,1,0,8,0,183.7532766,1,-1.637775346,0.934915839,-1.751789067,0.079810085,0.18781545,43.68836551,0,-1.983643622,1.211195727,-1.637756456,0.101472508,0.205010924,145.9443042,1,-1.800939684,0.757359542,-2.377919051,0.017410648,0.05026102,152.9114085,1,-2.722416897,0.865025536,-3.147209861,0.001648366,0.011284453,141.329384,1,-1.143822442,0.595191053,-1.921773583,0.054634254,0.11981196,N,-,,zinc alcohol dehydrogenase,F:zinc ion binding; F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process,IPR020843 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); PF13602 (PFAM); PTHR11695:SF294 (PANTHER); IPR002085 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_02252,3053,2955,2506,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,34.1642052,0,-3.196689278,1.193004755,-2.679527692,0.00737261,0.029730972,10.96243437,0,0.011068933,1.225394925,0.009032952,0.992792845,0.996447484,28.31830011,0,-2.634619242,1.195436224,-2.203897781,0.027531534,0.07174498,44.69545224,1,-0.757701635,0.863592268,-0.877383532,0.380278355,0.526143528,27.77750174,0,-2.709637619,1.191772943,-2.27361901,0.022988903,0.060844552,N,-,,negative acting factor,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (G3DSA:4.10.240.GENE3D); PTHR38791 (PANTHER); IPR001138 (SUPERFAMILY),,
RL4_JR_02253,1134,1532,1347,0,3,0,0,0,0,0,0,0,0,0,1,0,0,0,40.17492659,1,0.224451484,0.866547883,0.259017983,0.795621366,0.895518627,5.139782896,0,1.103833608,1.252230932,0.881493644,0.378050693,0.542409926,13.33811277,0,-1.54842302,1.201752854,-1.288470433,0.197582255,0.322676338,25.02366479,1,-1.020246143,1.15220715,-0.885471109,0.375902595,0.521439908,13.13787222,0,-1.629375124,1.204568926,-1.352662425,0.1761635,0.292930766,N,-,,N-acetylglucosamine-6-phosphate deacetylase,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; P:N-acetylglucosamine metabolic process; F:N-acetylglucosamine-6-phosphate deacetylase activity; F:hydrolase activity",IPR006680 (PFAM); G3DSA:3.20.20.140 (GENE3D); IPR011059 (G3DSA:2.30.40.GENE3D); PTHR11113 (PANTHER); PTHR11113:SF1 (PANTHER); IPR011059 (SUPERFAMILY); IPR032466 (SUPERFAMILY),,
RL4_JR_02254,148,154,213,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,2.056799475,0,0.857182442,1.287735254,0.665651141,0.50563411,NA,0.652658955,0,4.08101036,1.485873682,2.746539231,0.006022768,0.023358481,1.700147393,0,1.422955093,1.227631668,1.159105886,0.246413027,0.380635564,1.961786845,0,1.000380666,1.242857856,0.804903522,0.420875356,0.56389612,20.98629157,1,4.234761904,0.722803412,5.858801762,4.66E-09,2.34E-07,N,-,,actin-like ATPase domain-containing,"P:glycolytic process; F:hexokinase activity; P:carbohydrate phosphorylation; F:nucleotide binding; F:glucose binding; P:carbohydrate metabolic process; C:cell; F:ATP binding; P:cellular glucose homeostasis; P:phosphorylation; F:transferase activity; F:phosphotransferase activity, alcohol group as acceptor; F:kinase activity",PR00475 (PRINTS); IPR022673 (PFAM); G3DSA:3.30.420.40 (GENE3D); IPR022672 (PFAM); G3DSA:3.40.367.20 (GENE3D); PTHR19443:SF24 (PANTHER); IPR001312 (PANTHER); IPR001312 (PROSITE_PROFILES); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_02255,111,176,122,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,1.65237178,0,1.17341088,1.37217985,0.855143646,0.39247163,NA,0.52650134,0,4.391108044,1.5692942,2.798142021,0.005139751,0.02102852,24.89314344,1,4.151615686,0.885814541,4.686777527,2.78E-06,6.36E-05,1.573887098,0,1.318837337,1.283995487,1.027135493,0.304356668,0.450067367,1.340548704,0,1.663797103,1.239034618,1.342817286,0.179331145,0.296736042,N,-, Effector probability:0.719,glutathione-dependent formaldehyde-activating gfa,F:carbon-sulfur lyase activity; P:metabolic process,IPR006913 (G3DSA:3.90.1590.GENE3D); PTHR28620:SF2 (PANTHER); PTHR28620 (PANTHER); PTHR28620 (PANTHER); PTHR28620:SF2 (PANTHER); IPR011057 (SUPERFAMILY); IPR011057 (SUPERFAMILY),,
RL4_JR_02256,1918,2073,2792,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,27.10491463,0,-2.862837236,1.201066275,-2.383579737,0.01714517,0.057989343,8.598544287,0,0.361369221,1.22393456,0.295252077,0.767801322,0.859604577,22.39999402,0,-2.296504054,1.199038085,-1.915288666,0.0554557,0.122343323,25.84743751,0,-2.719190881,1.198929942,-2.268014824,0.023328303,0.082561395,29.54627452,1,-1.447878748,1.13657265,-1.273898988,0.202699217,0.324941351,N,-,,hypothetical protein SPI_09297,,IPR003615 (PFAM),,
RL4_JR_02257,10,9,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100459438,0,5.212954971,3.917374786,1.330726636,0.183278975,NA,0.032419424,0,8.413094378,2.634893699,3.192954,0.001408254,0.015023052,0.083407737,0,5.774227763,1.511937489,3.819091599,0.000133944,0.001378099,0.096174303,0,5.351318925,2.363311199,2.264331048,0.023553761,0.082979065,0.081449974,0,5.703132224,1.299911765,4.387322569,1.15E-05,0.000113466,N,-,,pantothenate transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF242 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.37, the major facilitator superfamily (mfs).
RL4_JR_02258,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.016612338,0,7.812771892,3.97064423,1.967633321,0.049110243,NA,0.005355656,0,11.01441033,3.970129233,2.774320352,0.005531718,0.021974647,0.013687801,0,8.385893671,2.919029933,2.872835792,0.004068055,0.016555546,0.015782304,0,7.96124824,3.970963317,2.004865723,0.044977404,0.115138395,0.013184218,0,8.339720293,1.621041499,5.144667981,2.68E-07,4.88E-06,N,-,,sarcosine oxidase,F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process; C:cellular_component,IPR023753 (G3DSA:3.50.50.GENE3D); IPR006076 (PFAM); PTHR10961:SF15 (PANTHER); PTHR10961 (PANTHER); PTHR10961:SF15 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_02259,3,2,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.043469247,0,6.42090492,3.931231211,1.633306355,0.102404581,NA,0.013690453,0,9.654521714,3.132390562,3.082157708,0.002055059,0.015023052,0.035926095,0,6.983858195,1.804618853,3.86999071,0.00010884,0.001228418,0.041468766,0,6.563755678,3.30892245,1.983653524,0.047294478,0.118822975,0.035917442,0,6.885729319,1.394959814,4.936148876,7.97E-07,1.20E-05,N,-,,methyltransferase type 12,F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108:SF852 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_02260,100,128,108,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,1.351783698,0,1.462995483,1.373129201,1.065446341,0.286673995,NA,0.431146278,0,4.679336308,1.59150756,2.940191064,0.003280099,0.016267106,1.117500238,0,2.029122271,1.237963962,1.639080242,0.101196549,0.195555233,1.28917754,0,1.606638616,1.26865339,1.266412582,0.205365409,0.337278956,12.68096491,1,4.146209259,0.864671336,4.795127453,1.63E-06,2.16E-05,N,-,,mg2+ transporter,P:transmembrane transport; C:membrane; C:integral component of membrane; F:metal ion transmembrane transporter activity; P:metal ion transport,IPR002523 (PFAM); G3DSA:1.20.58.340 (GENE3D); PTHR21535 (PANTHER); PTHR21535:SF54 (PANTHER); SSF144083 (SUPERFAMILY),,
RL4_JR_02261,75,80,79,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,31.48674175,1,5.680721072,0.5607942,10.12977858,4.08E-24,9.24E-22,0.299584404,0,5.204521499,1.684862196,3.088989421,0.002008386,0.015023052,0.776544448,0,2.554047458,1.241011051,2.058037643,0.03958652,0.094880192,0.895809623,0,2.131660903,1.291314791,1.650767821,0.098785993,0.194139787,0.764500737,0,2.473904923,1.21582203,2.034759087,0.04187512,0.097557659,N,-,,pantothenate transporter liz1,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF242 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.18, the major facilitator superfamily (mfs).
RL4_JR_02262,322,436,523,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,13.14378305,1,0.490495928,1.168995837,0.419587403,0.674786892,0.820826878,1.624795185,0,2.765188181,1.34833205,2.050821369,0.040284346,0.099647641,4.236433652,0,0.106038895,1.22011003,0.086909289,0.930743616,0.958641437,4.888876515,0,-0.316761654,1.222844451,-0.259036751,0.795606885,0.868332403,4.196188338,0,0.017274383,1.22661747,0.014082942,0.988763809,0.992390322,N,-,,adp-ribosylglycohydrolase family,F:hydrolase activity,IPR005502 (PFAM); PTHR16222 (PANTHER); PTHR16222:SF12 (PANTHER); IPR005502 (SUPERFAMILY),,
RL4_JR_02263,167,286,244,2,0,26,0,0,0,0,4,16,6,1,0,0,0,0,122.2235013,1,5.534323423,0.893496218,6.194008782,5.87E-10,1.71E-08,0.891105996,0,3.63185943,1.457121723,2.492488702,0.012685137,0.040377029,137.6690419,1,6.011144679,0.564619658,10.64636096,1.81E-26,4.27E-24,62.55931162,1,4.213253685,0.686436289,6.137865599,8.36E-10,2.76E-08,2.28660416,0,0.893296354,1.23918109,0.72087636,0.470985589,0.602133153,N,-,,lactose permease,,IPR005828 (PFAM); IPR003663 (TIGRFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF51 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.82, the major facilitator superfamily (mfs).
RL4_JR_02264,4548,5269,6025,0,0,10,0,0,0,0,0,0,0,2,0,0,1,2,101.6439546,1,-0.203598175,0.640107118,-0.318068913,0.750432664,0.870005683,20.16762956,0,-0.868471757,1.199946507,-0.723758727,0.469213872,0.627722748,52.44711138,0,-3.523816538,1.19286996,-2.954065956,0.00313617,0.013974728,68.53717653,1,-2.222119762,1.020230721,-2.178056115,0.029401859,0.091233167,70.4081769,1,-1.385740926,0.849945167,-1.630388618,0.103019389,0.195295134,N,-,,High-affinity nickel transport nic1,F:nickel cation transmembrane transporter activity; F:metal ion binding; C:integral component of membrane; P:nickel cation transmembrane transport; C:plasma membrane,IPR011541 (PFAM); PTHR31611 (PANTHER),2.A.52.1.8, the ni(2+)-co(2+) transporter (nicot) family.
RL4_JR_02265,1319,998,753,0,3,0,0,0,2,0,0,0,0,0,0,0,2,0,36.3310621,1,0.635707256,0.892138242,0.712565863,0.476114442,0.665320592,22.73502072,1,3.092118114,1.048968892,2.947769128,0.00320076,0.016125399,10.22685356,0,-1.165220873,1.22347292,-0.952387956,0.340900265,0.484321399,11.79124348,0,-1.586753381,1.224476854,-1.295862291,0.195022933,0.324557396,17.70641255,1,0.423606275,1.009057116,0.419804061,0.674628598,0.76852099,N,-,,calpain family cysteine protease,,IPR001300 (SMART); G3DSA:3.90.70.10 (GENE3D); IPR001300 (PFAM); PTHR10183:SF289 (PANTHER); PTHR10183:SF289 (PANTHER); PTHR10183 (PANTHER); IPR001300 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY),,
RL4_JR_02266,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein SPSK_00228,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_02267,4651,5497,6145,1,7,1,0,0,2,0,0,3,2,0,0,0,0,0,135.2468218,1,-0.09709853,0.640075251,-0.151698617,0.879424648,0.941268208,39.50791977,1,0.732509555,0.986170201,0.742782083,0.457613625,0.616607043,73.45409665,1,-1.163494727,0.857511177,-1.356827477,0.174836035,0.293782575,80.88158058,1,-2.241535036,1.017831459,-2.20226543,0.027646565,0.088414866,53.29898798,0,-3.649804369,1.198040439,-3.046478441,0.002315391,0.009607923,N,-,,mynd finger family,F:metal ion binding,IPR027974 (PFAM); IPR002893 (PFAM); SSF144232 (SUPERFAMILY),,
RL4_JR_02268,16499,19600,24101,4,9,6,0,0,1,0,5,0,2,4,0,0,7,0,376.2370596,1,-0.957086249,0.459658525,-2.082167949,0.037327132,0.107299063,85.81130244,1,-1.873170784,1.110272524,-1.687127028,0.091578929,0.189098719,238.2718215,1,-2.301186183,0.691653666,-3.327078702,0.000877616,0.005183771,264.3640735,1,-2.566603483,0.636692064,-4.031153566,5.55E-05,0.000648184,224.0060873,1,-2.189951465,0.662073363,-3.307717224,0.000940597,0.004545846,N,-,,adenylosuccinate synthetase,,IPR001114 (SMART); G3DSA:3.90.170.10 (GENE3D); IPR001114 (PFAM); IPR001114 (TIGRFAM); G3DSA:1.10.300.10 (GENE3D); G3DSA:3.40.440.10 (GENE3D); IPR001114 (PANTHER); IPR001114 (HAMAP); IPR027417 (SUPERFAMILY),,
RL4_JR_02269,4461,5525,5978,3,0,1,0,0,0,0,0,0,0,1,0,0,0,0,98.0351464,1,-1.347702787,0.760416738,-1.772321307,0.076341236,0.181624907,20.33962728,0,-0.880716687,1.202619439,-0.73233199,0.463965959,0.622764014,52.89207814,0,-3.535996117,1.19491179,-2.959211004,0.003084278,0.013803367,65.03966681,1,-3.011771867,1.148746987,-2.621788699,0.008746964,0.043734822,52.24165672,0,-3.620895305,1.19965602,-3.018277943,0.002542156,0.010366223,N,-,,actin filament organization app1,,IPR019236 (PFAM); PTHR28208:SF1 (PANTHER); PTHR28208 (PANTHER),,
RL4_JR_02270,863,949,737,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.24992366,0,-1.459679941,1.203333676,-1.213030076,0.225118322,0.396014979,3.284557869,0,1.74989338,1.28551694,1.361237122,0.173438766,0.309257843,8.488127564,0,-0.896290017,1.204222146,-0.744289598,0.456701293,0.595167213,9.790213483,0,-1.318349815,1.20299224,-1.095892201,0.273125952,0.415225265,8.325865789,0,-0.971350978,1.200564856,-0.809078304,0.418470107,0.554292234,Y,-,,Extracellular membrane CFEM domain,C:membrane; C:integral component of membrane,IPR008427 (PFAM); PTHR35607 (PANTHER),,
RL4_JR_02271,3877,4256,5441,0,0,15,0,0,0,0,0,3,0,0,1,0,0,4,111.5593352,1,0.361388189,0.905714243,0.399009061,0.689886528,0.831574216,17.23232609,0,-0.641566806,1.204141423,-0.532800213,0.594171887,0.730322749,64.35897763,1,-0.898271691,0.861126886,-1.043135113,0.29688572,0.437811529,61.40094331,1,-2.770877223,1.148951893,-2.411656433,0.015880238,0.067842788,73.85010726,1,-0.724124711,0.765146429,-0.946387102,0.343951181,0.480876238,Y,-,,vacuolar sorting receptor,C:intracellular membrane-bounded organelle; C:membrane; C:endomembrane system; C:cytoplasmic part,IPR018939 (PFAM); IPR009011 (G3DSA:2.70.130.GENE3D); PTHR15071 (PANTHER); PTHR15071 (PANTHER); PTHR15071:SF7 (PANTHER); PTHR15071:SF7 (PANTHER); IPR009011 (SUPERFAMILY),9.B.247.1.4, the mannose 6-phosphate receptor (m6pr) family.
RL4_JR_02272,587,657,1154,0,0,4,0,0,0,7,4,0,1,1,0,0,0,2,24.82731259,1,1.29763681,0.839623396,1.545498632,0.122225699,0.25575524,3.01142438,0,1.874948444,1.314133786,1.426756137,0.153650198,0.28159466,116.7450336,1,3.594264102,0.603518134,5.955519646,2.59E-09,1.28E-07,22.42286594,1,0.523234724,1.058459639,0.494336019,0.621068891,0.738846496,22.58027561,1,0.829386705,1.026483083,0.807988674,0.419097102,0.554759859,N,-,,nadp-dependent alcohol dehydrogenase,C:integral component of membrane,PTHR37019 (PANTHER); PTHR37019:SF1 (PANTHER),,
RL4_JR_02273,1196,926,1744,0,0,2,0,0,0,0,0,0,0,3,2,0,2,1,22.99753292,1,-0.332765821,1.053308059,-0.315924499,0.752059816,0.870626363,4.873936378,0,1.180343647,1.27136852,0.928404021,0.353198033,0.516927486,12.71158866,0,-1.479219009,1.217608038,-1.214856475,0.224420837,0.354653551,45.97333447,1,1.144343746,0.716561406,1.596993275,0.110267206,0.211130004,27.70308791,1,0.6327672,0.892735493,0.708795837,0.478451182,0.607971664,N,-,,heterokaryon incompatibility partial,C:membrane,no IPS match,,
RL4_JR_02274,61,67,123,0,0,19,0,0,0,0,0,0,2,0,0,0,6,0,73.55181198,1,6.372235632,1.066476,5.975038941,2.30E-09,5.92E-08,0.314827673,0,5.132604398,1.71192497,2.998147985,0.002716257,0.015349618,0.824580797,0,2.466504645,1.289165633,1.913256591,0.055715212,0.122742221,19.57630068,1,3.814901907,1.061986195,3.592233049,0.000327856,0.002922136,23.98477365,1,5.464366236,0.76553246,7.137994174,9.47E-13,9.78E-11,Y,-,,biotrophy-associated secreted 2,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_02275,619,882,1026,0,0,0,0,0,0,5,0,1,0,1,0,0,0,0,10.13441691,0,-1.443472765,1.22226856,-1.180978397,0.237611305,0.411899802,3.206256749,0,1.784572953,1.288480318,1.385021509,0.166045891,0.299219602,70.20934996,1,2.572586246,0.654741187,3.929165137,8.52E-05,0.001054991,13.66003356,1,-0.351840047,1.166370668,-0.301653717,0.762916054,0.84522926,8.280842025,0,-0.963480917,1.223859875,-0.787247736,0.431136858,0.565668094,N,-,,hypothetical protein SPI_03025,,no IPS match,,
RL4_JR_02276,17446,12007,11212,4,0,2,0,0,0,0,4,4,5,3,1,0,4,1,210.4009937,1,-2.080515768,0.679446958,-3.062072385,0.002198103,0.011292269,52.47720522,0,-2.248088852,1.220514205,-1.841919449,0.065486933,0.145715264,192.4864319,1,-1.083279616,0.587403769,-1.84418227,0.065156581,0.138901922,224.0303617,1,-1.365182854,0.56838545,-2.401861014,0.016311905,0.069115323,155.0162341,1,-2.041059692,0.714616054,-2.856162664,0.004287954,0.015804708,N,-,,WD repeat domain-containing,,IPR020472 (PRINTS); IPR001680 (SMART); IPR001810 (SMART); G3DSA:1.20.1280.50 (GENE3D); IPR001810 (PFAM); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22844:SF221 (PANTHER); PTHR22844 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001810 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR001810 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_02277,351,240,308,0,0,1,0,0,0,0,0,0,0,3,0,0,7,0,7.401127369,1,1.002860941,1.15804667,0.865993545,0.386493701,0.579279004,1.14990737,0,3.264017008,1.396444952,2.337376066,0.019419638,0.056193705,2.974484792,0,0.616217106,1.217252115,0.506236217,0.612690833,0.728256609,15.46537559,1,2.487648909,0.874526836,2.844565548,0.004447203,0.025569526,29.9496535,1,3.915465293,0.619509329,6.320268491,2.61E-10,1.69E-08,Y,-,,glycoside hydrolase family 55,C:integral component of membrane; F:hydrolase activity,IPR024429 (G3DSA:3.30.750.GENE3D); IPR012334 (G3DSA:2.160.20.GENE3D); IPR024535 (PFAM); PTHR31375:SF6 (PANTHER); PTHR31375 (PANTHER); IPR011050 (SUPERFAMILY); IPR011050 (SUPERFAMILY),,
RL4_JR_02278,6766,3717,5601,6,14,0,0,0,1,4,3,4,0,6,4,0,0,0,236.4373538,1,1.385505873,1.036760828,1.336379457,0.181425277,0.338681917,29.93369914,1,0.018881885,1.145496394,0.016483583,0.986848599,0.993621956,146.9356667,1,0.752979513,0.520121511,1.447699233,0.147701184,0.259245283,123.8851126,1,0.075601282,0.559678849,0.135079756,0.892548816,0.934062714,52.2577959,0,-3.621378813,1.215373197,-2.979643472,0.002885841,0.01146298,N,-,,inositol phospholipid synthesis Scs3p,C:membrane,IPR019388 (PFAM); IPR019200 (PFAM); IPR019388 (PANTHER); PTHR23129:SF0 (PANTHER); IPR011146 (SUPERFAMILY),9.B.287.1.2, the fat storage-inducing transmembrane protein 2 (fit2) family.
RL4_JR_02279,29,16,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.278042819,0,3.744133356,2.591026044,1.445038874,0.148446967,NA,0.089353357,0,6.949822873,2.161443571,3.215361699,0.001302803,0.015023052,0.231117278,0,4.30157103,1.354912745,3.174795608,0.001499421,0.0078776,0.266546705,0,3.880089413,1.673603233,2.318404588,0.020427343,0.077565768,0.227481255,0,4.220914289,1.266227377,3.333456821,0.00085774,0.004215833,N,-,,hypothetical protein CMQ_7542,,IPR017877 (PROSITE_PROFILES),,
RL4_JR_02280,92,181,125,0,0,4,0,0,0,0,0,13,0,0,0,0,0,0,16.88519044,1,3.857355182,0.858513328,4.49306383,7.02E-06,8.56E-05,0.511328519,0,4.433264266,1.598554371,2.77329589,0.005549164,0.022001033,85.81127417,1,6.035075433,1.700717957,3.548545724,0.000387365,0.002821353,1.532010941,0,1.357688686,1.312164672,1.034693827,0.30081192,0.446448902,1.306986891,0,1.700410433,1.260809298,1.348665842,0.177444322,0.294625083,N,-,,Clavaminate synthase,,IPR027443 (G3DSA:2.60.120.GENE3D); IPR010856 (PFAM); PTHR30613:SF1 (PANTHER); PTHR30613 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_02281,346,422,551,0,0,2,0,0,0,0,0,10,0,0,2,0,0,0,12.91385443,1,1.213096849,1.043321071,1.162726301,0.244940567,0.420501925,1.670771501,0,2.724916046,1.340612337,2.032590609,0.042093901,0.103215714,69.34417123,1,3.96692263,1.496902192,2.650088064,0.008047079,0.027495319,24.29833019,1,1.396695716,1.031021817,1.354671349,0.17552229,0.299377216,4.317523367,0,-0.023875905,1.224188494,-0.019503455,0.984439481,0.989521468,N,-,,fungal specific transcription factor domain-containing,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transmembrane transport; F:transmembrane transporter activity; P:transcription, DNA-templated; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:transporter activity; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (G3DSA:4.10.240.GENE3D); PTHR19444 (PANTHER); PTHR19444:SF22 (PANTHER),,
RL4_JR_02282,40,54,81,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.69923873,0,2.413771594,1.774248662,1.360447183,0.173688456,NA,0.220334546,0,5.647495237,1.817751306,3.106858028,0.001890872,0.015023052,0.576550487,0,2.982817957,1.299045994,2.29616039,0.021666712,0.059252781,0.665470178,0,2.560056543,1.403663125,1.823839707,0.068176309,0.148230929,0.573477239,0,2.888967522,1.272219726,2.270808622,0.023158566,0.061158184,N,-,,---NA---,,no IPS match,,
RL4_JR_02283,9436,9393,19988,3,0,114,0,0,0,0,1,22,0,3,1,0,31,2,619.7063931,1,1.614224873,1.381556577,1.168410255,0.24264132,0.417521175,48.52100774,0,-2.135046158,1.234051683,-1.730110811,0.083610479,0.175983628,278.0644149,1,0.277440765,1.467178828,0.189098125,0.850015911,0.904230439,168.5549688,1,-2.52936406,0.836031395,-3.025441478,0.002482704,0.015849548,261.4132828,1,0.284437218,0.856172282,0.332219605,0.739723441,0.818109082,N,-,,sugar transporter,"C:nucleus; C:integral component of plasma membrane; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:sugar:proton symporter activity; P:hexose transmembrane transport; P:glucose import; F:glucose transmembrane transporter activity",IPR003663 (PRINTS); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF161 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.51, the major facilitator superfamily (mfs).
RL4_JR_02284,622,756,642,0,3,10,3,0,1,1,0,0,1,2,0,0,0,0,70.33844606,1,3.255931823,0.477718531,6.815586185,9.39E-12,4.05E-10,78.90742045,1,4.723696946,0.753488845,6.269100036,3.63E-10,6.56E-08,17.78780524,1,0.403008735,1.196772006,0.336746459,0.736308037,0.82249578,25.08498957,1,1.330179292,0.860185547,1.546386469,0.12201126,0.227088972,6.605953433,0,-0.63744729,1.201267474,-0.530645592,0.595664395,0.706468672,N,-,,---NA---,,no IPS match,,
RL4_JR_02285,195,220,141,0,0,1,0,0,0,0,0,1,0,0,0,0,1,1,6.059111335,1,1.679171596,1.18755269,1.4139765,0.157368803,0.306762878,0.719825909,0,3.939952295,1.504863589,2.618145806,0.008840902,0.030730635,8.35493035,1,2.259196978,1.218255887,1.854451928,0.063674532,0.13663437,2.140698305,0,0.875092673,1.260603782,0.694185346,0.487565981,0.627747401,13.04188916,1,2.90417361,0.997791926,2.910600431,0.00360735,0.013733113,N,-,,glycosyl hydrolase family 43,"P:metabolic process; F:hydrolase activity, acting on glycosyl bonds",IPR013320 (G3DSA:2.60.120.GENE3D); IPR006710 (PFAM); IPR023296 (G3DSA:2.115.10.GENE3D); PTHR22925:SF44 (PANTHER); IPR006710 (PANTHER); IPR023296 (SUPERFAMILY); IPR013320 (SUPERFAMILY),,
RL4_JR_02286,330,652,396,0,0,2,0,0,0,0,0,0,1,0,0,0,1,0,13.22410138,1,1.108930291,1.098966655,1.009066368,0.312942806,0.500978692,1.776681901,0,2.636398762,1.396405885,1.887988865,0.059027445,0.134525246,4.606003937,0,-0.014327372,1.251160979,-0.011451262,0.990863414,0.99621844,14.6264371,1,0.51876172,1.194653916,0.434235985,0.664117084,0.771073196,8.385537007,1,0.834533075,1.178565088,0.70809248,0.478887829,0.608373811,N,-,,ribonuclease e inhibitor rraa dimethylmenaquinone methyltransferase,C:membrane; F:transferase activity,IPR002347 (PRINTS); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02287,3191,2404,3153,2,2,6,0,0,1,0,0,1,0,1,0,0,2,0,93.9422037,1,0.817876295,0.494321392,1.654543599,0.098017112,0.218237883,20.54217753,1,0.901216042,1.123587072,0.802088298,0.422501883,0.58568336,35.42640681,1,-1.70364161,1.193419606,-1.42752943,0.153427348,0.267073328,37.37915117,1,-2.140618404,1.14617751,-1.867615081,0.061815743,0.1389619,36.22408663,1,-1.079665523,0.979865346,-1.10185091,0.270526493,0.402865237,N,-,,hypothetical protein NECHADRAFT_93097,,no IPS match,,
RL4_JR_02288,314,290,328,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,3.72742405,0,-0.000552795,1.205854829,-0.000458426,0.999634229,0.999879358,1.190841206,0,3.213544081,1.369817453,2.345965205,0.018977879,0.05515359,10.93025938,1,1.524335933,1.191414747,1.279433495,0.200744445,0.32627015,3.561384871,0,0.140315889,1.202794895,0.116658202,0.907130914,0.943181404,6.902139715,1,1.411488886,1.124875201,1.254795985,0.20955283,0.33271482,Y,-,,hypothetical protein CMQ_7603,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_02289,12,2,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.105783753,0,5.138023287,3.916838474,1.311778191,0.189594986,NA,0.033881256,0,8.348237089,2.776465607,3.006785701,0.002640258,0.015349618,0.088103433,0,5.691381298,1.703235878,3.341510928,0.000833237,0.004979749,0.101626943,0,5.270718758,2.543147429,2.072517974,0.038217162,0.104214587,0.087435034,0,5.599653296,1.450414892,3.86072518,0.000113051,0.000768216,N,-,,pre-mRNA splicing factor ATP-dependent RNA helicase PRP43,,IPR022137 (PFAM); PTHR40780:SF2 (PANTHER); PTHR40780 (PANTHER),,
RL4_JR_02290,2101,1720,2470,4,20,2,0,0,2,0,0,0,0,3,0,0,0,0,233.1763098,1,3.014079209,0.865877855,3.48095195,0.000499635,0.003365833,26.75116445,1,2.10532973,0.994760949,2.116417751,0.034309294,0.087896399,20.76960542,0,-2.187503713,1.195988289,-1.829034393,0.067394456,0.142502396,35.99609376,1,-0.311058024,0.86374434,-0.360127424,0.718751845,0.812024373,20.52145842,0,-2.272856919,1.202491407,-1.890123211,0.058741484,0.126479533,N,-,,aminotransferase family,F:catalytic activity,IPR000192 (PFAM); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR11601 (PANTHER); PTHR11601:SF32 (PANTHER); PTHR11601 (PANTHER); PTHR11601:SF32 (PANTHER); PTHR11601 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_02291,2371,698,755,0,2,0,0,0,1,0,0,0,0,0,6,0,0,0,31.16719134,1,-0.188089805,1.175936974,-0.159948883,0.872921341,0.939046053,14.36174972,1,2.054126391,1.281406807,1.60302441,0.108929265,0.216192553,12.70142577,0,-1.477926989,1.312827131,-1.125759024,0.260267533,0.397128636,72.44590175,1,1.920543797,1.839344182,1.04414596,0.296417865,0.441422397,12.31942172,0,-1.536707607,1.321258658,-1.163063415,0.244803774,0.374699654,N,-,,RNA-dependent RNA polymerase,"F:FAD binding; F:metal ion binding; F:oxidoreductase activity; F:RNA-directed RNA polymerase activity; P:transcription, RNA-templated; P:oxidation-reduction process",IPR007855 (PFAM); PTHR23079:SF14 (PANTHER); IPR007855 (PANTHER); PTHR23079:SF14 (PANTHER); PTHR23079:SF14 (PANTHER); IPR007855 (PANTHER); PTHR23079:SF14 (PANTHER); IPR007855 (PANTHER); IPR007855 (PANTHER),,
RL4_JR_02292,42166,8450,23595,2,8,2,0,0,1,2,3,1,2,7,0,0,5,1,383.8891976,1,-1.742636013,0.883332731,-1.972796832,0.048518714,0.12981974,104.5580287,1,-2.199187935,1.245493312,-1.765716374,0.077443444,0.166217672,296.616082,1,-2.298841202,0.822112535,-2.796260979,0.005169764,0.019406261,328.4677764,1,-2.407829092,0.825082533,-2.918288772,0.003519582,0.021173958,265.9793964,1,-2.75463323,0.915750834,-3.008059756,0.002629214,0.010678217,N,-,,c6 zinc finger domain containing,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR007219 (SMART); IPR007219 (PFAM); PTHR30108:SF12 (PANTHER); PTHR30108 (PANTHER),,
RL4_JR_02293,4841,5718,7262,0,2,2,0,0,0,0,3,4,1,4,3,0,2,1,94.96157695,1,-1.530312667,0.770786521,-1.985391057,0.04710098,0.127235032,22.6045668,0,-1.033059556,1.204215727,-0.857869178,0.390964705,0.555382041,108.4201287,1,-0.072143169,0.592801336,-0.121698729,0.90313762,0.940385197,122.2268748,1,-0.377314028,0.562563996,-0.670704187,0.502408995,0.639860512,73.40050264,1,-1.57094035,0.86599954,-1.814019844,0.069674671,0.1444127,N,-,,clavaminate synthase,F:dioxygenase activity; P:oxidation-reduction process,IPR027443 (G3DSA:2.60.120.GENE3D); PTHR10209:SF205 (PANTHER); PTHR10209:SF205 (PANTHER); PTHR10209 (PANTHER); PTHR10209 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_02294,1747,1195,1317,0,0,0,0,0,0,0,0,4,0,2,0,0,0,0,16.99519016,0,-2.189462791,1.20018255,-1.824274809,0.068110537,0.167514549,5.471844716,0,1.013527991,1.2625139,0.80278561,0.422098661,0.585431988,40.11619732,1,1.17773506,0.765820289,1.537873934,0.124079442,0.227568889,24.30772994,1,-0.333805993,1.032905911,-0.323171732,0.746565188,0.832761102,13.85370868,0,-1.706063569,1.203524825,-1.417555778,0.156320499,0.266590037,N,-,,family Taurine catabolism dioxygenase,F:taurine dioxygenase activity; P:oxidation-reduction process,G3DSA:3.60.130.10 (GENE3D); IPR003819 (PFAM); PTHR30468 (PANTHER); PTHR30468:SF1 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_02295,3743,2521,6120,1,0,1,0,0,0,0,0,0,0,1,1,0,0,0,62.92760383,1,-1.979341372,1.081728545,-1.829794897,0.067280614,0.166074206,15.52098559,0,-0.490682141,1.253799373,-0.391356186,0.695533973,0.807240395,40.58009296,0,-3.153755813,1.23385432,-2.556019589,0.010587716,0.034213225,60.47802179,1,-1.839618658,1.074346451,-1.712314175,0.086838786,0.176059813,40.40382846,0,-3.250207179,1.248750299,-2.602767889,0.009247454,0.029517802,N,-,,oxoglutarate iron-dependent oxygenase,,no IPS match,,
RL4_JR_02296,1630,1014,1214,2,3,0,0,0,0,0,0,0,0,1,0,0,0,0,59.53303082,1,1.071546176,0.701263961,1.528021167,0.126507283,0.262101935,4.952808701,0,1.157301343,1.275081443,0.907629351,0.364074081,0.52857159,12.78002539,0,-1.486848634,1.210799492,-1.227989146,0.219451042,0.348614836,18.74903716,1,-0.962723498,1.162844533,-0.827903878,0.407724939,0.551458055,12.53999228,0,-1.562333143,1.210402691,-1.290754849,0.196788699,0.31816078,N,-,,ankyrin unc44,,IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24123 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY),8.A.28.1.2, the ankyrin (ankyrin) family.
RL4_JR_02297,6557,5878,7991,5,8,0,0,0,0,1,3,8,6,18,5,0,10,5,195.9209927,1,0.374566901,0.871639202,0.429727002,0.667394239,0.815304313,25.96169267,0,-1.232822813,1.197049473,-1.029884596,0.303064183,0.463876555,154.0650122,1,0.507209969,0.461558808,1.098906489,0.271808856,0.410592787,254.1070474,1,1.259773785,0.3286532,3.833140183,0.000126518,0.001305803,142.110808,1,0.524739155,0.453265023,1.157687286,0.246991674,0.377136284,N,-,,Autophagy-related 33,C:membrane,PTHR37278 (PANTHER); PTHR37278:SF1 (PANTHER),,
RL4_JR_02298,1759,1669,1353,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,19.18934334,0,-2.364484109,1.197950523,-1.973774429,0.048407398,0.129733098,28.47696899,1,1.768880878,1.129083911,1.56665139,0.117196199,0.229228971,15.91182525,0,-1.802951181,1.20100585,-1.501200998,0.133303582,0.240136204,22.36239505,1,-1.278289048,1.152511837,-1.109133118,0.26737276,0.408605402,15.59320496,0,-1.876649449,1.197202921,-1.56752829,0.116991259,0.215018424,N,-,,hypothetical protein CMQ_390,P:biological_process; C:cellular_component; F:molecular_function,IPR022105 (PFAM); IPR022099 (PFAM); PTHR13367:SF17 (PANTHER); PTHR13367 (PANTHER); PTHR13367 (PANTHER); PTHR13367 (PANTHER); PTHR13367:SF17 (PANTHER),,
RL4_JR_02299,25297,23663,27121,0,0,1,0,0,2,0,0,0,0,2,0,0,0,0,308.0831787,1,-5.403734207,1.139528332,-4.742079731,2.12E-06,2.96E-05,115.9096405,1,-1.490927583,0.976850379,-1.526259922,0.126945145,0.243267467,251.9657637,0,-5.788097728,1.187719766,-4.873285678,1.10E-06,2.92E-05,298.6879311,1,-4.481388633,1.009503236,-4.43920185,9.03E-06,0.00012986,248.333796,0,-5.869919601,1.193081132,-4.919966835,8.66E-07,1.28E-05,N,-,,Peptidase cysteine trypsin,,G3DSA:2.40.10.10 (GENE3D),,
RL4_JR_02300,3188,4863,4281,0,0,0,0,0,0,0,1,0,0,0,0,0,5,0,49.65983347,0,-3.736303422,1.213572712,-3.078763542,0.002078616,0.010807743,15.77149034,0,-0.513724133,1.222365796,-0.420270376,0.674287948,0.79196908,48.82746973,1,-2.206204779,1.205413697,-1.83024698,0.067213016,0.142237577,47.28911837,0,-3.590597859,1.207585804,-2.973368723,0.002945504,0.018364055,59.72046864,1,-0.353865948,0.724890302,-0.488164826,0.625433096,0.729888209,N,-,,pua rna binding domain-containing,P:biological_process; C:cellular_component; F:molecular_function,IPR021719 (PFAM); PTHR39600 (PANTHER),,
RL4_JR_02301,2959,4606,4738,0,1,7,0,0,0,0,1,0,0,0,0,0,0,0,84.19003542,1,-0.088955445,0.643330936,-0.138273228,0.890024483,0.945788685,15.65471995,0,-0.503024563,1.224552533,-0.410782346,0.681232139,0.797620788,48.62686459,1,-2.199144811,1.209089792,-1.818843254,0.068935347,0.145124029,47.06413589,0,-3.583734587,1.212027699,-2.956809148,0.003108405,0.019174726,40.33849216,0,-3.247847817,1.216835612,-2.669093332,0.007605631,0.025255524,N,-,,PUA domain-containing,F:RNA binding; C:cytosol; P:ribosome biogenesis,IPR002478 (SMART); IPR015947 (G3DSA:2.30.130.GENE3D); IPR002478 (PFAM); IPR004521 (TIGRFAM); IPR016437 (PIRSF); IPR016437 (PANTHER); IPR002478 (PROSITE_PROFILES); IPR015947 (SUPERFAMILY),,
RL4_JR_02302,49,22,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.346655282,0,3.426001277,2.465619197,1.389509491,0.164677877,NA,0.113598391,0,6.603909951,2.163778686,3.052026529,0.00227302,0.0150814,0.289902387,0,3.975833804,1.432286364,2.775865151,0.005505504,0.020352142,0.334066925,0,3.554763709,1.713839514,2.074152032,0.038065194,0.103895617,0.281202283,0,3.91496897,1.337792344,2.926439957,0.003428657,0.013184637,N,-,,MFS SP sugar:H+ symporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,IPR003663 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR003663 (TIGRFAM); IPR005828 (PFAM); PTHR23500:SF107 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.73, the major facilitator superfamily (mfs).
RL4_JR_02303,275,246,297,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.268448412,0,0.188947847,1.215027427,0.155509121,0.876419964,0.939923479,1.043607586,0,3.403926295,1.390563257,2.447875907,0.014370114,0.044547038,2.707176074,0,0.752040301,1.206039798,0.623561762,0.532915429,0.662414428,3.122975206,0,0.329748176,1.20809244,0.272949457,0.784892068,0.861035561,2.669216882,0,0.66977864,1.203136294,0.556693903,0.577736583,0.691113292,Y,-,,secreted,P:nucleocytoplasmic transport; P:biological_process; F:structural constituent of nuclear pore; C:cellular_component; F:molecular_function; C:nuclear pore,IPR033400 (PFAM); PTHR36848 (PANTHER); PTHR36848:SF1 (PANTHER); PTHR36848:SF1 (PANTHER); IPR008979 (SUPERFAMILY),,
RL4_JR_02304,12954,9958,8183,5,15,35,1,0,0,0,0,6,9,13,1,0,25,1,428.6536079,1,1.359370494,0.395480062,3.437266814,0.000587616,0.003828894,62.50842988,1,-0.934642359,1.13519608,-0.823331207,0.410319672,0.573971216,142.4699363,1,-1.128889865,0.671058426,-1.682252722,0.092519845,0.18269376,264.9120092,1,0.315105359,0.444296722,0.709222786,0.478186235,0.61881846,205.0606341,1,0.314513041,0.791299735,0.397463852,0.691025438,0.78096133,N,-,,hypothetical protein SPI_08258,,PTHR32093 (PANTHER),,
RL4_JR_02305,32,22,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.25697271,0,3.857993571,2.773677177,1.390931001,0.164246351,NA,0.083890703,0,7.04142662,2.278393382,3.090522768,0.001998045,0.015023052,0.21425068,0,4.412777494,1.456436824,3.029844771,0.002446795,0.011618831,0.246924901,0,3.991057821,1.836417063,2.17328509,0.029758867,0.091778412,0.207656341,0,4.352677968,1.33443398,3.261815897,0.00110701,0.005176922,N,-,,---NA---,,no IPS match,,
RL4_JR_02306,268,252,437,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,11.44683421,1,1.676392357,1.05936035,1.582457146,0.113545248,0.242805277,1.205721082,0,3.195473698,1.396956818,2.287453454,0.022169369,0.0624891,3.148589111,0,0.533933087,1.232592022,0.433179087,0.664884671,0.769026894,3.633556809,0,0.111144074,1.240091342,0.089625715,0.928584649,0.957620653,3.127778206,0,0.441128147,1.240176946,0.355697748,0.722066932,0.804548001,N,-, Effector probability:0.594,hypothetical protein CMQ_7276,P:biological_process; C:cellular_component; F:molecular_function,PTHR38117 (PANTHER),,
RL4_JR_02307,821,1124,996,0,7,0,0,0,2,0,0,1,1,0,1,0,2,0,67.90288959,1,2.143627288,0.998641224,2.14654396,0.031829605,0.094907135,22.52242948,1,3.18698271,1.007073865,3.164596779,0.00155298,0.015023052,16.27255768,1,-0.138043367,1.201231965,-0.11491816,0.908509991,0.94374668,30.22395062,1,0.227525103,1.024244462,0.222139451,0.824205327,0.889667264,17.35072716,1,0.481833674,0.992233017,0.485605362,0.627246994,0.731162309,N,-,,zinc-binding oxidoreductase,F:oxidoreductase activity,IPR020843 (SMART); IPR011032 (G3DSA:3.90.180.GENE3D); IPR013149 (PFAM); IPR013154 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR11695:SF460 (PANTHER); IPR002085 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_02308,10840,8856,8473,0,2,1,0,0,0,0,2,2,0,18,2,0,0,3,132.5647645,1,-2.600043048,0.858495522,-3.028604088,0.002456864,0.012341809,36.23502785,0,-1.713775638,1.20725988,-1.41955818,0.155736348,0.284799153,122.2350017,1,-1.540123793,0.75184169,-2.0484682,0.040514145,0.096577632,199.3688609,1,0.059191009,0.56037262,0.105627947,0.91587755,0.949156622,113.8615095,1,-2.200980073,0.84234183,-2.612929804,0.008976974,0.028827104,N,-,,c2h2 type zinc finger domain containing,F:binding,IPR015880 (SMART); IPR007087 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_02309,5351,3123,2336,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,63.32289868,1,-1.735727448,1.088261853,-1.594953864,0.110722553,0.238268158,14.05815304,0,-0.347785036,1.283739103,-0.270915668,0.786455894,0.870952578,36.01316978,0,-2.981449741,1.241653875,-2.401192313,0.016341746,0.047650873,41.51110132,0,-3.402594367,1.248227601,-2.725940657,0.006411853,0.034114559,35.05204591,0,-3.045236607,1.240559052,-2.454729263,0.014099073,0.041340981,N,-,,alternative oxidase,F:alternative oxidase activity; F:metal ion binding; C:integral component of membrane; P:oxidation-reduction process; C:mitochondrial inner membrane; C:respiratory chain,IPR002680 (PFAM); IPR002680 (PIRSF); PTHR31803 (PANTHER); IPR002680 (PTHR31803:PANTHER),,
RL4_JR_02310,22023,25281,27155,1,8,25,0,1,2,3,2,0,0,5,0,0,1,0,468.0714172,1,-0.659875553,0.473518154,-1.393559143,0.163450773,0.314340266,152.0808588,1,-0.904698515,0.847530496,-1.067452462,0.285767569,0.445417206,295.650554,1,-2.600031439,0.671758196,-3.87048711,0.000108618,0.001228418,304.7486789,1,-3.151723359,0.67892135,-4.642251066,3.45E-06,5.50E-05,247.3482241,1,-4.911888197,1.130532279,-4.344757147,1.39E-05,0.000132681,N,-,,eukaryotic translation initiation factor 3 subunit,,IPR023194 (G3DSA:1.10.246.GENE3D); IPR013906 (PFAM); IPR013906 (PANTHER); IPR013906 (HAMAP),,
RL4_JR_02311,3933,3913,7012,0,1,0,0,0,0,6,0,1,1,1,0,0,0,0,67.15269715,1,-3.033973888,1.183699434,-2.563128612,0.010373361,0.038998103,18.68130734,0,-0.758059928,1.227031167,-0.617800059,0.536707145,0.68390183,121.7662576,1,0.455076471,1.149489904,0.395894274,0.692183025,0.789417703,69.69990119,1,-2.108189003,1.052197035,-2.003606675,0.04511221,0.115278131,48.58930173,0,-3.516346308,1.229454025,-2.860087679,0.004235239,0.015627476,N,-,,mitochondrial distribution and morphology 31,,IPR012571 (PFAM); PTHR31068:SF0 (PANTHER); PTHR31068:SF0 (PANTHER); PTHR31068 (PANTHER); PTHR31068 (PANTHER),,
RL4_JR_02312,5899,9218,14499,0,0,9,0,0,0,0,0,0,0,4,4,0,0,0,152.7077555,1,-1.376618675,0.872025486,-1.578645001,0.114417506,0.244030854,37.15544928,0,-1.750010427,1.239242255,-1.412161682,0.15790236,0.287487769,97.4558227,0,-4.417698536,1.237795036,-3.569006506,0.000358338,0.002653847,167.0905188,1,-1.093818854,0.664708351,-1.645562076,0.099853952,0.19563105,97.16531068,0,-4.516147824,1.255998267,-3.595664058,0.000323565,0.001864597,N,-,,pre-rrna-processing pno1,"P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:RNA binding; P:protein complex assembly; C:cytosol; F:unfolded protein binding; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:nucleolus",IPR004088 (G3DSA:3.30.1370.GENE3D); PTHR12826 (PANTHER); IPR004088 (SUPERFAMILY),,
RL4_JR_02313,3422,2814,4087,8,3,3,0,0,0,0,0,1,0,4,1,0,9,1,157.1516376,1,1.25362413,0.566962904,2.211121965,0.027027392,0.083489886,13.11179626,0,-0.247311906,1.212244123,-0.204011635,0.838344406,0.903339516,40.5734806,1,-1.939909,1.195005501,-1.623347338,0.104515175,0.200248228,64.99332934,1,-0.287645855,0.683609321,-0.420775209,0.673919236,0.777865055,75.78708828,1,0.893913798,0.545508949,1.638678519,0.10128023,0.192864835,N,-,,Small ubiquitin-related SUMO,C:nucleus; P:protein sumoylation; P:mitotic sister chromatid segregation; F:protein tag; C:cellular_component; F:molecular_function; C:septin ring,IPR022617 (PFAM); G3DSA:3.10.20.90 (GENE3D); PTHR10562 (PANTHER); PTHR10562:SF27 (PANTHER); IPR000626 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY),,
RL4_JR_02314,821,977,763,0,0,5,0,0,0,0,3,0,1,1,0,0,3,2,29.39811424,1,1.544983594,0.699260135,2.209454704,0.02714303,0.083749182,3.296336914,0,1.744720766,1.283578492,1.359263011,0.174063261,0.31002434,32.05625295,1,1.506459386,0.862902008,1.745805864,0.080844692,0.164153963,23.16005204,1,0.409733945,1.024949845,0.399759995,0.689333299,0.789885077,34.68458763,1,1.963863553,0.683350724,2.873873525,0.004054713,0.015054627,N,-,,sporulation sps19,P:single-organism cellular process; P:single-organism metabolic process,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24322:SF427 (PANTHER); IPR002347 (PANTHER); IPR002347 (PANTHER); PTHR24322:SF427 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02315,9426,8217,5896,0,3,9,0,0,0,0,0,3,2,0,0,0,2,1,152.8948725,1,-0.425520605,0.552838371,-0.769701647,0.441476893,0.631411026,30.48217984,0,-1.464351052,1.227981838,-1.19248592,0.233070768,0.38328876,97.95906028,1,-1.712112356,0.886327283,-1.931693166,0.053397389,0.119021392,109.0989491,1,-2.764424231,1.042812417,-2.650931447,0.008027013,0.040677432,91.76263131,1,-1.966237027,0.867856614,-2.265624293,0.023474396,0.061814893,Y,-,,histidine acid phosphatase,,IPR000560 (PFAM); IPR029033 (G3DSA:3.40.50.GENE3D); PTHR11567:SF127 (PANTHER); PTHR11567 (PANTHER); IPR029033 (SUPERFAMILY),,
RL4_JR_02316,9059,8770,7626,3,8,12,0,1,7,6,6,20,7,26,3,0,13,4,242.218438,1,0.475334893,0.363613205,1.307254212,0.191126389,0.351173217,136.738295,1,2.002401749,0.581480217,3.443628331,0.000573964,0.015023052,328.0887296,1,1.582040938,0.357926591,4.420015098,9.87E-06,0.000185376,296.0096125,1,1.1830753,0.35582236,3.324904314,0.000884489,0.006683171,162.703024,1,0.375340661,0.420555144,0.892488575,0.372131114,0.508478749,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23502:SF29 (PANTHER); PTHR23502 (PANTHER); PTHR23502 (PANTHER); PTHR23502:SF29 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.2.33, the major facilitator superfamily (mfs).
RL4_JR_02317,2571,3575,3511,5,3,29,2,2,1,13,10,35,9,39,10,0,11,3,223.9021905,1,2.374569135,0.506051527,4.692346545,2.70E-06,3.65E-05,142.9967093,1,2.830468845,0.690451577,4.099445842,4.14E-05,0.002253726,481.8358273,1,3.832411211,0.383804142,9.985330524,1.77E-23,3.31E-21,373.585141,1,3.271899849,0.332137772,9.851032099,6.78E-23,7.63E-21,96.19205395,1,1.464077917,0.495987004,2.951847339,0.003158791,0.012343788,Y,-,,extracellular membrane partial,P:biological_process; C:cellular_component; F:molecular_function,IPR008427 (PFAM),,
RL4_JR_02318,41,22,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.338687483,0,3.459543987,2.402801731,1.439795861,0.149925163,NA,0.109918002,0,6.651272433,2.104265585,3.160852166,0.001573083,0.015023052,0.282285664,0,4.014005168,1.361253896,2.948755688,0.003190561,0.01416721,0.325422369,0,3.592478845,1.621247007,2.215873849,0.026700143,0.086889189,0.27562667,0,3.943734373,1.276661616,3.089099196,0.002007644,0.008515876,N,-,,Zinc MYND-type,F:metal ion binding,IPR002893 (PFAM); IPR002893 (PROSITE_PROFILES); SSF144232 (SUPERFAMILY),,
RL4_JR_02319,1601,1241,1443,0,2,1,0,0,0,2,0,0,0,0,4,0,2,0,36.94743506,1,0.11713877,0.846942053,0.138307892,0.889997089,0.945788685,5.485580074,0,1.009894165,1.244782339,0.81130181,0.417192371,0.581095525,36.3333687,1,0.192598646,1.031756302,0.186670676,0.851918849,0.905588663,54.91169463,1,0.697681239,0.743916297,0.937849112,0.348321958,0.495331436,21.68094928,1,-0.048526712,0.976112587,-0.049714257,0.960350095,0.973947415,N,-,,transcription factor tfiiic complex subunit,,IPR015943 (G3DSA:2.130.10.GENE3D); PTHR15052 (PANTHER); PTHR15052 (PANTHER); PTHR15052:SF2 (PANTHER); PTHR15052:SF2 (PANTHER); IPR017986 (SUPERFAMILY),,
RL4_JR_02320,978,754,656,0,1,33,2,0,3,1,5,34,16,67,8,15,24,30,143.5813246,1,3.919123844,1.054948923,3.714989189,0.000203212,0.001561023,75.84175983,1,4.770949035,0.712596101,6.695165791,2.15E-11,4.64E-09,279.1827843,1,5.152946133,0.707131784,7.287108636,3.17E-13,2.69E-11,504.0118745,1,5.818856823,0.441044048,13.1933689,9.58E-40,2.62E-37,561.762501,1,6.081805016,0.439892757,13.82565391,1.78E-43,2.58E-40,N,-, Effector probability:0.698,short-chain dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); PTHR24322:SF57 (PANTHER); PTHR24322:SF57 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02321,566,308,642,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,6.006314459,0,-0.689039641,1.252362292,-0.550191941,0.58218773,0.755565941,20.67517115,1,4.144473183,1.048221745,3.953813402,7.69E-05,0.003835161,4.984644104,0,-0.128723065,1.239395437,-0.10385956,0.9172808,0.950516972,5.750326141,0,-0.551028736,1.244269402,-0.44285324,0.657871891,0.766715365,4.932497349,0,-0.216180956,1.246797366,-0.173389006,0.862345666,0.908180765,N,-,,probable sphingolipid long chain base kinase,,PTHR39398 (PANTHER); PTHR39398:SF1 (PANTHER),,
RL4_JR_02322,56093,32728,51790,4,4,6,0,0,0,0,7,1,4,3,1,0,8,4,653.8788457,1,-2.656495674,0.495304364,-5.363360117,8.17E-08,1.63E-06,179.2248899,0,-4.020110408,1.219312968,-3.297029159,0.000977134,0.015023052,525.4726683,1,-2.85123047,0.634798628,-4.49155109,7.07E-06,0.000141469,594.1714619,1,-3.325799457,0.600903517,-5.534664654,3.12E-08,7.89E-07,517.5947885,1,-2.599980312,0.570769632,-4.555218371,5.23E-06,5.90E-05,N,-,,RAN kinase,P:7-methylguanosine RNA capping; P:negative regulation of signal transduction involved in conjugation with cellular fusion; P:protein autophosphorylation; F:methyltransferase activity; P:negative regulation of transcription factor import into nucleus; F:protein serine/threonine kinase activity; P:negative regulation of meiotic nuclear division; P:negative regulation of transcription from RNA polymerase II promoter; C:nucleus; F:ATP binding; P:RNA methylation; P:negative regulation of induction of conjugation with cellular fusion; C:cytosol; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24343 (PANTHER); PTHR24343:SF163 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.2, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_02323,52,33,62,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.583445631,0,2.674823686,1.878098107,1.424219361,0.154382982,NA,0.186041211,0,5.891645892,1.871767853,3.147637075,0.001645959,0.015023052,0.483760835,0,3.235664786,1.297090908,2.494555136,0.012611513,0.038701649,0.558102545,0,2.813756622,1.422098409,1.978594874,0.047861637,0.11960225,0.478799692,0,3.148330503,1.258660497,2.501334165,0.012372637,0.037305823,N,-,,---NA---,,no IPS match,,
RL4_JR_02324,14372,12899,18169,6,5,2,0,4,0,0,0,0,1,15,1,0,2,6,289.3468057,1,-0.999220298,0.56087329,-1.781543738,0.074823666,0.179269154,211.0313927,1,1.155635438,1.55835699,0.74157298,0.458346099,0.617349197,150.0247876,0,-5.040081715,1.195002377,-4.217633213,2.47E-05,0.000399906,252.2131097,1,-0.764927866,0.482679589,-1.584752874,0.113022493,0.214418727,200.2652306,1,-1.46499977,0.58901583,-2.487199318,0.012875324,0.038534631,N,-,,serine threonine- kinase prp4,P:cellular macromolecule metabolic process; P:phosphorylation; P:primary metabolic process; F:kinase activity,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24056:SF45 (PANTHER); PTHR24056 (PANTHER); PTHR24056:SF45 (PANTHER); PTHR24056 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_02325,8445,8638,13043,0,4,6,3,0,0,2,0,3,2,4,6,0,12,3,175.1313982,1,-0.983196901,0.55355048,-1.776164841,0.075705751,0.180851397,105.0145608,1,0.447308048,0.855612312,0.522792907,0.601118376,0.735467207,140.9519367,1,-1.29842055,0.692920154,-1.873838627,0.060952671,0.131940312,207.0896283,1,-0.499805126,0.500738782,-0.998135444,0.318213685,0.464185789,166.9178216,1,-0.112843853,0.53310033,-0.211674702,0.832360826,0.886798924,N,-, Effector probability:0.575,Coiled-coil domain-containing 72,P:biological_process; C:cellular_component; F:molecular_function,IPR015157 (PFAM); PTHR28632 (PANTHER),,
RL4_JR_02326,644,725,1003,0,0,1,0,0,2,0,0,0,0,0,0,0,2,0,13.29641569,1,-0.400738584,1.163932407,-0.344297127,0.730622845,0.85798491,21.75953538,1,3.51413537,1.004890402,3.49703347,0.000470463,0.015023052,7.828995438,0,-0.779980712,1.209165004,-0.645057299,0.518890054,0.649189683,9.034443941,0,-1.202746943,1.209183558,-0.994676892,0.319893437,0.466165954,15.48100607,1,0.788312409,1.006777131,0.783005876,0.433623662,0.568341692,N,-,,hemolysin-iii channel,C:membrane,IPR004254 (PFAM); PTHR20855:SF52 (PANTHER); IPR004254 (PANTHER); PTHR20855:SF52 (PANTHER),1.C.113.1.9, the hly iii (hly iii) family.
RL4_JR_02327,8661,6469,6579,0,4,6,0,0,1,0,0,5,2,1,0,0,9,5,141.707761,1,-0.504701447,0.515307383,-0.979418234,0.327373371,0.516878646,37.29393556,1,-0.421372904,1.128270804,-0.373467879,0.708800248,0.816857296,104.539951,1,-0.853560512,0.690573981,-1.236016032,0.216452604,0.345097034,105.7212588,1,-2.078055266,0.863502455,-2.406542395,0.016104335,0.068539886,142.2367024,1,0.351405244,0.454267941,0.77356382,0.439188775,0.573261099,N,-,,DUF221 domain,C:cell division site; C:cell tip; C:integral component of membrane,IPR032880 (PFAM); IPR027815 (PFAM); IPR003864 (PFAM); PTHR13018:SF43 (PANTHER); PTHR13018 (PANTHER),1.A.17.5.5, the calcium-dependent chloride channel (ca-clc) family.
RL4_JR_02328,13939,13860,12620,0,1,2,0,0,0,6,0,3,5,4,3,0,1,2,177.7626605,1,-3.134585943,0.85427256,-3.66930426,0.000243211,0.001820293,51.92018476,0,-2.232688314,1.197363003,-1.864671206,0.062227505,0.14028214,220.2175854,1,-0.869095544,0.520558327,-1.669544982,0.095009423,0.18662697,246.4215579,1,-0.963589607,0.452429501,-2.129811617,0.033187169,0.097510182,150.5226537,1,-2.73667689,0.836802249,-3.270398582,0.00107396,0.005052904,N,-,,hypothetical protein CMQ_7392,,no IPS match,,
RL4_JR_02329,5618,3910,3779,0,0,36,0,0,0,4,4,3,2,21,7,0,4,22,190.6352274,1,1.445873601,1.342848653,1.076721192,0.281604842,0.464771873,17.15376524,0,-0.634906646,1.231054318,-0.515742187,0.606034486,0.739515499,139.3439894,1,1.020822828,0.505557024,2.019204126,0.043466008,0.101595125,221.276801,1,1.858916504,0.415334615,4.47570811,7.62E-06,0.00011257,220.7565565,1,2.091170093,0.866934464,2.412143225,0.01585905,0.045385213,N,-,,potassium sodium efflux P-type fungal-type,"F:nucleotide binding; F:ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; P:inorganic cation transmembrane transport; F:cation-transporting ATPase activity; C:membrane; C:cell part; F:metal ion transmembrane transporter activity; P:metal ion transport; P:single-organism cellular process",PR00119 (PRINTS); IPR004014 (SMART); IPR001757 (TIGRFAM); IPR023299 (G3DSA:3.40.1110.GENE3D); PF13246 (PFAM); IPR008250 (G3DSA:2.70.150.GENE3D); IPR023214 (PFAM); IPR023298 (G3DSA:1.20.1110.GENE3D); IPR006068 (PFAM); IPR004014 (PFAM); IPR008250 (PFAM); PTHR24093 (PANTHER); PTHR24093 (PANTHER); PTHR24093:SF232 (PANTHER); PTHR24093 (PANTHER); PTHR24093:SF232 (PANTHER); IPR023214 (SUPERFAMILY); SSF81653 (SUPERFAMILY); SSF81665 (SUPERFAMILY); IPR023299 (SUPERFAMILY),3.A.3.9.2, the p-type atpase (p-atpase) superfamily.
RL4_JR_02330,3420,2141,4856,0,3,6,0,0,0,1,1,1,0,0,3,0,0,1,88.20989049,1,0.377748996,0.636864887,0.593138363,0.553088558,0.732212348,13.10492862,0,-0.246569969,1.251732068,-0.196983025,0.843840822,0.907014633,59.59523896,1,-0.492772651,0.898303868,-0.548558976,0.583308145,0.70469905,68.34949413,1,-0.934547508,0.911814173,-1.024931983,0.305395282,0.451076183,41.31869294,1,-2.055881722,1.169614987,-1.757742287,0.078791369,0.159488727,N,-,,hypothetical protein SPI_01976,,no IPS match,,
RL4_JR_02331,17394,14910,19563,1,8,13,0,0,5,0,0,1,5,6,1,0,6,0,330.7847035,1,-0.625929046,0.371775504,-1.683621001,0.092254937,0.208712085,112.9388354,1,0.329727939,0.680282368,0.484692761,0.627894302,0.755379734,177.9528048,1,-4.270904576,1.191301461,-3.585074571,0.000336982,0.002549367,278.0606048,1,-1.33507672,0.453833314,-2.941777696,0.003263341,0.019918807,192.3820059,1,-2.148930083,0.65067231,-3.302630293,0.000957826,0.004615891,N,-,,rnapii degradation factor,,IPR003892 (PFAM); PTHR16308 (PANTHER); IPR009060 (SUPERFAMILY),,
RL4_JR_02332,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.011718044,0,8.30924678,3.99658426,2.0790871,0.037609346,NA,0.004006569,0,11.4341231,3.991291091,2.864768027,0.004173148,0.018371529,0.009992212,0,8.834284459,3.994251091,2.211749902,0.02698395,0.070608817,0.011494389,0,8.415706565,3.9944702,2.106839241,0.035131517,0.099498352,0.009494587,0,8.783878684,1.912952289,4.591791826,4.39E-06,5.09E-05,N,-, Effector probability:0.729,---NA---,,no IPS match,,
RL4_JR_02333,2362,2284,1920,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,26.34945676,0,-2.821961808,1.193759963,-2.363927335,0.018082359,0.060387648,8.456380934,0,0.385530445,1.234496111,0.312297821,0.754814196,0.850426235,45.37060546,1,0.14932333,0.858500186,0.173935116,0.861916455,0.912479576,25.19077715,0,-2.681934329,1.195610777,-2.243150012,0.024887143,0.085359864,21.42132522,0,-2.334770658,1.19317999,-1.956763169,0.050375319,0.112793036,N,-,,abc transporter,F:nucleotide binding; F:ATPase activity; C:membrane; P:transport,IPR003593 (SMART); G3DSA:1.20.1560.10 (GENE3D); IPR011527 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24223 (PANTHER); PTHR24223:SF257 (PANTHER); PTHR24223:SF257 (PANTHER); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (SUPERFAMILY); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.208.41, the atp-binding cassette (abc) superfamily.
RL4_JR_02334,281,381,541,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,4.810402061,0,-0.36850867,1.25863827,-0.292783621,0.769687549,0.879181045,1.517347696,0,2.86384431,1.374114851,2.084137515,0.037147661,0.093643567,3.967081452,0,0.200728353,1.235017095,0.16253083,0.870887852,0.918328155,4.578709234,0,-0.2222702,1.241008942,-0.179104431,0.857855703,0.911415424,18.67294144,1,1.818835968,1.018634726,1.7855625,0.074170123,0.151497377,N,-,,hypothetical protein SPI_01979,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_02335,1614,1810,2584,2,0,0,0,0,0,0,0,0,0,13,2,0,1,0,44.12724052,1,-0.927104459,1.032554937,-0.897874221,0.36925261,0.561170415,7.597315412,0,0.5399597,1.235882635,0.436902085,0.66218236,0.783564396,19.81980263,0,-2.119954926,1.205827183,-1.758091836,0.078731885,0.160734342,94.29328278,1,1.973031448,0.524477433,3.761899606,0.000168628,0.001660852,23.5164093,1,-1.282304492,1.147194523,-1.117774245,0.263663424,0.395964427,N,-,,tetratricopeptide repeat 15,P:biological_process; C:cellular_component,IPR011990 (G3DSA:1.25.40.GENE3D); PTHR21581 (PANTHER); PTHR21581:SF6 (PANTHER); IPR011990 (SUPERFAMILY),,
RL4_JR_02336,2866,4189,4603,0,0,22,0,0,0,7,5,2,3,8,1,0,0,1,130.8049722,1,0.998963168,1.12674809,0.886589626,0.375299881,0.567080408,14.8141325,0,-0.423408795,1.221840379,-0.34653364,0.728941707,0.83098862,168.3085332,1,1.594786406,0.483338615,3.299522023,0.000968496,0.005604756,114.2162709,1,0.781983132,0.50674339,1.543154085,0.122793395,0.228175018,45.572731,1,-2.230936147,1.144291195,-1.94962275,0.0512211,0.114181778,N,-, Effector probability:0.563,dolichol-phosphate mannosyltransferase,C:endoplasmic reticulum membrane; P:GPI anchor biosynthetic process; F:dolichyl-phosphate beta-D-mannosyltransferase activity; P:protein N-linked glycosylation; P:dolichol metabolic process; P:protein O-linked mannosylation; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity,IPR001173 (PFAM); IPR029044 (G3DSA:3.90.550.GENE3D); PTHR10859 (PANTHER); IPR029044 (SUPERFAMILY),4.D.1.1.13, the putative vectorial glycosyl polymerization (vgp) family.
RL4_JR_02337,26,12,19,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0.226102691,0,4.042434051,2.849027975,1.418881838,0.155933468,NA,0.072982816,0,7.24186422,2.26725877,3.194105726,0.001402647,0.015023052,6.687019477,1,5.557767204,1.237779899,4.490109435,7.12E-06,0.000141869,0.217110712,0,4.176075148,1.806970726,2.311091756,0.020827787,0.078120428,0.184884242,0,4.519392718,1.286376538,3.51327359,0.000442621,0.002450269,N,-,,short-chain dehydrogenase reductase sdr,F:oxidoreductase activity; P:single-organism metabolic process,IPR016040 (G3DSA:3.40.50.GENE3D); PS51257 (PROSITE_PROFILES); IPR016040 (SUPERFAMILY),,
RL4_JR_02338,42,13,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.304474528,0,3.61305983,2.58470853,1.397859677,0.16215521,NA,0.099193128,0,6.799294566,2.203197597,3.086102932,0.002027986,0.015023052,0.25454521,0,4.16265448,1.434937727,2.900930404,0.003720565,0.01574077,0.293401311,0,3.741681921,1.753279367,2.134104805,0.032834203,0.097077583,0.248733465,0,4.091653679,1.336493754,3.061483577,0.002202431,0.009191925,N,-,,polysaccharide deacetylase,P:metabolic process; F:hydrolase activity,IPR002509 (G3DSA:3.20.20.GENE3D),,
RL4_JR_02339,11,5,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.087423688,0,5.413253504,3.918952533,1.381301115,0.167186395,NA,0.02839477,0,8.604153749,2.725160011,3.157302219,0.001592362,0.015023052,0.072929056,0,5.966321707,1.573573874,3.791573948,0.000149696,0.001477113,0.084071312,0,5.544971426,2.513829218,2.205786847,0.027398928,0.088070176,0.071255695,0,5.892667429,1.327332621,4.439480605,9.02E-06,9.18E-05,N,-,,polysaccharide deacetylase family,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; P:carbohydrate metabolic process; C:membrane part",no IPS match,,
RL4_JR_02340,1363,1110,1698,0,0,3,0,0,0,1,2,3,3,15,2,0,1,2,28.06922999,1,0.135445922,0.871007328,0.155504917,0.876423278,0.939923479,5.289841095,0,1.062236332,1.246961164,0.851859996,0.394291802,0.558419144,60.00927582,1,1.811687755,0.628781628,2.881266999,0.0039608,0.016313725,123.253309,1,2.975797211,0.417430405,7.128846333,1.01E-12,4.81E-11,32.19972491,1,0.545230276,0.860792131,0.633405274,0.526469022,0.650378092,N,-,,hypothetical protein FOMG_09848,,no IPS match,,
RL4_JR_02341,1042,1388,1024,0,0,10,0,0,0,0,2,6,0,12,2,0,0,0,52.10757318,1,1.96522157,0.666908598,2.946762983,0.003211192,0.01523076,4.446910762,0,1.312771318,1.27193222,1.03210792,0.302021564,0.462560489,66.18846714,1,2.465051179,0.575174768,4.285742903,1.82E-05,0.000314119,80.68715385,1,2.679378091,0.515915247,5.193446221,2.06E-07,4.33E-06,11.30292898,0,-1.41234752,1.207743265,-1.169410388,0.242238326,0.371647547,N,-,,---NA---,,no IPS match,,
RL4_JR_02342,4998,5177,4552,2,7,17,0,0,1,4,3,13,9,12,6,0,4,7,200.2281684,1,1.406428875,0.355816806,3.952676914,7.73E-05,0.000681583,28.30446181,1,0.13997825,1.119954677,0.124985638,0.90053492,0.944488746,201.249024,1,1.70609072,0.3856964,4.423403273,9.72E-06,0.000184115,246.2300733,1,1.661202306,0.332543996,4.995436168,5.87E-07,1.13E-05,115.0871622,1,0.596169212,0.474316107,1.256902734,0.208788858,0.331850351,N,-,,umta methyltransferase family,F:methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108:SF923 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_02343,174,192,218,0,0,46,0,0,0,0,0,0,0,0,0,0,0,0,177.992182,1,6.258611535,2.029419388,3.083941926,0.002042775,0.010648534,0.744140729,0,3.891839782,1.451623833,2.681024997,0.007339703,0.026868889,1.933793677,0,1.237454239,1.21545434,1.018100145,0.308630367,0.449773115,2.231121492,0,0.814979167,1.224342884,0.665646183,0.50563728,0.642114318,1.909264145,0,1.153408932,1.211213074,0.952275827,0.340957114,0.478275253,Y,-,,L-asparaginase,P:cellular amino acid metabolic process,IPR006034 (PRINTS); IPR006034 (SMART); IPR027473 (G3DSA:3.40.50.GENE3D); IPR006034 (PIRSF); IPR027474 (G3DSA:3.40.50.GENE3D); IPR027474 (PFAM); PIRSF500176 (PIRSF); PTHR11707:SF29 (PANTHER); PTHR11707 (PANTHER); IPR006034 (PROSITE_PROFILES); IPR006034 (SUPERFAMILY),,
RL4_JR_02344,36,50,61,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4.407625733,1,3.60557742,1.203503704,2.99590056,0.002736357,0.013415382,0.186286292,0,5.889770122,1.860123016,3.166333663,0.001543736,0.015023052,0.485987538,0,3.229655639,1.289712421,2.504167276,0.012273999,0.03790786,0.560852705,0,2.806983283,1.410693569,1.989789523,0.046614126,0.11755119,0.481647699,0,3.140960813,1.253849115,2.505054854,0.01224324,0.037003824,N,-,,NADH:flavin oxidoreductase NADH oxidase,F:FMN binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR001155 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR22893:SF70 (PANTHER); PTHR22893 (PANTHER); SSF51395 (SUPERFAMILY),,
RL4_JR_02345,1,0,1,0,0,59,0,0,0,0,0,0,0,0,0,0,0,0,225.3024658,1,14.82275626,3.14670334,4.710566792,2.47E-06,3.37E-05,0.002502822,0,12.10389348,4.040376809,2.995733828,0.002737853,0.015349618,0.006502266,0,9.448056946,3.305547956,2.858242286,0.00425995,0.016940088,0.007499321,0,9.02784755,4.040049892,2.234588134,0.025444401,0.085851084,0.00645541,0,9.348501478,1.703823852,5.486776974,4.09E-08,1.17E-06,Y,-,,copper amine oxidase,P:amine metabolic process; F:copper ion binding; F:quinone binding; F:primary amine oxidase activity; P:oxidation-reduction process,IPR000269 (PRINTS); G3DSA:3.10.450.40 (GENE3D); IPR015328 (PFAM); IPR015798 (PFAM); G3DSA:3.10.450.40 (GENE3D); IPR015798 (G3DSA:2.70.98.GENE3D); IPR000269 (PANTHER); PTHR10638:SF20 (PANTHER); IPR016182 (SUPERFAMILY); IPR015798 (SUPERFAMILY); IPR016182 (SUPERFAMILY),,
RL4_JR_02346,6,13,25,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0.175498156,0,4.408033915,3.269101514,1.348393097,0.177531983,NA,0.054616193,0,7.659194345,2.460587607,3.11275011,0.001853529,0.015023052,7.987116814,1,5.940010073,1.283058732,4.62956989,3.66E-06,8.05E-05,0.166472212,0,4.558971008,2.08870944,2.182673627,0.029059853,0.09053262,0.144670069,0,4.877017774,1.392495198,3.502358775,0.000461158,0.002534868,Y,-,,fad dependent oxidoreductase,,PF13450 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR10742:SF282 (PANTHER); PTHR10742 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_02347,378,518,296,0,0,2,0,0,0,2,14,23,3,6,6,0,5,1,12.45603565,1,1.332442796,1.07320897,1.241550186,0.214402571,0.38281816,1.544491173,0,2.838504003,1.397681238,2.030866499,0.042268539,0.103497469,285.3984298,1,6.213228306,0.481054371,12.9158546,3.66E-38,1.55E-35,114.4155262,1,4.464000095,0.501594534,8.899618708,5.60E-19,4.81E-17,30.56849254,1,3.284944273,0.688394992,4.771888686,1.83E-06,2.40E-05,Y,-,,cellobiose dehydrogenase,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; P:oxidation-reduction process",IPR012132 (PIRSF); IPR023753 (G3DSA:3.50.50.GENE3D); IPR007867 (PFAM); IPR000172 (PFAM); G3DSA:3.30.410.10 (GENE3D); PTHR11552 (PANTHER); PTHR11552:SF121 (PANTHER); SSF54373 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_02348,21,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.105662018,0,5.139661811,3.916849906,1.312192689,0.189455128,NA,0.035222526,0,8.293377571,2.996154127,2.768007659,0.005640013,0.022256613,0.089255481,0,5.674574785,1.944384622,2.918442534,0.003517847,0.015259076,0.102783632,0,5.254907906,2.806965042,1.872095957,0.061193329,0.138114681,0.086254629,0,5.618104746,1.659344165,3.385738091,0.000709871,0.003631856,N,-,,kinase domain-containing,,IPR000719 (SMART); IPR001245 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24055:SF199 (PANTHER); PTHR24055 (PANTHER); PTHR24055 (PANTHER); PTHR24055:SF199 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_02349,137,135,178,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1.797558065,0,1.051548083,1.29440006,0.812382597,0.416572129,NA,0.571651889,0,4.272232063,1.51015262,2.82900682,0.00466927,0.019750253,1.48691103,0,1.616320297,1.22459471,1.319881822,0.186874478,0.308884443,11.35086161,1,2.143585087,1.150483245,1.863204088,0.062433558,0.139909847,1.470174584,0,1.530359686,1.218659225,1.255773276,0.209198184,0.332360208,N,-,,heterokaryon incompatibility,C:membrane; C:integral component of membrane,IPR010730 (PFAM); PTHR33112:SF6 (PANTHER); PTHR33112 (PANTHER); PTHR33112 (PANTHER); PTHR33112:SF6 (PANTHER),,
RL4_JR_02350,7651,10539,8595,3,4,8,0,0,6,1,17,16,5,15,11,0,14,19,200.6563163,1,-0.219500185,0.461071799,-0.476065084,0.634028011,0.791550676,90.6451255,1,1.504982995,0.659611929,2.281618826,0.022511854,0.063260685,337.5072205,1,1.559678736,0.441106613,3.53583168,0.000406494,0.002916613,315.5463535,1,0.999010134,0.362585088,2.7552433,0.005864851,0.031840006,281.6863352,1,1.27400359,0.562849326,2.26348959,0.023605526,0.062144032,N,-,,---NA---,,no IPS match,,
RL4_JR_02351,40,49,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.456898485,0,3.027879267,2.13303972,1.419513776,0.155749283,NA,0.147098269,0,6.231014467,1.997076043,3.120068708,0.001808089,0.015023052,0.378511557,0,3.591838753,1.343244117,2.674002966,0.007495179,0.025942287,0.436484187,0,3.169353903,1.529935422,2.071560576,0.03830644,0.104401804,0.369217106,0,3.523926902,1.274902204,2.764076249,0.00570842,0.019971579,N,-,,ino80 chromatin remodeling complex,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR003594 (G3DSA:3.30.565.GENE3D); PTHR32387 (PANTHER); IPR003594 (SUPERFAMILY),,
RL4_JR_02352,208,196,246,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.597090648,0,0.520677819,1.236990139,0.420923177,0.67381118,0.820073342,0.82759307,0,3.738483904,1.430425576,2.613546602,0.008960786,0.031046571,2.149650973,0,1.08464592,1.211984557,0.89493378,0.370822488,0.515263792,2.480025726,0,0.662266215,1.218216727,0.543635792,0.586692125,0.711834364,2.12236393,0,1.000596871,1.208972883,0.827642112,0.407873211,0.543906247,N,-,,c6 zinc finger domain containing,"P:acyl-CoA metabolic process; F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; C:membrane; C:integral component of membrane; F:acyl-CoA hydrolase activity",no IPS match,,
RL4_JR_02353,2488,1918,3635,0,2,8,0,0,0,0,0,2,2,5,2,0,0,2,78.51441794,1,0.868270513,0.595381142,1.458343994,0.144745749,0.289420545,10.13611887,0,0.124020159,1.240741872,0.099956455,0.920378896,0.95598514,39.43446428,1,-0.722255792,1.060547734,-0.681021485,0.495857896,0.629002047,88.45895855,1,0.939764863,0.57020008,1.648131763,0.099325636,0.194822174,40.97199617,1,-0.921085627,1.008547657,-0.91327923,0.361095703,0.498512953,N,-,,prolyl 4-hydroxylase,"F:L-ascorbic acid binding; F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process",IPR006620 (SMART); IPR005123 (PFAM); PTHR10869 (PANTHER); PTHR10869:SF50 (PANTHER); IPR005123 (PROSITE_PROFILES),,
RL4_JR_02354,11843,5780,4063,16,11,1,2,0,0,1,9,6,0,0,4,0,3,0,339.4801919,1,1.501598164,0.99925257,1.502721343,0.132910917,0.271343157,72.92858076,1,0.386535651,1.078034562,0.358555899,0.719927343,0.824790853,192.9355073,1,0.799770837,0.609707615,1.31172847,0.189611767,0.312541441,121.8449507,1,-1.241882745,1.555499743,-0.798381838,0.424648939,0.567375364,81.73652327,1,-1.904227136,0.975457987,-1.952136495,0.050922001,0.113765504,N,-,,FAD binding domain-containing,F:oxidoreductase activity,PR00420 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR002938 (PFAM); G3DSA:3.30.9.10 (GENE3D); G3DSA:3.40.30.20 (GENE3D); IPR012941 (PFAM); PTHR13789 (PANTHER); PTHR13789:SF228 (PANTHER); IPR012336 (SUPERFAMILY); SSF54373 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_02355,4476,3025,3540,2,2,0,0,0,0,1,0,4,0,0,0,0,0,0,80.18189889,1,-0.794402933,0.756746758,-1.049760604,0.293828192,0.478945557,14.16367426,0,-0.358587251,1.226021827,-0.292480316,0.769919408,0.860738265,73.64388204,1,0.133124961,0.690101821,0.19290626,0.847032382,0.902149509,42.18427834,0,-3.42582443,1.20126521,-2.851846872,0.004346603,0.02518706,35.91731171,0,-3.080427338,1.199874365,-2.567291566,0.010249639,0.032049905,N,-,,amidase,"F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (PFAM); PIRSF001221 (PIRSF); IPR023631 (G3DSA:3.90.1300.GENE3D); PTHR11895:SF80 (PANTHER); PTHR11895:SF80 (PANTHER); IPR000120 (PANTHER); IPR023631 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_02356,166,241,240,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.600352556,0,0.519131226,1.275926202,0.406866185,0.684106273,0.828155361,0.82479929,0,3.743380028,1.450546545,2.580668673,0.009860917,0.033237497,2.146086791,0,1.087340637,1.229458412,0.884406196,0.37647698,0.520263847,2.47635973,0,0.664662061,1.241067725,0.53555664,0.592265003,0.715594648,2.11998677,0,1.002456394,1.227027939,0.816979273,0.413940273,0.549946892,N,-,,3-hydroxyisobutyrate dehydrogenase,,IPR006115 (PFAM); IPR013328 (G3DSA:1.10.1040.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR029154 (PFAM); PTHR22981:SF27 (PANTHER); PTHR22981 (PANTHER); IPR008927 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR008927 (SUPERFAMILY),,
RL4_JR_02357,98,88,136,0,0,1,0,0,0,0,0,2,0,0,0,0,2,0,5.101749411,1,2.482697676,1.178251964,2.107102514,0.035108694,0.102182208,0.407557845,0,4.760302326,1.60434995,2.967122182,0.003006015,0.015613125,14.0590134,1,3.917928675,1.049976249,3.73144505,0.000190385,0.001705711,1.224870107,0,1.679813559,1.280051473,1.312301571,0.189418402,0.317911605,8.772643423,1,3.672394224,1.007993679,3.643271084,0.000269195,0.001606064,N,-,,fructose-bisphosphate aldolase,F:aldehyde-lyase activity; P:carbohydrate metabolic process; F:zinc ion binding,IPR013785 (G3DSA:3.20.20.GENE3D); IPR000771 (PIRSF); IPR000771 (PFAM); PTHR30304 (PANTHER); PTHR30304:SF7 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_02358,35,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.215406959,0,4.112435912,3.126335253,1.315417439,0.188369648,NA,0.071340423,0,7.275331975,2.481523034,2.931801106,0.003370025,0.016450773,0.18076641,0,4.657578484,1.62180265,2.871852801,0.00408073,0.01656508,0.208211091,0,4.236955011,2.105310198,2.012508663,0.044166344,0.114077612,0.173979908,0,4.607424577,1.466055491,3.142735459,0.00167377,0.007298417,N,-,,dihydroxyacetone kinase,P:glycerol metabolic process; F:ATP binding; F:glycerone kinase activity; P:phosphorylation,IPR004007 (SMART); IPR004007 (PFAM); G3DSA:3.30.1180.20 (GENE3D); IPR012734 (TIGRFAM); IPR004006 (PFAM); G3DSA:3.40.50.10440 (GENE3D); PTHR28629 (PANTHER); PTHR28629:SF3 (PANTHER); IPR004007 (PROSITE_PROFILES); IPR004006 (PROSITE_PROFILES); SSF82549 (SUPERFAMILY); IPR004007 (SUPERFAMILY),,
RL4_JR_02359,17,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.078042411,0,5.576580717,3.920410885,1.422448024,0.15489623,NA,0.026205791,0,8.719840308,3.919765876,2.224581923,0.026109317,0.070833157,0.066137119,0,6.107138078,2.463904193,2.478642674,0.013188335,0.040180171,0.076138449,0,5.687825331,3.920130333,1.450927609,0.146800019,0.261819657,0.0636743,0,6.056251238,1.936735089,3.127041624,0.001765749,0.007620721,N,-, Effector probability:0.67,ribose 5-phosphate isomerase,P:carbohydrate metabolic process; F:ribose-5-phosphate isomerase activity,IPR003500 (G3DSA:3.40.1400.GENE3D); IPR011860 (TIGRFAM); IPR003500 (TIGRFAM); IPR003500 (PFAM); IPR003500 (PIRSF); IPR003500 (PANTHER); IPR003500 (SUPERFAMILY),,
RL4_JR_02360,375,297,355,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.100100479,0,-0.138180143,1.20683975,-0.114497507,0.908843422,0.955724256,1.313205504,0,3.072440167,1.363916197,2.252660518,0.024280562,0.066984969,3.400268559,0,0.423241445,1.206019354,0.35094084,0.725632732,0.814175527,3.922021592,0,0.00111378,1.20636196,0.000923255,0.999263349,0.999460773,3.346883904,0,0.343254656,1.202250761,0.285510034,0.775253418,0.84464737,N,-,,triosephosphate isomerase,P:gluconeogenesis; P:pentose-phosphate shunt; P:glycolytic process; F:triose-phosphate isomerase activity,IPR013785 (G3DSA:3.20.20.GENE3D); IPR000652 (PFAM); IPR000652 (PANTHER); PTHR21139:SF2 (PANTHER); IPR000652 (PROSITE_PROFILES); IPR000652 (SUPERFAMILY),,
RL4_JR_02361,1,5,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.079403967,0,5.552034727,3.920181071,1.41626997,0.156696477,NA,0.024377933,0,8.821942972,3.049259325,2.893142901,0.003814077,0.017631542,0.064993917,0,6.129984183,1.903677802,3.220074414,0.001281573,0.007010146,0.075099547,0,5.707074464,2.949888199,1.934674834,0.05303021,0.126787733,0.065931453,0,6.01148431,1.582107336,3.799669071,0.000144889,0.000947728,N,-,,ankyrin repeat,,IPR031359 (PFAM),,
RL4_JR_02362,10,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.055646524,0,6.064898101,3.925894143,1.544845041,0.12238375,NA,0.018542663,0,9.220038812,3.189859906,2.890421236,0.003847259,0.01770089,0.046835964,0,6.606608933,1.963470444,3.364761081,0.0007661,0.004649876,0.05393333,0,6.1857299,3.239326602,1.909572779,0.056188243,0.131685525,0.044958525,0,6.555259777,1.535290409,4.269719747,1.96E-05,0.000176304,N,-, Effector probability:0.809,---NA---,,no IPS match,,
RL4_JR_02363,3801,3733,3537,2,1,20,0,0,1,0,0,1,0,3,3,3,2,5,148.8933428,1,1.461271327,0.567954711,2.572865934,0.010086027,0.038115088,23.58600819,1,0.553830665,1.118259875,0.495261144,0.620415795,0.750106518,43.26420282,1,-2.049456942,1.188563186,-1.724314675,0.084651052,0.169939966,83.34805357,1,-0.115212353,0.610783725,-0.188630358,0.850382537,0.906328757,128.7588345,1,0.901968013,0.490911115,1.837334673,0.066160504,0.139035929,N,-, Effector probability:0.566,alcohol dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR023210 (PFAM); IPR023210 (G3DSA:3.20.20.GENE3D); IPR001395 (PANTHER); PTHR11732:SF203 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.6, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_02364,1482,1917,1936,0,0,1,0,0,0,2,0,0,0,0,0,0,0,0,25.23839162,1,-1.576238225,1.15312731,-1.36692472,0.171648903,0.325351243,6.808001181,0,0.698281499,1.233376517,0.566154365,0.571288849,0.711878091,39.83436647,1,-0.123525685,1.035787613,-0.119257735,0.905071167,0.941623728,20.41578915,0,-2.378773609,1.197128857,-1.987065633,0.046915124,0.118133706,17.46319406,0,-2.039978498,1.203154033,-1.695525628,0.089975753,0.176346205,N,-,,Major facilitator superfamily general substrate transporter,P:transmembrane transport; C:integral component of membrane,IPR006076 (PFAM); IPR011701 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF264 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR023753 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_02365,4,2,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.086175795,0,5.433699585,3.919126214,1.386456901,0.165607432,NA,0.026698968,0,8.69055804,2.926565484,2.969541631,0.002982444,0.015552961,0.070972123,0,6.001808688,1.817309616,3.302579062,0.000958001,0.005548513,0.081978813,0,5.580245497,2.7801091,2.007203781,0.044727969,0.114768711,0.071987779,0,5.882922826,1.540263221,3.819426931,0.000133762,0.000884035,,,,,,,,
RL4_JR_02366,3,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.023358204,0,7.315437055,3.952125779,1.851013218,0.064167652,NA,0.007508467,0,10.52125751,3.951891025,2.662334929,0.007760062,0.027959129,0.019506799,0,7.865462077,2.651210638,2.966743557,0.003009719,0.01361501,0.022497964,0,7.445332924,3.951772468,1.884048989,0.059558349,0.136354635,0.019366229,0,7.768283252,1.545930068,5.024990078,5.03E-07,7.99E-06,N,-,,pectate lyase,F:pectate lyase activity; C:extracellular region,IPR012334 (G3DSA:2.160.20.GENE3D); IPR004898 (PFAM); PTHR33407:SF7 (PANTHER); PTHR33407 (PANTHER); IPR011050 (SUPERFAMILY),,
RL4_JR_02367,351,293,253,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.593648921,0,0.052281361,1.231318063,0.042459672,0.96613226,0.982922264,1.156728251,0,3.255571395,1.403850898,2.319029322,0.020393446,0.058410432,2.983025484,0,0.612418996,1.219672324,0.502117646,0.615584768,0.730105458,3.440010475,0,0.190574531,1.223825767,0.155720312,0.876253486,0.923604291,2.921932227,0,0.539128848,1.209091852,0.445895692,0.655672594,0.754396024,N,-,,MFS DHA1 multidrug resistance,P:regulation of anion transmembrane transport; P:transmembrane transport; C:integral component of membrane; P:chloride transport; F:voltage-gated chloride channel activity,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); PTHR23502:SF9 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.77, the major facilitator superfamily (mfs).
RL4_JR_02368,837,647,593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.310536383,0,-1.15727646,1.206863123,-0.958912769,0.337602691,0.527542736,2.677049849,0,2.044948636,1.31053492,1.56039233,0.118667196,0.231524549,6.902217143,0,-0.59798308,1.210074654,-0.494170403,0.62118584,0.734597061,7.959372572,0,-1.019757852,1.209342179,-0.843233511,0.39909786,0.543346219,6.761125383,0,-0.671163336,1.204913259,-0.557022118,0.577512317,0.691031577,N,-, Effector probability:0.583,Cutinase transcription factor 1 beta,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); PTHR19444 (PANTHER); PTHR19444:SF29 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_02369,629,619,609,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.441573812,0,-0.997771265,1.1904523,-0.838144682,0.401949451,0.593717838,2.380416593,0,2.214345587,1.292783403,1.712851188,0.08673992,0.181363659,6.163502347,0,-0.434658103,1.195238643,-0.363658007,0.716113405,0.807881893,7.109572789,0,-0.856826269,1.192458725,-0.718537464,0.472425956,0.613481186,6.061968819,0,-0.513549473,1.192464013,-0.43066245,0.666713826,0.763110727,N,-,,Peroxisomal (S)-2-hydroxy-acid oxidase GLO4,F:FMN binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR012133 (PIRSF); IPR013785 (G3DSA:3.20.20.GENE3D); IPR000262 (PFAM); PTHR10578 (PANTHER); PTHR10578:SF65 (PANTHER); IPR012133 (PROSITE_PROFILES); SSF51395 (SUPERFAMILY),,
RL4_JR_02370,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003906015,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,0,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,N,-,,O-acetylhomoserine (thiol)-lyase,"F:pyridoxal phosphate binding; F:lyase activity; P:cellular amino acid metabolic process; F:transferase activity, transferring alkyl or aryl (other than methyl) groups",IPR006235 (TIGRFAM); IPR000277 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR015421 (G3DSA:3.40.640.GENE3D); IPR000277 (PIRSF); IPR006235 (PTHR11808:PANTHER); IPR000277 (PANTHER); IPR006235 (PTHR11808:PANTHER); IPR000277 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_02371,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,nadp-dependent leukotriene b4 12-hydroxydehydrogenase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR011032 (G3DSA:3.90.180.GENE3D); PF16884 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013149 (PFAM); PTHR11695:SF528 (PANTHER); IPR002085 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_02372,32,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.148628181,0,4.647522617,3.913937665,1.18742888,0.235058494,NA,0.04991328,0,7.79043744,2.946659444,2.643820091,0.008197622,0.029073695,0.12589359,0,5.178606418,1.986228244,2.607256459,0.009127097,0.030445711,0.144929726,0,4.759258171,2.69423923,1.766457157,0.077319183,0.162519562,0.121068113,0,5.130098743,1.758832274,2.916764048,0.003536832,0.013498087,N,-,,homoserine O-acetyltransferase,F:homoserine O-acetyltransferase activity; P:methionine biosynthetic process; C:cytoplasm,IPR000073 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR008220 (PIRSF); IPR008220 (TIGRFAM); PTHR32268 (PANTHER); PTHR32268:SF13 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_02373,17,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.086157906,0,5.433988325,3.919128684,1.386529702,0.165585217,NA,0.028713134,0,8.588271336,3.059869963,2.806743894,0.005004501,0.020667464,0.072761003,0,5.969342822,1.955644395,3.052366186,0.002270449,0.010919729,0.083789921,0,5.549662147,2.93040401,1.89382151,0.058248706,0.134804147,0.070304632,0,5.912176019,1.631295479,3.624221421,0.000289833,0.001702182,N,-,,Dihydrofolate reductase,,IPR029058 (G3DSA:3.40.50.GENE3D); IPR005645 (PFAM); IPR029058 (SUPERFAMILY),,
RL4_JR_02374,3807,3704,5675,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,108.8592798,1,-0.352694581,0.703294471,-0.501489198,0.616026878,0.77932821,16.67228313,0,-0.593915409,1.212578441,-0.489795455,0.624278647,0.752972887,43.46606511,0,-3.252874234,1.202291036,-2.705563076,0.00681887,0.024094055,50.15678054,0,-3.675592782,1.203925441,-3.053006986,0.002265607,0.014633629,43.09305198,0,-3.343162178,1.211495814,-2.759532587,0.005788411,0.020199651,N,-,,hypothetical protein SPI_04303,,IPR003615 (PFAM),,
RL4_JR_02375,3378,2490,3183,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,36.090976,0,-3.275976862,1.19063506,-2.75145338,0.005933146,0.024924103,11.56362044,0,-0.066000738,1.219633252,-0.054115234,0.956843355,0.977320494,29.94257002,0,-2.715173184,1.19462294,-2.2728286,0.023036511,0.062225623,34.53667315,0,-3.137276235,1.193961733,-2.627618748,0.008598482,0.043098829,125.6300026,1,1.592746273,1.988500524,0.800978553,0.423144062,0.558537291,N,PKS,,polyketide synthase,F:oxidoreductase activity; P:oxidation-reduction process; F:phosphopantetheine binding; F:transferase activity,IPR020806 (SMART); SM00822 (SMART); IPR020841 (SMART); IPR020807 (SMART); IPR020843 (SMART); IPR020801 (SMART); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR013154 (PFAM); IPR014031 (PFAM); IPR014043 (PFAM); IPR032821 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PF13602 (PFAM); IPR014030 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR009081 (PFAM); IPR001227 (G3DSA:3.40.366.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); G3DSA:3.30.70.250 (GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR013968 (PFAM); IPR020807 (PFAM); PTHR11712:SF278 (PANTHER); PTHR11712 (PANTHER); PTHR11712 (PANTHER); PTHR11712:SF278 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR016039 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR011032 (SUPERFAMILY); IPR016035 (SUPERFAMILY); IPR016036 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_02376,94,134,135,0,0,0,0,0,0,0,0,0,2,3,0,0,1,0,1.458521696,0,1.353297188,1.371632912,0.986632193,0.323822982,NA,0.462690484,0,4.577368522,1.57571316,2.904950367,0.003673113,0.017256186,1.203861227,0,1.921388601,1.242732642,1.546099729,0.122080484,0.224791819,32.04841979,1,4.546688217,0.694283875,6.548745231,5.80E-11,2.27E-09,5.049787866,1,2.76504055,1.150568104,2.4031959,0.016252478,0.046327799,Y,-,,tripeptidyl peptidase a,P:proteolysis; F:serine-type endopeptidase activity,IPR015366 (SMART); IPR015366 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); PTHR14218 (PANTHER); PTHR14218:SF18 (PANTHER); IPR030400 (PROSITE_PROFILES); IPR000209 (SUPERFAMILY); IPR009020 (SUPERFAMILY),,
RL4_JR_02377,969,735,1072,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,11.05739469,0,-1.569474365,1.198648385,-1.309370108,0.190409012,0.350309308,3.530399117,0,1.645648612,1.270216234,1.295565722,0.195125145,0.338013418,9.164844074,0,-1.007275422,1.20171252,-0.83819999,0.401918393,0.544162468,19.8848542,1,-0.4792496,1.150223775,-0.416657706,0.676928794,0.779839942,9.048960541,0,-1.091577885,1.206822035,-0.904506094,0.365727105,0.502099923,N,-, Effector probability:0.716,"D-aminopeptidase, putative",P:proteolysis; F:aminopeptidase activity,no IPS match,,
RL4_JR_02378,8946,2485,2426,2,8,0,0,0,3,2,33,60,3,2,23,0,0,11,139.0930238,1,0.541224194,1.093627161,0.49488913,0.620678384,0.782127627,46.24515545,1,1.349956682,1.09433702,1.23358404,0.217357943,0.364556272,716.951753,1,3.879535934,0.845821122,4.586709685,4.50E-06,9.60E-05,310.6452935,1,2.256136834,1.348609336,1.672935797,0.094339936,0.18747632,125.6154311,1,0.887687633,1.914021087,0.463781532,0.642804276,0.744241657,N,-,,2-deoxy-D-gluconate 3-dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02379,1102,1378,1291,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,34.24278443,1,0.995343676,0.689789031,1.442968256,0.149029414,0.295523081,4.825310603,0,1.194914634,1.24845555,0.95711428,0.338509577,0.501447964,12.52226095,0,-1.457371328,1.197172932,-1.217344035,0.223473347,0.353617405,14.44689687,0,-1.879795295,1.195725795,-1.572095628,0.115928375,0.218645196,12.33799904,0,-1.538748711,1.199784445,-1.282520971,0.199659953,0.321443318,Y,-,,fad binding domain-containing,F:FAD binding; F:oxidoreductase activity; P:oxidation-reduction process,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789:SF222 (PANTHER); PTHR13789 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_02380,28,24,44,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0.381741347,0,3.286870627,2.263706994,1.451985896,0.146505527,NA,0.120916873,0,6.513110308,2.028809273,3.210311779,0.001325911,0.015023052,0.315664429,0,3.851263347,1.327207469,2.901779441,0.003710497,0.01574077,9.999558015,1,4.378539239,1.176898025,3.720406651,0.000198902,0.001912522,0.313555077,0,3.759612781,1.269895003,2.96056979,0.003070705,0.012064762,N,-,,---NA---,,no IPS match,,
RL4_JR_02381,307,114,213,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,2.508438181,0,0.570642807,1.367777599,0.417204381,0.676528921,0.821975634,0.811405365,0,3.76703559,1.54863336,2.432490277,0.014995394,0.046134766,2.091640424,0,1.124176334,1.287659211,0.873038708,0.38264198,0.52634068,22.46958565,1,3.63677209,0.825196519,4.407158789,1.05E-05,0.000146876,2.053234828,0,1.048024172,1.280744574,0.818292885,0.413189968,0.54938259,N,-,,major facilitator superfamily transporter,,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501 (PANTHER); PTHR23501:SF56 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.36.3, the major facilitator superfamily (mfs).
RL4_JR_02382,13,5,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.134036251,0,4.796655886,3.593178172,1.334934049,0.181897933,NA,0.042738809,0,8.013261962,2.545740753,3.147713274,0.00164553,0.015023052,0.111305821,0,5.354163003,1.527001044,3.506325698,0.000454339,0.003150498,0.128412822,0,4.933300667,2.209102268,2.233169889,0.025537743,0.085851084,0.110490895,0,5.262655609,1.346355007,3.908817199,9.27E-05,0.000652142,N,-,,amidoligase enzyme,F:ligase activity,IPR022025 (PFAM); PTHR36847 (PANTHER); PTHR36847:SF1 (PANTHER); SSF55931 (SUPERFAMILY),,
RL4_JR_02383,13,7,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11534676,0,5.013427825,3.767083468,1.330851272,0.183237953,NA,0.037247803,0,8.212400699,2.56649901,3.199845652,0.001375012,0.015023052,0.096009827,0,5.569355405,1.486307996,3.747107208,0.000178886,0.00164211,0.11070504,0,5.147892887,2.247022751,2.290983874,0.021964346,0.080296448,0.094136633,0,5.492307059,1.29733227,4.233539229,2.30E-05,0.000202361,N,-,,hypothetical protein CMQ_7599,,no IPS match,,
RL4_JR_02384,1082,921,1458,0,0,0,0,0,0,0,2,4,0,1,1,0,0,0,13.78426699,0,-1.88740803,1.205840014,-1.56522259,0.117530727,0.248720017,4.381138942,0,1.334137509,1.259395196,1.059347783,0.289441421,0.44886258,53.08842466,1,2.072336408,0.637100192,3.252763749,0.001142885,0.006420957,26.80916128,1,-0.010692566,1.02899805,-0.01039124,0.991709139,0.994951945,11.29794136,0,-1.411772689,1.214603842,-1.162331816,0.245100708,0.37509744,N,-,,mitochondrial carrier,C:membrane,IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); PTHR24089 (PANTHER); PTHR24089:SF42 (PANTHER); PTHR24089:SF42 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.8.7, the mitochondrial carrier (mc) family.
RL4_JR_02385,9333,7130,5122,0,5,3,0,0,1,0,4,12,3,1,3,0,12,0,138.0334562,1,-0.778962745,0.644082219,-1.209415074,0.22650342,0.397978656,37.37642128,1,-0.427696678,1.156232136,-0.369905545,0.71145287,0.818890829,181.3022801,1,0.764837108,0.544829721,1.403809444,0.160375601,0.275707689,143.8032211,1,-0.765124133,0.648328327,-1.180149165,0.237940893,0.375842675,116.5309402,1,-0.080977723,0.701310092,-0.11546636,0.908075483,0.940974748,N,-,,c6 zinc finger domain containing,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); PTHR31944 (PANTHER); PTHR31944:SF71 (PANTHER); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_02386,2448,2533,2252,0,0,0,0,0,0,0,1,2,2,5,0,0,2,0,29.02817657,0,-2.961619618,1.189247849,-2.490330018,0.012762453,0.046150749,9.292450257,0,0.249502649,1.223300532,0.203958588,0.838385861,0.903339516,44.88117168,1,0.006451787,0.852452472,0.0075685,0.993961268,0.997508315,66.41240515,1,0.706596552,0.576737572,1.225161296,0.220514454,0.355923616,31.33864304,1,-0.804849358,0.969819214,-0.829896279,0.406597429,0.54318498,N,-,,zn 2cys6 cluster transcripitional activator,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR007219 (PFAM); PTHR31313 (PANTHER); PTHR31313:SF38 (PANTHER); PTHR31313:SF38 (PANTHER),,
RL4_JR_02387,1606,1637,1546,0,1,5,0,0,1,0,0,3,0,9,3,0,2,0,46.3079348,1,0.93606321,0.609954007,1.534645561,0.124870915,0.259805387,15.52170967,1,1.763030476,1.124119371,1.568365888,0.116795767,0.228578259,35.40005124,1,0.601363402,0.850006485,0.707480958,0.479267642,0.615593201,83.35516101,1,2.072640297,0.452035685,4.585125393,4.54E-06,7.01E-05,23.35825495,1,-0.209485561,0.968548162,-0.216288224,0.828763088,0.88515045,N,-,,histidine kinase group,P:phosphorylation; F:kinase activity,no IPS match,,
RL4_JR_02388,4576,3313,2710,0,0,5,0,0,0,0,0,1,0,0,0,0,0,0,61.51365397,1,-0.52732291,0.744837829,-0.707970097,0.478963828,0.667929386,13.71430092,0,-0.312052969,1.247670728,-0.250108431,0.802503496,0.880344683,41.7726807,1,-1.989724618,1.213587296,-1.639539755,0.101100898,0.195477751,40.67038294,0,-3.373068501,1.216556236,-2.772636728,0.005560415,0.030484479,34.46450167,0,-3.020851732,1.210951969,-2.494609042,0.012609598,0.037851223,N,-,,c6 zinc finger domain containing,,IPR021858 (PFAM); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR38111 (PANTHER); IPR001138 (SUPERFAMILY),,
RL4_JR_02389,29,27,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.301352351,0,3.628184105,2.498631673,1.452068404,0.146482586,NA,0.097090047,0,6.830357849,2.126765556,3.211617674,0.001319899,0.015023052,0.250064003,0,4.189667391,1.342218016,3.121450718,0.001799624,0.009091512,0.288359304,0,3.767200054,1.62979928,2.311450311,0.020807995,0.078120428,0.244475608,0,4.118026332,1.254215722,3.283347721,0.00102582,0.004883137,Y,-,,predicted protein,,no IPS match,,
RL4_JR_02390,607,709,889,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,8.823246117,0,-1.243639714,1.208352074,-1.029203111,0.303384241,0.489519113,12.17704552,1,2.896485802,1.132592465,2.557394555,0.010545953,0.03501021,7.288966176,0,-0.676835947,1.205098515,-0.561643665,0.574358824,0.697386511,12.42239428,1,-0.153105718,1.154843481,-0.13257703,0.8945279,0.934983524,7.214275821,0,-0.764564241,1.212813014,-0.630405703,0.52842918,0.651845206,N,-,,auxin efflux carrier superfamily,C:membrane,IPR004776 (PFAM); PTHR31794 (PANTHER); PTHR31794:SF4 (PANTHER),2.A.69.2.3, the auxin efflux carrier (aec) family.
RL4_JR_02391,425,622,494,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.211246987,0,-0.736970246,1.226325612,-0.600958048,0.547867929,0.727932665,1.977750598,0,2.48170343,1.334305666,1.859921226,0.062896672,0.141323523,5.129663182,0,-0.169700147,1.21691621,-0.139450971,0.889093797,0.930948735,5.918101438,0,-0.59214017,1.218076453,-0.486127261,0.62687694,0.743397636,5.047943327,0,-0.249332644,1.2168649,-0.204897556,0.837652165,0.890511148,N,-,,methyltransferase domain-containing,F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_02392,14086,12382,12733,4,0,1,0,0,0,0,0,0,2,5,4,0,4,0,200.9480817,1,-2.328067335,0.66434379,-3.504311128,0.00045779,0.00313174,50.26782623,0,-2.186031742,1.195968222,-1.827834304,0.067574423,0.149407095,130.0468974,0,-4.833895516,1.189142782,-4.065025318,4.80E-05,0.000701628,227.2215439,1,-1.05838942,0.462985108,-2.286011801,0.022253568,0.080470492,143.2741539,1,-2.298249904,0.744606669,-3.086528768,0.002025083,0.008564995,N,-,,Zinc C2H2,F:metal ion binding,no IPS match,,
RL4_JR_02393,4850,4587,5432,1,2,2,0,0,0,0,0,1,0,3,0,0,4,0,93.17131285,1,-0.942208552,0.660334458,-1.426865645,0.153618625,0.301835439,18.964839,0,-0.779744726,1.196789558,-0.651530355,0.514704189,0.665261188,55.71650449,1,-2.470350666,1.186694725,-2.081706958,0.037369245,0.090503075,68.81400218,1,-1.546747009,0.847652478,-1.824741918,0.068039984,0.148087885,63.98557334,1,-0.903376729,0.748033213,-1.207669276,0.2271745,0.354304038,N,-,,annexin,F:calcium ion binding; F:calcium-dependent phospholipid binding,IPR009117 (PRINTS); IPR001464 (PRINTS); IPR018502 (SMART); IPR018502 (G3DSA:1.10.220.GENE3D); IPR018502 (PFAM); IPR018502 (G3DSA:1.10.220.GENE3D); IPR018502 (G3DSA:1.10.220.GENE3D); IPR018502 (G3DSA:1.10.220.GENE3D); PTHR10502 (PANTHER); PTHR10502:SF102 (PANTHER); SSF47874 (SUPERFAMILY),3.A.5.9.1, the general secretory pathway (sec) family.
RL4_JR_02394,512,811,610,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.801654827,0,-1.065902215,1.230837265,-0.865997679,0.386491434,0.579279004,2.482616162,0,2.153701492,1.322683233,1.628282145,0.103465074,0.207833593,6.439829696,0,-0.497884138,1.220993831,-0.407769577,0.683442851,0.782587555,7.429813246,0,-0.920357408,1.222451313,-0.75287858,0.451522881,0.593646172,6.336209262,0,-0.577284663,1.22259702,-0.47217902,0.636799014,0.739118203,N,-,,duf1275 domain,C:membrane; C:integral component of membrane,IPR010699 (PFAM); PTHR37488:SF2 (PANTHER); PTHR37488 (PANTHER),9.B.143.5.3, the 6 tms duf1275/pf06912 (duf1275) family.
RL4_JR_02395,3088,2225,2219,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,30.09546841,0,-3.013830527,1.19952191,-2.51252645,0.011987012,0.043832381,9.695930582,0,0.188176447,1.240498584,0.151694206,0.879428128,0.931613973,25.00442826,0,-2.455107297,1.203082489,-2.040680768,0.041282568,0.098080566,28.83407585,0,-2.876871351,1.20295801,-2.39149773,0.016779788,0.07027382,39.94798428,1,0.070829759,0.7679755,0.09222919,0.926515946,0.952205976,N,-,,MFS multidrug transporter,P:transmembrane transport; C:integral component of membrane,PR01036 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF77 (PANTHER); PTHR23501 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_02396,136,101,91,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,8.9491902,1,3.221754143,1.043398824,3.087749448,0.002016784,0.010553513,0.423199832,0,4.706245329,1.618753235,2.907327211,0.003645317,0.017177791,1.09027721,0,2.064563482,1.250509851,1.650977383,0.098743193,0.192138535,1.257199059,0,1.642755179,1.286357555,1.277059534,0.20158123,0.332791448,1.067179391,0,1.991952178,1.225519302,1.625394374,0.104078554,0.196823937,N,-,,hypothetical protein SPI_02313,P:biological_process; C:cellular_component; F:molecular_function,IPR025676 (PFAM); PTHR38788 (PANTHER),,
RL4_JR_02397,6451,5965,5804,0,5,71,0,0,0,0,1,0,1,9,1,2,5,3,384.1498938,1,2.134819585,1.113510664,1.917197252,0.055212877,0.143083434,23.38382764,0,-1.08189381,1.202087386,-0.900012613,0.368113538,0.532596517,68.33039863,1,-2.767762113,1.189189954,-2.327434825,0.019942134,0.055495922,124.8191172,1,0.013753158,0.472022266,0.029136672,0.976755588,0.985749913,132.8855574,1,0.148867049,0.481990783,0.308858704,0.757429011,0.831082385,N,-,,Glutathione S-transferase,C:cytoplasm; P:glutathione metabolic process; F:glutathione transferase activity,IPR010987 (G3DSA:1.20.1050.GENE3D); IPR012336 (G3DSA:3.40.30.GENE3D); IPR004046 (PFAM); IPR004045 (PFAM); PTHR11260 (PANTHER); PTHR11260:SF186 (PANTHER); IPR010987 (PROSITE_PROFILES); IPR004045 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR010987 (SUPERFAMILY),1.A.12.2.2, the intracellular chloride channel (clic) family.
RL4_JR_02398,501,695,697,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7.604942136,0,-1.02912644,1.215441541,-0.846709945,0.397156814,0.589413369,24.72592962,1,3.120065936,1.123833471,2.7762707,0.005498641,0.021974647,6.27864149,0,-0.461434413,1.209492207,-0.38151086,0.702824214,0.798241596,7.24467166,0,-0.884061217,1.209456723,-0.730957297,0.464805237,0.606463018,6.200258318,0,-0.545988949,1.214142266,-0.449691082,0.652933203,0.752441233,N,-,,pyridoxamine 5 -phosphate oxidase,"F:oxidoreductase activity, acting on the CH-NH2 group of donors; P:organic substance biosynthetic process; P:cellular biosynthetic process; P:single-organism metabolic process",IPR012349 (G3DSA:2.30.110.GENE3D); IPR011576 (PFAM); IPR000659 (PIRSF); IPR019576 (PFAM); IPR000659 (PTHR10851:PANTHER); PTHR10851 (PANTHER); IPR012349 (SUPERFAMILY),2.A.7.2.4, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_02399,23,14,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.211215369,0,4.14076906,2.910193105,1.422850275,0.154779564,NA,0.068154437,0,7.340738948,2.277614898,3.222993911,0.001268583,0.015023052,0.175684384,0,4.697918415,1.382001259,3.399358997,0.00067544,0.004214081,0.202579975,0,4.276207568,1.812468632,2.359327766,0.018308077,0.073881739,0.172197584,0,4.622136002,1.267613829,3.646328161,0.000266014,0.001589961,N,-, Effector probability:0.767,RNA recognition motif (RRM) superfamily,"F:nucleotide binding; P:L-arabinose metabolic process; P:carbohydrate metabolic process; F:alpha-L-arabinofuranosidase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; C:extracellular region; F:cellulose binding",IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (SUPERFAMILY),,
RL4_JR_02400,247,151,194,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.357067602,0,0.66046161,1.278013629,0.516787611,0.605304429,0.772539664,0.758676925,0,3.863998801,1.483741533,2.604226352,0.009208192,0.031670173,1.959274258,0,1.218549739,1.235418524,0.986345692,0.323963505,0.466942842,2.25946155,0,0.796723946,1.24938196,0.637694453,0.523672597,0.65808428,1.924394749,0,1.141461905,1.224887785,0.931891002,0.351392858,0.488648907,N,-,,methyltransferase domain-containing,C:membrane; C:integral component of membrane; F:methyltransferase activity; F:transferase activity; P:methylation,IPR025714 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); PTHR10108:SF912 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_02401,940,741,1519,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.70391675,0,-1.769645268,1.235794947,-1.431989403,0.152146854,0.300027565,4.021491968,0,1.457682095,1.294258866,1.126267807,0.26005218,0.416231525,10.50664032,0,-1.204393618,1.227707099,-0.981010551,0.326587538,0.469588445,12.12490974,0,-1.627221993,1.230169863,-1.322762037,0.185914526,0.31362622,10.44809297,0,-1.298952098,1.241883007,-1.045953678,0.29558242,0.430490794,N,-, Effector probability:0.806,hypothetical protein UCRPA7_7418,"C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:protein heterodimerization activity; C:cytosol; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding; P:transcription initiation from RNA polymerase II promoter",PTHR42070 (PANTHER),,
RL4_JR_02402,3278,2641,5346,0,0,0,0,0,0,0,0,0,1,5,0,0,0,2,44.73248147,0,-3.585617352,1.230478719,-2.914001922,0.003568277,0.01650524,14.15728303,0,-0.358014146,1.238668152,-0.289031526,0.772557252,0.862066485,36.99081921,0,-3.020158683,1.220379017,-2.474771068,0.013332161,0.040532971,72.05883708,1,-0.18262192,0.698057642,-0.261614384,0.793618753,0.866752677,51.5170288,1,-1.403092912,1.01860636,-1.377463333,0.168369044,0.282662339,N,-,,arsenical-resistance,P:inorganic anion transport; F:inorganic anion transmembrane transporter activity; P:transmembrane transport; F:antiporter activity; C:integral component of membrane,IPR002657 (PFAM); IPR004706 (TIGRFAM); IPR004706 (PIRSF); IPR004706 (PTHR10361:PANTHER); IPR002657 (PANTHER),2.A.59.1.7, the arsenical resistance-3 (acr3) family.
RL4_JR_02403,1154,1269,1514,2,1,9,0,0,0,0,0,0,0,0,1,0,0,0,78.26455415,1,2.203848614,0.474089168,4.648595168,3.34E-06,4.40E-05,5.009000722,0,1.140960435,1.239771991,0.920298606,0.357416737,0.521577325,13.02640362,0,-1.51444357,1.194970485,-1.267348096,0.20503085,0.331427802,24.66513605,1,-0.98726449,1.144796191,-0.862393235,0.388471162,0.533384617,12.87232737,0,-1.599940554,1.201517476,-1.331599903,0.182991697,0.30157625,N,-,,antibiotic biosynthesis monooxygenase,P:oxidation-reduction process; F:monooxygenase activity,IPR007138 (PFAM); G3DSA:3.30.70.900 (GENE3D); IPR011008 (SUPERFAMILY),,
RL4_JR_02404,1087,900,1087,0,0,9,0,0,0,0,0,0,1,0,0,0,3,0,46.64233806,1,2.148855879,0.512070775,4.196404058,2.71E-05,0.000273128,3.926607615,0,1.492238046,1.256029029,1.188060158,0.23480971,0.385272148,10.1750825,0,-1.158055122,1.193150582,-0.970585893,0.331754534,0.474994046,21.04928096,1,-0.630955096,1.141341823,-0.552818694,0.580387566,0.706640706,21.60444411,1,0.965027895,0.845417754,1.141480517,0.253670015,0.384492351,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF14 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.3.52, the major facilitator superfamily (mfs).
RL4_JR_02405,1039,1019,1462,0,0,17,0,0,0,0,0,0,0,0,2,0,1,0,78.96231798,1,2.450576674,0.95418965,2.568228102,0.010221987,0.038499985,4.45970497,0,1.308498437,1.252649283,1.044584829,0.296214894,0.456013257,11.6153607,0,-1.349106951,1.20191713,-1.122462537,0.261665828,0.398766235,32.67317034,1,-0.022387568,1.023489796,-0.021873758,0.982548658,0.989190158,15.36284911,1,-0.508774194,1.140747542,-0.446000693,0.655596745,0.754394482,N,-,,hypothetical protein HMPREF1624_02663,C:integral component of membrane,no IPS match,,
RL4_JR_02406,1031,1183,1365,0,0,0,0,0,0,0,0,0,1,0,2,0,7,0,14.33390085,0,-1.943654608,1.196406405,-1.624577234,0.104252671,0.228623805,4.555559998,0,1.277859093,1.245884846,1.025663887,0.305050042,0.466281566,11.84726263,0,-1.377542347,1.196243573,-1.151556739,0.249503267,0.384138196,42.25231536,1,0.534486855,0.851281814,0.627861239,0.530094845,0.663294719,38.72928599,1,1.919443929,0.612959288,3.131437872,0.001739526,0.007536457,N,-,,class II aldolase adducin domain,,IPR001303 (SMART); IPR001303 (PFAM); IPR001303 (G3DSA:3.40.225.GENE3D); PTHR10672 (PANTHER); PTHR10672:SF17 (PANTHER); IPR001303 (SUPERFAMILY),,
RL4_JR_02407,74,108,95,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.115077798,0,1.740693755,1.46127989,1.191211736,0.233570473,NA,0.354446904,0,4.961903079,1.651144899,3.005128795,0.002654684,0.015349618,0.920624103,0,2.308626541,1.252507982,1.843203056,0.065299369,0.139089167,1.06220507,0,1.885963896,1.298397602,1.45253187,0.146353774,0.26120782,0.907498622,0,2.226839166,1.232518728,1.806738604,0.070803045,0.146123285,N,-,,domain-containing,,IPR018392 (SMART); IPR018392 (PFAM); IPR018392 (G3DSA:3.10.350.GENE3D); PTHR21666:SF212 (PANTHER); PTHR21666:SF212 (PANTHER); PTHR21666 (PANTHER); IPR018392 (SUPERFAMILY); IPR018392 (SUPERFAMILY); IPR018392 (SUPERFAMILY),,
RL4_JR_02408,216,243,145,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.435519111,0,0.613671725,1.3082722,0.46907037,0.639019337,0.794440682,0.783362107,0,3.817929147,1.500169385,2.544998708,0.010927814,0.035976392,2.018233098,0,1.176340342,1.248927523,0.94188039,0.346253881,0.490061016,2.327453575,0,0.754408296,1.266268951,0.595772561,0.551327176,0.680339751,1.972307439,0,1.106370031,1.233929716,0.896623217,0.369920005,0.506072159,N,-,,glycoside hydrolase family 18,F:hydrolase activity,IPR011583 (SMART); IPR013781 (G3DSA:3.20.20.GENE3D); IPR001223 (PFAM); IPR029070 (G3DSA:3.10.50.GENE3D); PTHR11177 (PANTHER); PTHR11177:SF183 (PANTHER); IPR017853 (SUPERFAMILY); IPR029070 (SUPERFAMILY),9.B.29.2.7, the small 4-5 tms putative permease (4-5pp) family.
RL4_JR_02409,46,54,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.505391832,0,2.88235168,2.059371831,1.399626642,0.161625152,NA,0.162978928,0,6.083116114,1.970377956,3.087283886,0.002019946,0.015023052,0.418929282,0,3.44538948,1.345493244,2.560688801,0.010446488,0.033821634,0.483058891,0,3.023079129,1.515132002,1.995257922,0.046014757,0.116387562,0.408195753,0,3.378999416,1.28099779,2.637787078,0.008344896,0.027185351,N,-,,glycoside hydrolase family 18,"F:chitinase activity; P:carbohydrate metabolic process; F:chitin binding; P:chitin catabolic process; P:metabolic process; C:membrane; C:integral component of membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:hydrolase activity; F:hydrolase activity, acting on glycosyl bonds",no IPS match,,
RL4_JR_02410,208,303,280,0,1,3,0,0,0,0,3,1,0,1,0,0,0,0,22.64799242,1,2.937782614,0.777048607,3.780693496,0.000156392,0.001252058,1.010665966,0,3.450216914,1.415688778,2.437129522,0.014804376,0.045602523,32.65450857,1,3.616661636,0.762897748,4.740689883,2.13E-06,5.12E-05,7.042567692,1,1.318945418,1.166651073,1.130539754,0.258248857,0.398107442,2.591599569,0,0.712633491,1.222770637,0.582802261,0.560026423,0.678505149,N,-,,histone-lysine n-methyltransferase,,IPR001214 (SMART); IPR007728 (SMART); IPR001214 (PFAM); IPR007728 (PFAM); G3DSA:2.170.270.10 (GENE3D); PTHR22884:SF370 (PANTHER); PTHR22884 (PANTHER); IPR001214 (PROSITE_PROFILES); IPR003616 (PROSITE_PROFILES); IPR007728 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY),,
RL4_JR_02411,2544,2062,3188,0,3,2,0,0,0,0,0,0,0,0,0,0,0,0,62.70747717,1,-0.001057302,0.689101826,-0.001534319,0.998775791,0.999756184,9.882091768,0,0.16065277,1.223657465,0.131289004,0.89554669,0.941970775,25.70298511,0,-2.494953832,1.199659922,-2.079717582,0.037551444,0.090863008,29.6545856,0,-2.917439318,1.199723371,-2.431760011,0.015025659,0.065631958,25.42831202,0,-2.58215484,1.20745704,-2.138506592,0.03247565,0.08008182,N,-,,ubiquitin domain-containing,C:intracellular organelle; F:methyltransferase activity; P:chromatin silencing; F:binding; P:methylation,IPR000626 (SMART); IPR000626 (PFAM); G3DSA:3.10.20.90 (GENE3D); IPR032752 (PFAM); PTHR13609 (PANTHER); PTHR13609:SF4 (PANTHER); PTHR13609:SF4 (PANTHER); PTHR13609 (PANTHER); IPR000626 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY),,
RL4_JR_02412,13551,12267,11822,0,1,22,0,0,0,1,7,5,3,11,3,0,4,6,242.7748644,1,-0.521933879,0.884625132,-0.590005709,0.555186822,0.733713606,48.33580669,0,-2.129485707,1.198298434,-1.777091288,0.075553221,0.163059639,223.4430642,1,-0.258543148,0.44165056,-0.58540206,0.558277404,0.684427275,245.1186873,1,-0.394301322,0.392013887,-1.005835089,0.314494905,0.460755755,182.3921009,1,-0.897685538,0.491224204,-1.827445656,0.06763279,0.141279554,N,-,,Coatomer subunit beta,P:ER to Golgi vesicle-mediated transport; F:structural molecule activity; C:cytosol; C:Golgi membrane; P:intracellular protein transport; C:COPI vesicle coat,IPR016460 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR002553 (PFAM); IPR011710 (PFAM); IPR029446 (PFAM); IPR016460 (PANTHER); IPR016024 (SUPERFAMILY),9.B.278.1.1, the organellar-targeting adaptor protein complex (o-apc) family.
RL4_JR_02413,2536,3613,4954,0,0,6,0,0,0,0,0,0,2,5,0,0,0,2,67.34140971,1,-0.379116452,0.750421203,-0.505204878,0.613414945,0.778295802,14.01126648,0,-0.343045417,1.234734893,-0.277829208,0.781143469,0.867727633,36.63186143,0,-3.006066542,1.217843825,-2.468351425,0.013573699,0.04108225,80.96242964,1,0.073933858,0.648112689,0.114075621,0.909177848,0.944436822,51.12507772,1,-1.389786925,1.014480815,-1.369948947,0.170702839,0.285774842,N,-,,mago nashi,C:nucleus; F:ATP binding; C:cytosol,IPR004023 (PFAM); IPR004023 (G3DSA:3.30.1560.GENE3D); IPR004023 (PANTHER); IPR004023 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_02414,5901,6807,8304,0,6,0,0,0,0,0,3,0,2,1,0,0,4,3,132.1607601,1,-0.955550908,0.91280727,-1.046826575,0.295179571,0.480366037,26.69585517,0,-1.273053592,1.198860362,-1.061886465,0.28828723,0.447758684,93.02012548,1,-1.520499659,0.858900704,-1.77028573,0.076679554,0.157753263,102.8199374,1,-2.028027193,0.859524613,-2.359475416,0.018300793,0.073881739,106.2730754,1,-0.591451993,0.605726647,-0.976433835,0.328849521,0.465418144,N,-,,vacuolar import and degradation,,IPR018618 (PFAM); PTHR15898 (PANTHER),,
RL4_JR_02415,1331,1314,3067,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,22.66439883,0,-2.604731903,1.267271404,-2.055386,0.039841737,0.112388965,7.118506007,0,0.633852542,1.296295498,0.488972262,0.624861335,0.75331663,18.6966847,0,-2.035802282,1.249101753,-1.629813004,0.103141024,0.198215591,25.59505518,1,-1.516125051,1.209053077,-1.253977249,0.209850275,0.343308133,18.69301856,0,-2.138202963,1.270202602,-1.683355836,0.092306227,0.179489255,N,-,,tRNA guanosine-2 -O-methyltransferase TRM11,F:methyltransferase activity; C:cytoplasmic part; P:methylation,PIRSF017259 (PIRSF); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR13370 (PANTHER); PTHR13370 (PANTHER); PTHR13370:SF3 (PANTHER); PTHR13370:SF3 (PANTHER); IPR016691 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_02416,1672,1634,3507,0,0,4,0,0,0,0,0,1,0,4,0,0,1,0,42.33313006,1,-0.22448754,0.874698003,-0.256645768,0.797452241,0.896831455,8.516345175,0,0.375200824,1.273737777,0.294566771,0.76832485,0.859715247,28.83142533,1,-1.330376167,1.234915984,-1.077300953,0.281345836,0.420544109,41.82496251,1,-0.065292955,0.852930832,-0.076551289,0.938980511,0.96402126,26.14934443,1,-1.46661441,1.187391348,-1.235156726,0.216772181,0.342014626,N,-,,ribonuclease p 40kda subunit,,IPR013893 (PFAM); PTHR15396 (PANTHER); PTHR15396:SF1 (PANTHER),,
RL4_JR_02417,1759,1733,3775,0,0,0,0,0,0,0,0,0,3,0,0,0,0,3,28.85790073,0,-2.953262871,1.254746232,-2.353673432,0.018588934,0.061771293,9.07803625,0,0.283057719,1.273928516,0.222192781,0.824163814,0.89413981,23.81421935,0,-2.38482981,1.239129214,-1.924601392,0.054279245,0.120403829,55.42611013,1,-0.403979983,0.929070315,-0.434821753,0.663691814,0.770893612,45.8731134,1,-0.198461918,0.93430823,-0.212415894,0.831782587,0.886550118,N,-,,ankyrin repeat,,PF13857 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24148 (PANTHER); PTHR24148:SF17 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),,
RL4_JR_02418,414,396,669,0,0,12,2,0,0,0,0,1,0,0,0,0,3,0,51.71272719,1,3.352676675,0.780203788,4.29718072,1.73E-05,0.000185441,46.48827584,1,4.247728141,0.997285733,4.259288987,2.05E-05,0.001206861,11.36654354,1,0.867186832,1.214414573,0.714078085,0.475178897,0.611816247,5.617533901,0,-0.517349449,1.226536027,-0.421797189,0.673173057,0.777535616,16.41579123,1,1.988716626,0.903180995,2.201902649,0.027672186,0.070645709,N,-,,Mob1 phocein,P:phosphorylation; F:kinase activity,IPR005301 (SMART); IPR005301 (PFAM); IPR005301 (G3DSA:1.20.140.GENE3D); IPR005301 (PANTHER); IPR005301 (PANTHER); PTHR22599:SF20 (PANTHER); IPR005301 (SUPERFAMILY),,
RL4_JR_02419,2715,2196,2005,0,1,2,0,0,0,0,0,2,0,1,0,3,2,0,43.33259956,1,-0.586347196,0.862148994,-0.680099612,0.49644139,0.683971102,8.909117144,0,0.310282434,1.238774806,0.250475254,0.802219839,0.880128898,35.9807038,1,-0.515982301,1.042881411,-0.494766035,0.620765282,0.73427126,30.51608176,1,-1.808741816,1.152507291,-1.569397286,0.116555396,0.219394569,78.31999845,1,0.571986722,0.680502813,0.840535426,0.400608247,0.537738102,N,-,,casein kinase i,F:nucleotide binding; C:cytoplasm; F:protein kinase activity; P:phosphorylation,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); PTHR11909:SF155 (PANTHER); PTHR11909 (PANTHER); PTHR11909:SF155 (PANTHER); PTHR11909 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_02420,6088,6578,6708,3,8,25,0,0,2,0,6,3,2,4,3,0,4,2,267.4088929,1,1.453958367,0.334759907,4.343287043,1.40E-05,0.00015601,43.53284367,1,0.47854572,0.981655784,0.487488311,0.625912324,0.753905951,130.8157134,1,0.172617831,0.506997945,0.340470475,0.733502254,0.820459266,137.7108898,1,-0.332677779,0.502751269,-0.66171445,0.508154242,0.643896278,93.48289458,1,-0.693293819,0.616084846,-1.125321979,0.260452619,0.392247921,N,-,,26S protease regulatory subunit 6a,"F:ATP binding; C:proteasome regulatory particle, base subcomplex; P:proteasome regulatory particle assembly; C:cytosol; F:peptidase activity; P:ubiquitin-dependent protein catabolic process; P:positive regulation of RNA polymerase II transcriptional preinitiation complex assembly",IPR003593 (SMART); IPR005937 (TIGRFAM); IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.8.60 (GENE3D); PTHR23073 (PANTHER); PTHR23073:SF7 (PANTHER); IPR027417 (SUPERFAMILY),9.B.307.1.2, the ftsh aaa(+) zinc metaloprotease (ftsh) family.
RL4_JR_02421,4224,4690,7185,0,0,2,0,0,0,0,0,1,2,7,0,0,6,0,71.87851612,1,-2.397284836,1.053951108,-2.274569302,0.022931779,0.073536736,20.31310162,0,-0.878869965,1.216094898,-0.722698506,0.469865134,0.628100222,59.54674599,1,-2.578474361,1.208937035,-2.132844214,0.032937508,0.082581316,107.9264594,1,-0.112071696,0.577898372,-0.193929765,0.846230877,0.903616075,75.83776859,1,-0.505649369,0.709445274,-0.712739076,0.476007232,0.606006943,N,-,,upf0132 domain containing,,PTHR36460 (PANTHER); SSF160369 (SUPERFAMILY),,
RL4_JR_02422,2695,2831,3930,2,3,0,0,0,1,0,0,0,2,1,0,0,0,0,81.92695787,1,-0.227880849,0.698591715,-0.326200332,0.74427279,0.865788881,21.35894841,1,0.799433152,1.121485009,0.712834452,0.475948204,0.633221309,31.21406163,0,-2.775189716,1.198835958,-2.314903635,0.020618206,0.056892538,58.65420706,1,-0.872269706,0.863470487,-1.010190527,0.312404017,0.458418938,30.91608732,0,-2.864057099,1.207547231,-2.371797164,0.017701806,0.049524946,N,-,,anthranilate phosphoribosyltransferase,P:tryptophan biosynthetic process; C:cytosol; F:anthranilate phosphoribosyltransferase activity,IPR005940 (TIGRFAM); G3DSA:1.20.970.10 (GENE3D); IPR017459 (PFAM); IPR000312 (PFAM); IPR000312 (G3DSA:3.40.1030.GENE3D); PTHR11922 (PANTHER); PTHR11922:SF5 (PANTHER); PTHR11922:SF5 (PANTHER); PTHR11922 (PANTHER); IPR000312 (SUPERFAMILY),,
RL4_JR_02423,6394,5034,6797,7,0,3,0,0,0,0,2,1,0,6,3,0,2,2,154.5821958,1,-0.086536761,0.651697078,-0.132786787,0.894362005,0.94830577,23.21924987,0,-1.071744258,1.201900101,-0.891708268,0.372549321,0.537171542,82.41742946,1,-1.316824724,0.854615646,-1.54083854,0.123356087,0.226488398,122.4577012,1,-0.256419098,0.521847957,-0.491367447,0.623166584,0.740385081,81.86650131,1,-1.179554212,0.754604584,-1.563142124,0.118019169,0.216396974,N,-,,tRNA ligase,"F:GTP-dependent polyribonucleotide 5'-hydroxyl-kinase activity; F:ATP binding; C:nuclear inner membrane; P:mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response; C:cytosol; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:positive regulation of translation in response to stress; P:phosphorylation; F:2',3'-cyclic-nucleotide 3'-phosphodiesterase activity; F:RNA ligase (ATP) activity",IPR015966 (PFAM); IPR019039 (PFAM); IPR012387 (PIRSF); IPR015965 (PFAM); PTHR32004 (PANTHER); PTHR32004:SF1 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_02424,2586,2362,2859,4,4,0,0,0,0,4,4,8,2,10,6,0,6,16,103.5000958,1,0.726427865,0.550919632,1.318573205,0.187311836,0.345878217,9.956155533,0,0.14991905,1.211413675,0.123755455,0.901508903,0.944583723,153.4768077,1,2.319583955,0.391469365,5.925326885,3.12E-09,1.50E-07,146.3559872,1,1.975110929,0.371251504,5.320142567,1.04E-07,2.31E-06,166.4915621,1,2.566694093,0.607894081,4.222271894,2.42E-05,0.000210555,Y,-,,stress response,,IPR018803 (PFAM),,
RL4_JR_02425,2,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.040984783,0,6.50730889,3.932736253,1.654651742,0.097995161,NA,0.01304591,0,9.727021012,3.213044486,3.027353357,0.002467054,0.015349618,0.03371866,0,7.083567406,1.886092913,3.755683168,0.000172869,0.001608574,0.038900324,0,6.657749675,3.441297493,1.934662635,0.053031708,0.126787733,0.032949531,0,7.016500935,1.42683985,4.917511196,8.77E-07,1.29E-05,N,-, Effector probability:0.668,hypothetical protein HMPREF1624_02682,,no IPS match,,
RL4_JR_02426,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.008141456,0,8.841220392,4.035983802,2.190598582,0.028480854,NA,0.002675567,0,12.01934062,4.032893235,2.980327006,0.002879408,0.015349618,0.006783092,0,9.399044527,3.291065204,2.855927776,0.004291127,0.016940088,0.007815077,0,8.97609272,4.035428601,2.224322026,0.026126786,0.086108719,0.006504647,0,9.346543544,1.704039324,5.484934187,4.14E-08,1.17E-06,N,-, Effector probability:0.907,hypothetical protein NECHADRAFT_80791,,IPR012317 (PFAM); IPR012317 (G3DSA:3.90.228.GENE3D); IPR012317 (PROSITE_PROFILES); SSF56399 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_02427,904,335,481,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.816215778,0,-0.871431093,1.293001616,-0.673959786,0.50033688,0.687278712,2.217698613,0,2.316498495,1.421488146,1.629629133,0.103179903,0.207421594,5.693030664,0,-0.320239993,1.272848756,-0.251593122,0.801355575,0.869543807,6.562393067,0,-0.741441265,1.282017671,-0.578339349,0.563035033,0.690830067,5.562616827,0,-0.389687839,1.274015411,-0.305873725,0.759700793,0.83219415,N,-,,Metallo-dependent phosphatase,,IPR004843 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); PTHR32440:SF11 (PANTHER); PTHR32440:SF11 (PANTHER); PTHR32440 (PANTHER); PTHR32440 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_02428,624,392,692,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,6.782643035,0,-0.864417959,1.226227574,-0.704940891,0.480847021,0.669411263,2.166434794,0,2.350133882,1.33248907,1.763717193,0.077779605,0.166797704,5.626401095,0,-0.303434537,1.22191154,-0.248327744,0.803880834,0.871320593,6.490567453,0,-0.725728246,1.223546939,-0.593134782,0.553090955,0.682017528,20.29209948,1,1.314205028,1.003415522,1.309731611,0.190286646,0.310349918,N,-,,Aminoglycoside phosphotransferase,F:transferase activity,G3DSA:3.90.1200.10 (GENE3D); IPR002575 (PFAM); PTHR21310 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_02429,163345,115560,138115,0,1,7,3,0,0,0,0,0,0,0,0,0,0,0,1698.109126,1,-5.130865593,0.594096972,-8.636410951,5.80E-18,5.70E-16,601.1637402,1,-3.336454889,0.882704957,-3.77980758,0.00015695,0.007188434,1381.049092,0,-8.242556013,1.214153432,-6.788726861,1.13E-11,7.79E-10,1592.782976,0,-8.664509223,1.2105068,-7.157753451,8.20E-13,3.92E-11,1357.383966,0,-8.320391757,1.233460114,-6.745570175,1.52E-11,1.28E-09,N,-,,amino acid permease,,IPR004841 (PFAM); IPR002293 (PIRSF); PTHR11785:SF371 (PANTHER); IPR002293 (PANTHER),2.A.3.10.17, the amino acid-polyamine-organocation (apc) family.
RL4_JR_02430,761,541,248,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.226104105,0,-0.740625821,1.326393583,-0.558375606,0.576587927,0.751406439,2.030787179,0,2.44359405,1.461971079,1.671438023,0.094635191,0.193906357,5.188954008,0,-0.186331614,1.292544576,-0.144158753,0.885375111,0.928807857,5.980507224,0,-0.607347865,1.305582775,-0.465192921,0.641793307,0.754302664,5.031339735,0,-0.244806799,1.289587509,-0.189833414,0.849439672,0.899830161,N,-,,mfs quinate transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; F:transmembrane transporter activity; C:membrane; C:integral component of membrane; P:transport; F:transporter activity,no IPS match,,
RL4_JR_02431,10,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.091633168,0,5.345465871,3.918393948,1.364198174,0.172505203,NA,0.029566591,0,8.545649019,2.675544672,3.193984802,0.001403235,0.015023052,0.076222203,0,5.902557784,1.525581294,3.869054902,0.000109258,0.001229229,0.087891321,0,5.480871085,2.437407268,2.248648044,0.024534897,0.084725728,0.074721166,0,5.825636223,1.304096077,4.467183305,7.93E-06,8.26E-05,,,,,,,,
RL4_JR_02432,5960,6161,7102,0,1,7,0,0,0,0,0,0,1,1,0,0,3,0,111.6705427,1,-0.665742352,0.547481226,-1.216009465,0.223981317,0.394321247,24.50588884,0,-1.149549496,1.193514657,-0.963163283,0.335465588,0.498690363,63.64534934,0,-3.803009871,1.188023434,-3.201123616,0.001368928,0.007371434,86.75154739,1,-2.491254261,1.011116096,-2.463865693,0.01374476,0.06243414,74.390071,1,-1.68272757,0.845375474,-1.990509096,0.046534883,0.106022883,N,-,,hypothetical protein SPI_02465,P:biological_process; C:cellular_component,no IPS match,,
RL4_JR_02433,691,749,747,2,3,25,0,0,1,0,0,0,3,1,0,0,0,0,148.3947535,1,4.189793444,0.519379005,8.066928789,7.21E-16,5.30E-14,12.17707474,1,2.897201367,1.126441738,2.57199398,0.010111465,0.033856516,7.256485153,0,-0.670208226,1.194229372,-0.561205612,0.574657377,0.697521862,40.31954497,1,1.646392962,0.73648725,2.235467024,0.025386704,0.085851084,7.146457913,0,-0.750930222,1.194554132,-0.62862804,0.529592599,0.652962136,N,-,,kinesin family,F:nucleotide binding,IPR001752 (PRINTS); IPR001752 (SMART); IPR001752 (PFAM); IPR001752 (G3DSA:3.40.850.GENE3D); PTHR24115:SF505 (PANTHER); PTHR24115:SF505 (PANTHER); IPR027640 (PANTHER); PTHR24115:SF505 (PANTHER); IPR027640 (PANTHER); PTHR24115:SF505 (PANTHER); IPR027640 (PANTHER); IPR001752 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_02434,855,1567,1899,3,1,18,0,0,0,10,52,60,67,136,55,0,77,59,124.284986,1,2.766842082,0.645578266,4.285835237,1.82E-05,0.000194143,5.458422668,0,1.016978648,1.292125189,0.787058914,0.431247379,0.593109355,922.7382889,1,6.008801002,0.525865526,11.42649728,3.08E-30,9.75E-28,1715.921971,1,6.686410477,0.372176243,17.96571008,3.62E-72,2.62E-69,746.0130361,1,5.712287402,1.0096972,5.657426211,1.54E-08,7.10E-07,Y,-,,---NA---,,no IPS match,,
RL4_JR_02435,816,1118,847,1,1,3,0,0,0,0,0,0,0,0,0,0,1,0,40.74008737,1,1.455822034,0.700462598,2.07837226,0.037675086,0.107866361,3.576658657,0,1.626959806,1.284129293,1.266975074,0.205164203,0.349961587,9.263899031,0,-1.022491151,1.209248094,-0.845559448,0.397798556,0.539808781,10.68682981,0,-1.44479993,1.20891857,-1.195117658,0.232041064,0.369114811,12.96403688,1,-0.171114114,1.138638977,-0.150279516,0.880544094,0.920987837,N,-,,snoal-like polyketide cyclase family,F:binding,IPR032710 (SUPERFAMILY),,
RL4_JR_02436,7722,6950,5855,0,0,13,0,0,0,0,6,1,0,11,0,0,4,0,131.9574746,1,-0.382240541,0.830923472,-0.460018947,0.64550262,0.79800127,26.46075326,0,-1.260234963,1.212959478,-1.038975321,0.298816214,0.45904048,121.8396336,1,-0.275638134,0.595975755,-0.462498904,0.643723588,0.751765787,122.8754522,1,-0.281640752,0.586123434,-0.480514402,0.630861665,0.746312235,82.35887173,1,-1.372137692,0.757411244,-1.811615161,0.070045681,0.144973941,N,-,,Hydrolase,F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); PTHR10992:SF406 (PANTHER); PTHR10992 (PANTHER); PTHR10992:SF406 (PANTHER); PTHR10992 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_02437,304,290,407,0,0,9,0,0,0,0,0,1,0,0,4,0,1,1,38.36187315,1,3.712889986,0.575670824,6.449675455,1.12E-10,3.83E-09,1.269702614,0,3.120945821,1.366186352,2.284421754,0.022346756,0.062866556,9.803272253,1,1.425908321,1.200534094,1.187728302,0.23494047,0.36734167,42.35396927,1,3.161230631,1.33829066,2.362140546,0.018169752,0.073580744,14.49592974,1,2.055197645,0.990259814,2.075412549,0.037948316,0.090300047,N,-,,PAN domain-containing,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_02438,120,65,152,0,2,0,0,0,0,0,0,0,0,0,0,0,1,0,17.35404571,1,3.258533471,1.068622754,3.049283255,0.002293881,0.011674036,0.424795126,0,4.700501931,1.647213616,2.853607988,0.004322583,0.018725049,1.106163925,0,2.04276628,1.285198042,1.589456421,0.111957385,0.210836415,1.27622492,0,1.620494615,1.33483047,1.21400781,0.224744742,0.360224871,4.957568407,1,2.877782704,1.189738991,2.418835331,0.015570287,0.04477325,N,-,,F-box cyclin partial,,no IPS match,,
RL4_JR_02439,7,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.072865792,0,5.676447738,3.921387131,1.447561169,0.147739818,NA,0.023570913,0,8.873453593,2.84855047,3.115076839,0.00183897,0.015023052,0.060448584,0,6.2400649,1.651168252,3.779181735,0.000157345,0.001533532,0.069692725,0,5.816273643,2.726832053,2.132978317,0.032926505,0.097138839,0.05874396,0,6.175676409,1.349716797,4.575534973,4.75E-06,5.44E-05,N,-,,---NA---,,no IPS match,,
RL4_JR_02440,1442,1651,2413,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.98775524,0,-2.560987355,1.214267477,-2.109080087,0.034937669,0.101866157,6.954930249,0,0.667408016,1.243353591,0.536780543,0.591419213,0.728620408,18.15566,0,-1.993435899,1.209394973,-1.648291868,0.099292793,0.192907356,20.95245785,0,-2.416297007,1.21017392,-1.996652685,0.045862925,0.116206736,18.01780784,0,-2.085112038,1.22119017,-1.707442534,0.08773983,0.173103231,N,-,,abc1 family,C:integral component of membrane; P:phosphorylation; F:kinase activity,IPR004147 (PFAM); PTHR10566:SF76 (PANTHER); PTHR10566 (PANTHER); PTHR10566:SF76 (PANTHER); PTHR10566 (PANTHER); PTHR10566 (PANTHER); PTHR10566:SF76 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_02441,9355,10842,16062,0,0,6,0,0,0,0,3,2,1,3,0,0,8,2,167.6941605,1,-2.069979928,0.730019874,-2.835511746,0.004575233,0.020241189,45.77173754,0,-2.050894894,1.207861072,-1.69795595,0.089516076,0.185606971,156.0569308,1,-1.575218268,0.704296475,-2.236584059,0.025313538,0.067228294,159.2938463,1,-2.424411222,0.784633225,-3.089865613,0.002002471,0.013251645,164.2852677,1,-0.937725395,0.597276366,-1.570002511,0.116414527,0.214308561,N,-,,cytochrome c heme lyase,,IPR000511 (PFAM); IPR000511 (PANTHER); PTHR12743:SF3 (PANTHER),,
RL4_JR_02442,1572,1730,2332,0,0,3,0,0,0,0,0,0,0,3,0,0,0,1,33.97151437,1,-0.306658935,0.877645982,-0.349410743,0.726780969,0.855813965,7.139860504,0,0.629561722,1.231739984,0.511115763,0.609269999,0.742389662,18.60449798,0,-2.028665373,1.200766417,-1.689475442,0.091128354,0.180686145,33.50292143,1,-0.157576654,0.872923939,-0.180515904,0.85674757,0.910524735,25.79203401,1,-1.180000825,1.138427939,-1.036517802,0.299960639,0.435052495,N,-,,---NA---,,no IPS match,,
RL4_JR_02443,1605,1567,2424,0,3,0,0,0,0,0,0,0,1,0,0,0,0,1,46.34171742,1,-0.235718221,0.875311701,-0.269296321,0.787701663,0.890526979,7.072897102,0,0.643142459,1.238162124,0.519433156,0.603458715,0.737577099,18.4434592,0,-2.016143716,1.205418659,-1.672567204,0.094412528,0.185706709,30.59497563,1,-1.487587498,1.157866838,-1.284765613,0.198874202,0.329192398,25.65481983,1,-1.168085167,1.144460594,-1.020642539,0.307423827,0.442706052,N,-,,actin arp-6,"P:chromatin remodeling; C:cytoplasm; C:nuclear chromosome part; P:regulation of transcription, DNA-templated",IPR004000 (SMART); G3DSA:3.30.420.40 (GENE3D); IPR004000 (PFAM); G3DSA:3.90.640.10 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR004000 (PANTHER); IPR030054 (PTHR11937:PANTHER); IPR004000 (PANTHER); IPR030054 (PTHR11937:PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_02444,2151,1938,2626,0,0,3,0,0,0,0,0,1,0,2,0,0,0,0,38.25480435,1,-0.547117782,0.857707337,-0.637883994,0.523549198,0.707255234,8.535043542,0,0.372080239,1.219321057,0.305153624,0.760249152,0.854741965,28.6822471,1,-1.320719986,1.192355427,-1.107656288,0.268010284,0.406066465,33.61669241,1,-0.979736001,1.018119961,-0.962299178,0.335899342,0.482751006,21.92110012,0,-2.368031256,1.199636935,-1.973956609,0.048386677,0.109234137,N,-,,L-galactose dehydrogenase,"P:dehydro-D-arabinono-1,4-lactone biosynthetic process; F:oxidoreductase activity; P:oxidation-reduction process; F:D-arabinose 1-dehydrogenase [NAD(P)+] activity",IPR023210 (PFAM); IPR023210 (G3DSA:3.20.20.GENE3D); PTHR11732:SF14 (PANTHER); IPR001395 (PANTHER); IPR001395 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.4, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_02445,2206,1802,2048,0,2,2,0,0,0,0,3,2,0,0,0,0,6,2,47.85264262,1,0.028987855,0.734165775,0.039484073,0.968504452,0.984007287,7.751552355,0,0.511051834,1.22690774,0.416536482,0.677017478,0.793911614,56.5903973,1,1.004807889,0.667649943,1.504992098,0.132326108,0.238765405,23.14245306,0,-2.559674605,1.189110389,-2.152596285,0.031350421,0.094726884,57.63320518,1,1.39648815,0.540708674,2.582699739,0.00980306,0.030863178,N,-,,C2H2 zinc finger,C:intracellular membrane-bounded organelle; C:cytoplasmic part,PTHR31315:SF1 (PANTHER); PTHR31315 (PANTHER); PTHR31315 (PANTHER),,
RL4_JR_02446,1582,1327,2193,0,0,0,1,0,0,0,3,0,0,6,0,0,1,1,20.30870266,0,-2.446448251,1.207777776,-2.025578132,0.042808034,0.118651995,28.76281766,1,1.702100611,1.124456324,1.513709848,0.130099446,0.247345341,40.3345546,1,0.527515638,0.870705945,0.60584821,0.544615553,0.672059308,43.46077195,1,0.952102737,0.666481543,1.428550793,0.153133386,0.270023603,27.88089875,1,-0.292962112,0.999389269,-0.293141142,0.76941427,0.840198392,N,-,,General substrate transporter,C:integral component of plasma membrane; P:proton transport; F:sugar:proton symporter activity; P:glucose import; F:glucose transmembrane transporter activity; P:glucose transmembrane transport,IPR003663 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); IPR003663 (TIGRFAM); PTHR23500:SF64 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.119, the major facilitator superfamily (mfs).
RL4_JR_02447,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.00781203,0,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,0,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,0,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,0.007662926,0,9.0007212,4.037607722,2.229221316,0.025799183,0.085851084,0.006329724,0,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,,,,,,,,
RL4_JR_02448,308,201,193,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,10.44033429,1,2.122230334,1.051987148,2.017353861,0.043658599,0.120297674,0.905978743,0,3.608076031,1.466682219,2.460025753,0.013892705,0.043321613,2.331895424,0,0.967593863,1.239582181,0.780580649,0.435049177,0.575367454,2.688693619,0,0.545980543,1.251512798,0.43625646,0.662650668,0.770083497,2.281150059,0,0.896146723,1.227030314,0.730337884,0.465183677,0.596200598,N,-,,hypothetical protein CMQ_7418,,no IPS match,,
RL4_JR_02449,2077,2447,2534,2,2,3,0,0,4,0,0,0,0,0,0,0,0,0,75.91561251,1,0.618900682,0.579824142,1.06739378,0.285794056,0.469588703,46.52515649,1,2.884114545,0.756766591,3.811101838,0.000138349,0.006434128,23.40250733,0,-2.359593975,1.191998362,-1.979527867,0.047756605,0.109238109,27.00020415,0,-2.782065183,1.190947278,-2.336010363,0.019490701,0.075837092,23.08412066,0,-2.442574235,1.196090996,-2.042130778,0.041138561,0.096173615,N,-,,metallo-beta-lactamase superfamily,F:hydrolase activity,IPR001279 (G3DSA:3.60.15.GENE3D); PTHR23200 (PANTHER); PTHR23200:SF37 (PANTHER); PTHR23200 (PANTHER); IPR001279 (SUPERFAMILY),,
RL4_JR_02450,192,234,253,1,0,1,0,0,0,0,0,0,0,0,3,0,0,0,16.60661868,1,2.188824222,1.020218424,2.145446671,0.031917151,0.095133401,0.865317472,0,3.67418924,1.42733614,2.574158348,0.010048427,0.03366772,2.249749354,0,1.019197944,1.216651825,0.837707159,0.402195192,0.544337438,31.50162831,1,2.934202457,0.855227469,3.430902963,0.000601576,0.00485722,2.221671808,0,0.934814254,1.214363376,0.769797799,0.441419846,0.575306899,N,-,,---NA---,,IPR001623 (SMART); IPR001623 (G3DSA:1.10.287.GENE3D); IPR001623 (SUPERFAMILY),,
RL4_JR_02451,16,13,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140837291,0,4.725581005,3.511071785,1.345908399,0.17833206,NA,0.045792739,0,7.91499004,2.518299633,3.142989792,0.001672317,0.015023052,0.117201578,0,5.283700407,1.510456715,3.498081311,0.000468618,0.003223024,0.135097536,0,4.861185617,2.160797251,2.249718531,0.024466818,0.084618174,0.113798288,0,5.220185138,1.323597907,3.943935776,8.02E-05,0.00057722,N,-,,major facilitator superfamily transporter,,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.2.33, the major facilitator superfamily (mfs).
RL4_JR_02452,5376,4391,5564,0,0,2,0,0,0,0,3,10,4,11,0,1,2,3,68.82228181,1,-2.308796466,1.009866284,-2.286239775,0.022240235,0.071742126,19.558759,0,-0.824230481,1.201847365,-0.685802961,0.492837369,0.648379657,139.2279403,1,1.026214225,0.448933781,2.285892195,0.022260566,0.06059854,139.8744915,1,0.713342737,0.420357564,1.696990369,0.089698481,0.180529368,95.83030004,1,-0.329948854,0.620455744,-0.531784671,0.594875141,0.70586087,N,-,,ubiquitin-conjugating enzyme,F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; P:protein polyubiquitination; C:integral component of membrane; C:endoplasmic reticulum; P:ER-associated ubiquitin-dependent protein catabolic process,SM00212 (SMART); IPR016135 (G3DSA:3.10.110.GENE3D); IPR000608 (PFAM); PTHR24067:SF42 (PANTHER); PTHR24067 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_02453,15395,13618,22668,12,4,18,3,0,10,5,5,9,2,26,2,0,14,1,427.3232165,1,0.05935183,0.441728714,0.134362625,0.893115834,0.947715788,225.9907481,1,1.685488536,0.510342044,3.302664468,0.000957709,0.015023052,323.2364238,1,-0.152237786,0.423408096,-0.359553318,0.719181198,0.810079045,338.5736296,1,-0.270724225,0.573693294,-0.47189714,0.63700021,0.751529611,230.2073646,1,-1.020561356,0.661386707,-1.543062999,0.122815491,0.222930593,N,-,,sorting assembly machinery 50 kda subunit,,IPR000184 (PFAM); PTHR12815 (PANTHER),1.B.33.3.3, the outer membrane protein insertion porin (bam complex) (ompip) family.
RL4_JR_02454,1272,1472,1441,2,0,6,0,0,0,0,0,1,3,11,3,0,4,0,59.83622678,1,1.541637382,0.546661467,2.820095207,0.00480094,0.021046266,5.353408566,0,1.04507743,1.238534864,0.843801382,0.398780403,0.562729017,20.38746996,1,-0.645003126,1.191324787,-0.541416692,0.588220404,0.708113266,116.9930064,1,2.775182739,0.392358302,7.073082753,1.52E-12,7.07E-11,29.12569028,1,0.920080229,0.753986779,1.220286953,0.222356114,0.34893919,N,-,,glycosyl hydrolase family 43,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:hydrolase activity",IPR000182 (PFAM); IPR016181 (G3DSA:3.40.630.GENE3D); PTHR13170 (PANTHER); PTHR13170 (PANTHER); PTHR13170:SF21 (PANTHER); PTHR13170:SF21 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_02455,37,39,30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.426106349,0,3.128446919,2.129473531,1.469117542,0.141800911,NA,0.136695054,0,6.336679676,1.975619845,3.207438766,0.001339226,0.015023052,0.353024975,0,3.691986507,1.2989411,2.842304787,0.004478865,0.017453437,0.407160812,0,3.269453787,1.477471989,2.212870234,0.026906593,0.087153604,0.346067951,0,3.617231628,1.237304025,2.92347843,0.003461442,0.013285841,N,-,,---NA---,,no IPS match,,
RL4_JR_02456,98,91,114,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.210540668,0,1.621952528,1.383449803,1.172397094,0.241037666,NA,0.385897394,0,4.839182812,1.608451252,3.008597746,0.002624564,0.015349618,1.00213082,0,2.185610857,1.232228901,1.773705238,0.07611192,0.156904311,1.156128065,0,1.763327051,1.265040187,1.393890146,0.163350781,0.283674591,0.989199368,0,2.101945905,1.21677924,1.727466936,0.084083838,0.167527107,N,-,,glycosyl hydrolase family 3 n terminal domain-containing,"P:polysaccharide catabolic process; C:membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR001764 (PRINTS); IPR026891 (SMART); IPR001764 (PFAM); IPR026891 (PFAM); IPR001764 (G3DSA:3.20.20.GENE3D); IPR002772 (G3DSA:3.40.50.GENE3D); IPR002772 (PFAM); PTHR30620:SF32 (PANTHER); IPR026892 (PANTHER); PTHR30620:SF32 (PANTHER); IPR026892 (PANTHER); IPR017853 (SUPERFAMILY); IPR002772 (SUPERFAMILY),,
RL4_JR_02457,73,85,62,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.885714878,0,2.07290547,1.562097173,1.327001614,0.184508149,NA,0.283769491,0,5.282882323,1.723369441,3.065438087,0.002173514,0.015045494,0.733228752,0,2.637361885,1.260413479,2.092457697,0.036397592,0.088685734,0.845711172,0,2.214964979,1.323758239,1.673239807,0.094280097,0.187394185,0.718930632,0,2.562573456,1.227590695,2.087481981,0.036844588,0.088317106,N,-,,---NA---,,no IPS match,,
RL4_JR_02458,589,323,302,0,0,17,0,0,0,0,0,0,0,0,0,0,0,0,69.75588247,1,3.970579323,1.004322863,3.953488932,7.70E-05,0.000680008,1.57198174,0,2.813029494,1.422591532,1.97739789,0.047996672,0.114149981,4.034716494,0,0.17658099,1.252677919,0.140962802,0.887899328,0.930341408,4.65113217,0,-0.244725155,1.260591986,-0.194135103,0.846070096,0.903544021,3.936599813,0,0.10907045,1.246074601,0.087531236,0.930249258,0.954476463,N,-,,anthranilate n-hydroxycinnamoyl benzoyltransferase,"F:transferase activity, transferring acyl groups",IPR023213 (G3DSA:3.30.559.GENE3D); IPR023213 (G3DSA:3.30.559.GENE3D); IPR003480 (PFAM),,
RL4_JR_02459,1345,840,829,0,5,5,0,0,3,0,0,1,0,0,0,0,1,0,71.17132446,1,2.357601661,0.563925426,4.180697576,2.91E-05,0.000290189,32.02529477,1,3.653210425,0.921015149,3.966504165,7.29E-05,0.003691215,16.50774992,1,-0.172413194,1.217291545,-0.14163673,0.887366953,0.930143959,11.54020782,0,-1.55575929,1.222085091,-1.273036797,0.203004985,0.334698489,13.65055882,1,-0.276942585,1.148494454,-0.241135327,0.809450234,0.871047254,N,-,,2og-Fe oxygenase family,F:metal ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR027443 (G3DSA:2.60.120.GENE3D); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_02460,39,17,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.290297982,0,3.681930205,2.60468311,1.413580866,0.157485003,NA,0.094710239,0,6.866181478,2.199763105,3.121327683,0.001800376,0.015023052,0.242504771,0,4.233144473,1.414217052,2.993277777,0.002759984,0.012770603,0.279502084,0,3.811923364,1.738038913,2.193232463,0.028290635,0.089465864,0.236145282,0,4.16646272,1.311948846,3.175781383,0.001494335,0.006653537,N,-,,---NA---,,no IPS match,,
RL4_JR_02461,149,103,137,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.549813941,0,1.265387546,1.328035477,0.952826613,0.340677928,NA,0.496937485,0,4.474383066,1.558884822,2.870246091,0.004101525,0.018371529,1.28637184,0,1.82542138,1.234917683,1.478172517,0.139361608,0.248309912,1.483696789,0,1.403424381,1.259154879,1.114576455,0.265031965,0.405968025,1.266367355,0,1.745158349,1.220413697,1.429972765,0.152724836,0.262353462,Y,-,,biotrophy-associated secreted 2,P:biological_process; F:ATP citrate synthase activity; C:cellular_component,no IPS match,,
RL4_JR_02462,8935,7430,9810,0,1,2,0,0,0,0,0,2,0,8,2,0,0,0,120.0801264,1,-2.500101317,0.853931238,-2.927754842,0.003414191,0.015943316,33.34063244,0,-1.593704209,1.196012227,-1.332514979,0.182691023,0.321935677,99.52129708,1,-2.426183818,1.032894975,-2.348916277,0.01882814,0.05350137,151.1773359,1,-0.640642937,0.498229882,-1.285838045,0.198499589,0.328883708,85.37291907,0,-4.329495157,1.195198851,-3.622405723,0.000291876,0.0017112,N,-,,DNA polymerase sigma subunit,F:nucleotidyltransferase activity,IPR002934 (PFAM); IPR002058 (PFAM); G3DSA:3.30.460.10 (GENE3D); PTHR23092:SF15 (PANTHER); PTHR23092 (PANTHER); PTHR23092:SF15 (PANTHER); PTHR23092 (PANTHER); PTHR23092:SF15 (PANTHER); SSF81301 (SUPERFAMILY); SSF81631 (SUPERFAMILY),,
RL4_JR_02463,133,101,185,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.665089382,0,1.161839716,1.355754392,0.85696917,0.391461923,NA,0.52891939,0,4.384237981,1.554259127,2.8207896,0.004790561,0.020095342,1.378408731,0,1.725380102,1.249810659,1.380513192,0.167428691,0.28466018,1.590483351,0,1.302930248,1.277887283,1.019597163,0.307919551,0.45367949,1.366996268,0,1.635168878,1.245153971,1.313226249,0.189106721,0.308749471,N,-,,High-affinity glucose transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,IPR003663 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR003663 (TIGRFAM); IPR005828 (PFAM); PTHR23500:SF72 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.39, the major facilitator superfamily (mfs).
RL4_JR_02464,38,31,29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.392248782,0,3.247810391,2.204534077,1.473241183,0.140686014,NA,0.126142924,0,6.452546799,2.005441504,3.217519327,0.001293043,0.015023052,0.325565346,0,3.808377798,1.30264838,2.92356545,0.003460475,0.015042441,0.375455509,0,3.386226239,1.500496273,2.256737521,0.024024481,0.08365596,0.319223984,0,3.732885894,1.237429627,3.016644997,0.002555889,0.010409646,Y,-, Effector probability:0.559,hypothetical protein F503_05618,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_02465,844,738,1123,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,10.77973189,0,-1.532725518,1.204767758,-1.272216581,0.203296178,0.367870166,3.42701112,0,1.688492706,1.271293035,1.328169556,0.184122099,0.323724837,24.60653408,1,0.856151507,1.041976615,0.821660961,0.411269884,0.553388663,10.29266655,0,-1.390901235,1.203800034,-1.155425482,0.247916232,0.386951109,8.831190045,0,-1.056388084,1.212846069,-0.870999305,0.383754532,0.51973176,Y,-,,hypothetical protein F503_04603,C:integral component of membrane,no IPS match,,
RL4_JR_02466,799,598,1019,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29.73820041,1,0.390997477,1.029513527,0.379788577,0.704102363,0.839727461,3.057907281,0,1.852895397,1.290957242,1.435287968,0.151205055,0.278424153,7.957555141,0,-0.80352951,1.212514115,-0.662697036,0.507524609,0.639236021,9.181087553,0,-1.226032572,1.21275209,-1.010950699,0.312040027,0.458150417,7.87898437,0,-0.89181723,1.221021965,-0.730385903,0.465154333,0.596200598,N,-,,hypothetical protein F503_04603,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_02467,538,303,619,0,3,0,0,0,0,0,0,0,1,1,0,0,0,0,29.81690585,1,1.731557631,0.904022645,1.915391876,0.055442546,0.143496286,1.847103034,0,2.580173491,1.368274243,1.885713703,0.059333545,0.135051528,4.801176522,0,-0.074632389,1.237312738,-0.060318129,0.951902263,0.972469277,18.86262088,1,1.239185351,1.057146467,1.172198357,0.241117428,0.379675577,4.751499689,0,-0.162244702,1.244432212,-0.130376489,0.896268567,0.932461903,N,-,,phospholipase d transphosphatidylase,F:catalytic activity,G3DSA:3.30.870.10 (GENE3D); IPR025202 (PFAM); G3DSA:3.30.870.10 (GENE3D); PTHR21248 (PANTHER); PTHR21248:SF11 (PANTHER); PTHR21248 (PANTHER); PTHR21248:SF11 (PANTHER); IPR001736 (PROSITE_PROFILES); IPR001736 (PROSITE_PROFILES); SSF56024 (SUPERFAMILY); SSF56024 (SUPERFAMILY),,
RL4_JR_02468,360,375,394,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.65392323,1,1.461108602,1.005272949,1.453444662,0.146100334,0.291771487,1.44322077,0,2.93623902,1.342898231,2.18649407,0.028779478,0.07669981,3.743280789,0,0.284718857,1.20027147,0.237212051,0.812492288,0.87816647,4.318317971,0,-0.137612184,1.199122933,-0.114760697,0.908634802,0.944066431,3.688245574,0,0.203381871,1.198520406,0.169694124,0.865250695,0.910077049,N,-,,upf0187 domain membrane,,IPR021134 (PFAM); PTHR33281 (PANTHER); PTHR33281:SF1 (PANTHER),1.A.46.2.1, the anion channel-forming bestrophin (bestrophin) family.
RL4_JR_02469,2704,2374,2426,2,1,2,0,0,0,0,0,0,1,9,4,0,3,0,65.80777085,1,0.043759859,0.659168741,0.06638643,0.947070174,0.973563316,9.624387223,0,0.198856344,1.220168945,0.162974434,0.870538564,0.925295741,24.89633253,0,-2.448848722,1.189795975,-2.058208947,0.03957008,0.094863247,112.6732969,1,1.657340155,0.420754398,3.938972866,8.18E-05,0.000900588,36.05091285,1,-0.317736562,0.835598393,-0.380250326,0.703759605,0.790236886,N,-,,AP-2 complex subunit mu-1,P:vesicle-mediated transport; C:clathrin adaptor complex; P:intracellular protein transport,IPR001392 (PRINTS); IPR001392 (PIRSF); IPR028565 (PFAM); G3DSA:2.60.40.1170 (GENE3D); G3DSA:3.30.450.60 (GENE3D); PTHR10529 (PANTHER); IPR028565 (PROSITE_PROFILES); IPR011012 (SUPERFAMILY); IPR028565 (SUPERFAMILY),9.B.278.1.1, the organellar-targeting adaptor protein complex (o-apc) family.
RL4_JR_02470,1417,1238,1452,0,0,1,0,0,0,0,1,5,0,4,1,0,2,0,20.23069034,1,-1.191175023,1.136763642,-1.047865166,0.294700733,0.479873969,5.246329381,0,1.074214036,1.237563712,0.868007057,0.385390469,0.55004545,53.93535828,1,1.824741969,0.610413326,2.989354742,0.002795673,0.012894486,41.36826419,1,1.046672021,0.66293474,1.578846238,0.11437133,0.216526231,21.1182102,1,0.012247308,0.97220974,0.012597393,0.989949001,0.993186051,Y,-,,lipolytic enzyme,F:hydrolase activity,IPR013830 (G3DSA:3.40.50.GENE3D); IPR013830 (PFAM); PTHR30383 (PANTHER); PTHR30383:SF3 (PANTHER); IPR013830 (SUPERFAMILY),,
RL4_JR_02471,12732,10335,7332,0,1,0,1,0,0,0,0,0,5,5,3,0,3,1,129.963341,1,-4.07840036,1.180278338,-3.455456421,0.000549362,0.003628903,61.72376874,1,-0.904143926,1.143909736,-0.790397963,0.429295391,0.591725227,101.340681,0,-4.474070393,1.21716714,-3.675806095,0.0002371,0.001965084,212.3706978,1,-0.41531836,0.51226611,-0.810747289,0.41751081,0.561021494,117.8850928,1,-1.938274905,0.792313444,-2.446348626,0.014431138,0.042205452,N,-,,ubiquitin fusion degradation,,IPR000494 (G3DSA:3.80.20.GENE3D),,
RL4_JR_02472,17394,8071,11072,6,14,32,0,0,3,0,0,2,1,1,2,0,2,1,439.8130857,1,1.070455524,0.441382407,2.425233782,0.015298532,0.053199241,75.10561045,1,0.054446328,0.92937719,0.058583672,0.953283717,0.975106641,133.9114319,1,-2.920564369,1.082260471,-2.698578067,0.00696364,0.024462142,172.0011656,1,-2.372012164,0.809883599,-2.928830968,0.003402394,0.020554438,133.5245184,1,-2.600805995,0.908246163,-2.863547463,0.00418926,0.015480388,N,-,,ubiquitin fusion degradation,,IPR032353 (PFAM); IPR004854 (PFAM); PTHR12555:SF15 (PANTHER); PTHR12555:SF15 (PANTHER); IPR004854 (PANTHER); IPR004854 (PANTHER),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_02473,1042,974,1048,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,12.26168292,0,-1.718387687,1.1840455,-1.45128518,0.146700466,0.292441156,3.920147671,0,1.494630673,1.25283336,1.193000379,0.232869225,0.383144066,10.15698392,0,-1.155404074,1.19007709,-0.970864899,0.33161556,0.474862224,11.71633966,0,-1.577623657,1.187073792,-1.32900218,0.183847251,0.310552788,25.44137375,1,1.379649405,0.74237784,1.858419433,0.063109475,0.134043095,Y,-,,hypothetical protein CMQ_7343,,PTHR38049 (PANTHER); PTHR38049:SF2 (PANTHER),,
RL4_JR_02474,1104,761,724,0,0,15,0,0,0,0,5,0,1,1,2,0,10,0,67.622878,1,2.760810306,0.887721779,3.109995013,0.001870905,0.009898082,3.339315752,0,1.726031692,1.305169768,1.32245761,0.186015816,0.325865713,47.81538047,1,2.231760626,0.70811652,3.151685583,0.00162331,0.008406336,42.51141824,1,1.420651173,0.770058336,1.844861755,0.065057651,0.143822865,47.02329766,1,2.837455608,0.597393154,4.749729036,2.04E-06,2.63E-05,N,-,,hypothetical protein SPI_02272,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,1.G.20.2.1, the hantavirus gc envelope fusion glycoprotein (gc-efg) family.
RL4_JR_02475,120,131,144,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.582292236,0,1.235701007,1.310874588,0.942653873,0.345857974,NA,0.503899645,0,4.454292193,1.538081096,2.896006072,0.003779451,0.017556495,1.308647092,0,1.800861209,1.223764358,1.471575142,0.141135642,0.25045701,1.509800543,0,1.378431606,1.243732936,1.108301925,0.267731445,0.409050985,1.291134171,0,1.717840416,1.212814036,1.416408752,0.156655863,0.266892245,N,-, Effector probability:0.648,polyketide synthase,P:secondary metabolic process; F:catalytic activity,IPR016040 (G3DSA:3.40.50.GENE3D); IPR013968 (PFAM); IPR016040 (SUPERFAMILY),,
RL4_JR_02476,29480,28104,21117,3,4,3,0,0,0,0,0,0,0,0,0,0,0,0,389.8094941,1,-2.302841156,0.542995246,-4.240996899,2.23E-05,0.000229216,101.6816798,0,-3.202388603,1.210879138,-2.644680632,0.008176805,0.029030383,262.1882833,0,-5.845464602,1.206844803,-4.843592638,1.28E-06,3.34E-05,302.3611714,0,-6.267302539,1.206816328,-5.193253021,2.07E-07,4.33E-06,256.6479539,0,-5.917430537,1.206277039,-4.905531933,9.32E-07,1.36E-05,N,-,,ABC transporter CDR4,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR013525 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR010929 (PFAM); IPR029481 (PFAM); IPR003439 (PFAM); PTHR19241 (PANTHER); PTHR19241:SF179 (PANTHER); PTHR19241 (PANTHER); PTHR19241:SF179 (PANTHER); PTHR19241:SF179 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.205.4, the atp-binding cassette (abc) superfamily.
RL4_JR_02477,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.011692083,0,8.312151371,3.996763216,2.079720745,0.037551154,NA,0.003838345,0,11.49092626,3.994647088,2.876581086,0.004020089,0.018157671,0.009833003,0,8.854297471,3.046863773,2.906036545,0.003660387,0.015609839,0.011330785,0,8.434549956,3.995610333,2.110954085,0.034776259,0.099426657,0.009620272,0,8.767548331,1.615958211,5.425603379,5.78E-08,1.50E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_02478,391,253,250,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.568831708,0,0.062122769,1.251888986,0.049623225,0.960422639,0.979880926,1.153045513,0,3.260162269,1.425688686,2.286728022,0.022211703,0.062573576,2.968646203,0,0.619260412,1.233705559,0.501951545,0.615701606,0.730158493,3.422920887,0,0.1976383,1.240995679,0.159257847,0.87346573,0.921809518,2.905063661,0,0.547386375,1.224008739,0.447207898,0.654724959,0.753648274,N,-,,hypothetical protein SPI_04986,,no IPS match,,
RL4_JR_02479,2400,2603,5642,0,0,6,0,0,0,0,4,2,0,0,0,0,1,0,65.20187288,1,-0.36123626,0.836838264,-0.431667953,0.665982762,0.814433724,13.27929263,0,-0.265652528,1.266425204,-0.209765668,0.83385057,0.900418847,79.24333532,1,0.457382877,0.715921972,0.638872523,0.522905864,0.652842393,40.2589141,0,-3.358453288,1.250862224,-2.684910635,0.00725492,0.037535037,38.71493491,1,-2.112148978,1.194584249,-1.768103824,0.077043548,0.156325837,N,-,,conserved fungal,P:regulation of cell cycle,PF13324 (PFAM),,
RL4_JR_02480,1889,2112,1904,0,2,15,0,0,0,0,0,0,0,8,0,0,14,6,97.0098956,1,1.974833863,0.547991485,3.603767424,0.000313638,0.002244436,7.575514121,0,0.544211731,1.227956872,0.443184727,0.657632125,0.779638366,19.62172666,0,-2.105318535,1.192232946,-1.765861732,0.077419049,0.15891811,54.72733295,1,1.162677955,0.555742568,2.092116064,0.036428135,0.101328259,117.5376655,1,2.725905683,0.387778511,7.029542906,2.07E-12,1.98E-10,Y,-,,glucosidase 2 subunit beta,"C:endoplasmic reticulum lumen; F:alpha-1,4-glucosidase activity; P:polysaccharide biosynthetic process; P:N-glycan processing; C:glucosidase II complex; P:phosphorylation; F:kinase activity",IPR028146 (PFAM); IPR002172 (G3DSA:4.10.400.GENE3D); IPR009011 (G3DSA:2.70.130.GENE3D); IPR009011 (PFAM); IPR026874 (PTHR12630:PANTHER); PTHR12630 (PANTHER); IPR009011 (SUPERFAMILY),,
RL4_JR_02481,1470,1337,1726,0,0,4,0,0,0,1,0,0,0,0,1,0,2,2,33.37581409,1,0.433538811,0.743611287,0.583018062,0.559881141,0.737103369,5.769616466,0,0.937012185,1.232308444,0.760371472,0.447032571,0.608098869,26.05602587,1,-0.754879051,1.190336776,-0.63417267,0.525968141,0.655695292,26.92435008,1,-1.189678346,1.141958384,-1.041787829,0.297510058,0.442723301,37.24916744,1,0.826062765,0.75141847,1.09933785,0.271620729,0.404078736,N,-,,duf602 domain-containing,C:nucleus; P:mitotic DNA replication termination,IPR027799 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR006735 (PANTHER); SSF57850 (SUPERFAMILY),,
RL4_JR_02482,32837,27148,22135,0,6,14,0,0,0,2,1,6,2,16,2,0,9,5,430.6510536,1,-1.507901008,0.498273288,-3.026252952,0.002476051,0.012415071,106.0722593,0,-3.263377564,1.213275789,-2.689724458,0.007151104,0.026330838,342.2730653,1,-1.923705895,0.558158166,-3.446524682,0.000567847,0.003716147,417.2294507,1,-1.387814376,0.477467018,-2.906618306,0.003653587,0.021837408,339.001587,1,-1.583046468,0.491169325,-3.223015744,0.001268486,0.005829968,N,-,,FKBP12-rapamycin complex-associated,F:ATP binding; C:integral component of membrane; F:protein serine/threonine kinase activity; P:protein phosphorylation; F:macromolecular complex binding,SM01345 (SMART); IPR024585 (SMART); IPR000403 (SMART); IPR003152 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); G3DSA:3.30.1010.10 (GENE3D); IPR011989 (G3DSA:1.25.10.GENE3D); IPR009076 (G3DSA:1.20.120.GENE3D); IPR003152 (PFAM); IPR000403 (G3DSA:1.10.1070.GENE3D); IPR009076 (PFAM); IPR024585 (PFAM); IPR000403 (PFAM); IPR003151 (PFAM); IPR026683 (PTHR11139:PANTHER); IPR026683 (PTHR11139:PANTHER); PTHR11139 (PANTHER); IPR026683 (PTHR11139:PANTHER); PTHR11139 (PANTHER); PTHR11139 (PANTHER); IPR003152 (PROSITE_PROFILES); IPR000403 (PROSITE_PROFILES); IPR014009 (PROSITE_PROFILES); IPR009076 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR011009 (SUPERFAMILY),,
RL4_JR_02483,42,33,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.369783083,0,3.332962557,2.355134746,1.415189752,0.157012868,NA,0.120157514,0,6.52294763,2.099991927,3.10617748,0.001895229,0.015023052,0.307734655,0,3.890272974,1.383296426,2.812320557,0.004918546,0.018741196,0.354734289,0,3.46840186,1.632271968,2.124892131,0.033595615,0.098223396,0.299076433,0,3.826835642,1.296514804,2.951632816,0.003160986,0.0123476,N,-,,---NA---,,no IPS match,,
RL4_JR_02484,43,29,27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.395547867,0,3.235695128,2.21708711,1.459435271,0.144445344,NA,0.127805853,0,6.43370675,2.019651679,3.185552646,0.001444778,0.015023052,0.328971265,0,3.793333553,1.321311932,2.870884204,0.004093254,0.016595704,0.379309882,0,3.371477948,1.525878565,2.209532282,0.02713764,0.087561696,0.321787629,0,3.720814443,1.251238416,2.973705407,0.002942274,0.011636924,N,-,,tor pathway phosphatidylinositol 3-kinase,,no IPS match,,
RL4_JR_02485,7787,8687,12707,0,0,0,0,0,0,0,0,0,0,2,1,0,4,1,116.5132515,0,-4.966686572,1.217439592,-4.079616439,4.51E-05,0.000427916,36.87355326,0,-1.739029383,1.206078343,-1.441887581,0.14933409,0.27578173,96.22767415,0,-4.399408166,1.205839126,-3.648420482,0.000263858,0.002106699,128.7071904,1,-2.514101078,0.880307968,-2.85593357,0.004291049,0.024912197,118.2781115,1,-1.578541707,0.731592055,-2.15768022,0.030952703,0.077077254,N,-,,suppressor srp40,F:nucleotide binding,no IPS match,,
RL4_JR_02486,19891,17544,15170,0,1,99,1,0,0,0,0,4,0,16,4,0,5,5,596.908489,1,0.89674341,1.448597115,0.619042659,0.535888256,0.719278775,90.09444829,1,-1.692167103,1.119668851,-1.511310332,0.130709403,0.248225249,200.9268292,1,-2.451742307,0.761435588,-3.21989456,0.001282378,0.007010146,304.4681079,1,-0.732521555,0.459978277,-1.592513366,0.111269402,0.212408856,227.5931774,1,-1.388778706,0.511955127,-2.712696157,0.006673827,0.022751683,N,-,,ammonium transporter mep2,,IPR029020 (G3DSA:1.10.3430.GENE3D); IPR024041 (PFAM); IPR001905 (TIGRFAM); IPR001905 (PANTHER); PTHR11730:SF17 (PANTHER); IPR024041 (SUPERFAMILY),1.A.11.3.3, the ammonium transporter channel (amt) family.
RL4_JR_02487,1999,1582,1673,0,0,3,0,0,0,0,3,0,0,1,2,0,0,0,32.45558225,1,-0.192689944,0.853029325,-0.225889003,0.821287751,0.90986066,6.742552148,0,0.712258804,1.239152756,0.574794997,0.565429951,0.707626356,40.9546273,1,0.475060607,0.855208878,0.555490734,0.578559047,0.700750699,43.37965561,1,-0.033006553,0.85358985,-0.038667931,0.969155142,0.982842128,17.11518576,0,-2.011049382,1.193177358,-1.685457212,0.091900394,0.179043965,N,-,,copper amine oxidase,P:amine metabolic process; F:copper ion binding; F:quinone binding; F:primary amine oxidase activity; P:oxidation-reduction process,G3DSA:3.10.450.40 (GENE3D); G3DSA:3.10.450.40 (GENE3D); IPR015802 (PFAM); IPR015798 (G3DSA:2.70.98.GENE3D); IPR015798 (PFAM); PTHR10638:SF27 (PANTHER); IPR000269 (PANTHER); IPR016182 (SUPERFAMILY); IPR016182 (SUPERFAMILY); IPR015798 (SUPERFAMILY),,
RL4_JR_02488,517,376,373,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.059195384,0,-0.441307261,1.217229499,-0.36255058,0.716940633,0.848021123,1.62972466,0,2.760965448,1.359950797,2.030195103,0.042336711,0.103585253,4.203056771,0,0.11762297,1.216029532,0.096727067,0.922943144,0.954820805,4.846816277,0,-0.304164228,1.217085543,-0.249911955,0.802655437,0.873670856,4.119367226,0,0.043604679,1.209117716,0.036063221,0.971231949,0.980367224,N,-,,AAT family amino acid variant,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PIRSF); IPR004841 (PFAM); PTHR11785:SF212 (PANTHER); IPR002293 (PANTHER),2.A.3.10.14, the amino acid-polyamine-organocation (apc) family.
RL4_JR_02489,70,105,108,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.137188109,0,1.712310257,1.466513969,1.167605828,0.242965798,NA,0.36025957,0,4.938356754,1.64862217,2.995444828,0.002740449,0.015349618,0.938173968,0,2.281093094,1.256853615,1.814923446,0.069535675,0.146023475,1.082610535,0,1.858341603,1.303841145,1.425282221,0.154075637,0.271118496,0.927596935,0,2.19520886,1.240722238,1.769299198,0.076843957,0.155983374,N,-, Effector probability:0.769,guanylate kinase,P:purine ribonucleotide metabolic process; P:guanosine-containing compound metabolic process; F:kinase activity,IPR008145 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR017665 (TIGRFAM); G3DSA:3.30.63.10 (GENE3D); IPR008145 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23117 (PANTHER); IPR008144 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),8.A.24.1.8, the ezrin/radixin/moesin-binding phosphoprotein 50 (ebp50) family.
RL4_JR_02490,506,644,629,0,0,0,0,0,0,0,0,0,0,5,0,0,0,1,7.144621088,0,-0.939006023,1.206701581,-0.778159271,0.436475124,0.62673552,2.272994338,0,2.280929828,1.301466569,1.752584263,0.079673395,0.169672649,5.903561118,0,-0.372530705,1.203666372,-0.309496646,0.756943763,0.836513335,26.86919103,1,2.227975192,0.687903032,3.238792519,0.001200369,0.008638047,13.18748174,1,0.480954375,1.131562165,0.425035751,0.670810613,0.766067839,N,-, Effector probability:0.731,carbonic anhydrase,"F:zinc ion binding; F:oxidoreductase activity, acting on the CH-CH group of donors; F:flavin adenine dinucleotide binding; F:carbonate dehydratase activity; P:oxidation-reduction process; F:monooxygenase activity",IPR001765 (SMART); IPR001765 (G3DSA:3.40.1050.GENE3D); IPR001765 (PFAM); IPR001765 (PANTHER); PTHR11002:SF4 (PANTHER); IPR001765 (SUPERFAMILY),,
RL4_JR_02491,1761,1636,2435,0,0,4,0,0,1,0,0,0,0,0,0,0,2,0,38.52981909,1,0.055105232,0.770749442,0.071495649,0.943003287,0.971842636,16.76510472,1,1.496729841,1.126496663,1.328658921,0.183960523,0.323609388,19.23615348,0,-2.07685611,1.200375253,-1.730172381,0.083599481,0.168363069,22.19563328,0,-2.499477122,1.200040161,-2.082827894,0.037266914,0.102674151,26.77076551,1,-0.504202334,0.997120326,-0.505658465,0.613096431,0.720473695,N,-,,hypothetical protein CMQ_7617,,no IPS match,,
RL4_JR_02492,2448,2199,4062,2,1,3,0,0,2,0,7,12,10,6,8,0,4,21,74.23295001,1,0.107184542,0.680544424,0.15749823,0.874852203,0.939702998,29.71481248,1,1.64039975,1.02075762,1.607041396,0.108045288,0.214769121,161.5136643,1,2.356880738,0.491945408,4.790939604,1.66E-06,4.19E-05,227.3126974,1,2.418452467,0.491064355,4.924919601,8.44E-07,1.57E-05,198.5753103,1,2.636256553,0.870785062,3.027448066,0.002466281,0.010105663,Y,-,,fumarate reductase succinate dehydrogenase flavo,"F:oxidoreductase activity, acting on the CH-CH group of donors; P:oxidation-reduction process",IPR014614 (PIRSF); IPR023753 (G3DSA:3.50.50.GENE3D); IPR003953 (PFAM); PTHR11632 (PANTHER); PTHR11632 (PANTHER); PTHR11632:SF38 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_02493,1905,1841,3626,1,0,2,0,0,0,0,3,0,0,2,0,0,0,1,47.00994961,1,-0.673537022,0.921598109,-0.730835941,0.464879367,0.653088665,9.243819806,0,0.256950142,1.25717434,0.20438704,0.838051057,0.903285359,47.7296941,1,0.001968084,0.90186323,0.002182242,0.998258824,0.999245831,35.95560028,1,-1.127454159,1.06879857,-1.054879928,0.291480243,0.435993125,31.47461773,1,-1.561603475,1.171215437,-1.333318727,0.182427231,0.300924684,N,-, Effector probability:0.566,peptidyl-tRNA hydrolase,C:mitochondrion; P:mitochondrial translation; F:aminoacyl-tRNA hydrolase activity,IPR001328 (PFAM); IPR001328 (G3DSA:3.40.50.GENE3D); PTHR17224:SF1 (PANTHER); IPR001328 (PANTHER); IPR001328 (SUPERFAMILY),,
RL4_JR_02494,3314,2658,3284,0,1,2,0,0,0,2,5,3,0,1,11,0,5,4,52.59166441,1,-0.999569621,0.847021811,-1.180099035,0.237960828,0.412162301,11.8211716,0,-0.097781733,1.213124858,-0.080603189,0.93575753,0.964339006,111.4807097,1,1.398730466,0.487233586,2.87075954,0.004094869,0.016595704,145.3308785,1,1.589763729,1.412755264,1.125293085,0.260464859,0.400781883,78.93628048,1,0.963075702,0.518672049,1.85681049,0.063338121,0.134415945,N,-,,hob3,C:medial cortex; P:small GTPase mediated signal transduction; C:cell cortex of cell tip; P:mitotic actomyosin contractile ring assembly; P:actin filament organization; P:positive regulation of GTPase activity,IPR003005 (PRINTS); IPR004148 (SMART); IPR004148 (PFAM); IPR027267 (G3DSA:1.20.1270.GENE3D); PTHR22834:SF20 (PANTHER); PTHR22834 (PANTHER); IPR004148 (PROSITE_PROFILES); SSF103657 (SUPERFAMILY),8.A.34.2.1, the endophilin (endophilin) family.
RL4_JR_02495,2357,2691,2378,0,2,29,0,0,0,9,0,1,9,3,0,0,2,1,156.5891307,1,2.227785133,0.887369063,2.510550824,0.012054297,0.044000134,9.52972433,0,0.213119707,1.221754612,0.174437407,0.861521718,0.918992816,130.8113279,1,2.037397202,1.370457502,1.486654784,0.137106011,0.24528384,124.3179914,1,1.568412386,0.565774,2.772153523,0.005568677,0.030510201,39.35842103,1,-0.301709998,0.840819238,-0.358828609,0.719723309,0.802643298,N,-,,D-isomer specific 2-hydroxyacid dehydrogenase,F:NAD binding; P:oxidation-reduction process; F:transporter activity,IPR016040 (G3DSA:3.40.50.GENE3D); IPR006140 (PFAM); PTHR10996:SF130 (PANTHER); PTHR10996 (PANTHER); PTHR10996:SF130 (PANTHER); PTHR10996 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02496,305,300,300,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33.82207256,1,2.363226372,0.842755945,2.80416458,0.005044715,0.021936179,1.159537561,0,3.252009522,1.376609554,2.362332523,0.018160345,0.053280873,3.003039921,0,0.602682189,1.203826719,0.500638655,0.616625453,0.730958924,3.464037804,0,0.180472177,1.204423333,0.14984115,0.880889943,0.92661179,2.954382795,0,0.523396608,1.197847113,0.436947756,0.662149237,0.759087525,N,-,,salicylate hydroxylase,F:FAD binding; F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process,IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789 (PANTHER); PTHR13789:SF204 (PANTHER); SSF54373 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_02497,455,421,483,0,0,5,0,0,0,0,2,1,0,6,5,0,0,0,24.52719265,1,2.495225837,0.660539565,3.777556968,0.000158374,0.001266684,1.735627128,0,2.670062842,1.320453314,2.022080458,0.043168041,0.105085836,26.68543533,1,2.426100553,0.847555018,2.862469694,0.004203535,0.016914382,77.43794421,1,3.786989128,0.461399639,8.207611805,2.26E-16,1.63E-14,4.435396331,0,-0.062846257,1.197050676,-0.052500916,0.958129566,0.972440041,Y,-,,glycosyl hydrolase family 10,"P:xylan catabolic process; C:membrane; F:endo-1,4-beta-xylanase activity",IPR001000 (PRINTS); IPR001000 (SMART); IPR001000 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR31490 (PANTHER); IPR001000 (PROSITE_PROFILES); IPR017853 (SUPERFAMILY),,
RL4_JR_02498,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.011718044,0,8.30924678,3.99658426,2.0790871,0.037609346,NA,0.004006569,0,11.4341231,3.991291091,2.864768027,0.004173148,0.018371529,0.009992212,0,8.834284459,3.994251091,2.211749902,0.02698395,0.070608817,0.011494389,0,8.415706565,3.9944702,2.106839241,0.035131517,0.099498352,0.009494587,0,8.783878684,1.912952289,4.591791826,4.39E-06,5.09E-05,N,-, Effector probability:0.895,hypothetical protein SPSK_08099,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_02499,15,12,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.187016581,0,4.316286563,3.062682852,1.409315548,0.158741883,NA,0.059459361,0,7.537160543,2.3241087,3.243032714,0.001182646,0.015023052,0.154819894,0,4.878982603,1.390256451,3.509411949,0.000449099,0.003130151,0.178632476,0,4.457380777,1.880053588,2.370879641,0.017745809,0.072500326,0.153361306,0,4.791123932,1.27417216,3.760185698,0.000169787,0.001085288,N,-, Effector probability:0.819,hypothetical protein SPSK_10809,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_02500,17,25,33,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.300330038,0,3.633030349,2.522925469,1.440007005,0.149865417,NA,0.094725871,0,6.865329787,2.132460324,3.219440808,0.001284409,0.015023052,0.247591855,0,4.202302593,1.354866493,3.101635927,0.001924545,0.0095792,0.285764535,0,3.779710732,1.652163333,2.287734303,0.022152999,0.080442001,0.245885356,0,4.111452529,1.278979402,3.214635454,0.001306103,0.005938164,N,-, Effector probability:0.721,hypothetical protein F503_04168,,no IPS match,,
RL4_JR_02501,1039,986,1186,0,0,0,0,0,0,0,1,0,0,7,5,0,1,1,12.83623752,0,-1.784554927,1.187321268,-1.503009316,0.132836642,0.271259405,4.093308925,0,1.432233748,1.247983627,1.147638252,0.251117932,0.405393255,18.46905453,1,-0.258864059,1.189023877,-0.217711405,0.827653977,0.888802071,88.51635286,1,2.66998889,0.44608567,5.985372467,2.16E-09,6.76E-08,21.70993049,1,0.373386804,0.973344437,0.383612204,0.701265894,0.788398531,N,-,,hypothetical protein SPI_02441,,no IPS match,,
RL4_JR_02502,2217,2961,3320,0,4,0,0,0,0,0,0,0,0,2,1,0,1,0,66.12305721,1,-0.412814543,0.780594009,-0.528846671,0.596911819,0.766746437,10.80415889,0,0.031974725,1.222457818,0.026156097,0.979132833,0.989243725,28.13614262,0,-2.625379129,1.201654629,-2.184803409,0.028903264,0.074400367,50.1255838,1,-0.738407969,0.87089785,-0.847869781,0.396510496,0.540550528,31.690757,1,-1.783428997,1.139711701,-1.564807131,0.117628139,0.215914596,N,-,,translocation SEC72,C:nucleus; C:cytosol,IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR019734 (PFAM); PTHR22904:SF362 (PANTHER); PTHR22904 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_02503,1051,1421,1049,0,0,3,0,0,0,0,0,1,0,3,0,0,0,0,25.64962095,1,0.353592845,0.888194659,0.398102872,0.690554358,0.832103414,4.532334408,0,1.285318468,1.27125723,1.011060891,0.311987287,0.473666615,18.23206757,1,-0.401623641,1.205729589,-0.333095949,0.739061857,0.82458257,25.56993034,1,0.502583107,0.883148079,0.569081357,0.569300929,0.696156028,11.52388934,0,-1.440277829,1.20840777,-1.191880643,0.233308049,0.361144168,N,-,,tetratricopeptide repeat domain containing,"C:nucleus; F:zinc ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PTHR35392 (PANTHER); PTHR35392:SF3 (PANTHER),,
RL4_JR_02504,223,347,339,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.656077435,0,0.027545956,1.258212656,0.021892926,0.982533368,0.991333724,1.15853141,0,3.253197909,1.401689949,2.320911205,0.020291637,0.058168209,3.015869769,0,0.59647012,1.229037753,0.485314725,0.627453112,0.73926579,3.480134132,0,0.173738686,1.236175745,0.140545296,0.888229167,0.931630491,2.980165355,0,0.51104781,1.230528767,0.415307487,0.677916821,0.771138952,N,-,,taurine catabolism dioxygenase family,F:dioxygenase activity; P:oxidation-reduction process,IPR003819 (PFAM); G3DSA:3.60.130.10 (GENE3D); PTHR10696 (PANTHER); PTHR10696:SF15 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_02505,5743,5766,5901,5,1,5,0,0,0,2,3,8,0,4,0,0,2,2,147.1797027,1,-0.030739369,0.458690063,-0.067015555,0.94656932,0.973563316,22.28483652,0,-1.012453343,1.19683683,-0.845940999,0.39758566,0.561704304,155.4086177,1,0.855275072,0.426899907,2.003455748,0.045128393,0.104668923,82.66399277,1,-1.364113322,0.737043027,-1.850791977,0.064199486,0.14245448,79.30256829,1,-1.115377997,0.736336109,-1.514767488,0.129831297,0.232005273,N,-,,venom 2,,IPR002791 (PFAM); PTHR12260 (PANTHER); PTHR12260:SF6 (PANTHER); IPR002791 (SUPERFAMILY),,
RL4_JR_02506,2631,1827,2406,0,0,0,0,0,0,2,0,0,0,9,7,0,1,0,27.35028407,0,-2.875912485,1.194522166,-2.407584026,0.016058466,0.055136771,8.770543908,0,0.332854329,1.23284901,0.269987911,0.787169554,0.871568261,44.84129025,1,-0.482274642,1.037450343,-0.464865278,0.642027937,0.750824862,129.7347937,1,1.98970298,0.440279743,4.51917903,6.21E-06,9.34E-05,26.20613305,1,-1.466136739,1.130478364,-1.296917116,0.194659707,0.315544764,N,-,,1-acyl-sn-glycerol-3-phosphate acyltransferase 2,"F:transferase activity, transferring acyl groups; P:metabolic process; C:integral component of membrane; C:endoplasmic reticulum",IPR002123 (SMART); G3DSA:3.40.1130.10 (GENE3D); IPR002123 (PFAM); IPR032098 (PFAM); PTHR10983:SF16 (PANTHER); PTHR10983 (PANTHER); SSF69593 (SUPERFAMILY),,
RL4_JR_02507,6664,7879,8576,0,2,1,0,0,0,0,4,1,0,1,0,0,1,0,112.5148663,1,-2.316906453,0.861044374,-2.690809583,0.007127887,0.028973243,29.46889201,0,-1.415612525,1.196151397,-1.183472701,0.236621859,0.387303761,114.4667545,1,-0.926262578,0.673143334,-1.376025775,0.168813653,0.286228342,92.3869022,1,-3.545762055,1.146020452,-3.09397799,0.001974921,0.013112183,79.4850807,1,-3.224727764,1.127561513,-2.859912943,0.004237573,0.015630393,N,-,,poly(p) ATP NAD kinase,F:kinase activity; P:phosphate-containing compound metabolic process,IPR002504 (PFAM); IPR017437 (G3DSA:2.60.200.GENE3D); IPR017438 (G3DSA:3.40.50.GENE3D); IPR002504 (PANTHER); PTHR20275:SF6 (PANTHER); IPR016064 (SUPERFAMILY),,
RL4_JR_02508,1412,1472,1932,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.24612519,0,-2.368863378,1.19698604,-1.979023396,0.047813372,0.128563444,6.113525725,0,0.853460534,1.232965411,0.692201522,0.488810783,0.644657035,15.91226094,0,-1.803166696,1.196842834,-1.506602742,0.131912514,0.238265677,18.3602073,0,-2.225777362,1.19580593,-1.861319891,0.062699016,0.140262381,15.74228707,0,-1.890331553,1.204950086,-1.568804862,0.116693415,0.214626854,Y,-,,carbohydrate-binding module family 18,,no IPS match,,
RL4_JR_02509,5818,8838,12826,1,0,5,0,0,0,0,1,0,0,0,0,0,2,0,139.0817191,1,-1.643940149,0.752525858,-2.184563004,0.028920903,0.088000862,34.58516352,0,-1.646590878,1.230008624,-1.338682384,0.180674093,0.319159367,98.41113369,1,-3.350159708,1.227259078,-2.729790121,0.006337466,0.022703646,104.5425794,0,-4.735134989,1.235163797,-3.833608953,0.000126277,0.001304646,97.85582386,1,-2.762869967,1.04618069,-2.64091088,0.008268347,0.026988075,N,-,,elongator complex 3,F:histone acetyltransferase activity; C:transcription elongation factor complex; C:Elongator holoenzyme complex; C:cytosol; P:histone acetylation; P:tRNA wobble uridine modification; F:iron-sulfur cluster binding; C:histone acetyltransferase complex; P:regulation of transcription from RNA polymerase II promoter; P:transcription elongation from RNA polymerase II promoter,IPR006638 (SMART); IPR007197 (PFAM); IPR016181 (G3DSA:3.40.630.GENE3D); IPR005910 (PIRSF); IPR023404 (G3DSA:3.80.30.GENE3D); IPR032432 (PFAM); IPR005910 (TIGRFAM); IPR000182 (PFAM); PTHR11135:SF0 (PANTHER); PTHR11135 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY); SSF102114 (SUPERFAMILY),,
RL4_JR_02510,11168,13714,13881,2,8,68,0,0,2,9,12,8,5,20,21,0,17,7,499.4396323,1,1.204119326,0.782553565,1.53870531,0.123876255,0.258460995,68.25289345,1,-0.520263072,0.982684229,-0.52943057,0.596506796,0.732037075,374.3025498,1,0.881287877,0.341213668,2.58280356,0.009800111,0.032184259,477.4686676,1,1.100766665,0.429279747,2.564217561,0.01034087,0.049739341,244.0105902,1,0.224606979,0.426998906,0.526013009,0.598879168,0.709141512,N,-,,succinyl- ligase subunit alpha,F:cofactor binding; P:metabolic process; F:ligase activity,PR01798 (PRINTS); IPR003781 (SMART); IPR016102 (G3DSA:3.40.50.GENE3D); IPR005811 (PFAM); IPR003781 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR005810 (TIGRFAM); IPR005810 (PIRSF); PTHR11117 (PANTHER); IPR016040 (SUPERFAMILY); IPR016102 (SUPERFAMILY),,
RL4_JR_02511,10675,6603,9245,0,1,3,0,0,0,2,3,1,0,1,1,0,0,1,125.0002061,1,-2.114890103,0.776987987,-2.721908367,0.006490614,0.026905705,33.8967021,0,-1.617555267,1.215369452,-1.330916508,0.183216485,0.322693102,139.8398964,1,-0.846598977,0.64081387,-1.321130856,0.186457736,0.308436197,114.7608919,1,-2.951768572,1.034769422,-2.852585812,0.00433651,0.025147289,93.62410292,1,-3.407074429,1.13750372,-2.995220471,0.002742465,0.011031967,N,-, Effector probability:0.643,ubiquitin-conjugating enzyme,C:nucleus; F:ubiquitin-protein transferase activity; F:ATP binding; P:vesicle organization; C:cytosol; C:proteasome complex; P:ER-associated ubiquitin-dependent protein catabolic process; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process,SM00212 (SMART); IPR016135 (G3DSA:3.10.110.GENE3D); IPR000608 (PFAM); PTHR24067 (PANTHER); PTHR24067:SF29 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_02512,6441,5917,8343,0,5,12,0,0,0,5,5,0,6,6,0,0,0,3,168.4643082,1,0.292262928,0.445853953,0.655512698,0.512137714,0.697828027,26.26992304,0,-1.249856971,1.198819542,-1.04257307,0.297146067,0.456960269,162.9056699,1,0.267360002,0.508882205,0.525386818,0.599314316,0.717957417,158.7935642,1,-0.006781461,0.472952165,-0.014338576,0.988559863,0.993268693,89.69588066,1,-1.75144674,0.855491548,-2.047298706,0.040628765,0.095289841,N,-,,26S protease regulatory subunit 4,"C:proteasome regulatory particle, base subcomplex; C:CENP-A containing chromatin; F:peptidase activity; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of RNA polymerase II transcriptional preinitiation complex assembly; F:ATP binding; P:protein complex localization; P:peptide catabolic process; P:nonfunctional rRNA decay; P:proteasome regulatory particle assembly; C:cytosolic proteasome complex; C:nuclear proteasome complex; F:TBP-class protein binding; P:ER-associated ubiquitin-dependent protein catabolic process; F:proteasome-activating ATPase activity",IPR003593 (SMART); IPR005937 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.8.60 (GENE3D); IPR003959 (PFAM); PTHR23073 (PANTHER); IPR027417 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_02513,454,594,642,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,6.780176958,0,-0.863545089,1.214235486,-0.711184197,0.4769701,0.666173956,2.151719819,0,2.359996802,1.309283129,1.802510663,0.071465099,0.15630288,5.598974936,0,-0.296193925,1.208388272,-0.245114863,0.806367495,0.873332404,10.47210386,1,0.227483345,1.156669583,0.196670984,0.844085018,0.902690377,5.533211371,0,-0.381775633,1.213440683,-0.314622411,0.753048362,0.82795251,N,-,,DUF500 domain containing,,IPR007461 (PFAM); PTHR15629 (PANTHER); PTHR15629:SF8 (PANTHER),,
RL4_JR_02514,19815,22521,33766,5,9,49,0,0,3,0,0,0,1,17,0,0,7,0,613.3250241,1,0.109129147,0.54000879,0.202087724,0.839848145,0.919624667,124.1932385,1,-0.949760737,0.877113822,-1.082824957,0.278886126,0.437928229,250.8388843,0,-5.781633189,1.211983889,-4.770387827,1.84E-06,4.56E-05,366.9935704,1,-1.604544216,0.689726398,-2.326348854,0.019999948,0.076714457,276.0594246,1,-2.570614098,0.723445671,-3.553292529,0.000380441,0.002145942,N,-,,40S ribosomal S20,"P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:RNA binding; F:structural constituent of ribosome; C:cytosolic small ribosomal subunit; P:cytoplasmic translation",IPR001848 (PRINTS); IPR027486 (SMART); IPR027486 (G3DSA:3.30.70.GENE3D); IPR027486 (PFAM); IPR005729 (TIGRFAM); IPR001848 (PANTHER); PTHR11700:SF8 (PANTHER); IPR027486 (SUPERFAMILY),,
RL4_JR_02515,3,4,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.055820182,0,6.060509136,3.925836179,1.543749882,0.122648937,NA,0.017537841,0,9.297779581,2.966257817,3.134514986,0.001721385,0.015023052,0.046002333,0,6.628866407,1.691453704,3.919035082,8.89E-05,0.001083112,0.053103852,0,6.207345942,2.981800204,2.081744422,0.037365821,0.102862679,0.04588756,0,6.53495445,1.360650987,4.802814617,1.56E-06,2.09E-05,,,,,,,,
RL4_JR_02516,7994,4947,5018,4,2,3,0,0,0,1,4,2,0,2,0,0,2,0,139.3848837,1,-0.308525139,0.582304978,-0.529834281,0.596226835,0.766349223,23.16287768,0,-1.068204625,1.234692471,-0.865158451,0.386951827,0.551573918,115.058749,1,-0.078476732,0.619604612,-0.126656146,0.899212557,0.93764836,76.76414174,1,-2.419980005,1.052709958,-2.298809836,0.02151574,0.079593302,66.05486474,1,-2.120501572,1.002009798,-2.116248339,0.034323692,0.083521713,N,-,,SCF E3 ubiquitin ligase complex F-box grrA,"C:nucleus; F:ubiquitin-protein transferase activity; C:cellular bud neck contractile ring; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; C:SCF ubiquitin ligase complex; P:cellular response to DNA damage stimulus; P:cellular response to methylmercury; F:protein binding, bridging; F:ligase activity; P:mitotic cell cycle arrest in response to pheromone",IPR006553 (SMART); IPR001810 (PFAM); G3DSA:1.20.1280.50 (GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR001611 (PFAM); IPR026940 (PTHR24006:PANTHER); PTHR24006 (PANTHER); IPR001810 (SUPERFAMILY); SSF52047 (SUPERFAMILY),,
RL4_JR_02517,2227,1729,3459,1,4,3,0,0,1,0,1,13,1,5,1,0,3,0,83.00440626,1,0.779347762,0.624280028,1.248394515,0.211886617,0.379211835,18.70739701,1,1.158245051,1.14923556,1.007839551,0.313531495,0.475369352,116.6834843,1,1.993268952,1.183490586,1.684228818,0.092137456,0.182140829,67.11294972,1,0.66479013,0.64461473,1.031298385,0.302400916,0.448257395,35.78624763,1,-0.34000438,0.912472287,-0.372618857,0.709432136,0.794676225,N,-,,chalcone isomerase,C:integral component of membrane; F:intramolecular lyase activity; C:intracellular part,IPR016087 (PFAM); PTHR28039 (PANTHER); PTHR28039:SF6 (PANTHER); IPR016087 (SUPERFAMILY),,
RL4_JR_02518,35207,18918,22123,0,1,0,0,0,3,1,2,0,2,0,0,0,2,0,311.4936828,1,-5.39279554,1.188084544,-4.539067165,5.65E-06,7.04E-05,126.3305663,1,-1.005866196,0.922496625,-1.090373849,0.275548496,0.43383137,279.4965568,1,-3.371365537,0.896307343,-3.761394531,0.000168969,0.001592774,310.0248857,1,-4.441719139,1.058302893,-4.197020691,2.70E-05,0.000343576,255.1252143,1,-4.213408798,1.027234143,-4.101702447,4.10E-05,0.000327741,N,-, Effector probability:0.759,glutaredoxin,,IPR014025 (PRINTS); IPR012336 (G3DSA:3.40.30.GENE3D); IPR011899 (TIGRFAM); IPR002109 (PFAM); PTHR10168 (PANTHER); IPR002109 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY),,
RL4_JR_02519,10540,7521,11441,0,0,6,0,0,2,0,0,0,0,6,0,0,4,2,140.3271617,1,-1.723651689,0.666728639,-2.585237215,0.009731202,0.037114141,56.26708147,1,-0.125738464,0.996824748,-0.126138987,0.899621907,0.944164458,97.35659243,0,-4.416236894,1.199788359,-3.680846595,0.000232461,0.001941777,136.3778746,1,-1.573654688,0.655197698,-2.401801306,0.016314567,0.069115323,126.2964398,1,-1.306777437,0.653642664,-1.999222983,0.045584233,0.104468166,N,-,,BAG domain-containing,F:chaperone binding; C:membrane; C:integral component of membrane; C:cellular_component,IPR003103 (SMART); IPR003103 (PFAM); IPR003103 (G3DSA:1.20.58.GENE3D); PTHR14942 (PANTHER); PTHR14942:SF0 (PANTHER); IPR003103 (PROSITE_PROFILES); IPR003103 (SUPERFAMILY),,
RL4_JR_02520,42438,40644,59720,6,14,71,2,0,0,6,3,2,5,17,0,0,33,3,1013.276779,1,-0.299898844,0.553068506,-0.542245384,0.587649474,0.759633087,225.4765826,1,-2.358270948,0.988448036,-2.385831995,0.017040534,0.050880319,574.017305,1,-2.371764329,0.514871476,-4.606517242,4.09E-06,8.86E-05,658.3124489,1,-2.047216448,0.493432176,-4.1489318,3.34E-05,0.00041295,616.0582837,1,-1.448124945,0.820692973,-1.764514858,0.077645336,0.15742071,N,-,,60S ribosomal L16,F:structural constituent of ribosome; C:large ribosomal subunit; P:translation,IPR005822 (PFAM); IPR005822 (G3DSA:3.90.1180.GENE3D); IPR005755 (TIGRFAM); IPR005755 (PTHR11545:PANTHER); IPR005822 (PANTHER); IPR005822 (SUPERFAMILY),,
RL4_JR_02521,583,1270,873,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,11.04350336,0,-1.567329616,1.263563558,-1.240404257,0.214825907,0.383231051,12.87808094,1,2.570219119,1.187374731,2.164623392,0.030416538,0.079884847,9.095054912,0,-0.996008141,1.244888176,-0.800078401,0.423665374,0.564738413,10.49497246,0,-1.41872288,1.249657186,-1.135289658,0.256253974,0.395514282,8.959289906,0,-1.077089238,1.252145264,-0.860195114,0.389681497,0.525719542,N,-, Effector probability:0.629,DNA repair swi5,P:positive regulation of catalytic activity; P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:cellular response to ionizing radiation; F:enzyme activator activity; P:DNA recombinase assembly; C:Swi5-Sfr1 complex,IPR010760 (PFAM); PTHR28529 (PANTHER); PTHR28529:SF1 (PANTHER),,
RL4_JR_02522,3125,2733,2662,0,9,3,0,0,0,1,0,2,7,0,2,0,0,1,117.657255,1,1.218079018,0.618495602,1.96942228,0.048904619,0.130443857,10.94320092,0,0.013593064,1.220144761,0.011140534,0.991111324,0.995339699,52.35390005,1,-0.225166103,0.852112093,-0.264244698,0.79159137,0.862469978,117.0808106,1,1.078831882,0.662334007,1.628833594,0.103348251,0.200767659,35.14275029,1,-1.776212462,1.11722249,-1.589846676,0.11186937,0.20775447,N,-,,"type II inositol-1,4,5-trisphosphate 5-phosphatase",F:hydrolase activity; P:phosphatidylinositol dephosphorylation,IPR000300 (SMART); IPR005135 (G3DSA:3.60.10.GENE3D); PTHR11200:SF135 (PANTHER); PTHR11200 (PANTHER); PTHR11200 (PANTHER); PTHR11200 (PANTHER); PTHR11200:SF135 (PANTHER); PTHR11200:SF135 (PANTHER); IPR005135 (SUPERFAMILY),,
RL4_JR_02523,915,1023,1593,1,0,8,0,0,1,0,0,2,0,1,3,0,0,0,54.7015791,1,1.886535611,0.620602846,3.039843636,0.00236701,0.011986386,13.83093916,1,2.225613632,1.144901913,1.943933892,0.051903424,0.121415866,24.62909502,1,0.462627598,1.05885412,0.436913441,0.662174124,0.767030987,46.34136549,1,0.989539473,0.779515994,1.269428056,0.204288435,0.336000715,11.55429138,0,-1.44410991,1.228619978,-1.175391851,0.239837982,0.369034646,N,-,,decapping enzyme,P:positive regulation of catalytic activity; P:deadenylation-dependent decapping of nuclear-transcribed mRNA; F:enzyme activator activity,IPR011993 (G3DSA:2.30.29.GENE3D); IPR010334 (PFAM); IPR010334 (PANTHER); IPR011993 (SUPERFAMILY),,
RL4_JR_02524,786,831,930,6,0,0,0,2,0,2,0,0,0,0,0,0,0,0,70.59040822,1,2.324333859,1.06661958,2.179159188,0.029319845,0.08881964,79.92056883,1,3.427091014,0.972299639,3.524727229,0.000423919,0.015023052,30.57635812,1,0.941256089,1.02795679,0.915657251,0.359846693,0.503745564,9.733021083,0,-1.310109159,1.19076299,-1.100226637,0.271233388,0.412968128,8.323152403,0,-0.970851654,1.19681881,-0.811193512,0.417254551,0.553293099,N,-,,hypothetical protein F503_04202,,no IPS match,,
RL4_JR_02525,103,84,61,0,8,0,0,0,1,0,0,0,0,0,1,0,0,0,65.07578845,1,5.985120622,1.75534781,3.409649408,0.000650464,0.00418163,9.699890522,1,6.017605885,1.181043787,5.095159003,3.48E-07,3.46E-05,0.826526984,0,2.464383546,1.273102443,1.93573075,0.052900686,0.118148367,10.58828815,1,2.996239669,1.175174582,2.549612385,0.010784275,0.051578073,0.807246165,0,2.394733643,1.238971772,1.932839551,0.053255966,0.117450808,N,-, Effector probability:0.659,hypothetical protein SPI_07547,,no IPS match,,
RL4_JR_02526,258,377,290,20,55,3,0,0,2,0,0,2,0,2,2,4,0,0,657.0495894,1,7.440796834,0.999390737,7.445332999,9.67E-14,5.44E-12,19.94540374,1,4.845380769,1.023136808,4.735809259,2.18E-06,0.000176886,16.07807729,1,2.381174306,1.054402725,2.258315773,0.02392598,0.064238714,30.84776409,1,2.878696666,0.770007866,3.738528909,0.0001851,0.001798598,67.12937236,1,4.192750876,1.803670175,2.324566285,0.020095163,0.054709204,N,-, Effector probability:0.782,Superoxide dismutase,F:metal ion binding; P:removal of superoxide radicals; P:oxidation-reduction process; F:superoxide dismutase activity,IPR001189 (PRINTS); IPR019831 (PFAM); G3DSA:1.10.287.990 (GENE3D); IPR001189 (PIRSF); IPR019832 (PFAM); IPR001189 (PANTHER); PTHR11404:SF6 (PANTHER); IPR019831 (SUPERFAMILY); IPR019832 (SUPERFAMILY),,
RL4_JR_02527,114,87,49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.003891673,0,1.892125565,1.610550048,1.174831895,0.240061977,NA,0.326031138,0,5.082700032,1.758230881,2.890803527,0.003842583,0.017687413,0.835463808,0,2.448884679,1.312778118,1.865421617,0.06212233,0.133928123,0.963086231,0,2.027389906,1.388784742,1.459830199,0.144336747,0.258519293,0.812592435,0,2.385220602,1.275486803,1.87004726,0.061477255,0.131154069,Y,-,,---NA---,,no IPS match,,
RL4_JR_02528,20979,18420,19529,7,36,130,0,1,9,10,44,42,42,93,30,0,61,27,1090.968758,1,1.884947556,0.630169377,2.991176062,0.002779052,0.013537964,198.2406446,1,1.107739174,0.53029104,2.088926817,0.036714311,0.092743264,924.1417299,1,1.928644901,0.373362013,5.165616304,2.40E-07,7.63E-06,1278.639453,1,2.237853425,0.207762468,10.77121122,4.71E-27,6.71E-25,626.5363727,1,1.246379532,0.773177412,1.612022692,0.106957002,0.200879177,N,-,,glycoside hydrolase family 72,"C:primary cell septum; C:anchored component of external side of plasma membrane; F:1,3-beta-glucanosyltransferase activity; P:chromatin silencing; C:cellular bud scar; P:fungal-type cell wall organization; P:filamentous growth; P:fungal-type cell wall (1->3)-beta-D-glucan biosynthetic process; C:mitochondrion; C:membrane raft; C:integral component of membrane; C:ER to Golgi transport vesicle; C:nuclear periphery; F:hydrolase activity",IPR012946 (SMART); IPR012946 (PFAM); IPR004886 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR31468:SF2 (PANTHER); PTHR31468 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_02529,2556,2139,1744,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,25.81019528,0,-2.79217529,1.203393957,-2.320250383,0.020327336,0.066411859,8.315721354,0,0.409731,1.249574669,0.327896372,0.742990017,0.841562224,21.42909728,0,-2.232459073,1.205700229,-1.851587168,0.064085127,0.137336419,24.71091399,0,-2.654209404,1.205571181,-2.201619818,0.027692175,0.088448981,44.13511737,1,0.862594144,0.652024148,1.322948156,0.185852619,0.3047381,N,-,,n amino acid transport system,C:integral component of membrane,IPR013057 (PFAM); PTHR22950:SF20 (PANTHER); PTHR22950:SF20 (PANTHER); PTHR22950 (PANTHER); PTHR22950 (PANTHER); PTHR22950 (PANTHER),2.A.18.4.1, the amino acid/auxin permease (aaap) family.
RL4_JR_02530,1674,1282,2130,3,7,7,0,0,1,0,0,0,0,3,1,0,0,0,133.2298673,1,2.407535669,0.447799975,5.37636401,7.60E-08,1.53E-06,15.81851232,1,1.69388247,1.135887199,1.491241799,0.135898023,0.255674641,16.75692947,0,-1.877806989,1.205915683,-1.557162757,0.119431848,0.221006769,41.00344901,1,0.415362917,0.770536782,0.539056573,0.589847819,0.713952082,16.58845017,0,-1.965903726,1.215026329,-1.617992696,0.105664172,0.19907885,N,-,,importin 13,F:DNA binding; P:biological_process; F:molecular_function,IPR018306 (SMART); IPR018306 (PFAM); PTHR28094:SF1 (PANTHER); PTHR28094 (PANTHER),,
RL4_JR_02531,6199,4662,5787,2,0,3,0,0,0,3,0,0,0,1,0,0,0,0,97.99926878,1,-1.106827832,0.672083758,-1.646859961,0.099586833,0.22070888,21.28135422,0,-0.945995363,1.206382805,-0.784158526,0.432947097,0.594531341,88.30571042,1,-1.173827586,0.852858438,-1.376345163,0.168714797,0.286108643,67.56033042,1,-3.070013739,1.146260351,-2.678286601,0.007399987,0.038129704,54.23145795,0,-3.674861909,1.19352837,-3.078989995,0.002077037,0.008740646,N,-,,class 3,P:lipid metabolic process; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR002921 (PFAM); PTHR21493:SF115 (PANTHER); PTHR21493 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_02532,4563,3297,3671,2,0,2,0,0,0,0,0,0,3,6,3,0,0,5,73.79890477,1,-0.894368923,0.751270467,-1.190475284,0.233859639,0.407321319,14.79727298,0,-0.421719336,1.220710465,-0.345470402,0.729740758,0.831337754,38.22324987,0,-3.067392761,1.197368542,-2.56177831,0.010413777,0.033748104,124.9938296,1,0.832982553,0.470092371,1.771955055,0.076402018,0.160992807,74.35956499,1,-0.161079097,0.683296419,-0.235738243,0.813635793,0.874343282,N,-,,dna polymerase epsilon subunit c,,IPR019384 (PFAM); PTHR21705:SF5 (PANTHER); PTHR21705 (PANTHER); PTHR21705:SF5 (PANTHER); PTHR21705 (PANTHER),,
RL4_JR_02533,17885,12471,16429,0,1,6,0,0,3,1,1,3,5,5,11,0,4,0,217.3461058,1,-2.146076418,0.60485387,-3.548090744,0.000388035,0.002712584,87.91076848,1,-0.25924457,0.86595827,-0.299373052,0.764655421,0.857505226,193.1387466,1,-1.94310825,0.683253643,-2.843904704,0.004456437,0.017386326,351.0720094,1,-0.219498173,0.482966286,-0.454479286,0.649483898,0.759803469,167.7565698,1,-2.569488482,0.775432008,-3.313621896,0.00092096,0.004463722,N,-,,glucose-repressible alcohol dehydrogenase transcriptional effector,C:nucleus; F:nuclease activity; C:cytosol,IPR005135 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); IPR005135 (G3DSA:3.60.10.GENE3D); PTHR12121 (PANTHER); PTHR12121:SF34 (PANTHER); PTHR12121 (PANTHER); PTHR12121:SF34 (PANTHER); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR005135 (SUPERFAMILY); IPR032675 (SUPERFAMILY),1.A.25.3.7, the gap junction-forming innexin (innexin) family.
RL4_JR_02534,7555,5663,7134,3,8,8,0,0,2,0,1,2,2,3,1,0,14,0,206.0010745,1,0.549683479,0.386683389,1.421533725,0.155161656,0.304207833,44.76318517,1,0.403870416,0.993831828,0.40637702,0.684465602,0.799648263,88.18052108,1,-1.480387844,0.856199401,-1.729022286,0.083805107,0.168676521,117.9669903,1,-0.98794695,0.62076852,-1.591490093,0.111499323,0.212508887,120.3460032,1,0.207405518,0.672366804,0.308470789,0.757724124,0.831176966,N,-,,sam binding domain-containing containing,F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13649 (PFAM); PTHR10108 (PANTHER); PTHR10108:SF832 (PANTHER); PTHR10108:SF832 (PANTHER); PTHR10108 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_02535,2171,2874,2881,0,1,0,0,0,0,1,0,0,7,7,5,0,2,0,39.84117551,1,-2.14352072,1.154568509,-1.856555677,0.063374395,0.158773787,10.11369662,0,0.127274277,1.22155164,0.104190665,0.917018042,0.954060707,37.36025762,1,-1.565662314,1.197107186,-1.307871453,0.190916914,0.314079108,171.7775159,1,2.073047985,0.403657699,5.13565823,2.81E-07,5.79E-06,33.67059736,1,-0.947318626,0.988919046,-0.957933443,0.338096321,0.475183961,N,-,,thioesterase thiol ester dehydrase-isomerase,F:isomerase activity,PF13279 (PFAM); IPR029069 (G3DSA:3.10.129.GENE3D); PTHR31793 (PANTHER); PTHR31793:SF1 (PANTHER); IPR029069 (SUPERFAMILY),,
RL4_JR_02536,18517,16413,23511,4,2,1,0,0,0,8,1,2,7,1,13,3,11,3,293.1681632,1,-2.362472251,0.60965966,-3.875067365,0.000106595,0.000903954,74.1683982,0,-2.747232898,1.192402657,-2.303947313,0.021225601,0.060332922,302.3048851,1,-1.062561452,0.524277236,-2.026716743,0.042691389,0.100377978,417.0214203,1,-0.289030554,0.763824482,-0.378399176,0.70513408,0.802298926,303.4206695,1,-0.786189684,0.450304823,-1.745905539,0.080827367,0.162427007,N,-,,ubiquitination network signaling,C:membrane,PTHR18937 (PANTHER); PTHR18937:SF262 (PANTHER),,
RL4_JR_02537,32355,20427,31683,3,5,15,0,0,0,1,1,12,4,14,3,0,3,2,463.3532216,1,-1.287933214,0.421057902,-3.058803096,0.002222232,0.011380392,107.5674736,0,-3.283583907,1.208163774,-2.71783013,0.006571157,0.024762936,375.6685477,1,-1.373375061,0.559614832,-2.454143426,0.014122064,0.042349461,443.8661714,1,-1.277205553,0.425777497,-2.999701867,0.00270244,0.017080027,301.1879037,1,-3.080809512,0.724448404,-4.252627922,2.11E-05,0.00018798,N,-,,C6 zinc finger,"F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; C:mediator complex; F:RNA polymerase II transcription cofactor activity; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31001 (PANTHER); PTHR31001:SF14 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_02538,2713,2676,3085,0,1,8,0,0,0,0,0,0,0,4,0,0,9,0,72.45958021,1,0.690616195,0.509563745,1.355308735,0.175319213,0.330160236,10.81035045,0,0.031169701,1.207864186,0.025805634,0.979412368,0.989243725,28.05895789,0,-2.621434421,1.187029678,-2.208398383,0.027216514,0.07112545,48.41660471,1,-0.323227452,0.737594442,-0.438218394,0.661227976,0.769178913,62.41969665,1,1.047285667,0.532627651,1.966262296,0.04926832,0.110779866,N,-,,kinesin family,"C:microtubule plus-end; P:nuclear migration during mitotic telophase; C:condensed chromosome kinetochore; C:kinesin complex; P:karyogamy involved in conjugation with cellular fusion; C:astral microtubule; F:ATP-dependent microtubule motor activity, minus-end-directed; F:microtubule binding; C:nucleus; F:ATP binding; P:mitotic spindle elongation; C:microtubule minus-end; P:cytoplasmic microtubule organization; C:cortical microtubule; P:minus-end directed microtubule sliding; P:establishment or maintenance of microtubule cytoskeleton polarity",IPR001752 (PRINTS); IPR001752 (SMART); IPR001752 (PFAM); G3DSA:1.20.120.20 (GENE3D); IPR001752 (G3DSA:3.40.850.GENE3D); IPR027640 (PANTHER); IPR001752 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_02539,30111,32744,39939,15,20,0,0,0,3,0,0,0,1,3,2,0,3,1,722.4477143,1,-0.427099925,1.156222187,-0.369392605,0.711835109,0.844759376,158.8487938,1,-1.380711118,0.852765745,-1.619097772,0.105426228,0.21084152,340.0034236,0,-6.220418626,1.195889615,-5.201498992,1.98E-07,6.39E-06,432.9168203,1,-3.323863467,0.623614524,-5.329996875,9.82E-08,2.20E-06,355.0233628,1,-3.698139967,0.77924186,-4.745817901,2.08E-06,2.67E-05,N,-,,dihydroxy-acid dehydratase,F:dihydroxy-acid dehydratase activity; P:branched-chain amino acid biosynthetic process,IPR004404 (TIGRFAM); IPR000581 (PFAM); PTHR21000:SF5 (PANTHER); IPR000581 (PANTHER); SSF143975 (SUPERFAMILY); IPR015928 (SUPERFAMILY),,
RL4_JR_02540,2387,2892,3593,2,0,2,0,0,0,0,0,1,1,0,3,0,1,0,63.28141881,1,-0.517639811,0.767675712,-0.674294891,0.500123851,0.687278712,11.25740746,0,-0.027327787,1.218276427,-0.022431516,0.982103741,0.990676395,35.82871591,1,-1.723556431,1.199329759,-1.437099696,0.150689668,0.263176451,72.06304773,1,-0.334292618,0.757963496,-0.441040525,0.659183659,0.767651552,32.89665785,1,-1.844564784,1.138819066,-1.619717161,0.105293048,0.198490432,N,-, Effector probability:0.829,atp-dependent clp protease proteolytic subunit,P:proteolysis; F:serine-type endopeptidase activity,IPR001907 (PRINTS); IPR023562 (PFAM); IPR029045 (G3DSA:3.90.226.GENE3D); IPR023562 (PANTHER); IPR029045 (SUPERFAMILY),3.A.26.1.1, the plasmodium translocon of exported proteins (ptex) family.
RL4_JR_02541,7317,7659,11229,5,0,3,2,0,0,1,0,0,7,9,0,0,2,2,166.3711502,1,-1.024424055,0.617546936,-1.658860234,0.097143959,0.216767074,77.76681237,1,0.085513201,0.983421913,0.086954744,0.930707485,0.960895671,97.49567228,1,-3.28262525,1.202288954,-2.730313073,0.00632742,0.022698409,201.0218505,1,0.055576969,0.461604675,0.120399494,0.904166692,0.94125928,108.1383119,1,-1.708815054,0.783519648,-2.180947289,0.029187315,0.07354942,N,-,,Heat shock partial,C:integral component of mitochondrial outer membrane; C:nucleus; F:ATP binding; F:heat shock protein binding; P:response to heat; P:protein import into mitochondrial matrix; F:metal ion binding; P:positive regulation of ATPase activity; C:endoplasmic reticulum; F:unfolded protein binding; P:protein folding; F:ATPase activator activity,IPR001623 (PRINTS); IPR001305 (PFAM); G3DSA:2.60.260.20 (GENE3D); IPR001305 (G3DSA:2.10.230.GENE3D); IPR001623 (PFAM); G3DSA:2.60.260.20 (GENE3D); IPR001623 (G3DSA:1.10.287.GENE3D); IPR002939 (PFAM); PTHR24078:SF319 (PANTHER); PTHR24078 (PANTHER); IPR001623 (PROSITE_PROFILES); IPR001305 (PROSITE_PROFILES); IPR008971 (SUPERFAMILY); IPR001305 (SUPERFAMILY); IPR008971 (SUPERFAMILY); IPR001623 (SUPERFAMILY),,
RL4_JR_02542,6131,5872,8619,1,0,0,0,0,0,0,0,2,1,0,1,0,1,0,92.32582961,1,-3.512913102,1.158265699,-3.032907824,0.002422096,0.012212272,26.11778347,0,-1.24148305,1.202263337,-1.032621566,0.301781032,0.462332012,81.02585054,1,-2.081602411,1.042765512,-1.996232505,0.045908621,0.105896304,97.44330077,1,-2.571282325,1.024916275,-2.508773044,0.01211513,0.056527967,71.23675366,1,-3.058897351,1.137723662,-2.688611876,0.007174979,0.024098766,N,-,,glutamyl-trna synthetase,"F:ligase activity, forming aminoacyl-tRNA and related compounds; P:tRNA aminoacylation for protein translation; F:organic cyclic compound binding; F:heterocyclic compound binding",IPR000924 (PRINTS); IPR014729 (G3DSA:3.40.50.GENE3D); IPR004527 (TIGRFAM); IPR020061 (G3DSA:1.10.1160.GENE3D); G3DSA:3.90.800.10 (GENE3D); IPR020058 (PFAM); IPR020751 (G3DSA:1.10.10.GENE3D); PTHR11451 (PANTHER); PTHR11451 (PANTHER); PTHR11451:SF26 (PANTHER); IPR004527 (HAMAP); IPR008925 (SUPERFAMILY); SSF52374 (SUPERFAMILY),,
RL4_JR_02543,2462,2424,3132,0,0,13,0,0,1,0,0,0,2,0,2,0,2,0,81.67684524,1,1.002492638,0.787504523,1.272999213,0.203018321,0.367641168,19.57086877,1,1.03308701,1.11569073,0.925961813,0.354465826,0.518483106,26.50201138,0,-2.539104885,1.192008764,-2.130105886,0.033162873,0.08304176,68.47217549,1,-0.206740203,0.741807254,-0.278698007,0.780476592,0.858481857,33.9145963,1,-0.958705172,0.982717068,-0.97556581,0.329279674,0.465896688,N,-,,cop9 signalosome complex subunit 5,,IPR000555 (SMART); IPR000555 (PFAM); G3DSA:3.40.140.10 (GENE3D); PTHR10410 (PANTHER); PTHR10410:SF6 (PANTHER); SSF102712 (SUPERFAMILY),,
RL4_JR_02544,39179,40032,52747,9,5,43,0,3,3,0,1,2,5,19,4,0,17,1,822.0848209,1,-0.764807508,0.483057906,-1.583262585,0.113361627,0.242476181,310.6838517,1,-0.701188616,0.63506319,-1.104124168,0.269539279,0.426759984,456.8286821,1,-4.176734926,0.86429344,-4.83254267,1.35E-06,3.47E-05,664.3760775,1,-1.510107721,0.364703463,-4.140645415,3.46E-05,0.00042299,504.2555199,1,-2.202457731,0.743249083,-2.963283483,0.003043761,0.011982147,N,-,,60S ribosomal L32,F:structural constituent of ribosome; P:cytoplasmic translation; C:cytosolic large ribosomal subunit,IPR001515 (SMART); IPR001515 (PFAM); PTHR23413 (PANTHER); IPR001515 (PRODOM); IPR001515 (SUPERFAMILY),,
RL4_JR_02545,3220,2638,2752,0,8,2,0,0,0,0,0,1,0,3,0,0,8,1,106.1464844,1,0.939561344,0.613914042,1.530444459,0.125906751,0.261200895,11.04782835,0,-0.00014196,1.220249543,-0.000116337,0.999907176,0.999907176,35.05906599,1,-1.685144276,1.191692028,-1.414076991,0.157339298,0.271687371,44.97479426,1,-0.766297777,0.856862238,-0.89430686,0.371157731,0.517057241,66.30656734,1,1.045573332,0.519368697,2.013162014,0.044097588,0.101636257,N,-,,alpha-L-rhamnosidase A,F:catalytic activity,IPR008979 (G3DSA:2.60.120.GENE3D); IPR012341 (G3DSA:1.50.10.GENE3D); IPR008902 (PFAM); PTHR34987:SF1 (PANTHER); PTHR34987 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_02546,2138,1702,3519,0,0,2,0,0,0,0,0,0,0,2,0,0,0,1,36.85079579,1,-1.267029455,1.070445663,-1.18364668,0.236552954,0.410967464,9.24382954,0,0.256953702,1.254572244,0.204813795,0.837717609,0.903022112,24.15763431,0,-2.405494258,1.223507816,-1.966063662,0.049291257,0.111863862,35.90214808,1,-1.122756481,1.064080923,-1.055142008,0.291360382,0.435961171,31.39571189,1,-1.557738926,1.166665486,-1.335206145,0.181808886,0.30000244,N,-,,Kynureninase 1,F:pyridoxal phosphate binding; P:tryptophan catabolic process; P:quinolinate biosynthetic process; P:'de novo' NAD biosynthetic process from tryptophan; C:cytoplasm; F:kynureninase activity; P:anthranilate metabolic process; P:L-kynurenine catabolic process,IPR010111 (PIRSF); IPR000192 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR015421 (G3DSA:3.40.640.GENE3D); IPR010111 (TIGRFAM); PTHR14084:SF0 (PANTHER); IPR010111 (PANTHER); IPR010111 (HAMAP); IPR015424 (SUPERFAMILY),,
RL4_JR_02547,23445,19081,14671,0,3,3,3,0,1,5,3,0,1,12,1,0,2,2,264.8032703,1,-2.631123843,0.672619754,-3.911755235,9.16E-05,0.000792443,150.3204143,1,-0.086609567,0.797613728,-0.108585853,0.913530982,0.95163567,269.3718288,1,-1.508249268,0.603212105,-2.500363065,0.012406609,0.038224134,286.7377407,1,-1.38608891,0.540444133,-2.56472191,0.010325853,0.049714341,208.6543011,1,-2.828432347,0.780295723,-3.624821029,0.000289162,0.001700443,N,-,,NAD-specific glutamate dehydrogenase,,IPR006096 (SMART); IPR016210 (PIRSF); IPR006096 (PFAM); IPR028971 (PFAM); G3DSA:3.40.192.10 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR11606 (PANTHER); PTHR11606:SF9 (PANTHER); SSF53223 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_02548,1332,3118,1797,0,0,12,0,0,0,0,1,3,2,2,0,0,0,2,71.20401957,1,1.166472686,0.93734749,1.244439974,0.213337679,0.381430572,8.054811129,0,0.45569131,1.302971119,0.349732472,0.726539482,0.829183971,48.23938366,1,0.599383653,0.833981704,0.718701202,0.472325043,0.608993725,50.76326619,1,0.118685274,0.843197014,0.140756279,0.888062483,0.931582329,35.27313153,1,-0.549758751,1.043610577,-0.526785339,0.598342665,0.70889533,N,-,,uracil phosphoribosyltransferase,"F:transferase activity, transferring glycosyl groups",IPR029057 (PFAM); IPR029057 (G3DSA:3.40.50.GENE3D); PTHR10285 (PANTHER); IPR029057 (SUPERFAMILY),,
RL4_JR_02549,1398,1073,826,0,0,7,0,0,0,0,0,0,0,0,0,0,0,2,39.94003826,1,1.606860644,0.675952928,2.377178317,0.017445652,0.058762028,4.269117841,0,1.37165523,1.299603121,1.055441625,0.291223394,0.450383987,10.98043001,0,-1.267796204,1.220028154,-1.039153236,0.298733475,0.439589783,12.66045374,0,-1.689368724,1.220630445,-1.384013262,0.166354394,0.287150978,25.45702995,1,0.361718299,0.994215186,0.363822947,0.715990226,0.799713297,N,-,,dna ligase 4,P:DNA ligation involved in DNA repair; F:DNA binding; F:ATP binding; F:DNA ligase (ATP) activity; P:DNA replication; P:DNA recombination; P:DNA biosynthetic process,IPR001357 (SMART); G3DSA:3.30.470.30 (GENE3D); IPR012308 (G3DSA:1.10.3260.GENE3D); G3DSA:3.30.1490.70 (GENE3D); IPR001357 (G3DSA:3.40.50.GENE3D); IPR012309 (PFAM); G3DSA:2.40.50.140 (GENE3D); IPR012310 (PFAM); IPR001357 (PFAM); IPR000977 (TIGRFAM); IPR012308 (PFAM); PTHR10459 (PANTHER); IPR029710 (PTHR10459:PANTHER); IPR001357 (PROSITE_PROFILES); IPR012310 (PROSITE_PROFILES); IPR001357 (PROSITE_PROFILES); SSF56091 (SUPERFAMILY); IPR001357 (SUPERFAMILY); IPR001357 (SUPERFAMILY); IPR012340 (SUPERFAMILY),,
RL4_JR_02550,8218,13275,6377,0,0,2,0,0,0,0,0,0,1,2,0,0,5,6,120.7053179,1,-3.235214237,1.111049157,-2.911855175,0.003592892,0.016606692,36.20828209,0,-1.712713262,1.251604006,-1.368414653,0.17118232,0.306728172,93.42684547,0,-4.356760801,1.237457293,-3.520736292,0.00043035,0.00303403,125.0948084,1,-2.480097369,0.932720624,-2.658992741,0.007837465,0.039997144,154.823899,1,-0.341935198,0.608340238,-0.562078877,0.574062279,0.689148446,N,-,,hypothetical protein CMQ_3131,F:lipid binding,IPR027842 (PFAM); PTHR31138:SF1 (PANTHER); PTHR31138 (PANTHER),,
RL4_JR_02551,2848,2892,4543,0,0,1,0,0,0,0,0,0,0,0,0,0,6,0,44.81886191,1,-2.513910589,1.166608372,-2.154888177,0.031170586,0.093385839,12.98201789,0,-0.232986784,1.222410499,-0.19059619,0.848841975,0.910129432,33.87840537,0,-2.893359454,1.206519407,-2.398104363,0.016480169,0.048026837,39.0956976,0,-3.31616558,1.208339011,-2.744399999,0.006062162,0.032665988,56.78435785,1,0.149742904,0.698098456,0.214501124,0.83015629,0.885461702,N,-,,DFDF domain-containing,"C:nucleus; C:cytoplasmic stress granule; P:mycelium development; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:deadenylation-independent decapping of nuclear-transcribed mRNA; P:cytoplasmic mRNA processing body assembly; C:cytoplasmic mRNA processing body; F:mRNA binding",IPR019050 (SMART); IPR004443 (PFAM); IPR019050 (PFAM); IPR004443 (G3DSA:3.40.50.GENE3D); PTHR13612 (PANTHER); PTHR13612:SF0 (PANTHER); PTHR13612:SF0 (PANTHER); PTHR13612:SF0 (PANTHER); PTHR13612 (PANTHER); PTHR13612 (PANTHER); IPR025762 (PROSITE_PROFILES); IPR004443 (PROSITE_PROFILES); IPR004443 (SUPERFAMILY),,
RL4_JR_02552,2362,2174,2031,0,0,0,0,0,0,0,0,0,0,2,0,0,5,0,26.31424416,0,-2.820046225,1.187776046,-2.374223857,0.017585885,0.059161093,8.438546293,0,0.388568333,1.227881587,0.316454239,0.751657754,0.848464388,21.81399552,0,-2.258139157,1.192248005,-1.894017979,0.058222623,0.127035741,33.18288822,1,-0.954075303,1.016199514,-0.938866128,0.347799482,0.494931754,40.72187803,1,0.598550142,0.669733109,0.893714428,0.371474704,0.507855979,N,-,,dna repair and recombination pif1,P:DNA repair; P:G-quadruplex DNA unwinding; P:DNA replication; P:DNA recombination; P:telomere maintenance; P:mitochondrial genome maintenance; C:replication fork; C:nucleus; F:DNA binding; F:ATP binding; F:ATP-dependent 5'-3' DNA helicase activity; P:DNA duplex unwinding; C:mitochondrion; P:negative regulation of telomere maintenance via telomerase; F:telomerase inhibitor activity; P:negative regulation of telomerase activity,IPR003593 (SMART); IPR010285 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003840 (PANTHER); IPR010285 (HAMAP); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_02553,2435,1933,2075,0,0,3,0,0,0,0,0,1,0,4,1,0,1,0,37.20502596,1,-0.486090004,0.851622029,-0.570781388,0.568147841,0.744929297,8.26445001,0,0.418630048,1.230220518,0.340288624,0.733639183,0.833808198,27.86340217,1,-1.266364479,1.192935709,-1.061552998,0.288438661,0.427944836,50.32238079,1,0.389835056,0.675411913,0.577181196,0.563817058,0.691454423,24.85066608,1,-1.375162786,1.121369731,-1.226324154,0.220076715,0.346185189,N,-,,na(+) h(+) antiporter 2,P:cellular potassium ion homeostasis; P:sodium ion export from cell; F:sodium:proton antiporter activity; P:potassium ion export across plasma membrane; C:membrane raft; C:integral component of membrane; P:response to osmotic stress; P:hydrogen ion transmembrane transport; C:plasma membrane,IPR006153 (PFAM); IPR013928 (PFAM); IPR004712 (PTHR31382:PANTHER); PTHR31382 (PANTHER),2.A.36.4.4, the monovalent cation:proton antiporter-1 (cpa1) family.
RL4_JR_02554,14490,15337,19497,10,0,0,0,0,0,0,0,0,0,5,0,0,2,1,297.8601464,1,-1.053591242,1.409570647,-0.747455436,0.454788693,0.643417159,62.66282,0,-2.504039214,1.190837197,-2.102755289,0.035487166,0.090206202,163.0464455,0,-5.16015919,1.194343125,-4.320499765,1.56E-05,0.000275055,208.1847555,1,-2.55902358,0.686002137,-3.73034345,0.000191219,0.001847416,176.3235009,1,-3.037288251,0.860868934,-3.528165705,0.00041845,0.002334726,N,-,,mitochondrial import receptor subunit tom-22,C:integral component of mitochondrial outer membrane; P:protein import into mitochondrial outer membrane,IPR005683 (PFAM); PTHR12504:SF0 (PANTHER); PTHR12504 (PANTHER); PD033325 (PRODOM),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_02555,40950,20127,23067,15,11,4,0,0,0,2,0,17,0,9,4,0,6,0,589.0652693,1,-0.466181758,0.746975226,-0.624092664,0.532566732,0.71613901,108.5868313,0,-3.297183863,1.241140412,-2.656576026,0.007893865,0.028323893,411.6553195,1,-1.040935946,1.236752797,-0.84166856,0.399973501,0.542079214,396.3285244,1,-1.990171282,0.589366459,-3.376797663,0.00073335,0.005690981,295.8872378,1,-2.92308783,0.779774429,-3.748632583,0.000177801,0.001125149,N,-,,transmembrane gtpase fzo1,C:integral component of mitochondrial outer membrane; F:GTP binding; F:protein homodimerization activity; F:GTPase activity; P:mitochondrial fusion; P:mitochondrion localization; C:mitochondrial inner membrane,IPR027417 (G3DSA:3.40.50.GENE3D); IPR022812 (PFAM); IPR027094 (PANTHER); IPR027094 (PANTHER); IPR027091 (PTHR10465:PANTHER); IPR027091 (PTHR10465:PANTHER); IPR030381 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.N.6.1.1, the mitochondrial inner/outer membrane fusion (mmf) family.
RL4_JR_02556,11402,7285,8148,0,4,8,0,0,1,0,3,2,0,2,5,1,11,0,169.5951789,1,-0.569949798,0.517343374,-1.101685703,0.270598335,0.452179683,43.87957293,1,-0.727591518,1.136665743,-0.64011036,0.522100854,0.671561274,125.4954437,1,-1.148459363,0.699122081,-1.642716479,0.100441608,0.194571065,158.7922758,1,-1.120470971,0.624397216,-1.794484251,0.07273591,0.155402214,145.7182378,1,-0.251107321,0.55985781,-0.448519815,0.653778089,0.752900722,N,-,,DOA4-independent degradation 4,P:protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:protein retention in Golgi apparatus; C:ESCRT III complex; P:intralumenal vesicle formation,IPR005024 (PFAM); PTHR10476 (PANTHER); PTHR10476:SF4 (PANTHER),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_02557,3003,2382,2408,0,2,2,0,0,0,0,2,0,3,0,2,0,0,1,54.81911143,1,-0.336010603,0.74504555,-0.450993369,0.651994328,0.803227081,10.0134176,0,0.141691736,1.228221619,0.11536333,0.908157143,0.948789395,41.54868137,1,-0.679411881,1.03630404,-0.655610569,0.512074724,0.643206514,77.03442225,1,0.167368151,0.676609135,0.247363127,0.804627208,0.875158501,32.74857341,1,-1.645375988,1.121495262,-1.467127008,0.142341508,0.248956257,N,-,,---NA---,,no IPS match,,
RL4_JR_02558,8258,6827,7101,2,1,6,0,0,0,0,1,1,2,5,5,0,2,4,139.775661,1,-0.683791706,0.511719526,-1.336262681,0.18146343,0.338681917,28.46622306,0,-1.365641461,1.203038674,-1.135160066,0.256308258,0.41173658,87.93717653,1,-2.190524949,1.0327088,-2.121144846,0.033909615,0.084515249,171.7407102,1,-0.104144836,0.454228725,-0.229278401,0.81865254,0.885656263,109.4853366,1,-0.870131822,0.615026195,-1.41478823,0.157130596,0.267324715,N,-,,phosphatase 2C,"P:peptidyl-threonine dephosphorylation; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:pheromone-dependent signal transduction involved in conjugation with cellular fusion; P:mitochondrion inheritance; C:nucleus; P:peptidyl-serine dephosphorylation; F:magnesium-dependent protein serine/threonine phosphatase activity; P:inactivation of MAPK activity involved in osmosensory signaling pathway; F:metal ion binding; C:cytosol; F:MAP kinase threonine phosphatase activity; P:negative regulation of stress-activated MAPK cascade; P:peptidyl-tyrosine dephosphorylation",IPR001932 (SMART); IPR001932 (PFAM); IPR001932 (G3DSA:3.60.40.GENE3D); PTHR13832:SF332 (PANTHER); IPR015655 (PANTHER); IPR015655 (PANTHER); PTHR13832:SF332 (PANTHER); IPR001932 (PROSITE_PROFILES); IPR001932 (SUPERFAMILY),,
RL4_JR_02559,15232,8765,7639,3,5,12,0,0,0,1,7,0,0,15,0,0,7,5,242.3291525,1,-0.066634858,0.501853214,-0.132777586,0.894369281,0.94830577,41.0051738,0,-1.892203166,1.247872212,-1.516343699,0.129432467,0.246633177,171.1917167,1,-0.687169285,0.673247868,-1.020677997,0.307407022,0.448700792,181.4698109,1,-0.879323693,1.506107889,-0.583838449,0.559329008,0.6881174,166.4680678,1,-0.421097432,0.571047746,-0.737411952,0.46087187,0.591948202,N,-,,Gpi-anchored cell surface glyco,,IPR029006 (G3DSA:3.40.20.GENE3D); SSF55753 (SUPERFAMILY),,
RL4_JR_02560,6664,5081,4787,5,3,1,0,0,0,2,2,0,0,1,0,0,10,2,144.2995223,1,-0.112961098,0.596803841,-0.189276762,0.849875907,0.924808277,21.29655173,0,-0.947002177,1.219796394,-0.77636086,0.437535948,0.598882876,92.74545278,1,-0.754321039,0.757083734,-0.996350872,0.319079694,0.461716171,67.34323652,1,-3.065665837,1.155605186,-2.652866112,0.007981152,0.040505848,107.148269,1,0.488965354,0.499873536,0.978178116,0.327986238,0.464428426,N,-,,c6 zinc finger domain containing,"C:nucleus; P:aromatic amino acid family catabolic process; P:positive regulation of transcription from RNA polymerase II promoter; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31644:SF2 (PANTHER); PTHR31644 (PANTHER); PTHR31644:SF2 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_02561,2638,2764,3391,6,8,0,0,0,1,0,0,3,2,7,0,0,6,0,159.6412751,1,1.716476183,0.885665175,1.938064442,0.052615361,0.138373989,20.56386635,1,0.899074479,1.114384541,0.806790158,0.419787391,0.583533457,48.5796467,1,-0.27073502,0.853689385,-0.317135277,0.751140958,0.833357798,80.26146477,1,0.783999819,0.520546444,1.50610926,0.132039128,0.241665974,51.90153357,1,0.41485813,0.642529407,0.645664036,0.518496956,0.643657353,N,-,,transcription initiation factor TFIID subunit 14,"C:SWI/SNF complex; P:translational initiation; C:transcription factor TFIIF complex; P:transcription initiation from RNA polymerase II promoter; P:regulation of transcription from RNA polymerase II promoter; P:nucleosome mobilization; F:transcription factor activity, core RNA polymerase II binding; F:translation initiation factor activity; C:transcription factor TFIID complex; C:NuA3a histone acetyltransferase complex; C:NuA3b histone acetyltransferase complex; C:mediator complex; C:Ino80 complex; P:histone acetylation; F:TBP-class protein binding",IPR005033 (PFAM); IPR016665 (PIRSF); IPR005033 (PANTHER); IPR016665 (PTHR23195:PANTHER); IPR005033 (PROSITE_PROFILES),,
RL4_JR_02562,15330,14974,18184,2,4,38,0,0,0,6,4,7,9,11,5,0,13,2,391.13187,1,0.145380163,0.661778913,0.219680864,0.826119709,0.912449971,61.7655595,0,-2.483223986,1.187526536,-2.091089261,0.036520063,0.092321698,303.7097378,1,-0.22037347,0.389156985,-0.566284247,0.571200567,0.695089374,361.1975839,1,-0.166086814,0.333230522,-0.498414169,0.618192152,0.736202722,223.2805322,1,-0.791482682,0.497960237,-1.589449566,0.111958932,0.207844552,N,-,,Ran-specific GTPase-activating,C:nucleus; P:RNA export from nucleus; C:cytoplasm; P:protein import into nucleus; P:G1/S transition of mitotic cell cycle; F:Ran GTPase binding; P:ubiquitin-dependent protein catabolic process,IPR000156 (SMART); IPR000156 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); PTHR23138 (PANTHER); IPR000156 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_02563,11908,9664,7446,9,4,31,0,0,2,1,1,9,1,8,1,0,8,1,357.338948,1,1.111276402,0.459498871,2.418452955,0.015586661,0.053897737,56.30243125,1,-0.137236548,1.023515169,-0.13408355,0.893336507,0.940442239,174.0427236,1,-0.162746075,0.548440779,-0.296743205,0.766662569,0.84338714,162.4738331,1,-0.834171795,0.560318416,-1.48874599,0.136554269,0.248118836,132.7140513,1,-0.75260937,0.586993571,-1.28214244,0.199792684,0.321554748,N,-,,ste ste20 paka kinase,F:ATP binding; C:mitochondrion; F:protein kinase activity; P:protein phosphorylation,IPR000095 (SMART); IPR001849 (SMART); IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000095 (G3DSA:3.90.810.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR000095 (PFAM); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); PTHR24361:SF360 (PANTHER); PTHR24361:SF360 (PANTHER); PTHR24361:SF360 (PANTHER); PTHR24361 (PANTHER); PTHR24361 (PANTHER); IPR001849 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR000095 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_02564,11741,12354,17123,3,2,11,0,0,2,0,0,3,0,11,0,0,3,0,252.8437467,1,-0.775391834,0.458423331,-1.691431874,0.090754349,0.206285921,70.98007228,1,-0.598878578,0.985776255,-0.607519785,0.543506017,0.689999737,155.5588644,1,-2.500750748,0.867206349,-2.88368593,0.003930505,0.016228563,201.1309774,1,-1.285390185,0.595915175,-2.157001935,0.031005514,0.094188667,146.3440059,1,-2.800280866,0.87763902,-3.190697772,0.001419297,0.006364207,N,-,,glycyl-tRNA synthetase,F:glycine-tRNA ligase activity; F:ATP binding; P:glycyl-tRNA aminoacylation; C:cytoplasm,IPR002315 (PRINTS); IPR004154 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.930.10 (GENE3D); IPR004154 (PFAM); IPR002315 (TIGRFAM); IPR027031 (PANTHER); IPR027031 (PANTHER); PTHR10745:SF0 (PANTHER); PTHR10745:SF0 (PANTHER); IPR006195 (PROSITE_PROFILES); SSF55681 (SUPERFAMILY); IPR004154 (SUPERFAMILY),,
RL4_JR_02565,5713,5806,4773,2,0,2,0,0,0,0,3,2,3,7,15,0,3,1,93.19336224,1,-1.401117437,0.754148399,-1.857880277,0.063186018,0.158460354,20.98165905,0,-0.925503733,1.211886633,-0.763688375,0.44505297,0.606383923,90.73693686,1,-0.430717086,0.678536903,-0.634773266,0.525576301,0.655448938,263.0718811,1,1.571421914,0.541070005,2.904285768,0.00368092,0.021974833,72.12452657,1,-1.027976894,0.748715436,-1.372987446,0.169756249,0.28442529,N,-,,solute carrier family 35 member e3,,PTHR11132 (PANTHER); PTHR11132:SF47 (PANTHER),2.A.7.9.15, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_02566,10823,20023,17157,4,14,42,1,0,1,3,3,2,13,13,5,0,29,2,506.4335916,1,0.758654704,0.523226248,1.449955362,0.147070967,0.292921131,93.00388034,1,-0.814014161,1.012417697,-0.80402996,0.421379672,0.584835464,229.3252993,1,-1.287420623,0.602212847,-2.137816602,0.032531631,0.081846479,405.5477952,1,0.207992345,0.452634829,0.459514673,0.645864618,0.757486303,284.2682528,1,-0.086046511,0.805959638,-0.106762805,0.914977156,0.945610259,N,-,,dtdp-glucose -dehydratase,"F:UDP-glucose 4,6-dehydratase activity; F:dTDP-glucose 4,6-dehydratase activity; P:nucleotide-sugar metabolic process",IPR016040 (PFAM); G3DSA:3.90.25.10 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10366 (PANTHER); IPR005888 (PTHR10366:PANTHER); IPR016040 (SUPERFAMILY),9.B.18.2.1," the xanthan glycosyl transferase, gumd (gumd) family."
RL4_JR_02567,667,463,601,0,0,6,0,0,0,0,1,0,0,0,3,0,0,0,29.80955649,1,2.388419487,0.636292229,3.753651824,0.000174277,0.001375001,2.212781192,0,2.319666107,1.315027394,1.763967898,0.077737384,0.16677783,13.56909438,1,0.633091878,1.200620039,0.527304107,0.597982422,0.717210525,35.51023549,1,1.591937669,0.859126585,1.852972189,0.063886345,0.142111804,5.6349027,0,-0.408304858,1.206811178,-0.338333672,0.735111751,0.815046702,N,-,,methyltransferase type 12,F:methyltransferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); PTHR10108:SF839 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_02568,3619,3984,3221,0,0,13,0,0,0,0,1,0,0,9,1,0,7,0,93.14871719,1,0.549031736,0.809253477,0.678442233,0.497491339,0.684357543,13.93186482,0,-0.334757102,1.218820294,-0.274656652,0.783580037,0.869384757,43.86657701,1,-2.020035844,1.195497589,-1.689702985,0.091084792,0.180635149,87.29053076,1,0.593190092,0.52686635,1.125883429,0.260214865,0.400528353,62.38194402,1,0.338830606,0.59400894,0.570413311,0.568397403,0.685040318,N,-,,vacuolar membrane pep3,"P:lysosome organization; C:endosome; P:regulation of SNARE complex assembly; P:endosome organization; P:vesicle docking involved in exocytosis; P:intracellular protein transport; F:protein binding, bridging; C:HOPS complex",IPR007810 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR23323:SF26 (PANTHER); PTHR23323 (PANTHER); PTHR23323:SF26 (PANTHER); PTHR23323 (PANTHER); IPR000547 (PROSITE_PROFILES); IPR011044 (SUPERFAMILY),,
RL4_JR_02569,451,308,753,0,0,7,0,0,0,0,0,0,0,8,2,0,0,0,32.71768593,1,2.680580533,0.776577377,3.451788079,0.000556885,0.003669683,1.894030841,0,2.543911275,1.383439854,1.838830412,0.065940134,0.14659478,4.953649055,0,-0.11976053,1.253476851,-0.095542674,0.923883796,0.955110748,57.08011439,1,3.416046164,0.633994357,5.388133389,7.12E-08,1.67E-06,4.933788968,0,-0.216490403,1.267421059,-0.170811745,0.864371793,0.90974682,Y,-,,aspartic-type endopeptidase,F:aspartic-type endopeptidase activity; P:proteolysis; C:integral component of membrane,IPR001461 (PRINTS); IPR033121 (PFAM); IPR021109 (G3DSA:2.40.70.GENE3D); IPR021109 (G3DSA:2.40.70.GENE3D); IPR001461 (PANTHER); PTHR13683:SF318 (PANTHER); IPR033121 (PROSITE_PROFILES); IPR021109 (SUPERFAMILY),8.A.32.1.4,The β-Amyloid Cleaving Enzyme (BACE1) Family
RL4_JR_02570,5673,4839,5320,2,0,10,4,0,6,1,0,0,1,13,2,0,4,3,121.6122704,1,0.204244459,0.448607594,0.455285336,0.648903975,0.800411295,165.7898814,1,3.052661315,0.508087441,6.008141643,1.88E-09,3.06E-07,63.54373529,1,-2.562742957,1.18836801,-2.15652301,0.031042849,0.078884991,141.2590837,1,0.747414162,0.407739285,1.833068803,0.06679234,0.146506161,89.15979566,1,-0.172260804,0.568971791,-0.302758074,0.762074237,0.83407217,N,-,,ste ste11 kinase,"F:identical protein binding; P:MAPK cascade involved in conjugation with cellular fusion; F:SAM domain binding; C:cell division site; C:barrier septum; P:MAPK cascade involved in ascospore formation; P:pseudohyphal growth; P:osmosensory signaling pathway via Sho1 osmosensor; P:invasive growth in response to glucose limitation; P:signal transduction involved in filamentous growth; F:MAP kinase kinase kinase kinase activity; C:plasma membrane; P:mitotic cell cycle arrest in response to pheromone; F:ATP binding; P:activation of MAPKK activity; P:activation of MAPKKK activity; P:MAPK cascade involved in cell wall organization or biogenesis; P:cellular response to heat; C:cell tip; C:cytoplasm; P:MAPK cascade involved in osmosensory signaling pathway; P:induction of conjugation with cellular fusion; P:regulation of transposition, RNA-mediated; F:MAP kinase kinase kinase activity",IPR029458 (SMART); IPR001660 (SMART); IPR000719 (SMART); IPR000719 (PFAM); IPR001660 (PFAM); IPR013761 (G3DSA:1.10.150.GENE3D); IPR029458 (PFAM); G3DSA:3.10.20.90 (GENE3D); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24361 (PANTHER); PTHR24361:SF371 (PANTHER); PTHR24361:SF371 (PANTHER); PTHR24361:SF371 (PANTHER); PTHR24361 (PANTHER); PTHR24361 (PANTHER); IPR001660 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR000159 (PROSITE_PROFILES); IPR013761 (SUPERFAMILY); IPR011009 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_02571,11555,10220,7445,6,12,0,0,0,9,0,12,10,3,15,5,0,4,8,273.8208982,1,0.357320604,1.002718187,0.356351973,0.721576992,0.851888405,122.2248276,1,1.851248032,0.654160018,2.829962059,0.004655352,0.019724352,256.4846581,1,0.814409165,0.478473026,1.702100475,0.088736535,0.17670509,248.5793358,1,0.373340055,0.421029835,0.886730641,0.375223937,0.520858564,169.56674,1,-0.243469227,0.530392604,-0.459035863,0.646208412,0.747243053,N,-,,leucine rich repeat domain containing,,SM00368 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR24114:SF2 (PANTHER); PTHR24114 (PANTHER); SSF52047 (SUPERFAMILY),,
RL4_JR_02572,3102,2322,3878,2,0,1,0,0,0,0,0,0,0,1,0,0,0,0,60.94727926,1,-0.981254226,0.873585639,-1.123249035,0.261331743,0.440848709,11.78116161,0,-0.092938276,1.22548128,-0.075838185,0.939547836,0.967063575,30.6475037,0,-2.748774251,1.204166024,-2.282720319,0.022446848,0.061005155,39.37069192,1,-2.225087994,1.158630276,-1.920446961,0.054801467,0.129550513,30.33312706,0,-2.836615918,1.212337365,-2.339790887,0.01929454,0.053172894,N,-,,hydroxyacyl-thioester dehydratase,P:cellular protein modification process,IPR029069 (G3DSA:3.10.129.GENE3D); PTHR28152:SF1 (PANTHER); PTHR28152 (PANTHER); IPR029069 (SUPERFAMILY),,
RL4_JR_02573,1860,1877,3942,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30.51028065,0,-3.0335893,1.251006455,-2.424918983,0.015311803,0.053200039,9.600829412,0,0.202281276,1.267979969,0.159530341,0.873251056,0.927275505,25.17740821,0,-2.465133116,1.236064064,-1.9943409,0.046114812,0.106275065,29.06246147,0,-2.888319848,1.241472913,-2.326526675,0.019990471,0.076714457,25.12675881,0,-2.564929121,1.253987518,-2.045418382,0.040813628,0.095656941,N,-,,prephenate dehydratase,C:cytoplasm; F:catalytic activity; P:metabolic process,IPR001086 (PFAM); IPR008242 (PIRSF); G3DSA:3.30.70.260 (GENE3D); G3DSA:3.40.190.10 (GENE3D); G3DSA:3.40.190.10 (GENE3D); PTHR21022 (PANTHER); IPR001086 (PROSITE_PROFILES); IPR002912 (PROSITE_PROFILES); SSF53850 (SUPERFAMILY); SSF55021 (SUPERFAMILY),,
RL4_JR_02574,18766,22479,27624,3,1,15,0,0,2,2,0,1,1,15,0,0,0,2,371.1758711,1,-1.3417209,0.502632923,-2.669385226,0.007599024,0.030508286,106.1878783,1,-1.342835075,0.987087428,-1.360401356,0.17370295,0.309569428,256.3591136,1,-3.225507007,0.863513806,-3.735327661,0.000187471,0.001692633,332.2558918,1,-1.553080175,0.601613715,-2.581523888,0.009836518,0.047951251,240.0958915,1,-4.030575437,0.995199638,-4.050016983,5.12E-05,0.000398571,N,-,,eukaryotic peptide chain release factor subunit 1,"C:nucleus; C:cytoplasmic stress granule; C:cytosol; P:cytoplasmic translational termination; C:translation release factor complex; P:DNA-templated transcription, termination; F:translation release factor activity, codon specific",IPR005140 (SMART); G3DSA:3.30.420.60 (GENE3D); IPR004403 (TIGRFAM); IPR024049 (G3DSA:3.30.960.GENE3D); IPR005140 (PFAM); IPR029064 (G3DSA:3.30.1330.GENE3D); IPR005141 (PFAM); IPR005142 (PFAM); IPR004403 (PANTHER); IPR024049 (SUPERFAMILY); SSF53137 (SUPERFAMILY); IPR029064 (SUPERFAMILY),,
RL4_JR_02575,1878,2149,2497,2,4,1,0,0,0,1,0,0,0,2,1,0,0,0,82.11573652,1,0.768221809,0.590819925,1.300263882,0.193510543,0.354515834,8.302613444,0,0.411924003,1.220174862,0.337594238,0.735668985,0.835547794,32.66352743,1,-1.281780723,1.192918598,-1.074491357,0.282602517,0.421986413,42.57337625,1,-0.354044212,0.856289182,-0.413463371,0.679267153,0.781678726,21.33730681,0,-2.329057711,1.200500272,-1.940072623,0.052370865,0.115978785,N,-,,duf1770 domain containing,,IPR013898 (PFAM); PTHR38699 (PANTHER),,
RL4_JR_02576,3521,3463,3450,6,0,9,0,0,0,0,0,0,2,2,0,0,0,0,136.565759,1,1.144960911,0.405383861,2.824387008,0.004737115,0.020821865,13.37013209,0,-0.275395494,1.20729152,-0.228110187,0.819560581,0.891041052,34.62480466,0,-2.924715345,1.186924624,-2.464112115,0.013735314,0.041415838,66.5876555,1,-0.615058589,0.734960228,-0.836859691,0.402671441,0.546372283,34.06154499,0,-3.003849066,1.185660931,-2.533480684,0.011293596,0.034598385,N,-,,hypothetical protein HMPREF1624_04838,P:biological_process; C:cellular_component; F:molecular_function,IPR028942 (PFAM); PTHR42107 (PANTHER),,
RL4_JR_02577,47992,47770,73316,8,17,131,2,0,0,7,4,4,0,34,1,0,40,6,1391.180082,1,0.120539391,0.698875319,0.172476245,0.863063135,0.932574881,258.3138329,1,-2.59371844,0.994808635,-2.607253647,0.009127172,0.031480012,692.1482215,1,-2.166124352,0.477747363,-4.53403728,5.79E-06,0.000118592,789.1187777,1,-2.022699079,0.98595693,-2.051508556,0.040217447,0.107734397,751.2937278,1,-1.32166437,0.796772939,-1.65877166,0.097161813,0.186672364,N,-,,60S ribosomal l2,F:structural constituent of ribosome; P:cytoplasmic translation; C:cytosolic large ribosomal subunit,IPR022669 (SMART); IPR002171 (SMART); IPR014726 (G3DSA:4.10.950.GENE3D); IPR022666 (PFAM); G3DSA:2.40.50.140 (GENE3D); IPR002171 (PIRSF); IPR022669 (PFAM); IPR014722 (G3DSA:2.30.30.GENE3D); PTHR13691:SF16 (PANTHER); IPR002171 (PANTHER); IPR008991 (SUPERFAMILY); IPR012340 (SUPERFAMILY),,
RL4_JR_02578,12340,12142,15055,9,3,48,0,0,1,4,2,4,0,1,4,0,23,0,455.9503853,1,0.976015687,0.60315985,1.618170848,0.105625783,0.230523045,59.70342378,1,-1.269802291,1.104462043,-1.149702065,0.250266604,0.404353469,216.7279549,1,-0.691335801,0.487662938,-1.417650895,0.156292713,0.270433674,193.4216236,1,-2.194668063,0.666836972,-3.291161342,0.000997747,0.007357746,217.9375853,1,-0.428753112,1.620947998,-0.264507629,0.791388787,0.858086471,N,-,,adenosine kinase,C:nucleus; P:AMP biosynthetic process; C:cytosol; F:adenosine kinase activity; P:purine nucleobase metabolic process; P:purine ribonucleoside salvage; P:phosphorylation,IPR001805 (PRINTS); IPR011611 (PFAM); G3DSA:3.30.1110.10 (GENE3D); IPR029056 (G3DSA:3.40.1190.GENE3D); PTHR10584 (PANTHER); IPR001805 (PTHR10584:PANTHER); IPR029056 (SUPERFAMILY),,
RL4_JR_02579,6292,4392,6277,0,4,0,0,0,0,0,0,5,7,5,6,0,4,0,99.57430134,1,-1.41491439,0.762074726,-1.856660957,0.063359406,0.158773787,21.61572257,0,-0.968501131,1.210612664,-0.800009086,0.423705533,0.586535476,88.52109245,1,-0.490615178,0.690100981,-0.710932445,0.477126099,0.613621789,207.6822559,1,0.941318962,0.429740417,2.190436188,0.028492618,0.089620303,70.67855911,1,-1.10489228,0.773377761,-1.428657941,0.153102572,0.262784123,N,-,,Telomerase activating Est1,,IPR018834 (PFAM); IPR019458 (PFAM); PTHR15696 (PANTHER); PTHR15696:SF0 (PANTHER); PTHR15696:SF0 (PANTHER); IPR011990 (SUPERFAMILY),,
RL4_JR_02580,2571,2297,3694,0,0,6,0,0,0,0,0,0,0,2,0,0,3,0,57.01541255,1,0.051805839,0.678169071,0.076390742,0.939108235,0.969777845,10.82371468,0,0.029331969,1.224584628,0.023952586,0.980890428,0.990183795,28.20901204,0,-2.629166534,1.203866884,-2.183934594,0.028967055,0.074526673,40.57329686,1,-1.334199613,1.035510173,-1.288446649,0.197590529,0.327752966,39.54523692,1,-0.533217085,0.881272909,-0.605053303,0.54514358,0.666454812,N,-,,farnesyltransferase subunit beta,C:cytoplasmic part; F:transferase activity,IPR008930 (G3DSA:1.50.10.GENE3D); IPR001330 (PFAM); PTHR11774 (PANTHER); IPR026872 (PTHR11774:PANTHER); PTHR11774 (PANTHER); IPR008930 (SUPERFAMILY),,
RL4_JR_02581,3829,4490,4524,5,25,27,0,0,0,0,0,0,0,7,0,0,4,3,405.2075456,1,2.788255391,0.417212903,6.683051675,2.34E-11,9.19E-10,16.41137791,0,-0.571100095,1.20334358,-0.474594375,0.635076116,0.761459423,42.60246203,0,-3.223864992,1.190530916,-2.707922112,0.006770591,0.023975328,77.23160499,1,-0.142994472,0.586956272,-0.243620315,0.807524893,0.87708534,79.53892893,1,0.123116818,0.582533632,0.211347142,0.8326164,0.886833689,N,-,,mannose-1-phosphate guanyltransferase,F:GTP binding; P:fungal-type cell wall biogenesis; P:cell wall mannoprotein biosynthetic process; C:cell tip; P:GDP-mannose biosynthetic process; P:protein glycosylation; C:cytosol; F:mannose-1-phosphate guanylyltransferase activity; P:cell cycle,IPR005835 (PFAM); IPR029044 (G3DSA:3.90.550.GENE3D); G3DSA:2.160.10.10 (GENE3D); IPR001451 (PFAM); PTHR22572:SF108 (PANTHER); PTHR22572 (PANTHER); IPR029044 (SUPERFAMILY); IPR011004 (SUPERFAMILY),,
RL4_JR_02582,2466,1841,2447,0,0,5,0,0,0,0,2,0,0,0,0,0,3,3,46.01693946,1,0.173327713,0.678369249,0.255506442,0.798331968,0.897559449,8.61680248,0,0.358358417,1.226934848,0.292076159,0.770228395,0.860988604,38.01604133,1,-0.467630807,1.035432727,-0.451628382,0.65153672,0.758091915,25.75746988,0,-2.71416273,1.194105602,-2.272967086,0.023028163,0.081940754,55.68312777,1,0.837869918,0.628308925,1.333531777,0.182357354,0.300858435,N,-,,glycerol kinase,P:carbohydrate metabolic process; P:glycerol-3-phosphate metabolic process; F:glycerol kinase activity; P:phosphorylation,IPR000577 (PIRSF); IPR005999 (TIGRFAM); IPR018485 (PFAM); IPR018484 (PFAM); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); PTHR10196:SF75 (PANTHER); PTHR10196 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_02583,1014,1077,748,0,0,0,0,0,0,0,0,1,0,0,1,0,3,2,11.42454894,0,-1.616254855,1.213077114,-1.332359531,0.182742074,0.340289851,3.6705878,0,1.58959091,1.293292079,1.229104342,0.219032687,0.366696801,15.96659008,1,-0.092086154,1.208741418,-0.076183502,0.939273108,0.963640145,20.55429795,1,-0.524081943,1.161511519,-0.451206841,0.65184048,0.761970168,35.58002635,1,1.815010136,0.69541432,2.609969459,0.009055031,0.029008788,N,-,,lipase esterase family,P:metabolic process; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR013094 (PFAM); PTHR23024 (PANTHER); PTHR23024:SF47 (PANTHER); PTHR23024 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_02584,2917,3730,5064,0,0,3,5,0,0,0,0,0,1,6,0,0,1,1,58.29629213,1,-1.378886971,0.906437083,-1.521216417,0.128205537,0.264584055,126.3647604,1,2.888423401,1.409926717,2.04863371,0.040497946,0.100078176,38.65366598,0,-3.083575822,1.208804588,-2.550929946,0.010743592,0.03463953,77.99108606,1,-0.021714322,0.635550459,-0.034166165,0.972744647,0.984707014,49.57865561,1,-1.496024898,1.004934877,-1.488678454,0.136572061,0.241577939,N,-, Effector probability:0.764,50S ribosomal 27,F:structural constituent of ribosome; C:mitochondrial large ribosomal subunit; P:translation,IPR019189 (PFAM); PTHR21338 (PANTHER),,
RL4_JR_02585,10262,15219,19829,0,0,5,0,0,0,0,0,0,1,3,0,0,0,0,200.5730486,1,-2.659457509,0.80054349,-3.322064999,0.000893539,0.005448049,57.2456464,0,-2.373593555,1.214912041,-1.953716379,0.050734768,0.119233184,149.6096585,0,-5.036076027,1.218872303,-4.131750318,3.60E-05,0.000550567,194.0220819,1,-2.753707631,0.802069197,-3.433254441,0.000596382,0.004822979,148.5542739,0,-5.128625237,1.234002521,-4.156089755,3.24E-05,0.000268141,N,-,,small nucleolar ribonucleo complex subunit utp14,P:rRNA processing; C:intracellular part,IPR006709 (PFAM); PTHR14150:SF12 (PANTHER); IPR006709 (PANTHER),,
RL4_JR_02586,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_02587,2269,3726,3387,0,5,38,0,0,0,0,2,9,9,13,0,0,4,2,222.94142,1,2.382549598,0.890426636,2.67573936,0.007456461,0.029994974,11.9769489,0,-0.116673949,1.235317574,-0.094448546,0.924752854,0.958737823,105.3374088,1,1.461561665,0.548715232,2.663606876,0.007730785,0.026657516,171.9206131,1,1.964464796,0.490069643,4.008542097,6.11E-05,0.000704538,60.94331008,1,0.330969732,0.673189699,0.491644083,0.622970974,0.728694676,N,-,,calcium proton exchanger,P:potassium ion transmembrane transport; F:potassium:proton antiporter activity; C:fungal-type vacuole membrane; C:integral component of membrane; P:calcium ion transmembrane transport; C:endoplasmic reticulum; F:calcium:proton antiporter activity; P:cellular calcium ion homeostasis,IPR004837 (PFAM); IPR004713 (TIGRFAM); IPR004798 (TIGRFAM); IPR030177 (PTHR31503:PANTHER); PTHR31503 (PANTHER),2.A.19.2.8, the ca(2+):cation antiporter (caca) family.
RL4_JR_02588,1442,1391,1399,0,0,0,0,0,0,0,0,1,0,5,4,0,0,0,16.95216648,0,-2.185617388,1.184174868,-1.845688038,0.064937515,0.161610814,5.422877353,0,1.026492773,1.237558538,0.829449874,0.40684989,0.570794747,20.54085034,1,-0.660843873,1.188102435,-0.556217927,0.578061886,0.700370815,74.79658895,1,1.855701561,0.502986075,3.689369654,0.00022481,0.002119372,13.81284852,0,-1.701719207,1.188254553,-1.432116715,0.152110422,0.261702297,N,-,,glycoside hydrolase family 81,F:beta-glucanase activity,IPR005200 (PFAM); PTHR31983 (PANTHER); PTHR31983:SF0 (PANTHER),,
RL4_JR_02589,1541,1592,1656,0,2,2,0,0,0,0,0,0,1,9,0,0,0,0,42.84471925,1,0.363753292,0.733283266,0.496061085,0.619851314,0.781764585,6.124438916,0,0.850956313,1.228854173,0.692479492,0.488636261,0.644594843,15.88086655,0,-1.800205246,1.188417705,-1.514791676,0.129825169,0.235645734,63.73673041,1,1.807159928,0.484931544,3.726628942,0.000194058,0.001873056,15.64313742,0,-1.881207121,1.190110916,-1.580698989,0.11394688,0.210565109,N,-,,chaperone dnaJ 6,C:nuclear lumen; C:intracellular non-membrane-bounded organelle,IPR001623 (PRINTS); IPR001623 (SMART); G3DSA:2.40.50.140 (GENE3D); IPR001623 (PFAM); IPR018856 (PFAM); IPR001623 (G3DSA:1.10.287.GENE3D); PTHR24078 (PANTHER); PTHR24078:SF267 (PANTHER); IPR001623 (PROSITE_PROFILES); IPR012340 (SUPERFAMILY); IPR001623 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_02590,400,434,542,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,21.52382841,1,1.184189458,1.015849812,1.165713125,0.243730452,0.418865183,1.748464585,0,2.65937259,1.323036243,2.010052713,0.04442561,0.107475149,11.0483185,1,0.964833825,1.197694574,0.805575851,0.420487455,0.561685577,5.249452723,0,-0.419493983,1.20498824,-0.348131184,0.727741666,0.818618416,4.498888421,0,-0.083258339,1.210210796,-0.068796559,0.945151557,0.965072561,N,-,,DRAP deaminase,F:zinc ion binding; F:tRNA-specific adenosine-34 deaminase activity; C:cytosol; C:tRNA-specific adenosine-34 deaminase complex; P:tRNA modification,G3DSA:3.40.140.10 (GENE3D); IPR002125 (PFAM); IPR002125 (PROSITE_PROFILES); IPR016193 (SUPERFAMILY),,
RL4_JR_02591,2070,2546,2681,2,5,1,0,0,3,0,0,3,0,7,0,0,3,0,93.27121736,1,0.817871465,0.573672037,1.42567776,0.153961379,0.302436053,37.4415025,1,2.427776653,0.859442998,2.824825683,0.004730634,0.019923787,43.68338906,1,-0.00599359,0.85794038,-0.006986022,0.994426006,0.997776897,55.9880538,1,0.665202661,0.597294892,1.113692199,0.265411257,0.406364582,35.45792289,1,-0.293024684,0.856766993,-0.342012107,0.732341781,0.81242035,N,-,,l-galactonate dehydratase,P:carbohydrate metabolic process; P:cellular amino acid catabolic process; F:metal ion binding; F:carbonate dehydratase activity; P:D-galacturonate catabolic process,IPR013342 (SMART); IPR029065 (PFAM); IPR029017 (G3DSA:3.30.390.GENE3D); IPR029065 (G3DSA:3.20.20.GENE3D); IPR001354 (PANTHER); IPR001354 (PANTHER); PTHR13794:SF58 (PANTHER); PTHR13794:SF58 (PANTHER); IPR029017 (SUPERFAMILY); IPR029065 (SUPERFAMILY),,
RL4_JR_02592,4374,2662,3087,11,9,10,0,0,8,0,1,2,4,2,1,0,9,1,261.3330468,1,2.33243626,0.442537961,5.270590249,1.36E-07,2.64E-06,88.04072977,1,3.259294078,0.644747853,5.055145296,4.30E-07,4.14E-05,54.389752,1,-0.479752015,0.879489957,-0.545488907,0.585417308,0.706264822,93.59340392,1,0.28096789,0.620134843,0.453075477,0.650494393,0.760625445,75.00184224,1,0.91026164,0.570322731,1.596046573,0.110478396,0.205661658,N,-,,mating-type switching swi10,,no IPS match,,
RL4_JR_02593,779,646,1671,2,0,0,0,0,0,0,0,0,0,1,0,0,0,1,32.39317606,1,0.092489338,1.105078519,0.083694811,0.933299083,0.967083853,3.856598036,0,1.518066426,1.338631574,1.134043493,0.256776304,0.412161395,10.12449037,0,-1.15092851,1.257817975,-0.915019925,0.36018117,0.50393507,15.6987035,1,-0.631557543,1.215452424,-0.519606963,0.603337544,0.724477304,17.48691917,1,-0.303303685,1.204154671,-0.251881002,0.801133044,0.865743833,N,-,,DNA repair rad10,"C:nucleotide-excision repair factor 1 complex; P:nucleic acid phosphodiester bond hydrolysis; C:site of double-strand break; F:polyubiquitin binding; F:endonuclease activity; P:double-strand break repair via single-strand annealing, removal of nonhomologous ends; C:cytosol; F:damaged DNA binding; P:gene conversion at mating-type locus",IPR004579 (TIGRFAM); PF03834 (PFAM); PTHR12749 (PANTHER); PTHR12749:SF0 (PANTHER); IPR004579 (PRODOM); IPR010994 (SUPERFAMILY); IPR011335 (SUPERFAMILY),,
RL4_JR_02594,812,713,1318,0,0,2,0,0,0,0,0,0,0,4,2,0,17,0,18.94257158,1,0.107165954,1.059010137,0.101194455,0.919396098,0.961460663,3.578396627,0,1.626095989,1.291137403,1.259429078,0.207875392,0.353074618,9.346162688,0,-1.035553754,1.221757269,-0.847593692,0.396664289,0.539239268,46.10262344,1,1.83889333,0.67220232,2.735624788,0.006226197,0.033425371,74.9171832,1,2.977588293,1.531464399,1.944275228,0.05186227,0.115144041,Y,-,,glycosyl hydrolase family 47,,IPR001382 (PRINTS); IPR001382 (G3DSA:1.50.10.GENE3D); IPR001382 (PFAM); PTHR11742:SF45 (PANTHER); PTHR11742 (PANTHER); IPR001711 (PROSITE_PROFILES); IPR001382 (SUPERFAMILY),,
RL4_JR_02595,12402,12021,18504,0,1,1,0,0,0,4,1,0,0,0,0,0,0,0,182.9818195,1,-3.785357105,1.038259694,-3.645867337,0.000266491,0.001971022,54.27153324,0,-2.296631995,1.200785818,-1.912607527,0.055798315,0.128771215,193.6174339,1,-1.780039267,0.693932266,-2.565148435,0.010313167,0.033497115,163.2748741,0,-5.378350114,1.205287038,-4.462298143,8.11E-06,0.000118812,140.2864703,0,-5.046013892,1.215637217,-4.150920869,3.31E-05,0.000273474,N,-,,ribonuclease p complex subunit,,IPR012590 (PFAM); IPR009723 (PFAM); PTHR22731:SF3 (PANTHER); PTHR22731 (PANTHER); PTHR22731:SF3 (PANTHER); PTHR22731 (PANTHER),,
RL4_JR_02596,1287,1123,1500,1,0,0,0,0,0,0,0,0,0,0,0,0,4,0,25.66888461,1,-1.116537286,1.142825212,-0.976997422,0.328570428,0.517766574,4.974636664,0,1.150892341,1.241263318,0.927194355,0.353825633,0.517771152,12.9209465,0,-1.502772017,1.194110991,-1.258486044,0.208216031,0.335356261,14.9064785,0,-1.925180219,1.192288023,-1.614693918,0.106376995,0.205547152,28.20172046,1,1.015209668,0.763453673,1.32975936,0.18359757,0.302166027,N,-,,60S ribosomal L37,,no IPS match,,
RL4_JR_02597,22378,25891,35670,1,0,30,5,0,1,0,2,0,0,24,0,0,17,7,460.0920864,1,-1.321827752,1.066590963,-1.239301473,0.215233874,0.38346339,227.1570168,1,-0.001501012,0.659795271,-0.002274967,0.998184841,0.999073169,292.7345169,1,-4.100276138,1.050506105,-3.90314356,9.50E-05,0.001128758,415.9908408,1,-1.663063267,1.734076864,-0.959048184,0.337534472,0.484550763,391.8549997,1,-0.937932331,0.513003634,-1.82831518,0.067502263,0.1410651,N,-,,60S ribosomal L37,F:structural constituent of ribosome; F:metal ion binding; C:ribosome; F:rRNA binding; P:translation,IPR011331 (G3DSA:2.20.25.GENE3D); IPR001569 (PFAM); PTHR10768 (PANTHER); IPR001569 (PRODOM); IPR011332 (SUPERFAMILY),,
RL4_JR_02598,663,767,306,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.025567438,0,-0.91482082,1.30022242,-0.703587944,0.481689421,0.669898108,2.270459244,0,2.282649041,1.42047817,1.606958198,0.108063538,0.214769121,5.826722574,0,-0.353521711,1.2731148,-0.277682508,0.781256089,0.854612279,6.718056263,0,-0.775072117,1.282433165,-0.604376227,0.545593538,0.675735115,5.666826466,0,-0.416326134,1.270788343,-0.327612491,0.743204677,0.820604946,N,-,,---NA---,,no IPS match,,
RL4_JR_02599,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_02600,73303,62002,81223,7,13,1,0,0,3,4,6,12,5,18,4,0,6,0,1042.485727,1,-2.344294261,0.848441539,-2.763059274,0.005726237,0.024305223,303.9305011,1,-2.462801922,0.861561943,-2.858531465,0.004256069,0.018576943,885.1295365,1,-2.025142274,0.382435054,-5.295388724,1.19E-07,4.02E-06,983.07526,1,-2.267988515,0.35700727,-6.352779634,2.11E-10,7.57E-09,729.498612,1,-4.253059555,0.71270841,-5.967460876,2.41E-09,1.31E-07,N,-,,urea transporter,C:integral component of plasma membrane; P:spermidine transmembrane transport; F:symporter activity; F:spermidine transmembrane transporter activity,IPR001734 (PFAM); PTHR11819:SF114 (PANTHER); IPR001734 (PANTHER); IPR001734 (PROSITE_PROFILES),2.A.21.6.5, the solute:sodium symporter (sss) family.
RL4_JR_02601,782,921,966,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.70347632,0,-1.522221047,1.196325534,-1.27241374,0.203226155,0.367870166,3.406170785,0,1.697361877,1.263734863,1.343131321,0.179229455,0.316994679,8.847952083,0,-0.956345063,1.196476405,-0.799301231,0.424115765,0.565189945,10.20826334,0,-1.378826816,1.194657075,-1.154161177,0.248434096,0.387520447,8.729533338,0,-1.039602807,1.200308957,-0.86611268,0.386428373,0.52272375,N,-,,N-glycosylation EOS1,C:endoplasmic reticulum membrane; C:integral component of membrane; P:cellular response to oxidative stress,IPR021100 (PFAM); PTHR28147 (PANTHER),,
RL4_JR_02602,4846,7238,9735,0,1,5,0,0,0,0,0,1,0,0,1,0,0,0,114.459885,1,-1.310344104,0.729760567,-1.795580857,0.072561203,0.175497863,27.5348425,0,-1.317699101,1.224766342,-1.07587795,0.281981845,0.441112872,78.50246299,1,-3.019228961,1.220138802,-2.474496307,0.01334242,0.040551984,92.74255012,1,-3.450242357,1.179527336,-2.925105888,0.00344339,0.020777311,71.54376773,0,-4.074529574,1.232408696,-3.306151268,0.00094587,0.004566969,N,-,,hypothetical protein CMQ_3265,P:protein insertion into mitochondrial membrane from inner side; F:ribosome binding; C:mitochondrial inner membrane,IPR024621 (PFAM),,
RL4_JR_02603,2824,4663,8152,0,0,5,3,0,1,1,4,1,0,2,0,0,8,0,81.50341177,1,-1.17685699,0.900133808,-1.307424496,0.191068582,0.351146091,95.85021202,1,1.852973198,0.834048985,2.221659915,0.026306297,0.071252968,100.2992082,1,-0.077139863,0.727855213,-0.105982429,0.915596293,0.949257232,67.3191989,1,-2.230636476,1.112187453,-2.005629959,0.044895743,0.115085715,82.21981811,1,-0.189380876,0.815209792,-0.232309374,0.816297732,0.876517853,N,-,,drap deaminase,F:RNA binding; P:tRNA pseudouridine synthesis; C:mitochondrion; F:pseudouridine synthase activity; F:deaminase activity,IPR006145 (PFAM); IPR006225 (TIGRFAM); PTHR11079 (PANTHER); PTHR11079:SF85 (PANTHER); PTHR11079 (PANTHER); PTHR11079:SF85 (PANTHER); PTHR11079:SF85 (PANTHER); IPR020103 (SUPERFAMILY),,
RL4_JR_02604,381,450,415,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,5.004362256,0,-0.425266821,1.208285987,-0.351958746,0.724869202,0.854549559,1.59628335,0,2.7908381,1.337571112,2.086496991,0.036933628,0.093181001,10.63748797,1,1.101823369,1.19609641,0.92118274,0.356955028,0.500458759,8.786162874,1,0.664484054,1.149614584,0.578005937,0.563260111,0.690855073,4.074293073,0,0.059819175,1.202120701,0.049761372,0.960312549,0.973947415,N,-, Effector probability:0.709,thioesterase family,,IPR029069 (G3DSA:3.10.129.GENE3D); IPR006683 (PFAM); PTHR31793 (PANTHER); PTHR31793:SF7 (PANTHER); IPR029069 (SUPERFAMILY),,
RL4_JR_02605,11248,10775,8495,0,1,11,0,0,0,4,0,0,0,1,1,0,4,7,172.547004,1,-0.870823827,0.591348082,-1.472607849,0.140856807,0.283590778,39.37714656,0,-1.833746668,1.211568293,-1.51353141,0.130144729,0.247384966,145.8853315,1,-1.627456348,0.758881191,-2.144546957,0.031989087,0.080681993,130.825062,1,-3.164772983,1.027881716,-3.078927211,0.002077474,0.013614516,166.5382976,1,-0.447635717,0.503380134,-0.8892598,0.373863471,0.510088619,N,-,,C2H2 finger domain-containing,,IPR015880 (SMART); PTHR23225 (PANTHER); PTHR23225 (PANTHER); PTHR23225:SF2 (PANTHER); PTHR23225:SF2 (PANTHER); PTHR23225 (PANTHER); PTHR23225:SF2 (PANTHER); PTHR23225:SF2 (PANTHER); PTHR23225 (PANTHER),,
RL4_JR_02606,10,11,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.10893032,0,5.09622941,3.870222016,1.316779603,0.187912512,NA,0.035099512,0,8.298566351,2.604823775,3.185845596,0.001443316,0.015023052,0.090312446,0,5.659980484,1.508789943,3.751337627,0.000175894,0.001628499,0.10414153,0,5.236639502,2.308923835,2.268000106,0.0233292,0.082561395,0.088129545,0,5.590568118,1.303050226,4.290370399,1.78E-05,0.000162854,N,-,,hypothetical protein SPI_04811,,no IPS match,,
RL4_JR_02607,84,73,87,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.974857081,0,1.934349447,1.470780268,1.315185884,0.188447438,NA,0.311562197,0,5.147919454,1.672533338,3.077917395,0.002084527,0.015023052,0.807726833,0,2.496852294,1.239321553,2.014692868,0.04393684,0.102445087,0.931750363,0,2.074682692,1.286287139,1.612923451,0.10676114,0.205935709,0.79593038,0,2.415384912,1.216400903,1.985681617,0.047068687,0.106902302,N,-,,---NA---,,no IPS match,,
RL4_JR_02608,3,5,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.060055623,0,5.955126877,3.924495823,1.517424695,0.129159493,NA,0.018877885,0,9.191848796,2.924816039,3.142710062,0.001673916,0.015023052,0.049454688,0,6.525389546,1.666681531,3.91519881,9.03E-05,0.001097837,0.057087465,0,6.103185966,2.899172377,2.105147667,0.035278456,0.099766434,0.049227345,0,6.434426621,1.352148257,4.758669464,1.95E-06,2.53E-05,N,-,,mate efflux family,P:drug transmembrane transport; F:antiporter activity; C:integral component of membrane; F:drug transmembrane transporter activity,IPR002528 (TIGRFAM); IPR002528 (PFAM); PTHR11206 (PANTHER); PTHR11206:SF113 (PANTHER),2.A.66.1.38, the multidrug/oligosaccharidyl-lipid/polysaccharide (mop) flippase superfamily.
RL4_JR_02609,931,802,706,0,0,11,0,0,0,0,0,0,0,0,0,0,0,1,51.77673399,1,2.618582562,0.629149407,4.162099704,3.15E-05,0.000312197,3.142200676,0,1.813815396,1.290071889,1.405980094,0.159730036,0.290244068,8.108804175,0,-0.830388045,1.20390536,-0.689745285,0.490354383,0.624430276,9.351458189,0,-1.252263461,1.20243241,-1.041441873,0.297670518,0.442766856,15.3136064,1,0.030558036,1.125884267,0.027141365,0.978346983,0.98545197,N,-,,benzoate 4-monooxygenase cytochrome p450,F:oxidoreductase activity; F:metal ion binding; C:membrane,IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24305 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_02610,1006,838,697,1,0,8,0,0,1,0,0,0,1,1,2,0,0,0,50.79694206,1,2.389517706,0.564895687,4.230015841,2.34E-05,0.000239487,12.65866349,1,2.666198486,1.153422163,2.311554756,0.020802232,0.059331829,8.454350466,0,-0.89059626,1.20979336,-0.736155685,0.461635957,0.599026203,42.34364092,1,1.440650049,0.761297873,1.892360533,0.058442961,0.134982775,8.276103018,0,-0.962811689,1.204727644,-0.799194485,0.42417765,0.559509992,N,-,,amino acid transporter,F:putrescine transmembrane transporter activity; F:gamma-aminobutyric acid:proton symporter activity; C:fungal-type vacuole membrane; C:integral component of membrane; P:putrescine transport; P:gamma-aminobutyric acid transport; P:amino acid transmembrane transport,IPR002293 (PFAM); IPR002293 (PIRSF); IPR002293 (PANTHER); PTHR11785:SF413 (PANTHER),2.A.3.4.6, the amino acid-polyamine-organocation (apc) family.
RL4_JR_02611,122,163,137,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,1.698478008,0,1.133652156,1.323349539,0.856653607,0.39163635,NA,0.541281009,0,4.351126682,1.536902355,2.831101577,0.004638799,0.019681638,1.403583208,0,1.700231936,1.233640915,1.378222718,0.168134535,0.285411474,9.642440375,1,2.996714274,1.035789005,2.893170578,0.003813741,0.022627374,8.746788584,1,2.557523415,1.136735904,2.249883553,0.024456338,0.06401769,Y,-,,"Carboxy-cis,cis-muconate cyclase",C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR019405 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR30344 (PANTHER); PTHR30344:SF4 (PANTHER); SSF75011 (SUPERFAMILY),,
RL4_JR_02612,1692,1409,1631,0,3,0,0,0,0,0,1,1,0,0,2,0,2,3,42.93545872,1,-0.023445241,0.841344026,-0.027866415,0.977768695,0.98879844,6.051692348,0,0.868193208,1.234446934,0.703305411,0.48186544,0.638826716,30.01443532,1,0.041127138,1.029918525,0.039932419,0.968147005,0.981231383,37.3485931,1,-0.462464616,1.010522555,-0.457648979,0.647204649,0.758267423,45.24511476,1,1.091278529,0.666671655,1.636905545,0.101650207,0.193387514,N,-,,Zn(2)-C6 fungal-type DNA-binding domain,"C:nucleus; F:oxidoreductase activity, acting on CH-OH group of donors; F:zinc ion binding; F:oxidoreductase activity; F:catalytic activity; F:flavin adenine dinucleotide binding; P:regulation of transcription, DNA-templated; P:oxidation-reduction process; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR021858 (PFAM); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_02613,17935,8823,9957,5,5,2,0,0,1,0,3,5,2,4,0,0,5,3,244.0719172,1,-0.771009674,0.651758099,-1.182969072,0.236821405,0.410967464,56.77717764,1,-1.187788493,1.163744186,-1.020661162,0.307415001,0.469046524,177.798366,1,-0.951068028,0.636679199,-1.493794723,0.135229281,0.242612306,175.0564642,1,-1.873403335,0.711768072,-2.632041825,0.008487341,0.042626156,160.3918447,1,-1.217442307,0.646689108,-1.882577411,0.05975766,0.128269304,N,-,,patatin-like phospholipase,P:metabolic process,IPR002641 (PFAM); G3DSA:3.40.1090.10 (GENE3D); PTHR10622 (PANTHER); PTHR10622:SF9 (PANTHER); IPR016035 (SUPERFAMILY),,
RL4_JR_02614,529,511,424,0,1,10,0,0,0,0,7,3,0,3,1,0,2,2,52.07139984,1,3.461476997,0.51796743,6.682808216,2.34E-11,9.19E-10,1.886189157,0,2.550130723,1.332797672,1.913366729,0.055701121,0.128641293,79.26778536,1,4.042981439,0.510406073,7.921107623,2.35E-15,2.43E-13,27.28769141,1,2.20352365,0.756053424,2.914507863,0.003562498,0.021394007,27.22807666,1,2.457526454,0.749561496,3.278618854,0.001043164,0.00494246,N,-,,methyltransferase domain-containing,F:methyltransferase activity; F:transferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF923 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_02615,522,305,454,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,5.09229346,0,-0.450899963,1.230182286,-0.366531016,0.713968873,0.846346711,1.63581038,0,2.755509605,1.366999384,2.015735806,0.043827609,0.106358921,4.231487139,0,0.107673442,1.224510533,0.087931822,0.929930865,0.958133531,23.50476631,1,1.4443316,1.038197007,1.39119222,0.164167146,0.284475843,4.164601129,0,0.027871571,1.223985576,0.02277116,0.981832813,0.988176664,N,-,,hypothetical protein SPBR_09042,P:biological_process; C:cellular_component; F:molecular_function,IPR022085 (PFAM),,
RL4_JR_02616,19,16,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.223462458,0,4.059476259,2.824513967,1.437230018,0.150652646,NA,0.071328929,0,7.274794549,2.233628688,3.256939968,0.001126202,0.015023052,0.185123789,0,4.621834946,1.351886043,3.418805135,0.000628968,0.003996829,0.21356064,0,4.199920203,1.751723878,2.397592598,0.016503209,0.069610783,0.182670443,0,4.53867074,1.254583218,3.617672127,0.000297265,0.001736817,Y,-, Effector probability:0.909,arthropod defensin domain-containing,,no IPS match,,
RL4_JR_02617,1698,1326,1974,5,6,5,0,0,0,0,5,9,0,0,5,0,0,0,137.3881754,1,2.368644211,0.43986928,5.384882096,7.25E-08,1.48E-06,6.34886546,0,0.798977189,1.238275433,0.645233821,0.518775672,0.669178967,114.197427,1,2.750189855,0.451546734,6.09059849,1.12E-09,5.81E-08,67.20487103,1,1.2358661,1.550777564,0.796933183,0.425489838,0.568273923,16.298032,0,-1.940428824,1.205837401,-1.609196084,0.107573472,0.201774992,N,-,,SET domain,F:metal ion binding,IPR002893 (PFAM); IPR002893 (PROSITE_PROFILES); SSF144232 (SUPERFAMILY),,
RL4_JR_02618,8,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.079941085,0,5.542454306,3.920092425,1.413858069,0.15740358,NA,0.025728245,0,8.746318596,2.737676335,3.194796436,0.001399295,0.015023052,0.066389199,0,6.102275299,1.545047659,3.949570916,7.83E-05,0.000993261,0.076560536,0,5.680087299,2.555416781,2.222763559,0.026231748,0.086316686,0.065100894,0,6.025567918,1.306169566,4.613159021,3.97E-06,4.68E-05,N,-,,heterokaryon incompatibility -domain-containing partial,C:membrane; C:integral component of membrane,IPR010730 (PFAM); PTHR24148:SF30 (PANTHER); PTHR24148:SF30 (PANTHER); PTHR24148 (PANTHER); PTHR24148 (PANTHER),,
RL4_JR_02619,13,7,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.154147293,0,4.595022976,3.368731045,1.364021917,0.172560668,NA,0.048920795,0,7.818319639,2.45592376,3.183453724,0.001455294,0.015023052,0.127725117,0,5.155649643,1.475115458,3.495082108,0.000473916,0.003250627,0.147383623,0,4.734528442,2.076136487,2.28045144,0.022580928,0.080997621,0.127042108,0,5.062132901,1.324013382,3.823324577,0.000131664,0.000875312,N,-,,hypothetical protein FOWG_14719,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_02620,1938,1848,3267,0,0,3,0,0,0,0,0,0,2,2,0,0,0,0,39.52874769,1,-0.643282763,0.912064384,-0.705304114,0.480621001,0.669325047,8.878211954,0,0.315171762,1.243700082,0.253414603,0.799947844,0.878302645,23.19630531,0,-2.346911729,1.215239669,-1.93123364,0.053454166,0.119083633,53.41769547,1,-0.035013986,0.786446626,-0.044521758,0.964488509,0.979562405,23.05564474,0,-2.44082466,1.228527442,-1.98678888,0.046945797,0.10667105,N,-,,hypothetical protein SPI_04739,,PTHR39472:SF1 (PANTHER); PTHR39472 (PANTHER),,
RL4_JR_02621,2289,2381,3821,0,0,4,0,0,0,0,2,1,3,4,0,0,3,1,49.12535242,1,-0.50739177,0.805076136,-0.630240728,0.528537096,0.712893834,10.70790787,0,0.04484467,1.231377,0.036418311,0.970948814,0.98515877,50.14718624,1,-0.211928028,0.877861726,-0.241413906,0.809234336,0.875380748,76.25324119,1,0.493233929,0.622728808,0.792052533,0.428330046,0.570862408,46.71667267,1,-0.107739169,0.800030037,-0.134668905,0.892873659,0.929885394,N,-,,metaphase-anaphase transition,C:intracellular part,IPR003126 (SMART); IPR003126 (PFAM); PTHR13513 (PANTHER); IPR003126 (PROSITE_PROFILES),,
RL4_JR_02622,1499,1824,1329,0,0,4,0,0,1,0,0,0,2,0,0,0,4,0,34.01136716,1,0.361747425,0.779302942,0.464193584,0.642509058,0.796362353,15.37609302,1,1.796208821,1.143482743,1.57082285,0.116223803,0.227820427,15.50483184,0,-1.765552099,1.205122134,-1.465039973,0.142910012,0.252896515,36.50859072,1,-0.434790374,1.028775583,-0.422628979,0.67256598,0.777330003,30.6511771,1,0.756675268,0.772195323,0.979901388,0.327134798,0.463535508,N,-,,dna replication licensing factor mcm2,"P:DNA replication initiation; P:negative regulation of ATP-dependent DNA helicase activity; P:double-strand break repair via break-induced replication; P:DNA strand elongation involved in DNA replication; C:DNA replication preinitiation complex; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; F:chromatin binding; C:MCM complex; C:nuclear chromosome, telomeric region; F:single-stranded DNA binding; C:nuclear pre-replicative complex; F:DNA replication origin binding; F:ATP binding; F:DNA helicase activity; C:nuclear chromatin; C:cytoplasm; P:DNA duplex unwinding; C:replication fork protection complex",IPR008045 (PRINTS); IPR001208 (PRINTS); IPR031327 (SMART); IPR001208 (PFAM); IPR027925 (PFAM); IPR033762 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.1640.10 (GENE3D); G3DSA:2.40.50.140 (GENE3D); IPR008045 (PFAM); PTHR11630 (PANTHER); IPR008045 (PTHR11630:PANTHER); IPR001208 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR012340 (SUPERFAMILY),,
RL4_JR_02623,1701,1854,1999,19,4,3,0,0,2,2,0,0,0,0,5,0,4,0,256.9909331,1,3.327034068,0.875820044,3.798764472,0.000145419,0.001175807,25.84672317,1,2.282198255,0.985609044,2.315520812,0.020584447,0.058857563,40.54610591,1,-0.184278282,1.027538264,-0.179339581,0.857671069,0.909411595,69.41140979,1,1.077113095,1.547313208,0.696118336,0.486354725,0.626586282,33.59533963,1,0.513240858,0.752296616,0.682232045,0.495092235,0.623251135,N,-,,---NA---,,no IPS match,,
RL4_JR_02624,631,618,1070,0,4,1,0,0,0,0,2,1,0,0,0,0,0,0,45.09291319,1,1.786257696,0.732830548,2.437477124,0.01479015,0.05198537,2.919872541,0,1.919495829,1.302821388,1.47333767,0.140660008,0.262783426,29.81344648,1,1.66137233,0.883712359,1.879992186,0.060109143,0.130394305,8.804134785,0,-1.165530433,1.223868435,-0.95233311,0.340928071,0.487831645,7.581901149,0,-0.836316536,1.234613134,-0.677391575,0.498157542,0.62608582,N,-,,Kinetochore fta4,,IPR025207 (PFAM); PTHR42040 (PANTHER),,
RL4_JR_02625,2219,2527,4986,0,0,0,0,0,0,0,0,0,0,1,0,0,5,0,38.71635234,0,-3.377224437,1.253179382,-2.694924993,0.007040448,0.028679942,12.1699713,0,-0.139803015,1.260129308,-0.110943388,0.911661239,0.950652603,31.92824965,0,-2.807820901,1.235910159,-2.271864893,0.023094672,0.062366086,40.86813773,1,-2.287319496,1.196492196,-1.911687769,0.055916254,0.131283172,51.17181476,1,-0.069820276,0.821036484,-0.085039189,0.932230236,0.955637454,N,-,,hypothetical protein SPBR_01134,P:biological_process; F:ATP binding; F:protein kinase activity; P:protein phosphorylation; C:cellular_component; F:molecular_function,IPR019034 (PFAM),,
RL4_JR_02626,3688,3696,6937,2,0,0,0,0,0,0,0,0,0,5,0,0,0,0,77.10622922,1,-2.149397892,1.06831853,-2.011944782,0.044225758,0.121275205,17.97576715,0,-0.702519012,1.233506626,-0.569529986,0.568996527,0.710158181,47.04455824,0,-3.36700505,1.222060061,-2.755187863,0.005865844,0.021397866,74.35574541,1,-0.820522956,0.766649931,-1.070270698,0.28449748,0.428842785,46.84238602,0,-3.463522078,1.235556178,-2.803208902,0.005059688,0.018083073,N,-,,pyridoxal-dependent decarboxylase,F:lyase activity,IPR015422 (G3DSA:3.90.1150.GENE3D); IPR002129 (PFAM); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR11999 (PANTHER); PTHR11999:SF108 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_02627,844,1000,862,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,26.15093911,1,1.160423034,0.757066492,1.532788792,0.125327903,0.260490454,3.473437585,0,1.669201541,1.270993368,1.313304682,0.189080302,0.329750312,8.997354773,0,-0.980376102,1.198889747,-0.817736664,0.41350757,0.555661089,10.37906226,0,-1.402636037,1.19717917,-1.171617476,0.241350669,0.379806577,8.847380892,0,-1.058954752,1.198022781,-0.883918711,0.376740096,0.51263662,N,-,,tam domain,P:metabolic process; F:methyltransferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_02628,4907,4282,4732,1,4,4,0,0,2,3,0,4,2,0,0,0,0,0,113.0434688,1,-0.000134256,0.497226469,-0.00027001,0.999784563,0.999898937,36.57226625,1,0.952394538,0.986755492,0.965177843,0.334455743,0.497700827,105.3394721,1,0.293502409,0.566133159,0.518433524,0.60415583,0.721228385,71.83966097,1,-2.020931899,1.008992897,-2.002919847,0.045185892,0.115278131,45.40181,0,-3.418477638,1.186582611,-2.88094365,0.003964865,0.014807916,N,-,,UBA TS-N domain-containing,P:biological regulation,IPR001164 (PRINTS); IPR015940 (SMART); IPR001164 (SMART); G3DSA:1.10.8.10 (GENE3D); IPR001164 (PFAM); PTHR23180 (PANTHER); PTHR23180:SF282 (PANTHER); PTHR23180:SF282 (PANTHER); PTHR23180 (PANTHER); IPR001164 (PROSITE_PROFILES); IPR015940 (PROSITE_PROFILES); IPR009060 (SUPERFAMILY); SSF57863 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_02629,11184,12309,16681,0,5,7,0,0,0,2,0,1,0,6,0,0,3,0,227.322591,1,-1.13576836,0.511163333,-2.221928464,0.02628814,0.081901495,50.9028123,0,-2.204180253,1.197731781,-1.840295372,0.065724885,0.146148348,161.2889761,1,-2.446038258,0.862905104,-2.834654988,0.00458752,0.017774226,177.1384558,1,-2.020676296,0.655602219,-3.082168175,0.002054987,0.013484604,142.9764653,1,-2.764451528,0.879023087,-3.144913448,0.00166136,0.007263069,N,-,,calpain family cysteine protease,F:cysteine-type peptidase activity,IPR001300 (SMART); G3DSA:3.90.70.10 (GENE3D); IPR001300 (PFAM); PTHR10183 (PANTHER); PTHR10183 (PANTHER); PTHR10183:SF289 (PANTHER); PTHR10183:SF289 (PANTHER); IPR001300 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY),,
RL4_JR_02630,4093,4739,9677,3,2,6,0,0,0,0,0,1,1,4,2,0,2,0,142.7340151,1,-0.112456844,0.624520105,-0.180069213,0.857098232,0.928096512,23.11271994,0,-1.065142149,1.24878173,-0.852945013,0.393689798,0.557956894,67.18303523,1,-2.772492845,1.239930992,-2.236005763,0.025351394,0.06730916,114.683576,1,-0.626871317,0.684399494,-0.915943571,0.359696492,0.505752949,68.34472273,1,-2.196611812,1.064763968,-2.063003519,0.039112294,0.092396634,N,-,,ribosomal S18,F:structural constituent of ribosome; C:mitochondrial small ribosomal subunit; P:translation,IPR001648 (PFAM); IPR001648 (G3DSA:4.10.640.GENE3D); PTHR13479 (PANTHER); PTHR13479:SF40 (PANTHER); IPR001648 (PRODOM); IPR001648 (SUPERFAMILY),,
RL4_JR_02631,3474,3447,4071,0,0,7,0,0,0,0,0,0,0,3,0,0,0,0,70.69463515,1,-0.0519178,0.577325555,-0.089928117,0.928344338,0.96562962,14.01081462,0,-0.342965061,1.201829202,-0.285369219,0.775361287,0.863959373,36.38254189,0,-2.996220206,1.187482265,-2.523170487,0.0116302,0.036262441,54.00863433,1,-1.111586593,0.848940615,-1.309380861,0.190405371,0.319234043,35.90278989,0,-3.079797258,1.191847119,-2.584053951,0.009764652,0.030761388,N,-,,siderophore esterase,"F:hydrolase activity, acting on ester bonds; C:cytoplasm; P:iron assimilation",IPR029058 (G3DSA:3.40.50.GENE3D); IPR000801 (PFAM); PTHR40841:SF1 (PANTHER); PTHR40841 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_02632,2155,2994,2954,0,0,8,0,0,1,1,1,1,0,3,0,0,0,0,63.10848117,1,0.49565872,0.635162108,0.780365696,0.435175654,0.625844419,19.71690907,1,1.011676414,1.128043734,0.896841481,0.36980351,0.533973056,52.29446655,1,-0.148653255,0.863228522,-0.172206144,0.863275468,0.913345265,43.05335977,1,-0.689810856,0.875378264,-0.788014603,0.430688164,0.57302466,26.53987239,0,-2.643838209,1.206388482,-2.191531374,0.028413362,0.072119651,N,-,,V-type H+-transporting ATPase 21kDa proteolipid subunit,"C:vacuolar proton-transporting V-type ATPase, V0 domain; P:ATP hydrolysis coupled proton transport; C:integral component of membrane; C:endoplasmic reticulum; F:hydrogen-exporting ATPase activity, phosphorylative mechanism; F:proton-transporting ATPase activity, rotational mechanism; P:vacuolar acidification",IPR000245 (PRINTS); G3DSA:1.20.120.610 (GENE3D); IPR002379 (PFAM); PTHR10263:SF18 (PANTHER); PTHR10263 (PANTHER); IPR002379 (SUPERFAMILY); IPR002379 (SUPERFAMILY),3.A.2.2.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_02633,741,902,768,0,0,0,3,0,0,1,0,0,0,5,0,0,0,0,9.694605776,0,-1.379291959,1.201215497,-1.148246891,0.250866657,0.428242349,70.03051116,1,4.064604299,0.852064245,4.770302618,1.84E-06,0.000153879,19.08781939,1,0.147755334,1.196414814,0.123498416,0.901712429,0.939303531,29.30718946,1,1.786807374,0.687439488,2.599221321,0.009343551,0.046058157,7.884789666,0,-0.892764822,1.200233048,-0.743826229,0.45698161,0.588519308,N,-,,gephyrin,P:heterocycle biosynthetic process; P:cofactor biosynthetic process; P:organic cyclic compound biosynthetic process; P:organonitrogen compound biosynthetic process; P:molybdopterin cofactor metabolic process; P:organophosphate biosynthetic process,IPR001453 (SMART); IPR001453 (PFAM); IPR001453 (G3DSA:3.40.980.GENE3D); G3DSA:2.170.190.11 (GENE3D); IPR005110 (PFAM); IPR001453 (TIGRFAM); G3DSA:3.90.105.10 (GENE3D); IPR005111 (G3DSA:2.40.340.GENE3D); IPR005111 (PFAM); IPR001453 (G3DSA:3.40.980.GENE3D); PTHR10192 (PANTHER); PTHR10192:SF5 (PANTHER); PTHR10192:SF5 (PANTHER); IPR001453 (SUPERFAMILY); IPR005111 (SUPERFAMILY); IPR005110 (SUPERFAMILY); IPR001453 (SUPERFAMILY),,
RL4_JR_02634,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_02635,1241,1248,1689,0,0,2,0,0,0,0,2,0,2,2,0,0,0,2,24.32371269,1,-0.439451896,1.022268068,-0.429879314,0.667283434,0.815291037,5.301327672,0,1.059106237,1.240024251,0.854101229,0.393048903,0.557282672,29.48462301,1,0.226804267,1.036991384,0.218713743,0.826873043,0.888311218,42.56911713,1,0.712574535,0.750801061,0.949085679,0.342577037,0.489499365,28.38435148,1,0.007958151,0.983777179,0.008089383,0.993545676,0.995368843,N,-,,rpp14 family,P:RNA phosphodiester bond hydrolysis; P:tRNA processing; C:endoplasmic reticulum; F:ribonuclease activity; P:protein lipoylation,IPR016819 (PIRSF); IPR002759 (PFAM); PTHR10993 (PANTHER); SSF160350 (SUPERFAMILY),,
RL4_JR_02636,1585,1780,2306,0,0,6,0,0,0,0,0,4,0,5,0,0,0,0,45.58884491,1,0.656384768,0.656329069,1.000084864,0.31726944,0.505820616,7.193874731,0,0.618695136,1.229793545,0.503088619,0.614901968,0.746824781,44.73288755,1,0.772249509,0.757776897,1.019098777,0.308156075,0.449340645,41.67972309,1,0.555870683,0.695113315,0.799683549,0.423894167,0.566562905,18.54912686,0,-2.127035216,1.208074862,-1.760681629,0.078292304,0.15857363,N,-,,atp-binding domain 1 family member b,F:ATP binding; C:cytoplasm; P:establishment of mitotic sister chromatid cohesion; P:RNA polymerase II complex import to nucleus; P:RNA polymerase III complex localization to nucleus,IPR004130 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR030231 (PTHR21231:PANTHER); IPR004130 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_02637,4312,5923,10198,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,93.32671716,1,-2.713102437,1.092111055,-2.484273394,0.01298161,0.046674295,25.59997466,0,-1.212591516,1.241214028,-0.976939907,0.328598904,0.491514423,67.15368808,0,-3.880425306,1.235757295,-3.14011928,0.001688791,0.008663744,81.53261905,1,-3.360068941,1.198192911,-2.804280439,0.005042902,0.028194028,66.98543718,0,-3.979553187,1.251063796,-3.180935456,0.001468003,0.006550698,N,-,,mitotic checkpoint bub3,C:bub1-bub3 complex; P:mitotic spindle assembly checkpoint; F:ubiquitin binding; C:mitotic checkpoint complex; C:kinetochore,IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR10971:SF5 (PANTHER); PTHR10971 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_02638,577,557,639,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,23.11251745,1,0.810552444,1.003555363,0.807680846,0.419274333,0.610792859,2.262905631,0,2.287336525,1.292104937,1.770240528,0.076687081,0.164979093,5.871403904,0,-0.364789652,1.194633237,-0.305357026,0.760094248,0.838812383,6.773388418,0,-0.787141264,1.191895404,-0.660411359,0.508989885,0.644211184,20.52001651,1,1.237935523,0.970102932,1.276086777,0.201924845,0.323956435,N,-,,---NA---,,no IPS match,,
RL4_JR_02639,25144,13418,14862,1,0,5,0,0,0,0,0,5,0,2,0,0,0,1,241.8674695,1,-2.584520078,0.723601426,-3.571745419,0.00035461,0.002493887,68.90950664,0,-2.641106954,1.232100496,-2.143580789,0.032066491,0.083353114,209.7006789,1,-2.174274678,0.753117769,-2.887031443,0.003888954,0.016142586,212.3253221,1,-3.998099314,1.068721035,-3.741013025,0.00018328,0.001784337,180.6601358,1,-4.40935618,1.159630198,-3.802381301,0.000143312,0.000942229,N,-,,GATA factor SREP,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR000679 (PRINTS); IPR000679 (SMART); IPR000679 (PFAM); IPR013088 (G3DSA:3.30.50.GENE3D); PTHR10071 (PANTHER); PTHR10071:SF177 (PANTHER); PTHR10071 (PANTHER); PTHR10071 (PANTHER); PTHR10071:SF177 (PANTHER); IPR000679 (PROSITE_PROFILES); IPR000679 (PROSITE_PROFILES); SSF57716 (SUPERFAMILY); SSF57716 (SUPERFAMILY),,
RL4_JR_02640,3580,4965,4925,0,1,16,0,0,0,0,0,4,0,6,2,3,1,9,123.228749,1,0.637539811,0.746069949,0.854530881,0.392810907,0.584985647,17.18344061,0,-0.637434975,1.212372042,-0.525775053,0.599044509,0.734261144,70.67969205,1,-0.483534535,0.763687486,-0.633157599,0.526630732,0.656072876,94.89957922,1,-0.011758364,0.573478124,-0.020503596,0.983641644,0.9896037,162.3427012,1,1.222164425,0.653199767,1.871042348,0.061339212,0.131052863,N,-,,copi-coated vesicle,,IPR013714 (PFAM); PTHR28128:SF1 (PANTHER); PTHR28128 (PANTHER),,
RL4_JR_02641,3949,4305,9346,0,2,2,0,0,0,1,0,2,0,1,0,0,2,1,93.57876463,1,-1.503207067,0.867420881,-1.732961588,0.083102496,0.193581826,21.95244941,0,-0.990838867,1.253125879,-0.790693803,0.429122693,0.591725227,81.72402911,1,-1.255346663,0.92386271,-1.358802178,0.174209283,0.293252692,70.57129602,1,-3.140711105,1.207529765,-2.600938873,0.009296902,0.045866315,72.71582994,1,-1.567908975,0.944498478,-1.66004394,0.096905613,0.186350845,N,-,,bcp1,C:nuclear envelope; P:ribosomal large subunit export from nucleus; C:endoplasmic reticulum; P:protein export from nucleus,IPR025602 (PFAM); IPR025602 (PIRSF); IPR025602 (PANTHER),,
RL4_JR_02642,1775,2116,2204,0,0,4,0,0,0,0,0,0,1,0,0,0,1,0,39.7212227,1,-0.007007791,0.754918192,-0.009282848,0.992593465,0.997238607,7.778814431,0,0.505964019,1.223149735,0.413656648,0.67912558,0.795798695,20.20729076,0,-2.147808879,1.193147546,-1.800120098,0.071841677,0.150180701,32.62639934,1,-1.620609326,1.144270073,-1.416282191,0.1566929,0.274844218,23.79751836,1,-1.301256302,1.127290556,-1.154322012,0.248368175,0.378610023,N,-,,chorismate mutase,,IPR008238 (TIGRFAM); IPR008238 (G3DSA:1.10.590.GENE3D); IPR008238 (PANTHER); IPR008238 (PROSITE_PROFILES); IPR020822 (SUPERFAMILY),,
RL4_JR_02643,7766,7969,7650,0,0,12,0,0,1,0,1,0,1,7,2,0,4,1,139.5913955,1,-0.624175937,0.752587268,-0.829373501,0.406893091,0.598419658,39.35888605,1,-0.523073659,1.111833923,-0.470460244,0.638026231,0.763639767,85.48347917,1,-3.127936937,1.187871667,-2.633228002,0.008457755,0.028647143,146.2236274,1,-0.469303666,0.482881134,-0.97188238,0.331109067,0.47769725,99.17338498,1,-1.228089063,0.665980285,-1.844032159,0.065178454,0.13754311,N,-,,mitochondrial division 1,,IPR020472 (PRINTS); IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22844 (PANTHER); PTHR22844:SF142 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_02644,4255,6543,4501,0,0,9,0,0,0,0,0,0,0,1,0,0,0,2,96.16368905,1,-0.361843192,0.739624674,-0.489225421,0.624682114,0.785111183,19.70457349,0,-0.834917554,1.229584233,-0.679024285,0.497122475,0.652135004,51.03609476,0,-3.484429064,1.21233502,-2.874147002,0.004051204,0.016538058,62.88827719,1,-2.961315039,1.169392749,-2.532352832,0.011329992,0.053630747,64.86042866,1,-1.861888787,0.995511488,-1.870283578,0.061444449,0.131146163,N,-,,norsolorinic acid reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR020471 (PRINTS); IPR023210 (G3DSA:3.20.20.GENE3D); IPR023210 (PFAM); PTHR11732:SF217 (PANTHER); IPR001395 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.6, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_02645,1231,1108,1375,0,0,6,0,0,0,0,0,0,0,4,0,0,0,1,37.74756961,1,1.302669094,0.610980365,2.132096495,0.032998915,0.097502769,4.733834303,0,1.222491228,1.241278237,0.984864788,0.324690492,0.486963573,12.28619876,0,-1.430077417,1.191256485,-1.20047818,0.229953682,0.361067321,30.22003264,1,0.865589815,0.741755747,1.166947231,0.243231681,0.381403247,19.48641562,1,-0.578643671,1.123310283,-0.51512363,0.606466631,0.714673492,N,-,,hypothetical protein SPI_03954,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_02646,663,1050,809,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,10.17586409,0,-1.449236737,1.225120797,-1.182933748,0.236835405,0.410967464,3.236843248,0,1.770966442,1.299590665,1.36271096,0.172973622,0.30857226,8.399018029,0,-0.881116139,1.217474647,-0.723724425,0.469234935,0.606012818,9.69035161,0,-1.303611968,1.218356473,-1.069975822,0.284630192,0.428876495,12.12766677,1,-0.03288217,1.149554294,-0.028604277,0.977180201,0.984962928,N,-,,SAP domain-containing,F:nucleotide binding,IPR003034 (SMART); IPR003034 (G3DSA:1.10.720.GENE3D); IPR003034 (PFAM); PTHR12381 (PANTHER); IPR003034 (PROSITE_PROFILES); SSF68906 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_02647,38058,44715,57036,6,3,13,0,0,2,0,0,1,2,1,0,0,2,0,693.409339,1,-2.054266268,0.422436868,-4.862895322,1.16E-06,1.72E-05,196.0826167,1,-2.366131952,0.995109527,-2.377760324,0.017418143,0.051657324,468.5232936,1,-5.701041928,1.204950744,-4.731348527,2.23E-06,5.33E-05,555.7811897,1,-4.757527259,0.871250004,-5.460576457,4.75E-08,1.16E-06,465.1875614,1,-5.09710819,1.017913003,-5.00741043,5.52E-07,8.66E-06,N,-,,carbamoyl-phosphate synthase subunit arginine-specific small,,PR00099 (PRINTS); PR00097 (PRINTS); PR00096 (PRINTS); IPR002474 (SMART); IPR002474 (PFAM); IPR017926 (PFAM); IPR002474 (G3DSA:3.50.30.GENE3D); IPR006274 (TIGRFAM); IPR029062 (G3DSA:3.40.50.GENE3D); PTHR11405 (PANTHER); PTHR11405:SF45 (PANTHER); IPR017926 (PROSITE_PROFILES); IPR006274 (HAMAP); IPR029062 (SUPERFAMILY); IPR002474 (SUPERFAMILY),,
RL4_JR_02648,33,64,51,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.597849438,0,2.639975607,1.897754831,1.39110467,0.164193689,NA,0.189367348,0,5.866283546,1.881429096,3.117993422,0.001820869,0.015023052,0.492613,0,3.210964325,1.312368765,2.446693651,0.014417332,0.043030977,0.568450321,0,2.78797176,1.442483266,1.932758477,0.053265958,0.127056344,0.486004631,0,3.128202642,1.270009707,2.463132861,0.013772887,0.040573314,N,-,,MFS multidrug transporter,P:transmembrane transport; C:membrane; C:integral component of membrane; F:molecular_function,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501 (PANTHER); PTHR23501:SF44 (PANTHER); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.3.65, the major facilitator superfamily (mfs).
RL4_JR_02649,1330,1289,1346,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,15.87703501,0,-2.091108463,1.183583363,-1.766760609,0.077268328,0.183296023,5.074747403,0,1.122205657,1.238570103,0.906049366,0.364909724,0.529323047,19.64757658,1,-0.566045934,1.187364283,-0.476724745,0.63355814,0.744359129,15.16766108,0,-1.950069825,1.185956702,-1.644301029,0.100114037,0.19595102,12.94332684,0,-1.607908673,1.188902301,-1.352431291,0.176237385,0.293005505,N,-,,kinase-like domain,F:ATP binding; C:membrane; C:integral component of membrane; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,G3DSA:3.90.1200.10 (GENE3D); IPR011009 (SUPERFAMILY),,
RL4_JR_02650,233,390,288,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.67937883,0,0.018476958,1.269990284,0.014548897,0.988392069,0.994241985,1.169976278,0,3.239093347,1.417054708,2.285792729,0.022266387,0.062692732,3.035880403,0,0.587118383,1.236940913,0.47465354,0.635033938,0.745217966,3.50268337,0,0.164577981,1.245510879,0.132136927,0.894875988,0.935144946,2.987606822,0,0.507449181,1.234285435,0.411127902,0.680978751,0.77340548,N,-,,phosphotransferase enzyme family,P:phosphorylation; F:kinase activity; F:hydrolase activity,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); PTHR21310 (PANTHER); PTHR21310:SF18 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_02651,397,521,506,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,5.720659663,0,-0.618319848,1.214576422,-0.509082703,0.610694255,0.776624121,1.819019084,0,2.602360716,1.326230795,1.962223111,0.049736514,0.117350349,4.725773082,0,-0.051487808,1.208155437,-0.042616874,0.966006944,0.979942282,5.452489807,0,-0.474012215,1.208172003,-0.392338354,0.694808229,0.79410016,16.24310249,1,2.05984235,0.865447516,2.380089273,0.017308444,0.04865297,N,-,,phospholipase carboxylesterase,C:membrane; P:proteolysis; F:serine-type peptidase activity,IPR003140 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR10655:SF25 (PANTHER); PTHR10655 (PANTHER); PTHR10655:SF25 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_02652,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,pfs domain-containing,P:proteolysis; C:membrane; C:integral component of membrane; F:serine-type endopeptidase activity,no IPS match,,
RL4_JR_02653,91,149,97,0,0,1,0,0,0,0,0,0,2,0,2,0,0,1,5.181447134,1,2.395510572,1.209432799,1.980689273,0.04762613,0.128250486,0.434427205,0,4.668452541,1.624993073,2.872906118,0.00406715,0.018256181,1.125136229,0,2.019467339,1.266512713,1.594510121,0.110821826,0.209440804,39.19310568,1,4.398440809,0.787518381,5.585191301,2.33E-08,6.06E-07,8.470298963,1,2.883709808,1.157688174,2.490921021,0.012741244,0.038195046,N,-,,C2H2 type zinc finger domain,P:primary metabolic process; P:cellular metabolic process; P:organic substance metabolic process; F:hydrolase activity,PTHR35391 (PANTHER); PTHR35391:SF1 (PANTHER); PTHR35391 (PANTHER),,
RL4_JR_02654,142,229,209,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.335501255,0,0.67414185,1.305052178,0.51656314,0.605461152,0.772618814,0.740479929,0,3.898979978,1.483106761,2.628927385,0.008565465,0.029937719,1.926403443,0,1.243222986,1.240312385,1.002346668,0.316176191,0.458854323,2.222897644,0,0.82050462,1.256945144,0.652776794,0.513900186,0.648860933,1.901945682,0,1.159073801,1.235921702,0.937821384,0.34833621,0.48586639,N,-,,subtilisin-like protease,C:membrane; P:metabolic process; F:peptidase activity,IPR015500 (PRINTS); IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (PFAM); IPR015500 (PANTHER); PTHR10795:SF363 (PANTHER); IPR000209 (SUPERFAMILY),,
RL4_JR_02655,11456,8166,11124,0,0,9,0,0,0,0,0,4,0,1,0,2,2,1,156.8626156,1,-1.255782476,0.610817394,-2.055904903,0.039791683,0.112325451,39.22758989,0,-1.828282843,1.203514358,-1.519120093,0.12873227,0.245668936,127.6238737,1,-1.666816053,0.757116622,-2.201531448,0.027698423,0.072039566,121.2362737,1,-3.953643192,1.150672977,-3.435939898,0.000590502,0.004783066,147.2696948,1,-1.584177397,0.689633047,-2.297130922,0.021611302,0.058195329,N,-,,hypothetical protein FAVG1_00691,,no IPS match,,
RL4_JR_02656,23,9,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.217198536,0,4.100328351,2.930673426,1.399107903,0.161780628,NA,0.069625311,0,7.309504494,2.310476866,3.163634573,0.001558123,0.015023052,0.180623315,0,4.656478899,1.435870112,3.242966657,0.001182921,0.006605564,0.208336915,0,4.235321985,1.873281244,2.260910901,0.023764775,0.083143865,0.17853249,0,4.570424832,1.317692578,3.468506167,0.000523361,0.002809663,N,-,,amidase family,"C:membrane; C:integral component of membrane; F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (PFAM); IPR023631 (G3DSA:3.90.1300.GENE3D); IPR000120 (PANTHER); IPR000120 (PANTHER); IPR000120 (PANTHER); PTHR11895:SF102 (PANTHER); PTHR11895:SF102 (PANTHER); IPR023631 (SUPERFAMILY),,
RL4_JR_02657,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.029648088,0,6.97664877,3.942675632,1.769521366,0.076806908,NA,0.009380309,0,10.20408939,3.94302723,2.58788205,0.009656804,0.032844816,0.024166482,0,7.562206266,3.792600156,1.993937129,0.046158926,0.106304132,0.027885294,0,7.139351614,3.943211133,1.810542569,0.070211689,0.151199763,0.023378497,0,7.509203087,2.346454125,3.200234349,0.001373159,0.006196135,N,-, Effector probability:0.891,dipeptidyl peptidase III,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_02658,52,43,41,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.544318922,0,2.775133803,1.894445941,1.464878856,0.142953973,NA,0.174928368,0,5.980811275,1.879272315,3.182514437,0.001460022,0.015023052,0.45168227,0,3.335938863,1.27727272,2.611767096,0.00900756,0.030116424,0.520913655,0,2.913819694,1.400764709,2.080163553,0.037510534,0.102992322,0.443096047,0,3.259993265,1.228683737,2.653240347,0.007972308,0.026114403,N,-,,hypothetical protein CMQ_1309,,no IPS match,,
RL4_JR_02659,85,45,84,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.848530585,0,2.134411734,1.630875428,1.308752157,0.190618318,NA,0.271874586,0,5.344414627,1.759313238,3.03778458,0.002383243,0.015223444,0.704877056,0,2.692894763,1.286745084,2.092795842,0.036367383,0.088654801,0.813037074,0,2.271041764,1.365698079,1.662916423,0.096329167,0.190546897,0.695709612,0,2.60912892,1.259206643,2.072041896,0.038261534,0.090917164,N,-,,hypothetical protein CMQ_978,,no IPS match,,
RL4_JR_02660,921,1001,1117,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.17113572,0,-1.707663481,1.191465063,-1.433246793,0.151787321,0.299535793,3.875274213,0,1.511206235,1.252080697,1.20695594,0.227449113,0.377069852,10.0660138,0,-1.14246707,1.193114533,-0.957550208,0.338289617,0.481558504,11.61337241,0,-1.564928333,1.190936475,-1.314031743,0.188835522,0.317390382,9.933504675,0,-1.226026137,1.197462299,-1.023853643,0.305904409,0.441082617,N,-,,O-methyltransferase mdmC,F:O-methyltransferase activity; P:methylation,IPR002935 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10509 (PANTHER); PTHR10509:SF31 (PANTHER); IPR002935 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_02661,539,824,742,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,8.474344999,0,-1.185270623,1.222436267,-0.96959707,0.332247374,0.521947636,2.690179358,0,2.037821361,1.304249477,1.56244752,0.1181826,0.230846058,6.993282046,0,-0.616906939,1.214705924,-0.507865259,0.61154784,0.727358851,45.31827252,1,1.749292705,0.774612485,2.258281062,0.023928142,0.083494502,14.26491541,1,0.238516589,1.144882794,0.208332757,0.834969156,0.888417281,N,-,,uncharacterized protein FFUJ_02079,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR007219 (PFAM); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_02662,1045,1117,959,3,0,2,0,1,0,1,2,1,0,5,0,0,0,3,50.3669418,1,1.310479591,0.671940124,1.950292214,0.0511413,0.135194662,42.34773227,1,2.386084926,1.117707244,2.134803133,0.032777094,0.084808218,43.63304188,1,1.639020104,0.744632517,2.20111272,0.027728045,0.072053062,32.0289921,1,1.419308611,0.680671929,2.085158136,0.037054949,0.102305195,32.28991235,1,0.966213172,0.837965165,1.153046943,0.248891117,0.379178838,N,-,,alpha beta hydrolase,C:cellular_component; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR000073 (PFAM); PTHR10992:SF752 (PANTHER); PTHR10992 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_02663,1478,1181,814,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,13.93350919,0,-1.902783344,1.228099102,-1.5493728,0.121292129,0.254370485,4.506676866,0,1.293531236,1.306480071,0.990088762,0.322130736,0.48434452,11.58168492,0,-1.34470217,1.226161135,-1.096676555,0.272782809,0.411634097,13.35318675,0,-1.766219283,1.227606868,-1.438749919,0.15022139,0.266419964,22.88206543,1,0.768520003,0.892496132,0.86109057,0.389188162,0.525263949,N,-,,RNA-dependent RNA polymerase,"F:nucleotide binding; F:RNA-directed RNA polymerase activity; P:transcription, RNA-templated",IPR007855 (PFAM); PTHR23079:SF17 (PANTHER); PTHR23079:SF17 (PANTHER); IPR007855 (PANTHER),,
RL4_JR_02664,124,229,180,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.152671443,0,0.791787625,1.343957757,0.589146215,0.555763194,0.73388089,0.682588835,0,4.0164587,1.520056945,2.642308048,0.008234313,0.029193594,1.774475831,0,1.361854698,1.256288561,1.084030167,0.278351424,0.417300431,2.047563416,0,0.939120551,1.279434055,0.73401247,0.462941138,0.604944777,1.749552286,0,1.2795849,1.249445951,1.024121851,0.305777725,0.44096275,N,-,,short chain dehydrogenase,,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24322:SF476 (PANTHER); PTHR24322:SF476 (PANTHER); IPR002347 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02665,5239,5233,5744,0,1,9,0,0,0,4,1,0,0,1,3,0,2,4,107.2918121,1,-0.098970113,0.488070142,-0.202778462,0.839308193,0.919440881,20.71422336,0,-0.907026262,1.195537177,-0.758676752,0.448045947,0.608851663,105.85607,1,-0.404282504,0.659279796,-0.613218404,0.539731937,0.668026381,94.90490484,1,-1.243475483,0.732703406,-1.697106188,0.089676587,0.180529368,90.14172703,1,-0.421634848,0.612246069,-0.688668934,0.49103163,0.619525888,N,-,,26S protease regulatory subunit 8,"F:protein domain specific binding; C:proteasome regulatory particle, base subcomplex; P:nucleotide-excision repair; P:negative regulation of sequence-specific DNA binding transcription factor activity; F:peptidase activity; P:positive regulation of sequence-specific DNA binding transcription factor activity; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of RNA polymerase II transcriptional preinitiation complex assembly; C:nuclear envelope; P:positive regulation of transcription elongation from RNA polymerase II promoter; F:ATP binding; P:chromatin remodeling; P:nonfunctional rRNA decay; P:proteasome regulatory particle assembly; C:nuclear proteasome complex; F:TBP-class protein binding; P:ER-associated ubiquitin-dependent protein catabolic process; C:proteasome storage granule; F:proteasome-activating ATPase activity",IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005937 (TIGRFAM); G3DSA:1.10.8.60 (GENE3D); IPR003959 (PFAM); PTHR23073 (PANTHER); PTHR23073:SF12 (PANTHER); IPR027417 (SUPERFAMILY),9.B.307.1.2, the ftsh aaa(+) zinc metaloprotease (ftsh) family.
RL4_JR_02666,3968,3029,2956,0,2,2,0,0,3,0,0,3,0,0,0,0,0,0,63.4550153,1,-0.688941107,0.754776831,-0.912774582,0.361361109,0.552574307,40.94457398,1,1.953038164,0.884592408,2.207839617,0.027255455,0.073274826,52.54478596,1,-0.45889188,0.866558944,-0.529556453,0.596419494,0.715675116,38.11180025,0,-3.279332269,1.199264589,-2.734452679,0.006248408,0.033473612,32.40124112,0,-2.931798228,1.196103907,-2.45112336,0.014241114,0.041697882,N,-,,calcium permease,P:potassium ion transport; P:sodium ion transport; P:inorganic cation transmembrane transport; F:monovalent cation:proton antiporter activity; F:metal ion transmembrane transporter activity; C:fungal-type vacuole; C:membrane part; C:intracellular organelle part; P:single-organism transport,IPR004837 (PFAM); IPR005185 (PFAM); PTHR31503:SF10 (PANTHER); PTHR31503 (PANTHER); PTHR31503:SF10 (PANTHER); PTHR31503 (PANTHER); PTHR31503 (PANTHER); PTHR31503:SF10 (PANTHER),2.A.19.7.1, the ca(2+):cation antiporter (caca) family.
RL4_JR_02667,47749,18069,22183,1,13,4,0,0,0,0,1,9,0,4,8,3,20,4,478.5809256,1,-1.462445339,0.845192415,-1.730310534,0.083574809,0.194141112,113.8773496,0,-3.365815946,1.271526579,-2.64706692,0.008119328,0.028934273,358.1055537,1,-1.964504704,0.74342201,-2.6425162,0.008229253,0.027985541,429.4211767,1,-1.951857618,0.769859779,-2.535341721,0.011233768,0.053299861,439.207065,1,-0.806333892,0.594320564,-1.356732275,0.174866293,0.29115626,N,-,,#NAME?,F:phosphatase activity; P:dephosphorylation; P:regulation of biological process,IPR000242 (PRINTS); IPR003595 (SMART); IPR000242 (SMART); IPR001763 (SMART); IPR029021 (G3DSA:3.90.190.GENE3D); IPR000242 (PFAM); IPR001763 (PFAM); IPR001763 (G3DSA:3.40.250.GENE3D); PTHR19134:SF299 (PANTHER); PTHR19134:SF299 (PANTHER); PTHR19134 (PANTHER); PTHR19134 (PANTHER); PTHR19134:SF299 (PANTHER); IPR000242 (PROSITE_PROFILES); IPR001763 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES); IPR029021 (SUPERFAMILY); IPR001763 (SUPERFAMILY),,
RL4_JR_02668,7203,5415,7981,0,2,2,0,1,0,0,0,0,0,3,0,0,4,1,105.6940035,1,-1.732557089,0.757724168,-2.286527423,0.022223422,0.071716248,64.52816852,1,-0.32175134,1.114162859,-0.288783042,0.77274741,0.86209074,67.99777322,0,-3.898454981,1.197295402,-3.256051075,0.001129734,0.00635766,90.47723781,1,-2.025547897,0.870184578,-2.327722126,0.019926863,0.076714457,89.95092721,1,-1.057124422,0.699649717,-1.510933825,0.130805312,0.233292898,N,-, Effector probability:0.762,thioesterase family,F:isomerase activity,IPR029069 (G3DSA:3.10.129.GENE3D); IPR006683 (PFAM); PTHR21660:SF9 (PANTHER); PTHR21660 (PANTHER); IPR029069 (SUPERFAMILY),,
RL4_JR_02669,5904,5982,7528,2,3,2,0,0,0,0,0,1,0,2,0,0,1,0,129.4047739,1,-0.824207221,0.580839166,-1.418993878,0.155900801,0.305216879,24.68850112,0,-1.160277414,1.195334861,-0.970671443,0.331711917,0.494990189,70.69066098,1,-2.853561409,1.191090295,-2.395755738,0.016586139,0.04825232,82.08574804,1,-2.512405123,1.017494118,-2.469208498,0.013541229,0.061620201,67.29571902,1,-2.971110911,1.126912449,-2.636505536,0.008376483,0.027253179,N,-,,Bladder cancer-related BC10,C:integral component of membrane,IPR009598 (SMART); PF06726 (PFAM); PTHR13259:SF1 (PANTHER); IPR009598 (PANTHER); IPR009598 (PRODOM),,
RL4_JR_02670,39560,35589,43591,0,9,13,0,0,0,2,2,9,2,10,0,0,16,0,596.1247978,1,-1.827488259,0.382558694,-4.777014056,1.78E-06,2.52E-05,151.4078661,0,-3.776780814,1.190946358,-3.17124343,0.001517879,0.015023052,489.1944263,1,-1.918075631,0.448534452,-4.276317283,1.90E-05,0.000324943,511.9715289,1,-2.571260571,0.465063615,-5.528836249,3.22E-08,8.14E-07,449.2683926,1,-2.288396468,0.860401151,-2.659685502,0.007821365,0.025770035,N,-,,WD40 repeat-like-containing domain,F:molecular_function,IPR015943 (G3DSA:2.130.10.GENE3D); IPR017986 (SUPERFAMILY),,
RL4_JR_02671,9548,13953,14938,0,1,0,0,0,0,6,1,2,0,7,0,0,3,0,162.3621014,1,-4.419029997,1.173905522,-3.764383006,0.000166961,0.00132368,48.88632648,0,-2.145851701,1.206422415,-1.778690179,0.07529057,0.162631488,214.6092224,1,-0.769030814,0.562709728,-1.366656333,0.171733051,0.290351605,175.0377537,1,-1.771320998,0.647677457,-2.734881348,0.006240277,0.03344775,137.5539335,1,-2.708462578,0.88887087,-3.047082167,0.002310745,0.009592578,N,-,,tRNA (adenine-N(1)-)-methyltransferase non-catalytic subunit,P:cellular macromolecule metabolic process; P:gene expression; P:cellular nitrogen compound metabolic process; F:transferase activity; P:primary metabolic process; C:intracellular part; P:methylation,IPR017423 (PFAM); IPR017423 (PANTHER),,
RL4_JR_02672,6042,6747,7611,0,5,11,0,0,2,0,2,8,2,2,7,0,1,2,163.7624715,1,0.237720376,0.4311233,0.551397652,0.58136111,0.755334732,44.75194827,1,0.409299605,0.981439827,0.417039938,0.676649195,0.793723856,135.231649,1,0.239129994,0.496933065,0.481211678,0.630366062,0.741390235,172.0379112,1,-0.059399869,0.489657515,-0.121309012,0.903446282,0.940993068,85.29149196,1,-1.750774338,0.846088607,-2.069256486,0.038522025,0.091407429,N,-, Effector probability:0.628,ARP2 3 complex ARPC3 subunit,P:endocytosis; C:Arp2/3 protein complex; C:nucleus; P:establishment of mitochondrion localization; C:actomyosin contractile ring; C:cell tip; F:actin binding; C:mitochondrion; C:actin filament bundle; P:Arp2/3 complex-mediated actin nucleation; P:establishment or maintenance of cell polarity regulating cell shape; C:cytosol; C:actin cortical patch; P:actin cortical patch localization,IPR007204 (G3DSA:1.10.1760.GENE3D); IPR007204 (PFAM); IPR007204 (PIRSF); IPR007204 (PANTHER); PTHR12391:SF0 (PANTHER); IPR007204 (SUPERFAMILY),,
RL4_JR_02673,1111,1139,1366,0,0,3,0,0,0,0,0,0,0,3,0,0,0,5,25.91956435,1,0.345159287,0.853332563,0.404483904,0.685856912,0.828896683,4.604607204,0,1.262412536,1.241751651,1.016638501,0.309325432,0.470896679,11.96498953,0,-1.391838693,1.192473612,-1.167186157,0.2431352,0.376779544,25.83915021,1,0.490538046,0.853067146,0.575028646,0.565271923,0.692819056,48.64249214,1,1.502851399,0.679145321,2.212856885,0.026907514,0.069146847,N,-,,hypothetical protein SPI_07217,,no IPS match,,
RL4_JR_02674,134,161,137,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.736879303,0,1.101378983,1.305334829,0.843752084,0.398807956,NA,0.554627198,0,4.315999878,1.526650701,2.827103722,0.004697111,0.01983486,1.436647345,0,1.666655983,1.227679118,1.357566451,0.174601294,0.293485556,1.657274424,0,1.244275565,1.24634261,0.998341511,0.318113785,0.464106927,1.412601968,0,1.58816011,1.213302917,1.308955981,0.190549262,0.31057812,Y,-,,duf1620 domain-containing,C:membrane; C:integral component of membrane,PTHR12231 (PANTHER),,
RL4_JR_02675,48,59,53,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,38.82856149,1,6.454891081,0.609566035,10.58932209,3.34E-26,1.01E-23,0.205034573,0,5.751636041,1.815671819,3.167772932,0.001536114,0.015023052,0.531655343,0,3.100847605,1.265792106,2.44972898,0.014296378,0.042770842,0.613339918,0,2.678256847,1.362342093,1.965920939,0.049307744,0.121802535,0.523359733,0,3.020979015,1.22797889,2.460122921,0.013888944,0.040879522,Y,-,,disulfide isomerase,C:cell; C:nucleus; C:tRNA (m1A) methyltransferase complex; F:tRNA (adenine-N1-)-methyltransferase activity; P:cell redox homeostasis; P:tRNA methylation; F:isomerase activity,IPR013766 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR18929:SF74 (PANTHER); PTHR18929:SF74 (PANTHER); PTHR18929 (PANTHER); PTHR18929 (PANTHER); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY),,
RL4_JR_02676,49,80,80,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.840634278,0,2.148226978,1.633119562,1.315413169,0.188371082,NA,0.266028102,0,5.375807184,1.748448168,3.07461627,0.002107735,0.015045485,0.69311681,0,2.717896434,1.277525079,2.12747012,0.033381041,0.083455984,0.799859439,0,2.295061663,1.354231907,1.694733119,0.09012606,0.181094902,0.685504868,0,2.63171279,1.252370375,2.101385375,0.035607151,0.085913698,N,-,,2OG-Fe(II)oxygenase superfamily,F:oxidoreductase activity; F:ion binding,IPR006620 (SMART); IPR005123 (PFAM); PTHR10869:SF77 (PANTHER); PTHR10869 (PANTHER),,
RL4_JR_02677,492,559,771,0,0,3,0,0,1,0,2,2,0,0,0,0,9,0,18.73655364,1,1.316835949,0.887794698,1.483266291,0.138003675,0.278809801,11.68471243,1,3.175081425,1.138967441,2.787684099,0.005308628,0.02143356,34.69723091,1,2.417470293,0.761985382,3.172594055,0.001510836,0.007929344,6.939838573,0,-0.822233154,1.212698624,-0.678019367,0.497759413,0.636099213,40.70588542,1,3.185309501,0.627568335,5.075637703,3.86E-07,6.42E-06,Y,-,,cellulase,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR013781 (G3DSA:3.20.20.GENE3D); IPR001547 (PFAM); PTHR34142 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_02678,175,143,167,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.937189569,0,0.943598638,1.267135139,0.744670879,0.456470708,NA,0.620281829,0,4.154541003,1.49528442,2.778428603,0.005462252,0.021922645,1.60621106,0,1.505223138,1.21905396,1.234746932,0.216924703,0.345631995,1.85269512,0,1.083100827,1.231870434,0.879232749,0.379275091,0.525042426,1.580961607,0,1.425218198,1.207649991,1.180158332,0.237937248,0.366898811,Y,-,,acid phosphatase,"F:hydrolase activity, acting on ester bonds",IPR007312 (PFAM); PTHR31956 (PANTHER); PTHR31956:SF8 (PANTHER),,
RL4_JR_02679,2272,2616,2868,3,2,9,0,0,0,0,0,2,2,2,1,0,0,0,111.6656994,1,1.460922707,0.439389004,3.32489592,0.000884515,0.005413261,9.887678178,0,0.159873357,1.213842316,0.131708505,0.895214858,0.941970775,38.69220572,1,-0.674562537,1.03303957,-0.652988091,0.513763956,0.644768351,65.92862841,1,0.142642647,0.6693198,0.213115833,0.831236616,0.894259752,25.36473535,0,-2.578504297,1.196804764,-2.154490336,0.031201739,0.077610944,N,-,,replication factor C,C:Ctf18 RFC-like complex; F:ATPase activity; C:nucleus; C:Elg1 RFC-like complex; F:DNA binding; F:ATP binding; P:sister chromatid cohesion; P:leading strand elongation; C:cytosol; C:DNA replication factor C complex; C:Rad17 RFC-like complex,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.8.60 (GENE3D); IPR013748 (PFAM); IPR003959 (PFAM); G3DSA:1.20.272.10 (GENE3D); PTHR11669:SF18 (PANTHER); PTHR11669 (PANTHER); IPR027417 (SUPERFAMILY); IPR008921 (SUPERFAMILY),,
RL4_JR_02680,68,84,77,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.920150163,0,2.017838535,1.52211923,1.325677053,0.184946692,NA,0.29326132,0,5.235301171,1.696736573,3.085512068,0.00203202,0.015023052,0.760695648,0,2.583927018,1.248149021,2.070207142,0.038432951,0.092597619,0.877588118,0,2.161388169,1.303471059,1.658178871,0.097281368,0.192062179,0.749124748,0,2.503468591,1.222427149,2.047949109,0.040564986,0.095206417,N,-,,hypothetical protein FIBSPDRAFT_875427,,no IPS match,,
RL4_JR_02681,23,20,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.248268175,0,3.907672061,2.698749401,1.44795662,0.147629183,NA,0.0796966,0,7.115013115,2.190679478,3.247856743,0.001162778,0.015023052,0.205913098,0,4.469306997,1.341521568,3.331520791,0.000863728,0.005119665,0.23748523,0,4.047003943,1.694973298,2.38765056,0.016956456,0.070747485,0.202107938,0,4.392487954,1.248076207,3.519406853,0.000432513,0.00240615,N,-,,---NA---,,no IPS match,,
RL4_JR_02682,2876,2244,2674,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.11329092,0,-3.061875817,1.18703209,-2.579438115,0.009896119,0.037620008,9.969381671,0,0.148025822,1.220744805,0.121258613,0.9034862,0.945717406,25.80695244,0,-2.500726412,1.192102819,-2.097743897,0.035927775,0.087867604,29.76636985,0,-2.922824129,1.190826264,-2.454450508,0.014110009,0.063721604,25.39554578,0,-2.580325501,1.19263112,-2.163557078,0.030498359,0.076095584,Y,-,,histidine phosphatase,P:dephosphorylation; F:acid phosphatase activity,IPR000560 (PFAM); IPR016274 (PIRSF); IPR029033 (G3DSA:3.40.50.GENE3D); PTHR20963 (PANTHER); PTHR20963:SF20 (PANTHER); PTHR20963:SF20 (PANTHER); IPR029033 (SUPERFAMILY),,
RL4_JR_02683,9,17,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.153717272,0,4.599427357,3.352610267,1.371894432,0.170096304,NA,0.048808049,0,7.822417907,2.438043367,3.208481856,0.001334377,0.015023052,0.126725011,0,5.170503013,1.447141452,3.572907823,0.000353039,0.002629723,0.146218897,0,4.74694763,2.046676563,2.319344304,0.020376375,0.077502177,0.124746679,0,5.091814986,1.295482216,3.930439895,8.48E-05,0.000604155,N,-,,cytochrome P450,F:oxidoreductase activity; F:binding,IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305 (PANTHER); PTHR24305:SF90 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_02684,2,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.015927524,0,7.869332732,3.973176761,1.980614809,0.047634487,NA,0.00517839,0,11.06015741,3.759614657,2.941832721,0.003262761,0.016208996,0.013285358,0,8.423639838,2.241829332,3.757484888,0.00017163,0.001605896,0.015314398,0,8.001728236,3.972774847,2.014140882,0.043994744,0.113902079,0.012960057,0,8.348352688,1.510574778,5.526606699,3.26E-08,1.06E-06,,,,,,,,
RL4_JR_02685,302,288,282,5,3,4,0,0,0,0,0,0,0,0,0,0,2,0,93.12500855,1,4.426998407,0.448751454,9.865145556,5.89E-23,1.17E-20,1.118439076,0,3.304084806,1.384788843,2.385984566,0.017033466,0.050877602,2.894531932,0,0.655804966,1.205612357,0.543960057,0.58646896,0.7068644,3.338718603,0,0.233653951,1.206840564,0.193607969,0.846482858,0.903738755,10.5666523,1,2.24717074,0.97380307,2.307623388,0.021020093,0.056875584,Y,-,,arylsulfatase,P:phenol-containing compound metabolic process; F:arylsulfatase activity,IPR012083 (PIRSF); G3DSA:3.30.1120.10 (GENE3D); IPR000917 (PFAM); IPR017849 (G3DSA:3.40.720.GENE3D); PTHR10342 (PANTHER); PTHR10342 (PANTHER); PTHR10342:SF218 (PANTHER); IPR017850 (SUPERFAMILY),2.A.127.1.2, the enterobacterial cardiolipin transporter (clt) family.
RL4_JR_02686,2091,1932,2268,0,0,7,0,0,0,0,0,0,0,1,0,0,0,0,51.8801873,1,0.764934092,0.564038388,1.356173814,0.175043872,0.329972117,8.028978766,0,0.4602981,1.217867216,0.377954258,0.705464575,0.814787569,20.82754834,0,-2.191481256,1.187603414,-1.845297201,0.064994317,0.138731282,28.03822152,1,-1.666271664,1.138040801,-1.464158106,0.143150754,0.257086569,20.53315368,0,-2.273667524,1.190914599,-1.90917764,0.05623918,0.122470334,N,-,,---NA---,,no IPS match,,
RL4_JR_02687,1873,1244,1687,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,19.13050437,0,-2.360261764,1.19855447,-1.969256987,0.048923588,0.130443857,6.137683507,0,0.847825541,1.250842684,0.677803493,0.497896296,0.652642619,22.38230233,1,-0.838740534,1.201191316,-0.69825724,0.485016335,0.620850345,18.31962266,0,-2.222561143,1.201991127,-1.849066181,0.064448257,0.142818692,15.63363337,0,-1.880423483,1.205187965,-1.56027403,0.118695138,0.217321568,N,-,,short-chain dehydrogenase,F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process; C:cellular_component,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24320 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02688,2263,1553,2870,0,0,3,0,0,0,0,0,0,2,2,1,0,0,0,38.0083662,1,-0.556517597,0.899814744,-0.618480194,0.53625885,0.719539424,8.453526151,0,0.385910038,1.246046879,0.309707479,0.756783415,0.852170622,22.00125326,0,-2.270607863,1.212516126,-1.872641373,0.061117924,0.132156742,61.66689983,1,0.376612555,0.707977867,0.531955267,0.594756978,0.717615452,21.79264095,0,-2.359567581,1.222584592,-1.929983083,0.053608934,0.11807493,N,-,,hypothetical protein SPI_07209,C:membrane; C:integral component of membrane,PTHR12231 (PANTHER),,
RL4_JR_02689,2047,1535,2665,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,28.65591035,1,-1.790636426,1.163389648,-1.539154513,0.123766579,0.258298223,7.901636021,0,0.483306989,1.241250865,0.389370918,0.697001782,0.807676249,20.56950819,0,-2.173538812,1.208076364,-1.799173361,0.071991262,0.150369205,23.7326942,0,-2.596071687,1.208737051,-2.147755531,0.031733181,0.095261147,28.09542371,1,-0.605037311,1.008399224,-0.599997796,0.548507705,0.668750672,N,-,,p63 related,C:membrane; C:integral component of membrane,no IPS match,8.A.23.1.4, the basigin (basigin) family.
RL4_JR_02690,11,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100130011,0,5.21763594,3.91740922,1.331909853,0.182889813,NA,0.032414903,0,8.413285704,2.64045518,3.186301274,0.001441044,0.015023052,0.08328612,0,5.775940629,1.519053402,3.802328884,0.000143342,0.001426939,0.096022153,0,5.353509617,2.371004813,2.257907528,0.023951425,0.083537093,0.081275051,0,5.704955249,1.303839177,4.375505316,1.21E-05,0.000118061,N,-,,p63 related,,no IPS match,,
RL4_JR_02691,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.023765515,0,7.291767558,3.951391854,1.845366855,0.064984191,NA,0.00801766,0,10.43077191,3.949162813,2.641261555,0.008259793,0.029217138,0.02010604,0,7.826608423,2.804730448,2.790502891,0.005262623,0.019647061,0.023140929,0,7.406611064,3.950587192,1.874812706,0.060818495,0.137784371,0.019164096,0,7.780288866,1.717906591,4.528935918,5.93E-06,6.54E-05,N,-,,p63 related,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_02692,1,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.020137004,0,7.532070575,3.959425631,1.902313941,0.057130124,NA,0.00635021,0,10.76388836,3.598755407,2.991003039,0.002780627,0.015349618,0.016578504,0,8.1036955,2.10844956,3.843438162,0.000121323,0.001301133,0.019134407,0,7.680437669,3.959684783,1.939658859,0.052421163,0.126072273,0.016425528,0,8.020782431,1.468643254,5.461355174,4.73E-08,1.26E-06,,,,,,,,
RL4_JR_02693,18,34,35,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,30.89854627,1,6.962991039,0.75359166,9.239740043,2.47E-20,3.36E-18,0.11045639,0,6.643823934,2.082274405,3.190657254,0.001419496,0.015023052,0.288336841,0,3.983175793,1.353291514,2.943324296,0.003247081,0.014361488,0.332784236,0,3.56018174,1.607104916,2.215276491,0.026741092,0.086975124,0.285689381,0,3.895161639,1.284120103,3.033331252,0.002418699,0.009938852,Y,-,,hypothetical protein G647_03043,F:nucleotide binding; P:tRNA aminoacylation for protein translation; F:ATP binding; F:aminoacyl-tRNA ligase activity; C:cytoplasm; F:proline-tRNA ligase activity; P:prolyl-tRNA aminoacylation,PTHR34587 (PANTHER); PTHR34587:SF1 (PANTHER),,
RL4_JR_02694,16,19,18,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,7.849918363,1,5.850391056,1.055277735,5.543934891,2.96E-08,6.54E-07,0.067840595,0,7.347273748,2.257084051,3.255206091,0.001133101,0.015023052,0.175974054,0,4.695960624,1.359000597,3.455451479,0.000549372,0.003630446,0.203013516,0,4.273267876,1.782451725,2.397410161,0.016511429,0.069610783,0.17332357,0,4.615697608,1.255515394,3.67633693,0.000236607,0.001437963,Y,-,,---NA---,,no IPS match,,
RL4_JR_02695,13,15,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.203551035,0,4.194117662,2.96536817,1.414366588,0.157254295,NA,0.064310345,0,7.423931044,2.293237428,3.237314617,0.001206603,0.015023052,0.16803007,0,4.761009341,1.389803552,3.425670725,0.000613283,0.003922224,0.193923965,0,4.338922934,1.842356749,2.355093787,0.018518031,0.074196702,0.16692258,0,4.670087173,1.281888776,3.64312978,0.000269343,0.001606064,N,-,,transcription factor,,IPR001005 (SMART); IPR001005 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); IPR009057 (G3DSA:1.10.10.GENE3D); IPR009057 (G3DSA:1.10.10.GENE3D); PTHR10641 (PANTHER); PTHR10641:SF538 (PANTHER); IPR017930 (PROSITE_PROFILES); IPR017930 (PROSITE_PROFILES); IPR017877 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY),,
RL4_JR_02696,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.00781203,0,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,0,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,0,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,0.007662926,0,9.0007212,4.037607722,2.229221316,0.025799183,0.085851084,0.006329724,0,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,N,-,,copper amine oxidase,P:amine metabolic process; F:copper ion binding; F:quinone binding; F:primary amine oxidase activity; P:oxidation-reduction process,G3DSA:3.10.450.40 (GENE3D); G3DSA:3.10.450.40 (GENE3D); IPR015798 (PFAM); IPR015798 (G3DSA:2.70.98.GENE3D); IPR000269 (PANTHER); PTHR10638:SF27 (PANTHER); IPR016182 (SUPERFAMILY); IPR016182 (SUPERFAMILY); IPR015798 (SUPERFAMILY),,
RL4_JR_02697,26,56,54,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.548263965,0,2.764838456,1.997438702,1.384191892,0.166299705,NA,0.172800231,0,5.998237935,1.92860203,3.110148098,0.001869936,0.015023052,0.45119359,0,3.337290006,1.335766475,2.498408269,0.012475242,0.038388862,0.520764746,0,2.914193198,1.49045375,1.955238932,0.050554875,0.124029104,0.447003956,0,3.248888533,1.291524914,2.515544607,0.011884864,0.03613641,N,-, Effector probability:0.804,#NAME?,,IPR016040 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR15020 (PANTHER); PTHR15020:SF24 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02698,623,429,610,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,6.617283968,0,-0.828830672,1.207420953,-0.68644715,0.492431181,0.680083557,2.118962367,0,2.382143109,1.319026693,1.805985521,0.070920601,0.15538059,5.490742092,0,-0.268175169,1.209226942,-0.22177406,0.824489773,0.886578276,22.37971787,1,2.0110344,0.768380795,2.617236679,0.008864485,0.044169741,5.411710992,0,-0.349977095,1.210810615,-0.28904363,0.77254799,0.842620748,N,-,,fungal Zn binuclear cluster domain-containing,,PTHR31263:SF4 (PANTHER); PTHR31263 (PANTHER),,
RL4_JR_02699,7109,8884,9318,4,4,7,0,0,0,0,3,6,3,17,4,3,0,2,200.5816892,1,-0.11718756,0.440709682,-0.26590648,0.790311234,0.892336706,32.27608019,0,-1.546882114,1.198220157,-1.290983218,0.196709497,0.340067212,146.4225249,1,-0.223432265,0.526606351,-0.42428707,0.671356468,0.77398244,231.4803333,1,0.645675075,0.374076594,1.726050453,0.084338336,0.17222747,145.63656,1,-1.219666653,0.709681567,-1.71861115,0.0856852,0.170076975,N,-,,vacuolar carboxypeptidase,"F:peptidase activity, acting on L-amino acid peptides",IPR011650 (G3DSA:3.30.70.GENE3D); IPR017141 (PIRSF); G3DSA:3.40.630.10 (GENE3D); IPR011650 (PFAM); IPR002933 (PFAM); PTHR11014 (PANTHER); PTHR11014:SF94 (PANTHER); IPR011650 (SUPERFAMILY); SSF53187 (SUPERFAMILY),,
RL4_JR_02700,2406,1685,2986,0,0,3,0,0,0,0,1,1,0,3,5,0,5,0,39.57609072,1,-0.635576868,0.892851784,-0.711850364,0.476557441,0.665825587,8.956798494,0,0.302483995,1.240100098,0.243919016,0.807293541,0.883358844,37.64285341,1,-0.533538005,1.051923892,-0.507202098,0.612013023,0.727602392,87.09430123,1,0.990861021,0.595751857,1.663210967,0.096270213,0.190526956,42.37044982,1,0.445439846,0.740327529,0.60167943,0.547387545,0.667988296,N,-, Effector probability:0.574,NACHT nucleoside triphosphatase,,no IPS match,,
RL4_JR_02701,2034,1063,1232,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,37.35806013,1,-0.43450754,1.053290193,-0.412524054,0.679955354,0.82423117,5.579033589,0,0.985538936,1.2983411,0.759075513,0.447807387,0.608802825,14.35189611,0,-1.654185289,1.228644044,-1.346350309,0.178189568,0.298256704,26.18186321,1,-1.121572931,1.181644469,-0.949162765,0.342537836,0.489499365,14.04147594,0,-1.725479735,1.229041383,-1.403923219,0.160341715,0.271981883,N,-, Effector probability:0.616,hypothetical protein SPI_08080,,no IPS match,,
RL4_JR_02702,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003880053,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,0,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,Stage V sporulation K,F:nucleotide binding; P:biological_process; F:ATP binding; C:cellular_component,IPR000641 (PRINTS); IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003959 (PFAM); PTHR13779 (PANTHER); PTHR13779:SF20 (PANTHER); PTHR13779 (PANTHER); PTHR13779:SF20 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.24.5.1, the type vii or esx protein secretion system (t7ss) family.
RL4_JR_02703,449,421,388,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.042382029,0,-0.436293112,1.202337515,-0.362870747,0.71670144,0.848021123,1.616720563,0,2.772517151,1.340814382,2.067785957,0.038660155,0.096383765,4.179495532,0,0.125832608,1.203766716,0.104532386,0.916746868,0.950255482,4.820557263,0,-0.296213448,1.202692304,-0.246291963,0.805456231,0.875495903,4.103805147,0,0.049209653,1.197111075,0.041107006,0.967210589,0.978517907,N,-, Effector probability:0.771,Isochorismatase hydrolase,F:catalytic activity,IPR000868 (G3DSA:3.40.50.GENE3D); IPR000868 (PFAM); PTHR11080 (PANTHER); IPR000868 (SUPERFAMILY),,
RL4_JR_02704,23,27,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.281796316,0,3.725012724,2.563931663,1.452851797,0.146264907,NA,0.090244208,0,6.935761071,2.144474897,3.234246799,0.00121964,0.015023052,0.233251109,0,4.290082852,1.337610416,3.207273807,0.001339994,0.007246847,0.269038383,0,3.867248322,1.645440185,2.350281923,0.018759197,0.074426671,0.228776982,0,4.214811886,1.250390016,3.370797776,0.000749509,0.003788704,N,-,,hypothetical protein V502_09458,,no IPS match,,
RL4_JR_02705,52,29,36,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,8.102730266,1,4.708219562,1.063961489,4.425178552,9.64E-06,0.000112464,0.150331254,0,6.199408445,1.961539294,3.160481396,0.001575087,0.015023052,0.387491661,0,3.556611915,1.314600336,2.70547011,0.006820779,0.024094055,0.446803775,0,3.135007876,1.482660386,2.114447722,0.034477045,0.099396379,0.379886316,0,3.481302057,1.255212255,2.773476791,0.00554608,0.019504709,N,-,,Intracellular serine protease,P:proteolysis; F:serine-type endopeptidase activity; F:peptidase activity; P:cytolysis in other organism; C:extracellular region,IPR000209 (SUPERFAMILY),,
RL4_JR_02706,16,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.070611731,0,5.721002192,3.921844868,1.458752803,0.144633157,NA,0.023875713,0,8.854922489,3.305547417,2.678806676,0.007388504,0.027008464,0.059915679,0,6.250200828,2.165792431,2.885872504,0.003903302,0.016192218,0.068954882,0,5.830975741,3.279194377,1.778173256,0.075375404,0.159426774,0.057268128,0,6.207809394,1.78683076,3.4742011,0.000512377,0.002762415,N,-,,serine ase,P:proteolysis; F:serine-type endopeptidase activity; P:cytolysis in other organism; C:extracellular region,G3DSA:1.20.5.300 (GENE3D),,
RL4_JR_02707,37,35,35,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.428564852,0,3.120081519,2.107680762,1.480338757,0.138782865,NA,0.137171373,0,6.331539062,1.960879214,3.228928643,0.001242549,0.015023052,0.355073202,0,3.683032537,1.28578909,2.864414208,0.004177813,0.016830951,0.40956565,0,3.260722717,1.456208467,2.239186758,0.025143767,0.085659704,0.349161548,0,3.604213979,1.230187685,2.929808209,0.003391713,0.013072361,N,-,,neutral alkaline non-lysosomal ceramidase,,IPR010730 (PFAM); PTHR33112:SF6 (PANTHER); PTHR33112 (PANTHER); PTHR33112 (PANTHER); PTHR33112:SF6 (PANTHER),,
RL4_JR_02708,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.015598098,0,7.897226533,3.974462125,1.986992525,0.046923225,NA,0.005173869,0,11.06112819,3.972197013,2.784637357,0.005358762,0.021575731,0.013163741,0,8.434663406,2.923591714,2.885034652,0.003913706,0.016192218,0.015162248,0,8.01507741,3.973383284,2.01719211,0.043675469,0.113446415,0.012785134,0,8.357399562,1.610627411,5.188909306,2.12E-07,4.23E-06,Y,-, Effector probability:0.688,---NA---,,no IPS match,,
RL4_JR_02709,1,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.036367992,0,6.679190678,3.936010002,1.696944539,0.089707146,NA,0.011364897,0,9.923974403,3.304196637,3.003445464,0.002669414,0.015349618,0.029826272,0,7.256289866,1.93461134,3.750773974,0.00017629,0.001628499,0.03443735,0,6.832645641,3.627452579,1.883593373,0.059619999,0.136354635,0.029686193,0,7.168275379,1.426437213,5.025300317,5.03E-07,7.99E-06,Y,-, Effector probability:0.564,mannose-6-phosphate class i,,no IPS match,,
RL4_JR_02710,94,110,70,0,0,0,0,0,0,0,0,0,0,4,0,0,0,1,1.104667643,0,1.754252898,1.482856372,1.183022801,0.236800111,NA,0.354654974,0,4.961219037,1.674226755,2.963289783,0.003043699,0.015677493,0.914855329,0,2.318091358,1.264700703,1.832916951,0.066814922,0.141584479,17.10145767,1,4.581929246,0.798827422,5.735818679,9.70E-09,2.67E-07,8.260697142,1,3.184568107,1.146461046,2.777737735,0.005473878,0.019284278,N,-,,serine threonine- kinase eg2,F:nucleotide binding; C:spindle midzone; P:mitotic cell cycle checkpoint; P:establishment of localization; P:meiotic chromosome segregation; P:mitotic sister chromatid segregation; F:protein kinase activity; C:protein complex; P:protein phosphorylation; P:regulation of cell cycle process; P:protein localization to chromosome,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR030616 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_02711,12,9,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.116031574,0,5.004987779,3.748275497,1.335277458,0.181785553,NA,0.037425068,0,8.205732575,2.553726124,3.213239077,0.00131247,0.015023052,0.09641227,0,5.564337428,1.470259356,3.784595829,0.000153959,0.001507424,0.111172946,0,5.142048767,2.227724295,2.30820698,0.020987627,0.078455086,0.094360794,0,5.49009865,1.287095787,4.265493451,1.99E-05,0.000179355,N,-,,quinate permease,C:integral component of plasma membrane; F:sugar:proton symporter activity; P:hexose transmembrane transport; P:glucose import; F:glucose transmembrane transporter activity,IPR003663 (PRINTS); IPR005828 (PFAM); IPR003663 (TIGRFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500 (PANTHER); PTHR23500:SF125 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.119, the major facilitator superfamily (mfs).
RL4_JR_02712,20,21,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.213625199,0,4.124586508,2.914625746,1.415134177,0.157029159,NA,0.06885898,0,7.326176621,2.288596474,3.201165738,0.001368728,0.015023052,0.177172538,0,4.687318179,1.398382524,3.351957063,0.000802425,0.004831005,0.204299446,0,4.264492452,1.830689757,2.329445738,0.019835464,0.076540006,0.172919304,0,4.617954062,1.276267354,3.618328126,0.000296512,0.00173511,N,-,,Aromatic-ring hydroxylase partial,P:secondary metabolite biosynthetic process; F:monooxygenase activity,PR00420 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR002938 (PFAM); PTHR13789 (PANTHER); PTHR13789:SF199 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_02713,1542,1658,1068,0,0,0,0,0,2,0,0,2,3,3,0,0,4,0,17.18933308,0,-2.205678019,1.217454349,-1.811713121,0.070030535,0.171015637,24.28497076,1,2.621903775,1.036628467,2.529260827,0.011430305,0.037213749,27.2446596,1,0.170047018,1.059660701,0.160473082,0.872508425,0.919366704,56.40178358,1,1.255717051,0.662730047,1.894764024,0.058123671,0.134694836,29.37402892,1,0.872516867,0.790362251,1.103945521,0.269616771,0.401924294,Y,-,,Piso0_004744 partial,C:membrane; C:integral component of membrane,PTHR35204 (PANTHER); PTHR35204:SF1 (PANTHER); PTHR35204 (PANTHER); PTHR35204 (PANTHER); PTHR35204:SF1 (PANTHER); PTHR35204:SF1 (PANTHER),,
RL4_JR_02714,17,19,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.185676165,0,4.326893925,3.099343262,1.396067992,0.162694021,NA,0.059837724,0,7.52882792,2.357456425,3.193623365,0.001404993,0.015023052,0.153932559,0,4.89039473,1.424975691,3.431914497,0.000599336,0.003859849,0.177502113,0,4.467384748,1.925507938,2.320107157,0.020335081,0.077461512,0.150164052,0,4.821742069,1.28623347,3.748730057,0.000177732,0.001125149,N,-,,NAD dependent epimerase dehydratase,,IPR016040 (G3DSA:3.40.50.GENE3D); IPR008030 (PFAM); G3DSA:3.90.25.10 (GENE3D); PTHR10366 (PANTHER); PTHR10366:SF366 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02715,131,78,90,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.191257141,0,1.645047082,1.442102448,1.140728306,0.253983004,NA,0.384533902,0,4.844428153,1.653418808,2.929946199,0.003390207,0.016488617,0.991047841,0,2.201943576,1.262187048,1.744546166,0.081063899,0.164467116,1.142750774,0,1.780265464,1.307165487,1.361928144,0.173220563,0.29641004,0.971249472,0,2.127671564,1.236906896,1.720154985,0.085404273,0.169685688,N,-,,Zinc-regulated transporter 1,C:membrane; F:zinc ion transmembrane transporter activity; C:cell part; P:zinc II ion transmembrane transport,IPR003689 (PFAM); IPR004698 (TIGRFAM); PTHR11040:SF32 (PANTHER); PTHR11040 (PANTHER),2.A.5.1.1, the zinc (zn(2+))-iron (fe(2+)) permease (zip) family.
RL4_JR_02716,1,17,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.122469153,0,4.927369454,3.915471437,1.258435806,0.208234189,NA,0.038123864,0,8.178489289,2.888846037,2.831057518,0.004639438,0.019681638,0.100079113,0,5.510408049,1.850244139,2.978205921,0.002899411,0.013288202,0.115567192,0,5.086243064,2.657519911,1.91390591,0.055632179,0.130813304,0.099427782,0,5.418855735,1.594879111,3.397659232,0.00067965,0.003503798,N,-,,Major facilitator superfamily general substrate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23502:SF2 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.86, the major facilitator superfamily (mfs).
RL4_JR_02717,1028,785,1300,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,12.38427378,0,-1.732926968,1.208648318,-1.433772705,0.151637136,0.299456732,3.942341412,0,1.486395854,1.27061697,1.169822133,0.242072555,0.394312584,10.25708392,0,-1.169720707,1.208423987,-0.967972102,0.333058303,0.476456444,11.83409652,0,-1.592215941,1.208184388,-1.317858397,0.187551055,0.315493343,33.3161356,1,1.885980159,0.68552481,2.751147924,0.005938682,0.020620423,N,-,,Peptidase cysteine trypsin partial,C:membrane; C:integral component of membrane,G3DSA:2.40.10.10 (GENE3D),,
RL4_JR_02718,61,93,72,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.911526763,0,2.031500487,1.569879263,1.294048871,0.195648541,NA,0.290136559,0,5.250792654,1.719585494,3.053522301,0.002261719,0.015081,0.752594033,0,2.599597678,1.267124868,2.051571825,0.040211293,0.096059256,0.868281105,0,2.176905403,1.332007781,1.634303818,0.102195072,0.199138781,0.740576043,0,2.520174131,1.239294683,2.033555187,0.041996464,0.097718442,N,-,,hypothetical protein AOL_s00007g432,,no IPS match,1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_02719,5,4,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.071392318,0,5.705427545,3.921683256,1.454841499,0.145713147,NA,0.022543485,0,8.935667567,2.826664954,3.161205064,0.001571178,0.015023052,0.059006866,0,6.269203115,1.616037845,3.879366523,0.000104729,0.001196699,0.068102495,0,5.848329611,2.709719644,2.158278487,0.030906186,0.094084527,0.058798379,0,6.174851928,1.342882693,4.598206499,4.26E-06,5.00E-05,N,-, Effector probability:0.778,Acyl-coenzyme A thioesterase mitochondrial,F:hydrolase activity,IPR029069 (G3DSA:3.10.129.GENE3D); PTHR12655:SF0 (PANTHER); PTHR12655:SF0 (PANTHER); PTHR12655 (PANTHER); PTHR12655 (PANTHER); IPR033120 (PROSITE_PROFILES); IPR029069 (SUPERFAMILY),,
RL4_JR_02720,7,11,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.116612542,0,4.997866532,3.749172283,1.333058647,0.182512558,NA,0.036929439,0,8.224465902,2.555526497,3.218305861,0.001289502,0.015023052,0.09617788,0,5.567315466,1.474961325,3.774550134,0.000160297,0.001544095,0.110986432,0,5.144391518,2.234936147,2.301806933,0.021346062,0.079255558,0.095087696,0,5.483474573,1.295331626,4.233259239,2.30E-05,0.000202437,N,-,,DNA repair rad5,,IPR001650 (SMART); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000330 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10799:SF711 (PANTHER); PTHR10799:SF711 (PANTHER); PTHR10799 (PANTHER); PTHR10799 (PANTHER); PTHR10799 (PANTHER); PTHR10799:SF711 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_02721,6,17,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.192439921,0,4.27516445,3.155861789,1.35467417,0.175521391,NA,0.05997637,0,7.524355925,2.422754459,3.105703055,0.001898272,0.015023052,0.157962677,0,4.850440835,1.521792321,3.187321138,0.001435972,0.007639403,0.182406666,0,4.427302979,2.03642859,2.174052653,0.029701181,0.091712247,0.15802921,0,4.749780989,1.387553187,3.423134359,0.000619035,0.00324081,N,-, Effector probability:0.614,aminopeptidase,,IPR016117 (G3DSA:3.60.70.GENE3D); IPR005321 (PFAM); PTHR36512:SF2 (PANTHER); PTHR36512 (PANTHER); IPR016117 (SUPERFAMILY),,
RL4_JR_02722,88,97,125,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.239573753,0,1.587795658,1.39976949,1.134326522,0.256657608,NA,0.393422719,0,4.811265729,1.60813639,2.991826911,0.002773134,0.015349618,1.024424395,0,2.153814111,1.240016562,1.736923664,0.082400646,0.166644854,1.182061555,0,1.731299385,1.275570214,1.357274861,0.174693892,0.298225536,1.01378548,0,2.066765865,1.227944736,1.683109838,0.09235383,0.179547337,N,-,,hypothetical protein UCRPA7_5194,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_02723,35,24,35,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,38.5597019,1,7.205896503,0.650648408,11.07494679,1.66E-28,6.45E-26,0.119759841,0,6.527235562,2.024106965,3.224748334,0.001260835,0.015023052,0.310435828,0,3.875947748,1.309523301,2.959815793,0.00307823,0.013795487,0.358082975,0,3.454188017,1.522718152,2.268435568,0.023302672,0.082525202,0.306094185,0,3.793416107,1.246537036,3.043163579,0.00234105,0.0096787,N,-,,major facilitator superfamily transporter,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; P:carbohydrate metabolic process; P:transmembrane transport; F:catalytic activity; C:membrane; C:integral component of membrane",G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF242 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.37, the major facilitator superfamily (mfs).
RL4_JR_02724,504,482,508,0,0,0,0,0,0,0,5,11,2,0,0,0,3,0,5.981181148,0,-0.682688327,1.191658236,-0.572889362,0.566719608,0.743415109,1.911992934,0,2.530466491,1.311335358,1.92968677,0.05364566,0.124770536,115.654744,1,4.686806166,0.399927116,11.71915076,1.02E-31,3.43E-29,24.3389639,1,1.197646867,1.008607569,1.187426016,0.235059623,0.372511925,16.45807222,1,2.007341778,0.840248047,2.388987141,0.016894894,0.047835794,N,-,,MFS quinate transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR003663 (PRINTS); IPR003663 (TIGRFAM); G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR23500 (PANTHER); PTHR23500:SF116 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.7, the major facilitator superfamily (mfs).
RL4_JR_02725,2593,2125,2868,0,0,7,0,0,0,0,2,2,0,2,0,0,5,0,56.98647885,1,0.479487922,0.586729588,0.817221309,0.413801967,0.604873042,9.658419428,0,0.193707881,1.217748821,0.159070473,0.873613351,0.927395316,53.75219339,1,0.360833412,0.744996307,0.484342552,0.628142782,0.739859994,36.94275656,1,-1.155788947,1.017643327,-1.135750529,0.256060987,0.39533661,44.04349997,1,0.376471182,0.690784658,0.544990653,0.585759946,0.698492976,N,-,,dihydrodipicolinate synthase,P:metabolic process; F:lyase activity,IPR002220 (PRINTS); IPR002220 (SMART); IPR002220 (PIRSF); IPR002220 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); IPR002220 (PANTHER); PTHR12128:SF23 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_02726,848,700,891,0,0,1,0,0,0,0,0,1,0,5,0,5,0,0,13.55279071,1,-0.437997197,1.141861993,-0.383581554,0.701288614,0.838858189,3.110618114,0,1.828304147,1.271331386,1.438101951,0.150405129,0.27728208,14.56567871,1,0.138611068,1.192497433,0.116235946,0.907465549,0.943145592,29.36361266,1,1.787283316,0.673841402,2.652379787,0.007992658,0.040543921,88.07788076,1,3.183701466,1.90415646,1.671974721,0.094529307,0.182985697,N,-,,c6 finger domain,F:binding,IPR021858 (PFAM),,
RL4_JR_02727,5487,4737,3842,0,0,5,0,0,0,0,0,0,3,3,0,0,1,0,75.49552192,1,-0.91709272,0.712757592,-1.2866825,0.198204975,0.360927721,18.16056806,0,-0.717182625,1.2249934,-0.585458358,0.558239559,0.702072183,46.81457303,0,-3.359870927,1.202737106,-2.793520638,0.00521377,0.019513571,93.95709064,1,-0.46178491,0.64404882,-0.71700296,0.47337227,0.614394851,49.68898079,1,-2.502211738,1.128457057,-2.217374354,0.026597521,0.068646418,N,-,,related to membrane,C:membrane; C:integral component of membrane,IPR018823 (PFAM); IPR018820 (PFAM); PF13515 (PFAM); PTHR37994 (PANTHER),2.A.85.3.5, the aromatic acid exporter (arae) family.
RL4_JR_02728,1276,1085,1278,0,3,3,2,0,0,0,0,0,1,0,0,0,3,0,50.02427651,1,1.348743713,0.602459482,2.238729331,0.025173533,0.079169499,49.27367241,1,2.914926616,0.978754705,2.97819934,0.002899473,0.015349618,12.04903946,0,-1.401913886,1.191212459,-1.176879804,0.239243484,0.37205853,23.21095693,1,-0.874976474,1.139904873,-0.767587273,0.442732426,0.584822676,23.44895791,1,0.722801437,0.842474326,0.8579507,0.390919687,0.527249478,N,-,,hypothetical protein FOCG_14455,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_02729,391,637,337,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,5.532805729,0,-0.570104417,1.273670643,-0.447607409,0.654436555,0.804822955,1.769177495,0,2.642542892,1.397879366,1.890394089,0.058705273,0.133922645,4.570273372,0,-0.003044039,1.248936063,-0.002437305,0.998055314,0.999239715,14.58399851,1,0.530084571,1.192102206,0.444663695,0.65656281,0.76595212,4.473818837,0,-0.075184742,1.246304218,-0.060326156,0.951895871,0.968735118,N,-,,multidrug resistance 3 (p glyco 3),"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); G3DSA:1.20.1560.10 (GENE3D); IPR011527 (PFAM); PTHR24221 (PANTHER); PTHR24221:SF247 (PANTHER); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY),3.A.1.201.18, the atp-binding cassette (abc) superfamily.
RL4_JR_02730,94,76,89,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.034383659,0,1.848825579,1.444732812,1.279700692,0.200650421,NA,0.331272159,0,5.059449935,1.658310712,3.050966202,0.002281063,0.015100664,0.857734327,0,2.410255573,1.239252384,1.944927121,0.05178375,0.116269392,0.989351552,0,1.98817138,1.28254225,1.550180028,0.121098312,0.225897426,0.844179453,0,2.330295826,1.216005408,1.916353176,0.055320157,0.121001639,N,-,,heterokaryon incompatibility or allele,,IPR010730 (PFAM); PTHR24148 (PANTHER); PTHR24148 (PANTHER); PTHR24148:SF29 (PANTHER); PTHR24148:SF29 (PANTHER),,
RL4_JR_02731,35,29,46,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.438020762,0,3.08848883,2.107335389,1.4655896,0.142760126,NA,0.139300354,0,6.309056482,1.961426703,3.216564999,0.001297351,0.015023052,0.36258442,0,3.65165413,1.299137786,2.810828975,0.004941404,0.018765519,0.418347484,0,3.22967001,1.472941706,2.192666551,0.028331412,0.089465864,0.358989134,0,3.56419214,1.249242068,2.853083667,0.004329722,0.015929664,N,-,,methyltransferase type 11,F:transferase activity,no IPS match,,
RL4_JR_02732,47,78,106,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.925232753,0,2.009791936,1.635889174,1.228562404,0.219235919,NA,0.291026748,0,5.246080407,1.744529739,3.007160204,0.002637008,0.015349618,0.762010382,0,2.580717648,1.299317789,1.98620974,0.04701004,0.107994019,0.879593602,0,2.157705426,1.378357872,1.565417421,0.117485066,0.220652253,0.758049808,0,2.486373723,1.281521581,1.940173118,0.052358654,0.115977111,N,-,,methyltransferase type 11,,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108 (PANTHER); PTHR10108:SF854 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_02733,25,10,38,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.287446807,0,3.696025502,2.66652348,1.386083989,0.165721259,NA,0.09114589,0,6.92066591,2.23185621,3.100856534,0.001929618,0.015023052,0.23831008,0,4.256361618,1.450902616,2.93359566,0.003350604,0.014701072,0.27500133,0,3.834622836,1.797299362,2.133547097,0.032879872,0.097114559,0.237560212,0,4.159352265,1.360872941,3.056385456,0.002240231,0.009334294,Y,-,,6-hydroxy-D-nicotine oxidase,F:oxidoreductase activity,IPR016169 (G3DSA:3.30.465.GENE3D); IPR012951 (PFAM); IPR016167 (G3DSA:3.30.43.GENE3D); IPR006094 (PFAM); PTHR11748 (PANTHER); PTHR11748:SF33 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY),,
RL4_JR_02734,121,64,107,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.158861725,0,1.684728247,1.471290287,1.145068557,0.252180759,NA,0.37226214,0,4.891096444,1.665418943,2.936856497,0.003315575,0.016335522,0.9633235,0,2.242466428,1.270184488,1.765465135,0.077485625,0.158959365,1.111019145,0,1.820641996,1.320484265,1.378768415,0.167966168,0.289045478,0.948783163,0,2.161560998,1.249738884,1.729610101,0.08369996,0.167019839,Y,-,,amine oxidase,F:oxidoreductase activity; P:oxidation-reduction process,PF13450 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10742 (PANTHER); PTHR10742:SF282 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_02735,82,80,118,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.116974792,0,1.737971255,1.447281198,1.200852507,0.22980842,NA,0.354457736,0,4.961689922,1.641707784,3.022273495,0.002508838,0.015349618,0.923549242,0,2.303145635,1.248300499,1.845025006,0.065033901,0.138754262,1.065676339,0,1.88070648,1.292306008,1.455310482,0.145583326,0.260153755,0.914986125,0,2.214575258,1.234837437,1.793414413,0.072906685,0.149489709,N,-,,heterokaryon incompatibility,,PTHR33112:SF6 (PANTHER); PTHR33112 (PANTHER),,
RL4_JR_02736,20,11,18,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4.013105001,1,5.199310309,1.221521702,4.256420742,2.08E-05,0.000216151,0.062462334,0,7.466311564,2.317151343,3.222194177,0.001272129,0.015023052,0.161678167,0,4.81685427,1.397436038,3.446922893,0.00056701,0.003715478,0.186470461,0,4.395501366,1.869408518,2.351279201,0.01870899,0.074402404,0.159264737,0,4.734973429,1.277000228,3.707887693,0.000208995,0.001294237,N,-,,ankyrin repeat-containing,F:GTP binding; F:catalytic activity; P:nucleoside metabolic process; F:methyltransferase activity; F:transferase activity; P:methylation,IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24188 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); SSF57997 (SUPERFAMILY); IPR020683 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_02737,2195,2232,4739,0,0,0,0,0,0,0,0,0,1,3,0,0,2,3,36.41477969,0,-3.288811855,1.253619662,-2.623452675,0.008704354,0.033862717,11.45428281,0,-0.05236782,1.26353925,-0.041445345,0.966940864,0.982766887,30.04649969,0,-2.72019037,1.236963662,-2.199086727,0.027871756,0.072333673,56.03049828,1,-0.447966296,0.835560978,-0.536126396,0.591871199,0.715460349,59.81270531,1,0.141803902,0.780107022,0.181774934,0.855759357,0.90387685,N,-,,hypothetical protein SPI_06201,,no IPS match,,
RL4_JR_02738,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.769,Major intracellular serine protease,P:proteolysis; F:serine-type endopeptidase activity,IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (PFAM); IPR000209 (SUPERFAMILY),3.A.24.5.1, the type vii or esx protein secretion system (t7ss) family.
RL4_JR_02739,132,103,129,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.452371263,0,1.359128314,1.329238216,1.022486637,0.306550634,NA,0.464895198,0,4.57053924,1.56569516,2.919175684,0.003509584,0.016859993,1.204377075,0,1.920473102,1.229236573,1.56232994,0.118210282,0.219589155,1.389219049,0,1.498376829,1.253497112,1.195357225,0.23194749,0.369081933,1.186240318,0,1.839563094,1.21423653,1.514995676,0.129773499,0.231965716,Y,-,,ribonuclease t2,"P:RNA phosphodiester bond hydrolysis, endonucleolytic; F:RNA binding; F:ribonuclease T2 activity",IPR001568 (G3DSA:3.90.730.GENE3D); IPR001568 (PFAM); IPR001568 (PANTHER); PTHR11240:SF22 (PANTHER); IPR001568 (SUPERFAMILY),,
RL4_JR_02740,201,322,205,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2.944331936,0,0.340028923,1.295282666,0.262513297,0.792925735,0.893712096,0.939230701,0,3.556069043,1.462133757,2.432109256,0.015011179,0.046169295,2.431299793,0,0.907628354,1.24588329,0.728501908,0.466306401,0.603385226,2.804758592,0,0.485248616,1.259453566,0.385285038,0.700026245,0.797992089,17.11708118,1,2.537092546,1.007541848,2.518101409,0.011798934,0.035907488,N,-,,Fructosyl amino acid oxidasesarcosine oxidase,"F:oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor; C:membrane; P:oxidation-reduction process",IPR006076 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR10961 (PANTHER); PTHR10961 (PANTHER); PTHR10961:SF16 (PANTHER); PTHR10961:SF16 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_02741,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_02742,3,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.03570914,0,6.704690225,3.936529512,1.703198263,0.088530972,NA,0.011355855,0,9.925019721,3.208789691,3.093072678,0.001980956,0.015023052,0.029583037,0,7.265489162,1.82460137,3.981959721,6.83E-05,0.000905719,0.03413305,0,6.844908572,3.525972948,1.941282215,0.052224056,0.125807414,0.029336347,0,7.176326256,1.386327053,5.176503079,2.26E-07,4.41E-06,N,-,,heterokaryon incompatibility,P:biological_process; C:cellular_component; F:molecular_function,IPR010730 (PFAM); PTHR33112:SF6 (PANTHER); PTHR33112 (PANTHER),,
RL4_JR_02743,7,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.047097758,0,6.305020123,3.929348277,1.604596915,0.108582541,NA,0.015357903,0,9.490431812,3.199757225,2.965984962,0.003017152,0.015636999,0.039453631,0,6.850906374,1.907238823,3.592054802,0.000328081,0.00249924,0.045475289,0,6.431022742,3.335096098,1.928287088,0.053819427,0.127765932,0.038656011,0,6.771971772,1.448562711,4.674959336,2.94E-06,3.61E-05,Y,-,,hypothetical protein FOZG_14563,,IPR011042 (G3DSA:2.120.10.GENE3D); PTHR42060 (PANTHER); PTHR42060:SF1 (PANTHER); SSF63829 (SUPERFAMILY),,
RL4_JR_02744,22,7,23,0,0,12,0,0,0,0,0,0,0,4,0,0,0,0,46.02746836,1,8.108237224,0.979315497,8.279494452,1.24E-16,1.01E-14,0.0656097,0,7.395117382,2.368310103,3.122529171,0.001793043,0.015023052,0.170387868,0,4.740481136,1.481052724,3.200751101,0.001370699,0.007373515,16.24289079,1,6.952678484,0.897150352,7.749736111,9.21E-15,5.69E-13,0.168688057,0,4.652316762,1.351239606,3.44299911,0.000575301,0.003043408,Y,-,,Selenium binding,F:selenium binding,IPR015943 (G3DSA:2.130.10.GENE3D); SSF63829 (SUPERFAMILY); IPR011048 (SUPERFAMILY),,
RL4_JR_02745,10,19,16,0,0,11,0,0,0,0,0,0,0,0,3,0,0,0,42.18570721,1,8.250119539,0.839561377,9.826702094,8.64E-23,1.60E-20,0.057492857,0,7.585982917,2.359097822,3.215628808,0.001301591,0.015023052,0.149646573,0,4.930038617,1.420120687,3.471563131,0.000517438,0.003469231,29.07854269,1,6.869531502,0.901762476,7.617894605,2.58E-14,1.50E-12,0.147753302,0,4.847425446,1.290436874,3.756421987,0.00017236,0.001098958,Y,-,,oxalate decarboxylase,"P:oxalate metabolic process; F:dTDP-4-dehydrorhamnose 3,5-epimerase activity; F:nutrient reservoir activity",IPR006045 (SMART); IPR006045 (PFAM); IPR014710 (G3DSA:2.60.120.GENE3D); IPR017774 (TIGRFAM); PTHR31238 (PANTHER); PTHR31238:SF27 (PANTHER); IPR011051 (SUPERFAMILY),,
RL4_JR_02746,51,89,79,0,0,30,0,0,0,0,0,9,0,0,1,0,2,0,115.439302,1,7.117772557,1.273734725,5.588112201,2.30E-08,5.14E-07,0.279592246,0,5.304110934,1.739533455,3.049157185,0.002294844,0.015122662,59.21627498,1,6.407480282,1.44944362,4.420648168,9.84E-06,0.000185178,10.47499159,1,3.17863845,1.177059668,2.7004905,0.006923731,0.036228827,8.439673479,1,4.216994831,1.026294238,4.10895304,3.97E-05,0.000319132,N,-, Effector probability:0.567,short chain dehydrogenase reductase family oxidoreductase,,IPR002347 (PRINTS); IPR002347 (PRINTS); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24321:SF6 (PANTHER); PTHR24321 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02747,835,318,457,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.38157698,0,-0.776381788,1.29044245,-0.601639994,0.547413801,0.727566273,2.074751586,0,2.412623508,1.422633806,1.695885123,0.089907638,0.186348958,5.328403074,0,-0.224750393,1.270263101,-0.176932159,0.859561678,0.91055796,6.14227208,0,-0.645995927,1.279339331,-0.504944944,0.613597506,0.732713144,5.208491846,0,-0.294799075,1.270753052,-0.231987698,0.816547569,0.876634942,N,-,,hypothetical protein SPBR_05205,,no IPS match,,
RL4_JR_02748,77483,38037,57232,0,0,0,0,0,0,0,0,0,3,0,0,0,2,0,685.8164282,0,-7.524007679,1.242475042,-6.055661021,1.40E-09,3.69E-08,221.2584661,0,-4.324069926,1.238782065,-3.490581635,0.00048197,0.015023052,570.9056702,0,-6.96811769,1.234179893,-5.645949777,1.64E-08,6.76E-07,686.2536326,1,-4.992667469,0.92065197,-5.422969408,5.86E-08,1.39E-06,568.3041145,1,-5.402139433,1.053888218,-5.12591311,2.96E-07,5.19E-06,N,-,,multidrug resistance,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23520 (PANTHER); PTHR23520:SF5 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.63.4, the major facilitator superfamily (mfs).
RL4_JR_02749,1250,126,315,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.63840085,0,-0.83323881,1.565851355,-0.532131487,0.594634931,0.765146966,2.205948714,0,2.324156359,1.688839454,1.376185495,0.168764212,0.30303909,5.597449806,0,-0.295796604,1.460752232,-0.202496082,0.839528921,0.896414363,6.446639624,0,-0.715746909,1.50208904,-0.476500986,0.633717505,0.74879096,5.413413141,0,-0.350414148,1.480676896,-0.236658078,0.81292206,0.873669022,N,-,,TPR domain-containing,P:biological_process; C:cellular_component; F:molecular_function,IPR019734 (SMART); IPR001214 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); G3DSA:2.170.270.10 (GENE3D); IPR013105 (PFAM); IPR001214 (PFAM); PTHR12197 (PANTHER); PTHR12197:SF177 (PANTHER); PTHR12197 (PANTHER); PTHR12197:SF177 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR001214 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY); IPR011990 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_02750,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.012047471,0,8.273092713,3.994385999,2.07118008,0.03834197,NA,0.00401109,0,11.43263965,3.991205167,2.86445802,0.004177235,0.018371529,0.010113829,0,8.82019535,3.041025661,2.900401487,0.00372685,0.01574077,0.01164654,0,8.398490877,3.993441208,2.103071121,0.035459553,0.099858856,0.00966951,0,8.76562085,1.6165792,5.422326879,5.88E-08,1.50E-06,N,-,,beta-lactamase family,F:hydrolase activity,IPR001466 (PFAM); IPR021860 (PFAM); IPR012338 (G3DSA:3.40.710.GENE3D); PTHR22935 (PANTHER); PTHR22935:SF68 (PANTHER); IPR012338 (SUPERFAMILY),9.B.306.1.3, The Putative Calcium Binding Protein with Similarity to the C-termini of Anoctamins (1.A.17.5) (CBP) Family
RL4_JR_02751,195,338,332,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,3.481429678,0,0.098146716,1.281271232,0.076601045,0.938940927,0.969777845,1.100905271,0,3.326790346,1.424408939,2.335558458,0.019514266,0.056370833,2.869337234,0,0.668309783,1.241168433,0.538452127,0.590264947,0.709888611,3.311325634,0,0.245457746,1.25169471,0.196100331,0.844531638,0.902753677,18.28060005,1,3.145393598,0.830886066,3.785589539,0.000153345,0.000992086,N,-,,Zinc finger,"F:nucleic acid binding; F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR24409:SF23 (PANTHER); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR001138 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); IPR001138 (SUPERFAMILY),,
RL4_JR_02752,129,147,160,13,0,40,0,0,0,0,1,2,0,1,0,0,0,0,285.3391722,1,7.358176266,0.907040327,8.112292303,4.97E-16,3.72E-14,0.556036847,0,4.312244553,1.515745588,2.844965928,0.004441617,0.019050679,22.28503543,1,4.062701554,0.856754562,4.741966645,2.12E-06,5.10E-05,5.678295401,1,2.182286757,1.155508226,1.888594739,0.058946153,0.135439596,1.425703255,0,1.574832063,1.213914571,1.297317044,0.194522122,0.315510768,N,-,,alpha-D-xyloside xylohydrolase,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:carbohydrate binding",IPR000322 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR22762:SF80 (PANTHER); PTHR22762 (PANTHER); SSF51011 (SUPERFAMILY); IPR017853 (SUPERFAMILY); IPR011013 (SUPERFAMILY),,
RL4_JR_02753,1,0,12,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,15.32468223,1,8.39638441,2.647987745,3.170854709,0.001519911,0.008288394,0.015343114,0,9.488873655,3.928893785,2.415151484,0.015728667,0.047924613,0.041389086,0,6.78028101,2.681380868,2.528652714,0.011450126,0.035767071,0.047845763,0,6.356860344,3.927994724,1.618347475,0.105587735,0.204295015,0.042651432,0,6.638244104,2.019223889,3.287522569,0.001010731,0.004831344,N,-,,maltose permease mal31,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR003663 (TIGRFAM); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF98 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.10, the major facilitator superfamily (mfs).
RL4_JR_02754,2,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.024398406,0,7.255705004,3.950296292,1.836749567,0.066246874,NA,0.007858478,0,10.45906412,3.503672134,2.985172048,0.002834189,0.015349618,0.020190067,0,7.823842655,2.055674641,3.805973231,0.000141248,0.001415819,0.023281625,0,7.398324204,3.950337591,1.872833406,0.061091393,0.137947378,0.019639628,0,7.759148925,1.450103779,5.350754226,8.76E-08,2.01E-06,N,-,,FAD-binding,F:FAD binding; P:oxidation-reduction process; F:monooxygenase activity,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789:SF186 (PANTHER); PTHR13789 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_02755,147,154,141,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1.773529621,0,1.071184087,1.286756742,0.832468214,0.405144713,NA,0.567277887,0,4.283459044,1.516298954,2.824943612,0.004728894,0.019923787,1.468466563,0,1.634969663,1.221608782,1.338374189,0.180774488,0.301708032,20.31840233,1,2.956433407,1.016001002,2.909872532,0.003615762,0.021655188,1.443528869,0,1.556748129,1.206913604,1.289858796,0.197099689,0.318435352,Y,-, Effector probability:0.649,hypothetical protein UCRPA7_592,P:proteolysis; F:serine-type endopeptidase activity,no IPS match,,
RL4_JR_02756,539,514,582,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,6.540549727,0,-0.811763846,1.190906292,-0.681635365,0.495469547,0.683007868,2.087997799,0,2.403399335,1.300214786,1.848463316,0.064535346,0.144136535,5.41560749,0,-0.248191991,1.195167467,-0.207662941,0.835492156,0.89413558,34.18422864,1,1.654743429,0.842988494,1.962949009,0.049652099,0.122392356,5.337608986,0,-0.329955062,1.195789386,-0.27593075,0.782601256,0.851110388,N,-,,Bifunctional polynucleotide phosphatase kinase,P:DNA repair; F:organic cyclic compound binding; F:heterocyclic compound binding; P:polynucleotide dephosphorylation; P:single-organism cellular process; F:nucleobase-containing compound kinase activity; C:intracellular part; P:single-organism metabolic process,IPR013954 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR023214 (G3DSA:3.40.50.GENE3D); IPR006551 (TIGRFAM); IPR006549 (TIGRFAM); PF13671 (PFAM); PTHR12083 (PANTHER); PTHR12083:SF6 (PANTHER); PTHR12083 (PANTHER); PTHR12083:SF6 (PANTHER); IPR023214 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_02757,4363,5008,3981,0,9,6,0,0,0,0,6,0,3,6,0,0,2,0,148.7019819,1,0.815343395,0.507087383,1.60789525,0.107858122,0.234017703,17.18484663,0,-0.637510783,1.215266986,-0.52458496,0.599871744,0.734830182,91.50503638,1,0.11119468,1.323452019,0.084018671,0.933041587,0.960165991,103.274682,1,0.177840041,0.534163849,0.332931631,0.739185892,0.826533093,51.35467928,1,-1.693174809,0.977600243,-1.731970528,0.08327881,0.16647541,N,-,,only prolin and serin are matching in the corresponding,,no IPS match,,
RL4_JR_02758,712,366,706,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.070571614,0,-0.924370876,1.24377066,-0.74320042,0.457360349,0.645750386,2.26546187,0,2.285668032,1.352553434,1.689891117,0.091048787,0.188234442,5.874146156,0,-0.365558106,1.235629992,-0.29584755,0.767346508,0.843681151,6.775512277,0,-0.787670926,1.239191436,-0.635632964,0.525015679,0.659281129,5.798869814,0,-0.449649185,1.241563878,-0.362163553,0.717229814,0.800675587,Y,-,,---NA---,,no IPS match,,
RL4_JR_02759,169,208,284,0,0,0,0,0,0,4,0,3,1,5,0,0,0,0,2.643023391,0,0.495451426,1.281317584,0.3866734,0.698998011,0.837360613,0.835945569,0,3.723915327,1.448828137,2.570294731,0.010161203,0.033945054,65.95783769,1,4.709311496,0.607908915,7.746738659,9.43E-15,9.09E-13,31.88798772,1,3.91999631,0.660608733,5.933915364,2.96E-09,9.02E-08,2.164052532,0,0.972670069,1.235899389,0.787013958,0.431273695,0.565774315,Y,-,,---NA---,,no IPS match,,
RL4_JR_02760,4820,4671,5610,0,0,26,0,0,0,7,3,9,2,3,4,0,16,0,159.660237,1,0.841401333,1.187235468,0.708706365,0.478506714,0.667520139,19.24511627,0,-0.800916991,1.196460584,-0.669405245,0.503237006,0.656920941,209.4797622,1,1.62176016,0.370248217,4.380197087,1.19E-05,0.000217075,126.8522316,1,0.037547094,0.503649259,0.074550083,0.940572692,0.965068758,111.0833151,1,0.510717097,1.412442999,0.361584218,0.71766276,0.801051201,N,-, Effector probability:0.643,ribosomal ymr-31,C:ribosome,IPR020373 (PFAM); PTHR31601:SF2 (PANTHER); PTHR31601 (PANTHER); IPR020373 (PRODOM),,
RL4_JR_02761,4339,4251,5215,2,0,1,0,0,0,1,3,0,1,3,0,0,0,4,79.13681671,1,-1.5685924,0.849102949,-1.847352434,0.064696078,0.161108244,17.57882792,0,-0.670270805,1.198289398,-0.559356367,0.575918533,0.715507273,80.26642754,1,-0.497263859,0.73888343,-0.672993653,0.500951329,0.633509139,74.03397149,1,-1.022054166,0.741269552,-1.378788813,0.167959877,0.289045478,74.55191094,1,-0.759164192,0.748446101,-1.014320458,0.310429865,0.446019922,N,-,,cytochrome c1 heme lyase,C:intracellular membrane-bounded organelle; C:cytoplasmic part,IPR000511 (PFAM); IPR000511 (PANTHER),,
RL4_JR_02762,943,1182,1158,0,0,3,0,0,0,0,0,0,0,6,0,0,0,0,24.63842675,1,0.471953655,0.866460313,0.544691601,0.585965642,0.758426055,4.195062979,0,1.39683213,1.254980306,1.113031116,0.265695066,0.422856204,10.89419888,0,-1.256455472,1.197953938,-1.048834544,0.294254276,0.434894932,36.63860967,1,1.602129584,0.634152417,2.526410909,0.011523461,0.054292715,10.74254522,0,-1.338968143,1.201494261,-1.114419091,0.265099437,0.397296003,N,-,,duf647 domain containing,C:integral component of membrane,IPR006968 (PFAM); PTHR12770:SF22 (PANTHER); IPR006968 (PANTHER),,
RL4_JR_02763,1952,2458,2956,0,2,4,0,0,0,0,3,0,1,2,0,0,7,1,60.79916043,1,0.310200173,0.650787543,0.476653519,0.633608866,0.791550676,9.35130614,0,0.240309162,1.224904793,0.196185992,0.844464592,0.907028954,47.89141702,1,-0.008215845,0.865493579,-0.00949267,0.992426059,0.996955886,45.44836987,1,-0.5308604,0.869503558,-0.610532752,0.541508954,0.672403503,58.50309673,1,1.064260215,0.598914776,1.776981062,0.075571356,0.153739196,N,-,,diphosphomevalonate decarboxylase,"F:ATP binding; P:isopentenyl diphosphate biosynthetic process, mevalonate pathway; C:cytosol; F:diphosphomevalonate decarboxylase activity",IPR014721 (G3DSA:3.30.230.GENE3D); IPR006204 (PFAM); IPR029765 (TIGRFAM); IPR005935 (PIRSF); IPR013750 (G3DSA:3.30.70.GENE3D); PTHR10977:SF3 (PANTHER); IPR005935 (PANTHER); IPR013750 (SUPERFAMILY); IPR020568 (SUPERFAMILY),,
RL4_JR_02764,104,89,170,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.44278886,0,1.368615411,1.412895279,0.968660191,0.332714761,NA,0.456599202,0,4.596303915,1.598262985,2.875812028,0.004029896,0.018161447,1.192816162,0,1.933943998,1.263177151,1.531015658,0.125765523,0.229953071,1.376549682,0,1.511317807,1.301418693,1.161284846,0.24552608,0.384227444,1.185779629,0,1.840444252,1.257832187,1.463187436,0.143416098,0.250346478,N,-,,short-chain dehydrogenase reductase,F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24322:SF484 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02765,1600,1706,1800,0,1,7,0,0,0,0,0,0,0,3,0,0,2,1,55.19938548,1,1.252058356,0.537625479,2.328867221,0.019866101,0.06511356,6.5240909,0,0.759748649,1.225915944,0.619739594,0.535429244,0.683173428,16.92764865,0,-1.892311193,1.188992106,-1.591525447,0.111491373,0.210232569,31.56329505,1,-0.007144556,0.848210844,-0.00842309,0.993279426,0.995343843,31.77099541,1,0.239407458,0.839143245,0.285299869,0.775414413,0.84464737,N,-,,snf7 family,P:filamentous growth; P:vesicle-mediated transport; C:fungal-type vacuole membrane; C:integral component of membrane; P:late endosome to vacuole transport via multivesicular body sorting pathway,IPR005024 (PFAM); PTHR22761 (PANTHER); SSF58100 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_02766,4083,3666,4835,2,1,11,0,0,0,0,1,2,0,2,0,1,0,0,120.3803886,1,0.745228999,0.444078941,1.678145325,0.093318732,0.210418523,16.00943447,0,-0.535360306,1.202402233,-0.445242275,0.656144679,0.778421992,62.43050425,1,-0.784379481,0.852143796,-0.920477841,0.357323108,0.500730095,56.00506236,1,-1.885510384,1.01602323,-1.855774876,0.063485653,0.141521849,57.10045224,1,-2.339015231,1.125261222,-2.078641995,0.037650268,0.089759587,N,-,,WD domain-containing,,IPR020472 (PRINTS); IPR001680 (SMART); IPR001810 (PFAM); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); G3DSA:1.20.1280.50 (GENE3D); PTHR22844:SF209 (PANTHER); PTHR22844 (PANTHER); PTHR22844:SF209 (PANTHER); PTHR22844 (PANTHER); PTHR22844 (PANTHER); PTHR22844:SF209 (PANTHER); PTHR22844 (PANTHER); IPR001810 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_02767,17,13,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.168023625,0,4.470869811,3.200216972,1.397052091,0.162397907,NA,0.054132058,0,7.673156545,2.37378473,3.232456781,0.001227307,0.015023052,0.13956149,0,5.030564371,1.402749415,3.586217407,0.000335509,0.002544342,0.160936149,0,4.608355004,1.944960495,2.369382317,0.017817824,0.072627002,0.136706436,0,4.955682091,1.268025849,3.908186963,9.30E-05,0.000653392,N,-,,major facilitator superfamily transporter,C:membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662:SF242 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.12, the major facilitator superfamily (mfs).
RL4_JR_02768,417,381,426,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,4.895413938,0,-0.393806799,1.19581293,-0.329321409,0.741912764,0.864275929,1.564739428,0,2.819608854,1.333745583,2.114053003,0.034510741,0.088323063,4.055335866,0,0.169128108,1.198784312,0.141083017,0.88780436,0.930341408,4.677984518,0,-0.253114895,1.196925226,-0.211470934,0.832519811,0.894921232,19.08053571,1,2.302023381,0.839463144,2.742256641,0.006101865,0.021057048,N,-,,alpha-ketoglutarate-dependent sulfonate dioxygenase,F:dioxygenase activity; P:oxidation-reduction process,G3DSA:3.60.130.10 (GENE3D); IPR003819 (PFAM); PTHR30468 (PANTHER); PTHR30468:SF15 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_02769,12865,9094,7227,8,6,16,0,0,0,0,0,4,0,3,0,0,0,4,306.4896516,1,0.675545295,0.42082314,1.60529503,0.108428892,0.234818929,37.80393782,0,-1.774929125,1.234262859,-1.438047911,0.150420461,0.27728208,123.1612186,1,-1.615520576,0.79806815,-2.024288997,0.042940425,0.100678292,124.0611311,1,-2.563146628,0.913554865,-2.805684393,0.005020984,0.028117634,124.3306876,1,-1.798675641,0.796021417,-2.259581969,0.023847208,0.062715059,N,-,,cdc24 calponin,P:regulation of Rho protein signal transduction; P:regulation of exit from mitosis; C:mating projection tip; F:Rho guanyl-nucleotide exchange factor activity; P:positive regulation of GTPase activity; C:nucleus; C:incipient cellular bud site; C:cellular bud tip; P:protein localization to cell cortex; C:cytoplasm; C:cellular bud neck; P:cellular bud site selection; P:septin ring organization; P:intracellular signal transduction,IPR001849 (SMART); IPR000270 (SMART); IPR000219 (SMART); G3DSA:3.10.20.240 (GENE3D); IPR000219 (PFAM); IPR000219 (G3DSA:1.20.900.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR000270 (PFAM); IPR010481 (PFAM); PF15411 (PFAM); IPR033511 (PTHR22826:PANTHER); PTHR22826 (PANTHER); PTHR22826 (PANTHER); IPR000219 (PROSITE_PROFILES); IPR000270 (PROSITE_PROFILES); IPR000219 (SUPERFAMILY); SSF54277 (SUPERFAMILY); IPR011993 (SUPERFAMILY),,
RL4_JR_02770,1473,1260,3062,0,1,2,0,1,0,0,0,0,0,4,0,0,4,0,38.61817271,1,-0.335168148,0.953496369,-0.351514865,0.725202122,0.85460265,45.56579276,1,1.546602292,1.162527754,1.330378811,0.183393492,0.322836335,18.96736459,0,-2.056542372,1.245724394,-1.650880709,0.098762936,0.192138535,37.94043295,1,0.161179727,0.868917296,0.1854949,0.85284088,0.907897583,34.38777058,1,0.371382789,0.893571279,0.4156163,0.677690797,0.771138952,N,-, Effector probability:0.765,37s ribosomal mrp10,F:structural constituent of ribosome; P:mitochondrial translation; C:mitochondrial small ribosomal subunit; P:mitochondrial respiratory chain complex assembly,IPR017264 (PIRSF); PTHR28066 (PANTHER); PTHR28066:SF1 (PANTHER),,
RL4_JR_02771,600,582,396,0,0,0,0,0,0,0,1,1,1,0,0,0,0,2,6.345136703,0,-0.767833167,1.229040817,-0.624741796,0.532140537,0.71589751,2.043470053,0,2.434607254,1.351755434,1.80107081,0.07169172,0.156663124,19.60533472,1,1.612581019,1.057122065,1.52544448,0.127148272,0.231978573,15.38207921,1,0.323841384,1.167894933,0.277286402,0.7815602,0.859317384,19.87669993,1,1.419570826,0.991185908,1.432194319,0.152088217,0.261702297,N,-,,ga4 desaturase,,no IPS match,,
RL4_JR_02772,3302,3061,4719,0,0,20,0,0,0,0,0,0,0,10,0,0,1,0,120.5433955,1,0.971961137,1.066162949,0.911644076,0.361956112,0.553215358,14.02025751,0,-0.343978528,1.215108402,-0.283084643,0.777111954,0.864870724,36.53219708,0,-3.00216371,1.201160729,-2.499385501,0.012440889,0.038306437,82.26983703,1,0.497093329,0.596857289,0.832851233,0.404928636,0.548628722,40.06208693,1,-2.162955285,1.14102058,-1.895632141,0.058008704,0.125258718,N,-,,Zinc C2H2-type DNA-binding,F:nucleic acid binding; F:metal ion binding,IPR015880 (SMART); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_02773,623,675,1025,0,0,0,0,0,0,0,0,0,0,1,0,0,2,0,9.269424609,0,-1.314883336,1.221255005,-1.076665668,0.281629655,0.464771873,2.933042406,0,1.913018557,1.292390879,1.480216696,0.138815426,0.260206797,7.65620587,0,-0.747806269,1.21496935,-0.615493938,0.538228572,0.66671064,12.84708356,1,-0.224962583,1.166106497,-0.1929177,0.847023423,0.903985681,15.31994674,1,0.81540234,1.016175056,0.802423102,0.422308254,0.557989178,N,-, Effector probability:0.895,---NA---,,no IPS match,,
RL4_JR_02774,1008,898,1139,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,12.16006974,0,-1.706556554,1.188923356,-1.435379787,0.151178903,0.298986058,3.879120761,0,1.509764726,1.253206846,1.204721097,0.228310989,0.378102721,10.06996906,0,-1.143121524,1.193112386,-0.958100458,0.338012104,0.481298811,11.6170904,0,-1.56549834,1.190805698,-1.314654727,0.188625968,0.317143462,24.66821263,1,0.460397653,0.973424231,0.472967118,0.636236639,0.738749537,N,-,,VPS4-associated 1,,IPR013640 (PFAM); PTHR28218 (PANTHER),,
RL4_JR_02775,1220,2246,5537,1,0,0,0,0,0,0,3,0,0,0,0,0,4,0,45.82735726,1,-2.294186881,1.308318471,-1.753538555,0.079509608,0.187251553,11.10241318,0,-0.007341206,1.352511911,-0.005427831,0.995669239,0.997829394,52.90713477,1,-0.280485714,1.313972062,-0.213463987,0.830965076,0.890716113,33.93051242,0,-3.111718866,1.324963091,-2.348532489,0.018847555,0.074601835,45.02419375,1,-0.334299837,1.018415873,-0.328254739,0.742719063,0.820247656,N,-,,tyrosine- phosphatase YVH1,F:phosphatase activity; P:dephosphorylation,IPR020422 (SMART); IPR029021 (G3DSA:3.90.190.GENE3D); IPR000340 (PFAM); PTHR10159:SF310 (PANTHER); IPR024950 (PANTHER); IPR024950 (PANTHER); PTHR10159:SF310 (PANTHER); IPR020422 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES); IPR029021 (SUPERFAMILY),,
RL4_JR_02776,6933,8417,5555,0,2,10,0,0,0,0,4,2,1,4,0,0,4,0,138.4895955,1,-0.297519671,0.578294453,-0.514477823,0.606917961,0.77321973,27.0226805,0,-1.290553311,1.223623048,-1.054698433,0.291563269,0.450703025,114.1376332,1,-0.534963795,0.652154334,-0.820302445,0.412043713,0.554296234,105.8271807,1,-1.334925938,0.715787017,-1.86497646,0.062184704,0.139635064,83.77409621,1,-1.418679687,0.785031274,-1.807163273,0.070736826,0.146016383,N,-,,c2h2 finger domain containing,F:nucleic acid binding; F:metal ion binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_02777,1961,2808,1783,1,3,6,0,0,0,3,1,2,1,1,0,0,0,0,83.4780135,1,1.20162972,0.568269454,2.114542161,0.034468988,0.100860115,8.463099297,0,0.384379525,1.258265613,0.305483612,0.759997849,0.854741965,75.93100811,1,1.161390547,0.655961,1.770517678,0.076640942,0.157705873,38.56313181,1,-0.948956117,1.045844721,-0.907358519,0.364217238,0.510549568,21.45145796,0,-2.336759312,1.216098105,-1.921522041,0.054665926,0.119855458,N,-,,siderophore biosynthesis,C:membrane; F:transferase activity,IPR016181 (G3DSA:3.40.630.GENE3D); PF13523 (PFAM); PTHR31438:SF1 (PANTHER); PTHR31438:SF1 (PANTHER); PTHR31438 (PANTHER); PTHR31438 (PANTHER); PTHR31438 (PANTHER); IPR016181 (SUPERFAMILY),,
RL4_JR_02778,1743,1652,1920,0,0,3,0,0,0,0,0,0,0,0,2,0,4,0,32.71049652,1,-0.20489671,0.843633215,-0.242874162,0.808102882,0.902685257,6.78278423,0,0.703635998,1.223480386,0.575110158,0.565216798,0.707447067,17.59810041,0,-1.948409043,1.188001808,-1.640072456,0.100990103,0.19534272,39.57202685,1,-0.631767344,1.007540074,-0.627039421,0.530633395,0.663865455,32.79367397,1,0.581261467,0.747511058,0.777595811,0.436807331,0.571700392,N,-,,negative regulator of DNA transposition,P:chromatin assembly,IPR013719 (SMART); IPR013719 (PFAM); PTHR13711:SF212 (PANTHER); PTHR13711:SF212 (PANTHER); PTHR13711 (PANTHER); PTHR13711 (PANTHER); PTHR13711 (PANTHER); PTHR13711:SF212 (PANTHER); IPR011993 (SUPERFAMILY),,
RL4_JR_02779,0,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.057163849,0,6.026917829,3.925398306,1.535364658,0.12469428,NA,0.017724148,0,9.283253919,3.925961694,2.36458087,0.018050486,0.053079354,0.046648011,0,6.611531982,2.396598802,2.758714549,0.00580292,0.021216598,0.053876058,0,6.187117566,3.925643917,1.576077122,0.115008031,0.217219867,0.046461567,0,6.518083574,1.719256984,3.791221227,0.000149908,0.000973587,N,-, Effector probability:0.709,Argininosuccinate lyase,P:mycelium development; P:protein tetramerization; P:arginine biosynthetic process via ornithine; C:cytosol; F:argininosuccinate lyase activity,G3DSA:1.10.40.30 (GENE3D); IPR029419 (PFAM); IPR000362 (PANTHER); IPR009049 (PTHR11444:PANTHER); IPR008948 (SUPERFAMILY),,
RL4_JR_02780,615,611,721,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,7.787572049,0,-1.063533919,1.192310483,-0.891994103,0.372396093,0.564580437,2.48173643,0,2.154148433,1.283712594,1.678061306,0.093335132,0.191980939,6.444464446,0,-0.499172359,1.195053,-0.41769893,0.676167255,0.777528043,65.24657087,1,2.883471634,1.661397441,1.735570046,0.082639886,0.169928685,6.359483785,0,-0.582647003,1.198451857,-0.486166382,0.626849205,0.730951076,N,-,,plasma membrane fusion prm1,P:plasma membrane fusion involved in cytogamy; C:integral component of membrane; C:mating projection tip,IPR026777 (PANTHER),9.B.63.1.3, the yeast pheromone-induced plasma membrane mating cell fusion protein (prm1) family.
RL4_JR_02781,2204,2672,4850,0,0,0,0,0,0,0,0,0,0,0,2,0,3,0,38.74421383,0,-3.378259023,1.247114914,-2.708859453,0.006751493,0.027859728,12.18549216,0,-0.141640177,1.254363546,-0.112917964,0.910095595,0.95008123,31.94755205,0,-2.808690739,1.231405872,-2.280881392,0.022555466,0.061203844,56.14844198,1,-1.451731743,1.070429418,-1.356214355,0.175030976,0.29872801,43.44002486,1,-0.748306703,0.937890404,-0.797861562,0.424950831,0.560040759,N,-,,54s ribosomal l24,F:structural constituent of ribosome; C:mitochondrial large ribosomal subunit,G3DSA:2.30.170.40 (GENE3D); IPR026569 (PFAM); IPR026569 (PANTHER); SSF143800 (SUPERFAMILY),,
RL4_JR_02782,45,81,50,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.71284406,0,2.386234902,1.772568092,1.346202108,0.178237346,NA,0.227007077,0,5.604863467,1.827272963,3.06733782,0.002159746,0.015045494,0.588100344,0,2.9556965,1.305099193,2.264729391,0.023529291,0.063370721,0.67848145,0,2.532888661,1.409491637,1.797022838,0.072331994,0.154866027,0.57746878,0,2.87919931,1.265408391,2.275312327,0.022887201,0.060726652,N,-,,hypothetical protein SPI_07754,,G3DSA:1.10.601.10 (GENE3D),,
RL4_JR_02783,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_02784,13546,14423,15420,38,38,50,0,1,0,7,8,10,17,49,7,0,25,4,1051.625354,1,2.28997793,0.307074825,7.45739391,8.83E-14,5.00E-12,93.75404822,1,-1.405641256,1.102790428,-1.274622286,0.202442966,0.346780792,349.0373872,1,0.49122733,0.330246355,1.487457237,0.136894089,0.244947996,588.2383716,1,1.426702794,0.320686961,4.448895548,8.63E-06,0.000125744,267.7565221,1,0.143199702,0.578958608,0.247340138,0.804644998,0.868183142,N,-,,aspartate aminotransferase,F:pyridoxal phosphate binding; F:L-phenylalanine:2-oxoglutarate aminotransferase activity; P:asparagine biosynthetic process from oxaloacetate; F:L-aspartate:2-oxoglutarate aminotransferase activity; P:replicative cell aging; P:aspartate biosynthetic process; P:chronological cell aging,IPR000796 (PRINTS); IPR015421 (G3DSA:3.40.640.GENE3D); IPR004839 (PFAM); IPR000796 (PANTHER); IPR015424 (SUPERFAMILY),9.A.70.1.1, the aspartate amino transferase (aat) family.
RL4_JR_02785,2638,3040,3011,0,2,9,0,0,0,2,0,0,1,1,0,0,2,0,85.24988569,1,0.9241472,0.489187018,1.889149068,0.058871857,0.150286455,11.11158214,0,-0.008461308,1.2117826,-0.006982529,0.994428793,0.997384883,50.97108654,1,-0.830831991,1.029314667,-0.807170069,0.419568508,0.561050267,46.58536071,1,-1.348650274,1.013127509,-1.331175258,0.18313135,0.309653461,36.13076353,1,-1.072985177,0.974458105,-1.101109603,0.270848958,0.403066175,N,-,,c6 zinc finger domain containing,"P:regulation of transcription, DNA-templated; F:binding",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31001 (PANTHER); PTHR31001 (PANTHER); PTHR31001:SF4 (PANTHER); PTHR31001 (PANTHER); PTHR31001:SF4 (PANTHER); PTHR31001:SF4 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_02786,583,326,322,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.907337585,0,-0.397370528,1.260053861,-0.315359954,0.752488369,0.870775614,1.591334718,0,2.795369219,1.409788802,1.982828361,0.047386605,0.113017723,4.088519716,0,0.15745729,1.245598877,0.126410912,0.899406665,0.937754179,4.713451397,0,-0.263937946,1.252070978,-0.210801106,0.833042476,0.895250261,3.993440946,0,0.088383334,1.239155023,0.071325486,0.943138712,0.964009496,N,-,,ubid family decarboxylase,C:membrane,PTHR33048 (PANTHER); PTHR33048:SF47 (PANTHER),9.B.313.1.1, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_02787,1015,623,510,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.582112001,0,-1.203694448,1.247060094,-0.965225697,0.334431779,0.52447029,2.785726068,0,1.987548264,1.358217534,1.463350467,0.143371505,0.267109585,7.14899494,0,-0.648686824,1.240844427,-0.522778529,0.601128383,0.71932704,8.241334052,0,-1.070007771,1.244406415,-0.85985395,0.389869556,0.534519871,6.971200565,0,-0.715303633,1.237174721,-0.578175113,0.563145899,0.680655632,N,-,,alternative sulfate transporter,P:transmembrane transport; C:membrane part; F:transporter activity,G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF217 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.38, the major facilitator superfamily (mfs).
RL4_JR_02788,619,386,345,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.39132181,0,-0.533027248,1.248415544,-0.426963001,0.669406276,0.816661642,1.746664081,0,2.661011486,1.390473437,1.913744927,0.055652756,0.128640601,4.488512695,0,0.022832015,1.238613069,0.018433533,0.985293002,0.992879961,5.174761622,0,-0.398613946,1.243213573,-0.320631913,0.748489351,0.83446115,4.383445693,0,-0.046025591,1.231925853,-0.037360683,0.970197421,0.980201888,N,-,,alternative sulfate transporter,P:transmembrane transport; C:integral component of membrane; F:transporter activity,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662:SF217 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.38, the major facilitator superfamily (mfs).
RL4_JR_02789,1557,1058,866,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13.92288787,0,-1.901728292,1.225758139,-1.55147107,0.120788835,0.253706312,4.508057323,0,1.293080043,1.305262302,0.990666812,0.321848302,0.483991756,24.58255907,1,0.466094828,1.069625737,0.435755061,0.663014452,0.767565273,13.35661651,0,-1.766618488,1.226613217,-1.440240872,0.149799264,0.265947456,11.31079737,0,-1.413487092,1.222265102,-1.156448866,0.247497603,0.37764556,N,-,,arylsulfotransferase (ASST) domain,P:biological_process; F:transferase activity; C:cellular_component; F:molecular_function,PF14269 (PFAM); PTHR35340 (PANTHER); PTHR35340:SF4 (PANTHER); IPR011047 (SUPERFAMILY),,
RL4_JR_02790,11469,11869,16131,23,17,1,0,0,2,0,0,0,0,2,0,0,6,4,529.1517259,1,1.205788953,1.012881048,1.19045465,0.233867744,0.407321319,68.80892775,1,-0.536686089,0.983392885,-0.545749412,0.585238201,0.723736234,130.3361561,0,-4.837118048,1.196912006,-4.041331379,5.31E-05,0.000759995,158.4139582,1,-3.538174379,1.026300812,-3.447502269,0.000565796,0.004627368,181.642693,1,-0.996554908,0.53916437,-1.848332279,0.064554289,0.136453481,N,-,,tryptophan synthase,F:tryptophan synthase activity; P:tryptophan biosynthetic process,G3DSA:3.40.50.1100 (GENE3D); IPR002028 (TIGRFAM); IPR006654 (TIGRFAM); IPR013785 (G3DSA:3.20.20.GENE3D); G3DSA:3.40.50.1100 (GENE3D); IPR002028 (PFAM); IPR001926 (PFAM); PTHR10314 (PANTHER); PTHR10314:SF3 (PANTHER); IPR023026 (HAMAP); IPR002028 (HAMAP); IPR001926 (SUPERFAMILY); IPR011060 (SUPERFAMILY),,
RL4_JR_02791,1,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.027541723,0,7.078723576,3.945295464,1.794218872,0.072778241,NA,0.008512063,0,10.33794658,3.547909559,2.913813446,0.003570432,0.016958421,0.022640737,0,7.647789673,2.139964045,3.573793536,0.000351846,0.002628851,0.026154368,0,7.228083251,3.945511663,1.831976146,0.066954975,0.146670023,0.022957385,0,7.534458652,1.521548665,4.951835473,7.35E-07,1.12E-05,N,-,,hypothetical protein RHECNPAF_334005,,no IPS match,,
RL4_JR_02792,103,149,135,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,1.557207445,0,1.258898597,1.354353764,0.929519769,0.352619785,NA,0.494810854,0,4.480583215,1.560898473,2.870515471,0.004098031,0.018370361,1.28562318,0,1.826752281,1.240634145,1.47243431,0.140903634,0.25013298,48.04469186,1,4.87728877,1.527419756,3.193155483,0.001407272,0.00985382,1.267832721,0,1.744308661,1.228415739,1.419966063,0.155617561,0.265839009,Y,-,,inosine uridine-preferring nucleoside hydrolase,F:hydrolase activity,IPR001910 (PFAM); IPR001910 (G3DSA:3.90.245.GENE3D); IPR023186 (PANTHER); PTHR12304:SF24 (PANTHER); IPR001910 (SUPERFAMILY),,
RL4_JR_02793,305,299,466,0,2,4,0,0,0,0,1,0,1,3,0,0,0,0,35.56030397,1,3.099411797,0.654004709,4.739127642,2.15E-06,2.99E-05,1.351969189,0,3.030336032,1.368978446,2.213574684,0.02685805,0.072475923,11.36902495,1,1.332293872,1.208471104,1.102462332,0.270260726,0.408681044,25.41594947,1,2.662514711,0.772914658,3.444771921,0.000571541,0.004651814,3.497273892,0,0.280044936,1.228354521,0.227983804,0.819658832,0.879003927,N,-,,hypothetical protein CMQ_6713,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_02794,369,259,310,0,1,6,0,0,1,0,0,0,0,1,0,0,4,0,34.66256467,1,3.502599126,0.589773526,5.938888357,2.87E-09,7.32E-08,10.5803049,1,4.115222276,1.148581605,3.582873222,0.000339836,0.013332619,3.106375856,0,0.553687742,1.215489387,0.455526595,0.648730439,0.755989432,7.594190018,1,1.077928888,1.158435673,0.930503879,0.352110256,0.498617671,18.49505099,1,3.074985396,0.77001679,3.993400449,6.51E-05,0.000484901,N,-,,microtubule associated partial,C:microtubule organizing center,no IPS match,,
RL4_JR_02795,18686,15394,15132,5,7,0,0,0,1,0,4,1,3,4,0,0,0,7,303.2988381,1,-1.020946231,0.854816344,-1.194345708,0.232342765,0.405704682,72.62635905,1,-1.600451692,1.116592237,-1.433335857,0.151761879,0.279094067,201.2458658,1,-2.019459679,0.678863278,-2.974766412,0.002932117,0.013415737,232.4036503,1,-2.049514309,0.583224475,-3.514108885,0.000441232,0.003782788,211.9022316,1,-1.696138747,0.673459026,-2.5185478,0.011783989,0.035872786,N,-,,fungal specific transcription factor domain-containing,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR007219 (PFAM); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31001 (PANTHER); PTHR31001 (PANTHER); PTHR31001:SF28 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_02796,3455,3146,3683,1,2,1,0,0,0,0,1,4,0,5,0,0,3,0,71.01438445,1,-0.730828443,0.731046354,-0.999701918,0.317454783,0.506017218,13.12917429,0,-0.249186306,1.204600587,-0.206862182,0.836117492,0.901777438,67.88744146,1,0.239626462,0.662685215,0.361599228,0.717651542,0.8091663,59.33681612,1,-0.283108167,0.66351443,-0.426679743,0.669612607,0.775103195,45.14225677,1,-0.775283964,0.839025185,-0.92402943,0.355470993,0.492727238,Y,-,,glucosidase ii beta subunit,P:biological_process; F:molecular_function,IPR009011 (G3DSA:2.70.130.GENE3D); IPR012913 (PFAM); PTHR15414 (PANTHER); PTHR15414:SF0 (PANTHER); IPR009011 (SUPERFAMILY),8.A.67.1.4, the os-9 quality control (erad) protein (os-9) family.
RL4_JR_02797,646,440,454,0,0,0,1,0,0,0,1,0,4,0,0,0,0,1,6.148423841,0,-0.722645381,1.216804747,-0.593887707,0.552587222,0.732056927,24.29421551,1,3.408313273,1.139430307,2.991243301,0.00277844,0.015349618,12.95352997,1,0.797353705,1.208469265,0.659804703,0.509379165,0.640774685,43.14218831,1,2.198703739,0.77105416,2.85155551,0.004350589,0.02518706,12.37340044,1,0.698829009,1.13653453,0.614877059,0.538635914,0.66101693,N,-,,key lime pathogenicity,F:metal ion binding,PTHR42031 (PANTHER); PTHR42031:SF1 (PANTHER),,
RL4_JR_02798,6212,7376,8054,0,1,6,0,0,0,0,1,9,5,5,0,0,0,2,117.6761763,1,-1.040353824,0.601324907,-1.730102665,0.083611934,0.194166285,27.58186316,0,-1.32014079,1.196937793,-1.102931829,0.270056771,0.427378773,138.0301621,1,0.143942755,0.512480797,0.280874437,0.778806708,0.853315921,149.3443857,1,-0.340550229,0.499447657,-0.681853692,0.49533147,0.634036805,85.52742032,1,-2.369768545,0.977686698,-2.423852701,0.015356833,0.044273329,N,-,,membrane,C:integral component of membrane,IPR006696 (PFAM); PTHR10584:SF191 (PANTHER); PTHR10584 (PANTHER),,
RL4_JR_02799,867,665,1102,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,10.47890191,0,-1.491922405,1.210450884,-1.232534442,0.217749509,0.385587257,3.335391646,0,1.727587978,1.281597963,1.347995259,0.177659907,0.315044426,23.02028649,1,0.891681701,1.047772191,0.85102631,0.394754738,0.537998246,19.32522777,1,-0.399826429,1.158564997,-0.345104876,0.730015528,0.819991926,8.591076053,0,-1.016642797,1.218056421,-0.834643436,0.403918498,0.540890728,N,-,,MFS transporter,P:transmembrane transport; C:integral component of membrane,PR01036 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501:SF78 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.65, the major facilitator superfamily (mfs).
RL4_JR_02800,164,164,225,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.208210762,0,0.754690753,1.271719741,0.593441093,0.552885995,0.732105307,0.701435357,0,3.977042617,1.468337119,2.708535094,0.006758096,0.025269838,1.826021082,0,1.319924196,1.223182019,1.079090581,0.28054735,0.419784417,2.106940691,0,0.897399408,1.235531259,0.726326753,0.467638483,0.609065292,1.807135368,0,1.232635249,1.221276457,1.009300754,0.312830419,0.448260401,Y,-, Effector probability:0.691,---NA---,,no IPS match,,
RL4_JR_02801,4890,5153,5311,0,0,6,0,0,0,0,0,0,1,1,2,0,0,0,84.44392682,1,-0.753152909,0.61549578,-1.223652433,0.221083371,0.39055828,19.63548169,0,-0.829859263,1.197739838,-0.692854355,0.488400957,0.644368416,50.92127862,0,-3.481198054,1.186697628,-2.933517327,0.003351449,0.014701072,91.33783428,1,-1.165279372,0.734103908,-1.587349364,0.112433541,0.213661712,50.16218731,0,-3.56229657,1.187785754,-2.999107,0.002707722,0.010926937,N,-,,Histone deacetylation Rxt3,,IPR013951 (PFAM); IPR004043 (G3DSA:2.170.130.GENE3D); PTHR12618 (PANTHER); PTHR12618:SF19 (PANTHER); PTHR12618 (PANTHER); PTHR12618:SF19 (PANTHER); IPR004043 (SUPERFAMILY),,
RL4_JR_02802,2418,2357,2642,0,3,1,0,0,0,0,2,6,0,3,2,0,0,0,57.52771142,1,-0.261518295,0.731246903,-0.357633372,0.720617701,0.850890028,9.471783496,0,0.221884626,1.211929896,0.183083714,0.854732334,0.914158991,79.24842708,1,1.386202889,0.531140187,2.60986256,0.009057861,0.030274606,59.64967011,1,0.199461443,0.65863184,0.302842091,0.762010205,0.844685058,24.21813712,0,-2.511788042,1.18940083,-2.111809559,0.034702787,0.084321027,N,-,,DUF1674 domain-containing,C:mitochondrion,IPR012875 (PFAM); PTHR28524 (PANTHER); PTHR28524:SF3 (PANTHER),,
RL4_JR_02803,351,234,278,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.440759229,0,0.114751327,1.234106246,0.092983345,0.925916793,0.964672373,1.106848128,0,3.319106092,1.409639277,2.354578328,0.018543735,0.054170184,2.858624793,0,0.673615354,1.221572791,0.55143284,0.581336993,0.70307678,3.296673737,0,0.251743424,1.226639723,0.205230125,0.837392334,0.898239408,2.807148583,0,0.596849832,1.21434336,0.491500058,0.623072811,0.728729607,N,-,,serine threonine kinase,F:kinase activity,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24361:SF159 (PANTHER); PTHR24361 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR008984 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_02804,2009,1238,1946,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,32.09690522,1,-0.185093997,0.884631555,-0.209232868,0.834266455,0.917340408,6.613604887,0,0.740063032,1.255012984,0.589685559,0.555401479,0.700358013,24.98022504,1,-0.948358561,1.207109877,-0.785643941,0.432076114,0.57278232,19.76677527,0,-2.332260353,1.209154368,-1.928835899,0.053751238,0.12772384,16.89626771,0,-1.992461098,1.214217971,-1.640941861,0.100809484,0.192149102,N,-,,BTN1,P:regulation of intracellular pH; P:arginine transport; P:vacuole organization; P:lysine transport; P:vacuolar transport; C:fungal-type vacuole; C:vacuolar membrane; C:integral component of organelle membrane,IPR003492 (PRINTS); IPR003492 (PFAM); IPR018460 (PIRSF); PTHR10981:SF0 (PANTHER); IPR003492 (PANTHER); IPR020846 (SUPERFAMILY),2.A.57.5.3, the equilibrative nucleoside transporter (ent) family.
RL4_JR_02805,644,559,794,9,1,0,0,0,0,0,3,2,0,0,0,0,0,0,106.5622427,1,3.49763811,1.094840126,3.194656487,0.001399974,0.007764096,2.535997149,0,2.122906451,1.289181807,1.646708354,0.099618006,0.202030346,43.11941168,1,2.608996728,0.675874464,3.860179468,0.000113304,0.001251467,7.606581716,0,-0.95463834,1.200813993,-0.794992685,0.426617758,0.569329748,6.51780592,0,-0.618173467,1.208044202,-0.511714278,0.608850992,0.716982588,N,-,,alkaline ceramidase family,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; C:integral component of membrane; P:ceramide metabolic process",IPR008901 (PFAM); PTHR12956:SF29 (PANTHER); PTHR12956 (PANTHER),,
RL4_JR_02806,2818,2355,2711,0,0,1,0,0,0,0,0,0,0,0,0,0,4,0,35.3189919,1,-2.131754662,1.137037254,-1.874832733,0.060815738,0.154031293,10.0838563,0,0.131555846,1.216282314,0.108162262,0.91386698,0.951662713,26.11432761,0,-2.517803006,1.189154479,-2.117305236,0.034233951,0.084968011,30.12203684,0,-2.939955781,1.187510983,-2.47572934,0.013296433,0.060788385,41.14659293,1,0.015693463,0.745065256,0.021063205,0.983195236,0.988663399,N,-,,hypothetical protein SPI_07771,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_02807,27,26,29,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0.328105414,0,3.505410016,2.380774264,1.472382354,0.140917655,NA,0.104751949,0,6.720463499,2.066185665,3.252594194,0.001143567,0.015023052,8.11462902,1,5.030609596,1.210378041,4.156230058,3.24E-05,0.000503155,0.313391347,0,3.646739416,1.553719013,2.347103554,0.018919996,0.074786514,0.267711573,0,3.987627063,1.238572615,3.219534338,0.00128399,0.005879872,N,-,,hypothetical protein CSUB01_05827,C:membrane,no IPS match,,
RL4_JR_02808,66675,57510,55239,0,2,15,0,0,0,0,0,12,2,19,18,0,14,6,791.6425792,1,-2.991939937,0.620801735,-4.819477407,1.44E-06,2.10E-05,230.5923843,0,-4.383680033,1.205256636,-3.637134119,0.000275688,0.011206899,673.7987011,1,-2.881727589,1.60075427,-1.80023108,0.071824158,0.150175088,955.4490727,1,-1.381176703,0.537117065,-2.571463082,0.010126981,0.049036674,683.0952019,1,-2.235932588,0.45814358,-4.8804189,1.06E-06,1.52E-05,N,-,,transcription regulator,,IPR001487 (PRINTS); IPR001487 (SMART); IPR001487 (G3DSA:1.20.920.GENE3D); IPR027353 (PFAM); IPR001487 (PFAM); PTHR22880:SF5 (PANTHER); PTHR22880 (PANTHER); PTHR22880:SF5 (PANTHER); PTHR22880 (PANTHER); IPR001487 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); IPR027353 (PROSITE_PROFILES); IPR001487 (SUPERFAMILY); IPR001487 (SUPERFAMILY),,
RL4_JR_02809,14611,18928,23607,0,3,4,0,0,0,0,1,0,0,3,0,0,1,0,268.1402237,1,-2.417536888,0.634803317,-3.808324284,0.000139912,0.001136852,72.43411663,0,-2.713095039,1.199971291,-2.260966624,0.023761324,0.065966023,196.7248179,1,-4.410560582,1.205947599,-3.657340158,0.000254846,0.002054189,230.0052399,1,-3.509031127,0.886743401,-3.957211437,7.58E-05,0.000843711,190.9977472,1,-4.533628304,1.150275943,-3.941339756,8.10E-05,0.000582261,N,-,,small nucleolar ribonucleo complex component,C:intracellular ribonucleoprotein complex; C:viral nucleocapsid,IPR007148 (PFAM),,
RL4_JR_02810,6204,6212,3235,1,1,23,0,0,0,3,0,3,2,9,3,0,3,1,168.9976772,1,0.91336277,0.812401135,1.124275596,0.260896128,0.440455116,20.38615261,0,-0.883967863,1.260223564,-0.701437339,0.483030127,0.639616816,105.0759705,1,-0.097889694,0.694927133,-0.14086325,0.887977975,0.930341408,144.0168058,1,0.554732965,0.544282535,1.019200378,0.308107847,0.453777367,69.97356469,1,-0.991451022,0.81819444,-1.211754778,0.225606264,0.352471195,N,-,,hypothetical protein CMQ_6712,,no IPS match,,
RL4_JR_02811,11860,7445,10099,2,7,29,0,0,3,0,0,1,0,14,0,0,6,8,303.9825247,1,0.818460567,0.493064389,1.659946622,0.096925191,0.216450257,65.74017574,1,0.400988894,0.88127445,0.455010235,0.649101876,0.772965787,103.7333276,1,-3.452623254,1.20383475,-2.868020927,0.004130482,0.0167079,168.3030906,1,-0.840688476,1.402072997,-0.599603928,0.548770229,0.678507579,177.7183032,1,-0.050812681,0.495046033,-0.102642335,0.918246842,0.947925089,N,-,,duf1741 domain containing,C:intracellular part,IPR013636 (SMART); IPR013636 (PFAM); PTHR13608 (PANTHER); PTHR13608:SF3 (PANTHER),,
RL4_JR_02812,3897,3735,5827,0,0,7,3,0,0,0,0,5,0,6,0,0,1,0,80.38006009,1,-0.406531704,0.66383708,-0.612396801,0.540275258,0.722314906,83.94713397,1,1.607697307,0.853642295,1.883338392,0.059654524,0.135514035,76.84859189,1,-0.157629207,0.701071257,-0.224840493,0.822103363,0.884832342,75.25214755,1,-0.449347856,0.668012,-0.672664347,0.501160854,0.63867258,47.84212182,1,-2.443996455,1.143573376,-2.137157533,0.032585181,0.080312793,N,-, Effector probability:0.719,iron sulfur assembly 1,C:mitochondrial matrix; F:iron ion binding; F:structural molecule activity; P:biotin biosynthetic process; F:iron-sulfur cluster binding; P:iron-sulfur cluster assembly,IPR000361 (PFAM); IPR000361 (G3DSA:2.60.300.GENE3D); IPR016092 (TIGRFAM); PTHR10072 (PANTHER); PTHR10072:SF41 (PANTHER); IPR000361 (SUPERFAMILY),,
RL4_JR_02813,1217,1196,1986,0,2,6,0,0,0,0,0,1,0,0,0,0,0,2,56.45656896,1,1.447732224,0.610714445,2.370555071,0.017761398,0.059604065,5.546280694,0,0.993908111,1.257259968,0.790535081,0.429215343,0.591725227,20.97991291,1,-0.705444774,1.210797894,-0.582628015,0.560143742,0.686119867,16.71165901,0,-2.090067795,1.214038985,-1.721582108,0.085145247,0.173599602,29.11201856,1,-0.054891098,1.005878038,-0.054570332,0.956480775,0.971265859,N,-,,aaa family ATPase,"F:DNA binding; F:ATP binding; P:DNA repair; C:cytoplasm; P:positive regulation of catalytic activity; P:regulation of DNA repair; F:single-stranded DNA-dependent ATPase activity; F:enzyme activator activity; P:DNA strand renaturation; P:DNA replication, Okazaki fragment processing",IPR003593 (SMART); G3DSA:1.20.272.10 (GENE3D); G3DSA:1.10.3710.10 (GENE3D); IPR032423 (PFAM); IPR021886 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003959 (PFAM); G3DSA:1.10.8.60 (GENE3D); PTHR13779:SF7 (PANTHER); PTHR13779 (PANTHER); PTHR13779 (PANTHER); PTHR13779:SF7 (PANTHER); IPR008921 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_02814,1386,1156,1837,0,2,1,0,0,0,0,0,4,0,0,0,0,0,0,37.2763704,1,0.09457116,0.868419881,0.10890027,0.913281592,0.95740828,5.54445475,0,0.994404781,1.247483761,0.797128437,0.425376442,0.588204966,40.42835449,1,1.146570402,0.76427123,1.500214003,0.133558977,0.240346032,16.65332085,0,-2.085041616,1.203665346,-1.732243619,0.083230196,0.170775754,14.2920265,0,-1.750926507,1.213284278,-1.443129643,0.148983954,0.257685206,N,-,,hypothetical protein CMQ_6838,P:mycelium development,no IPS match,,
RL4_JR_02815,847,1326,1135,0,0,2,0,0,0,1,4,0,0,2,2,0,0,0,20.96555773,1,-0.125851938,1.048534449,-0.120026518,0.904462142,0.953456484,4.232971233,0,1.383860652,1.275838441,1.084667626,0.278068891,0.437119633,53.44048124,1,1.88415681,0.700303326,2.690486737,0.007134787,0.024942191,39.98428536,1,1.042500951,0.774112986,1.346703866,0.178075627,0.302752262,10.84396494,0,-1.352525843,1.217604664,-1.110808691,0.266650705,0.398922475,N,-,,thymidylate synthase,F:thymidylate synthase activity; C:nucleus; P:dTMP biosynthetic process; P:methylation,IPR000398 (PRINTS); IPR023451 (PFAM); IPR023451 (G3DSA:3.30.572.GENE3D); IPR000398 (TIGRFAM); PTHR11548 (PANTHER); IPR000398 (HAMAP); IPR023451 (SUPERFAMILY),,
RL4_JR_02816,1151,976,2266,0,0,5,0,0,0,2,0,1,0,2,0,0,0,0,36.51458383,1,0.706239136,0.825886599,0.85512846,0.392480035,0.584920009,5.490170243,0,1.008565507,1.298207443,0.776890868,0.43722316,0.598697622,43.02856444,1,0.770141418,0.909762514,0.846530172,0.397257049,0.539511107,24.63256408,1,-0.384845556,1.086933593,-0.354065381,0.723289886,0.815604198,14.35876741,0,-1.757638582,1.2606787,-1.394200268,0.163257137,0.276140747,N,-,,hypothetical protein F503_07171,,IPR018961 (PFAM); PTHR39394:SF1 (PANTHER); PTHR39394 (PANTHER),,
RL4_JR_02817,90,172,133,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,9.233192078,1,2.921299806,1.08967211,2.680898024,0.007342489,0.029637404,0.50593547,0,4.44852587,1.591488281,2.795198635,0.005186784,0.021136506,1.315384692,0,1.793821638,1.268650777,1.413960146,0.157373604,0.271700268,1.517838359,0,1.371037162,1.304989181,1.050611899,0.293436874,0.438143098,1.296923479,0,1.711576606,1.256532988,1.362142198,0.173153013,0.288540859,N,-,,bzip transcription factor,,IPR021833 (PFAM); PTHR37012:SF2 (PANTHER); PTHR37012 (PANTHER),,
RL4_JR_02818,208,289,226,0,0,6,0,0,0,0,0,0,0,0,0,0,4,0,25.82470896,1,3.606134393,0.673937648,5.350842775,8.75E-08,1.74E-06,0.92887119,0,3.572036606,1.434525964,2.490046674,0.012772632,0.040564509,2.407289364,0,0.921895213,1.226234222,0.751810051,0.452165297,0.591742692,2.777144614,0,0.499487,1.234946556,0.404460417,0.68587418,0.786998648,17.80929574,1,3.434303109,0.784583649,4.377230027,1.20E-05,0.000117471,N,-,,3-oxoacyl-[acyl-carrier ] reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); SM00822 (SMART); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); PTHR24322:SF644 (PANTHER); PTHR24322:SF644 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02819,518,765,608,0,3,64,0,0,0,0,4,3,2,1,0,0,11,0,276.0403279,1,5.186237948,1.157091963,4.482131165,7.39E-06,8.90E-05,2.426652672,0,2.186592199,1.315234736,1.662510987,0.096410362,0.196985403,57.16271598,1,3.155281079,0.604742476,5.217561534,1.81E-07,5.92E-06,29.89834098,1,1.441079522,0.873276813,1.650197853,0.098902476,0.194217915,48.66087973,1,3.379858354,0.616082486,5.486048425,4.11E-08,1.17E-06,N,-, Effector probability:0.616,oxidoreductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); IPR002347 (PANTHER); PTHR24322:SF627 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02820,20597,10647,10829,0,0,79,0,0,0,0,0,0,0,3,0,0,0,0,469.2297828,1,0.872597143,1.656859048,0.526657439,0.598431496,0.768093793,54.41590293,0,-2.300430252,1.245079481,-1.84761719,0.064657741,0.144314367,139.7049008,0,-4.937248663,1.233669901,-4.002082452,6.28E-05,0.000859,173.0841817,1,-3.101704793,0.941912583,-3.292985833,0.000991295,0.007315495,136.378699,0,-5.005264877,1.236010286,-4.049533351,5.13E-05,0.000399089,N,-,,siderophore iron transporter 1,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF92 (PANTHER); PTHR23501 (PANTHER); PTHR23501:SF92 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.16.1, the major facilitator superfamily (mfs).
RL4_JR_02821,38787,33418,48309,1,9,17,0,0,1,2,3,7,8,15,10,1,6,6,627.5559762,1,-1.580833193,0.409551343,-3.859914564,0.000113427,0.000949061,162.3521513,1,-2.874474302,1.114055777,-2.580188857,0.00987463,0.033264183,488.9334764,1,-2.049292557,0.478050858,-4.286766824,1.81E-05,0.000313209,689.9507231,1,-1.061135036,0.339035008,-3.129868629,0.001748845,0.011867999,476.7085089,1,-2.191575959,0.504417441,-4.344766424,1.39E-05,0.000132681,N,-,,Aspartyl-tRNA synthetase,F:ATP binding; F:aspartate-tRNA ligase activity; C:cytosol; P:aspartyl-tRNA aminoacylation,IPR002312 (PRINTS); G3DSA:3.30.930.10 (GENE3D); G3DSA:2.40.50.140 (GENE3D); IPR004364 (PFAM); IPR018150 (PANTHER); IPR004523 (PTHR22594:PANTHER); IPR006195 (PROSITE_PROFILES); IPR012340 (SUPERFAMILY); SSF55681 (SUPERFAMILY),9.B.111.1.5,The 6 TMS Lysyl tRNA Synthetase (LysS) Family
RL4_JR_02822,338,82,326,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.93243655,0,0.345362905,1.464163494,0.235877282,0.813527897,0.904930541,0.941829982,0,3.551895821,1.61164173,2.203899139,0.027531438,0.073899023,2.442800716,0,0.900213693,1.349606572,0.667019346,0.504759776,0.636842137,2.817412666,0,0.478252806,1.388819214,0.344359295,0.730576097,0.820348561,2.416304293,0,0.81327,1.355269325,0.600079988,0.548452929,0.668750672,N,-,,alpha- -mannosyltransferase,"F:transferase activity, transferring glycosyl groups; C:integral component of membrane",IPR021848 (PFAM),,
RL4_JR_02823,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.015953485,0,7.867140353,3.973076766,1.980112848,0.04769085,NA,0.005346613,0,11.01668392,3.970228347,2.774823752,0.005523163,0.021974647,0.013444566,0,8.408299533,2.921098072,2.878472179,0.003996065,0.01637703,0.015478003,0,7.987409939,3.972128364,2.010864002,0.044339824,0.114176173,0.012834372,0,8.355328124,1.611812863,5.183807821,2.17E-07,4.29E-06,N,-,,hypothetical protein CMQ_6572,,PTHR41677 (PANTHER); PTHR41677:SF1 (PANTHER),,
RL4_JR_02824,2050,1949,2895,1,0,0,0,0,0,0,0,0,0,3,1,0,18,1,37.56032262,1,-1.932268357,1.155343614,-1.672462057,0.094433244,0.212344654,8.728899687,0,0.339655576,1.225665512,0.277119306,0.781688498,0.868102385,22.73822686,0,-2.318141656,1.20037477,-1.93118159,0.0534606,0.119083633,47.90706096,1,-0.022663159,0.762486158,-0.029722715,0.976288196,0.98573175,99.37847164,1,2.172513887,0.657221734,3.305602624,0.000947724,0.004573739,N,-,,succinate-semialdehyde dehydrogenase (NADP+),F:succinate-semialdehyde dehydrogenase [NAD(P)+] activity; P:gamma-aminobutyric acid catabolic process; P:oxidation-reduction process,IPR016163 (G3DSA:3.40.309.GENE3D); IPR015590 (PFAM); IPR016162 (G3DSA:3.40.605.GENE3D); PTHR11699 (PANTHER); PTHR11699:SF49 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_02825,3,1,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.039233805,0,6.56842602,3.933856213,1.669716854,0.094975398,NA,0.012350409,0,9.802636223,3.283143771,2.985746865,0.002828867,0.015349618,0.03247374,0,7.128711554,1.941149078,3.672418382,0.000240266,0.001976672,0.037485153,0,6.709174874,3.545096953,1.892522253,0.058421432,0.134982775,0.032577657,0,7.024994113,1.450913835,4.841772091,1.29E-06,1.79E-05,N,-,,pantothenate transporter liz1,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662 (PANTHER); PTHR11662:SF173 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_02826,1421,1463,2819,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,30.69489374,1,-1.650468727,1.193009098,-1.383450243,0.166526854,0.318155989,7.148879454,0,0.627711734,1.269111668,0.494607172,0.620877438,0.750480228,25.22304567,1,-1.076145339,1.226825313,-0.877178949,0.380389448,0.524310793,21.61222827,0,-2.461030043,1.232801058,-1.996291313,0.045902223,0.116248126,26.02491378,1,-1.191410072,1.173979576,-1.014847359,0.310178595,0.445769046,N,-,,O-methyltransferase,C:integral component of membrane; F:methyltransferase activity; P:transport; F:transporter activity; P:methylation,PF13649 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); PTHR10108:SF705 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_02827,83,410,144,0,0,0,0,0,0,0,0,0,0,13,6,0,4,1,2.619457756,0,0.508621165,1.582080569,0.321488788,0.747840008,0.86813987,0.828357604,0,3.737287205,1.701922213,2.195921279,0.028097578,0.075179405,2.148616731,0,1.085852414,1.402813498,0.774053298,0.438899274,0.579022185,112.4418177,1,5.518988004,0.829539938,6.653070881,2.87E-11,1.17E-09,24.91346249,1,3.837600383,0.960728376,3.994469694,6.48E-05,0.000483789,N,-, Effector probability:0.691,cytochrome p450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24279:SF80 (PANTHER); PTHR24279 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_02828,0,12,14,0,0,0,0,0,0,0,0,0,0,27,5,0,7,12,0.10514604,0,5.147280835,3.916903239,1.314119987,0.188805829,NA,0.032422719,0,8.411835649,3.91726995,2.14737196,0.031763681,0.082778574,0.085829661,0,5.731124371,2.281944915,2.51150864,0.012021634,0.037310554,156.588456,1,10.6417469,2.018632916,5.271759327,1.35E-07,2.95E-06,115.4957196,1,10.42112105,1.894774858,5.499925761,3.80E-08,1.17E-06,N,-,,NAD(P)-binding,,IPR008030 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR14194 (PANTHER); PTHR14194:SF46 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02829,89,128,88,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1.231216469,0,1.597829742,1.441465377,1.108475976,0.267656309,NA,0.393109539,0,4.812641995,1.638070403,2.937994598,0.003303428,0.016310876,1.017431548,0,2.164677784,1.25823037,1.720414509,0.085357122,0.171119901,19.79820703,1,3.501422226,1.040059255,3.366560326,0.000761119,0.005882697,0.998733428,0,2.088492471,1.235490983,1.690414984,0.09094859,0.177771135,N,-,,hypothetical protein NECHADRAFT_88940,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; F:transmembrane transporter activity; C:membrane; C:integral component of membrane; P:transport; F:transporter activity,G3DSA:1.20.1250.20 (GENE3D); IPR020846 (SUPERFAMILY),,
RL4_JR_02830,2895,4002,1702,0,0,5,0,0,0,1,0,0,0,22,3,0,0,13,53.95476828,1,-0.310956445,0.854088836,-0.364079744,0.715798462,0.847794399,11.21593935,0,-0.021916953,1.294157443,-0.016935306,0.986488226,0.993421755,39.92673448,1,-1.700003596,1.24413142,-1.366418023,0.171807795,0.290429473,150.4379946,1,1.980939542,0.72306262,2.739651433,0.006150437,0.033036169,123.8799186,1,1.791042638,1.882761642,0.951284856,0.341459792,0.478582558,N,-,,3-oxoacyl-(acyl-carrier ) reductase,F:oxidoreductase activity; P:oxidation-reduction process; F:binding,IPR002347 (PRINTS); SM00822 (SMART); IPR007219 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR007219 (PFAM); IPR012338 (G3DSA:3.40.710.GENE3D); PF13561 (PFAM); IPR001466 (PFAM); PTHR22935 (PANTHER); PTHR22935:SF54 (PANTHER); IPR016040 (SUPERFAMILY); IPR012338 (SUPERFAMILY),,
RL4_JR_02831,46,66,44,0,0,0,0,0,0,0,0,0,1,9,0,0,7,11,0.629938139,0,2.564557289,1.819121473,1.409777921,0.158605268,NA,0.201238143,0,5.778713465,1.847398268,3.128027977,0.001759834,0.015023052,0.520616589,0,3.131598848,1.29028449,2.427060755,0.015221707,0.045020321,46.0171112,1,6.67417026,0.583906839,11.43019711,2.95E-30,4.82E-28,108.5548827,1,7.872294771,0.509175632,15.46086315,6.37E-54,6.45E-50,N,-,,O-acetylhomoserine (thiol)-lyase,"F:pyridoxal phosphate binding; F:lyase activity; P:cellular amino acid metabolic process; F:transferase activity, transferring alkyl or aryl (other than methyl) groups",IPR000277 (PFAM); IPR000277 (PIRSF); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR015421 (G3DSA:3.40.640.GENE3D); IPR006235 (PTHR11808:PANTHER); IPR000277 (PANTHER); IPR000277 (PANTHER); IPR006235 (PTHR11808:PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_02832,10,36,10,0,0,0,0,0,0,0,0,1,8,60,9,0,5,28,0.230336561,0,4.01618892,2.998019992,1.339613789,0.180370939,NA,0.073269812,0,7.236672337,2.400213485,3.015011949,0.002569691,0.015349618,6.68804043,1,5.556935087,1.331040639,4.174880107,2.98E-05,0.000469425,402.1293838,1,10.89420492,0.694823626,15.67909395,2.10E-55,1.33E-52,225.7210558,1,10.27472521,1.502514506,6.838353415,8.01E-12,7.11E-10,N,-,,FAD binding domain,F:FAD binding; F:oxidoreductase activity; P:oxidation-reduction process,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789:SF187 (PANTHER); PTHR13789 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_02833,27,28,71,0,0,18,0,0,0,0,2,39,0,0,4,0,5,0,69.23350861,1,7.290539829,1.113152,6.549455807,5.77E-11,2.09E-09,0.156458605,0,6.14113792,1.993376203,3.080772165,0.002064646,0.015023052,269.5482887,1,9.367940505,1.59829372,5.861213359,4.59E-09,2.10E-07,39.01654685,1,6.209356435,1.552145924,4.000497853,6.32E-05,0.000725614,19.71527255,1,6.170326736,0.886101281,6.963455381,3.32E-12,3.11E-10,N,-,,mfs hexose transporter,C:integral component of plasma membrane; F:sugar:proton symporter activity; P:hexose transmembrane transport; P:glucose import; F:glucose transmembrane transporter activity,IPR005828 (PFAM); IPR003663 (TIGRFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500 (PANTHER); PTHR23500:SF1 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.10, the major facilitator superfamily (mfs).
RL4_JR_02834,346,405,423,0,0,1,0,0,0,0,0,9,3,0,0,0,10,0,8.526651209,1,0.609779353,1.151952796,0.529344045,0.596566807,0.766544654,1.498576449,0,2.881920758,1.341033759,2.149029238,0.031632082,0.082559237,62.38079248,1,3.993894771,1.386495737,2.880567653,0.003969597,0.016336669,32.4273529,1,2.138283137,0.850380435,2.514501803,0.011920069,0.055746283,42.44491377,1,4.013441132,0.546586089,7.342742921,2.09E-13,2.62E-11,N,-,,c6 zinc finger domain containing,"P:regulation of transcription, DNA-templated",PTHR31944 (PANTHER); PTHR31944:SF57 (PANTHER); PTHR31944:SF57 (PANTHER); PTHR31944 (PANTHER),,
RL4_JR_02835,112,90,120,4,0,8,0,0,0,0,0,17,0,0,4,0,0,0,72.09415387,1,5.837259797,0.468836938,12.45051172,1.39E-35,9.45E-33,0.410258469,0,4.750874147,1.596768551,2.975305434,0.00292697,0.015438659,111.542799,1,6.728198957,1.803043923,3.731577956,0.000190284,0.001705711,39.76893031,1,4.794799689,1.335437001,3.590434954,0.000330127,0.002939782,1.049910938,0,2.015780374,1.218257723,1.654641982,0.097997142,0.188134446,N,-,,glycoside hydrolase family 51,P:L-arabinose metabolic process; F:alpha-L-arabinofuranosidase activity,IPR010720 (SMART); IPR010720 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR31776 (PANTHER); PTHR31776:SF4 (PANTHER); PTHR31776 (PANTHER); IPR017853 (SUPERFAMILY); SSF51011 (SUPERFAMILY),,
RL4_JR_02836,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003906015,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,0,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,N,-,,multidrug resistance,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011527 (PFAM); G3DSA:1.20.1560.10 (GENE3D); PTHR24221 (PANTHER); PTHR24221:SF247 (PANTHER); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY),3.A.1.201.10, the atp-binding cassette (abc) superfamily.
RL4_JR_02837,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.007760107,0,8.901087564,4.041366561,2.202494486,0.027630398,NA,0.002334598,0,12.18995876,4.048442383,3.01102439,0.002603679,0.015349618,0.006343058,0,9.480780804,4.042868098,2.345063102,0.01902386,0.053738157,0.007335717,0,9.055356819,4.042572319,2.23999872,0.025091006,0.08557795,0.006581095,0,9.341867313,1.819064456,5.135533973,2.81E-07,4.95E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_02838,1766,1969,2096,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,39.39044955,1,-0.906302152,1.008429627,-0.898726226,0.368798504,0.5607937,7.443739918,0,0.569489177,1.221703716,0.466143444,0.641112829,0.766257432,19.32729287,0,-2.083578599,1.190346814,-1.75039625,0.080049963,0.162866926,31.93321448,1,-1.556721769,1.140888811,-1.364481582,0.172416047,0.29533285,19.06217136,0,-2.166383995,1.194344885,-1.813868022,0.069698047,0.144431585,N,-,,kinase-like domain,F:ATP binding; C:membrane; C:integral component of membrane; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); IPR011009 (SUPERFAMILY),,
RL4_JR_02839,37,37,37,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.015572136,0,7.899458556,3.974566037,1.987502153,0.046866778,NA,0.005005645,0,11.10559461,3.974227246,2.79440352,0.005199555,0.021136506,0.013004533,0,8.449602389,2.844306081,2.970707845,0.002971143,0.013488722,0.014998643,0,8.029635455,3.97405316,2.020515361,0.043329958,0.113246213,0.012910819,0,8.3508871,1.560789616,5.350424565,8.77E-08,2.01E-06,N,-, Effector probability:0.665,GTP-binding rhb1,F:GTP binding; C:nucleus; P:small GTPase mediated signal transduction; F:GTPase activity; C:membrane; F:GDP binding; P:regulation of L-arginine import; C:cytosol,PR00449 (PRINTS); SM00174 (SMART); SM00175 (SMART); SM00173 (SMART); IPR005225 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001806 (PFAM); IPR020849 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_02840,1009,1532,1595,0,0,0,0,0,0,0,0,0,0,3,1,0,0,1,322.4728468,0,-4.053536036,0.84716782,-4.784808792,1.71E-06,2.44E-05,97.93334189,0,-3.148210072,1.186785088,-2.652721291,0.007984577,0.028538096,254.0436835,0,-5.799946521,1.187729544,-4.883221565,1.04E-06,2.81E-05,293.0663141,1,-6.222265842,1.185436548,-5.248923576,1.53E-07,3.32E-06,269.7285269,1,-2.961089901,0.687823873,-4.305011816,1.67E-05,0.000154109,N,-,,hypothetical protein SPI_03136,,no IPS match,,
RL4_JR_02841,63,71,75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.202568047,0,1.631596896,1.441900599,1.131559899,0.257819507,NA,0.380599286,0,4.859069467,1.629863687,2.98127353,0.002870523,0.015349618,0.992324352,0,2.19990289,1.253536563,1.754957098,0.079266646,0.161532916,1.14515064,0,1.777173318,1.296320611,1.370936559,0.170394734,0.292712365,0.98280934,0,2.111697566,1.240849149,1.701816509,0.088789771,0.174596316,N,-,,glycoside hydrolase family 18,"P:carbohydrate metabolic process; F:transaminase activity; C:extracellular region; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:cellulose binding",IPR013781 (G3DSA:3.20.20.GENE3D); PTHR11177:SF185 (PANTHER); PTHR11177 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_02842,44,71,65,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11275845,0,5.046375733,3.794256226,1.330003941,0.183516973,NA,0.035930364,0,8.26432905,2.564796575,3.22221619,0.001272031,0.015023052,0.093165559,0,5.614035034,1.470926576,3.816665716,0.000135267,0.00138889,0.107482178,0,5.190844374,2.250112472,2.306926626,0.021058911,0.078592508,0.091671463,0,5.535573298,1.288583105,4.295860528,1.74E-05,0.000159594,Y,-,,DNAse1,,no IPS match,,
RL4_JR_02843,2092,2058,3060,1,0,4,0,0,0,0,1,0,0,6,1,0,6,0,21.42344948,1,-1.293523991,1.155535694,-1.119415002,0.262963134,0.442685358,5.584170885,0,0.984114141,1.240922888,0.793050197,0.427748577,0.590612938,47.75715866,1,0.750882828,0.858890015,0.874247942,0.381983243,0.525791754,42.14476114,1,0.937353443,0.689307965,1.359847107,0.173878312,0.297183982,22.12475642,1,-0.10078422,0.997001063,-0.101087375,0.9194811,0.948390295,N,-,,kinase-like domain,,G3DSA:3.90.1200.10 (GENE3D); IPR002575 (PFAM); PTHR21310:SF16 (PANTHER); PTHR21310 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_02844,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.363072995,0,3.359435456,2.41382406,1.391748269,0.16399864,NA,0.113976372,0,6.598521301,2.11897749,3.114011986,0.00184562,0.015023052,0.298337897,0,3.934006714,1.404632511,2.800737334,0.0050986,0.019201401,0.344396413,0,3.510713709,1.672536062,2.099036181,0.035813711,0.100391425,0.296260715,0,3.842633949,1.332768049,2.883197832,0.003936601,0.01474587,N,-, Effector probability:0.788,methyltransferase domain-containing,F:methyltransferase activity; F:transferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR029063 (SUPERFAMILY),,
RL4_JR_02845,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,118.6266804,0,-0.269330342,0.655148292,-0.41109829,0.681000464,0.825249121,39.37485394,0,0.723873453,1.03305774,0.700709577,0.483484278,0.640050727,76.1774416,0,-1.163398206,0.902370963,-1.289268222,0.197304855,0.322439766,98.60635181,0,-0.911429515,0.739332433,-1.232773613,0.217660239,0.352609586,76.19396134,0,-1.037770652,0.826978524,-1.254894319,0.209517127,0.332710305,N,-, Effector probability:0.739,hypothetical protein GGTG_13556,,no IPS match,,
RL4_JR_02846,371,366,463,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,3.93273123,1,-0.077779756,1.264216733,-0.061524068,0.950941847,0.976014987,1.242600786,0,3.152078897,1.397343873,2.255764638,0.024085375,0.066573502,3.242527642,0,0.491794798,1.234227978,0.398463499,0.690288559,0.788056086,3.742153758,0,0.068900771,1.241843552,0.05548265,0.955753952,0.974326295,3.213439199,0,0.402278892,1.239604121,0.324522067,0.745542818,0.822379457,N,-,,Ergosterol biosynthesis ERG4 ERG24 family,"F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; C:integral component of membrane; P:oxidation-reduction process",IPR001171 (PFAM); PTHR21257 (PANTHER); PTHR21257 (PANTHER); PTHR21257:SF31 (PANTHER); PTHR21257:SF31 (PANTHER),,
RL4_JR_02847,807,927,1035,0,3,0,0,0,0,0,0,0,0,0,0,0,4,3,0.040274007,1,6.531826109,3.933179874,1.660698549,0.096774005,NA,0.01270042,0,9.764079872,3.151935634,3.097804336,0.001949601,0.015023052,0.033157009,0,7.103683003,1.795339638,3.956734901,7.60E-05,0.000971254,0.038268814,0,6.680470673,3.382020971,1.975289547,0.048235299,0.120143272,0.032851055,1,7.019562835,1.379627322,5.088013788,3.62E-07,6.09E-06,N,-,,Cytochrome P450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_02848,6,15,14,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0.019504112,1,7.575372061,3.961019049,1.912480593,0.055814579,NA,0.006509392,0,10.7300969,3.9588721,2.710392412,0.006720365,0.025175252,0.016494478,0,8.109867811,2.851793459,2.843778109,0.004458208,0.017386326,0.018993711,0,7.690398192,3.960048927,1.941995752,0.052137615,0.125807414,0.015949996,0,8.040879118,1.654939983,4.858713428,1.18E-06,1.67E-05,N,-,,hypothetical protein IQ07DRAFT_576909,,no IPS match,,
RL4_JR_02849,1515,1364,1804,2,0,0,0,0,0,0,0,2,0,0,0,0,0,0,4.875599514,1,-0.388107842,1.23539978,-0.314155667,0.753402812,0.870813525,1.572128382,0,2.812840267,1.380688994,2.037272898,0.041622702,0.102308157,4.05559521,1,0.169017626,1.228482036,0.137582497,0.890570389,0.931343244,4.676621692,0,-0.252715496,1.232037797,-0.205119921,0.837478432,0.898239408,3.97924854,0,0.093513517,1.224502501,0.07636858,0.939125866,0.960857861,N,-,,intracellular serine protease,P:proteolysis; C:membrane; C:integral component of membrane; F:serine-type endopeptidase activity; F:peptidase activity,IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (PFAM); IPR000209 (SUPERFAMILY),,
RL4_JR_02850,1672,1456,1667,0,2,2,0,0,0,0,3,1,0,0,0,0,0,0,3.542971043,1,0.072526204,1.29526375,0.055993387,0.955347075,0.977466894,1.148448093,0,3.265894929,1.466109596,2.227592628,0.025907693,0.070361595,2.95382531,1,0.626359207,1.260718816,0.496827047,0.61931102,0.733236437,7.416993936,0,1.148210665,1.204806871,0.953024666,0.340577573,0.487605759,2.890544944,0,0.554613751,1.254108084,0.442237602,0.658317279,0.756493298,N,-,,ankyrin repeat domain-containing 28,P:biological_process; F:zinc ion binding; F:metal ion binding; C:cellular_component,IPR002110 (SMART); IPR000433 (SMART); PF13637 (PFAM); IPR000433 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); PTHR24198 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR000433 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR020683 (SUPERFAMILY),8.A.28.1.1, the ankyrin (ankyrin) family.
RL4_JR_02851,18575,19434,14625,0,0,13,0,2,0,0,0,2,5,11,5,0,3,4,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_02852,1259,1796,2045,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,"ankyrin 2,3",F:nucleotide binding; F:ATP binding; P:signal transduction; C:membrane; C:integral component of membrane; F:protein kinase activity; P:phosphorylation; F:protein serine/threonine kinase activity; P:protein phosphorylation; F:kinase activity,IPR002110 (SMART); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24198 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_02853,13616,21271,25548,3,0,1,0,0,0,0,0,0,0,3,0,0,1,0,0.01625695,1,7.841892454,3.971935915,1.97432502,0.048344798,NA,0.005182911,0,11.05900183,3.759459354,2.941646868,0.00326472,0.016208996,0.013406975,0,8.413847212,2.242522468,3.751956706,0.00017546,0.001628189,0.015466548,1,7.98848385,3.972176633,2.011109925,0.044313847,0.114176173,0.01313498,1,8.343198162,1.511882806,5.518415931,3.42E-08,1.07E-06,N,-, Effector probability:0.722,integral membrane,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_02854,57,90,81,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0.015927524,1,7.869332732,3.973176761,1.980614809,0.047634487,NA,0.00517839,0,11.06015741,3.759614657,2.941832721,0.003262761,0.016208996,0.013285358,0,8.423639838,2.241829332,3.757484888,0.00017163,0.001605896,0.015314398,0,8.001728236,3.972774847,2.014140882,0.043994744,0.113902079,0.012960057,0,8.348352688,1.510574778,5.526606699,3.26E-08,1.06E-06,N,-,,major facilitator superfamily transporter,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF262 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_02855,2012,2889,3128,0,0,4,0,0,0,0,1,1,0,0,1,0,6,1,41.43920193,1,1.407511132,0.736845239,1.910185555,0.056109326,0.144762772,3.005779134,0,1.877826065,1.275709155,1.471986038,0.141024648,0.263221738,7.78210353,1,-0.771043232,1.194858777,-0.645300722,0.518732325,0.649072557,8.976686139,1,-1.193216721,1.19232211,-1.00075031,0.316947538,0.463204688,7.651677282,1,-0.849513838,1.192497597,-0.712382012,0.476228251,0.606172522,N,-,,peptidase family t4,F:ATP binding; P:proteolysis; F:aminopeptidase activity,IPR005321 (PFAM); IPR016117 (G3DSA:3.60.70.GENE3D); PTHR36512 (PANTHER); PTHR36512:SF1 (PANTHER); IPR016117 (SUPERFAMILY); IPR016117 (SUPERFAMILY),,
RL4_JR_02856,916,1105,1010,0,0,0,0,0,0,0,1,5,0,4,0,0,0,0,29.41305285,0,3.970131913,0.595796184,6.663573916,2.67E-11,1.02E-09,0.855877826,0,3.690083138,1.43147005,2.577827694,0.009942356,0.033441294,2.219019636,1,1.039288756,1.214627759,0.855643837,0.392194814,0.535623945,2.559917494,1,0.616913018,1.221149093,0.50519058,0.613424986,0.732713144,2.184361464,0,0.959240645,1.207461492,0.794427525,0.426946585,0.561479955,Y,-,,glycoside hydrolase family 13,F:alpha-amylase activity; F:starch binding; F:calcium ion binding; P:carbohydrate catabolic process,IPR006047 (SMART); IPR002044 (SMART); IPR006047 (PFAM); IPR015340 (PFAM); IPR013780 (G3DSA:2.60.40.GENE3D); IPR013781 (G3DSA:3.20.20.GENE3D); IPR002044 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR015902 (PANTHER); PTHR10357:SF165 (PANTHER); IPR002044 (PROSITE_PROFILES); SSF51011 (SUPERFAMILY); IPR017853 (SUPERFAMILY); IPR013784 (SUPERFAMILY),8.A.9.1.2, the rbat transport accessory protein (rbat) family.
RL4_JR_02857,1941,2497,2090,3,1,9,0,0,2,0,5,2,5,3,0,0,1,3,2.909471472,1,0.356766412,1.272766594,0.280307807,0.779241362,0.886370752,0.921004135,1,3.584091757,1.433599722,2.500064489,0.01241707,0.039670907,2.404103003,1,0.923100304,1.233101601,0.748600361,0.454098114,0.593351743,2.774367293,1,0.500352714,1.244063676,0.402192206,0.687542578,0.788310421,2.386657267,1,0.831314196,1.237560719,0.671736088,0.501751723,0.629466829,N,-,,beta-glucosidase d,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR001764 (PRINTS); IPR026891 (SMART); IPR026891 (PFAM); IPR001764 (PFAM); IPR002772 (G3DSA:3.40.50.GENE3D); IPR001764 (G3DSA:3.20.20.GENE3D); IPR002772 (PFAM); PTHR30620:SF57 (PANTHER); IPR026892 (PANTHER); IPR017853 (SUPERFAMILY); IPR002772 (SUPERFAMILY),,
RL4_JR_02858,3,2,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,219.4882979,0,5.263662883,2.105796956,2.499606084,0.012433147,0.045220513,1.815139691,0,2.605511279,1.334789558,1.952001545,0.050938021,0.11954432,25.52756653,0,2.364000718,0.859659915,2.749925497,0.005960882,0.021668928,24.35314894,0,1.284639312,1.018901958,1.26080758,0.207378182,0.339702976,20.04011908,0,2.492347805,0.756096794,3.296334312,0.000979554,0.004700465,Y,-,,glycoside hydrolase family 15,"F:glucan 1,4-alpha-glucosidase activity; F:starch binding; P:polysaccharide catabolic process; C:fungal-type vacuole",IPR000165 (PRINTS); IPR002044 (SMART); IPR012341 (G3DSA:1.50.10.GENE3D); IPR011613 (PFAM); IPR002044 (PFAM); IPR008291 (PIRSF); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR31616:SF0 (PANTHER); PTHR31616 (PANTHER); IPR002044 (PROSITE_PROFILES); IPR008928 (SUPERFAMILY); IPR013784 (SUPERFAMILY),,
RL4_JR_02859,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.06630546,0,1.691895502,0.890075057,1.900845876,0.057322203,0.147101143,24.09036619,0,3.561037569,1.12528508,3.164564814,0.001553151,0.015023052,4.630963641,0,-0.022349145,1.215345478,-0.018389129,0.985328425,0.992879961,5.343809743,0,-0.445060178,1.216826345,-0.365754884,0.714547988,0.808947768,12.30053046,0,1.549926552,1.005207909,1.541896494,0.123098748,0.223284633,N,-,,glutamyl-trna amidotransferase subunit a,F:catalytic activity,IPR023631 (G3DSA:3.90.1300.GENE3D); IPR023631 (PFAM); PTHR11895:SF93 (PANTHER); IPR000120 (PANTHER); IPR023631 (SUPERFAMILY),,
RL4_JR_02860,2171,1563,2300,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,53.21350256,1,-2.783133684,1.174462625,-2.369708175,0.01780213,0.059691647,15.98329129,0,-0.532949439,1.247189077,-0.427320484,0.669145915,0.788825193,47.61776221,0,-2.210946062,1.216936029,-1.81681371,0.069245643,0.145632595,71.47784263,1,-0.369701222,0.711303057,-0.51975205,0.603236404,0.724441773,98.93246612,0,0.388210499,0.600738229,0.646222398,0.518135336,0.643436639,N,-,,Copper-translocating P-type ATPase,P:cation transport; F:cation-transporting ATPase activity; P:ion transmembrane transport; C:membrane; F:binding,PR00119 (PRINTS); IPR008250 (G3DSA:2.70.150.GENE3D); IPR023299 (G3DSA:3.40.1110.GENE3D); PF00702 (PFAM); G3DSA:3.30.70.100 (GENE3D); IPR006121 (PFAM); IPR023214 (G3DSA:3.40.50.GENE3D); TIGR01511 (TIGRFAM); IPR027256 (TIGRFAM); IPR001757 (TIGRFAM); IPR008250 (PFAM); PTHR24093 (PANTHER); PTHR24093:SF285 (PANTHER); IPR006121 (PROSITE_PROFILES); SSF81665 (SUPERFAMILY); IPR023214 (SUPERFAMILY); SSF81653 (SUPERFAMILY); IPR006121 (SUPERFAMILY),3.A.3.5.14, the p-type atpase (p-atpase) superfamily.
RL4_JR_02861,171,136,85,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.747735409,0,-0.856631536,1.246860265,-0.687030905,0.492063254,0.679825704,2.18020863,0,2.341166214,1.369113412,1.709987056,0.087268267,0.182167332,5.603834231,0,-0.297249618,1.237176821,-0.240264458,0.810125247,0.876063661,6.461229303,0,-0.718833872,1.240711643,-0.579372231,0.562338037,0.6902258,5.466075338,0,-0.364344463,1.231073004,-0.29595683,0.76726305,0.838210874,N,-, Effector probability:0.714,hypothetical protein V502_01235,F:N-acetyltransferase activity,IPR016181 (G3DSA:3.40.630.GENE3D); IPR016181 (SUPERFAMILY),,
RL4_JR_02862,814,728,999,0,0,6,0,0,0,0,0,0,1,0,2,0,0,2,39.98172796,1,-2.332021312,1.15408325,-2.020669923,0.043313945,0.119619217,11.61626932,0,-0.072551079,1.2316957,-0.058903412,0.953029041,0.975027218,30.03839757,0,-2.71977548,1.202779243,-2.261242448,0.023744248,0.063830793,42.66680959,1,-1.423152697,1.033327342,-1.377252532,0.168434186,0.289786938,29.54303137,1,-2.798567332,1.204169556,-2.32406418,0.020122054,0.054740269,N,-,,C6 transcription,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31001:SF4 (PANTHER); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_02863,926,892,1158,1,5,0,0,0,0,0,0,1,0,1,0,0,5,1,4.595249075,1,-0.30252101,1.250417315,-0.241936037,0.808829726,0.902858546,1.487580898,0,2.892653539,1.40435652,2.059771503,0.03942039,0.097965428,3.824207206,1,0.253932104,1.23763539,0.205175213,0.837435235,0.894985149,14.04431482,1,0.786013046,1.177620766,0.667458548,0.504479279,0.641315028,3.735743445,1,0.184624352,1.229421819,0.15017169,0.880629161,0.920987837,N,-,,NAD dependent epimerase dehydratase,F:catalytic activity,IPR016040 (G3DSA:3.40.50.GENE3D); IPR016040 (PFAM); PTHR10366 (PANTHER); PTHR10366:SF267 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02864,2815,2845,5169,0,1,3,0,0,0,0,0,0,0,2,0,0,0,0,0.526218472,1,2.823980446,2.047465674,1.379256552,0.167815667,NA,9.549686802,0,6.924708094,1.231076014,5.624923248,1.86E-08,2.61E-06,0.438099974,0,3.380473223,1.360398179,2.484914546,0.012958254,0.039615493,0.504994073,1,2.958842474,1.52913341,1.93497994,0.052992757,0.126754469,0.425659856,0,3.317792049,1.294816268,2.562365125,0.010396196,0.032408092,N,-,,Alpha beta hydrolase fold-3,P:metabolic process; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR013094 (PFAM); PTHR23024 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_02865,4518,3428,2827,2,1,5,0,0,0,0,1,1,5,1,0,0,0,3,860.7231321,1,3.399432597,0.515089347,6.599695017,4.12E-11,1.53E-09,177.1774158,0,3.191601707,0.626998977,5.090282158,3.58E-07,3.48E-05,240.3928867,1,1.586266352,0.470289997,3.372953627,0.000743665,0.004549161,198.990474,1,1.078540787,0.628001079,1.717418686,0.0859027,0.174827103,185.6552416,1,1.374721742,0.608043027,2.260895498,0.023765729,0.062517019,N,-,,mannitol-1-phosphate 5-dehydrogenase,F:mannitol-1-phosphate 5-dehydrogenase activity; F:coenzyme binding; P:mannitol metabolic process; P:oxidation-reduction process; C:extracellular region,IPR000669 (PRINTS); IPR013328 (G3DSA:1.10.1040.GENE3D); IPR013118 (PFAM); IPR013131 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR30524:SF0 (PANTHER); PTHR30524 (PANTHER); IPR023028 (HAMAP); IPR016040 (SUPERFAMILY); IPR008927 (SUPERFAMILY),,
RL4_JR_02866,9435,8653,11012,0,0,5,0,0,3,2,0,0,3,6,3,0,3,0,3.19074688,1,0.22358312,1.293593898,0.172838725,0.862778197,0.932504575,1.008372242,1,3.453308708,1.441648165,2.395389383,0.016602723,0.049882091,2.636843009,1,0.789770225,1.248516937,0.632566689,0.527016646,0.656355827,3.043182761,1,0.366912513,1.2619714,0.290745506,0.771245966,0.851566565,2.624008863,1,0.694482956,1.256135328,0.55287272,0.580350569,0.692975759,N,-,,polyketide synthase,F:catalytic activity; P:metabolic process; C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_02867,3374,2600,3318,1,2,3,0,0,4,3,5,1,1,3,0,0,5,0,130.7523845,1,3.45378652,0.96313668,3.585977557,0.000335818,0.002380193,3.302597505,1,1.741959341,1.351332309,1.289068077,0.19737442,0.340867409,14.98726903,1,0.065252437,1.238222946,0.052698456,0.95797217,0.975214705,9.785865205,1,-1.317901819,1.249059967,-1.055114929,0.291372765,0.435961171,8.300352941,1,-0.967065742,1.245619131,-0.776373547,0.437528459,0.57201655,N,-,,ankyrin repeat,,IPR002110 (SMART); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24123 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),8.A.28.1.1, the ankyrin (ankyrin) family.
RL4_JR_02868,6941,7123,6239,0,0,2,0,0,2,0,0,7,0,8,0,0,0,0,24.30976559,1,0.590664298,1.011523957,0.583935056,0.559264007,0.736695452,2.664415356,1,2.051757174,1.298920649,1.579586233,0.114201654,0.22498037,6.88046722,1,-0.593459875,1.203106295,-0.49327302,0.62181969,0.735174885,7.935033757,1,-1.015367623,1.201453994,-0.845115692,0.398046248,0.542206143,6.751596401,0,-0.669131921,1.198767985,-0.558183009,0.576719422,0.690630887,N,-,,hypothetical protein Z520_04391,F:organic cyclic compound binding; F:heterocyclic compound binding; F:metal ion binding,IPR029060 (G3DSA:3.40.50.GENE3D); IPR000571 (G3DSA:4.10.1000.GENE3D); IPR021139 (PFAM); IPR001878 (PROSITE_PROFILES),,
RL4_JR_02869,7956,7665,5868,0,1,6,0,0,0,0,0,0,2,3,0,0,9,0,0.027974995,1,7.057164904,3.944726748,1.789012358,0.073612825,NA,0.00918948,0,10.233268,3.441762488,2.973263853,0.00294651,0.0154422,0.023399187,0,7.608647542,2.028930759,3.750077478,0.00017678,0.001628499,0.026960938,1,7.186064547,3.944404775,1.821837503,0.068479645,0.148587944,0.022629567,1,7.543781739,1.445745696,5.21791748,1.81E-07,3.72E-06,N,-,,FAD-dependent monooxygenase,F:FAD binding; F:oxidoreductase activity; P:oxidation-reduction process,PR00420 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR002938 (PFAM); PTHR13789 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_02870,261,281,201,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,Zn2Cys6 transcription factor,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_02871,2497,2281,1984,0,3,3,0,0,0,0,1,5,0,0,0,0,10,0,20.52373502,1,-0.798502223,1.139830618,-0.700544634,0.483587241,0.671735861,3.99046348,0,1.468939359,1.250329006,1.174842263,0.240057828,0.391913764,10.36031812,1,-1.184119592,1.192229395,-0.993197782,0.320613579,0.463169502,79.39920606,0,2.43847114,1.752635332,1.39131689,0.164129354,0.28445904,17.9451234,1,0.40009841,0.978418993,0.408923388,0.682595885,0.774460257,N,-,,bikaverin cluster-transcription factor,F:binding,IPR001138 (SMART); IPR007219 (SMART); IPR001138 (PFAM); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31001:SF49 (PANTHER); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_02872,9376,10101,17546,3,0,2,0,0,0,1,0,0,0,1,0,0,1,3,113.3369766,1,4.494530933,0.438723803,10.24455683,1.25E-24,3.10E-22,20.31022654,0,4.463757833,1.008275502,4.427121185,9.55E-06,0.000635949,32.68922477,1,2.587732758,0.866558084,2.986219627,0.002824497,0.013003733,229.6806002,1,5.712781781,0.630534455,9.060221423,1.30E-19,1.23E-17,226.7576539,1,5.863669288,0.755607517,7.760205078,8.48E-15,1.21E-12,N,-,,NMRA-like transcription factor,,IPR016040 (G3DSA:3.40.50.GENE3D); IPR008030 (PFAM); PTHR14194 (PANTHER); PTHR14194:SF65 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02873,10759,13538,16359,0,0,5,0,0,0,0,0,0,1,3,1,0,3,0,0.15506576,1,4.586547168,3.369187999,1.361321235,0.173412195,NA,0.050612076,0,7.770346821,2.469924572,3.145985472,0.001655282,0.015023052,0.129560433,0,5.13761939,1.49487734,3.436816689,0.000588594,0.003812491,0.149323973,1,4.716326977,2.088500742,2.25823572,0.023930967,0.083494502,0.126135101,1,5.069921675,1.326948086,3.820738526,0.000133053,0.00087992,Y,-,,aspartic-type endopeptidase,C:membrane,IPR021109 (G3DSA:2.40.70.GENE3D); IPR021109 (G3DSA:2.40.70.GENE3D); IPR033121 (PROSITE_PROFILES); IPR021109 (SUPERFAMILY),,
RL4_JR_02874,3145,2958,4840,0,3,5,0,0,0,0,0,0,0,0,1,0,0,0,1.748319671,1,1.091687502,1.366761494,0.798740313,0.424441007,NA,0.566397687,0,4.285796299,1.579982512,2.712559327,0.006676583,0.025076205,1.454952814,0,1.64828225,1.264266932,1.303745442,0.19232039,0.31597722,1.677395431,1,1.226762715,1.294378934,0.947761651,0.343250808,0.490253138,1.419807111,0,1.580140656,1.242969947,1.271262157,0.203635401,0.325977618,Y,-,,nadh-cytochrome b5 reductase,F:oxidoreductase activity; C:membrane,IPR001834 (PRINTS); IPR001433 (PFAM); IPR008333 (PFAM); G3DSA:2.40.30.10 (GENE3D); G3DSA:3.40.50.80 (GENE3D); PTHR19370:SF101 (PANTHER); PTHR19370 (PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY); IPR017938 (SUPERFAMILY),5.B.1.2.4, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_02875,28,35,38,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.02508322,0,7.217568703,3.949166819,1.827618086,0.06760689,NA,0.008035744,0,10.42767063,3.949072273,2.640536793,0.00827748,0.029234005,0.02059251,0,7.795564077,2.8039136,2.780244041,0.005431806,0.020128699,0.023749531,0,7.370910942,3.949521934,1.866279277,0.062002303,0.139336241,0.019863789,0,7.747075735,1.739901792,4.452593686,8.48E-06,8.72E-05,,,,,,,,
RL4_JR_02876,4452,4330,7955,5,2,0,0,0,0,0,0,1,0,1,0,0,0,0,0.003880053,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,0,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,Y,-,,SGNH hydrolase- subgroup,"F:hydrolase activity, acting on ester bonds; F:hydrolase activity",IPR013830 (G3DSA:3.40.50.GENE3D); PTHR37981:SF1 (PANTHER); PTHR37981 (PANTHER); IPR013830 (SUPERFAMILY),,
RL4_JR_02877,4689,3472,6264,0,3,3,0,0,0,0,1,0,1,0,3,0,9,1,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-, Effector probability:0.807,glycoside hydrolase family 18,"F:hydrolase activity, hydrolyzing O-glycosyl compounds; P:organic substance metabolic process",IPR001223 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR11177 (PANTHER); PTHR11177:SF174 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_02878,21857,29055,36198,1,7,39,0,0,0,4,0,0,10,21,6,0,19,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,Y,-,,peptidoglycan-binding protein,,IPR018392 (PFAM); PTHR21666:SF212 (PANTHER); PTHR21666 (PANTHER); IPR018392 (SUPERFAMILY); IPR018392 (SUPERFAMILY),,
RL4_JR_02879,8499,17804,16102,26,60,50,0,0,9,0,2,7,9,13,1,0,13,8,0.142862521,1,4.704761181,3.441152919,1.367204914,0.171561085,NA,0.045591642,1,7.920290803,2.459262807,3.22059553,0.001279245,0.015023052,0.118491356,1,5.264569122,1.443312108,3.647561114,0.000264741,0.002110426,0.136695804,1,4.843357747,2.079200402,2.329432864,0.019836146,0.076540006,0.117219703,1,5.177787664,1.290376682,4.012617198,6.00E-05,0.000452044,N,-,,hypothetical protein CMQ_3775,,no IPS match,,
RL4_JR_02880,1370,2104,1828,0,0,2,0,0,1,1,0,0,3,5,1,0,2,0,9.034356394,1,-1.277623016,1.240927737,-1.029570842,0.303211509,0.489415953,2.860287061,1,1.949352,1.318659076,1.478283535,0.139331903,0.260976595,7.44626894,1,-0.707475285,1.227765488,-0.576229982,0.564459742,0.689138108,17.90508642,1,-0.176769956,1.176655669,-0.150230829,0.880582504,0.92661179,7.355042778,1,-0.792415359,1.234745658,-0.641764038,0.521026403,0.645386876,N,-,,Short-chain dehydrogenase reductase SDR,,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02881,5867,5882,8108,0,2,2,0,0,1,0,2,3,1,3,0,0,0,0,0.610235978,1,2.610146886,1.814889896,1.438184703,0.150381654,NA,0.196618397,1,5.812152358,1.849866564,3.141930597,0.001678378,0.015023052,0.507227936,1,3.168293559,1.282448106,2.470504299,0.01349227,0.040875959,0.58491475,1,2.746492823,1.392620207,1.972176484,0.048589463,0.120758055,0.497477893,0,3.092588672,1.237188121,2.499691533,0.012430149,0.037434639,N,-,,phosphotransferase enzyme family,F:transferase activity,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); PTHR21310:SF21 (PANTHER); PTHR21310 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_02882,2563,3107,2836,0,0,7,0,0,0,0,0,1,0,2,0,0,6,2,3.96203846,1,-0.088659662,1.26483931,-0.070095593,0.944117574,0.972375702,1.250770938,0,3.142554221,1.396013567,2.251091461,0.024379745,0.067203644,3.269970537,1,0.479433263,1.235881964,0.387928036,0.69806929,0.79425191,3.774010552,1,0.056494055,1.24379469,0.045420724,0.963771963,0.979049977,3.25057342,1,0.385624127,1.244491651,0.309864776,0.75666379,0.830721105,N,-,,microsomal signal peptidase 12kda subunit,P:biological_process; C:cellular_component; F:molecular_function,IPR000073 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR37017 (PANTHER); PTHR37017:SF4 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_02883,12861,13938,19318,1,9,21,0,0,0,1,4,1,0,11,0,0,1,0,0.019807577,1,7.554471241,3.960244045,1.907577199,0.056445884,NA,0.006345689,0,10.76483733,3.598854133,2.991184674,0.002778974,0.015349618,0.016456887,1,8.11166391,2.107222176,3.849458308,0.000118379,0.001287296,0.018982256,1,7.691271347,3.960080967,1.942200529,0.052112829,0.125807414,0.016250605,1,8.025401699,1.467255338,5.469669453,4.51E-08,1.22E-06,N,-,,ferric-chelate reductase,F:nucleotide binding; F:ATP binding; F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,IPR013112 (PFAM); IPR013121 (PFAM); G3DSA:3.40.50.80 (GENE3D); PTHR32361:SF9 (PANTHER); PTHR32361 (PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY),5.B.1.5.4, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_02884,2778,2552,1877,0,1,1,0,0,0,0,0,7,0,6,4,0,5,2,0.003906015,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,1,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,N,-,,ferric-chelate reductase,F:nucleotide binding; F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process; P:phosphorylation; F:kinase activity,IPR013130 (PFAM); PTHR32361:SF9 (PANTHER); PTHR32361 (PANTHER),5.B.1.5.3, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_02885,1378,960,1223,1,1,3,0,0,0,0,0,2,0,0,5,0,0,4,8.007376696,1,-1.103837809,1.242923593,-0.888097881,0.374488103,0.56638423,2.541966729,0,2.119463161,1.331614318,1.591649423,0.111463498,0.220401159,13.12906108,1,0.421455913,1.225111354,0.344014372,0.730835478,0.818561608,7.650669908,1,-0.962962496,1.236028651,-0.779077811,0.43593388,0.577802138,6.583885165,1,-0.632744514,1.244563009,-0.508406975,0.611167962,0.718874956,N,-,,cell division kinase,P:cell division; F:ATP binding; P:positive regulation of protein kinase activity; F:protein kinase activator activity; F:protein kinase activity; P:protein phosphorylation; C:intracellular part,IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); PTHR24056:SF206 (PANTHER); PTHR24056 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_02886,615,629,770,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,86.57773038,0,1.530642548,0.912545638,1.677332601,0.093477461,0.210663471,8.109240291,0,0.445931439,1.217968853,0.366127128,0.714270215,0.8210133,21.0722915,0,-2.208323078,1.190729468,-1.854596814,0.063653823,0.136618891,69.90731096,0,0.695614813,0.612070777,1.136494077,0.255749843,0.395036943,40.10797464,0,0.628998857,0.686995846,0.915578837,0.359887836,0.497252229,Y,-,,palmitoyl- thioesterase 1,F:palmitoyl-(protein) hydrolase activity; P:protein depalmitoylation; C:endoplasmic reticulum; P:vacuolar acidification; C:lysosome,IPR002472 (PRINTS); IPR002472 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR030294 (PTHR11247:PANTHER); PTHR11247 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_02887,1161,1306,2325,0,0,0,0,0,0,0,2,1,1,3,0,0,0,0,0.011666121,0,8.315060612,3.996942811,2.080355163,0.037492969,NA,0.003670122,0,11.54963874,3.998254364,2.888670325,0.003868744,0.017716233,0.009673795,1,8.874006407,3.050060812,2.909452288,0.003620626,0.015525295,0.01116718,1,8.453598072,3.996777749,2.115103366,0.034421138,0.099376683,0.009745957,0,8.762396083,1.617624164,5.416830608,6.07E-08,1.53E-06,N,-,,heterokaryon incompatibility,P:biological_process; C:cellular_component; F:molecular_function,IPR010730 (PFAM); PTHR24148 (PANTHER),,
RL4_JR_02888,3998,3655,6185,0,3,0,0,0,0,0,0,0,3,2,0,0,0,0,7.816121812,1,-1.068867676,1.232257604,-0.86740603,0.385719579,0.578863195,2.470087811,0,2.160838102,1.314140951,1.644297059,0.100114856,0.202661117,6.453972105,0,-0.501387659,1.222383295,-0.410172211,0.681679624,0.781311504,7.448480003,1,-0.924295309,1.224389106,-0.754903245,0.450307039,0.592278354,25.71535175,0,2.278544131,0.762981956,2.986366994,0.002823136,0.01127584,N,-,,nadph-dependent 1-acyldihydroxyacetone phosphate reductase,F:oxidoreductase activity; C:membrane; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); PTHR24322:SF484 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02889,208,177,214,0,0,2,0,0,0,0,3,0,0,5,7,0,0,0,50.1283249,1,7.039898787,0.802774333,8.769461719,1.80E-18,1.93E-16,0.155418277,0,6.151397328,1.922939186,3.19895573,0.001379263,0.015023052,0.402685306,1,3.501958798,1.289316487,2.716135901,0.00660488,0.023454158,0.464541124,1,3.079224516,1.438128245,2.141133467,0.032263276,0.096106406,0.395945751,0,3.423660263,1.237646192,2.766267359,0.005670203,0.019858458,N,-,,alpha-ketoglutarate-dependent taurine dioxygenase,F:sulfonate dioxygenase activity; P:sulfur compound catabolic process; P:oxidation-reduction process,IPR003819 (PFAM); G3DSA:3.60.130.10 (GENE3D); PTHR30468:SF2 (PANTHER); PTHR30468 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_02890,8,7,20,0,0,0,0,0,0,0,1,18,0,0,1,0,19,0,3.850408941,0,7.806489765,1.348266845,5.790018346,7.04E-09,1.68E-07,0.010356779,0,10.05972386,3.29154909,3.056227808,0.002241409,0.015045494,0.026570716,1,7.4235516,1.892858295,3.92187393,8.79E-05,0.001074667,0.030628796,1,7.001724368,3.702391942,1.891135373,0.058606276,0.135014457,0.025920114,1,7.349611104,1.404773655,5.231882785,1.68E-07,3.49E-06,N,-,,pantothenate transporter liz1,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF173 (PANTHER); PTHR11662 (PANTHER); PTHR11662:SF173 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_02891,8357,7619,8995,0,3,24,0,0,0,1,6,1,1,8,5,0,10,0,0.012706323,1,8.20293094,3.990270723,2.055732934,0.039808266,NA,0.004020132,0,11.42967648,3.991033794,2.863838561,0.004185413,0.018371529,0.010357064,1,8.787173804,3.991470463,2.201487869,0.027701505,0.072039566,0.01195084,1,8.36455496,3.991447685,2.095619339,0.036115972,0.100959199,0.010019356,1,8.741909568,1.949319774,4.484594926,7.31E-06,7.74E-05,N,-,,2og-fe oxygenase,F:dioxygenase activity; F:iron ion binding; P:oxidation-reduction process,PR00682 (PRINTS); IPR027443 (G3DSA:2.60.120.GENE3D); IPR026992 (PFAM); IPR005123 (PFAM); PTHR10209 (PANTHER); PTHR10209:SF161 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_02892,12188,10410,14304,0,2,2,0,0,0,0,0,2,0,1,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,allantoate permease,F:allantoate transmembrane transporter activity; P:transmembrane transport; F:dipeptide transporter activity; P:dipeptide transport; P:tripeptide transport; C:integral component of membrane; C:plasma membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF268 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.4, the major facilitator superfamily (mfs).
RL4_JR_02893,21793,18573,22147,2,3,5,0,0,0,0,0,1,5,6,0,1,0,0,0.052980331,1,6.136545757,3.926865623,1.562708365,0.118121206,NA,0.016720552,0,9.36808833,3.050966171,3.070531695,0.00213678,0.015045494,0.043514072,1,6.713731957,1.777075021,3.777967659,0.000158113,0.001535778,0.050219654,1,6.288914864,3.109085787,2.022753727,0.043098545,0.113020659,0.042870411,1,6.636706693,1.395704367,4.755094884,1.98E-06,2.57E-05,N,-, Effector probability:0.57,DSBA oxidoreductase,F:protein disulfide oxidoreductase activity; C:membrane; P:oxidation-reduction process,IPR001853 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR014440 (PIRSF); PTHR13887 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_02894,1019,936,1108,0,4,2,0,0,0,0,0,0,0,3,2,0,4,0,0.410626736,1,3.181684475,2.201304114,1.445363434,0.148355829,NA,0.129615244,0,6.41288113,2.003826546,3.200317484,0.001372763,0.015023052,0.338950844,0,3.748781381,1.326212833,2.826681576,0.004703307,0.018094969,0.391200032,1,3.326430491,1.527948673,2.177056436,0.029476357,0.091352346,0.337086469,1,3.655640101,1.273856054,2.869743478,0.004108049,0.015224992,N,-,,ankyrin repeat-containing,F:nucleic acid binding; F:DNA binding; F:catalytic activity; P:nucleoside metabolic process,IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); PTHR24198 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),8.A.28.1.2, the ankyrin (ankyrin) family.
RL4_JR_02895,3840,4022,2797,0,0,0,0,0,0,0,0,0,0,3,0,0,4,0,5.594884509,0,2.01481801,1.17676538,1.712166286,0.086866029,0.199417297,0.564126843,0,4.291416517,1.525150457,2.813766011,0.004896486,0.020348467,1.466657782,0,1.636573415,1.234107716,1.326118778,0.184800357,0.306206026,1.692282595,1,1.21394681,1.254924524,0.967346471,0.33337086,0.480002838,1.447666121,1,1.55288632,1.225375637,1.267273702,0.20505744,0.327580717,N,-,,aflatoxin B1 aldehyde reductase member 2,C:cytoskeleton; F:oxidoreductase activity; P:actin filament organization; P:oxidation-reduction process,IPR020471 (PRINTS); IPR023210 (G3DSA:3.20.20.GENE3D); IPR023210 (PFAM); IPR001395 (PANTHER); PTHR11732:SF261 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.6, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_02896,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26.90996624,0,7.66307645,0.92827237,8.255202567,1.52E-16,1.21E-14,0.056128982,0,7.619926198,2.443382323,3.118597579,0.00181714,0.015023052,32.64155146,0,7.921152682,1.33130724,5.94990581,2.68E-09,1.31E-07,0.170771581,0,4.522321504,2.063990012,2.191057844,0.028447607,0.089617928,0.148059092,0,4.843821192,1.381998712,3.504939007,0.000456712,0.002515702,Y,-,,hypothetical protein PFICI_14669,P:carbohydrate metabolic process,IPR024749 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); IPR025277 (PFAM); PTHR37836:SF1 (PANTHER); PTHR37836 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_02897,6673,2566,2367,0,3,4,0,0,0,0,0,2,0,0,0,0,0,0,331.0865717,1,-3.055960359,0.730583045,-4.182906217,2.88E-05,0.000287941,94.56306627,0,-3.09769446,1.218582871,-2.542046614,0.011020547,0.036218122,246.9712042,1,-5.75921025,1.226661682,-4.695027435,2.67E-06,6.15E-05,289.0568429,0,-5.237721507,1.184367296,-4.422379379,9.76E-06,0.000138432,252.6306916,0,-4.205194298,1.046862894,-4.016948468,5.90E-05,0.000444665,N,-,,electron transfer flavo alpha-subunit,C:intracellular ribonucleoprotein complex; C:intracellular non-membrane-bounded organelle; F:binding,IPR016094 (G3DSA:3.30.190.GENE3D); IPR028364 (PFAM); PTHR23105:SF31 (PANTHER); PTHR23105 (PANTHER); IPR023674 (SUPERFAMILY),,
RL4_JR_02898,8570,7016,8068,3,2,3,0,0,0,0,0,0,0,2,0,0,1,0,37.86884188,1,2.65188604,0.631901044,4.196679311,2.71E-05,0.000273128,2.35877688,0,2.227577399,1.331561316,1.672906364,0.094345731,0.193569337,47.12926235,0,2.432281919,0.765733808,3.176406599,0.001491118,0.007854359,7.006871904,1,-0.835800516,1.217947532,-0.686236882,0.492563744,0.631452001,50.84717052,1,3.13997956,0.569818005,5.510495517,3.58E-08,1.12E-06,N,-,,transcription factor Tos4,C:nucleus,PTHR23105 (PANTHER); PTHR23105:SF42 (PANTHER); IPR000253 (PROSITE_PROFILES),,
RL4_JR_02899,9808,19083,30152,3,10,1,0,0,1,3,0,8,0,4,1,0,1,0,207.8612595,1,1.894930553,0.652407268,2.90452091,0.003678156,0.016867004,13.97878355,1,-0.339619364,1.329374622,-0.255473031,0.798357771,0.87792752,106.2524964,1,0.999521788,1.732845295,0.576809592,0.564068089,0.688940202,87.66465984,1,0.018074346,0.813671902,0.02221331,0.9822778,0.989116134,87.54350563,1,0.944680492,0.688715783,1.371655065,0.170170843,0.284978463,N,-,,hypothetical protein CMQ_4050,,no IPS match,,
RL4_JR_02900,127,150,247,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,86.72460444,0,0.242935303,0.516538055,0.470314433,0.638130387,0.793641655,14.78429663,0,-0.420441536,1.211180621,-0.347133639,0.728490923,0.830755422,250.6644498,0,2.598771626,0.409319215,6.349009595,2.17E-10,1.21E-08,140.7265011,0,1.23089524,0.400351555,3.074535928,0.002108303,0.013771981,239.2623134,0,2.581872339,0.469084231,5.504069781,3.71E-08,1.15E-06,N,-,,conserved serine-threonine rich,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_02901,11039,10716,13553,5,2,21,0,0,1,2,9,6,3,1,7,0,2,2,257.9738836,1,-0.222304773,0.528901425,-0.420314188,0.674255946,0.820369875,92.14520572,1,0.812284778,0.770840661,1.05376483,0.291990599,0.451007035,220.5013891,1,-0.002507966,0.529631522,-0.004735303,0.996221789,0.998589048,158.1583562,1,-1.876645738,0.721321041,-2.601678908,0.009276866,0.045815218,166.100217,1,-0.819409743,0.569961947,-1.437656929,0.150531419,0.259514834,N,-,,ring zinc finger,F:binding; P:cellular process,SM01197 (SMART); IPR001841 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001841 (PFAM); PTHR12389 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_02902,1475,1064,1815,0,4,17,0,0,0,0,0,1,0,6,0,0,0,0,24.80299237,1,1.297386473,0.846764183,1.532169757,0.12548055,0.260608534,3.00968601,0,1.875875988,1.321926891,1.419046696,0.155885403,0.284917307,7.849177905,1,-0.783537148,1.233283973,-0.635325817,0.525215939,0.655080222,25.10503506,1,1.458903836,0.827140439,1.763792177,0.077766975,0.16312647,7.768570431,0,-0.871342961,1.242825516,-0.701098384,0.483241619,0.611755613,N,-,,binding domain-containing,F:cofactor binding,IPR003781 (SMART); IPR003781 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR33303:SF2 (PANTHER); PTHR33303 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02903,3607,3298,4541,1,1,2,0,0,3,1,0,1,1,2,0,0,6,0,187.4199816,1,0.397445393,0.435325048,0.912985352,0.361250245,0.552508343,36.86151959,1,-0.398572801,1.12474129,-0.354368426,0.723062793,0.826338946,186.943839,1,0.580536576,0.45566182,1.274051394,0.202645203,0.328410442,172.5775734,1,0.315237394,0.435285402,0.724208514,0.468937732,0.610074811,148.2185309,1,0.395591534,0.44405219,0.890867205,0.373000416,0.509254208,N,-,,SAFF domain-containing,C:cell part,IPR018808 (PFAM); PTHR23065 (PANTHER); PTHR23065:SF21 (PANTHER); PTHR23065:SF21 (PANTHER); PTHR23065 (PANTHER); SSF103657 (SUPERFAMILY),,
RL4_JR_02904,4802,5004,5743,1,0,11,0,0,4,0,2,0,0,8,2,0,0,1,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,4.011588141,1,11.75557537,4.070305888,2.888130694,0.003875388,0.022892827,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_02905,1012,774,820,0,0,0,0,0,0,0,0,0,0,3,0,0,0,1,1.78411169,0,1.062555493,1.290151803,0.823589512,0.410172837,NA,0.572443939,0,4.270409336,1.521625468,2.806478615,0.005008624,0.020667464,1.479086762,0,1.62459292,1.225315936,1.325856355,0.184887282,0.306299925,1.705900606,1,1.202496632,1.2420495,0.968155159,0.332966886,0.47955757,1.451443966,1,1.548628288,1.208259226,1.281702017,0.199947197,0.321701155,N,-,,spindle assembly checkpoint component mad1,C:nuclear part; P:mitotic cell cycle checkpoint; P:cellular localization; C:kinetochore,IPR008672 (PFAM); IPR008672 (PANTHER); PTHR23168:SF0 (PANTHER),,
RL4_JR_02906,8840,10070,15034,2,8,18,0,0,1,1,0,1,3,1,0,0,2,0,47.09805722,1,0.36212245,0.729089607,0.496677565,0.619416446,0.781764585,6.149505763,1,0.84505456,1.228575194,0.687832999,0.491557953,0.647348742,51.12528922,1,1.336156074,0.660956525,2.021549109,0.043222954,0.101176691,31.71529768,1,-0.494167501,1.007558071,-0.490460566,0.623808028,0.740886367,26.93357415,1,-0.210234264,0.96763854,-0.217265286,0.828001609,0.884617103,N,-,,mitochondrial import mmp37,,IPR015222 (PFAM); IPR015222 (PANTHER); PTHR13619:SF0 (PANTHER); IPR015222 (PANTHER); PTHR13619:SF0 (PANTHER),,
RL4_JR_02907,5122,3753,4078,1,5,8,0,0,5,0,0,0,0,2,0,0,10,0,2.71897569,1,0.454823126,1.264269388,0.359751751,0.719032788,0.850002823,0.864106468,1,3.676247781,1.439743512,2.553404651,0.010667548,0.035298111,25.77399234,0,3.431948726,0.867635869,3.955517344,7.64E-05,0.000973755,2.590397381,1,0.599787315,1.234671307,0.485787037,0.627118166,0.743509536,2.214189487,1,0.93973071,1.221099905,0.769577253,0.441550703,0.575306899,N,-,,acyl- N-acyltransferase,"F:transferase activity, transferring acyl groups; C:membrane; C:integral component of membrane; F:transferase activity; F:N-acetyltransferase activity",IPR016181 (G3DSA:3.40.630.GENE3D); IPR000182 (PFAM); PTHR23091:SF184 (PANTHER); PTHR23091 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_02908,2683,3291,4459,0,1,1,0,0,1,0,0,0,2,0,0,0,3,0,4.355504159,1,-0.224889957,1.234364074,-0.182190945,0.855432879,0.92758379,10.7730581,1,3.90023677,1.156324366,3.372960809,0.000743645,0.015023052,3.604179854,0,0.339623652,1.220882457,0.278178828,0.780875086,0.854564844,4.157196142,1,-0.082512361,1.224083818,-0.067407444,0.946257343,0.968741719,3.534291436,1,0.264904622,1.214082271,0.218193304,0.827278502,0.884308808,N,-,,integral membrane,C:integral component of membrane,PF10914 (PFAM); IPR016964 (PIRSF); PTHR31204 (PANTHER); PTHR31204:SF1 (PANTHER); IPR033118 (PROSITE_PROFILES),,
RL4_JR_02909,4800,2992,4268,0,0,0,0,0,0,0,0,2,0,2,0,0,2,0,33.58853282,0,-1.093411969,1.063554001,-1.028073768,0.303915129,0.490181815,8.186495029,0,0.432202325,1.249670108,0.345853135,0.72945309,0.831160179,43.54607957,1,-0.388029234,1.0576791,-0.366868584,0.713717046,0.806436538,55.36567379,1,0.38998401,0.724655282,0.538164862,0.590463236,0.714355391,28.99767121,1,-0.673795146,1.027206608,-0.655948999,0.51185694,0.638088096,Y,-,,hypothetical protein SPSK_03525,C:integral component of membrane,PTHR31204:SF2 (PANTHER); PTHR31204 (PANTHER),,
RL4_JR_02910,11380,5975,12669,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,10.32522578,0,1.63954273,1.17230997,1.398557355,0.161945762,0.312343503,0.732371187,0,3.914746811,1.473169682,2.65736314,0.007875456,0.028277888,1.911147574,0,1.254251797,1.235436527,1.015229653,0.309996369,0.4514389,2.205534527,0,0.831476742,1.250930159,0.664686782,0.50625085,0.642402915,1.895461162,1,1.163877863,1.236198124,0.941497839,0.346449796,0.483768333,N,-,,L-saccharopine oxidase,C:membrane,IPR006076 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR10961:SF21 (PANTHER); PTHR10961 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_02911,3764,3735,2428,0,0,14,0,0,0,2,4,1,3,1,0,0,0,1,117.8641383,1,1.488693946,0.829071667,1.795615512,0.072555687,0.175497863,31.90074424,0,1.126652048,1.108722441,1.016171412,0.309547768,0.471125265,141.5287033,1,2.361282048,0.401758222,5.877370812,4.17E-09,1.92E-07,99.55483009,1,0.896049329,0.541702832,1.654134473,0.098100193,0.193242112,50.90226265,1,0.410421619,0.677243831,0.606017508,0.544503127,0.66607396,N,-,,methyltransferase domain-containing,F:methyltransferase activity; F:transferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF852 (PANTHER); PTHR10108 (PANTHER); PTHR10108:SF852 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_02912,9593,8361,7677,8,1,17,0,0,0,0,2,2,1,3,0,0,2,0,67.25600618,1,0.220624023,0.666861941,0.330839128,0.740766004,0.863803468,10.21460065,0,0.113010275,1.249950562,0.090411796,0.927959984,0.959733049,26.33154659,1,-2.52967112,1.211295573,-2.088401193,0.03676166,0.089396434,76.28476268,1,0.394137866,0.655304108,0.60145795,0.547535011,0.677393938,25.75494898,1,-2.6005623,1.208440299,-2.151998988,0.031397434,0.078031178,N,-,,Zn(2)-C6 fungal-type DNA-binding domain,"F:DNA binding; C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR021858 (PFAM),,
RL4_JR_02913,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,67.67743976,0,2.769640108,0.851456389,3.252826739,0.001142631,0.006578396,3.321141336,0,1.733877164,1.26783187,1.367592348,0.171439713,0.306901084,107.6529767,0,3.700747336,0.42624711,8.682164057,3.88E-18,5.18E-16,58.89063734,0,2.387691244,0.538689617,4.432406283,9.32E-06,0.000133266,75.11190108,0,2.981999216,0.500492462,5.958130124,2.55E-09,1.37E-07,Y,-,,lipase 1 precursor,F:hydrolase activity,IPR005152 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR005152 (PIRSF); PTHR34853 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_02914,601,1150,1004,0,6,1,0,0,0,3,0,0,0,0,0,0,0,0,101.7026474,1,2.070291777,1.079026318,1.918666618,0.055026539,0.142734832,6.854100807,0,0.688578407,1.240099591,0.555260571,0.578716444,0.717879196,17.77695281,1,-1.962882106,1.200436957,-1.635139683,0.102019769,0.196532541,39.13340442,0,-0.635666886,1.023762632,-0.620912374,0.534657279,0.66700406,29.08075357,0,0.15335765,0.860674834,0.178183031,0.858579236,0.906057737,N,-,,4-aminobutyrate aminotransferase,F:pyridoxal phosphate binding; P:glutamate metabolic process; F:4-aminobutyrate transaminase activity; P:gamma-aminobutyric acid catabolic process; C:cytosol,IPR005814 (PIRSF); IPR005814 (PFAM); IPR004631 (TIGRFAM); IPR015421 (G3DSA:3.40.640.GENE3D); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR005814 (PANTHER); PTHR11986:SF7 (PANTHER); IPR015424 (SUPERFAMILY),9.B.313.1.2, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_02915,1147,1910,1529,0,0,7,0,0,0,0,0,0,0,3,4,0,0,2,84.96228157,1,0.83463093,0.83842306,0.995477069,0.319504292,0.508004368,11.19027357,0,-0.018719427,1.223751697,-0.015296753,0.987795433,0.993982043,37.03245726,0,-1.716657144,1.203853092,-1.425968962,0.153877302,0.267488633,70.61288554,1,-0.032686177,0.69865444,-0.04678447,0.962685007,0.978772417,36.31847808,1,-1.830838557,1.144187793,-1.600120686,0.109571813,0.204500388,N,-,,px domain containing,,IPR024555 (PFAM); IPR024554 (PFAM); PTHR11632 (PANTHER); PTHR11632:SF27 (PANTHER),,
RL4_JR_02916,1471,1437,1481,0,0,3,0,0,0,0,0,7,0,0,0,0,2,0,49.66962334,1,0.200351445,0.702274928,0.285289189,0.775422595,0.883628653,8.475842904,0,0.382163062,1.246078023,0.306692723,0.759077269,0.853898657,44.06106316,1,-0.427820737,1.045984834,-0.409012371,0.682530582,0.781932739,25.28185157,0,-2.687253923,1.207187666,-2.22604488,0.026011175,0.086108719,21.56687354,1,-2.344575171,1.209632412,-1.938254256,0.05259221,0.116341737,N,-,,c-type cyclin,"P:carbohydrate metabolic process; C:cytoplasm; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR013763 (G3DSA:1.10.472.GENE3D); IPR006671 (PFAM); PTHR10026:SF63 (PANTHER); PTHR10026 (PANTHER); IPR013763 (SUPERFAMILY); IPR013763 (SUPERFAMILY),,
RL4_JR_02917,1563,1023,1294,0,0,10,0,0,1,0,6,2,0,0,0,0,4,2,64.63543079,1,-0.872519583,0.851657029,-1.024496427,0.305600858,0.492413944,11.03609139,1,0.001363879,1.221345896,0.001116702,0.999109001,0.999651886,28.57393364,1,-2.64767518,1.194963065,-2.215696249,0.026712312,0.070097316,32.95784096,0,-3.069769513,1.194254901,-2.57044749,0.010156722,0.049110226,28.13070797,1,-2.727892531,1.196462693,-2.279964555,0.022609791,0.060180777,N,-,,hypothetical protein CMQ_3433,,IPR025676 (PFAM); PTHR38788 (PANTHER); PTHR38788:SF3 (PANTHER),,
RL4_JR_02918,5804,4412,5297,0,0,3,0,0,0,1,2,1,0,4,0,0,1,3,186.6191346,1,1.314265803,0.335631099,3.915804611,9.01E-05,0.00078115,17.41428727,0,-0.656667928,1.198959105,-0.547698354,0.583899043,0.722433212,132.990827,1,0.842205509,0.478530847,1.759981647,0.078410918,0.160272994,124.3267744,1,0.460715607,0.454971808,1.012624516,0.311239545,0.457373062,82.36296335,1,0.227220749,0.535444454,0.424359143,0.671303913,0.766199089,N,-,,peptidase family M3,F:metal ion binding; P:proteolysis; C:integral component of membrane; F:metalloendopeptidase activity,IPR024077 (G3DSA:1.10.1370.GENE3D); IPR024080 (G3DSA:1.20.1050.GENE3D); IPR024079 (G3DSA:3.40.390.GENE3D); IPR001567 (PFAM); PTHR11804 (PANTHER); PTHR11804:SF40 (PANTHER); SSF55486 (SUPERFAMILY),,
RL4_JR_02919,4181,3226,4864,0,0,4,0,0,0,0,0,0,0,3,0,0,3,0,125.4295932,1,1.659118899,0.862897411,1.922730185,0.054513944,0.141993855,10.65414814,0,0.052185384,1.210403409,0.043114042,0.965610626,0.982401322,60.85116444,0,-0.18315873,0.845699864,-0.216576516,0.828538389,0.88932598,207.679445,1,2.369545093,0.330157267,7.177019357,7.12E-13,3.45E-11,50.04698421,1,0.256986522,0.671052931,0.382960137,0.701749321,0.788854433,N,-,,myosin regulatory light chain cdc4,P:mitotic actomyosin contractile ring assembly actin filament organization; C:nucleus; C:cellular bud tip; C:actomyosin contractile ring; P:protein localization to medial cortex; C:cellular bud neck; C:medial cortical node; F:calcium ion binding; P:vesicle targeting; C:myosin II complex; C:cytosol; C:vesicle; F:myosin V binding,IPR002048 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR23048 (PANTHER); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY),8.A.82.1.5, the calmodulin calcium binding protein (calmodulin) family.
RL4_JR_02920,1061,651,858,3,0,0,0,0,0,0,0,0,0,0,0,0,1,0,17.49290508,1,0.326347599,1.008531008,0.323587075,0.746250674,0.867224074,3.153093852,0,1.808796056,1.271807716,1.422224471,0.154961097,0.283586372,14.66110507,0,0.121938759,1.190992253,0.102384175,0.918451744,0.951340849,47.95633371,0,1.487482454,0.737075717,2.018086363,0.043582268,0.113446415,15.39062079,1,0.01537037,1.118584928,0.013740905,0.989036689,0.992546869,N,-,,chromosome segregation,"F:DNA binding; C:spindle microtubule; F:ubiquitin-protein transferase activity; C:cytoplasm; P:regulation of transcription, DNA-templated; P:regulation of signal transduction; P:protein ubiquitination; P:mitotic spindle assembly",IPR001370 (SMART); IPR001370 (G3DSA:1.10.1170.GENE3D); IPR001370 (PFAM); IPR001370 (G3DSA:1.10.1170.GENE3D); PTHR10044 (PANTHER); IPR001370 (PROSITE_PROFILES); IPR001370 (PROSITE_PROFILES); SSF57924 (SUPERFAMILY); SSF57924 (SUPERFAMILY),,
RL4_JR_02921,3980,3556,4914,0,0,0,6,0,0,0,0,5,0,0,0,0,0,0,0.257368698,0,3.855553911,2.709771885,1.422833388,0.15478446,NA,0.081652835,1,7.079430015,2.213864713,3.197769933,0.001384947,0.015023052,0.213143491,1,4.417362186,1.391137899,3.175358957,0.001496513,0.007872642,0.245951309,0,3.995786944,1.75128605,2.281630088,0.022511189,0.080886247,0.211886287,0,4.324516065,1.299850696,3.326932915,0.000878075,0.004308593,N,-, Effector probability:0.588,---NA---,,no IPS match,,
RL4_JR_02922,3442,3592,4935,1,0,0,0,0,0,0,0,2,1,5,0,0,5,0,1.966832835,1,0.921858156,1.263210085,0.729774222,0.465528204,NA,0.628044419,0,4.136601272,1.486900538,2.782029576,0.005402012,0.021715315,1.628187796,1,1.485785477,1.215432448,1.222433611,0.221543695,0.35127774,1.878247546,1,1.063478156,1.226898498,0.866802069,0.386050469,0.531370445,1.603525689,1,1.405089986,1.205066419,1.165985512,0.243620303,0.373170283,N,-,,short chain dehydrogenase reductase partial,,IPR018712 (PFAM); PTHR33840 (PANTHER); PTHR33840 (PANTHER); PTHR33840:SF2 (PANTHER); PTHR33840:SF2 (PANTHER),,
RL4_JR_02923,55,39,60,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0.674314529,0,2.466231329,1.744367096,1.413825871,0.157413036,NA,0.213872816,0,5.690628767,1.804666676,3.153285227,0.00161444,0.015023052,0.556671568,1,3.034063463,1.27199981,2.385270374,0.017066573,0.049465212,0.64234412,0,2.611400503,1.367058695,1.910232906,0.056103232,0.131552854,0.550236092,0,2.94886563,1.239835025,2.378433881,0.017386355,0.04881776,N,-,,linoleate diol synthase,F:organic cyclic compound binding; F:heterocyclic compound binding; F:oxidoreductase activity; P:response to stimulus; F:isomerase activity,IPR001128 (G3DSA:1.10.630.GENE3D); IPR019791 (G3DSA:1.10.640.GENE3D); IPR019791 (PFAM); PTHR11903 (PANTHER); PTHR11903:SF13 (PANTHER); IPR019791 (PROSITE_PROFILES); IPR010255 (SUPERFAMILY); IPR001128 (SUPERFAMILY),,
RL4_JR_02924,1825,2295,2375,0,0,4,0,0,1,0,0,2,0,4,1,0,3,2,42.9563009,1,5.904164061,0.740210114,7.976335304,1.51E-15,1.09E-13,0.303346172,1,5.186577452,1.707804327,3.036985778,0.002389567,0.015240832,8.629313838,1,3.49892221,1.215383076,2.878863693,0.003991108,0.01637703,0.907192884,1,2.11368997,1.327322674,1.592446216,0.111284479,0.212408856,0.773224965,1,2.457888384,1.238701211,1.984246372,0.047228381,0.107216897,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF241 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.4, the major facilitator superfamily (mfs).
RL4_JR_02925,443,435,334,0,1,0,0,0,0,0,0,0,0,0,3,0,0,0,70.64913495,1,1.222513751,0.49778086,2.455927596,0.014052147,0.049864033,7.587852583,0,0.541856526,1.224305503,0.442582775,0.658067546,0.779971862,26.14274851,0,-1.145201956,1.187611997,-0.964289649,0.334900729,0.478078819,59.58783136,1,0.528279748,0.660311293,0.800046514,0.423683848,0.566562905,38.26862813,0,0.436858811,0.73636004,0.59326795,0.553001845,0.672731428,N,-,,triacylglycerol lipase,F:carboxylic ester hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR002018 (PFAM); PTHR11559:SF240 (PANTHER); PTHR11559 (PANTHER); IPR029058 (SUPERFAMILY),8.A.117.1.3, the neuroligin (nlg) family.
RL4_JR_02926,1492,1307,1387,4,12,8,0,0,3,0,0,2,0,8,0,0,0,3,62.84905559,1,-0.881498232,0.856266686,-1.029466925,0.303260314,0.489415953,11.03779765,1,0.001130172,1.213402513,0.000931407,0.999256845,0.999651886,54.67829382,1,0.160783417,0.749697796,0.214464305,0.830185,0.89043256,51.71867382,1,-1.33063021,1.016714616,-1.308754875,0.190617397,0.319483718,85.86206287,1,1.569766597,0.526519355,2.981403404,0.002869306,0.011415593,N,-,,mannosyl transferase,F:mannosyltransferase activity; P:mannosylation; C:integral component of membrane; P:protein glycosylation; C:endoplasmic reticulum,IPR005599 (PFAM); PTHR22760:SF2 (PANTHER); IPR005599 (PANTHER),,
RL4_JR_02927,3685,3858,5118,0,2,3,0,0,0,2,0,0,0,5,1,0,1,2,113.9368165,1,-0.80774399,0.684118467,-1.18070777,0.237718834,0.411918064,61.84045197,0,-0.160028784,1.137546334,-0.140678915,0.888123603,0.936726194,61.50722535,1,-3.753711881,1.223863241,-3.067100764,0.00216146,0.010460143,83.02942205,1,-1.911512076,0.925693288,-2.064951858,0.038927556,0.105554767,61.16492651,1,-3.848407367,1.235908101,-3.113829713,0.00184676,0.007926315,N,-,,snornp assembly factor,P:ribonucleoprotein complex biogenesis; P:cellular process,G3DSA:2.40.10.230 (GENE3D); IPR007504 (PFAM); PTHR31633 (PANTHER); IPR009000 (SUPERFAMILY),,
RL4_JR_02928,36006,38442,60215,2,10,36,0,1,1,0,4,1,1,17,0,0,13,1,235.8976011,1,1.894513635,0.502586709,3.769525938,0.000163558,0.001302625,63.47884404,1,2.325675295,0.677008115,3.435225138,0.000592062,0.015023052,118.5215936,1,1.032863582,0.466383686,2.214622021,0.026786019,0.070254316,130.0164124,1,1.036160463,0.40519891,2.557164985,0.010552915,0.050663,95.71568259,1,0.855818684,0.468037394,1.828526298,0.067470603,0.141028045,N,-,,variant SH3 domain-containing,P:pseudouridine synthesis; C:membrane; C:integral component of membrane; P:ribosome biogenesis,IPR001452 (SMART); IPR001452 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR001452 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY),,
RL4_JR_02929,633,700,914,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0.536884991,0,2.794846243,1.923950839,1.452659905,0.146318204,NA,0.17203362,0,6.004703782,1.891892118,3.173914477,0.00150398,0.015023052,0.445702487,0,3.354219278,1.289400945,2.601378021,0.009285008,0.030820137,0.514088245,1,2.932437141,1.421872579,2.062376886,0.039171868,0.106070792,0.439313122,0,3.272162586,1.24409705,2.630150586,0.008534705,0.027668288,N,-,,short-chain dehydrogenase,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; C:membrane; C:integral component of membrane",IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24320 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_02930,19100,19350,23982,1,2,8,0,1,0,3,2,3,2,0,0,0,4,0,105.7036769,1,2.254552917,0.528543389,4.265596667,1.99E-05,0.000209864,5.148373709,1,1.101426656,1.245663678,0.884208696,0.376583565,0.541215227,45.84780475,1,1.582572108,0.679086588,2.330442297,0.019782786,0.055158615,68.38157176,1,1.916226251,0.524465954,3.653671389,0.000258517,0.002388217,20.87167899,1,0.035930104,0.981427202,0.036610055,0.970795926,0.98031006,N,-,,phosphoglycerate mutase,,IPR013078 (SMART); IPR029033 (G3DSA:3.40.50.GENE3D); PTHR16469:SF28 (PANTHER); PTHR16469 (PANTHER); PTHR16469:SF28 (PANTHER); PTHR16469 (PANTHER); PTHR16469:SF28 (PANTHER); IPR029033 (SUPERFAMILY),,
RL4_JR_02931,51391,25940,28185,14,4,2,0,0,6,8,40,100,7,31,23,0,39,45,53.66486187,1,0.013246719,0.665638386,0.019900774,0.984122527,0.991904074,9.687940701,1,0.189306631,1.212810125,0.156089257,0.875962667,0.928925357,66.20718654,1,0.368672689,0.738169031,0.499442098,0.617467968,0.731482063,58.38954023,1,0.416516711,0.613902646,0.678473555,0.497471486,0.63589178,81.31231562,1,1.523947642,0.481831577,3.162822268,0.001562477,0.006917393,Y,-,,peptidase C13 family,F:GPI-anchor transamidase activity; P:proteolysis; F:peptidase activity; P:attachment of GPI anchor to protein; C:GPI-anchor transamidase complex,IPR001096 (PRINTS); IPR001096 (PIRSF); IPR028361 (PIRSF); IPR001096 (PFAM); IPR028361 (PTHR12000:PANTHER); IPR001096 (PANTHER),,
RL4_JR_02932,42155,27600,29012,10,29,15,0,0,4,7,3,3,6,12,3,0,30,3,23.21265551,1,-0.335404299,1.011651808,-0.331541244,0.740235693,0.863625206,4.994411645,1,1.145258392,1.25068751,0.915703069,0.359822655,0.52404675,19.40866724,1,-0.539522186,1.193183051,-0.452170508,0.651146153,0.757724558,14.89002514,1,-1.923355191,1.192764044,-1.612519425,0.106848956,0.206026601,27.76063542,1,0.63625325,0.837627145,0.759590055,0.447499665,0.579848235,N,-,,GPI-anchor transamidase precursor,F:GPI-anchor transamidase activity; P:proteolysis; F:peptidase activity; P:attachment of GPI anchor to protein; C:GPI-anchor transamidase complex,IPR024761 (PFAM); IPR024764 (PFAM),,
RL4_JR_02933,2864,1989,3175,3,0,2,0,0,0,0,0,0,0,0,0,0,0,0,185.618165,1,2.726420796,0.637224708,4.278586132,1.88E-05,0.000199531,27.21260806,0,2.024007614,0.996110614,2.031910498,0.042162718,0.103328825,80.01818056,0,1.372662124,0.578259794,2.37378102,0.017606989,0.050697713,69.5570684,0,0.851004473,0.574785872,1.480559135,0.138724092,0.250907722,74.14288651,0,1.600177647,0.490019855,3.265536348,0.00109257,0.005123441,N,-,,mitochondrial carnitine carrier,P:transmembrane transport; C:integral component of membrane; F:carnitine:acyl carnitine antiporter activity; C:mitochondrial inner membrane; P:fatty acid metabolic process,IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089:SF70 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.8.4, the mitochondrial carrier (mc) family.
RL4_JR_02934,3576,4662,5089,3,0,9,0,0,1,0,0,1,0,0,1,0,0,6,45.43516799,1,-0.885967954,0.851064637,-1.041011359,0.297870277,0.483759717,10.84558175,1,0.026463441,1.212221615,0.02183053,0.98258314,0.990805593,34.64695239,1,-1.664252138,1.190071694,-1.398446956,0.161978891,0.277615421,46.1190054,1,-1.314087811,1.013328503,-1.296803364,0.194698853,0.324231231,53.73139929,1,-0.072298476,0.748287188,-0.09661862,0.923029269,0.950339686,N,-,,cation efflux zinc transporter,P:zinc II ion transport; C:intracellular membrane-bounded organelle; P:cation transmembrane transport; C:integral component of membrane; F:cation transmembrane transporter activity; C:endomembrane system; C:cytoplasmic part,IPR002395 (PRINTS); IPR002524 (PFAM); IPR002524 (TIGRFAM); IPR027469 (G3DSA:1.20.1510.GENE3D); PTHR11562:SF13 (PANTHER); PTHR11562:SF13 (PANTHER); IPR002524 (PANTHER); IPR002524 (PANTHER); SSF161111 (SUPERFAMILY),2.A.4.4.3, the cation diffusion facilitator (cdf) family.
RL4_JR_02935,26042,31914,37290,7,2,11,0,0,1,0,5,1,1,7,0,0,8,2,80.04092463,1,2.401780106,0.479865607,5.005109914,5.58E-07,9.15E-06,4.106174175,1,1.427682279,1.251463058,1.140810566,0.253948763,0.408854681,77.76179071,1,2.760704563,0.514522294,5.365568403,8.07E-08,2.87E-06,36.37860998,1,1.638225349,0.626132628,2.616419071,0.008885743,0.04421039,14.40031123,1,-0.381943918,1.130623379,-0.337817106,0.735501019,0.815210489,N,-,,chitobiosyldiphosphodolichol beta-mannosyltransferase,"P:glycosylation; F:transferase activity, transferring glycosyl groups; C:membrane; P:primary metabolic process; P:organic substance metabolic process",PTHR13036:SF0 (PANTHER); IPR026051 (PANTHER); SSF53756 (SUPERFAMILY),,
RL4_JR_02936,35645,38098,34505,0,1,36,0,0,1,6,19,15,1,20,3,0,48,11,60.47703479,1,0.357220583,0.702547105,0.508464956,0.611127309,0.776912733,26.57466825,1,2.134413405,1.003061674,2.127898473,0.033345502,0.085974429,53.53592197,1,0.270337295,0.861961009,0.313630538,0.753801663,0.834947018,52.3587689,1,-0.230822509,0.863875807,-0.267194089,0.789319727,0.863704986,20.06437034,1,-2.240302655,1.207418528,-1.855448299,0.063532236,0.13471495,N,-,,ubiquitin-conjugating enzyme E2 G1,F:ATP binding; P:chromatin silencing at silent mating-type cassette,SM00212 (SMART); IPR000608 (PFAM); IPR016135 (G3DSA:3.10.110.GENE3D); PTHR24067 (PANTHER); PTHR24067:SF157 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_02937,708,715,816,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,53.9274979,1,-0.242450156,0.743911268,-0.325912735,0.74449038,0.865918523,11.01360709,0,0.00425407,1.2295377,0.003459894,0.99723941,0.998719432,28.74277686,0,-2.656172324,1.208755346,-2.197444117,0.027988743,0.072557892,33.17090354,0,-3.079054101,1.210529466,-2.543559811,0.010972927,0.052334939,28.50182009,0,-2.746743944,1.219105158,-2.253082047,0.024253976,0.063603085,N,-,,C2H2 finger domain-containing,F:nucleic acid binding; C:nucleus; F:zinc ion binding; C:cytosol; C:mitotic spindle pole body,IPR022755 (PFAM); PTHR23067 (PANTHER); SSF57667 (SUPERFAMILY),,
RL4_JR_02938,192,193,235,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.09536564,0,-3.060980902,1.239430682,-2.469666876,0.013523892,0.048283551,28.54745164,0,1.797420716,1.035408245,1.735953644,0.082572031,0.174305339,25.64543519,0,-2.491697123,1.226836974,-2.03099285,0.04225572,0.099673091,57.53861105,0,-0.528294036,0.908363067,-0.581589075,0.560843503,0.689143261,25.54752424,0,-2.588881608,1.242594596,-2.083448308,0.037210379,0.089016767,N,-,,diphthine synthase,C:nucleus; P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine; F:diphthine synthase activity; C:cytosol; P:methylation,IPR014776 (G3DSA:3.30.950.GENE3D); IPR000878 (PFAM); IPR014777 (G3DSA:3.40.1010.GENE3D); IPR004551 (PIRSF); IPR004551 (TIGRFAM); PTHR10882 (PANTHER); IPR004551 (PTHR10882:PANTHER); IPR000878 (SUPERFAMILY),,
RL4_JR_02939,233,159,231,0,1,0,0,0,0,0,0,0,0,0,0,0,6,0,144.3819525,1,-3.493509914,1.069754874,-3.265710678,0.001091897,0.006322001,43.20465572,0,-1.967613019,1.21427814,-1.6203973,0.105146959,0.210460258,112.7460609,0,-4.627948885,1.213769601,-3.812872625,0.000137361,0.001401411,139.4310901,0,-4.098018464,1.170971113,-3.499675114,0.000465826,0.003943548,134.9043517,1,-1.603838832,0.729411685,-2.198811542,0.027891325,0.071061601,N,-,,RNA processing factor 1,P:ribosomal large subunit biogenesis; P:rRNA processing; C:intracellular part,IPR007109 (SMART); IPR007109 (PFAM); IPR007109 (G3DSA:3.40.50.GENE3D); PTHR22734 (PANTHER); PTHR22734:SF3 (PANTHER); PTHR22734 (PANTHER); IPR007109 (PROSITE_PROFILES); IPR004154 (SUPERFAMILY),,
RL4_JR_02940,153,97,112,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,83.36492558,1,-0.16637271,0.562935451,-0.295544915,0.767577647,0.877998908,15.41212379,0,-0.480456977,1.201932819,-0.399736965,0.689350263,0.803038711,39.94750342,0,-3.131030053,1.18589675,-2.640221463,0.008285187,0.028119085,78.99958778,0,-0.815619922,0.732845655,-1.112949113,0.265730285,0.406619635,69.50709253,0,-0.00438548,0.608483976,-0.007207224,0.994249517,0.995527725,N,-,,ADP-ribose pyrophosphatase,F:hydrolase activity,IPR020476 (PRINTS); IPR015797 (G3DSA:3.90.79.GENE3D); IPR000086 (PFAM); PTHR11839 (PANTHER); PTHR11839:SF11 (PANTHER); IPR000086 (PROSITE_PROFILES); IPR015797 (SUPERFAMILY),,
RL4_JR_02941,1607,1377,1998,0,2,3,0,0,0,0,0,1,3,0,0,0,3,0,38.22576419,1,1.205663538,0.680027515,1.772962874,0.076234859,0.181483434,4.943152989,0,1.160128227,1.282006333,0.904931745,0.365501548,0.529953684,12.73821585,1,-1.482100063,1.214455384,-1.220382471,0.222319919,0.352287817,14.68810688,1,-1.903761318,1.214513381,-1.567509546,0.116995637,0.219967944,12.48018524,1,-1.555436788,1.213097342,-1.282202783,0.19977152,0.321554748,N,-, Effector probability:0.57,sesB-related regulatory,C:membrane; C:integral component of membrane; F:ADP binding,IPR007751 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR22731 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_02942,14,25,20,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,6.295241546,0,-0.756351641,1.229463202,-0.615188515,0.538430232,0.721175355,2.01696388,0,2.453430822,1.345641582,1.823242425,0.068266682,0.150543651,5.209518735,1,-0.191918712,1.221363508,-0.157134801,0.875138611,0.921466802,6.008663264,0,-0.613994662,1.222874356,-0.502091371,0.61560325,0.734675024,5.104038936,0,-0.265350648,1.216736147,-0.218083969,0.827363688,0.884308808,N,-,,hemolysin-III channel Izh2,C:membrane; C:integral component of membrane; F:molecular_function,IPR004254 (PFAM); IPR004254 (PANTHER); PTHR20855:SF52 (PANTHER); IPR004254 (PANTHER); PTHR20855:SF52 (PANTHER),1.C.113.1.9, the hly iii (hly iii) family.
RL4_JR_02943,2083,2038,3134,0,2,3,0,0,0,3,0,0,1,0,0,0,0,0,0.330463321,1,3.495200482,2.400510784,1.456023654,0.145386081,NA,0.105120044,0,6.715484693,2.081694733,3.225969969,0.001255465,0.015023052,0.272835202,1,4.063599664,1.328380764,3.059062413,0.002220309,0.010719317,0.314783609,1,3.640633625,1.584586009,2.297529831,0.021588563,0.079759412,0.268684664,0,3.983601961,1.254728521,3.174871612,0.001499028,0.006671499,N,-,,"hypothetical protein K441DRAFT_472075, partial",,no IPS match,,
RL4_JR_02944,982,1151,1087,0,0,0,0,0,0,0,3,0,0,3,2,0,0,0,5.275894192,0,2.299710637,1.19459607,1.925094762,0.054217504,0.14149277,0.464642861,0,4.5714267,1.59377149,2.868307488,0.004126743,0.018371529,1.203687484,1,1.92205235,1.253135307,1.533794745,0.125080156,0.229030838,20.65918484,1,3.259164003,1.040524171,3.132232862,0.001734822,0.01179319,1.182677571,0,1.844595205,1.235219296,1.493334188,0.135349731,0.239750879,N,-,,Ankyrin repeat domain-containing 50,"P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:snoRNA binding; F:catalytic activity; P:nucleoside metabolic process; P:RNA processing",IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24123 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),8.A.28.1.2, the ankyrin (ankyrin) family.
RL4_JR_02945,1775,1277,2249,0,0,3,0,0,0,0,4,0,1,1,0,0,0,3,0.007760107,1,8.901087564,4.041366561,2.202494486,0.027630398,NA,0.002334598,0,12.18995876,4.048442383,3.01102439,0.002603679,0.015349618,0.006343058,1,9.480780804,4.042868098,2.345063102,0.01902386,0.053738157,0.007335717,1,9.055356819,4.042572319,2.23999872,0.025091006,0.08557795,0.006581095,1,9.341867313,1.819064456,5.135533973,2.81E-07,4.95E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_02946,934,1004,967,0,1,7,0,0,0,0,0,0,0,9,0,0,4,0,0.012047471,1,8.273092713,3.994385999,2.07118008,0.03834197,NA,0.00401109,0,11.43263965,3.991205167,2.86445802,0.004177235,0.018371529,0.010113829,0,8.82019535,3.041025661,2.900401487,0.00372685,0.01574077,0.01164654,1,8.398490877,3.993441208,2.103071121,0.035459553,0.099858856,0.00966951,1,8.76562085,1.6165792,5.422326879,5.88E-08,1.50E-06,N,-,,ankyrin repeat,"P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:snoRNA binding; F:catalytic activity; P:nucleoside metabolic process; P:RNA processing",IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24188 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_02947,469,688,630,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.602864553,0,0.517607015,1.252572882,0.413235047,0.679434413,0.824051985,0.826665105,0,3.740088295,1.435031467,2.606276156,0.009153263,0.031556311,13.22086986,0,2.04557916,1.198307247,1.707057323,0.087811398,0.175263719,2.481782803,0,0.661335553,1.226322336,0.539283624,0.589691167,0.713847808,2.126266657,0,0.998108529,1.216728527,0.820321466,0.412032872,0.547916054,N,-, Effector probability:0.805,L-PSP endoribonuclease family,,IPR013813 (G3DSA:3.30.1330.GENE3D); IPR006175 (PFAM); PTHR11803:SF18 (PANTHER); IPR006175 (PANTHER); IPR013813 (SUPERFAMILY),,
RL4_JR_02948,2175,2991,2499,14,4,6,0,0,4,0,0,1,3,3,1,0,0,1,4.429493181,1,-0.249597297,1.311680381,-0.190288199,0.849083301,0.924435568,1.3910859,1,2.989113515,1.430264366,2.089902809,0.036626531,0.09254462,3.652919091,1,0.319651761,1.268268876,0.25203785,0.801011808,0.869272542,4.216939453,1,-0.10361144,1.281641622,-0.080842756,0.935567005,0.962370815,3.650554744,1,0.218156779,1.283102973,0.170022815,0.864992194,0.910077049,N,-,,hypothetical protein MMYC01_206328,,PTHR42470 (PANTHER),,
RL4_JR_02949,46627,32080,45609,1,12,11,0,0,0,0,5,1,2,3,2,0,9,0,365.6771129,1,-1.382860095,0.422912414,-3.269849856,0.001076046,0.00628061,92.30199607,0,-1.990404783,1.105669682,-1.800180304,0.071832173,0.15683461,260.0331858,1,-2.15947804,0.623657885,-3.462600395,0.000534982,0.003556245,268.8854896,1,-2.961011427,0.683928294,-4.329417942,1.50E-05,0.000202913,243.7452342,1,-2.259270047,0.620207502,-3.642764784,0.000269725,0.001607398,N,-,,L-aminoadipate-semialdehyde dehydrogenase,F:L-aminoadipate-semialdehyde dehydrogenase activity; C:cytosol; P:oxidation-reduction process; P:lysine biosynthetic process via aminoadipic acid; P:negative regulation of lysine biosynthetic process via aminoadipic acid,IPR014397 (PIRSF); IPR009081 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.300.30 (GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR013120 (PFAM); G3DSA:2.30.38.10 (GENE3D); IPR014397 (TIGRFAM); IPR000873 (PFAM); IPR010080 (TIGRFAM); G3DSA:3.40.50.980 (GENE3D); G3DSA:3.40.50.980 (GENE3D); PTHR24095 (PANTHER); PTHR24095:SF205 (PANTHER); PTHR24095 (PANTHER); PTHR24095:SF205 (PANTHER); PTHR24095 (PANTHER); PTHR24095:SF205 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR016040 (SUPERFAMILY); SSF56801 (SUPERFAMILY); IPR009081 (SUPERFAMILY),4.C.1.1.7, the fatty acid transporter (fat) family.
RL4_JR_02950,48,49,65,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.39696177,0,-2.309105156,1.164120378,-1.983562181,0.047304669,0.127700691,11.26276913,0,-0.028030701,1.223428776,-0.022911592,0.981720794,0.990676395,29.38326842,0,-2.687985042,1.204737967,-2.231178162,0.02566933,0.067959283,33.90847324,0,-3.110798481,1.205973029,-2.57949258,0.009894558,0.048158441,29.14012662,0,-2.778703335,1.214969205,-2.287056596,0.02219252,0.059350043,N,-,,wd repeat containing 5,C:Set1C/COMPASS complex; P:mycelium development; C:cytosol; F:binding; P:histone H3-K4 methylation,IPR020472 (PRINTS); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR22847 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),8.A.92.1.4,The G-Protein αβγ Complex (GPC) Family
RL4_JR_02951,55,48,42,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,190.2393971,0,-1.531105584,0.594622707,-2.574919469,0.010026343,0.037955872,76.96381088,0,0.022862136,0.883717297,0.025870419,0.979360695,0.989243725,172.1181459,0,-1.382925897,0.640967032,-2.157561664,0.030961928,0.078699111,153.1700975,0,-3.491498461,1.036800013,-3.367571776,0.000758333,0.005865638,183.1827632,0,-0.782758392,0.507856382,-1.541298722,0.1232441,0.223508241,N,-,,E3 ubiquitin- ligase ubr1,F:zinc ion binding; P:protein catabolic process; F:ligase activity,IPR003126 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR003769 (PFAM); IPR003126 (PFAM); PTHR21497 (PANTHER); PTHR21497:SF32 (PANTHER); PTHR21497 (PANTHER); PTHR21497:SF32 (PANTHER); IPR003126 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY),,
RL4_JR_02952,6274,6390,5442,0,0,5,0,0,0,2,17,44,10,11,18,0,5,1,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_02953,801,632,840,0,4,31,11,2,6,167,388,828,156,386,114,10,213,27,208.4592647,1,0.120303015,0.446680209,0.269326944,0.7876781,0.890526979,41.79574489,1,-0.635737541,1.110072996,-0.572698861,0.566848608,0.708785997,216.0191249,1,0.618698972,0.410287344,1.507965043,0.131563474,0.237847966,168.4164948,1,-0.070362853,0.460899429,-0.152664222,0.878663077,0.925076807,139.5413601,1,-0.350116481,0.523954488,-0.668219261,0.503993642,0.631317039,N,-, Effector probability:0.683,Cytochrome b-c1 complex subunit 9,"F:ubiquinol-cytochrome-c reductase activity; P:mitochondrial respiratory chain complex III assembly; P:hydrogen ion transmembrane transport; C:mitochondrial respiratory chain complex III; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:aerobic respiration",IPR008027 (PFAM); IPR008027 (G3DSA:1.20.5.GENE3D); IPR008027 (PANTHER); PTHR12980:SF0 (PANTHER); IPR008027 (SUPERFAMILY),,
RL4_JR_02954,9321,8200,8217,0,3,5,0,0,0,0,1,3,4,10,5,0,4,4,41.54683219,1,2.939504416,0.766311512,3.835913166,0.000125099,0.001032908,1.06474255,0,3.374925498,1.40838112,2.396315492,0.016560829,0.049800568,90.16259875,1,5.110932815,0.493284562,10.36102326,3.73E-25,7.87E-23,12.50589902,1,1.248646034,1.161193074,1.075313022,0.282234608,0.425800883,10.45930103,1,2.290580923,1.00868792,2.270851944,0.023155942,0.061158184,N,-,,fatty acid desaturase,F:oxidoreductase activity; P:lipid metabolic process; C:integral component of membrane; P:oxidation-reduction process,IPR001199 (SMART); IPR001199 (G3DSA:3.10.120.GENE3D); IPR012171 (PIRSF); IPR001199 (PFAM); IPR005804 (PFAM); PTHR19353 (PANTHER); PTHR19353:SF20 (PANTHER); IPR001199 (PROSITE_PROFILES); IPR001199 (SUPERFAMILY),,
RL4_JR_02955,1957,2115,2554,3,0,2,0,0,0,0,0,0,0,1,0,0,0,0,67.7985326,1,0.954819326,0.635725674,1.501936078,0.133113618,0.271621034,16.45262274,0,1.557999437,1.140807277,1.36569907,0.172033436,0.307555966,18.46171572,0,-2.017574717,1.212414372,-1.664096669,0.096093113,0.188244325,44.5865518,1,-0.107976922,0.880976511,-0.12256504,0.902451539,0.940247153,33.77200888,0,0.462020492,0.815719842,0.566396044,0.571124583,0.687018701,N,-,,rna binding,,IPR015362 (SMART); IPR015362 (PFAM); PTHR22959 (PANTHER); PTHR22959:SF0 (PANTHER); IPR015362 (SUPERFAMILY),,
RL4_JR_02956,474,503,800,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,56.24765682,0,1.303766719,0.524003955,2.488085646,0.01284328,0.046401895,6.995656009,0,0.659051874,1.228690587,0.536385549,0.591692117,0.728639536,29.20656084,0,-1.030122322,1.190695116,-0.865143653,0.386959948,0.530909677,42.26813934,0,0.309736554,0.743410025,0.416642961,0.676939581,0.779839942,41.03951911,0,1.107552768,0.631792082,1.753033632,0.079596234,0.160732324,N,-,,inosine-uridine preferring nucleoside hydrolase,P:cellular metabolic compound salvage; F:ribosylpyrimidine nucleosidase activity; P:pyridine nucleotide biosynthetic process; P:pyrimidine ribonucleoside catabolic process,IPR001910 (G3DSA:3.90.245.GENE3D); IPR001910 (PFAM); PTHR12304:SF9 (PANTHER); IPR023186 (PANTHER); IPR001910 (SUPERFAMILY),,
RL4_JR_02957,1543,1588,2364,0,1,2,0,2,0,0,0,1,0,4,0,0,0,2,50.58843986,1,-1.282067217,1.01689371,-1.260768165,0.207392387,0.373406994,19.10293786,1,1.100075745,1.126626658,0.976433264,0.328849804,0.491671746,47.3856036,1,-0.635767307,1.036993148,-0.613087278,0.539818632,0.668026381,33.13504788,1,-1.944672972,1.150651818,-1.690062051,0.091016084,0.182482743,24.92876848,1,-2.553543161,1.203510984,-2.121744791,0.033859175,0.082677292,N,-,,red,C:nucleus,IPR012916 (PFAM); PTHR12765:SF5 (PANTHER); PTHR12765 (PANTHER),,
RL4_JR_02958,9734,10413,8319,0,7,6,0,0,0,0,0,2,5,14,1,0,7,0,15.31572961,1,-0.67867177,1.151815319,-0.58921926,0.555714199,0.73388089,3.698734103,0,1.578526363,1.281152698,1.232114146,0.217906448,0.365234155,55.75762643,1,2.088715775,0.684045828,3.053473449,0.002262087,0.010889859,11.01360184,1,-1.488408208,1.203888516,-1.23633392,0.216334468,0.351023475,9.374002075,1,-1.142556459,1.203080582,-0.949692379,0.342268583,0.479185482,N,-,,dna polymerase iv,P:DNA metabolic process; P:cellular response to DNA damage stimulus,IPR001357 (SMART); IPR031991 (PFAM); IPR001357 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.70.270 (GENE3D); IPR025527 (PFAM); IPR017961 (PFAM); G3DSA:1.10.150.20 (GENE3D); IPR001126 (PFAM); IPR017961 (G3DSA:3.30.1490.GENE3D); PTHR11076 (PANTHER); PTHR11076:SF12 (PANTHER); IPR001126 (PROSITE_PROFILES); IPR001357 (PROSITE_PROFILES); SSF56672 (SUPERFAMILY); IPR017961 (SUPERFAMILY); IPR001357 (SUPERFAMILY),,
RL4_JR_02959,9970,9037,10490,0,0,17,0,0,3,0,2,1,1,8,1,0,5,3,84.02083127,1,-1.646653285,0.956201017,-1.722078576,0.085055285,0.196678293,41.17509008,1,0.162633179,1.160118929,0.140186644,0.888512525,0.937020606,56.03181733,1,-2.479568482,1.240820054,-1.998330438,0.045680848,0.105611533,69.21612765,1,-1.61769708,0.961128535,-1.683122518,0.092351376,0.184465819,60.72213353,1,-1.86162004,1.052571119,-1.768640623,0.076953867,0.156175166,N,-,,mitochondrial intermediate peptidase,F:metallopeptidase activity,IPR001567 (PFAM); IPR024077 (G3DSA:1.10.1370.GENE3D); IPR024079 (G3DSA:3.40.390.GENE3D); PTHR11804 (PANTHER); PTHR11804:SF5 (PANTHER); SSF55486 (SUPERFAMILY),,
RL4_JR_02960,3140,3660,6199,1,0,13,0,0,0,0,1,4,7,8,0,1,3,0,122.5721936,1,-2.620602779,0.897821315,-2.918846696,0.00351329,0.016339478,35.21088678,0,-1.672466977,1.20453397,-1.38847639,0.164992029,0.297712892,110.7459434,1,-2.501574166,1.044900689,-2.394078397,0.016662187,0.048417905,118.0065202,1,-2.467357,0.88449566,-2.789563717,0.005277911,0.02920819,129.3244566,1,-0.7140018,0.608658913,-1.173073761,0.240766227,0.370056051,N,-,,MICOS subunit MIC26,C:integral component of mitochondrial inner membrane,IPR019166 (PFAM); IPR033181 (PANTHER),,
RL4_JR_02961,5695,6260,11183,0,3,4,1,0,0,2,0,2,1,1,6,0,2,0,28.5178445,1,-2.936170037,1.218537273,-2.409585741,0.015970643,0.054929897,9.023373297,1,0.291775764,1.239935913,0.235315197,0.8139641,0.88762601,36.56323864,1,-0.55584421,1.058211792,-0.525267451,0.599397281,0.71797185,35.21896251,1,-1.080258072,1.048032821,-1.030748322,0.302658858,0.448408098,23.411263,1,-2.462907036,1.225378435,-2.00991544,0.044440139,0.102216359,N,-,,mitochondrial deoxynucleotide carrier,P:nitrogen compound transport; P:transmembrane transport; C:integral component of membrane; P:single-organism transport; C:mitochondrial inner membrane; P:organic substance transport,IPR002067 (PRINTS); IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089:SF59 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.16.1, the mitochondrial carrier (mc) family.
RL4_JR_02962,13579,10892,7342,0,0,9,0,0,0,0,6,0,4,0,6,0,8,0,71.75513111,1,2.028819504,0.55144768,3.679078861,0.000234078,0.001763257,5.705075347,0,0.953220231,1.237849829,0.770061286,0.441263539,0.602681088,14.83543619,1,-1.702106126,1.19722717,-1.421706898,0.155111357,0.268936179,38.78634447,1,0.596577733,0.752718108,0.792564609,0.428031535,0.570689925,44.13139242,1,0.870608295,0.761749037,1.142906984,0.253077212,0.384111344,N,-,,hypothetical protein SPI_00823,,no IPS match,,
RL4_JR_02963,605,883,705,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,105.1662839,0,-2.406375508,0.958799132,-2.509780649,0.012080618,0.044075885,29.50722544,0,-1.417517482,1.230484929,-1.151999061,0.249321459,0.403007316,77.31000396,0,-4.083615031,1.227654036,-3.32635654,0.000879893,0.005191164,93.24828792,1,-3.562519956,1.188566823,-2.997324078,0.00272361,0.017160269,84.77174701,0,-2.536263968,1.045160625,-2.426673859,0.015237947,0.044007161,N,-,,superoxide dismutase,F:metal ion binding; P:removal of superoxide radicals; P:oxidation-reduction process; F:superoxide dismutase activity,G3DSA:1.10.287.990 (GENE3D); IPR019832 (PFAM); IPR001189 (PANTHER); PTHR11404:SF22 (PANTHER); IPR019831 (SUPERFAMILY); IPR019832 (SUPERFAMILY),,
RL4_JR_02964,1452,1660,1757,2,0,0,0,4,0,1,1,0,2,3,0,0,0,0,123.5952134,1,1.05081698,1.106917872,0.949317927,0.342458938,0.532554331,36.03423499,1,0.614075216,1.12783885,0.544470707,0.586117601,0.724292804,35.80420572,1,-2.973088511,1.209508902,-2.458095601,0.013967599,0.041973276,101.3497512,1,0.747234356,0.539951425,1.383891812,0.166391584,0.287150978,58.65097907,0,0.067932515,0.703833293,0.096517905,0.923109254,0.950339686,N,-,,sam and ph domain-containing,,IPR001849 (SMART); IPR001660 (SMART); IPR013761 (G3DSA:1.10.150.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR001660 (PFAM); PTHR12844 (PANTHER); PTHR12844:SF25 (PANTHER); IPR001660 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR013761 (SUPERFAMILY); IPR011993 (SUPERFAMILY),,
RL4_JR_02965,886,755,1071,0,0,0,0,0,0,0,0,4,0,0,0,0,0,2,2.6119908,0,0.512565497,1.2664874,0.404714249,0.685687567,0.828896683,0.842112124,0,3.713559007,1.466457468,2.532333252,0.011330625,0.036936742,2.169402893,1,1.071942367,1.232076596,0.870028999,0.384284557,0.528097849,2.501575397,0,0.650167495,1.243209008,0.522975212,0.600991503,0.722602894,2.122694453,1,1.000092848,1.217781112,0.821241878,0.411508507,0.547437951,N,-,,---NA---,,no IPS match,,
RL4_JR_02966,599,784,1185,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,24.40414168,0,-1.517972068,1.137355769,-1.334650168,0.18199087,0.339510981,6.595900798,0,0.743980149,1.232493758,0.603638067,0.546084299,0.692404518,17.06654771,1,-1.904091704,1.190543183,-1.59934703,0.109743515,0.207857142,57.90301791,0,0.422428488,0.736258632,0.573750133,0.566136898,0.693381681,16.77946408,0,-1.98244982,1.188983467,-1.667348517,0.095445125,0.18435366,N,-,,transcriptional regulatory pro-1,"C:nucleus; F:zinc ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR021858 (PFAM); PTHR31263 (PANTHER); PTHR31263 (PANTHER); PTHR31263:SF4 (PANTHER); PTHR31263:SF4 (PANTHER); PTHR31263 (PANTHER); PTHR31263:SF4 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_02967,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.72602014,0,5.665756266,0.913237567,6.204033286,5.50E-10,1.63E-08,0.146585781,0,6.236120118,2.039737397,3.057315186,0.002233293,0.015045494,0.375490391,0,3.603236303,1.381120837,2.608921832,0.009082799,0.030347939,27.72660754,0,5.923571016,0.845972502,7.002084589,2.52E-12,1.12E-10,0.364724125,0,3.541000519,1.305781259,2.711786905,0.00669216,0.022798829,Y,-,,hypothetical protein SPSK_02411,C:membrane,no IPS match,,
RL4_JR_02968,861,599,1072,0,0,12,0,0,0,4,0,0,0,3,0,0,2,2,105.3443223,1,-0.114007493,0.677538279,-0.168267235,0.866373049,0.934656352,20.21986331,0,-0.872201607,1.201889056,-0.725692278,0.468027437,0.626719634,79.81974341,1,-0.707477125,0.74612324,-0.948204113,0.343025554,0.486453383,99.87048034,1,-0.420772701,0.580198789,-0.725221613,0.468316086,0.609629772,55.65378329,1,-2.678525375,1.125869915,-2.379071809,0.017356294,0.0487604,N,-,,secretory component shr3,P:ER to Golgi vesicle-mediated transport; C:integral component of endoplasmic reticulum membrane; F:unfolded protein binding; P:protein folding,IPR013248 (SMART); IPR013248 (PFAM); PTHR28228 (PANTHER),,
RL4_JR_02969,1695,1164,1506,4,0,23,0,1,1,2,10,9,5,49,3,0,2,13,92.71721881,1,3.431246407,1.098696037,3.123017006,0.001790074,0.009538487,2.797448763,1,1.981495936,1.307570641,1.51540259,0.129670482,0.246775477,35.85688092,1,1.754775637,0.866186726,2.025862999,0.042778826,0.100415681,21.97149467,1,0.65075051,1.031389507,0.630945444,0.528076197,0.661811052,14.43459324,1,0.200941323,1.132301473,0.177462741,0.859144929,0.906318234,N,-,,hypothetical protein SPI_00817,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_02970,4394,3668,7689,0,2,7,2,0,0,1,1,2,0,2,5,0,2,1,92.56507184,1,1.92333757,0.43630426,4.408248436,1.04E-05,0.000120247,6.249992034,1,0.821693607,1.230824731,0.667595952,0.504391543,0.657834196,57.82116691,1,1.318376155,0.661672091,1.99249171,0.046317134,0.106619978,40.0163557,1,0.476820184,0.735283504,0.648484811,0.516671432,0.651225974,23.28838894,1,-0.973670759,1.115792059,-0.872627432,0.382866183,0.518875667,N,-,,DNA helicase,F:nucleotide binding; F:helicase activity; P:cellular process,IPR003593 (SMART); PF13086 (PFAM); PF13087 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10887:SF140 (PANTHER); PTHR10887 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_02971,280,277,520,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.163342315,0,1.679476757,1.407411273,1.193309155,0.232748318,NA,0.370431267,0,4.89824076,1.622638389,3.018689064,0.002538709,0.015349618,0.9617987,0,2.245277464,1.23591062,1.8166989,0.06926323,0.145632595,1.1096402,0,1.822791357,1.272274892,1.432702451,0.151942889,0.268719956,15.67939364,0,3.852512483,0.980549323,3.928932888,8.53E-05,0.000607099,N,-,,lipase esterase,P:metabolic process; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR013094 (PFAM); PTHR23024 (PANTHER); IPR029058 (SUPERFAMILY),8.A.117.1.3, the neuroligin (nlg) family.
RL4_JR_02972,2847,4290,3815,7,2,5,0,0,0,0,0,4,0,9,2,0,0,0,5.394442757,1,2.185633966,1.20539806,1.813205147,0.069800186,0.17064127,0.49811947,0,4.470884197,1.576917974,2.835204032,0.004579643,0.01948642,14.29643709,1,3.624008967,1.066868956,3.396864203,0.000681628,0.004236219,22.84612385,1,4.09780071,0.793564966,5.16378732,2.42E-07,5.02E-06,16.72813855,0,4.290229767,0.828559687,5.177936887,2.24E-07,4.41E-06,N,-,,zinc mynd-type domain containing,F:metal ion binding; P:metabolic process; F:hydrolase activity,IPR002893 (PFAM); PTHR12298 (PANTHER); IPR002893 (PROSITE_PROFILES); SSF144232 (SUPERFAMILY),,
RL4_JR_02973,3610,4338,5424,0,2,13,0,0,0,2,0,1,0,6,0,0,7,0,67.75750827,1,4.761557767,0.939764219,5.066757884,4.05E-07,6.86E-06,0.908465731,0,3.603967468,1.430511875,2.519355156,0.011757,0.038020561,34.85060353,1,4.080195938,0.691537307,5.900181952,3.63E-09,1.71E-07,300.365898,1,6.739172141,0.319061337,21.12187021,5.01E-99,7.24E-96,43.72516921,1,4.47969041,0.573082085,7.816839031,5.42E-15,7.83E-13,Y,-,,glycoside hydrolase family 76,"F:mannan endo-1,6-alpha-mannosidase activity; P:carbohydrate catabolic process; C:integral component of membrane",IPR014480 (PIRSF); IPR005198 (PFAM); IPR012341 (G3DSA:1.50.10.GENE3D); PTHR12145 (PANTHER); PTHR12145:SF23 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_02974,17826,12348,11681,1,1,1,0,0,0,8,0,5,10,10,2,0,10,9,42.36003677,1,0.763679756,0.754316907,1.012412355,0.311340934,0.499492495,4.658346123,0,1.245744995,1.256146637,0.991719405,0.321334422,0.483290791,23.13762276,1,-0.442159079,1.19660651,-0.369510842,0.711746993,0.804941901,59.6606016,1,2.172635992,0.524875592,4.139335155,3.48E-05,0.000424901,11.86587644,1,-1.482465297,1.199353409,-1.236053766,0.216438579,0.341611943,N,-,,extracellular developmental signal biosynthesis,F:catalytic activity,IPR008146 (SMART); IPR014746 (G3DSA:3.30.590.GENE3D); IPR008146 (PFAM); G3DSA:3.20.20.140 (GENE3D); IPR006680 (PFAM); PTHR20852 (PANTHER); PTHR20852:SF16 (PANTHER); SSF55931 (SUPERFAMILY); IPR032466 (SUPERFAMILY),,
RL4_JR_02975,11019,9718,12467,0,0,17,0,0,4,0,0,0,1,2,0,0,4,2,78.72814587,1,0.69466327,0.64703915,1.07360315,0.283000585,0.466313628,56.31357638,1,1.581573299,0.974678836,1.622660964,0.104661901,0.209693425,36.86628316,0,-1.773688389,1.189442271,-1.491193337,0.135910743,0.243619043,197.0047299,1,2.349973482,0.330496388,7.110436207,1.16E-12,5.45E-11,49.27209419,1,0.104004667,0.684590262,0.151922504,0.879248059,0.91985809,N,-,,copii-coated vesicle,P:ER to Golgi vesicle-mediated transport; C:integral component of Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:ER to Golgi transport vesicle,IPR012936 (PFAM); PF13850 (PFAM); PTHR10984 (PANTHER); PTHR10984:SF30 (PANTHER),,
RL4_JR_02976,4727,4871,5739,1,1,0,0,2,0,3,8,0,1,0,0,0,0,0,71.85375183,1,-1.7376789,0.891393707,-1.949395522,0.051248209,0.135345707,19.17220525,1,-0.795474995,1.212379635,-0.656126985,0.511742423,0.66297924,86.44553253,1,-0.621193422,0.760912998,-0.816379038,0.414283382,0.556156371,155.9000672,1,0.763092165,0.451482605,1.690191727,0.090991281,0.182469146,57.24966537,0,-1.884814358,1.003214742,-1.878774581,0.060275279,0.129216007,N,-,,ubiquinone biosynthesis,P:lipid homeostasis; C:integral component of mitochondrial membrane; P:phosphorylation; F:kinase activity; C:mitochondrial inner membrane; P:mitochondrion organization,IPR004147 (PFAM); PTHR10566:SF58 (PANTHER); PTHR10566:SF58 (PANTHER); PTHR10566 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_02977,3411,3976,6766,0,0,2,2,0,1,1,0,0,4,5,0,0,3,0,5.500624373,1,-0.562094045,1.220596855,-0.460507532,0.645151966,0.79800127,1.746333437,1,2.66109025,1.332957481,1.996380446,0.045892528,0.110155126,4.549616776,1,0.002973626,1.213653644,0.002450144,0.99804507,0.999239715,5.2496796,1,-0.419659791,1.214828969,-0.345447632,0.729757873,0.819884428,4.507681414,1,-0.086140577,1.220849333,-0.07055791,0.94374961,0.964321809,N,-,,hypothetical protein CMQ_930,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_02978,5764,8040,13490,0,3,0,0,0,0,0,3,0,0,1,0,0,3,0,78.74864183,1,0.774512978,0.674934324,1.147538288,0.251159218,0.428334491,30.89330074,0,1.291941726,1.129960965,1.143350758,0.252892989,0.407359552,30.05704174,1,-1.322543394,1.203116023,-1.099265049,0.271652473,0.41047905,60.29608153,1,0.595337249,0.646155387,0.92135307,0.356866122,0.502890673,29.18265429,1,-1.42468878,1.13304323,-1.257400197,0.208608758,0.331736088,N,-,,peroxisomal membrane receptor,C:peroxisomal membrane; P:protein exit from endoplasmic reticulum; P:protein import into peroxisome membrane; C:Pex17p-Pex14p docking complex; P:ER-dependent peroxisome organization; P:peroxisome inheritance; C:cytosol; C:endoplasmic reticulum; F:peroxisome membrane targeting sequence binding; P:protein stabilization,IPR006708 (PFAM); IPR006708 (PANTHER),9.A.17.1.2, the integral membrane peroxisomal protein importer-2 (ppi2) family.
RL4_JR_02979,9632,10363,16693,0,5,10,0,0,0,0,1,0,0,0,0,0,0,0,81.18775868,1,-0.568193363,0.628906532,-0.903462335,0.36628057,0.558513285,26.65410071,0,0.27162345,1.118922459,0.242754489,0.808195593,0.883620198,57.82575582,1,-1.478499312,1.037010231,-1.425732619,0.153945537,0.267561308,63.74780322,0,-1.420591352,0.863219827,-1.645688976,0.09982781,0.195617684,66.33369809,0,-1.144081542,0.848781042,-1.347911282,0.177686919,0.294805252,N,-,,SUMO-conjugating enzyme ubc9,C:nucleus; F:ATP binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; C:cytoplasm; P:protein sumoylation; F:ligase activity; F:SUMO transferase activity,SM00212 (SMART); IPR000608 (PFAM); IPR016135 (G3DSA:3.10.110.GENE3D); PTHR24067 (PANTHER); IPR027230 (PTHR24067:PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),3.A.20.1.1, the peroxisomal protein importer (ppi) family.
RL4_JR_02980,9117,7238,7603,1,3,4,0,0,0,0,3,2,1,6,2,0,1,3,501.5993146,1,-0.588743766,0.440486858,-1.336575101,0.181361371,0.338646387,170.5762401,0,-0.214256296,0.678752075,-0.315662086,0.752259008,0.848680971,300.9189296,1,-2.185085691,0.586477081,-3.725781894,0.000194711,0.001729168,334.5340579,1,-2.359293623,0.531178947,-4.441617343,8.93E-06,0.000128777,289.1810874,1,-2.153525923,0.574159284,-3.7507465,0.000176309,0.001120071,N,-,,asparagine synthetase,P:mycelium development; P:asparagine biosynthetic process; F:asparagine synthase (glutamine-hydrolyzing) activity,IPR029055 (G3DSA:3.60.20.GENE3D); IPR017932 (PFAM); IPR014729 (G3DSA:3.40.50.GENE3D); IPR001962 (PFAM); PTHR11772:SF2 (PANTHER); PTHR11772 (PANTHER); PTHR11772:SF2 (PANTHER); PTHR11772 (PANTHER); IPR017932 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY); SSF52402 (SUPERFAMILY),,
RL4_JR_02981,1212,1271,2056,0,0,3,0,0,0,0,0,0,0,0,0,0,2,0,3.049844534,1,0.288682776,1.243704836,0.232115184,0.816448552,0.906572382,0.971765507,0,3.506755673,1.415476351,2.477438547,0.013232919,0.041688021,2.526313637,0,0.851580538,1.220767417,0.697578037,0.485441121,0.620923046,2.914613344,0,0.42919605,1.227557711,0.349634112,0.726613307,0.817997129,2.498231495,1,0.765252721,1.221407224,0.626533646,0.530964975,0.654505922,N,-,,kinase subdomain-containing,P:phosphorylation; F:kinase activity,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); PTHR21310 (PANTHER); PTHR21310:SF16 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_02982,2592,3238,5528,1,0,1,0,0,0,0,0,0,0,7,2,0,0,0,603.6643017,1,-0.548182361,1.126331957,-0.486696979,0.626473086,0.786271914,162.6751374,0,-0.478656206,0.678213342,-0.705760527,0.480337073,0.637379431,423.9994965,0,-1.396903095,0.432586907,-3.22918487,0.001241436,0.006858605,524.6688774,1,-0.792120425,0.337609146,-2.346264708,0.018962635,0.074881699,379.3421727,0,-1.606664735,0.457110769,-3.514825826,0.000440042,0.002439995,N,-, Effector probability:0.669,outer mitochondrial membrane porin,F:voltage-gated anion channel activity; P:regulation of anion transmembrane transport; F:porin activity; P:transmembrane transport; C:pore complex; C:mitochondrial outer membrane; P:anion transport,IPR001925 (PRINTS); IPR023614 (G3DSA:2.40.160.GENE3D); IPR027246 (PFAM); PTHR11743:SF23 (PANTHER); PTHR11743 (PANTHER),1.B.8.1.1, the mitochondrial and plastid porin (mpp) family.
RL4_JR_02983,1039,1132,2464,0,0,0,0,0,0,3,3,0,0,0,0,0,0,0,32.78184124,0,0.468829599,0.764036435,0.613622044,0.539465113,0.721704886,5.583934595,0,0.984191357,1.2459929,0.789885205,0.429594813,0.591774455,22.35001351,1,-0.708026145,1.199119904,-0.590454835,0.554885757,0.681755267,62.3313816,0,1.242286806,0.630535051,1.970210546,0.048814245,0.121108609,14.33603159,0,-1.755380745,1.207914375,-1.453232763,0.146159138,0.254140697,N,-,,heat shock DNAj,C:membrane; C:integral component of membrane,IPR001623 (PRINTS); IPR001623 (SMART); IPR001623 (G3DSA:1.10.287.GENE3D); IPR001623 (PFAM); PTHR24078 (PANTHER); IPR001623 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_02984,2672,2561,4404,0,0,5,0,0,0,0,0,0,3,3,3,0,1,1,457.224633,1,-0.767438463,0.504255477,-1.521923902,0.128028149,0.264418644,184.2645649,0,-0.445918752,0.757443873,-0.588715241,0.556052312,0.701004048,373.8451599,0,-1.029933035,1.286295107,-0.800697312,0.423306899,0.564483541,314.9111866,1,-2.896006413,0.640508523,-4.521417452,6.14E-06,9.28E-05,282.4832678,1,-2.42798014,0.624013598,-3.890909025,9.99E-05,0.000693537,N,-,,methionyl aminopeptidase,P:protein initiator methionine removal; C:cytoplasm; F:metal ion binding; P:proteolysis; F:metalloaminopeptidase activity,IPR001714 (PRINTS); IPR011991 (G3DSA:1.10.10.GENE3D); IPR002468 (TIGRFAM); IPR000994 (PFAM); IPR000994 (G3DSA:3.90.230.GENE3D); PTHR10804 (PANTHER); IPR002468 (PTHR10804:PANTHER); IPR002468 (HAMAP); IPR000994 (SUPERFAMILY); IPR011991 (SUPERFAMILY),,
RL4_JR_02985,597,427,472,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,914.6716499,1,-1.94361162,0.645857283,-3.009351554,0.00261806,0.012952172,235.9003994,0,-4.41651158,1.306989612,-3.379148189,0.000727108,0.015023052,655.0413203,0,-3.780222433,0.874786114,-4.321310515,1.55E-05,0.000274525,726.2392545,0,-4.43315136,0.864006475,-5.130923768,2.88E-07,5.90E-06,610.6263897,0,-4.197682616,0.881164706,-4.763788869,1.90E-06,2.48E-05,N,-, Effector probability:0.743,MSF1,C:mitochondrial intermembrane space; P:phospholipid transport; F:phosphatidic acid transporter activity,IPR006797 (PFAM); PTHR11158:SF26 (PANTHER); PTHR11158 (PANTHER); IPR006797 (PROSITE_PROFILES),,
RL4_JR_02986,14936,11654,11180,2,2,3,0,0,0,1,0,1,1,9,9,0,2,1,5.182772804,1,2.395174251,1.165873108,2.054403891,0.039936617,0.112578756,0.438169104,0,4.656001545,1.591754815,2.925074579,0.003443737,0.016643092,1.132675248,1,2.009151681,1.237863226,1.623080515,0.104572194,0.200281668,1.306327334,1,1.58721147,1.267498209,1.252239616,0.210482564,0.344092573,1.113203,1,1.931053307,1.218672979,1.584554135,0.113067673,0.209442039,Y,-,,glutaminase,F:catalytic activity,IPR033433 (PFAM); IPR032515 (PFAM); IPR032514 (PFAM); IPR014870 (PFAM); PTHR31987:SF1 (PANTHER); PTHR31987 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_02987,729,1124,871,0,5,14,1,0,0,0,0,0,1,3,1,0,0,2,38.42006058,1,7.834860899,0.719000429,10.89687932,1.19E-27,4.05E-25,0.075326457,1,7.196190511,2.22955927,3.227629159,0.001248207,0.015023052,0.194872766,0,4.54767418,1.367660513,3.32514841,0.000883715,0.005209069,4.23633887,1,5.069072393,1.195983537,4.238413186,2.25E-05,0.000291084,11.77342223,1,6.654014252,0.896694682,7.420601893,1.17E-13,1.51E-11,N,-,,acyltransferase family,"F:transferase activity, transferring acyl groups other than amino-acyl groups; C:integral component of membrane",IPR002656 (PFAM); PTHR23028 (PANTHER); PTHR23028 (PANTHER); PTHR23028:SF72 (PANTHER); PTHR23028:SF72 (PANTHER); PTHR23028 (PANTHER),,
RL4_JR_02988,589,657,841,0,0,0,0,0,2,0,0,0,0,1,0,0,3,0,40.59632797,0,-1.428836294,1.040297043,-1.373488758,0.169600454,0.322442438,10.45771694,1,0.079014892,1.228377556,0.064324597,0.948711768,0.972638561,27.20254617,0,-2.576669905,1.20403253,-2.140033463,0.032352063,0.081455429,31.3884363,1,-2.999327146,1.204894967,-2.489285148,0.012800026,0.059043399,26.86200966,1,-2.66124502,1.210058772,-2.199269228,0.027858784,0.071032534,N,-,,ferric reductase like transmembrane component,C:membrane,G3DSA:3.40.50.80 (GENE3D); IPR013112 (PFAM); IPR013121 (PFAM); IPR013130 (PFAM); PTHR11972 (PANTHER); PTHR11972:SF82 (PANTHER); PTHR11972:SF82 (PANTHER); PTHR11972 (PANTHER); IPR017927 (PROSITE_PROFILES); IPR017938 (SUPERFAMILY); SSF52343 (SUPERFAMILY),5.B.1.5.1, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_02989,1662,997,1411,0,0,0,0,0,0,3,0,0,2,11,2,0,2,4,32.95656936,0,4.252812261,0.638121334,6.664582477,2.65E-11,1.02E-09,0.764154546,0,3.853567129,1.464891258,2.630616509,0.008523015,0.02979964,24.17226901,1,3.603591495,0.870244304,4.140896387,3.46E-05,0.000532281,32.95274797,1,3.822995945,0.695594235,5.496014415,3.88E-08,9.58E-07,1.962635225,1,1.113742561,1.226702552,0.907915745,0.363922739,0.500291725,N,-,,kinase-related,P:metabolic process; F:transferase activity,IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10285 (PANTHER); PTHR10285:SF81 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_02990,12910,12156,16948,4,0,4,0,0,0,0,0,0,2,5,3,0,8,2,472.2856413,1,0.464091393,0.565220315,0.821080525,0.411600402,0.602951352,144.8171474,0,0.68488298,0.627985515,1.090603148,0.275447544,0.433739894,269.3455919,0,-0.532583285,0.525051233,-1.014345367,0.310417983,0.451922874,286.6660579,1,-0.935443223,0.409058575,-2.286819739,0.022206347,0.080442001,163.4163187,1,-4.301150164,1.118145849,-3.846680796,0.000119729,0.00080602,N,-,,c-1-tetrahydrofolate synthase,F:ATP binding; F:formate-tetrahydrofolate ligase activity; P:folic acid-containing compound biosynthetic process; P:oxidation-reduction process; F:methylenetetrahydrofolate dehydrogenase (NADP+) activity,IPR000672 (PRINTS); IPR020631 (PFAM); IPR000559 (PFAM); IPR020630 (PFAM); G3DSA:3.40.192.10 (GENE3D); G3DSA:3.30.1510.10 (GENE3D); G3DSA:3.10.410.10 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10025:SF36 (PANTHER); PTHR10025 (PANTHER); IPR000672 (HAMAP); IPR000559 (HAMAP); IPR027417 (SUPERFAMILY); SSF53223 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_02991,23222,19516,22015,7,2,4,0,0,0,0,0,4,4,6,2,0,3,1,357.4127123,1,-0.54201962,0.434176467,-1.248385532,0.211889905,0.379211835,66.1551879,0,-2.58228219,1.201650957,-2.148945312,0.031638735,0.082559237,207.7156217,1,-2.412856706,0.768417115,-3.140035093,0.001689276,0.008663744,289.5286453,1,-0.922845669,0.473665922,-1.948304969,0.051378483,0.125200274,205.1042909,1,-1.936245829,0.647060426,-2.992372507,0.002768183,0.01111855,N,-,,eukaryotic translation initiation factor 3 subunit 2,"C:multi-eIF complex; F:translation initiation factor activity; P:formation of translation preinitiation complex; P:cellular response to osmotic stress; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:eukaryotic 43S preinitiation complex; C:cytosolic small ribosomal subunit; C:eukaryotic translation initiation factor 3 complex, eIF3e; C:nuclear periphery; C:eukaryotic 48S preinitiation complex; P:regulation of translational initiation; P:translation reinitiation",IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR19877 (PANTHER); IPR027525 (HAMAP); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),8.A.92.1.3,The G-Protein αβγ Complex (GPC) Family
RL4_JR_02992,1236,2632,2387,2,4,60,0,0,0,11,4,1,13,40,19,8,17,19,51.49535528,1,0.862234714,0.631126759,1.366183103,0.1718815,0.32556519,6.415838723,0,0.783829896,1.23093618,0.636775414,0.524271143,0.673692079,66.22317087,1,1.748679888,0.583005838,2.999420888,0.002704934,0.012567812,82.02048702,1,2.076315937,0.477330231,4.349852164,1.36E-05,0.0001869,82.80928026,1,2.04073999,1.654643018,1.233341553,0.217448361,0.342730197,N,-,,ubiquinone biosynthesis coq7,"F:2-octoprenyl-3-methyl-6-methoxy-1,4-benzoquinone hydroxylase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; P:oxidation-reduction process; C:extrinsic component of mitochondrial inner membrane; P:ubiquinone biosynthetic process",IPR011566 (PFAM); PTHR11237:SF4 (PANTHER); IPR011566 (PANTHER); IPR009078 (SUPERFAMILY),,
RL4_JR_02993,18372,15347,16415,0,7,9,0,0,0,1,0,7,1,19,0,0,0,1,109.3142255,1,-0.288249178,0.573081431,-0.502981186,0.614977499,0.778967874,19.08057506,0,-0.788558993,1.206346022,-0.653675628,0.513320809,0.6639194,86.19418118,1,-0.305173792,0.682990782,-0.446819782,0.655005187,0.760903329,70.63122313,1,-2.133022868,1.025505135,-2.079972878,0.037528021,0.102992322,49.16757132,1,-3.533418489,1.205368079,-2.931402075,0.003374357,0.013015378,N,-,,RNA polymerase 2 transcription elongation factor,F:DNA binding; F:translation elongation factor activity; P:histone modification; C:Cdc73/Paf1 complex; P:translational elongation; P:transcription elongation from RNA polymerase II promoter,IPR004343 (SMART); IPR004343 (PFAM); IPR031102 (PANTHER); PTHR13115:SF8 (PANTHER); IPR004343 (PROSITE_PROFILES); IPR004343 (SUPERFAMILY),,
RL4_JR_02994,9630,6697,9261,4,8,2,2,0,0,3,0,2,1,10,2,0,3,5,38.70746026,1,-0.849845457,1.030302309,-0.824850579,0.409456427,0.60078157,7.183630496,1,0.620739983,1.236890808,0.501855118,0.615769438,0.747647462,18.73601283,1,-2.038822156,1.205122351,-1.691796816,0.090684721,0.180018062,21.62123191,1,-2.461618956,1.205422664,-2.042121017,0.041139529,0.109528721,18.57367139,1,-2.128944531,1.215649393,-1.751281696,0.079897399,0.161115573,N,-,,ion transporter,F:ion channel activity; P:ion transmembrane transport; C:integral component of membrane,G3DSA:1.20.5.170 (GENE3D); PTHR12305 (PANTHER),1.A.51.1.5, the voltage-gated proton channel (vpc) family
RL4_JR_02995,18786,11610,16339,0,5,4,0,0,0,0,3,2,1,13,0,0,0,1,207.9293173,1,1.023345678,0.653537746,1.565855506,0.117382448,0.248599692,29.76820551,0,0.031807109,1.128383396,0.028188211,0.97751204,0.988344851,52.85601344,1,-3.53503629,1.201602981,-2.941933688,0.003261698,0.014407254,74.29234252,1,-2.222148459,1.030095527,-2.157225617,0.030988089,0.094165438,52.12457588,1,-3.617691851,1.204917983,-3.002438258,0.002678263,0.010838294,N,-,,hypothetical protein CMQ_1406,,IPR029196 (PFAM); PTHR38645 (PANTHER),,
RL4_JR_02996,57891,16646,41755,0,9,2,0,0,2,0,2,8,0,5,5,0,0,0,175.4977786,1,1.351390324,0.398997482,3.386964541,0.000706705,0.004476082,14.97517293,1,-0.438969721,1.218088616,-0.36037585,0.718566084,0.82389283,38.72181394,1,-3.086101194,1.196466041,-2.579347083,0.009898727,0.032415756,90.07561637,1,0.486322405,0.529984173,0.917616845,0.358819496,0.504730119,76.31734686,0,0.587867621,0.544008483,1.080622157,0.279865222,0.413497449,N,-,,signal transducing adaptor molecule,C:intracellular membrane-bounded organelle; C:cytoplasmic part; P:intracellular protein transport,PR00499 (PRINTS); IPR001452 (PRINTS); IPR002014 (SMART); IPR001452 (SMART); G3DSA:2.30.30.40 (GENE3D); IPR001452 (PFAM); IPR004152 (PFAM); IPR002014 (PFAM); IPR008942 (G3DSA:1.25.40.GENE3D); PTHR13856:SF83 (PANTHER); PTHR13856 (PANTHER); PTHR13856:SF83 (PANTHER); PTHR13856 (PANTHER); PTHR13856 (PANTHER); PTHR13856:SF83 (PANTHER); PTHR13856:SF83 (PANTHER); PTHR13856 (PANTHER); IPR003903 (PROSITE_PROFILES); IPR002014 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR008942 (SUPERFAMILY); IPR001452 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_02997,2142,1798,2151,0,0,0,0,0,0,0,1,0,0,4,0,0,0,7,63.27022861,0,1.48571053,0.633414942,2.345556493,0.018998699,0.062822935,5.031329883,0,1.134652856,1.287958505,0.88097004,0.378334036,0.542575391,12.97277375,1,-1.508311054,1.219742906,-1.236581124,0.216242631,0.344870888,64.24503108,1,1.628566884,0.635315364,2.56339918,0.01036528,0.049833077,12.68684669,1,-1.579030894,1.217601522,-1.296837155,0.194687224,0.315544764,N,-,,snf2 family helicase,C:cytoplasm,IPR014001 (SMART); IPR001650 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000330 (PFAM); IPR001650 (PFAM); PTHR10799:SF737 (PANTHER); PTHR10799 (PANTHER); PTHR10799:SF737 (PANTHER); PTHR10799 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_02998,3019,2696,2725,6,17,4,0,0,2,3,8,6,3,12,3,0,18,2,417.8671348,1,-1.601478093,0.422479423,-3.790665309,0.000150244,0.001209963,110.2895465,1,-2.273657271,1.106005391,-2.055737964,0.03980778,0.098661693,309.2763791,1,-2.232318114,0.587924539,-3.796946657,0.000146489,0.001453978,446.6448736,1,-1.133013728,0.370908985,-3.054694747,0.002252897,0.014575451,328.88344,1,-1.570090608,0.874057704,-1.796323745,0.072443044,0.148749912,N,-,,eukaryotic peptide chain release factor GTP-binding subunit,"F:GTP binding; C:cytoplasmic stress granule; F:translation elongation factor activity; F:translation release factor activity; F:GTPase activity; C:cytosol; P:cytoplasmic translational termination; C:translation release factor complex; P:translational elongation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",IPR000795 (PRINTS); IPR003285 (PRINTS); IPR004161 (PFAM); PF00009 (PFAM); IPR004160 (PFAM); G3DSA:2.40.30.10 (GENE3D); G3DSA:2.40.30.10 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23115:SF36 (PANTHER); PTHR23115 (PANTHER); IPR000795 (PROSITE_PROFILES); IPR009001 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR009000 (SUPERFAMILY),,
RL4_JR_02999,3271,3057,3768,2,0,4,0,0,2,0,1,1,1,7,4,0,2,1,134.0393239,1,1.500266935,0.450853779,3.327613084,0.000875934,0.005376879,10.60864153,1,0.058372367,1.225950527,0.047613967,0.962023901,0.979638423,49.5609499,1,-0.755810974,1.03513603,-0.730156184,0.465294722,0.60223009,47.67137998,1,-0.302808545,0.758260234,-0.399346466,0.689637933,0.789885077,42.38496754,1,-0.059128941,0.756546342,-0.078156404,0.937703641,0.959693658,N,-,,kelch domain-containing,,IPR006652 (PFAM); IPR015915 (G3DSA:2.120.10.GENE3D); PF13418 (PFAM); PTHR23244 (PANTHER); IPR011043 (SUPERFAMILY),,
RL4_JR_03000,13966,13413,12275,3,6,13,0,1,8,0,1,3,0,3,0,0,4,4,200.8321425,1,-1.172331532,0.593999637,-1.973623316,0.048424591,0.129736555,57.65762272,1,-1.211235673,1.121588185,-1.079929058,0.280173772,0.4392007,162.9668998,1,-1.942304472,0.757646941,-2.56360102,0.010359255,0.033602892,215.9474338,1,-1.010571589,0.497007389,-2.033313006,0.04202091,0.111202748,173.5763445,1,-0.799460369,0.703226109,-1.136846824,0.255602325,0.386725815,N,-, Effector probability:0.606,nadh-ubiquinone oxidoreductase 24 kda subunit,"C:plasma membrane respiratory chain complex I; C:mitochondrial respiratory chain complex I; F:metal ion binding; P:mitochondrial electron transport, NADH to ubiquinone; F:NADH dehydrogenase (ubiquinone) activity; F:2 iron, 2 sulfur cluster binding",IPR002023 (PIRSF); IPR012336 (G3DSA:3.40.30.GENE3D); IPR002023 (TIGRFAM); PF01257 (PFAM); PTHR10371 (PANTHER); PTHR10371:SF3 (PANTHER); IPR012336 (SUPERFAMILY),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_03001,930,763,598,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,973.6393146,0,1.300998551,0.305182334,4.263020521,2.02E-05,0.000211753,153.5530898,0,0.379791681,0.602169242,0.630705878,0.528232855,0.67697809,352.6523623,0,-0.745740654,0.39780228,-1.874651533,0.060840679,0.131726055,330.9795579,0,-1.654916654,0.43641731,-3.7920509,0.000149408,0.001506319,231.6519802,0,-4.05087404,0.97222379,-4.16660658,3.09E-05,0.000259347,N,-, Effector probability:0.65,hypothetical protein AKAW_08879,P:regulation of catalytic activity; C:integral component of membrane; F:enzyme regulator activity,no IPS match,,
RL4_JR_03002,1022,1279,1102,3,0,0,0,0,0,0,0,0,0,3,0,0,0,0,20.02353966,1,1.648507015,1.0250521,1.608217782,0.10778749,0.233988915,1.274548797,0,3.115440724,1.377488137,2.261682435,0.023717031,0.065897278,3.315587481,0,0.459388033,1.219620639,0.376664693,0.706422805,0.800696874,3.825331352,1,0.036933765,1.223580767,0.030184983,0.975919525,0.985457783,10.64670276,0,1.310506538,1.144949235,1.144597942,0.252375745,0.383506592,N,-,,deoxycytidylate deaminase,F:catalytic activity; F:binding,IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:3.40.140.10 (GENE3D); IPR002125 (PFAM); PTHR11086:SF4 (PANTHER); IPR015517 (PANTHER); IPR002125 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR016193 (SUPERFAMILY),3.A.11.1.4, the bacterial competence-related dna transformation transporter (dna-t) family.
RL4_JR_03003,871,747,975,0,0,21,0,0,0,6,0,0,3,0,1,0,0,0,106.874593,1,0.673316154,0.541068104,1.24442034,0.213344901,0.381430572,59.62470172,0,2.655819975,0.750258158,3.539874835,0.000400317,0.014734571,130.9934762,1,1.649318575,0.528699593,3.119576026,0.001811115,0.009145002,70.73319311,1,-0.504767176,0.778832901,-0.648107155,0.516915647,0.651371615,51.41710439,0,-0.01897697,0.719975038,-0.026357816,0.97897194,0.98578726,N,-,,ubiquitin-like modifier-activating enzyme atg7,P:late nucleophagy; C:pre-autophagosomal structure; P:protein catabolic process; P:protein transport; P:C-terminal protein lipidation; P:mitophagy; P:cellular response to nitrogen starvation; P:piecemeal microautophagy of nucleus; C:cytosol; F:Atg8 activating enzyme activity; P:macroautophagy; F:Atg12 activating enzyme activity; P:protein modification by small protein conjugation,IPR032197 (PFAM); IPR000594 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR006285 (TIGRFAM); PTHR10953 (PANTHER); IPR006285 (PTHR10953:PANTHER); IPR006285 (PTHR10953:PANTHER); PTHR10953 (PANTHER); IPR000594 (SUPERFAMILY),9.A.15.2.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_03004,4200,4272,5049,2,0,12,1,0,0,14,2,8,1,9,0,0,4,1,36.09631009,1,-3.276145205,1.187133724,-2.759710333,0.005785263,0.024479466,11.58136514,1,-0.06818843,1.218687189,-0.055952364,0.955379755,0.976324189,42.94283382,1,-0.895583555,1.033757437,-0.866338197,0.386304725,0.530154404,91.98902903,1,1.214585351,0.485027147,2.504159529,0.012274268,0.057033942,29.42581548,1,-2.792833224,1.190234593,-2.346456103,0.018952899,0.052388233,N,-,,sugar transporter,P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23511 (PANTHER); PTHR23511:SF5 (PANTHER); PTHR23511:SF5 (PANTHER); PTHR23511 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.19.38, the major facilitator superfamily (mfs).
RL4_JR_03005,10157,10334,6785,7,9,13,0,0,0,0,3,1,4,5,2,0,0,5,55.15206301,1,0.846720028,0.70807724,1.195801785,0.231773919,0.404884718,7.771365716,0,0.507304927,1.249765558,0.405920074,0.684801328,0.799764514,35.97158405,1,-0.328513154,1.058368222,-0.310395897,0.756259914,0.836213998,70.61908671,1,0.568877658,0.721520387,0.788442944,0.43043766,0.572841918,31.33822351,1,-0.564385408,1.011908607,-0.557743461,0.577019576,0.690771032,N,-,,membrane associated chaperone,C:integral component of membrane,IPR001623 (PRINTS); IPR001623 (SMART); IPR001623 (PFAM); IPR001623 (G3DSA:1.10.287.GENE3D); PTHR24078:SF177 (PANTHER); PTHR24078 (PANTHER); IPR001623 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY),3.A.5.8.1, the general secretory pathway (sec) family.
RL4_JR_03006,2976,2528,2177,1,0,0,0,0,2,0,2,4,0,1,6,0,6,2,32.17572751,1,0.535106173,0.739880113,0.723233621,0.469536366,0.658383925,5.390363346,1,1.035146866,1.234796524,0.838313719,0.401854533,0.565568907,13.98386419,1,-1.616679118,1.189922643,-1.358642201,0.174259996,0.293252692,16.13233222,1,-2.039030435,1.187591206,-1.716946391,0.085988968,0.174887515,13.78004968,1,-1.698244397,1.192314858,-1.42432545,0.154352284,0.264436019,N,-,,increased sodium tolerance 1,C:intracellular membrane-bounded organelle; C:endomembrane system; C:cytoplasmic part; P:transport,IPR005061 (PFAM); IPR005061 (PANTHER); PTHR12161:SF5 (PANTHER),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_03007,1357,917,1839,4,0,0,0,0,0,0,0,0,0,0,1,0,0,0,157.098071,1,-2.43485937,0.816388697,-2.982475602,0.002859274,0.013859751,43.2531978,0,-1.969206842,1.239610045,-1.588569606,0.112157595,0.221540063,146.3563197,0,-1.481510378,0.732588262,-2.02229609,0.043145772,0.101066127,193.1798507,1,-0.789093713,0.57649623,-1.368775149,0.171069571,0.293373884,124.0917806,0,-2.112301659,0.82766407,-2.55212439,0.010706829,0.033212818,N,-,,vacuolar -sorting bro1,P:protein transport,IPR004328 (SMART); G3DSA:1.20.140.50 (GENE3D); G3DSA:3.30.450.60 (GENE3D); IPR022775 (PFAM); IPR004328 (PFAM); IPR004328 (G3DSA:1.25.40.GENE3D); IPR025304 (PFAM); PTHR23030:SF13 (PANTHER); PTHR23030 (PANTHER); IPR004328 (PROSITE_PROFILES); IPR011012 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_03008,683,743,651,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,180.1083904,0,-0.14906979,1.094379815,-0.136213943,0.891652153,0.946655162,31.7900235,0,-1.525008439,1.193106898,-1.278182569,0.201185061,0.345329179,104.8346761,0,-1.773016366,0.851703377,-2.081729878,0.03736715,0.090503075,248.5106442,0,0.625184102,0.596236685,1.048550213,0.29438518,0.438782563,149.3805748,0,0.040668654,0.468736815,0.086762235,0.930860506,0.954813355,N,-,,coatomer subunit delta,"C:nucleus; P:retrograde vesicle-mediated transport, Golgi to ER; P:protein transport; C:cytosol; C:COPI vesicle coat",G3DSA:3.30.450.60 (GENE3D); IPR028565 (PFAM); IPR022775 (PFAM); PTHR10121:SF0 (PANTHER); IPR027059 (PANTHER); IPR028565 (PROSITE_PROFILES); IPR028565 (SUPERFAMILY); IPR011012 (SUPERFAMILY),9.B.278.1.1, the organellar-targeting adaptor protein complex (o-apc) family.
RL4_JR_03009,136,191,208,0,0,87,0,0,0,0,0,0,4,20,0,0,14,6,490.1720178,1,-2.068634684,0.414336743,-4.992641179,5.96E-07,9.68E-06,125.3996611,0,-3.504865148,1.197792902,-2.926102786,0.003432375,0.016607314,379.5780268,0,-2.669479655,1.493999214,-1.786801244,0.073969618,0.153456642,518.2709139,1,-1.232316625,0.354782483,-3.473442701,0.000513827,0.004281892,322.2944596,1,-5.298516904,1.123772066,-4.714939146,2.42E-06,3.05E-05,N,-,,conserved glutamic acid-rich,,IPR018822 (PFAM),,
RL4_JR_03010,24817,31290,28172,26,64,56,0,0,19,9,12,17,22,59,15,2,25,11,138.9231891,1,1.064785972,0.426978711,2.493768296,0.012639502,0.045787326,14.15092754,1,-0.357299403,1.21278153,-0.294611514,0.768290665,0.859715247,100.5007792,1,0.976988701,0.518269695,1.885097103,0.059416729,0.129195654,95.69580763,1,0.820537407,0.491234042,1.670359415,0.094848274,0.188227906,115.351625,1,1.507901051,0.425575426,3.543205174,0.000395295,0.002219835,N,-,,duf803 domain membrane,P:magnesium ion transport; C:integral component of membrane; F:magnesium ion transmembrane transporter activity; P:magnesium ion transmembrane transport,IPR008521 (PFAM); PTHR12570:SF2 (PANTHER); IPR008521 (PANTHER); SSF103481 (SUPERFAMILY),2.A.7.25.6, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_03011,64,69,115,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,312.8207624,0,0.158919133,0.38614251,0.411555655,0.680665141,0.824968982,222.9824021,0,1.750477981,0.581894971,3.008236999,0.002627681,0.015349618,175.9816508,0,-1.611867207,0.687979982,-2.342898411,0.019134592,0.053975652,203.0762418,0,-1.302109476,0.543145051,-2.397351265,0.016514084,0.069610783,158.7514813,0,-1.205478077,0.642588856,-1.875971028,0.060659258,0.129819275,N,-,,---NA---,,no IPS match,,
RL4_JR_03012,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,599.1444269,0,-1.130363927,0.818097304,-1.381698634,0.167064254,0.318883993,129.7124041,0,-3.553665658,1.202704248,-2.954729447,0.003129434,0.015941545,338.4183816,0,-6.213678366,1.209223627,-5.13856844,2.77E-07,8.71E-06,450.7066161,0,-2.358189668,0.791048959,-2.98109193,0.002872226,0.017929275,428.3591531,0,-1.63936074,1.034856887,-1.584142465,0.113161303,0.209521261,N,-,,40S ribosomal S3,C:nucleus; P:DNA repair; F:RNA binding; F:structural constituent of ribosome; C:cytosolic small ribosomal subunit; F:damaged DNA binding; F:oxidized purine nucleobase lesion DNA N-glycosylase activity; P:translation,IPR005703 (TIGRFAM); PF00189 (PFAM); IPR004044 (PFAM); IPR001351 (G3DSA:3.30.1140.GENE3D); PTHR11760:SF20 (PANTHER); PTHR11760 (PANTHER); IPR004044 (PROSITE_PROFILES); IPR009019 (SUPERFAMILY); IPR001351 (SUPERFAMILY),,
RL4_JR_03013,1,2,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.473843136,0,-0.264131526,1.227185244,-0.215233623,0.829585178,0.914808851,1.43019747,0,2.949254478,1.368514795,2.155076794,0.031155825,0.081527405,3.711071774,0,0.296893335,1.219407195,0.243473498,0.807638613,0.874121586,16.31565865,0,2.162856062,0.883769286,2.447308474,0.01439276,0.064800619,3.663673208,0,0.212810751,1.221173839,0.174267368,0.861655343,0.907870562,N,-,,C6 zinc finger domain partial,"C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:transferase activity; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR36206 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_03014,10,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.932257991,0,0.947175075,1.287193186,0.735845314,0.461824841,NA,0.616017458,0,4.164398148,1.500306408,2.775698436,0.005508327,0.021974647,1.600649831,0,1.509893675,1.227084401,1.230472552,0.218520199,0.347627042,1.846627045,0,1.087598749,1.243114831,0.874898056,0.381629377,0.527179238,1.581829739,0,1.424542538,1.22140263,1.166316908,0.24348634,0.373077964,Y,-,,beta-lactamase family,,IPR001466 (PFAM); IPR012338 (G3DSA:3.40.710.GENE3D); PTHR22935:SF64 (PANTHER); PTHR22935 (PANTHER); IPR012338 (SUPERFAMILY),9.B.306.1.3, The Putative Calcium Binding Protein with Similarity to the C-termini of Anoctamins (1.A.17.5) (CBP) Family
RL4_JR_03015,17,3,6,0,0,0,0,0,0,0,0,1,0,0,1,0,3,0,43.61502647,0,-0.807612616,0.853073179,-0.946709656,0.343786748,0.533906776,19.70121494,0,1.013977173,1.127236086,0.899525118,0.368373023,0.532749724,33.18496182,1,-1.587240519,1.193182748,-1.330257684,0.183433384,0.304956395,58.07198082,1,-0.2379146,0.746752553,-0.318598978,0.750030629,0.835338259,52.17831312,1,0.009145178,0.743731929,0.012296337,0.99018919,0.993328599,N,-,,phosphatase,F:protein tyrosine phosphatase activity; P:peptidyl-tyrosine dephosphorylation,IPR010569 (PFAM); IPR030564 (PANTHER); PTHR10807:SF71 (PANTHER); PTHR10807:SF71 (PANTHER); IPR030564 (PANTHER); IPR010569 (PROSITE_PROFILES); IPR029021 (SUPERFAMILY),,
RL4_JR_03016,375,516,468,0,0,3,0,0,0,0,0,0,3,2,0,0,0,3,154.7144336,1,-0.802676763,0.491605036,-1.632767574,0.102517889,0.225733047,33.81959075,0,-1.614269903,1.191082609,-1.355296342,0.17532316,0.311446301,146.4921935,0,-0.447109998,0.533164481,-0.838596744,0.401695638,0.544021741,134.1874141,1,-1.950387117,0.734823764,-2.654224334,0.007949096,0.040403914,162.3523134,1,0.234823974,0.426596606,0.550459078,0.582004537,0.694741327,N,-,,phosphatase pp2a regulatory subunit a,P:regulation of translation; P:mitotic spindle assembly checkpoint; C:nucleus; C:cellular bud tip; C:cytoplasm; C:cellular bud neck; C:spindle pole body; C:mating projection tip; C:protein phosphatase type 2A complex; P:dephosphorylation,IPR011989 (G3DSA:1.25.10.GENE3D); PF13646 (PFAM); PTHR10648 (PANTHER); IPR021133 (PROSITE_PROFILES); IPR021133 (PROSITE_PROFILES); IPR021133 (PROSITE_PROFILES); IPR021133 (PROSITE_PROFILES); IPR021133 (PROSITE_PROFILES); IPR021133 (PROSITE_PROFILES); IPR021133 (PROSITE_PROFILES); IPR021133 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),,
RL4_JR_03017,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28.80328098,0,1.979787358,0.864209518,2.290865022,0.021971222,0.071099256,1.516191994,0,2.864972731,1.346814496,2.127221485,0.033401685,0.086072264,3.948189371,0,0.207510541,1.213012565,0.171070397,0.864168412,0.913717076,13.86785932,0,0.735637841,1.15474603,0.63705596,0.524088393,0.65836166,3.909656236,0,0.119207271,1.218807716,0.097806463,0.922085976,0.949951211,N,-,,hypothetical protein CMQ_549,,no IPS match,,
RL4_JR_03018,12,37,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2312.952103,0,-0.812812671,0.366223997,-2.219441318,0.026456715,0.082316508,647.5581644,0,-2.007510876,0.795201315,-2.524531635,0.011585258,0.037621424,1434.713612,0,-2.537187529,0.496527723,-5.109860761,3.22E-07,9.95E-06,1699.475095,0,-2.26343536,0.465772394,-4.859530941,1.18E-06,2.14E-05,1337.319697,0,-2.969721078,1.09354528,-2.715681859,0.006613944,0.022585559,N,-,,cell division control 48,"F:ATPase activity; C:Hrd1p ubiquitin ligase ERAD-L complex; C:Doa10p ubiquitin ligase complex; C:VCP-NPL4-UFD1 AAA ATPase complex; P:SCF complex disassembly in response to cadmium stress; C:mitotic spindle midzone; P:cell division; F:ATP binding; P:piecemeal microautophagy of nucleus; F:ubiquitin binding; P:nucleus-associated proteasomal ubiquitin-dependent protein catabolic process; P:regulation of catalytic activity; P:sister chromatid biorientation; C:cytosol; P:mitotic spindle disassembly; P:ER-associated misfolded protein catabolic process; P:positive regulation of histone H2B ubiquitination; P:establishment of endoplasmic reticulum localization involved in endoplasmic reticulum polarization at cell division site; P:positive regulation of protein localization to nucleus; C:Cdc48p-Npl4p-Vms1p AAA ATPase complex; P:cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process; C:mating projection tip; F:protein phosphatase type 1 regulator activity; P:mitochondria-associated ubiquitin-dependent protein catabolic process; C:RQC complex; C:nuclear chromatin; P:ribophagy; P:vesicle fusion; P:nonfunctional rRNA decay; P:ribosome-associated ubiquitin-dependent protein catabolic process; P:endoplasmic reticulum membrane fusion; P:protein processing; P:retrograde protein transport, ER to cytosol; P:regulation of mitotic sister chromatid segregation",IPR003593 (SMART); IPR003338 (SMART); IPR004201 (SMART); G3DSA:1.10.8.60 (GENE3D); IPR004201 (PFAM); G3DSA:2.40.40.20 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR029067 (G3DSA:3.10.330.GENE3D); IPR003959 (PFAM); IPR015415 (PFAM); IPR005938 (TIGRFAM); G3DSA:1.10.8.60 (GENE3D); IPR003338 (PFAM); PTHR23077:SF69 (PANTHER); PTHR23077 (PANTHER); PTHR23077:SF69 (PANTHER); PTHR23077 (PANTHER); IPR029067 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR009010 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_03019,659,735,558,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,79.23741895,0,0.766171508,0.506864003,1.511591875,0.13063772,0.26790913,10.37691343,0,0.09023522,1.218390669,0.074060991,0.940961855,0.967928445,26.85026321,0,-2.557879924,1.190397633,-2.148760929,0.031653356,0.080054603,30.96933055,1,-2.979956653,1.188911516,-2.506457892,0.012194758,0.056768702,26.40413203,0,-2.636512923,1.189421873,-2.216633965,0.026648115,0.068741952,N,-,,hypothetical protein SPI_00344,,no IPS match,,
RL4_JR_03020,506,501,511,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,125.7759468,1,-1.80693287,0.669667694,-2.698253009,0.006970444,0.028546628,52.89681113,0,0.014512157,0.985528812,0.014725249,0.988251376,0.99408933,94.86630064,0,-3.314646447,1.188084531,-2.789907923,0.005272303,0.019674456,109.9529894,0,-2.97079584,1.012229595,-2.934903163,0.003336518,0.020265294,86.87815835,1,-4.354704001,1.186053032,-3.671592994,0.000241043,0.001460541,Y,-,,transmembrane glyco,C:integral component of plasma membrane; P:axial cellular bud site selection; C:cellular bud neck; F:calcium ion binding; C:membrane; C:integral component of membrane; C:septin ring,IPR006644 (SMART); IPR013320 (G3DSA:2.60.120.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR008009 (PFAM); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY); IPR015919 (SUPERFAMILY),,
RL4_JR_03021,3,3,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,65.49516278,0,-3.101604168,1.145452814,-2.707753765,0.006774026,0.027910356,19.62522037,0,-0.829147571,1.197699234,-0.692283628,0.48875923,0.644657035,51.01874763,0,-3.48399847,1.190455225,-2.926610256,0.00342678,0.014915186,78.13378952,0,-2.16314716,1.014077098,-2.133119034,0.032914963,0.097138839,50.40835433,0,-3.569366775,1.195804896,-2.98490731,0.002836643,0.011311262,N,-,,n2n2-dimethylguanosine trna methyl transferase,F:transferase activity,IPR019410 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR14614:SF35 (PANTHER); PTHR14614 (PANTHER); PTHR14614:SF35 (PANTHER); PTHR14614 (PANTHER); IPR033684 (HAMAP); IPR029063 (SUPERFAMILY),,
RL4_JR_03022,1,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,105.7255932,0,1.980963405,0.594937753,3.329698603,0.0008694,0.005340789,6.393075679,0,0.789019629,1.252023803,0.63019539,0.528566755,0.677243359,16.60892829,0,-1.864851688,1.208610163,-1.54297204,0.12283756,0.22586405,47.24471808,0,1.172439887,0.641725441,1.827011696,0.067698011,0.147597407,106.1821664,0,2.668650505,0.47725593,5.591654999,2.25E-08,8.07E-07,N,-,,allergen asp f7,,IPR009009 (G3DSA:2.40.40.GENE3D); PTHR34586 (PANTHER); PTHR34586:SF2 (PANTHER); IPR009009 (SUPERFAMILY),,
RL4_JR_03023,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,74.21319711,0,0.991854453,0.529356638,1.873697961,0.060972067,0.154238016,7.96141597,0,0.472518095,1.226223741,0.385344109,0.699982485,0.810017459,20.60101554,0,-2.175656775,1.190697152,-1.827212546,0.067667818,0.142901333,27.77309104,0,-1.650436128,1.141441862,-1.445922199,0.148199025,0.263850031,27.97996002,0,-0.583650095,0.96997357,-0.601717524,0.547362183,0.667988296,N,-,,vacuolar fusion ccz1,,IPR013176 (PFAM); PTHR13056 (PANTHER),,
RL4_JR_03024,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,129.4926854,0,-1.873020999,0.693594548,-2.700455195,0.006924466,0.028372575,35.43761986,0,-1.681686123,1.206486124,-1.393871085,0.163356537,0.295477997,138.4848294,0,-0.716816883,0.594101708,-1.206555836,0.227603243,0.358506581,154.9869559,0,-1.201981848,0.590107222,-2.036887199,0.041661347,0.110598097,134.315411,0,-1.135431969,0.655342199,-1.732578752,0.083170569,0.166291866,N,-,,mitogen-activated kinase maf1,P:transfer RNA gene-mediated silencing; C:cytoplasm; P:negative regulation of transcription from RNA polymerase III promoter; C:nucleolus; F:RNA polymerase III core binding; P:cellular metabolic process; P:transcription factor TFIIIB complex assembly,IPR015257 (PFAM); IPR015257 (PIRSF); PTHR22504:SF0 (PANTHER); IPR015257 (PANTHER); PTHR22504:SF0 (PANTHER),,
RL4_JR_03025,196,252,175,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,67.68252733,0,1.277512677,0.544772495,2.345038872,0.019025096,0.062862184,6.500339242,0,0.765033218,1.232142099,0.620896907,0.534667456,0.682631684,16.84916908,0,-1.885548229,1.192430814,-1.58126426,0.113817628,0.213347466,27.46039763,0,-0.581550452,1.015781666,-0.572515208,0.566972986,0.694231646,16.58335933,0,-1.965398709,1.193214143,-1.647146675,0.099527901,0.190387304,N,-,,carboxymuconolactone decarboxylase,P:cellular oxidant detoxification; P:oxidation-reduction process; F:peroxiredoxin activity,IPR029032 (G3DSA:1.20.1290.GENE3D); IPR003779 (PFAM); PTHR34846:SF2 (PANTHER); PTHR34846 (PANTHER); IPR029032 (SUPERFAMILY),,
RL4_JR_03026,101,111,62,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.11083536,0,-1.576370932,1.206608834,-1.306447365,0.191400467,0.351518463,3.575663477,0,1.627334003,1.290359675,1.261147597,0.207255675,0.35251923,9.233964117,0,-1.01799969,1.210477982,-0.840989844,0.400353624,0.542449155,10.6487945,0,-1.439845636,1.209924068,-1.190029749,0.2340347,0.371352661,9.068365375,0,-1.094734153,1.209983552,-0.904751269,0.365597174,0.502057695,N,-,,hypothetical protein CMQ_428,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_03027,1479,1574,2337,0,1,4,0,4,0,1,0,0,0,11,0,0,0,0,53.4082307,1,0.930635665,0.563541917,1.651404514,0.098656004,0.219256275,25.94137692,1,2.262233469,0.987723478,2.290351014,0.022000977,0.062152913,94.8650018,1,1.965952334,0.503866749,3.901730638,9.55E-05,0.001132221,101.9386634,1,1.489425538,0.512801555,2.904487169,0.003678553,0.021973656,18.36311937,0,-2.112539403,1.19215817,-1.772029464,0.076389666,0.155279135,N,-,,BUD32 kinase,C:nucleus; F:ATP binding; C:EKC/KEOPS complex; P:cellular bud site selection; C:membrane; C:cytosol; P:telomere maintenance via recombination; F:protein serine/threonine kinase activity; P:protein phosphorylation; P:positive regulation of transcription from RNA polymerase II promoter; P:tRNA threonylcarbamoyladenosine metabolic process,IPR000719 (SMART); IPR022495 (TIGRFAM); IPR010440 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR022495 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_03028,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,288.4843557,0,-1.26801375,0.586838619,-2.160753754,0.030714366,0.0921883,62.58447286,0,-2.502213876,1.19270091,-2.097939102,0.035910525,0.091099333,173.5965616,0,-4.193745338,1.193509995,-3.513791551,0.000441759,0.003090789,211.5819617,0,-2.296081969,0.632532747,-3.62998118,0.000283442,0.002590117,205.5405659,0,-1.462192615,0.54140547,-2.70073484,0.006918647,0.02338161,N,-,,glutamate-cysteine ligase modifier subunit,P:glutathione biosynthetic process; F:glutamate-cysteine ligase catalytic subunit binding; F:ligase activity,IPR023210 (G3DSA:3.20.20.GENE3D); IPR032963 (PANTHER); IPR023210 (SUPERFAMILY),,
RL4_JR_03029,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30.32376418,0,-3.024691283,1.187609864,-2.546872819,0.010869304,0.040507894,19.03723216,0,1.110865592,1.113739299,0.997419767,0.318560801,0.480487339,47.22475935,0,-0.631000859,1.027333398,-0.614212348,0.539075014,0.667517564,78.54727598,0,0.661580004,0.566860537,1.167094835,0.243172074,0.381385127,70.72417024,0,1.492283286,0.497338699,3.000537238,0.002695038,0.010888771,N,-,,AP-1 complex subunit sigma-1,P:protein transport; F:protein transporter activity,G3DSA:3.30.450.60 (GENE3D); IPR022775 (PFAM); IPR016635 (PIRSF); IPR016635 (PANTHER); IPR011012 (SUPERFAMILY),9.B.278.1.1, the organellar-targeting adaptor protein complex (o-apc) family.
RL4_JR_03030,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,152.4719554,0,-1.626192242,0.651445987,-2.496281005,0.012550314,0.045524882,40.47814696,0,-1.873533046,1.214479449,-1.54266344,0.122912457,0.237654229,136.2679444,0,-1.693877911,0.761144749,-2.225434667,0.026052072,0.068649449,164.6499741,0,-1.403607235,0.601451526,-2.333699683,0.019611453,0.076078911,116.9012923,0,-2.897745014,0.979932992,-2.95708486,0.003105626,0.012178337,N,-,,osmolarity two-component system sln1,F:phosphorelay sensor kinase activity; F:histidine phosphotransfer kinase activity; P:phosphorelay signal transduction system; C:integral component of membrane; P:signal transduction by protein phosphorylation; C:intracellular; F:phosphorelay response regulator activity,IPR004358 (PRINTS); IPR001789 (SMART); IPR003661 (SMART); IPR003594 (SMART); IPR003594 (G3DSA:3.30.565.GENE3D); IPR001789 (PFAM); G3DSA:3.40.50.2300 (GENE3D); IPR003661 (G3DSA:1.10.287.GENE3D); IPR003661 (PFAM); IPR003594 (PFAM); PTHR24423 (PANTHER); IPR005467 (PROSITE_PROFILES); IPR001789 (PROSITE_PROFILES); IPR003661 (SUPERFAMILY); IPR011006 (SUPERFAMILY); IPR003594 (SUPERFAMILY); IPR003594 (SUPERFAMILY),9.B.238.3.1,The Uncharacterized Bacterial 5 TMS Protein-1 (UBP1) Family
RL4_JR_03031,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,75.30313235,0,2.371104942,0.475846151,4.982923442,6.26E-07,1.01E-05,3.831146497,0,1.527766026,1.257294599,1.21512176,0.224319655,0.37338654,16.41864198,0,-0.159548482,1.189645198,-0.134114342,0.893312159,0.933418547,11.44228374,0,-1.54349703,1.189022273,-1.298122891,0.194245109,0.323693472,24.49187592,0,0.482143655,0.966359532,0.49892782,0.617830234,0.724439041,N,-,,hypothetical protein SPI_00357,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_03032,3660,4705,4644,0,1,2,0,0,0,0,0,2,0,0,0,0,0,0,93.02179361,1,0.681554292,0.524759957,1.29879249,0.194015153,0.355200991,21.64083711,0,0.764683787,1.139156209,0.671272106,0.502047201,0.656111167,38.11289013,1,-1.831686252,1.201422166,-1.52459835,0.127359309,0.232279886,109.0223174,0,0.860668593,0.518388736,1.660276417,0.096858858,0.191317974,46.04980627,0,-0.654936543,0.850978475,-0.769627626,0.441520813,0.575306899,N,-,,orm1,P:negative regulation of sphingolipid biosynthetic process; P:cellular sphingolipid homeostasis; C:integral component of membrane; C:SPOTS complex; P:response to unfolded protein,IPR007203 (PIRSF); IPR007203 (PFAM); IPR007203 (PANTHER); IPR029887 (PTHR12665:PANTHER),,
RL4_JR_03033,3364,3615,6858,0,4,0,0,0,0,0,0,0,0,1,0,0,0,0,23.82368692,1,-2.676642202,1.256806756,-2.129716593,0.033195018,0.097869519,7.741917844,0,0.512881437,1.313484995,0.390473769,0.696186248,0.807389704,19.8325328,0,-2.12076548,1.247245814,-1.700358868,0.089063444,0.177286336,22.86150705,1,-2.54199229,1.252499523,-2.029535535,0.042403773,0.111865088,19.28461411,0,-2.183191868,1.246961955,-1.750808723,0.079978864,0.161215607,Y,-,,---NA---,,IPR018392 (PFAM); IPR018392 (G3DSA:3.10.350.GENE3D),,
RL4_JR_03034,1207,1120,1614,0,0,26,0,0,0,0,1,12,0,0,0,0,15,0,9.8634316,1,-1.404412185,1.241005464,-1.131672846,0.257772002,0.4366495,3.197714155,0,1.788563684,1.341973711,1.332785933,0.182602063,0.321890993,8.208598657,1,-0.848062292,1.23617634,-0.686036663,0.492689989,0.626167471,9.463274978,0,-1.269448316,1.238953164,-1.024613644,0.305545524,0.451157607,8.002983301,1,-0.914406971,1.232279958,-0.742044829,0.458060175,0.5897583,N,-,,---NA---,,no IPS match,,
RL4_JR_03035,11211,12244,17361,0,2,6,3,0,0,0,3,1,0,4,3,0,4,1,784.9437899,1,-2.339727577,0.899583051,-2.600902246,0.009297894,0.035796235,213.762975,1,-4.274347638,1.204796783,-3.547774777,0.0003885,0.014476338,552.4486803,1,-6.920705447,1.199394388,-5.770166609,7.92E-09,3.40E-07,649.1879531,1,-5.046593855,0.868571135,-5.810225155,6.24E-09,1.79E-07,546.421404,1,-6.068129816,1.134489295,-5.348776618,8.86E-08,2.02E-06,N,-,,amino acid permease,C:cell division site; C:cell tip; C:integral component of membrane; C:Golgi apparatus; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR004756 (TIGRFAM); IPR002293 (PIRSF); IPR002293 (PFAM); PTHR11785:SF217 (PANTHER); IPR002293 (PANTHER),2.A.3.4.7, the amino acid-polyamine-organocation (apc) family.
RL4_JR_03036,1504,1240,1108,0,6,3,0,0,0,1,0,0,0,1,0,0,0,0,8.104480283,1,-1.121218018,1.198285046,-0.935685563,0.349435106,0.539597122,2.581008768,0,2.097531316,1.285258795,1.631991411,0.102681296,0.206710436,6.708741267,1,-0.557245343,1.199904648,-0.464408021,0.642355444,0.750895853,7.740012256,1,-0.979715799,1.19833415,-0.817564783,0.413605744,0.557104983,6.629986445,0,-0.642784536,1.20551507,-0.533203235,0.593892902,0.705191232,N,-,,pantothenate transporter liz1,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662 (PANTHER); PTHR11662 (PANTHER); PTHR11662:SF319 (PANTHER); PTHR11662:SF319 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.3, the major facilitator superfamily (mfs).
RL4_JR_03037,8806,12437,15080,0,0,1,0,0,0,0,3,0,3,5,1,0,0,0,34.91027118,1,-0.058823541,0.841956449,-0.069865301,0.944300872,0.972432026,6.14914727,0,0.845142472,1.227905502,0.688279733,0.491276642,0.647150204,31.63224436,1,0.017958345,1.026247488,0.017499039,0.986038499,0.993397728,48.08885853,1,1.079052503,0.60521825,1.782914682,0.074600193,0.157952102,23.43215649,0,-0.216727262,0.969806532,-0.223474739,0.823166041,0.881310793,N,-,,duf124 domain-containing,C:mitochondrion,IPR002838 (PFAM); IPR002838 (G3DSA:3.60.160.GENE3D); IPR002838 (TIGRFAM); PTHR31801:SF0 (PANTHER); PTHR31801 (PANTHER); PTHR31801:SF0 (PANTHER); PTHR31801 (PANTHER); IPR016031 (SUPERFAMILY),,
RL4_JR_03038,2998,3867,3953,0,2,2,0,0,0,0,2,0,0,6,0,0,0,9,140.755193,1,-0.627969822,0.484622444,-1.295791868,0.1950472,0.356770193,30.10085132,0,-1.446214878,1.194824217,-1.210399704,0.226125555,0.375712881,166.7350144,1,0.186933795,0.463267324,0.403511721,0.686571814,0.784875005,108.9716904,1,-2.778933462,1.00970232,-2.752230441,0.005919085,0.032065502,91.63926112,1,-2.494304107,0.968760076,-2.574738749,0.010031583,0.031484741,N,-,,peptide alpha-n-acetyltransferase,C:integral component of membrane; F:transferase activity,IPR009688 (PFAM); PTHR21377:SF0 (PANTHER); PTHR21377:SF0 (PANTHER); PTHR21377 (PANTHER); PTHR21377 (PANTHER),,
RL4_JR_03039,1214,1277,1581,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,69.46150602,1,1.672873101,0.829358576,2.017068551,0.04368836,0.12032736,63.38886521,0,3.010153749,0.868576825,3.465616007,0.000529018,0.015023052,198.9459472,0,3.545339427,0.41238855,8.597085018,8.18E-18,1.06E-15,400.8695528,0,4.418568215,0.525563665,8.407293941,4.20E-17,3.15E-15,96.49079625,0,2.734166713,0.574565296,4.758670135,1.95E-06,2.53E-05,N,-,,peptide-n4-(n-acetyl-beta-glucosaminyl)asparagine amidase a,C:membrane,IPR021102 (PFAM); PTHR31104 (PANTHER); PTHR31104:SF1 (PANTHER),,
RL4_JR_03040,84506,61138,69095,1,1,15,1,0,0,2,0,10,5,23,12,0,6,3,1.867163737,1,0.997095858,1.323169253,0.753566376,0.451109641,NA,0.59598678,1,4.212265542,1.52800969,2.756700804,0.005838775,0.022864389,1.543146275,1,1.563577636,1.239890767,1.261060795,0.207286944,0.334220899,1.780146386,1,1.141167249,1.26095518,0.90500223,0.365464206,0.511730754,1.515736227,1,1.486528329,1.225892862,1.212608683,0.225279468,0.352107843,N,-, Effector probability:0.571,dienelactone hydrolase,F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR002925 (PFAM); PTHR17630 (PANTHER); PTHR17630:SF44 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_03041,321,398,430,0,0,2,1,0,0,0,2,47,0,1,2,0,21,2,73.43063416,1,-0.205118603,0.655179572,-0.313072341,0.754225702,0.871279139,13.53649552,1,-0.293218517,1.233141592,-0.237781711,0.812050405,0.886016406,183.5811358,1,2.00220072,0.442391543,4.52585668,6.02E-06,0.000122039,89.7021366,1,0.731921648,0.557166919,1.313648789,0.188964422,0.317501622,71.72907151,1,0.417144758,0.598964258,0.696443489,0.486151136,0.614516885,N,-,,phospholipase d p1,P:cell motility; F:catalytic activity; P:signal transduction,IPR001736 (SMART); IPR001736 (PFAM); G3DSA:3.30.870.10 (GENE3D); PTHR18896:SF74 (PANTHER); IPR015679 (PANTHER); PTHR18896:SF74 (PANTHER); IPR015679 (PANTHER); IPR001736 (PROSITE_PROFILES); IPR001736 (PROSITE_PROFILES); SSF56024 (SUPERFAMILY); SSF56024 (SUPERFAMILY),,
RL4_JR_03042,73,48,130,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,491.7582155,0,3.262440674,0.822848681,3.964812426,7.35E-05,0.000651343,43.17609901,0,1.708830822,0.907624634,1.882750598,0.059734175,0.135645498,96.57561098,0,0.527393135,0.629244983,0.838136417,0.401954092,0.544162468,357.2030589,0,2.833848636,0.393403747,7.20341038,5.87E-13,2.89E-11,129.7663091,0,1.548854791,0.544023444,2.847036849,0.004412825,0.016164927,N,-, Effector probability:0.788,glycolipid transfer,F:glycolipid binding; C:cytoplasm; F:glycolipid transporter activity; P:glycolipid transport,IPR014830 (G3DSA:1.10.3520.GENE3D); IPR014830 (PFAM); PTHR10219 (PANTHER); IPR014830 (SUPERFAMILY),,
RL4_JR_03043,209,183,279,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.57897723,0,1.488179995,1.153079562,1.290613453,0.196837749,0.3592399,0.8209942,0,3.750149856,1.445160695,2.594970835,0.009459895,0.032349004,2.125481957,0,1.101529608,1.218372811,0.904098974,0.365942922,0.510022873,14.48657165,0,2.977280667,0.867632643,3.431499139,0.000600255,0.004850425,2.088815083,0,1.023729799,1.208398852,0.847178725,0.39689551,0.533816025,N,-,,FAD binding domain,F:oxidoreductase activity,IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR025700 (PFAM); PTHR38663 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_03044,991,1103,1030,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0.294528601,0,3.661294669,2.530228093,1.447021587,0.147890878,NA,0.094432564,0,6.870383655,2.138447455,3.212790494,0.001314521,0.015023052,0.243767381,0,4.226735996,1.347804007,3.136016791,0.001712594,0.008761143,0.281152828,0,3.803817027,1.645702717,2.311363399,0.020812791,0.078120428,0.238670653,1,4.153791857,1.258968056,3.299362392,0.000969047,0.004661094,N,-,,oxysterol-binding,,IPR000648 (PFAM); PTHR10972:SF92 (PANTHER); IPR000648 (PANTHER); SSF144000 (SUPERFAMILY),2.D.1.1.3, the pi4p/ps counter transporter (p/p-ct) family.
RL4_JR_03045,1000,753,1164,0,0,0,0,0,0,0,0,0,2,0,0,0,5,0,4.833516451,0,-0.375664703,1.211272996,-0.310140409,0.756454184,0.872432934,1.542402688,0,2.840289621,1.344169124,2.113044832,0.034596931,0.088454189,4.005125263,0,0.186884775,1.20873337,0.154612075,0.87712715,0.922875117,12.64359997,1,1.486259727,1.026524368,1.447856254,0.147657256,0.263070512,3.955249773,1,0.102387775,1.21113367,0.08453879,0.932628063,0.95585172,N,-,,beta-ig-h3 fasciclin,C:membrane,PTHR39614:SF2 (PANTHER); PTHR39614 (PANTHER),9.B.313.1.5, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_03046,7298,8928,7442,2,3,2,0,0,1,0,6,2,4,2,1,0,16,1,0.43115159,1,3.111640647,2.223048073,1.39971811,0.161597749,NA,0.137435764,1,6.328963009,2.038759054,3.104321227,0.001907161,0.015023052,0.355486067,1,3.682406296,1.371503792,2.68494066,0.007254268,0.025306812,0.410097486,1,3.259351584,1.582957553,2.059026522,0.039491698,0.106627584,0.348189056,1,3.609378236,1.302492043,2.771132657,0.005586166,0.019625237,,,,,,,,
RL4_JR_03047,9782,9308,6687,0,0,1,0,0,0,0,1,4,6,9,0,0,6,1,22.40221296,1,-0.999543399,1.143630747,-0.874008855,0.382113432,0.574296495,4.587429458,0,1.267847688,1.245828052,1.017674699,0.308832575,0.470287848,11.90240678,1,-1.38414198,1.193198221,-1.160026855,0.246037872,0.380230105,13.7313734,1,-1.80652124,1.191151249,-1.516617845,0.129363197,0.237886373,11.72786459,1,-1.465583988,1.195430436,-1.225988517,0.220202996,0.346311795,N,-,,amino acid permease,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; F:amino acid transmembrane transporter activity; P:oxidation-reduction process; F:monooxygenase activity; P:amino acid transmembrane transport; F:heme binding",IPR002293 (PIRSF); IPR002293 (PFAM); IPR002293 (PANTHER); PTHR11785:SF409 (PANTHER),2.A.3.4.2, the amino acid-polyamine-organocation (apc) family.
RL4_JR_03048,812,710,942,0,3,0,0,0,0,0,0,0,0,0,0,0,2,0,11.9716013,1,-1.683703516,1.215521258,-1.385169946,0.166000508,0.317676454,3.815367922,0,1.533741431,1.282196745,1.196182596,0.231625311,0.381717909,9.8891666,0,-1.11673914,1.211068617,-0.922110543,0.356470918,0.49998775,11.40870874,0,-1.539120336,1.211048876,-1.270898613,0.20376472,0.335466307,9.724140298,1,-1.195273124,1.212395252,-0.985877437,0.32419326,0.460326159,N,-,,mucoidy inhibitor,,IPR025554 (PFAM); IPR011935 (PFAM); PTHR31005:SF8 (PANTHER); PTHR31005:SF8 (PANTHER); PTHR31005 (PANTHER); PTHR31005 (PANTHER); PTHR31005 (PANTHER); PTHR31005:SF8 (PANTHER),,
RL4_JR_03049,12367,15427,16999,0,0,3,0,0,0,0,0,0,1,4,0,0,5,0,286.3915261,1,2.788820692,0.849043083,3.284663344,0.001021043,0.006010225,29.97438228,0,1.61722576,0.993290412,1.628149976,0.103493089,0.20784862,150.9354008,0,1.875650696,0.447339095,4.192905821,2.75E-05,0.000439085,155.5742195,1,1.740876672,0.682126222,2.552132753,0.010706572,0.051279109,50.75289284,1,-0.521807055,0.842590019,-0.619289385,0.535725736,0.658946126,N,-,,hypothetical protein HMPREF1624_02401,C:integral component of membrane,no IPS match,,
RL4_JR_03050,181,310,322,0,0,0,5,0,4,4,0,1,0,4,0,0,6,0,0.176135869,0,4.402533988,3.380283034,1.302415787,0.192774289,NA,0.05607473,1,7.621362328,2.566031404,2.97009706,0.002977057,0.015540881,0.146427031,1,4.958863653,1.64467752,3.01509785,0.002568964,0.012089411,0.168945777,1,4.537458027,2.223605853,2.040585575,0.041292037,0.109848102,0.145960015,1,4.861573436,1.47927275,3.286461836,0.001014545,0.004843126,N,-, Effector probability:0.778,hypothetical protein CMQ_1426,,no IPS match,,
RL4_JR_03051,4,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.015546175,0,7.901693524,3.974670246,1.988012347,0.046810324,NA,0.004837421,0,11.15127369,3.976377874,2.804379775,0.005041348,0.020752135,0.012845324,0,8.465148078,2.926591813,2.892493596,0.00382197,0.0159891,0.014835038,0,8.044321045,3.974735672,2.023863147,0.042984235,0.112837795,0.013036505,0,8.346276886,1.6170378,5.161460596,2.45E-07,4.55E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_03052,1188,1098,1339,0,0,0,0,0,0,0,2,0,0,4,0,0,1,1,128.8902741,0,4.789237949,1.068549538,4.481998989,7.39E-06,8.90E-05,1.368670658,0,3.012827969,1.462789604,2.059645462,0.039432447,0.097971337,87.99425905,1,4.631210416,1.722865041,2.688086592,0.007186276,0.025096191,32.95264522,1,2.372068208,0.93692527,2.53175817,0.011349223,0.053685903,3.425215382,1,0.309799946,1.263997903,0.245095301,0.806382641,0.869502049,Y,-, Effector probability:0.685,hypothetical protein CMQ_1599,,no IPS match,,
RL4_JR_03053,45,15,79,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,65.27051082,1,-0.185294398,0.8958631,-0.206833385,0.836139982,0.918684172,12.49007113,0,-0.177182897,1.362334885,-0.130058255,0.896520337,0.942408473,76.25510225,0,0.335275611,1.5655276,0.214161418,0.830421182,0.890497198,46.16171427,0,-2.26641582,1.270856009,-1.783377348,0.074524898,0.157825683,31.18266901,0,-2.876481492,1.312738526,-2.191206729,0.028436836,0.072161144,Y,-,,pyridine nucleotide-disulfide oxidoreductase family,,IPR029045 (G3DSA:3.90.226.GENE3D); PTHR37049 (PANTHER); PTHR37049:SF2 (PANTHER); IPR029045 (SUPERFAMILY),,
RL4_JR_03054,1028,1156,1369,0,0,0,0,0,0,0,0,0,2,2,0,0,3,1,38.04337954,0,0.663372769,0.702712186,0.944017739,0.345160584,0.535098583,6.105470196,0,0.855473731,1.260129607,0.678877574,0.497215436,0.652171487,44.37637283,0,0.630037991,0.865722939,0.727759382,0.466760893,0.603664701,27.78321323,1,-1.2577345,1.15646572,-1.087567473,0.276786097,0.419529825,15.40975748,1,-1.859611811,1.201825845,-1.547322201,0.121785571,0.221776748,N,-,,hypothetical protein SPSK_07813,C:integral component of membrane,PF13398 (PFAM); PTHR33979:SF2 (PANTHER); PTHR33979 (PANTHER); SSF140990 (SUPERFAMILY),,
RL4_JR_03055,10261,14370,14664,13,4,32,0,1,1,17,27,27,9,37,15,2,40,12,831.1516462,1,-0.057841547,0.768717268,-0.07524424,0.940020385,0.970425386,153.6010982,1,-1.978187747,1.013829504,-1.951203569,0.051032835,0.119739071,382.8253302,1,-3.423465083,0.767783083,-4.458896217,8.24E-06,0.000161324,503.6609754,1,-1.777024547,0.473399545,-3.753752122,0.000174207,0.001712473,386.9936252,1,-2.390716184,0.748697531,-3.193166912,0.001407216,0.006313737,N,-,,3-isopropylmalate dehydrogenase,"P:ATP hydrolysis coupled proton transport; P:arginine homeostasis; P:lysine homeostasis; C:fungal-type vacuole membrane; P:leucine biosynthetic process; P:histidine homeostasis; P:cellular protein metabolic process; F:proton-transporting ATPase activity, rotational mechanism; P:vacuolar acidification; C:proton-transporting V-type ATPase, V1 domain; F:3-isopropylmalate dehydrogenase activity; F:magnesium ion binding; F:ATP binding; F:NAD binding; P:ATP metabolic process; C:cytosol; P:oxidation-reduction process",IPR024084 (SMART); IPR024084 (G3DSA:3.40.718.GENE3D); IPR004429 (TIGRFAM); IPR024084 (PFAM); PTHR11835:SF35 (PANTHER); IPR001804 (PANTHER); SSF53659 (SUPERFAMILY),,
RL4_JR_03056,31786,32254,31713,22,18,15,7,0,3,3,20,40,12,30,10,0,28,26,155.8442106,1,2.962164958,0.734496755,4.032917693,5.51E-05,0.000509538,5.401413622,1,1.032198969,1.268507962,0.813711068,0.415810492,0.579496407,20.52865416,1,-0.659584832,1.212474099,-0.543999111,0.586442084,0.7068644,45.5581824,1,1.229070049,0.672112801,1.82866633,0.067449609,0.147323861,25.40647263,1,0.47945455,0.888940913,0.539354802,0.589642062,0.701707319,N,-, Effector probability:0.629,macro domain-containing,,IPR002589 (SMART); IPR002589 (PFAM); G3DSA:3.40.220.10 (GENE3D); PTHR11106 (PANTHER); IPR002589 (PROSITE_PROFILES); SSF52949 (SUPERFAMILY),,
RL4_JR_03057,140,176,142,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4987.412227,0,-3.289064697,0.255817678,-12.85706571,7.85E-38,5.82E-35,1620.571967,0,-3.24947453,0.612639088,-5.304060077,1.13E-07,1.35E-05,3884.691066,0,-4.770952204,0.460829675,-10.3529622,4.06E-25,8.38E-23,4704.276691,0,-3.475680495,0.659014502,-5.274057677,1.33E-07,2.92E-06,3980.552605,0,-3.554504803,1.139790987,-3.118558441,0.001817381,0.007810264,N,-,,elongation factor 3,F:ATPase activity; F:ATP binding; F:translation elongation factor activity; P:translational elongation,IPR003593 (SMART); IPR003439 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR015688 (PTHR19211:PANTHER); PTHR19211 (PANTHER); IPR015688 (PTHR19211:PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.121.7, the atp-binding cassette (abc) superfamily.
RL4_JR_03058,4,11,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,630.0157752,0,6.837795727,1.400756508,4.881502023,1.05E-06,1.59E-05,1.753756947,0,2.65501329,1.32136834,2.00929083,0.0445063,0.107644628,117.5900819,0,4.63818746,1.325850981,3.498272072,0.000468283,0.003223024,333.0303724,0,6.077945327,0.361276371,16.82353404,1.64E-63,1.11E-60,212.9785506,0,5.565288576,2.027179076,2.745336434,0.006044889,0.020903177,Y,-,,hypothetical protein SPBR_02558,,no IPS match,,
RL4_JR_03059,7,6,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,350.6596716,0,-1.439898441,0.434674236,-3.312592099,0.000924357,0.005589995,111.7008854,0,-0.735415313,0.853000711,-0.862150879,0.388604496,0.553251916,217.2540791,0,-5.574259018,1.195741284,-4.661760107,3.14E-06,7.08E-05,286.612361,0,-2.935149846,0.677921525,-4.3296307,1.49E-05,0.000202913,218.63073,0,-4.73128025,1.136351816,-4.16356993,3.13E-05,0.000261738,N,-,,GMP synthase,F:ATP binding; F:GMP synthase (glutamine-hydrolyzing) activity; F:pyrophosphatase activity; P:GMP biosynthetic process,PR00097 (PRINTS); PR00096 (PRINTS); G3DSA:3.30.300.10 (GENE3D); IPR029062 (G3DSA:3.40.50.GENE3D); IPR017926 (PFAM); IPR004739 (TIGRFAM); IPR001674 (TIGRFAM); IPR022310 (PFAM); IPR014729 (G3DSA:3.40.50.GENE3D); IPR001674 (PFAM); PTHR11922:SF2 (PANTHER); PTHR11922 (PANTHER); IPR025777 (PROSITE_PROFILES); IPR017926 (PROSITE_PROFILES); IPR022955 (HAMAP); IPR029062 (SUPERFAMILY); SSF54810 (SUPERFAMILY); SSF52402 (SUPERFAMILY),,
RL4_JR_03060,377,464,505,0,0,5,0,2,0,0,0,0,0,1,0,0,1,0,15.14630977,1,-2.023070285,1.201146999,-1.684282013,0.09212718,0.208480869,4.849295224,1,1.187805717,1.260870441,0.942052156,0.346165938,0.509334753,12.53783964,0,-1.459102779,1.201916647,-1.213980006,0.224755359,0.354980227,18.47326431,1,-0.934662553,1.153000842,-0.810634753,0.417575453,0.561033899,12.30312689,1,-1.534701235,1.199648328,-1.279292605,0.200794036,0.322602287,N,-,,SMP-30 Gluconolaconase LRE-like region,C:integral component of membrane; F:hydrolase activity,IPR013658 (PFAM); IPR011042 (G3DSA:2.120.10.GENE3D); PTHR10907 (PANTHER); PTHR10907:SF46 (PANTHER); PTHR10907:SF46 (PANTHER); PTHR10907 (PANTHER); SSF63829 (SUPERFAMILY),1.A.6.2.6, the epithelial na(+) channel (enac) family.
RL4_JR_03061,128,129,219,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6.266682224,1,-0.749811853,1.206657988,-0.621395507,0.534339427,0.717435985,2.009246784,0,2.458946875,1.324748577,1.856161175,0.063430588,0.142194937,5.191700056,0,-0.187000139,1.206654743,-0.154974023,0.876841797,0.922854971,5.987987203,0,-0.609035381,1.205733293,-0.505116169,0.613477246,0.732713144,5.092804283,0,-0.26222416,1.200797881,-0.218374935,0.827136993,0.884308808,N,-,,hypothetical protein SPBR_02379,,no IPS match,,
RL4_JR_03062,28,81,57,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.63462957,0,1.537542426,0.760761329,2.021057549,0.043273808,0.119567496,2.690706203,0,2.037601474,1.304874329,1.561530814,0.118398559,0.231146197,6.94189253,0,-0.606262742,1.206936575,-0.502315328,0.615445729,0.730105458,17.64071469,0,-0.077336103,1.153413867,-0.067049743,0.946542103,0.968827831,6.804858745,0,-0.680467315,1.202051174,-0.566088475,0.571333638,0.687039581,N,-,,hsp70 family chaperone,F:nucleotide binding,IPR013126 (PRINTS); IPR013126 (PFAM); G3DSA:3.30.420.40 (GENE3D); PTHR19375:SF213 (PANTHER); PTHR19375 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),1.A.33.1.6, the cation channel-forming heat shock protein-70 (hsp70) family.
RL4_JR_03063,153,153,229,0,0,3,0,0,0,0,0,0,3,1,0,0,0,0,99.97157534,1,1.635539737,0.734055443,2.228087471,0.025874683,0.080844757,8.250817566,0,0.421010548,1.357148734,0.310216955,0.756395978,0.8519239,86.1976177,0,1.479200786,0.733114952,2.017692836,0.043623261,0.101878177,96.67587677,1,1.754699455,0.684030552,2.565235499,0.01031058,0.049664425,106.7872474,0,2.283236854,0.64915926,3.517221419,0.00043609,0.002420729,N,-,,major facilitator superfamily transporter,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23520 (PANTHER); PTHR23520:SF3 (PANTHER); PTHR23520:SF3 (PANTHER); PTHR23520 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.63.4, the major facilitator superfamily (mfs).
RL4_JR_03064,2,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.70577989,0,4.86938285,0.96874001,5.026511553,4.99E-07,8.30E-06,0.220373548,0,5.647790193,1.899010851,2.974069469,0.002938785,0.0154422,7.06233297,0,3.978965623,1.264123223,3.147608991,0.001646117,0.008494032,0.64957368,0,2.595457166,1.480782258,1.752760848,0.079643066,0.165855226,0.547580556,0,2.954250242,1.298785185,2.274625763,0.022928389,0.060788149,N,-,,ankyrin repeat,P:cation transport; P:transmembrane transport; C:membrane,G3DSA:1.20.58.340 (GENE3D); IPR002523 (PFAM); PTHR21535 (PANTHER); PTHR21535 (PANTHER); PTHR21535:SF47 (PANTHER); PTHR21535:SF47 (PANTHER); SSF144083 (SUPERFAMILY),,
RL4_JR_03065,177,130,65,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,599.7823367,0,2.649332428,0.960359248,2.758688932,0.005803375,0.024524381,67.87074493,0,0.914891975,0.868128877,1.053866539,0.291944024,0.451007035,126.7433016,0,-0.502239407,0.639593086,-0.785248337,0.43230798,0.573014662,160.2638604,0,-0.346634324,0.568106368,-0.610157434,0.541757523,0.672629666,94.2703423,0,-1.364550522,0.767169441,-1.77868206,0.075291902,0.153232263,Y,-,,aminopeptidase Y,F:metal ion binding; P:proteolysis; F:aminopeptidase activity; C:fungal-type vacuole,IPR003137 (PFAM); IPR007484 (PFAM); G3DSA:3.50.30.30 (GENE3D); G3DSA:3.40.630.10 (GENE3D); IPR029514 (PTHR12147:PANTHER); PTHR12147 (PANTHER); IPR029514 (PTHR12147:PANTHER); PTHR12147 (PANTHER); SSF52025 (SUPERFAMILY); SSF53187 (SUPERFAMILY),9.B.229.1.5," the transferrin receptor, cd71, (tfr) family."
RL4_JR_03066,1659,2067,2051,0,4,0,0,0,0,0,2,1,0,4,2,0,1,0,4.985179324,1,-0.419768529,1.200760576,-0.349585535,0.726649768,0.855813965,1.595028082,0,2.791991594,1.337170355,2.087984963,0.036799191,0.092888133,4.12855048,1,0.143526489,1.201428799,0.119463167,0.90490842,0.941551166,4.762210018,1,-0.278635388,1.200043688,-0.232187704,0.816392228,0.883872039,4.058463682,1,0.065329344,1.196307712,0.054609147,0.956449851,0.971265859,N,-,,c6 zinc finger domain containing,F:binding,IPR007219 (SMART); IPR001138 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31944:SF30 (PANTHER); PTHR31944 (PANTHER); IPR001138 (SUPERFAMILY),,
RL4_JR_03067,1598,1948,1636,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,33.61929164,0,-3.173582063,1.259136383,-2.52044346,0.011720707,0.043032189,10.57438414,0,0.062942836,1.27233557,0.04947031,0.960544497,0.97872271,40.74479325,0,-0.799561729,1.093420083,-0.731248439,0.464627418,0.601520202,32.02963353,1,-3.028565488,1.248329151,-2.426095302,0.015262262,0.065631958,47.01863787,0,0.12401565,0.834152754,0.148672589,0.881811991,0.92168333,N,-,,sugar transporter family,P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane; P:carbohydrate transport,IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23508 (PANTHER); PTHR23508:SF10 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.12.2, the major facilitator superfamily (mfs).
RL4_JR_03068,101,105,143,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0.118259674,1,4.977822633,3.915780953,1.271220912,0.203650069,NA,0.036952044,0,8.223605274,2.764380738,2.974845383,0.002931363,0.0154422,0.096785967,0,5.558932995,1.725748422,3.221172289,0.001276674,0.006994072,0.111747183,0,5.134801581,2.513812142,2.042635365,0.041088548,0.109421763,0.095962311,0,5.470712745,1.487617587,3.677499373,0.000235532,0.001432287,N,-,,4-coumarate:coenzyme a ligase,C:integral component of membrane,no IPS match,,
RL4_JR_03069,1408,1523,1738,0,8,3,0,0,0,0,0,1,3,5,0,0,0,0,1.900203605,1,0.971678243,1.473672132,0.659358498,0.509665586,NA,0.59752386,0,4.208398296,1.618330802,2.600456156,0.009309991,0.031922674,1.561532618,1,1.546117979,1.313697514,1.176920837,0.239227104,0.37205853,1.802472357,1,1.12292537,1.358651711,0.826499802,0.40852063,0.552205823,1.547470856,0,1.456626152,1.310120882,1.111825765,0.266213072,0.398500234,N,-,,Peptidase ubiquitin carboxyl-terminal hydrolase 1,P:proteolysis; F:thiol-dependent ubiquitinyl hydrolase activity,IPR001578 (PRINTS); IPR001578 (PFAM); IPR001578 (G3DSA:3.40.532.GENE3D); PTHR10589:SF27 (PANTHER); IPR001578 (PANTHER); SSF54001 (SUPERFAMILY),,
RL4_JR_03070,9843,15565,18056,0,3,3,0,0,0,3,0,1,0,2,0,1,4,0,19.29373544,1,7.053851329,1.0251169,6.881021403,5.94E-12,2.66E-10,0.063557577,0,7.441668162,2.442617986,3.046595171,0.002314492,0.015159195,0.164944145,1,4.790668603,1.559212437,3.072492554,0.002122791,0.010317398,0.190342946,1,4.366788062,2.060023098,2.119776261,0.034024918,0.0989162,0.161834163,1,4.715818372,1.413731064,3.335725226,0.000850772,0.004192577,N,-,,mfs transporter,P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane; P:anion transport,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF278 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.38, the major facilitator superfamily (mfs).
RL4_JR_03071,10438,13263,14714,3,6,15,1,0,0,0,0,2,3,9,5,0,23,10,11.11921847,1,-0.024655018,1.168612149,-0.021097691,0.983167727,0.991333724,2.353195358,1,2.230931528,1.334678484,1.671512319,0.094620527,0.193906357,6.071781671,1,-0.413177143,1.22123291,-0.338327882,0.735116115,0.821810462,15.02482794,1,0.877402379,1.048338582,0.836945615,0.402623139,0.546372283,17.18459301,1,1.189706135,0.998651977,1.191312051,0.233531105,0.361434184,N,-,,alpha-ketoglutarate-dependent taurine dioxygenase,F:dioxygenase activity; P:oxidation-reduction process,IPR003819 (PFAM); G3DSA:3.60.130.10 (GENE3D); PTHR30468:SF15 (PANTHER); PTHR30468 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_03072,269,230,370,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,136.7581906,0,-0.02815115,0.64856458,-0.043405315,0.965378441,0.982724897,24.11917871,0,-1.126588811,1.262247846,-0.892525834,0.372111152,0.536668564,118.1678142,0,0.016189709,0.649563493,0.024923983,0.980115598,0.989291339,114.2046353,1,-1.039362264,0.788032386,-1.318933438,0.187191366,0.31515008,113.5842491,0,0.062129062,0.626978882,0.09909275,0.921064628,0.949617349,N,-,,fungal specific transcription factor domain containing,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; C:integral component of membrane; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); PTHR31313 (PANTHER); PTHR31313:SF31 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_03073,1114,1346,1598,2,10,3,0,0,1,1,0,4,1,2,0,0,1,0,62.75776308,1,-0.509969314,0.658156416,-0.774845161,0.43843116,0.628516646,13.9463585,1,-0.336294368,1.203066875,-0.279530901,0.779837427,0.866847621,36.16362424,1,-2.987502039,1.18595874,-2.519060687,0.011766837,0.036632061,68.68816505,1,-0.677915869,0.733148465,-0.924663832,0.355140798,0.501475817,47.21798093,1,-0.86102366,0.837381694,-1.028233201,0.303840144,0.439106689,N,-,,alpha beta hydrolase family,C:membrane,IPR013595 (PFAM); IPR000073 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR10992:SF863 (PANTHER); PTHR10992 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_03074,5315,6838,3794,6,3,4,1,0,0,8,13,8,0,3,9,0,10,8,154.4724497,1,-0.124753681,0.621179304,-0.200833608,0.840828683,0.919624667,34.03706812,1,-0.245005422,1.163694843,-0.210540954,0.833245491,0.900214629,107.2291395,1,-0.420256654,0.699614359,-0.600697581,0.54804143,0.675395184,118.8507726,1,-0.313423191,0.651847374,-0.480822971,0.630642323,0.746223684,134.2197797,1,0.555797759,0.557265124,0.997366847,0.318586478,0.454009769,N,-,,potassium ion channel yvc1,F:calcium activated cation channel activity; P:potassium ion transmembrane transport; F:calcium channel activity; C:fungal-type vacuole membrane; F:sodium channel activity; C:integral component of membrane; P:regulation of ion transmembrane transport; P:calcium ion transmembrane transport; F:voltage-gated ion channel activity; P:sodium ion transmembrane transport; F:potassium channel activity; P:cellular cation homeostasis,IPR013122 (PFAM); PTHR10582 (PANTHER); PTHR10582:SF2 (PANTHER),1.A.4.4.1, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_03075,172,294,141,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,129.4298381,0,1.097273953,0.435421399,2.520027623,0.011734563,0.04306368,102.966417,0,2.346827418,0.758094067,3.095694217,0.001963527,0.015023052,64.18164312,0,-0.141808717,0.750386042,-0.188981016,0.850107695,0.904233065,62.29396841,0,-0.662300993,0.753757708,-0.878665633,0.379582598,0.525396282,71.69439377,0,-0.059951222,0.676997347,-0.088554589,0.929435899,0.954028637,N,-,,aaa family ATPase,F:ATP binding; P:mycelium development,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003959 (PFAM); PTHR23077 (PANTHER); PTHR23077:SF49 (PANTHER); IPR027417 (SUPERFAMILY),9.B.307.1.2, the ftsh aaa(+) zinc metaloprotease (ftsh) family.
RL4_JR_03076,2973,4586,4267,0,1,15,0,0,0,0,3,7,0,5,0,0,6,1,11.86709418,1,-0.164855866,1.16287694,-0.141765531,0.887265212,0.945072411,2.551001261,0,2.114368011,1.294729405,1.633057844,0.102456832,0.206463876,30.17898013,1,1.864837442,0.866936901,2.151064789,0.031471086,0.079733052,19.70861742,1,1.323666749,0.878426162,1.50686171,0.131846108,0.241356326,6.590082439,1,-0.634022797,1.218268498,-0.520429444,0.602764293,0.711552811,N,-,,conserved mitochondrial,,PTHR28180 (PANTHER); PTHR28180:SF2 (PANTHER); IPR029032 (SUPERFAMILY),,
RL4_JR_03077,12011,22417,27251,19,17,9,0,0,1,0,10,20,14,19,0,0,5,6,0.868037948,1,2.101699121,1.567304453,1.340964174,0.179932085,NA,0.278948649,1,5.307471993,1.72969968,3.068435553,0.002151827,0.015045494,0.721129877,1,2.660389505,1.262677235,2.10694343,0.035122483,0.086410698,0.831672629,1,2.238556945,1.328218125,1.685383524,0.0919146,0.183738466,0.709036362,1,2.581621002,1.23273213,2.094227075,0.036239757,0.0871148,Y,-,,hypothetical protein MGU_04043,,no IPS match,,
RL4_JR_03078,3166,2907,5256,0,0,0,0,0,0,0,0,1,3,1,0,0,0,0,2.179532892,0,0.773414904,1.297312961,0.59616679,0.551063809,0.730740661,0.701514769,0,3.976997467,1.505262303,2.642062754,0.008240279,0.029204517,1.812124791,1,1.331131528,1.242080009,1.071695477,0.283856833,0.423110509,2.089774514,1,0.909315777,1.259653588,0.721877654,0.470369701,0.611281379,1.780735344,0,1.253381114,1.231351357,1.017890716,0.308729894,0.444144669,Y,-,,---NA---,,no IPS match,,
RL4_JR_03079,1547,3028,1522,0,3,4,0,0,0,0,2,3,4,3,6,0,0,2,45.56996459,1,-2.38238112,1.154227798,-2.064047603,0.039013203,0.110773507,21.48270739,0,0.783294363,1.140598299,0.686739901,0.492246648,0.647918797,63.70122425,1,0.349945952,0.700237694,0.499753092,0.617248944,0.73130817,67.93521477,1,-0.442831984,0.764539011,-0.579214373,0.562444534,0.690272837,52.67293866,1,-0.610080904,0.850641983,-0.717200557,0.473250356,0.603721317,N,-,,c6 zinc finger domain containing,F:binding,IPR007219 (SMART); IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR007219 (PFAM); PTHR31001:SF50 (PANTHER); PTHR31001 (PANTHER); PTHR31001:SF50 (PANTHER); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_03080,1742,1981,1538,0,0,3,0,0,0,0,0,4,3,2,0,0,7,0,1041.007369,1,1.80690784,0.302389632,5.975429205,2.29E-09,5.92E-08,228.0797237,0,1.324201229,0.522259602,2.535522991,0.011227956,0.036678992,716.5744686,1,1.437987865,0.42069144,3.418153374,0.000630476,0.003996829,361.7330922,1,-0.575355661,0.402442113,-1.42966067,0.152814433,0.269790085,253.9215572,1,-1.164865991,0.845154124,-1.378288242,0.168114312,0.28246887,N,-,,dihydrolipoyllysine-residue acetyltransferase component-pyruvate dehydrogenase complex,C:mitochondrial pyruvate dehydrogenase complex; P:acetyl-CoA biosynthetic process from pyruvate; P:glycolytic process; C:ribosome; F:dihydrolipoyllysine-residue acetyltransferase activity,IPR023213 (G3DSA:3.30.559.GENE3D); IPR004167 (PFAM); IPR006257 (TIGRFAM); IPR000089 (PFAM); G3DSA:2.40.50.100 (GENE3D); IPR004167 (G3DSA:4.10.320.GENE3D); IPR001078 (PFAM); PTHR23151 (PANTHER); PTHR23151:SF9 (PANTHER); IPR000089 (PROSITE_PROFILES); IPR004167 (SUPERFAMILY); SSF52777 (SUPERFAMILY); IPR011053 (SUPERFAMILY),,
RL4_JR_03081,2489,2874,3378,0,0,6,4,0,2,2,0,0,0,4,1,0,7,1,190.9354533,1,-0.347750681,0.652629399,-0.532845564,0.59414049,0.764872671,61.59562738,1,0.532376091,0.951404553,0.559568576,0.575773744,0.715507273,174.3522091,1,0.207399436,0.608407331,0.340889114,0.73318706,0.820287965,219.3799416,1,0.205256818,0.699111873,0.293596527,0.76906623,0.849994059,168.4245597,1,0.080124633,0.859855279,0.093183859,0.925757497,0.951893435,N,-,,Sec7 domain-containing,F:ARF guanyl-nucleotide exchange factor activity; P:regulation of ARF protein signal transduction; F:NAD+ binding; P:positive regulation of GTPase activity,IPR000904 (SMART); IPR023394 (G3DSA:1.10.1000.GENE3D); IPR000904 (PFAM); IPR015403 (PFAM); IPR032629 (PFAM); IPR032691 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); G3DSA:1.10.220.20 (GENE3D); PTHR10663:SF142 (PANTHER); PTHR10663 (PANTHER); PTHR10663 (PANTHER); PTHR10663:SF142 (PANTHER); IPR000904 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR000904 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_03082,2607,2166,3221,0,1,4,0,0,3,0,0,0,0,1,0,0,1,5,30.32094872,1,0.551151487,0.850105562,0.648332997,0.516769596,0.701970996,4.020135276,1,1.458275797,1.2508492,1.16582862,0.243683743,0.396299301,10.43613565,0,-1.19451557,1.192767143,-1.001465858,0.316601638,0.459340067,12.04006218,1,-1.61693131,1.190533736,-1.35815665,0.174413983,0.297898377,10.29077369,1,-1.276995314,1.195953731,-1.067763142,0.285627368,0.419918266,N,-,,hypothetical protein SPBR_02895,,no IPS match,,
RL4_JR_03083,5174,4229,4453,0,0,11,0,0,0,0,0,5,1,5,0,0,0,0,585.9726804,1,1.497545115,1.743617143,0.858872672,0.390410768,0.58332803,68.23623324,0,-0.522258489,0.989102225,-0.528012652,0.597490555,0.732888923,172.2849713,1,-1.659529272,0.671061634,-2.472990836,0.013398758,0.04068607,194.298679,1,-1.353982594,0.522368971,-2.592004252,0.009541859,0.046807812,133.3803171,0,-3.217392251,0.972391513,-3.3087416,0.000937163,0.004531411,Y,-,,L-asparaginase,P:asparagine metabolic process; F:asparaginase activity,IPR006034 (PRINTS); IPR006034 (SMART); PIRSF500176 (PIRSF); IPR027473 (G3DSA:3.40.50.GENE3D); IPR027474 (G3DSA:3.40.50.GENE3D); IPR004550 (TIGRFAM); IPR006034 (PIRSF); IPR027474 (PFAM); PTHR11707 (PANTHER); PTHR11707:SF29 (PANTHER); IPR006034 (PROSITE_PROFILES); IPR006034 (SUPERFAMILY),,
RL4_JR_03084,8674,8804,7770,0,1,0,0,0,0,0,0,0,1,5,2,0,8,0,32.63203984,1,-1.773147271,1.154820898,-1.535430537,0.124678108,0.259536617,7.838673072,0,0.494854891,1.233489641,0.401182851,0.688285506,0.80198295,20.39022708,0,-2.160911874,1.201986331,-1.797784067,0.072211233,0.150673233,23.52507647,1,-2.5834001,1.201858898,-2.14950366,0.031594496,0.095065163,31.40216693,1,-0.570047316,0.992493156,-0.574358939,0.565724933,0.682834381,N,-,,dna-directed rna polymerase iii subunit,P:biological_process; F:DNA-directed RNA polymerase activity; P:RNA biosynthetic process; C:cellular_component; P:regulation of transcription from RNA polymerase III promoter; F:molecular_function,IPR024661 (PIRSF); IPR024661 (PFAM),,
RL4_JR_03085,911,1295,1815,0,0,4,0,0,0,0,2,0,0,3,0,0,0,0,53.12063696,1,-0.46704563,0.780022673,-0.598759045,0.549333577,0.729286139,10.6598429,0,0.051339661,1.224715049,0.041919679,0.966562729,0.982682143,81.36360614,1,1.019660599,0.610088106,1.671333353,0.094655852,0.186004629,74.78294657,1,0.667051721,0.584073648,1.142067826,0.253425828,0.393131689,27.58016485,0,-2.69933082,1.215020623,-2.221633747,0.026308067,0.068055488,N,-,,nucleoporin nup49,P:nucleocytoplasmic transport; C:nuclear pore,IPR025574 (PFAM); IPR024882 (PANTHER),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_03086,6038,5956,4686,0,2,6,0,0,0,1,0,6,0,7,0,0,0,1,26.03349805,1,-0.575401897,1.010991119,-0.569146342,0.569256831,0.745784042,5.857322522,0,0.915254193,1.229827951,0.744213198,0.456747505,0.616262096,15.21793773,1,-1.738772792,1.191050269,-1.45986516,0.144327136,0.254736389,21.56889262,1,-1.21394227,1.141496673,-1.063465447,0.287570927,0.431804187,57.13458696,1,2.080803739,0.515457352,4.036810671,5.42E-05,0.000415921,N,-,,pre-mrna polyadenylation factor fip1,P:mRNA metabolic process; F:binding,IPR007854 (PFAM); PTHR13484 (PANTHER),,
RL4_JR_03087,1075,1399,1340,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10.05122828,0,-1.431445648,1.229206575,-1.164528141,0.244210046,0.419601001,3.214545429,0,1.780979952,1.312182404,1.357265534,0.174696854,0.310824672,19.37927214,1,0.096255012,1.215553739,0.079186143,0.936884566,0.962067081,9.584625832,0,-1.287742176,1.223258417,-1.052714748,0.292471747,0.437147507,8.144755806,0,-0.939588915,1.220918042,-0.769575747,0.441551596,0.575306899,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR001991 (PRINTS); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF43 (PANTHER); PTHR23501 (PANTHER); PTHR23501:SF43 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.65, the major facilitator superfamily (mfs).
RL4_JR_03088,1053,1013,1099,0,2,4,0,0,0,0,0,0,2,1,0,0,0,1,6.862702499,1,-0.880988458,1.25438738,-0.702325671,0.482476088,0.67076345,2.216627087,0,2.317267982,1.375134386,1.685121109,0.091965208,0.189702839,5.696730965,0,-0.320962641,1.242076977,-0.258408011,0.796092035,0.865696644,6.568405801,1,-0.742561729,1.246370672,-0.595779206,0.551322737,0.680339751,5.55422751,1,-0.38740464,1.23656647,-0.313290591,0.754059898,0.828494542,N,-,,Signal transducer and activator of transcription 2,,no IPS match,,
RL4_JR_03089,1328,1914,1657,0,1,0,0,0,0,1,1,1,0,2,2,0,0,0,994.5546606,1,-5.633424663,0.891128729,-6.321673267,2.59E-10,8.09E-09,305.9897308,0,-4.791822654,1.202695801,-3.984234957,6.77E-05,0.00351404,825.1330471,1,-4.633194906,0.771800288,-6.003100775,1.94E-09,9.61E-08,988.4976407,1,-3.408813779,0.680662188,-5.008084537,5.50E-07,1.06E-05,791.321005,0,-6.607532342,1.160963314,-5.691422167,1.26E-08,5.88E-07,N,-,,---NA---,,no IPS match,,
RL4_JR_03090,1220,991,1743,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.3091539,0,-2.705676119,1.190044561,-2.273592273,0.022990512,0.073638241,7.745423824,0,0.512181842,1.221791705,0.419205532,0.67506593,0.792325758,20.10295472,0,-2.140325684,1.19081968,-1.797354981,0.072279283,0.150784146,23.19244761,0,-2.562735198,1.189270351,-2.154880255,0.031171206,0.094465268,31.04267571,0,-0.545138305,0.972866236,-0.560342506,0.57524584,0.689663477,N,-,,transport bos1,"F:SNAP receptor activity; C:Golgi apparatus; P:intra-Golgi vesicle-mediated transport; F:SNARE binding; P:retrograde transport, endosome to Golgi; P:protein targeting to vacuole; P:Golgi to vacuole transport; C:endoplasmic reticulum membrane; C:late endosome membrane; P:ER to Golgi vesicle-mediated transport; C:ER to Golgi transport vesicle membrane; C:integral component of membrane; C:SNARE complex; P:vesicle fusion with Golgi apparatus",IPR027027 (PIRSF); PF12352 (PFAM); G3DSA:1.20.5.110 (GENE3D); PTHR21230 (PANTHER); PTHR21230 (PANTHER); PTHR21230:SF1 (PANTHER); PTHR21230:SF1 (PANTHER),,
RL4_JR_03091,9458,9648,12222,1,8,9,0,0,1,5,1,3,4,15,0,0,11,0,9.74541656,1,-1.38690148,1.19922896,-1.156494319,0.247479022,0.423789643,3.101706481,1,1.83246036,1.272895992,1.439599442,0.149980758,0.27672352,19.12477087,1,0.140996309,1.194264091,0.118061248,0.906019128,0.942222666,13.3046705,1,-0.296386485,1.147948008,-0.258188073,0.796261762,0.868832448,7.943284133,1,-0.903419923,1.20165403,-0.751813667,0.452163122,0.584130447,N,-,,thiamine pyrophosphokinase,F:thiamine diphosphokinase activity; F:ATP binding; F:thiamine binding; P:thiamine metabolic process; P:phosphorylation; F:kinase activity; P:thiamine diphosphate biosynthetic process,IPR007373 (SMART); IPR007373 (PFAM); IPR016966 (PIRSF); IPR007371 (G3DSA:3.40.50.GENE3D); IPR006282 (TIGRFAM); IPR007371 (PFAM); IPR007373 (G3DSA:2.60.120.GENE3D); PTHR13622 (PANTHER); IPR007371 (SUPERFAMILY); IPR007373 (SUPERFAMILY),,
RL4_JR_03092,278,304,456,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,77.317496,0,-1.265861364,0.833315219,-1.519066657,0.128745718,0.265430268,18.2172549,0,-0.721761976,1.234916447,-0.584462194,0.558909394,0.70270705,76.37309367,0,-0.575335597,0.796160669,-0.722637553,0.469902591,0.606488249,111.0641841,0,0.193281398,0.593851521,0.325470915,0.744824692,0.831369199,59.03707593,0,-1.315821784,0.922004529,-1.427131584,0.15354197,0.263359723,N,-,,mitochondrial intermembrane space import and assembly 40,C:mitochondrion,PTHR21622 (PANTHER); PTHR21622:SF0 (PANTHER),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_03093,9373,13358,22273,2,4,30,3,0,2,0,0,0,0,15,0,0,5,0,399.1458348,1,-1.565399042,0.809656197,-1.933412044,0.053185459,0.13955837,118.071963,1,-1.548017058,1.043294648,-1.483777436,0.137867975,0.258857289,281.8431708,0,-3.3841435,0.899262716,-3.763242308,0.000167725,0.001586956,357.1580699,1,-1.926436557,0.588804832,-3.271774369,0.001068748,0.007801786,272.0762024,1,-2.768077902,0.74290188,-3.726034324,0.000194516,0.001213991,N,-,,CCR4-Not complex component,P:positive regulation of transcription elongation from RNA polymerase II promoter; C:nucleus; P:response to pheromone involved in conjugation with cellular fusion; P:pseudohyphal growth; C:cytosol; P:regulation of cell cycle; C:CCR4-NOT core complex; P:nuclear-transcribed mRNA poly(A) tail shortening; P:transcription elongation from RNA polymerase II promoter,IPR032193 (PFAM); IPR032191 (PFAM); IPR024557 (PFAM); IPR032194 (PFAM); IPR007196 (PFAM); PTHR13162:SF8 (PANTHER); PTHR13162 (PANTHER),,
RL4_JR_03094,243,442,535,0,0,0,0,0,0,1,0,0,0,3,0,3,0,0,165.0770795,0,-1.33539065,0.589662942,-2.264667754,0.023533076,0.074993294,35.34815998,0,-1.678064012,1.194216735,-1.405158681,0.159974098,0.290439542,115.4650168,1,-1.92438714,0.85462265,-2.251738987,0.024338771,0.065049029,141.0708181,1,-1.44816362,0.621991342,-2.32826974,0.019897785,0.076700608,98.57379358,1,-2.753914734,0.985178916,-2.795344773,0.005184439,0.018466235,N,-,,hypothetical protein SPI_00149,,no IPS match,,
RL4_JR_03095,4441,7049,6266,0,4,21,0,0,0,3,9,1,0,12,2,0,19,7,40.68313397,1,1.782783099,0.692248693,2.575350619,0.010013852,0.037943773,2.886813321,0,1.936014708,1.299276352,1.490071535,0.136205428,0.256135973,7.48263351,1,-0.71470151,1.211441721,-0.589959466,0.555217825,0.681997726,8.630979088,1,-1.136852736,1.211232054,-0.938592017,0.347940253,0.494997199,7.378908767,1,-0.797274689,1.215231886,-0.656067947,0.511780407,0.638088096,N,-,,ubiquinone menaquinone biosynthesis-related,P:biological_process; C:membrane; C:integral component of membrane; F:methyltransferase activity; F:transferase activity; C:cellular_component; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF714 (PANTHER); PTHR10108:SF714 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_03096,1699,1839,3212,0,0,4,0,0,0,1,4,0,0,0,0,0,0,0,3.977792133,1,-0.09402772,1.234872061,-0.076143694,0.939304778,0.969858041,1.274625853,0,3.115549616,1.389797084,2.241729856,0.024978837,0.068450087,17.63482208,1,2.290479417,1.047991065,2.185590596,0.028845571,0.074321568,13.11055486,0,0.999298709,1.159113763,0.862123064,0.388619801,0.533384617,25.32497546,0,2.634984744,0.853935717,3.085694499,0.002030774,0.008581871,N,-,,impact,P:mycelium development,IPR001498 (PFAM); IPR001498 (G3DSA:3.30.230.GENE3D); IPR023582 (PANTHER); PTHR16301:SF4 (PANTHER); IPR020568 (SUPERFAMILY),,
RL4_JR_03097,5114,4470,6053,0,0,76,0,0,0,0,0,0,0,5,2,0,0,0,248.7822026,1,0.250719644,0.430627864,0.582218812,0.560419304,0.737403335,35.84255561,0,-1.698075855,1.194382379,-1.421718777,0.155107907,0.283701162,243.9815493,0,0.650207986,0.374062178,1.73823504,0.082169407,0.166310092,135.1902556,1,-1.254444073,0.571997628,-2.193093139,0.028300669,0.089465864,181.5869032,0,0.272535,0.398176059,0.684458531,0.493685667,0.621874146,N,-,,electron transfer flavo -ubiquinone oxidoreductase,F:oxidoreductase activity; P:oxidation-reduction process; F:iron-sulfur cluster binding,IPR007859 (PFAM); G3DSA:3.30.70.20 (GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); PF13450 (PFAM); PTHR10617 (PANTHER); IPR007859 (PTHR10617:PANTHER); SSF54373 (SUPERFAMILY); SSF54862 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_03098,318,456,317,0,0,44,0,0,0,0,0,0,0,0,1,0,0,0,149.5887186,1,-1.134363804,0.565722166,-2.00516061,0.04494588,0.122795876,97.52391941,0,0.748187418,0.840891452,0.889755053,0.373597426,0.538251688,116.3871929,0,-0.97904221,0.665751903,-1.470581166,0.14140442,0.250761788,201.9671545,1,0.114620777,0.412405568,0.277932175,0.781064424,0.859035118,97.49547975,0,-1.2768279,0.680374519,-1.876654496,0.060565463,0.129673359,N,-, Effector probability:0.631,TATA-box-binding,"F:RNA polymerase II core promoter sequence-specific DNA binding; F:DNA binding, bending; P:regulation of transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript; F:chromatin binding; C:transcription factor TFIIIB complex; P:translational initiation; F:RNA polymerase III regulatory region DNA binding; P:regulation of transcription from RNA polymerase III promoter; F:TFIIIB-type transcription factor activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase I transcription factor binding; P:regulation of transcription from RNA polymerase II promoter; C:RNA polymerase transcription factor SL1 complex; F:translation initiation factor activity; P:RNA polymerase II transcriptional preinitiation complex assembly; C:transcription factor TFIID complex; F:transcription factor activity, RNA polymerase I transcription factor recruiting; F:transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly; P:transposon integration; P:transcription of nuclear large rRNA transcript from RNA polymerase I promoter; P:RNA polymerase III transcriptional preinitiation complex assembly",IPR000814 (PRINTS); IPR012295 (G3DSA:3.30.310.GENE3D); IPR000814 (PFAM); IPR000814 (PANTHER); IPR000814 (HAMAP); SSF55945 (SUPERFAMILY); SSF55945 (SUPERFAMILY),,
RL4_JR_03099,823,1052,979,0,0,8,0,0,0,0,1,1,0,1,0,0,0,1,47.3083632,1,-0.388341292,0.741208542,-0.523929866,0.600327321,0.76883364,10.25801278,0,0.106878962,1.218721015,0.087697645,0.930116992,0.960711748,33.03713822,1,-1.579169515,1.189712248,-1.327354171,0.184391552,0.305728804,77.81789495,1,0.115799225,0.665278469,0.174061284,0.861817299,0.914632241,26.07560146,1,-2.618410818,1.187549141,-2.204886289,0.027462075,0.070351153,N,-,,fructosyl-amino acid oxidase,"F:oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor; C:intracellular part",IPR023753 (G3DSA:3.50.50.GENE3D); IPR006076 (PFAM); PTHR10961:SF7 (PANTHER); PTHR10961 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_03100,4861,8492,16124,4,0,0,0,0,1,0,0,0,0,0,0,0,2,0,46.92404745,1,-1.100504101,1.011883916,-1.087579398,0.27678083,0.459967001,8.602049022,1,0.360887711,1.232687896,0.292764869,0.769701883,0.860590131,22.21728353,0,-2.284562818,1.195614277,-1.91078583,0.056032109,0.123265771,29.63517772,0,-1.759608978,1.147329118,-1.53365669,0.125114134,0.23171403,29.51435565,1,-0.690074372,0.97314921,-0.70911466,0.478253326,0.607872825,N,-,,coatamer subunit,C:nucleus; F:RNA binding; C:cytosol; P:RNA processing; C:cellular_component,IPR000061 (PFAM); PTHR23140 (PANTHER); IPR006569 (PROSITE_PROFILES); IPR000061 (SUPERFAMILY),,
RL4_JR_03101,1808,1848,2516,0,0,4,1,0,0,0,2,0,0,0,4,0,0,0,18.71393249,1,-2.328270069,1.205967517,-1.930624197,0.053529543,0.140100742,6.00896241,1,0.878468962,1.260619881,0.696854758,0.485893693,0.642160571,15.50673349,1,-1.765733101,1.206488177,-1.46353121,0.14332208,0.253404251,37.154516,1,-0.433684101,1.030462675,-0.420863474,0.673854779,0.777865055,22.55242763,0,-0.902405705,1.131440704,-0.797572247,0.425118762,0.560108314,N,-,,copper-sensing transcription factor,"F:DNA binding; C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:copper ion binding; P:regulation of transcription, DNA-templated",no IPS match,,
RL4_JR_03102,1621,1650,2702,0,1,7,0,0,0,2,0,3,0,2,0,0,5,0,10.60835983,1,2.053147014,1.016715723,2.019391427,0.043446552,0.119944829,0.946299864,0,3.545131264,1.405888885,2.52162977,0.011681258,0.037851326,10.30061895,1,1.853381223,1.19409393,1.552123477,0.120632682,0.222699721,2.835417676,1,0.469205193,1.212668422,0.38691961,0.698815723,0.797150653,2.425020454,1,0.808377135,1.206248749,0.670157906,0.502757135,0.630314015,N,-,,hypothetical protein Z517_07193,,no IPS match,,
RL4_JR_03103,2676,3242,3846,0,2,1,0,0,0,0,0,1,0,0,0,0,0,0,0.103984103,1,5.16312392,3.917015042,1.318127162,0.187461083,NA,0.033413978,0,8.369145316,2.599835839,3.219105295,0.001285913,0.015023052,0.086298441,1,5.723858674,1.48047138,3.866240679,0.000110526,0.001235059,0.099526406,0,5.30162042,2.309223535,2.295845482,0.021684718,0.079926381,0.084691284,0,5.646634252,1.288041276,4.383892317,1.17E-05,0.00011491,N,-,,nicotinamide n-methyltransferase,P:metabolic process; F:methyltransferase activity; P:single-organism cellular process,IPR029063 (G3DSA:3.40.50.GENE3D); IPR019410 (PFAM); PTHR14614 (PANTHER); PTHR14614:SF10 (PANTHER); IPR025784 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_03104,3506,3187,3042,0,5,7,0,0,0,0,4,2,2,3,0,0,2,0,5.87405988,1,1.804510173,1.155801069,1.56126363,0.118461561,0.250170701,0.659188039,0,4.066784741,1.488203417,2.732680691,0.00628212,0.023995329,1.705505188,1,1.418689514,1.221685905,1.161255531,0.245537998,0.379863492,1.967102382,1,0.996651961,1.234128969,0.807575209,0.419335163,0.562312308,1.677486962,1,1.339634697,1.210174022,1.106976908,0.268303912,0.400497879,N,-,,hypothetical protein SPI_00454,,no IPS match,,
RL4_JR_03105,1127,1328,1059,0,0,5,0,0,0,0,0,0,0,2,0,0,0,0,1.847166248,1,1.012213797,1.291608643,0.783684595,0.433225204,NA,0.587822559,0,4.231980804,1.506006469,2.810068144,0.004953101,0.020513621,1.528731305,0,1.576236039,1.225548228,1.286147704,0.198391518,0.323612064,1.76378439,1,1.153843168,1.242225436,0.928851668,0.352965964,0.499270799,1.51167282,0,1.490114255,1.220094391,1.221310634,0.221968429,0.348546889,N,-,,hypothetical protein CMQ_822,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03106,260,228,284,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.198771807,0,-0.172022374,1.254023565,-0.137176348,0.890891405,0.946340115,1.344821861,0,3.038217783,1.401343933,2.168074312,0.030153033,0.079357514,3.473368812,0,0.392973218,1.232550025,0.318829427,0.749855862,0.832771034,4.006231501,0,-0.029142718,1.238412718,-0.023532315,0.981225662,0.988449888,3.402160912,0,0.319877342,1.225597603,0.260997037,0.794094793,0.860467656,N,-,,c2h2 transcription factor,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated",IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007219 (PFAM); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_03107,1301,1373,1754,0,3,4,0,0,0,0,3,3,1,6,0,0,0,0,8.813652174,1,0.518871182,1.241741343,0.4178577,0.676051161,0.821696271,1.58062054,0,2.805059633,1.43597478,1.953418452,0.050770032,0.119260678,4.110295859,1,0.149897218,1.272283379,0.117817477,0.906212281,0.94232674,4.743220339,1,-0.272908151,1.284677714,-0.212433164,0.831769115,0.89463052,4.049943679,0,0.068465566,1.27686736,0.053619951,0.957237961,0.971796603,N,-, Effector probability:0.608,kinase-like domain,F:ATP binding; C:membrane; C:integral component of membrane; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,IPR011009 (SUPERFAMILY),,
RL4_JR_03108,4784,4439,4296,1,9,2,0,0,4,4,1,5,7,1,1,0,0,4,13.41536475,1,-0.417255464,1.146080477,-0.364071697,0.715804471,0.847794399,3.064719314,1,1.849805003,1.275274929,1.450514678,0.146915049,0.272657522,37.96804525,1,2.0221086,0.74327901,2.720524289,0.006517848,0.023242936,26.81829815,1,1.090439343,0.852786874,1.278677447,0.201010665,0.332066076,11.6720244,1,0.050831898,1.124111918,0.045219606,0.963932267,0.976274303,N,-,,nicotinamide N-methyltransferase,F:catalytic activity; P:metabolic process,IPR008775 (PFAM); G3DSA:2.60.120.620 (GENE3D); PTHR40470 (PANTHER); PTHR40470:SF1 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_03109,6732,7839,7570,7,3,2,0,0,0,0,0,0,6,0,0,0,0,0,5.111278993,1,-0.455788583,1.317196319,-0.346029348,0.729320659,0.857173155,1.629706745,0,2.761002412,1.443884959,1.912203875,0.055850049,0.128861226,4.214170685,0,0.113974476,1.275269889,0.089372827,0.928785618,0.95734327,4.86151393,1,-0.308378064,1.28768741,-0.239482084,0.810731787,0.879624876,4.126073418,0,0.041569825,1.275194884,0.032598802,0.973994526,0.982631982,N,-,,glycoside hydrolase family 92,P:biological_process; C:cellular_component; F:molecular_function,IPR012808 (PFAM); IPR012808 (TIGRFAM); PTHR36452:SF1 (PANTHER); PTHR36452 (PANTHER),,
RL4_JR_03110,29828,18627,19768,3,8,0,0,0,8,0,0,0,0,0,2,0,2,0,11.62304678,1,-0.119560234,1.154508281,-0.103559443,0.917518974,0.960708991,2.485463252,1,2.152026032,1.295167322,1.661581477,0.09659672,0.197265741,20.79179204,0,1.321259351,1.038384663,1.272418014,0.203224637,0.329086089,15.46466311,1,0.79985305,1.024777132,0.780514148,0.435088303,0.577134688,10.21532157,1,0.348009905,1.132294985,0.307349153,0.758577626,0.831683646,N,-,,glycoside hydrolase family 92,P:carbohydrate metabolic process; P:mycelium development; F:catalytic activity; C:membrane,G3DSA:3.30.2080.10 (GENE3D); IPR014718 (G3DSA:2.70.98.GENE3D); G3DSA:1.20.1050.60 (GENE3D); IPR012939 (PFAM); IPR005887 (TIGRFAM); G3DSA:1.20.1610.10 (GENE3D); PTHR12143:SF22 (PANTHER); PTHR12143 (PANTHER); IPR008928 (SUPERFAMILY),1.C.96.1.3," the haemolytic lectin, cel-iii (cel-iii) family"
RL4_JR_03111,2802,2465,2915,0,3,4,0,0,0,0,0,1,0,4,0,0,8,0,0.710912924,1,2.389868076,1.680582209,1.422047707,0.155012402,NA,0.226187057,0,5.609832327,1.776351725,3.158063939,0.001588207,0.015023052,7.086905374,1,3.915171648,1.205492994,3.24777636,0.001163107,0.006512882,0.678612071,1,2.531922692,1.340665884,1.88855607,0.058951338,0.135439596,0.581414364,1,2.868782494,1.229773606,2.332772861,0.01966007,0.053953079,N,-,,Glycoside Hydrolase Family 92,P:carbohydrate metabolic process; F:catalytic activity; F:metal ion binding; F:nickel cation transmembrane transporter activity; C:membrane; C:integral component of membrane; P:nickel cation transmembrane transport; F:carbohydrate binding; F:hydrolase activity,IPR014718 (G3DSA:2.70.98.GENE3D),,
RL4_JR_03112,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,549.258108,0,-0.856041208,0.577059516,-1.48345393,0.137953848,0.278778175,132.3316609,0,-1.758024667,1.088795255,-1.614651294,0.106386231,0.212311007,352.141259,0,-2.07426097,0.690799001,-3.002698277,0.002675976,0.012478849,389.6276021,0,-2.669210729,0.685367529,-3.89456841,9.84E-05,0.00105624,313.0033897,0,-3.316065644,0.913077113,-3.631747635,0.000281508,0.001664879,N,-,,ubiquitin- ligase E3 C,F:catalytic activity; P:primary metabolic process; P:organic substance metabolic process,IPR000569 (SMART); G3DSA:3.30.2160.10 (GENE3D); IPR000569 (PFAM); PTHR11254:SF336 (PANTHER); PTHR11254:SF336 (PANTHER); PTHR11254 (PANTHER); PTHR11254:SF336 (PANTHER); PTHR11254 (PANTHER); PTHR11254 (PANTHER); PTHR11254 (PANTHER); IPR000569 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); IPR000569 (SUPERFAMILY),8.A.30.1.1, the nedd4-family interacting protein-2 (nedd4) family.
RL4_JR_03113,1254,1181,1250,0,0,0,0,0,0,0,0,0,0,3,3,0,0,0,734.3720906,0,-3.318968633,0.464891709,-7.139229564,9.39E-13,4.58E-11,243.6100526,0,-2.105933772,0.860146776,-2.448342343,0.014351522,0.044505548,604.4523909,0,-3.782784175,0.674351788,-5.609511592,2.03E-08,8.12E-07,731.0795267,1,-2.573962744,0.54956044,-4.683675456,2.82E-06,4.59E-05,599.1784162,0,-2.995464468,0.535613048,-5.592590542,2.24E-08,8.07E-07,N,-,,polyadenylate-binding,F:nucleotide binding; P:regulation of macromolecule metabolic process; F:RNA binding; C:intracellular ribonucleoprotein complex; C:intracellular non-membrane-bounded organelle; C:cytoplasmic part; P:regulation of nitrogen compound metabolic process; P:regulation of primary metabolic process; P:regulation of cellular metabolic process,IPR000504 (SMART); IPR002004 (SMART); IPR002004 (G3DSA:1.10.1900.GENE3D); IPR002004 (PFAM); IPR006515 (TIGRFAM); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR24012:SF491 (PANTHER); PTHR24012 (PANTHER); PTHR24012:SF491 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR002004 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR002004 (SUPERFAMILY); IPR012677 (SUPERFAMILY),9.A.60.1.1, the small nuclear rna exporter (snrna-e).
RL4_JR_03114,364,319,390,0,5,0,0,0,0,0,0,0,0,2,0,0,0,0,320.4724239,1,-0.414706719,0.86666376,-0.478509357,0.632287716,0.790892853,67.01565541,0,-1.469172862,1.153233489,-1.273959589,0.202677738,0.346948091,175.1882833,0,-2.602763011,0.900283442,-2.891048407,0.00383959,0.016016484,299.5789081,1,-0.265102039,0.524932179,-0.505021504,0.613543732,0.732713144,189.8358694,0,-1.472959269,0.63172318,-2.331653035,0.019718951,0.05404829,N,-,,gns1 sur4 family,C:membrane; F:transferase activity; P:fatty acid metabolic process,IPR002076 (PFAM); IPR002076 (PANTHER); PTHR11157:SF12 (PANTHER); PTHR11157:SF12 (PANTHER); IPR002076 (PANTHER),,
RL4_JR_03115,12,16,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.29544576,0,-1.835045171,1.233118809,-1.488133307,0.136715741,0.276824775,4.243536099,0,1.380310642,1.299009201,1.062587271,0.287969162,0.447470657,17.47934243,0,-0.305968317,1.22071215,-0.250647392,0.802086737,0.869979206,24.70175005,0,0.582277639,0.912747636,0.637939355,0.523513158,0.657965581,29.36351935,0,0.886394325,0.881925078,1.005067604,0.314864298,0.450346238,N,-,,GMC oxidoreductase,F:oxidoreductase activity,IPR007867 (PFAM); IPR000172 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR11552 (PANTHER); PTHR11552:SF92 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_03116,87,148,142,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32.22070286,0,-3.112337538,1.194326411,-2.605935454,0.009162373,0.035408165,48.63429336,0,1.025607511,1.116972454,0.918203047,0.358512574,0.522514654,26.71565176,0,-2.550686899,1.196932166,-2.131020429,0.033087459,0.082896973,30.81786289,0,-2.972938748,1.196508417,-2.484678508,0.012966848,0.05963162,26.35877575,0,-2.634018908,1.201461186,-2.192346235,0.028354516,0.071996597,N,-,,hypothetical protein CMQ_1639,,no IPS match,,
RL4_JR_03117,5825,5111,4643,2,2,3,0,0,1,0,2,4,0,14,0,0,3,0,467.8180514,1,-0.77389261,0.75427962,-1.02600228,0.304890509,0.491560628,286.9728687,1,1.073702611,0.465636965,2.305879238,0.021117381,0.060079465,346.808003,1,-1.23917595,0.586644962,-2.112309881,0.034659879,0.085772822,441.7262928,1,-0.896403291,0.335072301,-2.675253336,0.00746728,0.038398278,311.5531303,1,-1.666762344,0.471535469,-3.534754974,0.000408153,0.002283179,N,-,,autophagy 8,P:nucleocytoplasmic transport; P:late nucleophagy; P:membrane fusion; C:Cvt vesicle membrane; C:fungal-type vacuole membrane; P:protein transport; F:structural constituent of nuclear pore; F:protein tag; C:autophagosome membrane; C:nuclear pore; P:cellular response to nitrogen starvation,IPR004241 (PFAM); G3DSA:3.10.20.90 (GENE3D); IPR004241 (PANTHER); PTHR10969:SF43 (PANTHER); IPR029071 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_03118,2427,2732,2604,0,3,18,0,0,0,0,0,0,0,0,2,0,6,5,462.8641689,1,-2.203019026,0.670743552,-3.284443091,0.001021841,0.006010225,134.4303585,0,-2.588935017,1.185290247,-2.184220299,0.028946064,0.077022098,331.9379577,0,-5.175050044,1.255496893,-4.121913861,3.76E-05,0.000568605,466.4968638,1,-1.872876871,0.574613896,-3.259365783,0.001116616,0.008088496,328.3632454,1,-4.012039645,0.953456031,-4.207891622,2.58E-05,0.000222875,N,-,,topoisomerase ii-associated pat1,F:isomerase activity,PF01803 (PFAM),,
RL4_JR_03119,1762,2134,3319,0,0,2,0,0,0,0,0,2,0,0,0,0,0,0,112.4635753,1,0.189404715,0.634523748,0.298499017,0.765322326,0.877265637,15.0300509,0,-0.444230963,1.243915654,-0.357123058,0.720999683,0.825560949,57.59312569,1,-1.251634683,1.055856632,-1.185421056,0.235851011,0.368310293,44.59795474,0,-3.506080302,1.216019193,-2.883244215,0.003936022,0.023156432,37.8353251,0,-3.155477632,1.211187296,-2.605276361,0.009180018,0.029330288,N,-,,vacuolar morphogenesis,C:nucleus; C:TORC2 complex; P:vesicle-mediated transport; P:vacuole fusion; C:cytosol; C:HOPS complex,IPR013745 (PFAM); PTHR32428 (PANTHER); PTHR32428 (PANTHER); PTHR32428:SF2 (PANTHER); PTHR32428 (PANTHER); PTHR32428:SF2 (PANTHER); PTHR32428:SF2 (PANTHER); PTHR32428:SF2 (PANTHER),,
RL4_JR_03120,567,429,974,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,16.22840887,0,0.224976537,1.154617254,0.19484945,0.845510808,0.922395985,1.956151458,0,2.497420243,1.314943068,1.899261119,0.057530152,0.131925737,12.93766192,1,0.801517457,1.200402261,0.667707387,0.504320394,0.636625893,47.60665747,0,3.270379717,0.546918924,5.979642635,2.24E-09,6.97E-08,5.044056223,0,-0.248303829,1.21491677,-0.204379291,0.838057112,0.890848111,N,-,,gon7 family,,IPR014849 (PFAM),,
RL4_JR_03121,416,1022,557,2,0,1,0,0,0,0,0,1,0,0,0,0,2,0,58.76652419,1,0.017071379,0.751297377,0.022722532,0.981871602,0.991069033,7.9057872,0,0.482648572,1.230921869,0.392103337,0.694981862,0.807240395,20.47554711,1,-2.166766783,1.19550728,-1.812424583,0.069920617,0.146649333,45.28980827,0,0.132555525,0.751401487,0.176411049,0.859971025,0.912876674,27.85158562,1,-0.577072802,0.977645661,-0.59026785,0.55501109,0.674624023,N,-,,vacuolar sorting 39 domain 1,C:membrane; P:transport,IPR001180 (PFAM); IPR019453 (PFAM); IPR019452 (PFAM); IPR032914 (PTHR12894:PANTHER); IPR032914 (PTHR12894:PANTHER); PTHR12894 (PANTHER); PTHR12894 (PANTHER); IPR001180 (PROSITE_PROFILES),,
RL4_JR_03122,1735,1449,1374,0,3,0,0,0,1,0,0,1,0,2,0,0,2,0,25.54890679,1,-2.777603365,1.182824767,-2.34827968,0.018860353,0.062520424,8.173323306,1,0.434607908,1.220797216,0.356003358,0.721838051,0.825858018,42.01427095,1,0.190637174,0.847024613,0.225066865,0.821927258,0.884832342,61.67305573,1,0.108875498,0.734870685,0.148155996,0.882219659,0.927086045,28.56823714,1,-0.624724745,0.9693935,-0.644449075,0.51928427,0.644167899,N,-,,spx domain-containing,P:sodium ion transport; P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR004331 (PFAM); IPR001898 (PFAM); PTHR10283 (PANTHER); PTHR10283:SF92 (PANTHER); IPR004331 (PROSITE_PROFILES),2.A.47.2.2, the divalent anion:na(+) symporter (dass) family.
RL4_JR_03123,13329,12300,12076,0,6,23,0,3,0,7,4,4,5,11,1,0,10,2,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,hypothetical protein VE00_11115,,no IPS match,,
RL4_JR_03124,2395,4164,2053,0,2,0,0,0,1,0,0,0,0,0,0,0,0,0,201.911645,1,-0.514668121,0.478371354,-1.075875712,0.281982846,0.465119931,75.05665534,1,0.808937975,0.782219693,1.034157004,0.301062771,0.461371289,125.5588103,0,-1.993422062,0.862314967,-2.311709918,0.020793674,0.057267454,238.281117,0,0.153532438,0.420757016,0.364895728,0.715189243,0.809272491,95.11012808,0,-4.485324353,1.198333533,-3.742968238,0.000181859,0.001145815,N,-,,related to ATROPHIN-1,C:Ino80 complex,IPR006880 (SMART); IPR025124 (PFAM); IPR006880 (PFAM); IPR029523 (PANTHER),,
RL4_JR_03125,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,82.91090583,0,1.857547364,0.534730344,3.473802045,0.000513139,0.003436939,44.98358905,0,1.659429551,1.126917739,1.472538317,0.140875568,0.262991976,23.73843424,0,-0.956965705,1.204719197,-0.794347519,0.426993147,0.567632697,71.42802231,0,1.023547153,0.6441956,1.588876349,0.112088312,0.21320574,17.01002632,0,-2.002136316,1.212014207,-1.651908289,0.098553248,0.188772538,N,-,,peroxin 14 17,"C:peroxisomal membrane; P:protein import into peroxisome matrix, docking",IPR006785 (PFAM); IPR025655 (PANTHER); PTHR23058:SF5 (PANTHER),,
RL4_JR_03126,1580,2763,1778,0,0,2,0,0,0,0,0,2,0,0,0,0,0,2,1.590381597,1,1.228159321,1.359340619,0.903496374,0.366262512,NA,0.513670757,0,4.426699712,1.581816766,2.798490828,0.005134203,0.021014315,1.323228226,1,1.784952927,1.2538659,1.42355967,0.154573978,0.268285093,1.525739969,0,1.363299773,1.283619068,1.062075041,0.28820162,0.432622891,1.29602704,1,1.711613294,1.234158276,1.386866926,0.165482345,0.278818319,N,-,,chromo domain containing,C:nucleus,no IPS match,,
RL4_JR_03127,737,612,1527,0,0,4,0,0,1,0,0,0,0,0,0,0,0,1,272.2624049,1,-1.40641916,0.483352241,-2.90971892,0.003617539,0.01670169,65.56967474,1,-2.569435182,1.193834889,-2.152253385,0.031377403,0.082067719,357.3249223,0,0.129080033,0.367388806,0.351344492,0.72532992,0.813925971,326.5740845,0,-0.59273201,0.384411944,-1.541918818,0.123093322,0.228640596,224.2549033,1,-1.239791174,0.502993085,-2.46482747,0.013707924,0.040428992,N,-, Effector probability:0.842,ras rab-11b,F:GTP binding; P:small GTPase mediated signal transduction; C:intracellular,PR00449 (PRINTS); SM00174 (SMART); SM00176 (SMART); SM00175 (SMART); SM00173 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); IPR001806 (PFAM); PTHR24073:SF87 (PANTHER); PTHR24073 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_03128,526,490,608,0,3,2,0,0,0,0,0,1,0,3,0,0,1,1,133.9983689,1,-3.376824833,1.062815697,-3.177244033,0.001486819,0.008157005,49.30453524,0,-0.937620426,1.127261335,-0.831768462,0.405539649,0.569419986,115.3779639,1,-3.55393655,1.211038103,-2.934619928,0.003339565,0.014674372,132.4164368,1,-2.659740091,0.900112667,-2.954896858,0.003127736,0.019251262,103.605221,1,-4.608732406,1.224553524,-3.763602255,0.000167483,0.00107327,N,-,,ribosome biogenesis BRX1,"C:cell division site; F:5S rRNA binding; C:cytosol; F:rRNA primary transcript binding; C:nucleolus; P:ribosomal large subunit assembly; C:preribosome, large subunit precursor; F:hydrolase activity",IPR007109 (SMART); IPR007109 (PFAM); IPR007109 (G3DSA:3.40.50.GENE3D); IPR026532 (PANTHER); IPR007109 (PROSITE_PROFILES); IPR004154 (SUPERFAMILY),,
RL4_JR_03129,3348,3352,5828,1,3,7,0,0,0,0,0,0,2,5,1,0,0,0,88.47494728,1,1.332296781,0.540031496,2.467072367,0.013622282,0.048613552,96.47088594,0,3.25358759,0.74296262,4.379207653,1.19E-05,0.000772851,25.26990775,0,-1.079666829,1.192896242,-0.905080251,0.365422874,0.509368192,38.9930929,1,-0.151971124,0.855377483,-0.177665565,0.85898563,0.912233009,22.38866563,0,-1.195632467,1.128696434,-1.05930384,0.289461427,0.423954426,N,-,,histone deacetylase,P:biological_process; C:cellular_component; F:molecular_function; F:hydrolase activity,G3DSA:1.20.1280.50 (GENE3D); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY),,
RL4_JR_03130,4518,3451,5119,0,0,1,0,0,0,2,1,0,1,0,0,0,0,0,48.80328247,1,-1.031837069,0.868686118,-1.187813467,0.234906908,0.408607794,78.9029395,0,2.119218515,0.857567055,2.471198611,0.013466101,0.042238572,37.42869592,1,-1.800089797,1.196723584,-1.504181769,0.132534571,0.239006055,106.3056198,1,1.004917262,0.493387329,2.036771527,0.041672943,0.110599881,68.59420214,0,0.921114041,0.535388437,1.720459349,0.085348977,0.169609105,N,-,,histone deacetylase 6 10,P:negative regulation of transcription from RNA polymerase II promoter; P:gene silencing involved in chronological cell aging; P:regulation of chromatin silencing at telomere; P:negative regulation of chromatin silencing involved in replicative cell aging; P:negative regulation of transcription by transcription factor localization; P:gene silencing by RNA; P:chromatin organization involved in regulation of transcription; F:chromatin binding; C:HDA1 complex; P:positive regulation of transcription from RNA polymerase II promoter; F:hydrolase activity,IPR000286 (PRINTS); IPR019154 (PFAM); IPR023801 (G3DSA:3.40.800.GENE3D); IPR017321 (PIRSF); IPR023801 (PFAM); PTHR10625:SF102 (PANTHER); IPR000286 (PANTHER); SSF52768 (SUPERFAMILY),,
RL4_JR_03131,1384,1244,1039,0,0,0,0,0,0,0,0,2,3,0,1,0,0,2,6.605160723,0,-0.8260715,1.276097427,-0.647342031,0.517410605,0.702452274,2.082963966,0,2.406724886,1.372838466,1.75310129,0.079584622,0.169519264,5.457313133,1,-0.259440115,1.253037611,-0.207048945,0.835971634,0.89445961,6.298881805,1,-0.68248331,1.260203074,-0.541566137,0.588117425,0.713051003,5.443667652,1,-0.358351279,1.268810679,-0.28243085,0.777613162,0.846594975,N,-,,---NA---,,no IPS match,,
RL4_JR_03132,8752,4805,6549,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,114.1547295,1,-0.05988493,0.539815263,-0.11093597,0.911667121,0.956734502,16.7234099,0,-0.598246831,1.20619655,-0.495977899,0.619910004,0.749937739,43.29449593,0,-3.247086383,1.189426011,-2.729960799,0.006334186,0.022701442,53.95188701,0,-2.721980844,1.141543952,-2.384473098,0.017103598,0.071002023,58.0053608,0,-0.710162571,0.742208684,-0.956823312,0.338656444,0.475773067,N,-,,serine arginine repetitive matrix 1,F:hydrolase activity,no IPS match,,
RL4_JR_03133,439,279,438,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15200.26789,0,1.955033331,0.756884155,2.583002059,0.009794474,0.037320097,2140.696787,0,0.264774871,0.924183122,0.286496112,0.774498171,0.863377807,4722.081681,0,-0.260567904,0.400457401,-0.650675711,0.515255845,0.646400413,5689.033678,0,-0.129254089,0.268832638,-0.480797606,0.630660352,0.746223684,3464.631385,0,-1.457128315,1.172618665,-1.242627598,0.214005095,0.338718824,N,-, Effector probability:0.633,glyceraldehyde 3-phosphate dehydrogenase,F:NADP binding; F:NAD binding; P:glycolytic process; P:oxidation-reduction process; P:glucose metabolic process; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,IPR020831 (PRINTS); IPR020828 (SMART); IPR006424 (TIGRFAM); IPR020828 (PFAM); IPR020831 (PIRSF); G3DSA:3.30.360.10 (GENE3D); IPR020829 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR020831 (PANTHER); IPR016040 (SUPERFAMILY); SSF55347 (SUPERFAMILY),3.A.23.6.1, the type vi symbiosis/virulence secretory system (t6ss) family.
RL4_JR_03134,4632,5160,5605,0,1,3,0,0,0,0,2,4,5,5,1,0,10,1,186.7866051,1,-0.509182121,0.520959198,-0.977393475,0.328374392,0.51775769,34.02228622,0,-1.622913061,1.207656516,-1.34385319,0.178995866,0.316692213,129.816968,1,-1.13319578,0.694904788,-1.630720927,0.102949219,0.197959713,137.0543786,1,-1.405150521,0.654672334,-2.146341687,0.031845728,0.095395857,99.47062449,1,-2.18845257,0.887536353,-2.465761049,0.013672251,0.04033553,N,-,,urease accessory,P:urea metabolic process; C:nucleus; F:GTPase activity; F:nickel cation binding; C:cytosol,IPR027417 (G3DSA:3.40.50.GENE3D); IPR003495 (PFAM); IPR004400 (TIGRFAM); IPR004400 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_03135,984,1059,1603,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,348.1414622,0,-2.682894023,0.620325809,-4.324975655,1.53E-05,0.000166376,97.14726307,0,-3.136596133,1.20236356,-2.608691945,0.009088902,0.03139859,253.4925677,1,-5.79681383,1.209944458,-4.79097515,1.66E-06,4.19E-05,332.6575124,0,-2.336359732,0.644972604,-3.62241701,0.000291863,0.002655089,262.931729,0,-3.712566521,0.904411439,-4.104953077,4.04E-05,0.000323677,N,-,,ribosome biogenesis tsr1,"F:GTP binding; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:mycelium development; C:cytoplasm; F:GTPase activity; F:ribonucleoprotein complex binding; F:U3 snoRNA binding; P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:nucleolus; C:preribosome, small subunit precursor",IPR007034 (SMART); IPR012948 (SMART); IPR012948 (PFAM); IPR007034 (PFAM); PTHR12858 (PANTHER); PTHR12858:SF1 (PANTHER); IPR030387 (PROSITE_PROFILES),,
RL4_JR_03136,636,749,759,4,0,2,0,0,0,0,0,0,1,1,0,0,0,0,221.2613611,1,-4.882815252,1.19600467,-4.082605507,4.45E-05,0.000423926,67.38471639,0,-2.608838538,1.216405671,-2.144710929,0.031975967,0.083203273,175.7265047,0,-5.2681987,1.221115586,-4.314250642,1.60E-05,0.000281967,222.8595197,1,-2.717081527,0.759565821,-3.577150855,0.00034736,0.003066275,185.5272601,0,-3.188536356,0.919223794,-3.468726961,0.000522931,0.002808845,N,-,,small nucleolar ribonucleo complex subunit,C:intracellular ribonucleoprotein complex; C:viral nucleocapsid; C:nucleolus,IPR001680 (SMART); IPR012952 (SMART); IPR012952 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR14085:SF3 (PANTHER); PTHR14085 (PANTHER); PD023243 (PRODOM); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_03137,6910,5481,3408,0,6,7,0,0,2,0,1,2,0,1,0,0,1,3,83.32029338,1,0.870792477,0.712423549,1.222296031,0.221595699,0.390955389,8.720484723,1,0.341037521,1.277640937,0.266927516,0.789524971,0.873109554,33.95708112,1,-1.365732649,1.238149153,-1.103043721,0.270008179,0.408409755,74.41609003,1,0.952020631,0.66545877,1.430623013,0.152538288,0.269443505,49.15309253,1,0.496861466,0.787047864,0.631297648,0.527845924,0.651380611,N,-,,peptidyl-tRNA hydrolase PTH2,C:integral component of membrane; F:aminoacyl-tRNA hydrolase activity,IPR002833 (PFAM); IPR023476 (G3DSA:3.40.1490.GENE3D); IPR002833 (TIGRFAM); PTHR12649 (PANTHER); PTHR12649:SF11 (PANTHER); IPR023476 (SUPERFAMILY),,
RL4_JR_03138,8965,6566,8250,3,5,9,0,0,0,0,5,2,0,5,9,0,2,2,82.82099193,1,0.7207994,0.791709898,0.910433736,0.362593813,0.554035036,8.36629368,0,0.400882623,1.258332945,0.318582315,0.750043266,0.847219946,32.93646849,1,-1.299891963,1.221788085,-1.06392588,0.287362278,0.427015368,33.26139223,1,-0.979242792,1.064343281,-0.920044134,0.357549697,0.503442583,21.70692901,1,-2.353838242,1.237038418,-1.902801245,0.057066485,0.123805048,N,-,,nicotinamide riboside kinase 1,C:cytoplasm; P:NAD biosynthetic process; F:kinase activity,IPR000764 (PRINTS); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23404 (PANTHER); IPR026681 (PTHR23404:PANTHER); IPR026681 (PTHR23404:PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_03139,2861,3027,2225,0,0,1,0,0,0,0,0,0,0,12,0,0,3,0,102.523947,1,-0.860221541,0.601259717,-1.430698775,0.152516564,0.300466103,21.4558323,0,-0.957763844,1.197164896,-0.800026669,0.423695346,0.586535476,71.28027363,0,-1.783763231,1.025866367,-1.738787125,0.082072214,0.166246318,76.16456562,1,-1.720964981,0.845177135,-2.0362181,0.04172846,0.110689194,74.03518698,1,-0.751997802,0.665265899,-1.130371786,0.258319598,0.390079929,N,-,,sart-1 family,"F:DNA binding; P:mRNA splicing, via spliceosome",IPR005011 (PFAM); PTHR14152 (PANTHER); IPR005011 (PTHR14152:PANTHER); PTHR14152 (PANTHER); IPR005011 (PTHR14152:PANTHER),,
RL4_JR_03140,730,482,514,3,0,0,0,0,0,0,0,0,2,5,0,0,0,0,15.7955921,1,-2.083766266,1.20201016,-1.733567931,0.082994775,0.193581826,5.088279563,0,1.118402581,1.26846125,0.881700234,0.377938934,0.542409926,39.11184389,0,1.283964682,0.766686652,1.674692887,0.093994504,0.185006038,32.46132728,1,0.363071059,0.871801258,0.416460811,0.677072838,0.77990472,12.84479236,0,-1.596959871,1.202031991,-1.328550225,0.183996403,0.302590462,N,-,,meiotically up-regulated,C:integral component of membrane,IPR000008 (SMART); IPR000008 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); PTHR10774 (PANTHER); PTHR10774:SF72 (PANTHER); PTHR10774 (PANTHER); PTHR10774:SF72 (PANTHER); PTHR10774:SF72 (PANTHER); IPR000008 (PROSITE_PROFILES); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY),9.A.57.1.1, the extended-synaptotagmin (e-syt) family.
RL4_JR_03141,775,832,687,7,3,13,0,0,0,0,0,1,0,6,0,0,5,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_03142,1201,1173,1312,3,0,5,0,0,0,1,3,0,0,2,6,0,7,0,16.09203263,1,0.54339029,1.017405259,0.534094241,0.593276334,0.764001315,117.6989937,0,5.064658722,1.54212282,3.284212293,0.001022679,0.015023052,6.997199725,1,-0.617970354,1.199173465,-0.515330244,0.606322268,0.72314638,12.08453678,1,-0.093599826,1.147851962,-0.081543465,0.93500976,0.962317601,6.915850748,1,-0.703674018,1.205056226,-0.583934594,0.559264318,0.677825139,N,-,,glucan 4-alpha-glucosidase,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_03143,3124,2535,3392,0,1,3,0,0,0,0,0,3,0,5,0,0,2,1,18.61155118,1,1.35405873,0.865010915,1.565366063,0.117497101,0.248713376,2.275041561,0,2.279561426,1.296568892,1.758149096,0.078722144,0.168281727,26.75953719,1,2.027177699,0.85773409,2.363410435,0.018107603,0.05187362,100.9241701,1,3.47176688,0.509381739,6.815648493,9.38E-12,3.99E-10,9.714969241,1,0.465900819,1.136655529,0.409887435,0.681888523,0.774069455,N,-,,dna polymerase iota,P:DNA repair; C:membrane; C:integral component of membrane; F:damaged DNA binding,IPR001126 (PFAM); G3DSA:1.10.150.20 (GENE3D); G3DSA:3.30.70.270 (GENE3D); IPR017961 (G3DSA:3.30.1490.GENE3D); IPR017961 (PFAM); PTHR11076 (PANTHER); PTHR11076:SF10 (PANTHER); PTHR11076:SF10 (PANTHER); PTHR11076 (PANTHER); PTHR11076 (PANTHER); IPR001126 (PROSITE_PROFILES); SSF56672 (SUPERFAMILY),,
RL4_JR_03144,3358,3211,5552,0,0,3,0,0,0,0,0,0,0,1,0,0,2,3,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_03145,5637,6289,7940,1,1,4,0,0,0,0,7,1,0,9,4,0,2,0,180.907806,1,-2.777791863,0.771536575,-3.600337239,0.000317805,0.002266303,52.64497955,0,-2.252729957,1.193692083,-1.88719519,0.059134077,0.134658072,149.9991115,1,-3.090576158,1.038588166,-2.975747518,0.002922754,0.013383066,216.673512,1,-1.431617522,0.527942842,-2.711690371,0.006694109,0.035343784,199.7507296,1,-0.713247195,0.494660253,-1.441893077,0.149332539,0.258063144,N,-,,bhlh family transcription factor,F:protein dimerization activity,IPR011598 (SMART); IPR011598 (G3DSA:4.10.280.GENE3D); IPR011598 (PFAM); PTHR12565 (PANTHER); PTHR12565:SF83 (PANTHER); PTHR12565 (PANTHER); PTHR12565:SF83 (PANTHER); IPR011598 (PROSITE_PROFILES); IPR011598 (SUPERFAMILY),,
RL4_JR_03146,819,1144,2017,0,2,0,0,0,0,0,4,1,1,0,0,0,0,0,48.3091482,1,3.351512451,0.490894301,6.827360691,8.65E-12,3.75E-10,1.892395055,0,2.545281101,1.311502971,1.940736054,0.052290301,0.121982582,12.75510188,1,0.85419866,1.191844801,0.716702929,0.473557418,0.610194133,17.70157994,1,1.774981094,0.853355173,2.080002735,0.037525282,0.102992322,4.84668956,0,-0.190784308,1.200689395,-0.158895639,0.873751097,0.916138219,N,-,,integral membrane,C:membrane,IPR026749 (PANTHER); IPR026749 (PANTHER); PTHR12459:SF2 (PANTHER); PTHR12459:SF2 (PANTHER),1.B.69.2.2, the peroxysomal membrane porin 4 (pxmp4) family.
RL4_JR_03147,1951,1522,1977,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,109.8461871,1,2.093598661,0.468889471,4.465015302,8.01E-06,9.56E-05,6.775658708,0,0.705095716,1.231522172,0.572540009,0.566956189,0.708785997,24.14106364,0,-0.990287755,1.19741939,-0.827018306,0.408226686,0.550426138,68.49567504,0,1.759874709,0.603416374,2.916517987,0.003539623,0.021281879,17.46497485,1,-2.040162054,1.207560366,-1.689490739,0.091125425,0.177986468,N,-,,sad1 interacting factor 1,C:membrane; C:integral component of membrane,IPR028143 (PFAM); PTHR28263:SF1 (PANTHER); PTHR28263 (PANTHER),,
RL4_JR_03148,2295,2514,3697,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,156.9349578,1,0.433369446,0.524945237,0.825551726,0.409058429,0.600460689,18.9604868,0,-0.779384172,1.213884416,-0.642057976,0.52083554,0.670895563,93.88906637,0,-0.022767852,0.625646787,-0.036390904,0.970970667,0.983207345,81.84775105,0,-0.811449264,0.684822825,-1.184903941,0.236055429,0.373680616,85.63187249,0,-0.072541638,0.583552372,-0.124310416,0.9010695,0.936206125,N,-,,pre-rrna processing,C:integral component of membrane,IPR022185 (PFAM); PTHR42086 (PANTHER); PTHR42086:SF1 (PANTHER),,
RL4_JR_03149,14266,9145,17712,6,3,9,0,0,0,5,0,5,2,0,4,0,4,2,807.0683134,1,-0.456375637,0.365595123,-1.248308877,0.211917964,0.379211835,186.3551815,0,-1.178541269,0.782619455,-1.505893141,0.132094608,0.250198656,388.233855,1,-6.411795508,1.209027927,-5.303265013,1.14E-07,3.86E-06,650.7403931,1,-1.012703988,0.417983573,-2.422832026,0.015400046,0.066098119,490.9958083,1,-1.559973589,0.53716022,-2.904112276,0.003682961,0.013950608,N,-,,40S ribosomal S10,C:ribosome,IPR005326 (PFAM); PTHR12146 (PANTHER),,
RL4_JR_03150,3247,3442,5870,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,162.0338421,0,-0.111535159,0.54606449,-0.204252722,0.838156013,0.918937779,29.26009045,0,-1.405381963,1.209842404,-1.161623992,0.245388232,0.398308512,127.1349115,0,-0.444488624,0.607659925,-0.731475956,0.464488486,0.601494171,132.3094352,1,-0.952741304,0.611256454,-1.558660524,0.11907675,0.223186244,112.8094342,0,-0.922407611,0.673715089,-1.369136042,0.170956754,0.286010762,N,-,,upf0667 family,,IPR024974 (PFAM); PTHR12786 (PANTHER),,
RL4_JR_03151,171,268,320,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,522.0420644,0,0.698427554,0.473018804,1.476532324,0.139801044,0.281812928,135.3495035,0,-0.348924414,0.852446346,-0.409321262,0.682303914,0.798006594,390.6774703,0,0.453641629,0.522398892,0.868381683,0.385185419,0.528976829,504.2359667,0,0.587847075,0.321618756,1.827776098,0.067583162,0.147505774,304.1219126,0,-0.031473327,0.46048007,-0.068348946,0.945507862,0.965166076,N,-, Effector probability:0.723,cytochrome c oxidase subunit 6b,F:cytochrome-c oxidase activity; C:mitochondrion; P:hydrogen ion transmembrane transport,IPR003213 (G3DSA:1.10.10.GENE3D); IPR003213 (PFAM); IPR003213 (PIRSF); PTHR11387 (PANTHER); PD015172 (PRODOM); IPR003213 (SUPERFAMILY),3.D.4.8.1, the proton-translocating cytochrome oxidase (cox) superfamily.
RL4_JR_03152,417,273,344,0,0,6,0,0,0,1,1,0,0,0,0,0,1,0,680.926634,1,0.975238755,0.806619678,1.209044091,0.226645907,0.398143262,183.645302,0,1.012907733,0.554562688,1.826498169,0.067775257,0.149688228,491.0805319,1,0.699189372,0.63481873,1.101400036,0.27072259,0.409318324,830.7782685,0,1.417739336,0.333330576,4.253253189,2.11E-05,0.000274544,437.8175685,1,0.541247386,0.577069809,0.937923588,0.34828368,0.485860052,N,-,,NADH-ubiquinone reductase complex 1 MLRQ subunit,C:integral component of membrane,IPR010530 (PFAM),,
RL4_JR_03153,913,689,635,0,1,0,0,0,0,0,3,1,0,0,0,0,0,0,28.03204584,1,-1.75433103,1.170333111,-1.499001449,0.133873256,0.272693639,7.657445681,0,0.528578003,1.242274221,0.425492209,0.6704779,0.789320458,19.99710691,1,-2.132809368,1.21100595,-1.761188183,0.078206558,0.159984479,53.73711435,0,0.48998505,0.709485817,0.690619937,0.489804415,0.629748534,50.03037981,0,0.961273632,0.678653236,1.416443009,0.156645839,0.266892245,N,-,,Peptidyl-prolyl cis-trans isomerase E,F:nucleotide binding; F:nucleic acid binding; C:nucleus; F:peptidyl-prolyl cis-trans isomerase activity; C:cytosol; P:protein peptidyl-prolyl isomerization; P:protein folding,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); IPR024936 (PANTHER); IPR024936 (PANTHER); PTHR11071:SF274 (PANTHER); PTHR11071:SF274 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_03154,176,243,249,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,319.1521027,0,0.425063676,0.363648185,1.168887111,0.242449117,0.417431998,45.09924183,0,-2.029495886,1.210806982,-1.676151456,0.09370853,0.192601532,167.1867949,0,-1.051345345,0.596239421,-1.763293917,0.077850931,0.159488271,202.6931,0,-1.163677673,0.536778023,-2.167893661,0.030166778,0.09264138,207.2942509,0,-0.512116884,0.478241467,-1.070833291,0.284244395,0.418590601,N,-,,transport SEC31,C:intracellular membrane-bounded organelle; C:membrane; C:endomembrane system; C:cytoplasmic part; P:transport,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR009917 (PFAM); IPR024298 (PFAM); IPR001680 (PFAM); PTHR13923 (PANTHER); PTHR13923:SF11 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),3.A.5.9.1, the general secretory pathway (sec) family.
RL4_JR_03155,188,548,324,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,97.51868163,1,1.634879922,0.586166412,2.789105428,0.005285386,0.02271769,8.889856147,0,0.313293451,1.226539081,0.255428837,0.798391901,0.87792752,36.17097575,0,-0.528555246,1.045231914,-0.505682268,0.613079718,0.728328921,30.75227541,0,-1.821844054,1.155524585,-1.576638072,0.114878827,0.21708625,42.26962025,0,0.461531268,0.725020656,0.636576715,0.524400596,0.648366426,N,-,,Ornithine carbamoyltransferase,C:mitochondrion; P:arginine biosynthetic process via ornithine; C:cytosol; F:amino acid binding; F:ornithine carbamoyltransferase activity,IPR002292 (PRINTS); IPR006130 (PRINTS); IPR006132 (PFAM); IPR006130 (G3DSA:3.40.50.GENE3D); IPR002292 (TIGRFAM); IPR006130 (G3DSA:3.40.50.GENE3D); IPR006131 (PFAM); PTHR11405 (PANTHER); PTHR11405:SF1 (PANTHER); IPR006130 (SUPERFAMILY),,
RL4_JR_03156,490,362,353,0,0,7,0,0,0,0,0,2,0,0,1,0,0,0,190.6023415,1,0.0550713,0.447303741,0.123118353,0.902013378,0.952449539,59.46562947,0,0.673986968,0.863695328,0.780352684,0.43518331,0.596792503,101.0249116,1,-1.762117308,0.868054428,-2.029961777,0.042360425,0.099803803,141.4176447,1,-0.716876061,0.549062492,-1.305636555,0.191676183,0.320729203,110.8716175,0,-1.055900389,0.658713683,-1.602973211,0.108940569,0.203660129,N,-,,acetolactate synthase,F:acetolactate synthase activity; C:acetolactate synthase complex; P:regulation of catalytic activity; F:amino acid binding; P:branched-chain amino acid biosynthetic process; F:enzyme regulator activity; C:mitochondrial nucleoid,IPR004789 (TIGRFAM); G3DSA:3.30.70.1150 (GENE3D); G3DSA:3.30.70.260 (GENE3D); IPR002912 (PFAM); IPR019455 (PFAM); PTHR31242 (PANTHER); PTHR31242:SF2 (PANTHER); PD002844 (PRODOM); IPR002912 (PROSITE_PROFILES); SSF55021 (SUPERFAMILY); SSF55021 (SUPERFAMILY),,
RL4_JR_03157,8,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,95.65354078,0,-1.354883734,0.708174537,-1.913205944,0.055721693,0.143944766,24.31863138,0,-1.138512833,1.201492849,-0.947581864,0.343342363,0.506679019,100.3852584,0,-0.657213454,0.682794663,-0.962534549,0.335781157,0.478862999,129.2241642,0,-0.220330865,1.389772222,-0.158537393,0.874033358,0.922312428,85.49565693,0,-0.960588072,0.705528811,-1.361515018,0.173350991,0.288823232,N,-,,kh domain-containing,C:nucleus; F:RNA binding,IPR004087 (SMART); IPR010378 (PFAM); IPR004088 (G3DSA:3.30.1370.GENE3D); IPR004088 (PFAM); PTHR15744 (PANTHER); IPR031121 (PTHR15744:PANTHER); IPR004088 (PROSITE_PROFILES); IPR004088 (SUPERFAMILY); SSF101447 (SUPERFAMILY); IPR004088 (SUPERFAMILY),,
RL4_JR_03158,5,1,4,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,152.629167,1,-0.771632318,0.60429419,-1.276915004,0.201632256,0.36569941,28.63719072,0,-1.374275601,1.226950724,-1.120073996,0.262682231,0.419181702,113.422023,0,-1.171410017,0.771630333,-1.51809742,0.128989842,0.234619683,137.970924,0,-0.559787691,0.570478037,-0.981260724,0.326464186,0.473018014,72.06692082,0,-4.085062198,1.205788209,-3.387877049,0.000704358,0.003610951,N,-,,DENN domain-containing,F:metal ion binding; C:intracellular; P:intracellular signal transduction,IPR005113 (SMART); IPR001194 (SMART); IPR005112 (SMART); IPR005113 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001194 (PFAM); IPR005112 (PFAM); PTHR12296 (PANTHER); PTHR12296 (PANTHER); PTHR12296:SF21 (PANTHER); PTHR12296:SF21 (PANTHER); PTHR12296:SF21 (PANTHER); IPR001194 (PROSITE_PROFILES); IPR005113 (PROSITE_PROFILES); IPR002219 (PROSITE_PROFILES); IPR005112 (PROSITE_PROFILES); SSF57889 (SUPERFAMILY),,
RL4_JR_03159,32,12,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.84057389,0,1.12988666,0.689846042,1.637882354,0.101446238,0.223947954,23.29114277,0,2.916507759,1.013065797,2.87889273,0.00399074,0.018114025,11.7587217,0,-1.366782998,1.20637979,-1.132962446,0.257230024,0.393621034,21.58700503,0,-0.07070209,1.034148956,-0.068367414,0.945493161,0.968057261,11.60171662,0,-1.45010252,1.211465866,-1.19698174,0.231313672,0.35897575,N,-,,Type 1 phosphatase regulator ypi-1,C:intracellular part,IPR011107 (PFAM); PTHR20835:SF0 (PANTHER); IPR011107 (PANTHER),,
RL4_JR_03160,45,22,28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,125.3185341,0,-4.082470085,1.18756148,-3.437691567,0.000586696,0.003825949,82.98141659,0,-0.113592637,0.997548283,-0.113871819,0.909339406,0.949547243,175.1472818,0,-0.602177322,0.607659778,-0.990977755,0.321696443,0.464270105,133.420324,0,-2.576934188,0.898187348,-2.869038618,0.004117215,0.024054705,122.5546396,0,-1.65272629,0.757938506,-2.180554592,0.029216377,0.073586024,N,-,,DUF974 domain containing,P:biological_process; F:GTPase activity; C:cytosol; P:ribosome biogenesis; F:molecular_function,IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11089 (PANTHER); PTHR11089 (PANTHER); PTHR11089 (PANTHER); PTHR11089:SF41 (PANTHER); PTHR11089:SF41 (PANTHER); PTHR11089:SF41 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_03161,397,335,435,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,86.11280225,0,-1.565243672,0.792595138,-1.974833805,0.048287011,0.129538125,22.46725416,0,-1.024280378,1.20873597,-0.847397946,0.396773349,0.560917524,69.6426287,0,-2.721405545,1.203226343,-2.261756952,0.023712424,0.063811325,75.61140231,1,-2.388773029,1.036610677,-2.304407124,0.0211998,0.078972767,65.43963456,1,-2.835416749,1.142098062,-2.482638615,0.013041332,0.038868863,N,-, Effector probability:0.598,50S ribosomal mrp49,C:ribosome,IPR007741 (PFAM); PTHR13274:SF2 (PANTHER); PTHR13274 (PANTHER); PTHR13274:SF2 (PANTHER); PTHR13274 (PANTHER),,
RL4_JR_03162,16,10,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,73.73342113,0,-0.046710796,0.631281564,-0.073993601,0.941015477,0.971255599,12.29645208,0,-0.154607413,1.227436665,-0.125959585,0.899763916,0.944164458,31.73033174,0,-2.79876155,1.198378442,-2.335457191,0.01951955,0.054842592,65.96323695,0,0.068974566,0.638938259,0.107951849,0.914033888,0.947849339,42.67736554,0,-0.669888111,0.848140781,-0.789831271,0.429626314,0.564124812,N,-,,ubiquitin- ligase,F:catalytic activity; C:cell part,IPR000569 (SMART); IPR000569 (PFAM); G3DSA:3.30.2160.10 (GENE3D); PTHR11254:SF301 (PANTHER); PTHR11254 (PANTHER); PTHR11254 (PANTHER); PTHR11254:SF301 (PANTHER); IPR000569 (PROSITE_PROFILES); IPR000569 (SUPERFAMILY),8.A.30.1.1, the nedd4-family interacting protein-2 (nedd4) family.
RL4_JR_03163,230,354,353,4,0,0,0,0,0,0,1,0,0,0,0,0,0,2,26.98463205,1,-2.856482685,1.187843667,-2.404763157,0.01618295,0.055424226,8.60540854,0,0.360249057,1.217628409,0.295861245,0.767336049,0.85936883,22.34527091,1,-2.292985976,1.190707101,-1.925734696,0.054137509,0.120168416,25.77870305,0,-2.715371902,1.189300251,-2.283167686,0.022420493,0.080726669,22.05810469,1,-2.377024897,1.19592034,-1.987611396,0.046854685,0.106580616,N,-,,DUF726 domain-containing,C:membrane; C:integral component of membrane,IPR029058 (G3DSA:3.40.50.GENE3D); IPR007941 (PFAM); PTHR17920:SF6 (PANTHER); IPR007941 (PANTHER); IPR007941 (PANTHER); PTHR17920:SF6 (PANTHER),,
RL4_JR_03164,94,183,166,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,155.6247511,0,0.34641655,0.57114408,0.606530931,0.544162249,0.724898046,24.35918467,0,-1.140867192,1.19818546,-0.952162441,0.341014606,0.503905086,69.71506505,0,-2.831431458,1.190662481,-2.378030301,0.017405396,0.05026102,118.6711574,0,-0.201701377,0.504726152,-0.399625373,0.689432465,0.789885077,77.74450102,0,-1.267369109,0.754643371,-1.679427869,0.093068686,0.18066318,N,-,,vesicular-fusion sec17,P:intracellular protein transport; P:negative regulation of G0 to G1 transition; C:intracellular,IPR000744 (PRINTS); PF14938 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR000744 (PANTHER); PTHR13768:SF8 (PANTHER); IPR011990 (SUPERFAMILY),1.F.1.1.2, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_03165,1091,1348,1603,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,434.621723,1,-2.578464793,0.590026559,-4.37008259,1.24E-05,0.000140335,117.2700967,0,-3.408179264,1.215800814,-2.803238183,0.005059229,0.020783007,348.5177434,0,-2.910201755,0.72946279,-3.989513646,6.62E-05,0.000892542,401.3847804,0,-2.459242668,0.7455852,-3.298405962,0.000972354,0.007217807,345.8098117,0,-2.358617851,0.79840423,-2.954165025,0.003135163,0.0122704,N,-,,Ribosomal RNA-processing 12,C:nucleus; C:integral component of membrane; C:mitotic spindle pole body,IPR012978 (PFAM); PTHR21576:SF2 (PANTHER); PTHR21576 (PANTHER); PTHR21576:SF2 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_03166,115,110,183,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,65.58871416,0,-1.980347386,1.025481734,-1.931138624,0.053465912,0.13997911,15.84735116,0,-0.520673063,1.22003006,-0.426770684,0.669546361,0.788825193,77.64360601,0,-0.033804469,0.691308117,-0.048899279,0.960999563,0.977117375,47.43048506,0,-3.594962381,1.203663726,-2.986683325,0.002820217,0.017659058,47.95310584,0,-2.319571317,1.136908381,-2.040244717,0.041325958,0.096544837,N,-,,vesicle transport through interaction with t-SNAREs 1,"P:vesicle fusion; C:integral component of Golgi membrane; F:SNAP receptor activity; C:SNARE complex; P:vacuole fusion, non-autophagic; P:intra-Golgi vesicle-mediated transport; C:fungal-type vacuole; P:intracellular protein transport; P:Golgi to vacuole transport",IPR000727 (SMART); PF12352 (PFAM); G3DSA:1.20.5.110 (GENE3D); IPR007705 (PFAM); IPR027027 (PIRSF); G3DSA:1.20.58.400 (GENE3D); PTHR21230:SF26 (PANTHER); PTHR21230 (PANTHER); IPR010989 (SUPERFAMILY); SSF58038 (SUPERFAMILY),1.F.1.1.2, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_03167,36,30,73,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28.32616091,0,-2.926503047,1.188250759,-2.462866551,0.013783121,0.049061912,9.054177641,0,0.286922946,1.220667472,0.235054143,0.81416671,0.887751313,56.68925007,0,0.055169494,0.850515949,0.064865913,0.948280761,0.970030759,55.0212047,0,-0.453896087,0.849968492,-0.534015191,0.593331024,0.716284323,23.15019384,0,-2.446760572,1.195798839,-2.046130581,0.040743525,0.095514747,N,-,,amine oxidase,F:oxidoreductase activity; C:membrane; P:oxidation-reduction process,IPR023753 (G3DSA:3.50.50.GENE3D); IPR002937 (PFAM); PTHR10742 (PANTHER); PTHR10742:SF299 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_03168,1726,1499,1696,1,0,6,0,0,0,0,0,1,6,2,0,0,0,1,42.48450333,1,0.21128048,0.811743169,0.260279961,0.794647829,0.894787714,6.611832588,0,0.740382732,1.26109373,0.58709572,0.557139422,0.701500837,28.36769306,1,-0.961811104,1.218540355,-0.789314117,0.429928438,0.57038813,23.97638316,1,-1.401653797,1.176943671,-1.190926831,0.23368231,0.370851629,17.20833809,1,-2.018798715,1.236187722,-1.633084264,0.102451276,0.194473035,N,-, Effector probability:0.773,cytochrome-c oxidase assembly,C:mitochondrial intermembrane space; F:copper ion binding; F:oxidoreductase activity; P:protein complex assembly; C:integral component of membrane; C:mitochondrial ribosome; P:aerobic respiration; C:mitochondrial inner membrane,IPR007533 (PFAM); IPR007533 (PIRSF); IPR023471 (G3DSA:2.60.370.GENE3D); PTHR21320:SF3 (PANTHER); IPR007533 (PANTHER); IPR023471 (SUPERFAMILY),3.D.4.8.1, the proton-translocating cytochrome oxidase (cox) superfamily.
RL4_JR_03169,650,654,906,0,2,3,0,0,0,0,0,0,0,0,0,0,4,0,303.7845122,1,0.064366412,0.491029473,0.13108462,0.895708367,0.948615976,115.4916373,0,1.166692272,0.641008445,1.820088769,0.068745488,0.151533499,235.3946746,0,-0.291482977,0.459925254,-0.633761626,0.5262364,0.655948943,257.9339073,0,-0.35678306,0.417990286,-0.853567826,0.393344492,0.538118224,177.5805038,1,-1.245280509,1.491723516,-0.834793107,0.403834207,0.540890728,N,-,,WD repeat,C:RAVE complex; C:nucleus; P:cellular response to zinc ion; P:cellular response to calcium ion; P:early endosome to late endosome transport; C:cytosol; P:regulation of protein complex assembly; C:endosome membrane; P:vacuolar acidification; C:extrinsic component of membrane; F:protein complex binding,IPR001680 (SMART); IPR022033 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR13950 (PANTHER); IPR017986 (SUPERFAMILY); IPR017986 (SUPERFAMILY),,
RL4_JR_03170,1877,1928,3460,0,2,1,0,0,1,0,0,0,0,4,0,0,0,0,55.5482468,1,-1.979016674,1.066133202,-1.856256488,0.063417008,0.158795565,15.53099707,1,-0.491533632,1.256565811,-0.391172215,0.695669944,0.807240395,50.97718562,0,-2.167786501,1.223199265,-1.772226785,0.076356919,0.157224302,65.27821802,1,-1.77777319,1.059729691,-1.677572314,0.093430621,0.186071015,57.92633439,0,-0.597753854,0.802336771,-0.745016152,0.456261956,0.587891614,N,-,,ddhd domain-containing,F:nucleotidyltransferase activity; F:metal ion binding; C:intracellular part,IPR004177 (SMART); IPR004177 (PFAM); PTHR23509 (PANTHER); PTHR23509 (PANTHER); PTHR23509 (PANTHER); PTHR23509:SF6 (PANTHER); PTHR23509:SF6 (PANTHER); PTHR23509:SF6 (PANTHER); PTHR23509 (PANTHER); IPR004177 (PROSITE_PROFILES),,
RL4_JR_03171,6732,6148,5736,1,9,0,0,0,0,6,0,4,2,4,0,0,14,4,95.11045952,1,-1.035516179,0.669323255,-1.54710922,0.121836911,0.255192181,20.33722298,0,-0.880499669,1.206804075,-0.729612774,0.465626912,0.624615574,126.8868949,1,0.308483722,0.540645606,0.57058398,0.56828168,0.692665992,98.53968118,1,-1.195362763,0.741046963,-1.613072886,0.106728674,0.205912314,51.62858467,1,-3.603888202,1.18727684,-3.035423652,0.00240198,0.009886199,N,-,,DNA repair helicase rad15,"P:phosphorylation of RNA polymerase II C-terminal domain; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; C:core TFIIH complex; P:positive regulation of mitotic recombination; P:transcription from RNA polymerase II promoter; C:holo TFIIH complex; F:damaged DNA binding; C:nucleotide-excision repair factor 3 complex; F:ATP binding; F:ATP-dependent 5'-3' DNA helicase activity; C:cytosol; P:regulation of transposition, RNA-mediated; F:4 iron, 4 sulfur cluster binding",IPR001945 (PRINTS); IPR006555 (SMART); IPR006554 (SMART); IPR010614 (PFAM); IPR010643 (PFAM); IPR006555 (PFAM); IPR013020 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11472:SF1 (PANTHER); PTHR11472:SF1 (PANTHER); PTHR11472 (PANTHER); IPR014013 (PROSITE_PROFILES),,
RL4_JR_03172,297,329,288,0,3,0,0,0,0,0,2,1,0,2,2,0,0,4,5.902606031,1,-0.663707093,1.228081049,-0.540442419,0.588891961,0.760395792,1.906809102,0,2.534449881,1.360526896,1.86284438,0.062484164,0.140672755,4.90776545,1,-0.105975747,1.22481488,-0.086523889,0.931049966,0.958772317,5.658779057,1,-0.527589155,1.226706662,-0.430085832,0.667133206,0.773044031,4.799347825,1,-0.17677904,1.218050532,-0.145132764,0.88460605,0.923893428,N,-,,epithelial zinc-finger ezf,F:nucleic acid binding; F:metal ion binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR14596 (PANTHER); PTHR14596:SF38 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY),,
RL4_JR_03173,1386,1813,1237,0,2,21,0,0,0,0,1,1,3,9,2,0,7,0,841.3533477,1,-3.079268504,0.424833947,-7.248169607,4.22E-13,2.14E-11,236.6342316,0,-4.420997855,1.19220265,-3.708260383,0.000208688,0.008891461,655.2177216,1,-4.237017257,0.745703672,-5.681904779,1.33E-08,5.53E-07,724.5735517,1,-4.781969725,0.747859866,-6.394205578,1.61E-10,5.94E-09,674.1792506,1,-2.726173077,0.52127941,-5.22977318,1.70E-07,3.52E-06,N,-,,dna-directed rna polymerase i subunit rpa1,P:mRNA export from nucleus; F:DNA binding; C:DNA-directed RNA polymerase I complex; F:zinc ion binding; F:RNA polymerase I activity; P:mycelium development; P:transcription of nuclear large rRNA transcript from RNA polymerase I promoter; C:cytosol,IPR006592 (SMART); G3DSA:2.40.40.20 (GENE3D); IPR007080 (PFAM); IPR007081 (PFAM); IPR007083 (PFAM); IPR000722 (PFAM); G3DSA:3.30.1490.180 (GENE3D); IPR007066 (PFAM); IPR015699 (PTHR19376:PANTHER); PTHR19376 (PANTHER); SSF64484 (SUPERFAMILY),,
RL4_JR_03174,14614,9209,10914,5,0,5,0,0,0,0,10,0,6,5,9,0,0,3,3032.704317,1,-0.401950123,0.526590301,-0.763307115,0.44528026,0.634054598,625.9526667,0,-2.715609672,0.697179705,-3.895135862,9.81E-05,0.004799085,2008.668108,1,-1.328367722,0.308469672,-4.306315477,1.66E-05,0.000291256,2381.636693,1,-1.158761669,0.615249213,-1.883402114,0.059645894,0.136354635,1887.143292,1,-1.503920998,0.545711537,-2.755890054,0.005853267,0.020386765,N,-,,histone H3,C:nucleus; F:DNA binding; P:mycelium development; F:protein heterodimerization activity; C:nucleosome,IPR000164 (PRINTS); IPR000164 (SMART); IPR007125 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); IPR000164 (PANTHER); IPR009072 (SUPERFAMILY),,
RL4_JR_03175,44,147,94,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,935.4083533,0,0.659185359,0.824586898,0.799412846,0.424051064,0.615334148,161.4847373,0,-1.715323532,1.004204327,-1.708141944,0.087610008,0.182654686,626.7471748,0,0.018570889,0.571527251,0.032493444,0.974078544,0.985348619,888.403664,0,0.651083073,0.337414075,1.9296263,0.053653158,0.12764056,456.7915095,0,-0.73683088,0.526131519,-1.400468995,0.161372922,0.273456206,N,-,,Histone H4,"C:nucleus; F:DNA binding; P:mycelium development; F:protein heterodimerization activity; P:DNA-templated transcription, initiation; C:nucleosome; P:nucleosome assembly",IPR001951 (PRINTS); IPR001951 (SMART); IPR009072 (G3DSA:1.10.20.GENE3D); PF15511 (PFAM); PTHR10484 (PANTHER); IPR009072 (SUPERFAMILY),,
RL4_JR_03176,2773,3060,2909,0,2,2,0,0,1,3,3,2,4,3,0,0,6,0,385.5819554,1,-0.883734843,0.387435012,-2.280988594,0.022549122,0.072480589,94.36885563,1,-1.130683478,0.980435352,-1.153246337,0.248809289,0.402243872,243.9565575,1,-1.801423293,0.571109802,-3.154250348,0.00160911,0.008340061,257.1281252,1,-2.794946076,0.662275302,-4.220217888,2.44E-05,0.000312807,241.7442272,1,-1.570760078,0.494911926,-3.173817391,0.001504483,0.006691729,N,-,,pentafunctional arom polypeptide,P:aromatic amino acid family biosynthetic process; P:chorismate biosynthetic process; P:cellular amino acid biosynthetic process; F:shikimate 3-dehydrogenase (NADP+) activity; F:shikimate kinase activity; F:ATP binding; F:3-dehydroquinate dehydratase activity; F:3-phosphoshikimate 1-carboxyvinyltransferase activity; F:3-dehydroquinate synthase activity; F:metal ion binding; C:cytosol; P:oxidation-reduction process; P:phosphorylation,PR01100 (PRINTS); IPR001381 (TIGRFAM); IPR031322 (PFAM); G3DSA:3.40.50.1970 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013785 (G3DSA:3.20.20.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.20.1090.10 (GENE3D); IPR006264 (TIGRFAM); IPR016037 (TIGRFAM); IPR010110 (TIGRFAM); IPR030960 (PFAM); IPR001381 (PFAM); IPR001986 (PFAM); IPR001986 (G3DSA:3.65.10.GENE3D); IPR001986 (G3DSA:3.65.10.GENE3D); IPR013708 (PFAM); G3DSA:3.40.192.10 (GENE3D); IPR008289 (PIRSF); PTHR21090:SF1 (PANTHER); PTHR21090 (PANTHER); IPR006264 (HAMAP); IPR008289 (HAMAP); IPR000623 (HAMAP); IPR016037 (HAMAP); SSF56796 (SUPERFAMILY); IPR016040 (SUPERFAMILY); SSF51569 (SUPERFAMILY); SSF53223 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR013792 (SUPERFAMILY),,
RL4_JR_03177,335,395,331,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3963.220734,0,-4.486570478,1.07885068,-4.158657506,3.20E-05,0.000315407,1276.882606,1,-4.402287998,1.075911272,-4.091683128,4.28E-05,0.002318066,3321.550616,0,-4.231378914,0.837655813,-5.051452932,4.38E-07,1.29E-05,3692.854839,0,-5.980697114,0.865539855,-6.909788246,4.85E-12,2.09E-10,3134.323899,0,-5.09828745,1.091298866,-4.67176097,2.99E-06,3.66E-05,N,-,,c2h2 transcription factor,P:positive regulation of macromolecule metabolic process; F:binding; P:positive regulation of cellular metabolic process; P:regulation of transcription from RNA polymerase II promoter,IPR015880 (SMART); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES),,
RL4_JR_03178,281,197,284,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,465.4181369,0,-1.690079719,0.479180127,-3.527023814,0.000420259,0.002905485,112.2014049,0,-3.344421058,1.214457428,-2.753839681,0.005890061,0.023010112,325.6534962,0,-2.849464358,0.703841383,-4.04844675,5.16E-05,0.000744622,396.4859878,0,-2.072286849,0.530096716,-3.90926181,9.26E-05,0.001002522,347.0783261,0,-1.781190193,0.509018349,-3.499265196,0.000466542,0.002556137,N,-,,GTPase-activator for Ras-like GTPase,F:nucleic acid binding; P:nucleic acid phosphodiester bond hydrolysis; C:bicellular tight junction; F:zinc ion binding; F:exonuclease activity; P:signal transduction; F:GTPase activator activity; F:structural molecule activity; P:positive regulation of GTPase activity,IPR001936 (SMART); IPR001936 (PFAM); IPR001251 (PFAM); IPR001936 (G3DSA:1.10.506.GENE3D); G3DSA:1.10.494.10 (GENE3D); PTHR10194 (PANTHER); PTHR10194 (PANTHER); IPR028553 (PTHR10194:PANTHER); IPR028553 (PTHR10194:PANTHER); IPR028553 (PTHR10194:PANTHER); PTHR10194 (PANTHER); IPR001936 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR008936 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_03179,69,60,141,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,272.2186918,0,-4.420409078,1.007908099,-4.385726322,1.16E-05,0.000131345,84.53272695,0,-2.935919639,1.187936954,-2.471443986,0.013456863,0.042222681,352.1557379,0,-0.843206763,0.410216804,-2.055514925,0.039829296,0.095326664,299.5452603,0,-2.122306373,0.50662945,-4.189070279,2.80E-05,0.000354945,261.9679877,0,-1.650213234,0.518908809,-3.18016038,0.001471936,0.006565352,N,-,,5 -3 exoribonuclease 2,"F:nucleic acid binding; C:nucleus; F:5'-3' exoribonuclease activity; P:RNA phosphodiester bond hydrolysis, exonucleolytic; F:zinc ion binding; P:termination of RNA polymerase II transcription, poly(A)-coupled; P:signal transduction; P:termination of RNA polymerase II transcription, exosome-dependent; F:GTPase activator activity; P:nuclear mRNA surveillance; P:rRNA processing; P:positive regulation of GTPase activity",IPR004859 (PFAM); IPR017151 (PIRSF); IPR027073 (PANTHER),,
RL4_JR_03180,2310,1424,1419,11,15,3,0,0,0,0,8,0,0,0,3,0,6,0,270.4074733,1,0.609016093,0.517809881,1.176138414,0.239539569,0.41410549,36.9517376,0,-1.742031582,1.202828628,-1.448279116,0.147539006,0.273114451,150.3831765,1,-0.77383282,1.391916138,-0.555947876,0.578246488,0.700510643,131.4704786,1,-2.087977117,0.748515676,-2.789490166,0.00527911,0.02920819,139.6954783,1,-0.42681683,0.494969506,-0.862309344,0.388517312,0.524498371,N,-,,intracellular transport,F:identical protein binding; P:ER to Golgi vesicle-mediated transport; P:SNARE complex assembly; C:ER to Golgi transport vesicle membrane; P:Golgi vesicle docking; F:protein transporter activity; C:Golgi membrane; F:transferase activity; P:intracellular protein transport; P:methylation; P:vesicle fusion with Golgi apparatus,IPR006955 (PFAM); IPR006953 (PFAM); IPR024095 (PANTHER); IPR016024 (SUPERFAMILY); SSF57997 (SUPERFAMILY),,
RL4_JR_03181,69,115,238,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.1883637,0,-1.118159412,1.017058042,-1.099405704,0.271591144,0.453369159,8.633428119,0,0.355530728,1.221320132,0.291103634,0.770972061,0.861249222,62.17949343,0,0.533463855,0.748764972,0.712458348,0.476180995,0.61295059,41.97370258,0,-0.016963844,0.759376424,-0.022339176,0.982177399,0.989113404,33.81727589,0,-0.194358208,0.864786136,-0.224747137,0.822175993,0.880902849,N,-,,arginine methyltransferase,C:membrane; F:protein-arginine N-methyltransferase activity; P:cellular component organization; C:cytoplasmic part; P:protein methylation; P:Golgi vesicle transport,IPR025799 (PANTHER); IPR025799 (PANTHER); PTHR11006:SF59 (PANTHER); SSF57667 (SUPERFAMILY),,
RL4_JR_03182,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46.19347616,0,-3.631980376,1.202520961,-3.020305253,0.0025252,0.012607457,24.04328309,0,0.507765105,1.121463736,0.452769972,0.650714388,0.774248388,60.34184161,0,-1.232025748,1.039791936,-1.18487719,0.236066007,0.368589182,76.17285097,0,0.164455486,0.598649737,0.274710696,0.783538513,0.860634351,37.84246045,0,-3.155713195,1.207950561,-2.612452278,0.008989524,0.028849107,N,-,,arginine N-methyltransferase 3,F:protein transporter activity; C:Golgi membrane; F:methyltransferase activity; P:protein methylation; P:intracellular protein transport; P:vesicle fusion with Golgi apparatus,G3DSA:2.70.160.11 (GENE3D); IPR029063 (G3DSA:3.40.50.GENE3D); PF13649 (PFAM); PTHR11006:SF59 (PANTHER); IPR025799 (PANTHER); IPR025799 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_03183,244,218,188,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,119.3940643,0,0.266786808,0.438813834,0.607972646,0.543205616,0.724232992,19.49465474,0,-0.819471285,1.198251121,-0.683889438,0.494044984,0.649100136,104.5668106,0,-0.057508387,0.603989621,-0.095214197,0.924144694,0.955282916,98.56731437,0,-0.574795809,0.602741872,-0.953635107,0.340268379,0.487371356,57.45520045,0,-1.877603557,0.965100599,-1.945500355,0.051714787,0.115029046,N,-,,oligopeptide transporter,P:transmembrane transport; C:integral component of membrane,IPR004813 (PFAM); IPR004813 (TIGRFAM); PTHR31645 (PANTHER); PTHR31645:SF0 (PANTHER); PTHR31645:SF0 (PANTHER); PTHR31645 (PANTHER),2.A.67.2.7, the oligopeptide transporter (opt) family.
RL4_JR_03184,474,607,784,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,245.493555,1,0.709063124,0.325904838,2.175675354,0.029579544,0.089340956,29.17090207,0,-1.400920245,1.19685829,-1.170498009,0.241800615,0.393933015,121.7244502,0,-0.899899537,0.661828193,-1.359717743,0.173919261,0.293013159,119.1992209,0,-0.768261405,0.54033565,-1.421822538,0.155077775,0.272692336,182.5664969,0,0.205296006,0.723169432,0.283883689,0.776499517,0.845578553,N,-,,nicotinamide mononucleotide adenylyl transferase,F:ATP binding; F:nicotinamide-nucleotide adenylyltransferase activity; P:NAD biosynthetic process,IPR014729 (G3DSA:3.40.50.GENE3D); IPR004821 (PFAM); IPR005248 (TIGRFAM); IPR005248 (PANTHER); PTHR12039:SF0 (PANTHER); SSF52374 (SUPERFAMILY),,
RL4_JR_03185,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,91.58674466,0,-1.308457795,0.757273679,-1.727853261,0.084014536,0.194823929,23.31994482,0,-1.077942589,1.232174151,-0.874829737,0.381666554,0.546116605,82.27608632,0,-1.316002669,0.883264748,-1.489930026,0.136242636,0.244127512,81.33283103,0,-1.864337185,0.902672961,-2.065351756,0.03888973,0.105480449,126.1047721,0,0.414589928,0.51725398,0.801521001,0.422830091,0.558387201,N,-,,dual specificity phosphatase,P:inactivation of MAPK activity; C:nucleus; P:nuclear DNA replication; F:protein tyrosine phosphatase activity; P:peptidyl-tyrosine dephosphorylation; F:protein tyrosine/serine/threonine phosphatase activity,IPR020422 (SMART); IPR000340 (PFAM); IPR029021 (G3DSA:3.90.190.GENE3D); IPR029021 (G3DSA:3.90.190.GENE3D); PTHR10159:SF368 (PANTHER); PTHR10159:SF368 (PANTHER); IPR024950 (PANTHER); IPR024950 (PANTHER); IPR000387 (PROSITE_PROFILES); IPR020422 (PROSITE_PROFILES); IPR029021 (SUPERFAMILY); IPR029021 (SUPERFAMILY),,
RL4_JR_03186,6440,3710,3990,1,1,0,0,0,0,0,0,1,0,8,0,0,0,2,116.3561923,1,0.461181724,0.467448122,0.986594453,0.323841491,0.513299751,34.54491142,0,1.123869933,0.993991843,1.130663134,0.258196904,0.413850999,70.90510186,1,-0.342284073,0.744987879,-0.459449184,0.645911636,0.753625608,121.97372,1,0.348698933,0.518281162,0.672798779,0.501075315,0.63867258,40.23692255,1,-3.244257347,1.192230404,-2.721166427,0.0065052,0.022289391,N,-,,#NAME?,,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR11227 (PANTHER); PTHR11227 (PANTHER); PTHR11227:SF17 (PANTHER); PTHR11227:SF17 (PANTHER); PTHR11227:SF17 (PANTHER); PTHR11227 (PANTHER); IPR017986 (SUPERFAMILY),9.A.15.1.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_03187,4598,3450,4060,0,0,7,0,0,0,0,1,1,3,3,2,0,8,3,218.9629258,1,-1.820442781,0.534082155,-3.408544478,0.000653104,0.004195296,55.49478663,0,-2.328766526,1.190208838,-1.956603288,0.050394128,0.118658655,171.2945301,1,-2.161694066,0.740159399,-2.920579094,0.003493815,0.015174338,225.9532296,1,-1.662062822,0.53234956,-3.122126791,0.001795496,0.012087365,149.3089784,1,-4.128506315,1.122450998,-3.678117193,0.000234962,0.001429682,N,-,,leucine carboxyl methyltransferase,P:mycelium development; F:methyltransferase activity; P:tRNA modification; P:methylation,IPR003347 (SMART); G3DSA:2.60.120.650 (GENE3D); PF13621 (PFAM); IPR015915 (G3DSA:2.120.10.GENE3D); PF13418 (PFAM); IPR007213 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR007213 (PANTHER); PTHR13600:SF6 (PANTHER); IPR003347 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY); IPR029063 (SUPERFAMILY); IPR011043 (SUPERFAMILY),,
RL4_JR_03188,44,34,65,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,72.02650506,0,-0.535394219,0.679888583,-0.787473467,0.431004755,0.622214969,14.32613165,0,-0.375032324,1.221863938,-0.306934604,0.75889315,0.853898657,43.49155977,1,-2.058385401,1.197092677,-1.719487087,0.085525717,0.171356097,52.29726379,0,-2.491649811,1.150267558,-2.166148035,0.030299877,0.092909222,36.30565953,0,-3.095942541,1.195035183,-2.590670623,0.009578912,0.030317752,N,-,,major facilitator superfamily transporter,C:integral component of plasma membrane; F:substrate-specific transmembrane transporter activity; P:transmembrane transport,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23514 (PANTHER); PTHR23514:SF3 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.7.13, the major facilitator superfamily (mfs).
RL4_JR_03189,1762,2244,1869,1,0,53,0,0,1,0,0,7,3,19,3,0,25,0,21.44594365,1,-0.899305722,1.155411112,-0.778342629,0.436367051,0.62673552,4.317143711,1,1.355450848,1.275451424,1.062722439,0.287907842,0.447444062,19.00494469,1,-0.329803866,1.205201116,-0.273650482,0.784353235,0.857166683,120.2916408,1,2.817388861,0.505914719,5.568900752,2.56E-08,6.62E-07,18.69778102,1,0.291354731,0.996275401,0.292443968,0.769947195,0.840599024,N,-,,hypothetical protein SPBR_03806,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03190,3658,3489,3321,4,0,0,0,0,0,1,0,3,5,0,6,0,0,0,28.75687849,1,-2.948191115,1.191095415,-2.475193068,0.013316417,0.047647074,9.241143379,0,0.257482973,1.231006518,0.209164589,0.834319755,0.900662242,23.86832752,1,-2.388019839,1.196006908,-1.996660574,0.045862068,0.105857367,27.52686772,1,-2.809935115,1.194951338,-2.351505894,0.018697593,0.0743863,23.42681411,0,-2.46392135,1.193482713,-2.064480132,0.038972216,0.092130209,N,-,,hypothetical protein CMQ_4544,,no IPS match,,
RL4_JR_03191,164,172,197,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,124.0933992,0,-1.720358625,0.752348894,-2.286650036,0.022216258,0.071716248,26.6987517,0,-1.273180682,1.195555475,-1.064928151,0.286908445,0.446507884,108.3121898,0,-0.530014124,0.618578285,-0.856826269,0.391540906,0.534947386,108.0557564,0,-0.842697674,0.583702275,-1.443711478,0.148820151,0.264816174,79.58633258,0,-2.331580065,0.973447731,-2.395177462,0.016612323,0.047141191,N,-,,FAD binding domain-containing,F:FAD binding; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity,PR00420 (PRINTS); G3DSA:3.40.30.20 (GENE3D); IPR012941 (PFAM); IPR002938 (PFAM); G3DSA:3.30.310.130 (GENE3D); G3DSA:3.30.9.10 (GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR003653 (PFAM); PTHR13789:SF250 (PANTHER); PTHR13789 (PANTHER); IPR003653 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); SSF54373 (SUPERFAMILY); IPR023753 (SUPERFAMILY); SSF54001 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_03192,921,1152,1389,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,488.2597653,0,-3.076604496,0.625454565,-4.918989596,8.70E-07,1.36E-05,139.3856768,0,-3.657417228,1.232661008,-2.967090875,0.003006321,0.015613125,415.916899,0,-2.498375891,0.620487988,-4.026469393,5.66E-05,0.000798366,417.3968698,1,-5.773906177,1.18262323,-4.88228713,1.05E-06,1.92E-05,422.6040583,0,-1.940545306,0.563887686,-3.441368473,0.00057878,0.003060128,N,-,,regulator of g- signaling,P:biological_process; C:cellular_component,IPR016137 (SMART); IPR016137 (PFAM); PTHR10845 (PANTHER); PTHR10845:SF168 (PANTHER); PTHR10845:SF168 (PANTHER); PTHR10845 (PANTHER); IPR016137 (PROSITE_PROFILES); IPR016137 (SUPERFAMILY),,
RL4_JR_03193,32763,29970,45725,5,6,32,0,0,0,5,1,0,0,14,0,0,8,2,604.9890466,1,-2.339005901,0.532924296,-4.389002186,1.14E-05,0.000130107,189.2468502,0,-1.725860336,0.933295077,-1.849211871,0.064427225,0.14392681,597.354753,1,-1.084704285,0.550836201,-1.969195711,0.048930621,0.111319912,519.184829,1,-3.143192429,0.651847363,-4.821976136,1.42E-06,2.53E-05,470.9423214,1,-2.313058633,0.93783489,-2.466381512,0.013648588,0.040289198,N,-,,hypothetical protein CMQ_4328,,no IPS match,,
RL4_JR_03194,424,267,433,2,1,0,0,0,0,0,2,0,0,0,0,0,0,0,14.87892256,1,-0.62461064,1.183960161,-0.527560522,0.5978044,0.767409645,3.502619094,0,1.657076335,1.29880741,1.275844534,0.202010481,0.346391681,9.118015034,1,-0.999689007,1.222825859,-0.817523607,0.413629264,0.555747635,14.53346432,0,-0.477372389,1.175684014,-0.406038003,0.684714677,0.786113631,9.00682262,0,-1.08471565,1.23007247,-0.881830686,0.377868375,0.513614887,N,-,,glycerol-3-phosphate dehydrogenase,P:glycerol-3-phosphate metabolic process; C:glycerol-3-phosphate dehydrogenase complex; C:integral component of membrane; F:sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity; P:oxidation-reduction process,IPR000447 (PRINTS); IPR031656 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR006076 (PFAM); PTHR11985 (PANTHER); PTHR11985 (PANTHER); PTHR11985:SF15 (PANTHER); PTHR11985:SF15 (PANTHER); SSF54373 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_03195,3971,2095,2561,1,1,3,0,0,0,0,0,2,0,0,0,0,0,2,119.5292254,1,0.08405267,0.525718512,0.159881511,0.872974414,0.939046053,18.53290484,0,-0.746545852,1.208552605,-0.617718955,0.536760615,0.68390183,61.25807932,1,-1.586640032,1.044101803,-1.519621964,0.128606015,0.234097009,89.06666184,0,-0.326393999,0.608705638,-0.536209915,0.591813481,0.715460349,47.79573928,1,-3.492593262,1.207529874,-2.892345223,0.003823775,0.014397815,N,-,,transcription initiation factor TFIIH subunit 1,"F:translation initiation factor activity; F:ATP binding; P:transcription, DNA-templated; F:phosphatidylinositol phosphate binding; C:core TFIIH complex; P:nucleotide-excision repair; P:translational initiation",IPR001680 (SMART); IPR005607 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR013876 (PFAM); IPR005607 (PFAM); IPR027079 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR005607 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR005607 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR017986 (SUPERFAMILY),1.I.1.1.1, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_03196,5172,3371,7749,0,2,5,0,0,0,0,0,0,0,11,0,0,4,0,167.1691314,1,-0.756345633,0.48678636,-1.553752726,0.120243411,0.252755925,35.94120009,0,-1.702062845,1.196984605,-1.421958844,0.155038199,0.283624914,112.7852499,0,-1.952977678,0.856131629,-2.281165198,0.022538673,0.061174672,125.2774785,1,-2.46488666,0.856156239,-2.879015007,0.003989194,0.023428413,99.43906829,1,-3.503144836,1.127214021,-3.107790331,0.001884917,0.008056053,N,-,,mitochondrial AAA ATPase,F:nucleotide binding,IPR003593 (SMART); G3DSA:1.10.8.60 (GENE3D); IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23074:SF88 (PANTHER); PTHR23074 (PANTHER); PTHR23074 (PANTHER); PTHR23074:SF88 (PANTHER); IPR027417 (SUPERFAMILY),1.R.1.1.1, the membrane contact site (mcs) family.
RL4_JR_03197,526,607,689,0,1,0,0,0,0,0,0,5,0,1,0,0,1,0,142.7080356,1,-0.795012575,0.506881655,-1.56843825,0.11677889,0.247707277,30.69661647,0,-1.474472555,1.199777087,-1.228955421,0.21908852,0.366729619,98.90751165,1,-1.719186926,0.851442233,-2.019146877,0.043471956,0.101595125,132.5338096,1,-1.226014,0.612300705,-2.002307019,0.045251722,0.115278131,107.8832358,1,-1.247900987,0.666080735,-1.873498092,0.060999636,0.130354857,N,-,,C2H2 finger domain-containing,P:cellular response to DNA damage stimulus,IPR015880 (SMART); IPR007087 (PROSITE_PROFILES),,
RL4_JR_03198,1002,1115,1187,4,0,3,0,0,0,0,1,0,0,5,1,0,0,2,162.0623636,1,-1.317997701,0.736716796,-1.78901541,0.073612334,0.177147321,40.1742878,0,-1.8626741,1.260138777,-1.478149974,0.139367641,0.260995237,116.0740644,1,-2.69358931,1.096872381,-2.455699822,0.014061056,0.04220401,118.8172299,1,-4.919780193,1.251591121,-3.930820625,8.47E-05,0.000925309,120.484048,1,-2.876699544,1.039636023,-2.767025652,0.00565703,0.019819181,N,-,,hmg-i hmg- DNA-binding,P:DNA metabolic process; P:cellular response to DNA damage stimulus,IPR019021 (PFAM); PTHR28122:SF1 (PANTHER); PTHR28122 (PANTHER),,
RL4_JR_03199,5686,4015,17660,0,0,2,0,0,0,1,0,0,0,2,3,0,1,0,838.3592878,1,0.100536113,0.252877658,0.397568192,0.690948511,0.832103414,223.1935093,0,-0.14386211,0.589469177,-0.24405366,0.807189261,0.883358844,801.957875,1,0.537931048,0.318792651,1.687401028,0.091526266,0.181333057,812.9304266,1,0.227770802,0.338373917,0.673133449,0.500862395,0.63867258,588.8349265,1,-0.21194672,0.705596985,-0.300379288,0.763887861,0.835131583,N,-, Effector probability:0.557,cytochrome c oxidase polypeptide v,"F:cytochrome-c oxidase activity; C:integral component of membrane; P:mitochondrial electron transport, cytochrome c to oxygen; P:hydrogen ion transmembrane transport; C:mitochondrial respiratory chain complex IV",IPR004203 (G3DSA:1.10.442.GENE3D); IPR004203 (PFAM); IPR004203 (PANTHER); PS51257 (PROSITE_PROFILES); IPR004203 (SUPERFAMILY),3.D.4.8.1, the proton-translocating cytochrome oxidase (cox) superfamily.
RL4_JR_03200,1450,1341,1122,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,78.64350388,0,1.717192847,0.562962296,3.050280383,0.002286278,0.011642608,5.539524356,0,0.995820329,1.279020454,0.778580456,0.436226895,0.597818662,42.89451002,1,0.775498522,0.876622984,0.884643154,0.376349124,0.520158161,93.66106942,0,2.145407276,0.523621621,4.097247306,4.18E-05,0.000500376,44.10789835,0,1.4796343,0.653018621,2.265837839,0.023461314,0.061796514,N,-,,ATP-dependent Clp protease ATP-binding subunit,F:ATP binding; C:mitochondrial matrix; P:protein catabolic process; P:proteolysis; F:ATP-dependent peptidase activity; P:protein refolding,IPR019489 (SMART); IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR019489 (PFAM); IPR003959 (PFAM); G3DSA:1.10.8.60 (GENE3D); PTHR11262:SF4 (PANTHER); PTHR11262 (PANTHER); PTHR11262 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_03201,618,631,412,0,0,4,0,0,0,0,0,2,0,0,1,0,0,0,2867.851903,1,0.667477643,0.331483679,2.013606352,0.044050879,0.120999014,463.0149976,0,-1.137145453,0.531485043,-2.139562474,0.032390142,0.083947753,1613.818176,1,-0.391724837,0.336573032,-1.163862816,0.244479611,0.378631112,2056.225643,1,-0.071758803,0.336813153,-0.213052259,0.831286201,0.894259752,1463.663425,0,-0.69150404,0.638783855,-1.082532119,0.279016151,0.412715636,N,-,,glycoside hydrolase family 13,"F:ATP binding; P:glycogen biosynthetic process; F:1,4-alpha-glucan branching enzyme activity; P:ATP hydrolysis coupled proton transport; F:cation binding; F:ADP binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; C:mitochondrial proton-transporting ATP synthase, catalytic core; P:mitochondrial ATP synthesis coupled proton transport; F:proton-transporting ATP synthase activity, rotational mechanism",IPR003593 (SMART); IPR006047 (SMART); IPR005722 (TIGRFAM); IPR006047 (PFAM); IPR024034 (G3DSA:1.10.1140.GENE3D); IPR004100 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); IPR013780 (G3DSA:2.60.40.GENE3D); G3DSA:2.40.10.170 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000194 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR006048 (PFAM); IPR004193 (PFAM); PTHR10357:SF159 (PANTHER); IPR015902 (PANTHER); IPR005722 (HAMAP); IPR014756 (SUPERFAMILY); IPR000793 (SUPERFAMILY); IPR017853 (SUPERFAMILY); IPR004100 (SUPERFAMILY); IPR027417 (SUPERFAMILY); SSF51011 (SUPERFAMILY),3.A.2.1.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_03202,1888,2424,2589,0,0,7,0,0,0,0,1,6,0,3,3,0,0,1,20.09310914,1,2.332844685,0.759756346,3.070516879,0.002136886,0.011047349,1.540874267,0,2.841737364,1.349662466,2.105517072,0.035246323,0.089684082,3.996304999,1,0.19009709,1.21107577,0.156965481,0.875272053,0.921511467,4.609861873,1,-0.232127245,1.211854144,-0.191547181,0.84809692,0.904871719,3.942120676,1,0.107135759,1.212028518,0.088393761,0.92956372,0.954063118,N,-,,c6 zinc finger domain,"C:nucleus; F:zinc ion binding; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31263:SF4 (PANTHER); PTHR31263 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_03203,1062,934,1324,1,1,2,0,0,0,1,4,0,0,2,0,0,5,1,6.092578473,1,-0.709498645,1.269152795,-0.559033276,0.57613901,0.751061369,1.918756893,0,2.525188238,1.368100444,1.845762311,0.064926725,0.144787026,12.87097106,1,0.820507703,1.233559447,0.665154569,0.505951635,0.637894541,17.83841969,1,1.695165682,0.937375732,1.808416437,0.070541712,0.151803365,5.013189498,1,-0.239469658,1.260938125,-0.189913885,0.849376612,0.899830161,N,-,,origin recognition complex subunit 5,C:nuclear pre-replicative complex; F:DNA replication origin binding; F:ATP binding; P:DNA replication initiation; P:regulation of chromatin silencing at telomere; C:DNA replication preinitiation complex; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; C:nuclear origin of replication recognition complex; P:chromatin silencing at silent mating-type cassette,IPR020796 (PFAM); PF13191 (PFAM); IPR020796 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_03204,3077,4207,2994,0,0,12,0,0,0,0,0,0,0,0,0,0,0,4,148.6429432,1,-0.77548738,0.536830696,-1.444566015,0.148579824,0.29484656,32.44129162,0,-1.554274729,1.198634058,-1.296704961,0.194732722,0.337456704,84.44235228,0,-4.210930608,1.196697847,-3.518791832,0.000433517,0.003050469,140.1252619,0,-0.926148869,0.562626275,-1.646117343,0.099739602,0.19548267,124.2632862,1,-1.04912819,0.656151157,-1.598912354,0.109840079,0.204812301,N,-,,splicing factor 3B subunit 2,C:nucleus,IPR006568 (SMART); IPR006568 (PFAM); IPR007180 (PFAM); PTHR12785:SF6 (PANTHER); PTHR12785 (PANTHER),,
RL4_JR_03205,177,132,136,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,132.6088162,0,-1.466750746,0.658819967,-2.226330136,0.025992076,0.081141243,27.61516502,0,-1.321867946,1.195257664,-1.105927187,0.268758036,0.425989484,87.26849175,0,-2.148406819,1.027485383,-2.090936625,0.036533745,0.088953256,133.792194,0,-1.063780646,0.60557103,-1.756657096,0.078976275,0.164943807,99.98680968,0,-1.409741778,0.741617288,-1.900901989,0.057314852,0.124078014,N,-,,triose-phosphate transporter,F:phosphoenolpyruvate transmembrane transporter activity; P:phosphoenolpyruvate transmembrane import into Golgi lumen; C:integral component of membrane; C:Golgi apparatus,IPR004853 (PFAM); PTHR11132 (PANTHER); PTHR11132:SF119 (PANTHER),2.A.7.9.18, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_03206,235,484,356,0,2,0,0,0,0,0,0,0,0,1,0,0,0,0,81.73549268,1,-1.686361325,0.851246476,-1.981049406,0.047585733,0.128204892,19.19583175,0,-0.797190671,1.209351788,-0.659188401,0.509774794,0.661276492,69.15260776,0,-1.043806662,0.858070693,-1.216457653,0.223810633,0.354040445,74.9307367,1,-1.555105174,0.857703639,-1.813103156,0.069815913,0.150497363,71.28396737,0,-0.896384821,0.748150972,-1.198133606,0.230865008,0.35845855,N,-,,F-box At-B,P:biological_process; C:cellular_component; F:molecular_function,IPR032675 (G3DSA:3.80.10.GENE3D); PTHR24006:SF439 (PANTHER); PTHR24006 (PANTHER); PTHR24006:SF439 (PANTHER); PTHR24006 (PANTHER); SSF52047 (SUPERFAMILY),,
RL4_JR_03207,351,445,310,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,57.02538763,0,-2.888519419,1.146570845,-2.519268158,0.011759906,0.043117892,103.1188942,0,1.595765834,0.857340938,1.861296671,0.062702293,0.141038358,50.59865764,0,-2.311884257,1.19403952,-1.936187385,0.052844755,0.118049492,76.22144172,1,-0.658327569,0.680819281,-0.966963756,0.333562153,0.480209981,43.26673329,0,-3.348976137,1.190098124,-2.814033624,0.004892411,0.017584545,N,-,,zinc finger domain-containing,F:zinc ion binding; F:metal ion binding,IPR019135 (PFAM),,
RL4_JR_03208,1112,1000,871,0,1,1,0,0,0,0,0,0,2,0,0,0,8,0,38.26022228,1,-3.360121927,1.208669519,-2.780017097,0.005435604,0.023265296,12.35474175,0,-0.161440469,1.243621042,-0.129814842,0.89671292,0.942408473,44.8126886,0,-0.988170054,1.055599534,-0.936122102,0.349210325,0.492808103,36.68449282,1,-3.224268939,1.211027437,-2.662424352,0.007758001,0.039631562,31.13621687,1,-2.874343566,1.207051262,-2.3812937,0.017251951,0.048548083,N,-,,hypothetical protein CMQ_4318,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_03209,475,344,413,0,2,16,0,0,0,1,3,0,2,1,0,0,3,0,26.58095488,1,-1.365531631,1.160926694,-1.176242771,0.239497878,0.41410549,5.892070402,0,0.906665481,1.247112288,0.727011906,0.467218662,0.626050741,15.35892613,1,-1.752133249,1.206701932,-1.452001694,0.146501134,0.257496091,21.73433626,1,-1.228714541,1.159535761,-1.059660756,0.289298962,0.434012742,15.22800029,1,-1.842431725,1.217441252,-1.513363969,0.130187232,0.2324772,N,-,,hypothetical protein CMQ_4503,,no IPS match,,
RL4_JR_03210,1267,1475,1460,0,1,2,0,0,0,0,0,1,0,4,1,0,2,0,237.7350325,1,-1.720668045,0.601228521,-2.861920193,0.004210829,0.018843634,54.4939366,0,-2.302524214,1.195430311,-1.926104929,0.054091273,0.125633747,220.8205522,1,-0.952655962,0.531752557,-1.791539974,0.073206686,0.152248251,173.0464334,1,-4.431848673,1.151401236,-3.849091468,0.000118557,0.001234966,140.3947309,1,-5.047124048,1.207288108,-4.18054648,2.91E-05,0.000246603,N,-,,-like helicase 2,"P:DNA repair; C:ASTRA complex; P:transcription, DNA-templated; C:Swr1 complex; P:histone exchange; P:rRNA processing; P:regulation of transcription from RNA polymerase II promoter; F:ATP binding; C:R2TP complex; F:ATP-dependent 5'-3' DNA helicase activity; P:box C/D snoRNP assembly; F:ATP-dependent 3'-5' DNA helicase activity; P:DNA duplex unwinding; C:cytosol; C:Ino80 complex",IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.8.60 (GENE3D); IPR010339 (PFAM); PTHR11093:SF2 (PANTHER); IPR027238 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_03211,3774,3049,2979,2,1,3,0,0,0,0,1,0,0,1,0,0,0,0,46.57698287,1,-3.64394161,1.188801629,-3.065222591,0.002175081,0.011216376,14.88549691,0,-0.430328943,1.207900354,-0.356261956,0.721644397,0.825815876,45.10441374,1,-2.120000854,1.191375397,-1.779456634,0.075164929,0.155268259,44.53366448,1,-3.50404938,1.190994452,-2.942120658,0.003259729,0.01991838,49.29571531,0,-1.487005346,0.975058132,-1.525042761,0.127248432,0.228681288,N,-,,lin1 family,F:molecular_function,IPR003169 (G3DSA:3.30.1490.GENE3D); IPR003169 (PFAM); PTHR13138:SF3 (PANTHER); PTHR13138:SF3 (PANTHER); PTHR13138:SF3 (PANTHER); PTHR13138 (PANTHER); PTHR13138 (PANTHER); PTHR13138 (PANTHER); IPR003169 (PROSITE_PROFILES); IPR003169 (SUPERFAMILY),,
RL4_JR_03212,1246,1243,1799,0,0,2,0,0,0,0,0,0,1,2,0,0,0,0,59.82266791,1,0.024059636,0.67129907,0.035840413,0.971409609,0.984931592,9.682171387,0,0.190171969,1.22073893,0.155784308,0.87620304,0.928925357,32.95435076,0,-1.499551581,1.193248391,-1.256696922,0.208863403,0.336173782,38.27942763,1,-1.933748929,1.145546324,-1.688058256,0.091400047,0.182962727,24.76589576,0,-2.544090825,1.197821785,-2.123931003,0.033675914,0.082339682,N,-,,ubiquitin fusion degradation 1,"P:positive regulation of protein localization to nucleus; C:Hrd1p ubiquitin ligase ERAD-L complex; P:cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process; C:Doa10p ubiquitin ligase complex; F:polyubiquitin binding; C:VCP-NPL4-UFD1 AAA ATPase complex; C:nucleus; C:RQC complex; P:nonfunctional rRNA decay; P:ribosome-associated ubiquitin-dependent protein catabolic process; C:cytosol; P:retrograde protein transport, ER to cytosol; P:ER-associated misfolded protein catabolic process",IPR004854 (PFAM); IPR004854 (PANTHER),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_03213,5673,5347,7416,0,0,6,0,0,3,5,3,2,0,3,5,0,1,1,1.401310573,1,1.410741693,1.420387045,0.99320935,0.320607943,NA,0.453679598,1,4.605881846,1.630873069,2.824181681,0.004740151,0.019950023,1.167201004,1,1.965945402,1.271644219,1.545986978,0.122107713,0.224791819,1.345703777,1,1.544434035,1.312553847,1.176663372,0.239329893,0.377387964,1.141993252,1,1.894090044,1.248760798,1.516775709,0.129323322,0.2314652,N,-, Effector probability:0.605,hypothetical protein CMQ_4606,,no IPS match,,
RL4_JR_03214,13935,11094,10334,4,2,7,0,0,0,0,2,0,7,3,0,0,0,0,2.334454379,1,0.674514435,1.240058018,0.543937804,0.586484273,0.758848327,0.746432569,0,3.887444957,1.452253706,2.67683597,0.007432101,0.027132749,1.934319948,1,1.237076552,1.212149413,1.020564412,0.307460858,0.448713629,20.8558146,1,2.555863967,1.012418644,2.52451294,0.011585874,0.054460062,1.905055628,0,1.156309708,1.203986256,0.960401086,0.336853392,0.473831702,N,-,,hypothetical protein CMQ_4863,,no IPS match,,
RL4_JR_03215,1203,1070,1964,0,0,6,0,0,0,0,0,0,0,6,0,0,0,0,32.04874266,1,0.518388922,0.78395914,0.661244822,0.508455321,0.694920172,5.313781863,0,1.055704139,1.249041334,0.845211532,0.397992745,0.562166141,13.85759474,0,-1.60371572,1.205824271,-1.329974656,0.183526622,0.304973664,15.99130631,1,-2.026488282,1.205750325,-1.680686491,0.092823826,0.185234273,13.73815081,0,-1.693870148,1.216334213,-1.392602568,0.163740006,0.276540644,N,-,,hypothetical protein CI238_07614,,no IPS match,,
RL4_JR_03216,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.477361664,0,2.964544953,2.009325418,1.475393148,0.140106877,NA,0.152888329,0,6.175082228,1.922754808,3.211580697,0.001320069,0.015023052,0.395453336,0,3.527890418,1.281032494,2.753942959,0.005888203,0.021443225,0.4561289,0,3.105481208,1.42827503,2.174287965,0.029683516,0.091712247,0.388440803,0,3.450529882,1.228828868,2.807982439,0.004985295,0.017880307,N,-,,T51016related to CYC8,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03217,7229,5644,4745,0,1,1,0,0,0,0,1,0,5,8,0,0,2,0,0.100277707,1,5.21553814,3.917393774,1.331379596,0.18306414,NA,0.031241857,0,8.465019033,2.732747903,3.097621637,0.001950803,0.015023052,0.08229328,1,5.790904519,1.63608694,3.539484594,0.000400909,0.002884722,0.095029069,1,5.3679932,2.503057148,2.144574767,0.031986862,0.095572329,0.082329771,1,5.691922653,1.397717826,4.072297389,4.66E-05,0.000365944,N,-,,IBR finger domain-containing,F:ubiquitin-protein transferase activity; F:zinc ion binding; F:metal ion binding; C:membrane; C:integral component of membrane; P:protein ubiquitination,IPR013083 (G3DSA:3.30.40.GENE3D); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),,
RL4_JR_03218,5836,4207,4917,0,1,2,0,0,0,0,0,1,3,3,2,0,7,0,0.528816598,1,2.816838199,1.919561694,1.467438222,0.142256883,NA,0.168245006,0,6.036834981,1.881143501,3.209130499,0.00133137,0.015023052,0.437207274,1,3.382485534,1.274149189,2.654701321,0.007937866,0.027204791,0.504431114,1,2.960044366,1.401614603,2.111881797,0.034696589,0.099426657,0.431617004,1,3.298981482,1.23218384,2.677345193,0.007420814,0.024723836,N,-,,hypothetical protein CMQ_4790,,no IPS match,,
RL4_JR_03219,5122,5570,4532,0,1,8,0,0,0,0,4,5,4,9,2,0,3,1,1.281405512,1,1.539689965,1.435529974,1.072558562,0.283469225,NA,0.410326005,0,4.750596712,1.634912294,2.90571961,0.003664096,0.017234192,7.562854898,1,3.060136884,1.223739761,2.500643504,0.01239679,0.03820551,1.227435308,1,1.676813917,1.309111868,1.280879013,0.200236166,0.331056691,1.050457136,1,2.014833038,1.250035675,1.611820429,0.107001021,0.200924581,N,-,,heat shock mitochondrial precursor,F:DNA binding; F:protein binding; C:mitochondrial matrix; P:cellular component organization; P:protein folding; C:mitochondrial envelope,no IPS match,,
RL4_JR_03220,7856,7500,6382,5,3,6,0,0,0,3,0,5,2,5,0,0,6,1,11.00744354,1,-1.562870098,1.207068142,-1.294765426,0.195401162,0.357260425,3.544500929,0,1.639969244,1.292202786,1.269126844,0.204395827,0.349185364,15.64787072,1,-0.042878742,1.207223677,-0.035518474,0.971666316,0.983518274,19.86296451,1,-0.474994821,1.159690749,-0.409587489,0.682108576,0.783921605,12.8405046,1,-0.151644171,1.139103169,-0.133125932,0.894093787,0.930964582,N,-,,fungal specific transcription factor,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter; F:hydrolase activity",IPR001138 (SMART); IPR007219 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31313:SF43 (PANTHER); PTHR31313 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_03221,1412,1241,1881,0,0,1,0,0,0,2,0,0,3,1,1,0,2,2,7.899903275,1,-1.084383519,1.20107593,-0.902843436,0.366608995,0.558513285,2.534524128,0,2.123814992,1.302521534,1.630541175,0.10298717,0.207161395,6.55772562,1,-0.524294746,1.205492266,-0.434921701,0.663619263,0.768043172,7.563466149,1,-0.94632833,1.204304846,-0.785788028,0.431991682,0.574306168,6.452008843,1,-0.603652732,1.205266433,-0.500845884,0.616479591,0.723274143,N,-,,short chain dehydrogenase,C:intracellular organelle; P:cellular process,IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24320:SF67 (PANTHER); PTHR24320 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_03222,152,174,169,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2889.244888,0,-2.569416989,0.349149891,-7.359065696,1.85E-13,9.94E-12,1018.281006,0,-1.569810534,0.528893211,-2.968104906,0.00299642,0.01558642,2167.297123,0,-3.862635012,0.648653028,-5.954855436,2.60E-09,1.28E-07,2407.270329,0,-5.625790885,0.647879684,-8.683388327,3.84E-18,3.02E-16,2112.92889,0,-4.075243375,1.293301212,-3.151039633,0.001626904,0.00713709,N,-,,heat shock 60,F:ATPase activity; F:unfolded protein binding; P:protein refolding; P:'de novo' protein folding; C:mitochondrial nucleoid; F:single-stranded DNA binding; P:protein import into mitochondrial intermembrane space; F:DNA replication origin binding; F:ATP binding; C:mitochondrial intermembrane space; C:mitochondrial membrane; F:actin binding; F:chaperone binding; P:chaperone-mediated protein complex assembly; P:protein maturation; P:protein stabilization,IPR001844 (PRINTS); IPR002423 (PFAM); IPR001844 (TIGRFAM); IPR027409 (G3DSA:3.50.7.GENE3D); IPR027413 (G3DSA:1.10.560.GENE3D); IPR027413 (G3DSA:1.10.560.GENE3D); PTHR11353 (PANTHER); IPR027409 (SUPERFAMILY); SSF48592 (SUPERFAMILY); SSF54849 (SUPERFAMILY),,
RL4_JR_03223,1037,1276,1630,0,0,10,0,0,0,0,0,3,2,3,10,1,5,7,462.2142244,1,0.000372657,0.606740711,0.000614195,0.999509943,0.999877636,85.27993912,0,-1.862972312,1.108642901,-1.680407921,0.092877976,0.19136263,366.6340679,1,-0.279305705,0.40891944,-0.68303357,0.49458563,0.62770276,391.5263752,1,-0.574563258,0.372334632,-1.543136761,0.122797597,0.228175018,329.0056412,1,-0.412008349,0.555687587,-0.741438821,0.458427414,0.590156079,N,-,,cofilin,F:actin filament binding; P:cell division; P:actin filament severing; P:actin filament depolymerization; C:nuclear matrix; P:Golgi to plasma membrane protein transport; P:endocytosis; C:actin cortical patch; P:cell cycle,IPR017904 (PRINTS); IPR002108 (SMART); IPR002108 (PFAM); IPR029006 (G3DSA:3.40.20.GENE3D); IPR017904 (PANTHER); PTHR11913:SF12 (PANTHER); IPR002108 (PROSITE_PROFILES); SSF55753 (SUPERFAMILY),,
RL4_JR_03224,2192,1732,2716,2,2,5,0,3,0,2,0,2,0,6,0,0,2,0,31.27775189,1,1.331602301,0.658385612,2.022526429,0.043121996,0.119250591,3.900507133,1,1.501890718,1.256258516,1.195526795,0.231881274,0.38201534,21.16716256,1,-0.185038907,1.188571022,-0.155681826,0.876283823,0.922480756,19.66991024,1,0.159344502,1.011371143,0.157552945,0.874809085,0.922643664,9.930829918,1,-1.225724522,1.189637673,-1.03033432,0.302853094,0.438243186,N,-,,ubiquitin supergroup,,PF17183 (PFAM); PF12754 (PFAM); G3DSA:3.10.20.90 (GENE3D); PTHR12650 (PANTHER); PTHR12650:SF20 (PANTHER); IPR029071 (SUPERFAMILY),,
RL4_JR_03225,26701,26894,39298,8,14,59,0,0,0,0,2,0,2,28,0,0,12,0,22.73555094,1,0.674536428,0.908175989,0.742737571,0.457640579,0.646034234,3.582531399,0,1.624558661,1.292204415,1.257199435,0.208681428,0.353995266,15.80513085,1,-0.067343994,1.213398591,-0.055500307,0.955739885,0.97422732,20.0502053,1,-0.499325451,1.167437483,-0.427710656,0.668861791,0.774411164,23.90257097,1,0.5909484,1.000124325,0.59087494,0.554604218,0.674356636,N,-, Effector probability:0.722,maintenance of ploidy mob1,C:nucleus; C:medial cortex; P:positive regulation of septation initiation signaling; C:cellular bud neck; F:protein kinase activator activity; C:cytosol; C:Sid2-Mob1 complex; P:activation of protein kinase activity; P:protein phosphorylation; C:mitotic spindle pole body; F:kinase activity; P:cellular protein localization,IPR005301 (SMART); IPR005301 (G3DSA:1.20.140.GENE3D); IPR005301 (PFAM); IPR005301 (PANTHER); IPR005301 (SUPERFAMILY),,
RL4_JR_03226,3404,4248,6563,0,0,0,0,0,3,3,0,1,0,5,1,0,0,0,499.5466255,0,0.650709767,0.373605256,1.741703994,0.081560253,0.191142932,120.2701977,1,0.618122206,0.646680324,0.955838895,0.339153635,0.502034672,296.9204175,1,-0.237799847,0.448199461,-0.530567008,0.595718863,0.714979264,425.8218621,1,0.402559296,0.382706575,1.051874523,0.292857122,0.437600113,298.2047611,0,-0.017164388,0.542506994,-0.031639018,0.974759927,0.983288779,N,-,,atp synthase subunit 5,"C:mitochondrial proton-transporting ATP synthase, stator stalk; F:proton-transporting ATPase activity, rotational mechanism; P:ATP synthesis coupled proton transport; F:proton-transporting ATP synthase activity, rotational mechanism",IPR000711 (PRINTS); IPR000711 (TIGRFAM); IPR000711 (PFAM); IPR026015 (G3DSA:1.10.520.GENE3D); IPR000711 (PANTHER); PTHR11910:SF1 (PANTHER); IPR026015 (SUPERFAMILY),3.A.2.1.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_03227,531,673,825,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,124.325815,0,1.274651981,0.55667208,2.289771712,0.022034554,0.071254313,10.42412868,1,0.083702649,1.244202565,0.067274133,0.946363469,0.971313226,33.47278811,0,-1.602656023,1.209657654,-1.324883961,0.185209641,0.306733586,64.49777512,1,0.4978453,0.635978025,0.782802676,0.433742996,0.57585057,52.78528675,0,0.298520707,0.707550316,0.42190739,0.673092616,0.767448576,N,-,,glycoside hydrolase family 63,C:endoplasmic reticulum membrane; P:protein N-linked glycosylation; F:mannosyl-oligosaccharide glucosidase activity; P:oligosaccharide metabolic process,IPR031335 (PFAM); PTHR10412:SF10 (PANTHER); IPR004888 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_03228,6,8,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,55.4954646,0,-0.279363262,0.703872818,-0.396894516,0.691445248,0.832196708,11.55752255,0,-0.065297555,1.215548945,-0.053718574,0.957159385,0.977477612,79.58050911,0,0.686699055,0.627613281,1.094143601,0.273892003,0.41256343,88.67447098,0,0.590227508,0.558118896,1.057530056,0.290269745,0.435146753,82.07755959,0,0.990151452,0.554591005,1.785372362,0.074200939,0.15152975,N,-,,phosphatase 2c,F:protein serine/threonine phosphatase activity; P:hyphal growth; C:mitochondrial intermembrane space; P:positive regulation of catalytic activity; P:protein dephosphorylation; F:mannosyl-oligosaccharide glucosidase activity; P:oligosaccharide metabolic process; P:pathogenesis,IPR001932 (SMART); IPR001932 (PFAM); IPR001932 (G3DSA:3.60.40.GENE3D); IPR015655 (PANTHER); PTHR13832:SF10 (PANTHER); IPR001932 (PROSITE_PROFILES); IPR001932 (SUPERFAMILY),,
RL4_JR_03229,1826,2013,1816,0,0,7,0,0,0,0,0,1,2,1,0,0,0,0,43.38545122,1,1.886119383,0.576254067,3.273069102,0.001063865,0.006225974,26.39440921,0,2.359809132,1.114151551,2.118032443,0.03417232,0.087634209,47.09095479,1,1.610543996,0.744019474,2.164653013,0.030414268,0.077595422,25.88759244,1,0.093683632,1.017491635,0.092073123,0.926639943,0.956882144,22.05335038,0,0.895959817,0.857256033,1.045148454,0.295954363,0.430846574,N,-,,hypothetical protein SPBR_03784,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_03230,2200,1960,2555,0,2,6,0,0,4,0,1,3,0,2,3,0,7,0,466.4929043,1,-0.775295753,0.325145961,-2.384454507,0.017104463,0.057883397,103.8403329,1,-2.178788741,1.111613292,-1.96002401,0.049992984,0.117845595,369.6082069,1,-0.849642992,0.424572037,-2.00117511,0.045373522,0.105095675,442.8316458,1,-0.662078546,0.337326876,-1.962721006,0.049678601,0.122413199,346.7319691,1,-0.802427222,0.517746203,-1.549846658,0.121178325,0.221028741,N,-,,NADH dehydrogenase,F:electron carrier activity; C:membrane; F:NADH dehydrogenase (ubiquinone) activity; P:ATP synthesis coupled electron transport; F:iron-sulfur cluster binding,IPR019574 (SMART); PF13510 (PFAM); IPR006656 (PFAM); IPR012675 (G3DSA:3.10.20.GENE3D); G3DSA:3.40.50.740 (GENE3D); IPR010228 (TIGRFAM); IPR019574 (PFAM); IPR015405 (PFAM); PTHR11615:SF115 (PANTHER); PTHR11615 (PANTHER); PTHR11615:SF115 (PANTHER); IPR001041 (PROSITE_PROFILES); IPR006963 (PROSITE_PROFILES); SSF53706 (SUPERFAMILY); SSF54862 (SUPERFAMILY); IPR001041 (SUPERFAMILY),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_03231,931,1048,921,0,0,1,0,0,0,0,0,5,0,2,2,0,4,0,0.890363851,1,2.065025179,2.021154852,1.021705574,0.306920272,NA,0.295721487,0,5.22340378,2.029012463,2.574357662,0.01004264,0.03365947,0.750017954,1,2.603996929,1.516411277,1.717210211,0.085940771,0.172153613,0.863813204,1,2.183997334,1.672941701,1.305483229,0.191728354,0.320761663,0.724457211,1,2.550625959,1.474665288,1.729630431,0.083696325,0.167019839,N,-, Effector probability:0.641,NADH-ubiquinone oxidoreductase 78 kDa mitochondrial precursor,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_03232,162,107,77,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35.5880418,0,1.463125441,0.701681845,2.085169299,0.037053936,0.10658886,4.044482701,0,1.44950336,1.287231251,1.126062904,0.260138895,0.41628153,58.69253947,0,2.401058389,0.624576865,3.844296075,0.000120899,0.001300724,21.44049833,0,-0.674951659,1.1697155,-0.57702207,0.563924547,0.691502487,18.12237539,0,0.361005005,1.020248973,0.353840106,0.723458715,0.805281459,N,-,,Acyl binding,F:fatty-acyl-CoA binding; C:integral component of membrane,IPR014352 (G3DSA:1.20.80.GENE3D); IPR000582 (PFAM); PTHR23310 (PANTHER); IPR000582 (PROSITE_PROFILES); IPR000582 (SUPERFAMILY),1.R.1.1.1, the membrane contact site (mcs) family.
RL4_JR_03233,50,39,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,56.91577437,0,-1.391678624,1.017528316,-1.367705058,0.171404416,0.325114445,14.25500675,0,-0.367939046,1.281917911,-0.287022315,0.774095234,0.863137457,37.49433305,0,-3.03965353,1.257244601,-2.417710546,0.015618495,0.045938887,96.26194148,0,0.387505113,0.690864815,0.560898608,0.574866659,0.701521625,37.55225996,0,-3.144608086,1.27857023,-2.459472317,0.013914143,0.040941789,N,-,,rnase3 domain-containing,C:nucleus; F:RNA binding; P:RNA phosphodiester bond hydrolysis; P:posttranscriptional gene silencing by RNA; P:snRNA 3'-end processing; P:production of small RNA involved in gene silencing by RNA; P:negative regulation of cellular process,IPR000999 (SMART); IPR000999 (PFAM); IPR000999 (G3DSA:1.10.1520.GENE3D); IPR014720 (G3DSA:3.30.160.GENE3D); PTHR11207 (PANTHER); IPR000999 (PROSITE_PROFILES); IPR014720 (PROSITE_PROFILES); IPR000999 (SUPERFAMILY); SSF54768 (SUPERFAMILY),,
RL4_JR_03234,1429,1126,811,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,50.22469237,1,-3.752629448,1.200941444,-3.124739733,0.001779624,0.009501424,16.14931763,0,-0.547842272,1.224626321,-0.447354644,0.654619019,0.777523317,41.65719719,0,-3.191469637,1.200875917,-2.657618153,0.0078695,0.027013862,48.04078087,0,-3.613335055,1.201541234,-3.007250149,0.002636227,0.016703255,40.79830893,0,-3.264232743,1.196626701,-2.727862198,0.006374623,0.02191353,N,-,,pumilio-family RNA binding repeat,F:RNA binding,IPR001313 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR001313 (PFAM); PTHR12537 (PANTHER); PTHR12537:SF48 (PANTHER); IPR033133 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),,
RL4_JR_03235,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.34686519,0,-2.299857087,1.195200759,-1.924243329,0.05432409,0.141605304,5.90070038,0,0.904669915,1.252734645,0.72215606,0.470198535,0.628379928,15.23593897,0,-1.740409741,1.200677354,-1.449523251,0.147191512,0.258529991,38.91777471,0,0.556688614,0.75875719,0.733684795,0.463140867,0.605071133,14.95275487,0,-1.816196518,1.198768087,-1.515052442,0.129759124,0.231965716,N,-,,FMP40 Found in Mitochondrial Proteome,,IPR003846 (PFAM); PTHR32057 (PANTHER),,
RL4_JR_03236,503,1231,552,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,86.95374688,0,0.842303544,0.48655429,1.73116045,0.083423151,0.193997545,10.92688705,0,0.015745626,1.215984129,0.012948875,0.989668581,0.994581551,39.34659187,0,-1.670699069,1.189035397,-1.405087749,0.159995187,0.275240657,41.92831488,0,-2.105363194,1.140665392,-1.845732509,0.064931055,0.143605707,27.79080423,0,-2.710312428,1.187253144,-2.282842915,0.022439623,0.059866283,N,-, Effector probability:0.559,alcohol dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR020471 (PRINTS); IPR020471 (PIRSF); IPR023210 (G3DSA:3.20.20.GENE3D); IPR023210 (PFAM); IPR001395 (PANTHER); PTHR11732:SF207 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.4, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_03237,564,559,432,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,22.41180324,0,0.230166052,1.033664607,0.222669956,0.823792386,0.91111269,3.380848889,0,1.708196795,1.291247075,1.322904677,0.18586708,0.325717898,50.4304524,1,2.453652773,0.643815125,3.811113904,0.000138342,0.001409029,43.47483032,0,2.132328478,0.618623712,3.446890957,0.000567077,0.00463037,8.590434924,0,-1.016438992,1.210140811,-0.83993448,0.400945124,0.538118953,N,-,,mitotic apparatus p62,F:DNA binding; C:nucleus; P:DNA recombination; P:double-strand break repair,IPR010585 (PFAM); IPR014751 (G3DSA:1.20.5.GENE3D); PTHR42067 (PANTHER); SSF58022 (SUPERFAMILY),,
RL4_JR_03238,19822,20234,23500,2,1,7,0,0,0,0,3,0,3,10,10,0,7,6,118.2733629,1,-0.205731647,0.682093159,-0.301618107,0.762943203,0.875892296,18.08026294,0,-0.710791854,1.231763054,-0.577052422,0.563904043,0.706549342,53.05662509,1,-2.390150195,1.207402755,-1.979579874,0.047750756,0.109238109,92.36749048,1,-0.26180519,0.621091182,-0.421524565,0.673372077,0.777676774,57.12088706,1,-1.228848486,0.865138227,-1.420407107,0.155489195,0.265664546,N,-,,cytokinesis regulator,F:GTPase activator activity; P:negative regulation of septation initiation signaling; C:cytosol; C:mitotic spindle pole body; P:positive regulation of GTPase activity,PTHR35140:SF1 (PANTHER); PTHR35140:SF1 (PANTHER); PTHR35140 (PANTHER),,
RL4_JR_03239,6662,4914,5284,1,3,3,1,0,0,0,0,2,1,2,0,0,0,2,203.2520887,1,-5.769455929,1.259076291,-4.582292565,4.60E-06,5.85E-05,82.68383029,1,-0.906321319,1.026845968,-0.882626359,0.377438182,0.541904862,173.9301791,1,-4.2366476,1.231070181,-3.441434668,0.000578638,0.003771709,212.2158607,1,-3.843536987,1.06718565,-3.601563597,0.000316309,0.002831679,182.0879897,1,-2.756818576,0.877274109,-3.142482548,0.001675217,0.007301581,N,-,,trna (cytosine-5-)-methyltransferase ncl1,P:ribosomal large subunit biogenesis; P:rRNA processing; F:S-adenosylmethionine-dependent methyltransferase activity; C:intracellular part; P:methylation,IPR023273 (PRINTS); IPR023267 (PRINTS); IPR011023 (TIGRFAM); IPR031341 (PFAM); IPR001678 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR22807 (PANTHER); PTHR22807:SF30 (PANTHER); PTHR22807 (PANTHER); IPR001678 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_03240,398,282,419,0,4,1,0,0,0,0,0,0,0,0,0,0,0,0,54.50953837,1,0.4251445,0.781379594,0.544094706,0.586376303,0.758828979,7.2071212,0,0.61600559,1.281636537,0.480639848,0.630772489,0.757555664,18.90757399,0,-2.051981932,1.238904396,-1.656287554,0.0976636,0.190656823,45.89542152,0,0.714292009,0.763531356,0.935511034,0.349525,0.496136355,18.87399989,0,-2.152099704,1.257808497,-1.710991546,0.087082673,0.17224303,N,-,,small nuclear ribonucleo,C:nucleus; F:RNA cap binding; P:deadenylation-dependent decapping of nuclear-transcribed mRNA; C:cytoplasmic mRNA processing body; C:viral nucleocapsid,IPR001163 (SMART); G3DSA:2.30.30.100 (GENE3D); IPR001163 (PFAM); PTHR15588 (PANTHER); PTHR15588:SF8 (PANTHER); PTHR15588 (PANTHER); PTHR15588:SF8 (PANTHER); IPR010920 (SUPERFAMILY),,
RL4_JR_03241,498,452,417,1,4,3,1,0,0,0,0,0,0,1,0,0,0,0,52.88066608,1,-1.184685789,0.874777982,-1.354270241,0.175650177,0.330630859,80.08254679,1,1.971195479,0.845569222,2.331205333,0.019742535,0.056932746,34.21945868,0,-2.907777817,1.196658829,-2.429913813,0.015102414,0.044730637,84.90159846,1,0.662374203,0.532137071,1.244743582,0.213226021,0.347641622,45.419028,0,-0.799890191,0.864323264,-0.925452576,0.354730541,0.492141235,N,-,,deacetylase complex subunit,P:biological_process; F:carbon-sulfur lyase activity; P:metabolic process; C:cellular_component; F:molecular_function,IPR013907 (SMART); IPR013907 (PFAM),,
RL4_JR_03242,505,692,864,0,0,1,0,0,0,0,0,0,0,1,3,0,11,0,100.4043355,1,4.213487901,0.714512744,5.897008748,3.70E-09,9.12E-08,10.99970652,0,3.681503049,1.172336176,3.140313441,0.001687672,0.015023052,4.183833965,0,0.124074556,1.2322921,0.100685995,0.91979973,0.952639638,4.82456144,1,-0.297673322,1.236396894,-0.24075871,0.809742133,0.878833647,4.107886384,1,0.047627224,1.229811932,0.038727242,0.969107854,0.979752074,N,-,,7alpha-cephem-methoxylase p8 chain related,F:methyltransferase activity; P:methylation,PTHR34598 (PANTHER); PTHR34598:SF1 (PANTHER),,
RL4_JR_03243,5681,6758,9428,0,1,2,0,0,0,1,0,0,0,0,0,0,0,0,125.2457509,1,2.89376044,2.033275322,1.423201476,0.154677758,0.303550914,23.41840384,0,2.880958008,1.002054224,2.875052007,0.00403961,0.018171436,31.54756594,1,0.999820603,0.855603226,1.168556374,0.242582414,0.376094103,27.22332787,0,-0.089733939,1.015711602,-0.088345884,0.929601771,0.958118474,11.84087699,0,-1.479562786,1.193113516,-1.240085512,0.214943767,0.339700667,N,-,,hypothetical protein CMQ_4609,,no IPS match,,
RL4_JR_03244,1630,1620,1352,0,0,8,0,0,0,0,0,0,0,1,0,0,0,0,95.47647633,1,1.945997696,0.821020253,2.370218869,0.017777558,0.059633766,5.573631254,0,0.98688032,1.273110707,0.77517243,0.438237777,0.599600268,14.43878626,0,-1.662968566,1.21665858,-1.366832563,0.171677794,0.290306662,20.66533818,1,-1.139616057,1.170161328,-0.973896531,0.330107916,0.476932456,14.2353974,0,-1.745246297,1.222499675,-1.427604712,0.153405667,0.263215112,N,-,,calcipressin family,F:nucleotide binding; P:calcium-mediated signaling; C:cellular_component; F:molecular_function; C:intracellular,IPR006931 (PFAM); IPR006931 (PANTHER); PTHR10300:SF14 (PANTHER); IPR006931 (PANTHER); PTHR10300:SF14 (PANTHER); IPR012677 (SUPERFAMILY),,
RL4_JR_03245,1171,1082,998,0,0,0,0,0,0,0,0,1,0,3,0,0,0,0,49.6368712,0,-0.099255375,0.818288094,-0.12129637,0.903456295,0.953302497,9.602025427,0,0.202114885,1.263598605,0.15995181,0.872919035,0.927047159,31.66391151,1,-1.502618191,1.230711215,-1.220934833,0.222110695,0.352011376,113.8316109,1,1.339082942,0.67188224,1.993032205,0.046257921,0.116798366,54.88833782,0,0.399911741,0.768349126,0.520481806,0.602727806,0.711552811,N,-,,phenylalanyl-tRNA synthetase,F:magnesium ion binding; F:ATP binding; P:tRNA processing; C:mitochondrion; F:phenylalanine-tRNA ligase activity; P:phenylalanyl-tRNA aminoacylation; F:tRNA binding,IPR005121 (SMART); IPR002319 (PFAM); G3DSA:3.30.930.10 (GENE3D); IPR005121 (PFAM); IPR004530 (TIGRFAM); IPR005121 (G3DSA:3.30.70.GENE3D); PTHR11538:SF41 (PANTHER); PTHR11538:SF41 (PANTHER); PTHR11538 (PANTHER); PTHR11538 (PANTHER); IPR006195 (PROSITE_PROFILES); IPR005121 (PROSITE_PROFILES); SSF55681 (SUPERFAMILY); IPR005121 (SUPERFAMILY),,
RL4_JR_03246,2823,3034,5036,0,4,0,0,0,0,0,0,0,1,2,0,0,1,0,67.72859577,1,-0.672824027,0.668442803,-1.006554375,0.314148969,0.50224638,15.50902035,0,-0.489534472,1.200847473,-0.407657495,0.683525147,0.798946918,40.26566627,0,-3.142531692,1.187928878,-2.645387068,0.008159752,0.027805617,62.49901575,1,-0.847060163,0.74179011,-1.14191353,0.253489964,0.39316573,61.83196186,1,-0.995189393,0.839794301,-1.185039469,0.236001842,0.364700648,N,-,,mitochondrial dicarboxylate carrier,P:transmembrane transport; F:structural constituent of ribosome; C:integral component of membrane; P:translation,IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); PTHR24089 (PANTHER); PTHR24089:SF39 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.2.7, the mitochondrial carrier (mc) family.
RL4_JR_03247,91,72,172,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,116.8297489,0,-3.164782727,1.059407346,-2.987314312,0.002814402,0.013666602,34.5171544,0,-1.643758589,1.210903043,-1.357465074,0.174633484,0.310766547,118.8405024,0,-1.490614565,0.774715793,-1.924079228,0.054344653,0.120522513,185.9294999,0,-0.397736394,0.528725141,-0.752255498,0.451897425,0.594061468,96.90157781,0,-3.457952179,1.152817458,-2.999566112,0.002703644,0.010914832,N,-,,DNA-directed RNA polymerase II subunit RPB3,"F:DNA binding; F:RNA polymerase II activity; P:transcription, RNA-templated; C:cytosol; F:protein dimerization activity; P:termination of RNA polymerase II transcription; C:DNA-directed RNA polymerase II, core complex",IPR011263 (SMART); G3DSA:3.30.1360.10 (GENE3D); IPR011262 (PFAM); IPR011262 (G3DSA:2.170.120.GENE3D); IPR009025 (PFAM); PTHR11800 (PANTHER); IPR011262 (SUPERFAMILY); IPR009025 (SUPERFAMILY),,
RL4_JR_03248,4336,3156,2984,4,0,8,0,0,0,0,0,2,5,3,2,0,2,1,210.0746277,1,0.603015902,0.755869611,0.797777676,0.424999518,0.616052962,45.11722812,0,0.386302955,0.98876459,0.390692546,0.696024509,0.807389704,92.65797789,1,-1.503399836,0.859008758,-1.750156588,0.080091298,0.162918283,109.803148,1,-1.284998605,0.683072835,-1.88120291,0.059944322,0.136635808,71.65852724,1,-3.067503851,1.132637565,-2.708283696,0.006763218,0.022963643,N,-,,mitochondrial co-chaperone,C:mitochondrial part; F:protein binding; P:protein folding,IPR000740 (PRINTS); IPR013805 (G3DSA:3.90.20.GENE3D); IPR009012 (G3DSA:2.30.22.GENE3D); IPR000740 (PFAM); IPR000740 (PANTHER); SSF58014 (SUPERFAMILY); IPR009012 (SUPERFAMILY),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_03249,4792,3991,4927,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,6.281476959,0,-0.753264329,1.235847484,-0.60951237,0.542184876,0.723618138,39.53629062,0,4.99432285,0.83049747,6.013652092,1.81E-09,3.01E-07,18.20584975,0,1.621008095,1.064280428,1.523102419,0.127733084,0.232753643,6.00619143,1,-0.613429231,1.230069014,-0.498694971,0.617994288,0.73605366,8.950735569,0,0.666755351,1.148601018,0.580493435,0.561581912,0.679576534,N,-,,hypothetical protein SPSK_01460,,no IPS match,,
RL4_JR_03250,141649,81694,108106,3,14,26,0,0,0,1,5,6,7,12,4,0,2,1,88.76436473,1,0.55230943,0.556950041,0.991667815,0.321359596,0.509850561,21.47881645,0,0.78371792,1.141377335,0.686642266,0.492308187,0.647918797,77.41232363,1,0.382507116,0.691432037,0.553209998,0.580119621,0.702141659,86.5595618,1,0.176428825,0.657594836,0.268294116,0.788472935,0.863182746,49.84989724,1,0.066546773,0.699515022,0.095132729,0.924209402,0.950881714,N,-,,replication factor C subunit 1,C:nucleus; C:Elg1 RFC-like complex; F:ATP binding; F:DNA clamp loader activity; F:pyridoxal phosphate binding; P:mitotic DNA replication; P:UV-damage excision repair; F:L-phenylalanine:2-oxoglutarate aminotransferase activity; P:DNA strand elongation involved in DNA replication; P:cellular amino acid metabolic process; F:L-aspartate:2-oxoglutarate aminotransferase activity; C:DNA replication factor C complex,IPR003593 (SMART); IPR001357 (SMART); IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.8.60 (GENE3D); IPR001357 (G3DSA:3.40.50.GENE3D); G3DSA:1.20.272.10 (GENE3D); IPR012178 (PIRSF); IPR013725 (PFAM); IPR001357 (PFAM); PTHR23389 (PANTHER); PTHR23389:SF10 (PANTHER); IPR001357 (PROSITE_PROFILES); IPR001357 (SUPERFAMILY); IPR008921 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_03251,189325,107393,51831,42,63,20,0,0,2,2,4,12,0,4,10,0,27,0,85.14261209,1,-0.776174925,0.756091101,-1.026562704,0.304626423,0.491231936,16.86103456,1,-0.610160072,1.23442105,-0.494288454,0.621102478,0.75061556,44.13524202,1,-3.274908583,1.221748365,-2.680509896,0.007351009,0.025561249,107.1407243,1,-0.085082479,0.671794428,-0.126649576,0.899217757,0.93793961,51.31026151,1,-2.428780304,1.165512355,-2.083873495,0.037171676,0.088953727,N,-,,ribosomal L16p L10e,F:structural constituent of ribosome; P:mitochondrial translation; P:protein maturation; F:rRNA binding; C:mitochondrial large ribosomal subunit,IPR000114 (PRINTS); IPR016180 (G3DSA:3.90.1170.GENE3D); IPR000114 (TIGRFAM); IPR016180 (PFAM); PTHR12220:SF13 (PANTHER); IPR000114 (PANTHER); IPR016180 (SUPERFAMILY),,
RL4_JR_03252,602,702,765,0,1,0,0,0,0,0,0,0,0,3,0,0,0,0,382.0361723,1,-0.45596589,0.489081747,-0.932289729,0.351186815,0.541482146,67.59167882,0,-2.61324329,1.201355846,-2.175244994,0.029611762,0.078360851,218.8606281,0,-2.105991334,0.677811592,-3.107045318,0.001889674,0.009466137,245.9174198,1,-2.144299713,0.584788291,-3.666796592,0.000245608,0.002279359,190.5322113,0,-2.413751587,0.689504229,-3.500705996,0.000464027,0.002547294,N,-,,transcriptional corepressor Cyc8,"P:negative regulation of transcription from RNA polymerase II promoter; F:transcriptional repressor activity, RNA polymerase II transcription factor binding; P:chromatin organization; P:organelle organization",IPR019734 (SMART); IPR001440 (PFAM); PF13432 (PFAM); IPR019734 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PF12895 (PFAM); PTHR14017:SF1 (PANTHER); PTHR14017 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); SSF81901 (SUPERFAMILY); IPR011990 (SUPERFAMILY),3.A.20.1.2, the peroxisomal protein importer (ppi) family.
RL4_JR_03253,5,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,67.23490449,0,0.396776247,0.625502056,0.634332442,0.525863888,0.709794441,10.2285294,0,0.110941736,1.234127241,0.089894893,0.92837074,0.959755758,42.29875915,0,-0.720405551,1.050407795,-0.685834163,0.49281769,0.626167471,77.40985625,0,0.886947161,0.570735514,1.554042354,0.120174314,0.224661176,71.25226384,0,0.989526544,0.598447733,1.653488666,0.098231451,0.188405653,N,-,,eukaryotic integral membrane,"P:retrograde vesicle-mediated transport, Golgi to ER; C:integral component of membrane; C:Golgi apparatus",SM01160 (SMART); IPR013861 (PFAM); PTHR13377:SF3 (PANTHER); PTHR13377 (PANTHER); SSF144091 (SUPERFAMILY),,
RL4_JR_03254,655,684,620,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,189.3239381,1,-0.020459935,0.645768368,-0.031683086,0.974724783,0.987085638,30.13826765,0,-1.447987215,1.20213572,-1.204512262,0.228391646,0.378174421,77.92303884,0,-4.0949844,1.191187381,-3.437733193,0.000586605,0.003802044,109.9314827,0,-1.487055218,0.677219697,-2.195823931,0.028104548,0.089203307,88.13782281,0,-1.965214012,0.839289441,-2.341521191,0.019205336,0.052999189,N,-,,WD repeat,F:molecular_function,IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22846 (PANTHER); PTHR22846:SF2 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),8.A.92.1.3,The G-Protein αβγ Complex (GPC) Family
RL4_JR_03255,19333,18467,16937,0,0,0,0,0,0,0,0,0,0,3,2,0,0,0,80.85661782,0,0.004088839,0.600844171,0.006805157,0.994570312,0.997870116,11.83981417,0,-0.100042074,1.206948588,-0.08288843,0.933940254,0.963741793,46.3788022,0,-0.92673935,1.025449901,-0.903739275,0.366133668,0.51021848,35.40638619,1,-3.173112988,1.183999913,-2.679994275,0.007362342,0.037974382,30.22995086,0,-2.831680707,1.187051317,-2.385474551,0.017057102,0.048120134,N,-,,hypothetical protein HMPREF1624_07276,,no IPS match,,
RL4_JR_03256,1,2,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.96754211,0,-0.581055566,1.036733378,-0.560467694,0.575160469,0.750296858,5.895255998,0,0.905971599,1.265960313,0.71563981,0.474213785,0.631528467,32.80438504,0,0.085966056,1.050703744,0.081817597,0.934791763,0.960990232,57.68649752,0,1.73647758,0.625502959,2.776130082,0.005501019,0.030188521,44.79607583,0,1.138069776,0.704773141,1.614802991,0.106353365,0.200042323,Y,-,,zinc metalloprotease mde10,P:integrin-mediated signaling pathway; P:proteolysis; C:integral component of membrane; F:metalloendopeptidase activity,IPR001762 (SMART); PF13688 (PFAM); IPR001762 (G3DSA:4.10.70.GENE3D); IPR001762 (PFAM); IPR024079 (G3DSA:3.40.390.GENE3D); PTHR11905:SF129 (PANTHER); PTHR11905 (PANTHER); PTHR11905 (PANTHER); PTHR11905 (PANTHER); PTHR11905:SF129 (PANTHER); IPR001762 (PROSITE_PROFILES); IPR001590 (PROSITE_PROFILES); IPR001762 (SUPERFAMILY); SSF55486 (SUPERFAMILY),8.A.77.1.3, the sheddase (sheddase) family.
RL4_JR_03257,32,20,27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,557.4460051,0,1.806304748,0.320481605,5.636219734,1.74E-08,3.97E-07,59.17674205,0,-0.23324146,0.996165167,-0.234139346,0.814876801,0.888142886,296.441582,0,0.724704164,0.494920771,1.464283188,0.143116589,0.253085125,339.0009563,0,0.965221457,0.353435331,2.730970483,0.006314813,0.033704522,384.3658207,0,1.583405224,0.669339791,2.365622433,0.017999791,0.050205249,N,-,,acetyl-coenzyme a synthetase,F:ATP binding; F:acetate-CoA ligase activity; F:AMP binding; P:acetyl-CoA biosynthetic process from acetate,IPR000873 (PFAM); G3DSA:3.40.50.980 (GENE3D); IPR032387 (PFAM); G3DSA:3.40.50.980 (GENE3D); G3DSA:3.30.300.30 (GENE3D); IPR025110 (PFAM); IPR011904 (TIGRFAM); PTHR24095 (PANTHER); PTHR24095:SF210 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.4, the fatty acid transporter (fat) family.
RL4_JR_03258,242,251,292,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.125352685,0,-1.292224921,1.186376855,-1.089219598,0.276057059,0.459134596,2.914826989,0,1.922116432,1.271644465,1.511520306,0.130655939,0.248170278,7.557207072,0,-0.728897365,1.191888001,-0.611548539,0.540836495,0.669040649,8.717763921,0,-1.151180618,1.188872698,-0.96829595,0.332896587,0.479524533,7.445319349,0,-0.810110132,1.192805449,-0.679163674,0.497034161,0.624996384,N,-,,replication factor C subunit 5,C:Ctf18 RFC-like complex; C:nucleus; C:Elg1 RFC-like complex; F:DNA binding; P:sister chromatid cohesion; P:UV-damage excision repair; P:leading strand elongation; C:cytosol; C:DNA replication factor C complex; C:Rad17 RFC-like complex; F:hydrolase activity,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.20.272.10 (GENE3D); G3DSA:1.10.8.60 (GENE3D); PF13177 (PFAM); PTHR11669:SF1 (PANTHER); PTHR11669 (PANTHER); IPR027417 (SUPERFAMILY); IPR008921 (SUPERFAMILY),3.A.15.4.1, the outer membrane protein secreting main terminal branch (mtb) family.
RL4_JR_03259,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1981.841303,0,-0.963504032,0.582290199,-1.654680146,0.097989397,0.218235735,958.6486442,0,0.254042127,0.394341134,0.644219193,0.519433307,0.669925596,1191.912874,0,-3.589468569,0.524450652,-6.844244649,7.69E-12,5.48E-10,1467.437663,0,-2.530054746,1.046415124,-2.417830828,0.015613334,0.06687183,1286.414209,0,-2.24345073,0.715108009,-3.137219417,0.001705584,0.007411606,N,-,,60S ribosomal L3,F:structural constituent of ribosome; C:cytosolic large ribosomal subunit; P:ribosomal large subunit assembly; P:translation,G3DSA:2.40.30.10 (GENE3D); G3DSA:3.30.1430.10 (GENE3D); IPR000597 (PFAM); PTHR11363 (PANTHER); IPR009000 (SUPERFAMILY),,
RL4_JR_03260,323,432,307,0,0,4,0,0,0,0,0,0,0,0,5,0,0,0,99.14092636,1,-0.263384285,0.525408665,-0.501294141,0.616164128,0.77932821,43.01463158,0,0.016500319,1.109417714,0.014872955,0.988133537,0.99408933,135.8246273,0,0.592139431,0.481353882,1.230154056,0.218639421,0.347733346,91.23359129,1,-0.673438611,0.609974778,-1.104043371,0.269574324,0.41087461,56.62740556,0,-2.704557359,1.115348494,-2.424854092,0.01531454,0.044176559,N,-,,Nuclease A inhibitor,,IPR012489 (G3DSA:3.40.1460.GENE3D); PTHR42093 (PANTHER); PTHR42093:SF1 (PANTHER),,
RL4_JR_03261,103,129,103,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,11.94598928,0,5.19178417,0.93197293,5.570745673,2.54E-08,5.65E-07,0.1585907,0,6.122454796,1.960150071,3.123462273,0.001787368,0.015023052,19.90360149,0,5.877448574,0.904754066,6.496183657,8.24E-11,4.85E-09,4.48130393,0,4.008244352,1.206589641,3.321961516,0.00089387,0.006718958,0.397203306,1,3.417749737,1.262155888,2.707866571,0.006771724,0.022984816,N,-,,subtilisin-like serine protease pr1c,F:peptidase activity,IPR010435 (PFAM),,
RL4_JR_03262,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.028989235,0,7.007862205,3.943457352,1.777085836,0.075554118,NA,0.009371267,0,10.20542587,3.943060679,2.588199043,0.009647921,0.032836671,0.023923247,0,7.578638811,2.646523591,2.86362035,0.004188297,0.016866474,0.027580994,0,7.154567648,3.943595748,1.814224405,0.069643184,0.150228434,0.023028651,0,7.530921912,1.643407127,4.582505327,4.59E-06,5.28E-05,N,-, Effector probability:0.636,subtilisin-like serine protease pr1c,C:cell wall; C:membrane; P:proteolysis; F:serine-type endopeptidase activity,IPR000209 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); IPR015500 (PANTHER); IPR000209 (SUPERFAMILY),2.A.7.3.49, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_03263,2420,2914,2989,1,0,8,0,0,0,0,0,3,0,8,4,0,9,0,0.076693923,1,5.602501866,3.920657842,1.428969854,0.153012898,NA,0.024401764,0,8.822618199,2.77139161,3.183461394,0.001455255,0.015023052,0.063301697,1,6.171987502,1.570728475,3.92937901,8.52E-05,0.001054991,8.096209656,1,7.465836438,1.09920216,6.792050371,1.11E-11,4.66E-10,0.062285878,1,6.094256416,1.317593987,4.625291612,3.74E-06,4.44E-05,Y,-,,subtilisin-like serine protease pr1c,F:serine-type peptidase activity,IPR015500 (PRINTS); IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (PFAM); PTHR10795:SF363 (PANTHER); IPR015500 (PANTHER); PTHR10795:SF363 (PANTHER); IPR000209 (SUPERFAMILY),1.I.3.1.1,The Bacterial (Planctomycetes) Nuclear Pore-like Complex (B-NPC) Family
RL4_JR_03264,921,886,1667,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,153.4496969,1,0.487982152,0.528943784,0.922559575,0.356236771,0.547097059,244.3480013,0,3.395998293,1.833194896,1.85250259,0.063953686,0.143058389,95.2532441,0,-0.757482853,0.786644581,-0.962928966,0.335583172,0.478648074,83.37863975,0,-2.259038032,1.055715452,-2.139817152,0.032369546,0.096281333,70.72230958,0,-1.14377394,0.838971153,-1.363305443,0.172786267,0.288071951,N,-,,anthranilate synthase component I,C:nucleus; F:ATP binding; F:GMP synthase (glutamine-hydrolyzing) activity; P:tryptophan biosynthetic process; C:cytosol; F:pyrophosphatase activity; P:GMP biosynthetic process; F:anthranilate synthase activity,IPR019999 (PRINTS); IPR006805 (PFAM); IPR005801 (G3DSA:3.60.120.GENE3D); IPR015890 (PFAM); PTHR11236 (PANTHER); PTHR11236:SF9 (PANTHER); IPR005801 (SUPERFAMILY),,
RL4_JR_03265,1348,1721,2486,0,0,7,0,0,0,0,0,0,0,2,0,0,0,0,7.029562525,1,1.160813087,1.15682249,1.003449619,0.315643973,0.5039185,1.027268412,0,3.426679902,1.406317944,2.436632425,0.01482474,0.045637476,2.663156264,0,0.775596944,1.216111841,0.637767776,0.523624859,0.653578852,12.70724979,1,1.303700977,1.152089304,1.131597154,0.257803837,0.397542469,2.625766683,0,0.693320217,1.213289855,0.571438238,0.567702615,0.684365875,N,-, Effector probability:0.854,glutathione-dependent formaldehyde-activating enzyme,F:carbon-sulfur lyase activity; P:metabolic process; C:cellular_component,IPR006913 (G3DSA:3.90.1590.GENE3D); PTHR28620 (PANTHER); PTHR28620:SF2 (PANTHER); IPR011057 (SUPERFAMILY),,
RL4_JR_03266,6626,7053,10084,4,0,0,0,0,0,0,2,1,0,1,0,3,10,0,1350.452433,1,-5.505103601,1.038965479,-5.298639571,1.17E-07,2.29E-06,433.061956,0,-5.292906489,1.33867528,-3.95383897,7.69E-05,0.003835161,1119.113641,1,-6.09175003,1.199176077,-5.07994626,3.78E-07,1.14E-05,1279.354306,1,-6.689448841,1.215366778,-5.504057675,3.71E-08,9.23E-07,1084.936176,1,-5.545237154,1.095940062,-5.059799661,4.20E-07,6.91E-06,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23502:SF31 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.16, the major facilitator superfamily (mfs).
RL4_JR_03267,7591,7274,9782,0,1,5,0,0,0,0,1,0,2,0,1,0,2,0,481.7743084,1,-3.954781263,1.133459168,-3.48912548,0.000484604,0.003283552,147.9182435,0,-3.743134245,1.31904828,-2.837753782,0.004543221,0.01937905,376.8894433,1,-6.369004153,1.310184442,-4.861150804,1.17E-06,3.08E-05,434.2427392,1,-6.789532056,1.325224979,-5.123305221,3.00E-07,6.12E-06,365.2404562,1,-6.42648295,1.331257862,-4.827376523,1.38E-06,1.89E-05,N,-, Effector probability:0.577,major facilitator superfamily transporter,C:membrane,PTHR23502 (PANTHER); PTHR23502:SF31 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.2.16, the major facilitator superfamily (mfs).
RL4_JR_03268,17134,13193,11666,0,2,12,0,0,0,0,0,2,10,5,0,0,0,1,44.31777642,1,-0.390351734,0.996450072,-0.391742391,0.695248565,0.835383335,9.419861964,0,0.229807543,1.361168284,0.168831103,0.865929493,0.922091327,51.02091305,1,0.023826329,0.979239067,0.024331473,0.980588209,0.989482211,50.61065844,1,-0.468756623,1.003143612,-0.467287652,0.640294089,0.753484153,27.6845696,1,-1.566392815,1.240486296,-1.262724804,0.206688097,0.329457963,N,-,,myo-inositol transporter 1,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR003663 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR23500 (PANTHER); PTHR23500:SF89 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.104, the major facilitator superfamily (mfs).
RL4_JR_03269,973,800,1912,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.76365669,0,-0.689489221,1.242581899,-0.554884327,0.578973783,0.753552667,3.773526326,0,1.549585163,1.386710189,1.117454227,0.26380016,0.420567841,9.752077635,0,-1.096794506,1.278605951,-0.857804944,0.391000179,0.534601115,15.25705416,0,-0.577240224,1.237514999,-0.466451093,0.640892647,0.75397801,9.604195355,0,-1.177510976,1.29043885,-0.912488784,0.361511471,0.498678971,N,-,,regulator of G,"F:hydrogen ion transmembrane transporter activity; P:ATP hydrolysis coupled proton transport; C:membrane; C:integral component of membrane; C:proton-transporting V-type ATPase, V0 domain",PTHR39466 (PANTHER),,
RL4_JR_03270,935,838,1394,0,1,55,0,0,0,0,0,0,0,2,0,0,1,0,0.275358737,1,3.758205685,2.635139728,1.42618839,0.15381397,NA,0.089545412,0,6.947110898,2.198184122,3.160386261,0.001575601,0.015023052,0.229584265,0,4.312424614,1.392474206,3.096951165,0.001955221,0.009646518,0.264644137,1,3.890829195,1.725832521,2.254465104,0.024166924,0.08405706,0.223709994,1,4.24464251,1.288923708,3.293168156,0.000990652,0.00474922,Y,-,,glycolipid-anchored surface 5,"P:fungal-type cell wall organization; F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:fungal-type cell wall; P:mycelium development; P:fungal-type cell wall (1->3)-beta-D-glucan biosynthetic process; C:anchored component of external side of plasma membrane; C:integral component of membrane; F:1,3-beta-glucanosyltransferase activity; F:hydrolase activity",IPR004886 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR31468:SF8 (PANTHER); PTHR31468 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_03271,190,157,209,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49.01894439,0,-1.379959135,1.047383357,-1.317530134,0.187660987,0.346366138,10.68599543,0,0.047900904,1.264026986,0.037895475,0.969771021,0.984457153,38.54828706,0,-1.629429724,1.21975664,-1.335864606,0.181593532,0.302825385,35.69177183,0,-2.067753911,1.177732843,-1.755707097,0.079138434,0.16510048,26.86191394,0,-2.661316231,1.220118677,-2.181194569,0.029169028,0.073530818,N,-,,kinase domain-containing,F:protein kinase activity; P:phosphorylation,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24362:SF281 (PANTHER); PTHR24362 (PANTHER); PTHR24362 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_03272,1854,1312,1308,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,249.6138602,0,1.377372755,0.325806435,4.227579963,2.36E-05,0.00024179,58.39354356,0,1.6682984,0.762107807,2.189058272,0.028592605,0.076322349,87.83893664,0,-0.427452053,0.668394783,-0.639520331,0.522484492,0.652477241,111.7130358,0,0.161020134,0.482861176,0.333470865,0.738778879,0.826169223,64.64082369,0,-1.433824959,0.834489677,-1.718205747,0.085759094,0.170156932,N,-,,cysteinyl-tRNA synthetase,F:ATP binding; C:cytosol; F:cysteine-tRNA ligase activity; P:cysteinyl-tRNA aminoacylation,IPR024909 (PRINTS); IPR015803 (TIGRFAM); IPR032678 (PFAM); G3DSA:1.20.120.640 (GENE3D); IPR014729 (G3DSA:3.40.50.GENE3D); IPR024909 (PANTHER); PTHR10890:SF3 (PANTHER); PTHR10890:SF3 (PANTHER); IPR024909 (PANTHER); IPR015803 (HAMAP); SSF52374 (SUPERFAMILY); IPR009080 (SUPERFAMILY),,
RL4_JR_03273,5437,5357,3295,12,24,5,0,0,1,0,0,0,0,3,4,0,0,1,23.1882471,1,-0.354955387,1.064490509,-0.333450965,0.738793898,0.862613513,4.905412172,1,1.171059238,1.273557149,0.919518405,0.357824484,0.521962736,52.04118924,0,1.655260661,0.726266031,2.27913821,0.022658851,0.061427996,123.3328349,1,2.832335093,0.484686456,5.843643987,5.11E-09,1.49E-07,12.74771889,1,-1.585913754,1.234993082,-1.284147885,0.199090216,0.320832156,N,-,,epidermal retinal dehydrogenase 2,F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); IPR002347 (PANTHER); PTHR24322:SF515 (PANTHER); PTHR24322:SF515 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_03274,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,91.55337041,0,0.422929512,0.734565343,0.575754786,0.564780938,0.741611955,14.56565835,0,-0.399010428,1.20307267,-0.331659457,0.740146418,0.83960126,79.48458661,0,0.092823478,0.667821691,0.138994405,0.889454571,0.930948735,103.0526043,0,0.80506065,0.464959432,1.731464284,0.08336899,0.170941884,45.1059562,0,-1.470672479,0.978972695,-1.502260979,0.133029722,0.236468739,N,-,,26S proteasome non-ATPase regulatory subunit 11,"C:nucleus; F:structural molecule activity; C:proteasome regulatory particle, lid subcomplex; P:proteasome assembly; C:proteasome storage granule; P:ubiquitin-dependent protein catabolic process",SM00753 (SMART); IPR000717 (SMART); IPR011991 (G3DSA:1.10.10.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR000717 (PFAM); PTHR10678:SF2 (PANTHER); PTHR10678 (PANTHER); IPR011991 (SUPERFAMILY),,
RL4_JR_03275,8426,7600,11118,0,0,10,0,0,1,0,0,0,1,2,1,0,0,0,150.4684565,1,0.67808194,0.546858242,1.239959257,0.214990464,0.383358351,39.00396121,1,0.758778403,1.010204318,0.751113799,0.452584172,0.612195241,113.373901,0,0.296019475,0.565571432,0.523398917,0.600696678,0.719187933,112.398766,1,-0.028814655,1.337071533,-0.021550571,0.982806463,0.989190158,100.6557223,0,0.450511568,0.502599471,0.896362997,0.370058923,0.506193813,N,-,,dicer 2,P:RNA metabolic process; F:organic cyclic compound binding; F:heterocyclic compound binding; F:hydrolase activity,IPR001650 (SMART); IPR014001 (SMART); IPR000999 (SMART); IPR011545 (PFAM); IPR000999 (G3DSA:1.10.1520.GENE3D); IPR005034 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000999 (PFAM); IPR001650 (PFAM); PTHR14950 (PANTHER); PTHR14950:SF3 (PANTHER); PTHR14950:SF3 (PANTHER); PTHR14950:SF3 (PANTHER); PTHR14950 (PANTHER); PTHR14950 (PANTHER); IPR000999 (PROSITE_PROFILES); IPR000999 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR005034 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR000999 (SUPERFAMILY); IPR000999 (SUPERFAMILY),,
RL4_JR_03276,27,29,26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,40.87800099,0,0.17829542,0.887230873,0.200957187,0.840732051,0.919624667,24.19590415,0,2.643399586,1.041609766,2.537802229,0.0111551,0.036511005,14.02046629,0,-1.620494193,1.21934916,-1.328982909,0.183853609,0.305183626,42.81433089,0,0.692658563,0.787128368,0.879981704,0.378869221,0.524624024,21.1127301,0,-0.755678601,1.147890081,-0.658319653,0.510332752,0.636815271,N,-,,intracellular transport,,IPR014848 (PFAM); PTHR12507 (PANTHER); PTHR12507:SF3 (PANTHER); PTHR12507 (PANTHER); PTHR12507:SF3 (PANTHER),,
RL4_JR_03277,37,34,35,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.499669061,0,0.090308494,1.258882495,0.071737032,0.942811185,0.971842636,1.131082051,0,3.28789508,1.433588028,2.293472753,0.021820802,0.061764586,26.4413351,0,3.056596518,0.887338404,3.444679622,0.000571737,0.003735087,23.41602436,0,3.212346391,0.741141279,4.334323945,1.46E-05,0.000199564,2.851304461,0,0.574319617,1.228875898,0.467353634,0.64024689,0.741874543,N,-,,---NA---,,no IPS match,,
RL4_JR_03278,33,17,41,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,53.53898506,0,0.381934048,0.757997881,0.503872184,0.614351199,0.778846477,6.202042132,0,0.832811885,1.243941881,0.669494208,0.503180274,0.656920941,16.07345605,0,-1.817536642,1.199758557,-1.514918673,0.129793001,0.235645734,125.9612213,0,2.271672455,0.481988258,4.713128213,2.44E-06,4.05E-05,38.61778234,0,1.034008002,0.689113816,1.500489437,0.133487668,0.236949971,N,-,,wd repeat-containing,P:phosphorylation; F:kinase activity,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR22847 (PANTHER); PTHR22847:SF414 (PANTHER); PTHR22847 (PANTHER); PTHR22847:SF414 (PANTHER); PTHR22847 (PANTHER); PTHR22847:SF414 (PANTHER); PTHR22847:SF414 (PANTHER); PTHR22847 (PANTHER); IPR017986 (SUPERFAMILY); IPR017986 (SUPERFAMILY),,
RL4_JR_03279,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30.27241105,0,-3.022280133,1.21791289,-2.481524055,0.013082188,0.046932493,9.566568516,0,0.207450636,1.235619623,0.167891989,0.866668253,0.922344239,24.98735204,0,-2.45419299,1.211067088,-2.026471542,0.042716486,0.100377978,28.83764119,0,-2.877109566,1.212845245,-2.372198414,0.017682592,0.072425666,24.81061866,0,-2.546651353,1.223036686,-2.082236276,0.037320893,0.089163295,N,-,,26S proteasome non-ATPase regulatory subunit 11,C:proteasome complex,IPR010487 (PFAM); PTHR13475 (PANTHER),,
RL4_JR_03280,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.439220577,0,0.611290858,1.264110689,0.483573838,0.628688345,0.787961211,0.785457935,0,3.814027576,1.47122728,2.592412218,0.00953055,0.032524689,8.523885979,0,2.133169915,1.207918999,1.765987551,0.077397937,0.158916507,10.35853453,0,2.466770246,1.038038948,2.376375424,0.017483664,0.072063371,1.983353106,0,1.098042277,1.213600454,0.904780707,0.365581575,0.502057695,N,-,,serine threonine- kinase nek9,P:phosphorylation; F:kinase activity,IPR009091 (G3DSA:2.130.10.GENE3D); IPR000408 (PFAM); PTHR22870 (PANTHER); IPR000408 (PROSITE_PROFILES); IPR000408 (PROSITE_PROFILES); IPR009091 (SUPERFAMILY),,
RL4_JR_03281,2,2,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,178.8815071,0,1.780887735,0.594899436,2.993594591,0.00275712,0.0134913,13.39937694,0,-0.278578486,1.20866288,-0.230484853,0.817715033,0.88999049,45.87985221,0,-1.970634903,1.192405064,-1.652655598,0.098400976,0.191726613,88.80287083,0,0.369298593,0.546968047,0.675173979,0.499565237,0.637602171,68.37791191,0,0.401516683,0.591171746,0.679187878,0.497018827,0.624996384,N,-,,proteasome subunit alpha type-2,"C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:nuclear outer membrane-endoplasmic reticulum membrane network; C:proteasome core complex, alpha-subunit complex; F:threonine-type endopeptidase activity; C:proteasome storage granule; P:proteasomal ubiquitin-independent protein catabolic process",IPR000426 (SMART); IPR000426 (PFAM); IPR001353 (PFAM); IPR029055 (G3DSA:3.60.20.GENE3D); PTHR11599:SF16 (PANTHER); PTHR11599 (PANTHER); IPR023332 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY),,
RL4_JR_03282,210,200,230,1,7,10,0,0,0,2,0,2,1,0,0,0,2,0,110.7305274,1,-0.131236654,0.818816114,-0.160276101,0.872663584,0.939046053,163.705484,0,2.33329607,0.650864235,3.584919781,0.000337182,0.013279978,85.0156465,1,-0.731507098,0.769768157,-0.950295348,0.341962202,0.485353335,135.7617433,1,0.109654538,0.548542911,0.199901477,0.841557635,0.90109677,68.30794938,1,-1.441289237,0.877969803,-1.641615954,0.100669619,0.192042688,N,-,,ring finger domain-containing,P:biological_process; F:zinc ion binding; F:metal ion binding; C:membrane; C:integral component of membrane; C:cellular_component,IPR011016 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR011016 (PFAM); PTHR23012:SF7 (PANTHER); PTHR23012:SF7 (PANTHER); IPR033275 (PANTHER); IPR033275 (PANTHER); IPR011016 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_03283,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.71148036,0,-3.413861434,1.222150794,-2.7933226,0.005216964,0.022506604,12.5982512,0,-0.189691853,1.236369804,-0.153426469,0.878061973,0.930556307,39.36313868,0,-1.887731075,1.21452705,-1.55429315,0.120114507,0.221985992,37.92282903,0,-3.272227799,1.218403246,-2.685668976,0.007238476,0.037488272,40.34974432,0,-1.289040224,1.022155129,-1.261100382,0.207272683,0.3299742,N,-,,glycosyltransferase family 34,"P:cell wall mannoprotein biosynthetic process; P:mannosylation; F:alpha-1,6-mannosyltransferase activity; P:protein N-linked glycosylation; C:endoplasmic reticulum; C:alpha-1,6-mannosyltransferase complex",IPR008630 (PFAM); PTHR31306 (PANTHER); PTHR31306:SF4 (PANTHER),,
RL4_JR_03284,539,419,644,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,483.5975864,1,2.236814538,0.529138034,4.227279827,2.37E-05,0.000241809,28.20313401,0,-1.352257702,1.257336053,-1.075494255,0.282153503,0.441210838,128.5387899,0,-0.20496187,0.643570791,-0.318476029,0.750123875,0.832887364,187.2928879,0,0.459515345,0.540133304,0.850744329,0.394911393,0.53931452,104.2704994,0,-1.062759533,0.768999273,-1.382003299,0.166970688,0.280826946,N,-,,sphingosine-1-phosphate lyase,F:pyridoxal phosphate binding; C:perinuclear endoplasmic reticulum; C:cortical endoplasmic reticulum; P:cellular response to starvation; P:carboxylic acid metabolic process; P:calcium-mediated signaling; F:sphinganine-1-phosphate aldolase activity; F:carboxy-lyase activity; P:sphingolipid metabolic process,IPR015421 (G3DSA:3.40.640.GENE3D); IPR002129 (PFAM); PTHR11999:SF5 (PANTHER); PTHR11999 (PANTHER); PTHR11999:SF5 (PANTHER); PTHR11999 (PANTHER); IPR015424 (SUPERFAMILY),8.A.47.2.5,The Neuropilin and Tolloid-like (Neto) Family
RL4_JR_03285,66,40,63,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51.46012495,0,0.259331907,0.749898275,0.345822781,0.729475904,0.857173155,9.210788081,0,0.262196338,1.275389737,0.205581346,0.83711795,0.902567948,63.5241076,0,0.761704857,0.72855928,1.045494687,0.295794395,0.436802101,81.99776618,0,0.940819077,0.637868202,1.474942746,0.140227937,0.253220592,34.93156082,0,-0.288481503,0.913113124,-0.315931833,0.752054249,0.827340174,N,-,,pyruvate dehydrogenase kinase,P:phosphorylation; F:kinase activity,IPR004358 (PRINTS); IPR003594 (SMART); IPR003594 (PFAM); IPR018955 (G3DSA:1.20.140.GENE3D); IPR003594 (G3DSA:3.30.565.GENE3D); IPR018955 (PFAM); PTHR11947:SF23 (PANTHER); PTHR11947 (PANTHER); IPR005467 (PROSITE_PROFILES); IPR003594 (SUPERFAMILY); IPR018955 (SUPERFAMILY),,
RL4_JR_03286,66,58,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.94174005,0,1.08156589,0.914301919,1.182941726,0.236832243,0.410967464,2.715231247,0,2.024393292,1.327876264,1.524534587,0.127375224,0.243768579,7.045913662,0,-0.627958561,1.228622365,-0.511107871,0.609275525,0.725512281,48.74514355,0,2.272918793,0.671175529,3.386474469,0.000707969,0.005548129,25.55194167,0,1.517878685,0.891205494,1.703174739,0.088535372,0.174265884,N,-,,hypothetical protein VP1G_05036,,no IPS match,,
RL4_JR_03287,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14.68068472,0,-0.596778042,1.151839424,-0.518108713,0.604382421,0.772087659,3.487292797,0,1.66342377,1.28170965,1.297816373,0.194350442,0.336851913,9.019417768,0,-0.984112429,1.204979767,-0.816704526,0.414097304,0.55604558,10.4024093,0,-1.406103062,1.20380175,-1.168052017,0.242785784,0.381176316,23.60204244,0,0.628725922,0.981813439,0.640372088,0.521930725,0.646269853,N,-,,hydroxyproline-rich glyco dz-hrgp,,PTHR39611 (PANTHER); PTHR39611:SF1 (PANTHER),,
RL4_JR_03288,3,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.456741506,0,1.3549249,1.372876665,0.986923979,0.323679908,NA,0.461262088,0,4.581743664,1.574089326,2.910726594,0.003605894,0.017053643,1.202698757,0,1.922408151,1.243601612,1.545839224,0.122143402,0.224791819,1.387901997,0,1.499725723,1.274247329,1.176950259,0.23921536,0.377384781,1.19162924,0,1.833619467,1.235816146,1.483731599,0.13788014,0.2433391,N,-,,STC1 domain,,IPR024630 (PFAM),,
RL4_JR_03289,221,232,172,0,0,1,0,0,0,3,2,14,3,15,3,0,23,0,59.1217738,1,1.51903014,0.577835036,2.628830109,0.008567915,0.033507696,5.955103329,0,0.891459097,1.263604165,0.705489204,0.480505848,0.637439394,46.72423849,1,1.073524082,0.767618179,1.398513105,0.16195904,0.277615421,71.46722404,1,2.027180941,0.553256983,3.664085591,0.000248224,0.002301525,26.2511456,1,-0.145262403,0.983876838,-0.147642872,0.882624619,0.922247086,N,-,,serine threonine- kinase mak,C:nucleus; F:ATP binding; P:regulation of meiotic nuclear division; F:protein serine/threonine kinase activity; P:protein phosphorylation,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24055:SF52 (PANTHER); PTHR24055 (PANTHER); PTHR24055 (PANTHER); PTHR24055:SF52 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_03290,303,290,285,0,0,36,0,0,0,0,0,0,0,0,0,0,0,0,55.03467056,1,1.425589209,0.527107785,2.704549714,0.006839703,0.028109975,5.836992256,0,0.920309628,1.234627133,0.745415035,0.456020857,0.615609912,26.18766136,0,-0.767405732,1.188253491,-0.645826617,0.518391648,0.648806657,27.07324188,0,-1.202292264,1.139170327,-1.055410447,0.291237647,0.435952273,14.88058197,0,-1.809178824,1.19028161,-1.519958646,0.128521369,0.230192617,N,-,,hsp70,F:ATP binding,G3DSA:3.30.420.40 (GENE3D); IPR013126 (PFAM); PTHR19375 (PANTHER); PTHR19375:SF181 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_03291,4,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,60.41280934,0,4.415438406,0.720932627,6.124620026,9.09E-10,2.51E-08,0.734773802,0,3.910278403,1.48451181,2.634050047,0.008437305,0.029625732,1.895686991,0,1.266672566,1.230702672,1.02922712,0.303372961,0.444768644,2.186238905,0,0.844673631,1.24391178,0.679046251,0.497108557,0.635588349,1.856496885,0,1.193604817,1.215328302,0.982125418,0.326038065,0.462408657,N,-,,nicotinamide N- partial,F:methyltransferase activity; F:transferase activity; P:methylation,no IPS match,,
RL4_JR_03292,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.327423851,0,3.508575737,2.436660381,1.439911678,0.149892389,NA,0.105139354,0,6.715492542,2.111057734,3.181103213,0.001467153,0.015023052,0.271021365,0,4.073956398,1.355761041,3.004922163,0.002656488,0.012405114,0.312565285,0,3.651100794,1.625679602,2.245891989,0.024710927,0.085043555,0.264864166,0,4.003478312,1.269781053,3.152888683,0.001616634,0.007110523,N,-,,---NA---,,no IPS match,,
RL4_JR_03293,137,105,117,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.1717331,0,-0.870274915,1.145987371,-0.759410563,0.447606997,0.636607022,4.206614768,0,1.392907583,1.258095375,1.107155793,0.268226577,0.425680372,29.80466866,0,0.571603592,1.033084957,0.553297759,0.580059535,0.702141659,52.53548048,0,1.639908499,0.619084037,2.648927126,0.008074774,0.040840321,10.70638052,0,-1.334124586,1.195125219,-1.116305274,0.264291485,0.3966135,N,-,,hypothetical protein SPSK_08557,,IPR019510 (PFAM); PTHR40641:SF1 (PANTHER); PTHR40641 (PANTHER); IPR009097 (SUPERFAMILY),,
RL4_JR_03294,3,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26.60297565,0,1.072652371,0.803783498,1.334504096,0.182038705,0.339516202,3.597197194,0,1.618551941,1.287866395,1.256770071,0.208836906,0.354137572,9.377204497,0,-1.040341609,1.218147629,-0.854035738,0.393085188,0.536305834,14.83169804,0,-0.517593728,1.170542631,-0.442182723,0.658356987,0.767161295,16.66782445,0,-0.19059842,1.156082777,-0.16486572,0.869049674,0.913203235,N,-,,hypothetical protein SPBR_02014,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_03295,3,6,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,88.07939132,0,0.275112422,0.616723886,0.44608686,0.655534504,0.805641833,31.65482849,0,1.407690058,1.014273755,1.387879802,0.165173649,0.297966081,33.68631498,0,-2.885158082,1.212132211,-2.38023382,0.017301656,0.050025121,50.91013638,0,-1.028848995,0.899744857,-1.143489721,0.25283532,0.392631536,33.46852955,0,-2.978512037,1.224141054,-2.433144472,0.014968327,0.043487608,N,-,,cytochrome oxidase assembly,P:mitochondrial respiratory chain complex IV assembly; C:integral component of mitochondrial inner membrane,IPR014807 (PFAM); PTHR28523 (PANTHER); PS51257 (PROSITE_PROFILES),,
RL4_JR_03296,2048,1144,914,0,2,3,0,0,0,0,0,0,0,4,1,0,0,2,70.85402067,1,-0.788780186,0.819482154,-0.962534916,0.335780973,0.525878514,13.59582616,0,-0.299638611,1.242013716,-0.241252256,0.809359612,0.883938066,35.58265655,0,-2.964163925,1.223338423,-2.423012201,0.01539241,0.045418896,53.10327528,1,-1.120301394,0.922770546,-1.214062801,0.224723744,0.360224871,50.16570123,1,-1.346527062,1.023542781,-1.315555233,0.188323367,0.30765233,N,-,,50S ribosomal l3,F:structural constituent of ribosome; C:mitochondrial large ribosomal subunit; P:translation,G3DSA:4.10.960.10 (GENE3D); IPR000597 (PFAM); IPR019927 (TIGRFAM); G3DSA:2.40.30.10 (GENE3D); IPR019927 (PANTHER); IPR009000 (SUPERFAMILY),,
RL4_JR_03297,512,907,1307,4,0,3,0,0,0,0,0,0,0,3,3,0,0,0,88.9121607,1,1.793722404,0.682269218,2.629053688,0.008562284,0.033501734,7.51774083,0,0.555165512,1.22925776,0.451626607,0.651537999,0.775137238,41.74003524,0,0.305605466,0.859936208,0.355381554,0.722303766,0.812051866,50.49900148,1,-0.182216163,0.858414535,-0.212270594,0.831895936,0.89463052,41.44162026,0,0.054542495,0.857124823,0.063634249,0.94926146,0.967123393,N,-,,coiled-coil domain-containing 25,,IPR008532 (PFAM); PTHR13049 (PANTHER),,
RL4_JR_03298,271,328,488,4,0,0,0,0,2,0,0,0,0,0,0,0,0,0,93.28286334,1,-0.269507221,0.628586712,-0.428751064,0.668104395,0.815805367,14.431278,1,-0.385646645,1.204355376,-0.320210008,0.748809137,0.846203649,79.21645779,0,0.358910561,0.619485779,0.579368523,0.562340539,0.687659816,102.8733554,0,0.281312603,0.543530025,0.517565893,0.604761184,0.725498458,71.85296198,0,0.5903584,0.572435713,1.031309519,0.302395696,0.437831606,N,-,,60s ribosomal l3,C:ribosome,IPR010400 (G3DSA:2.60.120.GENE3D); IPR019350 (PFAM); IPR010400 (PFAM); PTHR12175 (PANTHER); IPR010400 (PROSITE_PROFILES); IPR008979 (SUPERFAMILY),3.A.3.6.25, the p-type atpase (p-atpase) superfamily.
RL4_JR_03299,695,283,335,0,3,0,0,0,0,0,0,0,0,0,0,0,1,0,13.70665011,1,-1.879140271,1.202569267,-1.562604602,0.118145625,0.24963274,4.348803904,0,1.344844103,1.252619415,1.073625466,0.282990579,0.442383111,17.8236584,0,-0.350740525,1.198639908,-0.292615424,0.769816123,0.845478241,25.10252579,0,0.560657354,0.869310937,0.644944553,0.518963118,0.653382439,33.30370854,1,0.843213187,0.858953493,0.98167502,0.326259975,0.46259379,N,-,,kinetochore spc25,P:cell division; C:nucleus; C:condensed chromosome kinetochore; P:mitotic nuclear division,IPR022214 (PFAM); IPR013255 (PFAM); PTHR14281:SF0 (PANTHER); PTHR14281 (PANTHER),,
RL4_JR_03300,1939,1783,2328,0,0,2,0,0,1,1,0,0,1,0,0,0,0,3,33.95109942,1,-0.132862635,1.030326087,-0.128952025,0.89739561,0.949416858,13.80549119,1,2.233628869,1.150262372,1.941842943,0.052156116,0.121809924,27.15987773,1,0.493349077,1.052151638,0.468895414,0.639144395,0.74866341,30.57009931,1,0.553885731,0.881591915,0.62827905,0.529821153,0.663095078,11.316131,1,-1.414152461,1.217799211,-1.161236145,0.245545879,0.375608404,N,-,,chy zinc finger,F:metal ion binding,IPR001841 (SMART); IPR001841 (PFAM); IPR008913 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PF14599 (PFAM); IPR004039 (G3DSA:2.20.28.GENE3D); PTHR21319 (PANTHER); IPR008913 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR017921 (PROSITE_PROFILES); SSF161245 (SUPERFAMILY); SSF57850 (SUPERFAMILY); SSF161219 (SUPERFAMILY),,
RL4_JR_03301,18,9,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,353.9676855,0,1.062255943,0.45479541,2.33567868,0.019507994,0.064197749,126.8991083,0,0.901985061,0.768031459,1.174411608,0.240230198,0.392068698,205.318138,0,0.202823434,0.466818363,0.434480411,0.663939617,0.768197106,208.6668108,0,-0.136002216,0.451451518,-0.301255418,0.763219734,0.84522926,130.5321067,0,-0.927416765,0.592880762,-1.564255116,0.117757668,0.21607401,N,-,,dolichyl-phosphate-mannose- mannosyltransferase,C:endoplasmic reticulum membrane; C:integral component of membrane; P:protein O-linked mannosylation; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity,IPR016093 (SMART); G3DSA:2.80.10.50 (GENE3D); IPR003342 (PFAM); IPR016093 (PFAM); IPR032421 (PFAM); PTHR10050:SF32 (PANTHER); IPR027005 (PANTHER); IPR016093 (PROSITE_PROFILES); IPR016093 (PROSITE_PROFILES); IPR016093 (PROSITE_PROFILES); IPR016093 (SUPERFAMILY),9.B.142.5.4, the integral membrane glycosyltransferase family 39 (gt39) family.
RL4_JR_03302,6,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,74.35204128,0,2.696302028,0.498565963,5.408114931,6.37E-08,1.31E-06,4.017902061,0,1.459095182,1.272473289,1.146660755,0.251521856,0.405915853,46.91401374,0,1.952193798,0.683804644,2.854899885,0.00430504,0.016965443,72.19139339,0,2.145219518,0.56636082,3.787725849,0.000152032,0.001527112,17.93283894,0,0.398495047,0.987739125,0.403441594,0.686623393,0.777896594,N,-, Effector probability:0.749,GTP-binding rab2,F:GTP binding; P:small GTPase mediated signal transduction; C:intracellular,PR00449 (PRINTS); SM00173 (SMART); SM00176 (SMART); SM00175 (SMART); SM00174 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); IPR001806 (PFAM); PTHR24073:SF354 (PANTHER); PTHR24073 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_03303,149,105,136,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,264.3267481,0,1.770793628,0.582077625,3.042194977,0.002348597,0.011913429,18.24678552,0,-0.724027505,1.236833356,-0.585388081,0.558286801,0.702072183,59.97370051,0,-1.551292759,1.059403637,-1.464307565,0.143109931,0.253085125,134.6122914,0,0.267105186,0.618139612,0.432111421,0.665660434,0.771763643,57.55111033,0,-1.247471586,0.875322514,-1.425156518,0.154111962,0.264068982,N,-,,Choline transporter ctl1,C:integral component of membrane,IPR007603 (PFAM); IPR007603 (PANTHER); PTHR12385:SF44 (PANTHER),,
RL4_JR_03304,29,21,28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,394.4614885,0,1.19346422,0.705260441,1.692231906,0.090601765,0.206029972,37.34756209,0,-1.757408898,1.210481902,-1.451825834,0.146550039,0.272199773,164.2891637,0,-0.414275149,0.543693456,-0.761964567,0.446081152,0.585521274,252.2801222,0,0.20341838,0.412026896,0.493701702,0.621516863,0.739205713,129.2916535,0,-0.763039611,0.577313665,-1.321707169,0.18626568,0.305176,N,-,,rna-binding fus tls,,IPR001202 (SMART); G3DSA:2.20.70.10 (GENE3D); IPR001202 (PFAM); IPR001202 (PROSITE_PROFILES); IPR001202 (SUPERFAMILY),8.A.58.2.4, the dispanin (dispanin) family.
RL4_JR_03305,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47.88103564,0,0.063674688,0.697325686,0.091312695,0.927244131,0.965346812,9.151353443,0,0.271477471,1.221928796,0.222171269,0.824180559,0.89413981,39.50482594,0,-0.560688521,1.03868468,-0.539806288,0.589330631,0.708852861,52.84110823,0,0.226996091,0.687119656,0.330358896,0.741128796,0.827955455,31.29556319,0,-0.810263183,0.992986117,-0.815986416,0.414507905,0.550594808,Y,-,,hypothetical protein HMPREF1624_03421,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,IPR019008 (PFAM); PTHR13605 (PANTHER),3.A.27.1.1, the c-terminal tail-anchored membrane protein biogenesis/ insertion complex-2 (tamp-b2) family.
RL4_JR_03306,746,850,755,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,69.68793695,0,2.189373778,0.580249736,3.773157735,0.000161194,0.001286715,22.68314183,0,3.117282583,1.031315014,3.022628915,0.002505893,0.015349618,10.207048,0,-1.162646734,1.221150787,-0.952091049,0.341050808,0.484467291,50.31657624,0,1.549768721,1.399681707,1.107229389,0.268194764,0.409462697,21.68292763,0,0.924644286,0.904413318,1.022369162,0.30660621,0.441779975,N,-,,O-acetylhomoserine (thiol)-lyase,"F:pyridoxal phosphate binding; C:integral component of membrane; F:lyase activity; P:cellular amino acid metabolic process; F:transferase activity, transferring alkyl or aryl (other than methyl) groups",IPR000277 (PFAM); IPR015421 (G3DSA:3.40.640.GENE3D); IPR000277 (PIRSF); IPR006235 (TIGRFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR000277 (PANTHER); IPR006235 (PTHR11808:PANTHER); IPR000277 (PANTHER); IPR006235 (PTHR11808:PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_03307,69,62,99,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.23459507,0,1.410862342,0.904332657,1.560114334,0.118732865,0.250443365,2.163698002,0,2.351948244,1.337120105,1.758965581,0.078583355,0.168093981,25.1188366,0,2.089559884,0.889488216,2.349170957,0.018815266,0.05350137,31.84504721,0,2.295221823,0.722612543,3.176282844,0.001491754,0.010352304,42.74440336,0,2.8433831,0.677308631,4.198061224,2.69E-05,0.0002308,N,-,,MARVEL-like domain,C:membrane,IPR008253 (PFAM); PTHR37451 (PANTHER); PTHR37451:SF2 (PANTHER),9.A.27.1.4, the non-classical protein exporter (ncpe) family.
RL4_JR_03308,132,115,153,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,397.025901,0,3.545671362,1.42719374,2.484365832,0.01297824,0.046674295,99.44318634,0,2.792569523,0.773162742,3.611878033,0.000303988,0.012258812,186.5737371,0,2.748290453,0.452588688,6.072379904,1.26E-09,6.48E-08,671.2002905,0,4.426315588,0.372016607,11.89816665,1.21E-32,2.27E-30,445.7728411,0,4.084808662,0.757058043,5.39563472,6.83E-08,1.65E-06,N,-,,amp-binding enzyme,P:fatty acid catabolic process; C:intracellular membrane-bounded organelle; C:cytoplasmic part; P:single-organism transport; F:fatty acid ligase activity; P:organic substance transport,IPR000873 (PFAM); G3DSA:3.40.50.980 (GENE3D); G3DSA:2.30.38.10 (GENE3D); G3DSA:3.40.50.980 (GENE3D); PTHR24096:SF221 (PANTHER); PTHR24096 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.15, the fatty acid transporter (fat) family.
RL4_JR_03309,1876,1754,2422,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,54.30025491,0,0.298681542,0.730709498,0.408755522,0.682719083,0.826598736,6.471284789,0,0.771491398,1.232215883,0.626100839,0.531248802,0.679724481,16.75006261,0,-1.877105123,1.190237965,-1.577083892,0.114776223,0.21482612,28.95547663,0,-1.350053027,1.139882644,-1.184378966,0.236263083,0.373950869,54.36999662,0,1.659675082,0.53554282,3.099052064,0.001941409,0.00827305,N,-,,WD40 repeat,P:nuclear division; P:chromatin silencing; P:nuclear chromosome segregation; C:intracellular organelle part,IPR015943 (G3DSA:2.130.10.GENE3D); PTHR19842:SF2 (PANTHER); PTHR19842 (PANTHER); PTHR19842:SF2 (PANTHER); PTHR19842 (PANTHER); IPR017986 (SUPERFAMILY),,
RL4_JR_03310,2155,1242,2621,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_03311,11387,7535,13053,7,10,9,0,0,2,8,2,0,1,0,0,0,11,0,388.0819795,1,-0.699363869,0.700168015,-0.998851495,0.317866636,0.50652664,75.05521538,1,-2.76435249,1.195358318,-2.312572262,0.020746168,0.059231607,218.1454207,1,-3.003724047,0.853678692,-3.518565093,0.000433887,0.003050469,245.1906501,1,-3.11041073,0.745563767,-4.171890945,3.02E-05,0.000379948,221.583639,1,-1.912875463,0.571551611,-3.346811429,0.000817468,0.004068754,N,-,,related to RNA binding NRD1,F:nucleic acid binding; P:ncRNA 3'-end processing; P:RNA catabolic process,IPR000504 (SMART); IPR006569 (SMART); IPR000504 (PFAM); IPR008942 (G3DSA:1.25.40.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR23189:SF50 (PANTHER); PTHR23189:SF50 (PANTHER); PTHR23189 (PANTHER); PTHR23189 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR006569 (PROSITE_PROFILES); IPR008942 (SUPERFAMILY); IPR012677 (SUPERFAMILY),9.A.60.1.1, the small nuclear rna exporter (snrna-e).
RL4_JR_03312,811,922,1083,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,537.2109032,0,0.720057982,0.536538522,1.3420434,0.179581924,0.336627744,66.78517762,0,-2.595960395,1.19391555,-2.174324972,0.029680738,0.078481643,173.8993408,0,-5.253130357,1.198424898,-4.383362165,1.17E-05,0.000214331,291.2012059,1,-1.230367764,0.458048338,-2.686109001,0.00722895,0.037488272,274.2654754,0,-0.419684467,0.472101672,-0.888970514,0.374018927,0.510163227,N,-,,citrate synthase,F:citrate (Si)-synthase activity; C:mitochondrion; P:citrate metabolic process; P:tricarboxylic acid cycle,IPR002020 (PRINTS); IPR010109 (TIGRFAM); IPR016142 (G3DSA:1.10.580.GENE3D); IPR002020 (PFAM); PTHR11739:SF8 (PANTHER); IPR002020 (PANTHER); IPR002020 (SUPERFAMILY),,
RL4_JR_03313,67,33,67,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,137.2843815,0,-0.233388243,0.684572189,-0.340925685,0.733159528,0.859100276,25.97096545,0,-1.233289351,1.223879709,-1.007688372,0.313604089,0.475408206,67.24214122,0,-3.882283059,1.211374009,-3.204859135,0.001351286,0.007296223,97.62833265,1,-1.314742973,0.735552428,-1.787422518,0.073869225,0.15692948,95.48898544,0,-1.282880144,0.785333565,-1.633548088,0.102353776,0.194324391,N,-,,mitochondrial DNA replication YHM2,P:alpha-ketoglutarate transport; F:DNA binding; P:tricarboxylic acid transmembrane transport; F:tricarboxylate secondary active transmembrane transporter activity; C:integral component of membrane; P:mitochondrial citrate transport; C:mitochondrial nucleoid; P:mitochondrial genome maintenance,IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); PTHR24089 (PANTHER); PTHR24089:SF344 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.29.1, the mitochondrial carrier (mc) family.
RL4_JR_03314,142,198,225,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,8903.020345,0,-0.027558493,0.451543311,-0.061031782,0.951333898,0.976101363,2036.366506,0,-1.302831373,0.658626409,-1.978103754,0.047917003,0.114034767,4454.151099,0,-2.375402912,0.439719313,-5.402089115,6.59E-08,2.36E-06,4597.147364,1,-3.906865899,0.470889964,-8.296770363,1.07E-16,7.91E-15,4002.445739,0,-3.391759958,0.999673084,-3.392869139,0.000691647,0.003554783,N,-,,plasma membrane atpase,"C:integral component of plasma membrane; F:ATP binding; P:regulation of intracellular pH; F:metal ion binding; C:intracellular membrane-bounded organelle; P:hydrogen ion transmembrane transport; F:hydrogen-exporting ATPase activity, phosphorylative mechanism; P:ATP biosynthetic process",IPR001757 (PRINTS); PR00119 (PRINTS); IPR004014 (SMART); PF00702 (PFAM); IPR001757 (TIGRFAM); IPR023299 (G3DSA:3.40.1110.GENE3D); IPR006534 (TIGRFAM); IPR004014 (PFAM); IPR023299 (G3DSA:3.40.1110.GENE3D); IPR008250 (G3DSA:2.70.150.GENE3D); IPR008250 (PFAM); IPR023298 (G3DSA:1.20.1110.GENE3D); PTHR24093:SF271 (PANTHER); PTHR24093 (PANTHER); PTHR24093 (PANTHER); PTHR24093:SF271 (PANTHER); IPR023214 (SUPERFAMILY); SSF81665 (SUPERFAMILY); SSF81653 (SUPERFAMILY),3.A.3.3.1, the p-type atpase (p-atpase) superfamily.
RL4_JR_03315,16,2,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.778360675,0,-1.39194938,1.217802458,-1.143000961,0.253038192,0.430635883,3.094513346,0,1.835720959,1.285268414,1.42827828,0.153211777,0.281045598,8.073563917,0,-0.82434215,1.212054812,-0.680119531,0.496428779,0.62934649,9.317046129,0,-1.247165383,1.2124945,-1.028594672,0.303670183,0.449221786,8.005934676,0,-0.914794035,1.222184185,-0.748491141,0.454163967,0.586139187,N,-,,plasma membrane ATPase,F:nucleotide binding; F:ATPase activity; F:ATP binding; F:metal ion binding; C:membrane; C:integral component of membrane; P:ATP biosynthetic process; F:hydrolase activity,IPR017986 (SUPERFAMILY),,
RL4_JR_03316,180,189,131,0,0,0,0,0,0,0,0,0,2,1,0,0,0,0,0.731387426,0,2.348920229,1.653319724,1.420729575,0.155395391,NA,0.234724177,0,5.556550189,1.771959786,3.135821835,0.001713733,0.015023052,0.60682058,0,2.909707457,1.257341056,2.314175174,0.020658115,0.056971604,0.69987334,1,2.487660301,1.334977099,1.863447922,0.062399273,0.139900939,0.596205983,0,2.83185646,1.221889163,2.317605022,0.020470797,0.055582413,N,-,,---NA---,,no IPS match,,
RL4_JR_03317,60,88,63,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,93.13574754,0,0.127708298,0.503872197,0.25345375,0.799917597,0.898489296,16.07665871,0,-0.541374434,1.199277835,-0.451417026,0.651689014,0.775225785,57.39325512,0,-1.369138181,1.025953944,-1.334502576,0.182039203,0.303218969,91.13152833,0,0.106774713,0.529249261,0.201747497,0.840114129,0.900217542,64.27517739,0,-0.084519469,0.618730033,-0.13660153,0.891345767,0.928946134,N,-,,nuclear pore,C:nuclear pore nuclear basket; P:ribosomal large subunit export from nucleus; F:protein binding; P:nuclear pore organization; P:protein import into nucleus; F:structural constituent of nuclear pore; C:nuclear pore linkers,IPR007231 (PFAM); IPR007231 (PANTHER),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_03318,179,136,190,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.68104586,0,-2.135590898,1.161088461,-1.839300768,0.06587096,0.163385617,10.05031941,0,0.1362841,1.227493082,0.111026369,0.911595436,0.950652603,39.19349059,0,-0.706278667,1.04879218,-0.673420989,0.500679499,0.633372392,30.22750725,0,-2.945039848,1.205563431,-2.442874239,0.014570814,0.065394277,52.63954473,0,0.556796754,0.672773855,0.827613544,0.407889396,0.543906247,N,-,,ribitol kinase,"P:carbohydrate metabolic process; P:phosphorylation; F:phosphotransferase activity, alcohol group as acceptor; F:kinase activity",IPR018485 (PFAM); G3DSA:3.30.420.40 (GENE3D); IPR006003 (TIGRFAM); IPR018484 (PFAM); G3DSA:3.30.420.40 (GENE3D); PTHR10196:SF71 (PANTHER); PTHR10196 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_03319,23,113,53,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.144607763,0,0.796950835,1.265751407,0.629626663,0.528938874,0.712907261,0.681959365,0,4.017707946,1.469986872,2.733159066,0.006273003,0.023969549,1.773274825,0,1.362373882,1.218740558,1.117853897,0.263629398,0.401049441,11.68126392,0,1.88964908,1.148528479,1.645278383,0.099912416,0.195669866,1.752169152,0,1.277268847,1.214511179,1.051673191,0.292949515,0.42776375,N,-,,Survival motor neuron,C:nucleus; F:RNA binding; C:cytoplasm; P:mRNA processing,no IPS match,,
RL4_JR_03320,100,129,150,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,344.1355865,0,9.538514587,2.302258972,4.14311105,NA,NA,0.146807595,0,6.233151427,1.965760555,3.170859955,0.001519884,0.015023052,0.384391526,0,3.567200557,1.328705479,2.684718783,0.007259086,0.025306812,16.49002494,0,5.814343839,0.826534553,7.034604683,2.00E-12,9.11E-11,15.82501829,0,6.027832582,0.854507397,7.054160797,1.74E-12,1.69E-10,Y,-,,serine-threonine rich,F:electron carrier activity,IPR008972 (G3DSA:2.60.40.GENE3D); PTHR34883:SF4 (PANTHER); PTHR34883 (PANTHER); IPR008972 (SUPERFAMILY),,
RL4_JR_03321,65,46,72,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,260.7398505,0,1.093982875,0.726862553,1.505075301,0.132304718,0.270443972,192.5045725,0,2.444624516,0.616271723,3.966796505,7.28E-05,0.003691215,92.16571353,0,-2.108719644,1.034391858,-2.038608123,0.041489154,0.098428997,192.2252833,0,0.22964853,0.450390494,0.509887605,0.610130206,0.73012272,88.4212494,0,-1.112032973,0.700289727,-1.587961283,0.112295094,0.20835401,N,-,,serf family,C:integral component of membrane,IPR007513 (PFAM),,
RL4_JR_03322,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.69929166,0,0.96808795,1.181420487,0.819427089,0.412542785,0.603624069,1.170355109,0,3.238427487,1.411135175,2.294909478,0.021738313,0.0616,3.053141568,0,0.578317337,1.238412917,0.466982643,0.640512297,0.749571898,3.523077442,0,0.155665523,1.247415795,0.124790405,0.900689483,0.938991044,3.031405848,0,0.486214341,1.245168283,0.390480827,0.69618103,0.785297786,N,-,,hypothetical protein CMQ_4588,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03323,0,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,128.6939509,0,-0.855947456,0.582926595,-1.468362336,0.142005827,0.285059925,39.67379516,0,-0.538986326,1.122642173,-0.480105183,0.631152603,0.75792225,114.8288639,0,-0.961214294,0.678354613,-1.416979078,0.156489044,0.270668131,136.8714957,0,-1.189566123,0.627167575,-1.896727719,0.057863883,0.134343458,84.65399421,0,-2.511493167,0.977928799,-2.568175892,0.010223527,0.03197813,N,-,,mrna cleavage factor complex component pcf11,P:RNA metabolic process; C:intracellular part,IPR006569 (SMART); IPR008942 (G3DSA:1.25.40.GENE3D); IPR006903 (PFAM); IPR021605 (PFAM); PTHR15921 (PANTHER); IPR006569 (PROSITE_PROFILES); IPR008942 (SUPERFAMILY),,
RL4_JR_03324,0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,55.67595044,0,-1.46160836,1.078423118,-1.355319944,0.175315643,0.330160236,126.562462,0,3.00355933,1.635030068,1.837005563,0.066209074,0.146928976,79.71436764,0,0.891946724,0.688872232,1.294792681,0.195391758,0.320140177,88.44539054,0,0.622148207,0.647643412,0.960633884,0.336736285,0.483747856,84.71211069,0,1.062564067,0.638318402,1.664630165,0.095986563,0.185152211,Y,-,,ring finger domain,F:zinc ion binding; F:metal ion binding; C:membrane; C:integral component of membrane; C:cellular_component,IPR001841 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001841 (PFAM); PTHR22765:SF27 (PANTHER); PTHR22765 (PANTHER); PTHR22765:SF27 (PANTHER); PTHR22765 (PANTHER); PTHR22765:SF27 (PANTHER); PTHR22765 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),8.A.112.1.6, the respiratory supercomplex factor (rcf) family.
RL4_JR_03325,4,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,82.35026581,0,2.361612983,0.516423896,4.573012596,4.81E-06,6.06E-05,4.201394252,0,1.394569078,1.267482798,1.100266671,0.271215949,0.428877963,45.5427817,0,1.567923565,0.763897573,2.052531152,0.040118071,0.095859181,93.21665199,0,2.638276347,0.492596,5.355862308,8.51E-08,1.96E-06,10.84512596,0,-1.352763959,1.219588882,-1.109196697,0.267345337,0.399597216,N,-,,tubulin specific chaperone cofactor B,,IPR000938 (SMART); IPR000626 (PFAM); G3DSA:3.10.20.90 (GENE3D); IPR000938 (PFAM); IPR000938 (G3DSA:2.30.30.GENE3D); PTHR18916 (PANTHER); IPR000938 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY); IPR000938 (SUPERFAMILY),,
RL4_JR_03326,2351,3232,2912,2,1,7,0,0,0,2,0,0,0,4,0,0,0,0,40.89667235,1,-0.072879869,0.751959385,-0.096919955,0.922789962,0.962640224,8.167556761,0,0.435632411,1.223095979,0.356171894,0.721711839,0.825815876,21.18749379,1,-2.216109368,1.192329436,-1.858638479,0.063078399,0.135585077,62.98428256,1,0.118541286,0.743057043,0.159531878,0.873249845,0.921773841,20.8702914,0,-2.297118403,1.194505265,-1.923070974,0.054471137,0.119557829,N,-,,MYB DNA-binding domain-containing,F:DNA binding,IPR001005 (SMART); IPR001005 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); PTHR23246:SF5 (PANTHER); PTHR23246 (PANTHER); IPR017930 (PROSITE_PROFILES); IPR017877 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY),,
RL4_JR_03327,339,371,298,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.767222996,0,-0.35569106,1.276571728,-0.278629905,0.78052886,0.887216726,1.510208274,0,2.870620416,1.399595391,2.051035917,0.040263449,0.099647641,28.01275635,0,2.614247098,0.904110558,2.891512632,0.003833922,0.016016484,16.58761783,0,2.045744042,0.936627766,2.184159082,0.02895056,0.090442587,3.924482225,0,0.11369545,1.260879853,0.090171518,0.928150918,0.953289515,N,-,,tRNA (uracil-5-)-methyltransferase TRM9,F:methyltransferase activity; C:intracellular part; P:single-organism process; P:cellular process; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR013216 (PFAM); PTHR13069 (PANTHER); PTHR13069:SF21 (PANTHER); PTHR13069:SF21 (PANTHER); PTHR13069 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_03328,375,354,322,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.91884065,0,-1.229195202,1.168392905,-1.052039255,0.29278154,0.47779792,5.371767443,0,1.040136205,1.26275338,0.823704946,0.410107229,0.573939565,13.95419174,0,-1.613580279,1.211115046,-1.332309664,0.182758453,0.304171292,16.10051226,0,-2.036153806,1.211514986,-1.680667453,0.092827526,0.185234273,13.75413346,0,-1.695513854,1.215943295,-1.394402075,0.163196222,0.276083834,N,-,,oxidoreductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR000683 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.360.10 (GENE3D); PTHR22604:SF115 (PANTHER); PTHR22604 (PANTHER); SSF55347 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_03329,19,8,30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35.93788596,0,1.62503302,0.758461145,2.142539577,0.032150087,0.095669375,2.576476523,0,2.100150079,1.296493828,1.619868937,0.105260434,0.210604094,6.684237077,0,-0.551648137,1.205312467,-0.457680604,0.647181925,0.754759798,7.711547866,0,-0.974065991,1.204493009,-0.808693769,0.418691313,0.561936578,6.582213323,0,-0.632235738,1.206335135,-0.524096264,0.600211587,0.710036548,N,-,,aldo-keto reductase (AKR),,IPR023210 (PFAM); IPR023210 (G3DSA:3.20.20.GENE3D); PTHR11732:SF198 (PANTHER); IPR001395 (PANTHER); IPR023210 (SUPERFAMILY),,
RL4_JR_03330,1,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,871.6700099,0,0.8535248,0.334172669,2.554143051,0.010644951,0.039817309,239.9046276,0,0.940907968,0.540957515,1.73933801,0.081975325,0.173331012,915.9719766,0,1.398371978,0.279844006,4.99696956,5.82E-07,1.68E-05,1012.696999,0,1.318635875,0.679399635,1.940883989,0.05227235,0.125826526,506.212312,0,0.197185366,0.541878041,0.36389252,0.71593827,0.799713297,Y,-,,glycoside hydrolase,P:biological_process; P:carbohydrate metabolic process; C:cellular_component; F:molecular_function; F:hydrolase activity,IPR013781 (G3DSA:3.20.20.GENE3D); IPR024655 (PFAM); PTHR34154:SF3 (PANTHER); PTHR34154 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_03331,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,89.61993624,0,1.685150001,0.473894922,3.555957076,0.000376606,0.002637209,7.338174798,0,0.590119663,1.241443555,0.475349573,0.634537831,0.76108448,41.10462574,0,-0.222841158,1.037358833,-0.214815887,0.829910866,0.890327181,39.20728505,0,-0.167650641,0.863600243,-0.194129914,0.846074159,0.903544021,18.63347107,0,-2.133668301,1.198880518,-1.779717218,0.075122251,0.152979242,N,-,,c6 transcription factor,"C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31263:SF8 (PANTHER); PTHR31263 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_03332,2,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,55.10196875,0,2.25314532,0.701265348,3.212971133,0.001313695,0.007330454,2.19777943,0,2.329505607,1.328022848,1.754115609,0.0794107,0.169307567,5.675858923,0,-0.315896268,1.213870129,-0.260238934,0.794679474,0.864717863,10.55714371,0,0.208205563,1.162033302,0.179173491,0.857801478,0.911415424,5.573919135,0,-0.392633056,1.2115268,-0.324081197,0.745876562,0.822657973,N,-,,hypothetical protein SPI_00029,,no IPS match,,
RL4_JR_03333,3135,5034,3673,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,300.1278417,1,0.861138181,0.646508011,1.331983777,0.18286552,0.340331164,33.79339659,0,-1.613126427,1.20809969,-1.335259367,0.181791472,0.320741378,278.2345655,0,1.194639052,0.366067003,3.263443695,0.001100671,0.006228367,188.2917272,1,-0.064793212,0.434178594,-0.149231705,0.881370803,0.92661179,96.79343768,0,-2.655496709,0.973497616,-2.727789637,0.006376025,0.02191353,N,-,,6-phosphofructo-2-kinase 1,"F:ATP binding; P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:carbohydrate phosphorylation; F:6-phosphofructo-2-kinase activity",IPR003094 (PRINTS); IPR013078 (SMART); IPR029033 (G3DSA:3.40.50.GENE3D); IPR013079 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR013078 (PFAM); PTHR10606:SF32 (PANTHER); PTHR10606:SF32 (PANTHER); IPR003094 (PANTHER); IPR003094 (PANTHER); PTHR10606:SF32 (PANTHER); IPR003094 (PANTHER); IPR027417 (SUPERFAMILY); IPR029033 (SUPERFAMILY),,
RL4_JR_03334,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46.63753449,0,-0.648241488,0.864624212,-0.749737839,0.453412613,0.642400156,9.215418913,0,0.261421357,1.224592459,0.21347621,0.830955543,0.898699862,23.96197585,0,-2.393769228,1.198706265,-1.996960639,0.045829459,0.105810135,27.64546533,0,-2.816232476,1.198498208,-2.349801158,0.018783442,0.074464508,23.69789973,0,-2.480479521,1.206208024,-2.05642764,0.039741314,0.093620477,N,-,,cytidine deaminase,"F:nucleic acid binding; P:RNA phosphodiester bond hydrolysis, endonucleolytic; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding; P:adenosine to inosine editing; F:tRNA-specific adenosine-34 deaminase activity; C:cytosol; C:tRNA-specific adenosine-34 deaminase complex; F:pseudouridine synthase activity; P:enzyme-directed rRNA pseudouridine synthesis; P:tRNA modification",G3DSA:3.40.140.10 (GENE3D); IPR002125 (PFAM); PTHR11079 (PANTHER); PTHR11079:SF98 (PANTHER); IPR002125 (PROSITE_PROFILES); IPR016193 (SUPERFAMILY),9.B.317.1.6,"The Complex I Integral Membrane Chaparone, TMEM126 (TMEM126) Family"
RL4_JR_03335,1,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49.95878583,0,0.43121861,0.617650433,0.69815965,0.485077358,0.673003586,8.659118281,0,0.351340738,1.224182065,0.287000396,0.774112017,0.863137457,109.6639724,0,1.71377037,0.513180275,3.339509434,0.000839265,0.005006753,126.0213071,0,1.747826193,0.449294412,3.890157872,0.000100179,0.001072212,47.97005767,0,0.259230215,0.736896864,0.351786291,0.72499854,0.80657183,N,-,,ribonuclease h,"F:nucleic acid binding; P:RNA phosphodiester bond hydrolysis, endonucleolytic; F:RNA-DNA hybrid ribonuclease activity; C:nuclear chromatin; C:nucleolus",IPR002156 (PFAM); IPR011320 (G3DSA:3.40.970.GENE3D); IPR011320 (PFAM); G3DSA:1.10.601.10 (GENE3D); IPR004931 (PFAM); IPR012337 (G3DSA:3.30.420.GENE3D); PTHR10642 (PANTHER); IPR002156 (PROSITE_PROFILES); IPR012337 (SUPERFAMILY); IPR009027 (SUPERFAMILY); IPR009027 (SUPERFAMILY),,
RL4_JR_03336,213,236,273,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0.708817882,0,2.394188727,1.68986176,1.416795613,0.156542693,NA,0.228065872,0,5.598143985,1.791920636,3.124102638,0.001783482,0.015023052,0.588353057,0,2.954644182,1.266819981,2.332331528,0.019683257,0.054941631,0.678497701,1,2.532580273,1.352158662,1.872990459,0.061069702,0.137947378,0.576561173,1,2.880181606,1.226522267,2.348250565,0.018861828,0.052218196,N,-,,sodium hydrogen exchanger family,F:solute:proton antiporter activity; C:integral component of membrane; P:hydrogen ion transmembrane transport,IPR006153 (PFAM); PTHR31382 (PANTHER); PTHR31382:SF1 (PANTHER),2.A.36.4.5, the monovalent cation:proton antiporter-1 (cpa1) family.
RL4_JR_03337,141,137,150,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.119226813,0,4.96568659,3.713215068,1.337301099,0.181124373,NA,0.038415102,0,8.16776828,2.548197777,3.205311752,0.001349163,0.015023052,0.099181356,0,5.522148093,1.477002409,3.738753612,0.000184935,0.001681223,0.114372899,0,5.100797696,2.217838247,2.299896173,0.021454103,0.079510539,0.09742718,0,5.443016253,1.294714758,4.20402735,2.62E-05,0.000225945,N,-,,---NA---,,no IPS match,,
RL4_JR_03338,141,166,149,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,184.8819027,0,-1.58643885,0.654055934,-2.42554003,0.01528563,0.053177044,48.4759111,0,-2.13366568,1.211491321,-1.761189406,0.07820635,0.167429078,258.0150626,0,-0.020848093,0.450471956,-0.046280557,0.963086636,0.978257159,181.9107257,1,-1.517426012,0.584281144,-2.597081949,0.009401949,0.046233479,138.0207104,0,-2.25433665,0.77237778,-2.918696921,0.003514978,0.013434938,N,-,,ankyrin repeat,C:membrane,IPR002110 (SMART); IPR002909 (SMART); PF13857 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR002909 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR24189 (PANTHER); PTHR24189 (PANTHER); PTHR24189:SF22 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR014756 (SUPERFAMILY); IPR020683 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_03339,288,237,462,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,105.0565502,0,-3.819099802,1.185019961,-3.222814745,0.001269376,0.007131936,31.9557512,0,-1.532515525,1.216307448,-1.259973807,0.207678811,0.352883151,83.49768872,0,-4.194688697,1.214416017,-3.454078863,0.000552176,0.003644217,128.4607916,0,-1.014573855,0.663004541,-1.530266826,0.125950696,0.232879985,82.9085671,0,-4.28722599,1.225979236,-3.496980915,0.000470555,0.002573946,N,-,,ribosomal biogenesis gar2,F:nucleotide binding; F:nucleic acid binding,IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR24012:SF243 (PANTHER); PTHR24012:SF243 (PANTHER); PTHR24012 (PANTHER); PTHR24012 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_03340,434,350,987,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,115.9066377,0,0.365592677,0.742787943,0.492189838,0.622585148,0.783803956,14.68638849,0,-0.410846339,1.240752517,-0.331126742,0.740548753,0.839869409,92.52700466,0,0.741049016,0.594577496,1.24634555,0.212637562,0.340797923,109.3009123,0,0.692260918,0.531622585,1.302166119,0.192859605,0.322121989,79.47492072,0,0.791140842,0.628129917,1.259517848,0.207843348,0.330674716,N,-,,golgi matrix,C:membrane,IPR019459 (PFAM); PTHR18921 (PANTHER); IPR000237 (PROSITE_PROFILES),1.C.105.2.2, the bacillus thuringiensis vegetative insecticidal protein-3 (vip3) family.
RL4_JR_03341,20,10,16,0,0,0,0,0,0,0,1,0,0,3,0,0,0,0,4.991822675,0,2.613973575,1.170827464,2.232586487,0.025576226,0.080157838,0.376152948,0,4.87625403,1.63293169,2.986195969,0.002824716,0.015349618,0.971934007,1,2.230584169,1.242383788,1.795406694,0.072588927,0.151243115,1.121008765,1,1.808334598,1.280528137,1.41217873,0.157897342,0.276402245,0.953364856,0,2.155205321,1.21726357,1.770533,0.076638392,0.155690955,N,-,,---NA---,,no IPS match,,
RL4_JR_03342,21645,8295,17441,0,0,2,0,0,0,0,0,0,0,0,1,0,0,0,0.998570673,1,1.899666348,1.459604266,1.301494105,0.193089381,NA,0.319243409,0,5.112783922,1.66595553,3.068979831,0.002147911,0.015045494,0.827514457,0,2.461923552,1.238927443,1.987141027,0.046906771,0.107805709,28.8913632,1,4.370706952,0.853415637,5.121428249,3.03E-07,6.17E-06,0.815345847,0,2.380571828,1.21643237,1.957011246,0.050346146,0.11275265,N,-,,chorismate synthase,C:membrane; C:integral component of membrane,PTHR39470 (PANTHER),,
RL4_JR_03343,28,9,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49.50142875,0,-0.066028937,0.732353608,-0.090159913,0.92816014,0.96556984,8.245300712,0,0.421944922,1.216100887,0.346965393,0.728617318,0.830805959,40.88954243,0,0.174667902,0.845906507,0.20648606,0.836411252,0.894492905,66.90963727,0,0.410182805,0.658090203,0.623292678,0.533092209,0.665872022,48.11565118,0,1.094705691,0.580651101,1.885307181,0.059388377,0.127638998,Y,-,,chd5 domain containing,C:endoplasmic reticulum membrane; C:GET complex; P:tail-anchored membrane protein insertion into ER membrane; C:integral component of membrane; P:transport,IPR028945 (PFAM); PTHR11760 (PANTHER); PTHR11760:SF21 (PANTHER),3.A.19.1.2, the tms recognition/insertion complex (trc) family.
RL4_JR_03344,3545,3548,5807,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.29028163,0,-1.721896947,1.266876273,-1.359167414,0.174093545,0.328686678,3.952649538,0,1.482672304,1.348239128,1.099710187,0.271458415,0.429194326,16.7292162,0,-0.20411106,1.248798908,-0.163445899,0.870167366,0.91785157,11.79855115,0,-1.5877994,1.260956637,-1.259202222,0.207957299,0.340486361,25.52905137,0,1.28406353,0.887448425,1.446916231,0.147920387,0.256454438,N,-,,prenyltransferase alpha subunit repeat-containing 1-B,F:protein prenyltransferase activity; P:protein prenylation; F:transferase activity,G3DSA:1.25.40.120 (GENE3D); IPR002088 (PFAM); PTHR11129:SF3 (PANTHER); PTHR11129 (PANTHER); SSF48439 (SUPERFAMILY),,
RL4_JR_03345,6605,7381,10737,1,1,10,0,0,0,4,5,1,4,3,1,0,7,0,2219.71195,1,-4.14950047,0.45489185,-9.12194947,7.38E-20,9.41E-18,831.0526901,0,-2.766589832,1.017912428,-2.717905544,0.006569659,0.024762936,4749.997606,1,0.785986768,0.877589243,0.895620331,0.370455574,0.515177504,2741.529172,1,-1.476282769,1.34525464,-1.097400243,0.272466467,0.414409341,2784.535159,1,-0.653825734,1.20003632,-0.544838288,0.585864743,0.698525733,N,-, Effector probability:0.914,hypothetical protein SPI_01021,C:integral component of membrane,no IPS match,,
RL4_JR_03346,2628,2123,3847,0,0,0,0,0,1,0,0,0,2,2,4,0,0,0,146.7552393,0,2.478005958,0.773787563,3.202437046,0.001362701,0.00758316,6.510733539,1,0.762755174,1.243137005,0.613572897,0.539497598,0.686546981,68.94801995,0,1.281511357,0.676508132,1.894302962,0.058184808,0.127008702,107.5163954,1,2.499274582,0.455961048,5.481333531,4.22E-08,1.03E-06,50.89697773,0,1.641354531,0.55158,2.975732498,0.002922897,0.011578377,Y,-,,eukaryotic aspartyl protease,C:membrane; F:peptidase activity,IPR001461 (PRINTS); IPR021109 (G3DSA:2.40.70.GENE3D); IPR033121 (PFAM); IPR021109 (G3DSA:2.40.70.GENE3D); IPR001461 (PANTHER); PTHR13683:SF249 (PANTHER); IPR033121 (PROSITE_PROFILES); IPR021109 (SUPERFAMILY),8.A.32.1.4,The β-Amyloid Cleaving Enzyme (BACE1) Family
RL4_JR_03347,60,59,113,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,55.1902678,0,0.380370645,0.622902405,0.610642441,0.541436319,0.723138537,9.021583445,0,0.292163933,1.231017019,0.237335413,0.812396591,0.886298587,23.31501829,0,-2.354203225,1.196140428,-1.968166254,0.049048912,0.111532106,105.7250948,0,1.310174255,0.504381276,2.597587017,0.009388133,0.046187972,34.48492087,0,-0.228800189,0.848270842,-0.269725397,0.787371521,0.854792735,N,-,,transmembrane amino acid transporter,C:integral component of membrane; C:endoplasmic reticulum,IPR013057 (PFAM); PTHR22950:SF54 (PANTHER); PTHR22950 (PANTHER),2.A.18.6.20, the amino acid/auxin permease (aaap) family.
RL4_JR_03348,3,2,3,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,79.65539386,0,1.987759074,0.913162499,2.176785704,0.02949656,0.089222447,15.2899209,0,1.81834995,1.125706253,1.615297015,0.10624639,0.212115573,85.92780938,1,2.2188081,1.591000772,1.394599009,0.163136794,0.279363481,63.11554664,0,1.834288496,0.513646012,3.571114059,0.000355466,0.003121504,15.11691503,0,-1.831816066,1.198066384,-1.5289771,0.126270121,0.227367059,N,-,,---NA---,,no IPS match,,
RL4_JR_03349,8,23,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,260.5159745,0,0.404766541,0.413800808,0.978167593,0.327991441,0.517290234,38.11698778,0,-1.78685916,1.190632929,-1.500764103,0.133416586,0.251873961,171.2299169,0,-0.449347774,0.511664098,-0.878208527,0.379830566,0.523858597,221.3451531,0,-0.390896185,0.43928563,-0.889845144,0.373549043,0.519191148,105.1368301,0,-3.590352754,1.124109996,-3.193951452,0.001403397,0.006306878,N,-,,gtp-binding rhoa,"P:regulation of exocyst localization; P:small GTPase mediated signal transduction; P:positive regulation of protein kinase C signaling; P:regulation of cell wall (1->3)-beta-D-glucan biosynthetic process; P:positive regulation of endocytosis; P:regulation of cell size; C:mating projection tip; C:Golgi apparatus; C:1,3-beta-D-glucan synthase complex; P:budding cell bud growth; P:regulation of fungal-type cell wall organization; F:GTP binding; C:peroxisome; C:incipient cellular bud site; C:cellular bud tip; P:regulation of vacuole fusion, non-autophagic; C:cellular bud neck; F:GTPase activity; P:actin cytoskeleton reorganization",PR00449 (PRINTS); SM00173 (SMART); SM00175 (SMART); SM00174 (SMART); IPR005225 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001806 (PFAM); PTHR24072 (PANTHER); PS51420 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_03350,723,1190,921,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,166.897827,0,-0.63924979,0.648285472,-0.986062187,0.324102598,0.513304017,60.80726051,0,0.584022311,0.918129605,0.636100075,0.524711196,0.674000854,113.039994,1,-1.432296257,0.816055005,-1.755146709,0.079234216,0.161499337,141.1587005,0,-1.52466914,0.757483146,-2.012809327,0.044134692,0.114024945,119.9061664,0,-0.830697105,0.716994845,-1.158581698,0.246626733,0.376749497,N,-,,kow motif domain containing,C:intracellular,IPR005824 (SMART); IPR014722 (G3DSA:2.30.30.GENE3D); PTHR12903:SF0 (PANTHER); PTHR12903 (PANTHER); IPR008991 (SUPERFAMILY),,
RL4_JR_03351,519,459,492,0,0,6,0,0,3,0,0,2,0,0,0,0,9,0,37.57150094,1,0.10608931,0.786721542,0.134849886,0.892730563,0.947553465,7.199321788,1,0.617707764,1.26303475,0.489066325,0.624794741,0.75331663,32.8779017,1,-0.203522034,1.053419627,-0.193201293,0.846801326,0.902042995,52.03248126,0,0.600996343,0.707655223,0.849278466,0.39572636,0.539989691,29.71516322,1,0.096923014,0.87058201,0.111331285,0.911353648,0.943116893,N,-,,tpr domain containing,,PTHR42345:SF1 (PANTHER); PTHR42345:SF1 (PANTHER); PTHR42345 (PANTHER); PTHR42345 (PANTHER),1.C.104.1.7, the heterokaryon incompatibility prion/amyloid protein (het-s) family
RL4_JR_03352,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,90.65278477,0,1.211708251,0.586407717,2.06632385,0.038797911,0.110437319,10.5315025,0,0.06890647,1.21693907,0.056622777,0.95484569,0.976060198,40.29503166,0,-0.761868272,1.033320581,-0.737300975,0.46093934,0.59858259,44.81443958,0,-1.269602341,1.015118913,-1.250693219,0.211046426,0.344763643,38.44618391,0,-0.456955804,0.844499356,-0.541096687,0.588440942,0.700689702,N,-,,VTC domain-containing,C:integral component of membrane,IPR003807 (PFAM); IPR018966 (PFAM); PTHR10783 (PANTHER); PTHR10783:SF45 (PANTHER); IPR004331 (PROSITE_PROFILES),4.E.1.1.2, the vacuolar (acidocalcisome) polyphosphate polymerase (v-ppp) family.
RL4_JR_03353,10209,9217,12484,7,5,27,0,0,0,0,18,73,5,7,5,0,27,3,2943.304449,1,-1.462903004,0.507075888,-2.88497844,0.003914405,0.017733515,842.5140907,0,-2.086803283,0.590685267,-3.532851416,0.000411103,0.015022343,2025.953495,1,-2.838517362,0.644378835,-4.405044373,1.06E-05,0.000195747,2328.54273,1,-2.859735296,0.580890407,-4.92302035,8.52E-07,1.59E-05,1988.942585,1,-2.799788181,0.444988882,-6.29181603,3.14E-10,2.01E-08,N,-,,glutamate synthase,P:glutamate biosynthetic process; F:FMN binding; F:iron ion binding; F:glutamate synthase (NADH) activity; F:flavin adenine dinucleotide binding; C:mitochondrion; C:cytosol; P:oxidation-reduction process; F:iron-sulfur cluster binding,PR00419 (PRINTS); IPR006982 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); IPR028261 (PFAM); IPR002489 (G3DSA:2.160.20.GENE3D); IPR002932 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (PFAM); IPR017932 (PFAM); IPR006005 (TIGRFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR002489 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); IPR012220 (PIRSF); IPR023753 (G3DSA:3.50.50.GENE3D); G3DSA:1.10.1060.10 (GENE3D); IPR029055 (G3DSA:3.60.20.GENE3D); PTHR11938 (PANTHER); PTHR11938:SF1 (PANTHER); IPR017932 (PROSITE_PROFILES); SSF51971 (SUPERFAMILY); IPR009051 (SUPERFAMILY); IPR029055 (SUPERFAMILY); SSF51395 (SUPERFAMILY); IPR002489 (SUPERFAMILY); SSF51971 (SUPERFAMILY),3.D.8.1.2, the na(+)- or h(+)-pumping formyl methanofuran dehydrogenase (fmf-dh) family.
RL4_JR_03354,215,111,183,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0.948207864,1,1.974380925,1.495548178,1.320172064,0.186777577,NA,0.30457319,0,5.180753996,1.691451835,3.062903649,0.002192006,0.015045494,0.786762204,0,2.535201617,1.247202077,2.03271119,0.04208171,0.099383525,0.907372739,0,2.113148016,1.299174175,1.626531728,0.10383659,0.201445769,0.772191674,0,2.45879147,1.217860451,2.018943524,0.04349309,0.100517584,N,-,,---NA---,,no IPS match,,
RL4_JR_03355,868,691,712,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,50.31300571,1,-2.693458262,1.13752435,-2.367824709,0.017893011,0.059898724,14.87352845,0,-0.429151288,1.205803545,-0.355904815,0.721911849,0.825858018,38.5379474,0,-3.07924501,1.188348978,-2.591195909,0.009564303,0.031560952,73.35943758,0,-1.172095754,0.845633491,-1.38605645,0.165729667,0.286399194,37.95510679,0,-3.160024557,1.189516232,-2.656562788,0.007894175,0.025945295,N,-,,Anaphase-promoting subunit 15 MND2,P:biological_process; P:regulation of mitotic metaphase/anaphase transition; C:anaphase-promoting complex; P:anaphase-promoting complex-dependent catabolic process; C:cellular_component; F:molecular_function,IPR008402 (PFAM),,
RL4_JR_03356,25816,27439,26440,5,2,8,0,0,0,0,3,4,4,6,0,0,8,4,32.48654636,1,-1.637855153,1.154851188,-1.418239138,0.156120959,0.305428005,7.15337816,0,0.626931163,1.240108588,0.505545377,0.613175836,0.745533431,18.53500288,1,-2.023115376,1.200424004,-1.68533399,0.091924151,0.181836676,49.96499489,1,-0.102451184,0.859473297,-0.119202289,0.905115093,0.941762442,49.11027972,1,1.461557408,0.587800454,2.486485673,0.012901176,0.038600594,N,-, Effector probability:0.771,blocked early in transport 1,"C:endoplasmic reticulum membrane; P:ER to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to ER; P:vesicle fusion; C:integral component of membrane; F:SNAP receptor activity; C:SNARE complex; C:ER to Golgi transport vesicle",G3DSA:1.20.5.110 (GENE3D); PTHR12791:SF28 (PANTHER); PTHR12791 (PANTHER); IPR000727 (PROSITE_PROFILES); SSF58038 (SUPERFAMILY),,
RL4_JR_03357,4628,4652,5823,3,5,13,0,0,0,1,1,2,0,13,0,0,4,0,136.8432298,1,1.107564644,0.658767586,1.68126767,0.092710935,0.209395295,15.29898258,0,-0.469857671,1.200261014,-0.391462911,0.695455098,0.807240395,85.429055,1,0.285005137,0.609160814,0.467865184,0.639881002,0.749179515,79.52276835,1,-0.021172622,0.569013724,-0.037209335,0.970318096,0.983358259,54.62483494,1,-0.59527888,0.749653886,-0.794071625,0.427153735,0.561606489,N,-,,Histone chaperone domain CHZ,,IPR019098 (SMART); IPR019098 (PFAM),,
RL4_JR_03358,617,509,568,0,1,0,0,0,0,0,0,0,0,0,7,0,0,0,64.6522752,1,0.998465321,0.724166024,1.378779573,0.167962727,0.320149515,8.37201313,0,0.399868037,1.239182491,0.322686965,0.746932325,0.844837299,29.70506282,0,-1.299655601,1.209278448,-1.074736429,0.282492749,0.421974496,33.2530802,1,-0.970582094,1.044676388,-0.929074405,0.352850528,0.499247008,25.57079061,0,-1.426225558,1.153828955,-1.236080575,0.216428614,0.341611943,Y,-,,cyclin-dependent kinase regulator pho80,P:negative regulation of cellular process; P:regulation of cellular metabolic process,PTHR39219 (PANTHER); PTHR39219:SF1 (PANTHER),,
RL4_JR_03359,1456,1254,1319,1,1,1,0,0,0,1,1,0,0,3,2,0,3,0,127.2130016,1,-0.743202105,0.57668453,-1.288749856,0.197485064,0.359938148,23.55877208,0,-1.092648107,1.208073785,-0.904454778,0.365754303,0.530189498,60.86172034,1,-3.738462808,1.19356951,-3.132170164,0.001735193,0.008841012,86.23875459,1,-1.451167556,0.755221972,-1.921511305,0.054667279,0.129323877,81.8340615,1,-1.585129517,0.837214004,-1.893338513,0.058312867,0.125701038,N,-,,Nuc-1 negative regulatory preg,F:protein kinase binding; F:cyclin-dependent protein serine/threonine kinase regulator activity; P:negative regulation of phosphate metabolic process; P:regulation of protein localization; P:negative regulation of calcium-mediated signaling; C:cyclin-dependent protein kinase holoenzyme complex; P:cellular metal ion homeostasis; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of transcription from RNA polymerase II promoter; C:nucleus; P:negative regulation of macroautophagy; P:phosphorylation; F:kinase activity,IPR013922 (PFAM); PTHR15615:SF16 (PANTHER); PTHR15615 (PANTHER); IPR013763 (SUPERFAMILY),1.G.20.2.1, the hantavirus gc envelope fusion glycoprotein (gc-efg) family.
RL4_JR_03360,3757,2348,2796,0,1,3,0,1,0,0,2,2,0,0,4,0,2,1,203.836994,1,0.050296055,0.406032205,0.123872084,0.901416557,0.952214332,53.31440254,1,-0.565138777,1.11331292,-0.507618987,0.611720573,0.744658525,170.7898742,1,0.266947003,0.453139804,0.589105173,0.555790723,0.682526666,192.6485792,1,-0.006636407,0.420946194,-0.015765452,0.98742151,0.992617434,109.6323707,1,-0.617829893,0.548457974,-1.126485385,0.259960123,0.391739284,N,-,,armadillo repeat,C:cytosol,IPR000225 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR15651 (PANTHER); PTHR15651:SF7 (PANTHER); PTHR15651:SF7 (PANTHER); PTHR15651:SF7 (PANTHER); PTHR15651 (PANTHER); PTHR15651 (PANTHER); PTHR15651 (PANTHER); PTHR15651 (PANTHER); PTHR15651:SF7 (PANTHER); PTHR15651:SF7 (PANTHER); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_03361,143,85,145,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4548.352198,0,0.473449969,0.901337797,0.525274731,0.599392221,0.768824351,1577.368279,0,0.573327672,0.64521769,0.888580212,0.37422873,0.538902149,6141.672963,0,1.516338188,0.701998103,2.160031745,0.030770212,0.078349504,4512.775514,0,0.540663765,0.873784193,0.61876121,0.53607368,0.667948069,3950.643132,0,0.647390335,1.113327977,0.581491123,0.5609095,0.679249932,N,-,,heat shock 30,F:ion channel activity; P:ion transmembrane transport; C:integral component of membrane,IPR001425 (PRINTS); IPR001425 (SMART); G3DSA:1.20.1070.10 (GENE3D); IPR001425 (PFAM); PTHR28286 (PANTHER); PTHR28286:SF1 (PANTHER); SSF81321 (SUPERFAMILY),3.E.1.4.9, the ion-translocating microbial rhodopsin (mr) family.
RL4_JR_03362,1201,1104,950,6,3,1,0,0,0,0,0,3,2,0,2,0,0,0,110.5320045,1,0.175838974,0.621708114,0.28283204,0.777305592,0.885032662,18.15596935,0,-0.716835261,1.252911372,-0.572135649,0.56723008,0.708827514,100.2421831,1,0.269383616,0.660898795,0.407601917,0.683565957,0.782587555,83.51681422,1,-0.520623482,0.707664274,-0.735692759,0.461917698,0.604169618,75.11375951,0,-0.736444304,0.807007457,-0.912561957,0.36147297,0.498678971,N,-,,sexual development activator,"C:nucleus; C:cytoplasm; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:sporulation resulting in formation of a cellular spore",IPR021740 (PFAM); PTHR33572:SF3 (PANTHER); PTHR33572 (PANTHER); PTHR33572 (PANTHER); PTHR33572:SF3 (PANTHER),,
RL4_JR_03363,63,20,38,0,0,19,0,0,0,1,0,0,1,9,0,0,4,5,40.74613849,1,0.476307511,0.694890276,0.685442764,0.493064567,0.680843049,6.972497983,0,0.663886558,1.250334749,0.530967054,0.59544161,0.731173114,17.98630184,1,-1.979814596,1.202669156,-1.646183896,0.099725904,0.193600201,24.75309028,1,-1.455184406,1.154718703,-1.260206838,0.207594757,0.340002735,17.63212669,1,-2.053980588,1.200070284,-1.711550244,0.086979584,0.172121532,N,-,,hypothetical protein SPBR_01449,,no IPS match,,
RL4_JR_03364,74,97,95,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,103.1346595,0,-1.862659544,0.770860661,-2.41633753,0.015677521,0.054102037,27.94996428,0,-1.339290452,1.200263817,-1.115830064,0.264494882,0.421409917,80.55906029,0,-3.033448401,1.196388444,-2.535504598,0.011228545,0.035707308,111.9791745,0,-0.932908033,0.609616913,-1.53031849,0.125937914,0.232879985,79.66298936,0,-2.419256422,0.991087038,-2.441013079,0.014646124,0.04268632,N,-,,elongator complex 1,"P:RNA metabolic process; P:regulation of transcription, DNA-templated; P:gene expression; C:intracellular part",IPR015943 (G3DSA:2.130.10.GENE3D); IPR006849 (PFAM); IPR006849 (PANTHER); SSF69322 (SUPERFAMILY),,
RL4_JR_03365,584,399,798,0,0,2,0,0,0,0,0,1,0,2,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_03366,69,73,249,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,105.1258362,0,-0.949148132,0.683664772,-1.388323885,0.165038442,0.316423881,19.62501524,0,-0.829082105,1.214692254,-0.682544984,0.494894408,0.649885989,63.68343484,0,-1.65647774,1.040512866,-1.591981987,0.111388752,0.210079332,148.8604255,0,0.379003895,0.664120638,0.570685315,0.568212975,0.695412754,49.755949,0,-3.550608365,1.194151862,-2.973330678,0.002945869,0.011646592,N,-,,hypothetical protein F503_01520,P:mycelium development; C:cellular_component; F:molecular_function,IPR025040 (PFAM),,
RL4_JR_03367,13,15,27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,107.3485798,0,-3.061789332,1.131972462,-2.704826694,0.006834003,0.028109975,32.53748774,0,-1.558502259,1.278591481,-1.218921197,0.222874104,0.371407915,83.3168672,0,-4.191547249,1.256589894,-3.335652523,0.000850995,0.005058995,117.6974104,0,-1.92604179,0.871773933,-2.209336294,0.027151259,0.087577729,111.3241095,0,-1.091404396,0.755073739,-1.445427564,0.148337826,0.25694907,N,-,,hpt domain-containing,"C:nucleus; P:metabolic process; P:osmosensory signaling via phosphorelay pathway; C:cytosol; P:cellular response to oxidative stress; F:transferase activity, transferring phosphorus-containing groups; F:protein histidine kinase binding; F:signal transducer activity; P:negative regulation of G2/M transition of mitotic cell cycle; P:positive regulation of stress-activated MAPK cascade",IPR008207 (SMART); IPR008207 (G3DSA:1.20.120.GENE3D); IPR008207 (PFAM); PTHR28242 (PANTHER); PTHR28242:SF9 (PANTHER); IPR008207 (PROSITE_PROFILES); IPR008207 (SUPERFAMILY),,
RL4_JR_03368,636,718,656,0,0,1,0,0,0,1,0,2,0,0,0,0,0,0,240.1620908,1,-0.716785125,0.579521916,-1.236855941,0.216140569,0.384329012,120.9749354,0,-0.327519989,0.988027663,-0.331488683,0.740275388,0.83965346,179.747687,1,-0.666051167,0.521830902,-1.276373562,0.201823498,0.32734077,149.7599132,0,-2.760644556,0.856532047,-3.223048763,0.00126834,0.009068453,156.7375975,0,-1.471642937,0.636021715,-2.313824987,0.020677324,0.056083018,N,-,,ankyrin repeat nuc-2,C:nucleus; F:aspartic-type endopeptidase activity; P:proteolysis; P:lipid metabolic process; P:phosphorylation; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:phosphoric diester hydrolase activity; P:negative regulation of protein serine/threonine kinase activity; F:kinase activity,IPR002110 (SMART); IPR030395 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR004331 (PFAM); PF13637 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR017946 (G3DSA:3.20.20.GENE3D); PTHR24198 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR030395 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR004331 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR017946 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_03369,156,187,158,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,23.61796424,0,0.591982556,0.858884697,0.689245667,0.490668683,0.678598471,3.88180688,1,1.508755103,1.259859755,1.197557979,0.231089143,0.381082487,23.07510297,0,0.674545445,1.03758706,0.650109731,0.515621344,0.646698524,75.52251224,1,2.199327361,0.558447534,3.938288249,8.21E-05,0.000901824,9.949156348,0,-1.22838903,1.203194954,-1.020939313,0.307283192,0.442616975,N,-,,snf7 family,P:vacuolar transport; C:intracellular,IPR005024 (PFAM); PTHR22761 (PANTHER),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_03370,47913,32414,32915,8,5,26,0,0,0,4,3,5,0,1,4,0,2,7,63.11294855,1,1.257305168,0.547168237,2.297840194,0.021570886,0.069998126,7.169968911,0,0.623573709,1.231457823,0.506370334,0.612596696,0.745155601,51.09292454,1,1.104298876,0.679746923,1.624573557,0.104253455,0.200011746,46.81602716,1,0.587598101,0.679219918,0.865107288,0.386979905,0.5321136,25.68250651,1,-1.173749042,1.125949979,-1.042452208,0.297202072,0.432476427,N,-,,cue domain-containing,F:protein binding,IPR003892 (SMART); IPR003892 (PFAM); G3DSA:1.10.8.10 (GENE3D); PTHR16461 (PANTHER); PTHR16461:SF5 (PANTHER); PTHR16461 (PANTHER); PTHR16461:SF5 (PANTHER); IPR003892 (PROSITE_PROFILES); IPR009060 (SUPERFAMILY),,
RL4_JR_03371,2292,2565,3117,0,2,0,1,0,0,1,0,0,2,3,0,0,0,2,45.6798528,1,-3.615825824,1.20587176,-2.998516048,0.002712979,0.013308767,14.73899265,1,-0.416014065,1.235045407,-0.336841109,0.736236681,0.835915613,44.46558176,1,-2.095868423,1.206247055,-1.737511742,0.082296883,0.166501528,43.77896968,1,-3.479333695,1.207940378,-2.880385289,0.003971895,0.02335391,48.74314652,1,-0.935175903,0.864393621,-1.081886631,0.279302906,0.413019121,N,-,,hypothetical protein SPSK_01428,,IPR018744 (PFAM); PTHR38113:SF1 (PANTHER); PTHR38113 (PANTHER); PTHR38113:SF1 (PANTHER),,
RL4_JR_03372,1617,2440,2426,0,2,9,5,0,0,0,1,2,2,0,0,0,0,0,81.70843701,1,0.715560744,0.834359568,0.857616754,0.391104121,0.583829354,11.40624405,1,-0.046287863,1.241638867,-0.03727965,0.970262031,0.984659342,36.22107488,1,-1.74275716,1.215371324,-1.4339298,0.151592297,0.264515755,52.91901591,1,-1.361468697,1.048220169,-1.298838486,0.193999364,0.323385505,44.21181288,0,-1.087913826,1.010660908,-1.07643802,0.281731406,0.415457397,N,-,,ATP dependent RNA helicase,F:ATP binding; C:cytoplasm; C:spliceosomal complex; P:RNA processing; F:ATP-dependent RNA helicase activity; F:poly(A) RNA binding,IPR014001 (SMART); IPR001650 (SMART); IPR007502 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011709 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR007502 (PFAM); PTHR18934 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.A.53.1.4, the hepatitis c virus p7 viroporin cation-selective channel (hcv-p7) family.
RL4_JR_03373,628,611,524,0,1,7,0,0,0,0,0,0,0,0,0,0,0,0,307.9670736,1,4.782298527,0.324426381,14.7407819,3.53E-49,7.19E-46,22.38580314,0,3.234767036,1.021945203,3.165303802,0.001549211,0.015023052,49.1098634,0,2.107878797,0.686377714,3.071018702,0.002133298,0.010358517,56.20612652,0,2.52354306,0.546944927,4.613888772,3.95E-06,6.18E-05,82.16088134,0,3.441968936,0.602007707,5.717483176,1.08E-08,5.12E-07,N,-,,hypothetical protein SPI_01819,C:membrane; C:integral component of membrane,PTHR42088:SF1 (PANTHER); PTHR42088 (PANTHER),,
RL4_JR_03374,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,163.6642767,0,-0.786455773,0.627176306,-1.253962825,0.209855518,0.376843785,36.68749811,0,-1.731682815,1.222376884,-1.416652129,0.15658466,0.285885629,154.5496656,0,-0.557859888,0.589388712,-0.946505892,0.343890619,0.487409236,158.7092482,0,-0.714271658,0.572386835,-1.247882752,0.212073998,0.346174058,130.3903331,0,-0.854935232,0.590187902,-1.448581424,0.147454512,0.255821956,N,-,,transmembrane alpha-helix domain-containing,C:integral component of membrane,no IPS match,1.G.20.2.1, the hantavirus gc envelope fusion glycoprotein (gc-efg) family.
RL4_JR_03375,1374,1517,3616,0,3,2,0,0,0,0,0,5,1,1,0,0,0,0,10.00618778,1,0.215628308,1.15118743,0.18730947,0.851417998,0.925868839,1.971719035,0,2.486086038,1.312976503,1.893473366,0.058294947,0.133317093,5.115858509,1,-0.165879706,1.202038354,-0.13799868,0.890241461,0.931320671,5.902040501,1,-0.588274359,1.200735357,-0.489928405,0.624184562,0.741159691,5.040146935,0,-0.247110899,1.202133837,-0.205560223,0.837134452,0.890054219,N,-,,carboxylesterase 3,C:membrane; C:integral component of membrane; F:carboxylic ester hydrolase activity; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR002018 (PFAM); PTHR11559 (PANTHER); PTHR11559:SF240 (PANTHER); PTHR11559 (PANTHER); PTHR11559 (PANTHER); PTHR11559:SF240 (PANTHER); PTHR11559:SF240 (PANTHER); PTHR11559:SF240 (PANTHER); IPR029058 (SUPERFAMILY),8.A.117.1.3, the neuroligin (nlg) family.
RL4_JR_03376,2225,2459,1829,2,0,0,0,0,0,0,4,0,1,7,0,0,0,0,34.63028524,1,3.341122154,0.659782391,5.063975942,4.11E-07,6.94E-06,0.972156869,0,3.506261403,1.401511114,2.5017721,0.012357344,0.039545871,35.73076401,1,3.271263628,0.846725502,3.863428728,0.000111807,0.001243128,2.907945539,1,0.432754132,1.208511241,0.358088628,0.720276989,0.813203001,2.483901164,0,0.773622973,1.201310521,0.643982517,0.519586771,0.644234148,N,-,,carboxylesterase family,F:hydrolase activity,no IPS match,,
RL4_JR_03377,1368,1099,831,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,3.419954075,0,0.123799839,1.261819625,0.098112152,0.921843238,0.962237952,1.082389454,0,3.351238132,1.408980432,2.37848451,0.017383967,0.051595126,2.821190646,1,0.692634242,1.229539085,0.563328365,0.573211307,0.696243704,11.27884246,1,1.982702491,1.04771099,1.892413566,0.0584359,0.134982775,17.52344146,0,2.30775819,1.002815959,2.301277887,0.021375929,0.057668873,N,-,,dash complex subunit dad2,C:intracellular non-membrane-bounded organelle; C:intracellular organelle part,IPR013963 (PFAM),,
RL4_JR_03378,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.11980177,0,-0.71556525,1.205811018,-0.593430678,0.552892963,0.732105307,1.959464333,0,2.495134405,1.323712107,1.884952469,0.059436255,0.135194107,5.067293043,0,-0.152005076,1.205302019,-0.126113683,0.899641937,0.937806319,5.844830804,0,-0.574118104,1.204254086,-0.47674167,0.633546086,0.748723121,24.27740971,0,2.694884841,0.685388914,3.931906085,8.43E-05,0.000601328,N,-,,shugoshin family,P:single-organism cellular process,IPR011516 (PFAM),,
RL4_JR_03379,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,55.18898492,0,1.782406272,0.537059452,3.318824882,0.000903971,0.005499325,14.80959162,0,1.94050079,1.126176718,1.723087291,0.084872741,0.178059002,14.0915629,0,-1.627875201,1.195135506,-1.362084209,0.173171311,0.2920517,16.2557486,0,-2.050173495,1.193427733,-1.717886587,0.085817304,0.174758689,32.49438364,0,0.511734775,0.847574506,0.603763765,0.546000713,0.666938982,N,-,,vacuolar sorting,"C:nucleus; C:endosome; C:cytosol; C:retromer, cargo-selective complex; F:protein transporter activity; P:intracellular protein transport; P:retrograde transport, endosome to Golgi",IPR029052 (G3DSA:3.60.21.GENE3D); IPR000979 (TIGRFAM); IPR024654 (PFAM); IPR000979 (PANTHER); IPR029052 (SUPERFAMILY),9.A.3.1.2, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_03380,1888,1514,1289,2,0,7,0,0,0,0,2,3,0,4,1,0,1,1,452.2458151,1,0.640328483,0.391234722,1.636686234,0.101696047,0.224347309,97.3482988,0,-1.490892983,1.125564443,-1.324573632,0.185312606,0.325140267,288.2258076,1,-0.230957359,0.449859507,-0.513398862,0.607672342,0.724199504,201.5793876,1,-2.462692496,0.708158408,-3.477601155,0.000505922,0.004226453,169.0843172,1,-2.919981261,0.870802357,-3.353207807,0.000798807,0.003990095,N,-,,alanine-glyoxylate aminotransferase 1,F:transaminase activity,IPR000192 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR015421 (G3DSA:3.40.640.GENE3D); IPR024169 (PIRSF); PTHR21152:SF21 (PANTHER); PTHR21152 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_03381,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,284.5726157,0,-0.543048766,0.633535274,-0.857172108,0.391349775,0.583982342,190.949358,0,0.554136989,0.834208494,0.664266778,0.50651958,0.659418477,186.1093738,0,-1.314934942,0.632433286,-2.079167828,0.037601928,0.090939648,251.0081635,0,-0.72672533,0.510518742,-1.423503725,0.154590183,0.271882162,176.1571237,0,-1.38489005,0.60191213,-2.300817648,0.021401941,0.057719755,N,-,,exportin-1,P:mRNA export from nucleus; C:nucleus; P:ribosomal large subunit export from nucleus; F:catalytic activity; C:spindle pole body; P:protein localization to kinetochore; F:protein transporter activity; C:kinetochore; P:protein export from nucleus; F:Ran GTPase binding,IPR014877 (SMART); IPR001494 (SMART); IPR013598 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR014877 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR001494 (PFAM); PTHR11223 (PANTHER); PTHR11223:SF2 (PANTHER); PTHR11223 (PANTHER); PTHR11223:SF2 (PANTHER); IPR001494 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_03382,909,1015,574,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,60.3952361,0,1.05152304,0.525981109,1.999165032,0.045590501,0.12414129,8.343773512,0,0.404836091,1.226945792,0.329954342,0.741434462,0.840308994,35.93257505,0,-0.421343762,1.032714323,-0.407996435,0.683276292,0.782587555,52.98407604,1,0.838242139,0.586628903,1.428913808,0.153029008,0.26990949,48.26093167,0,1.079779127,0.586982218,1.839543166,0.065835335,0.138541795,N,-,,TBC domain-containing,C:nucleus; C:cytosol,IPR000195 (SMART); IPR000195 (PFAM); G3DSA:1.10.8.270 (GENE3D); PTHR22957:SF313 (PANTHER); PTHR22957 (PANTHER); PTHR22957 (PANTHER); PTHR22957:SF313 (PANTHER); PTHR22957 (PANTHER); PTHR22957:SF313 (PANTHER); IPR000195 (PROSITE_PROFILES); IPR000195 (SUPERFAMILY); IPR000195 (SUPERFAMILY),8.A.87.1.4, the tbc1 domain (tbc1) family.
RL4_JR_03383,745,1015,852,0,0,0,0,0,0,0,1,0,0,0,3,0,0,0,58.48481487,0,-0.033410045,0.797252088,-0.041906501,0.966573234,0.983082464,8.461940201,0,0.384579995,1.251728678,0.307239102,0.758661385,0.853898657,34.86904021,1,-0.447371002,1.055338367,-0.423912383,0.671629713,0.774175021,34.54026302,1,-1.732051421,1.163904659,-1.488138575,0.136714352,0.248239594,36.52884107,0,-0.127704417,0.867022725,-0.147290737,0.882902543,0.922347116,N,-,,hypothetical protein VP1G_06046,,no IPS match,,
RL4_JR_03384,1734,1790,2048,1,2,2,0,0,0,0,0,1,5,10,0,0,1,5,217.8326575,1,-1.953406333,1.229011433,-1.589412662,0.111967258,0.240290826,54.9925852,0,-2.315639655,1.302625607,-1.777670915,0.075457919,0.162923434,151.3069237,1,-3.98093573,1.285308556,-3.097260741,0.00195318,0.009646518,241.5324587,1,-1.026975551,0.73462313,-1.397962451,0.162124343,0.282046216,263.6824695,1,0.080554087,0.682770686,0.117981173,0.906082575,0.939871537,N,-,,serine threonine kinase,F:phosphorelay sensor kinase activity; F:ATP binding; P:phosphorelay signal transduction system; P:signal transduction by protein phosphorylation; C:intracellular,IPR004358 (PRINTS); IPR000719 (SMART); IPR003018 (SMART); IPR003661 (SMART); IPR001789 (SMART); IPR003594 (SMART); IPR003018 (PFAM); PF13191 (PFAM); IPR003661 (PFAM); IPR003594 (G3DSA:3.30.565.GENE3D); IPR029016 (G3DSA:3.30.450.GENE3D); IPR000719 (PFAM); IPR003661 (G3DSA:1.10.287.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); G3DSA:3.40.50.2300 (GENE3D); IPR001789 (PFAM); IPR003594 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24423:SF498 (PANTHER); PTHR24423 (PANTHER); PTHR24423 (PANTHER); PTHR24423:SF498 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR001789 (PROSITE_PROFILES); IPR005467 (PROSITE_PROFILES); IPR029016 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR003594 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011006 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR003661 (SUPERFAMILY),9.B.238.3.1,The Uncharacterized Bacterial 5 TMS Protein-1 (UBP1) Family
RL4_JR_03385,6629,5206,4815,0,0,0,3,0,0,0,0,0,0,3,0,0,8,1,193.565037,0,1.79545856,0.552163213,3.251680876,0.001147248,0.006594398,12.95202937,1,-0.229564321,1.208411853,-0.189971921,0.849331133,0.910253245,53.03136109,0,-0.47423031,0.847259031,-0.559722934,0.575668437,0.698250847,38.68194006,1,-3.300758022,1.185410731,-2.784484683,0.005361285,0.029582024,47.72231704,1,-1.276677499,0.962868226,-1.325910923,0.184869204,0.303617307,N,-,,udp-galactopyranose mutase,F:oxidoreductase activity; P:oxidation-reduction process,PF13450 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR10668:SF63 (PANTHER); PTHR10668 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_03386,31977,31706,39097,5,4,74,0,0,0,0,5,1,8,23,3,0,25,1,130.9627547,1,-1.677327792,0.696907613,-2.406815138,0.016092313,0.055206515,76.1902421,0,0.154356448,0.981613535,0.157247676,0.875049655,0.928335878,82.01853122,1,-4.168883864,1.197388823,-3.48164588,0.000498342,0.003376986,168.4900112,1,-0.513057405,0.519547451,-0.987508271,0.32339353,0.46984639,88.63170923,1,-2.587770655,0.988260085,-2.61851176,0.008831425,0.028422815,N,-,,DUF250 domain membrane,C:integral component of membrane,IPR004853 (PFAM); PTHR11132:SF125 (PANTHER); PTHR11132 (PANTHER),2.A.7.9.20, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_03387,1133,1246,1421,2,2,1,0,0,0,0,0,0,0,1,0,0,0,0,578.6525153,1,-0.858820618,0.770294197,-1.114925467,0.264882362,0.444814803,158.2130478,0,-0.868884677,0.771168397,-1.126711987,0.259864273,0.415996547,360.2179233,0,-2.948409319,0.691684206,-4.262652368,2.02E-05,0.000341859,502.9358266,1,-1.312206366,0.456543988,-2.874216724,0.004050309,0.023704845,392.7293529,0,-1.680448166,0.96828836,-1.735483184,0.082655258,0.165555783,N,-,,60S ribosomal L27-A,F:structural constituent of ribosome; C:ribosome; P:translation,IPR014722 (G3DSA:2.30.30.GENE3D); IPR001141 (PFAM); IPR001141 (PANTHER); IPR001141 (PRODOM); IPR008991 (SUPERFAMILY),,
RL4_JR_03388,594,515,661,0,0,5,0,0,0,0,0,0,0,2,0,0,0,2,1.409794587,1,1.401934547,1.461146088,0.959475961,0.337319024,NA,0.446837235,0,4.627466894,1.632158086,2.835183022,0.004579944,0.01948642,1.167115091,0,1.965343677,1.284958343,1.529499916,0.12614056,0.230472303,1.346815675,1,1.542798333,1.332080617,1.158186909,0.246787769,0.385486912,1.160903272,1,1.870902821,1.278703018,1.463125365,0.143433078,0.250346478,N,-,,Non-classical export 1,C:integral component of membrane; P:protein secretion,IPR024242 (PFAM),,
RL4_JR_03389,513,768,662,0,0,0,0,0,0,0,0,3,1,3,0,0,0,0,23.52638274,0,-1.457038127,1.166035749,-1.249565571,0.211458286,0.378804721,28.55448537,0,1.749743722,1.125754124,1.554285865,0.120116244,0.23385586,22.7870855,1,-0.875095768,1.207192876,-0.724901369,0.468512541,0.605507615,66.3268646,1,0.866440312,0.703660366,1.231333118,0.2181983,0.353255163,16.16358667,0,-1.928445948,1.220792223,-1.579667622,0.114183004,0.210852256,N,-,,hypothetical protein CMQ_4409,,PTHR21405 (PANTHER),,
RL4_JR_03390,1270,1307,1581,4,0,1,0,0,3,0,1,1,1,2,0,0,0,5,79.7652183,1,-1.411496703,0.983506104,-1.435168218,0.151239168,0.299032751,17.04217252,1,-0.625503716,1.286415979,-0.48623752,0.626798772,0.754484144,88.46831422,1,-0.14517821,1.484740173,-0.097780213,0.92210682,0.954446809,94.96846616,1,-0.17356956,0.728675944,-0.238198559,0.811727095,0.880516053,80.56432617,1,-0.108376148,0.761244781,-0.142367017,0.886790114,0.925453505,N,-,,4-hydroxyphenylpyruvate dioxygenase,P:aromatic amino acid family metabolic process; F:4-hydroxyphenylpyruvate dioxygenase activity; F:metal ion binding; P:oxidation-reduction process,IPR029068 (G3DSA:3.10.180.GENE3D); IPR029068 (G3DSA:3.10.180.GENE3D); IPR005956 (TIGRFAM); IPR004360 (PFAM); PTHR11959:SF9 (PANTHER); IPR005956 (PANTHER); IPR005956 (PANTHER); IPR029068 (SUPERFAMILY),,
RL4_JR_03391,40,39,37,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.682683369,0,1.14699105,1.396380468,0.821402961,0.411416778,NA,0.544940402,0,4.341547803,1.601337033,2.711201774,0.006703982,0.025169771,34.60892376,0,4.152941477,0.899631838,4.616267791,3.91E-06,8.49E-05,25.68238997,0,4.491449687,0.739169207,6.076348483,1.23E-09,3.96E-08,27.32022017,0,4.29162434,0.802218164,5.349697295,8.81E-08,2.02E-06,Y,-,,outer membrane autotransporter,,IPR027372 (PFAM); PTHR37957 (PANTHER),,
RL4_JR_03392,2115,1689,2173,0,0,1,0,0,0,0,0,0,0,5,0,0,1,0,93.63925448,1,-0.695932055,0.625094205,-1.113323479,0.265569526,0.445510219,21.53383588,0,-0.962984884,1.217652816,-0.790853412,0.429029537,0.591725227,95.2529676,0,-0.769469877,0.75518168,-1.018920211,0.308240848,0.449342942,102.7363276,1,-0.509434327,0.599910665,-0.849183648,0.395779111,0.539989691,88.10271081,1,-0.468534762,0.62813086,-0.745919031,0.455716329,0.587442953,N,-,,dil and ankyrin domain containing,F:DNA binding; P:allantoin catabolic process; F:allantoicase activity,IPR002710 (SMART); IPR002110 (SMART); IPR002710 (PFAM); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24193:SF65 (PANTHER); PTHR24193 (PANTHER); PTHR24193:SF65 (PANTHER); PTHR24193 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002710 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),1.A.1.4.4, the voltage-gated ion channel (vic) superfamily.
RL4_JR_03393,1280,1122,1105,2,0,0,0,0,0,0,2,0,0,0,0,0,0,0,87.26949102,1,-1.204613227,0.733725089,-1.641777342,0.100636156,0.222611107,60.00559297,0,-0.046680743,1.121067545,-0.041639545,0.966786048,0.982708212,119.6754625,1,0.017995546,0.601556713,0.029914961,0.976134874,0.986364853,85.17724817,0,-1.05216429,0.720372546,-1.460583549,0.144129764,0.258228515,89.95763863,0,-0.318520422,0.634622436,-0.50190539,0.615734073,0.722734465,N,-,,allantoicase,P:allantoin catabolic process; F:allantoicase activity,IPR015908 (PFAM); IPR008979 (G3DSA:2.60.120.GENE3D); IPR005164 (TIGRFAM); IPR005164 (PIRSF); PTHR12045:SF3 (PANTHER); IPR005164 (PANTHER); IPR008979 (SUPERFAMILY); IPR008979 (SUPERFAMILY),,
RL4_JR_03394,1804,1785,1471,6,3,0,0,0,0,0,3,1,0,0,0,0,0,0,46.98240756,1,-0.401499833,0.785922415,-0.510864463,0.609445967,0.775432064,10.21180096,0,0.113366656,1.245736612,0.091003712,0.927489642,0.959733049,26.36370614,1,-2.531512728,1.209353692,-2.093277381,0.036324401,0.088576876,34.41386917,0,-2.007480285,1.163766723,-1.724985124,0.084530153,0.172484442,33.60868571,0,-0.947316212,0.998731293,-0.948519605,0.342864997,0.479887765,N,-,,cytochrome b561,C:integral component of membrane; P:oxidation-reduction process,IPR006593 (SMART); IPR006593 (PFAM); PTHR15422 (PANTHER); IPR006593 (PROSITE_PROFILES),5.B.2.1.5, the eukaryotic cytochrome b561 (cytb561) family.
RL4_JR_03395,3717,2744,2477,0,0,0,0,0,0,0,0,3,1,1,0,0,0,0,213.6623934,0,-0.122637037,0.443109458,-0.276764656,0.781960822,0.887515867,33.51358816,0,-1.601141065,1.210231008,-1.323004495,0.185833883,0.325716115,305.4174391,1,1.441294957,0.380097183,3.791911701,0.000149492,0.001477113,119.0561201,1,-2.917998378,1.024103377,-2.84932014,0.004381277,0.02531988,103.500449,0,-2.09865741,0.847958862,-2.474951918,0.013325411,0.039564416,N,-,,sensor histidine kinase response,"P:signal transduction; F:transferase activity, transferring phosphorus-containing groups",IPR004358 (PRINTS); IPR003661 (SMART); IPR001610 (SMART); IPR000014 (SMART); IPR003594 (SMART); IPR001789 (SMART); IPR000014 (TIGRFAM); G3DSA:3.30.450.20 (GENE3D); IPR001789 (PFAM); IPR003661 (G3DSA:1.10.287.GENE3D); IPR003594 (G3DSA:3.30.565.GENE3D); IPR013655 (PFAM); G3DSA:3.40.50.2300 (GENE3D); IPR003661 (PFAM); IPR003594 (PFAM); PTHR24423 (PANTHER); PTHR24423 (PANTHER); PTHR24423:SF442 (PANTHER); PTHR24423:SF442 (PANTHER); PTHR24423 (PANTHER); IPR005467 (PROSITE_PROFILES); IPR000014 (PROSITE_PROFILES); IPR000700 (PROSITE_PROFILES); IPR000700 (PROSITE_PROFILES); IPR001789 (PROSITE_PROFILES); IPR000014 (SUPERFAMILY); IPR003661 (SUPERFAMILY); IPR011006 (SUPERFAMILY); IPR000014 (SUPERFAMILY); IPR003594 (SUPERFAMILY),9.B.238.3.1,The Uncharacterized Bacterial 5 TMS Protein-1 (UBP1) Family
RL4_JR_03396,1692,1940,1789,0,1,0,0,0,0,0,0,1,3,15,0,0,0,0,70.08314903,1,-1.67318959,0.851622325,-1.964708464,0.04944799,0.131656887,18.75526941,0,-0.763707334,1.203842352,-0.634391483,0.525825367,0.674538485,69.4455084,1,-1.009241773,0.852203634,-1.184273022,0.236305004,0.368840106,64.08928373,1,-2.110107689,1.015958712,-2.07696205,0.037805062,0.103508992,73.84543547,0,-0.858910237,0.746174185,-1.151085437,0.249697089,0.380120737,N,-,,phosphoglycerate mutase family domain-containing,C:cytoplasm; P:metabolic process; F:phosphatase activity,IPR013078 (SMART); IPR029033 (G3DSA:3.40.50.GENE3D); IPR013078 (PFAM); PTHR23029:SF26 (PANTHER); PTHR23029 (PANTHER); IPR029033 (SUPERFAMILY),,
RL4_JR_03397,295,149,243,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,89.15457262,0,-1.789475691,0.864193884,-2.070687753,0.038387986,0.109384976,39.43961415,0,0.736728918,0.987471069,0.746076458,0.455621229,0.615316622,82.48028967,0,-1.146951085,0.85625361,-1.33949927,0.180408192,0.301195999,62.12514001,1,-3.984313548,1.195923828,-3.331578028,0.000863551,0.006554312,53.27764499,0,-3.649234501,1.202067691,-3.03579784,0.002399002,0.009877955,N,-,,duf1168 domain,,IPR009548 (PFAM); IPR009548 (PANTHER),,
RL4_JR_03398,22821,15263,16767,9,2,5,0,0,0,0,0,0,0,2,0,0,5,0,397.1183129,1,-0.616437484,0.637093002,-0.967578489,0.333254925,0.522926269,88.28590651,0,-1.920208716,1.124230342,-1.708020718,0.087632498,0.182663951,228.3192757,0,-3.094607342,0.885589729,-3.49440293,0.000475123,0.003252373,253.9499526,1,-3.242580738,0.804156063,-4.032277919,5.52E-05,0.000646581,294.1124429,1,-1.043294663,0.574206095,-1.81693415,0.069227197,0.1437206,N,-,,T-complex 1 subunit gamma,C:nucleus; C:chaperonin-containing T-complex; F:ATP binding; P:mycelium development; F:unfolded protein binding; P:protein folding,IPR017998 (PRINTS); IPR012719 (TIGRFAM); IPR027413 (G3DSA:1.10.560.GENE3D); IPR027409 (G3DSA:3.50.7.GENE3D); IPR002423 (PFAM); IPR027410 (G3DSA:3.30.260.GENE3D); PTHR11353 (PANTHER); IPR012719 (PTHR11353:PANTHER); SSF48592 (SUPERFAMILY); SSF54849 (SUPERFAMILY); IPR027409 (SUPERFAMILY),,
RL4_JR_03399,19931,10383,19822,1,2,5,0,0,0,3,1,6,11,12,2,0,1,1,2.035670942,1,0.871991412,1.303910154,0.668751147,0.503654235,NA,0.645730511,0,4.096371376,1.497253291,2.735924108,0.006220537,0.023876729,9.526409249,1,2.398484444,1.209900047,1.982382305,0.047436469,0.108704297,11.5778387,1,1.965710339,1.162885984,1.690372372,0.090956737,0.182436007,1.6692861,1,1.347054279,1.23478793,1.090919539,0.275308288,0.408065645,N,-,,class ii aldolase,P:biological_process; C:cellular_component; F:molecular_function,IPR001303 (SMART); IPR001303 (G3DSA:3.40.225.GENE3D); IPR001303 (PFAM); PTHR10672 (PANTHER); PTHR10672:SF20 (PANTHER); IPR001303 (SUPERFAMILY),,
RL4_JR_03400,492,277,582,0,0,1,0,0,0,0,4,0,0,0,1,0,3,0,58.21485523,1,-1.902187297,1.027751877,-1.850823472,0.064194953,0.160153648,14.71426086,0,-0.413651141,1.211591875,-0.341411287,0.732793979,0.83322635,99.48291598,1,0.90043214,0.538947625,1.670722902,0.094776423,0.186205416,63.47163572,1,-1.742747799,1.024932901,-1.700353065,0.089064535,0.179722188,60.33199132,1,-0.530604751,0.768611408,-0.690342018,0.48997913,0.618625917,N,-,,hypothetical protein CMQ_4406,,no IPS match,,
RL4_JR_03401,47,20,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20.32356438,0,-0.77492773,1.141694012,-0.678752557,0.497294659,0.684284288,3.921453414,0,1.494103073,1.250664721,1.194647174,0.23222491,0.382394752,10.18781347,0,-1.15987702,1.192806031,-0.972393658,0.330854746,0.473973885,11.75382567,0,-1.582340379,1.190590269,-1.329038562,0.183835248,0.310552788,10.05855594,0,-1.244099828,1.197911446,-1.038557425,0.299010615,0.434196131,N,-,,l-amino-acid amidase,P:proteolysis; F:peptidase activity,IPR002410 (PRINTS); IPR005945 (PIRSF); IPR029058 (G3DSA:3.40.50.GENE3D); IPR000073 (PFAM); IPR005945 (TIGRFAM); PTHR10992 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_03402,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36.71599169,0,-3.300656218,1.198984309,-2.752876908,0.00590741,0.024836203,11.65459281,0,-0.077340639,1.213511255,-0.063732939,0.949182877,0.973022997,30.33330272,0,-2.73386861,1.196195863,-2.28546904,0.02228534,0.060649672,44.31290446,0,-2.206256173,1.148996934,-1.920158451,0.054837888,0.12958667,29.99428462,0,-2.820375226,1.203117312,-2.34422296,0.01906677,0.052645498,N,-,,tfiih basal transcription factor complex p47 subunit,"F:zinc ion binding; P:transcription, DNA-templated; C:core TFIIH complex; P:cellular protein metabolic process; P:nucleotide-excision repair",IPR004595 (SMART); IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR012170 (PIRSF); G3DSA:3.10.370.10 (GENE3D); IPR002035 (G3DSA:3.40.50.GENE3D); IPR004595 (PFAM); PTHR12695 (PANTHER); IPR012170 (PTHR12695:PANTHER); PTHR12695 (PANTHER); IPR002035 (PROSITE_PROFILES); SSF57889 (SUPERFAMILY); IPR002035 (SUPERFAMILY),,
RL4_JR_03403,3551,2892,2251,0,1,4,0,0,0,0,1,0,0,0,0,0,0,0,80.16928894,1,3.047419881,0.529997747,5.749873279,8.93E-09,2.11E-07,3.175979525,0,1.798384978,1.305133658,1.377931653,0.168224391,0.302337942,14.71644855,1,0.112232419,1.212934076,0.092529694,0.9262772,0.956186157,65.64175272,0,2.721087241,1.416831526,1.920543968,0.054789225,0.129550513,15.78540341,0,0.733451549,1.004915415,0.729863964,0.465473341,0.59649634,N,-,,chitin synthase export chaperone,C:integral component of membrane; F:transferase activity,IPR022057 (PFAM); PTHR35329 (PANTHER); PTHR35329:SF1 (PANTHER),,
RL4_JR_03404,8484,7155,6030,2,4,0,0,0,0,0,0,0,0,7,0,0,4,0,30.34173248,1,1.432490028,0.67841857,2.111513588,0.034728191,0.101460084,3.600725495,0,1.617222576,1.269137869,1.274268632,0.202568229,0.346877959,22.32769457,0,0.785512952,1.038641402,0.756288889,0.449476009,0.588755998,39.66806507,1,0.882728347,0.854237989,1.033351781,0.301439303,0.447124662,16.91467747,1,0.550986277,0.985064385,0.559340369,0.575929449,0.690011321,N,-,,hexose transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR003663 (PRINTS); IPR003663 (TIGRFAM); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500 (PANTHER); PTHR23500:SF88 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.39, the major facilitator superfamily (mfs).
RL4_JR_03405,91206,53377,67241,6,14,20,0,0,5,2,3,7,5,8,7,0,7,5,28.28444217,1,-2.924325545,1.215443882,-2.405973314,0.016129443,0.055310633,8.964818556,1,0.301171567,1.238760837,0.243123255,0.807909917,0.883444333,29.88945808,1,-1.397165371,1.209803313,-1.15486985,0.248143728,0.382666733,26.99190411,1,-2.781709459,1.212509711,-2.294174995,0.021780449,0.080104267,27.0795912,1,-1.52316532,1.153754775,-1.320181162,0.18677454,0.305705176,N,-,,mitochondrial carrier,F:structural constituent of ribosome; C:mitochondrion; C:integral component of membrane; P:transport; P:translation,IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089 (PANTHER); PTHR24089:SF357 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.8.8, the mitochondrial carrier (mc) family.
RL4_JR_03406,1794,1426,2061,0,2,0,0,0,0,0,0,1,0,1,5,0,3,0,149.4912261,1,-2.191037574,0.814529969,-2.689941019,0.007146465,0.029019841,41.08097764,0,-1.894910587,1.223245414,-1.549084563,0.121361393,0.235781195,120.5653823,1,-2.749847554,1.073542272,-2.561471146,0.01042299,0.033767152,133.4717616,1,-4.02899313,1.182923604,-3.405962241,0.000659313,0.005234902,114.8373274,1,-3.01058071,1.042121962,-2.888894794,0.003865984,0.014529728,N,-,,ribosome biogenesis ATPase,F:nucleotide binding,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003959 (PFAM); G3DSA:1.10.8.60 (GENE3D); G3DSA:1.10.8.60 (GENE3D); PTHR23077 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.16.1.1, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_03407,1144,1085,1066,0,0,4,0,0,0,0,3,1,0,7,0,0,0,3,659.2615989,1,-2.757982373,0.433875173,-6.356626389,2.06E-10,6.65E-09,342.5527524,0,0.269586124,0.484036944,0.556953611,0.577559124,0.71704323,675.9674563,1,-1.4108362,0.377064061,-3.741635297,0.000182827,0.001669015,728.372748,1,-1.510308986,0.342083887,-4.41502522,1.01E-05,0.000142226,653.5312187,1,-1.236937624,0.882430718,-1.401739081,0.160993176,0.272904052,N,-, Effector probability:0.818,cytochrome c,F:metal ion binding; F:electron carrier activity; C:mitochondrion; P:oxidation-reduction process; C:respiratory chain; F:heme binding,IPR002327 (PRINTS); IPR009056 (G3DSA:1.10.760.GENE3D); IPR009056 (PFAM); IPR002327 (PANTHER); IPR009056 (PROSITE_PROFILES); IPR009056 (SUPERFAMILY),3.D.4.6.1, the proton-translocating cytochrome oxidase (cox) superfamily.
RL4_JR_03408,2482,1566,2315,0,2,2,0,0,2,0,0,0,0,0,0,0,0,0,200.6786512,1,-0.659305707,0.816944951,-0.807038107,0.419644529,0.611223008,76.53475101,1,0.739929245,0.80328541,0.921128699,0.356983238,0.521191383,127.9267963,0,-1.653414456,0.775217524,-2.13283937,0.032937905,0.082581316,115.9874445,0,-4.885005928,1.211576275,-4.031942543,5.53E-05,0.000646757,128.7587013,0,-1.344908146,0.659259484,-2.040028515,0.041347486,0.096552182,N,-,,hypothetical protein SPSK_01888,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03409,2,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,107.654761,0,-0.934712549,0.732376919,-1.276272539,0.201859194,0.36594829,24.13362846,0,-1.127490143,1.236478451,-0.911855878,0.361844591,0.526309951,74.28328672,0,-2.831388523,1.229251164,-2.303344187,0.021259485,0.058312389,119.5323578,0,-0.845488583,0.712323375,-1.186944881,0.235249363,0.37263764,89.59270567,0,-0.753112585,0.741353227,-1.015862018,0.309695098,0.445406657,N,-,,3 exoribonuclease family,C:nucleus; P:nucleic acid phosphodiester bond hydrolysis; P:rRNA metabolic process; P:ncRNA catabolic process; C:cytoplasmic part; C:exosome (RNase complex),IPR001247 (PFAM); PTHR11097:SF8 (PANTHER); PTHR11097 (PANTHER); PTHR11097:SF8 (PANTHER); PTHR11097 (PANTHER); IPR020568 (SUPERFAMILY),,
RL4_JR_03410,444,317,424,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,137.9796981,0,-2.211464107,0.784358053,-2.819457387,0.004810492,0.021053644,55.63531954,0,-0.110819151,1.022014708,-0.108432051,0.913652978,0.95163567,155.1483733,0,-0.567577405,0.594958508,-0.95397813,0.340094713,0.483516202,137.5892958,1,-2.440591288,0.882238839,-2.766361195,0.005668571,0.030890356,100.6132705,0,-3.518748135,1.141329624,-3.083025325,0.002049077,0.008644544,N,-,,psp1 domain-containing,,IPR007557 (PFAM); PTHR21600:SF3 (PANTHER); PTHR21600 (PANTHER); PTHR21600 (PANTHER); PTHR21600 (PANTHER); PTHR21600:SF3 (PANTHER); IPR007557 (PROSITE_PROFILES),,
RL4_JR_03411,291,343,491,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,215.3550643,0,-4.074583935,1.015640127,-4.011838276,6.02E-05,0.000549163,66.59857267,0,-2.591896529,1.196646455,-2.165966831,0.030313722,0.07965615,213.3806419,0,-2.403429426,0.745954571,-3.221951467,0.001273207,0.006985447,226.8429727,0,-2.16394526,0.593156902,-3.648183564,0.000264101,0.002430929,169.5085573,0,-5.319003241,1.194930816,-4.451306445,8.53E-06,8.76E-05,N,-,,hira-interacting 5,C:mitochondrial matrix; F:iron ion binding; P:intracellular sequestering of iron ion; F:iron-sulfur cluster binding; P:iron-sulfur cluster assembly,IPR014824 (SMART); IPR001075 (PFAM); IPR014824 (PFAM); IPR014824 (G3DSA:3.30.1370.GENE3D); IPR017065 (PTHR11178:PANTHER); PTHR11178 (PANTHER); IPR001075 (PRODOM); SSF117916 (SUPERFAMILY); IPR014824 (SUPERFAMILY),,
RL4_JR_03412,206,521,382,0,0,0,0,0,0,1,1,2,0,1,0,0,0,0,60.35071967,0,1.512910115,0.534707955,2.829413892,0.004663335,0.020575167,5.526005479,0,0.999325457,1.244259874,0.803148504,0.421888905,0.585221255,14.28606319,1,-1.647498979,1.193424713,-1.380480027,0.167438895,0.28466018,16.47705161,1,-2.069516559,1.191223627,-1.737303149,0.082333676,0.169574546,48.77658758,0,2.036328323,0.522329584,3.898550616,9.68E-05,0.000675257,N,-,,hit finger domain,P:biological_process; F:metal ion binding,IPR007529 (PFAM); PTHR13483 (PANTHER); IPR007529 (PROSITE_PROFILES); SSF144232 (SUPERFAMILY),,
RL4_JR_03413,3089,2959,3551,0,0,6,0,0,2,0,0,5,0,0,0,0,3,3,51.5718758,1,-0.553405848,0.857144819,-0.645638679,0.518513382,0.702896672,8.847579271,1,0.320287583,1.235562897,0.259224021,0.795462398,0.87622923,22.83972862,1,-2.324424036,1.19804085,-1.940187629,0.052356891,0.117301886,58.43347407,0,0.920938397,0.582447844,1.581151697,0.113843357,0.21573348,26.25015424,1,-1.468437945,1.123798537,-1.306673658,0.191323569,0.311408822,N,-,,hypothetical protein CMQ_4279,,no IPS match,,
RL4_JR_03414,3729,2653,2723,0,0,4,0,0,0,0,0,0,0,1,0,0,3,0,85.41863767,1,-3.508647172,1.195648771,-2.93451326,0.003340713,0.015692176,25.72921211,0,-1.219842273,1.227864684,-0.993466372,0.320482731,0.482661832,82.92035091,0,-2.057021496,1.067934659,-1.926167934,0.054083408,0.120100993,77.60100859,1,-4.30518927,1.227589312,-3.507027333,0.000453143,0.003858763,66.72860478,1,-3.974006923,1.232543536,-3.224232497,0.001263108,0.005807888,N,-,,U3 small nucleolar RNA-associated 11,"C:intracellular organelle; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",IPR007144 (PFAM); IPR007144 (PIRSF); IPR007144 (PANTHER),,
RL4_JR_03415,8,2,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29.84490541,0,-0.538683904,1.007976858,-0.534420905,0.593050359,0.763830885,5.769375367,0,0.937108417,1.240403331,0.755486859,0.449956914,0.610370858,22.7848857,0,-0.750572536,1.192628059,-0.629343348,0.529124298,0.658575657,38.58185291,0,0.588492496,0.746207319,0.788644766,0.430319659,0.572760161,14.71221415,0,-1.792778193,1.195736367,-1.499308913,0.133793511,0.237368022,N,-,,acetylserotonin methytransferase,C:cytoplasm; C:membrane; C:integral component of membrane; F:transferase activity; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_03416,16945,10608,11585,0,0,5,0,0,0,0,0,1,4,5,0,0,4,1,41.69766096,1,0.728677114,0.681445034,1.069311652,0.284929262,0.46845081,5.851450599,0,0.916690786,1.233517136,0.743152048,0.457389631,0.616486404,38.74838352,1,0.670276471,0.854638529,0.784280662,0.432875444,0.573391469,43.24211692,1,0.877813399,0.677116427,1.296399501,0.194837884,0.324302741,49.07414633,1,1.590941437,0.596082373,2.668995945,0.007607837,0.025255524,N,-,,acetylserotonin methytransferase,C:cytoplasm; C:membrane,IPR003697 (PFAM); IPR003697 (TIGRFAM); IPR029001 (G3DSA:3.90.950.GENE3D); IPR029001 (SUPERFAMILY),,
RL4_JR_03417,631,578,587,0,7,1,0,0,0,1,0,3,0,0,0,0,0,0,6.60870924,1,-0.82696141,1.207853354,-0.684653818,0.493562398,0.681184578,2.115609384,0,2.384424054,1.319083809,1.807636511,0.070663092,0.154950567,5.48320055,1,-0.266199451,1.20942325,-0.22010446,0.825789801,0.887599103,6.324743661,0,-0.688364082,1.209022045,-0.569356105,0.569114499,0.696096195,5.405534163,0,-0.348325385,1.211313559,-0.287560048,0.773683531,0.843586663,N,-,,methyltransferase,F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108:SF905 (PANTHER); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_03418,49,23,25,0,0,0,0,0,0,0,0,1,0,4,0,0,0,2,24.74635579,0,2.219529094,0.737675371,3.008815507,0.002622683,0.012965269,1.68379557,0,2.713779521,1.323255234,2.050836037,0.040282917,0.099647641,4.371306078,1,0.060782441,1.199178407,0.050686737,0.959575145,0.976355655,14.35524732,1,0.587627164,1.141785451,0.514656377,0.606793162,0.727074646,4.31308691,1,-0.022473729,1.200725555,-0.018716791,0.985067033,0.990053972,N,-,,#NAME?,,IPR008030 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR14194:SF29 (PANTHER); PTHR14194:SF29 (PANTHER); PTHR14194 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_03419,615,539,1047,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,13.95900902,0,-1.905567852,1.211292311,-1.573169279,0.115679627,0.246088742,4.430311971,0,1.318024906,1.263273489,1.043340905,0.296790432,0.456621486,11.54734342,0,-1.34064828,1.209229383,-1.108679874,0.267568307,0.405700396,41.9072099,1,0.588540161,0.868556665,0.677607098,0.498020844,0.636192411,33.54533572,0,0.821716556,0.873865444,0.940323893,0.347051447,0.484408038,N,-,,helix-loop-helix dna-binding domain-containing,F:DNA binding; F:protein dimerization activity,IPR011598 (SMART); IPR011598 (PFAM); IPR011598 (G3DSA:4.10.280.GENE3D); PTHR15741 (PANTHER); IPR011598 (PROSITE_PROFILES); IPR011598 (SUPERFAMILY),,
RL4_JR_03420,1099,894,648,0,0,7,0,0,0,0,0,0,0,1,0,0,4,0,57.86219649,1,-1.557185126,1.065029688,-1.4621049,0.143712466,0.287848342,11.91849037,0,-0.109679803,1.246154101,-0.088014639,0.929865041,0.960711748,31.17721103,0,-2.773489993,1.223501153,-2.266847061,0.02339957,0.063068186,48.01714817,1,-0.929049033,0.921802164,-1.007861632,0.313520893,0.45965813,38.75832466,1,-1.221684026,1.036697807,-1.178437938,0.238622061,0.367515723,Y,-,,threonyl-tRNA synthetase,F:ATP binding; F:RNA binding; C:cytoplasm; F:threonine-tRNA ligase activity; P:threonyl-tRNA aminoacylation,IPR002320 (PRINTS); IPR004154 (PFAM); IPR004154 (G3DSA:3.40.50.GENE3D); IPR002320 (TIGRFAM); G3DSA:3.30.930.10 (GENE3D); IPR002314 (PFAM); PTHR11451:SF5 (PANTHER); PTHR11451:SF5 (PANTHER); PTHR11451 (PANTHER); PTHR11451 (PANTHER); IPR006195 (PROSITE_PROFILES); SSF55681 (SUPERFAMILY); IPR004154 (SUPERFAMILY),,
RL4_JR_03421,1554,2495,1155,0,0,0,0,0,0,0,0,1,1,3,0,0,0,0,14.52305262,0,-1.96271506,1.190705157,-1.648363618,0.099278077,0.220267405,4.627135341,0,1.255362684,1.243342099,1.009667963,0.312654397,0.474394814,12.0218512,1,-1.398719907,1.193633405,-1.171816993,0.241270539,0.374463121,17.88116883,1,-0.874019073,1.143772533,-0.764154627,0.444775102,0.586908368,11.87370369,0,-1.483475823,1.199445127,-1.236801742,0.216160695,0.34127975,N,-,,hypothetical protein HMPREF1624_07503,P:mycelium development; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_03422,2433,2388,1653,0,0,20,0,0,0,0,0,0,0,6,0,0,0,0,5.374502234,1,-0.528227407,1.214675513,-0.434871208,0.663655915,0.812075139,1.723557225,0,2.680221983,1.34552769,1.991948589,0.046376699,0.111106496,4.45221385,0,0.034716673,1.211325304,0.028660074,0.9771357,0.987068525,13.15820344,1,1.332607492,1.031110212,1.292400635,0.196218437,0.326064611,4.365494687,0,-0.039898158,1.204614206,-0.033121109,0.97357801,0.982309651,N,-,,urease,P:urea catabolic process; F:nickel cation binding; F:urease activity; C:cytosol,IPR005848 (PRINTS); IPR006680 (PFAM); IPR011612 (PFAM); IPR002026 (PFAM); IPR005848 (TIGRFAM); IPR002026 (TIGRFAM); IPR008221 (PIRSF); IPR002019 (PFAM); IPR002019 (G3DSA:2.10.150.GENE3D); G3DSA:3.20.20.140 (GENE3D); IPR011059 (G3DSA:2.30.40.GENE3D); IPR002019 (TIGRFAM); IPR002026 (G3DSA:3.30.280.GENE3D); PTHR22642:SF7 (PANTHER); PTHR22642:SF7 (PANTHER); PTHR22642 (PANTHER); PTHR22642 (PANTHER); PTHR22642 (PANTHER); PTHR22642:SF7 (PANTHER); IPR002026 (PRODOM); IPR017951 (PROSITE_PROFILES); IPR005848 (HAMAP); IPR002026 (SUPERFAMILY); IPR032466 (SUPERFAMILY); IPR002019 (SUPERFAMILY); IPR011059 (SUPERFAMILY),,
RL4_JR_03423,2578,3699,2576,0,0,6,0,0,0,3,0,0,1,10,2,0,5,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,Uncharacterised,,no IPS match,,
RL4_JR_03424,727,799,1047,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,186.4420614,1,-0.818234916,0.465116855,-1.759202891,0.078543053,0.185672046,41.0969917,0,-1.895425902,1.201614402,-1.577399454,0.114703641,0.225648601,190.8273548,0,-0.392579917,0.495496162,-0.792296585,0.428187762,0.568819434,224.7560628,0,-0.235827719,0.404809026,-0.582565367,0.560185926,0.68866956,167.4313156,0,-0.65094701,0.500896537,-1.299563805,0.193750512,0.314532643,N,-,,high mobility group,,IPR009071 (SMART); IPR009071 (PFAM); IPR009071 (G3DSA:1.10.30.GENE3D); PTHR13711:SF211 (PANTHER); PTHR13711 (PANTHER); IPR009071 (PROSITE_PROFILES); IPR009071 (SUPERFAMILY),,
RL4_JR_03425,662,425,385,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,49.99915784,1,1.351578055,0.609236335,2.218479064,0.026522185,0.082488749,4.641252116,0,1.251046856,1.247935203,1.002493441,0.316105333,0.477768879,42.044335,0,1.42452155,0.739984215,1.925070186,0.054220578,0.120320899,158.1685803,0,3.479349341,0.345851873,10.06022987,8.28E-24,9.64E-22,122.8030986,0,3.241388308,0.386437891,8.387863571,4.95E-17,8.79E-15,N,-,,nima-interacting,,IPR010816 (PFAM); PTHR14905 (PANTHER); PTHR14905:SF11 (PANTHER),,
RL4_JR_03426,160,397,275,0,0,1,0,0,0,0,1,0,0,0,1,0,0,1,19.8559146,1,5.254611045,0.777602702,6.757449568,1.40E-11,5.73E-10,0.245537403,0,5.491763844,1.807139365,3.038926576,0.002374227,0.015223444,0.632271149,1,2.851297467,1.299142566,2.194753325,0.028181297,0.072931353,0.729131405,1,2.429054919,1.393041305,1.743706314,0.081210314,0.167944123,0.617382345,1,2.782129192,1.256087293,2.214917074,0.026765757,0.068945383,N,-,,hypothetical protein SPBR_06515,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03427,369,221,307,0,5,1,0,0,1,0,1,0,0,0,0,0,0,0,0.806207066,1,2.208607404,1.639795946,1.346879415,0.178019072,NA,0.258718663,1,5.416263559,1.765629281,3.067610861,0.002157774,0.015045494,0.667598003,1,2.772771521,1.275634437,2.173641163,0.029732095,0.076127396,0.769957206,0,2.350408085,1.353575383,1.736444172,0.082485328,0.169714274,0.65350192,0,2.700190996,1.237656179,2.181697181,0.029131889,0.073505471,Y,-, Effector probability:0.761,glycoside hydrolase family 45,P:carbohydrate metabolic process; F:cellulase activity,IPR009009 (G3DSA:2.40.40.GENE3D); IPR000334 (PFAM); PTHR39730 (PANTHER); IPR009009 (SUPERFAMILY),,
RL4_JR_03428,79,129,92,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,155.9182389,0,-3.536400185,1.056603093,-3.346952333,0.000817053,0.005057295,46.65869382,0,-2.078544058,1.232998221,-1.685764037,0.091841257,0.189485774,119.9498163,0,-4.717295185,1.220005988,-3.866616419,0.000110356,0.001234522,150.3266952,1,-2.86820937,0.91577131,-3.132014881,0.001736111,0.01179319,136.5018698,0,-1.907432111,0.752694624,-2.534138082,0.01127243,0.034564917,N,-,,ring finger domain,C:cell part,IPR001841 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001841 (PFAM); PTHR22765 (PANTHER); PTHR22765 (PANTHER); PTHR22765:SF43 (PANTHER); PTHR22765 (PANTHER); PTHR22765:SF43 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),8.A.112.1.6, the respiratory supercomplex factor (rcf) family.
RL4_JR_03429,1151,673,715,0,2,0,0,0,0,0,0,0,4,7,4,0,2,8,93.31937007,1,-0.881459968,0.672505881,-1.310709678,0.189955868,0.349889358,18.38547242,0,-0.734981117,1.206688419,-0.609089394,0.542465188,0.688970666,106.359463,0,0.432113502,0.546326269,0.790944032,0.428976652,0.56941912,62.98545043,1,-2.082966651,1.01945308,-2.043219734,0.041030691,0.109296434,62.3968043,1,-0.861775581,0.758656998,-1.135922536,0.255988986,0.387137936,N,-,,transcriptional regulator,P:biological_process; F:transferase activity; C:cellular_component,IPR019340 (PFAM); PTHR13556 (PANTHER),,
RL4_JR_03430,2211,1237,1203,0,3,5,0,0,0,0,0,0,3,11,2,0,3,2,8.83390904,1,-1.245550595,1.197241046,-1.040350729,0.298176984,0.483796307,2.813691654,0,1.973003556,1.278444169,1.54328488,0.122761671,0.237482079,7.313043263,0,-0.681666919,1.199207072,-0.56843137,0.569742094,0.693944774,36.51827857,1,2.395539853,0.592021786,4.046371113,5.20E-05,0.000613846,7.226826036,1,-0.767144456,1.204954349,-0.636658523,0.524347296,0.648366426,N,-,,3-amino-3-carboxypropyl transferase,F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); IPR021829 (PFAM); PTHR10108:SF757 (PANTHER); PTHR10108:SF757 (PANTHER); PTHR10108 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_03431,68,29,52,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,106.7363364,0,2.782056423,0.438116187,6.350042539,2.15E-10,6.91E-09,4.521001227,0,1.288821733,1.249057702,1.031835223,0.302149316,0.462686138,11.77066547,0,-1.368224811,1.19956392,-1.140601837,0.254035652,0.389734345,21.60503735,0,-0.068566927,1.024903463,-0.066900864,0.946660625,0.968827831,19.36733625,0,0.206986859,0.993585189,0.208323213,0.834976607,0.888417281,N,-,,glycosyl hydrolase family 18,F:chitinase activity; P:carbohydrate metabolic process; F:chitin binding; P:chitin catabolic process; C:extracellular region,IPR011583 (SMART); IPR013781 (G3DSA:3.20.20.GENE3D); IPR029070 (G3DSA:3.10.50.GENE3D); IPR001223 (PFAM); PTHR11177 (PANTHER); IPR029070 (SUPERFAMILY); IPR017853 (SUPERFAMILY),9.B.29.2.7, the small 4-5 tms putative permease (4-5pp) family.
RL4_JR_03432,18762,23606,31629,8,5,33,0,0,3,0,1,0,0,6,5,0,14,5,54.29110755,1,0.569582031,0.643698795,0.884858004,0.376233221,0.567659088,8.803715683,1,0.327448021,1.238275644,0.264438715,0.791441882,0.873795221,38.4749498,1,-0.496621498,1.044280187,-0.475563459,0.634385413,0.744726104,81.34012543,1,1.391613772,0.520352365,2.674368114,0.007487022,0.038460729,30.10393986,1,-0.733806532,0.988356757,-0.742451071,0.457814087,0.589516422,N,-,,garp complex subunit,P:vesicle-mediated transport; C:cytoplasm; P:intracellular transport; P:vacuolar transport,IPR007234 (PFAM); PTHR12820:SF0 (PANTHER); PTHR12820 (PANTHER),,
RL4_JR_03433,3001,2984,2191,0,0,6,0,0,0,0,8,15,1,1,0,1,16,0,62.35090726,1,1.059978898,0.747238374,1.418528457,0.156036537,0.305336067,5.093955925,0,1.116643697,1.267036448,0.881303532,0.378153555,0.542470278,49.84095091,1,1.590211632,0.710068893,2.239517387,0.025122271,0.066825506,34.63742165,1,-0.205361389,1.045270578,-0.196467205,0.844244499,0.90273266,13.23089634,1,-1.639591177,1.231355693,-1.331533355,0.183013577,0.30157625,N,-,,pantetheine-phosphate adenylyltransferase family,F:catalytic activity,IPR014729 (G3DSA:3.40.50.GENE3D); PTHR10695 (PANTHER); SSF52374 (SUPERFAMILY),,
RL4_JR_03434,67,80,99,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1656.005676,0,-2.950521692,0.520366512,-5.670083728,1.43E-08,3.29E-07,461.0746912,0,-5.383339171,1.216834413,-4.42405237,9.69E-06,0.000636677,1243.837748,1,-5.189232747,0.803817179,-6.455737552,1.08E-10,6.22E-09,1553.717841,0,-3.014042806,0.63340079,-4.758508125,1.95E-06,3.31E-05,1298.736079,0,-3.297624701,0.870518342,-3.788116278,0.000151794,0.000984569,N,-,,heat shock SSB1,F:ATP binding; C:cytosol,IPR013126 (PRINTS); G3DSA:3.30.30.30 (GENE3D); IPR029048 (G3DSA:1.20.1270.GENE3D); IPR029047 (G3DSA:2.60.34.GENE3D); G3DSA:3.90.640.10 (GENE3D); IPR013126 (PFAM); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); PTHR19375 (PANTHER); PTHR19375:SF220 (PANTHER); IPR029048 (SUPERFAMILY); SSF53067 (SUPERFAMILY); IPR029047 (SUPERFAMILY); SSF53067 (SUPERFAMILY),1.A.33.1.3, the cation channel-forming heat shock protein-70 (hsp70) family.
RL4_JR_03435,75,73,122,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,332.0702846,0,-1.276390138,0.405044096,-3.151237484,0.001625802,0.00878364,72.50501991,0,-2.714478778,1.189969538,-2.281132997,0.022540578,0.063323822,275.1048975,0,-1.212445295,0.482969413,-2.510397683,0.012059526,0.037405222,304.1333775,0,-1.574966613,0.46037341,-3.421063374,0.000623768,0.005004477,211.7925878,0,-2.040660617,0.586005419,-3.482323799,0.000497082,0.002695746,N,-,,transcription initiation spt5,"P:intracellular mRNA localization; C:DSIF complex; P:7-methylguanosine mRNA capping; P:transcription from RNA polymerase II promoter; P:regulation of transcription-coupled nucleotide-excision repair; P:translational elongation; F:RNA polymerase II core binding; F:RNA polymerase I transcription factor binding; P:mRNA splicing, via spliceosome; F:transcription factor activity, core RNA polymerase II binding; P:positive regulation of transcription elongation from RNA polymerase II promoter; F:RNA polymerase I core binding; F:translation elongation factor activity; P:negative regulation of transcription elongation from RNA polymerase I promoter; P:positive regulation of transcription elongation from RNA polymerase I promoter; P:regulation of rRNA processing; F:rRNA binding",IPR005824 (SMART); IPR024945 (SMART); IPR017071 (PIRSF); IPR014722 (G3DSA:2.30.30.GENE3D); PF12815 (PFAM); IPR005824 (PFAM); IPR022581 (PFAM); IPR005100 (PFAM); PTHR11125:SF7 (PANTHER); PTHR11125 (PANTHER); IPR008991 (SUPERFAMILY),,
RL4_JR_03436,1727,1426,2565,0,0,0,0,0,0,0,0,0,3,9,0,0,1,0,52.87408857,0,-3.826794796,1.198573815,-3.192790254,0.001409053,0.007798542,16.80498464,0,-0.605307174,1.20624684,-0.50181037,0.615800918,0.747647462,51.52643273,0,-2.298230829,1.194735413,-1.923631629,0.054400774,0.120594139,78.48319785,1,-0.193062235,0.603860001,-0.319713567,0.749185474,0.835039952,43.12422362,1,-3.344188283,1.199253744,-2.788557719,0.005294331,0.018782447,N,-,,WD repeat,C:cytoplasm,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR19919:SF0 (PANTHER); PTHR19919 (PANTHER); PTHR19919 (PANTHER); PTHR19919:SF0 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),3.A.20.1.4, the peroxisomal protein importer (ppi) family.
RL4_JR_03437,8030,3638,6735,3,4,5,0,0,0,0,0,1,0,0,5,0,4,0,97.97142919,1,1.436885277,0.577970803,2.486086267,0.012915665,0.046580901,6.967914589,0,0.664760629,1.227287087,0.541650472,0.588059315,0.725705672,18.12495361,1,-1.990954213,1.195321078,-1.665622943,0.095788538,0.187829394,38.24848607,1,-0.101940771,0.857674418,-0.11885719,0.905388499,0.941950118,17.91211139,1,-2.076608841,1.202105853,-1.727475859,0.084082237,0.167527107,N,-,,NADPH2:quinone reductase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); IPR013149 (PFAM); PTHR11695:SF31 (PANTHER); IPR002085 (PANTHER); PTHR11695:SF31 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_03438,17658,16500,22016,2,6,6,0,0,0,1,0,1,0,3,0,0,3,0,2026.01844,1,0.94878992,0.608579594,1.55902355,0.118990806,0.250639555,410.4917434,0,0.249454008,0.62897665,0.396602971,0.691660261,0.804755728,857.7330456,1,-0.948096245,0.346985497,-2.732380039,0.006287856,0.022597891,817.6322949,1,-1.924742149,0.556846556,-3.456503644,0.000547232,0.004504652,703.4393945,1,-1.734349212,0.554841921,-3.125843858,0.001772957,0.007648567,N,-,,pyruvate kinase,F:magnesium ion binding; P:pyruvate biosynthetic process; F:pyruvate kinase activity; F:potassium ion binding; C:cytosol; P:canonical glycolysis; F:kinase activity,IPR001697 (PRINTS); IPR015793 (PFAM); IPR015813 (G3DSA:3.20.20.GENE3D); IPR015795 (PFAM); IPR015794 (G3DSA:3.40.1380.GENE3D); IPR015806 (G3DSA:2.40.33.GENE3D); IPR001697 (TIGRFAM); IPR001697 (PANTHER); PTHR11817:SF37 (PANTHER); IPR015813 (SUPERFAMILY); IPR011037 (SUPERFAMILY); IPR015795 (SUPERFAMILY),,
RL4_JR_03439,1826,2310,3578,0,1,6,0,0,0,0,1,2,0,0,3,0,3,1,252.8654537,1,1.444480145,0.442217023,3.266450794,0.001089047,0.006309977,22.35493466,0,-1.017023349,1.209940535,-0.840556473,0.400596452,0.564412297,110.394889,1,-0.256923575,0.63665815,-0.403550281,0.686543453,0.784875005,151.0047108,1,0.030772875,0.534285217,0.057596344,0.954070162,0.972903655,95.84937213,1,-0.042977193,0.593254039,-0.072443153,0.942249244,0.963469359,N,-, Effector probability:0.674,duf1748 domain containing,C:cytosol,IPR013726 (PFAM); PTHR28075 (PANTHER); PTHR28075:SF1 (PANTHER),,
RL4_JR_03440,1118,1072,1959,0,1,0,0,0,0,0,0,0,0,1,0,0,6,0,65.63201803,1,-0.316107822,0.781203658,-0.404642015,0.685740671,0.828896683,10.04154212,0,0.137547158,1.232542495,0.111596281,0.911143521,0.950652603,26.16685,0,-2.520755751,1.207830141,-2.087011795,0.036887068,0.089635216,71.59787546,1,0.882605825,0.585297605,1.507960766,0.131564569,0.240928063,25.94316308,1,-2.6110698,1.218144359,-2.143481419,0.032074462,0.079363129,N,-,,autophagy-related 28,,no IPS match,,
RL4_JR_03441,7578,10654,9712,0,2,12,0,0,0,2,2,0,0,4,0,0,1,1,52.68244846,1,1.082415508,0.597468298,1.811670197,0.070037171,0.171015637,7.117083433,0,0.634291038,1.248352536,0.508102494,0.611381466,0.74442478,18.36060541,1,-2.009481174,1.201779308,-1.672088345,0.094506903,0.185856232,59.85669045,1,1.08785359,0.599385034,1.814949537,0.069531665,0.150140351,41.14934538,1,1.092973835,0.639757127,1.708419944,0.087558449,0.172913848,N,-,,DNA mismatch repair MSH6,F:ATPase activity; F:FAD binding; P:reciprocal meiotic recombination; P:interstrand cross-link repair; C:nuclear chromosome; P:meiotic mismatch repair; F:four-way junction DNA binding; F:damaged DNA binding; F:ATP binding; P:maintenance of DNA repeat elements; F:oxidoreductase activity; C:cytosol; C:MutSalpha complex; P:oxidation-reduction process; F:guanine/thymine mispair binding; F:single base insertion or deletion binding,IPR007696 (SMART); IPR000432 (SMART); PIRSF037677 (PIRSF); IPR007860 (G3DSA:3.30.420.GENE3D); IPR007861 (PFAM); IPR000432 (PFAM); IPR016151 (G3DSA:3.40.1170.GENE3D); IPR007696 (PFAM); IPR007860 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.1420.10 (GENE3D); IPR007695 (PFAM); PTHR11361:SF34 (PANTHER); PTHR11361 (PANTHER); IPR027417 (SUPERFAMILY); IPR016151 (SUPERFAMILY); IPR007860 (SUPERFAMILY); IPR007696 (SUPERFAMILY),,
RL4_JR_03442,1445,1530,2024,0,2,5,0,0,0,0,0,0,0,1,0,0,1,0,83.760354,1,2.388759198,1.074002522,2.224165353,0.026137321,0.081509276,116.3768272,0,4.516170547,1.516712095,2.97760568,0.002905095,0.015363307,44.91396977,0,1.651876393,0.779222715,2.11990277,0.034014246,0.084650989,123.4970089,1,2.835884549,0.545094807,5.202552862,1.97E-07,4.15E-06,43.01523834,1,1.944511909,0.731271847,2.659082142,0.007835386,0.025807834,N,-,,Choriogenin Hminor,,PTHR39601:SF3 (PANTHER); PTHR39601 (PANTHER),,
RL4_JR_03443,99,160,167,5,1,2,3,0,0,0,0,0,0,0,0,0,0,0,0.419237069,1,3.151547937,2.507743949,1.256726365,0.208852738,NA,0.136371889,1,6.339841786,2.248172921,2.819997398,0.004802404,0.020121305,0.351031084,0,3.698742565,1.563749743,2.365303388,0.018015306,0.051696984,0.404651022,0,3.277737932,1.85347127,1.768432014,0.076988708,0.161993074,0.344766442,0,3.621639177,1.483165649,2.44183054,0.014613004,0.042638809,N,-,,hypothetical protein SPI_04334,C:integral component of membrane,no IPS match,,
RL4_JR_03444,73,115,102,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,100.0910114,0,4.784610433,0.394596668,12.12531889,7.76E-34,4.87E-31,1.139398279,0,3.277249368,1.375649467,2.382328818,0.017203528,0.051216417,2.954882279,0,0.625828634,1.20314261,0.520161641,0.602950918,0.720646888,3.408720249,0,0.203530452,1.203784172,0.169075534,0.865737229,0.916519181,10.63299838,0,2.213117402,0.976244613,2.266970155,0.023392049,0.061670812,N,-,,hypothetical protein VDAG_09517,,no IPS match,,
RL4_JR_03445,1121,1466,845,0,0,1,0,0,1,4,1,0,0,6,2,0,0,5,3.998495182,1,5.316477352,1.205877563,4.408803609,1.04E-05,0.000120247,0.057302028,1,7.590676457,2.33091931,3.256516184,0.001127885,0.015023052,0.148879278,1,4.936348807,1.379439929,3.578516689,0.00034555,0.002593289,19.44233378,1,6.261285864,1.044337775,5.995460487,2.03E-09,6.38E-08,0.147004372,1,4.852804514,1.262383751,3.84415952,0.000120966,0.000812191,N,-,,hypothetical protein FPOA_03771,,no IPS match,,
RL4_JR_03446,122,219,149,0,6,2,0,0,0,0,0,0,7,6,0,0,0,1,0.091477399,1,5.347890021,3.918413476,1.364810032,0.172312765,NA,0.028557247,0,8.5942981,2.741235269,3.135191714,0.001717418,0.015023052,0.075266954,0,5.918296642,1.6153516,3.663782326,0.000248518,0.002031802,0.086909692,1,5.496514151,2.533362002,2.169652086,0.030033212,0.092287185,0.075475278,1,5.816402718,1.376709633,4.224858008,2.39E-05,0.00020851,N,-, Effector probability:0.737,hypothetical protein FG05_30721,,no IPS match,,
RL4_JR_03447,485,515,417,0,2,1,2,0,1,0,0,0,0,2,0,0,0,0,7.727955545,1,6.967102977,1.42433075,4.891492356,1.00E-06,1.52E-05,0.0292811,1,8.560650869,3.012146565,2.842043268,0.004482541,0.019176787,0.07494127,0,5.930141806,1.905770622,3.111676578,0.001860282,0.009365238,0.08641084,1,5.506428806,2.865304228,1.921760612,0.054635887,0.12931004,0.0723765,0,5.876346269,1.583004854,3.712146716,0.000205509,0.001274045,N,-,,hypothetical protein FOZG_10364,,no IPS match,,
RL4_JR_03448,4698,3824,4690,0,0,4,0,0,0,2,0,0,3,6,0,0,0,0,28.21928016,1,-1.764269431,1.151170359,-1.532587612,0.125377496,0.260527155,7.778912408,0,0.505906529,1.231186578,0.410909718,0.681138737,0.797603689,31.28471913,1,-1.186649892,1.197840397,-0.990657766,0.32185272,0.464429439,23.32124732,1,-2.570846214,1.198661546,-2.144764068,0.031971716,0.095572329,19.98078628,0,-2.234340359,1.206293723,-1.852235749,0.063991977,0.13554786,N,-,,glycoside hydrolase family 78,F:catalytic activity,IPR008902 (PFAM); PTHR34987 (PANTHER); PTHR34987:SF1 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_03449,3654,2850,3908,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,22.77961617,0,-2.612092414,1.227224801,-2.128454715,0.033299401,0.098070943,7.300759227,0,0.597445431,1.272853218,0.469374962,0.638801642,0.764116074,18.92637123,1,-2.053402856,1.224425664,-1.6770335,0.093535931,0.184304743,29.85347346,0,-0.769524027,1.063190044,-0.723787842,0.469195995,0.61014763,26.04502965,0,-1.195529389,1.160638208,-1.030062065,0.302980872,0.438277937,N,-,,Major facilitator superfamily general substrate transporter,F:allantoate transmembrane transporter activity; P:transmembrane transport; F:dipeptide transporter activity; P:dipeptide transport; P:tripeptide transport; C:integral component of membrane; C:plasma membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF268 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.36, the major facilitator superfamily (mfs).
RL4_JR_03450,1048,1143,1361,0,3,18,0,0,0,0,0,0,0,1,2,0,0,0,72.62057878,1,4.337729811,1.08152599,4.010749488,6.05E-05,0.000551087,1.22064862,0,3.17766011,1.458403433,2.178862199,0.029341907,0.07785027,3.206497956,0,0.507661523,1.277519291,0.39738071,0.691086738,0.7887005,3.7015964,1,0.084407463,1.294701892,0.065194516,0.948019128,0.969760928,3.206661231,0,0.405190464,1.291867583,0.313647056,0.753789116,0.828318251,N,-,,p-loop containing nucleoside triphosphate hydrolase,F:GTP binding,IPR006073 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10903 (PANTHER); PTHR10903:SF43 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_03451,114,103,137,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0.933271934,1,1.997133844,1.629989277,1.225243547,0.220483471,NA,0.294082467,0,5.230909236,1.742740217,3.001542733,0.002686153,0.015349618,0.770588044,0,2.564079598,1.301301704,1.970395943,0.04879301,0.111074455,0.889445284,0,2.141337788,1.379795519,1.551924005,0.120680408,0.225357642,0.768494857,0,2.4662793,1.286158707,1.91755441,0.055167536,0.120772173,N,-,,efflux pump antibiotic resistance,P:transmembrane transport; C:integral component of membrane,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR011701 (PFAM); IPR002347 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR23501 (PANTHER); PTHR23501:SF83 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR016040 (SUPERFAMILY),2.A.1.3.65, the major facilitator superfamily (mfs).
RL4_JR_03452,102,94,88,0,0,82,0,0,0,0,0,0,0,0,0,0,3,0,0.003880053,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,1,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,Y,-,,---NA---,,no IPS match,,
RL4_JR_03453,40,84,86,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,24.0322226,0,1.478666058,0.747432412,1.978327452,0.047891778,0.128731837,2.790704722,0,1.984846931,1.277427397,1.553784533,0.120235821,0.233998651,15.09350274,1,0.292480204,1.193390614,0.245083379,0.806391872,0.873332404,8.364892382,0,-1.091711745,1.19561635,-0.913095363,0.361192389,0.507222322,126.8382445,0,4.136101796,1.779633081,2.324131778,0.020118432,0.054740269,Y,-,,22kda glyco,,no IPS match,,
RL4_JR_03454,35,22,15,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,42.55193265,0,4.032479127,2.003811533,2.012404391,0.044177326,0.121183129,0.763958764,0,3.854033032,1.923283992,2.003881407,0.045082766,0.10867534,1.93424476,0,1.237193824,1.552750248,0.796775802,0.425581251,0.56647181,2.227345834,0,0.817460696,1.64798278,0.496037159,0.619868195,0.737678123,1.866642539,1,1.185549053,1.553186774,0.763301023,0.445283892,0.578055601,N,-,,cyanide hydratase,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; P:nitrogen compound metabolic process; F:cyanide hydratase activity",IPR003010 (PFAM); IPR003010 (G3DSA:3.60.110.GENE3D); PTHR23088:SF22 (PANTHER); PTHR23088 (PANTHER); IPR003010 (PROSITE_PROFILES); IPR003010 (SUPERFAMILY),,
RL4_JR_03455,1681,1304,1692,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,2.635910512,0,0.499507674,1.285795096,0.388481552,0.697659704,0.836658786,0.85008608,0,3.699989643,1.479390593,2.501022826,0.01238352,0.039584659,2.18803278,1,1.059704347,1.241868491,0.853314465,0.39348494,0.536618825,2.52300693,0,0.637942381,1.255613533,0.508072241,0.611402682,0.731309741,2.137666776,1,0.990064049,1.227028038,0.806879727,0.41973578,0.55546004,N,-,,short chain dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_03456,233,206,256,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38.01119795,0,-3.350647873,1.202432832,-2.786557205,0.005327121,0.022872977,12.22648957,0,-0.146372639,1.233915512,-0.118624523,0.905572836,0.947020172,31.52920119,0,-2.789581525,1.202931365,-2.318986441,0.020395772,0.056417156,82.92153415,0,0.251888389,1.453151172,0.173339425,0.862384636,0.914883114,30.86840344,0,-2.861856614,1.198967621,-2.38693403,0.01698954,0.048036607,N,-,,Transcription factor SFP1,F:metal ion binding,IPR015880 (SMART); IPR022190 (PFAM),,
RL4_JR_03457,24755,1189,2603,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0.003880053,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,0,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,,,,,,,,
RL4_JR_03458,753,603,289,0,0,2,0,0,0,0,0,0,0,0,6,0,0,0,1.987850913,1,0.906175634,1.361016944,0.665807754,0.505533988,NA,0.63471205,0,4.121224042,1.547810166,2.662615955,0.007753585,0.027959129,1.649840439,0,1.466190941,1.266895722,1.157309884,0.247145777,0.381360135,1.903282347,1,1.043972453,1.295022053,0.806142606,0.420160627,0.563013016,1.633100543,0,1.378413098,1.262963784,1.091411421,0.275091889,0.407804594,N,-,,MFS general substrate transporter,P:nucleocytoplasmic transport; P:transmembrane transport; C:membrane; C:integral component of membrane; F:structural constituent of nuclear pore; C:nuclear pore,PR01036 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501:SF73 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_03459,1226,931,649,0,0,0,0,0,0,1,0,0,0,4,0,0,0,0,158.6257673,0,5.565720216,1.17492881,4.737070168,2.17E-06,3.01E-05,1.118448036,0,3.304185648,1.513534871,2.183091855,0.029029046,0.077202314,2.86820538,1,0.669130958,1.288744212,0.51921161,0.603613183,0.721069644,67.49216471,1,4.392218081,1.595594008,2.752716581,0.005910304,0.032035239,2.78818136,0,0.606865537,1.278803433,0.474557326,0.635102529,0.738133087,Y,-,,ABC transporter,F:oxidoreductase activity; P:oxidation-reduction process,PF13343 (PFAM); G3DSA:3.40.190.10 (GENE3D); G3DSA:3.40.190.10 (GENE3D); PTHR30006:SF2 (PANTHER); PTHR30006 (PANTHER); SSF53850 (SUPERFAMILY),3.A.1.11.8, the atp-binding cassette (abc) superfamily.
RL4_JR_03460,627,1322,874,0,0,8,0,0,0,2,0,0,0,5,0,0,0,0,0.007760107,1,8.901087564,4.041366561,2.202494486,0.027630398,NA,0.002334598,0,12.18995876,4.048442383,3.01102439,0.002603679,0.015349618,0.006343058,1,9.480780804,4.042868098,2.345063102,0.01902386,0.053738157,0.007335717,1,9.055356819,4.042572319,2.23999872,0.025091006,0.08557795,0.006581095,0,9.341867313,1.819064456,5.135533973,2.81E-07,4.95E-06,N,-,,hypothetical protein CMQ_36,P:proteolysis; F:cysteine-type peptidase activity,no IPS match,,
RL4_JR_03461,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.105354028,0,1.753180197,1.442651987,1.215248177,0.224271451,NA,0.355885288,0,4.956173708,1.65749318,2.990162353,0.002788292,0.015349618,0.917689174,0,2.313271167,1.250024214,1.850581086,0.064229843,0.13753446,1.058264033,0,1.891313172,1.294047606,1.461548372,0.143865011,0.257948156,0.898873572,0,2.239630402,1.221785068,1.833080516,0.066790598,0.139852799,Y,-,,alpha beta-Hydrolase,F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR000073 (PFAM); IPR029058 (SUPERFAMILY),,
RL4_JR_03462,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.9990184,0,0.001336125,1.142322363,0.001169657,0.999066749,0.999802078,2.301673015,0,2.262889443,1.301071153,1.739251107,0.081990603,0.173331012,18.94982887,0,1.435455906,1.033834363,1.388477649,0.164991646,0.281777231,25.48997013,0,0.935697788,1.012618626,0.924037702,0.355466687,0.501546851,5.847792388,0,-0.461733762,1.193634047,-0.386830254,0.698881878,0.786941616,N,-,,dihydrodipicolinate synthetase,P:metabolic process; F:lyase activity,IPR002220 (PRINTS); IPR002220 (SMART); IPR002220 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR12128:SF25 (PANTHER); PTHR12128:SF25 (PANTHER); IPR002220 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_03463,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.383774649,0,3.279124945,2.291073152,1.431261565,0.152355265,NA,0.122898165,0,6.489800831,2.057055201,3.154898725,0.001605538,0.015023052,0.318902294,0,3.836711035,1.356232899,2.828947033,0.004670143,0.01798967,0.367846439,0,3.415176906,1.586263818,2.152969051,0.031321111,0.094723687,0.31516766,0,3.751091813,1.289648319,2.90861606,0.003630324,0.01380805,N,-,,fad binding domain,F:FAD binding; F:oxidoreductase activity; P:secondary metabolite biosynthetic process; P:oxidation-reduction process; F:monooxygenase activity,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789:SF199 (PANTHER); PTHR13789 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_03464,3934,3720,5496,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,16.9881733,0,-0.317091661,1.160702131,-0.273189523,0.784707533,0.889119538,21.60600317,0,3.589089236,1.006833152,3.564730887,0.00036423,0.014017996,7.424953707,0,-0.703592336,1.210164369,-0.581402291,0.560969354,0.686747814,16.59081789,1,0.591068549,1.036465447,0.570273279,0.568492361,0.69558733,11.22038618,1,0.1348241,1.148534623,0.117387928,0.90655265,0.940070215,N,-,,methyltransferase domain-containing,F:catalytic activity,PF13649 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); PTHR10108:SF705 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_03465,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,115.0237698,0,-0.363131498,0.743401055,-0.488473209,0.625214698,0.785211598,60.71232621,0,1.514460722,0.764909001,1.979922735,0.047712211,0.113687148,95.54589746,0,-0.90001538,0.755221484,-1.191723751,0.233369582,0.365223937,112.7187709,0,-0.445250246,0.568858427,-0.782708358,0.433798393,0.57585057,82.98597091,0,-0.666056347,0.675324135,-0.986276534,0.323997432,0.460159068,N,-,,SPFH domain Band 7 family,C:membrane; F:hydrolase activity,IPR001972 (PRINTS); IPR001107 (SMART); IPR032435 (PFAM); IPR001107 (PFAM); PTHR10264:SF27 (PANTHER); IPR001972 (PANTHER); IPR001107 (SUPERFAMILY),8.A.21.2.2, the stomatin/podocin/band 7/nephrosis.2/spfh (stomatin) family.
RL4_JR_03466,593,760,661,0,0,0,0,0,0,0,0,0,0,1,0,0,5,0,130.9025506,0,-0.401539874,0.910830772,-0.440850141,0.659321491,0.80846907,26.2299945,0,-1.247600051,1.242971816,-1.003723524,0.315511895,0.477272893,152.1084657,0,0.382297713,0.543743964,0.703084059,0.482003366,0.618165959,124.7984094,1,-0.471114626,0.609851514,-0.772507102,0.439814142,0.581743097,85.10595206,1,-1.073719956,0.751160299,-1.429415209,0.15288493,0.262499561,N,-,,endosomal peripheral membrane,C:trans-Golgi network; P:vesicle-mediated transport; F:ARF guanyl-nucleotide exchange factor activity,IPR032629 (PFAM); IPR032691 (PFAM); IPR032817 (PFAM); PTHR10663 (PANTHER); PTHR10663:SF169 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_03467,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,80.5353565,0,-1.764946509,0.849839233,-2.076800459,0.03781998,0.108182116,20.03768858,0,-0.859115466,1.197786052,-0.717252856,0.473218091,0.630915901,67.66859044,0,-1.686788193,1.028145282,-1.640612686,0.10087784,0.195200163,121.9340192,0,0.115938507,0.480932995,0.241069978,0.80950088,0.878665996,62.44918213,0,-1.91548374,0.968687797,-1.977400506,0.047996377,0.108595154,N,-, Effector probability:0.642,ubiquitin-conjugating enzyme,C:nucleus; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; C:cytoplasm; P:protein K63-linked ubiquitination; F:ligase activity; P:postreplication repair,SM00212 (SMART); IPR016135 (G3DSA:3.10.110.GENE3D); IPR000608 (PFAM); PTHR24067:SF46 (PANTHER); PTHR24067 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),3.A.16.1.3, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_03468,261,98,99,3,1,31,0,0,0,0,0,0,0,0,0,0,1,0,105.69418,1,2.415180235,0.42691693,5.657260377,1.54E-08,3.52E-07,120.4826024,0,4.054256881,1.572096113,2.578886143,0.009911945,0.033365051,53.21599351,0,1.754504364,0.619735132,2.831055191,0.004639471,0.01790698,69.84935983,0,2.196476047,0.478206004,4.593158661,4.37E-06,6.79E-05,51.58570859,1,1.7027367,0.585757324,2.906897841,0.003650324,0.013863289,N,-,,ubiquitin-conjugating enzyme,F:DNA binding,IPR008011 (PFAM),,
RL4_JR_03469,692,1758,941,0,0,2,0,0,0,0,1,0,0,3,0,0,10,2,146.72927,1,-1.558191606,0.887564444,-1.755581375,0.079159915,0.186810302,34.15594173,0,-1.62853419,1.27760617,-1.274676209,0.202423871,0.346780792,87.39389224,1,-4.26046893,1.255802982,-3.39262527,0.000692263,0.004289148,100.7238898,1,-4.681439544,1.266785705,-3.695526028,0.000219432,0.002072527,92.3820887,1,-3.376561516,1.188319233,-2.841459955,0.004490749,0.016405795,N,-,,bzip family transcription factor,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR004827 (PFAM); G3DSA:1.20.5.170 (GENE3D); PTHR40618:SF1 (PANTHER); PTHR40618 (PANTHER); SSF57959 (SUPERFAMILY),,
RL4_JR_03470,13379,26290,10045,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,182.59456,0,-2.956877685,0.936244252,-3.158233204,0.001587285,0.008615484,50.20304548,0,-2.18417327,1.250493114,-1.746649578,0.080698142,0.171314301,185.9891738,0,-1.368711965,0.708827073,-1.930953285,0.05348883,0.119120306,168.4278045,1,-2.292237733,0.800668712,-2.862904094,0.004197776,0.024454823,125.3754776,0,-4.883901329,1.237478912,-3.946654188,7.93E-05,0.000571114,N,-,,c4-dicarboxylate transporter malic acid transporter,P:transmembrane transport; C:integral component of membrane,IPR004695 (PFAM); PTHR31162 (PANTHER); PTHR31162:SF3 (PANTHER),2.A.16.2.3, the telurite-resistance/dicarboxylate transporter (tdt) family.
RL4_JR_03471,46,35,44,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,313.4411689,0,2.591487484,0.738051458,3.51125583,0.000445995,0.003060073,13.75247372,0,-0.316076102,1.206987138,-0.261871972,0.793420149,0.874836465,56.44796976,0,-0.55910628,0.846373491,-0.660590491,0.508874969,0.640379141,140.28918,0,1.251744773,0.399591428,3.132561624,0.00173288,0.011791273,42.74909187,0,-1.371741172,0.964708558,-1.421922881,0.15504864,0.26522954,N,-,,heat shock DNAj,F:unfolded protein binding; P:protein folding,IPR001623 (PRINTS); IPR001623 (SMART); IPR001623 (G3DSA:1.10.287.GENE3D); IPR001623 (PFAM); PTHR24078:SF198 (PANTHER); PTHR24078 (PANTHER); IPR001623 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_03472,3,1,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein SPI_06084,F:arylformamidase activity; P:tryptophan catabolic process to kynurenine,IPR010839 (PFAM); PTHR13943:SF46 (PANTHER); PTHR13943 (PANTHER); PTHR13943 (PANTHER); PTHR13943:SF46 (PANTHER),,
RL4_JR_03473,5,17,29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,172.423616,0,0.730396137,0.436311532,1.674024367,0.094125811,0.211828514,30.70871172,0,-0.034069575,1.13986648,-0.029889093,0.976155505,0.987570816,85.53797545,0,-0.77391013,0.769100321,-1.006253813,0.314293492,0.456711255,115.3944309,0,-0.135672897,0.560232013,-0.242172696,0.808646351,0.878020837,73.1491951,0,-0.757921561,0.709607639,-1.068085404,0.285481989,0.419793857,Y,-,,Niemann-Pick C1,P:lipid transport; C:fungal-type vacuole membrane; C:integral component of membrane; F:sphingolipid transporter activity; P:sphingolipid metabolic process,IPR000731 (PFAM); IPR032190 (PFAM); IPR003392 (PFAM); G3DSA:1.20.1640.10 (GENE3D); IPR004765 (PTHR10796:PANTHER); PTHR10796 (PANTHER); IPR000731 (PROSITE_PROFILES); SSF82866 (SUPERFAMILY); SSF82866 (SUPERFAMILY),2.A.6.6.3, the resistance-nodulation-cell division (rnd) superfamily.
RL4_JR_03474,40,49,33,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,22.16138181,0,3.134733547,0.968587526,3.236396776,0.00121049,0.006848251,0.971595486,0,3.507170128,1.581477883,2.217653605,0.02657846,0.071855548,9.020402413,0,1.816749888,1.295774891,1.402056715,0.160898311,0.276343957,10.93302739,1,2.098033524,1.169337383,1.794207177,0.072780107,0.155447875,2.476214426,0,0.778278443,1.332380249,0.584126374,0.559135292,0.677797219,N,-,,cytochrome partial,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; F:methyltransferase activity; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding; P:methylation",IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305:SF69 (PANTHER); PTHR24305 (PANTHER); PTHR24305 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_03475,193,205,204,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3204.355317,0,-1.846385614,0.262939889,-7.022082577,2.19E-12,1.04E-10,884.6312949,0,-3.912555361,0.879387847,-4.449180615,8.62E-06,0.000580417,2261.885642,0,-3.389547074,0.633004634,-5.354695517,8.57E-08,3.00E-06,2605.13223,0,-3.531410631,1.32282601,-2.669595703,0.007594263,0.03891291,2183.253842,0,-3.654619875,0.769173647,-4.751358668,2.02E-06,2.61E-05,N,-,,hsp90 co-chaperone aha1,P:positive regulation of ATPase activity; F:chaperone binding; C:cytosol; P:protein folding; F:ATPase activator activity; P:response to stress,IPR015310 (SMART); IPR023393 (G3DSA:3.30.530.GENE3D); IPR015310 (PFAM); IPR013538 (PFAM); PTHR13009:SF8 (PANTHER); PTHR13009 (PANTHER); SSF55961 (SUPERFAMILY); IPR015310 (SUPERFAMILY),,
RL4_JR_03476,144,223,141,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.55775965,0,-0.4059695,1.158408428,-0.350454546,0.725997597,0.855261862,3.079442407,0,1.842919075,1.306221339,1.410878096,0.158280562,0.288046718,14.43323165,0,0.162719514,1.208413857,0.134655452,0.892884297,0.933245423,32.43144921,0,1.108755469,0.872743595,1.270425214,0.203933207,0.335575281,15.48934234,0,0.791123106,0.993414785,0.796367356,0.425818546,0.560717009,N,-,,hypothetical protein CMQ_3534,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_03477,82,112,115,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,30.72223345,0,-1.654886406,1.16999376,-1.414440369,0.157232644,0.306720208,7.198684173,0,0.617706079,1.248405895,0.494795868,0.620744221,0.750408815,29.85367127,0,-1.080728888,1.210769513,-0.892596713,0.37207318,0.516150846,21.67558642,1,-2.465269984,1.214161368,-2.030430262,0.042312823,0.111712473,18.64796873,0,-2.134728582,1.225290257,-1.742222767,0.081469472,0.163536558,N,-,,Ras guanyl-nucleotide exchange factor,,PF13233 (PFAM); PTHR28015:SF1 (PANTHER); PTHR28015 (PANTHER),,
RL4_JR_03478,1620,1531,2092,0,0,3,0,0,0,0,0,1,6,0,1,0,3,0,26.43950859,1,-0.64143175,1.096439354,-0.585013433,0.558538685,0.736473022,5.922001935,0,0.899334134,1.292160113,0.695992799,0.486433339,0.642442362,15.52496868,1,-1.767630666,1.240267985,-1.425200592,0.154099225,0.267690556,21.93154502,1,-1.247098723,1.197901295,-1.041069684,0.297843208,0.44292333,15.49258102,1,-1.867282021,1.258992548,-1.483155738,0.138033038,0.243448695,N,-,,GTP-binding,F:GTP binding; P:biological_process,IPR027417 (G3DSA:3.40.50.GENE3D); IPR006073 (PFAM); PTHR11649 (PANTHER); IPR030393 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_03479,470,472,706,0,0,0,0,0,0,0,4,0,0,2,0,0,21,2,73.14388033,0,2.318629693,0.516970695,4.48503119,7.29E-06,8.84E-05,4.821337103,0,1.196034277,1.256032226,0.952232158,0.340979255,0.503905086,12.52873104,1,-1.458311747,1.203910192,-1.211312735,0.22577557,0.356202566,14.45395767,1,-1.880706518,1.203205234,-1.5630804,0.118033685,0.221518269,39.40888224,1,1.818189533,0.639359064,2.843769071,0.004458335,0.01629626,N,-,,palmitoyltransferase swf1,F:metal ion binding; C:intracellular membrane-bounded organelle; C:cytoskeletal part; F:palmitoyltransferase activity; C:membrane; C:actin cytoskeleton; P:single-organism organelle organization; C:endomembrane system; C:cytoplasmic part,IPR001594 (PFAM); PTHR22883 (PANTHER); IPR001594 (PROSITE_PROFILES),8.A.114.1.3, the huntington-interacting protein 14 (hip14) family.
RL4_JR_03480,472,324,607,0,1,0,0,0,0,0,4,1,1,6,0,0,13,0,26.88491527,1,-1.682490298,1.141069337,-1.474485593,0.140350894,0.282781574,7.368088059,0,0.584211943,1.225949382,0.476538388,0.633690865,0.760429038,19.1141036,1,-2.067655575,1.192098531,-1.73446701,0.082835254,0.167241403,22.04955715,1,-2.489946385,1.190465911,-2.091573024,0.036476728,0.101407707,18.85243348,1,-2.150484502,1.19617782,-1.79779667,0.072209235,0.148329987,N,-,,transcription factor,F:DNA binding,IPR009057 (G3DSA:1.10.10.GENE3D); IPR001606 (PFAM); IPR015010 (PFAM); IPR001606 (G3DSA:1.10.150.GENE3D); PTHR16466 (PANTHER); PTHR16466:SF6 (PANTHER); PTHR16466:SF6 (PANTHER); IPR009057 (SUPERFAMILY); IPR001606 (SUPERFAMILY),,
RL4_JR_03481,2782,2324,2418,3,8,0,0,0,0,0,0,0,3,15,8,0,3,0,2.477586331,1,0.588649847,1.241060263,0.474312057,0.635277395,0.791837971,0.789509895,0,3.806449578,1.439150292,2.644928469,0.008170819,0.029019308,2.050666417,0,1.152662348,1.212709326,0.950485267,0.341865736,0.485284452,2.365827887,1,0.73028509,1.219771304,0.598706567,0.549368577,0.678750073,2.024510456,1,1.068704695,1.209080568,0.88389866,0.37675092,0.51263662,N,-,,subfamily B member partial,F:protein binding; C:cytoplasm,IPR001623 (PRINTS); IPR001623 (SMART); IPR001623 (G3DSA:1.10.287.GENE3D); IPR001623 (PFAM); PTHR24078:SF198 (PANTHER); PTHR24078 (PANTHER); IPR001623 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_03482,5977,7064,6529,9,3,3,0,1,0,3,0,2,0,28,3,0,2,1,100.7892069,1,6.166063142,1.187996973,5.190302065,2.10E-07,3.87E-06,0.477713728,1,4.531146164,1.56619819,2.893086069,0.003814767,0.017631542,1.245678346,1,1.871501416,1.243542769,1.504975513,0.132330372,0.238765405,41.55331907,1,5.36680457,0.605840575,8.858443607,8.11E-19,6.85E-17,1.23529722,1,1.781490161,1.237424017,1.439676406,0.149958972,0.258781919,Y,-,,hypothetical protein SPSK_09892,,no IPS match,,
RL4_JR_03483,125,156,226,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.370557169,0,3.329644343,2.390464309,1.392886031,0.163654257,NA,0.117695945,0,6.5519617,2.114502584,3.098582972,0.001944485,0.015023052,0.307309157,0,3.889769459,1.408003654,2.762613185,0.005734068,0.021025607,0.354598214,0,3.467928354,1.66953437,2.077182966,0.037784675,0.103481157,0.305853178,0,3.794838305,1.339641555,2.832726628,0.004615284,0.016725035,N,-,,3-dehydroshikimate dehydratase,F:dioxygenase activity; P:oxidation-reduction process; F:isomerase activity,IPR013022 (PFAM); IPR013022 (G3DSA:3.20.20.GENE3D); PTHR12110:SF14 (PANTHER); PTHR12110 (PANTHER); IPR013022 (SUPERFAMILY),,
RL4_JR_03484,24,22,27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.90061436,0,1.608808069,1.049257364,1.533282609,0.125206238,0.260303896,1.290629603,0,3.097437788,1.393095895,2.223420368,0.026187468,0.070988095,3.358154505,0,0.441419308,1.231344717,0.358485566,0.719979967,0.810556225,3.875057917,0,0.018701433,1.237834545,0.015108185,0.987945871,0.992947384,3.315869885,0,0.357037545,1.233023055,0.289562749,0.772150769,0.842368983,N,-,,Amidase,"C:membrane; C:integral component of membrane; F:transferase activity; F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (G3DSA:3.90.1300.GENE3D); IPR023631 (PFAM); PTHR11895:SF8 (PANTHER); IPR000120 (PANTHER); PTHR11895:SF8 (PANTHER); IPR023631 (SUPERFAMILY),,
RL4_JR_03485,1598,2150,1680,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,9.175905815,0,-1.300104819,1.210508611,-1.074015342,0.282815805,0.466183248,2.910561187,0,1.924183588,1.283829834,1.498783979,0.133929682,0.252728606,14.0754055,0,0.229180621,1.202036094,0.190660349,0.848791706,0.903212868,12.75430868,1,-0.208956932,1.156367133,-0.180701203,0.856602114,0.910465716,7.491374341,0,-0.818920166,1.212903594,-0.675173337,0.499565645,0.627478247,N,-,,cycloheximide resistance,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23502:SF55 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.86, the major facilitator superfamily (mfs).
RL4_JR_03486,180,188,289,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,161.3217937,0,5.103343381,1.377042876,3.706016327,0.000210545,0.001609769,1.517967767,0,2.863364101,1.335205652,2.14451167,0.031991911,0.083209089,10.43906367,0,1.172329833,1.191788987,0.983672316,0.325276656,0.468435401,66.36909281,0,3.354383172,0.572437485,5.859824448,4.63E-09,1.38E-07,35.35369218,0,3.0697596,0.674233096,4.55296487,5.29E-06,5.95E-05,Y,-,,hypothetical protein CMQ_3760,,no IPS match,,
RL4_JR_03487,7,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.635466619,0,-0.314827481,1.232987299,-0.255337165,0.798462698,0.897559449,1.489353734,0,2.890947052,1.377987071,2.097949331,0.035909622,0.091099333,3.841635133,0,0.24755059,1.222508276,0.202493999,0.839530549,0.896414363,12.45362351,0,1.540303937,1.043429264,1.476193921,0.139891841,0.2527209,11.4814674,0,1.837289264,0.995877521,1.844894804,0.065052843,0.137335286,N,-,,glutathione-S-transferase,C:cytoplasm; P:metabolic process; F:glutathione transferase activity; F:transferase activity,PF13410 (PFAM); IPR010987 (G3DSA:1.20.1050.GENE3D); IPR012336 (G3DSA:3.40.30.GENE3D); IPR004045 (PFAM); PTHR11260 (PANTHER); IPR010987 (PROSITE_PROFILES); IPR004045 (PROSITE_PROFILES); IPR010987 (SUPERFAMILY); IPR012336 (SUPERFAMILY),1.A.12.2.1, the intracellular chloride channel (clic) family.
RL4_JR_03488,8,6,4,0,0,10,0,0,0,0,0,0,0,1,0,0,4,0,12.04880977,1,0.838259099,1.180103337,0.710326861,0.477501467,0.666687825,1.285640636,0,3.10309456,1.40161494,2.213942268,0.026832751,0.07242696,3.333631692,0,0.45214645,1.233287557,0.366618838,0.713903355,0.806467035,11.86921734,1,1.739391633,1.055303005,1.64823906,0.099303624,0.19481674,3.278265417,1,0.373485246,1.230514553,0.303519568,0.761493937,0.833527147,N,-,,Glutathione-dependent formaldehyde-activating enzyme centromere V,C:membrane,IPR006913 (G3DSA:3.90.1590.GENE3D); IPR006913 (PFAM); PTHR33337 (PANTHER); IPR011057 (SUPERFAMILY),,
RL4_JR_03489,4472,5041,8229,0,0,3,0,0,0,0,1,0,2,1,1,0,5,0,187.4352117,1,0.881973943,0.36097893,2.443283722,0.01455429,0.05133329,22.30959449,0,-1.01404445,1.204245702,-0.84205777,0.399755618,0.56368071,314.3617163,1,2.197006546,0.310234996,7.081749561,1.42E-12,1.12E-10,850.9803928,1,3.609286978,0.358193851,10.07635102,7.03E-24,8.28E-22,295.8375964,1,2.310069292,0.386019684,5.984330301,2.17E-09,1.20E-07,N,-,,Amidase family,"C:membrane; F:transferase activity; F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (PFAM); IPR023631 (G3DSA:3.90.1300.GENE3D); PTHR11895:SF44 (PANTHER); IPR000120 (PANTHER); IPR023631 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_03490,678,783,896,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,80.43878076,0,-1.480274848,0.85298408,-1.735407358,0.082668678,0.193185641,109.8755314,0,2.045611997,1.259360775,1.624325641,0.104306328,0.209191331,53.90214629,0,-3.563317283,1.224498333,-2.910022159,0.003614031,0.015523315,93.50980571,0,-0.94217213,0.742491374,-1.268933434,0.204464806,0.336126996,118.1809942,0,0.645064662,0.595416449,1.083384014,0.278638008,0.412276755,N,-,,smr domain containing,C:nucleus; C:nucleolus,PTHR13308:SF24 (PANTHER); PTHR13308 (PANTHER); IPR002625 (SUPERFAMILY),,
RL4_JR_03491,17,15,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,44.40819266,0,-2.50077646,1.188752292,-2.10369854,0.035404752,0.10275061,12.7904435,0,-0.211537625,1.240921839,-0.17046813,0.864641996,0.921641353,57.00713566,0,-0.46624427,0.896742601,-0.519930991,0.603111674,0.720715603,38.64156146,1,-3.299296751,1.225746585,-2.691663018,0.007109674,0.037010515,40.68375069,0,-2.02949163,1.165025147,-1.7420153,0.081505767,0.163556536,N,-,,wd repeat-containing jip5,P:mycelium development; P:ribosomal large subunit biogenesis; C:nucleolus,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22840 (PANTHER); IPR017986 (SUPERFAMILY),,
RL4_JR_03492,3,3,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,3.880771922,1,-0.058546495,1.403240236,-0.04172236,0.966720028,0.983109199,1.218217945,0,3.180711922,1.527542096,2.082241746,0.037320394,0.093899336,16.1832994,0,2.311682403,1.147304971,2.014880491,0.043917173,0.102422819,3.677646081,0,0.094094425,1.344723227,0.069973079,0.944215087,0.967373791,3.158085959,0,0.427320509,1.32832044,0.321699867,0.747680079,0.823929125,N,-,,glycoside hydrolase family 18,F:chitinase activity; F:chitin binding; P:chitin catabolic process; C:membrane; C:extracellular region,IPR011583 (SMART); IPR013781 (G3DSA:3.20.20.GENE3D); IPR001223 (PFAM); PTHR11177:SF182 (PANTHER); PTHR11177 (PANTHER); IPR017853 (SUPERFAMILY),9.B.29.2.7, the small 4-5 tms putative permease (4-5pp) family.
RL4_JR_03493,2,2,3,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1.151526926,1,1.694367265,1.482104617,1.143217048,0.252948486,NA,0.366881143,0,4.912243582,1.662675147,2.954421728,0.003132556,0.015941545,0.950686342,0,2.262545474,1.26691062,1.785876161,0.074119312,0.153735692,1.096775079,0,1.83993251,1.316810852,1.397264085,0.162334172,0.282362736,0.934184513,0,2.184979471,1.243762561,1.756749671,0.078960487,0.159735251,Y,-,,MARVEL-like domain,P:mycelium development; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,IPR008253 (PFAM),,
RL4_JR_03494,7,25,9,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,467.6268032,1,-2.054199896,1.215520836,-1.689975058,0.091032726,0.206715679,274.3899428,0,0.144624805,1.764675364,0.081955474,0.934682121,0.963917721,315.8853107,0,-6.114266281,1.234146333,-4.954247414,7.26E-07,2.04E-05,381.9115241,0,-4.236999946,0.92352514,-4.587855557,4.48E-06,6.94E-05,335.9967648,0,-3.137446151,0.806813249,-3.888689429,0.000100787,0.000698951,N,-,,purine permease,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR006043 (PFAM); IPR006042 (TIGRFAM); IPR006043 (PANTHER); PTHR11119:SF36 (PANTHER),2.A.40.4.1, the nucleobase/ascorbate transporter (nat) or nucleobase:cation symporter-2 (ncs2) family.
RL4_JR_03495,32,19,41,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.719166471,0,2.373376595,2.033151924,1.167338538,0.243073681,NA,0.224285917,0,5.621918761,1.985908355,2.830905438,0.004641644,0.019682749,0.589423924,0,2.951575813,1.448963589,2.037025524,0.041647484,0.098698298,0.680604721,0,2.527929667,1.614430633,1.565833561,0.117387587,0.220510078,0.587470587,0,2.854204241,1.414845864,2.017325219,0.043661586,0.10081495,N,-,,carboxypeptidase,F:carboxypeptidase activity; P:proteolysis; F:serine-type carboxypeptidase activity,IPR001563 (PRINTS); IPR029058 (G3DSA:3.40.50.GENE3D); IPR001563 (PFAM); PTHR11802:SF67 (PANTHER); IPR001563 (PANTHER); PTHR11802:SF67 (PANTHER); IPR001563 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_03496,6,3,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.173884253,0,0.777646817,1.285320687,0.60502163,0.545164625,0.725759304,0.692692717,0,3.995286784,1.483816858,2.692574061,0.007090279,0.026156963,1.796276302,0,1.344299663,1.228543514,1.094222262,0.27385751,0.41256343,2.072310827,0,0.921833087,1.242628827,0.741841061,0.458183639,0.600298829,1.767754356,0,1.264626462,1.218929911,1.037489072,0.299507986,0.434707334,N,-,,---NA---,,no IPS match,,
RL4_JR_03497,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.887208001,0,0.981147217,1.39768491,0.701980261,0.482691474,NA,0.607494004,0,4.184539979,1.586521994,2.637555606,0.008350593,0.029410127,1.571003301,0,1.536985366,1.284574826,1.19649345,0.231504053,0.362865309,1.811723344,0,1.115206156,1.319217906,0.845354016,0.39791321,0.542097855,1.547229555,0,1.456202416,1.275029968,1.142092698,0.25341549,0.384353572,N,-,,---NA---,,no IPS match,,
RL4_JR_03498,89,87,99,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.182493457,0,-0.166962655,1.262520083,-0.132245544,0.894790079,0.948391329,1.339822152,0,3.04342227,1.409879148,2.158640529,0.030878066,0.080991911,3.474293761,0,0.392022979,1.241786493,0.315692739,0.752235738,0.83385904,4.007443486,0,-0.030085777,1.249629284,-0.024075762,0.980792177,0.988219039,3.429823457,0,0.307939439,1.244149356,0.247510026,0.804513534,0.868133809,N,-,,---NA---,,no IPS match,,
RL4_JR_03499,415,341,480,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,157.6587581,0,-1.638611158,0.6368587,-2.57295874,0.010083323,0.038115088,46.42358006,0,-0.828870017,1.118231117,-0.741233188,0.458552064,0.617380153,119.6921318,0,-1.989095242,0.861885237,-2.30784234,0.021007907,0.05771616,130.9913801,0,-1.804430619,0.696632478,-2.590218912,0.009591492,0.047005737,136.3469372,0,-0.873196639,0.57775579,-1.511359391,0.13069691,0.233140629,N,-, Effector probability:0.778,mitochondrial import inner membrane translocase subunit tim-17,C:mitochondrial inner membrane presequence translocase complex; P:protein import into mitochondrial matrix; F:P-P-bond-hydrolysis-driven protein transmembrane transporter activity; C:integral component of membrane; P:mitochondrial genome maintenance,IPR003397 (PFAM); IPR005678 (PANTHER),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_03500,534,643,582,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,137.6885136,0,0.239650397,0.603103489,0.397361981,0.691100547,0.832103414,21.91675226,0,-0.988430422,1.25844224,-0.785439642,0.432195846,0.593983211,56.32086635,1,-3.62661142,1.233415041,-2.940300953,0.003278936,0.014464465,126.8928678,0,-0.013542765,0.594584273,-0.022776863,0.981828264,0.988860158,81.36670731,0,-0.766005412,0.752034839,-1.018577029,0.308403814,0.443738613,N,-,,wd repeat-containing,P:proteolysis; C:intracellular part; F:metallopeptidase activity,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR011650 (G3DSA:3.30.70.GENE3D); G3DSA:3.40.630.10 (GENE3D); IPR001680 (PFAM); IPR002933 (PFAM); IPR017149 (PIRSF); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR11014:SF82 (PANTHER); PTHR11014 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); SSF53187 (SUPERFAMILY); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_03501,3102,3550,5256,3,7,0,0,0,0,0,4,0,0,0,0,0,0,0,1.584682325,1,1.233260032,1.46274,0.843116365,0.399163367,NA,0.514538723,0,4.424234765,1.650002626,2.681350136,0.007332575,0.026862224,1.322713644,1,1.785357285,1.304707324,1.368396768,0.171187915,0.289623405,1.524831863,0,1.364050046,1.351908064,1.008981367,0.31298357,0.459136286,1.294370504,0,1.713487391,1.286253668,1.332153551,0.182809736,0.301408334,Y,-,,extracellular serine-rich,,IPR008972 (G3DSA:2.60.40.GENE3D); PTHR34883:SF3 (PANTHER); PTHR34883 (PANTHER); IPR008972 (SUPERFAMILY),,
RL4_JR_03502,273,160,236,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1.284774517,0,1.536354095,1.409091231,1.09031556,0.275574163,NA,0.408769791,0,4.756204161,1.612715415,2.949189992,0.00318608,0.016079667,1.060952887,0,2.104001528,1.247586192,1.686457851,0.091707647,0.181645484,1.224065575,0,1.681388183,1.284431007,1.309052938,0.190516419,0.319367342,1.044953988,1,2.023299268,1.229885365,1.645112077,0.0999467,0.191116212,N,-, Effector probability:0.577,cupin domain-containing,,IPR013096 (PFAM); IPR014710 (G3DSA:2.60.120.GENE3D); PTHR36156:SF1 (PANTHER); PTHR36156 (PANTHER); IPR011051 (SUPERFAMILY),,
RL4_JR_03503,3,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.18452689,0,-2.698334671,1.199544369,-2.24946633,0.024482843,0.077415128,96.92267822,0,3.170542119,0.746630082,4.246469831,2.17E-05,0.001248946,26.4796,0,-1.169810873,1.196712409,-0.977520467,0.32831155,0.471197354,50.99232444,0,-0.213881486,0.857875515,-0.249315293,0.803116902,0.874079183,27.4854385,0,-0.555471267,0.991742987,-0.560095987,0.575413968,0.689665549,N,-,,kinase-like domain partial,F:zinc ion binding; P:phosphorylation; F:kinase activity; F:ligase activity,G3DSA:3.90.1200.10 (GENE3D); IPR002575 (PFAM); IPR000058 (G3DSA:4.10.1110.GENE3D); PTHR21310:SF3 (PANTHER); PTHR21310 (PANTHER); SSF118310 (SUPERFAMILY); IPR011009 (SUPERFAMILY),,
RL4_JR_03504,2150,2727,3704,0,0,0,2,0,0,1,0,1,4,2,0,0,4,5,0.722905221,0,2.365621743,1.727264408,1.36957708,0.170818958,NA,0.229297029,1,5.58998544,1.798773522,3.107664958,0.001885717,0.015023052,0.59820944,1,2.929287472,1.288527638,2.273360218,0.023004481,0.06215569,0.690289557,1,2.507039955,1.383774647,1.811740054,0.070026372,0.150854683,0.593958491,1,2.837765519,1.262100884,2.24844587,0.024547773,0.064223825,N,-,,uncharacterized protein LW93_536,,no IPS match,,
RL4_JR_03505,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.038930341,0,6.579265881,3.934059818,1.672385826,0.094448265,NA,0.012514112,0,9.784819881,3.933914426,2.487298609,0.012871731,0.040829727,0.032511331,0,7.129411942,2.472023449,2.884038962,0.003926102,0.016223614,0.037496607,0,6.708925314,3.933842061,1.705438401,0.088112692,0.17817875,0.032277048,0,7.034858667,1.614942479,4.35610479,1.32E-05,0.000127669,N,-,,4-coumarate- ligase,F:catalytic activity,IPR000873 (PFAM); IPR025110 (PFAM); G3DSA:3.40.50.980 (GENE3D); G3DSA:2.30.38.10 (GENE3D); G3DSA:3.40.50.980 (GENE3D); G3DSA:3.30.300.30 (GENE3D); PTHR24096:SF231 (PANTHER); PTHR24096 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.7, the fatty acid transporter (fat) family.
RL4_JR_03506,8062,7735,5174,6,22,17,0,0,0,0,0,2,1,12,7,0,1,0,7.75055105,1,6.75010617,1.106977125,6.097782889,1.08E-09,2.91E-08,0.036107629,0,8.257407505,2.58772028,3.190996944,0.001417828,0.015023052,0.093568002,1,5.608671066,1.505727431,3.724891339,0.000195399,0.001733763,0.107950084,1,5.184805827,2.282683685,2.271364124,0.023124944,0.082096796,0.091895624,1,5.533077258,1.309372971,4.225745744,2.38E-05,0.000208048,N,-,,integral membrane,C:membrane,PTHR33048 (PANTHER); PTHR33048:SF54 (PANTHER),2.A.1.7.25, the major facilitator superfamily (mfs).
RL4_JR_03507,822,994,1108,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,26.93320271,0,7.67328807,0.644833595,11.89964066,1.19E-32,6.46E-30,0.064978719,0,7.409318328,2.277903678,3.252691674,0.001143175,0.015023052,0.168545285,1,4.757112654,1.366318795,3.48170037,0.000498241,0.003376986,0.194426234,1,4.335322919,1.810847582,2.394084937,0.01666189,0.069971644,0.166244915,1,4.674256363,1.259220552,3.712023564,0.000205609,0.001274045,N,-,,siderophore iron transporter,P:transmembrane transport; C:integral component of membrane; F:transporter activity,G3DSA:1.20.1250.20 (GENE3D); IPR010573 (PFAM); PTHR23501:SF22 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.47, the major facilitator superfamily (mfs).
RL4_JR_03508,669,1286,881,0,0,2,0,0,0,1,0,0,0,1,1,0,0,0,42.68569034,1,6.479262998,0.615105561,10.53357897,6.05E-26,1.76E-23,0.21737594,0,5.667270989,1.789297151,3.167316834,0.001538526,0.015023052,0.563885849,1,3.015650729,1.256616933,2.39981704,0.016403268,0.047816495,0.65052077,1,2.593214638,1.341737087,1.932729343,0.053269548,0.127056344,0.555587543,0,2.934543876,1.222722629,2.400007823,0.016394721,0.046622318,N,-,,salicylate hydroxylase,F:FAD binding; F:oxidoreductase activity; C:membrane; P:oxidation-reduction process,PR00420 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR002938 (PFAM); PTHR13789:SF239 (PANTHER); PTHR13789 (PANTHER); SSF54373 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_03509,1097,1834,1481,0,0,10,0,0,0,1,0,1,0,2,8,0,2,0,20.6023728,1,0.982585774,0.896904282,1.095530252,0.2732844,0.455363772,2.934761044,0,1.912256634,1.31311548,1.456274534,0.145316742,0.270435019,7.599013145,1,-0.736946178,1.22030226,-0.603904624,0.545907054,0.67325655,8.764499403,1,-1.158976359,1.221293519,-0.948974461,0.342633602,0.489511107,7.487771036,1,-0.818413269,1.22421384,-0.668521497,0.503800764,0.631248399,N,-,,Chromate transport,C:membrane,IPR003370 (PFAM); PTHR33567:SF3 (PANTHER); PTHR33567 (PANTHER),2.A.51.1.6, the chromate ion transporter (chr) family.
RL4_JR_03510,39792,42183,41796,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,4.732528012,1,-0.34474353,1.203074975,-0.286551992,0.774455378,0.882773086,1.515164484,1,2.866106045,1.345271188,2.130504296,0.033130002,0.085590065,3.920177867,0,0.218258147,1.202973495,0.181432216,0.856028334,0.908688308,4.521734258,0,-0.203870328,1.202020237,-0.169606402,0.865319687,0.916460443,30.87571102,0,3.548233952,0.581287701,6.104092598,1.03E-09,6.09E-08,N,-,,hypothetical protein SPI_03677,"P:signal transduction; F:3',5'-cyclic-nucleotide phosphodiesterase activity",no IPS match,,
RL4_JR_03511,1072,1083,899,0,2,1,0,0,0,0,0,0,0,0,1,0,0,0,1.778849114,1,1.066888318,1.294437946,0.824209705,0.409820414,NA,0.567122,0,4.283820194,1.515221274,2.827191162,0.004695829,0.01983486,1.470972514,0,1.6324373,1.223495745,1.334240276,0.182125124,0.303312182,1.696989355,1,1.210004843,1.240201202,0.975652048,0.329236923,0.475877779,1.448699514,0,1.551774708,1.211779231,1.280575429,0.200342835,0.322165629,N,-,,hypothetical protein SPI_03677,,no IPS match,,
RL4_JR_03512,5634,5953,7564,0,2,8,0,0,0,6,3,1,6,12,7,0,0,1,25.36372683,1,0.403833484,0.849378646,0.47544577,0.634469278,0.791774801,4.432267661,0,1.31745027,1.243470423,1.059494657,0.289374561,0.44882766,11.51075709,1,-1.336015795,1.191511817,-1.121277839,0.262169616,0.399188628,13.27976343,1,-1.758444218,1.189218173,-1.47865569,0.139232361,0.251692135,11.36141475,1,-1.419833601,1.19636457,-1.186790078,0.235310434,0.363909904,Y,-,,Allergen Asp f 15,,IPR010829 (PFAM); PTHR38850:SF1 (PANTHER); PTHR38850 (PANTHER),,
RL4_JR_03513,136,114,216,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.788164299,0,0.418605691,1.274315458,0.328494557,0.742537759,0.864386849,0.886238154,0,3.639783648,1.44518398,2.51856075,0.011783555,0.038089197,2.301462646,0,0.986664718,1.231298577,0.80132044,0.422946161,0.564362064,2.655398218,0,0.564088109,1.242188225,0.454108401,0.649750807,0.760019284,2.267823003,0,0.905199737,1.226708335,0.737909503,0.460569444,0.59181494,N,-,,pantothenate transporter,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF241 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.4, the major facilitator superfamily (mfs).
RL4_JR_03514,9,2,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.409440517,0,3.186241108,2.370574987,1.344079443,0.178922699,NA,0.129949902,0,6.409780102,2.130026486,3.009249014,0.002618944,0.015349618,0.336587355,0,3.761179197,1.448645888,2.596341333,0.009422241,0.031201332,0.388360274,0,3.337943718,1.702662592,1.960425826,0.04994604,0.122892747,0.329697443,0,3.688166331,1.37118485,2.689765958,0.007150215,0.024027854,N,-,,M20 Peptidase Aminoacylase 1 2-like amidohydrolase subfamily,P:metabolic process; C:cellular_component; F:hydrolase activity,IPR011650 (G3DSA:3.30.70.GENE3D); IPR017144 (PIRSF); IPR011650 (PFAM); IPR017439 (TIGRFAM); IPR002933 (PFAM); G3DSA:3.40.630.10 (GENE3D); PTHR30575 (PANTHER); PTHR30575:SF0 (PANTHER); SSF53187 (SUPERFAMILY); IPR011650 (SUPERFAMILY),,
RL4_JR_03515,310,323,292,0,0,1,0,0,0,0,0,1,0,11,0,0,0,1,0.003880053,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,1,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,zinc-binding oxidoreductase,F:zinc ion binding; F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process,IPR020843 (SMART); IPR013154 (PFAM); IPR013149 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002085 (PANTHER); PTHR11695:SF460 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_03516,3029,2749,2366,0,0,6,0,0,1,0,0,6,0,4,1,0,0,1,6.723322256,1,-0.851455065,1.246769522,-0.682929002,0.494651707,0.682110991,2.176470414,1,2.343636937,1.371499805,1.708813176,0.087485561,0.182508007,38.08396087,1,2.815778963,0.743680356,3.786275837,0.000152922,0.001500176,26.50308154,1,2.255523404,0.765393251,2.946881754,0.003209959,0.019661729,20.89377062,1,2.209611287,0.81930114,2.696946433,0.006997853,0.023617753,Y,-,,carbohydrate esterase family 16,"F:hydrolase activity, acting on ester bonds; F:hydrolase activity",IPR001087 (PFAM); IPR013830 (G3DSA:3.40.50.GENE3D); PTHR22835:SF53 (PANTHER); PTHR22835 (PANTHER); IPR013830 (SUPERFAMILY),,
RL4_JR_03517,607,792,351,3,0,0,0,0,0,0,0,0,0,1,0,0,0,0,81.08216255,1,0.405632301,0.626043707,0.647929684,0.517030431,0.702091392,20.15589319,0,0.950232209,1.148259335,0.827541462,0.407930232,0.57173495,111.3492704,0,1.66728263,0.546717889,3.049621502,0.002291299,0.011009546,99.13930555,1,0.725639077,0.717756366,1.010982433,0.312024838,0.458150417,42.62821935,0,-0.085998861,0.779953989,-0.110261454,0.912202026,0.943388651,N,-,,related to component of actin cortical patches las17,,no IPS match,,
RL4_JR_03518,476,774,884,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,204.1245613,0,-1.103336374,0.530214858,-2.080923152,0.037440941,0.107512564,46.13130661,0,-2.062137617,1.21863673,-1.692167621,0.090614018,0.187603823,150.2493067,0,-1.879366357,0.774770509,-2.425707141,0.015278594,0.045162185,217.3533292,0,-0.801493815,0.503440001,-1.592034428,0.111376969,0.212451359,209.241206,0,-0.204218439,0.519900562,-0.392802881,0.694465077,0.783711425,N,-,,proteasome activator subunit 4,P:DNA repair; F:peptidase activator activity; F:proteasome binding; P:regulation of proteasomal protein catabolic process; P:histone exchange; P:proteasome assembly; C:nucleus; P:proteasome core complex import into nucleus; P:sequestration of proteasome core complex in proteasome storage granule; C:proteasome core complex; F:lysine-acetylated histone binding; P:positive regulation of peptidase activity; C:proteasome storage granule; P:proteasomal ubiquitin-independent protein catabolic process,IPR032372 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR021843 (PFAM); IPR032430 (PFAM); PTHR32170:SF3 (PANTHER); PTHR32170 (PANTHER); PTHR32170:SF3 (PANTHER); PTHR32170 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_03519,80444,108074,71464,0,1,1,0,0,0,3,0,6,2,8,0,0,10,0,2.070628706,1,0.847449575,1.272491398,0.665976663,0.505426017,NA,0.659151488,0,4.066758644,1.480366095,2.747130361,0.006011923,0.023333086,1.713855094,1,1.411353654,1.222077689,1.154880468,0.248139379,0.382666733,1.97734503,1,0.988960581,1.235120699,0.800699544,0.423305606,0.566269891,1.694343264,1,1.325519926,1.218014424,1.088262914,0.276479058,0.409501237,Y,-, Effector probability:0.553,scp-like extracellular,C:membrane,IPR001283 (PRINTS); IPR014044 (SMART); IPR014044 (G3DSA:3.40.33.GENE3D); IPR014044 (PFAM); IPR001283 (PANTHER); IPR014044 (SUPERFAMILY),8.B.9.1.5, the triflin toxin (triflin or crisp) family.
RL4_JR_03520,80,157,125,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.150163691,0,1.695752939,1.406841203,1.205362009,0.228063581,NA,0.369197378,0,4.903108352,1.633533527,3.001535181,0.00268622,0.015349618,0.954502603,0,2.25614712,1.2394956,1.8202139,0.068726437,0.14471432,1.100863162,0,1.834148715,1.277152058,1.436123994,0.150967062,0.267274261,0.937988267,0,2.178148999,1.216522991,1.790470887,0.073378243,0.150152529,N,-,,MFS general substrate transporter,P:transmembrane transport; C:integral component of membrane; F:transporter activity,G3DSA:1.20.1250.20 (GENE3D); IPR010573 (PFAM); PTHR23501 (PANTHER); PTHR23501:SF2 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.3.47, the major facilitator superfamily (mfs).
RL4_JR_03521,20094,24241,28332,6,7,24,3,0,0,1,9,6,3,9,8,2,14,0,0.377887255,1,3.30151467,2.264467021,1.457965446,0.144850068,NA,0.119917797,1,6.525126158,2.0272344,3.218732948,0.001287583,0.015023052,0.312652108,1,3.865173995,1.320766482,2.926462813,0.003428405,0.014915845,0.360769205,1,3.443227486,1.538203017,2.238474016,0.02519016,0.08578889,0.310138844,1,3.775305517,1.262568291,2.990179259,0.002788138,0.011171308,N,-,,Fungal trichothecene efflux pump,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR010573 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF2 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.47, the major facilitator superfamily (mfs).
RL4_JR_03522,9520,13332,18060,0,3,6,0,0,1,1,0,0,0,2,2,0,7,2,0.141163466,1,4.721847555,3.622899366,1.303333899,0.192460793,NA,0.045232589,1,7.931488225,2.619133404,3.028287224,0.002459442,0.015349618,0.117564853,1,5.27552682,1.629885071,3.236747739,0.001209002,0.006717859,0.135607842,1,4.854624942,2.303745059,2.107275249,0.035093728,0.099498352,0.116596458,1,5.184841855,1.433832634,3.616071871,0.000299107,0.001743501,N,-,,NAD(P)-binding domain,,IPR016040 (G3DSA:3.40.50.GENE3D); IPR016040 (PFAM); IPR016040 (SUPERFAMILY),,
RL4_JR_03523,352,477,619,0,0,0,0,0,0,0,1,3,0,2,5,0,7,0,0.34572392,0,3.430017729,2.488102546,1.37856767,0.16802809,NA,0.108107002,0,6.674639463,2.157827936,3.09322136,0.001979964,0.015023052,0.283929238,1,4.005007702,1.430670086,2.799392915,0.00511988,0.019247553,0.327818994,1,3.581711995,1.721640489,2.08040646,0.037488267,0.102975775,0.283103707,1,3.90804322,1.355933277,2.882179593,0.003949346,0.014770447,N,-,,---NA---,,no IPS match,,
RL4_JR_03524,1293,1757,2299,0,1,2,0,0,0,0,4,3,0,1,1,0,1,2,57.57116355,1,1.027724966,0.693051674,1.482898036,0.138101503,0.278938367,5.013118039,0,1.139862654,1.273331135,0.89518164,0.370689998,0.535131546,20.7636415,1,-0.540791111,1.206140427,-0.448364966,0.653889822,0.760145835,54.22754407,1,1.591781736,0.6115256,2.602968274,0.009242051,0.045713611,27.38662971,1,0.117103663,0.983410567,0.119079118,0.905212675,0.939354139,N,-,,pho85 cyclin-1,F:protein kinase binding; P:regulation of cell cycle; P:regulation of cyclin-dependent protein serine/threonine kinase activity,IPR013763 (G3DSA:1.10.472.GENE3D); IPR006671 (PFAM); PTHR15615 (PANTHER); PTHR15615:SF10 (PANTHER); IPR013763 (SUPERFAMILY),,
RL4_JR_03525,5919,7027,5609,0,0,4,0,0,0,1,2,0,2,2,1,0,2,4,36.99121237,1,-0.748618943,1.010750326,-0.740656643,0.458901654,0.647142558,6.670597071,0,0.727672183,1.225715346,0.593671431,0.552731895,0.698732639,25.18452835,1,-0.965439888,1.191247807,-0.81044421,0.417684917,0.559026223,81.97281908,1,1.698140736,0.490558827,3.461645463,0.000536884,0.004433943,31.86220535,1,-0.323705277,0.976049504,-0.331648421,0.740154752,0.81813866,N,-,,cell division control 2,"P:negative regulation of double-strand break repair via nonhomologous end joining; P:synaptonemal complex assembly; P:positive regulation of transcription from RNA polymerase II promoter; C:astral microtubule; F:RNA polymerase II core binding; P:cell division; F:ATP binding; P:chromatin remodeling; P:vesicle-mediated transport; P:negative regulation of transcription, DNA-templated; P:positive regulation of triglyceride catabolic process; P:positive regulation of meiotic cell cycle; P:positive regulation of spindle pole body separation; P:negative regulation of meiotic cell cycle; P:regulation of filamentous growth; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of nuclear cell cycle DNA replication; P:meiotic DNA double-strand break processing; P:regulation of protein localization; P:7-methylguanosine mRNA capping; C:cyclin-dependent protein kinase holoenzyme complex; P:negative regulation of sister chromatid cohesion; P:negative regulation of mitotic cell cycle; C:endoplasmic reticulum; F:cyclin-dependent protein serine/threonine kinase activity; C:ribosome; P:positive regulation of mitotic cell cycle; C:nucleus; C:cellular bud neck; F:histone binding; C:spindle pole body; P:regulation of double-strand break repair via homologous recombination; P:regulation of budding cell apical bud growth; P:peptidyl-serine phosphorylation",IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); PTHR24056 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_03526,8744,8231,7766,0,4,12,0,2,3,0,5,4,2,24,2,0,0,3,25.36256379,1,-2.767070194,1.190447809,-2.324394378,0.020104367,0.065736041,8.095163873,1,0.448431514,1.223934635,0.366385182,0.714077675,0.820978445,21.01378597,1,-2.204358269,1.193645512,-1.846744487,0.064784181,0.138341077,24.24181526,1,-2.626694319,1.192446272,-2.202777921,0.027610405,0.088405467,40.04472284,1,0.629272896,0.693138226,0.907860615,0.363951869,0.500291725,N,-,,alkylated dna repair,P:metabolic process; C:intracellular part,IPR027450 (G3DSA:2.60.120.GENE3D); IPR027450 (PFAM); IPR004574 (PANTHER); PTHR16557:SF2 (PANTHER); PTHR16557:SF2 (PANTHER); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_03527,15087,12079,16635,5,0,7,0,0,0,3,4,1,3,25,2,0,13,2,292.6324559,1,-0.590545667,0.868767865,-0.679750818,0.496662253,0.683971102,55.65213665,0,-2.332834214,1.215101463,-1.919867834,0.054874596,0.127074047,192.9113494,1,-1.359781485,0.609050483,-2.232625246,0.025573668,0.067723728,190.6996081,1,-2.370476321,0.707524771,-3.350379264,0.00080701,0.006190132,144.2252798,1,-4.117600228,1.135380659,-3.626625303,0.00028715,0.001690342,N,NRPS,,non-ribosomal peptide synthetase,F:catalytic activity; P:metabolic process; C:cytosol; F:phosphopantetheine binding; P:ferrichrome biosynthetic process,IPR020806 (SMART); G3DSA:2.30.38.10 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); G3DSA:3.40.50.980 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR009081 (PFAM); IPR000873 (PFAM); IPR023213 (G3DSA:3.30.559.GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR010071 (TIGRFAM); G3DSA:3.40.50.980 (GENE3D); IPR001242 (PFAM); G3DSA:3.30.300.30 (GENE3D); PTHR24095:SF118 (PANTHER); PTHR24095 (PANTHER); PTHR24095:SF118 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR009081 (PROSITE_PROFILES); IPR009081 (PROSITE_PROFILES); IPR009081 (PROSITE_PROFILES); IPR009081 (PROSITE_PROFILES); IPR009081 (PROSITE_PROFILES); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF56801 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR009081 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY); IPR009081 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF56801 (SUPERFAMILY); SSF56801 (SUPERFAMILY); SSF52777 (SUPERFAMILY); IPR009081 (SUPERFAMILY),4.C.1.1.4, the fatty acid transporter (fat) family.
RL4_JR_03528,15754,11377,15991,7,5,6,0,0,0,0,0,3,0,3,0,0,2,5,52.84826235,1,-0.643248642,0.780918959,-0.823707293,0.410105894,0.601518139,11.93583019,0,-0.111710276,1.220697236,-0.0915135,0.92708458,0.959634629,84.58181715,1,0.862253969,0.599864003,1.437415756,0.150599895,0.263146933,113.3069799,1,1.441422697,0.637782005,2.260055453,0.023817809,0.083277769,65.00547311,1,0.725905377,0.589166305,1.232089091,0.217915806,0.343354736,N,-,,L-ornithine n5-oxygenase,C:cytoplasm; F:oxidoreductase activity; P:oxidation-reduction process,PR00368 (PRINTS); IPR025700 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR23024 (PANTHER); PTHR23024:SF214 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_03529,508,296,344,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.752086299,0,1.088471204,1.297257788,0.83905544,0.4014382,NA,0.557766086,0,4.307710562,1.516615272,2.840344971,0.004506477,0.019254775,1.450096023,0,1.652446322,1.225183265,1.348733997,0.177422422,0.297191363,10.98529815,0,2.179711187,1.150624211,1.894372781,0.058175547,0.134727221,9.154404655,0,3.230332939,0.993080902,3.252839657,0.00114258,0.005318905,N,-,,translation initiation factor eIF-2B subunit family,C:membrane,no IPS match,,
RL4_JR_03530,481,442,346,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,109.466544,0,1.303293789,0.464417948,2.806295054,0.005011478,0.021816242,8.90133217,0,0.311492392,1.218929178,0.255545931,0.798301473,0.87792752,23.07739373,0,-2.3394754,1.190181647,-1.965645669,0.049339555,0.111923292,45.24517006,0,-1.020212467,1.011333704,-1.008779261,0.313080509,0.459145446,30.46577813,0,-0.752240327,0.974627418,-0.771823482,0.440218982,0.574162767,N,-,,choline dehydrogenase,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; F:oxidoreductase activity; P:oxidation-reduction process",IPR023753 (G3DSA:3.50.50.GENE3D); IPR000172 (PFAM); IPR012132 (PIRSF); IPR007867 (PFAM); PTHR11552 (PANTHER); PTHR11552 (PANTHER); PTHR11552:SF123 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_03531,50,51,97,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,15.22278294,1,-2.030623033,1.192033839,-1.703494453,0.088475575,0.202407107,4.851154518,0,1.187150184,1.242969654,0.955091848,0.339531251,0.502373239,34.74406975,0,0.363700172,1.031556325,0.352574225,0.724407663,0.81343203,79.72707316,0,2.11225847,1.728834382,1.22178185,0.221790134,0.357185479,12.45085381,0,-1.551960717,1.201030761,-1.292190647,0.19629113,0.317585121,N,-,,u1 zinc finger domain-containing,F:nucleic acid binding; C:nucleus; F:zinc ion binding; C:nucleolus,IPR003604 (SMART); IPR013085 (PFAM); PTHR13173 (PANTHER); SSF57667 (SUPERFAMILY),,
RL4_JR_03532,8914,7020,6148,6,1,0,0,0,1,2,1,6,1,3,8,0,5,1,237.4690296,1,2.054123241,1.032371626,1.989712995,0.04662256,0.126248347,33.0593677,1,1.264950885,0.997971579,1.267521953,0.204968719,0.349884082,190.9143616,1,2.172395614,0.405511044,5.3571799,8.45E-08,2.98E-06,157.8954049,1,1.457086851,0.387741896,3.757878287,0.00017136,0.001686124,132.8018287,1,1.510968719,1.66223255,0.908999598,0.363350338,0.49992148,Y,-,,covalently-linked cell wall,C:cellular bud tip; C:fungal-type cell wall; C:endoplasmic reticulum; F:structural constituent of cell wall; C:extracellular region; C:plasma membrane,PTHR23124 (PANTHER); PTHR23124:SF55 (PANTHER); IPR000420 (PROSITE_PROFILES),,
RL4_JR_03533,6362,4025,4256,0,1,0,0,0,3,0,1,0,0,5,0,0,0,0,1.375162933,1,1.437835356,1.386437781,1.037071678,0.299702454,NA,0.438746675,1,4.65395213,1.597242422,2.913741875,0.003571251,0.016958421,1.140080961,1,1.999272429,1.249250476,1.60037756,0.10951485,0.207510452,1.315246447,1,1.577094795,1.283683523,1.228569789,0.219233148,0.354388951,1.12728256,0,1.913163139,1.237698247,1.545742788,0.122166699,0.222071424,N,-, Effector probability:0.722,---NA---,,no IPS match,,
RL4_JR_03534,5954,7563,8689,0,2,7,0,0,0,0,0,5,1,1,1,0,1,0,23.44904093,1,2.795575098,0.68704253,4.06899861,4.72E-05,0.000445816,1.39987793,0,2.980256599,1.369464515,2.176220388,0.029538785,0.078188175,3.61745859,1,0.333967962,1.213495811,0.275211467,0.783153778,0.856318052,4.171968146,1,-0.087967058,1.214948423,-0.072403944,0.942280446,0.966135647,3.553950093,1,0.256583992,1.208239403,0.212361881,0.831824722,0.886550118,N,-,,g- coupled receptor,C:membrane,no IPS match,,
RL4_JR_03535,1441,1836,2619,4,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5.153614906,1,2.42652558,1.170266644,2.07348094,0.038127543,0.108830254,0.423988385,0,4.703326992,1.586491554,2.964608906,0.003030679,0.015659284,1.103658919,0,2.046325348,1.23594908,1.655671242,0.097788414,0.19082689,1.27345713,0,1.623841018,1.266693211,1.281952886,0.199859174,0.33059535,1.091922878,1,1.959594789,1.225273712,1.599311868,0.109751324,0.20472221,Y,-,,hypothetical protein F503_04291,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_03536,234,270,205,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.945249854,0,5.306098134,1.067948291,4.968497236,6.75E-07,1.08E-05,0.097396917,0,6.825249451,2.111563659,3.232320003,0.001227895,0.015023052,0.254253329,0,4.163994368,1.339911203,3.107664417,0.001885721,0.009455462,13.61728198,0,5.474803321,1.046057852,5.233748124,1.66E-07,3.56E-06,0.25221508,0,4.074627804,1.267379035,3.21500332,0.00130443,0.005936089,N,-,,chitin binding,F:chitin binding; C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03537,2315,2048,2380,0,0,0,0,0,0,0,2,0,0,0,0,0,4,0,4.294838955,0,-0.205030442,1.425891382,-0.143791066,0.885665458,0.944154115,1.415134709,0,2.96467064,1.58137634,1.874740734,0.0608284,0.137600628,3.603160162,1,0.3397478,1.350927496,0.251492253,0.801433551,0.869543807,4.151178769,0,-0.080696374,1.37956517,-0.058494064,0.953355091,0.972468295,3.490706604,1,0.282519119,1.34979976,0.209304467,0.834210565,0.888064554,N,-,,hypothetical protein MPH_13308,C:membrane; C:integral component of membrane,IPR025444 (PFAM); IPR011008 (SUPERFAMILY),,
RL4_JR_03538,2488,2259,2257,3,6,7,0,0,3,0,0,0,0,3,0,0,0,0,8.357614525,1,-1.165471022,1.429457907,-0.815323779,0.414887001,0.606309276,2.768741841,1,1.996349946,1.551674112,1.28657811,0.198241378,0.341591073,7.024624239,0,-0.623413512,1.371180288,-0.454654663,0.649357702,0.756425886,8.091174557,1,-1.043519686,1.395475158,-0.747788078,0.454587994,0.596900978,6.779466754,0,-0.675044414,1.380988454,-0.488812497,0.62497445,0.729657168,N,-,,hypothetical protein SPSK_01423,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03539,8034,10337,10364,4,2,2,2,0,0,0,5,0,1,2,0,0,1,0,9.318156295,1,0.376954071,1.290610613,0.292074207,0.770229887,0.879607274,1.807285965,1,2.611780341,1.515781636,1.72305844,0.084877957,0.178059002,4.607310772,1,-0.014905139,1.321832801,-0.011276115,0.991003152,0.99621844,5.308619265,1,-0.435501704,1.341013815,-0.324755568,0.745366075,0.831790092,4.467264773,1,-0.073323856,1.321535863,-0.055483819,0.955753021,0.970903916,N,-,,AAA- core,F:nucleotide binding,no IPS match,,
RL4_JR_03540,263,314,402,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.58470774,0,-0.394333713,1.222790132,-0.32248683,0.747083914,0.867821524,3.105882579,0,1.830576362,1.391422477,1.315615058,0.188303277,0.328765263,7.952444317,0,-0.802394168,1.267220722,-0.633192114,0.526608195,0.656072876,9.165674736,0,-1.223415763,1.274532736,-0.959893558,0.337108789,0.484121289,7.743894789,0,-0.866949706,1.267673596,-0.683890324,0.494044424,0.622241547,N,-,,AAA family,F:nucleotide binding,IPR003593 (SMART); IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23077:SF47 (PANTHER); PTHR23077 (PANTHER); IPR027417 (SUPERFAMILY),3.A.29.1.2, the mitochondrial inner membrane i-aaa protease complex (mimp) familly.
RL4_JR_03541,1319,1625,1345,0,0,2,0,0,0,0,0,0,3,5,2,0,0,0,269.3546398,1,-0.806170569,0.557553212,-1.445907856,0.148203048,0.29417043,74.80054154,0,-0.724674263,1.049066755,-0.690779933,0.489703848,0.645498417,155.0254852,0,-4.018694402,1.232287385,-3.261166551,0.001109548,0.006264957,223.7278507,1,-1.182032846,0.669300874,-1.766070973,0.077383943,0.162588176,245.8915876,0,-0.448828296,0.541497887,-0.828864354,0.407181168,0.543492219,N,-,,sulfite reductase flavo component,"F:oxidoreductase activity, acting on the aldehyde or oxo group of donors; C:integral component of membrane; P:oxidation-reduction process",IPR001709 (PRINTS); IPR019752 (G3DSA:3.40.920.GENE3D); G3DSA:3.40.50.80 (GENE3D); IPR023173 (G3DSA:1.20.990.GENE3D); IPR019752 (PFAM); G3DSA:2.40.30.10 (GENE3D); IPR009014 (G3DSA:3.40.50.GENE3D); IPR003097 (PFAM); IPR029061 (G3DSA:3.40.50.GENE3D); IPR001433 (PFAM); PTHR19384:SF55 (PANTHER); PTHR19384 (PANTHER); IPR017927 (PROSITE_PROFILES); IPR009014 (SUPERFAMILY); IPR002869 (SUPERFAMILY); IPR017938 (SUPERFAMILY); SSF52343 (SUPERFAMILY),,
RL4_JR_03542,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_03543,734,1060,1084,3,0,3,0,0,0,2,0,0,3,0,0,0,1,0,39.02935644,1,0.021266849,0.775974965,0.027406617,0.978135421,0.988924125,7.53143276,0,0.552533448,1.230363479,0.449081477,0.653372882,0.77645796,138.1710155,1,2.767513068,0.439380231,6.298674526,3.00E-10,1.64E-08,22.64841891,1,-2.528583879,1.200954768,-2.10547803,0.035249718,0.099766288,19.44171664,1,-2.194843649,1.210624943,-1.812983998,0.069834289,0.144654701,N,-,,ubiquinone biosynthesis mitochondrial,C:extrinsic component of mitochondrial inner membrane; P:ubiquinone biosynthetic process,IPR007715 (PFAM); PTHR12922:SF7 (PANTHER); PTHR12922 (PANTHER),,
RL4_JR_03544,6731,6561,4040,0,0,14,0,0,0,0,0,2,3,6,0,0,0,0,0.275376625,1,3.758113719,2.584191018,1.45427087,0.145871223,NA,0.087531247,0,6.979387443,2.145418603,3.253158816,0.001141297,0.015023052,0.227795385,1,4.322366654,1.333361455,3.241706619,0.001188163,0.006631179,0.262833029,1,3.900346699,1.647825533,2.366965811,0.017934589,0.073044135,0.225393141,0,4.236064588,1.254121545,3.377714548,0.000730909,0.003722563,N,-,,hypothetical protein MAC_02345,,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); IPR011009 (SUPERFAMILY),,
RL4_JR_03545,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.617961888,0,0.042629087,1.329540988,0.032063011,0.974421802,0.987036672,1.139603691,0,3.276937436,1.463271799,2.239459162,0.025126056,0.068758528,2.976440463,0,0.615434216,1.270848542,0.484270309,0.628194045,0.739859994,3.435471896,0,0.192352306,1.287713622,0.149375065,0.881257686,0.92661179,2.94934719,0,0.526013477,1.276475983,0.412082549,0.680278919,0.772870742,Y,-,,hypothetical protein SPI_02215,F:metal ion binding; C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03546,4121,3785,3587,0,0,3,0,0,0,0,0,0,4,4,0,0,7,0,133.9509334,1,-0.164643088,0.6781928,-0.242767379,0.808185608,0.902685257,61.36113427,0,1.3180887,0.855496281,1.5407299,0.123382537,0.23824457,70.32644001,0,-1.706818251,1.039075071,-1.642632277,0.100459038,0.194571065,60.8673531,1,-3.954814028,1.198364869,-3.300175207,0.000966245,0.007188265,52.16994217,1,-3.6189356,1.203595232,-3.0067713,0.002640383,0.010719278,N,-,,copper-transporting atpase 1,P:cation transport; F:metal ion binding; C:membrane; F:hydrolase activity,PR00119 (PRINTS); IPR001757 (PRINTS); IPR027256 (TIGRFAM); G3DSA:3.30.70.100 (GENE3D); IPR008250 (PFAM); IPR008250 (G3DSA:2.70.150.GENE3D); IPR023214 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.70.100 (GENE3D); IPR001757 (TIGRFAM); IPR023299 (G3DSA:3.40.1110.GENE3D); PF00702 (PFAM); IPR006121 (PFAM); PTHR24093:SF50 (PANTHER); PTHR24093 (PANTHER); IPR006121 (PROSITE_PROFILES); IPR006121 (PROSITE_PROFILES); IPR023214 (SUPERFAMILY); IPR006121 (SUPERFAMILY); SSF81653 (SUPERFAMILY); IPR006121 (SUPERFAMILY); SSF81665 (SUPERFAMILY),3.A.3.5.9, the p-type atpase (p-atpase) superfamily.
RL4_JR_03547,141,109,157,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,47.9530581,0,1.832691773,0.628427929,2.916311783,0.003541964,0.016436484,3.307077024,0,1.739895092,1.268133435,1.372012632,0.170059506,0.305040283,8.609248742,1,-0.917050228,1.201210599,-0.763438342,0.445202021,0.584670548,19.56902444,0,-0.389396519,1.149584465,-0.338728063,0.734814598,0.823099658,15.88547201,0,-0.067606673,1.136076798,-0.059508893,0.952546782,0.969095027,N,-,,c3hc zinc finger domain-containing,P:biological_process; C:nucleus; F:zinc ion binding,IPR012935 (PFAM); IPR013909 (PFAM); PTHR15835 (PANTHER),,
RL4_JR_03548,198,148,249,0,0,2,0,0,0,0,0,1,0,0,0,0,1,0,32.51054722,1,-1.020568199,1.034730151,-0.986313386,0.323979353,0.513304017,7.893203621,0,0.484837886,1.233284417,0.393127392,0.694225394,0.806834876,62.25200046,1,1.220897388,0.640194268,1.907073289,0.056511098,0.124076849,107.5473457,0,1.785519308,1.869465275,0.955096268,0.339529016,0.486723954,35.12112102,1,-0.565031215,0.993926228,-0.568484057,0.569706328,0.686041423,N,-,,g patch domain-containing 1,C:intracellular part,IPR000467 (SMART); IPR000467 (PFAM); IPR011666 (PFAM); PTHR13384:SF19 (PANTHER); PTHR13384:SF19 (PANTHER); PTHR13384 (PANTHER); PTHR13384 (PANTHER); IPR000467 (PROSITE_PROFILES),,
RL4_JR_03549,652,625,593,0,0,0,0,0,0,0,0,0,2,3,0,0,0,0,83.31002838,0,2.063034432,0.950024824,2.171558448,0.029888984,0.09010877,5.91718103,0,0.900661518,1.253236156,0.718668636,0.472345113,0.630416302,15.26916388,0,-1.743510055,1.200464921,-1.452362352,0.146400879,0.257364559,29.64359333,1,0.130327908,0.869545624,0.149880472,0.880858919,0.92661179,30.05582837,0,0.394431509,0.84651263,0.465948759,0.641252179,0.742868424,N,-,,general stress response Whi2,P:response to heat; P:response to salt stress; P:positive regulation of catalytic activity; F:phosphatase activator activity; P:actin filament organization; P:endocytosis; P:mitophagy; P:regulation of growth,G3DSA:3.30.710.10 (GENE3D); PTHR13384:SF16 (PANTHER); PTHR13384 (PANTHER); IPR011333 (SUPERFAMILY),,
RL4_JR_03550,1596,1522,1798,0,0,3,0,0,0,2,0,0,0,2,0,0,0,0,2.767827676,1,0.429179726,1.269698278,0.338017097,0.735350304,0.860348933,0.880724543,0,3.648799724,1.443870339,2.52709653,0.011500989,0.037395762,2.285558565,1,0.99670265,1.228876181,0.81106841,0.417326386,0.558936247,2.636929685,1,0.574183772,1.239137604,0.463373696,0.643096529,0.755464945,2.250594126,0,0.916198557,1.223248555,0.748988055,0.453864405,0.58588384,Y,-,,glucose sorbosone dehydrogenase,F:catalytic activity; C:membrane; P:metabolic process,IPR011042 (G3DSA:2.120.10.GENE3D); PTHR19328:SF37 (PANTHER); PTHR19328 (PANTHER); IPR011041 (SUPERFAMILY),,
RL4_JR_03551,1038,1466,1603,0,3,2,0,0,0,2,7,3,6,9,0,0,0,1,107.7158125,1,1.526878171,0.477330321,3.198787303,0.001380069,0.007658916,9.298226304,0,0.248546567,1.220534272,0.203637516,0.838636774,0.903339516,35.24952423,1,-1.444937161,1.195242062,-1.208907556,0.226698363,0.357491312,71.23906396,1,0.880458062,0.558735229,1.575805527,0.115070628,0.217267527,42.82836443,1,0.12171274,0.764513541,0.159202857,0.873509053,0.916138219,N,-,,transport SEC13,"C:nuclear pore outer ring; F:identical protein binding; P:nuclear pore distribution; P:COPII-coated vesicle budding; P:protein transport; F:structural molecule activity; C:Golgi membrane; P:positive regulation of GTPase activity; C:endoplasmic reticulum membrane; C:Seh1-associated complex; P:positive regulation of transcription, DNA-templated; P:ER-associated ubiquitin-dependent protein catabolic process; C:COPII vesicle coat; P:mRNA transport",IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR11024:SF2 (PANTHER); PTHR11024 (PANTHER); PTHR11024 (PANTHER); PTHR11024:SF2 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_03552,13773,21633,29993,2,0,0,0,0,0,2,0,0,1,6,0,0,1,0,13.61468146,1,-0.447139071,1.144209803,-0.390784164,0.695956781,0.835711944,3.145148072,0,1.8124339,1.281168765,1.41467225,0.157164614,0.286582638,34.12370009,1,1.979785673,0.750500446,2.637954028,0.008340789,0.028288826,29.43305271,1,1.770865205,0.682140793,2.596040616,0.009430492,0.046328835,7.98428144,1,-0.911051722,1.196106717,-0.761680968,0.446250437,0.578822146,N,-,,peroxin 20,,no IPS match,,
RL4_JR_03553,551,586,738,0,0,0,0,0,0,0,2,0,0,1,0,0,0,1,13.45798468,0,1.084273247,1.140456634,0.95073606,0.341738378,0.531839314,1.083708222,0,3.349535875,1.384859889,2.418682137,0.015576845,0.047546204,2.810371435,1,0.698091134,1.205193111,0.579235915,0.56243,0.68768615,7.25355137,1,1.222737787,1.146648309,1.066358165,0.286261765,0.43060472,2.770082323,1,0.616254235,1.202064457,0.51266322,0.608186922,0.716283888,N,-,,---NA---,,no IPS match,,
RL4_JR_03554,417,347,459,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,9.042044403,0,-1.279155435,1.201380627,-1.064737858,0.286994573,0.4709921,2.878385446,0,1.940195812,1.280341529,1.515373647,0.129677807,0.246775477,7.485289827,0,-0.715264226,1.202302645,-0.594911962,0.551902321,0.679005252,8.636101233,1,-1.137758212,1.201171638,-0.947207024,0.343533297,0.49036422,7.402384131,1,-0.801777001,1.209027196,-0.663158781,0.507228867,0.63411437,N,-,,hypothetical protein SPI_04985,,no IPS match,,
RL4_JR_03555,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.629720992,0,1.192854724,1.313717327,0.907999537,0.363878466,NA,0.520315117,0,4.408002977,1.53916264,2.863896811,0.004184643,0.018371529,14.34811975,0,3.572322321,1.043319002,3.423998137,0.00061707,0.003941464,1.558119008,0,1.332713334,1.251321588,1.065044626,0.286855735,0.431135732,1.333402766,0,1.670953573,1.220272271,1.369328479,0.17089662,0.285957408,N,-,,CAMK family kinase,F:transferase activity,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24362 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.3, the pock size-determining protein (psdp) family.
RL4_JR_03556,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,332.0638575,0,-0.419814284,0.622283539,-0.674635045,0.499907662,0.68715193,63.82624811,0,-2.530554051,1.279840398,-1.977241892,0.048014294,0.114160144,303.2682914,0,-0.238825593,0.569976894,-0.419009254,0.675209369,0.777062595,334.1569169,0,-0.261075084,0.607056068,-0.430067498,0.667146542,0.773044031,401.9276866,0,0.738520843,0.783626013,0.942440438,0.345967192,0.483227731,N,-,,hypothetical protein CMQ_3359,,no IPS match,,
RL4_JR_03557,0,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,99.22964279,0,-0.095981652,0.897573357,-0.106934604,0.91484086,0.958796472,18.63635564,0,-0.754509326,1.277225411,-0.590740929,0.55469402,0.699989137,47.76215165,0,-3.388803894,1.244127738,-2.723839193,0.006452792,0.023051539,67.08767576,0,-1.564240982,0.963618689,-1.623298718,0.104525564,0.202549537,46.54342957,0,-3.454311971,1.243453816,-2.777997806,0.005469499,0.019275557,N,-,,GPI mannosyltransferase 2,F:mannosyltransferase activity; C:intracellular membrane-bounded organelle; C:integral component of membrane; C:cytoplasmic part; P:single-organism metabolic process,IPR007315 (PFAM); PTHR12468:SF2 (PANTHER); IPR007315 (PANTHER),9.B.142.11.8, the integral membrane glycosyltransferase family 39 (gt39) family.
RL4_JR_03558,16968,19569,23078,2,0,3,0,0,0,1,1,0,0,4,0,0,0,1,44.7895437,1,-0.553597281,0.869072167,-0.636998055,0.52412611,0.707800167,8.632315948,0,0.355724331,1.23117129,0.288931633,0.772633696,0.862066485,22.44088749,1,-2.299154207,1.201727014,-1.913208392,0.05572138,0.122742221,37.92468546,1,-0.429348777,0.875741253,-0.490268987,0.623943569,0.740960432,22.19263776,1,-2.38580721,1.209421019,-1.972685419,0.048531414,0.109438879,N,-,,YT521-B-like family,P:GPI anchor biosynthetic process; F:RNA binding; P:mannosylation; C:integral component of membrane; F:dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,IPR007275 (PFAM); PTHR12357:SF3 (PANTHER); PTHR12357 (PANTHER); IPR007275 (PROSITE_PROFILES),,
RL4_JR_03559,3122,4121,6922,1,0,2,0,0,1,0,0,0,0,3,0,0,0,0,48.99673801,1,0.016743173,0.865146322,0.019352996,0.984559507,0.992185739,6.013022929,1,0.877400834,1.250585023,0.701592309,0.482933449,0.639616816,15.59651849,0,-1.774255431,1.204477224,-1.473050212,0.140737497,0.2499257,17.99094187,1,-2.196473585,1.203938002,-1.824407553,0.068090481,0.14816594,15.39013651,0,-1.857758319,1.209951177,-1.535399406,0.12468575,0.225414457,N,-,,hypothetical protein CMQ_3319,C:membrane,IPR018852 (PFAM); PTHR28297 (PANTHER),,
RL4_JR_03560,2709,3411,5707,1,0,4,0,0,0,0,0,0,0,1,0,0,0,0,32.88334677,1,-1.784866533,1.179435248,-1.513323039,0.130197623,0.267342615,8.061327295,0,0.454547899,1.279664862,0.355208549,0.722433361,0.826267851,31.77747006,0,-1.221268792,1.222556915,-0.99894637,0.317820672,0.460540794,35.90780687,1,-0.335871496,0.919594496,-0.365238697,0.714933234,0.809172054,42.66358486,0,0.374617231,0.793363936,0.47218838,0.636792333,0.739118203,N,-,,ABC transporter,"F:ATP binding; P:lipid transport; F:ATPase activity, coupled to transmembrane movement of substances; C:intracellular membrane-bounded organelle; C:integral component of membrane",IPR003593 (SMART); IPR003439 (PFAM); PF12698 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR19229:SF36 (PANTHER); IPR026082 (PANTHER); IPR026082 (PANTHER); IPR026082 (PANTHER); PTHR19229:SF36 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.211.19, the atp-binding cassette (abc) superfamily.
RL4_JR_03561,4636,4609,5265,0,3,6,0,0,0,0,4,0,6,1,0,0,1,3,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,Y,-,,ATP-binding cassette subfamily member 8,F:ATP binding,no IPS match,,
RL4_JR_03562,480,877,768,2,0,0,0,0,0,0,0,0,0,0,0,0,0,2,39.9030019,1,0.238374711,0.853351521,0.27933941,0.779984364,0.88684494,27.4047417,0,2.043337058,1.124525451,1.817066084,0.069206995,0.152384861,19.67407275,0,-0.569037416,1.197848271,-0.475049662,0.634751576,0.744983185,15.19593966,0,-1.952852105,1.198254356,-1.629747553,0.103154863,0.200487329,12.96038977,1,-1.609893216,1.200528,-1.340987645,0.179924464,0.297474722,N,-,,serine threonine- phosphatase 2a activator 1,F:phosphatase regulator activity; P:cellular macromolecule metabolic process; P:regulation of catalytic activity; P:primary metabolic process; C:intracellular part; P:response to stress; F:isomerase activity,IPR004327 (PFAM); IPR004327 (PANTHER); PTHR10012:SF3 (PANTHER); SSF140984 (SUPERFAMILY),,
RL4_JR_03563,2282,2656,2748,0,0,1,2,0,0,0,0,1,0,2,0,0,0,0,175.0473024,1,0.900399507,0.447846451,2.010509417,0.044377301,0.121649872,39.81517776,1,0.704637966,1.003571452,0.702130341,0.482597882,0.63929535,88.24728355,1,-0.442684483,0.68280565,-0.648331606,0.516770496,0.647658394,170.4931091,1,0.501705814,0.561307258,0.893816722,0.37141996,0.517169335,76.17541496,0,-0.717112482,0.679590546,-1.055212562,0.29132812,0.426010574,N,-,,2-dehydropantoate 2-reductase,P:pantothenate biosynthetic process; F:NADP binding; C:cytoplasm; P:oxidation-reduction process; F:2-dehydropantoate 2-reductase activity,IPR013332 (PFAM); IPR013328 (G3DSA:1.10.1040.GENE3D); IPR013752 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR21708 (PANTHER); PTHR21708:SF23 (PANTHER); PTHR21708:SF23 (PANTHER); PTHR21708 (PANTHER); IPR016040 (SUPERFAMILY); IPR008927 (SUPERFAMILY),,
RL4_JR_03564,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.242354819,0,3.942585634,2.788140297,1.414055684,0.157345554,NA,0.076548008,0,7.172964922,2.245820723,3.193916971,0.001403565,0.015023052,0.199503704,0,4.515049045,1.401672654,3.221186511,0.00127661,0.006994072,0.230244391,0,4.091769754,1.789683678,2.286308918,0.022236193,0.080442001,0.197204808,0,4.430543729,1.298424703,3.412245406,0.000644301,0.003354008,N,-, Effector probability:0.729,---NA---,,no IPS match,,
RL4_JR_03565,225,122,202,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,519.4797523,1,-2.219775492,0.551400968,-4.025701117,5.68E-05,0.00052246,180.4133209,0,-1.930758729,0.986801354,-1.956582975,0.050396518,0.118658655,381.6288305,1,-3.40397022,0.746744099,-4.558415959,5.15E-06,0.000107366,415.2247086,0,-4.913918011,1.016223572,-4.835469426,1.33E-06,2.39E-05,338.214547,0,-6.315575526,1.197912154,-5.272152475,1.35E-07,2.91E-06,N,-,,copper fist DNA-binding domain containing,F:binding,IPR001083 (PRINTS); IPR001083 (SMART); IPR001083 (SMART); IPR001083 (PFAM); IPR001083 (G3DSA:3.90.430.GENE3D); PTHR28088 (PANTHER); PTHR28088:SF1 (PANTHER); IPR001083 (PROSITE_PROFILES); IPR001083 (SUPERFAMILY),,
RL4_JR_03566,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,379.3430232,0,1.77612621,0.368313096,4.822327054,1.42E-06,2.07E-05,37.82071171,0,-0.446951861,1.109722357,-0.402760076,0.687124734,0.801091518,152.7475309,0,-0.174988567,0.541988602,-0.322863924,0.746798299,0.830559813,217.8197207,0,0.677322953,0.362069811,1.87069712,0.061387074,0.138354552,87.60228196,0,-2.413903754,0.97332451,-2.480060585,0.013136006,0.039072286,N,-,,hypothetical protein ACRE_031000,,no IPS match,,
RL4_JR_03567,6498,4917,3318,1,0,6,0,0,0,0,0,1,0,1,0,0,0,1,66.63647217,1,0.441732697,0.578166284,0.764023619,0.444853167,0.633797644,10.07829718,0,0.132325394,1.219388546,0.108517826,0.913584941,0.95163567,26.13400155,1,-2.518926255,1.19348193,-2.110569244,0.034809354,0.085995582,78.14123076,1,0.782293479,0.548309129,1.426738017,0.153655423,0.270708164,40.49995053,1,-0.913267014,0.975105291,-0.936582975,0.348973113,0.486503157,N,-,,xeroderma pigmentosum group C-complementing,C:nucleus; F:DNA binding; P:DNA repair,IPR018326 (SMART); IPR018328 (SMART); IPR018327 (SMART); IPR018325 (PFAM); IPR018326 (PFAM); IPR018327 (PFAM); IPR018328 (PFAM); IPR004583 (PANTHER); PTHR12135:SF1 (PANTHER); IPR004583 (PANTHER); PTHR12135:SF1 (PANTHER); SSF54001 (SUPERFAMILY),,
RL4_JR_03568,8,4,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.608759532,0,-0.590197905,1.229156015,-0.480165168,0.631109952,0.79038916,1.779453446,0,2.633969793,1.339412995,1.966510555,0.049239664,0.116367939,15.70935828,0,0.936474264,1.208604471,0.774839318,0.438434613,0.578635383,18.67726963,0,1.287326233,1.037048046,1.241337119,0.214481238,0.348950732,4.601336032,0,-0.115822125,1.228260344,-0.094297699,0.924872677,0.951370096,N,-,,set domain-containing,,G3DSA:2.170.270.10 (GENE3D); IPR001214 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY),,
RL4_JR_03569,2362,478,865,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.550026988,0,0.546944995,1.286477082,0.425149428,0.670727748,0.817535882,0.808695213,0,3.771699437,1.460372434,2.582696954,0.009803139,0.033186412,2.109292642,0,1.111762878,1.237231494,0.898589216,0.368871505,0.51346492,12.06926196,0,1.641178415,1.168376517,1.404665697,0.160120711,0.279039965,5.953670804,0,1.947913052,1.162109105,1.676187755,0.093701422,0.181574526,N,-,,---NA---,,no IPS match,,
RL4_JR_03570,23856,12022,8684,0,0,29,5,0,2,15,42,26,32,148,42,5,123,68,0.229830226,1,4.019111635,2.811251927,1.429651892,0.152816954,NA,0.073705443,1,7.227920832,2.241325477,3.224842133,0.001260422,0.015023052,22.33023114,1,6.424481632,1.059729663,6.062377843,1.34E-09,6.86E-08,0.219438785,1,4.161314933,1.766198802,2.356085243,0.018468679,0.074129552,0.186305655,1,4.511140674,1.263398449,3.570639713,0.00035611,0.002024491,N,-,,---NA---,,no IPS match,,
RL4_JR_03571,708,390,473,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,259.0024707,0,1.579738896,0.386322674,4.089169505,4.33E-05,0.000413556,31.47770573,0,-0.084567553,1.132019714,-0.074705018,0.940449415,0.967597985,63.56371165,0,-2.683719205,1.201279963,-2.234049752,0.0254798,0.067545821,123.445769,1,-0.169014332,0.540772123,-0.312542613,0.754628183,0.838982141,113.4777271,0,0.573905652,0.543482916,1.055977354,0.290978561,0.425560874,N,-,,viral a-type inclusion repeat domain-containing,,PTHR13140 (PANTHER),,
RL4_JR_03572,11,6,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.768710644,0,-1.060019038,1.198521108,-0.88443919,0.376459175,0.567890893,2.470871301,0,2.16045845,1.286150497,1.679786663,0.092998831,0.191466749,6.424317027,0,-0.494672025,1.198640701,-0.412694166,0.679830699,0.779980547,7.412224692,0,-0.917203949,1.196930873,-0.766296509,0.443499895,0.585760036,6.347501298,0,-0.579903989,1.203841319,-0.481711319,0.630011034,0.733539757,N,-,,nuclear membrane fusion kar5,,no IPS match,,
RL4_JR_03573,12,11,8,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,82.11393959,0,-1.727451984,0.937426991,-1.842758956,0.065364212,0.16237553,19.58503162,0,-0.826211894,1.242234542,-0.665101369,0.505985659,0.659141436,79.99195624,0,-1.066489401,0.904272536,-1.179389353,0.238243173,0.371039205,92.66035575,0,-0.465018379,0.697613018,-0.666585007,0.505037248,0.641672753,74.38232637,1,-0.510023562,0.779244763,-0.654510092,0.512783227,0.638692358,N,-,,54s ribosomal l6,C:nucleus; F:structural constituent of ribosome; P:cytoplasmic translation; F:rRNA binding; C:mitochondrial large ribosomal subunit,IPR019906 (PRINTS); IPR020040 (PFAM); IPR020040 (G3DSA:3.90.930.GENE3D); IPR020040 (G3DSA:3.90.930.GENE3D); IPR000702 (PANTHER); PTHR11655:SF14 (PANTHER); IPR000702 (PANTHER); PTHR11655:SF14 (PANTHER); IPR020040 (SUPERFAMILY); IPR020040 (SUPERFAMILY),,
RL4_JR_03574,5,4,4,0,0,2,0,0,0,0,3,21,0,4,3,0,13,0,94.5475791,1,-0.838424788,0.705050067,-1.189170567,0.234372554,0.408026312,132.9460101,0,2.353078604,1.596689182,1.473723647,0.140556013,0.26265658,86.48519891,1,-0.520066732,0.759316106,-0.684914659,0.493397775,0.626745179,83.34921151,1,-0.498706056,0.652218975,-0.764629787,0.444492027,0.586687755,46.36220764,1,-3.448650228,1.2107493,-2.84836029,0.004394514,0.016138722,N,-,,"3 ,5 -bisphosphate nucleotidase","F:magnesium ion binding; P:methionine biosynthetic process; C:nucleus; F:3'(2'),5'-bisphosphate nucleotidase activity; F:inositol-1,3,4-trisphosphate 1-phosphatase activity; C:integral component of membrane; C:cytosol; P:phosphatidylinositol phosphorylation; F:inositol-1,4-bisphosphate 1-phosphatase activity; P:dephosphorylation; P:sulfate assimilation",IPR006239 (TIGRFAM); IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); G3DSA:3.30.540.10 (GENE3D); IPR000760 (PANTHER); PTHR20854:SF34 (PANTHER); IPR000760 (PANTHER); SSF56655 (SUPERFAMILY),,
RL4_JR_03575,33111,32948,43025,0,0,2,0,0,0,5,7,3,0,8,2,0,8,0,131.7065501,1,-0.549290818,0.582255351,-0.943384749,0.345484141,0.535286435,26.01291272,0,-1.235610761,1.230486327,-1.00416456,0.315299301,0.477201051,79.93768114,1,-2.062160943,1.059109394,-1.94707077,0.051526251,0.115896859,104.4790206,1,-1.561416119,0.782986585,-1.994179912,0.046132397,0.116597732,73.13531336,1,-2.283924678,0.996595152,-2.291727663,0.021921363,0.058826876,N,-,,serine threonine kinase,F:ATP binding; F:protein serine/threonine kinase activity; P:protein phosphorylation,IPR000719 (SMART); IPR001772 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR028375 (G3DSA:3.30.310.GENE3D); IPR000719 (PFAM); PTHR24343 (PANTHER); PTHR24343 (PANTHER); PTHR24343:SF108 (PANTHER); PTHR24343:SF108 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR001772 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR028375 (SUPERFAMILY),8.A.104.1.1, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_03576,3530,2569,3356,0,3,0,0,0,0,2,0,2,0,1,2,0,5,0,26.02685616,1,-1.627636921,1.139771288,-1.428038184,0.153280868,0.301462229,7.078792129,0,0.641994491,1.222022649,0.525354003,0.599337122,0.734489099,18.38209006,1,-2.011311807,1.189505297,-1.690880917,0.090859549,0.180294408,21.20693697,1,-2.43372573,1.187602536,-2.049276299,0.040435105,0.108193826,18.14231548,1,-2.095059744,1.194574034,-1.753813229,0.079462516,0.160543091,N,-,,cell differentiation family,P:positive regulation of transcription elongation from RNA polymerase II promoter; P:mRNA catabolic process; C:CCR4-NOT complex,PF04078 (PFAM); PTHR12262:SF0 (PANTHER); IPR007216 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_03577,937,722,652,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,215.7083803,0,-2.229624049,0.672698998,-3.314445322,0.000918251,0.005561317,60.26932235,0,-2.447848888,1.204144093,-2.032853795,0.042067296,0.103175472,169.628324,0,-3.286539101,1.05027978,-3.12920344,0.001752809,0.008917306,204.7684361,0,-2.270090185,0.669161507,-3.392439883,0.000692731,0.005454047,243.2615248,0,-0.782452708,1.809994413,-0.432295648,0.66552655,0.762010213,N,-,,potassium:hydrogen antiporter,F:solute:proton antiporter activity; C:integral component of membrane; P:hydrogen ion transmembrane transport,IPR006153 (PFAM); PTHR32468:SF0 (PANTHER); PTHR32468 (PANTHER),2.A.37.4.1, the monovalent cation:proton antiporter-2 (cpa2) family.
RL4_JR_03578,1767,2589,2887,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1717.143695,1,-4.485607385,1.01429219,-4.422401579,9.76E-06,0.000113757,539.2078494,0,-4.669453796,1.150625083,-4.058188776,4.95E-05,0.002662667,1364.609588,0,-8.225278806,1.228843072,-6.693514405,2.18E-11,1.43E-09,1577.49059,0,-7.70217465,1.180599219,-6.523953706,6.85E-11,2.66E-09,1335.690025,0,-8.297147762,1.246449511,-6.656625629,2.80E-11,2.18E-09,N,-,,nitrite reductase,F:oxidoreductase activity; C:membrane; F:iron-sulfur cluster binding; P:single-organism metabolic process,PR00368 (PRINTS); IPR006066 (PRINTS); IPR005117 (G3DSA:3.90.480.GENE3D); IPR006067 (PFAM); IPR012748 (PFAM); IPR005117 (PFAM); IPR012748 (TIGRFAM); G3DSA:3.30.413.10 (GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR007419 (PFAM); IPR017941 (G3DSA:2.102.10.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (PFAM); PTHR11493:SF52 (PANTHER); PTHR11493 (PANTHER); IPR017941 (PROSITE_PROFILES); IPR023753 (SUPERFAMILY); IPR005117 (SUPERFAMILY); IPR017941 (SUPERFAMILY); IPR023753 (SUPERFAMILY); SSF56014 (SUPERFAMILY),,
RL4_JR_03579,2,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.67888332,0,-2.540591906,1.21198534,-2.096223298,0.036062387,0.104362169,7.003995497,0,0.657381492,1.268074416,0.518409238,0.60417277,0.738222692,67.55849791,0,1.628924974,0.619212054,2.630641578,0.008522386,0.028789002,20.79446209,0,-2.405300602,1.214867337,-1.979887457,0.047716176,0.119437894,25.01761951,0,-1.117671676,1.140953823,-0.979594137,0.3272865,0.463659691,N,-,,sterol regulatory element binding sre1,F:DNA binding; P:cellular response to hypoxia; P:positive regulation of transcription from RNA polymerase II promoter; P:cellular metabolic process; P:positive regulation of lipid biosynthetic process,IPR011598 (SMART); IPR011598 (PFAM); IPR019006 (PFAM); IPR011598 (G3DSA:4.10.280.GENE3D); PTHR12565:SF124 (PANTHER); PTHR12565 (PANTHER); PTHR12565:SF124 (PANTHER); PTHR12565:SF124 (PANTHER); PTHR12565 (PANTHER); PTHR12565 (PANTHER); IPR011598 (PROSITE_PROFILES); IPR011598 (SUPERFAMILY),,
RL4_JR_03580,439,331,372,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_03581,9905,63302,50037,5,5,2,1,0,0,0,0,0,0,0,2,0,0,0,96.82075591,1,0.57959745,0.518506906,1.117820115,0.263643829,0.443282431,30.70643717,1,1.525364237,0.994930742,1.533136099,0.125242325,0.240830292,46.67905191,0,-0.940590504,1.035031369,-0.908755552,0.363479173,0.507567331,69.45688793,1,0.324757976,0.589020821,0.551352286,0.581392203,0.70747217,92.33813768,0,1.20259216,1.402664936,0.857362389,0.391244639,0.52761747,Y,-,,rna polymerase ii transcription initiation nucleotide excision repair factor tfiih,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03582,205,195,155,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,32.74146326,1,1.498878383,0.857583636,1.747792658,0.080499937,0.189092568,2.129822967,0,2.374859487,1.317936232,1.801953258,0.07155276,0.156460799,25.00516379,0,2.127066463,0.864044936,2.461754447,0.013825929,0.041634058,6.354420333,0,-0.694720204,1.205701754,-0.576195731,0.56448289,0.692019526,5.408513456,1,-0.34893705,1.202413522,-0.29019721,0.77166537,0.842020894,N,-,,REP helicase,P:DNA repair; C:mitotic spindle; F:organic cyclic compound binding; F:heterocyclic compound binding; F:helicase activity,IPR027417 (G3DSA:3.40.50.GENE3D); IPR014016 (PFAM); G3DSA:1.10.486.10 (GENE3D); IPR014017 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000212 (PANTHER); IPR014017 (PROSITE_PROFILES); IPR014016 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_03583,187,166,205,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,465.703576,0,5.742964324,1.216334168,4.721534981,2.34E-06,3.21E-05,12.12526934,0,2.922462604,1.144412498,2.553679385,0.010659136,0.035281809,20.16838688,0,1.161178893,1.055661034,1.099954299,0.271352034,0.410086281,8.275608097,1,-1.076188926,1.217402399,-0.884004276,0.376693905,0.522323253,7.117381171,0,-0.745075587,1.227241347,-0.60711415,0.54377516,0.665424643,N,-,,neutral alkaline non-lysosomal ceramidase,C:integral component of membrane,IPR031331 (PFAM); IPR031329 (PFAM); IPR006823 (PANTHER); PTHR12670:SF5 (PANTHER),,
RL4_JR_03584,36,14,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,76.26301998,0,-1.232443936,0.81175219,-1.518251445,0.128951023,0.265786368,17.92469788,0,-0.698405848,1.224845241,-0.570199259,0.568542559,0.709766623,46.85258682,0,-3.361095356,1.214559358,-2.767337252,0.005651626,0.02078353,71.41046834,0,-1.47914204,0.895748868,-1.651290997,0.09867917,0.194005164,53.91430809,0,-2.513638793,1.155922253,-2.174574274,0.029662034,0.074486134,N,-,,tRNA (guanine-N(7)-)-methyltransferase,C:tRNA methyltransferase complex; P:RNA (guanine-N7)-methylation; F:RNA binding; F:tRNA (guanine-N7-)-methyltransferase activity; P:tRNA modification,IPR003358 (TIGRFAM); IPR003358 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR23417:SF16 (PANTHER); PTHR23417 (PANTHER); IPR025763 (HAMAP); IPR003358 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_03585,11,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,239.1806657,0,0.003208045,0.595013558,0.00539155,0.995698187,0.998267888,39.8269752,0,-1.850183667,1.215073888,-1.522692312,0.127835702,0.244418772,143.8127812,0,-1.666020002,0.780657799,-2.134123305,0.032832689,0.08235831,165.1044348,0,-1.402023991,0.636580277,-2.202430771,0.027634894,0.088405467,133.2475001,0,-1.646271665,0.743336959,-2.214704442,0.026780358,0.068960102,N,-,,homoserine dehydrogenase,P:methionine biosynthetic process; P:isoleucine biosynthetic process; F:NADP binding; P:threonine biosynthetic process; C:integral component of membrane; P:oxidation-reduction process; F:homoserine dehydrogenase activity; P:homoserine biosynthetic process,G3DSA:3.30.360.10 (GENE3D); IPR005106 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR022697 (PIRSF); IPR001342 (PFAM); PTHR21499:SF1 (PANTHER); PTHR21499 (PANTHER); IPR016040 (SUPERFAMILY); SSF55347 (SUPERFAMILY),,
RL4_JR_03586,488,397,539,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,11.01530456,1,1.861289801,1.032848976,1.802092895,0.071530791,0.173830264,1.072858162,0,3.364030981,1.394384539,2.41255614,0.015841098,0.048151228,13.86031391,0,1.670341034,1.199832542,1.392145133,0.163878454,0.280396394,19.26594551,0,2.990127714,0.764804623,3.909662185,9.24E-05,0.001001934,2.756182064,0,0.623764943,1.215989112,0.512969184,0.607972877,0.716115097,N,-,,hypothetical protein SPI_05197,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03587,2551,3412,4704,0,2,4,0,0,0,0,0,1,5,4,0,0,2,0,12.09315753,1,1.45836394,1.039895638,1.402413749,0.16079173,0.310470754,1.411930207,0,2.967753084,1.358431424,2.184691131,0.028911501,0.076950358,3.680977313,1,0.308677255,1.217147268,0.253607154,0.799799069,0.868608214,12.2708782,1,1.603289609,1.036760577,1.546441527,0.121997972,0.227088972,3.647640677,1,0.219360444,1.223310219,0.179317102,0.857688719,0.905442423,N,-,,hypothetical protein SPBR_01827,,IPR025066 (PFAM); PTHR15885 (PANTHER),,
RL4_JR_03588,7408,5740,4271,0,6,13,0,0,0,1,0,0,0,1,0,0,8,3,247.4812963,1,-0.463351562,0.426383272,-1.08670202,0.277168521,0.460237515,138.6871408,0,0.503325716,0.763129208,0.659555042,0.509539413,0.661193394,222.2323607,1,-0.405680052,0.465248148,-0.871964896,0.383227529,0.526859791,206.5136176,1,-0.960267196,0.478457606,-2.007005812,0.044749044,0.114792012,187.0820285,1,-0.52726051,0.564554234,-0.93394129,0.350334179,0.487528688,N,-,,glucan 4-alpha-glucosidase,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,PTHR42078:SF1 (PANTHER); PTHR42078:SF1 (PANTHER); PTHR42078 (PANTHER); PTHR42078 (PANTHER); PTHR42078:SF1 (PANTHER); PTHR42078 (PANTHER),,
RL4_JR_03589,2321,1690,1048,6,9,2,0,0,0,0,4,0,0,8,0,0,2,0,1.095546045,1,1.765876072,1.453285326,1.215092481,0.224330821,NA,0.348257666,0,4.987153881,1.648368467,3.02550915,0.002482149,0.015349618,0.906643476,1,2.329736917,1.249226246,1.86494394,0.062189263,0.134015346,1.046096936,1,1.907418232,1.294531045,1.473443406,0.140631513,0.253574969,0.897735219,1,2.241887095,1.234576316,1.81591617,0.069383232,0.143897015,N,-,,---NA---,,no IPS match,,
RL4_JR_03590,2,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.738648061,0,1.09946731,1.316851525,0.834921241,0.403762054,NA,0.554849958,0,4.315265888,1.532246317,2.816300381,0.004858022,0.020277485,1.441207846,0,1.661228553,1.235980772,1.344056955,0.17892997,0.299002094,1.662618694,0,1.239009906,1.257626602,0.985196961,0.324527333,0.471155613,5.284691241,0,2.50426475,1.1489123,2.179683123,0.029280958,0.07371201,N,-,,hypothetical protein SPI_05185,,no IPS match,,
RL4_JR_03591,937,947,825,0,0,1,0,0,0,0,0,4,6,0,0,0,0,0,68.6307364,1,0.360194018,0.667064432,0.539968856,0.58921851,0.760504468,31.70376017,0,1.166442246,1.149936046,1.014354016,0.310413858,0.472269513,123.7927134,1,2.000765578,1.890475747,1.058339723,0.289900589,0.429518414,91.11268356,1,1.094849805,0.572558057,1.912207489,0.055849586,0.131201173,64.67234732,0,0.964777399,0.62404802,1.545998653,0.122104893,0.222038801,N,-,,mitochondrial chaperone BCS1,F:nucleotide binding; C:membrane,IPR014851 (SMART); IPR003593 (SMART); IPR014851 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003959 (PFAM); PTHR23070:SF33 (PANTHER); PTHR23070 (PANTHER); PTHR23070 (PANTHER); PTHR23070 (PANTHER); PTHR23070:SF33 (PANTHER); IPR027417 (SUPERFAMILY),3.A.28.1.2," the aaa-atpase, bcs1 (bcs1) family."
RL4_JR_03592,7349,6741,9303,0,0,1,0,0,0,0,4,0,2,0,0,0,0,0,303.0379197,1,-3.213009964,1.087622917,-2.954158022,0.003135234,0.014905152,91.54103046,0,-3.050823642,1.581201843,-1.929433397,0.053677081,0.124814935,234.7227494,1,-5.685822925,1.334662555,-4.26012021,2.04E-05,0.000343606,295.8804444,1,-3.166593693,0.947095204,-3.343479809,0.000827347,0.006331738,229.4283469,0,-5.755681283,1.361427762,-4.227680264,2.36E-05,0.000206446,N,-,,methylmalonate-semialdehyde dehydrogenase,F:methylmalonate-semialdehyde dehydrogenase (acylating) activity; P:oxidation-reduction process,IPR016163 (G3DSA:3.40.309.GENE3D); IPR010061 (TIGRFAM); IPR015590 (PFAM); IPR016162 (G3DSA:3.40.605.GENE3D); IPR010061 (PTHR11699:PANTHER); PTHR11699 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_03593,1177,783,1142,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,1449.417358,0,-0.489829252,0.490424813,-0.998785621,0.317898553,0.50652664,436.8588353,0,-1.149541911,0.613958903,-1.872343419,0.061159108,0.138243074,1237.806007,1,-0.395559959,0.414558761,-0.954171028,0.339997077,0.483445282,1223.005369,1,-1.064913709,0.31284751,-3.40393858,0.000664217,0.005258167,993.977445,1,-1.184567745,0.979668431,-1.209151696,0.226604572,0.353742104,Y,-,,Calreticulin family,P:mycelium development; F:calcium ion binding; C:integral component of endoplasmic reticulum membrane; F:unfolded protein binding; P:protein folding; P:ER-associated ubiquitin-dependent protein catabolic process,IPR001580 (PRINTS); IPR001580 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); IPR009033 (G3DSA:2.10.250.GENE3D); IPR001580 (PANTHER); PTHR11073:SF1 (PANTHER); IPR013320 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR009033 (SUPERFAMILY),,
RL4_JR_03594,1759,1297,1859,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2,46.95073941,0,-3.655452385,1.207416816,-3.027498322,0.002465871,0.012371817,14.93251932,1,-0.434914992,1.219286704,-0.356696247,0.721319215,0.825815876,67.55766202,1,-0.275512585,0.765601073,-0.359864419,0.718948526,0.809909334,78.23462328,0,-0.021722438,0.621609044,-0.034945499,0.9721232,0.984570111,38.5028326,1,-3.180681649,1.212716735,-2.622773775,0.008721716,0.028141831,N,-,,Methylthioribulose-1-phosphate dehydratase,F:methylthioribulose 1-phosphate dehydratase activity; F:zinc ion binding; C:cytoplasm; P:L-methionine biosynthetic process from S-adenosylmethionine; P:L-methionine biosynthetic process from methylthioadenosine,IPR001303 (SMART); IPR001303 (PFAM); IPR017714 (TIGRFAM); IPR001303 (G3DSA:3.40.225.GENE3D); IPR017714 (PANTHER); IPR027514 (HAMAP); IPR001303 (SUPERFAMILY),,
RL4_JR_03595,23,17,29,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,368.2161961,1,1.724471266,0.319399633,5.399102213,6.70E-08,1.37E-06,66.13443161,0,1.212653297,0.763054946,1.589208358,0.11201336,0.221315485,353.7498891,0,2.000283391,0.356655107,5.608452966,2.04E-08,8.14E-07,285.0697263,0,1.161735676,0.349677517,3.322305894,0.000892768,0.006718958,174.6787146,0,0.736777855,0.428728866,1.718517024,0.085702352,0.170077678,Y,-,,hypothetical protein SPSK_03631,,no IPS match,,
RL4_JR_03596,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.44544343,0,1.366154201,1.647950117,0.829002157,0.407103187,NA,0.47488738,0,4.540098419,1.784422088,2.544296246,0.010949817,0.036020166,1.208572076,0,1.915962798,1.389254051,1.379130618,0.167854485,0.285031669,1.392521065,0,1.495290235,1.468228515,1.018431545,0.308472917,0.454032314,1.167713236,0,1.862210762,1.362065577,1.367196112,0.171563844,0.28669482,N,-, Effector probability:0.686,---NA---,,no IPS match,,
RL4_JR_03597,1531,1895,1463,0,0,1,2,0,0,0,0,0,0,1,0,0,0,0,56.61321203,1,1.858227235,0.564054504,3.294410774,0.000986283,0.005847451,13.67803147,1,2.276912542,1.133988466,2.007879807,0.044656065,0.10787797,11.17528989,0,-1.293398878,1.202946263,-1.075192565,0.282288523,0.421766383,16.90439711,1,-0.769359709,1.154060221,-0.666654734,0.504992699,0.641672753,11.04884401,0,-1.379629479,1.210095789,-1.140099397,0.254244893,0.385190714,N,-, Effector probability:0.616,short chain dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_03598,304,301,309,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,15.28202852,0,-0.674490806,1.151845747,-0.5855739,0.558161892,0.736095169,3.649223638,0,1.597867748,1.264511623,1.263624406,0.206364869,0.351276024,20.56030063,0,-0.095871542,1.197456243,-0.080062668,0.936187414,0.961689995,18.97256571,1,0.241786446,1.025832621,0.235697755,0.813667212,0.882053589,24.11704938,0,0.549447237,0.985432585,0.557569584,0.577138331,0.690805722,N,-,,DNA replication complex gins sld5,P:double-strand break repair via break-induced replication; P:DNA-dependent DNA replication; C:GINS complex; C:cytosol; C:replication fork protection complex; P:cellular protein localization,IPR021151 (PFAM); IPR031633 (PFAM); IPR008591 (PIRSF); IPR008591 (PANTHER); PTHR21206:SF0 (PANTHER); SSF158573 (SUPERFAMILY),,
RL4_JR_03599,3409,3706,3365,0,0,7,0,0,0,0,4,0,2,1,0,0,1,0,57.10682167,1,0.270202845,0.788528794,0.342667061,0.731848945,0.858436189,45.82277509,0,2.912843771,0.900802579,3.233609495,0.001222365,0.015023052,40.22026359,1,-0.383644714,1.09032659,-0.351862201,0.724941608,0.813670603,120.0853872,1,1.857067092,0.581278948,3.194795026,0.001399302,0.009818386,20.78622358,1,-2.291386812,1.251969876,-1.830225197,0.067216272,0.140610456,Y,-,,hypothetical protein SPSK_03118,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03600,132,201,179,0,0,0,0,0,0,0,0,1,1,0,0,0,0,3,172.9831855,0,1.533669353,0.595024497,2.577489431,0.009952092,0.037762405,34.45137415,0,1.128581944,1.003998659,1.124087102,0.260976076,0.417248435,60.10830016,1,-0.755672856,0.864571847,-0.874042867,0.38209491,0.525841956,62.88731076,1,-0.873904008,0.765145854,-1.142140422,0.253395656,0.393131689,39.96448078,1,-3.234458258,1.198584059,-2.698566056,0.006963892,0.023510971,N,-,,fibroin-3 related,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03601,24723,32431,31289,10,4,3,0,0,1,1,0,0,0,0,3,0,4,0,205.1424545,1,0.474095571,0.395301255,1.19932726,0.230400719,0.402830919,48.83100999,1,0.194808014,0.992261342,0.196327324,0.844353976,0.907028954,257.0011258,1,1.292859452,0.365209308,3.540050662,0.00040005,0.002882464,326.7984571,1,1.497065003,0.309922559,4.830448643,1.36E-06,2.45E-05,174.982175,1,0.716612981,0.417653391,1.715807883,0.086197211,0.170892258,N,-, Effector probability:0.697,aldehyde dehydrogenase,"F:oxidoreductase activity; P:metabolic process; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",IPR020999 (PFAM); PTHR28187 (PANTHER),,
RL4_JR_03602,13710,20136,18918,0,0,0,0,0,0,0,2,0,0,1,2,0,1,0,11.24507846,0,-1.593372461,1.18772319,-1.341535195,0.179746751,0.336710446,3.593316202,0,1.620235337,1.259874458,1.286029196,0.198432872,0.341762385,9.309553902,1,-1.029639927,1.191877033,-0.863881003,0.387653264,0.531644763,10.73899005,1,-1.451864573,1.189123579,-1.220953481,0.222103634,0.357235789,23.89197622,1,0.573683278,0.966232322,0.593732237,0.552691218,0.67243434,N,-,,ADP-ribosylation factor family,F:GTP binding; P:small GTPase mediated signal transduction; C:intracellular,IPR006689 (PRINTS); SM00175 (SMART); SM00177 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR006689 (PFAM); IPR005225 (TIGRFAM); PTHR11711:SF112 (PANTHER); PTHR11711 (PANTHER); IPR024156 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_03603,8604,10328,12477,2,1,1,0,0,0,0,0,1,3,1,4,0,11,0,412.4137334,1,-5.832317412,1.189797705,-4.901940377,9.49E-07,1.45E-05,129.1042946,0,-3.546881476,1.211672027,-2.927261995,0.003419607,0.016584684,336.9219286,1,-6.207281614,1.217848324,-5.096925035,3.45E-07,1.05E-05,444.0672241,1,-3.041272072,0.631713209,-4.814324012,1.48E-06,2.61E-05,363.4198068,1,-3.585778939,0.843652575,-4.250302841,2.13E-05,0.000189605,N,-,,dna-directed rna polymerase i subunit rpa2,F:DNA binding; C:DNA-directed RNA polymerase I complex; F:RNA polymerase I activity; F:ribonucleoside binding; F:oxidoreductase activity; F:metal ion binding; P:transcription of nuclear large rRNA transcript from RNA polymerase I promoter; P:oxidation-reduction process,IPR007120 (PFAM); IPR007641 (PFAM); IPR009674 (PFAM); IPR014724 (G3DSA:2.40.50.GENE3D); G3DSA:3.90.1100.10 (GENE3D); IPR007645 (PFAM); IPR007642 (PFAM); IPR007120 (G3DSA:2.40.270.GENE3D); IPR007642 (G3DSA:3.90.1110.GENE3D); IPR007644 (PFAM); IPR015712 (PANTHER); IPR015712 (PANTHER); PTHR20856:SF5 (PANTHER); SSF64484 (SUPERFAMILY),,
RL4_JR_03604,0,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.85404194,0,-1.78653225,1.195704096,-1.494125726,0.135142761,0.274252399,4.133536376,0,1.418190884,1.270203257,1.116507044,0.264205157,0.421014577,10.67203232,0,-1.226742338,1.201396273,-1.021097173,0.307208402,0.448540217,12.30749621,0,-1.648620628,1.199771569,-1.374112098,0.169406884,0.291213022,10.47092328,0,-1.302193351,1.198305394,-1.086695726,0.277171303,0.410307772,Y,-,,tyrosinase,"C:nucleus; F:DNA binding; F:DNA-directed RNA polymerase activity; F:ribonucleoside binding; F:oxidoreductase activity; F:metal ion binding; P:transcription, DNA-templated; P:oxidation-reduction process",IPR002227 (PRINTS); IPR008922 (G3DSA:1.10.1280.GENE3D); IPR002227 (PFAM); PTHR11474:SF32 (PANTHER); PTHR11474:SF32 (PANTHER); PTHR11474 (PANTHER); PTHR11474 (PANTHER); IPR008922 (SUPERFAMILY),,
RL4_JR_03605,0,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,83.48245728,0,0.710569424,0.72279844,0.983081014,0.325567568,0.51482462,12.0268018,0,-0.12263458,1.211444809,-0.101230019,0.919367868,0.955641561,65.7627367,0,0.054293552,0.739971788,0.073372462,0.941509731,0.96515234,64.03084991,0,0.313886494,0.580205167,0.540992242,0.58851293,0.71327429,42.24639123,0,-0.64526046,0.839422145,-0.768696017,0.44207379,0.575765002,Y,-,,choriogenin Hminor,,G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.150 (GENE3D); IPR003695 (PFAM); PTHR39601:SF2 (PANTHER); PTHR39601 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_03606,316,442,354,0,0,16,0,0,0,0,0,0,0,0,1,0,0,0,47.54842728,1,1.784888488,0.575139229,3.103402444,0.001913093,0.010095092,3.970604045,0,1.47613319,1.256692767,1.174617399,0.240147819,0.391997456,10.30425692,0,-1.176311986,1.196253753,-0.983329818,0.325445139,0.468544737,25.21080749,1,0.135763848,1.016456571,0.133565812,0.89374592,0.934639273,10.16795285,0,-1.25977322,1.200583137,-1.049301112,0.294039554,0.42898422,N,-,,alternative oxidase,C:membrane,no IPS match,,
RL4_JR_03607,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,136.3871585,0,0.591367235,0.563901276,1.048707035,0.294312976,0.479338242,167.9459738,0,2.960611891,0.61680592,4.799908358,1.59E-06,0.000135021,53.05706367,0,-1.318690399,1.047531588,-1.258855022,0.208082702,0.335236995,177.7081741,0,1.442154139,0.418438269,3.446515884,0.000567865,0.004631355,73.16416352,0,-0.006555639,0.648667253,-0.01010632,0.991936461,0.994391749,N,-,,erythrocyte band 7 integral membrane,C:membrane,IPR001972 (PRINTS); IPR001107 (SMART); IPR001107 (PFAM); PTHR10264:SF19 (PANTHER); IPR001972 (PANTHER); IPR001107 (SUPERFAMILY),8.A.21.1.3, the stomatin/podocin/band 7/nephrosis.2/spfh (stomatin) family.
RL4_JR_03608,18,16,26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,115.4633985,0,-0.025415524,0.722022483,-0.03520046,0.971919895,0.98532652,19.73497271,0,-0.837138672,1.302297947,-0.642816549,0.520343143,0.67065558,61.50582796,0,-2.505578481,1.264579637,-1.98135286,0.047551716,0.108892462,70.16474832,0,-1.663497125,1.005151572,-1.65497142,0.097930295,0.192944978,48.91992636,0,-3.526145767,1.265382442,-2.786624542,0.005326015,0.018881618,N,-,,pirin,,IPR014710 (G3DSA:2.60.120.GENE3D); IPR012093 (PIRSF); IPR003829 (PFAM); IPR008778 (PFAM); PTHR13903:SF8 (PANTHER); IPR012093 (PANTHER); IPR011051 (SUPERFAMILY),,
RL4_JR_03609,35,15,9,0,0,61,0,0,0,0,0,0,0,0,0,0,0,0,351.9277208,1,-0.968655656,0.459434817,-2.108363624,0.034999548,0.101973684,97.10597331,0,-1.181128465,0.978248804,-1.207390655,0.227281733,0.377050291,263.0140804,0,-1.655048283,0.536006455,-3.087739462,0.002016852,0.009899587,366.5319157,0,-0.575727672,0.35515661,-1.621052956,0.105006282,0.203364309,300.4453292,0,-0.830599154,0.420961824,-1.973098526,0.048484338,0.109381445,N,-, Effector probability:0.855,perilipin mpl1,,PTHR11736:SF79 (PANTHER); PTHR11736 (PANTHER),,
RL4_JR_03610,34,13,25,0,0,4,0,0,0,0,0,7,1,0,2,0,1,0,4.671725791,1,-0.326564663,1.214438278,-0.26890182,0.788005236,0.890526979,1.495620298,0,2.884756112,1.355545922,2.128113895,0.033327642,0.085969008,3.875831753,1,0.234284056,1.212057439,0.193294516,0.846728321,0.902042995,4.470666354,1,-0.187869653,1.21309504,-0.154868041,0.876925349,0.92394929,3.820129412,1,0.152458994,1.211736577,0.125818595,0.899875522,0.935233549,N,-,,integral membrane,C:integral component of membrane,PTHR33048 (PANTHER),9.B.313.1.4, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_03611,6,7,10,0,0,11,0,0,0,0,0,1,2,0,2,0,0,0,8.569204825,1,3.7110074,1.059307847,3.503237902,0.000459639,0.003135228,0.297164186,0,5.216295726,1.714395808,3.042643771,0.002345098,0.015170793,0.769930987,1,2.566830051,1.266718934,2.026361161,0.042727788,0.100377978,8.911398364,1,3.857881522,1.051444746,3.669124351,0.000243383,0.002262855,96.86356983,0,7.055644233,0.726165967,9.716297042,2.57E-22,7.23E-20,N,-,,nonspecific lipid-transfer,"F:transferase activity, transferring acyl groups other than amino-acyl groups; P:metabolic process",IPR016039 (G3DSA:3.40.47.GENE3D); IPR020616 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR020617 (PFAM); PTHR18919 (PANTHER); PTHR18919:SF83 (PANTHER); IPR016039 (SUPERFAMILY); IPR016039 (SUPERFAMILY),,
RL4_JR_03612,265,316,272,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,65.84199543,0,-3.11223484,1.184830726,-2.626733737,0.008620876,0.033666399,20.10263694,0,-0.863774155,1.249832481,-0.691111944,0.489495195,0.645307419,157.2136915,0,1.174745716,0.526903076,2.229529055,0.025778724,0.068191369,94.23684694,0,-0.632787422,0.694505428,-0.911133875,0.36222484,0.508249238,158.1750518,0,1.200068838,0.61530798,1.950354744,0.051133852,0.114138062,N,-,,c6 zinc finger domain containing,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR007219 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); PTHR31001 (PANTHER); PTHR31001:SF50 (PANTHER); PTHR31001 (PANTHER); PTHR31001:SF50 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_03613,823,1091,829,0,0,2,0,0,0,0,0,0,1,11,0,0,4,0,0.019807577,1,7.554471241,3.960244045,1.907577199,0.056445884,NA,0.006345689,0,10.76483733,3.598854133,2.991184674,0.002778974,0.015349618,0.016456887,0,8.11166391,2.107222176,3.849458308,0.000118379,0.001287296,0.018982256,1,7.691271347,3.960080967,1.942200529,0.052112829,0.125807414,0.016250605,1,8.025401699,1.467255338,5.469669453,4.51E-08,1.22E-06,Y,-,,glycoside hydrolase family 61,F:binding,IPR005103 (PFAM); PTHR33353:SF10 (PANTHER); PTHR33353 (PANTHER),,
RL4_JR_03614,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,95.63987656,0,-0.468608514,0.625989822,-0.748588073,0.454105523,0.643046842,16.55700299,0,-0.583822768,1.209824368,-0.482568201,0.629402362,0.756515326,75.38526809,0,-0.101093122,0.679373181,-0.148803522,0.881708671,0.926169183,117.7129674,0,0.402796881,0.5013783,0.803379166,0.421755613,0.564776562,107.8098553,0,0.796133775,1.52095104,0.523444709,0.600664818,0.710067867,N,-,,heavy-metal-associated domain-containing,P:cellular iron ion homeostasis; P:copper ion transport; C:cytosol; P:cellular response to oxidative stress; F:copper chaperone activity,IPR006121 (PFAM); G3DSA:3.30.70.100 (GENE3D); PTHR22814:SF15 (PANTHER); PTHR22814 (PANTHER); IPR006121 (PROSITE_PROFILES); IPR006121 (SUPERFAMILY),3.A.3.5.33, the p-type atpase (p-atpase) superfamily.
RL4_JR_03615,0,2,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,139.6026926,1,-0.27987732,0.588502916,-0.475575077,0.634377135,0.791774801,33.49027924,0,-0.210051415,1.127458126,-0.186305291,0.852205358,0.912278496,77.29018784,0,-1.967331884,1.052617598,-1.868990114,0.06162419,0.133024157,173.4726093,0,0.289243759,0.500343173,0.578090748,0.563202853,0.690855073,62.46169149,0,-3.878674889,1.218033774,-3.184373843,0.001450675,0.006484807,N,-,,nulp1-pending,C:RQC complex; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:ribosome-associated ubiquitin-dependent protein catabolic process; C:cytosol,IPR006994 (PFAM); PTHR22684:SF0 (PANTHER); IPR006994 (PANTHER); IPR006994 (PANTHER); PTHR22684:SF0 (PANTHER); IPR006994 (PANTHER); PTHR22684:SF0 (PANTHER),,
RL4_JR_03616,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,97.90957583,0,2.992371874,0.739726608,4.045240287,5.23E-05,0.000484683,31.1892443,0,4.038101327,0.855056609,4.722612848,2.33E-06,0.000184121,7.9285928,0,-0.798072256,1.194886269,-0.667906458,0.504193305,0.636544833,9.147249325,1,-1.220506069,1.192685565,-1.023325933,0.306153766,0.451866893,7.819952485,0,-0.880859463,1.197967157,-0.735295169,0.46215975,0.593301314,N,-,,nad dependent epimerase dehydratase family,F:coenzyme binding; F:catalytic activity,IPR016040 (G3DSA:3.40.50.GENE3D); IPR001509 (PFAM); PTHR10366 (PANTHER); PTHR10366:SF474 (PANTHER); PTHR10366:SF474 (PANTHER); PTHR10366 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_03617,19,19,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.807322371,0,1.044015956,1.333359484,0.78299661,0.433629103,NA,0.57369346,0,4.267170599,1.530668759,2.78778186,0.005307027,0.02143356,1.491469941,0,1.612446627,1.241005743,1.299306338,0.19383882,0.318002476,1.720940095,0,1.189776018,1.263765527,0.941453136,0.346472694,0.493464064,1.471618624,0,1.529224645,1.232033899,1.241219617,0.21452463,0.339225656,Y,-,,murein transglycosylase,P:carbohydrate metabolic process; F:polygalacturonase activity,IPR012334 (G3DSA:2.160.20.GENE3D); IPR000743 (PFAM); PTHR31736:SF12 (PANTHER); PTHR31736 (PANTHER); IPR011050 (SUPERFAMILY),,
RL4_JR_03618,9,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.084176526,0,5.46803547,3.91942346,1.395112196,0.162982009,NA,0.027068289,0,8.673149337,2.710606404,3.199708126,0.001375668,0.015023052,0.069841554,0,6.029654598,1.531669627,3.936654805,8.26E-05,0.001035271,0.08054415,0,5.607022862,2.505696814,2.237710018,0.025239972,0.085851084,0.068440679,0,5.954283782,1.302034219,4.573062438,4.81E-06,5.49E-05,N,-,,nicotinamide mononucleotide permease,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF278 (PANTHER); PTHR11662 (PANTHER); PTHR11662:SF278 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.38, the major facilitator superfamily (mfs).
RL4_JR_03619,100,123,126,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.537670136,0,2.060216885,1.187638584,1.734717036,0.082790937,0.193249919,0.554551287,0,4.316184866,1.56332701,2.760897009,0.005764285,0.022622969,1.430239216,0,1.67263004,1.252347973,1.335595279,0.181681594,0.302870909,1.649221911,0,1.250933776,1.279200299,0.977902974,0.328122314,0.474797286,1.403030436,0,1.597199748,1.235952055,1.292282934,0.19625918,0.317584177,N,-,,N-sulfoglucosamine sulfohydrolase precursor,F:sulfuric ester hydrolase activity; P:metabolic process,IPR017849 (G3DSA:3.40.720.GENE3D); IPR000917 (PFAM); G3DSA:3.30.1120.10 (GENE3D); PTHR10342 (PANTHER); PTHR10342:SF76 (PANTHER); IPR017850 (SUPERFAMILY),2.A.127.1.7, the enterobacterial cardiolipin transporter (clt) family.
RL4_JR_03620,102,134,100,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,328.7730166,0,-0.427760575,0.521956658,-0.81953275,0.412482525,0.603624069,56.8117868,0,-2.362624562,1.19495847,-1.977160396,0.048023503,0.114160144,181.7949853,0,-1.886945663,0.685961132,-2.750805514,0.005944893,0.021626336,207.9726074,0,-2.671324781,0.757426439,-3.526843854,0.000420545,0.003633119,157.715382,0,-3.430085361,0.992781419,-3.455025744,0.00055024,0.002927579,N,-,,g2 m phase checkpoint control,P:biological_process; P:vesicle-mediated transport; C:intracellular ribonucleoprotein complex; C:membrane; C:integral component of membrane; C:viral nucleocapsid; P:intracellular protein transport; C:cellular_component; F:molecular_function; C:intracellular,IPR025609 (SMART); IPR019050 (SMART); IPR025609 (PFAM); IPR019050 (PFAM); PTHR13586 (PANTHER); PTHR13586:SF0 (PANTHER); IPR025762 (PROSITE_PROFILES); IPR025768 (PROSITE_PROFILES); IPR025761 (PROSITE_PROFILES); IPR010920 (SUPERFAMILY),,
RL4_JR_03621,3,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,307.4439761,0,1.724994098,0.450671657,3.827607245,0.000129395,0.001064117,23.33083124,0,-1.07866612,1.23015047,-0.876857056,0.380564284,0.54484748,98.76692918,0,-0.598815649,0.727227008,-0.823423282,0.410267328,0.552480238,224.4064576,0,1.069381167,0.451287134,2.36962476,0.017806147,0.072619429,64.20302541,0,-2.901716477,1.163109651,-2.494791849,0.012603104,0.03784981,N,-,,denn domain-containing,,IPR005113 (SMART); IPR001194 (SMART); IPR001194 (PFAM); IPR005113 (PFAM); IPR007529 (PFAM); PTHR12296 (PANTHER); PTHR12296:SF22 (PANTHER); IPR007529 (PROSITE_PROFILES); IPR005113 (PROSITE_PROFILES); IPR001194 (PROSITE_PROFILES); SSF144232 (SUPERFAMILY),,
RL4_JR_03622,108,132,81,0,0,4,0,0,0,0,0,0,0,0,0,0,1,0,31.77769976,1,-0.684231334,1.044057541,-0.655357878,0.512237365,0.697828027,6.447190238,0,0.77691073,1.279267258,0.607309165,0.543645757,0.690090589,51.71662774,0,0.968442467,0.780782482,1.24034861,0.21484648,0.343564328,65.82141361,0,1.559885659,0.593936226,2.626352109,0.008630549,0.043238152,73.38595802,1,2.294879937,0.538310409,4.263116408,2.02E-05,0.000180953,N,-,,kinesin family,F:ATP binding; F:microtubule motor activity; P:microtubule-based movement; F:microtubule binding,IPR001752 (PRINTS); IPR001752 (SMART); IPR001752 (PFAM); IPR001752 (G3DSA:3.40.850.GENE3D); IPR027640 (PANTHER); PTHR24115:SF431 (PANTHER); IPR027640 (PANTHER); PTHR24115:SF431 (PANTHER); PTHR24115:SF431 (PANTHER); IPR027640 (PANTHER); IPR001752 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_03623,43,30,94,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.000298167,0,0.471688717,1.150118732,0.410121759,0.681716632,0.82563009,1.660432827,0,2.734035122,1.339777885,2.040662973,0.041284338,0.101649251,4.29282399,0,0.087281264,1.205232171,0.072418631,0.942268758,0.96563695,25.00931425,0,2.692344644,0.682503593,3.944806552,7.99E-05,0.000882781,4.214220194,0,0.010969498,1.198788877,0.009150484,0.992699072,0.994860745,N,-,,ercc4 domain-containing,F:nuclease activity; P:cell cycle process; P:DNA metabolic process; P:cellular response to DNA damage stimulus,IPR006166 (SMART); IPR006166 (PFAM); PTHR21077:SF5 (PANTHER); IPR033310 (PANTHER),,
RL4_JR_03624,16,13,18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,28.38560458,0,2.574741857,0.69641324,3.69714662,0.000218036,0.001662375,1.631248174,1,2.759623705,1.351720727,2.041563505,0.041194849,0.101478281,12.06314026,0,1.073847256,1.203737351,0.892094322,0.372342378,0.516382772,42.26135333,0,3.376520214,0.577121475,5.850623072,4.90E-09,1.44E-07,4.143074536,1,0.035633621,1.208841704,0.029477491,0.97648377,0.984456654,Y,-,,mannosylphosphate transferase,F:transferase activity,IPR007074 (PFAM); PTHR15407:SF32 (PANTHER); IPR009644 (PANTHER),,
RL4_JR_03625,67,68,97,0,0,0,0,0,0,0,5,0,0,1,0,0,0,0,52.2656974,0,1.072320237,0.74464806,1.440036299,0.14985713,0.296803706,3.829932843,0,1.528164304,1.258505658,1.214268918,0.224645051,0.373805228,9.944391365,1,-1.125039271,1.196885658,-0.939972221,0.34723181,0.49097414,19.49536604,1,0.177198451,1.019695692,0.173775816,0.862041651,0.914702289,9.818134964,0,-1.209256169,1.201917993,-1.006105388,0.314364877,0.449878135,N,-,,ubiquitin metalloprotease fusion,P:proteolysis; F:peptidase activity; F:metallopeptidase activity,IPR013536 (PFAM); PTHR23153 (PANTHER); PTHR23153:SF36 (PANTHER); PTHR23153:SF36 (PANTHER); IPR013536 (PROSITE_PROFILES),,
RL4_JR_03626,4,9,9,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14.81941064,1,-1.991688689,1.201927444,-1.657078969,0.097503511,0.217450421,4.704821243,0,1.231350078,1.249281114,0.985646917,0.324306407,0.48645961,20.08386284,0,-0.462879743,1.197751231,-0.386457331,0.699157998,0.795222511,32.74878872,0,-0.099249541,1.021455455,-0.097164826,0.922595501,0.954067965,34.54914047,0,1.116357547,0.764998346,1.459294067,0.144484188,0.25192051,N,-,,er lumen retaining receptor,C:endoplasmic reticulum membrane; P:protein transport; C:integral component of membrane; F:ER retention sequence binding; P:protein retention in ER lumen,IPR000133 (PRINTS); IPR000133 (PFAM); PTHR10585:SF14 (PANTHER); IPR000133 (PANTHER),9.B.191.1.1, the endoplasmic reticulum retention receptor (kdelr) family.
RL4_JR_03627,214,328,373,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0.693175934,1,2.426388081,1.780567003,1.362705294,0.172975409,NA,0.224737945,0,5.619464886,1.844984488,3.045806034,0.002320575,0.015159195,0.576818988,0,2.98337556,1.309296245,2.278610033,0.022690257,0.061487195,0.664982956,0,2.561698987,1.416964697,1.807877778,0.070625525,0.15191915,19.86489699,0,5.791900879,0.76588956,7.562318616,3.96E-14,5.35E-12,Y,-,,hypothetical protein SPBR_03449,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_03628,43,44,66,0,0,9,0,0,0,0,0,2,0,0,0,0,3,0,126.4482221,1,1.298100352,0.590223151,2.19933825,0.02785388,0.085297279,10.35697484,0,0.092919873,1.228030139,0.075665792,0.939684992,0.967106405,55.70886478,1,0.248615504,0.767793193,0.323805298,0.746085445,0.830131777,43.22202832,0,-0.704102727,0.887090753,-0.793721188,0.427357762,0.569941695,68.92747768,1,1.188549622,0.594057842,2.000730463,0.045421445,0.104165827,N,-,,c2h2 finger domain containing,F:binding,no IPS match,,
RL4_JR_03629,3,9,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.333640672,0,3.481347168,2.43186015,1.431557307,0.152270555,NA,0.108124243,0,6.675166123,2.119708757,3.149095885,0.001637764,0.015023052,0.277393169,0,4.040103821,1.37084238,2.947168748,0.003206981,0.014215184,28.25659379,0,6.00127367,0.915331333,6.556394883,5.51E-11,2.16E-09,0.270067904,0,3.974058873,1.280371627,3.103832348,0.001910315,0.00815084,N,-, Effector probability:0.748,unnamed protein product,,IPR025676 (PFAM); PTHR38788 (PANTHER); PTHR38788:SF3 (PANTHER),,
RL4_JR_03630,5516,8695,5337,0,3,3,0,0,0,0,0,5,0,1,0,0,0,0,3.46494523,1,0.105053409,1.22332084,0.085875598,0.93156531,0.966629651,1.110201672,0,3.314781785,1.394948808,2.376274861,0.01748843,0.051789903,9.368979992,1,1.630062134,1.198973421,1.359548181,0.173972946,0.293013159,3.310573447,1,0.245986508,1.214613222,0.202522502,0.839508269,0.899854036,2.81748071,0,0.591850742,1.202669785,0.492114086,0.622638695,0.728400793,N,-,,hypothetical protein CMQ_6508,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; P:carbohydrate metabolic process; F:chitin binding; F:catalytic activity",IPR017956 (SMART),,
RL4_JR_03631,1314,1390,961,0,0,5,0,0,0,0,0,0,4,0,0,0,0,1,4.867205507,1,-0.385150945,1.236014187,-0.31160722,0.755339046,0.871701222,1.550953084,0,2.832423103,1.364561861,2.075701501,0.037921567,0.095081026,4.020294883,0,0.18191518,1.221482303,0.148929853,0.881608985,0.926169183,8.649658863,1,0.705190572,1.167790346,0.603867444,0.545931775,0.675905994,3.953483413,1,0.103264484,1.219288845,0.084692388,0.932505948,0.955823317,N,-,,DUF895 domain membrane,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23294:SF24 (PANTHER); PTHR23294 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.58.5, the major facilitator superfamily (mfs).
RL4_JR_03632,333,281,232,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8.699185055,0,3.384811839,1.164125902,2.907599455,0.003642145,0.016771036,0.22149196,0,5.640228221,1.804216923,3.126136414,0.001771194,0.015023052,0.572456243,1,2.993499556,1.273130535,2.351290362,0.018708428,0.053269926,0.66020081,0,2.571689062,1.364746073,1.884371835,0.059514697,0.136354635,0.562682445,0,2.915039337,1.235168163,2.360034385,0.018273241,0.050842695,N,-,,duf895 domain membrane,P:transmembrane transport; C:membrane; C:integral component of membrane,PTHR23294:SF24 (PANTHER); PTHR23294 (PANTHER),2.A.1.58.5, the major facilitator superfamily (mfs).
RL4_JR_03633,1231,783,805,0,0,2,0,0,0,1,0,0,6,0,0,0,0,0,1.590565071,1,1.227955544,1.313840197,0.934630822,0.349978589,NA,0.50846938,0,4.441252164,1.544245972,2.876000485,0.004027491,0.018161447,1.318657626,1,1.789572245,1.228923978,1.456210699,0.145334383,0.255845121,1.521124669,1,1.36742904,1.250409657,1.093584836,0.274137103,0.416262472,1.300448053,0,1.707003894,1.217331555,1.402250592,0.160840429,0.27273645,N,-,,taurine catabolism dioxygenase,F:oxidoreductase activity; P:oxidation-reduction process,G3DSA:3.60.130.10 (GENE3D); IPR003819 (PFAM); PTHR10696:SF21 (PANTHER); PTHR10696 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_03634,635,397,341,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,103.57508,1,0.794855559,0.49505779,1.605581359,0.108365924,0.234757982,11.55034066,1,-0.064332345,1.216024241,-0.052903834,0.957808529,0.977885375,62.39208885,0,0.421640456,0.673718367,0.625840822,0.531419353,0.661025867,82.01598885,0,-0.052296304,0.668077178,-0.078278837,0.937606251,0.963294094,85.54931701,0,1.155504733,0.493746798,2.340277928,0.019269394,0.053132521,N,-,,sucrase ferredoxin domain-containing,C:membrane; C:integral component of membrane,PTHR40021:SF1 (PANTHER); PTHR40021 (PANTHER); PTHR40021:SF1 (PANTHER); PTHR40021 (PANTHER),,
RL4_JR_03635,935,561,504,0,0,3,0,0,0,0,0,3,0,0,0,0,1,2,0.015875601,1,7.873726156,3.973377595,1.981620414,0.047521741,NA,0.004841942,0,11.15004198,3.976319002,2.804111535,0.005045545,0.020752135,0.012966942,1,8.453583283,2.925374836,2.889743624,0.003855561,0.016036854,0.014987188,0,8.030738991,3.97410421,2.020767088,0.043303881,0.113246213,0.013211428,1,8.338311818,1.621864357,5.141189386,2.73E-07,4.92E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_03636,4,12,27,0,0,1,0,0,0,0,0,0,1,0,6,0,0,1,58.18319878,1,-0.021827198,0.791100974,-0.027590912,0.97798843,0.988898068,8.325277514,0,0.407966158,1.243536754,0.32806924,0.742859311,0.841546944,21.66150227,0,-2.248157402,1.210240277,-1.857612446,0.06322407,0.13584051,29.00319697,1,-1.724859566,1.164649226,-1.481012074,0.138603356,0.25073414,36.53484271,1,-0.130725187,0.881166019,-0.148354775,0.882062789,0.921755159,N,-,,nuclear envelope,C:viral envelope; C:spindle pole body; P:cellular component assembly; C:integral component of membrane; P:cell cycle process; P:microtubule cytoskeleton organization; C:nuclear pore,IPR019049 (PFAM); PTHR13269:SF6 (PANTHER); PTHR13269 (PANTHER),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_03637,1937,2686,1373,0,0,8,0,0,0,0,0,0,0,0,0,0,4,0,89.02760539,1,-0.330453601,0.611132846,-0.540723025,0.588698506,0.760266331,18.59595682,0,-0.751441972,1.205271756,-0.62346269,0.532980513,0.681251263,83.57361363,0,-0.270251534,0.680909582,-0.396897827,0.691442806,0.788840091,110.5626434,0,0.313679183,0.505016321,0.621126822,0.534516183,0.666992402,55.25195098,1,-2.558831243,1.13321995,-2.258018174,0.023944526,0.062938299,N,-,,SNARE domain-containing,P:vesicle fusion; P:vesicle docking; C:fungal-type vacuole membrane; C:late endosome; C:integral component of membrane; F:SNAP receptor activity; C:SNARE complex; C:endoplasmic reticulum; F:SNARE binding; P:intracellular protein transport; P:Golgi to vacuole transport,IPR000727 (SMART); IPR006011 (SMART); PF14523 (PFAM); IPR000727 (PFAM); G3DSA:1.20.5.110 (GENE3D); G3DSA:1.20.58.70 (GENE3D); PTHR19957:SF38 (PANTHER); PTHR19957 (PANTHER); IPR000727 (PROSITE_PROFILES); IPR010989 (SUPERFAMILY),8.A.91.1.3, the syntaxin (syntaxin) family.
RL4_JR_03638,93,50,56,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,10.02604269,0,-1.428145897,1.252867015,-1.139902225,0.254327038,0.43222826,3.173362988,0,1.79938956,1.326634195,1.356356988,0.174985612,0.311065044,8.294927509,1,-0.863418158,1.24015092,-0.69622023,0.486290921,0.621538856,17.59581076,0,0.413368514,1.078920923,0.383131428,0.701622318,0.799541471,12.11639297,0,-0.03361223,1.184965847,-0.028365569,0.977370585,0.985056458,N,-,,mitochondrial export translocase oxa2,C:membrane,IPR001708 (PANTHER),2.A.9.1.2, the membrane protein insertase (yidc/alb3/oxa1) family.
RL4_JR_03639,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44.63377978,0,1.467873614,0.607000391,2.418241628,0.015595717,0.053897737,4.253509145,0,1.376846839,1.245805936,1.105185647,0.269079155,0.426298201,30.53866152,0,1.1278078,0.848996891,1.328400388,0.184045871,0.305305653,84.985142,0,2.492124344,0.463355443,5.378428986,7.51E-08,1.75E-06,18.26079817,0,-0.424869159,1.123134635,-0.378288716,0.705216127,0.791345815,N,-,,"alpha-1,2-mannosyltransferase alg11","C:endoplasmic reticulum membrane; P:oligosaccharide-lipid intermediate biosynthetic process; P:mycelium development; P:mannosylation; C:integral component of membrane; P:protein glycosylation; P:oligosaccharide biosynthetic process; F:GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity",IPR031814 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR001296 (PFAM); PTHR12526 (PANTHER); PTHR12526:SF315 (PANTHER); SSF53756 (SUPERFAMILY),,
RL4_JR_03640,4838,3981,4954,0,2,19,0,2,0,0,1,4,7,11,4,0,0,1,172.6410824,1,0.436326124,1.178990408,0.370084541,0.7113195,0.844759376,24.65998853,1,-1.15855634,1.205888658,-0.960749014,0.33667838,0.499686006,76.84807943,1,-1.9888912,1.037683034,-1.91666543,0.05528045,0.122037861,95.00130553,1,-1.509384798,0.753841205,-2.002258284,0.04525696,0.115278131,92.57355811,1,-0.931633523,0.676984511,-1.376151902,0.16877461,0.28320234,Y,-,,gamma-glutamyltranspeptidase,"F:transferase activity, transferring acyl groups",IPR000101 (PRINTS); IPR000101 (PFAM); IPR000101 (PANTHER); IPR000101 (PANTHER); PTHR11686:SF9 (PANTHER); IPR029055 (SUPERFAMILY),,
RL4_JR_03641,25918,14035,15440,3,3,4,0,0,1,0,0,5,0,6,0,0,2,0,58.92914511,1,-2.940726444,1.168707637,-2.516220782,0.011862085,0.043466106,17.43705307,1,-0.658618027,1.215725469,-0.541748975,0.587991446,0.725705672,52.01096059,1,-2.357434151,1.20606621,-1.954647375,0.050624705,0.114275255,52.52256918,1,-3.742075792,1.20860095,-3.096204577,0.001960151,0.013039768,60.60385753,1,-0.83250612,0.80447355,-1.034845857,0.300740903,0.435871979,N,-,,tRNA (uracil-5-)-methyltransferase,F:RNA methyltransferase activity; P:RNA processing; P:methylation,IPR010280 (PFAM); G3DSA:2.40.50.140 (GENE3D); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR11061:SF30 (PANTHER); PTHR11061 (PANTHER); IPR025795 (PROSITE_PROFILES); IPR010280 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_03642,38721,23742,31974,1,3,13,0,0,1,2,4,5,5,2,0,0,0,0,10.22688837,1,0.164095642,1.166258943,0.14070258,0.888104907,0.945379342,2.041193923,1,2.436148777,1.32621091,1.836924097,0.066221101,0.146928976,5.293867201,1,-0.215163395,1.213133775,-0.17736164,0.859224337,0.910295855,10.11905569,1,0.308483295,1.161195333,0.265660123,0.790500977,0.864571956,5.209924604,0,-0.294902765,1.212986362,-0.243121254,0.807911467,0.870395546,N,-,,actin cytoskeleton organization,C:polysome; C:nucleus; C:actomyosin contractile ring; P:intracellular mRNA localization; P:mitotic actomyosin contractile ring assembly; F:myosin binding; C:cytosol; P:mating type switching; P:cellular protein localization,IPR000225 (SMART); IPR024660 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR22904 (PANTHER); PTHR22904:SF340 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_03643,1290,715,700,0,2,3,0,0,0,0,0,1,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_03644,2194,1822,3033,0,0,3,0,0,0,6,0,1,2,0,0,0,2,0,13.8511299,1,-1.894389636,1.232034532,-1.537610828,0.124143798,0.258820625,4.402933805,0,1.326971646,1.290811936,1.028013151,0.303943642,0.464929764,11.47473406,1,-1.331537434,1.226320648,-1.085798756,0.277568037,0.416619541,13.23985372,1,-1.754123682,1.22848422,-1.427876446,0.153327424,0.27025804,19.1061584,1,0.225898246,1.034588026,0.218346085,0.82715947,0.884308808,N,-,,transcription factor tfiih subunit,"P:nucleic acid metabolic process; C:nuclear part; P:cellular nitrogen compound biosynthetic process; P:cellular protein metabolic process; P:regulation of transcription, DNA-templated; P:gene expression; C:protein complex; P:cellular macromolecule biosynthetic process",IPR004600 (PFAM); PTHR12831:SF0 (PANTHER); IPR004600 (PANTHER); IPR004600 (PANTHER); PTHR12831:SF0 (PANTHER),,
RL4_JR_03645,477,463,893,0,1,6,0,0,0,0,0,3,0,1,0,0,0,0,18.9820236,1,0.117255285,1.022390075,0.114687425,0.908692881,0.955724256,3.650937845,0,1.597315113,1.28206875,1.245888812,0.212805218,0.359241897,9.418933419,1,-1.046503611,1.204322784,-0.868956084,0.384871151,0.52861695,10.86199489,1,-1.468332487,1.202941727,-1.220618135,0.222230637,0.35738329,24.67410109,0,1.48265775,0.762463929,1.94456117,0.051827816,0.115128706,N,-,,threonine aspartase,C:proteasome complex; F:hydrolase activity,IPR000246 (PFAM); PTHR10188:SF8 (PANTHER); IPR000246 (PANTHER); IPR029055 (SUPERFAMILY),,
RL4_JR_03646,8,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,144.8585056,0,-0.240563776,0.445670345,-0.539779635,0.589349013,0.760504468,27.66486461,0,-1.324442549,1.19721902,-1.106265877,0.268611457,0.425823832,98.37967939,0,-1.56213384,0.845452274,-1.847690151,0.06464718,0.138165093,183.5869359,0,0.412852191,0.379495536,1.08789736,0.276640422,0.419452468,89.74373264,0,-1.115796634,0.664920874,-1.678089345,0.093329658,0.180958022,N,-,,actin 3,F:ATP binding; C:cell division site; F:actin binding; C:cell cortex of cell tip; P:actin filament polymerization; P:mitotic actomyosin contractile ring assembly; P:Arp2/3 complex-mediated actin nucleation; C:cytosol; P:actin cortical patch assembly; C:actin cortical patch; P:actin cortical patch localization; C:Arp2/3 protein complex,IPR004000 (SMART); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.90.640.10 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR004000 (PFAM); IPR004000 (PANTHER); PTHR11937:SF31 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_03647,317,120,222,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9285.930111,0,2.666564926,0.809744789,3.293093036,0.000990917,0.00587066,1336.982034,0,1.294174,1.125419702,1.14994788,0.250165339,0.404306811,2703.53199,0,0.685766606,0.462402636,1.483050815,0.13806091,0.246556475,1586.792159,0,-1.675733436,0.764603504,-2.191637139,0.028405718,0.08952213,1559.374254,0,-1.000206389,0.577596255,-1.731670489,0.083332248,0.166503062,N,-,,alcohol dehydrogenase 1,F:zinc ion binding; C:cytoplasm; P:oxidation-reduction process; F:alcohol dehydrogenase (NAD) activity,IPR020843 (SMART); IPR013149 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013154 (PFAM); PTHR11695:SF280 (PANTHER); IPR002085 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_03648,16,10,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51.7856524,0,3.491870025,0.563619192,6.19544202,5.81E-10,1.70E-08,1.558981497,0,2.825031638,1.376403878,2.052472884,0.040123728,0.099347449,4.017657833,0,0.182886856,1.223794591,0.149442445,0.881204521,0.92609097,4.633130295,0,-0.238942822,1.226584646,-0.194803369,0.845546885,0.903295441,7.790423828,0,1.040500268,1.141525336,0.911499934,0.36203202,0.49892122,N,-,,f-box domain-containing,"F:nucleotide binding; P:L-arabinose metabolic process; P:carbohydrate metabolic process; F:alpha-L-arabinofuranosidase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; C:extracellular region; F:cellulose binding",no IPS match,,
RL4_JR_03649,4098,1999,2461,0,0,11,0,0,0,0,0,3,0,2,0,0,2,0,16.40430458,1,1.865780029,0.903694264,2.06461422,0.038959517,0.110704193,1.565531174,0,2.818796976,1.357050413,2.077149787,0.037787737,0.094933599,4.082502671,1,0.159455647,1.223523696,0.130324936,0.896309352,0.935488235,23.33585329,1,1.494652391,1.037263184,1.440957719,0.149596628,0.265783649,4.043750886,1,0.070669794,1.229863554,0.057461491,0.954177581,0.970179555,N,-,,mgmt family,P:DNA dealkylation involved in DNA repair; F:methylated-DNA-[protein]-cysteine S-methyltransferase activity; F:damaged DNA binding,IPR014048 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); PTHR10815:SF2 (PANTHER); PTHR10815 (PANTHER); IPR014048 (SUPERFAMILY),,
RL4_JR_03650,6434,4917,4525,0,0,1,0,0,0,1,0,0,2,0,0,0,0,0,175.6324665,1,-1.994861946,0.704916392,-2.829927022,0.004655862,0.020553314,45.5443052,0,-2.043708612,1.215273415,-1.681686266,0.092629693,0.190956772,119.1064015,1,-4.707130932,1.216880029,-3.868196387,0.000109643,0.001229911,174.0744266,1,-2.056504231,0.720132197,-2.855731545,0.00429378,0.024913767,145.4603499,0,-1.500492615,0.726675034,-2.064874317,0.038934894,0.092063475,N,-,,phosphoglycerate mutase,F:catalytic activity; C:intracellular part,IPR013078 (SMART); IPR013078 (PFAM); IPR029033 (G3DSA:3.40.50.GENE3D); PTHR23029 (PANTHER); PTHR23029:SF6 (PANTHER); IPR029033 (SUPERFAMILY),,
RL4_JR_03651,1889,1205,1469,0,4,3,0,0,0,0,0,2,3,4,0,0,0,1,3.299209873,1,0.175823938,1.251232399,0.140520608,0.888248671,0.945379342,1.050683434,0,3.394241084,1.412391722,2.403186758,0.016252885,0.04908622,2.725209241,1,0.742877286,1.22364255,0.607103182,0.543782438,0.671454251,3.1440619,1,0.320417826,1.230298043,0.26043919,0.794525017,0.867432154,2.682178738,1,0.663055624,1.219081278,0.5438978,0.586511803,0.699050266,N,-,,regulator of chromosome condensation,,IPR000408 (PRINTS); IPR009091 (G3DSA:2.130.10.GENE3D); IPR000408 (PFAM); PTHR22870 (PANTHER); IPR000408 (PROSITE_PROFILES); IPR000408 (PROSITE_PROFILES); IPR000408 (PROSITE_PROFILES); IPR000408 (PROSITE_PROFILES); IPR000408 (PROSITE_PROFILES); IPR000408 (PROSITE_PROFILES); IPR009091 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_03652,60247,46241,67344,17,13,79,0,0,0,6,0,11,0,19,17,0,12,11,3.734608075,1,-0.003538492,1.231940907,-0.002872291,0.997708247,0.999396344,1.189398585,0,3.215201969,1.383927575,2.323244385,0.020166028,0.057857293,20.66176905,1,2.38513187,1.042906868,2.287003704,0.022195607,0.060441237,3.568528618,1,0.137186603,1.221987685,0.112265127,0.910613191,0.9453459,3.059634357,1,0.472817569,1.220669079,0.387342956,0.698502329,0.786687808,N,-,,glycosyltransferase family 4,P:GPI anchor biosynthetic process; C:integral component of membrane; F:phosphatidylinositol N-acetylglucosaminyltransferase activity; C:endoplasmic reticulum,IPR013234 (PFAM); IPR001296 (PFAM); G3DSA:3.40.50.2000 (GENE3D); PTHR12526:SF232 (PANTHER); PTHR12526 (PANTHER); PTHR12526:SF232 (PANTHER); PTHR12526:SF232 (PANTHER); PTHR12526 (PANTHER); PTHR12526 (PANTHER); PTHR12526 (PANTHER); SSF53756 (SUPERFAMILY),2.A.38.4.5, the k(+) transporter (trk) family.
RL4_JR_03653,515,659,508,0,2,24,0,0,0,2,2,1,2,12,2,0,20,0,241.3787739,1,-0.410343782,0.434722646,-0.943920879,0.345210081,0.535098583,56.44958969,0,-1.173490418,1.106097429,-1.060928619,0.288722342,0.448159415,135.3253015,1,-2.925697497,1.032661772,-2.833161425,0.00460901,0.017837011,239.0642825,1,-0.449125437,0.410045583,-1.095306123,0.273382546,0.415490585,128.4994575,1,-3.16354258,0.981891191,-3.221887119,0.001273493,0.005845732,N,-,,ATP-dependent RNA helicase dbp6,F:organic cyclic compound binding; F:heterocyclic compound binding; F:hydrolase activity,IPR014001 (SMART); IPR001650 (SMART); IPR011545 (PFAM); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24031:SF68 (PANTHER); PTHR24031 (PANTHER); PTHR24031 (PANTHER); PTHR24031:SF68 (PANTHER); PTHR24031 (PANTHER); PTHR24031:SF68 (PANTHER); PTHR24031:SF68 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_03654,1572,1341,2350,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,3.387570906,1,0.137419821,1.388222059,0.098989798,0.921146371,0.961964073,1.107994913,0,3.317718226,1.555765664,2.132530819,0.032963234,0.085224483,2.827977508,0,0.689377206,1.314412099,0.524475701,0.599947716,0.718496628,3.259019506,0,0.268496885,1.340733872,0.200261133,0.841276358,0.900930521,2.740697069,1,0.631502567,1.304732236,0.484009324,0.628379252,0.732179104,N,-,,hypothetical protein SPSK_03386,,no IPS match,,
RL4_JR_03655,96,64,103,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,185.4493735,0,-1.902963758,0.863078592,-2.204855705,0.027464222,0.08445274,50.32903927,0,-2.187788094,1.261081203,-1.734851085,0.082767185,0.174608055,128.9262563,0,-4.821406016,1.246545986,-3.867812396,0.000109816,0.001229911,148.6177166,0,-5.242635165,1.255049197,-4.177234787,2.95E-05,0.000372522,125.3473742,1,-4.883575053,1.248251352,-3.912333079,9.14E-05,0.000644508,N,-,,peroxisomal copper amine oxidase,P:amine metabolic process; F:copper ion binding; F:quinone binding; F:primary amine oxidase activity; P:oxidation-reduction process,IPR015798 (PFAM); IPR015802 (PFAM); G3DSA:3.10.450.40 (GENE3D); IPR015800 (PFAM); G3DSA:3.10.450.40 (GENE3D); IPR015798 (G3DSA:2.70.98.GENE3D); IPR000269 (PANTHER); PTHR10638:SF18 (PANTHER); IPR016182 (SUPERFAMILY); IPR016182 (SUPERFAMILY); IPR015798 (SUPERFAMILY),,
RL4_JR_03656,758,404,1026,1,1,5,0,0,1,0,0,0,3,1,0,0,0,2,51.04593354,1,-2.716593293,1.14684093,-2.368762068,0.017847731,0.059819963,15.18494323,1,-0.459020018,1.219590885,-0.376372129,0.706640263,0.815391329,72.41392917,0,-0.680150099,0.85728349,-0.793378278,0.427557462,0.568205795,85.82970972,1,-0.206364295,0.627265685,-0.328990252,0.742163056,0.828672358,65.48415447,1,0.217094276,0.594472372,0.365188168,0.71497095,0.799015548,N,-,,c6 zinc finger domain containing,"C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR021858 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_03657,13703,8622,11841,8,1,6,0,0,0,0,0,2,1,3,1,0,1,0,15.1934924,1,0.697292275,1.037598621,0.67202506,0.501567743,0.688159346,21.19524704,0,3.804473694,1.032926233,3.683199797,0.000230324,0.00959401,6.279793208,1,-0.46163816,1.216982321,-0.379330211,0.704442668,0.799168262,7.241122335,1,-0.883317604,1.217215853,-0.725686904,0.468030732,0.609336654,13.51077105,1,0.403729885,1.137019296,0.355077426,0.722531588,0.804800036,N,-,,actin-like ATPase domain-containing,,G3DSA:3.30.420.40 (GENE3D); PTHR19375 (PANTHER); PTHR19375 (PANTHER); PTHR19375:SF181 (PANTHER); PTHR19375:SF181 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_03658,6688,11083,15154,4,0,7,0,1,0,0,0,0,0,4,0,0,0,0,3.719102198,1,0.002645325,1.247431182,0.002120618,0.998307993,0.999533212,1.201363679,1,3.200943164,1.417908577,2.257510262,0.023976209,0.066416855,3.092958134,0,0.560101209,1.231704482,0.454736682,0.649298688,0.756425886,3.566278496,1,0.138468365,1.2381058,0.111838879,0.91095116,0.945599804,3.026191975,0,0.488469458,1.222005216,0.399727801,0.689357013,0.779772065,N,-,,related to interaptin (abpD),C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03659,411,614,903,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22.01091927,0,3.373210328,0.688267753,4.901014629,9.53E-07,1.45E-05,0.938352574,0,3.557374909,1.431064342,2.485824575,0.012925166,0.040960718,2.423409833,0,0.911955674,1.220402067,0.747258382,0.454907609,0.593971992,2.794806269,0,0.490055213,1.226919453,0.399419222,0.689584333,0.789885077,2.379106488,0,0.835515613,1.210716098,0.690100358,0.490131078,0.618698063,N,-,,uba ts-n domain containing,F:NAD+ ADP-ribosyltransferase activity,IPR012317 (G3DSA:3.90.228.GENE3D); IPR012317 (PFAM); SSF56399 (SUPERFAMILY),,
RL4_JR_03660,10397,7492,4673,1,5,7,1,0,0,0,5,12,0,1,0,0,11,1,8.326124725,1,0.672051771,1.150753138,0.584010374,0.559213332,0.736695452,23.75769335,1,3.859963232,1.12458422,3.432346962,0.000598381,0.015023052,3.740747358,1,0.285568042,1.209183071,0.236166093,0.813303789,0.878750007,4.314492859,1,-0.136476915,1.209650972,-0.112823383,0.91017058,0.945080209,11.04526928,1,1.141928078,1.129032347,1.011421933,0.311814528,0.44722198,N,-,,hypothetical protein SPI_07157,,no IPS match,,
RL4_JR_03661,3648,3395,4046,0,3,11,0,0,0,0,0,0,1,9,1,0,7,0,243.7180337,1,-5.061515244,1.149651904,-4.402650251,1.07E-05,0.000123045,76.54576662,0,-2.792743454,1.192212557,-2.342487871,0.019155657,0.055588749,233.8850799,0,-2.618911977,0.748331323,-3.499669061,0.000465836,0.003214809,256.2521114,1,-3.135258575,0.747792258,-4.192686592,2.76E-05,0.000349769,203.5939521,1,-4.59393218,1.13183444,-4.058837599,4.93E-05,0.000385294,N,-,,WD domain containing partial,F:DNA binding,IPR001487 (PFAM); IPR001487 (G3DSA:1.20.920.GENE3D); PTHR15398 (PANTHER); IPR001487 (SUPERFAMILY),,
RL4_JR_03662,2910,3935,3016,0,3,0,0,0,0,0,0,1,0,3,3,0,2,2,44.43052659,1,3.159954068,0.617295684,5.119028289,3.07E-07,5.35E-06,1.981022005,0,2.479205351,1.314211471,1.886458463,0.059233201,0.134853454,24.07249365,1,1.650463589,1.039105347,1.588350588,0.112207084,0.210953486,19.27746832,1,1.133669676,1.025115011,1.105895108,0.268771922,0.409960186,19.83761409,1,1.429563572,0.989073765,1.445355871,0.148357952,0.25694907,N,-,,hypothetical protein SPBR_03522,P:cell division; P:chromosome segregation; F:microtubule binding,no IPS match,,
RL4_JR_03663,2537,2027,2603,1,0,0,0,0,1,0,0,2,2,2,3,0,2,3,0.09852673,1,5.240635614,3.917580038,1.337722666,0.180986859,NA,0.030546356,1,8.49664538,2.784194826,3.051742393,0.002275173,0.0150814,0.081048361,1,5.810676786,1.703905136,3.410211438,0.000649125,0.004084366,0.093613898,1,5.388948425,2.573944114,2.093654014,0.036290812,0.1010789,0.081957897,1,5.696398487,1.467669336,3.881254684,0.000103919,0.000715282,N,-,,aspartic ase,F:aspartic-type endopeptidase activity; P:proteolysis,IPR001461 (PRINTS); IPR021109 (G3DSA:2.40.70.GENE3D); IPR021109 (G3DSA:2.40.70.GENE3D); IPR033121 (PFAM); IPR001461 (PANTHER); PTHR13683:SF345 (PANTHER); IPR033121 (PROSITE_PROFILES); IPR021109 (SUPERFAMILY),8.A.32.1.4,The β-Amyloid Cleaving Enzyme (BACE1) Family
RL4_JR_03664,24,34,30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,159.6807982,0,1.816356855,0.418187824,4.343399669,1.40E-05,0.00015601,30.01511689,0,1.605384424,1.010681609,1.588417569,0.112191947,0.221540063,72.115056,0,0.474475539,0.685566191,0.692092966,0.488878949,0.623351445,76.30171279,0,0.604296876,0.574939174,1.051062274,0.293229989,0.437963364,40.19086152,0,-0.555272619,0.859395425,-0.646120055,0.518201608,0.643436639,Y,-,,Hypoxia up-regulated 1,F:ATP binding,IPR013126 (PRINTS); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.90.640.10 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR029048 (G3DSA:1.20.1270.GENE3D); IPR013126 (PFAM); PTHR19375:SF231 (PANTHER); PTHR19375:SF231 (PANTHER); PTHR19375 (PANTHER); PTHR19375 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY); IPR029048 (SUPERFAMILY),3.A.16.1.4, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_03665,216,216,194,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,303.3385788,0,-0.508272359,0.636533832,-0.798500148,0.424580307,0.615773537,182.3087873,0,1.339914143,0.56482031,2.372283927,0.0176785,0.052184828,217.5256164,1,-1.620302941,0.664878605,-2.436990645,0.014810062,0.044021454,243.2987086,0,-1.713573979,0.590169897,-2.903526576,0.003689857,0.021989286,198.4802848,0,-1.418493075,0.602267804,-2.355253039,0.018510096,0.051402832,N,-,,threonine synthase,F:pyridoxal phosphate binding; P:threonine biosynthetic process; F:threonine synthase activity,IPR029144 (G3DSA:3.90.1380.GENE3D); IPR004450 (TIGRFAM); IPR029144 (PFAM); IPR001926 (PFAM); G3DSA:3.40.50.1100 (GENE3D); G3DSA:3.40.50.1100 (GENE3D); PTHR10314:SF1 (PANTHER); PTHR10314 (PANTHER); PTHR10314 (PANTHER); IPR001926 (SUPERFAMILY),,
RL4_JR_03666,1311,1107,1755,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,68.34734594,0,1.366000878,0.508947956,2.683969671,0.007275371,0.029411533,6.828881482,0,0.693885507,1.225499242,0.566206394,0.571253484,0.711878091,17.71092564,0,-1.957545149,1.189306008,-1.645955822,0.099772855,0.193606646,83.18374903,1,2.018389986,0.441846351,4.568081147,4.92E-06,7.54E-05,39.54322712,1,0.189448183,0.835647815,0.226708165,0.820650678,0.879827204,Y,-,,histidine acid phosphatase,C:membrane; C:integral component of membrane; P:dephosphorylation; F:acid phosphatase activity,IPR029033 (G3DSA:3.40.50.GENE3D); IPR000560 (PFAM); PTHR11567:SF127 (PANTHER); PTHR11567:SF127 (PANTHER); PTHR11567 (PANTHER); PTHR11567 (PANTHER); IPR029033 (SUPERFAMILY),,
RL4_JR_03667,8849,7268,7952,0,0,2,0,0,0,0,4,2,0,3,3,0,0,1,14.31726041,1,0.845633129,1.112107859,0.760387693,0.447022878,0.635998018,2.097468589,0,2.396711894,1.376754756,1.740841557,0.081711355,0.172993587,5.506709063,1,-0.27239991,1.257412387,-0.2166353,0.828492573,0.88932598,14.38016989,1,0.997122065,1.09615957,0.909650467,0.363006874,0.509275419,5.500318112,1,-0.373250417,1.274522593,-0.292855081,0.769632925,0.840346529,N,-,,gcn5-related n-acetyltransferase,F:transferase activity; F:N-acetyltransferase activity,IPR016181 (G3DSA:3.40.630.GENE3D); PTHR13355:SF8 (PANTHER); PTHR13355 (PANTHER); PTHR13355 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_03668,11059,7014,6650,9,4,8,0,0,0,0,1,8,5,21,1,0,9,0,886.3164647,1,-0.761464354,0.674111833,-1.129581646,0.258652548,0.437777488,186.0598164,0,-3.082923847,1.121685027,-2.748475527,0.00598731,0.023264321,482.9700831,1,-4.81907911,1.051249395,-4.584144478,4.56E-06,9.68E-05,631.7930004,1,-2.304450786,0.479228089,-4.808672191,1.52E-06,2.67E-05,518.3302006,1,-2.493652388,0.721683238,-3.455328121,0.000549623,0.002926973,N,-, Effector probability:0.852,40S ribosomal S5,F:RNA binding; F:structural constituent of ribosome; C:small ribosomal subunit; P:translation,IPR023798 (G3DSA:1.10.455.GENE3D); IPR000235 (PIRSF); IPR023798 (PFAM); IPR005716 (TIGRFAM); IPR000235 (PANTHER); IPR023798 (SUPERFAMILY),,
RL4_JR_03669,9315,5307,4748,6,19,1,0,0,1,1,0,2,0,0,3,0,6,4,876.9152886,1,-0.073416635,0.404732802,-0.181395317,0.856057295,0.927670176,183.3952042,1,-1.143343065,0.772855187,-1.479375547,0.139039972,0.260574448,505.2667525,1,-1.722850755,0.465851147,-3.698285958,0.00021706,0.001850672,629.6210714,1,-1.095289515,0.768409387,-1.425398406,0.154042069,0.271118496,492.4090375,1,-1.538446289,1.125223793,-1.367235833,0.171551397,0.28669482,N,-, Effector probability:0.59,40S ribosomal s25,C:ribosome,IPR004977 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); IPR004977 (PANTHER); IPR004977 (PRODOM); IPR011991 (SUPERFAMILY),,
RL4_JR_03670,292,481,358,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,3677.86026,0,-0.845295673,0.650031551,-1.300391761,0.193466732,0.354515185,941.701308,0,-1.810586013,0.508572877,-3.5601309,0.00037067,0.014158194,2501.382175,0,-1.881889949,0.513695779,-3.663432767,0.000248858,0.002031802,3256.629981,1,-1.162533281,0.705285252,-1.648316448,0.099287751,0.19481674,2455.938892,0,-1.885629435,0.995514236,-1.894126036,0.058208283,0.125576012,N,-,,ADP ATP carrier,P:transmembrane transport; F:structural constituent of ribosome; C:integral component of membrane; C:mitochondrial inner membrane; F:transporter activity; P:translation,IPR002113 (PRINTS); IPR002067 (PRINTS); IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089 (PANTHER); PTHR24089:SF340 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.1.7, the mitochondrial carrier (mc) family.
RL4_JR_03671,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.53764531,0,-2.234757622,1.183125745,-1.888858925,0.058910735,0.150286455,5.612441281,0,0.976911839,1.236024134,0.790366314,0.429313869,0.591725227,14.5342205,0,-1.672395629,1.189482222,-1.405986233,0.159728213,0.274921528,83.88889947,0,1.48793598,0.573984052,2.592294985,0.009533799,0.046790941,21.66824476,0,-0.818613253,1.117272946,-0.732688692,0.463748323,0.59481274,N,-,,CENP-S centromere X,P:DNA repair; P:kinetochore assembly,IPR018552 (PFAM); PTHR28680 (PANTHER),,
RL4_JR_03672,882,657,518,4,2,0,0,0,0,3,0,0,0,1,0,0,0,0,2.555570081,1,0.543903576,1.301546357,0.417890283,0.676027337,0.821696271,0.827572456,0,3.738667469,1.498820048,2.494407167,0.012616772,0.040197347,2.128096889,1,1.099491791,1.252386002,0.877917662,0.379988404,0.52391467,2.453518349,1,0.677997015,1.269288329,0.534155242,0.593234132,0.716282274,2.080457752,0,1.028969505,1.239097099,0.830418783,0.40630205,0.5431487,Y,-,,---NA---,,PS51257 (PROSITE_PROFILES),,
RL4_JR_03673,4115,3888,3463,3,4,12,0,0,4,0,2,1,1,6,2,0,1,0,5.506826773,1,-0.563386844,1.220252293,-0.461697018,0.64429861,0.797479603,1.748814313,1,2.659128668,1.333080633,1.994724551,0.04607293,0.110457176,4.54732688,1,0.004009411,1.211453759,0.003309587,0.997359337,0.999239715,5.246881522,1,-0.418590699,1.212218518,-0.345309606,0.729861626,0.819910015,11.85506701,1,0.857166092,1.138223073,0.753073903,0.451405505,0.583564957,N,-,,S-adenosyl-L-methionine-dependent methyltransferase,F:methyltransferase activity; F:transferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PTHR35897:SF1 (PANTHER); PTHR35897 (PANTHER); SSF82199 (SUPERFAMILY); IPR029063 (SUPERFAMILY),,
RL4_JR_03674,794,1016,1137,0,0,2,0,0,0,0,0,0,0,0,0,0,2,0,0.497980612,1,2.903404141,1.978662615,1.46735685,0.142279006,NA,0.159687732,0,6.112189277,1.913092622,3.194925957,0.001398667,0.015023052,0.413350363,0,3.463145875,1.286502147,2.691908353,0.007104447,0.024844703,0.476755243,0,3.041305036,1.429222979,2.127943002,0.03334181,0.097850963,0.406910388,1,3.382673564,1.237362707,2.733776881,0.006261246,0.021555631,N,-,,hydrophobic surface binding a,P:biological_process; F:molecular_function,IPR021054 (PFAM); PTHR38123:SF2 (PANTHER); PTHR38123 (PANTHER),,
RL4_JR_03675,2145,1956,2249,3,0,14,0,0,0,0,0,1,1,7,7,0,2,1,6.155736748,1,-0.72436832,1.235670054,-0.586214999,0.557731044,0.735764853,1.946589543,0,2.504444814,1.334713088,1.87639189,0.060601487,0.137197105,5.084312877,1,-0.157294804,1.223648586,-0.128545733,0.897717109,0.936474808,5.867616178,1,-0.580159611,1.226275895,-0.47310692,0.6361369,0.750945434,5.050192175,1,-0.250067117,1.234129243,-0.202626361,0.839427085,0.891742654,N,-,,GTPase-activating SAC7,P:signal transduction,IPR000198 (SMART); IPR000198 (G3DSA:1.10.555.GENE3D); IPR000198 (PFAM); IPR000198 (PROSITE_PROFILES); IPR008936 (SUPERFAMILY),,
RL4_JR_03676,184,405,336,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.377532741,0,0.648475988,1.331978833,0.486851571,0.62636352,0.786271914,0.755005191,0,3.871016364,1.504336593,2.573238184,0.010075184,0.0337462,1.960322057,0,1.218206745,1.255637115,0.970190137,0.331951726,0.475142246,2.261865316,0,0.795556833,1.276184319,0.623387093,0.533030178,0.665872022,1.929922119,0,1.137993683,1.248795104,0.911273338,0.362151371,0.499017778,N,-,,C6 zinc finger domain,F:binding,IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31944:SF80 (PANTHER); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_03677,3425,3395,2054,0,0,8,0,0,0,2,0,0,3,4,0,0,0,0,0.80549304,1,2.209755948,1.582597636,1.39628412,0.162628954,NA,0.257808502,0,5.421216549,1.735075589,3.124484365,0.00178117,0.015023052,0.667278009,1,2.77289066,1.248215576,2.221483783,0.026318212,0.069260613,0.769683852,1,2.350602984,1.312942212,1.790332402,0.07340049,0.156163052,0.656026691,0,2.694416495,1.216923903,2.214120774,0.026820472,0.06900792,N,-,,C6 zinc finger domain,"P:biological_process; C:nucleus; F:zinc ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; C:cellular_component; F:molecular_function; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PTHR36206:SF1 (PANTHER); PTHR36206 (PANTHER),,
RL4_JR_03678,154321,65335,38675,10,18,15,0,4,6,0,12,15,8,4,0,0,23,2,0.258131396,1,3.851329653,2.673764627,1.440414618,0.14975013,NA,0.082334773,1,7.067641269,2.187900662,3.230330057,0.001236474,0.015023052,0.214023558,1,4.411888427,1.358561556,3.247470391,0.001164358,0.006516284,0.246910029,1,3.990351255,1.705530483,2.339654022,0.019301611,0.075572463,0.211733392,1,4.325210054,1.269333407,3.407465707,0.000655691,0.003397582,N,-,,aldo-keto reductase (AKR13),F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process,IPR020471 (PRINTS); IPR023210 (G3DSA:3.20.20.GENE3D); IPR023210 (PFAM); PTHR11732:SF245 (PANTHER); IPR001395 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.6, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_03679,1900,546,506,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0.509004199,1,2.872055663,2.088523146,1.375161041,0.169081524,NA,0.160281598,0,6.106753917,1.975265803,3.091611218,0.001990734,0.015023052,0.418560642,0,3.445721392,1.359848172,2.53390155,0.011280042,0.035707308,0.483115989,0,3.022512269,1.537907697,1.965340492,0.049374842,0.121902042,0.414551985,0,3.35768286,1.309657798,2.563786407,0.010353724,0.03229558,N,-,,---NA---,,no IPS match,,
RL4_JR_03680,8538,2429,2430,0,0,0,0,0,2,0,10,0,0,0,0,0,0,2,62.605056,0,-0.768621288,0.865194877,-0.88837938,0.374336713,0.56638423,10.41443884,1,0.085014357,1.235086762,0.068832701,0.945122789,0.97033501,26.92204687,1,-2.561754466,1.202835486,-2.12976296,0.033191188,0.083072333,31.04897971,0,-2.983683455,1.202960528,-2.480283754,0.013127787,0.06019875,26.46800407,1,-2.640003857,1.20389318,-2.192888788,0.028315393,0.07197925,N,-,,HC-toxin efflux carrier TOXA,C:membrane,IPR007219 (SMART); IPR001138 (SMART); IPR001138 (PFAM); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); IPR007219 (PFAM); G3DSA:1.20.1250.20 (GENE3D); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31944:SF64 (PANTHER); PTHR31944 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_03681,8637,3470,3876,2,2,7,0,0,0,0,3,0,0,0,0,0,1,2,50.27759867,1,-2.69314494,1.149462849,-2.342959533,0.019131458,0.063136907,14.91122512,0,-0.432802446,1.219821205,-0.354808101,0.722733359,0.826338946,60.71230896,1,-1.246458619,1.038638932,-1.200088481,0.230104979,0.361231633,44.48736938,0,-3.502527854,1.1985612,-2.922277023,0.003474823,0.020942015,37.94338786,1,-3.159590887,1.199037763,-2.635105401,0.008411116,0.027348282,N,-,,C6 zinc finger domain containing,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_03682,3102,2031,2015,0,0,0,0,0,1,0,0,0,0,1,1,1,2,2,0.106442605,0,5.129173146,3.916776945,1.309539251,0.190351751,NA,0.033890298,1,8.347806546,2.656742808,3.14212069,0.001677289,0.015023052,0.088346668,0,5.687130926,1.569122031,3.624403211,0.000289629,0.002267697,0.101931244,1,5.266452832,2.387926544,2.205450099,0.027422526,0.088070176,0.08778488,1,5.594459628,1.351823081,4.138455473,3.50E-05,0.000285752,,,,,,,,
RL4_JR_03683,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.244425958,0,-0.745056567,1.333203493,-0.558846846,0.576266248,0.751107214,1.973399656,0,2.484693283,1.440395499,1.725007669,0.084526091,0.177541624,5.169711374,0,-0.181310414,1.292801668,-0.140246117,0.888465536,0.930659605,5.966478151,0,-0.604245274,1.306956983,-0.462329887,0.643844771,0.755881395,5.162256358,0,-0.281809013,1.311634924,-0.21485324,0.829881743,0.885461702,N,-,,short-chain dehydrogenase reductase family,,IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24320 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_03684,35286,16629,17029,6,9,10,1,0,2,2,3,15,11,20,12,0,3,6,17.32145861,1,3.510783786,0.857018672,4.096507931,4.19E-05,0.000401608,0.644531182,1,4.098975542,1.534049683,2.671996603,0.007540141,0.027424114,1.688745688,1,1.432573148,1.267191681,1.130510222,0.258261294,0.394602677,1.949281084,1,1.009548542,1.295286723,0.779401598,0.435743183,0.577700632,5.54356246,1,2.260735953,1.189268728,1.900946271,0.05730905,0.124078014,N,-,,A G-specific adenine glycosylase,"P:DNA repair; F:DNA binding; P:base-excision repair; F:catalytic activity; F:4 iron, 4 sulfur cluster binding; F:hydrolase activity",IPR003651 (SMART); IPR003265 (SMART); IPR000445 (PFAM); IPR011257 (G3DSA:1.10.340.GENE3D); IPR023170 (G3DSA:1.10.1670.GENE3D); IPR003265 (PFAM); IPR029119 (PFAM); IPR015797 (G3DSA:3.90.79.GENE3D); PTHR10359:SF1 (PANTHER); PTHR10359 (PANTHER); PTHR10359:SF1 (PANTHER); PTHR10359 (PANTHER); PTHR10359:SF1 (PANTHER); IPR011257 (SUPERFAMILY); IPR015797 (SUPERFAMILY),,
RL4_JR_03685,321,114,164,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,153.0060079,0,0.415506595,0.449442969,0.92449237,0.355230022,0.546167833,46.37865348,0,1.460957056,0.851713556,1.715315021,0.086287486,0.180604205,178.9272648,0,1.452859996,0.388634491,3.738371218,0.000185216,0.001681223,196.9192363,0,1.203393038,0.360773153,3.335594756,0.000851171,0.006484658,61.94160881,0,-0.834708261,0.737144015,-1.132354389,0.257485472,0.389106465,N,-,,endothelin-converting enzyme,P:mycelium development; C:membrane; F:metallopeptidase activity,IPR018497 (PRINTS); IPR008753 (PFAM); IPR018497 (PFAM); IPR024079 (G3DSA:3.40.390.GENE3D); PTHR11733:SF65 (PANTHER); PTHR11733:SF65 (PANTHER); IPR000718 (PANTHER); IPR000718 (PANTHER); SSF55486 (SUPERFAMILY),,
RL4_JR_03686,80,80,116,0,0,2,0,0,0,0,0,0,0,5,0,0,0,0,0.36394111,1,3.355677355,2.344654118,1.431203575,0.152371879,NA,0.116384253,0,6.568330596,2.077903154,3.161037887,0.00157208,0.015023052,0.302286199,0,3.913808704,1.361315,2.875020626,0.004040011,0.016505679,0.348700577,1,3.492264349,1.6065068,2.173824817,0.029718294,0.09171759,0.29904274,0,3.826918207,1.291970534,2.962078551,0.003055698,0.012011124,N,-,,hypothetical protein FLAG1_10981,,no IPS match,,
RL4_JR_03687,28978,14721,23581,0,3,15,0,0,0,2,11,4,2,11,4,2,15,1,26.82859325,1,0.201872971,1.00202982,0.201464035,0.840335749,0.919624667,3.460656737,0,1.674502354,1.264379853,1.324366527,0.185381346,0.325204503,8.958569576,1,-0.974263672,1.192527934,-0.81697346,0.413943595,0.556020542,27.99176545,1,0.917301787,0.847050563,1.082936282,0.278836706,0.422321863,8.812285932,1,-1.053349254,1.190979087,-0.884439757,0.37645887,0.512524681,N,-,,methyltransferase,F:transferase activity,PTHR34598:SF3 (PANTHER); PTHR34598 (PANTHER),,
RL4_JR_03688,6528,5176,5253,0,0,6,0,0,0,0,7,5,0,7,0,0,4,0,0.381012682,1,3.289593187,2.26822158,1.450296222,0.146975932,NA,0.122585549,0,6.49364004,2.041169889,3.181332468,0.001465993,0.015023052,0.316891658,1,3.846284427,1.334682194,2.881797962,0.003954132,0.016305678,0.365453056,1,3.424777753,1.555388008,2.201880004,0.027673786,0.088418139,0.311773455,1,3.766357799,1.266401238,2.974063579,0.002938842,0.011627891,N,-,,hypothetical protein CMQ_1837,,no IPS match,,
RL4_JR_03689,2773,2605,2265,0,0,0,0,0,0,0,0,0,0,3,0,0,0,2,0.028000956,0,7.055878882,3.944693089,1.788701611,0.073662883,NA,0.009357704,0,10.20743274,3.943110964,2.588674991,0.009634598,0.032802355,0.023558395,0,7.598623139,2.645711945,2.872052323,0.004078154,0.016563847,0.027124543,1,7.177671765,3.944187486,1.819809984,0.068787947,0.148883703,0.022503881,1,7.551623722,1.62772123,4.639383934,3.49E-06,4.20E-05,N,-, Effector probability:0.583,hypothetical protein SPI_06561,,no IPS match,,
RL4_JR_03690,1413,770,1269,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,60.40098498,0,2.651098252,0.519954672,5.098710322,3.42E-07,5.92E-06,3.06886311,0,1.847746497,1.279236791,1.444413192,0.148622782,0.274768913,19.05216026,0,0.153768003,1.199569974,0.128185938,0.898001828,0.93657881,73.43218378,0,2.685463938,0.53839602,4.987897085,6.10E-07,1.17E-05,31.05975707,0,2.259766375,0.669505265,3.375277977,0.000737412,0.00374438,Y,-,,"hypothetical beta-1,6-N-acetylglucosaminyltransferase","F:transferase activity, transferring glycosyl groups; C:membrane; C:integral component of membrane; F:transferase activity",no IPS match,,
RL4_JR_03691,556,299,514,0,0,0,0,0,0,0,0,0,2,0,0,0,3,1,43.30552556,0,0.368636997,0.91186838,0.404265578,0.686017435,0.828896683,33.06051682,0,3.295378352,0.954384446,3.452883548,0.000554628,0.015023052,44.00521057,0,1.355365656,0.815656427,1.661686969,0.096575555,0.189006558,27.88722342,1,-0.154641189,1.069322312,-0.144616069,0.885014009,0.929358142,20.03392223,1,0.113951341,1.03114771,0.110509231,0.912005529,0.943388651,N,-,,hypothetical protein F503_07155,,no IPS match,,
RL4_JR_03692,519,339,475,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,9.407728053,0,-1.336239405,1.191041527,-1.121908325,0.261901421,0.441262245,3.018386505,0,1.871783252,1.281225156,1.460932329,0.144034013,0.26824513,7.804025306,0,-0.775201386,1.197568426,-0.647312812,0.517429511,0.648003014,28.271397,1,0.546195356,1.014520705,0.538377732,0.590316296,0.714348333,7.667659274,0,-0.852667541,1.194543263,-0.713802143,0.475349534,0.605397992,N,-,,POZ- AT hook- and zinc finger-containing 1,"C:nucleus; F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PTHR24335:SF3 (PANTHER); PTHR24335 (PANTHER),,
RL4_JR_03693,66,208,120,0,0,0,0,0,0,0,0,2,0,3,0,0,0,0,3.654294983,0,0.027991503,1.282639063,0.021823367,0.982588855,0.991333724,23.49767224,0,4.156744199,1.169066423,3.555609945,0.000377103,0.014296025,38.18217779,1,3.415304934,0.797415839,4.282966009,1.84E-05,0.000316987,3.510028723,1,0.161390222,1.265009327,0.127580263,0.898481152,0.937461012,2.971652155,0,0.514705258,1.244028628,0.413740686,0.679064027,0.771923574,N,-,,FAD-dependent oxidoreductase,"F:oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor",IPR010031 (PIRSF); IPR006094 (PFAM); IPR016167 (G3DSA:3.30.43.GENE3D); IPR007173 (PFAM); IPR016169 (G3DSA:3.30.465.GENE3D); PTHR13878 (PANTHER); PTHR13878:SF63 (PANTHER); PTHR13878:SF63 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY),,
RL4_JR_03694,105,214,115,0,0,6,0,0,0,0,11,41,0,0,0,0,2,0,2.710907189,1,0.45885062,1.242386795,0.369329924,0.711881824,0.844759376,0.861859279,0,3.679932547,1.424663091,2.583019502,0.009793979,0.033177594,2.241710921,1,1.024153208,1.214666335,0.843156,0.399141203,0.541337072,2.586480457,0,0.601642486,1.221345038,0.492606485,0.622290665,0.739691592,6.076527622,1,1.867597541,1.137661195,1.64161136,0.100670572,0.192042688,N,-,,kinase,F:kinase activity,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24055:SF210 (PANTHER); PTHR24055:SF210 (PANTHER); PTHR24055 (PANTHER); PTHR24055 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_03695,468,965,653,0,0,1,0,0,0,0,6,0,2,0,0,0,0,0,1.941673518,1,0.940663467,1.449095364,0.649138415,0.516248914,NA,0.617474202,0,4.161193635,1.609249347,2.585797933,0.009715387,0.032988643,1.599340141,1,1.511958265,1.304657417,1.158892936,0.246499829,0.380653487,1.845217812,1,1.089364758,1.345235217,0.809795005,0.418058004,0.561309812,1.56847948,0,1.437167185,1.29257961,1.111859705,0.266198476,0.398500234,N,-,,membrane transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23511 (PANTHER); PTHR23511:SF4 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.19.48, the major facilitator superfamily (mfs).
RL4_JR_03696,45,36,68,0,0,3,0,0,0,0,0,0,0,0,1,0,0,0,7.47910413,1,-1.00498015,1.228283939,-0.81819856,0.413243817,0.604382047,2.380275388,0,2.214433328,1.322697247,1.674180038,0.094095221,0.193151862,6.174534457,0,-0.437188741,1.219049701,-0.358630777,0.71987132,0.810556225,7.123705139,1,-0.859655282,1.220251446,-0.704490279,0.481127502,0.621511805,6.075974828,0,-0.516774826,1.220329522,-0.423471543,0.671951256,0.766394835,N,-,,monocarboxylate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11360 (PANTHER); PTHR11360:SF97 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.13.19, the major facilitator superfamily (mfs).
RL4_JR_03697,601,503,628,0,0,0,0,0,0,4,0,0,2,0,0,0,3,0,96.70538032,0,5.06229559,0.715747241,7.072742029,1.52E-12,7.29E-11,38.45807243,0,6.062462158,0.882607587,6.868808117,6.47E-12,1.56E-09,24.64024201,1,3.293428647,0.927664315,3.550237511,0.000384884,0.002811373,46.96123883,1,4.161029021,1.35497284,3.070931681,0.00213392,0.013921351,14.00275946,1,2.959575192,0.961849066,3.076964253,0.002091204,0.008792956,N,-,,quinate permease,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR003663 (PRINTS); IPR005828 (PFAM); IPR003663 (TIGRFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF35 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.7, the major facilitator superfamily (mfs).
RL4_JR_03698,458,672,743,0,2,6,0,0,5,2,10,31,4,1,1,0,11,0,36.99904977,1,4.333671112,0.555565985,7.800461568,6.17E-15,3.99E-13,45.46173544,1,5.389115801,0.982162737,5.486988661,4.09E-08,5.37E-06,359.0622236,1,7.433860806,0.38209286,19.45563917,2.61E-84,4.41E-81,291.7708262,1,6.919645558,0.318560331,21.72161719,1.28E-104,3.24E-101,100.9688058,1,5.688834494,0.412666002,13.78556621,3.11E-43,3.94E-40,N,-,,Nadp-dependent alcohol dehydrogenase,C:membrane,PTHR37019 (PANTHER); PTHR37019:SF4 (PANTHER),,
RL4_JR_03699,402,282,506,0,0,2,0,0,0,3,0,1,0,1,0,0,0,0,0.063632212,1,5.871484231,3.923499215,1.496491756,0.134525555,NA,0.020208887,0,9.09376304,2.86739618,3.171435849,0.001516874,0.015023052,0.052663808,1,6.434100201,1.61681847,3.979482125,6.91E-05,0.000910129,0.060766778,1,6.012947256,2.8019383,2.145995597,0.03187333,0.095422077,0.052217284,0,6.34554593,1.331241818,4.766636567,1.87E-06,2.45E-05,N,-,,major facilitator superfamily transporter,C:membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF262 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_03700,352,185,216,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.987806982,0,1.91562036,1.8028269,1.062564775,0.287979368,NA,0.311358364,0,5.148942484,1.856936449,2.77281567,0.005557359,0.022016277,8.653638895,0,3.454390809,1.307308063,2.642369391,0.008232821,0.027988023,0.93564762,0,2.069082884,1.509476875,1.370728441,0.170459625,0.292774166,0.798811978,0,2.41083054,1.370746901,1.758771468,0.078616333,0.159166241,N,-,,Maleamate amidohydrolase,P:metabolic process; F:hydrolase activity,IPR000868 (G3DSA:3.40.50.GENE3D); IPR000868 (PFAM); PTHR11080 (PANTHER); PTHR11080:SF38 (PANTHER); IPR000868 (SUPERFAMILY),,
RL4_JR_03701,122,247,146,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,16.53816856,1,1.833201326,0.893109267,2.052605873,0.040110818,0.112835879,1.627999556,0,2.762518962,1.364286282,2.024882166,0.042879465,0.104534188,4.206109517,0,0.116782032,1.22104967,0.095640689,0.923805948,0.955110748,24.12195704,0,1.450989285,1.034394777,1.402742277,0.160693705,0.279990323,4.122665252,0,0.04272795,1.215101224,0.035164107,0.971948883,0.980861401,N,-,,n-carbamoylsarcosine amidase,F:metal ion binding; P:metabolic process,IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); PTHR31313 (PANTHER); PTHR31313:SF31 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_03702,749,820,1393,0,4,13,0,0,4,1,0,1,0,3,1,0,2,7,1.441295862,1,1.370505358,1.371750658,0.999092181,0.317750038,NA,0.46242346,1,4.578384135,1.591268527,2.877191408,0.004012321,0.018157671,1.193743919,1,1.934075055,1.246016444,1.552206686,0.120612777,0.222699721,1.376790886,1,1.511891319,1.27690161,1.18403118,0.236400721,0.374051773,8.890422889,1,3.522837222,0.997314763,3.532322344,0.000411927,0.002301744,N,-,,major facilitator superfamily,C:membrane,IPR001958 (PRINTS); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502:SF17 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.36, the major facilitator superfamily (mfs).
RL4_JR_03703,626,549,590,0,0,1,0,0,0,0,0,2,0,2,0,0,3,0,9.757225359,1,0.271312917,1.206999728,0.224782915,0.822148158,0.909928731,1.885526883,0,2.550595666,1.379070803,1.849503057,0.064385207,0.143864694,4.894954555,1,-0.102141879,1.244411805,-0.082080448,0.934582741,0.960970512,5.647941213,1,-0.524749249,1.250386957,-0.419669484,0.674726921,0.778389861,12.18267426,1,0.761394619,1.16917236,0.651225298,0.514901062,0.640857192,N,-,,2og-Fe oxygenase family,F:dioxygenase activity; F:iron ion binding; P:oxidation-reduction process,PR00682 (PRINTS); IPR005123 (PFAM); IPR026992 (PFAM); IPR027443 (G3DSA:2.60.120.GENE3D); PTHR10209:SF146 (PANTHER); PTHR10209 (PANTHER); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_03704,187,187,275,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,21.94399958,0,3.368202022,0.747117701,4.508261573,6.54E-06,8.01E-05,0.910254402,0,3.601278367,1.455862159,2.473639654,0.013374452,0.042003166,2.355825617,0,0.953136898,1.238076098,0.769853242,0.441386953,0.5813896,2.71760991,1,0.530796861,1.25011909,0.424597037,0.671130454,0.776319924,2.31225806,0,0.877144467,1.229489657,0.713421591,0.475584917,0.605545433,N,-,,mfs general substrate transporter,P:transmembrane transport; F:transmembrane transporter activity; F:iron ion binding; F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process; P:anion transport,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF258 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_03705,462,429,394,0,0,1,0,0,0,0,0,3,0,0,0,0,0,0,21.09446115,1,3.863507478,0.77163647,5.006901084,5.53E-07,9.10E-06,0.640868795,0,4.107570276,1.541612541,2.664463455,0.007711124,0.027875715,1.655045648,1,1.462641858,1.257485493,1.163148097,0.244769421,0.378910362,1.908976674,0,1.040410475,1.282238461,0.811401706,0.41713502,0.560915594,1.62040144,0,1.390092508,1.241926335,1.119303512,0.263010678,0.395101352,N,-,,2og-fe oxygenase superfamily,F:iron ion binding; F:oxidoreductase activity; P:oxidation-reduction process,PR00682 (PRINTS); IPR026992 (PFAM); IPR005123 (PFAM); IPR027443 (G3DSA:2.60.120.GENE3D); PTHR10209:SF146 (PANTHER); PTHR10209 (PANTHER); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_03706,1498,4172,2590,15,10,24,0,0,2,6,27,32,0,7,2,0,18,16,1.419493902,1,1.392146642,1.347551775,1.033093249,0.301560262,NA,0.452174243,1,4.610483296,1.571072168,2.934609491,0.003339677,0.016393895,1.175334211,1,1.955440986,1.233242624,1.58560931,0.112827963,0.211798627,1.355995484,1,1.53315035,1.260359301,1.216439113,0.223817692,0.359193871,1.161729951,1,1.8699212,1.222607768,1.529453067,0.126152166,0.227235488,N,-,,hypothetical protein IQ07DRAFT_592123,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_03707,90,111,140,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0.714590108,0,2.382297821,1.724376731,1.381541387,0.167112562,NA,0.227626284,0,5.600600246,1.8007017,3.11023211,0.001869404,0.015023052,0.59225998,0,2.943788433,1.285050522,2.290795873,0.021975222,0.059918436,0.683303959,0,2.521751033,1.379698818,1.827754724,0.067586371,0.147505774,0.586524808,1,2.855682239,1.255734974,2.274112212,0.022959241,0.060829057,N,-,,mei5,,no IPS match,,
RL4_JR_03708,788,846,1169,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.03109235,0,6.903208781,3.940901152,1.751682804,0.079828365,NA,0.009674842,0,10.15397018,3.941794771,2.575976368,0.009995748,0.033549109,56.04824633,0,11.13864894,1.520228568,7.326956734,2.35E-13,2.04E-11,17.68813092,0,9.315260687,1.042805561,8.932883597,4.15E-19,3.65E-17,23.18928711,0,9.986869047,2.313033988,4.31764907,1.58E-05,0.000147298,Y,-,,glycoside hydrolase family 39,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR013781 (G3DSA:3.20.20.GENE3D); IPR017853 (SUPERFAMILY),,
RL4_JR_03709,272,150,208,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.024701871,0,7.238701169,3.949789044,1.832680452,0.066850106,NA,0.007694775,0,10.48756637,3.950855392,2.654505246,0.00794248,0.02841517,0.020152476,0,7.824018738,2.683596837,2.915497078,0.003551224,0.015351236,0.023270171,0,7.399037905,3.950359032,1.873003908,0.061067845,0.137947378,0.019940236,0,7.746134954,1.600920209,4.838551548,1.31E-06,1.80E-05,Y,-,,ankyrin unc44,F:catalytic activity; P:nucleoside metabolic process,IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PF13637 (PFAM); IPR020683 (PFAM); PTHR24123 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_03710,105,112,108,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0.008141456,0,8.841220392,4.035983802,2.190598582,0.028480854,NA,0.002675567,0,12.01934062,4.032893235,2.980327006,0.002879408,0.015349618,0.006783092,0,9.399044527,3.291065204,2.855927776,0.004291127,0.016940088,0.007815077,1,8.97609272,4.035428601,2.224322026,0.026126786,0.086108719,0.006504647,0,9.346543544,1.704039324,5.484934187,4.14E-08,1.17E-06,N,-,,AAA- core,F:ATP binding,IPR003593 (SMART); G3DSA:1.10.8.60 (GENE3D); IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23074:SF88 (PANTHER); PTHR23074 (PANTHER); IPR027417 (SUPERFAMILY),9.B.307.1.2, the ftsh aaa(+) zinc metaloprotease (ftsh) family.
RL4_JR_03711,9,28,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.008470882,0,8.791019641,4.031633903,2.180510397,0.029219649,NA,0.002680088,0,12.01721297,4.032710343,2.979934573,0.0028831,0.015349618,0.006904709,0,9.374372631,4.033343739,2.324218623,0.02011378,0.055743746,9.643251784,0,10.04300316,3.543455384,2.834240049,0.004593481,0.026231809,0.006679571,0,9.335361424,1.822923296,5.121093929,3.04E-07,5.22E-06,N,-,,TAM domain methyltransferase,F:methyltransferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_03712,1,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.662190745,0,2.492156088,1.804022056,1.381444356,0.167142376,NA,0.210410102,0,5.71399606,1.838284905,3.108329969,0.001881479,0.015023052,0.548511517,0,3.054360118,1.301930652,2.346023665,0.018974903,0.053738157,0.632897791,0,2.632247722,1.413291147,1.862495018,0.062533347,0.14001551,0.544381299,0,2.963338671,1.270679063,2.332090579,0.019695927,0.053999799,N,-,,kinase-like domain,F:ATP binding; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_03713,20,17,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.646379961,0,2.526968691,1.979245409,1.276733385,0.201696391,NA,0.209704716,0,5.719088265,1.958492348,2.920148384,0.003498648,0.016823426,0.540000825,0,3.077507124,1.398593935,2.200429335,0.027776448,0.072123304,0.622545394,0,2.656288334,1.55388498,1.709449778,0.087367667,0.176938641,0.529924084,0,3.001533009,1.35070956,2.222189802,0.026270481,0.067993002,N,-,,spherulin 4-like cell surface,,IPR021986 (PFAM); PTHR35040 (PANTHER); PTHR35040:SF2 (PANTHER),,
RL4_JR_03714,25,26,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.390449132,0,3.254542161,2.236169806,1.455409223,0.145556005,NA,0.125675647,0,6.458033484,2.026612419,3.186614975,0.001439483,0.015023052,0.323760354,0,3.817087831,1.323668629,2.883718588,0.003930098,0.016228563,0.373354972,0,3.394597099,1.533649729,2.213410946,0.026869327,0.087153604,0.316480234,0,3.745960511,1.251466418,2.993256916,0.002760173,0.011094383,N,-,,related to ariadne-2,F:binding,IPR018957 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR002867 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR22770:SF34 (PANTHER); PTHR22770 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); SSF57850 (SUPERFAMILY); IPR012677 (SUPERFAMILY),,
RL4_JR_03715,83,3839,522,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0.024398406,1,7.255705004,3.950296292,1.836749567,0.066246874,NA,0.007858478,0,10.45906412,3.503672134,2.985172048,0.002834189,0.015349618,6.518923071,0,8.800064975,1.355094697,6.494059045,8.36E-11,4.89E-09,0.023281625,0,7.398324204,3.950337591,1.872833406,0.061091393,0.137947378,0.019639628,0,7.759148925,1.450103779,5.350754226,8.76E-08,2.01E-06,N,-,,methyltransferase type 11,P:metabolic process; F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108 (PANTHER); PTHR10108:SF818 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_03716,5527,5155,6938,0,0,5,0,0,0,3,2,0,0,2,0,0,0,0,74.67803022,1,5.277793771,1.086279261,4.858597565,1.18E-06,1.75E-05,156.8560602,0,7.857117955,1.687522346,4.656008244,3.22E-06,0.000251025,1.750085382,1,1.381826728,1.27766022,1.081529116,0.279461816,0.418671507,6.03114368,1,1.901919182,1.213811132,1.566898781,0.117138353,0.220123575,17.16784677,0,3.842867181,0.868844945,4.422960854,9.74E-06,9.83E-05,N,-,,hypothetical protein GLRG_01903,,no IPS match,,
RL4_JR_03717,375,325,283,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,71.58798679,0,4.772122447,1.124977066,4.241973095,2.22E-05,0.000228699,0.896359634,0,3.623315281,1.551708277,2.335049271,0.019540847,0.056431513,2.344435604,0,0.959796667,1.310162377,0.732578407,0.463815605,0.601133923,12.34159752,0,1.497161076,1.238872928,1.208486393,0.226860227,0.362582446,2.325313786,0,0.869004103,1.314869283,0.660905319,0.508673035,0.635594774,N,-, Effector probability:0.931,hypothetical protein VE04_00185,,no IPS match,,
RL4_JR_03718,57,101,72,0,0,79,0,0,0,0,2,0,7,11,0,0,9,1,0.328790228,1,3.502438402,2.380806382,1.471114337,0.141260198,NA,0.104929215,0,6.718064949,2.066812675,3.250446947,0.001152238,0.015023052,0.272067908,1,4.067172585,1.308198485,3.108987383,0.001877297,0.009436821,0.313859253,1,3.644691825,1.555175854,2.343588228,0.019099244,0.075140729,0.267935734,1,3.986773122,1.238942964,3.217882693,0.001291406,0.005905821,N,-,,mfs drug efflux,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501 (PANTHER); PTHR23501:SF12 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_03719,217726,185592,181333,0,4,7,0,0,0,2,3,0,4,32,12,2,4,4,0.548809156,1,2.763434528,1.939996427,1.424453412,0.154315262,NA,0.176332933,0,5.969410668,1.906797684,3.130594671,0.001744528,0.015023052,0.454536961,1,3.327590107,1.307301574,2.545388283,0.010915629,0.035104773,0.524200448,1,2.90510755,1.445492989,2.009769381,0.044455603,0.114387034,0.444364565,1,3.256671184,1.252286288,2.600580406,0.009306621,0.02965991,N,NRPS,,AMP-binding enzyme,F:catalytic activity,IPR020806 (SMART); G3DSA:3.30.300.30 (GENE3D); IPR000873 (PFAM); G3DSA:2.30.38.10 (GENE3D); G3DSA:3.40.50.980 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR009081 (PFAM); IPR001242 (PFAM); PTHR24095:SF181 (PANTHER); PTHR24095:SF181 (PANTHER); PTHR24095 (PANTHER); PTHR24095 (PANTHER); SSF52777 (SUPERFAMILY); SSF56801 (SUPERFAMILY); IPR009081 (SUPERFAMILY),4.C.1.1.7, the fatty acid transporter (fat) family.
RL4_JR_03720,72337,78431,89858,0,0,1,0,0,2,1,1,6,8,11,1,1,5,2,0.027290181,1,7.091350195,3.945632481,1.797265769,0.072293438,NA,0.009012214,1,10.25971965,3.9444458,2.601054791,0.009293761,0.031888626,0.022996744,1,7.629964171,2.64422221,2.885523063,0.003907638,0.016192218,0.026493032,1,7.210264675,3.945038372,1.827679225,0.067597708,0.147505774,0.022405406,1,7.555360148,1.62483867,4.649914042,3.32E-06,4.02E-05,N,-,,alpha beta hydrolase fold-3 domain containing,P:metabolic process; C:membrane; C:integral component of membrane; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR013094 (PFAM); PTHR23024 (PANTHER); PTHR23024:SF190 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_03721,54,62,60,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36.6846853,0,2.436519491,0.751376353,3.24274178,0.001183855,0.006749046,20.23623693,0,4.537343528,1.000359741,4.535711847,5.74E-06,0.000408435,3.845316214,0,0.245604114,1.209411427,0.203077389,0.839074545,0.896264053,26.10646756,0,2.543784149,0.754731783,3.370447897,0.000750461,0.005809188,3.801658423,0,0.15957403,1.213065253,0.131546122,0.895343303,0.93207392,N,-,,Fungal transcriptional regulatory,"F:DNA binding; C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_03722,391,268,588,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.216468301,0,4.105660368,3.140899911,1.307160522,0.1911582,NA,0.070240939,0,7.297812163,2.490631961,2.930104598,0.003388479,0.016488617,0.179419141,0,4.669352343,1.626058933,2.871576329,0.004084301,0.016566293,0.206825488,0,4.247019626,2.118445215,2.00478143,0.044986419,0.115138395,0.173313207,0,4.615047359,1.467935971,3.143902357,0.001667111,0.007275644,N,-,,AB hydrolase superfamily,"P:regulation of transcription, DNA-templated; C:intracellular part",PF13649 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR35897:SF1 (PANTHER); PTHR35897 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_03723,1632,1508,1900,3,1,0,0,0,0,0,0,1,2,2,3,0,0,0,9.243438987,1,2.549836307,1.194643153,2.134391597,0.032810739,0.097017038,0.399715765,0,4.788588273,1.672735579,2.862728774,0.004200099,0.018413607,1.027798722,1,2.149429553,1.283236266,1.675006864,0.093932885,0.184967367,1.184931233,1,1.727982281,1.334513938,1.29484019,0.195375365,0.325037063,1.005161131,0,2.078154586,1.257078032,1.653162758,0.098297744,0.18842572,N,-,,acyl- synthetase,F:catalytic activity; P:metabolic process,G3DSA:3.40.50.980 (GENE3D); IPR000873 (PFAM); IPR025110 (PFAM); G3DSA:2.30.38.10 (GENE3D); G3DSA:3.30.300.30 (GENE3D); G3DSA:3.40.50.980 (GENE3D); PTHR24095 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.4, the fatty acid transporter (fat) family.
RL4_JR_03724,3171,3327,2401,0,0,4,0,0,0,0,1,0,1,7,0,0,3,0,46.53847374,1,2.309325067,0.706639515,3.268038398,0.001082957,0.006295511,11.46815646,0,3.316644526,1.155906013,2.869302944,0.004113776,0.018371529,34.02498178,1,2.177035319,0.866126248,2.513531166,0.011952922,0.037120055,18.24603164,1,1.627449427,0.881590277,1.846038311,0.064886643,0.143538838,5.27320153,1,-0.312569391,1.207184785,-0.25892423,0.795693703,0.861646924,N,-,,2-isopropylmalate synthase,"P:carboxylic acid metabolic process; F:transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer",IPR013785 (G3DSA:3.20.20.GENE3D); IPR000891 (PFAM); PTHR10277:SF28 (PANTHER); PTHR10277 (PANTHER); PTHR10277:SF28 (PANTHER); PTHR10277 (PANTHER); IPR000891 (PROSITE_PROFILES); IPR013709 (SUPERFAMILY); SSF89000 (SUPERFAMILY); SSF51569 (SUPERFAMILY),,
RL4_JR_03725,1008,947,1191,0,0,2,0,0,0,0,0,0,2,2,7,0,1,0,67.70073988,1,3.845252036,0.578125984,6.651235444,2.91E-11,1.10E-09,1.411377433,0,2.968532291,1.405096714,2.112688942,0.0346274,0.088460201,3.629605787,0,0.329347122,1.234561561,0.266772539,0.789644299,0.860997187,4.184883336,1,-0.092229917,1.239989813,-0.074379576,0.940708359,0.965110157,3.545234951,1,0.260169751,1.225125126,0.212361779,0.831824802,0.886550118,N,NRPS,,HC-toxin synthetase,F:catalytic activity,IPR020806 (SMART); G3DSA:3.30.300.30 (GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); G3DSA:2.30.38.10 (GENE3D); IPR000873 (PFAM); G3DSA:3.40.50.980 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR001242 (PFAM); IPR010071 (TIGRFAM); IPR009081 (PFAM); PTHR24095:SF198 (PANTHER); PTHR24095 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR009081 (PROSITE_PROFILES); IPR009081 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF56801 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY); IPR009081 (SUPERFAMILY); SSF52777 (SUPERFAMILY),4.C.1.1.16, the fatty acid transporter (fat) family.
RL4_JR_03726,1479,1451,2323,0,0,2,0,0,0,1,0,1,0,2,2,0,2,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_03727,709,503,1326,0,2,0,0,0,0,0,0,0,0,1,0,0,0,0,0.003880053,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,0,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,ankyrin repeat,F:binding,PTHR35391 (PANTHER); PTHR35391:SF1 (PANTHER),,
RL4_JR_03728,1480,1238,1099,0,0,6,0,0,0,0,0,0,2,6,3,0,3,0,40.26145297,1,14.12414455,3.955391524,3.570858779,0.000355813,0.00250019,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,hypothetical protein AK830_g113,,PTHR35186:SF4 (PANTHER); PTHR35186 (PANTHER),,
RL4_JR_03729,6518,5051,3872,1,1,12,0,0,0,0,0,8,2,10,4,0,4,3,0.032513901,1,6.841150577,3.939469924,1.736566266,0.082463758,NA,0.010365821,0,10.05853554,3.291505598,3.055907164,0.002243807,0.015045494,0.026813951,1,7.413232561,1.896098142,3.909730408,9.24E-05,0.001112306,0.030933097,1,6.988069561,3.69388563,1.8917937,0.058518473,0.135014457,0.02626996,1,7.342077327,1.408084227,5.21423164,1.85E-07,3.78E-06,N,-,,methyltransferase type 12,F:methyltransferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); PTHR10108:SF905 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_03730,16201,19628,27381,14,21,24,0,0,6,11,18,21,7,24,5,0,31,10,1.378497559,1,1.434475568,1.509992135,0.949988768,0.34211796,NA,0.449703833,1,4.618654096,1.691616232,2.730320275,0.006327282,0.024095091,1.151037575,1,1.98621414,1.313596491,1.512042817,0.13052297,0.236662525,1.326641514,1,1.56511911,1.36998323,1.142436692,0.253272547,0.393129624,1.119987631,1,1.922209449,1.286776915,1.493817169,0.135223413,0.239610965,N,-,,aaa family atpase,F:nucleotide binding; F:ATP binding; F:hydrolase activity,IPR027417 (G3DSA:3.40.50.GENE3D); IPR003959 (PFAM); PTHR23077:SF85 (PANTHER); PTHR23077 (PANTHER); IPR027417 (SUPERFAMILY),1.A.37.8.4, the cd20 ca(2+) channel (cd20) family.
RL4_JR_03731,59,101,62,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.16198884,0,-0.89339473,1.148719034,-0.777731285,0.436727445,0.62673552,4.275831306,0,1.369310632,1.263396907,1.083832503,0.278439071,0.437429812,11.07278378,0,-1.280042945,1.201183637,-1.065651334,0.286581285,0.426042427,28.81799229,0,1.00250977,0.762799973,1.314249876,0.188762129,0.317319701,33.00132944,0,0.877276473,0.850795692,1.031124723,0.302482335,0.43789443,N,-,,cytochrome p450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24279 (PANTHER); PTHR24279:SF60 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_03732,406,481,476,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.551795429,0,1.263972683,1.359432915,0.929779373,0.352485328,NA,0.497040905,0,4.474223761,1.574418875,2.841825535,0.004485603,0.019181781,1.284186827,0,1.828707488,1.245720832,1.467991416,0.142106555,0.251826844,1.481202353,0,1.40644313,1.274030003,1.103932503,0.269622418,0.41088606,1.258732739,0,1.75447503,1.225845439,1.43123674,0.152362377,0.262046725,N,-,,"homogentisate 1,2-dioxygenase","P:L-phenylalanine catabolic process; P:tyrosine metabolic process; P:oxidation-reduction process; F:homogentisate 1,2-dioxygenase activity",IPR014710 (G3DSA:2.60.120.GENE3D); IPR005708 (PFAM); IPR005708 (PANTHER); IPR011051 (SUPERFAMILY),,
RL4_JR_03733,2,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.9193781,0,2.395106595,0.6498075,3.685870962,0.000227922,0.00172645,3.085764647,0,1.83996258,1.315579021,1.398595258,0.161934389,0.293324962,7.943324912,0,-0.80069415,1.218732391,-0.656989308,0.511187792,0.642730403,30.82892952,0,1.489438282,0.783866769,1.900116628,0.057417816,0.133552811,7.769911464,0,-0.871795405,1.214506716,-0.717818513,0.472869197,0.603681833,N,-,,NCS1 family nucleobase:cation symporter-1,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR001248 (PFAM); IPR026030 (PIRSF); PTHR31806 (PANTHER); PTHR31806:SF5 (PANTHER),2.A.39.2.4, the nucleobase:cation symporter-1 (ncs1) family.
RL4_JR_03734,1,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,514.2256758,0,0.653366856,0.949023173,0.688462489,0.491161584,0.679019861,86.98902443,0,-1.624590457,1.119447339,-1.451243306,0.146712122,0.272380796,432.7847581,0,0.704134463,0.575993641,1.222469162,0.221530259,0.35127774,496.9140372,0,0.701803867,0.363154915,1.932519257,0.053295448,0.127058254,247.0872928,0,-0.678404546,0.570824438,-1.188464439,0.234650482,0.363000173,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:cytoplasm; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23294:SF25 (PANTHER); PTHR23294 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.58.1, the major facilitator superfamily (mfs).
RL4_JR_03735,11,7,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.692877464,0,2.427118051,1.779528658,1.363910629,0.172595695,NA,0.219087374,0,5.655887419,1.823264064,3.102067074,0.001921744,0.015023052,0.570929865,0,2.99778531,1.297854476,2.309800803,0.020899185,0.057511103,0.658875721,0,2.574852526,1.403076279,1.835147927,0.066483774,0.146050817,0.564595533,0,2.911809824,1.264654153,2.302455431,0.021309502,0.057504986,,,,,,,,
RL4_JR_03736,10498,8563,8600,0,1,23,0,0,0,5,4,5,4,27,6,0,6,3,0.179762809,1,4.373749117,3.257376749,1.342721292,0.179362238,NA,0.056689132,0,7.606512494,2.470898911,3.078439372,0.002080879,0.015023052,0.147523164,1,4.951450756,1.551009054,3.192406094,0.001410928,0.007537856,0.170261274,1,4.527508879,2.09773116,2.158288424,0.030905414,0.094084527,0.145260922,1,4.872033674,1.395539209,3.491147825,0.00048095,0.002620893,N,-,,Heterokaryon incompatibility,P:biological_process; C:cellular_component; F:molecular_function,IPR010730 (PFAM); PTHR33112 (PANTHER); PTHR33112:SF6 (PANTHER),,
RL4_JR_03737,2252,2616,1871,0,0,4,0,2,0,0,2,1,1,4,0,0,2,2,363.7735473,1,1.918562662,0.443187245,4.329011457,1.50E-05,0.000164235,61.04362104,1,1.460026092,0.818786688,1.783158072,0.074560575,0.161364581,574.6744459,1,3.101753577,0.415439318,7.466201309,8.25E-14,7.40E-12,176.7812246,1,0.395992189,0.562812928,0.703594692,0.481685218,0.621995005,247.3644079,1,1.817844535,0.672687594,2.702360727,0.006884902,0.02329089,N,-,,acetyl- hydrolase,F:acetyl-CoA hydrolase activity; P:acetyl-CoA metabolic process; F:acetate CoA-transferase activity; F:biotin carboxylase activity,IPR026888 (PFAM); G3DSA:3.40.810.20 (GENE3D); G3DSA:3.40.1080.10 (GENE3D); IPR003702 (PFAM); IPR003702 (PANTHER); PTHR21432:SF10 (PANTHER); SSF100950 (SUPERFAMILY); SSF100950 (SUPERFAMILY),,
RL4_JR_03738,23,26,53,0,0,0,0,0,0,2,3,2,1,2,0,0,2,0,80.91988086,0,-0.451260432,0.69232911,-0.65180046,0.514529905,0.700055864,16.03614488,0,-0.53772575,1.25014938,-0.430129198,0.667101662,0.787452247,54.31973406,1,-1.368901464,1.070615245,-1.278611967,0.201033734,0.326475184,94.3513783,1,0.234297741,0.611247852,0.383310534,0.701489529,0.799480131,48.23015392,1,-1.59912524,1.015995899,-1.573948519,0.115499352,0.212856013,N,-,,Ras guanine-nucleotide exchange cdc25p,P:small GTPase mediated signal transduction; F:guanyl-nucleotide exchange factor activity; C:intracellular; P:positive regulation of GTPase activity,IPR000651 (SMART); IPR001895 (SMART); IPR001452 (SMART); G3DSA:1.20.870.10 (GENE3D); IPR000651 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR001895 (G3DSA:1.10.840.GENE3D); IPR001895 (PFAM); PTHR23113 (PANTHER); PTHR23113:SF208 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR001895 (PROSITE_PROFILES); IPR000651 (PROSITE_PROFILES); IPR023578 (SUPERFAMILY); IPR001452 (SUPERFAMILY),,
RL4_JR_03739,56,83,84,0,2,11,3,2,20,22,38,63,15,93,11,0,51,9,90.26884903,1,-0.315304102,0.603297415,-0.522634598,0.601228559,0.769625386,14.81518239,1,-0.423483409,1.201393276,-0.352493573,0.724468137,0.82745707,38.4230098,1,-3.074931876,1.185780948,-2.593170249,0.009509568,0.031426868,44.32436819,1,-3.497234043,1.184340018,-2.952896964,0.00314807,0.019328525,45.23357764,1,-2.223284519,1.117049252,-1.990319151,0.04655579,0.106046653,N,-,,PLC-like phosphodiesterase,P:lipid metabolic process; F:phosphoric diester hydrolase activity,IPR017946 (G3DSA:3.20.20.GENE3D); PTHR13593 (PANTHER); PTHR13593:SF42 (PANTHER); IPR017946 (SUPERFAMILY),,
RL4_JR_03740,1,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,126.3196197,0,-1.992005276,0.755408615,-2.636990414,0.00836452,0.032996978,31.55936367,0,-1.514483255,1.205557946,-1.256250901,0.209025017,0.35439719,81.76622707,0,-4.164461681,1.197302535,-3.478203344,0.000504787,0.003404705,136.2206751,0,-1.50793012,0.680113874,-2.217173001,0.026611272,0.086692126,80.56931886,0,-4.245953758,1.199868205,-3.538683449,0.000402128,0.00225196,N,-,,r3h domain,F:nucleotide binding; F:nucleic acid binding; P:cell cycle process,IPR000504 (SMART); IPR001374 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR001374 (G3DSA:3.30.1370.GENE3D); PTHR23003:SF13 (PANTHER); PTHR23003 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR001374 (PROSITE_PROFILES); IPR001374 (SUPERFAMILY); IPR012677 (SUPERFAMILY),,
RL4_JR_03741,2,5,3,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,28.91267899,0,-2.955862395,1.185422756,-2.493509071,0.012648735,0.045800436,9.244029694,0,0.257029153,1.217896928,0.211043437,0.832853377,0.89988705,86.99979185,0,1.589577974,0.512560425,3.101249914,0.001927056,0.009579507,114.1480506,1,1.409130867,0.477977237,2.948112916,0.003197203,0.019595446,23.547727,0,-2.471280407,1.187537097,-2.081013227,0.037432695,0.089363212,N,-,,3-oxoadipate enol-lactonase,F:hydrolase activity,IPR000073 (PRINTS); IPR029058 (G3DSA:3.40.50.GENE3D); IPR000073 (PFAM); PTHR10992 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_03742,7,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,102.0855052,0,-0.227767234,0.658980287,-0.345635883,0.729616375,0.857173155,20.29902735,0,-0.877838261,1.201862503,-0.730398243,0.465146792,0.624100719,151.9771358,0,0.772521856,0.492675008,1.568015107,0.116877607,0.217752832,68.94127702,0,-2.232874594,1.022862869,-2.182965733,0.029038334,0.090493422,56.02311699,0,-2.689075771,1.130086096,-2.379531773,0.017334649,0.048713105,N,-, Effector probability:0.594,histone h2a,"F:chromatin DNA binding; F:identical protein binding; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; C:Swr1 complex; P:histone exchange; P:DNA-templated transcription, termination; C:nucleosome; P:regulation of transcription from RNA polymerase II promoter; P:nuclear-transcribed mRNA catabolic process, non-stop decay; F:protein heterodimerization activity; C:mitochondrion; C:nuclear euchromatin; C:Ino80 complex; P:chromatin silencing at silent mating-type cassette",IPR002119 (PRINTS); IPR002119 (SMART); IPR032454 (PFAM); IPR007125 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); PTHR23430 (PANTHER); IPR009072 (SUPERFAMILY),,
RL4_JR_03743,296,222,301,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,170.5930547,0,-1.922556328,0.627743225,-3.062647676,0.002193882,0.011277687,44.30720295,0,-2.003970943,1.191324671,-1.682136694,0.092542336,0.190815549,115.2043995,0,-4.659076151,1.191175793,-3.911325413,9.18E-05,0.00110894,198.8960961,0,-0.900512017,0.472694317,-1.905062076,0.056772002,0.132507267,175.6086395,0,-0.468533963,0.762063271,-0.614822916,0.538671673,0.66101693,N,-,,striatin pro11,C:nucleus; P:nucleotide-excision repair; F:damaged DNA binding,IPR020472 (PRINTS); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); IPR013258 (PFAM); PTHR15653:SF0 (PANTHER); PTHR15653 (PANTHER); PTHR15653 (PANTHER); PTHR15653:SF0 (PANTHER); PTHR15653:SF0 (PANTHER); PTHR15653 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_03744,0,0,7,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,117.9950894,1,1.774768564,0.538462325,3.29599395,0.000980741,0.005831551,7.809676989,0,0.50019597,1.260106883,0.396947257,0.691406355,0.804600497,34.68165399,0,-0.338839925,1.064464601,-0.31831958,0.750242533,0.832887364,23.46785233,0,-2.579872414,1.223217656,-2.109086966,0.034937076,0.099498352,38.75871716,0,-0.016265362,0.894011476,-0.018193683,0.985484342,0.990240563,N,-,,DNA repair rad14,C:nucleus; P:nucleotide-excision repair; F:damaged DNA binding,IPR022656 (PFAM); IPR022656 (G3DSA:3.90.530.GENE3D); IPR000465 (TIGRFAM); PTHR10142 (PANTHER); PTHR10142 (PANTHER); IPR000465 (PTHR10142:PANTHER); IPR009061 (SUPERFAMILY),,
RL4_JR_03745,747,598,886,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,685.0105365,0,-2.673745254,0.756486871,-3.53442387,0.000408665,0.002830128,194.1180759,0,-4.135273259,1.230725173,-3.360029802,0.000779341,0.015023052,543.3351968,0,-3.632063923,0.731297314,-4.966603671,6.81E-07,1.94E-05,621.9256581,1,-3.528948787,0.639109768,-5.521663048,3.36E-08,8.44E-07,555.645376,0,-2.624072313,0.660782066,-3.971161516,7.15E-05,0.000527437,N,-, Effector probability:0.724,phosphate transporter,P:phosphate ion transport; C:integral component of membrane; P:protein maturation,IPR019263 (PFAM); IPR012098 (PIRSF); PTHR28112:SF1 (PANTHER); PTHR28112 (PANTHER),9.A.64.1.1, the srp-independent targeting (snd) family.
RL4_JR_03746,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.39308201,0,0.134993174,1.273144482,0.106031307,0.915557513,0.959301077,1.09892947,0,3.329528672,1.450553001,2.29535127,0.021713002,0.061545506,2.824848951,0,0.690913114,1.2455587,0.554701367,0.579098941,0.701142845,3.256787339,0,0.269433099,1.256108527,0.214498264,0.83015852,0.893806361,2.759841614,0,0.621367834,1.234936487,0.503157726,0.614853384,0.722119303,N,-,,hypothetical protein A1O3_03286,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR021858 (PFAM),,
RL4_JR_03747,33,21,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.505730173,0,-0.274143958,1.305017757,-0.21006914,0.833613711,0.91726742,1.468496935,0,2.911292386,1.462590479,1.990504128,0.04653543,0.111434024,3.759575294,0,0.278509784,1.273533186,0.218690638,0.826891043,0.888311218,4.333296138,0,-0.142581701,1.286132009,-0.11086086,0.911726683,0.946206129,3.65777141,0,0.215067571,1.266368624,0.169830148,0.865143716,0.910077049,N,-,,phytanoyl- dioxygenase family,F:dioxygenase activity; C:cytoplasm; P:oxidation-reduction process,IPR008775 (PFAM); G3DSA:2.60.120.620 (GENE3D); PTHR20883 (PANTHER); PTHR20883:SF0 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_03748,157,126,131,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.011718044,0,8.30924678,3.99658426,2.0790871,0.037609346,NA,0.004006569,0,11.4341231,3.991291091,2.864768027,0.004173148,0.018371529,0.009992212,0,8.834284459,3.994251091,2.211749902,0.02698395,0.070608817,0.011494389,0,8.415706565,3.9944702,2.106839241,0.035131517,0.099498352,0.009494587,0,8.783878684,1.912952289,4.591791826,4.39E-06,5.09E-05,N,-,,general amidase-B,"P:biological_process; C:cellular_component; F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (G3DSA:3.90.1300.GENE3D); IPR023631 (PFAM); PTHR11895:SF45 (PANTHER); PTHR11895:SF45 (PANTHER); IPR000120 (PANTHER); PTHR11895:SF45 (PANTHER); IPR000120 (PANTHER); IPR000120 (PANTHER); IPR023631 (SUPERFAMILY),,
RL4_JR_03749,262,282,331,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003906015,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,0,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,N,-,,---NA---,,no IPS match,,
RL4_JR_03750,1,19,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.01164016,0,8.317974459,3.997123045,2.080990344,0.03743479,NA,0.003501898,0,11.6103591,4.002138943,2.901038485,0.003719282,0.017380689,0.009514587,0,8.898423346,3.998182413,2.22561715,0.026039836,0.068649449,0.011003575,0,8.472850999,3.997973129,2.11928663,0.034066251,0.0989162,0.009871642,0,8.75387984,1.939189559,4.514195015,6.36E-06,6.91E-05,Y,-,,GPI anchored cell wall,,IPR018620 (PFAM); PTHR39613 (PANTHER),,
RL4_JR_03751,8,6,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,siderophore iron transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF3 (PANTHER); PTHR23501:SF3 (PANTHER); PTHR23501 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.16.8, the major facilitator superfamily (mfs).
RL4_JR_03752,42,18,45,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.85834142,0,3.592931833,1.028177993,3.494464829,0.000475013,0.003229298,0.327865203,0,5.074385006,1.667347382,3.043387995,0.002339305,0.015168767,0.850773704,0,2.422497705,1.248380938,1.940511611,0.052317544,0.117264803,58.79325048,0,5.805946182,1.677572471,3.460921232,0.00053833,0.004438595,0.837981195,0,2.341791974,1.225651228,1.910651187,0.056049422,0.122138108,N,-,,aminoglycoside phosphotransferase,F:transferase activity,IPR015897 (SMART); IPR004119 (PFAM); G3DSA:3.90.1200.10 (GENE3D); IPR012877 (PANTHER); IPR011009 (SUPERFAMILY),1.C.59.5.2, the clostridium perfringens enterotoxin (cpe) family
RL4_JR_03753,611,574,640,12,30,0,0,0,1,2,1,15,0,0,2,0,0,2,0.036038566,1,6.691887793,3.936267545,1.700059185,0.089119794,NA,0.011360376,1,9.924477985,3.208780189,3.092913008,0.001982022,0.015023052,0.029704654,1,7.260895838,1.826299019,3.975743163,7.02E-05,0.000916158,0.0342852,1,6.838770256,3.522579786,1.941409612,0.052208613,0.125807414,0.02951127,1,7.172883508,1.387887465,5.168202531,2.36E-07,4.41E-06,N,-,,heterokaryon incompatibility,F:ATP binding; F:protein kinase activity; P:protein phosphorylation,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); IPR010730 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24359:SF23 (PANTHER); PTHR24359 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_03754,372,313,452,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.269974426,0,3.786854344,2.632876229,1.438295619,0.150350195,NA,0.085564743,0,7.012342219,2.174001634,3.225545975,0.001257326,0.015023052,0.222622065,0,4.356797022,1.358716561,3.206553264,0.001343354,0.007261142,0.256889574,0,3.933757081,1.691989225,2.324930338,0.020075685,0.076878334,0.219785137,0,4.273825203,1.270089409,3.364979799,0.000765493,0.003856026,N,-,,kinase-like domain,P:biological_process; P:phosphorylation; C:cellular_component; F:kinase activity,G3DSA:3.90.1200.10 (GENE3D); IPR002575 (PFAM); PTHR21310 (PANTHER); PTHR21310:SF8 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_03755,7826,8978,11837,0,0,10,2,0,0,0,0,1,0,0,0,0,2,0,0.588620679,1,2.66226032,1.819939247,1.462829226,0.143514114,NA,0.187623041,1,5.879590737,1.839755168,3.195854992,0.001394172,0.015023052,0.487017969,1,3.226870608,1.264214022,2.552471774,0.010696158,0.034508572,0.561857243,0,2.804509638,1.370780279,2.045922079,0.040764038,0.108757934,0.48029237,1,3.144588536,1.22607637,2.564757476,0.010324794,0.032235135,N,-,,alcohol dehydrogenase,F:metal ion binding,IPR013154 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); IPR013149 (PFAM); IPR002085 (PANTHER); PTHR11695:SF585 (PANTHER); IPR002085 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_03756,21027,10888,21175,0,0,5,0,0,0,0,0,0,0,0,0,0,4,3,197.9325124,1,0.667892098,1.272898365,0.524701827,0.599790487,0.76883364,25.50203198,0,-1.206997947,1.201745819,-1.004370415,0.315200105,0.477201051,65.95658391,0,-3.854444605,1.189670731,-3.239925556,0.001195609,0.006658056,134.8145874,0,0.007078087,0.460158935,0.01538183,0.987727559,0.99282652,87.97227566,1,-0.738603679,0.615188353,-1.200613885,0.229901012,0.357564938,N,-,,amino acid permease,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PFAM); IPR002293 (PIRSF); IPR002293 (PANTHER); PTHR11785:SF406 (PANTHER); PTHR11785:SF406 (PANTHER); IPR002293 (PANTHER),2.A.3.4.7, the amino acid-polyamine-organocation (apc) family.
RL4_JR_03757,131,186,251,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.011692083,0,8.312151371,3.996763216,2.079720745,0.037551154,NA,0.003838345,0,11.49092626,3.994647088,2.876581086,0.004020089,0.018157671,0.009833003,0,8.854297471,3.046863773,2.906036545,0.003660387,0.015609839,0.011330785,0,8.434549956,3.995610333,2.110954085,0.034776259,0.099426657,0.009620272,0,8.767548331,1.615958211,5.425603379,5.78E-08,1.50E-06,N,-, Effector probability:0.814,---NA---,,no IPS match,,
RL4_JR_03758,74,79,79,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47.29139392,0,2.556230064,0.697420986,3.665261178,0.000247086,0.001845907,2.925577217,0,1.916891123,1.317784464,1.454631751,0.145771236,0.271031677,7.544160809,0,-0.726191998,1.219500463,-0.595483167,0.551520548,0.678856417,113.540823,0,3.517363633,0.489936039,7.179230256,7.01E-13,3.41E-11,53.70696734,0,3.217403178,0.634426475,5.071357053,3.95E-07,6.53E-06,N,-,,flavin-binding monooxygenase,"F:NADP binding; F:flavin adenine dinucleotide binding; C:integral component of membrane; P:oxidation-reduction process; F:N,N-dimethylaniline monooxygenase activity",PF13450 (PFAM); IPR025700 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR23023 (PANTHER); PTHR23023:SF93 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_03759,84,64,73,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.596730157,0,-1.027601069,1.243302521,-0.826509278,0.408515257,0.599940138,47.07679376,0,3.877921674,1.028370613,3.770937855,0.000162635,0.007316414,6.306714229,0,-0.467731839,1.235036171,-0.378719142,0.704896437,0.79954341,48.53248285,0,2.226797839,0.740619735,3.006668247,0.002641278,0.016724793,6.152647292,0,-0.535031733,1.229711135,-0.435087329,0.66349904,0.760376659,N,-,,nacht and tpr domain containing,,IPR011990 (G3DSA:1.25.40.GENE3D); PF13424 (PFAM); IPR031350 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_03760,34,10,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.071799629,0,5.697359258,3.921600215,1.452814909,0.146275151,NA,0.023052678,0,8.904539474,2.792824257,3.188363697,0.001430804,0.015023052,0.059606107,0,6.257104983,1.570338809,3.984557311,6.76E-05,0.00090065,0.068745459,0,5.835286923,2.661006641,2.19288702,0.02831552,0.089465864,0.058596247,0,6.177431932,1.31339725,4.703399472,2.56E-06,3.20E-05,N,-,,alpha beta-hydrolase,P:metabolic process; P:proteolysis; C:membrane; C:integral component of membrane; F:serine-type peptidase activity; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR029058 (G3DSA:3.40.50.GENE3D); IPR029058 (SUPERFAMILY),,
RL4_JR_03761,81,30,70,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.664622076,0,1.16227983,1.395118967,0.833104458,0.40478582,NA,0.52589136,0,4.392453417,1.573236335,2.791985742,0.005238566,0.021218395,1.375542985,0,1.728366511,1.267103864,1.364029075,0.172558415,0.291357804,1.587538463,0,1.305600668,1.301418413,1.003213613,0.315757806,0.46201629,1.369258604,0,1.632895305,1.26559858,1.290215816,0.196975736,0.318285881,N,-,,3-ketoacyl- thiolase,"F:transferase activity, transferring acyl groups other than amino-acyl groups; P:metabolic process",IPR002155 (PIRSF); IPR020616 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR020617 (PFAM); IPR002155 (TIGRFAM); IPR016039 (G3DSA:3.40.47.GENE3D); PTHR18919:SF97 (PANTHER); PTHR18919 (PANTHER); IPR016039 (SUPERFAMILY); IPR016039 (SUPERFAMILY),,
RL4_JR_03762,11,14,27,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0.192162417,0,4.277227407,3.079376026,1.388991592,0.164835307,NA,0.060308297,0,7.51651844,2.354389239,3.192555553,0.001410198,0.015023052,0.158159476,1,4.848560577,1.441637314,3.363231882,0.000770356,0.004670112,0.182581725,0,4.425923107,1.934923676,2.287388987,0.022173129,0.080442001,0.157602916,0,4.753718906,1.319246273,3.603359739,0.00031413,0.001814358,N,-,,domain-containing,"F:hydrogen ion transmembrane transporter activity; P:ATP hydrolysis coupled proton transport; F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:membrane; P:proteolysis; C:integral component of membrane; P:oxidation-reduction process; C:proton-transporting V-type ATPase, V0 domain; F:dipeptidyl-peptidase activity; F:heme binding; F:hydrolase activity",IPR018392 (G3DSA:3.10.350.GENE3D); IPR018392 (PFAM); PTHR21666:SF212 (PANTHER); PTHR21666 (PANTHER); IPR018392 (SUPERFAMILY),,
RL4_JR_03763,1293,743,1369,0,1,0,0,0,0,0,0,0,0,0,0,0,3,0,0.18814274,1,4.307707018,3.44805445,1.249315253,0.211549791,NA,0.062496433,0,7.466357303,2.669791419,2.796606975,0.005164231,0.021103088,0.157928874,0,4.852545181,1.767931039,2.744759312,0.006055529,0.021918548,0.181881663,0,4.432062223,2.343120049,1.891521617,0.058554748,0.135014457,0.151448817,1,4.807890495,1.579459722,3.04400956,0.002334477,0.009655466,Y,-,,glycoside hydrolase family 18,F:chitinase activity; P:carbohydrate metabolic process; F:chitin binding; P:chitin catabolic process,IPR001002 (SMART); IPR011583 (SMART); IPR001223 (PFAM); IPR029070 (G3DSA:3.10.50.GENE3D); IPR013781 (G3DSA:3.20.20.GENE3D); IPR001002 (G3DSA:3.30.60.GENE3D); IPR001002 (PFAM); PTHR11177 (PANTHER); PTHR11177:SF197 (PANTHER); IPR001002 (PRODOM); IPR001002 (PROSITE_PROFILES); IPR001002 (PROSITE_PROFILES); IPR029070 (SUPERFAMILY); IPR001002 (SUPERFAMILY); IPR017853 (SUPERFAMILY),9.B.29.2.7, the small 4-5 tms putative permease (4-5pp) family.
RL4_JR_03764,66,152,128,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.899888174,0,2.049828463,1.511567732,1.356094351,0.17506915,NA,0.28768771,0,5.262958493,1.696728371,3.101827365,0.001923301,0.015023052,0.745510848,0,2.612632263,1.241582371,2.104276224,0.035354359,0.086854533,0.859968556,0,2.190422721,1.294790815,1.691719385,0.090699491,0.181992141,0.734142061,0,2.532027971,1.215742928,2.082700145,0.037278564,0.089104217,N,-,,glycosyl hydrolase family 18,F:chitinase activity; P:carbohydrate metabolic process; F:chitin binding; P:chitin catabolic process; C:extracellular region,no IPS match,,
RL4_JR_03765,596,877,914,0,1,3,0,0,0,0,0,1,2,1,0,0,2,2,1.819155648,1,1.034441771,1.340071957,0.771930019,0.440155876,NA,0.575229418,0,4.263200485,1.529262004,2.787750218,0.005307545,0.02143356,1.500793419,1,1.603059522,1.244509769,1.288105213,0.197709341,0.322736112,1.731994109,1,1.180256633,1.268539467,0.930405923,0.352160953,0.498619725,1.48754011,1,1.513608401,1.240847856,1.21981788,0.222533922,0.349110049,N,-,,hypothetical protein PFICI_08017,F:nucleic acid binding,no IPS match,,
RL4_JR_03766,2017,2914,3077,0,0,0,0,0,0,0,0,0,1,3,0,0,0,0,1.22560972,0,1.604073544,1.376708775,1.165150955,0.243957894,NA,0.39190334,0,4.816938839,1.607860594,2.995868457,0.002736645,0.015349618,1.015847367,0,2.166064776,1.23249625,1.757461555,0.078839169,0.16088848,1.171804036,1,1.74392605,1.264594723,1.37903948,0.167882582,0.289045478,1.001006229,0,2.084576968,1.214829774,1.715941618,0.086172729,0.170877179,N,-,,alcohol dehydrogenase,F:oxidoreductase activity; F:metal ion binding; P:oxidation-reduction process,G3DSA:1.20.1090.10 (GENE3D); G3DSA:3.40.50.1970 (GENE3D); IPR001670 (PFAM); PTHR11496:SF70 (PANTHER); PTHR11496 (PANTHER); SSF56796 (SUPERFAMILY),,
RL4_JR_03767,29,9,38,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.097316121,0,5.258979772,3.917718241,1.342357834,0.17948,NA,0.031765838,0,8.443075814,2.817696757,2.996445871,0.002731467,0.015349618,0.080957067,0,5.818221539,1.721352081,3.380029922,0.000724779,0.004457878,0.09330156,0,5.395453905,2.609207693,2.067851447,0.038653994,0.104959993,0.078132217,0,5.763373325,1.434154912,4.018654663,5.85E-05,0.000442261,N,-, Effector probability:0.587,hypothetical protein TGAM01_00008,,IPR019405 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR30344 (PANTHER); PTHR30344:SF1 (PANTHER); IPR011045 (SUPERFAMILY),,
RL4_JR_03768,568,299,196,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,201.2710723,0,-0.017618023,0.4362176,-0.040388154,0.967783675,0.983700376,41.27512334,0,-0.612674372,1.114074339,-0.549940296,0.582360324,0.721058251,243.3121178,0,0.896217339,0.393376008,2.278271477,0.022710408,0.061492423,165.5785837,0,-0.076034051,0.573557327,-0.13256574,0.894536829,0.934983524,100.6335897,0,-2.047168054,0.857771297,-2.386612913,0.017004385,0.048050269,N,-,,zinc-binding dehydrogenase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR013154 (PFAM); PF13602 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); IPR002085 (PANTHER); PTHR11695:SF575 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_03769,4694,3715,3370,2,3,36,0,0,0,4,11,12,0,4,0,0,1,0,77.90246482,1,6.775910623,0.508530658,13.32448794,1.67E-40,2.27E-37,0.218456114,0,5.659997021,1.808091868,3.130370265,0.001745861,0.015023052,33.06071197,1,6.131020516,0.706181037,8.681938757,3.89E-18,5.18E-16,0.654124697,1,2.584800798,1.373792199,1.881507845,0.059902869,0.136572067,0.560074743,1,2.922069337,1.244957938,2.347122941,0.018919011,0.052308844,N,-,,NADH oxidase,P:mycelium development; F:catalytic activity,IPR013785 (G3DSA:3.20.20.GENE3D); IPR001155 (PFAM); PTHR22893:SF36 (PANTHER); PTHR22893 (PANTHER); SSF51395 (SUPERFAMILY),,
RL4_JR_03770,150,137,135,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.36342667,0,-1.608812901,1.202969747,-1.337367714,0.181102638,0.338348483,3.653008237,0,1.59645439,1.28381148,1.243527118,0.213673654,0.36036467,9.440070226,0,-1.049856932,1.207434547,-0.869493866,0.384577062,0.528356381,22.92173276,0,0.819073385,0.878513399,0.93234023,0.351160723,0.49776037,9.276928021,0,-1.127533758,1.207311859,-0.933920883,0.350344706,0.487528688,Y,-,,GPI anchored,F:lyase activity; C:periplasmic space,IPR008397 (PFAM); IPR008397 (G3DSA:1.50.10.GENE3D); IPR008929 (SUPERFAMILY),,
RL4_JR_03771,35,56,46,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.62727112,0,1.022802364,1.062252208,0.962862074,0.335616744,0.525722235,24.23055713,0,3.457831937,1.149310742,3.008613607,0.002624427,0.015349618,4.954807049,0,-0.119591377,1.22970621,-0.097251991,0.922526281,0.954602983,9.726514847,0,0.403293551,1.178271482,0.342275576,0.732143514,0.821133092,4.852081008,0,-0.192304262,1.225469427,-0.156922938,0.875305582,0.916680701,N,-,,D-isomer specific 2-hydroxyacid dehydrogenase,F:NAD binding; P:oxidation-reduction process,IPR006140 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10996:SF130 (PANTHER); PTHR10996 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_03772,4,12,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.138370716,0,4.751209233,3.755324818,1.265192617,0.205802289,NA,0.04313403,0,8.000317795,2.716312913,2.945285779,0.003226565,0.016175973,0.113205263,0,5.332491115,1.722589748,3.095624551,0.001963989,0.009681812,0.130717985,0,4.908478465,2.433036741,2.01742883,0.043650781,0.113446415,0.112513524,0,5.240544215,1.509427306,3.471875853,0.000516835,0.00278053,N,-,,2`-hydroxyisoflavone reductase,,IPR008030 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR14194:SF70 (PANTHER); PTHR14194 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_03773,207,22,12,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,23.9019993,0,5.176980003,0.658286522,7.864326298,3.71E-15,2.50E-13,0.314449972,0,5.134560333,1.675920839,3.063724857,0.002185999,0.015045494,0.818185614,0,2.47842112,1.249895732,1.982902299,0.047378344,0.108642889,4.955665614,0,3.001549151,1.168198645,2.569382497,0.010187994,0.049190956,0.808578764,1,2.393298176,1.230379322,1.945170999,0.051754401,0.115066603,N,-,,bZIP transcription factor domain-containing,"F:transcription factor activity, sequence-specific DNA binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",no IPS match,,
RL4_JR_03774,10857,53,357,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_03775,332,255,512,18,55,3,0,0,4,4,9,0,1,0,0,0,3,0,0.771013904,1,2.272896013,1.73948379,1.306649724,0.191331701,NA,0.250162615,1,5.464866322,1.827733966,2.989968138,0.002790065,0.015349618,0.641440785,1,2.830256004,1.318120157,2.147191201,0.031778063,0.080309813,0.73945441,1,2.408620179,1.41883642,1.697602448,0.089582821,0.180395,0.624275113,1,2.765483968,1.27201968,2.17408898,0.029698453,0.074559098,N,-,,neutral amino acid permease,F:nucleotide binding; F:ATP binding; F:metal ion binding; C:membrane; C:integral component of membrane; F:hydrolase activity,IPR027417 (G3DSA:3.40.50.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR031350 (PFAM); PF05729 (PFAM); IPR027417 (SUPERFAMILY),,
RL4_JR_03776,0,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.86860436,0,1.806022988,1.207133964,1.49612474,0.134621152,0.273602232,0.648400048,0,4.09052871,1.523798907,2.684428169,0.007265399,0.026654099,1.68946559,0,1.432514834,1.25490642,1.141531202,0.253648935,0.389318044,1.949689134,0,1.009661543,1.279090175,0.789359158,0.42990212,0.572354893,5.5310915,0,2.273067045,1.170551387,1.941877195,0.052151969,0.115645792,N,-,,HET domain-containing,,PTHR10622 (PANTHER); PTHR10622:SF10 (PANTHER),,
RL4_JR_03777,5,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.524641152,0,2.828265443,1.956474008,1.44559316,0.148291346,NA,89.41700102,0,8.977531205,1.282879551,6.997953315,2.60E-12,6.57E-10,0.436021424,0,3.387092828,1.300453522,2.604547392,0.00919957,0.030616845,0.502749423,0,2.965129695,1.441148566,2.057476768,0.039640387,0.106858073,0.426217016,0,3.315770016,1.244171031,2.665043579,0.007697835,0.025470776,N,-,,Serine threonine kinase,F:kinase activity,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); PTHR24359 (PANTHER); PTHR24359:SF23 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_03778,3,4,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.72759011,0,0.360782395,1.007648307,0.358043964,0.720310413,0.850811319,3.100558031,0,1.83302869,1.272355397,1.440657771,0.149681391,0.27622152,8.0334551,0,-0.81691492,1.194904934,-0.683665199,0.494186604,0.627353627,29.32504411,0,1.794990015,0.671930293,2.6713932,0.007553711,0.038724719,7.904181906,0,-0.896325702,1.193937164,-0.750731051,0.452814532,0.584714594,N,-,,heterokaryon incompatibility,F:ATP binding; F:protein kinase activity; P:protein phosphorylation,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR010730 (PFAM); PTHR24359:SF23 (PANTHER); PTHR24359:SF23 (PANTHER); PTHR24359 (PANTHER); PTHR24359 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_03779,1,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.060488895,0,5.944959279,3.924371582,1.514881849,0.129802328,NA,0.019555301,0,9.142824185,2.921355044,3.129651839,0.001750136,0.015023052,0.050213138,0,6.507311045,1.666663344,3.90439441,9.45E-05,0.001128758,0.057894035,0,6.083712452,2.886882259,2.107364245,0.035086018,0.099498352,0.048899527,0,6.439506893,1.343501154,4.793078794,1.64E-06,2.18E-05,N,-,,aromatic amino acid aminotransferase,F:transferase activity,IPR004839 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); PTHR11751:SF377 (PANTHER); PTHR11751 (PANTHER); PTHR11751:SF377 (PANTHER); PTHR11751 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_03780,19,24,50,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.218212777,0,4.093677663,2.878566432,1.422123741,0.154990332,NA,0.069807098,0,7.3058077,2.266950782,3.222746501,0.001269679,0.015023052,0.181147375,0,4.652513839,1.384691034,3.359965309,0.000779523,0.004714389,0.208956971,0,4.231149423,1.804636699,2.344599013,0.019047552,0.075082357,7.544416966,0,5.506003514,1.164209813,4.729391088,2.25E-06,2.88E-05,N,-,,hypothetical protein Ao3042_04875,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03781,7917,7536,8673,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.932444209,0,-1.261498788,1.241272217,-1.016295033,0.309488913,0.497255946,2.821316704,0,1.969022203,1.316465043,1.495688939,0.134734734,0.254010985,7.378887263,0,-0.694606488,1.229954564,-0.564741583,0.572249546,0.695910439,12.52775272,0,-0.172923277,1.182427513,-0.146244294,0.88372854,0.928575287,15.06399477,0,0.857262049,1.039033498,0.825057181,0.409339128,0.545264922,N,-,,amino acid transporter,P:transmembrane transport; C:membrane; P:amino acid transport,IPR002293 (PIRSF); IPR004841 (PFAM); PTHR11785:SF278 (PANTHER); IPR002293 (PANTHER),2.A.3.10.3, the amino acid-polyamine-organocation (apc) family.
RL4_JR_03782,67,68,92,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.47390681,0,2.975044069,2.044686789,1.455012125,0.145665905,NA,0.150216057,0,6.200332045,1.935822203,3.202944999,0.0013603,0.015023052,0.391092169,0,3.543420465,1.297420753,2.731126704,0.00631182,0.022658635,0.451292899,0,3.120699442,1.456452185,2.142672087,0.032139438,0.095906812,11.96823832,0,5.646560769,0.887906537,6.359408943,2.03E-10,1.33E-08,N,-,,related to aminotransferase,F:transferase activity,IPR004839 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR11751:SF294 (PANTHER); PTHR11751:SF294 (PANTHER); PTHR11751:SF294 (PANTHER); PTHR11751 (PANTHER); PTHR11751 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_03783,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202614679,0,4.200692592,2.963168857,1.417635239,0.156297286,NA,0.06463323,0,7.416853157,2.292013703,3.235954979,0.001212365,0.015023052,0.167983634,0,4.761288754,1.384418461,3.439197676,0.000583441,0.003786831,18.81832747,0,6.087412893,1.047455693,5.81161851,6.19E-09,1.78E-07,0.16614644,0,4.674925141,1.273574998,3.670710517,0.000241877,0.001464717,N,-,,proline permease,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR004841 (PFAM); PTHR11785:SF408 (PANTHER); IPR002293 (PANTHER),2.A.3.10.3, the amino acid-polyamine-organocation (apc) family.
RL4_JR_03784,2,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.327368677,0,3.508614033,2.389068435,1.468611774,0.141938119,NA,0.104238236,0,6.727436929,2.069949849,3.250048272,0.001153854,0.015023052,0.270944606,0,4.072292619,1.312338724,3.103080435,0.001915176,0.009556057,0.312596232,0,3.650233231,1.562812308,2.335682418,0.019507799,0.075837584,0.267738783,0,3.987498158,1.245146532,3.202432852,0.001362721,0.006165124,N,-,,phytanoyl- dioxygenase family,F:dioxygenase activity; P:oxidation-reduction process,IPR008775 (PFAM); G3DSA:2.60.120.620 (GENE3D); SSF51197 (SUPERFAMILY),,
RL4_JR_03785,721,1086,1006,0,2,7,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,arginine metabolism regulation II,"F:nucleotidyltransferase activity; F:zinc ion binding; F:lyase activity; P:regulation of transcription, DNA-templated; P:RNA processing; C:periplasmic space; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter; C:nucleus; F:RNA binding; C:membrane; C:integral component of membrane; F:transferase activity",IPR021858 (PFAM),,
RL4_JR_03786,865,1084,1301,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0.206725135,1,4.171532069,3.486794111,1.196380382,0.231548154,NA,0.066749873,0,7.370304777,2.740915119,2.68899417,0.007166767,0.026378915,0.172829693,0,4.720599542,1.839058712,2.566856354,0.010262512,0.033375415,29.10514685,0,7.079857578,2.054698456,3.44569178,0.0005696,0.00463974,22.26738524,0,7.068942956,1.964608498,3.598143326,0.000320497,0.001847968,Y,-,,Carboxylesterase family,F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR002018 (PFAM); PTHR11559 (PANTHER); PTHR11559:SF206 (PANTHER); IPR029058 (SUPERFAMILY),8.A.117.1.3, the neuroligin (nlg) family.
RL4_JR_03787,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0.003880053,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,1,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,,,,,,,,
RL4_JR_03788,5,8,4,0,0,17,0,0,0,0,0,2,2,5,2,0,6,0,0.015875601,1,7.873726156,3.973377595,1.981620414,0.047521741,NA,0.004841942,0,11.15004198,3.976319002,2.804111535,0.005045545,0.020752135,0.012966942,1,8.453583283,2.925374836,2.889743624,0.003855561,0.016036854,0.014987188,1,8.030738991,3.97410421,2.020767088,0.043303881,0.113246213,0.013211428,1,8.338311818,1.621864357,5.141189386,2.73E-07,4.92E-06,N,-,,amidase signature enzyme,"C:membrane; C:integral component of membrane; F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (PFAM); IPR023631 (G3DSA:3.90.1300.GENE3D); IPR023631 (G3DSA:3.90.1300.GENE3D); IPR000120 (PANTHER); PTHR11895:SF102 (PANTHER); IPR023631 (SUPERFAMILY),,
RL4_JR_03789,305,341,451,0,0,1,0,0,0,0,5,4,0,0,0,0,5,0,0.003906015,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,1,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,N,-,,---NA---,,no IPS match,,
RL4_JR_03790,539,582,740,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,81.66805209,0,-1.78995279,0.843668379,-2.121630768,0.033868757,0.099496333,20.48881034,0,-0.891224963,1.202084328,-0.741399703,0.458451125,0.617362232,68.71151614,0,-1.71543465,1.028751826,-1.667491231,0.095416767,0.187318081,226.3545091,0,1.464399715,0.32367635,4.524271589,6.06E-06,9.20E-05,162.9839957,0,1.152782924,0.774682708,1.488071067,0.136732153,0.241776641,N,-,,fungal specific transcription factor domain-containing variant,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR007219 (PFAM); G3DSA:1.20.1000.10 (GENE3D); PTHR31944 (PANTHER); PTHR31944:SF53 (PANTHER); PTHR31944 (PANTHER); PTHR31944:SF53 (PANTHER),,
RL4_JR_03791,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,110.5156489,0,1.099327442,0.704581785,1.560255268,0.11869957,0.250443365,11.43965879,0,-0.050410014,1.299976847,-0.038777625,0.969067684,0.983940526,29.34670678,0,-2.686098027,1.249858974,-2.149120888,0.031624818,0.080002414,124.523091,0,1.532983109,0.614150978,2.496101391,0.012556671,0.058091301,62.57631427,0,0.627963003,0.699779257,0.897372988,0.369519921,0.505661468,N,-,,hypothetical protein SPBR_06363,F:molecular_function,IPR016641 (PANTHER); PTHR21713:SF6 (PANTHER),,
RL4_JR_03792,16,12,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28.58109773,0,2.654311506,0.66017632,4.02060999,5.80E-05,0.000530889,1.800419717,0,2.61716846,1.328821189,1.969541486,0.048890943,0.115705899,4.682078323,0,-0.03813511,1.210533099,-0.03150274,0.974868607,0.985851408,5.402384523,0,-0.460740218,1.21106042,-0.380443626,0.703616136,0.800973227,4.623478223,0,-0.122608375,1.213793469,-0.101012551,0.919540497,0.948390295,N,-,,O-methyltransferase,F:O-methyltransferase activity; P:methylation,IPR002935 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10509 (PANTHER); PTHR10509:SF14 (PANTHER); IPR002935 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_03793,3005,2294,2659,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0.059700235,1,5.963515993,3.92459899,1.519522379,0.128631059,NA,0.01870514,0,9.204618068,2.944209338,3.126346333,0.00176993,0.015023052,0.049173862,0,6.532242087,1.692627142,3.859232743,0.000113744,0.001251467,0.05677171,1,6.110881599,2.925574729,2.088779869,0.036727543,0.10179753,0.049178108,0,6.434922459,1.370190079,4.696372099,2.65E-06,3.30E-05,N,-,,---NA---,,no IPS match,,
RL4_JR_03794,33,18,28,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,18.91758865,0,1.277217485,0.896291388,1.425002518,0.154156473,0.302746391,2.379780141,0,2.214750918,1.320934006,1.676655236,0.093609919,0.192467926,6.164977222,1,-0.434923176,1.216508766,-0.357517503,0.720704425,0.8109015,16.42432515,0,0.094614071,1.162768769,0.081369635,0.935147997,0.962317601,20.78941683,0,1.184291107,0.991291046,1.194695657,0.23220596,0.359768224,N,-,,transcriptional Coactivator p15,"F:DNA binding; C:nucleus; F:transcription coactivator activity; P:positive regulation of transcription initiation from RNA polymerase II promoter; F:double-stranded DNA binding; P:regulation of transcription, DNA-templated; F:single-stranded DNA binding",IPR009044 (G3DSA:2.30.31.GENE3D); IPR003173 (PFAM); PTHR13215 (PANTHER); PTHR13215:SF6 (PANTHER); IPR009044 (SUPERFAMILY),,
RL4_JR_03795,441,314,273,0,0,3,0,0,0,0,0,0,2,0,3,0,4,0,38.42614879,1,0.374293618,0.740634453,0.5053689,0.613299758,0.778295802,6.041936379,0,0.870509576,1.229580639,0.707972741,0.478962185,0.636227722,35.17922818,0,0.621589151,0.849555365,0.731664088,0.464373621,0.601494171,34.13954247,1,0.513363321,0.741888376,0.691968411,0.488957167,0.629138558,39.20946229,1,0.352662342,0.840369272,0.419651638,0.674739959,0.768561378,N,-,,integral membrane DUF92,C:integral component of membrane,IPR002794 (PFAM); PTHR13353:SF5 (PANTHER); IPR002794 (PANTHER),,
RL4_JR_03796,2106,3490,2323,0,0,14,0,0,0,0,0,0,2,2,1,0,0,0,67.1908049,1,0.559285464,0.637764213,0.87694708,0.380515382,0.572738836,8.205144591,0,0.429032047,1.248269304,0.343701512,0.731070774,0.832010161,165.6910708,0,2.601011591,0.526477641,4.94040276,7.80E-07,2.17E-05,38.0395919,1,-0.900452688,1.03099003,-0.873386417,0.382452492,0.527925219,20.72396705,0,-2.287066061,1.202162332,-1.902460259,0.05711101,0.123875101,N,-,,oxysterol binding,P:DNA metabolic process; P:cellular macromolecule biosynthetic process,IPR001849 (SMART); IPR000648 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); PF15409 (PFAM); IPR000648 (PANTHER); IPR000648 (PANTHER); PTHR10972:SF100 (PANTHER); PTHR10972:SF100 (PANTHER); IPR001849 (PROSITE_PROFILES); IPR009038 (SUPERFAMILY); IPR011993 (SUPERFAMILY); SSF144000 (SUPERFAMILY),2.D.1.1.6, the pi4p/ps counter transporter (p/p-ct) family.
RL4_JR_03797,3340,2844,2644,0,0,0,0,0,0,1,0,0,0,3,0,0,0,2,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_03798,3486,3041,3998,0,0,0,0,0,0,0,0,1,1,9,1,0,0,1,14.36230624,0,2.647221419,0.87991154,3.008508581,0.002625334,0.012965269,0.928336097,0,3.572879206,1.429975806,2.4985592,0.012469931,0.039792132,2.403660111,1,0.924094994,1.221577892,0.756476521,0.449363544,0.588755998,2.772761822,1,0.501783919,1.228958665,0.408300079,0.683053382,0.784502558,2.361785414,1,0.846555619,1.213197165,0.697788985,0.485309169,0.613759097,N,-,,DNA polymerase alpha epsilon subunit B,F:DNA binding; F:DNA-directed DNA polymerase activity; C:cytoplasm; P:DNA-dependent DNA replication; C:integral component of membrane; C:nuclear chromosome part; P:DNA biosynthetic process; C:macromolecular complex; P:transport,IPR007185 (PFAM); PTHR12708:SF0 (PANTHER); PTHR12708 (PANTHER); PTHR12708:SF0 (PANTHER); PTHR12708 (PANTHER),,
RL4_JR_03799,905,1335,1186,0,0,0,0,0,0,0,6,0,0,0,0,0,2,0,0.00781203,0,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,0,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,1,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,0.007662926,0,9.0007212,4.037607722,2.229221316,0.025799183,0.085851084,0.006329724,1,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_03800,203,192,349,2,0,0,0,0,0,4,0,0,0,0,0,0,0,0,15.87314566,1,-2.090740891,1.191849543,-1.754198677,0.07939647,0.187093125,5.055480682,0,1.12767329,1.239776706,0.909577737,0.363045244,0.527677192,19.62379264,1,-0.56344481,1.191311265,-0.472961875,0.636240379,0.746125055,15.14242436,0,-1.947675627,1.190975244,-1.635361974,0.101973189,0.19878293,20.30761916,0,-0.672947602,1.124338171,-0.598527756,0.549487845,0.669663508,N,-, Effector probability:0.764,hypothetical protein CMQ_3146,,PTHR37331 (PANTHER); PTHR37331:SF1 (PANTHER),,
RL4_JR_03801,593,499,853,0,3,0,0,0,0,0,3,0,1,3,0,0,0,0,2.371086808,1,0.651977968,1.250420228,0.521407086,0.602083216,0.770529521,0.761097423,0,3.859405787,1.461929766,2.639939262,0.008292089,0.029265175,1.967928046,1,1.212258345,1.220115486,0.99356033,0.320436966,0.463023925,2.269688123,1,0.790263067,1.229489046,0.642757306,0.52038159,0.654924002,1.934299383,0,1.134121731,1.209509449,0.937670832,0.348413598,0.485907394,N,-,,transcription factor cmr1,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR001138 (G3DSA:4.10.240.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR31944:SF70 (PANTHER); PTHR31944:SF70 (PANTHER); PTHR31944 (PANTHER); PTHR31944 (PANTHER); PTHR31944:SF70 (PANTHER); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); IPR001138 (SUPERFAMILY),,
RL4_JR_03802,67,324,199,0,0,5,0,0,0,0,0,0,0,2,0,0,0,0,0.28029363,1,3.732415028,2.663676892,1.401226642,0.16114631,NA,0.088483886,0,6.963360599,2.215916422,3.142429259,0.001675522,0.015023052,0.23189184,0,4.295599896,1.427116837,3.009984736,0.002612608,0.012239725,0.267642704,1,3.873736542,1.772013484,2.186064935,0.028810855,0.090174077,0.231580334,0,4.196496705,1.340629678,3.13024303,0.001746617,0.00756071,,,,,,,,
RL4_JR_03803,80,235,146,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,75.16489532,0,2.450771755,0.653354717,3.751058487,0.00017609,0.001385284,2.833660664,0,1.962907434,1.29298022,1.518126422,0.128982532,0.246007384,7.318386508,0,-0.682480948,1.201983667,-0.567795525,0.570173819,0.694136573,12.45173034,0,-0.157682867,1.15066846,-0.137035882,0.891002433,0.932926539,7.182109448,0,-0.758304293,1.197854963,-0.633051844,0.526699788,0.650451312,N,-,,Alcohol dehydrogenase -like domain-containing,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR016040 (G3DSA:3.40.50.GENE3D); IPR013154 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR002085 (PANTHER); PTHR11695:SF570 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_03804,240,652,529,0,0,0,0,0,0,0,0,3,0,0,0,0,1,0,39.80321426,0,3.168409658,0.698466886,4.536234602,5.73E-06,7.10E-05,1.596190835,0,2.790828726,1.395269292,2.000207946,0.045477814,0.109289277,4.168631793,1,0.129408568,1.250169797,0.103512793,0.917555997,0.950704832,24.08194635,0,1.484824545,1.068456385,1.389691302,0.164622637,0.284972508,4.132159508,1,0.03946605,1.258467651,0.031360401,0.974982121,0.983334393,N,-,,Versicolorin reductase,F:nucleotide binding; P:melanin biosynthetic process; F:tetrahydroxynaphthalene reductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); SM00822 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); PTHR24322:SF416 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_03805,2544,3663,3596,0,2,6,0,0,0,0,0,0,0,0,0,0,2,0,2.048184083,1,0.863540954,1.299149546,0.664697114,0.50624424,NA,0.657607151,0,4.070360949,1.510229884,2.695192959,0.007034788,0.02602563,1.697005863,0,1.426465813,1.236057941,1.154044455,0.248481944,0.38310762,1.957165898,0,1.004398534,1.253239611,0.801441739,0.42287596,0.565902603,1.661893895,1,1.353438344,1.219449892,1.109876144,0.267052402,0.399392706,N,-,,transcription factor,"C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PR00755 (PRINTS); IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_03806,1466,2165,1952,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,145.6327365,1,5.562019911,0.524093643,10.61264525,2.60E-26,8.17E-24,1.051149869,0,3.393635269,1.408622367,2.409187407,0.015988086,0.048452516,2.719991696,0,0.745714417,1.217952578,0.612268844,0.540359899,0.668532766,377.2238061,1,6.864440334,0.464296055,14.78461913,1.84E-49,7.77E-47,137.3834399,1,5.867184751,0.404879502,14.49118745,1.38E-47,6.97E-44,N,-,,family Taurine catabolism dioxygenase,F:dioxygenase activity; P:oxidation-reduction process,IPR003819 (PFAM); G3DSA:3.60.130.10 (GENE3D); PTHR10696 (PANTHER); PTHR10696:SF23 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_03807,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32.36649419,0,0.438584338,0.874346945,0.501613622,0.615939336,0.77932821,5.550350421,0,0.993006854,1.327621124,0.747959517,0.454484577,0.614059166,36.36437221,0,0.214607281,1.084729014,0.197844142,0.843167009,0.899307079,16.39735728,0,-2.062519241,1.251104778,-1.64855836,0.099238145,0.194774595,13.83683183,0,-1.704263996,1.24564944,-1.368173051,0.171257915,0.286372649,N,PKS,,Conidial yellow pigment biosynthesis polyketide synthase,F:catalytic activity; P:metabolic process,IPR020801 (SMART); IPR020806 (SMART); IPR020841 (SMART); SM01294 (SMART); IPR014030 (PFAM); IPR032088 (PFAM); IPR014031 (PFAM); IPR001031 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR014043 (PFAM); G3DSA:3.30.70.250 (GENE3D); IPR001227 (G3DSA:3.40.366.GENE3D); IPR030918 (TIGRFAM); IPR009081 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); PTHR11712 (PANTHER); PTHR11712:SF269 (PANTHER); PTHR11712:SF269 (PANTHER); PTHR11712 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR009081 (PROSITE_PROFILES); IPR029058 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR016035 (SUPERFAMILY); IPR016036 (SUPERFAMILY),,
RL4_JR_03808,27,47,60,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_03809,116,184,277,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,53.29979477,1,2.021378042,0.663598761,3.046084714,0.002318425,0.011776906,21.78832475,0,3.491969799,1.027850707,3.397351169,0.000680416,0.015023052,7.837043653,0,-0.781406593,1.215279651,-0.642985006,0.520233829,0.650308345,9.03833822,0,-1.203330218,1.215425242,-0.990048731,0.322150301,0.468504072,19.28983771,0,1.326230742,0.8806369,1.505990428,0.132069631,0.23513364,N,-,,glutathione S-transferase,F:transferase activity,IPR016639 (PIRSF); IPR010987 (G3DSA:1.20.1050.GENE3D); PF13410 (PFAM); IPR004045 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR32419:SF20 (PANTHER); IPR016639 (PANTHER); IPR010987 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR010987 (SUPERFAMILY),,
RL4_JR_03810,78,131,126,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.688424515,0,2.436422352,1.725639127,1.411895635,0.157980693,NA,0.220598094,0,5.646196418,1.805322006,3.127528717,0.001762826,0.015023052,0.569940814,0,3.000895985,1.272680754,2.35793303,0.018377008,0.05252649,0.657369089,0,2.578423055,1.364683981,1.889392043,0.058839316,0.135305037,0.558769252,0,2.926207788,1.231560697,2.376015893,0.017500709,0.049084399,Y,-,,iron transport multicopper oxidase fet3,F:copper ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR008972 (G3DSA:2.60.40.GENE3D); IPR011706 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); IPR001117 (PFAM); IPR011707 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); PTHR11709 (PANTHER); PTHR11709:SF75 (PANTHER); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY),2.A.108.1.5, the iron/lead transporter (ilt) family.
RL4_JR_03811,4101,9554,16404,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,72.61237997,0,1.773453344,0.602447171,2.943749144,0.003242627,0.015353077,5.623070425,0,0.974200321,1.284144034,0.758637891,0.4480692,0.608851663,14.57264334,0,-1.676118238,1.224830493,-1.368449142,0.171171531,0.289623405,70.2521123,1,2.052625906,0.62244048,3.297706322,0.00097478,0.00722522,47.99553849,1,1.455177737,0.680824354,2.13737615,0.03256741,0.080288537,N,-,,60S ribosomal l19,F:malate transmembrane transporter activity; C:vacuolar membrane,PF13515 (PFAM); PTHR31086:SF5 (PANTHER); PTHR31086 (PANTHER),2.A.85.3.4, the aromatic acid exporter (arae) family.
RL4_JR_03812,1666,1995,2386,0,0,7,0,0,0,0,3,0,2,2,0,0,0,0,82.48674047,1,2.548801093,0.969010152,2.630314128,0.0085306,0.033409812,4.389191281,0,1.33154684,1.245656137,1.068952177,0.285091219,0.444604164,11.39006998,1,-1.320818569,1.191630411,-1.108412941,0.267683518,0.405753547,30.4751941,1,0.570162885,0.847987447,0.672371845,0.501347002,0.638829398,11.23536208,0,-1.403766973,1.195493757,-1.174215227,0.240308828,0.369538189,N,-, Effector probability:0.589,haloacid dehalogenase-like hydrolase,P:metabolic process; F:hydrolase activity,IPR023214 (G3DSA:3.40.50.GENE3D); PF13242 (PFAM); IPR023214 (G3DSA:3.40.50.GENE3D); PTHR18901 (PANTHER); PTHR18901:SF22 (PANTHER); IPR023214 (SUPERFAMILY),,
RL4_JR_03813,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49.02337817,0,0.491661638,0.605087273,0.812546653,0.416478028,0.607954084,17.73918964,0,1.318601529,1.121024297,1.176247055,0.239496166,0.391296424,21.63879825,0,-2.246526956,1.188648158,-1.889984805,0.058759992,0.128042652,103.9363816,0,1.756608671,0.428420269,4.100199734,4.13E-05,0.000495793,44.08488575,0,0.617310051,0.662067367,0.93239764,0.351131064,0.488351926,N,-,,map kinase kinase ste7,"P:MAPK cascade involved in conjugation with cellular fusion; P:activation of MAPK activity involved in conjugation with cellular fusion; C:cell division site; P:MAPK cascade involved in ascospore formation; C:mating projection tip; P:pseudohyphal growth; P:invasive growth in response to glucose limitation; F:protein serine/threonine kinase activity; P:signal transduction involved in filamentous growth; P:mitotic cell cycle arrest in response to pheromone; C:nucleus; F:ATP binding; P:MAPK cascade involved in cell wall organization or biogenesis; C:cell tip; F:MAP kinase kinase activity; C:cytosol; P:regulation of transposition, RNA-mediated",IPR000719 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); PTHR24361:SF408 (PANTHER); PTHR24361 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.3, the pock size-determining protein (psdp) family.
RL4_JR_03814,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.51144447,0,0.693891391,0.968324052,0.716590061,0.473627079,0.662866652,3.699402228,0,1.578259134,1.361599037,1.159121806,0.246406539,0.399443784,9.605970525,0,-1.074853624,1.263837909,-0.850467941,0.395064977,0.538077735,71.11387848,0,2.603426018,0.65822237,3.95523783,7.65E-05,0.000849773,31.89910068,0,1.468659207,0.859118854,1.709494793,0.087359335,0.172621638,N,-,,acetyl- acetyltransferase,"F:transferase activity, transferring acyl groups other than amino-acyl groups; P:metabolic process",IPR002155 (PIRSF); IPR016039 (G3DSA:3.40.47.GENE3D); IPR002155 (TIGRFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR020617 (PFAM); IPR020616 (PFAM); PTHR18919:SF101 (PANTHER); PTHR18919 (PANTHER); IPR016039 (SUPERFAMILY); IPR016039 (SUPERFAMILY),,
RL4_JR_03815,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,59.13879987,0,0.195264471,0.614296706,0.317866706,0.750586048,0.870005683,77.21655022,0,2.331399782,0.850758258,2.740378669,0.006136844,0.023645653,40.91751415,0,-0.721040128,1.033056978,-0.697967434,0.48519756,0.620879873,98.88545301,0,1.092928057,0.495677753,2.204916499,0.027459955,0.088070176,29.9655305,0,-1.689620458,1.119458612,-1.509319272,0.131217212,0.233829232,N,-, Effector probability:0.823,ubiquitin-conjugating enzyme E2 2,"F:ubiquitin protein ligase activity; F:ubiquitin conjugating enzyme activity; P:error-free postreplication DNA repair; P:transcription from RNA polymerase II promoter; P:error-prone translesion synthesis; P:negative regulation of SREBP signaling pathway by positive regulation of transcription factor catabolic process in response to increased oxygen levels; P:chromatin silencing at telomere; P:meiotic DNA double-strand break formation; C:chromosome, telomeric region; F:ATP binding; P:chromatin remodeling; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway; P:histone H2B conserved C-terminal lysine ubiquitination; P:chromatin assembly; C:cytosol; P:cellular response to hyperoxia; C:Rad6-Rad18 complex; P:chromatin silencing at silent mating-type cassette; P:regulation of histone H3-K4 methylation; F:ligase activity; P:error-free translesion synthesis; P:histone monoubiquitination; P:mitotic G1 DNA damage checkpoint; P:protein polyubiquitination; P:regulation of dipeptide transport; P:double-strand break repair via homologous recombination; P:telomere maintenance via recombination; P:DNA-templated transcription, termination; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; C:nuclear chromatin; F:ubiquitin protein ligase binding; P:ER-associated ubiquitin-dependent protein catabolic process; C:HULC complex; P:negative regulation of transcription by transcription factor catabolism; P:sporulation resulting in formation of a cellular spore",SM00212 (SMART); IPR000608 (PFAM); IPR016135 (G3DSA:3.10.110.GENE3D); PTHR24067 (PANTHER); PTHR24067:SF26 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),3.A.16.1.3, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_03816,403,1036,769,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.040351892,0,6.529113989,3.933130431,1.660029867,0.096908444,NA,0.013205091,0,9.710152174,3.260029733,2.978547121,0.002896185,0.015349618,0.033634633,0,7.086242177,1.924497404,3.68212613,0.000231297,0.001935248,0.038759628,0,6.662724842,3.498781597,1.904298584,0.056871309,0.132584698,0.032474,0,7.027341165,1.424307949,4.933863614,8.06E-07,1.21E-05,N,-,,serine threonine- kinase fnkB,,no IPS match,,
RL4_JR_03817,306,761,486,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,11.51177505,1,-1.627169601,1.196522307,-1.359915809,0.173856568,0.328391266,3.674227097,0,1.588117393,1.265029526,1.255399467,0.209333783,0.354861254,9.52163505,0,-1.062102193,1.197416579,-0.886994728,0.375081739,0.518866346,10.98411578,0,-1.484395077,1.195591283,-1.241557293,0.214399947,0.348890946,43.04585149,0,2.070394914,0.621002441,3.333956164,0.000856202,0.004212362,N,-,,hypothetical protein SPSK_00843,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03818,573,1029,524,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,60.88372336,0,-0.486318483,0.71546932,-0.679719548,0.496682056,0.683971102,13.46960017,0,-0.286075102,1.235121364,-0.231616998,0.816835504,0.889607163,34.70414904,0,-2.928016817,1.205084244,-2.429719607,0.015110508,0.044730637,123.1857494,0,0.788573661,0.548645077,1.437311105,0.150629615,0.26700365,63.42158207,0,-0.340915902,0.760901338,-0.448042191,0.654122748,0.753040685,N,-,,kinesin heavy chain,F:ATP binding; F:microtubule motor activity; P:microtubule-based movement; C:microtubule; F:microtubule binding,IPR001752 (PRINTS); IPR001752 (SMART); IPR001752 (G3DSA:3.40.850.GENE3D); IPR001752 (PFAM); PTHR24115:SF9 (PANTHER); IPR027640 (PANTHER); IPR027640 (PANTHER); IPR001752 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_03819,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_03820,6020,10533,7967,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.41268813,1,-0.168232013,1.035087577,-0.162529255,0.870889092,0.938163636,23.13205603,0,2.97046817,1.006317104,2.951821209,0.003159058,0.01603027,58.99378077,0,2.086145611,0.636228967,3.278922715,0.001042042,0.005950158,46.85585121,0,1.753321589,0.613800157,2.856502345,0.004283368,0.024881873,40.75601767,0,1.261753127,0.781456624,1.61461697,0.106393668,0.20008096,N,-,,transcription-silencing clr2,F:catalytic activity,IPR018839 (PFAM); IPR031915 (PFAM),,
RL4_JR_03821,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,282.973986,0,2.755618196,0.83574401,3.297203646,0.000976527,0.005814967,12.2831739,0,-0.153045352,1.235523179,-0.123870886,0.901417505,0.944583723,70.66605887,0,0.585207743,0.655414183,0.89288233,0.371920191,0.516150846,99.13762362,0,0.825083186,0.532512737,1.549414932,0.121282007,0.226022514,46.44605197,0,-0.269099953,0.769023005,-0.349924452,0.726395396,0.80768212,N,-,,hypothetical protein CMQ_3030,,no IPS match,,
RL4_JR_03822,19726,16955,23864,0,4,16,0,0,0,0,3,5,3,4,2,0,2,10,142.2737639,1,-0.637826405,0.560504062,-1.137951442,0.255140759,0.433271922,36.99253216,0,-0.405076525,1.119046907,-0.361983508,0.717364355,0.823038735,86.2688019,1,-2.158677249,1.043386941,-2.068913424,0.038554212,0.092845585,140.3005826,1,-0.50421182,0.543672689,-0.927417969,0.353709565,0.499973383,85.98334905,1,-2.371473369,0.991304978,-2.392274245,0.016744326,0.047449285,N,-,,f-box and wd domain-containing,"C:proteasome regulatory particle, base subcomplex; P:ubiquitin-dependent protein catabolic process",IPR003903 (SMART); G3DSA:1.20.1280.50 (GENE3D); IPR001810 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR10223:SF2 (PANTHER); IPR027040 (PANTHER); IPR001810 (PROSITE_PROFILES); IPR003903 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR001810 (SUPERFAMILY),,
RL4_JR_03823,73,56,55,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,167.4548214,0,-1.016223732,0.544412168,-1.866644047,0.061951312,0.156276687,35.70397062,0,-1.692523008,1.202007078,-1.408080733,0.159107166,0.289290952,108.5833919,0,-2.524079256,1.041756318,-2.422907558,0.015396844,0.045418896,128.8521688,0,-2.053494939,0.763962449,-2.687952715,0.007189158,0.037366643,106.6665984,0,-2.73979365,0.990144132,-2.767065481,0.005656339,0.019819181,N,-,,NADPH-dependent fmn FAD containing oxidoreductase,F:nucleotide binding; F:oxidoreductase activity; F:cofactor binding; P:metabolic process,IPR001709 (PRINTS); IPR001094 (PRINTS); G3DSA:3.40.50.80 (GENE3D); IPR029039 (G3DSA:3.40.50.GENE3D); IPR008254 (PFAM); G3DSA:2.40.30.10 (GENE3D); IPR023173 (G3DSA:1.20.990.GENE3D); IPR001433 (PFAM); IPR003097 (PFAM); PTHR19384 (PANTHER); PTHR19384:SF80 (PANTHER); PTHR19384 (PANTHER); PTHR19384:SF80 (PANTHER); PTHR19384 (PANTHER); IPR017927 (PROSITE_PROFILES); IPR008254 (PROSITE_PROFILES); IPR029039 (SUPERFAMILY); IPR017938 (SUPERFAMILY); SSF52343 (SUPERFAMILY),,
RL4_JR_03824,136,109,210,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,644.1014298,0,0.729329001,1.031312513,0.707185253,0.479451361,0.668266565,115.5368319,0,-0.229013317,0.754971948,-0.303340167,0.761630639,0.855518042,391.1676665,0,-0.207099907,0.481039477,-0.430525803,0.666813201,0.770905202,365.9334453,0,-0.732320997,0.377290232,-1.941001737,0.052258067,0.125826526,315.6539209,0,-0.508005163,0.651667841,-0.779546161,0.435658057,0.570467538,N,-,,rnp domain containing,F:nucleotide binding; C:cytosol; F:single-stranded telomeric DNA binding,IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR24012 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_03825,1,2,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,144.7818655,0,1.971932727,0.976816384,2.018734287,0.043514844,0.120052114,10.11588068,0,0.127013204,1.227949598,0.103435194,0.917617581,0.954390173,71.65792969,0,1.085968949,0.600259909,1.809164553,0.070425443,0.147532069,74.16584909,0,0.592226617,0.589908461,1.003929688,0.315412506,0.461731476,29.55122871,0,-1.666925211,1.125281171,-1.481341068,0.13851571,0.244042994,N,-,,zinc finger gcs1,P:cellular localization; C:intracellular membrane-bounded organelle; P:cellular component organization; C:endomembrane system; C:cytoplasmic part; P:single-organism cellular process; P:Golgi vesicle transport,IPR001164 (PRINTS); IPR001164 (SMART); IPR001164 (PFAM); PTHR23180 (PANTHER); PTHR23180:SF35 (PANTHER); PTHR23180 (PANTHER); IPR001164 (PROSITE_PROFILES); SSF57863 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_03826,135,665,306,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,105.7955746,0,0.193626533,0.785908367,0.246372913,0.805393573,0.901661738,17.97016941,0,-0.701991353,1.201882417,-0.584076564,0.559168801,0.702832063,60.87104531,0,-1.528421085,1.027236131,-1.487896539,0.136778181,0.244783861,81.93043602,0,-1.447349808,0.842711121,-1.717492236,0.085889272,0.174827103,80.51912626,0,0.33737302,0.514268506,0.656025046,0.51180801,0.638088096,N,-,,electron transfer flavo beta-subunit,F:electron carrier activity; F:GTPase activator activity; P:positive regulation of GTPase activity,IPR014730 (SMART); IPR014730 (PFAM); IPR012255 (PIRSF); IPR014729 (G3DSA:3.40.50.GENE3D); PTHR21294:SF8 (PANTHER); IPR012255 (PANTHER); SSF52402 (SUPERFAMILY),,
RL4_JR_03827,1926,1610,1157,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,4.680607102,0,3.057952252,1.189763183,2.570219263,0.010163417,0.038350209,0.276424727,0,5.320736804,1.737621446,3.062080534,0.002198043,0.015045494,0.713759544,0,2.676244741,1.266546192,2.113025768,0.034598562,0.085725856,0.823224663,1,2.253872715,1.334743206,1.688618983,0.091292471,0.182855839,0.699263795,1,2.602558498,1.23180164,2.112806489,0.034617334,0.084153783,N,-,,Heterokaryon incompatibility OR allele,C:membrane; C:integral component of membrane,IPR010730 (PFAM); PTHR24148 (PANTHER); IPR000433 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),,
RL4_JR_03828,587,359,509,5,3,0,0,0,0,0,1,4,0,0,1,0,2,0,0.081943604,1,5.507287276,3.919772014,1.405001938,0.160020702,NA,0.025923595,0,8.735678845,2.847508074,3.067832862,0.002156172,0.015045494,0.067278111,1,6.085445774,1.701639983,3.576224017,0.000348593,0.002610322,0.077637043,1,5.660635378,2.694917296,2.10048575,0.035686133,0.100339377,0.066024747,1,6.011836517,1.41296979,4.254752337,2.09E-05,0.000186693,N,-,,---NA---,,no IPS match,,
RL4_JR_03829,2,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.63469979,0,-0.692545461,1.135913312,-0.609681614,0.542072736,0.723618138,3.71826169,0,1.570910796,1.257111568,1.249619235,0.211438673,0.357411865,9.631737976,0,-1.078811102,1.190894305,-0.905883165,0.364997696,0.508985768,11.11024058,0,-1.501007853,1.187933371,-1.26354549,0.206393209,0.338418015,9.480774418,0,-1.158813869,1.19059523,-0.973306326,0.330401079,0.467156951,N,-,,---NA---,,no IPS match,,
RL4_JR_03830,1085,2384,2019,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,256.7916404,0,3.901269082,0.497836377,7.836448401,4.63E-15,3.07E-13,5.52906764,0,0.998446432,1.238011882,0.806491801,0.419959334,0.583584346,14.38581224,0,-1.657632994,1.197190929,-1.384602032,0.16617419,0.283080515,98.11983209,0,2.611320666,0.645106301,4.047892047,5.17E-05,0.000610583,41.24434778,0,1.633282552,0.619965482,2.63447337,0.008426791,0.027390454,N,-,,alpha beta,F:dioxygenase activity; P:oxidation-reduction process; F:hydrolase activity,IPR000639 (PRINTS); IPR000073 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR10992 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_03831,179,268,292,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,203.4581196,0,7.579242308,2.114731654,3.584020836,0.000338345,0.002396024,19.09539189,0,6.648307873,1.044991792,6.362067077,1.99E-10,3.66E-08,0.885843112,0,2.363348429,1.286710271,1.836737051,0.066248723,0.140578929,5.034102393,1,2.883398953,1.20508308,2.392697236,0.016725036,0.07014954,0.881828577,0,2.268034632,1.27458667,1.779427548,0.075169693,0.153045072,N,-,,integral membrane,C:membrane,PTHR33048 (PANTHER); PTHR33048:SF6 (PANTHER),9.B.313.1.1, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_03832,228,568,326,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0.003880053,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,0,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,,,,,,,,
RL4_JR_03833,147,146,85,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.222334556,0,4.066719619,3.513309252,1.157518262,0.247060683,NA,0.074670802,0,7.209410679,2.80368707,2.571403476,0.010128725,0.033880684,0.187699865,0,4.60292761,1.929994151,2.384943813,0.01708173,0.049480811,0.216071986,0,4.183381759,2.491552527,1.679026114,0.093146954,0.18561862,0.179282122,0,4.564688384,1.754861811,2.601166859,0.009290725,0.029618575,N,-,,alcohol oxidase,F:flavin adenine dinucleotide binding; P:oxidation-reduction process; F:alcohol oxidase activity,IPR012132 (PIRSF); IPR023753 (G3DSA:3.50.50.GENE3D); IPR007867 (PFAM); IPR000172 (PFAM); PTHR11552 (PANTHER); PTHR11552:SF119 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_03834,35,90,46,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.759,---NA---,,no IPS match,,
RL4_JR_03835,61,175,111,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.077075272,0,5.595456026,3.920590277,1.427197343,0.15352302,NA,0.024742733,0,8.803208189,2.798482533,3.145707749,0.001656855,0.015023052,0.06374173,0,6.163463073,1.610773498,3.826399603,0.000130031,0.001356816,0.073512734,0,5.739273429,2.646664366,2.168493105,0.030121189,0.09252944,0.062209431,0,6.094991127,1.335902929,4.562450605,5.06E-06,5.73E-05,N,-,,Lysine-specific demethylase 4c,,no IPS match,,
RL4_JR_03836,69,78,69,0,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0.031118311,0,6.902049499,3.940873852,1.75140077,0.0798769,NA,0.009843066,0,10.13007798,3.941222014,2.570288591,0.010161383,0.033945054,0.025849857,0,7.458988742,2.558827109,2.915003017,0.003556851,0.015355889,0.029833681,1,7.03823786,3.9407549,1.786012589,0.07409722,0.157153744,0.025947324,0,7.35121082,1.604102053,4.582757566,4.59E-06,5.28E-05,N,-,,ubiquitin-conjugating enzyme E2,P:biological_process; C:cellular_component; F:molecular_function,PTHR41677 (PANTHER); PTHR41677:SF1 (PANTHER),,
RL4_JR_03837,15,13,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.800464413,0,1.04941056,1.281056094,0.81917612,0.412685938,NA,0.576117356,0,4.261148448,1.511840628,2.818516958,0.004824606,0.020177422,1.491182481,0,1.612781782,1.220218843,1.321715191,0.186263008,0.308226004,1.720046861,0,1.190545977,1.235092636,0.963932536,0.33507975,0.481892941,1.465885037,0,1.534515057,1.205718338,1.272697784,0.203125304,0.325439144,N,-,,duf895 domain membrane,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23294:SF24 (PANTHER); PTHR23294 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.58.5, the major facilitator superfamily (mfs).
RL4_JR_03838,16,19,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.335925516,0,3.471416655,2.460411764,1.410908818,0.158271502,NA,0.109605385,0,6.655546956,2.147015065,3.099906966,0.001935814,0.015023052,0.280275027,0,4.024807443,1.403608097,2.867472374,0.004137649,0.016729058,0.323028986,0,3.603331658,1.683393121,2.140517039,0.032313005,0.096169659,0.272232466,0,3.961894204,1.309438704,3.025643118,0.00248105,0.010157957,Y,-,,endoglucanase 2,"P:polysaccharide catabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR013781 (G3DSA:3.20.20.GENE3D); IPR001547 (PFAM); PTHR31297 (PANTHER); PTHR31297:SF19 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_03839,896,831,747,0,0,0,0,0,1,0,0,2,0,1,0,0,0,0,63.20057104,0,-0.60172129,0.733535403,-0.820302997,0.412043398,0.603275313,999.6159034,1,6.412422991,0.562517899,11.39950036,4.21E-30,5.32E-27,1366.077394,1,5.430602226,0.620044914,8.758401367,1.98E-18,2.78E-16,207.943134,1,2.146252051,0.336482956,6.378486677,1.79E-10,6.49E-09,69.1473181,0,1.065193254,0.496460307,2.145575868,0.031906832,0.079008017,Y,-,,polygalacturonase,P:carbohydrate metabolic process; F:polygalacturonase activity; P:cell wall organization; C:extracellular region,IPR006626 (SMART); IPR012334 (G3DSA:2.160.20.GENE3D); IPR000743 (PFAM); PTHR31884 (PANTHER); PTHR31884:SF1 (PANTHER); IPR011050 (SUPERFAMILY),,
RL4_JR_03840,190,254,251,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,serine threonine kinase,P:phosphorylation; F:kinase activity,no IPS match,,
RL4_JR_03841,25,30,44,0,0,0,0,0,0,0,1,0,0,2,0,0,0,0,0.003906015,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,0,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,N,-,,BAF1 ABF1 chromatin reorganising factor,,no IPS match,,
RL4_JR_03842,1920,2077,1752,0,0,2,0,0,0,6,1,2,5,11,1,0,6,2,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,serine threonine kinase,F:kinase activity,G3DSA:1.10.510.10 (GENE3D); IPR011009 (SUPERFAMILY),,
RL4_JR_03843,2347,1723,2275,0,0,4,0,0,1,0,0,0,0,0,1,0,6,0,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,acetamidase,"F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (PFAM); IPR023631 (G3DSA:3.90.1300.GENE3D); IPR000120 (PANTHER); PTHR11895:SF45 (PANTHER); IPR023631 (SUPERFAMILY),,
RL4_JR_03844,2327,3527,3356,2,10,2,0,0,0,2,0,0,0,0,5,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.62,acetamidase,"F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (G3DSA:3.90.1300.GENE3D); IPR023631 (PFAM); IPR023631 (SUPERFAMILY),,
RL4_JR_03845,7627,5550,4576,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0.003880053,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,1,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,major facilitator superfamily transporter,C:membrane,no IPS match,,
RL4_JR_03846,1210,1207,2084,0,8,3,0,0,0,0,0,0,1,0,0,0,1,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,Y,-,,---NA---,,no IPS match,,
RL4_JR_03847,4425,4466,4799,7,7,11,0,0,2,0,3,0,1,2,3,0,6,0,486.7976064,1,-2.256364779,0.905945001,-2.490620044,0.012752041,0.046133548,125.0514767,1,-3.500860519,1.216227955,-2.878457533,0.003996251,0.018122783,336.2738513,1,-5.19441324,1.218772938,-4.262002445,2.03E-05,0.000341859,375.2530433,1,-6.578895684,1.221309115,-5.386757212,7.17E-08,1.68E-06,320.8625029,1,-6.239590627,1.232409339,-5.062920596,4.13E-07,6.81E-06,Y,-, Effector probability:0.913,hypothetical protein CC84DRAFT_1221594,,no IPS match,,
RL4_JR_03848,6458,6410,8371,6,2,11,0,0,1,0,0,1,0,1,5,0,6,0,13.1588425,1,3.414151154,0.887113071,3.84860878,0.000118791,0.000986857,0.539758516,1,4.355018343,1.531801426,2.84306978,0.004468129,0.019147501,69.21572007,1,5.350751796,0.596506891,8.970142469,2.96E-19,4.28E-17,128.3126058,1,6.069991731,0.533767756,11.37197155,5.77E-30,9.12E-28,102.0723461,1,6.334207664,0.485453768,13.04801422,6.52E-39,6.60E-36,N,-,,serum paraoxonase arylesterase family,C:membrane; C:integral component of membrane; F:arylesterase activity,IPR011042 (G3DSA:2.120.10.GENE3D); PTHR11799:SF2 (PANTHER); PTHR11799 (PANTHER); PTHR11799 (PANTHER); PTHR11799:SF2 (PANTHER),1.A.6.2.6, the epithelial na(+) channel (enac) family.
RL4_JR_03849,478,555,501,0,1,6,0,0,0,0,0,0,0,0,0,0,2,0,0.151862448,1,4.616744203,3.426698656,1.347286314,0.177888038,NA,0.047439653,0,7.862525015,2.493881349,3.152726179,0.001617535,0.015023052,0.124843259,0,5.189380196,1.516322301,3.422346419,0.000620832,0.003960491,0.144149307,0,4.766776883,2.135267037,2.232403161,0.025588329,0.085851084,0.124877546,1,5.089703262,1.358969964,3.745265455,0.000180203,0.001136795,N,-,,Heterokaryon incompatibility OR allele,C:membrane,IPR010730 (PFAM); PTHR24148 (PANTHER),,
RL4_JR_03850,18047,16322,16271,5,6,10,6,0,0,1,0,8,3,11,3,0,16,1,33.91047148,1,1.529086193,0.665300815,2.298338072,0.021542555,0.069934009,3.38597217,1,1.705922936,1.260090459,1.353809898,0.175797035,0.312069026,8.79413276,1,-0.947662247,1.193205865,-0.79421521,0.427070155,0.567632697,28.77022252,1,0.37076556,1.01064271,0.366861163,0.713722582,0.808452969,8.680648259,1,-1.031558628,1.197749734,-0.861247219,0.389101899,0.525217534,N,-,,serine threonine kinase,F:ATP binding; F:protein kinase activity; P:phosphorylation; F:protein serine/threonine kinase activity; P:protein phosphorylation; F:kinase activity,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR001245 (PFAM); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.23.1.17, the basigin (basigin) family.
RL4_JR_03851,5741,6197,10808,0,0,2,0,0,0,0,0,1,0,3,0,0,1,0,0.020847779,1,7.484746689,3.95773732,1.891168131,0.058601904,NA,0.0066957,0,10.69142447,3.957502982,2.701558158,0.006901541,0.025663996,0.017140155,1,8.060827653,2.849422316,2.828933994,0.004670333,0.01798967,0.019765917,1,7.636122347,3.958094408,1.929242095,0.053700815,0.127664111,0.016524003,1,8.013712819,1.673765623,4.787834515,1.69E-06,2.23E-05,N,-,,mRNA 3 -end-processing YTH1,F:methyltransferase activity; F:transferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_03852,986,941,1847,0,0,0,0,0,1,0,0,0,0,0,0,0,3,0,0.015901563,0,7.871528,3.973277037,1.981117331,0.047578117,NA,0.005010166,1,11.10419825,3.765442626,2.948975554,0.003188292,0.016079667,0.01312615,0,8.436770725,2.240862621,3.76496562,0.000166572,0.001577526,0.015150793,0,8.016170674,3.973433359,2.017441832,0.043649426,0.113446415,0.013085742,1,8.344620785,1.511525422,5.520661885,3.38E-08,1.07E-06,N,-,,hypothetical protein SPSK_02386,P:transmembrane transport; F:actin binding; C:membrane; C:integral component of membrane; F:metal ion transmembrane transporter activity; P:metal ion transport,IPR002523 (PFAM); G3DSA:1.20.58.340 (GENE3D); PTHR21535 (PANTHER); SSF144083 (SUPERFAMILY),1.A.35.3.2, the cora metal ion transporter (mit) family.
RL4_JR_03853,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.13964132,0,4.737749744,3.458790963,1.369770476,0.170758561,NA,66.9801163,0,10.18520094,0.889208893,11.45422749,2.24E-30,3.24E-27,0.115563061,0,5.301302556,1.424181033,3.722351607,0.000197376,0.001739686,0.133332246,0,4.879481549,2.071070778,2.356018733,0.018471986,0.074129552,0.114279002,0,5.215851886,1.277120971,4.084070345,4.43E-05,0.000350053,N,-,,probable disease resistance At1g58390,F:ADP binding,IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR002182 (PFAM); IPR011990 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_03854,860,985,772,0,4,0,0,0,0,0,0,0,1,1,0,0,0,0,0.081688811,1,5.510663741,3.919802441,1.405852419,0.159767953,NA,0.025859075,0,8.737803924,3.91992849,2.229072277,0.025809096,0.070150288,0.067875775,0,6.068087497,2.320448516,2.6150494,0.008921455,0.029881676,0.078333863,1,5.64640515,3.919752688,1.440500358,0.149725889,0.265947456,0.068096015,0,5.961510982,1.797812845,3.315979746,0.000913224,0.004434723,Y,-,,peptidase family M20 M25 M40,F:carboxypeptidase activity; P:metabolic process; P:proteolysis; C:cellular_component; F:hydrolase activity,IPR002933 (PFAM); IPR011650 (G3DSA:3.30.70.GENE3D); G3DSA:3.40.630.10 (GENE3D); IPR017439 (TIGRFAM); PTHR11014:SF89 (PANTHER); PTHR11014 (PANTHER); SSF53187 (SUPERFAMILY); IPR011650 (SUPERFAMILY),,
RL4_JR_03855,3533,4083,2974,0,0,10,0,0,0,0,0,2,0,3,0,0,1,0,0.147401427,1,4.659705278,3.388268272,1.375246853,0.169054927,NA,0.046767983,0,7.883474859,2.434855253,3.237759144,0.001204725,0.015023052,0.121906119,1,5.223771429,1.425878117,3.663546952,0.000248747,0.002031802,0.140667963,1,4.802102921,2.043163235,2.35032759,0.018756895,0.074426671,0.120860097,1,5.135256144,1.283344931,4.001462133,6.30E-05,0.000471793,N,-,,MFS transporter,P:transmembrane transport; C:integral component of membrane,PTHR34598 (PANTHER); PTHR34598:SF3 (PANTHER),,
RL4_JR_03856,31596,27937,20731,5,17,11,0,0,4,1,1,19,4,17,9,0,10,2,0.683158688,1,2.447439368,1.848807414,1.323793571,0.185571612,NA,0.214711484,1,5.684854398,1.859494925,3.057203502,0.002234125,0.015045494,0.562068223,1,3.019965496,1.330091024,2.270495359,0.023177545,0.062556508,0.648815994,1,2.59685219,1.452566685,1.787767967,0.073813451,0.156843902,0.558648047,1,2.926962385,1.298630235,2.253884367,0.024203443,0.06349142,N,-, Effector probability:0.603,short chain dehydrogenase,,IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24322:SF540 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_03857,759,925,834,0,0,2,0,0,0,0,1,2,2,0,5,0,6,4,0.765358656,1,2.283481795,1.690184474,1.351025187,0.176687364,NA,0.241752647,0,5.513754763,1.77638395,3.103920615,0.001909746,0.015023052,7.129913076,1,3.813891376,1.221289002,3.122841006,0.001791145,0.009057717,0.728447242,1,2.429764444,1.36912241,1.774687513,0.075949498,0.160239356,0.626039187,1,2.762542367,1.256679541,2.198287055,0.027928656,0.071121138,N,-,,metabolite transport,F:glycerol-3-phosphate transmembrane transporter activity; P:glycerol-3-phosphate transport; P:transmembrane transport; P:glycerophosphodiester transport; C:integral component of membrane; F:glycerophosphodiester transmembrane transporter activity; C:plasma membrane,G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR24064 (PANTHER); PTHR24064:SF269 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.9.7, the major facilitator superfamily (mfs).
RL4_JR_03858,14858,18923,22824,21,15,51,0,0,0,5,19,14,6,9,0,0,49,2,0.039667078,1,6.553067504,3.933570323,1.665933736,0.095726613,NA,0.013027825,0,9.728928478,3.213081995,3.027911673,0.002462501,0.015349618,0.03323219,1,7.100815649,1.88048573,3.776053993,0.000159332,0.00154173,0.038291723,1,6.679597135,3.451898553,1.935050243,0.05298413,0.126754469,11.61385689,1,9.201994087,1.013696725,9.077659873,1.11E-19,2.44E-17,N,-,,tannase and feruloyl esterase,P:nucleocytoplasmic transport; P:biological_process; F:structural constituent of nuclear pore; C:cellular_component; F:molecular_function; C:nuclear pore; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR011118 (PFAM); IPR011118 (PANTHER); PTHR33938:SF4 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_03859,544,389,581,0,0,1,0,0,0,0,1,1,0,3,0,0,3,1,0.086583105,1,5.426995141,3.919068992,1.384766421,0.166123902,NA,0.027208161,0,8.663944987,2.799378351,3.094953201,0.00196844,0.015023052,0.071571365,1,5.989961237,1.665860093,3.595716869,0.000323499,0.002466196,0.082621778,1,5.569206082,2.619461092,2.126088491,0.033495892,0.09810411,0.071785646,1,5.886263996,1.406205044,4.185921548,2.84E-05,0.000241852,N,-,,kinase-like domain,P:phosphorylation; F:kinase activity,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); PTHR21310 (PANTHER); PTHR21310:SF16 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_03860,1490,1383,1431,4,0,13,3,0,0,1,0,2,0,0,0,0,2,0,15.91148548,1,5.030332462,1.209262819,4.159833896,3.18E-05,0.000314166,0.202971618,1,5.766501891,2.130453089,2.706702119,0.00679552,0.025353577,0.523286481,1,3.124230128,1.546732693,2.019890148,0.043394783,0.101461614,8.626849652,0,4.324746125,1.310815736,3.299278461,0.000969337,0.007205975,0.509018337,1,3.060991095,1.489840633,2.054576192,0.039919957,0.093975719,N,-,,fungal specific transcription factor,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transmembrane transport; P:transcription, DNA-templated; F:metal ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR007219 (SMART); IPR007219 (PFAM); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); PS51257 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_03861,523,566,601,0,0,5,0,0,0,0,0,0,0,1,0,0,0,1,20.97182333,1,3.939969029,0.795361335,4.953684389,7.28E-07,1.16E-05,0.597935479,0,4.207556702,1.562048379,2.693614846,0.007068179,0.026110988,1.549873453,0,1.557284087,1.267252762,1.228866201,0.219121976,0.348310705,35.16991549,1,4.600763952,0.673863979,6.827437129,8.64E-12,3.69E-10,5.383257871,1,2.406514039,1.174036871,2.049777225,0.040386175,0.094984906,N,-,,tartrate transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF266 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.3, the major facilitator superfamily (mfs).
RL4_JR_03862,1,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,162.1192337,0,2.592369105,0.79333613,3.267680628,0.001084326,0.006295511,16.35328582,0,1.580150984,1.118337864,1.412945976,0.157671609,0.287248386,74.11049788,0,1.638039662,0.573569475,2.855869661,0.004291913,0.016940088,142.3090373,0,2.298160001,0.453112263,5.071943952,3.94E-07,7.83E-06,25.28358543,0,-1.14173088,1.127462419,-1.012655377,0.311224799,0.44665601,Y,-,,3-phytase B,F:zinc ion binding; F:protein tyrosine phosphatase activity; P:galactose metabolic process; F:UDP-glucose:hexose-1-phosphate uridylyltransferase activity; P:dephosphorylation; F:3-phytase activity; F:acid phosphatase activity,IPR005850 (PFAM); IPR005849 (PFAM); IPR011146 (G3DSA:3.30.428.GENE3D); IPR029033 (G3DSA:3.40.50.GENE3D); IPR001937 (TIGRFAM); IPR011146 (G3DSA:3.30.428.GENE3D); IPR000560 (PFAM); IPR001937 (PANTHER); PTHR11943:SF2 (PANTHER); IPR011146 (SUPERFAMILY); IPR029033 (SUPERFAMILY); IPR011146 (SUPERFAMILY),,
RL4_JR_03863,1629,1945,2304,0,1,20,0,0,0,0,0,1,3,6,0,0,4,2,47.11985796,1,0.639247633,0.722252144,0.885075438,0.376115946,0.567659088,6.208231595,0,0.83127643,1.252946146,0.66345743,0.507037635,0.659670301,43.54424156,1,0.980394843,0.775747873,1.263806035,0.206299655,0.333000272,18.70194665,1,-2.252337987,1.213900328,-1.855455457,0.063531214,0.14159224,16.07124862,1,-1.920155822,1.224204447,-1.568492768,0.116766176,0.214721674,N,-,,transmembrane domain-containing,C:integral component of membrane,IPR005352 (PFAM); PTHR15451 (PANTHER); PTHR15451:SF19 (PANTHER),,
RL4_JR_03864,592,464,979,0,2,1,0,0,0,0,0,0,0,2,5,0,0,0,96.87498279,1,0.549073682,0.652360274,0.841672467,0.399971314,0.591652942,14.16759402,0,-0.359065975,1.225187096,-0.29307032,0.769468402,0.860424124,51.34838031,0,-1.201232549,1.054997036,-1.138612251,0.254864916,0.390698899,127.1675806,1,0.71709819,0.572469501,1.252639989,0.210336755,0.343937281,62.71805017,0,-0.462299401,0.794940802,-0.581551985,0.560868493,0.679249932,N,-,,3-ketoacyl- reductase,C:endoplasmic reticulum membrane; C:integral component of membrane; P:fatty acid elongation; P:oxidation-reduction process; F:ketoreductase activity,IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PIRSF); PTHR24322:SF651 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_03865,8964,14237,14977,0,0,21,0,0,2,0,3,7,5,14,0,0,7,13,200.8675359,1,-0.628389278,0.499879622,-1.257081206,0.208724232,0.375142605,42.35500023,1,-1.938959939,1.191327816,-1.627562047,0.103617782,0.2080165,141.4838228,1,-1.769513984,0.744331567,-2.377319548,0.017438973,0.05032844,140.6907009,1,-3.281998644,1.015083477,-3.23323029,0.001223989,0.00878305,108.78163,1,-4.67907014,1.197621617,-3.906968672,9.35E-05,0.000655783,N,-,,non-repetitive WGA-negative nucleoporin,P:nucleocytoplasmic transport; F:protein binding; C:cytoplasm; C:membrane; F:structural constituent of nuclear pore; P:macromolecule localization; C:nuclear pore; P:organic substance transport,IPR007187 (PFAM); IPR014908 (PFAM); IPR004870 (PANTHER); PTHR10350:SF6 (PANTHER); PTHR10350:SF6 (PANTHER); IPR004870 (PANTHER),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_03866,20018,23112,24718,5,2,14,0,0,0,0,0,0,6,2,0,2,7,2,7.659584149,1,-1.039699995,1.238421094,-0.839536729,0.401168187,0.593100774,2.419501356,0,2.190680807,1.322146565,1.656912225,0.097537222,0.198566325,14.16836491,0,0.489384136,1.218860141,0.401509672,0.688044919,0.78602649,7.300256825,1,-0.895308977,1.229664763,-0.728091919,0.46655732,0.608166818,10.150566,1,0.360031983,1.16787294,0.308280097,0.75786921,0.831176966,N,-,,hypothetical protein F503_02747,,no IPS match,,
RL4_JR_03867,168,437,347,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,69.70145305,1,-4.225447005,1.218451876,-3.467881733,0.000524578,0.00349146,22.04115914,0,-0.996645113,1.213801009,-0.821094319,0.411592546,0.575433667,97.22331499,0,-0.814901945,0.767837844,-1.061294323,0.288556165,0.428035548,112.1144483,0,-0.118822527,0.577353145,-0.20580563,0.836942744,0.897959657,79.12095597,1,-1.491747413,0.878372501,-1.698308418,0.089449567,0.175619497,N,-,,HD domain-containing,C:nucleus; C:cytosol; F:hydrolase activity,IPR003607 (SMART); IPR006674 (G3DSA:1.10.3210.GENE3D); IPR006674 (PFAM); PTHR11845 (PANTHER); SSF109604 (SUPERFAMILY),,
RL4_JR_03868,1026,2243,1463,3,9,3,0,0,0,4,1,0,0,2,6,0,3,0,0.056556919,1,6.041995283,3.925593591,1.539129088,0.123772785,NA,0.018051554,0,9.257735916,2.937574681,3.151489552,0.0016244,0.015023052,0.046723192,1,6.610654828,1.657969338,3.98719969,6.69E-05,0.000897703,0.053898967,1,6.186747994,2.938934179,2.105099202,0.035282674,0.099766434,0.04586035,1,6.535713558,1.339679768,4.878564051,1.07E-06,1.53E-05,Y,-, Effector probability:0.626,glycoside hydrolase family 61,F:hydrolase activity,IPR005103 (PFAM); PTHR33353 (PANTHER); PTHR33353:SF11 (PANTHER),,
RL4_JR_03869,25886,25252,35965,6,2,34,0,0,2,0,0,1,0,6,0,0,15,1,228.7363663,1,-1.805587136,0.578037206,-3.123652103,0.001786215,0.009530375,55.56856562,1,-2.330694725,1.196291426,-1.948266681,0.051383062,0.120365506,242.5224675,1,-0.68403867,0.497463013,-1.375054332,0.169114601,0.286642595,199.0458297,1,-1.751860102,0.592610686,-2.956173661,0.003114817,0.019183405,247.3579727,1,-0.369136421,1.716679408,-0.215029329,0.829744452,0.885461702,N,-,,glycosyltransferase family 32,"P:N-glycan processing; F:alpha-1,6-mannosyltransferase activity; C:alpha-1,6-mannosyltransferase complex",IPR007577 (PFAM); PTHR31834 (PANTHER); PTHR31834:SF8 (PANTHER); IPR029044 (SUPERFAMILY),,
RL4_JR_03870,1652,1007,1773,0,0,2,0,0,1,0,3,1,0,0,0,0,1,0,84.67230681,1,2.334803883,0.48869703,4.777610136,1.77E-06,2.52E-05,4.286350431,1,1.365732972,1.249434774,1.093080648,0.274358392,0.432495818,24.14665142,1,0.529089108,1.036627804,0.510394479,0.609775124,0.725936424,52.98002288,0,2.262374003,0.536739058,4.215035163,2.50E-05,0.000319269,11.01842394,1,-1.375573512,1.203434988,-1.143039322,0.253022265,0.384085523,N,-,,acyltransferase,"F:transferase activity, transferring acyl groups; C:membrane",IPR002656 (PFAM); PTHR23028:SF58 (PANTHER); PTHR23028 (PANTHER); PTHR23028 (PANTHER); PTHR23028:SF58 (PANTHER),,
RL4_JR_03871,2099,1741,2636,0,2,0,0,0,2,0,7,1,0,0,0,0,0,0,39.97236598,1,-3.42327472,1.275714355,-2.683417887,0.007287387,0.029445518,21.89629323,1,0.731691364,1.182231515,0.618907003,0.535977625,0.683588612,69.97529731,1,0.270274898,0.780520146,0.346275364,0.729135781,0.817200337,37.99606201,0,-3.274988122,1.260073352,-2.599045616,0.009348335,0.046059315,32.90821905,0,-2.954149254,1.271120998,-2.324050392,0.020122793,0.054740269,N,-,,pre-mrna-splicing factor cwc2,F:nucleotide binding; F:U6 snRNA binding; F:pre-mRNA binding; F:metal ion binding; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome; C:Prp19 complex; P:spliceosomal snRNP assembly,IPR000504 (SMART); IPR000504 (PFAM); IPR032297 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR14089 (PANTHER); PTHR14089:SF2 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000571 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR000571 (SUPERFAMILY),,
RL4_JR_03872,2050,2315,2535,0,0,0,0,0,0,0,0,0,0,5,0,0,1,0,27.16071259,0,3.029728044,0.718169662,4.218680075,2.46E-05,0.000250427,1.366988592,0,3.014650401,1.410265187,2.137647889,0.032545332,0.084294741,60.84373603,0,4.006160837,0.620613689,6.455160279,1.08E-10,6.22E-09,270.6855684,1,6.098522524,0.415108931,14.69137875,7.32E-49,2.96E-46,49.41222289,1,4.277663558,0.579957056,7.375828114,1.63E-13,2.07E-11,Y,-,,alkaline elastase,F:peptidase activity,IPR015500 (PRINTS); IPR010435 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (PFAM); PTHR10795:SF359 (PANTHER); IPR015500 (PANTHER); IPR000209 (SUPERFAMILY),2.A.7.3.49, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_03873,795,1022,865,1,9,29,0,0,2,0,0,0,1,0,10,0,1,7,74.73634656,1,-1.635124788,0.930808112,-1.756672258,0.078973689,0.186527896,17.98252049,1,-0.703060689,1.239281721,-0.567313046,0.570501515,0.711176728,70.62194173,0,-0.958405595,0.905644221,-1.05825839,0.289937657,0.429518414,74.41330049,1,-0.830492495,0.779864893,-1.064918426,0.286912846,0.431135732,84.46955509,1,-0.054821027,0.68383033,-0.080167586,0.93610397,0.958540928,N,-,,50S ribosomal subunit l15,F:nucleotide binding; F:translation initiation factor activity; F:structural constituent of ribosome; C:large ribosomal subunit; C:nucleolus; F:translation initiation factor binding; P:translational initiation; C:eukaryotic translation initiation factor 3 complex,IPR005749 (TIGRFAM); IPR021131 (PFAM); G3DSA:3.100.10.10 (GENE3D); IPR005749 (PANTHER); IPR030878 (HAMAP); IPR021131 (SUPERFAMILY),,
RL4_JR_03874,28,125,78,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,79.18267898,0,0.467973567,0.564792089,0.828576703,0.407343975,0.598606871,21.74636146,0,0.752758068,1.133415859,0.664149934,0.506594353,0.659418477,31.9482284,0,-2.808620105,1.199145693,-2.342184208,0.01917125,0.054048938,66.54128937,0,0.058145621,0.641273248,0.090672146,0.927753104,0.957076935,38.69060892,0,-1.948109485,1.124958805,-1.731716287,0.083324089,0.166503062,N,-,,sorting nexin mvp-1,F:phosphatidylinositol binding; C:intracellular part,IPR001683 (SMART); IPR001683 (PFAM); IPR001683 (G3DSA:3.30.1520.GENE3D); PTHR10555:SF153 (PANTHER); PTHR10555 (PANTHER); IPR001683 (PROSITE_PROFILES); IPR001683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_03875,137,587,516,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,111.3147061,1,-2.234131156,0.842508937,-2.651759595,0.008007353,0.031772368,27.90960813,0,-1.337156914,1.194002291,-1.119894764,0.26275861,0.41920597,147.1831708,1,-0.156723144,0.530354092,-0.295506618,0.767606897,0.843802054,127.5726587,0,-0.264683174,0.478105863,-0.553607882,0.579847231,0.706237605,71.22619504,0,-4.068114322,1.186026869,-3.430035548,0.000603502,0.00317097,N,-,,defective in cullin neddylation 1,"C:nucleus; F:ubiquitin conjugating enzyme binding; P:positive regulation of ubiquitin-protein transferase activity; F:ubiquitin binding; C:cytosol; F:cullin family protein binding; P:protein neddylation; F:NEDD8 transferase activity; F:protein binding, bridging",IPR005176 (PFAM); IPR014764 (PANTHER); PTHR12281:SF2 (PANTHER); IPR005176 (PROSITE_PROFILES),,
RL4_JR_03876,7479,8151,8684,0,0,2,0,0,0,0,1,0,0,1,0,0,0,0,86.50075752,1,-1.901377983,0.894125701,-2.126522009,0.033459819,0.098472295,21.7565247,0,-0.977898323,1.213148932,-0.806082664,0.420195187,0.583831939,115.9889845,1,-0.003486641,0.608943198,-0.005725725,0.995431557,0.998095149,152.7107709,1,0.199797678,0.531441336,0.375954343,0.706950839,0.803399182,56.32484827,0,-3.729473258,1.216510146,-3.06571488,0.002171503,0.009077814,N,-,,hypothetical protein SPI_00024,F:structural constituent of ribosome; F:rRNA binding; C:ribosome; P:translation,IPR022190 (PFAM); IPR000529 (PFAM); IPR000529 (TIGRFAM); IPR014717 (G3DSA:3.30.70.GENE3D); PTHR21011 (PANTHER); IPR000529 (SUPERFAMILY),,
RL4_JR_03877,3854,4589,4108,3,7,16,1,0,0,0,3,4,2,6,0,0,3,0,106.7496504,1,0.048933831,0.52689412,0.092872229,0.926005069,0.964672373,17.15674661,1,-0.63519001,1.213075635,-0.523619461,0.600543243,0.735335897,121.3036952,1,0.978913483,0.490154772,1.997151795,0.045808696,0.105786322,96.532152,1,-0.372863854,0.6304113,-0.591461247,0.554211413,0.683284047,59.22022144,1,-0.765355604,0.766431968,-0.998595618,0.317990624,0.453344842,N,-,,chitin synthase export chaperone,C:endoplasmic reticulum membrane; P:ER to Golgi vesicle-mediated transport; P:fungal-type cell wall chitin biosynthetic process; C:integral component of membrane; F:unfolded protein binding; F:transferase activity; P:protein folding,IPR022057 (PFAM); PTHR35329 (PANTHER); PTHR35329:SF2 (PANTHER),,
RL4_JR_03878,31350,29030,40364,3,11,37,0,0,2,7,2,0,4,30,0,0,23,2,5.501841419,1,-0.562300853,1.200368767,-0.46844009,0.639469905,0.794758605,1.752133864,1,2.656371778,1.318914906,2.014058501,0.044003392,0.106759907,17.54970276,1,1.822091723,1.033431329,1.763147364,0.077875639,0.159500904,31.89969601,1,2.311802638,0.740348517,3.122586976,0.001792691,0.012076513,11.86038427,1,0.853314668,1.127586302,0.75676218,0.449192355,0.581000587,N,-,,"ankyrin 2,3 unc44",,IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); G3DSA:1.20.1280.50 (GENE3D); IPR001810 (SUPERFAMILY); IPR020683 (SUPERFAMILY),,
RL4_JR_03879,4233,3614,4021,0,2,26,0,0,1,1,0,1,1,2,2,0,2,1,3.060775598,1,0.283680649,1.22747662,0.2311088,0.817230279,0.907070015,0.974433538,1,3.502831927,1.401850853,2.498719403,0.012464296,0.039786693,2.532593514,1,0.848130948,1.21022042,0.700807005,0.483423466,0.619359551,2.921936227,1,0.425688114,1.214245214,0.350578375,0.725904682,0.817460228,2.501943755,1,0.7632416,1.209740627,0.630913423,0.528097135,0.651594381,N,-,,haloacid dehalogenase,C:nucleus; C:cytosol,IPR023214 (G3DSA:3.40.50.GENE3D); PTHR12725 (PANTHER); PTHR12725:SF74 (PANTHER); IPR023214 (SUPERFAMILY),,
RL4_JR_03880,1204,1685,1474,6,0,4,0,0,0,0,0,0,4,0,0,0,0,2,5.080853264,1,-0.447592586,1.212462515,-0.369159937,0.712008515,0.844759376,1.616607899,0,2.772475358,1.335502549,2.075979084,0.037895885,0.095040177,15.27505024,0,1.078256908,1.197962237,0.900075874,0.368079874,0.512436833,23.47619374,1,1.441045311,1.020551713,1.412025763,0.157942376,0.276433285,8.019794818,1,0.958868431,1.139565919,0.841433053,0.400105375,0.537348047,N,-,,"Carboxy-cis,cis-muconate cyclase",,IPR019405 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR30344 (PANTHER); PTHR30344:SF1 (PANTHER); SSF75011 (SUPERFAMILY),,
RL4_JR_03881,6293,5349,6302,0,0,15,0,0,0,0,3,4,2,13,3,0,3,4,20.21475274,1,-0.041440745,1.04589982,-0.039622098,0.96839441,0.984007287,13.38791328,0,2.376482039,1.150313919,2.065942174,0.03883394,0.09676936,10.42612421,1,-1.193289381,1.215773311,-0.981506478,0.326343041,0.469370216,20.05166761,1,0.097136336,1.046904382,0.092784343,0.92607489,0.956655996,14.17908354,1,-0.353189856,1.154675668,-0.305877976,0.759697555,0.83219415,N,-,,presenilins-associated rhomboid-like mitochondrial,C:membrane; P:proteolysis; F:peptidase activity,IPR022764 (PFAM); IPR022764 (G3DSA:1.20.1540.GENE3D); PTHR22936:SF13 (PANTHER); IPR002610 (PANTHER); SSF144091 (SUPERFAMILY),9.B.104.1.6, the rhomboid protease (rhomboid) family.
RL4_JR_03882,21651,24204,34710,2,16,8,0,0,0,0,1,0,0,10,0,0,0,3,18.82174577,1,-2.336769436,1.191946614,-1.960464847,0.049941483,0.13262455,6.041727701,0,0.870578158,1.245694161,0.698869904,0.484633338,0.641152613,35.11911823,1,0.623787031,0.860622786,0.724808873,0.468569292,0.605507615,18.01852351,1,-2.198622226,1.196159573,-1.838067659,0.066052436,0.145480761,15.35832795,1,-1.854799769,1.197557439,-1.548819044,0.121425226,0.221279772,N,-,,C6 transcription,F:binding,IPR007219 (SMART); IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); PTHR31001 (PANTHER); PTHR31001:SF54 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_03883,1054,1260,1561,0,1,0,0,0,0,0,0,0,0,5,0,0,4,0,14.95154709,1,-0.631853652,1.150162153,-0.549360497,0.582758078,0.755945365,31.70971721,0,3.796489935,0.881732733,4.30571509,1.66E-05,0.001039987,9.229224807,0,-1.017084512,1.201727491,-0.846352039,0.397356386,0.539511107,10.64423348,1,-1.439042394,1.200117289,-1.199084795,0.230494976,0.367232357,9.049403627,1,-1.091628249,1.197169799,-0.911840784,0.361852537,0.498789775,Y,-,,ase T,P:proteolysis; F:serine-type endopeptidase activity,IPR015500 (PRINTS); IPR010259 (G3DSA:3.30.70.GENE3D); IPR000209 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); IPR010259 (PFAM); IPR015500 (PANTHER); PTHR10795:SF389 (PANTHER); IPR000209 (SUPERFAMILY); IPR009020 (SUPERFAMILY),1.I.3.1.1,The Bacterial (Planctomycetes) Nuclear Pore-like Complex (B-NPC) Family
RL4_JR_03884,2740,3750,4287,0,9,18,0,0,0,0,1,4,2,14,0,0,6,0,2.240390307,1,0.733655426,1.331064118,0.551179628,0.581510544,0.755334732,0.711720363,0,3.955972474,1.509209768,2.62122109,0.008761542,0.030507165,1.855628132,1,1.296571563,1.256452556,1.031930379,0.302104733,0.443390594,2.141128975,1,0.874059418,1.278544617,0.683636227,0.494204903,0.63307498,1.84191456,1,1.20494118,1.257150328,0.958470243,0.337825689,0.475001403,N,-,,zinc finger,F:nucleic acid binding; F:metal ion binding,no IPS match,,
RL4_JR_03885,29936,30609,33391,18,8,92,0,0,1,1,8,3,13,35,4,0,16,0,290.4113358,1,-0.290427693,0.55378764,-0.524438741,0.599973417,0.76883364,54.4096789,1,-2.300269801,1.191184437,-1.931077783,0.053473434,0.124427149,168.3451376,1,-2.131438837,0.738670569,-2.885506648,0.003907842,0.016192218,170.6770465,1,-3.64427013,1.010473603,-3.60649711,0.000310358,0.002800693,177.4898315,1,-1.160179848,0.541175289,-2.143815269,0.032047691,0.079316274,N,-,,glycolipid 2-alpha-mannosyltransferase,"P:cell wall mannoprotein biosynthetic process; P:mannosylation; C:integral component of membrane; P:protein N-linked glycosylation; C:Golgi apparatus; F:alpha-1,2-mannosyltransferase activity",IPR002685 (PFAM); IPR002685 (PIRSF); IPR029044 (G3DSA:3.90.550.GENE3D); PTHR31121:SF2 (PANTHER); IPR002685 (PANTHER); IPR029044 (SUPERFAMILY),,
RL4_JR_03886,66911,30012,30425,58,76,25,0,4,11,2,7,10,1,2,12,0,0,0,12.98162052,1,-1.800780865,1.200341918,-1.500223259,0.13355658,0.272184507,4.12219422,1,1.422043901,1.253955516,1.134046529,0.256775031,0.412161395,10.73208355,1,-1.234990498,1.199839283,-1.029296602,0.303340319,0.444768644,16.39488034,1,-0.710928583,1.150636003,-0.617857064,0.536669564,0.668443761,10.62068819,0,-1.322553273,1.208001858,-1.094827184,0.273592355,0.406414699,N,-,,dihydroxy-acid dehydratase,F:dihydroxy-acid dehydratase activity; P:branched-chain amino acid biosynthetic process,IPR000581 (PFAM); IPR000581 (PANTHER); PTHR21000:SF13 (PANTHER); PTHR21000:SF13 (PANTHER); IPR000581 (PANTHER); SSF143975 (SUPERFAMILY); IPR015928 (SUPERFAMILY),,
RL4_JR_03887,46661,56818,78265,7,30,87,0,0,0,2,0,8,1,28,2,0,33,3,22.88933083,1,1.657957311,0.784472622,2.113467397,0.034560783,0.101056224,2.4235297,0,2.188440721,1.309393695,1.671338979,0.094654741,0.193907163,12.78797605,1,0.498060291,1.20557925,0.413129449,0.679511774,0.779797915,7.256080044,1,-0.886232934,1.211582351,-0.731467352,0.464493739,0.606369147,6.193576169,1,-0.544428612,1.212924802,-0.44885603,0.653535516,0.752792617,N,-,,hypothetical protein CMQ_7755,,no IPS match,,
RL4_JR_03888,30594,30628,40360,13,17,37,0,0,7,2,3,5,1,4,0,0,2,4,107.498422,1,-1.163149486,0.674679745,-1.72400238,0.084707413,0.19609622,22.23334459,1,-1.009155017,1.201123274,-0.840176057,0.400809681,0.564412297,57.71850722,1,-3.662007242,1.192682865,-3.07039478,0.00213776,0.010370236,94.66632787,1,-0.587228641,0.594482711,-0.987797677,0.323251746,0.469707796,56.97668225,1,-3.746090823,1.196664563,-3.130443516,0.001745426,0.007558783,N,-,,---NA---,,no IPS match,,
RL4_JR_03889,1176,1401,2278,0,3,4,0,0,0,0,2,1,0,2,2,0,0,1,247.7850715,1,0.385242811,0.354558347,1.086542778,0.277238926,0.460237515,133.0788528,0,2.060183412,0.519189294,3.968077604,7.25E-05,0.003691215,137.088604,1,-1.51211563,0.737157906,-2.051277776,0.040239903,0.09608226,128.4195599,1,-2.044326369,0.738828238,-2.766984615,0.005657743,0.030881209,99.30330739,1,-2.762075201,0.975445884,-2.831602704,0.004631536,0.016765927,N,-,,cell wall glucanase,"C:cellular bud neck septin ring; P:fungal-type cell wall organization; F:chitin binding; F:transferase activity, transferring glycosyl groups; C:fungal-type cell wall; C:membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds; P:cell wall chitin metabolic process",IPR013320 (G3DSA:2.60.120.GENE3D); IPR000757 (PFAM); PTHR10963 (PANTHER); PTHR10963:SF22 (PANTHER); IPR000757 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),,
RL4_JR_03890,12371,11488,14301,0,3,12,0,0,4,0,0,7,1,7,1,0,3,0,14.74323774,1,2.459139077,0.896609452,2.742709295,0.00609346,0.025505618,1.04550316,1,3.401203613,1.415729116,2.402439544,0.016286126,0.049164381,9.22114127,1,1.705325958,1.213347664,1.405471827,0.159881021,0.275137763,3.141111074,1,0.321212069,1.238369886,0.259382978,0.795339762,0.868134443,2.697419459,1,0.654597178,1.233593359,0.530642593,0.595666474,0.706468672,N,-,,short chain dehydrogenase reductase,F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24322:SF468 (PANTHER); PTHR24322:SF468 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_03891,1534,1029,1054,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,38.06852159,1,1.229008417,0.668161657,1.839387825,0.065858164,0.163385617,4.834657955,0,1.192052073,1.262137884,0.944470559,0.34492924,0.508149809,19.06248038,1,-0.500550087,1.205606768,-0.4151852,0.678006333,0.778511525,85.30676574,0,1.936201157,0.5915599,3.273043283,0.001063962,0.007772448,19.78800474,0,-0.610279601,1.143516353,-0.533686815,0.593558233,0.704985133,N,-,,hypothetical protein CMQ_4916,,IPR027911 (PFAM),,
RL4_JR_03892,1080,906,1017,0,0,6,0,0,0,0,0,0,0,6,0,0,1,0,858.3990154,1,1.152367114,0.313063537,3.680936866,0.000232379,0.001752074,139.3152559,0,0.238800737,0.651210583,0.366702789,0.713840726,0.820892505,542.6668446,0,0.642726129,0.359985465,1.785422443,0.074192821,0.153793636,435.4698454,1,-0.276324275,0.397789404,-0.69464966,0.487274883,0.627532204,323.5124516,1,-0.704280119,0.47443998,-1.484445134,0.137690869,0.243132202,N,-,,cytochrome c subunit,"F:zinc ion binding; F:cytochrome-c oxidase activity; P:mitochondrial electron transport, cytochrome c to oxygen; P:hydrogen ion transmembrane transport; P:aerobic respiration; C:mitochondrial respiratory chain complex IV",IPR002124 (G3DSA:2.60.11.GENE3D); IPR002124 (PFAM); PTHR10122:SF0 (PANTHER); IPR002124 (PANTHER); IPR002124 (PRODOM); IPR002124 (PROSITE_PROFILES); SSF57802 (SUPERFAMILY),3.D.4.8.1, the proton-translocating cytochrome oxidase (cox) superfamily.
RL4_JR_03893,3899,5051,7711,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,47.03520048,0,1.940207702,0.776456195,2.498798664,0.012461509,0.045283291,2.147312845,0,2.362920599,1.309164997,1.804906642,0.071089292,0.155682782,5.594244184,0,-0.295067605,1.209666069,-0.243924842,0.807289029,0.873930082,6.455384837,1,-0.717782329,1.209827588,-0.593293074,0.552985033,0.681969971,24.84037569,0,2.515418379,0.723198326,3.478186119,0.000504819,0.002733313,N,-,,ohcu decarboxylase,C:cellular_component; F:molecular_function,IPR018020 (G3DSA:1.10.3330.GENE3D); IPR018020 (PFAM); PTHR37987 (PANTHER); PTHR37987:SF1 (PANTHER); SSF158694 (SUPERFAMILY),,
RL4_JR_03894,1150,10938,4503,2,2,7,0,0,0,0,0,0,0,0,0,0,0,0,94.83806381,1,-1.203524116,0.728379161,-1.65233189,0.098466912,0.219060013,21.98952436,0,-0.993274135,1.213058909,-0.818817724,0.412890417,0.576934945,57.40436234,0,-3.654129981,1.207572805,-3.026012151,0.002478023,0.01175059,74.26974923,0,-2.36270641,1.043305869,-2.264634447,0.023535121,0.082950712,84.0047752,0,-0.412088075,0.678571219,-0.607287876,0.543659883,0.665424643,N,-,,cell cycle control,F:ubiquitin-protein transferase activity; P:protein ubiquitination,IPR003613 (SMART); IPR001680 (SMART); IPR013915 (PFAM); IPR001680 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22840 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR003613 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); SSF57850 (SUPERFAMILY),8.A.92.1.4,The G-Protein αβγ Complex (GPC) Family
RL4_JR_03895,1451,2893,1385,0,0,0,0,0,4,0,0,1,0,0,0,0,0,0,53.62114319,0,-0.645855358,0.737825614,-0.875349602,0.381383713,0.573411045,12.26554312,1,-0.151019468,1.210633964,-0.124744119,0.900726128,0.944488746,42.85605143,1,-1.83957608,1.189024808,-1.547130109,0.121831875,0.22450367,119.5128201,0,0.983113206,0.465439165,2.112227073,0.034666977,0.099426657,31.31340735,0,-2.882514131,1.191180683,-2.419879848,0.015525636,0.044670948,N,-,,cell cycle control,P:biological_process; F:ubiquitin-protein transferase activity; C:cellular_component; P:protein ubiquitination,IPR013083 (G3DSA:3.30.40.GENE3D); PTHR28042 (PANTHER),,
RL4_JR_03896,66,48,79,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.749284943,0,2.314163547,1.914912304,1.208495837,0.226856596,NA,0.244690919,0,5.49684056,1.935720321,2.839687376,0.004515777,0.019278233,0.624330953,0,2.869253702,1.404099879,2.043482622,0.041004686,0.097544173,0.719528305,0,2.448044883,1.543690751,1.585838926,0.112775853,0.214071149,0.604100353,0,2.813009623,1.351830768,2.080888888,0.037444077,0.089363212,N,-, Effector probability:0.638,---NA---,,no IPS match,,
RL4_JR_03897,6320,3685,3277,4,6,2,0,0,0,1,5,3,2,1,0,0,7,0,1.512347431,1,1.300988758,1.321834742,0.984229508,0.32500268,NA,0.482215364,0,4.517790149,1.551386539,2.91209833,0.003590096,0.016988757,1.250922736,1,1.866145829,1.225504312,1.522757456,0.127819397,0.232867299,1.443124674,1,1.443727965,1.247373848,1.157414008,0.247103254,0.385860648,1.232407058,1,1.785040435,1.211622259,1.473264809,0.140679646,0.246817088,N,-,,phenazine biosynthesis,F:catalytic activity; P:biosynthetic process; F:isomerase activity,G3DSA:3.10.310.10 (GENE3D); IPR003719 (PFAM); PTHR13774:SF15 (PANTHER); PTHR13774 (PANTHER); SSF54506 (SUPERFAMILY),,
RL4_JR_03898,681,546,664,1,0,7,0,0,1,0,3,0,0,0,2,0,1,0,38.40518648,1,0.065900631,0.765796165,0.086055055,0.931422652,0.966629651,16.73902243,1,1.501830888,1.126730738,1.332910195,0.182561276,0.321875151,19.14827338,1,-2.070254117,1.199392327,-1.726085844,0.08433197,0.169400172,52.75187538,1,0.555620086,0.685039504,0.811077438,0.417321202,0.560915594,22.80609159,1,-1.228511545,1.137673923,-1.079845041,0.28021119,0.413769822,N,-,,formate dehydrogenase,C:membrane,PTHR40978 (PANTHER); PTHR40978:SF3 (PANTHER),,
RL4_JR_03899,640,666,907,0,0,0,0,0,0,0,0,0,2,1,0,0,0,0,7.253400417,0,-0.961052907,1.204628816,-0.797800031,0.424986543,0.616052962,2.304353082,0,2.261093362,1.295563976,1.745257976,0.080939973,0.171683657,5.997200526,0,-0.395469008,1.202957712,-0.328747223,0.742346757,0.827028026,6.919771948,1,-0.8180683,1.201953569,-0.680615559,0.496114779,0.6346383,13.2980401,0,0.454379675,1.134961142,0.400348222,0.688900055,0.779516435,N,-,,acyl- thioesterase ii,F:catalytic activity,IPR029069 (G3DSA:3.10.129.GENE3D); PF13622 (PFAM); IPR029069 (G3DSA:3.10.129.GENE3D); IPR003703 (PANTHER); IPR003703 (PANTHER); PTHR11066:SF39 (PANTHER); PTHR11066:SF39 (PANTHER); PTHR11066:SF39 (PANTHER); IPR029069 (SUPERFAMILY); IPR029069 (SUPERFAMILY),,
RL4_JR_03900,473,363,407,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,62.59704629,0,0.954726573,0.676371672,1.411541335,0.158085056,0.307451483,14.63581466,0,1.986703125,1.136703552,1.747775946,0.080502832,0.171043171,39.5929238,0,1.235396186,0.756230556,1.633623736,0.102337881,0.196933797,25.31851854,0,-1.048065867,1.149667122,-0.911625502,0.361965893,0.508026707,54.41671982,0,1.783871916,0.588089127,3.033335994,0.002418661,0.009938852,N,-,,Peptidase rhomboid domain,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03901,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.899325095,0,2.050714296,1.525907364,1.343931056,0.178970682,NA,0.286169174,0,5.27050356,1.697961808,3.104017732,0.001909119,0.015023052,0.743956357,0,2.615334543,1.24596724,2.099039572,0.035813413,0.087642008,19.48287671,0,3.936872563,1.020721474,3.856950857,0.00011481,0.001200882,0.735098306,0,2.530439747,1.224241993,2.066944086,0.038739423,0.09179421,N,-,,Glycoside catalytic domain,P:carbohydrate metabolic process; F:hydrolase activity,no IPS match,,
RL4_JR_03902,29,21,35,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.563995211,0,-0.292593959,1.261553414,-0.231931487,0.816591228,0.906607409,1.440148834,0,2.939200814,1.381572344,2.12743171,0.03338423,0.086049191,3.762566791,0,0.277147434,1.235660881,0.224290854,0.822530992,0.885130077,4.342577281,0,-0.145827435,1.242170917,-0.117397239,0.906545272,0.942962436,3.734485355,0,0.185448209,1.243807264,0.149097223,0.881476917,0.921618524,N,-,,sodium nucleoside partial,,IPR031818 (PFAM),,
RL4_JR_03903,161,93,116,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.60111862,0,1.003398838,1.14365376,0.877362427,0.380289814,0.572504947,1.150709586,0,3.263061635,1.38414451,2.35745734,0.018400569,0.053834517,2.975966624,0,0.615818215,1.207252107,0.510099101,0.609982035,0.726012006,3.432510977,0,0.193720895,1.208651964,0.160278476,0.872661713,0.921441219,2.923336092,0,0.538564334,1.198945416,0.449198376,0.653288559,0.752593771,N,-,,hypothetical protein CMQ_3294,,IPR022025 (PFAM),,
RL4_JR_03904,2163,1540,2437,2,0,2,0,0,0,0,0,0,0,0,0,0,8,0,14.42702896,1,0.862513771,1.011292987,0.852882184,0.393724642,0.585918576,2.17855991,0,2.342191121,1.30904444,1.789237286,0.073576609,0.159674668,5.632345162,0,-0.304704226,1.200561509,-0.253801429,0.79964897,0.868567842,6.49609373,0,-0.726719026,1.198493544,-0.6063604,0.544275458,0.674515179,5.533443725,1,-0.382078373,1.196366621,-0.319365624,0.749449275,0.825519355,N,-,,thioredoxin,P:single-organism metabolic process,PR00421 (PRINTS); IPR013766 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR005746 (PANTHER); IPR005746 (PANTHER); PTHR10438:SF284 (PANTHER); PTHR10438:SF284 (PANTHER); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY),8.A.88.1.3, the calciquestrin (casq) family.
RL4_JR_03905,206,194,163,0,0,1,0,0,0,0,0,0,0,3,0,0,0,0,151.6831364,1,0.385291152,0.498345757,0.773140227,0.439439396,0.629622313,66.96112244,0,0.672834087,1.005305516,0.669283195,0.503314845,0.656937829,309.4851215,0,2.213826043,0.532102147,4.1605283,3.18E-05,0.0004953,330.6919707,1,2.095888655,0.39384597,5.321594772,1.03E-07,2.30E-06,287.771455,0,2.158318973,0.592062022,3.645427157,0.000266948,0.001594082,N,-,,wd repeat domain-containing,C:intracellular organelle,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR14221 (PANTHER); PTHR14221:SF0 (PANTHER); PTHR14221 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_03906,61,107,61,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,123.840336,0,1.981927859,0.425526794,4.65758652,3.20E-06,4.24E-05,18.40138944,0,1.20896711,1.115345705,1.083939361,0.278391686,0.437423261,114.0714286,0,2.040758646,0.450673647,4.528240466,5.95E-06,0.000120912,54.9923026,0,-0.454297586,0.847956808,-0.535755573,0.59212749,0.715594648,34.38385111,0,-0.769759583,0.976146728,-0.788569547,0.430363636,0.564799975,N,-,,translation factor,"P:nuclear-transcribed mRNA catabolic process, non-stop decay; C:nucleus; P:nucleic acid phosphodiester bond hydrolysis; F:metal ion binding; P:RNA surveillance; F:endonuclease activity; C:cytosol; P:negative regulation of G0 to G1 transition; P:nuclear-transcribed mRNA catabolic process, no-go decay",IPR005140 (SMART); IPR005140 (PFAM); IPR004405 (TIGRFAM); IPR005141 (PFAM); IPR005142 (PFAM); IPR029064 (G3DSA:3.30.1330.GENE3D); IPR004405 (PANTHER); IPR029064 (SUPERFAMILY); SSF53137 (SUPERFAMILY); SSF159065 (SUPERFAMILY),,
RL4_JR_03907,106278,127565,160754,16,15,18,0,0,0,1,2,3,5,27,4,0,38,4,16.89659358,1,3.886350415,0.789381271,4.923286832,8.51E-07,1.34E-05,0.514293156,0,4.42470289,1.548452289,2.857500305,0.004269922,0.018605318,7.839905962,1,2.726296961,1.211624294,2.250117446,0.024441491,0.065306322,11.18292499,1,2.293446592,1.163241088,1.971600399,0.048655242,0.120850936,9.051182883,1,3.331117404,1.014242423,3.284340439,0.001022214,0.004875136,N,-,,Nitrogen assimilation transcription factor nirA,"F:DNA binding; C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (G3DSA:4.10.240.GENE3D),,
RL4_JR_03908,2140,2072,2334,0,5,2,0,0,0,0,4,0,0,0,0,0,0,0,4.631294942,1,-0.313520898,1.286458464,-0.243708528,0.807456568,0.902441818,10.8473639,0,3.822925105,1.186404965,3.222276724,0.001271762,0.015023052,3.81585825,1,0.257161098,1.252037384,0.205394105,0.837264226,0.894896856,4.403052706,0,-0.165518457,1.261322458,-0.131226124,0.895596431,0.935608116,3.75796225,0,0.176440577,1.2536674,0.140739543,0.888075705,0.926604134,N,-, Effector probability:0.888,stress responsive a b barrel domain containing,,IPR013097 (SMART); G3DSA:3.30.70.900 (GENE3D); IPR013097 (PFAM); PTHR33178 (PANTHER); PTHR33178:SF2 (PANTHER); IPR013097 (PROSITE_PROFILES); IPR011008 (SUPERFAMILY),,
RL4_JR_03909,48,61,68,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,180.2679155,0,0.93077654,0.487127939,1.910743492,0.056037553,0.144623333,20.57048498,0,-0.896972672,1.217392639,-0.736798173,0.461245095,0.619840304,89.86559665,0,-0.716364815,0.762196487,-0.939868954,0.347284784,0.490980471,73.62592476,0,-1.685200942,0.885933232,-1.902176012,0.057148148,0.133047826,86.60100717,0,-0.222963888,0.618138876,-0.360701933,0.718322279,0.801610611,N,-,,aldo keto reductase,C:nucleus; C:cytoplasm; F:alditol:NADP+ 1-oxidoreductase activity; P:cellular response to oxidative stress; P:oxidation-reduction process; P:arabinose catabolic process; P:D-xylose catabolic process,IPR020471 (PRINTS); IPR023210 (G3DSA:3.20.20.GENE3D); IPR020471 (PIRSF); IPR023210 (PFAM); PTHR11732:SF206 (PANTHER); IPR001395 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.4, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_03910,1600,1411,3529,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.962897247,0,1.952434316,1.613993366,1.209691661,0.226397231,NA,0.309749791,0,5.156597597,1.752496406,2.94242977,0.003256476,0.016208996,56.14729077,0,6.011045654,1.590593251,3.779121816,0.000157382,0.001533532,0.919520169,0,2.094355713,1.37753686,1.520362739,0.128419834,0.236452231,0.778014075,0,2.448533341,1.266329427,1.933567434,0.053166335,0.117323929,N,-,,nucleoside hydrolase,C:endoplasmic reticulum; F:hydrolase activity,IPR001910 (G3DSA:3.90.245.GENE3D); IPR023186 (PANTHER); PTHR12304:SF25 (PANTHER); IPR001910 (SUPERFAMILY),,
RL4_JR_03911,57,60,96,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,108.1144196,0,-0.547927662,0.641833602,-0.853691145,0.393276142,0.585571594,23.4028219,0,-1.083117882,1.201695375,-0.901324832,0.367415635,0.531988714,76.60604291,0,-1.915423396,1.038793985,-1.843891497,0.065198955,0.138904507,78.31776862,0,-2.441057795,1.026593604,-2.377822915,0.017415187,0.071941563,83.41108733,0,-0.668502514,0.664181359,-1.006505987,0.314172233,0.449673998,N,NRPS-Like,,hybrid NRPS PKS enzyme,F:catalytic activity; P:metabolic process,IPR002347 (PRINTS); SM00822 (SMART); G3DSA:3.40.50.980 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); G3DSA:3.30.300.30 (GENE3D); IPR010080 (TIGRFAM); IPR025110 (PFAM); G3DSA:2.30.38.10 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR009081 (PFAM); IPR000873 (PFAM); IPR013120 (PFAM); G3DSA:3.40.50.980 (GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); PTHR24095:SF163 (PANTHER); PTHR24095 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR016040 (SUPERFAMILY); SSF56801 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR009081 (SUPERFAMILY),4.C.1.1.4, the fatty acid transporter (fat) family.
RL4_JR_03912,22,26,43,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.008115494,0,8.845278576,4.03634189,2.191409652,0.028422161,NA,0.002507343,0,12.10167175,4.040174693,2.995333784,0.002741447,0.015349618,0.006623884,0,9.426891884,3.299070491,2.857438757,0.00427075,0.016940088,0.007651472,0,9.002876608,4.037800151,2.229648886,0.025770762,0.085851084,0.006630333,0,9.341240721,1.70468121,5.479758129,4.26E-08,1.17E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_03913,1703,2571,2580,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.07841425,0,-1.811332411,1.199946538,-1.509510927,0.131168265,0.268762641,4.158729195,0,1.409372019,1.255623363,1.122448069,0.261671976,0.417898981,23.80337919,0,0.57381998,1.038662482,0.552460486,0.580632899,0.702560951,12.46762211,0,-1.667261269,1.197497827,-1.392287511,0.163835352,0.284144046,10.66223678,0,-1.328143641,1.203232896,-1.103812608,0.269674434,0.401951075,N,-,,choline dehydrogenase,F:oxidoreductase activity; P:shamixanthone biosynthetic process,IPR023753 (G3DSA:3.50.50.GENE3D); IPR007867 (PFAM); IPR000172 (PFAM); IPR012132 (PIRSF); PTHR11552 (PANTHER); PTHR11552:SF58 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_03914,2389,2174,2972,0,0,2,0,0,0,2,0,0,0,2,0,0,0,0,34.22023342,1,-3.199136742,1.208946389,-2.646218865,0.008139713,0.032219205,20.21717888,0,0.943385291,1.12847058,0.835985721,0.403162936,0.567016151,28.27345093,1,-2.632447648,1.204494032,-2.185521538,0.028850629,0.074321568,48.67344013,1,-0.361746933,0.780430286,-0.463522418,0.642989949,0.755427389,28.0422714,0,-2.723302832,1.214881166,-2.24162075,0.024985894,0.065285722,N,-,,duf1446 domain-containing,C:membrane,IPR010839 (PFAM); PTHR13943 (PANTHER); PTHR13943:SF46 (PANTHER); PTHR13943:SF46 (PANTHER); PTHR13943 (PANTHER),,
RL4_JR_03915,2119,2005,3625,0,1,5,0,0,0,0,0,0,0,3,0,0,0,0,18.07525884,1,1.412527977,0.968113112,1.459052625,0.144550624,0.289172141,2.080155676,0,2.408672581,1.370359781,1.757693574,0.078799662,0.16834322,47.13858386,0,3.11924806,0.701928018,4.443828969,8.84E-06,0.00016966,18.33498974,1,1.570206138,0.949987258,1.652870735,0.098357174,0.193560037,13.16843493,0,1.279080249,1.067236841,1.198497091,0.230723555,0.358328587,Y,-,,feruloyl esterase B,"P:carbohydrate metabolic process; C:extracellular region; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:cellulose binding",IPR029058 (G3DSA:3.40.50.GENE3D); IPR010126 (PFAM); IPR010126 (TIGRFAM); PTHR11731 (PANTHER); PTHR11731:SF134 (PANTHER); IPR029058 (SUPERFAMILY); IPR029058 (SUPERFAMILY),,
RL4_JR_03916,4213,3857,3866,0,1,5,0,0,0,0,1,0,0,6,4,0,0,2,39.90596171,1,-0.609382416,1.087343684,-0.560432203,0.575184671,0.750296858,6.210705743,0,0.830681889,1.289605176,0.644136597,0.519486861,0.669925596,16.28697745,1,-1.836718672,1.240078031,-1.481131531,0.138571527,0.247213937,18.80145564,1,-2.26000302,1.244828841,-1.815513061,0.069445101,0.150017419,16.23526253,1,-1.93481553,1.257996659,-1.538013251,0.124045375,0.224599324,N,-,,hypothetical protein SPSK_03747,,no IPS match,,
RL4_JR_03917,115,132,187,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,233.9584967,0,-2.663467894,0.804760229,-3.309641552,0.000934155,0.005636714,62.79586498,0,-2.507095975,1.239417537,-2.02280176,0.04309359,0.104929834,215.6687358,0,-1.569968998,0.688101817,-2.28159403,0.02251332,0.06114782,246.2725775,0,-1.612254046,0.64848906,-2.486170002,0.012912627,0.059427429,172.0923372,0,-3.640376609,1.079878407,-3.371098622,0.000748691,0.003786459,N,-,,ribosome assembly rrb1,C:cytosol; P:ribosome biogenesis; C:nucleolus,IPR020472 (PRINTS); IPR001680 (SMART); IPR022052 (PFAM); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22850 (PANTHER); PTHR22850 (PANTHER); PTHR22850:SF6 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),3.A.20.1.1, the peroxisomal protein importer (ppi) family.
RL4_JR_03918,512,523,733,0,0,4,0,0,0,0,0,0,1,0,0,0,4,0,56.30058459,1,2.007247957,0.811993052,2.472001395,0.013435899,0.047990397,3.375757729,0,1.710188438,1.395052906,1.22589504,0.220238176,0.368007345,8.904158346,0,-0.965592031,1.292108475,-0.747299511,0.454882788,0.593971992,19.59440576,1,-0.427611996,1.248019007,-0.342632599,0.731874874,0.821133092,8.93352785,1,-1.072980179,1.317702859,-0.814280831,0.415484088,0.551491399,N,-, Effector probability:0.644,phospho phosphatase,F:phosphatase activity; F:thiosulfate sulfurtransferase activity; P:dephosphorylation,IPR001763 (SMART); IPR001763 (PFAM); IPR001763 (G3DSA:3.40.250.GENE3D); PTHR10828 (PANTHER); IPR001763 (PROSITE_PROFILES); IPR001763 (SUPERFAMILY),,
RL4_JR_03919,6,8,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.1419081,0,0.102938994,1.008679836,0.102053189,0.918714457,0.961445874,3.667828846,0,1.59059409,1.255119942,1.267284534,0.205053569,0.349949793,9.518665389,0,-1.061773421,1.191659956,-0.891003692,0.372927189,0.516935631,10.9812894,0,-1.484153522,1.189093529,-1.248138592,0.211980308,0.346174058,28.68709053,0,1.783717553,0.678202922,2.630064683,0.008536862,0.027668288,N,-,,hypothetical protein CMQ_3356,,IPR028163 (PFAM),,
RL4_JR_03920,573,430,491,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,86.20303718,1,-2.385229295,1.108641666,-2.15148805,0.031437698,0.094047943,30.72142647,0,-0.037524309,1.174532115,-0.031948304,0.974513278,0.986927705,100.391003,0,-0.494431678,1.459882754,-0.338679032,0.734851538,0.821696153,95.44039417,1,-1.007581366,0.791751414,-1.272598127,0.203160684,0.334852991,56.11716778,0,-3.724148066,1.267936716,-2.937171878,0.003312205,0.012804915,N,-,,Ribosomal S21,F:structural constituent of ribosome; C:ribosome; P:translation,IPR001911 (PFAM); PTHR41237 (PANTHER); PTHR41237:SF1 (PANTHER),,
RL4_JR_03921,146,80,71,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,145.7755592,0,-1.409137503,0.668328657,-2.10844992,0.03499209,0.101973684,32.31580126,0,-1.548680549,1.199923434,-1.290649474,0.196825252,0.340151136,84.1922317,0,-4.206643114,1.198671889,-3.50942001,0.000449085,0.003130151,123.7988005,0,-1.896092799,0.759041577,-2.498009141,0.012489297,0.057847271,106.5253744,0,-1.14614771,0.677320568,-1.692179101,0.09061183,0.177289911,N,-,,RNA-binding rbm25,C:nucleus,IPR002483 (SMART); IPR002483 (PFAM); IPR002483 (G3DSA:1.20.1390.GENE3D); PTHR18806 (PANTHER); PTHR18806:SF4 (PANTHER); PTHR18806:SF4 (PANTHER); PTHR18806 (PANTHER); IPR002483 (PROSITE_PROFILES),,
RL4_JR_03922,526,335,395,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,36.32801325,0,4.655762977,0.683926666,6.807400869,9.94E-12,4.23E-10,0.621295874,0,4.151990982,1.517230585,2.736558981,0.006208546,0.023854849,1.621592982,0,1.491028897,1.246818313,1.195867017,0.231748458,0.363080297,1.871282643,1,1.068395417,1.26938342,0.841664859,0.399975574,0.544102201,1.610295951,0,1.398939377,1.246329203,1.122447723,0.261672123,0.39357497,Y,-,,infection structure specific,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; P:carbohydrate metabolic process; F:chitin binding; F:catalytic activity; C:cellular_component",no IPS match,,
RL4_JR_03923,212,172,219,1,2,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,carnitinyl- dehydratase,F:catalytic activity; P:metabolic process,IPR001753 (PFAM); IPR029045 (G3DSA:3.90.226.GENE3D); PTHR11941:SF13 (PANTHER); PTHR11941 (PANTHER); IPR029045 (SUPERFAMILY),,
RL4_JR_03924,52,45,48,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,71.03052421,0,2.334060077,0.479143634,4.871316056,1.11E-06,1.65E-05,4.827741093,0,1.194175552,1.239749607,0.963239307,0.335427443,0.498690363,12.5277189,0,-1.45805342,1.190452984,-1.224788748,0.220654825,0.350142547,18.46426576,1,-0.933027623,1.140138907,-0.818345569,0.413159892,0.556726632,12.34915823,0,-1.540072708,1.193302434,-1.290597139,0.196843408,0.31816078,Y,-,,infection structure specific,C:cellular_component,no IPS match,,
RL4_JR_03925,432,488,357,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.2387269,1,2.06867843,0.805199824,2.569149133,0.010194857,0.038415541,1.829656166,0,2.593948216,1.356188975,1.912674609,0.055789722,0.128771215,4.759884074,0,-0.061843697,1.229883486,-0.050284192,0.959895921,0.976583891,5.492551923,0,-0.484560224,1.233646292,-0.392786998,0.694476809,0.793900608,12.41933216,0,1.507223689,1.022352698,1.474269782,0.140408968,0.246513057,Y,-,,---NA---,,no IPS match,,
RL4_JR_03926,85,118,89,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0.073195219,0,5.670045927,3.92132251,1.445952459,0.148190537,NA,0.023575434,0,8.873177793,2.856741563,3.106048481,0.001896056,0.015023052,0.060570201,0,6.237527714,1.664360544,3.747702225,0.000178462,0.001641007,0.069844875,1,5.813238664,2.736616148,2.124243354,0.0336498,0.098242279,0.058918883,0,6.173085354,1.360587746,4.537072579,5.70E-06,6.35E-05,N,-, Effector probability:0.829,hypothetical protein ANO11243_092120,,no IPS match,,
RL4_JR_03927,192,193,178,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0.023687631,1,7.296282206,3.951530923,1.846444416,0.064827703,NA,0.007512988,0,10.52011027,3.508613538,2.998366778,0.002714308,0.015349618,0.019628416,0,7.855683688,2.049267543,3.833410486,0.000126379,0.00133277,0.022650115,0,7.436112476,3.951487371,1.88185151,0.05985618,0.136569486,0.019541152,0,7.761609809,1.449154076,5.355958994,8.51E-08,1.99E-06,N,-,,hypothetical protein FOQG_11679,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_03928,19,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,88.0903998,0,0.251344805,0.671143282,0.374502452,0.708030532,0.842613141,13.29281582,0,-0.267034652,1.286104504,-0.207630602,0.835517408,0.901326723,34.0997163,0,-2.902699369,1.242997738,-2.335241071,0.019530831,0.054842592,43.31826121,0,-2.380591338,1.203893363,-1.977410468,0.047995252,0.119764935,37.13267165,0,-2.043857795,1.176282021,-1.737557624,0.082288792,0.164952291,N,-,,major facilitator superfamily transporter,P:mycelium development,G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR23502 (PANTHER); PTHR23502:SF15 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.2.33, the major facilitator superfamily (mfs).
RL4_JR_03929,7,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1121.444943,0,-2.968123594,0.856349405,-3.466019333,0.000528225,0.003512031,399.4075115,0,-2.166585441,0.899429053,-2.408845294,0.01600308,0.048481727,871.3927361,0,-4.120493629,0.769222833,-5.356696986,8.48E-08,2.98E-06,1047.180191,0,-3.361231868,0.612825217,-5.484813251,4.14E-08,1.01E-06,852.6700589,0,-3.660596572,1.007612585,-3.632940503,0.00028021,0.001658166,N,-,,2og-fe oxygenase superfamily,F:oxidoreductase activity; P:oxidation-reduction process,IPR005123 (PFAM); G3DSA:1.20.1280.50 (GENE3D); PTHR33099 (PANTHER); PTHR33099:SF6 (PANTHER); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY),,
RL4_JR_03930,359,256,196,0,2,0,0,0,0,1,0,0,0,0,0,0,0,0,39.7622168,1,-3.415692355,1.292297091,-2.643116957,0.008214665,0.032452901,12.61449987,0,-0.191536864,1.304273848,-0.146853258,0.883247847,0.933998611,39.46213629,1,-1.892053271,1.264392691,-1.496412693,0.134546144,0.241686508,42.04929283,0,-2.335025293,1.232828569,-1.894038921,0.058219844,0.134798976,32.83456372,0,-2.950935503,1.286315941,-2.294098525,0.02178484,0.058538085,N,-,,hypothetical protein CMQ_4248,,IPR010733 (PFAM); IPR010733 (PANTHER),,
RL4_JR_03931,1775,1870,1753,6,0,13,0,0,3,12,4,19,4,38,25,0,18,14,24.74827915,1,-2.731666776,1.232319345,-2.216687409,0.02664446,0.082679918,7.940030283,1,0.476351625,1.275844283,0.373361884,0.708879124,0.816857296,27.07066689,1,-1.211880755,1.226118651,-0.988387832,0.322962745,0.465765645,23.7273335,1,-2.595712604,1.231286605,-2.108130304,0.03501972,0.099498352,20.29413784,1,-2.25681001,1.236548445,-1.825088227,0.067987717,0.141874615,Y,-, Effector probability:0.828,hypothetical protein VM1G_03608,P:cellular nitrogen compound biosynthetic process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_03932,4491,4892,4702,6,6,8,0,0,2,0,0,2,0,11,2,0,8,2,90.59812263,1,-3.512465372,1.211980379,-2.898120657,0.003754061,0.017138015,26.28175778,1,-1.250498976,1.249287487,-1.000969744,0.316841436,0.478664392,68.4884245,1,-3.90882262,1.238483747,-3.156135581,0.001598745,0.008296103,91.05540531,1,-2.080674914,0.953870446,-2.181297181,0.029161443,0.090709557,67.98677996,1,-4.000971441,1.25042872,-3.199679739,0.001375804,0.006198347,N,-,,phosphoesterase,C:membrane; C:integral component of membrane; F:hydrolase activity,IPR004843 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); PTHR12905 (PANTHER); PTHR12905 (PANTHER); PTHR12905:SF0 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_03933,1426,1780,1209,0,0,0,0,0,0,0,5,0,4,0,3,0,5,3,160.0197697,0,-0.550063804,0.570702845,-0.963835748,0.335128281,0.525259658,29.36352833,0,-1.410471636,1.219791105,-1.156322284,0.247549357,0.400911134,76.60621034,1,-4.070426636,1.215442583,-3.348925479,0.000811256,0.004871386,88.39791201,1,-4.493142218,1.219792877,-3.68352882,0.000230027,0.002160507,76.06220515,1,-4.162893005,1.226435567,-3.39430225,0.000688037,0.003541625,N,-,,cyanamide hydratase,P:cyanamide metabolic process; F:cyanamide hydratase activity,IPR003607 (SMART); IPR006674 (G3DSA:1.10.3210.GENE3D); IPR006674 (PFAM); IPR017771 (TIGRFAM); PTHR35569:SF3 (PANTHER); PTHR35569 (PANTHER); SSF109604 (SUPERFAMILY),,
RL4_JR_03934,24601,20783,23812,3,6,15,0,2,0,1,1,3,2,7,7,0,2,4,435.5883002,1,-3.413756575,0.629759243,-5.420732785,5.94E-08,1.24E-06,136.2260699,1,-2.604604083,1.118276305,-2.329123914,0.019852502,0.057184697,424.2232235,1,-1.876979449,0.495391328,-3.78888233,0.000151327,0.001488853,382.9598066,1,-5.646386295,1.151107551,-4.905177009,9.33E-07,1.72E-05,346.3868174,1,-3.329302285,0.707451509,-4.706050155,2.53E-06,3.18E-05,N,-,,U-box domain-containing,F:ubiquitin-protein transferase activity; P:protein ubiquitination,IPR003613 (SMART); IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); IPR003613 (PFAM); PTHR22904:SF345 (PANTHER); PTHR22904 (PANTHER); IPR013026 (PROSITE_PROFILES); IPR003613 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR011990 (SUPERFAMILY),1.A.87.4.2, the mechanosensitive calcium channel (mca) family.
RL4_JR_03935,1002,1014,1436,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20.26562335,0,-0.767278564,1.14682234,-0.669047452,0.503465209,0.690065385,3.908433883,0,1.498957687,1.259375433,1.190238946,0.23395249,0.384177012,29.6308347,0,1.249620425,0.856343593,1.459251211,0.144495978,0.254901078,31.74961548,0,1.453875242,0.679922525,2.138295451,0.032492772,0.096477804,39.43952359,0,1.416089046,0.74764923,1.89405538,0.058217659,0.125576012,N,-,,duf803 domain membrane,C:membrane; P:transport,IPR008521 (PFAM); IPR008521 (PANTHER); PTHR12570:SF5 (PANTHER); SSF103481 (SUPERFAMILY),2.A.7.25.7, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_03936,2369,2628,3683,0,0,2,0,0,0,0,0,0,0,6,0,0,0,0,96.62278374,1,1.27853151,0.947095188,1.349950381,0.1770319,0.332694365,10.161627,0,0.120487383,1.218349087,0.098893974,0.921222453,0.956566852,26.28959216,0,-2.527418836,1.189672963,-2.124465222,0.033631261,0.083945485,66.28265491,1,0.108674383,0.66491789,0.163440305,0.870171771,0.920155528,25.84477502,0,-2.605618138,1.187905,-2.193456663,0.028274494,0.071893332,Y,-,,glucose sorbosone dehydrogenase,F:catalytic activity,IPR011042 (G3DSA:2.120.10.GENE3D); PTHR19328:SF37 (PANTHER); PTHR19328 (PANTHER); PTHR19328:SF37 (PANTHER); PTHR19328 (PANTHER); IPR011041 (SUPERFAMILY),,
RL4_JR_03937,1966,1461,1767,0,0,0,0,0,0,0,4,1,4,0,0,0,6,0,63.62273694,0,1.581993244,0.503125149,3.144333467,0.001664656,0.008946157,6.913679725,0,0.676065205,1.227906459,0.550583638,0.581919128,0.720707563,43.91342856,1,0.842172552,0.741958032,1.135067639,0.256346979,0.392507081,88.57765525,1,1.52097002,0.512207656,2.969440228,0.002983428,0.018534092,25.01902241,1,-1.121548917,1.121036045,-1.000457498,0.317089156,0.452240931,Y,-,,hypothetical protein CMQ_3762,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,IPR028000 (PFAM),,
RL4_JR_03938,852,646,1195,0,0,2,0,0,0,0,0,3,1,0,0,0,5,0,60.92603835,1,-0.054136136,0.609968101,-0.088752405,0.929278683,0.96586144,12.1592392,0,-0.138459755,1.210419065,-0.114389932,0.908928695,0.949320657,57.50424524,1,0.027860354,0.741879307,0.037553756,0.970043479,0.982665778,93.33323473,1,0.830275433,0.487243522,1.704025594,0.088376306,0.178637851,64.71635313,1,0.342196649,0.615318173,0.556129599,0.578122262,0.691329621,N,-,,transcriptional adapter 2-alpha,"P:positive regulation of histone acetylation; F:zinc ion binding; C:Ada2/Gcn5/Ada3 transcription activator complex; F:chromatin binding; P:chromatin silencing at telomere; C:SAGA complex; P:regulation of transcription from RNA polymerase II promoter; C:chromosome, telomeric region; F:DNA binding; F:histone acetyltransferase activity; F:phosphatidylserine binding; P:cellular response to osmotic stress; C:SLIK (SAGA-like) complex; F:transcription coactivator activity; P:chromatin silencing at rDNA; P:histone acetylation; P:regulation of reciprocal meiotic recombination",IPR001005 (SMART); IPR016827 (PIRSF); IPR001005 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); IPR007526 (PFAM); IPR016827 (PTHR12374:PANTHER); PTHR12374 (PANTHER); IPR017884 (PROSITE_PROFILES); IPR007526 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY); IPR009057 (SUPERFAMILY),,
RL4_JR_03939,276,253,472,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,39.50080844,1,-0.777672597,1.013036929,-0.767664608,0.442686468,0.632032937,6.810259111,0,0.697768303,1.22634149,0.568983687,0.569367211,0.710445624,56.92959793,0,1.188535434,0.674927547,1.760982256,0.078241406,0.160023434,33.76327823,0,-0.646085081,1.016859137,-0.635373237,0.525185019,0.659364348,25.23279146,0,-0.378782327,0.985630837,-0.38430446,0.700752803,0.788259319,N,-,,DNA repair,"P:nucleotide phosphorylation; C:site of double-strand break; P:DNA double-strand break processing involved in repair via synthesis-dependent strand annealing; P:base-excision repair; P:reciprocal meiotic recombination; P:double-strand break repair via break-induced replication; P:DNA catabolic process, endonucleolytic; F:double-stranded telomeric DNA binding; F:single-stranded telomeric DNA binding; F:endodeoxyribonuclease activity; P:double-strand break repair via nonhomologous end joining; P:ascospore formation; P:regulation of transcription involved in meiotic cell cycle; F:adenylate kinase activity; F:3'-5' exonuclease activity; F:protein complex scaffold; P:mitochondrial double-strand break repair via homologous recombination; F:G-quadruplex DNA binding; C:mitochondrion; F:manganese ion binding; C:Mre11 complex; P:intra-S DNA damage checkpoint; P:cellular protein localization",IPR007281 (SMART); IPR029052 (G3DSA:3.60.21.GENE3D); IPR004843 (PFAM); IPR007281 (PFAM); IPR003701 (TIGRFAM); IPR003701 (PIRSF); IPR003701 (PTHR10139:PANTHER); PTHR10139 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_03940,5935,4554,6252,0,1,4,0,3,0,0,0,3,1,0,0,0,3,0,18.74674771,1,-0.574627253,1.164368346,-0.493509855,0.621652378,0.783113048,3.399194098,1,1.700235237,1.27787822,1.330514294,0.18334888,0.322813944,8.868487128,1,-0.959840976,1.210863414,-0.792691367,0.427957661,0.568662995,10.23425226,1,-1.382644388,1.211134015,-1.141611392,0.253615587,0.393250116,8.796424892,1,-1.050657768,1.221408133,-0.860202041,0.38967768,0.525719542,N,-,,anaphase-promoting complex subunit 10,P:protein K11-linked ubiquitination; C:anaphase-promoting complex; C:mitochondrion; P:anaphase-promoting complex-dependent catabolic process; P:chromatin assembly; C:cytosol; F:enzyme regulator activity,IPR004939 (SMART); IPR008979 (G3DSA:2.60.120.GENE3D); IPR004939 (PFAM); PTHR12936 (PANTHER); PTHR12936:SF0 (PANTHER); IPR004939 (PROSITE_PROFILES); IPR008979 (SUPERFAMILY),,
RL4_JR_03941,3049,3087,3291,0,3,18,0,0,5,0,7,0,1,10,1,0,0,0,13.75175645,1,-1.883973799,1.200565067,-1.569239228,0.116592207,0.247490872,23.12692173,1,2.975849131,0.996765948,2.985504407,0.002831111,0.015349618,11.37540547,1,-1.318998508,1.200692946,-1.098531071,0.271972658,0.410595167,17.13684526,1,-0.794976578,1.151749082,-0.690234176,0.490046935,0.629980347,26.70169232,0,1.184705367,0.782011961,1.514945328,0.12978625,0.231965716,N,-,,cytidylyltransferase,F:catalytic activity,IPR014729 (G3DSA:3.40.50.GENE3D); IPR004821 (PFAM); PTHR31285 (PANTHER); SSF52374 (SUPERFAMILY),,
RL4_JR_03942,3371,3410,3791,1,0,12,0,0,0,2,0,2,4,2,0,0,1,0,40.66609381,1,-1.432499667,1.041627834,-1.375250949,0.169053658,0.321552749,10.45577631,0,0.079226146,1.226312347,0.064605193,0.94848835,0.97250801,33.78041112,1,-1.619136596,1.204709313,-1.344006042,0.178946433,0.299002094,56.84188126,1,0.022875234,0.706190154,0.032392457,0.974159077,0.985055494,34.78422356,1,-1.014128953,1.007001223,-1.007078175,0.313897209,0.449534545,N,-,,mitochondrial ribosomal s19,F:RNA binding; F:structural constituent of ribosome; P:mitochondrial translation; C:mitochondrial small ribosomal subunit,IPR002222 (PRINTS); IPR002222 (PFAM); IPR023575 (G3DSA:3.30.860.GENE3D); IPR002222 (PIRSF); IPR002222 (PANTHER); PTHR11880:SF8 (PANTHER); IPR023575 (SUPERFAMILY),,
RL4_JR_03943,4296,3441,4928,1,0,10,0,0,1,0,2,3,2,0,0,0,0,1,86.93486409,1,-0.975966492,0.779369978,-1.252250561,0.210478578,0.377713206,16.09316091,1,-0.542913818,1.216055757,-0.446454708,0.655268822,0.777929981,61.47380619,1,-0.806778633,0.876041564,-0.920936479,0.357083592,0.500569688,58.07582799,1,-2.673804525,1.160027863,-2.304948537,0.021169456,0.078888752,41.64196174,1,-3.293745005,1.214654285,-2.711672816,0.006694463,0.022799005,N,-, Effector probability:0.701,Transcription initiation factor TFIID subunit 10,F:translation initiation factor activity; F:protein complex scaffold; F:identical protein binding; P:RNA polymerase II transcriptional preinitiation complex assembly; C:transcription factor TFIID complex; C:SLIK (SAGA-like) complex; P:histone acetylation; F:chromatin binding; P:translational initiation; C:SAGA complex; P:regulation of transcription from RNA polymerase II promoter,IPR003923 (PFAM); IPR003923 (PIRSF); PTHR21242:SF0 (PANTHER); PTHR21242:SF0 (PANTHER); IPR003923 (PANTHER); IPR003923 (PANTHER),,
RL4_JR_03944,1762,1523,2830,0,2,1,0,0,0,0,0,0,0,2,0,0,0,0,31.76525223,1,1.833104074,0.714422229,2.565855315,0.010292175,0.038728581,2.703988786,0,2.030484388,1.308478197,1.55179077,0.120712295,0.23477111,34.34560455,0,2.192098323,0.769164759,2.849972386,0.004372302,0.017177024,20.1176556,1,1.243973795,0.887861668,1.401089651,0.161187266,0.280705378,6.887206051,0,-0.697596324,1.214549774,-0.574366188,0.565720029,0.682834381,N,-,,glycoside hydrolase family 5,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR013781 (G3DSA:3.20.20.GENE3D); IPR001547 (PFAM); PTHR34142 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_03945,20,11,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.43897384,0,0.193077867,1.010001658,0.191165891,0.848395626,0.923936927,3.464474649,0,1.672911926,1.270962495,1.316255934,0.188088156,0.328586177,15.45988656,0,-0.012914159,1.193996428,-0.010815911,0.99137032,0.996346293,22.37034619,0,0.905432516,0.857991418,1.055293208,0.291291246,0.435961171,8.809913558,0,-1.053004028,1.195168906,-0.881050388,0.378290548,0.514050704,N,-,,alternative oxidase,C:membrane; C:integral component of membrane,IPR019378 (PFAM),,
RL4_JR_03946,4,0,1,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,42.42886119,1,-1.4921692,1.005023516,-1.484710732,0.137620468,0.278290451,20.50957527,0,0.905920991,1.117973256,0.810324385,0.417753764,0.581748499,57.50129974,0,0.161101207,0.737706119,0.21838128,0.82713205,0.888475848,61.32221985,1,0.433415179,0.572414097,0.757170694,0.448947605,0.590874107,28.34000443,0,-2.73854682,1.186148397,-2.308772518,0.020956208,0.056724284,N,-,,dual specificity phosphatase,F:phosphatase activity; P:dephosphorylation,IPR000340 (PFAM); IPR029021 (G3DSA:3.90.190.GENE3D); PTHR12305 (PANTHER); PTHR12305:SF32 (PANTHER); PTHR12305 (PANTHER); PTHR12305:SF32 (PANTHER); IPR029023 (PROSITE_PROFILES); IPR029021 (SUPERFAMILY),1.A.51.2.3, the voltage-gated proton channel (vpc) family
RL4_JR_03947,1113,627,1201,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,163.3694284,0,-1.530114152,0.604181104,-2.532542214,0.011323873,0.0418199,58.48172121,0,-0.20974674,1.000085257,-0.20972886,0.8338793,0.900418847,125.0913645,0,-2.661488271,1.041336872,-2.555837927,0.010593245,0.034220169,118.7510745,0,-4.918990083,1.202307134,-4.091292436,4.29E-05,0.000512796,227.4610518,0,-0.127060764,0.677043702,-0.187669959,0.851135381,0.901060825,N,-,,endoplasmic reticulum,"C:cell division site; C:Golgi apparatus; P:nuclear pore complex assembly; C:nuclear pore; P:establishment of spindle pole body localization to nuclear envelope; C:nuclear membrane; P:nuclear envelope organization; P:mitotic cytokinesis, site selection; C:integral component of membrane; F:structural constituent of nuclear pore; C:cortical endoplasmic reticulum; P:endoplasmic reticulum tubular network organization; P:cellular protein localization; P:organic substance transport",IPR005344 (PFAM); PTHR12703 (PANTHER); PTHR12703:SF4 (PANTHER),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_03948,25736,9338,6830,8,3,1,0,0,0,16,66,193,14,13,41,0,49,91,44.78081838,1,5.23418834,0.627153061,8.345950394,7.06E-17,5.98E-15,0.316034818,0,5.127256822,1.672526843,3.065575206,0.002172517,0.015045494,0.821824344,1,2.471508819,1.247239004,1.981583971,0.047525823,0.108857789,8.971348497,1,3.768234441,1.033921455,3.644604165,0.000267804,0.002460877,0.812688907,1,2.385446842,1.228841529,1.941216004,0.052232083,0.11573742,N,-,,iron zinc ion transporter,P:transmembrane transport; C:cell division site; C:cell tip; C:membrane; C:integral component of membrane; C:Golgi apparatus,IPR007251 (PFAM),9.A.9.1.1, the low affinity fe(2+) transporter (fet) family.
RL4_JR_03949,15,9,8,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,28.93856685,1,-0.799657562,1.0413376,-0.767913847,0.44253837,0.632032937,25.59548883,0,2.318240379,1.027399762,2.256415141,0.024044644,0.066497238,25.54156671,0,-0.994842246,1.210652135,-0.821740794,0.411224436,0.553388663,48.49373108,0,1.070483552,0.655861771,1.632178609,0.102641866,0.199778718,40.59302637,0,1.10264408,0.690655571,1.596518042,0.110373181,0.205541375,Y,-,,cell wall,,no IPS match,,
RL4_JR_03950,744,727,1373,1,0,0,0,0,0,2,0,0,0,0,0,0,0,0,19.98041531,1,-0.731199749,1.165731134,-0.627245621,0.530498243,0.714327258,3.853639141,0,1.519381384,1.296456784,1.171949117,0.241217486,0.393172848,9.92877911,1,-1.122496781,1.215434103,-0.923535696,0.355728107,0.499274267,11.44964162,0,-1.544286918,1.215504212,-1.270490799,0.203909858,0.335575281,9.708878366,0,-1.193109398,1.211147584,-0.985106534,0.324571744,0.460651656,N,-,,hypothetical protein HMPREF1624_08161,C:membrane; C:integral component of membrane,IPR033400 (PFAM); IPR008979 (G3DSA:2.60.120.GENE3D); IPR008979 (SUPERFAMILY),,
RL4_JR_03951,3421,4612,3595,0,0,2,0,0,2,0,0,1,0,18,0,0,0,0,0.441188469,1,3.078361704,2.216139628,1.38906487,0.164813025,NA,0.139069115,1,6.311612273,2.03304514,3.104511626,0.001905934,0.015023052,0.362762896,1,3.652338927,1.375292169,2.655682196,0.007914817,0.02714101,0.418692807,1,3.229074884,1.58641841,2.035449705,0.041805644,0.11083586,0.358743545,0,3.566450371,1.314874409,2.712388611,0.006680023,0.02276514,N,-, Effector probability:0.593,Short-chain dehydrogenase reductase SDR,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); IPR002347 (PANTHER); PTHR24322:SF484 (PANTHER); IPR002347 (PANTHER); PTHR24322:SF484 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_03952,779,572,480,0,0,0,0,0,0,0,1,0,0,3,0,0,2,2,0.632159737,0,2.559293119,1.823263862,1.403687734,0.160411857,NA,0.199635776,0,5.789871778,1.840119368,3.146465322,0.001652569,0.015023052,0.5214736,1,3.12778969,1.291682903,2.421484161,0.015457275,0.045557336,0.601842111,1,2.705122068,1.40449146,1.926050919,0.054098016,0.128216857,0.517641589,1,3.036860432,1.259936736,2.410327714,0.015938197,0.045585945,N,-,,Ankyrin repeat domain-containing 27,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR002110 (SMART); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24198 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),1.A.4.7.2, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_03953,4,9,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.70474055,0,-0.135145054,1.159558232,-0.116548743,0.907217658,0.955051208,2.50115891,0,2.1428619,1.293253997,1.656953627,0.097528851,0.198566325,6.514137005,0,-0.514689134,1.206388272,-0.426636387,0.66964419,0.772590061,7.516730861,0,-0.937378351,1.205979586,-0.777275471,0.436996263,0.578679985,6.446419754,0,-0.602195085,1.213637234,-0.49619035,0.619760118,0.726136056,N,-,,duf1857 domain containing,,IPR023393 (G3DSA:3.30.530.GENE3D); IPR015075 (PFAM); SSF55961 (SUPERFAMILY),,
RL4_JR_03954,3074,3120,1544,0,0,21,0,0,0,0,0,0,0,0,0,0,0,0,59.16433727,1,3.301948307,0.513733722,6.427353637,1.30E-10,4.40E-09,2.259553774,0,2.289422016,1.29917357,1.762214125,0.078033126,0.167164298,18.87129279,0,1.452931361,1.038953932,1.398456002,0.161976176,0.277615421,10.7883427,0,0.158662549,1.150809794,0.13787035,0.890342884,0.932428807,5.806184587,0,-0.451378209,1.208345452,-0.373550633,0.708738668,0.794418135,N,-,,short-chain dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); IPR002347 (PANTHER); PTHR24322:SF484 (PANTHER); PTHR24322:SF484 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_03955,710,929,1005,0,0,0,0,0,0,0,0,2,0,1,0,0,3,0,2.024454173,0,0.880200841,1.305302478,0.674327105,0.500103375,NA,0.652993152,0,4.080524068,1.52145583,2.681986546,0.00731864,0.026820882,1.681438521,1,1.439619317,1.241389971,1.159683379,0.24617774,0.380388192,1.938854311,1,1.017840649,1.260218021,0.807670286,0.419280413,0.562312308,1.644232943,1,1.368554739,1.223249705,1.118786077,0.263231413,0.395374285,N,-,,major facilitator superfamily transporter,C:membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501:SF77 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_03956,271,428,215,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.28928112,0,-1.153616635,1.218774408,-0.946538283,0.343874106,0.533940799,2.677276949,0,2.044827966,1.326041541,1.54205423,0.123060416,0.237804034,29.03256425,0,1.243982473,1.051571605,1.182974576,0.236819224,0.369309584,19.98217967,0,1.263866971,0.895916301,1.410697595,0.1583338,0.276974729,6.742940363,0,-0.667288725,1.214844196,-0.549279263,0.582813816,0.695543362,N,-,,fungal transcriptional regulatory,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31845 (PANTHER); PTHR31845:SF14 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_03957,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.257582398,0,-0.192452832,1.230308473,-0.156426487,0.875696861,0.939867402,1.373083457,0,3.008180608,1.388777459,2.16606382,0.03030631,0.07965615,10.03768329,0,1.327562391,1.210675246,1.096547067,0.272839437,0.411658191,32.16191727,0,3.40762852,0.638106517,5.340218959,9.28E-08,2.12E-06,3.466631083,0,0.29245851,1.215058434,0.240695016,0.809791502,0.871321887,N,-,,cupin 2 domain-containing,,IPR014710 (G3DSA:2.60.120.GENE3D); PTHR36156 (PANTHER); IPR011051 (SUPERFAMILY),,
RL4_JR_03958,3,5,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003906015,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,0,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,N,-,,kinase-like domain,C:membrane; C:integral component of membrane; P:phosphorylation; F:kinase activity,G3DSA:3.90.1200.10 (GENE3D); IPR011009 (SUPERFAMILY),,
RL4_JR_03959,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49.39701433,0,-3.728710611,1.223018,-3.048778196,0.002297741,0.011679108,15.62573169,0,-0.500393083,1.227580816,-0.407625368,0.683548737,0.798946918,40.82195798,0,-3.162331931,1.213915459,-2.605067681,0.009185611,0.030600569,47.11065178,0,-3.585202006,1.217293805,-2.945223241,0.003227217,0.019755486,40.57312058,0,-3.256232877,1.225946514,-2.656097015,0.007905087,0.025969826,N,-,,alpha-glucosidase,P:carbohydrate metabolic process; F:catalytic activity,IPR006047 (SMART); IPR006047 (PFAM); G3DSA:3.90.400.10 (GENE3D); IPR013780 (G3DSA:2.60.40.GENE3D); IPR013781 (G3DSA:3.20.20.GENE3D); IPR015902 (PANTHER); PTHR10357:SF136 (PANTHER); IPR015902 (PANTHER); IPR017853 (SUPERFAMILY),8.A.9.1.2, the rbat transport accessory protein (rbat) family.
RL4_JR_03960,389,271,274,0,0,4,0,0,0,5,0,4,1,1,1,0,2,0,20.97431874,1,-2.492830933,1.220272784,-2.042847276,0.041067559,0.114854009,6.639373546,0,0.734448699,1.25361047,0.585866755,0.55796506,0.702061382,17.29702659,1,-1.923461135,1.213130908,-1.585534687,0.112844902,0.211798627,23.97221493,1,-1.400654103,1.167327103,-1.19988142,0.230185397,0.366796843,24.47274263,1,-1.070617506,1.149937682,-0.931022197,0.351842082,0.489030476,N,-,,MFS SP general alpha glucoside:H+ symporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR003663 (TIGRFAM); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500 (PANTHER); PTHR23500:SF100 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.10, the major facilitator superfamily (mfs).
RL4_JR_03961,73,68,77,0,0,0,0,0,0,0,0,2,0,1,5,0,2,0,27.99484503,0,0.104455244,0.942472723,0.110831052,0.911750321,0.956734502,5.246485504,0,1.074186828,1.292705065,0.830960485,0.405995953,0.569891975,13.6307877,1,-1.57974543,1.230484478,-1.283840193,0.199197877,0.324590263,19.73980683,1,-1.0579817,1.185986512,-0.892068915,0.372355995,0.518156192,13.42711329,1,-1.660803642,1.237236506,-1.342349368,0.179482743,0.296938362,N,-,,sucrose utilization SUC1,"C:nucleus; F:zinc ion binding; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31001 (PANTHER); PTHR31001:SF28 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_03962,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.642229375,0,1.182170803,1.305590329,0.905468412,0.365217287,NA,0.524683471,0,4.396061775,1.534935017,2.864005138,0.004183212,0.018371529,1.35901217,0,1.746742218,1.224801112,1.42614356,0.153826907,0.267488633,1.56768654,0,1.324399414,1.243813738,1.064789183,0.286971341,0.431159643,1.336557865,0,1.667931489,1.209694301,1.378804122,0.167955155,0.28224829,N,-,,hypothetical protein ZTR_03659,,no IPS match,,
RL4_JR_03963,12,13,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.986743961,0,1.916982037,1.50708773,1.271977735,0.20338103,NA,0.312946225,0,5.14146413,1.679972236,3.060445894,0.002210077,0.015045494,0.814695668,0,2.484563904,1.253157536,1.98264291,0.047407331,0.108684741,0.940082405,0,2.061922133,1.30675441,1.577895676,0.114589578,0.216822927,0.805539587,0,2.398747442,1.233927053,1.94399453,0.051896111,0.115154092,N,-,,ariadne ring,F:zinc ion binding; F:metal ion binding,IPR002867 (SMART); IPR002867 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR22770 (PANTHER); PTHR22770:SF34 (PANTHER); IPR007087 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); SSF57850 (SUPERFAMILY),,
RL4_JR_03964,0,4,4,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,79.87065988,1,0.709540973,0.580909221,1.221431762,0.221922587,0.391447452,11.43283345,0,-0.049550772,1.242390222,-0.039883421,0.968186069,0.983587184,59.47441475,0,0.129139541,0.769444921,0.167834678,0.86671334,0.915356338,84.52767211,0,0.266885232,0.666388706,0.40049483,0.68879209,0.789630878,51.26493656,0,-0.135804924,0.764590016,-0.177617967,0.859023013,0.906284048,N,-,,fatty acid desaturase,C:membrane; P:single-organism metabolic process,IPR001199 (SMART); IPR001199 (PFAM); IPR005804 (PFAM); IPR001199 (G3DSA:3.10.120.GENE3D); IPR012171 (PIRSF); PTHR19353:SF20 (PANTHER); PTHR19353 (PANTHER); IPR001199 (PROSITE_PROFILES); IPR001199 (SUPERFAMILY),,
RL4_JR_03965,3,3,1,0,0,3,0,0,0,0,0,0,4,8,0,0,0,2,26.40914259,1,2.035047475,0.705097614,2.886192542,0.003899335,0.017702158,2.358630039,0,2.22763935,1.325675458,1.680380621,0.092883284,0.19136263,38.57365949,0,2.709469456,0.70169559,3.861317494,0.000112777,0.001250555,26.28158092,1,0.91759926,1.031339558,0.889715955,0.373618425,0.519199362,13.32159466,1,0.448360681,1.134630787,0.395159982,0.692724824,0.782096214,N,-,,phospholipase carboxylesterase,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03966,84,89,79,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.656143462,0,0.488626105,1.270489332,0.384596779,0.700536181,0.838793781,0.847494803,0,3.704323331,1.452792835,2.549794604,0.01077864,0.035595887,2.19518357,0,1.055006449,1.228931393,0.858474651,0.390630422,0.534280248,2.532369485,0,0.632628631,1.239616779,0.510342101,0.609811812,0.729827967,2.157261544,0,0.977274752,1.220233748,0.80089143,0.423194502,0.558537291,N,-,,glyoxalase family,F:kynurenine 3-monooxygenase activity; F:dioxygenase activity; F:flavin adenine dinucleotide binding; P:kynurenine metabolic process; F:NAD(P)H oxidase activity; P:secondary metabolite biosynthetic process; P:NAD metabolic process; P:oxidation-reduction process,IPR004360 (PFAM); IPR029068 (G3DSA:3.10.180.GENE3D); PTHR13789 (PANTHER); PTHR13789:SF237 (PANTHER); IPR029068 (SUPERFAMILY),,
RL4_JR_03967,7,4,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.480186498,0,0.098443178,1.24714904,0.078934574,0.937084663,0.96903748,1.102368612,0,3.324803761,1.395291506,2.382873935,0.017178076,0.051170242,2.874674507,0,0.665323865,1.222483137,0.544239708,0.58627653,0.7068644,12.95259077,0,1.19384814,1.159774148,1.029379851,0.303301213,0.448899983,2.849502381,0,0.575635548,1.22712259,0.469093758,0.63900262,0.740602281,N,-,,magnesium dependent phosphatase,F:phosphatase activity; P:dephosphorylation,IPR023214 (G3DSA:3.40.50.GENE3D); IPR010036 (PFAM); IPR024734 (PANTHER); IPR024734 (PANTHER); PTHR17901:SF14 (PANTHER); PTHR17901:SF14 (PANTHER); IPR023214 (SUPERFAMILY),,
RL4_JR_03968,11,15,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.667446928,0,2.481041041,1.733649016,1.431109191,0.152398924,NA,0.213061275,0,5.696262895,1.804489708,3.156716756,0.001595563,0.015023052,0.552004618,0,3.046765254,1.264885214,2.40872865,0.016008195,0.04693512,0.636785148,0,2.624189615,1.356570312,1.934429488,0.053060344,0.126799434,0.542873675,0,2.968098774,1.227179482,2.418634615,0.01557888,0.04477325,N,-,,hypothetical protein SPSK_03594,,no IPS match,,
RL4_JR_03969,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,84.80069051,0,-1.712455353,0.842431004,-2.032754428,0.042077339,0.117036118,28.83818395,0,0.100386752,1.112573044,0.090229358,0.928104955,0.959733049,71.2692917,0,-1.061489723,0.847750453,-1.25212522,0.210524239,0.338241052,111.4659878,0,-0.156509688,0.532514135,-0.293907105,0.768828889,0.849994059,72.47912405,0,-0.609180066,0.669596098,-0.909772425,0.36294254,0.499771099,N,-,,sec14 cytosolic factor,,IPR011074 (SMART); IPR001251 (SMART); IPR001251 (G3DSA:3.40.525.GENE3D); IPR001251 (PFAM); IPR011074 (PFAM); G3DSA:1.10.8.20 (GENE3D); PTHR23324 (PANTHER); PTHR23324 (PANTHER); PTHR23324:SF70 (PANTHER); PTHR23324:SF70 (PANTHER); IPR001251 (PROSITE_PROFILES); IPR011074 (SUPERFAMILY); IPR001251 (SUPERFAMILY),,
RL4_JR_03970,79,23,38,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.02020363,0,2.931492494,0.706760145,4.147789765,3.36E-05,0.000328769,1.251333643,0,3.141968219,1.380164764,2.276516761,0.022815099,0.063882276,3.253643476,0,0.486600291,1.219388159,0.399052827,0.68985428,0.787649118,7.765335655,0,1.009960715,1.163503227,0.868034305,0.385375553,0.530657891,10.58388693,0,1.338183813,1.143968104,1.16977371,0.242092046,0.371503784,N,-,,major facilitator superfamily MFS-1,,no IPS match,,
RL4_JR_03971,12,2,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0.337313033,1,3.465544332,2.357198216,1.470196401,0.141508569,NA,0.107945751,0,6.677273723,2.060792441,3.240148591,0.001194674,0.015023052,0.279291033,0,4.029779297,1.310063248,3.07601889,0.002097846,0.010235464,0.322153689,0,3.607193603,1.550583985,2.326345195,0.020000143,0.076714457,0.274363934,0,3.952403345,1.238969632,3.190072817,0.00142237,0.006375162,N,-,,extracellular serine protease,P:proteolysis; F:serine-type endopeptidase activity; F:peptidase activity,IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (PFAM); IPR000209 (SUPERFAMILY),,
RL4_JR_03972,0,1,0,0,4,0,0,0,0,0,13,16,2,1,12,0,15,1,4.365131983,1,-0.228122652,1.239681892,-0.184017088,0.85400005,0.927316971,1.401998527,0,2.978152681,1.38882093,2.144374856,0.032002863,0.083209089,10.1152755,1,1.296586004,1.213041181,1.068872208,0.285127257,0.424504169,12.19408531,1,1.62613053,1.046517959,1.553848661,0.12022052,0.224706067,3.539747247,1,0.262600138,1.217189755,0.215742974,0.829188102,0.885324215,N,-,,hypothetical protein SPSK_00843,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_03973,97,62,60,0,0,0,0,0,0,0,0,5,0,2,5,0,1,1,11.8466793,0,-0.159488272,1.141367268,-0.139734401,0.888869845,0.945636818,2.570086673,0,2.103751099,1.288624185,1.632555965,0.102562419,0.206635511,39.86081528,1,1.872897636,0.847250297,2.210560022,0.02706632,0.070787761,7.671479268,1,-0.966551531,1.19312729,-0.810099257,0.417883131,0.561202212,6.537282314,1,-0.622471943,1.192298334,-0.52207734,0.601616483,0.710695005,N,-,,kinase-like domain,C:membrane; C:integral component of membrane,IPR011009 (SUPERFAMILY),,
RL4_JR_03974,150,75,71,5,1,0,0,0,0,2,0,15,4,0,3,0,5,0,0.332488551,1,3.486284192,2.412570511,1.445049658,0.148443938,NA,0.104918947,0,6.717917269,2.088724293,3.216277655,0.001298651,0.015023052,0.27412498,1,4.055522875,1.342973197,3.019809244,0.002529339,0.01193801,0.316381877,1,3.632893728,1.605449173,2.26285191,0.02364482,0.083034578,0.272106079,1,3.965199316,1.274597555,3.110942196,0.001864914,0.007987419,Y,-,,Endonuclease Exonuclease phosphatase,P:nucleic acid phosphodiester bond hydrolysis; F:exonuclease activity; F:endonuclease activity; C:membrane; C:integral component of membrane,IPR005135 (G3DSA:3.60.10.GENE3D); IPR005135 (PFAM); PTHR12121:SF36 (PANTHER); PTHR12121 (PANTHER); IPR005135 (SUPERFAMILY),,
RL4_JR_03975,282,268,599,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,17.96793456,0,3.103809101,0.877235478,3.538170969,0.000402909,0.00279501,0.849643554,0,3.700544013,1.498637002,2.469273085,0.013538785,0.042427116,2.217226335,1,1.040292374,1.268357592,0.820188549,0.412108629,0.554296234,12.19431033,0,1.573206476,1.198099189,1.313085336,0.189154194,0.317609655,61.11914295,0,4.784993249,1.650968932,2.898293939,0.003751988,0.014169666,Y,-,,metal dependent amidohydrolase,C:membrane; F:hydrolase activity,IPR011059 (G3DSA:2.30.40.GENE3D); IPR006680 (PFAM); G3DSA:3.20.20.140 (GENE3D); PTHR11271 (PANTHER); PTHR11271:SF41 (PANTHER); PS51257 (PROSITE_PROFILES); IPR032466 (SUPERFAMILY); IPR011059 (SUPERFAMILY),,
RL4_JR_03976,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,173.4815341,0,-0.436763004,0.578463049,-0.755040455,0.450224709,0.639089561,31.64791295,0,-1.518557243,1.225880349,-1.238748336,0.215438712,0.362177486,95.86863136,0,-2.373518067,1.073427566,-2.211158109,0.02702489,0.070697671,99.6650047,0,-3.662423541,1.184209444,-3.092716038,0.001983338,0.013142211,82.53009394,0,-4.280627763,1.238544454,-3.456176119,0.000547897,0.00292108,N,-,,high-affinity nicotinic acid transporter,"F:magnesium ion binding; F:5'-3' exonuclease activity; F:DNA binding; F:5'-flap endonuclease activity; P:nucleic acid phosphodiester bond hydrolysis; P:transmembrane transport; P:base-excision repair; C:mitochondrion; C:integral component of membrane; P:DNA replication, removal of RNA primer; C:nucleoplasm",G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662:SF253 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_03977,23,67,52,0,0,4,0,0,0,0,0,1,0,0,0,0,0,0,3.011069854,1,0.307121313,1.316310511,0.233319806,0.81551308,0.906040195,0.961802163,0,3.521602157,1.479842129,2.379714761,0.017326044,0.05145957,2.499862016,1,0.866794353,1.263649673,0.685945141,0.492747703,0.626167471,2.883838573,0,0.444542382,1.281262921,0.346956409,0.728624068,0.819065026,2.474698904,0,0.778824711,1.265935023,0.615216972,0.538411441,0.660937905,N,-,,neutral amino acid permease,,IPR031350 (PFAM),,
RL4_JR_03978,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.081232829,0,5.519675454,3.919883997,1.408122143,0.159094905,NA,0.025578105,0,8.754487385,2.812300264,3.112927697,0.001852414,0.015023052,0.06671646,0,6.096177266,1.649357587,3.69609193,0.000218944,0.001861114,0.077005533,0,5.672036896,2.653243297,2.13777489,0.032535018,0.096546617,0.065926272,0,6.014183387,1.371035755,4.3865985,1.15E-05,0.000113733,N,-,,camk kinase,F:transferase activity,IPR000719 (SMART); IPR000253 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); IPR000253 (G3DSA:2.60.200.GENE3D); PTHR24362:SF13 (PANTHER); PTHR24362 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR000253 (PROSITE_PROFILES); IPR008984 (SUPERFAMILY); IPR011009 (SUPERFAMILY),8.A.104.1.1, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_03979,63,165,114,0,0,16,0,1,2,9,9,22,3,29,5,0,58,1,71.51931685,1,1.112242896,0.607559627,1.83067282,0.067149392,0.165900891,5.542146447,1,0.995070439,1.231710787,0.807876694,0.419161569,0.583036059,20.87978351,1,-0.695356675,1.187421799,-0.58560208,0.558142951,0.684345311,20.60205426,1,-1.131997639,1.138378401,-0.994394867,0.320030666,0.46624904,45.06395706,1,1.852946196,0.552015624,3.35669158,0.000788811,0.003944053,N,-,,multidomain presynaptic cytomatrix related,,PTHR40012 (PANTHER),1.G.20.2.1, the hantavirus gc envelope fusion glycoprotein (gc-efg) family.
RL4_JR_03980,1408,1887,1580,3,0,0,0,0,0,0,0,3,0,3,1,0,0,0,31.19855834,1,4.236178611,0.86201727,4.914261883,8.91E-07,1.38E-05,0.318396542,0,5.11650669,1.668861721,3.065866168,0.002170404,0.015045494,0.828897107,1,2.459233344,1.247171786,1.971848122,0.048626947,0.110828278,0.956420833,1,2.036828061,1.296719875,1.570754101,0.116239777,0.218922572,0.820319541,0,2.37220208,1.229990814,1.92863398,0.053776317,0.118417837,N,-,,methyltransferase type 12,F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108 (PANTHER); PTHR10108:SF852 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_03981,19,21,37,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,25.30985204,0,-1.265789393,1.138515191,-1.111789639,0.266228608,0.446340523,109.9655758,0,4.421686777,0.569027427,7.770603963,7.81E-15,2.64E-12,14.31824982,0,-1.650854391,1.189401787,-1.38797033,0.16514608,0.281945854,16.51838463,1,-2.07325089,1.187060915,-1.74654128,0.080716941,0.167299698,14.12478571,0,-1.733919474,1.19365432,-1.452614416,0.146330841,0.254320657,N,-,,short chain dehydrogenase reductase family,,IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24319 (PANTHER); PTHR24319:SF34 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_03982,41,156,83,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.340484179,0,1.474721106,1.404090571,1.050303403,0.293578641,NA,0.431937387,0,4.676667958,1.621053651,2.884955692,0.003914688,0.017832794,1.114918161,0,2.031869759,1.258424964,1.61461336,0.10639445,0.203080734,1.285682879,0,1.61013682,1.296637545,1.241778651,0.214318242,0.348814049,1.094727633,0,1.955094174,1.23808077,1.579132979,0.114305559,0.211029653,N,-,,ankyrin repeat-containing,F:catalytic activity; P:metabolic process; P:lipid metabolic process; P:nucleoside metabolic process,IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24198 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.23.6.1, the type vi symbiosis/virulence secretory system (t6ss) family.
RL4_JR_03983,218,389,189,0,0,0,0,0,0,0,0,0,0,1,4,0,0,0,6.919296783,0,1.211418298,1.157119565,1.046925775,0.295133813,0.480366037,0.98673299,0,3.484714681,1.403228647,2.48335486,0.013015136,0.041207134,2.56602977,0,0.829132174,1.21362891,0.683184264,0.494490415,0.627660602,27.0301035,1,3.688023629,0.635004768,5.807867621,6.33E-09,1.81E-07,2.537117448,0,0.743063214,1.214367416,0.611893241,0.540608394,0.663104091,N,-, Effector probability:0.584,family,C:membrane,IPR002818 (PFAM); IPR029062 (G3DSA:3.40.50.GENE3D); IPR029062 (SUPERFAMILY),,
RL4_JR_03984,210,679,212,0,0,0,0,0,0,0,3,0,0,0,0,0,2,1,22.98213471,0,8.840266866,0.920032933,9.608641768,7.35E-22,1.20E-19,0.023039115,0,8.905331617,2.922505288,3.047156716,0.002310172,0.015159195,0.059241255,1,6.264799227,1.734605907,3.611655652,0.000304248,0.002351306,0.068289008,0,5.84455129,2.826422993,2.06782612,0.038656377,0.104959993,3.918607161,1,7.108089745,1.24617483,5.703926586,1.17E-08,5.51E-07,N,-,,enoyl- hydratase isomerase family,"F:transferase activity, transferring acyl groups",IPR023213 (G3DSA:3.30.559.GENE3D); IPR003480 (PFAM); IPR023213 (G3DSA:3.30.559.GENE3D); PTHR31642:SF31 (PANTHER); PTHR31642 (PANTHER),,
RL4_JR_03985,414,504,222,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,8.247765083,1,4.91979683,1.197494652,4.108408184,3.98E-05,0.00038372,0.075811818,0,7.186647963,2.241426238,3.206283499,0.001344614,0.015023052,0.197164228,0,4.530007178,1.390061302,3.258854247,0.001118631,0.006305692,0.227459868,1,4.108636105,1.778646208,2.309979402,0.020889294,0.078247912,0.195258626,0,4.441830549,1.289502655,3.444607525,0.000571889,0.00302844,N,-,,integral membrane pth11,C:membrane,PTHR33048 (PANTHER); PTHR33048:SF27 (PANTHER),9.B.313.1.1, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_03986,27,70,53,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.135483763,0,4.781332119,3.507626049,1.363124818,0.172843176,NA,0.043598012,0,7.985227233,2.475839386,3.225260604,0.00125858,0.015023052,0.112588331,0,5.339612784,1.439116974,3.710339659,0.000206981,0.001791132,0.129839447,0,4.917911853,2.102269495,2.339334641,0.019318121,0.075572463,0.11056216,0,5.261265085,1.2799363,4.110567911,3.95E-05,0.000317159,N,-, Effector probability:0.572,"3 ,5 -bisphosphate nucleotidase",,no IPS match,,
RL4_JR_03987,287,303,326,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,44.7384962,0,4.410936758,0.692682257,6.367907812,1.92E-10,6.28E-09,0.87084983,0,3.665072949,1.442154307,2.541387514,0.011041347,0.036227071,2.258857386,1,1.013673058,1.22576394,0.826972491,0.408252654,0.550426138,2.606030952,0,0.591201575,1.235290757,0.478593054,0.632228161,0.747470207,2.22342234,1,0.93371725,1.219337901,0.765757588,0.443820554,0.576759917,N,-,,---NA---,,no IPS match,,
RL4_JR_03988,100,119,149,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,20.18550231,0,-1.191635134,1.210244457,-0.984623501,0.324809041,0.51412343,5.213690848,0,1.083260363,1.314444878,0.824120039,0.409871355,0.573763376,13.49754965,1,-1.565547303,1.242408746,-1.260090375,0.207636762,0.334678328,34.19614966,0,-0.203732717,1.076773158,-0.18920672,0.849930801,0.905962809,20.95912822,0,0.004637795,1.046176869,0.004433089,0.996462919,0.99725087,N,-,,glicosidase,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:carbohydrate binding",IPR013785 (G3DSA:3.20.20.GENE3D); IPR025887 (PFAM); IPR000322 (PFAM); PTHR22762 (PANTHER); PTHR22762:SF7 (PANTHER); PTHR22762 (PANTHER); PTHR22762:SF7 (PANTHER); IPR017853 (SUPERFAMILY); IPR011013 (SUPERFAMILY),,
RL4_JR_03989,0,4,1,0,0,0,1,0,0,0,0,0,0,0,2,0,3,0,0.778227249,0,2.259647542,1.726035021,1.309155095,0.19048182,NA,0.247911464,1,5.477785542,1.805080667,3.034648614,0.002408161,0.015301572,0.642009071,0,2.829156184,1.30584697,2.166529655,0.030270736,0.077291534,0.740663399,1,2.406393765,1.401571121,1.716925905,0.085992711,0.174887515,0.630057938,1,2.753385939,1.268782803,2.170100298,0.029999249,0.075165155,N,-,,methyltransferase domain-containing,F:transferase activity,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); PTHR10108:SF818 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_03990,16,18,32,0,4,0,0,0,0,0,0,0,0,2,0,0,0,0,19.98278853,1,1.66283077,1.024426032,1.623182854,0.104550322,0.228787963,1.263016903,0,3.128563833,1.380041778,2.267006611,0.023389822,0.065149086,3.283301695,0,0.473514601,1.219802956,0.388189419,0.697875863,0.794121078,3.787903472,1,0.051125213,1.223816549,0.041775226,0.966677884,0.981214394,3.247136665,0,0.38698364,1.222810841,0.316470567,0.751645362,0.827128496,Y,-,,"hypothetical beta-1,6-N-acetylglucosaminyltransferase","F:transferase activity, transferring glycosyl groups; F:transferase activity",no IPS match,,
RL4_JR_03991,3293,2128,2509,1,7,6,0,0,1,0,3,4,2,5,5,0,3,5,0.316439293,1,3.557657988,2.420598015,1.469743413,0.14163126,NA,0.101081828,1,6.77195591,2.081761635,3.252992944,0.001141963,0.015023052,0.261991669,1,4.121519246,1.310522809,3.144942781,0.001661193,0.008554384,0.302224167,1,3.699153746,1.569519004,2.35687095,0.01842965,0.074086903,0.257965616,1,4.041215954,1.238992157,3.261696154,0.001107478,0.005176922,Y,-,,cytochrome P450 oxidoreductase,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; F:methyltransferase activity; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding; P:methylation",IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24305 (PANTHER); PTHR24305:SF69 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_03992,3668,2840,4411,0,1,5,0,0,3,0,0,4,0,0,0,0,0,0,18.40104211,1,-2.303946102,1.239153493,-1.859290327,0.062985997,0.158125859,5.851830469,1,0.916664131,1.286487295,0.712532596,0.476135034,0.633386624,15.17590479,1,-1.734647807,1.228130039,-1.412430078,0.157823365,0.272250161,17.50921505,0,-2.157150117,1.230716433,-1.75275966,0.07964327,0.165855226,14.91926183,0,-1.812837648,1.232999555,-1.470266263,0.141489655,0.247987978,N,-,,Aldo keto reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR020471 (PRINTS); IPR023210 (PFAM); IPR020471 (PIRSF); IPR023210 (G3DSA:3.20.20.GENE3D); IPR001395 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.4, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_03993,3160,2687,3042,0,2,12,0,0,0,0,6,2,1,3,1,0,4,0,11.98431485,1,1.496523739,1.03437016,1.446797091,0.147953762,0.293747089,10.75759206,0,3.91709165,1.137587665,3.443331685,0.000574594,0.015023052,3.59041752,1,0.344737841,1.21355596,0.284072471,0.776354843,0.851447936,4.142976733,1,-0.07792604,1.215876784,-0.064090409,0.948898239,0.970207017,3.551264337,1,0.258041516,1.217337849,0.211971981,0.832128893,0.886687544,N,-,,histone deacetylase superfamily,F:hydrolase activity,IPR000286 (PRINTS); IPR023801 (G3DSA:3.40.800.GENE3D); IPR023801 (PFAM); PTHR10625:SF104 (PANTHER); IPR000286 (PANTHER); SSF52768 (SUPERFAMILY),,
RL4_JR_03994,3390,3389,4164,9,6,0,0,0,2,0,11,37,4,8,0,0,21,3,1.077976319,1,1.789568721,1.501911904,1.191527091,0.233446728,NA,0.343132965,1,5.008767578,1.676466679,2.98769289,0.002810919,0.015349618,0.889835315,1,2.357934041,1.265948792,1.862582479,0.062521031,0.134529845,1.026614448,1,1.935271157,1.319259769,1.466937144,0.142393155,0.256262121,0.875216392,1,2.279101155,1.242180161,1.834758939,0.066541415,0.139575684,N,-,,methyltransferase type 11,P:metabolic process; F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108 (PANTHER); PTHR10108:SF818 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_03995,269,292,294,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.781134216,0,-0.86361267,1.202329616,-0.718282789,0.47258294,0.661859506,2.163269999,0,2.352342398,1.30582294,1.801425236,0.071635881,0.156574907,5.60811929,0,-0.298381385,1.201443212,-0.248352467,0.803861708,0.871320593,6.46963861,0,-0.720705785,1.199909451,-0.600633477,0.548084136,0.677824829,5.519822543,0,-0.378282032,1.200466261,-0.31511259,0.75267617,0.827700934,N,-,,vitamin h,P:biological_process; P:transmembrane transport; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF187 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_03996,3099,4114,3560,0,0,2,2,0,0,0,9,4,0,1,4,0,2,1,1.435450747,1,1.3764541,1.466078004,0.938868257,0.347798389,NA,0.456544102,1,4.596807317,1.637844579,2.806619978,0.005006426,0.020667464,1.183432658,1,1.94654375,1.285533666,1.514191189,0.129977356,0.235864985,1.365375124,1,1.523893442,1.331852328,1.144190996,0.252544436,0.392300156,1.162442508,1,1.86950996,1.267438153,1.475030522,0.140204338,0.246319607,N,-,,3-hydroxyphenylacetate 6 hydroxylase,F:oxidoreductase activity; F:metal ion binding; C:membrane,IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24281 (PANTHER); PTHR24281:SF5 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_03997,928,1527,999,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,73.28158285,0,10.63031917,0.824085307,12.89953731,4.53E-38,3.69E-35,0.013522229,0,9.671624683,3.186096873,3.035571443,0.002400803,0.015281694,0.035766887,0,6.989640269,1.87415957,3.729479805,0.000191875,0.001713457,19.31187428,0,8.317833309,1.137923059,7.309662324,2.68E-13,1.38E-11,0.036043127,0,6.882749414,1.442931322,4.769977137,1.84E-06,2.42E-05,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF240 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_03998,5093,5200,7206,0,3,6,0,0,1,3,1,7,0,2,0,0,2,0,3.973770905,1,-0.093028852,1.216738065,-0.076457583,0.939055059,0.969777845,1.265521231,1,3.125724847,1.364928158,2.29002884,0.022019645,0.062188294,3.289543981,1,0.470818744,1.208943076,0.389446578,0.696945822,0.793419487,98.5359522,1,4.461862276,0.712103379,6.265750747,3.71E-10,1.28E-08,18.33770629,1,2.595656524,0.857477912,3.027082665,0.002469264,0.010113795,N,-,,mitochondrial ATPase (Afg1),F:nucleotide binding; F:ATP binding,IPR027417 (G3DSA:3.40.50.GENE3D); IPR005654 (PFAM); PTHR12169:SF2 (PANTHER); IPR005654 (PANTHER); IPR005654 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_03999,9489,6418,5924,19,13,21,1,0,1,0,6,28,0,2,2,0,9,1,0.008115494,1,8.845278576,4.03634189,2.191409652,0.028422161,NA,0.002507343,1,12.10167175,4.040174693,2.995333784,0.002741447,0.015349618,0.006623884,1,9.426891884,3.299070491,2.857438757,0.00427075,0.016940088,0.007651472,1,9.002876608,4.037800151,2.229648886,0.025770762,0.085851084,0.006630333,1,9.341240721,1.70468121,5.479758129,4.26E-08,1.17E-06,N,-,,Fe-containing alcohol dehydrogenase,F:oxidoreductase activity; F:metal ion binding; P:oxidation-reduction process,G3DSA:1.20.1090.10 (GENE3D),,
RL4_JR_04000,3834,3960,6568,0,0,6,0,0,1,0,0,5,3,2,1,0,0,0,0.088360044,1,5.398099443,3.91882538,1.377478943,0.168364221,NA,0.028071886,1,8.62017846,2.686227051,3.209028238,0.001331844,0.015023052,0.072975492,1,5.965663164,1.520514789,3.923449614,8.73E-05,0.001074055,0.084200553,1,5.542863866,2.463561021,2.249939749,0.02445277,0.084615276,0.072031835,0,5.883635947,1.302189146,4.518265235,6.23E-06,6.83E-05,N,-, Effector probability:0.737,---NA---,,no IPS match,,
RL4_JR_04001,1366,1583,1799,0,2,26,0,0,0,0,19,53,0,2,0,0,7,0,0.012021509,1,8.275938237,3.994557068,2.071803731,0.038283749,NA,0.003842866,0,11.4894157,3.940199092,2.915948011,0.003546096,0.016928889,0.009954621,1,8.839817482,2.38250595,3.710302374,0.000207012,0.001791132,0.011482935,1,8.417149062,3.994556965,2.107154594,0.035104181,0.099498352,0.009795195,1,8.760474239,1.567861258,5.587531547,2.30E-08,8.07E-07,N,-,,aflatoxin biosynthesis ketoreductase nor-1,P:mycelium development,IPR002347 (PRINTS); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04002,11805,12894,15576,4,12,9,1,0,2,1,3,0,0,3,2,0,0,5,0.431500476,1,3.110188158,2.136851807,1.455500165,0.145530845,NA,0.136479168,1,6.338529083,1.973549217,3.211741074,0.001319332,0.015023052,0.356250207,1,3.677266484,1.308825263,2.809593142,0.004960416,0.018822809,0.411129554,1,3.254863963,1.491450769,2.182347571,0.029083891,0.090552212,0.353484787,1,3.587217897,1.258991207,2.849279548,0.004381836,0.016098001,N,-,,hypothetical protein UCREL1_6906,,IPR013830 (G3DSA:3.40.50.GENE3D),,
RL4_JR_04003,1300,1544,1685,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,91.75366829,1,1.375425511,0.593927991,2.315811904,0.020568541,0.067146121,9.502438695,0,0.217158524,1.240376665,0.175074661,0.861020968,0.918555464,101.8484579,0,1.671848474,1.089264252,1.534841955,0.124822654,0.228667724,68.6887048,0,1.017650058,0.647626216,1.57135402,0.11610044,0.218795982,97.19680452,0,1.983594629,0.590272537,3.360472502,0.000778093,0.003896236,N,-,,amino acid permease,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PFAM); IPR002293 (PIRSF); IPR002293 (PANTHER); PTHR11785:SF360 (PANTHER),2.A.3.4.2, the amino acid-polyamine-organocation (apc) family.
RL4_JR_04004,6149,6920,8234,3,2,13,0,0,6,6,2,0,12,25,17,0,0,9,11.49808392,1,-1.625472202,1.216144947,-1.336577689,0.181360526,0.338646387,3.667675223,1,1.590705548,1.286329949,1.23662327,0.216226977,0.363020312,111.908169,1,3.267072636,0.526630045,6.203733854,5.51E-10,2.94E-08,151.9045384,1,3.782463649,0.428221231,8.832966166,1.02E-18,8.39E-17,101.6328942,1,3.639424708,0.716906275,5.076569751,3.84E-07,6.42E-06,N,-,,benzoate 4-monooxygenase,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305:SF29 (PANTHER); PTHR24305 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_04005,1805,1705,1984,0,2,10,0,0,0,0,0,0,0,0,0,0,0,2,1.032726948,1,1.851087026,1.71359195,1.080237933,0.280036241,NA,0.322123549,0,5.099436852,1.789595071,2.849492007,0.004378911,0.018901479,0.849734753,0,2.423208542,1.360537333,1.781067291,0.074901458,0.154882019,0.981213711,0,1.999762407,1.455219298,1.374200033,0.169379591,0.291213022,0.853037726,1,2.315790306,1.350304213,1.71501376,0.086342704,0.171147197,N,-,,hypothetical protein THAR02_04796,F:catalytic activity,PTHR37540 (PANTHER),,
RL4_JR_04006,5643,5111,5376,5,4,0,0,0,0,2,5,4,4,9,0,0,1,2,3.918276594,1,6.165289287,1.233602859,4.997791017,5.80E-07,9.44E-06,0.03190571,0,8.435500578,2.61896232,3.220932395,0.001277743,0.015023052,0.082686878,1,5.78461532,1.486945564,3.89026704,0.000100134,0.001162113,0.095379188,1,5.36283416,2.344415503,2.287493046,0.022167061,0.080442001,0.081477184,1,5.702781747,1.291087444,4.417037571,1.00E-05,0.000100609,N,-,,mfs general substrate transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF242 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_04007,13195,12995,11975,1,3,3,0,0,1,1,0,3,0,1,1,0,4,3,30.56045265,1,11.78717557,1.156230038,10.19449001,2.10E-24,5.03E-22,0.003842866,1,11.4894157,3.940199092,2.915948011,0.003546096,0.016928889,0.009954621,1,8.839817482,2.38250595,3.710302374,0.000207012,0.001791132,18.63601568,1,10.17653682,1.329401572,7.654975773,1.93E-14,1.15E-12,0.009795195,1,8.760474239,1.567861258,5.587531547,2.30E-08,8.07E-07,N,-,,taurine catabolism dioxygenase,F:dioxygenase activity; P:oxidation-reduction process,G3DSA:3.60.130.10 (GENE3D); IPR003819 (PFAM); PTHR10696 (PANTHER); PTHR10696:SF21 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_04008,1101,1920,1764,0,1,2,3,0,0,0,0,1,0,2,1,0,0,0,299.3280567,1,-3.156584317,0.920779119,-3.428166702,0.000607672,0.003937561,83.44155849,1,-2.917164883,1.219273005,-2.392544467,0.016732,0.050210883,214.8887441,1,-5.558450147,1.215798017,-4.571853277,4.83E-06,0.000101121,257.4348193,1,-5.027407486,1.170488906,-4.295134675,1.75E-05,0.000231374,210.0060105,0,-5.628070396,1.215495373,-4.630268876,3.65E-06,4.36E-05,Y,-,,kxY xW signal peptide domain,C:membrane; C:integral component of membrane,IPR002889 (SMART); PTHR19297 (PANTHER); IPR002889 (PROSITE_PROFILES),3.A.20.1.2, the peroxisomal protein importer (ppi) family.
RL4_JR_04009,1809,1519,1126,0,0,2,0,0,0,0,0,0,0,0,0,0,2,0,2.816781592,1,0.403746352,1.325969727,0.30449138,0.760753559,0.87398931,0.911826449,0,3.598859121,1.508137103,2.386294398,0.017019121,0.050876415,2.340453805,0,0.962521194,1.267234845,0.75954445,0.447526935,0.586910698,2.6983285,0,0.540998043,1.286323414,0.420577,0.674063991,0.777943453,2.279332063,1,0.897497526,1.253064073,0.716242326,0.473841732,0.604161634,N,-,,membrane TE19,F:zinc ion binding; P:integrin-mediated signaling pathway; C:membrane; P:proteolysis; C:integral component of membrane; F:metalloendopeptidase activity; F:metallopeptidase activity,no IPS match,1.B.12.5.5, the autotransporter-1 (at-1) family.
RL4_JR_04010,2947,3822,4557,6,1,19,0,0,0,2,2,3,5,3,0,0,3,6,0.433816104,1,3.102263876,2.244769287,1.381996757,0.166972697,NA,0.139746252,0,6.304522708,2.061462664,3.058276444,0.002226141,0.015045494,0.361481019,1,3.656157894,1.396847425,2.617435396,0.008859326,0.029728808,0.416860345,1,3.234766001,1.617842634,1.999431795,0.045561655,0.115674963,0.356338078,1,3.573878395,1.331092055,2.68492204,0.007254673,0.024306274,N,-,,UDP-glucoronosyl and UDP-glucosyl,"F:transferase activity, transferring hexosyl groups; P:metabolic process; C:integral component of membrane",G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); IPR002213 (PFAM); IPR002213 (PANTHER); PTHR11926:SF16 (PANTHER); SSF53756 (SUPERFAMILY),,
RL4_JR_04011,739,955,855,1,0,4,0,0,0,0,0,2,0,2,0,0,0,0,0.056834422,1,6.035084056,3.925503824,1.537403688,0.124194484,NA,0.017719627,0,9.283528721,3.127944429,2.967932753,0.002998099,0.01558642,0.046526393,1,6.615349589,1.874839435,3.528488609,0.00041794,0.002974018,0.053723907,1,6.191227113,3.168498919,1.953993759,0.050701955,0.124269498,0.046286644,0,6.52556757,1.461295222,4.46560522,7.98E-06,8.31E-05,N,-,,AChain First Crystal Structure Of An (r)-selective Omega-transaminase From Aspergillus Terreus,F:catalytic activity; P:metabolic process,G3DSA:3.20.10.10 (GENE3D); IPR001544 (PFAM); G3DSA:3.30.470.10 (GENE3D); IPR001544 (PANTHER); IPR001544 (SUPERFAMILY),,
RL4_JR_04012,49,62,53,0,0,20,0,0,0,3,0,0,0,2,0,0,0,0,10.1758674,1,-1.449477838,1.244906504,-1.164326665,0.244291654,0.419652836,3.206688788,0,1.78431302,1.310835497,1.361202854,0.173449593,0.309257843,14.89475078,1,0.080910573,1.226315703,0.065978584,0.947394876,0.969320437,17.71412225,1,0.400004257,1.068289273,0.374434404,0.708081151,0.804419535,8.361173852,0,-0.977452927,1.24724156,-0.783691755,0.433221002,0.567887447,N,-,,hypothetical protein SPI_01886,,IPR003615 (PFAM),,
RL4_JR_04013,29181,20422,17990,2,8,18,0,0,3,5,6,15,2,7,8,0,17,0,1.139703356,1,1.708983187,1.41180301,1.210496914,0.226088274,NA,0.362690056,1,4.92864953,1.626087246,3.03098714,0.002437556,0.015349618,0.942730357,1,2.273790013,1.235831102,1.839887351,0.065784777,0.139858271,1.087675451,1,1.851406369,1.273159133,1.454183001,0.145895577,0.260619745,0.931253576,1,2.189201271,1.219946986,1.79450525,0.072732561,0.14923062,N,-,,Retinol dehydrogenase 14,,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24320:SF70 (PANTHER); PTHR24320 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04014,1838,2074,3201,1,0,7,0,0,0,0,1,0,0,2,0,0,5,0,2.142376348,1,0.798588499,1.26840687,0.629599632,0.528956564,0.712907261,0.687758286,0,4.005652024,1.485945183,2.695692997,0.007024237,0.025996099,1.776154782,1,1.360568171,1.223785042,1.111770551,0.266236817,0.404165772,10.07165091,1,2.659784533,1.029791236,2.582838579,0.009799116,0.047806532,1.741829163,1,1.285537963,1.208549179,1.063703476,0.287463049,0.421881921,N,-,,Zn(II)2Cys6 transcription factor,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; C:integral component of membrane; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR007219 (PFAM); PTHR31944 (PANTHER); PTHR31944:SF44 (PANTHER),,
RL4_JR_04015,1083,1413,1795,0,0,5,0,0,0,0,0,4,1,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,dynamin partial,F:nucleotide binding; F:GTP binding; F:GTPase activity,IPR020850 (PROSITE_PROFILES),,
RL4_JR_04016,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.015901563,0,7.871528,3.973277037,1.981117331,0.047578117,NA,0.005010166,0,11.10419825,3.765442626,2.948975554,0.003188292,0.016079667,0.01312615,0,8.436770725,2.240862621,3.76496562,0.000166572,0.001577526,0.015150793,0,8.016170674,3.973433359,2.017441832,0.043649426,0.113446415,0.013085742,0,8.344620785,1.511525422,5.520661885,3.38E-08,1.07E-06,N,-, Effector probability:0.61,Dynamin,F:nucleotide binding; F:GTP binding; F:GTPase activity,IPR022812 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR022812 (PANTHER); PTHR11566:SF66 (PANTHER); IPR027417 (SUPERFAMILY),1.R.1.1.1, the membrane contact site (mcs) family.
RL4_JR_04017,2153,2593,3061,3,4,6,0,0,0,0,0,0,2,2,0,0,6,0,0.00781203,1,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,0,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,0,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,0.007662926,1,9.0007212,4.037607722,2.229221316,0.025799183,0.085851084,0.006329724,1,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,N,-, Effector probability:0.593,dynamin family,F:nucleotide binding; F:GTP binding; F:GTPase activity; F:hydrolase activity,IPR022812 (PRINTS); IPR027417 (G3DSA:3.40.50.GENE3D); IPR022812 (PFAM); PTHR11566:SF66 (PANTHER); IPR022812 (PANTHER); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_04018,544,700,795,0,0,4,0,0,0,0,1,0,0,0,0,0,0,1,0.02328032,1,7.320019174,3.952269238,1.852105394,0.06401069,NA,0.007003795,0,10.61631824,3.954945293,2.684314813,0.007267863,0.026654099,31.39088339,1,10.691271,3.846334006,2.77960026,0.005442585,0.020161262,16.06835971,0,9.588673013,3.89376656,2.462570076,0.013794521,0.062632076,11.60135033,1,9.526976226,3.898962123,2.443464678,0.014546994,0.042486591,Y,-,,serine protease precursor,F:serine-type peptidase activity,IPR015500 (PRINTS); IPR000209 (PFAM); IPR010259 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); IPR010259 (G3DSA:3.30.70.GENE3D); IPR015500 (PANTHER); PTHR10795:SF389 (PANTHER); IPR000209 (SUPERFAMILY); IPR009020 (SUPERFAMILY),1.I.3.1.1,The Bacterial (Planctomycetes) Nuclear Pore-like Complex (B-NPC) Family
RL4_JR_04019,1793,1823,1578,0,0,5,0,1,0,0,0,0,0,6,0,0,9,2,0.056201531,1,6.050897074,3.925709845,1.541351071,0.123231365,NA,0.017878809,1,9.271080936,2.927330225,3.167077243,0.001539794,0.015023052,0.046442367,0,6.61767028,1.640481976,4.033979268,5.48E-05,0.000779778,0.053583212,1,6.194888622,2.929514691,2.114646716,0.034460069,0.099396379,0.045811113,1,6.536490326,1.333421829,4.902042386,9.48E-07,1.38E-05,N,-,,acetylornithine deacetylase or succinyl-diaminopimelate desuccinylase,P:metabolic process; F:hydrolase activity,IPR002933 (PFAM); G3DSA:3.40.630.10 (GENE3D); IPR011650 (G3DSA:3.30.70.GENE3D); IPR011650 (PFAM); PTHR11014 (PANTHER); IPR011650 (SUPERFAMILY); SSF53187 (SUPERFAMILY),,
RL4_JR_04020,123331,55445,95671,15,43,85,0,0,2,1,4,5,9,43,9,0,15,0,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,allantoate permease,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF241 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.4, the major facilitator superfamily (mfs).
RL4_JR_04021,745,614,665,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0.593341315,1,2.650762341,1.813308135,1.461837781,0.143785668,NA,0.18997695,0,5.861712063,1.840991987,3.183996511,0.001452568,0.015023052,6.990280193,0,4.176441832,1.205511424,3.464456453,0.000531304,0.003534852,0.566974636,1,2.79160799,1.371158043,2.035949105,0.041755466,0.110731822,0.483052967,0,3.136001114,1.223248989,2.563665404,0.010357334,0.032296891,Y,-,,glycoside hydrolase family 45,C:extracellular region; P:cellulose catabolic process; F:cellulase activity; F:cellulose binding,IPR009009 (PFAM); IPR009009 (G3DSA:2.40.40.GENE3D); IPR007112 (PROSITE_PROFILES); IPR009009 (SUPERFAMILY),,
RL4_JR_04022,18738,14892,15779,0,4,10,0,0,1,0,2,2,7,5,1,0,2,3,48.25508745,1,0.780119648,0.640743323,1.217522868,0.223405341,0.393657555,6.713373352,1,0.718435724,1.230972273,0.583632742,0.559467426,0.703032811,23.97594448,1,-0.976677801,1.196667691,-0.816164595,0.414406003,0.556166931,20.1665441,1,-2.36112291,1.197193215,-1.972215412,0.048585021,0.120758055,17.28885152,1,-2.025518795,1.205943518,-1.679613319,0.093032574,0.180658768,N,-,,ATP-dependent exoDNAse beta subunit,F:ATP binding,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR018647 (PFAM); IPR027417 (SUPERFAMILY),,
RL4_JR_04023,568,751,631,0,5,6,0,0,0,0,0,0,1,4,0,0,1,1,35.84590886,1,0.219760438,0.791036004,0.277813445,0.781155569,0.887242075,105.2526456,0,3.73127539,0.72240941,5.165042621,2.40E-07,2.59E-05,17.06946774,0,-1.904279197,1.211620796,-1.571679195,0.11602497,0.216722655,19.68368435,1,-2.326035044,1.211764231,-1.919544235,0.054915494,0.129729205,28.27205477,1,0.217017943,0.869754203,0.249516406,0.802961352,0.867105769,N,-,,NAD dependent epimerase dehydratase,F:coenzyme binding; F:catalytic activity,IPR001509 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10366 (PANTHER); PTHR10366:SF267 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04024,10381,15420,14780,11,8,45,3,0,0,2,0,13,0,13,1,0,8,8,24.84670929,1,0.533585918,1.06671609,0.500213621,0.616924669,0.779762571,12.18267547,1,2.890263771,1.177596713,2.454374863,0.014112977,0.04391379,38.68489151,1,2.143769971,0.811630343,2.64131324,0.008258532,0.028052699,17.75047137,1,-0.149261836,1.190177041,-0.125411456,0.900197819,0.938768454,7.263080538,1,-0.774394782,1.253778854,-0.617648622,0.536806986,0.659667909,N,-,,MFS general substrate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23511:SF12 (PANTHER); PTHR23511 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.19.38, the major facilitator superfamily (mfs).
RL4_JR_04025,2816,3281,5292,2,0,0,0,0,0,0,0,0,1,2,3,0,0,0,113.3269976,1,1.46734419,0.599930517,2.445856891,0.014450835,0.051056695,10.77362862,0,0.036044424,1.258811342,0.028633698,0.977156736,0.988089958,68.36127436,0,0.754315338,0.692603969,1.089100513,0.276109564,0.415107399,70.87238834,1,0.097722228,1.422009209,0.068721234,0.945211516,0.968057261,39.34080525,0,-0.541333747,0.920133725,-0.588320733,0.556317032,0.675465877,N,-,,MFS sugar transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR003663 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR003663 (TIGRFAM); IPR005828 (PFAM); PTHR23500 (PANTHER); PTHR23500:SF108 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.131, the major facilitator superfamily (mfs)
RL4_JR_04026,3723,4554,5093,0,2,12,0,0,1,3,0,1,1,1,0,0,14,0,92.66135772,1,-1.73174404,0.859073114,-2.015828469,0.043817916,0.120562076,24.52122581,1,-1.150480441,1.234415856,-0.93200394,0.351334489,0.514721045,64.04359989,1,-3.812022795,1.226469332,-3.108127284,0.00188277,0.009450253,122.0814723,1,-0.715252628,1.59992424,-0.447054061,0.654836027,0.76455409,71.40474247,1,-2.259566192,1.03956671,-2.173565361,0.029737792,0.074639352,N,-,,fungal specific transcription factor,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR007219 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31313:SF35 (PANTHER); PTHR31313 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04027,1637,2011,3354,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0.96787274,0,1.944863847,1.546220972,1.257817532,0.208457754,NA,0.306277652,0,5.172523425,1.699013703,3.044427137,0.002331239,0.015159195,28.13744778,0,5.325468659,0.77404752,6.880028063,5.98E-12,4.36E-10,10.55651395,1,3.043405143,1.169500322,2.602312359,0.009259747,0.045778779,0.790065122,0,2.426792788,1.246997755,1.946108386,0.051641722,0.114917018,N,-,,amidohydrolase,F:hydrolase activity,G3DSA:3.20.20.140 (GENE3D); IPR006680 (PFAM); PTHR35563 (PANTHER); PTHR35563:SF1 (PANTHER); IPR032466 (SUPERFAMILY),,
RL4_JR_04028,5603,8880,8472,0,0,36,2,2,0,0,1,0,0,15,0,0,12,0,5.334497959,1,-0.517625915,1.230493648,-0.420665247,0.673999542,0.82018023,1.689129361,1,2.709171875,1.341666305,2.019259084,0.043460298,0.105619481,23.89897051,1,2.446694428,0.875414482,2.794898278,0.005191605,0.019466595,13.10391059,1,1.343516546,1.040357218,1.291399265,0.196565265,0.3264444,27.52267944,1,3.102812533,0.690571766,4.493106562,7.02E-06,7.50E-05,N,-,,MFS quinate transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR003663 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); IPR003663 (TIGRFAM); PTHR23500:SF140 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.119, the major facilitator superfamily (mfs).
RL4_JR_04029,12620,12587,12831,5,4,3,0,0,0,0,0,1,0,0,0,0,4,0,0.440513298,1,3.080245727,2.139046963,1.440008462,0.149865005,NA,0.142127287,0,6.280300435,1.994216111,3.149257696,0.001636858,0.015023052,0.366739943,1,3.635705955,1.332130237,2.729242123,0.006348008,0.022733367,0.422890639,0,3.214232503,1.519553556,2.115247922,0.034408822,0.099376683,0.360148213,1,3.558255781,1.269881729,2.80203715,0.005078103,0.018136081,N,-,,homeobox domain-containing,"F:DNA binding; C:nucleus; P:regulation of transcription, DNA-templated",IPR009057 (G3DSA:1.10.10.GENE3D); IPR008422 (PFAM),,
RL4_JR_04030,202,349,323,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,46.5428858,1,-3.642842718,1.255530208,-2.901437732,0.003714546,0.017014748,15.14070735,0,-0.454824969,1.283500782,-0.354362829,0.723066987,0.826338946,38.8515749,0,-3.090915244,1.244492835,-2.483674599,0.013003457,0.039712519,44.78449337,0,-3.512111427,1.251842311,-2.80555418,0.005023014,0.028117634,37.92755207,0,-3.158986147,1.246066951,-2.535165661,0.011239416,0.034474125,N,-,,bZIP transcription factor,,IPR019357 (PFAM); PTHR21614 (PANTHER),,
RL4_JR_04031,1034,1190,1760,0,0,3,0,0,0,0,0,0,0,0,3,0,0,0,8.5613017,1,-1.200299982,1.22510847,-0.979749966,0.327209555,0.516720006,2.76427395,0,1.998657866,1.329897767,1.502865796,0.132873655,0.251110369,7.124684433,0,-0.643863694,1.224769309,-0.525702015,0.599095264,0.717921094,8.215214241,1,-1.06551434,1.226122985,-0.869010983,0.384841124,0.530138283,6.984203952,0,-0.718013527,1.223496216,-0.586853901,0.557301833,0.676452492,N,-, Effector probability:0.655,peroxisomal dehydratase,F:catalytic activity; P:metabolic process,IPR002539 (PFAM); IPR029069 (G3DSA:3.10.129.GENE3D); IPR029069 (G3DSA:3.10.129.GENE3D); PTHR13078 (PANTHER); IPR029069 (SUPERFAMILY),,
RL4_JR_04032,864,760,1101,0,1,5,0,0,0,0,0,0,0,0,0,0,0,0,58.30450091,1,-3.96789662,1.189175628,-3.336678389,0.00084786,0.005228149,18.70883755,0,-0.760112012,1.209542036,-0.628429595,0.529722555,0.678114544,48.3790151,0,-3.407325507,1.192785789,-2.856611421,0.004281897,0.016940088,55.79812453,0,-3.829331333,1.192415696,-3.211406346,0.00132087,0.009339603,47.55133958,0,-3.485224837,1.19109906,-2.92605792,0.00343287,0.013195828,N,-,,3-isopropylmalate dehydrogenase leu2a,"F:magnesium ion binding; F:zinc ion binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; C:cytoplasm; F:metal ion binding; F:oxidoreductase activity; F:NAD binding; P:leucine biosynthetic process; P:oxidation-reduction process; P:branched-chain amino acid biosynthetic process; F:3-isopropylmalate dehydrogenase activity",no IPS match,,
RL4_JR_04033,1849,1718,2177,0,1,7,0,0,0,1,0,0,2,0,0,0,2,3,1.810790119,1,1.041210001,1.290793386,0.806643427,0.419871946,NA,0.58016584,0,4.251078562,1.517925287,2.80058485,0.00510101,0.020895354,1.499968942,1,1.604436212,1.225270881,1.30945429,0.190380512,0.313351113,1.730083678,1,1.182245781,1.241757953,0.952074258,0.341059323,0.487950494,1.472433741,1,1.528079765,1.208976611,1.263944854,0.206249821,0.32932967,N,-,,telomere-associated recQ-like helicase,F:organic cyclic compound binding; F:heterocyclic compound binding,IPR027417 (G3DSA:3.40.50.GENE3D); IPR022698 (PFAM); IPR027417 (SUPERFAMILY),2.A.16.2.2, the telurite-resistance/dicarboxylate transporter (tdt) family.
RL4_JR_04034,28333,27800,31624,1,4,29,0,0,0,0,2,3,0,4,1,0,4,0,75.69497021,1,-4.344456432,1.586953072,-2.737608634,0.006188768,0.025838263,25.16104533,0,-1.187594493,2.028361854,-0.585494393,0.558215335,0.702072183,63.86661327,1,-3.807985614,2.004510031,-1.899708934,0.057471327,0.125912079,73.55537437,1,-4.227921267,2.002714929,-2.111094897,0.034764156,0.099426657,61.82033385,1,-3.863779656,1.985741864,-1.945761292,0.05168342,0.114984538,N,-,,monocarboxylate permease,"F:NADP binding; P:transmembrane transport; F:flavin adenine dinucleotide binding; C:integral component of membrane; F:symporter activity; P:oxidation-reduction process; F:N,N-dimethylaniline monooxygenase activity",G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11360:SF155 (PANTHER); PTHR11360 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.13.4, the major facilitator superfamily (mfs).
RL4_JR_04035,601,818,757,0,4,2,0,0,0,0,2,0,0,3,0,0,3,0,19.58111193,1,-2.393800893,1.22673794,-1.95135474,0.051014862,0.134947873,6.327501888,0,0.803901441,1.287557648,0.624361513,0.532390195,0.680754618,16.30611995,1,-1.838377331,1.226259916,-1.499174284,0.133828425,0.24070921,18.80142886,1,-2.259978306,1.228148409,-1.840150823,0.065746098,0.145028156,15.98765931,1,-1.912734043,1.228529109,-1.556930177,0.119487064,0.218438011,N,-,,C6 transcription,,IPR007219 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); IPR001138 (PFAM); PTHR31944 (PANTHER); PTHR31944:SF31 (PANTHER); PTHR31944 (PANTHER),,
RL4_JR_04036,1182,1385,2146,0,0,5,0,0,0,4,0,0,0,2,0,0,0,0,0.035431636,1,6.715551724,3.936753579,1.705860321,0.088034089,NA,0.011687781,0,9.885319828,3.359280101,2.942689961,0.003253741,0.016208996,0.029779836,1,7.257979779,2.012015736,3.6073176,0.000309379,0.002380055,0.034308109,1,6.837812722,3.693344738,1.851387619,0.064113809,0.142418003,0.028910053,0,7.188090183,1.475261667,4.872417107,1.10E-06,1.57E-05,N,-,,o-methyltransferase,F:transferase activity,IPR001077 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); PTHR11746 (PANTHER); PTHR11746:SF63 (PANTHER); IPR016461 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_04037,169,215,271,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.668067603,0,0.481684076,1.519959482,0.316905866,0.751315031,0.870021756,0.837205263,0,3.721616991,1.643811908,2.264016323,0.023573111,0.065569395,2.205190977,0,1.047705978,1.371315441,0.764015299,0.444858125,0.584446361,2.545828047,0,0.624396133,1.419607287,0.439837228,0.660055003,0.768306907,2.215395279,0,0.938636945,1.386216018,0.677121698,0.498328743,0.626157672,N,-,,alcohol dehydrogenase -like domain-containing,,IPR020843 (SMART); IPR011032 (G3DSA:3.90.180.GENE3D); IPR013149 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR11695:SF446 (PANTHER); PTHR11695:SF446 (PANTHER); IPR002085 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_04038,4318,5040,5304,5,2,0,0,0,0,0,0,0,4,2,0,0,5,0,7.562826007,1,-1.021030904,1.224888615,-0.833570409,0.404523106,0.596537086,2.421438316,0,2.18974235,1.326803978,1.650388744,0.098863452,0.200821967,6.256776554,0,-0.456218607,1.218713735,-0.374344355,0.708148137,0.80202391,7.216774893,1,-0.878329897,1.219565375,-0.72019911,0.471402412,0.61238766,25.43513697,1,2.36909585,0.721733322,3.282508619,0.001028878,0.004893092,N,HYBRID,,polyketide synthase,F:catalytic activity,IPR020841 (SMART); IPR020801 (SMART); IPR020806 (SMART); IPR020807 (SMART); SM00822 (SMART); IPR029063 (G3DSA:3.40.50.GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR014030 (PFAM); IPR009081 (G3DSA:1.10.1200.GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR013217 (PFAM); IPR001242 (PFAM); G3DSA:3.30.70.250 (GENE3D); IPR010071 (TIGRFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013968 (PFAM); IPR014031 (PFAM); IPR014043 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); G3DSA:3.30.300.30 (GENE3D); IPR020807 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR001227 (G3DSA:3.40.366.GENE3D); IPR009081 (PFAM); G3DSA:2.30.38.10 (GENE3D); IPR000873 (PFAM); IPR032821 (PFAM); IPR013120 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR11712:SF189 (PANTHER); PTHR11712 (PANTHER); PTHR11712:SF189 (PANTHER); PTHR11712 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR009081 (PROSITE_PROFILES); IPR016040 (SUPERFAMILY); IPR009081 (SUPERFAMILY); SSF56801 (SUPERFAMILY); SSF52777 (SUPERFAMILY); IPR016036 (SUPERFAMILY); IPR029063 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR016035 (SUPERFAMILY); SSF52777 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR009081 (SUPERFAMILY),4.C.1.1.6, the fatty acid transporter (fat) family.
RL4_JR_04039,6843,5257,5570,5,3,14,0,0,0,1,29,23,0,9,9,0,2,12,1.052185639,1,1.824267902,1.646975923,1.107646977,0.268014307,NA,0.329425835,0,5.06722415,1.748300562,2.898371287,0.003751062,0.017473407,13.86289351,1,4.198833484,1.113350138,3.771350396,0.000162366,0.001552218,50.28299382,1,5.546730242,0.718465342,7.720247475,1.16E-14,7.00E-13,20.16667102,1,5.109198129,0.871970427,5.859370882,4.65E-09,2.34E-07,N,-,,Cytochrome P450,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:iron ion binding; C:membrane; P:oxidation-reduction process; F:heme binding",IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24287:SF7 (PANTHER); PTHR24287 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_04040,32937,21752,25111,1,1,1,1,0,0,1,0,7,4,8,4,0,4,5,0.081085132,1,5.5222583,3.919907466,1.408772617,0.158902414,NA,0.026751152,1,8.690506914,3.919504638,2.217246238,0.026606269,0.071911525,0.0677093,1,6.074911347,2.329345147,2.607991072,0.009107533,0.030410509,0.077998616,1,5.65351733,3.919816767,1.442291226,0.149220234,0.265388174,0.064871552,1,6.031500662,1.773110288,3.401650029,0.000669804,0.003460082,N,-,,short-chain,C:membrane,IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24320 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04041,3193,3268,8019,0,0,2,0,0,4,0,0,0,0,5,0,0,0,0,0.012376897,1,8.237661038,3.992283311,2.063395906,0.039075029,NA,0.004015611,1,11.43115744,3.991119401,2.864148198,0.004181323,0.018371529,0.010235446,0,8.805715205,3.038577053,2.897973312,0.003755825,0.015764501,0.01179869,1,8.381441139,3.992433907,2.099331219,0.035787713,0.10034633,0.009844433,0,8.758432769,1.618956569,5.409924478,6.31E-08,1.56E-06,N,-,,NADH:flavin oxidoreductase NADH oxidase,F:nucleotide binding; F:coenzyme binding; F:oxidoreductase activity; C:membrane,IPR001155 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR22893 (PANTHER); PTHR22893:SF6 (PANTHER); SSF51395 (SUPERFAMILY),,
RL4_JR_04042,10618,11927,14623,3,0,33,0,0,0,2,2,15,0,17,1,0,18,1,27.94773107,1,-2.906902974,1.189241864,-2.444332866,0.01451203,0.051250711,8.9120168,0,0.309783358,1.217915263,0.254355428,0.799220982,0.878023957,23.11677878,1,-2.341845147,1.190135202,-1.967713537,0.049101007,0.111532106,26.66851848,1,-2.764204089,1.188698133,-2.325404586,0.020050337,0.076839386,22.77200664,1,-2.422934473,1.192140894,-2.032422917,0.04211086,0.097949106,N,-,,calcium-translocating P-type PMCA-type,F:ATP binding; F:metal ion binding; C:integral component of membrane; P:calcium ion transmembrane transport; F:calcium-transporting ATPase activity,IPR001757 (PRINTS); PR00119 (PRINTS); IPR004014 (SMART); IPR004014 (PFAM); IPR008250 (G3DSA:2.70.150.GENE3D); IPR023298 (G3DSA:1.20.1110.GENE3D); IPR006408 (TIGRFAM); IPR008250 (PFAM); IPR001757 (TIGRFAM); IPR006068 (PFAM); IPR023299 (G3DSA:3.40.1110.GENE3D); PF13246 (PFAM); PTHR24093 (PANTHER); PTHR24093:SF346 (PANTHER); SSF81653 (SUPERFAMILY); IPR023299 (SUPERFAMILY); SSF81665 (SUPERFAMILY); IPR023214 (SUPERFAMILY),3.A.3.2.27, the p-type atpase (p-atpase) superfamily.
RL4_JR_04043,37810,29940,25293,1,10,15,2,0,3,2,12,16,7,13,5,0,6,3,56.58040369,1,-2.881200636,1.222887731,-2.356063082,0.018469781,0.061449467,16.68437737,1,-0.594904645,1.267424315,-0.469380805,0.638797466,0.764116074,43.41951161,1,-3.251267298,1.243097688,-2.615455993,0.00891084,0.029871607,54.11863141,1,-2.730938503,1.205927789,-2.264595384,0.02353752,0.082950712,42.82723666,1,-3.334222843,1.251724137,-2.663704202,0.007728549,0.025555701,N,-,,fungal specific transcription factor,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PTHR31944:SF82 (PANTHER); PTHR31944 (PANTHER),,
RL4_JR_04044,2316,2490,2968,0,1,4,0,0,0,0,1,0,2,6,0,0,0,0,0.359679708,1,3.372658058,2.368482841,1.423974031,0.15445399,NA,0.114875985,0,6.587104226,2.090988312,3.150234838,0.001631393,0.015023052,0.298674637,1,3.931062424,1.371933504,2.865344721,0.004165555,0.016801625,0.344553359,1,3.509488368,1.624964945,2.15973174,0.030793443,0.093949923,0.29582864,0,3.842588687,1.301684852,2.952011526,0.003157111,0.01234199,N,-,,hypothetical protein AK830_g7546,C:membrane,no IPS match,,
RL4_JR_04045,686,582,731,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.250368039,1,3.895205323,2.994347269,1.300852898,0.193308811,NA,0.079435504,0,7.118971861,2.436762759,2.921487467,0.003483643,0.016759237,0.207922157,0,4.453322276,1.616637836,2.754681461,0.00587493,0.021418003,0.239932469,0,4.031434068,2.060064493,1.956945563,0.050353869,0.123745855,0.207775543,0,4.352536343,1.49663557,2.908213884,0.003634996,0.01382063,N,-, Effector probability:0.57,#NAME?,F:isomerase activity,IPR009959 (PFAM); IPR032710 (G3DSA:3.10.450.GENE3D); IPR032710 (SUPERFAMILY),,
RL4_JR_04046,102,102,77,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,31.61101094,0,0.402762266,0.913293592,0.440999773,0.659213162,0.808457753,4.383134792,1,1.333463403,1.285780972,1.037084411,0.29969652,0.460043702,11.4686257,0,-1.330723281,1.22629834,-1.085154597,0.277853189,0.416800369,17.2489285,0,-0.809061615,1.180841878,-0.685156607,0.493245103,0.63208539,22.98841244,0,0.741243131,0.921503004,0.804384932,0.421174701,0.557073004,N,-,,polyketide synthase,,IPR029063 (G3DSA:3.40.50.GENE3D); IPR007213 (PFAM); PTHR13600:SF19 (PANTHER); IPR007213 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_04047,215,333,440,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,129.3550963,0,8.489157791,0.476026306,17.83337953,3.89E-71,1.59E-67,28.24324639,0,8.845184507,0.896831905,9.862700532,6.04E-23,3.60E-20,0.279935133,0,4.024676973,1.326261421,3.034603065,0.002408524,0.011485587,0.322979751,0,3.602892969,1.574541436,2.28821731,0.022124869,0.080442001,4.137747025,1,4.864745043,1.163392975,4.181514886,2.90E-05,0.000245761,N,-,,ribonucleoside-triphosphate reductase,P:DNA replication; P:oxidation-reduction process; F:iron-sulfur cluster binding; F:ribonucleoside-triphosphate reductase activity,IPR012833 (PFAM); IPR007197 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); IPR012833 (TIGRFAM); IPR012840 (TIGRFAM); G3DSA:3.20.70.20 (GENE3D); PF13394 (PFAM); PTHR21075 (PANTHER); SSF51998 (SUPERFAMILY); SSF102114 (SUPERFAMILY),,
RL4_JR_04048,847,745,864,0,0,3,0,0,0,0,0,0,0,1,0,0,0,0,0.016282912,1,7.839735781,3.971839371,1.973830019,0.048401074,NA,0.005351135,0,11.01554673,3.970178753,2.774571981,0.00552744,0.021974647,0.013566183,0,8.397347712,2.840476149,2.956316924,0.00311337,0.013891475,0.015630153,1,7.974278064,3.97154097,2.007854917,0.044658711,0.114728762,0.013009295,0,8.347323895,1.562419104,5.342563895,9.16E-08,2.07E-06,N,-,,sterigmatocystin 8-o-methyltransferase,F:O-methyltransferase activity; P:methylation,IPR001077 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); PTHR11746 (PANTHER); PTHR11746:SF87 (PANTHER); IPR016461 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY); IPR029063 (SUPERFAMILY),,
RL4_JR_04049,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100918671,0,5.206451862,3.917327132,1.329082736,0.183820675,NA,0.033265064,0,8.376514102,2.943245785,2.846012435,0.004427047,0.019044014,0.084325395,0,5.758725774,1.857209724,3.100740696,0.001930373,0.009584645,0.097144477,0,5.337080139,2.753612717,1.938210157,0.052597588,0.126308286,0.080996471,0,5.710625989,1.547915073,3.689237277,0.000224927,0.001375303,N,-,,Fungal specific transcription factor,F:binding,IPR007219 (SMART); IPR007219 (PFAM); PTHR31845 (PANTHER),,
RL4_JR_04050,2621,2231,3182,0,1,6,0,0,0,1,1,6,0,2,0,0,4,2,44.23566631,1,8.927162881,0.975754246,9.148986967,5.75E-20,7.56E-18,0.023365295,0,8.883293304,2.925313983,3.036697379,0.002391855,0.015242306,0.061616744,1,6.205634628,1.759011154,3.527910903,0.000418853,0.002977857,28.00793796,1,8.472841929,1.656024415,5.116375008,3.11E-07,6.32E-06,3.922526135,1,7.019605303,1.283406256,5.469511519,4.51E-08,1.22E-06,N,-,,high-affinity methionine permease,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PFAM); IPR002293 (PANTHER); PTHR11785:SF353 (PANTHER); PTHR11785:SF353 (PANTHER),2.A.3.8.4, the amino acid-polyamine-organocation (apc) family.
RL4_JR_04051,11753,11434,12153,0,0,6,0,0,4,1,4,4,1,1,0,0,2,0,0.008115494,1,8.845278576,4.03634189,2.191409652,0.028422161,NA,0.002507343,1,12.10167175,4.040174693,2.995333784,0.002741447,0.015349618,0.006623884,1,9.426891884,3.299070491,2.857438757,0.00427075,0.016940088,0.007651472,1,9.002876608,4.037800151,2.229648886,0.025770762,0.085851084,0.006630333,1,9.341240721,1.70468121,5.479758129,4.26E-08,1.17E-06,Y,-,,glycosyl hydrolase,F:catalytic activity; C:membrane; C:integral component of membrane; F:hydrolase activity,IPR005198 (PFAM); IPR012341 (G3DSA:1.50.10.GENE3D); PTHR12145 (PANTHER); PTHR12145:SF14 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_04052,2691,3603,3281,0,3,0,0,0,0,4,2,0,7,13,5,0,3,0,20.65054425,1,-2.470357864,1.188608808,-2.078360725,0.037676147,0.107866361,6.621606253,0,0.738386302,1.237168377,0.596835739,0.550617055,0.696929577,17.11712221,1,-1.908308408,1.193294481,-1.59919319,0.109777683,0.207857142,19.74252808,1,-2.330338845,1.191364231,-1.956025526,0.050462147,0.123921717,16.80627427,1,-1.984732224,1.190052608,-1.667768476,0.095361696,0.18429799,N,-,,Pyrimidine pathway regulatory 1,F:binding,IPR007219 (SMART); IPR001138 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04053,32,37,60,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.425614596,0,-1.17713467,1.214281201,-0.969408626,0.33234135,0.521960332,2.669412296,0,2.048918104,1.291639727,1.586292262,0.112673027,0.22240179,6.958870032,0,-0.609997974,1.209335673,-0.504407492,0.613975054,0.729030564,8.030287094,0,-1.03275304,1.209379291,-0.853952972,0.393131047,0.537971598,6.894564641,0,-0.699173091,1.21814805,-0.57396397,0.565992183,0.683035859,N,-,,Glycerate dehydrogenase,F:oxidoreductase activity,IPR016040 (G3DSA:3.40.50.GENE3D); IPR006140 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR006139 (PFAM); PTHR10996 (PANTHER); PTHR10996:SF135 (PANTHER); IPR016040 (SUPERFAMILY); SSF52283 (SUPERFAMILY),,
RL4_JR_04054,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.027974995,0,7.057164904,3.944726748,1.789012358,0.073612825,NA,0.00918948,0,10.233268,3.441762488,2.973263853,0.00294651,0.0154422,0.023399187,0,7.608647542,2.028930759,3.750077478,0.00017678,0.001628499,0.026960938,0,7.186064547,3.944404775,1.821837503,0.068479645,0.148587944,0.022629567,0,7.543781739,1.445745696,5.21791748,1.81E-07,3.72E-06,N,-, Effector probability:0.785,isoflavone reductase family,C:membrane,IPR016040 (G3DSA:3.40.50.GENE3D); IPR008030 (PFAM); PTHR15020 (PANTHER); PTHR15020:SF31 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04055,24148,26035,33623,0,3,5,2,0,3,0,0,1,2,5,1,0,18,0,0.808834231,1,2.203750728,1.776484024,1.240512551,0.214785875,NA,0.264004434,1,5.387179618,1.855197713,2.903830455,0.003686277,0.01729833,0.674739312,1,2.757065662,1.351537333,2.039947839,0.041355521,0.098167244,0.777651255,1,2.335868323,1.461265093,1.598524685,0.109926256,0.210793176,0.654846987,1,2.696375744,1.305142405,2.065962867,0.038831986,0.091945749,N,-,,extradiol ring-cleavage dioxygenase class iii subunit b,"F:dioxygenase activity; P:cellular aromatic compound metabolic process; F:ferrous iron binding; P:oxidation-reduction process; F:transferase activity; F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR004183 (G3DSA:3.40.830.GENE3D); IPR004183 (PFAM); IPR004183 (SUPERFAMILY),,
RL4_JR_04056,176,215,232,0,1,3,0,0,0,0,0,1,0,0,0,0,0,0,31.34559786,1,5.644118136,0.981455952,5.750760515,8.88E-09,2.11E-07,0.251849272,0,5.455014701,1.916198816,2.846789516,0.004416255,0.019013754,0.654517656,1,2.801120343,1.407312653,1.990403722,0.04654648,0.107074884,0.755341491,0,2.378007512,1.543210647,1.540948098,0.123329418,0.228995115,0.643526518,0,2.722807915,1.369946795,1.98752822,0.046863892,0.106580616,Y,-,,hexose transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR003663 (PRINTS); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500 (PANTHER); PTHR23500:SF21 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.83, the major facilitator superfamily (mfs).
RL4_JR_04057,329,359,234,2,0,5,0,0,0,0,0,1,0,2,1,0,2,0,27.99980084,1,1.696650992,0.789394455,2.149306955,0.031610076,0.094356018,2.855776705,0,1.951727645,1.344420908,1.451723663,0.146578457,0.272199773,7.366955726,1,-0.691901157,1.236807938,-0.5594249,0.575871771,0.698261717,8.496733095,1,-1.11392226,1.24016609,-0.898204094,0.369076751,0.514987936,14.92456661,1,0.888677636,1.027691555,0.864731866,0.387185975,0.523119562,N,-,,glycoside hydrolase family 3 domain,"P:cellular macromolecule metabolic process; P:polysaccharide catabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:binding",IPR001764 (PRINTS); IPR011658 (SMART); IPR011658 (PFAM); IPR002772 (PFAM); IPR001764 (G3DSA:3.20.20.GENE3D); IPR001764 (PFAM); IPR002772 (G3DSA:3.40.50.GENE3D); IPR026892 (PANTHER); PTHR30620:SF18 (PANTHER); IPR026892 (PANTHER); PTHR30620:SF18 (PANTHER); IPR017853 (SUPERFAMILY); IPR002772 (SUPERFAMILY); SSF56988 (SUPERFAMILY),,
RL4_JR_04058,9522,6996,6174,0,1,2,0,0,0,1,0,0,6,6,2,0,1,2,12.37014041,1,-1.731027275,1.369044625,-1.264405296,0.206084593,0.371462242,3.962045552,0,1.479337023,1.449197681,1.020797261,0.307350502,0.469018813,10.19872038,1,-1.161228946,1.322736459,-0.877898949,0.37999856,0.52391467,21.07519327,1,-0.617662275,1.28215509,-0.481737568,0.629992385,0.745781936,9.924077976,1,-1.224683287,1.333344976,-0.918504445,0.358354833,0.495810698,N,-,,Salicylate hydroxylase,"F:FAD binding; C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; C:membrane; P:oxidation-reduction process; F:monooxygenase activity; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PR00420 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR002938 (PFAM); PTHR13789 (PANTHER); PTHR13789:SF186 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_04059,118,248,207,0,0,2,0,0,0,0,0,0,0,0,0,1,0,3,0.189048313,1,4.301165677,3.22354684,1.334296007,0.182106866,NA,0.060387606,0,7.51578115,2.478710867,3.032133054,0.002428321,0.015349618,0.155626357,0,4.875097511,1.578843423,3.08776503,0.002016679,0.009899587,0.179514431,0,4.451466273,2.105836737,2.113870556,0.034526325,0.099426657,0.151536227,1,4.810268339,1.420449493,3.386440955,0.000708055,0.003628066,N,-,,nucleobase transmembrane transporter,F:vitamin B6 transporter activity; P:transmembrane transport; C:integral component of membrane; P:vitamin B6 transport; C:plasma membrane,IPR026030 (PIRSF); IPR001248 (PFAM); PTHR31806 (PANTHER); IPR030175 (PTHR31806:PANTHER),2.A.39.2.4, the nucleobase:cation symporter-1 (ncs1) family.
RL4_JR_04060,1326,1944,2451,0,0,2,0,0,0,0,0,0,0,3,1,0,0,2,21.5852898,1,1.228574118,1.11964016,1.097293721,0.272513015,0.454541234,1.763393539,0,2.647214482,1.44086132,1.837244462,0.066173815,0.146888454,4.578861459,0,-0.005836733,1.280983933,-0.004556445,0.996364495,0.998625867,5.283604307,1,-0.428553587,1.293878692,-0.331216202,0.740481183,0.827707217,11.86805978,1,0.86552573,1.205012677,0.718271058,0.472590172,0.603553922,N,-,,N-carbamoyl-L-amino acid,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines; P:metabolic process",IPR011650 (PFAM); IPR011650 (G3DSA:3.30.70.GENE3D); G3DSA:3.40.630.10 (GENE3D); IPR010158 (PIRSF); IPR002933 (PFAM); IPR010158 (TIGRFAM); PTHR32494 (PANTHER); PTHR32494:SF9 (PANTHER); SSF53187 (SUPERFAMILY); IPR011650 (SUPERFAMILY),,
RL4_JR_04061,1438,1936,991,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.18508182,0,2.034944708,0.766014149,2.656536711,0.007894785,0.031463439,1.898605312,0,2.540672205,1.337155439,1.900057488,0.057425576,0.131739516,4.900417231,0,-0.103699909,1.210819021,-0.085644434,0.931749075,0.959225914,5.651603836,0,-0.525635492,1.210613892,-0.434189213,0.664151046,0.771073196,4.802020704,0,-0.177453716,1.203876799,-0.14740189,0.882814813,0.922347116,N,-,,gal4-like transcription factor,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR007219 (SMART); IPR007219 (PFAM); PTHR31944 (PANTHER),,
RL4_JR_04062,988,1181,697,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,4.50300332,0,-0.272984595,1.319171747,-0.206936357,0.836059563,0.918684172,1.43029212,0,2.949280389,1.449528865,2.034647575,0.041886347,0.102806402,3.708880738,0,0.298227661,1.272615238,0.234342362,0.814719201,0.879718427,4.279302864,1,-0.124358234,1.286148119,-0.096690445,0.922972228,0.954341296,3.642761296,0,0.22134395,1.273382259,0.173823648,0.862004059,0.90810437,N,-, Effector probability:0.567,CMP dCMP deaminase zinc-binding,,IPR002125 (PFAM); G3DSA:3.40.140.10 (GENE3D); PTHR11079:SF69 (PANTHER); PTHR11079 (PANTHER); IPR002125 (PROSITE_PROFILES); IPR016193 (SUPERFAMILY),,
RL4_JR_04063,658,699,460,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0.104868536,0,5.151049055,3.91692972,1.315073137,0.188485324,NA,0.032754646,1,8.397129249,2.714354268,3.093601063,0.001977432,0.015023052,0.08602646,0,5.727812924,1.629481917,3.515112912,0.000439567,0.003079707,0.099328438,0,5.304403026,2.470286546,2.147282482,0.0317708,0.095284166,0.085718794,0,5.634062193,1.394581326,4.039966754,5.35E-05,0.000412302,Y,-,,extracellular dioxygenase,"P:cellular aromatic compound metabolic process; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:ferric iron binding; P:oxidation-reduction process",IPR000627 (PFAM); IPR015889 (G3DSA:2.60.130.GENE3D); PTHR34315 (PANTHER); PTHR34315:SF1 (PANTHER); IPR015889 (SUPERFAMILY),,
RL4_JR_04064,891,829,859,0,2,0,8,0,0,0,0,0,0,2,5,0,2,0,29.37431487,1,-0.100458623,1.006589395,-0.099800995,0.920502318,0.961641428,4.271231048,1,1.370860151,1.253361436,1.093746873,0.274066011,0.432102206,11.07098479,0,-1.279817064,1.194895484,-1.071070299,0.284137822,0.423466996,16.78211065,1,-0.754948482,1.144690689,-0.659521816,0.509560742,0.644751626,18.27563345,1,-0.426532346,1.125076899,-0.379113949,0.704603248,0.79074572,N,-,,adp-ribosylation crystallin j1,P:biological_process; C:cellular_component; F:molecular_function; F:hydrolase activity,IPR005502 (PFAM); IPR005502 (SUPERFAMILY),,
RL4_JR_04065,39,43,31,0,0,3,0,0,0,0,0,0,1,0,0,0,0,3,0.154398835,1,4.592699859,3.391109156,1.354335602,0.175629333,NA,0.048420644,0,7.832818277,2.475482736,3.164157908,0.001555324,0.015023052,0.12736911,0,5.159433791,1.504604859,3.429095527,0.000605596,0.003890265,0.147044959,1,4.737764159,2.108887281,2.246570598,0.024667483,0.084922906,0.127594087,1,5.057300843,1.355124864,3.731981442,0.00018998,0.001191786,N,-, Effector probability:0.749,Alcohol dehydrogenase zinc-type,F:metal ion binding,IPR016040 (G3DSA:3.40.50.GENE3D); PTHR11695:SF559 (PANTHER); IPR002085 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04066,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.802249128,0,2.215712041,1.636681607,1.353783186,0.175805559,NA,0.257046692,0,5.425596216,1.762508184,3.078338169,0.002081586,0.015023052,0.663948849,0,2.780659466,1.272186419,2.185732708,0.028835166,0.074319558,0.765798533,0,2.358210579,1.349086835,1.748005033,0.080463156,0.166978777,0.650588428,0,2.706755892,1.23538089,2.191029434,0.028449663,0.072175603,N,-, Effector probability:0.719,aldehyde dehydrogenase,"P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",IPR015590 (PFAM); IPR016163 (G3DSA:3.40.309.GENE3D); PTHR11699 (PANTHER); PS51257 (PROSITE_PROFILES); IPR016161 (SUPERFAMILY),,
RL4_JR_04067,856,984,1459,0,0,3,0,0,0,0,0,0,0,0,1,0,0,0,1.817226127,1,1.036218111,1.344620755,0.770639682,0.440920533,NA,0.579811588,0,4.251970867,1.544140068,2.753617341,0.005894064,0.023016865,1.501204383,0,1.603356715,1.248360839,1.284369603,0.199012663,0.324340664,1.731786899,1,1.180917514,1.273026097,0.927645958,0.35359125,0.499875929,9.195134434,0,3.184019739,1.011473977,3.1479008,0.001644475,0.00720169,N,-,,ferro-O2-oxidoreductase,F:copper ion binding; F:metal ion binding; F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process,IPR011707 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); IPR001117 (PFAM); IPR011706 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); IPR008972 (G3DSA:2.60.40.GENE3D); PTHR11709:SF49 (PANTHER); PTHR11709 (PANTHER); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY),2.A.108.1.7, the iron/lead transporter (ilt) family.
RL4_JR_04068,5,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.381288614,0,3.288910145,2.310599958,1.423400937,0.154619961,NA,0.121200574,0,6.510235342,2.064666972,3.153164859,0.001615106,0.015023052,0.314263457,0,3.860077567,1.360675783,2.836882684,0.004555635,0.017704893,0.362586971,0,3.43688693,1.594759238,2.155113353,0.031152965,0.094438255,4.169297771,0,4.709654646,1.1881624,3.963813907,7.38E-05,0.000539233,N,-,,phospholipase c,"F:hydrolase activity, acting on ester bonds",G3DSA:2.80.10.50 (GENE3D); IPR007312 (PFAM); PTHR31956 (PANTHER); PTHR31956:SF1 (PANTHER),,
RL4_JR_04069,2,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34.40490219,0,-0.198998706,1.002292265,-0.198543592,0.842619782,0.920863894,4.560035659,0,1.27647117,1.243753113,1.02630591,0.304747413,0.465889338,11.82471033,0,-1.374815682,1.190379496,-1.154938981,0.248115415,0.382666733,36.92274751,0,0.522759682,0.844372221,0.619110469,0.535843587,0.667825741,23.23593905,0,0.748726795,0.842933884,0.888239053,0.374412176,0.510493304,N,-,,endonuclease exonuclease phosphatase family,F:nuclease activity,IPR002110 (SMART); IPR005135 (G3DSA:3.60.10.GENE3D); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR33607:SF1 (PANTHER); PTHR33607 (PANTHER); PTHR33607:SF1 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR005135 (SUPERFAMILY); IPR020683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_04070,836,802,1294,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0.617098757,0,2.594113185,1.80359857,1.438298537,0.150349367,NA,0.19581222,0,5.817885219,1.83096556,3.177495714,0.001485529,0.015023052,0.509705142,0,3.161042625,1.27238034,2.484353559,0.012978688,0.039660801,0.588140853,0,2.738498498,1.377885545,1.987464422,0.046870955,0.118051845,0.504025895,1,3.075337972,1.237787804,2.484543765,0.012971756,0.038731652,N,-, Effector probability:0.745,hypothetical protein SPBR_06178,,no IPS match,,
RL4_JR_04071,56,50,77,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,267.7536279,0,0.303983051,0.38978909,0.779865468,0.435470066,0.626112936,47.10529182,0,-0.855923506,1.128448469,-0.758495873,0.448154183,0.608851663,187.9997482,0,-0.018045075,0.482142289,-0.037426866,0.970144652,0.982665778,431.1443406,0,1.419987546,0.37018891,3.835845724,0.000125133,0.001294148,222.8924435,0,0.635847033,0.422166074,1.50615379,0.132027699,0.235100325,N,-,,calcofluor white hypersensitive,C:integral component of membrane; P:transport; F:transporter activity,IPR019402 (PFAM); PTHR14859:SF1 (PANTHER); IPR027317 (PANTHER); IPR005135 (SUPERFAMILY),9.B.131.1.1, the post-gpi attachment protein (p-gap2) family.
RL4_JR_04072,31,38,36,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2.336039944,0,0.673756203,1.263848464,0.533098882,0.593965133,0.764767606,0.742883289,0,3.894303338,1.458011071,2.670969663,0.007563248,0.027478535,1.930230128,1,1.240282967,1.220228838,1.016434728,0.309422415,0.450732738,40.76818789,0,3.936605581,1.337435414,2.943398642,0.003246301,0.019860301,1.904552784,0,1.15705885,1.215008448,0.952305189,0.340942227,0.478275253,N,-,,short chain dehydrogenase reductase family,,IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24319 (PANTHER); PTHR24319:SF26 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04073,99,152,98,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.238627284,0,3.964697984,2.762725469,1.435067664,0.151267817,NA,0.075825381,0,7.186388852,2.217753894,3.240390592,0.001193661,0.015023052,0.19752908,0,4.527509377,1.363180424,3.321284035,0.000896043,0.005274151,0.227916319,0,4.105834142,1.741278199,2.357942657,0.018376531,0.074009818,0.195783395,0,4.438815246,1.270138698,3.494748451,0.000474509,0.002589974,Y,-,,---NA---,,no IPS match,,
RL4_JR_04074,1517,755,1532,0,1,0,0,0,0,0,0,0,2,1,0,0,4,0,2.007820933,1,0.891945062,1.309399537,0.681186328,0.495753598,NA,0.635764432,0,4.118813601,1.49997363,2.745924007,0.006034074,0.023385719,1.658652802,0,1.458560028,1.236696236,1.179400394,0.238238778,0.371039205,1.914078361,1,1.035872993,1.255501765,0.825066935,0.409333591,0.553146934,1.645213692,1,1.368113644,1.235692742,1.107163292,0.268223335,0.400497879,N,-,,Dihydrolipoamide succinyltransferase,F:dihydrolipoyllysine-residue succinyltransferase activity; C:mitochondrial matrix; C:oxoglutarate dehydrogenase complex; P:tricarboxylic acid cycle,G3DSA:2.40.50.100 (GENE3D); IPR001078 (PFAM); IPR000089 (PFAM); IPR023213 (G3DSA:3.30.559.GENE3D); PTHR23151 (PANTHER); PTHR23151:SF8 (PANTHER); IPR000089 (PROSITE_PROFILES); IPR011053 (SUPERFAMILY); SSF52777 (SUPERFAMILY),,
RL4_JR_04075,2631,2836,6276,0,0,0,0,0,0,0,0,0,3,1,0,0,7,0,0.965026323,0,1.949227828,1.575350018,1.237329993,0.215964597,NA,0.310221589,0,5.154376328,1.730692385,2.978216333,0.002899313,0.015349618,11.86927729,0,3.475812632,1.225052352,2.837276812,0.004550015,0.017689841,20.97971356,1,5.070784178,0.757883402,6.690718079,2.22E-11,9.07E-10,0.780932748,1,2.443112333,1.249962855,1.954547947,0.05063645,0.113305579,N,-,,Long-chain specific acyl- dehydrogenase,F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; P:oxidation-reduction process,G3DSA:1.20.140.10 (GENE3D); G3DSA:2.40.110.10 (GENE3D); IPR009075 (PFAM); IPR013786 (G3DSA:1.10.540.GENE3D); IPR013786 (PFAM); IPR006091 (PFAM); PTHR10909 (PANTHER); PTHR10909 (PANTHER); PTHR10909:SF314 (PANTHER); PTHR10909:SF314 (PANTHER); IPR009075 (SUPERFAMILY); IPR009100 (SUPERFAMILY),,
RL4_JR_04076,315,360,410,0,0,0,0,0,0,0,2,1,0,0,0,0,0,0,0.027871149,0,7.062319586,3.944861964,1.79025772,0.07341249,NA,0.008516584,0,10.33793613,3.946534188,2.61949742,0.008805944,0.030640689,0.022762354,1,7.643370404,2.643689835,2.891175169,0.003838041,0.016016484,0.026306519,0,7.22009277,3.945298707,1.830049714,0.067242505,0.147035061,0.023132308,0,7.526601169,1.646614409,4.570955488,4.86E-06,5.54E-05,N,-,,alcohol dehydrogenase,F:zinc ion binding; P:oxidation-reduction process; F:alcohol dehydrogenase (NAD) activity,IPR020843 (SMART); IPR013149 (PFAM); IPR013154 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); IPR002085 (PANTHER); PTHR11695:SF531 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_04077,54,57,65,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0.003906015,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,0,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,N,-,,4-hydroxyacetophenone monooxygenase,F:nucleotide binding; F:coenzyme binding; F:monooxygenase activity,IPR020946 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR23023:SF95 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_04078,2617,4141,6021,0,0,0,0,0,0,0,0,0,0,6,1,0,4,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_04079,2873,3553,4232,0,0,6,0,0,0,0,0,1,0,3,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.78,Oxoglutarate iron-dependent oxygenase,F:oxidoreductase activity; P:oxidation-reduction process,PTHR41677:SF1 (PANTHER); PTHR41677 (PANTHER),,
RL4_JR_04080,4258,4913,5892,0,2,15,0,0,0,0,0,0,1,10,0,0,0,0,123.3997376,1,-0.993175148,0.605778318,-1.639502633,0.101108623,0.223474436,29.76102112,0,-1.429806527,1.207739793,-1.183869684,0.236464652,0.387234301,108.2849865,0,-1.251612424,0.75297185,-1.662230034,0.09646666,0.188866461,182.6269699,1,0.129095742,0.440148856,0.293300187,0.769292711,0.85005879,87.04124617,0,-1.948284525,0.846947327,-2.300360911,0.021427781,0.057747215,N,-,,anucleate primary sterigmata B,C:microtubule organizing center; P:nuclear division; P:cell cycle process; P:reproductive process; P:microtubule cytoskeleton organization; P:establishment of localization in cell; P:cellular protein localization; P:establishment of organelle localization,IPR012943 (PFAM); IPR024545 (PFAM); PTHR13140 (PANTHER),,
RL4_JR_04081,5669,4916,5201,4,2,2,0,0,1,0,0,0,0,0,0,0,2,0,99.15679708,1,-4.73395766,1.299029434,-3.644226634,0.000268197,0.001978256,31.33556057,1,-1.504208481,1.271259827,-1.183242363,0.236713108,0.387390474,88.03447135,0,-3.198567591,1.25722584,-2.544147193,0.010954491,0.035187843,94.09594274,0,-4.583231502,1.271692666,-3.604040209,0.000313309,0.002812278,87.73531399,1,-3.29306343,1.201115224,-2.741671545,0.006112743,0.021087402,N,-,,hypothetical protein MGG_10856,P:mycelium development,no IPS match,,
RL4_JR_04082,2181,2316,2481,7,1,23,0,0,0,0,0,1,1,2,0,0,0,0,33.42496128,1,1.590384343,0.678766714,2.343049992,0.01912682,0.063136907,3.257465477,0,1.76179683,1.284344449,1.371747923,0.170141924,0.305134046,8.41974102,1,-0.884820846,1.203233056,-0.735369463,0.462114514,0.599493509,17.73370442,1,0.414634454,1.027075502,0.403703967,0.686430422,0.787369211,15.63948353,0,-0.026852811,1.12902213,-0.023784131,0.981024798,0.987527226,N,-,,glycosyltransferase family 90,,IPR006598 (SMART); IPR006598 (PFAM); PTHR12203 (PANTHER); PTHR12203:SF22 (PANTHER); PTHR12203:SF22 (PANTHER); PTHR12203 (PANTHER),,
RL4_JR_04083,12905,18828,16618,0,0,6,0,0,0,0,0,0,0,2,0,0,0,0,111.278463,1,-1.699952575,0.881031081,-1.929503524,0.053668383,0.14032906,26.17049058,0,-1.244391301,1.250735872,-0.994927329,0.31977161,0.481836667,81.75201125,0,-2.109871516,1.098911766,-1.919964442,0.054862391,0.121378244,89.00933184,1,-3.380582822,1.208399522,-2.797570472,0.005148853,0.028629645,72.58376471,0,-3.091731476,1.196300214,-2.584411036,0.009754547,0.030739117,N,-,,siderophore iron transporter,P:transmembrane transport; C:integral component of membrane,IPR029063 (G3DSA:3.40.50.GENE3D); IPR023165 (G3DSA:1.10.8.GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501 (PANTHER); PTHR23501 (PANTHER); PTHR23501:SF3 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR000961 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.16.8, the major facilitator superfamily (mfs).
RL4_JR_04084,9850,9348,11005,2,3,8,0,0,0,0,0,8,5,6,1,0,1,1,36.52980798,1,0.619295341,0.901612125,0.686875569,0.492161144,0.679825704,3.946989666,0,1.484658314,1.285201172,1.15519527,0.248010471,0.401336849,16.81897143,1,-0.216770726,1.218237661,-0.177937962,0.858771697,0.909911529,25.55779726,1,0.134374635,1.049591544,0.128025646,0.898128678,0.937189824,10.26326027,1,-1.273173647,1.236083155,-1.03000647,0.303006969,0.438277937,N,-,,---NA---,,no IPS match,,
RL4_JR_04085,9199,7092,4896,4,1,4,0,0,0,0,0,2,4,5,0,0,1,7,0.231699687,1,4.007273617,2.875660984,1.393513922,0.163464438,NA,0.072495003,0,7.250906973,2.291944907,3.163648023,0.001558051,0.015023052,0.190595625,1,4.579203726,1.442967541,3.17346274,0.001506322,0.007909755,0.220055424,1,4.156489687,1.860684326,2.233850003,0.025492944,0.085851084,0.190481181,1,4.479926278,1.339089274,3.345502324,0.000821337,0.004078487,,,,,,,,
RL4_JR_04086,31882,38564,45690,18,20,27,0,0,5,6,9,22,8,17,8,0,23,12,170.4338076,1,1.940607511,1.323509228,1.466259146,0.142577701,0.285996775,11.76756022,1,-0.091183194,1.224299819,-0.074477831,0.940630181,0.967685607,30.44125779,1,-2.738909197,1.19760799,-2.28698307,0.022196811,0.060441237,75.22930497,1,0.785018826,0.568473074,1.380925257,0.167301943,0.288279812,29.88795824,1,-2.815255583,1.195916994,-2.354056006,0.018569813,0.051540394,N,-,,Urea carboxylase,"F:nucleotide binding; F:ligase activity, forming carbon-nitrogen bonds",IPR005482 (SMART); IPR003833 (SMART); IPR003778 (SMART); IPR003778 (PFAM); IPR014084 (TIGRFAM); IPR014085 (TIGRFAM); IPR013815 (G3DSA:3.30.1490.GENE3D); IPR016185 (G3DSA:3.40.50.GENE3D); G3DSA:2.40.50.100 (GENE3D); IPR023631 (G3DSA:3.90.1300.GENE3D); IPR029000 (G3DSA:2.40.100.GENE3D); IPR013816 (G3DSA:3.30.470.GENE3D); IPR024946 (G3DSA:3.30.1360.GENE3D); IPR005479 (PFAM); IPR000089 (PFAM); IPR005481 (PFAM); IPR003778 (TIGRFAM); IPR003833 (PFAM); IPR005482 (PFAM); IPR023631 (PFAM); PTHR18866:SF91 (PANTHER); PTHR18866 (PANTHER); PTHR18866 (PANTHER); PTHR18866:SF91 (PANTHER); IPR011764 (PROSITE_PROFILES); IPR011761 (PROSITE_PROFILES); IPR000089 (PROSITE_PROFILES); SSF56059 (SUPERFAMILY); IPR016185 (SUPERFAMILY); IPR029000 (SUPERFAMILY); SSF160467 (SUPERFAMILY); IPR029000 (SUPERFAMILY); IPR023631 (SUPERFAMILY); IPR011054 (SUPERFAMILY); IPR011053 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_04087,15557,13298,12500,3,6,29,0,0,1,0,11,4,6,43,2,0,10,21,9.606803838,1,-1.366384361,1.188339636,-1.149826464,0.250215353,0.427488346,3.063849464,1,1.85016605,1.266668867,1.46065487,0.14411018,0.268288255,7.951420546,1,-0.802283896,1.192178936,-0.672955939,0.500975322,0.633509139,9.173108985,1,-1.224659832,1.189437168,-1.029612883,0.303191765,0.4488036,7.841346028,1,-0.884847138,1.195003073,-0.740455952,0.459023379,0.590622914,N,-,,Transcriptional activator DAL81,F:binding,IPR007219 (SMART); IPR001138 (SMART); IPR001138 (PFAM); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31668:SF4 (PANTHER); PTHR31668 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04088,217,521,405,0,0,0,0,0,0,0,0,3,1,0,0,0,0,0,11.98306853,0,1.496912276,1.033994029,1.447699148,0.147701208,0.293546989,1.378386625,0,3.002455013,1.357554501,2.211664438,0.026989859,0.072715293,3.590891989,1,0.344439057,1.213818653,0.283764841,0.7765906,0.851447936,4.143575259,1,-0.078235346,1.216208904,-0.064327227,0.948709674,0.970207017,3.555434081,0,0.256305068,1.218899951,0.210275722,0.833452482,0.887444146,N,-, Effector probability:0.596,helix-turn-helix-domain containing type,,IPR018531 (PFAM); IPR027369 (G3DSA:1.20.120.GENE3D); PTHR36922:SF2 (PANTHER); PTHR36922 (PANTHER); SSF109854 (SUPERFAMILY),,
RL4_JR_04089,5679,8164,9784,0,1,0,0,0,0,2,0,1,2,5,0,0,2,0,152.776609,1,-0.101552852,0.452939434,-0.224208459,0.822595102,0.910176433,45.73166291,0,0.353604149,0.987400975,0.358116062,0.720256459,0.824803245,173.9313441,1,0.605403798,1.766345894,0.342743627,0.731791339,0.819088504,156.805676,1,-0.552640072,0.559304992,-0.988083567,0.323111723,0.469571723,92.13443288,1,-0.845195977,0.638254379,-1.324230597,0.185426472,0.304335067,N,-,,fungal specific transcription factor,"C:nucleus; F:zinc ion binding; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); PTHR19444 (PANTHER); PTHR19444:SF22 (PANTHER); PTHR19444 (PANTHER); PTHR19444 (PANTHER); PTHR19444:SF22 (PANTHER); PTHR19444:SF22 (PANTHER),,
RL4_JR_04090,723,1038,1236,0,0,0,0,0,0,0,0,0,0,0,1,0,3,0,49.22040734,0,-1.414811603,1.005372266,-1.407251474,0.159352833,0.308714105,10.58054715,0,0.062165144,1.208504595,0.051439725,0.958975131,0.978272787,27.47189397,0,-2.590928722,1.187724041,-2.181423152,0.029152133,0.074964743,31.69375855,1,-3.013341848,1.186279978,-2.540160757,0.011080153,0.052719242,38.68567699,1,-0.469366635,0.843690124,-0.556325862,0.57798811,0.691329621,N,-,,fungal specific transcription factor,,IPR007219 (SMART); IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); IPR001138 (PFAM); PTHR31944:SF20 (PANTHER); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04091,372,373,319,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,142.0242198,1,-1.032764791,0.855371491,-1.207387436,0.227282972,0.398747201,28.17949128,0,-1.351083519,1.251592053,-1.079491929,0.28036849,0.439310715,86.93230187,0,-2.214877584,1.099882746,-2.01373973,0.044036866,0.102602396,120.0248981,0,-1.161723999,0.741160519,-1.56743913,0.117012084,0.219967944,89.14938763,0,-1.591535934,0.899027046,-1.770287047,0.076679335,0.155742882,N,-,,U3 small nucleolar RNA-associated 6,,IPR003107 (SMART); IPR013949 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR23271 (PANTHER); IPR011990 (SUPERFAMILY),,
RL4_JR_04092,1739,2358,1470,0,0,4,0,0,0,0,0,2,0,6,0,0,0,2,17.39716957,1,1.597404258,0.912667958,1.75025785,0.080073831,0.188308535,1.893211493,0,2.544747757,1.354197074,1.879156148,0.060223175,0.136554431,4.905800931,1,-0.105291841,1.226759265,-0.085829261,0.931602145,0.959172187,36.96496866,1,2.518880478,0.714789219,3.523948616,0.000425167,0.003666791,8.681501798,1,0.745003015,1.152955023,0.646168324,0.518170351,0.643436639,N,-,,Thymocyte nuclear 1,C:nucleus,IPR002740 (G3DSA:3.10.590.GENE3D); IPR002740 (PFAM); PTHR14087:SF8 (PANTHER); PTHR14087 (PANTHER); IPR015947 (SUPERFAMILY),,
RL4_JR_04093,693,769,641,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,192.39672,0,-0.202281417,0.429982136,-0.470441444,0.63803966,0.793641655,35.41527584,0,-1.680777291,1.203928648,-1.396077163,0.16269126,0.294537817,130.0469733,0,-1.18669899,0.676867096,-1.753223043,0.079563729,0.162007883,191.7648881,0,-0.574390406,0.70146662,-0.818842107,0.412876503,0.556580354,97.51912028,0,-3.473070082,1.125542254,-3.085686093,0.002030831,0.008581871,N,-,,arid bright DNA binding domain-containing,C:nucleus; P:cellular response to nutrient levels; P:organic substance catabolic process; F:binding; P:primary metabolic process; P:positive regulation of transcription from RNA polymerase II promoter; C:intracellular organelle part; P:cellular catabolic process; P:single-organism catabolic process,SM01014 (SMART); IPR001606 (SMART); IPR001606 (G3DSA:1.10.150.GENE3D); IPR001606 (PFAM); PTHR13964 (PANTHER); IPR001606 (PROSITE_PROFILES); IPR001606 (SUPERFAMILY),,
RL4_JR_04094,1801,1073,1660,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,79.55307207,1,0.394352211,0.621892582,0.63411628,0.526004939,0.709867376,11.55228017,0,-0.064655571,1.231996681,-0.052480313,0.958145982,0.977939102,30.17043849,0,-2.726136712,1.211861067,-2.249545584,0.024477806,0.065386097,46.8526078,1,-0.869077703,0.898370051,-0.967393895,0.333347161,0.480002838,33.83296268,0,-1.89160067,1.155244511,-1.637402863,0.10154632,0.193262499,N,-,,mitochondrial large ribosomal subunit,C:intracellular,IPR007740 (PFAM); PTHR13477:SF0 (PANTHER); IPR007740 (PANTHER),,
RL4_JR_04095,4800,3832,6236,0,7,0,0,0,0,3,0,0,0,2,0,0,7,1,509.3961432,1,-0.91020349,0.41122704,-2.213384338,0.02687116,0.083256711,330.2537857,0,1.060648746,1.818964036,0.583105946,0.559821981,0.703352671,310.0603911,1,-3.120313952,0.771849598,-4.042645045,5.29E-05,0.000756817,373.5762775,1,-2.361652716,0.549293814,-4.299434396,1.71E-05,0.000227526,288.7754978,1,-3.852396698,0.901557872,-4.273044269,1.93E-05,0.00017447,N,-,,eukaryotic translation initiation factor 3 subunit E,F:translation initiation factor activity; P:formation of translation preinitiation complex; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; P:regulation of translational initiation; C:eukaryotic translation initiation factor 3 complex,SM00753 (SMART); IPR019010 (SMART); IPR000717 (SMART); IPR011991 (G3DSA:1.10.10.GENE3D); IPR016650 (PIRSF); IPR000717 (PFAM); IPR019010 (PFAM); IPR016650 (PANTHER); IPR016650 (HAMAP); IPR011991 (SUPERFAMILY),,
RL4_JR_04096,4355,4407,6375,1,0,3,0,0,0,0,0,0,0,0,0,0,5,0,63.20399726,1,-0.013391296,0.763018131,-0.01755043,0.985997502,0.992567574,19.44859757,0,1.046636558,1.169370934,0.895042392,0.370764427,0.535131546,54.72291958,0,0.296941218,0.801112529,0.370661059,0.710889998,0.804199829,109.1966745,0,1.212457489,0.612559107,1.979331422,0.047778704,0.119535305,25.51775762,1,-2.587189017,1.230771992,-2.102086361,0.035545711,0.08583361,N,-,,20s cyclosome subunit (Apc1),C:nucleus; P:anaphase-promoting complex-dependent catabolic process; P:mitotic cell cycle phase transition; P:mitotic nuclear division,IPR024990 (PFAM); IPR024990 (PANTHER),,
RL4_JR_04097,1364,908,1360,0,2,0,0,0,0,0,0,4,0,0,0,0,0,0,118.5792745,1,1.902270765,0.659785501,2.883165454,0.003937006,0.017803822,8.740744934,0,0.337813098,1.263544495,0.267353544,0.789196965,0.872842185,48.56329553,1,0.491722101,0.795037497,0.618489194,0.536252919,0.665077123,38.06521353,0,-0.455373116,0.909685639,-0.500582945,0.616664668,0.735421644,71.44155394,0,0.895117504,0.669385263,1.337223201,0.181149791,0.299089346,N,-,,vacuolar assembly,"P:regulation of SNARE complex assembly; C:fungal-type vacuole membrane; F:phosphatidylinositol binding; P:vacuole fusion, non-autophagic; P:intracellular protein transport; P:positive regulation of GTPase activity; P:vacuolar protein processing; P:regulation of vacuole fusion, non-autophagic; P:piecemeal microautophagy of nucleus; C:endosome; P:vesicle-mediated transport; F:catalytic activity; F:Rab guanyl-nucleotide exchange factor activity; F:Rab GTPase binding; C:HOPS complex",IPR000547 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR000547 (PFAM); PTHR12616 (PANTHER); PTHR12616:SF1 (PANTHER); PTHR12616 (PANTHER); PTHR12616:SF1 (PANTHER); PTHR12616 (PANTHER); PTHR12616:SF1 (PANTHER); PTHR12616 (PANTHER); PTHR12616:SF1 (PANTHER); PTHR12616:SF1 (PANTHER); IPR000547 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),,
RL4_JR_04098,17051,12048,14214,7,3,47,0,0,1,0,0,1,1,6,0,0,1,0,69.17491704,1,-0.057620559,0.677379817,-0.085063885,0.932210602,0.966922166,11.97384041,1,-0.116358516,1.228464943,-0.09471863,0.92453832,0.958737823,135.4766483,1,1.9059512,0.488926803,3.89823423,9.69E-05,0.001136711,67.3985825,1,-0.154219911,0.711894608,-0.216633065,0.828494315,0.892774047,146.1618796,1,2.166923672,0.726094548,2.984354694,0.002841771,0.011323469,N,-,,cue domain-containing,,IPR003892 (SMART); IPR003892 (PFAM); PTHR21494 (PANTHER); IPR003892 (PROSITE_PROFILES); IPR009060 (SUPERFAMILY),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_04099,1324,986,1464,0,0,13,0,0,0,0,0,0,0,5,6,0,1,0,12.9394573,1,-1.795958385,1.297120882,-1.384572872,0.166183111,0.317712942,4.07752636,0,1.437819003,1.359253996,1.057800093,0.29014659,0.449405323,21.70542251,0,-0.259980345,1.26001991,-0.206330347,0.836532875,0.894492905,12.27529968,1,-1.644827045,1.27729158,-1.287745939,0.197834417,0.32799631,10.5142026,1,-1.307992563,1.282795312,-1.019642457,0.307898062,0.443199868,N,-,,isotrichodermin C-15 hydroxylase,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24305:SF35 (PANTHER); PTHR24305:SF35 (PANTHER); PTHR24305 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_04100,40645,43489,50744,11,14,73,0,0,3,0,4,14,4,19,7,0,28,10,1007.722656,1,-0.41377825,0.507632823,-0.815113269,0.415007477,0.606309276,293.9267657,1,-0.668455135,0.595378043,-1.122740657,0.261547655,0.417803625,593.3053413,1,-2.203848441,0.461406749,-4.77636802,1.78E-06,4.47E-05,796.8828318,1,-1.122950919,0.411004398,-2.732211443,0.006291075,0.033648778,682.7282208,1,-1.093969873,0.828560198,-1.320326364,0.186726077,0.305705176,N,-,,40S ribosomal S26E,F:structural constituent of ribosome; C:cytosolic small ribosomal subunit; F:mRNA binding; P:translation,IPR000892 (PFAM); IPR000892 (PANTHER),,
RL4_JR_04101,1110,1266,1486,0,2,3,0,0,0,0,0,0,1,1,0,0,0,1,1263.725353,1,-0.279801105,0.62422582,-0.448236995,0.653982166,0.804703848,394.1017518,0,-0.272906044,0.495212531,-0.551088729,0.581572851,0.720523917,759.5322095,0,-1.818158022,0.657900338,-2.763576667,0.005717166,0.020978829,932.9401251,1,-1.244120275,0.538516907,-2.310271524,0.020873126,0.078216286,842.8035856,1,-0.966858979,0.507997302,-1.903275817,0.057004565,0.123735244,N,-,,Ubiquitin-40S ribosomal S27a,"C:nucleus; F:structural constituent of ribosome; C:cytosolic small ribosomal subunit; F:metal ion binding; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, LSU-rRNA,5S); P:cytoplasmic translation; F:protein tag; P:ribosomal small subunit assembly",IPR019956 (PRINTS); IPR000626 (SMART); IPR002906 (SMART); IPR000626 (PFAM); G3DSA:3.10.20.90 (GENE3D); IPR002906 (PFAM); PTHR10666 (PANTHER); IPR000626 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY); IPR011332 (SUPERFAMILY),3.A.25.1.1, the symbiont-specific erad-like machinery (selma) family.
RL4_JR_04102,115,64,59,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46.10249106,0,1.093891284,0.623155979,1.755405262,0.079190013,0.186822477,6.152544302,0,0.844268282,1.237696851,0.682128488,0.495157708,0.650063077,110.6769026,0,2.595689935,0.488041913,5.318579956,1.05E-07,3.61E-06,59.89292647,0,1.612722137,0.55234913,2.919751387,0.003503107,0.021087373,23.58793746,0,-0.240486885,0.997271769,-0.241144784,0.809442904,0.871047254,N,-,,chitinase,F:chitinase activity; P:carbohydrate metabolic process; P:chitin catabolic process,IPR011583 (SMART); IPR001223 (PFAM); IPR029070 (G3DSA:3.10.50.GENE3D); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR11177:SF222 (PANTHER); PTHR11177:SF222 (PANTHER); PTHR11177 (PANTHER); PTHR11177 (PANTHER); IPR017853 (SUPERFAMILY); IPR029070 (SUPERFAMILY),9.B.29.2.7, the small 4-5 tms putative permease (4-5pp) family.
RL4_JR_04103,1795,2071,1840,4,6,0,0,0,0,2,4,10,2,3,5,0,8,2,687.4589634,1,-2.528812855,0.466182483,-5.424512816,5.81E-08,1.22E-06,187.3221278,0,-4.083863576,1.203814467,-3.392436033,0.000692741,0.015023052,554.4981692,1,-2.960613283,1.648494338,-1.795949925,0.072502481,0.151172491,617.9498881,1,-3.044331387,0.543999091,-5.596206755,2.19E-08,5.70E-07,540.6583205,1,-2.645067112,0.701142026,-3.772512577,0.000161612,0.001041578,N,-,,nucleolar 56,C:box C/D snoRNP complex; C:small-subunit processome; P:rRNA modification; F:snoRNA binding; P:maturation of SSU-rRNA; C:90S preribosome,IPR012976 (SMART); IPR002687 (PFAM); IPR012974 (PFAM); PTHR10894:SF0 (PANTHER); PTHR10894 (PANTHER); IPR002687 (PROSITE_PROFILES); IPR002687 (SUPERFAMILY),,
RL4_JR_04104,313,274,227,1,0,7,0,0,0,0,0,0,1,1,0,0,3,2,84.28625784,1,-0.06143105,0.593837849,-0.103447515,0.917607803,0.960708991,15.71326985,0,-0.508439097,1.208825461,-0.42060588,0.674042899,0.79196908,40.93833087,0,-3.166428144,1.198226387,-2.642595906,0.008227316,0.027985541,83.3436941,1,0.220065812,0.581226454,0.378623186,0.704967702,0.802270201,63.34584873,1,-0.332060872,0.706480708,-0.470021146,0.63833991,0.740257884,N,-,,vacuolar sorting-associated vps4,C:nucleus; F:ATP binding; P:protein retention in Golgi apparatus; F:protein homodimerization activity; P:protein homooligomerization; P:intralumenal vesicle formation; C:endoplasmic reticulum; C:endosome membrane; P:cytoplasmic microtubule organization; P:sterol metabolic process; F:microtubule-severing ATPase activity; P:late endosome to vacuole transport via multivesicular body sorting pathway,IPR003593 (SMART); IPR007330 (SMART); IPR015415 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003959 (PFAM); IPR007330 (PFAM); G3DSA:1.10.8.60 (GENE3D); IPR007330 (G3DSA:1.20.58.GENE3D); PTHR23074 (PANTHER); PTHR23074:SF83 (PANTHER); IPR027417 (SUPERFAMILY); IPR007330 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_04105,44,33,40,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.68460913,0,1.22872261,0.748739703,1.641054434,0.100786116,0.22288239,3.313085801,0,1.737325079,1.263100747,1.375444582,0.168993655,0.303289677,28.10433928,0,1.485978323,0.85305042,1.741958375,0.081515728,0.165212678,9.931586322,0,-1.339239576,1.193078359,-1.122507643,0.26164666,0.401937859,8.496994859,0,-1.000664049,1.19957199,-0.83418424,0.404177171,0.541022455,N,-,,prefoldin subunit,C:prefoldin complex; F:unfolded protein binding; P:protein folding,IPR002777 (PFAM); IPR009053 (G3DSA:1.10.287.GENE3D); PTHR21431:SF0 (PANTHER); PTHR21431 (PANTHER); IPR009053 (SUPERFAMILY),,
RL4_JR_04106,1401,1358,1451,0,2,1,0,0,0,0,0,1,0,2,0,0,4,0,34.28399853,1,-0.383447353,1.000692687,-0.383181928,0.701584877,0.838858189,5.181025988,0,1.092291814,1.237320413,0.882788162,0.377350738,0.541856173,19.92628196,1,-0.59637039,1.187545327,-0.502187476,0.615535652,0.730105458,63.66558589,1,1.531773908,1.543564809,0.992361253,0.321021333,0.467444956,32.17162485,1,0.982460678,0.740565341,1.326636049,0.184629105,0.303419849,N,-,,hypothetical protein F503_03802,,no IPS match,,
RL4_JR_04107,1116,1065,850,0,0,12,0,0,0,0,0,0,0,3,0,0,0,0,52.04246206,1,-0.13485779,0.702770915,-0.191894382,0.847824938,0.923562004,10.57189029,0,0.063355176,1.23295544,0.051384806,0.959018892,0.978272787,27.36059985,0,-2.58507837,1.202646088,-2.149492186,0.031595405,0.07996797,69.27324347,1,0.67369452,0.585773257,1.150094362,0.250105008,0.389423041,26.93445128,0,-2.665201523,1.205146503,-2.211516621,0.027000082,0.069367123,N,-,,Mov34 MPN PAD-1 family,F:thiol-dependent ubiquitin-specific protease activity; P:protein deubiquitination; P:protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; C:endosome; C:cell division site; P:late endosome to vacuole transport; C:transport vesicle; P:endocytosis,IPR000555 (SMART); IPR000555 (PFAM); G3DSA:3.40.140.10 (GENE3D); PTHR12947 (PANTHER); PTHR12947:SF4 (PANTHER); SSF102712 (SUPERFAMILY),,
RL4_JR_04108,19591,14891,13688,0,3,16,0,0,0,0,0,0,0,3,0,0,0,4,54.92859396,1,-0.246911454,0.689694599,-0.358001142,0.720342459,0.850811319,11.42946941,0,-0.04914281,1.217017215,-0.040379717,0.967790401,0.983334113,29.63194302,0,-2.700048795,1.193832231,-2.261665186,0.023718097,0.063811325,43.49656615,1,-2.172500056,1.145943761,-1.895817343,0.057984202,0.134468631,43.89593265,1,-1.093067631,0.972862831,-1.123557809,0.261200663,0.393140585,N,-,,arginase,C:nucleus; F:zinc ion binding; P:regulation of ornithine metabolic process; F:ornithine carbamoyltransferase inhibitor activity; C:mating projection tip; C:cytosol; F:arginase activity; F:manganese ion binding; P:arginine catabolic process to ornithine,IPR006035 (PRINTS); IPR006035 (PFAM); IPR014033 (TIGRFAM); IPR023696 (G3DSA:3.40.800.GENE3D); PTHR11358:SF2 (PANTHER); IPR006035 (PANTHER); IPR006035 (PROSITE_PROFILES); SSF52768 (SUPERFAMILY),,
RL4_JR_04109,2620,1908,1803,0,0,0,0,0,3,0,0,0,0,0,0,0,3,0,9.535646486,0,-1.35553271,1.212376723,-1.118078798,0.263533341,0.443234406,12.44599799,1,2.762740576,1.156094916,2.389717779,0.016861324,0.050494178,7.908325943,0,-0.794226513,1.212523312,-0.655019582,0.512455146,0.64344654,13.13160351,0,-0.270137134,1.162780909,-0.232319891,0.816289564,0.883855399,7.739407269,1,-0.866033099,1.207440432,-0.717247059,0.473221667,0.603721317,Y,-,,multicopper oxidase,F:metal ion binding,IPR008972 (G3DSA:2.60.40.GENE3D); IPR008972 (G3DSA:2.60.40.GENE3D); IPR008972 (G3DSA:2.60.40.GENE3D); IPR011707 (PFAM); IPR011706 (PFAM); IPR001117 (PFAM); PTHR11709 (PANTHER); PTHR11709:SF105 (PANTHER); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY),2.A.108.1.1, the iron/lead transporter (ilt) family.
RL4_JR_04110,7893,7303,5999,4,1,12,0,0,0,0,0,3,0,3,0,0,4,0,12.32329058,1,-1.725782579,1.239464552,-1.392361384,0.163812992,0.314665973,3.964181811,0,1.478481069,1.318995189,1.120914679,0.262324182,0.418808418,18.09550814,1,-0.207217512,1.229711165,-0.168509092,0.866182791,0.915082394,11.82380335,1,-1.590885051,1.237987942,-1.285056984,0.198772372,0.32917407,33.2584452,1,1.854653819,0.745048784,2.489305207,0.012799304,0.038321111,Y,-,,hypothetical protein SPI_02128,,IPR032382 (PFAM),,
RL4_JR_04111,502,284,450,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,5.815351175,1,1.846823891,1.15593502,1.597688329,0.110112357,0.237205337,0.641061133,0,4.107061961,1.495781693,2.745762955,0.006037037,0.023385719,1.656454521,0,1.461048166,1.221934642,1.195684381,0.231819749,0.363080297,5.922017108,0,1.985576946,1.156504427,1.716877946,0.086001475,0.174887515,5.486746061,0,2.314187717,1.129843248,2.04823786,0.040536698,0.095184154,N,-,,plasma membrane Pth11,C:integral component of membrane,PTHR33048 (PANTHER); PTHR33048:SF54 (PANTHER),2.A.1.7.25, the major facilitator superfamily (mfs).
RL4_JR_04112,23519,25122,35726,6,1,50,0,0,3,2,4,1,6,15,2,0,32,0,0.5767809,1,2.691580477,1.837931031,1.464462176,0.143067711,NA,0.184957742,1,5.900352694,1.85295733,3.184289567,0.001451098,0.015023052,0.478177805,1,3.25369109,1.268676024,2.564635123,0.010328436,0.033525194,0.551519542,1,2.831456479,1.379569466,2.052420375,0.040128826,0.107667923,0.469617378,1,3.176431045,1.224384579,2.594308275,0.009478146,0.030074029,N,-,,chaperone protein,,IPR001623 (PRINTS); IPR001623 (SMART); IPR001623 (PFAM); IPR001623 (G3DSA:1.10.287.GENE3D); PTHR24078 (PANTHER); IPR001623 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_04113,9439,6917,8231,8,4,0,0,1,0,0,0,1,0,2,0,0,2,0,56.2040084,1,8.696035463,2.009832593,4.326746165,1.51E-05,0.000165367,0.043229917,1,7.997170812,2.720581761,2.939507618,0.003287342,0.016287065,32.60508361,1,8.291089225,1.647499615,5.032528778,4.84E-07,1.41E-05,51.49172143,1,8.823517292,0.84308936,10.46569642,1.24E-25,1.59E-23,89.91775767,1,9.838254762,0.775853798,12.68055243,7.58E-37,6.40E-34,Y,-,,hypothetical protein FOVG_02130,,no IPS match,,
RL4_JR_04114,2907,3109,3626,0,2,18,0,0,0,2,2,0,0,11,0,0,10,1,12.35003162,1,-1.728598782,1.194041218,-1.447687698,0.147704412,0.293546989,13.33427489,0,2.397345176,1.134723794,2.112712528,0.03462538,0.088460201,10.22917252,1,-1.165494616,1.197267971,-0.973461784,0.330323845,0.473397273,11.79860616,1,-1.587580294,1.195270687,-1.328218212,0.18410603,0.31093804,10.04347293,1,-1.241949048,1.193993828,-1.040163708,0.298263849,0.433523037,N,-,,Transcription factor atf21,F:DNA binding,G3DSA:1.20.5.170 (GENE3D); SSF57959 (SUPERFAMILY),,
RL4_JR_04115,13689,9206,11020,7,1,13,0,0,1,2,3,0,0,4,1,0,3,4,86.04691068,1,0.771281569,0.52686284,1.463913395,0.143217613,0.287068621,30.83124306,1,1.509558431,0.997253966,1.513715144,0.130098102,0.247345341,31.26957241,1,-2.777647097,1.19371152,-2.326899799,0.019970599,0.0555446,99.64781564,1,0.710672696,0.519049408,1.369181208,0.170942639,0.293255543,53.55009084,1,0.079784701,0.67707476,0.117837359,0.906196528,0.939893448,N,-,,hypothetical protein HMPREF1624_04036,C:membrane,PTHR34502 (PANTHER); PTHR34502:SF6 (PANTHER),,
RL4_JR_04116,506,768,802,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0.287857368,0,3.694196618,2.525313888,1.462866314,0.143503963,NA,0.092219754,0,6.904357691,2.123623385,3.2512157,0.001149126,0.015023052,0.238667664,0,4.255928971,1.321964169,3.219398128,0.0012846,0.007014719,0.275286138,1,3.833796514,1.61534885,2.373355151,0.017627305,0.072316235,0.234734833,0,4.176659548,1.242416106,3.361723601,0.000774576,0.003887049,Y,-,,het domain,F:methyltransferase activity; F:transferase activity; P:methylation,IPR001214 (SMART); G3DSA:2.170.270.10 (GENE3D); IPR001214 (PFAM); PTHR12197 (PANTHER); IPR001214 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY),,
RL4_JR_04117,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,70.3248252,0,1.554939334,0.516466572,3.010725998,0.002606239,0.012911966,25.80886231,0,2.284805178,0.998664455,2.287860718,0.022145634,0.062439583,40.48273121,0,0.40169144,0.857748849,0.468308924,0.639563688,0.748981235,69.10292798,0,1.295284164,0.554442486,2.336192113,0.019481231,0.075835242,33.49955622,0,0.510514896,0.769505047,0.66343281,0.507053398,0.633973284,N,-,,aspartyl glutamyl-trna(asn gln) amidotransferase subunit b,"C:intracellular part; F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor; P:translation",IPR018027 (PFAM); IPR006075 (PFAM); PTHR11659:SF0 (PANTHER); IPR017959 (PANTHER); IPR004413 (HAMAP); SSF55931 (SUPERFAMILY),,
RL4_JR_04118,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.210745999,0,-0.176516079,1.212907013,-0.145531419,0.884291311,0.943629629,1.353028848,0,3.029381531,1.370676074,2.210136727,0.027095675,0.072903354,37.33329925,0,3.518747479,0.680605598,5.170024296,2.34E-07,7.52E-06,12.05437679,0,1.683288683,1.027090511,1.638890307,0.101236107,0.197612412,3.43201903,0,0.306957204,1.204272836,0.254890084,0.798807995,0.864141188,N,-,,methyltransferase domain-containing,C:membrane; C:integral component of membrane; F:methyltransferase activity; F:transferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF905 (PANTHER); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_04119,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.91388556,0,-0.070794891,1.218597582,-0.058095381,0.953672654,0.977149147,1.256854988,0,3.13579171,1.381690322,2.269532948,0.023235936,0.064809629,3.245521313,0,0.490768772,1.212239456,0.404844744,0.685591637,0.784020076,23.80101952,0,3.091053207,0.689862837,4.48067796,7.44E-06,0.000110302,10.54823642,0,1.350777323,1.125924365,1.199705206,0.23025385,0.357845858,N,-,,Zinc iron partial,P:ion transport,IPR003689 (PFAM); IPR004698 (TIGRFAM); PTHR11040 (PANTHER); PTHR11040:SF55 (PANTHER),2.A.5.1.1, the zinc (zn(2+))-iron (fe(2+)) permease (zip) family.
RL4_JR_04120,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,62.18700387,0,-0.810812724,0.779041517,-1.040782432,0.297976536,0.483759717,23.1352904,0,0.598377384,1.144505002,0.52282636,0.601095094,0.735467207,57.58728854,0,-1.120282353,1.047659087,-1.069319559,0.2849257,0.424328889,68.95785407,0,0.075872798,0.646308642,0.117394065,0.906547787,0.942962436,50.11621581,0,-0.433870797,0.774682194,-0.560062952,0.575436499,0.689665549,N,-,,Transcription factor jumonji aspartyl beta-hydroxylase,,IPR003347 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_04121,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3993.690567,0,-1.828442519,1.400505191,-1.305559259,0.191702483,0.35199389,994.5190291,0,-6.49233476,1.215034305,-5.34333453,9.13E-08,1.11E-05,2655.053178,0,-5.159550074,0.572589089,-9.010912322,2.04E-19,3.00E-17,3081.074118,0,-5.081228445,0.665666236,-7.633297541,2.29E-14,1.34E-12,2578.06958,0,-6.925419822,0.978053227,-7.080820992,1.43E-12,1.42E-10,N,-,,hexose transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR003663 (PRINTS); IPR005828 (PFAM); IPR003663 (TIGRFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF143 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.57, the major facilitator superfamily (mfs).
RL4_JR_04122,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,129.288558,0,-1.942668249,0.783654697,-2.478985014,0.013175684,0.047226376,40.74336525,0,-0.590538915,1.142778699,-0.51675702,0.605325786,0.739185379,91.84063682,0,-3.184958302,1.210367111,-2.631398583,0.008503424,0.02877295,114.8091833,0,-1.8575658,0.786068954,-2.363107956,0.01812239,0.073513299,78.95323676,0,-4.216716041,1.206716639,-3.494371343,0.00047518,0.002592238,Y,-,,cfem domain containing,C:membrane; C:integral component of membrane; F:methyltransferase activity; F:transferase activity; P:methylation,IPR008427 (PFAM),,
RL4_JR_04123,3,19,15,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,102.2195264,1,-2.234009995,0.876062085,-2.55005899,0.010770469,0.040213038,27.87503679,0,-1.335372292,1.21834167,-1.096057309,0.273053696,0.430908872,71.95149869,0,-3.9799687,1.204384682,-3.304566023,0.000951236,0.005531482,110.910792,0,-2.048730198,0.871074723,-2.351956892,0.018674939,0.074366666,78.33883517,0,-2.392211212,0.990325497,-2.415580756,0.015710138,0.04505112,N,-,,ATP-dependent RNA helicase DHH1,P:regulation of translation; F:ATP binding; F:RNA binding; C:cytoplasmic mRNA processing body; F:helicase activity; P:mRNA processing; P:mRNA transport,IPR014001 (SMART); IPR001650 (SMART); IPR001650 (PFAM); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24031 (PANTHER); PTHR24031:SF76 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_04124,59,32,37,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.56996074,0,-2.063068104,1.183584087,-1.74306847,0.081321655,0.19074815,4.9730312,0,1.151397595,1.238108078,0.929965336,0.352389033,0.515967277,35.03482217,0,0.328085042,1.025493561,0.319928914,0.749022218,0.832210375,65.44808057,0,1.407596982,0.604838124,2.327229263,0.019953066,0.076714457,42.5235864,0,1.371088767,0.664814768,2.062362077,0.039173277,0.092475969,N,-,,hsp40 co-chaperone,F:ATP binding; C:membrane; C:integral component of membrane; C:cytosol; F:protein kinase activity; P:protein phosphorylation; C:cellular_component,IPR001623 (PRINTS); IPR001623 (PFAM); IPR001623 (G3DSA:1.10.287.GENE3D); IPR001623 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_04125,3051,4830,4011,0,4,12,0,0,1,0,0,0,3,1,0,0,0,0,8.387556409,1,4.009669312,1.09474946,3.662636484,0.000249633,0.00185982,0.237320715,1,5.540585666,1.805396569,3.068902291,0.002148468,0.015045494,0.618177118,0,2.883188068,1.301063334,2.216024381,0.026689832,0.070056485,0.713394744,1,2.460220812,1.399317259,1.758157985,0.078720632,0.16464499,0.610854968,0,2.798156001,1.269692419,2.203806182,0.027537978,0.070456799,N,-,,Phosphatidylethanolamine-binding PEBP,P:proteolysis; F:peptidase activity,IPR008914 (PFAM); IPR008914 (G3DSA:3.90.280.GENE3D); PTHR11362:SF5 (PANTHER); PTHR11362 (PANTHER); IPR008914 (SUPERFAMILY),,
RL4_JR_04126,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36.39946408,0,-0.435212447,0.842796816,-0.516390711,0.605581552,0.772651596,7.969617839,0,0.471029716,1.219617786,0.386210927,0.699340462,0.809367042,63.67826455,0,1.225833764,0.606462279,2.021286084,0.043250159,0.101194742,72.46532191,0,1.126212625,0.527924878,2.133281971,0.032901602,0.097138839,50.50560262,0,0.947893735,0.607670346,1.559881508,0.118787885,0.21742591,N,-,,n-carbamyl-d-amino acid amidohydrolase,F:hydrolase activity,IPR003010 (G3DSA:3.60.110.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.360.10 (GENE3D); IPR000683 (PFAM); IPR003615 (PFAM); IPR003010 (PFAM); PTHR23088 (PANTHER); PTHR23088:SF24 (PANTHER); IPR003010 (PROSITE_PROFILES); IPR016040 (SUPERFAMILY); IPR003010 (SUPERFAMILY),,
RL4_JR_04127,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,Y,-,,---NA---,,no IPS match,,
RL4_JR_04128,1145,1046,993,0,0,0,0,0,0,4,0,3,0,1,0,0,0,0,7.453830288,0,-1.0002089,1.263042125,-0.791904625,0.42841629,0.619354969,2.410388792,0,2.196364633,1.379652775,1.591969133,0.11139164,0.220302107,6.189369231,1,-0.440639466,1.248848363,-0.352836645,0.72421091,0.813301303,7.1360646,1,-0.862164521,1.253961732,-0.687552497,0.491734631,0.630868365,6.028623635,0,-0.505646436,1.244345099,-0.406355468,0.684481435,0.775990878,N,-,,nuclear condensin complex subunit smc4,C:nucleus; F:ATP binding; P:chromosome organization; C:chromosome,IPR010935 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR010935 (PFAM); IPR003395 (PFAM); IPR024704 (PIRSF); PTHR18937:SF231 (PANTHER); PTHR18937:SF231 (PANTHER); PTHR18937 (PANTHER); PTHR18937 (PANTHER); IPR010935 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_04129,80,104,51,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_04130,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47.53379411,0,1.003981964,0.606713819,1.65478671,0.097967771,0.218235735,6.60840562,0,0.741169972,1.229114681,0.603011244,0.546501209,0.69275958,28.26739309,0,-0.953412302,1.194307776,-0.798296989,0.424698165,0.565732217,77.00869359,0,1.031665969,0.627137525,1.64503945,0.099961676,0.19572848,17.00822345,0,-2.001914868,1.203634842,-1.663224426,0.09626752,0.18554773,N,-,,hypothetical protein CMQ_5432,C:cytosol; C:nuclear pore,IPR025151 (PFAM); PTHR21583 (PANTHER),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_04131,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.950291944,0,0.933752408,1.386960722,0.673236375,0.500796923,NA,0.616173526,0,4.163877948,1.555593627,2.676713169,0.007434825,0.027132749,1.612448937,0,1.499160421,1.275472377,1.175376628,0.23984407,0.372877973,1.860961017,0,1.076356509,1.307293906,0.823346994,0.410310696,0.554141097,1.606572627,0,1.402245304,1.277283411,1.097834115,0.272276932,0.404876477,N,-,,---NA---,,no IPS match,,
RL4_JR_04132,604,789,878,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3.101312579,0,0.265065083,1.254019608,0.211372359,0.832596724,0.916665376,0.987839442,0,3.483221967,1.421223268,2.450861906,0.014251462,0.044249477,2.561996485,0,0.83198647,1.223798304,0.679839535,0.496606071,0.62934649,2.955742725,1,0.409532714,1.231174588,0.332635776,0.739409234,0.82669153,2.521416142,0,0.752237212,1.218517635,0.617337977,0.537011822,0.659667909,Y,-,,laccase,"F:oxidoreductase activity, oxidizing metal ions; F:copper ion binding; F:hydroquinone:oxygen oxidoreductase activity",IPR008972 (G3DSA:2.60.40.GENE3D); IPR011707 (PFAM); IPR011706 (PFAM); IPR001117 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); PTHR11709 (PANTHER); PTHR11709:SF126 (PANTHER); PTHR11709 (PANTHER); PTHR11709:SF126 (PANTHER); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY),2.A.108.1.5, the iron/lead transporter (ilt) family.
RL4_JR_04133,1699,2966,1615,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,286.7457982,0,-1.67870965,0.527443742,-3.182727399,0.001458949,0.008041964,78.28090838,0,-1.723926406,1.115316331,-1.545683819,0.122180947,0.236918687,220.8077304,0,-2.151623791,0.693634393,-3.101956609,0.001922461,0.009573536,443.958456,0,0.290214752,0.600419177,0.483353569,0.62884471,0.74489307,209.0355918,0,-1.893255671,0.67467899,-2.806157742,0.005013614,0.017950086,N,-,,T-complex 1 subunit eta,C:nucleus; C:chaperonin-containing T-complex; F:ATP binding; F:unfolded protein binding; P:protein folding,IPR017998 (PRINTS); IPR027410 (G3DSA:3.30.260.GENE3D); IPR002423 (PFAM); IPR012720 (TIGRFAM); IPR027409 (G3DSA:3.50.7.GENE3D); IPR027413 (G3DSA:1.10.560.GENE3D); IPR012720 (PTHR11353:PANTHER); PTHR11353 (PANTHER); SSF48592 (SUPERFAMILY); IPR027409 (SUPERFAMILY); SSF54849 (SUPERFAMILY),,
RL4_JR_04134,843,551,1117,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,207.2710421,1,-1.213637839,0.874426101,-1.387924992,0.165159887,0.316582321,49.28688603,0,-2.157603227,1.196089034,-1.803881789,0.07124984,0.156000624,214.9311982,0,-0.406358276,0.455730163,-0.89166421,0.372572942,0.516631758,218.3801152,0,-1.037813796,0.464140292,-2.235991606,0.025352321,0.085851084,181.189767,0,-1.07540884,0.517159001,-2.079454942,0.037575555,0.089602566,N,-,,histone acetyltransferase,"P:negative regulation of transcription from RNA polymerase II promoter; C:chromosome, telomeric region; P:DNA repair; P:chromatin silencing at rDNA; F:sequence-specific DNA binding; P:histone acetylation; P:chromatin silencing at silent mating-type cassette; F:N-acetyltransferase activity; P:chromatin silencing at telomere",IPR016181 (G3DSA:3.40.630.GENE3D); IPR000182 (PFAM); IPR015416 (PFAM); PTHR23091:SF210 (PANTHER); PTHR23091 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_04135,3,11,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,190.7197786,0,0.534109043,0.55832035,0.956635458,0.338751286,0.528501241,102.1084535,0,0.513165309,1.031584217,0.497453626,0.618869198,0.749246308,134.6449673,0,0.105460254,0.647121088,0.162968347,0.870543357,0.918060515,85.07197103,0,-2.600508391,1.09171855,-2.382031881,0.017217407,0.071394906,82.10147664,0,-1.43974286,0.886281487,-1.624475836,0.104274293,0.197070401,N,-,,37s ribosomal mrp4,F:structural constituent of ribosome; C:mitochondrion; C:small ribosomal subunit; P:translation,IPR001865 (PRINTS); G3DSA:3.40.50.10490 (GENE3D); IPR005706 (TIGRFAM); IPR001865 (PFAM); PTHR12534:SF0 (PANTHER); IPR005706 (PANTHER); IPR005706 (HAMAP); IPR023591 (SUPERFAMILY),,
RL4_JR_04136,122,245,349,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,153.2869827,0,0.644297815,0.420481986,1.532283989,0.12545237,0.260608534,40.42818867,0,0.67161802,0.981899582,0.683998682,0.493975998,0.649100136,134.1636181,0,0.531309145,1.499069298,0.354426006,0.723019648,0.812504264,99.47774381,0,-0.733473278,0.605755636,-1.210840204,0.225956654,0.361652089,96.00998855,0,-0.477660817,0.610945016,-0.781839289,0.434309028,0.56901901,N,-,,mitochondrial ribosomal subunit S4,F:structural constituent of ribosome; C:integral component of membrane; C:small ribosomal subunit; P:translation,IPR000270 (SMART); IPR000644 (SMART); IPR000644 (PFAM); IPR000270 (PFAM); G3DSA:3.10.20.240 (GENE3D); G3DSA:3.10.580.10 (GENE3D); PTHR13780 (PANTHER); PTHR13780:SF48 (PANTHER); IPR000644 (PROSITE_PROFILES); IPR000644 (PROSITE_PROFILES); IPR000644 (PROSITE_PROFILES); IPR000644 (PROSITE_PROFILES); SSF54277 (SUPERFAMILY); SSF54631 (SUPERFAMILY); SSF54631 (SUPERFAMILY),3.A.1.12.3, the atp-binding cassette (abc) superfamily.
RL4_JR_04137,4,17,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,58.52508389,0,1.016082261,0.565237421,1.797620297,0.0722372,0.174921661,7.595266557,0,0.540455904,1.231718979,0.438781827,0.660819629,0.782409204,89.4109208,0,1.721676288,0.544868246,3.159802947,0.001578759,0.00822189,70.69078933,0,1.191479629,0.550997732,2.162403871,0.030587059,0.093563135,19.34671207,0,-2.187758459,1.195405629,-1.830138996,0.067229157,0.140610456,N,-,,Metallothionein expression activator,,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR14596:SF34 (PANTHER); PTHR14596 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_04138,217,320,166,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.93539277,0,-0.405212141,1.232701251,-0.328718853,0.742368203,0.864312802,1.576703091,0,2.808690382,1.363958129,2.059220383,0.039473131,0.098048352,10.57900263,0,1.122477835,1.209801551,0.927819801,0.353501051,0.496787985,12.72993537,0,1.453594792,1.042009635,1.3949917,0.163018342,0.283212203,4.005723428,0,0.084294384,1.216117842,0.069314323,0.944739425,0.964846347,N,-,,MYND finger family,F:metal ion binding,IPR002893 (PFAM); IPR002893 (PROSITE_PROFILES); SSF144232 (SUPERFAMILY),,
RL4_JR_04139,37578,36050,51349,14,17,68,0,0,1,0,2,2,1,35,0,0,13,6,26.95854312,1,-0.286033602,1.027521179,-0.278372464,0.780726455,0.887242075,4.804142658,1,1.20116194,1.253831897,0.957992808,0.338066385,0.501011413,34.65556957,1,0.378560612,1.041625777,0.363432453,0.716281862,0.807981903,30.4876834,1,0.818219991,0.773897827,1.057271338,0.29038777,0.435218162,12.40070827,1,-1.54612712,1.214877286,-1.272661147,0.20313831,0.325439144,N,-,,integral membrane,P:intracellular transport; P:protein transport; C:integral component of membrane; P:cellular component organization; C:Golgi apparatus part; P:cellular protein localization; P:Golgi vesicle transport,IPR019185 (PFAM); PTHR12952:SF0 (PANTHER); PTHR12952 (PANTHER),,
RL4_JR_04140,6991,6723,9841,0,1,23,0,0,0,3,0,3,0,4,5,0,6,1,17.71412847,1,-2.249187799,1.244705245,-1.807004355,0.0707616,0.172320338,5.573736824,0,0.986782014,1.282655708,0.76932727,0.441699053,0.603031806,34.09995315,1,0.706511015,0.910864128,0.775649182,0.437956153,0.578079282,34.51558222,1,0.200089501,0.915222259,0.218623945,0.826942999,0.891956734,14.54921243,1,-1.776626519,1.248792673,-1.422675323,0.154830297,0.265030729,N,-,,Cytochrome c oxidase subunit 6B new16,F:cytochrome-c oxidase activity; C:mitochondrion; P:hydrogen ion transmembrane transport,IPR003213 (G3DSA:1.10.10.GENE3D); IPR003213 (PFAM); PTHR11387 (PANTHER); PTHR11387:SF20 (PANTHER); IPR003213 (SUPERFAMILY),,
RL4_JR_04141,4282,4505,6001,0,0,0,0,0,0,1,1,2,0,0,0,0,0,0,133.6354863,0,-1.615162659,0.634443383,-2.54579479,0.010902926,0.040614645,35.55841788,0,-1.686587371,1.204657917,-1.400055026,0.161496841,0.29268953,156.4770693,1,-0.687566873,0.582483031,-1.180406701,0.237838498,0.370670713,127.6541045,0,-2.03363362,0.752259424,-2.703367422,0.006864082,0.036009759,105.3492377,0,-2.197264579,0.844254742,-2.602608513,0.009251753,0.029522219,N,-,,phosphatidylinositol-4-phosphate 5-kinase its3,F:phosphatidylinositol phosphate kinase activity; C:cell part; P:phosphatidylinositol metabolic process; P:phosphorylation,IPR002498 (SMART); IPR027484 (G3DSA:3.30.800.GENE3D); IPR027483 (G3DSA:3.30.810.GENE3D); IPR002498 (PFAM); PTHR23086:SF8 (PANTHER); IPR023610 (PANTHER); IPR002498 (PROSITE_PROFILES); SSF56104 (SUPERFAMILY),,
RL4_JR_04142,3633,8314,10846,7,4,4,0,0,3,0,0,0,0,3,1,0,4,1,153.6425124,1,1.829222848,0.422457941,4.329952575,1.49E-05,0.000163975,9.724917652,1,0.183876395,1.222861363,0.150365692,0.880476108,0.931748998,51.14911772,0,0.351211037,0.746948069,0.470194718,0.638215908,0.747835399,62.71866473,1,0.630736672,0.581344677,1.084961637,0.277938647,0.421087655,35.93185521,1,-0.86358796,0.968012195,-0.892125083,0.372325892,0.508676245,N,-,,cleavage and polyadenylylation specificity,C:mRNA cleavage and polyadenylation specificity factor complex; P:mRNA polyadenylation; P:mRNA cleavage,IPR022712 (SMART); IPR001279 (PFAM); IPR022712 (PFAM); IPR011108 (PFAM); IPR001279 (G3DSA:3.60.15.GENE3D); IPR025069 (PFAM); IPR027075 (PTHR11203:PANTHER); IPR027075 (PTHR11203:PANTHER); PTHR11203 (PANTHER); PTHR11203 (PANTHER); IPR027075 (PTHR11203:PANTHER); PTHR11203 (PANTHER); PTHR11203 (PANTHER); IPR027075 (PTHR11203:PANTHER); IPR001279 (SUPERFAMILY),,
RL4_JR_04143,14218,18889,19431,9,9,12,0,0,0,0,0,6,1,9,1,0,5,0,194.1182571,1,0.735561657,0.60057259,1.224767279,0.220662917,0.39003888,24.76728071,0,-1.16482851,1.195627872,-0.97424001,0.329937383,0.492861008,83.08644935,1,-1.98904065,1.025271775,-1.940013076,0.052378101,0.117317675,133.0897978,1,0.059292144,0.442668521,0.133942535,0.893448015,0.934559584,82.47536086,1,-0.959053527,0.665482441,-1.441140244,0.149545066,0.25821006,N,-,,Sec23 Sec24 trunk domain-containing,,IPR006895 (PFAM); IPR007123 (PFAM); IPR006896 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); IPR006900 (PFAM); IPR012990 (PFAM); IPR029006 (G3DSA:3.40.20.GENE3D); G3DSA:2.60.40.1670 (GENE3D); PTHR13803 (PANTHER); PTHR13803:SF9 (PANTHER); PTHR13803:SF9 (PANTHER); PTHR13803 (PANTHER); SSF81995 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR006900 (SUPERFAMILY); IPR006895 (SUPERFAMILY); IPR007123 (SUPERFAMILY),,
RL4_JR_04144,3455,4733,8080,0,0,2,3,0,0,0,0,0,0,0,1,0,0,1,0.336503234,1,3.468773675,2.426149592,1.429744352,0.152790406,NA,0.108545085,1,6.669132299,2.116028191,3.151721857,0.001623108,0.015023052,0.280282295,0,4.023306854,1.373961223,2.92825357,0.003408719,0.01488136,0.323200629,1,3.601996219,1.643106902,2.192186166,0.028366067,0.089498947,0.275582614,1,3.944146059,1.293022009,3.050331727,0.002285887,0.009508878,N,-,,serine threonine kinase,P:phosphorylation; F:kinase activity,IPR019261 (PFAM); PTHR35596 (PANTHER),,
RL4_JR_04145,1860,1396,2961,0,0,1,0,0,0,0,2,0,0,3,0,0,0,0,25.78375569,1,-1.615997528,1.206141625,-1.339807445,0.180307955,0.337219691,6.923459016,0,0.673934667,1.284518712,0.524659283,0.599820067,0.734830182,18.14343451,1,-1.992476763,1.239032863,-1.608090328,0.107815397,0.205096408,40.99966506,1,0.534458275,0.797610794,0.670074025,0.502810603,0.63996725,18.10070995,0,-2.09175431,1.257531643,-1.663381054,0.096236183,0.18554773,N,-,,asparaginyl-tRNA synthetase,F:nucleotide binding; P:tRNA aminoacylation for protein translation; F:aminoacyl-tRNA ligase activity,IPR002312 (PRINTS); G3DSA:3.30.930.10 (GENE3D); IPR004522 (TIGRFAM); G3DSA:2.40.50.140 (GENE3D); IPR004364 (PFAM); IPR018150 (PANTHER); IPR018150 (PANTHER); IPR004522 (PTHR22594:PANTHER); IPR004522 (PTHR22594:PANTHER); IPR006195 (PROSITE_PROFILES); SSF55681 (SUPERFAMILY); IPR012340 (SUPERFAMILY),9.B.111.1.5,The 6 TMS Lysyl tRNA Synthetase (LysS) Family
RL4_JR_04146,9046,6350,9408,0,3,0,0,0,4,7,0,2,0,8,7,0,7,0,13.63592133,1,-1.871774263,1.233280749,-1.517719517,0.129085122,0.265920943,4.314839751,1,1.3561075,1.287294158,1.053455803,0.292132141,0.451031349,11.27462891,1,-1.306163799,1.225667328,-1.065675627,0.286570299,0.426042427,13.01138261,1,-1.729014545,1.227902531,-1.408104064,0.159100258,0.277787569,11.21219911,1,-1.400778311,1.239889683,-1.129760438,0.258577183,0.390352464,N,-,,---NA---,,no IPS match,,
RL4_JR_04147,3724,2898,2178,0,3,16,0,0,0,0,0,1,0,11,4,0,0,0,46.86010712,1,-0.946059828,0.852556068,-1.109674616,0.267139265,0.447315707,11.33938566,0,-0.037748247,1.217536111,-0.031003801,0.975266508,0.987263486,29.36558708,1,-2.687100672,1.192696181,-2.252963256,0.024261466,0.064876672,71.58805462,1,0.592353024,0.553528193,1.070140656,0.284556001,0.42886715,40.49473386,0,-0.564534182,0.847419244,-0.666180508,0.50529573,0.632400404,N,-,,camp-independent regulatory pac2,,IPR018608 (PFAM); PTHR28027:SF1 (PANTHER); PTHR28027 (PANTHER),1.G.20.2.1, the hantavirus gc envelope fusion glycoprotein (gc-efg) family.
RL4_JR_04148,27,9,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,440.639446,0,-0.501475976,0.362148966,-1.384722925,0.166137206,0.317712942,142.4612207,0,0.01316664,0.688800955,0.019115305,0.984749122,0.992120268,341.4899664,0,-0.733215641,0.415622774,-1.764137306,0.077708865,0.159288226,422.2653707,0,-0.371169311,0.687389879,-0.539969124,0.589218326,0.713702063,253.63415,0,-1.73459998,0.64554699,-2.687023574,0.007209186,0.024185889,N,-,,histone H1,F:DNA binding; P:negative regulation of chromatin silencing; P:chromosome condensation; C:nuclear nucleosome; P:nucleosome assembly; P:negative regulation of DNA recombination,IPR005819 (PRINTS); IPR005818 (SMART); IPR011991 (G3DSA:1.10.10.GENE3D); IPR005818 (PFAM); PTHR11467 (PANTHER); IPR005818 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY),,
RL4_JR_04149,235,310,369,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,92.26231895,1,1.994048296,0.499244057,3.99413527,6.49E-05,0.000582734,7.31300368,0,0.595099704,1.235454398,0.48168488,0.630029818,0.756843321,175.93706,0,2.957505901,0.390973359,7.564469126,3.89E-14,3.59E-12,147.1526866,0,2.67931834,0.385726259,6.946165262,3.75E-12,1.65E-10,55.37537641,0,0.842334766,0.667358596,1.262192127,0.206879661,0.329555784,N,-,,hypothetical protein CMQ_5423,,no IPS match,,
RL4_JR_04150,1642,1261,1105,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0.176794722,1,4.39718587,3.271499002,1.344089015,0.178919604,NA,0.056083772,0,7.62108074,2.4728787,3.08186598,0.002057074,0.015023052,0.146670265,0,4.956165217,1.548678611,3.200254193,0.001373064,0.007382317,0.169250078,0,4.534830546,2.101427217,2.157976498,0.030929659,0.094099399,0.146309861,0,4.858278905,1.399508072,3.471418995,0.000517716,0.002783786,N,-,,---NA---,,no IPS match,,
RL4_JR_04151,214,143,94,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,273.2574596,0,3.016252842,1.044253927,2.888428537,0.00387172,0.017598847,19.36849759,0,1.061709814,1.12138885,0.94678114,0.343750314,0.507059266,329.2210375,0,3.532907491,0.318221318,11.10204532,1.23E-28,3.27E-26,778.6322225,0,4.638944207,0.579066122,8.011078588,1.14E-15,7.52E-14,338.0036085,0,3.758663366,0.559753321,6.714856751,1.88E-11,1.55E-09,N,-,,acyl- dehydrogenase,"P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:electron carrier activity; F:oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor; P:lipid homeostasis; F:long-chain-acyl-CoA dehydrogenase activity",IPR001199 (SMART); IPR006091 (PFAM); G3DSA:1.20.140.10 (GENE3D); IPR013786 (PFAM); G3DSA:2.40.110.10 (GENE3D); IPR009075 (PFAM); IPR013786 (G3DSA:1.10.540.GENE3D); IPR001199 (G3DSA:3.10.120.GENE3D); IPR001199 (PFAM); PTHR10909:SF254 (PANTHER); PTHR10909 (PANTHER); IPR001199 (PROSITE_PROFILES); IPR001199 (SUPERFAMILY); IPR009100 (SUPERFAMILY); IPR009075 (SUPERFAMILY),,
RL4_JR_04152,2590,2784,2038,0,0,15,0,0,1,0,0,1,0,4,0,0,0,3,37.08146929,1,0.727287559,0.719466017,1.010871316,0.312078024,0.500084958,5.707526814,1,0.952639219,1.248755009,0.762871189,0.44554022,0.606721123,14.84861759,1,-1.703255934,1.204967737,-1.413528248,0.157500462,0.271780241,21.14513276,1,-1.179664323,1.157443225,-1.019198434,0.30810877,0.453777367,29.39771857,1,-0.091837306,0.990006327,-0.092764363,0.926090763,0.952042743,N,-,,flap endonuclease-1,"F:5'-flap endonuclease activity; P:nucleic acid phosphodiester bond hydrolysis; C:site of double-strand break; P:UV-damage excision repair; F:double-stranded DNA 5'-3' exodeoxyribonuclease activity; P:removal of RNA primer involved in mitotic DNA replication; P:gene conversion at mating-type locus, DNA repair synthesis; P:base-excision repair, base-free sugar-phosphate removal; C:nucleolus; P:double-strand break repair via nonhomologous end joining; P:replicative cell aging; C:nucleoplasm; F:magnesium ion binding; F:DNA binding; F:single-stranded DNA 5'-3' exodeoxyribonuclease activity; C:mitochondrion; C:cytosol; F:5'-3' exodeoxyribonuclease activity involved in UV-damage excision repair",IPR006084 (PRINTS); IPR008918 (SMART); IPR006085 (SMART); IPR006086 (SMART); IPR006085 (PFAM); G3DSA:1.10.150.20 (GENE3D); IPR006086 (PFAM); IPR029060 (G3DSA:3.40.50.GENE3D); PTHR11081:SF9 (PANTHER); IPR006084 (PANTHER); IPR023426 (HAMAP); IPR029060 (SUPERFAMILY); IPR020045 (SUPERFAMILY),,
RL4_JR_04153,8812,10431,7882,0,3,14,1,0,0,0,0,3,4,3,3,0,0,0,246.4839068,1,-5.080226002,1.183565582,-4.292306298,1.77E-05,0.000189311,76.66159538,1,-2.794931536,1.205297386,-2.318872975,0.020401925,0.058418185,211.2983595,1,-4.494723735,1.212911769,-3.705730168,0.000210783,0.001811552,276.0361882,1,-2.345209622,0.628361009,-3.732264713,0.000189766,0.001836883,206.1254289,0,-4.607264695,1.159007115,-3.975182407,7.03E-05,0.00051974,N,-,,H ACA ribonucleo complex subunit 1,C:box H/ACA snoRNP complex; P:snRNA pseudouridine synthesis; C:viral nucleocapsid; P:rRNA processing; F:box H/ACA snoRNA binding,G3DSA:2.40.10.230 (GENE3D); IPR007504 (PFAM); IPR021154 (PANTHER); IPR021154 (PRODOM); IPR009000 (SUPERFAMILY),,
RL4_JR_04154,2411,2163,2377,6,1,13,0,0,4,0,4,0,5,5,0,0,1,0,0.275801825,1,3.755913898,2.719729631,1.380987968,0.16728266,NA,0.086026274,1,7.004015341,2.249820363,3.113144256,0.001851055,0.015023052,0.226605747,1,4.329706155,1.457767484,2.970093793,0.002977088,0.013509656,0.261664886,1,3.906653418,1.821604054,2.144622708,0.031983025,0.095572329,0.226874155,1,4.227479125,1.366915651,3.092713967,0.001983352,0.008426957,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501 (PANTHER); PTHR23501 (PANTHER); PTHR23501:SF8 (PANTHER); PTHR23501:SF8 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.52, the major facilitator superfamily (mfs).
RL4_JR_04155,3546,3892,5673,1,0,4,0,0,0,3,4,1,1,2,2,0,6,0,65.78008575,1,-1.081656424,0.800030176,-1.352019532,0.176369067,0.331830915,16.22933118,0,-0.555016927,1.234098858,-0.449734576,0.652901837,0.776387977,54.97482418,1,-1.388773111,1.058427844,-1.312109388,0.189483229,0.312482197,48.41248151,1,-3.624511657,1.213685928,-2.986367043,0.002823136,0.017666409,49.03442777,1,-1.623869499,1.00524552,-1.615395907,0.106224986,0.199986609,N,-,,PH domain-containing,P:single-organism cellular process,IPR001849 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); IPR033191 (PTHR31941:PANTHER); PTHR31941 (PANTHER); IPR001849 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY),,
RL4_JR_04156,10874,10307,12730,0,0,5,0,0,1,0,0,0,3,1,2,0,3,0,147.7562198,1,-0.423928919,0.607645421,-0.697658379,0.485390863,0.673324037,27.31031375,1,-1.305843579,1.238449584,-1.054418037,0.291691568,0.450832501,127.6211704,0,-0.313328749,0.627568262,-0.499274371,0.617586108,0.731526568,85.06433403,1,-3.423115778,1.178850745,-2.90377369,0.003686946,0.021989286,68.81859546,1,-4.018528051,1.219066637,-3.296397365,0.000979334,0.004700465,N,-,,histone promoter control,P:cellular process,IPR014840 (PFAM),,
RL4_JR_04157,1405,1428,2247,0,0,13,0,0,0,0,0,1,0,1,0,0,4,0,44.48249651,1,-3.577518414,1.245176457,-2.873101553,0.004064634,0.018292637,14.00386857,0,-0.342298617,1.24844877,-0.274179145,0.783946954,0.869393146,36.7021725,1,-3.008849447,1.229567235,-2.447080047,0.014401885,0.043022922,73.66999485,1,-0.388863039,0.752528896,-0.516741671,0.605336503,0.72590656,48.17844457,1,-0.947016919,0.934984523,-1.012869086,0.311122696,0.44665601,N,-,,transcription factor,,IPR013930 (PFAM); IPR013929 (PFAM); PTHR21483 (PANTHER); PTHR21483:SF18 (PANTHER); PTHR21483 (PANTHER),,
RL4_JR_04158,11,12,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,221.0217689,0,1.322995718,0.30769794,4.299657382,1.71E-05,0.000184593,21.78703419,0,-0.979864719,1.196887745,-0.818677209,0.412970603,0.576934945,141.1161159,0,0.649982523,0.456887126,1.422632606,0.154842687,0.268596293,126.5854365,0,0.433750818,0.437288013,0.991911063,0.321240912,0.467456774,93.83287541,0,0.064978265,0.511408166,0.127057543,0.898894855,0.934522066,N,-,,ap-1 complex subunit beta-1,C:endosome; P:mycelium development; C:AP-1 adaptor complex; P:endosomal transport; F:protein transporter activity; P:intracellular protein transport; P:negative regulation of G0 to G1 transition; P:Golgi to vacuole transport,IPR011989 (G3DSA:1.25.10.GENE3D); IPR016342 (PIRSF); IPR002553 (PFAM); IPR026739 (PANTHER); PTHR11134:SF3 (PANTHER); IPR026739 (PANTHER); IPR016024 (SUPERFAMILY),9.B.278.1.1, the organellar-targeting adaptor protein complex (o-apc) family.
RL4_JR_04159,30,60,36,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.770337696,0,1.073592058,1.322555387,0.811755839,0.416931746,NA,0.560961957,0,4.299422468,1.523592738,2.821897453,0.004774044,0.020034359,1.462443822,0,1.640235293,1.23560693,1.327473368,0.184352144,0.305713531,9.710776405,0,2.934001169,1.039625459,2.822171334,0.004769969,0.027084939,1.449200954,0,1.551186745,1.231702473,1.25938429,0.207891561,0.330699459,N,-, Effector probability:0.589,"hypothetical protein GLRG_01990, partial",C:integral component of membrane,no IPS match,,
RL4_JR_04160,274,386,426,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,22.58993694,0,-0.277127129,1.012887819,-0.273601009,0.784391259,0.889119538,4.80102511,0,1.202229875,1.255713741,0.957407597,0.338361566,0.501302074,12.40262354,1,-1.443514696,1.196655829,-1.206290615,0.227705455,0.358576765,14.30415802,1,-1.865472557,1.194654926,-1.561515813,0.118402096,0.222168499,12.17145683,0,-1.519269755,1.192963703,-1.27352555,0.202831612,0.32505066,N,-,,ribosomal l32,C:ribosome,no IPS match,,
RL4_JR_04161,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.16703777,0,-2.203804439,1.190100053,-1.851780809,0.064057305,0.159956991,5.505701647,0,1.004645933,1.246536024,0.80595018,0.420271576,0.583857932,14.22994386,0,-1.641783423,1.194806142,-1.374100255,0.16941056,0.287096169,16.41237385,0,-2.063800759,1.192797577,-1.730218773,0.083591196,0.171293434,13.96837321,0,-1.717897597,1.191304098,-1.442031132,0.149293591,0.258039879,N,-,,nitric oxide synthase,F:nitric-oxide synthase activity; F:FMN binding; F:oxidoreductase activity; P:oxidation-reduction process; P:nitric oxide biosynthetic process,G3DSA:3.40.50.80 (GENE3D); IPR004030 (G3DSA:3.90.340.GENE3D); G3DSA:3.90.1230.10 (GENE3D); IPR004030 (PFAM); IPR029039 (G3DSA:3.40.50.GENE3D); PTHR19384 (PANTHER); PTHR19384:SF76 (PANTHER); PTHR19384 (PANTHER); PTHR19384:SF76 (PANTHER); IPR008254 (PROSITE_PROFILES); IPR029039 (SUPERFAMILY); IPR004030 (SUPERFAMILY); SSF52343 (SUPERFAMILY),,
RL4_JR_04162,1985,1488,2770,3,4,4,0,0,2,0,0,0,0,0,0,0,2,0,0.035379714,1,6.717599509,3.936796011,1.7063621,0.087940682,NA,0.011351334,1,9.9256058,3.304263835,3.003878109,0.002665621,0.015349618,0.02946142,0,7.270685843,1.930259349,3.766688578,0.000165427,0.001575526,0.033980899,0,6.851114306,3.637888442,1.88326674,0.059664228,0.136365759,0.029161424,1,7.180408442,1.419489436,5.058444437,4.23E-07,6.94E-06,,,,,,,,
RL4_JR_04163,93,69,120,0,0,5,0,0,0,0,0,0,0,0,0,0,2,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_04164,504,539,703,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,11.21996833,1,-1.590292156,1.250096989,-1.272135019,0.203325151,0.367870166,3.638402474,0,1.602299743,1.343960372,1.192222461,0.233174029,0.383334013,9.333316006,0,-1.033308373,1.242567593,-0.831591278,0.405639687,0.547851679,40.12993563,0,1.793839849,0.72391894,2.477956786,0.013213715,0.060510567,16.80943923,0,0.550871595,1.034782191,0.532355118,0.594480065,0.705722905,N,-,,dna polymerase epsilon,F:nucleotide binding; F:DNA binding; F:3'-5' exonuclease activity; P:DNA repair; P:nucleic acid phosphodiester bond hydrolysis; F:DNA-directed DNA polymerase activity; F:zinc ion binding; P:DNA replication; P:DNA biosynthetic process; C:epsilon DNA polymerase complex,IPR013697 (SMART); IPR006172 (SMART); IPR006133 (PFAM); G3DSA:1.10.287.690 (GENE3D); IPR006134 (PFAM); IPR012337 (G3DSA:3.30.420.GENE3D); IPR013697 (PFAM); IPR029703 (PANTHER); PTHR10670:SF0 (PANTHER); IPR029703 (PANTHER); PTHR10670:SF0 (PANTHER); PTHR10670:SF0 (PANTHER); IPR012337 (SUPERFAMILY); SSF56672 (SUPERFAMILY),,
RL4_JR_04165,28,22,26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.97010363,0,-0.412578785,1.031872384,-0.399835088,0.689277985,0.831135544,5.187313528,0,1.090456315,1.249502228,0.872712581,0.382819759,0.547379799,24.5818948,0,-0.605520511,1.201538603,-0.503954271,0.614293512,0.729199858,23.61397338,0,-0.27089753,1.032391362,-0.262398098,0.793014539,0.866402222,24.96760608,0,0.530876731,0.878853718,0.604055851,0.545806511,0.666782206,N,-,,mitochondrial cytochrome c oxidase 20,C:integral component of membrane; C:mitochondrial inner membrane,IPR016529 (PIRSF); IPR022533 (PFAM); PTHR31586 (PANTHER); PTHR31586:SF1 (PANTHER),,
RL4_JR_04166,1441,1407,1870,0,0,4,0,0,0,1,0,0,0,0,0,0,0,0,15.44859363,1,-0.698825683,1.208534975,-0.578242002,0.563100745,0.740014708,3.670296593,0,1.589502162,1.322149852,1.202210294,0.229282062,0.379152595,9.611828171,1,-1.075977095,1.243959747,-0.864961344,0.387060006,0.530975,11.09372564,0,-1.498990255,1.248737261,-1.200404843,0.229982149,0.366588359,13.44449012,0,-0.24928315,1.191669179,-0.209188216,0.834301311,0.888067785,N,-,,hypothetical protein F503_03751,,no IPS match,,
RL4_JR_04167,702,806,915,0,0,5,0,0,0,0,0,0,4,0,0,0,0,0,66.76633019,1,2.123974508,0.713764901,2.975734035,0.002922882,0.014092715,4.778389851,0,1.209048187,1.328820609,0.909865619,0.362893383,0.527588261,12.25601833,0,-1.426407745,1.24270809,-1.147822048,0.251042034,0.386106723,14.12779852,1,-1.847630692,1.24630456,-1.482487308,0.138210678,0.250157868,15.81064448,0,-0.566361429,1.17294,-0.482856266,0.629197796,0.732879696,N,-,,zinc mynd-type domain containing,F:binding,IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31845 (PANTHER); PTHR31845:SF14 (PANTHER); PTHR31845:SF14 (PANTHER),,
RL4_JR_04168,16,17,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,564.6705618,0,-0.052487782,1.343924805,-0.039055594,0.968846065,0.984044596,121.2855153,0,-0.892848929,0.854424611,-1.044970987,0.296036379,0.455807762,432.9422779,0,-0.204147524,0.412441645,-0.494973109,0.620619102,0.734184131,657.6968084,0,0.522757005,0.328766279,1.590056644,0.111822038,0.212899235,369.6255174,0,-0.546051372,0.404569977,-1.349708092,0.177109636,0.294117609,Y,-,,wsc domain containing,C:integral component of membrane; C:plasma membrane,IPR002889 (SMART); IPR013320 (G3DSA:2.60.120.GENE3D); IPR002889 (PFAM); PTHR19297 (PANTHER); IPR002889 (PROSITE_PROFILES),,
RL4_JR_04169,2212,1827,1979,0,0,15,0,0,0,0,0,2,4,7,0,0,0,1,72.58998763,1,-2.291349416,1.037305503,-2.208943661,0.02717856,0.083827104,19.27855333,0,-0.803456344,1.213872604,-0.661895113,0.508038444,0.660293417,50.25844064,1,-3.462346611,1.205218472,-2.872795838,0.004068569,0.016555546,66.01666934,1,-2.169111507,1.039447482,-2.086792787,0.036906869,0.102009236,57.20537979,1,-2.614408686,1.14429167,-2.284739769,0.022328091,0.059665327,N,-,,WD40 repeat-like-containing domain,P:transport,IPR015943 (G3DSA:2.130.10.GENE3D); IPR017986 (SUPERFAMILY),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_04170,9978,7501,5324,12,2,7,0,0,2,0,3,1,0,1,0,0,3,0,332.7615201,1,0.102978401,0.598611088,0.17202889,0.863414817,0.932574881,86.6689246,1,0.411834218,0.79531803,0.517823314,0.604581551,0.738454743,133.2115129,1,-3.834622765,1.20518853,-3.181761749,0.001463822,0.007747221,150.1369454,1,-4.272200393,1.160580874,-3.681088057,0.000232241,0.002177257,124.0023231,1,-4.868009983,1.202928208,-4.046800091,5.19E-05,0.000402847,N,-,,glycosyltransferase family 20,"P:ascospore formation; F:identical protein binding; C:alpha,alpha-trehalose-phosphate synthase complex (UDP-forming); F:alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity; P:trehalose biosynthesis in response to heat stress; C:cytosol; P:cellular response to oxidative stress",IPR012766 (TIGRFAM); IPR001830 (PFAM); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); PTHR10788:SF6 (PANTHER); PTHR10788 (PANTHER); SSF53756 (SUPERFAMILY),,
RL4_JR_04171,11485,10731,7505,7,1,5,8,0,0,0,2,5,1,9,1,0,12,0,174.3128421,1,0.456670275,0.399180355,1.144019913,0.252615379,0.430147414,24.38219017,1,-1.142221258,1.207360084,-0.946048551,0.344123823,0.507388396,77.37015058,1,-1.967263506,1.035781271,-1.899303994,0.057524518,0.12596126,90.3510075,1,-1.899202309,0.858505831,-2.212218298,0.026951585,0.087183642,125.4243705,1,0.223100724,0.483126784,0.461785045,0.644235476,0.745642913,N,-,,vacuolar import and degradation 27,,IPR013863 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR31913:SF0 (PANTHER); PTHR31913 (PANTHER); IPR011044 (SUPERFAMILY),,
RL4_JR_04172,1100,970,838,0,0,2,0,0,0,0,0,0,0,2,0,0,0,0,152.1405475,1,3.181407134,0.643639528,4.942839887,7.70E-07,1.22E-05,5.288226075,0,1.062683067,1.253994779,0.847438191,0.396750925,0.560917524,98.98746203,0,2.67335807,0.52026362,5.138468208,2.77E-07,8.71E-06,100.8347606,1,2.412968078,0.4787213,5.040444358,4.64E-07,9.08E-06,147.6570974,0,3.424464944,0.550399847,6.221776703,4.92E-10,3.00E-08,Y,-,,prenylcysteine oxidase,"P:metabolic process; F:oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor",IPR023753 (G3DSA:3.50.50.GENE3D); PF13450 (PFAM); IPR010795 (PFAM); IPR017046 (PIRSF); PTHR10742:SF298 (PANTHER); PTHR10742 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_04173,5757,6651,7222,4,5,22,0,0,0,2,8,0,4,7,5,0,12,0,472.8888267,1,-0.056543157,0.317631631,-0.178014881,0.858711289,0.929176823,266.5110124,0,1.214268035,1.842994098,0.658856171,0.509988133,0.661383713,235.6617167,1,-2.267634328,0.671602885,-3.376451142,0.000734274,0.004499874,333.7980525,1,-0.884126321,0.386006288,-2.290445386,0.021995511,0.080340747,196.1230701,1,-4.571192257,1.131502471,-4.039931306,5.35E-05,0.000412302,N,-,,T-complex 1 subunit zeta,C:nucleus; C:chaperonin-containing T-complex; F:ATP binding; C:integral component of membrane; F:unfolded protein binding; P:protein folding,IPR017998 (PRINTS); IPR027409 (G3DSA:3.50.7.GENE3D); IPR012722 (TIGRFAM); IPR027413 (G3DSA:1.10.560.GENE3D); IPR002423 (PFAM); IPR027410 (G3DSA:3.30.260.GENE3D); PTHR11353 (PANTHER); IPR012722 (PTHR11353:PANTHER); SSF54849 (SUPERFAMILY); SSF48592 (SUPERFAMILY); IPR027409 (SUPERFAMILY),,
RL4_JR_04174,1257,1254,2317,0,0,4,0,1,0,1,0,3,0,2,0,0,1,0,92.41319907,1,3.422384038,0.448646133,7.628248154,2.38E-14,1.44E-12,30.36648574,1,4.486697663,0.863061965,5.198581153,2.01E-07,2.21E-05,13.62390749,1,0.619323804,1.193078283,0.519097374,0.603692839,0.721069644,36.3615608,1,2.536769357,0.617340327,4.109191069,3.97E-05,0.000479154,43.58936169,1,3.18622653,0.548752419,5.806309764,6.39E-09,3.12E-07,N,-,,heterokaryon incompatibility partial,P:transmembrane transport; C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_04175,1845,1564,2760,1,2,1,0,0,0,0,0,0,0,1,0,0,0,0,88.62182097,1,-1.253752464,0.844925567,-1.483861435,0.137845685,0.278628616,19.11365134,0,-0.791054342,1.241016839,-0.637424342,0.523848477,0.673234419,50.06485798,0,-3.456757987,1.22958556,-2.811319602,0.004933875,0.018765519,79.46067787,1,-1.18038655,0.824808771,-1.431103295,0.152400613,0.269388304,53.69711989,0,-2.626676684,1.175861338,-2.233831999,0.025494129,0.066408042,N,-,,pdcd2 domain,P:mycelium development; C:intracellular part,IPR007320 (PFAM); PTHR12298 (PANTHER),,
RL4_JR_04176,2667,10584,8460,2,4,0,2,0,0,0,0,0,0,4,0,0,16,2,258.7305377,1,-0.928172217,0.856357186,-1.083861072,0.278426402,0.461667193,103.2860638,1,0.538499791,0.707140568,0.76151732,0.446348138,0.607522655,191.4528163,0,-2.153325426,0.771521842,-2.791010324,0.00525438,0.019643774,201.9325182,1,-1.806599018,0.629737937,-2.868810837,0.004120181,0.024058152,157.6181222,1,-2.924990922,0.895676806,-3.265676752,0.001092028,0.005123441,N,-,,eukaryotic translation initiation factor 3 subunit,F:translation initiation factor activity; P:formation of translation preinitiation complex; C:eukaryotic 43S preinitiation complex; F:ribosome binding; C:eukaryotic 48S preinitiation complex; P:regulation of translational initiation; C:eukaryotic translation initiation factor 3 complex,IPR011991 (G3DSA:1.10.10.GENE3D); IPR016020 (G3DSA:1.25.40.GENE3D); IPR033464 (PFAM); IPR009374 (PANTHER); IPR011991 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_04177,3328,4251,7344,1,0,4,0,0,0,0,0,0,1,1,1,0,6,3,25.18312236,1,-2.756760184,1.182033479,-2.332218362,0.019689207,0.064663667,8.050885725,0,0.456383078,1.219482997,0.374243084,0.708223473,0.816605814,20.86326341,0,-2.193922834,1.187332066,-1.847775274,0.064634859,0.138165093,28.07797321,1,-1.668589234,1.137569104,-1.466802525,0.142429783,0.256282486,20.54568497,1,-2.274559311,1.188569373,-1.913695038,0.055659133,0.121582353,N,-,,hypothetical protein MMYC01_206328,,PTHR42470 (PANTHER),,
RL4_JR_04178,45723,34613,35514,9,32,8,10,0,3,3,6,25,12,32,6,0,25,15,61.20174496,1,1.880615558,0.957865568,1.963339763,0.049606708,0.131950285,14.18876716,1,2.109976351,1.203036323,1.753875848,0.079451783,0.169307567,25.65518388,1,0.327855736,1.115637056,0.293873115,0.768854863,0.844605754,55.55510274,1,1.434880728,0.759113412,1.890206002,0.058730414,0.135146692,24.25043795,1,0.557132691,0.993784323,0.560617307,0.57505845,0.689663477,N,-,,ESCRT-II complex subunit,C:cytoplasm,IPR014041 (G3DSA:1.10.10.GENE3D); IPR008570 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); IPR008570 (PANTHER); PTHR13149:SF0 (PANTHER); PTHR13149:SF0 (PANTHER); IPR011991 (SUPERFAMILY); IPR011991 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_04179,520,675,571,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.03545739,0,-1.806558463,1.186353818,-1.522782188,0.127813208,0.264108447,4.162137863,0,1.40821451,1.248779446,1.127672717,0.259458164,0.415609359,10.78988748,0,-1.242574557,1.190280996,-1.043933795,0.296516021,0.43747132,16.45863301,0,-0.717389782,1.139324938,-0.629662143,0.528915656,0.662371183,10.62532583,0,-1.323173327,1.191020003,-1.110958106,0.266586383,0.398922475,N,-,,brct domain-containing,"C:nuclear telomeric heterochromatin; C:site of double-strand break; C:nuclear rDNA heterochromatin; P:negative regulation of transposition, RNA-mediated; C:Cul8-RING ubiquitin ligase complex; P:regulation of DNA recombination; C:chromosome, centromeric region; C:nucleolus; P:postreplication repair; P:double-strand break repair",IPR001357 (SMART); IPR001357 (G3DSA:3.40.50.GENE3D); IPR001357 (PFAM); IPR001357 (G3DSA:3.40.50.GENE3D); IPR001357 (G3DSA:3.40.50.GENE3D); IPR001357 (PFAM); PTHR13561:SF33 (PANTHER); PTHR13561 (PANTHER); PTHR13561:SF33 (PANTHER); PTHR13561 (PANTHER); IPR001357 (PROSITE_PROFILES); IPR001357 (PROSITE_PROFILES); IPR001357 (PROSITE_PROFILES); IPR001357 (PROSITE_PROFILES); IPR001357 (PROSITE_PROFILES); IPR001357 (SUPERFAMILY); IPR001357 (SUPERFAMILY); IPR001357 (SUPERFAMILY); IPR001357 (SUPERFAMILY),,
RL4_JR_04180,80,77,85,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13.15972446,0,1.108697521,1.143783914,0.969324281,0.332383418,0.521960332,1.752235487,0,2.656382959,1.441106655,1.843293798,0.065286126,0.145364314,20.23149383,1,1.830684304,1.11042048,1.648640617,0.099221282,0.192842439,21.29124648,0,2.2056722,0.900514447,2.449346822,0.014311557,0.06448799,16.04672856,0,2.069641857,0.976337707,2.119801216,0.034022813,0.082967481,N,-,,toxin biosynthesis,P:primary metabolic process; P:organic substance metabolic process; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR000073 (PFAM); PTHR11614 (PANTHER); PTHR11614:SF113 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_04181,2498,1049,1722,0,1,8,2,0,0,0,0,0,0,0,0,0,0,0,59.5552702,1,-0.856712933,0.743150915,-1.152811516,0.248987757,0.425790347,14.12030265,1,-0.354170198,1.203790115,-0.294212582,0.768595467,0.859883147,62.62825431,0,-0.188871973,0.740115422,-0.255192592,0.798574352,0.867691536,96.84639005,0,0.12363315,0.567991866,0.217667113,0.827688489,0.892380572,36.09979749,0,-3.087678754,1.189869525,-2.594972549,0.009459847,0.030039519,N,-,,Trafficking particle complex subunit 11,F:transferase activity,IPR021773 (PFAM); IPR012880 (PFAM); PTHR14374 (PANTHER),,
RL4_JR_04182,1431,727,964,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,109.3964535,0,-1.094117765,0.650225928,-1.682673234,0.092438366,0.209011139,24.77026342,0,-1.165059286,1.202522031,-0.968846521,0.332621772,0.495919513,93.22650987,0,-1.005438132,0.756539829,-1.328995637,0.183849409,0.305183626,112.1937649,0,-0.560159153,0.577796472,-0.969474858,0.332308318,0.478949712,63.92916505,0,-3.912179385,1.206803068,-3.241771164,0.001187894,0.005496994,N,-,,rxt2,,IPR013904 (PFAM); PTHR28232 (PANTHER),,
RL4_JR_04183,1055,1124,1034,0,0,6,0,0,0,0,0,0,4,0,1,0,0,1,68.96437362,1,-3.032566969,1.144569304,-2.649526733,0.00806046,0.031952006,18.907926,0,-0.775383784,1.211088797,-0.640236939,0.522018571,0.671561274,61.88029713,0,-1.603409213,1.037116652,-1.546025909,0.122098311,0.224791819,64.40137788,1,-2.120461411,1.021319546,-2.076197816,0.037875659,0.103618225,51.89877096,1,-2.569688261,1.122312338,-2.289637362,0.022042347,0.059057251,N,-,,zinc finger 58,F:nucleic acid binding; F:metal ion binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY),,
RL4_JR_04184,3202,3485,3555,0,1,2,0,0,3,0,0,2,3,0,0,0,2,0,208.1131915,1,-2.371326219,0.91227442,-2.599356254,0.009339879,0.035907036,99.20163782,1,-0.552976476,1.089061108,-0.507755232,0.611625009,0.744631746,141.716285,1,-4.957878379,1.287724352,-3.850108427,0.000118066,0.001287296,190.7563207,1,-2.634684393,0.911390875,-2.890839117,0.003842148,0.022762869,155.3973335,1,-2.862637348,1.009057882,-2.836940675,0.004554807,0.016583037,N,-,,transcription initiation factor iie subunit beta,"F:DNA binding; F:translation initiation factor activity; P:regulation of transcription, DNA-templated; C:transcription factor TFIIE complex; P:translational initiation; P:transcription initiation from RNA polymerase II promoter",IPR016656 (PIRSF); PTHR12716:SF8 (PANTHER); PTHR12716 (PANTHER); PTHR12716 (PANTHER); PTHR12716:SF8 (PANTHER); IPR003166 (PROSITE_PROFILES),,
RL4_JR_04185,5312,5930,6624,0,0,2,0,0,0,0,0,7,1,15,1,0,0,2,287.947494,1,-3.761348031,0.929660327,-4.045937986,5.21E-05,0.000484683,84.76647364,0,-2.939907772,1.225075576,-2.399776658,0.016405078,0.049449731,227.2735307,1,-4.62684064,1.225705146,-3.774839858,0.00016011,0.00154377,306.3709821,1,-2.270632113,0.630667036,-3.600365936,0.00031777,0.002842242,288.8835216,1,-1.196615131,0.657949297,-1.818704171,0.068956575,0.14330569,N,-,,cytochrome b5,C:endoplasmic reticulum membrane; F:metal ion binding; C:integral component of membrane; P:oxidation-reduction process; C:organelle membrane; F:heme binding,IPR001199 (PRINTS); IPR001199 (SMART); IPR001199 (PFAM); IPR001199 (G3DSA:3.10.120.GENE3D); PTHR19359 (PANTHER); IPR001199 (PROSITE_PROFILES); IPR001199 (SUPERFAMILY),,
RL4_JR_04186,514,492,525,0,0,1,0,0,2,0,0,0,2,3,0,0,2,0,183.9505676,1,0.363875871,0.669977149,0.543116838,0.58704936,0.758977604,27.6596684,1,-1.324217953,1.208412119,-1.095833062,0.273151837,0.430996554,160.8395341,0,0.409729711,0.505231282,0.810974549,0.417380287,0.558936247,183.3837013,1,0.10285754,0.520671825,0.197547736,0.84339893,0.902209631,86.12507848,1,-2.371735187,0.996053242,-2.381132943,0.017259482,0.048555781,N,-,,2-oxoisovalerate dehydrogenase subunit beta,F:actin binding; P:actin filament capping; F:catalytic activity; C:cytoskeletal part; P:metabolic process; C:actin cytoskeleton,IPR002189 (PRINTS); IPR005475 (SMART); IPR002189 (PFAM); IPR009014 (G3DSA:3.40.50.GENE3D); IPR029061 (G3DSA:3.40.50.GENE3D); IPR005475 (PFAM); IPR033248 (PFAM); IPR033247 (PANTHER); PTHR11624:SF21 (PANTHER); IPR029061 (SUPERFAMILY); IPR009014 (SUPERFAMILY); SSF90096 (SUPERFAMILY),,
RL4_JR_04187,6061,3731,4721,1,2,12,0,0,0,0,1,1,6,3,0,0,0,2,215.6062594,1,-0.966490193,0.487783503,-1.981391719,0.047547362,0.128143831,46.25095962,0,-2.065902241,1.201840647,-1.718948553,0.08562374,0.179363307,271.4793059,1,0.424537479,0.530693711,0.799967043,0.423729892,0.564750057,173.6801803,1,-1.833847837,0.633406824,-2.895213262,0.00378901,0.02250072,229.9076274,1,-0.533480189,0.739047265,-0.72184854,0.470387602,0.601727666,N,-,,glycerol-3-phosphate O-acyltransferase,"F:zinc ion binding; F:transferase activity, transferring acyl groups; P:metabolic process; C:integral component of membrane",IPR002123 (SMART); PTHR31605:SF0 (PANTHER); PTHR31605:SF0 (PANTHER); PTHR31605 (PANTHER); SSF69593 (SUPERFAMILY),,
RL4_JR_04188,19648,11107,16122,0,4,9,0,0,1,0,0,1,1,0,4,0,7,0,139.6973574,1,3.676275329,0.88042227,4.175581937,2.97E-05,0.000296341,3.134988876,1,1.816975696,1.293060429,1.405174619,0.15996936,0.290439542,8.160948078,1,-0.839937115,1.215151436,-0.691220115,0.489427225,0.623579314,17.43907891,1,0.451595054,1.044106116,0.43251835,0.665364718,0.771685885,8.083999316,1,-0.928876269,1.224315181,-0.758690477,0.448037735,0.580100008,N,-,,Sterigmatocystin 8-O-methyltransferase,F:O-methyltransferase activity; P:methylation,IPR001077 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR11746:SF87 (PANTHER); PTHR11746 (PANTHER); IPR016461 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY); IPR029063 (SUPERFAMILY),,
RL4_JR_04189,103,91,112,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,43.78875239,0,0.579224853,0.668433176,0.866541151,0.38619347,0.579254186,6.532797556,0,0.757786362,1.226389974,0.617899998,0.53664126,0.68390183,32.65755422,0,-0.071934534,1.030463987,-0.069807906,0.944346554,0.966961881,19.58011286,1,-2.318596556,1.189666275,-1.948947031,0.051301751,0.125103619,16.75983636,0,-1.980712375,1.197254914,-1.654378154,0.098050702,0.188201585,N,-,,Phosphoethanolamine N-methyltransferase 3,F:methyltransferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); PTHR10108:SF905 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_04190,28,9,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,75.46907629,0,1.322367678,0.618574191,2.137767299,0.032535634,0.096419743,7.948149942,0,0.474824341,1.260185,0.376789392,0.706330124,0.815219329,59.74584514,0,1.178506381,0.699083668,1.685787316,0.091836772,0.181699331,37.59581619,0,-0.872944355,1.056261592,-0.826447124,0.408550501,0.552205823,35.35881754,0,-0.567561887,1.020534963,-0.556141541,0.578114099,0.691329621,N,-,,3-keto steroid reductase,C:endoplasmic reticulum membrane; F:3-keto sterol reductase activity; P:ergosterol biosynthetic process; P:oxidation-reduction process; C:mitochondrial outer membrane,IPR016040 (G3DSA:3.40.50.GENE3D); IPR016040 (SUPERFAMILY),,
RL4_JR_04191,38,18,32,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,73.49056273,1,2.546917877,0.494979185,5.145505012,2.67E-07,4.74E-06,4.408268576,0,1.325309745,1.248346391,1.061652242,0.288393588,0.447855154,19.26715337,0,-0.363313649,1.189835237,-0.305347864,0.760101225,0.838812383,34.84802377,0,0.978074487,0.739369213,1.322849897,0.1858853,0.31362622,33.3501532,0,0.823033409,0.83743295,0.982805142,0.325703351,0.461998659,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR10924:SF6 (PANTHER); PTHR10924 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.28.2, the major facilitator superfamily (mfs).
RL4_JR_04192,35,25,44,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,317.4675106,0,-0.171191117,0.424616215,-0.403166697,0.686825597,0.829477901,75.89013578,0,-0.723708383,0.973575349,-0.743351178,0.457269094,0.616486404,214.8551449,0,-1.034143028,0.508520032,-2.033632822,0.04198863,0.099297568,283.4519358,0,-0.364858319,0.373601562,-0.976597411,0.328768501,0.475404324,190.8045751,0,-1.656675737,0.583892756,-2.837294557,0.004549762,0.016570625,N,-,,ubiquionol cytochrome c reductase hinge,"F:ubiquinol-cytochrome-c reductase activity; P:hydrogen ion transmembrane transport; P:mitochondrial electron transport, ubiquinol to cytochrome c; C:mitochondrial envelope",IPR023184 (PFAM); IPR023184 (G3DSA:1.10.287.GENE3D); PTHR15336:SF0 (PANTHER); IPR003422 (PANTHER); IPR023184 (SUPERFAMILY),,
RL4_JR_04193,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,174.405564,0,1.51342242,0.76088239,1.98903594,0.046697236,0.126353583,13.5737257,0,-0.297195464,1.244598448,-0.238788233,0.811269795,0.885260119,41.43940137,0,-1.976041182,1.211529111,-1.631030706,0.102883841,0.197909178,44.29863717,0,-2.413858011,1.167919708,-2.066801335,0.038752878,0.105165609,49.27107061,0,-0.800966388,0.868658735,-0.922072565,0.356490726,0.493838912,N,-,,ww-domain ligand,C:intracellular part,PTHR31606:SF1 (PANTHER); PTHR31606 (PANTHER); PTHR31606:SF1 (PANTHER); IPR011993 (SUPERFAMILY),,
RL4_JR_04194,0,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.15118337,0,0.80225126,0.655477289,1.223919232,0.220982698,0.390464988,5.653367585,0,0.966419498,1.234853011,0.782619056,0.433850848,0.59520714,21.14616288,0,-0.721828596,1.188284898,-0.607454153,0.54354956,0.671275051,28.93068751,0,0.201857158,0.847961533,0.2380499,0.811842392,0.880525945,22.14424121,0,-0.093668431,0.970614336,-0.096504273,0.92312008,0.950339686,N,-,,gtpase binding rid1,C:cell part,IPR010473 (SMART); IPR010473 (PFAM); PTHR11584 (PANTHER); PTHR11584:SF405 (PANTHER); PTHR11584:SF405 (PANTHER); PTHR11584 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_04195,21,27,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,138.080811,0,-4.151194712,1.156110456,-3.590655799,0.000329847,0.002343982,40.63843401,0,-1.879279696,1.195712307,-1.571682156,0.116024283,0.22760148,113.6413025,0,-3.574402417,1.195574736,-2.989693834,0.002792572,0.012892381,122.0773709,0,-4.958842838,1.19673843,-4.143631319,3.42E-05,0.000419857,108.5363707,0,-3.694319436,1.135172608,-3.254412068,0.001136273,0.005296854,N,-,,sucrase ferredoxin domain-containing,C:cytoplasm; C:cellular_component; F:molecular_function,IPR012336 (G3DSA:3.40.30.GENE3D); IPR009737 (PFAM); PTHR31902 (PANTHER); PTHR31902 (PANTHER); PTHR31902:SF4 (PANTHER); PTHR31902:SF4 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_04196,105,94,148,3,0,51,0,0,0,0,0,28,0,0,6,0,0,4,1.319673965,1,1.497783188,1.569860361,0.954086889,0.340039662,NA,0.419183554,0,4.720003417,1.708111268,2.763288028,0.005722225,0.022484611,1.086422724,1,2.069964934,1.325969816,1.561095063,0.118501323,0.219807144,1.253505357,1,1.647237324,1.390969576,1.184236775,0.236319349,0.373981464,1.066010447,1,1.994446179,1.305325356,1.527930313,0.126529841,0.227631102,N,-,,kinase domain-containing,"C:nucleus; F:ATP binding; F:zinc ion binding; F:protein kinase activity; P:protein phosphorylation; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24055 (PANTHER); PTHR24055:SF210 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_04197,124,136,166,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,80.54640366,1,-0.683827353,0.648786332,-1.054010108,0.291878289,0.476896271,18.42495298,0,-0.738038858,1.210792132,-0.609550425,0.54215966,0.688826515,93.18193721,0,0.222396261,0.594514172,0.374080673,0.708344297,0.802156339,162.7537072,0,0.709783971,0.489234719,1.45080458,0.146834284,0.261834647,76.31906115,0,-0.814852318,0.748135433,-1.089177551,0.276075597,0.408986762,N,-,,serine threonine- kinase partial,F:ATP binding; F:RNA binding; P:RNA phosphodiester bond hydrolysis; F:ribonuclease activity; F:protein kinase activity; P:protein phosphorylation,G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR11909 (PANTHER); PTHR11909:SF149 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_04198,48,32,47,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,81.70647172,0,1.803516469,0.526526667,3.425308882,0.000614101,0.003976059,5.159253462,0,1.098355497,1.250018405,0.87867146,0.379579438,0.54382209,13.36165287,0,-1.551110267,1.197934274,-1.294820843,0.19538204,0.320140177,32.74730983,0,0.338086925,0.859320425,0.393435225,0.693998057,0.793442901,20.52417674,0,-0.696318305,1.128011694,-0.617297062,0.537038804,0.659667909,N,-,,glutamyl-tRNA synthetase,F:ATP binding; C:intracellular membrane-bounded organelle; C:integral component of membrane; F:glutamate-tRNA ligase activity; C:cytoplasmic part; P:glutamyl-tRNA aminoacylation,IPR000924 (PRINTS); IPR020059 (PFAM); IPR010987 (G3DSA:1.20.1050.GENE3D); IPR020061 (G3DSA:1.10.1160.GENE3D); G3DSA:3.90.800.10 (GENE3D); IPR020058 (PFAM); IPR020056 (G3DSA:2.40.240.GENE3D); IPR004526 (TIGRFAM); IPR020056 (G3DSA:2.40.240.GENE3D); IPR014729 (G3DSA:3.40.50.GENE3D); PTHR11451 (PANTHER); PTHR11451:SF37 (PANTHER); SSF52374 (SUPERFAMILY); IPR010987 (SUPERFAMILY); IPR011035 (SUPERFAMILY),,
RL4_JR_04199,63,83,76,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.606585053,0,1.213714915,1.332519961,0.910841827,0.362378721,NA,0.517464172,0,4.41612233,1.562660693,2.826027652,0.00471292,0.019885024,1.333885383,0,1.773684591,1.240026709,1.43035999,0.152613725,0.265839875,1.538188282,0,1.351796542,1.26463956,1.068918437,0.285106423,0.429377144,1.30597573,0,1.700790723,1.218995562,1.395239471,0.162943638,0.275748677,N,-,,beta-glucosidase 6,"P:carbohydrate metabolic process; C:barrier septum; P:fungal-type cell wall disassembly involved in conjugation with cellular fusion; C:integral component of membrane; C:plasma membrane of cell tip; C:endoplasmic reticulum; F:hydrolase activity, hydrolyzing O-glycosyl compounds; C:actin fusion focus",IPR013781 (G3DSA:3.20.20.GENE3D); IPR001547 (PFAM); PTHR31297:SF1 (PANTHER); PTHR31297 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_04200,14,16,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.44502172,0,1.069206674,1.056980309,1.011567259,0.311745007,0.499944126,1.87822294,0,2.556256765,1.373233261,1.861487657,0.062675342,0.141009071,4.829086887,0,-0.08262225,1.231698694,-0.06707992,0.946518079,0.968717048,5.567789495,0,-0.50416829,1.234788885,-0.40830323,0.683051068,0.784502558,8.576221036,0,0.776668841,1.151381141,0.674554076,0.499959119,0.627774507,N,-,,fluconazole resistance 1,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); PTHR23502:SF7 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.63, the major facilitator superfamily (mfs).
RL4_JR_04201,15,5,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.975524006,0,1.93338547,1.488576754,1.298814767,0.194007506,NA,0.313753628,0,5.137917778,1.687744774,3.044250444,0.002332609,0.015159195,0.809918156,0,2.493321852,1.250157712,1.994405849,0.04610772,0.106275065,0.934029377,0,2.071356751,1.301566715,1.591433407,0.111512071,0.212508887,0.794471394,0,2.417642761,1.220751389,1.980454646,0.047652465,0.107959094,N,-,,---NA---,,no IPS match,,
RL4_JR_04202,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,76.94776838,0,-3.347135317,1.142154709,-2.930544601,0.003383684,0.015828036,23.40506412,0,-1.08323008,1.201857539,-0.901296572,0.367430656,0.531988714,124.5035417,0,0.250772902,0.515394294,0.48656515,0.626566525,0.73863059,97.23857458,0,-1.422465039,0.743859866,-1.912275557,0.055840859,0.131201173,94.11667766,0,-0.218438008,0.558210944,-0.391318032,0.695562172,0.78477457,N,-,,transcription factor,,IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); G3DSA:3.30.450.20 (GENE3D); PTHR31986 (PANTHER); PTHR31986 (PANTHER); PTHR31986:SF10 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04203,509,723,764,0,0,0,0,0,0,0,2,0,0,0,0,0,3,0,136.4151906,0,1.06516549,0.42021634,2.534802642,0.011251069,0.041645292,16.21612895,0,-0.553855139,1.199268409,-0.461827506,0.644205024,0.768853113,42.12204968,1,-3.207541707,1.188083034,-2.699762236,0.006938905,0.024392177,60.63135726,0,-1.323984176,0.85079037,-1.556181432,0.119664955,0.223957056,41.57638048,1,-3.291463409,1.192550224,-2.760020789,0.005779768,0.020179364,N,-,,riboflavin kinase,P:small molecule metabolic process; P:flavin-containing compound biosynthetic process; P:single-organism cellular process; P:single-organism biosynthetic process; F:kinase activity; P:phosphate-containing compound metabolic process,IPR015865 (SMART); IPR015865 (PFAM); IPR023465 (G3DSA:2.40.30.GENE3D); IPR023468 (PANTHER); IPR015865 (SUPERFAMILY),,
RL4_JR_04204,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,101.7607882,0,0.479875115,0.525829245,0.912606364,0.361449606,0.552606051,14.97712466,0,-0.439183293,1.212749858,-0.3621384,0.71724861,0.823038735,50.02999185,0,-2.133138393,1.198597359,-1.779695556,0.075125798,0.155219098,44.95443847,0,-3.517569284,1.199608464,-2.932264476,0.003365,0.02038837,38.48555887,0,-3.180005084,1.204294959,-2.640553347,0.008277076,0.026999161,N,-,,lactoylglutathione lyase,C:nucleus; C:cytoplasm; F:metal ion binding; P:glutathione metabolic process; P:methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione; F:lactoylglutathione lyase activity,IPR004361 (TIGRFAM); IPR004360 (PFAM); IPR029068 (G3DSA:3.10.180.GENE3D); PTHR10374:SF8 (PANTHER); PTHR10374 (PANTHER); IPR029068 (SUPERFAMILY); IPR029068 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_04205,2,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,315.6584852,0,0.575478835,0.322478561,1.784549128,0.074334479,0.178569105,42.44579626,0,-1.942045475,1.189955441,-1.632032098,0.102672724,0.206710436,224.3251113,0,-0.061990234,0.433919235,-0.142861227,0.886399781,0.929457419,310.7040736,0,0.479682615,0.329974772,1.453694815,0.146030936,0.260769529,165.3431145,0,-0.611296753,0.489797736,-1.248059575,0.212009241,0.335982715,N,-,,NADH-ubiquinone oxidoreductase kDa mitochondrial,F:NADH dehydrogenase (ubiquinone) activity; P:oxidation-reduction process,IPR010218 (TIGRFAM); IPR001268 (PFAM); PTHR10884 (PANTHER); PTHR10884:SF10 (PANTHER); IPR001268 (PRODOM); IPR010218 (HAMAP); SSF143243 (SUPERFAMILY),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_04206,9,2,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.16132161,0,4.529699827,3.48517317,1.299705813,0.193701817,NA,0.050133304,0,7.783053295,2.592600186,3.00202605,0.002681892,0.015349618,0.13211282,0,5.108790283,1.6435935,3.108305237,0.001881636,0.009449249,0.152572985,0,4.685136836,2.265383371,2.068143033,0.038626575,0.104959993,0.132081886,0,5.00879122,1.467727417,3.412616785,0.000643424,0.003351164,N,-,,---NA---,,no IPS match,,
RL4_JR_04207,2312,1937,3358,0,1,0,0,0,0,0,0,0,0,2,0,0,0,0,0.6783471,1,2.457498456,1.726374217,1.423502756,0.154590464,NA,0.215484788,0,5.679715334,1.796807322,3.161004112,0.001572263,0.015023052,0.561040003,0,3.022155891,1.266828314,2.385608104,0.01705091,0.049433968,0.647351764,1,2.599884761,1.358072686,1.914392939,0.055569967,0.130813304,0.555395774,0,2.934858275,1.237356216,2.371878234,0.017697922,0.049524946,N,-,,adenylosuccinate lyase,"F:N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity; P:'de novo' AMP biosynthetic process; P:protein tetramerization; P:'de novo' IMP biosynthetic process; F:(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity",G3DSA:1.20.200.10 (GENE3D); IPR008948 (SUPERFAMILY),,
RL4_JR_04208,73,106,117,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,477.3009044,0,-1.904612378,0.686517095,-2.774311653,0.005531866,0.023615363,136.0757025,0,-1.775848344,1.009933079,-1.758382195,0.078682501,0.168234954,375.5186433,0,-2.067143751,0.5608209,-3.685924956,0.000227873,0.001916106,363.1373664,0,-4.742354284,1.034911481,-4.582376724,4.60E-06,7.10E-05,352.3122678,0,-2.045286085,0.804662153,-2.541794809,0.01102849,0.033998741,N,-,,general negative regulator of transcription subunit 4,F:zinc ion binding; P:deadenylation-independent decapping of nuclear-transcribed mRNA; P:protein polyubiquitination; P:conjugation with cellular fusion; F:sequence-specific DNA binding; P:nuclear-transcribed mRNA poly(A) tail shortening; P:transcription elongation from RNA polymerase II promoter; F:nucleotide binding; P:positive regulation of transcription elongation from RNA polymerase II promoter; F:ubiquitin-protein transferase activity; F:RNA binding; C:cytosol; C:CCR4-NOT core complex; P:proteasomal protein catabolic process,IPR003954 (SMART); IPR000504 (SMART); IPR000504 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); PF14570 (PFAM); PTHR12603 (PANTHER); PTHR12603:SF0 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR012677 (SUPERFAMILY),4.D.3.1.9, the glycan glucosyl transferase (opgh) family.
RL4_JR_04209,1557,1340,1473,0,0,0,0,0,0,0,0,0,4,0,2,0,0,0,223.2711464,0,-4.896602281,1.193889494,-4.101386524,4.11E-05,0.000394622,69.29137217,0,-2.649088244,1.229044303,-2.155405008,0.031130155,0.081526372,193.4460296,0,-3.478260499,1.074358443,-3.237523306,0.001205721,0.006703305,258.7350393,1,-2.284659571,0.731557621,-3.123007,0.001790135,0.012067321,217.9830991,0,-1.660749764,0.641018143,-2.590799938,0.009575314,0.030315839,N,-,,ccr4-not core complex subunit,P:cellular macromolecule metabolic process; F:organic cyclic compound binding; F:heterocyclic compound binding; P:primary metabolic process; C:intracellular part,no IPS match,,
RL4_JR_04210,1071,836,784,0,3,76,0,0,0,10,8,1,12,68,6,0,0,6,5.276405176,1,2.295885052,1.237136505,1.85580576,0.063481249,0.15890765,0.473256941,0,4.545047359,1.657565976,2.742000877,0.006106618,0.023556092,1.213040017,1,1.910793458,1.295567473,1.474869891,0.140247526,0.249361777,45.38151636,1,5.018505963,0.683726709,7.339929683,2.14E-13,1.11E-11,1.180109548,1,1.847014386,1.268825776,1.455687945,0.145478904,0.253262363,N,-,,developmental regulator,"C:nucleus; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:sporulation resulting in formation of a cellular spore",IPR021740 (PFAM); PTHR33572 (PANTHER); PTHR33572:SF5 (PANTHER),,
RL4_JR_04211,6377,5793,5594,0,0,4,0,0,0,0,0,0,0,3,0,1,2,4,35.25395405,1,0.91916408,0.665390386,1.381390683,0.167158869,0.318915354,5.156309995,0,1.099194963,1.237240736,0.888424484,0.37431246,0.538946048,197.1265524,0,3.936646915,0.359450959,10.9518331,6.51E-28,1.69E-25,142.5807853,1,2.936941883,0.370236288,7.932614873,2.15E-15,1.37E-13,47.9189468,1,2.123719941,0.526560689,4.033191207,5.50E-05,0.000421106,Y,-,,glycoside hydrolase family 43,"P:carbohydrate metabolic process; C:integral component of membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR023296 (G3DSA:2.115.10.GENE3D); PTHR22925:SF31 (PANTHER); IPR006710 (PANTHER); IPR023296 (SUPERFAMILY),,
RL4_JR_04212,6205,3897,4986,0,2,4,0,0,0,0,0,0,0,1,0,0,4,0,34.55839326,1,-1.882678747,1.145826573,-1.643074782,0.100367462,0.222197491,8.463413776,0,0.384299254,1.222800923,0.314277857,0.753310015,0.849204139,41.44872244,0,0.134881302,0.854707964,0.157809811,0.874606667,0.921056663,25.32562093,1,-2.68965386,1.191586681,-2.257203696,0.02399535,0.083632673,21.62032964,1,-2.348057169,1.194728822,-1.965347388,0.049374044,0.110968302,N,-,,artemis,,IPR001279 (G3DSA:3.60.15.GENE3D); PTHR23240:SF8 (PANTHER); PTHR23240 (PANTHER); PTHR23240:SF8 (PANTHER); PTHR23240 (PANTHER); PTHR23240:SF8 (PANTHER); IPR001279 (SUPERFAMILY),,
RL4_JR_04213,7,10,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,406.8007629,0,-2.166346016,0.486036657,-4.457165903,8.31E-06,9.88E-05,105.5510566,0,-3.256280055,1.193116096,-2.729223138,0.006348373,0.024166316,296.3830465,0,-3.503840066,0.859419382,-4.076985159,4.56E-05,0.000669408,355.3641166,0,-2.808878089,0.586897951,-4.785973581,1.70E-06,2.93E-05,335.77561,0,-1.619153409,0.654831858,-2.472624674,0.013412492,0.03971965,N,-,,c6 zinc finger domain containing,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31001:SF14 (PANTHER); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY); SSF81995 (SUPERFAMILY),,
RL4_JR_04214,115,184,177,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28.68268873,0,-2.944490567,1.187497024,-2.479577218,0.013153825,0.047168747,9.203102481,0,0.263425096,1.225716542,0.214915184,0.829833446,0.897966019,23.79674733,0,-2.383703131,1.192928868,-1.998193854,0.045695648,0.105621629,27.4461198,0,-2.805713894,1.191540984,-2.354693571,0.018537986,0.074217914,23.38584181,0,-2.46139406,1.191509429,-2.06577808,0.038849439,0.091945749,N,-,,potassium channel,P:potassium ion transmembrane transport; C:integral component of membrane; F:potassium channel activity,IPR003280 (PRINTS); IPR013099 (PFAM); G3DSA:1.10.287.70 (GENE3D); G3DSA:1.10.287.70 (GENE3D); PTHR11003:SF127 (PANTHER); PTHR11003 (PANTHER); PTHR11003 (PANTHER); PTHR11003:SF127 (PANTHER); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY),1.A.1.7.1, the voltage-gated ion channel (vic) superfamily.
RL4_JR_04215,27,26,49,0,1,0,0,0,0,0,0,15,21,18,14,0,34,7,3.485134048,1,0.096292859,1.219166676,0.078982523,0.937046525,0.96903748,1.118429754,0,3.304079961,1.393899204,2.370386576,0.017769495,0.052407585,2.892248371,1,0.656751721,1.212091766,0.541833333,0.587933327,0.707925428,3.335775271,1,0.234738924,1.214846119,0.193225232,0.846782579,0.90382391,2.843153436,1,0.578510334,1.205416272,0.479925771,0.631280176,0.734510662,N,-,,alpha beta hydrolase fold domain-containing,P:biological_process; P:metabolic process; C:cellular_component; F:molecular_function; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR029058 (SUPERFAMILY),,
RL4_JR_04216,246,198,270,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.010734267,0,-0.106384581,1.213507109,-0.087667044,0.930141314,0.966266756,1.287134221,0,3.101387268,1.374301387,2.256700966,0.024026766,0.066484125,3.328717095,0,0.453961408,1.210720664,0.374951401,0.707696611,0.801738194,3.839175696,0,0.03194936,1.212143269,0.026357742,0.978971999,0.987161786,3.272644153,0,0.375561132,1.205432005,0.311557292,0.755376995,0.829611897,Y,-,,hypothetical protein F503_05590,C:integral component of plasma membrane; C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_04217,3751,7353,4599,0,3,7,0,0,0,0,0,4,3,1,0,0,3,0,6.338508868,1,-0.76650643,1.2506292,-0.612896637,0.539944687,0.722228031,2.05581671,0,2.425903215,1.381685417,1.755756546,0.079129987,0.168835103,5.27824615,1,-0.210982668,1.241637204,-0.169922959,0.865070725,0.914002924,6.084941969,1,-0.63235626,1.245953095,-0.507528143,0.611784295,0.731496928,5.149123058,1,-0.278254668,1.235923423,-0.225139084,0.821871076,0.880762558,Y,-,,glycoside hydrolase family 2,"P:polysaccharide catabolic process; C:extracellular region; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR006102 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); IPR013812 (G3DSA:2.60.40.GENE3D); IPR008979 (G3DSA:2.60.120.GENE3D); PTHR10066 (PANTHER); IPR028829 (PTHR10066:PANTHER); IPR006102 (SUPERFAMILY); IPR006102 (SUPERFAMILY); IPR017853 (SUPERFAMILY); IPR008979 (SUPERFAMILY); IPR006102 (SUPERFAMILY),,
RL4_JR_04218,4405,3621,4156,0,0,4,0,0,0,0,0,2,2,0,0,0,1,1,3.788862325,1,-0.024328966,1.26413493,-0.019245545,0.984645225,0.992185739,1.202092596,0,3.199828395,1.406053006,2.275752324,0.022860838,0.063966053,3.135669237,1,0.539845056,1.237090966,0.436382667,0.662559112,0.767286536,3.618293025,1,0.11719617,1.245493804,0.094096149,0.92503278,0.956002541,3.113008718,1,0.447892203,1.243993733,0.360043777,0.718814396,0.802043932,N,-,,---NA---,,no IPS match,,
RL4_JR_04219,10506,8213,7519,7,10,0,0,0,1,1,2,20,2,3,9,6,2,3,147.1257938,1,-1.774643761,0.777546054,-2.282364822,0.02246781,0.072247693,34.55509452,1,-1.645341496,1.23122032,-1.33635018,0.181434842,0.320350621,90.37060588,1,-4.308813339,1.228233577,-3.508138372,0.000451254,0.003133401,151.6469791,1,-0.902447653,0.63045056,-1.431432866,0.152306195,0.269268416,97.69593799,1,-2.760485912,1.046710552,-2.637296343,0.008356979,0.027207206,N,-,,hypothetical protein CMQ_2231,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,PTHR42044:SF1 (PANTHER); PTHR42044 (PANTHER),,
RL4_JR_04220,224166,136119,154850,11,39,35,0,0,5,5,1,19,2,9,7,0,25,3,36.43709502,1,0.636352883,0.91070712,0.698745918,0.484710832,0.672617182,3.938483559,1,1.487785339,1.300177488,1.144294031,0.252501718,0.406978087,10.27359422,1,-1.172032104,1.229432506,-0.953311466,0.340432284,0.483928172,15.86620163,1,-0.650135532,1.18358717,-0.54929248,0.582804747,0.708466065,24.93376428,1,0.449525614,1.023531423,0.439190829,0.66052327,0.757974614,N,-,,hypothetical protein SPSK_07839,,no IPS match,,
RL4_JR_04221,23167,30189,36580,2,4,20,0,0,0,2,0,2,1,1,3,0,11,0,0.572848924,1,2.701451958,1.841254293,1.467180263,0.142327024,NA,0.183453995,0,5.912108048,1.852869632,3.190784686,0.00141887,0.015023052,0.474687859,1,3.264207012,1.266885892,2.576559604,0.0099789,0.032599672,0.547524474,1,2.841924581,1.377935086,2.062451714,0.03916475,0.106070792,0.466578202,1,3.185952113,1.223620193,2.603709984,0.009222076,0.029446079,N,-,,hypothetical protein CMQ_2491,,no IPS match,,
RL4_JR_04222,1936,2695,3737,0,3,9,0,0,0,1,0,0,0,0,0,0,0,2,1.217267074,1,1.614162643,1.391454617,1.160054107,0.246026778,NA,0.389011324,0,4.827712358,1.614791429,2.989681683,0.002792683,0.015349618,1.007307296,1,2.17888993,1.235927273,1.762959663,0.077907293,0.159510129,1.161963808,0,1.756502909,1.269894808,1.383187724,0.166607313,0.287425293,0.990260571,1,2.100631525,1.214694256,1.729350011,0.083746471,0.167019839,N,-,,phosphoribosyl transferase domain,P:small molecule metabolic process; P:organic cyclic compound metabolic process; F:oxidoreductase activity; P:primary metabolic process; F:kinase activity; P:cellular metabolic process,IPR029057 (G3DSA:3.40.50.GENE3D); IPR006094 (PFAM); IPR000836 (PFAM); IPR016167 (G3DSA:3.30.43.GENE3D); IPR005919 (PFAM); PTHR11748:SF84 (PANTHER); PTHR11748 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR029057 (SUPERFAMILY); IPR029063 (SUPERFAMILY); IPR016166 (SUPERFAMILY),,
RL4_JR_04223,5242,4876,6697,0,5,6,0,0,0,5,4,3,4,7,2,0,1,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_04224,443,452,484,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.105705868,0,5.139074172,3.916845805,1.312044034,0.189505277,NA,0.033376584,0,8.369364618,2.790936302,2.998765903,0.002710755,0.015349618,0.087625809,0,5.698574239,1.722760034,3.3078166,0.000940264,0.005470821,0.101136128,0,5.277509243,2.564142553,2.058196506,0.039571274,0.106813956,0.08781209,0,5.594731709,1.476800886,3.788413024,0.000151613,0.000984024,N,-,,---NA---,,no IPS match,,
RL4_JR_04225,103,104,69,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.1526544,0,-0.467870387,1.199735601,-0.389977914,0.696552879,0.836027421,1.646604192,0,2.746010173,1.330983186,2.063144149,0.039098935,0.097262083,4.270114718,0,0.094545423,1.201935435,0.078660983,0.937302281,0.96230081,4.925808829,0,-0.327721193,1.200696072,-0.272942671,0.784897284,0.861035561,4.209931325,0,0.012352625,1.202130328,0.010275612,0.991801392,0.994354797,N,-,,methyltransferase domain-containing,F:methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108 (PANTHER); PTHR10108:SF875 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_04226,216,236,160,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.257214477,0,-0.496860975,1.203993189,-0.412677563,0.679842866,0.824217283,1.685336814,0,2.712494672,1.337806162,2.027569276,0.042604227,0.104038598,4.362105483,0,0.063860494,1.206399914,0.052934764,0.957783886,0.975121084,14.66655197,0,0.591867309,1.148652156,0.515271142,0.606363561,0.72665442,4.292671947,0,-0.015807711,1.204187828,-0.01312728,0.989526247,0.992860296,N,-,,hypothetical protein SPI_02555,,no IPS match,,
RL4_JR_04227,5103,5531,5374,0,10,2,0,0,2,0,4,1,3,6,1,0,1,4,81.1059713,1,0.045010876,0.56431139,0.079762479,0.936426166,0.968626105,13.36247583,1,-0.274569585,1.207103296,-0.227461548,0.820064866,0.891397827,85.48044091,1,0.70299244,0.566081791,1.241856655,0.214289455,0.342998647,137.3492261,1,1.591867734,0.382360874,4.163260007,3.14E-05,0.000391204,68.08794629,1,0.423673133,0.565697336,0.748939595,0.453893614,0.58588384,N,-,,integral peroxisomal membrane,C:integral component of peroxisomal membrane; P:peroxisome organization,IPR006614 (SMART); IPR010482 (PFAM); PTHR31679 (PANTHER); PTHR31679:SF2 (PANTHER),3.A.20.1.5, the peroxisomal protein importer (ppi) family.
RL4_JR_04228,32769,56197,63535,22,50,113,0,1,12,24,9,27,35,74,47,6,21,37,6.418098157,1,1.466577431,1.159159622,1.265207486,0.20579696,0.371025767,0.832342239,1,3.730360093,1.444475514,2.58250144,0.009808695,0.03319412,2.152521452,1,1.083305775,1.218113155,0.889330988,0.373825222,0.517730034,2.482809046,1,0.661125687,1.225748447,0.539364899,0.589635096,0.713847808,2.113281394,1,1.006837599,1.206713977,0.834363086,0.404076412,0.5409591,N,-,,---NA---,,no IPS match,,
RL4_JR_04229,2166,4034,5900,0,0,0,0,0,0,0,1,0,0,2,1,0,1,3,4.895095791,0,-0.393945803,1.224760322,-0.321651344,0.747716842,0.86813987,1.563132825,0,2.821017376,1.356456537,2.079696104,0.037553416,0.09436834,4.059013144,1,0.167595199,1.218363909,0.137557586,0.890590078,0.931343244,4.68247778,1,-0.2547036,1.220553188,-0.208678821,0.834698975,0.896217086,4.010232236,1,0.082441314,1.221629665,0.067484702,0.94619584,0.965491057,N,-,,D-lactate dehydrogenase,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; F:catalytic activity; F:oxidoreductase activity; P:oxidation-reduction process",IPR016169 (G3DSA:3.30.465.GENE3D); IPR006094 (PFAM); IPR016167 (G3DSA:3.30.43.GENE3D); PTHR11748 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY),,
RL4_JR_04230,2925,4000,5243,0,2,6,0,0,0,0,0,2,0,0,0,0,0,0,1.192928727,1,1.64298393,1.463931788,1.122309074,0.261731049,NA,0.377781115,0,4.869682618,1.643412131,2.963153627,0.003045046,0.015677493,0.986371736,1,2.208048685,1.265127005,1.745317803,0.080929565,0.164243803,1.138272754,0,1.785516425,1.312772778,1.360110794,0.173794866,0.29709151,0.979922459,0,2.115552913,1.25501225,1.685683078,0.091856858,0.178993589,N,-,,capsule polysaccharide synthase,,PF13641 (PFAM); IPR029044 (G3DSA:3.90.550.GENE3D); PTHR10587 (PANTHER); PTHR10587:SF1 (PANTHER); IPR029044 (SUPERFAMILY),4.D.1.1.8, the putative vectorial glycosyl polymerization (vgp) family.
RL4_JR_04231,125,115,266,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,49.28349582,0,-1.765722793,1.038581184,-1.700129773,0.089106518,0.203394229,13.44284819,0,-0.283220321,1.239958034,-0.228411215,0.819326572,0.890887545,81.69170632,1,0.472287843,1.278195359,0.36949582,0.711758188,0.804941901,51.97011774,0,-1.063508192,0.892142198,-1.192083722,0.233228419,0.370580062,33.9185462,0,-2.997823189,1.20685553,-2.483995071,0.012991761,0.038779946,N,-,,HET domain-containing,P:biological_process; C:cellular_component,IPR010730 (PFAM); PTHR10622:SF10 (PANTHER); PTHR10622:SF10 (PANTHER); PTHR10622 (PANTHER); PTHR10622 (PANTHER),,
RL4_JR_04232,1740,1341,1733,0,0,1,0,0,0,0,0,2,0,0,0,0,6,0,25.76845026,1,0.340768071,0.889199283,0.383230258,0.701549045,0.838858189,4.619395887,0,1.25785617,1.285543499,0.97846255,0.327845605,0.490460126,27.59075928,1,0.440342699,1.054686411,0.417510546,0.676305012,0.777528043,13.72721144,0,-1.806153006,1.214744017,-1.486858943,0.13705207,0.24859409,11.66476225,1,-1.457959386,1.213286015,-1.201661742,0.22949461,0.357042551,N,-,,c6 zinc finger domain containing,"C:nucleus; F:zinc ion binding; F:oxidoreductase activity; P:regulation of transcription, DNA-templated; P:oxidation-reduction process; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR021858 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04233,131,202,195,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49.56380564,0,1.354151455,0.535572044,2.528420726,0.011457696,0.042202452,15.4466329,0,1.781162691,1.118278892,1.592771449,0.111211472,0.220074785,15.73789757,0,-1.787169747,1.188369488,-1.503883906,0.132611262,0.239086185,83.98733509,0,1.359681763,0.565883369,2.402759714,0.016271875,0.069049765,15.50614074,0,-1.868517428,1.190524819,-1.569490529,0.116533685,0.214449938,N,-,,monoamine oxidase n,F:oxidoreductase activity; P:oxidation-reduction process,IPR001613 (PRINTS); IPR002937 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR10742:SF218 (PANTHER); PTHR10742 (PANTHER); IPR023753 (SUPERFAMILY),3.D.7.1.4, the h2:heterodisulfide oxidoreductase (hho) family
RL4_JR_04234,278,366,341,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,70.40685879,1,-0.785237553,0.742328527,-1.057803283,0.290145136,0.474999067,13.68782725,0,-0.309267153,1.216666367,-0.254192243,0.799347043,0.878023957,43.20923123,0,-1.993491025,1.19245443,-1.671754472,0.094572748,0.185949602,60.84681086,0,-0.349901925,0.680955856,-0.513839365,0.607364303,0.727500718,60.67175585,0,-0.396935022,0.73990425,-0.536468093,0.591635082,0.703252548,N,-,,choline transport,C:membrane,IPR002293 (PFAM); IPR002293 (PIRSF); PTHR11785:SF388 (PANTHER); IPR002293 (PANTHER),2.A.3.4.1, the amino acid-polyamine-organocation (apc) family.
RL4_JR_04235,2029,2182,2443,0,5,15,0,0,0,0,0,2,2,0,0,1,0,1,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_04236,2467,2669,3259,0,0,5,0,0,0,0,1,0,2,3,0,0,0,1,17.5066868,1,3.448748972,0.754094341,4.573365404,4.80E-06,6.06E-05,0.712160893,0,3.955282255,1.465553262,2.698832146,0.006958326,0.02585219,34.34014404,1,4.439103103,0.677123028,6.555829474,5.53E-11,3.42E-09,15.77701363,1,2.616868277,1.018391943,2.56960819,0.010181359,0.049182378,1.817850536,1,1.224237394,1.208185529,1.013285927,0.310923607,0.446539223,N,-,,methyltransferase type 12,F:methyltransferase activity; F:transferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); PTHR10108:SF818 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_04237,2427,2706,4261,2,0,5,0,0,0,0,0,0,0,4,2,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein OIDMADRAFT_144098,,IPR018306 (SMART); IPR018306 (PFAM),,
RL4_JR_04238,2908,3639,4796,0,0,0,0,0,0,0,1,0,1,0,1,0,0,0,7.897697685,0,5.520166202,1.128536406,4.891438303,1.00E-06,1.52E-05,0.082811093,0,7.059093768,2.23406981,3.159746279,0.001579066,0.015023052,0.216071785,1,4.397662594,1.418706085,3.099770023,0.00193671,0.009606687,0.249314867,1,3.976146113,1.78467062,2.227943952,0.025884253,0.085955415,0.214826988,0,4.304342766,1.323492053,3.252261891,0.001144905,0.005324833,N,-,,ino80 chromatin remodeling complex,,IPR003594 (G3DSA:3.30.565.GENE3D); PTHR32387:SF0 (PANTHER); PTHR32387 (PANTHER); PTHR32387 (PANTHER); IPR003594 (SUPERFAMILY),,
RL4_JR_04239,2092,2456,3066,6,3,1,0,0,0,0,0,0,0,0,0,0,4,0,10.70714015,1,0.059817807,1.160086125,0.051563247,0.958876705,0.978906038,2.185484655,0,2.337481065,1.305649085,1.790282773,0.073408464,0.159416536,5.693880741,0,-0.32061956,1.208340251,-0.265338806,0.790748472,0.861829856,6.570174544,0,-0.743295993,1.208244221,-0.615186881,0.538431311,0.67004934,5.639414098,1,-0.409271478,1.216123355,-0.3365378,0.736465352,0.815743539,Y,-,,hypothetical protein F503_01139,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_04240,156,188,162,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0.011718044,0,8.30924678,3.99658426,2.0790871,0.037609346,NA,0.004006569,0,11.4341231,3.991291091,2.864768027,0.004173148,0.018371529,0.009992212,0,8.834284459,3.994251091,2.211749902,0.02698395,0.070608817,0.011494389,1,8.415706565,3.9944702,2.106839241,0.035131517,0.099498352,0.009494587,1,8.783878684,1.912952289,4.591791826,4.39E-06,5.09E-05,,,,,,,,
RL4_JR_04241,54,36,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.095816686,0,5.281103088,3.917887262,1.34794667,0.177675536,NA,0.030570187,0,8.497106502,2.638153894,3.220853234,0.001278096,0.015023052,0.079356141,0,5.843855056,1.493997387,3.91155641,9.17E-05,0.00110894,0.091547725,0,5.421975129,2.37930231,2.278808836,0.022678431,0.081131698,0.078312322,0,5.760729343,1.293357933,4.454087454,8.43E-06,8.68E-05,N,-,,serine threonine CMGC group,F:kinase activity,G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24055 (PANTHER); PTHR24055:SF229 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_04242,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.04813796,0,6.274313624,3.928874038,1.596975002,0.11027128,NA,0.015707914,0,9.459210455,3.077804754,3.073362741,0.00211661,0.015045494,0.040136899,0,6.830151423,1.777248069,3.843105271,0.000121487,0.001301521,0.04625895,0,6.4072971,3.182478206,2.013304314,0.044082625,0.113919494,0.038929409,0,6.764900625,1.378262534,4.908281591,9.19E-07,1.34E-05,N,-, Effector probability:0.682,kinase domain,F:nucleotide binding; F:ATP binding; F:protein kinase activity; P:phosphorylation; F:protein serine/threonine kinase activity; P:protein phosphorylation; F:kinase activity,G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24055 (PANTHER); PTHR24055:SF210 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_04243,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.134920684,0,4.787276498,3.607467894,1.327046183,0.184493406,NA,0.042079476,0,8.035162939,2.561084446,3.137406481,0.001704496,0.015023052,0.111033841,0,5.357507585,1.554631134,3.446159972,0.000568614,0.003718763,0.128214853,0,4.935485768,2.236029842,2.20725398,0.02729632,0.087982757,0.111518405,0,5.252322702,1.382138182,3.800142974,0.000144613,0.000947704,N,-,,ankyrin unc44,P:biological_process; F:zinc ion binding; F:aspartic-type endopeptidase activity; P:proteolysis; C:cellular_component; F:molecular_function,IPR002110 (SMART); PF13857 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24123 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR000433 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY); SSF57850 (SUPERFAMILY); IPR020683 (SUPERFAMILY),8.A.28.1.2, the ankyrin (ankyrin) family.
RL4_JR_04244,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.04836354,0,6.267742868,3.928773854,1.595343255,0.110635498,NA,0.015039539,0,9.519515391,3.18704762,2.986938548,0.002817864,0.015349618,0.039621684,0,6.845799889,1.889562971,3.622954088,0.000291258,0.002273471,17.70421752,0,8.726583188,0.980675793,8.898540428,5.66E-19,4.81E-17,0.039607073,0,6.750697207,1.443374481,4.677024082,2.91E-06,3.58E-05,N,-,,intracellular serine protease,P:proteolysis; F:serine-type endopeptidase activity; F:peptidase activity,no IPS match,,
RL4_JR_04245,161,114,187,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.13502453,0,4.786174999,3.532318174,1.354967125,0.175428032,NA,0.042752372,0,8.012792064,2.491509474,3.216039171,0.001299731,0.015023052,0.111670673,0,5.349674407,1.461737008,3.659806367,0.000252406,0.002044019,0.128869273,0,4.928327512,2.131775809,2.311841372,0.020786427,0.078120428,0.111015664,0,5.257596363,1.302761656,4.035731585,5.44E-05,0.000417521,N,-,,intracellular serine protease,P:proteolysis; C:membrane; C:integral component of membrane; F:serine-type endopeptidase activity; F:peptidase activity; C:cellular_component,IPR015500 (PRINTS); IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (PFAM); IPR000209 (SUPERFAMILY),,
RL4_JR_04246,608,846,955,0,0,2,0,0,0,0,2,4,0,3,0,0,4,0,2.24218507,1,0.73258759,1.252547757,0.584877971,0.558629772,0.736474092,0.716460489,0,3.946534354,1.463779437,2.696126379,0.007015105,0.025989957,1.858255376,1,1.294772362,1.217202923,1.063727614,0.287452111,0.427086171,2.143607995,1,0.872558338,1.226953544,0.711158415,0.476986074,0.617767649,1.832482177,1,1.212295637,1.210652881,1.001356918,0.316654285,0.451934391,N,-,,phosphotransferase enzyme family,F:transferase activity,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); PTHR21310 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_04247,3,9,10,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0.004235441,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001340044,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003452355,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003983613,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003339785,0,10.24113992,1.835951848,5.578109216,2.43E-08,8.07E-07,N,-,,monooxygenase,"F:zinc ion binding; F:oxidoreductase activity, acting on the CH-CH group of donors; F:flavin adenine dinucleotide binding; F:carbonate dehydratase activity; P:oxidation-reduction process; F:monooxygenase activity",IPR013107 (PFAM); IPR013786 (G3DSA:1.10.540.GENE3D); IPR013786 (PFAM); G3DSA:1.20.140.10 (GENE3D); PIRSF016578 (PIRSF); G3DSA:2.40.110.10 (GENE3D); PTHR10909 (PANTHER); PTHR10909:SF274 (PANTHER); IPR009100 (SUPERFAMILY); IPR009075 (SUPERFAMILY),,
RL4_JR_04248,7321,8621,9072,0,2,7,0,0,0,1,0,0,0,3,0,0,2,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,Urea active transporter,P:urea transmembrane transport; C:integral component of membrane; F:urea transmembrane transporter activity,IPR001734 (PFAM); IPR001734 (TIGRFAM); IPR031155 (PTHR11819:PANTHER); IPR031155 (PTHR11819:PANTHER); IPR001734 (PANTHER); IPR001734 (PROSITE_PROFILES),2.A.21.6.1, the solute:sodium symporter (sss) family.
RL4_JR_04249,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.16665838,0,-0.943393385,1.221063544,-0.772599747,0.439759294,0.629948432,2.284269193,0,2.27383866,1.31981529,1.722846127,0.084916355,0.178102641,5.92073064,0,-0.376610185,1.214244861,-0.310159999,0.756439288,0.836319243,6.830468987,0,-0.798987991,1.214699444,-0.657765997,0.510688507,0.645694447,5.822425847,0,-0.455278437,1.213937627,-0.375042693,0.707628716,0.793613286,N,-,,C6 zinc finger domain-containing (nucleus ),,IPR007219 (SMART); IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04250,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.08118269,0,2.421797099,0.881211978,2.748257126,0.0059913,0.025142504,1.091585344,0,3.339115884,1.405037319,2.37653181,0.017476254,0.051768993,2.835128625,0,0.685751172,1.223574874,0.560448883,0.575173297,0.697835809,3.271131519,0,0.263193676,1.22991762,0.21399293,0.83055257,0.894135542,2.79457694,0,0.603832539,1.221323189,0.494408478,0.621017727,0.727081925,N,-,,DUF1479 domain,,IPR010856 (PFAM); IPR027443 (G3DSA:2.60.120.GENE3D); PTHR30613 (PANTHER); PTHR30613:SF1 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_04251,9,6,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0.204114114,0,4.190176508,2.948936584,1.420911026,0.155342627,NA,0.065828881,0,7.390936924,2.288976551,3.228926448,0.001242558,0.015023052,0.16958456,0,4.74956255,1.380308235,3.440943427,0.00057969,0.003771709,0.195548559,1,4.3273591,1.825616144,2.370355408,0.017770993,0.072551744,0.165966335,0,4.675922261,1.263052477,3.702080751,0.000213839,0.001320192,N,-,,hypothetical protein OCS_03019,,IPR003615 (PFAM),,
RL4_JR_04252,77,40,48,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.797,pre-mRNA-splicing factor ATP-dependent RNA helicase prp43,F:nucleic acid binding; C:nucleus; F:ATP binding; F:ATP-dependent helicase activity; P:rRNA processing,IPR014001 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011545 (PFAM); PTHR18934:SF109 (PANTHER); PTHR18934 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_04253,727,725,1063,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0.008115494,0,8.845278576,4.03634189,2.191409652,0.028422161,NA,0.002507343,0,12.10167175,4.040174693,2.995333784,0.002741447,0.015349618,0.006623884,0,9.426891884,3.299070491,2.857438757,0.00427075,0.016940088,0.007651472,1,9.002876608,4.037800151,2.229648886,0.025770762,0.085851084,0.006630333,0,9.341240721,1.70468121,5.479758129,4.26E-08,1.17E-06,N,-,,pre-mRNA-splicing factor ATP-dependent RNA helicase prp43,F:nucleotide binding; F:ATP-dependent helicase activity; P:rRNA processing,IPR007502 (SMART); IPR001650 (SMART); IPR011709 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR007502 (PFAM); IPR001650 (PFAM); PTHR18934 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.A.53.1.5, the hepatitis c virus p7 viroporin cation-selective channel (hcv-p7) family.
RL4_JR_04254,109,115,68,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.389955865,0,3.256337104,2.314120339,1.407159796,0.15938001,NA,0.122479393,0,6.494657536,2.067437408,3.141404674,0.001681395,0.015023052,0.3207354,0,3.829274363,1.37481733,2.785296838,0.005347874,0.019897787,0.37024648,0,3.406174618,1.612615919,2.112204511,0.034668912,0.099426657,0.318868254,0,3.736412215,1.312002075,2.84787066,0.004401281,0.016146003,N,-,,Short-chain dehydrogenase reductase SDR,,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24320 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04255,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.795278997,0,-0.36421126,1.208142342,-0.301463865,0.763060801,0.87590404,1.532248232,0,2.849837936,1.344583631,2.119494742,0.034048678,0.087361398,3.974964462,0,0.197824777,1.207218163,0.163868291,0.86983483,0.917695687,4.585369704,0,-0.224442037,1.207286127,-0.18590625,0.852518281,0.907897583,11.28687345,0,1.050819111,1.131695592,0.928535128,0.353130055,0.49045841,N,-,,Transcription fungi,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR001138 (SMART); IPR001138 (PFAM); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31001:SF35 (PANTHER); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04256,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.26038805,0,-2.21158483,1.188597168,-1.860668096,0.062791062,0.157917652,5.526181133,0,0.99928379,1.242076313,0.804526887,0.421092748,0.584597557,14.29718723,0,-1.648577934,1.192673202,-1.382254528,0.166893563,0.284019235,26.12637502,0,-1.121250316,1.142125024,-0.981722922,0.32623637,0.472884861,14.04726392,0,-1.725989504,1.190140256,-1.45024042,0.146991487,0.255275556,N,-,,major facilitator superfamily transporter,,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23502:SF51 (PANTHER); PTHR23502:SF51 (PANTHER); PTHR23502 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.31, the major facilitator superfamily (mfs).
RL4_JR_04257,3,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44.92538455,0,4.387364846,0.597649112,7.341038011,2.12E-13,1.13E-11,0.930521119,0,3.569418641,1.413108541,2.52593381,0.011539122,0.037495664,2.415312642,0,0.916879209,1.211845854,0.756597224,0.449291205,0.588742449,2.786536428,0,0.494441197,1.216731937,0.406368225,0.684472063,0.785924205,10.1019211,0,2.501195676,0.984246439,2.541229082,0.011046352,0.034026258,N,-,,---NA---,,no IPS match,,
RL4_JR_04258,1944,1923,3041,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,30.33469496,0,-0.898526723,1.059440316,-0.848114527,0.396374192,0.588787447,7.176021047,0,0.622248729,1.254120001,0.496163628,0.61977897,0.749868843,40.89379655,0,-0.197728639,1.05664565,-0.187128617,0.851559791,0.905397115,53.73607866,1,1.140460896,0.662613101,1.721156576,0.085222415,0.173721956,18.64598724,0,-2.134568498,1.231911842,-1.732728288,0.083143974,0.166271526,N,-, Effector probability:0.61,ER membrane DUF1077 domain-containing,C:ER membrane protein complex; P:protein folding in endoplasmic reticulum,IPR009445 (PIRSF); IPR009445 (PFAM); IPR009445 (PANTHER); PTHR19315:SF9 (PANTHER),3.A.27.1.1, the c-terminal tail-anchored membrane protein biogenesis/ insertion complex-2 (tamp-b2) family.
RL4_JR_04259,131,88,104,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,96.23494317,0,1.391091142,0.478711166,2.905909117,0.003661878,0.016839684,9.580862605,0,0.205415073,1.235382452,0.166276502,0.867939357,0.923308688,24.72934863,0,-2.439101454,1.199640239,-2.033194098,0.042032917,0.099361082,51.80227162,0,-0.5348441,0.862508605,-0.620102915,0.535190033,0.667257614,31.9550922,0,-0.845222069,0.978895993,-0.863444202,0.387893286,0.523935368,N,-,,AP-1 complex subunit beta,P:vesicle-mediated transport; F:protein transporter activity; C:AP-2 adaptor complex; P:intracellular protein transport,IPR002553 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR016342 (PIRSF); PTHR11134:SF13 (PANTHER); IPR026739 (PANTHER); IPR016024 (SUPERFAMILY),9.B.278.1.1, the organellar-targeting adaptor protein complex (o-apc) family.
RL4_JR_04260,549,379,605,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.183597121,0,-0.166942373,1.205315671,-0.138505104,0.889841236,0.945788685,1.340172822,0,3.043159775,1.360934991,2.236080192,0.025346519,0.069264974,3.466792954,0,0.39554935,1.204123222,0.328495741,0.742536864,0.827028026,13.63397506,0,0.923150355,1.143891001,0.807026504,0.419651214,0.562553758,3.406416268,0,0.317934384,1.197213553,0.265561966,0.790576581,0.857389448,Y,-,,hypothetical protein CMQ_5727,,no IPS match,,
RL4_JR_04261,7,20,29,0,0,2,0,0,0,0,0,0,0,2,0,0,0,0,160.4527157,1,0.735458594,0.448912559,1.638311468,0.101356737,0.223901505,19.22886501,0,-0.799666713,1.227508061,-0.651455366,0.514752581,0.665261188,90.69767823,0,-0.294234625,0.695722663,-0.42291942,0.672354053,0.774657157,132.0201123,1,0.107436216,0.563962198,0.190502512,0.848915375,0.90552762,63.37750412,0,-1.823940387,0.985815737,-1.850183881,0.064287051,0.136030595,N,-,,Membrane-anchored ubiquitin-fold 1,,G3DSA:3.10.20.90 (GENE3D); PF13881 (PFAM); PTHR13169 (PANTHER); PTHR13169:SF0 (PANTHER); IPR029071 (SUPERFAMILY),,
RL4_JR_04262,360,450,504,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.67349729,0,-3.087541262,1.199202393,-2.574662359,0.010033798,0.037966478,10.05142237,0,0.136145188,1.217464723,0.111826803,0.910960735,0.950652603,94.07077054,0,1.46758367,0.5332492,2.752153534,0.005920476,0.021545254,38.2232713,0,-1.221442025,1.024865644,-1.191806977,0.233336939,0.370580062,29.759099,0,-1.679310599,1.135177658,-1.479337254,0.139050201,0.244764132,N,-,,proteasome maturation factor ump1,C:nucleus; C:cytosol; C:proteasome complex; P:cellular response to DNA damage stimulus; P:proteasome assembly; P:ubiquitin-dependent protein catabolic process,PF05348 (PFAM); IPR008012 (PANTHER); PTHR12828:SF3 (PANTHER),,
RL4_JR_04263,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.287092185,0,0.704210671,1.255276737,0.561000336,0.574797308,0.750296858,0.727774709,0,3.92392692,1.456208784,2.694618357,0.007046929,0.026061023,1.89108449,0,1.269693221,1.215896525,1.044244469,0.296372298,0.437450524,2.181837649,0,0.847220002,1.225241702,0.691471732,0.489269139,0.629459979,1.866842055,0,1.185836133,1.211179118,0.979075775,0.327542541,0.463892604,N,-,,ABC transporter,F:nucleotide binding,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24220:SF70 (PANTHER); PTHR24220 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.152.1, the atp-binding cassette (abc) superfamily.
RL4_JR_04264,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_04265,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.31255703,0,0.384495096,0.895141392,0.429535601,0.667533492,0.815352332,4.459995419,0,1.308555684,1.287786903,1.016127499,0.309568676,0.471125265,11.49183841,0,-1.33343069,1.21485005,-1.097609281,0.272375138,0.411080188,22.88752489,0,-0.803065905,1.165289375,-0.689155777,0.490725243,0.630292158,11.23732398,0,-1.404024895,1.211031766,-1.159362566,0.246308429,0.376547311,N,-,,class 2 chitin synthase,P:chitin biosynthetic process; C:integral component of membrane; F:chitin synthase activity,IPR013616 (PFAM); IPR004834 (PFAM); IPR004835 (PANTHER); PTHR22914:SF15 (PANTHER); IPR004834 (PRODOM); IPR029044 (SUPERFAMILY),4.D.1.1.12, the putative vectorial glycosyl polymerization (vgp) family.
RL4_JR_04266,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1240.369692,0,-2.084153966,0.536924473,-3.881652019,0.000103749,0.000885342,335.4944613,0,-3.97366377,1.212465025,-3.277343007,0.00104789,0.015023052,917.4197092,0,-3.359519218,0.658860247,-5.098986067,3.41E-07,1.04E-05,1054.254924,0,-3.234447357,1.135682661,-2.848020375,0.004399211,0.025365609,857.2322334,0,-4.087460718,0.830661241,-4.920731238,8.62E-07,1.28E-05,N,-,,sulfite reductase beta subunit,"P:hydrogen sulfide biosynthetic process; F:FMN binding; P:cellular amino acid biosynthetic process; F:sulfite reductase (NADPH) activity; P:sulfate assimilation; C:sulfite reductase complex (NADPH); F:heme binding; P:fungal-type cell wall organization; F:NADP binding; P:sulfur amino acid biosynthetic process; C:cytosol; P:oxidation-reduction process; F:4 iron, 4 sulfur cluster binding",IPR006066 (PRINTS); IPR001094 (PRINTS); IPR006067 (PFAM); IPR008254 (PFAM); IPR002880 (PFAM); IPR005117 (G3DSA:3.90.480.GENE3D); IPR029061 (G3DSA:3.40.50.GENE3D); IPR005117 (PFAM); G3DSA:3.30.413.10 (GENE3D); IPR029039 (G3DSA:3.40.50.GENE3D); IPR009014 (G3DSA:3.40.50.GENE3D); IPR029061 (G3DSA:3.40.50.GENE3D); PTHR11493 (PANTHER); PTHR11493:SF47 (PANTHER); IPR008254 (PROSITE_PROFILES); SSF56014 (SUPERFAMILY); SSF56014 (SUPERFAMILY); IPR029039 (SUPERFAMILY); IPR005117 (SUPERFAMILY); IPR029061 (SUPERFAMILY); IPR005117 (SUPERFAMILY); IPR029061 (SUPERFAMILY); IPR009014 (SUPERFAMILY),,
RL4_JR_04267,6,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,205.3929854,0,-0.216935348,0.42670801,-0.508392961,0.611177788,0.776912733,43.87382789,0,-0.725320192,1.109360517,-0.653818286,0.513228884,0.663885337,148.9519178,0,-0.48165017,0.545095565,-0.88360684,0.376908485,0.520646951,196.906533,0,0.123923218,0.418526406,0.296094143,0.767158187,0.848626313,152.1717911,0,-0.294657302,0.504491143,-0.584068335,0.559174338,0.677797219,N,-,,duf1753 domain containing,C:membrane; C:Golgi apparatus,IPR013862 (PFAM); PTHR28077 (PANTHER),,
RL4_JR_04268,1498,2061,1139,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,132.613671,0,0.728288121,0.791695755,0.919909089,0.357620269,0.548808531,24.14030668,0,0.498715908,1.116482564,0.446684905,0.655102582,0.777823852,91.64953108,0,0.736356765,0.549226384,1.340716299,0.180012581,0.300634669,77.12191025,0,-0.749063919,0.744244911,-1.006475031,0.314187117,0.460434876,74.94820297,0,0.069071866,0.624082405,0.110677477,0.911872107,0.943364165,N,-,,ribose 5-phosphate isomerase a,"P:pentose-phosphate shunt, non-oxidative branch; F:identical protein binding; P:pyridoxine biosynthetic process; F:ribose-5-phosphate isomerase activity",IPR004788 (TIGRFAM); G3DSA:3.30.70.260 (GENE3D); IPR004788 (PFAM); G3DSA:3.40.50.1360 (GENE3D); PTHR11934:SF0 (PANTHER); IPR004788 (PANTHER); SSF75445 (SUPERFAMILY); SSF100950 (SUPERFAMILY),,
RL4_JR_04269,3,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,50.15300276,0,-1.793040424,1.032602184,-1.736429044,0.082488,0.19287392,13.48204021,0,-0.287481034,1.213667677,-0.236869647,0.812757918,0.886597225,35.10979627,0,-2.944833986,1.199046536,-2.455979729,0.014050108,0.042183658,56.5601026,0,-0.666985324,0.76906273,-0.867270378,0.385793883,0.531089472,54.0375545,0,-0.128942923,0.715100416,-0.180314429,0.856905729,0.904804516,N,-, Effector probability:0.76,ras rab-6b,,PR00449 (PRINTS); SM00175 (SMART); SM00174 (SMART); SM00173 (SMART); IPR005225 (TIGRFAM); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24073:SF352 (PANTHER); PTHR24073 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_04270,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.5910431,0,-2.064950236,1.210558199,-1.705783529,0.088048391,0.201486332,4.938190386,0,1.161485639,1.254196784,0.926079267,0.354404788,0.518468747,12.86983086,0,-1.496980564,1.206463242,-1.240800807,0.214679343,0.343351291,24.16369614,0,-0.968515684,1.157454021,-0.836763851,0.402725321,0.546372283,28.18427189,0,0.998434122,0.795388214,1.255279,0.209377496,0.332540729,N,-, Effector probability:0.767,GTP-binding ryh1,,IPR013684 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24073:SF464 (PANTHER); PTHR24073 (PANTHER); IPR027417 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_04271,25211,24030,27467,0,1,2,0,0,0,0,0,0,0,0,0,0,5,0,321.9338317,1,-1.867671718,0.594411175,-3.142053507,0.001677674,0.009010179,76.84675863,0,-2.798398583,1.197456872,-2.336951458,0.019441708,0.05622542,228.5113154,0,-3.036928971,0.865035004,-3.510758473,0.00044683,0.003121952,273.3185619,0,-2.174042425,0.573805651,-3.788813198,0.000151369,0.001521954,197.3895293,1,-5.538680432,1.210178591,-4.576746337,4.72E-06,5.42E-05,N,-,,p60 domain containing,,IPR011687 (PIRSF); IPR011687 (PFAM); IPR011687 (PANTHER),,
RL4_JR_04272,75,103,122,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,686.2547528,0,-3.866172115,0.623397711,-6.201774644,5.58E-10,1.65E-08,206.0797851,0,-4.221537614,1.223582259,-3.450146144,0.000560283,0.015023052,594.5522966,0,-2.894729225,0.575848853,-5.02689067,4.98E-07,1.45E-05,631.9808848,0,-4.298375108,0.741278943,-5.798593294,6.69E-09,1.90E-07,553.17354,0,-3.537672742,0.646748662,-5.469934376,4.50E-08,1.22E-06,N,-,,c6 zinc finger domain containing,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31845 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04273,8,11,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,383.9385338,0,-0.235034244,1.021675594,-0.23004782,0.818054611,0.907531826,104.7570167,0,-1.660550582,1.129577809,-1.470063035,0.141544683,0.263997656,198.5135703,0,-2.419075695,0.769800554,-3.14247071,0.001675285,0.008613805,248.9273592,0,-2.286414229,0.645305557,-3.543149759,0.000395378,0.003433279,216.7242383,0,-1.387855257,0.536271417,-2.587971713,0.009654291,0.030497299,N,-,,mitochondrial nadh dehydrogenase,F:oxidoreductase activity; F:calcium ion binding; C:integral component of membrane; P:oxidation-reduction process,IPR002048 (SMART); IPR023753 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR002048 (PFAM); PTHR22912 (PANTHER); PTHR22912:SF180 (PANTHER); IPR002048 (PROSITE_PROFILES); IPR023753 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR023753 (SUPERFAMILY),5.B.14.1.1, the flavin-based extracellular electron transfer (f-eet) family.
RL4_JR_04274,1234,1365,1805,0,0,1,0,0,0,3,0,0,1,4,0,0,2,0,269.9379808,1,-1.216537104,0.523258215,-2.324926907,0.020075869,0.065669182,63.55791579,0,-2.524504592,1.197243928,-2.108596696,0.034979408,0.089161816,224.1484423,1,-1.751787986,0.636037458,-2.754221413,0.005883195,0.021432698,229.6750119,1,-2.086626425,0.602785117,-3.461642243,0.00053689,0.004433943,208.4958624,1,-1.806802115,0.632780679,-2.855337046,0.004299118,0.01582857,N,-,,aminotransferase,F:transferase activity,IPR015421 (G3DSA:3.40.640.GENE3D); IPR004839 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); PTHR11751:SF294 (PANTHER); PTHR11751 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_04275,14,38,38,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,237.7794385,0,-0.879701225,0.427581762,-2.057387156,0.039649,0.112194429,47.46892145,0,-2.103379575,1.192106386,-1.764422706,0.077660838,0.16664893,122.979768,0,-4.753281382,1.186632823,-4.005688441,6.18E-05,0.000851754,194.8370459,0,-1.280643798,0.502016645,-2.550998677,0.010741473,0.051421947,159.2770654,0,-1.062379763,0.517910505,-2.051280584,0.04023963,0.094662234,N,-,,histone acetyltransferase esa1,"C:nucleus; F:histone acetyltransferase activity; P:regulation of transcription, DNA-templated; P:histone acetylation",IPR016181 (G3DSA:3.40.630.GENE3D); IPR002717 (PFAM); IPR025995 (PFAM); G3DSA:2.30.30.270 (GENE3D); PTHR10615 (PANTHER); IPR002717 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY); IPR016197 (SUPERFAMILY),,
RL4_JR_04276,3534,5159,7697,3,0,6,0,0,2,0,2,1,2,2,1,0,2,2,92.85862398,1,-3.631628171,1.149888181,-3.158244629,0.001587223,0.008615484,28.31187386,1,-1.357848375,1.195531515,-1.13576962,0.256052995,0.411457122,95.78549151,1,-2.182402403,1.032360448,-2.113992654,0.034515895,0.085541963,98.61853874,1,-2.701600935,1.018110246,-2.653544589,0.007965125,0.040465071,80.53893438,1,-2.434611989,0.984991537,-2.471708534,0.01344691,0.039798294,N,-,,RNA exonuclease 4,,IPR013520 (SMART); IPR013520 (PFAM); IPR012337 (G3DSA:3.30.420.GENE3D); PTHR12801 (PANTHER); IPR012337 (SUPERFAMILY),,
RL4_JR_04277,227,350,403,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.808500156,0,2.204574317,1.823312135,1.209104176,0.226622825,NA,0.254950202,0,5.437264047,1.859279086,2.924393702,0.003451279,0.016643092,0.664311491,0,2.7795083,1.363473196,2.038550012,0.041494959,0.098428997,0.766714677,0,2.356336781,1.481284615,1.590738713,0.111668391,0.212686692,0.655720799,0,2.695775613,1.330724782,2.025795003,0.042785796,0.099109171,N,-,,ribonuclease H2 subunit C,,IPR013924 (PFAM); PTHR21726:SF42 (PANTHER); PTHR21726 (PANTHER),,
RL4_JR_04278,2,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,54.08709187,0,-0.237612078,0.72660152,-0.327018416,0.743653956,0.865192381,11.16664886,0,-0.015571946,1.233461301,-0.012624592,0.9899273,0.994742791,28.92048405,0,-2.664978036,1.204827937,-2.211915871,0.026972478,0.070608817,45.39736248,0,-0.799206357,0.883294885,-0.904801297,0.365570665,0.51180904,43.14692805,0,-1.048692069,0.985064827,-1.064591934,0.287060631,0.421625026,N,-,,minichromosome maintenance 6,P:DNA replication initiation; P:double-strand break repair via break-induced replication; P:DNA strand elongation involved in DNA replication; C:DNA replication preinitiation complex; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; F:four-way junction helicase activity; C:MCM complex; C:MCM core complex; P:DNA unwinding involved in DNA replication; F:single-stranded DNA binding; C:nuclear pre-replicative complex; F:DNA replication origin binding; F:ATP binding; P:mitotic DNA replication; C:nuclear chromatin; F:RNA helicase activity; F:single-stranded RNA binding; C:cytosol; C:replication fork protection complex; F:single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity; F:3'-5' DNA/RNA helicase activity,IPR001208 (PRINTS); IPR008049 (PRINTS); IPR031327 (SMART); IPR033762 (PFAM); G3DSA:2.40.50.140 (GENE3D); IPR001208 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027925 (PFAM); PTHR11630 (PANTHER); PTHR11630 (PANTHER); PTHR11630 (PANTHER); IPR008049 (PTHR11630:PANTHER); PTHR11630 (PANTHER); IPR008049 (PTHR11630:PANTHER); IPR008049 (PTHR11630:PANTHER); IPR008049 (PTHR11630:PANTHER); PTHR11630 (PANTHER); IPR001208 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR012340 (SUPERFAMILY),,
RL4_JR_04279,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,254.0014578,0,-0.692671772,0.456699857,-1.516689266,0.129345156,0.266164997,88.78404326,0,0.360599848,0.780233828,0.462168948,0.643960169,0.768764399,190.4867788,0,-1.220475911,0.601008253,-2.030714062,0.042284009,0.099693999,214.928189,0,-1.236082786,0.512785349,-2.410526722,0.015929504,0.067995882,148.8224855,0,-2.320682374,0.761879992,-3.045994643,0.00231912,0.009615515,N,-,,hypothetical protein CMQ_1582,,no IPS match,,
RL4_JR_04280,531,306,388,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,382.7587352,0,1.02954834,0.346327068,2.972763132,0.002951321,0.014213033,77.48044632,0,-0.902071475,1.11144306,-0.811621852,0.417008649,0.580919562,208.8081934,0,0.042722454,0.462115681,0.092449695,0.926340757,0.956186157,360.7351856,0,1.156785686,0.412564432,2.803890973,0.005048998,0.028212528,183.8172369,0,0.01077717,0.478690866,0.02251384,0.982038072,0.98818679,N,-,,mitochondrial f1f0 ATP synthase subunit f,"C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:integral component of membrane; F:proton-transporting ATPase activity, rotational mechanism; P:ATP synthesis coupled proton transport; F:proton-transporting ATP synthase activity, rotational mechanism",IPR019727 (PFAM); PTHR28161 (PANTHER); PTHR28161:SF1 (PANTHER),,
RL4_JR_04281,433,199,260,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,147.258307,0,-0.119602456,0.563219256,-0.212355055,0.831830047,0.916417221,45.82751458,0,0.346040484,0.993607961,0.348266617,0.727639962,0.830159118,92.7083898,0,-2.116717781,1.041159236,-2.033039432,0.042048539,0.09936879,109.513587,1,-0.903811336,0.627234951,-1.44094543,0.1496001,0.265783649,107.8221545,0,-0.455098209,0.598395196,-0.760531187,0.446937135,0.57934176,N,-, Effector probability:0.613,NADH-ubiquinone oxidoreductase,"F:oxidoreductase activity, acting on NAD(P)H; P:electron transport chain",G3DSA:3.30.160.190 (GENE3D); IPR006885 (PFAM); IPR006885 (PANTHER),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_04282,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,230.9571232,0,-1.642408799,0.56820047,-2.890544599,0.00384575,0.017507603,55.00792996,0,-2.316075397,1.201192843,-1.928146184,0.053836946,0.125071739,143.4822725,0,-4.97575173,1.204481096,-4.131033477,3.61E-05,0.000551454,197.6681905,0,-1.76150807,0.619136097,-2.845106398,0.004439659,0.025540652,180.190863,0,-1.487407135,0.614773649,-2.419438662,0.015544482,0.044712466,N,-, Effector probability:0.674,CTLH domain-containing,,IPR006594 (SMART); IPR006595 (SMART); IPR013144 (SMART); IPR006594 (PFAM); IPR024964 (PFAM); PTHR12864 (PANTHER); IPR006595 (PROSITE_PROFILES); IPR006594 (PROSITE_PROFILES),,
RL4_JR_04283,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.5890522,0,-1.756263335,1.212219408,-1.448799882,0.147393477,0.293277069,13.3893509,0,2.376600204,1.14462494,2.07631349,0.037864966,0.094986169,44.99826991,0,1.641497303,0.761750185,2.1549024,0.031169473,0.079107481,11.99752351,0,-1.611730907,1.208219355,-1.333972098,0.182213001,0.308461233,10.23083868,0,-1.268555804,1.210191804,-1.048227066,0.294534003,0.429396225,N,-,,uridine kinase,F:ATP binding; P:pyrimidine nucleobase metabolic process; C:cell division site; F:uridine kinase activity; C:cytosol; P:CTP salvage; P:phosphorylation; C:mitotic spindle pole body; P:UMP salvage,IPR000764 (PRINTS); IPR029057 (G3DSA:3.40.50.GENE3D); IPR029057 (PFAM); IPR006083 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10285 (PANTHER); PTHR10285:SF70 (PANTHER); PTHR10285 (PANTHER); PTHR10285:SF70 (PANTHER); IPR029057 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_04284,1,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,62.07933962,0,-0.490440156,0.662428615,-0.740366803,0.459077456,0.647278584,13.72707294,0,-0.313439562,1.204272422,-0.260272971,0.79465322,0.875623764,35.60663048,0,-2.965125043,1.187373777,-2.497212841,0.01251738,0.038483436,53.11007956,0,-1.080017811,0.848303868,-1.273149695,0.202964928,0.334693793,50.19220987,0,-0.833843002,0.838987571,-0.993868122,0.320287076,0.455720439,N,-,,DUF1237 domain containing,"C:nucleus; P:DNA replication; C:endoplasmic reticulum; F:hydrolase activity, acting on glycosyl bonds",IPR008313 (SMART); IPR012341 (G3DSA:1.50.10.GENE3D); IPR008313 (PFAM); IPR008313 (PIRSF); PTHR31047:SF0 (PANTHER); PTHR31047 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_04285,2,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.004517727,0,-0.10371167,1.22654736,-0.084555781,0.932614554,0.966946573,1.275175915,0,3.114851029,1.372192912,2.269980411,0.023208772,0.064751705,3.309124371,0,0.462709211,1.212824627,0.3815137,0.702822108,0.798241596,3.817754546,0,0.040260602,1.215269557,0.033128948,0.973571758,0.984893994,10.98087636,0,2.045614675,0.990282061,2.065688913,0.038857863,0.091945749,N,-,,dna polymerase subunit cdc27,P:DNA metabolic process; C:intracellular part; P:cellular macromolecule biosynthetic process,IPR019038 (PFAM); PTHR17598 (PANTHER),,
RL4_JR_04286,779,809,755,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,4.294103427,1,-0.20455575,1.230135129,-0.166287219,0.867930923,0.93607543,1.362597049,0,3.019126817,1.363106805,2.214886468,0.026767858,0.072290358,3.545624093,0,0.362937345,1.215282846,0.298644341,0.765211429,0.842180032,4.091222742,0,-0.059709617,1.218008899,-0.049022316,0.960901512,0.977998372,7.364311542,0,1.206192673,1.14359917,1.054733778,0.291547099,0.426269224,N,-,,DNA repair rad18,,IPR001841 (SMART); IPR003034 (SMART); IPR006642 (SMART); IPR004580 (TIGRFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PF13923 (PFAM); PTHR14134:SF2 (PANTHER); PTHR14134 (PANTHER); IPR003034 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),1.F.1.2.1, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_04287,204,242,222,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,53.99287329,1,1.733678667,0.73712302,2.351952958,0.018675137,0.062032477,4.995824048,0,1.144697915,1.269122157,0.901960389,0.36707791,0.531706154,35.19657274,0,0.324076332,1.055524119,0.307028827,0.75882143,0.838130936,19.0801176,0,-0.995500119,1.172702756,-0.848893817,0.39594038,0.540136937,16.84025312,0,-0.684778091,1.163060438,-0.588772577,0.556013844,0.675340712,N,-,,snf7 family,F:binding; C:intracellular,IPR005024 (PFAM); PTHR22761:SF18 (PANTHER); PTHR22761 (PANTHER),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_04288,202,202,326,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,53.67501606,0,-2.796260661,1.170327781,-2.389297003,0.01688065,0.057332365,350.7839914,0,4.379772285,2.015554885,2.17298587,0.029781381,0.078604208,60.92850382,0,-0.79168023,0.889247303,-0.890281283,0.373314869,0.517306287,67.83022576,0,-0.618121214,0.739673658,-0.835667469,0.403342001,0.546826681,40.47754628,0,-3.252854721,1.20926309,-2.689947909,0.007146317,0.02402273,N,-,,C2H2 type zinc finger domain,,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR14596 (PANTHER); PTHR14596:SF30 (PANTHER); IPR007087 (PROSITE_PROFILES),,
RL4_JR_04289,535,452,424,0,0,56,0,0,0,0,1,2,1,0,1,0,4,0,22.67108787,1,3.042069996,0.742848512,4.095141804,4.22E-05,0.00040351,1.156960436,0,3.255258015,1.433605944,2.270678374,0.023166455,0.064682932,2.978506374,1,0.614416439,1.239580711,0.495664731,0.620130975,0.733778166,11.45737548,1,1.900421203,1.060259315,1.792411701,0.073067042,0.155726644,2.915579977,1,0.542163352,1.231034972,0.440412632,0.659638278,0.757330483,N,-,,C2H2 finger domain-containing,P:cellular nitrogen compound metabolic process,IPR015880 (SMART),,
RL4_JR_04290,360,498,540,0,0,3,1,0,0,0,0,0,0,0,0,0,2,0,8.50649376,1,-1.190759884,1.218618735,-0.977138993,0.328500346,0.51776262,2.698678422,1,2.033252675,1.298507528,1.565838188,0.117386504,0.229468171,7.020540142,0,-0.622558386,1.211893226,-0.513707291,0.607456654,0.724027685,8.100898835,0,-1.045218488,1.212190236,-0.862256151,0.388546576,0.533384617,6.93352048,1,-0.707259096,1.217220762,-0.581044226,0.561210647,0.679370851,N,-,,short chain dehydrogenase,,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24322:SF220 (PANTHER); PTHR24322:SF220 (PANTHER); PTHR24322:SF220 (PANTHER); IPR002347 (PANTHER); IPR002347 (PANTHER); IPR002347 (PANTHER); PTHR24322:SF220 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04291,5626,3350,3410,0,0,1,0,0,0,0,0,1,0,6,0,2,5,1,0.963588454,1,1.951151141,1.58169725,1.233580662,0.217359203,NA,0.312597823,0,5.143348737,1.742557881,2.951608548,0.003161234,0.016031068,0.802389248,1,2.506970273,1.292867354,1.939077713,0.052491876,0.117520511,0.925011969,1,2.085454487,1.363232077,1.529786837,0.126069501,0.233008674,0.782490312,1,2.439433862,1.256681607,1.941170976,0.052237542,0.11573742,N,-,,lipase esterase,P:metabolic process; C:membrane; C:integral component of membrane; F:triglyceride lipase activity; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR013094 (PFAM); PTHR23024 (PANTHER); IPR029058 (SUPERFAMILY),8.A.117.1.3, the neuroligin (nlg) family.
RL4_JR_04292,683,617,378,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.486232442,0,0.583486666,1.255966927,0.464571681,0.642238216,0.796362353,0.792238209,0,3.801434441,1.44816473,2.625001398,0.008664861,0.030230354,2.059168897,0,1.146530622,1.221491305,0.938631833,0.347919803,0.491535039,10.39883294,0,2.444069389,1.030916795,2.370772695,0.017750944,0.072500326,2.035556723,0,1.060743612,1.219543935,0.869787124,0.384416749,0.520419787,N,-,,ser thr phosphatase,,IPR029052 (G3DSA:3.60.21.GENE3D); IPR004843 (PFAM); PTHR37844 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_04293,3634,2336,3112,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,7.584679738,1,-1.025207738,1.196580373,-0.856781343,0.391565739,0.58409093,2.429216262,0,2.185092076,1.298584515,1.682672211,0.092438564,0.190640413,6.282701604,0,-0.462224709,1.199629469,-0.385306231,0.700010546,0.795923941,7.246666568,1,-0.884316035,1.197559362,-0.7384319,0.460252036,0.602385194,6.170187615,0,-0.539075331,1.19525057,-0.451014494,0.651979103,0.752015259,N,-,,mitochondrial 2-oxoglutarate malate carrier,P:transmembrane transport; C:integral component of membrane,IPR002067 (PRINTS); IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); PTHR24089 (PANTHER); PTHR24089:SF284 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.2.10, the mitochondrial carrier (mc) family.
RL4_JR_04294,517,337,296,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,96.42339743,0,-0.611360293,0.648261893,-0.943076092,0.345641984,0.535334072,20.44699802,0,-0.888264241,1.232265315,-0.720838468,0.471008905,0.629213691,60.49759756,0,-2.567678615,1.210220473,-2.121661855,0.033866144,0.08444681,70.02984412,1,-2.998911925,1.166209076,-2.571504533,0.010125769,0.049036674,88.29784603,0,-0.594449439,0.712187647,-0.834680919,0.403897388,0.540890728,N,-,,PAB-dependent poly(A)-specific ribonuclease subunit PAN2,"F:nucleic acid binding; F:poly(A)-specific ribonuclease activity; P:RNA phosphodiester bond hydrolysis, exonucleolytic; C:PAN complex; P:mRNA processing; P:nuclear-transcribed mRNA poly(A) tail shortening",IPR013520 (SMART); IPR028881 (PFAM); IPR013520 (PFAM); IPR012337 (G3DSA:3.30.420.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR15728 (PANTHER); PTHR15728:SF0 (PANTHER); IPR028889 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR012337 (SUPERFAMILY); SSF54001 (SUPERFAMILY),,
RL4_JR_04295,61,46,24,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,18.68901389,0,2.281314194,1.106717654,2.061333517,0.039271233,0.111318526,0.870070804,1,3.666485185,1.562789771,2.346115424,0.018970232,0.05515359,2.225032895,0,1.035380258,1.298519165,0.797354622,0.425245105,0.566173257,2.564518449,0,0.614285985,1.32668331,0.463023828,0.643347287,0.755584188,2.160439679,0,0.974680409,1.284096902,0.759039609,0.447828863,0.580090683,N,-,,dna rna helicase,F:ATP binding; C:membrane; C:integral component of membrane; P:TOR signaling; F:helicase activity; C:TORC1 complex,IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000330 (PFAM); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_04296,7955,4519,5899,35,41,28,1,0,14,6,2,15,1,25,2,0,25,4,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_04297,222,195,386,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,90.53500524,0,1.989587464,0.55184417,3.605342904,0.000311741,0.002238718,6.602571515,0,0.742535237,1.283688261,0.578438909,0.562967831,0.705854129,39.11655624,0,-0.051769735,1.061324894,-0.048778404,0.961095893,0.977117375,35.61895492,0,0.354008817,0.815820444,0.433929817,0.664339406,0.77111504,23.95789863,0,-1.026697455,1.149687456,-0.893023099,0.371844803,0.508156111,N,-,,TORC1 subunit TCO89,F:ATP binding; P:mycelium development; P:TOR signaling; C:cellular_component; C:TORC1 complex; F:molecular_function,PTHR22794 (PANTHER); PTHR22794:SF1 (PANTHER),,
RL4_JR_04298,1261,578,723,8,5,0,0,0,0,0,0,1,0,0,0,0,0,0,71.86765733,1,-1.103052017,0.771539964,-1.429675803,0.152810088,0.300899034,16.81089553,0,-0.605811056,1.223230295,-0.495255112,0.620420053,0.750106518,56.51391601,1,-1.438551191,1.049206273,-1.371085198,0.170348399,0.288444086,62.22558783,0,-1.388482991,0.883260851,-1.571996528,0.115951356,0.218645196,42.85240394,0,-3.335111831,1.206259566,-2.764837623,0.005695114,0.019933152,N,-,,Splicing factor spf30,C:nucleus,IPR002999 (SMART); G3DSA:2.30.30.140 (GENE3D); SSF63748 (SUPERFAMILY),,
RL4_JR_04299,803,634,636,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,42.68172629,1,-1.309968193,1.151078176,-1.138035817,0.255105527,0.433271922,9.6157141,0,0.200054658,1.3268458,0.15077461,0.880153516,0.931615043,25.37942899,0,-2.476645576,1.281987518,-1.931879634,0.053374364,0.11899627,29.30736339,0,-2.900409185,1.294852355,-2.239953593,0.025093936,0.08557795,25.49217813,0,-2.585756408,1.308801811,-1.975666893,0.048192517,0.108892933,N,-,,ATP-binding,F:ATP binding; F:hydrolase activity,IPR033756 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23264:SF36 (PANTHER); IPR019591 (PANTHER); IPR019591 (HAMAP); IPR027417 (SUPERFAMILY),3.A.1.132.3, the atp-binding cassette (abc) superfamily.
RL4_JR_04300,4,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,126.5871732,0,-3.180466067,1.066598184,-2.981878382,0.002864858,0.013870332,35.54288769,0,-1.685996182,1.220016427,-1.381945476,0.166988443,0.300543567,103.9786651,0,-3.386967463,1.217984845,-2.780796064,0.005422579,0.020101864,115.2566815,0,-3.064739458,1.060445894,-2.890047926,0.003851831,0.022806894,99.99712625,0,-2.791484718,1.030068225,-2.709999834,0.006728324,0.022868171,N,-,,transcription factor aatf che-1,C:nucleus,IPR012617 (PFAM); IPR025160 (PFAM); PTHR15565:SF0 (PANTHER); PTHR15565 (PANTHER),,
RL4_JR_04301,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.50237445,0,1.042579112,1.140942569,0.913787548,0.360828491,0.552283723,10.49568611,0,4.22161662,1.133519339,3.724344593,0.000195823,0.008434568,2.894369569,0,0.655648852,1.205404627,0.543924286,0.586493576,0.7068644,52.94551081,0,3.776999169,0.568240877,6.646827639,2.99E-11,1.21E-09,22.15293183,0,3.502135121,0.680251733,5.148292829,2.63E-07,4.82E-06,Y,-,,alkaline phosphatase,F:phosphatase activity; P:dephosphorylation,IPR001952 (PRINTS); IPR001952 (SMART); IPR017849 (G3DSA:3.40.720.GENE3D); IPR001952 (PFAM); PTHR11596:SF5 (PANTHER); PTHR11596 (PANTHER); PTHR11596:SF5 (PANTHER); PTHR11596 (PANTHER); IPR017850 (SUPERFAMILY),,
RL4_JR_04302,1021,942,1169,0,1,0,0,0,0,0,0,0,0,0,7,0,2,0,1383.719954,1,0.380734615,0.293760033,1.29607357,0.19495014,0.356749372,346.1461572,0,-0.261406483,0.601078937,-0.434895431,0.663638331,0.784736821,712.7258062,0,-1.215659797,0.422118466,-2.879901957,0.003977989,0.016348297,899.3951727,1,-0.929648451,0.431110777,-2.156402717,0.031052233,0.094217518,575.3933643,1,-2.208885647,0.563072806,-3.92291303,8.75E-05,0.000619862,Y,-,,er hsp70 chaperone,,IPR013126 (PRINTS); IPR029048 (G3DSA:1.20.1270.GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR029047 (G3DSA:2.60.34.GENE3D); G3DSA:3.90.640.10 (GENE3D); IPR013126 (PFAM); G3DSA:3.30.30.30 (GENE3D); G3DSA:3.30.420.40 (GENE3D); PTHR19375 (PANTHER); IPR029048 (SUPERFAMILY); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY); IPR029047 (SUPERFAMILY),1.A.33.1.6, the cation channel-forming heat shock protein-70 (hsp70) family.
RL4_JR_04303,327,381,519,3,5,10,0,0,2,2,0,1,4,42,2,0,10,25,46.0427472,1,2.900119084,0.533414791,5.436892891,5.42E-08,1.14E-06,47.14496843,1,3.806775942,0.989070058,3.848843578,0.000118677,0.005666255,6.514177099,1,-0.514450201,1.200886473,-0.428392036,0.668365722,0.771887594,43.61738551,1,2.905429906,0.544693811,5.334060806,9.60E-08,2.17E-06,6.39250929,1,-0.590213138,1.195690722,-0.493616892,0.621576769,0.727524619,N,-,,chalcone and stilbene synthase,"F:transferase activity, transferring acyl groups other than amino-acyl groups; P:biosynthetic process",IPR016039 (G3DSA:3.40.47.GENE3D); IPR001099 (PFAM); IPR012328 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); PTHR11877 (PANTHER); PTHR11877:SF10 (PANTHER); IPR016039 (SUPERFAMILY); IPR016039 (SUPERFAMILY),,
RL4_JR_04304,21,9,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,199.5752182,0,-5.743121884,1.231923208,-4.661915488,3.13E-06,4.16E-05,64.63529562,0,-2.54872364,1.229421114,-2.073108726,0.038162162,0.09547143,172.67107,0,-4.225750244,1.221670367,-3.458993816,0.000542197,0.003590063,191.5817004,0,-5.608993659,1.225427192,-4.577174143,4.71E-06,7.26E-05,173.9736214,0,-3.08044333,0.900430538,-3.421078252,0.000623734,0.003263724,N,-,,major facilitator superfamily transporter,C:integral component of plasma membrane; F:substrate-specific transmembrane transporter activity; P:transmembrane transport; P:glycerophosphodiester transport; F:glycerophosphodiester transmembrane transporter activity,IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR24064 (PANTHER); PTHR24064:SF200 (PANTHER); PTHR24064 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.9.7, the major facilitator superfamily (mfs).
RL4_JR_04305,197,134,106,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.979331464,0,-0.905650071,1.221050592,-0.741697418,0.458270684,0.646588074,69.15980224,0,4.552115276,0.863661952,5.270714157,1.36E-07,1.60E-05,78.70248065,0,3.527398466,1.120153472,3.149031409,0.001638126,0.008470065,6.672813756,0,-0.765697556,1.218400776,-0.628444738,0.529712638,0.663077172,9.583902103,0,0.497299817,1.152205385,0.431606919,0.666027129,0.762497137,N,-,,Cytochrome P450,"F:iron ion binding; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; F:metal ion binding; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24279:SF69 (PANTHER); PTHR24279 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_04306,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,113.2539784,0,-0.530433205,0.763036215,-0.695161245,0.486954257,0.674575111,24.19531839,0,-1.131133671,1.232940842,-0.917427368,0.358918737,0.522880751,83.29359451,0,-1.377959868,0.888277709,-1.551271471,0.120836641,0.222984803,183.2694884,0,0.677419428,0.477199294,1.419573407,0.155731912,0.273557531,103.0868546,0,-0.115921806,0.59589152,-0.194535082,0.845756929,0.896860011,N,-,,"Fructose-1,6-bisphosphatase",,IPR028343 (PRINTS); IPR033391 (PFAM); G3DSA:3.40.190.80 (GENE3D); IPR000146 (PIRSF); G3DSA:3.30.540.10 (GENE3D); IPR028343 (PIRSF); IPR000146 (PANTHER); SSF56655 (SUPERFAMILY),,
RL4_JR_04307,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,118.7479301,0,-0.152130675,0.876310057,-0.173603708,0.862176918,0.932101682,22.22676201,0,-1.008709957,1.232221277,-0.818611053,0.413008359,0.576934945,84.21697079,0,-1.236940874,0.882841871,-1.401089951,0.161187176,0.276650008,148.7916561,0,0.161114379,0.534567099,0.301392247,0.763115406,0.84522926,60.38885168,0,-2.806497294,1.148934719,-2.442695175,0.014578045,0.042556915,N,-,,peroxisomal biogenesis factor 11,P:peroxisome fission; C:integral component of peroxisomal membrane; P:fatty acid oxidation; P:regulation of peroxisome size; C:mitochondrion; C:endoplasmic reticulum; C:peroxisomal importomer complex,IPR008733 (PFAM); PTHR12652 (PANTHER); PTHR12652:SF10 (PANTHER),1.A.101.1.1, the peroxisomal pore-forming pex11 (pex11) family.
RL4_JR_04308,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,355.7163025,0,-2.589906887,0.586510979,-4.415785858,1.01E-05,0.000116959,152.599451,0,-0.616675477,0.787943444,-0.782639264,0.433838978,0.59520714,295.3204492,0,-3.029737366,0.763679261,-3.967290353,7.27E-05,0.000938722,347.0962468,0,-2.572651361,0.578919409,-4.443885145,8.83E-06,0.000127973,303.683013,0,-2.030375857,0.546711303,-3.713798939,0.000204171,0.001267463,N,-,,nucleoporin nup189,P:transport; C:nuclear pore,IPR007230 (G3DSA:3.30.1610.GENE3D); IPR021967 (PFAM); IPR025574 (PFAM); IPR007230 (PFAM); PTHR23198 (PANTHER); PTHR23198 (PANTHER); PTHR23198:SF6 (PANTHER); PTHR23198:SF6 (PANTHER); IPR007230 (PROSITE_PROFILES); IPR007230 (SUPERFAMILY),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_04309,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,133.3040612,0,0.454032449,0.576698344,0.78729626,0.431108459,0.622254566,20.55635003,0,-0.895974541,1.221601534,-0.733442547,0.463288557,0.622102252,73.87793897,0,-1.138631557,0.869984839,-1.308794712,0.190603899,0.313666104,97.12158412,0,-0.89594382,0.694679769,-1.289722055,0.197147179,0.327178362,74.47176076,0,-0.988041173,0.761653573,-1.297231719,0.19455147,0.315510768,N,-,,enth domain-containing,"F:phosphatidylinositol-4,5-bisphosphate binding; P:actin filament organization; P:endocytosis; C:actin cortical patch",IPR013809 (SMART); IPR003903 (SMART); IPR013809 (PFAM); IPR008942 (G3DSA:1.25.40.GENE3D); PTHR12276:SF60 (PANTHER); PTHR12276:SF60 (PANTHER); PTHR12276 (PANTHER); PTHR12276 (PANTHER); IPR003903 (PROSITE_PROFILES); IPR013809 (PROSITE_PROFILES); IPR003903 (PROSITE_PROFILES); IPR008942 (SUPERFAMILY),,
RL4_JR_04310,13,8,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,108.2982371,0,-0.692175549,0.597151494,-1.159128893,0.24640365,0.42248024,22.23051757,0,-1.008929156,1.216421816,-0.82942376,0.406864661,0.570794747,63.86964775,0,-2.691459264,1.199406639,-2.243992301,0.024832897,0.06617748,74.18389893,0,-2.354971408,1.029734105,-2.28697039,0.022197551,0.080442001,75.2177932,0,-1.112579294,0.757627445,-1.468504476,0.141967241,0.248559281,N,-,,histone acetyltransferase,"C:nucleus; F:transferase activity, transferring acyl groups other than amino-acyl groups; P:cellular macromolecule metabolic process; F:metal ion binding; P:negative regulation of chromatin organization; P:regulation of transcription, DNA-templated; P:chromatin organization; P:primary metabolic process; C:chromosomal part; P:regulation of gene expression, epigenetic",G3DSA:3.30.60.60 (GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); IPR016181 (G3DSA:3.40.630.GENE3D); IPR002717 (PFAM); PTHR10615:SF102 (PANTHER); PTHR10615 (PANTHER); PTHR10615:SF102 (PANTHER); PTHR10615:SF102 (PANTHER); PTHR10615 (PANTHER); IPR002717 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY); IPR016181 (SUPERFAMILY),,
RL4_JR_04311,511,917,813,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,72.45453193,0,-1.230892286,0.75154499,-1.637815835,0.101460117,0.223947954,36.95333535,0,0.923743169,0.981806585,0.940860636,0.346776282,0.509591976,73.28147643,0,-0.558468274,0.743840504,-0.750790352,0.452778837,0.592315925,101.1210998,1,-0.468688241,0.614089957,-0.763224078,0.445329772,0.587410622,73.00313488,0,-0.515045097,0.679221438,-0.758287457,0.448278915,0.580263872,N,-, Effector probability:0.79,small secreted,C:integral component of membrane,IPR017384 (PFAM); PTHR17098:SF2 (PANTHER); IPR017384 (PANTHER),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_04312,64,42,47,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.76827901,0,-2.789917486,1.243204767,-2.244133518,0.024823812,0.078341454,8.15629881,0,0.437529007,1.271998569,0.343969732,0.730869049,0.831981493,21.31979061,0,-2.225213498,1.232770254,-1.805051259,0.071066661,0.148744858,24.60374247,0,-2.648058053,1.23697419,-2.140754491,0.032293842,0.096169161,21.2195973,0,-2.321114071,1.248734253,-1.858773447,0.063059258,0.133964537,N,-,,Cytoplasmic tRNA 2-thiolation 1,P:regulation of cell shape; F:ATP binding; F:nucleotidyltransferase activity; P:regulation of translational fidelity; F:tRNA binding; P:tRNA wobble position uridine thiolation; P:protein urmylation; C:cytosolic tRNA wobble base thiouridylase complex; F:hydrolase activity,IPR014729 (G3DSA:3.40.50.GENE3D); IPR032442 (PFAM); IPR011063 (PFAM); PTHR11807:SF12 (PANTHER); PTHR11807:SF12 (PANTHER); PTHR11807 (PANTHER); PTHR11807 (PANTHER); IPR000541 (HAMAP); SSF52402 (SUPERFAMILY),,
RL4_JR_04313,248,289,456,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1478.668635,0,-0.169024656,0.534440373,-0.316264759,0.751801557,0.870450909,396.7173956,0,-1.041638821,0.594595387,-1.751844775,0.079800503,0.169907591,722.6863807,0,-3.165349761,0.5440663,-5.817948585,5.96E-09,2.66E-07,1096.709512,0,-1.063608618,0.608715674,-1.747299542,0.080585393,0.167178202,968.8620093,0,-0.977298888,0.735145891,-1.329394479,0.183717858,0.302314857,N,-,,60S ribosomal l8,,IPR001921 (PRINTS); IPR018492 (PRINTS); IPR004038 (PFAM); IPR029064 (G3DSA:3.30.1330.GENE3D); PTHR23105 (PANTHER); PTHR23105:SF47 (PANTHER); IPR029064 (SUPERFAMILY),,
RL4_JR_04314,2,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37.1295178,0,0.734097596,0.703696604,1.043201845,0.296854819,0.482610924,5.733305556,0,0.946152139,1.24344363,0.760912771,0.44670917,0.607822317,14.89769889,0,-1.707998327,1.200261325,-1.423022046,0.154729764,0.26850945,17.1888591,0,-2.13054506,1.199454975,-1.776260972,0.075689913,0.159924951,14.69726146,0,-1.791198345,1.205043952,-1.486417439,0.13716874,0.242463948,N,-, Effector probability:0.731,carbonic anhydrase,C:mitochondrial intermembrane space; F:zinc ion binding; P:cellular response to carbon dioxide; P:metabolic process; P:cellular response to oxidative stress; F:carbonate dehydratase activity; P:carbon utilization,IPR001765 (SMART); IPR001765 (PFAM); IPR001765 (G3DSA:3.40.1050.GENE3D); IPR001765 (PANTHER); PTHR11002:SF13 (PANTHER); IPR001765 (SUPERFAMILY),2.A.53.3.8, the sulfate permease (sulp) family.
RL4_JR_04315,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.465758172,0,0.104512025,1.214943686,0.086022115,0.931448837,0.966629651,1.111708434,0,3.312801506,1.391069662,2.381477792,0.01724333,0.051259028,2.874118531,0,0.665982126,1.208724556,0.550979231,0.581647912,0.703116832,3.314908559,0,0.243939862,1.210679675,0.201490012,0.840315438,0.900266335,2.823137352,0,0.588778756,1.200218092,0.490559807,0.62373782,0.729086288,N,-,,---NA---,,no IPS match,,
RL4_JR_04316,648,441,930,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,162.7351396,0,2.549954008,0.375459623,6.791553206,1.11E-11,4.62E-10,16.30683014,0,1.589155396,1.128807118,1.407818369,0.15918486,0.289380235,32.24995731,1,-0.151469255,1.032781363,-0.146661491,0.883399215,0.927271504,36.70102683,0,0.318177516,0.748414287,0.425135546,0.670737867,0.775962169,17.58464158,0,-2.050064737,1.189934107,-1.722838873,0.084917667,0.168917756,N,-,,family decarboxylase,,IPR016040 (G3DSA:3.40.50.GENE3D); IPR023401 (G3DSA:3.30.1780.GENE3D); IPR003462 (PFAM); PTHR13812:SF19 (PANTHER); PTHR13812 (PANTHER); PTHR13812:SF19 (PANTHER); PTHR13812 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04317,1916,2067,2382,0,0,16,0,0,0,0,0,0,3,2,1,0,5,0,29.40444833,1,-1.833095619,1.157355849,-1.583865171,0.113224405,0.242365523,8.170764334,0,0.435011534,1.238732439,0.351174734,0.725457264,0.82832244,27.71483317,0,-1.256386749,1.203487759,-1.043954738,0.296506331,0.43747132,24.47482768,1,-2.640485714,1.204778731,-2.191676899,0.028402845,0.08952213,20.95989991,1,-2.303368717,1.211494756,-1.901261814,0.057267728,0.124078014,N,-,,f-box domain containing,P:biological_process; C:cellular_component; F:molecular_function; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR029058 (SUPERFAMILY); IPR017986 (SUPERFAMILY),,
RL4_JR_04318,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.661342322,0,1.165420902,1.334041631,0.873601599,0.382335255,NA,0.535048449,0,4.367928053,1.559394818,2.801040508,0.005093812,0.02088223,1.378803582,0,1.725988363,1.242492789,1.389133505,0.164792157,0.281487138,1.589986712,0,1.304080579,1.267033589,1.029239154,0.303367308,0.448932182,1.34909233,0,1.654030823,1.221459256,1.354143263,0.175690676,0.292291741,N,-,,cytochrome P450 3A12,F:oxidoreductase activity; F:binding,IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24279:SF66 (PANTHER); PTHR24279 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_04319,511,557,892,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,386.9679237,0,4.179049393,2.298482871,1.818177306,0.069037037,0.169181181,34.65820146,0,2.928663955,0.881212044,3.323449757,0.000889114,0.015023052,65.81104425,0,1.524096319,0.630370327,2.417779288,0.015615545,0.045938887,378.5322763,0,4.304782023,0.368338133,11.68703871,1.48E-31,2.68E-29,260.3832194,1,4.046018127,0.488057911,8.290036977,1.13E-16,1.85E-14,N,-,,3-ketoacyl- thiolase,C:mitochondrial intermembrane space; P:fatty acid beta-oxidation; F:acetyl-CoA C-acyltransferase activity; F:mRNA binding; C:peroxisomal matrix,IPR016039 (G3DSA:3.40.47.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR020616 (PFAM); IPR020617 (PFAM); IPR002155 (PIRSF); IPR002155 (TIGRFAM); PTHR18919 (PANTHER); PTHR18919:SF96 (PANTHER); IPR016039 (SUPERFAMILY); IPR016039 (SUPERFAMILY),,
RL4_JR_04320,36,47,38,0,0,13,0,0,0,0,0,0,0,0,0,0,0,0,67.47390184,1,-2.286226735,1.032868104,-2.213474041,0.026864981,0.083256711,18.9956699,0,-0.782128727,1.207236766,-0.647866888,0.517071048,0.667320305,49.48454615,0,-3.439958446,1.199427965,-2.8679992,0.004130766,0.0167079,57.09896755,0,-3.862609258,1.200681341,-3.21701448,0.001295321,0.009223517,52.87995221,0,-2.600059113,1.138382687,-2.283993899,0.022371889,0.059750826,N,-,,30S ribosomal,F:structural constituent of ribosome; F:mRNA binding; P:ribosomal small subunit assembly; C:mitochondrial small ribosomal subunit; F:rRNA binding; P:translation,IPR023798 (PFAM); IPR023798 (G3DSA:1.10.455.GENE3D); IPR000235 (PANTHER); PTHR11205:SF19 (PANTHER); IPR000235 (PANTHER); PTHR11205:SF19 (PANTHER); IPR023798 (SUPERFAMILY),,
RL4_JR_04321,4,2,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1.386133026,1,1.426707835,1.428333291,0.998861991,0.317861551,NA,0.437951046,0,4.656589051,1.609045121,2.89400775,0.003803588,0.017620098,1.142541421,0,1.996684075,1.262801842,1.581153913,0.11384285,0.213355241,9.34176524,0,3.281167307,1.062496993,3.088166205,0.002013958,0.013284251,1.131737866,0,1.908136978,1.252768896,1.523135659,0.127724769,0.229180092,N,-,,hypothetical protein F503_00107,C:integral component of membrane,PTHR42030:SF1 (PANTHER); PTHR42030 (PANTHER); SSF54768 (SUPERFAMILY),,
RL4_JR_04322,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,110.7987403,0,1.331080561,1.067920336,1.246423086,0.21260911,0.380365158,39.25245447,0,2.145285863,0.907183634,2.364775754,0.018040991,0.053079354,107.5882307,0,1.495418389,0.541777431,2.760207982,0.005776457,0.0211504,205.2098911,0,2.513162652,0.633545901,3.966820162,7.28E-05,0.00081761,58.87911121,0,0.821832884,0.613823857,1.338874133,0.180611652,0.298367266,N,-,,2-nitropropane dioxygenase family,F:dioxygenase activity; F:nitronate monooxygenase activity; P:oxidation-reduction process,IPR013785 (G3DSA:3.20.20.GENE3D); IPR004136 (PFAM); PTHR32332 (PANTHER); PTHR32332:SF22 (PANTHER); SSF51412 (SUPERFAMILY),,
RL4_JR_04323,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,150.3291766,0,0.259770747,0.50203763,0.517432821,0.604854053,0.772207834,24.68069268,0,-1.159774479,1.217012794,-0.95296819,0.340606188,0.503742817,87.75551229,0,-1.396702154,0.866280869,-1.612297125,0.106897299,0.203732728,138.9564963,0,-0.446533516,0.573115835,-0.779133098,0.435901315,0.577802138,104.5802216,0,0.004191536,0.543085617,0.007718002,0.993841987,0.995368843,N,-,,hypothetical protein CMQ_1447,C:membrane,IPR006016 (PFAM); IPR014729 (G3DSA:3.40.50.GENE3D); PTHR31964 (PANTHER); PTHR31964:SF47 (PANTHER); SSF52402 (SUPERFAMILY),,
RL4_JR_04324,2,7,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,354.4147935,0,-2.924019685,0.646289984,-4.524315333,6.06E-06,7.46E-05,101.4172558,0,-3.19865481,1.205396943,-2.653611185,0.007963553,0.028473007,264.2808591,0,-5.856945314,1.211434668,-4.834718262,1.33E-06,3.44E-05,358.2378934,0,-2.542003378,0.59422775,-4.277826774,1.89E-05,0.000247842,284.8454602,0,-3.042955351,0.750151812,-4.05645271,4.98E-05,0.000388947,N,-,,fyve domain containing,P:vesicle-mediated transport; C:cytoplasmic part,IPR000306 (SMART); IPR000306 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR23164 (PANTHER); IPR017455 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_04325,26,29,48,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,63.75127078,0,-0.406390427,0.679233677,-0.598307241,0.549634946,0.729379601,12.98514763,0,-0.233228882,1.220299378,-0.191124314,0.848428199,0.90981992,88.89449274,0,0.611567175,1.55197609,0.394057086,0.693538894,0.790518775,42.69993041,0,-2.354045104,1.147204765,-2.051983373,0.040171278,0.107719319,47.6376634,0,-1.269686093,0.968582047,-1.310870976,0.189901358,0.309846462,N,-,,molybdenum cofactor biosynthesis 1 B,,IPR006638 (SMART); IPR013483 (TIGRFAM); IPR010505 (PFAM); IPR002820 (G3DSA:3.30.70.GENE3D); IPR013785 (G3DSA:3.20.20.GENE3D); IPR007197 (PFAM); IPR023045 (TIGRFAM); IPR002820 (PFAM); PTHR22960 (PANTHER); IPR023046 (HAMAP); SSF102114 (SUPERFAMILY); IPR002820 (SUPERFAMILY),,
RL4_JR_04326,118,164,160,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,36.59306749,1,2.658107902,0.708549227,3.751479501,0.000175794,0.001384294,1.574401365,0,2.810805044,1.36865215,2.053703013,0.040004445,0.099100585,10.57121059,0,1.125243299,1.212075437,0.928360781,0.353220455,0.496529282,4.697661495,0,-0.258867059,1.225995474,-0.211148462,0.832771425,0.895096675,3.995846604,0,0.08784729,1.218441439,0.072098081,0.942523853,0.963555535,N,-,,wd40 domain-containing,C:intracellular organelle,IPR015943 (G3DSA:2.130.10.GENE3D); PTHR16220:SF0 (PANTHER); PTHR16220 (PANTHER); SSF82171 (SUPERFAMILY),,
RL4_JR_04327,6,15,24,0,0,7,0,0,0,0,0,5,0,0,0,0,0,0,0.685576591,1,2.442428904,1.763555502,1.384945867,0.166069021,NA,0.217598416,0,5.665810784,1.816838554,3.118499864,0.001817742,0.015023052,0.565504465,1,3.011843536,1.2871872,2.339864423,0.019290741,0.054325303,0.652510179,0,2.588993238,1.387915938,1.865381878,0.062127896,0.139570655,0.557560935,0,2.929917974,1.251364725,2.341378109,0.019212698,0.05300506,N,-,,Nucleotide- alpha-beta plait,F:nucleotide binding; F:nucleic acid binding,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_04328,15879,27717,31024,0,2,4,0,0,0,0,0,0,0,1,0,0,2,0,65.66732635,1,1.314144541,1.907458489,0.688950532,0.490854398,0.6787102,6.607737004,0,0.741374111,1.626772248,0.455733193,0.64858185,0.772710156,16.75294318,0,-1.877349205,2.015872942,-0.931283498,0.351706936,0.495069347,19.29300333,1,-2.297179752,2.014014911,-1.140597192,0.254037586,0.393700518,16.19529615,1,-1.931290069,1.995887645,-0.967634663,0.333226859,0.469905564,N,-,,hypothetical protein HMPREF1624_04354,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_04329,716,632,476,0,0,8,0,0,0,3,1,0,0,0,0,0,4,4,37.07461661,1,0.115329549,0.885710747,0.130211301,0.896399254,0.948632537,33.69182405,0,3.141499264,0.915709185,3.430673534,0.000602085,0.015023052,31.87263998,1,0.177565821,1.056065801,0.168138975,0.866473948,0.915294475,54.71217402,0,0.727988132,0.781115637,0.931985096,0.351344228,0.497891342,13.97670767,1,-1.718760517,1.213115784,-1.416814899,0.156537053,0.266779609,N,-, Effector probability:0.644,gnat family,F:N-acetyltransferase activity,IPR000182 (PFAM); IPR016181 (G3DSA:3.40.630.GENE3D); PTHR21471 (PANTHER); PTHR21471:SF54 (PANTHER); IPR016181 (SUPERFAMILY),,
RL4_JR_04330,5790,3128,1760,5,11,7,0,0,0,0,9,0,0,2,4,0,8,3,312.6291299,1,-1.02300854,0.560741858,-1.824384119,0.068094021,0.167514549,70.15366668,0,-2.666924821,1.225157316,-2.17680194,0.029495348,0.078134498,245.1776451,1,-1.34913482,0.597339562,-2.258572689,0.023909978,0.064225158,264.6007832,1,-1.740656997,1.434325703,-1.213571641,0.224911342,0.360377803,219.6591859,1,-1.540658882,0.730057434,-2.110325586,0.034830321,0.084548405,N,-,,alternative nadh-dehydrogenase,F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process,PR00368 (PRINTS); IPR023753 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR22912 (PANTHER); PTHR22912:SF140 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),5.B.14.1.1, the flavin-based extracellular electron transfer (f-eet) family.
RL4_JR_04331,4152,3737,3625,1,0,8,0,0,0,0,13,17,4,10,2,0,16,19,54.1596343,1,-0.668215806,0.741372119,-0.901323086,0.367416563,0.559213492,12.46076451,0,-0.173789648,1.214527316,-0.143092416,0.886217194,0.935574723,51.74920892,1,-0.420034311,0.853978311,-0.491855948,0.622821182,0.735843348,46.51353122,1,-2.294939404,1.142969752,-2.007874136,0.044656668,0.114728762,51.03700478,1,0.026013874,0.677665574,0.03838748,0.969378743,0.979928093,N,-,,C6 zinc finger domain-containing,"C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PR00755 (PRINTS); IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR36206 (PANTHER); PTHR36206:SF1 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04332,14760,11958,8152,6,1,13,0,0,5,0,5,10,0,6,0,0,6,4,661.9145714,1,-0.318063533,0.312009826,-1.019402295,0.308012017,0.495223105,112.9618361,1,-3.354176683,1.187827107,-2.823792001,0.004745917,0.019954733,372.6218451,1,-2.006363353,0.509160805,-3.940529854,8.13E-05,0.001023837,445.4352943,1,-1.69371235,0.393574221,-4.303412826,1.68E-05,0.000223771,395.1092281,1,-1.089274952,0.435202667,-2.502914237,0.012317539,0.03720617,N,-,,phosphatase 2c ptc2,F:protein serine/threonine phosphatase activity; F:metal ion binding; P:protein dephosphorylation,IPR001932 (SMART); IPR001932 (G3DSA:3.60.40.GENE3D); IPR001932 (PFAM); PTHR13832:SF102 (PANTHER); IPR015655 (PANTHER); PTHR13832:SF102 (PANTHER); IPR015655 (PANTHER); IPR001932 (PROSITE_PROFILES); IPR001932 (SUPERFAMILY),,
RL4_JR_04333,504,944,918,0,0,4,0,0,0,0,0,0,0,4,0,0,0,0,110.5328578,1,-2.887598507,1.012221338,-2.852734277,0.004334485,0.019291177,29.4900495,0,-1.416657828,1.196870555,-1.183634957,0.236557596,0.387268073,76.58023894,0,-4.069937725,1.191949423,-3.414522167,0.00063894,0.004032317,124.3065409,1,-1.432332051,0.671720272,-2.132334114,0.03297939,0.097153424,98.06543123,0,-1.527430495,0.756340724,-2.019500534,0.043435222,0.100406763,N,-,,pentatricopeptide repeat domain-containing,F:RNA binding; C:integral component of membrane; C:cytosol; P:transport,PTHR24015 (PANTHER),,
RL4_JR_04334,7484,7646,6204,4,1,14,0,0,1,6,3,4,5,11,0,0,7,7,12.19771087,1,1.43402774,1.01713273,1.40987277,0.158577254,0.307870833,1.462856047,1,2.916753786,1.355898349,2.151159628,0.031463602,0.082250667,10.28331285,1,1.230538304,1.198771914,1.02649911,0.304656383,0.44603633,4.365039722,1,-0.153268138,1.208585556,-0.126816126,0.899085932,0.937898729,11.08788832,1,1.125145832,1.128128151,0.9973564,0.318591546,0.454009769,N,-,,meiotically up-regulated 65,C:integral component of membrane,PTHR12546 (PANTHER),3.A.20.1.5, the peroxisomal protein importer (ppi) family.
RL4_JR_04335,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,99.80616224,0,-0.243171913,0.608475404,-0.399641318,0.689420719,0.831135544,16.60664383,0,-0.588151882,1.211678091,-0.485402754,0.627390679,0.755014055,166.7726448,0,1.705761456,0.440554456,3.871851553,0.000108012,0.001223166,153.3863402,1,1.267910287,0.411882834,3.078327582,0.002081659,0.013632886,86.95766443,0,0.132937412,0.594769758,0.223510712,0.823138047,0.881310793,N,-,,calcofluor white hypersensitive,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,G3DSA:1.20.120.20 (GENE3D),,
RL4_JR_04336,161,150,134,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,71.055582,0,-2.145539569,1.002910159,-2.139313826,0.032410261,0.096207691,17.62673213,0,-0.674151569,1.204125843,-0.559868035,0.575569454,0.715400952,52.11809333,0,-2.360782797,1.187873175,-1.987403072,0.046877748,0.107763469,56.63077152,0,-2.797263142,1.139536706,-2.454737198,0.014098762,0.063699224,68.02518963,0,-0.205710954,0.612251547,-0.335990909,0.736877722,0.815789213,N,-,,pre-mrna-splicing factor prp1,"P:mRNA cis splicing, via spliceosome; C:U4/U6 x U5 tri-snRNP complex",IPR003107 (SMART); IPR019734 (SMART); PF14559 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR010491 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PF13432 (PFAM); PTHR11246 (PANTHER); IPR027108 (PTHR11246:PANTHER); IPR027108 (PTHR11246:PANTHER); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY),,
RL4_JR_04337,1620,1498,1695,0,3,1,0,0,0,0,2,3,1,1,0,0,1,1,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,hypothetical protein CISIN_1g031831mg,,no IPS match,,
RL4_JR_04338,182,257,237,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,223.8343529,0,-4.128957003,1.007712254,-4.097357142,4.18E-05,0.000400609,69.24186107,0,-2.648044886,1.192200899,-2.221139817,0.026341493,0.071329211,225.4242299,1,-2.145686585,0.665982522,-3.221836179,0.001273719,0.006985447,234.797264,0,-2.206510905,0.576154264,-3.829722421,0.000128288,0.001321378,243.264764,0,-1.276831305,0.478922307,-2.666051018,0.007674805,0.025427813,N,-,,transcription elongation factor spt6,"P:chromatin maintenance; P:regulation of transcription from RNA polymerase II promoter in response to stress; F:nucleosome binding; P:regulation of histone H3-K36 methylation; P:negative regulation of transcription from RNA polymerase II promoter by glucose; P:nucleobase-containing compound metabolic process; P:translational elongation; P:nucleosome assembly; P:regulation of nucleosome density; F:transcription factor activity, core RNA polymerase II binding; P:regulation of transcriptional start site selection at RNA polymerase II promoter; P:positive regulation of transcription elongation from RNA polymerase II promoter; C:nucleus; F:DNA binding; P:chromatin remodeling; F:translation elongation factor activity; F:histone binding; F:transcription antitermination factor activity, DNA binding; C:transcriptionally active chromatin; P:transcription antitermination; P:chromatin organization involved in regulation of transcription; P:positive regulation of transcription involved in G1/S transition of mitotic cell cycle; P:regulation of mRNA 3'-end processing; P:poly(A)+ mRNA export from nucleus",IPR006641 (G3DSA:3.30.420.GENE3D); IPR027999 (PFAM); IPR000980 (G3DSA:3.30.505.GENE3D); IPR028083 (PFAM); IPR000980 (PFAM); IPR023097 (G3DSA:1.10.150.GENE3D); IPR023323 (G3DSA:1.10.3500.GENE3D); G3DSA:2.40.50.140 (GENE3D); IPR003029 (PFAM); IPR017072 (PIRSF); IPR032706 (PFAM); IPR028088 (PFAM); IPR028231 (PFAM); IPR017072 (PTHR10145:PANTHER); PTHR10145 (PANTHER); IPR003029 (PROSITE_PROFILES); IPR012340 (SUPERFAMILY); IPR010994 (SUPERFAMILY); IPR000980 (SUPERFAMILY); IPR010994 (SUPERFAMILY); SSF158832 (SUPERFAMILY); IPR012337 (SUPERFAMILY),,
RL4_JR_04339,349,428,304,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,11.51344002,0,-0.100814558,1.177282203,-0.085633298,0.931757928,0.966629651,2.433155736,1,2.182624336,1.31325811,1.661991896,0.096514399,0.197158174,27.18761779,0,1.922323792,0.879686709,2.185236825,0.028871487,0.07435638,7.324977847,0,-0.900055186,1.221143333,-0.737059412,0.461086221,0.60339899,6.289209936,0,-0.566563238,1.228480413,-0.46119029,0.644662088,0.74596613,N,-,,cop9 signalosome complex subunit 12,P:RNA metabolic process; P:gene expression,PTHR12732 (PANTHER); PTHR12732:SF2 (PANTHER); PTHR12732:SF2 (PANTHER); PTHR12732 (PANTHER),3.A.22.1.1, the transcription-coupled trex/tap nuclear mrna export complex (trex) family.
RL4_JR_04340,1543,1999,2953,0,0,2,0,0,0,2,0,0,2,3,0,0,2,0,26.665189,1,3.238733269,0.674479498,4.801826114,1.57E-06,2.27E-05,1.190593854,0,3.213716231,1.386291115,2.318211662,0.020437821,0.058487877,3.103974792,1,0.554528551,1.222704647,0.453526166,0.650169906,0.756941041,3.581742304,1,0.131865339,1.228103522,0.107373146,0.914492958,0.948109891,6.938245622,1,1.392371784,1.1532405,1.207355953,0.227295091,0.354437516,Y,-,,sun domain containing,C:intracellular part,IPR005556 (PFAM); PTHR31654 (PANTHER),,
RL4_JR_04341,149,182,248,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,346.6497627,1,-0.493664039,0.427718763,-1.154179058,0.248426766,0.425234066,134.1282574,0,-0.349781626,0.878104985,-0.39833691,0.690381857,0.803962857,426.7722032,0,0.561668147,0.374395415,1.500200388,0.133562503,0.240346032,487.1616802,0,0.472055647,0.422784092,1.116540702,0.264190758,0.404897119,217.2299859,0,-1.37738816,0.604134375,-2.279936743,0.02261144,0.060180777,N,-,,ubiquitin carrier,C:membrane; C:integral component of membrane,IPR023395 (SUPERFAMILY),,
RL4_JR_04342,2259,2480,2783,0,10,2,1,0,0,1,6,9,2,1,5,0,3,2,70.38097862,1,1.228650455,0.52700245,2.3313942,0.019732583,0.064780045,7.457965554,1,0.566689116,1.224307889,0.462864874,0.643461227,0.768418421,19.39522112,1,-2.088732604,1.194491417,-1.748637598,0.080353683,0.16338636,55.29492341,1,0.233887953,0.745975715,0.313532931,0.753875805,0.83863867,19.17621091,1,-2.175022312,1.201841299,-1.809741697,0.070335853,0.145366506,N,-,,Leucine carboxyl methyltransferase 1,F:protein heterodimerization activity; C:mitochondrion; P:transcription from RNA polymerase II promoter; F:methyltransferase activity; F:transferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR007213 (PFAM); IPR016651 (PIRSF); IPR007213 (PANTHER); PTHR13600:SF21 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_04343,2844,3046,2000,0,3,3,0,0,0,0,0,0,2,2,2,0,0,0,101.8867661,1,0.095406021,0.530289468,0.179913098,0.857220792,0.928096512,14.83168417,0,-0.425084258,1.206243859,-0.352403252,0.724535864,0.82745707,82.79119472,0,0.330919109,0.611224086,0.541403908,0.588229214,0.708113266,80.27915739,1,-0.439098026,0.664080054,-0.66121249,0.508476052,0.644103594,45.19783644,0,-2.221735229,1.118144664,-1.986983706,0.046924203,0.106665919,N,-,,spt3,P:protein transport; P:pseudohyphal growth; P:transcription from RNA polymerase II promoter; F:methyltransferase activity; P:invasive growth in response to glucose limitation; P:regulation of nucleic acid-templated transcription; C:SAGA complex; F:transcription cofactor activity; C:SLIK (SAGA-like) complex; F:protein heterodimerization activity; C:cytosol; P:histone acetylation; P:methylation,IPR003195 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); IPR003195 (PANTHER); PTHR11380:SF3 (PANTHER); IPR009072 (SUPERFAMILY); IPR009072 (SUPERFAMILY),,
RL4_JR_04344,826,913,852,0,0,15,0,0,0,0,6,8,0,5,3,0,2,8,39.55973141,1,5.34044792,0.625855811,8.533032407,1.43E-17,1.34E-15,0.442609514,0,4.641552562,1.601307387,2.898601854,0.003748305,0.017473407,1.140939226,1,1.999123856,1.244674956,1.606141303,0.108242867,0.205600522,1.31569024,1,1.577212515,1.276484416,1.23559089,0.216610673,0.351302749,23.2135354,1,4.164282527,0.854443059,4.873680559,1.10E-06,1.57E-05,N,-,,AMP-binding enzyme,F:catalytic activity; C:membrane,G3DSA:3.40.50.980 (GENE3D); G3DSA:2.30.38.10 (GENE3D); IPR000873 (PFAM); G3DSA:3.30.300.30 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR025110 (PFAM); PTHR24096 (PANTHER); PTHR24096 (PANTHER); PTHR24096:SF231 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.7, the fatty acid transporter (fat) family.
RL4_JR_04345,1538,2055,1753,0,0,21,0,0,0,0,0,0,2,0,0,0,3,0,274.9183239,1,1.468723673,0.650791895,2.256825391,0.024018987,0.076155033,24.86839273,0,-1.170704716,1.199661138,-0.975862833,0.329132443,0.491948994,199.8480644,0,1.090106893,0.384913146,2.832085376,0.00462455,0.017876649,776.9437935,1,3.290579217,0.459695175,7.158176542,8.18E-13,3.92E-11,399.7257035,1,2.487493233,0.692780667,3.59059274,0.000329927,0.001895862,N,-,,myo-inositol-1-phosphate synthase,F:inositol-3-phosphate synthase activity; C:cytoplasm; P:inositol biosynthetic process; P:phospholipid biosynthetic process,IPR002587 (PIRSF); IPR013021 (PFAM); IPR002587 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.360.10 (GENE3D); IPR002587 (PANTHER); PTHR11510:SF5 (PANTHER); SSF55347 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_04346,2483,2518,3855,0,0,13,0,0,0,0,1,0,0,2,3,0,0,1,44.22269799,1,0.262226145,0.693967188,0.377865337,0.705530634,0.84061909,8.026790635,0,0.460735765,1.232720481,0.373755261,0.708586408,0.816705946,54.04088489,1,0.637237344,0.749506767,0.850208926,0.39520894,0.538143283,73.58495089,1,0.937474381,0.585005784,1.602504463,0.109044101,0.209342345,32.01282188,1,-0.065442532,0.851293201,-0.076874257,0.938723577,0.960543327,N,-,,hypothetical protein SPBR_05675,C:membrane; C:integral component of membrane,IPR001781 (SMART); IPR001781 (PFAM); IPR001781 (G3DSA:2.10.110.GENE3D); IPR021822 (PFAM); IPR001781 (G3DSA:2.10.110.GENE3D); PTHR36205:SF2 (PANTHER); PTHR36205 (PANTHER); IPR001781 (PROSITE_PROFILES); IPR001781 (PROSITE_PROFILES); SSF57716 (SUPERFAMILY),,
RL4_JR_04347,2680,1641,2311,0,1,4,0,0,0,2,0,0,0,0,0,0,0,0,23.94160962,1,-0.409163973,1.029844971,-0.397306376,0.691141546,0.832103414,23.92880208,0,2.732238049,0.998183103,2.73721128,0.006196248,0.023820139,13.4751175,1,-1.563342233,1.201996691,-1.300621078,0.193388188,0.317473978,15.54908365,0,-1.98603781,1.201405534,-1.653095274,0.098311475,0.19354534,36.15451415,0,1.2698327,0.708840629,1.791422004,0.073225601,0.149941386,N,-,,OTU-like cysteine protease,C:cytoplasm,IPR003323 (PFAM); PTHR12419 (PANTHER); PTHR12419:SF10 (PANTHER); IPR003323 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY),,
RL4_JR_04348,3235,2373,3029,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,53.34231602,1,4.11721343,0.786816065,5.23275212,1.67E-07,3.15E-06,1.194035773,0,3.209767386,1.41031663,2.275919688,0.022850817,0.063964593,29.07120772,0,3.373768156,0.775250191,4.351844343,1.35E-05,0.000243187,78.83571274,0,4.453442096,0.495679082,8.984527003,2.60E-19,2.39E-17,57.05924459,0,4.390931281,1.324227808,3.31584283,0.000913672,0.004434769,N,-,,nuclear migration,P:cortical protein anchoring; C:cell cortex; F:phospholipid binding,IPR024774 (PFAM); PTHR28190:SF1 (PANTHER); PTHR28190 (PANTHER),,
RL4_JR_04349,4478,4420,4721,3,7,12,0,0,0,5,0,5,0,6,5,0,6,2,0.344584694,1,3.434547278,2.416116498,1.421515594,0.155166923,NA,0.108701815,0,6.666566661,2.105039545,3.166955546,0.001540439,0.015023052,0.284798882,1,3.999351298,1.377549165,2.903236706,0.003693274,0.015703781,0.328713783,1,3.577281951,1.64372693,2.176323747,0.029531061,0.091437919,0.284147464,1,3.901629419,1.311275965,2.975444929,0.002925639,0.011584706,N,-, Effector probability:0.705,SMP-30 Gluconolaconase LRE-like region,,IPR011042 (G3DSA:2.120.10.GENE3D); SSF63829 (SUPERFAMILY),,
RL4_JR_04350,2597,2824,2914,0,1,22,0,0,0,3,0,0,10,11,4,0,4,1,116.4948979,1,-0.705798394,0.645240772,-1.093852751,0.274019564,0.456473799,35.70577683,0,-0.33686067,1.128325328,-0.298549241,0.765284,0.857951607,105.0819405,1,-0.761203438,0.687211208,-1.10767029,0.268004235,0.406066465,148.293151,1,-0.519847355,0.573559564,-0.906352866,0.364749112,0.511082862,81.42580579,1,-2.284632663,0.975988213,-2.340840426,0.019240389,0.053066994,N,-,,major facilitator superfamily transporter,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR21576 (PANTHER); PTHR21576:SF16 (PANTHER); PTHR21576 (PANTHER); PTHR21576:SF16 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.75.3, the major facilitator superfamily (mfs).
RL4_JR_04351,829,836,793,0,0,2,0,0,0,0,0,1,0,0,4,0,0,1,197.3702381,1,0.315764221,0.410431781,0.769346421,0.441687687,0.631513245,28.51145695,0,-1.367954213,1.20931683,-1.131179339,0.257979616,0.41363372,95.96126429,1,-2.1826092,1.039270156,-2.100136512,0.035716834,0.08744794,111.7937495,1,-1.705791934,0.759265328,-2.246634834,0.024663374,0.084922906,72.69583784,1,-4.09759881,1.200935878,-3.412004659,0.00064487,0.003355247,N,-,,serine incorporator,C:integral component of membrane,IPR005016 (PFAM); IPR029559 (PTHR10383:PANTHER); IPR005016 (PANTHER),9.A.29.3.1, the lantibiotic immunity protein/serine connector (lip/sip) family.
RL4_JR_04352,21,13,31,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.666650913,0,0.023127926,1.245012856,0.018576455,0.985178985,0.992355867,1.18381105,0,3.222173056,1.416640119,2.274517722,0.022934877,0.064111246,3.048891256,0,0.580794852,1.229879769,0.472237097,0.636757563,0.746558607,3.515545118,0,0.159131225,1.236047777,0.128741969,0.897561825,0.936694855,2.984299836,0,0.508574881,1.220246801,0.416780344,0.676839081,0.770518968,N,-,,---NA---,,no IPS match,,
RL4_JR_04353,160,162,169,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,443.8906071,0,1.226306422,0.6450038,1.901239065,0.057270706,0.147015237,146.866664,0,0.801126804,0.790747256,1.013126252,0.31099986,0.472876759,141.0570434,0,-1.428001325,0.705161513,-2.025069858,0.042860191,0.100536742,205.5127975,0,-0.746311649,0.519542646,-1.436478129,0.150866335,0.267189373,128.2324288,0,-1.480729737,0.678309875,-2.182969453,0.02903806,0.073301011,N,-,,cystathionine beta-lyase,C:nucleus; F:pyridoxal phosphate binding; P:'de novo' L-methionine biosynthetic process; C:cytoplasm; F:cystathionine beta-lyase activity,IPR000277 (PIRSF); IPR000277 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR006238 (TIGRFAM); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR11808:SF50 (PANTHER); IPR000277 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_04354,44,60,64,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,101.481382,0,0.983130327,0.484770686,2.028031718,0.042557011,0.118088468,100.9960098,0,2.567576646,0.755757315,3.397355996,0.000680404,0.015023052,30.5236324,0,-2.742930341,1.198739835,-2.288178185,0.022127147,0.06028397,43.23696926,0,-1.444297738,1.027706448,-1.405360198,0.159914196,0.278872069,30.16531505,0,-2.828615648,1.20508279,-2.347237609,0.018913189,0.052307031,N,-,,ATPase family AAA domain-containing 1,C:peroxisomal membrane; P:protein targeting to mitochondrion; F:ATP binding; C:integral component of membrane; C:mitochondrial outer membrane,IPR003593 (SMART); G3DSA:1.10.8.60 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003959 (PFAM); PTHR23074:SF20 (PANTHER); PTHR23074 (PANTHER); IPR027417 (SUPERFAMILY),1.R.1.1.1, the membrane contact site (mcs) family.
RL4_JR_04355,65,98,73,0,0,11,0,0,0,0,1,0,0,0,0,0,0,0,21.05662625,1,2.067400696,0.764747871,2.70337555,0.006863915,0.028166909,1.858445903,0,2.571515005,1.339690493,1.919484402,0.054923058,0.127157181,4.795640844,1,-0.072532833,1.210981442,-0.059895908,0.952238539,0.972482974,24.47818879,0,1.255128446,1.024044592,1.225658,0.220327402,0.355678403,8.559416947,0,0.783463775,1.130735454,0.692879817,0.488384977,0.617009751,N,-,,chromosome segregation,"F:DNA binding; P:regulation of transcription, DNA-templated",IPR020981 (PFAM); PTHR28006 (PANTHER),,
RL4_JR_04356,2059,1903,1960,0,3,6,0,0,0,0,0,1,0,2,3,0,3,1,145.1513869,1,0.094991375,0.628164326,0.151220582,0.879801715,0.941301297,24.37878468,0,-1.142015153,1.265833005,-0.902184687,0.366958768,0.531609654,81.9640718,1,-1.395653926,0.930289513,-1.500236115,0.133553251,0.240346032,113.4104824,1,-0.433153317,0.687075366,-0.630430574,0.528412913,0.661905325,64.68020692,1,-2.913630296,1.170244846,-2.489761272,0.012782893,0.038303281,N,-,,gpi inositol-deacylase,C:endoplasmic reticulum membrane; P:ER to Golgi vesicle-mediated transport; F:phosphatidylinositol deacylase activity; P:vesicle organization; P:protein transport; C:integral component of membrane; P:ER-associated ubiquitin-dependent protein catabolic process; P:protein retention in ER lumen,IPR029058 (G3DSA:3.40.50.GENE3D); IPR012908 (PFAM); PTHR15495:SF7 (PANTHER); PTHR15495 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_04357,2480,3010,3163,2,1,0,0,0,0,0,0,4,2,0,0,0,13,1,21.29115993,1,-1.282169496,1.150224133,-1.11471274,0.26497354,0.444857542,5.610983424,0,0.977328255,1.254644027,0.778968563,0.435998234,0.597586205,14.4858297,1,-1.667484973,1.20038295,-1.389127506,0.164793981,0.281487138,62.62482634,1,1.244181096,0.62753863,1.982636664,0.047408029,0.11896902,18.06024177,1,-0.811623785,1.125926355,-0.720849797,0.471001933,0.602133153,N,-,,DNA mismatch repair pms1,F:ATP binding; C:nucleus; P:maintenance of DNA repeat elements; C:mismatch repair complex; P:mismatch repair; F:mismatched DNA binding,IPR014790 (SMART); IPR013507 (SMART); IPR013507 (PFAM); IPR014721 (G3DSA:3.30.230.GENE3D); IPR014790 (PFAM); IPR003594 (G3DSA:3.30.565.GENE3D); IPR002099 (TIGRFAM); PF13589 (PFAM); IPR028831 (PTHR10073:PANTHER); IPR028831 (PTHR10073:PANTHER); PTHR10073 (PANTHER); PTHR10073 (PANTHER); PTHR10073 (PANTHER); IPR028831 (PTHR10073:PANTHER); IPR003594 (SUPERFAMILY); SSF118116 (SUPERFAMILY); IPR020568 (SUPERFAMILY),,
RL4_JR_04358,4072,6055,8526,0,3,4,0,1,0,0,0,0,0,3,0,0,0,0,66.15462074,1,3.240221276,0.480497915,6.743465837,1.55E-11,6.25E-10,2.606573327,1,2.083437856,1.297957665,1.605166265,0.108457219,0.215340128,6.736258359,0,-0.562780906,1.202144549,-0.46814745,0.639679148,0.749029806,11.78106631,1,-0.038058478,1.150475369,-0.033080655,0.97361027,0.984893994,10.47033833,0,0.29164707,1.125379729,0.259154366,0.795516139,0.861638951,N,-,,hypothetical protein SPI_00725,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_04359,4471,3869,4652,8,1,25,0,0,5,0,3,8,2,13,1,0,10,2,53.63062612,1,1.035215123,0.596742008,1.734778363,0.08278007,0.193249919,6.576176572,1,0.748217658,1.234057582,0.606306925,0.544310961,0.690848344,58.73639442,1,1.239181065,0.678602927,1.826076805,0.067838694,0.143172594,19.72911155,1,-2.329544512,1.197259943,-1.945729935,0.051687189,0.125559168,16.91053632,1,-1.993640233,1.205802203,-1.653372525,0.098255071,0.188415264,N,-,,NADPH-adrenodoxin reductase Arh1,C:mitochondrial matrix; P:oxidation-reduction process; F:NADPH-adrenodoxin reductase activity,PR00419 (PRINTS); IPR023753 (PFAM); IPR021163 (PIRSF); IPR023753 (G3DSA:3.50.50.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR11938 (PANTHER); PTHR11938:SF91 (PANTHER); SSF51971 (SUPERFAMILY),,
RL4_JR_04360,52,33,50,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,113.1077822,0,-0.006549487,0.829950555,-0.007891419,0.993703624,0.997603551,20.30595641,0,-0.878280458,1.213375574,-0.723832321,0.469168684,0.627722748,90.9324772,0,-0.384154259,0.681490753,-0.56369695,0.572960393,0.696189513,174.2322805,0,1.007196117,0.409420723,2.46005163,0.013891703,0.062988577,124.2007359,0,0.973321288,0.506441602,1.921882569,0.054620536,0.11981196,N,-,,electron transfer flavo subunit alpha,"F:acyl-CoA dehydrogenase activity; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:mycelium development; F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:electron carrier activity; F:oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor; P:lipid homeostasis; C:mitochondrion",IPR014730 (SMART); IPR014729 (G3DSA:3.40.50.GENE3D); IPR029035 (G3DSA:3.40.50.GENE3D); IPR001308 (PIRSF); IPR014731 (PFAM); IPR014730 (PFAM); PTHR10909:SF299 (PANTHER); PTHR10909 (PANTHER); SSF52402 (SUPERFAMILY); IPR029035 (SUPERFAMILY),,
RL4_JR_04361,1194,1476,1350,7,0,5,0,0,0,0,0,5,0,6,3,0,2,0,173.3435848,1,-2.730382063,0.804508174,-3.393852484,0.000689168,0.004406139,50.05025169,0,-2.179813997,1.202380636,-1.812915089,0.069844919,0.153488985,130.5697693,1,-4.839700693,1.204670551,-4.017447501,5.88E-05,0.000819277,193.3711019,1,-1.564744801,0.585158249,-2.674054075,0.007494037,0.038477242,163.174582,1,-1.721437603,0.672436709,-2.559999445,0.010467233,0.03255599,N,-,,swi snf complex,C:nucleus; F:DNA binding; P:positive regulation of cellular process; P:organic substance catabolic process; P:single-organism cellular process; P:cellular catabolic process; P:single-organism catabolic process,IPR001005 (SMART); IPR001005 (PFAM); IPR032451 (PFAM); IPR007526 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); PTHR12802:SF41 (PANTHER); PTHR12802 (PANTHER); PTHR12802 (PANTHER); IPR017884 (PROSITE_PROFILES); IPR007526 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY); IPR009057 (SUPERFAMILY),,
RL4_JR_04362,2488,2263,2855,0,1,4,0,0,0,3,1,0,1,5,0,0,7,4,292.5362028,1,2.717324247,1.201145837,2.262276706,0.023680313,0.07538202,12.7404889,0,-0.205786226,1.227792096,-0.167606736,0.866892671,0.922389112,242.0867091,1,2.547381833,0.411832527,6.185479937,6.19E-10,3.28E-08,507.0049811,1,3.69996886,0.355669775,10.40282059,2.41E-25,3.01E-23,405.3742824,1,3.516975224,0.310126659,11.34044792,8.27E-30,4.41E-27,N,-,,carnitine O-acetyltransferase,C:peroxisome; F:carnitine O-acetyltransferase activity; C:mitochondrion; P:carnitine metabolic process,IPR000542 (PFAM); PTHR22589:SF8 (PANTHER); IPR000542 (PANTHER); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY),4.C.2.1.1, the carnitine o-acyl transferase (crat) family.
RL4_JR_04363,1386,1310,1189,0,0,2,0,0,0,0,0,1,0,0,0,0,2,1,79.50496394,1,0.657078404,0.5599811,1.173393894,0.240637885,0.415388037,8.827431089,0,0.323533808,1.215575845,0.266156826,0.790118432,0.873574961,46.94985131,1,0.080980503,0.844439685,0.095898505,0.923601182,0.955092923,26.39605133,0,-2.749458502,1.18460592,-2.320990007,0.020287383,0.077428737,34.12200156,1,-0.199937359,0.836958177,-0.238885723,0.811194196,0.872182355,N,-,,adenylyl cyclase-associated,F:actin binding; P:cell morphogenesis; P:actin filament organization,IPR006599 (SMART); IPR016098 (G3DSA:2.160.20.GENE3D); IPR013992 (PFAM); IPR013912 (PFAM); IPR001837 (PANTHER); IPR028419 (PTHR10652:PANTHER); IPR017901 (PROSITE_PROFILES); IPR013912 (SUPERFAMILY); IPR013992 (SUPERFAMILY),,
RL4_JR_04364,2146,2354,2086,0,7,27,0,0,2,1,6,0,2,4,1,0,6,4,18.97797174,1,-0.309248452,1.138107858,-0.271721568,0.785836116,0.889847237,12.23073868,1,2.869560383,1.129042661,2.541587208,0.011035041,0.036218122,7.38812067,1,-0.696280524,1.194845199,-0.582737014,0.560070352,0.686119867,36.45887534,1,1.209789446,0.845801201,1.430347279,0.152617372,0.269536174,7.274187653,1,-0.776635012,1.194818824,-0.650002324,0.515690721,0.641620524,Y,-,,carbohydrate purine kinase,P:interspecies interaction between organisms; P:phosphorylation; F:kinase activity,IPR011611 (PFAM); IPR029056 (G3DSA:3.40.1190.GENE3D); PTHR10584 (PANTHER); PTHR10584:SF179 (PANTHER); PTHR10584 (PANTHER); PTHR10584:SF179 (PANTHER); IPR029056 (SUPERFAMILY),,
RL4_JR_04365,2879,2448,3187,0,0,3,0,0,0,0,0,1,0,1,1,0,1,3,39.8046676,1,-1.386125747,1.021775612,-1.356585272,0.174913024,0.329852162,10.34565531,0,0.094612251,1.23311114,0.076726458,0.938841156,0.966532768,39.68996234,1,-0.731655349,1.042134255,-0.702073985,0.482633025,0.618581687,62.87539865,1,0.689921095,0.589787578,1.169778953,0.242089936,0.380496833,30.0176053,1,-1.692910506,1.124970491,-1.504848811,0.132362951,0.235564449,N,-,,dna replication licensing factor mcm3,"F:ATPase activity; P:DNA replication initiation; P:double-strand break repair via break-induced replication; P:DNA strand elongation involved in DNA replication; C:DNA replication preinitiation complex; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; F:chromatin binding; C:MCM complex; P:chromatin silencing at telomere; C:chromosome, telomeric region; C:nuclear pre-replicative complex; F:DNA replication origin binding; F:ATP binding; F:DNA helicase activity; C:cytoplasm; F:oxidoreductase activity; P:DNA duplex unwinding; C:integral component of membrane; P:oxidation-reduction process; C:replication fork protection complex; P:chromatin silencing at silent mating-type cassette",IPR001208 (PRINTS); IPR008046 (PRINTS); IPR031327 (SMART); IPR003593 (SMART); IPR027925 (PFAM); IPR033762 (PFAM); G3DSA:3.30.1640.10 (GENE3D); IPR001208 (PFAM); G3DSA:2.40.50.140 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11630 (PANTHER); PTHR11630 (PANTHER); PTHR11630:SF46 (PANTHER); PTHR11630:SF46 (PANTHER); IPR001208 (PROSITE_PROFILES); IPR012340 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_04366,1045,933,1251,0,6,5,0,0,0,1,3,5,0,6,0,0,1,0,65.92055226,1,0.162643085,0.680465663,0.239017328,0.811092146,0.904262969,46.42140926,0,2.897529413,0.76185584,3.803251563,0.000142809,0.006577078,30.98600223,1,-1.381712431,1.193769793,-1.157436249,0.247094171,0.381338627,26.70174117,1,-2.766028143,1.193837696,-2.316921431,0.020508012,0.077696516,30.55688475,1,-0.760947156,0.983268934,-0.773895248,0.43899274,0.573115198,N,-,,exocyst complex exo70,F:pyridoxal phosphate binding; F:transaminase activity; P:exocytosis; C:exocyst,IPR005814 (PFAM); IPR015421 (G3DSA:3.40.640.GENE3D); IPR015422 (G3DSA:3.90.1150.GENE3D); PTHR11986:SF78 (PANTHER); IPR005814 (PANTHER); IPR015424 (SUPERFAMILY),9.B.313.1.2, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_04367,1633,2269,2224,0,4,1,0,0,2,3,0,0,0,0,3,0,0,0,52.30190782,1,0.540205322,0.617045644,0.875470604,0.381317898,0.573411045,8.082601669,1,0.45074574,1.23065761,0.366264131,0.714167992,0.820989031,28.73270666,1,-1.2338746,1.192308869,-1.034861546,0.300733575,0.441762437,42.71800881,1,-0.873995295,1.014687568,-0.861344243,0.389048475,0.533683215,28.22746556,0,-0.601188448,0.970095429,-0.619720936,0.535441529,0.658740575,N,-,,exocyst complex exo70,,IPR004140 (PFAM); PTHR12542:SF7 (PANTHER); IPR004140 (PANTHER); IPR016159 (SUPERFAMILY),1.F.2.1.1, the octameric exocyst (exocyst) family.
RL4_JR_04368,2151,2866,3684,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,24.89699335,1,1.254128782,0.898621364,1.395614251,0.162830689,0.313540486,3.019293863,0,1.871211219,1.349429589,1.386668289,0.165542935,0.298525848,7.918901348,0,-0.796390747,1.254920228,-0.634614638,0.525679779,0.655497239,29.19972711,0,1.718824305,0.816572655,2.104925134,0.035297825,0.099766434,7.89134039,0,-0.893994358,1.272024144,-0.702812414,0.48217266,0.610631418,N,-,,glutathione s-transferase,C:mitochondrion; C:membrane; P:metabolic process; F:transferase activity; P:cellular process,IPR010987 (G3DSA:1.20.1050.GENE3D); IPR004045 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR11260:SF124 (PANTHER); PTHR11260 (PANTHER); IPR004045 (PROSITE_PROFILES); IPR010987 (PROSITE_PROFILES); IPR010987 (SUPERFAMILY); IPR012336 (SUPERFAMILY),,
RL4_JR_04369,1809,2206,3785,0,0,0,0,0,2,0,0,0,3,0,0,0,0,0,60.80014706,0,1.330263433,0.624688818,2.129481741,0.033214424,0.097891355,24.34824429,1,2.604911051,1.038088166,2.50933508,0.012095868,0.038967021,198.6806894,0,3.792315618,0.463623382,8.179733306,2.84E-16,3.35E-14,148.8656612,1,3.074880373,0.428133576,7.182058465,6.87E-13,3.36E-11,197.9011553,0,3.909273959,0.459807782,8.501974328,1.86E-17,3.49E-15,N,-,,phosphatidylcholine-sterol o-acyltransferase,"F:transferase activity, transferring acyl groups; F:transferase activity",IPR029058 (G3DSA:3.40.50.GENE3D); PTHR11440:SF7 (PANTHER); PTHR11440 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_04370,7893,12143,14042,0,0,2,0,0,0,0,0,0,1,0,0,0,6,0,1.910852127,1,0.963368327,1.369474268,0.70345851,0.481770055,NA,0.601988949,0,4.197506643,1.540764562,2.724301133,0.006443772,0.024419268,1.576028472,0,1.532260729,1.262746733,1.213434721,0.224963658,0.355253795,20.44365059,1,2.879957561,1.058373876,2.721115501,0.006506202,0.034562067,1.568939545,1,1.436625213,1.263793254,1.136756514,0.255640087,0.386725815,N,-,,hypothetical protein CMQ_1580,,no IPS match,,
RL4_JR_04371,3951,3979,4115,0,2,5,0,0,0,0,0,0,0,1,3,0,4,2,62.16895854,1,0.757567965,0.792529627,0.955885988,0.339129839,0.528990674,75.68279156,0,2.600342199,0.887559886,2.929765348,0.003392181,0.016488617,52.94837334,0,0.487968588,0.803151113,0.607567592,0.5434743,0.671275051,142.0435917,1,2.17775063,0.552250607,3.943410114,8.03E-05,0.000886005,41.78567613,1,0.16185765,0.83840598,0.193054026,0.846916657,0.897721017,N,-,,hypothetical protein UCRPA7_6361,C:membrane,no IPS match,,
RL4_JR_04372,1669,1035,1137,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,100.2039251,1,-0.698541461,0.62077087,-1.125280671,0.260470118,0.440115361,130.9785981,0,2.495898633,1.396976963,1.786642657,0.073995263,0.16031251,85.31492819,0,-0.633377973,0.745611316,-0.849474732,0.395617185,0.538481901,103.1444576,0,-0.551796708,0.621100092,-0.888418333,0.374315768,0.520025679,56.60756519,0,-2.602036481,1.117916396,-2.32757699,0.019934576,0.054462382,N,-,,MIF domain-containing,,G3DSA:3.30.429.10 (GENE3D); IPR001398 (PFAM); IPR001398 (PANTHER); PTHR11954:SF6 (PANTHER); IPR001398 (PRODOM); IPR014347 (SUPERFAMILY),,
RL4_JR_04373,507,634,420,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29.93820681,0,-0.54557449,1.016745455,-0.536589062,0.591551501,0.76236688,5.817994489,0,0.925057487,1.252400533,0.73862751,0.460133215,0.618850438,15.01856096,0,-1.719600598,1.199684369,-1.433377514,0.151749981,0.264681976,25.3438462,0,-0.419477116,1.025481208,-0.409053928,0.682500086,0.784193528,14.72242583,0,-1.793756508,1.195771659,-1.500082808,0.133592954,0.237095295,N,-,,Gtr1 G domain containing,F:GTP binding; C:late endosome membrane; C:nuclear chromatin; C:fungal-type vacuole membrane; C:cytosol; P:positive regulation of transcription from RNA polymerase II promoter; P:positive regulation of TOR signaling; C:EGO complex; P:lysosomal microautophagy,IPR027417 (G3DSA:3.40.50.GENE3D); IPR006762 (PFAM); IPR006762 (PANTHER); PTHR11259:SF2 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_04374,22,33,27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29.64606174,0,-2.992107792,1.214899647,-2.462843576,0.013784004,0.049061912,9.585728539,0,0.204674564,1.259495845,0.162505152,0.870908071,0.925494121,24.6570005,0,-2.434910464,1.215302431,-2.003542824,0.045119056,0.104668923,42.07593784,0,-1.120708176,1.045697611,-1.071732558,0.283840173,0.427979412,24.09709805,0,-2.504613024,1.212567486,-2.065545261,0.038871438,0.09195638,N,-,,anaphase-promoting complex component cut20 apc4,C:nucleus; P:regulation of mitotic metaphase/anaphase transition; P:cellular protein metabolic process; C:intracellular organelle part,IPR024790 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR024977 (PFAM); IPR024789 (PANTHER); IPR017986 (SUPERFAMILY),,
RL4_JR_04375,101,152,108,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,71.43343834,1,-0.276453989,0.620113184,-0.445812146,0.655732948,0.805662322,14.14167535,0,-0.356343646,1.20636185,-0.295387031,0.767698239,0.859584245,75.88634686,0,0.138761514,0.668574315,0.207548378,0.835581615,0.894136801,90.6229259,1,0.295842735,0.537465934,0.550439974,0.582017637,0.708036859,47.69480118,0,-0.882249689,0.841446102,-1.048492216,0.294411887,0.429280005,N,-, Effector probability:0.575,NADH:ubiquinone oxidoreductase subunit,C:integral component of membrane,PTHR39476:SF1 (PANTHER); PTHR39476 (PANTHER),,
RL4_JR_04376,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51.68589432,0,1.146290817,0.600566545,1.908682437,0.05630307,0.145170811,16.09484737,0,1.633994738,1.126084432,1.451041051,0.14676843,0.272435365,23.98447383,0,-0.977433414,1.198260338,-0.815710395,0.414665792,0.556331365,33.49945218,0,-0.627056639,1.023980243,-0.612371814,0.540291786,0.671303759,40.47399588,0,1.128315963,0.667851357,1.689471695,0.091129072,0.177986468,N,-,,Sin3 associated polypeptide p18,,IPR010516 (PFAM); IPR010516 (PANTHER),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_04377,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,60.62082694,0,0.974143619,0.638714055,1.525163899,0.127218222,0.2630789,6.019913082,0,0.875711191,1.237273463,0.707774972,0.479085011,0.636307372,15.68068626,0,-1.782025484,1.200178811,-1.484799988,0.137596815,0.24594459,31.41759307,0,-0.469916591,1.024262516,-0.458785305,0.646388348,0.757574028,15.52750672,0,-1.870515636,1.209374289,-1.546680504,0.121940307,0.221897949,N,-,,mRNA splicing factor,"C:spliceosomal complex; C:spliceosomal snRNP complex; P:mRNA splicing, via spliceosome",IPR014906 (SMART); IPR014906 (PFAM); G3DSA:1.20.940.10 (GENE3D); IPR004098 (PFAM); PTHR13007 (PANTHER); PTHR13007:SF19 (PANTHER); PTHR13007 (PANTHER); IPR014906 (SUPERFAMILY); SSF47938 (SUPERFAMILY),1.B.12.3.1, the autotransporter-1 (at-1) family.
RL4_JR_04378,184,214,252,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,98.53613643,0,0.477248094,0.57520717,0.82969775,0.406709694,0.598341715,88.39004791,0,1.593897858,0.991064159,1.608269095,0.107776256,0.214450809,49.82681971,1,-0.33524936,0.867282228,-0.386551631,0.699088172,0.795222511,70.94738307,0,-0.09172822,0.688227527,-0.133281824,0.893970501,0.934681054,29.7905476,0,-2.810541025,1.199334131,-2.343417861,0.019107969,0.052744871,N,-,,cop9 signalosome subunit 1,C:COP9 signalosome; P:COP9 signalosome assembly; P:cullin deneddylation,SM00753 (SMART); IPR000717 (SMART); IPR000717 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); IPR019585 (PFAM); PTHR14145 (PANTHER); IPR033008 (PTHR14145:PANTHER); IPR011991 (SUPERFAMILY),,
RL4_JR_04379,253,272,590,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34.30368839,0,-1.86667313,1.164649641,-1.602776547,0.108983997,0.23570823,8.491980087,0,0.37946824,1.259394836,0.301309985,0.763178127,0.856512807,78.59308552,0,1.174020376,0.653722148,1.795901179,0.072510235,0.151172491,25.19867627,0,-2.682422772,1.213273155,-2.210897654,0.027042925,0.087339591,21.36358709,0,-2.330907542,1.209410831,-1.927308308,0.053941219,0.118680797,N,-,,fungal specific transcription factor,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR007219 (SMART); IPR001138 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31001 (PANTHER); PTHR31001:SF56 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04380,20041,19458,25772,3,6,7,0,0,1,0,4,2,0,5,0,0,6,1,56.54509243,1,0.717247167,0.784923461,0.913779754,0.360832587,0.552283723,8.291512588,1,0.413922552,1.283407686,0.322518368,0.747060025,0.844887326,50.09114356,1,0.192713286,0.903543276,0.213286171,0.831103759,0.890716113,63.28877932,1,0.489984012,1.45292161,0.337240502,0.735935608,0.823808516,44.19384926,1,0.79628455,0.744262089,1.06989804,0.284665206,0.418929536,N,-,,xaa-pro dipeptidase,"F:metal ion binding; F:peptidase activity, acting on L-amino acid peptides",IPR007865 (SMART); IPR029149 (G3DSA:3.40.350.GENE3D); IPR000994 (G3DSA:3.90.230.GENE3D); IPR007865 (PFAM); IPR000994 (PFAM); PTHR10804:SF97 (PANTHER); PTHR10804 (PANTHER); PTHR10804:SF97 (PANTHER); PTHR10804 (PANTHER); PTHR10804 (PANTHER); IPR000994 (SUPERFAMILY); IPR028980 (SUPERFAMILY),,
RL4_JR_04381,2376,2704,3826,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,23.26716878,1,2.87389344,0.664236578,4.326611232,1.51E-05,0.000165367,1.332782465,0,3.051096809,1.353912207,2.253541103,0.024225052,0.066868279,16.45289643,0,2.220691359,1.031410451,2.153062688,0.031313752,0.079374168,28.05567118,0,3.275716469,0.613643097,5.338146044,9.39E-08,2.13E-06,7.263791569,0,1.249579658,1.123990165,1.111735402,0.266251934,0.398500234,Y,-,,lectin family integral membrane,C:membrane,IPR005052 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); PTHR12223 (PANTHER); PTHR12223:SF26 (PANTHER); IPR005052 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),,
RL4_JR_04382,14562,13058,10179,0,1,8,0,0,3,1,2,3,0,2,0,0,6,5,73.03278928,1,1.030711057,0.57505756,1.792361543,0.073075071,0.176322516,6.796270284,1,0.700790161,1.226843892,0.5712138,0.567854725,0.709257839,28.70107627,1,-0.989224402,1.189386564,-0.83170975,0.405572796,0.547834421,103.8304759,1,1.712092711,0.488420957,3.505362915,0.000455985,0.003873197,25.09224125,1,-0.363175702,0.974239622,-0.37277862,0.709313216,0.794676225,N,-,,"dolichyl pyrophosphate Glc1Man9 c2 alpha-1,3-glucosyltransferase",,IPR004856 (PFAM); PTHR12413:SF2 (PANTHER); IPR004856 (PANTHER),,
RL4_JR_04383,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,88.757991,0,-0.072197197,0.63190455,-0.114253326,0.909036981,0.955724256,14.64983749,0,-0.407255075,1.245742604,-0.326917514,0.743730274,0.842062398,37.6820593,0,-3.046790283,1.214181365,-2.509337049,0.012095801,0.037494761,59.49422352,0,-0.789621684,0.804393023,-0.981636664,0.326278878,0.472884861,48.03311668,0,-1.437292161,0.994290139,-1.445546028,0.148304574,0.25694907,N,-,,chromatin assembly,P:negative regulation of transcription from RNA polymerase II promoter by pheromones; P:chromatin remodeling; P:chromatin silencing at telomere; C:CHRAC,IPR013136 (PFAM); IPR018501 (PFAM); IPR028941 (PFAM); IPR028942 (PFAM); PTHR32075:SF6 (PANTHER); PTHR32075 (PANTHER); IPR013136 (PROSITE_PROFILES); IPR018501 (PROSITE_PROFILES),,
RL4_JR_04384,7576,7827,10118,0,9,9,0,0,1,4,7,5,1,13,1,0,5,5,0.25183344,1,3.886851901,2.905463798,1.337773303,0.180970347,NA,0.078280542,1,7.139712018,2.361062948,3.023939715,0.002495062,0.015349618,0.207415787,1,4.456349199,1.552951377,2.869599953,0.004109914,0.016643508,0.239547987,1,4.033603682,1.970016333,2.047497583,0.040609254,0.108573725,0.209529956,1,4.341345652,1.451103679,2.991754286,0.002773794,0.01112264,N,-,,C-x8-C-x5-C-x3-H type zinc finger,,IPR000571 (PROSITE_PROFILES),,
RL4_JR_04385,287,208,345,3,1,0,0,0,0,0,7,5,1,0,0,0,2,0,34.6251134,1,-0.741468259,1.010690571,-0.733625385,0.463177085,0.651257956,6.603622657,0,0.742223702,1.226352625,0.605228616,0.545027105,0.691497161,17.16329581,1,-1.912356589,1.192317495,-1.603898791,0.108736363,0.206294465,69.40866372,1,1.210367071,0.572654773,2.113606884,0.034548857,0.099426657,16.95661935,1,-1.997548316,1.198742461,-1.666369867,0.095639769,0.184528877,N,-,,COP9 signalosome complex subunit 3,P:biological_process; F:molecular_function,PTHR10758:SF1 (PANTHER); PTHR10758 (PANTHER); PTHR10758 (PANTHER); PTHR10758:SF1 (PANTHER); PTHR10758 (PANTHER); PTHR10758:SF1 (PANTHER),,
RL4_JR_04386,1629,1449,2533,3,0,4,0,0,1,0,0,0,0,1,2,0,4,0,61.01733614,1,-0.762718657,0.755259842,-1.009875825,0.312554786,0.500580543,13.29694969,1,-0.267465005,1.218134962,-0.219569271,0.826206626,0.89567688,56.5368804,0,-1.082951015,1.034680618,-1.04665246,0.295259897,0.436190165,70.33502848,1,-0.288254155,0.6790423,-0.424501028,0.671200456,0.776319924,60.800799,1,0.406413503,0.591982484,0.686529608,0.4923792,0.620688149,N,-,,replication factor-a 1,"C:site of double-strand break; P:reciprocal meiotic recombination; P:heteroduplex formation; F:double-stranded DNA binding; P:double-strand break repair via homologous recombination; P:nucleotide-excision repair; C:DNA replication factor A complex; F:sequence-specific DNA binding; P:telomere maintenance via recombination; P:DNA topological change; P:DNA unwinding involved in DNA replication; P:premeiotic DNA replication; C:condensed nuclear chromosome; F:single-stranded DNA binding; C:chromosome, telomeric region; P:mitotic DNA replication; C:cytosol; P:protein ubiquitination",G3DSA:2.40.50.140 (GENE3D); IPR031657 (PFAM); IPR013955 (PFAM); G3DSA:2.40.50.140 (GENE3D); IPR007199 (PFAM); IPR004365 (PFAM); IPR004591 (TIGRFAM); G3DSA:2.40.50.140 (GENE3D); G3DSA:2.40.50.140 (GENE3D); PTHR23273:SF4 (PANTHER); PTHR23273 (PANTHER); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY),,
RL4_JR_04387,1932,1565,1986,0,0,9,0,0,0,1,0,0,1,3,0,0,6,0,47.09253588,1,-0.775166872,0.887396778,-0.873529059,0.382374774,0.574583424,9.958800313,0,0.149519591,1.23107604,0.121454391,0.903331138,0.945652888,108.1403474,1,1.643423492,0.525749613,3.125867242,0.001772816,0.008996484,52.5760777,1,-0.602212309,0.874453702,-0.688672605,0.49102932,0.630442793,94.80255332,1,1.862119749,0.638619522,2.915851591,0.003547192,0.013532524,N,-,,dienelactone hydrolase family,F:hydrolase activity,IPR002925 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR17630 (PANTHER); PTHR17630 (PANTHER); PTHR17630:SF34 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_04388,2675,2008,2965,2,0,0,0,0,1,2,0,0,0,1,0,0,0,0,177.3022292,1,0.438934938,0.38933246,1.127403912,0.259571746,0.438968968,36.24666101,1,-0.3651516,1.114461741,-0.327648394,0.743177527,0.841624852,112.5403016,1,-0.526126484,0.611005839,-0.86108258,0.389192563,0.532735336,195.262149,1,0.789219953,0.369991695,2.133074781,0.032918592,0.097138839,129.0298954,0,0.295949787,0.437577145,0.676337396,0.498826455,0.626627526,N,-,,hypothetical protein F503_05006,,IPR024312 (PFAM); PTHR13924 (PANTHER); PTHR13924:SF10 (PANTHER),,
RL4_JR_04389,1162,812,907,0,0,1,0,0,0,3,0,2,0,0,0,0,0,0,62.89050784,1,0.936021343,0.507985195,1.8426154,0.065385184,0.162378183,9.119532087,0,0.276562508,1.216629187,0.227318653,0.82017597,0.891422868,30.13507996,1,-1.412192645,1.187822457,-1.188892024,0.234482159,0.366738356,27.26518572,0,-2.796217355,1.186509836,-2.356674399,0.018439407,0.074086903,23.2848658,0,-2.455124349,1.190287112,-2.062632053,0.0391476,0.092436905,N,-,,#NAME?,F:DNA binding; P:cellular process,IPR018004 (SMART); IPR003163 (G3DSA:3.10.260.GENE3D); PTHR24157 (PANTHER); PTHR24157:SF0 (PANTHER); IPR003163 (PROSITE_PROFILES); IPR003163 (SUPERFAMILY),,
RL4_JR_04390,3387,3761,7967,2,0,1,1,0,0,0,0,1,0,3,0,0,1,1,1.59002481,1,1.228817718,1.35617127,0.906093312,0.364886465,NA,9.883575652,1,5.36565469,1.154332407,4.64827519,3.35E-06,0.00025863,1.312399539,1,1.797015123,1.242920345,1.445800714,0.148233106,0.259903755,1.51428163,1,1.374360971,1.270105874,1.082083785,0.2792153,0.422642385,1.29440329,1,1.714384384,1.231222827,1.392424138,0.163793999,0.276540644,N,-,,propionate- ligase,P:metabolic process; C:integral component of membrane; F:ligase activity,G3DSA:2.30.38.10 (GENE3D); G3DSA:3.30.300.30 (GENE3D); IPR025110 (PFAM); IPR000873 (PFAM); G3DSA:3.40.50.980 (GENE3D); PTHR24095:SF167 (PANTHER); PTHR24095:SF167 (PANTHER); PTHR24095 (PANTHER); PTHR24095 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.4, the fatty acid transporter (fat) family.
RL4_JR_04391,7854,7930,12075,0,0,3,0,0,0,1,1,0,0,3,0,0,8,1,1.027942937,1,1.858163425,1.551519885,1.197640742,0.231056908,NA,0.328467268,0,5.07187089,1.709652698,2.966608889,0.003011037,0.015629599,0.849204679,1,2.425569511,1.282160628,1.891782869,0.058519917,0.127601903,0.979575255,1,2.003055743,1.344943209,1.489323661,0.13640216,0.247903764,0.832237142,1,2.351635129,1.252953539,1.876873368,0.060535452,0.12966082,N,-,,amp-binding enzyme,F:catalytic activity; C:membrane; P:metabolic process,IPR032387 (PFAM); G3DSA:3.40.50.980 (GENE3D); IPR000873 (PFAM); PTHR24095:SF167 (PANTHER); PTHR24095 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.7, the fatty acid transporter (fat) family.
RL4_JR_04392,1985,1906,3271,0,0,0,0,0,0,0,0,2,0,2,0,0,0,0,9004.294585,0,2.67386104,0.414550652,6.450022514,1.12E-10,3.83E-09,1203.134864,0,1.165118167,0.759131424,1.534804291,0.124831908,0.240218361,5082.098624,1,2.013028583,0.41205624,4.885324842,1.03E-06,2.79E-05,5280.841203,1,1.823133265,0.36567432,4.98567486,6.17E-07,1.18E-05,3291.737309,0,1.210026485,1.09651693,1.103518287,0.269802154,0.40202737,Y,-,,clock-controlled 6,P:fungal-type cell wall organization; C:fungal-type cell wall; F:structural constituent of cell wall,PTHR35523:SF1 (PANTHER); PTHR35523 (PANTHER),,
RL4_JR_04393,1435,1261,1798,0,1,12,0,0,0,0,0,0,0,3,1,0,0,4,45.49656444,1,1.88686418,0.658152307,2.86691114,0.004144994,0.018589807,3.167930282,0,1.801908559,1.284559331,1.402744518,0.160693037,0.291484844,47.97085056,0,1.982432412,0.763323269,2.597107273,0.009401256,0.031144736,9.534664389,1,-1.280435771,1.212534279,-1.055999647,0.290968376,0.435788612,8.1872782,1,-0.947095784,1.221545411,-0.775325891,0.438147114,0.572344153,N,-,,zinc-binding alcohol dehydrogenase domain-containing 2,F:zinc ion binding; P:mycelium development; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR014189 (TIGRFAM); IPR013149 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013154 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); PTHR11695:SF610 (PANTHER); IPR002085 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_04394,5600,6326,11609,0,0,3,0,0,0,0,0,0,0,1,0,0,2,0,100.8426329,1,-0.049230446,0.552760273,-0.089062923,0.929031903,0.96586144,17.81012627,0,-0.689153928,1.207556092,-0.570701379,0.568202084,0.709429072,85.57986095,0,-0.199236161,0.687394513,-0.289842524,0.771936714,0.847439524,166.6834844,1,1.055557188,0.444123732,2.37671872,0.017467402,0.072063371,49.76250015,1,-2.505117437,1.136452775,-2.204330434,0.027501114,0.070404243,N,-,,glutamate-5-semialdehyde dehydrogenase,F:NADP binding; C:cytosol; F:glutamate-5-semialdehyde dehydrogenase activity; P:proline biosynthetic process; P:oxidation-reduction process,IPR015590 (PFAM); IPR016163 (G3DSA:3.40.309.GENE3D); IPR016162 (G3DSA:3.40.605.GENE3D); IPR000965 (TIGRFAM); IPR012134 (PIRSF); PTHR11063 (PANTHER); PTHR11063:SF8 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_04395,2614,3716,4499,0,0,21,1,0,0,0,0,0,3,8,0,0,6,0,41.06569361,1,0.961560209,0.672696996,1.429410589,0.152886257,0.30095077,5.051951609,1,1.12871577,1.254802001,0.89951703,0.368377329,0.532749724,13.05301727,0,-1.517311559,1.1979774,-1.266561088,0.205312273,0.33172382,15.05401958,1,-1.939252445,1.196192164,-1.621188052,0.104977314,0.203347103,24.39949511,1,0.608614241,0.848310657,0.717442644,0.473101015,0.603721317,N,-,,major facilitator superfamily transporter,F:polyamine transmembrane transporter activity; P:polyamine homeostasis; P:drug transmembrane transport; P:polyamine transmembrane transport; C:integral component of membrane; P:ascospore wall assembly; C:plasma membrane; F:drug transmembrane transporter activity,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502:SF5 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.43, the major facilitator superfamily (mfs).
RL4_JR_04396,264,212,176,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,262.5293429,0,-0.949152504,0.685019204,-1.385585249,0.165873585,0.317577261,94.92778727,0,0.205438586,0.76746155,0.267685835,0.788941154,0.872654613,149.7105008,0,-5.037051001,1.203588964,-4.185025913,2.85E-05,0.00045246,309.7312993,0,-0.512829621,0.648466791,-0.790834053,0.429040835,0.571508809,152.2216063,0,-4.198390213,1.146882594,-3.660697473,0.00025153,0.001517722,N,-,,threonine dehydratase,F:pyridoxal phosphate binding; P:cellular amino acid metabolic process,IPR001926 (PFAM); G3DSA:3.40.50.1100 (GENE3D); PTHR10314 (PANTHER); PTHR10314 (PANTHER); PTHR10314:SF36 (PANTHER); PTHR10314:SF36 (PANTHER); IPR001926 (SUPERFAMILY),,
RL4_JR_04397,1852,1606,1688,0,0,1,0,0,0,0,0,0,1,0,3,0,0,0,0.040655356,1,6.518621066,3.932940008,1.657442283,0.097430089,NA,0.013041388,0,9.727547776,3.165694826,3.072800225,0.002120604,0.015045494,0.033597042,0,7.088252504,1.82116787,3.892146693,9.94E-05,0.001157574,0.038748174,1,6.663211741,3.389605292,1.965778068,0.049324252,0.121806843,0.032774608,0,7.020929816,1.388659574,5.05590423,4.28E-07,7.01E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_04398,48,45,19,0,0,4,0,0,0,0,0,0,0,2,2,0,0,0,2112.275984,1,-0.766258384,0.372639532,-2.056299233,0.039753682,0.112295893,771.8154149,0,-0.475487964,0.664319043,-0.715752423,0.474144235,0.631528467,1199.430276,0,-3.369153976,0.515326089,-6.537906869,6.24E-11,3.83E-09,1376.788849,1,-3.256080167,0.65869956,-4.94319469,7.69E-07,1.45E-05,1101.560584,0,-5.104991542,0.800747093,-6.375285762,1.83E-10,1.22E-08,N,-,,ketol-acid reductoisomerase,P:isoleucine biosynthetic process; P:mycelium development; F:metal ion binding; P:valine biosynthetic process; F:double-stranded DNA binding; P:oxidation-reduction process; C:mitochondrial nucleoid; F:ketol-acid reductoisomerase activity; F:isomerase activity; P:mitochondrial genome maintenance,IPR013328 (G3DSA:1.10.1040.GENE3D); IPR000506 (PFAM); IPR013023 (TIGRFAM); IPR016207 (PIRSF); IPR013116 (PFAM); IPR013023 (PANTHER); IPR008927 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_04399,5433,4446,6002,0,0,11,0,0,0,0,1,3,0,5,2,0,1,0,66.89478957,1,1.168805786,0.566532272,2.063087742,0.039104293,0.110922399,6.169972175,0,0.840252117,1.234513533,0.680634188,0.496102988,0.651219615,15.99025715,1,-1.810200119,1.192550843,-1.517922804,0.12903386,0.23465759,74.31845867,1,1.530442762,1.633572747,0.936868447,0.348826232,0.49556133,23.12031793,1,-0.957002962,1.123106197,-0.852103715,0.39415653,0.530837306,N,-, Effector probability:0.779,NEDD8-conjugating enzyme Ubc12,F:ATP binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; C:cytoplasm; P:protein neddylation; F:NEDD8 transferase activity,SM00212 (SMART); IPR000608 (PFAM); IPR016135 (G3DSA:3.10.110.GENE3D); PTHR24067 (PANTHER); PTHR24067:SF39 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),3.A.20.1.1, the peroxisomal protein importer (ppi) family.
RL4_JR_04400,777,801,588,0,0,22,0,0,0,2,0,1,0,1,1,0,0,1,42.63356416,1,-0.157389507,0.735955131,-0.213857477,0.830658202,0.915620809,8.736498909,0,0.338483723,1.216585005,0.278224474,0.780840049,0.867485783,22.64660435,1,-2.312203609,1.187437276,-1.947221682,0.051508163,0.115881921,48.7607792,1,-0.415212386,0.843319589,-0.492354727,0.622468598,0.739784671,22.29903294,1,-2.392666646,1.188411421,-2.013331918,0.044079723,0.101618213,N,-,,chitin synthase 1,P:chitin biosynthetic process; C:integral component of membrane; F:chitin synthase activity; P:cell wall organization; C:plasma membrane,IPR013616 (PFAM); IPR004834 (PFAM); PTHR22914:SF11 (PANTHER); IPR004835 (PANTHER); IPR004834 (PRODOM); IPR029044 (SUPERFAMILY),4.D.1.1.12, the putative vectorial glycosyl polymerization (vgp) family.
RL4_JR_04401,1669,1586,1624,1,5,6,0,0,0,2,0,3,1,3,0,0,0,1,82.69137748,1,0.015686971,0.548340253,0.028608096,0.977177155,0.988445286,92.06529018,0,1.194894026,0.985134657,1.212924566,0.225158662,0.374352165,124.4454407,1,1.152536003,0.474082095,2.431089499,0.015053496,0.044640184,302.6976425,1,2.627018453,0.409506373,6.415085637,1.41E-10,5.28E-09,96.62454575,1,1.137083156,0.488049377,2.329852696,0.019813938,0.054235232,N,-,,opy2,P:mycelium development; C:membrane,IPR018571 (PFAM); PTHR12231:SF89 (PANTHER); PTHR12231 (PANTHER); PTHR12231:SF89 (PANTHER); PTHR12231 (PANTHER); PTHR12231:SF89 (PANTHER); PTHR12231 (PANTHER),,
RL4_JR_04402,86,101,103,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,39.13534555,0,-3.392741102,1.20594564,-2.813344971,0.004902902,0.021412139,12.62856833,0,-0.193064072,1.239754685,-0.155727641,0.876247709,0.928925357,32.5283472,0,-2.834618469,1.207298248,-2.347902413,0.018879467,0.053599474,37.50776702,0,-3.256282727,1.208299313,-2.694930545,0.00704033,0.03668726,35.69664069,1,-1.97710893,1.134458655,-1.742777421,0.081372502,0.163439115,N,-, Effector probability:0.635,Ras-2,F:GTP binding; P:small GTPase mediated signal transduction; C:membrane; C:intracellular; F:hydrolase activity,PR00449 (PRINTS); SM00175 (SMART); SM00173 (SMART); SM00174 (SMART); IPR005225 (TIGRFAM); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24070:SF249 (PANTHER); IPR020849 (PANTHER); IPR020849 (PANTHER); PTHR24070:SF249 (PANTHER); IPR020849 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_04403,89,148,155,0,0,1,0,0,0,0,0,2,1,3,0,0,4,0,58.80994641,1,-0.384971208,0.674840341,-0.570462648,0.568363949,0.744973184,12.73153811,0,-0.204775718,1.216370538,-0.168349784,0.86630811,0.922091327,52.41055794,1,-0.449480179,0.854736997,-0.525869572,0.598978832,0.717921094,84.66880746,1,0.605703381,0.521172718,1.162193185,0.245157002,0.383827841,32.31621632,1,-2.927976847,1.188360169,-2.463879995,0.013744212,0.040524213,N,-,,GPI ethanolamine phosphate transferase 1,C:endoplasmic reticulum membrane; P:GPI anchor biosynthetic process; F:mannose-ethanolamine phosphotransferase activity; F:sulfuric ester hydrolase activity; C:integral component of membrane; P:cell wall organization,IPR017849 (G3DSA:3.40.720.GENE3D); IPR002591 (PFAM); IPR017852 (PFAM); IPR007070 (PANTHER); IPR017850 (SUPERFAMILY),9.A.6.1.1, the atp exporter (atp-e) family.
RL4_JR_04404,258,183,273,0,0,17,0,0,0,0,0,5,8,22,14,0,5,3,254.181989,1,0.143564593,0.563003311,0.254997778,0.798724816,0.897559449,36.9875572,0,-1.743432651,1.209711925,-1.441196548,0.149529163,0.276041253,108.4549923,1,-2.570075324,1.041855102,-2.466826068,0.013631655,0.04119839,226.959166,1,0.089051145,0.416987211,0.213558456,0.8308914,0.894259752,176.7654387,1,0.205272992,0.432607308,0.474501904,0.63514204,0.738133087,N,-,,cullin family,F:ubiquitin protein ligase binding; C:cullin-RING ubiquitin ligase complex; F:serine-type endopeptidase activity; F:ligase activity; P:ubiquitin-dependent protein catabolic process,IPR016158 (SMART); IPR019559 (SMART); G3DSA:1.20.1310.10 (GENE3D); IPR019559 (PFAM); G3DSA:1.20.1310.10 (GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); G3DSA:1.20.1310.10 (GENE3D); G3DSA:4.10.1030.10 (GENE3D); IPR001373 (PFAM); PTHR11932 (PANTHER); PTHR11932:SF81 (PANTHER); IPR016158 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY); IPR016159 (SUPERFAMILY); IPR016158 (SUPERFAMILY),,
RL4_JR_04405,1111,1369,1148,2,0,2,0,0,0,1,0,0,0,9,1,0,0,0,103.4790904,1,0.079367218,0.530840108,0.149512474,0.881149267,0.94187837,16.68085217,0,-0.594636626,1.2063903,-0.492905676,0.622079236,0.751292402,43.34994098,1,-3.249018216,1.194490723,-2.720002889,0.006528135,0.023271421,59.32478929,1,-2.721339104,1.14768789,-2.371149098,0.017732876,0.072500326,46.70219137,0,-2.405136842,1.130624854,-2.127263375,0.033398206,0.081798944,N,-,,Pro-apoptotic serine protease NMA111,C:nucleus; F:ubiquitin protein ligase binding; P:apoptotic process; F:serine-type endopeptidase activity; P:ubiquitin-dependent protein catabolic process,IPR001940 (PRINTS); G3DSA:2.40.10.10 (GENE3D); IPR001478 (G3DSA:2.30.42.GENE3D); IPR025926 (PFAM); G3DSA:2.40.10.10 (GENE3D); PF13365 (PFAM); G3DSA:2.40.10.10 (GENE3D); PTHR22939:SF66 (PANTHER); PTHR22939 (PANTHER); IPR009003 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR009003 (SUPERFAMILY); IPR001478 (SUPERFAMILY); IPR001478 (SUPERFAMILY),,
RL4_JR_04406,2747,3051,3369,0,0,11,2,0,0,0,0,1,3,19,6,0,5,0,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,PS51257 (PROSITE_PROFILES),,
RL4_JR_04407,4593,4024,6550,0,0,3,0,0,0,2,1,1,4,8,3,0,2,0,64.98488454,1,-1.059326316,0.801001597,-1.322502126,0.186001002,0.343846855,15.7414862,0,-0.511039357,1.21864322,-0.419351085,0.674959567,0.792325758,85.36030531,1,-0.065192802,1.361077296,-0.047897943,0.961797579,0.97753626,75.34341357,1,-1.235974345,0.876717687,-1.409774621,0.158606243,0.277259705,40.77211214,1,-3.26328888,1.217180295,-2.681023423,0.007339738,0.024514063,N,-,,hypothetical protein HIM_09855,,no IPS match,,
RL4_JR_04408,414,381,585,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,151.7990472,0,-0.695249775,0.501928011,-1.385158349,0.166004054,0.317676454,38.21108681,0,-0.466495634,1.108093547,-0.420989397,0.673762824,0.791898201,96.93659724,0,-2.207540327,1.026406001,-2.150747683,0.031496121,0.079756559,113.2558076,0,-1.726178723,0.735793653,-2.346009259,0.018975636,0.074903827,115.504933,0,-0.343546567,0.522487089,-0.657521639,0.510845562,0.637219578,N,-,,metalloprotease m41,F:oxidoreductase activity; C:membrane; P:proteolysis; C:integral component of membrane; P:oxidation-reduction process; F:peptidase activity; F:metallopeptidase activity,no IPS match,,
RL4_JR_04409,2008,2670,1989,0,6,1,1,0,0,0,1,0,2,4,0,0,0,1,27.22992909,1,1.011451653,0.777013043,1.301717727,0.193012897,0.354001622,3.844938881,1,1.522638008,1.286419972,1.183624354,0.236561795,0.387268073,16.41380852,1,-0.158691945,1.205834463,-0.131603425,0.895297976,0.934625357,25.08123549,1,0.192788635,1.031963963,0.186817217,0.851803948,0.907461592,13.56658089,1,-0.263326002,1.13385496,-0.232239582,0.816351936,0.876517853,N,-,,inner centromere,,IPR005635 (PFAM),,
RL4_JR_04410,4749,3684,5137,0,1,5,0,0,1,0,0,2,0,3,0,0,0,3,100.114982,1,-0.705808122,0.612470362,-1.152395554,0.249158567,0.425950459,19.4200574,1,-0.813933091,1.208161272,-0.673695731,0.500504777,0.654538938,50.203874,1,-3.460731831,1.191721157,-2.90397784,0.003684542,0.015684377,61.91416384,1,-2.935619707,1.144249799,-2.565540942,0.010301506,0.049644337,57.04004532,1,-1.867239283,0.969934753,-1.925118444,0.054214542,0.119123749,N,-,,domain-containing,,no IPS match,,
RL4_JR_04411,25277,22034,29583,1,14,19,2,0,3,0,1,6,1,8,0,0,8,1,71.20523877,1,-1.290467357,0.910400082,-1.417472804,0.15634474,0.305719173,15.27065991,1,-0.467154336,1.255010623,-0.37223138,0.709720584,0.817454683,39.29669617,1,-3.107351834,1.223128401,-2.540495202,0.011069561,0.035487092,53.32996964,1,-1.823711817,1.06516296,-1.71214348,0.08687023,0.176088305,53.19299817,1,-1.473805108,1.006477927,-1.464319355,0.143106711,0.249949189,N,-,,guanine nucleotide-binding alpha-3 subunit,P:positive regulation of cAMP-dependent protein kinase activity; C:cell division site; P:regulation of cell size; P:pseudohyphal growth; P:positive regulation of cAMP biosynthetic process; P:signal transduction involved in regulation of aerobic respiration; C:mitotic spindle pole body; F:signal transducer activity; P:negative regulation of transcription from RNA polymerase II promoter by glucose; P:replicative cell aging; F:GTP binding; P:adenylate cyclase-activating glucose-activated G-protein coupled receptor signaling pathway; P:ascospore formation; C:nucleus; F:G-protein coupled receptor binding; C:heterotrimeric G-protein complex; P:detection of glucose; F:GTPase activity; C:mitochondrion; C:cytosol; F:G-protein beta/gamma-subunit complex binding,IPR002975 (PRINTS); IPR001019 (PRINTS); IPR001019 (SMART); IPR011025 (G3DSA:1.10.400.GENE3D); IPR001019 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10218:SF234 (PANTHER); IPR001019 (PANTHER); IPR011025 (SUPERFAMILY); IPR027417 (SUPERFAMILY),8.A.92.1.1,The G-Protein αβγ Complex (GPC) Family
RL4_JR_04412,256,200,310,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,482.5765018,0,0.031448347,0.507572629,0.06195832,0.950596024,0.975835204,74.01335601,0,-2.744202945,1.208581734,-2.270597733,0.023171341,0.064682932,492.913792,0,0.678609125,0.469559655,1.445203221,0.148400812,0.260067478,368.0655965,0,-0.716141197,0.445596452,-1.607151929,0.108021044,0.20777224,257.8723132,0,-1.377219911,0.590539335,-2.332139163,0.019693371,0.053999799,N,-,,glycogen phosphorylase,F:glycogen phosphorylase activity; F:pyridoxal phosphate binding; C:cytoplasm; P:glycogen catabolic process,IPR011833 (TIGRFAM); IPR000811 (PIRSF); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); IPR000811 (PFAM); PTHR11468:SF3 (PANTHER); IPR000811 (PANTHER); SSF53756 (SUPERFAMILY),,
RL4_JR_04413,28583,28185,34130,3,0,55,0,0,5,5,7,2,4,23,5,0,8,7,118.709972,1,0.8524819,0.551330153,1.546227602,0.12204961,0.255499285,58.76039769,1,1.341153434,1.015659459,1.320475501,0.18667631,0.326683543,119.772274,1,1.369560766,0.531475238,2.576904184,0.009968958,0.032577705,106.0290273,1,0.830006466,0.548753589,1.512530366,0.130398994,0.239356383,51.01959925,1,-0.483651553,0.796325032,-0.607354451,0.54361571,0.665424643,N,-,,CMGC MAPK P38 kinase,"P:regulation of cAMP-mediated signaling by regulation of transcription from RNA polymerase II promoter; F:MAP kinase activity involved in osmosensory signaling pathway; P:regulation of histone acetylation; P:positive regulation of recombination hotspot binding; F:SAP kinase activity; P:positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress; F:ATP binding; P:regulation of mRNA stability involved in cellular response to UV; P:MAPK cascade involved in osmosensory signaling pathway; P:response to arsenic-containing substance; P:cellular response to cation stress; C:cytosol; P:mRNA export from nucleus in response to heat stress; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of transcription factor import into nucleus in response to oxidative stress; P:transcription, DNA-templated; C:mitochondrial inner membrane; P:hyperosmotic response; P:MAPK cascade in response to starvation; C:nucleus; P:regulation of cytoplasmic translation in response to stress; C:mitochondrial intermembrane space; P:positive regulation of protein kinase activity; P:regulation of chromatin disassembly; P:regulation of chromatin assembly; P:regulation of reciprocal meiotic recombination",IPR008352 (PRINTS); IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); PTHR24055 (PANTHER); PTHR24055:SF215 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_04414,1504,1148,1745,0,0,4,0,0,0,0,1,0,3,2,1,0,0,0,37.29346535,1,0.14941116,0.745888185,0.20031308,0.841235733,0.919823229,7.060890382,0,0.645682671,1.235650202,0.522544868,0.601291015,0.735589516,18.27029965,1,-2.002472298,1.195158533,-1.675486759,0.093838767,0.184829509,62.65642166,1,0.648243008,0.672609572,0.963773093,0.3351597,0.481892941,32.70369582,0,-0.39486691,0.972704101,-0.405947615,0.684781091,0.77624368,N,-,,lalv9 family,P:post-Golgi vesicle-mediated transport; C:intracellular,IPR018307 (PFAM); PTHR31017 (PANTHER); PTHR31017:SF1 (PANTHER),,
RL4_JR_04415,21175,23302,30422,1,7,24,4,0,0,10,2,0,1,5,0,0,4,3,31.50744498,1,-1.707190291,1.141198394,-1.495962753,0.134663362,0.273619852,7.482599314,1,0.561959978,1.219882467,0.460667313,0.64503731,0.769755677,19.43789553,1,-2.091857789,1.189838903,-1.758101693,0.078730208,0.160734342,31.73808466,1,-1.565092083,1.140351421,-1.37246471,0.169918817,0.291993895,33.91819669,1,-0.489391765,0.972204443,-0.503383592,0.614694606,0.722016576,N,-,,tRNA nucleotidyltransferase,,IPR032828 (PFAM); G3DSA:3.30.460.10 (GENE3D); G3DSA:1.10.3090.10 (GENE3D); IPR002646 (PFAM); PTHR13734:SF5 (PANTHER); PTHR13734 (PANTHER); SSF81891 (SUPERFAMILY); SSF81301 (SUPERFAMILY),,
RL4_JR_04416,82882,70718,26081,4,13,12,0,0,0,4,1,0,0,3,2,0,3,2,98.88403311,1,1.660471153,1.034808473,1.604616889,0.108578142,0.235079746,8.476920647,0,0.381991224,1.251463218,0.305235678,0.760186661,0.854741965,44.07558199,1,0.141457336,0.875863807,0.161506087,0.871694818,0.91895644,73.8855182,1,1.032619802,0.584538901,1.766554458,0.077302874,0.162519019,55.53596757,1,1.06655275,0.618512165,1.724384434,0.084638466,0.168395454,N,-,,ubiquitin- ligase,C:membrane; F:transferase activity,PF13920 (PFAM); PTHR12183 (PANTHER); PTHR12183 (PANTHER); PTHR12183:SF15 (PANTHER); PTHR12183 (PANTHER); PTHR12183:SF15 (PANTHER); PTHR12183:SF15 (PANTHER),,
RL4_JR_04417,134,95,113,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,74.63040149,1,-4.324033573,1.231377348,-3.511542242,0.000445515,0.003059351,23.55487096,0,-1.092481808,1.222306812,-0.893786893,0.371435923,0.535947885,61.60360167,0,-3.755980993,1.217144265,-3.085896307,0.002029396,0.009954265,88.43554875,0,-1.874745259,0.899910237,-2.083258064,0.037227707,0.10262198,61.27309075,0,-3.850960146,1.229003537,-3.133400377,0.001727936,0.007502293,N,-,,tRNA-splicing endonuclease subunit sen34,P:nucleic acid phosphodiester bond hydrolysis; P:tRNA processing; F:nuclease activity,IPR006677 (PFAM); IPR011856 (G3DSA:3.40.1350.GENE3D); IPR016690 (PIRSF); PTHR13070 (PANTHER); IPR006677 (SUPERFAMILY),,
RL4_JR_04418,24,14,21,0,0,10,0,0,0,0,0,0,0,1,0,0,3,0,36.89973744,1,-0.716131598,1.053332179,-0.679872515,0.496585186,0.683971102,6.585453489,0,0.746152388,1.260374955,0.592008263,0.553845055,0.699568308,17.22630788,0,-1.917630018,1.220779318,-1.570824464,0.116223428,0.216973259,19.88234692,1,-2.340663775,1.222954192,-1.913942313,0.055627527,0.130813304,17.13295671,1,-2.012463028,1.235257207,-1.629185418,0.103273773,0.195645554,N,-,,elongator complex 4,C:intracellular part,IPR008728 (PFAM); IPR008728 (PANTHER); IPR008728 (PANTHER); PTHR12896:SF1 (PANTHER); PTHR12896:SF1 (PANTHER),,
RL4_JR_04419,2114,3083,3001,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,138.5900581,1,-2.665820998,0.901501299,-2.957090578,0.003105569,0.014801733,37.512309,0,-1.763802381,1.211735741,-1.455599865,0.145503266,0.270732363,126.6627555,0,-1.610997334,0.77685951,-2.073730595,0.038104338,0.091981001,113.0785341,0,-4.848370732,1.215243509,-3.98962899,6.62E-05,0.000752853,111.9927454,0,-2.810713476,1.009228469,-2.785012077,0.005352573,0.018942608,N,-,,RNA polymerase Rpb8,"F:DNA-directed RNA polymerase activity; P:transcription, DNA-templated",IPR005570 (SMART); IPR005570 (PIRSF); G3DSA:2.40.50.140 (GENE3D); IPR005570 (PFAM); IPR005570 (PANTHER); IPR012340 (SUPERFAMILY),,
RL4_JR_04420,155,225,219,0,0,8,0,0,0,0,2,1,2,3,0,0,0,0,154.7079001,1,-0.102844484,0.486184738,-0.211533757,0.832470794,0.916665376,26.78667222,0,-1.277959685,1.205739796,-1.059896745,0.289191577,0.448612589,77.54648054,1,-2.972406327,1.200598106,-2.475771294,0.013294871,0.040456049,153.6339448,1,-0.280352708,0.516792616,-0.542485901,0.587483817,0.71249801,68.99453081,0,-4.022196463,1.208032838,-3.329542325,0.000869888,0.004273469,N,-,,nudix hydrolase 20,F:hydrolase activity,IPR015797 (G3DSA:3.90.79.GENE3D); IPR000086 (PFAM); IPR031804 (PFAM); PTHR13622 (PANTHER); PTHR13622:SF8 (PANTHER); IPR000086 (PROSITE_PROFILES); IPR015797 (SUPERFAMILY),,
RL4_JR_04421,17385,15315,16224,5,23,11,2,0,4,0,12,2,0,8,7,0,1,0,138.979281,1,-2.223942227,0.771559945,-2.882397204,0.003946619,0.017837405,37.02154208,1,-1.744776525,1.213564318,-1.437728927,0.150510982,0.277382577,102.2853392,1,-3.430979484,1.204074241,-2.849475029,0.004379144,0.017197229,129.0992721,1,-3.059263868,1.032590838,-2.962706772,0.003049469,0.018872784,94.27449633,1,-4.47259025,1.207311517,-3.704586751,0.000211736,0.001309605,N,-,,duf775 domain containing,C:nucleus,IPR008493 (PFAM); IPR031318 (PTHR12925:PANTHER); PTHR12925 (PANTHER),,
RL4_JR_04422,13279,17022,21940,7,4,12,0,0,0,2,0,2,1,13,3,0,5,2,46.32397301,1,-0.511359225,0.854947924,-0.598117395,0.549761604,0.729379601,8.515502736,0,0.375461111,1.236183522,0.303726028,0.761336627,0.855489491,117.2272315,1,2.240558877,0.462774994,4.841572919,1.29E-06,3.37E-05,34.67222432,1,-1.741349199,1.149453076,-1.514937178,0.129788314,0.238505503,21.58163241,1,-2.345570039,1.195920504,-1.961309327,0.04984295,0.111823592,N,-,,GDA1 CD39 family,P:mycelium development; C:membrane; F:hydrolase activity,IPR000407 (PFAM); IPR000407 (PANTHER); PTHR11782:SF43 (PANTHER); IPR000407 (PANTHER),,
RL4_JR_04423,1467,1567,2019,0,2,4,0,0,0,0,3,4,2,11,0,0,0,9,0.863768473,1,2.108804674,1.569068361,1.343985212,0.178953169,NA,0.275257992,0,5.326541953,1.721923997,3.093366468,0.001978996,0.015023052,0.715570226,1,2.671132926,1.258818745,2.12193609,0.033843105,0.084432626,0.825550698,1,2.249009603,1.323738579,1.698983197,0.08932235,0.18004953,0.707631094,1,2.584991867,1.235939784,2.091519263,0.036481541,0.087571268,N,-,,nucleoside diphosphatase,C:membrane; C:integral component of membrane; F:hydrolase activity,no IPS match,,
RL4_JR_04424,4665,4160,6233,3,0,5,0,0,0,0,3,2,1,1,0,0,0,0,344.8459482,1,0.254340061,0.335497612,0.758097976,0.448392331,0.63750168,60.21253884,0,-1.284645085,1.108900522,-1.158485418,0.246665999,0.39973635,212.2424518,1,-0.705965636,0.504396323,-1.399624866,0.161625684,0.277244734,236.4839573,1,-0.845726467,0.441421851,-1.91591437,0.055375996,0.130512561,178.4336534,0,-1.299031727,0.558239763,-2.327013968,0.019964522,0.05451274,N,-,,mitochondrial pyruvate dehydrogenase kinase,,IPR004358 (PRINTS); IPR003594 (SMART); IPR018955 (G3DSA:1.20.140.GENE3D); IPR010259 (PFAM); IPR003594 (G3DSA:3.30.565.GENE3D); IPR018955 (PFAM); IPR010259 (G3DSA:3.30.70.GENE3D); IPR003594 (PFAM); PTHR11947:SF3 (PANTHER); PTHR11947 (PANTHER); IPR005467 (PROSITE_PROFILES); IPR003594 (SUPERFAMILY); IPR018955 (SUPERFAMILY); IPR009020 (SUPERFAMILY),,
RL4_JR_04425,1512,1758,2406,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,84.98692931,1,-0.653827731,0.707379083,-0.924296105,0.35533217,0.546221942,15.88639542,0,-0.524165222,1.237598249,-0.42353423,0.67190553,0.790633314,124.9257315,0,0.858980689,0.557066587,1.5419713,0.123080568,0.226146583,232.3989713,0,2.023778249,0.388924392,5.203526157,1.96E-07,4.13E-06,131.2112748,0,1.583649532,0.489752601,3.233570439,0.001222532,0.005639241,N,-,,chitin synthase,"C:myosin complex; F:DNA binding; F:ATP binding; F:transferase activity, transferring hexosyl groups; C:integral component of membrane; F:motor activity",IPR001609 (SMART); IPR001199 (PFAM); PF03142 (PFAM); IPR014876 (PFAM); IPR001199 (G3DSA:3.10.120.GENE3D); IPR009057 (G3DSA:1.10.10.GENE3D); IPR029044 (G3DSA:3.90.550.GENE3D); IPR001609 (PFAM); PTHR22914:SF13 (PANTHER); IPR004835 (PANTHER); IPR001199 (SUPERFAMILY); SSF109715 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR029044 (SUPERFAMILY),4.D.1.1.12, the putative vectorial glycosyl polymerization (vgp) family.
RL4_JR_04426,6001,4004,6005,8,7,2,0,0,1,0,0,0,1,1,0,0,0,0,269.950971,1,1.244629267,0.481042218,2.587359739,0.009671456,0.036954406,24.78654893,1,-1.165938895,1.220752892,-0.955098205,0.339528037,0.502373239,122.5920759,0,0.004946179,0.571538382,0.00865415,0.993095073,0.997232149,224.8874603,1,1.072622135,0.387119395,2.770778602,0.005592244,0.030622751,171.6427096,0,1.095985911,0.419249378,2.614162284,0.008944654,0.028732431,N,-,,Chitin synthase 8,,IPR001199 (SMART); IPR001609 (SMART); IPR001609 (PFAM); IPR014876 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); IPR001199 (G3DSA:3.10.120.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PF03142 (PFAM); IPR001199 (PFAM); IPR004835 (PANTHER); PTHR22914:SF18 (PANTHER); IPR001199 (PROSITE_PROFILES); IPR001609 (PROSITE_PROFILES); SSF109715 (SUPERFAMILY); IPR001199 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR029044 (SUPERFAMILY),4.D.1.1.12, the putative vectorial glycosyl polymerization (vgp) family.
RL4_JR_04427,4548,3240,3906,7,3,9,0,0,0,0,0,0,1,9,0,0,8,1,57.18641171,1,0.280939807,0.684867702,0.410210332,0.681651662,0.82563009,8.203066354,0,0.429410386,1.241834836,0.345787035,0.72950277,0.831160179,21.16577446,0,-2.214607433,1.200614811,-1.844561147,0.065101403,0.138842765,28.42113834,1,-1.689949341,1.152951782,-1.465758905,0.14271398,0.256611445,20.737205,1,-2.287955215,1.196881921,-1.911596436,0.055927977,0.121988532,N,-,,glutathione s-transferase gst3,F:transferase activity,IPR010987 (G3DSA:1.20.1050.GENE3D); IPR012336 (G3DSA:3.40.30.GENE3D); IPR004045 (PFAM); PF13410 (PFAM); IPR016639 (PIRSF); IPR016639 (PANTHER); PTHR32419:SF6 (PANTHER); IPR010987 (PROSITE_PROFILES); IPR010987 (SUPERFAMILY); IPR012336 (SUPERFAMILY),,
RL4_JR_04428,1339,1583,961,2,2,3,0,0,0,0,0,0,4,3,0,0,0,0,568.9695202,1,-0.325959132,0.860248383,-0.378912809,0.704752612,0.840182933,119.4828994,0,-1.556225226,1.010934558,-1.539392647,0.123708468,0.238705909,390.0785198,0,-1.00539908,0.440933662,-2.280159504,0.02259823,0.061303452,456.22881,1,-1.063596257,0.586015014,-1.814964177,0.069529415,0.150140351,337.3737856,0,-1.319479154,0.470063232,-2.807024809,0.005000139,0.017927198,N,-,,ubiquitin-activating enzyme e1 1,C:nucleus; F:ubiquitin-protein transferase activity; F:ATP binding; C:cytosol; F:ubiquitin activating enzyme activity; P:modification-dependent protein catabolic process; P:protein ubiquitination,IPR000011 (PRINTS); IPR018965 (SMART); IPR000594 (PFAM); IPR018965 (PFAM); IPR032420 (PFAM); IPR019572 (G3DSA:1.10.3240.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR032418 (PFAM); IPR018075 (TIGRFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR019572 (PFAM); PTHR10953:SF4 (PANTHER); PTHR10953 (PANTHER); IPR000594 (SUPERFAMILY); IPR000594 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_04429,23695,24796,30873,1,7,9,0,0,1,0,1,6,7,10,4,0,18,0,324.0346119,1,0.958313973,0.575184848,1.666097388,0.095694019,0.214234853,94.84604533,1,1.23575904,0.726663974,1.700592136,0.089019602,0.184870006,368.3134936,1,1.633709306,0.457552966,3.570535931,0.000356252,0.002644202,302.6894419,1,0.979990552,0.406791534,2.409073125,0.015993093,0.068181081,206.6708085,1,0.648405116,0.500931988,1.294397508,0.195528151,0.316553011,N,-, Effector probability:0.849,fkbp-type peptidyl-prolyl cis-trans isomerase,C:nucleus; F:peptidyl-prolyl cis-trans isomerase activity; F:macrolide binding; C:mitochondrion; P:regulation of homoserine biosynthetic process; P:protein peptidyl-prolyl isomerization; P:chromatin organization; P:protein folding; P:homoserine metabolic process,IPR001179 (PFAM); G3DSA:3.10.50.40 (GENE3D); PTHR10516:SF304 (PANTHER); IPR023566 (PANTHER); IPR001179 (PROSITE_PROFILES); SSF54534 (SUPERFAMILY),8.A.11.1.2, the immunophilin-like prolyl:peptidyl isomerase regulator (i-ppi) family.
RL4_JR_04430,3208,2371,2696,7,0,8,0,0,0,2,0,0,0,4,0,0,4,0,90.05789908,1,2.056027513,0.518697844,3.963825063,7.38E-05,0.000653334,6.396625339,0,0.788272511,1.270940538,0.620227688,0.535107895,0.683021704,22.96566584,1,-0.890640195,1.211565069,-0.735115445,0.462269189,0.599617331,100.5460843,1,2.053965039,0.51348512,4.000047827,6.33E-05,0.000725614,39.25747159,1,1.230878286,0.671493331,1.833046181,0.066795704,0.139852799,Y,-,,mucin family signaling,C:integral component of membrane,PTHR35778:SF1 (PANTHER); PTHR35778 (PANTHER),,
RL4_JR_04431,14177,9599,14120,0,1,11,0,0,1,2,2,0,2,6,3,0,13,0,6.329613541,1,-0.764278721,1.195542681,-0.639273472,0.522645043,0.707148923,2.019023058,1,2.451876464,1.305232981,1.878497172,0.060313184,0.136636089,18.23451926,1,1.620683451,1.031509184,1.571176949,0.116141553,0.216900402,6.041625299,1,-0.622050312,1.194775363,-0.520642065,0.60261614,0.72393502,5.159776788,1,-0.280992388,1.196995379,-0.234748097,0.814404254,0.874804448,N,-,,major facilitator superfamily transporter,C:membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF191 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_04432,22775,23303,22496,24,38,40,0,0,7,2,4,11,2,10,1,0,2,0,0.818155512,1,2.187267233,1.613067401,1.355967663,0.175109457,NA,0.263674576,1,5.388875761,1.756252454,3.068394723,0.002152121,0.015045494,0.679264744,1,2.747499293,1.269540356,2.164168535,0.030451417,0.077654949,0.783282196,1,2.325489336,1.342861523,1.731741729,0.083319557,0.17087513,0.664488585,1,2.675500846,1.231401052,2.172729057,0.029800715,0.074778747,N,-,,---NA---,,no IPS match,,
RL4_JR_04433,332,257,417,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,88.27654834,1,0.102319675,0.61854645,0.16541955,0.868613767,0.936578259,14.27780617,0,-0.370246302,1.227067064,-0.301732736,0.762855811,0.856340969,54.86943601,0,-1.205427546,1.055283591,-1.142278301,0.253338358,0.389036165,93.94348528,0,-0.072028469,0.669679007,-0.107556707,0.914347341,0.948055998,52.50728046,1,-0.555947142,0.819290919,-0.678571102,0.497409658,0.625235604,N,-, Effector probability:0.815,50S ribosomal L11,F:structural constituent of ribosome; F:rRNA binding; P:ribosomal large subunit assembly; C:mitochondrial large ribosomal subunit; P:translation,IPR000911 (SMART); IPR020783 (PFAM); IPR020783 (G3DSA:1.10.10.GENE3D); IPR020784 (G3DSA:3.30.1550.GENE3D); IPR006519 (TIGRFAM); IPR020784 (PFAM); PTHR11661:SF1 (PANTHER); IPR000911 (PANTHER); PD001367 (PRODOM); IPR020784 (SUPERFAMILY); IPR020783 (SUPERFAMILY),,
RL4_JR_04434,4301,2732,2850,2,4,4,0,0,5,3,0,10,0,1,3,0,5,0,315.8142704,1,1.763196674,0.373486292,4.720914019,2.35E-06,3.21E-05,31.01145373,1,-0.053385284,1.126014643,-0.047410826,0.962185801,0.979659843,111.3220497,1,-0.13342084,1.506510754,-0.08856282,0.929429358,0.957811769,91.52700588,1,-1.306190025,0.756310701,-1.727054798,0.084157823,0.172004328,66.2979572,1,-2.019390808,0.980288315,-2.059996817,0.039398845,0.092943455,N,-,,survival factor 1,C:nucleus; C:cytosol; P:cellular response to oxidative stress,IPR033394 (PFAM); IPR013931 (PFAM); PTHR10484:SF13 (PANTHER); PTHR10484 (PANTHER); SSF159245 (SUPERFAMILY),,
RL4_JR_04435,3383,2723,2925,0,0,0,0,0,0,0,0,2,1,12,0,0,0,0,111.0812954,0,-0.094571103,0.60436794,-0.156479351,0.875655194,0.939867402,15.6970149,0,-0.506864732,1.21762715,-0.416272528,0.677210593,0.794014319,82.97051739,1,-0.000872825,0.677948108,-0.001287451,0.998972763,0.999593402,65.36522049,1,-1.826700706,1.019759572,-1.79130528,0.073244319,0.155961879,39.75296976,0,-3.226800671,1.1914211,-2.708362871,0.006761605,0.022963643,N,-,,acetyltransferase,C:membrane; F:transferase activity,IPR016181 (G3DSA:3.40.630.GENE3D); IPR016181 (SUPERFAMILY),,
RL4_JR_04436,1418,2157,2559,0,0,8,0,0,0,0,2,0,3,0,2,0,1,1,140.3414411,1,-0.482093539,0.516588058,-0.933226256,0.350703161,0.540940894,49.47311267,0,-0.37493524,1.110952489,-0.337489896,0.735747628,0.835547794,176.8336037,1,0.361441788,0.49257014,0.733787452,0.463078289,0.60035915,128.090705,1,-1.041937277,0.62733775,-1.660887261,0.096736091,0.191150063,91.99317884,1,-1.799152399,0.856281764,-2.101121939,0.035630264,0.085935307,N,-,,zinc finger,F:ribokinase activity; P:D-ribose metabolic process; P:carbohydrate phosphorylation,IPR002139 (PRINTS); IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR011611 (PFAM); IPR029056 (G3DSA:3.40.1190.GENE3D); PTHR10584 (PANTHER); PTHR10584 (PANTHER); PTHR10584:SF190 (PANTHER); PTHR10584:SF190 (PANTHER); IPR011877 (HAMAP); IPR029056 (SUPERFAMILY),,
RL4_JR_04437,1322,1421,1474,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,56.28591071,1,0.462467472,0.689482749,0.670745531,0.502382652,0.689044667,7.174693664,0,0.622607761,1.235267529,0.504026655,0.614242646,0.74620308,18.63677297,0,-2.031057419,1.199795874,-1.692835809,0.090486725,0.179741413,21.50263116,0,-2.453582462,1.199255368,-2.045921601,0.040764085,0.108757934,18.37800907,0,-2.113641672,1.204162746,-1.755279077,0.079211584,0.160197982,N,-, Effector probability:0.684,glutathione-dependent formaldehyde-activating enzyme,F:carbon-sulfur lyase activity; P:metabolic process,IPR006913 (G3DSA:3.90.1590.GENE3D); IPR006913 (PFAM); PTHR28620:SF2 (PANTHER); PTHR28620 (PANTHER); IPR011057 (SUPERFAMILY); IPR011057 (SUPERFAMILY),,
RL4_JR_04438,15829,8642,9023,0,2,2,0,0,0,0,2,3,0,9,3,0,4,0,89.00752536,1,0.641095688,0.575174039,1.114611656,0.265016873,0.444857542,12.11928858,0,-0.133725569,1.230781396,-0.108650951,0.913479347,0.95163567,106.394631,1,1.059242636,0.58531975,1.809682036,0.07034511,0.147448011,102.5600613,1,0.462904467,0.64708683,0.71536685,0.47438239,0.615213862,42.39992567,1,-1.197266961,1.000375625,-1.196817407,0.231377732,0.358979396,N,-,,DUF323 domain containing,P:metabolic process; F:methyltransferase activity; C:intracellular part,IPR005532 (G3DSA:3.90.1580.GENE3D); IPR005532 (PFAM); IPR024775 (PFAM); IPR017805 (TIGRFAM); IPR019257 (PFAM); PTHR30468:SF6 (PANTHER); PTHR30468 (PANTHER); PTHR30468:SF6 (PANTHER); PTHR30468 (PANTHER); IPR016187 (SUPERFAMILY),,
RL4_JR_04439,7621,7707,9667,0,0,21,0,0,0,0,2,1,13,8,0,0,8,5,259.0352511,1,1.940187275,1.093904832,1.773634432,0.076123638,0.181424669,25.93255794,0,0.333738854,1.111857748,0.300163267,0.764052623,0.857184656,90.58316337,1,0.171518793,0.61166003,0.280415237,0.779158948,0.853609478,84.91133118,1,-0.349276148,0.614473547,-0.568415271,0.569753023,0.696624727,46.26204836,1,-2.389588593,1.122537046,-2.128739182,0.033275845,0.081538706,N,-,,translation initiation factor eIF-2B subunit alpha,,G3DSA:3.40.50.10470 (GENE3D); IPR000649 (PFAM); PTHR10233 (PANTHER); PTHR10233 (PANTHER); PTHR10233:SF18 (PANTHER); PTHR10233:SF18 (PANTHER); SSF100950 (SUPERFAMILY),,
RL4_JR_04440,34959,32186,30481,4,4,7,0,0,0,5,0,0,3,17,5,0,1,0,34.93049088,1,-1.148131786,1.019263996,-1.126432201,0.259982623,0.439481608,8.755066669,0,0.335405036,1.23336038,0.271944066,0.785665028,0.870171946,52.63895622,1,0.10601276,0.858547809,0.123479157,0.901727678,0.939303531,92.60884771,1,0.889536837,0.604347234,1.471896928,0.141048713,0.254113563,22.2952557,1,-2.392493672,1.200430968,-1.993028951,0.046258277,0.105606551,N,-,,adaptin ear-binding coat-associated 2,C:membrane; P:endocytosis,IPR011993 (G3DSA:2.30.29.GENE3D); IPR012466 (PFAM); PTHR12847 (PANTHER); PTHR12847:SF3 (PANTHER); IPR011993 (SUPERFAMILY),,
RL4_JR_04441,4103,3132,3833,6,0,9,0,0,0,0,4,5,1,11,0,0,11,5,106.2930087,1,2.620111006,0.943224102,2.777824485,0.005472417,0.023397318,4.5570806,0,1.277462036,1.305420893,0.978582496,0.327786311,0.490443909,11.71677692,1,-1.361494342,1.226235937,-1.110303736,0.266868164,0.404935335,22.82066969,1,-0.82933914,1.177702311,-0.704200995,0.481307611,0.621586679,18.81729319,1,-0.491350838,1.152005484,-0.426517794,0.669730584,0.765007013,N,-,,pyruvate formate lyase activating enzyme,,no IPS match,,
RL4_JR_04442,10318,11951,15632,4,7,17,7,0,2,4,0,1,0,5,4,0,9,0,67.19144159,1,1.779804016,0.565388711,3.147929878,0.001644311,0.008866022,5.184868061,1,1.091256674,1.279872649,0.852629107,0.393865016,0.558048949,13.35641824,1,-1.550460055,1.214190338,-1.276949755,0.201619987,0.32706309,52.32974005,1,1.098988362,0.708024894,1.552188872,0.120617038,0.225322418,13.0794317,1,-1.623093174,1.212376155,-1.338770288,0.180645466,0.298374445,N,-,,pyruvate formate lyase activating enzyme,F:metal ion binding; F:lyase activity; F:iron-sulfur cluster binding,IPR016431 (PIRSF); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR30352:SF7 (PANTHER); PTHR30352 (PANTHER); SSF102114 (SUPERFAMILY),,
RL4_JR_04443,28129,29861,44659,12,0,18,0,0,0,0,0,0,0,15,0,0,24,0,13.55423768,1,1.049780797,1.03842095,1.010939539,0.312045368,0.500084958,11.28784503,0,3.446339346,1.162586791,2.964371669,0.003033017,0.015663367,20.60406574,0,1.715766905,1.052263785,1.63054828,0.10298567,0.1979922,21.71737189,1,2.159172336,0.787029534,2.743445122,0.006079821,0.03270892,27.97700818,1,2.976293088,0.666124373,4.468074142,7.89E-06,8.24E-05,N,-,,pyruvate formate lyase activating enzyme,"F:oxidoreductase activity; F:metal ion binding; F:lyase activity; P:oxidation-reduction process; F:4 iron, 4 sulfur cluster binding",PTHR30352:SF7 (PANTHER); PTHR30352 (PANTHER),,
RL4_JR_04444,412,276,437,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,438.7733149,0,-1.519645586,0.439672425,-3.456313157,0.000547619,0.003620319,103.8922789,0,-3.233419876,1.214294512,-2.662797076,0.007749413,0.027959129,448.6262269,0,-0.499814837,0.426887297,-1.170835583,0.241664872,0.374960178,425.6420429,1,-1.239898196,0.439394233,-2.821835389,0.004774968,0.027084939,340.2316822,0,-1.600124331,0.52663965,-3.038366616,0.002378644,0.009810089,N,-,,hal kinase,F:nucleotide binding; P:negative regulation of transcription from RNA polymerase II promoter; C:cytoplasm; F:protein kinase activity; P:phosphorylation,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); PTHR24343:SF137 (PANTHER); PTHR24343 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.C.104.2.4, the heterokaryon incompatibility prion/amyloid protein (het-s) family
RL4_JR_04445,163,130,192,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,618.2083684,0,-2.940467147,0.662402395,-4.43909498,9.03E-06,0.000106254,171.519731,0,-3.956717849,1.197080647,-3.305306004,0.000948728,0.015023052,544.6998965,0,-2.0971661,0.460630089,-4.552820471,5.29E-06,0.000109811,523.8303683,0,-6.082869898,1.15083563,-5.285611375,1.25E-07,2.76E-06,451.9918952,0,-4.511532528,0.883363286,-5.107222138,3.27E-07,5.54E-06,N,-, Effector probability:0.682,heat shock,P:protein import into mitochondrial intermembrane space; F:ATP binding; C:mitochondrial matrix; F:metal ion binding; F:chaperone binding; P:chaperone-mediated protein complex assembly; P:chaperone mediated protein folding requiring cofactor; F:unfolded protein binding; P:protein refolding; P:response to unfolded protein,IPR020818 (PRINTS); IPR020818 (SMART); IPR020818 (G3DSA:2.30.33.GENE3D); IPR020818 (PFAM); IPR020818 (PANTHER); IPR011032 (SUPERFAMILY),,
RL4_JR_04446,3061,2379,2610,0,0,3,0,0,1,0,0,1,0,2,2,0,1,3,101.009049,1,0.222341729,1.055152007,0.210720093,0.833105695,0.916955782,14.0320608,1,-0.345116074,1.353109442,-0.255054073,0.798681336,0.877976962,35.76100259,1,-2.971323214,1.296071772,-2.292560705,0.021873309,0.059688781,41.20334422,1,-3.391867729,1.311807309,-2.585644786,0.009719704,0.047473229,34.66660329,1,-3.029282252,1.301969575,-2.326692043,0.019981662,0.054515298,Y,-,,endoglucanase b,F:chitin binding; P:oxidation-reduction process; F:monooxygenase activity; C:cellular_component; F:hydrolase activity,IPR005103 (PFAM); PTHR33353 (PANTHER); PTHR33353:SF12 (PANTHER),,
RL4_JR_04447,8313,8646,9536,1,1,8,0,0,0,0,5,3,0,1,3,0,12,4,159.0029303,1,-0.918163476,0.619296427,-1.482591268,0.138183038,0.279033967,30.91367399,0,-1.484687509,1.208837013,-1.228194945,0.219373796,0.367025051,128.6705062,1,-0.530513038,0.607604306,-0.873122577,0.382596269,0.52634068,147.4581561,1,-0.825412136,0.580833609,-1.421081912,0.155292948,0.272896567,79.73475909,1,-4.230922915,1.213653112,-3.486105605,0.000490107,0.002663628,N,-, Effector probability:0.839,cysteine dioxygenase,"F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:iron ion binding; P:oxidation-reduction process",IPR010300 (PFAM); IPR014710 (G3DSA:2.60.120.GENE3D); PTHR12918 (PANTHER); IPR011051 (SUPERFAMILY),,
RL4_JR_04448,363,335,499,0,3,0,0,0,0,0,0,0,1,0,0,0,0,0,33.88280504,1,0.933201391,0.862331015,1.082184653,0.279170486,0.462524945,3.13746674,0,1.815852305,1.279272051,1.419441864,0.155770235,0.284809667,8.159178141,0,-0.839623683,1.205232899,-0.696648493,0.4860228,0.621390831,9.413480337,1,-1.262097523,1.204494745,-1.047823187,0.294720077,0.439217071,8.070784608,0,-0.926510566,1.212465359,-0.764154258,0.444775322,0.577574726,N,-,,C4-dicarboxylate transporter malic acid transport,P:transmembrane transport; F:FMN binding; C:integral component of membrane; F:iron-sulfur cluster binding; F:N-acetyltransferase activity,IPR004695 (PFAM); PTHR31686:SF1 (PANTHER); PTHR31686 (PANTHER),2.A.16.4.1, the telurite-resistance/dicarboxylate transporter (tdt) family.
RL4_JR_04449,171125,88946,109419,26,44,60,0,4,2,5,14,7,5,29,13,0,34,1,83.61414405,1,1.645873161,1.107387389,1.486266845,0.137208553,0.277684786,47.26810005,1,3.02814665,0.859676332,3.52242645,0.000427616,0.015023052,44.79084974,1,0.59150666,0.862431651,0.685859174,0.492801917,0.626167471,28.27307363,1,-1.296583783,1.154233616,-1.123328731,0.261297906,0.401678229,19.86419432,1,-0.985418948,1.14275302,-0.862320143,0.388511371,0.524498371,Y,-,,C4-dicarboxylate transporter malic acid transport,P:transmembrane transport; F:FMN binding; F:catalytic activity; C:integral component of membrane; F:iron-sulfur cluster binding,IPR004695 (PFAM); PTHR31686 (PANTHER); PTHR31686:SF1 (PANTHER),2.A.16.4.3, the telurite-resistance/dicarboxylate transporter (tdt) family.
RL4_JR_04450,2966,2441,2694,2,0,7,0,0,0,0,0,0,0,0,0,0,0,0,169.5597195,1,-0.32065102,0.690460851,-0.464401449,0.642360152,0.796362353,28.34617782,0,-1.359601258,1.23057382,-1.104851441,0.269223967,0.426460875,89.94325538,0,-2.200239403,1.073837866,-2.048949355,0.040467067,0.096535602,85.71468547,0,-4.448664384,1.23389712,-3.605377069,0.0003117,0.002802811,89.40498578,0,-1.574745379,0.858668588,-1.833938495,0.066663124,0.139739768,N,-,,tRNA wybutosine-synthesizing 1,P:transmembrane transport; F:FMN binding; F:catalytic activity; P:wybutosine biosynthetic process; C:integral component of membrane; C:endoplasmic reticulum; F:iron-sulfur cluster binding,IPR007197 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); IPR008254 (PFAM); IPR013917 (PFAM); IPR029039 (G3DSA:3.40.50.GENE3D); PTHR13930 (PANTHER); PTHR13930:SF0 (PANTHER); IPR008254 (PROSITE_PROFILES); SSF102114 (SUPERFAMILY); IPR029039 (SUPERFAMILY),,
RL4_JR_04451,9073,8948,8594,0,0,5,0,0,2,0,0,1,0,2,0,0,0,0,98.25245395,1,-2.883109635,1.028430677,-2.80340688,0.005056583,0.021963515,47.53223964,1,0.260803922,0.986229785,0.264445392,0.791436738,0.873795221,110.0521137,1,-1.211160549,0.749618541,-1.615702498,0.106158651,0.2028979,135.7245509,1,-0.912244726,0.587989136,-1.551465273,0.120790223,0.225521116,96.94444512,0,-1.20127999,0.702478291,-1.710059949,0.087254788,0.172516057,N,-, Effector probability:0.666,MAS20 import receptor,C:integral component of mitochondrial outer membrane; F:mitochondrion targeting sequence binding; P:mitochondrial outer membrane translocase complex assembly; P:protein import into mitochondrial matrix; P:tRNA import into mitochondrion; C:mitochondrial outer membrane translocase complex,IPR002056 (PRINTS); IPR002056 (PFAM); IPR023392 (G3DSA:1.20.960.GENE3D); IPR002056 (TIGRFAM); IPR002056 (PIRSF); IPR002056 (PANTHER); PTHR12430:SF0 (PANTHER); IPR023392 (SUPERFAMILY),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_04452,4716,4763,5949,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,76.40979265,1,1.973215431,0.537726223,3.669554032,0.000242974,0.001820185,5.702176233,0,0.953923287,1.250437001,0.762871929,0.445539779,0.606721123,21.37940425,0,-0.744693988,1.207006535,-0.616975937,0.537250597,0.666057106,34.83088402,1,0.179086442,0.879001406,0.203738516,0.838557842,0.899216072,14.76598673,0,-1.797967937,1.220725602,-1.472868214,0.140786575,0.246919118,N,-,,exocyst complex component exo84,P:protein dephosphorylation; C:mating projection tip; P:Golgi to plasma membrane transport; P:spliceosomal complex assembly; C:exocyst; F:phosphoprotein phosphatase activity; C:incipient cellular bud site; C:cellular bud tip; C:cellular bud neck; C:cytosol; C:cytoplasmic vesicle; P:exocyst assembly; P:exocyst localization,IPR032403 (PFAM); PF08700 (PFAM); IPR033961 (PANTHER); PTHR21426:SF12 (PANTHER); PTHR21426:SF12 (PANTHER); IPR033961 (PANTHER); IPR033961 (PANTHER); PTHR21426:SF12 (PANTHER); IPR016159 (SUPERFAMILY),1.F.2.1.1, the octameric exocyst (exocyst) family.
RL4_JR_04453,1299,1984,1713,1,8,3,0,0,0,0,0,0,0,7,0,0,8,8,337.290647,1,0.726307643,0.407844565,1.780844236,0.074937901,0.179332178,40.06556379,0,-1.858802626,1.196948445,-1.552951284,0.120434773,0.234295748,155.1949462,0,-0.89299809,0.588583985,-1.517197398,0.129216853,0.234883841,148.4595059,1,-1.454873051,0.61097645,-2.381226069,0.017255119,0.071484484,172.0562875,1,-0.130861959,0.545031596,-0.240099766,0.810252916,0.871697738,N,-,,serine threonine- phosphatase PP2A catalytic subunit,,IPR006186 (PRINTS); IPR006186 (SMART); IPR004843 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); PTHR11668:SF240 (PANTHER); PTHR11668 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_04454,2265,1885,2065,1,3,4,0,0,0,0,0,0,0,1,0,0,2,0,4.746586139,1,-0.349191881,1.197404371,-0.291624024,0.770574105,0.879824149,1.515662747,0,2.865578858,1.336262401,2.144473163,0.031994994,0.083209089,3.930116699,0,0.214395247,1.19879737,0.17884194,0.858061813,0.909635371,4.533720666,1,-0.207899491,1.197086508,-0.173671234,0.862123846,0.914702289,3.872107488,1,0.133135428,1.19717541,0.111207954,0.911451444,0.943121704,N,-,,family c-likeg- -coupled receptor,,IPR021460 (PFAM); PTHR35184 (PANTHER),,
RL4_JR_04455,10746,7602,9337,0,0,5,0,0,0,0,1,6,4,3,0,0,0,6,153.782602,1,3.559627643,0.56271735,6.32578264,2.52E-10,7.91E-09,4.174939293,0,1.403846437,1.298786509,1.080890837,0.279745675,0.438821046,21.8195792,1,-0.27529007,1.214776939,-0.226617794,0.820720955,0.884310233,53.80070993,1,2.15543627,0.603537767,3.57133619,0.000355165,0.003121504,64.55091671,1,2.585664248,1.33655699,1.934570891,0.053042975,0.117137156,N,-,,sh3 domain-containing,C:integral component of membrane,G3DSA:2.30.30.40 (GENE3D); PTHR12231:SF97 (PANTHER); PTHR12231:SF97 (PANTHER); PTHR12231 (PANTHER); PTHR12231 (PANTHER); PTHR12231 (PANTHER); PTHR12231:SF97 (PANTHER); IPR001452 (SUPERFAMILY),,
RL4_JR_04456,1581,1810,1682,0,4,4,0,0,0,0,0,0,0,2,0,0,0,0,84.98623998,1,-0.555007592,0.705363417,-0.786839207,0.431375999,0.622420481,18.72758576,0,-0.761538164,1.236345836,-0.615958854,0.537921676,0.68505828,56.11555755,0,-2.442314782,1.212871189,-2.013663779,0.044044845,0.102602396,90.3408208,1,-0.529818368,0.670753574,-0.78988527,0.429594774,0.572020922,84.74211971,0,-0.051783718,0.620049558,-0.083515449,0.933441693,0.956395178,N,-,,phosphoinositide 3-kinase regulatory subunit 4,P:biological regulation; P:localization; P:phosphorylation; F:binding; F:kinase activity,IPR001680 (SMART); IPR000719 (SMART); IPR000719 (PFAM); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000357 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR17583 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR017986 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_04457,1153,730,906,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.897521983,0,-0.394164998,1.201236482,-0.328132723,0.742811313,0.86455377,1.565119297,0,2.819289575,1.337230287,2.108305206,0.035004598,0.089174254,11.89715211,0,1.131616821,1.192430865,0.948999942,0.342620642,0.48615156,18.00052078,0,1.481897453,1.013076478,1.462769578,0.14353044,0.257530694,46.0986457,0,4.009702058,0.496628991,8.073838075,6.81E-16,1.05E-13,N,-,,methyltransferase type 12,F:methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_04458,1925,1677,2027,0,1,6,0,0,2,3,3,3,2,1,6,0,0,0,13.23579319,1,-1.828732217,1.262172829,-1.448876236,0.147372149,0.293277069,13.53450841,1,2.322573348,1.178687545,1.970474158,0.048784054,0.115506946,10.90362919,1,-1.257843606,1.244583439,-1.010654302,0.312181916,0.454164351,21.89941882,1,-0.725131892,1.198334491,-0.605116432,0.545101637,0.675291089,10.87710674,0,-1.356971344,1.262740346,-1.074624209,0.282543009,0.416472262,N,-,,domain-containing 5,P:biological_process; F:methyltransferase activity; C:cellular_component; F:molecular_function; P:methylation,IPR003347 (SMART); PF13621 (PFAM); G3DSA:2.60.120.650 (GENE3D); PTHR12461 (PANTHER); PTHR12461:SF38 (PANTHER); IPR003347 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_04459,14246,17351,17397,2,8,2,0,0,0,1,0,0,0,6,0,0,6,3,702.1656961,1,0.121249647,0.44383409,0.273186873,0.78470957,0.889119538,143.1383072,0,-0.701617737,0.811114241,-0.865004832,0.387036137,0.551616415,378.8908232,1,-1.284946177,0.490950267,-2.617263424,0.008863791,0.029733936,418.2051033,1,-1.664101083,0.467500602,-3.559569925,0.000371463,0.003242292,359.4695104,1,-1.209241314,0.683332783,-1.769622862,0.076789988,0.155922997,N,-,,3-isopropylmalate dehydratase,"P:leucine biosynthetic process; F:4 iron, 4 sulfur cluster binding; P:branched-chain amino acid biosynthetic process; C:3-isopropylmalate dehydratase complex; F:3-isopropylmalate dehydratase activity",IPR001030 (PRINTS); IPR015932 (G3DSA:3.40.1060.GENE3D); IPR004430 (TIGRFAM); IPR001030 (PFAM); IPR012235 (PIRSF); IPR015931 (G3DSA:3.30.499.GENE3D); IPR004431 (TIGRFAM); IPR000573 (PFAM); IPR015928 (G3DSA:3.20.19.GENE3D); IPR015931 (G3DSA:3.30.499.GENE3D); PTHR11670:SF38 (PANTHER); IPR015937 (PANTHER); IPR004431 (HAMAP); IPR004430 (HAMAP); IPR001030 (SUPERFAMILY); IPR015928 (SUPERFAMILY),,
RL4_JR_04460,2334,2453,2788,0,0,0,0,0,1,2,0,0,3,3,1,0,10,1,18.31165924,0,2.443411975,1.010219954,2.418693044,0.015576378,0.053889776,0.730672472,1,3.918176502,1.456494381,2.69014186,0.007142165,0.026317071,1.897445872,1,1.264633549,1.215821227,1.040147614,0.298271325,0.43903735,2.189003102,1,0.842308258,1.22493305,0.687636159,0.491681932,0.630868365,1.873242446,1,1.180669645,1.211232891,0.97476683,0.329675934,0.46639218,N,-,,hypothetical protein SPI_00594,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_04461,12169,10589,8598,0,0,7,0,0,0,1,1,2,2,4,1,0,0,2,54.66127499,1,0.457231867,0.778605065,0.587244918,0.557039229,0.734971054,8.785435016,0,0.330326414,1.265975206,0.260926448,0.794149229,0.875449629,23.03244532,1,-2.33666888,1.232503136,-1.895872563,0.057976898,0.126690722,30.59844181,1,-1.815782104,1.191030812,-1.524546708,0.127372198,0.234907743,71.04209602,1,0.711274428,1.625101564,0.437679985,0.66161828,0.75868559,N,-,,Nuclear rim 1,C:membrane,IPR018819 (PFAM); PTHR28293 (PANTHER); PTHR28293:SF1 (PANTHER),,
RL4_JR_04462,1059,922,1012,0,6,4,0,0,0,0,0,1,0,0,0,0,0,2,28.94731367,1,0.050075676,0.892039112,0.056136188,0.955233315,0.977466894,5.576404364,0,0.986224221,1.260763908,0.782243381,0.434071555,0.595429228,25.52060032,1,-0.702174113,1.205730742,-0.582363946,0.560321561,0.686185495,92.60237248,0,2.122910382,0.52577236,4.037698716,5.40E-05,0.00063476,14.20642819,1,-1.742198692,1.21019013,-1.439607421,0.149978499,0.258781919,N,-,,V-type proton ATPase subunit F,"P:ATP hydrolysis coupled proton transport; F:proton-transporting ATPase activity, rotational mechanism; C:proton-transporting V-type ATPase, V1 domain",IPR005772 (TIGRFAM); IPR008218 (G3DSA:3.40.50.GENE3D); IPR008218 (PFAM); IPR005772 (PIRSF); IPR005772 (PANTHER); IPR008218 (SUPERFAMILY),3.A.2.2.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_04463,3806,3016,2688,0,4,6,0,0,1,0,0,1,4,4,2,0,2,1,361.2526999,1,2.146085408,0.569736199,3.766805428,0.00016535,0.00131474,22.44247931,1,-1.02262174,1.208920138,-0.845896853,0.397610288,0.561704304,77.49273547,1,-1.268006219,0.85881558,-1.476459263,0.139820643,0.248865013,117.1410255,1,-0.543070052,0.580387474,-0.935702572,0.349426346,0.496065866,56.96157069,1,-3.745724334,1.191330245,-3.144152808,0.001665684,0.007272555,Y,-,,ML domain-containing,C:membrane; C:fungal-type vacuole lumen; P:intracellular sterol transport,IPR003172 (SMART); G3DSA:2.70.220.10 (GENE3D); IPR003172 (PFAM); PTHR11306:SF0 (PANTHER); PTHR11306 (PANTHER); IPR014756 (SUPERFAMILY),,
RL4_JR_04464,2746,2038,1151,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,627.1710177,0,-2.625748696,0.511083799,-5.137608945,2.78E-07,4.91E-06,185.7043893,0,-3.081454005,1.140906548,-2.700882042,0.006915586,0.02570678,511.4093625,0,-2.851846895,0.623754669,-4.572065007,4.83E-06,0.000101121,635.7508664,0,-2.240597762,0.465092281,-4.817533756,1.45E-06,2.57E-05,464.7835635,0,-4.485092649,0.886596272,-5.058776798,4.22E-07,6.94E-06,N,-,,PHD-finger domain-containing,,IPR001214 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); G3DSA:2.170.270.10 (GENE3D); IPR001214 (PFAM); IPR001214 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY); IPR011011 (SUPERFAMILY),,
RL4_JR_04465,1115,782,566,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.82292875,0,-2.550144783,1.241133325,-2.054690445,0.039908913,0.112539549,6.873388435,0,0.684406835,1.270944192,0.538502666,0.590230065,0.727509586,18.00623901,0,-1.981519319,1.229703384,-1.611379903,0.107096945,0.203998019,24.79544407,0,-1.460275671,1.186643121,-1.230593803,0.218474824,0.353533258,17.94441405,0,-2.079231841,1.246582057,-1.667946229,0.095326401,0.184292067,N,-,,udp-n-acetylglucosamine-1-p transferase,C:endoplasmic reticulum membrane; F:UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity; C:integral component of membrane; P:UDP-N-acetylglucosamine metabolic process; P:protein N-linked glycosylation; P:dolichol metabolic process; F:phospho-N-acetylmuramoyl-pentapeptide-transferase activity,IPR000715 (PFAM); PTHR10571:SF0 (PANTHER); IPR033895 (PANTHER); PTHR10571:SF0 (PANTHER),9.B.146.1.5, the putative undecaprenyl-phosphate n-acetylglucosaminyl transferase (murg) family.
RL4_JR_04466,63050,50719,52765,0,2,27,0,0,0,0,0,0,0,3,0,0,1,0,6.238614944,1,-0.743318335,1.204932484,-0.616896253,0.537303158,0.720348261,1.988808908,0,2.473644336,1.313885818,1.882693536,0.059741912,0.135645498,5.158242012,0,-0.177755913,1.20278397,-0.147787066,0.882510817,0.926627206,43.19989099,1,2.157734081,0.745825219,2.893082759,0.003814808,0.022627374,5.079470246,1,-0.258323724,1.20224833,-0.214867193,0.829870863,0.885461702,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); PTHR23502:SF33 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.86, the major facilitator superfamily (mfs).
RL4_JR_04467,651,583,797,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.1809869,0,1.205535083,0.57184518,2.108149418,0.035018067,0.101991214,5.91041777,0,0.902303065,1.238264245,0.728683776,0.466195119,0.625092992,41.28420321,0,1.071002604,0.742719279,1.442001891,0.14930184,0.261239514,60.18779765,0,0.900820028,0.665321458,1.353962086,0.175748474,0.299571263,15.02278161,0,-1.822874813,1.188888051,-1.53326027,0.12521174,0.226139241,N,-,,cytochrome b2,F:nitrate reductase [NAD(P)H] activity; F:FMN binding; F:metal ion binding; F:L-lactate dehydrogenase (cytochrome) activity; P:oxidation-reduction process; F:nitrate reductase (NADH) activity; F:heme binding,IPR001199 (PRINTS); IPR001199 (SMART); IPR001199 (PFAM); IPR000262 (PFAM); IPR001199 (G3DSA:3.10.120.GENE3D); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR10578 (PANTHER); PTHR10578:SF10 (PANTHER); IPR012133 (PROSITE_PROFILES); IPR001199 (PROSITE_PROFILES); IPR001199 (SUPERFAMILY); SSF51395 (SUPERFAMILY),,
RL4_JR_04468,1565,1563,1683,0,1,2,0,0,0,0,2,0,0,5,1,0,2,0,34.14058077,1,0.998682116,0.698888447,1.428957828,0.153016355,0.301087174,4.847943439,0,1.188198325,1.270280779,0.935382433,0.349591247,0.512612285,12.50147605,1,-1.455002678,1.20597175,-1.206498144,0.227625474,0.358506581,22.43935951,1,-0.15818805,1.033478215,-0.153063749,0.878348003,0.924841258,12.25082488,1,-1.528673347,1.202872951,-1.270851876,0.20378135,0.326159685,N,-,,sh3 domain-containing,C:membrane; C:integral component of membrane,IPR011511 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR001452 (SUPERFAMILY),,
RL4_JR_04469,8127,7011,8440,0,2,8,0,0,0,2,6,3,1,0,1,0,0,2,41.23520192,1,-2.380012477,1.136765571,-2.093670444,0.036289348,0.104907334,11.98296233,0,-0.117375087,1.212201865,-0.096828004,0.922862984,0.957582689,37.51881607,1,-1.804352847,1.188315316,-1.518412515,0.128910439,0.234517391,45.09223961,1,-2.239108336,1.139743057,-1.964572912,0.04946369,0.122062705,30.51757677,1,-2.845380318,1.188027828,-2.395045175,0.016618318,0.047144989,N,-,,plasma membrane channel,C:integral component of membrane,IPR007632 (PFAM); IPR007632 (PANTHER); IPR030142 (PTHR12308:PANTHER),1.A.17.1.18, the calcium-dependent chloride channel (ca-clc) family.
RL4_JR_04470,1280,1940,1702,0,0,13,0,1,2,2,13,9,10,60,5,0,17,2,33.32088208,1,1.794716949,0.636495316,2.819686029,0.004807066,0.021053644,3.34864707,1,1.722002001,1.285755083,1.339292393,0.180475504,0.318975564,22.98347366,1,0.898841382,1.041350876,0.863149398,0.388055331,0.531979983,13.9775262,1,-0.397589955,1.153334771,-0.344730745,0.730296802,0.820132822,15.83894939,1,-0.06167259,1.126567468,-0.054743805,0.956342571,0.971265859,N,-,,calcineurin-like phosphoesterase,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:hydrolase activity,IPR004843 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); PTHR12905:SF0 (PANTHER); PTHR12905 (PANTHER); PTHR12905:SF0 (PANTHER); PTHR12905 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_04471,136,189,138,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36.96818874,0,0.774300539,0.664141967,1.165866001,0.243668627,0.418847168,5.710504586,0,0.951890039,1.234432147,0.771115725,0.440638341,0.602082487,22.65380016,0,-0.737889451,1.18975705,-0.62020179,0.535124944,0.664084938,82.41550042,0,2.060095434,0.467503956,4.406583959,1.05E-05,0.000147063,33.19433736,0,0.439524857,0.84079669,0.522748081,0.601149574,0.710392091,N,-,,peroxisome biosynthesis (pas10 peroxin-12),,IPR013083 (G3DSA:3.30.40.GENE3D); IPR006845 (PFAM); IPR017375 (PANTHER); IPR017375 (PANTHER); PTHR12888:SF0 (PANTHER); PTHR12888:SF0 (PANTHER); PTHR12888:SF0 (PANTHER); SSF57850 (SUPERFAMILY),3.A.20.1.1, the peroxisomal protein importer (ppi) family.
RL4_JR_04472,3750,3926,2799,0,2,4,0,0,0,6,8,3,1,10,0,0,4,3,13.31362796,1,1.112917627,1.031616364,1.078809591,0.280672618,0.463828589,1.808463096,0,2.610791825,1.331580645,1.960671202,0.049917391,0.117694812,15.76089434,1,0.921157303,1.200061056,0.767592031,0.442729598,0.582178784,52.11746127,1,3.407519615,0.539470256,6.316417958,2.68E-10,9.48E-09,15.84431959,1,1.556950469,0.985078584,1.58053428,0.113984563,0.210565109,N,-, Effector probability:0.744,thioesterase family,F:isomerase activity,IPR006683 (PFAM); IPR029069 (G3DSA:3.10.129.GENE3D); PTHR21660 (PANTHER); PTHR21660:SF4 (PANTHER); IPR029069 (SUPERFAMILY),,
RL4_JR_04473,2551,4515,4783,6,5,90,0,0,3,2,2,3,11,33,8,0,14,5,278.134778,1,-0.294907004,0.491866854,-0.599566736,0.548795022,0.728808365,49.5610158,1,-2.165608044,1.220484908,-1.774383305,0.07599977,0.163674397,200.7671222,1,-0.812594504,0.555393994,-1.463095592,0.143441224,0.253526353,164.9765674,1,-2.922867624,0.886730147,-3.296231252,0.000979913,0.007247349,129.0871248,1,-3.953515196,1.142675401,-3.459876002,0.000540424,0.002885968,N,-,,f-box domain-containing,,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR14596:SF38 (PANTHER); PTHR14596 (PANTHER); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_04474,203,237,199,0,1,0,0,0,0,0,0,0,0,3,0,0,0,0,187.0666557,1,-3.067819207,0.92761432,-3.307214152,0.000942288,0.005677391,52.85390648,0,-2.258411885,1.237974693,-1.824279525,0.068109824,0.150295976,135.8421905,0,-4.896798093,1.22675391,-3.991671071,6.56E-05,0.000886381,164.6310407,1,-3.615342704,1.070660754,-3.376739729,0.000733504,0.005690981,132.7521745,0,-4.966382767,1.228437849,-4.042844147,5.28E-05,0.000408768,N,-,,hypothetical protein SPI_00608,,no IPS match,,
RL4_JR_04475,24,30,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,586.3249866,0,-2.918569065,0.458861304,-6.360460215,2.01E-10,6.51E-09,192.9113952,0,-1.716982866,0.85667104,-2.004249923,0.045043295,0.108651469,426.7077357,0,-6.548113493,1.19048938,-5.500354394,3.79E-08,1.43E-06,525.1218365,0,-4.229747241,0.737709101,-5.733624857,9.83E-09,2.69E-07,450.7070682,0,-3.078288842,0.605383306,-5.084859144,3.68E-07,6.18E-06,N,-,,mitochondrial chaperone (Mdj1),F:heat shock protein binding; P:positive regulation of ATPase activity; F:unfolded protein binding; P:protein refolding; F:ATPase activator activity; P:'de novo' protein folding; P:mitochondrial genome maintenance; F:ATP binding; P:response to heat; P:misfolded or incompletely synthesized protein catabolic process; C:mitochondrial matrix; F:metal ion binding; C:extrinsic component of mitochondrial inner membrane,IPR001623 (PRINTS); IPR001623 (SMART); IPR001305 (PFAM); IPR001305 (G3DSA:2.10.230.GENE3D); IPR001623 (PFAM); IPR001623 (G3DSA:1.10.287.GENE3D); IPR002939 (PFAM); G3DSA:2.60.260.20 (GENE3D); G3DSA:2.60.260.20 (GENE3D); PTHR24078 (PANTHER); PTHR24078 (PANTHER); PTHR24078:SF255 (PANTHER); PTHR24078:SF255 (PANTHER); PTHR24078:SF255 (PANTHER); IPR012724 (HAMAP); IPR001305 (PROSITE_PROFILES); IPR001623 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY); IPR008971 (SUPERFAMILY); IPR001305 (SUPERFAMILY); IPR008971 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_04476,416,327,470,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,142.1154662,0,-5.253249106,1.207289495,-4.351275423,1.35E-05,0.000151463,45.07371758,0,-2.028715826,1.197910401,-1.693545547,0.090351673,0.187137228,117.3817935,0,-4.686084168,1.198399582,-3.910285217,9.22E-05,0.001112306,154.0724073,1,-3.358353042,1.02483607,-3.276966084,0.00104929,0.007693018,149.4656476,0,-1.796011911,0.706637425,-2.54163146,0.011033645,0.033998741,N,-,,c6 zinc finger domain-containing,,IPR001138 (SMART); IPR007219 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31001 (PANTHER); PTHR31001:SF54 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04477,26,54,26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30.13042394,0,-3.015439982,1.191238675,-2.53134829,0.011362496,0.041924578,9.674434645,0,0.191387397,1.228484842,0.15579142,0.876197434,0.928925357,24.9873001,0,-2.45408484,1.195000953,-2.053625844,0.040011919,0.095695881,70.72488804,0,0.198032217,0.67384833,0.293882479,0.768847707,0.849994059,32.23355021,0,-0.859472083,0.972453243,-0.883818414,0.376794244,0.51263662,N,-,,aflatoxin efflux pump,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF68 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_04478,1091,1255,1241,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,10.64421203,1,-1.514234667,1.194046187,-1.268154183,0.204742895,0.369615521,3.416894277,0,1.69289691,1.276792161,1.325898578,0.184873294,0.324538239,21.82412239,0,0.866039966,1.037784611,0.834508391,0.403994561,0.546358661,10.18000607,0,-1.374733184,1.196968115,-1.148512785,0.250756938,0.390181958,8.660453,0,-1.028277767,1.1944851,-0.86085441,0.389318233,0.525369467,N,-,,TIGR02452 family,,IPR012664 (TIGRFAM); IPR019261 (PFAM); PTHR35596 (PANTHER); SSF52949 (SUPERFAMILY),,
RL4_JR_04479,836,1210,923,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,111.0109761,0,1.859924126,0.82206798,2.262494308,0.02366688,0.07538202,7.448275969,0,0.568614234,1.227921344,0.463070568,0.643313786,0.768332996,51.79016658,0,1.053712248,0.672829204,1.566091724,0.117327145,0.218327529,38.30451571,0,0.211039979,0.747072602,0.28248925,0.777568388,0.856399427,33.73644115,0,-0.476430656,0.970975428,-0.490672207,0.623658307,0.729077515,N,-,,kyphoscoliosis peptidase,F:isomerase activity,IPR002931 (SMART); IPR002931 (PFAM); PTHR11039 (PANTHER); SSF54001 (SUPERFAMILY),,
RL4_JR_04480,3145,2462,3185,20,1,11,0,0,2,7,4,2,0,4,11,0,0,3,54.60983527,1,0.734768513,0.673773785,1.090527012,0.275481061,0.458647856,6.026865905,1,0.874159489,1.248472699,0.700183104,0.483812962,0.640304852,28.55867685,1,0.047547981,1.039227089,0.045753215,0.963506949,0.978487747,17.94624434,1,-2.192748647,1.196398345,-1.832791442,0.066833592,0.146533158,48.58782817,1,1.116536082,0.672172583,1.661085426,0.096696291,0.18602507,N,-,,f-box domain-containing,,IPR032675 (G3DSA:3.80.10.GENE3D); IPR001810 (PFAM); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY),,
RL4_JR_04481,18,3,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,89.19301445,0,-1.155122089,0.784824241,-1.471822643,0.141068777,0.28380742,27.81798213,0,0.175847492,1.14251006,0.153913298,0.877678098,0.930246881,86.70597587,0,-0.233460908,0.706100337,-0.330634183,0.740920822,0.826234837,73.38587243,0,-2.044572159,1.035960157,-1.973601152,0.048427113,0.120472854,46.46694003,0,-3.451940042,1.202678403,-2.870210384,0.004101988,0.015213416,N,-,,diaminohydroxyphosphoribosylamino-pyrimidine deaminase,F:methyltransferase activity; F:transferase activity; F:S-adenosylmethionine-dependent methyltransferase activity; P:protein methylation; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PTHR14614 (PANTHER); PTHR14614:SF47 (PANTHER); PTHR14614:SF47 (PANTHER); PTHR14614:SF47 (PANTHER); PTHR14614 (PANTHER),,
RL4_JR_04482,1,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,219.307716,0,-0.020281826,0.667611467,-0.030379685,0.975764246,0.987675955,37.19480558,0,-1.751495413,1.20385936,-1.454900357,0.145696849,0.270985235,235.263813,0,0.373248407,0.460142675,0.811157989,0.417274948,0.558936247,328.6969975,0,0.987694445,0.33119159,2.982244941,0.00286143,0.017872903,189.8689177,0,0.409199204,0.472738164,0.865593758,0.38671298,0.522976747,N,-,,long-chain-fatty-acid- ligase 1,P:metabolic process; F:ligase activity,G3DSA:3.40.50.980 (GENE3D); IPR000873 (PFAM); G3DSA:2.30.38.10 (GENE3D); G3DSA:3.40.50.980 (GENE3D); PTHR24096:SF153 (PANTHER); PTHR24096:SF153 (PANTHER); PTHR24096 (PANTHER); PTHR24096 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.14, the fatty acid transporter (fat) family.
RL4_JR_04483,543,245,270,10,3,0,0,0,0,0,0,13,0,0,3,0,0,0,168.0010558,1,-0.329250198,0.50554099,-0.651282891,0.51486389,0.700329309,32.81317926,0,-1.570664656,1.209010002,-1.299132888,0.193898328,0.336356277,150.6723922,1,-0.384109352,0.566562133,-0.677965098,0.497793823,0.630667584,261.9059305,1,0.784617326,0.353215462,2.221356113,0.026326851,0.08636862,112.8883653,0,-1.336195403,0.677413061,-1.972497253,0.04855287,0.109450818,N,-,,Calcium-binding NCS-1,,PR00450 (PRINTS); IPR002048 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR002048 (PFAM); IPR028846 (PANTHER); PTHR23055:SF103 (PANTHER); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY),8.A.82.2.7, the calmodulin calcium binding protein (calmodulin) family.
RL4_JR_04484,5727,1349,2599,0,1,5,0,0,0,4,0,0,1,0,0,0,0,0,59.57190617,1,0.60360701,0.659342662,0.915467851,0.359946073,0.551651336,7.757709488,0,0.509947009,1.2541046,0.40662239,0.68428535,0.799648263,20.0183838,1,-2.134182802,1.208640126,-1.765771925,0.07743412,0.15891811,23.08745688,1,-2.556138322,1.208880589,-2.114467174,0.034475386,0.099396379,30.82599364,0,-0.528502436,0.987477983,-0.535204273,0.592508612,0.704125551,N,-,,dna replication initiation factor cdc45,P:DNA replication initiation; P:double-strand break repair via break-induced replication; C:DNA replication preinitiation complex; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; F:chromatin binding; P:translational initiation; F:single-stranded DNA binding; P:mitotic DNA replication preinitiation complex assembly; P:cell division; C:nuclear pre-replicative complex; F:DNA replication origin binding; F:translation initiation factor activity; C:nuclear chromatin; P:regulation of chromatin silencing at telomere; C:cytosol; C:replication fork protection complex,IPR003874 (PFAM); PTHR10507:SF0 (PANTHER); IPR003874 (PANTHER); PTHR10507:SF0 (PANTHER); IPR003874 (PANTHER); PTHR10507:SF0 (PANTHER); IPR003874 (PANTHER),,
RL4_JR_04485,1900,1511,1322,0,0,5,0,0,0,2,0,1,0,0,1,0,0,0,64.20298535,1,-0.219898869,0.827308007,-0.265800484,0.79039287,0.892336706,31.82626211,0,1.146031491,1.143429455,1.002275642,0.316210484,0.477856452,32.75601816,1,-1.488112181,1.223420948,-1.21635336,0.223850343,0.354047941,56.69211608,1,-0.489307269,0.905070559,-0.540628865,0.588763418,0.713321719,36.39646477,0,-0.381937376,0.925245608,-0.412795665,0.679756328,0.772537077,N,-,,DNA replication initiation factor cdc45,P:DNA replication initiation; F:translation initiation factor activity; P:biological_process; P:translational initiation; C:cellular_component; F:molecular_function,PF12813 (PFAM); IPR029060 (SUPERFAMILY),,
RL4_JR_04486,42801,31467,30425,20,24,5,0,0,2,2,0,2,5,14,0,0,12,0,312.659051,1,-0.955924125,0.561421091,-1.702686524,0.088626748,0.202696106,132.4359882,1,-0.314602198,0.876404798,-0.35896905,0.719618243,0.82453881,211.2792966,1,-2.056729576,0.695998721,-2.955076662,0.003125914,0.013935161,202.7216591,1,-3.914855467,1.035924217,-3.779094459,0.0001574,0.001573367,212.056906,1,-2.588052616,0.766318058,-3.377256465,0.000732128,0.003726894,N,-,,ribose-phosphate pyrophosphokinase,F:magnesium ion binding; P:fungal-type cell wall organization; P:ribonucleoside monophosphate biosynthetic process; C:cytoplasm; P:nucleotide biosynthetic process; F:ribose phosphate diphosphokinase activity; P:phosphorylation; F:kinase activity; C:ribose phosphate diphosphokinase complex; P:5-phosphoribose 1-diphosphate biosynthetic process,SM01400 (SMART); IPR029099 (PFAM); IPR005946 (PFAM); IPR005946 (TIGRFAM); IPR029057 (G3DSA:3.40.50.GENE3D); IPR029057 (G3DSA:3.40.50.GENE3D); PTHR10210 (PANTHER); PTHR10210 (PANTHER); PTHR10210:SF57 (PANTHER); PTHR10210:SF57 (PANTHER); IPR029057 (SUPERFAMILY); IPR029057 (SUPERFAMILY),,
RL4_JR_04487,1065,1742,1409,10,0,10,0,0,0,0,0,1,1,5,0,0,3,0,23.30859251,1,0.623380222,0.869667563,0.716802889,0.473495729,0.662796526,3.76583601,0,1.552479682,1.260704498,1.231438204,0.218159016,0.365475928,16.30213791,1,-0.142670487,1.198333245,-0.119057439,0.905229849,0.941692046,11.31150352,1,-1.5270498,1.200053068,-1.272485226,0.20320077,0.33486455,9.703082796,1,-1.192204604,1.20931464,-0.98585146,0.324206009,0.460326159,N,-,,pre-mRNA-splicing factor CWC26,C:nuclear part; P:gene expression; C:macromolecular complex; P:cellular process,IPR018609 (PFAM); PTHR31809 (PANTHER),,
RL4_JR_04488,384704,396325,346457,14,21,40,0,3,6,3,9,5,19,46,2,0,68,5,103.5535586,1,-0.773316444,0.583545594,-1.325203124,0.18510379,0.342576387,23.30760604,1,-1.077196661,1.206999765,-0.892458054,0.372147466,0.536668564,87.61215243,1,-0.907845712,0.748723562,-1.212524567,0.225311644,0.355636902,164.2537303,1,0.125626652,0.609388295,0.206152059,0.836672135,0.897764451,108.7235375,1,0.245854983,0.492555991,0.499141189,0.617679922,0.724346678,N,-,,transcription initiation factor iif subunit alpha,"F:transcription factor activity, core RNA polymerase II binding; F:translation initiation factor activity; P:transcriptional start site selection at RNA polymerase II promoter; P:regulation of protein serine/threonine phosphatase activity; F:catalytic activity; F:protein phosphatase activator activity; P:positive regulation of catalytic activity; P:dephosphorylation of RNA polymerase II C-terminal domain; C:cytosol; P:translational initiation; C:transcription factor TFIIF complex; P:transcription elongation from RNA polymerase II promoter",PTHR13011 (PANTHER); IPR011039 (SUPERFAMILY),,
RL4_JR_04489,415,423,542,4,0,153,0,0,0,1,13,0,9,44,7,0,54,0,52.66716728,1,0.50075059,0.652282596,0.767689638,0.442671594,0.632032937,8.243107583,0,0.422379198,1.251086117,0.337610011,0.735657097,0.835547794,21.23854147,1,-2.219587424,1.206466943,-1.8397416,0.065806183,0.139874406,34.12572997,1,-1.689877072,1.158891129,-1.458184491,0.144789697,0.259147196,35.51986761,1,-0.59986302,0.981555369,-0.611135183,0.541110089,0.663285672,N,-,,caffeine-induced death 1,F:nucleotidyltransferase activity; P:RNA metabolic process; F:organic cyclic compound binding; F:heterocyclic compound binding; C:cytoplasm,G3DSA:3.30.460.10 (GENE3D); IPR002058 (PFAM); G3DSA:1.10.1410.10 (GENE3D); PTHR12271 (PANTHER); PTHR12271 (PANTHER); PTHR12271:SF58 (PANTHER); PTHR12271:SF58 (PANTHER); SSF81301 (SUPERFAMILY); SSF81631 (SUPERFAMILY); SSF81301 (SUPERFAMILY),,
RL4_JR_04490,21141,18534,26124,3,2,11,0,0,3,0,0,0,3,2,0,0,1,0,185.3852006,1,0.435795958,0.863291524,0.50480741,0.613694111,0.778424465,24.84563009,1,-1.169420663,1.203303331,-0.971841956,0.33112918,0.49427659,88.55640093,0,-1.41441713,0.857897388,-1.64870199,0.099208702,0.192842439,126.5821863,1,-0.888644304,0.632178599,-1.405685522,0.159817528,0.27879953,71.38074764,1,-2.240834783,0.985352627,-2.274145034,0.022957268,0.060829057,N,-,,hypothetical protein CMQ_1231,,no IPS match,,
RL4_JR_04491,1240,1423,1102,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,30.77918159,0,-0.61146218,1.011884199,-0.604280787,0.545656978,0.725807082,6.075268168,0,0.862578118,1.243095049,0.693895546,0.487747717,0.643842253,22.22362068,0,-0.824247603,1.195632909,-0.68938183,0.490583015,0.624430276,73.04465117,1,1.353035297,0.583104754,2.320398329,0.020319339,0.077430677,23.19682433,0,-0.199107319,0.981448777,-0.202870821,0.839236002,0.891633213,N,-,,repressor,F:3-dehydroquinate synthase activity; C:cytoplasm; P:chorismate biosynthetic process,IPR027417 (G3DSA:3.40.50.GENE3D); IPR001381 (PFAM); IPR006151 (PFAM); G3DSA:3.40.192.10 (GENE3D); IPR013785 (G3DSA:3.20.20.GENE3D); IPR031322 (PFAM); IPR013708 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR21090:SF17 (PANTHER); PTHR21090 (PANTHER); SSF53223 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_04492,542,562,456,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.68900931,0,-2.668577738,1.210747321,-2.204074864,0.02751908,0.084577523,7.579832852,0,0.543323887,1.251862555,0.434012412,0.664279428,0.785076375,35.3475551,0,-0.283607097,1.053104649,-0.269305712,0.787694437,0.85970445,76.62125539,0,1.207419707,0.583666465,2.068680967,0.038576034,0.104938836,26.77423718,0,-1.253515828,1.146152601,-1.093672716,0.274098545,0.406961345,N,-,,quinic acid utilization activator,"C:nucleus; F:zinc ion binding; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04493,829,646,615,0,0,4,0,0,0,0,0,0,0,0,1,0,0,0,56.41564575,1,2.364977636,0.660973543,3.578021631,0.000346205,0.002447434,58.21442211,0,5.679183347,0.623131268,9.113943785,7.94E-20,3.50E-17,12.88307496,0,0.817301181,1.189726718,0.686965476,0.492104485,0.625791319,5.81434187,1,-0.566817518,1.193431606,-0.474947635,0.634824298,0.749748748,12.33274671,0,0.708006426,1.121546705,0.63127681,0.527859547,0.651380611,N,-,,endoribonuclease l-psp,P:biological_process; C:cellular_component,IPR006175 (PFAM); IPR013813 (G3DSA:3.30.1330.GENE3D); PTHR11803:SF19 (PANTHER); IPR006175 (PANTHER); IPR013813 (SUPERFAMILY),,
RL4_JR_04494,3675,1302,1369,0,6,7,0,0,0,4,1,2,2,11,1,0,9,7,198.9770446,1,-4.672613698,1.528786895,-3.056419252,0.002239978,0.011435382,63.23086694,0,-2.517025767,2.002854292,-1.256719362,NA,NA,205.1511704,1,-1.739506176,1.733322236,-1.003567681,0.315587039,0.458064973,183.8254393,1,-5.549348663,1.970252647,-2.816567038,0.004853991,0.027365184,153.5732414,1,-5.176546419,1.945755997,-2.66042938,0.007804109,0.025729927,N,-,,family,C:membrane; C:integral component of membrane,IPR007272 (PFAM); PTHR30574 (PANTHER); PTHR30574:SF1 (PANTHER),9.B.102.1.11, the yede/yeee (yede/yeee) family.
RL4_JR_04495,87,49,33,0,3,0,0,0,0,0,0,1,0,0,0,0,0,0,37.9387783,1,1.862643196,0.65041,2.863798521,0.004185942,0.018742543,3.617633704,0,1.610520218,1.300795213,1.238104355,0.215677369,0.362458299,9.322791874,1,-1.03176776,1.216232877,-0.848330759,0.396253792,0.538841288,38.68670923,0,0.905976735,0.87829423,1.031518487,0.302297744,0.448201004,12.99464993,0,-0.176532687,1.143528774,-0.154375378,0.877313766,0.918291752,N,-,,alcohol dehydrogenase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR011032 (G3DSA:3.90.180.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013149 (PFAM); IPR002085 (PANTHER); PTHR11695:SF509 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_04496,5979,8344,6541,2,8,113,1,0,2,4,0,2,3,1,5,0,1,3,142.4329694,1,-1.03714774,0.819197257,-1.266053726,0.205493848,0.370703145,32.90045254,1,-1.574537525,1.22137887,-1.289147507,0.19734681,0.340867409,85.91755829,1,-4.235898471,1.218375295,-3.476677907,0.000507667,0.003421853,107.1841341,1,-2.951703563,1.060157468,-2.784212394,0.005365788,0.029582841,108.3743969,1,-1.219494278,0.739756444,-1.648507813,0.099248509,0.189888728,N,-,,ribosomal rna assembly krr1,"C:small-subunit processome; F:RNA binding; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:nucleolus; C:90S preribosome",IPR004087 (SMART); IPR024166 (PIRSF); IPR004088 (G3DSA:3.30.1370.GENE3D); IPR024166 (PANTHER); IPR004088 (SUPERFAMILY),,
RL4_JR_04497,419,426,398,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,80.13801582,0,-3.408533133,1.139838201,-2.990365763,0.002786436,0.013555005,24.45414362,0,-1.1464628,1.201512997,-0.954182604,0.339991219,0.502980286,85.39647371,0,-1.964772761,1.028511318,-1.91030738,0.056093648,0.123345484,76.97265956,0,-3.268908543,1.141251694,-2.864318679,0.004179073,0.024359884,62.15998156,0,-3.87170773,1.185667451,-3.265424657,0.001093001,0.005123441,N,-,,gata transcription factor,"P:negative regulation of transcription, DNA-templated; F:metal ion binding; P:transcription, DNA-templated; F:sequence-specific DNA binding; P:single-organism cellular process; C:intracellular part; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR000679 (PRINTS); IPR000679 (SMART); IPR013088 (G3DSA:3.30.50.GENE3D); IPR000679 (PFAM); PTHR10071:SF206 (PANTHER); PTHR10071 (PANTHER); IPR000679 (PROSITE_PROFILES); SSF57716 (SUPERFAMILY),,
RL4_JR_04498,2072,1941,4460,0,0,0,0,0,0,0,0,2,0,0,0,0,5,0,62.52571752,0,0.998522982,0.60274981,1.656612685,0.097597806,0.217541777,5.971274627,0,0.887495518,1.234114047,0.719135739,0.472057289,0.630222992,68.17074514,1,1.649689963,0.609689377,2.70578761,0.006814261,0.024087842,33.88437535,0,0.534646137,0.740584863,0.721924204,0.47034108,0.611281379,15.22161533,1,-1.84187184,1.190545427,-1.54708237,0.121843385,0.221802278,N,-,,Regulator of phospholipase D SRF1,P:mycelium development,PTHR36819 (PANTHER); PTHR36819:SF1 (PANTHER),,
RL4_JR_04499,2,16,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,60.6638781,0,-0.184610273,0.752927789,-0.245189878,0.806309413,0.901743694,9.130746448,0,0.274750565,1.22357442,0.22454749,0.822331319,0.893094164,64.76847803,0,0.459143237,0.748850498,0.61313071,0.539789916,0.668026381,47.41726762,0,0.220205798,0.689471224,0.319383595,0.749435649,0.835076998,23.42672091,0,-2.463882084,1.20267214,-2.04867312,0.040494089,0.095170005,N,-,,mitochondrial K+-H+ exchange-related-domain-containing,,IPR018786 (PFAM); PTHR28062:SF1 (PANTHER); PTHR28062 (PANTHER),,
RL4_JR_04500,75,210,185,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,167.2853361,0,-0.529535653,0.551072725,-0.960917913,0.336593443,0.526645437,31.76857704,0,-1.523990106,1.236304438,-1.232698079,0.217688429,0.364929162,235.5992535,0,1.001492912,0.530482789,1.887889548,0.05904078,0.128488576,162.0493078,0,-0.518785084,0.563877303,-0.920031861,0.35755611,0.503442583,102.523693,0,-1.317114835,0.728613855,-1.807699409,0.070653297,0.145933217,N,-,,cutinase transcription factor 1 alpha,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR007219 (SMART); IPR007219 (PFAM); PTHR19444:SF31 (PANTHER); PTHR19444 (PANTHER); PTHR19444 (PANTHER); PTHR19444:SF31 (PANTHER),,
RL4_JR_04501,7,30,12,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,102.6051455,1,-2.136993987,0.941673897,-2.26935672,0.023246642,0.074225481,26.34516255,0,-1.253933414,1.247946653,-1.004797289,0.31499447,0.47708724,243.9394169,0,1.455230988,0.684512584,2.125937524,0.033508462,0.083721537,447.8471545,0,2.19534516,0.47555255,4.61640919,3.90E-06,6.13E-05,244.8577456,0,1.363309226,0.623155468,2.187751363,0.028687718,0.072597638,N,-,,C6 zinc finger domain containing,,no IPS match,,
RL4_JR_04502,788,462,584,0,0,1,0,0,0,0,0,0,0,2,0,0,1,1,227.5693498,1,-2.006182466,0.594743184,-3.373191186,0.000743023,0.004680761,55.92295786,0,-2.339872184,1.191465658,-1.963860367,0.049546287,0.116983326,210.6288499,0,-1.170845571,0.545499116,-2.146374828,0.031843086,0.080373822,248.100355,1,-1.097315758,0.461814213,-2.37609785,0.017496822,0.072072956,189.4477195,1,-1.182850847,0.539511715,-2.192447012,0.028347245,0.071996597,N,-,,pre-mRNA-splicing factor SYF1,C:prespliceosome; C:catalytic step 2 spliceosome; C:post-mRNA release spliceosomal complex; C:catalytic step 1 spliceosome; P:generation of catalytic spliceosome for first transesterification step; C:Prp19 complex,IPR003107 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR11246:SF5 (PANTHER); PTHR11246 (PANTHER); PTHR11246 (PANTHER); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY),,
RL4_JR_04503,9060,3647,6110,0,3,10,0,0,0,0,3,5,0,1,4,0,6,4,80.65502825,1,0.935260378,0.612146709,1.52783698,0.126553018,0.262101935,10.38259771,0,0.089471119,1.244315153,0.071903905,0.942678382,0.969103249,71.14121063,1,0.600171979,0.6969084,0.861192057,0.389132274,0.532734975,30.93021487,1,-2.978064155,1.210104107,-2.460998304,0.013855102,0.062850766,49.43730579,1,0.525430497,0.66907294,0.785311236,0.43227111,0.566910097,N,-,,vacuolar ATP synthase subunit d,"F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport",IPR002699 (TIGRFAM); IPR002699 (PFAM); IPR002699 (PANTHER); PTHR11671:SF1 (PANTHER),3.A.2.2.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_04504,3659,3387,3873,0,0,5,0,0,0,0,0,0,1,2,1,0,3,0,69.46254134,1,0.993024117,0.583776125,1.701035851,0.088936255,0.203119253,6.946588422,0,0.669164693,1.226670873,0.545512824,0.585400863,0.723848954,18.07429951,0,-1.986963041,1.195180792,-1.662479061,0.096416758,0.188805273,34.50122583,1,-0.675030692,1.018305398,-0.662896115,0.50739709,0.643380781,32.60658124,1,-0.382403571,0.980808392,-0.389886113,0.696620763,0.78561876,N,-,,rna recognition domain-containing,"F:nucleotide binding; F:U1 snRNA binding; C:viral nucleocapsid; F:snRNA stem-loop binding; C:nucleolus; C:U1 snRNP; P:mRNA splicing, via spliceosome",IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR10501:SF13 (PANTHER); IPR024888 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_04505,5625,8783,4606,5,1,5,0,0,1,1,0,5,1,9,0,0,11,4,186.7885501,1,-4.669930984,1.138287901,-4.102592131,4.09E-05,0.000393034,86.70686637,1,-0.22010941,0.848423787,-0.259433332,0.795300915,0.876220125,188.1216484,1,-2.228136015,0.737328734,-3.021903138,0.002511909,0.011881961,220.3279696,1,-1.45141085,0.48878379,-2.969433275,0.002983496,0.018534092,149.1772289,1,-5.134670643,1.187976552,-4.322198643,1.54E-05,0.000145096,N,-,,pattern formation emb30,C:trans-Golgi network; P:vesicle-mediated transport; F:ARF guanyl-nucleotide exchange factor activity; P:regulation of ARF protein signal transduction; P:positive regulation of GTPase activity,IPR000904 (SMART); G3DSA:1.10.220.20 (GENE3D); IPR032691 (PFAM); IPR000904 (PFAM); IPR023394 (G3DSA:1.10.1000.GENE3D); PTHR10663:SF185 (PANTHER); PTHR10663:SF185 (PANTHER); PTHR10663 (PANTHER); PTHR10663 (PANTHER); PTHR10663 (PANTHER); IPR000904 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR000904 (SUPERFAMILY),,
RL4_JR_04506,3458,3955,3256,2,4,9,4,0,0,0,2,2,1,3,0,0,0,5,116.0621326,1,0.381393515,0.511861161,0.74511126,0.456204463,0.644676253,18.43179521,1,-0.738634547,1.202437888,-0.614280833,0.539029766,0.686124156,70.14468915,1,-0.988329709,0.857149479,-1.15304242,0.248892974,0.383413339,95.31001994,1,-0.498779721,0.625654625,-0.797212553,0.425327597,0.568132179,82.15962017,1,0.22612884,0.585402973,0.38627894,0.699290096,0.787313713,N,-,,mannan polymerase II complex ANP1 subunit,"P:mannosylation; F:alpha-1,6-mannosyltransferase activity; P:protein N-linked glycosylation; C:endoplasmic reticulum; C:alpha-1,6-mannosyltransferase complex",PF03452 (PFAM); PTHR24319 (PANTHER); PTHR24319:SF13 (PANTHER); IPR029044 (SUPERFAMILY),,
RL4_JR_04507,559,607,849,0,0,1,0,0,0,0,3,0,0,3,0,0,0,0,94.08579871,1,0.267134851,0.597743611,0.446905406,0.654943361,0.805056549,14.24427746,0,-0.366854621,1.229896492,-0.29828089,0.765488788,0.858059525,37.23436544,1,-3.029621463,1.214543053,-2.494453742,0.012615117,0.038701649,84.37757408,1,0.355450536,0.613006443,0.579847961,0.562017151,0.690016628,48.60078962,0,-0.949418616,0.904939324,-1.049151684,0.294108312,0.429022714,N,-,,3 exoribonuclease,"C:cytoplasmic exosome (RNase complex); C:nuclear exosome (RNase complex); P:polyadenylation-dependent snoRNA 3'-end processing; F:RNA binding; P:U4 snRNA 3'-end processing; P:rRNA catabolic process; P:nuclear mRNA surveillance; C:nucleolus; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:rRNA 3'-end processing",IPR027408 (G3DSA:3.30.230.GENE3D); IPR001247 (PFAM); PTHR11953:SF2 (PANTHER); PTHR11953 (PANTHER); PTHR11953:SF2 (PANTHER); PTHR11953 (PANTHER); IPR020568 (SUPERFAMILY); IPR015847 (SUPERFAMILY),,
RL4_JR_04508,88,56,74,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.29084981,0,-0.400345487,1.173552967,-0.341139683,0.732998429,0.859100276,47.62384811,0,3.56184475,0.996772571,3.573377572,0.000352406,0.013666874,14.31245486,0,0.184780734,1.210714115,0.152621277,0.878696945,0.92415623,52.99992677,0,2.333315967,0.616363916,3.785614161,0.000153329,0.001538613,7.726530783,0,-0.863507538,1.22285299,-0.70614174,0.480099997,0.60930214,N,-,,poly polymerase,F:tRNA adenylyltransferase activity; F:nucleotidyltransferase activity; F:RNA binding; C:mitochondrial matrix; C:mitochondrion; P:RNA processing; P:tRNA 3'-terminal CCA addition; F:transferase activity,IPR018870 (PFAM); PTHR32226 (PANTHER); PTHR32226:SF2 (PANTHER),,
RL4_JR_04509,231,133,184,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.7478768,0,-0.626300445,0.85959942,-0.728595705,0.466249007,0.654561933,85.76612463,0,1.958339188,0.989682595,1.978754802,0.04784362,0.113893019,81.96778773,0,1.400438484,1.393484699,1.004990213,0.314901563,0.457211078,71.06083778,0,0.749011526,0.587221359,1.275518193,0.202125889,0.333473135,23.0293412,0,-2.439228041,1.193491032,-2.043775759,0.040975705,0.095939446,N,-,,polyphosphoinositide phosphatase,P:phosphatidylinositol metabolic process; C:vacuolar membrane; C:extrinsic component of membrane; F:phosphoric ester hydrolase activity,IPR002013 (PFAM); PTHR11200:SF9 (PANTHER); PTHR11200:SF9 (PANTHER); PTHR11200 (PANTHER); PTHR11200 (PANTHER); PTHR11200 (PANTHER); IPR002013 (PROSITE_PROFILES),,
RL4_JR_04510,3866,2799,2733,0,1,0,0,0,1,0,0,5,3,1,0,0,0,3,39.73642468,1,3.163053844,0.740237564,4.273025308,1.93E-05,0.000203779,1.692294992,1,2.706420908,1.367393975,1.979254669,0.047787341,0.113785806,4.42627273,1,0.042745208,1.237606017,0.034538623,0.972447644,0.984015531,14.74414897,1,0.573567769,1.180684346,0.485792643,0.627114191,0.743509536,11.76498728,1,0.892320379,1.169823436,0.762782101,0.445593357,0.578266181,N,-,,alpha-ketoglutarate dependent xanthine dioxygenase,F:dioxygenase activity; P:oxidation-reduction process,G3DSA:3.60.130.10 (GENE3D); IPR003819 (PFAM); PTHR30468:SF17 (PANTHER); PTHR30468 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_04511,14688,21001,21780,24,40,65,4,0,7,24,10,28,3,14,6,0,17,0,22.16892544,1,1.502395809,0.848872275,1.769872634,0.076748361,0.182380753,11.45626002,1,3.326829714,1.125605305,2.955591715,0.003120699,0.015928259,5.395218413,1,-0.242750356,1.197072554,-0.202786669,0.839301778,0.896412195,6.224432522,1,-0.665179217,1.194887218,-0.556687868,0.577740708,0.704180169,5.323003254,1,-0.325942037,1.199489773,-0.271733903,0.785826631,0.853701142,N,-,,hypothetical protein PEX2_042250,,no IPS match,,
RL4_JR_04512,10944,9624,5095,2,7,3,0,0,3,0,3,10,0,6,10,0,1,11,88.43751544,1,2.083772544,0.728225,2.861440548,0.004217206,0.018861823,4.476935381,1,1.302936878,1.25567491,1.037638697,0.299438295,0.459786775,11.65309305,1,-1.353799949,1.203288231,-1.125083678,0.260553577,0.397505186,32.71592797,1,-0.025916923,1.025141248,-0.025281319,0.979830575,0.9874375,23.11791327,1,0.747280448,0.875113514,0.853924017,0.393147091,0.529830201,N,-,,trapp complex trs85,P:cellular localization; P:autophagy; C:cytoplasmic part; P:organelle organization,IPR024420 (PFAM); IPR024420 (PANTHER); PTHR12975:SF6 (PANTHER); PTHR12975:SF6 (PANTHER); IPR024420 (PANTHER),,
RL4_JR_04513,958,1067,1123,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0.424259599,1,3.134631984,2.174523817,1.441525707,0.14943622,NA,0.137509047,0,6.328215812,2.011750887,3.145625958,0.001657318,0.015023052,0.353091311,0,3.6915199,1.335410917,2.764332576,0.005703937,0.020945469,0.407065935,0,3.269713218,1.531405947,2.135105472,0.032752396,0.096983198,0.344389986,0,3.623010626,1.264279832,2.865671456,0.004161259,0.015388146,N,-,,hypothetical protein HMPREF1624_02051,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_04514,13210,13467,11814,0,0,113,0,0,2,2,2,1,2,7,0,0,2,0,22.09665969,1,-2.568136551,1.183619556,-2.169731429,0.030027198,0.090391837,7.076740513,1,0.642457861,1.228420927,0.522994885,0.600977813,0.735467207,18.31802737,1,-2.006202798,1.189764176,-1.686218864,0.091753652,0.181645631,38.46425827,1,-0.114881404,0.847362964,-0.1355752,0.892157112,0.933845834,18.01878981,1,-2.085251973,1.189075355,-1.75367521,0.079486176,0.160543091,N,-,,ef-hand calcium-binding domain,P:biological_process; C:cellular_component; F:molecular_function; F:hydrolase activity,IPR005645 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR22778:SF20 (PANTHER); PTHR22778 (PANTHER); PTHR22778 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_04515,2029,1607,2549,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,319.6644198,1,0.737638382,0.369493717,1.996348919,0.045895957,0.124712394,36.98426768,0,-1.743298408,1.209458537,-1.441387493,0.149475242,0.275992046,405.6536387,0,1.687674102,0.323806275,5.211987013,1.87E-07,6.06E-06,232.157857,0,0.309357674,0.431448427,0.717021213,0.473361007,0.614394851,160.6390959,1,-0.360285049,0.498937907,-0.722103982,0.47023055,0.601719616,Y,-,,mixed-linked glucanase,P:metabolic process; F:hydrolase activity,IPR013320 (G3DSA:2.60.120.GENE3D); IPR013320 (G3DSA:2.60.120.GENE3D); PTHR10963 (PANTHER); PTHR10963:SF34 (PANTHER); PTHR10963:SF34 (PANTHER); PTHR10963 (PANTHER); IPR000757 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),,
RL4_JR_04516,2330,2448,3656,0,1,3,0,0,0,0,6,1,2,6,0,0,0,0,0.160841236,1,4.533598275,3.433750164,1.320305223,0.186733133,NA,0.050737159,0,7.765397317,2.548520986,3.047021139,0.002311215,0.015159195,0.133225699,1,5.094613684,1.601611117,3.18093052,0.001468028,0.007761002,0.153772075,1,4.673102834,2.2068268,2.11756665,0.034211785,0.099168143,0.133475489,0,4.991040418,1.437337847,3.472419813,0.000515789,0.002777853,N,-,,---NA---,,no IPS match,,
RL4_JR_04517,1413,1461,1724,0,0,2,0,0,0,0,0,0,0,1,0,0,9,1,1253.811023,1,-3.243330888,0.431494332,-7.516508665,5.63E-14,3.26E-12,385.7780007,0,-2.842616869,0.870411787,-3.265829935,0.001091438,0.015023052,933.5064338,0,-6.70355713,1.200319743,-5.584809523,2.34E-08,9.17E-07,1098.987875,1,-5.038057898,0.68203105,-7.386845363,1.50E-13,7.93E-12,910.6264752,1,-7.744495836,1.212423706,-6.387614988,1.68E-10,1.14E-08,N,-, Effector probability:0.62,bzip transcription factor,"F:transcription factor activity, sequence-specific DNA binding; C:mitochondrion; P:secondary metabolite biosynthetic process; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding; F:monooxygenase activity; P:ubiquinone biosynthetic process",G3DSA:1.20.5.170 (GENE3D); SSF57959 (SUPERFAMILY),,
RL4_JR_04518,752,1064,672,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,63.2688885,0,-1.512199695,0.883387383,-1.711819441,0.086929948,0.199486503,16.44347016,0,-0.573977072,1.211061411,-0.473945472,0.635538792,0.761763881,42.84677921,1,-3.232173503,1.20053834,-2.692270123,0.007096744,0.024826343,124.5876244,0,0.314384121,0.558774774,0.5626312,0.573686042,0.700528782,42.45681026,0,-3.321703969,1.209206432,-2.747011496,0.006014103,0.020818048,N,-,,tpr domain-containing,C:membrane,IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR28142:SF1 (PANTHER); PTHR28142 (PANTHER); PTHR28142:SF1 (PANTHER); PTHR28142 (PANTHER); IPR011990 (SUPERFAMILY),,
RL4_JR_04519,678,657,369,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,103.725331,0,2.171677257,0.511061905,4.249342857,2.14E-05,0.000222244,29.44207528,0,1.555452506,1.114454745,1.395707195,0.162802687,0.294634149,32.86634114,0,-0.200614163,1.035252693,-0.193782798,0.846345957,0.901842592,29.39625832,0,-0.72066932,1.020473235,-0.706210898,0.480056994,0.620604835,62.47021166,0,1.319778205,1.381959136,0.955005232,0.339575051,0.476931252,N,-, Effector probability:0.867,progesterone binding,,IPR001199 (SMART); IPR001199 (G3DSA:3.10.120.GENE3D); IPR001199 (PFAM); PTHR10281 (PANTHER); IPR001199 (SUPERFAMILY),,
RL4_JR_04520,65118,82341,93106,3,0,0,0,0,0,0,2,2,1,15,0,0,1,0,0.008141456,1,8.841220392,4.035983802,2.190598582,0.028480854,NA,0.002675567,0,12.01934062,4.032893235,2.980327006,0.002879408,0.015349618,0.006783092,1,9.399044527,3.291065204,2.855927776,0.004291127,0.016940088,0.007815077,1,8.97609272,4.035428601,2.224322026,0.026126786,0.086108719,0.006504647,1,9.346543544,1.704039324,5.484934187,4.14E-08,1.17E-06,N,-, Effector probability:0.93,hypothetical protein F503_00071,,no IPS match,,
RL4_JR_04521,1834,2095,2132,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,38.61867224,0,-3.373602396,1.204907592,-2.799884754,0.005112085,0.022152697,12.26115556,0,-0.150562942,1.2194127,-0.123471686,0.901733594,0.944583723,61.97318238,0,0.01213165,0.761579572,0.015929589,0.987290564,0.994164479,44.8842622,0,-1.512651953,1.033232937,-1.463998967,0.143194231,0.257109698,39.37738865,1,-1.238170359,1.000679375,-1.237329748,0.215964688,0.341023467,N,-,,mitochondrial metalloendopeptidase OMA1,,IPR001915 (PFAM); G3DSA:3.30.2010.10 (GENE3D); PTHR22726 (PANTHER); PTHR22726:SF1 (PANTHER),,
RL4_JR_04522,705,862,861,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,22.98215434,0,2.966304513,0.677480287,4.378436645,1.20E-05,0.000135438,116.2569007,0,6.173165431,1.545192529,3.995078486,6.47E-05,0.003391805,16.22459182,1,2.317299819,1.040229253,2.227681842,0.025901739,0.06843142,55.08510804,1,4.100170628,0.508175643,8.068412334,7.12E-16,4.74E-14,19.19192183,0,1.357326221,1.123610246,1.208004489,0.227045536,0.354212026,N,-,,haloacid dehalogenase-like hydrolase,F:hydrolase activity,IPR023214 (G3DSA:3.40.50.GENE3D); PTHR12725:SF77 (PANTHER); PTHR12725 (PANTHER); IPR023214 (SUPERFAMILY),,
RL4_JR_04523,3228,4481,6769,0,1,3,0,0,0,0,2,2,3,7,0,0,3,0,1000.439141,1,-0.390943993,0.473099204,-0.826346758,0.408607417,0.599967477,211.5105744,0,-1.877256125,0.867433006,-2.164151136,0.030452752,0.079938474,514.1553106,1,-3.573062684,0.695530674,-5.137174845,2.79E-07,8.73E-06,788.4641502,1,-1.117376169,0.73279349,-1.52481727,0.127304681,0.234850526,602.2470361,1,-1.625512374,0.760736964,-2.136760077,0.032617511,0.080338877,N,-,,60S ribosomal L5,F:structural constituent of ribosome; F:5S rRNA binding; C:cytosolic large ribosomal subunit; P:ribosomal large subunit assembly; P:translation,IPR005485 (PRINTS); IPR025607 (PFAM); G3DSA:3.30.420.100 (GENE3D); IPR005485 (PFAM); IPR005485 (PANTHER); IPR005485 (HAMAP); SSF53137 (SUPERFAMILY),,
RL4_JR_04524,34863,23155,18612,2,0,19,0,0,2,1,2,0,1,11,1,0,6,0,171.4251034,1,0.056967526,0.581783039,0.09791885,0.921996732,0.962237952,46.05314545,1,0.317652428,1.03700868,0.306316074,0.759364002,0.854126283,162.7522179,1,0.345540542,0.533609204,0.647553564,0.51727374,0.648003014,138.3546308,1,-0.472087063,0.590350392,-0.799672652,0.423900482,0.566562905,136.5549016,1,0.268032012,0.527482695,0.508134229,0.611359212,0.718988175,N,-,,cell wall biogenesis mhp1,,SM00368 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR24106 (PANTHER); PTHR24106:SF53 (PANTHER); SSF52047 (SUPERFAMILY),,
RL4_JR_04525,8046,9058,10678,3,2,2,0,0,0,0,3,0,1,4,1,0,2,0,51.92489481,1,-1.143704202,0.861264922,-1.327935427,0.18419944,0.341776417,12.87704296,0,-0.221251961,1.207888607,-0.183172488,0.854662681,0.914158991,46.48380621,1,-1.057168917,1.034912432,-1.02150567,0.307014924,0.448446955,38.63522094,1,-3.299081422,1.192491814,-2.766544292,0.005665389,0.03088964,33.10555268,1,-2.962780528,1.199394612,-2.470229981,0.013502621,0.039915535,N,-,,hypothetical protein F503_00075,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,PTHR35395 (PANTHER),,
RL4_JR_04526,860,555,852,0,3,2,0,0,0,0,0,0,0,0,0,0,0,0,25.97382384,1,-2.801361823,1.255618723,-2.231060889,0.025677096,0.080350498,8.174518538,0,0.434299888,1.279602672,0.339402142,0.734306805,0.834241471,27.93946881,0,-1.271576829,1.237831983,-1.027261249,0.304297464,0.445730478,86.39072059,0,1.374943514,0.61106708,2.25006969,0.024444522,0.084615276,21.40649237,0,-2.333754352,1.259453728,-1.852989355,0.063883884,0.13537554,N,-,,yeats family,"P:regulation of transcription, DNA-templated; F:transferase activity; P:cellular process",IPR005033 (PFAM); IPR005033 (PANTHER); IPR005033 (PROSITE_PROFILES),,
RL4_JR_04527,329,382,277,0,0,0,0,0,0,0,1,1,1,0,0,0,0,3,51.11415174,0,1.99885295,0.758371327,2.635717991,0.008395948,0.033061029,2.96975377,0,1.895036033,1.351025993,1.402664377,0.160716945,0.291484844,33.79601646,1,2.008987164,0.843377235,2.382074213,0.017215428,0.049839574,28.27639576,1,0.59370993,1.088767447,0.54530463,0.58554402,0.71065917,7.798083237,1,-0.87687354,1.276010094,-0.687199532,0.491956999,0.620538759,N,-,,NAD dependent epimerase dehydratase family,F:coenzyme binding; F:catalytic activity; C:mitochondrion,IPR016040 (G3DSA:3.40.50.GENE3D); PTHR12126 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04528,9797,8539,9694,1,12,8,0,0,0,6,5,7,0,7,0,0,10,7,78.46921772,1,0.129645647,0.631061436,0.205440612,0.837227893,0.918937779,12.41512309,0,-0.168571263,1.226724296,-0.137415769,0.890702167,0.938703205,32.3873483,1,-2.82843129,1.208474907,-2.340496501,0.019258119,0.054248524,54.70881053,1,-0.944098751,0.8834323,-1.068671307,0.285217805,0.429417141,58.45400626,1,0.015642959,0.723616496,0.021617748,0.982752876,0.988530028,N,-,,syf2 splicing factor,C:Prp19 complex,IPR013260 (PFAM); PTHR13264:SF5 (PANTHER); IPR013260 (PANTHER),,
RL4_JR_04529,8241,7059,8672,3,2,2,3,0,0,1,0,4,1,6,8,0,5,0,0.031829087,1,6.870734861,3.940144606,1.743777335,0.081197924,NA,0.010188555,1,10.08215548,3.266315815,3.086705651,0.002023879,0.015023052,0.026411508,1,7.430367819,1.855946036,4.003547342,6.24E-05,0.000854851,0.030465191,1,7.009140538,3.678357594,1.905508195,0.056714043,0.132423019,0.0260458,1,7.3468273,1.393610729,5.271793008,1.35E-07,2.91E-06,N,-,,methylmalonate-semialdehyde dehydrogenase,"F:oxidoreductase activity; P:metabolic process; F:methylmalonate-semialdehyde dehydrogenase (acylating) activity; P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",no IPS match,,
RL4_JR_04530,2755,2715,2519,0,0,4,0,0,0,0,0,1,3,0,2,0,0,0,19.42693945,1,1.193774848,0.873115759,1.367258392,0.171544328,0.325228592,2.553191211,0,2.113198589,1.305384122,1.618832767,0.10548325,0.21084152,6.615509368,1,-0.537009533,1.209548437,-0.44397522,0.6570605,0.762580355,26.90123751,1,0.792554089,1.027310805,0.771484233,0.440419964,0.582299835,6.520485794,0,-0.618859927,1.212095883,-0.510570109,0.609652111,0.717607421,Y,-,,cell wall anchored,C:membrane,PF13854 (PFAM); IPR015915 (G3DSA:2.120.10.GENE3D); PTHR23244:SF300 (PANTHER); PTHR23244 (PANTHER); IPR011043 (SUPERFAMILY),,
RL4_JR_04531,2452,2249,1982,2,0,0,0,0,0,0,0,0,0,1,0,0,2,0,1.369845119,1,1.443695368,1.338458286,1.078625597,0.280754666,NA,0.438414185,0,4.65520634,1.577527155,2.950951636,0.003167965,0.016057157,1.134901951,0,2.006587273,1.226806612,1.635618242,0.10191951,0.196502213,1.309077495,1,1.584365905,1.252064874,1.265402406,0.205727113,0.337653918,1.116051007,1,1.927797546,1.208382706,1.595353472,0.110633214,0.20587093,N,-, Effector probability:0.652,---NA---,,no IPS match,,
RL4_JR_04532,1645,1748,1259,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,295.3438465,0,-1.249111037,0.729039412,-1.713365582,0.086645304,0.199225589,114.9931671,0,-0.936769673,1.082176344,-0.865634957,0.386690379,0.551278876,195.9900084,0,-2.832452438,0.952283911,-2.97437813,0.00293583,0.013424728,216.7618606,1,-3.847778125,1.115983787,-3.447879952,0.000565005,0.004624638,182.3406745,1,-2.778741717,0.914395979,-3.038882257,0.002374576,0.009797305,N,-,,cytochrome P450 E- group IV,,IPR024368 (PFAM),,
RL4_JR_04533,227,243,272,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,415.7875347,1,2.221708858,1.260627793,1.762382894,0.078004627,0.184613213,24.20317365,0,-1.131578414,1.243776335,-0.909792526,0.362931937,0.527588261,81.68537335,1,-1.381357315,0.902353403,-1.530838484,0.125809316,0.229991606,158.0580691,0,0.452562321,0.523290404,0.864839711,0.387126772,0.532200756,102.7757599,0,0.000703079,0.609041069,0.001154403,0.99907892,0.999177604,Y,-,,FAD binding domain-containing,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; P:oxidation-reduction process",IPR016169 (G3DSA:3.30.465.GENE3D); IPR012951 (PFAM); IPR006094 (PFAM); PTHR13878:SF58 (PANTHER); PTHR13878 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY),,
RL4_JR_04534,10,8,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34.01127444,0,1.028638329,0.673907774,1.526378486,0.126915632,0.262586287,4.757716982,0,1.215269594,1.244082052,0.976840388,0.328648178,0.491515493,12.33983233,0,-1.436201524,1.192641356,-1.20421912,0.228504898,0.359444311,26.27046602,0,0.446144329,0.853390683,0.52279025,0.601120225,0.722671845,12.1543278,0,-1.517117288,1.194271892,-1.27032822,0.20396774,0.326303265,N,-,,cfem domain-containing,C:membrane,PTHR33048:SF22 (PANTHER); PTHR33048 (PANTHER),2.A.1.7.25, the major facilitator superfamily (mfs).
RL4_JR_04535,194,147,174,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,120.3471577,1,-0.58367214,0.649886783,-0.898113572,0.369125004,0.56108101,35.80371243,0,-0.34217274,1.1275518,-0.303465207,0.761535359,0.855518042,133.441745,0,0.078833778,0.533172835,0.14785783,0.882454969,0.926627206,348.2943398,0,1.719710755,0.771750978,2.228323389,0.025858958,0.085915053,114.4577895,0,-0.764372407,0.632574433,-1.208351724,0.226912001,0.354112825,N,-,,phospholipid-transporting ATPase,F:magnesium ion binding; F:ATP binding; C:trans-Golgi network; P:response to pheromone involved in conjugation with cellular fusion; P:phospholipid translocation; C:integral component of membrane; F:phospholipid-translocating ATPase activity; P:ribosomal small subunit assembly; P:post-Golgi vesicle-mediated transport; P:intracellular protein transport; P:endocytosis; P:endocytic recycling,PR00119 (PRINTS); IPR008250 (PFAM); IPR023214 (G3DSA:3.40.50.GENE3D); IPR008250 (G3DSA:2.70.150.GENE3D); PF13246 (PFAM); IPR001757 (TIGRFAM); IPR032630 (PFAM); IPR006539 (TIGRFAM); IPR032631 (PFAM); IPR023299 (G3DSA:3.40.1110.GENE3D); IPR006539 (PANTHER); PTHR24092:SF55 (PANTHER); SSF81665 (SUPERFAMILY); SSF81653 (SUPERFAMILY); IPR023299 (SUPERFAMILY); IPR023214 (SUPERFAMILY),3.A.3.8.2, the p-type atpase (p-atpase) superfamily.
RL4_JR_04536,146,132,185,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47.62580867,0,3.393934445,0.605221162,5.607759047,2.05E-08,4.64E-07,1.449881889,0,2.929454638,1.36587515,2.144745541,0.031973198,0.083203273,25.92572786,0,2.107127501,1.050182169,2.00643999,0.044809325,0.104095826,22.99348,0,1.603991162,1.038476668,1.54456158,0.122452345,0.22778431,3.758677067,0,0.176071638,1.234045494,0.142678401,0.886544176,0.925387606,N,-, Effector probability:0.663,cript family,C:integral component of membrane,IPR019367 (PFAM); PTHR11805 (PANTHER),,
RL4_JR_04537,330,436,274,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.67618803,0,-0.158913681,1.00354109,-0.158352939,0.874178695,0.939103212,4.419792268,0,1.321550338,1.24399279,1.062345657,0.288078795,0.447572304,22.53233837,0,-0.368040057,1.18710663,-0.31003117,0.756537253,0.836319243,13.22301546,0,-1.752150931,1.186643738,-1.476560214,0.139793563,0.252616425,44.97172405,0,1.800993191,0.610568582,2.949698437,0.003180842,0.01240602,N,-,,epoxide hydrolase,F:catalytic activity; C:cellular_component; F:hydrolase activity,IPR000073 (PRINTS); IPR000639 (PRINTS); IPR029058 (G3DSA:3.40.50.GENE3D); IPR000073 (PFAM); PTHR10992 (PANTHER); PTHR10992:SF855 (PANTHER); PTHR10992:SF855 (PANTHER); PTHR10992 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_04538,240,598,393,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,42.88806263,1,-0.18165963,0.752911626,-0.241276166,0.809341082,0.902858546,8.848146087,0,0.320142923,1.229297347,0.260427572,0.794533977,0.875623764,22.91231817,0,-2.329110149,1.196657182,-1.946347027,0.051613068,0.11601481,34.45089218,0,-1.028202242,1.023176879,-1.004911528,0.314939453,0.461240257,37.29302376,0,-0.720577801,0.976842265,-0.737660344,0.460720876,0.591829341,N,-,,HASPIN kinase,P:phosphorylation; F:kinase activity,IPR024604 (SMART); IPR024604 (PFAM); PTHR24419:SF18 (PANTHER); PTHR24419 (PANTHER); PTHR24419 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_04539,756,855,779,0,0,1,0,0,0,0,3,1,0,2,1,0,1,0,434.5399232,1,-1.260571903,0.894550717,-1.409167617,0.158785611,0.308055413,173.6797014,0,-0.261475815,0.701692551,-0.372635871,0.709419471,0.817200852,274.6598726,1,-4.026123889,1.047124759,-3.844932375,0.000120586,0.001298734,367.8044196,1,-2.090165905,0.500531093,-4.175896232,2.97E-05,0.000374253,284.0207242,1,-3.278508299,0.778678357,-4.210349845,2.55E-05,0.000220841,N,-,,duf1682 domain,F:calcium ion binding; C:integral component of membrane; C:endoplasmic reticulum,IPR012879 (PFAM); IPR012879 (PANTHER),,
RL4_JR_04540,308,647,301,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,79.90050244,0,0.39973116,0.941522895,0.424558088,0.671158851,0.817535882,9.38486556,0,0.235139326,1.219653568,0.192791898,0.847121949,0.908996965,37.43243842,0,-0.603633549,1.039530974,-0.580678753,0.561456984,0.687042168,37.83040311,0,-1.894272244,1.149578385,-1.647797374,0.099394258,0.194864898,38.90611234,0,-0.81607086,0.984091799,-0.829262941,0.406955636,0.543492219,N,-, Effector probability:0.823,cell wall biogenesis,P:fungal-type cell wall organization; F:hydrolase activity,IPR002767 (TIGRFAM); IPR029756 (G3DSA:3.30.70.GENE3D); IPR002767 (PFAM); PTHR33777:SF1 (PANTHER); PTHR33777 (PANTHER); IPR029756 (SUPERFAMILY),,
RL4_JR_04541,563,717,662,0,0,1,0,0,0,0,1,1,0,2,0,0,1,0,100.5793731,1,-2.033487694,0.850373778,-2.391286921,0.016789426,0.057081661,24.5542458,0,-1.152353619,1.205229106,-0.956128269,0.339007434,0.501891656,105.0996405,1,-0.652748513,0.670591908,-0.973391574,0.330358725,0.473397273,103.8556881,1,-1.171033533,0.672224357,-1.742027823,0.081503576,0.168378638,62.30479181,1,-3.875065723,1.187619017,-3.262886219,0.001102838,0.005159997,N,-,,---NA---,,no IPS match,,
RL4_JR_04542,55,53,70,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0.820044434,0,2.183668859,1.668761226,1.308556806,0.190684521,NA,0.261503018,0,5.400437427,1.775066814,3.042385438,0.002347111,0.015170793,0.680241795,1,2.744023897,1.295303112,2.118441522,0.034137692,0.08481227,0.784778752,0,2.321980773,1.381472542,1.680801248,0.092801526,0.185234273,0.673784919,0,2.655520516,1.269852508,2.0912039,0.03650979,0.087618304,N,-,,Na+ proline symporter,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR001734 (TIGRFAM); IPR001734 (PFAM); IPR001734 (PANTHER); IPR001734 (PANTHER); PTHR11819:SF131 (PANTHER); PTHR11819:SF131 (PANTHER); IPR001734 (PROSITE_PROFILES),2.A.21.6.1, the solute:sodium symporter (sss) family.
RL4_JR_04543,46715,19634,21310,7,12,9,0,0,2,0,2,7,1,4,3,0,0,4,44.91408519,1,5.171304905,0.629716337,8.212118058,2.17E-16,1.70E-14,0.332301656,1,5.054899254,1.652604869,3.058746438,0.002222652,0.015045494,11.9338833,1,3.361348065,1.19892189,2.80364225,0.005052894,0.01907445,138.610247,1,6.942513388,0.682161375,10.17723026,2.51E-24,3.02E-22,19.80043278,1,4.930236585,0.765726396,6.438639981,1.21E-10,8.48E-09,N,-,,alkanesulfonate monooxygenase,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity",IPR011251 (PFAM); IPR016215 (TIGRFAM); IPR011251 (G3DSA:3.20.20.GENE3D); IPR016215 (PIRSF); PTHR30011:SF16 (PANTHER); PTHR30011 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_04544,59292,50575,58696,1,3,7,0,0,3,3,0,2,1,17,1,0,9,2,97.83200473,1,3.327922952,0.444322812,7.48987642,6.89E-14,3.93E-12,3.053629343,1,1.854916263,1.277406318,1.452095733,0.146474988,0.272190165,49.00364613,1,2.036977203,0.751794506,2.709486683,0.006738741,0.023870894,115.1216296,1,3.583085083,0.41814735,8.568953228,1.04E-17,8.13E-16,34.18440302,1,2.049465494,0.701272558,2.922494929,0.003472393,0.013317415,N,-,,acyl- dehydrogenase,"F:oxidoreductase activity, acting on the CH-CH group of donors; F:flavin adenine dinucleotide binding; P:oxidation-reduction process",G3DSA:1.20.140.10 (GENE3D); G3DSA:2.40.110.10 (GENE3D); IPR013786 (PFAM); IPR013786 (G3DSA:1.10.540.GENE3D); IPR013107 (PFAM); PIRSF016578 (PIRSF); PTHR10909 (PANTHER); PTHR10909:SF274 (PANTHER); IPR009075 (SUPERFAMILY); IPR009100 (SUPERFAMILY),,
RL4_JR_04545,15465,18885,10003,11,0,8,0,0,1,1,2,0,5,18,1,0,4,4,16.65923152,1,1.360135893,1.009489579,1.347350108,0.177867501,0.333956979,1.548252566,1,2.834898936,1.344679186,2.108234414,0.035010718,0.089174254,4.007042704,1,0.18637845,1.204861942,0.154688636,0.877066789,0.922875117,4.621765692,1,-0.235710626,1.204185015,-0.195742866,0.844811431,0.902862122,3.942313747,1,0.10702671,1.201494605,0.089077978,0.929019939,0.953707847,N,-,,tartrate dehydrogenase,"F:magnesium ion binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:NAD binding; P:oxidation-reduction process",IPR024084 (SMART); IPR011829 (TIGRFAM); IPR024084 (PFAM); IPR024084 (G3DSA:3.40.718.GENE3D); PTHR11835:SF33 (PANTHER); IPR001804 (PANTHER); SSF53659 (SUPERFAMILY),,
RL4_JR_04546,921,1457,909,0,0,0,0,0,0,0,0,1,0,3,0,0,1,2,22.87940268,0,1.666869949,0.772959042,2.156479007,0.031046281,0.093081794,91.66587361,0,4.845539528,0.754179027,6.424919489,1.32E-10,2.62E-08,6.281780794,1,-0.462106188,1.206640302,-0.382969297,0.701742529,0.797445433,7.24776066,1,-0.884627448,1.206100186,-0.733461,0.463277306,0.605093231,6.194695072,1,-0.544688823,1.209377957,-0.450387589,0.652430992,0.752204941,N,-,,ADP-ribosylation factor family,F:GTP binding; P:small GTPase mediated signal transduction; F:GTPase activity; C:nuclear outer membrane-endoplasmic reticulum membrane network; P:Golgi to plasma membrane protein transport; C:Golgi apparatus; P:protein localization to organelle; P:intracellular protein transport,PR00449 (PRINTS); SM00175 (SMART); SM00177 (SMART); SM00178 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR006689 (PFAM); PTHR11711 (PANTHER); PTHR11711:SF19 (PANTHER); IPR024156 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_04547,2894,2138,3057,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,79.92685531,0,-1.808392637,0.895645466,-2.019094279,0.043477421,0.119989446,20.32849005,1,-0.879961637,1.215022593,-0.724234794,0.468921601,0.627722748,53.07835351,0,-3.54109357,1.208201727,-2.930879414,0.00338004,0.014799383,93.20374944,0,-1.204092103,0.776722312,-1.550222112,0.121088214,0.225897426,60.05660467,0,-2.693887298,1.148363678,-2.345848575,0.018983818,0.052459378,N,-,,exosome complex exonuclease rrp45,"P:U4 snRNA 3'-end processing; P:U1 snRNA 3'-end processing; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; C:ribosome; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:cytoplasmic exosome (RNase complex); F:AU-rich element binding; P:nuclear polyadenylation-dependent mRNA catabolic process; C:nuclear exosome (RNase complex); P:nuclear polyadenylation-dependent rRNA catabolic process; F:exonuclease activity; P:nuclear mRNA surveillance; P:U5 snRNA 3'-end processing; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'",IPR001247 (PFAM); IPR015847 (PFAM); IPR027408 (G3DSA:3.30.230.GENE3D); IPR033100 (PTHR11097:PANTHER); PTHR11097 (PANTHER); IPR015847 (SUPERFAMILY); IPR020568 (SUPERFAMILY),,
RL4_JR_04548,24148,24605,27078,3,1,33,6,0,6,1,0,13,2,14,8,0,7,5,112.6746065,1,0.779906111,1.205173566,0.647131777,0.517546661,0.702478138,12.82362685,1,-0.215270359,1.227176062,-0.175419295,0.860750181,0.918363374,46.49040265,1,-1.062576725,1.056500568,-1.00575121,0.314535263,0.456865853,64.01259551,1,-0.278426687,0.718903009,-0.387293813,0.698538706,0.796924439,33.25070079,1,-2.969081555,1.221562121,-2.430561251,0.015075458,0.043661044,N,-,,pre-mRNA-splicing factor cwc15,C:nucleus; C:macromolecular complex,IPR006973 (PFAM); IPR006973 (PANTHER),1.A.17.1.13, the calcium-dependent chloride channel (ca-clc) family.
RL4_JR_04549,50564,20341,25927,0,6,8,0,0,1,1,0,0,4,10,2,0,2,1,78.00474923,1,-0.956868861,0.679111109,-1.409001927,0.158834598,0.308077188,18.89652134,1,-0.774519184,1.209704122,-0.640255059,0.522006793,0.671561274,115.439483,1,0.564668316,0.52275747,1.080172638,0.28006531,0.419435089,92.66628986,1,-0.783466336,0.674206648,-1.162056675,0.245212445,0.383855288,51.93899537,1,-2.570939918,1.122907119,-2.289539246,0.02204804,0.059057251,N,-,,c6 zinc finger domain containing,"P:negative regulation of transcription from RNA polymerase II promoter; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; P:leucine biosynthetic process; P:transcription from RNA polymerase II promoter; F:sequence-specific DNA binding; P:positive regulation of transcription from RNA polymerase II promoter; P:positive regulation of leucine biosynthetic process",PTHR31845:SF12 (PANTHER); PTHR31845 (PANTHER),,
RL4_JR_04550,5158,3288,3200,5,1,2,0,0,0,1,1,0,0,0,0,0,0,0,3.767021597,1,-0.015515742,1.253215751,-0.012380743,0.990121848,0.99512308,1.196573332,0,3.206630833,1.398069896,2.293612673,0.021812757,0.061759084,3.108777558,1,0.552809541,1.227128429,0.450490371,0.652356896,0.758784606,11.61014501,0,1.843718984,1.046347753,1.762051841,0.078060539,0.163467003,3.064786674,0,0.470658181,1.226112078,0.383862282,0.701080523,0.788398531,N,-,,Emopamil binding,C:membrane,IPR007905 (PFAM); PTHR14207:SF0 (PANTHER); IPR007905 (PANTHER); IPR033118 (PROSITE_PROFILES),,
RL4_JR_04551,446,463,634,1,0,0,0,0,0,0,1,0,0,8,1,0,0,0,7.195840753,1,-0.949486876,1.213604091,-0.782369541,0.433997429,0.624656144,2.281434809,0,2.275510248,1.302599716,1.746899082,0.080654845,0.171258305,12.44227625,1,0.579313434,1.202441131,0.481781119,0.629961443,0.741390235,6.858417923,1,-0.805163151,1.20835144,-0.666331933,0.505198959,0.641718663,9.744262029,0,0.458224288,1.143674624,0.400659662,0.688670714,0.779365153,N,-,,dolichol-phosphate mannosyltransferase,F:transferase activity,IPR013744 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR31591:SF4 (PANTHER); PTHR31591 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_04552,1925,2286,1946,3,0,1,0,0,0,0,0,0,0,3,1,0,2,0,40.28888152,1,-3.434657187,1.183880761,-2.901185068,0.003717543,0.017018918,12.90835376,0,-0.224689654,1.211321217,-0.185491388,0.852843634,0.91262113,39.90085355,0,-1.911076225,1.188490987,-1.607985459,0.107838363,0.205101558,58.58472295,1,-0.259357307,0.669352079,-0.387475165,0.698404467,0.796861081,32.84374157,1,-2.951357464,1.187110633,-2.486168839,0.012912669,0.038623566,N,-,,heat repeat,,IPR011989 (G3DSA:1.25.10.GENE3D); IPR016441 (PIRSF); PTHR18460 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_04553,2240,1940,2212,0,0,0,0,0,0,0,1,2,4,0,0,0,2,0,304.0836706,0,-4.042257001,0.945173225,-4.276736679,1.90E-05,0.000200934,93.32384427,0,-3.078649629,1.220869004,-2.521687108,0.011679354,0.037851326,280.6074207,1,-2.364861833,0.70478158,-3.35545352,0.00079235,0.00477485,282.7426686,1,-5.205023698,1.178455693,-4.416817475,1.00E-05,0.000141419,237.1574816,1,-5.803480992,1.228436544,-4.724282274,2.31E-06,2.94E-05,N,-,,amino-acid permease inda1,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR004762 (TIGRFAM); IPR004841 (PFAM); IPR002293 (PIRSF); IPR002293 (PANTHER); PTHR11785:SF404 (PANTHER),2.A.3.10.22, the amino acid-polyamine-organocation (apc) family.
RL4_JR_04554,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,140.0023509,0,-0.797920399,0.741146009,-1.076603515,0.281657433,0.464771873,28.79572657,0,-1.382257506,1.275627975,-1.083589834,0.2785467,0.43753099,80.41043748,0,-3.056950516,1.251915389,-2.441818787,0.01461348,0.043513785,97.2328338,0,-2.203544918,0.981970482,-2.244003215,0.024832195,0.085315904,121.3250755,0,-0.222669846,0.660142803,-0.337305573,0.735886559,0.815376169,N,-,,Serine threonine- kinase ppk30,F:ATP binding; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); PTHR22967:SF57 (PANTHER); PTHR22967:SF57 (PANTHER); PTHR22967 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.2, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_04555,11778,8348,9103,1,7,5,0,0,4,2,0,1,1,10,8,0,0,0,434.2661553,1,-4.279692812,1.16794492,-3.664293358,0.000248022,0.001849512,135.0628594,1,-3.611965738,1.335832367,-2.703906438,0.006852958,0.025530233,377.4826629,1,-3.5269751,1.683702605,-2.094773204,0.036191158,0.088352854,396.6505977,1,-6.658899142,1.346752831,-4.944410724,7.64E-07,1.45E-05,334.0988918,0,-6.29791132,1.354113372,-4.650948324,3.30E-06,4.02E-05,N,-, Effector probability:0.905,GTP-binding partial,,PTHR34724 (PANTHER),,
RL4_JR_04556,1955,1272,1998,2,0,11,0,1,0,0,0,1,2,1,3,0,0,0,111.5195966,1,-3.913892327,1.27863454,-3.060993742,0.002206037,0.01131166,35.30713017,1,-1.676362247,1.311177579,-1.278516559,0.20106735,0.345300936,90.20793757,1,-4.30619378,1.287196292,-3.345405674,0.000821623,0.004919049,103.9504464,1,-4.726931677,1.304198596,-3.624395617,0.000289638,0.002641968,87.72146573,0,-4.368650503,1.294049651,-3.37595277,0.000735605,0.003738958,N,-,,cytochrome p450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR001128 (PRINTS); IPR002403 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305 (PANTHER); PTHR24305:SF62 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_04557,176,106,117,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,805.1154437,0,-2.548726478,0.427494481,-5.962010257,2.49E-09,6.37E-08,222.6931911,0,-4.333398076,1.205092704,-3.595904333,0.000323267,0.012933219,652.4852433,0,-2.986530293,0.546908277,-5.460751676,4.74E-08,1.75E-06,915.4356755,0,-1.403559394,0.340853816,-4.117775215,3.83E-05,0.000462759,601.0735729,0,-3.885333261,0.682172705,-5.695527293,1.23E-08,5.77E-07,N,-,,translation initiation factor 5,,IPR002735 (SMART); IPR003307 (SMART); IPR003307 (PFAM); IPR016189 (G3DSA:3.30.30.GENE3D); IPR002735 (PFAM); IPR016021 (G3DSA:1.25.40.GENE3D); PTHR23001 (PANTHER); IPR003307 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR016190 (SUPERFAMILY); IPR016189 (SUPERFAMILY),,
RL4_JR_04558,14927,18535,17816,2,1,10,0,0,0,5,11,7,2,11,7,0,7,4,14.3513871,1,0.863105918,1.048799782,0.822946318,0.410538522,0.601828079,30.26040757,0,4.545726989,0.882574395,5.150531233,2.60E-07,2.71E-05,34.18486731,1,2.135755883,0.871686373,2.450142561,0.014279966,0.042747008,25.67099252,1,1.052042227,1.036415534,1.015077632,0.310068823,0.456049801,5.50481062,1,-0.374420523,1.228734712,-0.304720392,0.760579117,0.832705529,N,-,,dephospho- kinase,F:ATP binding; C:intracellular membrane-bounded organelle; F:dephospho-CoA kinase activity; C:integral component of membrane; P:coenzyme A biosynthetic process; P:phosphorylation,IPR027417 (G3DSA:3.40.50.GENE3D); IPR001977 (PFAM); IPR001977 (TIGRFAM); PTHR10695 (PANTHER); IPR001977 (PROSITE_PROFILES); IPR001977 (HAMAP); IPR027417 (SUPERFAMILY),,
RL4_JR_04559,8058,9389,14206,0,0,2,0,0,1,1,0,0,0,3,0,0,0,0,11.06167593,1,-1.569631062,1.192431191,-1.316328417,0.188063837,0.346874244,3.530671135,1,1.6456082,1.263145048,1.302786408,0.192647692,0.334588185,9.151692309,1,-1.004949893,1.194522439,-0.841298463,0.400180751,0.542287502,10.55736549,1,-1.42724096,1.192253023,-1.197095694,0.231269258,0.368176295,9.007939455,0,-1.084903454,1.194573083,-0.908193453,0.363776022,0.500284249,N,-,,hypothetical protein CMQ_1412,C:integral component of membrane,no IPS match,,
RL4_JR_04560,1635,1949,2080,1,6,2,4,0,0,0,0,1,1,2,0,0,1,0,136.8053766,1,-4.209617995,1.138395187,-3.697852946,0.000217431,0.001659308,42.4544611,1,-1.942325648,1.190118762,-1.632043548,0.102670313,0.206710436,110.1196888,1,-4.593948918,1.185990333,-3.873512953,0.000107278,0.001218944,127.0338471,1,-5.016258585,1.184954168,-4.233293338,2.30E-05,0.00029628,151.0112455,1,-0.694096331,0.54623106,-1.270700957,0.203835055,0.326189487,N,-,,mitochondrial import inner membrane translocase subunit tim23,C:integral component of membrane,IPR003397 (PFAM); PTHR15371 (PANTHER); PTHR15371:SF0 (PANTHER),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_04561,3155,3422,2714,0,0,3,3,0,0,0,0,1,5,6,0,0,8,1,102.2192513,1,-2.864240028,1.040293926,-2.75329881,0.005899802,0.024822375,28.61079889,1,-1.373004819,1.206650105,-1.137864915,0.255176894,0.410179533,92.20223875,1,-2.206680525,1.04645177,-2.10872645,0.0349682,0.086240817,143.2934747,1,-1.045227157,0.658915695,-1.586283595,0.112674992,0.21395992,137.4896325,1,-0.034390312,0.545003063,-0.063101135,0.949685971,0.967418499,N,-,,heat repeat,C:intracellular part,IPR019442 (PFAM); PTHR14387:SF0 (PANTHER); PTHR14387 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_04562,448,364,854,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,121.4184106,0,0.861926869,0.710594858,1.212965248,0.225143107,0.396014979,116.3165677,0,3.071990541,0.650050249,4.725773963,2.29E-06,0.000182707,39.79149715,0,-3.125360237,1.226087916,-2.549050682,0.01080166,0.034793512,71.57628009,0,-0.539286115,0.753938404,-0.715292008,0.474428626,0.615213862,169.4123053,0,1.890220681,0.559901363,3.37598871,0.000735509,0.003738958,N,-,,ph domain-containing,,IPR001849 (SMART); PF16746 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR031968 (PFAM); PTHR14248:SF28 (PANTHER); PTHR14248 (PANTHER); PTHR14248:SF28 (PANTHER); PTHR14248 (PANTHER); PTHR14248 (PANTHER); IPR001849 (PROSITE_PROFILES); SSF103657 (SUPERFAMILY); IPR011993 (SUPERFAMILY),9.B.198.1.3, the membrane-anchored lipid-binding protein (lam) family.
RL4_JR_04563,4319,4542,4171,3,3,2,0,0,0,0,0,0,0,1,0,0,4,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_04564,206738,257411,313682,414,887,213,1,7,92,78,53,134,108,209,91,0,91,77,251.4534463,1,-0.278314589,0.435589837,-0.638937288,0.522863729,0.707148923,44.98614766,1,-2.025910771,1.196021681,-1.69387462,0.090289111,0.187045923,173.4701035,1,-0.87285874,0.55941013,-1.560319869,0.11868431,0.219985345,195.5528408,1,-0.936058002,0.48658551,-1.923727654,0.05438873,0.128785288,194.1164624,1,-0.337987419,0.472941539,-0.714649468,0.474825669,0.605035226,N,-,,glycyl-tRNA synthetase,F:glycine-tRNA ligase activity; F:ATP binding; P:glycyl-tRNA aminoacylation; C:cytoplasm,IPR002315 (PRINTS); IPR004154 (PFAM); G3DSA:3.30.930.10 (GENE3D); IPR002314 (PFAM); IPR002315 (TIGRFAM); IPR004154 (G3DSA:3.40.50.GENE3D); PTHR10745:SF0 (PANTHER); IPR027031 (PANTHER); IPR006195 (PROSITE_PROFILES); IPR004154 (SUPERFAMILY); SSF55681 (SUPERFAMILY),,
RL4_JR_04565,6721,9106,11003,2,5,5,0,0,0,1,3,1,2,4,0,0,3,0,2138.107422,1,2.369677647,0.657392994,3.604659117,0.000312563,0.00224008,357.7850469,0,1.245112437,0.579309812,2.149303207,0.031610372,0.082537039,1892.226393,1,2.489583151,0.831120251,2.995454807,0.002740359,0.0126994,622.8403652,1,-0.266128564,0.493105437,-0.539699108,0.589404555,0.713842239,600.2249059,1,0.284138658,0.76299802,0.372397634,0.709596815,0.794676225,N,-,,coproporphyrinogen III oxidase,P:porphyrin-containing compound biosynthetic process; P:mycelium development; F:coproporphyrinogen oxidase activity; P:oxidation-reduction process,IPR001260 (PRINTS); IPR001260 (G3DSA:3.40.1500.GENE3D); IPR001260 (PFAM); IPR001260 (PANTHER); PTHR10755:SF0 (PANTHER); IPR001260 (SUPERFAMILY),,
RL4_JR_04566,19330,24916,32505,1,1,6,0,0,0,0,0,0,0,10,0,0,3,0,16.23764695,1,1.909864845,0.912893166,2.092101153,0.036429468,0.105163713,1.52170382,0,2.859721664,1.377274442,2.07636298,0.037860392,0.094986169,16.95977911,0,2.014409628,1.066122995,1.889472076,0.058828601,0.128109434,4.571610338,1,-0.220153494,1.238483239,-0.177760576,0.85891101,0.912233009,3.927250007,1,0.112644428,1.240289264,0.090821094,0.927634749,0.953049399,N,-,,coproporphyrinogen 3 oxidase,F:zinc ion binding; P:porphyrin-containing compound biosynthetic process; F:coproporphyrinogen oxidase activity; P:oxidation-reduction process,IPR007527 (PROSITE_PROFILES),,
RL4_JR_04567,11703,20532,20767,0,1,0,0,0,0,0,0,0,0,5,0,0,3,0,135.4475801,1,0.5482498,0.487705512,1.124141079,0.260953181,0.440455116,26.95504867,0,0.245535872,1.135251057,0.216283323,0.828766907,0.897378751,62.89073165,0,-1.4872742,1.043287855,-1.425564568,0.15399407,0.267599719,93.84762605,1,-0.650346965,0.689348806,-0.943422197,0.345464994,0.492098067,70.71293661,1,-0.443497264,0.684658184,-0.647764497,0.517137281,0.642771296,N,-,,26S proteasome regulatory subunit rpn-8,"C:nuclear envelope; C:mitotic spindle midzone; P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:proteasome regulatory particle, lid subcomplex; C:proteasome storage granule",IPR000555 (SMART); IPR024969 (PFAM); IPR000555 (PFAM); PTHR10540 (PANTHER); PTHR10540:SF7 (PANTHER),,
RL4_JR_04568,1419,2035,3511,4,0,4,0,0,0,1,0,0,3,5,0,0,3,2,656.8250361,1,0.498201527,0.322758589,1.543573256,0.122691748,0.256448701,86.64595915,0,-2.971550785,1.197030845,-2.482434599,0.013048802,0.041265009,327.8703538,1,-1.203614593,0.474661013,-2.535735105,0.011221158,0.035707308,301.9697557,1,-2.961793799,0.686785762,-4.312543976,1.61E-05,0.000216143,336.279644,1,-1.033056912,0.537714476,-1.92119974,0.054706531,0.11989256,N,-,,adenylate kinase,C:nucleus; F:adenylate kinase activity; F:ATP binding; P:DNA replication initiation; P:nucleotide phosphorylation; C:mitochondrial intermembrane space; P:mycelium development; P:ADP biosynthetic process; P:AMP metabolic process; P:ATP metabolic process; C:cytosol,IPR000850 (PRINTS); PF00406 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR006259 (TIGRFAM); IPR007862 (PFAM); IPR000850 (PANTHER); IPR000850 (HAMAP); IPR027417 (SUPERFAMILY); IPR007862 (SUPERFAMILY),,
RL4_JR_04569,1421,2341,2854,4,2,0,0,0,0,1,0,0,0,2,0,0,0,0,3.116347381,1,0.257529481,1.254041215,0.205359663,0.837291133,0.918937779,0.994577625,0,3.473283535,1.423715886,2.439590348,0.014703925,0.045348304,2.583814658,1,0.819124841,1.228171479,0.66694664,0.504806218,0.636842137,6.992348934,1,1.342163737,1.169858412,1.147287333,0.251262888,0.390789053,2.554154658,0,0.733254896,1.228574136,0.596834065,0.550618172,0.67079882,Y,-,,hypothetical protein CMQ_6771,C:BLOC-1 complex,IPR009395 (PFAM),,
RL4_JR_04570,5678,5355,5737,2,0,4,0,0,0,0,2,0,0,3,0,0,5,0,116.5797948,1,0.102050059,0.564143942,0.180893654,0.85645105,0.92787884,18.17016619,0,-0.718029846,1.214849419,-0.591044317,0.554490727,0.699819843,47.42263439,1,-3.378546303,1.20615161,-2.801095877,0.005092939,0.019201401,129.2256286,1,0.403685724,1.814784611,0.222442775,0.823969216,0.889507231,58.62888137,1,-1.28656897,0.886940961,-1.450568895,0.146899942,0.25525346,N,-,,enoyl reductase tsc13,"C:endoplasmic reticulum membrane; F:oxidoreductase activity, acting on the CH-CH group of donors; C:integral component of membrane; P:oxidation-reduction process; P:very long-chain fatty acid metabolic process",IPR001104 (PFAM); PTHR10556 (PANTHER); PTHR10556 (PANTHER); PTHR10556:SF28 (PANTHER); IPR001104 (PROSITE_PROFILES),2.A.90.3.2, the vitamin a receptor/transporter (stra6) family.
RL4_JR_04571,1579,1260,1106,0,0,0,0,0,0,0,0,4,1,2,0,0,0,0,757.6517369,0,-0.594903226,0.454093277,-1.310090363,0.190165268,0.350118928,146.3799361,0,-3.728065078,1.209856801,-3.081410194,0.002060226,0.015023052,437.7660719,1,-2.902133679,1.532034513,-1.894300458,0.05818514,0.127008702,636.1895535,1,-1.090540114,0.680326533,-1.602965725,0.108942222,0.209249078,459.8613341,0,-1.896052657,0.62685021,-3.024730034,0.002488551,0.010174602,N,-,,40S ribosomal S8,F:structural constituent of ribosome; C:ribosome; P:translation,IPR001047 (TIGRFAM); IPR022309 (PFAM); IPR001047 (PANTHER),,
RL4_JR_04572,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,85.41710339,0,0.259306859,0.55333555,0.468624976,0.639337722,0.794715394,14.29859003,0,-0.372254625,1.213552558,-0.306747839,0.759035313,0.853898657,76.26658788,0,0.124157928,0.679411222,0.182743417,0.854999348,0.908005182,80.63796849,0,-0.683716415,0.747154001,-0.915094363,0.360142094,0.506168615,43.81169774,0,-2.166801255,1.123562751,-1.928509337,0.053791804,0.118426183,N,-,,GTPase activating,,IPR000195 (SMART); G3DSA:1.10.8.270 (GENE3D); IPR000195 (PFAM); PTHR22957:SF275 (PANTHER); PTHR22957 (PANTHER); PTHR22957:SF275 (PANTHER); PTHR22957 (PANTHER); IPR000195 (PROSITE_PROFILES); IPR000195 (SUPERFAMILY); IPR000195 (SUPERFAMILY),8.A.87.1.4, the tbc1 domain (tbc1) family.
RL4_JR_04573,668,618,832,0,0,2,0,3,0,0,0,0,0,1,0,0,0,0,52.60352701,1,-0.136720837,0.670371174,-0.203947965,0.838394162,0.918937779,10.75457127,1,0.038675004,1.221408949,0.031664255,0.974739801,0.986927705,27.79681707,0,-2.607837312,1.192327001,-2.187182971,0.02872917,0.074084084,41.37150538,1,-2.080202378,1.143675072,-1.818875334,0.068930452,0.149064678,35.01933782,0,-1.013963837,0.970117824,-1.045196584,0.295932122,0.430846574,N,-,,ram signaling pathway,C:cell part; P:single-organism cellular process,IPR003591 (SMART); IPR001611 (PFAM); IPR019487 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR23155 (PANTHER); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); SSF52075 (SUPERFAMILY),8.A.43.1.2, the neat-domain containing methaemoglobin heme sequestration (n-mhs) family.
RL4_JR_04574,544,531,717,0,0,3,0,0,0,0,1,2,2,2,7,0,1,0,23.81954988,1,-2.676478364,1.211963155,-2.208382616,0.027217613,0.083890275,7.557451872,0,0.547544947,1.241953334,0.44087401,0.65930421,0.780888979,19.70469005,1,-2.11157461,1.209087753,-1.746419649,0.080738058,0.16400323,22.73739249,1,-2.534264791,1.209884474,-2.094633699,0.036203567,0.101052846,23.40611595,1,-1.274488559,1.150938849,-1.107346893,0.268143977,0.400497879,N,-,,ATP-dependent DNA helicase recQ,C:nucleus; F:DNA binding; F:ATP binding; C:cytoplasm; F:ATP-dependent 3'-5' DNA helicase activity; P:double-strand break repair via homologous recombination; F:four-way junction helicase activity; C:chromosome,IPR014001 (SMART); IPR001650 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR004589 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR011545 (PFAM); PTHR13710 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),2.A.16.2.2, the telurite-resistance/dicarboxylate transporter (tdt) family.
RL4_JR_04575,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20.92362819,0,-1.25246415,1.161837953,-1.078002441,0.281032667,0.464290096,5.432592187,0,1.023801116,1.252158874,0.817628767,0.413569196,0.577558969,27.1513201,0,0.181570379,1.04992124,0.172937142,0.862700836,0.912943398,16.3315366,0,-2.056891094,1.207396625,-1.703575321,0.088460455,0.178703533,14.02784448,0,-1.724005976,1.217642997,-1.415855041,0.15681795,0.267123443,N,-,,cruciform cutting endonuclease mitochondrial,,IPR012337 (G3DSA:3.30.420.GENE3D); IPR015242 (PFAM); PTHR28072 (PANTHER); IPR012337 (SUPERFAMILY),,
RL4_JR_04576,12549,12179,16761,0,0,4,0,0,0,0,0,2,0,5,4,0,9,4,605.8151286,1,-1.136933469,0.656791122,-1.731042687,0.083444151,0.193997545,172.3228265,0,-1.120013851,0.922633977,-1.213930853,0.22477413,0.373897082,469.1242736,1,-1.61983909,0.812313487,-1.994105867,0.046140486,0.106304132,449.8296,1,-2.733451809,0.689997249,-3.961540154,7.45E-05,0.000832215,349.5188223,1,-4.179426036,0.991522288,-4.215160955,2.50E-05,0.000216635,N,-,,glutathione reductase,F:NADP binding; F:flavin adenine dinucleotide binding; P:glutathione metabolic process; F:glutathione-disulfide reductase activity; P:cellular oxidant detoxification; C:cytosol; P:cell redox homeostasis; P:oxidation-reduction process,PR00411 (PRINTS); PR00368 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR006322 (TIGRFAM); IPR004099 (G3DSA:3.30.390.GENE3D); IPR004099 (PFAM); PIRSF000350 (PIRSF); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (PFAM); PTHR22912 (PANTHER); PTHR22912:SF155 (PANTHER); PTHR22912 (PANTHER); PTHR22912:SF155 (PANTHER); IPR023753 (SUPERFAMILY); IPR016156 (SUPERFAMILY),,
RL4_JR_04577,490,443,552,0,1,9,0,0,0,0,1,0,0,3,0,0,0,0,0.024424368,1,7.254236597,3.950252254,1.836398319,0.066298768,NA,0.008026702,0,10.42922052,3.949117497,2.640899018,0.008268636,0.029217138,0.020349275,1,7.811478659,2.652591909,2.944847502,0.003231139,0.014303476,0.02344523,1,7.388661107,3.950048324,1.870524232,0.061411055,0.138359353,0.019513942,0,7.763113732,1.549809071,5.00907749,5.47E-07,8.60E-06,,,,,,,,
RL4_JR_04578,1589,1558,2198,5,0,10,0,0,0,0,0,1,0,12,0,0,0,0,70.63528574,1,0.524690849,0.581091888,0.902939552,0.366557977,0.558513285,11.62547873,0,-0.073654033,1.223713324,-0.06018896,0.952005138,0.974435839,75.75813716,1,0.686727612,0.62740316,1.094555551,0.273711398,0.412544975,57.93526989,1,-0.817527211,0.857575204,-0.953300897,0.340437637,0.487474342,33.33867514,0,-1.86511097,1.122265216,-1.661916401,0.096529538,0.185805081,N,-,,exocyst complex component Sec6,,IPR010326 (PFAM); PTHR21292:SF1 (PANTHER); PTHR21292:SF1 (PANTHER); IPR010326 (PANTHER); IPR010326 (PANTHER),1.F.2.1.1, the octameric exocyst (exocyst) family.
RL4_JR_04579,5766,4332,4673,7,2,3,0,0,0,1,1,4,1,4,0,0,4,3,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,hypothetical protein TOPH_00759,,no IPS match,,
RL4_JR_04580,32630,34188,50929,7,19,30,0,0,4,0,0,0,6,27,4,0,16,6,78.82030069,1,-2.225477918,1.020871677,-2.179978119,0.029259084,0.088668501,18.89014106,1,-0.774021755,1.220110661,-0.634386519,0.525828605,0.674538485,48.75491549,0,-3.418486145,1.200324829,-2.847967535,0.004399941,0.017272201,84.48434004,1,-1.494375263,0.86291997,-1.731765766,0.083315276,0.17087513,66.77871389,1,-0.878967207,0.760026964,-1.156494768,0.247478838,0.37764556,N,-,,TBC domain-containing,,IPR001138 (SMART); IPR000195 (SMART); IPR007219 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); IPR000195 (PFAM); G3DSA:1.10.8.270 (GENE3D); PTHR22957 (PANTHER); PTHR22957 (PANTHER); PTHR22957:SF328 (PANTHER); PTHR22957:SF328 (PANTHER); PTHR22957 (PANTHER); PTHR22957:SF328 (PANTHER); IPR000195 (PROSITE_PROFILES); IPR001138 (PROSITE_PROFILES); IPR000195 (SUPERFAMILY); IPR001138 (SUPERFAMILY); IPR000195 (SUPERFAMILY),8.A.87.1.5, the tbc1 domain (tbc1) family.
RL4_JR_04581,7077,5964,10123,0,3,12,0,0,0,0,4,3,2,4,1,0,2,4,0.016612338,1,7.812771892,3.97064423,1.967633321,0.049110243,NA,0.005355656,0,11.01441033,3.970129233,2.774320352,0.005531718,0.021974647,0.013687801,1,8.385893671,2.919029933,2.872835792,0.004068055,0.016555546,0.015782304,1,7.96124824,3.970963317,2.004865723,0.044977404,0.115138395,0.013184218,1,8.339720293,1.621041499,5.144667981,2.68E-07,4.88E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_04582,13961,16961,20517,8,7,47,1,1,1,3,4,24,11,20,13,0,18,9,0.527281384,1,2.820974664,1.986443679,1.420113086,0.155574761,NA,0.171077686,1,6.013046256,1.936289297,3.105448275,0.001899908,0.015023052,0.439184108,1,3.376510625,1.324564022,2.549148678,0.010798625,0.034793512,0.506299495,1,2.954910622,1.475548814,2.002584119,0.045221946,0.115278131,0.428430816,1,3.3079955,1.265116756,2.614774869,0.008928629,0.028690055,N,-,,Major facilitator superfamily general substrate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11360 (PANTHER); PTHR11360:SF148 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.13.4, the major facilitator superfamily (mfs).
RL4_JR_04583,15269,18842,23756,1,31,50,2,0,7,0,20,22,25,34,25,0,30,18,4.530508875,1,-0.281768784,1.221558493,-0.230663358,0.817576342,0.907207263,1.453347356,1,2.926238549,1.367717433,2.139505192,0.032394776,0.083947753,3.753424617,1,0.281059963,1.214534732,0.23141369,0.816993431,0.881513535,4.329011421,1,-0.140961513,1.216076456,-0.115915008,0.907719901,0.9436,3.679486376,1,0.206739496,1.206592762,0.171341568,0.863955197,0.909649914,N,-,,hypothetical protein CMQ_7588,,no IPS match,,
RL4_JR_04584,1609,1744,2717,0,0,1,0,0,0,0,0,0,2,3,0,0,4,2,13.191356,1,-1.823741326,1.196635656,-1.524057315,0.127494394,0.26351641,4.196890174,0,1.396193958,1.25220869,1.114985041,0.264856832,0.421853793,10.9026246,0,-1.257597532,1.196444228,-1.051112541,0.293206905,0.433726871,12.57894055,1,-1.6800926,1.194828252,-1.406137323,0.159683351,0.278613464,10.75646611,1,-1.340840978,1.200627695,-1.116783316,0.264086984,0.396482906,N,-,,kinase domain containing,P:metabolic process; F:transferase activity,PF13649 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR12176:SF24 (PANTHER); PTHR12176 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_04585,13726,11281,9981,3,10,18,0,0,0,0,4,3,4,3,2,3,6,3,166.7085329,1,1.04916024,0.827309214,1.268159743,0.20474091,0.369615521,17.05842732,0,-0.626882493,1.237707277,-0.506486877,0.6125149,0.745155601,72.63611599,1,-0.8495324,0.880037822,-0.965336237,0.334376427,0.47771506,60.04621903,1,-2.739462684,1.168949251,-2.343525762,0.019102443,0.075140729,43.16293988,1,-3.345533629,1.212873287,-2.75835379,0.005809329,0.02024766,N,-,,arginine permease,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PIRSF); IPR004841 (PFAM); PTHR11785:SF206 (PANTHER); IPR002293 (PANTHER),2.A.3.10.10, the amino acid-polyamine-organocation (apc) family.
RL4_JR_04586,1991,2053,2981,0,2,14,0,0,0,0,0,2,0,1,0,0,5,0,0.18814274,1,4.307707018,3.44805445,1.249315253,0.211549791,NA,0.062496433,0,7.466357303,2.669791419,2.796606975,0.005164231,0.021103088,0.157928874,1,4.852545181,1.767931039,2.744759312,0.006055529,0.021918548,0.181881663,1,4.432062223,2.343120049,1.891521617,0.058554748,0.135014457,0.151448817,1,4.807890495,1.579459722,3.04400956,0.002334477,0.009655466,N,-,,hypothetical protein FPOA_08372,,no IPS match,,
RL4_JR_04587,7923,6547,10259,1,5,11,0,0,3,0,0,3,0,7,2,0,4,2,0.040681318,1,6.517724308,3.932923798,1.657221101,0.097474782,NA,0.013209612,1,9.709679974,3.260016285,2.978414562,0.002897438,0.015349618,0.03375625,1,7.081884304,1.925835259,3.677305351,0.000235711,0.001962448,0.038911778,1,6.657286499,3.496101185,1.904203038,0.056883746,0.132584698,0.032648923,1,7.023383841,1.426772274,4.922568213,8.54E-07,1.27E-05,N,-,,trichothecene 3-O-acetyltransferase,F:transferase activity,IPR023213 (G3DSA:3.30.559.GENE3D); IPR003480 (PFAM); IPR023213 (G3DSA:3.30.559.GENE3D); PTHR31642 (PANTHER); PTHR31642:SF31 (PANTHER),,
RL4_JR_04588,5750,5518,7920,0,0,5,0,0,0,1,0,4,0,14,0,0,4,1,0.267738254,1,3.798717713,2.703736252,1.404988268,0.160024767,NA,0.083855378,0,7.040954153,2.223196839,3.167040376,0.001539989,0.015023052,0.22030028,1,4.370368364,1.418006553,3.082050895,0.002055797,0.010069128,0.254340624,1,3.947618688,1.77669872,2.221884129,0.026291137,0.08636862,0.219992451,1,4.271981132,1.328821428,3.214864724,0.00130506,0.005936089,N,-,,amidohydrolase 2,,IPR006680 (PFAM); G3DSA:3.20.20.140 (GENE3D); PTHR21240 (PANTHER); PTHR21240:SF8 (PANTHER); PTHR21240 (PANTHER); IPR032466 (SUPERFAMILY),,
RL4_JR_04589,9213,7157,5776,4,2,2,0,0,0,3,0,1,0,6,3,0,0,0,8.503533335,1,-1.190166594,1.195875354,-0.995226292,0.319626217,0.508088597,2.721010004,0,2.0214353,1.287964744,1.569480305,0.116536065,0.228246527,7.040880245,1,-0.626602247,1.198481031,-0.522830342,0.601092323,0.71932704,8.12147682,1,-1.048743988,1.196387738,-0.876592056,0.380708255,0.526306811,6.917672571,0,-0.704020137,1.195189786,-0.58904464,0.555831329,0.675266645,N,-,,trihydroxytoluene oxygenase,,no IPS match,,
RL4_JR_04590,1321,884,1358,0,3,2,0,0,2,0,0,0,0,2,0,0,0,0,15.34085817,1,2.219810909,0.893331273,2.484868689,0.012959923,0.046674295,1.242406205,1,3.152323792,1.396754049,2.256892539,0.02401479,0.066469157,14.29387962,0,1.46155752,1.211154476,1.206747404,0.227529437,0.358466856,15.7536378,1,2.360191259,0.894372638,2.638935003,0.008316692,0.041893787,3.183506523,0,0.415465551,1.229156724,0.338008606,0.735356702,0.815210489,N,-, Effector probability:0.713,Alanine N-terminal,,IPR026956 (SMART); IPR026956 (PFAM); IPR001608 (PFAM); IPR029066 (G3DSA:3.20.20.GENE3D); PTHR28004 (PANTHER); PTHR28004:SF3 (PANTHER); IPR029066 (SUPERFAMILY),,
RL4_JR_04591,7756,8517,14209,0,0,1,2,0,0,5,0,3,0,2,1,0,4,1,9.799527353,1,-1.395010029,1.192257854,-1.17005732,0.241977903,0.416995296,3.145377801,1,1.812341044,1.280236232,1.415630178,0.156883811,0.286173713,14.62668103,1,0.127990382,1.194852215,0.107118169,0.914695233,0.948517314,9.374238748,1,-1.255802367,1.19592198,-1.050070479,0.29368571,0.438191544,7.979467022,1,-0.910155059,1.194001181,-0.762273165,0.445896987,0.578511344,N,-,,serine threonine kinase,F:ATP binding; F:protein kinase activity; P:phosphorylation; F:protein serine/threonine kinase activity; P:protein phosphorylation; F:kinase activity,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_04592,5196,4895,7683,0,0,4,0,0,0,1,0,0,0,2,0,0,0,1,334.036427,1,0.913676708,0.867708228,1.052976887,0.292351585,0.477382753,38.56375628,0,-1.803652841,1.197241289,-1.506507384,0.131936973,0.25003985,130.4546262,1,-1.632318556,0.742850812,-2.197370629,0.027993987,0.072557892,179.2594734,1,-0.582532291,0.458351019,-1.270930502,0.203753374,0.335466307,136.9620287,1,-0.668650492,0.548411235,-1.219250172,0.222749255,0.34939368,N,-,,tartrate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662 (PANTHER); PTHR11662:SF213 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_04593,3610,3202,2728,0,3,3,0,0,0,0,0,0,1,5,0,0,3,0,27.36044612,1,-2.876389366,1.262530009,-2.278274058,0.022710254,0.072912339,8.910090336,0,0.31010257,1.314001414,0.235998658,0.813433712,0.887143199,22.85096546,0,-2.325199031,1.252916534,-1.855829154,0.063477914,0.136328044,30.35091818,1,-1.803619719,1.213418822,-1.48639504,0.137174661,0.248771886,30.01876016,1,-0.751992897,1.059562247,-0.709720358,0.477877565,0.607471481,N,-,,triacylglycerol lipase,,no IPS match,,
RL4_JR_04594,2227,1974,2558,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,558.044148,0,-2.154555091,0.665491962,-3.237537363,0.001205662,0.006835154,188.2910565,0,-1.265735606,0.89521167,-1.413895338,0.157392635,0.286791765,480.0655803,0,-2.019601552,0.580254103,-3.480546784,0.000500391,0.003384077,501.5169763,0,-2.772438998,0.665137362,-4.168220216,3.07E-05,0.000385161,444.3759217,0,-2.185012968,0.79375417,-2.752757782,0.00590956,0.020533389,N,-,,ubiquitin conjugation factor e4,C:nucleus; C:ubiquitin ligase complex; C:cytoplasm; F:ubiquitin-ubiquitin ligase activity; P:ubiquitin-dependent protein catabolic process; P:protein ubiquitination,IPR003613 (SMART); IPR019474 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR003613 (PFAM); PTHR13931:SF2 (PANTHER); PTHR13931 (PANTHER); PTHR13931 (PANTHER); IPR003613 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),,
RL4_JR_04595,5721,6700,6631,1,1,16,0,0,0,0,0,1,0,9,1,0,4,0,58.40153676,1,-1.363032417,0.870689748,-1.565462806,0.117474432,0.248713376,24.45603721,0,0.467003872,1.131991393,0.412550727,0.679935808,0.796379339,91.69371184,1,0.319065307,0.633165572,0.503920808,0.614317028,0.729199858,62.62350009,1,-1.20794487,0.869035339,-1.3899836,0.164533857,0.284867528,38.33879868,1,-3.174547994,1.20069423,-2.643927084,0.008195031,0.026766028,N,-,,traf-like signal,P:biological_process; F:ubiquitin-protein transferase activity; F:zinc ion binding; F:metal ion binding; C:cellular_component; P:protein ubiquitination,IPR001841 (SMART); IPR001293 (PFAM); IPR001841 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR10131:SF52 (PANTHER); PTHR10131 (PANTHER); IPR001293 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR001293 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR008974 (SUPERFAMILY); IPR008974 (SUPERFAMILY),,
RL4_JR_04596,20655,33909,37904,2,3,5,0,0,0,1,4,0,0,12,0,0,11,0,319.7183026,1,1.261190662,0.407697474,3.09344733,0.001978457,0.010386261,50.99532382,0,-0.448489193,1.132232926,-0.396110361,0.692023615,0.804948636,88.26580846,1,-2.198743113,1.048694275,-2.096648343,0.036024716,0.088052687,101.289272,1,-1.749277281,0.783686094,-2.232114739,0.025607381,0.085851084,111.0070167,1,-0.27026212,0.600910273,-0.449754534,0.652887445,0.752441233,N,-,,transcription factor,"C:nucleus; F:zinc ion binding; P:meiotic cell cycle; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR013940 (PFAM); PTHR31986:SF7 (PANTHER); PTHR31986 (PANTHER),,
RL4_JR_04597,4566,3075,4822,0,2,0,0,0,0,0,3,2,0,0,0,0,0,1,0.023713592,1,7.294775898,3.951484475,1.846084919,0.064879876,NA,0.007681212,0,10.49009322,3.506163324,2.991900905,0.002772462,0.015349618,0.019787624,1,7.846564413,2.051149954,3.8254465,0.000130535,0.001356816,0.02281372,0,7.426217697,3.95118342,1.879492017,0.060177342,0.136951133,0.019415467,1,7.764816771,1.447934094,5.362686605,8.20E-08,1.94E-06,,,,,,,,
RL4_JR_04598,2500,1995,2606,0,0,0,0,0,0,3,0,0,3,0,0,0,0,0,260.7384266,0,-0.469983366,0.953908199,-0.492692448,0.622229915,0.783477642,50.28462135,0,-2.186515957,1.27972755,-1.708579265,0.087528912,0.182523207,129.4138769,1,-4.826848967,1.267778051,-3.807329652,0.000140475,0.001415819,174.9305134,1,-2.270750812,0.836555584,-2.714405183,0.00663949,0.035104355,148.1735109,0,-2.586566579,0.972294552,-2.660270566,0.00780779,0.025733684,N,-,,xanthine dehydrogenase,"F:xanthine dehydrogenase activity; F:oxidoreductase activity, acting on CH-OH group of donors; F:xanthine oxidase activity; F:iron ion binding; F:flavin adenine dinucleotide binding; F:electron carrier activity; P:oxidation-reduction process; F:2 iron, 2 sulfur cluster binding; F:molybdopterin cofactor binding",IPR000674 (SMART); IPR005107 (SMART); G3DSA:3.30.390.50 (GENE3D); IPR000674 (G3DSA:3.90.1170.GENE3D); IPR002346 (PFAM); IPR008274 (G3DSA:3.30.365.GENE3D); IPR008274 (G3DSA:3.30.365.GENE3D); IPR008274 (G3DSA:3.30.365.GENE3D); IPR008274 (PFAM); IPR002888 (G3DSA:1.10.150.GENE3D); IPR000674 (PFAM); IPR014307 (TIGRFAM); IPR002888 (PFAM); IPR001041 (PFAM); IPR016167 (G3DSA:3.30.43.GENE3D); IPR016208 (PIRSF); IPR016169 (G3DSA:3.30.465.GENE3D); IPR005107 (PFAM); IPR012675 (G3DSA:3.10.20.GENE3D); IPR008274 (G3DSA:3.30.365.GENE3D); PTHR11908:SF66 (PANTHER); PTHR11908 (PANTHER); PTHR11908 (PANTHER); PTHR11908 (PANTHER); PTHR11908:SF66 (PANTHER); IPR001041 (PROSITE_PROFILES); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY); IPR002888 (SUPERFAMILY); IPR000674 (SUPERFAMILY); IPR008274 (SUPERFAMILY); IPR005107 (SUPERFAMILY); IPR001041 (SUPERFAMILY),,
RL4_JR_04599,1282,1510,2464,1,0,3,0,0,0,1,0,0,0,1,0,0,0,0,20.62659183,1,1.449897996,1.029433411,1.408442722,0.159000016,0.308309206,1.469526966,0,2.910234574,1.367251252,2.128529464,0.03329321,0.085902082,10.3055843,1,1.222534385,1.207710836,1.012274088,0.31140702,0.453167267,4.39162194,1,-0.161695577,1.221356635,-0.132390141,0.894675712,0.935032162,3.741667793,0,0.182705155,1.215168943,0.150353707,0.880485563,0.920987837,N,-,,O-methyltransferase,F:transferase activity,IPR001077 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR11746:SF87 (PANTHER); PTHR11746 (PANTHER); IPR016461 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY); IPR029063 (SUPERFAMILY),,
RL4_JR_04600,14935,12609,11136,0,10,18,0,0,7,4,3,6,6,11,1,0,0,7,5.731742964,1,-0.621258574,1.192522032,-0.520961925,0.602393295,0.770753529,1.831105204,1,2.59281964,1.314792058,1.972037802,0.048605291,0.115272436,11.24520379,1,0.903936013,1.190151483,0.759513411,0.447545495,0.586910698,5.475344242,1,-0.480129574,1.193861366,-0.402165266,0.687562403,0.788310421,4.674712257,1,-0.138637231,1.195091698,-0.116005517,0.907648169,0.94065126,N,-,,methyltransferase domain-containing,F:methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108 (PANTHER); PTHR10108:SF905 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_04601,5627,3258,3127,0,0,2,0,0,0,1,0,0,0,0,2,0,3,1,40.81781965,1,-0.850248031,1.03357896,-0.822625134,0.410721201,0.601987704,7.263865648,0,0.604740603,1.253279137,0.482526666,0.62943186,0.756515326,18.8652558,1,-2.048754911,1.212252189,-1.690040183,0.091020267,0.180577932,29.78600088,1,-0.757696761,1.045570905,-0.724672767,0.468652806,0.609989672,18.64685595,1,-2.134672564,1.220353466,-1.749224814,0.080252166,0.161605645,N,-,,lariat debranching enzyme,"F:hydrolase activity, acting on ester bonds; P:single-organism cellular process; P:mRNA splicing, via spliceosome",IPR007708 (SMART); IPR029052 (G3DSA:3.60.21.GENE3D); IPR007708 (PFAM); IPR004843 (PFAM); PTHR12849 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_04602,5603,5345,4876,0,3,2,0,0,0,4,3,1,2,0,2,0,0,0,51.8819381,1,-2.606942798,1.150470654,-2.265979396,0.023452645,0.074766188,52.28642845,0,0.586330186,1.111333955,0.527591354,0.597782995,0.733158788,44.14312346,1,-2.031177745,1.195319096,-1.69927658,0.089267083,0.177621846,53.91767958,1,-1.11805652,0.866167579,-1.290808554,0.196770071,0.32671318,35.91535089,0,-3.080309982,1.202957053,-2.560615089,0.010448705,0.032521052,N,-,,transcription elongation factor polypeptide 1,F:ubiquitin-protein transferase activity; F:translation elongation factor activity; C:cytosol; C:Cul3-RING ubiquitin ligase complex; C:elongin complex; P:global genome nucleotide-excision repair; P:translational elongation; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process,IPR001232 (SMART); G3DSA:3.30.710.10 (GENE3D); IPR016073 (PFAM); PTHR20648 (PANTHER); IPR011333 (SUPERFAMILY),,
RL4_JR_04603,633,448,395,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.5776098,0,2.07090919,1.009713488,2.050986952,0.040268217,0.113200592,0.940429651,0,3.554150752,1.409352258,2.521832802,0.011674518,0.037851326,2.436224201,0,0.904343361,1.206942617,0.749284471,0.453685765,0.593119149,50.98663012,0,3.992957301,1.5348452,2.601537473,0.009280693,0.045815218,2.398127951,0,0.824269762,1.200241798,0.686753088,0.492238336,0.620688149,N,-, Effector probability:0.551,Ras family,P:regulation of cell shape; P:positive regulation of formin-nucleated actin cable assembly; P:barrier septum assembly; P:small GTPase mediated signal transduction; C:barrier septum; P:microtubule cytoskeleton organization; C:plasma membrane; F:GTP binding; C:incipient cellular bud site; P:regulation of barrier septum assembly; C:cellular bud neck; C:cell cortex; F:GTPase activity; P:maintenance of cell polarity; P:cellular protein localization,PR00449 (PRINTS); SM00174 (SMART); SM00173 (SMART); SM00175 (SMART); IPR005225 (TIGRFAM); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24072:SF39 (PANTHER); PTHR24072 (PANTHER); PS51420 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.50.1.1, the nuclear t-rna exporter (t-exporter) family.
RL4_JR_04604,59873,57991,67645,4,5,5,0,0,0,3,1,0,0,4,0,0,12,3,54.55928586,1,1.669761605,0.777333012,2.148064703,0.031708616,0.094580946,3.340996626,0,1.725300725,1.320293118,1.306755827,0.191295652,0.332982732,76.99753611,1,2.752616571,0.647437519,4.251555541,2.12E-05,0.000354075,27.31450314,1,0.957407319,0.905655457,1.057142992,0.290446333,0.435218162,8.489610054,1,-0.999404043,1.232106978,-0.811134147,0.417288638,0.553293099,N,-,,DASH complex subunit DAD1,C:mitotic spindle; C:DASH complex; P:mitotic spindle organization in nucleus,IPR013958 (PFAM); PTHR28025 (PANTHER); IPR013958 (PTHR28025:PANTHER),,
RL4_JR_04605,126885,153904,152058,27,31,203,2,0,3,19,18,34,20,115,8,3,60,26,1103.990709,1,5.117046077,2.608622638,1.961589232,0.049810327,0.132319325,28.62181002,1,1.806511107,0.983162289,1.83744955,0.066143558,0.146853496,1092.293942,1,5.398454774,0.243494905,22.17070934,6.59E-109,3.33E-105,658.6284001,1,4.445275003,0.459575512,9.672567166,3.94E-22,4.20E-20,1096.146016,1,5.420160061,1.090910033,4.968475764,6.75E-07,1.04E-05,N,-,,aldehyde dehydrogenase,F:aldehyde dehydrogenase (NAD) activity; C:nucleus; C:cytosol; C:Golgi apparatus; P:oxidation-reduction process,IPR016162 (G3DSA:3.40.605.GENE3D); IPR016163 (G3DSA:3.40.309.GENE3D); IPR015590 (PFAM); PTHR11699 (PANTHER); PTHR11699:SF211 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_04606,23080,37254,30939,6,8,116,2,0,0,20,8,6,19,54,15,0,16,13,95.79899665,1,-1.248426373,0.680135294,-1.835555932,0.06642336,0.164655657,23.132892,1,-1.066378206,1.200757346,-0.888088013,0.37449341,0.539129896,60.07160832,1,-3.719656117,1.193184001,-3.117420375,0.001824412,0.009202964,69.30103775,1,-4.142017217,1.193350931,-3.470912965,0.000518692,0.004318879,89.49153208,1,-0.605126528,0.635719091,-0.951877231,0.341159248,0.478396068,N,-,,myb DNA-binding,C:nucleus; F:DNA binding,IPR013867 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); PTHR21717:SF9 (PANTHER); PTHR21717 (PANTHER); IPR009057 (SUPERFAMILY),,
RL4_JR_04607,20781,18401,19875,9,4,7,0,0,2,0,2,5,0,3,2,0,7,3,0.551004793,1,2.757474667,1.907734958,1.445418115,0.148340478,NA,0.174562343,1,5.98350749,1.876512196,3.188632349,0.001429476,0.015023052,0.455234764,1,3.323584198,1.286174159,2.584085659,0.009763754,0.03211444,0.525327394,1,2.901220662,1.414212966,2.051473668,0.040220841,0.107734397,0.451338261,1,3.234418016,1.248849707,2.589917744,0.009599887,0.030374642,N,-,,hypothetical protein CMQ_6550,,no IPS match,,
RL4_JR_04608,493269,320584,129358,14,4,1,0,0,4,0,9,14,0,8,2,0,18,1,83.0653737,1,0.011099111,0.623791458,0.017792983,0.985804003,0.992495256,11.83462716,1,-0.099448342,1.208760169,-0.082273013,0.934429614,0.963917721,50.26685525,1,-0.352378294,0.854704419,-0.412280884,0.680133558,0.779980986,43.52605539,1,-1.451599661,1.01755743,-1.426553056,0.153708764,0.270708164,30.39729509,1,-2.839631734,1.197674622,-2.370954248,0.017742227,0.049618489,N,-,,thioredoxin 5,,IPR010357 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR010357 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_04609,33669,30201,22929,7,2,8,0,0,0,0,3,2,1,11,1,0,9,4,252.3980181,1,-0.187432815,0.430019602,-0.435870398,0.662930764,0.811552997,43.21203121,0,-1.967830163,1.219966932,-1.613019264,0.106740323,0.212849792,124.3274025,1,-2.7949424,1.054287465,-2.651024975,0.008024791,0.02742842,188.5833698,1,-1.265385052,0.593593354,-2.13173723,0.033028454,0.097241379,109.0150942,1,-4.682178535,1.206698689,-3.880155485,0.00010439,0.000718034,N,-,,hypothetical protein CMQ_6940,,no IPS match,,
RL4_JR_04610,22528,20061,23613,0,0,2,0,0,0,6,6,3,2,7,0,0,10,1,69.55267997,1,-1.145970783,0.736067183,-1.556883406,0.11949817,0.251318915,17.31959727,0,-0.648817922,1.198052437,-0.541560537,0.588121283,0.725705672,44.93741215,1,-3.300880013,1.186051717,-2.783082699,0.005384508,0.019968043,137.3731606,1,1.029400371,0.646764264,1.591616031,0.111471006,0.212508887,66.40425632,1,-1.15523382,0.835453182,-1.382763086,0.166737521,0.280481376,N,-,,regulator of nonsense transcripts 3,F:nucleotide binding; F:nucleic acid binding; C:nucleolus,IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR005120 (PFAM); PTHR13112 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_04611,10594,9332,8822,2,4,27,0,0,0,0,7,0,1,3,0,0,10,1,66.8323645,1,-0.945610084,0.737514767,-1.282157493,0.199787404,0.363185881,15.14749631,0,-0.455459047,1.205873847,-0.377700411,0.705653163,0.814809641,83.50320747,1,-0.269616637,0.737098567,-0.365780981,0.714528512,0.806903141,74.61453898,1,-0.222883894,0.6115297,-0.364469452,0.715507481,0.809442821,91.9119679,1,1.002389829,0.452966595,2.212944269,0.026901488,0.069146847,N,-,,serine threonine- phosphatase ppe1,"P:positive regulation of hydroxymethylglutaryl-CoA reductase (NADPH) activity; P:DNA repair; P:protein dephosphorylation; P:positive regulation of isopentenyl diphosphate biosynthetic process, mevalonate pathway; P:TOR signaling; P:tRNA wobble uridine modification; P:replicative cell aging; F:protein serine/threonine phosphatase activity; P:fungal-type cell wall organization; C:nuclear chromatin; P:G1/S transition of mitotic cell cycle; P:establishment or maintenance of cell polarity regulating cell shape; C:cytosol; P:cellular response to oxidative stress; P:regulation of mitotic sister chromatid segregation; P:actin cytoskeleton organization",IPR006186 (PRINTS); IPR006186 (SMART); IPR029052 (G3DSA:3.60.21.GENE3D); IPR004843 (PFAM); PTHR11668 (PANTHER); PTHR11668:SF24 (PANTHER); PTHR11668 (PANTHER); PTHR11668:SF24 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_04612,2051,1990,2765,0,2,0,0,0,0,3,0,1,0,4,0,0,3,0,20.60753214,1,1.009342347,0.847049736,1.191597499,0.233419106,0.406899663,2.925812396,0,1.916718928,1.275150789,1.503131194,0.132805216,0.251068203,23.26388337,1,1.091517032,1.029212355,1.06053627,0.288900699,0.428295603,24.78769641,1,1.564011492,0.740686181,2.111571044,0.034723258,0.099426657,19.03649415,1,1.395430094,0.839169064,1.662871232,0.096338214,0.18554773,Y,-,,secretory pathway,C:intracellular membrane-bounded organelle; F:calcium ion binding; C:endomembrane system; C:cytoplasmic part,IPR011992 (G3DSA:1.10.238.GENE3D); PTHR19237 (PANTHER); IPR011992 (SUPERFAMILY),8.A.82.2.1, the calmodulin calcium binding protein (calmodulin) family.
RL4_JR_04613,3444,3268,4871,0,0,0,0,0,1,2,0,0,0,8,0,0,0,0,30.39785473,0,1.43341581,0.666914732,2.149323955,0.031608729,0.094356018,3.609614592,1,1.613654761,1.259424938,1.281263148,0.200101252,0.343816818,22.36311145,1,0.781513141,1.03245709,0.756944912,0.449082867,0.588586893,10.80416121,1,-1.460839485,1.19176903,-1.225773995,0.220283736,0.355664619,9.238219762,0,-1.121423607,1.197622316,-0.936375009,0.34908014,0.486503157,N,-,,origin recognition complex subunit 6,F:DNA binding; P:DNA replication; C:nuclear origin of replication recognition complex,IPR008721 (PFAM),,
RL4_JR_04614,5114,4917,5205,0,3,9,0,0,0,3,1,2,2,3,1,0,2,0,38.81318798,1,3.245432714,0.750689682,4.323268045,1.54E-05,0.000167,0.851088067,0,3.69821994,1.440847868,2.566697028,0.010267228,0.034197065,2.202789871,1,1.050002001,1.219167567,0.861245024,0.389103107,0.532734975,2.540950109,1,0.62773687,1.226919693,0.511636477,0.608905451,0.729087949,2.164033809,1,0.972681806,1.209203221,0.804398954,0.421166605,0.557073004,N,-,,NAD dependent epimerase dehydratase,F:coenzyme binding; F:catalytic activity,IPR001509 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10366:SF381 (PANTHER); PTHR10366 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04615,7922,7321,7522,4,9,11,0,0,0,3,0,2,0,8,0,4,0,6,671.2585526,1,0.185398608,0.390220104,0.475112907,0.6347065,0.791837971,125.7697057,0,-0.967017551,0.865819285,-1.116881512,0.264044991,0.420891873,350.4811786,1,-1.371745925,1.240121602,-1.106138239,0.26866669,0.406756628,408.550639,1,-1.318517221,0.409923649,-3.216494641,0.00129767,0.009223517,330.9885582,1,-1.550061671,0.698680037,-2.218557263,0.02651686,0.068490614,N,-,,ATP-dependent metallopeptidase,P:protein import into mitochondrial intermembrane space; F:ATP binding; P:misfolded or incompletely synthesized protein catabolic process; C:integral component of membrane; P:protein maturation; F:ATP-dependent peptidase activity; P:protein folding; C:i-AAA complex; F:metalloendopeptidase activity; P:chronological cell aging,IPR003593 (SMART); IPR005936 (TIGRFAM); IPR000642 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.8.60 (GENE3D); IPR003959 (PFAM); PTHR23076:SF37 (PANTHER); PTHR23076 (PANTHER); IPR005936 (HAMAP); IPR027417 (SUPERFAMILY); SSF140990 (SUPERFAMILY),3.A.29.1.1, the mitochondrial inner membrane i-aaa protease complex (mimp) familly.
RL4_JR_04616,6544,6998,4457,0,0,5,0,0,0,0,2,1,0,3,0,0,6,6,91.37599581,1,-0.639968046,0.747252955,-0.856427588,0.39176131,0.584169031,16.36599398,0,-0.567145382,1.218246694,-0.465542312,0.641543144,0.766670567,50.38014151,1,-2.259915143,1.203119467,-1.878379667,0.060329245,0.130786569,66.40926786,1,-1.335662624,0.875536195,-1.525536729,0.12712528,0.234646192,45.92523071,1,-2.379525068,1.140968113,-2.085531613,0.037021072,0.088635221,N,-,,steroid 5 alpha-reductase,F:3-oxo-5-alpha-steroid 4-dehydrogenase activity; C:integral component of membrane; P:steroid metabolic process; C:endoplasmic reticulum; P:oxidation-reduction process,IPR016636 (PIRSF); IPR001104 (PFAM); PTHR10556:SF37 (PANTHER); PTHR10556 (PANTHER); PTHR10556:SF37 (PANTHER); PTHR10556 (PANTHER); IPR001104 (PROSITE_PROFILES),2.A.90.3.4, the vitamin a receptor/transporter (stra6) family.
RL4_JR_04617,4546,3520,4283,2,3,6,0,0,2,0,3,1,2,2,5,0,0,0,113.2457635,1,4.190155012,1.2206932,3.432602896,0.000597817,0.003889148,59.11215714,1,4.65116426,0.869651522,5.348308076,8.88E-08,1.10E-05,90.65152721,1,3.959034088,0.515165719,7.684971921,1.53E-14,1.45E-12,398.0165177,1,6.067959398,0.44310774,13.6940948,1.10E-42,3.48E-40,97.74035942,0,4.245933456,0.587239366,7.230328383,4.82E-13,5.42E-11,N,-,,3-oxoacyl-(acyl-carrier- ) reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); PTHR24322:SF319 (PANTHER); PTHR24322:SF319 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04618,14713,12946,15846,1,2,5,0,0,0,0,1,3,1,3,4,0,0,1,6.073469765,1,-0.70509078,1.23930903,-0.568938629,0.569397789,0.745848935,1.938196178,0,2.510726246,1.353088742,1.855551797,0.06351747,0.142334255,5.037767213,1,-0.144028427,1.230181281,-0.117079026,0.90679743,0.942741547,5.811753997,1,-0.566371715,1.233492373,-0.4591611,0.646118483,0.757555062,4.984518282,1,-0.231310427,1.236974361,-0.186996946,0.851663028,0.901430917,N,-,,trna wybutosine-synthesizing,P:metabolic process,IPR029063 (G3DSA:3.40.50.GENE3D); IPR026274 (PIRSF); IPR030382 (PFAM); PTHR23245 (PANTHER); PTHR23245 (PANTHER); PTHR23245:SF25 (PANTHER); PTHR23245:SF25 (PANTHER); PTHR23245 (PANTHER); PTHR23245 (PANTHER); PTHR23245:SF25 (PANTHER); PTHR23245:SF25 (PANTHER); IPR030382 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_04619,4414,3269,3470,0,2,3,0,0,0,0,0,1,0,0,1,0,0,0,32.9924949,1,1.828789154,0.653182365,2.799814039,0.005113205,0.022152697,3.224662495,0,1.776437297,1.285844708,1.381533311,0.167115043,0.300664498,8.341676845,1,-0.871180557,1.204813843,-0.723083124,0.469628817,0.606366808,35.30364249,1,1.740755914,0.689831113,2.523452307,0.011620882,0.054573948,12.04977656,0,-0.017873707,1.131270591,-0.015799675,0.987394208,0.991605471,N,-,,c2h2 finger domain containing,F:nucleic acid binding; F:metal ion binding,IPR015880 (SMART); IPR007087 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY),,
RL4_JR_04620,1362,859,1154,0,1,0,0,0,0,0,1,0,3,3,7,0,2,0,22.30872641,1,1.799959449,0.739984558,2.432428392,0.014997957,0.052489632,2.242441675,0,2.300442306,1.293003307,1.779146498,0.075215747,0.162559137,18.8180768,1,1.468309175,1.030667232,1.424620023,0.154267069,0.267875239,6.715033136,1,-0.774613354,1.192940307,-0.649331193,0.516124328,0.650698396,9.600764108,1,0.495254052,1.125018366,0.440218637,0.659778763,0.75739909,N,-,,hypothetical protein CMQ_6623,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_04621,2781,2182,2230,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,94.28650016,0,-2.611562044,1.071787374,-2.43664192,0.014824351,0.05206938,25.41516134,0,-1.202078003,1.254373578,-0.958309409,0.337906761,0.500926938,87.34264408,0,-1.986952602,1.074240845,-1.849634197,0.064366291,0.137797489,116.1047059,0,-0.932066199,0.706246424,-1.319746432,0.186919692,0.314902143,63.55791005,0,-3.903799214,1.228192711,-3.178490786,0.001480439,0.006600373,N,-,,tyrosine phosphatase,F:phosphatase activity; P:dephosphorylation,IPR004861 (PFAM); IPR029021 (G3DSA:3.90.190.GENE3D); PTHR31126:SF0 (PANTHER); PTHR31126 (PANTHER); IPR000387 (PROSITE_PROFILES); IPR029021 (SUPERFAMILY),,
RL4_JR_04622,6272,7172,7463,4,0,0,0,0,0,0,0,6,0,7,0,0,1,1,62.44279199,1,0.534798811,0.720575884,0.7421825,0.45797677,0.64633125,51.72399767,0,2.30836241,0.983793796,2.346388459,0.018956339,0.05515359,29.57260617,1,-1.058956136,1.199448665,-0.882869077,0.377307013,0.521039398,21.35066092,1,-2.443460471,1.200867162,-2.034746679,0.041876369,0.110994302,18.32772723,1,-2.109715807,1.210682325,-1.74258413,0.081406284,0.163474539,N,-,,hypothetical protein F503_00396,C:membrane,no IPS match,,
RL4_JR_04623,49747,28330,29970,3,2,3,0,0,0,0,4,4,0,1,0,0,11,4,118.5853483,1,0.338184079,0.486085347,0.695729837,0.486598037,0.674425209,26.41757733,0,0.291864093,1.113959737,0.262005962,0.793316846,0.874836465,63.81582423,1,-0.879668014,0.857621731,-1.025706302,0.305030043,0.44638973,55.14657952,1,-2.756494944,1.146434075,-2.404407722,0.016198695,0.068883574,55.40741185,1,-1.170132415,0.858426709,-1.363112777,0.172846971,0.288125712,N,-,,er associated chaperone,C:integral component of membrane; C:cytoplasmic part,IPR001623 (PRINTS); IPR001623 (SMART); IPR001623 (PFAM); IPR001623 (G3DSA:1.10.287.GENE3D); IPR015399 (PFAM); PTHR24078 (PANTHER); PTHR24078:SF234 (PANTHER); IPR001623 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_04624,58002,32108,34800,4,6,5,0,0,3,1,7,18,1,8,0,0,17,0,86.16813152,1,0.434646902,0.69773159,0.622942846,0.533322081,0.716895952,11.07438884,1,-0.003593749,1.249265862,-0.002876689,0.997704737,0.998987768,68.21080102,1,0.199905737,0.77288495,0.258648764,0.795906255,0.865680589,48.91025577,1,-0.380964116,0.794787229,-0.479328431,0.631704999,0.747176033,42.95289427,1,-0.505494866,0.865110225,-0.584312671,0.559009969,0.677797219,N,-,,duf455 domain containing,C:nucleus; C:cytosol,IPR033979 (PFAM); PTHR18063:SF6 (PANTHER); IPR007518 (PANTHER); PTHR18063:SF6 (PANTHER); IPR007518 (PANTHER),,
RL4_JR_04625,638,1106,1001,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,125.6371524,1,-4.003763576,1.155306114,-3.465543484,0.000529161,0.003515387,37.21363795,0,-1.752225524,1.212742682,-1.444845267,0.148501353,0.274594573,102.4987421,0,-3.434174763,1.20050623,-2.860605533,0.004228328,0.016940088,124.0296128,1,-3.082783365,1.028480934,-2.997414208,0.002722805,0.017160269,108.8455748,0,-2.779865599,0.9788652,-2.839886023,0.004512966,0.016472161,N,-,,domain-containing,C:polysome; P:stress granule assembly; C:cytoplasmic stress granule; P:positive regulation of translation; F:catalytic activity; P:mRNA polyadenylation,IPR009604 (SMART); IPR009604 (PFAM); PTHR12854:SF7 (PANTHER); PTHR12854 (PANTHER),,
RL4_JR_04626,4495,4000,6142,1,4,5,0,0,0,0,0,2,1,6,0,0,0,0,176.5003835,1,4.364299902,1.422169453,3.06876223,0.002149476,0.01109837,2.737056084,0,2.01291956,1.332452629,1.510687522,0.130868083,0.248433372,29.24481247,1,1.772866753,0.888437715,1.995487948,0.045989687,0.106049689,202.8111665,1,4.700967661,0.729260781,6.446209346,1.15E-10,4.35E-09,52.54350275,0,3.173092256,0.574981881,5.518595216,3.42E-08,1.07E-06,Y,-,,lipase esterase family,C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_04627,9671,7861,10701,0,3,8,0,0,0,0,0,3,0,2,1,0,0,1,3.107840656,1,0.261617324,1.248845568,0.20948733,0.834067825,0.917340408,1.001816435,0,3.462973249,1.434441703,2.414161023,0.015771491,0.047997302,2.583499706,1,0.819684971,1.228335284,0.667313706,0.504571773,0.636823075,11.00230342,1,2.112655928,1.043479574,2.024626051,0.042905777,0.112719511,2.532747076,1,0.745219202,1.218524644,0.611574994,0.540818987,0.663126406,Y,-,,hypothetical protein SPSK_00242,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_04628,8725,7384,7838,0,3,6,0,0,0,0,0,3,0,3,3,0,2,3,14.07088907,1,-1.916865899,1.279934774,-1.497627799,0.13422998,0.273215613,4.466152567,0,1.306522074,1.342588309,0.973136787,0.330485323,0.49353385,33.77030881,1,1.054462067,0.932310074,1.131020779,0.258046346,0.394356627,30.70334145,1,0.528125294,0.950289226,0.555752164,0.578380291,0.704705228,30.68544978,1,1.407644129,0.834866505,1.686070911,0.091782142,0.178882423,Y,-,,ribonuclease t2,"P:RNA phosphodiester bond hydrolysis, endonucleolytic; F:RNA binding; F:ribonuclease T2 activity",IPR001568 (PFAM); IPR001568 (G3DSA:3.90.730.GENE3D); IPR001568 (PANTHER); PTHR11240:SF22 (PANTHER); IPR001568 (SUPERFAMILY),,
RL4_JR_04629,15901,7108,8064,0,1,8,0,0,0,0,0,2,0,0,0,1,1,0,53.21179759,1,3.064665103,0.591278326,5.183117606,2.18E-07,3.99E-06,1.873571888,0,2.559620236,1.337705548,1.913440696,0.055691659,0.128641293,4.881389986,1,-0.098578019,1.220895736,-0.080742373,0.935646838,0.961430162,5.632362456,0,-0.521174637,1.222989266,-0.42614817,0.669999882,0.775285578,19.57002581,1,1.51511457,1.003850844,1.509302482,0.131221501,0.233829232,N,-,,F-box domain partial,,no IPS match,,
RL4_JR_04630,31416,30615,39068,14,19,37,0,1,6,8,21,33,9,52,14,0,46,11,0.32158995,1,3.534214231,2.439902892,1.448506103,0.14747556,NA,0.103548482,1,6.737146499,2.108245097,3.195618246,0.001395316,0.015023052,23.79641166,1,6.4987647,0.89109528,7.293007661,3.03E-13,2.60E-11,0.308506286,1,3.669194546,1.619499273,2.265635191,0.023473729,0.082871237,0.263021641,1,4.011453871,1.268510452,3.162334111,0.001565099,0.006919924,N,-,,pathway-specific nitrogen regulator,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR007219 (SMART); IPR007219 (PFAM); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31944:SF12 (PANTHER); PTHR31944 (PANTHER); PTHR31944:SF12 (PANTHER); PTHR31944 (PANTHER),,
RL4_JR_04631,1800,1373,1110,3,2,4,0,0,0,2,0,1,2,5,4,0,4,2,42.4907011,1,1.267445758,0.751532372,1.686481921,0.091703014,0.207751511,3.325276369,0,1.731982951,1.268252318,1.365645405,0.172050288,0.307555966,8.648882114,1,-0.923698879,1.200383061,-0.769503427,0.441594511,0.5813896,18.0019251,1,0.376534584,1.023946911,0.36772862,0.713075598,0.808136381,8.553728634,1,-1.010331189,1.207453479,-0.836745437,0.402735673,0.539949509,N,-,,mitochondrial chaperone Frataxin,P:sulfur compound metabolic process; F:iron ion binding; C:mitochondrion; P:oxidation-reduction process,IPR002908 (PRINTS); IPR002908 (SMART); IPR002908 (TIGRFAM); IPR002908 (PFAM); IPR017789 (TIGRFAM); IPR002908 (G3DSA:3.30.920.GENE3D); IPR002908 (PANTHER); IPR002908 (PROSITE_PROFILES); IPR002908 (SUPERFAMILY),9.B.21.1.2, the frataxin (frataxin) family.
RL4_JR_04632,88841,86034,104821,36,75,206,1,0,9,13,28,50,28,119,26,9,88,9,9.227037864,1,-1.308293283,1.256119655,-1.041535556,0.29762706,0.483480995,2.906563264,1,1.926069214,1.329167815,1.449079034,0.147315512,0.273005223,7.615982437,1,-0.740217749,1.240351992,-0.596780393,0.55065401,0.677872227,20.82555372,1,1.096597457,0.93638887,1.171091939,0.241561824,0.380020737,15.3146445,1,0.803528387,1.055452968,0.76131141,0.446471087,0.579034169,N,-,,AP-3 complex subunit sigma,C:nucleus; C:cytosol; F:protein transporter activity; C:AP-3 adaptor complex; P:protein targeting to vacuole; P:Golgi to vacuole transport,G3DSA:3.30.450.60 (GENE3D); IPR022775 (PFAM); IPR027155 (PTHR11753:PANTHER); IPR016635 (PANTHER); IPR011012 (SUPERFAMILY),9.B.278.1.1, the organellar-targeting adaptor protein complex (o-apc) family.
RL4_JR_04633,438,317,455,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,93.51856203,1,0.959028887,0.78435274,1.222701009,0.221442646,0.390938997,8.6077606,0,0.35980608,1.237308288,0.290797438,0.771206245,0.86141576,82.42768587,0,1.141232485,0.649621598,1.756764999,0.078957873,0.161098249,35.23273769,0,-1.771351451,1.163203052,-1.522822218,0.12780319,0.235573875,22.29547843,0,-2.392456641,1.221171875,-1.959148168,0.050095437,0.112290525,N,-,,hypothetical protein SPBR_04423,C:integral component of membrane,no IPS match,,
RL4_JR_04634,375,390,767,0,0,0,0,0,0,0,1,0,0,3,0,0,0,0,63.70869493,0,0.042690908,0.795133921,0.053690212,0.957181982,0.978157131,26.88432002,0,2.070186624,1.024374703,2.020927125,0.04328731,0.105325516,21.14077575,1,-2.21304949,1.21486236,-1.821646272,0.068508675,0.144311549,45.73718817,1,0.07370082,0.789852289,0.093309624,0.925657586,0.956453012,20.9314524,0,-2.301403044,1.224783101,-1.879029063,0.060240525,0.129168851,N,-,,DNA repair helicase RAD25,F:DNA binding; F:ATP binding; P:DNA duplex unwinding; P:nucleotide-excision repair; F:ATP-dependent DNA helicase activity; P:transcription initiation from RNA polymerase II promoter,PR00851 (PRINTS); IPR001650 (SMART); IPR014001 (SMART); IPR032438 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001161 (TIGRFAM); IPR006935 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR032830 (PFAM); PTHR11274:SF0 (PANTHER); PTHR11274 (PANTHER); PTHR11274 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_04635,7812,7284,10492,0,2,8,0,0,0,0,0,0,2,6,0,0,1,5,0.244488717,1,3.92956189,2.817270795,1.394811566,0.16307267,NA,0.078637525,0,7.133964752,2.282790747,3.125106741,0.001777406,0.015023052,0.203620059,0,4.483794663,1.44773434,3.097111494,0.001954164,0.009646518,0.234829948,1,4.062649276,1.844529331,2.202539807,0.0276272,0.088405467,0.200937896,1,4.399819231,1.336403952,3.292282416,0.000993778,0.004761949,N,-,,---NA---,,no IPS match,,
RL4_JR_04636,7456,6506,7658,3,2,0,0,0,0,0,2,0,3,1,2,0,0,4,33.9191137,1,-3.186413016,1.221541609,-2.608517788,0.009093529,0.035175441,10.93375379,0,0.014806166,1.257728057,0.011772152,0.990607398,0.995129822,34.72413015,1,-1.668164148,1.218755292,-1.368744127,0.171079271,0.289536367,32.54810266,1,-3.051707538,1.222624513,-2.49603006,0.012559196,0.058091301,27.72660236,1,-2.707020392,1.223018852,-2.213392203,0.026870618,0.069104649,Y,-,,---NA---,,no IPS match,,
RL4_JR_04637,5680,4278,5035,1,1,1,0,0,0,0,0,3,0,2,1,0,2,2,46.8310721,1,-1.681662054,1.047115602,-1.60599465,0.108275086,0.234672728,12.64399376,0,-0.19484779,1.24685563,-0.156271332,0.875819152,0.928925357,65.10369053,1,0.277839646,0.724245979,0.38362608,0.701255607,0.797086225,37.60283202,1,-3.259964375,1.216198804,-2.680453529,0.007352247,0.037974382,31.99090271,1,-2.913410685,1.214732635,-2.398396652,0.016467023,0.046768192,N,-,,diphthamide biosynthesis 3,C:nucleus; F:zinc ion binding; P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine; C:cytoplasm; F:iron ion binding; F:electron carrier activity; P:tRNA wobble uridine modification,IPR007872 (PFAM); PTHR21454 (PANTHER); IPR007872 (PROSITE_PROFILES); SSF144217 (SUPERFAMILY),,
RL4_JR_04638,4735,4588,3938,0,0,1,0,2,1,0,0,1,1,4,0,0,0,0,44.66131809,1,-1.587280666,1.017476714,-1.560016701,0.118755935,0.250443365,11.79147092,1,-0.094192949,1.211829312,-0.077727901,0.9380445,0.966007368,41.7211113,1,-1.787152739,1.193215204,-1.497762293,0.134195021,0.241226987,35.36280384,1,-3.171406496,1.193348912,-2.657568515,0.007870659,0.040146309,59.75760303,0,-0.178029343,0.758410771,-0.234739998,0.814410541,0.874804448,N,-,,C6 transcription,,IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR007219 (PFAM); PTHR31001:SF59 (PANTHER); PTHR31001 (PANTHER); PTHR31001:SF59 (PANTHER); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04639,4120,2786,2672,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0.28612753,0,3.70301762,2.615325387,1.415891743,0.156807203,NA,0.090074758,0,6.938075726,2.184508376,3.176035304,0.001493028,0.015023052,0.235392208,1,4.275918586,1.394796676,3.065621434,0.002172182,0.010507007,0.271701703,0,3.852764706,1.724454935,2.234192746,0.025470394,0.085851084,0.233422858,0,4.186936325,1.307103516,3.203217092,0.001359015,0.006151107,N,-,,Major facilitator superfamily general substrate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23502:SF60 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.86, the major facilitator superfamily (mfs).
RL4_JR_04640,1387,1255,2020,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,8.32708431,1,0.669422426,1.193561265,0.560861387,0.574892035,0.750296858,90.67036096,0,5.893226742,1.215810133,4.847160408,1.25E-06,0.00010835,3.716845283,0,0.294789752,1.235576287,0.238584825,0.811427533,0.877284531,4.289789185,1,-0.128179088,1.24217396,-0.103189322,0.917812715,0.95028671,3.688647033,0,0.203269024,1.243504441,0.163464654,0.870152601,0.913931025,N,-,,serine threonine CMGC group,,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24055:SF229 (PANTHER); PTHR24055 (PANTHER); PTHR24055 (PANTHER); PTHR24055:SF229 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_04641,11854,13957,17099,5,1,2,0,0,0,3,5,1,1,0,0,0,0,0,1.760480804,1,1.081690976,1.307754837,0.827135902,0.408160037,NA,0.566885118,0,4.284502444,1.537623917,2.786443678,0.005328988,0.021493864,1.461966507,1,1.641299933,1.234959288,1.329031612,0.183837541,0.305183626,1.68591057,1,1.219428057,1.255137469,0.971549402,0.331274765,0.477868214,1.432465858,0,1.567372289,1.216328845,1.288608994,0.197534055,0.318984419,N,-,,hypothetical protein F503_00426,,IPR003609 (PROSITE_PROFILES),,
RL4_JR_04642,4099,3273,4305,0,0,0,0,0,0,0,0,1,0,0,0,0,1,1,143.5383694,0,-0.397449979,0.525070981,-0.756945238,0.449082671,0.637927291,28.01335297,0,-1.34249893,1.221318155,-1.0992213,0.27167155,0.429263102,125.7296689,1,-0.356479205,0.613702879,-0.580866112,0.561330693,0.687005796,216.4662026,0,0.707740627,0.406949887,1.739134594,0.082011091,0.169116557,103.9472063,1,-1.083759812,0.693608456,-1.562495097,0.1181714,0.216480084,N,-,,uba ts-n domain-containing,C:cell part,IPR015940 (SMART); IPR002048 (SMART); IPR000261 (SMART); G3DSA:1.10.8.10 (GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR000261 (PFAM); IPR015940 (PFAM); PTHR11216:SF61 (PANTHER); PTHR11216:SF61 (PANTHER); PTHR11216 (PANTHER); PTHR11216 (PANTHER); PTHR11216 (PANTHER); PTHR11216:SF61 (PANTHER); PTHR11216 (PANTHER); IPR002048 (PROSITE_PROFILES); IPR000261 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR015940 (PROSITE_PROFILES); IPR000261 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR000261 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR009060 (SUPERFAMILY); IPR011992 (SUPERFAMILY),,
RL4_JR_04643,2692,2085,2821,1,1,3,0,0,0,0,1,0,1,0,0,0,0,0,701.6162648,1,1.204543131,0.524871458,2.294929763,0.02173715,0.070397645,69.07465838,0,-2.644577861,1.198034629,-2.207430234,0.027284016,0.073332132,313.4095232,1,-0.546477048,0.453518718,-1.204971319,0.228214374,0.359043096,354.1574787,1,-0.440603974,0.415127117,-1.061371218,0.288521232,0.433038463,323.5932963,0,-0.068332495,0.755939055,-0.090394185,0.927973977,0.953204476,N,-,,Tubulin alpha-B chain,F:GTP binding; C:cytoplasm; F:GTPase activity; F:structural constituent of cytoskeleton; C:microtubule; P:microtubule-based process,IPR002452 (PRINTS); IPR000217 (PRINTS); IPR018316 (SMART); IPR003008 (SMART); IPR018316 (PFAM); IPR023123 (G3DSA:1.10.287.GENE3D); IPR018316 (G3DSA:3.30.1330.GENE3D); IPR003008 (G3DSA:3.40.50.GENE3D); IPR003008 (PFAM); IPR000217 (PANTHER); PTHR11588:SF73 (PANTHER); IPR003008 (SUPERFAMILY); IPR008280 (SUPERFAMILY),,
RL4_JR_04644,164,88,100,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,400.211831,0,-3.45057029,0.72815773,-4.738767644,2.15E-06,2.99E-05,138.1892781,0,-1.797718402,0.999750806,-1.798166496,0.072150627,0.157360192,318.1638316,0,-5.133072282,1.209374265,-4.244403434,2.19E-05,0.000362571,411.8157401,0,-2.377599673,0.728502635,-3.263680267,0.001099752,0.007993531,332.3912939,0,-3.078789536,0.739303605,-4.164445455,3.12E-05,0.000260951,N,-,,ATP-dependent RNA helicase dob1,F:ATP binding; F:RNA binding; F:RNA helicase activity; P:RNA catabolic process,IPR001650 (SMART); IPR014001 (SMART); IPR012961 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR016438 (PIRSF); IPR025696 (PFAM); IPR012961 (PFAM); IPR011545 (PFAM); PTHR12131 (PANTHER); PTHR12131:SF4 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_04645,202,178,204,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,503.4894814,0,0.821629577,0.341600515,2.405235184,0.016162061,0.055394062,131.7265793,0,0.5835867,0.684689235,0.852338068,0.394026483,0.558199589,332.34171,0,0.35073008,0.383246072,0.91515636,0.360109551,0.50393507,371.6169823,1,0.201398516,0.349166695,0.576797611,0.564076184,0.69160467,276.5816935,0,0.190236592,0.487638048,0.390118434,0.696448972,0.785512514,N,-,,cytochrome-c oxidase chain VIIc,F:cytochrome-c oxidase activity; C:integral component of membrane; P:hydrogen ion transmembrane transport,IPR004202 (PFAM); IPR004202 (G3DSA:4.10.49.GENE3D); IPR004202 (PANTHER); PTHR13313:SF0 (PANTHER),3.D.4.8.1, the proton-translocating cytochrome oxidase (cox) superfamily.
RL4_JR_04646,1148,1262,1790,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,61.2138466,1,-2.149513854,1.089696482,-1.972580337,0.048543395,0.129841645,16.85487504,0,-0.609627863,1.241844336,-0.490905217,0.623493487,0.752474195,83.91940041,0,-0.132078584,0.729990971,-0.180931805,0.856421104,0.908688308,63.01599833,0,-1.438021325,0.933813974,-1.539944105,0.123573979,0.229323045,44.00500796,0,-3.373370288,1.242694729,-2.714560712,0.006636373,0.022646876,N,-,,pentatricopeptide repeat,P:mycelium development; C:cellular_component; F:molecular_function,IPR002885 (PFAM); IPR002885 (TIGRFAM); PTHR24015 (PANTHER); PTHR24015 (PANTHER); PTHR24015:SF886 (PANTHER); PTHR24015 (PANTHER); PTHR24015:SF886 (PANTHER); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES),,
RL4_JR_04647,41,41,37,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,70.85911769,0,-1.765286736,0.992098288,-1.779346621,0.075182952,0.179707742,18.63051465,0,-0.754124828,1.256325455,-0.600262317,0.548331428,0.694731596,104.3206701,0,0.020124829,0.704828017,0.028552823,0.977221239,0.987068525,131.9532541,0,0.242177968,0.76194445,0.317842027,0.75060477,0.83579383,52.72193091,0,-2.599394424,1.193037445,-2.17880372,0.029346252,0.073858018,N,-,,37S ribosomal rsm25,F:structural constituent of ribosome; C:mitochondrial small ribosomal subunit,IPR016939 (PIRSF); IPR016939 (PFAM); PTHR37799 (PANTHER),,
RL4_JR_04648,3,9,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.0434587,0,1.436050091,1.138588907,1.261254244,0.207217261,0.37325644,1.379673621,0,3.001002231,1.448945584,2.071162827,0.038343582,0.095806897,3.628517587,0,0.329366056,1.28053655,0.257209415,0.797017117,0.866516461,13.50153986,0,0.864374616,1.220463324,0.708234814,0.47879945,0.619295405,3.63023735,0,0.226230615,1.296539208,0.174488063,0.861481911,0.907870562,N,-,,glycosyltransferase family,C:endoplasmic reticulum; C:membrane part; F:transferase activity,IPR013969 (PFAM); IPR013969 (PANTHER); PTHR12154:SF4 (PANTHER); PTHR12154:SF4 (PANTHER),,
RL4_JR_04649,39,44,49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27.83907732,0,-0.744738849,1.095842219,-0.679604085,0.496755182,0.683971102,6.347165321,0,0.799324316,1.285425973,0.621836133,0.534049625,0.682187065,29.64046717,0,-0.060531316,1.086374504,-0.055718645,0.955565946,0.97422732,31.24692891,0,-0.034964645,0.943297158,-0.037066416,0.97043205,0.983358259,16.59049017,0,-1.966043086,1.255585026,-1.565838271,0.117386484,0.215549175,N,-,,integral inner nuclear membrane ima1,C:membrane; C:intracellular organelle part,IPR018617 (PFAM); PTHR28538:SF1 (PANTHER); PTHR28538 (PANTHER); PTHR28538:SF1 (PANTHER),,
RL4_JR_04650,126,70,127,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,6.470722907,0,-0.796462495,1.263927117,-0.630149068,0.528597058,0.712893834,2.076463843,0,2.411347286,1.381477565,1.745484217,0.080900617,0.171636146,5.380402587,1,-0.238886523,1.249447647,-0.191193704,0.848373836,0.902928853,6.205627293,0,-0.660909345,1.25547582,-0.526421405,0.598595447,0.721070165,5.309318082,0,-0.322413556,1.255694762,-0.25676109,0.797363209,0.862901079,N,-,,polypeptide N-acetylgalactosaminyltransferase 6,P:proteolysis; F:cysteine-type peptidase activity,PR01217 (PRINTS),,
RL4_JR_04651,1151,734,877,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,131.3236717,0,-4.1495953,1.148811286,-3.612077416,0.000303754,0.002202688,72.50176467,0,-0.230317037,0.985134439,-0.233792493,0.815146078,0.888253342,156.5355069,1,-1.373652278,0.677304213,-2.028117133,0.042548295,0.100199799,121.9884757,1,-4.957794142,1.195339608,-4.147602999,3.36E-05,0.000413837,104.2165991,1,-4.617232846,1.198435526,-3.852716934,0.000116814,0.000788497,N,-,,fungal transcriptional regulatory,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31944:SF57 (PANTHER); PTHR31944 (PANTHER); PTHR31944 (PANTHER); PTHR31944:SF57 (PANTHER); PTHR31944:SF57 (PANTHER); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04652,765,534,683,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.49038337,0,-1.624567929,1.185295141,-1.370602032,0.170499049,0.32392437,3.674025161,0,1.588186361,1.257795766,1.262674279,0.206706261,0.351762068,9.516803847,0,-1.061437099,1.190830285,-0.891342043,0.3727457,0.51680053,20.61308151,0,-0.534641872,1.138388013,-0.469648192,0.638606388,0.752372548,24.09594751,0,0.541158087,0.964984134,0.560794803,0.57493743,0.689663477,N,-,,MFS monosaccharide transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,IPR003663 (PRINTS); IPR005828 (PFAM); IPR003663 (TIGRFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500 (PANTHER); PTHR23500:SF16 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.38, the major facilitator superfamily (mfs).
RL4_JR_04653,235351,172023,208312,16,23,23,1,2,14,0,4,15,0,2,5,0,28,0,32.31108879,1,-0.192701302,0.871122453,-0.221210349,0.824928652,0.911522137,6.680823259,1,0.725480132,1.246085761,0.582207225,0.560427108,0.703627286,32.99462141,1,-0.099954533,1.043345588,-0.095801942,0.923677875,0.955092923,19.96462623,1,-2.346629111,1.202224947,-1.951905188,0.050949462,0.124634768,17.05791779,1,-2.006199427,1.206808092,-1.662401371,0.096432324,0.185693663,N,-,,alcohol dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR020471 (PRINTS); IPR023210 (G3DSA:3.20.20.GENE3D); IPR023210 (PFAM); IPR001395 (PANTHER); PTHR11732:SF245 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.1, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_04654,16643,20499,22449,5,3,39,0,0,1,8,2,10,5,10,8,0,8,14,6.525235481,1,-0.808602697,1.222807385,-0.66126743,0.508440825,0.694920172,2.080813627,1,2.408297077,1.329205309,1.811832274,0.070012117,0.153789637,5.408960562,1,-0.246597919,1.218633691,-0.202356065,0.839638373,0.896414363,24.8646777,1,1.08799036,1.035532226,1.050658137,0.293415629,0.438143098,13.07143388,1,1.322840682,1.012175144,1.306928638,0.191236949,0.311348144,N,-,,hypothetical protein CMQ_5175,P:biological_process; C:cellular_component; F:molecular_function,G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); IPR025340 (PFAM); PTHR24362:SF288 (PANTHER); PTHR24362 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_04655,1063,975,1006,0,0,5,0,0,0,1,0,0,0,2,0,0,0,0,0.100052127,1,5.218745972,3.917417402,1.33219043,0.182797621,NA,0.031910231,0,8.435303153,2.61488429,3.225880084,0.00125586,0.015023052,0.082808495,1,5.78289785,1.482382521,3.901083403,9.58E-05,0.001133378,0.095531338,1,5.360630045,2.338844455,2.291999382,0.021905679,0.080273303,0.081652107,0,5.701110239,1.289376022,4.421604047,9.80E-06,9.88E-05,N,-,,hypothetical protein TOPH_06902,,no IPS match,,
RL4_JR_04656,706,1151,940,0,0,3,0,0,0,0,0,1,1,0,0,0,0,2,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_04657,14529,14789,21226,6,12,37,0,0,6,2,3,13,8,30,4,0,23,6,125.6567368,1,-4.027675021,1.170392785,-3.441301991,0.000578922,0.003794748,47.34928997,1,-0.866199952,1.141609406,-0.758753342,0.448000121,0.608851663,125.0739204,1,-1.612539299,0.777814962,-2.0731657,0.038156861,0.09204195,155.7113879,1,-1.150236244,0.597642186,-1.924623581,0.054276467,0.128549527,126.4179533,1,-0.963188908,0.632313263,-1.52327804,0.127689159,0.229180092,N,-,,actin interacting 3,P:cytoskeleton organization; P:cell cycle process; P:single-organism organelle organization; P:cell budding; P:growth; C:cellular bud; C:site of polarized growth; P:regulation of actin cytoskeleton organization; C:cell tip; P:positive regulation of cytoskeleton organization; C:cytoplasm; P:establishment of cell polarity; F:cytoskeletal protein binding,IPR005613 (SMART); IPR022782 (PFAM); PTHR22741 (PANTHER),,
RL4_JR_04658,2376,3397,2312,6,2,4,0,0,0,0,0,1,1,6,0,0,3,2,341.8461308,1,-1.681372007,0.59847684,-2.809418666,0.004963106,0.021640308,87.57800792,0,-2.986971571,1.234749631,-2.41909088,0.015559352,0.047512679,284.0575296,1,-1.985641275,0.658802053,-3.014018043,0.002578125,0.012123054,267.2381623,1,-4.343562495,1.073667134,-4.045539216,5.22E-05,0.000615313,246.4141908,1,-2.394449613,0.733622085,-3.263873407,0.001099003,0.005146809,N,-,,beta-lactamase family,F:DNA binding; C:nucleus,IPR001005 (SMART); IPR012338 (G3DSA:3.40.710.GENE3D); IPR001466 (PFAM); IPR001005 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); IPR009057 (G3DSA:1.10.10.GENE3D); PTHR22935 (PANTHER); PTHR22935:SF54 (PANTHER); IPR017884 (PROSITE_PROFILES); IPR012338 (SUPERFAMILY); IPR009057 (SUPERFAMILY); IPR009057 (SUPERFAMILY),,
RL4_JR_04659,2693,2642,3787,0,0,5,0,0,0,2,1,3,2,4,2,0,4,5,157.5635329,1,1.699550385,0.58520719,2.904185756,0.003682096,0.016875585,29.46319744,0,1.671243084,1.027847568,1.625963942,0.103957326,0.208574045,64.49160524,1,0.219135965,0.785686781,0.278910082,0.780313831,0.854227641,36.33940539,1,-2.097078403,1.178837478,-1.778937674,0.075249981,0.159228015,31.74092421,1,-1.788117544,1.1675272,-1.531542514,0.125635368,0.226586765,N,-,,deoxyhypusine synthase,C:nucleus; P:deoxyhypusine biosynthetic process from spermidine; C:cytosol; F:deoxyhypusine synthase activity; P:peptidyl-lysine modification to peptidyl-hypusine,IPR002773 (PFAM); IPR002773 (TIGRFAM); IPR002773 (G3DSA:3.40.910.GENE3D); IPR002773 (PANTHER); IPR029035 (SUPERFAMILY),,
RL4_JR_04660,921,1106,1174,0,0,8,1,0,0,2,1,1,0,1,1,0,3,0,21.62831051,1,0.819180981,0.915971716,0.894329996,0.371145355,0.563312337,3.229932603,1,1.773915515,1.30484484,1.359483872,0.17399331,0.309954291,8.422301661,1,-0.885408267,1.225210192,-0.722658261,0.469889865,0.606488249,9.718319134,1,-1.308056805,1.227248234,-1.065845335,0.286493563,0.430761409,8.359519025,1,-0.977219867,1.23695131,-0.790022904,0.429514392,0.564051001,N,-,,fad dependent oxidoreductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13847:SF213 (PANTHER); PTHR13847:SF213 (PANTHER); PTHR13847 (PANTHER); PTHR13847 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_04661,25675,24720,23170,7,5,16,0,0,1,0,11,6,6,19,3,0,20,4,41.98600439,1,-0.807698376,1.01029984,-0.799464024,0.424021399,0.615334148,6.96303047,1,0.665811808,1.226378284,0.542909,0.587192459,0.725266879,31.06978359,1,-0.166598469,1.032148279,-0.161409434,0.871770937,0.91895644,36.89614417,1,0.30595992,0.746274783,0.409982927,0.681818472,0.783677152,36.76127534,1,0.549428773,0.750188738,0.732387392,0.463932152,0.594897802,N,-,,---NA---,,G3DSA:1.20.58.340 (GENE3D),,
RL4_JR_04662,163,26,37,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.48483424,0,-0.293225402,1.036324238,-0.282947548,0.777217045,0.885032662,4.894502512,0,1.174312039,1.260924025,0.931310702,0.351692868,0.515171521,53.09551941,0,1.902538695,0.652205492,2.917084749,0.003533198,0.015312539,63.68761976,0,1.810935116,0.585209863,3.094505458,0.001971413,0.013106078,24.21383088,0,0.60983594,0.88849575,0.686369,0.492480448,0.620735035,N,-,,hydroxymethylglutaryl- lyase,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; P:nitrogen compound metabolic process; F:lyase activity; P:cellular protein modification process",IPR013785 (G3DSA:3.20.20.GENE3D); IPR000891 (PFAM); PTHR10277 (PANTHER); PTHR10277:SF40 (PANTHER); PTHR10277 (PANTHER); PTHR10277:SF40 (PANTHER); IPR000891 (PROSITE_PROFILES); SSF51569 (SUPERFAMILY),3.B.1.1.6, the na(+)-transporting carboxylic acid decarboxylase (nat-dc) family.
RL4_JR_04663,1145,715,1334,0,0,6,0,0,0,0,2,5,1,0,0,0,2,0,39.27908466,1,0.936351255,0.671086666,1.395276202,0.162932565,0.313565433,5.096797693,0,1.1158899,1.239317099,0.900407087,0.36790365,0.532368942,30.81056798,1,0.286798143,1.031808718,0.277956696,0.781045601,0.854577953,52.52607187,1,0.793803847,0.742203148,1.069523687,0.284833761,0.429094158,39.39197488,1,1.320249946,0.682454952,1.934559843,0.053044332,0.117137156,N,-,,Nitrilase,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; P:nitrogen compound metabolic process; F:hydrolase activity",IPR003010 (PFAM); IPR003010 (G3DSA:3.60.110.GENE3D); PTHR23088 (PANTHER); PTHR23088:SF5 (PANTHER); PTHR23088 (PANTHER); IPR003010 (PROSITE_PROFILES); IPR003010 (SUPERFAMILY),,
RL4_JR_04664,2603,2445,6427,0,0,3,0,0,0,0,0,0,0,6,3,0,0,0,312.041391,1,-0.042861266,0.511641025,-0.083772146,0.933237595,0.967083853,97.57867579,0,-0.516997195,0.998286549,-0.517884565,0.604538812,0.738454743,136.7320077,0,-3.874184597,1.212071782,-3.196332638,0.001391865,0.007463584,222.3587751,1,-0.808131397,0.527408505,-1.532268421,0.12545621,0.232262595,156.0536422,0,-1.776686771,0.706770529,-2.513809925,0.011943478,0.036249316,N,-,,chorismate synthase,F:riboflavin reductase (NADPH) activity; C:nucleus; P:aromatic amino acid family biosynthetic process; F:chorismate synthase activity; C:cytosol; P:chorismate biosynthetic process; P:cellular amino acid biosynthetic process; P:oxidation-reduction process,IPR000453 (PIRSF); IPR000453 (PFAM); IPR000453 (G3DSA:3.60.150.GENE3D); IPR000453 (TIGRFAM); PTHR21085:SF0 (PANTHER); IPR000453 (PANTHER); IPR000453 (SUPERFAMILY),,
RL4_JR_04665,4683,4378,3451,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.43373318,0,0.118852238,1.147354447,0.103588075,0.917496252,0.960708991,30.25329379,0,4.557972819,0.870000804,5.239044374,1.61E-07,1.84E-05,5.486543288,0,-0.267046777,1.203023932,-0.221979605,0.82432976,0.886500371,10.34017334,0,0.257499565,1.150149441,0.223883572,0.822847899,0.888675731,5.405228972,0,-0.348241347,1.203511575,-0.289354381,0.772310201,0.842452143,N,-,,lipoate- ligase a,F:catalytic activity,G3DSA:3.90.1550.10 (GENE3D); IPR004143 (PFAM); PTHR12561 (PANTHER); PTHR12561:SF3 (PANTHER); IPR004143 (PROSITE_PROFILES); SSF55681 (SUPERFAMILY),,
RL4_JR_04666,1828,1335,1431,0,0,0,0,0,0,0,0,0,1,3,0,0,0,0,118.6091463,0,0.849647906,0.454568821,1.869129311,0.061604826,0.155498815,14.04323284,0,-0.346257059,1.209220681,-0.286347286,0.774612145,0.863409771,50.73047434,0,-1.174222185,1.031486596,-1.138378521,0.254962459,0.39074174,114.2202421,1,0.646888115,0.489956257,1.320297692,0.186735646,0.314700964,70.54740551,0,0.67468706,0.533864389,1.263779854,0.206309054,0.329340614,N,-,,vacuolar membrane,"F:zinc ion binding; P:regulation of SNARE complex assembly; C:CORVET complex; C:fungal-type vacuole membrane; P:late endosome to vacuole transport; P:vacuole fusion, non-autophagic; P:mismatch repair; P:intracellular protein transport; P:Golgi to endosome transport; F:ubiquitin-protein transferase activity; F:ATP binding; P:regulation of vacuole fusion, non-autophagic; C:cytosol; P:histone ubiquitination; P:histone catabolic process",IPR014790 (SMART); IPR001841 (SMART); IPR000547 (SMART); IPR014790 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR000547 (PFAM); PF13589 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR024763 (PFAM); IPR003594 (G3DSA:3.30.565.GENE3D); IPR016528 (PTHR23323:PANTHER); PTHR23323 (PANTHER); IPR016528 (PTHR23323:PANTHER); PTHR23323 (PANTHER); IPR000547 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR003594 (SUPERFAMILY); SSF57850 (SUPERFAMILY); IPR017986 (SUPERFAMILY); SSF118116 (SUPERFAMILY),,
RL4_JR_04667,2901,2904,2708,1,2,7,0,0,0,1,0,0,1,0,0,0,0,0,27.79737869,1,-1.738733972,1.145709468,-1.517604612,0.129114104,0.265920943,7.638688606,0,0.532152061,1.224481834,0.434593675,0.663857387,0.784904154,19.85260361,1,-2.122361289,1.19431337,-1.777055623,0.075559089,0.155944356,26.91568137,1,-1.597811303,1.145984889,-1.394269085,0.163236363,0.283542318,19.61837224,0,-2.20792051,1.201002756,-1.838397538,0.066003848,0.138821969,N,-,,hypothetical protein SPSK_00258,,no IPS match,,
RL4_JR_04668,792,1062,771,0,1,1,0,0,0,0,2,4,1,6,0,0,0,0,59.68061269,1,0.657781059,0.609077672,1.079962522,0.28015887,0.463409582,17.88620356,0,1.292694427,1.129261819,1.144725169,0.252323022,0.406837341,35.11734548,1,-0.461117352,1.043898135,-0.441726388,0.658687212,0.764040941,25.51988243,1,-2.700815472,1.200866229,-2.249056062,0.024508929,0.084669352,40.46863769,0,-0.139499116,0.861827607,-0.161864293,0.871412722,0.914876165,N,-,,btb poz domain-containing,P:protein homooligomerization,G3DSA:3.30.710.10 (GENE3D); PTHR31758 (PANTHER); IPR011333 (SUPERFAMILY),,
RL4_JR_04669,5777,4483,3733,3,4,0,0,0,0,0,0,1,2,5,0,0,3,0,85.615641,1,0.159193147,0.592115576,0.268854855,0.788041379,0.890526979,14.94262976,0,-0.435847434,1.216267581,-0.358348311,0.720082668,0.824790853,49.92034348,1,-2.129062164,1.200579073,-1.773362714,0.076168623,0.156967034,80.78712008,1,-0.448418914,0.691734809,-0.648252637,0.516821562,0.65133412,67.80924802,1,-0.509493352,0.7701431,-0.661556731,0.508255346,0.635162352,N,-,,hypothetical protein F503_00370,,no IPS match,,
RL4_JR_04670,10540,16533,23726,0,0,0,0,0,2,0,0,1,1,0,1,0,4,0,60.63631339,0,-1.418292034,0.849259907,-1.670032958,0.094912843,0.213070714,15.71114937,1,-0.508173285,1.203891122,-0.422109006,0.672945455,0.791305053,86.91636562,1,-0.008206444,0.66274438,-0.012382518,0.990120432,0.995825477,46.96010843,1,-3.580510002,1.186459405,-3.017810796,0.002546078,0.016192865,40.06141929,1,-3.237906982,1.187121681,-2.727527458,0.006381095,0.02192351,N,-,,methyltransferase,F:methyltransferase activity; P:methylation,PTHR34598 (PANTHER),,
RL4_JR_04671,1337,1463,2965,2,0,3,0,0,0,0,0,0,0,6,0,0,0,0,61.33479684,1,0.133984092,0.738962346,0.181313829,0.856121252,0.927670176,10.4617622,0,0.078500833,1.287500642,0.06097149,0.951381914,0.973896413,26.82609475,0,-2.556561892,1.237081447,-2.066607577,0.038771146,0.093259779,48.25839953,1,-0.67819077,0.927696298,-0.731048266,0.464749672,0.606463018,33.5086382,0,-1.679609726,1.165331559,-1.441314889,0.149495743,0.25821006,Y,-,,hypothetical protein HMPREF1624_07929,,PTHR35186 (PANTHER),,
RL4_JR_04672,2844,3465,4031,0,0,3,3,0,0,0,0,0,1,9,0,0,3,0,127.037561,1,1.114633914,0.49378268,2.257337002,0.023987025,0.07613634,66.19328805,1,2.078112651,0.87973644,2.362199129,0.018166881,0.053284605,53.53376908,0,-0.944750393,1.048411975,-0.901125146,0.367521785,0.511871034,60.26898164,1,0.043187087,0.677945561,0.063702883,0.949206809,0.970207017,34.57226236,1,-1.925251574,1.13471902,-1.696676922,0.089757758,0.175953011,N,-,,nb-arc domain containing,F:metal ion binding; F:ADP binding,PR00364 (PRINTS); IPR015880 (SMART); IPR002182 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR35391:SF1 (PANTHER); PTHR35391 (PANTHER); IPR011990 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_04673,552,299,414,0,10,4,0,0,1,0,0,0,0,0,0,0,0,0,813.6169292,1,-4.439609567,0.646433296,-6.867854107,6.52E-12,2.89E-10,270.1451888,1,-2.871283468,0.999366162,-2.873104549,0.004064596,0.018252812,663.8507421,0,-5.34032539,1.045368755,-5.108556538,3.25E-07,9.96E-06,893.5064341,0,-2.482644982,0.772584494,-3.213428437,0.001311605,0.009312762,673.7521067,0,-3.828761329,0.619571014,-6.179697307,6.42E-10,3.83E-08,N,-,,ankyrin repeat containing,,IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24197:SF34 (PANTHER); PTHR24197 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),3.A.23.6.1, the type vi symbiosis/virulence secretory system (t6ss) family.
RL4_JR_04674,1362,1101,1171,11,0,0,0,0,2,0,0,3,1,1,0,0,0,0,381.7698594,1,-1.481191674,0.716193941,-2.068143264,0.038626553,0.110026335,90.4624744,1,-3.033737558,1.243244111,-2.440178507,0.014680006,0.045315956,257.8987968,1,-3.312224586,0.940763295,-3.520784244,0.000430273,0.00303403,299.0209535,1,-3.136379665,0.806798665,-3.887437848,0.000101308,0.001080867,320.4501801,0,-1.201374072,0.864646811,-1.389439084,0.164699272,0.27765237,N,-,,sda1 domain-containing,C:cell; P:ribosomal large subunit export from nucleus; P:ribosomal large subunit biogenesis; P:actin cytoskeleton organization,IPR012977 (PFAM); IPR007949 (PFAM); IPR027312 (PTHR12730:PANTHER); PTHR12730 (PANTHER),,
RL4_JR_04675,1743,984,1651,7,0,2,0,0,0,0,0,0,0,1,0,0,0,0,153.1210089,1,-3.397074811,1.033025812,-3.288470406,0.001007334,0.00594633,42.16496633,0,-1.932473019,1.199977497,-1.610424383,0.107305241,0.213751109,109.8173781,0,-4.589980826,1.199741016,-3.825809707,0.000130343,0.001356816,134.7440669,1,-3.293199177,1.031117324,-3.193816166,0.001404055,0.009844914,116.3773164,0,-3.016652165,0.998486129,-3.021225911,0.002517535,0.010274098,N,-,,hmg-i hmg- DNA-binding,F:DNA binding,IPR017956 (PRINTS),,
RL4_JR_04676,1605,2362,3678,0,0,5,0,0,0,0,0,1,1,2,7,0,2,3,692.076466,1,-1.058866128,0.320488574,-3.303912251,0.000953457,0.005715136,153.3505994,0,-3.795167874,1.20042751,-3.161513581,0.001569515,0.015023052,623.6311161,1,-0.737160725,0.358647085,-2.05539305,0.039841056,0.095332275,761.8591972,1,-0.480503659,0.349316944,-1.37555211,0.168960342,0.290544067,572.8088444,1,-0.908361159,0.486103656,-1.86865733,0.061670504,0.131483229,N,-,,bzip transcription factor,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR004827 (SMART); IPR004827 (PFAM); G3DSA:1.20.5.170 (GENE3D); PTHR22952 (PANTHER); PTHR22952 (PANTHER); PTHR22952:SF131 (PANTHER); PTHR22952:SF131 (PANTHER); PTHR22952:SF131 (PANTHER); IPR004827 (PROSITE_PROFILES); SSF57959 (SUPERFAMILY),,
RL4_JR_04677,3961,3672,4539,0,0,5,0,0,0,0,0,0,0,4,0,0,0,3,34.14033576,1,3.711932332,0.592236985,6.267646946,3.67E-10,1.12E-08,1.1497301,0,3.264314211,1.395229983,2.339624471,0.019303138,0.055952567,14.04316582,0,1.57931077,1.200672874,1.315354751,0.188390705,0.310855159,3.429427432,1,0.195135424,1.21961257,0.159997878,0.872882746,0.921482411,2.918177009,1,0.5412657,1.20773546,0.448165776,0.65403356,0.753023629,N,-,,pathway-specific nitrogen regulator,,no IPS match,,
RL4_JR_04678,7110,7997,12255,0,0,2,0,0,0,0,2,2,0,6,6,0,0,1,47.24213368,1,2.550105788,0.553873669,4.604128942,4.14E-06,5.32E-05,2.641523242,0,2.064109828,1.281991229,1.610081085,0.107380156,0.213788737,6.869813236,1,-0.591370026,1.199484994,-0.493019945,0.621998495,0.735300416,19.96119035,1,1.286779473,0.860738683,1.49497112,0.134921979,0.245566249,81.15452404,1,3.558474898,0.489937931,7.263113704,3.78E-13,4.45E-11,N,-,,conserved membrane,C:intracellular membrane-bounded organelle; C:cytoplasmic part; C:membrane part,IPR025390 (PFAM); IPR019413 (PFAM); PTHR12943 (PANTHER); PTHR12943 (PANTHER); PTHR12943:SF29 (PANTHER); PTHR12943 (PANTHER); PTHR12943:SF29 (PANTHER),,
RL4_JR_04679,5718,7035,7964,0,13,6,0,0,2,1,0,2,2,3,0,0,1,0,26.33810321,1,2.045599419,0.710795668,2.877900796,0.00400331,0.018063608,2.304425234,1,2.261129888,1.308960071,1.727424646,0.084091428,0.176775375,13.82690334,1,0.569824594,1.202796906,0.473749634,0.635678454,0.745638822,44.15310228,1,1.959601082,0.760688485,2.576088795,0.009992498,0.048548006,9.75847308,1,0.455125524,1.139284977,0.399483477,0.689536996,0.779801417,N,-,,Rho-related GTP-binding,P:response to stimulus,SM00175 (SMART); SM00173 (SMART); SM00174 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001806 (PFAM); PTHR24072 (PANTHER); PTHR24072:SF157 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_04680,578,601,381,0,0,0,0,0,4,0,0,2,0,0,0,0,1,0,244.165371,0,1.772675179,0.339509268,5.221286571,1.78E-07,3.32E-06,19.35357839,1,-0.808978187,1.206300894,-0.670627197,0.502458052,0.656327321,69.54115853,1,-1.053469601,0.852889984,-1.235176424,0.216764851,0.345486045,71.36859659,0,-2.143881654,1.013836974,-2.114621688,0.034462204,0.099396379,63.88525909,1,-1.851101703,0.964222497,-1.919786883,0.054884824,0.120205245,N,-,,aminotransferase class i and ii,,IPR004839 (PFAM); IPR015421 (G3DSA:3.40.640.GENE3D); IPR015422 (G3DSA:3.90.1150.GENE3D); PTHR11751:SF428 (PANTHER); PTHR11751 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_04681,3466,3389,2510,0,4,5,0,0,1,3,0,2,5,1,0,0,5,0,2.011194523,1,0.889797553,1.361573296,0.653506907,0.513429538,NA,0.649148497,1,4.089090076,1.559531902,2.621998351,0.008741585,0.030448151,1.668801996,1,1.450638856,1.267781071,1.144234513,0.252526393,0.388124671,1.924204408,1,1.02889013,1.295192577,0.79439162,0.426967481,0.569624159,8.992785484,1,2.325394925,1.16251956,2.000306063,0.045467225,0.104247203,N,-,,aldehyde dehydrogenase,F:aldehyde dehydrogenase (NAD) activity; P:oxidation-reduction process,IPR016163 (G3DSA:3.40.309.GENE3D); IPR016162 (G3DSA:3.40.605.GENE3D); IPR015590 (PFAM); PTHR11699 (PANTHER); PTHR11699:SF207 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_04682,3334,3622,6472,0,3,2,0,0,0,0,0,0,0,2,5,0,0,1,0.051584741,1,6.174177739,3.927395434,1.572079472,0.115932122,NA,0.016197796,0,9.412096249,3.022269875,3.114247449,0.001844148,0.015023052,0.042549979,0,6.740408042,1.73336737,3.888620588,0.000100816,0.0011678,0.049120238,1,6.319618531,3.08669638,2.047372904,0.040621485,0.108577754,0.042547775,1,6.642922416,1.377267464,4.82326243,1.41E-06,1.92E-05,N,-,,---NA---,,no IPS match,,
RL4_JR_04683,20105,16555,15897,8,9,5,0,0,0,2,2,1,1,4,2,0,5,0,5.498709121,1,2.093852274,1.201236202,1.743081229,0.081319427,0.19074815,0.538709808,0,4.35810541,1.57496958,2.767104498,0.005655662,0.022298256,1.39027447,1,1.714205233,1.257781066,1.362880456,0.172920189,0.291773999,5.615076764,1,2.236794932,1.188763063,1.881615439,0.059888248,0.136569486,1.360566089,1,1.642211916,1.238296452,1.326186402,0.184777962,0.303565937,N,-,,"Alpha-1,3 1,6-mannosyltransferase alg-2",C:membrane; F:transferase activity,IPR028098 (PFAM); IPR001296 (PFAM); G3DSA:3.40.50.2000 (GENE3D); PTHR12526:SF389 (PANTHER); PTHR12526 (PANTHER); PTHR12526:SF389 (PANTHER); SSF53756 (SUPERFAMILY),,
RL4_JR_04684,2721,1949,3412,0,2,5,0,0,0,0,2,0,2,7,0,0,4,4,13.91154042,1,-1.900473586,1.212840518,-1.566960831,0.117123847,0.248245349,4.483697828,0,1.300906462,1.286538463,1.011167951,0.311936052,0.473659874,18.04612562,1,-0.378599341,1.210684223,-0.312715185,0.754497058,0.835098559,79.29182024,1,2.408074302,0.52108121,4.621303279,3.81E-06,6.00E-05,11.29038757,1,-1.410846306,1.209500514,-1.166470199,0.243424391,0.373039497,N,-,,WD repeat domain-containing,P:cytokinesis; C:intracellular part,IPR003591 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR24365 (PANTHER); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY); IPR032675 (SUPERFAMILY),8.A.43.1.12, the neat-domain containing methaemoglobin heme sequestration (n-mhs) family.
RL4_JR_04685,8700,7271,7518,0,10,4,0,0,0,0,0,0,0,5,0,0,3,0,7.367854193,1,1.017324999,1.146667639,0.887201281,0.374970543,0.566903204,1.13199229,0,3.286631528,1.376619743,2.387465053,0.016965016,0.050729657,2.938432659,0,0.633775006,1.204777448,0.526051518,0.598852413,0.717921094,22.33746057,1,1.952120017,1.011460024,1.930002146,0.053606572,0.127559704,2.899026557,1,0.550678458,1.203574448,0.45753585,0.647285941,0.748061882,N,-,,protamine P1,,no IPS match,,
RL4_JR_04686,3060,2993,3206,2,2,2,0,0,0,0,2,0,0,0,0,0,0,0,72.281767,1,-3.110087233,1.157492711,-2.686917336,0.00721148,0.029182168,20.05268134,0,-0.860175503,1.223933078,-0.70279619,0.482182772,0.639080008,58.18293577,1,-2.540853552,1.203293451,-2.111582631,0.034722264,0.085863255,73.24575003,0,-2.189233261,1.03225575,-2.120824477,0.033936576,0.098780018,50.61115688,0,-3.575190434,1.199188054,-2.981342602,0.002869875,0.011415593,N,-,,inositol polyphosphate kinase,F:kinase activity,IPR005522 (PFAM); PTHR12400:SF21 (PANTHER); IPR005522 (PANTHER); IPR005522 (PANTHER); PTHR12400:SF21 (PANTHER); SSF56104 (SUPERFAMILY),,
RL4_JR_04687,1909,1130,1569,0,0,2,0,0,0,1,0,1,0,10,0,0,2,3,166.0368501,1,1.954963709,0.459466072,4.254859777,2.09E-05,0.000217111,10.58442301,0,0.061662779,1.21043801,0.050942533,0.959371313,0.978272787,77.71590628,1,0.822543281,0.605831461,1.357709749,0.174555802,0.293457812,102.2738741,1,1.178921629,0.455327224,2.589174482,0.009620633,0.047102956,41.74312411,1,-0.987663899,0.963790656,-1.024770154,0.305471652,0.440661345,Y,-,,autophagy-related 27,,IPR018939 (PFAM); IPR009011 (G3DSA:2.70.130.GENE3D); PTHR15071 (PANTHER); PS51257 (PROSITE_PROFILES); IPR009011 (SUPERFAMILY),9.B.247.1.5, the mannose 6-phosphate receptor (m6pr) family.
RL4_JR_04688,8855,12153,10544,13,15,47,0,0,2,12,5,3,6,26,6,0,48,13,2.733958786,1,0.4468613,1.271128583,0.35154689,0.725178101,0.85460265,0.867425353,1,3.670691747,1.441994611,2.54556551,0.010910089,0.035959106,2.256392506,1,1.015055205,1.22859152,0.826194214,0.40869393,0.550947716,2.603607825,1,0.592390657,1.239168615,0.478054923,0.632611114,0.747745451,2.228182237,1,0.930636773,1.226306611,0.758894036,0.447915947,0.580090683,N,-, Effector probability:0.756,---NA---,,no IPS match,,
RL4_JR_04689,762,718,801,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.61711733,0,2.275672782,1.027897461,2.213910306,0.02683495,0.083207723,0.82672002,0,3.740091199,1.450518043,2.578452036,0.009924408,0.033395896,2.145061727,0,1.088233687,1.226360205,0.887368721,0.374880418,0.51876563,2.474787788,0,0.665737744,1.236833608,0.538259746,0.590397737,0.714355391,2.112187697,0,1.007776624,1.219804256,0.82617897,0.408702576,0.544631953,N,-,,---NA---,,no IPS match,,
RL4_JR_04690,95346,98900,136585,7,26,100,5,7,17,5,4,2,2,47,0,0,34,10,35.91687451,1,1.498335239,0.603783771,2.481575873,0.013080286,0.046932493,4.153669788,1,1.411131935,1.248051401,1.130668123,0.258194803,0.413850999,17.27039779,1,-0.278456701,1.18826209,-0.234339463,0.814721451,0.879718427,12.42595476,1,-1.662543913,1.187352623,-1.400210755,0.161450216,0.281018298,18.33721178,1,0.347778365,0.972723731,0.357530462,0.720694726,0.803372685,N,-,,Cyclin-like F- partial,F:N-acetyltransferase activity,IPR001810 (PFAM); G3DSA:1.20.1280.50 (GENE3D); IPR001810 (SUPERFAMILY),,
RL4_JR_04691,5337,5463,5358,0,0,9,1,0,0,2,6,2,1,5,0,0,1,0,849.3359358,1,-0.670427754,0.618130652,-1.084605256,0.278096526,0.461254517,206.6145844,1,-1.354659189,0.770089151,-1.759093981,0.078561547,0.168082854,579.6932684,1,-1.726524322,0.489600711,-3.526392592,0.000421262,0.002990783,680.307233,1,-1.449456812,0.564237808,-2.568875732,0.010202904,0.049219985,622.679948,1,-1.074715715,0.98456474,-1.091564294,0.275024658,0.40776463,N,-,,mitochondrial phosphate carrier,P:transmembrane transport; C:integral component of membrane,IPR002067 (PRINTS); IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); PTHR24089 (PANTHER); PTHR24089:SF125 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.4.3, the mitochondrial carrier (mc) family.
RL4_JR_04692,51,44,27,0,0,3,0,0,0,0,0,3,0,1,0,0,0,0,112.3987222,1,0.385509865,0.456603157,0.844299604,0.398502007,0.590351919,16.51081402,0,-0.579815506,1.201375105,-0.482626537,0.629360933,0.756515326,79.86123691,1,-0.088213703,0.66273563,-0.133105418,0.89411001,0.933963036,53.37879663,1,-2.705162104,1.138092121,-2.376927186,0.017457534,0.072057697,68.11637372,0,-0.677671926,0.738568849,-0.917547398,0.358855867,0.496134819,N,-,,Spt20 family,C:nucleus; C:membrane,IPR021950 (PFAM),,
RL4_JR_04693,2,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,116.3062591,0,-1.138933447,0.65484299,-1.739246605,0.081991395,0.191987887,25.72847324,0,-1.219812335,1.207830612,-1.009920036,0.312533602,0.474282627,116.4537757,0,-0.466860785,0.635820902,-0.734264607,0.462787484,0.600058977,85.29813831,0,-2.581439415,1.035299964,-2.493421719,0.012651848,0.058439763,74.043256,0,-2.305117311,1.000457592,-2.30406299,0.021219108,0.057306873,N,-,,translation initiation factor eIF-2B subunit gamma,P:regulation of GTPase activity; C:protein complex; C:intracellular part,IPR001451 (PFAM); IPR029044 (G3DSA:3.90.550.GENE3D); IPR025877 (PFAM); PTHR22572 (PANTHER); PTHR22572:SF93 (PANTHER); PTHR22572 (PANTHER); PTHR22572:SF93 (PANTHER); IPR029044 (SUPERFAMILY); IPR011004 (SUPERFAMILY),,
RL4_JR_04694,5,8,6,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,226.9352899,0,-1.019167926,0.83366732,-1.222511548,0.22151424,0.390955389,45.64697765,0,-2.046958015,1.213410837,-1.686945553,0.091613822,0.189132185,119.3337233,0,-4.709882552,1.215029418,-3.876352691,0.000106034,0.001209992,265.2006368,1,-0.237351412,0.488232139,-0.486144587,0.626864656,0.743397636,177.910722,0,-0.935677308,0.659127818,-1.419568833,0.155733244,0.265946888,N,-,,Zinc C2H2-type DNA-binding,F:nucleic acid binding; F:metal ion binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR14596 (PANTHER); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_04695,4281,4558,8056,2,3,11,10,0,0,3,0,1,0,0,2,0,4,0,63.37972481,1,2.826463953,0.951171245,2.971561607,0.002962894,0.014260349,2.335437185,1,2.24183766,1.290729306,1.736876702,0.082408937,0.174033644,6.053649624,1,-0.40884417,1.193952061,-0.342429301,0.732027841,0.819262642,62.85679944,1,2.931397128,1.630308957,1.798062334,0.07216713,0.154643851,5.962670603,1,-0.489743869,1.193799061,-0.410239784,0.681630059,0.773971555,N,-,,leucine rich repeat domain containing,F:aspartic-type endopeptidase activity; P:proteolysis,IPR032675 (G3DSA:3.80.10.GENE3D); SSF52047 (SUPERFAMILY),,
RL4_JR_04696,294,214,298,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,55.26789662,1,0.505432086,0.662256537,0.763196825,0.445346022,0.634054598,9.210470753,0,0.262294561,1.254409049,0.20909811,0.83437165,0.900662242,23.70914673,0,-2.378340749,1.210987075,-1.963968731,0.049533718,0.112212881,47.39612285,1,0.195347195,0.727486161,0.268523589,0.78829632,0.863157789,23.17836796,0,-2.448525322,1.20754351,-2.027691179,0.042591777,0.098749886,N,-,,mfs monocarboxylic acid transporter,C:membrane; C:vacuole,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR21576:SF1 (PANTHER); PTHR21576 (PANTHER); PTHR21576:SF1 (PANTHER); PTHR21576 (PANTHER); PTHR21576 (PANTHER); PTHR21576:SF1 (PANTHER); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.75.2, the major facilitator superfamily (mfs).
RL4_JR_04697,203574,66614,61611,1,3,0,0,0,0,0,2,0,0,2,0,0,4,0,2.553087297,1,0.545469099,1.306324679,0.417560127,0.676268754,0.821838299,0.826439536,0,3.740692067,1.501969402,2.490524814,0.012755459,0.040537129,2.123216395,1,1.103003023,1.253499587,0.87993888,0.378892421,0.522816801,2.447900725,1,0.681466126,1.270797396,0.536250805,0.591785226,0.715460349,2.071428933,1,1.035359195,1.237975746,0.836332374,0.402967945,0.540062802,N,-,,---NA---,,no IPS match,,
RL4_JR_04698,68916,23736,20622,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,252.073567,1,-0.167116308,1.279651082,-0.130595215,0.896095528,0.948632537,43.69925342,0,-1.98404626,1.201603243,-1.651165866,0.098704711,0.20053976,113.7945294,0,-4.641317233,1.20115353,-3.864049947,0.000111522,0.001242082,147.3459022,0,-2.367177625,0.775076411,-3.054121621,0.002257206,0.014594001,112.7083517,0,-4.730234322,1.211426771,-3.904680361,9.44E-05,0.000660646,N,-,,histidyl-tRNA synthetase,F:histidine-tRNA ligase activity; F:ATP binding; P:histidyl-tRNA aminoacylation; C:mitochondrion; C:cytosol; P:mitochondrial translation,IPR004154 (PFAM); PF13393 (PFAM); IPR015807 (TIGRFAM); G3DSA:3.30.930.10 (GENE3D); IPR004154 (G3DSA:3.40.50.GENE3D); IPR004516 (PIRSF); PTHR11476:SF7 (PANTHER); PTHR11476:SF7 (PANTHER); IPR004516 (PANTHER); IPR006195 (PROSITE_PROFILES); IPR004154 (SUPERFAMILY); SSF55681 (SUPERFAMILY),,
RL4_JR_04699,3870,933,2571,0,0,4,0,0,0,1,2,0,2,1,0,0,1,0,3.172373555,1,0.232219454,1.272290848,0.18252073,0.855174087,0.92758379,1.024189344,0,3.431180145,1.452257689,2.362652421,0.018144678,0.053265787,2.634683248,1,0.791648146,1.240836843,0.637995358,0.523476702,0.653474492,15.07266959,1,2.645084932,0.908945605,2.910058552,0.003613611,0.021655188,2.572875638,1,0.722704589,1.228054276,0.588495641,0.556199659,0.675404359,N,-,,fungal specific transcription factor domain-containing,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR007219 (PFAM); PTHR31001:SF26 (PANTHER); PTHR31001 (PANTHER); PTHR31001 (PANTHER),,
RL4_JR_04700,1407,432,1127,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,120.9643527,1,-5.020774276,1.210661973,-4.147131394,3.37E-05,0.00032932,38.3344937,0,-1.795084419,1.201368435,-1.494199753,0.135123417,0.254667066,99.94161542,0,-4.454041456,1.201334324,-3.707578622,0.00020925,0.001802938,139.3975656,1,-1.616532582,0.661405598,-2.444086634,0.014521939,0.065232756,99.04885014,0,-4.543847783,1.211613063,-3.75024661,0.000176661,0.001120071,N,-,,adenosine deaminase,F:adenine deaminase activity; C:nucleus; F:zinc ion binding; C:cytoplasm; P:adenine catabolic process; P:hypoxanthine salvage; P:purine ribonucleoside monophosphate biosynthetic process; P:nucleotide metabolic process,IPR001365 (PFAM); G3DSA:3.20.20.140 (GENE3D); IPR006330 (TIGRFAM); PTHR11409:SF41 (PANTHER); PTHR11409 (PANTHER); IPR028892 (HAMAP); IPR032466 (SUPERFAMILY),,
RL4_JR_04701,34,19,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28.8459895,0,2.58925182,0.659217802,3.9277638,8.57E-05,0.000748087,1.8941096,0,2.544059848,1.331711195,1.910369048,0.056085713,0.129316535,4.90639765,0,-0.105462651,1.21103704,-0.087084579,0.930604283,0.958632251,33.74109695,0,2.95244902,0.6165724,4.788487158,1.68E-06,2.90E-05,23.41448305,0,2.040474363,0.853870456,2.389676734,0.016863208,0.047759436,N,-,,hormone-sensitive lipase,,IPR029058 (G3DSA:3.40.50.GENE3D); IPR013094 (PFAM); PTHR23025 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_04702,3818,2218,2240,0,2,0,0,0,0,1,0,0,0,1,0,0,0,0,70.95555184,1,-0.038594,0.81782203,-0.047191196,0.962360844,0.980885012,10.49383377,0,0.074062066,1.288659834,0.057472162,0.954169081,0.9755656,27.26461548,1,-2.579936832,1.246865632,-2.069137817,0.038533156,0.092816957,31.46133462,1,-3.002657011,1.253960833,-2.394538117,0.016641314,0.069939175,26.83856297,0,-2.659992594,1.25561698,-2.118474532,0.0341349,0.083188063,N,-,,glutamate decarboxylase,F:pyridoxal phosphate binding; P:glutamate metabolic process; F:glutamate decarboxylase activity; P:cellular amino acid metabolic process,IPR002129 (PFAM); IPR010107 (TIGRFAM); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR11999:SF111 (PANTHER); PTHR11999 (PANTHER); IPR015424 (SUPERFAMILY),8.A.47.2.5,The Neuropilin and Tolloid-like (Neto) Family
RL4_JR_04703,5834,5251,5184,9,6,12,0,0,4,0,1,4,1,10,0,0,3,0,0.513249283,1,2.859809608,1.964196024,1.455969554,0.145401036,NA,0.16485708,1,6.066233307,1.910652714,3.174953387,0.001498606,0.015023052,0.426392487,1,3.418291911,1.293700677,2.642258732,0.008235512,0.027988023,0.49176534,1,2.996557288,1.435075218,2.088083781,0.036790278,0.101832029,0.419520599,1,3.338475774,1.244213347,2.683202026,0.007292092,0.024385697,N,-,,NB-ARC domain-containing,,no IPS match,,
RL4_JR_04704,918,1210,1763,0,0,2,0,0,0,0,5,0,2,8,6,0,0,0,98.56515742,1,1.106353766,0.502107848,2.203418588,0.027565259,0.08461458,19.3840567,0,1.059047759,1.124891529,0.941466561,0.346465818,0.509456699,26.05441422,1,-2.514543868,1.199995468,-2.095461138,0.03613002,0.088246157,73.40267842,1,0.767800918,0.570268104,1.346385871,0.178178105,0.302795118,55.26396655,0,0.064167472,0.773081244,0.083002237,0.933849761,0.956619671,N,-,,acetylornithine aminotransferase,F:pyridoxal phosphate binding; P:arginine metabolic process; F:transaminase activity,IPR004636 (TIGRFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR005814 (PFAM); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR11986:SF79 (PANTHER); IPR005814 (PANTHER); IPR004636 (HAMAP); IPR015424 (SUPERFAMILY),9.B.313.1.2, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_04705,3634,3415,4400,0,0,12,0,0,0,2,0,3,0,10,2,0,2,0,34.20019442,1,-3.198336751,1.189639261,-2.688492938,0.007177535,0.029073651,10.96868267,0,0.010212712,1.221687135,0.008359515,0.99333015,0.996480454,34.8779774,1,-1.676003725,1.193733828,-1.404001198,0.160318493,0.275656322,36.74366339,1,-2.112869285,1.146402251,-1.843043559,0.065322651,0.14431417,31.77525053,1,-1.78668307,1.124158662,-1.589351335,0.111981095,0.207847587,N,-,,tetraspanin tsp3,C:membrane; C:integral component of membrane,IPR008952 (SUPERFAMILY),,
RL4_JR_04706,5824,5485,4385,3,0,15,0,0,2,2,0,6,0,13,0,0,9,2,422.1654547,1,-2.697055904,0.708730218,-3.805476098,0.000141532,0.001148871,115.8056028,1,-3.390036383,1.237136591,-2.740228046,0.006139657,0.023647491,343.1915976,1,-2.854784903,0.739780492,-3.858962131,0.00011387,0.001251467,356.6809141,1,-4.712712473,1.066728743,-4.417910838,9.97E-06,0.000140929,290.0741934,1,-6.094060945,1.234472223,-4.936571946,7.95E-07,1.20E-05,N,-,,vacuolar iron transporter,C:integral component of membrane,IPR008217 (PFAM); PTHR31851:SF11 (PANTHER); PTHR31851 (PANTHER),2.A.89.1.2, the vacuolar iron transporter (vit) family.
RL4_JR_04707,1880,1043,1311,0,3,0,0,0,2,0,0,0,2,2,0,0,0,1,52.98345506,1,0.161670328,0.785527897,0.205811058,0.836938503,0.918937779,9.721765763,1,0.184351293,1.287569868,0.143177701,0.886149841,0.935574723,24.96615121,0,-2.452863609,1.236117749,-1.984328443,0.047219237,0.108351668,28.78517778,1,-2.874390724,1.240583169,-2.316967372,0.020505509,0.077696516,28.1791886,1,-1.590853698,1.16625084,-1.364075072,0.172543939,0.287762706,N,-,,sh3 domain-containing,C:cytoplasm; P:small GTPase mediated signal transduction; F:guanyl-nucleotide exchange factor activity; P:positive regulation of GTPase activity,IPR001452 (SMART); IPR032376 (PFAM); IPR001452 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR027007 (PFAM); IPR010703 (PFAM); IPR031057 (PTHR23317:PANTHER); IPR026791 (PANTHER); IPR031057 (PTHR23317:PANTHER); IPR031057 (PTHR23317:PANTHER); IPR026791 (PANTHER); IPR026791 (PANTHER); IPR027357 (PROSITE_PROFILES); IPR027007 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY),,
RL4_JR_04708,392,233,253,0,0,0,0,0,0,0,3,0,0,5,0,0,0,0,56.0816536,0,1.353638133,0.558974534,2.421645445,0.015450417,0.053575765,5.383175698,0,1.037063448,1.233937462,0.840450574,0.400655803,0.564412297,13.96049029,1,-1.614330449,1.188517682,-1.358272135,0.174377349,0.29325746,82.72388741,1,2.018265111,0.477388129,4.227723709,2.36E-05,0.000303323,33.06087297,0,1.235526204,0.672336469,1.837660549,0.066112441,0.138963766,N,-,,hypothetical protein CMQ_6728,,PTHR42041 (PANTHER),,
RL4_JR_04709,1439,1850,1543,1,3,0,0,0,0,0,0,0,3,3,7,0,4,1,114.5807864,1,1.477667198,0.483346336,3.057160233,0.002234448,0.011421445,9.329643175,0,0.243639709,1.222336382,0.199322963,0.842010118,0.905623888,51.04156052,0,0.000924891,0.859617402,0.001075934,0.999141529,0.999593402,100.2671013,1,1.355170923,0.497572121,2.723566825,0.006458115,0.034342654,35.62189963,1,-0.309246241,0.869396054,-0.355702375,0.722063466,0.804548001,N,-,,heme steroid binding domain,C:integral component of membrane; C:endomembrane system; F:heme binding,IPR001199 (SMART); IPR001199 (PFAM); IPR001199 (G3DSA:3.10.120.GENE3D); PTHR10281 (PANTHER); PTHR10281:SF4 (PANTHER); PTHR10281:SF4 (PANTHER); IPR001199 (SUPERFAMILY),,
RL4_JR_04710,1921,2295,3363,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,461.4686038,0,7.150926455,2.374640308,3.011372472,0.002600696,0.012900743,1.040346915,0,3.408432772,1.430220937,2.383151221,0.017165142,0.051167225,2.693385612,0,0.759330581,1.233217618,0.615731214,0.538071933,0.666679751,42.43497447,0,3.850170526,0.622714546,6.182881952,6.29E-10,2.09E-08,14.23494989,0,2.860332848,0.89044106,3.21226522,0.001316927,0.005982005,Y,-,,extracellular serine-rich,F:electron carrier activity,IPR008972 (G3DSA:2.60.40.GENE3D); PTHR34883 (PANTHER); PTHR34883:SF1 (PANTHER); IPR008972 (SUPERFAMILY),,
RL4_JR_04711,241,197,171,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,107.6654333,0,4.869395443,0.932099779,5.224113935,1.75E-07,3.28E-06,1.078890976,0,3.356129542,1.499227067,2.238573206,0.025183699,0.068894433,2.764801853,1,0.722055593,1.275177384,0.566239335,0.571231094,0.695089374,3.187175455,1,0.300727852,1.293031351,0.232575839,0.81609079,0.883734679,2.688878064,0,0.659079055,1.263361704,0.521686745,0.601888455,0.710850415,N,-,,---NA---,,IPR006793 (PFAM),,
RL4_JR_04712,3031,3677,3790,6,0,20,0,0,0,1,0,0,1,5,2,0,5,2,0.212896534,1,4.129430597,3.321035895,1.24341643,0.213714419,NA,0.070527656,0,7.29189256,2.631505781,2.770996215,0.005588508,0.02210507,0.178399767,1,4.67673129,1.758906344,2.658885908,0.007839951,0.026950723,0.205479044,1,4.256106641,2.291563648,1.857293663,0.063269386,0.141132965,0.171137682,1,4.631944633,1.585468592,2.921498827,0.003483516,0.01334491,N,-,,---NA---,,no IPS match,,
RL4_JR_04713,4584,4552,7145,0,0,12,0,3,3,0,4,0,0,4,6,0,2,1,10.14191794,1,-1.444781882,1.195191272,-1.20882901,0.226728544,0.398202683,3.252554111,1,1.76395858,1.279329399,1.378815011,0.167951797,0.301992317,8.41657297,1,-0.884312683,1.200843643,-0.736409513,0.461481517,0.599026203,13.71913361,1,-0.359643404,1.150229781,-0.31267092,0.754530691,0.83897975,8.280938738,1,-0.963676211,1.200918125,-0.802449552,0.422292959,0.557989178,N,-,,phospholipase carboxylesterase,P:proteolysis; F:serine-type peptidase activity,IPR003140 (PFAM); IPR001375 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR10655 (PANTHER); PTHR10655:SF35 (PANTHER); PTHR10655:SF35 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_04714,3096,2348,4555,0,0,0,0,0,0,0,0,1,0,0,0,0,2,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-, Effector probability:0.876,DUF3328 domain,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,IPR021765 (PFAM); PTHR33365 (PANTHER); PTHR33365:SF3 (PANTHER),,
RL4_JR_04715,10805,4736,6362,11,9,56,0,0,0,0,3,5,2,14,3,0,1,4,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,Tat pathway signal sequence,C:membrane; C:integral component of membrane,IPR021765 (PFAM); PTHR33365 (PANTHER); PTHR33365:SF3 (PANTHER),,
RL4_JR_04716,3259,1507,2432,0,0,6,0,0,0,1,2,2,0,4,4,0,3,0,0.520079535,1,2.840969319,2.060791696,1.378581505,0.168023822,NA,0.168643905,0,6.033847072,1.980101566,3.0472412,0.002309523,0.015159195,0.432205795,1,3.400199442,1.361716118,2.496995811,0.012525044,0.038483624,0.498255503,1,2.978316726,1.533640056,1.941992004,0.052138068,0.125807414,0.420079061,1,3.33715935,1.295521903,2.575918897,0.009997409,0.031396951,N,-,,multidrug resistance,"F:nucleotide binding; F:ATPase activity; F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:membrane; C:integral component of membrane; P:transport; F:hydrolase activity",IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.20.1560.10 (GENE3D); IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011527 (PFAM); PTHR24223:SF257 (PANTHER); PTHR24223 (PANTHER); PTHR24223:SF257 (PANTHER); PTHR24223 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY),3.A.1.208.41, the atp-binding cassette (abc) superfamily.
RL4_JR_04717,825,454,861,0,0,3,0,0,0,0,0,0,1,3,2,0,1,2,42.70352138,1,1.25265396,0.767995543,1.631069309,0.102875696,0.226337628,3.390461834,0,1.703958202,1.276256749,1.335121795,0.181836487,0.320764888,21.82368967,0,0.863462864,1.047355128,0.824422244,0.40969968,0.55193607,10.18371672,1,-1.375551192,1.2070465,-1.139600829,0.25445264,0.39387448,8.740042751,1,-1.041429668,1.2160817,-0.856381334,0.391786886,0.528278362,N,-,,zinc-binding oxidoreductase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); PF13602 (PFAM); IPR002085 (PANTHER); PTHR11695:SF575 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_04718,1071,724,931,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,26.06924967,1,3.501618617,0.656941206,5.330185689,9.81E-08,1.93E-06,1.001954596,0,3.462646613,1.405530171,2.463587538,0.01375543,0.042972983,2.608215842,0,0.805824721,1.218317916,0.66142401,0.508340433,0.639945106,24.6796394,0,3.102530379,0.759831041,4.083184564,4.44E-05,0.000530401,2.579201254,1,0.719500755,1.219280951,0.590102515,0.555121923,0.674624023,N,-,,sam dependent methyltransferase,F:methyltransferase activity; F:transferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); PTHR10108:SF891 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_04719,95,118,151,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.756496608,0,2.300260098,1.632079901,1.409404096,0.158715714,NA,0.242928145,0,5.50702244,1.762575047,3.124418702,0.001781567,0.015023052,0.627572298,0,2.861407051,1.256780978,2.276774634,0.022799687,0.061684669,0.723786476,0,2.439297507,1.33091803,1.832793194,0.066833332,0.146533158,0.615944086,0,2.784960363,1.220976626,2.280928484,0.022552679,0.060122664,N,-,,nf-x1 finger and helicase,"C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; F:metal ion binding; P:regulation of transcription, DNA-templated; F:helicase activity",IPR000967 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); PF13087 (PFAM); PF13086 (PFAM); PTHR10887 (PANTHER); PTHR10887 (PANTHER); PTHR10887:SF323 (PANTHER); PTHR10887:SF323 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_04720,1739,1642,1227,1,0,8,0,0,0,0,4,0,0,11,1,0,1,1,11.54080052,1,7.726108715,0.978079762,7.899262429,2.81E-15,1.94E-13,0.026913628,0,8.681154736,2.754080595,3.152106279,0.001620973,0.015023052,0.070047198,1,6.02598843,1.595376378,3.777157862,0.000158628,0.001536796,0.080836996,1,5.601985141,2.564627138,2.184327327,0.028938204,0.090433452,0.069091134,1,5.946064757,1.34110176,4.433716318,9.26E-06,9.38E-05,N,-,,Polyketide synthase,,IPR020807 (SMART); IPR020843 (SMART); IPR020806 (SMART); SM00822 (SMART); IPR020801 (SMART); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR001227 (G3DSA:3.40.366.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); IPR014043 (PFAM); IPR013149 (PFAM); IPR020807 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR009081 (PFAM); IPR013968 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR11712 (PANTHER); PTHR11712:SF262 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR016035 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016036 (SUPERFAMILY); IPR011032 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR029063 (SUPERFAMILY),,
RL4_JR_04721,1611,1387,1565,1,0,7,0,0,0,1,0,0,0,0,1,0,0,0,0.060714476,1,5.93969906,3.924307647,1.51356611,0.130135922,NA,0.018886927,0,9.191263886,3.101722258,2.963277535,0.00304382,0.015677493,0.049697922,1,6.519643827,1.865838632,3.494216334,0.000475456,0.003252373,0.057391766,1,6.095808088,3.108937781,1.960736598,0.049909758,0.122863189,0.049577191,0,6.42585789,1.468716501,4.375151968,1.21E-05,0.000118139,N,-,,ent-kaurene oxidase,F:oxidoreductase activity; F:binding,IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24279 (PANTHER); PTHR24279:SF78 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_04722,207,207,155,1,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0.316239674,1,3.55855631,2.436623161,1.460445902,0.144167565,NA,0.101918426,0,6.760255305,2.099364349,3.220143901,0.001281263,0.015023052,0.262666093,0,4.118249169,1.329380192,3.09787162,0.001949158,0.009644809,0.302890041,0,3.696107772,1.596115068,2.315690043,0.020575198,0.077828437,0.257162267,0,4.044491964,1.248003903,3.240768683,0.001192079,0.005513841,N,-,,aristolochene synthase,C:membrane; F:lyase activity,IPR008949 (G3DSA:1.10.600.GENE3D); IPR008949 (SUPERFAMILY),,
RL4_JR_04723,27,35,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.658656965,0,0.487149828,1.282970514,0.379704617,0.704164692,0.839727461,0.856304234,0,3.689473661,1.47477328,2.50172261,0.012359072,0.039545871,2.205425015,0,1.048310931,1.239931247,0.845458919,0.39785466,0.539808781,2.543194934,0,0.626471198,1.253065112,0.499951034,0.617109556,0.735706605,2.155617374,0,0.978056519,1.225510116,0.798081147,0.424823401,0.559996997,N,-,,hydroxymethylglutaryl- synthase,P:isoprenoid biosynthetic process; F:hydroxymethylglutaryl-CoA synthase activity,IPR013746 (PFAM); IPR013528 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR010122 (TIGRFAM); PTHR11877:SF26 (PANTHER); PTHR11877 (PANTHER); IPR016039 (SUPERFAMILY); IPR016039 (SUPERFAMILY),,
RL4_JR_04724,1051,1191,1034,0,1,0,0,0,0,1,1,0,3,3,0,0,0,0,0.250137637,1,3.896714956,2.771708311,1.405889263,0.15975701,NA,0.07848616,0,7.13627951,2.246179974,3.177073784,0.001487692,0.015023052,0.206247627,1,4.464765867,1.421420821,3.14105844,0.001683384,0.008646668,0.238101869,1,4.042564877,1.802076899,2.243281005,0.0248787,0.085359821,0.206283464,0,4.364245293,1.328898331,3.28410774,0.001023058,0.004875161,N,-,,benzoate 4-monooxygenase cytochrome P450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; P:transport; F:heme binding",IPR002403 (PRINTS); IPR001128 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24305 (PANTHER); PTHR24305:SF79 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_04725,897,685,1269,0,0,4,0,0,0,0,0,0,0,1,0,0,0,1,0.447106647,1,3.058914278,2.0792604,1.471154973,0.141249211,NA,0.143835426,0,6.26313185,1.956426325,3.201312399,0.001368031,0.015023052,0.371362036,0,3.6181373,1.295325094,2.793227211,0.005218502,0.019524064,0.428266515,1,3.196225715,1.461574766,2.186836957,0.028754428,0.090052146,0.364461089,1,3.541433067,1.237558888,2.86162792,0.004214714,0.015568762,N,-, Effector probability:0.812,Cytochrome P450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24279:SF69 (PANTHER); PTHR24279 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_04726,2839,2710,4690,0,4,4,0,0,2,0,0,0,0,3,0,0,0,0,0.710964847,1,2.389763827,1.674739806,1.426946335,0.153595364,NA,0.226523505,1,5.607715108,1.774802543,3.159627605,0.001579709,0.015023052,0.588490786,0,2.953479479,1.256134959,2.351243756,0.018710772,0.053269926,0.67893928,1,2.531259782,1.33668159,1.893689418,0.058266247,0.134813928,0.581162993,0,2.86930904,1.226379772,2.339657834,0.019301414,0.053177365,N,-,,MFS gliotoxin efflux transporter,P:transmembrane transport; C:membrane; C:integral component of membrane; F:transporter activity,PR01036 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501:SF57 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.79, the major facilitator superfamily (mfs).
RL4_JR_04727,2831,2725,5280,2,0,2,0,0,0,0,0,0,0,3,0,0,0,2,0.004235441,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001340044,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003452355,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003983613,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003339785,1,10.24113992,1.835951848,5.578109216,2.43E-08,8.07E-07,N,-, Effector probability:0.644,Cytochrome P450,F:oxidoreductase activity; F:metal ion binding; P:single-organism metabolic process,IPR002403 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24286 (PANTHER); PTHR24286 (PANTHER); PTHR24286:SF47 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_04728,1893,1625,2409,0,1,15,0,0,0,0,2,1,3,0,0,0,0,3,0.052347439,1,6.153492355,3.927102509,1.566929394,0.117131196,NA,0.016879734,0,9.354969155,2.985410384,3.133562208,0.001726983,0.015023052,0.043430046,1,6.716344243,1.689180226,3.976096889,7.01E-05,0.000916158,0.050078958,1,6.292820238,3.031593151,2.075746951,0.037917361,0.103648294,0.04239488,1,6.645641785,1.346502473,4.935484278,8.00E-07,1.20E-05,N,-,,Short chain dehydrogenase reductase family,F:oxidoreductase activity; C:membrane; P:single-organism process,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04729,3423,3471,4462,4,0,2,0,0,0,0,2,4,2,3,3,0,9,0,0.556609862,1,2.742930666,1.901737042,1.442329095,0.149209556,NA,0.176256919,0,5.96961912,1.873966218,3.18555322,0.001444775,0.015023052,0.459492004,1,3.310485842,1.285975453,2.574299403,0.010044331,0.032781692,0.530246818,1,2.887922407,1.412751817,2.044182405,0.040935531,0.109071644,0.455126368,1,3.222628032,1.247883701,2.582474656,0.009809457,0.030873717,N,-,,Cytochrome P450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305:SF71 (PANTHER); PTHR24305 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_04730,955,1094,1377,0,0,0,0,0,0,0,0,1,0,3,0,0,0,3,23.75517915,0,7.991688475,0.896360833,8.915704679,4.85E-19,5.49E-17,0.030765537,0,8.488163047,2.755289332,3.080679385,0.002065289,0.015023052,0.080245053,1,5.829978129,1.654035128,3.52470031,0.000423962,0.003001533,28.9984779,1,8.112529485,1.579826104,5.135077502,2.82E-07,5.79E-06,14.81020696,1,7.479801199,1.091385742,6.853489938,7.21E-12,6.46E-10,N,-,,family Taurine catabolism dioxygenase,F:dioxygenase activity; P:oxidation-reduction process,G3DSA:3.60.130.10 (GENE3D); IPR003819 (PFAM); PTHR10696:SF30 (PANTHER); PTHR10696 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_04731,1342,818,1318,2,0,0,0,0,1,0,2,0,1,2,0,0,0,0,24.60999373,1,-0.46410935,1.02298711,-0.453680545,0.650058771,0.801326603,5.445915259,1,1.020408288,1.255799415,0.812556747,0.416472239,0.580332048,14.06482439,1,-1.62492322,1.200714717,-1.353296664,0.175960875,0.295199858,72.56247708,1,1.984425369,0.512970153,3.868500644,0.000109507,0.001150161,25.37146194,0,0.501996724,0.850770109,0.590049789,0.55515727,0.674624023,N,-,,ABC multidrug transporter,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); IPR011527 (PFAM); G3DSA:1.20.1560.10 (GENE3D); PTHR24223:SF257 (PANTHER); PTHR24223 (PANTHER); PTHR24223 (PANTHER); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY); IPR011527 (SUPERFAMILY),3.A.1.208.41, the atp-binding cassette (abc) superfamily.
RL4_JR_04732,8292,11469,9602,2,15,25,4,0,0,1,9,4,6,10,0,0,7,1,0.019504112,1,7.575372061,3.961019049,1.912480593,0.055814579,NA,0.006509392,1,10.7300969,3.9588721,2.710392412,0.006720365,0.025175252,0.016494478,1,8.109867811,2.851793459,2.843778109,0.004458208,0.017386326,0.018993711,1,7.690398192,3.960048927,1.941995752,0.052137615,0.125807414,0.015949996,1,8.040879118,1.654939983,4.858713428,1.18E-06,1.67E-05,N,-,,umta methyltransferase family,F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108:SF923 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_04733,1239,848,1051,0,2,12,0,0,0,0,3,2,0,3,5,0,2,0,5.341090656,1,2.236017859,1.198215345,1.866123539,0.062024083,0.156363558,0.490183954,0,4.494312103,1.598946176,2.810796368,0.004941905,0.020484015,1.262408467,1,1.853381958,1.25955039,1.471463128,0.141165912,0.250466823,5.467359273,1,2.376271961,1.188037418,2.000165925,0.04548235,0.115502582,1.233468963,1,1.783481524,1.236194662,1.442718998,0.149099645,0.257792676,N,-,,hypothetical protein F503_06573,F:thiol-dependent ubiquitin-specific protease activity; C:nucleus; P:protein deubiquitination involved in ubiquitin-dependent protein catabolic process; C:cytoplasm; F:K63-linked polyubiquitin binding,IPR022099 (PFAM); IPR022105 (PFAM); PTHR13367 (PANTHER); PTHR13367 (PANTHER); PTHR13367:SF8 (PANTHER); PTHR13367:SF8 (PANTHER),,
RL4_JR_04734,6213,3975,3960,10,11,5,0,0,0,0,0,2,2,1,6,0,3,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-, Effector probability:0.756,---NA---,,no IPS match,,
RL4_JR_04735,11619,8598,8831,15,14,4,0,0,0,0,7,2,8,7,4,0,9,0,0.925292576,1,2.009525312,1.652702046,1.215902961,0.22402189,NA,0.300977577,0,5.197933243,1.783996199,2.913645919,0.003572348,0.016958421,0.772393345,1,2.561563596,1.3208366,1.939349346,0.052458814,0.117472469,0.890347083,1,2.140331791,1.405689835,1.522620238,0.127853744,0.235581284,0.754126456,1,2.492546633,1.285049658,1.93965005,0.052422234,0.116016419,N,-,,hypothetical protein Z517_06935,C:membrane; C:integral component of membrane,IPR021840 (PFAM),,
RL4_JR_04736,2226,2027,2966,0,0,5,0,0,0,0,2,0,1,4,0,0,2,0,183.609979,1,-0.056041877,0.618463418,-0.090614701,0.927798751,0.965431404,31.55768974,0,-1.514397426,1.258760958,-1.203085793,0.228943122,0.378777752,81.20485213,1,-4.15451082,1.240840991,-3.348141182,0.000813556,0.004882298,105.6549523,1,-2.32715364,0.957576994,-2.430252246,0.015088318,0.065631958,79.53392214,1,-4.227294706,1.243934386,-3.398326112,0.000677995,0.003497048,N,-,,PPPDE peptidase domain-containing 2,C:cell; P:cell redox homeostasis,IPR008580 (SMART); IPR012336 (G3DSA:3.40.30.GENE3D); IPR008580 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR013535 (PFAM); IPR013766 (PFAM); PTHR12378:SF7 (PANTHER); PTHR12378 (PANTHER); IPR013535 (PROSITE_PROFILES); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY),,
RL4_JR_04737,1111,684,1307,1,4,4,0,0,2,0,0,0,0,0,4,0,3,0,186.8207931,1,-0.419249579,0.486205937,-0.862288069,0.388529016,0.58138095,81.83087496,1,-0.086673496,0.977042321,-0.088710073,0.929312327,0.960445502,156.6716401,0,-0.768612108,0.579433629,-1.326488608,0.184677906,0.306103327,123.5585883,1,-2.529034942,0.862691732,-2.931562746,0.003372612,0.020398865,99.22498002,1,-3.559409887,1.128640034,-3.153715781,0.00161206,0.007099655,N,-,,ph-response regulator pala rim20,,IPR000269 (PRINTS); IPR004328 (SMART); IPR015798 (G3DSA:2.70.98.GENE3D); G3DSA:1.20.140.50 (GENE3D); IPR004328 (PFAM); IPR004328 (G3DSA:1.25.40.GENE3D); G3DSA:1.20.120.560 (GENE3D); IPR015798 (PFAM); G3DSA:3.10.450.40 (GENE3D); G3DSA:3.10.450.40 (GENE3D); IPR025304 (PFAM); PTHR10638:SF32 (PANTHER); IPR000269 (PANTHER); IPR004328 (PROSITE_PROFILES); IPR016182 (SUPERFAMILY); IPR016182 (SUPERFAMILY); IPR015798 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_04738,618,382,708,0,0,3,0,0,0,0,0,3,1,4,0,0,2,4,5.663289003,1,-0.604080236,1.234351599,-0.489390735,0.624565095,0.78508506,1.830730161,0,2.5931727,1.370597548,1.892001561,0.058490773,0.133567194,4.712748643,1,-0.047547766,1.229482213,-0.038673,0.9691511,0.982052421,5.433802171,1,-0.469127534,1.232312078,-0.380688904,0.703434104,0.800884999,4.612024423,1,-0.11936974,1.224040093,-0.097521103,0.922312577,0.950025763,N,-,,cytochrome P450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305:SF69 (PANTHER); PTHR24305 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_04739,2588,3084,2233,1,0,93,4,0,0,0,8,15,29,66,11,0,42,35,3.14846226,1,0.243299005,1.248185309,0.194922183,0.845453868,0.922395985,1.003533793,1,3.460485341,1.416010389,2.44382765,0.014532367,0.044969923,2.601768532,1,0.809769804,1.221129177,0.663131976,0.507246033,0.638964643,3.001545224,1,0.387355352,1.227611675,0.315535735,0.752354923,0.837374255,2.559820781,1,0.730417443,1.215449553,0.600944269,0.547877107,0.668344061,N,-,,kinase-like domain,P:phosphorylation; F:kinase activity,G3DSA:3.90.1200.10 (GENE3D); IPR002575 (PFAM); PTHR21310:SF6 (PANTHER); PTHR21310 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_04740,1812,1552,1689,1,3,0,0,0,0,0,0,0,0,0,1,0,6,2,1.528456685,1,1.285708443,1.315676342,0.977222439,0.328459041,NA,0.48857132,0,4.498935475,1.550394152,2.901801112,0.00371024,0.017370514,1.265322551,0,1.849747989,1.224797757,1.510247695,0.130980233,0.237174723,5.471172447,1,2.374345585,1.154686887,2.056267905,0.0397567,0.107040766,1.244487318,1,1.770837094,1.208536417,1.465274087,0.142846153,0.249580208,N,-,,alcohol dehydrogenase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR013149 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002085 (PANTHER); PTHR11695:SF294 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_04741,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.110192852,0,5.079200934,3.916436501,1.296893473,0.194667843,NA,0.034216478,0,8.333067015,2.73047186,3.051878005,0.002274145,0.0150814,0.090722156,0,5.648114033,1.682432601,3.35711162,0.000787613,0.004757634,0.104781078,0,5.22636002,2.485094826,2.103082734,0.035458538,0.099858856,0.091703854,0,5.533937971,1.466561264,3.773410704,0.000161031,0.001038495,N,-,,aldehyde dehydrogenase,F:oxidoreductase activity; P:metabolic process,IPR015590 (PFAM); IPR016162 (G3DSA:3.40.605.GENE3D); IPR016163 (G3DSA:3.40.309.GENE3D); PTHR11699 (PANTHER); PTHR11699:SF155 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_04742,21634,18045,18831,5,12,2,0,0,0,1,0,2,1,3,0,0,8,0,1.258818187,1,1.565820787,1.444353068,1.084098357,0.278321191,NA,0.40414044,0,4.772778109,1.644025797,2.903104148,0.003694837,0.017320774,1.042338789,1,2.129849096,1.26445207,1.684404769,0.09210347,0.18212022,1.20213057,1,1.707660251,1.308256912,1.305294271,0.191792664,0.320816244,1.019630611,1,2.058342792,1.238242843,1.66230946,0.096450742,0.185693813,N,PKS,,lovastatin nonaketide synthase,F:catalytic activity,IPR020841 (SMART); IPR020806 (SMART); SM00822 (SMART); IPR020807 (SMART); IPR020801 (SMART); IPR032821 (PFAM); IPR014043 (PFAM); IPR009081 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR001227 (G3DSA:3.40.366.GENE3D); IPR020807 (PFAM); IPR014031 (PFAM); IPR013968 (PFAM); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR013217 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR014030 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR11712 (PANTHER); PTHR11712:SF258 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR016035 (SUPERFAMILY); IPR016036 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_04743,15730,15221,21743,4,11,52,0,0,0,0,0,0,3,6,4,0,15,6,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,Polyketide enoylreductase,F:oxidoreductase activity,IPR020843 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013154 (PFAM); IPR013149 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR002085 (PANTHER); PTHR11695:SF460 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_04744,5739,8546,5872,1,0,12,0,0,0,0,0,0,0,5,0,0,0,4,0.023991096,1,7.278843323,3.950996105,1.842280561,0.065434122,NA,0.007349285,0,10.55064835,3.952814198,2.669148567,0.007604381,0.02755073,0.019590825,0,7.860208691,2.683050839,2.929578738,0.003394218,0.014837247,0.02263866,1,7.436844232,3.951509931,1.88202595,0.059832492,0.136569486,0.01984176,1,7.75009228,1.597955263,4.850005791,1.23E-06,1.73E-05,N,-,,glutathione S-transferase,C:membrane,IPR023352 (G3DSA:1.20.120.GENE3D); IPR001129 (PFAM); PTHR10250:SF17 (PANTHER); PTHR10250 (PANTHER); SSF161084 (SUPERFAMILY),,
RL4_JR_04745,531822,238411,361237,145,254,241,2,7,29,16,32,44,8,26,11,0,58,15,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-, Effector probability:0.572,---NA---,,no IPS match,,
RL4_JR_04746,639,763,1044,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.195588059,0,4.251412047,3.276252948,1.297644631,0.194409478,NA,0.062247674,0,7.470719428,2.541950122,2.938971683,0.003293032,0.016299299,0.162603092,0,4.807841736,1.650821321,2.912393774,0.003586702,0.015438677,0.187612278,0,4.386287209,2.190199658,2.002688291,0.045210756,0.115278131,0.162161382,0,4.709849446,1.497835702,3.144436629,0.001664069,0.007271775,N,-, Effector probability:0.576,---NA---,,no IPS match,,
RL4_JR_04747,69,55,59,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.959291299,0,-0.412292633,1.201416368,-0.343172146,0.731468958,0.858256561,1.581777398,0,2.803987974,1.332619873,2.104116884,0.035368252,0.089971714,4.103022519,0,0.152368403,1.20024025,0.126948253,0.898981355,0.937503836,4.733388737,0,-0.269978863,1.198869911,-0.225194461,0.821827998,0.888202467,4.042496138,0,0.071092035,1.199005018,0.059292525,0.952719115,0.969095027,N,-,,fungal specific transcription factor domain-containing,"F:zinc ion binding; F:oxidoreductase activity, acting on the CH-CH group of donors; P:transcription, DNA-templated; P:metabolic process; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter; F:DNA binding; C:nucleus; F:metal ion binding; C:membrane; C:integral component of membrane; P:oxidation-reduction process",IPR007219 (SMART); IPR007219 (PFAM); PTHR31944 (PANTHER),,
RL4_JR_04748,4069,4035,4485,0,2,7,0,0,0,0,2,0,1,6,1,0,6,0,9.901310673,1,-1.410121505,1.206476986,-1.16879271,0.242487158,0.417431998,3.183568925,0,1.794893186,1.295904887,1.385050094,0.16603715,0.299219602,8.226672301,1,-0.851378076,1.210186722,-0.703509682,0.481738175,0.617904128,9.487525961,1,-1.273279363,1.209608502,-1.052637578,0.292507128,0.437147507,8.084865902,1,-0.929121239,1.210077818,-0.767819413,0.44259448,0.576072645,N,-, Effector probability:0.892,stress responsive A B barrel domain-containing,,IPR013097 (SMART); IPR013097 (PFAM); G3DSA:3.30.70.900 (GENE3D); IPR013097 (PROSITE_PROFILES); IPR011008 (SUPERFAMILY),,
RL4_JR_04749,2384,2124,3444,0,1,0,0,0,0,0,0,2,0,0,0,0,5,1,126.4395123,1,-4.116170665,1.622347372,-2.537169742,0.011175275,0.041458798,40.76759958,0,-1.88381884,2.223220931,-0.847337668,0.396806936,0.560917524,103.5148811,1,-4.504679074,2.203558546,-2.04427474,0.040926413,0.097445674,140.8880856,0,-2.360529255,1.588849749,-1.48568438,0.137362624,0.248978978,129.7376996,1,-1.723346057,2.005777207,-0.859191166,0.390235056,0.526396209,N,-,,Fumarylacetoacetase,P:aromatic amino acid family metabolic process; F:fumarylacetoacetase activity,IPR015377 (PFAM); IPR011234 (G3DSA:3.90.850.GENE3D); IPR015377 (G3DSA:2.30.30.GENE3D); IPR011234 (PFAM); IPR005959 (TIGRFAM); IPR005959 (PTHR11820:PANTHER); PTHR11820 (PANTHER); PTHR11820 (PANTHER); IPR011234 (SUPERFAMILY); IPR015377 (SUPERFAMILY),,
RL4_JR_04750,159,171,206,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,9.579242221,0,0.316349743,1.188398795,0.266198304,0.79008649,0.89223776,1.852562123,0,2.576115284,1.375671144,1.872624352,0.061120276,0.138186159,4.772943236,0,-0.065644655,1.23441896,-0.053178586,0.957589617,0.975121084,13.52743152,1,1.219057424,1.062453647,1.14739822,0.251217076,0.390777831,4.663961441,0,-0.135317309,1.228245755,-0.1101712,0.912273602,0.943388651,N,-,,aminotransferase family,F:catalytic activity,IPR015421 (G3DSA:3.40.640.GENE3D); IPR000192 (PFAM); PTHR11601 (PANTHER); PTHR11601:SF32 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_04751,29,31,57,0,0,90,0,0,0,0,0,0,0,4,0,0,4,0,1.162845796,1,1.679968822,1.493338254,1.124975415,0.260599453,NA,0.366670342,0,4.912759441,1.657062482,2.96474001,0.003029388,0.015659284,0.959015403,0,2.24887511,1.272348113,1.767499859,0.077144553,0.158516633,5.118478005,1,2.769711042,1.194011288,2.31966906,0.020358787,0.077468176,0.953434119,1,2.155376334,1.261839057,1.708123015,0.087613519,0.172955134,Y,-,,alpha-N-,P:metabolic process; F:alpha-N-acetylglucosaminidase activity,IPR024733 (PFAM); IPR024732 (PFAM); IPR024240 (PFAM); PTHR12872:SF1 (PANTHER); IPR007781 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_04752,5951,7451,7719,8,0,25,7,0,1,2,0,0,3,4,7,0,5,0,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_04753,288,217,424,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.229018855,1,4.024405921,2.935580537,1.370906323,0.17040416,NA,0.073251728,0,7.237059887,2.345704553,3.085239306,0.002033884,0.015023052,0.188820956,0,4.595932517,1.494736307,3.074744687,0.002106828,0.010263947,0.217794699,0,4.172515666,1.928058082,2.164102681,0.03045647,0.093257059,0.184086674,0,4.529261669,1.364717764,3.318826638,0.000903965,0.00440167,N,-,,maltose permease,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR003663 (TIGRFAM); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500 (PANTHER); PTHR23500:SF162 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.11, the major facilitator superfamily (mfs).
RL4_JR_04754,9173,6773,7683,0,0,9,0,0,1,0,3,2,0,2,4,0,2,0,0.568099075,1,2.7132997,1.901643673,1.426818146,0.153632319,NA,0.180367192,1,5.936263709,1.87887165,3.159483358,0.001580491,0.015023052,0.470241088,1,3.276448066,1.298347791,2.523551923,0.01161759,0.036234283,31.84793517,1,5.899123286,0.71240345,8.280593375,1.23E-16,8.99E-15,15.19753732,1,4.890764239,1.012526485,4.830258085,1.36E-06,1.87E-05,N,-,,"Homogentisate 1,2-dioxygenase","P:L-phenylalanine catabolic process; P:tyrosine metabolic process; P:oxidation-reduction process; F:homogentisate 1,2-dioxygenase activity",IPR005708 (TIGRFAM); IPR014710 (G3DSA:2.60.120.GENE3D); IPR005708 (PFAM); IPR005708 (PANTHER); PTHR11056:SF0 (PANTHER); IPR011051 (SUPERFAMILY),,
RL4_JR_04755,4482,2162,2289,2,0,0,0,3,0,1,0,6,1,4,3,0,3,6,0.031881009,1,6.868464964,3.940092353,1.743224358,0.081294432,NA,0.010525003,1,10.03744526,3.395130433,2.956424048,0.003112289,0.015916638,0.026729924,1,7.416284522,2.018065453,3.674947466,0.000237898,0.001965084,0.030792401,1,6.99431031,3.814832404,1.83345153,0.06673545,0.146413095,0.025794429,1,7.353888809,1.456150082,5.050227238,4.41E-07,7.16E-06,N,-,,3-hydroxyphenylacetate 6-hydroxylase,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24281 (PANTHER); PTHR24281:SF5 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_04756,1044,850,1429,3,2,6,0,0,0,1,3,0,4,6,2,0,0,0,8.181742107,1,-1.13493853,1.196759374,-0.948343129,0.342954801,0.533020627,2.608546787,0,2.082229102,1.285115511,1.620266103,0.105175127,0.210475017,6.775787199,1,-0.571586949,1.199414074,-0.476555146,0.63367893,0.744383256,73.00286771,1,3.007738068,1.729386103,1.739194078,0.082000631,0.169116557,6.692130493,0,-0.656265023,1.204203441,-0.544978532,0.585768283,0.698492976,N,-,,c6 zinc finger domain-containing,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR031760 (PFAM); PTHR31001 (PANTHER),,
RL4_JR_04757,1927,2279,2176,0,0,4,0,0,0,0,0,0,0,0,4,0,0,0,2.127232879,1,0.808962259,1.540410712,0.52516011,0.599471893,0.768824351,0.67872949,0,4.024777328,1.678348731,2.398057837,0.016482262,0.049593776,1.751510031,0,1.380814024,1.36254486,1.013408119,0.310865263,0.452508975,2.020469275,1,0.958450699,1.416293297,0.676731791,0.498576142,0.636536217,1.708778973,0,1.313469078,1.35186506,0.97159777,0.331250692,0.4679903,N,-,,Phytanoyl- dioxygenase,F:dioxygenase activity; P:oxidation-reduction process,IPR008775 (PFAM); G3DSA:2.60.120.620 (GENE3D); PTHR31630 (PANTHER); PTHR31630:SF6 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_04758,370,253,580,0,0,0,0,0,0,1,0,2,0,3,0,0,0,0,1.902441111,0,0.970027694,1.392979126,0.696369153,0.486197676,NA,0.613608833,0,4.17033035,1.584697979,2.631624704,0.008497767,0.029773071,1.577414261,1,1.531930749,1.279250757,1.197521863,0.231103211,0.362405346,1.818875243,1,1.110132962,1.311979085,0.846151417,0.39746828,0.541637462,1.537476335,0,1.465663329,1.259508515,1.163678777,0.244554213,0.374386706,N,-,,NCS1 nucleoside transporter,P:transmembrane transport; C:membrane; C:integral component of membrane; P:transport; F:transporter activity,IPR001248 (PFAM); PTHR30618 (PANTHER); PTHR30618:SF1 (PANTHER),2.A.39.3.13, the nucleobase:cation symporter-1 (ncs1) family.
RL4_JR_04759,1083,1688,1425,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,17.48353721,1,-2.230158217,1.256900068,-1.774332164,0.076008223,0.181308505,5.558757904,0,0.990792671,1.308312631,0.757305744,0.44886671,0.609365456,14.41035265,0,-1.659968307,1.241235149,-1.337351998,0.181107765,0.302164637,16.62602946,0,-2.082478272,1.245505406,-1.671994568,0.094525393,0.187697511,14.15416816,0,-1.736890327,1.247267359,-1.392556547,0.163753931,0.276540644,N,-, Effector probability:0.552,glyoxalase-like domain-containing,,IPR004360 (PFAM); IPR029068 (G3DSA:3.10.180.GENE3D); IPR029068 (SUPERFAMILY),,
RL4_JR_04760,578,763,670,0,3,1,0,0,0,0,0,0,0,0,0,0,0,0,111.8656441,1,-4.907943802,1.229949764,-3.990361189,6.60E-05,0.000590138,36.05272108,0,-1.706496511,1.233069337,-1.383942054,0.166376198,0.299601473,92.79402639,0,-4.346955926,1.218179283,-3.568404081,0.000359162,0.002658011,128.6727425,0,-2.062126243,0.800768565,-2.575183809,0.010018683,0.048628554,102.1993351,0,-2.232808666,0.888018762,-2.514371047,0.01192449,0.03621496,N,-,,C6 transcription factor,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_04761,28972,22663,25137,15,35,35,0,1,11,15,35,34,27,107,4,0,32,18,177.7455476,1,-1.160133468,0.829474634,-1.398636462,0.161922027,0.312343503,42.37810635,1,-1.939708772,1.215739743,-1.59549672,0.110601203,0.219124168,109.3308922,1,-4.583553535,1.204863767,-3.804208956,0.000142258,0.001420706,126.0892709,1,-5.005467654,1.206800841,-4.147716412,3.36E-05,0.000413837,107.046497,1,-4.655877754,1.20254362,-3.871691369,0.000108083,0.000738918,N,-,,Zn(2)-C6 fungal-type DNA-binding domain partial,"F:DNA binding; C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR021858 (PFAM),,
RL4_JR_04762,2256,1597,1872,0,5,7,0,0,0,2,0,0,1,2,0,0,0,0,1.13055752,1,1.720939587,1.796160011,0.958121535,0.338001477,NA,0.359985289,0,4.939732835,1.864199264,2.649787998,0.008054229,0.028766729,0.929593772,1,2.294962503,1.422225138,1.613642201,0.106605058,0.203328863,1.072425643,1,1.872372289,1.530247583,1.22357474,0.221112694,0.35654818,0.906981536,0,2.227463887,1.393940609,1.59796183,0.110051472,0.205093163,N,-,,cytochrome p450,F:oxidoreductase activity; F:metal ion binding; C:membrane,IPR002403 (PRINTS); IPR001128 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305 (PANTHER); PTHR24305:SF69 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_04763,704,455,555,4,1,0,0,0,0,0,0,0,0,1,0,0,0,0,8.107058928,1,-1.121271331,1.196522662,-0.937108311,0.348702847,0.538772315,2.58933048,0,2.092983517,1.288748557,1.624043345,0.104366558,0.209229214,6.708125576,0,-0.556775061,1.198013014,-0.464748759,0.642111387,0.750830334,7.738251877,1,-0.979025735,1.195928885,-0.818632067,0.412996366,0.556580354,6.59860078,0,-0.635853091,1.196476566,-0.531437981,0.595115308,0.706063099,N,-,,RNA exonuclease,F:nucleic acid binding; P:nucleic acid phosphodiester bond hydrolysis; F:exonuclease activity,IPR013520 (SMART); IPR012337 (G3DSA:3.30.420.GENE3D); PTHR12801:SF65 (PANTHER); PTHR12801 (PANTHER); IPR012337 (SUPERFAMILY),,
RL4_JR_04764,9495,9134,7601,2,18,8,0,0,0,3,11,11,2,10,3,0,1,1,1.194400566,1,1.641633222,1.520742832,1.079494302,0.280367432,NA,0.383646063,0,4.847896556,1.69104586,2.866803717,0.004146401,0.018371529,0.988394049,1,2.206569672,1.292533085,1.707166878,0.08779104,0.175263719,1.139883311,1,1.784403225,1.350133145,1.321649818,0.186284786,0.314059523,16.40721139,1,4.695436016,0.845026222,5.556556585,2.75E-08,9.10E-07,N,-,,phytanoyl- dioxygenase family,F:dioxygenase activity; P:oxidation-reduction process,G3DSA:2.60.120.620 (GENE3D); IPR008775 (PFAM); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_04765,2387,1937,2940,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,7.474340395,1,-1.004199046,1.272057573,-0.789428928,0.429861354,0.621223902,2.422329574,0,2.189234019,1.390868741,1.57400476,0.115486349,0.226848986,6.212556139,0,-0.446051663,1.255855788,-0.355177455,0.722456653,0.812051866,11.17374335,0,0.075614929,1.208344791,0.062577279,0.950103123,0.970519988,17.62652545,0,1.652043069,0.932910975,1.7708475,0.076586065,0.155618178,N,-,,hexose transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; F:transmembrane transporter activity; C:membrane; C:integral component of membrane; P:transport; F:transporter activity,IPR003663 (PRINTS); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.127, the major facilitator superfamily (mfs).
RL4_JR_04766,2302,2320,2121,0,0,6,0,0,0,6,1,2,8,4,1,0,1,3,5.319636449,1,-0.513447377,1.303785333,-0.393812819,0.69371924,0.834221928,1.706490052,0,2.694607125,1.434249424,1.878757684,0.060277587,0.136586018,4.397272146,1,0.05262731,1.269094088,0.041468407,0.966922479,0.980579303,5.071472374,1,-0.369367586,1.279719401,-0.288631699,0.772863235,0.852608439,4.291707557,1,-0.015260422,1.266000642,-0.01205404,0.990382501,0.993424096,N,-,,Aromatic-ring hydroxylase partial,F:FAD binding; C:membrane; P:oxidation-reduction process; F:monooxygenase activity,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789:SF187 (PANTHER); PTHR13789 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_04767,69,57,51,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.548974253,0,0.070088828,1.287554365,0.054435626,0.956588095,0.978015059,1.120771304,0,3.300846922,1.42696084,2.313200776,0.020711603,0.059154302,2.932045391,0,0.636707643,1.248038468,0.510166681,0.609934692,0.726012006,3.383976625,0,0.213795835,1.259876374,0.169695884,0.865249311,0.916460443,2.918951823,0,0.540809849,1.257102674,0.430203404,0.667047686,0.763406558,N,-,,cytochrome P450,"P:small molecule metabolic process; P:mycelium development; F:iron ion binding; C:intracellular membrane-bounded organelle; P:secondary metabolite biosynthetic process; C:integral component of membrane; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; P:oxidation-reduction process; F:heme binding",IPR002401 (PRINTS); IPR023577 (SMART); IPR023577 (PFAM); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); IPR023577 (G3DSA:2.40.320.GENE3D); PTHR24279 (PANTHER); PTHR24279:SF52 (PANTHER); IPR033469 (SUPERFAMILY); IPR001128 (SUPERFAMILY),,
RL4_JR_04768,13,7,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.81069463,0,-0.103151963,1.164179887,-0.088604832,0.929395968,0.96586144,2.473510615,0,2.159027384,1.315982094,1.640620638,0.100876188,0.203887535,6.402655835,0,-0.489488235,1.214222274,-0.40312902,0.686853313,0.785019524,44.31486824,0,2.156243913,0.697137901,3.092994816,0.001981476,0.01313847,6.287354595,0,-0.56613531,1.212621618,-0.466868891,0.640593683,0.742191446,N,-,,tetracycline-efflux transporter,,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23507 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.11.4, the major facilitator superfamily (mfs).
RL4_JR_04769,15354,11106,11212,0,0,9,0,0,0,6,6,3,0,7,1,0,4,0,50.43338415,1,1.08287135,0.671953934,1.611526169,0.107065088,0.232792375,4.692345131,0,1.235266563,1.254891169,0.984361507,0.324937797,0.487117948,18.63490988,1,-0.450322557,1.194775532,-0.376909758,0.706240669,0.800669713,33.26897798,1,-0.089318333,1.016660896,-0.087854597,0.929992244,0.958388953,23.49879986,1,0.715592105,0.844901664,0.846953125,0.397021249,0.533905662,N,-,,ankyrin repeat,F:RNA binding,IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24123 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_04770,5983,8187,11132,0,0,1,0,0,0,0,0,0,0,8,0,0,0,0,228.0437025,1,11.92450234,0.791227941,15.07088124,2.52E-51,6.85E-48,0.017697022,0,9.285263723,3.003580217,3.091398615,0.00199216,0.015023052,44.3258584,0,9.782814042,1.649267303,5.931612192,3.00E-09,1.45E-07,0.052963156,1,6.211019435,3.027026005,2.051855327,0.040183724,0.107720469,0.045412029,0,6.542936755,1.372676591,4.766553752,1.87E-06,2.45E-05,N,-,,Pyoverdine dityrosine biosynthesis,F:oxidoreductase activity; P:oxidation-reduction process,IPR003819 (PFAM); G3DSA:3.60.130.10 (GENE3D); IPR007817 (PFAM); PTHR37285 (PANTHER); PTHR37285:SF2 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_04771,4123,4381,2835,3,5,0,0,0,0,0,2,6,3,7,1,0,11,0,25.55035921,1,3.62918352,0.862476585,4.207863246,2.58E-05,0.000261255,9.862836194,0,5.427077596,1.146024588,4.735568202,2.18E-06,0.000176886,1.256228096,1,1.860200105,1.233328793,1.508275908,0.131483927,0.237822589,1.44928421,1,1.437696546,1.25814801,1.142708595,0.2531596,0.393014558,1.236993333,1,1.779790878,1.218764261,1.460324146,0.144201009,0.251556722,N,-,,O-,F:methyltransferase activity,PF13578 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10509 (PANTHER); PTHR10509:SF10 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_04772,101,106,85,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,23.03336406,1,8.077315281,0.860550124,9.386222905,6.22E-21,8.90E-19,0.039064166,0,8.143030251,2.609834107,3.120133279,0.001807692,0.015023052,13.09897642,0,7.289358957,1.107970084,6.579021457,4.74E-11,2.94E-09,0.117093491,0,5.066442094,2.305035358,2.197988884,0.027949898,0.088851717,0.100570014,0,5.397784572,1.363553046,3.958617222,7.54E-05,0.000549117,Y,-,,hypothetical protein FOVG_19866,P:biological_process; C:cellular_component; F:molecular_function,PTHR33339 (PANTHER); PTHR33339:SF1 (PANTHER),,
RL4_JR_04773,87,74,89,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0.057163849,0,6.026917829,3.925398306,1.535364658,0.12469428,NA,0.017724148,0,9.283253919,3.925961694,2.36458087,0.018050486,0.053079354,0.046648011,0,6.611531982,2.396598802,2.758714549,0.00580292,0.021216598,0.053876058,1,6.187117566,3.925643917,1.576077122,0.115008031,0.217219867,0.046461567,0,6.518083574,1.719256984,3.791221227,0.000149908,0.000973587,,,,,,,,
RL4_JR_04774,2090,2050,2319,0,2,2,0,0,0,0,0,3,1,1,3,0,7,0,0.162973563,1,4.514788853,3.252131224,1.388255437,0.165059277,NA,0.051773628,0,7.736766616,2.392639206,3.233570108,0.001222533,0.015023052,0.134910652,1,5.077323237,1.417192838,3.582662219,0.00034011,0.002569456,0.155666606,1,4.655862366,1.979833155,2.351643802,0.018690664,0.0743863,0.133770916,1,4.988246316,1.284405969,3.883699109,0.000102879,0.000709964,N,-,,hypothetical protein CMQ_7227,,IPR025676 (PFAM),,
RL4_JR_04775,1374,528,1208,0,0,0,0,0,0,0,0,1,0,0,0,0,4,0,0.07382811,0,5.657824108,3.921199932,1.442880803,0.149054052,NA,0.023416252,0,8.882625675,2.9003261,3.062629983,0.002194012,0.015045494,0.060654228,1,6.235420048,1.726970931,3.610610888,0.000305477,0.002353612,0.069985571,0,5.810408735,2.791885443,2.081177346,0.037417676,0.102865591,0.059394414,1,6.164701453,1.416010187,4.353571401,1.34E-05,0.00012877,N,-,,qde-2-interacting,F:nucleic acid binding; P:nucleic acid phosphodiester bond hydrolysis; F:exonuclease activity,IPR012337 (G3DSA:3.30.420.GENE3D); IPR012337 (SUPERFAMILY),,
RL4_JR_04776,218875,159217,147382,2,8,9,0,4,0,7,161,256,13,0,63,0,185,49,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,hypothetical protein SPI_07275,P:cellular oxidant detoxification; P:oxidation-reduction process; F:peroxiredoxin activity,IPR029032 (G3DSA:1.20.1290.GENE3D); PTHR28180 (PANTHER); IPR029032 (SUPERFAMILY),,
RL4_JR_04777,1761,1803,1493,9,4,1,0,0,0,4,1,0,3,15,0,0,7,1,0.562860717,1,2.726755432,1.886656564,1.44528447,0.148377998,NA,0.181592421,0,5.926888545,1.882348171,3.148667519,0.001640167,0.015023052,0.467971104,1,3.284669043,1.290720163,2.544834377,0.010932958,0.03513818,0.53961452,1,2.862861094,1.415827725,2.022040566,0.043172161,0.113125811,0.458395589,1,3.210570793,1.240430628,2.588271138,0.009645902,0.030491651,N,-,,short chain dehydrogenase reductase family,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); PTHR24321 (PANTHER); PTHR24321:SF6 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04778,2727,2038,2269,0,1,5,0,0,0,0,0,0,2,3,5,0,3,0,2.254806943,1,0.724614166,1.258606812,0.575727192,0.564799593,0.741611955,0.724737176,0,3.930065198,1.475291981,2.66392365,0.007723509,0.027910517,1.871630126,0,1.284798121,1.222617883,1.050858276,0.293323686,0.43383623,2.158495685,1,0.862854851,1.233479873,0.699528927,0.484221542,0.624473712,13.41837041,1,3.408688437,0.855116069,3.986228957,6.71E-05,0.00049832,N,-,,hypothetical protein SPI_07277,,IPR010839 (PFAM); PTHR13943 (PANTHER); PTHR13943:SF46 (PANTHER),,
RL4_JR_04779,1360,1670,1591,0,0,16,0,0,1,0,9,0,1,9,0,0,0,0,0.609494419,1,2.61201713,1.791788074,1.457771244,0.144903607,NA,0.194486965,1,5.827802261,1.82866612,3.186914329,0.001437994,0.015023052,0.504317332,1,3.176774103,1.262686678,2.515884707,0.011873402,0.036895739,0.581786765,1,2.754336752,1.363855663,2.019522172,0.043432975,0.113446415,0.496690688,0,3.096197628,1.224235325,2.529086986,0.011435968,0.034981624,N,-,,hypothetical protein SPI_07277,,IPR010839 (PFAM),,
RL4_JR_04780,9302,9362,11264,0,9,18,0,0,0,3,0,6,4,3,6,0,0,1,397.2670643,1,5.066029561,2.309686793,2.193383785,0.02827974,0.086471557,3.706796385,0,1.575366722,1.256524892,1.253748917,0.209933282,0.355758359,29.09977577,1,1.329938423,0.84712361,1.569946117,0.116427647,0.217234335,200.5190487,1,4.047525082,0.305068108,13.2676113,3.57E-40,1.00E-37,101.7511082,1,3.640351353,0.683248732,5.328003086,9.93E-08,2.22E-06,Y,-,,glucose and galactose transporter,C:membrane,IPR021833 (PFAM); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23514:SF3 (PANTHER); PTHR23514 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.7.13, the major facilitator superfamily (mfs).
RL4_JR_04781,5883,6975,13251,0,5,6,0,0,3,0,1,3,1,1,3,0,7,1,8.172007516,1,5.477530299,1.244269844,4.402204493,1.07E-05,0.000123124,0.051087169,1,7.755619011,2.452736144,3.162027449,0.001566748,0.015023052,0.133908967,1,5.087222478,1.494185245,3.404679905,0.000662417,0.004144811,0.154555735,1,4.665881202,2.07403528,2.249663372,0.024470322,0.084618174,0.133748888,1,4.988458015,1.348066724,3.700453342,0.000215215,0.001326262,N,-,,peroxisomal dehydratase,,IPR029069 (G3DSA:3.10.129.GENE3D); IPR029069 (G3DSA:3.10.129.GENE3D); IPR029045 (G3DSA:3.90.226.GENE3D); IPR002539 (PFAM); IPR001753 (PFAM); PTHR11941 (PANTHER); PTHR11941:SF68 (PANTHER); IPR029069 (SUPERFAMILY); IPR029069 (SUPERFAMILY); IPR029045 (SUPERFAMILY),,
RL4_JR_04782,2369,1690,1517,0,0,4,0,0,0,0,1,1,2,3,0,0,3,0,0.067841691,1,5.779171201,3.922464066,1.473352236,0.140656082,NA,0.021380707,0,9.012249278,2.845302431,3.167413481,0.001538015,0.015023052,0.055956954,1,6.346731082,1.616137172,3.927099253,8.60E-05,0.001062624,0.064586787,1,5.925026861,2.75177054,2.153168942,0.031305404,0.094723687,0.055682755,1,6.25527072,1.337195735,4.677902087,2.90E-06,3.57E-05,N,-,,AMP-binding enzyme,P:metabolic process; F:ligase activity,G3DSA:2.30.38.10 (GENE3D); IPR025110 (PFAM); G3DSA:3.40.50.980 (GENE3D); IPR000873 (PFAM); G3DSA:3.40.50.980 (GENE3D); G3DSA:3.30.300.30 (GENE3D); PTHR24096 (PANTHER); PTHR24096:SF210 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.7, the fatty acid transporter (fat) family.
RL4_JR_04783,2544,2963,2710,0,1,13,0,0,0,0,0,2,1,1,0,0,3,0,0.500312558,1,2.896756108,1.959607862,1.478232541,0.139345547,NA,0.159887603,0,6.11041183,1.899708582,3.216499566,0.001297647,0.015023052,0.414360893,1,3.460053503,1.27339937,2.717178589,0.006584107,0.023405021,0.4779839,1,3.037783268,1.408685917,2.156465988,0.031047297,0.094217518,0.408009165,1,3.379602603,1.226853386,2.754691507,0.00587475,0.020440495,N,-,,4-coumarate- ligase,F:catalytic activity; P:metabolic process; F:ligase activity,G3DSA:3.30.70.900 (GENE3D); IPR007138 (PFAM); PTHR40624 (PANTHER); IPR007138 (PROSITE_PROFILES); IPR007138 (PROSITE_PROFILES); IPR011008 (SUPERFAMILY); IPR011008 (SUPERFAMILY),,
RL4_JR_04784,213697,145193,180632,26,52,30,0,2,8,3,4,27,10,39,2,3,27,11,42.59739532,1,0.761285472,0.766436662,0.993279041,0.320573989,0.509099202,4.730080944,1,1.223642007,1.271205897,0.962583646,0.335756508,0.498758712,12.24778884,1,-1.425545749,1.209915573,-1.178219192,0.238709233,0.371562422,14.12648626,1,-1.847599887,1.209645403,-1.527389665,0.126664145,0.233922296,12.06565623,1,-1.506683471,1.213751579,-1.24134419,0.214478627,0.339205888,N,-,,glyoxylate reductase,"F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:NAD binding; P:oxidation-reduction process",IPR016040 (G3DSA:3.40.50.GENE3D); IPR006140 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10996 (PANTHER); PTHR10996:SF152 (PANTHER); IPR016040 (SUPERFAMILY); SSF52283 (SUPERFAMILY),,
RL4_JR_04785,90,74,73,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.909857634,0,6.287884845,1.265864551,4.967265132,6.79E-07,1.09E-05,0.02956207,0,8.545855051,2.696944764,3.168717123,0.001531133,0.015023052,0.076100585,0,5.904477053,1.554601889,3.798063733,0.000145831,0.001448863,0.08773917,0,5.483272062,2.466761129,2.222863007,0.026225039,0.086316686,0.074546243,0,5.827912366,1.320132519,4.414641926,1.01E-05,0.000101629,N,-,,Taurine catabolism dioxygenase,,IPR003819 (PFAM); G3DSA:3.60.130.10 (GENE3D); PTHR30468 (PANTHER); PTHR30468:SF15 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_04786,4109,3444,4087,0,0,1,0,0,0,0,0,0,0,0,3,0,0,0,0.003906015,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,0,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,N,-,,MFS general substrate transporter,C:membrane,G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF256 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.38, the major facilitator superfamily (mfs).
RL4_JR_04787,1659,2156,1755,1,0,0,0,0,0,0,0,0,1,0,2,0,8,0,0.004235441,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001340044,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003452355,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003983613,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003339785,1,10.24113992,1.835951848,5.578109216,2.43E-08,8.07E-07,N,-,,MFS general substrate transporter,C:membrane,G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF256 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.38, the major facilitator superfamily (mfs).
RL4_JR_04788,3870,3707,4423,2,0,18,0,0,0,0,5,1,0,6,1,0,4,0,7.664753354,1,8.7365142,1.269722441,6.880648807,5.96E-12,2.66E-10,0.009184959,0,10.23380518,3.539552713,2.891270736,0.003836874,0.017677215,0.02327757,1,7.614533777,2.14554248,3.549001638,0.000386695,0.0028185,4.038396929,1,8.135735723,1.366982165,5.951603418,2.66E-09,8.20E-08,0.022454644,1,7.550675179,1.512512957,4.992139171,5.97E-07,9.23E-06,N,-,,Major facilitator superfamily general substrate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR010291 (PFAM); PTHR23294 (PANTHER); PTHR23294:SF24 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.58.5, the major facilitator superfamily (mfs).
RL4_JR_04789,1786,1870,2982,0,0,10,0,0,0,0,1,0,0,2,0,0,1,0,1224.457022,1,2.54292634,0.968389572,2.625933213,0.008641177,0.033706942,96.02241472,0,0.06728225,0.95275406,0.070618697,0.94370123,0.969701824,149.3703733,1,-5.033759328,1.283630467,-3.921501911,8.80E-05,0.001074667,180.1455077,1,-3.783147268,1.152779775,-3.281760619,0.001031611,0.007590891,145.0617732,1,-5.094310883,1.292899469,-3.940221961,8.14E-05,0.000584566,N,-,,mfs sp sugar:h+ symporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR003663 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); IPR003663 (TIGRFAM); PTHR23500:SF131 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); PS51257 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.58, the major facilitator superfamily (mfs).
RL4_JR_04790,6913,5771,5648,3,2,2,0,0,0,0,0,0,0,4,0,0,0,3,0.079762605,1,5.546735819,3.920131968,1.414935993,0.157087264,NA,0.025115349,0,8.781363554,3.92033129,2.239954459,0.02509388,0.068704422,0.065033085,0,6.133529048,2.537813137,2.416856055,0.015655207,0.046020126,0.075057146,1,5.709281908,3.920330252,1.456326774,0.145302308,0.259880916,0.063357445,1,6.068884322,2.019770365,3.004739759,0.002658082,0.010778165,N,-,,sugar transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:membrane; P:hexose transport,IPR003663 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR23500 (PANTHER); PTHR23500:SF107 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.73, the major facilitator superfamily (mfs).
RL4_JR_04791,8636,7917,7590,2,8,6,1,0,0,1,6,5,3,6,5,0,8,0,0.003906015,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,1,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,1,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,N,-,,General substrate transporter,F:transmembrane transporter activity; C:membrane; P:transport,IPR005828 (PFAM); PTHR23500 (PANTHER); PTHR23500:SF68 (PANTHER),2.A.1.1.73, the major facilitator superfamily (mfs).
RL4_JR_04792,288156,107812,82258,114,171,34,12,11,28,55,185,383,60,55,197,3,182,225,3.779138859,1,-0.020148481,1.369947301,-0.014707486,0.988265547,0.994237308,1.209146415,1,3.191662676,1.514674404,2.107160898,0.035103635,0.089388426,3.118340456,1,0.548512153,1.300190472,0.421870614,0.67311946,0.775186147,3.596813863,1,0.126352414,1.322002316,0.095576545,0.923856894,0.954982241,3.043665955,1,0.480531284,1.29622932,0.370714716,0.710850028,0.795727644,N,-,,Zn2 Cys6 DNA-binding,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_04793,6650,3517,3908,2,0,9,0,0,0,0,6,1,0,5,1,0,0,4,0.031803125,1,6.871871057,3.940170792,1.744054108,0.081149655,NA,0.010020331,0,10.10490469,3.293119274,3.068490342,0.002151433,0.015045494,0.0262523,1,7.43732106,1.888462672,3.93829392,8.21E-05,0.001030777,0.030301587,1,7.016598036,3.711718412,1.890390719,0.058705724,0.135146692,0.026171485,1,7.344178998,1.407152264,5.219178609,1.80E-07,3.71E-06,N,-,,cyanide hydratase,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; P:nitrogen compound metabolic process; F:hydrolase activity",IPR003010 (PFAM); IPR003010 (G3DSA:3.60.110.GENE3D); PTHR23088:SF2 (PANTHER); PTHR23088 (PANTHER); IPR003010 (PROSITE_PROFILES); IPR003010 (SUPERFAMILY),,
RL4_JR_04794,2193,1616,1609,0,0,5,0,0,0,0,0,0,0,1,0,0,0,0,53.64999228,1,8.429532695,0.930190656,9.062155847,1.28E-19,1.61E-17,0.060617618,0,7.509281915,2.334894722,3.216111564,0.001299403,0.015023052,0.157748188,0,4.851633681,1.412018923,3.435955143,0.000590469,0.003819748,12.21676046,1,6.706090801,0.919455152,7.293548561,3.02E-13,1.53E-11,19.45898042,0,7.644889478,0.775855114,9.853501437,6.62E-23,1.97E-20,N,-,,hypothetical protein F503_00329,C:integral component of membrane,no IPS match,,
RL4_JR_04795,6948,6121,8968,0,0,4,0,0,0,0,1,0,0,7,0,0,2,0,0.035050287,1,6.730617169,3.937067155,1.70955102,0.08734893,NA,0.011346813,0,9.926345839,3.936701811,2.521487864,0.011685971,0.037851326,0.029339802,1,7.277686007,2.507465381,2.902407372,0.003703067,0.015732205,0.033828749,1,6.857454783,3.936767031,1.741900074,0.081525931,0.168390463,0.028986501,1,7.188313632,1.598023481,4.49825282,6.85E-06,7.33E-05,,,,,,,,
RL4_JR_04796,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,56.18073668,0,-0.578436402,0.738416482,-0.783347089,0.433423318,0.623939902,11.70213085,0,-0.083183965,1.206244917,-0.06896109,0.945020591,0.97033501,63.58674941,0,-0.319745761,0.845028357,-0.378384652,0.705144868,0.799696051,62.3385893,0,-0.426101012,0.735861512,-0.579050549,0.562555066,0.690324814,111.3344597,0,1.481250851,0.5659297,2.617376063,0.008860866,0.028508506,N,-,,PLC-like phosphodiesterase,F:phosphatidylinositol phospholipase C activity; P:lipid catabolic process; F:signal transducer activity; C:intracellular; P:intracellular signal transduction,IPR001192 (PRINTS); IPR000909 (SMART); IPR001711 (SMART); IPR017946 (G3DSA:3.20.20.GENE3D); IPR001711 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR000909 (PFAM); IPR001192 (PANTHER); PTHR10336:SF93 (PANTHER); IPR000909 (PROSITE_PROFILES); IPR001711 (PROSITE_PROFILES); IPR000008 (SUPERFAMILY); IPR017946 (SUPERFAMILY),,
RL4_JR_04797,6020,4465,4799,4,0,1,0,0,0,0,0,2,1,1,8,0,0,0,92.79057669,1,-0.822381837,0.767447257,-1.071580919,0.283908308,0.467054643,18.19822999,0,-0.720233007,1.243041299,-0.579411969,0.56231123,0.70542458,53.76318269,1,-2.4119324,1.223472667,-1.971382333,0.04868016,0.110899627,54.52243925,1,-3.795987081,1.228894025,-3.088945836,0.002008681,0.013270842,80.06396903,0,-0.465729911,0.753431953,-0.618144624,0.536480009,0.659661805,N,-,,fluconazole resistance 1,,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); PTHR23502:SF1 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.86, the major facilitator superfamily (mfs).
RL4_JR_04798,13534,5600,5961,0,0,2,0,0,0,0,0,0,0,3,1,0,4,2,34.42552464,1,-3.207791163,1.223864544,-2.621034474,0.00876634,0.034038933,10.92169143,0,0.016331855,1.242833905,0.013140819,0.989515445,0.994526396,50.63237309,0,-0.80032434,1.05820823,-0.756301376,0.449468523,0.588755998,32.87787438,1,-3.066285406,1.22024656,-2.512840852,0.011976335,0.05598356,35.65704639,1,-1.794771211,1.158665431,-1.54899867,0.12138204,0.221240892,N,-,,hypothetical protein PFICI_06053,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR007219 (PFAM); PTHR31001 (PANTHER); PTHR31001:SF59 (PANTHER); PTHR31001:SF59 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04799,13092,10257,11200,7,3,2,0,2,0,0,5,4,0,2,1,0,0,6,21.8556752,1,-1.330946782,1.192798761,-1.115818381,0.264499884,0.444355448,5.701020135,1,0.954203121,1.281034842,0.744868984,0.456350927,0.615809103,14.91083808,1,-1.709412576,1.230338923,-1.389383482,0.164716171,0.281487138,26.8438503,1,-1.17790582,1.184687173,-0.994275828,0.3200886,0.46624904,14.84501585,1,-1.805689114,1.24632411,-1.448811829,0.147390139,0.255754098,N,-, Effector probability:0.551,glutamine amidotransferase,P:small molecule metabolic process; F:catalytic activity; P:organic substance biosynthetic process; P:organonitrogen compound metabolic process; P:single-organism cellular process; P:cellular biosynthetic process,IPR029062 (G3DSA:3.40.50.GENE3D); IPR002161 (PIRSF); IPR002161 (PFAM); IPR002161 (TIGRFAM); PTHR31559 (PANTHER); IPR002161 (PTHR31559:PANTHER); IPR002161 (PROSITE_PROFILES); IPR002161 (HAMAP); IPR029062 (SUPERFAMILY),,
RL4_JR_04800,1046,836,1169,0,0,3,0,0,0,0,0,2,6,2,0,0,0,0,563.9381431,1,-1.794990168,0.426988602,-4.20383626,2.62E-05,0.00026529,138.242343,0,-3.645547613,1.198937169,-3.040649426,0.002360685,0.015209965,360.0600191,1,-6.303108209,1.20393028,-5.235442877,1.65E-07,5.46E-06,455.429171,1,-3.405898367,0.643514805,-5.292649587,1.21E-07,2.66E-06,368.2137988,0,-4.212918126,0.895284812,-4.705673625,2.53E-06,3.18E-05,N,-,,pyridoxine biosynthesis pyroA,P:pyridoxal phosphate biosynthetic process; F:catalytic activity; P:vitamin B6 biosynthetic process,IPR013785 (G3DSA:3.20.20.GENE3D); IPR001852 (PIRSF); IPR033755 (PFAM); IPR001852 (TIGRFAM); PTHR31829 (PANTHER); IPR001852 (PROSITE_PROFILES); IPR001852 (HAMAP); IPR011060 (SUPERFAMILY),,
RL4_JR_04801,1656,2059,1884,1,0,8,0,0,0,0,0,5,1,4,0,0,0,1,0.388290844,1,3.262443921,2.206828993,1.478340158,0.139316754,NA,0.124470953,0,6.47173229,2.001645963,3.233205278,0.001224096,0.015023052,0.321916193,1,3.824477812,1.295410123,2.952329724,0.00315386,0.014041194,0.371296836,1,3.402240538,1.492206872,2.280005944,0.022607336,0.080997621,0.316310492,1,3.746492476,1.233410766,3.037505898,0.002385447,0.009834143,,,,,,,,
RL4_JR_04802,4796,3449,3180,0,0,0,0,0,0,0,0,1,0,0,0,0,3,0,43.0825664,0,2.541684259,0.631092829,4.027433276,5.64E-05,0.000519799,2.766147815,0,1.997544947,1.29279667,1.545134664,0.122313694,0.237106122,7.209030707,1,-0.661023189,1.211257794,-0.545732867,0.585249576,0.706264822,27.58899553,0,0.670348358,1.030842192,0.65029193,0.515503669,0.650297773,14.86716584,1,0.906444299,1.008922311,0.898428243,0.368957285,0.505096337,N,-,,actin-binding,F:actin binding,IPR007122 (PRINTS); IPR007122 (SMART); IPR029006 (G3DSA:3.40.20.GENE3D); IPR029006 (G3DSA:3.40.20.GENE3D); IPR007123 (PFAM); IPR029006 (G3DSA:3.40.20.GENE3D); IPR007122 (PANTHER); SSF55753 (SUPERFAMILY); SSF55753 (SUPERFAMILY); SSF55753 (SUPERFAMILY),,
RL4_JR_04803,2966,2041,4035,0,0,12,0,0,0,0,0,1,2,0,0,0,0,2,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_04804,1136,871,809,9,10,33,0,0,2,1,2,2,1,9,0,0,17,1,0.024043018,1,7.275864843,3.950905398,1.841568985,0.065538221,NA,0.007685733,1,10.48932229,3.438867284,3.050225969,0.002286692,0.015101794,0.019909242,1,7.839781561,1.975830508,3.967841133,7.25E-05,0.000937752,0.02296587,1,7.41710638,3.950905352,1.877318163,0.0604745,0.137403188,0.01959039,1,7.76041061,1.430427943,5.425237004,5.79E-08,1.50E-06,N,-,,hypothetical protein OIDMADRAFT_46844,,no IPS match,,
RL4_JR_04805,12159,8292,7999,0,1,11,0,0,0,0,6,2,0,10,1,0,6,2,651.0306408,1,-0.463708823,0.605015147,-0.766441676,0.443413543,0.632406938,119.5465587,0,-3.435903354,1.215562512,-2.826595359,0.004704573,0.019858087,344.7031872,1,-3.243797712,0.771537439,-4.204329628,2.62E-05,0.0004208,420.7804757,1,-2.33409004,0.531589038,-4.390779106,1.13E-05,0.000156439,340.2094735,1,-2.395439368,0.689914412,-3.472081939,0.000516439,0.002779873,N,-,,general substrate transporter,C:integral component of membrane; P:transport; F:transporter activity,G3DSA:1.20.1250.20 (GENE3D); IPR000109 (PFAM); IPR000109 (PANTHER); PTHR11654:SF118 (PANTHER); IPR020846 (SUPERFAMILY),2.A.17.2.4, the proton-dependent oligopeptide transporter (pot/ptr) family.
RL4_JR_04806,460,553,528,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5.041187694,1,-0.436312588,1.200262444,-0.363514321,0.716220717,0.847992575,1.610523689,0,2.777971346,1.33302122,2.083966335,0.03716323,0.093643567,4.177276421,0,0.126250673,1.202017591,0.1050323,0.916350179,0.949941553,4.818771647,0,-0.296031692,1.200868516,-0.246514659,0.805283858,0.875495903,4.119085239,0,0.04383336,1.202350375,0.036456395,0.970918448,0.98031006,N,-,,uncharacterized protein FFUJ_10965,F:arylformamidase activity; P:tryptophan catabolic process to kynurenine,G3DSA:3.50.30.50 (GENE3D); IPR007325 (PFAM); PTHR34861 (PANTHER); PTHR34861:SF5 (PANTHER); SSF102198 (SUPERFAMILY),,
RL4_JR_04807,254,238,269,2,0,3,0,0,0,3,0,0,0,0,0,0,0,0,3.827253631,1,-0.038907083,1.277020161,-0.030467086,0.975694542,0.987675955,1.227067332,0,3.170251259,1.43131473,2.214922542,0.026765382,0.072290358,3.180586801,1,0.519447272,1.24906346,0.4158694,0.677505572,0.778352612,3.668540735,0,0.097391434,1.259431805,0.07732966,0.938361296,0.963869266,3.138952366,0,0.435774446,1.250617563,0.348447406,0.727504206,0.808490387,N,-,,N-terminal domain,,IPR000073 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR22946:SF0 (PANTHER); PTHR22946 (PANTHER); PTHR22946 (PANTHER); PTHR22946:SF0 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_04808,208,306,338,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,0.240782321,0,3.951613334,2.819219204,1.401669416,0.161013988,NA,0.076465404,0,7.174069912,2.270938311,3.159077407,0.001582694,0.015023052,0.199614898,0,4.511855617,1.431752904,3.151280926,0.001625561,0.008413689,0.230332611,1,4.090379164,1.829696424,2.235550723,0.025381216,0.085851084,0.198576383,1,4.417828558,1.328761721,3.324771091,0.000884912,0.004332558,N,-,,Nitrosoguanidine resistance SNG1,C:membrane; C:integral component of membrane,IPR022703 (PFAM); PTHR34814 (PANTHER); PTHR34814:SF1 (PANTHER),9.B.316.1.3,The Nitrosoguanidine Resistance or DUF3533 (NGR) Family
RL4_JR_04809,510,555,458,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,37.92686715,0,-0.285926621,0.926757361,-0.308523712,0.75768386,0.872595179,7.220323127,0,0.613474659,1.299738083,0.471998679,0.636927731,0.762802771,25.07496263,0,-1.064619862,1.234955696,-0.8620713,0.388648283,0.532468345,56.73331539,0,0.840729587,0.714704155,1.176332306,0.239462111,0.377479974,37.13339234,1,0.493636419,0.828386502,0.59590109,0.551241305,0.671477167,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23502:SF25 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.86, the major facilitator superfamily (mfs).
RL4_JR_04810,1482,1183,1599,0,0,10,0,0,1,0,0,0,0,0,0,0,1,2,14.17015322,1,0.230210386,1.194887052,0.192662884,0.847222993,0.923399489,1.951913555,1,2.500494531,1.365938373,1.830605671,0.067159421,0.148672693,5.098050914,0,-0.161214798,1.243034348,-0.129694564,0.896808083,0.935912281,5.883049259,0,-0.583973797,1.248711018,-0.467661284,0.640026832,0.753278265,5.069654481,1,-0.255686747,1.255282202,-0.203688658,0.838596806,0.891047609,N,-,,MFS transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502:SF51 (PANTHER); PTHR23502 (PANTHER); PTHR23502:SF51 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.31, the major facilitator superfamily (mfs).
RL4_JR_04811,18215,11269,16778,5,11,34,0,1,0,6,3,7,1,4,0,0,1,2,22.1941204,1,-2.574561289,1.192336096,-2.15925803,0.030830154,0.092501802,7.084747788,1,0.640772478,1.230793519,0.520617364,0.60263335,0.736840531,18.39128972,1,-2.012054233,1.19561171,-1.682865947,0.092401045,0.182536207,21.21637705,1,-2.434384516,1.194384535,-2.038191591,0.041530776,0.11033826,25.52103083,1,-1.160422711,1.129249835,-1.027604942,0.304135699,0.439345691,N,-,,hypothetical protein CMQ_7124,,no IPS match,,
RL4_JR_04812,17960,12902,10584,8,0,10,1,3,0,0,2,5,6,9,0,0,5,3,2.786581314,1,0.419032364,1.697563387,0.246843427,0.8050294,0.901630269,0.909840364,1,3.601821068,1.813864049,1.985717215,0.047064732,0.112408972,2.336857111,1,0.964305146,1.489623407,0.647348277,0.517406563,0.648003014,2.693395996,1,0.543295443,1.562531266,0.347702126,0.7280639,0.818889912,2.290472008,1,0.890419939,1.4987671,0.594101604,0.552444158,0.672295324,N,-,,voltage-gated K+ channel beta subunit,,IPR005399 (PRINTS); IPR023210 (G3DSA:3.20.20.GENE3D); IPR023210 (PFAM); IPR001395 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.3, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_04813,2420,1900,2198,0,0,9,0,0,0,0,1,1,0,7,0,0,7,0,275.0535527,1,-2.66917647,0.879036285,-3.036480421,0.002393577,0.012105888,86.80841828,0,-1.901292403,1.243408072,-1.529097683,0.12624023,0.242298709,205.3285172,1,-4.484605686,1.315759991,-3.408376693,0.000653506,0.004109376,237.2005189,1,-4.212912998,1.201025976,-3.507761765,0.000451894,0.00385461,194.6216727,1,-5.518311475,1.343288027,-4.108062725,3.99E-05,0.00032011,N,-,,folylpolyglutamate synthase,P:folic acid-containing compound biosynthetic process; C:membrane; F:ligase activity,IPR001645 (TIGRFAM); IPR013221 (PFAM); IPR023600 (PIRSF); IPR004101 (G3DSA:3.90.190.GENE3D); IPR013221 (G3DSA:3.40.1190.GENE3D); PTHR11136:SF4 (PANTHER); IPR001645 (PANTHER); IPR004101 (SUPERFAMILY); IPR013221 (SUPERFAMILY),,
RL4_JR_04814,2046,2705,1803,0,4,0,0,0,0,0,0,2,1,0,0,0,2,1,2.877272187,1,0.372691635,1.24746553,0.298759064,0.765123887,0.877161421,0.920653663,0,3.584751218,1.43136711,2.504424751,0.012265069,0.039349296,2.387074351,1,0.933447741,1.223348551,0.763026809,0.445447408,0.584841078,2.753490857,1,0.511297464,1.231238885,0.415270725,0.67794373,0.780375201,2.354392688,1,0.850680053,1.220087154,0.697228924,0.485659541,0.614048807,N,-, Effector probability:0.671,structural toxin,,G3DSA:3.30.70.830 (GENE3D); PTHR41774 (PANTHER); PTHR41774:SF1 (PANTHER); IPR002678 (SUPERFAMILY),,
RL4_JR_04815,24725,9614,7786,5,0,0,0,0,0,1,0,0,6,6,0,0,14,10,7.640987839,1,11.20809083,2.995014191,3.742249658,0.00018238,0.001420856,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,1,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,duf895 domain membrane,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR010291 (PFAM); PTHR23294 (PANTHER); PTHR23294:SF19 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.58.5, the major facilitator superfamily (mfs).
RL4_JR_04816,3530,3203,3380,11,1,9,0,0,0,0,0,3,0,0,0,0,0,2,7.691636224,1,7.686122111,1.439702147,5.338689065,9.36E-08,1.85E-06,0.01768798,0,9.286131824,3.92599993,2.365290879,0.018015915,0.05304162,0.045675072,1,6.639812262,2.392218107,2.775588164,0.005510196,0.020352142,0.052658855,0,6.219354289,3.926069462,1.584117232,0.113167044,0.214652738,0.045062182,1,6.554453122,1.694032949,3.869141463,0.000109219,0.000744677,N,-,,Taurine catabolism dioxygenase,F:oxidoreductase activity,IPR003819 (PFAM); G3DSA:3.60.130.10 (GENE3D); PTHR10696 (PANTHER); PTHR10696:SF21 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_04817,6834,9078,8802,0,3,2,2,0,0,0,0,0,0,4,6,0,2,0,14.7771211,1,0.089663488,1.147202353,0.078158389,0.937702061,0.969307326,2.155811827,1,2.357301573,1.302580732,1.809716292,0.070339795,0.154348827,5.594932494,0,-0.295052206,1.200294407,-0.24581653,0.805824261,0.872904431,6.454808193,1,-0.717461929,1.198666264,-0.598550197,0.549472876,0.678796104,5.514038315,1,-0.376765702,1.20124576,-0.313645812,0.753790061,0.828318251,N,-, Effector probability:0.607,transmembrane 14,C:mitochondrion; C:integral component of membrane; C:endoplasmic reticulum,IPR005349 (PFAM); IPR005349 (PANTHER),2.A.126.1.8, the fatty acid exporter (fax) family.
RL4_JR_04818,27256,27949,40131,0,9,33,0,0,4,2,3,0,9,14,0,0,21,0,0.109129939,1,5.093613128,3.916533483,1.300541193,0.193415547,NA,37.54851363,1,10.87140642,0.877297053,12.39193314,2.89E-35,5.85E-32,0.089638023,1,5.669090834,1.574538004,3.600478883,0.000317632,0.002428778,8.126651938,1,6.945866005,1.116297653,6.22223471,4.90E-10,1.65E-08,0.088932894,1,5.581161523,1.356721991,4.113710518,3.89E-05,0.000313867,N,-,,integral membrane,,no IPS match,,
RL4_JR_04819,112,72,172,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.61195442,0,2.033023403,1.062292245,1.913808006,0.055644692,0.143864074,0.944075275,0,3.548561541,1.441847129,2.461121897,0.01385033,0.043242764,2.453971177,0,0.89405419,1.236426865,0.723095086,0.469621468,0.606366808,2.831545674,0,0.47139362,1.247803128,0.377778841,0.705594893,0.802352684,54.33417869,0,4.479426468,0.610490347,7.337423911,2.18E-13,2.69E-11,N,-, Effector probability:0.804,hypothetical protein TOPH_02733,,no IPS match,,
RL4_JR_04820,1395,1364,2186,0,0,1,1,0,0,0,0,1,2,0,3,0,0,0,13.66661331,1,3.01906629,0.923523574,3.269073335,0.001079003,0.006287506,0.707546611,1,3.964762023,1.515592492,2.615981567,0.008897136,0.030873093,1.827969791,1,1.319233489,1.251138335,1.054426559,0.291687668,0.431731864,2.108474483,1,0.89699324,1.271506838,0.705456875,0.48052596,0.621052508,1.790609385,0,1.245986572,1.237457514,1.006892405,0.313986482,0.449590529,N,-,,1-aminocyclopropane-1-carboxylate deaminase,"C:nucleus; F:DNA binding; F:zinc ion binding; F:pyridoxal phosphate binding; P:amine catabolic process; F:1-aminocyclopropane-1-carboxylate deaminase activity; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001926 (PFAM); IPR005965 (TIGRFAM); IPR027278 (PIRSF); G3DSA:3.40.50.1100 (GENE3D); PTHR10314:SF6 (PANTHER); PTHR10314 (PANTHER); IPR001926 (SUPERFAMILY),,
RL4_JR_04821,2737,6894,3554,1,2,0,0,0,0,4,0,0,3,4,0,0,2,4,0.028304421,1,7.040982679,3.944305359,1.785100807,0.074244967,NA,0.009194001,0,10.23263417,3.417489009,2.994196657,0.002751685,0.015349618,0.023520804,1,7.602821568,1.997858148,3.805486178,0.000141526,0.001415819,0.027113088,1,7.178283977,3.944203294,1.819957908,0.068765415,0.148866758,0.02280449,1,7.539230421,1.431110837,5.268096799,1.38E-07,2.93E-06,N,-,,major facilitator superfamily transporter,P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane; P:anion transport,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF210 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_04822,181,147,91,0,0,0,0,0,0,3,0,0,0,6,0,0,1,3,0.08267709,0,5.493584046,3.919649255,1.401549906,0.161049695,NA,0.025872638,0,8.736359924,2.831768059,3.085125527,0.002034663,0.015023052,0.068240627,1,6.058532883,1.689300224,3.586415723,0.000335254,0.002544314,0.078790314,1,5.637664269,2.673281567,2.108892807,0.034953835,0.099498352,0.068620784,1,5.95186682,1.420821656,4.189031602,2.80E-05,0.000238827,N,-,,Interferon-induced GTP-binding Mx,F:nucleotide binding; F:GTP binding; F:GTPase activity,IPR022812 (PRINTS); IPR001401 (SMART); IPR000375 (PFAM); IPR022812 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11566:SF66 (PANTHER); IPR022812 (PANTHER); IPR030381 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_04823,6557,5356,4797,0,0,7,0,0,0,3,0,1,2,5,0,0,3,3,0.003880053,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,1,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,methyltransferase type 11,P:metabolic process; F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108 (PANTHER); PTHR10108:SF818 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_04824,5453,4319,7367,0,0,5,0,1,0,3,3,1,0,5,0,0,5,2,42.26849139,1,7.667174234,0.909225006,8.432647783,3.38E-17,3.00E-15,0.084603062,1,7.029094254,2.235390538,3.144459161,0.001663941,0.015023052,0.218282376,1,4.386519819,1.420424722,3.088174792,0.0020139,0.009899088,0.251775598,1,3.963243631,1.780947815,2.225356408,0.026057321,0.086108719,0.213248098,1,4.316931611,1.31214039,3.289992171,0.001001902,0.004794071,Y,-,,extracellular proline-glycine rich,"P:biological_process; F:chitin binding; P:chitin catabolic process; C:extracellular region; F:hydrolase activity, hydrolyzing O-glycosyl compounds; C:fungal-type vacuole; C:cellular_component; F:molecular_function; F:chitinase activity; P:carbohydrate metabolic process; C:membrane; C:integral component of membrane; F:hydrolase activity",no IPS match,,
RL4_JR_04825,3370,2004,2592,0,0,4,0,0,0,0,0,0,0,1,0,0,2,0,12.88063252,1,3.666974929,0.898297151,4.082140218,4.46E-05,0.000424281,0.452539322,0,4.609414479,1.586780647,2.904884483,0.003673887,0.017256186,1.176122351,0,1.955192495,1.246523262,1.568516653,0.116760607,0.217617946,9.380223985,1,3.247520898,1.045185381,3.107124302,0.001889169,0.012642327,1.160085577,1,1.87248134,1.232769088,1.518923015,0.128781875,0.230577628,N,-,,NADPH-dependent oxidoreductase,F:oxidoreductase activity,IPR016446 (PIRSF); IPR029479 (PFAM); IPR000415 (G3DSA:3.40.109.GENE3D); PTHR23026:SF98 (PANTHER); PTHR23026 (PANTHER); IPR000415 (SUPERFAMILY),,
RL4_JR_04826,10392,7607,8088,5,5,5,0,0,0,2,11,17,0,0,2,0,1,2,0.032843327,1,6.827118804,3.939154689,1.733143109,0.083070236,NA,0.010370342,0,10.05785337,3.396249778,2.961458677,0.003061856,0.015724315,0.026935568,1,7.407293825,2.020172589,3.666663861,0.000245735,0.002014434,8.054261529,1,8.699501604,1.190595453,7.306849344,2.73E-13,1.39E-11,0.026444884,1,7.336414976,1.465878228,5.004791556,5.59E-07,8.75E-06,N,-,,pyridine nucleotide-disulfide oxidoreductase,F:oxidoreductase activity,IPR023753 (G3DSA:3.50.50.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR23023 (PANTHER); PTHR23023:SF29 (PANTHER); PTHR23023:SF29 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_04827,5246,4191,5254,0,0,3,0,0,0,0,1,2,0,2,0,0,1,3,7.828498255,1,-1.071265137,1.230714509,-0.870441625,0.384059107,0.576806636,2.490508832,0,2.148984197,1.321985555,1.625573131,0.104040495,0.208699542,6.48554493,1,-0.508456405,1.224367419,-0.415280901,0.677936281,0.778511525,7.482922017,1,-0.930985956,1.226369866,-0.759139621,0.44776904,0.589859684,6.428290035,1,-0.598251574,1.233908939,-0.484842564,0.627788027,0.731624513,N,-,,heterokaryon incompatibility,P:biological_process; F:metal ion binding; C:cellular_component; F:molecular_function; F:hydrolase activity,IPR010730 (PFAM); PTHR33112 (PANTHER),,
RL4_JR_04828,4764,4951,6584,0,3,0,0,0,2,2,0,1,0,0,0,0,0,0,1.687946009,1,1.142216036,1.343380891,0.850254789,0.395183447,NA,0.544371774,1,4.342916687,1.564464379,2.775976714,0.005503615,0.021974647,1.404070943,1,1.699284766,1.250488051,1.358897243,0.174179152,0.293252692,1.619061021,0,1.27757216,1.277253261,1.000249675,0.317189695,0.463372812,1.377334483,0,1.62386063,1.233624333,1.316333171,0.188062242,0.307392976,N,-,,family,,IPR008030 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR14194:SF53 (PANTHER); PTHR14194 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04829,15184,19799,27497,2,3,27,0,0,1,0,2,1,0,4,0,0,6,9,0.711151399,1,2.389274881,1.735191621,1.376951601,0.168527212,NA,0.22931879,1,5.590134491,1.817210146,3.076217962,0.002096445,0.015023052,0.591794988,1,2.945510639,1.293717426,2.276780525,0.022799335,0.061684669,0.682417383,1,2.523898474,1.391655697,1.813594037,0.069740249,0.150398301,0.581097611,1,2.868464762,1.254578593,2.286397025,0.022231042,0.059437365,N,-,,integral membrane,C:membrane; C:integral component of membrane; C:endoplasmic reticulum,IPR006838 (PFAM); PTHR10989:SF16 (PANTHER); PTHR10989 (PANTHER),9.B.203.1.3, the aig1 lipid hydrolase (aig1) family.
RL4_JR_04830,151,138,222,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0.744280302,0,2.323629559,1.738346615,1.336689438,0.181324031,NA,0.241539595,0,5.515351303,1.825912699,3.020599673,0.002522747,0.015349618,0.620481846,1,2.877600495,1.310586459,2.195658649,0.028116385,0.072820364,0.715302284,1,2.456194268,1.41078948,1.741006935,0.081682363,0.168679161,0.606159956,0,2.807496818,1.267512805,2.214965251,0.02676245,0.068945383,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:membrane; C:integral component of membrane; F:molecular_function,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF77 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_04831,3105,3966,4500,0,1,1,0,0,0,0,2,7,0,0,2,0,2,2,0.246794701,1,3.916160551,2.714091457,1.442899259,0.149048852,NA,0.078669172,0,7.13338422,2.196841539,3.247109131,0.001165837,0.015023052,44.48441147,1,7.574910132,1.331787047,5.687778801,1.29E-08,5.38E-07,4.247483141,1,4.998906926,1.188410793,4.206379609,2.59E-05,0.000330488,0.202162357,1,4.392260518,1.260037517,3.485817255,0.000490636,0.00266507,Y,-,,multicopper oxidase,F:metal ion binding,IPR008972 (G3DSA:2.60.40.GENE3D); IPR008972 (G3DSA:2.60.40.GENE3D); IPR011706 (PFAM); IPR011707 (PFAM); IPR001117 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); PTHR11709:SF95 (PANTHER); PTHR11709:SF95 (PANTHER); PTHR11709 (PANTHER); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY),1.B.76.1.4, the copper resistance putative porin (copb) family.
RL4_JR_04832,958,962,1159,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.115875805,1,5.006903906,3.784223427,1.323099442,0.18580231,NA,0.036415725,0,8.244141016,2.581455259,3.193602131,0.001405096,0.015023052,0.095457021,0,5.576533423,1.509628646,3.693976951,0.000220774,0.001871955,0.110191317,0,5.154374762,2.275463293,2.265197939,0.023500536,0.082935839,0.095114905,0,5.482729055,1.322860843,4.144600005,3.40E-05,0.000279758,N,-,,Glucose ribitol dehydrogenase,,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04833,2546,3043,3578,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0.10634201,0,5.131144493,3.916790618,1.310037986,0.190182985,NA,0.033782073,0,8.35371091,2.687860955,3.107940124,0.001883962,0.015023052,0.087468178,0,5.706734891,1.609859746,3.544864641,0.000392815,0.002846712,0.100918668,1,5.282264139,2.430361448,2.173447963,0.029746618,0.091768589,0.085664375,0,5.635045062,1.378786985,4.086958407,4.37E-05,0.000346267,N,-,,helix-turn-helix-domain containing type,F:binding,IPR018531 (PFAM); IPR027369 (G3DSA:1.20.120.GENE3D); IPR013700 (PFAM); PTHR36922 (PANTHER); SSF109854 (SUPERFAMILY),,
RL4_JR_04834,726,1035,702,0,4,10,0,0,0,0,0,1,0,14,0,0,2,0,0.128963478,1,4.85267137,3.606403225,1.345570938,0.178440929,NA,0.040776826,0,8.081519106,2.518532509,3.208820644,0.001332806,0.015023052,0.106254118,1,5.4238299,1.472627874,3.683096046,0.000230418,0.001932688,0.122621517,1,5.000635027,2.173056989,2.301198289,0.021380426,0.079353669,0.105057814,1,5.339947944,1.301218025,4.103807234,4.06E-05,0.000325029,,,,,,,,
RL4_JR_04835,1035,767,1020,0,0,5,0,0,0,0,0,2,0,0,3,0,2,0,0.135050491,1,4.785900203,3.523175224,1.358405387,0.174335086,NA,0.042920596,0,8.00726533,2.484384302,3.223038128,0.001268387,0.015023052,0.111829881,1,5.347860112,1.451185637,3.685166098,0.000228554,0.001920229,0.129032877,1,4.92655941,2.119814083,2.32405259,0.020122676,0.076947238,0.110889979,1,5.258679223,1.293494674,4.06548193,4.79E-05,0.000375348,N,-,,Zn2 Cys6 DNA-binding,"F:DNA binding; C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_04836,2093,1820,3196,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,83.01175411,0,-4.477551048,1.212865958,-3.691711372,0.00022275,0.001692458,26.43472673,0,-1.258830374,1.213331133,-1.037499442,0.299503155,0.459816614,68.56338354,1,-3.910360084,1.203907694,-3.248056396,0.001161962,0.006510076,79.10142465,0,-4.332794458,1.205956829,-3.592827168,0.00032711,0.002918048,67.47511166,1,-3.99005305,1.205159399,-3.310809385,0.000930266,0.004502361,N,PKS,,polyketide synthase,F:catalytic activity; P:metabolic process; F:binding,IPR020843 (SMART); SM00822 (SMART); IPR020806 (SMART); IPR020801 (SMART); IPR020841 (SMART); IPR020807 (SMART); IPR001227 (G3DSA:3.40.366.GENE3D); IPR014043 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR032821 (PFAM); G3DSA:3.30.70.250 (GENE3D); IPR020807 (PFAM); IPR014030 (PFAM); IPR009081 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR013217 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR014031 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR013968 (PFAM); PF13602 (PFAM); PTHR11712:SF270 (PANTHER); PTHR11712 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY); IPR011032 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016036 (SUPERFAMILY); IPR016035 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_04837,7756,9220,15735,0,0,5,0,0,0,0,0,2,1,0,0,0,2,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_04838,46498,49223,49110,0,6,8,2,0,12,10,5,7,3,22,6,0,41,3,28.8066627,1,1.394861782,0.742309596,1.879083593,0.06023308,0.152887824,2.977806233,1,1.891231996,1.272281067,1.486489145,0.137149786,0.257700043,18.80427778,1,0.199306421,1.192113366,0.167187473,0.867222541,0.915703067,8.922823285,1,-1.184856994,1.194424589,-0.991989787,0.321202507,0.467456774,7.637087874,1,-0.846809809,1.201236414,-0.704948501,0.480842286,0.609709223,N,-, Effector probability:0.622,Thioredoxin,C:cell; F:protein disulfide oxidoreductase activity; P:glycerol ether metabolic process; P:cell redox homeostasis; P:oxidation-reduction process,PR00421 (PRINTS); IPR013766 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR005746 (PANTHER); PTHR10438:SF284 (PANTHER); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY),8.A.88.1.3, the calciquestrin (casq) family.
RL4_JR_04839,13063,8166,9108,0,9,2,0,0,4,0,1,3,0,0,0,0,4,2,0.661815897,1,2.493210594,1.726907406,1.443743067,0.148811262,NA,0.211198475,1,5.70888278,1.800221039,3.171212122,0.001518042,0.015023052,0.54758817,1,3.058053277,1.258511599,2.429896776,0.015103124,0.044730637,0.631702119,0,2.635605068,1.347749645,1.955559831,0.050517029,0.123996343,4.399746937,1,3.907320493,1.138334085,3.432490113,0.000598066,0.00314567,N,-, Effector probability:0.654,Ctr copper transporter,P:copper ion transport; C:integral component of membrane; F:copper ion transmembrane transporter activity,IPR007274 (PFAM); PTHR12483:SF21 (PANTHER); IPR007274 (PANTHER),1.A.56.1.16, the copper transporter (ctr) family.
RL4_JR_04840,3999,6186,8998,0,1,6,0,0,0,1,0,0,0,2,4,0,5,1,16.96148207,1,3.740490873,1.036244758,3.609659632,0.000306599,0.002217407,0.301959412,0,5.19304833,1.716351678,3.025631865,0.002481142,0.015349618,0.781941735,1,2.543349047,1.271197083,2.000751166,0.045419212,0.105130397,8.925051942,1,3.83136767,1.055972793,3.628282563,0.000285313,0.002604863,0.770578491,1,2.461649894,1.245833735,1.975905633,0.048165466,0.108880407,N,-,,ferric reductase FRE2 precursor,C:membrane,G3DSA:3.40.50.80 (GENE3D); IPR013121 (PFAM); IPR013112 (PFAM); IPR013130 (PFAM); PTHR32361:SF3 (PANTHER); PTHR32361 (PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY),5.B.1.5.3, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_04841,12453,7400,8850,0,2,2,0,0,2,0,6,2,3,0,0,0,0,1,1.030724364,1,1.854075538,1.463729436,1.266679137,0.205270043,NA,0.327818767,1,5.074524745,1.659068713,3.058658574,0.002223304,0.015045494,0.851857837,1,2.420320194,1.242416113,1.948075341,0.051405949,0.11580637,0.982848556,1,1.99779587,1.28816237,1.550888239,0.120928469,0.225737602,0.840752155,1,2.336941138,1.222681339,1.911324778,0.055962857,0.122012042,N,-,,CMGC SRPK kinase,F:kinase activity,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24055:SF229 (PANTHER); PTHR24055:SF229 (PANTHER); PTHR24055 (PANTHER); PTHR24055 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_04842,19460,14975,17598,0,0,2,0,0,0,3,1,0,0,7,0,0,0,0,175.9376192,1,5.344419082,0.878583035,6.08299827,1.18E-09,3.15E-08,1.320804524,0,3.064140504,1.64338825,1.864526234,0.062247841,0.140296737,20.94343272,1,2.271687387,1.196972977,1.897860211,0.057714499,0.126199047,23.15909712,1,2.042482861,1.538715813,1.32739447,0.184378228,0.311345824,53.47330149,0,4.107281617,1.633648921,2.514176434,0.011931073,0.036222523,N,-,,cysteine transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662:SF89 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.20, the major facilitator superfamily (mfs).
RL4_JR_04843,1577,1370,1357,0,3,5,0,0,0,0,0,0,0,0,0,0,9,0,0.015927524,1,7.869332732,3.973176761,1.980614809,0.047634487,NA,0.00517839,0,11.06015741,3.759614657,2.941832721,0.003262761,0.016208996,0.013285358,0,8.423639838,2.241829332,3.757484888,0.00017163,0.001605896,0.015314398,0,8.001728236,3.972774847,2.014140882,0.043994744,0.113902079,0.012960057,1,8.348352688,1.510574778,5.526606699,3.26E-08,1.06E-06,Y,-,,Metallo-hydrolase partial,,IPR001279 (SMART); IPR001279 (G3DSA:3.60.15.GENE3D); IPR001279 (PFAM); PTHR23200 (PANTHER); PTHR23200:SF37 (PANTHER); IPR001279 (SUPERFAMILY),,
RL4_JR_04844,2538,2350,1978,0,3,0,0,0,0,0,0,0,0,8,0,0,1,0,0.011692083,1,8.312151371,3.996763216,2.079720745,0.037551154,NA,0.003838345,0,11.49092626,3.994647088,2.876581086,0.004020089,0.018157671,0.009833003,0,8.854297471,3.046863773,2.906036545,0.003660387,0.015609839,0.011330785,1,8.434549956,3.995610333,2.110954085,0.034776259,0.099426657,0.009620272,1,8.767548331,1.615958211,5.425603379,5.78E-08,1.50E-06,N,-,,allantoate permease,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF253 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_04845,4385,7242,8711,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,99.96356546,1,7.313288853,1.181153401,6.191650335,5.95E-10,1.73E-08,0.216698523,0,5.671716152,1.790719533,3.167283345,0.001538703,0.015023052,130.2653063,1,7.674010297,0.451306932,17.0039717,7.67E-65,7.77E-62,167.5586903,0,8.1507738,0.647868313,12.58091134,2.69E-36,6.05E-34,23.00795751,0,5.561274934,0.76340809,7.284799579,3.22E-13,3.84E-11,N,-,,amino acid permease,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PIRSF); IPR004841 (PFAM); IPR002293 (PANTHER); PTHR11785:SF362 (PANTHER),2.A.3.10.19, the amino acid-polyamine-organocation (apc) family.
RL4_JR_04846,1652,1280,1583,0,1,1,0,0,0,0,1,0,1,3,0,0,0,0,2.645172916,1,0.494133973,1.437025626,0.343858846,0.730952443,0.858001443,0.864695842,0,3.675328625,1.608033423,2.285604623,0.022277399,0.062706295,2.214060489,1,1.042241819,1.331385144,0.782825183,0.433729777,0.574297706,10.57484658,1,2.289522096,1.162744176,1.969067783,0.048945308,0.121314869,6.019114192,0,1.897618804,1.240799215,1.529352035,0.126177196,0.227240148,N,-,,transferase family,F:catalytic activity,IPR023213 (G3DSA:3.30.559.GENE3D); IPR023213 (G3DSA:3.30.559.GENE3D); IPR003480 (PFAM); PTHR31642:SF34 (PANTHER); PTHR31642 (PANTHER); PTHR31642:SF34 (PANTHER); PTHR31642 (PANTHER),,
RL4_JR_04847,1327,1504,1768,0,1,4,0,0,0,0,3,0,0,4,1,0,5,2,22.20311083,1,-2.575076393,1.30743694,-1.969560683,0.048888741,0.130443857,7.192872331,0,0.618944416,1.36320805,0.454035183,0.649803504,0.773619274,51.03303515,1,0.958045074,1.27495995,0.751431505,0.452393008,0.591887673,31.00988314,1,-1.483306538,1.247884443,-1.188656968,0.234574681,0.371918046,25.57620421,1,-1.146647181,1.226057969,-0.935230805,0.349669366,0.487054937,N,-,,hypothetical protein CMQ_6924,C:membrane; C:integral component of membrane,IPR022025 (PFAM); PTHR36847:SF1 (PANTHER); PTHR36847:SF1 (PANTHER); PTHR36847 (PANTHER),,
RL4_JR_04848,619,427,614,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,552.200752,0,-0.264601336,0.525825466,-0.503211337,0.614815695,0.778967874,104.1571024,0,-2.18624849,1.146448006,-1.906975702,0.056523734,0.13007155,250.3777898,0,-4.77923673,1.221650567,-3.912114362,9.15E-05,0.001107967,416.3558525,0,-1.126797596,0.499858627,-2.254232569,0.024181541,0.084079018,318.1441398,0,-2.069583315,0.679592207,-3.045331147,0.002324242,0.009628869,N,-,,iq calmodulin-binding domain-containing domain-containing,,IPR008862 (PFAM); PTHR12832:SF18 (PANTHER); IPR008862 (PANTHER); IPR008862 (PANTHER); PTHR12832:SF18 (PANTHER); IPR008862 (PANTHER); PTHR12832:SF18 (PANTHER),,
RL4_JR_04849,427,405,489,0,1,3,0,0,0,0,0,0,1,0,0,0,0,0,229.3593419,1,0.097843083,0.407688042,0.239994979,0.810334149,0.903772226,45.65893295,0,-0.798918053,1.120576824,-0.712952504,0.475875148,0.633221309,153.0957478,0,-0.548243712,0.552495533,-0.992304333,0.32104909,0.463666332,182.8938758,1,-0.378520355,0.462031345,-0.819252543,0.412642342,0.55647359,128.0565516,0,-2.204847004,0.845045864,-2.609144779,0.009076883,0.029064972,N,-,,aminopeptidase 2,F:zinc ion binding; P:peptide catabolic process; C:cytoplasm; P:proteolysis; F:metalloaminopeptidase activity; F:peptide binding; C:plasma membrane,IPR014782 (PRINTS); G3DSA:1.10.390.10 (GENE3D); IPR014782 (PFAM); IPR024571 (PFAM); IPR001930 (PANTHER); PTHR11533:SF171 (PANTHER); SSF63737 (SUPERFAMILY); SSF55486 (SUPERFAMILY),,
RL4_JR_04850,1060,923,1523,0,0,0,0,0,0,0,0,0,1,0,2,0,0,3,396.208516,0,0.257027442,0.897500473,0.286381401,0.774586019,0.88279865,79.72201007,0,-1.439068137,1.176998866,-1.222658899,0.221458557,0.369535693,175.5539147,0,-2.576413101,0.930633013,-2.768452294,0.005632323,0.020735141,286.5245936,1,-0.585519708,0.721523554,-0.811504635,0.417075932,0.560915594,142.8392748,1,-5.072036924,1.254840106,-4.041978656,5.30E-05,0.000409966,N,-,,jumonji family transcription factor,F:metal ion binding,IPR003347 (SMART); IPR003349 (SMART); IPR003347 (PFAM); PF13832 (PFAM); IPR003349 (PFAM); PTHR10694 (PANTHER); PTHR10694 (PANTHER); PTHR10694:SF7 (PANTHER); PTHR10694:SF7 (PANTHER); IPR003349 (PROSITE_PROFILES); IPR003347 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_04851,2594,2294,4609,2,0,0,0,0,0,0,0,0,0,3,0,0,2,0,0.70995235,1,2.391820708,2.055487553,1.163626948,0.244575226,NA,0.219962773,0,5.649742647,1.996986025,2.829134794,0.004667404,0.019750253,0.58228167,0,2.96861207,1.460435399,2.032689752,0.042083877,0.099383525,0.672558691,1,2.544767828,1.63070304,1.560534177,0.1186337,0.222520602,0.58606472,1,2.85749845,1.432030758,1.995416951,0.045997424,0.105177036,,,,,,,,
RL4_JR_04852,1168,1072,1397,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,4.242125427,0,4.076405035,1.247473093,3.267729828,0.001084138,0.006295511,0.13676711,0,6.335725913,2.031462317,3.11880061,0.001815888,0.015023052,0.352930525,0,3.690929118,1.358871099,2.716173095,0.006604138,0.023454158,48.58337897,1,6.793971005,1.64549049,4.128842461,3.65E-05,0.000443159,0.346789072,0,3.612791268,1.292504248,2.795187153,0.005186968,0.018466262,N,-,,hypothetical protein SPBR_07525,"P:biological_process; F:chitosanase activity; P:polysaccharide catabolic process; P:metabolic process; C:membrane; C:integral component of membrane; C:extracellular region; C:cellular_component; F:molecular_function; F:hydrolase activity, acting on glycosyl bonds; F:hydrolase activity",TIGR01167 (TIGRFAM),8.A.23.1.4, the basigin (basigin) family.
RL4_JR_04853,463,492,382,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,78.20543832,0,-0.473809673,0.605801104,-0.782120849,0.434143555,0.624756239,16.34936635,0,-0.565617342,1.203729131,-0.469887558,0.638435354,0.763948771,50.17461332,0,-2.25285753,1.186866055,-1.898156511,0.057675468,0.126140945,85.75811285,1,-0.579247879,0.660682196,-0.876742073,0.380626749,0.526282042,86.89609902,0,0.496356454,0.502795352,0.987193798,0.323547641,0.459584718,N,-,,sphingosine-1-phosphate phosphohydrolase,C:integral component of membrane; F:hydrolase activity,IPR000326 (SMART); IPR000326 (G3DSA:1.20.144.GENE3D); IPR000326 (PFAM); PTHR14969 (PANTHER); PTHR14969:SF3 (PANTHER); IPR000326 (SUPERFAMILY),9.B.105.2.1, the lead resistance fusion protein (pbrbc) family.
RL4_JR_04854,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.38395073,0,1.399042455,0.868310022,1.611224584,0.107130781,0.232873145,2.200374717,0,2.327712506,1.300054919,1.790472442,0.073377994,0.159404913,5.726547168,0,-0.328813265,1.203543551,-0.273204293,0.78469618,0.857379987,6.607555403,0,-0.751425419,1.202653236,-0.624806383,0.532098141,0.6652048,13.0291539,0,0.521305925,1.134897617,0.459341809,0.645988728,0.747074343,N,-,,3-oxoacyl-acyl carrier reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); SM00822 (SMART); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24322:SF328 (PANTHER); IPR002347 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04855,11923,10066,10010,0,3,9,0,0,0,4,1,5,4,9,3,0,3,7,100.1220254,1,0.391592191,0.565882918,0.69200214,0.488935985,0.676631003,13.53237619,0,-0.292883784,1.219405821,-0.240185654,0.810186335,0.884354687,35.30846831,1,-2.953001848,1.204911623,-2.450803686,0.014253767,0.042693827,44.75762411,1,-2.429747335,1.160160718,-2.094319603,0.036231519,0.101052846,35.02693637,1,-3.044166154,1.215166139,-2.505143994,0.012240155,0.037003824,N,-,,ubiquitin-like activating enzyme,F:SUMO activating enzyme activity; P:protein sumoylation; C:cytosol; C:SUMO activating enzyme complex,IPR019572 (G3DSA:1.10.3240.GENE3D); IPR028077 (PFAM); G3DSA:3.10.290.20 (GENE3D); IPR019572 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR000594 (PFAM); PTHR10953 (PANTHER); PTHR10953:SF5 (PANTHER); IPR000594 (SUPERFAMILY),3.A.25.1.1, the symbiont-specific erad-like machinery (selma) family.
RL4_JR_04856,1202,1249,1167,0,3,3,0,0,0,0,3,1,8,15,1,2,9,6,51.6011171,1,-0.178801701,0.755749568,-0.236588559,0.812975997,0.90481012,8.873719494,0,0.315928117,1.220027259,0.258951687,0.795672517,0.876284606,29.60010339,1,-1.379192106,1.195545281,-1.153609259,0.248660401,0.383230004,42.70197525,1,-0.056947512,0.759422634,-0.074987904,0.940224336,0.964906893,34.44148531,1,-0.234247407,0.864691274,-0.270902939,0.786465685,0.854212085,N,-,,upf0553 c,P:biological_process; F:molecular_function,IPR019438 (PFAM); IPR019438 (PANTHER); PTHR21314:SF0 (PANTHER),,
RL4_JR_04857,67,79,43,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,10.62833714,1,-1.512159453,1.20495532,-1.254950643,0.209496678,0.376319092,3.372084655,0,1.711824673,1.26883564,1.349130351,0.177295101,0.314507714,15.27903708,0,0.016416339,1.199371597,0.013687451,0.989079335,0.995046175,27.78999099,0,0.942837179,0.863904163,1.091367792,0.275111079,0.417553541,8.686916175,0,-1.032560334,1.210223257,-0.853198224,0.393549388,0.530231211,N,-,,DNA polymerase delta subunit 4,C:nucleus; P:DNA replication,IPR007218 (PFAM); PTHR14303:SF0 (PANTHER); PTHR14303 (PANTHER),,
RL4_JR_04858,68,80,52,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,84.12531435,0,1.455207783,0.545222608,2.669015853,0.007607386,0.030526835,8.144679595,0,0.439625994,1.238123757,0.355074355,0.722533889,0.826289461,29.07010592,0,-1.257072392,1.206312329,-1.042078707,0.29737519,0.438291807,44.55392782,0,0.359202889,0.7193214,0.499363552,0.617523292,0.735838923,21.01119403,0,-2.306833887,1.216762253,-1.895878904,0.057976059,0.125241647,N,-, Effector probability:0.655,guanylate kinase,P:GDP metabolic process; P:GMP metabolic process; F:guanylate kinase activity; P:phosphorylation,IPR008145 (SMART); G3DSA:3.30.63.10 (GENE3D); IPR008145 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR017665 (TIGRFAM); PTHR23117 (PANTHER); IPR008144 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),8.A.24.1.8, the ezrin/radixin/moesin-binding phosphoprotein 50 (ebp50) family.
RL4_JR_04859,16454,10185,9454,0,1,1,0,0,0,0,0,0,0,3,0,0,5,0,377.4339348,1,1.595498729,0.589095525,2.708387112,0.006761111,0.02788531,30.43416561,0,-1.462098379,1.194091427,-1.224444248,0.220784686,0.368654337,130.4065701,0,-0.489626136,0.571351278,-0.856961652,0.391466078,0.53491734,239.2843692,1,0.91373173,0.47698218,1.91565171,0.055409443,0.130560998,135.7974912,1,0.036316653,0.704624382,0.051540443,0.958894876,0.97302171,N,-,,cell division control 10,F:GTP binding; P:cell division,IPR016491 (PIRSF); IPR027417 (G3DSA:3.40.50.GENE3D); IPR030379 (PFAM); PTHR18884:SF57 (PANTHER); IPR016491 (PANTHER); IPR030379 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_04860,5213,3988,5208,0,4,1,0,0,0,0,5,3,0,2,0,0,4,0,77.40631369,1,-0.862415967,0.764739435,-1.127725245,0.259435973,0.438830327,17.06374084,0,-0.627399915,1.233211663,-0.508752823,0.610925492,0.743959075,57.65992228,1,-1.481034522,1.070453147,-1.383558474,0.166493691,0.28348169,99.68879041,1,0.326694234,0.730941818,0.446949711,0.65491137,0.76455409,48.32190047,1,-2.461358101,1.166651927,-2.10976217,0.034878846,0.084625877,N,-,,---NA---,,no IPS match,,
RL4_JR_04861,713,633,868,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,61.13329275,0,-1.852105358,1.013175815,-1.828019708,0.067546594,0.166529197,14.43121535,0,-0.385565563,1.2134273,-0.317749207,0.750675182,0.847743809,83.01356637,0,0.120018656,0.671764076,0.178661915,0.858203175,0.909674333,111.9540698,1,0.465296545,0.517255007,0.899549621,0.368359978,0.514575714,36.68942325,0,-3.111059652,1.190768049,-2.612649587,0.008984337,0.0288416,N,-,,required for cell viability,P:biological_process; P:RNA polymerase II complex import to nucleus; F:molecular_function; C:intracellular,IPR019414 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR019451 (PFAM); PTHR20959 (PANTHER); PTHR20959 (PANTHER); PTHR20959:SF1 (PANTHER); PTHR20959:SF1 (PANTHER); SSF81995 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_04862,1009,1126,1426,1,6,9,0,0,0,0,0,0,0,2,0,0,2,0,285.4435563,1,-1.7179297,0.536551423,-3.201798795,0.001365724,0.007594801,69.8104825,0,-2.659872344,1.199072419,-2.218274979,0.026536089,0.071796162,188.5614703,0,-4.357513885,1.204902197,-3.616487626,0.000298628,0.002316709,228.7246537,1,-3.986519422,1.032725711,-3.860191896,0.000113298,0.00118629,195.1738428,1,-3.70625282,1.001849386,-3.699411182,0.0002161,0.001329292,N,-,,pre-mrna-splicing factor atp-dependent rna helicase prp43,"F:nucleic acid binding; P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:ATP binding; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:post-mRNA release spliceosomal complex; P:spliceosomal complex disassembly; C:U2-type spliceosomal complex; P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:ATP-dependent RNA helicase activity",IPR001650 (SMART); IPR014001 (SMART); IPR007502 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003593 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR007502 (PFAM); IPR011709 (PFAM); IPR001650 (PFAM); PTHR18934 (PANTHER); PTHR18934:SF109 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.A.53.1.5, the hepatitis c virus p7 viroporin cation-selective channel (hcv-p7) family.
RL4_JR_04863,2079,2712,2050,0,0,7,0,0,0,0,2,0,1,9,1,0,2,0,83.17950245,1,-3.380049142,1.182397423,-2.858640484,0.004254607,0.018966711,61.24882775,0,1.462624824,0.794546111,1.840830637,0.065646382,0.146005861,73.0559924,1,-2.803100498,1.213704598,-2.309540972,0.020913581,0.057535079,102.198747,1,-1.143473188,0.721168053,-1.585584918,0.1128335,0.214140428,73.0839632,1,-1.680130324,0.901448477,-1.863811817,0.062348136,0.132648639,N,-,,arginine n-methyltransferase,"C:nucleus; P:peptidyl-arginine methylation, to symmetrical-dimethyl arginine; P:GDP metabolic process; C:cytosol; P:regulation of transcription, DNA-templated; P:GMP metabolic process; F:guanylate kinase activity; F:histone-arginine N-methyltransferase activity",IPR007857 (PIRSF); G3DSA:2.70.160.11 (GENE3D); IPR025799 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR007857 (PANTHER); IPR025799 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_04864,1000,1208,1833,3,2,0,0,0,0,0,3,2,0,0,2,0,0,0,64.75229366,1,4.342220463,0.888773077,4.885634562,1.03E-06,1.56E-05,1.163863901,0,3.246545967,1.373767635,2.363242432,0.018115815,0.053196482,3.024868829,1,0.591881576,1.207382047,0.490218963,0.623978963,0.736822634,3.489877621,1,0.16943113,1.20922174,0.140115848,0.888568459,0.931630491,2.98831966,0,0.506937942,1.208449938,0.419494368,0.67485487,0.7686058,N,-,,Major facilitator superfamily general substrate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF217 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.38, the major facilitator superfamily (mfs).
RL4_JR_04865,90731,114457,159791,5,14,9,0,0,0,3,0,1,9,20,0,0,23,2,176.5772046,1,1.529997126,0.603946867,2.533330679,0.011298431,0.041779351,14.81955741,0,-0.423883788,1.236351792,-0.342850466,0.731710958,0.832364387,68.94137973,1,-0.256598212,0.779531197,-0.329169907,0.742027267,0.826888724,102.2231644,1,0.402712119,0.567380307,0.70977458,0.477843935,0.618533603,105.7519867,1,1.219067642,0.510992614,2.385685445,0.017047325,0.048115901,N,-,,vesicular-fusion sec18,F:ATPase activity; F:ATP binding; P:Golgi vesicle docking; C:integral component of membrane; P:Golgi to plasma membrane protein transport; P:intra-Golgi vesicle-mediated transport; C:Golgi stack,IPR003593 (SMART); IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR004201 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.8.60 (GENE3D); G3DSA:2.40.40.20 (GENE3D); IPR029067 (G3DSA:3.10.330.GENE3D); PTHR23078 (PANTHER); PTHR23078:SF3 (PANTHER); IPR029067 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR009010 (SUPERFAMILY),1.F.1.1.2, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_04866,18879,18946,18764,5,4,6,0,0,0,4,3,3,5,3,3,0,7,0,0.614724641,1,2.599917777,1.963744514,1.323959282,0.185516568,NA,0.196969914,0,5.809788663,1.934802765,3.002780836,0.00267525,0.015349618,0.507651225,1,3.168209437,1.364652096,2.321624278,0.020253175,0.056084012,0.585510517,1,2.745641221,1.513415448,1.814201927,0.069646644,0.150228434,0.49530875,1,3.100397034,1.310593917,2.365642777,0.017998802,0.050205249,,,,,,,,
RL4_JR_04867,3692,4645,4840,0,0,0,0,0,0,0,1,0,0,7,0,0,0,0,112.363189,0,-2.46531907,0.867639954,-2.841407958,0.004491482,0.01989224,32.07760305,0,-1.537995515,1.194287863,-1.28779297,0.19781804,0.341167865,113.444334,1,-1.371329829,0.745265786,-1.840054722,0.065760204,0.139835392,137.5067751,1,-1.543035191,0.67295861,-2.292912471,0.021853045,0.080257454,90.14219197,0,-2.612819156,0.983508171,-2.656631875,0.007892558,0.025945295,N,-,,galactosyl transferase gma12 mnn10 family,"F:transferase activity, transferring hexosyl groups; C:integral component of membrane; P:protein N-linked glycosylation; C:Golgi membrane",IPR008630 (PFAM); PTHR31306:SF1 (PANTHER); PTHR31306 (PANTHER); PTHR31306 (PANTHER); PTHR31306:SF1 (PANTHER),1.B.12.3.1, the autotransporter-1 (at-1) family.
RL4_JR_04868,1561,1813,2102,6,1,2,0,0,0,0,0,0,1,2,0,0,0,0,22.92736462,1,0.643520132,0.920664513,0.698973538,0.484568568,0.672617182,3.621775447,0,1.608758938,1.292541949,1.24464737,0.2132614,0.359860197,9.456849654,0,-1.052418563,1.222735869,-0.860708015,0.389398877,0.532811763,22.94914781,1,0.799436246,0.908148206,0.880292711,0.37870076,0.524462481,9.378852816,0,-1.143127642,1.233883459,-0.926447011,0.354213723,0.491591873,N,-,,TPT-domain-containing,C:integral component of membrane,IPR004853 (PFAM); PTHR11132:SF77 (PANTHER); PTHR11132 (PANTHER),2.A.7.9.20, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_04869,49946,57863,64356,24,109,58,1,0,18,5,18,14,0,23,7,0,23,7,1.254896027,1,1.570320802,1.451264965,1.082035907,0.279236573,NA,0.398440138,1,4.793124417,1.635725954,2.9302735,0.003386638,0.016488617,1.035111876,1,2.139583213,1.262998002,1.694051147,0.090255564,0.179412396,1.194349681,1,1.716852311,1.307266381,1.31331482,0.189076887,0.317532506,1.020083412,1,2.058088716,1.245167876,1.652860434,0.098359271,0.188507973,N,-,,poly polymerase,P:biological_process; C:cellular_component; F:molecular_function,IPR009288 (PFAM); IPR013024 (G3DSA:3.10.490.GENE3D); IPR013024 (SUPERFAMILY),,
RL4_JR_04870,4491,6222,6870,7,3,23,0,0,0,2,3,1,4,2,4,0,8,1,1.956711679,1,0.929513427,1.323975207,0.702062562,0.482640148,NA,0.62323563,0,4.147744483,1.520715605,2.72749518,0.006381719,0.02428412,1.615812196,1,1.497127229,1.242209674,1.205212985,0.228121091,0.359027087,1.864137516,1,1.074614521,1.263013312,0.850833884,0.394861636,0.53931452,13.17070323,1,3.604009062,0.88470551,4.073682169,4.63E-05,0.00036434,N,-,,kinase domain containing,F:ATP binding; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_04871,2481,1999,3469,3,0,1,0,0,0,0,0,0,1,8,0,0,0,0,131.667787,1,-0.582348255,0.671340575,-0.867440873,0.385700495,0.578863195,73.68400184,0,1.574890662,0.76128514,2.068726393,0.038571769,0.096187102,70.22381949,0,-3.944923451,1.231452581,-3.203471665,0.001357814,0.00732366,97.10448676,1,-1.714982642,0.847540499,-2.023481643,0.043023514,0.112911634,81.6195698,0,-1.885755457,0.939948738,-2.006232235,0.044831476,0.102999477,N,-,,Ribosomal mitochondria,C:mitochondrion,IPR018305 (PFAM),,
RL4_JR_04872,2078,1896,1543,0,0,8,0,0,0,0,0,0,2,5,0,0,6,0,14.40344495,1,-1.950752922,1.230039878,-1.585926568,0.112755968,0.241687648,4.55149444,0,1.279073955,1.279012511,1.00004804,0.31728726,0.478983094,22.96903839,0,-0.422137824,1.218031086,-0.346573933,0.728911432,0.817039342,29.77907268,1,0.867506952,0.811912121,1.068473951,0.285306775,0.429423382,11.83502469,1,-1.478759897,1.236774722,-1.195658247,0.231829951,0.359405643,Y,-,,MFS transporter,C:membrane,PTHR36854 (PANTHER),,
RL4_JR_04873,1123,1771,809,0,0,18,5,0,0,0,0,5,5,6,4,0,8,0,511.7402989,1,0.091726358,0.695209247,0.131940647,0.895031238,0.948391329,96.38934921,1,-1.168539667,0.979883998,-1.192528574,0.233054053,0.38328876,291.8411363,1,-0.971325571,0.464156621,-2.092667707,0.036378828,0.088661351,242.3583617,1,-4.941590276,1.147327437,-4.307044456,1.65E-05,0.000220419,219.0672911,1,-2.654251095,0.717219751,-3.70075014,0.000214963,0.001325518,N,-,,phospho-2-dehydro-3-deoxyheptonate aldolase,C:nucleus; P:aromatic amino acid family biosynthetic process; C:cytoplasm; F:3-deoxy-7-phosphoheptulonate synthase activity; P:chorismate biosynthetic process; P:cellular amino acid biosynthetic process,IPR013785 (G3DSA:3.20.20.GENE3D); IPR006218 (PFAM); IPR006219 (PIRSF); IPR006219 (TIGRFAM); IPR006219 (PANTHER); PTHR21225:SF8 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_04874,61,7,39,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.26584713,0,3.739790242,0.777205629,4.811841429,1.50E-06,2.17E-05,0.689507579,0,4.001701945,1.516979654,2.63794042,0.008341124,0.029387,1.799118372,0,1.341170389,1.259035978,1.065235952,0.286769168,0.426259148,2.076028465,0,0.918595763,1.282686718,0.716149743,0.473898892,0.614920707,1.787210077,0,1.248459598,1.260096903,0.990764754,0.321800464,0.45761653,N,-,,thiol-specific monooxygenase,"F:NADP binding; F:flavin adenine dinucleotide binding; P:oxidation-reduction process; F:N,N-dimethylaniline monooxygenase activity",PR00419 (PRINTS); IPR020946 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR23023:SF4 (PANTHER); PTHR23023:SF4 (PANTHER); PTHR23023 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_04875,295,281,316,5,1,10,0,0,0,0,0,0,0,0,0,0,2,0,0.050570501,1,6.202124129,3.927797874,1.579033425,0.114328391,NA,0.016016009,0,9.428523409,3.927989708,2.400343206,0.016379706,0.049402678,0.042025918,0,6.758927614,2.415894156,2.797691943,0.005146918,0.01933484,0.048500182,0,6.337727433,3.927715782,1.613591152,0.106616137,0.20582108,0.042148691,1,6.652692698,1.696609624,3.921168784,8.81E-05,0.00062393,Y,-,,prp 4 c domain-containing,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_04876,14,14,17,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,1.835655895,1,1.021234031,1.284325069,0.795152299,0.426524916,NA,0.585161781,0,4.238553525,1.505278039,2.815794436,0.004865679,0.02028401,1.520012758,0,1.584546636,1.2224398,1.296216497,0.194900907,0.319439337,1.753598839,1,1.162236889,1.238033289,0.938776768,0.347845369,0.494931754,1.501172751,0,1.50011358,1.215286915,1.234369894,0.217065102,0.342333981,Y,-,,hypothetical protein PV06_04966,,no IPS match,,
RL4_JR_04877,4,6,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,89.60801376,0,0.782460477,0.512621024,1.526391701,0.126912343,0.262586287,19.68472725,0,1.017055627,1.116988434,0.910533713,0.362541111,0.527247288,95.0753306,0,1.091283979,0.569975515,1.914615541,0.055541552,0.122506028,54.90362067,0,0.320078836,0.617462551,0.518377731,0.604194749,0.725076667,26.32482018,0,-2.632101952,1.190832407,-2.210304268,0.027084053,0.0695111,N,-,,histidine phosphatase clade-1,F:sedoheptulose-bisphosphatase activity; P:dephosphorylation; P:ribose phosphate biosynthetic process,IPR013078 (SMART); IPR029033 (G3DSA:3.40.50.GENE3D); IPR013078 (PFAM); PTHR23029:SF48 (PANTHER); PTHR23029 (PANTHER); IPR029033 (SUPERFAMILY),,
RL4_JR_04878,6,15,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1.036670075,1,1.845463547,1.583543348,1.165401345,0.243856573,NA,0.333806349,0,5.048393869,1.734773681,2.910116706,0.003612938,0.017053643,0.863047588,0,2.401018798,1.30569764,1.838878102,0.065933117,0.140114794,0.995276894,0,1.979342076,1.37722103,1.437200008,0.150661171,0.26701284,0.849781675,0,2.320501707,1.281332528,1.811006632,0.070139825,0.145109466,N,-,,nucleoside-diphosphate-sugar epimerase family,C:membrane,IPR016040 (G3DSA:3.40.50.GENE3D); IPR008030 (PFAM); PTHR14194:SF64 (PANTHER); PTHR14194 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04879,2068,1615,2444,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1.89756942,1,0.973383437,1.329986603,0.731874618,0.4642451,NA,0.613404725,0,4.17070907,1.546506416,2.696858563,0.006999699,0.025971758,1.579223999,1,1.529820918,1.252098731,1.221805342,0.221781248,0.351544286,1.820849297,0,1.108216251,1.275840883,0.86861635,0.385057009,0.530291378,1.545782834,0,1.457435775,1.235007769,1.180102516,0.237959444,0.366898811,N,-,,NAD dependent epimerase dehydratase,F:coenzyme binding; F:catalytic activity,IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10366 (PANTHER); PTHR10366:SF262 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04880,2304,1185,2258,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,40.83678292,0,2.042838716,0.804621055,2.538882997,0.011120701,0.04129389,3.339093009,0,1.726154084,1.369805873,1.260145045,0.207617043,0.352883151,22.89886424,0,0.907147443,1.095616621,0.827978898,0.40768245,0.5498038,19.49985173,1,-0.372276138,1.207392281,-0.308330726,0.757830688,0.841803151,8.320801939,1,-0.970552237,1.253803796,-0.774086217,0.438879808,0.57307945,N,-,,Nonsense-mediated mRNA decay 1,F:nucleic acid binding; F:zinc ion binding; F:metal ion binding,IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (SUPERFAMILY),,
RL4_JR_04881,230,220,530,0,0,18,0,0,0,0,0,0,0,0,0,0,0,0,72.10615824,1,-0.04413683,0.655537048,-0.067329269,0.946319576,0.973563316,10.24242023,0,0.109047399,1.211060657,0.090042888,0.928253133,0.959733049,209.7181511,0,2.910535026,0.334769749,8.694139892,3.49E-18,4.78E-16,163.0814544,0,2.026029292,0.371228804,5.457629547,4.83E-08,1.17E-06,71.76068218,0,1.309755977,0.484861125,2.701301277,0.006906874,0.023349616,N,-,,subtilisin Carlsberg,F:serine-type peptidase activity; P:primary metabolic process; P:organic substance metabolic process,IPR015500 (PRINTS); IPR000209 (G3DSA:3.40.50.GENE3D); IPR010435 (PFAM); IPR000209 (PFAM); PTHR10795:SF401 (PANTHER); IPR015500 (PANTHER); IPR015500 (PANTHER); PTHR10795:SF401 (PANTHER); IPR000209 (SUPERFAMILY),2.A.7.3.49, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_04882,60,56,119,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.9800459,0,0.121341678,1.012725925,0.119816897,0.904628197,0.953456484,3.618863409,0,1.609949775,1.260477015,1.27725437,0.201512458,0.345830637,50.44852649,0,1.791062325,0.741868571,2.41425826,0.015767282,0.046322682,10.83909399,0,-1.465512907,1.193941026,-1.227458371,0.219650359,0.354909389,9.274781175,0,-1.127116836,1.200622626,-0.93877694,0.347845281,0.485315346,N,-,,hypothetical protein SPI_06373,,no IPS match,,
RL4_JR_04883,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.052080475,0,0.860368005,1.442215808,0.596559821,0.550801303,NA,0.645467526,0,4.096828257,1.590413324,2.575951921,0.009996455,0.033549109,1.695037578,0,1.427135366,1.307525142,1.091478336,0.275062459,0.413807619,1.956649126,0,1.004045257,1.347485669,0.745124998,0.456196158,0.59823677,1.695651933,0,1.324400795,1.313187524,1.008538971,0.313195788,0.448656955,N,-,,DUF1445 domain-containing,,G3DSA:3.40.1640.10 (GENE3D); PTHR32022 (PANTHER); SSF160920 (SUPERFAMILY),,
RL4_JR_04884,710,638,846,0,0,4,0,0,0,0,1,0,0,0,0,0,31,0,0.007760107,1,8.901087564,4.041366561,2.202494486,0.027630398,NA,0.002334598,0,12.18995876,4.048442383,3.01102439,0.002603679,0.015349618,0.006343058,1,9.480780804,4.042868098,2.345063102,0.01902386,0.053738157,0.007335717,0,9.055356819,4.042572319,2.23999872,0.025091006,0.08557795,0.006581095,1,9.341867313,1.819064456,5.135533973,2.81E-07,4.95E-06,,,,,,,,
RL4_JR_04885,452,36,96,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.54516264,1,-2.235264744,1.189748866,-1.878770223,0.060275875,0.15294886,5.58773045,0,0.983249866,1.232942237,0.797482507,0.425170858,0.588114572,14.51040182,0,-1.670037942,1.191243826,-1.401927889,0.160936781,0.276343957,26.37605317,0,-1.143189747,1.140946646,-1.001966,0.316360014,0.462614839,14.31443225,0,-1.753133936,1.195479088,-1.466469764,0.142520353,0.249096939,N,-,,alcohol dehydrogenase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR013154 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PF13602 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); PTHR11695:SF525 (PANTHER); IPR002085 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_04886,259,236,161,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,Y,-, Effector probability:0.71,mannose-6-phosphate class i,,no IPS match,,
RL4_JR_04887,3561,3338,2568,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,65.91259387,0,-4.144853354,1.193611204,-3.472532211,0.000515573,0.003450407,43.43072142,0,-0.010086108,1.118487038,-0.009017635,0.992805066,0.996447484,61.1874836,0,-2.622410174,1.195476715,-2.193610416,0.028263429,0.073069887,63.07969104,1,-4.006305974,1.195758905,-3.350429554,0.000806863,0.006190132,68.94023871,0,-1.453242886,0.850019842,-1.709657604,0.087329207,0.172595787,N,-, Effector probability:0.762,carbonic anhydrase,"F:zinc ion binding; F:carbonate dehydratase activity; F:threonine-type endopeptidase activity; C:nucleus; C:mitochondrial intermembrane space; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:cellular response to carbon dioxide; C:proteasome core complex, alpha-subunit complex; F:mRNA binding; P:cellular response to oxidative stress; C:proteasome storage granule; P:carbon utilization; P:proteasomal ubiquitin-independent protein catabolic process",IPR001765 (SMART); IPR001765 (G3DSA:3.40.1050.GENE3D); IPR001765 (PFAM); IPR001765 (PANTHER); PTHR11002:SF16 (PANTHER); IPR001765 (SUPERFAMILY),2.A.53.3.8, the sulfate permease (sulp) family.
RL4_JR_04888,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35.81731449,0,3.089826629,0.631169872,4.895396254,9.81E-07,1.49E-05,1.559053536,0,2.824753787,1.361405539,2.074880486,0.037997613,0.09522452,30.81231003,0,2.584899095,0.873175582,2.960342856,0.003072968,0.013778004,23.95057795,0,1.50385894,1.037117321,1.450037436,0.14704808,0.262077418,4.016194566,0,0.080335953,1.229521358,0.065339209,0.947903925,0.966421029,N,-,,hypothetical protein SPSK_10776,,no IPS match,,
RL4_JR_04889,188,99,215,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,182.0475884,0,-1.841915115,0.679920572,-2.709015127,0.006748326,0.027859728,43.80987754,0,-1.987695664,1.200087256,-1.656292619,0.097662574,0.198741572,176.0457897,0,-1.206040932,0.642031926,-1.878475016,0.060316212,0.13078632,182.348821,0,-1.702118853,0.649749834,-2.619652617,0.008801938,0.043922928,124.7530008,0,-2.550108812,0.881179194,-2.89397302,0.003804008,0.014344725,N,-,,hypothetical protein CMQ_2115,,IPR029208 (PFAM),,
RL4_JR_04890,343,363,149,1,0,38,0,0,0,0,0,0,0,16,0,0,0,0,349.2804493,1,-3.841531127,0.859203209,-4.47103908,7.78E-06,9.35E-05,106.5416823,0,-3.269750839,1.223118966,-2.673289296,0.007511144,0.027338297,282.2902427,0,-4.956643995,1.222659305,-4.053986237,5.04E-05,0.000728236,392.9416083,1,-1.802048583,0.610110644,-2.953642264,0.003140478,0.019317948,282.2334654,0,-3.82363769,0.913501041,-4.18569604,2.84E-05,0.000241888,N,-,,ncs1 allantoate transporter,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR001248 (PFAM); PTHR30618 (PANTHER); PTHR30618:SF10 (PANTHER),2.A.39.3.10, the nucleobase:cation symporter-1 (ncs1) family.
RL4_JR_04891,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.76142394,0,-1.529946294,1.198334559,-1.276727173,0.201698584,0.365738398,3.429017944,0,1.687745546,1.267971523,1.331059503,0.183169433,0.322666376,8.89646162,0,-0.964156077,1.19820344,-0.804668093,0.421011237,0.562162722,19.57590658,0,-0.436611633,1.146398023,-0.380855187,0.703310707,0.80083456,8.763540192,0,-1.045203771,1.199852098,-0.871110509,0.383693817,0.519719049,N,-,,hypothetical protein CMQ_2232,,no IPS match,,
RL4_JR_04892,109,89,78,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.71974067,0,1.989211091,0.701141694,2.837102838,0.004552495,0.02015152,2.803818538,0,1.978169014,1.310117394,1.509917373,0.131064509,0.248712966,39.76567928,0,2.447209266,0.712731776,3.433562735,0.000595704,0.003842254,8.38982859,0,-1.095681644,1.219015601,-0.898824956,0.368745905,0.514901709,22.59651346,0,1.82896903,0.79950917,2.287614826,0.022159962,0.059294295,N,-,,oxidoreductase molybdopterin binding domain-containing,P:single-organism metabolic process,IPR008335 (PRINTS); IPR001199 (SMART); IPR005066 (G3DSA:2.60.40.GENE3D); IPR001199 (G3DSA:3.10.120.GENE3D); IPR000572 (PFAM); IPR000572 (G3DSA:3.90.420.GENE3D); IPR005066 (PFAM); IPR001199 (PFAM); PTHR19372 (PANTHER); PTHR19372:SF7 (PANTHER); IPR001199 (PROSITE_PROFILES); IPR014756 (SUPERFAMILY); IPR000572 (SUPERFAMILY); IPR001199 (SUPERFAMILY),,
RL4_JR_04893,643,582,568,0,0,1,0,0,0,0,0,2,2,0,0,0,0,0,390.5684281,1,-0.131783264,0.623967239,-0.211202217,0.832729481,0.916665376,86.58159892,0,-0.978412694,0.992080063,-0.986223523,0.324023439,0.486251334,377.6076442,1,0.135565921,0.656711798,0.206431378,0.836453963,0.894492905,314.3943997,1,-0.791894542,1.803736259,-0.439030118,0.660639714,0.768759579,252.6792587,0,-0.719176329,0.691204158,-1.040468754,0.298122173,0.433441557,N,-,,26s proteasome regulatory subunit rpn2,"C:nucleus; C:proteasome regulatory particle, base subcomplex; P:regulation of catalytic activity; P:regulation of protein catabolic process; P:proteasome assembly; C:proteasome storage granule; F:enzyme regulator activity; F:protein binding, bridging; P:ubiquitin-dependent protein catabolic process",PF13646 (PFAM); IPR002015 (PFAM); IPR016642 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR10943 (PANTHER); PTHR10943:SF2 (PANTHER); PTHR10943:SF2 (PANTHER); PTHR10943 (PANTHER); PTHR10943 (PANTHER); PTHR10943:SF2 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_04894,39,18,40,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,133.4214391,0,-0.802470765,0.544655898,-1.473353669,0.140655696,0.283255781,27.46329012,0,-1.31393372,1.196298219,-1.098332923,0.27205914,0.429607273,84.31057901,0,-2.147229554,1.032779074,-2.079079261,0.037610066,0.090939648,82.27023604,0,-4.389505404,1.190856663,-3.686006505,0.000227801,0.002141579,85.84549989,0,-1.447600307,0.761070785,-1.902057385,0.057163653,0.12396273,N,-,,mRNA-capping enzyme subunit beta,P:macromolecule metabolic process; P:nucleobase-containing compound metabolic process,IPR004206 (G3DSA:3.20.100.GENE3D); IPR004206 (PFAM); PTHR28118:SF1 (PANTHER); PTHR28118 (PANTHER); IPR033469 (SUPERFAMILY),,
RL4_JR_04895,669,616,968,0,1,0,0,0,2,0,0,0,0,2,0,0,1,0,19.2316014,1,2.622952351,0.751376941,3.490860854,0.000481467,0.00326578,1.259008824,1,3.133190863,1.361886572,2.300625417,0.021412813,0.060796773,3.272667906,0,0.478381193,1.206085824,0.39663943,0.691633372,0.788968592,3.775881146,1,0.055882748,1.207168582,0.046292414,0.963077186,0.978772417,3.232582071,1,0.393649253,1.207500476,0.326003394,0.744421787,0.821447581,Y,-,,#NAME?,C:membrane,IPR008030 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10366:SF373 (PANTHER); PTHR10366 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04896,5592,5064,7662,0,0,11,0,0,4,2,0,2,1,6,1,0,6,0,5.463102388,1,-0.55202095,1.195012179,-0.46193751,0.644126134,0.797479603,1.749923324,1,2.658270276,1.325944066,2.004813283,0.044983012,0.108564151,26.71289148,1,2.417367771,0.850003187,2.843951421,0.004455784,0.017386326,5.223012694,1,-0.411998681,1.197415237,-0.344073358,0.730791118,0.820408036,19.89415188,1,2.545004317,0.746109696,3.411032359,0.000647174,0.003363777,N,-,,cupin domain-containing,,IPR013096 (PFAM); IPR014710 (G3DSA:2.60.120.GENE3D); IPR011051 (SUPERFAMILY),,
RL4_JR_04897,7964,7676,4547,0,0,13,0,0,0,2,3,6,1,7,1,0,5,0,35.82379981,1,0.58929187,0.734955721,0.80180595,0.422665216,0.614635086,5.238825633,0,1.076317475,1.242606985,0.866176907,0.386393155,0.551087998,37.6222661,1,0.836359484,0.848426122,0.985777621,0.32424225,0.467277682,81.14651727,1,1.757607207,0.53598147,3.27923129,0.001040903,0.007653698,13.32227576,1,-1.649566563,1.18882788,-1.387557098,0.165271953,0.278525054,N,-,,F-box domain-containing,,IPR021894 (PFAM); G3DSA:1.20.1280.50 (GENE3D); IPR013897 (PFAM); PTHR34826 (PANTHER); PTHR34826:SF2 (PANTHER); PTHR34826:SF2 (PANTHER); PTHR34826 (PANTHER); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY),,
RL4_JR_04898,4891,5318,5465,1,0,2,0,0,0,0,2,0,2,6,2,0,1,1,3.254872338,1,0.195352062,1.249752503,0.156312599,0.875786626,0.939867402,1.042017093,0,3.406246175,1.420379657,2.398123741,0.016479297,0.049593776,2.693451303,1,0.759896512,1.224589785,0.620531481,0.534907935,0.663897013,3.106740527,1,0.337728809,1.23128293,0.274290174,0.783861635,0.86067336,2.641616122,1,0.684934086,1.215343508,0.563572423,0.573045159,0.688672294,N,-,,major facilitator superfamily transporter,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); PTHR23502 (PANTHER); PTHR23502:SF54 (PANTHER); PTHR23502:SF54 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.23, the major facilitator superfamily (mfs).
RL4_JR_04899,1388,1266,1649,5,0,10,0,3,0,0,0,6,1,11,0,0,4,3,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,hypothetical protein TOPH_01913,,no IPS match,,
RL4_JR_04900,14046,6490,5740,1,4,0,0,0,0,0,0,0,0,0,0,0,0,1,41.88951419,1,2.799025935,0.575787046,4.861217279,1.17E-06,1.73E-05,2.396086915,0,2.204773855,1.298148583,1.698398692,0.089432539,0.185499213,19.22696208,0,1.367312126,1.042306475,1.311813904,0.189582932,0.312541441,23.23342345,0,1.831400756,0.763745311,2.397920785,0.016488431,0.069610783,6.159690802,1,-0.536660289,1.211521206,-0.442964008,0.657791768,0.756167111,N,-,,hypothetical protein SPI_01832,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_04901,18639,11337,8668,2,1,0,0,0,0,4,0,2,0,5,0,0,0,0,5.100625281,1,-0.452770548,1.216022545,-0.372337297,0.709641732,0.843500368,1.623899069,0,2.766078966,1.339626551,2.064813484,0.038940652,0.096951687,4.214890936,1,0.113626409,1.208713486,0.094006074,0.925104332,0.955956798,23.4873178,1,1.438659419,1.020979385,1.409097422,0.158806363,0.277417948,4.153146309,0,0.032184317,1.208371812,0.026634449,0.978751297,0.985672714,N,-,,hypothetical protein SPI_01833,P:biological_process; P:transmembrane transport; C:membrane; F:metal ion transmembrane transporter activity; P:metal ion transport; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_04902,3727,3435,3574,13,16,3,0,0,0,0,1,2,1,8,6,0,2,0,43.27327574,1,-3.53774107,1.241934471,-2.848573055,0.004391577,0.019492103,14.06059405,0,-0.348033972,1.273963144,-0.273189984,0.784707179,0.869397316,36.05474082,1,-2.983112323,1.234180028,-2.417080373,0.015645562,0.046005132,41.56193415,1,-3.404358356,1.239596868,-2.746343141,0.00602637,0.032536046,35.12419006,1,-3.048203347,1.232383503,-2.47342109,0.013382635,0.03965736,N,-,,squalene cyclase,F:intramolecular transferase activity; C:membrane; C:integral component of membrane; F:transferase activity; C:cellular_component; P:hopanoid biosynthetic process; F:isomerase activity,IPR032696 (PFAM); IPR008930 (G3DSA:1.50.10.GENE3D); IPR008930 (G3DSA:1.50.10.GENE3D); IPR018333 (TIGRFAM); IPR006400 (TIGRFAM); IPR032697 (PFAM); PTHR11764 (PANTHER); PTHR11764:SF12 (PANTHER); IPR008930 (SUPERFAMILY); IPR008930 (SUPERFAMILY),,
RL4_JR_04903,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,71.91152774,0,0.224521602,0.987929712,0.227264753,0.820217879,0.909272654,11.90889902,0,-0.108430871,1.336483632,-0.081131462,0.935337405,0.964200552,30.8676574,0,-2.759003863,1.286054058,-2.145324955,0.031926875,0.080545148,35.61664378,0,-3.181630668,1.300065983,-2.447283993,0.014393737,0.064800619,30.26689356,0,-2.83343328,1.297752618,-2.183338521,0.02901089,0.07328724,N,-,,leucoanthocyanidin dioxygenase,F:dioxygenase activity; F:iron ion binding; P:oxidation-reduction process,IPR005123 (PFAM); IPR027443 (G3DSA:2.60.120.GENE3D); IPR026992 (PFAM); PTHR10209 (PANTHER); PTHR10209:SF188 (PANTHER); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_04904,6997,4762,4801,4,3,11,0,0,1,1,0,3,3,6,0,0,5,0,15.91031485,1,-0.761709116,1.329468303,-0.572942668,0.566683514,0.743415109,3.983161989,1,1.471634754,1.486937577,0.989708496,0.322316621,0.484480077,10.15398896,1,-1.154997211,1.345715074,-0.858277679,0.390739151,0.53435677,11.69861727,1,-1.575460812,1.364761183,-1.154385714,0.24834207,0.387436588,13.7195589,1,-0.29655735,1.28776538,-0.230288338,0.817867722,0.87770248,N,-,,fungal specific transcription factor domain containing,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR007219 (PFAM); PTHR31001 (PANTHER); PTHR31001 (PANTHER); PTHR31001:SF59 (PANTHER); PTHR31001:SF59 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04905,127,426,198,0,0,5,0,0,0,0,0,1,0,2,0,0,0,0,26.22496711,1,3.145257916,0.927347979,3.391669562,0.000694682,0.004420603,0.711152599,0,3.957350189,1.553852385,2.546799314,0.010871593,0.035856067,1.829819963,1,1.317193644,1.275767188,1.032471799,0.301851152,0.443082654,2.109594462,1,0.89575884,1.302696079,0.687619203,0.491692612,0.630868365,1.791673474,0,1.244528737,1.263268399,0.985165732,0.32454267,0.460651656,N,-,,Cathepsin E,F:aspartic-type endopeptidase activity; P:proteolysis; F:peptidase activity; F:hydrolase activity,IPR001461 (PRINTS); IPR021109 (G3DSA:2.40.70.GENE3D); IPR033121 (PFAM); IPR021109 (G3DSA:2.40.70.GENE3D); PTHR13683:SF253 (PANTHER); IPR001461 (PANTHER); IPR033121 (PROSITE_PROFILES); IPR021109 (SUPERFAMILY),8.A.32.1.4,The β-Amyloid Cleaving Enzyme (BACE1) Family
RL4_JR_04906,234269,176221,216445,30,21,61,2,1,0,1,5,21,1,0,21,0,27,5,20.03125452,1,1.649561818,1.030589669,1.600599994,0.109465544,0.2364363,1.270244297,1,3.120304465,1.375417497,2.268623507,0.023291231,0.064918974,3.313012351,1,0.460594658,1.221059832,0.377208918,0.706018353,0.800507314,3.823171988,1,0.037839574,1.225613577,0.030873984,0.975370038,0.98517231,25.38112266,1,2.622286441,0.873151362,3.00324383,0.002671183,0.010818292,N,-, Effector probability:0.622,n-carbamoyl-l-amino acid hydrolase,,G3DSA:3.40.630.10 (GENE3D); PTHR32494 (PANTHER); PTHR32494:SF9 (PANTHER); SSF53187 (SUPERFAMILY),,
RL4_JR_04907,995,721,672,0,1,0,0,0,0,0,0,1,0,1,2,0,2,0,4.381799732,1,-0.233589818,1.233876537,-0.189313769,0.849846904,0.924808277,1.394932741,0,2.985364085,1.370012664,2.179077729,0.029325894,0.077848598,3.619178602,1,0.333526858,1.218489414,0.273721588,0.784298586,0.857166683,4.175497478,1,-0.088936278,1.221509861,-0.072808482,0.941958521,0.965967215,3.563281715,1,0.253207696,1.216657051,0.208117559,0.835137177,0.888417281,N,-,,urea active transport,P:transmembrane transport; C:membrane; C:integral component of membrane; P:transport; F:transporter activity; F:hydrolase activity,IPR015797 (G3DSA:3.90.79.GENE3D); IPR000086 (PFAM); PTHR12992:SF12 (PANTHER); PTHR12992 (PANTHER); IPR000086 (PROSITE_PROFILES); IPR015797 (SUPERFAMILY),,
RL4_JR_04908,1688,1444,2578,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,1718.968866,1,2.535370169,0.246639826,10.27964628,8.70E-25,2.29E-22,137.0681429,0,0.27844391,0.651153361,0.427616482,0.668930364,0.788782985,596.2644924,1,0.884517269,0.442032795,2.001021823,0.045390038,0.105107215,1256.836911,0,2.074498919,0.238317396,8.704773371,3.18E-18,2.52E-16,632.5902708,0,1.183357166,0.383537518,3.085375252,0.002032955,0.008587262,Y,-,,---NA---,,no IPS match,,
RL4_JR_04909,1207,1090,2441,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,531.9595362,1,1.536828259,1.060650283,1.448949086,0.147351802,0.293277069,91.22148158,0,0.535730332,1.381866526,0.387686019,0.698248404,0.808489934,696.5014219,0,2.388592937,0.69231885,3.450134195,0.000560308,0.003681089,426.9697516,1,1.162890722,0.660823323,1.759760411,0.078448438,0.164143508,231.0029122,0,0.320484666,0.737264316,0.434694395,0.663784267,0.760445316,N,-,,hypothetical protein CMQ_2358,,no IPS match,,
RL4_JR_04910,1301,972,1526,0,2,11,0,0,0,0,0,0,0,0,0,0,7,0,168.4868958,1,1.296717484,0.811902431,1.597134625,0.110235701,0.237408356,52.77869413,0,1.984689217,0.991474572,2.001755036,0.045311084,0.109069867,92.43236359,0,0.505272721,1.150209615,0.439287513,0.660453221,0.765502166,209.8068205,0,1.947844853,0.69759786,2.792217356,0.005234818,0.02899482,128.5004915,1,1.527726514,0.696159373,2.194506854,0.028198992,0.071719365,N,-,,LSB3-possible role in the regulation of actin cytoskeletal organization,,IPR007461 (PFAM); PTHR15629 (PANTHER); PTHR15629:SF8 (PANTHER),,
RL4_JR_04911,1998,1643,2140,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,288.2951515,1,0.971926311,0.354288391,2.74331967,0.006082144,0.025483695,286.7881056,0,3.00001469,1.436358939,2.088624653,0.036741524,0.092769427,177.681168,0,0.329678327,0.482805147,0.682839295,0.494708396,0.62777987,241.134811,0,0.797815776,0.411662463,1.938033822,0.052619096,0.126308286,126.3581105,0,-0.343423726,0.528497002,-0.649812061,0.515813627,0.641677476,N,-,,vacuolar sorting-associated 35,"C:retromer complex; C:late endosome; C:cytosol; F:protein transporter activity; P:intracellular protein transport; P:retrograde transport, endosome to Golgi",IPR005378 (PFAM); IPR005378 (PIRSF); IPR005378 (PANTHER),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_04912,198,188,234,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,239.236505,0,-0.414804966,0.497198308,-0.834284749,0.404120544,0.596061363,46.99217284,0,-2.088814994,1.216836196,-1.716595052,0.086053187,0.180188325,290.5679851,0,0.434115663,0.419939571,1.033757457,0.301249565,0.442456201,224.349443,0,-0.439475562,0.48947538,-0.897850188,0.369265424,0.514987936,163.0416938,0,-1.344456712,0.610932149,-2.200664531,0.027759782,0.070797931,N,-,,glutamate carboxypeptidase,C:membrane,IPR007365 (PFAM); IPR003137 (PFAM); G3DSA:3.40.630.10 (GENE3D); IPR007484 (PFAM); IPR007365 (G3DSA:1.20.930.GENE3D); G3DSA:3.50.30.30 (GENE3D); PTHR10404:SF49 (PANTHER); PTHR10404:SF49 (PANTHER); PTHR10404 (PANTHER); PTHR10404 (PANTHER); SSF52025 (SUPERFAMILY); SSF53187 (SUPERFAMILY); IPR007365 (SUPERFAMILY),9.B.229.1.3," the transferrin receptor, cd71, (tfr) family."
RL4_JR_04913,109,105,164,0,0,26,0,0,0,0,0,0,0,10,0,0,0,0,92.02430202,1,8.056458012,1.165446712,6.912763944,4.75E-12,2.15E-10,0.121337151,0,6.5086466,2.029903739,3.206381896,0.001344155,0.015023052,0.313571344,0,3.863218318,1.318155676,2.930775469,0.003381171,0.014799383,0.361685523,1,3.440406829,1.532902145,2.244374724,0.024808301,0.085296029,0.307411941,0,3.788663156,1.248494189,3.034586135,0.00240866,0.009905637,N,-,,general alpha-glucoside permease,P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane,IPR005828 (PFAM); PTHR23500:SF82 (PANTHER); PTHR23500 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.1.68, the major facilitator superfamily (mfs).
RL4_JR_04914,33,14,47,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.777397778,0,-0.358280588,1.22243927,-0.293086615,0.769455947,0.879039577,1.529453987,0,2.852592211,1.360428856,2.096833068,0.036008355,0.091278881,23.45035235,0,2.604112328,0.869369865,2.995402111,0.002740833,0.0126994,21.89633776,0,2.093720863,0.868872101,2.409699725,0.015965655,0.068092778,25.97597334,0,2.367857141,0.850455578,2.784222012,0.005365629,0.018982179,N,-,,alpha-L-rhamnosidase,,IPR016007 (PIRSF); IPR013737 (PFAM); IPR008979 (G3DSA:2.60.120.GENE3D); IPR008902 (PFAM); PTHR33307 (PANTHER); PTHR33307:SF5 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_04915,244,402,365,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,31.23440045,1,1.936499699,0.690099313,2.806117413,0.005014242,0.021816632,2.527094003,0,2.127960931,1.292708959,1.646125306,0.099737963,0.202131087,6.577959294,0,-0.528864531,1.205852006,-0.438581624,0.660964715,0.765868565,16.90200056,0,-0.000858008,1.152550572,-0.000744443,0.99940602,0.999504737,28.60771269,0,1.627976846,0.861370895,1.889983579,0.058760156,0.126479533,N,-,,cmgc cdk cdk5 kinase,,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); PTHR24056 (PANTHER); PTHR24056:SF46 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_04916,609,795,884,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1.425800103,0,1.386000859,1.404779138,0.986632576,0.323822795,NA,0.450978871,0,4.614308744,1.593648143,2.895437593,0.003786303,0.017572196,1.175773611,1,1.955323986,1.255051008,1.557963758,0.11924184,0.220735854,1.356880681,1,1.532507926,1.291018176,1.187053718,0.235206432,0.372627934,1.163987705,0,1.867592555,1.245302349,1.499710136,0.133689504,0.237225066,N,-,,WW domain-containing oxidoreductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24320 (PANTHER); PTHR24320:SF99 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04917,379,377,434,0,0,41,0,0,0,0,0,1,0,1,6,1,4,0,43.65294396,1,-0.829059696,0.889562237,-0.931986163,0.351343676,0.541621639,10.19734795,0,0.115356456,1.225695078,0.094115134,0.925017699,0.958737823,26.57688536,1,-2.543138434,1.203628675,-2.11289286,0.034609939,0.085730773,30.66906195,1,-2.965913976,1.204485205,-2.462391371,0.013801397,0.062635208,26.31365711,1,-2.631496422,1.21235783,-2.170560834,0.029964385,0.075096387,N,-,,secreted glycosyl hydrolase,P:glutamine metabolic process; F:transferase activity; F:hydrolase activity,IPR029010 (PFAM); IPR029062 (G3DSA:3.40.50.GENE3D); PTHR40469 (PANTHER); PTHR40469:SF1 (PANTHER); PTHR40469 (PANTHER); PTHR40469:SF1 (PANTHER); IPR029062 (SUPERFAMILY),,
RL4_JR_04918,412,436,304,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,2.858417219,0,0.38257571,1.231714055,0.310604323,0.756101441,0.87221091,0.916808444,0,3.590909563,1.425239582,2.519512935,0.011751732,0.038015671,10.21241917,0,1.906670417,1.197611993,1.592060223,0.111371174,0.210079332,2.73284706,1,0.522611298,1.218855085,0.4287723,0.668088939,0.773816819,2.32580199,1,0.868422873,1.202662997,0.722083306,0.470243261,0.601719616,N,-,,upf0187 domain membrane,P:mycelium development; C:integral component of membrane,IPR021134 (PFAM); PTHR33281 (PANTHER); PTHR33281:SF1 (PANTHER),1.A.46.2.1, the anion channel-forming bestrophin (bestrophin) family.
RL4_JR_04919,265,427,308,0,1,0,0,0,0,0,0,0,0,2,0,0,0,0,825.5186631,1,-5.122598714,0.863762339,-5.930565018,3.02E-09,7.62E-08,261.108825,0,-4.562988545,1.240254463,-3.679074481,0.000234082,0.009710562,934.4891503,0,-1.330131864,0.906548119,-1.467249046,0.142308319,0.252001349,810.5169738,1,-4.843042483,0.824689986,-5.872561283,4.29E-09,1.28E-07,682.1041938,0,-4.462204472,0.845262723,-5.279074008,1.30E-07,2.84E-06,N,-,,MFS SP sugar:H+ symporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR003663 (PRINTS); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); IPR003663 (TIGRFAM); PTHR23500:SF146 (PANTHER); PTHR23500:SF146 (PANTHER); PTHR23500 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.40, the major facilitator superfamily (mfs).
RL4_JR_04920,6178,5756,5436,2,6,13,0,0,0,6,11,16,24,99,17,1,33,13,144.976869,1,-1.564400146,0.657515198,-2.379260814,0.017347397,0.058527736,63.16861398,0,0.503786328,0.880143001,0.572391449,0.567056807,0.708785997,162.3466129,1,-0.287560211,1.56153116,-0.18415272,0.853893649,0.907402047,133.7139861,1,-2.380356423,0.874112061,-2.723170781,0.006465862,0.034365804,93.52651996,1,-3.471630516,1.143010512,-3.037269105,0.002387322,0.009837866,N,-,,phosphoribulokinase uridine kinase family,F:nucleotide binding; P:metabolic process; F:transferase activity; C:intracellular part,IPR027417 (G3DSA:3.40.50.GENE3D); IPR006083 (PFAM); PTHR10285:SF81 (PANTHER); PTHR10285 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_04921,4874,3670,7882,0,0,4,4,0,0,0,0,0,0,3,2,0,11,3,37.21339764,1,0.702274307,0.741236884,0.947435729,0.343416792,0.533433776,5.727864909,1,0.94744941,1.25435507,0.755327923,0.450052249,0.61040183,14.9541272,0,-1.713554099,1.212048427,-1.413767025,0.157430319,0.27171828,26.57043687,1,-1.184395696,1.164391607,-1.017179863,0.309067874,0.454775791,14.83782391,1,-1.804955937,1.223748041,-1.474940818,0.140228455,0.246319607,N,-,,lactose regulatory LAC9,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; C:integral component of membrane",IPR001138 (SMART); IPR007219 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); IPR001138 (PFAM); G3DSA:1.20.5.170 (GENE3D); PTHR31944:SF81 (PANTHER); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04922,2387,2982,4803,0,0,1,0,0,0,0,3,0,0,0,0,0,0,1,0.436607284,1,3.093097175,2.143824296,1.44279416,0.149078465,NA,0.140791764,0,6.293913805,1.994885684,3.155024799,0.001604845,0.015023052,8.206372761,1,4.609827974,1.229105925,3.750553862,0.000176444,0.001628499,19.68962829,0,4.990250937,1.05483841,4.730820274,2.24E-06,3.73E-05,0.356983351,1,3.571001879,1.26783144,2.816621962,0.004853161,0.017486924,N,-,,ankyrin repeat,,G3DSA:3.10.20.90 (GENE3D); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR22731 (PANTHER); IPR000626 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY); IPR029058 (SUPERFAMILY),,
RL4_JR_04923,131,451,376,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,38.09584311,0,2.273170864,0.707406195,3.213388406,0.001311788,0.007324821,2.076446619,0,2.41146692,1.352477783,1.782999285,0.07458642,0.161386007,44.56292191,1,2.917244616,0.715773251,4.075654702,4.59E-05,0.000672273,27.83661743,0,2.059327186,0.786676891,2.617754774,0.008851039,0.044124455,12.95783995,0,1.355632508,1.006363583,1.347060377,0.177960788,0.295005194,N,-,,FAD dependent oxidoreductase superfamily,F:oxidoreductase activity; P:oxidation-reduction process; C:cellular_component,IPR006076 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13847:SF195 (PANTHER); PTHR13847 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_04924,77,123,85,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.50620084,0,6.708725471,0.783449459,8.563060958,1.10E-17,1.05E-15,0.074345465,0,7.215214538,2.217219493,3.254172426,0.001137232,0.015023052,0.192346915,0,4.567323135,1.34598708,3.393288988,0.000690587,0.004284012,0.221855077,0,4.145135693,1.727671261,2.39926182,0.016428164,0.069480015,0.189098643,0,4.488528169,1.24944223,3.592425533,0.000327614,0.001884713,N,-, Effector probability:0.828,---NA---,,IPR001305 (G3DSA:2.10.230.GENE3D); IPR001841 (PROSITE_PROFILES),,
RL4_JR_04925,19473,38170,37600,0,0,22,0,4,0,0,0,0,1,2,0,0,6,0,5.239093104,1,-0.491417733,1.212023868,-0.405452191,0.685145154,0.828896683,1.679899213,1,2.717232524,1.345222691,2.019912794,0.043392434,0.105498605,4.340344801,0,0.07142464,1.209489027,0.059053566,0.952909443,0.972799758,5.006036678,1,-0.350613534,1.209446043,-0.28989597,0.771895825,0.851912495,4.257178717,1,-0.003656975,1.202662627,-0.003040732,0.997573851,0.998165356,N,-,,oxidoreductase,,IPR016040 (G3DSA:3.40.50.GENE3D); IPR008030 (PFAM); PTHR10366 (PANTHER); PTHR10366:SF417 (PANTHER); PTHR10366 (PANTHER); PTHR10366:SF417 (PANTHER); PTHR10366 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04926,17,79,82,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,50.48395227,0,-1.372844301,1.015711771,-1.351608143,0.176500704,0.331848984,10.3074686,0,0.099895667,1.216037319,0.082148521,0.934528609,0.963917721,79.48790943,0,0.858950798,0.619988387,1.385430464,0.165920881,0.282839367,64.60477689,0,0.535851731,0.588015067,0.911289117,0.362143059,0.508204916,34.14832569,0,-0.971419357,0.982492185,-0.988729857,0.322795331,0.458773544,N,-,,hypothetical protein CMQ_2386,C:membrane; C:integral component of membrane,PF16015 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (SUPERFAMILY),,
RL4_JR_04927,155,210,175,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.232340651,0,4.003333337,2.776766961,1.441724636,0.149380071,NA,0.07451821,0,7.211929707,2.218360406,3.251018043,0.001149926,0.015023052,0.19262774,0,4.565540513,1.347642471,3.387798034,0.000704561,0.004349984,0.222170832,0,4.1431733,1.729270819,2.395907717,0.016579264,0.069798356,0.189147881,0,4.488284934,1.249649699,3.59163447,0.000328611,0.001889371,,,,,,,,
RL4_JR_04928,212,87,178,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,344.3929014,0,-1.600837229,0.533407202,-3.001154133,0.002689584,0.013225814,108.4205281,0,-2.031470212,1.144801865,-1.77451686,0.075977696,0.16366168,270.8813134,0,-1.993166749,0.638192482,-3.123143573,0.001789304,0.009057459,311.8808953,0,-2.010882801,0.571123565,-3.520924237,0.000430045,0.003696657,242.4183037,0,-2.734764008,0.729906051,-3.746734262,0.000179152,0.001132279,N,-,,DNA helicase INO80,"F:ATPase activity; P:DNA repair; P:regulation of transcription from RNA polymerase II promoter in response to stress; P:histone exchange; P:transcription from RNA polymerase II promoter; F:helicase activity; P:telomere maintenance via recombination; P:positive regulation of transcription from RNA polymerase II promoter; P:chromatin silencing at telomere; P:nucleosome mobilization; P:regulation of chromosome segregation; C:chromosome, telomeric region; F:DNA binding; F:ATP binding; P:DNA duplex unwinding; C:Ino80 complex; P:nucleosome positioning",IPR001650 (SMART); IPR014001 (SMART); IPR000330 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR020838 (PFAM); PTHR10799 (PANTHER); IPR031047 (PTHR10799:PANTHER); PTHR10799 (PANTHER); PTHR10799 (PANTHER); IPR031047 (PTHR10799:PANTHER); IPR031047 (PTHR10799:PANTHER); PTHR10799 (PANTHER); IPR031047 (PTHR10799:PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR020838 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_04929,418,220,417,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.69474395,0,-2.402062971,1.218491391,-1.971341766,0.048684797,0.130091901,6.368449013,0,0.794636287,1.279655255,0.620976848,0.534614856,0.682631684,16.37571632,0,-1.844447487,1.218947528,-1.513147567,0.130242179,0.236303194,18.88078933,0,-2.265983986,1.219834259,-1.857616286,0.063223524,0.141061741,15.99371379,0,-1.913267408,1.215957658,-1.573465487,0.115611074,0.213023134,N,-,,DNA helicase INO80,P:cellular component organization,no IPS match,,
RL4_JR_04930,10244,7618,11270,3,0,3,0,0,1,0,3,0,0,5,0,0,5,3,1046.442918,1,-1.335370124,0.401792951,-3.323528001,0.000888865,0.005427665,282.7750908,1,-2.742332695,1.004296875,-2.730599649,0.006321922,0.024092806,643.4462417,1,-5.24464283,1.062887956,-4.93433273,8.04E-07,2.24E-05,801.2667667,1,-3.006755281,1.669422968,-1.801074586,0.071691125,0.153811602,661.6596136,1,-3.288759994,0.707954373,-4.645440611,3.39E-06,4.10E-05,N,-,,atp-binding cassette sub-family f member 2,"F:ATPase activity, uncoupled; P:ribosomal small subunit export from nucleus; C:nucleus; F:ATP binding; C:ribosome",IPR003593 (SMART); IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR032781 (PFAM); PTHR19211:SF15 (PANTHER); PTHR19211 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.121.10, the atp-binding cassette (abc) superfamily.
RL4_JR_04931,8330,3954,4706,2,1,11,0,0,0,0,0,0,2,6,2,0,3,2,11.55573529,1,1.648275247,1.030695003,1.599188161,0.1097788,0.236924722,10.62889009,0,4.058514934,1.143747625,3.548435726,0.000387527,0.014476338,3.239903538,0,0.493288656,1.213738403,0.406420902,0.684433364,0.783173847,13.37285994,1,1.021723777,1.152659069,0.88640588,0.375398852,0.521002626,3.186434678,1,0.414463349,1.209074934,0.342793765,0.731753617,0.812034784,N,-,,putative conserved hypothetical protein,,no IPS match,,
RL4_JR_04932,204,77,119,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36.98435965,0,-2.010038396,1.137144713,-1.767618819,0.07712465,0.18306165,9.265919786,0,0.253587328,1.217158919,0.208343647,0.834960654,0.901105847,37.01097473,0,-0.576124085,1.029571743,-0.559576435,0.575768382,0.698260554,27.69998618,0,-2.819044104,1.187333705,-2.374264364,0.017583956,0.072271927,23.6556288,0,-2.477919063,1.19096412,-2.080599257,0.037470602,0.089394403,N,-,,fungal transcriptional regulatory,"F:DNA binding; C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31845:SF5 (PANTHER); PTHR31845:SF5 (PANTHER); PTHR31845 (PANTHER); PTHR31845:SF5 (PANTHER); PTHR31845 (PANTHER); PTHR31845 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04933,87,126,106,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,53.79131532,0,-3.851596636,1.237585729,-3.112185722,0.001857076,0.009856882,17.15359981,0,-0.634896285,1.246680625,-0.509269393,0.610563409,0.743607607,50.90091183,0,-2.321742292,1.222690496,-1.898879806,0.057580281,0.126014433,70.49369501,0,-1.932405931,1.060127848,-1.822804612,0.068332989,0.148438428,58.65147037,0,-1.155001827,0.892187555,-1.294572895,0.195467608,0.316553011,N,-,,major facilitator superfamily transporter,C:membrane,PR01036 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501:SF73 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.79, the major facilitator superfamily (mfs).
RL4_JR_04934,1679,1974,2388,0,0,0,4,0,0,0,0,1,3,0,0,0,2,0,0.019755654,0,7.558048245,3.960375896,1.908416888,0.056337356,NA,0.006009241,1,10.83882119,3.962920982,2.73505862,0.006236917,0.023876729,0.016138471,1,8.137766329,2.852905856,2.852448255,0.004338388,0.017050402,0.018655047,1,7.714928872,3.960956383,1.94774396,0.051445607,0.125322509,0.016501975,1,8.014622944,1.673129863,4.790197772,1.67E-06,2.20E-05,N,-,,heterokaryon incompatibility,,IPR010730 (PFAM); PTHR33112 (PANTHER); PTHR33112:SF6 (PANTHER),,
RL4_JR_04935,56,43,83,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38.84095361,0,-0.61780372,0.931828558,-0.663001487,0.507329602,0.693730287,8.860162681,0,0.318200216,1.280891178,0.24842096,0.803808718,0.881346554,33.88830209,0,-1.361355326,1.228067241,-1.108534843,0.2676309,0.405734536,38.34364684,0,-0.482200025,0.93121426,-0.517818558,0.604584869,0.725441609,45.52448433,0,0.714026386,0.734458201,0.972181106,0.330960458,0.467783053,N,-,,drug proton antiporter yhk8,C:membrane,IPR013094 (PFAM); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23502:SF7 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR029058 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.2.63, the major facilitator superfamily (mfs).
RL4_JR_04936,5,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.064065484,0,5.861878125,3.923388396,1.494085605,0.135153246,NA,0.020886303,0,9.047832649,2.906333919,3.113142846,0.001851064,0.015023052,0.053422257,0,6.417095416,1.675140416,3.830780604,0.000127737,0.0013429,0.061573348,0,5.994643999,2.843191282,2.108420927,0.034994596,0.099498352,0.051889466,0,6.350558638,1.353278115,4.692722485,2.70E-06,3.35E-05,N,-,,cytochrome p450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:regulation of transcription, DNA-templated; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24279 (PANTHER); PTHR24279:SF60 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_04937,7,13,8,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0.131829291,1,4.820821549,3.552053825,1.357192708,0.174719987,NA,0.041762339,0,8.046815727,2.487808364,3.234499828,0.00121856,0.015023052,0.108901587,0,5.386863449,1.443423546,3.732004694,0.000189962,0.001705046,0.12566932,0,4.964860386,2.126394677,2.334872467,0.019550084,0.075899004,0.107949277,0,5.299058964,1.286770547,4.118107129,3.82E-05,0.00030917,N,-,,n-carbamoylsarcosine amidase,F:binding,IPR007219 (PFAM); PTHR31313:SF31 (PANTHER); PTHR31313 (PANTHER); IPR001138 (SUPERFAMILY),,
RL4_JR_04938,18,14,19,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0.011666121,1,8.315060612,3.996942811,2.080355163,0.037492969,NA,0.003670122,0,11.54963874,3.998254364,2.888670325,0.003868744,0.017716233,0.009673795,0,8.874006407,3.050060812,2.909452288,0.003620626,0.015525295,0.01116718,0,8.453598072,3.996777749,2.115103366,0.034421138,0.099376683,0.009745957,0,8.762396083,1.617624164,5.416830608,6.07E-08,1.53E-06,N,-,,purine-cytosine permease fcy22,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR001248 (PFAM); IPR026030 (PIRSF); PTHR31806:SF5 (PANTHER); PTHR31806 (PANTHER),2.A.39.2.4, the nucleobase:cation symporter-1 (ncs1) family.
RL4_JR_04939,53,58,59,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,0.068093233,1,5.773930313,3.922407253,1.472037436,0.141010769,NA,0.020880556,0,9.046075965,3.923057713,2.305873792,0.021117685,0.060079465,0.055600947,0,6.35663785,2.368710891,2.683585352,0.007283738,0.025366551,0.064248122,0,5.932621293,3.922596961,1.512421835,0.130426584,0.239363632,0.056234734,0,6.241008336,1.780123823,3.505940574,0.000454997,0.002507808,,,,,,,,
RL4_JR_04940,925,526,852,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,1.424003532,1,1.387797696,1.366195555,1.015811896,0.30971897,NA,0.458508257,0,4.590649551,1.594089264,2.879794536,0.003979344,0.0180704,1.18184342,0,1.948377791,1.244942208,1.565034728,0.117574767,0.218609171,1.362873546,0,1.526434132,1.27555657,1.196680859,0.23143097,0.368375817,15.88772834,0,3.567738637,0.984854702,3.622604056,0.000291652,0.0017112,N,-,,phytanoyl- dioxygenase,,IPR021858 (PFAM); G3DSA:1.20.1070.10 (GENE3D); IPR008775 (PFAM); IPR023041 (PFAM); G3DSA:2.60.120.620 (GENE3D); PTHR23112 (PANTHER); PTHR23112:SF17 (PANTHER); SSF51197 (SUPERFAMILY); SSF81321 (SUPERFAMILY),,
RL4_JR_04941,404,404,372,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,33.14127032,0,0.72406604,0.847238957,0.854618445,0.392762413,0.584985647,92.83886268,0,4.262586431,0.743691603,5.731658681,9.95E-09,1.49E-06,15.80575158,0,-0.067416548,1.191180679,-0.056596408,0.954866696,0.974110281,99.99177591,0,2.98846591,0.439528273,6.799257508,1.05E-11,4.45E-10,20.38556742,1,0.568129725,0.97067916,0.585290948,0.558352101,0.677287051,N,-,,Lipid droplet-associated hydrolase,C:lipid particle; C:cytoplasm,IPR029058 (G3DSA:3.40.50.GENE3D); PF10230 (PFAM); PTHR13390:SF0 (PANTHER); IPR019363 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_04942,134,159,150,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.50308886,0,8.552202736,1.003185196,8.525048785,1.53E-17,1.40E-15,0.015362424,0,9.490051181,3.077312212,3.083876619,0.002043223,0.015023052,0.039575248,0,6.846862609,1.770221938,3.867798981,0.000109822,0.001229911,0.045627439,0,6.426359845,3.189603331,2.014783401,0.043927349,0.113902079,3.899366617,0,7.690931225,1.238737043,6.208687523,5.34E-10,3.22E-08,N,-,,integral membrane,,PTHR33048 (PANTHER); PTHR33048:SF42 (PANTHER),9.B.313.1.6, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_04943,1107,1071,1301,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,42.60827714,1,-3.515403005,1.229339014,-2.859587929,0.004241918,0.018941197,13.43674877,0,-0.282650917,1.235200625,-0.228829966,0.819001075,0.890745101,35.14418534,0,-2.946263077,1.217809259,-2.419314072,0.015549808,0.045776753,44.57465339,0,-2.424234704,1.175509701,-2.062283876,0.039180717,0.106070792,34.94334172,0,-3.040716126,1.230726728,-2.470667173,0.013486127,0.039891041,N,-,,Ribosome biogenesis ALB1,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_04944,182,277,233,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,190.91578,0,0.744203453,0.915944959,0.812498007,0.41650593,0.607954084,22.10417464,0,-1.00070787,1.227521617,-0.815226271,0.414942803,0.578678844,133.8198578,0,0.610632885,0.521718603,1.170425746,0.24182968,0.375158394,307.3021527,0,1.785682937,0.38120563,4.684303677,2.81E-06,4.58E-05,176.4792607,0,1.415863273,0.44013997,3.216847754,0.001296074,0.005916476,Y,-,,integral membrane,C:integral component of membrane,IPR018825 (PFAM); IPR018827 (PFAM); PTHR31685:SF2 (PANTHER); PTHR31685 (PANTHER); PTHR31685:SF2 (PANTHER); PTHR31685 (PANTHER),9.B.57.1.1, the conidiation and conidial germination protein (ccgp) family.
RL4_JR_04945,18,59,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.927948245,0,0.491501005,1.149609723,0.427537272,0.668988044,0.816639901,1.641203146,0,2.750814212,1.344764407,2.045573335,0.040798367,0.100746785,36.73457071,0,3.236473872,0.682272014,4.74367086,2.10E-06,5.07E-05,52.74445588,0,2.776918248,0.677726883,4.097400177,4.18E-05,0.000500376,124.0602459,0,4.685656988,1.393888826,3.361571526,0.000775003,0.003887049,N,-,,monocarboxylate transporter,C:membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11360:SF124 (PANTHER); PTHR11360 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.13.19, the major facilitator superfamily (mfs).
RL4_JR_04946,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.11843533,0,2.104399408,0.560459701,3.754773811,0.000173498,0.001370181,3.198671553,0,1.788049553,1.267189145,1.411036041,0.158233987,0.288013742,70.81201166,0,3.122008425,0.508002417,6.14565664,7.96E-10,4.16E-08,69.59311476,0,2.891781067,0.464504681,6.225515441,4.80E-10,1.63E-08,8.167588567,0,-0.943730844,1.193955076,-0.790424081,0.429280143,0.563816507,N,-,,bar domain-containing,C:cytoplasm,IPR004148 (SMART); IPR027267 (G3DSA:1.20.1270.GENE3D); IPR004148 (PFAM); PTHR10663 (PANTHER); PTHR10663:SF184 (PANTHER); PTHR10663 (PANTHER); PTHR10663:SF184 (PANTHER); IPR004148 (PROSITE_PROFILES); SSF103657 (SUPERFAMILY),8.A.34.1.4, the endophilin (endophilin) family.
RL4_JR_04947,726,567,383,0,0,0,0,0,0,0,0,5,0,5,0,0,4,0,20.41756409,0,-1.209353186,1.164766804,-1.038279235,0.299140073,0.484780436,5.288100086,0,1.062707793,1.261550238,0.842382459,0.399573908,0.563542403,13.75489312,1,-1.593006876,1.211123192,-1.315313658,0.18840451,0.310855159,49.57403391,1,1.474587036,0.627381623,2.350382898,0.018754108,0.074426671,13.61470385,1,-1.680900349,1.22027627,-1.377475241,0.168365365,0.282662339,N,-,,cyclin ccl1,"P:regulation of macromolecule metabolic process; P:transcription, DNA-templated; C:holo TFIIH complex; P:regulation of primary metabolic process; P:regulation of cellular metabolic process",IPR031658 (PFAM); IPR013763 (G3DSA:1.10.472.GENE3D); IPR013763 (G3DSA:1.10.472.GENE3D); IPR027081 (PTHR10026:PANTHER); IPR027081 (PTHR10026:PANTHER); PTHR10026 (PANTHER); PTHR10026 (PANTHER); IPR013763 (SUPERFAMILY); IPR013763 (SUPERFAMILY),,
RL4_JR_04948,3566,2411,2385,0,5,2,0,0,1,0,9,2,1,0,6,0,4,0,122.6988396,1,0.25335202,0.542473944,0.467030763,0.640477868,0.795647701,63.90554283,1,0.885211868,1.005500096,0.88036975,0.378659038,0.542964554,62.76286301,1,-1.633905734,1.056967505,-1.54584292,0.122142509,0.224791819,82.75524286,1,-0.84861612,0.718623522,-1.180891099,0.237645988,0.375552618,89.41086073,1,-0.268892157,0.659897569,-0.407475599,0.683658712,0.7753186,N,-,,ubiquitin-conjugating enzyme,,SM00212 (SMART); IPR016135 (G3DSA:3.10.110.GENE3D); IPR000608 (PFAM); PTHR10044:SF120 (PANTHER); PTHR10044 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_04949,13553,12856,9255,1,3,7,0,0,0,0,4,0,5,6,1,0,5,10,0.219538555,1,4.085037236,2.967424391,1.376627236,0.168627526,NA,0.072007572,0,7.261793404,2.357177957,3.080714964,0.002065042,0.015023052,0.183581932,1,4.635300936,1.49277638,3.10515426,0.001901798,0.009522158,0.211540285,1,4.21404253,1.936077572,2.176587649,0.029511348,0.091432801,0.177822434,1,4.57560232,1.354559449,3.377926545,0.000730346,0.003721566,N,-,,2-polyprenyl-6-methoxyphenol hydroxylase,F:FAD binding; F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process,PR00420 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR002938 (PFAM); PTHR13789:SF251 (PANTHER); PTHR13789 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_04950,165,148,206,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.827404665,0,-0.038521145,1.290043095,-0.029860355,0.976178424,0.98792502,1.235157242,0,3.160974384,1.450707888,2.178918589,0.029337717,0.07785027,3.175167375,0,0.522454029,1.255427453,0.416156289,0.677295643,0.77822507,3.661131785,0,0.100776072,1.266857574,0.079548068,0.9365967,0.96313646,3.095663265,0,0.45594597,1.245441617,0.366091806,0.714296572,0.798823481,N,-,,Siderophore iron transporter 1,,G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF92 (PANTHER); PTHR23501:SF92 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.16.1, the major facilitator superfamily (mfs).
RL4_JR_04951,110,84,94,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12176.53254,0,-7.040900351,0.531026797,-13.25903022,4.00E-40,4.66E-37,4039.226146,0,-5.113539132,1.188766394,-4.301550882,1.70E-05,0.001041703,10950.05734,0,-3.404626644,0.571994536,-5.952201345,2.65E-09,1.29E-07,12463.8023,0,-3.677796031,0.464325286,-7.920731743,2.36E-15,1.49E-13,9944.746844,0,-6.015290191,1.231422253,-4.884831485,1.04E-06,1.50E-05,N,-,,UDP-glucose 6-dehydrogenase,"F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; P:single-organism metabolic process",IPR014027 (SMART); IPR001732 (PFAM); IPR017476 (PIRSF); IPR014027 (PFAM); IPR028357 (PIRSF); IPR014026 (PFAM); IPR017476 (TIGRFAM); IPR016040 (G3DSA:3.40.50.GENE3D); G3DSA:1.20.5.100 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR11374:SF3 (PANTHER); IPR017476 (PANTHER); PTHR11374:SF3 (PANTHER); IPR017476 (PANTHER); IPR014027 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR008927 (SUPERFAMILY),,
RL4_JR_04952,29,24,42,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1964.285535,0,-9.042113508,1.23225214,-7.337876082,2.17E-13,1.15E-11,632.107737,0,-5.83850501,1.236964315,-4.720027036,2.36E-06,0.000185031,1803.734111,0,-3.1469086,0.544014166,-5.784607826,7.27E-09,3.14E-07,1994.403698,0,-4.050702194,0.542542738,-7.466143976,8.26E-14,4.44E-12,1611.282096,0,-5.966631976,0.853739257,-6.988822319,2.77E-12,2.62E-10,Y,-,,glycosyltransferase family 2,P:polysaccharide catabolic process; C:integral component of membrane; F:transferase activity; F:cellulase activity,IPR002594 (PFAM); IPR001173 (PFAM); IPR029044 (G3DSA:3.90.550.GENE3D); IPR013319 (G3DSA:2.60.120.GENE3D); PTHR10587:SF82 (PANTHER); PTHR10587:SF82 (PANTHER); PTHR10587 (PANTHER); PTHR10587 (PANTHER); PS51257 (PROSITE_PROFILES); IPR029044 (SUPERFAMILY); IPR013320 (SUPERFAMILY),4.D.3.1.12, the glycan glucosyl transferase (opgh) family.
RL4_JR_04953,16,3,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.93538441,0,1.157949509,0.841437504,1.376156285,0.168773253,0.321244096,2.651867606,0,2.058533943,1.282396962,1.605223659,0.108444593,0.215340128,45.86044859,0,2.808203819,0.612312458,4.586226821,4.51E-06,9.60E-05,45.17128422,0,1.73212237,0.734360631,2.358680865,0.01834002,0.073951694,6.759126454,0,-0.670659473,1.192384008,-0.56245259,0.573807697,0.688963639,N,-, Effector probability:0.557,glutathione s-transferase,,IPR010987 (G3DSA:1.20.1050.GENE3D); IPR004046 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR11571:SF139 (PANTHER); PTHR11571 (PANTHER); IPR004045 (PROSITE_PROFILES); IPR010987 (PROSITE_PROFILES); IPR010987 (SUPERFAMILY); IPR012336 (SUPERFAMILY),,
RL4_JR_04954,12,33,41,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.35056852,0,0.664386931,1.2992547,0.511360037,0.609098973,0.775199598,0.748515677,0,3.883290507,1.48417448,2.616464951,0.008884549,0.030839986,8.446630515,0,2.188124169,1.218620474,1.795574763,0.072562173,0.151243115,2.247363005,0,0.804217095,1.259560373,0.638490312,0.523154559,0.657759829,1.929312021,0,1.138030501,1.241990885,0.916295373,0.359511994,0.496900542,N,-,,dehydrogenase reductase,,IPR002347 (PRINTS); SM00822 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24320 (PANTHER); PTHR24320:SF72 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04955,1625,1145,1121,3,1,1,0,0,0,0,1,0,0,5,2,0,0,2,63.69013149,1,1.062497272,0.607014846,1.750364558,0.080055428,0.188308535,5.714232177,0,0.950967973,1.238885005,0.767599873,0.442724938,0.603943642,84.35730556,1,2.428912032,0.502027321,4.838206864,1.31E-06,3.40E-05,110.9827553,1,2.42211654,0.422319007,5.73527712,9.74E-09,2.67E-07,29.65568093,1,0.434440506,0.841609475,0.516202014,0.605713323,0.713951967,N,-,,C6 transcription factor,C:membrane,PTHR10742 (PANTHER); PTHR10742:SF184 (PANTHER),,
RL4_JR_04956,1567,1674,2000,0,2,0,0,0,0,0,1,0,2,6,2,0,0,2,87.88295974,1,2.651296584,0.483313029,5.485671657,4.12E-08,8.93E-07,12.58343535,0,2.701240977,1.131379096,2.387564863,0.01696041,0.050729657,69.69050126,1,2.960013128,0.543518753,5.446018396,5.15E-08,1.87E-06,61.8922554,1,2.60788788,0.50993873,5.114120047,3.15E-07,6.38E-06,30.6024479,1,1.686661989,0.739984666,2.279320189,0.022648039,0.060234146,N,-,,Choriogenin Hminor,,PTHR39601:SF1 (PANTHER); PTHR39601 (PANTHER),,
RL4_JR_04957,2172,1770,2418,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,26.71229465,0,0.248470234,1.05201571,0.236184909,0.81328919,0.904930541,3.375050217,0,1.710493803,1.298321949,1.317465058,0.187682786,0.328104518,8.827324235,0,-0.953142348,1.225410387,-0.77781481,0.436678196,0.576918968,46.7940728,0,1.697192988,0.719484891,2.358900107,0.018329189,0.073937465,8.781525712,1,-1.048224433,1.239366412,-0.84577444,0.397678587,0.534443283,N,-,,dynactin p62 family,C:dynactin complex,IPR008603 (PFAM); IPR008603 (PANTHER),,
RL4_JR_04958,17863,13249,12029,2,12,1,0,0,0,0,3,4,1,4,0,0,1,0,328.9640335,1,-0.879340162,1.279519143,-0.687242678,0.491929814,0.679825704,69.21856272,0,-2.647591694,1.198669957,-2.208774549,0.027190326,0.07311915,180.4387428,1,-5.306386647,1.20423288,-4.406445578,1.05E-05,0.000194842,343.532309,1,-0.484314154,0.430481216,-1.125052931,0.260566605,0.400781883,287.6375358,1,-0.488634163,0.48607195,-1.005271263,0.314766249,0.450269606,N,-,,40S ribosomal s7,F:structural constituent of ribosome; C:cytosol; C:nucleolus; C:ribosome; P:translation,IPR000554 (PFAM); IPR000554 (PANTHER),,
RL4_JR_04959,2509,3484,3355,0,0,4,0,0,0,0,6,1,1,17,0,0,7,1,185.3269237,1,0.390120036,0.913199981,0.4272011,0.66923286,0.816661642,94.28885849,0,0.906210873,0.837807089,1.081646222,0.279409757,0.438546374,83.95113415,1,-2.138704818,1.02773096,-2.080996781,0.037434201,0.090622632,100.4762147,1,-2.642369285,1.008586777,-2.619873021,0.008796251,0.043918257,69.95265367,1,-4.042092699,1.189380139,-3.398486797,0.000677597,0.003496775,N,-,,nadp-dependent alcohol dehydrogenase 6,F:zinc ion binding; P:cellular nitrogen compound biosynthetic process; P:oxidation-reduction process; F:alcohol dehydrogenase (NADP+) activity,IPR016040 (G3DSA:3.40.50.GENE3D); IPR013154 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR013149 (PFAM); PTHR11695:SF582 (PANTHER); IPR002085 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_04960,139,127,173,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,12.56935298,0,-1.754231187,1.240000092,-1.414702465,0.157155751,0.306720132,4.079298394,0,1.437251511,1.327902321,1.082347314,0.279098229,0.438193311,10.47655683,0,-1.200088116,1.23696224,-0.970189774,0.331951907,0.475142246,12.07750421,1,-1.621423246,1.239733527,-1.307880452,0.190913861,0.319865907,10.23006477,1,-1.268619436,1.235943852,-1.026437758,0.304685288,0.43988857,N,-,,fungal specific transcription factor domain-containing,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR001138 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31944:SF64 (PANTHER); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_04961,2438,2022,2515,5,2,4,0,0,0,0,0,0,2,0,0,0,2,0,2.788128457,1,0.418625285,1.329156491,0.314955604,0.752795362,0.870775614,0.896157053,0,3.623859669,1.503528365,2.410236982,0.015942162,0.048356775,2.308052403,0,0.982725839,1.265346418,0.776645688,0.437367839,0.577528629,2.661731785,1,0.560781614,1.284501446,0.436575308,0.662419373,0.770034001,2.253094991,1,0.914397268,1.253084501,0.729717164,0.465563087,0.596535847,N,-,,CDR ABC transporter,F:nucleotide binding; F:ATPase activity; C:membrane; P:transport,IPR003593 (SMART); IPR010929 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR013525 (PFAM); IPR003439 (PFAM); PTHR19241 (PANTHER); PTHR19241 (PANTHER); PTHR19241:SF179 (PANTHER); PTHR19241 (PANTHER); PTHR19241:SF179 (PANTHER); PTHR19241:SF179 (PANTHER); PTHR19241 (PANTHER); PTHR19241:SF179 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.205.11, the atp-binding cassette (abc) superfamily.
RL4_JR_04962,1244,1092,1479,0,0,0,0,0,0,2,0,0,7,0,0,0,0,0,175.7220972,0,0.480245866,0.767164522,0.626001141,0.531314193,0.715257621,25.21216264,0,-1.190573195,1.205397646,-0.987701609,0.323298806,0.485554624,113.2770358,1,-0.689374177,0.686211302,-1.004609185,0.315085073,0.457401961,276.6723786,1,1.410544109,0.351937071,4.007944103,6.12E-05,0.00070552,99.89527937,0,-0.271753806,0.635776157,-0.427436297,0.669061575,0.76487911,N,-,,Delta(14)-sterol reductase,C:integral component of membrane; P:oxidation-reduction process; F:delta14-sterol reductase activity,IPR001171 (PFAM); PTHR21257 (PANTHER); PTHR21257:SF17 (PANTHER),,
RL4_JR_04963,3997,3726,3402,12,9,0,0,0,2,0,13,8,6,10,2,0,25,0,168.9985727,1,4.159421476,0.62337458,6.672427157,2.52E-11,9.77E-10,12.52339831,1,2.728726761,1.129029208,2.416878802,0.015654228,0.047740916,117.6745409,1,3.793134866,0.417343543,9.088758956,1.00E-19,1.51E-17,91.26771009,1,2.946185832,0.462647305,6.368103309,1.91E-10,6.90E-09,46.60865505,1,2.996870048,0.497603281,6.022609098,1.72E-09,9.71E-08,Y,-,,beta-glucosidase 1 precursor,F:beta-glucosidase activity; P:cellulose catabolic process; C:plasma membrane; F:scopolin beta-glucosidase activity,IPR001764 (PRINTS); IPR026891 (SMART); IPR001764 (G3DSA:3.20.20.GENE3D); IPR002772 (G3DSA:3.40.50.GENE3D); IPR002772 (PFAM); IPR001764 (PFAM); IPR026891 (PFAM); PTHR30620:SF52 (PANTHER); IPR026892 (PANTHER); PTHR30620:SF52 (PANTHER); IPR026892 (PANTHER); IPR026892 (PANTHER); PTHR30620:SF52 (PANTHER); IPR017853 (SUPERFAMILY); IPR002772 (SUPERFAMILY),,
RL4_JR_04964,122,83,141,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.52847158,0,-1.749372739,1.247177351,-1.402665577,0.160716587,0.31045083,4.040218374,0,1.451171159,1.328993593,1.091932397,0.274862817,0.433028281,16.88781245,0,-0.226079273,1.233153883,-0.183334194,0.854535806,0.907893851,11.97948272,0,-1.60956369,1.241401836,-1.296569446,0.194779371,0.324302741,10.13041115,0,-1.25440825,1.236139457,-1.01477891,0.310211229,0.445769046,N,PKS,,polyketide synthase,,IPR020806 (SMART); SM00822 (SMART); IPR020801 (SMART); IPR020843 (SMART); IPR020807 (SMART); IPR020841 (SMART); G3DSA:3.30.70.250 (GENE3D); IPR014030 (PFAM); IPR001227 (G3DSA:3.40.366.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR014043 (PFAM); IPR020807 (PFAM); IPR013149 (PFAM); IPR013154 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR014031 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR013217 (PFAM); IPR009081 (PFAM); IPR032821 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR013968 (PFAM); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR029063 (G3DSA:3.40.50.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR11712:SF278 (PANTHER); PTHR11712:SF278 (PANTHER); PTHR11712 (PANTHER); PTHR11712 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR016040 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR029063 (SUPERFAMILY); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR016035 (SUPERFAMILY); IPR016036 (SUPERFAMILY),,
RL4_JR_04965,432,304,356,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein BN1723_002880,,no IPS match,,
RL4_JR_04966,97,103,134,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0.712409109,1,2.386755698,1.698151866,1.405501914,0.159872081,NA,0.226818037,0,5.605763858,1.786214583,3.1383485,0.001699027,0.015023052,0.590014953,0,2.94937559,1.269853015,2.322611794,0.020200017,0.055952111,0.680724062,0,2.527278628,1.357394026,1.861860727,0.062622724,0.14018463,0.583857506,0,2.862406981,1.241107823,2.306332237,0.021092075,0.05701864,N,-,,hypothetical protein H634G_10015,,no IPS match,,
RL4_JR_04967,19,25,33,0,0,2,0,0,0,0,0,0,1,1,0,0,0,0,10.20413863,1,0.169944484,1.151205802,0.147623026,0.882640282,0.94282897,2.030061955,0,2.443957254,1.305754495,1.871682053,0.061250604,0.13841898,5.278809087,0,-0.211317907,1.201661483,-0.175854773,0.860408038,0.910977931,15.72595112,1,0.315969491,1.146220057,0.275662155,0.782807566,0.860298123,5.21545754,0,-0.296478143,1.206074428,-0.245820768,0.805820979,0.869081531,N,-,,mate efflux family,P:drug transmembrane transport; F:antiporter activity; C:integral component of membrane; F:drug transmembrane transporter activity,IPR002528 (PFAM); IPR002528 (TIGRFAM); PTHR11206 (PANTHER),2.A.66.1.38, the multidrug/oligosaccharidyl-lipid/polysaccharide (mop) flippase superfamily.
RL4_JR_04968,685,200,199,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30.37091193,0,1.24486034,0.991339295,1.255735898,0.209211739,0.375935985,3.564178604,0,1.631977819,1.432507239,1.139245775,0.254600658,0.409548015,9.261063577,0,-1.022111319,1.311019443,-0.779630939,0.435608139,0.576031453,10.68753259,0,-1.444964594,1.325791546,-1.089888225,0.275762384,0.418479338,9.103978235,0,-1.100222451,1.325732587,-0.82989772,0.406596614,0.54318498,N,-,,integral membrane,C:membrane,PTHR33048 (PANTHER),2.A.1.7.25, the major facilitator superfamily (mfs).
RL4_JR_04969,1427,387,295,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,61.31922529,0,2.526439261,0.654094488,3.862498933,0.000112233,0.000943915,3.604698892,0,1.615696416,1.303331512,1.239666502,0.215098772,0.361765213,9.335121643,0,-1.033545799,1.222268622,-0.845596279,0.397778002,0.539808781,10.76924948,0,-1.455894429,1.223665903,-1.18978099,0.234132483,0.371449607,20.74841307,0,1.070314503,0.893058985,1.198481311,0.230729694,0.358328587,N,-,,amino acid permease,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PIRSF); IPR002293 (PFAM); PTHR11785:SF374 (PANTHER); IPR002293 (PANTHER),2.A.3.4.1, the amino acid-polyamine-organocation (apc) family.
RL4_JR_04970,832,293,260,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0.044205983,1,6.397324931,3.930835799,1.627471932,0.103636905,NA,0.014204167,0,9.603704898,3.068196571,3.130081361,0.001747579,0.015023052,0.036646954,0,6.960689402,1.727343109,4.029708612,5.58E-05,0.000789644,0.042263882,0,6.537445918,3.222920291,2.028423085,0.042517086,0.11204724,0.035890232,0,6.886305187,1.356133201,5.077897349,3.82E-07,6.40E-06,N,-,,HET-domain-containing,,IPR010730 (PFAM); PTHR33112 (PANTHER),,
RL4_JR_04971,1281,555,558,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,HET-domain-containing partial,F:nucleotide binding; F:ATP binding; F:hydrolase activity,no IPS match,,
RL4_JR_04972,21157,10671,11555,1,7,8,0,0,2,1,0,0,0,12,1,3,11,2,15.58971526,1,6.182477187,0.909663414,6.796444807,1.07E-11,4.49E-10,0.100840042,1,6.775071035,2.170689735,3.121160489,0.001801398,0.015023052,0.262186891,1,4.118955545,1.41357201,2.913863259,0.003569862,0.015394895,0.302453082,1,3.697474477,1.718693098,2.151329102,0.031450233,0.094884865,0.259812723,1,4.029754717,1.3298187,3.030303842,0.002443078,0.010022758,N,-,,phosphorylase superfamily,F:ATP binding; F:identical protein binding; F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process; F:protein kinase activity; F:ADP binding; P:protein phosphorylation,IPR002182 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR031352 (PFAM); IPR027417 (SUPERFAMILY),,
RL4_JR_04973,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_04974,1649,1827,2468,0,0,4,0,0,0,0,6,11,0,0,0,0,0,0,0.14042998,1,4.729717274,3.460118107,1.366923651,0.171649238,NA,0.045283546,0,7.930803259,2.464763637,3.21767294,0.001292351,0.015023052,0.116602337,1,5.290466251,1.439738907,3.674601155,0.000238221,0.001965568,0.134454571,0,4.867860687,2.083159355,2.336768272,0.019451236,0.075776748,0.114000421,0,5.218044503,1.279454233,4.078336191,4.54E-05,0.00035768,N,-,,aaa family ATPase,F:nucleotide binding; F:ATP binding,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003959 (PFAM); PTHR23077:SF85 (PANTHER); PTHR23077 (PANTHER); IPR027417 (SUPERFAMILY),3.A.25.2.1, the symbiont-specific erad-like machinery (selma) family.
RL4_JR_04975,21,20,28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.079386078,0,5.552347332,3.920183973,1.416348664,0.156673446,NA,0.026392099,0,8.710419674,2.948812534,2.95387366,0.003138124,0.01595384,0.066782797,0,6.094350633,1.818609918,3.351103814,0.000804901,0.004841842,0.076910655,0,5.673662178,2.821075786,2.011169713,0.044307534,0.114176173,0.064248307,0,6.041442621,1.49773773,4.033711977,5.49E-05,0.000420491,N,-,,hypothetical protein CMQ_7224,,PTHR40619 (PANTHER),,
RL4_JR_04976,165,375,357,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.848017857,0,2.135484605,1.563609974,1.365739948,0.172020601,NA,0.26963945,0,5.356339092,1.717433036,3.118805206,0.00181586,0.015023052,0.70120958,0,2.700759202,1.24956579,2.161358149,0.030667684,0.078147404,0.809048664,0,2.278361869,1.311624004,1.737054111,0.08237762,0.169591174,0.692976825,0,2.615686462,1.226217569,2.13313406,0.03291373,0.080866664,N,-,,#NAME?,,IPR016040 (G3DSA:3.40.50.GENE3D); IPR008030 (PFAM); PTHR10366:SF373 (PANTHER); PTHR10366 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04977,5273,4270,6449,3,5,0,1,0,2,1,0,1,0,0,0,0,0,0,46.42356589,1,1.582779288,0.572217384,2.766045442,0.005674063,0.024133996,5.059583047,1,1.12645475,1.244322409,0.905275628,0.365319385,0.529841355,13.14733302,1,-1.527838096,1.197379902,-1.275984417,0.201961028,0.327472442,19.17948247,0,-1.003417266,1.148282172,-0.873842066,0.382204268,0.527654515,12.99154488,0,-1.613297234,1.203909465,-1.340048634,0.180229534,0.297833202,N,-,,AAA family,F:nucleotide binding; F:catalytic activity; C:membrane,IPR003593 (SMART); IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23077 (PANTHER); PTHR23077:SF81 (PANTHER); IPR027417 (SUPERFAMILY),3.A.29.1.2, the mitochondrial inner membrane i-aaa protease complex (mimp) familly.
RL4_JR_04978,770,778,1059,1,2,3,0,0,0,0,0,0,0,0,1,0,0,1,24.16190257,1,-2.697028832,1.209701594,-2.229499279,0.025780703,0.080643779,7.803148406,0,0.501502358,1.260977852,0.397709093,0.690844634,0.804312801,20.09587592,0,-2.139824997,1.212160324,-1.765298661,0.077513584,0.158984508,23.17144126,1,-2.561447171,1.212639531,-2.112290672,0.034661525,0.099426657,19.67157959,1,-2.211881684,1.21035592,-1.827463846,0.067630057,0.141279554,N,-,,zinc finger,F:ATP binding,PTHR10039 (PANTHER),,
RL4_JR_04979,1857,1705,2680,0,0,2,0,0,0,0,2,4,9,0,0,0,0,2,0.012021509,1,8.275938237,3.994557068,2.071803731,0.038283749,NA,0.003842866,0,11.4894157,3.940199092,2.915948011,0.003546096,0.016928889,0.009954621,1,8.839817482,2.38250595,3.710302374,0.000207012,0.001791132,0.011482935,1,8.417149062,3.994556965,2.107154594,0.035104181,0.099498352,0.009795195,1,8.760474239,1.567861258,5.587531547,2.30E-08,8.07E-07,N,-, Effector probability:0.807,hypothetical protein AC579_1384,,no IPS match,,
RL4_JR_04980,1794,1450,1352,0,0,17,0,0,0,0,0,0,0,3,0,0,2,1,0.255747528,1,3.864584288,2.802380986,1.379036008,0.167883652,NA,0.081798454,0,7.076933326,2.291505848,3.088333085,0.002012827,0.015023052,0.212694612,0,4.420634722,1.47364068,2.999805029,0.002701525,0.012563269,0.245354163,1,3.999285532,1.864868144,2.144540645,0.031989592,0.095572329,0.210885986,1,4.330596747,1.366234431,3.169731817,0.001525797,0.006763876,Y,-,,hypothetical protein F503_05912,,no IPS match,,
RL4_JR_04981,187,274,226,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14.13701954,0,0.234482986,1.163993435,0.201447,0.840349067,0.919624667,11.32098685,0,3.422399346,1.14212944,2.996507422,0.002730916,0.015349618,5.065081847,0,-0.151844261,1.215802873,-0.124892172,0.900608916,0.938524412,5.844802634,0,-0.574561813,1.217074785,-0.47208423,0.636866668,0.751459622,5.022917434,0,-0.242270441,1.224514194,-0.197850252,0.843162228,0.894545853,N,-,,fad-binding monooxygenase,F:oxidoreductase activity,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789 (PANTHER); PTHR13789:SF226 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_04982,2029,2542,2726,4,0,10,0,0,0,1,0,0,0,6,2,0,3,1,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,hypothetical protein V500_03061,,no IPS match,,
RL4_JR_04983,932,737,782,0,0,1,0,0,0,0,0,4,0,5,0,0,0,0,0.027238258,1,7.093982006,3.945703095,1.797900611,0.072192759,NA,0.008675766,0,10.31238283,3.945839548,2.613482556,0.008962466,0.031046571,0.022678328,1,7.647888047,2.595472134,2.946626914,0.003212606,0.014227655,0.026165823,1,7.227450403,3.945494755,1.831823599,0.066977706,0.146670023,0.022656777,0,7.544876423,1.566871272,4.815249699,1.47E-06,1.98E-05,,,,,,,,
RL4_JR_04984,288,256,305,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,7.18846955,1,-0.948238708,1.197105691,-0.792109431,0.428296871,0.619292073,2.303919546,0,2.261439317,1.304418532,1.733676165,0.082975558,0.174974708,5.963937685,0,-0.387366394,1.202202517,-0.322213927,0.747290635,0.830840372,6.878890956,1,-0.809461585,1.200512258,-0.67426349,0.500143811,0.638099306,5.869670524,0,-0.467178995,1.201533775,-0.388818862,0.697410147,0.785728517,N,-,,Zn(2)-C6 fungal-type DNA-binding domain,,no IPS match,,
RL4_JR_04985,728,628,912,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.092094566,0,0.832567181,1.309107356,0.635980829,0.524788918,NA,0.675698835,0,4.031152009,1.521719665,2.649076635,0.008071203,0.028807022,1.740742958,0,1.389293028,1.246895343,1.114201794,0.265192626,0.402943141,2.007156153,0,0.967646456,1.266584728,0.763980833,0.444878665,0.586968527,1.705173256,0,1.315886141,1.232053954,1.068042626,0.285501284,0.419793857,Y,-,,late sexual development,,PF13668 (PFAM),,
RL4_JR_04986,142,110,157,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2.20179286,0,0.759228755,1.380915301,0.549801102,0.582455802,0.755793612,0.696692594,0,3.986949152,1.544403989,2.58154549,0.009835903,0.033197402,1.812787837,1,1.331020488,1.276519967,1.042694609,0.297089755,0.437998643,2.091945948,0,0.908170485,1.305154259,0.695833828,0.486532902,0.626736085,1.78819205,0,1.248043707,1.271035699,0.981910821,0.326143784,0.462493811,N,-,,3-oxoacyl-[acyl-carrier- ] reductase,,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_04987,27605,10503,11038,2,6,18,0,0,0,5,5,7,5,20,2,0,42,11,0.855581596,1,2.122788485,1.556381015,1.363925969,0.172590867,NA,0.273375318,0,5.336642899,1.719115888,3.104295025,0.00190733,0.015023052,0.707985404,1,2.687634044,1.249351418,2.151223431,0.031458568,0.079721288,0.816692099,1,2.265182662,1.310151365,1.728947298,0.083818528,0.171550959,0.696131324,1,2.609151882,1.219661161,2.13924323,0.032415975,0.079993113,N,-,,caib baif family enzyme,,IPR025496 (PFAM); IPR010839 (PFAM),,
RL4_JR_04988,7397,3550,3427,0,0,11,0,0,0,0,0,0,0,3,0,0,0,0,26.11345443,1,2.101600197,0.695368288,3.022283636,0.002508754,0.012548382,2.234972388,0,2.305279937,1.305058905,1.766418303,0.077325697,0.166035363,5.801556973,0,-0.347348644,1.20456282,-0.288360755,0.773070606,0.848291615,6.693376588,1,-0.769801337,1.203662438,-0.639549189,0.522465725,0.657138567,5.717376496,0,-0.429002145,1.205918989,-0.355747068,0.722029993,0.804548001,N,-,,poly(aspartic acid) hydrolase,"P:biological_process; F:zinc ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; C:extracellular region; C:cellular_component; F:molecular_function; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; C:nuclear pore; P:regulation of transcription from RNA polymerase II promoter; F:DNA binding; P:nucleocytoplasmic transport; C:nucleus; F:metal ion binding; F:structural constituent of nuclear pore; F:hydrolase activity",IPR007219 (SMART); IPR010126 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR007219 (PFAM); PTHR31845:SF12 (PANTHER); PTHR31845 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_04989,2297,1744,2765,1,0,2,0,0,0,0,0,0,0,3,0,0,0,0,0.019400267,1,7.582626433,3.961290641,1.914180786,0.05559706,NA,0.005836496,0,10.87810754,3.964459573,2.74390679,0.006071277,0.023455523,0.015857645,0,8.163737005,3.961957144,2.060531376,0.03934777,0.094409272,0.018339292,1,7.738034468,3.961825153,1.953148907,0.050801953,0.124389486,0.016452737,0,8.01414473,2.194850325,3.651339975,0.000260876,0.00156479,N,-,,---NA---,,no IPS match,,
RL4_JR_04990,1742,1177,1807,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.122525898,1,4.926224186,3.751363907,1.313182167,0.189121572,NA,0.040078031,0,8.106927467,2.616813095,3.098015477,0.001948213,0.015023052,0.102587275,0,5.47373421,1.582385222,3.459166664,0.00054185,0.003590063,0.118227271,0,5.05300552,2.309752902,2.187682291,0.028692753,0.089914616,0.099990826,0,5.404228318,1.372545641,3.937376037,8.24E-05,0.000589759,N,-,,MFS transporter,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF203 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_04991,2855,1828,1541,0,1,0,0,0,0,1,0,0,0,3,0,0,2,2,0.145728334,1,4.675992976,3.485210745,1.34166721,0.179703923,NA,0.046577154,0,7.88926278,2.519371879,3.131440358,0.001739511,0.015023052,0.121138825,1,5.232217707,1.528332365,3.423481586,0.000618244,0.003946473,0.139743606,1,4.811326163,2.167040384,2.220229119,0.026403219,0.08636862,0.120111166,1,5.142048754,1.355524172,3.793402478,0.000148597,0.000966931,N,-,,MFS transporter,P:transmembrane transport; C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_04992,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.36371471,0,1.255758037,1.013382972,1.239174204,0.215280991,0.38346339,1.669529899,0,2.726027606,1.33360932,2.044097596,0.040943907,0.101032234,4.335638385,0,0.072498322,1.207037506,0.060063023,0.95210544,0.972469277,22.33719659,0,1.961266422,0.860172086,2.280086107,0.022602582,0.080997621,15.50790649,0,1.665832817,0.985794377,1.689838019,0.091058948,0.177918149,N,-,,von willebrand factor type a domain containing,,IPR002035 (SMART); IPR032838 (PFAM); IPR028992 (G3DSA:2.170.16.GENE3D); IPR002035 (G3DSA:3.40.50.GENE3D); PF14623 (PFAM); IPR002035 (PFAM); PTHR10338:SF120 (PANTHER); PTHR10338 (PANTHER); PTHR10338:SF120 (PANTHER); PTHR10338:SF120 (PANTHER); PTHR10338 (PANTHER); IPR002035 (PROSITE_PROFILES); IPR002035 (SUPERFAMILY),1.A.13.2.1, the epithelial chloride channel (e-clc) family.
RL4_JR_04993,1534,1087,1360,0,3,0,1,0,0,0,0,1,0,0,0,0,0,0,2.215313696,1,0.750284757,1.280458363,0.58595014,0.557909021,0.735880646,0.703272536,1,3.973329766,1.472885508,2.697650119,0.006983079,0.025919592,1.829447846,1,1.317580051,1.226042658,1.074660855,0.282526595,0.421974496,20.73545567,0,2.644317905,1.024960696,2.579921275,0.009882284,0.048136258,43.56202628,0,4.992077863,0.555026714,8.994301962,2.38E-19,5.12E-17,N,-,,aldo-keto reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR020471 (PRINTS); IPR023210 (PFAM); IPR023210 (G3DSA:3.20.20.GENE3D); IPR001395 (PANTHER); PTHR11732:SF245 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.6, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_04994,5662,5933,4751,4,1,16,0,0,2,0,1,4,7,1,4,0,4,1,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_04995,12,26,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,Y,-,,domain-containing,,IPR018392 (SMART); IPR018392 (PFAM); IPR018392 (G3DSA:3.10.350.GENE3D); PTHR21666:SF212 (PANTHER); PTHR21666 (PANTHER); IPR018392 (SUPERFAMILY),,
RL4_JR_04996,32793,36972,33718,4,7,2,0,1,1,2,2,0,2,0,0,0,0,0,0.027645568,1,7.073514936,3.945157288,1.792961451,0.072979088,NA,0.009184959,1,10.23380518,3.539552713,2.891270736,0.003836874,0.017677215,0.02327757,1,7.614533777,2.14554248,3.549001638,0.000386695,0.0028185,0.026808788,1,7.193883725,3.944608344,1.823725729,0.068193547,0.148230929,0.022454644,0,7.550675179,1.512512957,4.992139171,5.97E-07,9.23E-06,N,-, Effector probability:0.786,C2H2 finger domain-containing,F:DNA binding; F:metal ion binding; C:membrane; C:integral component of membrane; P:DNA integration; P:DNA recombination,no IPS match,,
RL4_JR_04997,6628,7606,8051,10,6,37,0,0,1,5,3,0,7,12,2,0,0,2,130.6982181,1,-0.311015967,0.471569179,-0.659534127,0.509552839,0.69594038,26.32026224,1,-1.252574432,1.193404754,-1.049580561,0.293910998,0.453155693,156.8130498,1,0.322869707,1.804276898,0.178946872,0.857979418,0.909635371,153.2376324,1,-0.409231384,0.49813788,-0.821522314,0.411348819,0.554950939,82.33121837,1,-1.770843741,0.835139651,-2.120416315,0.033970952,0.082880937,N,-,,Heterokaryon incompatibility,,IPR010730 (PFAM),,
RL4_JR_04998,2812,2180,2914,0,2,5,0,0,0,0,0,0,3,5,0,0,0,2,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,hypothetical protein PFICI_10918,,IPR031348 (PFAM),,
RL4_JR_04999,423,368,618,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,0.008141456,0,8.841220392,4.035983802,2.190598582,0.028480854,NA,0.002675567,0,12.01934062,4.032893235,2.980327006,0.002879408,0.015349618,0.006783092,1,9.399044527,3.291065204,2.855927776,0.004291127,0.016940088,0.007815077,1,8.97609272,4.035428601,2.224322026,0.026126786,0.086108719,0.006504647,0,9.346543544,1.704039324,5.484934187,4.14E-08,1.17E-06,Y,-,,hypothetical protein CNYM01_04694,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_05000,192,163,286,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0.060514857,0,5.944351428,3.924364182,1.514729814,0.129840841,NA,0.019723525,0,9.130812353,2.979649931,3.064390974,0.002181137,0.015045494,0.050372346,0,6.503044772,1.740925182,3.735395891,0.00018742,0.001692633,0.05805764,1,6.079750237,2.956756161,2.056223073,0.039761019,0.107040766,0.048773842,1,6.441765024,1.378828771,4.671910799,2.98E-06,3.66E-05,Y,-,,glycosylhydrolase family 18-6,F:chitinase activity; F:chitin binding; P:chitin catabolic process; C:extracellular region,IPR018392 (SMART); IPR011583 (SMART); IPR029226 (PFAM); IPR001223 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); IPR018392 (PFAM); IPR001002 (G3DSA:3.30.60.GENE3D); IPR029070 (G3DSA:3.10.50.GENE3D); PTHR11177 (PANTHER); PTHR11177 (PANTHER); PTHR11177 (PANTHER); PTHR11177:SF218 (PANTHER); PTHR11177:SF218 (PANTHER); IPR001002 (PRODOM); IPR029070 (SUPERFAMILY); IPR001002 (SUPERFAMILY); IPR017853 (SUPERFAMILY),9.B.29.2.7, the small 4-5 tms putative permease (4-5pp) family.
RL4_JR_05001,19,23,15,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,176.3896535,0,5.886633002,0.857781017,6.862629136,6.76E-12,2.98E-10,0.998036377,0,3.468330097,1.40970184,2.460328844,0.013880976,0.04329838,257.7015207,1,6.675685439,0.413662486,16.1380006,1.38E-58,1.16E-55,905.4515588,0,8.256004686,0.778809441,10.600802,2.95E-26,4.05E-24,338.0240983,0,7.134374692,0.780455745,9.141293066,6.17E-20,1.42E-17,Y,-,,serin endopeptidase,C:cell wall; P:proteolysis; C:integral component of membrane; F:serine-type endopeptidase activity,IPR015500 (PRINTS); G3DSA:3.50.30.30 (GENE3D); IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (PFAM); IPR010435 (PFAM); PTHR10795:SF363 (PANTHER); IPR015500 (PANTHER); PTHR10795:SF363 (PANTHER); SSF52025 (SUPERFAMILY); IPR000209 (SUPERFAMILY),2.A.7.3.49, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_05002,5929,6429,4768,3,9,23,0,0,1,0,0,1,3,5,1,0,13,1,8.695363292,1,-1.222354713,1.216639317,-1.004697691,0.31504244,0.503225411,2.777666259,1,1.991712888,1.305345233,1.525813124,0.127056411,0.243434601,13.68768384,1,0.305215927,1.207221389,0.252825148,0.800403333,0.869026146,12.30437228,1,-0.132887005,1.162310961,-0.114329994,0.908976207,0.944324245,7.058726672,1,-0.733101606,1.210883861,-0.605426853,0.544895413,0.666312326,N,-,,ankyrin repeat,F:ubiquitin-protein transferase activity; P:protein ubiquitination,IPR002110 (PRINTS); IPR003877 (SMART); IPR002110 (SMART); IPR029058 (G3DSA:3.40.50.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR003877 (PFAM); PTHR24123 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR001870 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY),8.A.28.1.1, the ankyrin (ankyrin) family.
RL4_JR_05003,581,615,746,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.396461512,0,3.232568634,2.283468505,1.415639685,0.156881026,NA,0.127879415,0,6.433069258,2.065441178,3.114622351,0.001841806,0.015023052,0.328616836,0,3.795871591,1.3695572,2.771605005,0.005578068,0.020580306,0.378917362,0,3.373416371,1.597662644,2.111469768,0.034731954,0.099426657,0.320066208,0,3.729936302,1.28991748,2.891608463,0.003832753,0.014420892,N,-,,hypothetical protein CSIM01_12623,,no IPS match,,
RL4_JR_05004,3558,4239,7841,0,2,1,0,0,0,2,0,1,1,6,0,0,6,0,1.772439175,1,1.072216951,1.346495574,0.796301875,0.425856596,NA,0.566103051,0,4.286501587,1.549153369,2.766996265,0.00565754,0.022298256,1.464791819,1,1.63880977,1.248010841,1.313137447,0.189136637,0.31196144,1.689709532,1,1.216419622,1.273192764,0.95540884,0.339370985,0.486566302,1.437445933,1,1.563035316,1.232323811,1.268364129,0.204667946,0.327216635,N,-,,hypothetical protein CSIM01_12622,P:proteolysis; C:membrane; C:integral component of membrane; F:serine-type endopeptidase activity; C:cellular_component; F:hydrolase activity,IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (SUPERFAMILY),,
RL4_JR_05005,3820,4372,5978,1,3,1,0,3,0,3,0,1,1,5,0,0,0,0,0.095028026,1,5.29287397,3.917978251,1.350919692,0.17672116,NA,0.029720026,1,8.536635326,2.721992522,3.136171484,0.001711691,0.015023052,0.078316866,1,5.860472851,1.609374892,3.641459104,0.000271097,0.002149247,0.0904254,1,5.439154287,2.499738527,2.175889289,0.02956354,0.09145458,0.078590902,0,5.757062329,1.379628656,4.172907184,3.01E-05,0.000253959,N,PKS-Like,,amino acid adenylation domain,F:catalytic activity; P:metabolic process,IPR020841 (SMART); IPR025110 (PFAM); G3DSA:3.40.50.980 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR000873 (PFAM); G3DSA:3.30.300.30 (GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); G3DSA:2.30.38.10 (GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR009081 (PFAM); IPR014031 (PFAM); IPR014030 (PFAM); PTHR24095 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR009081 (SUPERFAMILY); SSF56801 (SUPERFAMILY); IPR016039 (SUPERFAMILY),4.C.1.1.4, the fatty acid transporter (fat) family.
RL4_JR_05006,8298,6709,5089,0,4,5,0,0,0,0,0,2,0,2,2,0,2,0,6.588588446,1,-0.822551694,1.220957522,-0.673693949,0.50050591,0.687293476,2.107733385,0,2.389782774,1.331376893,1.794970896,0.072658337,0.158126787,5.467506225,1,-0.262089625,1.218550885,-0.215083037,0.829702579,0.890198061,24.93138008,1,1.072623074,1.035415637,1.035934784,0.300232568,0.445726504,16.62287376,1,1.332757421,1.001236027,1.331112131,0.183152118,0.301638124,N,-,,carbohydrate-binding module family 50,"P:ATP hydrolysis coupled proton transport; F:hydrogen ion transmembrane transporter activity; C:membrane; C:integral component of membrane; C:proton-transporting V-type ATPase, V0 domain",no IPS match,,
RL4_JR_05007,1780,1701,2075,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,53.38847797,1,-2.786701933,1.151393127,-2.420287101,0.015508257,0.053699645,15.9362475,0,-0.528681922,1.221822693,-0.43269938,0.66523318,0.785704813,41.12015595,0,-3.172752017,1.198522606,-2.647219169,0.008115674,0.027710988,119.6304475,0,0.719153727,1.510765512,0.476019423,0.634060541,0.749007813,73.61497874,0,-0.281201308,0.677387777,-0.415126044,0.678049635,0.771203387,N,NRPS,,peptide partial,F:catalytic activity,IPR020806 (SMART); G3DSA:3.40.50.980 (GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); G3DSA:3.30.300.30 (GENE3D); IPR001242 (PFAM); IPR009081 (PFAM); G3DSA:2.30.38.10 (GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); G3DSA:2.30.38.10 (GENE3D); IPR000873 (PFAM); G3DSA:3.40.50.980 (GENE3D); PTHR24095:SF39 (PANTHER); PTHR24095:SF39 (PANTHER); PTHR24095 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR009081 (PROSITE_PROFILES); IPR009081 (PROSITE_PROFILES); IPR009081 (PROSITE_PROFILES); IPR009081 (PROSITE_PROFILES); IPR009081 (SUPERFAMILY); SSF56801 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY); IPR009081 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY); IPR009081 (SUPERFAMILY); SSF56801 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF56801 (SUPERFAMILY),4.C.1.1.4, the fatty acid transporter (fat) family.
RL4_JR_05008,16483,11724,19314,0,0,7,0,0,0,0,0,2,0,6,0,0,0,12,18.082103,1,3.090634056,0.797498524,3.875410379,0.000106445,0.000903621,0.896840397,0,3.622694483,1.45076132,2.497098891,0.012521403,0.039931205,25.84982788,1,3.384570668,0.876746451,3.860375668,0.000113213,0.001251467,129.652095,1,5.691966295,0.426313986,13.35158238,1.16E-40,3.35E-38,6.138871121,1,1.826943882,1.147233246,1.592478154,0.111277308,0.206837755,N,-,,ABC transporter,"F:FAD binding; F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process",IPR003593 (SMART); IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.20.1560.10 (GENE3D); IPR011527 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24223 (PANTHER); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.208.35, the atp-binding cassette (abc) superfamily.
RL4_JR_05009,175636,119948,115247,0,9,1,0,0,1,0,0,0,0,1,0,0,0,0,34.91223549,1,6.471670902,0.738508397,8.76316495,1.90E-18,2.01E-16,0.172987765,1,5.996829855,1.906784102,3.144996778,0.001660887,0.015023052,41.50245759,0,6.193811972,0.781253597,7.928042819,2.23E-15,2.32E-13,71.14957074,1,7.109180491,0.555029596,12.80865119,1.47E-37,3.81E-35,30.61617129,0,6.451448691,0.682645492,9.450657425,3.37E-21,8.97E-19,N,-,,Acyl- N- partial,"F:transferase activity, transferring acyl groups",IPR019432 (SMART); PF13523 (PFAM); IPR016181 (G3DSA:3.40.630.GENE3D); PTHR31438 (PANTHER); PTHR31438:SF1 (PANTHER); IPR016181 (SUPERFAMILY),,
RL4_JR_05010,2385,1510,1538,0,0,0,0,0,0,0,3,4,0,0,0,0,0,1,87.93244866,0,9.831271483,1.255957576,7.827709843,4.97E-15,3.27E-13,0.033941255,0,8.347120657,2.655032763,3.143886122,0.001667203,0.015023052,15.77331126,1,7.543157609,1.098951997,6.863955505,6.70E-12,4.81E-10,142.6545721,0,10.48608463,0.496249656,21.13066376,4.16E-99,7.01E-96,22.18164502,1,7.905354374,0.934150921,8.462609411,2.61E-17,4.81E-15,N,-,,siderophore iron transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501:SF58 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.16.7, the major facilitator superfamily (mfs).
RL4_JR_05011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.035612562,0,0.872475452,1.307190895,0.66744303,0.504489188,NA,0.648613864,0,4.090157233,1.505788503,2.716289322,0.00660182,0.024846353,31.7091418,0,4.260685565,0.765628742,5.564949864,2.62E-08,1.02E-06,34.53433802,0,3.770960826,0.764076612,4.935317697,8.00E-07,1.50E-05,1.653923676,0,1.360672102,1.225234825,1.110539852,0.266766465,0.399026512,Y,-,,ferric-chelate reductase,F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process,IPR013112 (PFAM); IPR013121 (PFAM); G3DSA:3.40.50.80 (GENE3D); IPR013130 (PFAM); PTHR32361:SF9 (PANTHER); PTHR32361 (PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY),5.B.1.5.3, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_05012,3328,2555,3496,2,3,4,0,0,2,0,2,0,0,6,1,0,16,0,0.365106298,1,3.351303729,2.283644446,1.467524305,0.142233482,NA,0.115957664,1,6.573785517,2.030132561,3.238106537,0.001203259,0.015023052,0.301575763,1,3.918387538,1.30806045,2.995570686,0.002739318,0.0126994,0.347969393,1,3.495787202,1.528011864,2.287801086,0.022149108,0.080442001,0.297873298,1,3.834485009,1.246003232,3.077427819,0.002087954,0.008782939,N,-,,NACHT and Ankyrin domain,F:catalytic activity; P:nucleoside metabolic process,no IPS match,,
RL4_JR_05013,540,620,495,1,2,0,0,0,0,0,0,3,0,0,0,0,0,0,3.468197516,1,0.103407663,1.280995886,0.08072443,0.935661108,0.968396542,1.093932744,0,3.335838554,1.420763941,2.347918932,0.01887863,0.055021448,2.861383784,1,0.671985998,1.241980756,0.541059912,0.588466288,0.708221618,3.302559216,0,0.249006105,1.252853116,0.198751236,0.842457343,0.901625458,2.845696726,0,0.577556066,1.249844198,0.46210245,0.644007854,0.745464676,N,-,,amidohydrolase domain containing,F:dipeptidase activity,G3DSA:3.20.20.140 (GENE3D); IPR006680 (PFAM); IPR011059 (G3DSA:2.30.40.GENE3D); PTHR11271:SF33 (PANTHER); PTHR11271 (PANTHER); IPR011059 (SUPERFAMILY); IPR032466 (SUPERFAMILY),,
RL4_JR_05014,569,649,957,0,7,105,0,0,1,0,0,2,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_05015,3404,4427,6379,0,1,3,0,0,0,0,0,0,1,2,0,0,0,1,0.983206229,1,1.922058005,1.473770805,1.304177012,0.192173236,NA,0.315583555,0,5.129492402,1.678194522,3.056554133,0.00223897,0.015045494,0.81578359,0,2.482794282,1.244240604,1.9954294,0.045996067,0.106049689,0.940874279,1,2.06075918,1.292556288,1.594328386,0.110862503,0.211869166,0.801429545,1,2.405154418,1.21714619,1.976060425,0.048147934,0.108865081,N,-, Effector probability:0.554,hypothetical protein SPBR_08001,,no IPS match,,
RL4_JR_05016,7542,9859,14172,0,6,17,0,0,0,3,0,1,0,4,3,0,2,3,81.39850837,1,5.480712912,0.544917495,10.05787658,8.48E-24,1.82E-21,0.46648786,0,4.565536205,1.579031631,2.891351963,0.003835883,0.017677215,1.210559347,1,1.912825405,1.24362668,1.53810258,0.124023535,0.227507568,1.396445016,1,1.490718232,1.273486578,1.170580246,0.241767541,0.380214562,1.195220498,1,1.828678686,1.231659098,1.48472795,0.137615905,0.243084619,N,-,,HSCARG dehydrogenase,P:biological_process; C:cellular_component; F:molecular_function,IPR008030 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR14194 (PANTHER); PTHR14194:SF76 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_05017,231,296,315,0,0,2,0,0,0,1,0,0,0,4,0,0,0,0,0.008470882,1,8.791019641,4.031633903,2.180510397,0.029219649,NA,0.002680088,0,12.01721297,4.032710343,2.979934573,0.0028831,0.015349618,0.006904709,1,9.374372631,4.033343739,2.324218623,0.02011378,0.055743746,0.007967227,1,8.951770626,4.033311655,2.219459191,0.026455501,0.08636862,0.006679571,0,9.335361424,1.822923296,5.121093929,3.04E-07,5.22E-06,,,,,,,,
RL4_JR_05018,304,343,468,0,0,2,0,0,0,0,0,0,0,2,0,0,0,0,0.69798102,1,2.416320122,1.689812567,1.42993381,0.152736017,NA,0.222835299,0,5.631408329,1.783890999,3.156811897,0.001595042,0.015023052,0.578330522,0,2.978539371,1.259248166,2.365331515,0.018013938,0.051696984,0.667163499,1,2.556463415,1.343148168,1.903336859,0.056996604,0.132756066,4.431253027,0,3.824183998,1.142490554,3.347234676,0.000816221,0.004065045,N,-,,---NA---,,no IPS match,,
RL4_JR_05019,14724,11115,12748,2,2,15,4,0,0,3,2,7,1,10,1,0,14,1,0.036393954,1,6.67819153,3.935989831,1.696699386,0.089753509,NA,0.01153312,1,9.903776343,3.208470075,3.086759768,0.002023511,0.015023052,0.02998548,1,7.250181376,1.830255804,3.961294023,7.45E-05,0.000957729,0.034600955,1,6.826088494,3.515649023,1.941629682,0.052181947,0.125807414,3.890096191,1,8.100964871,1.257381166,6.442728021,1.17E-10,8.31E-09,N,-,,small secreted partial,,no IPS match,,
RL4_JR_05020,86,74,115,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,carboxypeptidase S1,F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR029058 (SUPERFAMILY),,
RL4_JR_05021,153,110,174,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0.042862317,0,6.440598283,3.931566406,1.638176141,0.101384955,NA,0.014017859,0,9.621871515,3.931023993,2.447675601,0.014378104,0.044547038,0.036001277,0,6.983256754,2.466412313,2.831341993,0.004635313,0.01790478,0.041491675,0,6.563171555,3.931248273,1.669487933,0.09502072,0.188533174,0.035316225,1,6.903939831,1.661677894,4.154800311,3.26E-05,0.000269315,N,-,,hypothetical protein A1O5_04777,,PTHR40619:SF3 (PANTHER); PTHR40619 (PANTHER),,
RL4_JR_05022,3262,2032,1981,2,1,3,1,0,0,9,0,0,3,4,2,0,3,4,0.180707238,1,4.366199753,3.483977076,1.253222871,0.210124609,NA,0.058548637,1,7.560565538,2.672494991,2.82902889,0.004668948,0.019750253,0.149517688,1,4.932459746,1.756262762,2.808497596,0.004977325,0.018865759,0.172365228,1,4.510007715,2.351008647,1.91832885,0.055069326,0.130001616,0.14422823,1,4.880330596,1.563514106,3.121385716,0.001800021,0.007742231,N,-,,aaa family atpase,F:nucleotide binding; F:ATP binding,IPR003593 (SMART); IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23077 (PANTHER); PTHR23077:SF85 (PANTHER); IPR027417 (SUPERFAMILY),3.A.25.2.1, the symbiont-specific erad-like machinery (selma) family.
RL4_JR_05023,42194,7558,21470,0,0,6,0,0,0,0,0,0,1,4,0,0,0,0,3271.439927,1,-1.685315149,0.538548504,-3.129365572,0.001751842,0.009359219,938.319318,0,-3.11162007,0.778427499,-3.997315195,6.41E-05,0.003377425,2307.511723,0,-3.16163792,0.484386955,-6.527091383,6.71E-11,4.07E-09,2760.211978,1,-2.741312458,0.422677026,-6.485596072,8.84E-11,3.39E-09,2254.771542,0,-3.162148733,0.80521155,-3.927103051,8.60E-05,0.000610876,N,-, Effector probability:0.654,tsa family,F:peroxidase activity; P:cellular oxidant detoxification; P:oxidation-reduction process; F:peroxiredoxin activity,IPR000866 (PFAM); IPR019479 (PFAM); IPR024706 (PIRSF); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR10681:SF114 (PANTHER); PTHR10681 (PANTHER); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY),,
RL4_JR_05024,77243,56509,81907,11,17,90,3,2,2,7,24,40,12,29,18,0,64,6,3.861628683,1,-0.051764117,1.287292739,-0.040211613,0.96792442,0.983720869,1.247362884,1,3.146655021,1.448644528,2.172137444,0.029845297,0.078731848,3.216915648,1,0.503185851,1.25762074,0.400109377,0.689075958,0.786937958,3.709278669,1,0.081559348,1.269340756,0.064253312,0.948768528,0.970207017,3.157981817,1,0.426992974,1.254824296,0.340281086,0.73364486,0.813509386,Y,-,,laccase,,IPR008972 (G3DSA:2.60.40.GENE3D); IPR008972 (G3DSA:2.60.40.GENE3D); IPR011707 (PFAM); IPR001117 (PFAM); IPR011706 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); PTHR11709 (PANTHER); PTHR11709:SF126 (PANTHER); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY),2.A.108.1.5, the iron/lead transporter (ilt) family.
RL4_JR_05025,3811,2981,5010,0,0,0,0,0,0,0,2,2,1,6,0,0,0,0,0.468957343,0,2.990002889,2.096960619,1.425874602,0.153904542,NA,0.147965852,0,6.221802714,1.965105098,3.166142472,0.001544751,0.015023052,0.38731982,1,3.556149007,1.33021194,2.673370235,0.007509332,0.025982392,0.447035931,1,3.133824178,1.506850235,2.079718412,0.037551368,0.103009375,0.385816255,0,3.460543797,1.285307217,2.692386498,0.007094268,0.023877226,Y,-,,---NA---,,no IPS match,,
RL4_JR_05026,7922,6025,8538,8,9,33,0,0,4,3,14,21,4,14,11,0,11,8,72.40890493,1,-1.220838451,0.737441401,-1.655505711,0.097821959,0.217981847,18.22695984,1,-0.722489506,1.197205244,-0.603480071,0.546189369,0.692451001,47.29990431,1,-3.374802113,1.186361097,-2.844666875,0.004445789,0.017386326,73.19119155,1,-2.057693629,1.008136948,-2.041085423,0.041242337,0.109744721,46.64672863,1,-3.457483643,1.189489515,-2.906695352,0.003652687,0.013867064,N,-,,gtp binding,,IPR011989 (G3DSA:1.25.10.GENE3D); PTHR10957 (PANTHER); PTHR10957:SF1 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_05027,204,111,46,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,802.8351078,0,-0.752786316,0.482340518,-1.560694753,0.11859579,0.250324568,237.833261,0,-0.36980436,0.624952097,-0.59173233,0.554029844,0.699568308,465.6758195,0,-3.691635471,0.771294705,-4.786283958,1.70E-06,4.28E-05,558.3778277,0,-2.594869195,0.508539676,-5.102589473,3.35E-07,6.76E-06,538.9922995,0,-1.549832865,0.605281611,-2.560515365,0.010451704,0.032521052,N,-,,60S ribosomal l13,F:structural constituent of ribosome; C:integral component of membrane; C:cytosol; C:ribosome; P:translation,IPR001380 (PFAM); IPR001380 (PANTHER),,
RL4_JR_05028,1139,886,1363,0,3,5,0,0,1,0,0,0,0,1,0,0,0,0,60.74583683,1,-0.480477498,0.713891807,-0.673039659,0.500922061,0.68750373,13.40848012,1,-0.279510895,1.233324192,-0.226632135,0.820709802,0.891811553,63.20185045,0,-0.504430971,0.867794135,-0.581279535,0.561052071,0.686747814,70.51704412,1,-0.297032516,0.698260107,-0.425389497,0.670552761,0.775836671,52.77493173,0,-0.379973594,0.762362437,-0.498415944,0.618190901,0.724694092,N,-,,capsular associated,C:intracellular ribonucleoprotein complex; C:membrane,IPR006598 (SMART); IPR006598 (PFAM); PTHR12203:SF22 (PANTHER); PTHR12203 (PANTHER); PTHR12203:SF22 (PANTHER); PTHR12203 (PANTHER); PTHR12203 (PANTHER),,
RL4_JR_05029,926,789,1161,0,0,1,0,0,0,1,0,0,0,2,0,0,0,2,156.0681739,1,2.903618051,0.591705574,4.907200777,9.24E-07,1.42E-05,6.348067738,0,0.799215467,1.249766392,0.639491886,0.522502991,0.671846452,29.48380712,1,-0.038246897,1.049622463,-0.036438718,0.970932542,0.983207345,136.5369005,1,2.513551132,0.485094049,5.181574863,2.20E-07,4.58E-06,125.0035178,1,2.983110723,0.447262449,6.669709757,2.56E-11,2.04E-09,N,-, Effector probability:0.587,Dienelactone hydrolase,F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR002925 (PFAM); PTHR17630 (PANTHER); PTHR17630:SF44 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_05030,3341,1441,1641,2,0,3,0,0,4,1,1,0,5,5,3,0,0,0,69.02953966,1,-1.545709849,0.92248366,-1.675595911,0.09381737,0.211309251,16.85437374,1,-0.609590399,1.236234739,-0.493102466,0.621940188,0.751226562,72.73711461,1,-0.849590528,0.893020655,-0.951367164,0.341418023,0.484761134,115.1187737,1,0.236600876,0.6128744,0.386051165,0.699458776,0.79770445,43.90643247,0,-3.370141411,1.236489757,-2.725571638,0.006419025,0.022046344,N,-,,protoheme ix farnesyltransferase,P:heme O biosynthetic process; C:mitochondrial membrane; F:protoheme IX farnesyltransferase activity; C:integral component of membrane; P:heme a biosynthetic process,IPR000537 (PFAM); PTHR11048:SF3 (PANTHER); PTHR11048 (PANTHER); IPR006369 (HAMAP),,
RL4_JR_05031,4735,3281,4261,0,5,22,0,0,2,0,0,3,0,4,0,0,0,0,17.82108838,1,0.279180141,1.008282716,0.276886766,0.781867054,0.887515867,3.258350473,1,1.761422272,1.269509217,1.387482854,0.165294576,0.298131094,8.434515155,1,-0.887203851,1.19371238,-0.743230837,0.457341937,0.595499424,13.74066578,1,-0.36206605,1.142230463,-0.316981609,0.751257557,0.836428718,8.292469916,0,-0.965561333,1.191198195,-0.810579917,0.417606954,0.553510984,N,-,,myb family transcription factor,F:DNA binding,IPR001005 (SMART); IPR009057 (G3DSA:1.10.10.GENE3D); PF13921 (PFAM); IPR017930 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY),,
RL4_JR_05032,8650,6501,8404,1,5,16,0,0,2,3,7,14,7,26,7,0,14,6,9.259396466,1,0.399087145,1.180799514,0.337980444,0.735377925,0.860348933,1.757553217,1,2.652065977,1.378654395,1.923662658,0.054396882,0.126169852,4.520371393,1,0.01273017,1.231565049,0.010336579,0.99175275,0.996576163,38.59386742,1,3.069788218,0.647697883,4.739537212,2.14E-06,3.59E-05,12.13526495,1,1.601388849,1.008985714,1.587127376,0.112483799,0.208598609,Y,-,,wsc domain-containing,C:membrane,IPR002889 (SMART); IPR002889 (PFAM); PTHR19297 (PANTHER); IPR002889 (PROSITE_PROFILES); IPR002889 (PROSITE_PROFILES); IPR002889 (PROSITE_PROFILES); IPR002889 (PROSITE_PROFILES); IPR002889 (PROSITE_PROFILES); IPR002889 (PROSITE_PROFILES); IPR002889 (PROSITE_PROFILES); IPR011047 (SUPERFAMILY),,
RL4_JR_05033,921,950,934,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0.56317882,0,2.725821618,1.927057691,1.414499229,0.157215374,NA,0.178849882,0,5.948427642,1.89347942,3.141532767,0.00168066,0.015023052,0.46638629,0,3.288260676,1.310600815,2.508971945,0.01210831,0.03749992,0.538150114,0,2.866204061,1.44740218,1.980240255,0.047676539,0.119397713,0.463002591,1,3.196952916,1.272489313,2.51236131,0.011992623,0.036370126,N,-,,ubiquitin specific peptidase y chromosome,,IPR001394 (PFAM); PTHR24006 (PANTHER); PTHR24006 (PANTHER); PTHR24006:SF149 (PANTHER); IPR028889 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY),,
RL4_JR_05034,23811,35857,42195,0,0,1,0,0,0,0,0,0,3,2,2,0,0,4,85.07899508,1,1.181421699,0.634069299,1.863237505,0.062428858,0.1571897,6.640757644,0,0.734140156,1.239848759,0.592120733,0.553769744,0.699568308,23.73317342,0,-0.956537365,1.198775552,-0.797928656,0.424911893,0.565878454,19.88123496,1,-2.340612005,1.199318459,-1.951618428,0.050983524,0.124687966,17.01321879,1,-2.002398489,1.205800217,-1.660638687,0.096786034,0.186162347,N,-,,dephospho- kinase,C:membrane; C:integral component of membrane; P:phosphorylation; F:kinase activity,PTHR36124 (PANTHER); PTHR36124:SF1 (PANTHER),,
RL4_JR_05035,1265,965,986,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.24645474,0,0.578696933,0.696486021,0.830880902,0.406040914,0.59770512,15.79785886,0,1.699024766,1.129259245,1.504548024,0.132440318,0.250618975,16.69080403,0,-1.872103345,1.200316455,-1.559674816,0.118836746,0.220172499,28.89176331,0,-1.34402024,1.151553912,-1.167136185,0.243155377,0.381385127,43.53027765,0,1.408452081,0.632921839,2.225317558,0.026059928,0.067551656,N,-,,GTP-binding GTR1,"P:transcription from RNA polymerase III promoter; C:fungal-type vacuole membrane; P:transcription from RNA polymerase I promoter; P:chromatin silencing at telomere; C:Gtr1-Gtr2 GTPase complex; F:GTP binding; C:chromosome, telomeric region; C:nucleus; C:late endosome membrane; P:phosphate ion transport; F:GTPase activity; F:GDP binding; C:cytosol; P:positive regulation of TOR signaling; C:EGO complex",IPR006762 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11259:SF1 (PANTHER); IPR006762 (PANTHER); IPR006762 (PANTHER); PTHR11259:SF1 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_05036,2992,3297,3095,0,0,12,0,0,0,1,3,0,0,7,0,0,3,0,103.0132531,1,-0.679979218,0.617150778,-1.101804036,0.270546875,0.452179683,21.53336828,0,-0.963006204,1.206140209,-0.798419783,0.424626927,0.587569891,80.13287297,1,-1.212706054,0.863963643,-1.403654036,0.160421896,0.275740454,133.0701526,1,0.341284061,0.480142649,0.710797222,0.477209902,0.617890619,81.76011723,1,-0.767211295,0.702462451,-1.0921741,0.274756584,0.407546208,N,-,,sep domain-containing,P:cellular macromolecule metabolic process; P:single-organism cellular process; P:primary metabolic process,IPR012989 (SMART); G3DSA:1.10.8.10 (GENE3D); IPR001012 (PFAM); IPR012989 (PFAM); PF14555 (PFAM); G3DSA:3.10.20.90 (GENE3D); PTHR23333:SF20 (PANTHER); PTHR23333 (PANTHER); IPR001012 (PROSITE_PROFILES); IPR012989 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY); IPR009060 (SUPERFAMILY); IPR012989 (SUPERFAMILY),,
RL4_JR_05037,1073,871,1174,0,2,5,0,0,0,0,0,0,1,1,0,0,0,0,77.19957335,1,0.479314854,0.665491182,0.720242231,0.471375866,0.660395727,12.37383472,0,-0.163746037,1.213739987,-0.134910309,0.892682789,0.939851798,84.44267386,0,0.804376685,0.591055519,1.360915614,0.173540359,0.292479206,53.23734861,1,-0.541679176,0.766105991,-0.707055136,0.479532215,0.620048263,81.37797368,0,1.113821217,0.532030166,2.093530194,0.036301852,0.08722265,N,-,,outer membrane Tom13,C:integral component of mitochondrial outer membrane; P:mitochondrial outer membrane translocase complex assembly; P:protein import into mitochondrial outer membrane,IPR013262 (PFAM); PTHR28241 (PANTHER),1.B.33.3.1, the outer membrane protein insertion porin (bam complex) (ompip) family.
RL4_JR_05038,3231,4696,4126,6,2,3,0,3,4,0,0,2,3,9,7,0,3,3,157.0520079,1,-0.908246771,0.550192288,-1.650780627,0.098783377,0.219345343,42.35027984,1,-0.660749353,1.117031213,-0.591522731,0.554170229,0.699589806,85.89551626,1,-4.23554588,1.199942162,-3.529791697,0.000415887,0.00296928,115.1591121,1,-1.959757916,0.772357329,-2.537372072,0.011168818,0.053041408,134.923862,1,-0.245274967,0.579202463,-0.423470173,0.671952256,0.766394835,N,-,,mitochondrial export translocase oxa1,C:mitochondrial membrane; C:membrane part; P:mitochondrion organization; P:protein insertion into membrane,IPR001708 (PFAM); PTHR12428:SF14 (PANTHER); PTHR12428:SF14 (PANTHER); IPR001708 (PANTHER); IPR001708 (PANTHER),2.A.9.1.1, the membrane protein insertase (yidc/alb3/oxa1) family.
RL4_JR_05039,7421,5163,2489,0,4,6,0,0,0,1,0,0,0,3,0,0,0,0,10.65379914,1,2.02728903,1.025208099,1.977441489,0.047991748,0.128915601,0.958888101,0,3.526012573,1.406986167,2.506074797,0.012207979,0.039215857,2.494794512,1,0.869796754,1.213978119,0.716484705,0.473692108,0.610290011,2.878515657,1,0.447270807,1.219270811,0.366834671,0.713742344,0.808452969,2.467233928,0,0.783428438,1.21476444,0.644922104,0.518977667,0.643952068,N,-,,conserved fungal,,IPR012469 (PFAM); PTHR31687:SF3 (PANTHER); PTHR31687 (PANTHER); PTHR31687:SF3 (PANTHER); PTHR31687 (PANTHER),,
RL4_JR_05040,20984,19432,20804,3,1,18,0,0,2,0,6,2,5,19,1,0,7,10,181.3942469,1,-2.739637203,0.798535321,-3.43082783,0.000601742,0.003902237,51.23408039,1,-2.213540673,1.205251614,-1.836579721,0.066271963,0.147009602,149.429999,1,-3.049584913,1.052024542,-2.89877735,0.003746208,0.015764501,197.0392492,1,-1.603105163,0.593987467,-2.698887187,0.006957176,0.036347473,175.2149198,1,-1.110326076,0.709437114,-1.565080334,0.117564074,0.215836129,N,-,,ATP-dependent RNA helicase FAL1,"F:translation initiation factor activity; F:ATP binding; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:cytosol; F:helicase activity; C:nucleolus; P:translational initiation",IPR014001 (SMART); IPR001650 (SMART); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); PTHR24031:SF313 (PANTHER); PTHR24031 (PANTHER); IPR014014 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_05041,436,307,430,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51.76069981,0,-2.595882198,1.211630064,-2.142470936,0.032155605,0.095669375,13.75117543,0,-0.316028409,1.259632831,-0.250889308,0.801899691,0.879873027,47.15733707,0,-2.022682576,1.237105785,-1.635011817,0.102046571,0.196532541,61.71582465,0,-0.463635939,0.80707729,-0.574462873,0.565654617,0.693120295,36.03898491,0,-3.085264225,1.256071378,-2.456280973,0.014038335,0.041187523,N,-,,splicing factor 3A subunit 3,"F:zinc ion binding; F:RNA binding; C:spliceosomal complex; C:cytosol; P:mRNA splicing, via spliceosome",IPR022755 (PFAM); IPR031774 (PFAM); IPR024598 (PFAM); PTHR12786 (PANTHER); IPR031776 (PTHR12786:PANTHER); IPR000690 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_05042,65,96,70,0,0,2,0,0,0,0,0,0,0,2,0,0,2,12,30.52657971,1,1.419548044,0.664041374,2.137740358,0.032537822,0.096419743,3.657499395,0,1.594703016,1.260970911,1.26466281,0.205992227,0.350900929,20.5391815,0,-0.09232954,1.189423086,-0.077625482,0.938125972,0.963048808,24.24651443,1,0.257889029,1.010931924,0.255100292,0.798645639,0.870522886,9.311372323,1,-1.132752712,1.190502652,-0.951491129,0.34135512,0.478568345,N,-,,GIY-YIG catalytic domain-containing,"F:5'-flap endonuclease activity; P:DNA repair; F:metal ion binding; P:DNA catabolic process, endonucleolytic; P:DNA-dependent DNA replication; P:DNA recombination; C:Slx1-Slx4 complex",IPR000305 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR20208 (PANTHER); PTHR20208:SF10 (PANTHER); IPR027520 (HAMAP); IPR000305 (PROSITE_PROFILES),,
RL4_JR_05043,7315,4097,4149,0,0,1,0,0,0,0,6,9,2,4,0,0,5,12,218.1569044,1,-1.143223505,0.620097737,-1.84361825,0.065238794,0.162126461,97.41536165,0,0.63065764,0.805347898,0.783087212,0.4335759,0.59520714,159.5815721,1,-2.011746035,0.815526645,-2.466806017,0.013632419,0.04119839,229.6115008,1,-0.919573889,0.574437673,-1.600824479,0.1094158,0.209966823,137.7573542,1,-2.726400671,0.92147535,-2.958734242,0.003089054,0.01212744,N,-,,phd transcription factor,"C:nucleus; F:DNA binding; F:zinc ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; F:methyltransferase activity; P:oxidation-reduction process; F:histone demethylase activity (H3-K4 specific); P:histone demethylation; P:methylation",IPR001965 (SMART); SM01014 (SMART); IPR003347 (SMART); IPR001606 (SMART); IPR003349 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001606 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR013637 (PFAM); IPR004198 (PFAM); IPR019787 (PFAM); IPR003349 (PFAM); IPR003347 (PFAM); IPR001606 (G3DSA:1.10.150.GENE3D); PTHR10694:SF8 (PANTHER); PTHR10694 (PANTHER); PTHR10694:SF8 (PANTHER); IPR019787 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR001606 (PROSITE_PROFILES); IPR003349 (PROSITE_PROFILES); IPR003347 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY); SSF51197 (SUPERFAMILY); IPR011011 (SUPERFAMILY); IPR001606 (SUPERFAMILY),,
RL4_JR_05044,2,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,144.9348644,0,0.949301161,0.461605335,2.05652121,0.039732304,0.112295893,26.11027642,0,0.317443999,1.122682352,0.282754956,0.777364686,0.865048961,56.62653979,0,-1.441696938,1.046714096,-1.377355041,0.168402506,0.285818435,70.4045801,0,-0.673830168,0.709910978,-0.949175585,0.342531317,0.489499365,57.97660276,0,-1.650464734,0.992457424,-1.663008099,0.096310814,0.18554773,N,-,,transcription initiation factor TFIID subunit 6,"F:protein binding; C:SAGA-type complex; P:cellular protein metabolic process; P:regulation of transcription, DNA-templated; P:transcription from RNA polymerase II promoter; P:DNA-templated transcription, initiation; P:chromatin organization",IPR004823 (SMART); IPR004823 (PFAM); IPR011442 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); PTHR10221 (PANTHER); IPR009072 (SUPERFAMILY),,
RL4_JR_05045,4017,4758,4126,2,2,2,0,0,0,0,0,5,0,5,5,0,17,0,11.10296863,1,-1.575403156,1.203560354,-1.308952352,0.190550491,0.350351794,3.545446192,0,1.63950768,1.275588548,1.285295076,0.19868919,0.342145625,9.204968973,1,-1.013578156,1.205666663,-0.840678595,0.400528015,0.542612823,10.6188367,1,-1.435892043,1.204874297,-1.191735974,0.233364788,0.370580062,9.091360003,1,-1.098326413,1.211369376,-0.906681673,0.364575158,0.50092597,N,-,,---NA---,,no IPS match,,
RL4_JR_05046,4823,5973,8281,0,6,4,0,0,1,0,1,1,6,4,3,0,0,0,161.6913033,1,-0.709059206,0.504674947,-1.40498198,0.160026637,0.309726525,73.05062972,1,0.663731555,0.842267649,0.788029263,0.430679589,0.592782536,147.8026998,1,-0.363033037,0.546066619,-0.664814556,0.506169111,0.638013589,195.9687328,1,0.186796235,0.407794467,0.458064663,0.646905985,0.758092952,112.3894758,0,-1.076714771,0.637925653,-1.687837392,0.091442448,0.178392058,N,-,,succinate dehydrogenase cytochrome b subunit,"F:oxidoreductase activity, acting on the CH-CH group of donors; P:oxidation-reduction process; C:membrane part; C:intracellular part",IPR000701 (PFAM); G3DSA:1.20.1300.10 (GENE3D); G3DSA:1.20.5.540 (GENE3D); PTHR10978:SF5 (PANTHER); PTHR10978 (PANTHER); SSF81343 (SUPERFAMILY),,
RL4_JR_05047,723,809,860,4,6,0,0,0,3,0,0,0,0,0,0,0,0,0,19.1811543,1,2.046251258,1.124514904,1.819674644,0.068808567,0.168874936,1.009366619,1,3.451950098,1.534126381,2.250108036,0.024442088,0.067320494,2.626330214,0,0.79564162,1.304817938,0.609772135,0.542012763,0.669938814,3.02979695,0,0.373353209,1.3314609,0.280408692,0.779163969,0.857503825,2.60483919,0,0.704905003,1.311065252,0.537658215,0.590813032,0.702522836,N,-,,succinate dehydrogenase cytochrome b560 subunit,"C:succinate dehydrogenase complex; F:oxidoreductase activity, acting on the CH-CH group of donors; C:membrane; C:integral component of membrane; P:tricarboxylic acid cycle; F:succinate dehydrogenase activity",no IPS match,,
RL4_JR_05048,115,175,159,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.861326226,0,-0.383839357,1.309175607,-0.293191651,0.769375666,0.879039577,1.529675685,0,2.85210589,1.424578039,2.002070657,0.045277133,0.109040004,4.01415372,0,0.183603404,1.269990792,0.144570658,0.885049866,0.928619011,33.53945688,0,2.181621254,0.942764597,2.31406786,0.020664,0.077869503,4.011089777,0,0.082243475,1.285608324,0.063972419,0.948992188,0.966946352,N,-, Effector probability:0.756,mitochondrial seryl-trna synthetase,C:integral component of membrane,IPR018811 (PFAM); PTHR28002 (PANTHER); PTHR28002:SF1 (PANTHER),,
RL4_JR_05049,8,7,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,771.8950149,0,0.075320923,0.479087661,0.157217414,0.875073504,0.939731725,140.8820105,0,-1.827910593,0.994642176,-1.837756971,0.066098225,0.146817255,483.7821335,0,-1.02953216,0.427743664,-2.406890497,0.016088993,0.04707708,586.1508489,0,-0.611505781,0.432067445,-1.415301682,0.156980062,0.275224784,376.0799755,0,-1.98027484,0.55598168,-3.561762753,0.000368373,0.002089512,N,-, Effector probability:0.878,nucleoside diphosphate kinase,C:nucleus; F:ATP binding; C:mitochondrial intermembrane space; F:identical protein binding; P:UTP biosynthetic process; P:CDP phosphorylation; P:CTP biosynthetic process; P:GTP biosynthetic process; C:integral component of membrane; C:cytosol; F:nucleoside diphosphate kinase activity; P:cellular response to DNA damage stimulus,IPR001564 (PRINTS); IPR001564 (SMART); IPR001564 (PFAM); G3DSA:3.30.70.141 (GENE3D); PTHR11349:SF62 (PANTHER); PTHR11349 (PANTHER); SSF54919 (SUPERFAMILY),,
RL4_JR_05050,189,107,136,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,156.5026658,1,0.451030186,0.501189015,0.899920333,0.368162648,0.560140038,28.80667441,0,0.101708657,1.126060864,0.090322522,0.928030924,0.959733049,80.42233712,0,-0.645224352,0.758664142,-0.850474296,0.395061445,0.538077735,110.327939,0,-0.519413631,0.647927467,-0.801653978,0.422753144,0.565813032,102.2338931,0,0.385873667,0.525726029,0.733982428,0.462959448,0.594101953,N,-,,glycoside hydrolase family 31,"C:endoplasmic reticulum lumen; P:carbohydrate metabolic process; P:fungal-type cell wall biogenesis; F:glucan 1,3-alpha-glucosidase activity; F:carbohydrate binding",IPR033403 (PFAM); IPR025887 (PFAM); IPR000322 (PFAM); PTHR22762 (PANTHER); PTHR22762:SF54 (PANTHER); PTHR22762:SF54 (PANTHER); PTHR22762:SF54 (PANTHER); PTHR22762 (PANTHER); IPR017853 (SUPERFAMILY); SSF51011 (SUPERFAMILY); IPR011013 (SUPERFAMILY),,
RL4_JR_05051,13078,13283,18458,7,8,4,0,0,0,0,1,4,4,0,0,0,1,1,1.485068401,1,1.327138052,1.471169821,0.902097115,0.367005281,NA,0.483382202,0,4.514492173,1.66176694,2.716681904,0.006593995,0.024839753,1.237748882,1,1.881585419,1.301421713,1.445792244,0.148235482,0.259903755,1.426699757,1,1.460329733,1.350154369,1.08160205,0.279429393,0.422849182,1.203706424,1,1.818341339,1.275214936,1.425909694,0.153894411,0.263837092,N,-,,general RNA polymerase II transcription factor TAF12,,no IPS match,,
RL4_JR_05052,3958,6971,7456,5,10,27,0,0,0,0,4,1,5,10,7,0,1,0,3.028792013,1,0.298948424,1.316907719,0.227007876,0.820417618,0.909370507,0.983501815,0,3.489672121,1.498421535,2.328898804,0.019864427,0.057202769,2.521798612,1,0.854748906,1.266832079,0.674713658,0.499857705,0.632623313,2.907054694,1,0.433417786,1.284239991,0.337489713,0.735747766,0.823808516,2.455503142,1,0.789990866,1.253692232,0.63013142,0.528608604,0.651907688,N,-,,---NA---,,no IPS match,,
RL4_JR_05053,2095,1664,1216,0,1,1,0,0,0,2,0,2,2,7,0,0,11,2,32.17205048,1,4.893404858,0.551665741,8.87023517,7.30E-19,8.16E-17,0.520750184,0,4.406914395,1.539424867,2.862701836,0.004200456,0.018413607,1.346625202,1,1.759720031,1.225076245,1.436416744,0.150883791,0.263415676,5.56474874,1,2.284205938,1.155964204,1.976017881,0.048152752,0.119967179,1.323264208,1,1.681867616,1.208519648,1.391675857,0.164020577,0.276692492,Y,-,,malate dehydrogenase,,IPR021851 (PFAM); PTHR35567:SF3 (PANTHER); PTHR35567 (PANTHER); PTHR35567:SF3 (PANTHER); PTHR35567 (PANTHER),,
RL4_JR_05054,447,453,391,0,0,1,0,0,0,0,0,0,0,5,0,0,0,0,234.6530612,1,-1.04446739,0.442357488,-2.361138714,0.018218914,0.060739642,99.18182088,0,0.674218311,0.669890553,1.006460396,0.314194154,0.476160087,254.2027583,0,-0.261126563,0.432778133,-0.60337282,0.546260699,0.673528598,226.6489955,1,-1.013155094,0.447184705,-2.265630023,0.023474045,0.082871237,180.0073786,0,-0.963681955,0.521328222,-1.848512924,0.064528177,0.136437994,N,-,,40S ribosomal S30,F:structural constituent of ribosome; C:cytosolic small ribosomal subunit; P:translation,IPR006846 (PFAM); PTHR12650 (PANTHER),,
RL4_JR_05055,400,492,375,0,1,4,0,0,0,0,1,0,1,7,0,0,0,0,63.59801261,1,-1.31051926,0.840110602,-1.559936581,0.118774869,0.250443365,14.67755346,0,-0.410001813,1.204041027,-0.340521464,0.733463862,0.83370255,38.02115936,1,-3.05973641,1.185998346,-2.579882527,0.009883393,0.032392188,81.42990183,1,-0.738536171,0.73204265,-1.008870413,0.313036786,0.459145446,49.00388306,0,-0.929414283,0.83316931,-1.115516705,0.264629064,0.396826018,N,-,,CMGC MAPK ERK1 kinase,C:nucleus; F:ATP binding; P:positive regulation of calcium-mediated signaling involved in cellular response to salt stress; P:MAPK cascade involved in cell wall organization or biogenesis; C:cell division site; F:MAP kinase activity involved in cell wall organization or biogenesis; C:cytosol; P:positive regulation of calcium ion transport into cytosol; C:mitotic spindle pole body; P:peptidyl-threonine phosphorylation,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24055 (PANTHER); PTHR24055:SF204 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_05056,1017,841,1152,4,0,0,0,0,0,0,0,0,0,2,0,0,0,0,65.37729785,1,1.602793875,0.813177935,1.971024799,0.048721039,0.130103515,6.183854983,0,0.836976291,1.257359111,0.665662088,0.505627111,0.65893622,29.12208449,0,-0.008538312,1.059077405,-0.008062028,0.993567502,0.997409756,51.52593145,1,0.519360121,0.781041451,0.66495846,0.506077062,0.642402915,31.40760127,0,0.662026456,0.814492828,0.812808208,0.416328029,0.552321972,N,-, Effector probability:0.864,low molecular weight phosphotyrosine phosphatase,F:non-membrane spanning protein tyrosine phosphatase activity; C:cytoplasm; P:peptidyl-tyrosine dephosphorylation; F:acid phosphatase activity,IPR017867 (PRINTS); IPR023485 (SMART); IPR023485 (PFAM); G3DSA:3.40.50.270 (GENE3D); IPR017867 (PTHR11717:PANTHER); PTHR11717 (PANTHER); IPR023485 (SUPERFAMILY),,
RL4_JR_05057,1014,1273,1409,0,0,0,0,0,0,0,1,0,2,0,0,0,2,2,68.55564208,0,6.687704648,0.68014995,9.832691523,8.14E-23,1.54E-20,0.167204015,0,6.045664017,1.889199111,3.200120084,0.001373703,0.015023052,79.7644273,1,7.73651591,0.550164383,14.06218969,6.48E-45,3.65E-42,0.502384433,1,2.965618114,1.416930537,2.09298765,0.036350257,0.101195038,0.431146654,1,3.300169648,1.243630699,2.653657272,0.007962466,0.02610089,Y,-,,cfem domain-containing,C:membrane; C:integral component of membrane,IPR008427 (PFAM); PTHR35607 (PANTHER),,
RL4_JR_05058,78,56,39,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,143.4010279,0,1.731327248,0.583462733,2.967331332,0.00300397,0.014405534,11.82013362,0,-0.097619112,1.279640066,-0.076286383,0.939191259,0.966794867,58.99572537,0,0.076088261,0.811183138,0.093799116,0.925268734,0.955956798,189.5310514,0,2.187287751,0.469859368,4.655196636,3.24E-06,5.19E-05,85.30875657,1,1.031570549,0.624433366,1.652010614,0.098532387,0.188768291,N,-,,capsule polysaccharide biosynthesis,C:membrane,PTHR12475:SF8 (PANTHER); PTHR12475 (PANTHER); PTHR12475:SF8 (PANTHER); PTHR12475 (PANTHER); IPR029069 (SUPERFAMILY),,
RL4_JR_05059,2275,2316,3611,7,1,4,0,0,0,0,2,2,0,3,0,0,9,1,1.353042806,1,1.461292008,1.415288805,1.032504463,0.301835858,NA,0.437130565,0,4.65946435,1.628984052,2.860349888,0.004231738,0.018518658,1.126268064,1,2.017371246,1.265203125,1.594503844,0.110823231,0.209440804,1.298626803,1,1.595757324,1.305387116,1.222439921,0.22154131,0.356955087,1.103692269,1,1.943297178,1.243003724,1.563388059,0.117961347,0.216330129,N,-,,Heterokaryon incompatibility,,IPR010730 (PFAM); PTHR10622 (PANTHER); PTHR10622:SF10 (PANTHER),,
RL4_JR_05060,36,30,17,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,62.39802336,0,2.052786372,0.643947231,3.187817688,0.001433509,0.007907076,3.453642521,0,1.677448819,1.316904068,1.273782092,0.202740653,0.346980731,15.38989558,0,-0.001585005,1.219708277,-0.001299495,0.998963153,0.999593402,14.26301881,1,-0.439929314,1.176701818,-0.373866435,0.70850369,0.804756547,8.703721807,0,-1.035529156,1.222925097,-0.846764171,0.397126583,0.533914042,N,-,,---NA---,,no IPS match,,
RL4_JR_05061,297,306,260,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,Y,-,,vacuolar sorting-associated,C:membrane; C:integral component of membrane,IPR009291 (PFAM); PTHR17204 (PANTHER); PTHR17204:SF7 (PANTHER); PTHR17204 (PANTHER),,
RL4_JR_05062,338,493,376,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,37.50909711,0,-3.331486178,1.237346125,-2.692444831,0.007093027,0.028860306,12.15141158,0,-0.137490305,1.273010216,-0.108004086,0.913992451,0.951695462,31.18904833,0,-2.773946288,1.23037308,-2.254557039,0.024161147,0.064728089,35.9571431,1,-3.195358582,1.234655742,-2.588056308,0.00965192,0.047233297,30.38680547,0,-2.839176726,1.227936153,-2.312153379,0.020769232,0.056302136,N,-,,ABC multidrug transporter,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011527 (PFAM); G3DSA:1.20.1560.10 (GENE3D); IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24223 (PANTHER); IPR011527 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY); IPR011527 (SUPERFAMILY),3.A.1.208.12, the atp-binding cassette (abc) superfamily.
RL4_JR_05063,70,45,58,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.206697602,1,4.172229398,2.980537448,1.399824518,0.161565874,NA,0.065528601,0,7.397397768,2.318643168,3.190399399,0.001420763,0.015023052,0.170239083,0,4.744587635,1.424708205,3.330217106,0.000867783,0.005137681,0.196438551,0,4.321049337,1.880944501,2.29727636,0.021603009,0.079770412,0.16761709,0,4.665319834,1.30238607,3.58213278,0.0003408,0.001947294,N,-,,benzoate 4-monooxygenase cytochrome P450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305:SF46 (PANTHER); PTHR24305 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_05064,142,109,148,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.181108047,0,4.362438398,3.199033385,1.363673921,0.172670216,NA,0.057928488,0,7.574677768,2.427302724,3.120615198,0.001804737,0.015023052,0.150600244,0,4.918391094,1.503490762,3.271314476,0.001070488,0.006083544,0.173724506,0,4.497328436,2.035006249,2.209982617,0.027106369,0.087488678,0.14927259,0,4.828701111,1.35864672,3.554052015,0.000379344,0.002142891,N,-,,heterokaryon incompatibility,F:N-acetyltransferase activity,IPR010730 (PFAM); PTHR33112 (PANTHER); PTHR33112:SF6 (PANTHER),,
RL4_JR_05065,3319,2626,3083,0,7,3,0,0,0,0,0,5,2,0,3,0,5,5,2.142768912,1,0.798027137,1.311770321,0.608358891,0.54294947,0.724228545,0.69238774,0,3.995949204,1.52140766,2.626481587,0.008627266,0.030143316,1.783405709,1,1.354344082,1.249626877,1.083798777,0.278454028,0.417392445,2.056310755,1,0.932728185,1.269589024,0.734669383,0.462540871,0.604611918,1.746819206,1,1.281079783,1.23532156,1.037041548,0.299716494,0.434790621,N,-,,aaa family ATPase,F:nucleotide binding; P:cell division; F:ATP binding,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003959 (PFAM); PTHR23077 (PANTHER); PTHR23077 (PANTHER); PTHR23077 (PANTHER); PTHR23077:SF74 (PANTHER); PTHR23077:SF74 (PANTHER); IPR027417 (SUPERFAMILY),3.A.25.2.1, the symbiont-specific erad-like machinery (selma) family.
RL4_JR_05066,0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.832090473,0,0.395624713,1.43443204,0.275805826,0.782697209,0.887825894,0.925100026,0,3.577896096,1.601817528,2.233647737,0.02550626,0.069570026,2.370433296,0,0.94376707,1.333813748,0.707570357,0.479212107,0.615593201,2.731981224,0,0.522798456,1.369236656,0.381817455,0.70259677,0.800381672,2.31325697,0,0.876027317,1.328031584,0.659643436,0.509482673,0.636146512,N,-,,hypothetical protein CMQ_442,,PTHR40619:SF2 (PANTHER); PTHR40619 (PANTHER),,
RL4_JR_05067,2230,1559,2791,0,4,0,0,0,0,0,0,0,0,1,0,0,2,1,1.340755181,1,1.474353301,1.485868346,0.992250292,0.321075445,NA,0.430476118,0,4.681435194,1.663864857,2.813591005,0.004899152,0.020348467,1.115204676,0,2.031210935,1.295070246,1.568417575,0.116783712,0.217617946,1.286224132,1,1.60934572,1.347619634,1.194213619,0.232394417,0.369560778,1.10040042,1,1.947805538,1.279848217,1.521903545,0.128033251,0.229521364,N,-,,ankyrin repeat-containing,"P:RNA phosphodiester bond hydrolysis, endonucleolytic; F:nucleic acid binding; F:DNA binding; F:lysophospholipase activity; F:ribonuclease III activity; P:RNA phosphodiester bond hydrolysis; F:RNA binding; F:1-alkyl-2-acetylglycerophosphocholine esterase activity; P:RNA processing; F:hydrolase activity",IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR002110 (PFAM); IPR020683 (PFAM); PTHR24198 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),8.A.28.1.2, the ankyrin (ankyrin) family.
RL4_JR_05068,4570,4096,6000,0,0,8,0,0,0,0,2,3,2,9,0,0,0,1,0.250518986,1,3.894539544,2.745852362,1.418335377,0.156092873,NA,0.078827128,0,7.130128604,2.226251852,3.202750218,0.00136122,0.015023052,0.20668766,1,4.461837396,1.3973927,3.192973168,0.00140816,0.007534997,0.238581229,1,4.039735539,1.769560109,2.282903824,0.022436034,0.080726669,0.206207017,1,4.364809385,1.306847202,3.339953883,0.000837923,0.004141085,,,,,,,,
RL4_JR_05069,760,534,1236,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0.771213588,0,2.272244526,1.779268572,1.277066634,0.201578723,NA,0.243435449,0,5.503544356,1.828935812,3.009151179,0.002619787,0.015349618,0.637754365,0,2.836874224,1.333484728,2.127414109,0.033385691,0.083455984,0.736077184,1,2.414312454,1.442722245,1.673442315,0.094240253,0.18735177,0.636440181,1,2.738108611,1.310302177,2.08967722,0.036646805,0.087926279,N,-,,aminoglycoside phosphotransferase,F:zinc ion binding; P:phosphorylation; F:kinase activity,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); PTHR21310:SF3 (PANTHER); PTHR21310 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_05070,1079,1023,1235,0,2,4,0,0,0,0,0,3,0,6,5,0,0,1,45.02998371,1,1.231324639,0.816189802,1.508625367,0.131394548,0.269122953,4.186711349,0,1.399582373,1.337686173,1.046271092,0.295435888,0.45522942,11.01134559,1,-1.272044607,1.261268533,-1.008543838,0.313193453,0.455374195,16.72434911,1,-0.753158907,1.219897552,-0.617395211,0.53697408,0.668737011,11.02159489,1,-1.376024018,1.283375886,-1.072190956,0.283634272,0.417898283,N,-,,Transcription factor tau55-related,,IPR019481 (PFAM),,
RL4_JR_05071,6055,7143,5998,0,0,25,0,0,0,0,0,2,1,3,0,0,2,3,245.3475785,1,0.191331853,1.033876915,0.185062507,0.853180009,0.926866435,58.14790898,0,-0.766884063,1.144333285,-0.670157962,0.502757099,0.656548491,106.8978633,1,-2.555751567,1.082046421,-2.361961112,0.018178549,0.052032692,116.4074474,1,-3.087836771,1.079244328,-2.861110028,0.004221605,0.024572283,104.8621546,1,-2.781936281,1.040957796,-2.672477493,0.007529343,0.025035991,N,-,,imidazole glycerol phosphate synthase hisHF,,IPR013785 (G3DSA:3.20.20.GENE3D); IPR010139 (TIGRFAM); IPR029062 (G3DSA:3.40.50.GENE3D); IPR017926 (PFAM); IPR006062 (PFAM); IPR014640 (PIRSF); IPR004651 (TIGRFAM); PTHR21235:SF2 (PANTHER); PTHR21235:SF2 (PANTHER); PTHR21235 (PANTHER); PTHR21235 (PANTHER); IPR010139 (HAMAP); IPR017926 (PROSITE_PROFILES); IPR011060 (SUPERFAMILY); IPR029062 (SUPERFAMILY),,
RL4_JR_05072,3659,4106,6038,0,0,1,0,0,0,0,0,1,0,0,0,0,4,0,542.4908594,1,-0.771090974,0.337840409,-2.282411908,0.022465033,0.072247693,211.5190853,0,-0.39470114,0.673875565,-0.585718137,0.558064944,0.702061382,407.1435444,1,-1.288058393,0.423730479,-3.039805859,0.002367307,0.011310342,448.3388779,0,-1.666484845,1.461396516,-1.140337223,0.254145836,0.393700518,383.4896818,1,-1.328449707,0.434901773,-3.05459713,0.00225363,0.009386263,N,-,,ornithine decarboxylase antizyme,F:ornithine decarboxylase inhibitor activity; P:negative regulation of catalytic activity,IPR002993 (PFAM); IPR016181 (SUPERFAMILY),,
RL4_JR_05073,448,629,514,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,55.12549156,1,-1.966220521,1.066112853,-1.844289294,0.065140991,0.162058064,15.39475997,0,-0.478821474,1.256906294,-0.380952403,0.703238567,0.812856089,85.80490664,0,0.284198617,0.67417106,0.42155268,0.673351552,0.775277051,72.24663849,1,-0.802343395,0.804650866,-0.997132332,0.318700281,0.46476168,83.530072,0,0.436346505,0.614016679,0.710642756,0.477305641,0.606973074,N,-,,yippee family,,IPR004910 (PFAM); PTHR13848 (PANTHER); PTHR13848 (PANTHER); PTHR13848:SF2 (PANTHER); PTHR13848:SF2 (PANTHER),,
RL4_JR_05074,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,461.1034449,0,0.742957328,0.385187418,1.928820343,0.053753169,0.140505721,82.31057239,0,-0.116779797,0.865002755,-0.135005116,0.89260783,0.939851798,345.5542786,0,0.528644109,0.364119542,1.451842177,0.146545493,0.257529348,301.3979235,0,-0.237277412,0.389274335,-0.609537775,0.542168042,0.67305682,201.8126925,0,-0.826781389,0.488860661,-1.691241402,0.090790707,0.177565367,N,-,,cytosolic non-specific dipeptidase,F:carboxypeptidase activity; F:dipeptidase activity; P:proteolysis; F:tripeptidase activity; F:metallopeptidase activity,G3DSA:3.40.630.10 (GENE3D); IPR017153 (PIRSF); IPR011650 (PFAM); IPR011650 (G3DSA:3.30.70.GENE3D); IPR002933 (PFAM); PTHR11014:SF15 (PANTHER); PTHR11014 (PANTHER); SSF53187 (SUPERFAMILY),,
RL4_JR_05075,1161,754,1578,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,5.690872145,0,-0.611047739,1.251037296,-0.488432871,0.625243263,0.785211598,1.795322508,0,2.621142204,1.35416502,1.935615059,0.052914865,0.123269105,20.38143865,0,1.782460677,1.064191463,1.674943597,0.093945299,0.184967367,5.419438254,0,-0.46550225,1.237221824,-0.376248011,0.706732526,0.803285454,4.669338549,1,-0.136924437,1.244086954,-0.110060182,0.912361646,0.943388651,N,-, Effector probability:0.798,mfs multidrug transporter,,IPR019240 (TIGRFAM); IPR019240 (PFAM); PTHR40069:SF1 (PANTHER); PTHR40069 (PANTHER),,
RL4_JR_05076,1118,889,828,0,0,2,0,0,0,0,0,0,0,0,0,0,4,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_05077,7390,7108,7085,0,3,9,0,0,0,1,2,0,3,11,3,0,5,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_05078,66009,94732,155538,266,604,133,0,3,88,34,63,122,8,8,29,10,27,35,23.49754784,1,-2.656814765,1.361431407,-1.951486319,0.050999222,0.134947873,7.552590162,1,0.548521136,1.405843441,0.390172276,0.696409161,0.80740861,19.58467299,1,-2.10270455,1.323014308,-1.589328655,0.111986213,0.210851482,22.58740185,1,-2.524662,1.340209448,-1.883781676,0.059594513,0.136354635,19.37281128,1,-2.189767557,1.346466989,-1.626306159,0.103884542,0.196530454,N,-,,HPP family,C:membrane; C:integral component of membrane,IPR007065 (PFAM); PTHR33741:SF1 (PANTHER); PTHR33741 (PANTHER),,
RL4_JR_05079,453,441,311,0,3,6,0,0,0,0,0,0,0,0,0,0,1,0,11.46342179,1,10.70744339,3.392834764,3.155898869,0.001600043,0.008668931,0.002334598,0,12.18995876,4.048442383,3.01102439,0.002603679,0.015349618,65.21609285,0,13.33188444,1.92255957,6.934445436,4.08E-12,3.01E-10,238.69791,0,15.02617754,1.121070935,13.4034137,5.77E-41,1.72E-38,53.69849469,1,13.10779991,2.234375164,5.866427501,4.45E-09,2.25E-07,N,-,,gpi anchored,C:membrane,PTHR34992 (PANTHER),8.A.23.1.4, the basigin (basigin) family.
RL4_JR_05080,302,430,502,0,0,3,0,0,0,0,0,0,2,0,0,0,0,0,226.3917619,1,8.33180673,1.312323734,6.348895868,2.17E-10,6.94E-09,0.227741099,0,5.599634129,1.858531977,3.01293397,0.002587352,0.015349618,447.3841359,0,9.558526454,0.53976918,17.70854433,3.60E-70,5.21E-67,1233.574803,1,10.8069812,0.440853668,24.51376044,1.05E-132,5.33E-129,501.753379,0,9.77501698,0.700009036,13.96412972,2.58E-44,5.23E-41,Y,-,,dynactin arp1 p25 subunit,P:biological_process; C:membrane; C:integral component of membrane; P:isoprenoid biosynthetic process; F:transferase activity; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_05081,8895,10541,16739,0,2,4,0,0,0,0,0,0,1,2,2,0,7,0,42.11267632,1,1.729769569,0.757711731,2.282886089,0.022437079,0.072205795,3.394439063,0,1.702214699,1.34158681,1.268806972,0.204509918,0.349316468,8.917993028,0,-0.967870137,1.255657664,-0.770807335,0.440821139,0.580876378,10.29532577,1,-1.391218003,1.262343665,-1.102091326,0.27042197,0.411980507,12.77630701,1,-0.145982779,1.205780857,-0.12106908,0.903636319,0.938199111,N,-, Effector probability:0.853,dynactin subunit 5,,IPR001451 (PFAM); G3DSA:2.160.10.10 (GENE3D); PTHR13061 (PANTHER); IPR011004 (SUPERFAMILY),,
RL4_JR_05082,229,325,265,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.55873786,0,-0.401313544,1.200371391,-0.334324482,0.738134718,0.862574715,3.004205542,0,1.878407234,1.326294844,1.416281788,0.156693018,0.28601916,20.8719688,0,1.019857437,1.082882331,0.941798944,0.346295586,0.490061016,9.089605947,0,-1.211529145,1.244570443,-0.973451645,0.330328882,0.476979453,31.01392797,0,2.198222441,0.775795606,2.833507209,0.004604027,0.016690216,N,-,,---NA---,,no IPS match,,
RL4_JR_05083,310,245,383,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0.003906015,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,0,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,N,-,,pea pathogenicity 2,,IPR032710 (G3DSA:3.10.450.GENE3D); IPR009959 (PFAM); PTHR41551 (PANTHER); IPR032710 (SUPERFAMILY),,
RL4_JR_05084,10963,12189,13789,2,2,15,0,0,1,0,0,2,0,10,6,0,2,0,0.012706323,1,8.20293094,3.990270723,2.055732934,0.039808266,NA,0.004020132,1,11.42967648,3.991033794,2.863838561,0.004185413,0.018371529,0.010357064,1,8.787173804,3.991470463,2.201487869,0.027701505,0.072039566,0.01195084,1,8.36455496,3.991447685,2.095619339,0.036115972,0.100959199,0.010019356,1,8.741909568,1.949319774,4.484594926,7.31E-06,7.74E-05,N,-,,S-adenosyl-L-methionine-dependent methyltransferase,,IPR011991 (G3DSA:1.10.10.GENE3D); IPR029063 (G3DSA:3.40.50.GENE3D); IPR001077 (PFAM); PTHR11746:SF87 (PANTHER); PTHR11746 (PANTHER); IPR016461 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY); IPR029063 (SUPERFAMILY),,
RL4_JR_05085,446,263,137,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140881141,0,4.725132574,3.58229578,1.319023571,0.187161232,NA,0.043946797,0,7.973045165,2.57531121,3.095954047,0.001961808,0.015023052,0.115571906,0,5.301613199,1.579652632,3.356189261,0.000790245,0.004767841,0.133450033,0,4.878302555,2.250700313,2.167459847,0.030199808,0.092714693,0.11535575,0,5.204697131,1.396886258,3.725927648,0.000194598,0.001213991,N,-,,5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase,F:methionine synthase activity; C:cytosol; C:extracellular region; P:homocysteine metabolic process; F:5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity,G3DSA:3.20.20.210 (GENE3D); PTHR30519:SF8 (PANTHER); PTHR30519 (PANTHER); SSF51726 (SUPERFAMILY),,
RL4_JR_05086,17696,13505,7366,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0.008115494,1,8.845278576,4.03634189,2.191409652,0.028422161,NA,0.002507343,0,12.10167175,4.040174693,2.995333784,0.002741447,0.015349618,0.006623884,0,9.426891884,3.299070491,2.857438757,0.00427075,0.016940088,0.007651472,0,9.002876608,4.037800151,2.229648886,0.025770762,0.085851084,0.006630333,0,9.341240721,1.70468121,5.479758129,4.26E-08,1.17E-06,Y,-,,cytochrome p450,F:oxidoreductase activity; F:binding,IPR002403 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24279 (PANTHER); PTHR24279:SF39 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_05087,4606,3614,3590,0,0,1,0,0,0,3,0,0,1,3,2,0,7,0,0.012350936,1,8.240449494,3.992446966,2.064009758,0.039016791,NA,0.003847388,0,11.48786319,3.994462804,2.875946969,0.004028174,0.018161447,0.010076238,1,8.824953261,3.04172355,2.901300239,0.003716176,0.01574077,0.011635085,1,8.399918427,3.993526077,2.103383893,0.035432225,0.099858856,0.009970118,1,8.753059774,1.62090679,5.400100629,6.66E-08,1.61E-06,N,-,,cytochrome P450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:membrane; P:oxidation-reduction process; F:heme binding",IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24279:SF80 (PANTHER); PTHR24279 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_05088,789,581,519,0,0,2,0,0,2,0,0,0,0,0,0,0,0,1,50.48388797,1,-0.459329266,0.905454536,-0.507291364,0.611950397,0.776912733,8.488055308,1,0.380139019,1.267225813,0.299977333,0.764194446,0.857184656,32.96438915,0,-1.30162988,1.218251916,-1.068440659,0.285321785,0.424698362,44.521939,0,-0.917732544,1.051322189,-0.872931775,0.382700266,0.528123237,36.85693994,1,0.243035801,0.806238834,0.301443928,0.763076001,0.834717428,N,-,,2-amino-3-carboxymuconate-6-semialdehyde decarboxylase,F:hydrolase activity,IPR006680 (PFAM); G3DSA:3.20.20.140 (GENE3D); PTHR21240:SF15 (PANTHER); PTHR21240 (PANTHER); IPR032466 (SUPERFAMILY),,
RL4_JR_05089,403,271,257,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.032513901,0,6.841150577,3.939469924,1.736566266,0.082463758,NA,0.010365821,0,10.05853554,3.291505598,3.055907164,0.002243807,0.015045494,0.026813951,0,7.413232561,1.896098142,3.909730408,9.24E-05,0.001112306,0.030933097,0,6.988069561,3.69388563,1.8917937,0.058518473,0.135014457,0.02626996,0,7.342077327,1.408084227,5.21423164,1.85E-07,3.78E-06,N,-,,trihydroxytoluene oxygenase,,no IPS match,,
RL4_JR_05090,291,209,231,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0.076312573,1,5.609581202,3.920726061,1.43075061,0.152501703,NA,0.024060795,0,8.842254518,2.786197298,3.173592381,0.00150565,0.015023052,0.062861663,0,6.180247225,1.588289423,3.891134158,9.98E-05,0.001160969,0.072554014,0,5.75750776,2.63728133,2.183122329,0.029026803,0.090493422,0.062362326,0,6.093054698,1.329097346,4.584355478,4.55E-06,5.26E-05,N,-, Effector probability:0.574,fumarylacetoacetate hydrolase family,P:metabolic process; F:hydrolase activity,IPR011234 (G3DSA:3.90.850.GENE3D); IPR011234 (PFAM); PTHR11820:SF6 (PANTHER); PTHR11820 (PANTHER); IPR011234 (SUPERFAMILY),,
RL4_JR_05091,430,315,385,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,12.25373129,1,-1.717339743,1.214807943,-1.41367181,0.157458286,0.306762878,3.935420914,1,1.489081848,1.290762351,1.153645244,0.248645641,0.402107554,10.15209044,0,-1.154572466,1.2134195,-0.951503141,0.341349025,0.484761134,15.71988631,0,-0.630733639,1.165092105,-0.541359466,0.58825984,0.713057414,9.936955452,1,-1.226576102,1.20991584,-1.013769769,0.310692624,0.446334111,N,-,,beta-lactamase family,,IPR001466 (PFAM); IPR012338 (G3DSA:3.40.710.GENE3D); PTHR22935:SF54 (PANTHER); PTHR22935 (PANTHER); IPR012338 (SUPERFAMILY),9.B.306.1.3, The Putative Calcium Binding Protein with Similarity to the C-termini of Anoctamins (1.A.17.5) (CBP) Family
RL4_JR_05092,20413,16686,23065,0,0,1,0,0,0,2,0,2,1,2,1,0,0,1,0.003906015,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,1,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,N,-,,dioxygenase,"F:translation initiation factor activity; F:ferric iron binding; F:hydroxyquinol 1,2-dioxygenase activity; F:catechol 1,2-dioxygenase activity; P:oxidation-reduction process; P:translational initiation; P:catechol-containing compound metabolic process",IPR015889 (G3DSA:2.60.130.GENE3D); IPR000627 (PFAM); IPR007535 (PFAM); PTHR33711 (PANTHER); PTHR33711:SF6 (PANTHER); IPR015889 (SUPERFAMILY),,
RL4_JR_05093,433,498,630,0,0,10,0,0,0,1,1,0,1,1,0,0,0,2,0.008470882,1,8.791019641,4.031633903,2.180510397,0.029219649,NA,0.002680088,0,12.01721297,4.032710343,2.979934573,0.0028831,0.015349618,0.006904709,1,9.374372631,4.033343739,2.324218623,0.02011378,0.055743746,0.007967227,1,8.951770626,4.033311655,2.219459191,0.026455501,0.08636862,0.006679571,1,9.335361424,1.822923296,5.121093929,3.04E-07,5.22E-06,N,-,,pisatin demethylase,F:oxidoreductase activity; F:binding,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); PTHR24305 (PANTHER); PTHR24305:SF69 (PANTHER); IPR016040 (SUPERFAMILY); IPR001128 (SUPERFAMILY),,
RL4_JR_05094,4,4,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.007760107,0,8.901087564,4.041366561,2.202494486,0.027630398,NA,0.002334598,0,12.18995876,4.048442383,3.01102439,0.002603679,0.015349618,0.006343058,0,9.480780804,4.042868098,2.345063102,0.01902386,0.053738157,0.007335717,0,9.055356819,4.042572319,2.23999872,0.025091006,0.08557795,0.006581095,0,9.341867313,1.819064456,5.135533973,2.81E-07,4.95E-06,N,-,,O-acetylhomoserine (thiol)-lyase,"F:pyridoxal phosphate binding; F:lyase activity; P:cellular amino acid metabolic process; F:transferase activity, transferring alkyl or aryl (other than methyl) groups",IPR006235 (TIGRFAM); IPR000277 (PIRSF); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR000277 (PFAM); IPR015421 (G3DSA:3.40.640.GENE3D); IPR006235 (PTHR11808:PANTHER); IPR000277 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_05095,2700,3442,2604,3,7,10,0,0,2,2,1,2,2,6,0,0,3,0,0.023713592,1,7.294775898,3.951484475,1.846084919,0.064879876,NA,0.007681212,1,10.49009322,3.506163324,2.991900905,0.002772462,0.015349618,0.019787624,1,7.846564413,2.051149954,3.8254465,0.000130535,0.001356816,0.02281372,1,7.426217697,3.95118342,1.879492017,0.060177342,0.136951133,0.019415467,1,7.764816771,1.447934094,5.362686605,8.20E-08,1.94E-06,N,-,,FAD binding domain,F:FAD binding; F:oxidoreductase activity; P:oxidation-reduction process,PR00420 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR002938 (PFAM); IPR003953 (PFAM); PTHR13789 (PANTHER); PTHR13789:SF187 (PANTHER); SSF54373 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_05096,12191,13868,20763,0,5,20,3,0,6,5,1,0,2,2,4,0,6,3,0.011666121,1,8.315060612,3.996942811,2.080355163,0.037492969,NA,0.003670122,1,11.54963874,3.998254364,2.888670325,0.003868744,0.017716233,0.009673795,1,8.874006407,3.050060812,2.909452288,0.003620626,0.015525295,0.01116718,1,8.453598072,3.996777749,2.115103366,0.034421138,0.099376683,0.009745957,1,8.762396083,1.617624164,5.416830608,6.07E-08,1.53E-06,N,-,,flavin-binding monooxygenase,F:oxidoreductase activity,PF13738 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR23023:SF130 (PANTHER); PTHR23023:SF130 (PANTHER); PTHR23023 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_05097,1679,1819,1841,0,3,6,0,0,0,0,0,0,2,11,0,0,0,3,0.044890798,1,6.375732468,3.930479306,1.622125947,0.104776383,NA,0.014381433,0,9.586492279,3.132536692,3.060296885,0.002211177,0.015045494,0.037049397,0,6.947472958,1.818666003,3.820092829,0.000133401,0.001376714,0.042731787,1,6.522158647,3.291181648,1.981707285,0.047512011,0.11910352,0.036114393,1,6.881843061,1.39717233,4.925550636,8.41E-07,1.26E-05,N,-,,DUF1857-domain-containing,,IPR023393 (G3DSA:3.30.530.GENE3D); IPR015075 (PFAM); SSF55961 (SUPERFAMILY),,
RL4_JR_05098,367,439,873,0,0,2,0,0,0,0,0,0,0,2,0,0,0,0,2.444994482,1,0.608011084,1.255209055,0.484390295,0.628108905,0.787840167,0.78452997,0,3.815724457,1.460276407,2.613015206,0.008974731,0.031067793,2.026386838,0,1.170425939,1.221498841,0.958188333,0.337967799,0.481298811,2.337115327,1,0.748359568,1.230865571,0.607994557,0.543191084,0.673940833,1.987255834,0,1.095422317,1.207977145,0.906823711,0.364500029,0.500890716,N,-,,kinase domain-containing,F:nucleotide binding; F:ATP binding; F:protein kinase activity; P:phosphorylation; F:protein serine/threonine kinase activity; P:protein phosphorylation; F:kinase activity,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24359 (PANTHER); PTHR24359:SF1 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_05099,37796,42180,59694,17,2,37,0,0,1,2,0,0,6,11,0,0,14,1,0.765397512,1,2.283282899,1.633138259,1.398095285,0.162084456,NA,0.245720979,1,5.490455044,1.762711248,3.11477847,0.001840831,0.015023052,13.63294312,1,4.659697497,1.049048613,4.441831806,8.92E-06,0.000170601,0.732918429,1,2.42095602,1.337166505,1.810512012,0.070216423,0.151199763,0.624919085,1,2.763837949,1.228251621,2.250221292,0.024434901,0.063978116,N,-,,serine threonine kinase,F:ATP binding; F:protein kinase activity; P:phosphorylation; F:protein serine/threonine kinase activity; P:protein phosphorylation; F:kinase activity,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR010730 (PFAM); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); PTHR24359 (PANTHER); PTHR24359 (PANTHER); PTHR24359:SF23 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_05100,32982,33928,48289,7,18,53,0,0,4,6,5,3,5,36,0,0,30,0,28.66718855,1,4.455977057,0.575684821,7.740306667,9.92E-15,6.37E-13,85.02600468,1,7.889817279,0.537809378,14.67028579,9.99E-49,5.06E-45,1.605059012,1,1.506168526,1.217465141,1.237134827,0.216037032,0.344652606,29.93265542,1,4.593134533,0.582996962,7.878487944,3.31E-15,2.08E-13,1.582142013,1,1.424263833,1.208319529,1.178714569,0.238511852,0.367401872,N,-,,Chloramphenicol acetyltransferase-like domain,"F:transferase activity, transferring acyl groups other than amino-acyl groups; F:phosphorus-oxygen lyase activity; P:intracellular signal transduction; C:intracellular; P:cyclic nucleotide biosynthetic process",IPR023213 (G3DSA:3.30.559.GENE3D),,
RL4_JR_05101,162026,181296,250740,20,29,228,3,1,9,21,31,10,16,177,14,0,66,35,16.22693638,1,4.679103093,0.753481802,6.209974923,5.30E-10,1.58E-08,0.305581308,1,5.175973241,1.685708738,3.070502707,0.002136987,0.015045494,0.79001776,1,2.529247017,1.243473775,2.034017177,0.041949864,0.09922907,12.94594572,1,4.407205789,0.867250262,5.081815459,3.74E-07,7.50E-06,0.775957753,1,2.451916913,1.215352023,2.017454093,0.043648147,0.100806909,N,-,,Alpha beta hydrolase fold-3,P:metabolic process; C:membrane; C:integral component of membrane; F:hydrolase activity,IPR019436 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR23024 (PANTHER); PTHR23024:SF132 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_05102,1538,1361,1486,0,0,0,0,0,0,0,0,0,1,0,6,0,0,1,4.234529511,0,-0.184324277,1.213347006,-0.151913901,0.879254844,0.941268208,1.357490918,0,3.024659343,1.366700479,2.213110619,0.02689002,0.072539289,3.508616383,0,0.378333898,1.208873867,0.312963914,0.754308078,0.835068552,4.046790123,1,-0.043729081,1.209619418,-0.036151107,0.971161872,0.98389173,3.443367704,1,0.302403736,1.200915373,0.251811029,0.801187132,0.865743833,N,-,,Integral membrane,C:membrane; C:integral component of membrane,PTHR33048 (PANTHER); PTHR33048:SF54 (PANTHER),2.A.1.7.25, the major facilitator superfamily (mfs).
RL4_JR_05103,296,171,174,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.01945219,0,7.578995213,3.961154526,1.913329854,0.055705838,NA,0.006172944,0,10.80242385,3.961531915,2.726829944,0.006394599,0.024293008,0.016176062,0,8.134334048,2.743339398,2.965121287,0.003025636,0.013662596,8.041842783,0,9.389556729,1.249656541,7.513709907,5.75E-14,3.22E-12,0.016201367,0,8.027987584,1.556646785,5.157231339,2.51E-07,4.63E-06,N,-,,methyltransferase type 12,F:transferase activity,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_05104,369,500,502,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0.691204371,0,2.430564623,1.746326402,1.391815768,0.163978194,NA,0.218896545,0,5.657128309,1.805708395,3.132913556,0.001730804,0.015023052,0.57016257,0,2.99957664,1.28049069,2.34252124,0.019153944,0.054015188,0.657951364,0,2.576798868,1.377401451,1.870768226,0.061377214,0.138354552,0.563846603,1,2.913671804,1.248808588,2.333161248,0.019639684,0.053933225,Y,-,,acid sphingomyelinase,"F:sphingomyelin phosphodiesterase activity; C:membrane; P:sphingomyelin catabolic process; F:hydrolase activity, acting on glycosyl bonds",IPR011160 (PIRSF); IPR004843 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); PTHR10340 (PANTHER); PTHR10340:SF34 (PANTHER); PTHR10340 (PANTHER); PTHR10340:SF34 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_05105,48,33,44,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,nacht and ankyrin domain containing,,no IPS match,,
RL4_JR_05106,412,434,698,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,61.01637194,0,-2.881021723,1.139537351,-2.528238078,0.011463659,0.042202452,16.9018583,0,-0.61358807,1.198841203,-0.511817636,0.608778646,0.741880262,111.5353077,0,0.867597484,0.484440128,1.790928195,0.073304819,0.15238973,50.59854366,0,-3.688205606,1.185604347,-3.110823283,0.001865666,0.012518134,70.2620527,0,0.057235464,0.582860667,0.098197506,0.921775463,0.949824604,N,-,,gaba permease,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PFAM); IPR002293 (PIRSF); IPR002293 (PANTHER); PTHR11785:SF369 (PANTHER),2.A.3.4.2, the amino acid-polyamine-organocation (apc) family.
RL4_JR_05107,141,260,187,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,62.28064639,0,1.582563817,0.582828475,2.715316572,0.006621244,0.027363785,4.645567891,0,1.249615715,1.244876626,1.003806874,0.31547171,0.477272893,57.56852253,0,2.207004536,0.587143579,3.758883886,0.000170673,0.001604358,51.18321469,0,0.929672912,0.745066961,1.247770953,0.212114949,0.346174058,11.93723993,0,-1.491173261,1.202516692,-1.240043711,0.214959227,0.339700667,N,-,,nitronate monooxygenase,F:dioxygenase activity; F:nitronate monooxygenase activity; P:oxidation-reduction process,IPR004136 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR31779 (PANTHER); PTHR31779:SF6 (PANTHER); SSF51412 (SUPERFAMILY),,
RL4_JR_05108,69,67,65,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.216539684,0,4.104671059,2.984285991,1.375428183,0.168998736,NA,0.069616269,0,7.309696702,2.356229504,3.102285533,0.001920326,0.015023052,0.18038008,0,4.658488321,1.487070644,3.132661074,0.001732293,0.008830684,0.208032615,0,4.23741003,1.940637859,2.18351405,0.028997975,0.090479045,0.178182644,0,4.573164382,1.359941622,3.362765217,0.00077166,0.003879371,N,-, Effector probability:0.749,hypothetical protein AFLA70_76g002780,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:heme binding",IPR011990 (G3DSA:1.25.40.GENE3D); G3DSA:1.20.58.320 (GENE3D); IPR010323 (PFAM); PTHR23004:SF7 (PANTHER); PTHR23004 (PANTHER); IPR011990 (SUPERFAMILY),,
RL4_JR_05109,23,15,27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20.77604059,0,-2.479058193,1.20284414,-2.060997024,0.039303324,0.111336444,6.642313008,0,0.73388362,1.247138459,0.588454004,0.556227598,0.701079248,50.39629809,0,0.512207689,0.86155231,0.594517225,0.552166225,0.679016134,19.82459363,0,-2.336303282,1.201432542,-1.94459797,0.051823384,0.125559168,32.89925587,0,-1.054813662,1.129097449,-0.934209587,0.350195791,0.487528688,N,-,,hydantoinase oxoprolinase,F:hydrolase activity,IPR027479 (G3DSA:3.40.1610.GENE3D); IPR010318 (PFAM); G3DSA:3.30.420.40 (GENE3D); IPR002821 (PFAM); IPR024071 (G3DSA:2.40.390.GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR008040 (PFAM); PTHR11365:SF10 (PANTHER); PTHR11365 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY); SSF160991 (SUPERFAMILY),,
RL4_JR_05110,22,55,49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.88544889,0,0.02352465,1.151759539,0.020424967,0.983704367,0.991605119,2.246075809,0,2.298054567,1.29670271,1.772229323,0.076356498,0.164407673,5.843616706,0,-0.358035782,1.201911442,-0.297888654,0.765788148,0.842516758,6.742436857,0,-0.780609992,1.200714398,-0.650121289,0.515613879,0.650297773,21.22063126,0,2.152059129,0.774054527,2.78024229,0.005431835,0.019172511,N,-,,metal-dependent amidase aminoacylase carboxypeptidase,,IPR002933 (PFAM); IPR017144 (PIRSF); IPR011650 (PFAM); IPR017439 (TIGRFAM); IPR011650 (G3DSA:3.30.70.GENE3D); G3DSA:3.40.630.10 (GENE3D); PTHR30575:SF0 (PANTHER); PTHR30575 (PANTHER); IPR011650 (SUPERFAMILY); SSF53187 (SUPERFAMILY),,
RL4_JR_05111,3273,2116,2748,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.18079822,1,-2.118494145,1.199430737,-1.766249672,0.077353971,0.18335681,5.206130728,0,1.085370955,1.263102705,0.85928955,0.390180788,0.554624843,68.77802116,0,1.931814467,1.547820941,1.24808653,0.211999371,0.340072096,25.12075261,0,-1.029178644,1.153409467,-0.892292523,0.372236161,0.518060636,20.51963577,0,-0.695973548,1.12714908,-0.617463617,0.536928972,0.659667909,N,-,,siderochrome-iron transporter,C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF46 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.16.8, the major facilitator superfamily (mfs).
RL4_JR_05112,4545,3116,3997,0,0,1,0,0,0,2,0,0,0,0,0,0,0,0,930.0134018,1,-1.494250611,0.552479793,-2.704624909,0.006838156,0.028109975,216.1483973,0,-4.290357589,1.198075389,-3.581041416,0.000342227,0.013374617,853.8335804,1,-0.941654228,0.313945944,-2.999415172,0.002704984,0.012567812,1126.210561,0,-0.401309389,0.251647937,-1.594725528,0.110773627,0.211739281,667.9748151,0,-1.912345603,0.458339446,-4.172334762,3.01E-05,0.000254174,N,-,,nmt1,P:thiamine biosynthetic process,IPR015168 (PFAM); G3DSA:3.40.190.10 (GENE3D); IPR027939 (PANTHER); PTHR31528:SF1 (PANTHER); SSF53850 (SUPERFAMILY),3.A.1.17.3, the atp-binding cassette (abc) superfamily.
RL4_JR_05113,10,4,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,87.59345988,0,-0.256935108,0.565335899,-0.454482208,0.649481795,0.800939584,18.20764568,0,-0.720973588,1.202724414,-0.599450364,0.548872601,0.695201105,80.47033977,0,-0.953972231,0.850551543,-1.1215925,0.262035742,0.399044803,54.52021999,0,-3.795940266,1.191034725,-3.187094537,0.001437098,0.010034908,54.00765562,0,-2.522494092,1.124637153,-2.242940388,0.024900659,0.065079807,Y,-,,histidine acid phosphatase,F:phosphatase activity,IPR029033 (G3DSA:3.40.50.GENE3D); IPR016274 (PIRSF); IPR000560 (PFAM); PTHR20963:SF23 (PANTHER); PTHR20963 (PANTHER); IPR029033 (SUPERFAMILY),,
RL4_JR_05114,492,241,851,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,68.8033112,0,10.0249896,2.005393992,4.999012483,5.76E-07,9.40E-06,0.022576358,0,8.936040997,3.062165982,2.918209219,0.003520481,0.016899299,27.39672045,0,9.130409201,0.879103986,10.38604004,2.87E-25,6.18E-23,16.11269319,0,8.507447935,0.993175397,8.565906852,1.07E-17,8.29E-16,36.88292961,0,9.417492577,1.842733546,5.110610049,3.21E-07,5.45E-06,Y,-,,endonuclease exonuclease phosphatase family,P:nucleic acid phosphodiester bond hydrolysis; F:exonuclease activity; F:endonuclease activity; F:carbohydrate binding,IPR001229 (SMART); IPR005135 (G3DSA:3.60.10.GENE3D); IPR001229 (PFAM); IPR001229 (G3DSA:2.100.10.GENE3D); PTHR33354 (PANTHER); IPR001229 (PROSITE_PROFILES); IPR005135 (SUPERFAMILY); IPR001229 (SUPERFAMILY),1.B.79.1.2," the porin-sphingomyelinase fusion protein, spmt (spmt) family."
RL4_JR_05115,121,140,253,0,0,4,0,0,0,0,0,0,0,0,0,0,1,0,0.918580916,1,2.020255981,1.50694688,1.34062853,0.18004109,NA,0.293743387,0,5.232959246,1.693709668,3.089643607,0.002003968,0.015023052,22.90053523,0,4.415740206,1.036024785,4.26219553,2.02E-05,0.000341859,0.877318181,0,2.161813819,1.295569317,1.66862073,0.095192568,0.188763171,0.747873077,1,2.505536087,1.21560087,2.061150291,0.039288704,0.092726837,N,-,,allantoate permease,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF303 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.4, the major facilitator superfamily (mfs).
RL4_JR_05116,4841,4620,4786,4,6,2,0,0,3,4,7,5,4,7,8,0,4,0,40.05844242,1,12.3109776,3.913789935,3.145538673,0.001657813,0.008917794,0.002671046,1,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,1,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,0.007662926,1,9.0007212,4.037607722,2.229221316,0.025799183,0.085851084,0.006329724,1,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,N,-,,Trans-aconitate 2-methyltransferase,F:methyltransferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF896 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_05117,36,17,39,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28.42988772,0,-0.764805046,1.041930557,-0.73402689,0.46293235,0.651225181,6.631539703,0,0.736215299,1.253690203,0.587238615,0.557043461,0.70146727,30.17719715,0,-0.098091385,1.05147531,-0.093289289,0.925673741,0.956010343,110.6520281,0,2.478381659,0.598312597,4.142285609,3.44E-05,0.000420992,61.43229094,0,1.466846282,0.611745175,2.39780605,0.016493596,0.046830527,N,-,,hypothetical protein NECHADRAFT_52057,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_05118,957,843,902,0,2,0,0,0,0,0,0,0,0,2,1,0,0,0,36.16395926,1,-0.526660277,1.048587976,-0.502256643,0.615487003,0.779196613,7.961407812,0,0.472543412,1.353773821,0.349056397,0.727046971,0.8296124,975.0231527,0,5.557916425,0.682002111,8.14941235,3.66E-16,4.26E-14,498.881175,1,4.361916536,0.596915475,7.307427466,2.72E-13,1.39E-11,664.2814142,0,5.037977013,1.07380852,4.691690298,2.71E-06,3.36E-05,N,-,,fungal specific transcription factor domain-containing,F:binding,IPR007219 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR007219 (PFAM); PTHR31001 (PANTHER); PTHR31001:SF41 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_05119,41,21,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44.90111457,0,0.598440599,0.909056549,0.65830954,0.510339249,0.696096331,5.518987884,0,1.001180194,1.369057047,0.731291801,0.464600937,0.623533636,261.4983258,0,4.18691005,0.633319617,6.611053781,3.82E-11,2.41E-09,33.96772866,0,0.238233201,0.979693788,0.243171084,0.807872866,0.877369169,150.8881044,0,3.397538484,0.799992076,4.246965174,2.17E-05,0.000192114,N,-,,fungal specific transcription factor,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR007219 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR007219 (PFAM); PTHR31313:SF40 (PANTHER); PTHR31313 (PANTHER); PTHR31313 (PANTHER); PTHR31313:SF40 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_05120,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.106779532,0,0.262475205,1.291981138,0.20315715,0.839012204,0.919330195,0.99983307,0,3.465913745,1.465957747,2.364265787,0.018065846,0.053095963,9.073371056,0,1.786951834,1.228269871,1.454852778,0.145710023,0.256372658,2.969032323,0,0.403130227,1.262413581,0.319332929,0.749474065,0.835076998,6.374952323,0,1.68342744,1.160929658,1.450068424,0.147039439,0.255276804,N,-,,cytochrome P450,"P:small molecule metabolic process; F:iron ion binding; C:intracellular membrane-bounded organelle; P:secondary metabolite biosynthetic process; C:integral component of membrane; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; P:oxidation-reduction process; F:heme binding",IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24279:SF80 (PANTHER); PTHR24279 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_05121,784,649,987,0,3,7,0,0,0,1,0,0,0,4,5,0,6,0,0.935709233,1,1.993508953,1.535195484,1.298537531,0.194102688,NA,0.301898849,0,5.193532347,1.715265889,3.027829319,0.002463172,0.015349618,33.27134382,1,5.676725758,0.707924254,8.018832137,1.07E-15,1.19E-13,0.896730738,1,2.130209988,1.324669965,1.608106204,0.107811921,0.207448821,16.20330957,1,5.070876975,0.786690718,6.445832981,1.15E-10,8.20E-09,N,-,,hypothetical protein Z518_03681,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); IPR003663 (TIGRFAM); PTHR23500 (PANTHER); PTHR23500:SF174 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.127, the major facilitator superfamily (mfs).
RL4_JR_05122,1802,1117,875,2,1,0,0,0,3,0,4,0,1,1,0,0,2,0,3.249921408,1,0.197549556,1.321276185,0.149514203,0.881147903,0.94187837,1.037172416,1,3.41298011,1.47727396,2.310323069,0.020870275,0.059506738,2.682143091,1,0.765951827,1.264437026,0.605765104,0.544670745,0.672059308,3.094052327,1,0.343613654,1.280911859,0.268257063,0.788501454,0.863182746,29.65161466,1,3.990736746,0.73304855,5.444027883,5.21E-08,1.38E-06,N,-,,unsaturated glucuronyl hydrolase,F:catalytic activity,IPR012341 (G3DSA:1.50.10.GENE3D); IPR010905 (PFAM); PTHR36845 (PANTHER); PTHR36845:SF1 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_05123,878,718,757,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0.032158513,0,6.856435058,3.93981678,1.740292872,0.081807605,NA,0.010193076,0,10.08155358,3.266297165,3.086538998,0.002025014,0.015023052,0.026533125,0,7.425284889,1.857672284,3.997090851,6.41E-05,0.000871421,0.030617342,1,7.002269079,3.674051998,1.905870979,0.056666947,0.132423019,0.026220723,0,7.343296924,1.395022181,5.263928434,1.41E-07,2.99E-06,N,-,,glycoside hydrolase family 18,"P:metabolic process; F:hydrolase activity, acting on glycosyl bonds",IPR011583 (SMART); IPR001223 (PFAM); IPR001002 (G3DSA:3.30.60.GENE3D); IPR013781 (G3DSA:3.20.20.GENE3D); IPR029070 (G3DSA:3.10.50.GENE3D); PTHR11177:SF218 (PANTHER); PTHR11177 (PANTHER); PTHR11177 (PANTHER); PTHR11177:SF218 (PANTHER); PTHR11177 (PANTHER); PTHR11177:SF218 (PANTHER); IPR001002 (SUPERFAMILY); IPR029070 (SUPERFAMILY); IPR017853 (SUPERFAMILY),,
RL4_JR_05124,436,250,230,0,0,0,1,0,0,2,0,2,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,Y,-,,class V chitinase Chi100,"F:binding; P:organic substance metabolic process; F:hydrolase activity, acting on glycosyl bonds",IPR018392 (SMART); IPR018392 (PFAM); IPR018392 (G3DSA:3.10.350.GENE3D); IPR018392 (SUPERFAMILY),,
RL4_JR_05125,202,211,265,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0.196986899,0,4.241524234,2.995116545,1.416146641,0.156732575,NA,0.063335101,0,7.446698855,2.304619703,3.231205065,0.001232695,0.015023052,0.163325529,0,4.804352877,1.383993544,3.471369429,0.000517811,0.003469437,0.188353538,0,4.381593949,1.847302385,2.371887778,0.017697465,0.072435007,0.159860772,1,4.731187849,1.263440251,3.744686656,0.000180619,0.00113871,N,-,,hypothetical protein SPI_06498,,no IPS match,,
RL4_JR_05126,106,248,123,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.092277851,0,1.770571534,1.537341271,1.151710142,0.249440203,NA,44.97062786,0,6.692526842,1.021025617,6.55471002,5.58E-11,1.15E-08,0.900482049,0,2.340738541,1.283309494,1.823985993,0.06815419,0.143658759,1.038998831,0,1.917959007,1.343286819,1.427810486,0.153346414,0.27025804,0.886361734,0,2.260861877,1.260359164,1.793823492,0.072841346,0.149385989,N,-,,CS1 fimbrial subunit A,,no IPS match,,
RL4_JR_05127,497,767,590,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.073169257,0,5.670550167,3.92132759,1.446079175,0.148154996,NA,0.02340721,0,8.883218135,2.831147332,3.137674269,0.00170294,0.015023052,0.060410993,0,6.240993125,1.631762129,3.82469541,0.000130934,0.001359563,0.06968127,0,5.816525343,2.705662511,2.149760112,0.031574195,0.09503232,0.059044568,0,6.171446376,1.345075057,4.588179926,4.47E-06,5.17E-05,N,-,,thermostable alkaline protease,P:proteolysis; C:membrane; C:integral component of membrane; F:serine-type endopeptidase activity; F:peptidase activity; F:hydrolase activity,IPR015500 (PRINTS); IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (PFAM); PTHR10795:SF363 (PANTHER); IPR015500 (PANTHER); PTHR10795:SF363 (PANTHER); IPR015500 (PANTHER); IPR000209 (SUPERFAMILY),,
RL4_JR_05128,143,351,242,4,0,14,0,0,4,0,2,1,0,11,0,0,3,0,39.27021831,1,1.706737727,0.642316408,2.657160405,0.007880194,0.031436001,3.981903174,1,1.471976075,1.267390675,1.161422522,0.245470114,0.398308512,10.37491412,1,-1.186199698,1.208200244,-0.981790646,0.326202997,0.469302138,15.98286955,1,-0.662756709,1.159868767,-0.571406635,0.567724032,0.694972044,10.28231325,1,-1.275872476,1.218093007,-1.047434366,0.294899289,0.429804995,N,-,,Rieske 2Fe-2S family,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR021858 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_05129,193,230,233,0,0,9,2,0,0,4,15,30,14,30,4,1,10,6,55.43367099,1,1.05192996,0.630324511,1.668870465,0.095143054,0.213483764,5.721236339,1,0.949243853,1.248995352,0.760005913,0.44725105,0.608314315,21.3035566,1,-0.737095961,1.197765523,-0.615392535,0.53829552,0.666711995,41.1469502,1,1.153690455,0.642276534,1.796251917,0.072454461,0.155071923,29.27157236,1,-0.087707482,0.975097935,-0.089947357,0.928329048,0.953375759,N,-,,exocyst complex component,C:cytoplasm; P:vesicle docking; P:exocytosis,IPR009976 (PFAM); IPR009976 (PANTHER); IPR009976 (PANTHER); IPR033960 (PTHR12100:PANTHER); IPR033960 (PTHR12100:PANTHER),1.F.2.1.1, the octameric exocyst (exocyst) family.
RL4_JR_05130,5,4,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,160.4286095,0,1.711659422,1.193537021,1.434106687,0.15154182,0.299413458,11.45359626,0,-0.052224423,1.21671579,-0.04292245,0.965763353,0.98244468,84.33569612,0,0.923101986,0.581461363,1.58755516,0.112386965,0.211134836,101.8507387,0,0.931727738,0.496779439,1.87553603,0.060719017,0.137657871,29.29033333,0,-2.786158947,1.197523321,-2.326600991,0.019986512,0.054515298,N,-,,di-cis-decaprenylcistransferase,"C:integral component of membrane; F:transferase activity, transferring alkyl or aryl (other than methyl) groups",IPR001441 (G3DSA:3.40.1180.GENE3D); PTHR21528 (PANTHER); PTHR21528:SF0 (PANTHER); IPR001441 (SUPERFAMILY),,
RL4_JR_05131,33,135,74,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,27.26048766,0,-1.419083875,1.146696417,-1.237541039,0.215886288,0.384237907,6.139756219,0,0.847298362,1.236686035,0.685136193,0.493257984,0.648711876,15.94759853,1,-1.806387285,1.196950539,-1.509157836,0.131258452,0.237508592,53.7148985,0,1.078628896,0.626019453,1.722995812,0.084889282,0.173147459,19.61350932,0,-0.961925601,1.132915754,-0.849070726,0.395841939,0.53274981,N,-,,tRNA (guanine-N(1)-)-methyltransferase,P:tRNA processing; C:mitochondrion; F:tRNA (guanine-N1-)-methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR030382 (PFAM); G3DSA:3.30.300.110 (GENE3D); PTHR23245:SF36 (PANTHER); PTHR23245 (PANTHER); PTHR23245:SF36 (PANTHER); PTHR23245:SF36 (PANTHER); PTHR23245 (PANTHER); PTHR23245 (PANTHER); IPR025792 (HAMAP); IPR030382 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_05132,410,504,347,0,0,3,0,0,0,0,0,0,0,0,2,0,0,0,104.6160844,1,-4.811309631,1.23028969,-3.910712793,9.20E-05,0.000794426,33.51303259,0,-1.601144537,1.229164832,-1.302628008,0.192701791,0.334624726,93.39755646,0,-3.290497148,1.21907323,-2.699179235,0.006951073,0.024426471,112.2686226,1,-2.404210069,0.916408543,-2.623513373,0.008702803,0.043545909,104.3711262,0,-2.105048716,0.892899426,-2.357542915,0.018396329,0.051143006,N,-,,phosphatase type 1 complex subunit hex2 reg1,C:cytoplasmic part; P:single-organism cellular process; P:regulation of primary metabolic process,IPR013860 (PFAM); PTHR28051:SF1 (PANTHER); PTHR28051 (PANTHER),,
RL4_JR_05133,123,138,97,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,42.52145589,0,0.659954774,0.694074551,0.950841337,0.341684925,0.531839314,6.192726779,0,0.83500541,1.258190658,0.663655707,0.506910695,0.659670301,15.96620781,0,-1.807889905,1.204654824,-1.500753467,0.133419338,0.2402165,18.41203666,0,-2.229689922,1.20383649,-1.852153461,0.064003789,0.142207235,41.94536874,1,1.062444728,0.685055302,1.550888995,0.120928288,0.220691946,N,-,,sis domain-containing,P:carbohydrate metabolic process; F:carbohydrate binding; F:isomerase activity,G3DSA:3.40.50.10490 (GENE3D); IPR001347 (PFAM); PTHR38418:SF1 (PANTHER); PTHR38418 (PANTHER); IPR001347 (PROSITE_PROFILES); SSF53697 (SUPERFAMILY),,
RL4_JR_05134,342,669,456,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,358.633924,1,-0.218663318,0.806657684,-0.271073247,0.786334697,0.889848586,59.48883964,0,-2.429018077,1.195481689,-2.031832105,0.042170656,0.103328825,154.1893473,0,-5.079562078,1.193100021,-4.257448655,2.07E-05,0.000346012,189.9085236,0,-3.201158726,0.860200617,-3.721409476,0.000198114,0.001906752,163.3101602,1,-2.958218973,0.85130712,-3.474913934,0.000511017,0.002758022,N,-,,U3 small nucleolar RNA-associated 15,"C:small-subunit processome; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:snoRNA binding; C:mitotic spindle; P:mycelium development; C:cytosol; C:viral nucleocapsid; C:rDNA heterochromatin; C:t-UTP complex; C:90S preribosome; P:positive regulation of transcription from RNA polymerase I promoter",IPR020472 (PRINTS); IPR001680 (SMART); IPR001680 (PFAM); IPR018983 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR19924:SF26 (PANTHER); PTHR19924 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_05135,204,300,202,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0.613205637,1,2.603112953,1.842170877,1.413068129,0.157635693,NA,0.198276805,0,5.800061612,1.868025151,3.104916232,0.001903329,0.015023052,0.510512238,0,3.158963391,1.301525886,2.427122983,0.015219096,0.045020321,0.588616971,0,2.737375704,1.420008236,1.927718187,0.053890189,0.127903929,0.499866616,0,3.08552885,1.25351706,2.461497293,0.013835844,0.040735075,N,-,,miz zinc finger domain containing,F:zinc ion binding; F:metal ion binding,no IPS match,,
RL4_JR_05136,152,217,126,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,1.46486165,1,1.346678589,1.413278419,0.952875648,0.34065308,NA,0.472819143,0,4.5461932,1.619819388,2.806605005,0.005006659,0.020667464,1.219628844,0,1.902334173,1.27203666,1.495502631,0.134783314,0.241983733,1.406337897,0,1.480703749,1.311565163,1.128959346,0.258914984,0.398770035,1.197210839,0,1.826029135,1.253639331,1.45658252,0.145231656,0.252918905,N,-,,MIZ SP-RING zinc finger,F:zinc ion binding; F:metal ion binding,IPR004181 (PFAM); PTHR10782 (PANTHER); PTHR10782:SF44 (PANTHER); PTHR10782 (PANTHER); PTHR10782:SF44 (PANTHER); IPR004181 (PROSITE_PROFILES),8.A.15.1.2, the k(+) channel accessory protein (kchap) family.
RL4_JR_05137,116,99,141,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.05362882,0,0.219163753,1.074427497,0.203981891,0.83836765,0.918937779,3.299771529,0,1.743041424,1.312906763,1.327620113,0.184303637,0.323821535,8.618605414,0,-0.918642637,1.232356558,-0.745435752,0.456008338,0.594619836,9.945794901,0,-1.34142827,1.235461235,-1.085771234,0.277580216,0.420670511,27.87226701,0,1.842125551,0.792443301,2.324614956,0.020092558,0.054709204,N,-,,triacylglycerol lipase,P:lipid metabolic process; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR002921 (PFAM); PTHR21493:SF119 (PANTHER); PTHR21493 (PANTHER); PTHR21493 (PANTHER); PTHR21493:SF119 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_05138,62,41,77,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,839.1733726,0,6.389767171,0.950613002,6.721733405,1.80E-11,7.18E-10,21.95564488,0,3.429620465,0.988223748,3.470489827,0.00051951,0.015023052,92.96099024,0,3.415519095,0.460775828,7.412539647,1.24E-13,1.10E-11,383.4392334,0,5.367692993,0.248442961,21.6053334,1.60E-103,3.24E-100,215.5837786,0,4.813274014,0.847347183,5.680403627,1.34E-08,6.24E-07,N,-,,glycoside hydrolase family 17,P:carbohydrate metabolic process; C:fungal-type cell wall; F:hydrolase activity,IPR013781 (G3DSA:3.20.20.GENE3D); PTHR16631 (PANTHER); PTHR16631:SF15 (PANTHER); IPR017853 (SUPERFAMILY),4.D.3.1.11, the glycan glucosyl transferase (opgh) family.
RL4_JR_05139,2,0,6,0,0,0,0,0,0,0,3,5,0,2,1,0,6,0,0.914928014,0,2.02576885,1.539035573,1.316258626,0.188087252,NA,0.292960761,0,5.23669032,1.710222354,3.061993844,0.00219868,0.015045494,0.759309843,1,2.585717034,1.259547248,2.052894036,0.040082856,0.095812006,0.875839079,1,2.163776173,1.320174986,1.639007098,0.101211781,0.197603025,0.748697855,1,2.503296963,1.234612899,2.027596637,0.042601432,0.098749886,N,-,,beta- -glucosidase,F:DNA binding; C:nucleus; F:ureidoglycolate lyase activity; F:ureidoglycolate hydrolase activity; C:cytosol; P:allantoin catabolic process; F:hydrolase activity,no IPS match,,
RL4_JR_05140,0,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.563166989,0,0.064620859,1.220753412,0.052935227,0.957783517,0.978289461,1.133968115,0,3.284123668,1.378681768,2.382075214,0.017215381,0.051221071,2.945889541,0,0.630268238,1.207900276,0.521788305,0.601817733,0.719679038,3.398796422,0,0.207789922,1.210078133,0.17171612,0.863660712,0.915373674,2.907062055,0,0.546833464,1.207098492,0.453014786,0.650538095,0.750791999,N,-,,mitochondrial cyt-4,P:RNA metabolic process,SM00955 (SMART); PF00773 (PFAM); PTHR23355:SF5 (PANTHER); PTHR23355 (PANTHER); PTHR23355 (PANTHER); IPR012340 (SUPERFAMILY),,
RL4_JR_05141,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,140.9532191,0,-2.316084479,0.77136481,-3.002579906,0.002677017,0.013181249,230.2254193,0,2.171857085,1.846348113,1.176298808,0.239475492,0.391296424,100.3632953,0,-4.460109667,1.19702388,-3.725998907,0.000194543,0.001729168,125.443565,0,-3.932267529,1.151127169,-3.416014871,0.000635448,0.005082076,103.1508607,0,-3.618198899,1.13628276,-3.184241656,0.001451338,0.006484906,N,-,,proteasome subunit alpha type 6,C:proteasome complex,IPR019327 (PFAM); PTHR22306 (PANTHER),,
RL4_JR_05142,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,85.85181148,0,-0.117965318,0.62010932,-0.1902331,0.849126475,0.924435568,14.74038591,0,-0.416234003,1.215012682,-0.342575851,0.731917572,0.832505862,38.44109392,0,-3.075625574,1.202610907,-2.557456911,0.010544062,0.034093926,72.44164468,1,-0.032644811,0.633912883,-0.051497314,0.958929242,0.976481804,45.46845536,0,-2.227563823,1.1413282,-1.951729417,0.050970338,0.113823263,N,-, Effector probability:0.58,proteasome subunit alpha type 6,"C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:proteasome core complex, alpha-subunit complex; C:cytosol; F:threonine-type endopeptidase activity; P:proteasomal ubiquitin-independent protein catabolic process",IPR000426 (SMART); IPR001353 (PFAM); IPR000426 (PFAM); IPR029055 (G3DSA:3.60.20.GENE3D); PTHR11599 (PANTHER); PTHR11599:SF11 (PANTHER); IPR023332 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY),,
RL4_JR_05143,55,36,76,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.932863349,0,0.9469326,1.28044653,0.739533107,0.459583344,NA,0.614637005,0,4.167660215,1.492460215,2.792476591,0.005230625,0.021203199,1.598143248,0,1.512399968,1.221161684,1.238492813,0.215533385,0.344173939,1.84391311,0,1.089915446,1.235416247,0.882225281,0.377654993,0.523228901,1.578993295,0,1.427428762,1.215365382,1.174485289,0.240200701,0.369497432,N,-,,hypothetical protein HMPREF1624_04619,,no IPS match,,
RL4_JR_05144,86,22,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22.03040038,0,-2.563748686,1.21526589,-2.109619555,0.034891139,0.101766861,6.967174598,0,0.664887922,1.244294862,0.534349166,0.593099982,0.729714114,18.17881119,0,-1.995244638,1.209568795,-1.649550357,0.099034936,0.192554194,20.97920589,0,-2.418108516,1.210372408,-1.997821909,0.045735971,0.11600118,18.02214187,0,-2.085448189,1.220371678,-1.70886315,0.087476302,0.172819035,N,-,,integral membrane,C:integral component of membrane,IPR018908 (PFAM); PTHR28668 (PANTHER); PTHR28668:SF1 (PANTHER); SSF103481 (SUPERFAMILY),2.A.7.32.4, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_05145,36,37,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,72.81547053,0,0.167811858,0.682648988,0.245824517,0.805818078,0.901743694,144.4611885,0,3.651862817,1.561427989,2.338796821,0.019345951,0.056044568,27.42792901,0,-2.588533723,1.216441643,-2.127955531,0.033340771,0.083384872,31.64188694,0,-3.010894519,1.218812943,-2.470349971,0.013498093,0.061479166,41.66721892,0,-0.963349301,1.000021071,-0.963329002,0.335382443,0.472361093,N,-,,c2 domain containing,,IPR000008 (SMART); IPR000008 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); PTHR10774:SF86 (PANTHER); PTHR10774 (PANTHER); IPR000008 (PROSITE_PROFILES); IPR000008 (SUPERFAMILY),1.F.1.1.3, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_05146,2,3,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,40.12739426,0,-0.672542341,0.910039337,-0.739025571,0.45989147,0.648090277,9.134582702,0,0.274211345,1.250365747,0.219304908,0.826412539,0.8957965,23.67282009,1,-2.37611434,1.213596517,-1.957911305,0.050240421,0.113585088,27.31061024,0,-2.798514285,1.21521672,-2.30289317,0.021284855,0.079144015,30.63200047,0,-1.515229274,1.144871127,-1.323493307,0.185671381,0.304638264,N,-,,2OG-Fe(II)oxygenase superfamily,P:biological_process; F:metal ion binding; F:oxidoreductase activity; P:oxidation-reduction process; C:cellular_component,IPR027443 (G3DSA:2.60.120.GENE3D); IPR026992 (PFAM); IPR005123 (PFAM); PTHR10209:SF198 (PANTHER); PTHR10209 (PANTHER); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_05147,109,241,175,0,0,19,7,0,0,0,0,0,0,1,0,0,4,0,119.8463833,1,-0.645442508,0.53014078,-1.21749266,0.223416828,0.393657555,24.51688391,1,-1.150186437,1.193906085,-0.963380999,0.335356358,0.498690363,83.09436173,0,-1.397252188,0.846150764,-1.651304057,0.098676504,0.192138535,93.42492451,1,-1.1845798,0.663598358,-1.78508549,0.074247451,0.157369781,62.69638154,1,-3.884093397,1.188550718,-3.267923985,0.001083395,0.005087834,N,-,,ino80 chromatin remodeling complex ies1,P:phosphorylation; F:kinase activity,PTHR37287 (PANTHER),,
RL4_JR_05148,106,315,285,0,0,18,0,0,0,0,0,0,0,0,1,0,0,0,185.7182514,1,-1.171670902,0.558496229,-2.097902979,0.035913717,0.10404265,43.30060543,0,-1.970777719,1.215856168,-1.620897085,0.105039712,0.210287177,124.7711734,0,-2.800003507,1.051467694,-2.662947727,0.007745945,0.026673712,154.2713751,1,-2.011576675,0.707918288,-2.841537941,0.004489651,0.02575508,144.2233124,0,-1.002638997,0.612420554,-1.637173983,0.101594122,0.193317136,N,-,,abc transporter,F:ATP binding; P:drug transmembrane transport; C:integral component of membrane; P:xenobiotic transport; F:xenobiotic-transporting ATPase activity; C:plasma membrane,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011527 (PFAM); G3DSA:1.20.1560.10 (GENE3D); IPR003439 (PFAM); PTHR24223 (PANTHER); IPR011527 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY),3.A.1.208.3, the atp-binding cassette (abc) superfamily.
RL4_JR_05149,26,28,28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,98.5497065,0,-0.34145536,0.633940539,-0.538623638,0.590146573,0.76117245,20.36680651,0,-0.882669009,1.202813248,-0.733837119,0.463048015,0.621861749,86.87850717,0,-0.405964383,0.682739702,-0.594610775,0.552103676,0.679016134,125.1026916,0,-0.049082712,0.530127486,-0.092586621,0.926231973,0.956655996,78.45592528,0,-0.984821922,0.766716352,-1.284467092,0.198978571,0.320703284,Y,-,,related to CSI2,C:integral component of membrane,PTHR36089:SF1 (PANTHER); PTHR36089 (PANTHER); PD039572 (PRODOM),,
RL4_JR_05150,47,56,33,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,84.29413854,0,-4.499688837,1.327806623,-3.38881337,0.000701958,0.00444955,26.31781118,0,-1.252472991,1.289976243,-0.970927176,0.331584544,0.494883332,69.22954158,0,-3.924335031,1.279435732,-3.067238887,0.002160461,0.010460143,104.0061193,0,-1.229434269,0.881066395,-1.39539344,0.162897228,0.283069805,73.03164992,0,-3.10369987,1.234274567,-2.514594363,0.011916941,0.03621496,N,-,,rrna-processing fcf1,"C:small-subunit processome; P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:nucleolus",IPR029060 (G3DSA:3.40.50.GENE3D); IPR006984 (PFAM); PTHR12416 (PANTHER); PTHR12416:SF2 (PANTHER); IPR029060 (SUPERFAMILY),,
RL4_JR_05151,5,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,236.2609801,0,-2.949639332,0.783777701,-3.763362145,0.000167644,0.001327807,64.6057972,0,-2.548063955,1.217000901,-2.093723968,0.036284577,0.091817974,211.8885004,0,-1.601841436,0.646014742,-2.479574122,0.013153939,0.040111589,236.8180718,0,-2.076546957,0.620920221,-3.344305577,0.000824888,0.006317696,178.3233541,0,-2.676699943,0.793257932,-3.37431223,0.000740004,0.003751897,N,-,,Nitrogen metabolic regulation,"C:nucleus; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated",IPR008030 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR14194 (PANTHER); PTHR14194:SF72 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_05152,379,321,465,0,4,0,0,0,2,0,0,0,0,3,1,0,0,0,50.72839657,1,-2.498155814,1.143073612,-2.185472387,0.028854228,0.087833133,12.94999357,1,-0.229363533,1.205609652,-0.190246929,0.849115639,0.910253245,33.62725395,0,-2.882572477,1.189220685,-2.423917204,0.015354106,0.045358904,76.69114391,1,-0.554744445,0.737783617,-0.7519067,0.452107169,0.594186965,33.16946167,0,-2.965542049,1.192906053,-2.485981223,0.012919478,0.038632521,N,-,,C6 transcription factor,F:binding,IPR007219 (SMART); IPR001138 (SMART); IPR007219 (PFAM); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31001:SF35 (PANTHER); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_05153,20,29,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,144.946739,0,-2.29755188,0.849662589,-2.704075605,0.00684947,0.028121781,38.16908626,0,-1.788832678,1.234449805,-1.449093087,0.147311588,0.273005223,106.3574524,0,-3.491037624,1.231193011,-2.835491748,0.00457552,0.017754911,136.6117613,0,-2.178699192,0.829145725,-2.627643279,0.008597863,0.043098829,106.9348866,0,-2.903004338,1.051378751,-2.761140394,0.005759991,0.02011725,N,-, Effector probability:0.706,c-8 sterol isomerase,C:endoplasmic reticulum membrane; C:integral component of membrane; P:sterol biosynthetic process; F:isomerase activity,IPR006716 (PFAM); PTHR10868:SF1 (PANTHER); PTHR10868 (PANTHER); IPR011051 (SUPERFAMILY),8.A.63.1.3," the sigma non-opioid intracellular recpetor, (s1r) family."
RL4_JR_05154,148,75,87,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,34.00372194,1,-3.189925241,1.209228129,-2.637984648,0.008340036,0.032916309,10.77556151,0,0.035801544,1.225429912,0.029215497,0.976692722,0.987831897,39.13384678,0,-1.659867779,1.202751537,-1.380058747,0.167568558,0.28468939,32.38412198,0,-3.044400486,1.204662732,-2.527180767,0.01149823,0.054249572,27.75732703,0,-2.708550871,1.211306097,-2.23605815,0.025347962,0.066061292,N,-,,Altered inheritance of mitochondria 1,,IPR002634 (PFAM); G3DSA:3.30.70.1500 (GENE3D); PTHR12735:SF19 (PANTHER); PTHR12735 (PANTHER); IPR002634 (SUPERFAMILY),,
RL4_JR_05155,640,533,446,0,5,0,0,0,1,2,0,1,0,3,0,0,0,0,79.57439984,1,-0.760785605,0.677439655,-1.123030809,0.26142441,0.440913859,16.56928816,1,-0.58495534,1.201169231,-0.486988282,0.626266635,0.754055235,54.1590832,1,-2.278504639,1.191484317,-1.912324491,0.055834586,0.122938093,53.72695914,1,-2.715730438,1.144353688,-2.373156539,0.017636787,0.072325829,76.9781571,0,0.26107945,0.57124293,0.457037515,0.647644081,0.748219571,N,-,,Transcription factor,C:membrane; C:integral component of membrane,PTHR23242 (PANTHER); PTHR23242:SF9 (PANTHER); PTHR23242 (PANTHER); PTHR23242:SF9 (PANTHER); SSF58113 (SUPERFAMILY),,
RL4_JR_05156,467,350,273,0,6,4,0,0,0,0,0,0,0,0,0,0,0,0,168.3554376,1,-0.51043926,0.485484456,-1.05140186,0.293074062,0.478084023,33.39025618,0,-1.595817918,1.213119114,-1.315466799,0.188353068,0.328765263,111.5423458,0,-1.828494114,0.863257849,-2.118132047,0.034163886,0.084856522,142.3420337,0,-0.956547182,0.569706206,-1.679018364,0.093148465,0.18561862,121.248147,0,-1.323905161,0.691514092,-1.914502072,0.055556035,0.121412659,N,-,,E3 ubiquitin- ligase MARCH6,F:metal ion binding; C:integral component of membrane; C:endoplasmic reticulum; C:intracellular organelle part,IPR011016 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR011016 (PFAM); PTHR13145 (PANTHER); PTHR13145:SF0 (PANTHER); PTHR13145:SF0 (PANTHER); PTHR13145 (PANTHER); IPR011016 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_05157,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_05158,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26.74729348,0,1.999589455,0.662825389,3.01676654,0.002554865,0.012708895,2.444901752,0,2.175768827,1.28774808,1.68959198,0.091106041,0.18825019,158.135025,0,4.725557012,0.358438905,13.18371679,1.09E-39,4.79E-37,464.1595251,0,6.012623874,0.304759186,19.72909809,1.21E-86,1.12E-83,172.1902803,0,5.050062198,0.353930177,14.26852676,3.44E-46,1.16E-42,N,-,,FAD binding domain-containing,F:oxidoreductase activity,IPR006094 (PFAM); IPR016169 (G3DSA:3.30.465.GENE3D); IPR012951 (PFAM); IPR016167 (G3DSA:3.30.43.GENE3D); PTHR11748 (PANTHER); PTHR11748:SF74 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY),,
RL4_JR_05159,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.753782934,1,-0.010793706,1.248792226,-0.008643316,0.993103718,0.997382756,1.188471464,0,3.216283458,1.389121807,2.315335806,0.020594562,0.058869854,3.101307423,0,0.555801338,1.225525593,0.453520792,0.650173775,0.756941041,3.57891862,0,0.133036743,1.231648782,0.108015162,0.913983665,0.947849339,3.07727258,0,0.464652544,1.231857622,0.37719663,0.706027484,0.79216847,N,-,,heterokaryon incompatibility,,IPR010730 (PFAM); PTHR33112 (PANTHER); PTHR33112:SF6 (PANTHER),,
RL4_JR_05160,2,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.674137621,0,2.466471353,1.728483022,1.426957234,0.153592222,NA,0.214312968,0,5.6875901,1.798344502,3.162681063,0.001563235,0.015023052,0.557746857,0,3.030640856,1.26617872,2.393533241,0.016686969,0.048476005,0.643531755,0,2.608418502,1.357699913,1.921203998,0.054705994,0.129385235,0.551930303,0,2.943812011,1.236146315,2.381443017,0.017244959,0.048541898,N,-,,SNF2 family domain-containing,F:ATP binding; F:zinc ion binding,IPR001650 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001650 (PFAM); IPR000330 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10799 (PANTHER); PTHR10799 (PANTHER); PTHR10799:SF271 (PANTHER); PTHR10799 (PANTHER); PTHR10799:SF271 (PANTHER); PTHR10799 (PANTHER); PTHR10799:SF271 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); SSF57850 (SUPERFAMILY),,
RL4_JR_05161,182,88,76,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.355058096,0,3.391467879,2.377120236,1.426712805,0.153662693,NA,0.111577253,0,6.628975982,2.083697825,3.181351876,0.001465895,0.015023052,8.135556058,0,4.920671342,1.239265451,3.970635457,7.17E-05,0.000930385,0.337757516,0,3.538349236,1.617816065,2.187114661,0.028734155,0.090016496,0.291750888,0,3.864292078,1.300637694,2.971074955,0.002967593,0.011718753,N,-,,DNA repair and recombination rad5c,F:ATP binding; F:zinc ion binding; F:helicase activity,no IPS match,,
RL4_JR_05162,1265,890,1194,0,0,1,0,0,0,0,0,0,0,4,0,0,0,3,1.222422617,1,1.607677132,1.530571307,1.050377153,0.293544746,NA,0.387205129,0,4.834090299,1.682302256,2.87349689,0.004059551,0.018246347,1.012014372,0,2.170997027,1.300671377,1.669135697,0.09509049,0.186749975,1.167867444,1,1.748450652,1.360930752,1.28474623,0.198880978,0.329192398,1.007492729,1,2.075369506,1.291198005,1.607320874,0.107983998,0.202320129,N,-,,zinc finger,F:nucleic acid binding; F:metal ion binding,IPR015880 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PF12874 (PFAM); PTHR10039 (PANTHER); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_05163,125,154,106,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34.92231587,0,-0.583271091,1.035521748,-0.563263004,0.573255806,0.749338386,5.983374232,0,0.884518345,1.250267989,0.707463002,0.479278797,0.636481236,15.59584626,0,-1.774126894,1.209014098,-1.467416218,0.142262865,0.252001349,26.02074865,0,-0.481251099,1.040167946,-0.462666727,0.643603271,0.755797161,15.43959497,0,-1.862299697,1.218290978,-1.528616505,0.126359542,0.227406748,N,-,,hypothetical protein SPI_05324,,no IPS match,,
RL4_JR_05164,1030,710,650,0,0,9,0,0,0,0,0,0,0,3,1,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_05165,12509,17669,20812,1,5,68,1,0,0,4,4,29,11,33,7,0,15,3,25.33449673,1,3.879879372,0.746546362,5.197104385,2.02E-07,3.74E-06,0.538821048,1,4.357733237,1.538310563,2.832804599,0.004614158,0.019615502,1446.315035,1,10.02412189,1.100056713,9.112368269,8.06E-20,1.24E-17,5.616429383,1,2.236933715,1.159966329,1.92844711,0.053799537,0.127765932,101.7392318,1,6.293925393,1.688924283,3.726588253,0.000194089,0.001213057,N,-,,hydrophobic surface binding,,IPR021054 (PFAM); PTHR38123:SF2 (PANTHER); PTHR38123 (PANTHER),,
RL4_JR_05166,38,69,65,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.269619038,0,3.788733515,2.631706412,1.439649004,0.149966728,NA,0.085391998,0,7.015206088,2.171944407,3.229919728,0.00123825,0.015023052,0.22234124,0,4.358392583,1.356072394,3.213982234,0.001309078,0.007119344,0.256573819,0,3.935459514,1.688909711,2.330177563,0.019796768,0.076496975,0.219735899,0,4.27409095,1.268825099,3.368542246,0.000755668,0.003817934,N,-,,---NA---,,no IPS match,,
RL4_JR_05167,6,25,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.207087493,0,1.626353113,1.482423242,1.097090944,0.272601639,NA,0.382736745,0,4.851121981,1.654694487,2.931732728,0.003370767,0.016450773,0.995096594,0,2.196433551,1.271839695,1.72697358,0.084172408,0.169231066,1.148242882,0,1.773631371,1.321729995,1.34190143,0.179627958,0.305003031,0.981328926,0,2.113986217,1.2536649,1.686245038,0.091748612,0.178851502,N,-,,cytochrome p450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24279:SF60 (PANTHER); PTHR24279 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_05168,6557,3900,8178,10,16,16,0,0,4,8,26,34,7,3,3,0,35,7,0.696007713,1,2.420473566,1.688866865,1.433193827,0.151802453,NA,0.223372844,1,5.628079316,1.788462299,3.146881721,0.001650217,0.015023052,0.57735916,1,2.981618984,1.259408426,2.36747581,0.017909891,0.051467424,0.665892441,1,2.559518287,1.34305363,1.905745407,0.056683245,0.132423019,0.567044559,1,2.904267087,1.221877295,2.376889315,0.017459326,0.0489819,N,-,,UDP-glucuronosyl UDP-glucosyltransferase,"F:transferase activity, transferring hexosyl groups; P:metabolic process; F:transferase activity",IPR002213 (PFAM); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); IPR002213 (PANTHER); PTHR11926:SF240 (PANTHER); SSF53756 (SUPERFAMILY),,
RL4_JR_05169,5703,2912,3870,0,2,4,0,0,0,0,0,2,2,7,0,0,2,0,0.035327791,1,6.71965004,3.936838561,1.706864515,0.087847238,NA,0.011014886,0,9.966993451,3.363288558,2.963466642,0.00304195,0.015677493,0.029143003,1,7.28414345,2.005451018,3.632172206,0.000281045,0.002210804,0.03365369,1,6.864580209,3.708652005,1.850963692,0.064174777,0.142437195,0.029412795,1,7.174448949,1.48334991,4.836653106,1.32E-06,1.82E-05,,,,,,,,
RL4_JR_05170,3850,3622,4129,0,5,1,0,0,0,0,0,0,0,0,0,0,0,1,0.003880053,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,1,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,multicopper oxidase,F:copper ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR008972 (G3DSA:2.60.40.GENE3D); IPR011707 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); IPR008972 (G3DSA:2.60.40.GENE3D); IPR001117 (PFAM); IPR011706 (PFAM); PTHR11709 (PANTHER); PTHR11709:SF87 (PANTHER); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY),2.A.108.1.5, the iron/lead transporter (ilt) family.
RL4_JR_05171,9231,6527,8982,2,0,2,0,0,0,0,0,0,2,1,2,0,0,0,0.104894498,1,5.150695702,3.916927234,1.31498376,0.18851536,NA,0.03292287,0,8.389922171,2.66705142,3.145766935,0.00165652,0.015023052,0.086185668,0,5.725464394,1.572778421,3.640350298,0.000272267,0.002153465,0.099492042,1,5.302110723,2.406941764,2.2028413,0.027605936,0.088405467,0.085593109,0,5.636385377,1.351336754,4.170970234,3.03E-05,0.000255276,Y,-, Effector probability:0.767,cytochrome p450,,no IPS match,,
RL4_JR_05172,2396,2452,2363,0,0,0,0,0,0,1,0,8,8,3,0,0,0,0,1.41599468,0,1.395709158,2.014259851,0.692914153,0.488363427,NA,0.473643889,0,4.543767102,2.055618766,2.210413321,0.02707649,0.072890488,1.196952091,1,1.929605524,1.604040825,1.202965345,0.228989732,0.359987151,1.378161662,1,1.510040431,1.742536056,0.86657629,0.386174209,0.531396285,1.152773509,0,1.880771432,1.587523517,1.18472036,0.23612803,0.364832875,N,-,,---NA---,,no IPS match,,
RL4_JR_05173,4475,5425,6042,0,0,10,0,0,0,4,7,0,0,2,0,0,1,0,45.42505203,1,-3.607736625,2.016504899,-1.789103824,0.073598096,0.177147321,15.20832074,0,-0.461264389,2.068257308,-0.223020795,0.823519322,0.893617343,38.40986833,1,-3.074403306,2.038979987,-1.507814361,0.131602046,0.237865317,44.22312132,1,-3.493894085,2.03690911,-1.71529209,0.086291688,0.175301633,36.96755978,1,-3.121963057,2.014572761,-1.549689898,0.121215964,0.221057571,N,-,,fad-dependent pyridine nucleotide-disulfide oxidoreductase,F:catalytic activity; P:single-organism process,PR00411 (PRINTS); PR00368 (PRINTS); IPR001763 (SMART); IPR004099 (PFAM); IPR001763 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (PFAM); IPR001763 (G3DSA:3.40.250.GENE3D); IPR004099 (G3DSA:3.30.390.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR22912 (PANTHER); PTHR22912:SF140 (PANTHER); IPR001763 (PROSITE_PROFILES); IPR001763 (SUPERFAMILY); IPR023753 (SUPERFAMILY); IPR016156 (SUPERFAMILY),2.A.53.3.4, the sulfate permease (sulp) family.
RL4_JR_05174,10493,10885,13456,0,2,4,0,0,0,0,0,0,2,7,2,0,16,0,6.572750881,1,-0.818928948,1.316981167,-0.621822824,0.534058377,0.717176665,2.14836888,0,2.362340936,1.451188814,1.627866004,0.103553301,0.207928291,5.497326153,0,-0.269740442,1.289404729,-0.209197652,0.834293945,0.893325426,25.60612938,1,1.122162838,1.121292973,1.00077577,0.316935226,0.463204688,5.352345126,1,-0.334095997,1.289837313,-0.259021811,0.795618412,0.861646924,N,-,,kinase-like domain,"F:ATP binding; C:membrane; P:phosphorylation; F:phosphotransferase activity, alcohol group as acceptor; F:kinase activity",G3DSA:1.10.510.10 (GENE3D); IPR011009 (SUPERFAMILY),,
RL4_JR_05175,2101,1342,2746,5,3,5,0,0,0,0,1,1,0,0,0,0,1,2,9.279617646,1,-1.316364356,1.246526877,-1.05602565,0.290956496,0.475808507,2.925170259,0,1.916922029,1.318200091,1.454196554,0.14589182,0.271206061,7.646112566,1,-0.745800243,1.231821553,-0.605445035,0.544883335,0.672089205,20.85990482,0,1.099000203,0.921313702,1.192862107,0.232923382,0.37022751,7.591541763,1,-0.838099888,1.244004518,-0.67371129,0.500494883,0.628099986,N,-,,guanine nucleotide exchange factor synembryn,P:G-protein coupled receptor signaling pathway; F:G-protein alpha-subunit binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; C:cytosol; P:positive regulation of GTPase activity,IPR008376 (PRINTS); IPR011989 (G3DSA:1.25.10.GENE3D); IPR019318 (PFAM); PTHR12425:SF5 (PANTHER); PTHR12425 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_05176,63695,32918,55633,0,2,17,0,0,0,1,3,1,2,6,0,0,12,2,1.389987118,1,1.422696454,1.43285284,0.992911774,0.320752952,NA,0.438950121,0,4.65329362,1.611077738,2.888311042,0.003873167,0.017716233,1.145553742,1,1.992866571,1.265128813,1.57522819,0.115203782,0.215436402,1.322093212,1,1.569964114,1.306075605,1.202046886,0.229345363,0.365803686,1.135154099,1,1.903781213,1.255464771,1.516395567,0.129419359,0.23156025,,,,,,,,
RL4_JR_05177,389,239,222,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1098.358145,0,-1.03560886,0.390181801,-2.654170076,0.007950374,0.031576998,276.8562545,0,-3.507592936,1.11847732,-3.13604297,0.001712441,0.015023052,692.0047815,0,-3.121365171,1.597199077,-1.954274339,0.050668782,0.114349253,869.7155003,0,-2.101532506,0.416858099,-5.041361824,4.62E-07,9.07E-06,673.314824,0,-3.062698307,0.918766758,-3.333488374,0.000857643,0.004215833,N,-, Effector probability:0.586,60S ribosomal L30,"F:structural constituent of ribosome; F:pre-mRNA 5'-splice site binding; P:negative regulation of mRNA splicing, via spliceosome; P:rRNA processing; C:ribosome; P:translation",IPR004038 (PFAM); IPR029064 (G3DSA:3.30.1330.GENE3D); IPR000231 (PANTHER); IPR029064 (SUPERFAMILY),,
RL4_JR_05178,577,310,242,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1386.717183,0,-0.560322295,0.751953095,-0.745155913,0.456177471,0.644676253,368.5145451,0,-0.667714294,0.589074075,-1.133498014,0.257005175,0.412394139,800.4460711,0,-2.522026284,0.431489733,-5.844927684,5.07E-09,2.29E-07,1080.250747,0,-1.360344819,0.377140591,-3.606996569,0.000309762,0.002797804,786.6429897,0,-2.359981628,0.608522184,-3.878217904,0.000105224,0.000721325,N,-,,60S ribosomal l10,F:structural constituent of ribosome; P:mycelium development; C:ribosome; P:translation,IPR001197 (TIGRFAM); IPR001197 (PIRSF); IPR016180 (G3DSA:3.90.1170.GENE3D); IPR016180 (PFAM); PTHR11726 (PANTHER); IPR016180 (SUPERFAMILY),,
RL4_JR_05179,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,215.0874968,0,1.149651521,0.484490101,2.37291024,0.017648552,0.059322987,20.46149017,0,-0.889354183,1.239439914,-0.717545218,0.473037746,0.630791386,67.61872369,0,-1.72882863,1.072144746,-1.612495548,0.106854148,0.203727193,133.0680492,0,0.220712139,0.558231182,0.395377661,0.692564193,0.792477717,64.04900456,0,-1.956845355,1.025015923,-1.909087762,0.056250771,0.122470334,N,-,,hypothetical protein SPSK_08750,,no IPS match,,
RL4_JR_05180,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49.83840616,0,-1.092095823,0.907485088,-1.20343115,0.22880952,0.400896276,12.38213696,0,-0.164623464,1.251374773,-0.131554085,0.895337004,0.941970775,51.35868205,0,-0.413383309,0.891422561,-0.463734403,0.642838046,0.751251573,59.37607718,0,-0.893116963,0.888797757,-1.004859605,0.314964458,0.461240257,34.98008299,0,-1.944870502,1.14272083,-1.701964689,0.088761988,0.174575588,N,-,,hypothetical protein CMQ_2661,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_05181,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.05196609,0,6.163799681,3.927247948,1.569495933,0.116532426,NA,0.016538765,0,9.383254298,2.969055373,3.16035005,0.001575797,0.015023052,0.042990012,0,6.7281633,1.662733622,4.046446895,5.20E-05,0.000748872,0.049599598,0,6.306149159,3.017563473,2.089814917,0.036634429,0.101650752,0.042471327,0,6.644455777,1.339631489,4.959913103,7.05E-07,1.08E-05,,,,,,,,
RL4_JR_05182,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.230927173,0,4.012038695,2.939105384,1.365054386,0.172235957,NA,0.07600962,0,7.183745645,2.362799926,3.040352916,0.002363011,0.015214845,0.193452526,0,4.559556145,1.51757553,3.004500307,0.002660175,0.012416602,0.222882524,0,4.138634689,1.94793309,2.124628772,0.033617601,0.098223396,0.187142098,0,4.501885797,1.381578706,3.258508384,0.001119996,0.005228196,N,-,,endonuclease exonuclease phosphatase family,P:nucleic acid phosphodiester bond hydrolysis; F:exonuclease activity; F:endonuclease activity,no IPS match,,
RL4_JR_05183,73,97,86,0,1,1,0,0,0,0,0,0,0,0,6,0,0,0,55.89822962,1,0.849243593,0.613307812,1.384693912,0.166146081,0.317712942,6.575923911,0,0.748372041,1.238630623,0.604193072,0.545715286,0.692196758,16.99415818,0,-1.897922039,1.193909966,-1.589669315,0.111909364,0.210791866,27.62332652,1,-0.594418665,1.017591578,-0.584142674,0.559124326,0.68794918,35.98615688,0,0.957286872,0.672362882,1.423765199,0.154514453,0.264624296,N,-,,m serotype,,PTHR38120 (PANTHER); PTHR38120:SF1 (PANTHER),,
RL4_JR_05184,2,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,284.0416716,0,-0.318941854,0.417540115,-0.76385919,0.44495116,0.633797644,49.30139747,0,-2.158054302,1.198784002,-1.800202788,0.071828624,0.15683461,150.5735365,0,-2.40965556,0.864988914,-2.785764675,0.005340162,0.019883709,194.8557829,0,-1.37249785,0.547982775,-2.504636847,0.012257718,0.057009367,157.18566,0,-1.710527563,0.659643552,-2.593108896,0.009511265,0.030150769,N,-,,eukaryotic translation initiation factor 1A,C:nucleus; F:translation initiation factor activity; F:RNA strand annealing activity; C:cytosol; P:translational initiation,IPR001253 (SMART); IPR001253 (TIGRFAM); IPR006196 (PFAM); G3DSA:2.40.50.140 (GENE3D); IPR001253 (PANTHER); IPR001253 (PRODOM); IPR006196 (PROSITE_PROFILES); IPR012340 (SUPERFAMILY),,
RL4_JR_05185,16,27,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,164.0320199,0,-2.093796577,0.685930952,-3.05248884,0.002269522,0.011564496,42.57699292,0,-1.946472379,1.208790514,-1.610264439,0.107340139,0.213751109,170.5229911,0,-0.774492737,0.558391374,-1.387006985,0.165439633,0.282288377,188.2372876,0,-0.618200362,0.541288039,-1.142091304,0.25341607,0.393131689,107.8818129,0,-4.667103115,1.197679481,-3.896788072,9.75E-05,0.000678785,N,-,,phospholipid metabolism enzyme regulator,P:positive regulation of phosphate metabolic process; C:vacuolar membrane; C:membrane part,IPR024260 (PFAM); PTHR28258 (PANTHER),,
RL4_JR_05186,46,48,53,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,124.4698052,0,-2.243325017,0.885634529,-2.533014402,0.011308631,0.041782522,34.34561707,0,-1.636560839,1.233185195,-1.327100622,0.1844754,0.323952116,102.9311057,0,-2.493408712,1.081769416,-2.304935484,0.021170187,0.058098935,103.8111774,0,-4.725004368,1.23823986,-3.815903945,0.000135685,0.001383498,108.7759271,0,-1.555046799,0.813953522,-1.910485988,0.056070669,0.122141894,N,-,,dimethyladenosine transferase,P:rRNA modification; F:rRNA methyltransferase activity; P:methylation,IPR020598 (SMART); IPR011530 (TIGRFAM); IPR001737 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR001737 (PANTHER); PTHR11727:SF7 (PANTHER); IPR001737 (PANTHER); PTHR11727:SF7 (PANTHER); IPR001737 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_05187,7163,6357,6354,0,0,31,0,0,0,0,0,0,2,10,0,0,6,0,112.0142896,1,2.117607403,0.485491305,4.361782348,1.29E-05,0.000144964,6.734052416,0,0.713961165,1.247296196,0.572407073,0.567046225,0.708785997,61.95248134,0,1.45331263,0.652228025,2.22822782,0.025865327,0.068353059,20.29164934,1,-2.370078846,1.212371412,-1.954911525,0.050593514,0.12409383,17.45985121,1,-2.039737323,1.223873412,-1.666624427,0.095589109,0.184490988,N,-,,arrestin,,IPR011021 (PFAM); PTHR11188:SF17 (PANTHER); PTHR11188 (PANTHER); PTHR11188:SF17 (PANTHER); PTHR11188 (PANTHER); PTHR11188 (PANTHER); PTHR11188:SF17 (PANTHER); PTHR11188:SF17 (PANTHER),,
RL4_JR_05188,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,786.5898532,0,-0.452353304,0.702329813,-0.644075327,0.519526589,0.70385422,166.6342344,0,-2.113276365,1.019043034,-2.073785202,0.038099264,0.095361214,536.9280841,0,-1.210669971,0.588856177,-2.055968873,0.039785517,0.095244401,522.3853313,0,-2.235550335,0.493438374,-4.530556302,5.88E-06,8.94E-05,522.6101559,0,-1.11025505,0.504956535,-2.198714096,0.027898258,0.071061601,N,-,,14-3-3 family,F:protein domain specific binding; P:oxidation-reduction process; F:monooxygenase activity,IPR000308 (PRINTS); IPR023410 (SMART); IPR000308 (PIRSF); G3DSA:1.20.190.20 (GENE3D); IPR023410 (PFAM); IPR000308 (PANTHER); IPR023410 (SUPERFAMILY),8.A.98.1.8, the 14-3-3 protein (14-3-3) family.
RL4_JR_05189,795,890,575,0,0,10,0,0,0,0,0,0,1,7,7,0,12,0,37.94510934,1,-2.248914751,1.162606299,-1.934373444,0.053067229,0.139337771,10.81175325,0,0.030925441,1.224020559,0.025265459,0.979843225,0.989521413,62.03829646,0,0.501360667,0.696294496,0.720041117,0.47149968,0.60808549,32.54245826,1,-3.051487532,1.205328465,-2.531664705,0.011352249,0.053685903,58.85279205,1,0.802437882,0.641255413,1.251354554,0.21080515,0.33444095,N,-,,hypothetical protein CMQ_2505,,no IPS match,,
RL4_JR_05190,754,708,426,0,0,0,2,0,0,0,0,0,4,1,0,0,0,0,192.2378093,0,0.436013914,0.792238416,0.550356944,0.582074574,0.75553928,25.9781468,1,-1.23368296,1.209182503,-1.020262,0.30760422,0.469193779,73.58001371,0,-2.917042348,1.195130655,-2.44077276,0.014655874,0.043614363,136.1038097,1,-0.034332613,0.484696132,-0.070833272,0.943530451,0.967123488,87.90527904,0,-1.723138925,0.839634595,-2.052248602,0.040145508,0.094462763,N,-,,synaptojanin 2,"F:phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; C:cell division site; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol dephosphorylation; F:inositol-2,4,5,6-tetrakisphosphate 5-phosphatase activity; F:inositol-2,4,5-triphosphate 5-phosphatase activity; F:inositol-1,2,4,5,6-pentakisphosphate 5-phosphatase activity; C:cell tip; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:calcium ion binding; F:nuclease activity; C:cytosol; F:inositol-4,5,6-triphosphate 5-phosphatase activity; F:inositol-1,2,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-4,5-bisphosphate 5-phosphatase activity; F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity",IPR000300 (SMART); IPR005135 (G3DSA:3.60.10.GENE3D); IPR002013 (PFAM); PTHR11200 (PANTHER); PTHR11200 (PANTHER); PTHR11200:SF148 (PANTHER); PTHR11200:SF148 (PANTHER); IPR002013 (PROSITE_PROFILES); IPR005135 (SUPERFAMILY),,
RL4_JR_05191,7,5,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,156.8563544,0,-2.108859534,0.688926,-3.061082805,0.002205381,0.01131166,41.84803771,0,-1.921570762,1.19514599,-1.607812584,0.107876232,0.214563882,116.5429998,0,-3.613422464,1.192562919,-3.029963791,0.002445831,0.011618831,193.3236763,0,-0.939996505,0.495804915,-1.895899932,0.057973278,0.134468631,133.1848036,0,-2.018422368,0.75639724,-2.668468713,0.007619788,0.025286905,N,-,,Pre-mRNA-processing factor 39,C:commitment complex; P:mRNA 5'-splice site recognition; F:pre-mRNA 5'-splice site binding; C:U2-type prespliceosome; C:U1 snRNP,IPR003107 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR17204 (PANTHER); PTHR17204:SF5 (PANTHER); IPR011990 (SUPERFAMILY),,
RL4_JR_05192,115,101,203,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,622.8125445,0,-1.534963345,0.529440153,-2.899219744,0.003740926,0.017106769,317.5981959,0,-0.373187977,0.721684746,-0.517106644,0.605081716,0.738976487,475.1032072,0,-1.800575026,0.602639165,-2.987816146,0.002809785,0.012941886,444.4244747,0,-4.501101913,0.893886103,-5.035431136,4.77E-07,9.30E-06,408.6919823,0,-2.831092242,0.600575913,-4.713962348,2.43E-06,3.06E-05,N,-,,Cytochrome c mitochondrial,F:peroxidase activity; P:response to oxidative stress; F:metal ion binding; C:integral component of membrane; P:cellular oxidant detoxification; P:oxidation-reduction process; F:heme binding,IPR002207 (PRINTS); IPR002016 (PRINTS); G3DSA:1.10.520.10 (GENE3D); IPR002016 (PFAM); G3DSA:1.10.420.10 (GENE3D); PTHR31356 (PANTHER); PTHR31356:SF7 (PANTHER); IPR002016 (PROSITE_PROFILES); IPR010255 (SUPERFAMILY),,
RL4_JR_05193,9,16,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,69.79111315,0,1.327938515,0.746047254,1.779965689,0.075081576,0.179570653,5.669676788,0,0.962167666,1.303035635,0.738404723,0.460268546,0.618867989,33.79409053,0,0.133073897,1.085580707,0.122583145,0.902437203,0.939752545,21.19102815,0,-1.186638807,1.205373409,-0.984457429,0.324890653,0.471486447,60.10761217,0,1.926855053,0.667971962,2.88463463,0.003918682,0.014689616,N,-,,f1f0 atp synthase assembly,P:protein complex assembly,IPR010591 (PFAM); IPR010591 (PANTHER),,
RL4_JR_05194,31,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,104.9366949,0,2.162295581,1.11612517,1.937323554,0.052705805,0.138567179,6.630732825,0,0.736329034,1.247963985,0.590024266,0.555174381,0.700246117,96.68363449,0,1.944873127,0.58866272,3.303883634,0.000953554,0.005535425,296.648435,0,3.868425545,0.472096687,8.194138296,2.52E-16,1.81E-14,125.4698618,0,2.857532417,0.481386928,5.936040738,2.92E-09,1.55E-07,N,-,,4-coumarate- ligase,P:metabolic process; C:integral component of membrane; F:monooxygenase activity; F:ligase activity,G3DSA:3.30.300.30 (GENE3D); IPR025110 (PFAM); IPR000873 (PFAM); G3DSA:3.40.50.980 (GENE3D); G3DSA:2.30.38.10 (GENE3D); G3DSA:3.40.50.980 (GENE3D); PTHR24096:SF213 (PANTHER); PTHR24096 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.7, the fatty acid transporter (fat) family.
RL4_JR_05195,77,70,78,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,99.13719752,0,4.831925927,1.165969339,4.144127778,3.41E-05,0.000332867,1.164949155,0,3.245215231,1.388754402,2.336781238,0.019450562,0.056234958,9.530965211,0,1.550397719,1.206787423,1.284731419,0.198886155,0.324238878,3.498911762,0,0.165921723,1.225655063,0.135373914,0.892316248,0.933915858,18.43927981,0,3.088527036,0.793176972,3.893868764,9.87E-05,0.000686066,Y,-,,small secreted,,PTHR38849 (PANTHER),,
RL4_JR_05196,111,154,189,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.44582396,0,1.097829195,1.209833008,0.907422089,0.364183633,0.555744496,1.062466239,0,3.377948781,1.453616137,2.323824492,0.020134903,0.057833565,2.784112828,0,0.711567761,1.262164274,0.563767946,0.572912069,0.696189513,3.213833621,0,0.288372165,1.278231659,0.225602427,0.821510653,0.88804914,2.772511593,0,0.61517574,1.271108132,0.483968063,0.628408535,0.732179104,N,-,,Metallophosphoesterase domain partial,F:hydrolase activity,IPR029052 (G3DSA:3.60.21.GENE3D); IPR004843 (PFAM); PTHR37844 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_05197,108,89,110,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.945541399,0,-0.082461786,1.260616734,-0.065413843,0.947844502,0.973991113,29.38298185,0,5.308219399,0.894319119,5.93548688,2.93E-09,4.63E-07,3.253521538,0,0.486924053,1.232122888,0.395191143,0.692701828,0.789812614,3.754759017,0,0.064059859,1.239242072,0.051692773,0.958773496,0.976481804,3.222955813,0,0.398016352,1.237042753,0.321748259,0.747643415,0.823929125,N,-,,ser Thr phosphatase,,SSF81301 (SUPERFAMILY),,
RL4_JR_05198,11,11,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,972.0568927,0,4.423098138,0.67659897,6.537252247,6.27E-11,2.26E-09,14.10435706,0,-0.352520727,1.208091279,-0.291799745,0.77043974,0.861034675,132.5014476,0,1.410592129,0.461991914,3.053283158,0.002263522,0.010891588,241.7523258,0,2.392735632,0.609854552,3.923452935,8.73E-05,0.00095237,101.1632592,0,1.401092068,0.511977572,2.736627825,0.006207247,0.021391552,Y,-,,hypothetical protein F503_05459,,no IPS match,,
RL4_JR_05199,6907,8519,9643,3,5,8,0,0,1,6,7,6,0,15,1,0,1,2,0.525796587,1,2.824866274,2.02676699,1.393779496,0.163384202,NA,0.167303198,1,6.044691893,1.947410862,3.103963324,0.00190947,0.015023052,0.436035959,1,3.385304624,1.343141005,2.52043874,0.011720864,0.036511392,0.503092708,1,2.963360692,1.506208661,1.967430389,0.049133614,0.121722006,0.432917314,1,3.293661882,1.298713402,2.536096014,0.0112096,0.034424384,N,-,,hypothetical protein SPI_06601,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_05200,63,41,68,1,6,5,0,0,0,0,0,5,0,0,0,0,0,0,32.63249476,1,0.111544068,1.170846955,0.095267846,0.924102081,0.963428087,4.088549979,0,1.433951792,1.429015331,1.003454449,0.315641644,0.477347456,16.96836524,1,-0.237379911,1.296477695,-0.183096023,0.854722676,0.907901833,12.06591816,0,-1.62007149,1.319837901,-1.227477623,0.219643127,0.354909389,21.79319795,0,0.851188785,1.033714064,0.823427691,0.410264821,0.546243816,N,-,,---NA---,,no IPS match,,
RL4_JR_05201,1152,753,947,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,11.52573841,0,-1.629277019,1.190389067,-1.368692862,0.171095302,0.324905837,3.695234735,0,1.579872927,1.266624559,1.247309564,0.212284012,0.35848161,9.56175838,0,-1.068327341,1.196853245,-0.892613481,0.372064198,0.516150846,11.02849704,1,-1.490397365,1.194686342,-1.247521892,0.212206198,0.346267165,16.77082231,0,-0.212712115,1.123773579,-0.189283783,0.849870405,0.900192264,N,-,,flavo oxygenase,F:FMN binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR002563 (SMART); IPR002563 (PFAM); IPR012349 (G3DSA:2.30.110.GENE3D); PTHR33798 (PANTHER); PTHR33798:SF5 (PANTHER); IPR012349 (SUPERFAMILY),,
RL4_JR_05202,468,630,385,0,0,2,1,0,0,0,0,0,0,1,0,0,0,0,85.34062587,1,5.14043556,0.799545809,6.429194555,1.28E-10,4.36E-09,0.875664748,1,3.657165236,1.443529495,2.533488404,0.011293348,0.036850827,2.259731452,0,1.013042406,1.220992153,0.829687893,0.406715269,0.54886502,6.617594497,1,1.53739591,1.160216461,1.325094033,0.185139965,0.312423691,2.215250895,0,0.938537168,1.208344353,0.776713332,0.43732792,0.572012038,N,-,,phenylacetyl- ligase,F:catalytic activity,G3DSA:3.30.300.30 (GENE3D); G3DSA:2.30.38.10 (GENE3D); IPR000873 (PFAM); G3DSA:3.40.50.980 (GENE3D); IPR025110 (PFAM); G3DSA:3.40.50.980 (GENE3D); PTHR24096:SF236 (PANTHER); PTHR24096 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.7, the fatty acid transporter (fat) family.
RL4_JR_05203,2,18,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,170.5182625,0,0.689513262,0.471327076,1.462918845,0.143489587,0.287472507,23.55832027,0,-1.092618094,1.201849608,-0.909113825,0.363290046,0.527881402,81.78905485,0,-1.33524059,0.849984221,-1.570900443,0.116205776,0.216973259,166.6160147,0,0.632662842,0.396399483,1.596023379,0.110483574,0.211499618,67.61216165,0,-2.145959057,0.965784438,-2.221985541,0.026284283,0.068011337,N,-,,Thioredoxin-like fold,,IPR012336 (G3DSA:3.40.30.GENE3D); PTHR12232:SF0 (PANTHER); PTHR12232 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_05204,67,86,94,0,0,6,0,0,0,0,0,0,0,1,0,0,0,0,77.98994736,1,0.186922444,0.672349302,0.278013889,0.781001697,0.887242075,13.98864722,0,-0.3406232,1.232155609,-0.276444954,0.782206333,0.868527041,55.61610844,0,-0.59000407,0.876549897,-0.6730981,0.500884883,0.633509139,93.02261876,1,0.592244948,0.548399252,1.079952144,0.280163491,0.423571054,35.3865697,0,-3.058905297,1.202838773,-2.543071745,0.010988266,0.033919572,N,-,,peroxisomal biogenesis factor 6,"F:ATPase activity; C:peroxisome; F:ATP binding; F:protein heterodimerization activity; C:cytosol; P:protein import into peroxisome matrix, receptor recycling; P:replicative cell aging",IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.8.60 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003959 (PFAM); PTHR23077:SF9 (PANTHER); PTHR23077 (PANTHER); PTHR23077:SF9 (PANTHER); PTHR23077 (PANTHER); PTHR23077:SF9 (PANTHER); PTHR23077 (PANTHER); PTHR23077:SF9 (PANTHER); PTHR23077 (PANTHER); PTHR23077 (PANTHER); PTHR23077:SF9 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.20.1.5, the peroxisomal protein importer (ppi) family.
RL4_JR_05205,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,52.79051179,0,1.514493991,0.643099401,2.354992074,0.018523101,0.061577611,4.160347563,0,1.408736779,1.258545811,1.119336909,0.262996435,0.41941861,98.23496639,0,3.144073267,0.481896093,6.52438008,6.83E-11,4.11E-09,38.19057028,0,1.360517687,0.69285904,1.9636284,0.049573201,0.122272513,21.96598208,0,0.33976806,0.994723715,0.341570283,0.732674305,0.812599079,N,-,,sterol esterase,P:lipid metabolic process; C:membrane; C:integral component of membrane; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR006693 (PFAM); PTHR11005 (PANTHER); PTHR11005:SF44 (PANTHER); PTHR11005 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_05206,86,67,39,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,70.97171846,0,-0.775070612,0.681455712,-1.137374885,0.255381602,0.433590657,16.66493472,0,-0.593202737,1.214808843,-0.488309532,0.625330611,0.753613102,56.05913131,0,-1.420656551,1.037861944,-1.368829987,0.171052425,0.289536367,57.68625562,0,-1.937834603,1.022108289,-1.895919076,0.057970746,0.134468631,57.02218056,0,-1.630284531,0.971014149,-1.678950336,0.093161723,0.180736242,N,-,,fungal transcriptional regulatory,"P:regulation of transcription, DNA-templated; F:binding",IPR001138 (SMART); IPR021858 (PFAM); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR38111:SF1 (PANTHER); PTHR38111 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_05207,114,203,192,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,18.22423916,1,-0.502456257,1.166268091,-0.430823977,0.666596364,0.814817672,3.300014041,0,1.743104796,1.312289559,1.328292817,0.184081392,0.323709494,8.497328799,0,-0.89799638,1.219636434,-0.736282022,0.461559085,0.599026203,9.797643155,0,-1.319601369,1.220164665,-1.081494496,0.279477208,0.422849182,8.317315196,1,-0.970018426,1.216679063,-0.797267295,0.42529581,0.560255019,N,-,,---NA---,,no IPS match,,
RL4_JR_05208,55,42,34,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,83.99620053,0,-1.005309349,0.710247644,-1.415434965,0.156941004,0.306517766,19.25998655,1,-0.802031638,1.209522287,-0.663097858,0.507267882,0.659781444,105.472694,0,0.026493008,1.511143697,0.017531759,0.986012396,0.993397728,130.7252359,0,0.194135961,0.514915544,0.37702486,0.70615513,0.80280942,94.43938691,0,0.080065977,0.581499007,0.137688932,0.890486267,0.92825836,N,-,,NAD dependent epimerase dehydratase family,C:intracellular membrane-bounded organelle; C:cytoplasmic part,IPR016040 (G3DSA:3.40.50.GENE3D); IPR001509 (PFAM); PTHR14097:SF7 (PANTHER); PTHR14097 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_05209,775,848,796,0,2,0,0,0,0,0,0,0,0,5,0,0,0,0,83.2179671,1,1.454826484,0.666359686,2.183245048,0.029017769,0.088068065,7.787591245,0,0.50426954,1.285324498,0.392328584,0.694815446,0.807240395,20.4372561,0,-2.164191002,1.243429729,-1.740501253,0.08177104,0.165669404,41.25192531,1,-0.288185883,0.936460329,-0.307739553,0.75828052,0.842118051,20.38887506,0,-2.263473291,1.262320741,-1.793104729,0.07295618,0.149560907,N,-,,zinc finger domain-containing ring-type,F:zinc ion binding,IPR013083 (G3DSA:3.30.40.GENE3D); IPR001841 (PFAM); PTHR22763 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),8.A.112.1.6, the respiratory supercomplex factor (rcf) family.
RL4_JR_05210,6,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,151.4249541,0,0.664215263,0.463057155,1.434413131,0.151454403,0.299385757,21.18230799,0,-0.939236131,1.213982826,-0.773681564,0.439119125,0.600481462,109.3131517,0,0.04192624,0.588420041,0.071252229,0.943197014,0.966294937,88.74235803,0,-0.970780757,0.686957228,-1.413160408,0.157608565,0.27603991,53.60485259,0,-3.658088284,1.19209648,-3.068617638,0.002150516,0.00900868,N,-,,agc yank kinase,F:ATP binding; F:protein serine/threonine kinase activity; P:peptidyl-serine phosphorylation; C:intracellular; P:intracellular signal transduction,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24356 (PANTHER); PTHR24356:SF0 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR000961 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.3, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_05211,21,12,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1013.241105,0,-1.915837357,0.723743977,-2.647120277,0.008118047,0.032149044,259.4731709,0,-4.553920943,1.240414413,-3.671289931,0.000241329,0.009929821,764.3742397,0,-2.783897534,0.541953215,-5.13678572,2.79E-07,8.73E-06,843.8444973,0,-3.603682153,0.620851907,-5.804415054,6.46E-09,1.85E-07,686.4797422,1,-3.884686357,0.693993544,-5.597582841,2.17E-08,8.07E-07,N,-,,transcription factor pap1,"F:transcription factor activity, sequence-specific DNA binding; P:response to heat; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:cellular response to organic substance; C:cytoplasm; F:sequence-specific DNA binding; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:response to reactive oxygen species; P:response to inorganic substance; P:cellular response to oxygen-containing compound",IPR004827 (SMART); IPR013910 (PFAM); G3DSA:1.20.5.170 (GENE3D); IPR023167 (G3DSA:1.10.238.GENE3D); IPR004827 (PFAM); PTHR22952:SF166 (PANTHER); PTHR22952 (PANTHER); IPR004827 (PROSITE_PROFILES); SSF57959 (SUPERFAMILY); SSF111430 (SUPERFAMILY),,
RL4_JR_05212,602,569,1075,0,0,0,0,0,0,0,0,0,0,1,0,0,2,0,198.4608206,0,-0.426884787,0.428410321,-0.996439083,0.319036851,0.507745344,84.83019675,0,-0.092959162,0.985104744,-0.094364749,0.924819417,0.958737823,142.8675587,0,-0.780761272,0.584893155,-1.334878457,0.18191613,0.303113709,169.825645,1,-0.54509029,0.474961442,-1.147651665,0.251112392,0.390675011,109.9002185,1,-1.869434409,0.757370941,-2.468320749,0.013574862,0.040094947,N,-,,bsd domain-containing,P:biological_process; C:cytosol; F:molecular_function,IPR005607 (SMART); IPR005607 (PFAM); PTHR16019:SF5 (PANTHER); PTHR16019 (PANTHER); PTHR16019:SF5 (PANTHER); PTHR16019 (PANTHER); IPR005607 (PROSITE_PROFILES); SSF140383 (SUPERFAMILY),,
RL4_JR_05213,30,43,45,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,78.17676389,0,-1.62193907,1.000599042,-1.620968041,0.105024493,0.229579264,18.25373341,0,-0.724631448,1.284275214,-0.564233772,0.572595047,0.712716068,47.93980088,0,-3.394174621,1.264651915,-2.683880507,0.007277311,0.02535289,55.34907619,0,-3.817674999,1.277249305,-2.988981858,0.002799088,0.017548459,51.67663213,1,-2.569826445,1.216574274,-2.112346529,0.034656738,0.084229349,N,-,,pre-rRNA-processing TSR2,"P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",IPR019398 (PFAM); PTHR21250:SF0 (PANTHER); PTHR21250 (PANTHER),,
RL4_JR_05214,18,12,21,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,202.2089894,0,-2.945410936,0.76035906,-3.873710583,0.000107191,0.00090806,69.23933014,0,-1.520873336,1.114124721,-1.365083556,0.17222679,0.307728079,201.9040008,0,-1.474522052,0.591380381,-2.49335639,0.012654176,0.038809718,178.8651979,1,-5.509916565,1.195256503,-4.609819357,4.03E-06,6.30E-05,171.6998458,0,-2.555383615,0.763766469,-3.345765649,0.000820557,0.004076615,N,-,,"3,4-dihydroxy-2-butanone 4-phosphate synthase","C:mitochondrial intermembrane space; F:metal ion binding; P:riboflavin biosynthetic process; C:cytosol; F:3,4-dihydroxy-2-butanone-4-phosphate synthase activity; P:aerobic respiration",IPR000422 (PFAM); IPR000422 (TIGRFAM); IPR017945 (G3DSA:3.90.870.GENE3D); PTHR21327 (PANTHER); IPR017945 (SUPERFAMILY),,
RL4_JR_05215,26,24,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,95.49086923,0,1.244508734,0.662267524,1.879163162,0.060222218,0.152887824,8.310279954,0,0.410637204,1.302956557,0.315158016,0.75264168,0.849018064,27.86974809,0,-1.266816801,1.241431073,-1.020448761,0.307515678,0.448713629,24.63750124,0,-2.649982413,1.249246906,-2.12126394,0.033899597,0.098715393,28.63807119,0,-0.656383162,1.048984727,-0.625731858,0.531490834,0.655063261,N,-,,hexaprenyldihydroxybenzoate methyltransferase,F:3-demethylubiquinone-n 3-O-methyltransferase activity; P:metabolic process; C:extrinsic component of membrane; F:polyprenyldihydroxybenzoate methyltransferase activity; C:mitochondrial inner membrane,IPR013216 (PFAM); IPR010233 (TIGRFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF901 (PANTHER); PTHR10108 (PANTHER); PTHR10108:SF901 (PANTHER); PTHR10108 (PANTHER); IPR010233 (HAMAP); IPR029063 (SUPERFAMILY),,
RL4_JR_05216,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.55115725,0,-1.862775781,1.229603057,-1.514940753,0.129787409,0.266768879,4.381448717,0,1.334139015,1.309087282,1.019136794,0.308138029,0.469654137,11.28583565,0,-1.307477475,1.228869376,-1.063967823,0.287343276,0.427015368,13.01257269,0,-1.72904493,1.230674047,-1.40495766,0.160033869,0.278984663,11.05914161,0,-1.381039761,1.229962709,-1.122830596,0.261509448,0.393429891,N,-,,hypothetical protein THITE_2038894,,IPR025676 (PFAM),,
RL4_JR_05217,28,1,24,0,0,0,0,0,0,0,0,0,0,0,3,0,0,3,171.8667876,0,0.869791469,0.458175329,1.898381283,0.057645873,0.147745848,35.97011973,0,1.004141931,0.981217256,1.023363506,0.306136007,0.46765902,51.1816113,0,-2.330871556,1.187477968,-1.962875623,0.049660628,0.11242491,110.4687701,1,0.02486143,0.531934282,0.046737785,0.962722215,0.978772417,44.06505503,1,-3.375329644,1.190556915,-2.835084658,0.004581354,0.016634172,N,-,,ph domain-containing,C:cell cortex of cell tip,IPR001849 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); PTHR31941 (PANTHER); PTHR31941:SF1 (PANTHER); IPR001849 (PROSITE_PROFILES); SSF103657 (SUPERFAMILY); IPR011993 (SUPERFAMILY),,
RL4_JR_05218,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1084.041732,0,-1.797530935,0.558180522,-3.22033977,0.001280387,0.007183907,316.4246147,0,-1.799320954,0.827891529,-2.173377659,0.029751905,0.078567384,779.1083046,0,-2.876533918,0.603791172,-4.764120531,1.90E-06,4.68E-05,911.4033477,0,-2.736163984,0.522225176,-5.239433315,1.61E-07,3.47E-06,726.4152781,0,-3.511655722,0.663404161,-5.293388151,1.20E-07,2.64E-06,N,-,,arrestin domain-containing,P:mycelium development,IPR011022 (SMART); IPR011021 (PFAM); IPR011022 (PFAM); PTHR11188 (PANTHER); PTHR11188:SF69 (PANTHER); PTHR11188 (PANTHER); PTHR11188:SF69 (PANTHER); IPR014756 (SUPERFAMILY),,
RL4_JR_05219,0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,436.392705,0,0.234697521,0.805681642,0.291303052,0.770819554,0.879981237,62.95968428,0,-2.510823123,1.21137877,-2.072698635,0.038200335,0.095525624,288.8492402,0,-0.487812572,0.476415603,-1.023922325,0.305871964,0.447492452,331.2814051,0,-0.560217388,0.474530806,-1.180571167,0.237773123,0.375694893,177.9034417,0,-2.615205475,0.770916123,-3.392334648,0.000692997,0.003559918,N,-,,catabolite repression creC,F:binding,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR14107 (PANTHER); PTHR14107 (PANTHER); PTHR14107:SF16 (PANTHER); PTHR14107:SF16 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_05220,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,214.4973076,0,1.629086987,0.421197491,3.867750928,0.000109844,0.000925729,34.57547074,0,1.115300432,1.00882381,1.10554531,0.268923373,0.426118093,41.20987985,0,-3.175980092,1.207052162,-2.631187112,0.008508718,0.028780844,63.59592132,0,-0.910619879,0.789321387,-1.153674401,0.248633683,0.387767327,48.21448379,0,-2.327090683,1.146002682,-2.030615389,0.042294025,0.098262278,N,-,,mitochondrial rho gtpase 1,F:zinc ion binding; P:small GTPase mediated signal transduction; P:phospholipid homeostasis; C:nuclear envelope; C:integral component of mitochondrial outer membrane; F:GTP binding; P:mitochondrion inheritance; F:ubiquitin-protein transferase activity; P:mitochondrion-ER tethering; F:GTPase activity; F:calcium ion binding; C:cytosol; P:regulation of mitochondrion organization; C:ERMES complex; P:protein ubiquitination,PR00449 (PRINTS); SM00173 (SMART); SM00175 (SMART); IPR002048 (SMART); SM00174 (SMART); IPR013567 (PFAM); IPR001806 (PFAM); IPR021181 (PIRSF); IPR011992 (G3DSA:1.10.238.GENE3D); IPR013566 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24072:SF73 (PANTHER); PTHR24072:SF73 (PANTHER); PTHR24072 (PANTHER); PTHR24072 (PANTHER); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR020860 (PROSITE_PROFILES); IPR020860 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_05221,5716,4984,5291,1,0,2,0,0,0,0,2,0,3,15,8,0,2,14,272.5584029,1,-1.314826278,0.437113302,-3.007975899,0.00262994,0.012979462,66.71451581,0,-2.594399292,1.189656178,-2.180797562,0.029198393,0.077591529,185.8148764,1,-3.423092824,1.028157101,-3.329348035,0.000870496,0.005150729,225.9960858,1,-2.934533819,0.733889325,-3.998605402,6.37E-05,0.000728141,207.6063738,1,-1.892707601,0.571274138,-3.313133702,0.000922569,0.004469382,N,-,,vitamin h transporter 1,C:nucleus; P:mycelium development; C:membrane; P:transport,IPR011701 (PFAM); IPR001394 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662 (PANTHER); PTHR11662:SF2 (PANTHER); PTHR11662:SF2 (PANTHER); IPR028889 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); SSF54001 (SUPERFAMILY),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_05222,3518,3643,1593,0,7,5,0,0,0,0,0,0,5,11,0,0,5,2,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,Y,-,,hypothetical protein FGSG_13748,,no IPS match,,
RL4_JR_05223,381,510,521,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,2.394183935,1,0.638434304,1.299018527,0.491474364,0.62309098,0.78395685,0.764329179,0,3.853357063,1.485476789,2.594020378,0.009486086,0.032395477,1.978306899,0,1.205144639,1.240249595,0.971695248,0.331202181,0.474404483,2.282118807,0,0.782780935,1.255879094,0.623293228,0.533091847,0.665872022,1.941986234,0,1.128950531,1.229512711,0.918209727,0.358509077,0.495956333,N,-,,DNA repair sae2 ctip,P:cellular response to DNA damage stimulus,IPR013882 (PFAM); IPR033316 (PANTHER),,
RL4_JR_05224,3,4,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,714.9236167,0,-1.431144116,0.774643689,-1.847486962,0.064676596,0.161108244,181.9545114,0,-2.245541722,0.993020575,-2.261324467,0.023739172,0.065922607,474.5972128,0,-3.132939939,0.638638147,-4.905657378,9.31E-07,2.54E-05,571.6075702,0,-2.329544731,0.494563912,-4.710300685,2.47E-06,4.09E-05,501.8917128,0,-2.123752305,0.996662528,-2.130864004,0.033100348,0.0811676,N,-, Effector probability:0.977,zinc knuckle,F:metal ion binding,IPR001878 (SMART); IPR001878 (G3DSA:4.10.60.GENE3D); IPR001878 (PFAM); IPR001878 (G3DSA:4.10.60.GENE3D); PTHR23002 (PANTHER); IPR001878 (PROSITE_PROFILES); IPR001878 (PROSITE_PROFILES); IPR001878 (PROSITE_PROFILES); IPR001878 (PROSITE_PROFILES); IPR001878 (PROSITE_PROFILES); IPR001878 (SUPERFAMILY); IPR001878 (SUPERFAMILY); IPR001878 (SUPERFAMILY),1.G.7.1.1, the reovirus fast fusion protein (r-fast) famly.
RL4_JR_05225,529,760,561,0,0,3,0,0,0,0,0,0,1,0,0,0,0,2,2.873752387,1,0.374896352,1.269695588,0.295264751,0.767791641,0.877998908,0.92562597,0,3.577159369,1.457043559,2.455080596,0.014085301,0.043841148,8.883013932,0,1.897757121,1.215966283,1.560698801,0.118594834,0.219900019,2.749442767,1,0.513953079,1.246151696,0.412432195,0.68002267,0.782323546,2.331105506,1,0.865122981,1.221952806,0.707983955,0.478955221,0.608383091,Y,-, Effector probability:0.709,glycosyltransferase family 90,C:membrane; C:integral component of membrane; F:transferase activity,PS51257 (PROSITE_PROFILES),,
RL4_JR_05226,1452,1593,1686,0,1,3,0,0,0,0,0,3,0,4,0,1,2,0,0.813449515,1,2.195444764,1.598199214,1.373699064,0.169535128,NA,0.258741831,0,5.415807748,1.735524827,3.120559074,0.001805081,0.015023052,0.673188301,1,2.759268767,1.256834314,2.195411707,0.028134078,0.072831399,0.776711851,1,2.337034539,1.325706685,1.762859436,0.0779242,0.163316606,0.666034382,1,2.672621036,1.233094378,2.167409959,0.030203609,0.075564995,N,-, Effector probability:0.669,acyl- dehydrogenase,"F:acyl-CoA dehydrogenase activity; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:electron carrier activity; F:oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor; P:lipid homeostasis",PTHR10909:SF297 (PANTHER); PTHR10909 (PANTHER),,
RL4_JR_05227,2627,1896,1847,1,3,2,0,0,0,10,1,4,0,1,1,0,0,0,10.89168366,1,-1.547640561,1.188594863,-1.302075761,0.192890488,0.353936258,159.6591468,0,5.48668806,1.619910693,3.387031201,0.000706534,0.015023052,22.01801214,1,0.835974451,1.031247763,0.810643651,0.417570342,0.559026223,48.94739844,1,1.342971148,0.737179251,1.821770142,0.06848987,0.148587944,23.98529026,0,1.145203353,0.844634889,1.355856084,0.175144963,0.291524371,N,-,,mhck ef2 kinase domain family,F:ATP binding; P:phosphorylation; F:protein serine/threonine kinase activity; P:protein phosphorylation; F:kinase activity,IPR004166 (SMART); IPR002035 (PFAM); IPR004166 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); PTHR14187 (PANTHER); IPR014010 (PROSITE_PROFILES); IPR002035 (PROSITE_PROFILES); IPR004166 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR002035 (SUPERFAMILY),1.A.4.5.8, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_05228,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33.77752316,0,0.369027626,0.797022659,0.463007698,0.64335885,0.797041989,5.862559373,0,0.913965231,1.252841016,0.729514136,0.465687224,0.624615574,21.76472507,0,-0.781463379,1.207156863,-0.647358602,0.517399882,0.648003014,17.61617765,0,-2.166001764,1.209626858,-1.790636303,0.073351677,0.15614975,15.09301193,0,-1.829539026,1.217129835,-1.503158475,0.132798183,0.236140077,N,-,,amine oxidase,F:oxidoreductase activity; P:cellular metabolic process; P:single-organism metabolic process; P:organic substance metabolic process,PR00419 (PRINTS); IPR002937 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR10742:SF61 (PANTHER); PTHR10742 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_05229,221,280,221,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,200.9214797,1,0.375505372,0.62991654,0.596119243,0.55109557,0.730740661,29.474266,0,-1.415839454,1.218699244,-1.161762807,0.245331826,0.398308512,126.8895753,0,-0.889701751,0.696254276,-1.27784027,0.201305752,0.326762776,162.4263676,0,-0.178293967,0.505658352,-0.352597691,0.724390069,0.816208485,123.6910413,0,-0.218593487,0.534248915,-0.409160376,0.682421971,0.774460257,N,-,,atg c terminal domain-containing,P:autophagy,IPR026854 (PFAM); IPR015412 (PFAM); IPR026885 (PFAM); PTHR13190:SF1 (PANTHER); PTHR13190:SF1 (PANTHER); IPR026849 (PANTHER); IPR026849 (PANTHER),9.A.15.1.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_05230,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,Y,-,,---NA---,,no IPS match,,
RL4_JR_05231,1186,1365,1407,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,94.0781044,0,0.135709645,0.554225531,0.244863576,0.806562066,0.901743694,53.9701815,0,0.422196606,1.112270776,0.379580777,0.704256632,0.813754068,51.77019816,1,-2.196200097,1.19688395,-1.83493153,0.066515835,0.141027501,50.97502028,0,-2.633994014,1.150941887,-2.288555177,0.022105211,0.080442001,54.98376408,1,-1.55171287,0.983910565,-1.577087313,0.114775436,0.211830348,N,-,,glycosyl transferase,"F:transferase activity, transferring glycosyl groups; P:mycelium development; C:integral component of membrane; P:transport",IPR029044 (G3DSA:3.90.550.GENE3D); PTHR11183:SF3 (PANTHER); PTHR11183 (PANTHER); IPR029044 (SUPERFAMILY),,
RL4_JR_05232,228,170,196,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,48.9782203,0,-2.502906237,1.195617951,-2.09339968,0.036313491,0.104939943,12.89428443,0,-0.223203373,1.247173137,-0.178967432,0.857963275,0.916646007,33.78050088,0,-2.88917166,1.226830353,-2.354988734,0.018523267,0.052840112,63.06194271,0,-0.107370929,0.740017222,-0.145092474,0.88463786,0.929145056,33.6528489,0,-2.986429189,1.241986818,-2.40455788,0.016192042,0.046188782,N,-,,Mitochondrial substrate carrier family L,"F:transferase activity, transferring glycosyl groups; P:transmembrane transport; C:integral component of membrane",IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089:SF223 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.8.5, the mitochondrial carrier (mc) family.
RL4_JR_05233,21,12,38,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,860.1586255,0,0.152692921,0.679211226,0.224809184,0.822127721,0.909928731,204.80294,0,-0.072844031,0.662061855,-0.11002602,0.912388739,0.951145023,350.3016646,0,-5.255344704,1.219984882,-4.307712974,1.65E-05,0.000289925,447.6881348,0,-2.448773735,0.795042144,-3.080055257,0.002069622,0.013571841,387.2480436,0,-2.335845907,0.84879428,-2.751957645,0.005924018,0.020576564,N,-,,60S ribosomal l22,F:structural constituent of ribosome; P:cytoplasmic translation; P:lipid metabolic process; C:cytosolic large ribosomal subunit; C:nucleolus; F:phosphoric diester hydrolase activity,IPR002671 (PFAM); IPR002671 (PANTHER),,
RL4_JR_05234,850,676,679,5,2,0,0,0,0,0,0,0,0,1,0,0,0,0,134.87116,1,-0.252509594,0.455049095,-0.554906266,0.578958776,0.753552667,25.68295097,0,-1.217203519,1.19636996,-1.017413977,0.308956536,0.470405844,180.4036823,0,0.856184439,0.405611797,2.110846984,0.034785466,0.085957544,179.4923577,1,0.062446878,0.4446144,0.140451767,0.888303059,0.931630491,133.5300128,0,0.469042388,0.421385907,1.113094623,0.265667793,0.39802995,N,-,,plasma membrane proteolipid 3,C:integral component of membrane; C:plasma membrane,IPR000612 (PFAM); IPR000612 (PANTHER),9.B.12.2.2, the sensitivity to sodium or salt stress-induced hydrophobic peptide (sna) family.
RL4_JR_05235,252,494,512,0,1,7,0,0,0,0,0,0,0,0,2,0,0,0,262.7071976,1,-1.336605112,0.64448293,-2.073918563,0.038086875,0.108754891,56.80533293,0,-2.362456299,1.208130817,-1.955463983,0.050528331,0.1188308,163.5846192,0,-3.194681229,1.053682153,-3.031921173,0.002430027,0.011567947,170.6435229,1,-5.442032857,1.211721978,-4.49115635,7.08E-06,0.000105166,153.8957094,0,-4.168825465,1.151690882,-3.619743395,0.000294895,0.001726903,N,-,,GTP-binding,F:GTP binding; C:cytoplasm; F:hydrolase activity,IPR006073 (PRINTS); IPR027417 (G3DSA:3.40.50.GENE3D); IPR013646 (PFAM); IPR006073 (PFAM); PTHR23305 (PANTHER); IPR031167 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_05236,179,193,137,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,113.0936599,0,-0.23576395,0.580362313,-0.406235803,0.68456935,0.828592991,20.57965912,0,-0.897636367,1.230536205,-0.729467661,0.465715643,0.624615574,59.76402531,0,-2.58436241,1.213028409,-2.130504439,0.03312999,0.082980707,61.43304965,0,-3.968144018,1.216362571,-3.262303621,0.001105107,0.008021149,67.90729979,0,-1.04971485,0.806062883,-1.302274142,0.192822688,0.313224726,N,-,,set domain-containing,P:peptidyl-lysine monomethylation; F:protein-lysine N-methyltransferase activity,IPR001214 (PFAM); G3DSA:3.90.1410.10 (GENE3D); PTHR13271:SF14 (PANTHER); PTHR13271 (PANTHER); IPR001214 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY),,
RL4_JR_05237,259,312,246,5,1,22,0,0,0,0,0,0,5,24,24,0,12,12,0.122572999,1,4.926191112,3.763915881,1.308794157,0.190604087,NA,0.03879676,0,8.153830646,2.622507743,3.109173145,0.001876117,0.015023052,0.100715946,0,5.502760619,1.585683174,3.470277486,0.000519921,0.003478969,0.116221612,1,5.078477729,2.323764562,2.185452783,0.028855664,0.090285415,0.09892504,1,5.427245246,1.378501019,3.937062919,8.25E-05,0.000589803,N,-, Effector probability:0.813,hypothetical protein XA68_3397,,PTHR42470 (PANTHER),,
RL4_JR_05238,1939,1476,842,0,0,4,0,0,0,2,0,0,0,0,0,0,0,0,99.00533213,1,-0.257594177,0.522343614,-0.493150811,0.621906031,0.783190707,20.71223057,0,-0.906874831,1.20319968,-0.753719309,0.451017785,0.611301824,139.0206638,1,0.596147092,0.48562821,1.227579206,0.219604972,0.348804634,198.2498275,0,1.382817152,0.371830092,3.718949011,0.000200053,0.001921766,192.7064396,0,1.762636682,0.383733199,4.593391159,4.36E-06,5.09E-05,N,-,,fungal specific transcription factor domain-containing,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; P:positive regulation of transcription from RNA polymerase II promoter; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding",IPR007219 (SMART); IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR007219 (PFAM); PTHR31001 (PANTHER); PTHR31001:SF23 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_05239,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.446175879,0,0.607180092,1.235259338,0.49154058,0.623044158,0.78395685,0.782577593,0,3.819251041,1.443926323,2.64504565,0.00816799,0.029019308,2.026560581,0,1.17003658,1.210875474,0.966273251,0.333907467,0.477343903,14.37238664,0,3.052936779,0.854557889,3.572533609,0.000353544,0.003110021,1.993830445,0,1.090655645,1.201454453,0.907779436,0.363994765,0.500291725,N,-,,glycerophosphoryl diester phosphodiesterase,C:membrane; P:lipid metabolic process; C:integral component of membrane; F:glycerophosphodiester phosphodiesterase activity; F:phosphoric diester hydrolase activity; C:cellular_component,IPR017946 (G3DSA:3.20.20.GENE3D); IPR030395 (PFAM); IPR004129 (PANTHER); PTHR23344:SF10 (PANTHER); IPR030395 (PROSITE_PROFILES); IPR017946 (SUPERFAMILY),,
RL4_JR_05240,972,579,820,0,5,1,0,0,2,0,0,0,0,0,0,0,3,0,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_05241,57,66,48,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,60.94810493,0,0.303909224,0.647222613,0.469559032,0.6386701,0.794127522,31.71240099,0,1.15722843,1.117246212,1.035786397,0.300301805,0.460406143,61.55952969,0,0.712207644,0.687056947,1.036606422,0.299919319,0.44082053,81.70491785,0,1.367522823,0.532139764,2.569856486,0.010174065,0.049170602,77.59142377,0,1.619640093,0.528372596,3.065337045,0.002174248,0.00908554,N,-,,glycosylphosphatidylinositol anchor biosynthesis 11,C:membrane,IPR009580 (PFAM); PTHR24320 (PANTHER),,
RL4_JR_05242,1130,1955,1280,0,4,6,0,0,0,0,0,0,1,11,0,0,3,3,35.14102157,1,0.639258299,0.768913702,0.831378472,0.405759857,0.597569544,5.003913812,0,1.142509663,1.259884308,0.906836966,0.364493019,0.528870174,12.95920917,0,-1.506807967,1.204059502,-1.251439788,0.210774069,0.338495665,22.97267671,1,-0.209645669,1.031482475,-0.203246952,0.838942016,0.899437518,12.7353442,1,-1.584490031,1.204274311,-1.315721855,0.188267416,0.307651321,N,-,,recombination hotspot-binding,C:nucleus; F:microsatellite binding; C:cytosol; F:GU repeat RNA binding; F:single-stranded telomeric DNA binding; P:pathogenesis,IPR002848 (PFAM); IPR016069 (G3DSA:1.20.58.GENE3D); IPR016068 (G3DSA:1.20.58.GENE3D); IPR002848 (PANTHER); PTHR10741:SF2 (PANTHER); IPR002848 (SUPERFAMILY),,
RL4_JR_05243,1149,1024,1270,0,0,18,0,0,0,0,0,0,1,2,0,0,0,0,901.2777301,1,-0.051249648,0.666756125,-0.076864158,0.938731611,0.969777845,156.3219449,0,-2.819655607,1.157092875,-2.436844673,0.014816042,0.045624575,471.3616965,0,-1.971619164,0.538280203,-3.662811956,0.000249462,0.002031818,499.1423089,1,-2.953163285,0.687332526,-4.296556868,1.73E-05,0.000230196,403.0103183,0,-2.85246702,0.753174309,-3.787260115,0.000152318,0.000986876,N,-,,ubiquitin carboxyl-terminal hydrolase,F:hydrolase activity,IPR028881 (PFAM); PTHR24006:SF524 (PANTHER); PTHR24006:SF524 (PANTHER); PTHR24006 (PANTHER); PTHR24006 (PANTHER); PTHR24006 (PANTHER); PTHR24006:SF524 (PANTHER); IPR028889 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY),,
RL4_JR_05244,2285,2102,2135,0,0,6,0,0,1,0,0,0,4,8,1,0,4,1,530.9908418,1,2.82256184,1.49772513,1.884565989,0.059488458,0.151516341,243.1162166,1,3.487304658,0.489855226,7.119051657,1.09E-12,2.97E-10,439.1879516,0,2.853796477,0.356604394,8.002695768,1.22E-15,1.34E-13,1321.985418,1,4.289272853,0.287428226,14.9229354,2.34E-50,1.08E-47,785.9711383,1,3.793911393,0.720012729,5.269228221,1.37E-07,2.93E-06,N,-,,acyl- dehydrogenase,F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; P:oxidation-reduction process,G3DSA:1.20.140.10 (GENE3D); IPR013786 (PFAM); IPR009075 (PFAM); G3DSA:2.40.110.10 (GENE3D); IPR013786 (G3DSA:1.10.540.GENE3D); IPR006091 (PFAM); PTHR10909 (PANTHER); PTHR10909:SF342 (PANTHER); IPR009075 (SUPERFAMILY); IPR009100 (SUPERFAMILY),,
RL4_JR_05245,572,1458,841,0,2,1,0,0,0,0,0,0,3,8,0,0,2,2,12.54111543,1,-1.750757579,1.20915127,-1.447922707,0.147638668,0.293546989,3.995296751,0,1.467251947,1.271731852,1.153743177,0.248605476,0.402106844,32.50098435,0,0.651438596,1.041751128,0.625330348,0.531754266,0.661361202,11.95328971,1,-1.606404371,1.205614029,-1.332436695,0.182716731,0.309107251,10.19615028,1,-1.263654074,1.207894952,-1.046162228,0.295486139,0.430474411,N,-,,spo12,,IPR007727 (PFAM),,
RL4_JR_05246,2998,2462,2551,0,1,5,3,0,0,0,1,1,0,5,5,0,1,0,57.70374062,1,-2.027705748,1.029702715,-1.969214725,0.048928439,0.130443857,15.88294005,1,-0.523924794,1.207746017,-0.433803785,0.664430933,0.785118751,82.99728147,1,-0.034940247,0.68071285,-0.051328907,0.959063434,0.976031182,57.36182751,1,-2.653432201,1.150958923,-2.305409991,0.021143622,0.078821494,40.927427,1,-3.268763727,1.204397093,-2.714024924,0.006647117,0.022675894,N,-,,GTP-binding 1,F:GTP binding; C:cell tip; P:cytoplasmic translation,IPR006073 (PRINTS); IPR005225 (TIGRFAM); IPR012675 (G3DSA:3.10.20.GENE3D); IPR004095 (PFAM); IPR006073 (PFAM); IPR031662 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11702:SF26 (PANTHER); PTHR11702 (PANTHER); IPR031167 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR012676 (SUPERFAMILY),9.A.8.1.6, the ferrous iron uptake (feob) family.
RL4_JR_05247,5,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.092636028,0,-1.11895009,1.219147713,-0.917813385,0.358716573,0.550077031,2.561861765,0,2.10824479,1.298773388,1.623258384,0.104534182,0.20952376,6.68147844,0,-0.551304566,1.212556761,-0.454662894,0.64935178,0.756425886,39.65882583,0,1.779965159,0.765773851,2.324400549,0.020104036,0.076941559,6.622223337,0,-0.64102234,1.221718995,-0.524688854,0.599799507,0.709707842,N,-,,urease accessory,P:urea metabolic process; C:cytoplasm; P:nitrogen compound metabolic process; F:nickel cation binding; C:nucleolus,IPR002639 (PFAM); PTHR33620:SF1 (PANTHER); PTHR33620 (PANTHER); PTHR33620 (PANTHER); PTHR33620:SF1 (PANTHER),,
RL4_JR_05248,885,1048,932,0,0,0,0,0,0,0,0,0,0,0,0,0,3,3,52.21643696,0,3.417847122,0.528755247,6.463949323,1.02E-10,3.53E-09,1.929918279,0,2.517064434,1.330472021,1.891858223,0.058509873,0.133567194,28.51584736,0,2.280514077,0.861979538,2.64567078,0.008152912,0.027805617,19.07574875,0,1.183882018,1.024146133,1.155969817,0.247693503,0.386663077,12.6127408,1,1.462356898,0.982672504,1.488142684,0.136713269,0.241776641,N,-,,urease accessory,P:nitrogen compound metabolic process; F:nickel cation binding,IPR021589 (PFAM),,
RL4_JR_05249,4186,3425,2818,0,0,5,0,0,0,0,0,0,6,2,2,0,0,4,650.0213709,1,1.090780316,0.67798514,1.608855786,0.107647879,0.233810277,112.2863508,0,0.323024806,0.709812721,0.455084555,0.649048409,0.772965787,283.4773518,0,-0.379931629,0.510613851,-0.744068395,0.456835098,0.595167213,214.151909,1,-3.88526372,1.021669267,-3.802858562,0.000143036,0.001451192,214.8641821,1,-1.361671902,0.512723967,-2.655760193,0.007912986,0.025978919,N,-,,kinase,F:translation initiation factor activity; F:ATP binding; P:DNA damage checkpoint; C:cytosolic ribosome; F:eukaryotic translation initiation factor 2alpha kinase activity; P:cellular amino acid biosynthetic process; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:translational initiation; P:chronological cell aging,IPR000719 (SMART); IPR006575 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR024435 (PFAM); IPR006575 (PFAM); IPR016135 (G3DSA:3.10.110.GENE3D); PF13393 (PFAM); G3DSA:3.30.930.10 (GENE3D); IPR000719 (PFAM); PTHR11042 (PANTHER); PTHR11042 (PANTHER); PTHR11042 (PANTHER); PTHR11042:SF90 (PANTHER); PTHR11042:SF90 (PANTHER); PTHR11042:SF90 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR006575 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR016135 (SUPERFAMILY); IPR011009 (SUPERFAMILY); SSF55681 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_05250,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.08157733,0,0.415204682,0.882959405,0.470242096,0.638182062,0.793641655,4.319066354,0,1.354753115,1.258569536,1.076422936,0.281738149,0.440920404,17.74893572,0,-0.341146325,1.202251505,-0.283756206,0.776597218,0.851447936,22.29427181,0,-0.774720678,1.154990581,-0.670759304,0.502373877,0.639860512,40.59405864,0,1.277856043,0.774545484,1.649814078,0.098980969,0.189448451,N,-,,hypothetical protein SPBR_08688,,PTHR42089 (PANTHER),,
RL4_JR_05251,1060,920,1479,0,0,2,0,0,2,1,3,2,0,6,1,0,0,4,34.24591969,1,0.338237029,0.788066782,0.429198435,0.667778822,0.815529885,6.023444183,1,0.874853515,1.249208162,0.700326448,0.483723458,0.64028362,15.6974559,1,-1.783586958,1.208308165,-1.47610271,0.139916321,0.248904031,26.13606898,1,-0.490100215,1.03908769,-0.471663961,0.637166665,0.751638411,22.9281337,1,-0.934704442,1.147014632,-0.814901934,0.415128446,0.551163849,N,-,,benzoylformate partial,F:transferase activity,PF03517 (PFAM); PTHR21399:SF0 (PANTHER); PTHR21399 (PANTHER); PTHR21399:SF0 (PANTHER),,
RL4_JR_05252,3538,3425,2543,3,2,52,0,0,0,0,0,6,0,6,4,0,4,0,46.68558045,1,-0.269874555,0.859405981,-0.314024525,0.753502412,0.870813525,16.6539126,0,1.517948026,1.138118373,1.333734752,0.182290801,0.321454267,33.12341437,1,-0.221027084,1.040612821,-0.212400885,0.831794295,0.891207975,80.40140199,1,1.793569983,0.497865484,3.602519239,0.000315148,0.002823782,37.00047071,1,0.105984475,0.843761737,0.125609482,0.900041057,0.935233549,N,-,,DNA damage repair,P:positive regulation of DNA repair; P:mitotic G2 DNA damage checkpoint; C:nucleus; C:site of double-strand break; P:mitotic DNA replication checkpoint,IPR001357 (SMART); IPR001357 (G3DSA:3.40.50.GENE3D); PTHR15321:SF3 (PANTHER); PTHR15321 (PANTHER); PTHR15321 (PANTHER); IPR001357 (PROSITE_PROFILES); IPR001357 (SUPERFAMILY),,
RL4_JR_05253,6620,5982,9215,0,5,4,0,0,1,0,1,1,4,5,0,0,0,2,173.616541,1,0.821503805,0.424662799,1.934484978,0.053053527,0.139337771,20.31283178,1,-0.878776391,1.221889387,-0.719194717,0.472020954,0.630222992,151.4314034,1,1.08062956,0.468038096,2.308849576,0.02095193,0.057609272,101.0243343,1,-0.62324467,0.640189101,-0.973532146,0.330288891,0.476979453,66.7818741,1,-0.996116688,0.767915409,-1.297169815,0.194572764,0.315510768,N,-,,hypothetical protein SPSK_05004,,IPR025122 (PFAM),,
RL4_JR_05254,9054,7494,11625,2,2,5,0,0,0,0,2,0,0,3,1,0,0,2,200.3795303,1,0.795345901,0.405226191,1.962720867,0.049678617,0.132055444,25.21138779,0,-1.190467307,1.199737352,-0.992273271,0.321064238,0.483027976,146.7059107,1,0.161510066,0.51593466,0.313043644,0.754247504,0.835068552,166.2720263,1,0.177377378,0.438129482,0.4048515,0.68558667,0.786836017,142.2119423,1,0.330878139,0.495071313,0.668344399,0.503913778,0.631295101,N,-,,vacuolar ATP synthase catalytic subunit a,"F:ATP binding; P:ATP hydrolysis coupled proton transport; P:arginine homeostasis; P:lysine homeostasis; C:fungal-type vacuole membrane; P:ATP metabolic process; P:histidine homeostasis; P:cellular protein metabolic process; C:cytosol; F:proton-transporting ATPase activity, rotational mechanism; P:vacuolar acidification; C:proton-transporting V-type ATPase, V1 domain",IPR024034 (G3DSA:1.10.1140.GENE3D); IPR005725 (TIGRFAM); IPR023366 (G3DSA:2.40.30.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000194 (PFAM); IPR004100 (PFAM); IPR031686 (PFAM); PTHR15184 (PANTHER); PTHR15184 (PANTHER); PTHR15184:SF7 (PANTHER); PTHR15184 (PANTHER); PTHR15184:SF7 (PANTHER); IPR022878 (HAMAP); IPR000793 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR004100 (SUPERFAMILY),3.A.2.2.7," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_05255,18256,18470,24750,0,14,75,0,0,4,11,1,9,5,14,3,0,24,3,8990.906453,1,-0.109038069,0.716478772,-0.152186042,0.879040203,0.941268208,2392.74381,1,-0.665151439,0.467022527,-1.424238448,0.154377459,0.28272275,6357.310541,1,-0.641844389,0.290903515,-2.206382375,0.027357238,0.071401051,7197.767081,1,-0.70288317,0.287978915,-2.440745255,0.01465699,0.065631958,4737.095201,1,-2.010637332,1.196139617,-1.680938667,0.092774828,0.180227386,Y,-,,clock-controlled 6,,PTHR35523:SF1 (PANTHER); PTHR35523 (PANTHER),,
RL4_JR_05256,2558,2949,2354,1,0,27,0,0,0,0,0,7,3,4,0,0,1,0,220.0812968,1,2.801902648,0.672333308,4.167430968,3.08E-05,0.000306474,36.40518079,0,2.581757933,0.889451365,2.902640923,0.003700306,0.017332023,21.36889666,1,-2.228371333,1.203818161,-1.851086323,0.064157135,0.13743691,48.71672743,1,0.610440259,0.660729155,0.92388879,0.35554422,0.501586349,51.12594098,1,0.895700052,0.637727803,1.404517802,0.160164715,0.271818259,Y,-,,DNAse1,,no IPS match,,
RL4_JR_05257,4873,4476,4681,0,0,13,0,0,0,0,1,1,2,0,1,0,9,0,99.19860014,1,0.328256714,0.505234285,0.649711874,0.515878352,0.701072064,15.55314348,0,-0.493577327,1.216521219,-0.405728498,0.684942101,0.799836634,55.85477223,1,-1.314603704,1.036116532,-1.268779779,0.204519619,0.330784403,93.03287585,1,0.313463618,0.530720925,0.590637383,0.554763412,0.683663528,99.05823484,1,0.015684873,0.619480818,0.025319384,0.979800212,0.986425092,N,-,,garp complex component,"C:cytosol; P:retrograde transport, endosome to Golgi",IPR012501 (PFAM); PTHR12965 (PANTHER); PTHR12965 (PANTHER); PTHR12965:SF0 (PANTHER),,
RL4_JR_05258,72,84,58,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,35.97139596,1,0.235408958,0.751551254,0.313230744,0.754105362,0.871263496,6.598393883,0,0.743424349,1.231158524,0.603841288,0.545949166,0.692398651,17.11531755,0,-1.908174053,1.19305813,-1.599397384,0.109732333,0.207857142,23.7567217,0,-1.383406616,1.144035471,-1.209234024,0.22657295,0.362237662,16.85732278,0,-1.989034762,1.195072463,-1.664363311,0.096039847,0.185219706,N,-,,dna replication licensing factor mcm5,"P:DNA replication initiation; P:double-strand break repair via break-induced replication; P:regulation of DNA-dependent DNA replication initiation; C:DNA replication preinitiation complex; P:establishment of chromatin silencing; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; F:chromatin binding; C:MCM complex; P:chromatin silencing at telomere; C:nuclear chromosome, telomeric region; F:single-stranded DNA binding; P:cell division; C:nuclear pre-replicative complex; F:DNA replication origin binding; F:ATP binding; F:DNA helicase activity; P:negative regulation of chromatin silencing at telomere; P:DNA duplex unwinding; P:negative regulation of helicase activity; C:cytosol; C:replication fork protection complex",IPR008048 (PRINTS); IPR001208 (PRINTS); IPR031327 (SMART); G3DSA:3.30.1640.10 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027925 (PFAM); IPR033762 (PFAM); G3DSA:2.40.50.140 (GENE3D); IPR001208 (PFAM); PTHR11630 (PANTHER); PTHR11630:SF42 (PANTHER); IPR001208 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR012340 (SUPERFAMILY),,
RL4_JR_05259,3,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,52.9787038,0,0.581259949,0.746261452,0.778895852,0.436041068,0.626731603,5.39250978,0,1.034559956,1.250601288,0.827250033,0.408095359,0.571808032,25.03390114,0,-0.652926223,1.19724475,-0.545357349,0.585507768,0.706264822,16.10632362,0,-2.036814389,1.198225533,-1.699858943,0.089157461,0.179801502,13.75117989,0,-1.695326819,1.201928895,-1.410505086,0.158390596,0.26930391,N,-,,amp-dependent synthetase ligase,P:metabolic process; C:integral component of membrane; F:ligase activity,G3DSA:3.40.50.980 (GENE3D); IPR000873 (PFAM); PTHR24096 (PANTHER); PTHR24096:SF245 (PANTHER); SSF56801 (SUPERFAMILY),,
RL4_JR_05260,1005,909,992,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_05261,1227,1438,1682,3,8,38,0,0,0,0,0,0,1,18,0,0,7,0,31.95754475,1,-0.172514329,0.879578093,-0.196133044,0.844506033,0.921916261,73.43560475,0,2.990865946,0.84915879,3.522151547,0.000428059,0.015023052,42.93560799,0,0.916249205,0.762111015,1.202251624,0.229266054,0.360193906,60.80906818,1,0.768313196,0.690351752,1.11293003,0.265738481,0.406619635,69.76436551,1,2.057949431,0.527756927,3.899426659,9.64E-05,0.000673747,N,-,,nuclear pore complex component,C:membrane; C:integral component of membrane,IPR012578 (PFAM); PTHR28003 (PANTHER); PTHR28003:SF1 (PANTHER),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_05262,59,83,127,0,0,53,0,0,2,0,0,0,0,1,0,0,0,0,99.72543846,1,1.094381145,0.502828531,2.176449976,0.02952163,0.089243625,12.12081469,1,-0.133909735,1.220106862,-0.109752464,0.912605691,0.951230029,37.92064916,0,-1.822965054,1.196675445,-1.523357951,0.127669176,0.232719254,53.90365505,1,-0.895988503,0.86315563,-1.038038185,0.299252278,0.444565972,30.98127621,0,-2.867133504,1.20076779,-2.387750177,0.016951861,0.047956856,N,-,,high-temperature-induced dauer-formation,C:integral component of membrane; P:signal peptide processing; C:Golgi trans cisterna; F:peptidase activity; P:intracellular protein transport; C:signal peptidase complex; C:Golgi medial cisterna,IPR007653 (PFAM); PF12722 (PFAM); IPR026705 (PANTHER); PTHR21575:SF12 (PANTHER),,
RL4_JR_05263,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,114.2374541,0,-1.207273778,0.603336579,-2.000995497,0.045392875,0.123768408,55.31935158,0,0.88855913,0.846288274,1.049948531,0.293741777,0.4530328,76.96757036,0,-2.988138182,1.185829358,-2.519871988,0.011739752,0.036558982,134.7295335,0,-0.087723342,0.450396707,-0.194769057,0.845573747,0.903295441,76.7842177,0,-3.097764868,1.116309941,-2.775004284,0.005520098,0.019433586,N,-,,5 -3 exoribonuclease 1,"F:5'-3' exonuclease activity; P:nucleic acid phosphodiester bond hydrolysis; F:RNA binding; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; C:cytoplasm",IPR004859 (PFAM); IPR027073 (PANTHER); IPR027073 (PANTHER); PTHR12341:SF34 (PANTHER); IPR027073 (PANTHER); PTHR12341:SF34 (PANTHER); PTHR12341:SF34 (PANTHER),,
RL4_JR_05264,44,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.76688086,0,-0.087748486,0.856577742,-0.102440773,0.918406822,0.961298801,43.87075834,0,3.370454114,0.783764132,4.300342379,1.71E-05,0.001041703,16.42161,0,-1.848441147,1.198189087,-1.542695696,0.122904627,0.22594633,30.97477226,0,0.027268185,0.865855391,0.031492771,0.974876557,0.98517231,30.83789237,0,-0.237329468,0.971581527,-0.244271285,0.807020721,0.870004771,N,-,,hypothetical protein SPI_02886,,PTHR42470 (PANTHER),,
RL4_JR_05265,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.019478151,0,7.57718263,3.961086708,1.912905015,0.055760213,NA,0.006341168,0,10.76585697,3.960170739,2.718533538,0.006557201,0.024747198,0.01633527,0,8.122024615,2.743094565,2.960898512,0.00306743,0.013767301,0.018830106,0,7.702177146,3.960482763,1.944757144,0.051804214,0.125559168,0.016075682,0,8.032689633,1.553673371,5.170127636,2.34E-07,4.41E-06,N,-, Effector probability:0.793,hypothetical protein XA68_6736,,no IPS match,,
RL4_JR_05266,6,9,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.004235441,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001340044,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003452355,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003983613,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003339785,0,10.24113992,1.835951848,5.578109216,2.43E-08,8.07E-07,N,-, Effector probability:0.596,hypothetical protein MAC_08234,,no IPS match,,
RL4_JR_05267,3,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,137.1732115,0,0.87045216,0.396963351,2.192777139,0.02832344,0.086540308,16.14677232,0,-0.547647658,1.20007348,-0.456345105,0.648141834,0.772549652,41.86495616,0,-3.19869471,1.185480683,-2.698225923,0.006971011,0.024479542,48.29428203,0,-3.620975048,1.184000566,-3.058254492,0.002226304,0.014412615,48.96738119,0,-1.608362319,0.967184165,-1.662932849,0.096325878,0.18554773,N,-,,histone acetyltransferase type b subunit 2,"C:chromosome, telomeric region; C:cytoplasm; F:histone binding; P:chromatin assembly or disassembly; P:histone acetylation; F:transferase activity; P:chromatin silencing at telomere; C:histone acetyltransferase complex",IPR020472 (PRINTS); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR022052 (PFAM); IPR001680 (PFAM); PTHR22850:SF82 (PANTHER); PTHR22850 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),3.A.20.1.2, the peroxisomal protein importer (ppi) family.
RL4_JR_05268,152,153,144,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.924541373,0,2.010982138,1.518385357,1.324421451,0.185363114,NA,0.295610708,0,5.223848128,1.698384494,3.075774742,0.002099564,0.015023052,0.765103251,0,2.575783949,1.248891951,2.062455401,0.039164399,0.09404658,0.88255336,0,2.153347424,1.303879743,1.651492353,0.098638081,0.193962045,0.751710422,0,2.498311929,1.22019075,2.047476535,0.040611318,0.095274246,N,-,,histidine kinase group,P:phosphorylation; F:kinase activity,no IPS match,,
RL4_JR_05269,43,25,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42.72327746,0,-2.436368106,1.137739751,-2.141410727,0.032240931,0.095853321,12.45324652,0,-0.172922075,1.211048033,-0.142787132,0.8864583,0.935656856,38.7526789,0,-1.860644375,1.188866305,-1.565057708,0.117569379,0.218609171,37.20402132,0,-3.244595593,1.187920173,-2.731324601,0.006308031,0.033686082,51.05587772,0,0.027755371,0.673803904,0.04119206,0.967142784,0.978517907,N,-,,RNA binding (Arp),F:nucleotide binding; F:nucleic acid binding; F:zinc ion binding; C:cytoplasmic stress granule,IPR001876 (SMART); IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR013520 (PFAM); IPR012337 (G3DSA:3.30.420.GENE3D); IPR000504 (PFAM); IPR001876 (PFAM); IPR001876 (G3DSA:4.10.1060.GENE3D); PTHR23111 (PANTHER); PTHR23111:SF26 (PANTHER); IPR001876 (PROSITE_PROFILES); IPR001876 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR001876 (SUPERFAMILY); IPR001876 (SUPERFAMILY); IPR012677 (SUPERFAMILY); IPR012337 (SUPERFAMILY),,
RL4_JR_05270,3332,3007,3025,1,1,2,4,9,59,36,15,126,9,10,5,0,10,0,47.61078709,1,-0.794346549,0.86589988,-0.917365353,0.358951222,0.550333409,19.57528029,1,1.031665566,1.127607044,0.914915858,0.360235804,0.524478208,39.42395605,1,-0.716541569,1.039410488,-0.689373041,0.490588544,0.624430276,34.49763098,1,-2.010444788,1.149663374,-1.748724743,0.080338611,0.166857115,40.72650649,1,-0.925370779,0.975921772,-0.948201798,0.343026732,0.480047777,Y,-, Effector probability:0.605,plasma membrane proteolipid 3,C:integral component of membrane,IPR000612 (PFAM); PTHR21659:SF18 (PANTHER); IPR000612 (PANTHER),9.B.12.2.1, the sensitivity to sodium or salt stress-induced hydrophobic peptide (sna) family.
RL4_JR_05271,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30.06764933,0,-1.474375264,1.145848502,-1.28671047,0.198195223,0.360927721,140.3017837,0,4.37063429,1.537732851,2.842258515,0.004479515,0.019176787,23.10511807,0,-0.9028663,1.197300792,-0.754084776,0.450798318,0.590258946,67.32793786,0,1.226573013,1.550811284,0.790923451,0.428988663,0.571508809,16.2987529,0,-1.940540329,1.196529692,-1.621807082,0.104844662,0.197903094,N,-,,hypothetical protein SPI_01596,,no IPS match,,
RL4_JR_05272,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,111.4885936,0,-0.751772061,0.625966503,-1.2009781,0.229759697,0.401968605,23.299135,0,-1.076670066,1.229299271,-0.875840482,0.381116759,0.545407018,75.72948744,0,-1.894113226,1.054931172,-1.795485124,0.072576441,0.151243115,130.6976475,0,0.211656627,0.599616836,0.352986465,0.724098588,0.816152533,104.803637,0,0.185634007,0.573338075,0.323777567,0.746106441,0.822821884,N,-,,CMGC CDK CRK7 kinase,"C:nucleus; F:ATP binding; P:positive regulation of cellular biosynthetic process; P:positive regulation of gene expression; P:regulation of transcription, DNA-templated; P:positive regulation of nitrogen compound metabolic process; P:positive regulation of macromolecule biosynthetic process; F:protein serine/threonine kinase activity; P:protein phosphorylation",IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24056:SF39 (PANTHER); PTHR24056 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_05273,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,105.2191209,0,1.634714461,0.432309464,3.781352476,0.000155979,0.001249974,9.347815668,0,0.240936048,1.228951972,0.196050011,0.844571022,0.907028954,91.77758872,0,1.57890106,0.526156021,3.000822944,0.002692511,0.012538629,111.3390771,0,1.273633209,0.503845393,2.527825453,0.01147714,0.054200577,67.88288955,0,0.945512264,1.369058787,0.690629411,0.48979846,0.618586679,N,-,,glycogen synthase,P:glycogen biosynthetic process; F:glycogen (starch) synthase activity,IPR008631 (PFAM); PTHR10176:SF3 (PANTHER); IPR008631 (PANTHER); SSF53756 (SUPERFAMILY); SSF53756 (SUPERFAMILY),,
RL4_JR_05274,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.14007811,0,-1.568465639,1.136382848,-1.380226428,0.167516939,0.319523776,6.818631344,0,0.696065419,1.226994821,0.567292875,0.570515217,0.711176728,39.84448528,0,0.45417863,0.845582054,0.537119523,0.591185056,0.710741896,51.35308113,0,0.675888397,0.659611937,1.024675813,0.305516179,0.451157607,32.81730975,0,0.584432156,0.739045001,0.790793734,0.429064367,0.56380954,N,-,,elmo ced-12 family,F:molecular_function,IPR006816 (PFAM); IPR001849 (PFAM); IPR024574 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR12771:SF3 (PANTHER); PTHR12771 (PANTHER); PTHR12771 (PANTHER); PTHR12771:SF3 (PANTHER); PTHR12771:SF3 (PANTHER); PTHR12771 (PANTHER); PTHR12771:SF3 (PANTHER); PTHR12771 (PANTHER); PTHR12771:SF3 (PANTHER); PTHR12771 (PANTHER); IPR006816 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),,
RL4_JR_05275,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.78860923,0,-1.887915348,1.19102554,-1.585117435,0.112939655,0.242017785,23.16005504,0,2.965921244,0.994600872,2.98202156,0.002863518,0.015349618,22.49553855,0,-0.363550679,1.192711185,-0.304810321,0.760510621,0.839024132,13.18044272,0,-1.747642893,1.193488295,-1.464315068,0.143107882,0.257086569,11.27356857,0,-1.408686022,1.199754064,-1.174145656,0.240336689,0.369538189,N,-,,zinc finger DNA-binding,F:binding,IPR010666 (PFAM),,
RL4_JR_05276,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,83.98379114,0,-0.226109562,0.675066028,-0.334944365,0.737667055,0.862354945,15.77028694,0,-0.513579312,1.255702648,-0.408997554,0.682541456,0.798138242,53.5507679,0,-1.342504151,1.073858516,-1.250168556,0.211237981,0.339186886,50.77190615,0,-2.629724762,1.182320212,-2.224206891,0.026134528,0.086108719,58.15329571,0,-0.990458683,0.881917232,-1.123074419,0.26140589,0.393332536,N,-,,hypothetical protein SPI_03125,C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_05277,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49.48308409,0,0.406032905,0.686551002,0.591409676,0.554245959,0.733063965,8.536422654,0,0.371944291,1.25216911,0.297039983,0.766435984,0.858700115,76.06816095,0,1.14995043,0.644963825,1.782968883,0.074591369,0.15430793,239.2202633,0,3.059091808,0.443153551,6.903006413,5.09E-12,2.18E-10,178.8116912,0,2.863515066,1.415072743,2.02358153,0.043013227,0.099522149,N,-,,oxysterol-binding,C:nucleus; C:cytosol,IPR000648 (PFAM); PTHR10972:SF89 (PANTHER); IPR000648 (PANTHER); SSF144000 (SUPERFAMILY),2.D.1.1.3, the pi4p/ps counter transporter (p/p-ct) family.
RL4_JR_05278,23484,40122,34201,6,4,0,0,0,0,1,0,0,0,0,0,0,0,0,138.2602252,1,0.824097613,1.342308259,0.613940656,0.539254543,0.721704886,15.20136432,0,-0.460646345,1.222555574,-0.376789697,0.706329898,0.815219329,57.08255859,1,-1.289133,1.047981436,-1.230110531,0.218655717,0.347733346,45.58590401,0,-3.537741087,1.207155305,-2.930642869,0.003382614,0.020447145,39.08242002,0,-3.202243421,1.212689992,-2.640611731,0.00827565,0.026999161,N,-, Effector probability:0.896,splicing factor U2AF 23 kDa subunit,"C:commitment complex; F:nucleotide binding; C:U2AF; P:mRNA cis splicing, via spliceosome; F:RNA binding; F:metal ion binding; C:cytosol; C:U2-type prespliceosome",IPR009145 (PRINTS); IPR000571 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000571 (PFAM); IPR009145 (PANTHER); IPR000571 (PROSITE_PROFILES); IPR000571 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_05279,116,133,177,0,0,3,0,0,0,4,3,0,3,3,9,0,7,10,124.1812817,1,-0.410486508,0.603696129,-0.679955508,0.496532633,0.683971102,32.75644236,0,-0.166799035,1.146393374,-0.145498952,0.884316943,0.934426328,115.752678,1,-0.238556376,1.540226031,-0.154884005,0.876912764,0.922854971,134.0357014,1,0.105504191,0.536557525,0.19663165,0.844115801,0.902690377,59.1799524,1,-3.800811053,1.213199725,-3.132881566,0.001730993,0.007505911,N,-,,c2 domain-containing,C:cellular bud; P:signal transduction; P:endoplasmic reticulum membrane organization; C:integral component of membrane; F:lipid binding; C:cortical endoplasmic reticulum; P:regulation of phosphatidylinositol dephosphorylation,IPR000008 (PRINTS); IPR000008 (SMART); IPR000008 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR017147 (PIRSF); PTHR10774 (PANTHER); PTHR10774:SF87 (PANTHER); PTHR10774:SF87 (PANTHER); PTHR10774 (PANTHER); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY); IPR000008 (SUPERFAMILY),9.A.57.1.1, the extended-synaptotagmin (e-syt) family.
RL4_JR_05280,6,12,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36.52361853,0,0.50420062,0.807707542,0.624236613,0.532472206,0.71613901,5.472537372,0,1.013284338,1.288182982,0.786599693,0.431516239,0.593371467,20.67580432,0,-0.674786863,1.22326916,-0.551625828,0.581204737,0.703000808,53.74498072,0,1.585727313,0.6452031,2.457718062,0.01398229,0.063285955,21.34745242,0,-0.777507654,1.161454997,-0.669425554,0.503224055,0.63082129,N,-,,fyve zinc finger,F:ubiquitin-protein transferase activity; F:zinc ion binding; F:metal ion binding; C:fungal-type vacuole membrane; C:late endosome; F:phosphatidylinositol-3-phosphate binding; F:ligase activity; P:protein ubiquitination,PR01217 (PRINTS); IPR000306 (SMART); IPR001841 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001841 (PFAM); IPR000306 (PFAM); PTHR22835 (PANTHER); IPR017455 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR011011 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_05281,843,819,996,0,1,4,0,0,0,0,0,0,2,0,0,0,0,0,4.9438212,1,-0.407773148,1.226889615,-0.332363355,0.739614906,0.863201488,1.589714161,0,2.796862218,1.367961964,2.044546771,0.040899562,0.100947419,4.099351872,0,0.153846382,1.219833333,0.126120822,0.899636286,0.937806319,4.727516399,1,-0.268033899,1.221831949,-0.219370511,0.826361439,0.891614405,4.012420049,0,0.081715039,1.211613521,0.067443156,0.946228914,0.965491057,N,-,,C6 transcription factor,F:binding,IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31986:SF11 (PANTHER); PTHR31986:SF11 (PANTHER); PTHR31986 (PANTHER); PTHR31986:SF11 (PANTHER); PTHR31986 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_05282,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.551791453,0,-0.289030357,1.210543816,-0.238760756,0.811291102,0.904291954,1.457424378,0,2.922089059,1.355141697,2.156297798,0.031060419,0.081364793,3.775847089,0,0.272012701,1.209336432,0.224927236,0.822035881,0.884832342,4.355303789,0,-0.150134014,1.209914726,-0.124086443,0.901246832,0.939363077,3.71998051,0,0.19078187,1.208043124,0.157926374,0.874514815,0.916489325,N,-,,efflux pump antibiotic resistance,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501 (PANTHER); PTHR23501:SF77 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_05283,1,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.06901638,0,1.770033048,0.591425581,2.992824635,0.002764085,0.013494559,3.965985925,0,1.47789445,1.27046447,1.163270981,0.244719576,0.397664399,10.2404106,0,-1.167153719,1.200053472,-0.972584761,0.33075972,0.473904812,21.1222126,0,-0.638856103,1.14864824,-0.556180806,0.578087259,0.704467636,10.04627599,0,-1.24245673,1.196258695,-1.038618766,0.298982074,0.434196131,N,-,,alpha beta hydrolase family,C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function; F:hydrolase activity,IPR000073 (PRINTS); IPR022742 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR10992 (PANTHER); PTHR10992:SF865 (PANTHER); PTHR10992 (PANTHER); PTHR10992:SF865 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_05284,11,10,14,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,42.81593878,0,3.485233291,0.769394939,4.529836521,5.90E-06,7.30E-05,1.50057736,1,2.880060835,1.423132578,2.023747386,0.04299615,0.104717765,3.859529959,0,0.240536625,1.25161945,0.192180319,0.847600962,0.902496502,4.449611793,0,-0.180899452,1.25983025,-0.143590338,0.88582397,0.929744,3.77634902,0,0.169011733,1.247123162,0.135521285,0.892199737,0.929279121,N,-,,ABC transporter transmembrane region,F:nucleotide binding; F:ATPase activity; C:membrane; P:transport,IPR003593 (SMART); IPR011527 (PFAM); IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.20.1560.10 (GENE3D); PTHR24221:SF213 (PANTHER); PTHR24221 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR011527 (SUPERFAMILY); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.201.10, the atp-binding cassette (abc) superfamily.
RL4_JR_05285,8,0,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.655520576,0,0.027552929,1.207514102,0.022817894,0.981795534,0.991069033,19.92424099,0,4.88288639,0.992141598,4.921562001,8.59E-07,7.56E-05,25.16702293,0,2.419657099,1.028249072,2.353181894,0.018613526,0.053022887,11.51516127,0,1.895816093,1.014641479,1.86845909,0.061698107,0.138820742,2.983510526,0,0.509225727,1.200293611,0.424250968,0.671382794,0.766202749,N,-,,hypothetical protein SPI_08603,C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_05286,11,10,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,128.4028361,0,1.360465835,0.46007915,2.957025623,0.003106223,0.014801733,13.02533191,0,-0.237704445,1.217500456,-0.195239717,0.845205287,0.907517547,66.26057232,0,0.241610194,0.685760367,0.352324523,0.724594899,0.813552042,75.05904599,0,0.509835777,0.56783863,0.89785328,0.369263775,0.514987936,33.22623768,0,-2.968005448,1.197396333,-2.478716,0.013185625,0.039185339,N,-,,calcium calmodulin-dependent kinase,F:ATP binding; F:calmodulin-dependent protein kinase activity; P:protein phosphorylation,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR020636 (PANTHER); PTHR24347:SF134 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.1, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_05287,31,64,75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,76.50177966,0,1.12500479,0.526855925,2.135317713,0.032735067,0.096863503,8.150519043,0,0.438677758,1.237064206,0.354611956,0.722880318,0.826338946,21.04211643,0,-2.206161239,1.197295245,-1.842620898,0.06538438,0.139240948,76.13251625,0,0.723062399,0.627757247,1.151818481,0.249395672,0.388541495,24.49298028,0,-1.350470085,1.122995994,-1.202560021,0.229146627,0.356665579,N,-, Effector probability:0.652,ubiquitin-conjugating enzyme,C:cellular_component,SM00212 (SMART); IPR000608 (PFAM); IPR016135 (G3DSA:3.10.110.GENE3D); PTHR24067:SF35 (PANTHER); PTHR24067 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),3.A.25.2.1, the symbiont-specific erad-like machinery (selma) family.
RL4_JR_05288,45,65,81,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,38.12655341,0,-0.282120777,0.844395258,-0.334109855,0.738296664,0.862574715,7.203697809,0,0.616819682,1.230063089,0.501453696,0.616051858,0.747772743,25.13216765,1,-1.068989075,1.189750373,-0.898498625,0.368919778,0.51346492,85.85611114,0,1.843502148,0.452540272,4.073675346,4.63E-05,0.00055124,33.04154838,0,-0.426476768,0.964355125,-0.442240371,0.658315275,0.756493298,N,-,,vacuolar sorting,"P:regulation of SNARE complex assembly; C:CORVET complex; C:fungal-type vacuole membrane; F:phosphatidylinositol binding; P:vacuole fusion, non-autophagic; P:endocytosis; P:protein targeting to vacuole; P:Golgi to vacuole transport; F:DNA binding; F:ATP binding; P:regulation of vacuole fusion, non-autophagic; P:piecemeal microautophagy of nucleus; F:oxidoreductase activity; P:vesicle docking involved in exocytosis; C:integral component of membrane; C:cytosol; P:oxidation-reduction process; F:ligase activity; P:vesicle fusion with vacuole",IPR001619 (PFAM); IPR027482 (G3DSA:3.40.50.GENE3D); G3DSA:3.90.830.10 (GENE3D); IPR001619 (PANTHER); IPR027121 (PTHR11679:PANTHER); IPR001619 (PANTHER); IPR027121 (PTHR11679:PANTHER); IPR001619 (SUPERFAMILY),,
RL4_JR_05289,6,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,17.94350054,0,-2.267816792,1.192172404,-1.902255735,0.05713773,0.146812472,5.762715194,0,0.938797413,1.248699989,0.751819829,0.452159416,0.6117842,14.89510449,0,-1.707790198,1.198063098,-1.42545931,0.154024474,0.26760662,52.49564856,0,1.177429732,0.627027422,1.877796234,0.060409046,0.137403188,26.21679187,1,0.416062254,0.850796011,0.489027039,0.624822554,0.729596167,N,-,,lysine-specific histone demethylase 1,F:catalytic activity; P:metabolic process; P:single-organism process,IPR009071 (SMART); IPR023753 (G3DSA:3.50.50.GENE3D); IPR009071 (PFAM); G3DSA:3.90.660.10 (GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); IPR009071 (G3DSA:1.10.30.GENE3D); IPR007526 (PFAM); IPR002937 (PFAM); PTHR10742:SF284 (PANTHER); PTHR10742:SF284 (PANTHER); PTHR10742 (PANTHER); PTHR10742 (PANTHER); IPR007526 (PROSITE_PROFILES); IPR009071 (PROSITE_PROFILES); IPR009071 (SUPERFAMILY); SSF54373 (SUPERFAMILY); IPR023753 (SUPERFAMILY); IPR009057 (SUPERFAMILY),,
RL4_JR_05290,6,3,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,519.2199304,0,0.423558599,0.297273533,1.424810995,0.154211843,0.302782242,89.81480402,0,-1.040505142,0.978939516,-1.062890123,0.287831783,0.447444062,227.3125888,0,-2.190499086,0.677259083,-3.234359111,0.001219161,0.006759464,395.3315802,0,-0.068202587,0.366619664,-0.186030903,0.852420528,0.907897583,303.5200337,0,-0.29617273,0.439194184,-0.674354856,0.500085736,0.627795522,N,-,,ATP synthase gamma chain,"C:mitochondrial proton-transporting ATP synthase, central stalk; F:proton-transporting ATPase activity, rotational mechanism; P:ATP synthesis coupled proton transport; F:proton-transporting ATP synthase activity, rotational mechanism",IPR000131 (PRINTS); PIRSF039089 (PIRSF); IPR000131 (PFAM); IPR000131 (TIGRFAM); G3DSA:3.40.1380.10 (GENE3D); G3DSA:1.10.287.80 (GENE3D); IPR000131 (PANTHER); PTHR11693:SF22 (PANTHER); IPR000131 (SUPERFAMILY),3.A.2.1.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_05291,25,110,19,0,0,4,0,0,0,0,0,0,0,2,0,0,0,0,265.0705274,1,-1.990258397,0.544059188,-3.658165218,0.000254027,0.001890834,64.4532535,0,-2.544654973,1.195055025,-2.129320341,0.033227766,0.085798839,166.7587394,0,-5.192630592,1.191085404,-4.359578728,1.30E-05,0.000236009,285.2868151,1,-0.983713191,0.411011727,-2.393394461,0.016693283,0.070052735,248.1958597,0,-0.550786907,0.575447882,-0.957144728,0.33849421,0.475611141,N,-,,DNA topoisomerase I,P:mitotic chromosome condensation; P:DNA strand elongation involved in DNA replication; P:nuclear migration; P:regulation of mitotic recombination; P:chromatin assembly or disassembly; P:DNA topological change; C:nucleolus; P:regulation of transcription from RNA polymerase II promoter; P:transcription elongation from RNA polymerase II promoter; F:DNA binding; P:chromatin remodeling; P:chromatin silencing at rDNA; C:cytosol; F:DNA topoisomerase type I activity; C:replication fork protection complex; F:DNA topoisomerase type II (ATP-hydrolyzing) activity,IPR001631 (PRINTS); IPR013499 (SMART); IPR014727 (G3DSA:1.10.132.GENE3D); IPR013034 (G3DSA:1.10.10.GENE3D); IPR013030 (G3DSA:2.170.11.GENE3D); IPR008336 (PFAM); IPR025834 (PFAM); IPR013500 (PFAM); IPR014711 (G3DSA:3.90.15.GENE3D); PTHR10290 (PANTHER); IPR011010 (SUPERFAMILY); IPR008336 (SUPERFAMILY),,
RL4_JR_05292,116,213,135,0,0,5,0,0,0,0,0,0,1,6,0,0,1,0,1.042713411,1,1.837174429,1.506373748,1.219600668,0.222616293,NA,0.330364067,0,5.063185038,1.67558634,3.021739266,0.002513269,0.015349618,7.360869568,0,3.363227072,1.218446531,2.760258237,0.005775569,0.0211504,70.98269119,1,6.266884743,0.509698795,12.29527086,9.60E-35,1.98E-32,8.22140492,1,3.251568856,1.158894426,2.805750709,0.005019951,0.017966422,Y,-,,glycoside hydrolase family 16,"P:fungal-type cell wall organization; C:incipient cellular bud site; F:transferase activity, transferring glycosyl groups; C:fungal-type cell wall; C:integral component of membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:carbohydrate binding; P:cell wall chitin metabolic process",IPR013320 (G3DSA:2.60.120.GENE3D); IPR000757 (PFAM); PTHR10963:SF38 (PANTHER); PTHR10963 (PANTHER); PS51257 (PROSITE_PROFILES); IPR000757 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),,
RL4_JR_05293,1691,1665,2129,4,12,1,0,0,1,2,1,4,2,4,9,0,0,1,1.063364821,1,1.808994113,1.440130969,1.256131666,0.209068237,NA,0.338461036,1,5.028393153,1.646280327,3.054396672,0.002255137,0.015081,0.879709486,1,2.37357194,1.238389349,1.916660492,0.055281078,0.122037861,1.014957833,1,1.951217425,1.280385369,1.523929804,0.127526247,0.235106201,0.869016935,1,2.288966067,1.220868692,1.87486671,0.060811063,0.130061684,N,-,,integral membrane,C:membrane,PTHR33048 (PANTHER),9.B.313.1.6, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_05294,1189,1636,2080,0,2,3,0,0,0,0,1,3,0,0,0,0,0,0,23.17097234,1,2.033965554,1.005174971,2.023494032,0.043022238,0.119056715,0.970885866,0,3.508166036,1.402339215,2.501652952,0.012361503,0.039545871,15.51434655,1,2.67778229,1.032424229,2.593684082,0.009495369,0.031394879,30.84021638,0,2.761999378,0.845355535,3.267263612,0.001085925,0.007910066,2.478665035,0,0.776741642,1.200494756,0.647017939,0.517620334,0.643121685,Y,-,,six-bladed beta-propeller,P:biological_process; C:cellular_component; F:molecular_function,IPR011042 (G3DSA:2.120.10.GENE3D); PTHR42060:SF1 (PANTHER); PTHR42060 (PANTHER); SSF63829 (SUPERFAMILY),,
RL4_JR_05295,2996,3151,5092,1,0,11,0,0,0,0,1,1,2,2,6,0,1,3,52.71566655,1,0.377594046,0.87756875,0.430272894,0.666997142,0.815185421,6.562258623,0,0.751349385,1.289943878,0.582466724,0.560252349,0.703627286,39.17716812,1,-0.051111649,1.073427934,-0.047615352,0.962022797,0.977667014,23.66983829,1,-1.380125591,1.191620006,-1.158192699,0.246785407,0.385486912,16.76545389,1,-1.981158836,1.241509856,-1.595765693,0.110541116,0.205740587,N,-,,amino transferase,F:pyridoxal phosphate binding; F:transaminase activity; P:cellular amino acid metabolic process; P:biosynthetic process,IPR015421 (G3DSA:3.40.640.GENE3D); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR004839 (PFAM); PTHR11751:SF377 (PANTHER); PTHR11751:SF377 (PANTHER); PTHR11751 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_05296,9983,10568,12731,1,1,13,0,0,0,0,4,0,0,1,1,0,0,0,9.11154551,1,3.058756764,1.027631158,2.976512282,0.002915474,0.014065309,0.472553805,0,4.546965487,1.569180521,2.897668832,0.003759473,0.017503859,1.223556612,1,1.897637686,1.234802517,1.536794475,0.124343647,0.22801215,1.411272017,1,1.475621718,1.260670692,1.170505294,0.241797685,0.380214562,5.065316852,0,2.746050144,1.139847295,2.409138625,0.015990223,0.045708924,N,-,,cytochrome p450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24287:SF5 (PANTHER); PTHR24287 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_05297,504,521,898,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,83.44872496,0,0.055911634,0.549714349,0.101710342,0.918986593,0.961445874,14.9587759,0,-0.437390675,1.212951807,-0.360600209,0.718398333,0.823793806,140.3994187,1,1.435510887,0.443294212,3.238280235,0.001202526,0.006689218,188.0240694,0,1.457457007,0.40719531,3.579257847,0.000344571,0.00304582,82.98241591,1,0.461557724,0.548416295,0.841619274,0.400001097,0.537279267,Y,-,,glycosyl hydrolase family 20,P:carbohydrate metabolic process; F:beta-N-acetylhexosaminidase activity,IPR025705 (PRINTS); IPR029018 (G3DSA:3.30.379.GENE3D); IPR025705 (PIRSF); IPR015883 (PFAM); IPR029019 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR22600:SF0 (PANTHER); PTHR22600 (PANTHER); IPR029018 (SUPERFAMILY); IPR017853 (SUPERFAMILY),,
RL4_JR_05298,4324,5744,7341,0,0,0,0,0,0,3,0,1,0,9,1,0,0,3,307.4909731,0,-1.097034311,0.39123732,-2.804012437,0.005047096,0.021936179,67.33583516,0,-2.607787646,1.188251985,-2.194641943,0.028189292,0.075404867,213.6651837,1,-1.862301052,0.616026363,-3.023086613,0.002502106,0.01184814,214.8248869,1,-3.947688726,1.010007835,-3.908572379,9.28E-05,0.001004313,195.3865863,1,-2.164132954,0.636441477,-3.40036442,0.000672961,0.00347462,N,-,,nuclear polyadenylated RNA-binding Nab2,C:nuclear envelope; F:pre-mRNA binding; P:negative regulation of mRNA catabolic process; P:snoRNA processing; C:cellular_component,PF14608 (PFAM); PTHR14738 (PANTHER); PTHR14738:SF29 (PANTHER),,
RL4_JR_05299,4,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.450644934,0,-0.79152806,1.202366149,-0.65830867,0.510339808,0.696096331,2.057981731,0,2.424325565,1.310020906,1.85060067,0.064227023,0.14354293,5.33512488,0,-0.226385639,1.201427334,-0.188430571,0.850539136,0.904501914,6.154691396,0,-0.648706606,1.199905736,-0.540631306,0.588761735,0.713321719,19.98223435,0,1.380797681,0.973818561,1.41792089,0.156213863,0.266468179,N,-,,nudix domain-containing,F:hydrolase activity,IPR015797 (G3DSA:3.90.79.GENE3D); IPR000086 (PFAM); PTHR12992:SF0 (PANTHER); PTHR12992 (PANTHER); PTHR12992 (PANTHER); PTHR12992:SF0 (PANTHER); IPR000086 (PROSITE_PROFILES); IPR015797 (SUPERFAMILY),,
RL4_JR_05300,11888,14597,17246,1,4,3,0,0,0,4,6,1,0,8,0,0,27,0,51.33469988,1,0.798898415,0.561260384,1.423400684,0.154620034,0.303510645,17.23836556,0,1.408007704,1.11661539,1.260960324,0.207323142,0.352574739,33.37729616,1,-0.338852574,1.027274603,-0.329855885,0.741508858,0.826492974,62.05065865,1,0.162518458,0.732926078,0.221739221,0.824516896,0.889908706,27.80355997,1,-0.571040332,0.9701116,-0.58863365,0.556107056,0.675372909,N,-, Effector probability:0.69,CTR2 short splice,C:integral component of membrane; F:copper ion transmembrane transporter activity; P:copper ion transmembrane transport,IPR007274 (PFAM); IPR007274 (PANTHER),1.A.56.1.10, the copper transporter (ctr) family.
RL4_JR_05301,969,1104,1296,4,1,6,0,0,0,0,0,2,0,10,0,0,0,0,70.32086969,1,-0.704039892,0.735277183,-0.957516305,0.338306721,0.528272823,50.42695311,0,2.366220828,0.755000786,3.134064058,0.001724032,0.015023052,70.52176098,1,0.26674975,0.664205367,0.40160734,0.687973027,0.78602649,88.2010959,1,0.245831663,0.564738334,0.435301888,0.663343315,0.770577221,44.15056903,0,-1.278033301,0.965449082,-1.323770797,0.185579178,0.304536333,N,-, Effector probability:0.719,"3-hydroxyanthranilate 3,4-dioxygenase","P:tryptophan catabolic process; P:quinolinate biosynthetic process; P:'de novo' NAD biosynthetic process from tryptophan; C:cytoplasm; F:ferrous iron binding; P:anthranilate metabolic process; P:oxidation-reduction process; F:3-hydroxyanthranilate 3,4-dioxygenase activity",IPR010329 (TIGRFAM); IPR010329 (PFAM); IPR014710 (G3DSA:2.60.120.GENE3D); IPR010329 (PANTHER); IPR010329 (HAMAP); IPR011051 (SUPERFAMILY),,
RL4_JR_05302,1916,2808,5308,0,0,0,0,0,1,1,0,4,0,0,0,0,0,0,125.5818798,0,0.805940889,0.591197756,1.363234011,0.172808772,0.326825614,16.62374149,1,-0.58965774,1.207007677,-0.488528574,0.625175491,0.753565702,95.40917786,1,0.382698835,0.584257418,0.655017503,0.512456485,0.64344654,119.181573,0,0.630145501,0.473211668,1.331635596,0.182979962,0.309449159,57.71108681,0,-1.116328648,0.852705846,-1.309160308,0.190480054,0.310565306,N,-, Effector probability:0.697,2-keto-4-pentenoate hydratase,P:metabolic process; F:hydrolase activity,IPR011234 (PFAM); IPR011234 (G3DSA:3.90.850.GENE3D); PTHR11820:SF7 (PANTHER); PTHR11820 (PANTHER); IPR011234 (SUPERFAMILY),,
RL4_JR_05303,379,422,253,0,0,6,0,0,0,2,2,3,12,29,4,0,10,1,12.81938673,1,-1.782713989,1.204090259,-1.480548468,0.138726936,0.279993653,4.074581826,0,1.438792784,1.260871469,1.141109796,0.253824235,0.408719203,21.67784605,1,-0.256459477,1.200344951,-0.213654814,0.830816251,0.890716113,21.87482753,1,-0.690054508,1.153590737,-0.598179654,0.549720066,0.679003811,10.50326395,1,-1.306546126,1.212709159,-1.077377965,0.281311444,0.415079914,N,-,,hypothetical protein SPBR_08663,P:mRNA processing,no IPS match,,
RL4_JR_05304,3683,3544,7123,1,0,2,0,0,0,0,3,0,0,5,0,0,4,3,161.1873985,1,-0.76926466,0.533297829,-1.442467263,0.149170601,0.295731169,33.03004318,0,-1.580223372,1.201182985,-1.315555907,0.188323141,0.328765263,86.08820368,1,-4.238774601,1.200180647,-3.531780497,0.000412772,0.002953288,193.1117052,1,-0.379467787,0.520920191,-0.728456668,0.466334085,0.608066016,107.7476845,1,-1.702018945,0.778289202,-2.186872105,0.028751862,0.072687291,N,-,,pwi domain mrna processing,P:mRNA processing,IPR002483 (SMART); IPR002483 (PFAM); IPR002483 (G3DSA:1.20.1390.GENE3D); PTHR23148 (PANTHER); IPR002483 (PROSITE_PROFILES); IPR002483 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_05305,3309,3550,2734,1,0,8,0,0,1,0,0,0,0,5,1,0,0,1,43.74391759,1,-3.55335274,1.187667235,-2.991875701,0.002772691,0.013528478,14.03900613,1,-0.345820703,1.214691168,-0.284698458,0.775875172,0.86424656,42.78653772,0,-2.030615476,1.191716844,-1.70394124,0.088392065,0.176192414,61.91018275,1,-0.385594319,0.678901288,-0.567968165,0.570056585,0.696828593,47.22261931,1,-0.862274283,0.839396458,-1.027255088,0.304300364,0.439520854,N,-,,oligopeptidase family,P:proteolysis; F:serine-type peptidase activity; P:histone acetylation; C:histone acetyltransferase complex,IPR015418 (PFAM); PTHR13476:SF0 (PANTHER); PTHR13476 (PANTHER),,
RL4_JR_05306,7205,7144,7465,2,0,1,0,0,0,5,0,3,0,11,0,0,0,0,195.7617909,1,1.334355047,0.446167145,2.990706647,0.002783327,0.013547962,34.7597012,0,1.104319833,0.994203822,1.110757984,0.266672536,0.423945251,120.7992979,1,1.181830076,0.497660283,2.374772745,0.017559758,0.050595925,102.1044845,1,0.127593837,0.546303232,0.233558634,0.815327645,0.883380674,82.1982936,0,0.352968844,0.549906959,0.641870117,0.520957518,0.645380506,N,-,,prolyl oligopeptidase,P:protein metabolic process,IPR011659 (PFAM); IPR001375 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR11731:SF150 (PANTHER); PTHR11731 (PANTHER); SSF82171 (SUPERFAMILY); IPR029058 (SUPERFAMILY),8.A.51.1.3, the dipeptidyl-aminopeptidase-like protein 6 beta subunit of kv4 channels (dpp6) family.
RL4_JR_05307,4360,5460,7382,1,0,2,0,0,0,3,0,4,6,3,2,0,0,0,1.46624428,1,1.345625754,1.450808309,0.927500722,0.353666617,NA,0.475432358,0,4.538426303,1.646648089,2.756160428,0.00584843,0.022883209,1.219467101,1,1.903185954,1.288366559,1.477208439,0.139619772,0.248594895,1.405841082,1,1.481671676,1.333562282,1.111062975,0.266541244,0.407571414,1.187166174,0,1.838429053,1.262023559,1.456731169,0.145190602,0.252890908,N,-,,hypothetical protein SPI_08626,,no IPS match,,
RL4_JR_05308,5035,3576,4832,1,3,5,0,0,0,0,4,7,4,2,0,0,4,0,286.8053279,1,3.220108095,0.859555075,3.746249878,0.000179498,0.001404878,53.44096204,0,1.997208666,0.985001274,2.027620389,0.042599006,0.104038598,22.79196207,1,-2.321418106,1.192082945,-1.947362904,0.051491242,0.115869601,89.21819764,1,1.165232893,0.513466976,2.2693434,0.023247451,0.082358448,51.84235445,1,0.242620499,0.737287658,0.329071694,0.742101499,0.819655032,N,-,,AMB domain,,IPR007138 (PFAM); IPR011008 (SUPERFAMILY),,
RL4_JR_05309,429,427,520,0,0,0,0,0,0,0,0,2,2,2,0,0,0,1,237.9300436,0,2.325600337,0.955393666,2.434180192,0.014925563,0.052303583,31.84094316,0,1.399283667,0.982612975,1.424043547,0.154433866,0.282774891,49.68600537,1,-1.074290043,1.029938848,-1.043061969,0.296919593,0.437811529,117.2382788,1,1.198018211,0.425060578,2.818464646,0.004825392,0.027294469,83.76031697,1,1.149044672,0.606840982,1.893485618,0.058293319,0.125701038,Y,-,,GPI anchored serine-threonine rich,C:membrane; C:integral component of membrane,IPR018466 (PFAM); PTHR39602:SF2 (PANTHER); PTHR39602 (PANTHER),,
RL4_JR_05310,239,232,295,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.020111042,0,7.533833619,3.95948959,1.902728482,0.057075983,NA,0.006181986,0,10.80045294,3.961457679,2.726383522,0.006403255,0.024293008,0.016419296,0,8.115760534,2.742902141,2.958822487,0.003088169,0.013803367,0.018970802,0,7.692145024,3.960113045,1.942405415,0.05208804,0.125807414,0.016551213,0,8.01449721,1.56545604,5.119592634,3.06E-07,5.23E-06,Y,-, Effector probability:0.758,hypothetical protein HMPREF1624_01113,,IPR011058 (G3DSA:2.30.60.GENE3D); IPR011058 (SUPERFAMILY),,
RL4_JR_05311,402,358,514,0,0,0,0,0,0,1,0,0,2,0,0,0,1,0,2.27173112,0,0.713729119,1.398943322,0.510191591,0.609917243,0.775756917,0.712898391,0,3.953493128,1.547689675,2.554448216,0.010635625,0.035215504,1.873087972,1,1.283109496,1.289829187,0.994790247,0.319838291,0.462511477,2.162366985,1,0.859872548,1.321659685,0.650600573,0.515304361,0.650150362,1.873025944,1,1.180950025,1.297029675,0.910503474,0.36255705,0.499440835,N,-,,integral membrane,C:membrane,PTHR33048 (PANTHER); PTHR33048:SF46 (PANTHER),2.A.1.7.25, the major facilitator superfamily (mfs).
RL4_JR_05312,1104,734,1329,0,0,2,0,0,1,0,0,0,0,2,0,0,1,0,68.59899671,1,0.152205822,0.619584441,0.245657916,0.805947052,0.901743694,11.95904364,1,-0.1145273,1.217756118,-0.094047813,0.925071176,0.958737823,38.95499981,0,-1.80861895,1.198424657,-1.509163667,0.131256963,0.237508592,53.23455891,1,-0.883105232,0.866961685,-1.018620832,0.308383011,0.453965976,52.83362425,1,-0.613104384,0.857570191,-0.714932014,0.474651054,0.604888851,N,-,,ABC bile acid transporter,F:nucleotide binding; F:ATPase activity; C:membrane; P:transport,IPR003593 (SMART); G3DSA:1.20.1560.10 (GENE3D); IPR011527 (PFAM); IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24223 (PANTHER); PTHR24223:SF227 (PANTHER); PTHR24223:SF227 (PANTHER); PTHR24223 (PANTHER); PTHR24223:SF227 (PANTHER); PTHR24223 (PANTHER); PTHR24223:SF227 (PANTHER); PTHR24223 (PANTHER); PTHR24223 (PANTHER); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY),3.A.1.208.12, the atp-binding cassette (abc) superfamily.
RL4_JR_05313,1819,1329,1569,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,41.56556298,0,1.298364405,0.700304536,1.853999707,0.063739202,0.159349313,4.595205507,0,1.265306352,1.285694056,0.984142648,0.32504538,0.487207069,11.97855229,1,-1.393527909,1.22455478,-1.137987399,0.255125744,0.390873643,37.89095649,0,1.406987197,0.713650409,1.971535614,0.048662644,0.120850936,11.88688228,0,-1.485099417,1.236933118,-1.200630329,0.229894631,0.357564938,N,-,,DNA-binding partial,F:DNA binding,IPR001005 (SMART); IPR009057 (G3DSA:1.10.10.GENE3D); IPR017877 (PROSITE_PROFILES),,
RL4_JR_05314,1004,967,803,0,0,1,0,0,3,0,0,0,0,0,0,0,0,0,11.4499544,1,1.681879189,1.042590837,1.613172809,0.106706969,0.232277207,1.227525667,1,3.169796036,1.405953628,2.254552336,0.024161442,0.066729091,3.169883829,0,0.524459849,1.228171528,0.42702492,0.669361177,0.772351556,3.65552226,0,0.102637285,1.233759124,0.0831907,0.933699907,0.961426987,3.113510386,0,0.447432742,1.223021825,0.365841993,0.714482983,0.798823481,N,-,,hypothetical protein MGG_10306,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,IPR021765 (PFAM); PTHR33365:SF3 (PANTHER); PTHR33365 (PANTHER),,
RL4_JR_05315,185,122,258,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.56050281,0,2.732734191,1.925026032,1.41958298,0.155729123,NA,0.181224326,0,5.92977228,1.905555526,3.111833897,0.001859291,0.015023052,0.466801366,0,3.287939506,1.313638074,2.502926469,0.012317113,0.038017821,0.538222258,0,2.866426146,1.450450556,1.976231547,0.048128558,0.119965942,0.457422498,0,3.21345954,1.262061844,2.546198156,0.010890335,0.033642998,N,-,,hypothetical protein SPI_01511,C:membrane; C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,no IPS match,,
RL4_JR_05316,14741,12908,14928,0,5,21,0,0,0,0,1,3,0,2,0,0,10,0,0.003906015,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,1,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,N,-, Effector probability:0.825,glycosyl transferase,F:transferase activity,no IPS match,,
RL4_JR_05317,946,987,1316,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,15.99379512,0,-2.101914103,1.201778955,-1.749002255,0.08029063,0.188763964,5.097456367,0,1.115687453,1.252110948,0.891045202,0.372904921,0.537454593,13.25030601,0,-1.539094333,1.203254895,-1.279109139,0.200858626,0.326350943,24.59900737,1,-1.010721241,1.153802198,-0.87599178,0.381034502,0.526618423,20.46753551,0,-0.68802092,1.138679435,-0.604227054,0.545692697,0.66672361,N,-,,hypothetical protein ESCO_004577,P:nucleocytoplasmic transport; F:oxidoreductase activity; C:membrane; C:integral component of membrane; F:structural constituent of nuclear pore; P:oxidation-reduction process; C:nuclear pore,PR00368 (PRINTS); IPR023753 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR38688:SF1 (PANTHER); PTHR38688 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_05318,521,744,626,0,0,4,0,0,0,0,0,1,0,0,0,0,0,0,0.383570208,1,3.28005732,2.223039626,1.475483065,0.140082718,NA,0.122117045,0,6.49908068,2.004408215,3.242393756,0.001185301,0.015023052,0.317386972,1,3.844182523,1.297269351,2.963287863,0.003043718,0.013719768,0.366179444,0,3.422017001,1.498850415,2.283094408,0.022424808,0.080726669,0.313549896,0,3.759733326,1.239876884,3.032344077,0.002426624,0.009966028,N,-,,unnamed protein product,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_05319,5954,4857,6659,3,0,2,0,0,0,0,0,0,0,7,0,0,0,0,0.806594808,1,2.207597133,1.699464892,1.298995433,0.193945497,NA,22.5736247,0,6.338259702,1.17619305,5.388792002,7.09E-08,8.86E-06,0.672659184,0,2.760989557,1.312387935,2.103790718,0.035396707,0.086937472,0.775460461,1,2.339626617,1.405636069,1.664461142,0.09602031,0.190181072,16.09982028,0,5.244475364,0.851634706,6.158127808,7.36E-10,4.36E-08,N,-,,Peptidase caspase catalytic subunit p20,F:hydrolase activity,IPR029030 (G3DSA:3.40.50.GENE3D); PF00656 (PFAM); PTHR31810 (PANTHER),,
RL4_JR_05320,8761,8925,10347,1,9,14,1,0,8,4,0,0,1,3,0,0,2,0,7.185389782,1,-0.947605538,1.209327561,-0.783580535,0.433286281,0.623937114,2.287136341,1,2.271901581,1.30470378,1.74131601,0.081628201,0.172892501,18.94683742,1,1.433078302,1.044820568,1.371602307,0.170187275,0.288267688,20.18794223,1,0.928309557,1.026493083,0.904350524,0.365809564,0.512001913,5.886255903,1,-0.471148417,1.214829453,-0.387830914,0.698141167,0.786457423,N,-,,hypothetical protein HIM_10633,,IPR024983 (PFAM),,
RL4_JR_05321,269,202,356,0,0,3,0,0,0,0,0,1,0,0,0,0,0,0,0.104972382,1,5.149636152,3.916919783,1.314715756,0.188605449,NA,0.033427541,0,8.368574682,2.609830544,3.206558641,0.001343329,0.015023052,0.086663293,1,5.718820455,1.498300236,3.816872159,0.000135154,0.00138889,0.099982857,0,5.295283701,2.324189221,2.278335883,0.022706573,0.081131698,0.085216053,0,5.641541852,1.299229672,4.342220604,1.41E-05,0.000133845,N,-,,hypothetical protein MMYC01_208050,,no IPS match,,
RL4_JR_05322,1329,934,1549,0,0,6,0,0,0,0,0,1,2,1,5,0,0,1,0.698998511,1,2.414389404,1.69297623,1.426121266,0.153833341,NA,0.223581757,0,5.626748024,1.78740187,3.14800388,0.001643895,0.015023052,0.578612925,1,2.978848835,1.260208743,2.363774138,0.018089837,0.051837394,0.667425399,1,2.556389054,1.344304986,1.90164366,0.057217756,0.13317926,0.568493181,1,2.901324142,1.223149765,2.372010547,0.017691586,0.049523723,N,-,,cytochrome p450 monooxygenase,F:oxidoreductase activity; F:metal ion binding; C:membrane,IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305 (PANTHER); PTHR24305:SF74 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_05323,17996,20329,27215,21,29,40,0,0,6,7,11,25,4,25,5,0,13,8,13.73168243,1,-0.464177422,1.145381279,-0.405260178,0.685286274,0.828896683,3.155361277,1,1.807696407,1.266245841,1.427603036,0.153406149,0.281249238,19.26752633,1,0.11554271,1.191130587,0.097002555,0.922724366,0.954692026,9.457795459,1,-1.2687209,1.192979088,-1.06348964,0.287559961,0.431804187,8.090997361,1,-0.930027579,1.199320529,-0.77546207,0.43806667,0.572312908,N,-,,hypothetical protein CMQ_3244,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_05324,455,554,683,4,0,0,0,0,0,0,0,0,0,0,0,0,5,0,207.2583543,1,-0.124981757,0.421720762,-0.296361405,0.766954096,0.877722899,149.5680868,0,1.406616411,1.595743394,0.881480329,0.378057897,0.542409926,104.086588,0,-2.476245349,1.028163192,-2.408416648,0.016021884,0.046948063,170.3002595,0,-0.223107433,0.432805433,-0.515491295,0.606209751,0.72665442,95.93196802,1,-3.448098926,1.122038795,-3.073065692,0.002118718,0.008882826,N,-, Effector probability:0.816,Endoribonuclease L-PSP,,IPR006175 (PFAM); IPR006056 (TIGRFAM); IPR013813 (G3DSA:3.30.1330.GENE3D); PTHR11803:SF22 (PANTHER); IPR006175 (PANTHER); IPR013813 (SUPERFAMILY),,
RL4_JR_05325,4677,5027,7716,1,0,4,0,0,0,0,0,0,0,2,0,0,7,0,68.35813407,1,-0.748567667,0.753221729,-0.993821125,0.320309959,0.508778943,15.569168,0,-0.49515465,1.22202733,-0.405191142,0.685337016,0.799928652,51.73335291,0,-2.194909399,1.209463336,-1.814779608,0.069557785,0.146039614,118.528999,1,0.610254883,0.522119161,1.168803845,0.242482671,0.380818527,55.10289985,1,-1.545135103,1.003757857,-1.539350444,0.123718765,0.224088103,N,-,,mitochondrial carrier,P:transmembrane transport; C:integral component of membrane; C:endoplasmic reticulum,IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089:SF133 (PANTHER); PTHR24089:SF133 (PANTHER); PTHR24089 (PANTHER); PTHR24089 (PANTHER); PTHR24089:SF133 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.10.5, the mitochondrial carrier (mc) family.
RL4_JR_05326,3396,2799,3409,0,0,4,0,0,0,1,0,0,2,4,5,0,0,0,51.60871496,1,-0.577216829,0.752509079,-0.767056299,0.443048043,0.63225902,30.3571272,0,1.568825317,0.993435552,1.579191839,0.114292061,0.225070865,36.55692478,1,-1.758852749,1.191440575,-1.476240431,0.139879359,0.248904031,50.72099279,1,-0.430187873,0.749792197,-0.573742798,0.566141863,0.693381681,33.43239778,0,-1.869605227,1.121503982,-1.667051795,0.095504106,0.1844324,N,-,,dolichyl-phosphate-mannose- mannosyltransferase,P:fungal-type cell wall organization; P:filamentous growth; P:cell wall mannoprotein biosynthetic process; P:multicellular organism development; C:integral component of membrane; P:regulation of endoplasmic reticulum unfolded protein response; C:dolichyl-phosphate-mannose-protein mannosyltransferase complex; P:protein O-linked mannosylation; P:chain elongation of O-linked mannose residue; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity,IPR016093 (SMART); IPR003342 (PFAM); IPR032421 (PFAM); G3DSA:2.80.10.50 (GENE3D); IPR016093 (PFAM); IPR027005 (PANTHER); PTHR10050:SF26 (PANTHER); IPR016093 (PROSITE_PROFILES); IPR016093 (PROSITE_PROFILES); IPR016093 (PROSITE_PROFILES); IPR016093 (SUPERFAMILY),9.B.142.5.2, the integral membrane glycosyltransferase family 39 (gt39) family.
RL4_JR_05327,91,71,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.629648399,0,0.502729047,1.245248937,0.403717708,0.686420316,0.829233961,0.83611295,0,3.723681484,1.430536145,2.602997133,0.009241273,0.031773153,2.174835252,0,1.067811768,1.21556632,0.878447972,0.379700661,0.523858597,2.50931132,0,0.645313027,1.222876102,0.52770107,0.597706831,0.72036444,2.150191352,0,0.981872186,1.214580668,0.80840426,0.4188579,0.554660769,N,-,,---NA---,,no IPS match,,
RL4_JR_05328,116,131,130,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.80816684,0,-1.889964526,1.193255814,-1.583872044,0.11322284,0.242365523,4.410828567,0,1.324442412,1.253302648,1.056761839,0.290620294,0.449724142,11.44479782,0,-1.327753949,1.197424814,-1.108841184,0.2674987,0.405700396,21.22563095,0,-0.026122442,1.021210817,-0.025579872,0.97959244,0.987381314,18.65819025,0,-0.475367002,1.129635492,-0.420814507,0.673890538,0.768103403,N,-,,f-box domain containing,,no IPS match,,
RL4_JR_05329,1858,1573,2374,0,0,4,0,0,1,0,0,0,2,3,0,0,1,0,660.9411293,1,-1.310596532,0.486268295,-2.695212798,0.007034369,0.028679942,154.1237021,1,-3.802423511,1.234365923,-3.080467017,0.002066762,0.015023052,505.8731282,0,-1.751329289,0.54978043,-3.185506786,0.001445007,0.007675368,542.6052692,1,-2.225724105,0.53427036,-4.165913502,3.10E-05,0.000387481,410.1575242,1,-3.611454158,0.761387409,-4.743254373,2.10E-06,2.70E-05,N,-,,zinc finger transcription factor ace1,F:binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR14596:SF31 (PANTHER); PTHR14596 (PANTHER); IPR007087 (PROSITE_PROFILES),,
RL4_JR_05330,534,555,726,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,28.06252449,0,-1.322780882,1.138105583,-1.162265525,0.245127626,0.420646018,5.767480451,0,0.937617847,1.239249517,0.756601341,0.449288738,0.609856592,34.41470489,0,0.693295089,0.85105977,0.814625615,0.415286643,0.556869136,21.21873774,0,-1.184749596,1.141444817,-1.037938565,0.299298658,0.444565972,29.39130178,1,-0.105482795,0.964823739,-0.109328566,0.91294189,0.943795859,N,-,,ATP-dependent DNA helicase MPH1,F:nucleotide binding; F:DNA binding; P:DNA repair; F:helicase activity,IPR014001 (SMART); IPR001650 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR006935 (PFAM); G3DSA:1.20.1320.20 (GENE3D); IPR001650 (PFAM); PTHR14025 (PANTHER); PTHR14025:SF20 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_05331,1590,1126,1392,3,2,0,0,0,1,0,0,4,0,0,1,0,3,4,279.8399103,1,-1.760821185,0.581306318,-3.029076291,0.002453027,0.012330127,67.3707381,1,-2.608552929,1.210472092,-2.15498808,0.031162767,0.081527405,182.2865807,1,-4.306917888,1.2154264,-3.543544791,0.000394786,0.002852831,289.8492634,1,-1.09700129,0.497529991,-2.2048948,0.027461478,0.088070176,226.8193691,1,-1.560196386,0.617219405,-2.527782458,0.011478545,0.035090661,N,-,,mRNA export factor mex67,P:ribosomal small subunit export from nucleus; P:ribosomal large subunit export from nucleus; C:nuclear membrane; F:RNA binding; C:mitotic spindle; C:nuclear RNA export factor complex; C:cytosol; F:structural constituent of nuclear pore; C:nucleolus; P:poly(A)+ mRNA export from nucleus; C:nuclear pore,IPR005637 (SMART); IPR032710 (G3DSA:3.10.450.GENE3D); IPR002075 (PFAM); IPR005637 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); G3DSA:1.10.8.10 (GENE3D); IPR030217 (PANTHER); PTHR10662:SF22 (PANTHER); IPR001611 (PROSITE_PROFILES); IPR005637 (PROSITE_PROFILES); IPR018222 (PROSITE_PROFILES); IPR009060 (SUPERFAMILY); IPR032675 (SUPERFAMILY); IPR032710 (SUPERFAMILY),3.A.22.1.1, the transcription-coupled trex/tap nuclear mrna export complex (trex) family.
RL4_JR_05332,69,69,87,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,22.82644431,0,3.006204297,0.705401371,4.261693299,2.03E-05,0.000212741,39.53790862,0,4.128892958,1.133177827,3.643640794,0.000268809,0.010971289,33.66497096,0,3.376298316,0.763333116,4.42309949,9.73E-06,0.000184115,16.89731844,1,1.870969076,1.032246968,1.812520776,0.069905767,0.150626918,64.44649649,0,4.865052411,0.541145069,8.990292421,2.47E-19,5.20E-17,N,-,,pre-mrna splicing factor clf1,F:oxidoreductase activity; C:membrane; P:proline biosynthetic process,IPR015915 (G3DSA:2.120.10.GENE3D); SSF117281 (SUPERFAMILY),,
RL4_JR_05333,259,388,492,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.288386414,0,3.691579105,2.541045791,1.452779449,0.146285,NA,0.091387676,0,6.917204847,2.13110533,3.24582964,0.001171089,0.015023052,0.238114858,0,4.25884466,1.335224983,3.189608279,0.001424658,0.007599175,0.274772415,0,3.83638256,1.636009966,2.34496283,0.019028977,0.075055858,0.235713105,0,4.172260435,1.258125808,3.316250576,0.00091234,0.004432553,N,-,,Ankyrin repeat-containing domain,,IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24188 (PANTHER); PTHR24188:SF41 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),,
RL4_JR_05334,316,299,281,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100381553,1,5.21406149,3.917382915,1.331006338,0.183186925,NA,0.031914752,0,8.435105118,2.619026669,3.220702262,0.001278769,0.015023052,0.082930113,0,5.781183614,1.489466149,3.88137966,0.000103866,0.001189519,0.095683488,0,5.358428983,2.34491095,2.285131119,0.022305141,0.080484515,0.08182703,0,5.69939373,1.293325531,4.406774316,1.05E-05,0.000104663,N,-,,---NA---,,no IPS match,,
RL4_JR_05335,633,521,544,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0.293433225,1,3.666384105,2.548966404,1.43838071,0.150326063,NA,0.093181435,0,6.888970368,2.146652807,3.209168406,0.001331195,0.015023052,0.243007353,0,4.228390011,1.362802883,3.102715781,0.001917537,0.009558417,0.280400114,0,3.806725853,1.668774162,2.281151002,0.022539513,0.080907954,0.241271871,0,4.137200024,1.284106054,3.221852285,0.001273648,0.005845732,N,-,,heterokaryon incompatibility,P:biological_process; C:cellular_component; F:molecular_function,IPR010730 (PFAM); PTHR33112:SF1 (PANTHER); PTHR33112:SF1 (PANTHER); PTHR33112 (PANTHER); PTHR33112 (PANTHER),,
RL4_JR_05336,6988,5790,4494,0,6,9,2,0,0,1,10,25,9,33,5,0,18,22,15.65392939,1,-0.72447283,1.21490559,-0.59632027,0.550961292,0.730740661,3.746626469,1,1.559821509,1.332278353,1.170792504,0.241682192,0.393866872,9.796431377,1,-1.103414461,1.249910032,-0.882795108,0.377346984,0.521039398,11.30539486,1,-1.526251536,1.255414305,-1.215735339,0.224085757,0.359510108,9.756949793,1,-1.2002271,1.266937994,-0.947344784,0.343463118,0.480392881,N,-,,f-box domain containing,,G3DSA:1.20.1280.50 (GENE3D); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY),,
RL4_JR_05337,2132,2280,2673,3,1,15,0,0,1,1,6,5,3,0,0,0,1,1,0.199318845,1,4.224724459,3.040850842,1.389323146,0.164734509,NA,0.063534972,1,7.442218294,2.350843662,3.165764876,0.001546758,0.015023052,0.164336058,1,4.796166989,1.448900768,3.310210813,0.000932257,0.005433606,0.189582195,1,4.372513025,1.924818886,2.271649066,0.023107715,0.082093197,7.882030914,1,6.370500558,1.063790916,5.988489336,2.12E-09,1.18E-07,,,,,,,,
RL4_JR_05338,117,113,177,0,0,4,0,0,0,0,0,1,0,0,1,0,2,0,262.5666539,1,-1.601067461,0.482487885,-3.318357848,0.000905484,0.005504425,64.91505847,0,-2.554978757,1.188772242,-2.149258426,0.03161392,0.082537039,189.5149361,1,-2.804444876,0.85292828,-3.28801957,0.001008948,0.00579387,247.2535898,1,-1.740225217,0.513792664,-3.38701842,0.000706566,0.005541429,170.465453,1,-4.364362574,1.129099058,-3.865349583,0.00011093,0.000755325,N,-,,phosphorus acquisition-controlling,F:binding,IPR011598 (SMART); IPR011598 (G3DSA:4.10.280.GENE3D); IPR011598 (PFAM); PTHR10985:SF94 (PANTHER); PTHR10985 (PANTHER); PTHR10985:SF94 (PANTHER); IPR011598 (PROSITE_PROFILES); IPR011598 (SUPERFAMILY),,
RL4_JR_05339,256,523,365,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,154.9621273,0,0.166478306,0.67385928,0.247052035,0.804867954,0.901630269,22.86000128,1,-1.04924476,1.209778445,-0.867303236,0.385775884,0.550440302,65.74743219,0,-2.73795319,1.198337629,-2.284792802,0.02232498,0.060741225,120.492829,0,-0.210028574,1.333979037,-0.157445183,0.874894006,0.922643664,146.1333199,0,1.001003578,0.515673192,1.941158844,0.052239013,0.11573742,N,-,,HSP20-like chaperone,,IPR008978 (G3DSA:2.60.40.GENE3D); IPR031107 (PANTHER); PTHR11527:SF42 (PANTHER); IPR031107 (PANTHER); PTHR11527:SF42 (PANTHER); PTHR11527:SF42 (PANTHER); IPR031107 (PANTHER); IPR002068 (PROSITE_PROFILES); IPR008978 (SUPERFAMILY),9.B.113.1.2," the collagen secretory protein, mia3 (mia3) family."
RL4_JR_05340,4344,6428,5273,5,1,15,0,0,0,2,1,1,0,3,0,0,5,2,141.0140133,1,-0.115270031,0.499532171,-0.230755971,0.817504388,0.907207263,23.50952169,0,-1.089689628,1.200465834,-0.907722317,0.36402495,0.52857159,88.47606286,1,-0.928933065,0.750778181,-1.237293635,0.21597809,0.344652606,94.60609182,1,-0.890792186,0.639459592,-1.393039054,0.163607981,0.283857616,87.12369496,1,-0.649732226,0.648057432,-1.002584329,0.31606146,0.451484521,N,-,,sister chromatid separation,C:nuclear envelope; C:integral component of membrane; P:single-organism cellular process,IPR011015 (G3DSA:1.10.720.GENE3D); IPR018996 (PFAM); IPR025856 (PFAM); PTHR13428:SF7 (PANTHER); PTHR13428:SF7 (PANTHER); PTHR13428 (PANTHER),,
RL4_JR_05341,82,105,51,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,77.9197985,0,1.562646784,1.113069167,1.403908068,0.160346227,0.310141058,5.550513417,0,0.992810033,1.254486609,0.791407438,0.428706271,0.591677785,14.48588981,1,-1.667702803,1.211040657,-1.377082423,0.168486766,0.285865598,28.75142645,0,0.193532279,0.890869861,0.217239674,0.828021567,0.892526745,25.96056223,0,0.420270896,0.893954705,0.470125492,0.638265362,0.740256219,N,-,,sucrose transporter,C:membrane,PF13347 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR19432 (PANTHER); PTHR19432:SF30 (PANTHER); PTHR19432:SF30 (PANTHER); PTHR19432:SF30 (PANTHER); PTHR19432 (PANTHER); PTHR19432 (PANTHER); PTHR19432:SF30 (PANTHER); PTHR19432 (PANTHER); IPR020846 (SUPERFAMILY),2.A.2.6.1, the glycoside-pentoside-hexuronide (gph):cation symporter family.
RL4_JR_05342,5064,6135,7212,0,0,9,0,0,0,0,2,0,0,2,0,0,6,0,106.2061132,1,-0.73896724,0.597539458,-1.236683586,0.216204575,0.384329012,22.62098952,0,-1.034108916,1.201770838,-0.86048761,0.389520311,0.553965766,101.2833916,1,-0.538767838,0.678251715,-0.794347919,0.426992915,0.567632697,71.90088542,1,-3.165579774,1.149740029,-2.753300481,0.005899772,0.031995281,62.06357038,1,-2.847376252,1.132749384,-2.513685987,0.011947676,0.03625119,N,-,,ATP phosphoribosyltransferase,F:magnesium ion binding; F:ATP phosphoribosyltransferase activity; C:cytosol; P:histidine biosynthetic process,IPR013115 (TIGRFAM); G3DSA:3.40.190.10 (GENE3D); IPR013820 (TIGRFAM); IPR015867 (G3DSA:3.30.70.GENE3D); IPR013820 (PFAM); IPR013115 (PFAM); PTHR21403:SF0 (PANTHER); IPR001348 (PANTHER); PTHR21403:SF0 (PANTHER); PTHR21403:SF0 (PANTHER); IPR001348 (PANTHER); IPR001348 (PANTHER); IPR020621 (HAMAP); SSF53850 (SUPERFAMILY); IPR011322 (SUPERFAMILY),,
RL4_JR_05343,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.75260041,0,2.307711694,1.714756024,1.34579594,0.178368335,NA,0.237396067,0,5.539950391,1.788279159,3.097922582,0.001948823,0.015023052,0.620504593,0,2.877019204,1.289550443,2.231024944,0.025679477,0.067968372,0.716169192,0,2.454226228,1.38208099,1.775747041,0.07577462,0.159970398,0.616271202,0,2.785193626,1.264503949,2.202597808,0.027623109,0.070555997,N,-,,cyclin-dependent kinase 13,,no IPS match,,
RL4_JR_05344,920,1163,1175,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,89.6482683,0,1.417460236,0.506762686,2.797088804,0.005156536,0.02228126,8.578231973,0,0.364792376,1.226224136,0.297492412,0.7660906,0.858448915,44.48768216,1,-0.458749683,1.039323719,-0.441392489,0.658928879,0.7642337,74.10549152,0,1.004937229,0.564443506,1.780403565,0.075009939,0.158786458,41.42387978,0,0.520064904,0.718205439,0.724117189,0.468993793,0.600399817,N,-,,arp2 3 actin-organizing complex subunit sop2,C:cell division site; C:cell tip; F:ubiquitin binding; P:mitotic cytokinesis; P:Arp2/3 complex-mediated actin nucleation; C:cytosol; C:actin cortical patch; C:Arp2/3 protein complex,IPR001680 (SMART); IPR017383 (PIRSF); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); IPR017383 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_05345,2364,2497,3714,0,0,0,0,0,1,0,0,0,0,4,0,0,0,0,63.24275567,0,0.386237558,0.785260386,0.491859216,0.622818871,0.783890227,10.31281409,1,0.099078266,1.26135403,0.078549133,0.937391248,0.96553111,27.00868254,0,-2.566427216,1.232075912,-2.083010626,0.037250255,0.090319,40.48555185,1,-2.034396012,1.190123706,-1.709398781,0.087377107,0.176938641,38.50656362,0,-0.505816446,0.938415832,-0.539010989,0.589879272,0.701824633,N,-,,U2 small nuclear ribonucleo B,"F:nucleotide binding; C:integral component of membrane; F:snRNA binding; P:mRNA splicing, via spliceosome",IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR10501:SF18 (PANTHER); IPR024888 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_05346,371,443,849,0,0,3,0,0,0,0,2,4,0,3,0,0,2,0,29.92645585,1,0.591819237,0.889256062,0.665521735,0.505716846,0.692221146,3.868079752,0,1.513800855,1.276226882,1.1861534,0.235561725,0.38606797,10.09935691,1,-1.147349804,1.214856712,-0.944432205,0.344948831,0.488701646,39.59177693,1,0.78931308,0.87835855,0.898622869,0.368853573,0.514910028,25.47065403,1,1.331927681,0.816266457,1.631731489,0.102736064,0.194867487,N,-,,Autophagy-related atg10,C:integral component of membrane,IPR007135 (PFAM); PTHR14957 (PANTHER),,
RL4_JR_05347,998,1539,2412,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,197.0474057,1,1.776712813,0.315972141,5.623004641,1.88E-08,4.28E-07,15.34532166,0,-0.474185031,1.203307728,-0.394067968,0.693530859,0.806258389,87.88717038,0,0.283662667,0.606458605,0.467736239,0.639973222,0.749200844,57.89004478,0,-1.237390028,0.845836656,-1.462918424,0.143489702,0.257503232,110.3365814,0,1.120529243,0.42918218,2.610847551,0.009031815,0.02895729,N,-,,"mannosyl-oligosaccharide alpha-1,2-mannosidase","F:calcium ion binding; C:integral component of membrane; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; P:protein N-linked glycosylation; P:protein deglycosylation involved in glycoprotein catabolic process; C:endoplasmic reticulum; P:ER-associated ubiquitin-dependent protein catabolic process",IPR001382 (PRINTS); IPR001382 (PFAM); IPR001382 (G3DSA:1.50.10.GENE3D); PTHR11742 (PANTHER); PTHR11742:SF7 (PANTHER); IPR001382 (SUPERFAMILY),,
RL4_JR_05348,9314,16127,24626,1,2,2,0,0,0,0,4,3,3,7,0,0,2,0,75.07299429,1,-0.41813578,0.673405411,-0.620927265,0.534647481,0.717731471,15.49273911,0,-0.487976939,1.239041783,-0.393834127,0.693703506,0.80634668,39.90384557,1,-3.129463839,1.210902986,-2.584405089,0.009754715,0.032095136,80.68178609,1,-0.253667538,0.665313411,-0.381275251,0.702999016,0.800659734,39.07103375,1,-3.201843733,1.208811361,-2.64875384,0.008078915,0.026420871,N,-,,general amino-acid permease GAP1,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR004762 (TIGRFAM); IPR004841 (PFAM); PTHR11785:SF247 (PANTHER); IPR002293 (PANTHER),2.A.3.10.24, the amino acid-polyamine-organocation (apc) family.
RL4_JR_05349,426,747,1547,3,0,4,0,0,0,0,0,0,1,0,0,0,0,0,70.15987701,1,0.276264448,0.55720517,0.495803814,0.620032833,0.781764585,12.71572689,0,-0.20299664,1.218068808,-0.166654494,0.867641914,0.923089284,73.20437712,0,0.547162324,0.622979282,0.87829939,0.379781267,0.523858597,120.5760496,1,1.334339395,0.431959447,3.089038571,0.002008054,0.013270842,62.46020936,0,0.277734315,0.617496171,0.44977496,0.652872715,0.752441233,N,-,,hypothetical protein SPSK_06071,,IPR032710 (G3DSA:3.10.450.GENE3D); IPR032710 (SUPERFAMILY),,
RL4_JR_05350,898,951,1023,0,0,2,0,0,0,0,0,0,0,0,0,0,5,0,545.4703251,1,-0.589353507,0.391278834,-1.506223839,0.132009722,0.270043959,149.8165221,0,-0.345480798,0.730032743,-0.47324014,0.636041863,0.762256185,307.7242318,0,-3.022185192,0.767950713,-3.935389525,8.31E-05,0.001039454,319.6237886,0,-4.006139118,0.887171879,-4.515629058,6.31E-06,9.47E-05,298.7760909,1,-3.691859235,0.880728037,-4.191826626,2.77E-05,0.000236436,N,-,,ATPase GET3,"F:ATPase activity; C:GET complex; F:identical protein binding; P:retrograde vesicle-mediated transport, Golgi to ER; F:guanyl-nucleotide exchange factor activity; F:unfolded protein binding; P:protein insertion into ER membrane; P:posttranslational protein targeting to membrane; P:positive regulation of GTPase activity; P:pheromone-dependent signal transduction involved in conjugation with cellular fusion; C:nucleus; F:ATP binding; P:response to heat; F:metal ion binding; C:cytosol; P:response to metal ion; P:ATP-independent chaperone mediated protein folding",IPR027417 (G3DSA:3.40.50.GENE3D); IPR025723 (PFAM); IPR016300 (TIGRFAM); PTHR10803:SF3 (PANTHER); IPR016300 (PANTHER); IPR027542 (HAMAP); IPR027417 (SUPERFAMILY),3.A.19.1.1, the tms recognition/insertion complex (trc) family.
RL4_JR_05351,3395,4593,9127,1,1,0,0,0,1,4,0,0,2,3,0,0,0,0,85.47729629,1,-0.232913302,0.644003301,-0.361664764,0.717602561,0.848681023,13.90928109,1,-0.332480338,1.211664534,-0.274399661,0.783777503,0.869393146,36.196092,1,-2.988785204,1.197314638,-2.496240426,0.01255175,0.038548256,41.76567901,1,-3.411434264,1.197905302,-2.847833012,0.004401801,0.025366101,35.7779759,0,-3.074760192,1.203636541,-2.554558695,0.01063225,0.033009388,N,-,,transthyretin domain,F:hydroxyisourate hydrolase activity; P:purine nucleobase metabolic process; F:hydrolase activity,IPR023416 (PFAM); IPR023416 (G3DSA:2.60.40.GENE3D); PTHR10395:SF7 (PANTHER); PTHR10395 (PANTHER); PTHR10395:SF7 (PANTHER); PTHR10395 (PANTHER); PTHR10395 (PANTHER); IPR023416 (SUPERFAMILY),9.B.35.1.3, the putative thyronine-transporting transthyretin (transthyretin) family.
RL4_JR_05352,7045,8014,10424,0,5,1,0,0,0,0,0,0,2,2,0,0,6,0,57.51996641,1,-1.334620501,0.868792871,-1.536178007,0.124494728,0.259287208,14.82735,0,-0.424640744,1.224539465,-0.346775875,0.728759703,0.830874714,92.93726163,0,0.735251406,0.565352638,1.30051822,0.193423416,0.317479682,52.14344842,1,-1.770163885,1.029142851,-1.7200371,0.085425698,0.174024094,68.40083704,1,0.425991756,0.58010404,0.734336819,0.462743483,0.593975376,N,-, Effector probability:0.575,hypothetical protein SPBR_05364,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_05353,144,125,224,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,71.24258764,1,0.25586921,0.535930116,0.477430176,0.63305583,0.791368291,13.01915563,0,-0.237037914,1.208512606,-0.196140208,0.844500426,0.907028954,55.8698236,0,-1.05810187,1.027531339,-1.029751434,0.303126704,0.444632679,100.3701934,0,1.15325714,0.462343923,2.494370711,0.012618069,0.058310335,81.97973472,0,0.825571066,0.511525956,1.61393778,0.106540923,0.20020914,N,-,,gamma-tocopherol methyltransferase,C:cytoplasm; F:S-adenosylmethionine-dependent methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR013216 (PFAM); PTHR10108:SF912 (PANTHER); PTHR10108:SF912 (PANTHER); PTHR10108 (PANTHER); PTHR10108 (PANTHER); PTHR10108:SF912 (PANTHER); IPR025774 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_05354,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,64.19625484,0,-2.96446414,1.14535513,-2.588248887,0.009646525,0.036877391,18.00431725,0,-0.704750707,1.210319027,-0.582285077,0.560374676,0.703627286,53.11536646,0,-2.392012664,1.194390797,-2.002705202,0.04520894,0.104783725,67.41565229,0,-2.041311009,1.019881714,-2.001517412,0.045336659,0.115335094,60.98122167,0,-1.222090625,0.847657964,-1.441726117,0.149379653,0.258100509,N,-,,c2h2 transcription factor,F:metal ion binding,IPR015880 (SMART); IPR007087 (PROSITE_PROFILES),,
RL4_JR_05355,1178,1264,1337,1,0,12,0,0,0,0,0,0,0,1,0,0,0,0,2735.754978,1,-3.295811346,1.052380616,-3.131767438,0.001737575,0.009295169,811.1379275,0,-6.198276019,1.444744048,-4.290224299,1.78E-05,0.001081858,2167.356401,0,-4.747133662,1.007549769,-4.711562454,2.46E-06,5.75E-05,2497.778943,1,-4.668333988,0.868192296,-5.377073733,7.57E-08,1.76E-06,2132.062113,0,-4.518228999,1.163705317,-3.882622975,0.000103336,0.000711751,N,-,,S-(hydroxymethyl)glutathione dehydrogenase,C:nucleus; P:furaldehyde metabolic process; F:zinc ion binding; P:formaldehyde catabolic process; P:amino acid catabolic process to alcohol via Ehrlich pathway; F:S-(hydroxymethyl)glutathione dehydrogenase activity; C:cytosol; P:ethanol oxidation; F:alcohol dehydrogenase (NAD) activity; F:hydroxymethylfurfural reductase (NADH) activity,IPR020843 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); IPR014183 (TIGRFAM); IPR013154 (PFAM); IPR013149 (PFAM); IPR002085 (PANTHER); PTHR11695:SF269 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_05356,339,585,508,0,1,3,0,0,0,0,0,0,0,0,0,0,2,0,419.7014636,1,-0.3224917,0.887725531,-0.363278614,0.716396767,0.847992575,92.01289595,0,-1.104085875,1.030199607,-1.071720342,0.283845661,0.443228864,220.5619845,0,-2.549326296,0.803992745,-3.170832464,0.001520028,0.007952848,284.0038773,0,-1.954994462,0.671074229,-2.913231318,0.003577095,0.021456214,209.1133851,1,-2.348393314,0.744526942,-3.154208639,0.00160934,0.00709076,N,-, Effector probability:0.891,an1-type zinc finger,F:zinc ion binding; P:cellular response to arsenic-containing substance; C:cytosol,IPR000058 (SMART); IPR000058 (G3DSA:4.10.1110.GENE3D); IPR000058 (PFAM); PTHR14677:SF16 (PANTHER); PTHR14677 (PANTHER); IPR000058 (PROSITE_PROFILES); SSF118310 (SUPERFAMILY),9.B.104.1.8, the rhomboid protease (rhomboid) family.
RL4_JR_05357,6,9,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41.1651876,0,1.841158879,0.758166166,2.428437144,0.015164053,0.052904287,2.242936539,0,2.3000778,1.302393573,1.766038967,0.077389312,0.166136715,27.97946092,0,1.476541869,1.037936055,1.422574986,0.1548594,0.268596293,34.99795666,0,1.560926259,0.858025948,1.819206357,0.068879953,0.149005685,13.14149829,0,0.493609102,1.138130086,0.433701831,0.664504977,0.761098743,N,-,,dna repair ntg1,"F:5-formyluracil DNA N-glycosylase activity; C:nucleus; F:DNA binding; F:metal ion binding; P:base-excision repair, AP site formation; C:mitochondrion; F:5-hydroxymethyluracil DNA N-glycosylase activity; F:8-oxo-7,8-dihydroguanine DNA N-glycosylase activity; F:4 iron, 4 sulfur cluster binding",IPR003265 (SMART); IPR000445 (PFAM); IPR011257 (G3DSA:1.10.340.GENE3D); IPR023170 (G3DSA:1.10.1670.GENE3D); IPR003265 (PFAM); PTHR10359:SF16 (PANTHER); PTHR10359 (PANTHER); IPR030841 (HAMAP); IPR011257 (SUPERFAMILY),,
RL4_JR_05358,2,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.06360118,0,-3.530788726,1.1998867,-2.942601769,0.003254668,0.015388595,23.11791058,0,0.601454236,1.126407115,0.533958129,0.593370503,0.72995822,48.68804667,0,-1.151268627,1.043791329,-1.102968184,0.270040982,0.408409755,74.87888461,0,0.110164236,0.607698349,0.181281118,0.856146926,0.910268574,84.03336335,0,0.732039923,0.553758595,1.321947739,0.186185554,0.305135762,N,-,,lipid particle,C:lipid particle; F:lysophospholipase activity; C:membrane; P:cellular lipid metabolic process,IPR007751 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR12482 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_05359,5266,2377,2634,2,1,5,0,0,0,0,0,0,0,1,0,0,1,0,71.55735328,1,-4.263390568,1.212377761,-3.51655293,0.000437189,0.003009782,32.22714617,0,-0.132813453,1.132894008,-0.117233785,0.906674795,0.947780881,83.41337284,0,-1.295224121,0.875369804,-1.479630798,0.138971803,0.247789808,68.46179634,1,-4.124434575,1.210341538,-3.40766176,0.000655221,0.005207307,73.38909189,1,-2.087841406,0.996871236,-2.094394271,0.036224873,0.0871148,N,-,,RNA exonuclease,F:nucleic acid binding; P:nucleic acid phosphodiester bond hydrolysis; P:ncRNA 3'-end processing; F:exonuclease activity,IPR013520 (SMART); IPR012337 (G3DSA:3.30.420.GENE3D); PTHR12801:SF51 (PANTHER); PTHR12801 (PANTHER); PTHR12801 (PANTHER); PTHR12801:SF51 (PANTHER); IPR012337 (SUPERFAMILY),,
RL4_JR_05360,119310,83898,43969,1,13,4,3,0,1,1,1,4,3,7,4,0,13,0,158.5514261,1,-2.239205712,0.736923623,-3.038585875,0.002376913,0.01202907,66.48417683,1,-1.075687821,1.114402865,-0.965259382,0.334414911,0.497700827,115.1450092,1,-4.658328594,1.202301262,-3.874510276,0.000106839,0.001215327,204.1512117,1,-0.891568706,0.502157459,-1.775476377,0.075819263,0.160031277,129.4919086,1,-2.165948667,0.79913157,-2.710378051,0.006720656,0.022857454,N,-,,SPFH domain Band 7 family,P:mitochondrion inheritance; P:mitochondrion morphogenesis; P:negative regulation of proteolysis; P:protein folding; P:inner mitochondrial membrane organization; P:replicative cell aging; C:mitochondrial inner membrane,IPR000163 (PRINTS); IPR001107 (SMART); IPR001107 (PFAM); IPR000163 (PANTHER); IPR001107 (SUPERFAMILY),8.A.21.2.3, the stomatin/podocin/band 7/nephrosis.2/spfh (stomatin) family.
RL4_JR_05361,3453,1493,5142,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,347.1882884,0,0.051974565,0.7814597,0.066509591,0.946972122,0.973563316,65.49020343,0,-1.427423927,1.112014555,-1.283637809,0.199268714,0.342851933,284.2934864,1,-0.236599661,0.454398641,-0.520687431,0.602584531,0.720510901,290.7083834,1,-0.3390796,0.402673554,-0.842070697,0.399748382,0.544006347,160.2585371,0,-2.507887885,0.794624305,-3.156067425,0.001599119,0.007048794,N,-, Effector probability:0.806,family,"F:ubiquinol-cytochrome-c reductase activity; P:hydrogen ion transmembrane transport; C:mitochondrial respiratory chain complex III; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:aerobic respiration",IPR004205 (PFAM); IPR004205 (G3DSA:1.20.5.GENE3D); PTHR12119:SF2 (PANTHER); IPR004205 (PANTHER); IPR004205 (PRODOM); IPR004205 (SUPERFAMILY),,
RL4_JR_05362,2572,1246,2429,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,517.423254,0,-1.106528404,0.671292114,-1.64835603,0.099279633,0.220267405,145.2823955,0,-1.706248605,0.991903619,-1.720175804,0.08540049,0.179043861,349.5205886,1,-2.213353026,0.57257539,-3.865609778,0.000110812,0.001235706,389.8769512,0,-2.333859637,0.541066692,-4.31344171,1.61E-05,0.000215838,438.9191252,0,-0.969955432,0.452148933,-2.145212252,0.03193588,0.079058873,N,-,,TATA-box-binding,"F:RNA polymerase II core promoter sequence-specific DNA binding; F:DNA binding, bending; P:regulation of transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript; F:chromatin binding; C:transcription factor TFIIIB complex; P:translational initiation; F:transcription factor activity, RNA polymerase II core promoter sequence-specific; F:RNA polymerase III regulatory region DNA binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase I transcription factor binding; P:regulation of transcription from RNA polymerase II promoter; C:RNA polymerase transcription factor SL1 complex; F:translation initiation factor activity; P:RNA polymerase II transcriptional preinitiation complex assembly; C:transcription factor TFIID complex; F:transcription factor activity, RNA polymerase I transcription factor recruiting; P:transposon integration; P:transcription of nuclear large rRNA transcript from RNA polymerase I promoter; C:integral component of membrane; P:RNA polymerase III transcriptional preinitiation complex assembly",IPR000814 (PRINTS); IPR000814 (PFAM); IPR012295 (G3DSA:3.30.310.GENE3D); IPR000814 (PANTHER); IPR000814 (HAMAP); SSF55945 (SUPERFAMILY); SSF55945 (SUPERFAMILY),,
RL4_JR_05363,7381,3820,9685,0,1,0,0,0,0,0,0,0,0,3,0,0,0,0,391.513895,1,-2.550368757,0.595824658,-4.280401497,1.87E-05,0.000198168,108.5666948,0,-3.296925254,1.20553936,-2.734813449,0.006241564,0.023885485,289.3620493,0,-4.993176705,1.210677395,-4.124283418,3.72E-05,0.000565319,367.037105,1,-3.055841597,0.65605577,-4.657899126,3.19E-06,5.14E-05,310.7279991,0,-2.568417058,0.708614469,-3.624561975,0.000289452,0.001700927,N,-,,h aca ribonucleo complex subunit 2,C:intracellular ribonucleoprotein complex; P:ncRNA metabolic process; C:viral nucleocapsid; P:ribosome biogenesis,IPR029064 (G3DSA:3.30.1330.GENE3D); IPR004038 (PFAM); PTHR23105:SF61 (PANTHER); PTHR23105 (PANTHER); IPR029064 (SUPERFAMILY),,
RL4_JR_05364,7173,5503,10631,2,4,4,0,0,0,0,0,0,0,0,0,0,0,0,47.2819681,1,-0.550424313,0.910933903,-0.604241769,0.545682915,0.725807082,8.697345097,0,0.344948629,1.260033361,0.273761505,0.784267909,0.869397316,36.9609357,0,-0.492147285,1.066258436,-0.461564727,0.644393494,0.752419452,47.77092759,0,-0.027694622,0.804536813,-0.034423064,0.972539792,0.984647651,29.67783301,0,-1.452326552,1.158010279,-1.254156873,0.209784992,0.333031207,N,-,,duf1761 domain containing,P:mycelium development; C:cytoplasm; C:integral component of membrane,IPR013879 (PFAM); PTHR40638 (PANTHER),,
RL4_JR_05365,37071,26861,35418,2,1,3,0,0,1,5,1,5,0,1,0,0,4,1,210.8923757,1,-1.894973214,0.596056581,-3.179183443,0.001476906,0.008119002,52.41779229,1,-2.246460567,1.204130507,-1.865628812,0.062093316,0.140073221,204.741088,1,-0.902048023,0.551625096,-1.635255591,0.101995479,0.196532541,230.77337,1,-1.369037782,0.531569033,-2.575465644,0.010010522,0.048612246,144.744322,1,-2.772750223,0.856906108,-3.235769004,0.001213155,0.005601093,N,-,,NIF domain,C:intracellular membrane-bounded organelle; C:nuclear outer membrane-endoplasmic reticulum membrane network; C:cytoplasmic part; P:single-organism cellular process; C:membrane part,IPR004274 (SMART); IPR023214 (G3DSA:3.40.50.GENE3D); IPR011948 (TIGRFAM); IPR004274 (PFAM); PTHR12210:SF70 (PANTHER); PTHR12210 (PANTHER); IPR004274 (PROSITE_PROFILES); IPR023214 (SUPERFAMILY),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_05366,926,1107,1018,0,1,0,0,0,0,0,0,3,0,5,0,0,0,4,29.08371173,1,0.454115115,0.874024075,0.519568199,0.603364568,0.77127047,4.329986936,0,1.351191172,1.282455628,1.053596821,0.292067545,0.451007035,17.66941277,1,-0.330874448,1.20821241,-0.273854535,0.784196412,0.857166683,16.89309148,1,-0.768528243,1.162807881,-0.660924522,0.508660719,0.644183084,10.95777372,1,-1.367762267,1.21012899,-1.130261549,0.258366032,0.390091868,N,-,,MFS multidrug transporter,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF8 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.52, the major facilitator superfamily (mfs).
RL4_JR_05367,2870,2464,2593,0,0,17,0,0,0,0,0,0,3,2,0,0,0,0,30.60887242,1,-0.895333294,1.009462874,-0.88694029,0.375111049,0.566938992,7.358746954,0,0.5860668,1.230792118,0.47617042,0.633952971,0.76056323,42.58224936,0,0.346127144,0.852994908,0.405778676,0.684905228,0.783500625,38.02321432,1,0.22774021,0.749673988,0.303785664,0.761291189,0.844165293,18.75498908,0,-2.143032032,1.194452133,-1.794154803,0.072788464,0.149307779,N,-,,Transcription fungi,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR015880 (SMART); IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR001138 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY); SSF57667 (SUPERFAMILY),,
RL4_JR_05368,1905,1583,1926,0,0,11,0,0,0,0,0,4,6,3,0,0,0,1,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_05369,3358,2795,3366,0,0,6,0,0,0,0,0,4,0,7,3,0,3,3,508.3084845,1,1.726035963,1.229575402,1.403765853,0.160388585,0.310141058,37.95879963,0,-1.780835432,1.24695072,-1.428152215,0.153248051,0.281061202,119.6956687,1,-2.568376554,1.073972406,-2.391473505,0.016780895,0.048734877,112.4664171,1,-4.840531222,1.237310185,-3.912140448,9.15E-05,0.000993833,122.3849858,1,-1.187715619,0.726460598,-1.634934671,0.102062743,0.193953693,N,-,,oxidoreductase -,,IPR008030 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR14194:SF62 (PANTHER); PTHR14194 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_05370,1581,1685,2091,1,1,0,0,0,0,0,5,0,1,1,0,0,2,0,194.4042461,1,-1.349418412,0.523730465,-2.576551302,0.00997914,0.037829842,45.33909408,0,-2.037146806,1.203713069,-1.692385717,0.090572454,0.187556133,124.9483835,1,-3.720869236,1.194440227,-3.115157336,0.001838468,0.009264635,247.2771791,1,-0.283737154,0.402680346,-0.704621313,0.481045931,0.621511805,157.3465122,1,-0.790320566,0.562907961,-1.403996071,0.16032002,0.271981883,N,-,,msp domain-containing,P:mycelium development; C:membrane,IPR016763 (PIRSF); IPR008962 (G3DSA:2.60.40.GENE3D); IPR000535 (PFAM); IPR016763 (PANTHER); PTHR10809:SF6 (PANTHER); IPR000535 (PROSITE_PROFILES); IPR008962 (SUPERFAMILY),1.R.1.1.1, the membrane contact site (mcs) family.
RL4_JR_05371,726,800,1163,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,104.0148958,1,0.952756257,0.485054086,1.964226847,0.049503791,0.13171948,51.87238687,0,0.631872371,1.119428893,0.564459587,0.572441396,0.712612448,71.49259218,0,0.202275904,0.676034495,0.299209442,0.764780245,0.841956851,44.3391203,0,-2.413888489,1.14676676,-2.104951568,0.035295524,0.099766434,78.85106568,0,0.432314129,0.57503026,0.751811094,0.452164669,0.584130447,N,-,,UBA TS-N domain-containing,C:nucleus; F:metal ion binding; C:cytosol,IPR015940 (SMART); IPR015940 (PFAM); G3DSA:1.10.8.10 (GENE3D); IPR001012 (PFAM); G3DSA:3.10.20.90 (GENE3D); PTHR13020 (PANTHER); IPR015940 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR001012 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY); IPR009060 (SUPERFAMILY),,
RL4_JR_05372,1046,985,1416,0,0,0,0,0,2,0,0,0,0,1,0,0,4,0,557.7990142,0,-0.95600478,0.622037885,-1.536891568,0.124319865,0.259055289,205.0556831,1,0.252784391,0.566467963,0.44624658,0.655419139,0.778017184,381.6978908,0,-2.452293275,0.587951382,-4.170911661,3.03E-05,0.000476194,491.0420766,1,-1.283415312,0.613313141,-2.09259386,0.036385425,0.101265099,417.0511546,1,-1.206297359,0.569866936,-2.116805315,0.034276374,0.083445128,N,-,,60S acidic ribosomal p1,"F:structural constituent of ribosome; F:protein kinase activator activity; P:cytoplasmic translation; P:activation of protein kinase activity; C:cytosolic large ribosomal subunit; F:large ribosomal subunit rRNA binding; P:translational elongation; C:preribosome, large subunit precursor",PF00428 (PFAM); PTHR21141 (PANTHER); IPR027534 (HAMAP),,
RL4_JR_05373,2230,2452,3591,0,0,2,0,0,0,0,0,1,1,4,0,0,2,0,263.3830685,1,0.159877364,0.479171013,0.333654082,0.738640603,0.862613513,78.99932296,0,0.625223631,0.846076734,0.738967998,0.45992643,0.618736752,270.6366337,1,0.605823985,0.469094896,1.291474261,0.196539275,0.321396158,213.8020331,1,-0.301710904,0.528095556,-0.571318771,0.56778358,0.694972044,134.1128686,1,-1.432286704,0.697668556,-2.052961527,0.040076309,0.094321857,N,-,,family UPF0662,C:nucleus; C:cytosol,IPR008207 (G3DSA:1.20.120.GENE3D); IPR018810 (PFAM); PTHR28086 (PANTHER); PTHR28086:SF1 (PANTHER),,
RL4_JR_05374,3633,3528,5580,2,2,0,0,0,0,0,0,3,0,0,1,0,0,0,55.4816524,1,1.211917441,0.703358137,1.7230446,0.08488046,0.196441076,6.711499163,0,0.718904748,1.258942748,0.571038476,0.567973562,0.709318741,17.42334849,1,-1.933904079,1.213858553,-1.59318734,0.11111817,0.209841514,29.73804981,1,-1.40408489,1.166908765,-1.203251643,0.228878956,0.365289947,28.73955785,0,0.168760671,0.886976838,0.190265025,0.849101459,0.899660137,N,-, Effector probability:0.754,Dimeric alpha-beta barrel,F:metal ion binding,IPR005545 (PFAM); G3DSA:3.30.70.1060 (GENE3D); PTHR33606 (PANTHER); PTHR33606:SF2 (PANTHER); IPR011008 (SUPERFAMILY),,
RL4_JR_05375,598,860,645,0,1,4,0,0,0,0,1,3,0,3,0,0,0,0,441.0241975,1,-0.210137648,0.343432356,-0.611874927,0.540620512,0.722539668,143.6400159,0,-0.196215097,0.747379724,-0.262537356,0.792907189,0.874556671,380.2963655,1,-0.078251134,0.384461114,-0.203534587,0.838717215,0.896166025,495.2882637,1,0.200419476,0.300444148,0.667077317,0.504722748,0.641516172,289.5133049,0,-0.726007335,0.488853705,-1.485121881,0.137511541,0.242942654,N,-,,cytochrome b-c1 complex subunit 7,"F:ubiquinol-cytochrome-c reductase activity; P:mitochondrial respiratory chain complex III assembly; P:hydrogen ion transmembrane transport; C:mitochondrial respiratory chain complex III; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:aerobic respiration",IPR003197 (G3DSA:1.10.1090.GENE3D); IPR003197 (PFAM); IPR003197 (PIRSF); IPR003197 (PANTHER); IPR003197 (PRODOM); IPR003197 (SUPERFAMILY),,
RL4_JR_05376,1011,799,894,0,0,2,0,0,0,0,0,1,0,3,0,0,0,0,78.58225221,1,0.130364028,0.570166993,0.228641835,0.819147306,0.908258855,60.99889732,0,2.530794854,0.717184024,3.528794243,0.000417458,0.015023052,57.24252018,1,-0.59428727,0.863220207,-0.688453844,0.491167027,0.624930876,78.90866202,1,-0.354166427,0.684823574,-0.517164479,0.605041346,0.725748564,69.37273156,0,0.140128929,0.625194801,0.224136427,0.822651149,0.881225442,N,-,,mannan polymerase II complex ANP1 subunit,C:integral component of membrane; P:vacuolar transport; F:transferase activity; C:intracellular,PF03452 (PFAM); PTHR24319:SF31 (PANTHER); PTHR24319 (PANTHER); IPR029044 (SUPERFAMILY),,
RL4_JR_05377,2952,2894,2836,0,0,2,0,0,1,0,2,2,0,7,0,0,0,0,3.676920284,1,0.019212968,1.241634888,0.015473927,0.987654085,0.993857747,68.10083373,1,5.472905573,0.852751027,6.417940757,1.38E-10,2.69E-08,3.035924641,1,0.586714335,1.219787685,0.480997097,0.630518562,0.741390235,3.503307387,1,0.16399511,1.224798156,0.133895621,0.893485113,0.934559584,3.005373513,0,0.498846633,1.22335397,0.407769661,0.68344279,0.775247395,N,-,,#NAME?,P:base-excision repair; F:catalytic activity,IPR003265 (SMART); IPR003265 (PFAM); IPR011257 (G3DSA:1.10.340.GENE3D); IPR023170 (G3DSA:1.10.1670.GENE3D); PTHR10242 (PANTHER); PTHR10242:SF0 (PANTHER); PTHR10242 (PANTHER); PTHR10242:SF0 (PANTHER); IPR011257 (SUPERFAMILY),,
RL4_JR_05378,11725,7889,11560,0,3,4,0,0,2,2,0,0,0,0,0,6,2,3,866.5788854,1,2.279703725,0.731694039,3.115651631,0.00183539,0.009767194,57.2101058,1,-1.196471871,1.104479341,-1.083290403,0.278679544,0.437671736,534.3135701,1,1.786074593,0.440169577,4.057696593,4.96E-05,0.000719851,559.1802913,0,1.621316707,0.497440768,3.259316105,0.001116812,0.008088496,439.1754463,1,1.478208121,0.80418497,1.838144429,0.066041126,0.138853687,Y,-,,GPI-anchored cell wall organization ecm33,C:fungal-type cell wall; C:cytosol; P:intracellular signal transduction; C:cell surface,PTHR31018 (PANTHER); IPR032675 (SUPERFAMILY); IPR032675 (SUPERFAMILY),,
RL4_JR_05379,80,69,100,2,2,2,0,0,0,0,0,0,0,2,0,0,0,0,21.36830116,1,0.379482616,1.031815772,0.367781368,0.713036263,0.845486894,69.96048901,0,4.099506001,0.854604066,4.79696524,1.61E-06,0.000135877,14.38540384,0,0.171155232,1.206031229,0.141916086,0.887146288,0.930047532,27.72522519,1,0.540680769,1.030750996,0.524550324,0.599895828,0.722159203,7.820098274,0,-0.880944849,1.220389517,-0.721855471,0.470383341,0.601727666,N,-,,g-patch DNA repair,F:nucleic acid binding,IPR000467 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000467 (PFAM); PTHR13288 (PANTHER); PTHR13288:SF8 (PANTHER); PTHR13288:SF8 (PANTHER); PTHR13288 (PANTHER); IPR000467 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_05380,2167,1250,1944,0,0,2,0,0,2,0,1,0,0,7,0,0,6,0,144.1326132,1,2.303955145,0.469490219,4.907354939,9.23E-07,1.42E-05,8.749250937,1,0.336394043,1.231776534,0.273096649,0.784778923,0.869397316,35.66627766,1,-0.495736819,1.041448595,-0.476006998,0.634069393,0.744460716,61.14470904,1,0.569551437,0.632997969,0.89976819,0.368243626,0.514555163,30.01167364,1,-0.72625605,0.983765475,-0.738241042,0.460367987,0.591751411,N,-,,peroxisomal-coenzyme A synthetase,F:catalytic activity; P:metabolic process; C:cytosol,G3DSA:3.40.50.980 (GENE3D); G3DSA:2.30.38.10 (GENE3D); G3DSA:3.30.300.30 (GENE3D); IPR025110 (PFAM); IPR000873 (PFAM); G3DSA:3.40.50.980 (GENE3D); PTHR24095 (PANTHER); PTHR24095:SF171 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.6, the fatty acid transporter (fat) family.
RL4_JR_05381,1123,1098,756,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,135.35037,1,-4.194734438,1.153324325,-3.637081389,0.000275745,0.002024776,41.79220952,0,-1.919669943,1.194104901,-1.607622531,0.107917875,0.214563882,108.7578626,0,-4.576002791,1.194096528,-3.83218834,0.000127008,0.00133713,145.5457465,0,-1.975733485,0.687247574,-2.874849706,0.004042199,0.023684757,107.5777066,0,-4.663015434,1.202493069,-3.877789863,0.00010541,0.000722106,N,-,,eukaryotic porin,F:protein channel activity; P:protein import into mitochondrial matrix; C:mitochondrial outer membrane translocase complex,IPR027246 (PFAM); IPR023614 (G3DSA:2.40.160.GENE3D); PTHR10802:SF2 (PANTHER); PTHR10802 (PANTHER),1.B.8.2.1, the mitochondrial and plastid porin (mpp) family.
RL4_JR_05382,19,50,40,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,79.07734568,0,-0.847270612,0.738889459,-1.146681145,0.251513426,0.428718455,52.76841195,0,0.538542152,1.115847595,0.482630562,0.629358075,0.756515326,37.30347454,0,-3.032225471,1.191446972,-2.544994063,0.01092796,0.035133269,65.66013855,0,-1.132356663,0.8514778,-1.329872208,0.18356038,0.310275266,52.07208466,0,-0.494183748,0.743159261,-0.664976909,0.506065263,0.633050504,N,-,,6-phosphofructo-2-kinase,"F:ATP binding; P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:carbohydrate phosphorylation; F:6-phosphofructo-2-kinase activity",IPR003094 (PRINTS); IPR013079 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR029033 (G3DSA:3.40.50.GENE3D); IPR013078 (PFAM); PTHR10606:SF39 (PANTHER); IPR003094 (PANTHER); IPR027417 (SUPERFAMILY); IPR029033 (SUPERFAMILY),,
RL4_JR_05383,38,51,69,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,60.37129489,0,-0.572505534,0.743777518,-0.769726861,0.441461933,0.631411026,30.53852141,0,1.54357164,1.000905388,1.542175372,0.123030983,0.237792555,122.3166497,0,1.421675962,0.494776704,2.873368837,0.004061197,0.016552156,51.15450469,0,-0.449942787,0.752647639,-0.597813324,0.549964499,0.679154842,60.0458387,0,0.390885768,0.614102623,0.636515386,0.524440556,0.648366426,N,-,,delta24(24(1))-sterol reductase,"P:ascospore formation; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; P:cellular response to cation stress; P:protein insertion into membrane raft; P:establishment of protein localization to plasma membrane; C:integral component of membrane; P:ergosterol biosynthetic process; P:oxidation-reduction process; P:endocytosis; P:protein targeting to vacuole; C:intracellular",IPR001171 (PFAM); PTHR21257 (PANTHER); PTHR21257 (PANTHER); PTHR21257:SF31 (PANTHER),,
RL4_JR_05384,538,643,789,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,257.6524225,1,0.283389158,0.563852574,0.502594421,0.615249453,0.779137695,37.67258775,0,-1.769934004,1.194093748,-1.482240408,0.138276338,0.25938345,110.9123406,0,-2.604928213,1.034261945,-2.518634883,0.011781075,0.036653843,277.0514429,0,0.386114325,0.37073557,1.041481737,0.297652025,0.442766856,122.628456,0,-1.868783901,0.756775828,-2.469402208,0.0135339,0.039985627,N,-,,vacuolar atp synthase 16 kda proteolipid subunit,"P:cellular iron ion homeostasis; C:vacuolar proton-transporting V-type ATPase, V0 domain; P:cellular copper ion homeostasis; P:ATP hydrolysis coupled proton transport; P:vacuole organization; C:integral component of membrane; C:endoplasmic reticulum; F:proton-transporting ATPase activity, rotational mechanism; P:vacuolar acidification; P:endocytosis; P:protein targeting to vacuole",IPR000245 (PRINTS); G3DSA:1.20.120.610 (GENE3D); IPR011555 (TIGRFAM); IPR002379 (PFAM); PTHR10263 (PANTHER); MF_01396 (HAMAP); IPR002379 (SUPERFAMILY),3.A.2.2.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_05385,575,499,705,1,0,11,0,0,0,0,0,2,0,1,0,0,0,0,139.1147902,1,-1.092082583,0.636395814,-1.716043001,0.086154172,0.198656229,26.35710211,0,-1.25461459,1.194519867,-1.050308684,0.293576214,0.452846455,84.17752878,1,-2.084630403,1.030909002,-2.02212843,0.043163086,0.101083294,104.7039552,1,-1.289916892,0.671788661,-1.920123048,0.054842359,0.12958667,67.61947636,0,-3.993139768,1.194542856,-3.34281834,0.000829322,0.004112087,N,-,,phosphoinositide phosphatase,F:phosphoric ester hydrolase activity,IPR002013 (PFAM); IPR022158 (PFAM); PTHR11200 (PANTHER); PTHR11200:SF11 (PANTHER); PTHR11200:SF11 (PANTHER); PTHR11200:SF11 (PANTHER); PTHR11200 (PANTHER); PTHR11200 (PANTHER); IPR002013 (PROSITE_PROFILES),,
RL4_JR_05386,205,168,132,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.66206551,0,-2.471103417,1.14271743,-2.162479851,0.030581209,0.091856222,12.72220956,0,-0.203778229,1.210411925,-0.168354446,0.866304443,0.922091327,133.361745,0,1.663250699,0.439179364,3.787178622,0.000152368,0.00149764,67.45564033,0,0.019879649,0.622238006,0.031948626,0.974513021,0.98517231,36.43627396,0,-2.009558413,1.125827925,-1.784960533,0.074267719,0.15160497,N,-,,25S rRNA (uridine(2843)-N(3))-methyltransferase,F:rRNA (uridine-N3-)-methyltransferase activity; C:cytoplasm; P:rRNA base methylation,IPR021463 (PFAM),,
RL4_JR_05387,891,616,567,0,0,0,0,0,0,2,0,0,0,3,0,0,0,0,3096.860386,0,1.339225747,0.52624406,2.544875749,0.010931663,0.040684537,553.6780978,0,0.289138232,0.457545308,0.631933553,0.527430298,0.676116651,1069.755667,1,-1.059311953,0.306760293,-3.453223828,0.000553929,0.003650343,1214.651804,1,-1.14070861,0.257395104,-4.431741673,9.35E-06,0.000133489,834.7858717,0,-2.371614543,0.521981878,-4.543480611,5.53E-06,6.17E-05,N,-,,transketolase,C:nucleus; F:transketolase activity; F:metal ion binding; P:metabolic process; C:cytosol,IPR005475 (SMART); IPR005475 (PFAM); IPR005474 (PFAM); IPR005478 (TIGRFAM); IPR009014 (G3DSA:3.40.50.GENE3D); IPR029061 (G3DSA:3.40.50.GENE3D); IPR033248 (PFAM); IPR029061 (G3DSA:3.40.50.GENE3D); IPR033247 (PANTHER); PTHR11624:SF60 (PANTHER); PTHR11624:SF60 (PANTHER); IPR009014 (SUPERFAMILY); IPR029061 (SUPERFAMILY); IPR029061 (SUPERFAMILY),,
RL4_JR_05388,448,309,309,0,0,0,0,0,0,0,0,1,0,7,0,0,0,0,16.71821899,0,-0.843727806,1.141165903,-0.739355955,0.45969088,0.648031484,4.130408395,0,1.419283914,1.256643442,1.129424518,0.258718795,0.414621856,10.68627545,1,-1.228592341,1.193481634,-1.029418724,0.303282954,0.444768644,21.63831329,1,-0.701288587,1.141853208,-0.614167024,0.539104962,0.670415463,29.09193024,0,0.914002794,0.834237591,1.095614491,0.273247517,0.406200428,N,-,,hypothetical protein CMQ_6122,,no IPS match,,
RL4_JR_05389,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32.46864966,0,-1.99486703,1.137881877,-1.753140699,0.079577859,0.187358203,9.180664098,0,0.266955315,1.221413398,0.218562622,0.826990772,0.896231327,45.93335908,0,0.026476975,0.848908777,0.031189423,0.975118475,0.985851408,67.5079543,0,1.197602028,0.509206932,2.351896554,0.018677969,0.074366666,45.43583344,0,-0.2334507,0.831157478,-0.28087421,0.778806882,0.847621163,N,-,,m repeat,,no IPS match,,
RL4_JR_05390,3451,3209,5754,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35.41906071,0,0.24906608,0.792323914,0.314348811,0.75325613,0.870775614,6.451344628,0,0.775893253,1.260575793,0.615507022,0.538219933,0.685351889,23.22390042,0,-0.913247699,1.210739458,-0.754289202,0.450675585,0.590174573,23.30347433,0,-1.351512708,1.166292301,-1.158811309,0.246533107,0.385207979,16.5009763,0,-1.958305259,1.218996988,-1.606489005,0.108166509,0.202474746,N,-,,Guanine nucleotide-binding alpha-2 subunit,F:GTP binding; F:G-protein coupled receptor binding; C:heterotrimeric G-protein complex; P:G-protein coupled receptor signaling pathway; F:GTPase activity; F:G-protein beta/gamma-subunit complex binding; F:signal transducer activity,IPR001019 (PRINTS); IPR002975 (PRINTS); IPR001019 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001019 (PFAM); IPR011025 (G3DSA:1.10.400.GENE3D); IPR001019 (PANTHER); PTHR10218:SF121 (PANTHER); IPR027417 (SUPERFAMILY); IPR011025 (SUPERFAMILY),8.A.92.1.1,The G-Protein αβγ Complex (GPC) Family
RL4_JR_05391,1245,1969,2003,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,178.6285702,0,-1.523303544,0.772512965,-1.971880879,0.048623207,0.129969895,42.29214628,0,-1.936802297,1.260136997,-1.536977568,0.124298803,0.239465642,142.9751589,0,-1.473658296,0.777060822,-1.896451671,0.057900345,0.126550754,125.8424134,1,-5.002659738,1.256941897,-3.980024653,6.89E-05,0.000781293,129.3564866,1,-2.367345484,0.94327342,-2.509712914,0.012082935,0.036606738,N,-,,glycoside hydrolase family 3,C:membrane; F:beta-glucosidase activity; P:cellulose catabolic process; F:scopolin beta-glucosidase activity,IPR001764 (PRINTS); IPR026891 (SMART); IPR002772 (G3DSA:3.40.50.GENE3D); IPR001764 (PFAM); IPR026891 (PFAM); IPR002772 (PFAM); IPR001764 (G3DSA:3.20.20.GENE3D); PTHR30620:SF32 (PANTHER); IPR026892 (PANTHER); IPR002772 (SUPERFAMILY); IPR017853 (SUPERFAMILY),,
RL4_JR_05392,938,1827,1324,0,0,3,0,0,0,0,0,0,0,1,0,0,0,0,4.6243845,1,-0.311702174,1.21837643,-0.255834048,0.798078982,0.897412589,1.488835503,0,2.891400078,1.368517958,2.112796592,0.034618182,0.088460201,3.841694214,0,0.247286127,1.216046837,0.20335247,0.838859547,0.896223518,23.05474854,1,1.576883251,1.027172563,1.535168782,0.124742375,0.231194681,3.767750872,0,0.172304232,1.209282656,0.142484664,0.886697193,0.92545192,N,-,,---NA---,,no IPS match,,
RL4_JR_05393,131,146,132,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30.21886082,0,-0.040003388,0.871036778,-0.045926175,0.963369092,0.981414217,6.043411183,0,0.870208652,1.258180327,0.691640645,0.48916303,0.645037545,31.26930359,0,0.051682459,1.044275166,0.049491227,0.960527829,0.976995355,17.97024947,0,-2.194679891,1.203113212,-1.824167392,0.06812677,0.148213052,15.26696561,0,-1.846188389,1.200716137,-1.53757273,0.124153119,0.224673875,N,-,,hypothetical protein CMQ_5971,,IPR029191 (PFAM),,
RL4_JR_05394,65,86,95,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,92.31914927,0,0.592555859,0.780556265,0.759145606,0.44776546,0.636721392,13.67999889,0,-0.308448741,1.211370006,-0.254628015,0.799010419,0.878023957,35.38512187,0,-2.956066558,1.189387666,-2.485368432,0.012941742,0.03960872,66.17182775,0,-0.335384554,0.668431313,-0.501748717,0.615844291,0.73478947,56.87333029,0,-0.808290197,0.831862678,-0.971663015,0.331218222,0.4679903,N,-,,leukotriene a-4 hydrolase,C:nucleus; F:zinc ion binding; P:peptide catabolic process; C:cytoplasm; P:proteolysis; F:metalloaminopeptidase activity; P:cellular lipid metabolic process; F:leukotriene-A4 hydrolase activity; F:peptide binding; C:plasma membrane; F:epoxide hydrolase activity,IPR014782 (PRINTS); IPR015211 (SMART); IPR014782 (PFAM); G3DSA:1.10.390.10 (GENE3D); IPR015211 (PFAM); IPR001930 (PANTHER); PTHR11533:SF174 (PANTHER); IPR016024 (SUPERFAMILY); SSF55486 (SUPERFAMILY); SSF63737 (SUPERFAMILY),,
RL4_JR_05395,3671,2772,2412,1,0,9,0,0,0,0,3,1,5,1,0,0,2,2,5.5103526,1,-0.564386623,1.20939344,-0.466669162,0.640736596,0.79572677,1.771616467,0,2.640538723,1.342602907,1.966730973,0.049214234,0.116335002,4.5718939,1,-0.003634468,1.209914099,-0.003003906,0.997603234,0.999239715,14.90782368,1,0.525158206,1.152533613,0.455655436,0.648637773,0.759155872,11.84665797,1,0.857432182,1.127119959,0.760728417,0.446819298,0.579337353,N,-,,signal sequence receptor alpha subunit,,no IPS match,,
RL4_JR_05396,760,541,530,0,0,5,0,0,0,0,0,5,0,0,2,0,0,1,157.3317369,1,1.172605494,0.679385728,1.725978993,0.084351192,0.195493473,17.0952617,0,-0.629973004,1.259404547,-0.500214967,0.616923721,0.748168653,56.876419,1,-1.457282838,1.078454917,-1.35126913,0.176609237,0.296025151,79.95621812,1,-0.435173863,0.714494097,-0.609065722,0.542480877,0.673362619,76.80015316,1,0.060917009,0.654840567,0.09302571,0.925883136,0.951925949,N,-,,kinesin family,F:ATP binding; F:microtubule motor activity; P:microtubule-based movement; F:microtubule binding,IPR001752 (PRINTS); IPR001849 (SMART); IPR001752 (SMART); IPR001752 (G3DSA:3.40.850.GENE3D); IPR022164 (PFAM); IPR032405 (PFAM); IPR000253 (G3DSA:2.60.200.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR001752 (PFAM); IPR027640 (PANTHER); PTHR24115:SF521 (PANTHER); IPR027640 (PANTHER); PTHR24115:SF521 (PANTHER); IPR027640 (PANTHER); IPR001849 (PROSITE_PROFILES); IPR001752 (PROSITE_PROFILES); IPR008984 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011993 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_05397,193,265,201,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.05444283,0,-2.194468508,1.244318097,-1.763591249,0.077800822,0.184291262,5.374578038,0,1.039264047,1.285606377,0.808384328,0.418869371,0.58273871,14.07884937,0,-1.626577668,1.232864901,-1.31934786,0.187052844,0.309078341,16.25029495,0,-2.049670498,1.236351888,-1.65783748,0.097350274,0.192101252,14.0334915,0,-1.724572565,1.249963811,-1.379697996,0.16767965,0.281832081,N,-,,kinase-like domain,,no IPS match,,
RL4_JR_05398,236,266,369,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,427.7366761,0,0.050766208,0.617451523,0.082218937,0.934472615,0.967685655,85.11268416,0,-0.940901599,0.976831324,-0.963218087,0.33543809,0.498690363,235.76264,0,-1.809216639,0.623032731,-2.903886987,0.003685612,0.015684377,219.1672672,1,-2.637428507,0.681100215,-3.872306085,0.00010781,0.00113588,186.003851,0,-2.732123775,0.774416418,-3.527977601,0.000418748,0.002334726,N,-,,spermidine synthase,F:spermidine synthase activity; F:spermine synthase activity; P:spermidine biosynthetic process; C:cytosol; F:putrescine N-methyltransferase activity; P:methylation,PF01564 (PFAM); G3DSA:2.30.140.10 (GENE3D); IPR029063 (G3DSA:3.40.50.GENE3D); IPR030668 (PIRSF); IPR001045 (TIGRFAM); PTHR11558 (PANTHER); IPR030374 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),2.A.1.86.5, the major facilitator superfamily (mfs).
RL4_JR_05399,51,62,53,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,97.36537861,0,1.067904479,0.448596444,2.380546017,0.017287002,0.058372252,21.27117092,0,0.810713641,1.113380152,0.728155284,0.466518535,0.625360961,79.05303466,0,0.863655821,0.570160267,1.514759747,0.129833258,0.235645734,51.66329629,0,-0.464013751,0.742036974,-0.625324299,0.531758235,0.664861957,30.46562066,0,-2.842895222,1.192988522,-2.383002997,0.017172055,0.048390496,N,-,,nitrilase family,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; P:nitrogen compound metabolic process",IPR003010 (PFAM); IPR003010 (G3DSA:3.60.110.GENE3D); PTHR23088 (PANTHER); PTHR23088:SF30 (PANTHER); IPR003010 (PROSITE_PROFILES); IPR003010 (SUPERFAMILY),,
RL4_JR_05400,5315,4559,5356,2,0,1,0,0,1,0,1,2,4,4,0,0,4,1,3.033920305,1,0.296768171,1.257409608,0.236015511,0.813420634,0.904930541,0.971500931,1,3.507343479,1.433967427,2.445901779,0.014449036,0.04474495,2.510694157,1,0.861286079,1.227246168,0.701803845,0.482801501,0.618714835,2.895911934,1,0.439123062,1.235425678,0.355442719,0.722257951,0.814803538,17.19275869,1,2.480510684,0.986539243,2.514355817,0.011925005,0.03621496,N,-,,acyl- dehydrogenase,"F:coenzyme binding; F:oxidoreductase activity, acting on the CH-CH group of donors; P:oxidation-reduction process",IPR006091 (PFAM); G3DSA:2.40.110.10 (GENE3D); G3DSA:1.20.140.10 (GENE3D); IPR009075 (PFAM); PTHR10909 (PANTHER); PTHR10909:SF301 (PANTHER); IPR009100 (SUPERFAMILY); IPR009075 (SUPERFAMILY),,
RL4_JR_05401,332,251,404,0,0,5,0,0,0,0,0,0,0,1,0,0,0,1,5.158838629,1,-0.469366869,1.212290341,-0.387173644,0.69862766,0.837162816,1.660072651,0,2.734354273,1.352407307,2.021842279,0.043192648,0.105120459,4.282834622,0,0.090549125,1.212198722,0.074698251,0.940454799,0.964656979,35.5983108,1,2.717160035,0.686113872,3.960217315,7.49E-05,0.000834996,4.197783805,1,0.016434969,1.204760364,0.013641691,0.989115843,0.992546869,N,-,,DNA excision repair,F:ATP binding; F:helicase activity,IPR014001 (SMART); IPR001650 (SMART); IPR029256 (PFAM); IPR000330 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); PTHR10799 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_05402,28,30,26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein STCU_10868,,no IPS match,,
RL4_JR_05403,381,420,283,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,112.4769759,0,1.07279427,0.433527489,2.474570353,0.013339654,0.047688388,12.13220456,0,-0.13521977,1.214367095,-0.111349995,0.911338812,0.950652603,31.37964092,1,-2.78274678,1.189648161,-2.339134267,0.019328486,0.054401331,125.4516155,1,1.330745913,0.419159471,3.174796243,0.001499417,0.010398358,69.44231111,0,1.047764192,0.500304983,2.09425096,0.03623763,0.0871148,N,-,,GTPase-activating gyp1,C:nucleus; P:vesicle-mediated transport; C:mitochondrion; C:cytosol; C:Golgi apparatus,IPR000195 (SMART); G3DSA:1.10.8.270 (GENE3D); IPR000195 (PFAM); PTHR22957 (PANTHER); PTHR22957:SF26 (PANTHER); PTHR22957:SF26 (PANTHER); IPR000195 (PROSITE_PROFILES); IPR000195 (SUPERFAMILY); IPR000195 (SUPERFAMILY),,
RL4_JR_05404,690,671,642,0,0,1,0,0,0,3,0,0,0,0,0,0,0,0,170.5575291,1,0.889932318,0.834093794,1.066945137,0.285996611,0.469826893,18.71381702,0,-0.760567928,1.220874642,-0.622969716,0.533304423,0.681579213,48.88121653,1,-3.422258218,1.211705889,-2.824330763,0.004737946,0.018196877,56.41144291,0,-3.845128848,1.214993553,-3.164731894,0.001552259,0.010713445,94.5370961,0,0.43063482,0.619260894,0.695401284,0.486803856,0.615188348,N,-,,60S ribosomal,C:mitochondrion; C:ribosome,IPR024388 (PFAM); PTHR28266 (PANTHER),,
RL4_JR_05405,19,28,36,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,64.7232745,0,-1.957153581,1.021800273,-1.915397395,0.055441843,0.143496286,15.48645543,0,-0.487415783,1.210185082,-0.402761354,0.687123793,0.801091518,75.37190756,0,-0.314198612,0.750606884,-0.418592767,0.675513777,0.777236217,128.2998673,0,0.652563243,0.487246409,1.339287946,0.180476951,0.306004045,77.93914571,0,0.519105176,0.556428925,0.932922702,0.35085988,0.488070643,N,-,,hypothetical protein HMPREF1624_05490,P:biological_process; C:cellular_component,no IPS match,,
RL4_JR_05406,131,277,260,0,0,4,0,0,0,0,0,0,0,0,1,0,0,8,78.1123748,1,-0.96079341,0.68096145,-1.410936566,0.158263319,0.307508978,18.92951231,0,-0.777037771,1.210083604,-0.642135608,0.520785138,0.670895563,61.97392044,0,-1.606188545,1.037154945,-1.548648591,0.121466218,0.223952649,81.84704437,1,-0.809796392,0.680982982,-1.189158045,0.234377481,0.371663585,82.20990604,1,-0.085133613,0.586849512,-0.1450689,0.884656473,0.923893428,N,-,,neutral trehalase,"P:ascospore formation; C:cytoplasm; F:calcium ion binding; P:conidium formation; P:trehalose catabolic process; P:pathogenesis; F:alpha,alpha-trehalase activity",IPR001661 (PRINTS); IPR011120 (PFAM); IPR001661 (PFAM); PTHR23403:SF6 (PANTHER); IPR001661 (PANTHER); IPR001661 (PANTHER); PTHR23403:SF6 (PANTHER); PTHR23403:SF6 (PANTHER); IPR001661 (PANTHER); PTHR23403:SF6 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_05407,6005,7039,12161,1,5,6,0,0,0,0,0,2,0,1,0,0,0,0,139.3665451,1,2.658116949,0.626480527,4.242936266,2.21E-05,0.000228108,15.08434284,0,1.863539632,1.206709677,1.544314815,0.122512085,0.237278305,139.651347,1,3.050545056,0.630416643,4.838934833,1.31E-06,3.40E-05,197.2334923,1,3.503592934,0.754623699,4.642834483,3.44E-06,5.50E-05,455.272183,0,4.978647066,1.037968524,4.796529903,1.61E-06,2.15E-05,N,-,,isocitrate lyase,F:isocitrate lyase activity; P:carboxylic acid metabolic process,IPR015813 (G3DSA:3.20.20.GENE3D); IPR006254 (PFAM); IPR006254 (TIGRFAM); PTHR21631:SF13 (PANTHER); PTHR21631 (PANTHER); PTHR21631:SF13 (PANTHER); PTHR21631 (PANTHER); IPR015813 (SUPERFAMILY),,
RL4_JR_05408,290,143,328,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,48.33080099,0,0.066315239,0.661551251,0.100242028,0.920152181,0.961623962,9.369651298,0,0.237553583,1.220571652,0.194624857,0.845686642,0.907841785,45.08084852,0,-0.004914784,0.849343834,-0.005786566,0.995383014,0.998095149,98.59006315,0,1.357199545,0.466452882,2.909617667,0.003618711,0.021655188,43.13162245,0,0.446406446,0.667226154,0.669048183,0.503464743,0.630966768,N,-,,histone h1-binding,C:nucleus; P:chromosome organization; P:single-organism cellular process; P:chromatin organization; C:intracellular organelle part,IPR019544 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR15081 (PANTHER); IPR011990 (SUPERFAMILY),,
RL4_JR_05409,3,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.917615348,0,2.021610773,1.509237864,1.339491157,0.180410831,NA,0.293333377,0,5.234877582,1.694384852,3.089544607,0.002004636,0.015023052,0.760601198,0,2.583428098,1.245342649,2.074471712,0.038035523,0.091858692,0.877383491,0,2.161335755,1.299099928,1.663717863,0.096168825,0.19036351,0.749845869,0,2.501309627,1.221185743,2.048263043,0.040534232,0.095184154,N,-,,---NA---,,no IPS match,,
RL4_JR_05410,1399,1380,1563,5,0,1,0,0,0,0,0,1,0,1,0,0,8,0,41.07322787,1,1.467041869,0.70568617,2.078887091,0.03762773,0.107859107,14.01302787,0,2.165937149,1.174867693,1.843558354,0.06524753,0.145310341,18.41298338,1,-0.423731982,1.222060274,-0.346735747,0.728789852,0.816993518,66.06651224,1,2.063513288,0.589789649,3.49872754,0.000467484,0.003951838,19.34677298,1,0.202792156,1.013216927,0.20014683,0.841365749,0.893287208,N,-,,Orp1 like,,no IPS match,,
RL4_JR_05411,74,75,102,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.12646467,1,-0.348887762,1.063602602,-0.328024548,0.742893102,0.86455377,4.888036812,0,1.176166702,1.273474854,0.923588478,0.355700615,0.519913592,281.5146021,0,4.459491399,0.556051895,8.019919432,1.06E-15,1.19E-13,166.1216647,0,3.493317274,0.497214115,7.025780585,2.13E-12,9.62E-11,174.0164355,0,3.876445937,0.608149097,6.374170338,1.84E-10,1.23E-08,N,-,,cytochrome p450,F:oxidoreductase activity; F:metal ion binding; C:membrane,IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24286:SF47 (PANTHER); PTHR24286 (PANTHER); PTHR24286 (PANTHER); PTHR24286:SF47 (PANTHER); PTHR24286 (PANTHER); PTHR24286:SF47 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_05412,1382,1358,1585,0,1,0,3,0,4,0,0,0,0,0,0,0,0,0,42.45380621,1,-3.510116644,1.195320351,-2.936548884,0.003318865,0.015641422,13.63493898,1,-0.303674546,1.222695441,-0.248364831,0.803852142,0.881346554,35.20153198,0,-2.948534964,1.196955699,-2.463361816,0.013764094,0.041472526,106.7527684,0,0.248173908,0.600500968,0.413278114,0.679402863,0.781699317,45.7355107,0,-1.345484598,0.972711156,-1.383231383,0.16659393,0.28033298,N,-,,cupin -type,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; P:DNA-templated transcription, termination; F:heme binding",G3DSA:1.10.720.10 (GENE3D); PTHR41807 (PANTHER),,
RL4_JR_05413,145,82,110,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,191.7654863,0,-0.186299889,0.416088877,-0.447740615,0.654340406,0.804822955,35.1797593,0,-1.671150933,1.200433219,-1.392123198,0.163885095,0.296275215,136.5631484,0,-0.707844778,0.587334624,-1.205181423,0.228133272,0.359027087,210.3464934,0,0.066857891,0.406925935,0.164299902,0.869495059,0.91953598,131.0287916,0,-0.783187553,0.552361085,-1.417890532,0.156222727,0.266468179,N,-,,hypothetical protein SPI_06288,C:membrane,IPR021822 (PFAM); PTHR36205:SF1 (PANTHER); PTHR36205 (PANTHER); PTHR36205:SF1 (PANTHER); PTHR36205 (PANTHER),,
RL4_JR_05414,244,224,309,0,0,1,0,0,0,0,0,0,0,6,0,0,0,0,100.1136119,1,-1.966961039,0.929651795,-2.115804056,0.034361476,0.100581601,33.55874248,0,-0.21583343,1.150280229,-0.187635521,0.851162379,0.911496572,155.540403,0,0.605443318,0.532009915,1.138030139,0.255107897,0.390873643,72.73355038,1,-4.211753374,1.231119237,-3.421076729,0.000623737,0.005004477,62.57207149,0,-3.881235566,1.236112519,-3.139872387,0.001690214,0.007360611,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502:SF64 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.40, the major facilitator superfamily (mfs).
RL4_JR_05415,10,2,6,0,0,6,0,0,0,0,0,0,0,0,0,0,1,0,77.68844227,1,-0.350723812,0.668985007,-0.524262589,0.600095913,0.76883364,12.74742932,0,-0.206609114,1.216404693,-0.169852283,0.865126308,0.921816506,65.49176723,0,0.277264835,0.679135059,0.408261702,0.683081553,0.782475406,141.9318319,0,1.371517962,0.418590786,3.276512547,0.001050976,0.007699809,58.43319218,1,-0.298014058,0.74806363,-0.398380627,0.690349636,0.780371783,N,-,,hypothetical protein SPBR_00621,,IPR014710 (G3DSA:2.60.120.GENE3D); PTHR42111 (PANTHER),,
RL4_JR_05416,22,12,26,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.562831505,1,2.726699595,1.929550328,1.413126963,0.157618397,NA,0.180859526,0,5.932516494,1.904122096,3.115617694,0.001835601,0.015023052,0.468053553,0,3.283564324,1.315825426,2.495440702,0.012580078,0.038617559,0.539809072,0,2.861947412,1.45437963,1.967813186,0.049089536,0.121642574,0.461144521,0,3.202042935,1.269399525,2.522486319,0.011652848,0.035580545,N,-,,transcription factor,,PTHR39609:SF2 (PANTHER); PTHR39609 (PANTHER),,
RL4_JR_05417,14,9,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.976563396,0,0.783794883,1.228451443,0.638034891,0.523450968,0.707239648,1.308522061,0,3.077384595,1.433609805,2.146598456,0.031825263,0.082896374,3.432433068,0,0.409433966,1.265585866,0.323513384,0.746306473,0.830195224,3.962081864,0,-0.013704144,1.279158289,-0.010713408,0.991452101,0.994792639,3.427457733,0,0.30911586,1.279080816,0.241670312,0.809035635,0.870911982,N,-, Effector probability:0.566,Telomere length regulation TEN1,C:CST complex; F:single-stranded telomeric DNA binding; P:telomere capping,IPR024222 (PFAM),,
RL4_JR_05418,191,267,221,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,171.6502145,1,-0.493036465,0.471198584,-1.046345388,0.295401597,0.480535639,35.1499754,0,-1.669923115,1.206335563,-1.384294028,0.166268442,0.299567314,103.8459161,0,-2.498047962,1.039190417,-2.403840451,0.016223852,0.047375334,164.34141,0,-0.989955892,0.551578348,-1.794769313,0.072690462,0.155402214,127.1541516,0,-0.790196934,0.561203079,-1.408040982,0.159118935,0.270406045,N,-,,vacuolar-sorting snf7,P:protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; F:identical protein binding; C:ESCRT III complex; P:cellular response to anoxia; P:intralumenal vesicle formation,IPR005024 (PFAM); PTHR22761 (PANTHER),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_05419,1002,1960,1070,0,0,1,0,0,0,0,0,0,2,0,0,0,2,0,157.111071,1,2.159280026,1.032111432,2.092099709,0.036429597,0.105163713,9.881866564,0,0.160787718,1.241101873,0.129552394,0.89692057,0.942450951,25.48318442,0,-2.482426784,1.203966073,-2.061874366,0.039219699,0.094157038,60.69326025,1,0.14383043,0.696014924,0.206648485,0.836284392,0.897538633,55.47632494,1,0.84656727,0.602221053,1.405741737,0.159800829,0.271291648,N,-,,pe repeat family,,no IPS match,,
RL4_JR_05420,49,90,53,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,62.0034017,0,-0.46434146,0.770433552,-0.602701503,0.546707282,0.726864081,10.85045469,0,0.025798057,1.221156267,0.021125926,0.983145204,0.99097747,43.95227364,0,-0.80749944,1.042984556,-0.77421994,0.438800739,0.579022185,48.66406648,0,-0.356418138,0.77258605,-0.461331315,0.644560921,0.756260354,53.93091283,0,-0.075002164,0.771924509,-0.097162564,0.922597297,0.95018794,N,-,,lysine-sensitive aspartokinase 3,C:membrane,no IPS match,,
RL4_JR_05421,339,251,406,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,103.4793084,1,-1.770580001,0.732196282,-2.418176716,0.015598499,0.053897737,26.86635058,0,-1.282193284,1.195546276,-1.072474825,0.283506815,0.442916497,102.8043791,0,-1.516733783,0.843343878,-1.798476069,0.072101598,0.15050651,80.27806191,0,-4.354108617,1.184899684,-3.674664341,0.000238162,0.002220436,68.4941739,0,-4.011694949,1.185215851,-3.384780036,0.000712353,0.003640876,N,-,,Nuclear polyadenylated RNA-binding 4,F:nucleotide binding; F:nucleic acid binding,no IPS match,,
RL4_JR_05422,26,26,27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,115.8818896,0,-3.139536263,1.028348279,-3.052989271,0.00226574,0.011552444,34.82841384,0,-1.656652694,1.21210698,-1.36675452,0.171702263,0.307170431,89.8402866,0,-4.300290238,1.199549231,-3.58492184,0.000337179,0.002549367,143.576638,0,-1.402795065,0.635825917,-2.206256503,0.027366045,0.088070176,88.02391199,0,-4.373617671,1.195699493,-3.657790018,0.000254399,0.001531387,N,-,,RNA recognition domain-containing,F:nucleotide binding; C:cytoplasmic stress granule; C:viral nucleocapsid; F:mRNA binding; P:mRNA polyadenylation; P:mRNA cleavage,IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR24012:SF492 (PANTHER); PTHR24012 (PANTHER); PTHR24012 (PANTHER); PTHR24012:SF492 (PANTHER); PTHR24012:SF492 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_05423,1123,2063,1360,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,40.45850401,0,1.635258894,0.5682066,2.877930129,0.004002938,0.018063608,4.391637034,0,1.330799147,1.2496156,1.064966817,0.286890946,0.446507884,11.37020178,0,-1.318113036,1.191262315,-1.10648429,0.26851696,0.406651564,13.11545549,0,-1.74027523,1.188599692,-1.464139055,0.143155958,0.257086569,11.18142918,0,-1.396798134,1.189523822,-1.17424982,0.240294976,0.369538189,N,-,,phytanoyl- dioxygenase,F:dioxygenase activity; P:oxidation-reduction process,G3DSA:2.60.120.620 (GENE3D); IPR008775 (PFAM); PTHR20883:SF15 (PANTHER); PTHR20883 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_05424,294,365,426,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,38.04900619,1,0.778272617,0.797555612,0.975822383,0.329152491,0.518283347,4.544601972,1,1.281303207,1.275434212,1.004601566,0.315088743,0.477158626,11.86631488,0,-1.37985937,1.219165393,-1.131806545,0.257715776,0.394126059,25.72986781,0,0.473998405,0.904343897,0.524135129,0.600184556,0.722318868,11.76967585,0,-1.470732986,1.230663435,-1.195073278,0.232058401,0.359605855,N,-,,hypothetical protein F503_08183,,IPR029058 (G3DSA:3.40.50.GENE3D); PTHR19359:SF32 (PANTHER); PTHR19359 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_05425,71,113,83,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.064897062,0,-0.702941699,1.233223546,-0.570003469,0.568675345,0.7451419,1.919490832,0,2.52467112,1.334283403,1.89215508,0.058470321,0.133567194,31.00625171,0,2.667556752,0.779815849,3.420752165,0.000624482,0.003976262,25.05374917,0,1.199990805,1.039065067,1.154875516,0.248141407,0.387242871,4.976006843,0,-0.228727397,1.232284936,-0.185612427,0.852748708,0.902108522,N,-,,DUF218 domain-containing,P:biosynthetic process,PTHR28110 (PANTHER); PTHR28110:SF1 (PANTHER),,
RL4_JR_05426,516,614,558,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.351462769,0,0.663900645,1.327050307,0.500282952,0.616875856,0.779762571,0.743659789,0,3.892607846,1.496057129,2.60191123,0.009270584,0.031852293,1.943888562,0,1.229539523,1.255017937,0.979698765,0.327234836,0.470318779,2.243379215,0,0.80676612,1.275805456,0.632358261,0.527152801,0.660817397,1.93383151,0,1.134789965,1.258658351,0.901586967,0.367276317,0.503748673,N,-,,---NA---,,no IPS match,,
RL4_JR_05427,85,168,101,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.262973767,0,3.824572531,2.649695507,1.443400769,0.148907608,NA,0.083347411,0,7.049925711,2.17427646,3.242423787,0.001185176,0.015023052,0.217400731,0,4.389362726,1.351150816,3.248610499,0.001159702,0.006501007,0.250870734,0,3.967430894,1.689092588,2.348853416,0.018831319,0.074566719,0.215674394,0,4.299743558,1.267638909,3.391930878,0.000694019,0.003563361,N,-,,dihydrofolate synthetase fol3,F:nucleotide binding; P:folic acid-containing compound biosynthetic process; F:acid-amino acid ligase activity,IPR013221 (PFAM); IPR001645 (TIGRFAM); IPR013221 (G3DSA:3.40.1190.GENE3D); IPR004101 (G3DSA:3.90.190.GENE3D); IPR001645 (PANTHER); PTHR11136:SF0 (PANTHER); IPR004101 (SUPERFAMILY); IPR013221 (SUPERFAMILY),,
RL4_JR_05428,2,2,7,5,0,6,0,0,0,0,0,0,0,0,2,0,0,0,62.93681671,1,-4.078186457,1.209969699,-3.370486434,0.000750356,0.004708773,20.29870158,0,-0.877781636,1.229566366,-0.713895289,0.475291931,0.632680816,66.68363819,0,-1.701216416,1.053587721,-1.614688917,0.106378079,0.203080734,68.37937352,1,-2.228836211,1.044472853,-2.133934074,0.032848178,0.097077583,51.32137678,0,-3.59529734,1.207354518,-2.977830692,0.002902963,0.011508418,N,-,,pre-mRNA-splicing factor ATP-dependent RNA helicase prp22,F:nucleotide binding; C:nucleus; C:mitochondrion; P:RNA processing; F:ATP-dependent RNA helicase activity; F:poly(A) RNA binding,IPR001650 (SMART); IPR014001 (SMART); IPR007502 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011709 (PFAM); IPR001650 (PFAM); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR007502 (PFAM); PTHR18934 (PANTHER); PTHR18934 (PANTHER); PTHR18934:SF145 (PANTHER); PTHR18934:SF145 (PANTHER); PTHR18934 (PANTHER); PTHR18934:SF145 (PANTHER); PTHR18934 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR009060 (SUPERFAMILY),1.A.53.1.4, the hepatitis c virus p7 viroporin cation-selective channel (hcv-p7) family.
RL4_JR_05429,320,284,392,0,0,0,0,0,0,0,0,0,0,2,9,0,2,1,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,hypothetical protein,,no IPS match,,
RL4_JR_05430,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,400.6025472,0,-2.592974017,0.840244837,-3.085974354,0.002028863,0.010593958,122.1247616,0,-2.433818307,1.108145334,-2.196298835,0.028070561,0.075126975,348.0261561,0,-2.201234242,0.558616462,-3.940510869,8.13E-05,0.001023837,429.1587696,0,-1.731091741,0.432776946,-3.99996293,6.34E-05,0.000725614,338.4967054,0,-2.452063358,0.589652558,-4.158488461,3.20E-05,0.000266309,N,-,,Importin subunit alpha-1,C:nucleus; C:cytoplasm; P:protein import into nucleus; F:protein transporter activity; P:protein targeting to membrane,IPR000225 (SMART); IPR002652 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR024931 (PIRSF); IPR000225 (PFAM); IPR032413 (PFAM); PTHR23316:SF0 (PANTHER); PTHR23316 (PANTHER); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR002652 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_05431,6,8,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.49639552,0,-1.494136631,1.187302368,-1.258429757,0.208236376,0.37449744,3.348221584,0,1.722120165,1.260396874,1.366331669,0.171834885,0.307299065,8.688062484,0,-0.93009265,1.191331721,-0.780716767,0.434969097,0.575336704,26.06919874,0,1.368041571,0.738083603,1.853504895,0.063810025,0.14210348,16.28726182,0,0.656844057,0.974275042,0.674187502,0.500192114,0.627797838,N,-,,telomere-binding alpha subunit central domain-containing,"F:DNA binding; C:nucleus; C:cytosol; P:telomere maintenance; F:single-stranded telomeric DNA binding; P:telomere capping; F:G-rich strand telomeric DNA binding; P:negative regulation of telomere maintenance via telomerase; C:nuclear chromosome, telomeric region",IPR011564 (SMART); IPR011564 (PFAM); G3DSA:2.40.50.140 (GENE3D); IPR032042 (PFAM); PTHR14513:SF0 (PANTHER); IPR028389 (PANTHER); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY),,
RL4_JR_05432,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,137.6685323,0,6.500259299,2.091661621,3.107701185,0.001885486,0.009968759,28.6124805,0,6.69145088,0.902241717,7.416472495,1.20E-13,3.69E-11,1.240392886,0,1.877585641,1.256650062,1.494119722,0.13514433,0.242588865,1.431054009,0,1.455322433,1.290713808,1.127533016,0.25951719,0.399575965,1.22825684,0,1.789438854,1.248119813,1.433707594,0.151655724,0.261186292,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:membrane; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11360 (PANTHER); PTHR11360 (PANTHER); PTHR11360:SF130 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.13.4, the major facilitator superfamily (mfs).
RL4_JR_05433,28,33,47,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,64.73118809,0,0.150630893,0.586881542,0.256663197,0.797438785,0.896831455,12.18785139,0,-0.141812053,1.218459449,-0.116386354,0.90734635,0.948287016,31.50018648,0,-2.788255512,1.192379513,-2.338396024,0.019366714,0.054478636,71.0021819,0,0.097948049,0.620088199,0.157958254,0.874489694,0.922592207,57.94476285,0,0.544402721,0.578500877,0.941057728,0.346675277,0.484016434,N,-,,c6 finger domain-containing,"C:nucleus; F:zinc ion binding; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES),,
RL4_JR_05434,2403,1799,3326,0,2,12,0,0,0,0,9,1,0,10,0,0,15,2,19.5631925,1,1.16707564,0.878157025,1.329005642,0.183846109,0.341721703,2.607298789,0,2.083053025,1.313304344,1.586115994,0.112712999,0.222427311,6.724309523,1,-0.56022666,1.211020505,-0.462607081,0.643646032,0.751762918,7.754692544,1,-0.98208676,1.210501357,-0.81130579,0.417190086,0.560915594,6.583927992,1,-0.632770623,1.205309938,-0.524985817,0.599593051,0.709546475,N,-,,g2 mitotic-specific cyclin,C:nucleus,IPR004367 (SMART); IPR013763 (SMART); IPR013763 (G3DSA:1.10.472.GENE3D); IPR006671 (PFAM); IPR013763 (G3DSA:1.10.472.GENE3D); IPR004367 (PFAM); PTHR10177 (PANTHER); PTHR10177:SF223 (PANTHER); IPR013763 (SUPERFAMILY); IPR013763 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_05435,821,1167,863,0,0,0,0,0,0,5,6,0,1,16,7,0,22,1,166.4848785,0,0.873914441,0.408372142,2.139995241,0.032355151,0.096122842,27.88604859,0,0.17176332,1.12567487,0.152586972,0.878723999,0.931058686,47.87874877,1,-3.392342303,1.196548565,-2.835106241,0.004581045,0.017769539,96.16209353,1,-0.494316212,0.62974232,-0.784949965,0.432482905,0.574759396,84.99145447,1,0.131171174,0.563391514,0.232824191,0.815897927,0.876216219,N,-,,calcium-binding mitochondrial carrier aralar1,P:L-glutamate transmembrane transport; P:L-aspartate transmembrane transport; P:cellular nitrogen compound biosynthetic process; F:antiporter activity; F:calcium ion binding; C:integral component of membrane; F:L-aspartate transmembrane transporter activity; F:uniporter activity; C:mitochondrial inner membrane; F:L-glutamate transmembrane transporter activity,IPR002067 (PRINTS); IPR002048 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); PTHR24089:SF13 (PANTHER); PTHR24089:SF13 (PANTHER); PTHR24089 (PANTHER); PTHR24089 (PANTHER); IPR002048 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY); IPR011992 (SUPERFAMILY),2.A.29.14.10, the mitochondrial carrier (mc) family.
RL4_JR_05436,45,64,151,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.909416572,0,-1.257869148,1.190905444,-1.056229236,0.290863497,0.475808507,2.845860068,0,1.956637599,1.277035948,1.53217112,0.125480213,0.241145001,7.38209793,0,-0.695177959,1.195875103,-0.58131318,0.561029399,0.686747814,8.515806761,0,-1.117479397,1.193557049,-0.936259727,0.349139478,0.495936759,7.279859738,0,-0.77773181,1.198582642,-0.64887625,0.516418367,0.642035359,N,-,,lysosomal cystine transporter,C:membrane; C:vacuole,IPR006603 (SMART); IPR006603 (PFAM); PTHR13131:SF5 (PANTHER); IPR005282 (PANTHER),2.A.43.1.1, the lysosomal cystine transporter (lct) family.
RL4_JR_05437,9,7,9,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,46.03930424,1,0.456535401,0.76079349,0.600077954,0.548454284,0.728593071,5.798060592,0,0.929896264,1.247460898,0.745431192,0.456011093,0.615609912,15.07143365,0,-1.724872241,1.203648266,-1.433036784,0.151847325,0.264778216,21.39929014,0,-1.200939899,1.155790063,-1.039064045,0.298774951,0.444018256,29.63453671,0,-0.11510097,0.989874673,-0.116278326,0.907431963,0.94064156,N,-,,alcohol dehydrogenase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); PF13602 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR002085 (PANTHER); PTHR11695:SF542 (PANTHER); PTHR11695:SF542 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_05438,1,1,1,0,0,8,0,0,0,0,0,0,2,0,0,0,0,0,107.0456728,1,-1.225245467,0.642885219,-1.905854157,0.05666913,0.145838403,27.00985673,0,-1.2898669,1.208639275,-1.067205846,0.285878893,0.445522118,89.25345503,0,-1.534857386,0.860462166,-1.783759294,0.074462787,0.154157721,103.0885373,1,-2.033334892,0.857870295,-2.370212494,0.017777865,0.072551744,83.50332292,0,-1.796923785,0.841271206,-2.135962544,0.032682467,0.080454651,N,-,,stag domain-containing,P:nitrogen compound metabolic process; F:nickel cation binding,IPR013721 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR11199 (PANTHER); PTHR11199:SF0 (PANTHER); PTHR11199 (PANTHER); PTHR11199:SF0 (PANTHER); IPR020839 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_05439,24374,24191,15825,4,0,0,0,0,0,0,0,0,0,0,1,0,0,0,15.60326421,1,-2.066020091,1.209320853,-1.708413516,0.087559641,0.200649312,4.951436364,0,1.15765916,1.255569896,0.922018888,0.356518723,0.520733408,20.72299415,0,-0.536261065,1.202948795,-0.445788771,0.655749834,0.761432941,18.87351747,1,-0.974461101,1.157549039,-0.841831377,0.399882346,0.544048476,12.72050569,0,-1.582801603,1.211745884,-1.306215787,0.191479186,0.311592214,N,-,,kynurenine formamidase,P:tryptophan metabolic process,IPR029058 (G3DSA:3.40.50.GENE3D); PTHR23024 (PANTHER); PTHR23024:SF147 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_05440,294,262,144,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.44494589,0,-1.536356971,1.010925442,-1.519752998,0.128573066,0.265208363,11.451947,0,-0.052009975,1.214990873,-0.042806885,0.965855476,0.98244468,36.18548826,0,-1.741013375,1.191665386,-1.460991814,0.144017688,0.254319871,50.29055148,0,-0.412465237,0.75010502,-0.549876652,0.582403979,0.708134489,36.98152994,0,-1.116769981,0.977768379,-1.142162096,0.253386648,0.384353572,N,-,,DNA-directed RNA polymerase-like subunit,F:DNA binding; F:DNA-directed RNA polymerase activity; P:transcription from RNA polymerase III promoter; C:DNA-directed RNA polymerase III complex,IPR007811 (PFAM); PTHR13408:SF0 (PANTHER); PTHR13408:SF0 (PANTHER); IPR007811 (PANTHER); IPR007811 (PANTHER); IPR007811 (PANTHER),,
RL4_JR_05441,51,16,43,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.935805111,0,-0.672024297,1.212907495,-0.554060635,0.579537349,0.754165847,1.892248494,0,2.545350775,1.325793853,1.919869193,0.054874424,0.127074047,4.917829394,0,-0.109284595,1.210794569,-0.090258577,0.928081737,0.957007486,15.308879,0,0.419078605,1.154645691,0.362949958,0.716642267,0.810388391,4.86179025,0,-0.195315832,1.215733496,-0.160656783,0.872363729,0.915447178,N,-,,urease accessory,P:nitrogen compound metabolic process,IPR002669 (PFAM); PTHR33643:SF1 (PANTHER); PTHR33643 (PANTHER); PTHR33643:SF1 (PANTHER); PTHR33643 (PANTHER),,
RL4_JR_05442,1,7,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,130.8398074,0,0.625070639,0.544490512,1.147991793,0.250971952,0.428310122,24.44153254,0,0.468627915,1.129435883,0.414922106,0.678198927,0.794896889,154.2422339,0,1.495803797,1.227412795,1.218664009,0.222971744,0.3529892,48.9092098,0,-2.569019981,1.150732458,-2.232508489,0.025581375,0.085851084,72.21826428,0,0.25051585,0.586142481,0.427397532,0.669089805,0.76487911,N,-,,glutamine amidotransferase,C:cytoplasm; F:omega peptidase activity; P:proteolysis; P:glutamine metabolic process; P:glutathione catabolic process; C:proteasome complex; F:transferase activity,IPR026869 (PFAM); IPR029055 (G3DSA:3.60.20.GENE3D); PTHR11907:SF1 (PANTHER); PTHR11907 (PANTHER); PTHR11907 (PANTHER); PTHR11907:SF1 (PANTHER); IPR017932 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY),,
RL4_JR_05443,617,704,1233,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,404.5937001,0,0.401076106,0.525017563,0.763928932,0.444909595,0.633797644,66.39509888,0,-1.451584485,1.126733085,-1.288312649,0.197637152,0.341071398,215.4610282,1,-1.024869224,0.540289491,-1.896889058,0.057842582,0.126451803,270.0174586,1,-0.475454146,0.507463141,-0.936923508,0.348797906,0.49556133,163.2689034,0,-2.172768898,0.703510904,-3.088465133,0.002011933,0.008526924,N,-,,mitochondrial dynamin GTPase,F:GTP binding; P:mitochondrion inheritance; C:mitochondrial intermembrane space; C:mitochondrial inner boundary membrane; C:mitochondrial crista; F:GTPase activity; C:fungal-type vacuole membrane; P:mitochondrial fusion; C:extrinsic component of mitochondrial inner membrane; C:intrinsic component of mitochondrial inner membrane; P:mitochondrial genome maintenance; P:mitochondrial membrane organization,IPR022812 (PRINTS); IPR001401 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000375 (PFAM); IPR022812 (PFAM); IPR022812 (PANTHER); PTHR11566:SF68 (PANTHER); PTHR11566:SF68 (PANTHER); IPR022812 (PANTHER); IPR030381 (PROSITE_PROFILES); IPR020850 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.N.6.1.1, the mitochondrial inner/outer membrane fusion (mmf) family.
RL4_JR_05444,87,89,109,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.56332514,0,2.467308766,0.686201599,3.595603349,0.000323641,0.002303892,1.753398379,0,2.655363489,1.337448435,1.98539504,0.047100537,0.112440392,4.539958133,0,0.006166001,1.209485399,0.005098036,0.995932373,0.998496667,9.24804637,0,0.530424254,1.155705862,0.458961291,0.646261964,0.757555062,11.83589684,0,0.861961962,1.132917944,0.760833533,0.446756503,0.579330122,N,-,,cation efflux family family,P:regulation of biological quality; P:zinc II ion transport; C:membrane; P:cation transmembrane transport; F:cation transmembrane transporter activity; C:Golgi apparatus,IPR027469 (G3DSA:1.20.1510.GENE3D); IPR002524 (PANTHER); IPR002524 (PANTHER); PTHR11562:SF47 (PANTHER); PTHR11562:SF47 (PANTHER),2.A.4.4.1, the cation diffusion facilitator (cdf) family.
RL4_JR_05445,194,184,156,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0.035761063,0,6.70265951,3.936487805,1.702700438,0.088624143,NA,0.011692302,0,9.884887072,3.247546872,3.043801202,0.002336095,0.015160123,0.029901453,0,7.253187862,1.882567949,3.852815973,0.000116767,0.001276621,0.034460259,1,6.831689268,3.563193266,1.917294056,0.055200585,0.130190058,0.029084976,0,7.181875612,1.407420995,5.102862355,3.35E-07,5.66E-06,Y,-,,hypothetical protein SPSK_08587,,no IPS match,,
RL4_JR_05446,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.42498316,0,-0.223109084,1.165159297,-0.191483761,0.848146602,0.923789049,2.667280867,0,2.05004474,1.298323253,1.578994087,0.114337413,0.225116377,6.956860985,0,-0.609653164,1.214065913,-0.502158209,0.615556237,0.730105458,8.02787494,0,-1.032390073,1.214734479,-0.849889495,0.395386526,0.539672227,6.901279986,0,-0.700623241,1.22431838,-0.572255757,0.567148718,0.683860995,N,-,,hypothetical protein UCDDA912_g00462,C:membrane; C:integral component of membrane,PTHR39400 (PANTHER),,
RL4_JR_05447,1,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.954944853,0,0.334765052,1.247916903,0.268259089,0.788499895,0.890815973,0.940292128,0,3.554358346,1.420124956,2.502849013,0.012319809,0.03948193,2.441256948,0,0.901537059,1.218961478,0.73959438,0.459546153,0.597467129,6.828162877,0,1.42531534,1.159719374,1.229017444,0.219065266,0.354205656,9.771561329,0,1.756563927,1.135294904,1.547231403,0.121807456,0.221776748,N,-,,alpha-methylacyl- racemase,F:catalytic activity; C:membrane; C:integral component of membrane; F:transferase activity; C:cellular_component; F:molecular_function,IPR003673 (PFAM); IPR023606 (G3DSA:3.40.50.GENE3D); PTHR24023:SF577 (PANTHER); PTHR24023 (PANTHER); IPR023606 (SUPERFAMILY),,
RL4_JR_05448,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,232.1521409,0,-0.38733847,0.909404774,-0.425925266,0.670162304,0.817382379,91.27908631,0,0.873642672,0.721845614,1.210290199,0.226167557,0.375720993,149.6366083,0,-1.82184494,0.760603278,-2.395263066,0.016608444,0.04830333,187.0982407,0,-0.93701181,0.520151913,-1.801419523,0.071636781,0.153788739,199.1439733,0,0.010029373,0.444597669,0.022558313,0.982002597,0.98818679,N,-,,vacuolar sorting 1,F:GTP binding; F:GTPase activity; P:peroxisome organization; P:protein targeting to vacuole; P:actin cytoskeleton organization; C:intracellular,IPR022812 (PRINTS); IPR001401 (SMART); IPR003130 (SMART); IPR022812 (PFAM); IPR000375 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003130 (PFAM); IPR022812 (PANTHER); IPR022812 (PANTHER); IPR030557 (PTHR11566:PANTHER); IPR030557 (PTHR11566:PANTHER); IPR030381 (PROSITE_PROFILES); IPR020850 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_05449,0,0,6,0,0,0,0,0,0,0,4,0,0,4,0,0,3,0,262.5992789,0,-3.761538718,0.95374377,-3.943971993,8.01E-05,0.000702263,185.8063467,0,0.436319152,0.70936615,0.615083131,0.538499822,0.685622038,256.6466903,1,-1.714892875,0.666364439,-2.57350599,0.01006739,0.032846362,306.8759639,1,-1.600054647,1.614944161,-0.990780168,0.321792935,0.468192768,201.6922057,1,-5.569790328,1.251480739,-4.450560168,8.56E-06,8.78E-05,N,-,,Na+ H+ K+ antiporter P-type ATPase,F:ATP binding; P:transmembrane transport; F:metal ion binding; C:integral component of membrane; F:hydrolase activity,PR00119 (PRINTS); IPR001757 (PRINTS); IPR004014 (SMART); IPR001757 (TIGRFAM); IPR004014 (PFAM); G3DSA:4.10.6.10 (GENE3D); PF13246 (PFAM); IPR008250 (G3DSA:2.70.150.GENE3D); IPR006068 (PFAM); IPR008250 (PFAM); PF00702 (PFAM); IPR023298 (G3DSA:1.20.1110.GENE3D); IPR023299 (G3DSA:3.40.1110.GENE3D); PTHR24093 (PANTHER); PTHR24093:SF263 (PANTHER); PTHR24093:SF263 (PANTHER); PTHR24093 (PANTHER); IPR023214 (SUPERFAMILY); SSF81653 (SUPERFAMILY); IPR023299 (SUPERFAMILY); SSF81665 (SUPERFAMILY),3.A.3.1.7, the p-type atpase (p-atpase) superfamily.
RL4_JR_05450,4,5,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,324.9387109,0,0.875266595,0.744917059,1.174985301,0.240000596,0.41481459,248.6082165,0,2.205582686,0.785951197,2.806259083,0.005012038,0.020673123,196.2948706,0,0.083844349,0.520132992,0.161197905,0.871937531,0.91895644,155.0247542,0,-1.732580796,0.7279587,-2.380053699,0.017310115,0.071682993,152.6563159,0,-0.28586603,0.569994183,-0.501524469,0.616002062,0.722881418,N,-,,WD domain-containing,P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:negative regulation of gluconeogenesis; C:GID complex,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR22838 (PANTHER); PTHR22838:SF0 (PANTHER); PTHR22838 (PANTHER); PTHR22838:SF0 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.15.2.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_05451,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,104.6148201,0,-0.012326711,0.51504156,-0.023933431,0.980905708,0.990865375,36.51986103,0,0.956077375,0.98824589,0.967448875,0.333319687,0.496667433,74.7087663,0,-0.514913344,0.74083522,-0.695044364,0.4870275,0.622009134,65.12819251,0,-1.452766999,0.852859962,-1.703406261,0.088492067,0.178731733,53.00807692,0,-1.743976859,0.969451648,-1.798931243,0.072029558,0.14808107,N,-,,Importin alpha re-exporter,C:nuclear envelope; P:protein import into nucleus; C:integral component of membrane; C:cytosol; P:protein export from nucleus; F:Ran GTPase binding; F:nuclear export signal receptor activity,IPR001494 (SMART); IPR001494 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR013713 (PFAM); IPR005043 (PFAM); PTHR10997 (PANTHER); PTHR10997:SF8 (PANTHER); IPR001494 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_05452,51,50,47,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,154.8661978,0,-0.597241104,0.698749279,-0.854728758,0.392701326,0.584985647,58.32765573,0,0.658999895,0.994585028,0.662587789,0.507594593,0.659801267,84.05152211,1,-3.126306257,1.263179867,-2.474949403,0.013325505,0.040524907,101.4600946,0,-2.284618057,1.004561923,-2.274243135,0.022951372,0.08173853,75.440844,0,-4.151055305,1.267023985,-3.276224724,0.001052048,0.004982221,N,-,,GTPase activating,P:biological regulation; C:intracellular part,IPR000331 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR024584 (PFAM); IPR018515 (PFAM); PTHR10063 (PANTHER); PTHR10063 (PANTHER); PTHR10063:SF0 (PANTHER); PTHR10063:SF0 (PANTHER); PTHR10063 (PANTHER); IPR000331 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR000331 (SUPERFAMILY),,
RL4_JR_05453,1479,1710,2096,0,1,5,0,0,0,0,0,1,0,0,0,0,0,0,56.80236847,1,0.508766377,0.561971747,0.905323763,0.365293891,0.55712611,9.625446379,0,0.198683754,1.216517506,0.163321739,0.870265119,0.92510224,57.41886037,1,0.687042557,0.6660958,1.031447063,0.302331221,0.443658687,42.07437733,0,-1.13860274,1.009285399,-1.128127625,0.259266024,0.399249961,31.89371065,0,-1.59689168,1.116475875,-1.430296628,0.152631902,0.26228751,N,-,,beta-n-acetyltransferase,F:transferase activity,IPR016181 (G3DSA:3.40.630.GENE3D); PTHR30480 (PANTHER); PTHR30480:SF6 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_05454,1972,1842,1306,0,0,4,4,0,1,0,0,0,0,0,0,0,3,0,10.98023041,1,-1.55896529,1.190081704,-1.309964925,0.190207702,0.350118928,3.509561513,1,1.654268807,1.263859985,1.308901957,0.190567564,0.331997627,9.089628897,0,-0.995120463,1.193582199,-0.833725959,0.404435427,0.546646342,30.54311051,0,1.617893096,0.670349808,2.413505719,0.01579988,0.067556497,8.940341102,1,-1.074059918,1.192127647,-0.900960497,0.367609323,0.504017117,N,-,,centromere I,"P:macromolecular complex subunit organization; C:condensed nuclear chromosome, centromeric region; P:chromosome organization; C:condensed chromosome kinetochore",IPR012485 (PFAM); PTHR23139 (PANTHER); PTHR23139:SF24 (PANTHER),,
RL4_JR_05455,744,446,1039,0,2,0,0,0,1,0,4,0,1,0,0,0,0,0,93.5507941,1,1.519026138,0.471561949,3.221265291,0.00127626,0.007165674,8.649934386,1,0.352791489,1.218768424,0.289465564,0.772225128,0.8619831,22.5041184,1,-2.30317782,1.194200143,-1.928636362,0.053776022,0.119523258,35.27808635,1,-1.775884635,1.145889264,-1.549787306,0.121192575,0.225897426,22.24817511,0,-2.389372765,1.201318612,-1.988958417,0.046705793,0.106292685,N,-,,ABC transporter,F:ATPase activity; C:nucleus; F:ATP binding; C:cytosol; C:CCR4-NOT complex; P:regulation of transcription from RNA polymerase II promoter,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); PTHR12847 (PANTHER); PTHR12847:SF5 (PANTHER); PTHR12847 (PANTHER); PTHR12847:SF5 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.1.1.4, the atp-binding cassette (abc) superfamily.
RL4_JR_05456,3104,1711,3714,1,2,14,0,0,0,0,1,5,0,0,4,0,3,0,7.530586271,1,-1.015189061,1.191719894,-0.851868855,0.394286885,0.586541285,2.401477611,0,2.201576046,1.287103984,1.710488098,0.087175652,0.182011542,17.30417741,1,0.510403983,1.189790261,0.42898652,0.667933035,0.771671122,7.192082604,1,-0.873729829,1.192796227,-0.732505527,0.46386007,0.605620014,6.150958712,1,-0.534575076,1.198302797,-0.44611018,0.65551766,0.754389214,N,-,,short chain dehydrogenase reductase,C:intracellular part,IPR002347 (PRINTS); IPR029058 (G3DSA:3.40.50.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); IPR003140 (PFAM); PTHR24320 (PANTHER); IPR016040 (SUPERFAMILY); IPR029058 (SUPERFAMILY),,
RL4_JR_05457,6004,4200,9316,0,0,4,0,0,0,0,0,0,0,0,5,0,2,0,0.976932663,1,1.931463613,1.506671542,1.281940728,0.199863439,NA,0.3106445,0,5.15219396,1.68326237,3.060838317,0.002207182,0.015045494,0.806903625,0,2.498772898,1.251581819,1.996491847,0.045880412,0.105857367,0.930984816,1,2.076143538,1.304805917,1.591151228,0.111575546,0.212589839,0.795662763,1,2.416599083,1.22881858,1.966603633,0.049228924,0.110740471,N,-,,hypothetical protein V499_05849,P:queuosine biosynthetic process; P:tRNA modification; F:queuine tRNA-ribosyltransferase activity,no IPS match,,
RL4_JR_05458,58,88,95,0,0,0,0,0,0,0,1,3,0,0,1,0,0,0,74.19265378,0,-0.131147514,0.659400652,-0.198888966,0.842349601,0.920794325,10.93395924,0,0.014793755,1.214519402,0.012180748,0.99028141,0.994962411,69.94131623,1,0.511977485,0.664895586,0.770011856,0.44129286,0.581346638,86.9129519,1,0.677403519,0.533521767,1.269683002,0.20419757,0.335905832,57.30927843,0,-0.07268224,0.737247928,-0.098585885,0.921467077,0.949701381,N,-,,lccl domain containing,C:membrane,IPR004043 (SMART); IPR004043 (G3DSA:2.170.130.GENE3D); IPR004043 (PFAM); PTHR31331 (PANTHER); PTHR31331:SF2 (PANTHER); PTHR31331:SF2 (PANTHER); PTHR31331 (PANTHER); IPR004043 (PROSITE_PROFILES); IPR004043 (SUPERFAMILY),,
RL4_JR_05459,339,454,538,0,0,0,0,0,0,0,0,3,0,2,0,0,6,0,71.34558724,0,1.260661005,0.740496665,1.702453319,0.088670422,0.20273234,36.242179,0,2.626916426,0.859236362,3.057268688,0.00223364,0.015045494,43.2732493,1,0.197066499,0.85687892,0.229981733,0.818105964,0.882337784,72.32756603,1,1.090390969,0.553687334,1.969326192,0.048915645,0.121283975,43.64880779,1,0.633144398,0.694231386,0.912007741,0.361764643,0.498789775,N,-,,tRNA-guanine transglycosylase,P:queuosine biosynthetic process; C:cytoplasm; F:transferase activity; C:cellular_component; P:tRNA modification; F:queuine tRNA-ribosyltransferase activity,IPR002616 (G3DSA:3.20.20.GENE3D); IPR002616 (PFAM); PTHR21148 (PANTHER); PTHR21148:SF26 (PANTHER); IPR002616 (SUPERFAMILY),,
RL4_JR_05460,50,24,37,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,119.1327408,0,-0.851684978,0.586693465,-1.451669448,0.146593538,0.29232708,62.49854336,0,1.398963497,0.778308283,1.797441357,0.07226558,0.157445353,82.07247656,0,-1.996887755,1.037346943,-1.924995072,0.054229975,0.120320899,87.71530274,0,-2.509529067,1.022217538,-2.454985336,0.014089034,0.06368369,149.5505364,0,0.717415167,0.420027795,1.708018315,0.087632944,0.172959758,N,-,,AP-3 complex subunit delta,C:nucleus; F:protein transporter activity; C:Golgi apparatus; C:AP-3 adaptor complex; P:protein targeting to vacuole; P:Golgi to vacuole transport,IPR002553 (PFAM); IPR017105 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR22781 (PANTHER); IPR016024 (SUPERFAMILY),9.B.278.1.1, the organellar-targeting adaptor protein complex (o-apc) family.
RL4_JR_05461,6035,2588,3095,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,57.39393342,0,0.435662901,0.617511552,0.705513768,0.480490567,0.669257648,9.761544496,0,0.17836021,1.221836633,0.145977134,0.883939439,0.934339495,38.38569645,0,-0.659185275,1.040787117,-0.633352647,0.52650338,0.656072876,29.29151651,0,-2.899668674,1.197996532,-2.42043161,0.015502095,0.066507929,28.97382318,0,-1.634979138,1.13598705,-1.439258606,0.150077266,0.258899042,N,-,,tetratricopeptide repeat domain-containing,C:intracellular membrane-bounded organelle; C:cytoplasmic part; C:intracellular organelle part,IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR12760 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY),3.A.27.1.1, the c-terminal tail-anchored membrane protein biogenesis/ insertion complex-2 (tamp-b2) family.
RL4_JR_05462,956,536,659,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,769.9050411,0,1.1915311,0.499336035,2.386230948,0.017022058,0.057717487,177.5726245,0,1.067333986,0.709542512,1.50425657,0.132515317,0.250681986,244.2034464,0,-1.971528907,0.672643707,-2.931015168,0.003378563,0.014799383,324.0161437,0,-1.150381044,0.498400765,-2.308144621,0.020991094,0.078455086,214.4096091,0,-2.143673798,0.698869854,-3.06734335,0.002159706,0.009033488,N,-,,kinetoplast-associated kap,,no IPS match,1.I.1.1.1, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_05463,5527,4277,4794,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38.13276681,0,0.7701305,0.761288016,1.011615163,0.311722093,0.499944126,4.591274656,0,1.266569553,1.250847166,1.012569391,0.311265886,0.472984319,11.95795848,0,-1.390985839,1.201600105,-1.157611282,0.247022703,0.381286453,41.87950152,0,1.669903727,0.611621104,2.730291217,0.00632784,0.033738484,19.55560941,0,0.182748563,0.996817873,0.183331949,0.854537568,0.903057392,N,-,,cyclase dehydrase family,C:mitochondrion; P:cellular respiration; F:ubiquinone binding; C:cellular_component; P:ubiquinone biosynthetic process; F:molecular_function; C:mitochondrial inner membrane,IPR023393 (G3DSA:3.30.530.GENE3D); IPR005031 (PFAM); PTHR12901 (PANTHER); SSF55961 (SUPERFAMILY),,
RL4_JR_05464,19,4,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,339.5415435,0,-3.42583326,0.716349518,-4.782348802,1.73E-06,2.47E-05,146.3583342,0,-1.534768201,0.980671928,-1.565016961,0.117578932,0.229799953,264.8656433,0,-5.860132384,1.19814678,-4.890997063,1.00E-06,2.72E-05,353.7584198,0,-2.1713745,0.632163355,-3.434831331,0.000592923,0.004798835,262.0859007,0,-5.947676777,1.210291843,-4.914250072,8.91E-07,1.31E-05,N,-,,actin-binding,"F:actin filament binding; C:actin filament bundle; C:mating projection tip; C:actin filament; F:tRNA (cytosine-3-)-methyltransferase activity; P:tRNA methylation; F:protein binding, bridging; C:actin cortical patch; P:actin filament bundle assembly",IPR026113 (PIRSF); IPR029063 (G3DSA:3.40.50.GENE3D); PF13649 (PFAM); PTHR22809:SF9 (PANTHER); PTHR22809:SF9 (PANTHER); IPR026113 (PANTHER); IPR026113 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_05465,8,3,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,217.3349089,0,2.938072018,1.170028734,2.511110995,0.012035185,0.043969117,7.847724411,0,0.49329538,1.273729083,0.387284381,0.698545687,0.808632141,158.8387273,0,2.703468258,0.487847375,5.541627147,3.00E-08,1.16E-06,62.58526297,0,0.938840522,0.644985739,1.455598884,0.145503537,0.260057071,122.1531891,0,2.729307172,0.502509993,5.431349043,5.59E-08,1.48E-06,N,-,,eisosome 1,P:biological_process; C:cellular_component; F:molecular_function,IPR024527 (PFAM); PTHR28298:SF1 (PANTHER); PTHR28298 (PANTHER),,
RL4_JR_05466,31,17,78,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.61949052,0,0.150070824,1.056485692,0.14204719,0.887042731,0.944958815,3.555281866,0,1.635615475,1.319331492,1.239730488,0.215075096,0.361765213,91.38299398,0,3.262219953,0.561339802,5.811488768,6.19E-09,2.74E-07,127.2348014,0,3.617267839,0.473485358,7.639661454,2.18E-14,1.29E-12,78.4276584,0,3.110577868,1.518472505,2.048491401,0.040511874,0.095170005,N,-,,fk506 suppressor,C:integral component of membrane,IPR019402 (PFAM); PTHR21324:SF2 (PANTHER); PTHR21324 (PANTHER),,
RL4_JR_05467,13,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,100.4421175,0,0.614772405,0.556707349,1.104300863,0.269462649,0.45055878,11.80471704,0,-0.095794926,1.230868916,-0.077827074,0.93796561,0.966007368,59.29993078,0,0.068870399,0.766379218,0.089864648,0.928394774,0.957135305,70.63333801,0,0.1322506,0.651183601,0.203092645,0.83906262,0.899471575,57.23688444,0,0.525081429,0.648044869,0.810254744,0.41779378,0.553541222,N,-,,serine threonine- kinase,F:ATP binding; F:RNA polymerase II carboxy-terminal domain kinase activity; P:transcription from RNA polymerase I promoter; C:cytosol; C:TFIIK complex; P:transcription from RNA polymerase II promoter; P:positive regulation of transcription from RNA polymerase II promoter; P:phosphorylation of RNA polymerase II C-terminal domain serine 5 residues involved in recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex; P:phosphorylation of RNA polymerase II C-terminal domain involved in recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); PTHR24056:SF0 (PANTHER); PTHR24056 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_05468,311,335,463,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.12248572,0,-1.701888479,1.236942173,-1.375883624,0.168857666,0.321273364,22.58472855,0,3.153442842,1.03267281,3.053670836,0.0022606,0.015081,21.05972862,0,-0.169684367,1.219861377,-0.139101352,0.889370059,0.930948735,19.55249509,0,0.152664476,1.060665196,0.143932767,0.885553561,0.92972105,9.899295075,0,-1.221040633,1.236246137,-0.987700262,0.323299466,0.459380311,N,-,,alpha beta hydrolase fold family,P:biological_process; C:cellular_component; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR022742 (PFAM); PTHR11614 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_05469,9,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,68.46579432,0,0.468204802,0.602442835,0.777177145,0.437054265,0.62706449,8.558260883,0,0.368203901,1.21514447,0.303012448,0.761880375,0.855625558,63.87994022,0,1.120379,0.606325192,1.847818655,0.064628581,0.138165093,46.95603889,0,0.021253306,0.733689229,0.028967723,0.976890333,0.985749913,44.33175222,0,0.262130559,0.73953655,0.354452472,0.722999816,0.804984982,N,-,,rfx dna-binding domain-containing,"P:negative regulation of transcription from RNA polymerase II promoter; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; P:transcription from RNA polymerase II promoter; P:positive regulation of transcription from RNA polymerase II promoter",IPR011991 (G3DSA:1.10.10.GENE3D); IPR003150 (PFAM); PTHR12619:SF5 (PANTHER); PTHR12619 (PANTHER); IPR003150 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY); SSF81995 (SUPERFAMILY),,
RL4_JR_05470,289,275,284,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,176.0219359,0,-0.925799056,0.4896472,-1.890747168,0.058658103,0.149822418,40.01018467,0,-1.856781878,1.191061585,-1.558930203,0.119012901,0.232040639,145.0056748,0,-1.363123615,0.6652821,-2.048940764,0.040467908,0.096535602,221.9947391,0,-0.55859555,0.464764615,-1.201889153,0.229406478,0.365843532,184.96081,0,-0.068513702,0.435227274,-0.157420516,0.874913445,0.916625828,N,-,,yop-1,P:vesicle-mediated transport; C:cell division site; C:integral component of membrane; C:cortical endoplasmic reticulum; P:nuclear pore complex assembly; P:endoplasmic reticulum tubular network organization; P:endoplasmic reticulum inheritance; P:cellular protein localization,IPR004345 (PFAM); IPR004345 (PANTHER),8.A.108.1.1, the curature-stabilizing protein yop1 (yop1) family.
RL4_JR_05471,347,515,512,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,61.7708842,1,-0.086128403,0.610480598,-0.141082949,0.887804414,0.945379342,34.74191906,0,0.753109342,1.111935969,0.677295603,0.49821842,0.652767881,94.03220993,0,0.601762469,0.60927702,0.987666447,0.323316032,0.46614234,112.7351194,0,1.071647156,0.442276488,2.423025384,0.015391851,0.066090964,81.83794694,0,1.287330157,0.543523582,2.368489977,0.017860864,0.049887242,N,-,,calcium influx-promoting ehs1,P:biological regulation; F:calcium channel activity; C:membrane; P:calcium ion transport; P:single-organism cellular process; P:sexual reproduction; C:intracellular,IPR020067 (G3DSA:1.10.2000.GENE3D); IPR010580 (PFAM); IPR024338 (PFAM); PTHR15819:SF11 (PANTHER); PTHR15819 (PANTHER); PD968187 (PRODOM); IPR020067 (PROSITE_PROFILES),8.A.41.1.6," the stretch-activated calcium channel auxiliary protein, mid1 (mid1) family."
RL4_JR_05472,13,22,42,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.85611911,0,0.559938431,1.077454581,0.519686343,0.603282207,0.77127047,2.589540018,0,2.092699106,1.326578891,1.577515759,0.114676899,0.225648601,17.84884932,0,0.389551146,1.22420024,0.318208683,0.750326647,0.832887364,7.824414521,0,-0.99529999,1.237198492,-0.804478826,0.421120493,0.564149906,6.747539417,0,-0.66809054,1.247646403,-0.535480676,0.592317516,0.703981084,N,-,,hypothetical protein DHEL01_04290,C:integral component of membrane,no IPS match,,
RL4_JR_05473,607,893,717,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,50.17313828,0,-1.256709186,1.024669223,-1.226453531,0.220028052,0.389199664,9.537985881,0,0.211819446,1.223747678,0.173090785,0.862580068,0.919734062,24.80889691,0,-2.443796465,1.199115063,-2.037999973,0.041549936,0.098513243,28.62583495,0,-2.866421287,1.199161064,-2.390355535,0.01683207,0.070336238,24.50480893,0,-2.528740578,1.20517625,-2.098232999,0.035884568,0.086404578,N,-,,basic leucine zipper transcription factor domain-containing partial,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",PTHR39607:SF2 (PANTHER); PTHR39607 (PANTHER),,
RL4_JR_05474,29,45,57,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,169.6095663,0,-0.004311227,0.64328726,-0.006701869,0.994652722,0.997870116,25.97700732,0,-1.233685512,1.228584387,-1.004152034,0.315305338,0.477201051,68.0212563,0,-3.8989455,1.224347913,-3.184507818,0.001450004,0.007697871,78.51413375,0,-4.322076621,1.230316795,-3.51297864,0.000443113,0.003792494,86.67121268,0,-1.404449459,0.832361611,-1.687306864,0.091544362,0.178522085,N,-,,igr domain-containing,C:mitochondrion,IPR019083 (SMART); IPR019083 (PFAM); PTHR28235 (PANTHER); IPR013761 (SUPERFAMILY),,
RL4_JR_05475,1344,952,1674,0,2,0,0,0,0,0,1,0,0,2,7,0,0,0,70.34233003,1,-0.849819427,0.781827934,-1.086964778,0.277052376,0.460230764,14.31638113,0,-0.37403436,1.236283409,-0.302547423,0.762234788,0.855833668,36.95194962,1,-3.018543052,1.208847494,-2.497042072,0.01252341,0.038483624,42.61830572,1,-3.440537959,1.210661217,-2.841866834,0.004485022,0.025743112,40.04259773,0,-2.161873575,1.137058267,-1.901286538,0.057264491,0.124078014,N,-,,E3 ubiquitin- ligase SHPRH,F:catalytic activity; F:metal ion binding,IPR014001 (SMART); IPR001841 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); PF13920 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR000330 (PFAM); PTHR10799 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.20.1.1, the peroxisomal protein importer (ppi) family.
RL4_JR_05476,943,2669,1799,0,0,14,0,0,0,1,0,7,0,1,0,0,0,0,54.92789366,1,0.582168794,0.585653486,0.994049907,0.320198571,0.50870106,8.989329913,0,0.297318735,1.217369809,0.244230416,0.807052372,0.883358844,62.53685134,1,0.791736912,0.668815083,1.183790454,0.236496022,0.368976071,75.54640346,1,0.948951277,0.537675868,1.764913274,0.077578342,0.162895213,56.65740806,0,0.77590173,0.617343463,1.256839631,0.208811712,0.331850351,N,-,,secretion pathway sls2,P:vesicle-mediated transport; C:cytoplasmic part; P:single-organism cellular process,IPR001810 (SMART); G3DSA:1.20.1280.50 (GENE3D); IPR001810 (PFAM); IPR009976 (PFAM); PTHR12100:SF1 (PANTHER); IPR009976 (PANTHER); PTHR12100:SF1 (PANTHER); IPR009976 (PANTHER); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY),,
RL4_JR_05477,141,1044,592,0,0,9,0,0,0,0,0,2,1,0,0,0,0,0,484.8911269,1,-0.204013147,0.34735758,-0.587328906,0.556982831,0.734971054,80.9345755,0,-2.873155447,1.189461133,-2.415510155,0.015713184,0.047891855,230.5216707,1,-3.117592875,0.848941134,-3.672331037,0.000240348,0.001976672,319.7429404,1,-1.875205384,0.481014537,-3.898438068,9.68E-05,0.001041715,228.7866406,0,-2.975322981,0.743696499,-4.000722048,6.31E-05,0.000472921,N,-,,leucyl-tRNA synthetase,F:ATP binding; P:DNA replication initiation; P:leucyl-tRNA aminoacylation; F:leucine-tRNA ligase activity; P:regulation of translational fidelity; F:aminoacyl-tRNA editing activity; C:cytosol; P:regulation of TOR signaling,IPR004493 (TIGRFAM); IPR002300 (PFAM); IPR009080 (G3DSA:1.10.730.GENE3D); IPR009008 (G3DSA:3.90.740.GENE3D); IPR014729 (G3DSA:3.40.50.GENE3D); IPR013155 (PFAM); PTHR11946 (PANTHER); PTHR11946:SF51 (PANTHER); PTHR11946 (PANTHER); PTHR11946 (PANTHER); PTHR11946:SF51 (PANTHER); PTHR11946:SF51 (PANTHER); PTHR11946 (PANTHER); PTHR11946:SF51 (PANTHER); SSF52374 (SUPERFAMILY); IPR009008 (SUPERFAMILY); IPR009080 (SUPERFAMILY),,
RL4_JR_05478,1746,4043,2162,0,0,5,0,0,0,8,6,10,11,17,0,0,1,2,2.89421238,1,0.364328392,1.225392429,0.297315687,0.766225506,0.877722899,0.924960792,0,3.578040903,1.413953731,2.530521916,0.011389297,0.03709217,2.398452367,1,0.926685455,1.210263195,0.765689198,0.443861256,0.583591085,2.766734285,1,0.504453959,1.214542909,0.415344699,0.677889583,0.780375201,2.364314168,1,0.844701267,1.205950068,0.700444645,0.483649663,0.61210648,N,-,,cation diffusion facilitator 1,P:response to zinc ion; P:regulation of sequestering of zinc ion; P:cation transmembrane transport; C:integral component of membrane; F:zinc ion transmembrane transporter activity,IPR027470 (G3DSA:3.30.70.GENE3D); IPR027470 (PFAM); IPR002524 (PFAM); IPR027469 (G3DSA:1.20.1510.GENE3D); IPR002524 (TIGRFAM); PTHR11562:SF35 (PANTHER); IPR002524 (PANTHER); SSF161111 (SUPERFAMILY); SSF160240 (SUPERFAMILY),2.A.4.5.2, the cation diffusion facilitator (cdf) family.
RL4_JR_05479,6616,16975,8475,0,0,18,0,0,0,1,1,18,4,17,2,0,9,1,26.35153425,1,0.297282571,1.050386316,0.283022128,0.777159874,0.885032662,3.285521973,0,1.749435179,1.308895718,1.336573384,0.181361932,0.320318526,28.02019549,1,1.488410449,0.893711419,1.66542624,0.095827748,0.187869891,32.47073018,1,1.008665813,0.890038259,1.133283657,0.257095152,0.396510041,8.386440099,1,-0.981750938,1.227169752,-0.800012335,0.423703651,0.559030423,N,-,,glycosyltransferase family 8,"F:transferase activity, transferring glycosyl groups",IPR002495 (PFAM); IPR029044 (G3DSA:3.90.550.GENE3D); PTHR11183 (PANTHER); PTHR11183:SF39 (PANTHER); IPR029044 (SUPERFAMILY),,
RL4_JR_05480,870,792,559,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,35.28398049,0,0.613370364,0.80751258,0.759579948,0.447505709,0.636573945,5.024158558,0,1.136659095,1.280401501,0.887736459,0.374682529,0.539290901,66.60344977,0,2.109935734,0.639823389,3.297684598,0.000974856,0.005636459,42.34752645,1,0.797318958,0.78926303,1.010206898,0.312396175,0.458418938,20.21544627,0,-0.657101143,1.153444377,-0.569686026,0.56889067,0.685390056,N,-,,glycosyl family 8,"F:transferase activity, transferring glycosyl groups; F:transferase activity",no IPS match,,
RL4_JR_05481,944,902,707,0,0,5,0,0,0,0,0,0,0,0,0,0,1,0,3.5238618,1,0.080742737,1.229392226,0.065676954,0.947635021,0.973933139,1.122242376,0,3.299158152,1.387833017,2.377201083,0.017444575,0.051705415,2.912454862,0,0.646911699,1.21256282,0.53350778,0.593682127,0.712981952,12.9953887,0,1.174903239,1.150225446,1.021454745,0.30703904,0.452777494,2.869614961,1,0.56558197,1.209489075,0.467620569,0.640055953,0.741738185,N,-,,Oxidoreductase NAD-binding domain-containing 1,F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process,IPR001433 (PFAM); G3DSA:3.40.50.80 (GENE3D); G3DSA:2.40.30.10 (GENE3D); PTHR19370 (PANTHER); PTHR19370 (PANTHER); PTHR19370:SF99 (PANTHER); PTHR19370:SF99 (PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY); IPR017938 (SUPERFAMILY),,
RL4_JR_05482,3018,3886,4135,0,2,3,0,0,0,0,0,0,0,1,0,0,3,0,21.65655583,1,3.035678219,1.016900251,2.985227132,0.002833678,0.013752021,0.490717542,0,4.492668279,1.566488915,2.867986,0.004130938,0.018371529,1.2662977,0,1.848661228,1.235148823,1.496711323,0.134468389,0.241632582,9.483518098,1,3.146437947,1.03404506,3.042844137,0.002343537,0.015046487,1.241279101,1,1.7740992,1.214392016,1.46089498,0.144044264,0.251326586,Y,-,,hypothetical protein SPBR_05770,,no IPS match,,
RL4_JR_05483,48,42,64,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,63.48317454,0,-0.041999233,0.656766624,-0.063948488,0.949011243,0.974698945,10.15498015,0,0.121404037,1.210017468,0.100332466,0.920080383,0.95583857,65.33412964,0,0.86981299,0.609270469,1.427630312,0.153398294,0.267068672,39.70023954,0,-2.003814505,1.136936925,-1.762467611,0.077990324,0.163385053,60.70992378,0,1.146056728,0.524899563,2.183382895,0.029007625,0.07328724,N,-, Effector probability:0.801,NADH:ubiquinone oxidoreductase subunit,,PTHR15224 (PANTHER),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_05484,30,10,30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.16264156,0,-2.203457697,1.19167181,-1.84904743,0.064450964,0.160595897,5.509166533,0,1.003740426,1.24941809,0.80336633,0.42176303,0.585126835,27.22892898,0,0.176983127,1.037073868,0.17065624,0.864494074,0.91375814,35.03806004,0,-0.318724014,1.017035543,-0.313385325,0.753987932,0.83863867,25.18913105,0,-0.040260664,0.970690672,-0.041476307,0.966916181,0.978415584,N,-,,Secretory pathway Sec39,C:intracellular,IPR013244 (PFAM); PTHR15922 (PANTHER); PTHR15922:SF2 (PANTHER); PTHR15922:SF2 (PANTHER),,
RL4_JR_05485,11,17,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,399.154221,0,-2.543642672,0.543123258,-4.683361709,2.82E-06,3.78E-05,110.6647161,0,-3.32454294,1.192263375,-2.788429982,0.00529642,0.021418441,308.8245447,0,-3.577997054,0.86207296,-4.15045735,3.32E-05,0.000514435,472.4443323,0,-1.329380711,0.387637787,-3.429440459,0.000604827,0.004879581,548.6332385,0,-0.31120753,0.656247864,-0.474222542,0.63534122,0.738133087,N,-,,transformer-sr ribonucleo,F:nucleotide binding; F:nucleic acid binding; C:intracellular ribonucleoprotein complex; C:viral nucleocapsid,IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR15241 (PANTHER); PTHR15241:SF2 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_05486,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.622437881,0,-0.593719613,1.257825252,-0.472020746,0.636911981,0.792787296,1.780663787,0,2.63296212,1.368012648,1.924662118,0.054271643,0.125937086,4.651303462,0,-0.028926424,1.239637047,-0.023334592,0.981383379,0.990087228,5.367613191,0,-0.451708513,1.245261959,-0.362741759,0.716797802,0.810388391,4.62499639,0,-0.123241492,1.25108579,-0.098507627,0.921529216,0.949701381,N,-,,dna polymerase beta,P:DNA repair; F:nucleotidyltransferase activity; P:nucleobase-containing compound biosynthetic process; P:cellular macromolecule biosynthetic process,IPR022312 (PRINTS); IPR002008 (PRINTS); IPR002054 (SMART); IPR010996 (PFAM); IPR029398 (G3DSA:3.30.210.GENE3D); G3DSA:3.30.460.10 (GENE3D); IPR028207 (PFAM); IPR027420 (G3DSA:1.10.8.GENE3D); IPR018944 (PFAM); IPR029398 (PFAM); G3DSA:1.10.150.20 (GENE3D); PTHR11276:SF29 (PANTHER); PTHR11276:SF29 (PANTHER); PTHR11276 (PANTHER); PTHR11276 (PANTHER); IPR001357 (PROSITE_PROFILES); SSF81585 (SUPERFAMILY); IPR010996 (SUPERFAMILY); SSF81301 (SUPERFAMILY),,
RL4_JR_05487,24,18,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,53.56582241,0,0.152220853,0.756822124,0.201131611,0.840595665,0.919624667,9.676440441,0,0.191012751,1.252744413,0.152475436,0.878811963,0.931058686,25.25598965,0,-2.469572117,1.222218124,-2.020565781,0.043324734,0.101321231,37.17179044,0,-1.186302338,1.062529333,-1.116489024,0.264212866,0.404897119,25.0257453,0,-2.559095732,1.233248794,-2.075084723,0.037978683,0.090351074,N,-,,glutathione s-transferase,C:integral component of membrane; F:transferase activity,IPR001129 (PFAM); IPR023352 (G3DSA:1.20.120.GENE3D); PTHR10250:SF17 (PANTHER); PTHR10250 (PANTHER); SSF161084 (SUPERFAMILY),,
RL4_JR_05488,472,386,706,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,235.1318453,0,-0.341410796,0.373303738,-0.914565704,0.36041967,0.552066029,61.19432695,0,-0.29740651,0.98046733,-0.303331382,0.761637333,0.855518042,198.5767377,0,-0.438533127,0.481064554,-0.911588941,0.361985146,0.505969573,203.7016422,1,-0.81785322,0.456246901,-1.792567179,0.073042158,0.155726644,148.8992346,0,-1.443659863,0.614295543,-2.350106358,0.018768047,0.05204779,N,-,,transporter SEC23,F:zinc ion binding; P:ER to Golgi vesicle-mediated transport; F:structural constituent of ribosome; C:ribosome; P:intracellular protein transport; C:COPII vesicle coat; P:translation,IPR006900 (PFAM); G3DSA:2.60.40.1670 (GENE3D); IPR002035 (G3DSA:3.40.50.GENE3D); IPR029006 (G3DSA:3.40.20.GENE3D); IPR006896 (PFAM); IPR012990 (PFAM); IPR007123 (PFAM); IPR006895 (PFAM); PTHR11141 (PANTHER); IPR007123 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR006895 (SUPERFAMILY); IPR006900 (SUPERFAMILY); SSF81995 (SUPERFAMILY),,
RL4_JR_05489,1826,1480,1522,0,2,1,0,0,0,0,0,0,0,2,0,0,0,0,957.7599198,1,0.272082124,0.419692561,0.648289127,0.516797965,0.701970996,157.4731285,0,-2.010307925,0.99107954,-2.028402206,0.042519215,0.103906204,417.3969642,0,-2.502593067,0.570738336,-4.384834362,1.16E-05,0.000213273,607.6839517,1,-1.016188576,0.484938675,-2.095499138,0.036126645,0.100961159,510.6613224,0,-1.319565825,0.493376063,-2.674563937,0.007482651,0.024897088,N,-, Effector probability:0.698,60S ribosomal L12,F:structural constituent of ribosome; C:ribosome; P:translation,IPR000911 (SMART); IPR020784 (PFAM); IPR020783 (PFAM); IPR020783 (G3DSA:1.10.10.GENE3D); IPR020784 (G3DSA:3.30.1550.GENE3D); IPR000911 (PANTHER); PTHR11661:SF2 (PANTHER); IPR020784 (SUPERFAMILY); IPR020783 (SUPERFAMILY),,
RL4_JR_05490,8427,6560,7376,0,0,4,0,0,0,0,0,4,2,2,2,0,0,0,154.8209802,1,-1.714408652,0.885155551,-1.93684449,0.052764356,0.138676422,55.92348493,0,-0.129011301,1.040667756,-0.12396973,0.901339242,0.944583723,121.4801998,1,-1.591938821,0.803046436,-1.982374554,0.047437335,0.108704297,252.3162073,1,0.377552684,0.453481087,0.832565448,0.405089853,0.548700302,175.6229059,0,0.05351219,0.514615922,0.103984715,0.917181478,0.947271757,N,-,,udp-n-acetylglucosaminyltransferase,"F:transferase activity, transferring glycosyl groups; F:transferase activity",IPR019734 (SMART); IPR029489 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (PFAM); IPR019734 (PFAM); PTHR23083:SF421 (PANTHER); PTHR23083 (PANTHER); PTHR23083:SF421 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY),,
RL4_JR_05491,58,132,129,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42.93905201,0,-3.526554645,1.219785694,-2.89112642,0.003838637,0.017488906,13.89602767,0,-0.331046532,1.25176822,-0.264463122,0.791423078,0.873795221,35.72310095,0,-2.96977827,1.217556311,-2.43913012,0.014722666,0.043774529,41.1865521,0,-3.391266703,1.220326403,-2.778983307,0.005452933,0.030002919,38.75045651,0,-2.110089217,1.145553138,-1.841982835,0.065477661,0.138060373,N,-,,trichome differentiation partial,F:DNA binding,IPR001005 (SMART); IPR009057 (G3DSA:1.10.10.GENE3D); PF13921 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); PTHR10641:SF221 (PANTHER); PTHR10641:SF221 (PANTHER); PTHR10641 (PANTHER); PTHR10641 (PANTHER); IPR017930 (PROSITE_PROFILES); IPR017877 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY),,
RL4_JR_05492,44,150,103,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,76.48221075,0,0.989759409,0.533535249,1.855096567,0.063582438,0.159067856,7.987059048,0,0.467889188,1.223146718,0.382529079,0.702068964,0.811689555,53.89163168,0,0.235512281,0.845998401,0.278383837,0.780717726,0.854552278,39.90282529,0,0.115309808,0.740538493,0.155710755,0.876261019,0.923604291,31.92133679,0,-0.051061119,0.8357354,-0.061097232,0.951281774,0.968304812,N,-,,hypothetical protein CMQ_6496,F:nucleotide binding; P:biological_process; C:nucleus; F:RNA 7-methylguanosine cap binding; C:cytosol; F:mRNA binding; C:cellular_component; F:molecular_function,IPR019416 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D),,
RL4_JR_05493,9,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,94.98276624,0,1.103506447,0.953471558,1.157356438,0.247126764,0.423453086,10.90779523,0,0.018281849,1.246147031,0.014670699,0.988294895,0.99408933,28.10609414,0,-2.623769428,1.209467759,-2.169358718,0.030055461,0.076877585,72.52734561,0,0.84568821,0.634863909,1.332077943,0.182834578,0.309254945,46.78922311,0,0.210469521,0.71238562,0.295443247,0.767655301,0.838548918,N,-,,hypothetical protein SPSK_05105,,no IPS match,,
RL4_JR_05494,630,427,651,0,4,2,0,0,0,0,0,4,0,2,0,0,3,1,0.461153386,1,3.014210206,2.062380986,1.461519587,0.143872904,NA,0.147477195,0,6.226850649,1.948090483,3.196386771,0.001391604,0.015023052,0.382606434,1,3.57425443,1.300254968,2.748887349,0.005979793,0.02169872,0.441347718,1,3.152485488,1.464338602,2.152839162,0.031331321,0.094723687,0.377677699,1,3.490340672,1.24900377,2.794499709,0.005198009,0.018486069,N,-, Effector probability:0.586,---NA---,,no IPS match,,
RL4_JR_05495,837,745,895,0,0,16,0,0,0,0,0,0,0,0,0,0,0,0,63.91386591,1,-0.220692716,0.687646159,-0.320939357,0.748256348,0.868242572,12.98856477,0,-0.233712248,1.219623104,-0.191626616,0.848034692,0.909687066,40.38004075,0,-1.931687935,1.203665839,-1.604837382,0.108529597,0.205990558,58.36883599,0,-1.560897987,1.032440726,-1.511852398,0.130571416,0.23952049,33.60613705,0,-2.984427456,1.214386669,-2.457559468,0.013988465,0.041080878,N,-,,signal recognition particle,C:signal recognition particle; F:binding,IPR013699 (PFAM); IPR031545 (PFAM); IPR026270 (PANTHER); IPR026270 (PANTHER); PTHR14094:SF9 (PANTHER),3.A.5.9.1, the general secretory pathway (sec) family.
RL4_JR_05496,347,417,233,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein SPBR_06347,P:cellular amino acid biosynthetic process,no IPS match,,
RL4_JR_05497,1800,2201,1413,0,0,8,0,0,0,6,0,0,0,2,4,0,2,0,451.0233828,1,1.343718731,0.741977932,1.810995546,0.070141541,0.171168021,87.41577534,0,1.032329643,0.683269621,1.510867177,0.130822295,0.248393035,149.4001329,1,-1.120685099,0.61729826,-1.815467775,0.069452054,0.145908403,138.8126324,1,-2.635319383,0.853312944,-3.088338694,0.002012789,0.013284251,111.2202724,1,-2.939433263,0.977926715,-3.005780718,0.002649,0.010745641,N,-,,aspartate kinase,P:methionine biosynthetic process; F:aspartate kinase activity; P:lysine biosynthetic process via diaminopimelate; P:threonine biosynthetic process; P:mitotic sister chromatid cohesion; C:cohesin complex; F:chromatin binding; F:ATP binding; F:protein heterodimerization activity; C:cytosol; P:phosphorylation; F:amino acid binding; P:homoserine biosynthetic process,IPR027795 (PFAM); IPR001048 (PFAM); IPR001048 (G3DSA:3.40.1160.GENE3D); IPR001341 (TIGRFAM); PTHR21499:SF3 (PANTHER); PTHR21499 (PANTHER); PTHR21499 (PANTHER); PTHR21499 (PANTHER); PTHR21499:SF3 (PANTHER); PTHR21499:SF3 (PANTHER); IPR002912 (PROSITE_PROFILES); IPR002912 (PROSITE_PROFILES); IPR001048 (SUPERFAMILY); SSF55021 (SUPERFAMILY); SSF55021 (SUPERFAMILY),,
RL4_JR_05498,20,20,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,207.4814538,0,-0.326030861,0.489681716,-0.665801582,0.505537933,0.692221146,49.1794231,0,-0.933518816,1.133671009,-0.823447728,0.410253431,0.573957876,157.2543958,0,-0.868582895,0.608673537,-1.427009459,0.153577168,0.267196297,300.7286787,0,0.516490401,0.394180712,1.310288364,0.190098302,0.318877619,115.8779591,0,-1.969203469,0.776289007,-2.536688595,0.011190645,0.034387035,N,-,,cohesin complex subunit,C:nucleus; F:ATP binding; F:aspartate kinase activity; F:protein heterodimerization activity; P:lysine biosynthetic process via diaminopimelate; P:threonine biosynthetic process; P:mitotic sister chromatid cohesion; C:cohesin complex; F:chromatin binding; P:phosphorylation; F:amino acid binding,IPR010935 (SMART); IPR024704 (PIRSF); IPR027417 (G3DSA:3.40.50.GENE3D); IPR010935 (PFAM); IPR003395 (PFAM); PTHR18937 (PANTHER); PTHR18937 (PANTHER); PTHR18937:SF237 (PANTHER); PTHR18937:SF237 (PANTHER); IPR027417 (SUPERFAMILY); IPR010935 (SUPERFAMILY),,
RL4_JR_05499,506,798,596,2,0,0,0,0,0,0,0,2,0,2,0,0,2,0,54.5692902,1,1.412985588,0.530551537,2.663239083,0.00773924,0.030964553,6.445693001,0,0.777157439,1.229392972,0.632147293,0.527290635,0.676027334,16.73317898,1,-1.875746169,1.192256987,-1.57327337,0.115655533,0.216192137,56.87599582,1,0.453773711,0.739587474,0.613549751,0.539512897,0.670747554,38.96732148,1,0.667566934,0.751214083,0.888650718,0.374190824,0.510260215,N,-,,f-box,C:integral component of membrane; C:endoplasmic reticulum; C:Golgi apparatus,IPR021261 (PFAM); PTHR31201:SF1 (PANTHER); PTHR31201 (PANTHER),,
RL4_JR_05500,6869,5566,3747,3,3,7,0,0,0,9,13,1,3,2,0,0,9,6,37.97850484,1,0.099153973,0.755489062,0.13124475,0.895581697,0.94860497,26.02402414,0,2.23991907,1.002703304,2.233880213,0.025490956,0.069547023,40.97345935,1,-0.213472857,1.036101102,-0.206034775,0.836763748,0.894598293,33.75888096,1,-0.171281174,0.866750002,-0.197613122,0.843347768,0.902209631,26.2844099,1,-0.463176296,0.986158101,-0.469677525,0.638585427,0.740355862,N,-,,WD repeat domain-containing,P:cell division; C:nucleus; P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; F:ubiquitin-protein transferase activator activity; C:cytoplasm; P:regulation of cell size; P:regulation of catalytic activity; P:positive regulation of mitotic metaphase/anaphase transition; F:cyclin binding; F:anaphase-promoting complex binding; P:negative regulation of spindle pole body separation,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); IPR024977 (PFAM); IPR033010 (PANTHER); IPR033010 (PANTHER); IPR033010 (PANTHER); PTHR19918:SF1 (PANTHER); PTHR19918:SF1 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_05501,11747,6900,7357,0,1,16,0,0,0,1,5,7,2,1,6,0,27,10,245.97718,1,-1.829567393,0.649994221,-2.814744093,0.004881609,0.021330566,175.3933322,0,0.616318776,1.631123911,0.377849146,0.705542662,0.814787569,272.3042189,1,-0.517817122,0.536507869,-0.965162212,0.334463571,0.477724209,347.2283812,1,0.053371517,0.603083016,0.088497795,0.929481037,0.958118474,192.2310507,1,-1.711803962,0.659964881,-2.593780382,0.00949271,0.030110806,N,-,,guanyl-nucleotide exchange factor,P:biological regulation,IPR000904 (SMART); IPR001849 (SMART); IPR023394 (G3DSA:1.10.1000.GENE3D); IPR001849 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR000904 (PFAM); PTHR10663 (PANTHER); PTHR10663:SF186 (PANTHER); PTHR10663:SF186 (PANTHER); PTHR10663 (PANTHER); IPR000904 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR000904 (SUPERFAMILY); IPR011993 (SUPERFAMILY),,
RL4_JR_05502,1338,1332,857,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,143.9265226,0,1.388572476,0.769513631,1.804480675,0.071155986,0.173074101,14.09973811,0,-0.352034141,1.224953974,-0.287385607,0.77381708,0.862998732,134.812194,0,1.415475879,0.471759396,3.00041905,0.002696084,0.012549497,109.2364785,0,0.640207255,0.511268999,1.252192596,0.210499693,0.344092573,73.5554232,0,0.535246317,0.557496938,0.960088352,0.33701075,0.473987199,N,-,,WD domain-containing,,no IPS match,,
RL4_JR_05503,829,1041,934,1,0,3,0,0,0,0,0,1,0,8,0,0,0,0,48.31453074,1,-1.038762228,0.917093499,-1.132667748,0.257353807,0.436249851,11.64486564,0,-0.076172713,1.236082858,-0.061624278,0.950862043,0.973667236,30.44054473,1,-2.738991084,1.215562609,-2.253270267,0.024242113,0.064859185,58.09086733,1,-0.828075458,0.887891884,-0.932630958,0.351010543,0.497706799,41.49344325,0,-1.153930077,1.015289414,-1.13655285,0.25572526,0.386796872,N,-,,n-acetyltransferase 5,P:mitochondrion inheritance; C:nucleus; C:NatB complex; P:cytoskeleton organization; P:N-terminal peptidyl-methionine acetylation; C:cytosol; F:peptide alpha-N-acetyltransferase activity,IPR000182 (PFAM); IPR016181 (G3DSA:3.40.630.GENE3D); PTHR23091 (PANTHER); PTHR23091:SF71 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_05504,22,15,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,76.19687587,0,1.238310785,0.552359377,2.241857087,0.02497061,0.078682981,8.055159716,0,0.455535361,1.23365622,0.369256324,0.711936677,0.819261374,49.6969103,0,0.612157954,0.764499183,0.800730684,0.423287575,0.564483541,193.8142751,0,2.696776668,0.668795564,4.032288507,5.52E-05,0.000646581,59.44667648,0,1.499961308,0.634908898,2.362482731,0.018152987,0.050563685,Y,-,,glutaminase a,C:cellular_component; F:molecular_function,IPR033433 (PFAM); IPR032514 (PFAM); IPR014870 (PFAM); PTHR31987 (PANTHER); PTHR31987 (PANTHER); PTHR31987:SF12 (PANTHER); PTHR31987:SF12 (PANTHER),,
RL4_JR_05505,84,110,86,0,0,11,0,0,0,0,0,0,0,2,0,0,0,0,113.3144008,1,-0.675191063,0.703485676,-0.959779404,0.33716625,0.527238311,19.96347401,0,-0.853822062,1.225276598,-0.69684026,0.485902768,0.642160571,58.7134451,0,-2.55562994,1.216739832,-2.100391449,0.035694421,0.087435353,106.8261817,1,-0.463931571,1.551113767,-0.299095773,0.764866971,0.846739349,59.649127,0,-1.960740154,1.026152874,-1.910768078,0.056034392,0.122138108,N,-,,transcription initiation factor TFIIE subunit alpha,F:translation initiation factor activity; C:transcription factor TFIIE complex; F:sequence-specific DNA binding; P:translational initiation; P:transcription initiation from RNA polymerase II promoter,IPR024550 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR13097 (PANTHER); PTHR13097:SF7 (PANTHER); IPR017919 (PROSITE_PROFILES),,
RL4_JR_05506,629,774,796,0,0,6,0,0,0,0,1,1,0,1,0,0,0,0,113.2513745,1,-1.406229913,0.708035831,-1.986099929,0.047022229,0.127106476,26.03515268,0,-1.236898359,1.212489408,-1.020131269,0.307666209,0.469217623,67.6817437,1,-3.891735012,1.205205579,-3.22910471,0.001241784,0.006858605,94.12938331,1,-1.623339247,0.784669748,-2.068818443,0.038563127,0.104931917,86.24993886,0,-1.087136909,0.732999051,-1.483135494,0.138038415,0.243448695,N,-,,atp-dependent permease mdl2,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:mycelium development; C:integral component of membrane; P:oligopeptide export from mitochondrion; C:mitochondrial inner membrane",IPR003593 (SMART); IPR003439 (PFAM); G3DSA:1.20.1560.10 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011527 (PFAM); PTHR24221 (PANTHER); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY),3.A.1.212.3, the atp-binding cassette (abc) superfamily.
RL4_JR_05507,1944,2038,2318,0,0,4,0,0,0,0,0,0,0,4,0,0,5,0,84.13004137,1,-1.002342468,0.696131538,-1.4398751,0.149902739,0.296821977,41.63067167,0,0.117030931,1.112684399,0.105178909,0.916233846,0.953636914,50.26547314,0,-3.462518932,1.195680254,-2.895856916,0.003781248,0.01586463,70.03381895,1,-1.588387956,0.867417965,-1.831167926,0.067075482,0.146745735,75.99451353,1,-0.607166187,0.693359794,-0.875687041,0.381200192,0.516963829,N,-,,ABC multidrug transporter mdr2,"C:nucleus; F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:regulation of cellular process; P:transmembrane transport; C:integral component of membrane; C:chromosomal part; P:cellular process",IPR006569 (SMART); IPR006903 (PFAM); IPR008942 (G3DSA:1.25.40.GENE3D); PTHR12460 (PANTHER); IPR006569 (PROSITE_PROFILES); IPR008942 (SUPERFAMILY),,
RL4_JR_05508,4354,2816,3345,0,0,10,0,0,0,4,0,2,0,5,0,0,2,1,177.7979236,1,0.945199321,0.689228904,1.371386655,0.170254455,0.323535021,17.67571798,0,-0.678190245,1.199599253,-0.565347339,0.571837536,0.712211091,58.92272983,1,-1.512084593,1.031778104,-1.465513358,0.142780911,0.252712227,105.1366686,1,0.475122175,0.603765125,0.786932128,0.431321599,0.573490635,78.65364914,1,-0.450963011,0.67781802,-0.66531576,0.505848552,0.632857604,N,-,,clathrin light chain,P:fungal-type cell wall organization; C:endosome; C:clathrin coat of trans-Golgi network vesicle; P:positive regulation of endocytosis; C:clathrin coat of coated pit; F:structural molecule activity; P:intracellular protein transport; P:endocytosis,IPR000996 (PFAM); PTHR10639:SF7 (PANTHER); IPR000996 (PANTHER),,
RL4_JR_05509,6414,4272,4317,0,0,0,0,0,0,0,0,2,3,6,0,0,0,0,651.2049375,0,0.987627486,0.421087194,2.345422753,0.019005516,0.062822935,324.1956732,0,1.828541745,0.458231111,3.990435612,6.60E-05,0.003441065,508.8317875,1,0.810869771,0.329938157,2.457641691,0.013985263,0.042013888,460.4082906,1,0.333515123,0.370582883,0.899974441,0.368133852,0.514495678,285.4347565,0,-0.607292346,0.462459427,-1.313179731,0.189122392,0.308749471,N,-,,hypothetical protein GGTG_06122,C:integral component of membrane,PF02238 (PFAM),,
RL4_JR_05510,2353,1534,1839,0,0,9,0,0,0,0,0,2,0,7,1,0,0,6,165.8554294,1,-0.924240383,0.662648011,-1.394768215,0.163085747,0.313712219,138.3426343,0,1.349335082,0.737201451,1.830347838,0.067197942,0.148672693,127.5725487,1,-1.414354233,0.799316335,-1.769454933,0.076817985,0.158005949,148.1243009,1,-0.863449568,0.629051091,-1.37262232,0.16986979,0.291959195,87.57052017,1,-4.366153464,1.24358546,-3.510939622,0.000446526,0.002466489,N,-,,pentatricopeptide repeat domain-containing,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_05511,7468,6911,6832,0,3,2,0,0,0,1,1,7,2,3,0,0,0,3,61.82394905,1,0.272939472,0.60872454,0.448379282,0.653879492,0.804703848,9.749929177,0,0.180151477,1.214574658,0.148324746,0.882086487,0.932965457,31.76739261,1,-1.508451054,1.187573247,-1.270196224,0.204014742,0.330101526,41.18399452,1,-0.585035352,0.848216371,-0.689724194,0.490367648,0.630143205,39.60413541,1,-0.867776186,0.965261456,-0.899006358,0.368649274,0.504930887,N,-,,syntaxin 16,F:SNAP receptor activity; P:endocytosis; P:protein secretion; P:mannosyl-inositol phosphorylceramide metabolic process; P:Golgi to vacuole transport; C:trans-Golgi network; P:protein exit from endoplasmic reticulum; P:vesicle fusion; C:cytosol; C:SNARE complex; P:positive regulation of cell-substrate adhesion; C:integral component of endosome membrane; P:CVT pathway,IPR000727 (SMART); G3DSA:1.20.58.70 (GENE3D); IPR000727 (PFAM); IPR028673 (PTHR19957:PANTHER); PTHR19957 (PANTHER); IPR000727 (PROSITE_PROFILES); IPR010989 (SUPERFAMILY),1.F.1.1.3, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_05512,28,30,40,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,548.2024554,0,1.051920708,0.647118963,1.625544556,0.104046578,0.228359425,125.0910526,0,-0.159586184,0.859563513,-0.18565956,0.852711743,0.912614026,273.5287828,0,-0.257872674,0.507903426,-0.507719895,0.611649794,0.727358851,312.582213,0,-0.181633559,0.496676496,-0.365697914,0.714590503,0.808947768,209.3652324,0,-1.064985205,0.531397934,-2.004119957,0.045057212,0.103471144,N,-,,calmodulin,F:calcium ion binding,PR00450 (PRINTS); IPR002048 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR002048 (PFAM); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR23050 (PANTHER); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY),8.A.82.1.1, the calmodulin calcium binding protein (calmodulin) family.
RL4_JR_05513,204,189,257,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,9.59807306,1,-1.365299254,1.192132241,-1.145258225,0.252102205,0.429542563,3.068460554,0,1.847990161,1.274639088,1.449814444,0.14711027,0.272869737,7.956144676,1,-0.803209465,1.197254755,-0.670875986,0.502299535,0.63462879,9.177697475,0,-1.225458806,1.195164826,-1.025347115,0.305199432,0.450953365,7.84355873,0,-0.885348602,1.199733022,-0.737954683,0.460541988,0.59181494,N,-,,"mannosyl-oligosaccharide alpha-1,2-mannosidase","C:membrane; F:hydrolase activity, acting on glycosyl bonds",IPR001382 (PRINTS); IPR001382 (PFAM); IPR001382 (G3DSA:1.50.10.GENE3D); PTHR11742 (PANTHER); PTHR11742:SF49 (PANTHER); PTHR11742:SF49 (PANTHER); PTHR11742 (PANTHER); IPR001382 (SUPERFAMILY),,
RL4_JR_05514,2118,1592,1468,0,1,5,0,0,0,0,2,0,0,0,0,0,0,0,1.129971513,1,1.721194259,1.437861507,1.19705149,0.231286486,NA,0.36194605,0,4.931635424,1.647210333,2.993931816,0.002754075,0.015349618,0.93784734,1,2.281126074,1.250413381,1.824297555,0.0681071,0.143589396,1.081759702,0,1.859152795,1.293990802,1.436758895,0.150786514,0.267094726,0.924437357,0,2.199154421,1.230798306,1.786770756,0.073974548,0.151189402,N,-,,---NA---,,no IPS match,,
RL4_JR_05515,7285,6457,5218,10,1,5,0,0,0,0,3,0,0,13,3,0,13,1,82.23962159,1,0.324019447,0.638751265,0.507270145,0.611965284,0.776912733,14.1261136,0,-0.354731328,1.22130339,-0.290453078,0.771469643,0.86142479,96.46142406,1,0.429471172,0.627509977,0.684405328,0.493719253,0.626917561,75.47473044,1,0.082848339,0.59940569,0.138217472,0.890068547,0.932334372,43.51399596,1,-1.40707862,0.976640892,-1.440732854,0.149660169,0.258364743,N,-,,tgf beta receptor associated,P:cellular process,IPR019453 (PFAM); PTHR12894:SF17 (PANTHER); PTHR12894 (PANTHER); PTHR12894 (PANTHER); IPR001180 (PROSITE_PROFILES),,
RL4_JR_05516,3291,2880,2691,0,3,9,0,0,0,3,5,1,1,7,0,0,6,0,70.08513996,1,0.288543155,0.601721438,0.479529458,0.631562017,0.790591212,9.723578537,0,0.184057393,1.214668613,0.151528895,0.879558519,0.931615043,25.18522723,1,-2.465487963,1.187015568,-2.077047706,0.037797156,0.091348391,50.39851572,1,-0.160981067,0.734699124,-0.219111554,0.82656315,0.891657558,51.80523159,1,0.87136419,0.568932708,1.531576893,0.125626878,0.226586765,N,-,,Golgi membrane,F:DNA binding; C:integral component of Golgi membrane; P:intra-Golgi vesicle-mediated transport,IPR012955 (PFAM); PTHR14043:SF2 (PANTHER); PTHR14043 (PANTHER); PTHR14043:SF2 (PANTHER); PTHR14043 (PANTHER),,
RL4_JR_05517,229412,107493,26788,5,5,4,0,1,0,0,19,28,5,0,11,0,29,9,2.866232628,1,0.378324738,1.274083931,0.296938631,0.766513363,0.877722899,19.66538839,1,5.23346478,1.01884437,5.136667516,2.80E-07,2.89E-05,8.868584442,1,1.905349172,1.214811008,1.568432586,0.116780211,0.217617946,12.0469955,1,1.473128949,1.167717124,1.261546071,0.207112172,0.339322127,2.352231904,1,0.852234699,1.23813789,0.688319699,0.49125148,0.619726044,Y,-,,malate dehydrogenase,C:integral component of Golgi membrane; P:intra-Golgi vesicle-mediated transport,IPR021851 (PFAM); PTHR35567 (PANTHER); PTHR35567:SF1 (PANTHER),,
RL4_JR_05518,6290,2896,2393,0,1,0,0,0,1,0,1,3,4,0,0,0,2,0,136.6773107,1,-0.838120097,0.503481544,-1.664649094,0.095982785,0.214645712,31.39594173,1,-1.506975558,1.195458191,-1.260584075,0.207458739,0.352686826,133.4351995,1,-1.000433428,0.661662102,-1.512000499,0.130533736,0.236662525,97.8041989,1,-3.631103291,1.138686003,-3.188853892,0.001428381,0.009987813,102.1225703,1,-2.009699881,0.833136726,-2.412208966,0.015856191,0.045385213,N,-,,ap-1 complex subunit gamma-1,P:vesicle-mediated transport; C:integral component of membrane; C:clathrin adaptor complex; F:protein transporter activity; C:Golgi apparatus; P:intracellular protein transport,IPR008152 (SMART); IPR002553 (PFAM); IPR008152 (PFAM); IPR008153 (G3DSA:2.60.40.GENE3D); IPR017107 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR22780:SF5 (PANTHER); PTHR22780 (PANTHER); IPR008153 (PROSITE_PROFILES); IPR013041 (SUPERFAMILY); IPR016024 (SUPERFAMILY),9.B.278.1.1, the organellar-targeting adaptor protein complex (o-apc) family.
RL4_JR_05519,1476,681,1004,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,33.87484545,0,-0.305465402,0.886888073,-0.344423847,0.730527557,0.85798491,25.86710628,1,2.270396792,1.00501651,2.259064173,0.023879393,0.066239304,25.03612411,0,-1.061685584,1.204262981,-0.881606094,0.377989858,0.521713609,58.63982931,0,0.338880413,0.770574058,0.439776566,0.660098941,0.768306907,18.38169403,0,-2.113973295,1.216553675,-1.737673675,0.08226833,0.164943928,N,-,,zinc finger rts2,F:metal ion binding,IPR019447 (SMART); IPR022755 (PFAM); IPR019447 (PFAM); PTHR12805 (PANTHER); SSF57667 (SUPERFAMILY),,
RL4_JR_05520,278,178,116,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,56.34330079,1,-1.529533122,1.01996171,-1.499598571,0.133718418,0.272446268,33.81018939,1,0.865694378,1.113310191,0.777585963,0.436813139,0.598379022,29.93819405,0,-2.714982961,1.196296316,-2.269490363,0.023238523,0.062665564,42.56767839,0,-1.41508286,1.024228851,-1.381608084,0.16709207,0.288097136,37.35226495,0,-1.139419966,0.990846468,-1.149946034,0.250166099,0.380777473,N,-, Effector probability:0.817,transcription elongation factor spt-4,"F:zinc ion binding; P:intracellular mRNA localization; P:negative regulation of transcription elongation from RNA polymerase II promoter; C:DSIF complex; P:transcription, DNA-templated; P:7-methylguanosine mRNA capping; P:chromosome segregation; P:chromatin silencing; P:regulation of transcription-coupled nucleotide-excision repair; C:chromosome, centromeric region; P:translational elongation; P:mRNA splicing, via spliceosome; F:transcription factor activity, core RNA polymerase II binding; P:positive regulation of transcription elongation from RNA polymerase II promoter; F:translation elongation factor activity; P:negative regulation of transcription elongation from RNA polymerase I promoter; F:rDNA binding; P:positive regulation of transcription elongation from RNA polymerase I promoter; F:transcription factor activity, core RNA polymerase I binding; C:cytosol; P:regulation of rRNA processing",IPR022800 (SMART); IPR009287 (PIRSF); IPR022800 (PFAM); IPR016046 (PANTHER); PTHR12882:SF1 (PANTHER); IPR029040 (SUPERFAMILY),,
RL4_JR_05521,4464,1827,1835,10,1,2,0,0,0,0,2,3,0,0,0,0,0,0,9.624522783,1,0.30246629,1.223420969,0.247229938,0.804730277,0.901630269,1.829774366,0,2.593685576,1.393063369,1.861857569,0.062623169,0.140954352,4.796401238,1,-0.073222937,1.259500052,-0.05813651,0.953639893,0.973251036,5.53620184,0,-0.496299597,1.268474183,-0.391257153,0.695607167,0.794744139,4.787221151,0,-0.172958867,1.275189946,-0.135633807,0.892110778,0.929279121,N,-,,ribonuclease P MRP subunit POP8,P:biological_process; P:tRNA processing; C:ribonuclease MRP complex; C:cellular_component; F:molecular_function; C:nucleolar ribonuclease P complex; P:mRNA cleavage,PTHR28173 (PANTHER),,
RL4_JR_05522,1297,1122,1164,0,0,1,0,0,0,0,1,0,2,1,1,0,2,0,522.403625,1,-4.778929493,0.915762517,-5.218524895,1.80E-07,3.35E-06,180.9939199,0,-2.253349142,1.036020152,-2.175005126,0.029629732,0.078387912,426.1465426,1,-5.562251185,1.225070049,-4.540353583,5.62E-06,0.000115516,496.0087008,1,-4.679244696,0.92297564,-5.069738021,3.98E-07,7.91E-06,439.8056625,1,-3.464476882,0.73366901,-4.722125145,2.33E-06,2.96E-05,N,-,,serine threonine- phosphatase 5,C:nucleus; F:phosphoprotein phosphatase activity; C:cytoplasm; P:protein dephosphorylation,IPR006186 (PRINTS); IPR006186 (SMART); IPR019734 (SMART); IPR004843 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR013235 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); PIRSF033096 (PIRSF); PTHR11668 (PANTHER); IPR011236 (PTHR11668:PANTHER); IPR011236 (PTHR11668:PANTHER); PTHR11668 (PANTHER); IPR013026 (PROSITE_PROFILES); IPR029052 (SUPERFAMILY); IPR011990 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_05523,4322,5223,7331,0,1,9,0,0,2,0,1,8,0,11,2,7,5,4,126.811638,1,-0.687422138,0.561305026,-1.224685519,0.220693732,0.39003888,25.46955368,1,-1.205187683,1.208686055,-0.99710564,0.318713236,0.480633994,81.65466848,1,-2.030262717,1.040025208,-1.952128372,0.050922966,0.114820513,84.11390499,1,-2.555870855,1.027730069,-2.486908705,0.012885846,0.059358141,64.98436447,1,-3.935819739,1.199696967,-3.280678243,0.001035578,0.004918024,N,-,,nuclear es2,,IPR019148 (PFAM); PTHR12940 (PANTHER),,
RL4_JR_05524,1702,1351,1571,0,0,2,0,0,0,1,0,0,3,0,0,0,0,0,45.87134807,1,-1.454776876,1.059824121,-1.372658772,0.169858452,0.3228577,10.74740755,0,0.039528634,1.245820438,0.031728998,0.97468817,0.986927705,54.11102147,1,0.172559077,0.8010264,0.215422459,0.829437961,0.89000847,36.4617045,1,-2.102525006,1.178815774,-1.783590831,0.074490177,0.157785155,27.98509071,0,-2.720364002,1.235803696,-2.201291363,0.027715404,0.070720379,N,-,,Atypical ABC1 ABC1-A kinase,"P:ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate; C:mitochondrion; P:phosphorylation; F:kinase activity",IPR004147 (PFAM); PTHR10566:SF65 (PANTHER); PTHR10566 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_05525,3616,2040,2184,2,1,0,0,0,0,0,1,0,1,0,0,0,0,0,93.73223818,1,-1.113627742,0.715023415,-1.557470313,0.119358864,0.251164207,20.97026656,0,-0.924794295,1.210651962,-0.763881218,0.444938031,0.606334324,65.76766716,1,-2.622645838,1.204358705,-2.177628498,0.029433706,0.075477923,63.12175123,1,-4.007263221,1.206652385,-3.320975677,0.000897034,0.006732739,54.21744592,0,-3.674457888,1.212933142,-3.029398539,0.002450412,0.010044705,N,-,,pre-rRNA processing,P:cleavage involved in rRNA processing; C:nucleolus,IPR009292 (PFAM); IPR009292 (PANTHER); PTHR21738:SF0 (PANTHER); PTHR21738:SF0 (PANTHER),,
RL4_JR_05526,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.12038252,0,-0.368141567,1.114523367,-0.330313009,0.741163464,0.864143424,4.86703134,0,1.182365474,1.317717146,0.897283213,0.369567812,0.533937396,12.77838351,0,-1.486758875,1.252166206,-1.187349465,0.235089804,0.367499347,18.76248472,0,-0.96711376,1.210425581,-0.79898655,0.424298211,0.566981574,12.77297972,0,-1.588797547,1.272867609,-1.248203298,0.211956617,0.335951901,N,-,,phospho phosphatase,F:phosphoprotein phosphatase activity,IPR004274 (SMART); IPR023214 (G3DSA:3.40.50.GENE3D); IPR004274 (PFAM); PTHR12210:SF40 (PANTHER); PTHR12210 (PANTHER); IPR004274 (PROSITE_PROFILES); IPR023214 (SUPERFAMILY),,
RL4_JR_05527,3826,3673,5651,3,0,0,0,0,4,1,5,0,0,4,2,0,4,0,1936.635141,1,-1.198828009,0.44639052,-2.685603644,0.007239892,0.029282616,449.4746695,1,-4.339931961,1.153730559,-3.761651218,0.000168795,0.007526635,1298.651329,1,-2.68841212,0.508471031,-5.287247367,1.24E-07,4.19E-06,1595.696912,1,-2.012515795,0.567318822,-3.547415871,0.00038903,0.003386869,1229.145231,1,-3.076880247,0.931813684,-3.302033763,0.000959865,0.004621319,N,-,,elongation factor 1-gamma,F:translation elongation factor activity; P:translational elongation,IPR001662 (SMART); IPR004045 (PFAM); IPR001662 (PFAM); IPR001662 (G3DSA:3.30.70.GENE3D); IPR004046 (PFAM); IPR010987 (G3DSA:1.20.1050.GENE3D); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR11260:SF143 (PANTHER); PTHR11260:SF143 (PANTHER); PTHR11260 (PANTHER); PTHR11260 (PANTHER); IPR004045 (PROSITE_PROFILES); IPR010987 (PROSITE_PROFILES); IPR001662 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR010987 (SUPERFAMILY); IPR001662 (SUPERFAMILY),,
RL4_JR_05528,4822,3028,4272,0,0,18,0,0,4,0,0,4,3,4,2,0,0,3,194.6024705,1,-0.659040565,0.508233872,-1.296726962,0.194725149,0.356420858,39.29710541,1,-1.830853056,1.201742916,-1.523498106,0.127634134,0.244125606,113.4512924,1,-3.527032408,1.200953588,-2.936859879,0.003315539,0.014600485,122.1541603,1,-3.965272485,1.156507329,-3.428661788,0.000606565,0.004888847,120.6359279,1,-1.682849365,0.729386788,-2.307211198,0.021043049,0.056922488,N,-,,ribosomal S9 S16,F:structural constituent of ribosome; P:mitochondrial translation; C:mitochondrial small ribosomal subunit,IPR000754 (PFAM); IPR014721 (G3DSA:3.30.230.GENE3D); PTHR21569:SF1 (PANTHER); IPR000754 (PANTHER); IPR020568 (SUPERFAMILY),,
RL4_JR_05529,4916,4866,6273,0,4,3,0,1,2,0,0,0,0,3,0,0,6,0,24.10689384,1,-1.159483352,1.157726741,-1.001517294,0.316576784,0.504983615,5.182726912,1,1.091877117,1.270901377,0.859135993,0.390265491,0.554657021,13.35784224,0,-1.55053516,1.208147026,-1.283399393,0.199352186,0.324737174,15.40395114,1,-1.972321985,1.207533916,-1.633347071,0.102396022,0.199491962,13.07196504,1,-1.622224236,1.204054644,-1.347301174,0.177883254,0.294979864,N,-,,hypothetical protein SPI_03251,,no IPS match,,
RL4_JR_05530,17882,15559,21373,4,3,9,0,1,1,1,6,2,3,19,9,0,15,1,149.6799413,1,-2.863719726,0.871725212,-3.285117473,0.001019399,0.006010225,42.56493026,1,-1.946088823,1.196056957,-1.627087081,0.103718604,0.208177615,132.8739563,1,-2.769327181,1.035530293,-2.674308225,0.007488359,0.025927547,170.4638716,1,-1.315685656,0.559071411,-2.353340966,0.018605565,0.074312167,109.4326234,1,-4.687675787,1.202757081,-3.897441854,9.72E-05,0.000677532,N,-,,calcineurin subunit B,P:fungal-type cell wall organization; C:nucleus; C:calcineurin complex; C:cell division site; F:calcium ion binding; P:regulation of catalytic activity; C:cytosol; F:calcium-dependent protein serine/threonine phosphatase regulator activity; P:adaptation of signaling pathway by response to pheromone involved in conjugation with cellular fusion; P:dephosphorylation; P:cellular ion homeostasis,IPR002048 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR002048 (PFAM); IPR002048 (PFAM); PTHR23056 (PANTHER); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY),8.A.82.1.6, the calmodulin calcium binding protein (calmodulin) family.
RL4_JR_05531,5682,4479,5652,0,0,10,0,0,0,0,1,0,0,0,3,0,5,9,151.8734383,1,-1.711435568,0.617472422,-2.771679362,0.005576794,0.02379471,153.4986281,0,1.252028101,1.597617039,0.783684745,0.433225116,0.594832423,123.9588671,1,-2.045421383,0.850893219,-2.40385202,0.016223339,0.047375334,135.2933339,1,-1.844473374,0.675487301,-2.730581865,0.006322263,0.033726508,98.55879276,1,-4.536699943,1.194993465,-3.796422387,0.000146799,0.000958313,N,-,,enhancer-polycomb 1,"F:histone acetyltransferase activity; P:DNA repair; P:positive regulation of macroautophagy; P:transcription, DNA-templated; P:histone acetylation; C:Piccolo NuA4 histone acetyltransferase complex; P:regulation of transcription from RNA polymerase II promoter",IPR019542 (PFAM); PTHR14898:SF0 (PANTHER); IPR024943 (PANTHER),,
RL4_JR_05532,3333,3305,5215,5,0,4,0,0,0,1,5,1,0,2,0,0,0,3,61.00475641,1,-0.525600806,0.769248687,-0.683265131,0.494439323,0.681933389,13.26263454,0,-0.263840631,1.235434735,-0.213560962,0.830889445,0.898699862,56.78865267,1,-1.082405055,1.058462835,-1.022619801,0.306487643,0.448134157,56.03223804,1,-0.67420293,0.811532832,-0.830777146,0.406099536,0.54970024,56.89720908,1,-0.395077521,0.807438664,-0.489297254,0.624631265,0.729562851,N,-,,O-sialoglyco endopeptidase,"F:chromatin DNA binding; C:nuclear chromatin; C:EKC/KEOPS complex; C:cytoplasm; F:metal ion binding; P:transcription, DNA-templated; P:proteolysis; P:telomere maintenance via recombination; P:tRNA threonylcarbamoyladenosine modification; F:peptidase activity; P:positive regulation of transcription from RNA polymerase II promoter; F:N(6)-L-threonylcarbamoyladenine synthase",IPR017861 (PRINTS); IPR000905 (PFAM); IPR017861 (TIGRFAM); G3DSA:3.30.420.40 (GENE3D); PTHR11735 (PANTHER); PTHR11735 (PANTHER); PTHR11735:SF14 (PANTHER); PTHR11735:SF14 (PANTHER); MF_01446 (HAMAP); SSF53067 (SUPERFAMILY),,
RL4_JR_05533,4901,5701,5368,1,0,5,0,0,0,0,0,3,0,3,2,0,0,1,71.97985364,1,-0.44748088,0.643046263,-0.695876652,0.48650608,0.674412337,15.73492907,0,-0.510378802,1.216756375,-0.419458498,0.67488108,0.792325758,53.72489046,1,-1.341034142,1.04100847,-1.288206754,0.197674002,0.322730462,122.9062103,1,0.622995381,0.497798309,1.251501601,0.21075153,0.344448626,47.45412648,1,-2.303456777,1.127870632,-2.042305839,0.041121203,0.096155239,N,-,,5 -AMP-activated kinase,C:cytoplasm; C:cytosol; P:phosphorylation; F:kinase activity,IPR006828 (SMART); IPR006828 (PFAM); IPR032640 (PFAM); PTHR10343:SF60 (PANTHER); PTHR10343:SF60 (PANTHER); PTHR10343 (PANTHER); PTHR10343 (PANTHER); IPR014756 (SUPERFAMILY); SSF160219 (SUPERFAMILY),,
RL4_JR_05534,1439,1173,1771,0,0,10,0,0,0,0,1,0,0,9,2,0,8,0,10.38047599,1,-1.478241629,1.197595758,-1.23434107,0.217075838,0.384996487,3.301870665,0,1.742178158,1.266089433,1.376030882,0.168812073,0.303071266,15.08694415,1,0.048240119,1.195551251,0.040349688,0.967814341,0.981188903,29.96682036,1,1.689960529,0.683258127,2.473385187,0.01338398,0.061066472,34.80481936,1,1.942078006,0.689810519,2.815378937,0.004871975,0.017536514,N,-,,hypothetical protein SPI_03261,C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_05535,450,367,512,0,0,4,0,0,0,0,0,1,0,0,0,0,1,0,221.4517854,1,4.564798953,0.578096119,7.896262928,2.87E-15,1.97E-13,12.43043019,0,2.771221798,1.136311085,2.438787964,0.014736612,0.045435269,40.44149012,1,2.325674167,0.69383989,3.351888815,0.000802622,0.004831005,33.2407366,0,2.040547743,0.655791034,3.111582253,0.001860876,0.012502569,130.4523086,1,3.753204127,0.521636479,7.195056858,6.24E-13,6.65E-11,N,-,,phosphoglycerate mutase family,C:cellular_component,IPR013078 (SMART); IPR013078 (PFAM); IPR029033 (G3DSA:3.40.50.GENE3D); PTHR23029 (PANTHER); PTHR23029:SF7 (PANTHER); IPR029033 (SUPERFAMILY),,
RL4_JR_05536,4452,3201,3340,0,0,1,0,0,0,3,0,0,0,0,0,0,0,0,16.72758336,1,4.033064536,0.811517433,4.969781758,6.70E-07,1.08E-05,0.459659159,0,4.586797909,1.587814497,2.888749232,0.003867774,0.017716233,7.69730656,1,2.889320187,1.218060107,2.372067002,0.017688883,0.050890096,20.65376777,0,3.264058419,1.041190591,3.134928848,0.001718958,0.011717218,1.186819404,0,1.839552911,1.244773293,1.477821641,0.139455524,0.245264406,N,-,,phosphoglycerate mutase family,,no IPS match,,
RL4_JR_05537,3917,3966,3432,0,1,7,0,0,0,1,0,1,0,13,0,0,7,0,44.90229777,1,4.624132299,0.609819443,7.582789227,3.38E-14,1.98E-12,0.683589137,0,4.014364604,1.512152129,2.65473594,0.007937051,0.02841517,1.775187845,1,1.361324165,1.249721934,1.08930165,0.276020885,0.415035711,18.09459331,1,3.616135557,0.80929286,4.468265735,7.89E-06,0.000115881,17.19059106,1,3.851742136,0.819271072,4.701425777,2.58E-06,3.23E-05,Y,-,,rhamnogalacturonase b,P:pectin catabolic process; F:polygalacturonase activity; F:rhamnogalacturonan alpha-L-rhamnopyranosyl-(1->4)-alpha-D-galactopyranosyluronide lyase activity,IPR000743 (PFAM); IPR012334 (G3DSA:2.160.20.GENE3D); PTHR31736 (PANTHER); PTHR31736:SF7 (PANTHER); IPR011050 (SUPERFAMILY),,
RL4_JR_05538,54,30,70,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,68.88536187,0,0.646422897,0.52353195,1.23473438,0.216929376,0.384996487,202.7444015,0,3.972588845,1.847529556,2.150216667,0.03153808,0.082381535,60.00217819,0,0.173826544,0.743702458,0.233731303,0.815193585,0.880040504,49.06861203,0,-0.357942326,0.746879322,-0.47925055,0.631760397,0.747176033,39.73747108,0,-0.522837172,0.840718174,-0.621893505,0.534011896,0.657210459,N,-,,vacuolar sorting-associated 27,C:endosome; C:membrane; F:binding; P:intracellular protein transport,IPR000306 (SMART); IPR003903 (SMART); IPR002014 (SMART); IPR002014 (PFAM); IPR008942 (G3DSA:1.25.40.GENE3D); IPR000306 (PFAM); IPR017073 (PIRSF); IPR013083 (G3DSA:3.30.40.GENE3D); IPR003903 (PFAM); PTHR13856 (PANTHER); PTHR13856:SF86 (PANTHER); PTHR13856:SF86 (PANTHER); PTHR13856 (PANTHER); PTHR13856 (PANTHER); IPR002014 (PROSITE_PROFILES); IPR003903 (PROSITE_PROFILES); IPR003903 (PROSITE_PROFILES); IPR017455 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY); IPR008942 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_05539,205,298,374,0,0,2,0,0,0,0,2,1,0,2,0,0,0,0,64.00056946,1,-0.578437259,0.698269133,-0.828387267,0.407451215,0.598606871,14.44515436,0,-0.386954443,1.225117477,-0.315850888,0.75211569,0.848613869,76.25612258,1,0.355475253,0.643328807,0.552556094,0.580567414,0.702560951,59.01986555,1,-0.751650253,0.768533992,-0.97803124,0.328058873,0.474785033,36.50831243,0,-3.10395822,1.195130558,-2.597170826,0.009399516,0.029899499,N,-,,ubiquitin carboxyl-terminal hydrolase,P:metabolic process; F:hydrolase activity,IPR001763 (SMART); IPR001394 (PFAM); IPR001763 (G3DSA:3.40.250.GENE3D); PTHR24006 (PANTHER); IPR028889 (PROSITE_PROFILES); IPR001763 (PROSITE_PROFILES); IPR001763 (SUPERFAMILY); SSF54001 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_05540,250,322,236,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,62.15544861,0,-0.17059459,0.658636764,-0.259011642,0.795626258,0.895518627,11.10470434,0,-0.007564566,1.214079855,-0.006230699,0.995028653,0.997689948,143.8011301,0,2.042951963,1.291258337,1.582140386,0.113617526,0.213011821,116.7981042,0,1.450116742,0.418027259,3.468952585,0.000522492,0.004343373,68.98033465,0,0.490186574,0.611813061,0.801203187,0.423014027,0.558537291,N,-,,AMP-binding enzyme,P:protein deubiquitination; F:ligase activity; F:thiol-dependent ubiquitinyl hydrolase activity,IPR000873 (PFAM); G3DSA:2.30.38.10 (GENE3D); G3DSA:3.40.50.980 (GENE3D); G3DSA:3.40.50.980 (GENE3D); PTHR24096 (PANTHER); PTHR24096:SF153 (PANTHER); PTHR24096 (PANTHER); PTHR24096:SF153 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.14, the fatty acid transporter (fat) family.
RL4_JR_05541,187,207,223,0,0,1,0,0,0,0,2,6,0,0,0,0,0,0,4.194388237,1,-0.171028895,1.283093376,-0.133294192,0.89396072,0.94830577,1.350820563,0,3.031667721,1.435232193,2.112318645,0.034659128,0.088479115,3.491327143,1,0.385043239,1.256336543,0.306480967,0.759238469,0.838476381,4.026201799,0,-0.036758343,1.266948316,-0.029013293,0.976853989,0.985749913,3.435760682,0,0.305406357,1.256679859,0.24302638,0.807984961,0.870395546,N,-,,---NA---,,no IPS match,,
RL4_JR_05542,258,182,237,0,0,6,0,0,0,0,0,5,0,0,8,0,0,0,641.0275186,1,-2.86480767,0.631494305,-4.536553456,5.72E-06,7.10E-05,185.9199166,0,-4.073017391,1.254352981,-3.24710624,0.001165849,0.015023052,532.5247558,1,-2.942082583,0.676002279,-4.352178497,1.35E-05,0.000243187,576.2328803,1,-4.13928017,0.789504008,-5.242886835,1.58E-07,3.42E-06,509.3719863,0,-3.020503141,0.734535839,-4.112124935,3.92E-05,0.000315528,N,-,,hypothetical protein SPI_05126,,IPR013860 (PFAM); IPR021711 (PFAM); PTHR28014 (PANTHER); PTHR28014:SF1 (PANTHER),,
RL4_JR_05543,1535,1431,2207,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,196.1651846,0,-1.362596015,0.829719206,-1.642237524,0.100540789,0.222520824,47.81880786,0,-2.113982733,1.32703182,-1.593015858,0.111156634,0.220009278,173.9453685,1,-1.156242996,1.595364842,-0.724751459,0.46860452,0.605507615,162.1862379,1,-2.49699699,0.956871034,-2.609543922,0.009066301,0.044954111,137.7023485,0,-2.039286002,0.961218604,-2.121563184,0.033874437,0.082685312,N,-,,vhs domain-containing,C:membrane; P:intracellular protein transport; C:intracellular,IPR002014 (SMART); IPR008942 (G3DSA:1.25.40.GENE3D); IPR004152 (G3DSA:1.20.58.GENE3D); IPR002014 (PFAM); PTHR13856 (PANTHER); PTHR13856:SF46 (PANTHER); IPR002014 (PROSITE_PROFILES); IPR004152 (PROSITE_PROFILES); SSF89009 (SUPERFAMILY); IPR008942 (SUPERFAMILY),,
RL4_JR_05544,2386,3356,1794,3,14,3,0,0,3,2,60,174,7,7,11,0,24,2,392.7739326,1,-1.614446024,0.662627155,-2.43643203,0.014832957,0.05206938,124.4851178,1,-1.033698953,1.033159729,-1.000521918,0.317057996,0.478851244,263.5577702,1,-3.92024064,1.139881311,-3.43916564,0.00058351,0.003786831,292.7681256,1,-5.2114579,1.256242318,-4.148449567,3.35E-05,0.000413316,238.9452895,1,-5.81431992,1.304751081,-4.456267564,8.34E-06,8.61E-05,N,-,,alpha-acetolactate decarboxylase,P:acetoin biosynthetic process; F:acetolactate decarboxylase activity,G3DSA:3.30.1330.80 (GENE3D); G3DSA:3.30.1330.80 (GENE3D); IPR005128 (PFAM); IPR005128 (PIRSF); PTHR35524 (PANTHER); SSF117856 (SUPERFAMILY),,
RL4_JR_05545,4,7,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1000.358824,0,-0.157630679,0.605147246,-0.260483179,0.794491089,0.894787714,222.3493366,0,-1.701753986,0.902702008,-1.885178022,0.059405807,0.135185607,468.9282386,0,-3.73982316,0.792142179,-4.721151403,2.35E-06,5.56E-05,524.251048,0,-3.777043295,0.722937068,-5.224581032,1.75E-07,3.72E-06,466.5081733,0,-3.051353333,0.63534412,-4.802678165,1.57E-06,2.09E-05,N,-,,pre-60S factor REI1,P:mycelium development; F:metal ion binding,IPR003604 (SMART); IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR022755 (PFAM); IPR015880 (PFAM); PTHR13182 (PANTHER); PTHR13182 (PANTHER); PTHR13182:SF8 (PANTHER); PTHR13182:SF8 (PANTHER); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY),,
RL4_JR_05546,73,50,80,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,309.138124,0,-0.65431188,0.470296709,-1.391274631,0.164142164,0.315075711,60.18650736,0,-2.445847077,1.223943528,-1.998333273,0.045680541,0.109724355,182.564859,0,-2.282974826,0.789953594,-2.890011316,0.00385228,0.016036854,201.6266427,0,-3.176572611,0.892218013,-3.560309887,0.000370417,0.003235959,178.2519136,0,-2.512411007,0.796697519,-3.15353186,0.001613076,0.007101042,N,-,,hect domain containing,F:catalytic activity,IPR000569 (SMART); IPR032353 (PFAM); IPR000569 (PFAM); PTHR11254:SF319 (PANTHER); PTHR11254 (PANTHER); PTHR11254:SF319 (PANTHER); IPR000569 (PROSITE_PROFILES); IPR000569 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_05547,8684,5634,5837,0,0,6,0,0,0,0,1,4,1,2,1,0,1,1,275.7044496,1,-1.394756304,0.543971826,-2.564023058,0.010346667,0.03891568,62.7565314,0,-2.506197808,1.204276109,-2.081082394,0.037426365,0.094119172,197.0680665,1,-2.732093231,0.876068121,-3.118585378,0.001817215,0.009171228,256.3681938,1,-1.529119424,0.536804615,-2.848558641,0.004391776,0.025351614,204.0367018,1,-1.661695808,0.622410226,-2.669775878,0.007590189,0.025221748,N,-,,t-complex 1 subunit epsilon,C:chaperonin-containing T-complex; F:ATP binding; F:unfolded protein binding; P:protein folding,IPR017998 (PRINTS); IPR027413 (G3DSA:1.10.560.GENE3D); IPR027409 (G3DSA:3.50.7.GENE3D); IPR012718 (TIGRFAM); IPR027410 (G3DSA:3.30.260.GENE3D); IPR002423 (PFAM); PTHR11353 (PANTHER); IPR027409 (SUPERFAMILY); SSF48592 (SUPERFAMILY); SSF54849 (SUPERFAMILY),,
RL4_JR_05548,3565,3954,4757,0,0,7,0,0,0,2,1,3,2,2,0,0,2,0,64.29307525,1,-2.199836824,1.014735566,-2.167891713,0.030166927,0.090745497,18.19328423,0,-0.719782908,1.212252101,-0.593756784,0.552674798,0.698732639,66.49149871,1,-0.96435051,0.858206837,-1.123680759,0.261148482,0.398172775,71.53563908,1,-1.475815171,0.85772819,-1.720609382,0.08532173,0.173867927,46.11538648,1,-3.440981157,1.189482856,-2.89283796,0.003817782,0.014380596,N,-,,Mediator of RNA polymerase II transcription subunit 13,F:RNA polymerase II transcription cofactor activity; P:regulation of transcription from RNA polymerase II promoter,IPR021643 (PFAM); IPR009401 (PFAM); PTHR10791 (PANTHER),,
RL4_JR_05549,5997,2703,1937,8,11,1,0,0,2,13,26,38,24,37,20,0,32,6,162.5875441,1,-0.122454915,1.067675264,-0.114693034,0.908688436,0.955724256,28.47246311,1,-1.366014205,1.209963224,-1.128971672,0.258909784,0.414796586,107.5358103,1,-1.594062516,0.871991454,-1.828071261,0.067538858,0.142718304,97.8108567,1,-2.166727319,0.89262175,-2.42737455,0.015208546,0.065631958,81.11561109,1,-3.179013493,1.148139465,-2.768839144,0.00562564,0.019729687,N,-,,methylthioadenosine phosphorylase,C:nucleus; F:S-methyl-5-thioadenosine phosphorylase activity; P:glutamate biosynthetic process; P:L-methionine biosynthetic process from methylthioadenosine; P:nucleoside metabolic process; C:cytosol; F:mRNA binding,IPR000845 (G3DSA:3.40.50.GENE3D); IPR010044 (TIGRFAM); IPR000845 (PFAM); IPR001369 (PANTHER); PTHR11904:SF15 (PANTHER); IPR000845 (SUPERFAMILY),,
RL4_JR_05550,20438,17408,24374,3,1,41,0,0,0,0,2,5,1,11,0,0,5,3,315.4489769,1,-1.448757071,0.427118573,-3.391931797,0.000694017,0.004419822,75.01521806,0,-2.763598123,1.190811066,-2.320769601,0.020299282,0.05817365,263.5831229,1,-1.285014048,0.497632565,-2.582254738,0.00981571,0.03222252,262.9819655,1,-3.081538491,0.741849522,-4.153859236,3.27E-05,0.000406635,206.5829995,1,-3.808472753,0.976863724,-3.898673539,9.67E-05,0.000675257,N,-,,essential cytoplasmic,,IPR019156 (PFAM); PTHR13255 (PANTHER); PTHR13255:SF0 (PANTHER); PTHR13255:SF0 (PANTHER); PTHR13255 (PANTHER),,
RL4_JR_05551,2744,825,1060,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4737.934617,0,-2.644409594,0.56954556,-4.643016782,3.43E-06,4.51E-05,1512.525474,0,-2.517849847,0.719584179,-3.499034469,0.000466946,0.015023052,3432.359359,0,-6.478380504,0.889238765,-7.285310492,3.21E-13,2.69E-11,4010.787277,0,-5.467338524,0.762409852,-7.171127848,7.44E-13,3.59E-11,3520.584144,0,-3.951881422,0.915049276,-4.318763508,1.57E-05,0.000147072,N,-,,rna binding effector scp160,"C:endoplasmic reticulum membrane; C:polysome; C:chromosome, telomeric region; P:meiotic telomere clustering; P:intracellular mRNA localization; F:G-protein alpha-subunit binding; C:cytosol; F:mRNA binding; P:chromatin silencing at silent mating-type cassette; P:chromatin silencing at telomere; P:chemotropism; P:pheromone-dependent signal transduction involved in conjugation with cellular fusion",IPR004087 (SMART); IPR004088 (G3DSA:3.30.1370.GENE3D); IPR004088 (PFAM); IPR004088 (G3DSA:3.30.1370.GENE3D); IPR004088 (G3DSA:3.30.1370.GENE3D); IPR004088 (G3DSA:3.30.1370.GENE3D); PTHR10627 (PANTHER); PTHR10627 (PANTHER); PTHR10627:SF31 (PANTHER); PTHR10627:SF31 (PANTHER); IPR004088 (PROSITE_PROFILES); IPR004088 (PROSITE_PROFILES); IPR004088 (PROSITE_PROFILES); IPR004088 (PROSITE_PROFILES); IPR004088 (PROSITE_PROFILES); IPR004088 (PROSITE_PROFILES); IPR004088 (PROSITE_PROFILES); IPR004088 (PROSITE_PROFILES); IPR004088 (SUPERFAMILY); IPR004088 (SUPERFAMILY); IPR004088 (SUPERFAMILY); IPR004088 (SUPERFAMILY); IPR004088 (SUPERFAMILY); IPR004088 (SUPERFAMILY); IPR004088 (SUPERFAMILY),,
RL4_JR_05552,12938,3194,11566,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,190.3847294,0,-0.446241723,0.494200257,-0.902957286,0.366548565,0.558513285,35.33952276,0,-1.677675029,1.224459811,-1.370134825,0.170644819,0.305981728,110.4794026,0,-1.924921474,0.883590132,-2.178523056,0.029367118,0.075345337,114.5426874,0,-3.787918098,1.16569223,-3.249501027,0.001156077,0.008343033,96.72764587,0,-2.728178445,0.996424126,-2.737969078,0.006181989,0.021311759,N,-,,STE STE20 PAKA kinase,F:ATP binding; F:protein serine/threonine kinase activity; P:protein phosphorylation,IPR000719 (SMART); IPR000095 (SMART); IPR000095 (PFAM); IPR000095 (G3DSA:3.90.810.GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); PTHR24361:SF281 (PANTHER); PTHR24361 (PANTHER); PTHR24361:SF281 (PANTHER); PTHR24361 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR000095 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_05553,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1200.773334,0,0.215967006,0.708896398,0.304652423,0.760630889,0.87398931,203.1743175,0,-1.805056369,0.858277013,-2.103116291,0.035455605,0.090148615,463.2495888,0,-5.680228878,1.198683423,-4.738723143,2.15E-06,5.16E-05,605.7149932,0,-2.742603291,0.474350272,-5.781810299,7.39E-09,2.07E-07,465.5071866,0,-4.522202906,0.876334451,-5.160361892,2.46E-07,4.57E-06,N,-,,d-arabinitol 2-dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); PTHR24322:SF452 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_05554,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,92.06758632,0,-1.561465221,0.736500187,-2.120115171,0.033996334,0.099799241,51.40074249,0,1.106583309,0.8580409,1.28966266,0.19716781,0.340684973,60.19141425,0,-3.722490509,1.188945764,-3.130917004,0.001742614,0.008869897,96.39638444,0,-1.412297089,0.73881401,-1.911573237,0.055930955,0.131283172,74.61394354,0,-1.184493523,0.740530709,-1.599519788,0.109705155,0.204682458,N,-,,chromatin structure-remodeling complex subunit RSC9,"C:nucleus; F:DNA binding; P:chromatin remodeling; F:metal ion binding; P:transcription, DNA-templated; P:single-organism cellular process; P:regulation of transcription from RNA polymerase II promoter",IPR001606 (SMART); SM01014 (SMART); IPR001606 (G3DSA:1.10.150.GENE3D); IPR001606 (PFAM); PTHR15348:SF0 (PANTHER); PTHR15348 (PANTHER); PTHR15348 (PANTHER); PTHR15348:SF0 (PANTHER); PTHR15348 (PANTHER); PTHR15348:SF0 (PANTHER); IPR003150 (PROSITE_PROFILES); IPR001606 (PROSITE_PROFILES); IPR001606 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_05555,58,30,36,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.140691635,0,1.707763162,1.416406408,1.205701381,0.227932652,NA,0.362703619,0,4.928596351,1.627137696,3.028997707,0.002453665,0.015349618,0.943095209,0,2.27329494,1.237316361,1.837278656,0.066168769,0.140497613,1.088131902,0,1.850842122,1.275395137,1.45119114,0.146726643,0.2617518,0.931778345,0,2.188484814,1.221576514,1.791524959,0.073209093,0.149941386,N,-,,hypothetical protein SPI_05115,,no IPS match,,
RL4_JR_05556,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,225.7180656,0,-1.028301105,0.501663542,-2.049782413,0.040385669,0.113374496,76.34402833,0,0.047537373,0.872252602,0.054499548,0.956537169,0.977197136,132.8847685,0,-3.815495677,1.203285429,-3.170898264,0.001519684,0.007952848,228.6975247,0,-1.059817848,0.546018694,-1.940991873,0.052259263,0.125826526,161.2873696,0,-1.274603861,0.598742938,-2.128799823,0.033270826,0.081538706,N,-,,sh3 domain-containing,,IPR001452 (PRINTS); IPR013315 (PRINTS); IPR001452 (SMART); IPR001452 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR007461 (PFAM); PTHR15629 (PANTHER); PTHR15629:SF2 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY),8.A.34.1.1, the endophilin (endophilin) family.
RL4_JR_05557,57,25,48,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,36.40005504,0,-1.22152629,1.013890194,-1.204791502,0.228283801,0.400158842,31.47929006,0,1.19222152,1.111954317,1.072185702,0.283636631,0.443050923,64.91430764,1,0.762406311,0.670518457,1.137040007,0.255521562,0.391420834,39.51166654,0,-0.505335036,0.857910556,-0.589029978,0.555841164,0.684658368,54.0545713,0,0.933919791,0.597635613,1.562690996,0.118125293,0.216480084,N,-, Effector probability:0.7,blocked early in transport 1,C:integral component of membrane,G3DSA:1.20.5.110 (GENE3D); PTHR12791 (PANTHER); PTHR12791:SF33 (PANTHER); SSF58038 (SUPERFAMILY),,
RL4_JR_05558,115,37,61,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,95.89182927,0,0.015070303,0.570710058,0.026406234,0.978933322,0.989524162,16.90277341,0,-0.613714653,1.215047997,-0.505094987,0.613492122,0.745558548,55.06820143,0,-2.308637304,1.20279292,-1.919397152,0.054934091,0.121483779,80.1348135,0,-0.41096335,0.653846853,-0.62853151,0.529655811,0.663077172,47.43025113,0,-2.430300106,1.141835378,-2.128415489,0.03330265,0.081584643,N,-,,stromal membrane-associated,C:cytoplasm,IPR001164 (PRINTS); IPR001164 (SMART); IPR001164 (PFAM); PTHR23180:SF160 (PANTHER); PTHR23180:SF160 (PANTHER); PTHR23180 (PANTHER); IPR001164 (PROSITE_PROFILES); SSF57863 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_05559,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,104.3312963,0,2.004079858,0.447123812,4.482158638,7.39E-06,8.90E-05,6.86253658,0,0.686794673,1.229318913,0.55867901,0.576380807,0.715843746,17.80340982,0,-1.965045521,1.192926626,-1.6472476,0.099507164,0.193249669,29.85141559,0,-1.437829387,1.143486653,-1.257408107,0.208605895,0.341382688,17.53829061,0,-2.046168957,1.195235972,-1.711937227,0.086908237,0.172032434,N,-, Effector probability:0.949,methionine-r-sulfoxide reductase,P:protein repair; C:mitochondrion; P:cellular response to oxidative stress; P:oxidation-reduction process; F:peptide-methionine (R)-S-oxide reductase activity,IPR002579 (TIGRFAM); IPR002579 (PFAM); IPR002579 (G3DSA:2.170.150.GENE3D); IPR028427 (PANTHER); PTHR10173:SF19 (PANTHER); IPR011057 (SUPERFAMILY),,
RL4_JR_05560,4292,4606,5785,1,3,8,0,0,4,0,1,1,2,9,0,0,1,0,157.075192,1,0.432373097,0.727930921,0.59397545,0.552528533,0.732056927,19.46914652,1,-0.817570386,1.203811067,-0.679151744,0.497041719,0.652113582,107.736813,1,0.164946568,0.570390412,0.289181874,0.772442202,0.847810587,121.0852873,1,0.019018048,0.510350628,0.03726467,0.970273975,0.983358259,160.4521399,1,0.7608186,0.89894837,0.846342933,0.397361464,0.534158898,N,-,,elongation factor Tu GTP binding domain-containing,F:GTP binding; F:translation elongation factor activity; F:GTPase activity; P:ribosome disassembly; P:translational elongation; C:intracellular,IPR000795 (PRINTS); IPR004161 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); IPR004160 (PFAM); G3DSA:2.40.30.10 (GENE3D); G3DSA:2.40.30.10 (GENE3D); PF00009 (PFAM); PTHR23115:SF188 (PANTHER); PTHR23115 (PANTHER); IPR000795 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR009001 (SUPERFAMILY); IPR009000 (SUPERFAMILY),,
RL4_JR_05561,650,577,562,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8.607652176,1,-1.207724486,1.205089256,-1.002186751,0.316253406,0.504595205,2.755341395,0,2.003360111,1.296824991,1.544819174,0.122390008,0.237106122,7.12506001,0,-0.643724844,1.204963489,-0.534227676,0.593184023,0.71246827,8.218413912,0,-1.065847553,1.203830671,-0.885379961,0.375951736,0.521439908,85.82350215,0,2.705485146,0.694176533,3.897402197,9.72E-05,0.000677532,N,-,,elongation factor tu gtp binding domain-containing,F:nucleotide binding; P:translation,IPR015033 (PFAM),,
RL4_JR_05562,2,1,0,0,0,2,0,0,0,1,0,0,0,0,1,0,0,0,195.5379863,1,-4.741326818,1.200853335,-3.948297998,7.87E-05,0.00069118,88.5364721,0,-0.290010885,0.894738565,-0.324129188,0.74584023,0.843790634,158.0136545,1,-5.114922159,1.223833821,-4.179425403,2.92E-05,0.000461576,194.4191706,1,-3.271529458,0.923423904,-3.542825178,0.000395865,0.003434562,198.4822851,0,-1.620846264,0.657023228,-2.466954279,0.013626776,0.040236542,N,-,,wd repeat-containing,"C:small-subunit processome; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:nucleolus; C:90S preribosome",IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR012580 (PFAM); PTHR14927 (PANTHER); PTHR14927 (PANTHER); PTHR14927:SF0 (PANTHER); PTHR14927:SF0 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),,
RL4_JR_05563,467,421,509,0,0,4,0,0,0,2,0,0,0,0,0,0,0,0,76.69017918,1,-4.363302535,1.241656631,-3.514097557,0.000441251,0.003032623,24.15620203,0,-1.128839793,1.228886403,-0.918587585,0.358311328,0.522371779,63.20981868,1,-3.793104871,1.223138647,-3.101124212,0.001927874,0.009579507,80.98265506,0,-2.511985085,1.067314569,-2.353556448,0.018594784,0.074298418,104.6133982,0,-0.173492606,0.641110355,-0.270612703,0.786688925,0.854271275,N,-,,hypothetical protein VP1G_09343,C:membrane,no IPS match,,
RL4_JR_05564,4079,2847,5071,0,2,0,0,0,0,0,0,3,0,2,0,0,0,0,1.649394069,1,1.175551584,1.675537365,0.701596758,0.482930674,NA,0.512420833,0,4.429740772,1.767455992,2.506280662,0.012200873,0.039205472,1.35810085,1,1.746855556,1.412019102,1.237133091,0.216037676,0.344652606,1.568527667,1,1.323034239,1.492682228,0.886346882,0.375430633,0.521002626,1.372190819,0,1.62979888,1.419387647,1.148240851,0.25086915,0.381560784,N,-,,glycoside hydrolase family 3,F:catalytic activity; P:metabolic process,no IPS match,,
RL4_JR_05565,957,1143,1300,0,0,0,0,0,0,0,0,0,2,0,0,0,0,1,2.956188226,0,0.333937196,1.460893055,0.228584286,0.819192039,0.908258855,0.921157084,0,3.583827137,1.583938724,2.262604659,0.023660071,0.065775126,2.426883684,0,0.909724602,1.338991106,0.679410489,0.496877806,0.629585846,88.04626543,1,4.87948876,0.771354091,6.325873965,2.52E-10,8.95E-09,25.59233012,1,3.805453425,0.92672249,4.106357045,4.02E-05,0.000321976,Y,-,,endo-N-acetyl-beta-D-glucosaminidase precursor,F:hydrolase activity,IPR013781 (G3DSA:3.20.20.GENE3D); IPR001223 (PFAM); PTHR11177 (PANTHER); PTHR11177:SF160 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_05566,3758,4205,3682,1,0,6,1,0,0,0,5,1,0,5,4,0,7,2,0.945820745,1,1.977838595,1.53799048,1.285988841,0.198446956,NA,0.303472201,1,5.185850957,1.710394767,3.031961426,0.002429703,0.015349618,0.785674915,1,2.536517752,1.266751111,2.002380523,0.045243822,0.10484057,0.906175029,1,2.11466582,1.328085105,1.5922668,0.111324769,0.21243183,0.773967515,1,2.455311479,1.241265407,1.978071302,0.047920664,0.108472327,N,-,,hypothetical protein F503_05488,,no IPS match,,
RL4_JR_05567,7575,8242,13323,0,0,11,0,0,3,0,0,2,3,11,0,0,2,4,21.89364054,1,-2.554746176,1.196655902,-2.134904589,0.032768804,0.096928175,6.954736624,1,0.667491326,1.227836131,0.543632256,0.586694558,0.724828795,37.5882477,1,0.412747533,0.858355675,0.480858397,0.630617143,0.741420039,20.87519669,1,-2.410930266,1.194764723,-2.017912162,0.04360041,0.113446415,25.6017583,1,-0.409475233,0.987431808,-0.4146871,0.678370977,0.771461954,N,-,,---NA---,,no IPS match,,
RL4_JR_05568,937,1127,1964,0,0,1,0,0,0,0,0,6,0,0,0,0,4,0,194.4595133,1,-0.901030698,0.502486204,-1.793145146,0.072949718,0.176072131,119.1965214,0,-0.274541419,0.981385557,-0.279748786,0.779670246,0.866847621,136.7347127,1,-1.790788063,0.757439678,-2.364264925,0.018065888,0.051789962,171.1212382,0,-1.3168866,0.563153197,-2.338416272,0.019365664,0.075643466,109.5985406,1,-4.689863746,1.205902387,-3.889090689,0.000100621,0.000698275,N,-,,alanine transaminase,F:pyridoxal phosphate binding; F:alanine-glyoxylate transaminase activity; P:biosynthetic process; F:glycine:2-oxoglutarate aminotransferase activity,IPR015422 (G3DSA:3.90.1150.GENE3D); IPR004839 (PFAM); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR11751:SF29 (PANTHER); PTHR11751 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_05569,1388,1429,2132,0,0,0,0,0,0,6,0,2,0,0,0,0,0,0,124.4678078,0,0.359634929,0.973878099,0.369281258,0.711918094,0.844759376,18.92506042,0,-0.776747419,1.201162459,-0.646663083,0.517850021,0.668240427,104.6862795,1,0.197751128,0.579258106,0.341386898,0.732812337,0.819959339,91.8160457,0,-0.548357816,0.625239851,-0.877035933,0.380467121,0.526260874,63.44351943,0,-1.828794618,0.98055151,-1.865067363,0.062171963,0.132434937,N,-,,26S proteasome subunit RPN7,C:proteasome complex,IPR000717 (SMART); SM00753 (SMART); IPR011991 (G3DSA:1.10.10.GENE3D); IPR019585 (PFAM); IPR000717 (PFAM); PTHR14145 (PANTHER); PTHR14145 (PANTHER); PTHR14145:SF1 (PANTHER); PTHR14145:SF1 (PANTHER); IPR011991 (SUPERFAMILY),,
RL4_JR_05570,4762,3867,5567,0,0,0,0,0,3,2,0,3,2,1,5,0,0,0,98.47808755,0,0.208852747,0.751794049,0.277805799,0.781161439,0.887242075,16.76351207,1,-0.601770504,1.2029659,-0.500239037,0.616906774,0.748168653,43.58114228,1,-3.256690894,1.192478036,-2.731027989,0.006313711,0.022658635,66.32748435,1,-0.968904605,0.753650409,-1.285615444,0.198577304,0.328904827,50.44222207,0,-2.407151793,1.127823097,-2.134334542,0.032815406,0.080683823,N,-,,mRNA capping enzyme,"P:RNA (guanine-N7)-methylation; C:cell division site; C:DNA-directed RNA polymerase II, holoenzyme; P:7-methylguanosine mRNA capping; C:P-TEFb-cap methyltransferase complex; C:cytosol; F:mRNA (guanine-N7-)-methyltransferase activity; P:transcription from RNA polymerase II promoter",IPR004971 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR12189:SF2 (PANTHER); PTHR12189 (PANTHER); PTHR12189 (PANTHER); PTHR12189:SF2 (PANTHER); IPR004971 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_05571,555,540,359,0,0,4,0,0,0,0,0,0,0,2,2,0,0,0,61.52557567,1,-0.152999349,0.713383382,-0.214470022,0.830180542,0.915217954,10.84743078,0,0.026190436,1.235246495,0.021202599,0.983084041,0.99097747,28.21743808,0,-2.629592941,1.209556725,-2.174013741,0.029704103,0.076106156,32.55490353,1,-3.052045096,1.211093828,-2.520073197,0.011733043,0.054922359,31.79434293,0,-1.789559542,1.149376041,-1.556983509,0.119474401,0.218438011,N,-,,hypothetical protein F503_05484,C:membrane,no IPS match,,
RL4_JR_05572,539,664,442,2,1,0,0,0,0,0,0,0,0,1,0,0,0,1,25.36413228,1,-1.584681041,1.149944236,-1.378050336,0.168187747,0.320503537,6.895569685,0,0.679832799,1.240510596,0.548026596,0.583673641,0.722242616,32.21573233,0,-0.149767029,1.040909978,-0.143880865,0.885594546,0.928901697,51.27678352,1,0.655276739,0.685557922,0.955829869,0.339158195,0.486330084,17.62248541,1,-2.053169809,1.204382147,-1.704749456,0.088241162,0.173787544,Y,-,,serine carboxypeptidase,F:serine-type carboxypeptidase activity; C:extracellular region; P:proteolysis involved in cellular protein catabolic process,IPR001563 (PRINTS); IPR029058 (G3DSA:3.40.50.GENE3D); IPR001563 (PFAM); PTHR11802:SF93 (PANTHER); IPR001563 (PANTHER); PTHR11802:SF93 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_05573,1417,1056,1696,0,4,1,0,0,0,0,3,0,0,0,0,0,7,0,2.094540346,1,0.831073329,1.280588357,0.648977733,0.516352769,NA,0.664943054,0,4.054153389,1.479798316,2.739666173,0.006150162,0.023678941,1.730536893,1,1.397606682,1.224200813,1.141648222,0.253600271,0.389302372,10.01997813,0,2.695486355,1.030434844,2.615872678,0.008899974,0.044237719,9.076609811,1,2.248766401,1.138193385,1.975733148,0.048185008,0.108892933,N,-,,formamidopyrimidine-DNA glycosylase,"F:hydrolase activity, hydrolyzing N-glycosyl compounds; F:zinc ion binding; P:base-excision repair; P:nucleotide-excision repair; F:DNA-(apurinic or apyrimidinic site) lyase activity; F:damaged DNA binding",IPR015886 (SMART); IPR012319 (PFAM); IPR015886 (PFAM); G3DSA:1.10.8.50 (GENE3D); G3DSA:3.20.190.10 (GENE3D); PTHR22993 (PANTHER); IPR010979 (SUPERFAMILY); IPR012319 (SUPERFAMILY),,
RL4_JR_05574,45,27,35,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,1.812980589,0,1.039172258,1.445172048,0.719064736,0.472101034,NA,0.591641516,0,4.222865634,1.634648066,2.583348503,0.009784643,0.033157066,61.56995725,0,5.395101406,0.689054479,7.829716764,4.89E-15,4.85E-13,1.745780872,1,1.16896761,1.351328031,0.865050959,0.38701082,0.5321136,51.66183061,0,5.307275357,1.404109544,3.779815742,0.000156944,0.00101408,Y,-,,glycoside hydrolase family 7,"F:lyase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; P:cellulose catabolic process",IPR001722 (PRINTS); IPR001722 (PFAM); IPR001722 (G3DSA:2.70.100.GENE3D); PTHR33753 (PANTHER); PTHR33753:SF2 (PANTHER); IPR013320 (SUPERFAMILY),,
RL4_JR_05575,6218,4484,6311,5,1,3,0,0,0,0,0,3,3,5,0,0,2,1,378.6251111,1,2.129691895,0.499046227,4.267524288,1.98E-05,0.000208329,30.82846304,0,-0.040002132,1.110855504,-0.036010203,0.971274223,0.98529141,55.77221787,1,-3.612503175,1.191617876,-3.031595319,0.002432651,0.011567947,64.34941579,1,-4.035049783,1.191705008,-3.385946821,0.000709331,0.005554508,55.09854424,1,-3.697713384,1.196649336,-3.090055936,0.002001188,0.008495,N,-,,vivid PAS VVD,P:mycelium development,G3DSA:3.30.450.20 (GENE3D); IPR000014 (PFAM); IPR000014 (TIGRFAM); PTHR24351 (PANTHER); IPR000014 (PROSITE_PROFILES); IPR000014 (SUPERFAMILY),1.A.1.4.12, the voltage-gated ion channel (vic) superfamily.
RL4_JR_05576,4701,4204,6302,1,3,5,0,0,0,0,0,0,0,3,0,0,2,0,28.78653792,1,-0.264665574,1.00466443,-0.263436792,0.792213936,0.893403551,4.772988627,0,1.210668708,1.247357132,0.970587073,0.331753946,0.494990189,23.4192517,0,-0.47548204,1.189503572,-0.399731494,0.689354293,0.787167027,45.22640973,1,1.191610952,0.664023591,1.79453105,0.072728447,0.155402214,12.13733576,1,-1.515181064,1.189156777,-1.274164259,0.202605209,0.324842081,N,-,,chromosomal organization and DNA repair,P:biological regulation; P:cellular macromolecule metabolic process; F:metal ion binding; C:intracellular membrane-bounded organelle; P:cellular response to stimulus; C:protein complex; C:cytoplasmic part; P:primary metabolic process; C:intracellular organelle part; F:ubiquitin-like protein transferase activity,IPR003613 (SMART); IPR004181 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR026846 (PANTHER); IPR026846 (PANTHER); PTHR21330:SF1 (PANTHER); PTHR21330:SF1 (PANTHER); IPR026846 (PANTHER); IPR004181 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),1.A.87.4.2, the mechanosensitive calcium channel (mca) family.
RL4_JR_05577,33681,33928,43041,7,3,19,0,0,4,0,6,3,2,7,0,0,5,1,37.27506829,1,-2.219464409,1.1489137,-1.931793841,0.053384957,0.139816319,10.72287861,1,0.042895062,1.226453349,0.034974882,0.97209977,0.985536245,47.26256662,1,-0.207108707,0.864578011,-0.239548895,0.810679987,0.876569923,32.02623543,1,-3.028406737,1.198242826,-2.527373143,0.011491933,0.054245139,27.34476145,1,-2.687011019,1.200915676,-2.23746852,0.025255735,0.065888769,N,-,,er membrane,C:perinuclear endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; P:cellular zinc ion homeostasis; P:septin ring assembly; C:cortical endoplasmic reticulum; P:endoplasmic reticulum inheritance; P:protein targeting to nuclear inner membrane,IPR013635 (PFAM); PTHR31726 (PANTHER),,
RL4_JR_05578,26408,15222,22646,0,2,14,0,0,0,3,2,1,1,7,2,0,11,3,222.6482139,1,-0.502258621,0.409684614,-1.225964079,0.220212193,0.389412569,39.44803732,0,-1.836349392,1.193529981,-1.53858673,0.12390522,0.238889264,137.349664,1,-1.344004767,0.661870991,-2.030614404,0.042294125,0.099693999,191.2035966,1,-0.487678855,0.425826857,-1.145251518,0.252104983,0.391737715,108.2545295,1,-2.893411824,0.966299575,-2.994321739,0.002750557,0.011060124,N,-,,hypothetical protein CMQ_6296,,no IPS match,,
RL4_JR_05579,72352,48753,36450,4,1,3,0,0,2,0,3,4,0,12,2,0,4,2,70.21974074,1,-0.603516396,0.769739219,-0.784053068,0.433008972,0.623783718,12.3129432,1,-0.156537723,1.238277533,-0.126415702,0.899402874,0.944130759,38.23570313,1,-1.837260576,1.205433811,-1.524148866,0.127471528,0.232400819,36.59896282,1,-3.22086806,1.207039043,-2.668404208,0.007621251,0.039031444,50.35511153,1,0.039653254,0.704434286,0.05629092,0.955110052,0.970445487,N,-,,cell division control,P:cell division; F:ATP binding; F:receptor signaling protein serine/threonine kinase activity; C:cytoplasm; P:protein phosphorylation; P:actin cytoskeleton organization,IPR000719 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); PTHR24361 (PANTHER); PTHR24361:SF129 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR016024 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_05580,5025,5966,5713,0,0,8,0,0,0,0,0,1,0,2,0,0,1,0,16.88261546,1,1.732293212,0.903736164,1.916812984,0.055261695,0.143164467,55.71989887,0,4.899953405,0.866947423,5.651961438,1.59E-08,2.26E-06,30.47916476,1,2.827725295,0.780294993,3.62391829,0.000290173,0.002267697,5.174915125,1,-0.398950881,1.227150139,-0.325103562,0.745102693,0.831587828,19.18380448,1,1.637364863,1.007970471,1.624417491,0.104286737,0.197070401,N,-,,aprataxin,P:nucleic acid metabolic process; F:DNA binding,IPR032566 (PFAM); IPR001310 (PFAM); IPR011146 (G3DSA:3.30.428.GENE3D); PTHR12486 (PANTHER); IPR026963 (PTHR12486:PANTHER); PTHR12486 (PANTHER); IPR011146 (SUPERFAMILY),,
RL4_JR_05581,3993,4686,8026,0,0,5,0,0,0,2,1,0,0,0,4,0,1,0,28.35480943,1,-1.345770048,1.140011571,-1.18048806,0.237806157,0.41198187,5.829834717,0,0.922065509,1.230488492,0.749349152,0.45364679,0.613222864,32.69936004,1,0.094275746,1.02783186,0.091722926,0.926918182,0.956489621,73.33229362,1,1.398592519,0.565688171,2.472373631,0.013421916,0.061159719,14.91796896,1,-1.812719262,1.193101838,-1.519333223,0.128678641,0.230433541,N,-,,high mobility group,"F:DNA binding; C:nucleus; P:regulation of transcription, DNA-templated; C:chromatin",IPR017956 (PRINTS); IPR017956 (SMART),,
RL4_JR_05582,1244,966,1694,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,106.3854896,1,0.484497597,0.49261923,0.983513367,0.32535484,0.514687761,15.16568011,0,-0.457234778,1.204470036,-0.379614905,0.704231295,0.813754068,113.8189913,0,1.027585156,0.49783353,2.064113994,0.039006909,0.093779613,73.56568681,1,-0.036147568,0.593017057,-0.06095536,0.95139476,0.971282538,58.22956008,0,-0.278773522,0.692837816,-0.40236476,0.687415601,0.778445695,Y,-,,signal sequence receptor alpha chain,C:integral component of membrane,PTHR12924 (PANTHER); PTHR12924:SF0 (PANTHER),,
RL4_JR_05583,1189,1041,2146,0,0,3,0,0,1,0,0,0,0,1,0,0,0,0,18.8555786,1,0.125835945,1.040257736,0.120966123,0.903717868,0.953385538,3.598567323,1,1.618080195,1.292829609,1.251580397,0.210722801,0.356439872,9.318166966,0,-1.031163387,1.215052056,-0.848657785,0.396071743,0.538666083,20.38271105,1,-0.501180242,1.164376114,-0.430428137,0.666884231,0.773005477,9.181016225,0,-1.112517702,1.218936482,-0.912695385,0.361402772,0.498664904,N,-,,hypothetical protein F503_07524,C:membrane,IPR013320 (G3DSA:2.60.120.GENE3D),,
RL4_JR_05584,773,721,1331,1,0,0,0,0,0,0,0,0,0,3,3,0,0,2,7.733524481,1,-1.053291166,1.248820021,-0.843429116,0.398988494,0.590841919,2.451388329,0,2.171934193,1.338636554,1.622497299,0.104696911,0.209693425,6.374246651,0,-0.483168543,1.232892301,-0.391898419,0.695133271,0.79206857,16.66759978,1,0.048044242,1.180334766,0.040703911,0.967531943,0.981884427,6.286395441,1,-0.565899312,1.238124234,-0.457061817,0.647626614,0.748219571,N,-,,ilp is an apoptosis inhibitor,,PTHR42087 (PANTHER); PTHR42087:SF1 (PANTHER),,
RL4_JR_05585,216,313,324,0,0,3,0,0,0,0,0,4,2,7,4,0,3,0,86.33811294,1,0.461842508,0.546844776,0.844558689,0.398357282,0.590351919,12.67892499,0,-0.198796135,1.226772592,-0.162048073,0.871267997,0.925682236,97.31000386,1,0.804773693,0.59033986,1.363237937,0.172807535,0.291632519,57.01587227,1,-1.51554351,1.023979824,-1.48005212,0.138859338,0.251062642,39.44019804,1,-1.982449363,1.123860638,-1.763963695,0.077738092,0.157577213,N,-,,mediator of rna polymerase ii transcription subunit 5,C:mediator complex; F:RNA polymerase II transcription cofactor activity; P:regulation of transcription from RNA polymerase II promoter,IPR014801 (PFAM); PTHR35784 (PANTHER),,
RL4_JR_05586,328,249,224,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_05587,5077,5497,8360,0,0,6,4,0,3,0,1,0,5,0,0,0,13,2,70.95050152,1,-3.223689838,1.143325981,-2.819571927,0.004808775,0.021053644,21.44111468,1,-0.956765847,1.200803216,-0.796771556,0.425583717,0.588411199,68.55197725,1,-1.78648793,1.031033152,-1.732716282,0.083146109,0.167750341,100.1900953,1,-0.173989252,0.529275644,-0.328730887,0.742359106,0.828799862,73.96388886,1,-0.755228403,0.672856826,-1.122420659,0.261683625,0.39357497,N,-,,Nucleic acid- OB-fold,"F:DNA binding; P:biological_process; P:telomere maintenance; C:cellular_component; F:molecular_function; C:nuclear chromosome, telomeric region",IPR011564 (SMART); G3DSA:2.40.50.140 (GENE3D); IPR012340 (SUPERFAMILY),,
RL4_JR_05588,920,1168,1659,0,2,0,0,0,0,0,0,0,2,3,0,0,0,1,98.45715719,1,-0.640024981,0.816899514,-0.783480673,0.433344899,0.623937114,17.11856774,0,-0.632026904,1.251271273,-0.505107819,0.61348311,0.745558548,60.54071617,0,-1.47277916,1.084269653,-1.358314471,0.17436392,0.29325746,92.06686473,1,-0.396307221,0.709039678,-0.558935182,0.576205958,0.702901846,75.27392122,1,-0.064832815,0.727915981,-0.089066344,0.929029185,0.953707847,N,-,,thiol-specific monooxygenase,F:nucleotide binding; F:coenzyme binding; C:intracellular membrane-bounded organelle; C:cytoplasmic part; F:monooxygenase activity,PR00419 (PRINTS); IPR020946 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PF13450 (PFAM); PTHR23023:SF125 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_05589,31,1,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,101.446767,0,0.72759505,0.461036023,1.578173971,0.114525648,0.244133849,13.03454217,0,-0.238718514,1.210351122,-0.197230795,0.843646933,0.906998859,33.73004083,0,-2.886946403,1.188118002,-2.429848212,0.015105147,0.044730637,107.2813812,0,1.101230897,0.434466156,2.534675907,0.01125514,0.05337625,44.74089694,0,-0.754867366,0.833046126,-0.906153144,0.3648548,0.501174176,N,-,,aromatic amino acid aminotransferase,F:transferase activity,IPR015422 (G3DSA:3.90.1150.GENE3D); IPR015421 (G3DSA:3.40.640.GENE3D); IPR004839 (PFAM); PTHR11751:SF396 (PANTHER); PTHR11751:SF396 (PANTHER); PTHR11751 (PANTHER); PTHR11751 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_05590,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1241.377686,0,-0.677534036,0.514706767,-1.316349578,0.188056738,0.346874244,399.873409,0,-0.890669686,1.72662556,-0.515844145,0.605963268,0.739515499,738.9568267,0,-2.728138532,0.487656912,-5.594380933,2.21E-08,8.72E-07,959.2572172,0,-1.659606756,0.383796392,-4.324185398,1.53E-05,0.000206823,778.3655657,0,-2.038736454,1.25731263,-1.621503201,0.104909764,0.19791529,N,-,,60S ribosomal L4-A,F:structural constituent of ribosome; P:mycelium development; C:ribosome; P:translation,IPR023574 (G3DSA:3.40.1370.GENE3D); IPR025755 (PFAM); IPR002136 (PFAM); PTHR19431 (PANTHER); IPR023574 (SUPERFAMILY),,
RL4_JR_05591,2844,3868,5692,0,0,3,0,0,0,1,3,1,1,3,2,0,1,2,36.17421514,1,-2.17429824,1.19934495,-1.812904819,0.069846503,0.170661307,38.61104664,0,2.205351317,0.95641289,2.305856957,0.021118626,0.060079465,26.88494519,1,-2.55969602,1.235986256,-2.070974501,0.038361179,0.092446698,68.24475489,1,0.128501099,1.428536566,0.089952964,0.928324592,0.957449984,52.13635069,1,0.031945767,0.811408919,0.039370737,0.96859481,0.979428988,N,-,,ser arg-related nuclear matrix,F:structural constituent of ribosome; C:ribosome; P:translation,no IPS match,,
RL4_JR_05592,271,246,233,0,0,4,0,0,0,0,17,3,0,0,0,0,6,0,0.125568619,1,4.891228461,3.693965267,1.324113279,0.185465426,NA,0.040623391,0,8.087891329,2.583306054,3.130829704,0.001743132,0.015023052,0.104159455,1,5.454541385,1.543268038,3.534409611,0.000408687,0.002928202,0.120087438,0,5.031277909,2.261831013,2.224426971,0.026119731,0.086108719,0.101188078,1,5.391210621,1.336402087,4.034123167,5.48E-05,0.000420073,N,-,,monooxygenase,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity",IPR011251 (PFAM); IPR016215 (PIRSF); IPR011251 (G3DSA:3.20.20.GENE3D); IPR016215 (TIGRFAM); PTHR30011:SF18 (PANTHER); PTHR30011 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_05593,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,Putative uncharacterized protein,,no IPS match,,
RL4_JR_05594,2,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.84109152,0,1.119486495,0.876244727,1.2775957,0.201392017,0.36550747,47.28810136,0,3.723997369,0.985760578,3.777790928,0.000158226,0.007214233,6.925804613,0,-0.602959547,1.204996836,-0.500382681,0.616805646,0.73100293,7.991096796,0,-1.025530246,1.204291379,-0.851563221,0.39445656,0.53912968,6.836044164,0,-0.686831231,1.209189779,-0.568009458,0.570028546,0.686041423,N,-,,high-affinity nicotinic acid transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR029003 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); IPR011701 (PFAM); PTHR11662:SF191 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR009072 (SUPERFAMILY),2.A.1.14.3, the major facilitator superfamily (mfs).
RL4_JR_05595,961,1229,860,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,80.43001988,0,1.723016712,0.625444262,2.754868526,0.005871572,0.024729111,6.201629405,0,0.832816598,1.275993084,0.652681123,0.513961875,0.664663613,38.3554895,0,0.017191213,1.067317118,0.01610694,0.987149077,0.994120885,54.67637598,1,0.823256856,0.740727912,1.111416004,0.266389327,0.40749236,16.10358486,0,-1.923055898,1.242874287,-1.547265011,0.121799355,0.221776748,N,-,,hypothetical protein SPI_01620,,no IPS match,,
RL4_JR_05596,1940,4138,3339,0,0,2,0,0,0,0,1,1,0,1,2,0,1,3,261.2851653,1,-6.131806859,1.337259263,-4.58535381,4.53E-06,5.78E-05,81.73463229,0,-2.887364618,1.269996488,-2.273521735,0.022994758,0.064243152,214.5546791,1,-5.556211824,1.281956161,-4.334166792,1.46E-05,0.00026033,263.762302,1,-3.382885336,0.949465301,-3.562937298,0.000366728,0.003212045,213.7701317,1,-5.653694623,1.310895411,-4.312849506,1.61E-05,0.000149842,N,-,,u3 small nucleolar rna-associated 13,"C:small-subunit processome; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:90S preribosome",IPR020472 (PRINTS); IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR013934 (PFAM); PTHR19854:SF15 (PANTHER); PTHR19854:SF15 (PANTHER); PTHR19854 (PANTHER); PTHR19854:SF15 (PANTHER); PTHR19854 (PANTHER); PTHR19854 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_05597,10,8,6,0,0,13,0,0,1,0,0,0,1,23,7,0,4,0,2321.298582,1,-1.63683443,0.540533627,-3.028182424,0.002460295,0.012351439,565.6208012,1,-5.678169916,1.252583315,-4.533167452,5.81E-06,0.000408435,1680.381988,0,-2.712301716,0.51932508,-5.222743555,1.76E-07,5.81E-06,1757.314603,1,-4.40445987,0.576990766,-7.633501491,2.28E-14,1.34E-12,1565.004564,1,-3.101837747,0.715954723,-4.332449588,1.47E-05,0.000139145,N,-,,dnaj heat shock family,C:intracellular organelle; P:cellular protein metabolic process; F:unfolded protein binding; P:protein folding,IPR001623 (PRINTS); IPR001623 (SMART); IPR001623 (PFAM); G3DSA:2.60.260.20 (GENE3D); IPR002939 (PFAM); IPR001623 (G3DSA:1.10.287.GENE3D); G3DSA:2.60.260.20 (GENE3D); PTHR24078 (PANTHER); PTHR24078:SF198 (PANTHER); IPR001623 (PROSITE_PROFILES); IPR008971 (SUPERFAMILY); IPR001623 (SUPERFAMILY); IPR008971 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_05598,5,12,33,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35.7244406,0,-3.261205449,1.296125617,-2.51611835,0.011865533,0.043466106,11.59713866,0,-0.070178238,1.329002663,-0.05280519,0.957887126,0.977885375,29.84235794,0,-2.710319825,1.275170542,-2.125456742,0.03354852,0.08378027,34.40306923,0,-3.131663232,1.286592187,-2.434076052,0.014929858,0.065631958,29.25628302,0,-2.784485356,1.285165839,-2.166635053,0.030262692,0.075639823,N,-,,General substrate transporter,C:integral component of plasma membrane; P:proton transport; F:sugar:proton symporter activity; P:glucose import; F:glucose transmembrane transporter activity; P:glucose transmembrane transport,IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF15 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.127, the major facilitator superfamily (mfs).
RL4_JR_05599,25,29,39,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,74.88992085,0,-2.237455391,1.01112645,-2.2128344,0.026909065,0.083310873,18.74720956,0,-0.763115464,1.199021726,-0.636448404,0.5244842,0.67379478,72.24979132,0,-1.008389573,0.851646834,-1.184046641,0.236394601,0.368874682,72.25664477,0,-1.126614941,0.748773678,-1.504613441,0.132423488,0.242194332,99.69053296,0,0.143273464,1.494517075,0.095866061,0.92362695,0.950649376,N,-,,trafficking pga2,C:membrane,IPR011431 (PIRSF); IPR011431 (PFAM); PTHR28199 (PANTHER),,
RL4_JR_05600,2721,2476,4563,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,58.62391235,0,-0.611152528,0.806823519,-0.757479812,0.448762456,0.637703494,11.77017974,0,-0.091606158,1.241056433,-0.073813048,0.941159145,0.967934654,52.84795429,0,-0.908082641,1.058777495,-0.857670895,0.391074216,0.534601115,39.44618061,0,-2.229192118,1.17459087,-1.897845603,0.057716424,0.134062581,34.35453581,0,-1.916943991,1.161237297,-1.650777146,0.098784088,0.189143134,N,-,,mRNA splicing yju2,F:first spliceosomal transesterification activity; C:U2-type catalytic step 1 spliceosome; P:generation of catalytic spliceosome for first transesterification step; C:mitotic spindle pole body,IPR007590 (PFAM); PTHR12111:SF1 (PANTHER); IPR007590 (PANTHER),2.A.1.82.2, the major facilitator superfamily (mfs).
RL4_JR_05601,204,292,254,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,73.94760461,0,-4.310765287,1.259103433,-3.423678448,0.000617797,0.003993703,24.0721119,0,-1.123751024,1.269688157,-0.885060649,0.376123922,0.540631402,61.65452184,0,-3.757137393,1.243400058,-3.021664159,0.002513893,0.011881961,71.06644585,0,-4.178269592,1.251439645,-3.338770358,0.000841501,0.006430338,59.99224505,0,-3.820502851,1.240655611,-3.079422538,0.002074023,0.008735226,N,-,,hypothetical protein F503_08280,,no IPS match,,
RL4_JR_05602,1736,1615,1640,0,0,3,0,0,0,0,0,0,0,2,0,0,0,0,12.21537715,1,-1.713116017,1.199108498,-1.428658057,0.153102539,0.301184112,3.890074323,0,1.50566315,1.260749404,1.19426045,0.232376103,0.382581477,10.11439638,0,-1.149509775,1.200774446,-0.957306994,0.338412326,0.481637068,30.61678562,1,0.175321251,1.020409836,0.171814544,0.863583331,0.915373674,10.00125691,0,-1.235903051,1.207869246,-1.023209305,0.306208894,0.441333104,N,-,,spc97 spc98 family,C:microtubule cytoskeleton; C:cytoskeletal part,IPR007259 (PFAM); PTHR19302:SF33 (PANTHER); IPR007259 (PANTHER); PTHR19302:SF33 (PANTHER); IPR007259 (PANTHER),,
RL4_JR_05603,650,573,715,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_05604,14,31,23,0,0,21,0,0,0,0,0,1,0,9,0,0,0,0,116.3892017,1,1.421806595,0.429952325,3.306893604,0.000943367,0.005677841,10.83964115,0,0.0272328,1.213152796,0.022447955,0.982090627,0.990676395,55.51802324,1,0.189280993,0.747664939,0.253162859,0.800142366,0.868887838,40.53393645,1,-1.325443118,1.019413983,-1.300201036,0.193532075,0.322839084,35.57341891,0,-1.047982471,0.984664229,-1.0643044,0.287190825,0.421726919,Y,-,,glycolipid 2-alpha-mannosyltransferase,"P:cell wall mannoprotein biosynthetic process; P:protein O-linked glycosylation; P:mannosylation; C:integral component of membrane; P:protein N-linked glycosylation; C:Golgi apparatus; F:alpha-1,2-mannosyltransferase activity",IPR002685 (PIRSF); IPR002685 (PFAM); IPR029044 (G3DSA:3.90.550.GENE3D); PTHR31121:SF7 (PANTHER); IPR002685 (PANTHER); IPR029044 (SUPERFAMILY),,
RL4_JR_05605,0,1,1,0,0,3,0,0,0,0,0,0,0,5,0,0,0,0,20.53347709,1,-2.462250134,1.308187082,-1.882185025,0.059810898,0.152147586,6.4073418,0,0.785715147,1.339711162,0.586481004,0.557552323,0.701671592,16.87988062,0,-1.888296948,1.277619048,-1.477981212,0.139412807,0.248357427,31.52593794,1,-0.092041856,1.015398402,-0.090646052,0.927773838,0.957076935,43.93161109,0,1.223879701,0.865097002,1.414731179,0.157147329,0.267324715,N,-,,mitogen-activated kinase organizer 1,P:phosphorylation; F:kinase activity,IPR020472 (PRINTS); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR22842:SF5 (PANTHER); PTHR22842 (PANTHER); PTHR22842 (PANTHER); PTHR22842:SF5 (PANTHER); PTHR22842 (PANTHER); PTHR22842:SF5 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),8.A.92.1.3,The G-Protein αβγ Complex (GPC) Family
RL4_JR_05606,0,1,5,0,0,6,0,0,0,0,0,0,2,2,0,0,4,0,409.002291,1,-1.743365332,0.480279048,-3.629900865,0.00028353,0.002078202,98.96967523,0,-3.163402371,1.199181436,-2.637968096,0.008340443,0.029387,305.7678309,0,-2.414644754,0.644407354,-3.747078207,0.000178906,0.00164211,358.6042466,1,-2.201714165,0.531378251,-4.14340286,3.42E-05,0.000419857,323.1072252,1,-1.488412137,0.541232944,-2.750039802,0.005958803,0.020670139,N,-,,phosphoribosylformylglycinamidine synthase,P:'de novo' IMP biosynthetic process; C:Golgi apparatus; F:phosphoribosylformylglycinamidine synthase activity,SM01211 (SMART); IPR010073 (TIGRFAM); IPR016188 (G3DSA:3.30.1330.GENE3D); IPR010918 (PFAM); IPR029062 (G3DSA:3.40.50.GENE3D); PF13507 (PFAM); PTHR10099 (PANTHER); PTHR10099:SF1 (PANTHER); IPR017926 (PROSITE_PROFILES); IPR010073 (HAMAP); IPR029062 (SUPERFAMILY); IPR010918 (SUPERFAMILY); SSF82697 (SUPERFAMILY); IPR010918 (SUPERFAMILY); SSF55326 (SUPERFAMILY); SSF55326 (SUPERFAMILY); SSF109736 (SUPERFAMILY),,
RL4_JR_05607,1490,1489,1939,0,0,6,0,0,0,0,0,0,0,3,0,0,0,0,184.392853,1,-0.840607487,0.974412424,-0.862681413,0.388312654,0.581257731,37.96557981,0,-1.781090606,1.266845105,-1.405926106,0.159746068,0.290244068,110.2428421,0,-2.610743733,1.102142736,-2.36878913,0.017846425,0.051299605,112.0860546,1,-4.835640685,1.256977248,-3.847039149,0.000119554,0.001242796,94.7011147,0,-4.479102994,1.249038653,-3.586040339,0.000335737,0.001922702,N,-,,fungal specific transcription factor,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31313:SF31 (PANTHER); PTHR31313 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_05608,89,88,126,0,0,11,0,0,0,0,0,0,0,6,0,0,0,0,30.26025999,1,-3.021706794,1.232641263,-2.451408114,0.014229851,0.050385037,9.53832226,0,0.211709762,1.249696473,0.169408945,0.865474988,0.92194673,53.60325644,0,-0.029615167,0.889702683,-0.033286588,0.973446049,0.984827401,52.88402367,1,0.342195107,0.720648509,0.474843287,0.634898677,0.749749137,36.42850581,0,-0.38076174,0.91879191,-0.414415643,0.678569735,0.771461954,N,-,,pq loop repeat,C:cytoplasm; C:integral component of membrane,IPR006603 (PFAM); PTHR14856:SF9 (PANTHER); PTHR14856 (PANTHER),2.A.43.2.13, the lysosomal cystine transporter (lct) family.
RL4_JR_05609,11728,12630,16344,0,1,58,0,0,0,5,0,13,11,23,5,0,27,2,194.2001806,1,-1.220924468,0.762739461,-1.600709718,0.109441228,0.2364363,44.58278669,0,-2.012896942,1.288841575,-1.561787718,0.118338006,0.231105016,169.5826707,1,-1.042322715,1.588661146,-0.656101345,0.511758919,0.643049186,132.2058379,1,-5.073824546,1.287909324,-3.939582122,8.16E-05,0.000899281,116.2421208,1,-3.802942782,1.220381055,-3.116192904,0.001832024,0.007866515,N,-,,polarity defective-2,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_05610,667,912,670,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,771.3011823,1,-1.571209775,0.609288243,-2.578762669,0.009915488,0.037676085,229.8972208,0,-2.377673824,1.056484834,-2.25055178,0.02441394,0.06726127,502.1326583,0,-3.893689046,0.839886345,-4.635971364,3.55E-06,7.85E-05,610.0572203,0,-3.180110458,0.654509519,-4.858768839,1.18E-06,2.14E-05,468.7311125,0,-6.786396803,1.280683333,-5.299043585,1.16E-07,2.57E-06,N,-,,methylenetetrahydrofolate reductase,P:methionine biosynthetic process; P:tetrahydrofolate interconversion; P:oxidation-reduction process; F:methylenetetrahydrofolate reductase (NAD(P)H) activity,IPR029041 (G3DSA:3.20.20.GENE3D); IPR003171 (PFAM); IPR004621 (TIGRFAM); PTHR21091 (PANTHER); PTHR21091:SF31 (PANTHER); PTHR21091 (PANTHER); PTHR21091 (PANTHER); PTHR21091:SF31 (PANTHER); IPR029041 (SUPERFAMILY),,
RL4_JR_05611,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,497.380134,0,-2.425127752,0.782504297,-3.099187775,0.00194052,0.01022995,134.6716402,0,-3.607783076,1.319735916,-2.733715914,0.006262405,0.023947134,385.7660221,0,-3.346414048,0.933469043,-3.584922362,0.000337178,0.002549367,408.5322303,0,-5.701017919,1.285763889,-4.433953985,9.25E-06,0.000132775,350.5136,0,-4.223699893,1.088858526,-3.879016229,0.00010488,0.000719937,N,-,,glutamine-dependent nad(+) synthetase,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:NAD+ synthase (glutamine-hydrolyzing) activity; F:ATP binding; P:NAD biosynthetic process; F:transferase activity",IPR014729 (G3DSA:3.40.50.GENE3D); IPR003694 (TIGRFAM); IPR003010 (G3DSA:3.60.110.GENE3D); IPR014445 (PIRSF); IPR003010 (PFAM); IPR022310 (PFAM); PTHR23090 (PANTHER); PTHR23090:SF9 (PANTHER); IPR003010 (PROSITE_PROFILES); IPR003010 (SUPERFAMILY); SSF52402 (SUPERFAMILY),,
RL4_JR_05612,11,4,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,151.7828972,0,-1.524652432,0.631575456,-2.414046361,0.015776455,0.054374448,43.68480446,0,-0.71748688,1.110563384,-0.646056669,0.518242656,0.668576621,108.7781064,0,-1.890439993,0.858836306,-2.201164507,0.02772438,0.072053062,128.3753771,0,-1.677028739,0.681820292,-2.459634539,0.013907856,0.06303359,92.17192519,0,-3.448853314,1.132438858,-3.045509512,0.002322864,0.009627098,N,-,,translation initiation factor eif4e3,F:translation initiation factor activity; C:cytoplasm; P:translational initiation,IPR001040 (PFAM); IPR023398 (G3DSA:3.30.760.GENE3D); PTHR11960:SF18 (PANTHER); IPR001040 (PANTHER); IPR023398 (SUPERFAMILY),,
RL4_JR_05613,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44.23141062,0,-3.569340284,1.252025017,-2.850853805,0.004360201,0.01938448,13.89779266,0,-0.331321746,1.253687197,-0.264277841,0.791565834,0.873795221,59.97377158,0,-0.588488365,0.914945386,-0.643195074,0.520097529,0.650250765,67.42939719,0,-0.421276059,0.770707883,-0.546609251,0.584647212,0.709886439,43.70299261,0,-2.151906502,1.179541811,-1.824357968,0.068097972,0.142046141,N,-,,u4 tri-snrnp-associated 2,P:protein deubiquitination; F:zinc ion binding; F:thiol-dependent ubiquitinyl hydrolase activity,IPR001607 (SMART); IPR001607 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001394 (PFAM); PTHR24006 (PANTHER); PTHR24006 (PANTHER); IPR033809 (PTHR24006:PANTHER); IPR033809 (PTHR24006:PANTHER); IPR001607 (PROSITE_PROFILES); IPR028889 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY); SSF54001 (SUPERFAMILY); SSF57850 (SUPERFAMILY),,
RL4_JR_05614,0,1,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.679928329,0,0.475263395,1.237354153,0.384096496,0.700906928,0.838793781,0.85609277,0,3.689646581,1.430611474,2.579069614,0.009906682,0.033358428,2.221036595,0,1.037474519,1.214874498,0.853976704,0.393117898,0.536305834,2.562130539,0,0.615232822,1.22138165,0.503718737,0.61445904,0.733655398,2.191045017,0,0.954488812,1.210954037,0.788212255,0.430572562,0.565000932,N,-,,subtilisin-like serine protease,C:integral component of membrane,PTHR34414 (PANTHER); PTHR34414:SF2 (PANTHER),,
RL4_JR_05615,6,9,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.74049422,0,5.938628611,1.000398559,5.936262658,2.92E-09,7.41E-08,0.089660227,0,6.94428454,2.198442464,3.158729261,0.001584586,0.015023052,13.23277261,0,6.076710971,1.105334267,5.497622894,3.85E-08,1.44E-06,0.271614863,0,3.852501678,1.749615643,2.201913142,0.027671445,0.088418139,0.235220727,0,4.174309751,1.332270837,3.133229095,0.001728944,0.007503456,Y,-,,glycoside hydrolase family 5,P:carbohydrate metabolic process; F:hydrolase activity,IPR013781 (G3DSA:3.20.20.GENE3D); PTHR31451:SF4 (PANTHER); PTHR31451 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_05616,40,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26.47753216,0,3.252600388,0.68978396,4.715390003,2.41E-06,3.30E-05,1.024749958,0,3.430250386,1.418344361,2.418489107,0.015585112,0.047546204,2.651566915,0,0.781961889,1.222559026,0.639610745,0.522425695,0.652477241,3.05820346,0,0.359962536,1.228818148,0.292933935,0.769572649,0.85018255,2.609571199,0,0.70216907,1.217557301,0.5767031,0.564140038,0.681531784,N,-,,hypothetical protein SPI_00934,,no IPS match,,
RL4_JR_05617,20023,12951,16321,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,375.5685488,1,3.825475794,0.438848194,8.717082224,2.85E-18,2.88E-16,64.02756567,0,3.682406405,0.621889621,5.921318323,3.19E-09,4.97E-07,42.24903343,0,-0.312760769,1.025668969,-0.304933442,0.760416845,0.839024132,52.10349393,1,-0.237301158,0.84231668,-0.281724396,0.778154847,0.856681588,31.03047656,0,-0.544603596,0.966892517,-0.563251433,0.573263684,0.688672294,N,-,,NADPH dehydrogenase,P:mycelium development; F:catalytic activity,IPR001155 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR22893:SF61 (PANTHER); PTHR22893 (PANTHER); SSF51395 (SUPERFAMILY),,
RL4_JR_05618,1248,624,1032,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,62.99524122,0,1.140968289,0.5717653,1.995518597,0.045986348,0.124849126,6.238289439,0,0.824369531,1.228589364,0.67098866,0.502227754,0.656111167,29.19165088,0,-0.007924825,1.030563359,-0.007689799,0.993864489,0.997508315,26.70621506,0,-0.52333111,1.013098241,-0.516565017,0.605459842,0.72590656,23.33405451,0,-0.976487773,1.122385014,-0.870011414,0.384294167,0.520323407,N,-,,pyroglutamyl peptidase type,,IPR016125 (G3DSA:3.40.630.GENE3D); PTHR23402:SF1 (PANTHER); PTHR23402:SF1 (PANTHER); IPR016125 (PANTHER); SSF53182 (SUPERFAMILY),,
RL4_JR_05619,9,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26.31324511,0,0.283785525,0.895246254,0.316991581,0.751249991,0.870021756,23.54895291,0,2.827823251,1.037309585,2.726113102,0.006408503,0.024303811,25.33327198,0,0.378091823,1.058719647,0.357121759,0.721000655,0.810983929,116.3392382,0,2.605727458,0.561821751,4.637996756,3.52E-06,5.61E-05,68.89757161,0,2.653822473,0.511214592,5.191210336,2.09E-07,4.21E-06,Y,-,,signal peptide-containing,,no IPS match,,
RL4_JR_05620,35,87,35,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,161.6990652,0,1.044738177,0.388573184,2.688652278,0.007174111,0.029073651,15.50586288,0,-0.489203095,1.206693326,-0.405407973,0.685177651,0.799927127,40.13385159,0,-3.137759338,1.188266333,-2.640619574,0.008275458,0.028095487,173.9097485,0,1.55303911,0.351845511,4.413980178,1.01E-05,0.000142716,39.47567112,0,-3.216698781,1.187024773,-2.709883445,0.006730686,0.022868521,N,-,,hypothetical protein CMQ_515,P:mycelium development,no IPS match,,
RL4_JR_05621,2872,4901,2522,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,79.86895565,1,0.71643412,0.555227652,1.29034301,0.19693159,0.359330778,10.53374856,0,0.068604752,1.226500847,0.055935348,0.955393311,0.976324189,27.29009042,0,-2.581260978,1.198733355,-2.153323729,0.031293245,0.079342052,59.56291536,0,0.478251174,0.613537217,0.779498228,0.435686281,0.577700632,102.6203259,0,1.909807963,0.450548126,4.238854525,2.25E-05,0.000198492,N,-,,inosine-uridine preferring nucleoside hydrolase,P:purine nucleoside catabolic process; C:cytosol; F:purine nucleosidase activity,IPR001910 (G3DSA:3.90.245.GENE3D); IPR001910 (PFAM); IPR023186 (PANTHER); PTHR12304:SF4 (PANTHER); IPR023186 (PANTHER); PTHR12304:SF4 (PANTHER); PTHR12304:SF4 (PANTHER); IPR023186 (PANTHER); IPR001910 (SUPERFAMILY),,
RL4_JR_05622,30,66,54,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22.21856436,0,-2.576056834,1.235027778,-2.085829063,0.03699411,0.106454303,7.001851548,0,0.657696769,1.263642048,0.520477116,0.602731074,0.736840531,24.82859147,0,-1.045420272,1.222547219,-0.855116478,0.392486668,0.535877954,47.80455097,0,0.30525588,0.800962913,0.381111129,0.70312079,0.800708356,22.10899199,0,-1.176925245,1.171659297,-1.004494436,0.315140352,0.450613764,N,-,,U6 snRNA-associated Sm LSm8,C:nucleus,IPR001163 (SMART); G3DSA:2.30.30.100 (GENE3D); IPR001163 (PFAM); PTHR15588 (PANTHER); IPR010920 (SUPERFAMILY),,
RL4_JR_05623,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,121.2608921,0,-1.272259702,0.760422127,-1.673096634,0.094308274,0.212122112,25.69889747,0,-1.218102234,1.250256597,-0.974281789,0.329916644,0.492861008,88.22667783,0,-1.454221896,0.904853813,-1.607134628,0.108024839,0.205394371,84.15947304,0,-2.576652937,1.075128586,-2.396599785,0.016547987,0.069724665,79.98455661,0,-1.362374637,0.830223452,-1.640973444,0.100802928,0.192149102,N,-,,"2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase",F:aldehyde-lyase activity; P:carbohydrate metabolic process; C:cytoplasm,IPR015813 (G3DSA:3.20.20.GENE3D); IPR005000 (PFAM); PTHR30502 (PANTHER); IPR015813 (SUPERFAMILY),,
RL4_JR_05624,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,99.03266392,0,-0.96503034,0.785666322,-1.228295413,0.219336092,0.388144,39.27025553,0,0.720104946,1.063443617,0.677144453,0.498314307,0.652767881,52.67503834,0,-3.530058097,1.232863895,-2.863299113,0.004192546,0.016876872,70.35853859,0,-2.995962613,1.192784437,-2.511738517,0.012013807,0.056081049,51.43765602,0,-3.598558948,1.231559979,-2.921951842,0.003478453,0.01333056,N,-,,glutaredoxin-like domain-containing,C:cellular_component; F:molecular_function,IPR008554 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR33558:SF1 (PANTHER); PTHR33558 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_05625,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,591.4201768,0,-0.573185842,0.34709674,-1.651372012,0.098662636,0.219256275,113.4360142,0,-3.360214005,1.211587573,-2.773397548,0.00554743,0.022001033,347.4280004,0,-2.38183448,0.614947252,-3.873233795,0.000107401,0.001218974,370.5654348,0,-3.667300353,0.771179326,-4.75544433,1.98E-06,3.35E-05,325.962341,0,-2.323344051,0.686655622,-3.383565175,0.000715512,0.003653334,N,-,,cord and cs domain containing,P:integrin-mediated signaling pathway,IPR007051 (PFAM); IPR008978 (G3DSA:2.60.40.GENE3D); IPR007052 (PFAM); PTHR12621 (PANTHER); IPR007051 (PROSITE_PROFILES); IPR007052 (PROSITE_PROFILES); IPR007051 (PROSITE_PROFILES); IPR008978 (SUPERFAMILY),,
RL4_JR_05626,260,97,137,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46.16276399,0,-1.662514674,1.061162721,-1.566691555,0.117186806,0.248249795,12.21746975,0,-0.145415377,1.239542289,-0.117313768,0.906611415,0.947780881,54.02085015,0,-0.962198578,1.058688244,-0.908859226,0.363424439,0.507567331,50.1123727,0,-1.492453882,1.050680613,-1.420463901,0.155472671,0.273149539,43.24532726,0,-0.725520984,0.908166542,-0.798885391,0.42435687,0.559625763,N,-,,hypothetical protein SPI_00791,C:integral component of membrane,no IPS match,,
RL4_JR_05627,84,26,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,63.05809384,0,-2.045756747,1.02126127,-2.003166875,0.04515938,0.123296593,16.44929677,0,-0.574430065,1.219952625,-0.4708626,0.637738857,0.763386082,55.53957616,0,-1.40469934,1.044267805,-1.345152396,0.178576026,0.298580295,86.31412868,0,-0.866955706,0.762643212,-1.136777582,0.255631277,0.395007148,41.84211486,0,-3.30069588,1.200510285,-2.749410747,0.005970252,0.020694557,N,-,,WASP-interacting vrp1p,C:cytoplasmic part; P:actin cytoskeleton organization,IPR003124 (PFAM); PTHR23202 (PANTHER); PTHR23202 (PANTHER); IPR028293 (PTHR23202:PANTHER); IPR028293 (PTHR23202:PANTHER); IPR028293 (PTHR23202:PANTHER); PTHR23202 (PANTHER); IPR003124 (PROSITE_PROFILES),,
RL4_JR_05628,475,263,325,0,0,5,0,0,2,0,0,0,2,1,1,0,1,0,106.4179606,1,2.685161503,0.431908692,6.216965648,5.07E-10,1.52E-08,5.485647585,1,1.009847846,1.234180134,0.818233756,0.413223724,0.577156138,37.75910465,0,0.767029678,0.846997569,0.905586634,0.365154686,0.509114418,16.41585114,1,-2.064292657,1.187541077,-1.738291582,0.082159449,0.169353506,17.89153999,1,-0.794111549,1.122536795,-0.707425853,0.479301876,0.6086707,N,-,,hypothetical protein SPI_00793,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_05629,98,25,107,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2586.51269,0,-6.664368205,0.800792076,-8.322220466,8.63E-17,7.19E-15,856.3381147,0,-4.016392276,0.898009117,-4.472551781,7.73E-06,0.000525065,2137.182656,0,-6.446420797,0.907682988,-7.102061935,1.23E-12,9.88E-11,2486.596367,0,-5.308462719,0.855794127,-6.202966991,5.54E-10,1.86E-08,2102.284071,0,-5.905000712,0.867565636,-6.806402267,1.00E-11,8.59E-10,N,-,,nuclear localization sequence binding,F:nucleotide binding; F:nucleic acid binding; C:nucleolus,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR24012 (PANTHER); PTHR24012:SF453 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY),9.A.60.1.1, the small nuclear rna exporter (snrna-e).
RL4_JR_05630,151,133,100,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,161.3170913,0,-0.86937996,0.522064815,-1.66527208,0.095858486,0.214485335,168.9976371,0,1.921648158,1.552246327,1.237978873,0.215723895,0.362476305,97.85805876,0,-3.362703286,1.193701916,-2.817037688,0.004846884,0.018525394,138.7942443,0,-1.236244239,0.59026682,-2.094382061,0.03622596,0.101052846,132.0226726,0,-0.650716809,0.551669584,-1.179540849,0.238182881,0.367006798,N,-,,NADH-ubiquinone oxidoreductase 12 kDa subunit,P:oxidation-reduction process; C:mitochondrial inner membrane; C:respiratory chain,PTHR13094 (PANTHER); IPR020163 (PRODOM),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_05631,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,73.64164255,0,-0.627770538,0.883036988,-0.710922132,0.47713249,0.666286692,13.09045315,0,-0.244988597,1.249578257,-0.196057026,0.844565531,0.907028954,45.37888445,0,-1.949771834,1.227995595,-1.587767776,0.112338861,0.211083635,76.20883884,0,-0.255335864,0.742936707,-0.343684545,0.731083536,0.820569087,34.20187685,0,-3.009777984,1.244948022,-2.41759329,0.015623529,0.044863365,N,-,,ribosomal mitochondrial,C:ribosome,IPR013870 (PFAM); PTHR28595 (PANTHER); PTHR28595:SF1 (PANTHER); PTHR28595:SF1 (PANTHER); PTHR28595 (PANTHER),,
RL4_JR_05632,235,338,251,0,0,13,0,1,6,9,28,39,10,69,9,3,17,2,30.74415631,1,-1.517958096,1.183945571,-1.282118142,0.199801206,0.363185881,6.533055582,1,0.757669505,1.264766348,0.599058874,0.549133625,0.695399794,30.08230445,1,-0.094482405,1.069380777,-0.088352444,0.929596558,0.95788657,50.37715642,1,0.714607456,0.731373216,0.977076327,0.328531367,0.475197155,24.36629003,1,-1.058584738,1.166174021,-0.907741657,0.36401473,0.500291725,N,-,,transcription initiation factor tfiid subunit 7,F:translation initiation factor activity; C:transcription factor TFIID complex; P:translational initiation; P:transcription initiation from RNA polymerase II promoter,IPR006751 (SMART); IPR006751 (PFAM); PTHR12228 (PANTHER); PTHR12228:SF0 (PANTHER),,
RL4_JR_05633,78,47,57,0,1,0,0,0,0,0,0,0,3,0,0,0,2,0,16.73818075,1,-2.167407052,1.231367522,-1.760162595,0.078380242,0.185394612,139.1500373,0,4.655375303,1.538156844,3.026593368,0.002473264,0.015349618,21.64435211,0,-0.636029929,1.218679035,-0.5219011,0.601739192,0.719670122,15.92934502,1,-2.020852495,1.223989441,-1.651037523,0.098730913,0.194069209,13.71311396,1,-1.691229949,1.235505312,-1.368856882,0.171044016,0.286062217,N,-,,bromodomain associated,C:intracellular part,IPR006565 (SMART); IPR009072 (G3DSA:1.10.20.GENE3D); IPR006565 (PFAM); PTHR12321 (PANTHER),,
RL4_JR_05634,82,78,54,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,101.5902639,0,-2.050402444,0.873924792,-2.346200112,0.018965922,0.062742899,25.03917615,0,-1.180574781,1.222536066,-0.965676852,0.334205906,0.497548489,147.8457445,1,0.446232801,0.509368137,0.876051659,0.381001951,0.524837575,141.9970061,0,-0.183945681,0.526270832,-0.34952665,0.726693967,0.817997129,63.19699367,0,-3.895587962,1.201647595,-3.241872224,0.001187473,0.005496994,N,-,,glycosyl hydrolase,"C:nucleus; P:carbohydrate catabolic process; C:cytosol; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR012341 (G3DSA:1.50.10.GENE3D); IPR011613 (PFAM); PTHR31616:SF0 (PANTHER); PTHR31616 (PANTHER); PTHR31616 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_05635,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,61.88184794,0,0.03821899,0.691612446,0.055260703,0.955930768,0.977792213,9.654604641,0,0.194272452,1.231261845,0.157783215,0.874627625,0.928082695,25.05703783,0,-2.458222544,1.202337746,-2.044535782,0.040900646,0.097407232,98.42842953,0,1.057163636,0.546704256,1.933702956,0.05314966,0.126947892,24.74048315,0,-2.542609679,1.208196363,-2.104467251,0.035337708,0.085412819,N,-,,triose-phosphate transporter,C:membrane; C:Golgi apparatus,IPR004853 (PFAM); PTHR11132 (PANTHER); PTHR11132:SF32 (PANTHER),2.A.7.9.16, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_05636,25,22,29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,180.5732988,0,-3.158636326,0.850523495,-3.713755523,0.000204206,0.001567181,71.40353156,0,-0.60727807,0.977520619,-0.621243234,0.534439597,0.682570801,158.7500677,0,-3.075455006,1.028748492,-2.989511071,0.002794243,0.012893764,176.864792,0,-3.58570743,1.011288348,-3.545682534,0.000391598,0.00340337,146.3353283,0,-2.786308858,0.849828407,-3.278672299,0.001042967,0.00494246,N,-,,rnp domain containing,F:nucleotide binding; F:nucleic acid binding; C:nucleus,IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR24012 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_05637,32,45,56,0,3,0,0,0,0,1,0,0,0,1,0,0,0,1,1542.538851,1,0.360174791,0.209402869,1.720008869,0.085430829,0.197434761,371.8265679,0,-0.237646708,0.498048178,-0.477156063,0.633250995,0.760081415,1030.595272,1,-0.296012658,0.284191927,-1.041594183,0.297599867,0.438431468,1186.869121,1,-0.330560061,0.315095643,-1.049078486,0.294141997,0.438549215,817.2059429,1,-1.004361866,0.814516738,-1.233077011,0.217547033,0.342827037,N,-,,6-phosphogluconate dehydrogenase,"F:NADP binding; P:pentose-phosphate shunt, oxidative branch; F:phosphogluconate dehydrogenase (decarboxylating) activity; C:cytosol; P:oxidation-reduction process",IPR006183 (PRINTS); IPR006114 (SMART); IPR006115 (PFAM); IPR006113 (TIGRFAM); IPR012284 (G3DSA:1.20.5.GENE3D); IPR006114 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR006113 (PIRSF); IPR013328 (G3DSA:1.10.1040.GENE3D); PTHR11811:SF31 (PANTHER); PTHR11811 (PANTHER); IPR016040 (SUPERFAMILY); IPR008927 (SUPERFAMILY),,
RL4_JR_05638,153,179,148,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,32.16642594,1,-1.982802417,1.186621449,-1.670964584,0.094728673,0.212715804,8.952763683,0,0.303105941,1.253752681,0.241758958,0.808966943,0.883777832,46.94792672,0,0.049259347,0.896480398,0.054947489,0.956180298,0.974445963,64.27772324,1,0.316643504,1.382906526,0.228969564,0.818892572,0.885821292,27.17143984,0,-1.530015011,1.169493635,-1.308271345,0.190781291,0.310856223,N,-,,cyclin-K,C:membrane; P:protein autophosphorylation; P:peptidyl-serine phosphorylation; C:intracellular part; P:peptidyl-threonine phosphorylation,IPR013763 (SMART); IPR006671 (PFAM); IPR013763 (G3DSA:1.10.472.GENE3D); PTHR10026 (PANTHER); PTHR10026:SF51 (PANTHER); IPR013763 (SUPERFAMILY); IPR013763 (SUPERFAMILY),,
RL4_JR_05639,51,63,87,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,66.24663574,0,0.207680723,0.687025793,0.302289558,0.762431338,0.875427847,11.17491735,0,-0.016742478,1.245581972,-0.01344149,0.989275565,0.994452863,29.20562434,0,-2.679249768,1.221178857,-2.19398637,0.028236389,0.073036588,71.09826016,0,0.542163621,0.645111396,0.840418607,0.40067372,0.544686012,40.63150767,0,-0.605273703,0.916715921,-0.660263107,0.509085001,0.635885225,N,-, Effector probability:0.882,DNA-directed RNA polymerase II subunit RPB7,"P:positive regulation of translational initiation; P:regulation of cell separation after cytokinesis; C:cytoplasmic mRNA processing body; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:transcription initiation from RNA polymerase II promoter; C:DNA-directed RNA polymerase II, core complex; F:single-stranded DNA binding; P:telomeric repeat-containing RNA transcription from RNA pol II promoter; F:DNA-directed RNA polymerase activity; P:transcription, RNA-templated; F:single-stranded RNA binding; P:nuclear-transcribed mRNA catabolic process, exonucleolytic; C:cytosol; F:translation initiation factor binding",IPR005576 (G3DSA:3.30.1490.GENE3D); IPR005576 (PFAM); G3DSA:2.40.50.140 (GENE3D); IPR003029 (PFAM); PTHR12709 (PANTHER); IPR012340 (SUPERFAMILY); IPR005576 (SUPERFAMILY),,
RL4_JR_05640,411,228,405,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.238886898,0,3.963146957,2.78529266,1.422883496,0.154769931,NA,0.07750762,0,7.15530673,2.247206023,3.184090225,0.001452097,0.015023052,0.199121161,0,4.517439313,1.396214456,3.235491005,0.001214337,0.006743801,0.229552367,0,4.09592614,1.780560101,2.300358263,0.021427931,0.079482067,0.194526542,0,4.44596538,1.284545777,3.461118677,0.000537936,0.002875598,N,-,,methyltransferase type 12,F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_05641,1741,1933,2189,0,0,0,0,0,0,0,0,2,0,5,0,0,0,1,0.707808463,0,2.396099265,1.769379124,1.354203422,0.175671487,NA,0.229501803,0,5.589081321,1.840002001,3.037540892,0.00238517,0.015223444,0.590018742,1,2.950133468,1.311884579,2.248775171,0.024526804,0.065465163,8.703386796,1,4.22792632,1.084763826,3.897554673,9.72E-05,0.001044411,0.576976504,1,2.878637632,1.267838497,2.270508144,0.02317677,0.061174347,N,-,,ankyrin and het domain,P:biological_process; C:cellular_component; F:molecular_function,IPR010730 (PFAM); PTHR24148 (PANTHER); PTHR24148:SF42 (PANTHER),,
RL4_JR_05642,151,122,141,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0.235440117,0,3.984150748,2.858955144,1.393568821,0.163447849,NA,0.077017737,0,7.164681049,2.304249263,3.109334204,0.001875095,0.015023052,0.196708082,0,4.535577306,1.457321948,3.112268578,0.001856555,0.009351126,0.226691078,1,4.114215172,1.865109463,2.205884026,0.027392121,0.088070176,0.190908177,0,4.473188331,1.330698266,3.361534652,0.000775106,0.003887049,N,-,,hypothetical protein EPUS_05254,C:membrane,no IPS match,,
RL4_JR_05643,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.164469368,0,0.235589881,1.289282279,0.182729481,0.855010283,0.92758379,0.998488767,0,3.467529225,1.436195316,2.414385554,0.015761774,0.047994559,2.611938923,0,0.803517751,1.244485654,0.645662526,0.518497934,0.648859467,3.014618759,0,0.380569051,1.257189409,0.302714172,0.762107696,0.844700649,2.59856488,0,0.708606758,1.251798348,0.566071012,0.571345508,0.687039581,N,-,,mfs monocarboxylate transporter,P:transmembrane transport; P:ion transmembrane transport; C:membrane; C:integral component of membrane; C:integral component of fungal-type vacuolar membrane; F:transporter activity,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11360 (PANTHER); PTHR11360:SF134 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.13.4, the major facilitator superfamily (mfs).
RL4_JR_05644,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.472292864,0,0.591593964,1.298442317,0.45561821,0.648664546,0.800356743,0.783943438,0,3.816535726,1.472550278,2.591786361,0.009547904,0.032572931,2.045307677,0,1.156185532,1.24261295,0.930447033,0.352139676,0.495379283,2.360160369,0,0.733559411,1.25873058,0.582777143,0.560043334,0.68857787,9.396061236,0,2.005879772,1.161177098,1.727453784,0.084086199,0.167527107,N,-,,"L-lysine 2,3-aminomutase",F:catalytic activity,IPR013785 (G3DSA:3.20.20.GENE3D); PTHR30538 (PANTHER); PTHR30538:SF0 (PANTHER); SSF102114 (SUPERFAMILY),,
RL4_JR_05645,3,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.74011999,0,5.502675631,0.759051016,7.249414752,4.19E-13,2.13E-11,0.204300452,0,5.756517469,1.834938748,3.137171459,0.001705863,0.015023052,22.67400815,0,4.932002675,1.057121595,4.665501773,3.08E-06,6.97E-05,8.639537677,0,4.37830813,1.062470386,4.120875451,3.77E-05,0.000457121,0.530628855,0,3.001026994,1.263968148,2.374290048,0.017582732,0.049246242,N,-,,hypothetical protein SPSK_02436,,no IPS match,,
RL4_JR_05646,2158,1631,2678,0,0,7,1,0,0,0,0,0,0,1,2,0,0,0,68.95870996,1,3.641984632,1.070958725,3.400676931,0.000672192,0.004307733,1.562405492,1,2.82180929,1.341291002,2.103800953,0.035395814,0.090019202,23.5379093,0,2.576978222,0.853838588,3.018109345,0.002543571,0.011993998,56.81247382,1,3.66692828,1.319782357,2.778434081,0.005462159,0.030024085,33.78874736,0,3.048886028,0.665358745,4.58231901,4.60E-06,5.28E-05,N,-,,mucin,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_05647,27,32,30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,182.1758393,0,0.788755687,0.399568011,1.974021104,0.048379343,0.12970052,21.778526,0,-0.979283141,1.213240867,-0.807163002,0.419572578,0.583369724,69.21995047,0,-1.805921432,1.040110894,-1.736277778,0.082514731,0.166715416,95.82283732,0,-0.996926877,0.682034538,-1.461695591,0.143824646,0.257921456,147.6452462,0,1.087016272,0.443748188,2.449624138,0.014300541,0.041859778,Y,-,,vacuolar sorting targeting pep1,C:integral component of membrane; C:Golgi apparatus; P:transport,IPR006581 (SMART); G3DSA:2.130.10.140 (GENE3D); IPR031778 (PFAM); IPR031777 (PFAM); PTHR12106:SF27 (PANTHER); PTHR12106 (PANTHER); PS51257 (PROSITE_PROFILES); SSF110296 (SUPERFAMILY); SSF110296 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_05648,51,118,56,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,618.6591116,0,3.362839293,1.001376529,3.358216609,0.000784471,0.004892749,56.16341841,0,0.231141976,1.104964031,0.209185068,0.834303768,0.900662242,338.2489556,0,2.654711337,0.286025812,9.281369819,1.67E-20,2.69E-18,299.5235883,1,2.338552804,0.472611574,4.948149669,7.49E-07,1.43E-05,140.2565844,0,1.481928958,0.384563808,3.853532044,0.000116426,0.000786787,Y,-,,septation sun4,P:mycelium development,IPR005556 (PFAM); PTHR31316 (PANTHER),,
RL4_JR_05649,12433,18539,14340,0,0,0,0,0,4,2,0,0,0,0,0,0,0,0,114.3936224,0,0.171522729,0.45643622,0.375786849,0.707075365,0.841934097,19.13059244,1,-0.792281897,1.200022951,-0.660222287,0.509111192,0.661016052,75.56204644,1,-0.624647679,0.738703261,-0.845600274,0.397775773,0.539808781,86.86938738,0,-0.559303515,0.609308497,-0.917931585,0.358654685,0.504568387,56.17464645,0,-2.5895723,1.11648364,-2.31940013,0.020373351,0.055332665,N,-,,c2h2 type zinc finger domain containing,F:nucleic acid binding; F:metal ion binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY),,
RL4_JR_05650,32550,25147,30133,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,50.4605909,0,1.29443645,0.563999475,2.295102227,0.021727266,0.070393582,5.57968643,0,0.98534582,1.232416796,0.7995232,0.4239871,0.586844992,36.6555805,0,0.741490401,0.845289103,0.877203312,0.380376217,0.524310793,109.9637593,1,2.545145693,0.397706363,6.399559907,1.56E-10,5.78E-09,14.25770724,1,-1.747419021,1.190681684,-1.467578652,0.14221871,0.248870453,N,-,,diacylglycerol acyltransferase,C:lipid particle; P:lipid storage; C:integral component of membrane; P:triglyceride biosynthetic process; C:endoplasmic reticulum; F:diacylglycerol O-acyltransferase activity; P:ceramide metabolic process,IPR007130 (PFAM); PTHR12317 (PANTHER); PTHR12317:SF0 (PANTHER),,
RL4_JR_05651,1466,1409,1720,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.791686519,0,2.234639897,1.630282073,1.37070752,0.17046615,NA,0.250919522,0,5.460081025,1.748331056,3.123024674,0.001790027,0.015023052,0.653971173,0,2.801214524,1.263171827,2.217603706,0.026581865,0.069821478,0.754647429,0,2.378709313,1.337894429,1.777949935,0.075412078,0.159471029,0.647794139,0,2.713068522,1.239430518,2.188963789,0.028599472,0.072441498,N,-,,---NA---,,no IPS match,,
RL4_JR_05652,14,3,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,207.430565,0,1.500141697,0.351781997,4.26440725,2.00E-05,0.000210714,38.51788502,0,0.369086623,1.106683998,0.333506785,0.738751768,0.838207084,125.4275466,0,1.190756779,0.447903321,2.658512952,0.007848633,0.026962865,126.7185431,0,0.441448295,0.479869806,0.91993347,0.357607527,0.503444969,99.05328831,0,1.040833631,0.498831743,2.086542498,0.03692951,0.088478771,N,-,,zinc finger MSN2 4,F:nucleic acid binding,IPR015880 (SMART); PF12874 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); PTHR14596 (PANTHER); PTHR14596 (PANTHER); PTHR14596:SF30 (PANTHER); PTHR14596:SF30 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_05653,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47.80317747,0,4.93532438,0.764555283,6.455156988,1.08E-10,3.72E-09,0.626752218,0,4.139407492,1.505019347,2.750401515,0.005952228,0.023168558,12.70564108,0,2.440160601,1.209674804,2.017203791,0.043674251,0.101950222,1.887585329,0,1.055994135,1.258748095,0.838924118,0.401511893,0.545459267,1.622808286,0,1.387915993,1.23786108,1.121221125,0.26219375,0.39416655,Y,-,,siderophore biosynthesis,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_05654,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.34361459,0,-0.2479551,1.16763203,-0.212357227,0.831828352,0.916417221,2.747019803,0,2.007745906,1.320721685,1.520188491,0.128463609,0.245294973,7.075478012,0,-0.633685619,1.217487816,-0.52048621,0.602724737,0.720593439,8.158992243,0,-1.055429517,1.217821138,-0.866653964,0.386131636,0.531396285,6.918518303,0,-0.704299968,1.211901033,-0.581153039,0.561137315,0.679367947,N,-,,GTPase domain,F:GTP binding; P:peptidyl-tyrosine phosphorylation; F:non-membrane spanning protein tyrosine kinase activity; C:extracellular region; C:microtubule; P:microtubule-based process,IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR022812 (PFAM); PTHR36681 (PANTHER); PTHR36681:SF2 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.135.6, the atp-binding cassette (abc) superfamily.
RL4_JR_05655,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,36.75021194,0,-1.006410904,1.01398867,-0.992526775,0.320940625,0.509383973,8.012713682,0,0.463269644,1.238035638,0.374197341,0.708257502,0.816605814,20.68662216,0,-2.181609297,1.197656084,-1.821565745,0.068520902,0.144311549,23.85693748,0,-2.603492408,1.196501323,-2.175921044,0.029561165,0.09145458,24.15376322,1,-1.326671181,1.124220082,-1.180081375,0.237967851,0.366898811,N,-,,ATP-binding l-psp endoribonuclease family,P:nucleic acid phosphodiester bond hydrolysis; F:ATP binding; F:endonuclease activity; F:hydrolase activity,IPR002761 (TIGRFAM); IPR014729 (G3DSA:3.40.50.GENE3D); G3DSA:3.90.1490.10 (GENE3D); IPR013813 (G3DSA:3.30.1330.GENE3D); IPR002761 (PFAM); IPR030662 (PANTHER); IPR013813 (SUPERFAMILY); IPR013813 (SUPERFAMILY); SSF52402 (SUPERFAMILY),,
RL4_JR_05656,1,2,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.09426992,0,-2.197632453,1.205887431,-1.822419238,0.068391398,0.16805332,5.468076597,0,1.014543116,1.259294955,0.805643754,0.420448289,0.583991809,49.32420724,0,1.502790961,0.68961967,2.179159074,0.029319853,0.075262219,35.58320858,0,-0.302546606,1.028109567,-0.294274673,0.768548025,0.849885184,33.1809203,0,1.202935129,0.702573867,1.712183137,0.086862924,0.1719959,N,-,,DNA-binding SMUBP- partial,F:DNA binding; C:membrane; C:integral component of membrane,IPR003807 (PFAM); PTHR34187:SF2 (PANTHER); PTHR34187 (PANTHER),9.B.51.1.4, the uncharacterized duf202/yidh (yidh) family.
RL4_JR_05657,423,667,461,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,94.58449484,1,-2.843754026,1.078714317,-2.63624389,0.008382946,0.033053683,28.02488345,0,-1.343092429,1.242838768,-1.080665058,0.279846131,0.438891004,119.655698,0,-0.810447577,0.72369052,-1.119881434,0.262764291,0.399885491,124.5489753,1,-0.613981172,0.640948735,-0.957925553,0.3381003,0.485225448,88.95621918,0,-1.820721417,0.884555161,-2.058346948,0.03955684,0.093229285,N,-,,BTB POZ domain-containing,,IPR000210 (SMART); IPR002110 (SMART); G3DSA:3.30.710.10 (GENE3D); PF13637 (PFAM); IPR000210 (PFAM); PF13540 (PFAM); IPR009091 (G3DSA:2.130.10.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR22872:SF2 (PANTHER); PTHR22872:SF2 (PANTHER); PTHR22872 (PANTHER); PTHR22872 (PANTHER); IPR000408 (PROSITE_PROFILES); IPR000408 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR000210 (PROSITE_PROFILES); IPR011333 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR009091 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_05658,584,1233,694,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,206.7142307,0,0.096807691,0.798657416,0.121213037,0.903522298,0.953302497,52.53135452,0,0.025754449,0.996417478,0.025847047,0.979379337,0.989243725,118.0652405,0,-1.849715239,0.866559022,-2.134551937,0.032797627,0.082311149,132.6293216,0,-1.647207176,0.698042042,-2.359753533,0.01828708,0.073855878,113.9656364,0,-1.19494587,0.67811509,-1.76215791,0.078042621,0.158162838,N,-,,mitochondrial 2-oxodicarboxylate carrier,P:transmembrane transport; C:integral component of membrane; C:mitochondrial inner membrane; F:transporter activity,IPR002067 (PRINTS); IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089 (PANTHER); PTHR24089:SF390 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.2.8, the mitochondrial carrier (mc) family.
RL4_JR_05659,70,114,72,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20.37888808,0,2.208857154,0.827706533,2.668647723,0.007615728,0.030545285,1.612692494,0,2.775895595,1.369003983,2.027675324,0.042593396,0.104038598,17.21425862,0,1.923812683,1.069640579,1.798559928,0.072088321,0.15050651,4.866657246,0,-0.310357223,1.241258029,-0.250034413,0.802560736,0.873670856,4.194834389,0,0.017644287,1.246789577,0.014151776,0.988708893,0.992390322,N,-,,domain-containing,"F:nucleic acid binding; F:DNA binding; P:regulation of DNA-templated transcription, elongation; F:methyltransferase activity; P:nucleobase-containing compound metabolic process; P:methylation; P:regulation of transcription from RNA polymerase II promoter",G3DSA:2.60.120.650 (GENE3D); PF13621 (PFAM); PTHR12461 (PANTHER); PTHR12461:SF45 (PANTHER); IPR003347 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_05660,723,502,937,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,64.71120454,0,-2.974814522,1.169265304,-2.544174116,0.010953647,0.04073038,17.93912721,0,-0.699571568,1.215769062,-0.575414847,0.565010766,0.707364127,46.82739559,0,-3.360327633,1.206787869,-2.784522217,0.005360665,0.019923411,63.35275805,0,-2.83131495,1.162610323,-2.435308627,0.014879093,0.065631958,50.3344373,0,-2.523865659,1.148263409,-2.197984922,0.02795018,0.071140165,N,-,,casein kinase ii subunit beta-1,C:protein kinase CK2 complex; F:protein serine/threonine kinase inhibitor activity; C:UTP-C complex; P:protein phosphorylation; P:cellular response to DNA damage stimulus; P:negative regulation of protein serine/threonine kinase activity; F:kinase activity; P:regulation of transcription from RNA polymerase III promoter; P:regulation of transcription from RNA polymerase I promoter,IPR000704 (PRINTS); IPR000704 (SMART); IPR016149 (G3DSA:1.10.1820.GENE3D); IPR000704 (PFAM); IPR016150 (G3DSA:2.20.25.GENE3D); IPR000704 (PANTHER); PTHR11740:SF2 (PANTHER); PTHR11740:SF2 (PANTHER); IPR000704 (PANTHER); IPR000704 (SUPERFAMILY),,
RL4_JR_05661,125,224,214,3,1,42,0,0,1,0,0,0,0,6,3,0,0,2,813.5478176,1,-0.060280896,0.260392558,-0.231500071,0.81692633,0.906856035,146.4862129,1,-2.716036022,1.108161766,-2.450938217,0.014248441,0.044249477,473.9818141,0,-1.473182744,0.429316936,-3.43145732,0.000600348,0.003863903,456.3136,1,-3.380677487,0.607545051,-5.564488559,2.63E-08,6.77E-07,349.6571287,1,-6.363579505,1.193138839,-5.333477796,9.63E-08,2.16E-06,N,-,,ABC-2 type transporter,F:ATP binding; P:drug transmembrane transport; P:sterol import; P:cellular response to drug; C:integral component of membrane; P:xenobiotic transport; F:xenobiotic-transporting ATPase activity; C:plasma membrane,IPR003593 (SMART); IPR003439 (PFAM); IPR029481 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR013525 (PFAM); IPR010929 (PFAM); PTHR19241:SF243 (PANTHER); PTHR19241 (PANTHER); PTHR19241 (PANTHER); PTHR19241:SF243 (PANTHER); PTHR19241 (PANTHER); PTHR19241:SF243 (PANTHER); PTHR19241:SF243 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.205.6, the atp-binding cassette (abc) superfamily.
RL4_JR_05662,13,14,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,239.7908001,0,3.482766998,0.924992846,3.765182632,0.000166427,0.00132202,28.3489737,0,1.795751886,1.115185672,1.610271662,0.107338563,0.213751109,117.8638043,0,2.743200025,0.433733549,6.324620336,2.54E-10,1.40E-08,99.08949799,0,2.486476458,0.419025991,5.933943271,2.96E-09,9.02E-08,49.42279879,0,1.565959775,0.575006098,2.723379425,0.00646178,0.022163117,N,-,,cytochrome p450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24296 (PANTHER); PTHR24296:SF0 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_05663,229,232,257,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,313.2648738,1,8.668705188,0.763923567,11.34760801,7.62E-30,3.66E-27,37.75807876,0,8.07085828,0.80149156,10.06979821,7.51E-24,5.85E-21,169.7747371,0,8.176556985,0.518774118,15.76130477,5.74E-56,4.47E-53,4.738170595,0,3.380488505,1.175628945,2.875472332,0.004034235,0.023665486,35.36241081,0,6.491284583,0.591912056,10.96663688,5.53E-28,2.33E-25,N,-,,Conidiation-specific 8,P:multicellular organism development,no IPS match,,
RL4_JR_05664,4,1,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,180.4778301,1,-0.010832924,0.432261642,-0.025061034,0.980006281,0.990079411,32.33636925,0,-1.549543929,1.200022775,-1.2912621,0.196612808,0.339958121,133.6992374,0,-0.575029523,0.575980118,-0.998349604,0.318109862,0.460801866,105.7806962,0,-3.669702717,1.142084424,-3.213162389,0.00131282,0.009314861,112.3367127,0,-1.068094091,0.611694677,-1.746122911,0.080789597,0.162414992,N,-,,Poly(rC)-binding 3,F:RNA binding,IPR004087 (SMART); IPR004088 (PFAM); IPR004088 (G3DSA:3.30.1370.GENE3D); PTHR10288 (PANTHER); PTHR10288:SF133 (PANTHER); PTHR10288:SF133 (PANTHER); PTHR10288 (PANTHER); IPR004088 (PROSITE_PROFILES); IPR004088 (PROSITE_PROFILES); IPR004088 (PROSITE_PROFILES); IPR004088 (SUPERFAMILY); IPR004088 (SUPERFAMILY); IPR004088 (SUPERFAMILY),,
RL4_JR_05665,8,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.64644321,0,2.44998509,0.632732054,3.872073611,0.000107913,0.000912287,2.940001654,0,1.909611987,1.285388525,1.485630181,0.137376967,0.258031112,7.666736353,0,-0.749783867,1.209686785,-0.619816531,0.535378584,0.664236861,8.847160252,0,-1.172543235,1.209767097,-0.969230555,0.332430169,0.47905714,15.32176276,0,0.817947776,1.007587081,0.811788669,0.416912905,0.552952995,N,-,,hypothetical protein SPBR_08537,C:nucleus,PTHR14401:SF6 (PANTHER); PTHR14401:SF6 (PANTHER); PTHR14401 (PANTHER); PTHR14401 (PANTHER),,
RL4_JR_05666,9,11,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.036038566,0,6.691887793,3.936267545,1.700059185,0.089119794,NA,0.011360376,0,9.924477985,3.208780189,3.092913008,0.001982022,0.015023052,0.029704654,0,7.260895838,1.826299019,3.975743163,7.02E-05,0.000916158,0.0342852,0,6.838770256,3.522579786,1.941409612,0.052208613,0.125807414,0.02951127,0,7.172883508,1.387887465,5.168202531,2.36E-07,4.41E-06,N,-,,hypothetical protein SPI_00295,,no IPS match,,
RL4_JR_05667,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.080903402,0,5.525451715,3.91993654,1.409576828,0.158664673,NA,0.025573584,0,8.754740283,2.769277932,3.161380149,0.001570234,0.015023052,0.066594843,0,6.098569007,1.592192263,3.830296848,0.000127989,0.001344148,0.076853382,0,5.674801142,2.597970908,2.184320511,0.028938705,0.090433452,0.065751349,0,6.017448515,1.334223413,4.510075643,6.48E-06,7.02E-05,N,-,,---NA---,,no IPS match,,
RL4_JR_05668,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,153.4350743,0,-1.494657615,0.654349707,-2.284187794,0.022360497,0.072016159,37.39841818,0,-1.759420832,1.211355758,-1.452439401,0.146379467,0.272062609,97.70077205,0,-4.421326507,1.211159519,-3.650490657,0.00026174,0.002096404,157.707137,0,-1.309927436,0.626948303,-2.089370735,0.036674363,0.101686282,167.9156922,0,-0.291703653,0.564622442,-0.516634889,0.605411056,0.713878218,N,-,,duf1750 domain containing,,IPR013859 (PFAM),,
RL4_JR_05669,13,33,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14.00859984,0,2.838245912,0.870078866,3.262055916,0.001106073,0.00638336,0.814778399,0,3.760977175,1.445304813,2.602203453,0.009262688,0.03183597,2.115753838,0,1.107449409,1.221538273,0.906602301,0.364617144,0.508805509,2.44078008,0,0.685172819,1.230708835,0.556730235,0.577711756,0.704180169,2.089659988,0,1.02283983,1.218724198,0.839270962,0.401317274,0.53847567,N,-,,phenylacetone monooxygenase,"F:NADP binding; F:flavin adenine dinucleotide binding; P:oxidation-reduction process; F:N,N-dimethylaniline monooxygenase activity",IPR023753 (G3DSA:3.50.50.GENE3D); PF13450 (PFAM); PTHR23023:SF133 (PANTHER); PTHR23023:SF133 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_05670,163,92,145,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19.42715828,1,-2.382430844,1.201861167,-1.982284568,0.0474474,0.127958972,6.176138486,0,0.838748189,1.240098033,0.676356358,0.498814419,0.65325392,16.07745528,0,-1.818093716,1.201910168,-1.512670218,0.130363448,0.236480837,32.19717615,0,-0.505786254,1.026546359,-0.492706685,0.622219853,0.739691592,15.91780918,0,-1.906354035,1.210966686,-1.574241519,0.115431624,0.212808666,N,-,,s-adenosylmethionine-dependent methyltransferase,F:methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PTHR14614:SF39 (PANTHER); PTHR14614 (PANTHER); PTHR14614 (PANTHER); PTHR14614:SF39 (PANTHER),,
RL4_JR_05671,606,1029,730,0,1,0,0,0,0,0,0,0,0,2,0,0,0,0,303.6248594,1,1.746506065,0.869761225,2.008029346,0.044640173,0.122165224,32.64476508,0,-0.157305471,1.111844209,-0.141481576,0.887489514,0.93624486,164.5636645,0,0.574904745,0.464988826,1.236383999,0.216315861,0.34493334,285.400747,1,1.728822754,0.684346101,2.526240378,0.011529057,0.054293813,189.5340352,0,1.421198332,0.64415293,2.206305779,0.027362597,0.07012055,Y,-,,extracellular matrix,C:membrane; C:integral component of membrane,IPR018466 (PFAM); PTHR40633 (PANTHER); PTHR40633:SF1 (PANTHER),,
RL4_JR_05672,0,0,1,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,90.91522608,1,-2.543859919,1.011758906,-2.514294566,0.011927077,0.043652352,23.34966157,0,-1.079806484,1.206333659,-0.89511428,0.370726001,0.535131546,126.1851253,0,0.254833417,0.522309583,0.487897264,0.625622612,0.737987985,85.75450708,0,-1.442289954,0.756932539,-1.905440552,0.056722828,0.132423019,74.20730148,0,-2.120772396,0.97355771,-2.178373581,0.029378235,0.073883415,Y,-,,5-azacytidine resistance azr1,F:phosphoprotein phosphatase activity; C:intracellular membrane-bounded organelle,IPR001932 (SMART); IPR001932 (SMART); PF13672 (PFAM); IPR001932 (G3DSA:3.60.40.GENE3D); PTHR12320 (PANTHER); PTHR12320 (PANTHER); PTHR12320:SF1 (PANTHER); PTHR12320:SF1 (PANTHER); IPR001932 (PROSITE_PROFILES); IPR001932 (SUPERFAMILY),,
RL4_JR_05673,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,327.9444422,1,-0.135282838,0.554785467,-0.24384712,0.807349225,0.902441818,73.04779211,0,-0.658490053,0.995128791,-0.661713397,0.508154917,0.660360004,153.2400624,0,-3.124575122,1.039763178,-3.005083454,0.00265508,0.012404259,292.5812339,0,-0.371605099,0.39053924,-0.951517955,0.341341509,0.488266011,225.9933734,0,-0.354815095,0.433863066,-0.817804332,0.413468924,0.549609145,N,-, Effector probability:0.615,succinate dehydrogenase iron-sulfur subunit,"F:succinate dehydrogenase (ubiquinone) activity; F:metal ion binding; F:electron carrier activity; F:3 iron, 4 sulfur cluster binding; P:tricarboxylic acid cycle; F:4 iron, 4 sulfur cluster binding; F:2 iron, 2 sulfur cluster binding; C:mitochondrial inner membrane",IPR025192 (PFAM); IPR012675 (G3DSA:3.10.20.GENE3D); G3DSA:1.10.1060.10 (GENE3D); PF13534 (PFAM); IPR004489 (TIGRFAM); PTHR11921 (PANTHER); PTHR11921:SF29 (PANTHER); IPR001041 (PROSITE_PROFILES); IPR017896 (PROSITE_PROFILES); IPR001041 (SUPERFAMILY); IPR009051 (SUPERFAMILY),3.D.10.1.6, the prokaryotic succinate dehydrogenase (sdh) family.
RL4_JR_05674,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.460279066,0,1.351293966,1.329788294,1.016172252,0.309547367,NA,0.466056751,0,4.56689485,1.561243374,2.925165242,0.003442734,0.016643092,15.55142385,0,3.735084863,1.038262506,3.597437876,0.000321367,0.002453636,1.395561682,0,1.491725611,1.252544112,1.190956547,0.233670644,0.370851629,1.193876133,0,1.830475447,1.216442952,1.504777058,0.132381404,0.235564449,Y,-,,hypothetical protein F503_01051,,no IPS match,,
RL4_JR_05675,33,36,36,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,55.7148296,0,0.497271316,0.680043095,0.731235004,0.464635623,0.652858665,7.044752668,0,0.649024268,1.241272975,0.522869894,0.601064797,0.735467207,53.39328556,0,1.140002311,0.680305772,1.675720473,0.093792958,0.184775229,78.63512698,0,1.479257467,0.52827847,2.800147179,0.005107931,0.028478966,33.31222772,0,0.533205696,0.756776222,0.704575118,0.481074688,0.60985116,N,-,,acid phosphatase,C:membrane; F:phosphatase activity,IPR000560 (PFAM); IPR029033 (G3DSA:3.40.50.GENE3D); PTHR20963:SF15 (PANTHER); PTHR20963:SF15 (PANTHER); PTHR20963 (PANTHER); PTHR20963 (PANTHER); IPR029033 (SUPERFAMILY),,
RL4_JR_05676,266,141,144,0,0,0,0,0,0,0,0,0,0,2,3,0,0,0,0.062799701,0,5.890103073,3.923716109,1.50115424,0.133315673,NA,0.021204667,0,9.026180504,3.32942941,2.711029246,0.006707471,0.025173534,0.053254204,0,6.420276099,2.159186363,2.973470103,0.002944531,0.01344023,0.061291956,1,6.00092728,3.349540569,1.791567278,0.073202309,0.155905211,0.050938403,0,6.376073784,1.752495106,3.638283361,0.000274461,0.001629436,N,-,,---NA---,,no IPS match,,
RL4_JR_05677,3937,3312,3694,0,0,10,0,0,0,0,0,3,4,3,0,0,10,0,264.1063546,1,-0.932241139,0.518206315,-1.798976802,0.07202235,0.174453187,75.5588667,0,-0.737610657,1.03166104,-0.714973841,0.474625207,0.63195953,152.5211166,1,-4.039258416,1.2197556,-3.311530945,0.00092787,0.005411148,313.3455961,1,-0.320023068,0.663532701,-0.482301878,0.629591514,0.745501645,161.9613896,1,-2.191783023,0.753886331,-2.907312326,0.00364549,0.013850127,N,-,,ammonium transporter MEP1,F:ammonium transmembrane transporter activity; C:integral component of plasma membrane; P:organic cation transport; P:ammonium transmembrane transport; P:nitrogen utilization,IPR024041 (PFAM); IPR029020 (G3DSA:1.10.3430.GENE3D); IPR001905 (TIGRFAM); IPR001905 (PANTHER); PTHR11730:SF25 (PANTHER); IPR024041 (SUPERFAMILY),1.A.11.3.1, the ammonium transporter channel (amt) family.
RL4_JR_05678,2925,3416,3755,0,0,3,0,0,0,0,0,2,0,0,1,0,1,0,52.21862088,1,-0.606292615,0.760383329,-0.797351273,0.42524705,0.616192795,11.77079599,0,-0.091661557,1.215122336,-0.075434016,0.939869396,0.967197847,94.46077797,1,1.234736254,0.526131694,2.346819757,0.018934412,0.053695234,44.93310999,1,-2.218546452,1.148582564,-1.931551569,0.053414878,0.127223158,52.69572494,1,-0.205635686,0.762886437,-0.269549537,0.787506827,0.854792735,N,-,,kinase-like domain,F:ATP binding; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; C:cellular_component; F:kinase activity,IPR011009 (SUPERFAMILY),,
RL4_JR_05679,678,660,823,5,0,1,0,0,0,2,0,2,0,0,0,0,2,0,37.70623876,1,2.744671662,0.558316715,4.915976159,8.83E-07,1.38E-05,24.59573691,0,3.19851576,1.116311748,2.865253156,0.00416676,0.018371529,12.41965476,1,0.585129524,1.193728926,0.490169511,0.624013953,0.736822634,16.14272001,0,0.150661004,1.144053143,0.131690564,0.895229049,0.93541735,5.828758954,1,-0.456861036,1.198042886,-0.381339468,0.702951371,0.789822778,N,-,,hypothetical protein SPI_00684,C:membrane; C:integral component of membrane,PTHR35392 (PANTHER); PTHR35392:SF3 (PANTHER),,
RL4_JR_05680,1104,1083,1692,0,0,7,3,0,0,1,0,0,1,1,0,0,4,1,0.272085613,1,3.775500386,2.620792038,1.440595183,0.149699082,NA,0.088050707,1,6.97135967,2.178681643,3.199806495,0.001375199,0.015023052,0.226337555,1,4.333142708,1.364242911,3.176225197,0.001492051,0.007855186,0.260953369,1,3.911142593,1.692433231,2.310958282,0.020835159,0.078120428,0.221020664,1,4.262515654,1.265740773,3.367605552,0.00075824,0.003827108,N,-,,family Taurine catabolism dioxygenase,F:dioxygenase activity; P:oxidation-reduction process,G3DSA:3.60.130.10 (GENE3D); IPR003819 (PFAM); PTHR10696 (PANTHER); PTHR10696:SF15 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_05681,30329,19724,27187,1,12,31,0,0,1,2,2,11,5,18,1,0,8,3,91.7788388,1,3.394933852,0.785759091,4.320578524,1.56E-05,0.000168824,2.922839182,1,1.918157657,1.271194673,1.508940918,0.131313882,0.249046115,66.07012916,1,3.032763385,1.378397106,2.20021021,0.027791984,0.072145141,93.02395207,1,3.27558927,0.426423869,7.681533587,1.57E-14,9.42E-13,15.19197773,1,0.854535387,0.973506299,0.877791328,0.380056971,0.515827994,N,-,,g- coupled receptor,F:G-protein coupled receptor activity; P:G-protein coupled receptor signaling pathway; C:integral component of membrane; P:cell surface receptor signaling pathway,IPR000832 (PFAM); PTHR42058 (PANTHER); IPR017981 (PROSITE_PROFILES),,
RL4_JR_05682,154,115,206,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,115.4522355,0,1.179400451,0.56039813,2.104575995,0.035328233,0.102565027,20.38122333,0,0.919596308,1.15876129,0.79360289,0.427426649,0.590314169,229.4357137,1,2.922259504,0.558530415,5.232050797,1.68E-07,5.55E-06,480.2121801,0,3.820659789,0.367672111,10.39148654,2.71E-25,3.35E-23,254.6023041,0,2.991322874,0.679091419,4.404889815,1.06E-05,0.000105473,N,-,,endoglucanase E1,"P:carbohydrate metabolic process; C:integral component of membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR001547 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR31263:SF0 (PANTHER); PTHR31263 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_05683,2227,2479,3768,0,0,0,0,0,0,1,0,2,0,0,0,0,3,0,31.25620936,0,0.598008906,0.768172338,0.778482739,0.436284478,0.626731603,5.144342516,0,1.102597395,1.26618277,0.870804296,0.383861019,0.548171732,13.2647544,1,-1.540456503,1.204869284,-1.278525831,0.201064083,0.326475184,40.65544402,0,1.06886469,0.695690708,1.536407888,0.124438373,0.230715717,16.85039839,1,-0.683514019,1.130250074,-0.60474583,0.545347891,0.666611346,N,-,,pyridine nucleotide-disulfide oxidoreductase family,P:regulation of transcription from RNA polymerase II promoter,IPR014839 (PFAM),,
RL4_JR_05684,3633,4107,4634,5,0,12,0,0,3,4,0,0,0,3,1,0,0,0,9.572040308,1,-1.361372719,1.206838824,-1.128048495,0.259299439,0.438781337,3.065921004,1,1.849178006,1.292745989,1.430426411,0.152594673,0.280175398,39.31644304,1,2.023610976,0.763639189,2.649956952,0.008050203,0.027496711,9.163702888,1,-1.223248569,1.20880118,-1.011951833,0.311561084,0.457646305,7.831548639,0,-0.883164853,1.212657113,-0.728289015,0.466436686,0.597579583,N,-,,swim zinc finger,F:zinc ion binding,G3DSA:1.10.601.10 (GENE3D),,
RL4_JR_05685,340,277,288,0,3,0,0,0,0,0,0,0,0,0,3,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_05686,184,97,100,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,90.05262416,0,3.199956648,1.061341224,3.015012113,0.00256969,0.012774851,12.54628353,0,2.71746983,1.140094779,2.383547298,0.017146681,0.051167071,8.180962148,0,-0.843174728,1.200369121,-0.702429538,0.48241133,0.618454135,29.4930594,0,1.7594615,0.685409537,2.567022203,0.010257604,0.049456307,8.025508778,0,-0.91844524,1.195660846,-0.768148629,0.442398889,0.576015767,N,-,,dual specificity phosphatase,"P:positive regulation of septation initiation signaling; C:condensed nuclear chromosome kinetochore; P:positive regulation of attachment of mitotic spindle microtubules to kinetochore; P:vacuolar transport; P:cellular response to DNA damage stimulus; P:mitotic actomyosin contractile ring maintenance; C:mitotic spindle pole body; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:mitotic cytokinesis checkpoint; F:protein tyrosine/serine/threonine phosphatase activity; C:mitotic spindle midzone; P:positive regulation of exit from mitosis; P:cellular response to osmotic stress; P:correction of merotelic kinetochore attachment, mitotic; C:actomyosin contractile ring; C:RENT complex; F:protein tyrosine phosphatase activity; P:protein localization to kinetochore; P:response to mitotic cell cycle spindle assembly checkpoint signaling; P:establishment of protein localization to spindle pole body; P:peptidyl-tyrosine dephosphorylation; P:meiotic spindle disassembly; P:chromosome passenger complex localization to spindle midzone",IPR020422 (SMART); IPR003595 (SMART); IPR029260 (PFAM); IPR029021 (G3DSA:3.90.190.GENE3D); IPR029021 (G3DSA:3.90.190.GENE3D); IPR000340 (PFAM); PTHR23339 (PANTHER); IPR026070 (PTHR23339:PANTHER); IPR000387 (PROSITE_PROFILES); IPR029021 (SUPERFAMILY); IPR029021 (SUPERFAMILY),,
RL4_JR_05687,0,2,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30.41071492,0,-3.028879018,1.235345194,-2.451848305,0.014212456,0.050359433,9.596089788,0,0.202994298,1.253770295,0.161907088,0.871379021,0.925703028,47.25523048,0,-0.614825015,1.065581552,-0.576985416,0.563949308,0.688940202,32.99892869,0,-1.939962231,1.182484031,-1.64058218,0.100884177,0.197039407,25.01201688,0,-2.558326965,1.240291357,-2.062682249,0.039142828,0.092436905,N,-,,transcription factor pcc1,P:biological_process; C:cellular_component; F:molecular_function,IPR015419 (PFAM); PTHR31283:SF5 (PANTHER); PTHR31283 (PANTHER),,
RL4_JR_05688,2080,3863,2913,0,0,8,0,0,0,0,1,0,0,3,0,0,6,0,189.9245838,1,5.048878224,0.802733464,6.289607259,3.18E-10,9.84E-09,1.814733232,0,2.60583675,1.663661287,1.566326494,0.117272202,0.229333312,15.66279078,1,0.951415509,1.619816208,0.587360161,0.556961844,0.683393735,5.289141618,1,-0.430205183,1.46518145,-0.293619048,0.769049019,0.849994059,4.422817182,1,-0.058869009,1.436391963,-0.040983945,0.967308695,0.978519387,N,-,,sulfate permease,C:integral component of plasma membrane; F:secondary active sulfate transmembrane transporter activity; F:anion:anion antiporter activity; P:regulation of intracellular pH; P:regulation of membrane potential; P:chloride transmembrane transport; F:oxalate transmembrane transporter activity; P:sulfate transmembrane transport; F:chloride channel activity; P:oxalate transport; P:bicarbonate transport; F:bicarbonate transmembrane transporter activity,IPR001902 (TIGRFAM); IPR002645 (PFAM); IPR011547 (PFAM); IPR002645 (G3DSA:3.30.750.GENE3D); PTHR11814:SF80 (PANTHER); PTHR11814:SF80 (PANTHER); IPR001902 (PANTHER); PTHR11814:SF80 (PANTHER); IPR001902 (PANTHER); IPR002645 (PROSITE_PROFILES); IPR002645 (SUPERFAMILY),2.A.53.1.2, the sulfate permease (sulp) family.
RL4_JR_05689,12823,16930,20095,0,0,3,0,0,0,0,0,0,1,1,0,0,1,0,629.2137334,1,-0.840264999,0.55414541,-1.51632583,0.129436983,0.266249851,192.9233023,0,-0.674360434,0.688494971,-0.979470385,0.327347615,0.489859929,584.1413364,0,-0.641656842,0.427526591,-1.500858322,0.13339221,0.240210376,631.1649315,1,-0.622920195,0.469738304,-1.326100489,0.184806414,0.311964812,463.9518125,1,-1.101750606,0.484328027,-2.274802496,0.02291778,0.060776601,N,-,,translation initiation factor,F:translation initiation factor activity; P:translational initiation,IPR005874 (PIRSF); IPR001950 (G3DSA:3.30.780.GENE3D); IPR005874 (TIGRFAM); IPR001950 (PFAM); PTHR10388 (PANTHER); IPR001950 (PROSITE_PROFILES); IPR001950 (SUPERFAMILY),,
RL4_JR_05690,1364,2035,2525,0,1,1,0,0,0,1,0,1,1,2,1,0,0,0,23.27116039,1,-2.642835518,1.230330465,-2.14806964,0.031708224,0.094580946,7.339783238,0,0.589697764,1.257245544,0.469039454,0.639041435,0.764222283,19.20376001,1,-2.074404424,1.221344898,-1.698459156,0.089421135,0.177893412,34.19950663,1,-0.225614109,0.91354552,-0.246965372,0.804935023,0.875305242,19.10776038,0,-2.169852992,1.236225144,-1.755224769,0.079220869,0.160197982,N,-,,cell cycle arrest BUB2,C:nucleus; P:regulation of vesicle fusion; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:activation of GTPase activity; F:GTPase activator activity; P:negative regulation of septation initiation signaling; C:cytosol; C:endomembrane system; P:intracellular protein transport; P:mitotic spindle orientation checkpoint; C:mitotic spindle pole body; F:Rab GTPase binding,IPR000195 (SMART); IPR000195 (PFAM); G3DSA:1.10.8.270 (GENE3D); PTHR22957 (PANTHER); PTHR22957:SF309 (PANTHER); PTHR22957:SF309 (PANTHER); PTHR22957 (PANTHER); IPR000195 (PROSITE_PROFILES); IPR000195 (SUPERFAMILY); IPR000195 (SUPERFAMILY); IPR000195 (SUPERFAMILY),,
RL4_JR_05691,2545,3521,3235,0,0,1,0,0,0,0,0,0,1,5,1,1,2,1,0.003880053,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,1,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,hypothetical protein SPBR_08689,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_05692,1433,1309,2504,0,1,15,0,0,3,0,0,0,1,0,0,0,1,2,301.2494712,1,2.321714909,0.467816166,4.96287875,6.95E-07,1.11E-05,43.96271296,1,1.63889901,0.901010326,1.818956966,0.068917996,0.151853303,90.42978823,0,0.448184774,0.615820947,0.72778423,0.46674568,0.603664701,55.20660645,1,-1.874240396,1.046068389,-1.791699679,0.073181086,0.155892804,40.0983867,1,-3.23924164,1.209009088,-2.679253344,0.007378654,0.024615774,N,-,,izh family channel,C:integral component of membrane; P:cellular zinc ion homeostasis; C:Golgi apparatus,IPR004254 (PFAM); PTHR20855:SF15 (PANTHER); IPR004254 (PANTHER),1.C.113.1.8, the hly iii (hly iii) family.
RL4_JR_05693,1191,1320,2373,0,0,1,0,0,0,0,0,0,0,2,4,0,0,0,20.22627697,1,-2.440576729,1.188274578,-2.053882809,0.039987036,0.112621878,15.82513409,0,1.693750661,1.118650082,1.5141023,0.129999896,0.247250939,67.52268393,0,1.279621656,0.666278417,1.920550964,0.054788342,0.121267419,42.27635839,1,0.021783489,0.847806824,0.02569393,0.979501465,0.987381314,16.53186343,0,-1.960957416,1.196810744,-1.638485805,0.101320393,0.192905035,N,-,,thoc5 family,C:nucleus; C:cytosol,IPR019163 (PFAM); PTHR13375 (PANTHER),,
RL4_JR_05694,23,18,28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,60.39967647,0,-4.018768343,1.223678032,-3.284171356,0.001022827,0.006011689,19.21406783,0,-0.798557434,1.228519102,-0.650016294,0.515681697,0.665951791,49.84729834,0,-3.450431224,1.212386044,-2.84598395,0.004427443,0.017353244,57.51095491,0,-3.872922264,1.21554837,-3.186152323,0.001441787,0.01006071,49.04841037,0,-3.529899755,1.214761483,-2.905837734,0.003662713,0.013889503,N,-,,sphingomyelinase family,C:integral component of membrane,IPR001173 (PFAM); PTHR36851 (PANTHER); PTHR36851:SF1 (PANTHER); IPR029044 (SUPERFAMILY),4.D.1.2.1, the putative vectorial glycosyl polymerization (vgp) family.
RL4_JR_05695,2162,2425,3513,0,1,4,0,0,1,1,0,1,0,4,0,0,0,0,1684.690589,1,-3.234784343,1.065647486,-3.035510697,0.002401287,0.01213736,502.0942178,1,-3.823772835,1.02397726,-3.734236084,0.000188286,0.008179524,1309.321502,1,-4.943879731,0.744468338,-6.640819329,3.12E-11,2.01E-09,1546.091811,1,-4.011959034,0.535566227,-7.491060548,6.83E-14,3.79E-12,1385.993515,0,-3.14475963,1.330038778,-2.364411987,0.018058718,0.050314947,N,-,,FK506-binding 4,F:peptidyl-prolyl cis-trans isomerase activity; P:protein peptidyl-prolyl isomerization; P:protein folding,G3DSA:3.10.50.40 (GENE3D); IPR001179 (PFAM); IPR023566 (PANTHER); IPR001179 (PROSITE_PROFILES); SSF54534 (SUPERFAMILY),8.A.11.1.2, the immunophilin-like prolyl:peptidyl isomerase regulator (i-ppi) family.
RL4_JR_05696,3305,3075,4957,0,2,22,3,0,0,0,1,1,0,3,2,0,7,1,7.408236462,1,-0.991537523,1.405036237,-0.705702456,0.480373193,0.669208421,2.299459281,1,2.264058943,1.491961772,1.517504661,0.129139318,0.246214696,6.092873995,1,-0.418295601,1.341374309,-0.311841071,0.755161309,0.835364193,7.037122948,1,-0.84229873,1.363030362,-0.617960358,0.53660147,0.668441177,6.149954626,1,-0.534334591,1.372368338,-0.38935217,0.697015649,0.785728517,N,-,,AGC NDR NDR kinase,F:nucleotide binding; P:G1/S transition of mitotic cell cycle; P:positive regulation of apoptotic process; P:hippo signaling; P:regulation of organ growth; F:protein serine/threonine kinase activity; P:peptidyl-serine phosphorylation; C:intracellular,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24356:SF151 (PANTHER); PTHR24356 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_05697,7768,6837,10873,6,9,20,0,0,0,3,5,3,4,13,3,0,11,1,50.59413908,1,-0.535112155,0.750512871,-0.712995308,0.475848661,0.665177069,11.25740366,0,-0.027269789,1.212144382,-0.022497146,0.982051389,0.990676395,40.27786336,1,-1.717473312,1.19018173,-1.443034512,0.149010749,0.261000835,75.10110838,1,0.767673092,0.523048758,1.467689349,0.142188625,0.255985034,36.49908977,1,-1.091734629,0.97493031,-1.119807865,0.262795647,0.394895507,N,-,,endonuclease Exonuclease phosphatase,C:intracellular membrane-bounded organelle; C:membrane; C:cytoplasmic part; P:single-organism cellular process; P:primary metabolic process; P:cellular metabolic process; P:single-organism metabolic process; P:organic substance metabolic process,IPR005135 (G3DSA:3.60.10.GENE3D); IPR005135 (PFAM); PTHR12393 (PANTHER); IPR005135 (SUPERFAMILY),,
RL4_JR_05698,779,650,1390,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,19.4598621,0,0.701187925,1.010288189,0.694047433,0.487652463,0.675312984,11.81288875,0,3.098183333,1.128774134,2.744732749,0.006056019,0.02343235,6.312808393,0,-0.469198601,1.19684141,-0.392030721,0.695035515,0.792046325,15.30579469,1,0.834904739,1.015906062,0.821832618,0.411172167,0.554848455,6.217035197,1,-0.549907776,1.196882442,-0.459450115,0.645910967,0.747069744,N,-,,F-box domain-containing,C:integral component of membrane,IPR001810 (PROSITE_PROFILES),,
RL4_JR_05699,408,343,554,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,31.6638858,0,-0.966019634,1.023634962,-0.943714966,0.345315324,0.535160033,7.639331722,0,0.532014718,1.227670282,0.433353096,0.66475827,0.785327172,26.37947226,0,-1.162615769,1.197048372,-0.971235412,0.331431063,0.47466517,26.94999033,0,-1.600262725,1.150435994,-1.39100544,0.164223777,0.284491802,35.1161723,1,0.38108778,0.779228992,0.489057496,0.624800992,0.729596167,N,-,,defects in morphology 1,P:nucleic acid phosphodiester bond hydrolysis; C:nucleus; F:exonuclease activity; F:single-stranded DNA 5'-3' exodeoxyribonuclease activity; C:cytosol; P:DNA metabolic process,IPR019190 (PFAM); PTHR14464 (PANTHER),,
RL4_JR_05700,29329,29888,43373,0,9,57,0,0,0,0,8,0,0,16,12,0,25,7,75.22589947,1,0.8804389,0.492229999,1.788673795,0.073667366,0.177199924,10.48577712,0,0.075143281,1.21134062,0.062033156,0.950536429,0.973667236,44.77700172,1,-0.752312876,1.028352167,-0.731571246,0.464430304,0.601494171,35.39921164,1,-2.051980033,1.140144264,-1.79975473,0.071899375,0.154137797,49.28904888,1,-0.032694426,0.745739579,-0.043841613,0.965030657,0.977191259,Y,-,,glycoside hydrolase family 92,P:carbohydrate metabolic process; F:carbohydrate binding; F:hydrolase activity,IPR014718 (G3DSA:2.70.98.GENE3D); G3DSA:1.20.1050.60 (GENE3D); G3DSA:1.20.1610.10 (GENE3D); IPR012939 (PFAM); G3DSA:3.30.2080.10 (GENE3D); PTHR12143 (PANTHER); PTHR12143:SF22 (PANTHER); PTHR12143 (PANTHER); PTHR12143:SF22 (PANTHER); PTHR12143:SF22 (PANTHER); PTHR12143 (PANTHER); PTHR12143 (PANTHER); IPR008928 (SUPERFAMILY),1.C.96.1.3," the haemolytic lectin, cel-iii (cel-iii) family"
RL4_JR_05701,1000,1323,1487,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.425579032,0,0.989717902,1.215229912,0.814428522,0.415399504,0.60677335,1.172477903,0,3.236057017,1.472804765,2.197207052,0.028005662,0.075012785,3.008553133,0,0.599961032,1.265120705,0.474232245,0.635334302,0.745321491,3.468073938,0,0.17870162,1.279211374,0.139696709,0.888899626,0.931638858,2.93550477,0,0.532354084,1.25646247,0.423692786,0.671789877,0.766394835,N,-,,regulator of g,F:phosphorelay sensor kinase activity; P:phosphorelay signal transduction system; P:signal transduction by protein phosphorylation; C:intracellular,IPR016137 (PFAM); IPR000014 (PFAM); G3DSA:3.30.450.20 (GENE3D); PTHR24351 (PANTHER); IPR000700 (PROSITE_PROFILES); IPR000014 (SUPERFAMILY); IPR016137 (SUPERFAMILY),1.A.1.4.12, the voltage-gated ion channel (vic) superfamily.
RL4_JR_05702,1520,1563,1932,0,0,0,4,0,0,0,0,0,0,1,0,0,0,0,125.0557028,0,0.539160016,0.487138911,1.106789056,0.268385141,0.44903322,62.18588822,1,2.415746532,0.715015526,3.378593116,0.000728578,0.015023052,39.46666387,0,-3.113553914,1.197436265,-2.600183413,0.009317395,0.030917504,108.1219115,1,0.377782716,0.535426552,0.705573368,0.480453491,0.621038121,83.5999332,0,0.43823317,0.550599477,0.795920062,0.4260785,0.560775355,N,-,,Sodium channel 60E,F:isomerase activity,no IPS match,,
RL4_JR_05703,753,762,1113,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,glucose-6-phosphate isomerase,F:glucose-6-phosphate isomerase activity; P:gluconeogenesis; P:pentose-phosphate shunt; C:mitochondrion; P:glycolytic process,IPR001672 (PRINTS); G3DSA:3.40.50.10490 (GENE3D); IPR001672 (PFAM); IPR023096 (G3DSA:1.10.1390.GENE3D); G3DSA:3.40.50.10490 (GENE3D); PTHR11469:SF4 (PANTHER); IPR001672 (PANTHER); IPR001672 (PROSITE_PROFILES); SSF53697 (SUPERFAMILY),,
RL4_JR_05704,3536,3224,5006,2,2,1,0,0,0,0,1,4,3,2,1,0,0,0,184.4714721,1,0.877926759,0.51447016,1.706467793,0.087921018,0.201251309,23.07483312,0,-1.062717711,1.209668072,-0.878520096,0.379661537,0.543862734,102.6382338,1,-0.560594829,0.676083926,-0.829179349,0.407002929,0.54910683,113.7572455,1,-0.595422992,0.587034037,-1.014290407,0.3104442,0.456403009,66.00213974,0,-2.852824214,1.123846804,-2.538445814,0.011134604,0.034256417,N,-,,serine threonine- kinase gad8,F:ATP binding; F:protein serine/threonine kinase inhibitor activity; P:induction of conjugation upon nitrogen starvation; P:negative regulation of TORC2 signaling; F:protein serine/threonine kinase activity; P:negative regulation of protein serine/threonine kinase activity; P:peptidyl-threonine phosphorylation,IPR000719 (SMART); IPR000961 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017892 (PFAM); IPR000719 (PFAM); PTHR24356 (PANTHER); PTHR24356:SF201 (PANTHER); IPR000961 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_05705,32,41,38,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.01714357,0,-2.191177256,1.197241717,-1.830187859,0.067221853,0.165979381,5.469429291,0,1.014191283,1.257123621,0.806755411,0.419807413,0.583533457,14.11501068,0,-1.630082159,1.20101806,-1.35725033,0.174701684,0.293605552,44.21512476,0,0.289963049,0.859584532,0.337329301,0.735868674,0.823808516,13.83312917,0,-1.70387388,1.196988772,-1.423466886,0.154600855,0.264727491,Y,-,,Cutinase,P:metabolic process; C:extracellular region; F:cutinase activity; F:carboxylic ester hydrolase activity; F:hydrolase activity,IPR011150 (PRINTS); IPR000675 (SMART); IPR000675 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR15087:SF13 (PANTHER); PTHR15087 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_05706,1,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.20842132,0,1.670778237,0.861930491,1.938414122,0.052572719,0.138326784,1.829287795,0,2.594183888,1.316317254,1.970789246,0.048747987,0.115490174,60.10750068,0,3.424984959,1.520932175,2.25189855,0.024328684,0.065039238,9.5008246,0,0.462809122,1.14932591,0.402678751,0.687184568,0.788055697,4.702712599,0,-0.147204378,1.2074481,-0.121913628,0.902967423,0.937696939,Y,-,,alkaline serine protease,F:peptidase activity,IPR015366 (SMART); IPR015366 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); PTHR14218:SF19 (PANTHER); PTHR14218 (PANTHER); IPR030400 (PROSITE_PROFILES); IPR000209 (SUPERFAMILY); IPR009020 (SUPERFAMILY),,
RL4_JR_05707,94,35,68,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.193054923,0,4.270619684,3.015495637,1.416224793,0.156709699,NA,0.061831354,0,7.481272679,2.307026421,3.242820547,0.001183527,0.015023052,0.159835583,0,4.835365427,1.378499275,3.507702553,0.000451994,0.003136387,0.18435847,0,4.412482579,1.85025779,2.384793407,0.017088715,0.070969335,0.156821595,0,4.759592055,1.260637281,3.775544422,0.000159659,0.001030301,N,-,,flagelliform silk,,no IPS match,,
RL4_JR_05708,18,13,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.04624456,0,3.639854289,1.072762011,3.392974632,0.00069138,0.004409915,0.322717798,0,5.096916169,1.710150948,2.980389641,0.002878819,0.015349618,0.845622186,0,2.430324382,1.292816315,1.879868279,0.060126032,0.130401874,0.976114606,0,2.007366196,1.361319017,1.474574418,0.140326997,0.253280256,0.842423637,0,2.333975587,1.279847416,1.823635816,0.068207148,0.14212747,N,-, Effector probability:0.568,dihydroorotate reductase,"P:'de novo' pyrimidine nucleobase biosynthetic process; F:oxidoreductase activity, acting on the CH-CH group of donors; C:cytoplasm; F:catalytic activity; C:membrane; C:integral component of membrane; F:dihydroorotate dehydrogenase activity; P:oxidation-reduction process",no IPS match,,
RL4_JR_05709,4,3,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,61.38640033,1,1.453078371,0.569692981,2.550634148,0.010752713,0.04016776,5.061900517,0,1.125880504,1.243858104,0.905151882,0.365384929,0.529860495,19.60694435,0,-0.56150743,1.190828978,-0.471526508,0.637264795,0.746980292,33.7451734,0,-0.203822053,1.011715629,-0.201461802,0.840337495,0.900266335,12.89023804,0,-1.601948873,1.191230671,-1.344784778,0.178694748,0.295876422,N,-,,c6 zinc finger domain-containing,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PTHR36206 (PANTHER); PTHR36206:SF1 (PANTHER); PTHR36206 (PANTHER); PTHR36206:SF1 (PANTHER),,
RL4_JR_05710,6900,6602,7140,0,2,0,0,0,0,0,4,0,0,0,0,0,0,0,37.70614947,1,-0.465889963,1.04968152,-0.44383935,0.657158737,0.80666581,5.551276532,0,0.992604986,1.264770018,0.784810654,0.432564592,0.594109228,21.0113199,1,-0.708561131,1.216321729,-0.582544169,0.560200199,0.686119867,16.74927305,0,-2.093301452,1.220640059,-1.714921149,0.086359684,0.175404575,18.2906558,0,-0.837656328,1.163787688,-0.719767305,0.471668279,0.602832785,N,-,,dna replication complex gins psf2,"C:DNA replication preinitiation complex; P:DNA-dependent DNA replication; C:nuclear replication fork; P:single-organism cellular process; F:hydrolase activity, acting on glycosyl bonds",IPR007257 (PIRSF); IPR021151 (PFAM); IPR007257 (PANTHER); SSF160059 (SUPERFAMILY); SSF158573 (SUPERFAMILY),,
RL4_JR_05711,11228,12232,12839,2,2,10,0,0,0,0,2,0,0,6,6,0,6,1,1.109078313,1,1.74832216,1.420722304,1.230586833,0.218477432,NA,0.356043244,0,4.955490168,1.643703844,3.014831527,0.00257122,0.015349618,0.919905454,1,2.309690553,1.239794117,1.862962988,0.062467474,0.134471764,1.060950263,1,1.88759739,1.279396435,1.475381155,0.140110099,0.253052935,0.902918231,1,2.233277783,1.214327135,1.839107205,0.065899419,0.138631129,N,-,,hard surface-induced,F:transferase activity,IPR002656 (PFAM); PTHR23028 (PANTHER); PTHR23028:SF73 (PANTHER); PTHR23028 (PANTHER); PTHR23028:SF73 (PANTHER); PTHR23028:SF73 (PANTHER),,
RL4_JR_05712,18,9,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.813558182,0,2.195150676,1.643456724,1.335691195,0.181650229,NA,0.261032446,0,5.403161524,1.767256837,3.057371974,0.00223287,0.015045494,0.676014878,0,2.753288042,1.283167311,2.145696838,0.031897174,0.080490276,0.77969914,0,2.331492184,1.363879751,1.709455824,0.087366548,0.176938641,0.666346055,0,2.671255343,1.253097184,2.131722405,0.033029674,0.081092494,Y,-,,set domain containing,P:carbohydrate metabolic process; F:zinc ion binding; P:GDP-mannose biosynthetic process; F:mannose-6-phosphate isomerase activity; F:isomerase activity,IPR001214 (SMART); G3DSA:2.170.270.10 (GENE3D); IPR001214 (PFAM); PTHR12197 (PANTHER); PTHR12197:SF177 (PANTHER); IPR001214 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY),,
RL4_JR_05713,976,1214,1344,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.77133217,0,0.047461417,1.150594531,0.041249472,0.967097014,0.983369991,2.216887117,0,2.317013861,1.302640827,1.778705084,0.075288125,0.162631488,5.749260228,0,-0.334259864,1.201061283,-0.278303754,0.780779195,0.854552278,6.632606569,0,-0.756615393,1.199498189,-0.630776603,0.528186603,0.661867495,32.68482616,0,2.9790317,0.598520567,4.977325529,6.45E-07,9.94E-06,N,-,,arginyl-tRNA synthetase,F:ligase activity; P:translation,IPR001278 (PRINTS); IPR008909 (SMART); IPR005148 (G3DSA:3.30.1360.GENE3D); IPR001278 (PFAM); IPR008909 (PFAM); IPR009080 (G3DSA:1.10.730.GENE3D); IPR001278 (TIGRFAM); IPR014729 (G3DSA:3.40.50.GENE3D); IPR001278 (PANTHER); PTHR11956:SF1 (PANTHER); PTHR11956:SF1 (PANTHER); IPR001278 (PANTHER); IPR005148 (SUPERFAMILY); SSF52374 (SUPERFAMILY); IPR009080 (SUPERFAMILY),,
RL4_JR_05714,0,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.956901373,0,0.92899208,1.273064845,0.729728799,0.465555974,NA,0.628137011,0,4.136415712,1.500508127,2.756676647,0.005839206,0.022864389,1.623979202,0,1.489437787,1.223502889,1.217355349,0.223469044,0.353617405,30.77885134,0,3.404048387,0.855051972,3.981101149,6.86E-05,0.000778635,1.595906121,0,1.411532878,1.210039379,1.166518134,0.243405021,0.373039497,N,-,,---NA---,,IPR016024 (SUPERFAMILY),,
RL4_JR_05715,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_05716,352,517,556,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,198.56066,1,0.315455035,0.485139746,0.650235395,0.515540181,0.700729223,26.35241998,0,-1.254389189,1.210470965,-1.03628193,0.300070634,0.460406143,301.1976377,0,1.843419409,0.428706947,4.299952262,1.71E-05,0.000297682,114.0318211,0,-1.03830953,0.657354929,-1.5795265,0.114215343,0.216357409,125.8064097,0,0.226592499,0.625249964,0.362403058,0.717050855,0.800675587,N,-,,dihydroorotate dehydrogenase,P:'de novo' pyrimidine nucleobase biosynthetic process; C:cytoplasm; C:membrane; F:dihydroorotate dehydrogenase activity; P:oxidation-reduction process,IPR013785 (G3DSA:3.20.20.GENE3D); IPR005720 (PFAM); PTHR11938 (PANTHER); SSF51395 (SUPERFAMILY),9.B.265.1.5,The Vitamin K Epoxide Reductase (VKER) Family
RL4_JR_05717,7414,8511,16805,0,1,8,0,0,0,0,2,3,7,3,1,0,1,3,24.75736844,1,-2.732199782,1.210409168,-2.257253047,0.023992267,0.07613634,7.869757055,0,0.48913499,1.241317929,0.394044893,0.693547895,0.806258389,33.49433987,1,-0.353279394,1.052733538,-0.33558292,0.737185406,0.823033199,27.66127591,1,-1.645106768,1.162528194,-1.415111287,0.157035869,0.275274962,24.17271607,1,-1.329882121,1.149358891,-1.157064283,0.247246098,0.377467844,N,-,,mpv17 pmp22 family,"P:small molecule metabolic process; F:oxidoreductase activity, acting on the CH-CH group of donors; C:cytoplasm; C:membrane; P:organic substance metabolic process",IPR007248 (PFAM); IPR007248 (PANTHER); PTHR11266:SF44 (PANTHER),9.B.192.1.2, the mpv17/pmp22 4 tms putative porin (mpv17) family.
RL4_JR_05718,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.96062557,0,-1.622990606,1.137020713,-1.427406367,0.153462797,0.301601902,44.59927535,0,3.229440605,0.759416592,4.252528374,2.11E-05,0.001226778,67.23824913,0,1.145291898,0.662025643,1.729981173,0.083633639,0.168398361,33.19234298,0,-0.122504782,0.847861603,-0.144486767,0.885116105,0.929358142,64.36512237,0,2.062317364,0.47911666,4.304415887,1.67E-05,0.000154109,N,-,,"endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase","P:N-glycan processing; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; C:Golgi membrane; C:endoplasmic reticulum; P:ER-associated ubiquitin-dependent protein catabolic process",IPR001382 (PRINTS); IPR001382 (G3DSA:1.50.10.GENE3D); IPR001382 (PFAM); PTHR11742:SF49 (PANTHER); PTHR11742 (PANTHER); PTHR11742 (PANTHER); IPR001382 (SUPERFAMILY),,
RL4_JR_05719,3149,10102,4026,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,13.34892663,1,-1.841153557,1.186885934,-1.551247263,0.12084244,0.253753571,4.272076125,0,1.370588032,1.252245341,1.094504397,0.27373382,0.431780229,11.06692023,0,-1.279256637,1.19319816,-1.072124213,0.283664245,0.423010284,74.26577609,0,1.866225451,0.573119393,3.256259471,0.001128905,0.008170241,10.89803671,0,-1.359834235,1.194297086,-1.138606341,0.254867383,0.385845133,N,-,,fungal specific transcription factor,F:binding,IPR001138 (SMART); IPR007219 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); IPR001138 (PFAM); PTHR31001:SF59 (PANTHER); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_05720,56370,177538,85899,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,76.21440553,0,1.571480728,0.81669485,1.924195712,0.054330056,0.141605304,7.283048533,0,0.601018086,1.22900957,0.489026368,0.624823029,0.75331663,29.9171924,0,-1.085415484,1.189553502,-0.912456214,0.361528609,0.505471018,21.73959831,0,-2.469351693,1.188733627,-2.07729607,0.037774242,0.103480572,18.52334019,1,-2.125045507,1.188637532,-1.787799434,0.073808372,0.150941177,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11360:SF97 (PANTHER); PTHR11360 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.13.4, the major facilitator superfamily (mfs).
RL4_JR_05721,7338,4588,6367,2,5,3,0,0,0,0,0,2,0,4,0,0,0,0,0.015572136,1,7.899458556,3.974566037,1.987502153,0.046866778,NA,0.005005645,0,11.10559461,3.974227246,2.79440352,0.005199555,0.021136506,0.013004533,1,8.449602389,2.844306081,2.970707845,0.002971143,0.013488722,0.014998643,1,8.029635455,3.97405316,2.020515361,0.043329958,0.113246213,0.012910819,0,8.3508871,1.560789616,5.350424565,8.77E-08,2.01E-06,,,,,,,,
RL4_JR_05722,4204,2930,3758,0,0,2,0,0,0,0,3,0,0,0,0,0,0,2,0.035353752,1,6.718624434,3.936817271,1.706613229,0.087893965,NA,0.01118311,0,9.946128198,3.317750481,2.99785299,0.002718888,0.015349618,0.029302211,1,7.277205732,1.946856684,3.73792575,0.000185545,0.001681223,0.033817295,0,6.857818428,3.655808315,1.875869257,0.060673235,0.137615704,0.029287109,1,7.177634907,1.434494667,5.003598181,5.63E-07,8.78E-06,N,-,,C-x8-C-x5-C-x3-H type zinc finger,F:metal ion binding,PTHR37543:SF1 (PANTHER); PTHR37543 (PANTHER),,
RL4_JR_05723,2575,1949,2384,0,0,0,0,0,0,0,0,2,1,7,0,0,0,0,0.8789804,0,2.083718603,1.571778793,1.325707289,0.184936672,NA,0.278473173,0,5.309752762,1.716495009,3.093369181,0.001978978,0.015023052,0.726104188,1,2.650202134,1.260697593,2.102171169,0.035538284,0.08717945,0.837900716,1,2.227686059,1.325720314,1.680358998,0.092887488,0.185260573,0.719678261,0,2.561176136,1.240818066,2.064102874,0.039007964,0.092193191,N,-,,Serine threonine- kinase ark1,F:nucleotide binding; F:ATP binding; F:protein kinase activity; P:phosphorylation; F:protein serine/threonine kinase activity; P:protein phosphorylation; F:kinase activity; P:cell cycle,no IPS match,,
RL4_JR_05724,11074,8781,12198,5,6,10,0,0,0,1,7,2,1,7,4,0,0,0,98.03376048,1,0.753240203,0.555447014,1.356097313,0.175068208,0.329972117,31.45148501,0,1.421326802,1.039415877,1.367428412,0.171491062,0.306901084,46.98781611,1,-1.020822532,1.05990368,-0.963127641,0.335483472,0.478640737,114.5409819,1,0.951010022,0.531123361,1.790563344,0.073363394,0.15614975,100.3125777,0,1.525454616,0.514997614,2.962061524,0.003055867,0.012011124,N,-,,hypothetical protein MYCTH_2135569,P:biological_process; C:cellular_component; F:molecular_function,PTHR42095 (PANTHER); PTHR42095:SF1 (PANTHER),,
RL4_JR_05725,184,77,259,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22.48127631,0,-0.265170387,1.008955429,-0.26281675,0.792691824,0.893695399,4.739849011,0,1.220658923,1.243881616,0.981330464,0.326429805,0.488775515,20.14108177,0,-0.469702976,1.190991377,-0.394379829,0.693300634,0.79033618,23.49928769,0,-0.904403472,1.142021832,-0.791931859,0.428400409,0.57088104,27.21756605,0,0.697927233,0.845778075,0.825189555,0.409263983,0.545236556,N,-,,DIE2 ALG10 family,C:membrane,IPR016900 (PFAM); IPR016900 (PANTHER),9.B.231.1.3, the die2/alg10 glycosyl transferase (die2/alg10) family.
RL4_JR_05726,1140,661,617,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37.27457281,1,0.700542654,0.736424106,0.951276103,0.341464235,0.531615501,5.750191948,0,0.941828445,1.252356643,0.752044915,0.452024048,0.6117842,33.92522722,0,0.112142002,1.049124974,0.106890985,0.914875465,0.948607047,93.25650261,0,2.068905583,0.535085741,3.866493578,0.000110411,0.001158461,18.76041952,0,-0.883091304,1.153310222,-0.765701445,0.443853967,0.576759917,N,-,,mediator of rna polymerase ii transcription subunit 4,C:mediator complex; F:RNA polymerase II transcription cofactor activity; P:regulation of transcription from RNA polymerase II promoter,IPR019258 (PFAM),,
RL4_JR_05727,42,16,33,0,0,2,0,0,0,0,0,0,0,1,4,0,0,0,50.33461069,1,-0.057765841,0.702500684,-0.082228875,0.934464712,0.967685655,9.931330435,0,0.153530368,1.221649226,0.125674673,0.899989451,0.944303226,47.94695438,0,-0.667641672,1.036484559,-0.64414049,0.519484336,0.6497726,29.77586842,1,-2.92323236,1.197172202,-2.441781021,0.014615009,0.06554087,25.46239149,0,-2.58404233,1.201937099,-2.149898136,0.031563273,0.07836639,N,-,,gmp synthase,P:glutamine metabolic process; F:transferase activity,IPR029062 (G3DSA:3.40.50.GENE3D); IPR017926 (PFAM); PTHR11922 (PANTHER); IPR017926 (PROSITE_PROFILES); IPR029062 (SUPERFAMILY),,
RL4_JR_05728,3067,880,836,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.3061335,0,-1.0131535,1.168864604,-0.866784311,0.3860602,0.579161293,4.58553573,0,1.268381992,1.263753748,1.003662299,0.315541415,0.477272893,11.95345768,0,-1.390401215,1.210625154,-1.148498534,0.250762818,0.385824129,36.43044535,0,0.515871031,0.874986847,0.589575755,0.55547511,0.684290728,11.83512929,0,-1.47872778,1.219812641,-1.212258121,0.225413589,0.352263095,Y,-,,exopolyphosphatase,F:pyrophosphatase activity; C:intracellular part,IPR004097 (SMART); IPR004097 (PFAM); G3DSA:3.90.1640.10 (GENE3D); IPR001667 (PFAM); PTHR12112 (PANTHER); SSF64182 (SUPERFAMILY),,
RL4_JR_05729,817,3077,2089,0,0,0,0,0,0,0,0,0,0,1,2,0,8,0,71.06475436,0,-1.124197394,0.910304022,-1.23496916,0.216841982,0.384996487,16.13229351,0,-0.546411857,1.280261955,-0.426796918,0.669527251,0.788825193,64.60455935,0,-1.353160887,1.105794386,-1.223700268,0.221065318,0.350738957,49.03007799,1,-3.642797459,1.270939932,-2.866223153,0.004154013,0.024241719,54.09881801,1,-1.188446742,0.99082512,-1.199451566,0.230352407,0.357882173,N,-,,ATPase synthesis mitochondrial,P:mitochondrial proton-transporting ATP synthase complex assembly; P:mRNA stabilization; C:mitochondrion; C:membrane; C:mitochondrial inner membrane,PF02410 (PFAM); PTHR28087 (PANTHER),,
RL4_JR_05730,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,204.437486,0,0.145107091,0.937970398,0.154703273,0.877055249,0.940212447,29.93481907,0,-1.43826308,1.194565344,-1.204005362,0.228587506,0.378374936,90.85608226,0,-2.274316422,1.034443933,-2.198588391,0.027907203,0.072407105,134.7846746,0,-0.979758115,0.579084945,-1.691907421,0.090663627,0.181956238,88.1953634,0,-2.502297076,0.980882978,-2.551065857,0.010739403,0.033273089,N,-,,dna-dependent rna polymerase,"F:nucleotidyltransferase activity; P:transcription, DNA-templated",IPR029262 (SMART); G3DSA:1.10.150.20 (GENE3D); IPR029262 (PFAM); IPR002092 (PFAM); G3DSA:3.30.70.370 (GENE3D); IPR029262 (G3DSA:1.10.1320.GENE3D); IPR024075 (G3DSA:1.10.287.GENE3D); G3DSA:1.10.287.280 (GENE3D); PTHR10102:SF0 (PANTHER); IPR002092 (PANTHER); PTHR10102:SF0 (PANTHER); IPR002092 (PANTHER); SSF56672 (SUPERFAMILY),,
RL4_JR_05731,445,411,512,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,Y,-,,---NA---,,no IPS match,,
RL4_JR_05732,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.156509109,0,0.788767245,1.264967059,0.623547656,0.532924696,0.71647984,0.688196549,0,4.004571214,1.474315211,2.71622458,0.006603111,0.024846353,1.786812896,0,1.35123437,1.221516566,1.106194061,0.268642533,0.406756628,2.06131001,0,0.928969424,1.233423267,0.753163532,0.451351651,0.593498112,1.764221602,0,1.267088176,1.216234243,1.041812614,0.297498565,0.432783472,N,-,,Heterokaryon incompatibility OR allele,,IPR010730 (PFAM); PTHR24148 (PANTHER),,
RL4_JR_05733,431,521,737,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,263.7186538,0,-0.123720218,0.450141089,-0.274847644,0.783433293,0.888413789,101.2581972,0,1.118375402,0.657463202,1.701046383,0.088934278,0.184730712,159.0351256,1,-1.539645101,0.697249516,-2.208169482,0.027232461,0.071148757,151.5271256,0,-2.419797632,0.787017176,-3.074643992,0.00210754,0.013771981,139.6358069,0,-1.650412896,0.709316544,-2.326764982,0.019977777,0.054515298,N,-,,multisynthetase complex auxiliary component p43,F:valine-tRNA ligase activity; P:valyl-tRNA aminoacylation; C:cytosol; F:tRNA binding,IPR010987 (G3DSA:1.20.1050.GENE3D); IPR002547 (PFAM); PF13410 (PFAM); G3DSA:2.40.50.140 (GENE3D); PTHR11586 (PANTHER); PTHR11586:SF22 (PANTHER); IPR002547 (PROSITE_PROFILES); IPR010987 (PROSITE_PROFILES); IPR012340 (SUPERFAMILY); IPR010987 (SUPERFAMILY),,
RL4_JR_05734,901,849,992,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,2.767595594,1,0.429227361,1.250165127,0.343336533,0.7313453,0.858256561,0.880263575,0,3.649515488,1.428477032,2.554829658,0.010623978,0.035199967,10.12952065,0,1.957813075,1.200791493,1.630435497,0.103009487,0.198000389,2.638148267,0,0.573400502,1.225818648,0.46776944,0.639949477,0.753278265,2.255162954,0,0.913257236,1.214508174,0.751956434,0.452077258,0.584130447,N,-,,Lymphoid-specific helicase,F:ATP binding; F:helicase activity; P:mitotic recombination,IPR001650 (SMART); IPR014001 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000330 (PFAM); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10799 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_05735,192,194,222,0,0,6,0,0,0,0,0,2,0,2,0,0,0,0,15.64835658,1,-0.720347153,1.164230523,-0.618732406,0.536092658,0.71943476,3.798969436,0,1.539991935,1.290065529,1.193731559,0.232582992,0.382859821,17.64451571,1,-0.142058713,1.207902626,-0.117607753,0.906378462,0.942402747,65.24552984,1,2.21143873,0.575019321,3.845851176,0.000120135,0.001247552,17.31724942,0,0.486321344,0.993543018,0.48948192,0.624500551,0.729556719,Y,-,,ferric reductase like transmembrane component,F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process,IPR013112 (PFAM); IPR013130 (PFAM); IPR013121 (PFAM); G3DSA:3.40.50.80 (GENE3D); PTHR32361:SF9 (PANTHER); PTHR32361 (PANTHER); PTHR32361 (PANTHER); PTHR32361:SF9 (PANTHER); PTHR32361 (PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY),5.B.1.5.3, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_05736,17,13,29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.92177422,0,-0.401784204,1.220580677,-0.329174639,0.742023691,0.864281735,1.570854726,0,2.813907472,1.35123166,2.082475977,0.037299015,0.093892223,4.079895325,0,0.160187914,1.215350784,0.131803852,0.89513944,0.934625357,4.706660852,0,-0.262140866,1.216981499,-0.215402507,0.829453516,0.893358319,4.031222011,0,0.074921878,1.218682831,0.06147775,0.950978734,0.968191019,N,-,,sh3 domain containing,,no IPS match,,
RL4_JR_05737,2334,3573,5870,0,0,3,0,0,1,0,0,0,0,4,0,0,0,0,7.97566782,1,-1.097752479,1.253050003,-0.876064384,0.380995034,0.573143552,2.558561562,1,2.110284494,1.355949839,1.556314573,0.119633308,0.233094965,6.597987255,0,-0.532843102,1.239196373,-0.42999085,0.667202297,0.771178908,7.609664285,1,-0.954833815,1.243015439,-0.768159256,0.442392576,0.584526273,6.449417525,0,-0.602901913,1.23694307,-0.487412822,0.625965809,0.730334456,N,-,,plasma membrane,C:membrane,PTHR31740 (PANTHER); PTHR31740:SF5 (PANTHER),9.B.313.1.3, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_05738,281,289,247,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44.20036939,0,-0.526042895,0.903287179,-0.582365064,0.560320809,0.737403335,8.439252947,0,0.388349934,1.257445537,0.308840362,0.757442965,0.852777405,55.17593898,0,0.173537896,0.88728097,0.195583926,0.844935842,0.900514718,29.354491,0,-1.745744667,1.176391079,-1.483983259,0.137813362,0.249572579,36.49712039,0,-0.648530583,1.013917302,-0.639628677,0.522414034,0.646769898,N,-,,sulfite reductase beta subunit,"C:nucleus; F:DNA-directed RNA polymerase activity; P:transcription, DNA-templated",IPR006886 (PFAM); PTHR12069 (PANTHER),,
RL4_JR_05739,345,347,279,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.65824757,0,1.167758436,1.435583338,0.813438276,0.415966822,NA,0.535708065,0,4.366004046,1.624810041,2.687085836,0.007207843,0.026501193,1.382017447,0,1.72195421,1.294160061,1.330557372,0.183334697,0.304909206,1.593539542,0,1.300377969,1.336413881,0.973035365,0.330535726,0.47721007,1.357645018,0,1.644697788,1.279870476,1.285050181,0.198774749,0.320527844,N,-,,3-hydroxyphenylacetate 6 hydroxylase,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:heme binding",IPR002401 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24281 (PANTHER); PTHR24281:SF5 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_05740,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.237461447,0,-0.491352926,1.315035859,-0.373642226,0.708670514,0.842882935,1.703729646,0,2.696863203,1.459758994,1.847471544,0.064678829,0.144329608,4.375179192,0,0.05959501,1.283767978,0.046421948,0.962973944,0.978252741,5.043349091,0,-0.361619664,1.29676045,-0.27886389,0.780349281,0.858435079,4.277455846,0,-0.010705879,1.283938244,-0.008338313,0.993347066,0.995313116,N,-,,membrane dipeptidase,F:metal ion binding; F:dipeptidase activity; P:proteolysis; C:integral component of membrane; F:metallopeptidase activity,IPR008257 (PFAM); G3DSA:3.20.20.140 (GENE3D); IPR008257 (PANTHER); PTHR10443:SF12 (PANTHER); IPR008257 (PROSITE_PROFILES); IPR032466 (SUPERFAMILY),,
RL4_JR_05741,392,378,279,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.435658588,0,-0.788175649,1.199823749,-0.656909525,0.511239093,0.697206373,2.054098175,0,2.427051,1.308640175,1.854635862,0.063648243,0.142564178,5.324075703,0,-0.223398804,1.199944329,-0.186174307,0.852308072,0.90581219,6.141839109,0,-0.645693398,1.198127534,-0.538918755,0.589942916,0.713981834,5.239894062,0,-0.303205364,1.198389166,-0.253010769,0.800259892,0.86511119,N,-,,FAD-binding domain-containing,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; P:oxidation-reduction process",IPR016167 (G3DSA:3.30.43.GENE3D); IPR016169 (G3DSA:3.30.465.GENE3D); IPR012951 (PFAM); IPR006094 (PFAM); PTHR11748:SF99 (PANTHER); PTHR11748 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY),,
RL4_JR_05742,32,44,53,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003880053,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,0,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,vitamin h,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF187 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_05743,1338,1495,1876,0,0,3,0,0,0,0,0,5,0,2,0,0,3,0,1.033351529,1,1.850243551,1.482013239,1.248466277,0.211860351,NA,0.333104538,0,5.051572034,1.682801767,3.001881822,0.002683163,0.015349618,0.858999147,1,2.408313538,1.258535357,1.913584331,0.055673289,0.122716389,25.06007145,1,5.244542716,0.670483889,7.822026453,5.20E-15,3.23E-13,78.05281089,1,6.652927366,1.557666388,4.271086171,1.95E-05,0.000175696,N,-,,Sterol 24-C-methyltransferase,F:sterol 24-C-methyltransferase activity; P:sterol biosynthetic process; P:methylation,IPR013705 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR013216 (PFAM); PTHR10108 (PANTHER); PTHR10108 (PANTHER); PTHR10108:SF878 (PANTHER); IPR030384 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_05744,960,893,1000,8,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0.438324227,1,3.08750285,2.109769109,1.463431632,0.143349309,NA,0.139136651,0,6.310727695,1.961863394,3.216700874,0.001296737,0.015023052,0.362546829,0,3.65180183,1.300612067,2.80775638,0.004988795,0.018888019,0.41833603,0,3.229712773,1.475332835,2.189141797,0.028586535,0.089799895,0.359289742,1,3.563212765,1.251550284,2.847039236,0.004412792,0.016164927,N,-,,hypothetical protein EN45_108630,,no IPS match,,
RL4_JR_05745,217660,120407,174282,6,23,46,1,2,3,0,8,10,4,16,18,0,29,10,109.2335395,1,3.359612739,0.871805027,3.853628547,0.00011638,0.000971234,25.13331052,1,2.902657856,1.155959313,2.511038082,0.012037671,0.0388166,43.83385672,1,2.45344345,0.726396714,3.37755307,0.000731338,0.004490036,75.87520078,1,2.944941537,1.791392599,1.64393977,0.100188644,0.19602126,22.64775404,1,1.796370005,0.83826225,2.142968986,0.032115589,0.079445477,Y,-,,eliciting plant response,,IPR009009 (G3DSA:2.40.40.GENE3D); IPR010829 (PFAM); IPR009009 (SUPERFAMILY),,
RL4_JR_05746,8,28,28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,integral membrane,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_05747,10,6,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.686777383,0,2.43982653,1.717050132,1.420940766,0.15533398,NA,0.220575489,0,5.646343176,1.80296394,3.131700558,0.00173797,0.015023052,0.569332727,0,3.002304498,1.268961886,2.365953249,0.017983715,0.05165025,0.656608338,0,2.580017914,1.359002408,1.898464565,0.057634911,0.133934698,0.557894637,0,2.928076722,1.227391503,2.385609413,0.01705085,0.048115901,N,-,,MFS general substrate transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF241 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.4, the major facilitator superfamily (mfs).
RL4_JR_05748,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.549789362,0,2.760884545,1.970676985,1.400982792,0.161219219,NA,0.174164106,0,5.987039692,1.915345455,3.125827602,0.001773055,0.015023052,0.452953725,0,3.332134851,1.321664185,2.521166033,0.011696665,0.036447225,0.522682186,0,2.909101208,1.468281042,1.981297262,0.047557947,0.119189162,0.446698166,0,3.249944541,1.27461105,2.549753936,0.010779897,0.033388333,N,-,,flavin-binding monooxygenase,F:nucleotide binding; F:coenzyme binding; F:monooxygenase activity,IPR023753 (G3DSA:3.50.50.GENE3D); IPR020946 (PFAM); PTHR23023 (PANTHER); PTHR23023:SF76 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_05749,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,177.3387458,0,-1.657857918,0.587835411,-2.82027569,0.004798241,0.021046266,43.63734564,0,-1.981969829,1.204828669,-1.645022135,0.099965247,0.202483641,135.0184449,0,-2.796156262,1.037339864,-2.695506419,0.007028172,0.024629012,242.0803513,0,-0.291416307,0.460190422,-0.63325157,0.526569374,0.660583798,197.327633,0,-0.100192573,0.443034574,-0.226150687,0.821084223,0.880105628,N,-,,topoisomerase ii,F:RNA binding; P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:cytoplasmic mRNA processing body assembly; C:cytoplasmic mRNA processing body; C:cytosol; P:regulation of translational initiation; C:intracellular organelle part,IPR019167 (PFAM); PTHR21551:SF0 (PANTHER); PTHR21551 (PANTHER); PTHR21551 (PANTHER),,
RL4_JR_05750,1202,2928,2595,0,0,0,0,0,0,0,0,4,0,6,3,0,11,0,206.092959,0,-0.815608134,0.745696835,-1.093752978,0.274063332,0.456473799,101.3657624,0,1.095353843,0.683413868,1.602767949,0.108985895,0.216262543,211.6691609,1,-0.377712556,0.505807862,-0.746751057,0.455213844,0.594119499,331.357758,1,0.629304719,0.385655452,1.631779652,0.102725913,0.199903877,243.7073538,1,0.489907439,0.553495375,0.885115686,0.37609424,0.512165996,N,-,,"alpha 1,2-mannosyltransferase",F:mannosyltransferase activity; P:mannosylation; C:integral component of membrane; P:protein glycosylation,IPR002685 (PIRSF); IPR029044 (G3DSA:3.90.550.GENE3D); IPR002685 (PFAM); PTHR31121:SF6 (PANTHER); PTHR31121:SF6 (PANTHER); IPR002685 (PANTHER); IPR002685 (PANTHER); IPR029044 (SUPERFAMILY),,
RL4_JR_05751,4,8,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,77.31718983,0,0.285080624,0.687788799,0.414488611,0.678516306,0.823800925,21.46071594,0,0.784235332,1.16172514,0.675060998,0.499637012,0.653811326,55.744158,0,-0.390797493,0.909318565,-0.429769619,0.667363235,0.771276871,91.29305222,0,0.857153912,0.625902073,1.369469679,0.170852506,0.29318719,50.90585282,0,-0.053648654,0.814021744,-0.065905677,0.947452921,0.966188757,N,-,,37S ribosomal s12,F:structural constituent of ribosome; C:mitochondrial ribosome; C:small ribosomal subunit; P:translation,IPR006032 (PRINTS); IPR006032 (PIRSF); IPR005679 (TIGRFAM); G3DSA:2.40.50.140 (GENE3D); IPR006032 (PFAM); PTHR11652:SF1 (PANTHER); IPR006032 (PANTHER); IPR012340 (SUPERFAMILY),,
RL4_JR_05752,9,23,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,59.71778991,0,2.647204427,0.832854881,3.178470209,0.001480544,0.008133522,3.203036118,0,1.786107141,1.299920536,1.374012558,0.169437784,0.304032839,38.88172641,0,1.95040501,0.77477864,2.517370651,0.011823437,0.036763047,164.179902,0,4.020906429,0.519576743,7.73881141,1.00E-14,6.12E-13,79.40629461,0,3.363020483,0.507707855,6.623928411,3.50E-11,2.66E-09,N,-,,acyl- dehydrogenase,F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; P:oxidation-reduction process,IPR006091 (PFAM); IPR009075 (PFAM); IPR013786 (PFAM); IPR013786 (G3DSA:1.10.540.GENE3D); G3DSA:1.20.140.10 (GENE3D); PIRSF016578 (PIRSF); G3DSA:2.40.110.10 (GENE3D); PTHR10909 (PANTHER); PTHR10909:SF10 (PANTHER); IPR009075 (SUPERFAMILY); IPR009100 (SUPERFAMILY),,
RL4_JR_05753,11,24,22,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,186.3365054,1,-1.617404635,0.67736911,-2.387774422,0.016950742,0.057522528,48.90278881,0,-2.146308996,1.213116917,-1.769251559,0.076851903,0.165262287,152.0835361,0,-1.982127293,0.769644799,-2.575379313,0.010013021,0.032700589,208.480874,0,-0.860323792,0.507651229,-1.694714291,0.090129633,0.181094902,150.4634817,1,-1.488915773,0.625484873,-2.380418515,0.017292985,0.048632434,N,-,,kinase c,P:fungal-type cell wall biogenesis; C:cell division site; P:regulation of cell wall (1->3)-beta-D-glucan biosynthetic process; C:barrier septum; P:protein phosphorylation; C:intracellular; F:protein kinase C activity; F:ATP binding; C:cell tip; F:metal ion binding; P:regulation of establishment or maintenance of cell polarity regulating cell shape; P:regulation of alpha-glucan biosynthetic process; P:intracellular signal transduction; P:negative regulation of peptidyl-tyrosine phosphorylation,IPR002219 (SMART); IPR011072 (SMART); IPR000008 (SMART); IPR000008 (G3DSA:2.60.40.GENE3D); IPR011072 (PFAM); G3DSA:3.30.60.20 (GENE3D); G3DSA:3.30.60.20 (GENE3D); IPR000008 (PFAM); IPR002219 (PFAM); IPR011072 (G3DSA:1.10.287.GENE3D); PTHR24356:SF203 (PANTHER); PTHR24356 (PANTHER); IPR002219 (PROSITE_PROFILES); SSF57889 (SUPERFAMILY); IPR000008 (SUPERFAMILY); SSF57889 (SUPERFAMILY); IPR011072 (SUPERFAMILY),,
RL4_JR_05754,1954,2449,1912,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,17.90394114,0,-0.9710098,1.142985747,-0.849537978,0.395582007,0.587931866,4.488007732,0,1.299408336,1.244682152,1.043967999,0.296500195,0.456313666,44.15321262,1,1.781061731,0.671400351,2.65275663,0.007983741,0.027315781,13.45154896,0,-1.777014356,1.191451556,-1.491470087,0.135838119,0.246967311,11.51476379,0,-1.439189591,1.199094844,-1.200229989,0.230050031,0.357741755,N,-,,mitochondrion biogenesis,C:integral component of membrane,IPR008839 (PFAM); PTHR31961 (PANTHER),,
RL4_JR_05755,5,15,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,148.2461164,0,-1.573693387,0.787952709,-1.997192687,0.045804255,0.124598571,36.77502889,0,-1.73516118,1.249343671,-1.388858182,0.164875879,0.297588025,127.9229613,0,-1.578549396,0.845069579,-1.867951983,0.061768764,0.133307817,115.4777864,0,-3.884855473,1.212011972,-3.205294636,0.001349243,0.009519919,100.20439,0,-3.579429872,1.200638103,-2.981272928,0.002870528,0.011415593,N,-,,u3 small nucleolar rna associated,"C:small-subunit processome; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:mitotic spindle; C:viral nucleocapsid; C:nucleolus",IPR020472 (PRINTS); IPR001680 (SMART); IPR001680 (PFAM); IPR007287 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22851:SF0 (PANTHER); PTHR22851 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.15.2.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_05756,549,600,635,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,353.8071307,0,2.256811384,0.454679346,4.963522979,6.92E-07,1.11E-05,56.89288376,0,1.748889146,0.804676579,2.1734063,0.029749751,0.078567384,135.9786072,0,0.823345299,0.505500535,1.628772358,0.103361218,0.198563373,57.63150121,0,-3.87593615,1.208202076,-3.208019774,0.001336523,0.009443333,48.90655956,1,-3.525742049,1.202323504,-2.932440428,0.003363094,0.012986777,N,-,,Uracil permease,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR012681 (TIGRFAM); IPR001248 (PFAM); PTHR30618 (PANTHER); PTHR30618:SF2 (PANTHER),2.A.39.3.7, the nucleobase:cation symporter-1 (ncs1) family.
RL4_JR_05757,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.759005462,0,2.295673172,1.684894016,1.362503012,0.173039194,NA,0.242687864,0,5.50851631,1.784961484,3.086070125,0.00202821,0.015023052,0.627507539,0,2.862131577,1.280071235,2.235915861,0.025357283,0.06730916,0.723827498,0,2.439545226,1.365925371,1.78600184,0.07409896,0.157153744,0.61534865,0,2.787299875,1.242145129,2.243940592,0.024836224,0.064928161,N,-,,P-loop containing nucleoside triphosphate hydrolase,F:hydrolase activity,IPR027417 (G3DSA:3.40.50.GENE3D); PF13521 (PFAM); IPR027417 (SUPERFAMILY),,
RL4_JR_05758,901,927,1549,1,0,0,0,0,0,0,3,0,0,3,0,0,1,0,5.810900471,1,-0.640855956,1.263053115,-0.507386386,0.611883736,0.776912733,1.8588673,0,2.571196443,1.384068129,1.85770945,0.063210286,0.141834297,4.801709066,1,-0.074315695,1.242634036,-0.059804973,0.952310965,0.972482974,5.538606052,1,-0.496480824,1.248102535,-0.397788491,0.690786102,0.791110652,4.701048721,1,-0.14666709,1.239772927,-0.118301575,0.90582871,0.939800767,N,-,,P-loop containing nucleoside triphosphate hydrolase,"F:nucleotide binding; F:ATP binding; F:RNA-directed RNA polymerase activity; P:transcription, RNA-templated; F:hydrolase activity",IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); PF13087 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR007855 (PFAM); PF13086 (PFAM); IPR007855 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_05759,3092,3832,3487,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0.105605273,0,5.141063224,3.916859695,1.3125472,0.189335571,NA,0.033268359,0,8.375262291,2.676833782,3.128794304,0.001755251,0.015023052,19.58294633,0,8.111305294,0.941905886,8.611587859,7.21E-18,9.47E-16,0.100123553,0,5.293299451,2.418223377,2.1889208,0.028602597,0.089799895,0.085691585,1,5.635007769,1.362089376,4.137032319,3.52E-05,0.000287046,Y,-,,Altered inheritance of mitochondria 6,C:membrane; P:lipid metabolic process; F:phosphoric diester hydrolase activity,PTHR31571:SF1 (PANTHER); PTHR31571 (PANTHER); IPR017946 (SUPERFAMILY),,
RL4_JR_05760,1655,1654,2689,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11.81027186,1,5.682403247,0.897720743,6.329811682,2.45E-10,7.73E-09,0.113478673,0,6.605231644,2.052870441,3.217558942,0.001292865,0.015023052,6.79211428,0,4.923223602,1.218930928,4.038968483,5.37E-05,0.000765528,8.36158018,0,5.254806645,1.051622715,4.996855404,5.83E-07,1.12E-05,0.287772313,0,3.88393894,1.247367368,3.113708951,0.001847516,0.007926315,N,-,,aminotriazole resistance,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF8 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.52, the major facilitator superfamily (mfs).
RL4_JR_05761,3431,5108,5657,3,0,8,0,0,0,0,0,0,0,0,0,0,2,0,0.629276035,1,2.565929065,1.765767762,1.453152063,0.146181539,NA,0.20066443,0,5.782669992,1.816731282,3.183007883,0.001457536,0.015023052,0.520615011,0,3.130789433,1.260695844,2.483382054,0.013014142,0.03972128,0.600605417,0,2.7083677,1.356974623,1.995886772,0.045946249,0.11631011,0.513066978,1,3.049407728,1.22423297,2.490872082,0.012742999,0.038195046,N,-,,hypothetical protein SPBR_09042,F:catalytic activity,IPR022085 (PFAM),,
RL4_JR_05762,5149,11178,7298,0,0,4,0,0,0,0,0,0,0,7,5,0,2,0,87.25450451,1,0.578933066,0.601067549,0.963174717,0.335459851,0.525634493,10.89397701,0,0.020091689,1.254918842,0.016010349,0.987226135,0.993726257,133.7177605,0,1.820874309,0.527136881,3.454272267,0.00055178,0.00364398,89.77924551,1,1.216114074,0.606909929,2.003780158,0.045093615,0.115278131,46.73486566,1,0.201483437,0.730745592,0.275723096,0.782760755,0.851192422,N,-,,hypothetical protein SPI_01158,,no IPS match,,
RL4_JR_05763,122,293,177,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,24.86571788,0,1.394105471,1.004754238,1.387508923,0.165286632,0.316676455,46.13515656,0,4.53471528,0.977642814,4.638417236,3.51E-06,0.000267196,3.921403842,0,0.217471521,1.200474811,0.181154589,0.856246237,0.908688308,4.523760613,1,-0.204857226,1.1992192,-0.170825505,0.864360974,0.915860351,11.23271636,0,1.069633738,1.124638759,0.951090943,0.341558212,0.478654242,N,-,,epimerase,F:oxidoreductase activity,IPR016040 (G3DSA:3.40.50.GENE3D); IPR001509 (PFAM); PTHR10366 (PANTHER); PTHR10366:SF267 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_05764,42,128,55,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44.36174868,0,2.060898829,0.634267568,3.24925778,0.001157066,0.00663341,2.823131674,0,1.968229568,1.28529261,1.531347455,0.125683543,0.241489906,7.332647021,0,-0.685278928,1.203288752,-0.569504973,0.569013497,0.693391026,8.460127219,0,-1.107783016,1.202301401,-0.921385449,0.356849223,0.502890673,14.59636099,0,0.168527103,1.13280512,0.148769722,0.881735343,0.92168333,N,-,,alcohol dehydrogenase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR013154 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR11695:SF566 (PANTHER); IPR002085 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_05765,775,632,717,0,0,0,0,0,0,2,0,0,0,0,3,0,0,0,0.093661648,0,5.314289066,3.918145699,1.356327578,0.174994965,NA,0.029930164,0,8.528492461,2.715005324,3.141243366,0.001682322,0.015023052,0.077270323,1,5.885767928,1.588761184,3.70462722,0.000211702,0.001814792,0.089131432,1,5.461406473,2.48867084,2.194507359,0.028198955,0.089334926,0.075519334,0,5.816332559,1.34447083,4.326112868,1.52E-05,0.000142675,N,-,,ankyrin repeat containing,,IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY),8.A.28.1.1, the ankyrin (ankyrin) family.
RL4_JR_05766,199,269,209,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0.100788864,0,5.208288775,3.917340571,1.329547095,0.183667539,NA,0.032423945,0,8.412899385,2.634923179,3.192844274,0.001408789,0.015023052,0.083529354,0,5.772482331,1.513135753,3.81491371,0.000136231,0.001394538,0.096326453,1,5.349128863,2.363525549,2.263199086,0.02362342,0.083034578,0.081624897,0,5.701367224,1.301125134,4.381874636,1.18E-05,0.000115534,N,-,,ankyrin repeat containing,,IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (SUPERFAMILY),,
RL4_JR_05767,0,2,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,486.9028287,0,-1.349042769,0.785280213,-1.717912596,0.085812559,0.198036451,111.1773623,0,-3.331193393,1.219890764,-2.730730891,0.006319405,0.024092285,544.4343051,0,-0.113155503,0.732337158,-0.154512852,0.877205378,0.922875117,576.5404518,0,-0.439142795,0.372818309,-1.177900292,0.238836359,0.376904322,418.4440207,0,-0.837151586,0.953669408,-0.87782158,0.380040552,0.515827994,N,-,,small oligopeptide transporter,P:nucleocytoplasmic transport; P:transmembrane transport; C:integral component of membrane; F:structural constituent of nuclear pore; C:cytoplasmic part; C:nuclear pore,IPR004648 (TIGRFAM); IPR004813 (TIGRFAM); IPR004813 (PFAM); PTHR22601:SF0 (PANTHER); PTHR22601 (PANTHER),2.A.67.1.2, the oligopeptide transporter (opt) family.
RL4_JR_05768,6,3,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.376219092,0,3.308382449,2.607632666,1.268730252,0.204537289,NA,44.74359187,0,8.494986474,1.599902018,5.309691704,1.10E-07,1.32E-05,0.308970097,0,3.884810882,1.578577564,2.460956604,0.013856713,0.041701949,0.35643751,0,3.461778564,1.894444794,1.827331456,0.067649948,0.147556167,0.30070576,0,3.820742881,1.48471936,2.573377153,0.010071139,0.031584338,N,-,,major facilitator superfamily transporter,C:membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23502 (PANTHER); PTHR23502:SF26 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.2.36, the major facilitator superfamily (mfs).
RL4_JR_05769,171,200,243,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.820964581,0,2.182412278,1.599334792,1.364575002,0.172386666,NA,0.262705922,0,5.394131844,1.742322721,3.095943008,0.001961881,0.015023052,0.679404052,0,2.747315488,1.25977334,2.18080142,0.029198108,0.075063901,0.783669919,0,2.324849138,1.328789945,1.749598683,0.080187587,0.166680213,0.666817005,0,2.671223836,1.226077432,2.178674662,0.029355845,0.073863801,N,-,,glycerate-and formate-dehydrogenase,F:oxidoreductase activity; P:metabolic process,IPR016040 (G3DSA:3.40.50.GENE3D); IPR006139 (PFAM); IPR006140 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10996 (PANTHER); PTHR10996:SF129 (PANTHER); IPR016040 (SUPERFAMILY); SSF52283 (SUPERFAMILY),,
RL4_JR_05770,79,75,257,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,54.64192447,0,3.899730865,0.584654525,6.670145702,2.56E-11,9.88E-10,0.9362769,0,3.560596371,1.422514255,2.503030363,0.012313498,0.039479641,2.421698656,0,0.91328892,1.215263563,0.751515101,0.452342716,0.591887673,6.804904337,0,1.437775047,1.15541652,1.244378129,0.213360429,0.347758265,6.238511501,0,1.766376178,1.129725436,1.563544664,0.117924539,0.216301804,N,-, Effector probability:0.577,l-fuculose-phosphate aldolase,,IPR001303 (SMART); IPR001303 (PFAM); IPR001303 (G3DSA:3.40.225.GENE3D); PTHR10672 (PANTHER); PTHR10672:SF17 (PANTHER); IPR001303 (SUPERFAMILY),,
RL4_JR_05771,29,36,46,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,53.21714978,0,4.149589395,0.818509837,5.06968787,3.98E-07,6.77E-06,1.153845281,0,3.259113043,1.429626933,2.279694771,0.022625798,0.063527968,22.47182922,0,3.006825834,0.893410398,3.365559481,0.000763886,0.004642006,42.7597002,0,3.702937693,0.635464827,5.827132414,5.64E-09,1.64E-07,26.08225306,0,3.674050768,0.701377389,5.23833649,1.62E-07,3.40E-06,N,-,,acyl transferase,"F:transferase activity, transferring acyl groups other than amino-acyl groups",IPR003480 (PFAM); IPR023213 (G3DSA:3.30.559.GENE3D); IPR023213 (G3DSA:3.30.559.GENE3D); PTHR31896 (PANTHER); PTHR31896:SF6 (PANTHER),,
RL4_JR_05772,112,122,172,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.068907855,0,5.757069673,3.922225865,1.467806769,0.142156718,NA,0.021898942,0,8.978896934,2.84802471,3.152675222,0.001617817,0.015023052,20.89722899,0,8.737376382,0.938931348,9.305660531,1.33E-20,2.17E-18,9.377800426,0,6.865780207,1.220443412,5.625644042,1.85E-08,4.91E-07,38.6611873,0,9.726692376,1.340517562,7.255923126,3.99E-13,4.59E-11,N,-,,integral membrane PTH11,C:membrane,PTHR33048 (PANTHER),9.B.313.1.4, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_05773,11625,8310,7953,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.45956769,0,11.59236661,3.031769075,3.823631129,0.000131501,0.001078173,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,13.00079674,0,11.96923112,3.050737987,3.923388756,8.73E-05,0.001074055,0.003831463,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,0,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,N,-,,integral membrane PTH11,C:integral component of membrane,no IPS match,,
RL4_JR_05774,155,160,136,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.28165515,0,1.994925408,1.02314585,1.949795729,0.051200471,0.13526342,1.013624495,0,3.446114786,1.427323495,2.414389449,0.015761605,0.047994559,10.45684486,0,1.76506699,1.207040562,1.46230959,0.143656392,0.253862334,22.28494545,0,2.134027246,1.02938138,2.073116229,0.038161464,0.104090739,25.7224565,0,3.898348871,0.652163363,5.977564961,2.26E-09,1.24E-07,N,PKS,,polyketide synthase,F:catalytic activity; P:metabolic process,SM00822 (SMART); IPR020843 (SMART); IPR020807 (SMART); IPR020801 (SMART); IPR020806 (SMART); IPR020841 (SMART); IPR029063 (G3DSA:3.40.50.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR009081 (PFAM); IPR013217 (PFAM); IPR032821 (PFAM); IPR001227 (G3DSA:3.40.366.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); PF13602 (PFAM); IPR013968 (PFAM); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR014043 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); IPR014031 (PFAM); IPR014030 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR020807 (PFAM); PTHR11712 (PANTHER); PTHR11712 (PANTHER); PTHR11712:SF278 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY); IPR016035 (SUPERFAMILY); IPR016036 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR029063 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_05775,14515,913,3900,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.27570123,0,3.756621929,2.873992218,1.307109291,0.191175596,NA,0.085918049,0,7.006170519,2.376793274,2.947740804,0.003201053,0.016125399,0.225727258,0,4.336472535,1.581932891,2.741249367,0.006120604,0.022098784,0.26065231,0,3.912697965,1.989591659,1.966583418,0.049231257,0.121802535,0.224753649,0,4.241135578,1.471155181,2.882860784,0.003940816,0.014750742,N,-,,salicylate hydroxylase,F:oxidoreductase activity,PR00420 (PRINTS); IPR002938 (PFAM); PF13450 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789 (PANTHER); PTHR13789:SF186 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_05776,2258,1130,1540,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.063987599,0,5.863602513,3.923408235,1.494517563,0.135040395,NA,0.020381632,0,9.081932401,2.851885807,3.184535782,0.001449864,0.015023052,0.052944633,0,6.427889387,1.596892492,4.025248675,5.69E-05,0.000801403,0.061082533,0,6.005768071,2.779991762,2.160354629,0.030745227,0.093848484,0.052266522,0,6.344923512,1.321260241,4.802175463,1.57E-06,2.10E-05,N,-,,retrograde regulation 2,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF191 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_05777,6,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,82.24133104,0,-0.263780712,0.683317737,-0.386029365,0.699474921,0.837808898,15.5420248,0,-0.492639723,1.230067032,-0.400498274,0.688789554,0.802477885,47.14511176,0,-2.194307389,1.215985242,-1.804551005,0.071144971,0.148877984,99.88832365,0,0.292575138,0.591196208,0.494886696,0.620680102,0.738557532,51.64166971,0,-1.570997595,1.016778763,-1.545073178,0.122328564,0.222245955,N,-,,phosphoserine phosphatase,F:coenzyme binding; F:phosphatase activity; C:cytosol; P:dephosphorylation,IPR006384 (TIGRFAM); IPR023214 (G3DSA:3.40.50.GENE3D); PF12710 (PFAM); IPR006383 (TIGRFAM); PTHR32440 (PANTHER); PTHR32440:SF5 (PANTHER); IPR023214 (SUPERFAMILY),,
RL4_JR_05778,182,81,416,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,85.26018684,0,2.276541737,0.990474194,2.298436195,0.021536975,0.069934009,5.250031681,0,1.073182367,1.246178991,0.86117835,0.389139822,0.553601304,293.539824,0,4.382051264,1.147230435,3.819678358,0.000133626,0.001377574,29.07292756,0,-0.269599072,1.023645015,-0.263371646,0.792264143,0.865897501,58.73501248,0,2.108980503,0.54496008,3.86997246,0.000108848,0.000742643,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23514 (PANTHER); PTHR23514:SF6 (PANTHER); PTHR23514 (PANTHER); PTHR23514:SF6 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.7.13, the major facilitator superfamily (mfs).
RL4_JR_05779,597,766,512,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,6.984486107,0,-0.906439372,1.254784511,-0.722386484,0.470056894,0.65900054,2.201771823,0,2.326773257,1.344505579,1.730579101,0.083526862,0.175924475,5.754566872,0,-0.335786643,1.236109753,-0.27164792,0.78589275,0.858385823,6.641902628,0,-0.758828163,1.240442993,-0.611739651,0.540710023,0.671576176,5.712391508,1,-0.427777959,1.247137674,-0.343007808,0.731592586,0.811945077,N,-,,eukaryotic translation initiation factor eif1a,F:translation initiation factor activity; P:translational initiation; C:intracellular part,IPR001253 (SMART); G3DSA:2.40.50.140 (GENE3D); IPR006196 (PFAM); PTHR21641 (PANTHER); IPR012340 (SUPERFAMILY),,
RL4_JR_05780,45,86,132,0,0,0,0,0,0,0,0,2,4,3,0,0,5,0,81.38202456,0,0.458835894,0.688067117,0.666847583,0.504869496,0.691571482,28.00303537,0,1.891926609,1.00379288,1.884777872,0.059459834,0.135217353,24.11816512,1,-2.403110892,1.205155665,-1.994025304,0.046149289,0.106304132,54.48029977,1,-0.092135746,0.76856147,-0.119880777,0.904577593,0.941301299,31.63158305,1,-0.834954996,1.005595258,-0.830309202,0.406363986,0.543159784,N,-,,glycosyltransferase family 58,"P:oligosaccharide-lipid intermediate biosynthetic process; P:mannosylation; C:integral component of membrane; P:protein glycosylation; C:endoplasmic reticulum; F:dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity",IPR007873 (PFAM); IPR007873 (PANTHER); PTHR12646:SF0 (PANTHER),,
RL4_JR_05781,11,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.416879943,0,-1.337432925,1.246038885,-1.073347663,0.283115158,0.46640821,31.12096194,0,4.035595189,0.919774138,4.387593671,1.15E-05,0.000748451,14.2600965,0,0.194573869,1.22545125,0.158777323,0.873844316,0.920391163,8.95590329,0,-1.189930919,1.23477991,-0.963678554,0.335207109,0.481892941,7.652705481,0,-0.849655259,1.237616909,-0.686525251,0.492381947,0.620688149,N,-,,D-amino-acid oxidase,F:oxidoreductase activity; P:single-organism metabolic process,IPR006076 (PFAM); IPR023209 (PIRSF); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR11530:SF9 (PANTHER); IPR023209 (PANTHER); SSF54373 (SUPERFAMILY); SSF51971 (SUPERFAMILY),9.B.2.1.1, the integral membrane caax protease-2 (caax protease2) family.
RL4_JR_05782,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,286.0490606,0,1.847752841,0.343475968,5.379569499,7.47E-08,1.52E-06,57.59847429,0,0.122531715,1.117818948,0.109616781,0.912713302,0.951244238,102.4790602,0,-0.034965304,0.621075235,-0.056298016,0.955104399,0.974156451,138.1769925,0,0.144160609,0.575517963,0.250488461,0.802209627,0.873479059,56.55746823,0,-1.853519012,0.971322032,-1.908243561,0.056359744,0.122659734,N,-,,udp-glucose 4-epimerase,F:coenzyme binding; F:UDP-glucose 4-epimerase activity; C:cytosol; P:galactose catabolic process via UDP-galactose; F:aldose 1-epimerase activity,IPR016040 (G3DSA:3.40.50.GENE3D); IPR005886 (TIGRFAM); G3DSA:3.90.25.10 (GENE3D); IPR001509 (PFAM); PTHR10366:SF433 (PANTHER); PTHR10366 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_05783,2145,2430,2391,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,90.92817758,0,-0.106319298,0.569067095,-0.186830866,0.851793245,0.926054923,17.99316687,0,-0.703877931,1.199262035,-0.586925884,0.557253485,0.701501953,46.76743303,0,-3.358462321,1.190341298,-2.821428044,0.004781036,0.018341497,63.27086102,0,-2.831430074,1.142964117,-2.477269437,0.013239192,0.060599826,65.4876513,0,-0.523069376,0.689241515,-0.758905789,0.447908916,0.580090683,N,-,,spindle pole body-associated sad1,C:membrane,IPR012919 (PFAM); IPR018539 (PTHR12911:PANTHER); PTHR12911 (PANTHER); PTHR12911 (PANTHER); PTHR12911 (PANTHER); IPR018539 (PTHR12911:PANTHER); IPR018539 (PTHR12911:PANTHER); IPR012919 (PROSITE_PROFILES),,
RL4_JR_05784,2547,6116,4358,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,193.1123587,1,-2.550336039,0.803588292,-3.173684913,0.00150517,0.008224498,49.01681473,0,-2.149703065,1.206067128,-1.782407475,0.074682807,0.161525508,127.8107294,0,-4.808881335,1.207155908,-3.98364561,6.79E-05,0.000901674,192.7679976,1,-1.886935731,0.656479581,-2.874325088,0.00404892,0.023704845,142.0334928,0,-2.323239692,0.810889168,-2.865052073,0.004169407,0.015412648,N,-,,ATP-dependent RNA helicase DBP4,F:nucleotide binding; F:nucleic acid binding; C:cytoplasm; F:RNA-dependent ATPase activity; F:helicase activity,IPR001650 (SMART); IPR014001 (SMART); IPR025313 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR025313 (PFAM); IPR001650 (PFAM); IPR011545 (PFAM); PTHR24031:SF54 (PANTHER); PTHR24031:SF54 (PANTHER); PTHR24031 (PANTHER); IPR014014 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_05785,35,16,40,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.03492048,0,6.735791797,3.937175613,1.710818226,0.087114674,NA,0.010505693,0,10.03349666,3.939000193,2.547219134,0.010858522,0.035824629,0.028543762,0,7.317085106,3.703947783,1.975482791,0.048213386,0.110139362,0.033010725,0,6.891577418,3.937482283,1.750249759,0.080075226,0.166583453,0.029614927,0,7.16478327,2.430424993,2.9479549,0.003198837,0.012457011,N,-,,dihydroxyacetone kinase,P:glycerol metabolic process; F:ATP binding; F:glycerone kinase activity; P:phosphorylation; F:kinase activity,no IPS match,,
RL4_JR_05786,24,4,36,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.019400267,0,7.582626433,3.961290641,1.914180786,0.05559706,NA,0.005836496,0,10.87810754,3.964459573,2.74390679,0.006071277,0.023455523,0.015857645,0,8.163737005,3.961957144,2.060531376,0.03934777,0.094409272,0.018339292,0,7.738034468,3.961825153,1.953148907,0.050801953,0.124389486,0.016452737,0,8.01414473,2.194850325,3.651339975,0.000260876,0.00156479,N,-,,duf895 domain membrane,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23294 (PANTHER); PTHR23294:SF24 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.58.1, the major facilitator superfamily (mfs).
RL4_JR_05787,799,1073,1609,1,0,2,0,0,0,0,0,0,0,1,0,0,3,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-, Effector probability:0.82,Pyridine nucleotide-disulfide class-II,F:FAD binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (SUPERFAMILY),,
RL4_JR_05788,28,21,36,3,9,7,0,0,3,0,0,0,0,0,0,0,1,0,3.768319669,1,-0.0159582,1.242526192,-0.012843351,0.98975277,0.994874704,1.204984527,1,3.196599131,1.39834378,2.285989452,0.022254876,0.062677755,3.116737964,0,0.54927802,1.222943444,0.449144253,0.653327599,0.759651845,3.595148968,0,0.127058248,1.227843385,0.103480826,0.917581366,0.950144337,3.05850241,1,0.473545683,1.215900837,0.389460776,0.696935321,0.785728517,N,-,,TAM domain methyltransferase,F:transferase activity,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_05789,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,234.4821226,0,-0.13504341,0.451534791,-0.299076423,0.764881735,0.877161421,63.24935804,0,-0.967464123,1.108139301,-0.873052803,0.382634297,0.547191913,159.2780833,0,-1.132815973,0.625111356,-1.812182682,0.069957974,0.146697293,167.5982809,0,-1.433413161,0.585907395,-2.446484161,0.014425714,0.064915711,128.2518417,0,-1.710254984,0.704216492,-2.428592632,0.015157553,0.043861166,N,-,,tryptophanyl-tRNA synthetase,F:ATP binding; C:cytoplasm; P:tryptophanyl-tRNA aminoacylation; F:tryptophan-tRNA ligase activity,IPR002306 (PRINTS); IPR002306 (TIGRFAM); IPR002305 (PFAM); IPR014729 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.240.10 (GENE3D); PTHR10055:SF1 (PANTHER); IPR002306 (PANTHER); SSF52374 (SUPERFAMILY),,
RL4_JR_05790,14,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,136.2223789,0,-2.710999164,0.871403137,-3.111073448,0.001864086,0.009881229,60.60881194,0,-0.870886789,1.109683384,-0.784806551,0.432566999,0.594109228,99.61325771,0,-4.449281489,1.195314805,-3.72226753,0.000197442,0.001739686,114.9374125,0,-4.871887191,1.196326749,-4.072371694,4.65E-05,0.000553684,117.721069,0,-1.627481679,0.708819921,-2.296043933,0.02167337,0.058331437,N,-,,Sas10 Utp3 C1D family,"C:nucleus; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",IPR007146 (PFAM); PTHR13237 (PANTHER); PTHR13237:SF7 (PANTHER),,
RL4_JR_05791,5,2,12,2,3,0,0,0,0,0,0,0,3,0,0,0,1,0,157.2055458,1,0.922540815,0.95520443,0.965804582,0.334141975,0.524116561,54.47224413,0,1.964116379,0.768699638,2.555115525,0.010615256,0.035182587,44.13176229,0,-3.274762579,1.19894209,-2.731376775,0.006307032,0.022658635,62.95773636,1,-1.404325289,0.874070112,-1.606650623,0.108131031,0.20794429,50.98373137,1,-2.423902285,1.134395474,-2.1367348,0.032619568,0.080338877,Y,-,,endosomal integral membrane,C:integral component of membrane,IPR004240 (PFAM); IPR004240 (PANTHER); PTHR10766:SF14 (PANTHER),8.A.68.1.1, the endomembrane protein-70 (emp70) family.
RL4_JR_05792,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20.59422654,0,-1.223942917,1.155681389,-1.059066044,0.289569703,0.474325691,5.321748385,0,1.053552298,1.243432907,0.847293242,0.396831693,0.560917524,13.86435824,0,-1.604419907,1.201251594,-1.33562354,0.181672352,0.302870909,25.63343132,0,-1.076514564,1.152029302,-0.934450679,0.350071466,0.496703138,13.72999741,0,-1.693013696,1.210488122,-1.398620659,0.161926768,0.27425703,N,-,,pre-mrna cleavage complex ii clp1,F:nucleotide binding; C:nucleus; P:mRNA 3'-end processing,IPR027417 (G3DSA:3.40.50.GENE3D); IPR032324 (PFAM); IPR010655 (PFAM); IPR032319 (PFAM); PTHR12755 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_05793,1842,1724,1586,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,377.3077674,0,-1.578063813,0.479846687,-3.288683357,0.001006572,0.005946136,87.4495359,0,-2.984850626,1.206458222,-2.474060496,0.013358707,0.041979769,291.2758463,0,-1.650206883,0.544323968,-3.031663089,0.002432105,0.011567947,340.0225866,0,-1.632757522,0.47345678,-3.448588319,0.000563525,0.004616256,243.389969,0,-3.074597326,0.763602133,-4.026438892,5.66E-05,0.000430449,Y,-,,stress response rci peptide,C:membrane,IPR000612 (PFAM); PTHR21659:SF0 (PANTHER); IPR000612 (PANTHER),9.B.12.2.2, the sensitivity to sodium or salt stress-induced hydrophobic peptide (sna) family.
RL4_JR_05794,567,663,877,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.655799034,0,-0.837151899,1.193217579,-0.701591992,0.482933647,0.671170816,2.127243472,0,2.376525341,1.302628826,1.824407148,0.068090542,0.15028619,12.01433464,0,0.687089083,1.192604217,0.576124982,0.564530707,0.689138108,54.53892682,0,2.813331684,1.529313538,1.83960425,0.06582636,0.145160008,5.436500436,0,-0.356516418,1.198966592,-0.297353088,0.766196955,0.837168045,N,-,,Argonaute-binding 1,P:gene silencing by RNA; C:ARC complex; P:chromatin silencing,IPR018606 (PFAM),,
RL4_JR_05795,4,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36.31836072,0,-2.177209698,1.142736677,-1.905259314,0.056746371,0.145944797,10.40437759,0,0.0863979,1.22007379,0.070813667,0.943546054,0.969699783,26.95445776,0,-2.563508012,1.193492724,-2.147904181,0.031721368,0.080206576,31.09115805,0,-2.985661667,1.192544882,-2.503605282,0.01229351,0.057070971,33.91699054,0,-1.709735458,1.124381302,-1.520601112,0.128359968,0.229951402,N,-,,inositol polyphosphate multikinase,"P:regulation of nitrogen compound metabolic process; F:phosphotransferase activity, alcohol group as acceptor; F:kinase activity; P:regulation of primary metabolic process; P:phosphate-containing compound metabolic process; P:regulation of cellular metabolic process",IPR005522 (PFAM); IPR005522 (PANTHER); PTHR12400:SF52 (PANTHER); IPR005522 (PANTHER); PTHR12400:SF52 (PANTHER); PTHR12400:SF52 (PANTHER); SSF56104 (SUPERFAMILY),,
RL4_JR_05796,103,63,36,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,160.1552219,0,-0.914022628,0.498635843,-1.833046384,0.066795673,0.165177055,33.54128771,0,-1.602336758,1.194931731,-1.340944187,0.179938574,0.318082125,146.0785453,0,-0.619565487,0.566089901,-1.094464829,0.273751165,0.412544975,194.7639322,0,-0.227177714,0.433106336,-0.524531034,0.59990924,0.722159203,89.3664146,0,-3.401059225,1.116511859,-3.046146978,0.002317945,0.009614581,N,-,,helicase associated domain-containing,F:nucleic acid binding; F:ATP binding; F:ATP-dependent helicase activity,IPR014001 (SMART); IPR001650 (SMART); IPR007502 (SMART); IPR022967 (SMART); IPR011709 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:2.40.50.140 (GENE3D); IPR001650 (PFAM); IPR003029 (PFAM); IPR007502 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR18934 (PANTHER); PTHR18934:SF85 (PANTHER); PTHR18934:SF85 (PANTHER); PTHR18934 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR003029 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR012340 (SUPERFAMILY),1.A.53.1.4, the hepatitis c virus p7 viroporin cation-selective channel (hcv-p7) family.
RL4_JR_05797,29,112,54,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,1.393732197,1,1.418587012,1.449476329,0.978689326,0.327733508,NA,0.452522567,0,4.609597139,1.650798089,2.792344605,0.005232759,0.021203359,1.161972402,0,1.97249373,1.285292897,1.534664771,0.124866194,0.228680417,1.339513294,0,1.551133752,1.331254624,1.165166847,0.243951463,0.382058555,1.13453236,0,1.90355431,1.26071313,1.50990282,0.131068223,0.233638338,Y,-,,"endo-beta-1,4-glucanase celB","C:integral component of membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds; P:cellulose catabolic process",IPR001722 (PRINTS); IPR001722 (PFAM); IPR001722 (G3DSA:2.70.100.GENE3D); PTHR33753 (PANTHER); PTHR33753:SF1 (PANTHER); IPR013320 (SUPERFAMILY),,
RL4_JR_05798,695,982,524,0,0,5,0,0,0,0,0,0,0,0,0,0,2,0,145.7449161,1,-2.513901823,0.910930129,-2.759708722,0.005785292,0.024479466,40.9622624,0,-1.890728276,1.239512658,-1.525380369,0.127164252,0.243502944,107.4162628,0,-4.558088278,1.238864676,-3.679246302,0.000233924,0.001950782,160.1055559,0,-1.300816421,0.75394585,-1.725344628,0.084465384,0.172387021,122.489254,1,-2.125429262,0.890597124,-2.386521588,0.017008609,0.048050269,N,-,,pre-rrna-processing esf1,C:nucleus; F:RNA binding; P:rRNA processing,IPR012580 (PFAM); PTHR12202:SF0 (PANTHER); PTHR12202 (PANTHER),,
RL4_JR_05799,760,1802,456,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0.008141456,0,8.841220392,4.035983802,2.190598582,0.028480854,NA,0.002675567,0,12.01934062,4.032893235,2.980327006,0.002879408,0.015349618,0.006783092,0,9.399044527,3.291065204,2.855927776,0.004291127,0.016940088,0.007815077,1,8.97609272,4.035428601,2.224322026,0.026126786,0.086108719,0.006504647,0,9.346543544,1.704039324,5.484934187,4.14E-08,1.17E-06,N,-,,integral component of membrane,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,IPR009311 (PFAM); PTHR16932:SF18 (PANTHER); IPR009311 (PANTHER),,
RL4_JR_05800,10,29,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.046075806,0,1.832446376,1.67630735,1.093144629,0.274330304,NA,0.329219937,0,5.068029837,1.77177473,2.860425623,0.004230728,0.018518658,0.864555333,0,2.398113331,1.346709813,1.780720173,0.074958176,0.154936009,0.997970985,0,1.975225898,1.434799488,1.3766564,0.168618505,0.290005497,0.865161443,0,2.295179411,1.335149476,1.719043038,0.085606536,0.169987482,,,,,,,,
RL4_JR_05801,267,704,397,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,377.4610373,1,0.739939831,0.694090525,1.066056666,0.286398027,0.470391605,65.84374019,0,-0.460850576,1.015292447,-0.453909194,0.649894186,0.77363624,158.6706681,0,-1.907824933,0.776762692,-2.456123283,0.014044497,0.042179319,223.9366146,0,-0.660013248,0.500223767,-1.319436004,0.187023392,0.31497203,146.999252,1,-1.895069535,0.734165881,-2.581255251,0.009844177,0.030963155,N,-,,mitochondrial ATPase,F:ATP binding,IPR005654 (PFAM); IPR007484 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:3.40.630.10 (GENE3D); IPR005654 (PANTHER); PTHR12169:SF6 (PANTHER); IPR027417 (SUPERFAMILY); SSF53187 (SUPERFAMILY),,
RL4_JR_05802,536,522,414,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,99.06777657,1,0.286816462,1.019328803,0.281377766,0.778420669,0.885931337,13.83181134,0,-0.324368224,1.223763261,-0.265057985,0.790964793,0.873795221,94.41244937,0,0.846627367,0.558036635,1.517153737,0.129227874,0.234883841,64.13108296,0,-1.065531592,0.86088742,-1.237713048,0.215822479,0.350642266,35.01776459,0,-3.04383482,1.194893203,-2.547369767,0.010853836,0.033586518,N,-,,iq calmodulin-binding motif,F:catalytic activity; C:membrane; C:integral component of membrane,G3DSA:3.30.870.10 (GENE3D); IPR025202 (PFAM); PTHR21248 (PANTHER); PTHR21248 (PANTHER); PTHR21248:SF5 (PANTHER); PTHR21248:SF5 (PANTHER); IPR001736 (PROSITE_PROFILES); SSF56024 (SUPERFAMILY); SSF56024 (SUPERFAMILY),,
RL4_JR_05803,243,556,309,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,570.4783171,0,0.862712737,0.299117492,2.884193534,0.003924175,0.017762852,64.83470417,0,-2.553183669,1.191878112,-2.142151655,0.03218128,0.083608552,210.244024,0,-1.80957815,0.625094352,-2.894888016,0.003792938,0.015900997,246.6392772,0,-1.425902071,0.635487154,-2.243793699,0.024845678,0.085333273,199.7876389,0,-2.319951446,0.695390124,-3.336186933,0.00084936,0.004188881,N,-,,prolyl-tRNA synthetase,F:ATP binding; F:RNA binding; P:chromosome organization; F:proline-tRNA ligase activity; C:cytosol; C:ribosome; P:prolyl-tRNA aminoacylation,IPR002316 (PRINTS); IPR016061 (SMART); IPR004499 (TIGRFAM); IPR004154 (G3DSA:3.40.50.GENE3D); IPR004154 (PFAM); IPR016061 (G3DSA:3.30.110.GENE3D); IPR002314 (PFAM); IPR016061 (PFAM); G3DSA:3.30.930.10 (GENE3D); PTHR11451:SF21 (PANTHER); PTHR11451 (PANTHER); IPR006195 (PROSITE_PROFILES); IPR004499 (HAMAP); IPR017449 (SUPERFAMILY); IPR004154 (SUPERFAMILY); SSF55681 (SUPERFAMILY),,
RL4_JR_05804,3,11,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,259.2596706,0,-1.174826896,1.068223928,-1.099794589,0.27142163,0.45318413,87.42610442,0,-0.2395536,0.851632193,-0.281287629,0.778489798,0.866015357,173.2934841,0,-3.252511783,1.038178224,-3.132903106,0.001730866,0.008830684,259.1894686,0,-0.847125076,0.461151839,-1.836976467,0.06621337,0.14567806,190.3571837,0,-1.74592421,0.615854003,-2.834964456,0.004583078,0.016634172,N,-,,T-complex 1 subunit alpha,C:nucleus; C:chaperonin-containing T-complex; F:ATP binding; P:mycelium development; F:unfolded protein binding; P:protein folding,IPR017998 (PRINTS); IPR027413 (G3DSA:1.10.560.GENE3D); IPR027410 (G3DSA:3.30.260.GENE3D); IPR002423 (PFAM); IPR012715 (TIGRFAM); IPR027409 (G3DSA:3.50.7.GENE3D); PTHR11353 (PANTHER); SSF48592 (SUPERFAMILY); IPR027409 (SUPERFAMILY); SSF54849 (SUPERFAMILY),,
RL4_JR_05805,1193,947,1207,0,2,0,0,0,0,0,0,0,0,1,0,0,0,1,81.84292948,1,2.98882583,0.5130247,5.825890697,5.68E-09,1.37E-07,2.735707426,0,2.013605601,1.287820594,1.563576177,0.117917133,0.230416452,24.67674846,0,1.185109046,1.03883551,1.140805291,0.253950958,0.389663459,60.20746166,1,2.822566746,0.533174588,5.293888364,1.20E-07,2.65E-06,14.37760854,1,0.21304053,1.133826496,0.187895177,0.850958823,0.900975365,N,-,,lysine acetyltransferase,F:transferase activity; F:N-acetyltransferase activity,IPR016181 (G3DSA:3.40.630.GENE3D); PTHR34815:SF1 (PANTHER); PTHR34815 (PANTHER); IPR016181 (SUPERFAMILY),,
RL4_JR_05806,9,8,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,104.9505025,0,4.556328757,0.742620023,6.135477921,8.49E-10,2.38E-08,10.95134416,0,3.728053877,1.131699526,3.294208216,0.000986994,0.015023052,10.5774649,0,1.122420554,1.193925281,0.940109546,0.347161373,0.490943112,84.64818026,0,4.058013681,0.455283631,8.913155242,4.96E-19,4.29E-17,48.56965365,0,3.526162369,0.580001195,6.079577764,1.20E-09,6.97E-08,Y,-,,hypothetical protein F503_02453,C:membrane,PTHR34587 (PANTHER); PTHR34587:SF1 (PANTHER),,
RL4_JR_05807,65,80,54,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,312.2970726,0,-0.478777957,0.396424283,-1.207741244,0.227146808,0.398679789,65.27362528,0,-1.421657033,1.109663578,-1.2811604,0.200137332,0.343820448,229.3460564,0,-0.842642385,0.498940765,-1.688862577,0.091245768,0.180883524,294.247561,0,-0.259109974,0.377569361,-0.686257944,0.492550464,0.631452001,223.2162695,0,-0.449066194,0.4739412,-0.947514575,0.343376633,0.480338271,N,-,,cytochrome b-c1 complex subunit rieske,"P:mycelium development; F:ubiquinol-cytochrome-c reductase activity; F:metal ion binding; P:hydrogen ion transmembrane transport; C:mitochondrial respiratory chain complex III; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:aerobic respiration; F:2 iron, 2 sulfur cluster binding",IPR005805 (PRINTS); IPR006317 (TIGRFAM); IPR017941 (G3DSA:2.102.10.GENE3D); IPR004192 (G3DSA:1.20.5.GENE3D); IPR017941 (PFAM); IPR004192 (PFAM); PTHR10134:SF1 (PANTHER); IPR014349 (PANTHER); IPR017941 (PROSITE_PROFILES); SSF81502 (SUPERFAMILY); IPR017941 (SUPERFAMILY),3.D.3.3.1, the proton-translocating quinol:cytochrome c reductase (qcr) superfamily.
RL4_JR_05808,128,191,131,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,110.2439406,0,2.296318784,0.416832576,5.508971508,3.61E-08,7.94E-07,15.7367884,0,1.713022891,1.128942023,1.517370119,0.129173264,0.246214696,22.9578991,0,-0.889934713,1.193528606,-0.745633334,0.455888941,0.594619836,31.02063799,0,0.027348237,0.859424364,0.031821576,0.97461434,0.98517231,16.17556667,1,-1.929489712,1.193603635,-1.616524662,0.105980926,0.199601353,N,-,,uv-damaged DNA-binding,C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:cullin-RING ubiquitin ligase complex; F:oxidoreductase activity; P:nucleotide-excision repair; F:iron-sulfur cluster binding; F:damaged DNA binding; P:single-organism process,IPR015943 (G3DSA:2.130.10.GENE3D); PF10433 (PFAM); IPR004871 (PFAM); IPR025952 (PFAM); PTHR10644 (PANTHER); PTHR10644 (PANTHER); PTHR10644:SF3 (PANTHER); PTHR10644:SF3 (PANTHER); SSF69322 (SUPERFAMILY); IPR001374 (SUPERFAMILY),,
RL4_JR_05809,22,45,27,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_05810,1214,1078,1280,2,0,0,0,0,0,0,0,0,0,1,2,0,3,0,0.851975795,1,2.128765196,1.552759791,1.3709559,0.170388704,NA,0.271311421,0,5.347446564,1.713857322,3.120123535,0.001807752,0.015023052,0.704858733,0,2.693333086,1.246298418,2.161065958,0.030690245,0.078185213,0.813207337,1,2.270994023,1.306179304,1.738654116,0.082095621,0.169256397,8.416961683,1,4.274757241,0.990875354,4.31412208,1.60E-05,0.000149256,N,-, Effector probability:0.56,---NA---,,IPR027417 (G3DSA:3.40.50.GENE3D); IPR000330 (PFAM); IPR027417 (SUPERFAMILY),,
RL4_JR_05811,42,52,60,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,48.33199012,0,0.295274836,0.657867374,0.448836419,0.653549665,0.804657133,7.99720059,0,0.466019638,1.218242797,0.382534285,0.702065103,0.811689555,49.42731923,0,0.635554597,0.736144896,0.863355299,0.387942149,0.531896846,53.62327371,0,0.698310504,0.607437174,1.1496012,0.250308164,0.389603406,32.03158355,0,-0.061584879,0.841008689,-0.0732274,0.941625163,0.963025735,N,-,,pq loop repeat,C:integral component of membrane,IPR006603 (SMART); IPR006603 (PFAM); PTHR16201 (PANTHER); PTHR16201:SF11 (PANTHER),2.A.43.4.1, the lysosomal cystine transporter (lct) family.
RL4_JR_05812,11940,8318,9110,4,9,10,0,0,1,1,6,5,17,16,10,0,12,11,12.82056548,1,-1.782793998,1.260228613,-1.414659196,0.157168443,0.306720132,4.033638523,1,1.453316443,1.315827994,1.104488162,0.269381436,0.426618969,23.57746153,1,0.592038098,1.090588589,0.542861079,0.587225455,0.707526311,37.89429661,1,1.363209474,0.773412759,1.762589844,0.077969691,0.16337813,10.56163498,1,-1.314528434,1.262932725,-1.040853885,0.297943367,0.433306031,N,-,,WD repeat-containing,,PTHR13211 (PANTHER); SSF101908 (SUPERFAMILY),,
RL4_JR_05813,165,207,210,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,28.12734058,0,-1.759384114,1.160032358,-1.516668136,0.129350493,0.266164997,17.1082944,0,1.430680539,1.133672574,1.261987431,0.206953309,0.35212328,31.19463573,0,-1.180209621,1.203634747,-0.980538011,0.326820616,0.469790135,32.53211772,1,-1.613257081,1.157936663,-1.393217032,0.163554171,0.283857616,19.93297433,0,-2.230875587,1.214886978,-1.83628241,0.0663159,0.13927577,N,-,,receptor-activated Ca2+-permeable cation channel,F:ion channel activity; P:ion transmembrane transport; C:integral component of membrane,IPR005821 (PFAM); PTHR35859:SF3 (PANTHER); PTHR35859 (PANTHER),1.A.4.4.1, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_05814,19,15,26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.588860217,0,0.054231757,1.210854306,0.044788012,0.96427628,0.981952767,1.149673116,0,3.264351695,1.382131411,2.361824404,0.018185254,0.053323041,9.473014675,0,1.578485557,1.194491064,1.321471214,0.186344295,0.308310122,3.430616446,0,0.194475513,1.20702878,0.161119201,0.871999518,0.921123614,2.923040665,0,0.538695418,1.19824147,0.449571669,0.65301932,0.752454833,Y,-,,transmembrane alpha-helix domain-containing,C:membrane; C:integral component of membrane,IPR013320 (G3DSA:2.60.120.GENE3D),,
RL4_JR_05815,137,148,218,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.279912281,0,3.734363197,2.692913945,1.386736922,0.165521997,NA,0.088142917,0,6.968852681,2.238544621,3.11311761,0.001851222,0.015023052,0.231451806,0,4.298298031,1.452304166,2.959640364,0.003079984,0.013797236,0.267163344,0,3.876284214,1.806386661,2.145877346,0.031882766,0.095422111,0.231656781,0,4.196087775,1.364106978,3.07606943,0.00209749,0.008815727,,,,,,,,
RL4_JR_05816,83,100,56,0,0,0,0,0,0,1,0,0,0,5,0,0,0,0,55.22831046,0,2.115778312,0.551605263,3.835674629,0.00012522,0.001032908,3.967284103,0,1.477371292,1.263320464,1.1694351,0.242228375,0.394502915,119.618827,1,3.529338409,0.448208368,7.874325114,3.43E-15,3.43E-13,91.97932067,1,3.054493666,0.464683012,6.573284552,4.92E-11,1.95E-09,48.06007106,0,2.339367539,0.572134285,4.088843474,4.34E-05,0.000343734,N,-,,DJ-1 family,,IPR029062 (G3DSA:3.40.50.GENE3D); IPR002818 (PFAM); PTHR11019 (PANTHER); PTHR11019 (PANTHER); PTHR11019:SF97 (PANTHER); IPR029062 (SUPERFAMILY),,
RL4_JR_05817,0,2,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.64563633,0,0.112317039,1.004012297,0.111868191,0.910927918,0.956734502,3.689103703,0,1.582294027,1.262924327,1.252881106,0.210248979,0.355995344,9.54347501,0,-1.065446394,1.19341268,-0.892772812,0.371978849,0.516150846,19.03083342,0,0.239661848,1.013962963,0.23636154,0.813152137,0.881589612,20.96029417,0,1.064709078,0.837945519,1.2706185,0.203864402,0.326189487,N,-,,prolyl oligopeptidase,P:proteolysis; F:serine-type peptidase activity,IPR011042 (G3DSA:2.120.10.GENE3D); IPR029058 (G3DSA:3.40.50.GENE3D); IPR001375 (PFAM); PTHR11731:SF150 (PANTHER); PTHR11731 (PANTHER); PTHR11731:SF150 (PANTHER); PTHR11731 (PANTHER); IPR029058 (SUPERFAMILY),8.A.51.1.3, the dipeptidyl-aminopeptidase-like protein 6 beta subunit of kv4 channels (dpp6) family.
RL4_JR_05818,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.426105733,0,0.12102208,1.210390948,0.099985943,0.920355486,0.961623962,1.096101772,0,3.33315542,1.385229039,2.406212494,0.016118886,0.048775893,2.839339118,0,0.683387082,1.205083223,0.567087044,0.570655045,0.694555383,3.275163884,0,0.261199009,1.206352782,0.21651959,0.828582757,0.892774334,2.795193906,0,0.603188519,1.199910277,0.502694685,0.615178947,0.722250329,N,-,,rta1 domain,C:integral component of membrane; P:response to stress,IPR007568 (PFAM); PTHR31465 (PANTHER); PTHR31465:SF8 (PANTHER),9.A.26.1.4, the lipid-translocating exporter (lte) family.
RL4_JR_05819,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.993278794,0,1.7218513,1.185195921,1.452798874,0.146279605,0.291986546,0.687988759,0,4.004957138,1.487008795,2.693297545,0.00707491,0.026126318,1.794621997,0,1.345099563,1.237213195,1.087201114,0.276947939,0.41593546,2.07104901,0,0.92231595,1.254522166,0.735193028,0.462221945,0.60433848,1.778586124,0,1.255751565,1.23627329,1.015755638,0.309745766,0.445416259,N,-,,3-hydroxyisobutyrate dehydrogenase,P:branched-chain amino acid catabolic process; F:phosphogluconate dehydrogenase (decarboxylating) activity; F:NAD binding; P:valine catabolic process; P:oxidation-reduction process; F:3-hydroxyisobutyrate dehydrogenase activity,IPR015815 (PIRSF); IPR011548 (TIGRFAM); IPR006115 (PFAM); IPR029154 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013328 (G3DSA:1.10.1040.GENE3D); PTHR22981:SF7 (PANTHER); PTHR22981 (PANTHER); IPR016040 (SUPERFAMILY); IPR008927 (SUPERFAMILY),,
RL4_JR_05820,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.642700245,0,0.032523231,1.284020257,0.02532922,0.979792367,0.989985897,1.181483145,0,3.225007355,1.4550494,2.216424649,0.026662433,0.072044086,17.37772543,0,2.403928051,1.078416815,2.22912701,0.025805455,0.068212645,3.50006867,0,0.165436293,1.266304691,0.130644934,0.896056195,0.935798759,6.827311318,0,1.443701289,1.170539199,1.233364326,0.217439869,0.342730197,N,-,,ankyrin repeat containing,,IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24198 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY),8.A.28.1.1, the ankyrin (ankyrin) family.
RL4_JR_05821,7957,8365,6789,0,0,8,0,0,0,0,4,0,0,9,6,0,3,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_05822,4374,12198,7837,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1656.991179,0,-0.679698569,0.433810168,-1.566811057,0.117158862,0.248249795,340.5882976,0,-3.989692859,1.124062617,-3.549351076,0.000386182,0.014476338,1117.407226,1,-1.730107196,0.39187622,-4.41493285,1.01E-05,0.000189084,1393.493435,0,-1.275904628,0.285186107,-4.473936828,7.68E-06,0.000113177,931.7412047,1,-2.985943467,0.562513888,-5.308212881,1.11E-07,2.46E-06,N,-, Effector probability:0.754,thioredoxin,"F:protein disulfide oxidoreductase activity; C:cytoplasm; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; P:cellular response to oxidative stress; P:cell redox homeostasis; P:oxidation-reduction process; P:protein folding; P:sulfate assimilation",PR00421 (PRINTS); IPR012336 (G3DSA:3.40.30.GENE3D); IPR013766 (PFAM); IPR005746 (PIRSF); IPR005746 (PANTHER); PTHR10438:SF215 (PANTHER); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY),8.A.88.1.3, the calciquestrin (casq) family.
RL4_JR_05823,998,708,836,0,1,4,0,0,0,0,0,0,0,2,0,0,0,1,150.7027148,1,0.608209222,0.683563253,0.889762899,0.373593212,0.565974637,27.00056828,0,0.242784745,1.122235683,0.216340248,0.828722539,0.897378751,65.03743103,0,-0.918267648,0.855713169,-1.073102158,0.283225283,0.422729289,177.7083952,1,1.460524675,0.611710495,2.387607678,0.016958434,0.070747485,93.83597313,1,0.537905403,0.491030895,1.095461422,0.273314538,0.406240413,N,-,,hypothetical protein SPI_07434,,PTHR42050 (PANTHER); PTHR42050 (PANTHER); PTHR42050:SF1 (PANTHER); PTHR42050 (PANTHER); PTHR42050:SF1 (PANTHER); PTHR42050:SF1 (PANTHER),,
RL4_JR_05824,4439,5453,11081,0,3,1,0,0,0,0,0,2,0,0,1,0,1,0,56.80571288,1,1.286029293,0.583269607,2.204862515,0.027463744,0.08445274,72.55213885,0,3.201580487,0.848802403,3.771879623,0.000162022,0.007316414,28.88869003,1,0.148302574,1.034459911,0.143362322,0.886004039,0.929234941,16.78075874,1,-2.095809994,1.19337789,-1.756199784,0.079054301,0.164992426,14.30419654,1,-1.752099435,1.194648963,-1.466622824,0.142478688,0.249067112,N,-,,kinetochore nuf2,C:spindle microtubule; C:Ndc80 complex; C:NMS complex; P:microtubule nucleation; C:condensed nuclear chromosome kinetochore; F:structural constituent of cytoskeleton; C:mitotic spindle pole body; C:meiotic spindle pole body; P:attachment of mitotic spindle microtubules to kinetochore,IPR005549 (PFAM); PTHR21650 (PANTHER),,
RL4_JR_05825,809,863,1465,0,3,0,0,0,0,0,0,1,0,1,1,0,0,0,0.3982758,1,3.225726927,2.230973701,1.445882991,0.148210023,NA,0.125767857,0,6.456336703,2.01635318,3.201987016,0.001364831,0.015023052,0.328874605,1,3.792216517,1.329410384,2.852555211,0.004336928,0.017050402,0.379564947,1,3.369952929,1.539252148,2.189344308,0.028571824,0.089798402,0.327116351,0,3.698856626,1.275263879,2.900463729,0.00372611,0.014092962,N,-,,hypothetical protein CMQ_3430,,no IPS match,,
RL4_JR_05826,10,18,30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,105.4740031,0,0.987636367,0.471544832,2.094469711,0.036218159,0.104775793,10.91970744,0,0.016630233,1.208507025,0.013760974,0.989020678,0.994396152,42.7142138,0,-0.815114131,1.029718355,-0.791589396,0.428600132,0.569068555,36.74550737,0,-2.11262712,1.141160325,-1.851297381,0.064126783,0.142418003,39.59925465,0,-0.519824466,0.848854402,-0.612383543,0.540284027,0.662834821,N,-,,AP-3 adaptor complex subunit beta,C:nucleus; C:cytosol; C:AP-3 adaptor complex; P:protein targeting to vacuole; P:Golgi to vacuole transport,IPR002553 (PFAM); IPR026740 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR026740 (PTHR11134:PANTHER); IPR026740 (PTHR11134:PANTHER); IPR026739 (PANTHER); IPR026739 (PANTHER); IPR026740 (PTHR11134:PANTHER); IPR026739 (PANTHER); IPR026739 (PANTHER); IPR016024 (SUPERFAMILY),9.B.278.1.1, the organellar-targeting adaptor protein complex (o-apc) family.
RL4_JR_05827,2952,3457,2735,0,0,35,0,0,0,0,0,0,0,10,0,0,0,0,36.94008513,1,-2.209341863,1.219917798,-1.81105798,0.070131877,0.171168021,10.80732589,0,0.031611444,1.309078256,0.024147864,0.980734664,0.990125301,56.34502339,0,0.203704469,0.839186937,0.242740276,0.808206604,0.874549344,31.8815028,1,-3.021822865,1.261327684,-2.395747673,0.016586504,0.069799815,26.91828152,0,-2.664333432,1.255314052,-2.122443724,0.033800494,0.082584459,N,-,,sequence orphan,C:membrane,PTHR37845 (PANTHER),,
RL4_JR_05828,770,762,869,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,74.12779825,0,0.602833883,0.53455672,1.127726695,0.25943536,0.438830327,11.32791341,0,-0.03632899,1.210931863,-0.030000854,0.976066372,0.987570816,51.62719756,0,-0.284086969,0.853269975,-0.332939137,0.739180226,0.824623759,97.36644621,0,1.26873631,0.463850112,2.735229069,0.006233688,0.033430132,58.55590699,0,-0.122058305,0.755155583,-0.161633321,0.871594616,0.914876165,N,-,,Vacuolar -sorting-associated 36,C:late endosome membrane; P:protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; F:zinc ion binding; F:ubiquitin binding; C:ESCRT II complex; F:phosphatidylinositol-3-phosphate binding,IPR001876 (SMART); IPR011991 (G3DSA:1.10.10.GENE3D); IPR031558 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); IPR007286 (PFAM); IPR021648 (PFAM); PTHR13128:SF12 (PANTHER); PTHR13128:SF12 (PANTHER); PTHR13128 (PANTHER); PTHR13128 (PANTHER); PTHR13128 (PANTHER); PTHR13128:SF12 (PANTHER); IPR021648 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR011991 (SUPERFAMILY); IPR001876 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_05829,303,339,445,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,260.2955153,1,-1.591687511,0.504566528,-3.154564209,0.00160738,0.008701398,176.1392683,0,0.77501411,1.580746144,0.490283727,0.623933141,0.752786194,203.7295714,0,-2.365427065,0.755296017,-3.131788085,0.001737452,0.008848072,250.0737021,0,-2.231105201,0.640869038,-3.481374616,0.000498847,0.004184614,247.8892247,0,-0.627485048,0.464650839,-1.350444239,0.176873528,0.293860388,N,-,,GANP domain-containing,"P:mRNA splicing, via spliceosome",IPR005062 (PFAM); PTHR12436:SF4 (PANTHER); PTHR12436 (PANTHER),3.A.22.1.1, the transcription-coupled trex/tap nuclear mrna export complex (trex) family.
RL4_JR_05830,7431,5964,7760,3,0,10,0,0,2,0,0,16,3,0,5,0,6,0,143.886182,1,-0.618964036,0.737492531,-0.83928177,0.401311211,0.593204722,26.98631505,1,-1.288628863,1.211286589,-1.063851342,0.287396049,0.446854501,85.43874125,1,-2.11069869,1.040870094,-2.027821439,0.042578475,0.10020095,92.48059601,1,-2.0633263,0.872751698,-2.364161887,0.018070914,0.073451628,94.50839735,1,-1.372741354,0.757299976,-1.81267846,0.069881429,0.144722738,N,-,,bud emergence 1,C:nucleus; C:cell division site; C:cell tip; P:cell morphogenesis; P:regulation of establishment or maintenance of cell polarity regulating cell shape; F:phosphatidylinositol binding; C:cytosol; P:phosphorylation; F:kinase activity; P:positive regulation of conjugation with cellular fusion; P:signal transduction involved in conjugation with cellular fusion,IPR001452 (PRINTS); IPR000270 (SMART); IPR001452 (SMART); IPR001683 (SMART); IPR001683 (G3DSA:3.30.1520.GENE3D); G3DSA:3.10.20.240 (GENE3D); IPR001683 (PFAM); IPR001452 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR000270 (PFAM); G3DSA:2.30.30.40 (GENE3D); PTHR10663 (PANTHER); IPR030507 (PTHR10663:PANTHER); PTHR10663 (PANTHER); IPR030507 (PTHR10663:PANTHER); IPR001452 (PROSITE_PROFILES); IPR000270 (PROSITE_PROFILES); IPR001683 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR001683 (SUPERFAMILY); IPR001452 (SUPERFAMILY); IPR001452 (SUPERFAMILY); SSF54277 (SUPERFAMILY),,
RL4_JR_05831,2608,2644,3045,0,2,0,0,0,0,0,0,0,0,0,0,0,3,0,22.54676313,1,-0.277440983,1.02304509,-0.271191354,0.786243862,0.889848586,4.764509144,0,1.213159461,1.256118975,0.965799805,0.334144366,0.497548489,23.43285772,0,-0.477290387,1.199101964,-0.398039867,0.690600799,0.788234779,23.57360447,0,-0.910761571,1.151966652,-0.790614528,0.429168966,0.571604286,34.65413499,1,1.103737627,0.765773307,1.441337294,0.149489416,0.25821006,N,-,,centromere binding B,F:DNA binding,IPR006600 (SMART); IPR006600 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); IPR009057 (G3DSA:1.10.10.GENE3D); PTHR19303 (PANTHER); PTHR19303:SF264 (PANTHER); IPR006600 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY); IPR009057 (SUPERFAMILY),,
RL4_JR_05832,4074,7505,10864,2,4,0,0,0,0,0,0,2,2,4,0,0,4,0,17.42735749,1,-0.388194501,1.139083533,-0.340795464,0.733257566,0.859100276,3.00437023,0,1.878464554,1.269055557,1.480206713,0.13881809,0.260206797,7.793432279,1,-0.773259281,1.192317638,-0.648534632,0.516639219,0.647654216,28.26127005,1,0.54388627,1.008523534,0.539289617,0.589687032,0.713847808,37.49767492,1,2.09773003,0.667023022,3.144913983,0.001661357,0.007263069,N,-,,smp-30 gluconolaconase lre-like region containing,F:hydrolase activity,IPR011042 (G3DSA:2.120.10.GENE3D); IPR013658 (PFAM); PTHR10907 (PANTHER); PTHR10907:SF46 (PANTHER); SSF63829 (SUPERFAMILY),,
RL4_JR_05833,401,629,441,0,0,3,0,0,0,0,0,0,0,3,2,0,1,0,170.4865616,1,0.230159078,0.48051536,0.478983811,0.631950146,0.790713081,49.15038722,0,-0.356622869,1.11544949,-0.319712253,0.74918647,0.84653555,175.3719191,0,0.485078845,0.495492248,0.978983721,0.327588023,0.470625961,184.887216,1,0.626239752,0.545890696,1.147188909,0.251303554,0.390792273,84.75346253,1,-1.442918933,0.791385572,-1.823281827,0.068260717,0.142209828,N,-, Effector probability:0.676,ATP synthase subunit mitochondrial,"C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:integral component of membrane; P:ATP synthesis coupled proton transport",IPR021278 (PFAM); PTHR28074 (PANTHER),,
RL4_JR_05834,10530,7683,9472,2,2,12,0,0,0,1,1,3,2,0,7,0,0,1,80.65843588,1,-0.108385293,0.629504687,-0.172175514,0.863299547,0.932574881,14.70451923,0,-0.41263108,1.2400721,-0.332747652,0.739324776,0.838763213,63.25952563,1,-0.641172618,0.876665382,-0.731376682,0.464549104,0.601495732,62.26498159,1,-1.714451034,1.039986868,-1.648531424,0.099243668,0.194774595,52.44298871,1,-0.532087239,0.782323129,-0.680137425,0.496417449,0.624608758,N,-,,mitochondrial fission process 1,P:ascospore formation; P:pathogenesis,IPR019560 (PFAM); PTHR11001 (PANTHER),,
RL4_JR_05835,2538,2445,4186,2,0,6,0,0,0,0,0,0,0,3,0,0,1,0,462.2514912,1,1.30192664,0.982941096,1.324521526,0.185329899,0.34291706,90.24347661,0,0.614030204,1.261543976,0.486729132,0.626450298,0.754154366,136.7837617,0,-1.838938462,0.911927604,-2.016539969,0.043743543,0.102064907,127.66973,1,-5.023451585,1.2984287,-3.8688698,0.000109341,0.001149613,107.7539773,1,-4.665387567,1.291324979,-3.612868675,0.000302828,0.001761134,N,-,,an1-type zinc finger 1,C:nucleus; F:zinc ion binding; P:proteasome-mediated ubiquitin-dependent protein catabolic process; F:proteasome binding; C:cytoplasm; P:cellular response to arsenic-containing substance,IPR000058 (SMART); IPR000058 (G3DSA:4.10.1110.GENE3D); IPR000058 (PFAM); PTHR14677:SF2 (PANTHER); PTHR14677 (PANTHER); IPR000058 (PROSITE_PROFILES); IPR000058 (PROSITE_PROFILES); SSF118310 (SUPERFAMILY); SSF118310 (SUPERFAMILY),9.B.104.1.8, the rhomboid protease (rhomboid) family.
RL4_JR_05836,22857,25361,36515,3,9,18,10,0,0,1,0,3,1,8,1,0,3,0,61.08373817,1,-4.035072183,1.249162391,-3.230222278,0.00123694,0.006983362,19.74936331,1,-0.838214288,1.263388081,-0.663465407,0.507032527,0.659670301,50.90956804,1,-3.480889283,1.237514328,-2.812807257,0.004911108,0.018726153,68.01156687,1,-2.946425338,1.198318984,-2.458798848,0.01394027,0.063123986,76.62809076,1,-0.417096257,0.734558926,-0.567818648,0.570158116,0.686100656,N,-,,xeroderma pigmentosum group C-complementing,C:nucleotide-excision repair factor 2 complex; P:mycelium development; C:cytoplasm; C:XPC complex; P:nucleotide-excision repair; P:mismatch repair; F:damaged DNA binding; F:single-stranded DNA binding,IPR018328 (SMART); IPR018326 (SMART); IPR018327 (SMART); IPR018325 (PFAM); IPR018327 (PFAM); IPR018326 (PFAM); IPR018328 (PFAM); PTHR12135:SF0 (PANTHER); PTHR12135:SF0 (PANTHER); IPR004583 (PANTHER); IPR004583 (PANTHER); SSF54001 (SUPERFAMILY),,
RL4_JR_05837,2150,3608,2025,0,3,2,0,0,1,0,2,2,1,3,6,0,0,0,14.27536779,1,-1.937839588,1.281953275,-1.511630436,0.130627904,0.26790913,4.662848434,1,1.244352512,1.368937223,0.908991655,0.363354531,0.52789932,11.93244341,1,-1.387821967,1.268906525,-1.093714896,0.274080039,0.412668994,13.75224614,1,-1.808774918,1.276175616,-1.417340134,0.156383507,0.274416465,11.61483097,0,-1.451753874,1.271756353,-1.141534595,0.253647524,0.384492351,N,-,,ring finger,,PTHR22770 (PANTHER); SSF57850 (SUPERFAMILY); SSF57850 (SUPERFAMILY),,
RL4_JR_05838,2122,2907,1723,3,0,16,0,0,0,0,0,4,0,3,0,1,1,4,11.73093053,1,-0.140187003,1.163346786,-0.120503194,0.90408455,0.953456484,2.507302276,0,2.139313166,1.296326476,1.650288879,0.098883866,0.200823132,19.53164998,1,1.297462029,1.046912306,1.239322551,0.215226071,0.343899738,7.540138311,1,-0.941871972,1.209239868,-0.778895897,0.436041041,0.57783455,14.19168333,1,1.051547411,1.003738328,1.047631023,0.294808639,0.429734734,N,-,,Sister chromatid cohesion DCC1,,IPR019128 (PFAM),,
RL4_JR_05839,2452,2800,4238,0,2,4,0,0,0,0,5,10,0,3,2,0,26,2,112.3286645,1,1.925204115,0.564130297,3.41269406,0.000643241,0.004141721,8.752155086,0,0.335935319,1.244940516,0.269840458,0.787282996,0.871568261,42.06308136,1,0.089972271,0.871927985,0.103187732,0.917813976,0.950792516,46.0822763,1,0.279587541,0.708117125,0.394832339,0.692966627,0.79271123,40.68408111,1,-0.155933367,0.849999322,-0.183451167,0.854444032,0.903057392,N,-,,rho guanyl nucleotide exchange factor,P:regulation of Rho protein signal transduction; F:Rho guanyl-nucleotide exchange factor activity; P:positive regulation of GTPase activity,IPR000219 (PFAM); IPR000219 (G3DSA:1.20.900.GENE3D); PTHR12673:SF136 (PANTHER); PTHR12673 (PANTHER); IPR000219 (PROSITE_PROFILES); IPR000219 (SUPERFAMILY),,
RL4_JR_05840,532,1510,1151,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4.143563096,0,-0.153151264,1.242272325,-0.123283165,0.901882871,0.952435012,39.6733891,0,3.976967283,1.142695779,3.480337772,0.000500782,0.015023052,3.442701962,1,0.405642469,1.229497374,0.329925445,0.741456296,0.826492974,3.969629375,0,-0.016025515,1.234419266,-0.01298223,0.98964197,0.993657756,3.365324403,0,0.335312357,1.219540545,0.274949741,0.783354852,0.851655522,N,-,,mitotic spindle checkpoint,F:DNA binding; C:nucleus; C:cytosol,IPR003511 (G3DSA:3.30.900.GENE3D); IPR003511 (PFAM); PTHR11842 (PANTHER); PTHR11842:SF10 (PANTHER); PTHR11842 (PANTHER); PTHR11842:SF10 (PANTHER); IPR003511 (PROSITE_PROFILES); IPR003511 (SUPERFAMILY),,
RL4_JR_05841,41677,46861,58194,8,11,66,1,1,5,4,4,5,9,31,3,0,43,5,384.1049804,1,0.277355176,0.36314432,0.763760194,0.445010162,0.633797644,58.08097402,1,-2.394493221,1.189693147,-2.012698171,0.044146392,0.107004258,259.9772502,1,-0.517191503,0.449022038,-1.151817636,0.249396019,0.384071387,240.8699003,1,-1.415680978,0.495235934,-2.858599065,0.004255162,0.024732214,199.0775278,1,-1.030953502,0.54557204,-1.889674372,0.058801524,0.126511991,N,-,,importin-beta domain-containing,C:nucleus; C:cytoplasm; F:protein transporter activity; P:transcription factor import into nucleus; F:Ran GTPase binding,IPR001494 (SMART); IPR001494 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR10997:SF9 (PANTHER); PTHR10997 (PANTHER); IPR001494 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_05842,51453,53428,70991,7,15,97,3,1,7,12,5,1,7,42,3,1,29,19,51.19419539,1,-1.83112663,1.040299085,-1.760192483,0.078375176,0.185394612,14.06487189,1,-0.348470861,1.240023229,-0.281019624,0.778695349,0.866053655,69.46524076,1,-0.162168725,0.770468835,-0.210480577,0.83329261,0.892347618,63.42254535,1,-0.698969546,0.782570883,-0.893170908,0.371765655,0.517476939,46.64719367,1,-1.382227892,0.988820436,-1.397855304,0.162156523,0.274554313,N,-,,pi31 proteasome regulator,P:biological_process; F:oxidoreductase activity; P:oxidation-reduction process; C:proteasome complex; C:cellular_component; F:molecular_function; P:ubiquitin-dependent protein catabolic process,IPR021625 (PFAM); IPR013886 (PFAM); PTHR13266 (PANTHER),,
RL4_JR_05843,1457,1377,2023,0,0,7,0,0,0,1,9,2,1,8,0,0,2,0,79.85033657,1,-1.911190256,0.880447555,-2.170703122,0.029953621,0.090203633,22.01464368,0,-0.994860607,1.220554231,-0.815089229,0.415021237,0.578708494,97.93562165,1,-0.491102242,0.690167743,-0.711569393,0.476731466,0.613294301,69.5577499,1,-3.115458287,1.158510442,-2.689193101,0.007162497,0.037247193,78.96198845,1,-0.555613267,0.660992442,-0.840574311,0.400586455,0.537738102,N,-,,Zinc CCHC-type,F:binding,IPR001878 (G3DSA:4.10.60.GENE3D); IPR001878 (PROSITE_PROFILES); IPR001878 (SUPERFAMILY),,
RL4_JR_05844,38382,50075,59076,3,3,11,0,0,0,6,0,0,2,9,0,0,13,1,52.8950751,1,-0.244366142,0.790181973,-0.309252996,0.757129084,0.872432934,9.316357766,0,0.245703548,1.24732725,0.196984029,0.843840036,0.907014633,24.23682551,1,-2.410212766,1.215073147,-1.983594791,0.04730103,0.108490175,39.99699845,1,-0.555089475,0.902764515,-0.614877374,0.538635706,0.670150716,24.00024644,1,-2.498777665,1.224935525,-2.039925868,0.04135771,0.096552182,N,-,,btb poz domain-containing,,G3DSA:3.30.710.10 (GENE3D); IPR011333 (SUPERFAMILY),,
RL4_JR_05845,3455,3847,5092,0,1,7,0,0,0,0,0,0,0,9,0,0,4,1,575.9518174,1,-0.261439572,0.398979706,-0.655270352,0.512293706,0.697828027,109.8095328,0,-2.269971203,1.148459452,-1.976535783,0.048094127,0.114275944,479.9716062,0,-0.230519548,0.507914075,-0.453855405,0.649932903,0.75683468,458.6139618,1,-0.882873062,0.43894118,-2.011369862,0.044286404,0.114176173,365.3034078,1,-0.957219862,0.885389175,-1.081128942,0.279639761,0.413275811,N,-,,mitochondrial phosphate carrier,C:integral component of membrane; F:hydrolase activity,PTHR40135 (PANTHER),,
RL4_JR_05846,776,861,962,0,0,4,0,0,0,0,0,3,0,0,0,0,0,0,44.46978984,1,-3.577122817,1.20524029,-2.967974809,0.002997689,0.01438538,14.11772168,0,-0.353972534,1.215952736,-0.291107148,0.770969373,0.861249222,36.78419402,1,-3.012081657,1.201792059,-2.506325145,0.012199338,0.03773483,54.4791517,0,-1.144410028,0.879162746,-1.301704415,0.19301745,0.322257178,40.31277056,0,-2.172965646,1.141722106,-1.903235153,0.057009868,0.123735244,N,-,,serine threonine- phosphatase,F:phosphoprotein phosphatase activity; P:glycogen metabolic process; P:protein dephosphorylation,IPR006186 (PRINTS); IPR006186 (SMART); IPR004843 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); PTHR11668:SF25 (PANTHER); PTHR11668 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_05847,1384,1257,1412,1,1,0,0,0,0,0,0,1,0,0,5,0,3,1,94.54899042,1,0.627708941,0.532430215,1.178950638,0.238417832,0.412760485,22.76340258,0,0.639340124,1.124765937,0.568420596,0.569749409,0.710659706,47.77302696,1,-1.113359588,1.042257421,-1.068219392,0.285421559,0.424698362,120.7128534,1,0.968928769,0.475509683,2.037663591,0.041583588,0.110449587,34.30039151,1,-3.013907836,1.202656139,-2.506042866,0.012209082,0.036922626,N,-,,rho GDP dissociation inhibitor,"C:cellular bud tip; P:regulation of vacuole fusion, non-autophagic; C:cellular bud neck; F:Rho GDP-dissociation inhibitor activity; P:regulation of catalytic activity; C:cytosol; P:actin filament organization",IPR000406 (PRINTS); IPR024792 (G3DSA:2.70.50.GENE3D); IPR000406 (PFAM); IPR000406 (PANTHER); IPR014756 (SUPERFAMILY),,
RL4_JR_05848,3247,2100,2931,0,0,5,0,0,0,0,0,0,0,7,1,0,0,0,111.4213359,1,-4.902219428,1.200012472,-4.085140397,4.41E-05,0.000420306,35.86235254,0,-1.698864109,1.211618331,-1.402144607,0.160872069,0.291661666,134.22197,0,-0.947171195,0.635137202,-1.491285965,0.135886432,0.243618601,220.6928265,1,0.235907298,0.432121316,0.545928399,0.585115156,0.710261474,151.8100435,0,-0.07110638,0.4955613,-0.143486548,0.885905935,0.925102887,N,-,,#NAME?,C:integral component of nuclear inner membrane; P:telomere tethering at nuclear periphery,IPR018004 (SMART); IPR003163 (G3DSA:3.10.260.GENE3D); PTHR38044 (PANTHER); PTHR38044:SF1 (PANTHER); IPR003163 (PROSITE_PROFILES); IPR003163 (SUPERFAMILY),,
RL4_JR_05849,2694,3285,2938,0,0,5,0,0,0,0,0,0,1,0,0,0,0,2,1.740624619,1,1.097861287,1.307524213,0.839648916,0.401105264,NA,0.554877084,0,4.315194753,1.525223212,2.829221795,0.004666135,0.019750253,1.44193755,0,1.660509121,1.23089172,1.349029402,0.177327522,0.297130724,1.663531596,1,1.238229379,1.250782927,0.989963448,0.322191985,0.468504072,1.425205096,1,1.574957416,1.223735298,1.287008243,0.198091415,0.319578645,N,-,,hypothetical protein CHGG_02698,"F:DNA binding; F:sigma factor activity; F:transcription factor activity, sequence-specific DNA binding; P:DNA integration; P:regulation of transcription, DNA-templated; P:DNA-templated transcription, initiation; P:transposition, DNA-mediated",PF13551 (PFAM); PTHR23022 (PANTHER); IPR009057 (SUPERFAMILY),,
RL4_JR_05850,886,859,628,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,16.92581844,0,1.731602533,0.884750978,1.957163741,0.05032822,0.13347777,1.750447302,1,2.657883239,1.348437091,1.971084344,0.048714229,0.115449644,4.525993595,0,0.011014317,1.215662986,0.009060337,0.992770996,0.997097309,17.25533378,1,1.87835274,0.88164467,2.130509949,0.033129535,0.097453964,19.17127983,0,1.628344156,0.983862692,1.655052244,0.097913901,0.188010287,N,-,,chromosome transmission fidelity 18,F:nucleotide binding; P:chromosome organization; C:intracellular membrane-bounded organelle; P:DNA metabolic process; C:chromosomal part,IPR003593 (SMART); IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23389 (PANTHER); PTHR23389:SF3 (PANTHER); PTHR23389:SF3 (PANTHER); PTHR23389:SF3 (PANTHER); PTHR23389 (PANTHER); PTHR23389 (PANTHER); PTHR23389 (PANTHER); PTHR23389:SF3 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_05851,1345,623,1142,0,0,0,0,0,0,0,1,0,0,0,0,0,6,0,0.466399817,0,2.997803726,2.131116381,1.406682316,0.159521612,NA,0.148434355,0,6.217317201,1.992919153,3.119703673,0.001810331,0.015023052,0.386824506,1,3.557998999,1.353446416,2.628843637,0.008567574,0.028931996,0.446309543,0,3.136132768,1.542076644,2.033707455,0.0419811,0.111155502,0.384039814,1,3.466441759,1.301996668,2.662404477,0.007758459,0.025621133,N,-,,bzip transcription factor,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR004827 (SMART); IPR004827 (PROSITE_PROFILES); SSF57959 (SUPERFAMILY),,
RL4_JR_05852,187,157,155,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,119.4909167,1,-1.063861964,0.795519105,-1.337317931,0.18111888,0.338348483,28.30512608,0,-1.357459982,1.238450113,-1.096095812,0.273036847,0.430908872,73.3629318,0,-4.007973906,1.226157503,-3.268726812,0.001080326,0.006127292,84.63995504,1,-4.430431133,1.232145963,-3.595703159,0.000323517,0.002888541,72.07204127,1,-4.085140609,1.228840948,-3.324385157,0.000886137,0.004334367,N,-,,guanine deaminase,F:zinc ion binding; F:guanine deaminase activity; C:cytosol; P:guanine catabolic process,G3DSA:3.20.20.140 (GENE3D); IPR006680 (PFAM); IPR014311 (PTHR11271:PANTHER); PTHR11271 (PANTHER); IPR032466 (SUPERFAMILY),,
RL4_JR_05853,52,47,45,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,535.3660333,0,-1.347778336,0.540394795,-2.494062392,0.012629034,0.04576973,125.1797125,0,-3.502334675,1.225779854,-2.857229757,0.004273564,0.018613172,464.829363,0,-1.338950042,0.544385978,-2.459560119,0.01391074,0.041814824,714.6770145,0,-0.091326504,1.124408715,-0.081221803,0.93526556,0.962317601,394.1753439,0,-1.695237256,0.604321399,-2.805191508,0.005028669,0.017984908,N,-,,fatty acid synthase beta subunit dehydratase,C:fatty acid synthase complex; F:enoyl-[acyl-carrier-protein] reductase (NADH) activity; P:oxidation-reduction process; P:fatty acid biosynthetic process,IPR003965 (PRINTS); IPR020801 (SMART); IPR032088 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); IPR016452 (PIRSF); IPR029069 (G3DSA:3.10.129.GENE3D); IPR029069 (G3DSA:3.10.129.GENE3D); IPR013565 (PFAM); IPR002539 (PFAM); IPR001227 (G3DSA:3.40.366.GENE3D); IPR014043 (PFAM); PF13452 (PFAM); PTHR10982:SF9 (PANTHER); PTHR10982 (PANTHER); IPR029069 (SUPERFAMILY); IPR016035 (SUPERFAMILY); SSF51412 (SUPERFAMILY); IPR016035 (SUPERFAMILY); IPR029069 (SUPERFAMILY),,
RL4_JR_05854,19,2,13,0,7,0,0,0,0,0,0,5,0,8,2,0,8,8,790.9034834,1,-0.528308772,0.417530315,-1.265318357,0.205757229,0.371025767,158.0713775,0,-2.836254931,1.150544677,-2.465141065,0.013695932,0.042866488,539.2920143,1,-1.461479624,0.588529381,-2.483273854,0.013018096,0.03972128,804.0206487,1,-0.270462437,0.934374756,-0.289458202,0.772230762,0.852003537,480.7574781,1,-1.637816213,0.558629866,-2.931845058,0.003369548,0.013006738,N,-,,fatty acid synthase subunit alpha,F:magnesium ion binding; C:fatty acid synthase complex; P:long-chain fatty acid biosynthetic process; P:palmitic acid biosynthetic process; F:fatty acid synthase activity; F:holo-[acyl-carrier-protein] synthase activity,IPR014030 (PFAM); IPR008278 (PFAM); IPR001227 (G3DSA:3.40.366.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR008278 (G3DSA:3.90.470.GENE3D); IPR004568 (TIGRFAM); IPR014031 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR026025 (PIRSF); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10982 (PANTHER); PTHR10982:SF14 (PANTHER); PTHR10982 (PANTHER); IPR004568 (PRODOM); IPR002582 (HAMAP); IPR008278 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016035 (SUPERFAMILY),,
RL4_JR_05855,1050,1091,935,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,14.03402874,0,0.939739625,1.032808774,0.909887337,0.362881929,0.554276498,2.060372676,1,2.422706429,1.337374527,1.811539236,0.070057421,0.153855764,5.310618176,0,-0.219736076,1.214605638,-0.180911457,0.856437076,0.908688308,6.124007409,0,-0.641516256,1.214721687,-0.528117891,0.597417514,0.720101467,5.19857884,0,-0.29200429,1.207699624,-0.241785527,0.808946354,0.870911982,N,-,,H+ symporter,F:inorganic phosphate transmembrane transporter activity; P:transmembrane transport; P:phosphate ion transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); IPR004738 (TIGRFAM); PTHR24064 (PANTHER); PTHR24064 (PANTHER); PTHR24064 (PANTHER); PTHR24064:SF296 (PANTHER); PTHR24064:SF296 (PANTHER); PTHR24064:SF296 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.9.2, the major facilitator superfamily (mfs).
RL4_JR_05856,2963,3464,2977,1,0,10,0,0,2,0,0,0,2,4,3,0,4,1,148.2311668,1,-3.434006573,1.06475858,-3.225150411,0.001259065,0.007093544,42.45278389,1,-1.942300102,1.218417137,-1.594117518,0.110909716,0.219606445,110.9962529,0,-4.605395042,1.218720804,-3.778876202,0.000157538,0.001533569,161.4830154,1,-1.558275804,0.662300452,-2.3528231,0.018631495,0.074340352,170.7648452,1,-0.554002396,0.581415214,-0.952851564,0.340665284,0.478064588,N,-,,homoserine O-acetyltransferase,F:homoserine O-acetyltransferase activity; P:methionine biosynthetic process; C:cytoplasm,IPR008220 (TIGRFAM); IPR000073 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR008220 (PIRSF); PTHR32268:SF13 (PANTHER); PTHR32268 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_05857,26,22,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,274.3731017,0,-0.635728854,1.445217454,-0.439884567,0.660020714,0.809204837,52.72426216,0,-2.254866705,1.212207207,-1.860133063,0.062866702,0.14131396,148.9894011,0,-3.082321685,1.048776592,-2.938968803,0.003293062,0.014520454,212.8385606,0,-1.296261066,0.531962514,-2.436752649,0.014819813,0.065631958,144.9059538,0,-2.778601867,0.865099064,-3.211888652,0.001318655,0.005987166,N,-,,THO complex subunit 2,P:nucleic acid metabolic process; P:cellular macromolecule metabolic process; P:gene expression,IPR021418 (PFAM); IPR032302 (PFAM); IPR021726 (PFAM); PTHR21597 (PANTHER); PTHR21597 (PANTHER); PTHR21597:SF0 (PANTHER); PTHR21597 (PANTHER); PTHR21597:SF0 (PANTHER); PTHR21597:SF0 (PANTHER),3.A.22.1.1, the transcription-coupled trex/tap nuclear mrna export complex (trex) family.
RL4_JR_05858,1952,1485,2103,1,0,10,0,0,2,0,2,1,3,5,0,0,4,0,250.401514,1,-1.317580188,0.501916357,-2.62509912,0.008662375,0.033755122,58.55074079,1,-2.40608669,1.212409494,-1.984549528,0.047194612,0.112586346,212.0818867,1,-1.237174846,0.580558146,-2.131009363,0.033088371,0.082896973,258.2015865,1,-1.337907001,0.538749732,-2.483355298,0.01301512,0.059790422,166.8458719,1,-2.511526015,0.771920623,-3.253606574,0.0011395,0.005308322,N,-,,THO complex subunit 2,P:mRNA export from nucleus; F:nucleic acid binding; P:transcription-coupled nucleotide-excision repair; P:DNA recombination; P:mRNA 3'-end processing; C:nucleoplasmic THO complex; P:transcription elongation from RNA polymerase II promoter,SSF81995 (SUPERFAMILY),,
RL4_JR_05859,410,311,333,0,0,0,0,0,0,0,1,4,0,2,0,0,0,0,20.90477699,0,-2.488185608,1.197066629,-2.078569018,0.037656981,0.107866361,6.719927009,0,0.717094152,1.24847174,0.574377561,0.565712334,0.707804728,17.36340188,1,-1.929011609,1.201965493,-1.604881022,0.108519991,0.205990558,29.66001851,1,-1.400190987,1.153086513,-1.214298295,0.224633836,0.360218181,24.77973503,0,-0.341361121,0.986492528,-0.346035181,0.729316276,0.810119893,N,-,,duf300 domain-containing,C:integral component of membrane,IPR005178 (PFAM); IPR005178 (PANTHER); PTHR23423:SF34 (PANTHER),2.A.82.1.3, the organic solute transporter (ost) family.
RL4_JR_05860,359,331,286,0,0,0,0,0,0,0,0,0,0,5,0,0,0,1,394.9598008,0,-0.058787324,0.495458287,-0.118652419,0.905550734,0.95392339,80.1928866,0,-0.835277991,0.991039531,-0.842830144,0.399323447,0.563338248,279.9111735,0,-0.308013958,0.413963368,-0.744060904,0.45683963,0.595167213,316.4800935,1,-0.669855696,0.413355926,-1.620530044,0.105118466,0.203503722,230.4991706,1,-0.867432914,0.452715394,-1.91606675,0.0553566,0.1210552,Y,-,,Carbohydrate-binding WSC,C:integral component of membrane,IPR002889 (SMART); IPR002889 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); IPR002889 (PROSITE_PROFILES),,
RL4_JR_05861,4086,3779,2772,0,1,3,0,0,1,2,0,0,0,7,0,0,4,0,106.308829,1,2.709644078,0.636766162,4.255320462,2.09E-05,0.00021694,48.50828907,1,3.1948356,1.003632369,3.183272778,0.001456204,0.015023052,28.97308843,1,0.689837333,1.050211156,0.656855842,0.511273614,0.642758484,11.60332459,1,-1.563752027,1.214221098,-1.287864318,0.197793198,0.327990415,17.27910176,1,-0.28448208,1.145528739,-0.248341286,0.803870358,0.867717204,N,-,,phosphatidylinositol-specific phospholipase c,C:membrane; P:lipid metabolic process; C:integral component of membrane; F:phosphoric diester hydrolase activity,IPR017946 (G3DSA:3.20.20.GENE3D); PTHR13593 (PANTHER); PTHR13593 (PANTHER); PTHR13593:SF37 (PANTHER); IPR000909 (PROSITE_PROFILES); IPR017946 (SUPERFAMILY),,
RL4_JR_05862,258692,210930,313865,2,1,221,0,0,0,1,5,3,1,3,8,0,0,3,50.90747002,1,0.687023554,0.676051682,1.01622934,0.309520188,0.497255946,6.164548993,0,0.841579373,1.244269973,0.676363965,0.49880959,0.65325392,39.46503845,1,0.604115487,0.857152957,0.704793097,0.480939005,0.617270092,26.40409636,1,-0.503576663,1.02183022,-0.49281833,0.622140958,0.739687317,23.36158309,1,-0.212246377,0.975524985,-0.217571441,0.827763038,0.884548893,Y,-,,Galactose oxidase beta-propeller,C:membrane; C:integral component of membrane,IPR007567 (PFAM); IPR011043 (SUPERFAMILY),,
RL4_JR_05863,9412,8718,6093,2,1,1,0,0,1,1,0,0,0,3,1,0,0,0,3.844327163,1,-0.045002175,1.213912879,-0.037071997,0.9704276,0.984504494,1.223806834,1,3.174120731,1.365588955,2.324360284,0.020106192,0.057780346,16.17676429,1,2.339841456,1.03468795,2.26139819,0.023734611,0.063830793,3.668052266,1,0.097745526,1.206328093,0.081027315,0.93542023,0.962317601,3.137986753,0,0.436516857,1.205380407,0.362140328,0.717247168,0.800675587,N,-,,hypothetical protein CMQ_3477,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_05864,9017,5828,6873,0,1,2,0,0,0,0,0,0,3,0,0,0,2,0,340.5050229,1,-1.204851204,0.691411913,-1.742595378,0.081404318,0.190887159,78.83528363,0,-2.835246334,1.212399971,-2.338540418,0.019359232,0.056066993,230.4775004,0,-2.686592761,0.790679299,-3.397828634,0.00067923,0.004229102,247.9519031,1,-3.631560315,0.902278935,-4.024875427,5.70E-05,0.000662664,224.3295248,1,-2.444713713,0.718190348,-3.403991325,0.000664089,0.003434064,N,-,,phosphate metabolism 7,C:integral component of membrane,IPR027815 (PFAM); IPR022257 (PFAM); IPR032880 (PFAM); IPR003864 (PFAM); PTHR13018:SF26 (PANTHER); PTHR13018 (PANTHER),1.A.17.5.8, the calcium-dependent chloride channel (ca-clc) family.
RL4_JR_05865,1303,1213,1377,0,0,0,0,0,0,2,0,0,5,1,0,0,2,3,13.52390883,0,-1.859940344,1.200914093,-1.54877052,0.121436895,0.254608632,4.313652801,0,1.356559773,1.26027888,1.076396498,0.281749968,0.440920404,11.20672814,1,-1.297446727,1.203014423,-1.078496402,0.280812287,0.419959308,24.96342267,1,0.574196739,0.872635038,0.658003306,0.510536007,0.64566099,26.51696198,1,1.208023979,0.782868848,1.543073251,0.122813004,0.222930593,N,-,,histone deacetylase,F:magnesium ion binding; C:membrane; C:integral component of membrane; F:transferase activity; P:fatty acid biosynthetic process; F:holo-[acyl-carrier-protein] synthase activity,IPR008278 (PFAM); IPR008278 (G3DSA:3.90.470.GENE3D); IPR008278 (SUPERFAMILY),,
RL4_JR_05866,40,78,68,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,35.64768097,1,0.597258938,0.757017337,0.788963354,0.430133425,0.621292395,5.13971601,0,1.103797889,1.241762274,0.888896299,0.374058815,0.538766411,35.5554425,0,0.854429982,0.856977449,0.997027382,0.318751219,0.461466801,15.42771519,0,-1.974666704,1.196335901,-1.650595542,0.09882119,0.194171269,17.07477152,0,-0.708394616,1.133928126,-0.624726206,0.532150771,0.655507727,N,-,,atp synthase f0,C:membrane,IPR013920 (PFAM); PTHR37992:SF1 (PANTHER); PTHR37992 (PANTHER),,
RL4_JR_05867,2059,2052,2116,0,0,3,0,0,0,0,3,3,1,5,2,0,4,2,40.3433973,1,0.513957456,0.679706219,0.756146466,0.449561385,0.638384992,6.828035328,0,0.694097933,1.242343055,0.558700699,0.576366002,0.715843746,37.12716198,1,0.449579515,0.860074774,0.522721429,0.601168124,0.71932704,60.30504319,1,0.945642479,0.624800974,1.51350993,0.130150181,0.239022397,17.2944062,1,-2.026064385,1.19349057,-1.697595638,0.089584107,0.175748708,N,-,,histone deacetylase HOS3,C:cell part,IPR000286 (PRINTS); IPR023801 (PFAM); IPR023801 (G3DSA:3.40.800.GENE3D); PTHR10625:SF104 (PANTHER); PTHR10625:SF104 (PANTHER); IPR000286 (PANTHER); IPR000286 (PANTHER); SSF52768 (SUPERFAMILY),,
RL4_JR_05868,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49.53004525,0,-0.025112981,0.863865141,-0.029070487,0.976808373,0.98831734,6.161917947,0,0.842088404,1.243055856,0.677434083,0.49813058,0.652767881,16.01733554,0,-1.812685215,1.20225,-1.507743992,0.131620062,0.237865317,18.47904531,0,-2.235110579,1.201657206,-1.860023447,0.062882209,0.140579016,15.83811004,0,-1.899130026,1.209904312,-1.569653077,0.116495843,0.214419271,Y,-,,queuine trna-ribosyltransferase,"F:transferase activity, transferring glycosyl groups; P:queuosine biosynthetic process; P:tRNA processing; F:transferase activity; P:tRNA modification; F:queuine tRNA-ribosyltransferase activity",no IPS match,,
RL4_JR_05869,751,721,378,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,178.8970765,0,-0.342507559,0.7445458,-0.460022149,0.645500323,0.79800127,34.24352327,0,-1.632272682,1.196824905,-1.363835826,0.172619242,0.308102975,95.61627785,0,-3.326876305,1.1951354,-2.783681503,0.005374578,0.019945832,102.8250064,0,-4.711247118,1.196318069,-3.93812251,8.21E-05,0.000901824,88.17722436,0,-4.376115805,1.203104463,-3.637353146,0.000275454,0.001633587,N,-,,queuine tRNA-ribosyltransferase,C:nucleus; P:queuosine biosynthetic process; C:cytosol; P:tRNA modification; F:queuine tRNA-ribosyltransferase activity,IPR002616 (PFAM); IPR002616 (G3DSA:3.20.20.GENE3D); IPR002616 (TIGRFAM); IPR004803 (TIGRFAM); PTHR21148:SF22 (PANTHER); PTHR21148:SF22 (PANTHER); PTHR21148 (PANTHER); PTHR21148 (PANTHER); IPR002616 (SUPERFAMILY),,
RL4_JR_05870,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,224.5903287,0,-1.25651889,0.479805896,-2.618806692,0.008823793,0.034213168,51.79029855,0,-2.229074377,1.198710086,-1.859560876,0.062947679,0.141401777,133.9193358,0,-4.876220578,1.191795537,-4.091490886,4.29E-05,0.000637186,181.7577079,0,-2.565381268,0.744221968,-3.447064692,0.000566713,0.00463037,143.0891673,0,-2.746902335,0.841513602,-3.26423997,0.001097582,0.005142533,N,-,,hypothetical protein CMQ_3779,,no IPS match,,
RL4_JR_05871,1509,1634,2059,0,0,7,0,0,0,1,0,0,2,0,4,0,0,0,152.64797,1,-1.465072429,0.629265898,-2.328224734,0.019900173,0.065166947,42.78026578,0,-0.679309555,1.115547152,-0.608947416,0.542559294,0.688970666,101.0726361,1,-2.427978981,1.037106795,-2.341107968,0.019226606,0.054189911,117.7134982,1,-2.360578322,0.861165856,-2.741142495,0.006122595,0.032904073,85.64820849,0,-4.334140094,1.200602046,-3.609972271,0.00030623,0.001777853,N,-,,37S ribosomal mitochondrial,,IPR016712 (PFAM); PTHR31344 (PANTHER); PTHR31344:SF3 (PANTHER),,
RL4_JR_05872,140,106,246,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,817.5871505,0,0.015531542,0.482601037,0.032182986,0.974326125,0.987036672,132.168866,0,-3.580730253,1.199737238,-2.984595409,0.002839536,0.015349618,455.7017945,0,-1.673421675,0.581083264,-2.879831134,0.003978882,0.016348297,522.4855957,0,-1.468486809,0.593016428,-2.476300386,0.013275184,0.060737114,421.3778281,0,-1.749229823,0.771712877,-2.266684769,0.02340949,0.061692109,N,-,,40S ribosomal s17,F:structural constituent of ribosome; C:cytosolic small ribosomal subunit; P:ribosomal small subunit assembly; P:translation,IPR001210 (G3DSA:1.10.60.GENE3D); IPR001210 (PFAM); IPR001210 (PANTHER); IPR001210 (HAMAP); IPR001210 (SUPERFAMILY),,
RL4_JR_05873,217,304,249,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,75.17764948,0,0.824718146,0.586101126,1.407126022,0.159390023,0.308714105,27.60653945,0,1.95452668,1.005417354,1.943995368,0.05189601,0.121415866,23.05533208,0,-2.338125489,1.204912833,-1.940493474,0.052319747,0.117264803,47.94958957,0,-0.045886801,0.771596187,-0.059469969,0.952577785,0.971988116,30.21465215,0,-1.489406481,1.143541381,-1.302450883,0.192762298,0.313224726,N,-,,rtr1 rpap2 family,,IPR007308 (PFAM); PTHR14732 (PANTHER); PTHR14732:SF0 (PANTHER); IPR007308 (PROSITE_PROFILES),,
RL4_JR_05874,14452,16930,23057,3,2,6,0,0,1,1,3,1,8,38,1,0,8,0,266.7086239,1,0.825741138,0.406396247,2.031862113,0.042167617,0.117247246,69.69643282,1,0.821891679,0.854175801,0.962204358,0.33594696,0.498893065,101.3940637,1,-1.204105442,0.745612271,-1.614921708,0.106327651,0.203080734,160.3841661,1,-0.132676875,0.456596091,-0.290578211,0.771373926,0.851596865,121.86039,1,-0.165483189,0.494269665,-0.334803449,0.737773358,0.816477785,N,-,,sh3 domain-containing,C:cell part,IPR001452 (PRINTS); IPR001452 (SMART); IPR001452 (PFAM); G3DSA:2.30.30.40 (GENE3D); PTHR10663 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY),,
RL4_JR_05875,13959,11760,12752,0,0,14,0,0,0,0,7,5,3,6,2,0,3,6,40.4158473,1,-2.356001119,1.266526475,-1.860206768,0.062856278,0.158022039,50.35414669,0,0.829532462,1.231242639,0.673735977,0.500479185,0.654538938,44.98069027,1,-0.937693108,1.13917004,-0.823137087,0.410430041,0.552552358,35.3036114,1,-3.168918642,1.301383533,-2.43503822,0.014890217,0.065631958,68.30206167,1,0.65174735,1.36097433,0.478882912,0.632021928,0.735120278,N,-,,hypothetical protein SPI_07400,,no IPS match,,
RL4_JR_05876,4849,4881,10640,2,5,13,0,2,0,0,7,2,0,2,0,0,4,0,99.83366141,1,0.419939901,0.568369039,0.738850768,0.45999762,0.648127907,91.1807575,1,1.308671726,1.015938894,1.288140196,0.197697165,0.341071398,79.01452121,1,0.354903874,0.663806143,0.534649878,0.592891986,0.71237105,113.8233765,1,1.032409824,0.565335212,1.826190554,0.067821564,0.147834948,170.281969,1,1.705989534,0.493742194,3.455223305,0.000549837,0.002926973,N,-,,gram domain-containing,C:membrane; C:integral component of membrane,IPR004182 (SMART); IPR004182 (PFAM); IPR031968 (PFAM); PTHR23319 (PANTHER); PTHR23319:SF4 (PANTHER); PTHR23319:SF4 (PANTHER),9.B.198.2.1, the membrane-anchored lipid-binding protein (lam) family.
RL4_JR_05877,5498,5641,5799,2,1,15,0,0,2,0,0,12,2,4,0,0,1,5,161.5303084,1,0.228328248,0.586297872,0.389440691,0.696950176,0.836135226,22.34063384,1,-1.016046499,1.213927778,-0.836990897,0.402597685,0.566378564,103.9251361,1,-0.507177652,0.681529568,-0.744175566,0.456770268,0.595167213,90.63980348,1,-0.815471027,0.650371806,-1.253853595,0.209895225,0.343326196,63.96648395,1,-2.801781048,1.124069387,-2.492533896,0.012683522,0.038050567,N,-,,hypothetical protein CMQ_3906,,PTHR40130 (PANTHER); PTHR40130:SF1 (PANTHER); PTHR40130:SF1 (PANTHER); PTHR40130 (PANTHER),,
RL4_JR_05878,1841,2192,1884,0,1,7,0,0,0,3,3,2,3,5,0,0,0,0,11.70984026,1,1.591209684,1.031533228,1.54256755,0.122935736,0.256892863,1.297798051,0,3.089375626,1.371713376,2.252202013,0.024309509,0.067046553,3.373782194,1,0.434302923,1.21623493,0.35708802,0.721025913,0.810983929,3.892326394,1,0.011895716,1.219277393,0.009756366,0.99221567,0.995065735,3.336217272,0,0.347953733,1.219275396,0.285377474,0.775354963,0.84464737,N,-,,cyclin domain-containing,C:intracellular part,IPR013763 (G3DSA:1.10.472.GENE3D); PTHR10026:SF13 (PANTHER); PTHR10026 (PANTHER); PTHR10026 (PANTHER); PTHR10026:SF13 (PANTHER); IPR013763 (SUPERFAMILY); IPR013763 (SUPERFAMILY),,
RL4_JR_05879,369,497,358,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,143.7208742,0,0.66731906,0.554564214,1.203321533,0.228851919,0.400896276,64.60848738,0,0.82386789,0.993707197,0.82908516,0.40705622,0.570826138,93.43635713,1,-0.359380266,0.692260463,-0.519140244,0.603662946,0.721069644,116.9155018,1,-0.520716122,0.656469645,-0.793206701,0.427657404,0.570266195,51.08211956,0,-3.588547077,1.207325846,-2.972310324,0.002955678,0.011680811,N,-,,translation elongation factor G,F:GTP binding; F:translation elongation factor activity; F:GTPase activity; P:ribosome disassembly; P:translational elongation; C:intracellular,IPR000795 (PRINTS); IPR005225 (TIGRFAM); IPR000640 (G3DSA:3.30.70.GENE3D); G3DSA:3.30.70.870 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PF00009 (PFAM); G3DSA:2.40.30.10 (GENE3D); IPR000640 (PFAM); IPR009022 (PFAM); PTHR23115 (PANTHER); PTHR23115 (PANTHER); PTHR23115:SF66 (PANTHER); PTHR23115:SF66 (PANTHER); PTHR23115:SF66 (PANTHER); PTHR23115:SF66 (PANTHER); PTHR23115 (PANTHER); PTHR23115 (PANTHER); IPR000795 (PROSITE_PROFILES); IPR009022 (SUPERFAMILY); IPR009022 (SUPERFAMILY); IPR009000 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_05880,1149,1034,1614,0,1,1,0,0,0,2,0,0,0,4,0,0,0,0,86.27710002,1,0.962013315,0.500762311,1.921097684,0.054719394,0.142392604,10.84107498,0,0.02707936,1.224543109,0.022113848,0.98235714,0.990676395,64.60242977,1,0.518101228,0.680970805,0.760827372,0.446760183,0.586108604,55.34295042,1,-0.719723902,0.859304002,-0.837566101,0.402274438,0.546128813,35.01762569,0,-1.767528075,1.128605479,-1.566116866,0.11732126,0.215468486,N,-,,Vacuolar sorting-associated 17,"C:nucleus; C:endosome; C:prospore membrane; P:ascospore-type prospore membrane assembly; C:retromer, tubulation complex; C:cytosol; F:protein transporter activity; F:phosphatidylinositol-3-phosphate binding; P:intracellular protein transport; P:retrograde transport, endosome to Golgi",IPR001683 (PFAM); IPR001683 (G3DSA:3.30.1520.GENE3D); IPR015404 (PFAM); PTHR10555:SF136 (PANTHER); PTHR10555 (PANTHER); IPR001683 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_05881,992,1297,2151,0,0,0,0,0,0,0,0,3,0,2,1,0,0,0,1.121550983,0,1.732205554,1.406266288,1.231776349,0.21803264,NA,0.358549361,0,4.945314409,1.630931376,3.032202631,0.002427762,0.015349618,0.928829645,1,2.295630895,1.232799311,1.862128632,0.062584961,0.13463879,1.071428659,1,1.873351413,1.269071838,1.476158682,0.139901298,0.2527209,8.279554147,0,3.150729832,1.127350258,2.794810051,0.005193022,0.018481316,N,-,,alcohol dehydrogenase -like domain-containing,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR011032 (G3DSA:3.90.180.GENE3D); IPR013154 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013149 (PFAM); IPR002085 (PANTHER); PTHR11695:SF418 (PANTHER); PTHR11695:SF418 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_05882,10648,8194,8873,0,0,6,0,0,0,3,4,0,0,3,1,0,2,1,36.66314881,1,0.186977942,0.752925946,0.248335103,0.803875141,0.901349047,6.80090838,0,0.69975296,1.225731883,0.570885827,0.568077039,0.709360447,17.68674277,1,-1.955675775,1.19342592,-1.638707306,0.101274232,0.195630666,20.40679747,1,-2.378225932,1.192110627,-1.994970834,0.046046061,0.116437654,17.48035076,1,-2.041418589,1.200327672,-1.70071776,0.088995999,0.174886165,N,-,,signalosome subunit,,IPR000555 (PFAM); IPR024969 (PFAM); PTHR10540 (PANTHER); PTHR10540:SF8 (PANTHER); PTHR10540 (PANTHER); PTHR10540:SF8 (PANTHER),,
RL4_JR_05883,2580,2651,2336,8,2,7,0,0,0,0,0,4,0,6,1,0,1,1,282.3532347,1,-1.417513697,0.690184736,-2.0538178,0.039993329,0.112621878,66.02316052,0,-2.579398128,1.230234962,-2.09667113,0.036022698,0.091292376,230.4097165,1,-1.452274913,0.644301973,-2.254028349,0.024194385,0.064796445,209.0672087,1,-4.713289679,1.197776796,-3.935031714,8.32E-05,0.000910546,179.7098699,1,-4.395849146,1.189237585,-3.696359082,0.000218714,0.001342106,N,-,,WD domain-containing,C:small-subunit processome; C:cell division site; C:cytosol; C:Pwp2p-containing subcomplex of 90S preribosome; P:rRNA processing; C:mitotic spindle pole body,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR007319 (PFAM); IPR001680 (PFAM); PTHR22840 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR011047 (SUPERFAMILY); SSF63829 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_05884,6506,6264,6583,4,0,20,0,0,0,1,1,0,1,10,1,0,5,0,492.2876202,1,-1.592579485,0.643887391,-2.473382004,0.013384099,0.047826317,115.4872162,0,-3.386067787,1.215209779,-2.786405975,0.005329608,0.021493864,378.7181008,1,-1.764970417,0.534353427,-3.303001962,0.000956557,0.005543786,363.4857271,1,-3.45631409,0.728206258,-4.746339452,2.07E-06,3.48E-05,306.7371851,1,-4.402955642,0.997698452,-4.413112631,1.02E-05,0.000102147,N,-,,cortical actin cytoskeleton asp1,F:inositol hexakisphosphate kinase activity; C:cytoplasm; P:single-organism cellular process; P:phosphate-containing compound metabolic process,IPR029033 (G3DSA:3.40.50.GENE3D); IPR000560 (PFAM); IPR013651 (PFAM); PTHR12750 (PANTHER); IPR029033 (SUPERFAMILY); SSF56059 (SUPERFAMILY),,
RL4_JR_05885,39,16,30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,132.5000366,0,1.917274362,0.382571002,5.011551723,5.40E-07,8.90E-06,19.18164936,0,1.088859517,1.12261381,0.96993241,0.332080184,0.495257938,123.0626174,0,2.138877667,0.427407206,5.004308854,5.61E-07,1.62E-05,58.94334876,0,0.404622909,0.615365779,0.657532353,0.510838675,0.645803669,40.35819375,0,0.063568234,0.740284227,0.085870037,0.93156973,0.955297186,N,-,,transcriptional activator xlnR,F:binding,IPR007219 (SMART); IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR007219 (PFAM); PTHR31313 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_05886,1458,1237,2843,0,0,1,0,0,0,0,0,0,0,5,0,0,0,0,76.83708496,1,-4.36607745,1.209916249,-3.60857824,0.00030788,0.002220762,43.11864828,0,0.496756935,0.99720145,0.498151035,0.618377591,0.749246308,63.51689026,0,-3.800110143,1.202853662,-3.159245603,0.001581781,0.00822883,93.35237334,1,-1.217414745,0.712478771,-1.708703183,0.087505944,0.177128685,77.70570376,0,-2.19161808,0.994393532,-2.203974593,0.027526131,0.070450474,N,-,,myb-like DNA-binding domain-containing,P:cell division; F:DNA binding; F:first spliceosomal transesterification activity; P:generation of catalytic spliceosome for second transesterification step; C:U2-type catalytic step 1 spliceosome; C:Prp19 complex,IPR001005 (SMART); IPR021786 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); IPR009057 (G3DSA:1.10.10.GENE3D); PF13921 (PFAM); PTHR10641:SF559 (PANTHER); PTHR10641:SF559 (PANTHER); PTHR10641 (PANTHER); PTHR10641 (PANTHER); IPR017930 (PROSITE_PROFILES); IPR017930 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY),,
RL4_JR_05887,990,816,1627,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.97402976,0,-0.634117299,0.852879344,-0.743501766,0.457177953,0.645715268,9.079829177,0,0.282827679,1.213716963,0.233026058,0.815741172,0.888606558,39.27907716,0,-0.547156272,1.029561573,-0.531445896,0.595109824,0.714442293,52.90169027,0,0.24925177,0.668135706,0.373055604,0.70910706,0.805122151,34.52383075,0,-0.778520605,0.975103853,-0.79839763,0.424639778,0.559827832,N,-,,set1 complex component ash2,P:biological regulation; P:nucleic acid metabolic process; C:nuclear part; F:methyltransferase activity; C:protein complex; P:histone H3-K4 methylation,IPR003877 (SMART); PTHR10598 (PANTHER); IPR001870 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),1.A.3.1.2," the ryanodine-inositol 1,4,5-triphosphate receptor ca(2+) channel (rir-cac) family."
RL4_JR_05888,3264,2499,3111,0,0,3,0,0,0,0,0,0,0,7,1,0,3,0,31.0041255,1,0.632208785,0.750178588,0.842744374,0.399371424,0.591194352,14.38440257,0,2.058477885,1.121719568,1.835109187,0.066489513,0.147427569,13.00506434,0,-1.512026505,1.193365263,-1.267027416,0.205145487,0.331560171,76.3231069,1,2.112709413,0.492135696,4.29294081,1.76E-05,0.000233063,12.8345434,1,-1.595687211,1.198110442,-1.331836494,0.182913923,0.301531011,N,-,,ring-like domain-containing,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_05889,19065,23618,21866,8,4,18,1,0,4,3,7,6,5,32,0,0,11,0,17.61386524,1,0.301749842,1.024287816,0.294594778,0.768303452,0.878337943,3.17065635,1,1.800667857,1.271836541,1.415801323,0.156833682,0.286133838,8.252539233,1,-0.856021357,1.201765835,-0.712302956,0.476277194,0.61299648,17.54512553,1,0.443415549,1.025626366,0.432336339,0.665496979,0.771750878,8.166698179,1,-0.943512947,1.209504198,-0.780082408,0.435342371,0.570151533,N,-,,DNA repair,P:DNA repair; C:Smc5-Smc6 complex,G3DSA:3.30.60.20 (GENE3D); IPR011513 (PFAM); IPR014857 (PFAM); IPR011513 (PTHR20973:PANTHER); PTHR20973 (PANTHER),,
RL4_JR_05890,2111,1829,1750,0,2,14,0,0,0,7,6,5,7,15,0,0,0,5,2.52861768,1,0.559578173,1.293978622,0.432447773,0.665416003,0.813862632,0.811773735,0,3.766516275,1.483658735,2.538667542,0.011127551,0.036462632,28.08888095,1,3.925769632,0.786673353,4.990342711,6.03E-07,1.73E-05,2.414960414,1,0.701168081,1.256975246,0.55782171,0.576966136,0.703574868,2.048783018,1,1.051540881,1.228474843,0.855972661,0.392012901,0.528442368,N,-,,flavin reductase,F:FMN binding; F:oxidoreductase activity; P:oxidation-reduction process; C:cellular_component,IPR002563 (SMART); IPR002563 (PFAM); IPR012349 (G3DSA:2.30.110.GENE3D); PTHR30466 (PANTHER); PTHR30466:SF6 (PANTHER); IPR012349 (SUPERFAMILY),,
RL4_JR_05891,16,5,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.50500911,0,0.474472438,1.018803277,0.465715461,0.641419184,0.796089716,2.835400906,0,1.962023464,1.286236374,1.525398833,0.12715965,0.243502944,59.55158753,0,2.940620435,0.580769767,5.063315282,4.12E-07,1.23E-05,8.465960073,0,-1.108674827,1.197991687,-0.925444507,0.354734737,0.501072713,7.212135417,0,-0.764137885,1.197300346,-0.638217376,0.523332188,0.64753005,N,-,,"2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase",F:catalytic activity,IPR005000 (PFAM); IPR015813 (G3DSA:3.20.20.GENE3D); PTHR30502:SF6 (PANTHER); PTHR30502 (PANTHER); IPR015813 (SUPERFAMILY),,
RL4_JR_05892,2702,2600,2482,0,4,55,0,0,1,12,6,19,8,48,50,0,39,22,25.12592946,1,-0.510173291,1.029929618,-0.495347722,0.62035469,0.781840501,5.580363938,1,0.985201429,1.251803937,0.787025348,0.431267028,0.593109355,14.45761099,1,-1.66467322,1.202054057,-1.384857204,0.166096135,0.2830428,34.33681612,1,0.22340569,0.866828589,0.257727644,0.79661711,0.868873019,14.21453844,1,-1.743022043,1.202742575,-1.449206238,0.147279996,0.255606781,N,-,,hexokinase family,"F:nucleotide binding; P:carbohydrate metabolic process; P:phosphorylation; P:single-organism cellular process; F:phosphotransferase activity, alcohol group as acceptor; F:kinase activity",PR00475 (PRINTS); IPR022672 (PFAM); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.40.367.20 (GENE3D); IPR022673 (PFAM); IPR001312 (PANTHER); IPR001312 (PANTHER); PTHR19443:SF29 (PANTHER); IPR001312 (PROSITE_PROFILES); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_05893,1165,1653,1659,0,0,5,0,0,0,0,0,0,0,1,0,0,0,2,29.86516281,1,-3.002713979,1.207163549,-2.487412731,0.012867602,0.046469188,9.460653341,0,0.223534283,1.226339714,0.182277618,0.855364862,0.914566224,46.79652525,0,-0.599309911,1.042034661,-0.575134335,0.565200449,0.689657628,28.45284236,1,-2.857709975,1.203335234,-2.374824483,0.017557297,0.072204561,39.14568321,1,-0.826107025,0.991671239,-0.83304526,0.404819204,0.54159546,N,-,,gamma interferon inducible lysosomal thiol reductase,C:integral component of membrane,IPR004911 (PFAM); PTHR13234:SF8 (PANTHER); IPR004911 (PANTHER),,
RL4_JR_05894,14933,19159,26595,0,0,1,0,0,0,1,0,0,0,4,3,0,0,1,41.954279,1,-1.175067432,1.067259179,-1.101014125,0.27089051,0.452389924,8.848278934,0,0.320040877,1.258641245,0.2542749,0.79928319,0.878023957,53.19851507,1,0.47262274,0.798832,0.591642222,0.554090194,0.680943084,45.36886879,1,-0.994252377,1.061233996,-0.93688327,0.348818606,0.49556133,30.45098962,1,-1.498949235,1.171534483,-1.279475131,0.200729792,0.322550253,N,-,,mRNA decapping hydrolase,C:cytoplasm; P:deadenylation-dependent decapping of nuclear-transcribed mRNA; F:hydrolase activity,IPR008594 (PFAM); PF11969 (PFAM); IPR011146 (G3DSA:3.30.428.GENE3D); IPR008594 (PIRSF); IPR008594 (PANTHER); PTHR12978:SF0 (PANTHER); IPR011145 (SUPERFAMILY); IPR011146 (SUPERFAMILY),,
RL4_JR_05895,10,22,37,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,131.9150411,0,2.400464083,0.658808758,3.643643249,0.000268806,0.001980956,6.615571024,0,0.739595952,1.240210829,0.596346955,0.550943469,0.697167399,17.248784,0,-1.919489714,1.205173316,-1.592708442,0.111225613,0.20992694,51.21022026,0,0.705826893,0.696080149,1.01400233,0.31058164,0.456538779,17.08903102,0,-2.008747428,1.215089652,-1.653168081,0.098296661,0.18842572,N,-,,histidinol-phosphatase,P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:histidine biosynthetic process; P:dephosphorylation; C:intracellular part; F:histidinol-phosphatase activity,IPR010140 (TIGRFAM); G3DSA:3.20.20.140 (GENE3D); IPR004013 (PFAM); IPR010140 (PANTHER); IPR016195 (SUPERFAMILY),,
RL4_JR_05896,5238,2956,4517,0,0,4,0,0,0,0,0,2,0,0,0,0,2,0,98.68699878,1,0.995544334,0.501631764,1.984611831,0.047187675,0.127427029,10.77586141,0,0.035755889,1.224583229,0.029198415,0.976706346,0.987831897,34.47784296,1,-1.655561153,1.199376054,-1.380352016,0.167478287,0.284679344,36.28843514,0,-2.093167935,1.153447162,-1.814706389,0.069569043,0.150189031,42.36601332,1,-1.008291555,0.985514198,-1.023112155,0.30625482,0.441336473,N,-,,hypothetical protein CMQ_3599,,no IPS match,,
RL4_JR_05897,9747,5301,6159,0,6,4,0,0,0,2,2,3,0,1,0,0,0,0,0.718100135,1,2.375329499,1.686295216,1.408608336,0.158951012,NA,0.231199674,0,5.578398529,1.791052715,3.11459204,0.001841995,0.015023052,0.596697906,1,2.933918691,1.270502963,2.309257653,0.020929288,0.057562649,4.699697155,1,3.457384538,1.176006735,2.939936003,0.0032828,0.02001105,0.585459725,0,2.857783543,1.23197572,2.319675214,0.020358454,0.055307041,N,-,,---NA---,,no IPS match,,
RL4_JR_05898,2685,2898,5598,0,0,0,0,0,0,0,0,0,0,3,2,0,3,0,0.896741607,0,2.054781947,1.530109569,1.342898566,0.179304821,NA,0.286469453,0,5.269008548,1.704501652,3.091231118,0.001993284,0.015023052,0.743301835,0,2.616484815,1.249945068,2.093279843,0.036324181,0.088576876,0.857453969,1,2.194412244,1.307634353,1.678154324,0.093316976,0.185917824,0.733447551,1,2.533197723,1.22603317,2.066173888,0.038812063,0.091923308,N,-,,---NA---,,no IPS match,,
RL4_JR_05899,5769,5420,5842,4,5,19,0,0,0,2,3,6,1,13,0,0,8,1,2.316055459,1,0.686077289,1.254866468,0.546733303,0.584561971,0.757803362,0.736977752,0,3.905803126,1.454281928,2.685726234,0.007237236,0.026580299,8.413581533,1,2.21347324,1.197598963,1.848259149,0.064564862,0.13813549,2.209255038,1,0.829231526,1.225217924,0.676803294,0.498530768,0.636536217,1.889996391,1,1.168067487,1.211201196,0.96438766,0.334851606,0.471802465,N,-,,hypothetical protein FOTG_16077,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_05900,121,136,186,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,2.200343322,0,0.759861679,1.30180081,0.58370042,0.559421885,0.736695452,0.711185752,0,3.957336585,1.512387823,2.616614949,0.008880646,0.030837014,1.830411304,0,1.316950899,1.245392813,1.057458245,0.290302501,0.429870195,2.110471621,1,0.89532936,1.263438729,0.708644859,0.478544891,0.619045231,1.790455393,0,1.245519123,1.22957731,1.012965279,0.311076746,0.44665601,N,-,,hypothetical protein K432DRAFT_430554,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_05901,1391,1206,1137,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0.455629452,1,3.031694651,2.068132261,1.465909463,0.142672954,NA,0.146851962,0,6.233247989,1.95494662,3.188449202,0.001430381,0.015023052,0.378585161,0,3.590596775,1.299400034,2.763272805,0.005722492,0.020990763,0.436560952,0,3.168651043,1.464005967,2.164370306,0.030435941,0.093257059,0.370889289,0,3.516191691,1.23993702,2.83578249,0.004571357,0.016607459,Y,-,,hypothetical protein K432DRAFT_447799,"F:DNA binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated",no IPS match,,
RL4_JR_05902,1534,1443,1305,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.612448354,0,0.512134421,1.275067655,0.401652743,0.687939608,0.830085982,0.843446142,0,3.711237977,1.474126263,2.517584871,0.01181625,0.038163395,2.172993611,0,1.069346237,1.238223244,0.863613441,0.387800278,0.531774349,2.505594753,0,0.64767649,1.250977135,0.517736473,0.604642147,0.725441609,2.128301858,0,0.996172054,1.22596735,0.812560019,0.416470362,0.552438414,N,-,,beta-tubulin cofactor d,C:microtubule cytoskeleton; C:cytoskeletal part; P:cellular component organization; P:single-organism cellular process,IPR011989 (G3DSA:1.25.10.GENE3D); IPR022577 (PFAM); PTHR12658 (PANTHER); IPR033162 (PTHR12658:PANTHER); IPR033162 (PTHR12658:PANTHER); PTHR12658 (PANTHER); PTHR12658 (PANTHER); IPR033162 (PTHR12658:PANTHER); PTHR12658 (PANTHER); IPR033162 (PTHR12658:PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_05903,4,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_05904,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.5808722,0,1.321266484,1.008861174,1.309661346,0.190310425,0.350226134,1.583410852,0,2.802509505,1.337716086,2.094995742,0.036171371,0.091623277,27.62782684,0,2.562792643,0.851001773,3.011500943,0.002599596,0.012201349,14.04015155,0,0.681044701,1.143105546,0.595784618,0.551319121,0.680339751,22.97980973,0,2.694089515,0.746110591,3.610844759,0.000305201,0.001773917,N,-,,glycosyl hydrolase,F:catalytic activity,IPR005198 (PFAM); IPR012341 (G3DSA:1.50.10.GENE3D); PTHR12145 (PANTHER); PTHR12145:SF14 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_05905,1243,965,587,0,0,0,0,0,0,0,0,0,1,5,0,0,2,0,288.215111,0,-1.594125381,0.483605573,-3.296333768,0.000979556,0.005828749,71.07594237,0,-2.685756821,1.201432032,-2.235462971,0.02538697,0.069338076,208.9750705,0,-2.920440497,0.859645249,-3.397262417,0.000680637,0.004232657,233.3785239,1,-3.033138614,0.756356,-4.010199711,6.07E-05,0.000702009,195.4572282,1,-2.8017399,0.760595277,-3.683614644,0.00022995,0.001400867,N,-,,dynein heavy chain,F:ATPase activity; F:ATP binding; F:microtubule motor activity; C:cytoplasm; C:integral component of membrane; C:dynein complex; P:microtubule-based movement; C:microtubule,IPR003593 (SMART); IPR011704 (PFAM); IPR024743 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR004273 (PFAM); IPR013602 (PFAM); PF12774 (PFAM); IPR024317 (PFAM); IPR013594 (PFAM); PF12781 (PFAM); PF12775 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10676:SF28 (PANTHER); PTHR10676:SF28 (PANTHER); PTHR10676:SF28 (PANTHER); IPR026983 (PANTHER); IPR026983 (PANTHER); IPR026983 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_05906,1248,1115,1736,0,0,2,0,0,0,1,0,0,0,2,0,0,3,0,160.4592971,1,-4.405356911,1.137700454,-3.872158877,0.000107876,0.000912287,48.71957937,0,-2.140908437,1.190890932,-1.797736787,0.072218729,0.157440873,170.6620654,1,-1.385476832,0.608326169,-2.277522984,0.022755014,0.061596727,229.6393953,1,-0.782655028,0.42579059,-1.838121947,0.066044438,0.145480761,153.8810422,1,-2.227759471,0.742852127,-2.998927231,0.00270932,0.01092903,N,-,,mutator-like element,C:integral component of membrane,no IPS match,,
RL4_JR_05907,809,633,1492,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,23.33392731,1,0.626343666,0.858829771,0.729298969,0.465818803,0.654183129,3.777720746,0,1.547969265,1.25473965,1.233697576,0.217315617,0.364545688,50.87446757,0,1.727025443,0.74153641,2.328982664,0.019859984,0.055312924,63.48253137,0,2.385005319,1.321715226,1.804477449,0.071156491,0.152866428,20.92865935,1,0.485540832,0.980141365,0.49537837,0.62033306,0.726532358,N,-,,Spc97 Spc98 family,C:microtubule cytoskeleton; C:cytoskeletal part; P:microtubule cytoskeleton organization,IPR007259 (PFAM); IPR007259 (PANTHER); PTHR19302:SF27 (PANTHER); PTHR19302:SF27 (PANTHER); PTHR19302:SF27 (PANTHER); IPR007259 (PANTHER),,
RL4_JR_05908,1828,967,892,1,0,11,0,0,0,0,0,0,0,0,0,0,1,0,64.39135011,1,0.814495131,0.683918313,1.190924582,0.233683193,0.407173748,5.776453904,0,0.93527608,1.23638757,0.756458657,0.449374251,0.609890878,15.03326094,0,-1.721206763,1.197567118,-1.437252859,0.150646158,0.263176451,59.07361835,0,1.71385334,0.539930151,3.174213065,0.001502434,0.010412142,29.60534956,1,-0.115704914,0.983606957,-0.117633282,0.906358233,0.939964878,N,-,,letm1,F:ribosome binding; C:membrane; C:integral component of membrane,IPR011685 (PFAM); PTHR14009 (PANTHER); PTHR14009:SF6 (PANTHER); IPR033122 (PROSITE_PROFILES),2.A.97.1.1, the mitochondrial inner membrane k(+)/h(+) and ca(2+)/h(+) exchanger (letm1) family.
RL4_JR_05909,25996,21205,25714,1,0,69,0,0,3,0,12,15,16,43,6,0,17,9,122.8202275,1,-1.553520565,0.699550841,-2.220740044,0.026368574,0.082073568,29.08195449,1,-1.396557135,1.208508892,-1.155603525,0.247843366,0.401130564,75.55458392,1,-4.050484371,1.202194138,-3.369243154,0.000753749,0.004599732,135.4806427,1,-0.753204321,0.57048387,-1.320290301,0.186738113,0.314700964,89.40880551,1,-2.439565663,0.990678053,-2.462521156,0.013796403,0.040630769,N,-,,RNA-binding (Nab3),F:organic cyclic compound binding; F:heterocyclic compound binding; P:ncRNA metabolic process; P:gene expression,IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR13968:SF1 (PANTHER); PTHR13968 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),9.A.60.1.1, the small nuclear rna exporter (snrna-e).
RL4_JR_05910,4576,4021,6664,0,1,1,0,0,0,0,0,0,0,2,0,0,0,1,2.041072969,1,0.868061379,1.34502533,0.645386641,0.518676658,NA,0.655129007,0,4.075617827,1.540556456,2.645549154,0.008155844,0.029019308,1.696735473,0,1.425876995,1.262084306,1.129779515,0.258569142,0.394953831,1.956949158,1,1.00393536,1.287646241,0.779667061,0.435586872,0.577700632,1.673030955,1,1.343462869,1.254661204,1.070777406,0.284269528,0.418590601,N,-,,Alpha beta-hydrolase,P:proteolysis; F:aminopeptidase activity; F:hydrolase activity,IPR000073 (PFAM); G3DSA:1.20.1440.110 (GENE3D); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR17630 (PANTHER); PTHR17630:SF54 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_05911,14384,13554,10093,10,8,4,0,0,4,0,0,1,0,1,0,0,0,0,11.75196732,1,-1.657179458,1.236500382,-1.340217506,0.180174642,0.337124938,3.705177295,1,1.575881501,1.293731381,1.218090188,0.223189702,0.37187262,9.690916407,1,-1.087744445,1.225682936,-0.887459892,0.374831351,0.51876563,11.1852495,1,-1.510791933,1.228008283,-1.230278291,0.218592911,0.353611315,9.634042369,0,-1.181875979,1.239265746,-0.953690508,0.340240326,0.477583106,N,-,,peptidyl-tRNA hydrolase ICT1,P:translational termination; F:translation release factor activity; F:hydrolase activity,IPR000352 (PFAM); G3DSA:3.30.160.200 (GENE3D); SSF75620 (SUPERFAMILY),,
RL4_JR_05912,7280,5565,6170,2,5,10,0,0,0,0,1,1,0,2,1,0,5,6,130.9122605,1,1.7281654,0.634208516,2.724916735,0.00643177,0.026702485,10.8889331,0,0.020673346,1.217399679,0.01698156,0.986451327,0.993421755,71.35033481,1,0.512238367,0.681044043,0.752136916,0.451968726,0.591561911,65.33078803,1,-0.310206466,0.75511148,-0.410808833,0.681212716,0.783175634,95.80801715,1,1.572417662,0.492438421,3.193125468,0.001407418,0.006313737,N,-,,Calcium calmodulin-dependent kinase type I,F:ATP binding; F:protein serine/threonine kinase activity; P:protein phosphorylation,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24347:SF246 (PANTHER); IPR020636 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.2, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_05913,1051,1418,1700,2,2,26,0,0,0,3,0,8,3,7,3,0,8,14,168.4457402,1,-0.225969684,0.721009107,-0.31340753,0.753971064,0.871231719,31.89083812,0,-1.529529174,1.204519783,-1.269824867,0.204147021,0.348958669,205.6414541,1,0.472617013,0.437701997,1.07976892,0.280245095,0.419580204,303.0545108,1,1.278496218,0.334770334,3.819024827,0.00013398,0.00136887,300.4604908,1,1.535547987,0.648142409,2.369152159,0.017828917,0.049825499,N,-,,pap2 superfamily,F:inositol phosphoceramide synthase activity; C:inositol phosphoceramide synthase complex; C:integral component of membrane; P:inositolphosphoceramide metabolic process; P:sphingolipid biosynthetic process,IPR000326 (SMART); IPR026841 (PFAM); IPR000326 (G3DSA:1.20.144.GENE3D); PTHR31310:SF7 (PANTHER); PTHR31310 (PANTHER); IPR000326 (SUPERFAMILY),,
RL4_JR_05914,17869,18195,22775,10,9,17,0,5,0,1,3,1,2,13,4,0,1,0,244.383889,1,-3.688290367,0.897583826,-4.109131936,3.97E-05,0.000382972,120.7035015,1,0.154907231,0.700489076,0.221141538,0.824982228,0.894725181,211.2384269,1,-3.56825455,1.043872175,-3.418286871,0.000630166,0.003996829,235.2580353,1,-4.086111738,1.030230457,-3.966211357,7.30E-05,0.000818792,213.560411,1,-2.35230939,0.698682766,-3.36677746,0.00076052,0.003832886,N,-,,dna-directed rna polymerase i subunit,P:translational termination; F:translation release factor activity; F:hydrolase activity,IPR013240 (PFAM),,
RL4_JR_05915,622,503,622,5,2,5,0,0,3,0,1,0,0,5,1,0,6,2,51.08899664,1,-1.816577881,1.013694706,-1.792036468,0.073127125,0.17635192,13.82884005,1,-0.324106136,1.203528131,-0.269296685,0.787701383,0.87156902,35.93282065,1,-2.978262734,1.189587893,-2.503608814,0.012293387,0.037956161,45.46883771,1,-2.453476861,1.141828112,-2.148726972,0.031656049,0.095162398,47.05558996,1,-0.860158943,0.848658093,-1.013551807,0.310796664,0.446420233,N,-,,RNA processing,C:heterochromatin; P:RNA metabolic process; C:nuclear chromatin; P:gene expression; P:cellular component organization or biogenesis,IPR032319 (PFAM); PTHR12755:SF10 (PANTHER); PTHR12755 (PANTHER); PTHR12755 (PANTHER); PTHR12755:SF10 (PANTHER),,
RL4_JR_05916,3166,4899,7128,0,3,1,0,0,0,0,0,0,0,3,1,0,1,0,42.58164891,1,-3.514556245,1.184136958,-2.968031882,0.002997132,0.01438538,13.60669249,0,-0.300728481,1.205689121,-0.249424562,0.803032388,0.880733972,35.28093182,0,-2.951865385,1.187841241,-2.485067265,0.012952696,0.039615493,40.69849866,1,-3.374126268,1.186620717,-2.843474938,0.004462452,0.025642636,46.35421915,1,-0.827590132,0.841206568,-0.983813208,0.325207364,0.461412843,N,-,,proline iminopeptidase,P:proteolysis; F:aminopeptidase activity; F:peptidase activity; F:hydrolase activity,PR00420 (PRINTS); G3DSA:3.30.9.10 (GENE3D); IPR029058 (G3DSA:3.40.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR000073 (PFAM); IPR002938 (PFAM); PTHR13789 (PANTHER); PTHR13789:SF87 (PANTHER); IPR029058 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_05917,12069,13005,19573,0,1,19,0,0,5,4,0,0,0,8,0,0,3,0,1.020440765,1,1.868470523,1.469718593,1.271311754,0.203617762,NA,0.328303285,1,5.072538164,1.676062229,3.026461713,0.002474342,0.015349618,24.37601743,1,4.83851254,0.866539567,5.583717956,2.35E-08,9.17E-07,0.976924769,1,2.006638492,1.297837625,1.546139866,0.122070793,0.227158018,8.195945494,1,3.289467226,1.133787241,2.901309088,0.003716071,0.014065504,N,-,,glycosyl hydrolase family 3 n terminal domain-containing,F:beta-glucosidase activity; C:extracellular region; P:cellulose catabolic process; F:scopolin beta-glucosidase activity,IPR001764 (PRINTS); IPR001764 (PFAM); IPR002772 (G3DSA:3.40.50.GENE3D); IPR001764 (G3DSA:3.20.20.GENE3D); IPR002772 (PFAM); PTHR30620:SF5 (PANTHER); IPR026892 (PANTHER); IPR026892 (PANTHER); IPR026892 (PANTHER); PTHR30620:SF5 (PANTHER); IPR017853 (SUPERFAMILY); IPR002772 (SUPERFAMILY),,
RL4_JR_05918,2157,1954,2186,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2.460638174,0,0.59877982,1.266272332,0.472868122,0.636307269,0.792413799,0.781478952,0,3.821215768,1.451405566,2.632769129,0.00846919,0.029683219,9.875199406,0,2.127769585,1.202736745,1.769106659,0.076876077,0.158073239,2.344869538,1,0.743346424,1.233397483,0.60268197,0.546720278,0.676799464,2.006899239,0,1.081539378,1.219448614,0.88690853,0.375128149,0.511400633,Y,-,,integral membrane,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_05919,705,1069,2087,0,0,12,0,0,1,0,0,2,0,3,3,0,3,0,0.020162965,1,7.530309459,3.959361818,1.901899802,0.057184255,NA,0.006518434,1,10.72863192,3.595247881,2.984114664,0.002844002,0.015349618,0.016737713,1,8.093068843,2.110155252,3.835295453,0.000125413,0.001330907,0.019298012,1,7.668814375,3.959262975,1.936929783,0.052753927,0.126422133,0.016299842,1,8.024147024,1.467629563,5.467419861,4.57E-08,1.23E-06,,,,,,,,
RL4_JR_05920,1053,1087,1113,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0.65691196,0,2.504083134,1.963367778,1.275401971,0.202167001,NA,0.206613951,0,5.740476165,1.930442799,2.973657737,0.002942731,0.0154422,0.53951309,0,3.079600117,1.381389662,2.229349329,0.025790671,0.068191369,0.622748466,1,2.656302054,1.530979799,1.735034032,0.082734778,0.17002022,0.533892793,0,2.992422439,1.340968575,2.231538079,0.025645508,0.066699401,N,-, Effector probability:0.596,---NA---,,no IPS match,,
RL4_JR_05921,277,704,376,0,0,2,0,0,0,0,2,0,0,4,0,0,3,0,151.7961427,1,0.88651044,0.594446614,1.491320532,0.135877361,0.275469063,16.77483413,0,-0.602687076,1.208126759,-0.498860796,0.617877454,0.748821312,184.9840866,1,1.803210765,0.394220161,4.574121119,4.78E-06,0.000100447,168.8055314,1,1.355777948,0.380641027,3.561828208,0.000368281,0.003220077,80.70838028,1,0.27251773,0.555388524,0.49067944,0.62365319,0.729077515,N,-,,snare-dependent exocytosis,C:cell division site; C:cell tip; F:transmembrane transporter activity; C:membrane; P:transport,IPR001680 (SMART); IPR013905 (PFAM); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR10241:SF25 (PANTHER); PTHR10241 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR017986 (SUPERFAMILY),1.F.1.1.3, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_05922,3439,3750,3857,0,0,4,0,0,0,0,0,4,5,2,0,0,0,0,0.431685457,1,3.109742433,2.137476458,1.454866285,0.145706283,NA,0.138221406,0,6.32069005,1.982880824,3.187629823,0.00143444,0.015023052,0.357123007,1,3.6755905,1.31191232,2.801704385,0.005083343,0.019174279,0.411916632,1,3.252823043,1.494897551,2.175950479,0.029558964,0.09145458,0.349981743,0,3.601525087,1.248700245,2.884219091,0.003923857,0.014703571,N,-,,---NA---,,no IPS match,,
RL4_JR_05923,5510,5920,8120,0,2,4,0,0,0,0,2,2,0,7,1,0,0,0,40.99889327,1,4.361577214,0.557480701,7.823727723,5.13E-15,3.35E-13,0.904484881,0,3.610420418,1.435080891,2.5158306,0.011875225,0.038329408,2.335671251,1,0.965222218,1.219067986,0.791770623,0.428494435,0.569002841,2.693635777,1,0.543304224,1.225665802,0.443272728,0.657568479,0.766683654,2.292196223,0,0.889220545,1.208255811,0.735953874,0.461758769,0.592861722,N,-,,general substrate transporter,P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane; P:anion transport,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662 (PANTHER); PTHR11662:SF311 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_05924,5656,4270,4825,1,0,0,0,0,0,0,0,2,0,2,0,0,1,0,0.136064732,1,4.775231484,3.504618202,1.362553981,0.17302312,NA,0.043102383,0,8.001318516,2.472298546,3.236388473,0.001210525,0.015023052,0.112353941,1,5.342170104,1.437087614,3.717358672,0.000201317,0.001766143,0.129652933,1,4.919916883,2.101608463,2.341024491,0.019230906,0.075464879,0.111289062,1,5.255431384,1.28428714,4.092099983,4.27E-05,0.000339739,,,,,,,,
RL4_JR_05925,18710,5293,19273,3,0,2,2,0,0,0,0,0,0,2,2,0,2,1,16.15754303,1,-0.177038289,1.161751219,-0.152389157,0.878880009,0.941268208,2.603940045,1,2.084774045,1.309415368,1.592141117,0.111353,0.220302107,6.758682745,0,-0.567934221,1.215030284,-0.467423922,0.640196611,0.749289074,17.10881104,1,-0.038479068,1.162042257,-0.033113312,0.973584227,0.984893994,28.77164046,1,1.598104131,0.871091863,1.834598851,0.066565149,0.139596548,N,-, Effector probability:0.908,domain-containing partial,P:negative regulation of transcription from RNA polymerase II promoter in response to iron; C:cytosol,IPR002634 (PFAM); IPR002634 (PIRSF); IPR002634 (G3DSA:3.30.300.GENE3D); PTHR12735 (PANTHER); PTHR12735:SF27 (PANTHER); IPR002634 (SUPERFAMILY),,
RL4_JR_05926,27824,13743,25007,0,3,0,0,0,0,0,1,0,4,4,0,0,15,2,80.70403128,1,0.684427267,0.565909272,1.209429321,0.22649795,0.397978656,34.65988425,0,0.761516934,1.107444854,0.68763418,0.491683178,0.647348742,39.88746599,1,-1.851267031,1.187001405,-1.559616546,0.118850524,0.220172499,50.2911978,1,-1.501306916,1.009208758,-1.487607895,0.13685433,0.2483689,53.70314804,1,-0.666608115,0.837412807,-0.796032864,0.426012934,0.560775355,N,-,,histone chaperone asf1,"P:positive regulation of histone acetylation; P:transcription, DNA-templated; P:regulation of transcription from RNA polymerase II promoter in response to stress; P:histone exchange; P:DNA replication-independent nucleosome assembly; P:nucleosome disassembly; P:chromatin silencing at telomere; P:DNA replication-dependent nucleosome assembly; P:positive regulation of transcription elongation from RNA polymerase II promoter; C:chromosome, telomeric region; C:nucleus; F:histone binding; C:cytosol; P:histone acetylation; P:chromatin silencing at silent mating-type cassette; P:histone H2B ubiquitination",IPR017282 (PIRSF); IPR006818 (PFAM); IPR006818 (G3DSA:2.60.40.GENE3D); PTHR12040:SF0 (PANTHER); IPR006818 (PANTHER); IPR006818 (SUPERFAMILY),,
RL4_JR_05927,5504,7482,8809,0,3,19,0,0,0,0,8,4,8,4,1,0,0,2,164.0971303,1,-0.911905929,0.51853321,-1.758625892,0.078641072,0.185849903,36.07046575,0,-1.707254347,1.193540819,-1.430411361,0.152598989,0.280175398,93.81385141,1,-4.362759493,1.192257039,-3.659244065,0.00025296,0.002044019,154.9464719,1,-0.907620792,0.524291101,-1.731139037,0.083426969,0.171026132,111.6920371,1,-1.83568657,0.764291211,-2.401815623,0.016313929,0.046476795,N,-,,mrna 3 -end-processing rna-14,C:nucleus; C:cytoplasmic part; P:mRNA processing,IPR003107 (SMART); IPR008847 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR19980 (PANTHER); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY),,
RL4_JR_05928,13167,9512,13638,0,6,6,0,0,0,3,1,17,0,4,2,6,4,0,0.213821567,1,4.122977524,2.943582329,1.400666624,0.161313788,NA,0.067457711,0,7.354756454,2.30579327,3.189685975,0.001424275,0.015023052,0.176739772,1,4.687249215,1.429081312,3.279903793,0.001038425,0.005939556,0.203991729,1,4.265585598,1.870814353,2.280068886,0.022603603,0.080997621,0.1763459,1,4.589890649,1.320563138,3.475707079,0.000509508,0.002751346,N,-,,piwi domain-containing,"P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:heterochromatin assembly involved in chromatin silencing by small RNA; P:co-transcriptional gene silencing by RNA interference machinery; P:production of siRNA involved in chromatin silencing by small RNA; P:translational initiation; P:chromatin silencing at telomere; C:mating-type region heterochromatin; P:negative regulation of transcription from RNA polymerase II promoter; C:chromosome, telomeric region; F:translation initiation factor activity; P:chromatin silencing at centromere; C:RITS complex; P:regulation of histone H3-K9 methylation; C:nuclear pericentric heterochromatin; F:single-stranded RNA binding; P:mitotic sister chromatid segregation; C:cytosol; F:endoribonuclease activity, producing 5'-phosphomonoesters; P:conversion of ds siRNA to ss siRNA involved in RNA interference; C:ARC complex; P:chromatin silencing at silent mating-type cassette; C:nuclear subtelomeric heterochromatin",IPR003100 (SMART); IPR003165 (SMART); IPR014811 (SMART); IPR014811 (PFAM); IPR012337 (G3DSA:3.30.420.GENE3D); IPR003165 (PFAM); IPR032473 (PFAM); G3DSA:3.40.50.2300 (GENE3D); IPR032474 (PFAM); IPR003100 (PFAM); G3DSA:2.170.260.10 (GENE3D); IPR032472 (PFAM); PTHR22891 (PANTHER); PTHR22891:SF0 (PANTHER); PTHR22891:SF0 (PANTHER); IPR003100 (PROSITE_PROFILES); IPR003165 (PROSITE_PROFILES); IPR003100 (SUPERFAMILY); IPR012337 (SUPERFAMILY),,
RL4_JR_05929,818,600,1061,1,14,2,0,0,0,0,0,0,0,2,0,0,0,0,3.400144753,1,0.132264343,1.228008721,0.107706355,0.914228628,0.958277932,1.08242271,0,3.351262853,1.390001221,2.410978351,0.015909793,0.048287533,47.09035891,0,3.762981616,1.205439494,3.121667768,0.001798298,0.009089348,3.242444451,1,0.275835086,1.214427455,0.227131793,0.820321263,0.887082429,2.770919263,0,0.616070615,1.208633812,0.509724789,0.610244283,0.717955307,N,-,,---NA---,,no IPS match,,
RL4_JR_05930,1640,1535,1958,0,1,4,0,0,0,0,2,0,0,0,0,0,0,0,37.37781432,1,1.954350741,0.627501673,3.11449487,0.001842602,0.009794345,3.381433696,0,1.707868865,1.272766951,1.341855132,0.179642972,0.317670539,42.00334991,1,1.477193514,0.858988393,1.719689725,0.085488856,0.171316149,10.14617472,0,-1.370021168,1.20305313,-1.13878692,0.254792039,0.394219039,8.683311975,0,-1.031937185,1.209105428,-0.853471634,0.393397812,0.53009753,N,-,,ngg1 interacting factor,C:cytoplasm,G3DSA:3.40.1390.30 (GENE3D); G3DSA:3.40.1390.30 (GENE3D); IPR002678 (TIGRFAM); IPR002678 (PFAM); PTHR13799:SF13 (PANTHER); IPR002678 (PANTHER); IPR002678 (SUPERFAMILY),,
RL4_JR_05931,1924,1424,2973,0,2,9,0,0,0,0,0,6,0,1,1,0,0,2,4.272255937,1,-0.1974627,1.232953681,-0.160154191,0.872759614,0.939046053,1.354682151,0,3.027454002,1.364981111,2.217945713,0.026558534,0.071820861,3.531517116,1,0.368406911,1.218429034,0.302362223,0.762375949,0.840070998,4.075124025,1,-0.054280571,1.221881935,-0.044423745,0.964566635,0.979562405,10.86614313,1,1.217540147,1.14646068,1.061999044,0.288236119,0.422648907,N,-,,vacuolar sorting-associated 51 67,P:biological_process; F:molecular_function,PF08700 (PFAM); PTHR15954 (PANTHER); IPR014812 (PTHR15954:PANTHER),,
RL4_JR_05932,1211,1020,1220,1,0,13,0,0,0,0,1,0,0,3,1,0,0,3,3.290819973,1,0.178961229,1.272159034,0.140675202,0.888126536,0.945379342,1.046264971,0,3.400140013,1.428241147,2.380648409,0.017282198,0.051344411,2.725737426,1,0.741946433,1.239032723,0.598811007,0.549298921,0.676480582,3.144996393,1,0.319430578,1.249504118,0.255645879,0.798224289,0.870157292,2.702857721,1,0.651677885,1.243452036,0.524087673,0.600217562,0.710036548,N,-,,mediated genome instability rmi1,C:RecQ helicase-Topo III complex,IPR013894 (PFAM); PTHR14790 (PANTHER),,
RL4_JR_05933,14046,14558,16162,3,3,22,0,0,2,0,6,3,0,16,5,0,2,5,99.16516681,1,-0.798770957,0.610193428,-1.309045494,0.190518941,0.350351794,23.0454707,1,-1.060898001,1.198386189,-0.88527222,0.376009829,0.540544169,59.87358603,1,-3.71485975,1.191852438,-3.116878928,0.001827766,0.009215291,82.40330034,1,-2.402915725,1.016717972,-2.363404396,0.018107898,0.073513299,89.25594671,1,-0.597951065,0.630896847,-0.947779447,0.343241746,0.480215929,N,-,,antiviral,"P:nuclear-transcribed mRNA catabolic process, non-stop decay; C:Ski complex; P:nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay",IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR019734 (PFAM); PF13432 (PFAM); PTHR15704:SF7 (PANTHER); PTHR15704 (PANTHER); PTHR15704:SF7 (PANTHER); PTHR15704 (PANTHER); IPR013026 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY),,
RL4_JR_05934,4612,2998,2910,8,6,1,0,0,0,0,0,1,0,1,0,0,2,1,223.809441,1,-1.810482189,0.737350472,-2.455388932,0.014073223,0.049917112,52.73510209,0,-2.255193516,1.231544949,-1.831190586,0.067072101,0.148566701,138.2211663,1,-4.921852695,1.234880379,-3.985691877,6.73E-05,0.000900612,171.5914487,1,-3.090511129,0.946232494,-3.266122384,0.001090311,0.007930604,164.7155202,1,-1.755845931,0.786292113,-2.233070767,0.025544278,0.06652083,N,-,,pre-rRNA processing utp22,C:nuclear part; C:preribosome; C:protein complex,IPR005554 (PFAM); IPR005554 (PANTHER),,
RL4_JR_05935,1542,1344,1536,0,2,3,0,0,0,0,0,1,0,3,0,0,2,0,37.07577042,1,-0.445177739,1.004114086,-0.443353743,0.657509888,0.806975428,14.79775625,0,1.943863624,1.123977783,1.72945022,0.083728549,0.176158879,14.04524498,1,-1.623089809,1.191778142,-1.361906005,0.173227551,0.292092075,29.84828963,1,-0.311090679,1.012134593,-0.307360978,0.758568626,0.842312279,13.83791623,1,-1.704375967,1.19396791,-1.427488923,0.153439016,0.263227725,N,-,,GTPase-activator for ras-like GTPase containing,P:small GTPase mediated signal transduction; F:GTPase activator activity; C:intracellular; P:positive regulation of GTPase activity,IPR001936 (SMART); IPR001936 (PFAM); IPR000593 (PFAM); IPR001936 (G3DSA:1.10.506.GENE3D); PTHR14149 (PANTHER); PTHR14149:SF17 (PANTHER); IPR001936 (PROSITE_PROFILES); SSF143885 (SUPERFAMILY); IPR008936 (SUPERFAMILY),,
RL4_JR_05936,9109,10091,12808,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,12.29859223,1,-1.722767075,1.231838655,-1.398533053,0.161953054,0.312343503,3.880137311,0,1.509321273,1.286536847,1.17316599,0.240729248,0.392614291,10.14345,1,-1.153582943,1.222333492,-0.943754672,0.345295029,0.489038171,11.7072282,0,-1.57659009,1.224203973,-1.287849186,0.197798467,0.327990415,25.16491964,1,0.955720366,0.899298659,1.062739676,0.287900023,0.422284088,N,-,,hypothetical protein MGU_10677,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",no IPS match,,
RL4_JR_05937,68,171,85,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,92.52446597,0,-0.318518211,0.651523104,-0.488882449,0.624924922,0.785174421,18.28744771,0,-0.727317987,1.223278513,-0.594564508,0.552134611,0.698501003,93.2529681,0,0.047504394,1.26776333,0.037471027,0.970109441,0.982665778,96.84656212,0,0.000318036,0.607891758,0.000523178,0.999582564,0.999582564,47.45769008,0,-3.482351488,1.224330672,-2.844290001,0.004451052,0.016275514,N,-,,hypothetical protein SPBR_06726,P:regulation of actin cortical patch localization; C:nucleus; C:cellular bud; C:cell division site; C:cell tip; P:actin cortical patch internalization; C:mating projection tip; C:cytosol; P:protein localization to actin cortical patch; P:endocytosis; P:actin cortical patch assembly; C:actin cortical patch,IPR018556 (PFAM); PTHR13357 (PANTHER); PTHR13357:SF1 (PANTHER),,
RL4_JR_05938,4579,5334,4422,0,0,6,0,0,0,0,0,7,2,3,8,0,0,4,2.617297226,1,0.509591285,1.279630895,0.398233027,0.690458423,0.832103414,0.845588122,0,3.707620875,1.477999367,2.508540232,0.012123116,0.039017546,2.17588747,1,1.067595275,1.240053282,0.860926938,0.389278284,0.532735336,2.508839145,1,0.645948157,1.253259759,0.515414424,0.606263455,0.72665442,2.126996366,1,0.997127256,1.225623295,0.81356748,0.415892774,0.551889166,N,-,,AAT family amino acid transporter,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_05939,1506,1100,1434,5,0,4,0,0,0,0,0,0,1,2,0,0,0,1,11.05415179,1,1.834307083,1.058160866,1.733486033,0.083009318,0.193581826,1.104004436,0,3.322908046,1.440278286,2.30712917,0.02104762,0.059961726,2.839417763,0,0.683635387,1.239088057,0.55172462,0.58113704,0.703000808,3.273880344,1,0.262008194,1.248164,0.209914878,0.83373411,0.895842668,2.772933737,1,0.614640546,1.227133693,0.500874965,0.616459123,0.723274143,N,-,,hsp70 family chaperone,F:nucleotide binding; F:ATP binding,G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); PTHR19375 (PANTHER); PTHR19375:SF213 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),9.A.41.1.1, the capsular polysaccharide exporter (cps-e) family.
RL4_JR_05940,159,131,111,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.46254912,0,-0.794358807,1.22787336,-0.64693871,0.517671611,0.702478138,2.085538138,0,2.405203523,1.351928845,1.779090321,0.075224955,0.162559137,5.367666207,0,-0.235143182,1.22409337,-0.192095789,0.847667173,0.902496502,6.189278358,0,-0.65680723,1.225651716,-0.53588407,0.592038675,0.715577364,35.77430424,0,3.083510751,0.625027686,4.933398667,8.08E-07,1.21E-05,N,-,,iron zinc ion transporter ( ),C:membrane,IPR007251 (PFAM),9.A.9.1.1, the low affinity fe(2+) transporter (fet) family.
RL4_JR_05941,625,466,359,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,33.73315629,1,-2.058829209,1.163245089,-1.769901483,0.076743554,0.182380753,76.42663547,0,2.453030544,0.857051195,2.862175048,0.004207445,0.018435165,24.690017,0,-2.436856758,1.204058652,-2.023868815,0.042983651,0.100756306,28.48938527,0,-2.859518758,1.204729075,-2.373578275,0.017616659,0.072301852,24.38401661,1,-2.521610663,1.210339644,-2.083390953,0.037215602,0.089016767,N,-,,MFS transporter,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502:SF12 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.64, the major facilitator superfamily (mfs).
RL4_JR_05942,96,74,74,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,74.49865741,0,-4.321455061,1.191302886,-3.627503224,0.000286175,0.002095707,23.72890916,0,-1.103054775,1.19607113,-0.922231753,0.356407704,0.520646381,61.60798909,0,-3.756055864,1.18933102,-3.158124863,0.001587875,0.008248153,109.7596754,0,-0.650095462,0.572875589,-1.134793443,0.256461874,0.395774497,60.7573714,0,-3.838756473,1.192047616,-3.220304643,0.001280544,0.005872061,N,-,,c2h2 finger domain containing,F:zinc ion binding; P:positive regulation of ATPase activity; P:regulation of cell size; C:cytosolic large ribosomal subunit; P:rRNA processing; C:nucleolus; P:endocytosis; F:ATPase activator activity; F:nucleic acid binding; P:ribosomal subunit export from nucleus; P:mycelium development; P:ribosomal large subunit biogenesis; C:mitochondrion,IPR001623 (PRINTS); IPR001623 (SMART); IPR003604 (SMART); IPR015880 (SMART); IPR001623 (PFAM); IPR001623 (G3DSA:1.10.287.GENE3D); IPR022755 (PFAM); PTHR24078:SF169 (PANTHER); PTHR24078 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR001623 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); IPR001623 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_05943,6617,5210,6499,0,0,1,0,0,0,0,4,5,0,2,2,0,7,1,168.7218318,1,-2.070225818,0.711884049,-2.908094121,0.003636389,0.01676026,42.6955676,0,-1.950475927,1.214611806,-1.60584305,0.108308399,0.215152652,129.6357957,1,-2.197864017,0.874281962,-2.51390754,0.011940173,0.037091842,145.6447232,1,-3.261276934,1.03152438,-3.161609165,0.001569,0.010814244,138.7265507,1,-1.119022596,0.607466124,-1.842115224,0.065458297,0.138060373,N,-,,ring-14,F:zinc ion binding; C:cytosol,IPR001841 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR004331 (PFAM); PF15227 (PFAM); PTHR23327:SF11 (PANTHER); PTHR23327 (PANTHER); PTHR23327:SF11 (PANTHER); PTHR23327 (PANTHER); IPR004331 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),3.A.20.1.2, the peroxisomal protein importer (ppi) family.
RL4_JR_05944,3940,4049,4736,0,4,14,0,0,0,0,0,0,0,3,0,0,0,0,235.0875547,1,0.003650165,0.418083533,0.008730706,0.993033993,0.997382756,55.97435,0,-0.11295778,0.992990339,-0.113755165,0.909431881,0.949547243,96.67984818,0,-4.406175439,1.198201461,-3.677324374,0.000235693,0.001962448,119.5575725,1,-3.107883753,1.02844203,-3.02193382,0.002511655,0.016024261,95.52923011,0,-4.491658456,1.204911827,-3.727790163,0.000193166,0.001209528,N,-,,cystathionine gamma-synthase,F:catalytic activity,IPR015421 (G3DSA:3.40.640.GENE3D); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR000277 (PFAM); PTHR11808:SF52 (PANTHER); IPR000277 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_05945,3149,4215,4389,0,3,8,0,0,0,1,0,0,0,0,0,0,0,0,188.2830507,1,1.318416569,0.753953684,1.748670504,0.080347991,0.188844401,34.8954127,0,1.083593173,1.016520744,1.065982352,0.28643162,0.445971521,63.7885071,1,-0.78421565,0.868501568,-0.902952486,0.366551113,0.510659621,79.28086382,0,-0.563229231,0.695318235,-0.810030864,0.417922437,0.561202212,66.70549145,0,-0.622671673,0.756235073,-0.823383753,0.410289799,0.546243816,N,-,,cystathionine gamma-synthase,C:membrane; C:integral component of membrane,PTHR35006 (PANTHER); PTHR35006 (PANTHER); PTHR35006:SF2 (PANTHER); PTHR35006:SF2 (PANTHER),,
RL4_JR_05946,10411,10393,12520,5,6,22,0,0,0,5,5,3,11,13,3,0,7,4,0.055239214,1,6.075263902,3.926031742,1.547431173,0.121759309,NA,0.01803347,0,9.259077449,3.029038685,3.056770947,0.002237352,0.015045494,0.046236723,1,6.622903908,1.773439882,3.734495867,0.000188092,0.001695672,0.053290366,1,6.202465871,3.054184749,2.030808999,0.042274374,0.111655196,0.045160658,1,6.548003867,1.397771063,4.684603968,2.81E-06,3.47E-05,N,-,,---NA---,,no IPS match,,
RL4_JR_05947,3,17,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,198.5906683,0,-4.726856533,1.142566027,-4.137053284,3.52E-05,0.000341659,60.75473297,0,-2.459416197,1.187656307,-2.070814748,0.038376111,0.095864511,177.2472044,0,-2.709008233,0.850005623,-3.187047426,0.001437332,0.007642621,194.0269414,0,-3.228668122,0.850271147,-3.797221783,0.000146327,0.001480079,155.6754999,0,-5.196180501,1.194560661,-4.34986742,1.36E-05,0.000130362,N,-, Effector probability:0.555,nucleolar essential 1,"C:small-subunit processome; P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:protein homodimerization activity; P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA base methylation; C:nuclear microtubule; C:cytosol; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:rRNA (pseudouridine) methyltransferase activity; C:nucleolus; C:90S preribosome; F:rRNA binding",IPR005304 (PFAM); PTHR12636:SF5 (PANTHER); IPR005304 (PANTHER); IPR029028 (SUPERFAMILY),,
RL4_JR_05948,51,49,70,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35.57141803,0,3.212746243,0.609889848,5.26774835,1.38E-07,2.66E-06,1.593288658,0,2.793417349,1.340578864,2.083739662,0.037183854,0.093672219,4.15168718,0,0.135050398,1.213035789,0.111332575,0.911352625,0.945906841,36.88338171,0,3.371560768,0.593248229,5.683220959,1.32E-08,3.60E-07,38.85757456,0,3.732233642,0.613167243,6.08681185,1.15E-09,6.74E-08,Y,-, Effector probability:0.647,ribosomal s17,F:structural constituent of ribosome; C:ribosome; P:translation,PTHR34587:SF2 (PANTHER); PTHR34587 (PANTHER),,
RL4_JR_05949,36989,23439,31277,8,3,2,0,0,2,3,0,6,1,1,0,0,14,0,84.50208848,1,-2.64564725,1.028366666,-2.572669201,0.010091761,0.038115088,24.4011401,1,-1.143392952,1.199475074,-0.953244445,0.340466232,0.503609411,70.02657063,1,-2.838555892,1.195643421,-2.374082307,0.017592628,0.050670774,81.32592623,1,-2.50076255,1.024857281,-2.440108098,0.014682868,0.065631958,62.85777849,1,-3.887794632,1.202420412,-3.233307248,0.001223659,0.005641869,N,-,,ribosomal s17,F:structural constituent of ribosome; C:ribosome; P:translation,IPR000266 (PFAM); G3DSA:2.40.50.140 (GENE3D); IPR000266 (PANTHER); PTHR10744:SF1 (PANTHER); IPR000266 (PRODOM); IPR000266 (HAMAP); IPR012340 (SUPERFAMILY),,
RL4_JR_05950,23627,11254,19409,0,1,0,0,0,0,0,1,1,0,1,5,0,7,2,116.3417623,1,-3.074929157,1.005749222,-3.057351764,0.002233021,0.011421445,33.46802999,0,-1.599183386,1.197258102,-1.335704794,0.181645782,0.320596095,155.085617,1,-0.258047723,0.50830329,-0.507664869,0.61168839,0.727358851,177.3101128,1,-0.15097186,0.423531,-0.356459999,0.721496103,0.814125493,111.57356,1,-1.381980727,0.668799261,-2.066361026,0.038794403,0.091902979,N,-,,aaa family ATPase,F:nucleotide binding,IPR003593 (SMART); IPR015415 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003959 (PFAM); PTHR23074 (PANTHER); PTHR23074:SF86 (PANTHER); IPR027417 (SUPERFAMILY),1.R.1.1.1, the membrane contact site (mcs) family.
RL4_JR_05951,164,127,72,0,0,1,0,0,0,0,0,0,3,4,0,0,0,0,40.57711139,1,0.177581503,0.8856708,0.20050509,0.841085577,0.919782325,5.279339342,0,1.065079464,1.264380704,0.842372444,0.399579512,0.563542403,26.76006084,0,0.219959094,1.058640892,0.207774983,0.835404667,0.89413558,78.49101645,1,2.024214231,0.553928143,3.654290281,0.000257894,0.00238464,13.6527059,0,-1.684905895,1.226535726,-1.373711224,0.169531351,0.284189558,N,-,,oligomeric Golgi complex subunit 6,F:nucleotide binding; C:nucleus; C:Golgi transport complex; C:cell division site; C:membrane; P:protein transport; C:cytosol; P:intra-Golgi vesicle-mediated transport,IPR010490 (SMART); PF06419 (PFAM); IPR010490 (PANTHER),,
RL4_JR_05952,1276,1361,1395,0,0,5,0,0,0,0,11,15,4,8,6,0,9,0,182.0012604,1,1.04318739,0.364885976,2.858940763,0.004250582,0.018966711,20.69509259,0,-0.905686052,1.206460071,-0.75069708,0.452834981,0.612370832,90.60980069,1,-0.413461407,0.673161719,-0.614208139,0.539077796,0.667517564,108.4637843,1,-0.097277781,0.522818993,-0.186063976,0.852394591,0.907897583,60.02777427,1,-2.69843727,1.120476471,-2.408294454,0.016027248,0.045788908,N,-,,autophagy Apg9,C:cytoplasmic vesicle membrane; P:piecemeal microautophagy of nucleus; P:late nucleophagy; P:protein localization to pre-autophagosomal structure; C:pre-autophagosomal structure; C:fungal-type vacuole membrane; C:mitochondrion; C:integral component of membrane; P:protein homooligomerization; C:endomembrane system; P:mitophagy; P:CVT pathway,IPR007241 (PFAM); PTHR13038:SF10 (PANTHER); IPR007241 (PANTHER),9.A.15.1.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_05953,1994,2379,2238,0,1,0,0,0,0,0,0,3,0,0,0,0,0,0,242.5156416,1,-0.865985125,0.479597921,-1.805648205,0.070973308,0.172681254,48.59541968,0,-2.137215353,1.208105027,-1.7690642,0.076883161,0.165262287,178.9490191,1,-1.152663276,0.599199043,-1.923673425,0.054395531,0.120594139,181.5341781,0,-2.138416774,0.685129585,-3.121185864,0.001801243,0.012117998,149.2425576,0,-1.912592273,0.684130839,-2.795652766,0.005179502,0.018459153,N,-,,nuclear import and export,P:nuclear export; P:intracellular protein transport; F:Ran GTPase binding; C:intracellular,IPR011989 (G3DSA:1.25.10.GENE3D); PTHR11223:SF3 (PANTHER); PTHR11223:SF3 (PANTHER); PTHR11223 (PANTHER); PTHR11223 (PANTHER); IPR001494 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),9.A.50.1.1, the nuclear t-rna exporter (t-exporter) family.
RL4_JR_05954,23705,29287,29681,4,1,7,0,0,0,0,2,1,1,5,1,0,15,1,77.82146555,1,0.21351636,0.59515992,0.358754602,0.719778677,0.850635514,22.39223585,0,0.680021802,1.122242088,0.605949295,0.544548424,0.691063082,33.91288687,1,-2.894826929,1.199833805,-2.412689921,0.015835285,0.046495483,79.10402193,1,0.001947619,0.638027722,0.003052561,0.997564412,0.998254564,68.34509836,1,0.70014088,0.614238346,1.139852118,0.254347916,0.385231511,N,-,,negative acting factor,"P:regulation of transcription, DNA-templated",PTHR38791 (PANTHER); PTHR38791:SF3 (PANTHER),,
RL4_JR_05955,2699,2143,2336,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,73.77257799,0,-0.379366218,0.675202996,-0.561855057,0.574214777,0.749991058,14.77072636,0,-0.41919037,1.217999492,-0.344163009,0.7307237,0.831981493,45.01729845,0,-2.116722222,1.20433605,-1.757584374,0.078818254,0.160878227,56.48556562,0,-1.214504677,0.885556232,-1.371459691,0.170231701,0.292481923,57.46626747,0,-0.276396196,0.733225066,-0.376959557,0.70620366,0.792278345,N,-, Effector probability:0.927,hypothetical protein CMQ_1974,C:integral component of membrane,PTHR42077 (PANTHER),,
RL4_JR_05956,333,251,289,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,234.5017804,0,0.640748893,0.349395494,1.833878526,0.066672028,0.165074534,31.1991164,0,-1.497897481,1.203515387,-1.244601854,0.213278139,0.359860197,190.8958742,0,0.291577788,0.474958552,0.613901543,0.53928039,0.667686764,154.3297878,0,-0.520074536,0.496677285,-1.047107553,0.295049976,0.439620289,90.79827312,0,-2.015964538,0.842157309,-2.39380994,0.016674387,0.04727756,N,-,,transport SEC24,C:endoplasmic reticulum membrane; F:zinc ion binding; P:ER to Golgi vesicle-mediated transport; C:cytosol; C:Golgi membrane; C:endoplasmic reticulum exit site; P:intracellular protein transport; C:COPII vesicle coat,IPR029006 (G3DSA:3.40.20.GENE3D); IPR006895 (PFAM); IPR006900 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); IPR012990 (PFAM); IPR007123 (PFAM); G3DSA:2.60.40.1670 (GENE3D); IPR006896 (PFAM); PTHR13803:SF4 (PANTHER); PTHR13803 (PANTHER); IPR007123 (SUPERFAMILY); SSF81995 (SUPERFAMILY); IPR002035 (SUPERFAMILY); IPR006895 (SUPERFAMILY); IPR006900 (SUPERFAMILY),,
RL4_JR_05957,385,285,335,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,165.8803373,0,0.441252919,0.4506972,0.979045175,0.327557659,0.51706954,44.46307231,0,-0.076344234,1.129253952,-0.067605904,0.946099356,0.971140622,85.77862866,0,-1.230445014,0.864881756,-1.422674262,0.154830605,0.268596293,156.4440126,0,0.378250066,0.467906903,0.808387445,0.418867577,0.562024147,75.2598178,0,-0.803942651,0.69520291,-1.156414393,0.247511697,0.37764556,N,-,,mitogen-activated kinase,F:ATP binding; P:MAPK cascade; F:MAP kinase activity; C:intracellular,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); PTHR24055 (PANTHER); PTHR24055:SF217 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_05958,737,466,383,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,92.60753328,0,0.277625623,0.559425484,0.496269175,0.619704511,0.781764585,50.73451477,0,2.311889723,0.786824064,2.938254977,0.003300654,0.016310876,66.61224434,0,0.225705935,0.688276919,0.327928961,0.742965375,0.827296685,72.72847193,0,0.18006765,0.599573367,0.300326299,0.763928275,0.845885147,41.17530258,0,-1.309668654,0.97675503,-1.340836354,0.17997359,0.297507363,N,-,,oxidation resistance 1,C:mitochondrion; P:cellular response to oxidative stress; P:tetrapyrrole biosynthetic process; F:uroporphyrinogen-III synthase activity,IPR006571 (SMART); IPR006571 (PFAM); PTHR23354 (PANTHER),,
RL4_JR_05959,296,224,434,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,216.3277291,0,1.598874718,0.863857803,1.850854057,0.064190552,0.160153648,44.81045182,0,1.58879559,0.855014156,1.858209691,0.063139242,0.141765063,71.85212595,0,-0.421856775,0.737103179,-0.572317128,0.567107148,0.691400863,205.3857834,0,1.481889613,0.638824938,2.319711588,0.020356485,0.077468176,57.1920141,0,-1.640932386,0.962485818,-1.704889938,0.088214953,0.173787544,N,-,,uroporphyrinogen-III synthase,P:heme biosynthetic process; P:tetrapyrrole biosynthetic process; F:uroporphyrinogen-III synthase activity,G3DSA:3.40.50.10090 (GENE3D); IPR003754 (PFAM); PTHR12390 (PANTHER); IPR003754 (SUPERFAMILY),,
RL4_JR_05960,7933,6111,13511,3,0,2,0,0,0,0,0,0,0,7,2,0,2,0,131.1027361,1,1.394290663,0.888572079,1.569136252,0.116616194,0.247490872,20.73276355,0,0.876542382,1.127643194,0.77732246,0.436968547,0.598429933,42.33296994,0,-0.866409879,1.035934609,-0.836355762,0.402954792,0.545025292,43.14516813,1,-2.157667505,1.145590076,-1.883455129,0.059638715,0.136354635,32.6608238,1,-1.831465665,1.120604074,-1.634355709,0.102184183,0.194111604,N,-,,augmenter of liver regeneration,C:mitochondrion; P:oxidation-reduction process; F:thiol oxidase activity; P:cellular process,IPR017905 (PFAM); IPR017905 (G3DSA:1.20.120.GENE3D); PTHR12645 (PANTHER); PTHR12645:SF0 (PANTHER); IPR017905 (PROSITE_PROFILES); IPR017905 (SUPERFAMILY),,
RL4_JR_05961,1007,675,1447,0,3,0,0,0,0,0,0,0,0,1,0,0,0,2,8327.039325,1,2.03236582,0.780805691,2.602908565,0.00924366,0.035637892,1560.043059,0,0.980801617,0.779894516,1.257608044,0.208533543,0.35388156,1810.832766,0,-1.610237588,0.620573124,-2.594758821,0.009465731,0.031327579,1647.527033,1,-3.952052985,0.440659933,-8.968487241,3.01E-19,2.72E-17,1458.725105,1,-3.154133564,0.502309056,-6.279268769,3.40E-10,2.15E-08,N,-,,pyruvate decarboxylase,F:magnesium ion binding; F:thiamine pyrophosphate binding; F:RNA binding; F:carboxy-lyase activity,IPR029035 (G3DSA:3.40.50.GENE3D); IPR012000 (PFAM); IPR029061 (G3DSA:3.40.50.GENE3D); IPR012001 (PFAM); IPR011766 (PFAM); IPR012110 (PIRSF); IPR029061 (G3DSA:3.40.50.GENE3D); PTHR18968 (PANTHER); IPR012110 (PTHR18968:PANTHER); IPR029061 (SUPERFAMILY); IPR029035 (SUPERFAMILY); IPR029061 (SUPERFAMILY),,
RL4_JR_05962,50,47,46,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27.28116683,0,-2.872212268,1.192001437,-2.409571145,0.015971282,0.054929897,8.679846573,0,0.347807047,1.217607839,0.285647839,0.775147859,0.86389251,22.57044063,0,-2.30744974,1.192823229,-1.934444002,0.053058561,0.118448703,26.04095976,0,-2.729967322,1.191851695,-2.290526021,0.021990842,0.080340747,22.31016397,0,-2.393402038,1.19975668,-1.994906199,0.046053111,0.105233074,N,-,,thump domain containing,C:nucleus; F:RNA binding; C:cytoplasm; F:oxidoreductase activity; P:oxidation-reduction process; F:thiol oxidase activity; P:tRNA modification,IPR004114 (PFAM); PTHR13452 (PANTHER); PTHR13452 (PANTHER); PTHR13452:SF10 (PANTHER); PTHR13452:SF10 (PANTHER); IPR004114 (PROSITE_PROFILES); SSF143437 (SUPERFAMILY),,
RL4_JR_05963,97,110,96,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30.04192856,0,0.346394827,1.029322663,0.33652696,0.736473525,0.861136737,3.178179821,0,1.797400925,1.299429437,1.383223186,0.166596443,0.299944716,8.206746601,0,-0.8476468,1.211813,-0.699486472,0.484248064,0.62018057,18.77763052,0,-0.318110579,1.160047757,-0.274221968,0.783914047,0.86067336,8.040811918,0,-0.921090718,1.20822752,-0.762348732,0.445851896,0.578511344,N,-,,hypothetical protein SPI_08745,,no IPS match,,
RL4_JR_05964,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37.27058757,0,-1.268662731,1.023769981,-1.239206808,0.21526892,0.38346339,9.423579266,0,0.22918964,1.220980982,0.187709426,0.85110444,0.911496572,24.52215884,0,-2.427106441,1.197516932,-2.026782566,0.042684654,0.100377978,90.90116753,0,1.063329955,0.534498583,1.989397144,0.046657385,0.117601698,24.26595464,0,-2.514643939,1.205605175,-2.085793916,0.036997295,0.088606696,N,-,,regulatory factor Sgt1,C:intracellular part,IPR010770 (PFAM); IPR010770 (PANTHER),,
RL4_JR_05965,9,2,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,52.94836787,0,-2.774288099,1.158120253,-2.395509526,0.016597283,0.056534712,54.16706604,0,0.408925474,1.131998696,0.361242001,0.717918547,0.823336906,47.2935722,0,-2.19950387,1.203882442,-1.827008844,0.06769844,0.142936184,75.94808294,0,-1.227709959,0.871040356,-1.409475404,0.158694641,0.277318475,62.73308677,0,-0.304394346,0.693202536,-0.439113145,0.660579555,0.757974614,N,-,,DNA repair,C:nucleus; F:ATP binding; P:chromosome organization; C:Smc5-Smc6 complex; F:double-stranded DNA-dependent ATPase activity; P:double-strand break repair via homologous recombination; P:resolution of recombination intermediates,IPR027417 (G3DSA:3.40.50.GENE3D); IPR003395 (PFAM); IPR027132 (PTHR19306:PANTHER); IPR033268 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_05966,449,371,471,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,116.0258122,0,-0.010750819,0.573143612,-0.018757636,0.98503445,0.992332803,66.19548189,0,2.079955405,0.714639151,2.910497419,0.003608539,0.017053643,58.24868378,0,-2.504758517,1.209088647,-2.071608665,0.038301951,0.092347929,103.4445764,0,-0.542170853,0.66292215,-0.817849959,0.413442867,0.557033803,110.3766415,0,0.601924469,0.545462722,1.10351165,0.269805035,0.40202737,N,-,,ubiquinone biosynthesis mitochondrial precursor,C:mitochondrion; P:ubiquinone biosynthetic process,IPR012762 (TIGRFAM); IPR013718 (PFAM); PTHR21427 (PANTHER),,
RL4_JR_05967,496,367,455,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,280.6023288,0,-1.876179616,0.481737885,-3.894606744,9.84E-05,0.000844638,90.95904434,0,-1.064014954,0.980202968,-1.085504725,0.277698172,0.436740351,282.0801146,0,-1.068087958,0.463510057,-2.304346889,0.021203179,0.058173708,421.4305295,1,-0.09008664,0.298602743,-0.301693946,0.762885384,0.84522926,256.1353925,0,-0.867112002,0.435102711,-1.992890368,0.046273453,0.105617384,N,-,,RNP domain,F:nucleotide binding; F:nucleic acid binding,IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR23003 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY),,
RL4_JR_05968,3465,3507,3457,0,3,4,0,0,0,0,4,3,4,15,0,0,5,2,86.78865684,1,-1.422805598,0.794706028,-1.790354606,0.073396923,0.176747304,20.64056765,0,-0.901929317,1.214419316,-0.742683606,0.457673258,0.616607043,53.85840553,1,-3.562129884,1.20737619,-2.950306553,0.003174588,0.014106686,62.15522702,1,-3.984998814,1.210081366,-3.293166001,0.00099066,0.007315495,57.25943362,1,-2.724212268,1.147734115,-2.373556936,0.017617677,0.049330469,N,-,,signal recognition particle 14kd,"F:endoplasmic reticulum signal peptide binding; P:SRP-dependent cotranslational protein targeting to membrane; P:mycelium development; F:7S RNA binding; C:nucleolus; C:signal recognition particle, endoplasmic reticulum targeting",IPR009018 (G3DSA:3.30.720.GENE3D); IPR003210 (PFAM); IPR003210 (PANTHER); IPR009018 (SUPERFAMILY),,
RL4_JR_05969,217,235,195,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,230.9862959,1,-2.711917893,0.697479042,-3.888171158,0.000101002,0.000864614,108.5533403,0,-0.86515374,0.979929892,-0.882873099,0.37730484,0.541856173,166.5157597,0,-5.190535655,1.198518874,-4.330791752,1.49E-05,0.000263426,222.7998797,0,-2.56499218,0.686374149,-3.737017463,0.000186216,0.001807706,202.0520166,0,-2.049606509,0.658692124,-3.11163051,0.001860572,0.007975568,N,-,,Suppressor of glycerol defect 1,"F:oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor; F:organic cyclic compound binding; F:heterocyclic compound binding; P:single-organism process",IPR003890 (SMART); IPR003891 (SMART); IPR016021 (G3DSA:1.25.40.GENE3D); IPR003890 (PFAM); IPR003891 (PFAM); PTHR18034:SF4 (PANTHER); PTHR18034 (PANTHER); PTHR18034 (PANTHER); PTHR18034:SF4 (PANTHER); IPR003891 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),,
RL4_JR_05970,440,302,489,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.203469689,0,-0.173704925,1.206076253,-0.144024828,0.885480864,0.944154115,1.343223074,0,3.039863181,1.356695269,2.240638153,0.025049523,0.068601535,3.479589632,0,0.390231844,1.202953157,0.324394879,0.745639096,0.829726337,4.013855988,0,-0.032010491,1.202617366,-0.026617353,0.978764932,0.987051289,3.423284234,0,0.310934898,1.198197505,0.259502208,0.795247779,0.861440437,N,-,,alkaline serine protease,P:proteolysis; F:serine-type endopeptidase activity,IPR015366 (SMART); IPR015366 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); PTHR14218 (PANTHER); PTHR14218:SF19 (PANTHER); PTHR14218:SF19 (PANTHER); PTHR14218 (PANTHER); PTHR14218 (PANTHER); IPR030400 (PROSITE_PROFILES); IPR000209 (SUPERFAMILY); IPR009020 (SUPERFAMILY),,
RL4_JR_05971,87,75,138,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,988.6725615,0,-1.827640662,0.702594773,-2.601272787,0.009287857,0.035791372,293.7475,0,-2.825282295,0.982488675,-2.875638535,0.004032112,0.018163344,750.9162689,0,-2.470252072,0.484987993,-5.093429333,3.52E-07,1.07E-05,878.3948349,0,-2.42322863,0.431888295,-5.610776344,2.01E-08,5.30E-07,796.1399913,0,-1.802157807,0.576765433,-3.12459399,0.001780506,0.007674596,N,-,,eukaryotic translation initiation factor 3 subunit 8,"C:multi-eIF complex; F:translation initiation factor activity; P:formation of translation preinitiation complex; C:cytoplasmic stress granule; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:eukaryotic 43S preinitiation complex; C:eukaryotic translation initiation factor 3 complex, eIF3e; C:cytosol; C:eukaryotic 48S preinitiation complex; F:translation initiation factor binding; P:regulation of translational initiation",SM00753 (SMART); IPR000717 (SMART); IPR011991 (G3DSA:1.10.10.GENE3D); IPR008905 (PFAM); IPR000717 (PFAM); PTHR13937 (PANTHER); PTHR13937:SF0 (PANTHER); IPR027516 (HAMAP); IPR011991 (SUPERFAMILY),,
RL4_JR_05972,4498,2919,3019,0,0,2,0,0,0,0,6,0,0,3,0,0,0,0,910.5312685,1,-1.988857666,0.463656064,-4.289510743,1.79E-05,0.000191459,230.9824153,0,-4.386119545,1.230881566,-3.56339689,0.000366087,0.01403609,672.3034097,1,-2.89874533,0.567656842,-5.106509984,3.28E-07,1.00E-05,783.4218949,1,-2.596290234,0.585566327,-4.433810683,9.26E-06,0.000132775,652.3305064,0,-2.721755483,0.604502313,-4.502473228,6.72E-06,7.21E-05,N,-,,pre-mRNA processing splicing factor 8,F:second spliceosomal transesterification activity; F:U6 snRNA binding; F:U5 snRNA binding; F:pre-mRNA intronic binding; P:generation of catalytic spliceosome for second transesterification step; C:catalytic step 2 spliceosome; F:U1 snRNA binding; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP; F:U2 snRNA binding; P:mRNA 3'-splice site recognition; P:spliceosomal tri-snRNP complex assembly,IPR000555 (SMART); IPR012591 (PFAM); IPR019581 (PFAM); IPR012984 (PFAM); IPR019580 (PFAM); IPR019582 (PFAM); IPR012592 (PFAM); IPR021983 (PFAM); PTHR11140:SF0 (PANTHER); IPR027652 (PANTHER); IPR012591 (PRODOM); IPR012337 (SUPERFAMILY); IPR012337 (SUPERFAMILY); SSF101447 (SUPERFAMILY),,
RL4_JR_05973,1558,965,1067,0,0,3,0,0,0,0,2,0,0,0,0,0,0,0,83.79523806,1,-0.472454805,0.633040323,-0.746326557,0.455470173,0.644196545,18.3837581,0,-0.734815818,1.223445495,-0.600611814,0.548098568,0.694610455,68.2538524,1,-0.976752975,0.869206851,-1.123729034,0.261127996,0.398172775,54.67537512,0,-3.799995045,1.202989214,-3.158793945,0.001584235,0.01091182,46.4745396,0,-3.452180921,1.198882669,-2.879498563,0.003983081,0.014848563,N,-,,dna repair and recombination rad26,F:ATP binding; F:DNA-dependent ATPase activity; P:transcription-coupled nucleotide-excision repair; P:histone H2A-H2B dimer displacement; C:cytosol,IPR014001 (SMART); IPR001650 (SMART); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000330 (PFAM); PTHR10799:SF752 (PANTHER); PTHR10799 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_05974,1522,1568,1657,0,0,8,0,0,1,0,0,0,5,0,2,0,0,0,831.5112259,1,-0.54580522,0.82075087,-0.665007178,0.506045902,0.692555355,190.1792971,1,-2.185202135,1.004006032,-2.176483074,0.029519158,0.078156662,462.8996113,0,-3.327398363,0.715784304,-4.648604813,3.34E-06,7.47E-05,660.6115511,1,-1.292109297,0.647396273,-1.995855323,0.045949673,0.11631011,545.8739354,0,-1.438168262,0.98610104,-1.458439048,0.144719564,0.252287464,N,-, Effector probability:0.627,40S ribosomal S14,"P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:structural constituent of ribosome; F:mRNA 5'-UTR binding; C:cytosolic small ribosomal subunit; P:ribosomal small subunit assembly; F:small ribosomal subunit rRNA binding; P:translation",IPR001971 (PFAM); IPR001971 (PIRSF); IPR001971 (G3DSA:3.30.420.GENE3D); PTHR11759:SF11 (PANTHER); IPR001971 (PANTHER); SSF53137 (SUPERFAMILY),,
RL4_JR_05975,3960,3415,3275,2,0,2,0,0,0,0,1,0,0,5,0,0,1,3,1056.471883,1,-1.098345445,0.593504512,-1.850610103,0.064225665,0.160181283,586.9542737,0,0.65135585,0.458978467,1.4191425,0.155857476,0.284917307,617.6653198,1,-5.238213686,1.062655164,-4.929363603,8.25E-07,2.28E-05,851.5240968,1,-2.074880248,1.012719305,-2.048820673,0.040479654,0.108255809,671.846677,1,-2.723063585,0.580139037,-4.693812019,2.68E-06,3.34E-05,N,-,,60s ribosomal l7,C:ribosome,IPR016082 (G3DSA:3.30.1390.GENE3D); IPR012988 (PFAM); IPR005998 (TIGRFAM); IPR016082 (PFAM); PTHR11524 (PANTHER); IPR016082 (SUPERFAMILY),,
RL4_JR_05976,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.50311676,0,-2.296764818,1.169166131,-1.964446932,0.049478285,0.131694567,11.21948214,0,-0.022483644,1.22954699,-0.01828612,0.9854106,0.992569021,29.28701855,0,-2.683264551,1.209294862,-2.218867072,0.026495769,0.06967355,37.80904958,0,-2.160315052,1.164748744,-1.854747699,0.063632264,0.141786239,29.07824219,0,-2.775645368,1.220800346,-2.273627605,0.022988386,0.060844552,N,-,,---NA---,,no IPS match,,
RL4_JR_05977,171,199,186,0,0,4,0,0,0,0,0,5,0,1,1,0,0,0,0.444844513,1,3.066141191,2.105241963,1.456431729,0.14527331,NA,0.141957837,0,6.281815027,1.966392778,3.19458813,0.001400305,0.015023052,0.368881042,1,3.626763674,1.309043004,2.770545858,0.005596242,0.020636988,0.42555396,1,3.204985555,1.484868282,2.158430882,0.030894347,0.094084527,0.364794089,0,3.540549387,1.256916419,2.816853479,0.004849664,0.017480546,N,-,,Pisatin demethylase,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; F:methyltransferase activity; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding; P:methylation",IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24305:SF69 (PANTHER); PTHR24305 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_05978,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.042167712,0,-0.117335929,1.221966981,-0.096022176,0.92350296,0.963049616,1.28469666,0,3.104066617,1.364094864,2.275550403,0.022872933,0.063966053,3.340002875,0,0.449120608,1.209895809,0.37120602,0.71048409,0.803950031,3.853711361,0,0.026566059,1.211780411,0.021923163,0.982509248,0.989190158,3.298186306,0,0.364725127,1.211034827,0.301168157,0.76328627,0.834731212,N,-,,Mg2+ transporter,P:transmembrane transport; C:integral component of membrane; F:metal ion transmembrane transporter activity; P:metal ion transport; F:carbohydrate binding,G3DSA:2.80.10.50 (GENE3D); IPR000772 (PROSITE_PROFILES); IPR000772 (SUPERFAMILY),,
RL4_JR_05979,23,11,32,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,43.21375571,1,0.043052794,0.75917534,0.056709948,0.954776249,0.977334789,7.641714544,0,0.531676289,1.246024956,0.426697945,0.669599347,0.788825193,34.05117347,0,-0.290862932,1.042826525,-0.27891785,0.78030787,0.854227641,22.72914582,0,-2.533598993,1.200851102,-2.10983609,0.034872477,0.099498352,19.30739438,0,-2.184903778,1.197926275,-1.823905046,0.068166429,0.14212747,N,-,,magnesium and cobalt transporter,P:cation transmembrane transport; C:integral component of membrane; F:metal ion transmembrane transporter activity; P:metal ion transport,G3DSA:1.20.58.340 (GENE3D); G3DSA:3.30.460.20 (GENE3D); IPR002523 (PFAM); G3DSA:1.20.58.340 (GENE3D); PTHR21535:SF42 (PANTHER); PTHR21535 (PANTHER); SSF144083 (SUPERFAMILY); SSF143865 (SUPERFAMILY),1.A.35.3.8, the cora metal ion transporter (mit) family.
RL4_JR_05980,494,514,717,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,40.99996467,1,-0.679613041,0.842846225,-0.806331002,0.420052019,0.611598139,9.436211346,0,0.227308994,1.213526587,0.187312743,0.851415432,0.91167111,96.1802247,0,1.715100806,0.480697349,3.567943135,0.000359795,0.002660745,151.516233,0,2.261298895,0.351470378,6.433824972,1.24E-10,4.70E-09,103.0585895,0,2.015275495,0.416361215,4.840209469,1.30E-06,1.80E-05,N,-,,glycolate oxidase,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; C:mitochondrion; C:membrane; P:oxidation-reduction process; P:cellular metabolic process",IPR004113 (PFAM); IPR016171 (G3DSA:1.10.45.GENE3D); IPR016169 (G3DSA:3.30.465.GENE3D); IPR006094 (PFAM); IPR016167 (G3DSA:3.30.43.GENE3D); PTHR11748 (PANTHER); PTHR11748:SF35 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016164 (SUPERFAMILY); IPR016166 (SUPERFAMILY),,
RL4_JR_05981,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,57.02970874,0,-2.005708272,1.023790937,-1.95909946,0.05010114,0.132918732,15.90027082,0,-0.525430244,1.223297008,-0.429519765,0.667545013,0.787840916,160.7743223,0,1.471910346,0.458598658,3.209582758,0.001329278,0.007202549,71.37397752,0,-0.325073973,0.653742538,-0.497250759,0.619012231,0.736996867,63.02090597,0,-0.311362773,0.685373698,-0.454296355,0.649615539,0.749983733,N,NRPS-Like,,nrps-like enzyme,F:catalytic activity; P:metabolic process; F:phosphopantetheine binding; C:cellular_component,IPR013120 (PFAM); IPR009081 (PFAM); IPR009081 (G3DSA:1.10.1200.GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR000873 (PFAM); G3DSA:3.40.50.980 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24095 (PANTHER); PTHR24095:SF164 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR016040 (SUPERFAMILY); SSF56801 (SUPERFAMILY); IPR009081 (SUPERFAMILY),4.C.1.1.13, the fatty acid transporter (fat) family.
RL4_JR_05982,8,7,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32.91154862,0,-3.142808361,1.188203098,-2.645009399,0.008168865,0.032318913,10.55602856,0,0.065565142,1.221632235,0.053670114,0.957197994,0.977477612,27.28434883,0,-2.580967576,1.192131514,-2.165002389,0.030387502,0.077570114,54.75100369,0,-0.680662651,0.851228882,-0.799623539,0.423928945,0.566562905,26.78680977,0,-2.657254623,1.188707292,-2.235415431,0.025390088,0.066154051,N,-,,DNA repair RAD5,F:ATP binding; P:DNA repair; F:zinc ion binding; C:integral component of membrane; P:cellular component organization; F:DNA secondary structure binding; F:nucleoside-triphosphatase activity; C:chromosomal part,IPR014001 (SMART); IPR001650 (SMART); IPR014905 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000330 (PFAM); IPR014905 (PFAM); PTHR10799 (PANTHER); PTHR10799 (PANTHER); PTHR10799 (PANTHER); PTHR10799:SF271 (PANTHER); PTHR10799 (PANTHER); PTHR10799:SF271 (PANTHER); PTHR10799:SF271 (PANTHER); PTHR10799 (PANTHER); PTHR10799:SF271 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_05983,6,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,115.428633,0,1.473055712,0.498609168,2.954329378,0.003133494,0.014905152,8.177928567,0,0.43380991,1.227021973,0.353546978,0.723678416,0.826850991,21.15417442,0,-2.213880207,1.191611444,-1.857887668,0.063184968,0.135785314,57.31642686,0,0.106097638,0.740505701,0.143277274,0.886071203,0.929848909,24.65651001,0,-1.3616131,1.119597347,-1.216163207,0.223922756,0.350579711,N,-,,squalene phytoene synthase,P:biosynthetic process; F:transferase activity,IPR002060 (PFAM); PTHR21181 (PANTHER); PTHR21181 (PANTHER); PTHR21181:SF13 (PANTHER); PTHR21181:SF13 (PANTHER); IPR008949 (SUPERFAMILY),,
RL4_JR_05984,6,8,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32.1495562,0,-0.179646462,0.867993324,-0.206967562,0.836035192,0.918684172,6.571078225,0,0.749347375,1.230451708,0.609001856,0.542523208,0.688970666,17.10098948,0,-1.907072977,1.196709222,-1.593597627,0.111026186,0.209785202,23.74361815,0,-1.382860623,1.148469833,-1.204089636,0.228554935,0.36494539,61.10348566,0,1.43191906,1.389681976,1.030393345,0.302825396,0.438243186,N,-,,chitinase,"P:metabolic process; F:hydrolase activity, acting on glycosyl bonds",IPR011583 (SMART); IPR001223 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR11177 (PANTHER); IPR017853 (SUPERFAMILY),9.B.29.2.7, the small 4-5 tms putative permease (4-5pp) family.
RL4_JR_05985,1,5,6,0,0,0,0,0,0,0,0,0,0,2,1,0,0,0,59.4563726,0,-0.71410754,1.000633014,-0.713655786,0.475440053,0.665021292,10.94421767,0,0.013449463,1.344510472,0.010003241,0.992018701,0.996053298,499.9086046,0,4.108399681,0.701590819,5.855834438,4.75E-09,2.16E-07,191.3903293,1,2.424729576,0.727274523,3.333994934,0.000856082,0.006516038,196.2007475,0,2.794105281,0.665819276,4.196492024,2.71E-05,0.000232109,N,-,,s-adenosyl-methionine-sterol-c- methyltransferase,F:sterol 24-C-methyltransferase activity; P:methylation,IPR013216 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); PTHR10108 (PANTHER); PTHR10108:SF843 (PANTHER); PTHR10108:SF843 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_05986,10,8,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14.45263402,0,-1.955713191,1.210976585,-1.614988444,0.106313197,0.231651459,4.591053977,0,1.266612528,1.262637146,1.003148476,0.315789229,0.477433692,24.95829089,0,0.424071774,1.05145674,0.403318328,0.68671406,0.784948984,13.80099375,0,-1.81402022,1.209486653,-1.499826572,0.133659332,0.243881298,11.85470741,0,-1.481175529,1.21959006,-1.21448639,0.224562044,0.351203382,N,-,,c6 zinc finger domain containing,"C:nucleus; F:zinc ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:carbohydrate binding; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_05987,196,159,207,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.24107518,0,0.201022397,1.268345449,0.158491835,0.874069254,0.939103212,1.047336967,0,3.398861956,1.448203988,2.346949729,0.018927808,0.055133029,2.697744877,0,0.757215772,1.241479661,0.609930066,0.541908135,0.669938814,3.110561608,0,0.335607746,1.251794293,0.268101355,0.788621303,0.863220615,2.642647819,0,0.683939649,1.232712367,0.554825008,0.57901436,0.691824451,N,-,,methyltransferase domain containing,F:transferase activity,PTHR10108 (PANTHER); PTHR10108:SF896 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_05988,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,64.46788104,0,-4.112863461,1.228590523,-3.347627533,0.000815065,0.005048822,20.41220191,0,-0.885890834,1.226551417,-0.722261473,0.470133735,0.628376293,59.81067192,0,-2.585639951,1.216924465,-2.124733314,0.033608872,0.083910289,61.52254842,0,-3.970254784,1.221549039,-3.250180434,0.001153318,0.008329062,56.84938596,0,-2.714080341,1.160888108,-2.337934485,0.019390647,0.053365127,N,-,,ankyrin repeat and kinase domain-containing 1,P:transmembrane transport; F:catalytic activity; C:integral component of membrane; F:metal ion transmembrane transporter activity; P:metal ion transport,IPR002110 (SMART); G3DSA:1.20.58.340 (GENE3D); IPR002110 (PFAM); IPR002523 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); PTHR24198 (PANTHER); PTHR24198:SF12 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_05989,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.012047471,0,8.273092713,3.994385999,2.07118008,0.03834197,NA,0.00401109,0,11.43263965,3.991205167,2.86445802,0.004177235,0.018371529,0.010113829,0,8.82019535,3.041025661,2.900401487,0.00372685,0.01574077,0.01164654,0,8.398490877,3.993441208,2.103071121,0.035459553,0.099858856,0.00966951,0,8.76562085,1.6165792,5.422326879,5.88E-08,1.50E-06,N,-,,hypothetical protein LY89DRAFT_729102,,no IPS match,,
RL4_JR_05990,505,717,556,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,123.1035677,0,0.070344261,0.457593244,0.153726617,0.877825297,0.940772371,29.91218912,0,0.02320168,1.108366822,0.020933214,0.983298932,0.991033734,88.40208292,0,-0.72091175,0.734163203,-0.981950263,0.326124352,0.469255676,162.9182913,0,0.480147186,0.422279706,1.137035899,0.255523279,0.395007148,74.6009207,0,-1.400645639,0.834654428,-1.67811443,0.093324762,0.180958022,N,-,,GTP-binding 1,F:GTP binding; F:translation elongation factor activity; F:GTPase activity; P:translational elongation; C:intracellular,G3DSA:2.40.30.10 (GENE3D); IPR004161 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PF00009 (PFAM); G3DSA:2.40.30.10 (GENE3D); PTHR23115:SF180 (PANTHER); PTHR23115 (PANTHER); PTHR23115 (PANTHER); PTHR23115:SF180 (PANTHER); IPR000795 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR009001 (SUPERFAMILY); IPR009000 (SUPERFAMILY),,
RL4_JR_05991,228,333,292,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,523.7874036,1,-5.469283988,1.23535901,-4.427283037,9.54E-06,0.000111533,201.2123463,0,-2.266102964,1.1414761,-1.985239082,0.047117878,0.112440392,514.9445641,0,-2.256378858,0.759770922,-2.969814705,0.002979794,0.013509824,516.5494965,0,-5.126488568,1.188869901,-4.312068598,1.62E-05,0.000216322,451.9545955,0,-3.159528194,0.9874761,-3.199599662,0.001376186,0.006198347,N,-,,arrestin n-terminal domain containing,P:ubiquitin-dependent endocytosis; F:ubiquitin protein ligase binding; P:positive regulation of receptor internalization; C:cytosol; C:Golgi apparatus; C:clathrin-coated vesicle; C:plasma membrane,IPR024391 (PFAM); PTHR11188:SF76 (PANTHER); PTHR11188 (PANTHER),,
RL4_JR_05992,21,16,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.4080507,0,0.393830826,0.85943733,0.458242634,0.646778133,0.798730852,4.482992141,0,1.301116756,1.263185492,1.030028261,0.302996739,0.463843466,11.57477455,0,-1.343841404,1.199237822,-1.12057957,0.262466865,0.399521056,33.40691801,0,1.256999237,0.687798725,1.827568432,0.067614347,0.147510292,26.08290625,0,0.267089874,0.971220483,0.275004367,0.783312883,0.851655522,N,-,,#NAME?,,IPR016040 (G3DSA:3.40.50.GENE3D); IPR016040 (PFAM); PTHR14194 (PANTHER); PTHR14194 (PANTHER); PTHR14194:SF73 (PANTHER); PTHR14194:SF73 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_05993,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.46452768,0,-1.621260786,1.196013414,-1.355554016,0.175241111,0.330160236,3.673853177,0,1.588289976,1.271456341,1.249189551,0.211595753,0.357533156,15.99570878,0,-0.096517912,1.196269574,-0.08068241,0.935694526,0.961430162,20.26611204,0,-0.530340141,1.147290871,-0.462254302,0.643898966,0.755881395,9.320913568,0,-1.134239424,1.19531996,-0.948900263,0.342671341,0.479683026,N,-,,hypothetical protein SPBR_05284,C:membrane,PTHR37846 (PANTHER),,
RL4_JR_05994,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.2279211,0,-1.931073075,1.14014832,-1.69370339,0.09032166,0.205636175,8.765524578,0,0.333714907,1.22126194,0.273254161,0.784657849,0.869397316,22.6948062,0,-2.315239904,1.189766483,-1.945961613,0.051659351,0.116067303,52.82628219,0,-0.005362367,0.738573243,-0.00726044,0.994207058,0.995770826,22.31498236,0,-2.393703515,1.188413128,-2.014201507,0.043988382,0.101453841,N,-,,N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase,,IPR024078 (G3DSA:3.40.50.GENE3D); IPR003737 (PFAM); IPR003737 (PANTHER); PTHR12993:SF11 (PANTHER); IPR024078 (SUPERFAMILY),,
RL4_JR_05995,17,37,43,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.545399724,0,2.772168688,1.926464064,1.4389932,0.150152449,NA,0.172867767,0,5.997533011,1.886697671,3.178852183,0.001478595,0.015023052,0.450977524,0,3.336867805,1.294176212,2.578372074,0.009926705,0.032471069,0.520407969,0,2.914664771,1.427666274,2.041558889,0.041195307,0.109648392,0.447550154,0,3.246289526,1.256512929,2.583570333,0.009778353,0.030794968,N,-,,mitochondrial ATPase expression domain-containing,,IPR024319 (PFAM),,
RL4_JR_05996,424,328,451,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,76.33273165,0,0.149513316,0.662501345,0.225680018,0.8214503,0.90986066,13.12977121,0,-0.249315759,1.233945077,-0.202047696,0.839879437,0.904100783,34.33497353,0,-2.912666498,1.216409042,-2.394479487,0.016643974,0.048392762,66.92134671,0,-0.598965308,0.791852483,-0.756410217,0.449403284,0.591260127,34.14740157,1,-3.007478456,1.229486146,-2.446126348,0.014440039,0.042219287,N,-,,U6 snRNA-associated Sm LSm3,"C:U4/U6 x U5 tri-snRNP complex; C:viral nucleocapsid; C:nucleolus; C:U6 snRNP; C:small nucleolar ribonucleoprotein complex; P:mRNA splicing, via spliceosome",IPR001163 (SMART); G3DSA:2.30.30.100 (GENE3D); IPR001163 (PFAM); PTHR13110 (PANTHER); IPR010920 (SUPERFAMILY),,
RL4_JR_05997,1471,1481,1351,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2.054358862,0,0.858935641,1.307878427,0.656739666,0.511348325,NA,0.650168469,0,4.086503762,1.495750268,2.732076236,0.006293658,0.024021268,1.696310286,0,1.426247175,1.23659347,1.153367869,0.248759424,0.383324263,1.9575709,1,1.003514789,1.254899659,0.799677315,0.42389778,0.566562905,1.682202701,0,1.336081982,1.235651804,1.081277087,0.279573877,0.413249037,Y,-,,hypothetical protein NECHADRAFT_82696,,no IPS match,,
RL4_JR_05998,217,256,255,0,0,11,0,0,0,0,0,0,0,0,0,0,2,0,19.44299879,1,-1.12143789,1.154697552,-0.971196213,0.331450579,0.521298212,4.998730821,0,1.143931111,1.259130992,0.908508422,0.363609666,0.528194179,25.96004072,0,0.30924219,1.04655686,0.295485321,0.767623164,0.843802054,28.59930044,0,-0.194623026,1.028757513,-0.189182604,0.849949701,0.905962809,12.78755785,1,-1.59050178,1.209800377,-1.314681174,0.188617076,0.308073543,N,-,,mitochondrial inheritance component mdm10,P:single-organism cellular localization; C:outer mitochondrial membrane protein complex; P:protein complex assembly; C:integral component of membrane; P:macromolecule localization; P:establishment of localization in cell; P:mitochondrion localization; P:outer mitochondrial membrane organization; P:single-organism transport; P:organic substance transport,IPR027539 (PFAM); PTHR28035 (PANTHER); PTHR28035 (PANTHER); PTHR28035:SF1 (PANTHER),1.B.8.6.5, the mitochondrial and plastid porin (mpp) family.
RL4_JR_05999,1560,1478,2666,0,0,2,0,0,0,2,0,0,0,8,0,0,0,0,3.28463398,1,0.182031087,1.213624033,0.149989685,0.880772753,0.94187837,1.049415167,0,3.395959932,1.390117346,2.442930406,0.014568546,0.045054331,46.28327215,1,4.149226776,0.611909938,6.780780179,1.20E-11,8.12E-10,31.72007012,1,2.650092186,0.844602727,3.137678936,0.001702913,0.011623825,6.538018108,0,1.595589747,1.124345818,1.419127213,0.155861931,0.266121763,N,-,,zip zinc iron transporter,P:transmembrane transport; C:membrane; F:metal ion transmembrane transporter activity; P:metal ion transport,IPR003689 (PFAM); IPR004698 (TIGRFAM); PTHR11040:SF69 (PANTHER); PTHR11040:SF69 (PANTHER); PTHR11040 (PANTHER); PTHR11040 (PANTHER),2.A.5.1.14, the zinc (zn(2+))-iron (fe(2+)) permease (zip) family.
RL4_JR_06000,2710,2623,2096,0,4,9,0,0,0,0,0,0,0,1,2,0,2,0,1.735454328,1,1.102247226,1.341298755,0.821776075,0.411204353,NA,0.56080354,0,4.300062472,1.562542086,2.751965858,0.00592387,0.023097615,1.443882159,0,1.65912554,1.25161544,1.325587307,0.184976433,0.306397482,1.664821118,1,1.237489021,1.277772288,0.96847383,0.332807783,0.479464827,1.413165114,1,1.586821886,1.232668518,1.28730625,0.197987566,0.319512927,N,-,,ankyrin repeat,F:ubiquitin-protein transferase activity; C:cytoplasm; P:protein ubiquitination,no IPS match,,
RL4_JR_06001,366,347,331,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,522.6076857,0,-0.777597134,0.898359903,-0.865574177,0.386723722,0.579517289,153.9467577,0,-0.387645919,0.709129679,-0.546650253,0.584619037,0.723147243,301.1781631,0,-4.097452452,1.04670252,-3.914629394,9.05E-05,0.001099112,460.9941822,1,-1.060497217,0.423161617,-2.506128098,0.012206139,0.056795568,338.3716981,0,-1.801976424,0.860318987,-2.094544526,0.036211501,0.087109311,N,-,,40S ribosomal s19,F:structural constituent of ribosome; C:ribosome; P:translation,IPR001266 (SMART); IPR001266 (PFAM); IPR001266 (PANTHER); IPR001266 (PRODOM); IPR011991 (SUPERFAMILY),,
RL4_JR_06002,6342,4007,4617,3,5,8,0,0,0,1,3,1,2,2,5,0,0,2,18.82579976,1,-2.337088553,1.21428187,-1.924667254,0.054271,0.141572686,6.008088197,0,0.878563776,1.261552918,0.696414525,0.486169269,0.642345039,22.1110226,1,-0.813934124,1.211422188,-0.671883124,0.501658105,0.634186502,18.01083399,1,-2.198071875,1.214311615,-1.810138228,0.070274354,0.151292332,15.44021641,1,-1.862434366,1.222301494,-1.52371111,0.127580893,0.22915674,N,-,,fatty acid transporter,F:catalytic activity; P:metabolic process,G3DSA:3.40.50.980 (GENE3D); G3DSA:3.30.300.30 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR000873 (PFAM); G3DSA:2.30.38.10 (GENE3D); IPR025110 (PFAM); PTHR24096 (PANTHER); PTHR24096:SF178 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.5, the fatty acid transporter (fat) family.
RL4_JR_06003,2226,2514,3178,0,0,0,0,0,0,0,7,2,0,2,0,0,1,0,0.822666777,0,2.179051923,1.715157182,1.270467772,0.203918056,NA,0.265171071,0,5.380486617,1.810650154,2.971577147,0.002962744,0.015490133,0.685193359,1,2.73390408,1.322827703,2.066712145,0.038761286,0.093259779,0.790139931,1,2.312324105,1.419988352,1.628410615,0.103437848,0.20088778,0.674315572,1,2.654038602,1.28990072,2.057552617,0.039633099,0.093387277,N,-,,scytalone dehydratase,P:melanin biosynthetic process; F:scytalone dehydratase activity,IPR004235 (PFAM); IPR004235 (PIRSF); IPR032710 (G3DSA:3.10.450.GENE3D); IPR004235 (PRODOM); IPR032710 (SUPERFAMILY),,
RL4_JR_06004,170,189,212,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.337104537,0,0.673187602,1.298385781,0.518480417,0.60412312,0.772004859,0.742348476,0,3.895374949,1.480596133,2.630950373,0.008514647,0.029790963,9.771604757,0,2.203594167,1.213072869,1.816538992,0.069287732,0.145653863,2.225305899,0,0.819008592,1.252901735,0.653689407,0.513311929,0.648444577,1.901262837,0,1.159595985,1.231106334,0.941913751,0.346236799,0.483537599,N,-,,alanine and arginine rich,P:biological_process; C:cellular_component; F:molecular_function,IPR018744 (PFAM); PTHR38113 (PANTHER); PTHR38113:SF2 (PANTHER),,
RL4_JR_06005,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49.99900025,0,-1.792278016,1.043575131,-1.717440329,0.085898748,0.198179295,13.62253622,0,-0.302359721,1.23873829,-0.244086845,0.80716356,0.883358844,97.86108681,0,0.856640698,1.539918157,0.556289757,0.578012788,0.700370815,60.55631645,0,-0.370805089,0.72624365,-0.510579458,0.609645563,0.72975906,34.35352427,0,-3.016173029,1.205382139,-2.502254622,0.012340514,0.037259006,N,-,,MFS transporter,C:membrane,IPR018823 (PFAM); PF13515 (PFAM); PTHR31086:SF1 (PANTHER); PTHR31086 (PANTHER),2.A.85.3.5, the aromatic acid exporter (arae) family.
RL4_JR_06006,1288,1285,872,0,0,3,0,0,0,0,0,0,0,0,1,0,0,0,20.49088742,1,-0.058283109,1.011852532,-0.057600399,0.954066932,0.977184938,4.113342633,0,1.425258553,1.257728385,1.133200593,0.257130025,0.41246753,10.64424006,0,-1.222892272,1.194483116,-1.023783639,0.30593748,0.44752363,29.61327744,1,0.667653979,0.851939524,0.783687059,0.433223758,0.575566271,40.98823203,0,2.117382124,0.574365535,3.68647141,0.000227385,0.001387747,Y,-,,phosphoglycerate mutase family,,IPR029033 (SUPERFAMILY),,
RL4_JR_06007,137922,54552,58953,10,10,16,0,0,1,3,3,4,0,23,0,0,2,5,0.124043222,1,4.908671284,3.647346533,1.345819828,0.178360629,NA,0.039259516,1,8.135992279,2.51974428,3.228896021,0.001242691,0.015023052,0.102399321,1,5.475912838,1.457163971,3.757924946,0.000171328,0.001605896,0.118169998,1,5.053686379,2.177715752,2.320636371,0.020306478,0.077430677,0.101493868,1,5.388522344,1.290837463,4.174439075,2.99E-05,0.000252678,,,,,,,,
RL4_JR_06008,8415,8032,10703,3,5,7,0,0,1,1,2,5,4,14,0,0,5,6,0.666388837,1,2.483289281,1.758039104,1.412533587,0.157792908,NA,0.214725429,1,5.685166906,1.825701098,3.113963678,0.001845922,0.015023052,0.55311023,1,3.044039416,1.281844859,2.3747331,0.017561644,0.050595925,0.637812595,1,2.621929065,1.381471949,1.897924215,0.057706066,0.134062581,0.54091713,1,2.972382637,1.236174695,2.404500471,0.016194585,0.046188782,N,-,,---NA---,,no IPS match,,
RL4_JR_06009,3418,4105,4023,3,7,0,0,0,1,0,1,7,0,1,3,0,2,4,73.08703323,1,4.203825308,0.983275069,4.275329905,1.91E-05,0.000201944,1.402519781,1,2.977550725,1.384367919,2.150837709,0.031489012,0.082295837,3.618668129,1,0.333507627,1.222787527,0.272743727,0.785050219,0.857650633,4.17291217,1,-0.08827302,1.226040232,-0.071998469,0.942603126,0.966368636,18.63657173,1,2.466915601,0.865773285,2.849378287,0.004380476,0.016098001,Y,-,,candidapepsin-4 precursor,F:aspartic-type endopeptidase activity; P:protein catabolic process; P:proteolysis,IPR001461 (PRINTS); IPR033121 (PFAM); IPR021109 (G3DSA:2.40.70.GENE3D); IPR021109 (G3DSA:2.40.70.GENE3D); IPR001461 (PANTHER); PTHR13683:SF318 (PANTHER); IPR033121 (PROSITE_PROFILES); IPR021109 (SUPERFAMILY),8.A.32.1.4,The β-Amyloid Cleaving Enzyme (BACE1) Family
RL4_JR_06010,2842,3576,4193,0,0,2,0,0,0,0,0,0,0,4,0,0,5,0,17.01840888,1,1.728096569,0.846144787,2.04231781,0.041120017,0.114921924,24.09321867,0,3.557183294,1.116698363,3.185446861,0.001445306,0.015023052,31.94960319,0,2.80314194,0.740614671,3.784885785,0.000153779,0.001507125,117.0680802,1,4.062024381,0.454777546,8.931893005,4.19E-19,3.66E-17,38.21192661,1,3.117602711,0.609649571,5.113761836,3.16E-07,5.36E-06,N,-,,DNA binding regulatory,F:nucleic acid binding; F:metal ion binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007219 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_06011,1004,1316,1571,0,0,0,0,0,0,0,0,0,1,0,0,0,4,0,14.49023047,0,-1.959451906,1.229082382,-1.594239682,0.110882362,0.238431681,13.97339876,0,2.179365825,1.156155662,1.885010727,0.05942839,0.135194107,18.48977903,0,-0.433251848,1.2197519,-0.355196698,0.722442238,0.812051866,42.09677849,1,0.551932348,0.888226253,0.621387113,0.534344949,0.666860915,23.13678379,1,0.191843655,1.021061724,0.187886442,0.850965671,0.900975365,N,-,,feruloyl esterase,,no IPS match,,
RL4_JR_06012,16043,21961,22267,6,1,3,0,0,0,2,0,1,2,6,0,0,0,0,531.3570605,1,-3.010211155,0.840050029,-3.583371288,0.000339188,0.002399909,157.1841736,0,-3.830791156,1.327254022,-2.88625319,0.003898584,0.017783446,678.2760267,1,-0.506292862,0.630816104,-0.802599772,0.4222061,0.563535209,554.9747792,1,-2.28901063,0.720294754,-3.177880471,0.001483559,0.010302493,461.8071708,0,-2.27066694,0.781636317,-2.905017195,0.003672329,0.013920754,N,-,,arrestin domain-containing,,IPR011022 (SMART); IPR011022 (PFAM); PTHR11188 (PANTHER); PTHR11188 (PANTHER); PTHR11188:SF46 (PANTHER); PTHR11188:SF46 (PANTHER); PTHR11188 (PANTHER),,
RL4_JR_06013,66285,50312,42949,2,2,3,0,0,0,0,4,5,0,5,0,0,5,2,1.719578727,1,1.115509945,1.347638025,0.827751907,0.407811016,NA,0.555961598,0,4.312578569,1.567860666,2.750613408,0.00594838,0.02316641,1.430915217,1,1.67215309,1.254156774,1.333288728,0.182437071,0.303735411,1.64983393,1,1.250544176,1.28141095,0.975911885,0.329108132,0.475805806,1.399953686,1,1.600370216,1.234744503,1.296114469,0.194936051,0.315745883,N,-,,---NA---,,no IPS match,,
RL4_JR_06014,21143,15877,14485,1,20,2,0,1,0,0,1,3,2,1,3,0,7,3,0.217927201,1,4.09555702,2.985925993,1.371620405,0.170181638,NA,0.067956635,1,7.343866501,2.351559887,3.122976601,0.00179032,0.015023052,0.179396086,1,4.665760617,1.492909425,3.125280434,0.001776356,0.009009935,0.207157318,1,4.243320708,1.944985,2.181672716,0.029133696,0.090678964,0.180314112,1,4.558474903,1.382009992,3.298438455,0.000972242,0.004672723,,,,,,,,
RL4_JR_06015,15306,13791,21105,0,3,12,0,0,0,4,1,1,2,5,0,0,2,5,16.2073104,1,-2.120932669,1.190850909,-1.781022841,0.074908719,0.179332178,14.53691009,0,2.01527576,1.119792934,1.799686083,0.07191022,0.156971155,34.24733674,1,0.849091464,0.851035557,0.997715615,0.318417279,0.461161847,34.09267425,1,-0.23631151,1.012490546,-0.233396263,0.815453715,0.883422733,13.24272438,1,-1.640881976,1.198661025,-1.368929115,0.171021434,0.286062217,N,-,,Lipopolysaccharide-modifying partial,C:membrane,IPR006598 (SMART); IPR006598 (PFAM); PTHR12203:SF22 (PANTHER); PTHR12203 (PANTHER); PTHR12203:SF22 (PANTHER),,
RL4_JR_06016,12312,12334,12420,5,2,6,0,0,0,0,0,0,0,6,3,0,8,1,18.41992012,1,0.912423138,1.010775025,0.90269656,0.366686963,0.558513285,2.11494205,0,2.384968215,1.314065225,1.814954213,0.069530946,0.15293182,13.30814197,0,0.700708964,1.195535924,0.586104482,0.557805304,0.68401416,6.303244893,1,-0.683135743,1.200057604,-0.56925246,0.569184824,0.696098121,5.364275554,1,-0.337233991,1.196191384,-0.281923107,0.778002471,0.846927752,N,-,,S-M checkpoint control rad4,C:nucleus; P:mitotic DNA integrity checkpoint; P:DNA metabolic process; P:cellular response to DNA damage stimulus; C:chromosomal part,IPR001357 (SMART); IPR001357 (PFAM); IPR001357 (G3DSA:3.40.50.GENE3D); IPR001357 (G3DSA:3.40.50.GENE3D); PTHR13561 (PANTHER); IPR001357 (PROSITE_PROFILES); IPR001357 (PROSITE_PROFILES); IPR001357 (PROSITE_PROFILES); IPR001357 (SUPERFAMILY); IPR001357 (SUPERFAMILY); IPR001357 (SUPERFAMILY); IPR001357 (SUPERFAMILY),,
RL4_JR_06017,6739,6737,8810,0,0,1,0,0,0,2,0,0,0,1,1,0,2,0,431.5619788,1,-1.296611052,0.710473737,-1.824995048,0.068001777,0.167398459,95.73927715,0,-3.115531817,1.204398634,-2.586794545,0.009687334,0.032926524,269.2895564,1,-3.383021,0.887113628,-3.813514857,0.000137004,0.001399628,324.235114,1,-3.128565654,0.711491327,-4.397194366,1.10E-05,0.000152304,255.3136365,1,-4.21327043,1.023515476,-4.116469686,3.85E-05,0.000311125,N,-,,hypothetical protein F503_04921,P:biological_process; C:cellular_component; F:molecular_function,IPR018843 (PFAM); PTHR42081:SF1 (PANTHER); PTHR42081 (PANTHER),1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_06018,32,100,67,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.43178798,0,0.117624008,1.176586856,0.099970527,0.920367724,0.961623962,2.091178017,0,2.40108804,1.324866426,1.812324618,0.069936053,0.153655899,5.460801164,0,-0.260324196,1.220902447,-0.213222765,0.831153212,0.890716113,6.302102743,0,-0.68319147,1.222911566,-0.55865975,0.576393954,0.703046474,5.421819329,0,-0.352496392,1.23127356,-0.286286008,0.774659074,0.844173358,N,-,,---NA---,,no IPS match,,
RL4_JR_06019,2539,3516,2625,0,0,5,0,0,0,0,0,0,0,3,0,0,0,2,7.464344743,1,-1.002156571,1.257814424,-0.796744378,0.425599505,0.616319055,2.394448209,0,2.205927307,1.365171268,1.615861218,0.106124322,0.211913669,6.174437458,0,-0.437115937,1.242125676,-0.35190959,0.724906067,0.813670603,7.121175662,1,-0.859109249,1.246502324,-0.689215922,0.490687399,0.630292158,6.034635496,1,-0.506995888,1.239706308,-0.408964514,0.682565703,0.774460257,N,-,,hmg-i hmg- DNA-binding,F:nucleotide binding; F:DNA binding; P:biological_process; F:ATP binding; P:mycelium development,IPR003593 (SMART); IPR003959 (PFAM); G3DSA:1.10.8.60 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23389 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_06020,15955,11605,12345,0,8,8,0,0,4,1,6,0,1,6,3,0,3,1,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_06021,8383,9820,12670,9,12,19,0,1,0,4,3,6,3,32,9,0,10,6,43.32119292,1,1.343711379,0.590275717,2.276413107,0.022821296,0.07321122,5.279112071,1,1.06520774,1.236683569,0.861342195,0.389049603,0.553550756,13.71727508,1,-1.588956484,1.193196016,-1.331681017,0.18296503,0.304460546,15.82633813,1,-2.011454812,1.191447062,-1.688245224,0.091364165,0.182927066,17.40092267,1,-0.74309733,1.127736026,-0.658928431,0.509941728,0.636641183,N,-,,hypothetical protein SPI_03828,,no IPS match,,
RL4_JR_06022,5894,6502,8983,0,2,12,0,0,2,2,0,0,0,7,0,0,6,2,6.274088555,1,-0.75192871,1.275739471,-0.589406165,0.555588842,0.73388089,1.991982264,1,2.471191883,1.383601279,1.78605782,0.074089897,0.160448852,5.198354627,1,-0.189301624,1.254343101,-0.150916941,0.880041236,0.925185616,25.26890231,1,1.172629451,1.077789256,1.08799512,0.276597262,0.419452468,5.167217812,1,-0.283208389,1.267029127,-0.223521609,0.823129567,0.881310793,N,-,,"3 ,5 -bisphosphate nucleotidase",,no IPS match,,
RL4_JR_06023,12016,12700,18797,3,1,5,0,0,0,0,0,0,0,8,0,0,6,2,0.254376328,1,3.872739099,2.726872959,1.420212513,0.155545822,NA,0.080390875,0,7.102304249,2.220305619,3.198795782,0.001380029,0.015023052,0.209458324,0,4.444787611,1.390524887,3.196481884,0.001391146,0.007463584,0.241727326,1,4.021552406,1.757025995,2.288840585,0.022088616,0.080442001,0.207000003,1,4.360520968,1.292621684,3.373393022,0.000742479,0.003762562,N,-,,---NA---,,no IPS match,,
RL4_JR_06024,879,1252,993,0,0,0,0,0,1,1,3,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,Maltose fermentation regulatory,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_06025,3630,3227,3902,0,0,5,0,0,0,0,0,0,0,3,0,0,2,1,2.401192731,1,0.63412526,1.279240061,0.49570466,0.620102799,0.781764585,0.762838332,0,3.856074796,1.463952728,2.634015923,0.008438153,0.029625732,1.982464325,0,1.201849148,1.228612442,0.97821665,0.327967183,0.470903384,2.287401008,1,0.779245791,1.241162308,0.627835527,0.53011169,0.663294719,1.955649864,1,1.118891813,1.223485424,0.914511763,0.360448,0.497958248,N,-,,major facilitator superfamily,P:transmembrane transport; C:integral component of membrane,PR01036 (PRINTS); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF83 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.79, the major facilitator superfamily (mfs).
RL4_JR_06026,286,373,337,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,253.9142019,0,2.437206392,0.929235944,2.622806843,0.00872087,0.033894644,31.65180045,0,1.409263452,1.011134958,1.393744169,0.163394873,0.295494534,40.13703682,0,-1.92126852,1.20860829,-1.589653601,0.111912908,0.210791866,72.20212831,0,0.178746458,0.635716853,0.281173068,0.778577661,0.857044881,60.00085255,1,0.191228518,0.683918247,0.279607276,0.779778824,0.848405394,N,-,,proteasome component c1,"C:nucleus; F:zinc ion binding; P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:proteasome core complex, alpha-subunit complex; F:mRNA binding; F:carbonate dehydratase activity; F:threonine-type endopeptidase activity; C:proteasome storage granule; P:carbon utilization; P:proteasomal ubiquitin-independent protein catabolic process",IPR000426 (SMART); IPR000426 (PFAM); IPR001353 (PFAM); IPR029055 (G3DSA:3.60.20.GENE3D); PTHR11599 (PANTHER); PTHR11599:SF10 (PANTHER); IPR023332 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY),,
RL4_JR_06027,285,380,405,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,114.0328947,0,-1.417885944,0.754222291,-1.879931103,0.060117468,0.152689386,28.7538158,0,-1.380194474,1.218876867,-1.132349388,0.257487574,0.412910207,105.1681793,0,-1.223459299,0.78364416,-1.561243433,0.118466325,0.219782494,119.6412461,0,-1.695815997,0.790813564,-2.14439417,0.032001317,0.095579155,113.0914029,1,-1.155751158,0.735457066,-1.571473321,0.116072747,0.213718232,N,-,,DNA polymerase,P:nucleic acid metabolic process; P:nucleobase-containing compound biosynthetic process; P:cellular macromolecule biosynthetic process,IPR007015 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR13213:SF2 (PANTHER); IPR007015 (PANTHER); PTHR13213:SF2 (PANTHER); IPR007015 (PANTHER); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_06028,1059,1069,1841,0,0,10,0,0,0,2,0,0,0,1,0,0,1,0,0.015901563,1,7.871528,3.973277037,1.981117331,0.047578117,NA,0.005010166,0,11.10419825,3.765442626,2.948975554,0.003188292,0.016079667,0.01312615,1,8.436770725,2.240862621,3.76496562,0.000166572,0.001577526,0.015150793,1,8.016170674,3.973433359,2.017441832,0.043649426,0.113446415,0.013085742,1,8.344620785,1.511525422,5.520661885,3.38E-08,1.07E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_06029,5215,4100,3124,0,0,1,15,0,0,0,0,3,0,5,0,0,0,0,129.7069183,1,-0.71098532,0.613271013,-1.159332995,0.246320477,0.42248024,73.77889569,1,0.26252153,0.973981006,0.269534548,0.78751836,0.871568261,75.76032383,1,-4.054408382,1.191254173,-3.403478849,0.000665336,0.004160505,110.0412022,1,-2.154854723,0.85181747,-2.529714169,0.011415548,0.053960049,108.8765239,0,-0.723995219,0.595442015,-1.21589542,0.224024763,0.350579711,N,-,,Tip elongation 1,C:spindle; C:cytoplasmic part; F:binding; P:organelle organization; P:sexual reproduction; P:regulation of biological process; P:microtubule-based process,IPR000938 (SMART); IPR000938 (G3DSA:2.30.30.GENE3D); IPR000938 (PFAM); IPR032108 (PFAM); PTHR18916 (PANTHER); PTHR18916:SF36 (PANTHER); IPR000938 (PROSITE_PROFILES); IPR000938 (SUPERFAMILY),,
RL4_JR_06030,405,235,258,0,0,5,0,0,0,0,0,0,0,2,0,0,0,0,65.62907522,1,-0.356440054,0.826649839,-0.431186262,0.666332942,0.814617734,10.60277367,0,0.059080151,1.238635686,0.047697763,0.961957117,0.979638423,38.79136029,0,-1.64219941,1.214409496,-1.352261668,0.176291622,0.295590657,36.0060952,1,-2.081698071,1.172248886,-1.77581578,0.075763286,0.159970398,76.67949911,0,1.194636549,0.589410932,2.026831342,0.042679664,0.098908583,N,-,,cytoskeleton-associated,C:integral component of membrane,no IPS match,,
RL4_JR_06031,544,794,778,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,235.4722668,0,-5.981741253,1.255711528,-4.76362693,1.90E-06,2.68E-05,92.91275911,0,-1.11972806,1.024912692,-1.092510679,0.274608699,0.432822992,193.9476571,0,-5.41053685,1.229634239,-4.400118895,1.08E-05,0.000199878,223.8631358,0,-5.83365364,1.234371332,-4.726011928,2.29E-06,3.81E-05,208.107565,0,-2.962658903,0.870866443,-3.401967003,0.000669027,0.003457836,N,-,,nop14-like family,"C:nuclear part; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:90S preribosome",IPR007276 (PFAM); PTHR23183:SF0 (PANTHER); IPR007276 (PANTHER),,
RL4_JR_06032,112,72,57,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14.8198456,0,0.773010169,1.030695652,0.749988775,0.453261465,0.642400156,24.61538425,0,3.189605206,1.131821128,2.818117747,0.004830609,0.020188037,12.46248021,0,0.574401748,1.206028429,0.476275462,0.633878144,0.74443184,6.878535558,0,-0.809423204,1.212313846,-0.667668035,0.504345518,0.641278208,5.873386166,0,-0.468094666,1.213755995,-0.385657964,0.699749999,0.787714584,N,-,,hypothetical protein F503_08353,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_06033,207,168,249,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,106.7926516,0,1.89885907,0.439077459,4.324656232,1.53E-05,0.000166395,6.889986897,0,0.680988978,1.223465519,0.556606596,0.577796246,0.717161692,25.74816275,0,-1.011593442,1.189987213,-0.850087657,0.395276354,0.538162695,37.99332388,1,-0.082944003,0.850233497,-0.097554381,0.92228615,0.954040383,51.36112454,0,1.153572146,0.624478283,1.847257424,0.06470984,0.136753733,N,-,,thioredoxin,"F:protein disulfide oxidoreductase activity; P:protein denaturation involved in proteasomal ubiquitin-dependent protein catabolic process; F:thioredoxin-disulfide reductase activity; P:glycerol ether metabolic process; C:proteasome complex; P:negative regulation of sequence-specific DNA binding transcription factor activity; P:cell redox homeostasis; P:protein folding; P:sulfate assimilation; C:mitochondrion; P:cellular oxidant detoxification; C:cytosol; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; P:oxidation-reduction process; C:nuclear periphery; P:negative regulation of transcription from RNA polymerase II promoter in response to hydrogen peroxide",IPR010400 (PFAM); IPR010400 (G3DSA:2.60.120.GENE3D); PTHR12175:SF2 (PANTHER); PTHR12175 (PANTHER); IPR010400 (PROSITE_PROFILES); IPR008979 (SUPERFAMILY),,
RL4_JR_06034,648,660,582,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,93.43063901,0,0.860930943,0.482896421,1.782848051,0.074611041,0.179022611,11.70676197,0,-0.083785911,1.207965735,-0.069361165,0.94470214,0.97033501,30.43692486,0,-2.73881323,1.191138351,-2.299324195,0.021486537,0.058849847,114.2727845,0,0.796078416,0.526574178,1.511806786,0.130583023,0.23952049,41.65818776,0,-0.624366504,0.853269902,-0.73173389,0.464331007,0.595333854,N,-, Effector probability:0.642,thioredoxin,"F:oxidoreductase activity, acting on a sulfur group of donors; C:nucleus; C:cytoplasm; P:regulation of transcription, DNA-templated; P:response to chemical; P:negative regulation of biological process; P:single-organism metabolic process; P:organic substance metabolic process; P:cellular process",PR00421 (PRINTS); IPR010400 (G3DSA:2.60.120.GENE3D); IPR010400 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR013766 (PFAM); IPR005746 (PANTHER); IPR013766 (PROSITE_PROFILES); IPR010400 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR008979 (SUPERFAMILY),8.A.88.1.3, the calciquestrin (casq) family.
RL4_JR_06035,6149,5665,3978,1,0,6,0,0,0,0,1,0,1,0,0,0,0,5,11.012871,1,-1.563436768,1.190008884,-1.313802602,0.188912642,0.34812499,3.508422647,0,1.654678983,1.257392109,1.315961005,0.188187131,0.328702354,9.111456552,1,-0.998759793,1.192602122,-0.8374627,0.402332535,0.544401842,24.15872908,1,0.312960637,1.011084273,0.309529725,0.756918604,0.841159134,8.991329319,1,-1.082269982,1.196774263,-0.904322574,0.36582438,0.502165381,N,-,,J domain-containing,P:biological_process; C:endoplasmic reticulum,IPR001623 (PFAM); IPR001623 (G3DSA:1.10.287.GENE3D); IPR001623 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY),,
RL4_JR_06036,331,214,121,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,21.08905015,1,0.916329576,0.881366369,1.039669323,0.298493558,0.484117385,3.053379355,0,1.855043107,1.279335394,1.450005304,0.14705704,0.272820997,30.09677052,0,1.031412331,1.040425363,0.991337166,0.321520971,0.464209169,9.181688907,0,-1.226041005,1.206214753,-1.016436752,0.309421452,0.455163766,37.69708293,0,2.064722706,0.702808571,2.937816627,0.003305325,0.012783198,N,-,,hypothetical protein CMQ_344,,no IPS match,,
RL4_JR_06037,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,66.24946251,0,-3.121899094,1.188489505,-2.626778849,0.008619733,0.033666399,19.68305184,0,-0.833406019,1.22780527,-0.678777033,0.497279148,0.652171487,72.31576217,0,-1.099947135,0.892815273,-1.231998565,0.21794962,0.346882873,104.6849988,0,-0.563888882,0.685809777,-0.822223451,0.410949734,0.55470818,73.96942914,0,-0.688606374,0.755784376,-0.911114857,0.362234859,0.4990649,Y,-,,endoplasmic reticulum domain containing,C:membrane,IPR001623 (PRINTS); IPR001623 (SMART); IPR001623 (G3DSA:1.10.287.GENE3D); IPR001623 (PFAM); IPR001623 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY); IPR001623 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_06038,2344,1402,1365,2,1,11,0,0,0,2,0,0,0,4,0,0,0,1,79.47395469,1,0.184808513,0.549067061,0.336586414,0.736428699,0.861136737,13.5989908,0,-0.299937623,1.204736674,-0.248965296,0.803387626,0.88102812,48.32632554,1,-1.133629017,1.031562741,-1.098943352,0.271792776,0.410592787,56.80500272,1,-0.661371436,0.746415247,-0.886063674,0.375583217,0.521142945,54.19254536,1,-0.11749805,0.687817097,-0.170827464,0.864359434,0.90974682,N,-,,prenylated rab acceptor 1,P:ER to Golgi vesicle-mediated transport; C:integral component of membrane; C:endoplasmic reticulum; C:Golgi apparatus; C:ER to Golgi transport vesicle,IPR004895 (PFAM); PTHR19317:SF0 (PANTHER); PTHR19317 (PANTHER),9.A.49.1.1, the prenylated rab acceptor protein 1 (pra1) family.
RL4_JR_06039,5182,3262,4728,0,1,3,0,0,0,0,0,2,0,3,0,0,0,0,238.6818733,1,0.843318485,0.472766686,1.783794227,0.074457108,0.178758413,38.85123472,0,-0.498332675,1.109816024,-0.449022779,0.653415225,0.77645796,125.5590875,1,-0.913965221,0.67094292,-1.362210098,0.17313159,0.292033358,161.4880294,1,0.003773702,0.447396406,0.008434807,0.993270077,0.995343843,120.3279763,0,-0.702781887,0.600183143,-1.170945728,0.241620593,0.370892739,N,-,,prenylated rab acceptor 1,C:intracellular membrane-bounded organelle; C:endomembrane system; C:cytoplasmic part,no IPS match,,
RL4_JR_06040,1296,1911,4561,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,34.60153668,1,-0.372876759,0.92742641,-0.402055359,0.687643285,0.829851172,7.320986945,0,0.593396302,1.262217562,0.470122046,0.638267825,0.763838605,19.13557121,0,-2.069288786,1.223731871,-1.690965835,0.090843328,0.180294408,22.08362735,0,-2.492168587,1.226435492,-2.032042129,0.042149391,0.111426263,19.03602008,0,-2.164442392,1.238616993,-1.747467056,0.080556355,0.162057042,N,-,,hypothetical protein F503_08358,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_06041,6352,9382,12411,1,0,1,0,0,0,1,0,0,0,2,0,0,2,0,592.6507605,1,-2.028739035,0.600273684,-3.379690111,0.000725676,0.004585643,166.1184199,0,-2.909357428,1.111516393,-2.617466955,0.008858507,0.030781257,428.0517683,1,-4.645371389,1.031250374,-4.504600925,6.65E-06,0.000133576,508.340895,1,-2.91866881,0.531086832,-5.495652747,3.89E-08,9.58E-07,445.5922279,1,-2.61045867,0.734161577,-3.555700479,0.000376973,0.002132321,Y,-,,cytochrome b2,F:FMN binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR000262 (PFAM); IPR012133 (PIRSF); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR10578:SF71 (PANTHER); PTHR10578 (PANTHER); IPR012133 (PROSITE_PROFILES); SSF51395 (SUPERFAMILY),,
RL4_JR_06042,307,262,305,0,1,0,0,0,1,0,0,0,3,3,1,0,5,0,198.8833711,1,0.380273315,0.412799531,0.921205782,0.356943,0.547872248,28.24060484,1,-1.354178056,1.201041246,-1.127503373,0.259529715,0.415658193,86.34389,0,-2.189078514,1.038269905,-2.108390607,0.034997216,0.086240817,215.324376,1,0.402547605,0.466279037,0.863319115,0.387962037,0.532987195,98.6415787,1,-1.148221064,0.688862558,-1.666836223,0.095546975,0.184444829,N,-,,cyclin-related 2,F:protein kinase binding; P:regulation of cyclin-dependent protein serine/threonine kinase activity,IPR013922 (PFAM); PTHR15615:SF34 (PANTHER); PTHR15615 (PANTHER); PTHR15615:SF34 (PANTHER); PTHR15615 (PANTHER),,
RL4_JR_06043,65361,38924,47113,26,30,73,0,2,8,4,13,10,15,14,13,0,14,4,28.53237172,1,4.559295445,0.577107913,7.900247674,2.78E-15,1.94E-13,0.577533978,1,4.257576931,1.512239447,2.815411898,0.004871475,0.020291799,1.494662004,1,1.609149014,1.220844199,1.318062547,0.187482711,0.309664727,5.735566139,1,2.133625093,1.15374934,1.849296913,0.064414951,0.142807397,1.470120866,1,1.530069777,1.207294341,1.267354384,0.205028603,0.327580717,N,-,,hypothetical protein CMQ_7834,P:mycelium development,IPR021765 (PFAM); PTHR33365:SF3 (PANTHER); PTHR33365 (PANTHER),,
RL4_JR_06044,711,658,591,0,0,10,2,0,0,0,0,0,0,9,0,0,0,0,17.53577763,1,3.279438645,0.900129908,3.643294836,0.00026917,0.001981851,0.59806593,1,4.206955288,1.529969909,2.749698058,0.00596502,0.023186611,1.561584432,0,1.545409504,1.25146806,1.234877303,0.216876172,0.34560906,1.802069278,1,1.122757849,1.276534762,0.879535663,0.379110905,0.524886902,1.551475544,0,1.4526212,1.250732446,1.16141642,0.245472595,0.375608404,Y,-,,glutaminyl-peptide cyclotransferase,F:catalytic activity,G3DSA:3.40.630.10 (GENE3D); IPR007484 (PFAM); PTHR12283 (PANTHER); PTHR12283:SF2 (PANTHER); SSF53187 (SUPERFAMILY),,
RL4_JR_06045,23000,13738,13286,0,0,0,0,0,0,0,0,1,0,0,0,0,3,0,3.274381337,0,0.18657182,1.218123294,0.15316333,0.878269475,0.940772371,1.044253636,0,3.40305731,1.390302908,2.447709265,0.014376761,0.044547038,34.08097775,1,3.575504384,0.741226597,4.823766979,1.41E-06,3.61E-05,15.16012018,0,2.63375329,0.854305851,3.082916131,0.002049829,0.013476961,2.669742251,1,0.669666325,1.202287197,0.556993642,0.577531773,0.691031577,N,-,,MFS transporter,P:transmembrane transport; C:integral component of membrane; P:phosphorylation; F:kinase activity,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); PTHR23502:SF46 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.78, the major facilitator superfamily (mfs).
RL4_JR_06046,602,423,731,0,0,0,3,0,0,6,0,1,0,0,0,0,1,0,18.14383218,0,-2.283881486,1.189726691,-1.919669033,0.054899718,0.14261292,5.813597769,1,0.926094629,1.242292528,0.745472269,0.455986269,0.615609912,21.55024221,1,-0.761109114,1.194022196,-0.63743297,0.523842859,0.653770353,36.63138452,0,-0.40034524,1.016231844,-0.393950694,0.693617442,0.793276471,14.81582923,1,-1.802907988,1.19675669,-1.506495015,0.131940146,0.234985748,N,-,,hypothetical protein F503_02190,,PTHR22705 (PANTHER),,
RL4_JR_06047,8229,4424,6234,0,0,10,0,0,0,0,1,2,1,11,6,0,7,2,97.63859155,1,0.026537015,0.545150823,0.048678299,0.961175671,0.980415288,15.48735874,0,-0.487463225,1.211304919,-0.402428173,0.68736894,0.801283935,70.61939597,1,-0.314096435,0.744738095,-0.421754221,0.673204423,0.775195812,75.56862248,1,-0.258336391,0.621645771,-0.415568484,0.677725792,0.780301756,61.43176816,1,-0.984488798,0.834005624,-1.180434245,0.237827549,0.366850081,N,-,,Ubiquitin-conjugating enzyme,F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; C:cytoplasm; F:ligase activity; P:protein ubiquitination,SM00212 (SMART); IPR016135 (G3DSA:3.10.110.GENE3D); IPR016135 (G3DSA:3.10.110.GENE3D); IPR000608 (PFAM); PTHR24067 (PANTHER); PTHR24067:SF22 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY); IPR016135 (SUPERFAMILY),3.A.20.1.1, the peroxisomal protein importer (ppi) family.
RL4_JR_06048,7333,3949,6118,0,0,13,0,0,0,1,2,0,3,4,4,0,1,0,8.811604189,1,0.520866777,1.217140017,0.427943186,0.668692484,0.81640127,1.576868941,0,2.80843758,1.402927951,2.001840207,0.04530192,0.109069867,10.60943068,1,1.111488669,1.237600795,0.898099511,0.3691325,0.513690368,12.76730545,1,1.42436331,1.084414819,1.313485656,0.189019351,0.317532506,4.064884991,1,0.063159532,1.258927166,0.05016933,0.959987452,0.973935166,N,-,,replication factor C,C:Ctf18 RFC-like complex; C:nucleus; C:Elg1 RFC-like complex; F:DNA binding; F:ATP binding; P:sister chromatid cohesion; P:UV-damage excision repair; P:leading strand elongation; C:cytosol; C:DNA replication factor C complex; C:Rad17 RFC-like complex; P:mitotic DNA replication checkpoint,IPR003593 (SMART); G3DSA:1.20.272.10 (GENE3D); IPR003959 (PFAM); IPR013748 (PFAM); G3DSA:1.10.8.60 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11669 (PANTHER); PTHR11669:SF24 (PANTHER); IPR027417 (SUPERFAMILY); IPR008921 (SUPERFAMILY),,
RL4_JR_06049,31921,24543,22815,0,1,8,1,0,3,1,1,2,0,6,2,0,8,2,49.52234827,1,2.251031405,0.681587424,3.302630488,0.000957825,0.005737105,2.484844871,1,2.152268031,1.316612359,1.634701374,0.102111664,0.205932311,35.17518601,1,2.304378169,0.779166875,2.957489909,0.003101549,0.013857053,44.42141037,1,2.140340553,0.71560503,2.990952361,0.002781089,0.017457237,18.0266577,1,1.571332071,0.908229628,1.730104395,0.083611625,0.166975879,N,-,,hypothetical protein CMQ_1866,,no IPS match,,
RL4_JR_06050,6606,4488,4900,0,2,14,0,0,0,0,1,2,3,2,0,0,2,2,709.2258213,1,-1.355137676,0.357255358,-3.793190632,0.000148724,0.001200089,223.9827248,0,-1.718162045,0.864969664,-1.986384166,0.046990683,0.112258602,499.1597988,1,-2.58207921,0.531387317,-4.859128409,1.18E-06,3.11E-05,537.038392,1,-3.466583651,0.592026162,-5.855456858,4.76E-09,1.40E-07,455.4775376,1,-3.451800958,0.651851768,-5.295377153,1.19E-07,2.61E-06,N,-,,sec63 brl domain-containing,F:nucleic acid binding; F:ATP binding; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP; C:spliceosomal complex; C:cytosol; P:spliceosome conformational change to release U4 (or U4atac) and U1 (or U11); F:ATP-dependent RNA helicase activity,IPR001650 (SMART); IPR004179 (SMART); IPR014001 (SMART); IPR003593 (SMART); IPR001650 (PFAM); PIRSF039073 (PIRSF); IPR000008 (G3DSA:2.60.40.GENE3D); G3DSA:1.10.150.20 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.3380.10 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011545 (PFAM); IPR004179 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24075 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF158702 (SUPERFAMILY); IPR027417 (SUPERFAMILY); SSF158702 (SUPERFAMILY); IPR014756 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011991 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.5.9.1, the general secretory pathway (sec) family.
RL4_JR_06051,6949,5088,5253,2,0,5,0,0,0,0,0,1,0,2,0,0,3,1,60.88128167,1,-2.990261746,1.15817569,-2.581872311,0.009826593,0.037408003,18.09413495,0,-0.71197674,1.206910815,-0.589916612,0.555246556,0.700249893,47.14836722,1,-3.370179922,1.198852615,-2.811171182,0.004936152,0.018765519,66.44041814,1,-1.499803935,0.874089929,-1.715846259,0.086190185,0.175165721,54.06197966,1,-2.521902187,1.136453016,-2.219099383,0.026479964,0.068447699,N,-,,pwwp domain-containing,F:nucleotide binding; F:nucleic acid binding; F:hydrolase activity,IPR000313 (SMART); G3DSA:2.30.30.160 (GENE3D); IPR000313 (PFAM); PTHR12550 (PANTHER); IPR000313 (PROSITE_PROFILES); SSF63748 (SUPERFAMILY),,
RL4_JR_06052,4294,4632,5358,0,0,4,0,0,2,0,0,4,0,2,4,0,3,2,6.484257481,1,-0.799353289,1.207214793,-0.662146698,0.50787721,0.694362709,2.059923642,1,2.422859504,1.306819979,1.85401168,0.063737489,0.142669364,11.86027067,1,0.727892076,1.198330456,0.607421828,0.543571006,0.671275051,6.186336555,1,-0.656447947,1.203944418,-0.545247718,0.585583156,0.71065917,5.304531065,1,-0.320948564,1.210909183,-0.265047593,0.790972799,0.857727277,N,-,,origin recognition complex subunit,F:DNA binding; F:DNA replication origin binding; C:nuclear chromatin; P:DNA replication; C:nuclear origin of replication recognition complex,IPR020795 (PFAM); PTHR12748:SF0 (PANTHER); IPR020795 (PANTHER),,
RL4_JR_06053,1958,1366,3179,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.17021613,0,1.801064607,1.021355229,1.763406655,0.077831928,0.184311428,1.123513943,0,3.297454099,1.37951681,2.390296425,0.016834779,0.050444534,2.921365475,0,0.642187325,1.208946618,0.531195766,0.595283127,0.714565612,3.37062632,0,0.219668907,1.211508509,0.181318501,0.856117585,0.910268574,2.886508938,0,0.55702593,1.209937965,0.460375611,0.645246637,0.746557217,N,-,,hypothetical protein CMQ_1886,C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_06054,58307,60158,78722,25,10,94,4,1,2,1,6,2,13,51,2,8,47,2,35.81996562,1,-0.414513429,0.86660064,-0.478321167,0.632421633,0.790909435,7.739726141,1,0.513184093,1.223926774,0.419293134,0.675001914,0.792325758,20.14516832,1,-2.143450124,1.19605226,-1.79210407,0.073116297,0.152091512,50.53801101,1,0.167330922,0.750283368,0.223023633,0.823517114,0.889208785,27.65213981,1,-0.566930157,0.989782786,-0.572782397,0.566792039,0.683675172,N,-,,translocation SEC66,"P:filamentous growth; C:Sec62/Sec63 complex; C:integral component of membrane; P:posttranslational protein targeting to membrane, translocation",IPR018624 (PFAM); IPR018624 (PANTHER),3.A.5.8.1, the general secretory pathway (sec) family.
RL4_JR_06055,1236,1652,1601,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,121.4962681,1,0.576420154,0.434051657,1.327998971,0.184178447,0.341776417,35.76039871,0,1.018847676,0.988963327,1.030217854,0.30290775,0.463777379,77.84440293,0,-0.131233943,0.665357876,-0.197238129,0.843641194,0.89971805,131.8162293,0,1.001218782,0.408158729,2.45301328,0.014166511,0.063919752,50.63006173,0,-2.416049593,1.114134887,-2.168543165,0.030117384,0.075381735,N,-,,nuclear localization 4,"P:positive regulation of protein localization to nucleus; C:Cdc48p-Npl4p-Vms1p AAA ATPase complex; P:cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process; C:Doa10p ubiquitin ligase complex; F:polyubiquitin binding; C:VCP-NPL4-UFD1 AAA ATPase complex; P:mitochondria-associated ubiquitin-dependent protein catabolic process; C:RQC complex; C:nuclear membrane; C:perinuclear region of cytoplasm; P:nonfunctional rRNA decay; P:ribosome-associated ubiquitin-dependent protein catabolic process; P:retrograde protein transport, ER to cytosol; P:mitotic spindle disassembly; P:mRNA transport; P:ER-associated misfolded protein catabolic process",IPR007716 (PFAM); IPR016563 (PIRSF); IPR007717 (PFAM); G3DSA:3.10.20.90 (GENE3D); PTHR12710 (PANTHER); IPR029071 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_06056,318,274,274,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,73.90232856,0,-1.395752825,0.875690726,-1.59388787,0.110961152,0.238529928,15.8039947,0,-0.516747139,1.211289306,-0.426609181,0.669664009,0.788825193,41.19737973,0,-3.175527979,1.200570711,-2.645015367,0.008168721,0.027817063,56.85217617,0,-2.647308578,1.155021625,-2.291999145,0.021905693,0.080273303,40.81843532,0,-3.264920239,1.209233405,-2.699991768,0.006934119,0.023425917,N,-,,Carbamoyl-phosphate synthase arginine-specific large chain,F:ATP binding; F:catalytic activity; F:metal ion binding; P:nitrogen compound metabolic process; C:mitochondrion,IPR005483 (PRINTS); IPR005480 (SMART); IPR005480 (PFAM); IPR016185 (G3DSA:3.40.50.GENE3D); IPR013816 (G3DSA:3.30.470.GENE3D); IPR005479 (PFAM); IPR006275 (TIGRFAM); IPR013815 (G3DSA:3.30.1490.GENE3D); IPR016185 (G3DSA:3.40.50.GENE3D); IPR005480 (G3DSA:1.10.1030.GENE3D); PTHR11405 (PANTHER); PTHR11405:SF5 (PANTHER); IPR011761 (PROSITE_PROFILES); IPR011761 (PROSITE_PROFILES); SSF56059 (SUPERFAMILY); IPR005480 (SUPERFAMILY); SSF56059 (SUPERFAMILY); IPR011607 (SUPERFAMILY); IPR016185 (SUPERFAMILY); IPR016185 (SUPERFAMILY),,
RL4_JR_06057,1968,1748,1677,5,8,7,0,0,1,0,1,1,0,4,0,0,0,0,0.484263299,1,2.943790632,2.01198356,1.463128571,0.143432201,NA,0.156050484,1,6.145617292,1.932014961,3.180936698,0.001467997,0.015023052,0.402227583,1,3.503357754,1.294701454,2.705919379,0.006811558,0.024086697,0.46382619,1,3.081320132,1.445915419,2.131051438,0.033084905,0.097379262,0.393868702,0,3.429645721,1.237698663,2.770986044,0.005588682,0.019627266,N,-,,Uncharacterised,,no IPS match,,
RL4_JR_06058,2302,1581,2551,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,327.0945568,1,0.817563314,0.42131606,1.940498812,0.052319098,0.137728043,36.45859695,0,-1.722701176,1.20642179,-1.427942689,0.153308355,0.281120864,95.14837724,1,-4.383134449,1.206088544,-3.634173023,0.000278874,0.002203995,113.8156975,0,-3.860081114,1.162605992,-3.320197162,0.000899539,0.006741548,135.7929328,0,-0.873370902,0.609713946,-1.432427301,0.15202157,0.261638347,N,-,,phenylalanyl-tRNA synthetase alpha chain,F:ATP binding; F:phenylalanine-tRNA ligase activity; C:cytosol; P:phenylalanyl-tRNA aminoacylation; F:tRNA binding; C:phenylalanine-tRNA ligase complex,IPR002319 (PFAM); IPR004529 (TIGRFAM); G3DSA:3.30.930.10 (GENE3D); PTHR11538 (PANTHER); PTHR11538 (PANTHER); PTHR11538:SF40 (PANTHER); IPR006195 (PROSITE_PROFILES); SSF55681 (SUPERFAMILY),,
RL4_JR_06059,161,143,110,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38.81289604,0,2.514359801,0.584922108,4.298623297,1.72E-05,0.000184967,2.624653114,0,2.073331663,1.284611873,1.613975167,0.106532813,0.212477858,6.831608637,0,-0.583377304,1.20212035,-0.485290266,0.62747046,0.73926579,11.8942333,0,-0.059337412,1.151129868,-0.051547105,0.958889568,0.976481804,6.75811098,0,-0.670340281,1.209059732,-0.55443107,0.579283867,0.692064797,N,-,,DUF1746 domain containing,P:biological_process; P:protein localization to Golgi apparatus; C:membrane; C:integral component of membrane; P:protein processing; C:endoplasmic reticulum; C:cellular_component; P:regulation of protein glycosylation; F:molecular_function,IPR013715 (PFAM); PTHR39405 (PANTHER),,
RL4_JR_06060,1632,1936,1498,0,0,96,0,0,3,1,4,1,9,47,9,0,25,20,91.41961194,1,-2.795718368,1.092699977,-2.55854162,0.010511224,0.039425546,26.37289865,1,-1.255496618,1.232232417,-1.018879718,0.308260074,0.469769417,80.09213503,1,-2.958216308,1.226268925,-2.412371583,0.01584912,0.046521281,79.67028833,1,-4.34315905,1.233610224,-3.520689896,0.000430426,0.003696657,80.21601429,1,-1.851194507,0.928413607,-1.993932975,0.04615938,0.105452103,N,-,,RNA-3 -phosphate cyclase family,"P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:positive regulation of catalytic activity; C:endoplasmic reticulum; F:enzyme activator activity; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:nucleolus; F:endoribonuclease activity",IPR023797 (G3DSA:3.65.10.GENE3D); IPR013791 (PFAM); IPR023797 (PFAM); IPR016443 (TIGRFAM); PTHR11096:SF1 (PANTHER); IPR000228 (PANTHER); PD397608 (PRODOM); IPR013792 (SUPERFAMILY),,
RL4_JR_06061,4459,4234,6311,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,65.08670574,1,0.390772388,0.66131,0.590906516,0.55458306,0.733272058,10.93308154,0,0.014827725,1.225002721,0.012104239,0.990342451,0.994962411,72.89645273,0,0.756191895,0.644501724,1.173296931,0.240676752,0.37380508,50.25602006,0,-0.760054452,0.877587498,-0.86607256,0.386450372,0.531631795,28.29797966,1,-2.736396474,1.2159788,-2.250365282,0.024425767,0.063970743,N,-,,Metallo-hydrolase oxidoreductase,F:hydrolase activity,IPR001279 (PFAM); IPR001279 (G3DSA:3.60.15.GENE3D); PTHR15032 (PANTHER); PTHR15032:SF5 (PANTHER); PTHR15032:SF5 (PANTHER); PTHR15032 (PANTHER); PTHR15032 (PANTHER); PTHR15032:SF5 (PANTHER); IPR001279 (SUPERFAMILY),,
RL4_JR_06062,78,128,139,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,184.1504698,0,-3.79382924,1.077741865,-3.520165046,0.000431278,0.002974107,54.27237453,0,-2.296647164,1.22139048,-1.880354564,0.060059771,0.136244959,157.6938566,0,-3.135636282,1.071795303,-2.925592484,0.00343801,0.014951207,220.8991878,1,-1.378501092,0.594792708,-2.317615992,0.0204702,0.077654844,152.777199,0,-2.893422847,0.93167612,-3.105610184,0.001898869,0.008108834,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane; F:transporter activity,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23504 (PANTHER); PTHR23504:SF3 (PANTHER); PTHR23504 (PANTHER); PTHR23504:SF3 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.48, the major facilitator superfamily (mfs).
RL4_JR_06063,3656,2626,2326,0,0,20,0,0,3,1,7,2,6,29,0,0,8,0,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,g-patch domain containing,F:nucleic acid binding,IPR025239 (SMART); IPR025239 (PFAM); PTHR21032:SF0 (PANTHER); PTHR21032 (PANTHER); PTHR21032 (PANTHER); PTHR21032:SF0 (PANTHER); IPR000467 (PROSITE_PROFILES),,
RL4_JR_06064,7839,5485,5878,0,3,13,0,0,0,1,0,2,1,2,5,0,9,1,47.85539778,1,3.198519296,0.772355927,4.141250405,3.45E-05,0.000336267,1.19986333,0,3.202742194,1.463176562,2.188896594,0.028604357,0.076333588,18.76645405,1,2.391305881,1.084228763,2.205536287,0.027416484,0.071518806,50.11547813,1,3.515789658,0.714703163,4.919230585,8.69E-07,1.61E-05,54.9214983,1,4.177240374,0.653321172,6.393854286,1.62E-10,1.10E-08,N,-,,---NA---,,no IPS match,,
RL4_JR_06065,25209,19941,35148,0,2,5,0,0,0,0,0,0,4,4,0,0,4,1,168.7354861,1,-0.349454576,0.634539212,-0.550721798,0.5818244,0.755334732,33.34292811,0,-1.593770676,1.234104535,-1.291438959,0.196551509,0.33992497,178.2659332,0,0.254724727,0.522138675,0.487848802,0.625656941,0.737987985,212.8018977,1,0.318792794,0.511279006,0.623520211,0.532942725,0.665872022,150.6988699,1,-0.19043993,0.556819802,-0.342013573,0.732340678,0.81242035,N,-,,c6 zinc finger domain containing,"P:regulation of transcription, DNA-templated; F:binding",IPR001849 (SMART); IPR001138 (SMART); IPR000198 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); IPR001138 (G3DSA:4.10.240.GENE3D); IPR000198 (G3DSA:1.10.555.GENE3D); IPR001138 (PFAM); IPR000198 (PFAM); IPR001849 (PFAM); PTHR31845 (PANTHER); PTHR31845:SF5 (PANTHER); PTHR31845:SF5 (PANTHER); PTHR31845 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR000198 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR008936 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR001138 (SUPERFAMILY),9.A.1.1.1, the non abc multidrug exporter (n-mde) family.
RL4_JR_06066,3629,3474,2984,0,1,4,0,0,0,5,0,0,0,1,0,0,0,2,105.3090068,1,0.468180817,0.562518031,0.832294772,0.405242581,0.596960812,13.23576252,0,-0.260859979,1.206679611,-0.216179984,0.828847455,0.897378751,164.5869551,1,2.112654997,0.417655648,5.058365683,4.23E-07,1.25E-05,215.1890711,1,2.0635449,0.81054293,2.545879833,0.01090027,0.05207089,86.92169308,1,1.059117974,0.492680218,2.149706716,0.031578421,0.078384778,N,-,,hypothetical protein SPSK_05362,,no IPS match,,
RL4_JR_06067,371,502,348,0,3,2,0,0,0,0,0,1,0,0,0,0,0,0,3.480728309,1,0.098502089,1.235394827,0.079733286,0.936449386,0.968626105,1.117117778,0,3.305846673,1.405947591,2.351329945,0.018706438,0.054598203,2.884283529,1,0.661097834,1.219291976,0.542198134,0.587682021,0.707793725,3.326522773,0,0.239081338,1.223839599,0.195353491,0.845116224,0.903026697,6.687298483,0,1.516490811,1.134104092,1.337170742,0.18116691,0.299089346,N,-,,---NA---,,no IPS match,,
RL4_JR_06068,42,70,58,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,76.1854347,0,1.678320422,0.59494671,2.820959245,0.004788029,0.021023001,7.184973476,0,0.620596464,1.250558365,0.496255498,0.61971416,0.749868843,62.85960554,0,1.130905954,0.686069121,1.648384862,0.09927372,0.192907322,69.55197209,0,1.069231863,1.5593942,0.685671309,0.492920403,0.631829229,33.59394153,0,0.505321947,0.765611477,0.660023996,0.50923843,0.63599841,N,-,,g2 mitotic-specific cyclin-b1,C:nucleus; P:regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle; F:cyclin-dependent protein serine/threonine kinase regulator activity; P:regulation of exit from mitosis; C:cytosol,IPR004367 (SMART); IPR013763 (SMART); IPR013763 (G3DSA:1.10.472.GENE3D); IPR006671 (PFAM); IPR013763 (G3DSA:1.10.472.GENE3D); IPR004367 (PFAM); PTHR10177:SF201 (PANTHER); PTHR10177 (PANTHER); IPR013763 (SUPERFAMILY); IPR013763 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_06069,3873,247,946,0,0,12,0,0,0,0,0,0,0,0,0,0,0,0,39.94767618,1,3.849982789,0.744074807,5.174187797,2.29E-07,4.14E-06,0.554445975,0,4.316336354,1.516101866,2.846996267,0.004413388,0.019009495,1.441105496,0,1.661478937,1.223315853,1.358176576,0.174407661,0.29325746,1.662648261,0,1.239100747,1.240589068,0.998800311,0.317891435,0.463983103,1.42386073,0,1.576496429,1.215971076,1.296491717,0.194806132,0.315588304,N,-,,nucleoside-diphosphate-sugar epimerase,F:coenzyme binding; F:catalytic activity,IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10366 (PANTHER); PTHR10366:SF435 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06070,1671,1561,1056,0,2,1,0,0,3,1,0,1,1,0,3,0,0,0,10.99090808,1,0.002804133,1.146657729,0.002445483,0.998048788,0.999396344,2.285919406,1,2.272757097,1.295003668,1.755019814,0.079255919,0.169068158,5.931695802,1,-0.379391615,1.197868209,-0.316722334,0.751454301,0.833357798,26.90115637,1,2.231296403,0.673671351,3.312143822,0.000925839,0.006933523,5.845702768,0,-0.461047513,1.198865412,-0.384569868,0.700556122,0.788171664,N,-,,raffinose synthase Sip1,F:catalytic activity; F:hydrolase activity,IPR008811 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR31268:SF6 (PANTHER); PTHR31268 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_06071,24698,13135,16763,3,1,15,0,0,0,1,1,7,0,14,0,0,11,0,16.97551202,1,-2.187633786,1.268910245,-1.724025631,0.084703216,0.19609622,5.370150737,0,1.040567328,1.318071985,0.789461683,0.429842216,0.591873611,13.97062492,1,-1.615286211,1.249239181,-1.29301597,0.196005536,0.320626926,16.12211857,1,-2.038100244,1.254761305,-1.624293191,0.10431325,0.202254243,13.77446042,1,-1.697657132,1.259414777,-1.347973013,0.177667063,0.294805252,N,-,,quinone oxidoreductase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR013149 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR013154 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR11695:SF605 (PANTHER); IPR002085 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_06072,3592,2826,3321,0,0,4,0,0,0,0,0,3,1,0,0,0,5,0,38.5880619,1,-2.277376764,1.187125693,-1.918395649,0.055060862,0.142734832,77.89363947,0,2.264820703,0.87652363,2.583867253,0.009769939,0.033129495,36.50912718,1,-1.690533069,1.219495713,-1.386255852,0.165668792,0.2824572,64.06929394,1,-0.031173746,0.730231253,-0.042690238,0.965948462,0.980572306,39.72792315,1,-1.06687693,1.021793721,-1.044121634,0.296429118,0.431475678,Y,-,,hypothetical protein SPBR_07248,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_06073,28940,27241,32389,15,11,18,0,0,0,4,2,3,6,8,2,0,16,6,606.6610402,1,-0.545037972,0.360922663,-1.51012399,0.131011789,0.26854125,127.838094,0,-2.505266595,1.109889321,-2.257222002,0.023994206,0.066448524,536.5102934,1,-0.522960159,0.368306044,-1.419906535,0.155634893,0.269664155,397.8611903,1,-2.789327079,0.556031561,-5.016490561,5.26E-07,1.02E-05,383.1333743,1,-1.660656782,0.476555437,-3.484708495,0.000492673,0.002674702,N,-,,mitochondrial-processing peptidase subunit beta,"F:zinc ion binding; P:mycelium development; C:mitochondrial matrix; C:mitochondrial respiratory chain complex III; P:protein processing; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:aerobic respiration; F:metalloendopeptidase activity",IPR011237 (G3DSA:3.30.830.GENE3D); IPR007863 (PFAM); G3DSA:3.40.50.1970 (GENE3D); G3DSA:1.20.1090.10 (GENE3D); IPR001670 (PFAM); IPR011237 (G3DSA:3.30.830.GENE3D); IPR011765 (PFAM); PTHR11851:SF103 (PANTHER); PTHR11851 (PANTHER); IPR011249 (SUPERFAMILY); IPR011249 (SUPERFAMILY); SSF56796 (SUPERFAMILY),,
RL4_JR_06074,7751,6551,8875,1,1,0,0,0,0,0,0,0,3,2,0,0,2,2,33.22605763,1,-0.283751637,0.926256956,-0.306342246,0.759344076,0.873023023,7.017947685,0,0.654533489,1.284856206,0.509421588,0.610456747,0.743567172,18.05590041,0,-1.98533378,1.226090102,-1.619239708,0.105395697,0.201630015,30.1326342,1,-1.453106859,1.180285128,-1.231149004,0.21826714,0.353292475,17.62119062,1,-2.05302972,1.224197308,-1.677041525,0.093534362,0.181320202,N,-,,choline transporter,C:integral component of plasma membrane; F:L-amino acid transmembrane transporter activity; P:L-alpha-amino acid transmembrane transport; F:antiporter activity; P:L-amino acid transport,IPR002293 (PFAM); IPR002293 (PANTHER); PTHR11785:SF312 (PANTHER),2.A.3.4.1, the amino acid-polyamine-organocation (apc) family.
RL4_JR_06075,434,322,387,0,0,2,0,0,0,0,0,1,0,0,0,0,0,1,217.5279311,1,0.18016005,0.362867805,0.496489487,0.619549103,0.781764585,61.1184788,0,0.608741773,0.84780067,0.718024642,0.472742093,0.63061353,140.809914,1,-0.746518438,1.489204803,-0.501286617,0.616169422,0.730627692,224.2305082,0,0.432506066,1.289025072,0.335529599,0.737225621,0.824978935,107.2732889,1,-1.115519565,0.616321431,-1.80996394,0.070301379,0.145324922,N,-,,nicotinate phosphoribosyltransferase,"C:chromosome, telomeric region; C:nucleus; F:nicotinate-nucleotide diphosphorylase (carboxylating) activity; F:nicotinate phosphoribosyltransferase activity; P:chromatin silencing at rDNA; P:NAD biosynthetic process; P:replicative cell aging; P:chromatin silencing at telomere; P:nicotinate nucleotide salvage; F:ligase activity",IPR007229 (PIRSF); IPR007229 (PFAM); G3DSA:3.20.140.10 (GENE3D); IPR007229 (PANTHER); PTHR11098:SF12 (PANTHER); PTHR11098:SF12 (PANTHER); SSF54675 (SUPERFAMILY); IPR002638 (SUPERFAMILY),,
RL4_JR_06076,3771,4893,4295,0,5,2,0,0,0,0,5,13,2,14,3,0,2,5,370.8004716,1,-3.918514537,0.836326114,-4.685390625,2.79E-06,3.76E-05,121.6949052,0,-2.429682877,1.12611632,-2.157577182,0.03096072,0.081187671,370.4128322,1,-1.989185982,0.601281325,-3.308245074,0.000938826,0.005465599,405.8468618,1,-2.368458768,0.547742991,-4.324032995,1.53E-05,0.000206823,310.559768,1,-3.242394148,0.787968555,-4.114877591,3.87E-05,0.000313031,N,-,,U3 small nucleolar RNA-associated 4,C:preribosome; C:nucleolus,IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22844 (PANTHER); PTHR22844:SF238 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR017986 (SUPERFAMILY),1.A.4.1.14, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_06077,4896,4317,4543,0,2,0,0,0,0,0,0,1,0,1,0,0,6,0,109.8008147,1,1.476440619,0.437767516,3.372659151,0.00074446,0.004682902,9.255622851,0,0.255210706,1.226599028,0.208063678,0.835179247,0.901245665,109.8509914,1,1.620194051,0.523149242,3.097001621,0.001954888,0.009646518,215.4344217,1,2.772813484,0.32764972,8.462737234,2.61E-17,1.97E-15,23.52696877,1,-2.470074798,1.193112111,-2.070278874,0.038426237,0.091244289,N,-,,PNG1,P:cellular protein metabolic process,IPR002931 (SMART); IPR018325 (PFAM); PTHR12143 (PANTHER); SSF54001 (SUPERFAMILY),,
RL4_JR_06078,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,227.3016593,0,-0.281608027,0.511082375,-0.551003206,0.581631477,0.755334732,38.0711489,0,-1.785138234,1.19676958,-1.49163069,0.135795988,0.255583301,153.1913708,0,-0.813954667,0.584270707,-1.393112228,0.163585856,0.279990398,114.3397797,0,-4.864381224,1.197070714,-4.063570488,4.83E-05,0.000573644,105.7910595,0,-2.866799975,0.992726018,-2.887805824,0.003879393,0.014553576,N,-,,duf1713 domain-containing,,IPR013177 (SMART); IPR013177 (PFAM),,
RL4_JR_06079,19285,16804,17963,0,0,2,0,0,0,3,0,2,0,7,0,0,4,7,5.173567623,1,-0.473374185,1.265169964,-0.37415857,0.708286345,0.842794633,1.633599046,0,2.757415161,1.37771877,2.001435431,0.045345486,0.109100786,28.32970832,1,2.503572669,0.894323217,2.79940476,0.005119692,0.019247553,23.86666558,1,1.443544858,1.054133178,1.36941412,0.170869863,0.29318719,45.26484904,1,3.450879463,0.65901987,5.236381511,1.64E-07,3.43E-06,N,-,,2og-Fe oxygenase family,F:oxidoreductase activity; F:metal ion binding; P:oxidation-reduction process,IPR026992 (PFAM); IPR027443 (G3DSA:2.60.120.GENE3D); IPR005123 (PFAM); PTHR10209 (PANTHER); PTHR10209:SF162 (PANTHER); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_06080,463,667,789,0,0,1,0,0,0,0,1,2,0,0,0,0,0,0,12.81631225,1,1.2473223,1.025869761,1.215868084,0.224035178,0.394321247,1.666319157,0,2.728942129,1.352329564,2.017956423,0.0435958,0.105821747,23.79485527,1,2.483791299,0.867968721,2.861613833,0.004214901,0.016940088,8.968875747,0,0.609692964,1.158103105,0.526458276,0.598569835,0.721070165,4.212263751,0,0.011491337,1.204581865,0.00953969,0.992388544,0.994647992,N,-,,carbohydrate esterase family 9,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; P:purine nucleobase metabolic process",IPR011059 (G3DSA:2.30.40.GENE3D); IPR013108 (PFAM); IPR011059 (G3DSA:2.30.40.GENE3D); PTHR11647 (PANTHER); PTHR11647:SF72 (PANTHER); IPR032466 (SUPERFAMILY); IPR011059 (SUPERFAMILY),,
RL4_JR_06081,276,258,408,0,0,6,0,0,0,0,0,0,0,0,0,0,1,0,323.9652328,1,-2.33502528,0.789010786,-2.959433914,0.003082048,0.014746831,86.75046106,0,-2.973291285,1.257012934,-2.365362523,0.018012429,0.05304162,227.9935611,0,-5.643861155,1.269799417,-4.44468715,8.80E-06,0.00016966,275.2722502,0,-3.843982756,1.008075892,-3.813187863,0.000137186,0.001395986,265.5317886,1,-2.231186554,0.775920657,-2.875534418,0.004033442,0.014981143,N,-,,tRNA(Met) cytidine acetyltransferase,P:ribosomal small subunit biogenesis; C:nucleolus; C:90S preribosome; P:negative regulation of G0 to G1 transition; F:N-acetyltransferase activity,IPR013562 (PFAM); IPR007807 (PFAM); IPR000182 (PFAM); IPR027992 (PFAM); IPR032672 (PANTHER); IPR033688 (PTHR10925:PANTHER); IPR033688 (HAMAP),,
RL4_JR_06082,21085,12574,19004,2,7,16,3,0,0,6,13,13,5,19,17,0,10,1,73.55897431,1,-0.532421942,0.781837011,-0.680988408,0.495878825,0.683456573,11.85253315,1,-0.10167011,1.225884591,-0.082936119,0.933902335,0.963741793,154.1720063,1,1.897244542,0.476151471,3.984539917,6.76E-05,0.00090065,128.4878699,1,1.114450451,0.543486336,2.050558364,0.040309975,0.107916048,104.6985208,1,1.328668846,0.640572987,2.074188066,0.038061848,0.09048514,Y,-,,hypothetical protein F503_05770,C:membrane; C:integral component of membrane,IPR028000 (PFAM); PD137583 (PRODOM),,
RL4_JR_06083,1831,1711,2330,0,3,6,0,0,0,0,0,0,0,1,3,0,0,0,260.5294548,1,2.158775565,0.603540237,3.576854419,0.000347754,0.002456255,16.03423934,0,-0.537577171,1.232568046,-0.436144011,0.662732247,0.783763818,102.3671092,0,0.61708769,0.591398222,1.043438527,0.296745238,0.437745707,52.21847812,1,-2.673142687,1.173517733,-2.277888618,0.022733215,0.081168718,63.40034303,0,-1.021307225,0.886978781,-1.151444935,0.249549237,0.379952785,Y,-,,glycosyl hydrolase family 31,"P:carbohydrate metabolic process; C:integral component of membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:carbohydrate binding",IPR000322 (PFAM); IPR031727 (PFAM); PTHR22762 (PANTHER); PTHR22762:SF82 (PANTHER); PTHR22762:SF82 (PANTHER); PTHR22762 (PANTHER); SSF51011 (SUPERFAMILY); IPR011013 (SUPERFAMILY); IPR017853 (SUPERFAMILY),,
RL4_JR_06084,4117,3444,4042,4,0,4,0,0,0,0,4,2,3,2,0,0,0,1,127.6087996,1,-1.861170697,0.712673613,-2.611533054,0.009013727,0.034899852,34.76098066,0,-1.65388563,1.209399161,-1.367526689,0.171460278,0.306901084,112.2481933,1,-1.898331773,0.86686955,-2.189870174,0.028533654,0.073654949,151.4138784,1,-1.61360745,0.691837218,-2.332351322,0.019682217,0.076324184,111.573655,1,-1.463134937,0.707174854,-2.068986091,0.038547392,0.09142477,N,-,,glucose transporter rco-3,C:integral component of plasma membrane; F:sugar:proton symporter activity; P:hexose transmembrane transport; P:glucose import; F:glucose transmembrane transporter activity,IPR003663 (PRINTS); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); IPR003663 (TIGRFAM); PTHR23500 (PANTHER); PTHR23500:SF128 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.117, the major facilitator superfamily (mfs).
RL4_JR_06085,136,112,95,0,0,10,0,0,0,0,0,0,0,0,0,0,0,3,0.138601118,1,4.748413389,3.502042684,1.355898205,0.175131559,NA,0.044083374,0,7.968633488,2.488513454,3.202166127,0.001363983,0.015023052,0.114879793,0,5.308747442,1.469025059,3.613789574,0.000301754,0.002335594,0.132548585,0,4.887673653,2.125113426,2.299958954,0.021450546,0.079510539,0.114005603,1,5.218165199,1.307864593,3.989835972,6.61E-05,0.000491885,N,-, Effector probability:0.596,Peptidase S8 subtilisin kexin partial,P:proteolysis; F:serine-type endopeptidase activity; F:peptidase activity,IPR000209 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (SUPERFAMILY),,
RL4_JR_06086,6940,6028,6444,2,4,38,0,0,0,4,5,8,21,100,11,0,28,31,0.00781203,1,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,0,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,1,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,0.007662926,1,9.0007212,4.037607722,2.229221316,0.025799183,0.085851084,0.006329724,1,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,N,-, Effector probability:0.797,Ankyrin-3,,no IPS match,,
RL4_JR_06087,1942,2355,1951,0,0,5,0,0,0,1,2,1,3,3,1,0,3,0,1.417122928,1,1.394458237,1.40295252,0.993945423,0.320249439,NA,0.455438032,0,4.60017203,1.612084397,2.853555334,0.0043233,0.018725049,1.178143098,1,1.952112931,1.262588694,1.546119445,0.122075723,0.224791819,1.358747199,1,1.530276756,1.300374398,1.176797051,0.23927652,0.377387964,1.159888128,1,1.871785999,1.246488624,1.501647078,0.133188278,0.236625955,N,-,,Ankyrin repeat-containing domain,,IPR013320 (SUPERFAMILY),,
RL4_JR_06088,1158,1227,1697,0,0,2,0,0,2,0,0,0,0,0,0,0,4,1,186.9219813,1,1.368461641,0.825229594,1.658279891,0.097260986,0.21696886,27.29383784,1,0.217969974,1.135585892,0.191944948,0.847785329,0.90961237,546.124719,0,3.47014323,0.542843318,6.392531905,1.63E-10,9.23E-09,450.7828154,0,2.839750145,0.381716051,7.439430797,1.01E-13,5.39E-12,722.4799768,1,3.964836119,0.546092884,7.260369496,3.86E-13,4.49E-11,N,-,,fumarate reductase,F:succinate dehydrogenase (ubiquinone) activity; P:oxidation-reduction process; F:fumarate reductase (NADH) activity,IPR001199 (SMART); IPR003953 (PFAM); IPR027477 (G3DSA:3.90.700.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR010960 (TIGRFAM); IPR001199 (PFAM); IPR001199 (G3DSA:3.10.120.GENE3D); PTHR11632 (PANTHER); PTHR11632:SF39 (PANTHER); IPR001199 (PROSITE_PROFILES); IPR023753 (SUPERFAMILY); IPR027477 (SUPERFAMILY); IPR001199 (SUPERFAMILY),3.D.10.1.6, the prokaryotic succinate dehydrogenase (sdh) family.
RL4_JR_06089,389,276,261,0,0,13,0,0,0,0,0,4,3,7,2,0,14,0,119.2148662,1,1.384839962,0.451882152,3.064604244,0.002179582,0.011232428,11.10971136,0,-0.008264976,1.223518792,-0.006755087,0.994610261,0.997468053,65.38135354,1,0.477857532,0.686075087,0.696509086,0.486110069,0.621390831,66.66972739,1,0.416966004,0.606900094,0.687042247,0.492056106,0.631120861,106.3803249,1,1.522711139,0.550745651,2.764817362,0.005695467,0.019933152,Y,-,,FAS1 domain-containing,,PTHR28156:SF1 (PANTHER); PTHR28156 (PANTHER); IPR000782 (SUPERFAMILY),,
RL4_JR_06090,24,18,45,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,381.1224308,0,-2.496075697,0.547212031,-4.561441552,5.08E-06,6.37E-05,102.8439985,0,-3.218788053,1.206354204,-2.668194833,0.007626002,0.027607437,313.4420645,0,-2.456745864,0.639640172,-3.840824842,0.000122622,0.001312284,370.8192378,0,-2.511717789,0.565367237,-4.442630604,8.89E-06,0.000128538,359.68443,0,-1.065936287,0.687663138,-1.550084958,0.121121126,0.220964216,N,-,,transcription factor,P:pyridine nucleotide biosynthetic process; F:transferase activity,IPR013194 (SMART); IPR003822 (PFAM); IPR013194 (PFAM); IPR031693 (PFAM); IPR003822 (G3DSA:1.20.1160.GENE3D); PTHR12346:SF0 (PANTHER); PTHR12346:SF0 (PANTHER); PTHR12346 (PANTHER); PTHR12346 (PANTHER); PTHR12346 (PANTHER); PTHR12346:SF0 (PANTHER); IPR003822 (PROSITE_PROFILES); IPR003822 (PROSITE_PROFILES); IPR003822 (PROSITE_PROFILES); IPR003822 (SUPERFAMILY); IPR003822 (SUPERFAMILY); IPR003822 (SUPERFAMILY),,
RL4_JR_06091,6958,7644,5818,0,0,9,0,0,1,1,0,4,5,1,2,0,0,2,201.925559,1,0.906642126,0.545973739,1.660596585,0.096794495,0.216283071,113.3028864,1,1.563444136,0.781380442,2.000874416,0.045405925,0.109142431,88.35899102,1,-0.969214811,0.777977518,-1.245813393,0.212832911,0.341044697,146.7350397,1,0.380140932,0.548688107,0.692817881,0.488423849,0.628612111,162.1591842,1,0.872326983,0.47992268,1.817640674,0.069119071,0.143554993,N,-,,acetyl- acetyltransferase,F:acetyl-CoA C-acetyltransferase activity; C:cytoplasm; P:ergosterol biosynthetic process,IPR016039 (G3DSA:3.40.47.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR020616 (PFAM); IPR002155 (TIGRFAM); IPR020617 (PFAM); IPR002155 (PIRSF); PTHR18919:SF69 (PANTHER); PTHR18919 (PANTHER); IPR016039 (SUPERFAMILY); IPR016039 (SUPERFAMILY),,
RL4_JR_06092,8553,5815,7964,3,5,10,0,0,0,2,0,0,2,2,0,0,0,0,53.3543314,1,-0.300664448,0.851171706,-0.353235952,0.723911557,0.854037669,7.374782228,0,0.582877104,1.224065344,0.476181363,0.633945176,0.76056323,19.16853513,1,-2.071772554,1.193378018,-1.736057244,0.082553713,0.166754548,31.42742884,1,-1.544548405,1.144320113,-1.349752038,0.177095534,0.301309407,37.88907266,0,0.45758019,0.759764917,0.60226549,0.546997429,0.667753673,N,-,,clavaminate synthase,F:dioxygenase activity; P:oxidation-reduction process,IPR027443 (G3DSA:2.60.120.GENE3D); PTHR10209:SF216 (PANTHER); PTHR10209:SF216 (PANTHER); PTHR10209 (PANTHER); PTHR10209 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_06093,394,266,258,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,113.8771358,0,0.8268424,0.990144849,0.835072163,0.403677079,0.595702216,14.43072885,0,-0.385523086,1.20756942,-0.319255423,0.749532832,0.846832384,37.37218584,0,-3.034865034,1.188666054,-2.553168758,0.010674776,0.034450568,47.12134277,0,-2.509712265,1.140450896,-2.200631586,0.027762116,0.088504855,56.05843038,0,-0.179640005,0.66839816,-0.268761968,0.788112862,0.855358852,N,-, Effector probability:0.71,Thioredoxin-like fold,,IPR012336 (G3DSA:3.40.30.GENE3D); PTHR13887 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_06094,13831,8882,9613,22,5,14,3,1,0,0,1,4,5,4,2,0,6,0,0.944266072,1,1.980390346,1.638034326,1.20900418,0.22666124,NA,0.307265999,1,5.168205554,1.776114519,2.909838019,0.003616161,0.017053643,0.787009227,1,2.534945796,1.316198081,1.925960714,0.054109279,0.120132093,0.907163492,1,2.113598496,1.397780802,1.51211012,0.130505851,0.239465701,0.765660518,1,2.470844212,1.277364586,1.934329665,0.053072608,0.117174042,N,-,,3-oxosteroid 1-dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,PR00411 (PRINTS); IPR003953 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR027477 (G3DSA:3.90.700.GENE3D); PTHR11632 (PANTHER); PTHR11632:SF59 (PANTHER); PTHR11632 (PANTHER); PTHR11632:SF59 (PANTHER); IPR027477 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_06095,3163,2411,3678,1,3,8,4,0,0,0,0,0,0,2,0,0,0,0,0.113113838,1,5.041886948,3.799215289,1.327086402,0.184480103,NA,0.036103108,1,8.257588955,2.57407184,3.207986983,0.001336675,0.015023052,0.093446384,0,5.610357364,1.485200718,3.777507846,0.000158406,0.001536109,0.107797934,1,5.186771309,2.262567697,2.292427014,0.021881015,0.080273303,0.091720701,0,5.53501625,1.295750754,4.271667395,1.94E-05,0.000175395,N,-,,major facilitator superfamily partial,P:transmembrane transport; C:integral component of membrane,PR01036 (PRINTS); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF83 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_06096,536,499,406,0,0,4,0,0,0,0,0,0,1,0,1,0,1,0,0.463103982,1,3.008199241,2.042991265,1.472448411,0.140899829,NA,0.147336097,0,6.228210438,1.932477007,3.222915675,0.001268929,0.015023052,0.38317693,0,3.572291796,1.285622788,2.778646917,0.005458582,0.020190971,0.442097015,1,3.150140026,1.441542389,2.185256604,0.028870037,0.09030248,0.378852922,1,3.486731062,1.238730913,2.814760676,0.004881357,0.017557279,N,-,,integral membrane,C:membrane,IPR013901 (PFAM),,
RL4_JR_06097,9250,5377,4129,0,4,10,0,0,0,0,0,3,1,8,0,0,1,0,0.01625695,1,7.841892454,3.971935915,1.97432502,0.048344798,NA,0.005182911,0,11.05900183,3.759459354,2.941646868,0.00326472,0.016208996,0.013406975,1,8.413847212,2.242522468,3.751956706,0.00017546,0.001628189,9.650751106,1,8.955260645,1.375122478,6.512336745,7.40E-11,2.86E-09,0.01313498,1,8.343198162,1.511882806,5.518415931,3.42E-08,1.07E-06,N,-,,HET-domain-containing partial,P:biological_process; C:cellular_component; F:molecular_function,IPR010730 (PFAM); PTHR10622:SF10 (PANTHER); PTHR10622 (PANTHER),,
RL4_JR_06098,1584,1524,1245,0,0,1,0,0,0,0,0,0,2,2,2,0,1,0,0.145927953,1,4.674043209,3.501248291,1.334964795,0.181887869,NA,0.045740556,0,7.914823427,2.531495623,3.126540436,0.001768762,0.015023052,0.120464401,0,5.239564292,1.550631695,3.378986968,0.000727535,0.004469393,0.139077732,1,4.81801326,2.189804238,2.200202729,0.027792515,0.088524638,0.120914516,1,5.134484074,1.387749179,3.699864608,0.000215715,0.001328216,Y,-,,Rhamnogalacturonase A,P:polysaccharide catabolic process; F:lyase activity; F:polygalacturonase activity; P:cell wall organization; C:extracellular region; F:cellulose binding,IPR012334 (G3DSA:2.160.20.GENE3D); IPR000743 (PFAM); PTHR31736 (PANTHER); PTHR31736:SF7 (PANTHER); IPR011050 (SUPERFAMILY),,
RL4_JR_06099,707,717,601,0,2,11,0,0,0,0,0,0,0,1,0,0,1,0,4.202534663,1,4.224100933,1.226027804,3.445354924,0.00057031,0.003755116,0.123190909,0,6.486858504,2.0446059,3.172669366,0.001510444,0.015023052,0.317744557,0,3.844375572,1.338422714,2.872317939,0.004074728,0.016563847,0.366464252,1,3.421580805,1.559773495,2.193639535,0.028261334,0.089465864,0.310724516,1,3.773116536,1.264108175,2.984805106,0.002837591,0.011311262,Y,-,,acid phosphatase,F:hydrolase activity,IPR002828 (G3DSA:3.40.1210.GENE3D); IPR002828 (PFAM); PTHR30457:SF2 (PANTHER); PTHR30457 (PANTHER); IPR002828 (SUPERFAMILY),,
RL4_JR_06100,1678,1418,2086,1,0,6,0,0,0,2,0,3,0,0,0,0,0,0,0.015520213,1,7.903931443,3.97477475,1.988523109,0.046753866,NA,0.004669197,0,11.19822047,3.97865899,2.814571568,0.00488423,0.020316236,0.012686116,1,8.48478896,3.975593067,2.134219679,0.032824803,0.08235831,0.014671433,0,8.059135983,3.975431149,2.027235709,0.042638313,0.112249849,0.01316219,0,8.337022933,2.087259438,3.994243736,6.49E-05,0.000483891,N,-,,zinc-binding oxidoreductase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR011032 (G3DSA:3.90.180.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002085 (PANTHER); PTHR11695:SF566 (PANTHER); IPR002085 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_06101,5102,5983,4690,0,0,13,0,0,0,1,1,3,6,12,1,0,15,2,7.002566342,1,-0.910138855,1.190464955,-0.764523853,0.444555127,0.633702731,2.242155724,0,2.300673846,1.299525553,1.770395235,0.076661323,0.16495874,5.802984477,1,-0.347731122,1.196217917,-0.29069212,0.771286799,0.846817867,6.693459879,1,-0.76985385,1.193493722,-0.645042228,0.518899821,0.653382439,5.705892577,1,-0.42627255,1.192788639,-0.357374757,0.720811272,0.803414148,N,-,,c6 zinc finger domain,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PTHR31001 (PANTHER),,
RL4_JR_06102,10718,11794,17075,0,0,4,0,0,0,0,0,0,2,6,0,0,3,3,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,integral membrane,C:integral component of membrane,no IPS match,,
RL4_JR_06103,3296,3774,2811,0,2,62,0,0,0,11,7,5,14,58,11,8,31,17,0.131577749,1,4.823544079,3.547763185,1.35960148,0.173956069,NA,0.042262489,0,8.030069987,2.48562636,3.230602201,0.001235297,0.015023052,0.109257594,1,5.382892645,1.438193103,3.742816339,0.000181969,0.001662686,0.126007984,1,4.961120149,2.11870567,2.341580626,0.019202278,0.075416239,0.107397298,1,5.303562851,1.278275695,4.148997647,3.34E-05,0.000275333,N,-,,glycosyl hydrolase family 2,F:catalytic activity,IPR006101 (PRINTS); IPR004199 (SMART); IPR008979 (G3DSA:2.60.120.GENE3D); IPR013812 (G3DSA:2.60.40.GENE3D); IPR013781 (G3DSA:3.20.20.GENE3D); IPR032312 (PFAM); IPR006102 (PFAM); IPR006104 (PFAM); IPR004199 (PFAM); IPR014718 (G3DSA:2.70.98.GENE3D); IPR013812 (G3DSA:2.60.40.GENE3D); IPR006103 (PFAM); PTHR10066 (PANTHER); PTHR10066 (PANTHER); PTHR10066:SF72 (PANTHER); PTHR10066 (PANTHER); PTHR10066:SF72 (PANTHER); PTHR10066:SF72 (PANTHER); IPR006102 (SUPERFAMILY); IPR011013 (SUPERFAMILY); IPR017853 (SUPERFAMILY); IPR006102 (SUPERFAMILY); IPR008979 (SUPERFAMILY),,
RL4_JR_06104,2335,2154,2418,0,6,1,0,0,0,1,0,2,0,0,0,0,3,0,1.328464414,1,1.487717101,1.407748992,1.056805659,0.290600291,NA,0.421715576,0,4.711005571,1.606099816,2.933196009,0.00335492,0.016427396,27.0942105,1,4.856574521,0.778236269,6.240488542,4.36E-10,2.36E-08,1.268439411,0,1.629330231,1.290991239,1.262076909,0.206921113,0.339118853,1.090233249,1,1.961587905,1.244316464,1.576438118,0.114924869,0.212067487,N,-,,MFS SP general alpha glucoside:H+ symporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR003663 (TIGRFAM); IPR005828 (PFAM); PTHR23500 (PANTHER); PTHR23500:SF162 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.11, the major facilitator superfamily (mfs).
RL4_JR_06105,793,663,775,1,0,0,0,0,1,0,0,0,3,0,0,0,0,0,3.269227212,1,0.188449681,1.303367684,0.144586737,0.885037169,0.944154115,1.04430516,1,3.402875961,1.46242129,2.326878023,0.019971758,0.057462802,2.714044782,0,0.748215976,1.259106501,0.594243597,0.552349197,0.679133261,7.142500348,1,1.269292058,1.202420719,1.055613928,0.291144635,0.435877484,2.68630661,0,0.660461564,1.262117754,0.52329631,0.600768068,0.710107015,N,-,,Zn(2)-C6 fungal-type DNA-binding domain,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_06106,3077,2652,2298,0,0,2,0,0,0,0,0,2,0,8,0,0,1,0,307.721917,1,2.623056201,0.603155971,4.348885405,1.37E-05,0.000152914,122.2640973,0,2.846625103,0.621312796,4.581629612,4.61E-06,0.000343379,468.9216216,1,3.536964283,0.568389612,6.222781357,4.88E-10,2.62E-08,243.8890273,1,2.356667356,0.294523577,8.001625481,1.23E-15,8.07E-14,217.0768457,1,2.476489388,0.869811271,2.847157161,0.004411158,0.016164927,Y,-,,glycoside hydrolase family 17,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR013781 (G3DSA:3.20.20.GENE3D); PTHR16631 (PANTHER); PTHR16631:SF13 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_06107,1991,2464,2524,1,3,1,0,0,4,0,1,0,0,0,0,0,2,0,20.16996029,1,8.329551389,1.156693681,7.201173074,5.97E-13,2.95E-11,0.012350409,1,9.802636223,3.283143771,2.985746865,0.002828867,0.015349618,0.03247374,1,7.128711554,1.941149078,3.672418382,0.000240266,0.001976672,22.67360604,0,9.01728396,0.991969085,9.090287285,9.88E-20,9.52E-18,0.032577657,1,7.024994113,1.450913835,4.841772091,1.29E-06,1.79E-05,N,-,,Major facilitator superfamily general substrate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662:SF89 (PANTHER); PTHR11662 (PANTHER); PTHR11662:SF89 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.20, the major facilitator superfamily (mfs).
RL4_JR_06108,2265,2100,1922,0,1,5,0,0,0,0,1,0,2,0,0,0,2,0,6.237037211,1,1.569670632,1.177296539,1.333283994,0.182438624,0.339955326,0.77313248,0,3.836836332,1.473194147,2.604433598,0.009202625,0.031670173,2.000049879,1,1.18937537,1.231812883,0.965548735,0.334270038,0.47771506,2.307078881,1,0.767088175,1.244720421,0.616273472,0.537714044,0.669250731,1.962943018,1,1.113426483,1.220358765,0.912376356,0.361570632,0.498692637,N,-,,5-oxoprolinase,F:hydrolase activity,IPR002821 (PFAM); IPR003692 (PFAM); IPR008040 (PFAM); PTHR11365 (PANTHER); PTHR11365:SF11 (PANTHER),,
RL4_JR_06109,443,809,1151,0,0,4,0,0,0,0,0,0,0,5,0,0,0,0,0.415068297,1,3.166478632,2.299609416,1.376963675,0.168523479,NA,0.131248032,0,6.39527736,2.078860345,3.076338137,0.0020956,0.015023052,0.341245461,0,3.741026496,1.402324427,2.667732534,0.007636502,0.026386331,0.393801459,1,3.317706099,1.636488036,2.027332938,0.042628375,0.112249849,0.335983111,0,3.66106114,1.332610769,2.747284673,0.006009095,0.020807828,N,-,,allantoate permease,C:membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662:SF303 (PANTHER); PTHR11662 (PANTHER); PTHR11662:SF303 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.4, the major facilitator superfamily (mfs).
RL4_JR_06110,1863,1313,1151,0,4,3,0,0,2,1,8,17,3,14,5,0,19,15,0.36373667,1,3.356659728,2.28171344,1.471113624,0.141260391,NA,0.115603132,1,6.578131617,2.027843635,3.243904758,0.001179032,0.015023052,0.300770877,1,3.921713632,1.304700186,3.005835113,0.002648526,0.012390792,0.347033582,1,3.499483671,1.523471666,2.297045458,0.021616177,0.079789934,0.297424976,1,3.836141629,1.244502358,3.082470359,0.002052902,0.008653468,N,-, Effector probability:0.957,FAD dependent oxidoreductase,"F:iron ion binding; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:heme binding",PTHR10961 (PANTHER); PTHR10961:SF21 (PANTHER),,
RL4_JR_06111,112,139,228,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,4.067221306,0,4.846321073,1.274761475,3.801747361,0.000143679,0.001163987,0.078023403,0,7.145071333,2.248451034,3.177774933,0.001484099,0.015023052,0.204564252,0,4.477718487,1.417438237,3.159021938,0.001582996,0.00822883,4.247741624,1,4.996047364,1.233955128,4.048807977,5.15E-05,0.000608909,0.203714637,0,4.38324254,1.319747501,3.321273605,0.000896076,0.004370315,N,-, Effector probability:0.66,---NA---,,no IPS match,,
RL4_JR_06112,1559,2019,3392,0,0,9,3,0,0,0,3,1,0,12,7,0,3,1,169.3836168,1,6.970534206,2.01501449,3.459297311,0.000541587,0.003586254,22.74624399,1,5.592031492,1.120048482,4.992669143,5.96E-07,5.37E-05,18.69906928,1,3.836665019,1.039366446,3.691349699,0.000223067,0.00188666,26.9858752,1,4.627001665,0.683665703,6.767930065,1.31E-11,5.44E-10,16.56016065,1,4.519989313,0.780808119,5.788860545,7.09E-09,3.45E-07,Y,-,,glycoside hydrolase family 61,P:metabolic process; F:hydrolase activity,IPR005103 (PFAM); PTHR33353:SF10 (PANTHER); PTHR33353 (PANTHER),,
RL4_JR_06113,5456,5086,4555,0,4,2,5,0,0,2,0,2,4,2,0,0,0,1,14.18193752,1,-1.928358017,1.189506935,-1.621140626,0.104987483,0.229559873,4.516985537,1,1.290130716,1.242596716,1.038253763,0.299151929,0.459416754,11.7347618,1,-1.363820194,1.192090232,-1.144057856,0.252599644,0.388178324,13.53850975,1,-1.786278891,1.189945617,-1.5011433,0.133318501,0.243435496,11.58617358,1,-1.448088908,1.197422793,-1.20933802,0.22653301,0.353737537,N,-,,Alpha beta hydrolase family,F:catalytic activity; F:binding,IPR029058 (G3DSA:3.40.50.GENE3D); PTHR19359:SF32 (PANTHER); PTHR19359 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_06114,1673,1541,1301,0,1,1,0,0,0,0,0,0,0,2,0,0,0,0,11.45566168,1,12.50377606,4.043464039,3.092342591,0.001985835,0.010418292,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,zinc-dependent alcohol dehydrogenase,F:zinc ion binding; F:metal ion binding; F:oxidoreductase activity; P:oxidation-reduction process; C:cellular_component,IPR016040 (G3DSA:3.40.50.GENE3D); IPR013154 (PFAM); IPR013149 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); PTHR11695:SF280 (PANTHER); IPR002085 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_06115,3234,2249,1930,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,1.565838918,0,1.250882442,1.315621024,0.950792378,0.341709782,NA,0.500118004,0,4.465235761,1.54597563,2.888296344,0.003873348,0.017716233,1.295672883,0,1.815586724,1.225899015,1.481024703,0.138599991,0.247213937,1.494641712,1,1.393224821,1.246706404,1.117524396,0.263770175,0.404417334,1.274572595,0,1.736461123,1.210366448,1.434657351,0.151384763,0.260897145,N,-,,hypothetical protein AK830_g5224,,no IPS match,,
RL4_JR_06116,3431,3868,3749,0,1,5,0,0,0,0,5,0,2,5,1,0,3,0,13.72528416,1,-1.881205775,1.217879221,-1.544657091,0.122429229,0.255965569,4.352127498,0,1.343704756,1.270890525,1.057293865,0.290377492,0.44960517,44.56240109,1,1.117584121,0.873824472,1.278957224,0.20091212,0.326385478,33.15795007,1,1.256669828,0.72748643,1.727413428,0.084093441,0.171974568,11.26633867,1,-1.40772707,1.225875756,-1.148344001,0.250826582,0.381553356,N,-,,hypothetical protein AK830_g5226,,IPR021889 (PFAM); PTHR37489 (PANTHER); PTHR37489:SF1 (PANTHER),,
RL4_JR_06117,1613,1495,2192,0,0,8,0,0,1,0,0,1,1,1,0,0,6,0,186.1362303,1,-0.405767114,0.480328085,-0.844770743,0.398238852,0.590351919,41.7351191,1,-0.634302202,1.127225781,-0.562710872,0.57363178,0.713480078,83.56998886,1,-4.195927421,1.199482371,-3.498115122,0.000468559,0.003223024,100.3887397,1,-3.671328155,1.153829612,-3.18186335,0.001463308,0.010182816,93.28274151,1,-2.594682057,0.980406111,-2.646538028,0.008132036,0.026586008,N,-,,AAT family amino acid transporter,P:transmembrane transport; C:membrane; P:amino acid transport,IPR004841 (PFAM); IPR002293 (PANTHER); PTHR11785:SF204 (PANTHER),2.A.3.1.2, the amino acid-polyamine-organocation (apc) family.
RL4_JR_06118,1371,1416,1963,3,0,3,0,0,0,0,0,0,1,1,0,0,0,0,95.32825628,1,5.117920753,0.395293235,12.94714986,2.44E-38,2.21E-35,0.907225812,0,3.606028049,1.417364039,2.54417916,0.010953489,0.036020537,13.41886424,0,1.919039152,1.191968603,1.609974581,0.107403406,0.204490843,92.29078125,1,5.071009581,0.420455347,12.06075655,1.70E-33,3.38E-31,24.76240725,0,3.505474333,0.742134165,4.723504859,2.32E-06,2.94E-05,N,-,,high affinity methionine permease,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PIRSF); IPR002293 (PFAM); PTHR11785:SF203 (PANTHER); IPR002293 (PANTHER),2.A.3.8.4, the amino acid-polyamine-organocation (apc) family.
RL4_JR_06119,2819,3545,2744,3,3,2,0,2,0,0,0,3,3,2,0,0,0,0,41.1310316,1,-0.158951062,0.874774737,-0.181705135,0.855814136,0.927670176,8.124687851,1,0.443126627,1.274238789,0.347757917,0.728021997,0.830407781,21.31202635,1,-2.224668955,1.23667668,-1.798909118,0.072033058,0.15042547,64.71782404,1,1.166505257,0.742879923,1.570247387,0.116357569,0.219062921,21.26154504,0,-2.323942221,1.254845543,-1.851974717,0.064029453,0.135598874,N,-,,Ribonuclease P subunit POP7,P:RNA metabolic process,IPR014612 (PFAM); IPR002775 (G3DSA:3.30.110.GENE3D); IPR020241 (PRODOM),,
RL4_JR_06120,2770,2086,1711,0,1,0,0,0,0,3,3,0,0,0,0,0,0,0,107.8689173,1,1.076602125,0.50327213,2.139204737,0.032419091,0.096207691,11.81007333,0,-0.096486924,1.219410479,-0.079125877,0.936932501,0.965156806,30.79493366,1,-2.75568703,1.202296354,-2.292019785,0.021904502,0.059757794,43.5592811,0,-1.45995295,1.033523664,-1.412597505,0.157774103,0.276282047,30.52770342,0,-2.845818521,1.211979728,-2.348074358,0.018870754,0.052218196,N,-,,37S ribosomal rsm22,P:tRNA aminoacylation for protein translation; F:aminoacyl-tRNA ligase activity; C:ribosome,IPR028241 (PFAM); IPR028241 (PTHR13618:PANTHER); IPR028241 (PTHR13618:PANTHER); IPR028241 (PTHR13618:PANTHER); PTHR13618 (PANTHER); PTHR13618 (PANTHER); PTHR13618 (PANTHER),,
RL4_JR_06121,1684,3044,1682,0,0,8,0,0,0,2,0,1,0,0,4,0,6,0,61.30864445,1,1.264717155,0.625017887,2.023489538,0.043022701,0.119056715,7.394275204,0,0.579158343,1.239444494,0.467272512,0.64030492,0.765552374,49.11526489,1,0.349916638,0.858293087,0.407688986,0.683502024,0.782587555,101.2278848,1,1.605179218,0.519059861,3.092474178,0.001984955,0.013144323,115.9618087,1,2.568573802,0.427367539,6.010222046,1.85E-09,1.04E-07,N,-,,nipsnap family,,G3DSA:3.30.70.900 (GENE3D); IPR012577 (PFAM); PTHR21017:SF17 (PANTHER); PTHR21017 (PANTHER); IPR011008 (SUPERFAMILY); IPR011008 (SUPERFAMILY),,
RL4_JR_06122,338,345,359,0,0,5,0,0,0,0,0,2,0,6,0,0,1,0,24.6916887,1,-2.728345092,1.254387574,-2.17504155,0.029627003,0.089451129,7.804562596,0,0.501122859,1.284552676,0.390114683,0.696451746,0.80740861,43.95241856,1,0.247013582,0.920840423,0.268247978,0.788508446,0.860304413,23.57085035,1,-2.586183613,1.246355819,-2.07499622,0.037986885,0.103765326,20.35443644,1,-2.261059328,1.258914583,-1.796038714,0.07248836,0.148812783,N,-,,dihydrofolate reductase,"F:hydrogen ion transmembrane transporter activity; C:proton-transporting ATP synthase complex, coupling factor F(o); P:ATP synthesis coupled proton transport",IPR005645 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR22778 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_06123,1635,1842,1837,4,0,3,0,0,0,1,0,0,5,2,3,0,2,0,121.4983553,1,-0.328466385,0.775432836,-0.423591019,0.671864106,0.818191876,24.11500513,0,-1.126370482,1.202260542,-0.936877194,0.348821732,0.511780485,116.1862714,1,-0.362134877,0.624726379,-0.579669579,0.562137462,0.6875737,138.9264302,1,-0.145638465,0.508359581,-0.286487105,0.774505068,0.853983207,65.80867465,1,-2.937284729,1.13193719,-2.594918476,0.009461336,0.030039519,N,-,,26S proteasome non-ATPase regulatory subunit 12,"P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:proteasome regulatory particle, lid subcomplex; C:nuclear proteasome complex; C:COP9 signalosome; C:proteasome storage granule; P:cullin deneddylation",IPR000717 (SMART); SM00753 (SMART); IPR000717 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); PTHR10855:SF1 (PANTHER); PTHR10855:SF1 (PANTHER); PTHR10855 (PANTHER); PTHR10855 (PANTHER); IPR011991 (SUPERFAMILY),,
RL4_JR_06124,4749,3749,2813,2,1,4,0,0,0,0,0,0,0,4,0,0,1,1,15.49556117,1,0.64612707,1.024678685,0.630565542,0.528324635,0.712762093,2.495665835,0,2.146046416,1.289058987,1.664816303,0.09594941,0.196281312,6.494118779,0,-0.510241045,1.202357011,-0.424367338,0.671297937,0.77398244,11.50480522,1,0.013817056,1.151062839,0.012003738,0.990422633,0.994153778,6.420850187,1,-0.596461738,1.208469572,-0.493567858,0.621611405,0.727524619,N,-,,"beta-1,3-glucan-binding","P:carbohydrate metabolic process; C:integral component of membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR000757 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); PTHR10963 (PANTHER); PTHR10963:SF28 (PANTHER); PTHR10963:SF28 (PANTHER); IPR000757 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),,
RL4_JR_06125,12,9,43,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.852431778,0,2.127882683,1.570468592,1.354934886,0.175438304,NA,0.271592391,0,5.34589101,1.722760348,3.103096153,0.001915074,0.015023052,0.706018048,0,2.690558878,1.25619355,2.141834654,0.03220679,0.081130017,32.9072408,0,5.933117271,0.59218937,10.01895266,1.26E-23,1.45E-21,23.86127416,0,5.761973232,0.672490108,8.56811597,1.05E-17,2.01E-15,N,-,,glycosyltransferase family 2,C:integral component of membrane; F:transferase activity,IPR029044 (G3DSA:3.90.550.GENE3D); IPR001173 (PFAM); PTHR35408:SF3 (PANTHER); PTHR35408 (PANTHER); IPR029044 (SUPERFAMILY),4.D.3.2.1, the glycan glucosyl transferase (opgh) family.
RL4_JR_06126,1628,1558,2006,1,0,1,0,0,0,0,0,0,3,3,1,0,0,0,34.7353612,1,-3.220702849,1.194501234,-2.696274191,0.007011992,0.028620751,11.04392453,0,0.000291013,1.212359071,0.000240038,0.999808477,0.999907176,36.5758019,0,-1.693911036,1.193546643,-1.419224834,0.155833478,0.269962035,33.15188381,1,-3.078260955,1.193762908,-2.578620037,0.009919583,0.048240047,28.41842318,0,-2.742529719,1.201411121,-2.28275706,0.022444683,0.059866283,N,-,,prion formation 1,C:polysome; F:ATPase activity; F:ATP binding; F:translation elongation factor activity; C:mitochondrion; P:ribosomal small subunit biogenesis; C:cytosol; P:translational elongation; P:poly(A)+ mRNA export from nucleus,IPR000953 (SMART); IPR003593 (SMART); IPR023780 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011989 (G3DSA:1.25.10.GENE3D); G3DSA:2.40.50.40 (GENE3D); IPR003439 (PFAM); PTHR19211 (PANTHER); PTHR19211:SF44 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR016197 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR016024 (SUPERFAMILY),3.A.1.121.9, the atp-binding cassette (abc) superfamily.
RL4_JR_06127,3404,3802,3132,0,1,3,0,0,0,2,0,0,2,3,0,0,7,0,1.488633839,1,1.32379664,1.327789551,0.996992813,0.318767998,NA,0.474534152,0,4.540955593,1.556105568,2.918153938,0.003521105,0.016899299,1.231135112,1,1.88916131,1.226751788,1.539970292,0.123567595,0.226753368,1.420310954,1,1.466725375,1.249627705,1.173729879,0.240503239,0.378944178,1.212991591,1,1.807974797,1.212676141,1.49089665,0.135988631,0.240630005,Y,-,,hypothetical protein F503_00878,,PS51257 (PROSITE_PROFILES),,
RL4_JR_06128,1951,2820,3062,0,1,2,0,0,0,2,6,2,2,1,0,0,16,1,236.7656384,1,3.876578848,2.137962033,1.813212203,0.069799098,0.17064127,14.22466556,0,2.102476958,1.159712984,1.812928705,0.069842818,0.153488985,30.17273492,1,0.360503323,1.062093829,0.339427001,0.734288081,0.821247518,74.71785107,1,2.177390449,1.529210679,1.423865579,0.154485388,0.271745057,24.01679944,1,0.624619285,0.904867099,0.690288425,0.490012825,0.618625917,Y,-,,glycosyl hydrolase family 16,"P:carbohydrate metabolic process; C:integral component of membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR013320 (G3DSA:2.60.120.GENE3D); IPR000757 (PFAM); PTHR10963:SF27 (PANTHER); PTHR10963 (PANTHER); IPR000757 (PROSITE_PROFILES); PS51257 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),,
RL4_JR_06129,7417,6767,6763,2,2,15,0,0,1,0,3,3,4,17,1,0,10,3,15.22011408,1,2.284030528,0.860199003,2.655235031,0.007925317,0.031519399,1.20915876,1,3.191595673,1.385193569,2.304079188,0.021218199,0.060332922,3.12280873,1,0.546314795,1.211412356,0.450973438,0.652008693,0.758466737,17.2484016,1,1.859096685,1.020906702,1.821025057,0.068603048,0.148747523,22.01080846,1,3.089010077,0.750878612,4.113860787,3.89E-05,0.000313867,N,-,,2-methylcitrate synthase,"F:citrate (Si)-synthase activity; P:propionate catabolic process, 2-methylcitrate cycle; F:2-methylcitrate synthase activity; C:mitochondrion; P:citrate metabolic process; P:tricarboxylic acid cycle",IPR002020 (PRINTS); IPR016142 (G3DSA:1.10.580.GENE3D); IPR002020 (PFAM); PTHR11739:SF15 (PANTHER); IPR002020 (PANTHER); IPR002020 (SUPERFAMILY),,
RL4_JR_06130,2479,2137,2523,0,0,9,0,0,0,0,0,1,0,0,0,0,0,0,46.84548565,1,0.613656145,0.609622232,1.00661707,0.314118828,0.50224638,29.96863346,0,1.452436727,1.113437374,1.304461985,0.192076113,0.333787344,79.85062352,1,1.514068763,0.569562615,2.658300813,0.007853576,0.026970693,48.24415713,0,0.499546742,0.667616795,0.748253708,0.454307141,0.596609572,64.80217109,0,1.582901495,0.515899515,3.068236058,0.002153265,0.0090159,N,-,,isocitrate lyase,"P:propionate catabolic process, 2-methylcitrate cycle; C:mitochondrial matrix; F:methylisocitrate lyase activity; F:isocitrate lyase activity",IPR015813 (G3DSA:3.20.20.GENE3D); IPR006254 (TIGRFAM); IPR006254 (PFAM); PTHR21631:SF13 (PANTHER); PTHR21631 (PANTHER); PTHR21631:SF13 (PANTHER); IPR015813 (SUPERFAMILY),,
RL4_JR_06131,103,154,138,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,388.2955549,0,1.483752717,0.677147265,2.191181733,0.028438644,0.086794784,61.55116275,1,0.569008556,0.885624586,0.642494083,0.52055243,0.670724318,209.1530667,0,0.537778765,0.537612806,1.000308696,0.31716114,0.459954073,156.4211783,0,-0.681844875,1.417470415,-0.481029352,0.630495638,0.746203195,93.45058514,0,-2.678534621,1.009698752,-2.652805716,0.00798258,0.026139594,N,-,,glucose 1-dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); PTHR24322:SF330 (PANTHER); PTHR24322:SF330 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06132,73,114,67,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,97.25682693,0,1.559839486,0.790676196,1.972791761,0.048519292,0.12981974,18.36428474,0,1.211721145,1.159441728,1.045090163,0.2959813,0.455792289,49.24432453,0,0.448065178,0.797381834,0.561920473,0.574170204,0.697241111,58.12517474,0,0.272829313,0.728765183,0.374372047,0.708127537,0.804419535,30.17078611,0,-1.485229633,1.150776317,-1.290632776,0.196831045,0.31816078,N,-,,glutamine synthetase,C:integral component of membrane; P:glutamine biosynthetic process; F:glutamate-ammonia ligase activity,IPR008146 (SMART); IPR008147 (G3DSA:3.10.20.GENE3D); IPR014746 (G3DSA:3.30.590.GENE3D); IPR008146 (PFAM); PTHR20852 (PANTHER); PTHR20852:SF35 (PANTHER); IPR008147 (SUPERFAMILY); SSF55931 (SUPERFAMILY),,
RL4_JR_06133,96686,100252,108478,150,290,1034,4,2,69,65,196,279,91,461,147,2,439,77,2.878262318,1,0.372551005,1.256162751,0.296578612,0.766788242,0.877722899,29.0484349,1,5.770812096,0.87248566,6.614219995,3.74E-11,7.88E-09,96.80835296,1,5.446018372,0.464455635,11.72559436,9.42E-32,3.29E-29,60.51678882,1,4.830804899,0.534539329,9.03732361,1.61E-19,1.51E-17,17.79286243,1,3.440919837,0.790371872,4.353545411,1.34E-05,0.00012877,N,-,,Methyltransferase type 11,P:nitrogen compound metabolic process; C:membrane; F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D),,
RL4_JR_06134,635,827,1038,0,3,3,0,0,0,3,0,1,0,0,0,0,0,0,1564.205089,1,-0.018466281,1.93785321,-0.009529246,0.992396876,0.997163902,341.0867036,0,-1.709857565,0.907869466,-1.883373799,0.059649729,0.135514035,663.85345,1,-5.357977039,1.123132215,-4.770566606,1.84E-06,4.56E-05,862.9834597,0,-2.586637215,0.775923237,-3.333625148,0.000857221,0.006516038,716.6042782,0,-2.710472634,0.68832373,-3.937787577,8.22E-05,0.000589691,N,-,,urea active transporter,F:putrescine transmembrane transporter activity; P:cellular nitrogen compound biosynthetic process; P:urea transmembrane transport; C:integral component of membrane; P:spermidine transmembrane transport; F:spermidine transmembrane transporter activity; P:putrescine transport; C:plasma membrane; F:urea transmembrane transporter activity,IPR001734 (PFAM); IPR001734 (TIGRFAM); IPR001734 (PANTHER); IPR031155 (PTHR11819:PANTHER); IPR001734 (PROSITE_PROFILES),2.A.21.6.6, the solute:sodium symporter (sss) family.
RL4_JR_06135,4335,3891,5831,1,1,7,0,0,0,0,5,0,0,9,8,0,1,0,107.7538616,1,1.11594536,0.831599936,1.341925741,0.179620075,0.336627744,9.993308028,0,0.144528317,1.230185455,0.117484983,0.906475744,0.947768565,26.03495444,1,-2.513399989,1.205915557,-2.084225529,0.037139658,0.09008191,30.0435436,1,-2.9361694,1.20701233,-2.432592715,0.014991153,0.065631958,25.75820025,1,-2.600712426,1.21408003,-2.142126022,0.032183342,0.079554771,N,-,,glycoside hydrolase family 3,C:integral component of membrane; F:beta-glucosidase activity; P:cellulose catabolic process; F:scopolin beta-glucosidase activity,IPR001764 (PRINTS); IPR026891 (SMART); IPR002772 (G3DSA:3.40.50.GENE3D); IPR001764 (G3DSA:3.20.20.GENE3D); IPR002772 (PFAM); IPR026891 (PFAM); IPR001764 (PFAM); IPR026892 (PANTHER); PTHR30620:SF44 (PANTHER); IPR026892 (PANTHER); IPR026892 (PANTHER); PTHR30620:SF44 (PANTHER); PTHR30620:SF44 (PANTHER); IPR002772 (SUPERFAMILY); IPR017853 (SUPERFAMILY),,
RL4_JR_06136,1521,1167,1248,1,0,4,0,0,0,0,0,0,0,0,0,0,3,0,0.007760107,1,8.901087564,4.041366561,2.202494486,0.027630398,NA,0.002334598,0,12.18995876,4.048442383,3.01102439,0.002603679,0.015349618,0.006343058,0,9.480780804,4.042868098,2.345063102,0.01902386,0.053738157,0.007335717,0,9.055356819,4.042572319,2.23999872,0.025091006,0.08557795,0.006581095,1,9.341867313,1.819064456,5.135533973,2.81E-07,4.95E-06,N,-, Effector probability:0.629,tetrahydroxynaphthalene reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); PTHR24322:SF533 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06137,11991,14372,18967,2,0,16,0,0,4,0,0,0,6,1,8,0,1,0,0.563204782,1,2.725754963,1.923353502,1.417188759,0.156427747,NA,0.179018106,1,5.947088599,1.891898573,3.143450016,0.001669689,0.015023052,0.466545499,0,3.28779287,1.308576756,2.512495239,0.011988072,0.037217799,0.538313719,1,2.865776937,1.444373246,1.984097216,0.047245003,0.118787102,0.462876905,1,3.19729358,1.270054447,2.517446073,0.011820906,0.035963545,N,-,,viral a-type inclusion,P:signal transduction; C:membrane; F:signal transducer activity,PTHR13140 (PANTHER),1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_06138,3,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1211.815723,0,-1.567810507,0.780733383,-2.008125362,0.044629972,0.122165224,333.6461134,0,-3.036746495,0.997028385,-3.045797433,0.002320641,0.015159195,777.0312006,0,-4.53021502,0.774573464,-5.848657656,4.96E-09,2.25E-07,875.8847094,0,-5.090291815,0.794361887,-6.408026235,1.47E-10,5.51E-09,784.062605,0,-3.577459638,0.87566103,-4.085438905,4.40E-05,0.000348268,N,-,,homocitrate synthase,C:cytosol; F:homocitrate synthase activity; P:lysine biosynthetic process via aminoadipic acid,IPR013785 (G3DSA:3.20.20.GENE3D); IPR011872 (TIGRFAM); IPR000891 (PFAM); PTHR10277 (PANTHER); PTHR10277:SF9 (PANTHER); IPR000891 (PROSITE_PROFILES); SSF51569 (SUPERFAMILY),3.B.1.1.6, the na(+)-transporting carboxylic acid decarboxylase (nat-dc) family.
RL4_JR_06139,79052,125930,123987,26,42,50,0,7,9,4,4,5,4,20,0,0,4,1,52.07383334,1,-3.804795913,1.242084178,-3.06323515,0.002189579,0.011269771,16.45719349,1,-0.57513712,1.243690623,-0.462443882,0.643763037,0.768688151,58.57752518,1,-1.408413213,1.072107414,-1.313686665,0.18895167,0.311707139,53.51115297,1,-2.712025692,1.184652855,-2.289299925,0.022061932,0.080442001,42.41213549,1,-3.320169932,1.233613909,-2.691417393,0.007114912,0.02393305,N,-,,aquaporin rerated other eukaryote,C:integral component of membrane; P:transport; F:transporter activity,IPR000425 (PRINTS); IPR000425 (PFAM); IPR023271 (G3DSA:1.20.1080.GENE3D); IPR000425 (PANTHER); PTHR19139:SF124 (PANTHER); IPR023271 (SUPERFAMILY),1.A.8.6.4, the major intrinsic protein (mip) family.
RL4_JR_06140,1722,1382,1729,2,2,3,0,0,0,0,0,0,6,0,0,0,0,1,43.75844571,1,-1.547916918,1.008627676,-1.534676229,0.124863378,0.259805387,11.51340192,0,-0.059745121,1.207233993,-0.049489264,0.960529393,0.97872271,42.89715943,0,-0.892405117,1.029482609,-0.866848171,0.386025204,0.529914464,34.49452831,1,-3.135533346,1.187454479,-2.640550355,0.008277149,0.041736123,44.59966047,1,-0.584286947,0.843356523,-0.692811322,0.488427966,0.617009751,N,-,,duf1275 domain,C:integral component of membrane,IPR007361 (PFAM); IPR010699 (PFAM); PTHR37488:SF2 (PANTHER); PTHR37488 (PANTHER),9.B.143.5.1, the 6 tms duf1275/pf06912 (duf1275) family.
RL4_JR_06141,2213,2287,2327,0,0,4,0,0,0,0,0,0,2,1,0,0,0,0,6.098324174,1,1.654253663,1.187323186,1.393263168,0.163540224,0.314374876,0.726193821,0,3.92716682,1.489925237,2.635814686,0.008393556,0.029526418,9.725548721,0,2.238695421,1.214106967,1.843902952,0.065197285,0.138904507,49.3792694,1,3.980129597,0.706414141,5.63427226,1.76E-08,4.68E-07,1.851248988,0,1.198038303,1.22964372,0.974297094,0.329909047,0.466591577,N,-,,iron transport multicopper oxidase fet3 precursor,"F:NADP binding; F:copper ion binding; F:flavin adenine dinucleotide binding; P:oxidation-reduction process; F:N,N-dimethylaniline monooxygenase activity",PR00419 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); PF13450 (PFAM); IPR020946 (PFAM); PTHR23023:SF4 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_06142,4526,3670,3796,0,1,7,0,2,0,2,3,6,5,38,6,0,13,1,166.700349,1,-0.423778219,1.003964692,-0.422104704,0.672948594,0.819267965,32.29713542,1,-1.547852882,1.205174777,-1.284338929,0.199023391,0.342546296,95.24998276,1,-3.244646326,1.202894727,-2.697365158,0.006989058,0.024517404,236.9665999,1,0.450975396,0.41112141,1.096939699,0.272667753,0.414653199,106.612988,1,-1.159209684,0.694180231,-1.669897287,0.094939687,0.183692783,N,-,,iron transport multicopper oxidase FET3,F:nucleotide binding; F:coenzyme binding; F:copper ion binding; F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process,IPR011706 (PFAM); IPR001117 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); IPR011707 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); PTHR11709:SF105 (PANTHER); PTHR11709 (PANTHER); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY),2.A.108.1.1, the iron/lead transporter (ilt) family.
RL4_JR_06143,4116,2956,2716,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,87.66525759,0,0.537773913,0.667399469,0.805775158,0.420372504,0.611846367,13.12794405,0,-0.249113107,1.238408558,-0.201155835,0.840576724,0.904658969,77.31821232,0,0.481538943,0.669681368,0.719056802,0.472105922,0.608788735,76.18096518,0,-0.259250139,0.723526512,-0.358314636,0.720107866,0.813102726,49.17946744,1,-0.802813372,0.90050957,-0.891510094,0.372655579,0.508852021,N,-,,plasma membrane iron permease,C:intracellular membrane-bounded organelle; C:endomembrane system; C:cytoplasmic part; C:membrane part,IPR004923 (PFAM); IPR004923 (PANTHER); PTHR31632:SF2 (PANTHER),2.A.108.1.3, the iron/lead transporter (ilt) family.
RL4_JR_06144,3496,3372,3036,0,0,5,0,0,0,0,0,3,2,7,0,0,0,0,578.6068428,1,8.173692818,2.436053101,3.35530158,NA,NA,0.640657713,0,4.10788189,1.483951855,2.76820429,0.005636611,0.022251863,1.661334382,1,1.456455782,1.21663193,1.197121122,0.231259348,0.362537882,9.93962871,1,2.759085686,1.020210834,2.704426963,0.006842231,0.035932359,36.38239455,0,5.117564435,0.546130808,9.370583676,7.21E-21,1.74E-18,N,-,,6-hydroxy-D-nicotine oxidase,F:oxidoreductase activity,IPR016167 (G3DSA:3.30.43.GENE3D); IPR006094 (PFAM); IPR016169 (G3DSA:3.30.465.GENE3D); PTHR11748:SF96 (PANTHER); PTHR11748 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY),,
RL4_JR_06145,11355,8778,8618,10,1,8,0,0,0,0,0,2,1,10,7,0,12,5,279.737608,1,8.162136652,2.221472986,3.674200273,NA,NA,0.31428599,0,5.135245137,1.713623608,2.996717081,0.002729039,0.015349618,0.816107696,1,2.481472807,1.280483193,1.937919078,0.052633096,0.117680535,0.941426987,1,2.059477842,1.345637038,1.530485402,0.125896624,0.232879985,4.667337407,1,3.322133672,1.172851482,2.832527156,0.004618164,0.016729486,N,-,,integral membrane,C:integral component of membrane,PTHR31740:SF6 (PANTHER); PTHR31740 (PANTHER),9.B.313.1.3, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_06146,4332,3614,5185,0,4,5,0,0,0,0,0,0,1,0,0,0,1,0,3.104848287,1,0.26307634,1.244243498,0.211434772,0.832548026,0.916665376,1.000554474,0,3.464807719,1.430822523,2.421549607,0.015454492,0.047317109,2.57981454,0,0.821823028,1.225281124,0.670722017,0.502397634,0.634673527,2.974903151,1,0.400042921,1.23224882,0.324644596,0.745450071,0.83179215,2.527860792,1,0.748027891,1.214362781,0.615983874,0.537905163,0.660476567,N,-, Effector probability:0.843,hypothetical protein CMQ_5032,,no IPS match,,
RL4_JR_06147,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,53.57661677,0,1.35315274,0.56439625,2.397522556,0.016506365,0.056342646,5.987008211,0,0.883659235,1.233179797,0.716569666,0.473639667,0.631189617,15.56751572,0,-1.771506211,1.195206168,-1.482176262,0.138293401,0.246884569,17.96187083,0,-2.194069342,1.193917324,-1.837706261,0.066105701,0.145536034,15.37736134,0,-1.85647253,1.201355957,-1.545314292,0.12227026,0.222218213,N,-,,major facilitator superfamily transporter,C:membrane,IPR001958 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23504 (PANTHER); PTHR23504:SF39 (PANTHER); PTHR23504:SF39 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.96, the major facilitator superfamily (mfs).
RL4_JR_06148,3483,3456,5533,0,0,4,0,0,0,4,0,0,3,0,0,0,0,0,6.088427332,1,-0.708211619,1.216132213,-0.582347553,0.560332601,0.737403335,1.93518114,0,2.513052061,1.322138619,1.900747792,0.057335055,0.131627451,5.028480992,1,-0.14106015,1.209411549,-0.116635358,0.907149017,0.943010232,5.801840008,1,-0.563607868,1.209529746,-0.465972722,0.641235026,0.75397801,4.960642441,0,-0.224158899,1.211742506,-0.184988889,0.853237751,0.902437295,N,-,,diaminopropionate ammonia-lyase,P:metabolic process; F:hydrolase activity,IPR002933 (PFAM); IPR011650 (PFAM); G3DSA:3.40.630.10 (GENE3D); IPR011650 (G3DSA:3.30.70.GENE3D); PTHR11014 (PANTHER); IPR011650 (SUPERFAMILY); SSF53187 (SUPERFAMILY),,
RL4_JR_06149,7573,6817,8210,3,2,4,0,0,1,2,0,0,1,2,1,0,7,2,4.886136267,1,2.749827434,1.159131451,2.372317163,0.01767691,0.059393834,0.341815246,1,5.014265047,1.647177058,3.044156681,0.002333336,0.015159195,0.88495072,1,2.365312298,1.23604783,1.913609038,0.055670129,0.122716389,1.020752554,1,1.94316636,1.276129492,1.522703121,0.127832997,0.235581284,0.870673574,1,2.285818725,1.213168061,1.884173181,0.059541554,0.12788677,N,-,,short-chain dehydrogenase reductase,F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); SM00822 (SMART); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24320:SF85 (PANTHER); PTHR24320 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06150,1108,1069,799,0,0,4,0,0,0,0,0,1,0,1,1,0,1,0,0.674890503,1,2.464890213,1.806633875,1.36435514,0.172455819,NA,0.21919146,0,5.655490709,1.859243918,3.041822891,0.002351502,0.015189473,7.061096896,1,3.982016702,1.240579306,3.209804229,0.001328254,0.007202549,0.648276296,1,2.598287942,1.429897178,1.817115232,0.069199471,0.149550618,0.54828543,1,2.952307145,1.267251364,2.329693405,0.019822361,0.054243624,Y,-, Effector probability:0.607,---NA---,,no IPS match,,
RL4_JR_06151,5662,4634,4839,2,1,3,0,0,0,0,0,0,0,1,0,0,2,0,84.87096909,1,6.770804477,1.085154372,6.239485049,4.39E-10,1.32E-08,0.275809099,0,5.323768719,1.711219157,3.111096961,0.001863937,0.015023052,0.714963717,0,2.672826854,1.245076229,2.14671744,0.031815783,0.080344972,0.82473609,1,2.250686071,1.303005135,1.727304068,0.084113069,0.171979972,0.704483078,1,2.591415086,1.218730099,2.126324023,0.033476289,0.081955665,Y,-,,hypothetical protein HMPREF1624_06251,,no IPS match,,
RL4_JR_06152,5538,2885,3434,0,3,0,0,0,0,0,0,0,0,2,0,0,0,2,0.051229353,1,6.183912504,3.927534739,1.574502306,0.115371369,NA,0.016025051,0,9.42699542,3.08226881,3.058459856,0.002224779,0.015045494,0.042269153,0,6.74882969,1.808352587,3.732031983,0.000189941,0.001705046,0.048804483,1,6.328598546,3.160627739,2.002323294,0.045249972,0.115278131,0.042498537,1,6.643580832,1.425595253,4.660215316,3.16E-06,3.85E-05,N,-,,"glucan 1,3-beta-glucosidase",F:hydrolase activity,IPR024535 (PFAM); IPR012334 (G3DSA:2.160.20.GENE3D); PTHR31375:SF21 (PANTHER); PTHR31375 (PANTHER); IPR011050 (SUPERFAMILY); IPR011050 (SUPERFAMILY),,
RL4_JR_06153,13684,21837,22681,7,17,11,0,0,0,7,6,27,7,8,5,0,4,7,72.48828246,1,-0.627251372,0.730697344,-0.858428427,0.390655936,0.583480616,12.28120055,0,-0.15283425,1.209143266,-0.126398794,0.899416257,0.944130759,44.80033958,1,-0.980842487,1.027394626,-0.954689136,0.339734926,0.483140383,98.9721511,1,0.825647057,0.477661478,1.728519244,0.083895174,0.171638439,95.4930963,1,1.433159154,0.428776543,3.342438336,0.000830458,0.004115706,N,-,,amino acid transporter,P:L-histidine transmembrane import into vacuole; P:L-tyrosine transmembrane import into vacuole; P:L-lysine import involved in cellular response to nitrogen starvation; F:L-histidine transmembrane transporter activity; F:L-lysine transmembrane transporter activity; P:L-glutamate import involved in cellular response to nitrogen starvation; P:lithium ion import; C:fungal-type vacuole membrane; F:L-serine transmembrane transporter activity; F:L-tyrosine transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:L-arginine transmembrane transporter activity; P:mycelium development; C:integral component of membrane; P:L-lysine transmembrane import into vacuole; P:L-arginine transmembrane import into vacuole; P:L-glutamate transmembrane import into vacuole; P:L-serine transmembrane import into vacuole,IPR013057 (PFAM); PTHR22950:SF72 (PANTHER); PTHR22950 (PANTHER),2.A.18.6.6, the amino acid/auxin permease (aaap) family.
RL4_JR_06154,4004,4274,2623,0,6,7,2,0,0,0,4,8,3,9,0,0,4,0,7.429874086,1,-0.995749044,1.245918653,-0.799208713,0.4241694,0.615396402,11.72196428,1,3.150319635,1.160512385,2.714593724,0.006635712,0.024950475,12.63028981,1,0.534306636,1.223404737,0.436737426,0.662301784,0.767091095,35.15808731,1,2.574362091,0.689339746,3.734533087,0.000188064,0.001823894,6.101467401,1,-0.522889287,1.244970962,-0.420001191,0.674484583,0.76852099,N,-,,nuclear distribution,,IPR009991 (PFAM); PTHR39597 (PANTHER); PTHR39597:SF1 (PANTHER),,
RL4_JR_06155,2080,1562,1876,0,0,4,0,0,0,0,0,0,3,1,1,0,0,2,132.3377805,1,0.480796246,0.477623311,1.006643175,0.314106279,0.50224638,20.05029181,0,-0.860025384,1.206378262,-0.712898609,0.4759085,0.633221309,89.72671612,0,-0.677360268,0.743506898,-0.911034275,0.362277315,0.506168304,164.0203314,1,1.083985672,0.504232405,2.149773916,0.031573102,0.09503232,85.81914161,1,0.149774618,0.548172821,0.273225181,0.784680125,0.852821625,N,-,,osmosensor,P:cellular response to heat; C:cellular bud neck; P:osmosensory signaling pathway; C:integral component of membrane; C:mating projection tip; P:establishment of cell polarity; C:HICS complex; F:osmosensor activity; F:MAP-kinase scaffold activity; P:signal transduction involved in filamentous growth; P:positive regulation of signal transduction; C:plasma membrane,IPR001452 (PRINTS); IPR001452 (SMART); G3DSA:2.30.30.40 (GENE3D); IPR001452 (PFAM); IPR001452 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY),,
RL4_JR_06156,1808,1876,2188,0,1,0,0,0,0,0,0,0,1,0,0,0,0,2,5.130171114,1,-0.461497886,1.245126994,-0.370643226,0.710903282,0.844553513,1.62341982,0,2.766343514,1.359434246,2.034922633,0.041858658,0.102763361,4.239932455,0,0.104657884,1.228958975,0.085159786,0.93213436,0.959329904,4.893024454,1,-0.318161029,1.233246608,-0.257986543,0.796417293,0.868832448,11.57817261,1,0.953111871,1.160714582,0.821142326,0.411565204,0.547437951,N,-,,mitotic spindle biogenesis,C:spindle microtubule; C:DASH complex; P:attachment of spindle microtubules to kinetochore,IPR013251 (PFAM); PTHR28262 (PANTHER),,
RL4_JR_06157,2781,1657,2178,0,0,19,0,0,0,0,2,1,1,5,2,0,5,2,144.599953,1,-0.192137527,0.45913487,-0.418477314,0.67559817,0.821390442,24.72854314,0,-1.162586643,1.193223919,-0.974323951,0.329895716,0.492861008,87.69546781,1,-1.40579498,0.845020123,-1.66362308,0.096187777,0.188393316,105.0072646,1,-1.185733786,0.659793176,-1.797129508,0.072315062,0.154866027,77.99515887,1,-2.213390389,0.967284283,-2.288252202,0.022122838,0.059226266,Y,-,,NAD(P)H-hydrate epimerase,F:nucleotide binding; C:nucleus; F:metal ion binding; C:mitochondrion; C:cytosol; F:NADHX epimerase activity,IPR004443 (TIGRFAM); IPR004443 (PFAM); IPR004443 (G3DSA:3.40.50.GENE3D); IPR032976 (PANTHER); IPR004443 (PROSITE_PROFILES); IPR004443 (SUPERFAMILY),,
RL4_JR_06158,4724,5238,8761,0,0,0,0,0,0,0,0,0,1,2,0,0,0,0,38.65367136,0,-2.279620023,1.179175739,-1.933231789,0.05320765,0.139571708,77.93749964,0,2.252320978,0.869613308,2.590025887,0.009596871,0.032699491,28.76374377,0,-2.657249687,1.216075377,-2.185102781,0.028881311,0.074362766,71.8794269,1,0.424964735,0.64147025,0.662485493,0.507660129,0.643571757,28.6023731,0,-2.751837052,1.229343601,-2.238460467,0.025191043,0.065787802,N,-,,ribosome biogenesis sqt1,C:intracellular organelle; C:cytosol,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR19857 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR011044 (SUPERFAMILY); IPR017986 (SUPERFAMILY),3.A.20.1.2, the peroxisomal protein importer (ppi) family.
RL4_JR_06159,1264,1537,2431,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_06160,7275,9410,13010,0,2,1,0,0,0,0,2,2,0,0,0,0,0,2,31.7248961,1,-3.089907799,1.244239939,-2.483369728,0.013014593,0.046751672,19.36989304,0,1.058458645,1.160241218,0.912274645,0.361624158,0.526140539,26.18285839,1,-2.52162442,1.230882047,-2.048632058,0.040498107,0.09656979,111.3158346,0,1.355362737,1.35519255,1.000125582,0.317249738,0.463380495,26.10787595,1,-2.620189116,1.247659904,-2.100082809,0.035721557,0.086114468,N,-, Effector probability:0.665,ribosomal S16,F:structural constituent of ribosome; P:mitochondrial translation; C:mitochondrial small ribosomal subunit,IPR000307 (TIGRFAM); IPR023803 (G3DSA:3.30.1320.GENE3D); IPR000307 (PFAM); IPR000307 (PANTHER); IPR023803 (SUPERFAMILY),,
RL4_JR_06161,6818,5541,8786,2,2,9,0,0,0,0,1,0,2,4,4,0,0,0,176.1627999,1,0.988609049,0.653037049,1.513863648,0.130060426,0.267195405,18.25890654,0,-0.724997515,1.232493879,-0.588236199,0.556373763,0.701079248,111.2624886,1,0.591218124,0.57227487,1.03310167,0.301556322,0.442714067,90.0030674,1,-0.50391263,0.676275074,-0.745129682,0.456193327,0.59823677,168.4212758,0,1.693199227,0.560297123,3.021966662,0.002511382,0.010257258,N,-,,glycine dehydrogenase,C:mitochondrion; C:cytosol; F:glycine binding; P:glycine decarboxylation via glycine cleavage system; F:glycine dehydrogenase (decarboxylating) activity; P:oxidation-reduction process; C:glycine cleavage complex,IPR003437 (TIGRFAM); IPR015421 (G3DSA:3.40.640.GENE3D); IPR015421 (G3DSA:3.40.640.GENE3D); IPR020581 (PFAM); PTHR11773:SF1 (PANTHER); IPR020581 (PANTHER); IPR015424 (SUPERFAMILY); IPR015424 (SUPERFAMILY),,
RL4_JR_06162,11545,7222,10216,0,2,2,0,0,0,0,0,1,2,0,0,0,0,0,12.33903629,1,-1.727544081,1.214748935,-1.422140848,0.154985367,0.304008324,3.906132222,0,1.499688704,1.269586133,1.18124219,0.237506525,0.388563286,10.19224795,1,-1.160542254,1.210440699,-0.95877663,0.337671285,0.480948802,11.76192881,1,-1.583353371,1.210697334,-1.307802807,0.190940202,0.319865907,10.11103992,0,-1.25160682,1.221379017,-1.024748913,0.305481677,0.440661345,N,-,,mitochondrial import receptor subunit,P:biological_process; C:cellular_component; F:molecular_function,IPR019603 (PFAM),,
RL4_JR_06163,2609,1960,2060,0,2,1,0,0,0,0,8,5,1,0,0,0,0,0,28.85536457,1,0.041218004,0.922951949,0.044658884,0.964379207,0.981952767,5.487378542,0,1.009319205,1.268838848,0.795466821,0.426342004,0.589206035,20.84911481,1,-0.692314713,1.218694507,-0.568078964,0.569981351,0.693985712,32.60936554,1,0.596861716,0.812439698,0.73465356,0.46255051,0.604611918,14.26501515,0,-1.748160209,1.235465164,-1.414981386,0.157073954,0.267324715,N,-, Effector probability:0.729,---NA---,,no IPS match,,
RL4_JR_06164,73,56,88,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.83878393,0,-1.550344492,1.171560657,-1.323315598,0.185730447,0.343488501,6.643560104,0,0.733495071,1.248441445,0.587528614,0.556848739,0.701396582,17.34549859,0,-1.927561308,1.211762852,-1.590708367,0.111675223,0.210491534,20.01808909,0,-2.350465123,1.212771376,-1.938094161,0.052611736,0.126308286,24.57608904,0,-1.079014881,1.151561862,-0.93700123,0.348757925,0.486320616,N,-,,nucleoporin nup44,F:identical protein binding; P:nuclear pore organization; C:membrane; P:NLS-bearing protein import into nucleus; C:cytosol; F:structural constituent of nuclear pore; C:nuclear periphery; F:nucleocytoplasmic transporter activity; C:nuclear pore central transport channel; P:protein targeting to nuclear inner membrane,IPR025712 (PFAM); IPR024864 (PANTHER),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_06165,11859,14071,13827,4,10,17,0,0,1,1,8,1,5,7,1,0,3,5,117.2246747,1,0.024038844,0.519164454,0.046302947,0.963068791,0.981230822,37.87490364,1,0.849360654,0.989751146,0.858155767,0.390806457,0.555269927,56.24595462,1,-2.485773505,1.195681168,-2.078960153,0.037621013,0.090944397,108.1185267,1,0.146170815,0.516956876,0.282752435,0.777366618,0.856270345,71.27271392,1,-1.293015159,0.854531909,-1.513126831,0.130247445,0.232511097,N,-, Effector probability:0.88,nadh-ubiquinone oxidoreductase kda subunit,C:mitochondrial respiratory chain complex I; F:NADH dehydrogenase (ubiquinone) activity; P:oxidation-reduction process,IPR016680 (PIRSF); IPR010625 (PFAM); PTHR13344 (PANTHER); PTHR13344:SF0 (PANTHER),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_06166,5127,3944,3216,2,1,2,0,0,0,5,2,2,8,18,4,0,16,4,520.7671976,1,0.516713697,0.973667106,0.530688254,0.595634827,0.765829616,69.09057719,0,-2.644900294,1.239184386,-2.134388008,0.032811032,0.084871962,299.8244507,1,-0.515515754,0.538120376,-0.957993373,0.3380661,0.481308002,255.8504397,1,-1.929564901,1.390342973,-1.387833749,0.165187675,0.285657594,234.957086,1,-1.244668406,0.675723183,-1.84197973,0.065478115,0.138060373,Y,-,,scp-like extracellular,P:biological_process; C:extracellular region; F:molecular_function,IPR001283 (PRINTS); IPR014044 (SMART); IPR014044 (PFAM); IPR014044 (G3DSA:3.40.33.GENE3D); IPR001283 (PANTHER); IPR001283 (PANTHER); PTHR10334:SF230 (PANTHER); IPR014044 (SUPERFAMILY),8.B.9.1.1, the triflin toxin (triflin or crisp) family.
RL4_JR_06167,7656,6276,5270,5,14,8,0,0,0,0,5,3,4,14,6,0,13,8,247.701057,1,1.105730181,0.687207615,1.609019105,0.107612164,0.23379495,24.90448303,0,-1.172816859,1.201049425,-0.976493419,0.328820007,0.491671746,175.3183961,1,0.797430444,0.44543026,1.790247578,0.073414119,0.152554299,320.5805087,1,1.803265237,0.312125612,5.777370282,7.59E-09,2.12E-07,108.7458883,1,-0.284858608,0.564547388,-0.504578737,0.613854747,0.721197414,N,-,,longevity-assurance,C:integral component of membrane; F:sphingosine N-acyltransferase activity; P:ceramide biosynthetic process; C:endoplasmic reticulum,IPR006634 (SMART); IPR013599 (PFAM); IPR006634 (PFAM); IPR016439 (PANTHER); PTHR12560:SF0 (PANTHER); IPR006634 (PROSITE_PROFILES),9.B.311.1.29,The 6-7 TMS TRAM-LAG (TRAM-LAG) Family
RL4_JR_06168,2377,2195,1788,0,3,2,0,0,0,0,0,0,0,1,0,0,0,0,29.70757361,1,0.732340635,0.788996106,0.928192965,0.353307483,0.543929505,4.649237125,0,1.248600997,1.283418034,0.972871631,0.330617106,0.493657818,35.50559616,0,1.0165908,0.877406843,1.158631036,0.246606612,0.380760309,13.81096449,1,-1.814823383,1.212859295,-1.496318155,0.134570766,0.245147357,19.43290429,0,0.198192878,0.995376103,0.199113558,0.842173915,0.893722974,N,-,,Kinesin light chain,C:membrane; C:integral component of membrane; F:ADP binding,PF13424 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (PFAM); PTHR19959:SF128 (PANTHER); PTHR19959 (PANTHER); IPR027417 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY),,
RL4_JR_06169,32283,22841,23133,8,21,2,0,0,2,4,6,6,12,4,3,0,10,6,794.5639325,1,0.986642578,0.592409465,1.665474029,0.095818221,0.214454059,84.18967653,1,-2.930049599,1.214204218,-2.413143979,0.015815571,0.048102526,385.3389686,1,-0.41159776,0.42900669,-0.959420377,0.337347014,0.480681715,297.0062026,1,-2.644678724,0.663662424,-3.984975835,6.75E-05,0.000766898,310.4863989,1,-1.575159477,0.677106688,-2.32630914,0.020002065,0.054524824,N,-,,bax inhibitor family,P:endoplasmic reticulum unfolded protein response; C:mitochondrion; P:apoptotic process; C:integral component of membrane; C:endoplasmic reticulum; C:fungal-type vacuole; P:calcium-mediated signaling,PF01027 (PFAM); PTHR23291:SF50 (PANTHER); IPR006214 (PANTHER),1.A.14.3.6, the calcium transporter a (cata) (formerly the testis-enhanced gene transfer (tegt) family.
RL4_JR_06170,6481,11405,9493,2,17,15,1,0,4,8,5,23,7,21,5,0,15,8,403.7388112,1,0.896515677,0.554976095,1.615413139,0.106221257,0.231566095,123.8168184,1,-0.417866483,0.987310078,-0.423237332,0.672122112,0.790704326,163.5708031,1,-1.340647452,0.620708946,-2.15986488,0.030783131,0.078362691,298.8652674,1,0.251447837,0.342955101,0.733180048,0.463448622,0.605160859,173.3639272,1,-0.576969132,0.498239052,-1.158016679,0.24685723,0.377021361,N,-,,septin,F:GTP binding; P:cell division; C:integral component of membrane,IPR027417 (G3DSA:3.40.50.GENE3D); IPR016491 (PIRSF); IPR030379 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR016491 (PANTHER); PTHR18884:SF52 (PANTHER); IPR030379 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_06171,1979,1714,1248,0,4,10,0,0,0,0,0,1,1,6,5,0,6,0,33.19530955,1,0.448620728,0.742576909,0.604140423,0.545750286,0.725807082,5.718227894,0,0.949925551,1.234286724,0.769614978,0.441528317,0.602961364,14.84372353,1,-1.702894352,1.192436493,-1.428079703,0.153268919,0.266889325,17.12412783,1,-2.125253858,1.190520665,-1.78514655,0.074237549,0.157369781,29.38018479,1,-0.099064656,0.974107671,-0.10169785,0.918996509,0.948312235,N,-,,wd repeat domain-containing phosphoinositide-interacting 4,P:autophagy; C:endomembrane system; F:binding; C:vacuole,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR11227 (PANTHER); PTHR11227:SF18 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_06172,496,535,548,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,42.52910641,0,0.012024362,0.84648083,0.014205121,0.988666335,0.994272677,5.915604345,0,0.900984337,1.237026547,0.728346808,0.466401316,0.625286638,81.75542346,1,2.030321103,1.636262769,1.240828271,0.214669195,0.343351291,27.00212242,0,-1.222522282,1.143595883,-1.069015987,0.285062466,0.429374809,29.84641466,0,-0.144608607,0.973542627,-0.148538547,0.881917767,0.92169874,N,-,,u2 snrnp component ist3,F:nucleotide binding; F:nucleic acid binding; P:mRNA export from nucleus; C:RES complex; P:generation of catalytic spliceosome for first transesterification step; C:U2 snRNP; P:spliceosomal complex assembly,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR23139 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_06173,81,69,54,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,154.0198324,0,-1.358064947,0.606871627,-2.237812557,0.025233281,0.079265733,35.60216178,0,-1.688352047,1.216008737,-1.388437431,0.165003885,0.297712892,109.3529076,0,-2.505180285,1.044979391,-2.397348986,0.016514187,0.048112122,246.1433055,0,0.519972993,0.396325441,1.311984897,0.18952523,0.318021703,156.1405003,0,-0.402499635,1.651155165,-0.243768511,0.80741011,0.870146606,N,-,,spermatogenesis-associated 20,F:catalytic activity,IPR024705 (PIRSF); IPR012336 (G3DSA:3.40.30.GENE3D); IPR012341 (G3DSA:1.50.10.GENE3D); IPR004879 (PFAM); PTHR12145 (PANTHER); PTHR12145:SF11 (PANTHER); PTHR12145 (PANTHER); PTHR12145:SF11 (PANTHER); IPR012336 (SUPERFAMILY); IPR008928 (SUPERFAMILY),,
RL4_JR_06174,3061,3077,5197,0,3,5,0,0,0,1,0,1,4,1,1,0,4,0,80.19171543,1,1.155400431,0.481524204,2.399464911,0.016419053,0.056115055,9.569132719,0,0.207166515,1.226352793,0.168928971,0.865852511,0.922091327,24.72710712,1,-2.439010553,1.193565469,-2.043466083,0.041006322,0.097544173,52.58785376,1,0.42345037,0.629464249,0.67271552,0.501128292,0.63867258,58.6679687,1,1.088359047,0.545995248,1.993348935,0.046223251,0.105550388,N,-,,dynein light intermediate chain,C:cytoplasmic dynein complex; F:microtubule motor activity; F:guanyl nucleotide binding; P:microtubule-based movement,IPR022780 (PFAM); PTHR12688:SF0 (PANTHER); IPR008467 (PANTHER),,
RL4_JR_06175,6552,4522,5845,13,8,14,0,0,1,5,0,0,1,2,1,0,1,1,97.6011323,1,-1.145568967,0.6871512,-1.667127945,0.095488967,0.213991408,40.44883626,1,0.665550427,0.99379718,0.669704483,0.503046193,0.656841276,79.91019445,1,-1.21885559,0.861304635,-1.41512717,0.157031213,0.271294198,69.05840188,1,-3.103985092,1.151400125,-2.695835293,0.007021237,0.036625466,55.73790056,1,-3.714375982,1.202918418,-3.087803733,0.002016416,0.008542348,N,-,,Aminoglycoside phosphotransferase,P:phosphorylation; F:transferase activity; F:kinase activity,G3DSA:3.90.1200.10 (GENE3D); IPR002575 (PFAM); PTHR21310 (PANTHER); PTHR21310:SF3 (PANTHER); IPR011009 (SUPERFAMILY),1.B.22.3.1, the outer bacterial membrane secretin (secretin) family.
RL4_JR_06176,4646,3904,3650,3,4,0,0,0,0,1,4,0,2,0,0,0,0,0,127.9020387,1,4.329302903,0.431429284,10.03479148,1.07E-23,2.24E-21,20.90071564,0,3.997850508,1.012891066,3.946969857,7.91E-05,0.003927064,5.546958368,1,-0.282492124,1.208429287,-0.233768022,0.815165076,0.880040504,10.4100638,1,0.241707544,1.1562388,0.209046387,0.834412027,0.896099043,12.81288998,0,0.576635049,1.130398937,0.510116411,0.609969908,0.717799317,N,-,,aflatoxin b1-aldehyde reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR023210 (PFAM); IPR023210 (G3DSA:3.20.20.GENE3D); IPR001395 (PANTHER); PTHR11732:SF203 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.6, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_06177,6683,6077,8646,0,4,6,1,0,0,7,2,2,0,2,4,0,0,3,12.2415268,1,0.76584598,1.143456241,0.669764135,0.50300816,0.689670684,1.35579992,1,3.026391675,1.361000329,2.22365242,0.026171839,0.070964734,3.509722952,1,0.377540878,1.206383531,0.312952613,0.754316664,0.835068552,4.048204636,1,-0.044564316,1.206615852,-0.036933309,0.970538181,0.983358259,3.453854909,1,0.297855997,1.202548971,0.247687208,0.80437643,0.868078379,N,-,,ADP-ribose pyrophosphatase,C:intracellular membrane-bounded organelle; C:cytoplasmic part; F:hydrolase activity,IPR020476 (PRINTS); IPR015797 (G3DSA:3.90.79.GENE3D); IPR000086 (PFAM); PTHR11839 (PANTHER); PTHR11839:SF11 (PANTHER); IPR000086 (PROSITE_PROFILES); IPR015797 (SUPERFAMILY),,
RL4_JR_06178,1551,2094,1968,1,2,2,0,0,0,0,0,0,0,0,0,0,0,0,27.15112974,1,-0.662667061,1.016488548,-0.651917882,0.514454148,0.700055864,6.246079658,0,0.822619148,1.240897009,0.662922984,0.507379881,0.659781444,29.15483679,0,-0.005931373,1.036311661,-0.005723542,0.995433299,0.998095149,42.70639105,0,1.036136245,0.63105357,1.641914876,0.100607646,0.19661309,23.23349381,0,-0.967587137,1.121389992,-0.862846239,0.388222013,0.524309441,N,-,,atp synthase f0,P:transmembrane transport; C:membrane; C:integral component of membrane; F:transporter activity,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23507 (PANTHER); PTHR23507:SF1 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.91, the major facilitator superfamily (mfs).
RL4_JR_06179,2324,3645,3539,0,3,7,0,0,0,5,0,3,4,0,3,0,1,1,15.74159566,1,-0.10236243,1.148572132,-0.089121464,0.928985379,0.96586144,2.467261941,0,2.162650032,1.295319293,1.669588373,0.095000832,0.194537411,6.394376702,1,-0.487664393,1.200897334,-0.406083334,0.684681371,0.783333054,15.39974929,1,0.813905331,1.021708529,0.796612055,0.425676374,0.568367894,6.291495229,1,-0.567076343,1.199970045,-0.472575416,0.636516125,0.73898931,N,-,,hypothetical protein SPBR_04038,,no IPS match,,
RL4_JR_06180,3899,4396,4674,15,7,0,0,0,1,1,3,2,0,4,2,0,1,0,15.79195625,1,-0.737257501,1.157325374,-0.637035632,0.524101634,0.707800167,3.824320239,1,1.530370432,1.273786485,1.201434032,0.229582882,0.379526037,9.901519454,1,-1.118522116,1.204230852,-0.928826988,0.352978756,0.496300353,23.45671629,1,0.752818505,0.873526673,0.861815132,0.388789257,0.533443946,9.72845856,1,-1.195923159,1.203459107,-0.993738094,0.320350392,0.455746483,N,-,,hypothetical protein CMQ_4995,,no IPS match,,
RL4_JR_06181,2640,1830,2379,0,0,2,0,0,0,2,1,0,3,0,4,0,0,0,15.21543247,1,-2.029832845,1.214309732,-1.671593987,0.094604411,0.212495261,4.814763623,0,1.19797096,1.258632984,0.951803246,0.341196775,0.50410068,12.56530945,1,-1.462490231,1.209924371,-1.208745163,0.226760765,0.357534027,14.50068923,1,-1.885325249,1.210281047,-1.557758219,0.119290574,0.223504267,12.46632256,0,-1.553714769,1.221253818,-1.272229201,0.203291695,0.325581843,N,-,,---NA---,,no IPS match,,
RL4_JR_06182,1626,957,945,2,9,0,0,0,0,0,0,0,1,0,0,0,0,1,138.9318447,1,-0.858955172,0.607401858,-1.414146435,0.157318912,0.306741798,30.42478979,0,-1.46169721,1.2121182,-1.205903195,0.227854819,0.37753257,85.95406235,0,-3.161311369,1.209781369,-2.613126181,0.008971817,0.0300366,103.7300283,1,-2.265838172,0.897871594,-2.523565938,0.011617127,0.054573948,112.9493362,1,-0.822069741,0.652564661,-1.259752159,0.207758783,0.330592123,N,-,,solute carrier,C:integral component of membrane; C:Golgi apparatus; P:transport,IPR009262 (PFAM); PTHR14233 (PANTHER); PTHR14233:SF4 (PANTHER); SSF103481 (SUPERFAMILY),2.A.7.24.11, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_06183,1749,1113,1163,0,4,5,0,0,0,0,0,0,0,2,3,0,0,0,0.205302013,1,4.181899863,2.957477694,1.414008928,0.157359281,NA,0.065005846,0,7.408729984,2.292921189,3.231131545,0.001233012,0.015023052,0.169274989,0,4.751856338,1.390155527,3.418219219,0.000630323,0.003996829,0.195339136,1,4.328855597,1.840216013,2.352362748,0.018654573,0.074340352,0.167294454,0,4.667838119,1.277712118,3.653278429,0.000258913,0.001555784,,,,,,,,
RL4_JR_06184,622,446,412,0,0,2,0,0,1,0,2,0,0,4,0,0,6,0,175.4116919,1,-0.731732337,0.468006851,-1.563507746,0.117933215,0.249313078,54.68572518,1,-0.0579911,0.982495823,-0.059024271,0.952932776,0.975027218,127.6840058,1,-1.524862267,0.737362431,-2.067995606,0.038640436,0.0930311,119.4131171,1,-2.467110773,0.849644804,-2.903696652,0.003687853,0.021989286,126.5679928,1,-1.481032235,0.666158991,-2.223241379,0.026199528,0.067848076,N,-,,hypothetical protein CMQ_5035,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_06185,33719,24292,22537,5,4,9,0,0,0,4,5,15,3,15,3,0,5,8,8.760968004,1,3.446708333,1.044207457,3.300788851,0.000964134,0.005766427,0.359145679,0,4.942993454,1.650235969,2.995325242,0.002741523,0.015349618,0.929439309,1,2.295150779,1.250078585,1.836005197,0.066356888,0.140749452,1.072135555,1,1.872693707,1.293970491,1.447246069,0.147828018,0.26328209,0.912669969,1,2.218462719,1.2254998,1.810251393,0.070256811,0.145262449,N,-,,Thioredoxin-like fold,F:antioxidant activity; F:oxidoreductase activity; P:cellular oxidant detoxification; P:oxidation-reduction process,IPR012336 (G3DSA:3.40.30.GENE3D); PTHR42336 (PANTHER); PTHR42336:SF2 (PANTHER); PTHR42336:SF2 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_06186,44548,37397,53038,2,7,1,0,0,0,2,4,7,0,0,1,0,3,0,163.5728837,1,-0.00901562,0.809909589,-0.011131638,0.991118421,0.996001981,25.35476769,0,-1.198646152,1.273214219,-0.941433212,0.3464829,0.509456699,80.59274448,1,-2.005595598,1.097187861,-1.827941841,0.067558281,0.142729556,78.82482682,1,-3.309521873,1.210734079,-2.733483702,0.006266822,0.03355451,63.11664377,1,-3.893745683,1.244866584,-3.127841757,0.00176095,0.007603247,N,-,,pap 25a associated domain family,P:biological_process; F:nucleotidyltransferase activity; C:cellular_component,IPR002934 (PFAM); IPR002058 (PFAM); G3DSA:3.30.460.10 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR12271:SF63 (PANTHER); PTHR12271 (PANTHER); SSF81301 (SUPERFAMILY); SSF81631 (SUPERFAMILY),,
RL4_JR_06187,6540,2206,2006,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,21.90669956,1,-2.555758476,1.191590334,-2.144829816,0.031966456,0.095210183,6.993770122,0,0.659420498,1.230655197,0.5358288,0.592076876,0.728987001,67.04902103,0,1.164863553,0.672464769,1.73222986,0.083232645,0.167872297,49.847393,0,-0.078965208,0.85273064,-0.092602757,0.926219154,0.956655996,17.91785954,0,-2.077131974,1.200263509,-1.730563296,0.083529683,0.166845145,N,-,,hypothetical protein SPSK_02513,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_06188,7850,6168,10421,5,0,3,0,0,0,0,2,5,0,4,4,0,0,0,18.73824792,1,-1.057461753,1.196926452,-0.883480979,0.376976455,0.568566079,4.832053672,0,1.192903621,1.321486507,0.902698298,0.36668604,0.531290595,12.43785154,1,-1.447705119,1.240502216,-1.167031466,0.243197663,0.376818662,18.35148723,1,-0.925398091,1.19618559,-0.773624176,0.439153071,0.581080089,27.27031393,0,0.679688,0.91150155,0.745679478,0.455861059,0.587524595,N,-,,homoserine O-acetyltransferase,F:homoserine O-acetyltransferase activity; P:methionine biosynthetic process; C:cytoplasm,IPR029058 (G3DSA:3.40.50.GENE3D); IPR008220 (TIGRFAM); IPR008220 (PIRSF); IPR000073 (PFAM); PTHR10992:SF756 (PANTHER); PTHR10992:SF756 (PANTHER); PTHR10992 (PANTHER); PTHR10992 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_06189,813,653,1008,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,2.008035126,1,0.891962517,1.280474637,0.696587415,0.486061034,NA,0.638239564,0,4.113312956,1.486850339,2.766460651,0.005666842,0.022301624,17.34537026,0,3.28254522,1.038484602,3.160899269,0.001572829,0.008195223,9.93784717,0,2.757708984,1.027199896,2.684685808,0.007259802,0.03754111,1.638961717,0,1.373722001,1.21654324,1.129201129,0.258812998,0.390591981,Y,-,,40S ribosomal s10,C:membrane,no IPS match,,
RL4_JR_06190,1444,1382,2072,0,8,0,1,0,2,2,0,1,0,0,1,0,1,0,17.26715117,1,3.34989472,1.055593141,3.173471472,0.001506277,0.008225039,0.394026854,1,4.809080559,1.641116276,2.930371619,0.003385569,0.016488617,7.526310605,1,3.111579666,1.225720638,2.538571653,0.011130601,0.035660191,10.82118423,1,2.680448819,1.179372506,2.2727754,0.023039718,0.081940754,1.017256732,1,2.062054196,1.256055309,1.641690602,0.10065414,0.192042688,N,-, Effector probability:0.555,high affinity copper transporter,C:integral component of membrane; F:copper ion transmembrane transporter activity; P:copper ion transmembrane transport,IPR007274 (PFAM); PTHR12483:SF44 (PANTHER); IPR007274 (PANTHER),1.A.56.1.16, the copper transporter (ctr) family.
RL4_JR_06191,5039,6672,10859,6,0,5,0,0,0,0,2,0,0,0,0,0,4,0,166.6657873,1,-4.440121076,1.172034376,-3.788388093,0.000151628,0.001219901,49.58143658,0,-2.166237928,1.20405259,-1.799122352,0.071999329,0.15709791,129.3806043,1,-4.826502326,1.206241148,-4.001274814,6.30E-05,0.000860774,162.9524014,0,-3.513968345,1.0366632,-3.389691411,0.000699713,0.005500464,136.0967603,1,-3.262132475,1.012904779,-3.22057171,0.001279352,0.005869251,N,-,,37S ribosomal rsm22,P:metabolic process; P:single-organism process,IPR015324 (PFAM); PTHR13184 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_06192,6615,6877,9188,0,0,2,0,0,2,2,0,2,4,3,0,0,4,1,62.3127736,1,1.499511062,0.718031425,2.088364115,0.036765002,0.105981938,6.434639261,1,0.779613277,1.240121158,0.628658959,0.529572352,0.678008013,16.76651984,1,-1.878563444,1.203865932,-1.560442399,0.118655372,0.21997198,23.35941668,1,-1.355016412,1.156652053,-1.171498731,0.241398368,0.379822607,16.59725185,1,-1.966615193,1.212826944,-1.621513443,0.104907569,0.19791529,N,-,,37S ribosomal rsm22,"F:oxidoreductase activity, acting on a sulfur group of donors; C:intracellular organelle; C:cytoplasmic part; P:cellular metabolic process; P:single-organism metabolic process; P:organic substance metabolic process",PR00421 (PRINTS); IPR013766 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR005746 (TIGRFAM); IPR005746 (PANTHER); PTHR10438:SF284 (PANTHER); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY),3.A.26.1.1, the plasmodium translocon of exported proteins (ptex) family.
RL4_JR_06193,1232,1300,1983,0,3,9,0,0,0,0,0,1,0,2,1,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_06194,9321,9305,12977,11,3,20,0,0,0,0,4,3,0,7,0,0,14,2,60.46539261,1,-4.020371326,1.287826578,-3.121826645,0.001797327,0.009570886,18.92123523,0,-0.776455704,1.27152428,-0.61064953,0.541431625,0.688346732,49.73658839,1,-3.447265839,1.255828661,-2.745012872,0.006050852,0.021917292,81.49337601,1,-0.719518528,0.824541472,-0.87262867,0.382865508,0.528205758,49.69384694,1,-3.548770054,1.274151773,-2.785201989,0.005349439,0.018938136,N,-,,deoxyribose-phosphate aldolase,C:cytosol; F:transferase activity,IPR003750 (PFAM); IPR029026 (G3DSA:3.40.1280.GENE3D); IPR003750 (PANTHER); PTHR12150:SF13 (PANTHER); IPR012340 (SUPERFAMILY); IPR029028 (SUPERFAMILY),,
RL4_JR_06195,391,379,416,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,72.23220139,0,0.310876785,0.642600127,0.483779527,0.628542346,0.787961211,145.7241533,0,3.488921511,1.551159998,2.249233809,0.024497625,0.067418422,56.91700162,0,0.041455034,0.782220522,0.052996607,0.957734611,0.975121084,49.00977888,0,-1.448911363,1.041650493,-1.390976506,0.164232551,0.284491802,49.94351693,0,0.031430858,0.747375074,0.042054998,0.966454854,0.978159281,N,-, Effector probability:0.724,mitochondrial genome maintenance Mgr2,C:mitochondrial inner membrane presequence translocase complex; P:protein import into mitochondrial matrix; C:integral component of membrane,IPR018450 (SMART); IPR018450 (PFAM); PTHR28525:SF1 (PANTHER); PTHR28525 (PANTHER),1.A.111.1.2, the reactive oxygen species modulator 1 (romo1) family.
RL4_JR_06196,1231,1204,786,0,9,18,0,0,0,1,0,0,1,8,0,0,14,0,263.5545499,1,-0.027325772,0.386501178,-0.070700359,0.943636235,0.972238496,54.00097499,0,-1.096663263,1.109053507,-0.988828091,0.322747258,0.485055344,147.9481419,1,-1.846545062,0.746816874,-2.472554019,0.013415144,0.040711905,177.8623722,1,-1.55640524,0.581846981,-2.6749391,0.007474283,0.038414777,185.0226573,1,-0.688392782,0.510493483,-1.348484957,0.177502455,0.294673284,N,-,,fha domain-containing,C:integral component of membrane,IPR000253 (SMART); IPR008160 (PFAM); IPR000253 (PFAM); IPR000253 (G3DSA:2.60.200.GENE3D); PTHR15715 (PANTHER); PTHR15715:SF20 (PANTHER); IPR000253 (PROSITE_PROFILES); IPR008984 (SUPERFAMILY),,
RL4_JR_06197,5142,5720,3594,0,0,7,0,0,0,0,1,0,2,4,0,0,4,3,22.0931956,1,-2.56786318,1.183804194,-2.16916209,0.03007038,0.09048844,51.67386686,0,2.310351567,0.973815395,2.372473857,0.017669414,0.052173222,18.29004179,1,-2.004030943,1.18753336,-1.687557597,0.091496185,0.18130894,21.09969941,1,-2.426371462,1.185199498,-2.047226197,0.04063588,0.108587566,18.03043947,1,-2.086132356,1.190752405,-1.751944693,0.079783318,0.161045873,N,-,,methyltransferase type 11,P:metabolic process; F:methyltransferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); IPR013216 (PFAM); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_06198,399,421,401,0,0,0,0,0,0,0,1,0,1,1,0,0,9,1,15.13739953,0,2.301757726,0.885967919,2.598014755,0.009376446,0.036030641,1.18780283,0,3.217308826,1.411535027,2.279297902,0.022649363,0.063576497,10.90378248,1,1.536977282,1.211422873,1.268737214,0.204534805,0.330784403,3.529409982,1,0.153437123,1.232568231,0.124485703,0.900930719,0.939145839,2.997789844,1,0.502065251,1.217821574,0.412265033,0.680145175,0.77280551,N,-,,parasitic phase-specific psp-1,C:integral component of membrane; P:response to stress,IPR007568 (PFAM); PTHR31465 (PANTHER); PTHR31465:SF9 (PANTHER),9.A.26.1.4, the lipid-translocating exporter (lte) family.
RL4_JR_06199,683,979,1655,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,150.6090311,0,0.352631267,0.446884768,0.789087685,0.430060759,0.621292395,41.11684128,1,0.154433999,1.106343666,0.139589536,0.888984308,0.93732283,99.65997903,0,0.207706993,0.565337746,0.36740337,0.713318158,0.806165777,60.29859096,1,-2.894440965,1.138447814,-2.54244501,0.011007992,0.052428002,62.84588396,0,-1.818154851,0.967892137,-1.878468458,0.060317108,0.129278306,N,-,,c6 transcription factor,"C:nucleus; F:zinc ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR021858 (PFAM); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31263:SF4 (PANTHER); PTHR31263 (PANTHER); PTHR31263 (PANTHER); PTHR31263:SF4 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_06200,34941,21153,26226,16,19,16,0,0,4,1,8,5,4,7,4,0,20,2,30.66140461,1,-0.081381435,0.885568468,-0.091897395,0.926779561,0.9649863,6.102608703,1,0.856098531,1.247203916,0.686414242,0.492451926,0.648023712,22.35551204,1,-0.836200604,1.202629183,-0.695310422,0.486860785,0.621874664,27.60793924,1,-1.269501462,1.155920681,-1.098260012,0.272090968,0.414024804,23.00439346,1,-0.943534972,1.137322141,-0.829611012,0.406758749,0.543328803,N,-,,actin cortical patch,C:membrane,IPR009571 (PFAM); PTHR36414 (PANTHER),1.H.1.7.2, the claudin tight junction (claudin1) family.
RL4_JR_06201,189,167,218,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,98.0287566,1,6.157636611,0.758997922,8.112850418,4.94E-16,3.72E-14,0.493189943,0,4.485439592,1.588493583,2.82370646,0.004747184,0.019954733,1.269648338,0,1.84477643,1.251832029,1.473661312,0.140572804,0.249808508,18.79939182,0,3.730474438,0.886128473,4.209857321,2.56E-05,0.000326262,50.36219582,0,5.68933368,0.537306298,10.58862273,3.37E-26,1.31E-23,N,-,,high-affinity methionine permease,C:integral component of plasma membrane; F:L-amino acid transmembrane transporter activity; P:L-alpha-amino acid transmembrane transport; F:antiporter activity; P:L-amino acid transport,IPR002293 (PIRSF); IPR002293 (PFAM); IPR002293 (PANTHER); PTHR11785:SF353 (PANTHER),2.A.3.8.4, the amino acid-polyamine-organocation (apc) family.
RL4_JR_06202,1595,1922,3495,0,0,7,0,0,0,0,0,0,0,1,0,3,0,0,1.431374217,1,1.38035234,1.33107946,1.037017234,0.299727826,NA,0.458319497,0,4.591167947,1.568917391,2.926328673,0.003429884,0.016607314,1.185798357,0,1.943413732,1.227420808,1.583331259,0.113345982,0.212620849,5.379343331,1,2.468053855,1.155816546,2.135333556,0.032733774,0.096965904,1.165223933,1,1.86563525,1.208659979,1.543556734,0.122695753,0.222804867,N,-,,family Taurine catabolism dioxygenase,F:oxidoreductase activity,G3DSA:3.60.130.10 (GENE3D); IPR003819 (PFAM); PTHR10696:SF30 (PANTHER); PTHR10696 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_06203,1233,1767,1338,0,0,3,0,0,0,1,0,0,6,5,0,0,0,0,0.987308612,1,1.915936042,1.490033564,1.28583415,0.198500949,NA,89.56309503,0,7.784328541,0.760330947,10.23807932,1.34E-24,1.13E-21,0.818681561,1,2.477081025,1.251087322,1.979942552,0.047709984,0.109180805,0.944398024,1,2.055032801,1.302881373,1.577298474,0.114726863,0.216947588,0.808021003,0,2.393444631,1.229819119,1.946176143,0.051633585,0.114917018,N,-,,"endo alpha-1,4 polygalactosaminidase precursor",C:membrane,IPR004352 (PFAM); PTHR35273 (PANTHER); PTHR35273:SF1 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_06204,6708,5205,5576,6,5,50,0,0,0,0,0,3,1,3,3,0,0,0,0.281663258,1,3.72545404,2.614517594,1.424910679,0.154183022,NA,0.088838418,0,6.957667982,2.17719394,3.195704275,0.0013949,0.015023052,0.232696725,1,4.290761359,1.385357417,3.097223364,0.001953426,0.009646518,0.268578515,1,3.868809567,1.713043784,2.25844173,0.023918134,0.083494502,0.232028655,0,4.194150974,1.304562689,3.214986148,0.001304508,0.005936089,N,-,,signal peptide,F:hydrolase activity,IPR000073 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR37017 (PANTHER); PTHR37017:SF4 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_06205,58779,35636,42895,3,1,11,0,0,1,1,0,7,6,9,2,0,1,2,0.186054264,1,4.323645796,3.097490387,1.395854468,0.162758324,NA,0.059614022,1,7.533496664,2.354989849,3.198950801,0.001379287,0.015023052,0.15461425,1,4.880822329,1.426652499,3.421171122,0.000623521,0.00397264,0.178339629,1,4.45967521,1.926851033,2.314488839,0.020640923,0.077838716,0.152710851,1,4.795671903,1.297242347,3.696820346,0.000218317,0.001340483,N,-, Effector probability:0.629,tyrosine- phosphatase non-receptor type partial,F:catalytic activity; C:membrane; C:integral component of membrane; P:nucleoside metabolic process; C:cytosol; F:molybdopterin synthase activity; P:Mo-molybdopterin cofactor biosynthetic process; C:molybdopterin synthase complex,no IPS match,,
RL4_JR_06206,1322,1458,2702,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2.045883049,0,0.864708983,1.365371386,0.633314124,0.526528532,NA,0.647412087,0,4.092551081,1.537765135,2.661362901,0.007782503,0.028023654,1.692320293,0,1.429428474,1.267932857,1.127369219,0.259586408,0.396244839,1.953011011,1,1.006710133,1.295989467,0.776788823,0.437283372,0.578984457,1.684207284,0,1.334141176,1.269617519,1.050821334,0.293340655,0.428211381,N,-,,---NA---,,no IPS match,,
RL4_JR_06207,466,565,522,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,1.981587099,0,0.910924935,1.268503804,0.718109738,0.472689626,NA,0.631467007,0,4.128694032,1.485542656,2.779249735,0.005448462,0.021875974,8.138968506,0,2.43634164,1.197203524,2.035027121,0.041848144,0.099057894,5.903906556,1,1.998840099,1.153005724,1.733590785,0.082990717,0.170407829,1.619464021,0,1.390758218,1.211815221,1.147665249,0.251106782,0.381807504,N,-,,Zn2 Cys6 DNA-binding,F:binding,IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31779:SF5 (PANTHER); PTHR31779 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_06208,1611,1535,1458,0,0,7,0,0,0,0,0,4,0,1,4,0,0,0,1.442985164,1,1.368559761,1.323198018,1.034281901,0.301004396,NA,0.4610885,0,4.582402451,1.56129611,2.934998954,0.003335488,0.016389297,1.195395393,1,1.931366048,1.22454053,1.577216924,0.11474562,0.214808554,1.378953316,1,1.509147561,1.247263421,1.209966985,0.226291562,0.361969749,1.177844507,0,1.850013622,1.210054227,1.52886836,0.126297081,0.227375169,N,-,,bicyclomycin resistance,C:membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23502:SF65 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.16, the major facilitator superfamily (mfs).
RL4_JR_06209,1539,1124,1102,0,0,5,0,0,0,0,0,0,0,2,0,0,0,0,0.05437592,1,6.099828806,3.926361778,1.553557505,0.120290003,NA,0.017243308,0,9.324817695,3.374329261,2.763458149,0.005719243,0.022481621,0.044478166,0,6.683869349,2.155360501,3.101044743,0.001928391,0.009579507,0.05131907,1,6.258398051,3.474813549,1.801074493,0.071691139,0.153811602,0.043193048,0,6.62403651,1.710107389,3.873462306,0.0001073,0.000734063,N,-, Effector probability:0.824,---NA---,,no IPS match,,
RL4_JR_06210,3359,2848,3153,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0.003906015,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,0,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,N,-,,cytochrome p450,F:oxidoreductase activity; F:metal ion binding; C:membrane; P:metabolic process,IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305 (PANTHER); PTHR24305:SF46 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_06211,1021,808,773,0,0,6,0,0,0,0,1,1,0,1,0,0,0,1,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-, Effector probability:0.795,Nonsense-mediated mRNA decay 1,F:nucleic acid binding; F:zinc ion binding; F:metal ion binding,no IPS match,,
RL4_JR_06212,1538,1307,1632,0,0,5,0,0,0,0,1,0,4,7,0,0,1,2,18.10468688,1,5.517249558,0.877729245,6.28582173,3.26E-10,1.00E-08,0.129453993,0,6.415071375,2.004248543,3.200736454,0.001370768,0.015023052,0.334312639,1,3.769470374,1.31176182,2.873593603,0.004058308,0.016547044,0.385534728,1,3.347757364,1.508419113,2.219381427,0.026460786,0.08636862,0.328346696,1,3.691719261,1.247804069,2.958572866,0.003090672,0.012129089,N,-,,xenobiotic compound family,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity",IPR016215 (TIGRFAM); IPR011251 (G3DSA:3.20.20.GENE3D); IPR011251 (PFAM); IPR016215 (PIRSF); PTHR30011 (PANTHER); PTHR30011:SF30 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_06213,407,538,466,0,0,2,0,0,0,1,0,0,2,7,0,0,1,1,1.908104625,1,0.965266499,1.349142952,0.715466436,0.474320874,NA,0.606529488,0,4.186706933,1.537703058,2.722701832,0.006475047,0.024519425,1.580587071,1,1.527968559,1.256611693,1.215943292,0.224006525,0.354184298,1.823723068,1,1.105522052,1.282870132,0.861756794,0.388821365,0.533443946,1.567988584,1,1.43721599,1.254316802,1.145815784,0.251871383,0.382797621,N,-,,MFS ACS allantoate permease,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF191 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_06214,16705,10193,11644,1,10,9,0,0,0,2,4,3,0,2,1,0,1,0,0.39080452,1,3.253243873,2.244487799,1.449437094,0.147215556,NA,0.125848392,0,6.4560767,2.033058166,3.17554943,0.00149553,0.015023052,0.324041179,1,3.815913826,1.330884753,2.867200799,0.004141202,0.016730846,0.373670727,1,3.393414446,1.544284378,2.19740256,0.027991709,0.088928789,0.316529471,1,3.745785918,1.257056845,2.979806308,0.002884307,0.011461385,Y,-, Effector probability:0.955,glycosyltransferase family 90,C:membrane; C:integral component of membrane; F:transferase activity,PS51257 (PROSITE_PROFILES),,
RL4_JR_06215,19414,10494,11020,0,3,0,0,0,0,0,0,0,0,2,0,0,0,0,2.220190036,1,0.747252075,1.319889329,0.566147524,0.571293499,0.74749196,0.712526355,0,3.954660312,1.514797791,2.610685291,0.009036101,0.031258855,1.837944312,0,1.311385354,1.249704163,1.049356634,0.294014009,0.434603275,2.119733299,1,0.889307992,1.26938543,0.700581534,0.483564206,0.623784888,1.797950476,0,1.239989544,1.234421372,1.004510754,0.31513249,0.450613764,N,-,,polysaccharide export (CAP59),P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,IPR021047 (PFAM); PTHR34144:SF5 (PANTHER); PTHR34144 (PANTHER),,
RL4_JR_06216,44215,41455,42983,2,4,5,0,0,3,0,0,0,0,1,3,0,8,0,49.29803814,1,1.746579261,0.532629287,3.279164895,0.001041148,0.006110564,4.644020637,1,1.250150136,1.241106096,1.007287081,0.313796836,0.475629167,12.04789594,0,-1.401721759,1.189610543,-1.178303073,0.238675803,0.371562422,100.5790112,1,2.885151888,0.396568873,7.275285789,3.46E-13,1.74E-11,38.898087,1,1.923281368,0.581246834,3.308889197,0.000936669,0.004531187,N,-,,"Beta-1,2-xylosyltransferase 1",C:membrane,IPR006598 (SMART); IPR006598 (PFAM); PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR12203:SF36 (PANTHER); PTHR12203 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_06217,9645,11722,14122,0,0,0,0,0,0,0,0,0,2,0,0,0,1,4,0.024701871,0,7.238701169,3.949789044,1.832680452,0.066850106,NA,0.007694775,0,10.48756637,3.950855392,2.654505246,0.00794248,0.02841517,0.020152476,0,7.824018738,2.683596837,2.915497078,0.003551224,0.015351236,0.023270171,1,7.399037905,3.950359032,1.873003908,0.061067845,0.137947378,0.019940236,1,7.746134954,1.600920209,4.838551548,1.31E-06,1.80E-05,N,-, Effector probability:0.784,NADH-quinone oxidoreductase,"F:quinone binding; F:metal ion binding; F:NADH dehydrogenase (ubiquinone) activity; P:oxidation-reduction process; F:4 iron, 4 sulfur cluster binding",IPR006138 (TIGRFAM); IPR006137 (PFAM); IPR006137 (G3DSA:3.40.50.GENE3D); PTHR11995 (PANTHER); PTHR11995:SF19 (PANTHER); PS51257 (PROSITE_PROFILES); SSF56770 (SUPERFAMILY),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_06218,2776,2499,2243,0,0,0,0,0,0,0,0,0,2,1,2,0,2,0,1.714936148,0,1.119580966,1.291045626,0.86718931,0.385838292,NA,0.546680369,0,4.336749854,1.518242666,2.856427336,0.004284381,0.018621961,1.418747162,0,1.684389919,1.220347078,1.380254806,0.167508205,0.284682401,1.636755793,1,1.261996817,1.236755526,1.02040928,0.307534394,0.453177957,1.398679183,1,1.602380281,1.209585084,1.324735483,0.1852589,0.304146746,N,-,,hypothetical protein HMPREF1624_03619,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR40626:SF1 (PANTHER); PTHR40626 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_06219,976,882,798,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0.166653997,0,4.48254314,3.235476443,1.385435258,0.165919416,NA,0.053777526,0,7.68242494,2.40034834,3.200545859,0.001371675,0.015023052,0.138756604,1,5.037678089,1.435751623,3.508739262,0.000450236,0.003130151,0.160000338,0,4.616435359,1.987632242,2.322580235,0.020201714,0.077185792,0.136258114,0,4.959240986,1.291840178,3.838896693,0.000123588,0.000827601,N,-,,intracellular serine protease,P:proteolysis; F:serine-type endopeptidase activity; F:peptidase activity; C:cellular_component,IPR015500 (PRINTS); IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (PFAM); IPR000209 (SUPERFAMILY),,
RL4_JR_06220,2100,1670,2061,0,10,2,0,0,0,0,0,5,0,4,0,0,0,2,0.128737897,1,4.855168781,3.592700719,1.35139806,0.176567955,NA,0.041445201,0,8.058639694,2.50882825,3.212112943,0.001317626,0.015023052,0.106769333,1,5.417939573,1.457718767,3.716724855,0.000201822,0.001769044,0.123123786,1,4.994955978,2.153322531,2.319650636,0.020359784,0.077468176,0.104380149,1,5.346033292,1.284891319,4.160689089,3.17E-05,0.000264407,N,-,,ankyrin unc44,P:biological_process; F:zinc ion binding; F:aspartic-type endopeptidase activity; P:proteolysis; C:cellular_component; F:molecular_function,IPR002110 (SMART); IPR000433 (SMART); IPR000433 (PFAM); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PF13637 (PFAM); PTHR24123 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR000433 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY),8.A.28.1.1, the ankyrin (ankyrin) family.
RL4_JR_06221,1802,1469,1415,0,4,1,0,0,0,0,0,2,0,0,0,0,1,4,3.579438405,1,0.057796462,1.209640669,0.04777986,0.961891688,0.980643887,1.144004182,0,3.271423315,1.3777212,2.374517656,0.017571896,0.051961066,2.965865752,1,0.620400077,1.204897348,0.514898699,0.60662381,0.723290478,3.421261578,0,0.198156024,1.205930697,0.16431792,0.869480875,0.91953598,2.92264028,1,0.538881506,1.201813958,0.448390121,0.65387167,0.752922855,N,-,,cytosine-purine permease,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR026030 (PIRSF); IPR001248 (PFAM); PTHR31806 (PANTHER); PTHR31806:SF5 (PANTHER),2.A.39.2.4, the nucleobase:cation symporter-1 (ncs1) family.
RL4_JR_06222,5930,4467,3884,0,4,0,0,0,1,0,5,0,2,0,0,0,0,0,39.02573071,1,2.083126982,0.738167631,2.822024286,0.004772156,0.020964594,2.35103998,1,2.232303146,1.347500986,1.656624499,0.097595416,0.198644842,6.079221786,1,-0.414695536,1.231821723,-0.336652235,0.736379074,0.82249578,7.01254124,1,-0.836926422,1.234790414,-0.67778824,0.497905968,0.636125922,5.959255989,0,-0.48882288,1.230595771,-0.397224573,0.691201863,0.781073534,N,-,,short chain dehydrogenase reductase family,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24322:SF627 (PANTHER); PTHR24322:SF627 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06223,8743,11028,9201,3,0,19,0,0,0,7,7,1,10,19,5,0,17,4,40.09766459,1,1.497764589,0.613132394,2.442807792,0.014573497,0.051378818,4.170094886,0,1.405476263,1.260659464,1.114873844,0.264904487,0.421863312,41.34714796,1,1.579265653,0.745473621,2.118472887,0.034135039,0.08481227,31.38175501,1,0.080209979,1.014730441,0.079045602,0.936996351,0.963171625,18.31340532,1,0.350265976,0.974623242,0.359386028,0.719306326,0.802355023,N,-,,hypothetical protein SPBR_04674,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_06224,9897,7974,7633,2,0,12,0,0,0,1,7,0,6,15,5,0,2,3,3.421412738,1,0.123266379,1.215707281,0.101394785,0.919237076,0.961445874,1.093427711,0,3.336707114,1.38696089,2.405768713,0.016138478,0.048820585,2.832296046,1,0.687195434,1.206237809,0.569701454,0.568880204,0.693312048,7.278749056,1,1.212019416,1.147819352,1.055932202,0.290999191,0.435788612,2.786246717,1,0.608003093,1.199885884,0.506717431,0.612353098,0.719934407,N,-,,trihydroxytoluene oxygenase,,no IPS match,,
RL4_JR_06225,2080,2332,1589,2,0,4,0,0,0,0,0,0,0,0,0,0,1,1,0.29148588,1,3.676103223,2.523118271,1.456968254,0.145125144,NA,0.093887203,0,6.878602761,2.130909287,3.228012945,0.001246533,0.015023052,0.2421952,0,4.234913597,1.335370499,3.171339789,0.001517375,0.007951298,0.279292661,0,3.812987162,1.629595645,2.339836372,0.01929219,0.075572463,0.237473401,1,4.159094091,1.250258635,3.326586976,0.000879166,0.004308593,N,-,,major facilitator superfamily transporter,P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane; P:anion transport,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF242 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_06226,1862,2030,3690,3,0,1,1,0,0,0,1,0,3,0,0,0,3,0,118.9349376,1,1.425596673,1.106546035,1.288330199,0.197631045,0.360123759,11.1984253,1,-0.01965759,1.229786576,-0.015984554,0.987246714,0.993726257,41.92663069,1,-0.84788999,1.042800849,-0.813089087,0.416166983,0.557754108,33.36614466,1,-3.087433737,1.19941951,-2.57410665,0.010049929,0.048733492,43.80798421,1,-0.135617999,0.760360498,-0.178360132,0.858440157,0.906046762,N,-,,ncs1 nucleoside transporter family,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transmembrane transport; P:transcription, DNA-templated; C:integral component of membrane; F:transporter activity",IPR001248 (PFAM); IPR012681 (TIGRFAM); PTHR30618:SF4 (PANTHER); PTHR30618 (PANTHER),2.A.39.3.1, the nucleobase:cation symporter-1 (ncs1) family.
RL4_JR_06227,19887,16986,13860,1,10,5,3,0,0,1,4,0,0,2,0,2,0,2,105.6969054,1,2.163212084,0.466432229,4.63778433,3.52E-06,4.61E-05,5.865619203,1,0.913273211,1.235525822,0.739177761,0.459799063,0.618647629,15.18428316,1,-1.735450163,1.190033263,-1.458320718,0.144752162,0.25516995,33.56113826,1,0.561386055,0.740228257,0.758395873,0.448214028,0.590138756,14.93048032,1,-1.813964526,1.188341964,-1.526466776,0.126893659,0.228165209,N,-,,hydantoinase,F:hydrolase activity,IPR027479 (G3DSA:3.40.1610.GENE3D); IPR008040 (PFAM); IPR002821 (PFAM); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR024071 (G3DSA:2.40.390.GENE3D); IPR010318 (PFAM); PTHR11365:SF10 (PANTHER); PTHR11365 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY); SSF160991 (SUPERFAMILY),,
RL4_JR_06228,893,861,1216,0,0,3,0,0,0,0,0,1,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_06229,6920,5263,6008,0,1,6,0,0,0,0,1,3,5,0,5,0,9,2,9.69803166,1,2.093097367,1.146184352,1.826143729,0.067828615,0.16702259,0.539350394,0,4.356267558,1.524210536,2.858048448,0.004262553,0.018590202,1.397342499,1,1.706488909,1.220617465,1.39805382,0.162096906,0.277770663,1.611898809,1,1.284186219,1.237299274,1.037894587,0.299319134,0.444565972,8.740502316,1,2.561586874,1.125306244,2.276346451,0.022825282,0.060638879,N,-,,Heterokaryon incompatibility,,IPR010730 (PFAM); PTHR33112:SF6 (PANTHER); PTHR33112 (PANTHER),,
RL4_JR_06230,2622,1999,1767,0,1,5,0,0,0,0,0,0,0,0,1,0,0,2,7.310821771,1,-0.972268159,1.216855863,-0.799000267,0.424290257,0.61546229,2.355242109,0,2.229739378,1.329619614,1.676975396,0.093547293,0.192378241,6.068278123,0,-0.412136654,1.216277743,-0.338850774,0.734722149,0.821642223,6.997630202,1,-0.833897981,1.21648245,-0.685499393,0.493028844,0.631888233,5.936510309,1,-0.483471191,1.209941844,-0.399582173,0.689464289,0.779801417,N,-,,2OG-Fe(II) oxygenase superfamily,F:oxidoreductase activity; P:oxidation-reduction process,IPR006620 (SMART); IPR005123 (PFAM); PTHR33099 (PANTHER); PTHR33099:SF6 (PANTHER),,
RL4_JR_06231,6811,5238,7479,0,12,3,0,0,0,1,0,2,0,1,5,0,2,0,0.139941534,1,4.734311518,3.914381982,1.209465898,0.226483905,NA,0.043705011,0,7.980803067,3.887085035,2.053158857,0.040057173,0.099206926,0.115767128,1,5.298299067,2.278850856,2.324987198,0.020072645,0.055743746,0.133678948,1,4.875468705,3.650389616,1.335602283,0.181679304,0.307609189,0.117202857,1,5.178928256,1.936043513,2.675006126,0.007472788,0.024872447,Y,-, Effector probability:0.629,C-8 sterol isomerase,C:endoplasmic reticulum membrane; C:integral component of membrane; P:sterol biosynthetic process; F:isomerase activity,IPR006716 (PFAM); PTHR10868:SF1 (PANTHER); PTHR10868 (PANTHER),8.A.63.1.2," the sigma non-opioid intracellular recpetor, (s1r) family."
RL4_JR_06232,1794,1311,1647,0,1,1,0,0,0,0,0,1,4,2,1,0,2,0,0.150960126,1,4.625247992,3.56968931,1.295700435,0.195078711,NA,0.050113151,0,7.784969361,2.632724058,2.957001641,0.003106465,0.015912771,0.126904119,1,5.167895494,1.678169196,3.079484182,0.002073594,0.01013668,0.146158383,1,4.74738984,2.31159625,2.053727955,0.040002029,0.107518064,0.122166889,1,5.116475181,1.477296002,3.463405556,0.000533384,0.002855902,Y,-,,hypothetical protein Z518_05620,F:metal ion binding; C:membrane; C:integral component of membrane,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_06233,2259,1378,2327,0,0,0,0,0,0,0,2,0,2,4,2,0,0,1,0.080140704,0,5.538914246,3.920059817,1.412966767,0.157665496,NA,0.024891647,0,8.792568009,2.8806732,3.052261537,0.002271241,0.0150814,0.065714776,1,6.115118213,1.724781412,3.545445337,0.00039195,0.002842482,0.075894662,1,5.692272628,2.744445474,2.074106657,0.038069406,0.103895617,0.065904244,1,6.013404663,1.430661376,4.203234088,2.63E-05,0.000226545,N,-,,ankyrin repeat domain-containing 29,P:biological_process; C:cellular_component; F:molecular_function,IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24123 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_06234,492,491,538,5,0,0,0,0,6,0,1,0,0,0,0,0,0,1,10.49046392,1,0.106784418,1.145113904,0.093252224,0.925703186,0.96460424,2.127220484,1,2.376513763,1.300579525,1.827272933,0.067658743,0.149479038,5.52431639,1,-0.276989636,1.19885725,-0.231044718,0.817280062,0.881634879,6.373203128,0,-0.699394301,1.196947776,-0.584314801,0.559008536,0.687890305,5.453881507,1,-0.361067687,1.202362743,-0.300298466,0.763949503,0.835131583,Y,-,,infection structure specific,,no IPS match,,
RL4_JR_06235,38283,3895,5897,1,0,0,0,0,0,0,0,7,0,0,0,0,0,0,2.059204311,1,0.85542662,1.262005611,0.677831075,0.497878806,NA,0.659177771,0,4.06678144,1.483546621,2.741256245,0.006120475,0.023596624,27.70249428,1,4.231197176,0.750368464,5.638825963,1.71E-08,7.02E-07,1.969625007,0,0.994742327,1.231175735,0.807961283,0.41911287,0.562245651,1.681657307,0,1.336127241,1.209740867,1.104473923,0.269387609,0.401700964,N,-,,Zinc C2H2-like,F:nucleic acid binding; F:metal ion binding,IPR015880 (SMART); PTHR38846 (PANTHER); IPR007087 (PROSITE_PROFILES),,
RL4_JR_06236,1218,761,832,0,0,7,0,0,0,0,0,0,3,0,0,0,1,0,418.2712107,1,2.304062705,1.014881134,2.270278389,0.023190697,0.074075846,22.96066071,0,-1.055594663,1.19520844,-0.883188763,0.377134292,0.54172925,163.2488504,0,0.812495434,0.434521025,1.869864488,0.061502638,0.132818411,316.3881086,1,1.925179607,0.301205678,6.39157808,1.64E-10,6.02E-09,77.8822903,1,-1.178317633,0.754733299,-1.561237109,0.118467816,0.216944591,Y,-,,GMC oxidoreductase,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; P:oxidation-reduction process",IPR023753 (G3DSA:3.50.50.GENE3D); IPR000172 (PFAM); IPR007867 (PFAM); IPR012132 (PIRSF); PTHR11552 (PANTHER); PTHR11552:SF101 (PANTHER); SSF54373 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_06237,5771,9301,10905,0,0,10,0,0,0,0,0,0,0,2,0,0,6,0,261.9523352,1,0.032564932,0.792898214,0.04107076,0.967239485,0.983392288,86.87100174,0,-0.246989954,1.004846218,-0.245798759,0.805838018,0.882950034,165.9024632,0,-1.108384907,1.556596261,-0.712056771,0.476429622,0.613114719,338.9896433,1,0.820256757,0.493472522,1.662213639,0.096469946,0.190773087,206.8910556,1,-0.048233492,0.606389871,-0.079542048,0.936601488,0.95895339,N,-,,integral membrane,C:membrane,PTHR33048 (PANTHER),9.B.313.1.5, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_06238,6765,6206,6085,0,0,1,0,0,0,2,0,0,0,1,0,0,0,0,1.188209598,1,1.64875407,1.41589056,1.164464342,0.244235886,NA,0.382370822,0,4.852538537,1.637255893,2.96382414,0.003038419,0.015675267,0.987285915,1,2.207383815,1.249004804,1.767314111,0.077175638,0.158548328,1.138557738,1,1.785543212,1.2889395,1.385280855,0.165966605,0.28671078,0.969237805,0,2.130728412,1.225514856,1.738639399,0.082098212,0.164668065,N,-,,glycerophosphoryl diester phosphodiesterase,P:lipid metabolic process; F:glycerophosphodiester phosphodiesterase activity,IPR030395 (PFAM); IPR017946 (G3DSA:3.20.20.GENE3D); IPR004129 (PANTHER); PTHR23344:SF7 (PANTHER); PTHR23344:SF7 (PANTHER); IPR004129 (PANTHER); IPR030395 (PROSITE_PROFILES); IPR017946 (SUPERFAMILY),,
RL4_JR_06239,1656,1411,1601,0,5,1,0,0,0,3,0,3,0,4,0,0,0,0,7.846720938,1,-1.07440933,1.227364118,-0.875379453,0.381367476,0.573411045,2.480915542,0,2.154563919,1.308717386,1.646317182,0.099698474,0.202112548,6.474545335,1,-0.505896763,1.21803306,-0.415339107,0.677893677,0.778511525,7.472012731,1,-0.928767803,1.219389723,-0.76166609,0.446259319,0.588330157,6.420274075,0,-0.596332939,1.227753033,-0.485710826,0.627172207,0.731159309,N,-,,Aminoglycoside phosphotransferase,P:phosphorylation; F:transferase activity; F:kinase activity,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); PTHR21310 (PANTHER); PTHR21310:SF13 (PANTHER); PTHR21310:SF13 (PANTHER); IPR011009 (SUPERFAMILY); IPR011009 (SUPERFAMILY),,
RL4_JR_06240,2447,1929,2808,0,4,0,0,0,0,3,1,0,0,5,0,0,0,0,995.2099464,1,-0.241495716,0.471944676,-0.511703443,0.608858576,0.775135497,231.1359666,0,-0.842076144,0.659801306,-1.276257165,0.201864627,0.346258898,570.5384569,1,-1.855575828,0.476413732,-3.894883177,9.82E-05,0.001149877,663.867524,1,-1.933932797,0.3923165,-4.929521947,8.24E-07,1.54E-05,517.8589619,0,-2.295596352,0.611454065,-3.754323477,0.00017381,0.001106811,N,-,,isoleucyl-tRNA synthetase,"F:oxidoreductase activity, acting on CH-OH group of donors; P:regulation of translational fidelity; F:aminoacyl-tRNA editing activity; F:methyltransferase activity; F:precorrin-2 dehydrogenase activity; P:isoleucyl-tRNA aminoacylation; F:ATP binding; F:isoleucine-tRNA ligase activity; F:flavin adenine dinucleotide binding; C:cytosol; P:siroheme biosynthetic process; P:oxidation-reduction process; P:methylation",IPR002301 (PRINTS); IPR009080 (G3DSA:1.10.730.GENE3D); IPR014729 (G3DSA:3.40.50.GENE3D); IPR002301 (TIGRFAM); IPR013155 (PFAM); IPR009008 (G3DSA:3.90.740.GENE3D); IPR002300 (PFAM); PTHR11946:SF73 (PANTHER); PTHR11946:SF73 (PANTHER); PTHR11946 (PANTHER); PTHR11946 (PANTHER); IPR009008 (SUPERFAMILY); SSF52374 (SUPERFAMILY); IPR009080 (SUPERFAMILY),,
RL4_JR_06241,10809,7661,6054,3,2,6,0,0,0,0,13,8,1,5,4,0,4,1,0.044864836,1,6.3765473,3.930492663,1.622327746,0.104733191,NA,0.014213209,0,9.602789024,3.132500188,3.065535019,0.002172809,0.015045494,0.036890189,1,6.952653479,1.816687159,3.827105534,0.000129659,0.001356816,0.042568182,1,6.527491029,3.293410922,1.981984995,0.04748092,0.119055056,0.036240078,1,6.879257296,1.398644089,4.918518837,8.72E-07,1.29E-05,N,-,,---NA---,,no IPS match,,
RL4_JR_06242,5019,9724,5664,0,2,1,0,0,0,0,5,21,8,23,21,3,5,15,62.88563314,1,-3.039781875,1.154432758,-2.633138963,0.008459973,0.033196949,18.79405193,0,-0.766679345,1.207318399,-0.635026639,0.525411041,0.674386325,48.80252635,1,-3.419880718,1.195900756,-2.859669335,0.004240829,0.016940088,56.30567494,1,-3.842372602,1.196480629,-3.21139558,0.00132092,0.009339603,51.97243683,1,-2.572358779,1.128917955,-2.278605604,0.022690521,0.060331282,N,-,,siroheme synthase,F:nucleotide binding; P:tRNA aminoacylation for protein translation; F:aminoacyl-tRNA ligase activity; P:porphyrin-containing compound biosynthetic process; C:cytoplasm; F:methyltransferase activity,IPR000878 (PFAM); IPR028162 (G3DSA:1.10.3280.GENE3D); IPR028162 (PFAM); G3DSA:3.30.160.110 (GENE3D); IPR014776 (G3DSA:3.30.950.GENE3D); IPR028281 (PFAM); IPR014777 (G3DSA:3.40.1010.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR006367 (PFAM); IPR012066 (PTHR21091:PANTHER); PTHR21091 (PANTHER); IPR000878 (SUPERFAMILY); SSF75615 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_06243,13412,13171,17443,4,0,3,0,0,0,2,3,3,5,6,1,0,8,2,8.733072652,1,-1.228696183,1.343819735,-0.914331104,0.360542891,0.5521511,2.760191117,0,2.000781544,1.433299466,1.395927084,0.162736454,0.29456695,7.174897221,1,-0.653872625,1.29987359,-0.503027856,0.614944687,0.729859322,12.29162449,1,-0.136641256,1.258570089,-0.108568651,0.913544627,0.947611858,7.059205291,1,-0.733211021,1.311893003,-0.558895443,0.57623308,0.690210208,N,-,,carbamoyl-phosphate synthase subunit l,F:ATP binding; F:metal ion binding; F:biotin carboxylase activity,IPR005482 (SMART); IPR005482 (PFAM); IPR000089 (PFAM); IPR005481 (PFAM); G3DSA:2.40.50.100 (GENE3D); IPR013815 (G3DSA:3.30.1490.GENE3D); IPR005479 (PFAM); IPR013816 (G3DSA:3.30.470.GENE3D); IPR016185 (G3DSA:3.40.50.GENE3D); PTHR18866 (PANTHER); IPR000089 (PROSITE_PROFILES); IPR011761 (PROSITE_PROFILES); IPR011764 (PROSITE_PROFILES); SSF56059 (SUPERFAMILY); IPR011053 (SUPERFAMILY); IPR011054 (SUPERFAMILY); IPR016185 (SUPERFAMILY),3.B.1.1.5, the na(+)-transporting carboxylic acid decarboxylase (nat-dc) family.
RL4_JR_06244,2617,3253,2166,1,0,10,0,0,0,2,2,1,0,0,0,0,6,0,93.92600092,1,1.146934627,0.959634854,1.195178168,0.232017427,0.405223328,10.38101715,0,0.089587007,1.229984661,0.072835874,0.941936724,0.968537537,27.09446502,1,-2.57097985,1.208133635,-2.128059161,0.033332179,0.083383983,66.58544335,0,0.306474917,0.657693666,0.465984291,0.641226745,0.75397801,50.03779591,1,0.471812133,0.699719066,0.674287948,0.500128265,0.627795522,N,-,,pyridoxamine phosphate oxidase,F:oxidoreductase activity; P:metabolic process; C:intracellular part,IPR012349 (G3DSA:2.30.110.GENE3D); IPR011576 (PFAM); PTHR28040:SF1 (PANTHER); PTHR28040 (PANTHER); PTHR28040:SF1 (PANTHER); IPR012349 (SUPERFAMILY),,
RL4_JR_06245,1634,1659,2177,2,2,3,0,0,0,0,0,0,0,1,1,0,0,2,146.1629763,1,2.003864169,0.423063094,4.736561039,2.17E-06,3.01E-05,56.608602,0,3.058627801,0.731779979,4.179709599,2.92E-05,0.001632279,55.61286562,0,0.360988803,0.762738748,0.473279749,0.636013608,0.745945525,81.2126247,1,1.002656548,0.54645044,1.834853582,0.066527387,0.146114923,28.38207797,1,-1.600096903,1.12936031,-1.416817015,0.156536434,0.266779609,N,-,,auxin efflux carrier superfamily,P:transmembrane transport; C:integral component of membrane; C:endoplasmic reticulum,IPR004776 (PFAM); PTHR31794:SF2 (PANTHER); PTHR31794 (PANTHER),2.A.69.2.3, the auxin efflux carrier (aec) family.
RL4_JR_06246,16090,14345,15300,0,0,1,0,0,3,2,1,1,1,9,0,0,0,0,78.07321413,1,-2.51980381,1.028842157,-2.44916462,0.014318799,0.050666569,78.89227105,1,2.103350605,0.666621521,3.155239576,0.001603664,0.015023052,64.88782533,1,-2.716815552,1.199335226,-2.265267869,0.023496247,0.063298563,104.589055,1,-1.325511595,0.760896903,-1.742038363,0.081501732,0.168378638,88.1015418,0,-0.18206663,0.579004072,-0.314447927,0.75318086,0.828008275,N,-,,STE STE7 kinase,P:peptidyl-tyrosine phosphorylation; P:positive regulation of transcription factor import into nucleus in response to oxidative stress; P:MAPK import into nucleus involved in osmosensory signaling pathway; P:actin filament organization; P:protein autophosphorylation; F:MAP-kinase scaffold activity; F:peptide alpha-N-acetyltransferase activity; P:activation of MAPK activity involved in osmosensory signaling pathway; P:hyperosmotic response; P:MAPK cascade in response to starvation; C:nucleus; F:ATP binding; P:regulation of cytoplasmic translation in response to stress; C:cellular bud tip; C:NatB complex; P:cellular response to heat; F:non-membrane spanning protein tyrosine kinase activity; C:cellular bud neck; C:Mcs4 RR-MAPKKK complex; P:N-terminal peptidyl-methionine acetylation; F:MAP kinase kinase activity; C:cytosol; P:positive regulation of G2/M transition of mitotic cell cycle,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24361:SF302 (PANTHER); PTHR24361 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_06247,4104,4755,5636,0,2,11,0,0,0,0,2,1,3,3,0,0,9,0,333.7021222,1,2.653898777,0.403048212,6.584569042,4.56E-11,1.69E-09,13.88007969,0,-0.32938508,1.227636241,-0.268308371,0.788461964,0.87221989,94.41767048,1,0.455952671,0.632778374,0.720556658,0.471182329,0.607907467,63.91604861,1,-1.068249357,0.865604227,-1.234108294,0.217162553,0.351972283,49.79518502,1,-1.357660932,0.975017619,-1.392447587,0.163786903,0.276540644,N,-,,NAD-dependent histone deacetylase SIR2,P:regulation of nucleobase-containing compound metabolic process; P:regulation of macromolecule metabolic process; P:negative regulation of cellular process; F:NAD+ binding; P:cellular process,IPR029035 (G3DSA:3.40.50.GENE3D); IPR003000 (PFAM); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PANTHER); PTHR11085:SF3 (PANTHER); IPR026590 (PROSITE_PROFILES); IPR029035 (SUPERFAMILY),,
RL4_JR_06248,2964,3099,5254,1,2,6,0,0,0,0,0,0,1,8,0,0,3,0,43.66041238,1,0.929215866,0.656280497,1.415882187,0.156810001,0.30640862,14.55474193,0,2.010170701,1.122740649,1.79041411,0.073387364,0.159404913,27.75411663,0,0.265940975,1.028706681,0.258519732,0.796005823,0.86569588,76.00260749,1,1.580334945,0.565526824,2.794447369,0.00519885,0.02887458,36.01669653,1,1.301867842,0.669462599,1.944646116,0.051817585,0.115128706,N,-,,phosducin family,P:positive regulation of transcription from RNA polymerase II promoter by pheromones; F:actin binding; C:cytoplasm; F:G-protein beta/gamma-subunit complex binding; P:protein folding,IPR024253 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR21148 (PANTHER); PTHR21148:SF1 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_06249,577,878,902,0,0,1,2,0,0,0,0,1,3,4,0,0,0,0,620.1653422,1,-1.141981907,0.826409658,-1.381859343,0.167014894,0.318883993,184.1363757,1,-0.733166766,0.690990876,-1.061036825,0.288673166,0.448151808,367.9841281,1,-5.328652539,1.19668393,-4.452848749,8.47E-06,0.000164979,425.1179183,1,-4.978314012,1.021110189,-4.875393535,1.09E-06,1.98E-05,376.0447579,0,-3.236784786,0.690267048,-4.689177608,2.74E-06,3.40E-05,N,-, Effector probability:0.954,40S ribosomal S27,F:structural constituent of ribosome; C:ribosome; P:translation,IPR000592 (PFAM); IPR023407 (G3DSA:2.20.25.GENE3D); IPR000592 (PANTHER); IPR000592 (PRODOM); IPR011332 (SUPERFAMILY),,
RL4_JR_06250,2717,2233,2119,0,0,3,0,2,0,0,0,9,3,4,0,0,0,0,27.72756621,1,-2.895594311,1.243754126,-2.328108305,0.019906353,0.065166947,8.72215822,1,0.340762512,1.263306206,0.269738651,0.787361323,0.871568261,22.85255231,1,-2.32534648,1.23007517,-1.890410063,0.058703139,0.127946303,26.37895365,1,-2.748538911,1.23436513,-2.226682239,0.025968518,0.086065875,22.76290289,0,-2.422377553,1.246305431,-1.943646792,0.051938059,0.115221921,N,-,,aspartyl-trna synthetase,F:nucleotide binding; P:tRNA aminoacylation for protein translation; F:ATP binding; F:aminoacyl-tRNA ligase activity; C:cytoplasm; F:aspartate-tRNA ligase activity; P:aspartyl-tRNA aminoacylation; F:ligase activity; P:translation,PF04938 (PFAM),,
RL4_JR_06251,301,435,606,0,0,9,0,0,0,0,0,0,0,0,1,0,0,1,17.21305689,1,0.339264717,1.078074544,0.314695045,0.752993207,0.870775614,3.016285628,0,1.872643296,1.315201992,1.423844632,0.154491453,0.282829171,7.893535747,0,-0.791792705,1.232148533,-0.642611409,0.520476278,0.650531091,9.111064465,1,-1.214892819,1.235477484,-0.983338696,0.325440771,0.472007994,7.851193207,1,-0.88663574,1.246023377,-0.711572316,0.476729655,0.606545333,N,-,,ribonucleotide reductase inhibitor,,IPR013900 (PFAM),,
RL4_JR_06252,504,529,596,0,1,2,0,0,1,0,0,0,0,0,0,0,0,0,273.5011978,1,0.104774479,0.621023038,0.168712709,0.866022622,0.934401872,44.22191737,1,-2.001155932,1.241304897,-1.612138917,0.106931714,0.213189444,180.0920711,0,-0.663821933,0.606367951,-1.09475102,0.27362573,0.412544975,175.5247561,0,-1.527199479,0.653540989,-2.33680749,0.019449196,0.075776748,148.5811382,0,-1.13378001,0.634727145,-1.786247869,0.074059134,0.151301196,N,-,,meiotic regulator-interacting,C:cytoplasm; C:integral component of membrane; P:TOR signaling; C:TORC1 complex; P:positive regulation of conjugation with cellular fusion,PR01547 (PRINTS); IPR001680 (SMART); IPR029347 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR029347 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR12848:SF16 (PANTHER); IPR004083 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_06253,1110,955,1469,5,3,0,0,0,0,0,0,0,0,0,2,0,3,0,296.3100689,1,0.240912495,0.412741439,0.583688654,0.559429802,0.736695452,72.11493354,0,0.16909155,0.892307536,0.189499184,0.849701595,0.910324706,167.3535176,0,-1.008568282,0.60819077,-1.658309089,0.097255095,0.190079264,245.3911523,1,-0.332870617,0.628131483,-0.529937802,0.596155056,0.719093393,171.4675502,1,-0.443234737,0.507048576,-0.874146498,0.382038478,0.517894289,N,-,,kelch domain-containing,,IPR006652 (SMART); PF13964 (PFAM); PF13418 (PFAM); IPR015915 (G3DSA:2.120.10.GENE3D); PF13415 (PFAM); PTHR23244 (PANTHER); PD936484 (PRODOM); SSF117281 (SUPERFAMILY),,
RL4_JR_06254,48,33,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,104.1056839,0,0.881849452,0.475018162,1.85645418,0.063388848,0.158773787,21.16509089,0,0.823515521,1.115723484,0.738100015,0.460453674,0.618997398,88.69653988,0,0.889954902,0.571650603,1.556816168,0.119514137,0.221078225,71.3693746,0,0.69151098,0.525322934,1.316354064,0.188055233,0.316236378,67.64837591,0,0.604741661,0.573826854,1.053874799,0.291940242,0.426597626,N,-,,GTP-binding RHO3,F:GTP binding; C:nucleus; P:positive regulation of formin-nucleated actin cable assembly; C:cellular bud; P:small GTPase mediated signal transduction; F:GTPase activity; P:regulation of cell separation after cytokinesis; P:establishment or maintenance of cell polarity regulating cell shape; C:cytosol; P:microtubule cytoskeleton organization; P:establishment or maintenance of actin cytoskeleton polarity; P:positive regulation of exocytosis,PR00449 (PRINTS); SM00174 (SMART); SM00175 (SMART); SM00173 (SMART); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); PTHR24072:SF0 (PANTHER); PTHR24072 (PANTHER); PTHR24072:SF0 (PANTHER); PTHR24072 (PANTHER); PS51420 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.60.1.1, the small nuclear rna exporter (snrna-e).
RL4_JR_06255,1977,1700,1849,0,0,0,0,0,0,0,0,0,1,2,0,0,0,0,102.8254404,0,-0.050694401,0.606783284,-0.08354614,0.933417291,0.967083853,27.17176441,0,0.227100064,1.14430704,0.198460776,0.84268457,0.906156722,76.88447061,0,-0.528968193,0.787051619,-0.672088311,0.501527478,0.634128161,61.46275731,1,-2.058627336,1.057200176,-1.947244602,0.051505417,0.125358737,57.48119212,0,-1.259506765,0.904635651,-1.392280708,0.163837411,0.27656782,N,-,,molybdopterin biosynthesis moeb,C:membrane; F:small protein activating enzyme activity,IPR000594 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10953 (PANTHER); PTHR10953 (PANTHER); PTHR10953:SF135 (PANTHER); IPR000594 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_06256,10087,10433,8166,7,11,12,0,0,0,10,13,15,0,16,6,0,4,7,96.41655939,1,-0.927029319,0.630639678,-1.469982545,0.141566482,0.284668316,22.10232749,0,-1.000634085,1.201374684,-0.832907584,0.404896852,0.569059419,86.05077741,1,-1.240204615,0.853869883,-1.452451527,0.146376098,0.257364559,83.56951923,1,-1.765265032,0.858389562,-2.056484736,0.039735816,0.107029832,68.29105433,1,-1.541151906,0.856816258,-1.798695917,0.072066795,0.148127548,N,-,,pre-mRNA-splicing factor cwc25,,IPR019339 (SMART); IPR022209 (PFAM); IPR019339 (PFAM); PTHR16196 (PANTHER),,
RL4_JR_06257,13,4,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42.13762932,0,-0.747044466,0.866449026,-0.8621909,0.388582476,0.58138095,9.745308245,0,0.180770761,1.215907407,0.148671486,0.881812862,0.932773518,25.36000696,0,-2.475541309,1.194721783,-2.072065097,0.038259371,0.092267239,37.28459962,0,-1.174317364,1.021286397,-1.149841384,0.250209207,0.389509259,32.79935542,0,-0.897507523,0.987312505,-0.909040976,0.363328497,0.49992148,N,-,,COP9 signalosome complex subunit 2,,SM00753 (SMART); IPR000717 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); IPR000717 (PFAM); PTHR10678:SF3 (PANTHER); PTHR10678 (PANTHER); IPR011991 (SUPERFAMILY),,
RL4_JR_06258,102115,82901,94384,7,6,5,0,0,3,0,1,0,0,3,2,0,0,0,93.29058576,1,-0.456151322,0.644882997,-0.707339664,0.479355423,0.668247016,16.62006821,1,-0.589300895,1.229208359,-0.479414975,0.631643442,0.758421699,49.32367896,1,-2.269574293,1.204125553,-1.884831933,0.059452532,0.129245745,53.39411223,1,-2.706958463,1.15908958,-2.335417822,0.019521604,0.075846601,86.1100301,0,-0.029407352,0.657580016,-0.044720568,0.964330039,0.97657948,N,-,,ubiquitin thiolesterase,,IPR019400 (PFAM); PTHR12931 (PANTHER); IPR003323 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY),,
RL4_JR_06259,3842,3636,5517,0,0,3,0,0,0,0,0,0,1,2,6,0,0,0,107.2663659,1,-0.114803285,0.950805407,-0.120743198,0.903894443,0.953448521,19.3672734,0,-0.810040407,1.259883614,-0.642948601,0.520257452,0.67065558,80.5297153,0,-1.029597642,0.916351367,-1.123583899,0.26118959,0.398175487,150.4625531,1,0.865815304,0.651422803,1.329114209,0.183810293,0.310552788,84.78197091,0,0.016793026,0.769804354,0.021814667,0.982595795,0.988530028,N,-,,hypothetical protein SPI_04581,F:NAD binding; P:oxidation-reduction process,no IPS match,,
RL4_JR_06260,1598,1973,2015,0,3,15,1,0,0,0,1,1,0,2,0,0,0,6,37.87270893,1,1.743191553,0.66138289,2.635676822,0.008396966,0.033061029,3.425013253,1,1.689327092,1.282780478,1.316926101,0.187863397,0.328363547,8.917524215,1,-0.967834611,1.212087146,-0.798485995,0.424588517,0.565732217,38.54883021,1,0.961898208,0.869877217,1.105786184,0.268819076,0.409970349,8.833937777,1,-1.056855652,1.221365225,-0.865306814,0.386870412,0.522976747,N,-,,---NA---,,no IPS match,,
RL4_JR_06261,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.8599099,0,1.600803733,0.613940134,2.607426433,0.009122567,0.035271044,4.877552548,0,1.179301437,1.256762561,0.938364552,0.348057097,0.510806718,20.52687398,0,-0.514291954,1.202938652,-0.427529661,0.668993586,0.772168276,18.64520214,0,-0.9522805,1.157370625,-0.8227965,0.410623727,0.554415954,16.40870862,0,-0.634592106,1.143655855,-0.554880302,0.578976536,0.691824451,N,-,,leucine rich repeat domain containing,,IPR003591 (SMART); IPR025875 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (SUPERFAMILY),8.A.43.1.2, the neat-domain containing methaemoglobin heme sequestration (n-mhs) family.
RL4_JR_06262,2930,2626,4137,0,0,0,0,0,0,0,3,1,0,2,0,0,2,0,0.028304421,0,7.040982679,3.944305359,1.785100807,0.074244967,NA,0.009194001,0,10.23263417,3.417489009,2.994196657,0.002751685,0.015349618,0.023520804,1,7.602821568,1.997858148,3.805486178,0.000141526,0.001415819,0.027113088,1,7.178283977,3.944203294,1.819957908,0.068765415,0.148866758,0.02280449,1,7.539230421,1.431110837,5.268096799,1.38E-07,2.93E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_06263,369,305,298,0,0,5,0,3,0,0,0,2,0,8,2,1,0,0,90.64321555,1,-0.053372361,0.587158672,-0.090899383,0.92757254,0.96537932,14.45930884,1,-0.388366133,1.219007247,-0.318592145,0.750035811,0.847219946,37.35993024,1,-3.034384718,1.195782565,-2.537572305,0.011162431,0.035707308,59.13622825,1,-0.750339952,0.760276898,-0.986929834,0.323677038,0.470123369,36.64810048,1,-3.109449127,1.192313216,-2.607912992,0.009109611,0.029132915,Y,-,,telomerase-binding EST1A,,IPR018834 (PFAM); PTHR15696:SF6 (PANTHER); PTHR15696:SF6 (PANTHER); PTHR15696 (PANTHER); PTHR15696 (PANTHER); IPR011990 (SUPERFAMILY),,
RL4_JR_06264,45887,39614,59117,13,8,60,0,0,3,1,0,4,1,45,5,0,28,3,207.8833795,1,-1.00812776,0.460765714,-2.187940053,0.028673969,0.087414888,43.71608944,1,-1.984558284,1.193697109,-1.662530863,0.09640638,0.196985403,154.2651077,1,-1.802416553,0.736093379,-2.448624868,0.014340271,0.042876819,245.0639108,1,-0.397767393,0.401006719,-0.991922016,0.321235568,0.467456774,165.4151093,1,-0.539273402,0.67007007,-0.804801507,0.420934232,0.556900444,Y,-,,duf1620 domain containing,C:integral component of membrane; C:endoplasmic reticulum,IPR002372 (PFAM); IPR011678 (PFAM); PTHR21573 (PANTHER); IPR026895 (PTHR21573:PANTHER); IPR011047 (SUPERFAMILY),3.A.27.1.1, the c-terminal tail-anchored membrane protein biogenesis/ insertion complex-2 (tamp-b2) family.
RL4_JR_06265,9633,5309,6268,0,8,6,0,0,2,4,2,5,4,5,0,0,8,5,21.23413788,1,-2.510567098,1.182789048,-2.1225823,0.033788869,0.099297405,6.787261291,1,0.702711286,1.225742546,0.573294358,0.566445405,0.708371681,17.58574975,1,-1.947322927,1.18761115,-1.63969741,0.101068098,0.195456241,45.64438222,1,0.677169952,0.659549489,1.026715907,0.304554257,0.450228041,32.752858,1,0.589348441,0.739780853,0.796652736,0.425652741,0.56065227,N,-,,5-p-4-tetraphosphate phosphorylase,F:catalytic activity,IPR019200 (PFAM); PTHR38420 (PANTHER); PTHR38420:SF1 (PANTHER); IPR011146 (SUPERFAMILY),,
RL4_JR_06266,3158,2969,4010,0,0,3,0,0,0,0,0,2,0,0,0,0,0,0,20.88178707,1,-1.248402159,1.153351438,-1.082412627,0.27906922,0.462451086,5.481660737,0,1.0109167,1.259441777,0.802670451,0.422165236,0.585444105,29.85888236,1,0.188459294,1.044703974,0.180394924,0.856842539,0.908844102,28.38050732,0,0.233222455,0.877545468,0.265766804,0.79041881,0.864571956,13.93635589,0,-1.714635924,1.206068312,-1.421673969,0.15512092,0.26522954,N,-, Effector probability:0.555,hypothetical protein OIDMADRAFT_110582,,IPR012816 (TIGRFAM); IPR012816 (PFAM); PTHR11079:SF10 (PANTHER); PTHR11079 (PANTHER); SSF143990 (SUPERFAMILY),,
RL4_JR_06267,1627,1510,3408,0,0,0,0,0,0,0,0,1,3,6,1,0,0,0,117.0957151,0,0.720724773,0.469909467,1.5337524,0.125090577,0.26012973,57.88706938,0,1.398174839,0.973232302,1.43663012,0.15082312,0.277821952,34.44329121,1,-2.917177617,1.188225883,-2.455069915,0.014085719,0.042252984,122.725963,1,1.18873292,0.418444483,2.840837833,0.004499519,0.02579707,56.79005548,0,-0.06430784,0.675986148,-0.09513189,0.924210069,0.950881714,N,-,,nicotinate-nucleotide diphosphorylase,C:nucleus; F:nicotinate-nucleotide diphosphorylase (carboxylating) activity; P:'de novo' NAD biosynthetic process from tryptophan,IPR013785 (G3DSA:3.20.20.GENE3D); IPR022412 (PFAM); IPR022412 (G3DSA:3.90.1170.GENE3D); IPR002638 (PFAM); IPR004393 (TIGRFAM); IPR027277 (PIRSF); PTHR32179 (PANTHER); SSF54675 (SUPERFAMILY); IPR002638 (SUPERFAMILY),,
RL4_JR_06268,524,592,1265,3,0,3,0,0,0,0,0,4,0,0,2,0,0,0,172.1691791,1,-0.45149274,0.522497968,-0.864104297,0.387530599,0.580406577,30.16776281,0,-1.449446761,1.206707351,-1.201158474,0.229689734,0.379640674,78.46968755,1,-4.105101372,1.202115774,-3.41489685,0.000638062,0.004031389,156.0076217,1,-0.077544145,0.578883322,-0.133954705,0.893438392,0.934559584,96.95114567,0,-1.297784214,0.7278416,-1.783058585,0.074576767,0.152021294,N,-,,"initiation-specific alpha-1,6-mannosyltransferase","P:N-glycan processing; P:mannosylation; F:alpha-1,6-mannosyltransferase activity; C:alpha-1,6-mannosyltransferase complex",IPR007577 (PFAM); PTHR31834 (PANTHER); PTHR31834:SF1 (PANTHER); IPR029044 (SUPERFAMILY),,
RL4_JR_06269,2893,2560,4387,0,3,4,0,0,0,0,0,0,1,2,0,0,3,2,10.91654224,1,3.090872429,1.228821065,2.515315303,0.011892597,0.043545695,0.274169438,0,5.33267311,1.815903827,2.936649523,0.003317788,0.016335522,0.704883367,0,2.694426352,1.330217414,2.025553359,0.042810575,0.10044363,16.85917422,1,4.910897242,0.880326404,5.578495906,2.43E-08,6.28E-07,0.686616011,1,2.628826612,1.288669063,2.039954777,0.04135483,0.096552182,N,-,,amp-binding enzyme,F:catalytic activity,G3DSA:2.30.38.10 (GENE3D); IPR000873 (PFAM); IPR025110 (PFAM); G3DSA:3.40.50.980 (GENE3D); G3DSA:3.30.300.30 (GENE3D); G3DSA:3.40.50.980 (GENE3D); PTHR24095 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.4, the fatty acid transporter (fat) family.
RL4_JR_06270,3,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.541950948,0,0.072956114,1.345020308,0.054241645,0.956742642,0.978015059,1.113059852,0,3.310768294,1.476567082,2.24220649,0.02494803,0.068416136,2.923411195,0,0.640976949,1.282271153,0.499876292,0.617162187,0.731290962,3.374724672,0,0.217763932,1.302047795,0.167247265,0.867175496,0.917849875,2.923705237,0,0.538455448,1.295726689,0.41556252,0.677730157,0.771138952,N,-,,RNA 3 -terminal phosphate cyclase,F:catalytic activity,IPR023797 (G3DSA:3.65.10.GENE3D); IPR023797 (PFAM); IPR017770 (PTHR11096:PANTHER); IPR000228 (PANTHER); IPR013792 (SUPERFAMILY),,
RL4_JR_06271,759,506,738,0,0,3,0,0,0,0,0,0,0,0,2,0,0,0,638.5744465,1,-0.598058871,0.422480751,-1.415588449,0.156896035,0.306503318,169.0995674,0,-0.580102986,0.711223467,-0.815640953,0.414705519,0.578507341,360.104603,0,-2.979369237,0.697028462,-4.274386772,1.92E-05,0.000326668,424.1652441,1,-2.524717974,0.534189491,-4.726259159,2.29E-06,3.81E-05,323.0146662,0,-4.559177082,1.015041361,-4.491617047,7.07E-06,7.54E-05,N,-,,N-acetyl-gamma-glutamyl-phosphate reductase,F:N-acetyl-gamma-glutamyl-phosphate reductase activity; F:nicotinate-nucleotide diphosphorylase (carboxylating) activity; P:arginine biosynthetic process; F:NAD binding; C:mitochondrion; P:NAD biosynthetic process; P:oxidation-reduction process; P:phosphorylation; F:acetylglutamate kinase activity,IPR000534 (SMART); IPR006855 (PFAM); IPR011241 (PIRSF); IPR001048 (G3DSA:3.40.1160.GENE3D); G3DSA:3.30.360.10 (GENE3D); IPR000706 (TIGRFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR000534 (PFAM); IPR001048 (PFAM); IPR004662 (TIGRFAM); PTHR23342:SF0 (PANTHER); PTHR23342:SF0 (PANTHER); PTHR23342 (PANTHER); IPR006855 (PROSITE_PROFILES); IPR016040 (SUPERFAMILY); SSF55347 (SUPERFAMILY); IPR001048 (SUPERFAMILY),,
RL4_JR_06272,118,112,112,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,391.7254391,0,-0.294487181,0.349655836,-0.842220122,0.399664753,0.591445963,97.71647861,0,-0.47225225,0.854883346,-0.552417183,0.580662561,0.719748523,361.7701329,0,0.075421412,0.383258171,0.196790095,0.843991802,0.89990237,398.4808646,0,-0.105326549,0.363778419,-0.289534904,0.772172074,0.852003537,319.9617632,0,-0.317437859,0.632727965,-0.501697217,0.615880522,0.722822568,N,-,,vesicle-associated membrane 4,"P:vesicle-mediated transport; F:hydrogen ion transmembrane transporter activity; P:ATP hydrolysis coupled proton transport; C:integral component of membrane; C:proton-transporting V-type ATPase, V0 domain",IPR001388 (PRINTS); IPR001388 (PFAM); IPR016444 (PIRSF); IPR001388 (G3DSA:1.10.3840.GENE3D); PTHR21136 (PANTHER); IPR001388 (PROSITE_PROFILES); SSF58038 (SUPERFAMILY),1.F.1.1.2, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_06273,27142,14790,9604,1,8,4,0,1,1,1,0,2,2,0,0,0,4,0,203.0161794,1,1.337405509,0.555664395,2.406858384,0.016090408,0.055206515,36.54058783,1,0.952961317,0.991710795,0.960926635,0.336589057,0.499626696,90.60600522,1,0.061875927,0.625955568,0.098850351,0.92125709,0.953953849,88.33831841,1,-0.458233138,0.629410056,-0.728035935,0.466591589,0.608166818,49.57768253,1,-2.498987769,1.132338222,-2.206926977,0.027319161,0.070044697,N,-,,lipoic acid synthetase,"F:metal ion binding; C:mitochondrion; F:lipoate synthase activity; F:4 iron, 4 sulfur cluster binding; P:lipoate biosynthetic process; P:protein lipoylation",IPR006638 (SMART); IPR003698 (TIGRFAM); IPR007197 (PFAM); IPR031691 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR10949:SF0 (PANTHER); IPR003698 (PANTHER); IPR003698 (HAMAP); SSF102114 (SUPERFAMILY),,
RL4_JR_06274,7942,6391,4311,0,3,83,0,0,0,0,0,3,1,12,3,0,9,1,63.44278477,1,-0.237626219,0.749280089,-0.317139375,0.751137849,0.870021756,11.34857252,0,-0.038991528,1.244270523,-0.031336858,0.975000897,0.987093326,98.93859043,1,1.28402741,0.62549071,2.052832103,0.040088864,0.095812006,38.28607888,1,-2.181457425,1.179213613,-1.849925578,0.064324277,0.14266885,33.4224919,1,-1.872622556,1.167721151,-1.603655594,0.108789989,0.203416185,N,-,,mitochondrial 40S ribosomal MRP2,F:structural constituent of ribosome; P:mitochondrial translation; C:mitochondrial small ribosomal subunit,G3DSA:4.10.830.10 (GENE3D); IPR001209 (PFAM); IPR001209 (PANTHER); SSF57716 (SUPERFAMILY),,
RL4_JR_06275,1146,1302,1270,0,0,5,0,0,0,0,0,0,0,3,0,0,0,0,9.22817762,1,2.950141612,1.02968652,2.865087144,0.004168945,0.018686952,0.506980701,0,4.445549415,1.54431454,2.878655416,0.003993744,0.018119534,1.315272553,0,1.793878376,1.228990403,1.459635788,0.144390198,0.254803271,1.517398159,1,1.371399911,1.250774376,1.096440683,0.272885968,0.414922726,1.295491104,0,1.713094194,1.215620833,1.409233988,0.158765991,0.269851546,N,-,,mitochondrial 40S ribosomal mrp2,C:intracellular,PTHR21357 (PANTHER); PTHR21357:SF4 (PANTHER); PTHR21357:SF4 (PANTHER); PTHR21357 (PANTHER),,
RL4_JR_06276,8198,5956,6421,0,0,10,0,0,1,0,5,4,3,5,23,2,4,0,69.30060603,1,-2.158434389,1.02620151,-2.103324121,0.035437446,0.102808922,17.59457976,1,-0.671589709,1.20711086,-0.556361252,0.577963922,0.717281856,72.58271936,1,-0.914877978,0.860765051,-1.062866084,0.287842686,0.427290227,56.88966988,1,-2.80525889,1.152593486,-2.433866687,0.014938496,0.065631958,45.38442155,1,-3.417904276,1.206134473,-2.833767174,0.004600284,0.016688596,N,-,,MFS maltose permease,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_06277,306,331,512,2,0,6,0,0,0,2,0,0,2,0,0,0,0,0,6.403480744,1,-0.781144895,1.209623716,-0.645775115,0.518425006,0.702893668,2.033085082,0,2.441799997,1.309350743,1.864893734,0.062196301,0.140243029,18.28834207,1,1.603503152,1.040645924,1.540872947,0.123347711,0.226488398,22.15127171,1,2.069069746,0.760604924,2.720294964,0.006522371,0.034611637,5.231275968,0,-0.300838566,1.210793856,-0.248463902,0.803775497,0.867707315,N,-,,---NA---,,no IPS match,,
RL4_JR_06278,1119,1129,1210,0,1,1,0,0,0,1,0,0,0,0,0,0,3,3,68.16876237,1,1.55781815,0.820254735,1.899188244,0.05753973,0.14752015,5.227689344,0,1.079413299,1.318581108,0.818617295,0.413004797,0.576934945,13.47266513,1,-1.562872624,1.24212539,-1.258224521,0.208310569,0.335443965,15.53812278,0,-1.984825896,1.246136789,-1.592783323,0.111208808,0.212379895,13.15636651,1,-1.631448482,1.243185608,-1.312312877,0.189414589,0.309176643,N,-,,hypothetical protein CMQ_2093,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_06279,2602,1872,2454,0,0,4,0,0,0,0,0,0,0,2,0,0,0,2,117.3633461,1,0.12927616,0.684922314,0.188745727,0.850292111,0.925014407,16.85600085,0,-0.609727452,1.266961829,-0.481251635,0.630337666,0.757123277,88.58679481,0,-0.174603727,1.359632245,-0.128419819,0.897816747,0.936482253,51.15056494,1,-3.703886669,1.259080034,-2.941740453,0.003263733,0.019918807,44.33000167,1,-3.383990777,1.268645215,-2.667405148,0.007643946,0.02535046,N,-,,wd repeat-containing,P:nucleic acid metabolic process; P:regulation of nucleobase-containing compound metabolic process; P:cellular macromolecule metabolic process; P:cellular macromolecular complex assembly; P:ribosome biogenesis; P:regulation of cellular macromolecule biosynthetic process; C:macromolecular complex; P:single-organism cellular process; C:chromosomal part; C:nucleoplasm,IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR18763:SF0 (PANTHER); PTHR18763 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR011047 (SUPERFAMILY),8.A.92.1.4,The G-Protein αβγ Complex (GPC) Family
RL4_JR_06280,29258,20270,29712,0,2,27,2,0,3,0,0,2,2,7,2,0,1,3,14.57360263,1,2.561185861,0.850756607,3.01048013,0.00260835,0.012911966,0.999101302,1,3.466868296,1.404456806,2.468476269,0.013568965,0.042508531,2.584684924,1,0.81910192,1.208380453,0.677851018,0.497866159,0.630680305,6.992802803,1,1.343947673,1.148889167,1.16978009,0.242089478,0.380496833,2.540481265,1,0.741012379,1.199819229,0.617603353,0.536836834,0.659667909,Y,-,,Pro-kumamolisin,P:proteolysis; F:serine-type endopeptidase activity,IPR015366 (SMART); IPR015366 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); PTHR14218:SF13 (PANTHER); PTHR14218 (PANTHER); PTHR14218 (PANTHER); IPR030400 (PROSITE_PROFILES); IPR000209 (SUPERFAMILY); IPR009020 (SUPERFAMILY),,
RL4_JR_06281,2063,2382,2945,5,0,0,0,0,0,0,0,2,0,0,1,0,0,2,0.972111432,1,1.938656368,1.565658193,1.238237297,0.215628086,NA,0.308182367,0,5.163676733,1.711283388,3.017429357,0.002549285,0.015349618,7.300228918,1,3.470749356,1.224349897,2.834769182,0.004585881,0.017774226,0.924854847,1,2.085738898,1.341100018,1.555244851,0.119887766,0.224208281,0.790781661,1,2.425556225,1.252782677,1.936134869,0.052851185,0.11681254,N,-,,methyltransferase domain-containing,F:methyltransferase activity,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); PTHR10108:SF905 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_06282,6913,6317,5874,0,3,0,0,0,0,2,0,3,2,3,0,0,0,0,64.44910369,1,-4.112442151,1.212795635,-3.390878093,0.000696691,0.004429933,20.79480352,0,-0.912618487,1.231567261,-0.741022042,0.458680076,0.617460539,66.60940125,1,-1.741650537,1.058218805,-1.645832156,0.09979832,0.193606646,98.74869327,1,-0.904844843,0.712285468,-1.270340172,0.203963485,0.335575281,52.56161631,0,-3.629746158,1.209610492,-3.000756178,0.002693101,0.010888771,N,-,,RNA binding,F:nucleotide binding; F:nucleic acid binding; P:biological_process; C:cellular_component,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR24012:SF383 (PANTHER); PTHR24012:SF383 (PANTHER); PTHR24012 (PANTHER); PTHR24012 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY),,
RL4_JR_06283,75,42,90,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,260.7057876,0,-0.302191408,0.49067658,-0.615866785,0.537982445,0.720903546,63.68495245,0,-0.386893312,0.998898246,-0.387320043,0.698519289,0.808632141,117.2018405,0,-4.683879607,1.207258222,-3.879766168,0.000104557,0.001196084,182.5975291,0,-1.251264453,0.571239364,-2.190438076,0.028492481,0.089620303,116.2968719,0,-4.775450875,1.219899378,-3.914626863,9.05E-05,0.000639302,N,-,,aspartate-semialdehyde dehydrogenase,P:methionine biosynthetic process; P:isoleucine biosynthetic process; P:lysine biosynthetic process via diaminopimelate; P:threonine biosynthetic process; F:aspartate-semialdehyde dehydrogenase activity; P:aspartate metabolic process; F:protein dimerization activity; C:nucleus; F:N-acetyl-gamma-glutamyl-phosphate reductase activity; F:NADP binding; F:NAD binding; C:cytosol; P:oxidation-reduction process; P:homoserine biosynthetic process,IPR000534 (SMART); IPR000534 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR012280 (PFAM); IPR012080 (PIRSF); IPR005676 (TIGRFAM); G3DSA:3.30.360.10 (GENE3D); PTHR10174:SF141 (PANTHER); PTHR10174:SF141 (PANTHER); PTHR10174 (PANTHER); PTHR10174 (PANTHER); IPR016040 (SUPERFAMILY); SSF55347 (SUPERFAMILY),,
RL4_JR_06284,77,85,99,0,5,1,0,0,0,1,0,0,4,1,10,0,3,1,153.1559006,1,2.555788503,1.344975555,1.900249037,0.057400446,0.147255609,7.371333202,0,0.583587217,1.281460851,0.455407761,0.648815913,0.772807092,19.20486393,1,-2.074388476,1.234376718,-1.680514908,0.092857176,0.183211559,54.25625633,1,1.063912533,0.721630821,1.474316926,0.14039628,0.253298705,26.6981949,1,-0.51422444,1.043886822,-0.492605548,0.622291327,0.72815205,N,-,,bacilysin biosynthesis oxidoreductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24322:SF383 (PANTHER); PTHR24322:SF383 (PANTHER); IPR002347 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06285,731,680,999,3,2,11,0,0,0,3,1,0,5,10,2,0,3,2,155.1148695,1,0.975674416,0.415350932,2.349036297,0.018822072,0.062418887,17.70319305,0,-0.680388074,1.211255681,-0.561721266,0.574305943,0.714230833,95.26681037,1,0.296126863,0.578394771,0.511980533,0.608664634,0.724870104,122.9231365,1,0.025828162,0.547587821,0.04716716,0.962380001,0.978772417,48.76474717,1,-2.47204773,1.118398132,-2.210346798,0.027081103,0.0695111,N,-,,Rho GTPase activator,P:regulation of cellular process; C:cell part,IPR000198 (SMART); IPR001060 (SMART); IPR000198 (G3DSA:1.10.555.GENE3D); IPR000198 (PFAM); IPR001060 (PFAM); PTHR23176 (PANTHER); PTHR23176:SF40 (PANTHER); PTHR23176:SF40 (PANTHER); IPR000198 (PROSITE_PROFILES); IPR031160 (PROSITE_PROFILES); SSF103657 (SUPERFAMILY); IPR008936 (SUPERFAMILY),9.A.1.1.1, the non abc multidrug exporter (n-mde) family.
RL4_JR_06286,449,349,412,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,3.716032182,1,0.003785422,1.20847228,0.003132403,0.997500708,0.999338177,1.186274487,0,3.219065933,1.370503225,2.348820399,0.018832988,0.054904236,3.077666888,0,0.56699392,1.203954264,0.470943072,0.637681389,0.747295564,3.550400788,0,0.144683778,1.204610227,0.120108376,0.904397297,0.941301299,3.034907615,0,0.48455165,1.202303202,0.403019512,0.68693387,0.778074218,N,-,,nonsense-mediated mrna decay 1,P:nucleic acid phosphodiester bond hydrolysis; P:biological_process; F:endonuclease activity; C:cellular_component; F:molecular_function,IPR027417 (G3DSA:3.40.50.GENE3D); PF13086 (PFAM); PF13087 (PFAM); IPR026122 (PTHR10887:PANTHER); PTHR10887 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_06287,523,705,664,0,0,4,4,0,0,0,0,0,0,0,0,0,0,0,4.380298681,1,-0.233332661,1.23052942,-0.189619734,0.849607122,0.924762496,1.3883349,1,2.992090358,1.359739883,2.200487311,0.027772339,0.074486385,3.617238738,0,0.333959124,1.216004254,0.274636477,0.783595539,0.85661605,4.174081472,0,-0.088754225,1.218820589,-0.072819762,0.941949545,0.965967215,3.580884446,0,0.246045399,1.220881413,0.201530956,0.840283426,0.892331122,N,-,,cryptochrome DASH,P:DNA repair; F:DNA photolyase activity,IPR002081 (PRINTS); IPR006050 (PFAM); IPR005101 (PFAM); G3DSA:1.25.40.80 (GENE3D); G3DSA:1.10.579.10 (GENE3D); IPR014133 (TIGRFAM); IPR014729 (G3DSA:3.40.50.GENE3D); PTHR11455 (PANTHER); IPR014133 (PTHR11455:PANTHER); PTHR11455 (PANTHER); IPR014133 (PTHR11455:PANTHER); IPR006050 (PROSITE_PROFILES); IPR006050 (SUPERFAMILY); IPR005101 (SUPERFAMILY),,
RL4_JR_06288,4222,4754,7127,0,1,2,0,0,0,0,0,0,3,1,0,0,0,1,15.50505223,1,0.642869931,1.027488565,0.62567113,0.531530673,0.71543099,2.517603886,0,2.133439662,1.304338662,1.635648566,0.10191316,0.205630649,44.35340323,0,2.317352719,0.755287274,3.068173923,0.002153712,0.010442617,35.4662707,1,1.405435424,0.863500014,1.627603244,0.103609041,0.201119927,21.16892397,1,1.094354408,0.987551373,1.108149346,0.267797323,0.400154648,N,-,,thioesterase family,C:mitochondrion; C:membrane; C:integral component of membrane; F:isomerase activity,IPR029069 (G3DSA:3.10.129.GENE3D); IPR006683 (PFAM); PTHR12418 (PANTHER); PTHR12418 (PANTHER); PTHR12418:SF16 (PANTHER); PTHR12418:SF16 (PANTHER); IPR029069 (SUPERFAMILY),,
RL4_JR_06289,2541,3139,4475,0,9,0,0,0,0,0,0,2,1,4,0,0,0,0,83.53046141,1,3.044191732,0.777957852,3.913054831,9.11E-05,0.000789263,3.358974502,0,1.717469434,1.286810795,1.334671298,0.181983951,0.320969081,34.74325387,1,1.865055034,0.776460498,2.401996032,0.016305885,0.047560007,143.0541072,1,3.599519617,0.778538666,4.623430758,3.77E-06,5.97E-05,34.60760487,0,1.621736543,0.783706509,2.06931616,0.038516428,0.091407429,N,-,,acyl- thioesterase II,F:catalytic activity,IPR029069 (G3DSA:3.10.129.GENE3D); PF13622 (PFAM); IPR029069 (G3DSA:3.10.129.GENE3D); PTHR11066:SF34 (PANTHER); PTHR11066:SF34 (PANTHER); IPR003703 (PANTHER); IPR003703 (PANTHER); IPR029069 (SUPERFAMILY); IPR029069 (SUPERFAMILY),,
RL4_JR_06290,5593,4191,4978,0,0,5,0,0,0,0,6,3,2,2,1,0,1,0,201.5222923,1,-2.565486457,0.725134943,-3.537943496,0.000403256,0.002795043,57.4769232,0,-2.379378103,1.218424242,-1.952832209,0.050839481,0.119396107,279.5007346,1,-0.065229632,0.461833763,-0.1412405,0.887679952,0.930317996,263.9339194,1,-0.819943968,0.469292978,-1.747189934,0.080604397,0.167178202,263.9829174,1,-0.128931247,0.506762595,-0.254421396,0.799170023,0.864394454,N,-,,oxysterol binding 1,C:cytoplasm,IPR002110 (PRINTS); IPR001849 (SMART); IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR001849 (PFAM); PF13857 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR000648 (PFAM); IPR002110 (PFAM); IPR000648 (PANTHER); IPR000648 (PANTHER); PTHR10972:SF96 (PANTHER); IPR000648 (PANTHER); PTHR10972:SF96 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); IPR020683 (SUPERFAMILY); SSF144000 (SUPERFAMILY),2.D.1.1.9, the pi4p/ps counter transporter (p/p-ct) family.
RL4_JR_06291,241,374,320,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,28.01425021,0,-1.751981305,1.151013676,-1.522120321,0.127978935,0.264383934,7.682442193,0,0.523910242,1.224571825,0.42783137,0.668773896,0.788690362,19.99587395,0,-2.132695961,1.196314766,-1.782721423,0.074631662,0.154355659,50.04312094,1,0.17773079,0.750177973,0.236918167,0.812720276,0.881215763,23.6377969,0,-1.290179505,1.133986065,-1.137738412,0.255229729,0.386278177,N,-,,phosphopantetheinyl transferase,F:transferase activity,IPR008278 (PFAM); IPR008278 (G3DSA:3.90.470.GENE3D); IPR008278 (G3DSA:3.90.470.GENE3D); PTHR12215:SF14 (PANTHER); PTHR12215 (PANTHER); IPR008278 (SUPERFAMILY); IPR008278 (SUPERFAMILY),,
RL4_JR_06292,488,582,728,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,25.38528216,0,-1.090323487,1.137941144,-0.958154552,0.337984831,0.528012304,4.89738469,0,1.173540336,1.242328469,0.944629673,0.344847972,0.508149809,12.68520078,1,-1.476015211,1.190172658,-1.24016898,0.214912899,0.343564844,14.63270954,0,-1.898217713,1.187545489,-1.598437895,0.109945557,0.210793176,12.48022119,1,-1.555326799,1.189365256,-1.307694832,0.190976837,0.311124774,N,-,,signal peptide peptidase,F:aspartic-type endopeptidase activity; C:membrane; P:proteolysis; C:integral component of membrane; C:Golgi apparatus; C:endoplasmic reticulum,IPR006639 (SMART); IPR007369 (PFAM); PTHR12174:SF23 (PANTHER); IPR007369 (PANTHER); PTHR12174:SF23 (PANTHER); IPR007369 (PANTHER),1.A.54.3.4, the presenilin er ca(2+) leak channel (presenilin) family.
RL4_JR_06293,3627,3126,3320,0,0,0,0,0,0,0,0,1,0,5,0,0,0,0,21.60908598,0,-2.535939436,1.234619621,-2.054024894,0.039973282,0.112621878,6.813270787,0,0.69708166,1.264835028,0.551124569,0.581548284,0.720523917,17.83454177,1,-1.96769884,1.224953256,-1.606346063,0.108197895,0.205563964,33.90859933,1,-0.654507402,1.057379082,-0.618990307,0.535922744,0.667842189,25.47871789,0,-0.416622693,1.038348176,-0.401236024,0.688246361,0.779037943,N,-, Effector probability:0.692,peptidyl-prolyl cis-trans isomerase-like 1,F:peptidyl-prolyl cis-trans isomerase activity; P:protein peptidyl-prolyl isomerization; P:protein folding,IPR002130 (PRINTS); IPR002130 (PFAM); IPR024936 (PIRSF); IPR029000 (G3DSA:2.40.100.GENE3D); PTHR11071:SF270 (PANTHER); IPR024936 (PANTHER); IPR002130 (PROSITE_PROFILES); IPR029000 (SUPERFAMILY),3.D.1.8.1, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_06294,19805,32066,20478,0,0,3,0,0,0,0,0,6,0,1,0,0,0,0,13.45599462,1,-1.852614981,1.228237836,-1.508351988,0.131464464,0.269198569,4.260849453,0,1.374275876,1.282682034,1.071408065,0.283985988,0.443322975,11.1272144,1,-1.287179773,1.221940581,-1.053389823,0.292162367,0.432371261,22.4761609,1,-0.756879034,1.173519242,-0.644965167,0.518949759,0.653382439,30.36081783,0,1.48665354,0.771999734,1.925717685,0.054139634,0.119010812,N,-,,transcriptional activator,,no IPS match,,
RL4_JR_06295,11728,4416,6181,0,5,3,0,0,0,0,0,1,0,3,0,0,7,3,31.9600477,1,2.90915687,0.628716134,4.627138885,3.71E-06,4.82E-05,1.549579228,0,2.833589355,1.343775932,2.108676966,0.034972474,0.089161816,17.02190127,1,1.997817303,1.041406627,1.918383513,0.0550624,0.121687784,12.66592288,1,1.479093428,1.027000559,1.440207033,0.149808834,0.265947456,7.835577979,1,1.024263708,1.138047312,0.900018564,0.368110371,0.504497527,N,-,,gcn5-related n-acetyltransferase,P:protein acetylation; F:N-acetyltransferase activity,IPR016181 (G3DSA:3.40.630.GENE3D); PTHR23091 (PANTHER); PTHR23091:SF219 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_06296,65981,16114,21717,0,3,0,0,0,0,3,0,0,0,0,0,0,0,0,739.3289754,1,1.730412656,0.590447852,2.930678213,0.003382229,0.015828036,72.74923558,0,-0.643899416,0.978071498,-0.658335732,0.510322422,0.661562955,231.1344918,1,-0.537267765,0.448017301,-1.199212092,0.230445486,0.361654023,258.4254288,0,-0.639445036,0.391589128,-1.6329489,0.102479744,0.199578267,240.7442796,0,-0.028648192,0.481537412,-0.05949318,0.952559297,0.969095027,N,-,,hexokinase,P:glycolytic process; F:glucokinase activity; P:fructose 6-phosphate metabolic process; P:mannose metabolic process; P:carbohydrate phosphorylation; F:fructokinase activity; F:glucose binding; C:nucleus; F:ATP binding; P:glucose 6-phosphate metabolic process; P:cellular glucose homeostasis; P:glycolytic fermentation; C:integral component of membrane; C:cytosol; F:mannokinase activity,PR00475 (PRINTS); IPR022672 (PFAM); IPR022673 (PFAM); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.40.367.20 (GENE3D); PTHR19443:SF16 (PANTHER); IPR001312 (PANTHER); IPR001312 (PANTHER); PTHR19443:SF16 (PANTHER); IPR001312 (PROSITE_PROFILES); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_06297,16098,4912,6190,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,336.8985785,1,-0.552579806,0.369243871,-1.496517203,0.134518928,0.273530762,117.9905842,0,-0.328436041,0.839441646,-0.391255357,0.695608494,0.807240395,218.7432134,0,-1.558074864,0.565413668,-2.755637068,0.005857795,0.02138634,248.155825,0,-1.563465417,0.47701473,-3.277604063,0.001046921,0.007681216,216.2312763,0,-1.328265485,0.496726782,-2.674036379,0.007494432,0.024928096,N,-,,hsp70,F:ATP binding,PR01217 (PRINTS); G3DSA:3.30.420.40 (GENE3D); IPR013126 (PFAM); G3DSA:3.30.420.40 (GENE3D); PTHR19375 (PANTHER); PTHR19375:SF205 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),1.A.33.1.1, the cation channel-forming heat shock protein-70 (hsp70) family.
RL4_JR_06298,61591,45486,68092,3,3,14,0,0,0,2,5,2,11,22,6,0,4,2,829.932389,1,-1.716577388,0.576114829,-2.979575078,0.002886485,0.013941944,204.3127338,0,-4.209121524,1.193549021,-3.526559405,0.000420997,0.015023052,570.9002734,1,-4.028227307,0.751990604,-5.356752176,8.47E-08,2.98E-06,726.3736537,1,-2.536935596,0.414337374,-6.122874153,9.19E-10,3.02E-08,536.5029246,1,-4.763898585,0.881552651,-5.403986458,6.52E-08,1.59E-06,N,-,,ctp synthase,F:ATP binding; P:'de novo' CTP biosynthetic process; P:glutamine metabolic process; F:CTP synthase activity,IPR004468 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR017456 (PFAM); IPR029062 (G3DSA:3.40.50.GENE3D); IPR017926 (PFAM); IPR004468 (PANTHER); IPR017926 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR029062 (SUPERFAMILY),,
RL4_JR_06299,454,485,744,0,0,2,0,0,3,2,0,1,0,0,2,0,0,0,55.14891219,1,0.127739432,0.685683444,0.186295051,0.852213388,0.926363334,10.22004422,1,0.112169877,1.227849108,0.091354774,0.927210697,0.959634629,93.15951368,1,1.438613226,0.54682422,2.630851331,0.008517129,0.028780844,34.71230849,1,-2.021188328,1.158245488,-1.745043127,0.080977362,0.167667851,34.02048678,0,-0.970427211,0.999971027,-0.970455329,0.331819581,0.468443009,N,-,,ankyrin repeat,"C:nucleus; F:zinc ion binding; C:cytosol; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PF13637 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24189 (PANTHER); PTHR24189:SF25 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),1.A.4.6.6, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_06300,865,973,918,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,80.94461745,0,-0.125506914,0.695100882,-0.180559279,0.856713521,0.927960568,13.02731025,0,-0.23800956,1.231659591,-0.193242972,0.846768686,0.908714232,34.05500868,0,-2.900849755,1.214406075,-2.388698323,0.01690818,0.049090454,39.30430575,0,-3.32383211,1.217496652,-2.730054414,0.006332387,0.033744958,33.84674089,0,-2.994716402,1.226833736,-2.441012432,0.014646151,0.04268632,N,-, Effector probability:0.877,dna-directed rna polymerase iii subunit rpc10,F:nucleic acid binding; P:tRNA 3'-trailer cleavage; F:zinc ion binding; F:DNA-directed RNA polymerase activity; C:cytosol; P:termination of RNA polymerase III transcription; C:nucleolus; P:tRNA transcription from RNA polymerase III promoter; C:DNA-directed RNA polymerase III complex,IPR001222 (SMART); IPR001529 (SMART); IPR001529 (PFAM); IPR012164 (PIRSF); IPR001222 (PFAM); G3DSA:2.20.25.10 (GENE3D); PTHR11239 (PANTHER); PTHR11239:SF12 (PANTHER); IPR001222 (PROSITE_PROFILES); SSF57783 (SUPERFAMILY),,
RL4_JR_06301,10996,10360,11896,0,0,1,0,0,0,0,0,0,0,0,0,0,11,0,9.217055942,1,-1.306763071,1.269094612,-1.029681364,0.303159606,0.489415953,2.908913881,0,1.924905902,1.34677126,1.429274561,0.152925335,0.28062187,7.618991291,0,-0.740795677,1.250877402,-0.592220849,0.55370271,0.680549501,8.79364344,0,-1.163804354,1.256894783,-0.92593618,0.354479148,0.50078155,7.599141169,1,-0.839619588,1.26818954,-0.662061594,0.507931748,0.634836311,N,-,,mediator of rna polymerase ii transcription subunit 31,P:DNA repair; C:core mediator complex; P:meiotic sister chromatid segregation; C:mediator complex; P:meiotic gene conversion; P:transcription from RNA polymerase II promoter; F:RNA polymerase II transcription cofactor activity; P:regulation of transcription from RNA polymerase II promoter,IPR008831 (PFAM); PTHR13186:SF0 (PANTHER); IPR008831 (PANTHER),,
RL4_JR_06302,5924,7092,9591,0,1,1,0,0,0,1,0,1,2,0,4,0,5,6,62.80042624,1,5.51993263,0.53867953,10.24715498,1.22E-24,3.10E-22,0.39054276,0,4.821851589,1.61090925,2.993248434,0.00276025,0.015349618,1.016509157,1,2.164840301,1.240403115,1.745271577,0.080937607,0.164243803,1.172865671,1,1.74245835,1.276348103,1.365190535,0.172193172,0.295000993,1.006007133,1,2.077691709,1.228217107,1.691632283,0.090716107,0.177453745,Y,-,,---NA---,,no IPS match,,
RL4_JR_06303,3698,5340,2850,0,2,15,2,0,6,0,0,0,0,4,1,0,9,13,288.7872082,1,-6.276198132,1.194320158,-5.255038268,1.48E-07,2.83E-06,92.67798058,1,-3.068632116,1.198056093,-2.561342607,0.010426847,0.034660279,259.1511589,0,-3.315835604,0.8618116,-3.847517952,0.000119321,0.001293363,317.3463939,1,-2.818289619,0.624489705,-4.512948084,6.39E-06,9.58E-05,266.4563366,1,-2.240834247,0.600474083,-3.731775126,0.000190135,0.001192024,N,-,,hypothetical protein CMQ_4960,"C:heterochromatin island; C:nucleus; C:NURS complex; C:MTREC complex; C:nuclear body; F:metal ion binding; P:nuclear-transcribed mRNA catabolic process, meiosis-specific transcripts; P:regulation of snoRNA processing; P:regulation of heterochromatin domain assembly; C:Mmi1 nuclear focus complex; P:negative regulation of meiotic cell cycle; P:regulation of heterochromatin island assembly",IPR019607 (PFAM); PTHR21563 (PANTHER),,
RL4_JR_06304,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,226.154165,0,1.614005591,0.781572088,2.065075781,0.038915831,0.110657144,18.10823936,0,-0.713030852,1.241187697,-0.574474637,0.565646659,0.707804728,59.5882738,0,-1.540299285,1.063228365,-1.448700333,0.147421288,0.258888658,72.34248892,0,-2.009225893,1.04758649,-1.91795705,0.055116457,0.130021932,64.15441963,0,-1.196352783,0.870249799,-1.374723423,0.169217207,0.283803912,N,-,,myosin heavy chain,F:nucleotide binding,IPR001609 (PRINTS); IPR001609 (SMART); IPR027401 (G3DSA:4.10.270.GENE3D); IPR001609 (PFAM); IPR004009 (PFAM); PTHR13140:SF376 (PANTHER); PTHR13140 (PANTHER); PTHR13140 (PANTHER); PTHR13140:SF376 (PANTHER); IPR001609 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF90257 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_06305,11645,9808,13956,0,9,10,0,0,0,1,0,7,1,8,2,0,7,7,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_06306,38566,22479,25571,60,127,45,0,3,14,4,83,140,9,11,17,0,54,15,73.41759915,1,0.171992735,0.545933465,0.315043401,0.752728701,0.870775614,13.66440289,1,-0.306843949,1.202266315,-0.255221281,0.798552195,0.877976962,56.31795765,1,-0.553980851,0.846895118,-0.654131591,0.51302703,0.644083042,56.97577303,1,-0.66286491,0.739376573,-0.896518681,0.369975808,0.515623545,35.00349721,1,-3.043200014,1.191319924,-2.554477562,0.010634728,0.033009388,N,-,,ankyrin repeat-containing,P:response to organic substance; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:mycelium development; P:cellular response to stress,IPR003604 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR16036:SF2 (PANTHER); PTHR16036:SF2 (PANTHER); PTHR16036 (PANTHER); PTHR16036 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),,
RL4_JR_06307,407,270,528,0,0,3,0,0,0,0,0,2,0,0,0,0,0,0,145.6826152,1,5.217942495,0.591929578,8.815140662,1.20E-18,1.30E-16,1.376319918,0,3.004688205,1.373315932,2.187907483,0.028676342,0.076485358,124.7969629,1,5.23614216,0.438481866,11.941525,7.19E-33,2.60E-30,120.1619557,0,5.031894111,0.439748678,11.44265886,2.56E-30,4.25E-28,130.9095865,0,5.247807107,1.816767849,2.888540278,0.003870345,0.014535326,Y,-,,adhesin Mad1,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_06308,5479,4249,3911,5,0,8,0,0,1,1,0,1,3,1,1,0,3,2,45.31113395,1,0.113360859,0.831235952,0.136376271,0.891523831,0.946655162,8.253492511,1,0.420429458,1.278465338,0.328854796,0.742265443,0.840968303,50.28337733,1,0.181550701,0.910997289,0.199287861,0.842037574,0.898291718,28.99585336,1,-1.726600211,1.199053726,-1.439969013,0.149876166,0.265947456,21.6071789,1,-2.347217071,1.258629962,-1.864898454,0.062195639,0.132435509,N,-,,mitochondrial GTPase,F:GTP binding; F:GTPase activity; C:mitochondrion; P:ribosome biogenesis; P:mitochondrial translation; C:mitochondrial inner membrane; F:hydrolase activity,IPR023179 (G3DSA:1.10.1580.GENE3D); IPR006073 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11089:SF4 (PANTHER); PTHR11089 (PANTHER); IPR027417 (SUPERFAMILY),9.A.8.1.11, the ferrous iron uptake (feob) family.
RL4_JR_06309,24069,17860,26187,9,23,29,0,0,0,4,5,3,0,1,4,4,13,0,142.7444727,1,-0.402468299,0.484700856,-0.830343694,0.40634449,0.597936211,28.17445491,0,-1.350774361,1.200006565,-1.125639143,0.260318293,0.416394083,114.6031085,1,-0.854098962,0.668739834,-1.277176741,0.201539857,0.326985498,127.1872489,1,-0.706321449,0.543332514,-1.299980087,0.193607794,0.322839084,75.61333104,1,-3.148255747,1.119122821,-2.813145874,0.004905939,0.01762691,N,-,,histone deacetylase complex subunit cti6,F:zinc ion binding; F:protein binding; P:negative regulation of chromatin silencing; C:Sin3-type complex,IPR001965 (SMART); IPR019787 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR15856 (PANTHER); IPR003903 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY),,
RL4_JR_06310,278,189,317,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,60.11545026,0,-0.446551924,0.696287777,-0.641332418,0.521306731,0.705745157,13.20661081,0,-0.257634879,1.228017317,-0.209797432,0.833825778,0.900418847,57.59681303,0,-0.491921433,0.865168786,-0.568584351,0.569638247,0.69390177,116.5074893,1,0.783459389,0.542995936,1.44284577,0.149063923,0.265203342,83.22415989,0,1.155624709,0.511815484,2.257893215,0.023952318,0.062942439,N,-,,hypothetical protein CMQ_4961,C:membrane; C:integral component of membrane,PTHR42082:SF1 (PANTHER); PTHR42082 (PANTHER),,
RL4_JR_06311,3747,4399,6229,0,5,5,0,0,0,0,0,0,8,0,0,0,3,0,145.2147335,1,-0.582511192,0.592833358,-0.982588419,0.325810046,0.515008401,39.94880912,0,-0.553843007,1.147150939,-0.482798722,0.629238658,0.756515326,78.69272001,0,-4.109152295,1.214360288,-3.38379996,0.000714901,0.004405146,110.011977,1,-2.766216834,1.046570827,-2.643124346,0.008214486,0.041461452,125.6435227,1,-0.394901463,0.569443412,-0.693486753,0.488004137,0.616628215,N,-,,hypothetical protein SPSK_08276,,no IPS match,,
RL4_JR_06312,29824,34013,52232,4,16,33,0,0,0,5,0,0,8,30,0,0,15,3,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_06313,3406,4152,3586,1,0,8,0,0,0,0,5,0,2,0,2,0,0,1,32.30830713,1,2.871244351,0.648290098,4.428949881,9.47E-06,0.000110833,1.770460542,0,2.641283992,1.337502473,1.974788118,0.048292198,0.114664234,24.11076169,1,2.378327924,0.876458351,2.713566391,0.006656323,0.023611988,9.336291903,1,0.505548684,1.165520603,0.433753537,0.664467425,0.771175227,4.575110128,1,-0.107575316,1.225997953,-0.087745102,0.930079272,0.954398766,N,-,,gluconate 5-dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); SM00822 (SMART); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); PTHR24322:SF629 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06314,3121,2618,2637,0,0,5,0,0,0,0,0,0,1,0,0,0,2,0,103.6403034,1,-3.029343548,1.19464909,-2.535760143,0.011220356,0.041550459,31.15583421,0,-1.495914659,1.31313405,-1.139194174,0.254622175,0.409548015,80.22077805,0,-4.136922083,1.291364606,-3.203527542,0.001357551,0.00732366,96.49384395,1,-3.618495646,1.263145594,-2.864670284,0.004174436,0.024346872,86.09005996,1,-3.257041672,1.234639158,-2.638051491,0.008338392,0.027181655,N,-,,hypothetical protein SPI_03984,,no IPS match,,
RL4_JR_06315,1809,1538,2639,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0.527997155,0,2.819161661,2.09471997,1.345841784,0.178353547,NA,0.165608902,0,6.05947655,1.984218258,3.053835698,0.002259358,0.015081,0.433819045,0,3.393766487,1.379305497,2.460489351,0.013874769,0.041743881,0.500812315,0,2.970472093,1.560424749,1.903630467,0.056958328,0.132697439,0.431206855,1,3.300707285,1.332193811,2.477647964,0.013225156,0.039291287,N,-,,methylcrotonoyl- carboxylase beta chain,F:transferase activity; F:ligase activity,IPR029045 (G3DSA:3.90.226.GENE3D); IPR000022 (PFAM); PTHR22855 (PANTHER); PTHR22855:SF35 (PANTHER); IPR011762 (PROSITE_PROFILES); IPR011763 (PROSITE_PROFILES); IPR029045 (SUPERFAMILY); IPR029045 (SUPERFAMILY),3.B.1.1.2, the na(+)-transporting carboxylic acid decarboxylase (nat-dc) family.
RL4_JR_06316,1327,1120,1850,0,0,1,0,0,0,0,0,2,0,0,0,0,0,0,0.011995548,1,8.278788502,3.994728753,2.072428196,0.038225526,NA,0.003674643,0,11.54805534,3.998155187,2.888345949,0.003872737,0.017716233,0.009795413,1,8.859139625,3.047426446,2.90708891,0.003648095,0.015596838,0.01131933,0,8.43600951,3.995699254,2.111272389,0.034748906,0.099426657,0.00992088,0,8.755100215,1.62018887,5.403752846,6.53E-08,1.59E-06,N,-,,Uncharacterised,F:methylmalonyl-CoA carboxytransferase activity; F:transferase activity; F:ligase activity,no IPS match,,
RL4_JR_06317,55297,20350,28860,11,2,17,0,0,4,9,3,0,1,8,1,0,3,0,12.88674333,1,1.155171609,1.220826244,0.946221147,0.344035802,0.534090214,1.648774492,1,2.744117105,1.518582522,1.807025345,0.070758328,0.155125794,49.79779729,1,3.490907612,1.510671525,2.310831677,0.020842154,0.057369758,14.28362542,1,0.624130386,1.275974806,0.489140054,0.624742546,0.741648291,4.260730284,1,-0.004771863,1.345944266,-0.003545365,0.997171214,0.997861094,N,-,,isovaleryl- dehydrogenase,F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; P:oxidation-reduction process,IPR006091 (PFAM); IPR009075 (PFAM); PIRSF016578 (PIRSF); IPR013786 (G3DSA:1.10.540.GENE3D); G3DSA:2.40.110.10 (GENE3D); IPR013786 (PFAM); G3DSA:1.20.140.10 (GENE3D); PTHR10909 (PANTHER); PTHR10909:SF211 (PANTHER); IPR009075 (SUPERFAMILY); IPR009100 (SUPERFAMILY),,
RL4_JR_06318,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22.36839285,0,0.755576409,0.846326081,0.892772213,0.37197917,0.564053172,3.4802043,0,1.666340846,1.25770679,1.324904071,0.18520297,0.325004242,584.0973718,0,6.020053662,0.615637168,9.7785741,1.39E-22,2.52E-20,320.1761686,0,4.849057934,0.895013679,5.417859022,6.03E-08,1.43E-06,68.54161738,0,2.886979431,0.490668272,5.883770356,4.01E-09,2.06E-07,N,-,,alcohol dehydrogenase,F:zinc ion binding; F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process; F:copper ion transmembrane transporter activity; P:copper ion transmembrane transport,IPR020843 (SMART); IPR011032 (G3DSA:3.90.180.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013149 (PFAM); IPR013154 (PFAM); PTHR11695:SF559 (PANTHER); IPR002085 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_06319,3120,3248,2661,0,0,9,0,0,0,0,5,1,0,1,2,0,1,0,31.86995394,1,0.51422152,0.816485503,0.629798715,0.528826287,0.712907261,27.60852615,0,1.991329546,1.144584197,1.739784238,0.081896911,0.173205293,20.26603174,1,-0.632504186,1.219267204,-0.518757647,0.603929756,0.721182454,15.88241253,1,-2.016640753,1.223879679,-1.647744291,0.099405155,0.194864898,39.58007946,1,0.971899205,0.802703139,1.210782863,0.225978635,0.352982671,N,-,,sterol esterase tgl1,"F:hydrolase activity, acting on ester bonds; P:lipid metabolic process; C:integral component of membrane",IPR029058 (G3DSA:3.40.50.GENE3D); IPR000073 (PFAM); PTHR11005:SF9 (PANTHER); PTHR11005 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_06320,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.71199169,0,-2.328252224,1.245012184,-1.870063806,0.061474958,0.155267092,5.887308846,0,0.90781914,1.280633838,0.708882675,0.478397287,0.635894595,54.64227107,0,1.382111283,1.160184402,1.191285869,0.23354138,0.36543631,17.80798444,0,-2.181702606,1.235956821,-1.765193224,0.077531297,0.162830197,38.53641237,0,1.233318329,0.76807611,1.605724112,0.108334541,0.202751798,N,-,,cytochrome c oxidase assembly,C:mitochondrial envelope,IPR018793 (PFAM); PTHR28627 (PANTHER),,
RL4_JR_06321,5965,4204,4532,2,0,0,0,0,0,0,0,0,2,0,1,0,3,1,96.05392218,1,1.625431757,0.508000325,3.199666768,0.001375866,0.007640784,17.59768945,0,1.340813638,1.15341746,1.162470384,0.245044448,0.3980645,40.6638663,0,0.179275049,0.88219952,0.203213723,0.838967987,0.896244793,41.7428776,1,-0.329370165,0.883676814,-0.372726952,0.709351675,0.80517777,20.71929487,1,-2.286740729,1.208843342,-1.891676654,0.058534076,0.126116272,N,-,,calcineurin-like phosphoesterase,C:membrane; C:integral component of membrane; C:fungal-type vacuole; F:hydrolase activity,IPR029052 (G3DSA:3.60.21.GENE3D); IPR004843 (PFAM); PTHR24032 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_06322,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_06323,62,38,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3390.941975,0,0.508533799,0.341550878,1.488896181,0.136514709,0.276486345,726.225048,0,-0.604388955,0.503688757,-1.199925444,0.230168297,0.38030746,2120.933095,0,-0.2265548,0.437030296,-0.518396097,0.604181937,0.721228385,2321.59409,0,-0.424515871,0.562532676,-0.754651043,0.450458389,0.592400465,1492.690432,0,-1.629169017,0.845671324,-1.926480149,0.054044448,0.11885318,N,-,,transaldolase,C:nucleus; P:carbohydrate metabolic process; F:sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity; P:pentose-phosphate shunt; C:cytosol,IPR013785 (G3DSA:3.20.20.GENE3D); IPR004730 (TIGRFAM); IPR001585 (PFAM); PTHR10683:SF18 (PANTHER); IPR001585 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_06324,393,415,319,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,118.7239503,0,-0.976641839,0.607388324,-1.607936473,0.107849093,0.234017703,26.53033828,0,-1.264085273,1.199791501,-1.053587455,0.292071835,0.451007035,75.58579248,0,-2.959578898,1.196726297,-2.473062476,0.013396072,0.04068607,87.74201991,0,-2.622612731,1.026684462,-2.554448642,0.010635612,0.050987486,91.1772056,0,-1.085191971,0.704229401,-1.54096374,0.123325611,0.223535949,N,-,,small nuclear ribonucleo,"F:RNA binding; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP; C:spliceosomal complex; C:viral nucleocapsid; C:U1 snRNP; C:small nucleolar ribonucleoprotein complex; P:mRNA splicing, via spliceosome",IPR001163 (SMART); IPR001163 (PFAM); G3DSA:2.30.30.100 (GENE3D); IPR016487 (PIRSF); PTHR11021 (PANTHER); IPR010920 (SUPERFAMILY),,
RL4_JR_06325,951,1151,1186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.823169861,0,2.178169529,1.688460369,1.290032961,0.197039214,NA,0.264170769,0,5.385881744,1.791757713,3.00592078,0.00264778,0.015349618,0.684481345,0,2.735261481,1.308071261,2.09106458,0.036522275,0.08894672,0.789462603,0,2.313490607,1.399225467,1.653408018,0.098247852,0.193495332,0.67541953,0,2.651784613,1.278239642,2.074559828,0.038027348,0.090424355,N,-,,hypothetical protein CMQ_4991,,no IPS match,,
RL4_JR_06326,5810,3286,4194,1,12,2,0,0,0,2,0,1,1,0,0,0,0,0,226.8228083,1,2.986173767,0.386023738,7.73572575,1.03E-14,6.55E-13,8.21844713,0,0.426710009,1.255953984,0.339749716,0.734045019,0.834114354,34.20263784,1,-0.402948118,1.056279889,-0.381478548,0.702848186,0.798241596,24.45627778,1,-2.63923902,1.212120017,-2.177374339,0.029452649,0.091306818,62.15544022,0,1.319551893,0.581148421,2.270593614,0.02317159,0.061174347,N,-,,nuclease domain-containing 1,F:transcription cofactor activity; P:posttranscriptional gene silencing by RNA; C:cytosol; C:RISC complex; P:regulation of nucleic acid-templated transcription,IPR016071 (SMART); IPR002999 (SMART); G3DSA:2.30.30.140 (GENE3D); IPR016071 (PFAM); IPR002999 (PFAM); IPR016071 (G3DSA:2.40.50.GENE3D); IPR016685 (PIRSF); IPR016071 (G3DSA:2.40.50.GENE3D); IPR030481 (PTHR12302:PANTHER); PTHR12302 (PANTHER); IPR016071 (PROSITE_PROFILES); IPR016071 (PROSITE_PROFILES); IPR002999 (PROSITE_PROFILES); IPR016071 (PROSITE_PROFILES); IPR016071 (PROSITE_PROFILES); IPR016071 (SUPERFAMILY); IPR016071 (SUPERFAMILY); IPR016071 (SUPERFAMILY); IPR016071 (SUPERFAMILY); SSF63748 (SUPERFAMILY); IPR016071 (SUPERFAMILY),,
RL4_JR_06327,31,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,984.0882831,0,0.758672537,0.614713748,1.234188336,0.217132733,0.384996487,299.2713824,0,0.663739275,0.486747307,1.363621874,0.172686604,0.308168866,449.8044579,0,-1.23440354,0.429345593,-2.875081429,0.004039233,0.016505679,668.8665962,0,-0.079877164,0.514540327,-0.155239851,0.876632233,0.923899381,405.0000846,0,-1.37558393,0.447570088,-3.073449206,0.002115997,0.008876105,N,-, Effector probability:0.928,superoxide dismutase,F:metal ion binding; P:removal of superoxide radicals; P:oxidation-reduction process; F:superoxide dismutase activity,IPR001424 (PRINTS); IPR001424 (PFAM); IPR001424 (G3DSA:2.60.40.GENE3D); IPR024134 (PANTHER); IPR001424 (SUPERFAMILY),,
RL4_JR_06328,4,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.46287358,0,3.009064022,2.094100281,1.436924511,0.150739444,NA,0.146386753,0,6.237584688,1.961730648,3.179633603,0.001474614,0.015023052,0.3815024,0,3.579371515,1.317607993,2.716567851,0.006596267,0.023440018,0.440266415,0,3.156447945,1.491814762,2.115844423,0.034358042,0.099376683,0.377360843,0,3.493394646,1.266168695,2.759027814,0.00579736,0.020219866,N,-,,---NA---,,no IPS match,,
RL4_JR_06329,12,21,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,425.1051028,0,-1.614114839,0.525360059,-3.072397326,0.002123469,0.010990516,173.1912034,0,-0.087303491,0.686638821,-0.127146162,0.898824716,0.944059746,339.7421674,0,-1.752906912,0.539191556,-3.250991029,0.001150035,0.006453965,385.0082094,0,-1.991698122,0.502600579,-3.962785169,7.41E-05,0.000829717,289.2510567,0,-2.779279645,0.669177785,-4.153275418,3.28E-05,0.000270895,N,-,,rho1 guanine nucleotide exchange factor 1,P:regulation of Rho protein signal transduction; C:actomyosin contractile ring; P:regulation of cell wall (1->3)-beta-D-glucan biosynthetic process; P:regulation of cell separation after cytokinesis; C:cytosol; F:Rho guanyl-nucleotide exchange factor activity; P:primary cell septum disassembly; P:positive regulation of GTPase activity; P:actin cortical patch localization,IPR000219 (SMART); IPR001180 (SMART); IPR001849 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR000219 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PF15405 (PFAM); IPR001180 (PFAM); IPR000219 (G3DSA:1.20.900.GENE3D); IPR024481 (PFAM); PF13087 (PFAM); PF13086 (PFAM); PTHR12673:SF110 (PANTHER); PTHR12673:SF110 (PANTHER); PTHR12673 (PANTHER); PTHR12673:SF110 (PANTHER); PTHR12673 (PANTHER); PTHR12673 (PANTHER); IPR001849 (PROSITE_PROFILES); IPR001180 (PROSITE_PROFILES); IPR000219 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR000219 (SUPERFAMILY),,
RL4_JR_06330,706,752,660,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_06331,365,228,385,0,0,3,0,0,0,1,0,0,0,3,0,0,0,0,61.846345,1,-0.509943464,0.701791072,-0.72663145,0.467451757,0.656021485,13.57009215,0,-0.296886499,1.209599974,-0.245441886,0.8061143,0.883061574,41.83527119,1,-1.992349234,1.195951829,-1.665910939,0.095731155,0.187800431,134.8687249,1,0.905021814,0.519927956,1.740667728,0.081741838,0.16876756,38.83441988,0,-2.112675662,1.134494966,-1.862216867,0.062572528,0.133042176,N,-,,brca1 c terminus domain-containing,C:cell part; P:cellular process,IPR003961 (SMART); IPR001357 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR031669 (PFAM); IPR001357 (PFAM); IPR031673 (PFAM); IPR001357 (G3DSA:3.40.50.GENE3D); PTHR13561 (PANTHER); PTHR13561:SF28 (PANTHER); IPR003961 (PROSITE_PROFILES); IPR001357 (PROSITE_PROFILES); IPR003961 (SUPERFAMILY); IPR001357 (SUPERFAMILY),,
RL4_JR_06332,909,781,758,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,21.70937127,0,1.896615266,0.790912759,2.398008181,0.016484497,0.056315129,2.037426774,0,2.438665141,1.32108898,1.845950711,0.064899363,0.144757899,5.315751726,1,-0.221490278,1.216317383,-0.182099081,0.85550497,0.908446855,6.134382382,0,-0.644283352,1.217624746,-0.52913129,0.596714377,0.719596602,5.272875258,0,-0.312308397,1.225531672,-0.254835027,0.798850521,0.864141188,N,-,,hypothetical protein CMQ_4994,,no IPS match,,
RL4_JR_06333,10889,8727,10560,1,3,47,0,0,0,1,0,3,3,9,0,0,10,0,95.96831223,1,-1.160864806,0.710755666,-1.633282522,0.102409591,0.22565006,22.00595987,0,-0.994305923,1.22454588,-0.811979314,0.416803502,0.580713702,115.6269079,1,0.169626401,0.582649788,0.291129259,0.770952463,0.846634422,96.30067347,1,-1.018024495,0.709013185,-1.435832952,0.151049881,0.267316889,74.9526849,1,-1.114573798,0.784003802,-1.421643358,0.155129811,0.26522954,N,-,,wiskott-Aldrich syndrome,P:potassium ion transmembrane transport; P:actin filament polymerization; P:mitotic actomyosin contractile ring assembly; C:mating projection tip; P:endocytosis; P:actin cortical patch assembly; P:mitotic actomyosin contractile ring contraction; F:voltage-gated potassium channel activity; F:actin binding; P:actin cortical patch internalization; P:actin nucleation; C:integral component of membrane; P:establishment or maintenance of cell polarity regulating cell shape; P:positive regulation of actin filament bundle assembly; P:positive regulation of Arp2/3 complex-mediated actin nucleation; C:actin cortical patch,IPR000697 (SMART); IPR000697 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); PTHR23202 (PANTHER); IPR028297 (PTHR23202:PANTHER); IPR003124 (PROSITE_PROFILES); IPR000697 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY),,
RL4_JR_06334,3630,1466,1797,0,0,0,0,0,0,0,0,0,0,1,0,0,2,0,104.2761451,0,2.336649956,1.063788739,2.196535713,0.028053622,0.085844504,5.019236386,0,1.138095845,1.271808337,0.894864275,0.370859646,0.535192663,19.50254385,0,-0.549968784,1.210134905,-0.454468987,0.649491309,0.756494479,109.0963765,1,2.391885704,0.572443956,4.178375334,2.94E-05,0.000371122,129.7306109,1,2.862014158,0.79348568,3.606888228,0.000309891,0.001794993,N,-,,hypothetical protein CMQ_4940,P:mycelium development,no IPS match,,
RL4_JR_06335,58643,24556,33883,0,5,14,0,0,4,2,4,6,2,9,0,0,15,1,98.91122488,1,0.036762442,0.682857623,0.053836174,0.957065689,0.978157131,18.23352715,1,-0.723002888,1.210369292,-0.59734074,0.55027991,0.696589951,95.3944246,1,0.246130012,0.584830523,0.420856988,0.673859515,0.775685473,82.39580434,1,-1.455537076,0.856085893,-1.700223177,0.089088954,0.179722188,57.71584113,1,-1.775175992,0.976959427,-1.817041674,0.069210733,0.143715887,N,-,,DNA excision repair ERCC-4,"P:nucleotide-excision repair, DNA incision, 5'-to lesion; F:endonuclease activity; P:double-strand break repair via single-strand annealing, removal of nonhomologous ends; P:DNA amplification; P:meiotic mismatch repair; F:single-stranded DNA binding",IPR006166 (SMART); IPR020819 (G3DSA:3.40.50.GENE3D); IPR006167 (TIGRFAM); IPR006166 (PFAM); PTHR10150 (PANTHER); IPR011335 (SUPERFAMILY); IPR010994 (SUPERFAMILY),,
RL4_JR_06336,4670,3112,4001,0,0,3,0,0,1,3,0,3,0,2,1,0,0,0,35.97281985,1,-3.271192249,1.216677993,-2.688626135,0.007174672,0.029073651,11.37560419,1,-0.042419299,1.229607818,-0.034498235,0.97247985,0.98570677,29.70893615,1,-2.703892747,1.20999078,-2.234639134,0.02544105,0.067496118,51.62136857,1,-0.820065872,0.885565445,-0.92603644,0.354427043,0.500777814,29.50391848,0,-2.796607182,1.221711688,-2.289089324,0.022074163,0.059111584,N,-,,mitochondrial inner membrane magnesium transporter mrs2,P:transmembrane transport; C:integral component of membrane; F:metal ion transmembrane transporter activity; P:metal ion transport,G3DSA:1.20.58.340 (GENE3D); IPR002523 (PFAM); PTHR13890 (PANTHER); PTHR13890:SF0 (PANTHER),1.A.35.5.5, the cora metal ion transporter (mit) family.
RL4_JR_06337,9286,6590,6383,10,11,11,1,0,0,0,1,1,0,4,0,0,10,0,75.76562182,1,-0.256256992,0.754307945,-0.339724636,0.734063907,0.859641161,11.99416487,1,-0.11880928,1.244886012,-0.095437878,0.923967031,0.95853175,31.35668166,1,-2.781771911,1.222280768,-2.275886183,0.022852823,0.061778899,56.24595396,1,-0.232868024,0.763133708,-0.305147082,0.760254134,0.843292408,31.19979324,1,-2.877247449,1.236284538,-2.327334331,0.019947478,0.054482928,N,-,,actin cortical patch,C:membrane; C:integral component of membrane; C:plasma membrane,no IPS match,,
RL4_JR_06338,3,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,884.2944812,0,-1.109165932,0.613073689,-1.809188605,0.070421707,0.171646337,335.9749629,0,-0.141248578,0.616292103,-0.229190959,0.818720499,0.890606007,737.2351124,0,-1.067204114,0.443682633,-2.405332177,0.016157771,0.047233935,721.0986578,0,-2.014222203,0.476871863,-4.223822707,2.40E-05,0.000308232,563.8077504,0,-2.707140321,0.712215096,-3.80101508,0.000144105,0.000945877,N,-,,g1 s-specific cyclin,F:protein kinase binding; P:regulation of cyclin-dependent protein serine/threonine kinase activity,IPR013922 (PFAM); PTHR15615 (PANTHER); PTHR15615:SF0 (PANTHER),,
RL4_JR_06339,11615,19886,6960,2,0,22,0,0,0,0,0,0,0,4,1,0,0,3,684.4783703,1,-0.765736754,0.325948474,-2.349257061,0.018810915,0.062407257,159.2006245,0,-2.031263193,0.999114075,-2.033064336,0.042046024,0.103148291,384.870194,0,-3.917324881,0.868481766,-4.510543609,6.47E-06,0.000130146,515.2504121,1,-1.964227448,0.434564457,-4.519991027,6.18E-06,9.32E-05,418.8670835,1,-2.329697093,0.53220565,-4.377437731,1.20E-05,0.000117471,N,-,,ATP-dependent RNA helicase SUB2,"P:transcription-coupled nucleotide-excision repair; C:spliceosomal complex; C:transcription export complex; P:chromatin silencing at telomere; F:ATP-dependent RNA helicase activity; P:mRNA splicing, via spliceosome; P:transcription elongation from RNA polymerase II promoter; P:mRNA export from nucleus; C:chromosome, telomeric region; F:ATP binding; F:RNA binding; P:RNA secondary structure unwinding; P:mRNA 3'-end processing",IPR014001 (SMART); IPR001650 (SMART); IPR001650 (PFAM); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24031 (PANTHER); PTHR24031:SF75 (PANTHER); PTHR24031 (PANTHER); PTHR24031:SF75 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.22.1.1, the transcription-coupled trex/tap nuclear mrna export complex (trex) family.
RL4_JR_06340,334,458,351,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,108.3223647,1,3.033800992,0.676691196,4.483287221,7.35E-06,8.89E-05,3.421135913,0,1.690954298,1.344616811,1.257573373,0.208546088,0.35388156,8.922444847,1,-0.968596866,1.252606808,-0.77326489,0.43936563,0.579486404,10.29501027,0,-1.391186643,1.258433724,-1.105490592,0.268947069,0.410103776,8.865219287,0,-1.061970322,1.267668004,-0.837735368,0.402179345,0.539346473,N,-,,rnase p rpr2 rpp21 subunit domain-containing,,IPR007175 (PFAM); PTHR14742:SF0 (PANTHER); IPR007175 (PANTHER); PTHR14742:SF0 (PANTHER); IPR007175 (PANTHER),,
RL4_JR_06341,477,459,496,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4.541935015,0,-0.285389392,1.218224628,-0.234266641,0.814777982,0.906040195,1.446942129,0,2.932541476,1.35338949,2.166812656,0.030249142,0.079527744,3.754032395,1,0.280708521,1.209348171,0.232115554,0.816448264,0.881113125,4.330970911,0,-0.141708854,1.210265465,-0.117089067,0.906789473,0.943020072,3.697473143,0,0.199861203,1.207628594,0.165498899,0.868551316,0.912912081,N,-,,duf1721 domain containing,,IPR013183 (PFAM); PTHR28289 (PANTHER),,
RL4_JR_06342,2091,1314,2322,1,1,0,0,0,0,0,0,0,0,2,0,0,0,0,0.399917937,1,3.219715913,2.392850285,1.345556775,0.1784455,NA,0.131604735,0,6.391550037,2.15628652,2.964146915,0.003035233,0.015666819,0.335409405,0,3.765092169,1.466737482,2.566984355,0.010258724,0.033373818,19.6570135,1,5.183810274,1.169897379,4.430995714,9.38E-06,0.000133763,23.4885275,0,6.714622973,0.916421594,7.327002132,2.35E-13,2.87E-11,N,-,,NACHT nucleoside triphosphatase,,PF05729 (PFAM); IPR031359 (PFAM); IPR007111 (PROSITE_PROFILES),,
RL4_JR_06343,3405,3125,4468,0,1,0,0,1,0,0,1,0,0,3,0,0,0,0,441.072178,1,-2.472726021,0.478176194,-5.171160861,2.33E-07,4.20E-06,120.7006538,1,-3.449765266,1.199842166,-2.875182556,0.00403794,0.018171436,482.429445,1,-0.980631246,0.463011717,-2.117940454,0.034180111,0.084875998,443.0330181,1,-1.994581855,0.436411288,-4.570417651,4.87E-06,7.48E-05,354.5947125,0,-2.534564943,0.558790836,-4.535802631,5.74E-06,6.37E-05,N,-,,2-dehydropantoate 2-reductase,F:NADP binding; C:cell division site; C:cell tip; C:cytoplasm; P:oxidation-reduction process; F:2-dehydropantoate 2-reductase activity,IPR013752 (PFAM); IPR013328 (G3DSA:1.10.1040.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013332 (PFAM); PTHR21708:SF25 (PANTHER); PTHR21708 (PANTHER); IPR008927 (SUPERFAMILY),,
RL4_JR_06344,253,231,251,0,0,2,0,0,0,0,0,0,0,0,5,0,0,0,70.5628583,1,0.481237376,0.638822543,0.75331934,0.45125804,0.640125733,11.60546925,0,-0.071167167,1.232639292,-0.057735598,0.953959238,0.975515338,61.34663883,0,0.108128097,0.763794389,0.141567022,0.887422017,0.930143959,50.61840265,1,-0.441541732,0.774574895,-0.570043949,0.56864789,0.695693558,29.38002466,0,-2.790538212,1.199645213,-2.326136247,0.020011283,0.054524824,N,-,,structural maintenance of chromosome complex subunit,P:sister chromatid cohesion; C:Smc5-Smc6 complex; P:double-strand break repair via homologous recombination; P:resolution of recombination intermediates,IPR027417 (G3DSA:3.40.50.GENE3D); IPR003395 (PFAM); IPR027131 (PTHR19306:PANTHER); IPR033268 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_06345,694,1170,725,4,0,1,0,0,0,5,0,2,1,2,0,0,0,0,56.29595793,1,0.728042793,0.610296066,1.192933781,0.232895308,0.40640854,8.161268509,0,0.436781706,1.245660657,0.350642612,0.725856484,0.828591331,38.61733544,1,-0.380744507,1.043208571,-0.364974481,0.715130455,0.807312749,41.60928552,1,-0.319118641,0.870580861,-0.366558301,0.713948517,0.808492198,50.07361987,0,0.37454525,0.754372821,0.496498866,0.619542487,0.726110393,N,-,,CAMK CAMKL GIN4 kinase,F:nucleotide binding; F:protein kinase activity; P:phosphorylation,IPR000719 (SMART); IPR031850 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); PTHR24343 (PANTHER); PTHR24343 (PANTHER); PTHR24343:SF59 (PANTHER); PTHR24343 (PANTHER); PTHR24343:SF59 (PANTHER); PTHR24343:SF59 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.2, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_06346,2407,2419,2920,0,0,281,0,0,2,25,51,60,28,75,7,0,161,61,0.06984096,1,5.736561475,3.922008065,1.462659276,0.143560635,NA,0.021011386,1,9.035728863,3.922941523,2.3033045,0.021261717,0.060418612,0.057087523,1,6.318118795,3.448454438,1.832159569,0.066927651,0.141781865,0.06602145,1,5.892593498,3.922164585,1.502383026,0.132998217,0.24311373,0.059229855,1,6.164142957,2.640023759,2.334881622,0.019549606,0.053758761,N,-,,---NA---,,no IPS match,,
RL4_JR_06347,6141,5044,7001,0,1,4,0,0,0,0,0,0,0,0,0,0,4,2,24.98463394,1,-2.745210522,1.200439117,-2.28683861,0.022205245,0.071714326,7.954245777,0,0.473810876,1.231530672,0.384733313,0.700435011,0.810448466,20.64360246,0,-2.17858785,1.198493597,-1.817771789,0.06909902,0.145408123,23.81683993,0,-2.601039705,1.197947165,-2.171247432,0.029912474,0.092083854,20.33722558,1,-2.259787894,1.201549813,-1.880727598,0.060008984,0.128754176,N,-, Effector probability:0.612,C2H2 finger domain-containing,F:nucleic acid binding; F:metal ion binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_06348,38,41,59,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,142.003588,0,0.75444545,0.875500965,0.861730003,0.388836111,0.58161441,88.62699029,0,1.483827006,0.891513086,1.664391728,0.096034172,0.196335668,308.7615405,0,2.375347093,0.496767733,4.781605038,1.74E-06,4.37E-05,802.7451367,0,3.755974786,0.47166471,7.963230459,1.68E-15,1.07E-13,579.4138355,0,3.544146862,1.040856932,3.405027871,0.000661573,0.003422804,N,-,,malate synthase,P:glyoxylate cycle; F:malate synthase activity; P:tricarboxylic acid cycle,G3DSA:1.20.1220.12 (GENE3D); IPR006252 (TIGRFAM); IPR006252 (PIRSF); G3DSA:3.20.20.360 (GENE3D); IPR001465 (PFAM); PTHR21631:SF1 (PANTHER); PTHR21631 (PANTHER); IPR011076 (SUPERFAMILY),,
RL4_JR_06349,2718,3046,3532,3,1,2,0,0,0,0,0,3,0,2,0,0,0,0,206.475354,1,1.498044912,0.468981791,3.194249628,0.001401948,0.007769765,18.4618006,0,-0.740916832,1.212926508,-0.610850556,0.541298521,0.688319551,121.9059423,1,0.867168376,0.497407871,1.743374858,0.081268157,0.164815469,285.0730161,1,2.166234308,0.373542259,5.799167984,6.66E-09,1.90E-07,228.2407544,0,2.235639298,0.421604753,5.302689973,1.14E-07,2.53E-06,N,-,,fumarate hydratase,C:mitochondrion; P:tricarboxylic acid cycle; F:fumarate hydratase activity; P:fumarate metabolic process; C:tricarboxylic acid cycle enzyme complex,IPR000362 (PRINTS); G3DSA:1.20.200.10 (GENE3D); G3DSA:1.10.40.30 (GENE3D); IPR005677 (TIGRFAM); IPR018951 (PFAM); IPR022761 (PFAM); IPR024083 (G3DSA:1.10.275.GENE3D); IPR000362 (PANTHER); PTHR11444:SF1 (PANTHER); IPR005677 (HAMAP); IPR008948 (SUPERFAMILY),,
RL4_JR_06350,14304,9632,9596,4,5,10,0,0,0,0,0,2,0,3,5,0,0,0,1.053443176,1,1.822372723,1.501660221,1.213571951,0.224911224,NA,0.334357074,0,5.045863654,1.674496591,3.013361556,0.002583709,0.015349618,0.871763924,1,2.386202155,1.265035378,1.886273061,0.059258167,0.12890625,5.017510278,1,2.907772231,1.184103157,2.455674755,0.014062036,0.063618462,0.864889345,0,2.295622808,1.250540457,1.835704551,0.066401365,0.139397432,N,-,,atp-dependent rna helicase ded1,F:nucleic acid binding; F:ATP binding; F:helicase activity,IPR001650 (SMART); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); PTHR24031 (PANTHER); PTHR24031 (PANTHER); PTHR24031:SF304 (PANTHER); PTHR24031:SF304 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_06351,4432,4241,4898,0,0,4,0,0,0,0,0,0,1,19,0,0,0,3,0.205454531,1,4.180528047,2.992302934,1.397093857,0.162385349,NA,0.065450518,0,7.398541609,2.326955072,3.179494825,0.00147532,0.015023052,0.170471895,0,4.739567364,1.434937374,3.302978549,0.000956637,0.005543786,0.196678921,1,4.31831409,1.895101267,2.278671945,0.022686574,0.081131698,0.169163589,1,4.648747992,1.315915539,3.532710005,0.000411323,0.002299641,N,-,,DEAD DEAH box helicase,F:nucleic acid binding; F:ATP binding; F:helicase activity,no IPS match,,
RL4_JR_06352,3949,4010,3855,0,1,3,0,0,0,4,0,0,1,5,0,0,10,2,37.3350267,1,-2.224105675,1.181830382,-1.881916144,0.059847402,0.152192988,10.57407042,0,0.062991305,1.241156061,0.050752123,0.959523042,0.978272787,27.65588003,1,-2.600578538,1.217697984,-2.135651511,0.032707829,0.08220806,39.94283064,1,-1.314797318,1.056345448,-1.244666052,0.21325453,0.347641622,27.50307386,1,-2.695290539,1.231216439,-2.189128129,0.028587529,0.072434616,N,-,,pre-rRNA-processing IPI1,P:nucleic acid metabolic process; P:cellular macromolecule metabolic process; C:nuclear lumen; P:cellular macromolecular complex assembly; C:intracellular non-membrane-bounded organelle; P:ribosome biogenesis; C:macromolecular complex,IPR024679 (PFAM),,
RL4_JR_06353,759,771,753,0,0,3,0,0,0,0,2,0,0,4,0,0,3,0,14.38771336,1,-0.558936013,1.178319876,-0.474349983,0.635250354,0.791837971,3.341178386,0,1.72505041,1.29184449,1.335339062,0.181765399,0.320741378,41.94009626,1,1.49934951,0.878693777,1.706339056,0.08794497,0.175473961,10.07527854,1,-1.360076283,1.221800829,-1.113173482,0.265633929,0.406582545,8.676184838,1,-1.030816285,1.233028255,-0.836003782,0.403152775,0.540210242,N,-,,Dynein light chain-related,,IPR004942 (SMART); IPR004942 (PFAM); G3DSA:3.30.450.30 (GENE3D); PTHR10779 (PANTHER); SSF103196 (SUPERFAMILY),,
RL4_JR_06354,963,821,1048,0,0,5,0,0,0,0,0,2,0,0,0,0,0,0,177.6165541,1,0.71648303,0.424092152,1.689451284,0.09113298,0.206804688,132.397224,0,2.396067241,1.418242182,1.689462683,0.091130797,0.18825019,137.8195601,1,0.593439855,0.511421265,1.160373837,0.245896634,0.380178447,117.5268867,0,-0.410826529,0.596308806,-0.688949292,0.490855179,0.630379082,85.98924191,0,-0.664267791,0.68484965,-0.969946895,0.332072963,0.46868509,N,-,,helicase-like protein,F:helicase activity,PTHR42345 (PANTHER); PTHR42345 (PANTHER); PTHR42345:SF2 (PANTHER); PTHR42345:SF2 (PANTHER); PTHR42345 (PANTHER); PTHR42345:SF2 (PANTHER),,
RL4_JR_06355,211,248,203,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,255.3126308,1,3.493731752,0.755808911,4.622506699,3.79E-06,4.91E-05,35.0466363,0,2.859173634,0.855640937,3.341557786,0.000833097,0.015023052,62.32642571,0,1.427545324,0.617272469,2.31266644,0.020740986,0.05715344,163.23757,0,2.992490177,0.539705614,5.544671205,2.95E-08,7.54E-07,144.4097899,0,3.103842907,0.719033734,4.316686076,1.58E-05,0.000147806,Y,-,,FMN-binding split barrel-related,F:FMN binding; F:oxidoreductase activity; P:oxidation-reduction process,PF13883 (PFAM); IPR012349 (G3DSA:2.30.110.GENE3D); PTHR37273:SF1 (PANTHER); PTHR37273 (PANTHER); IPR012349 (SUPERFAMILY),,
RL4_JR_06356,27870,20316,28432,14,20,17,0,0,3,1,11,0,2,10,6,0,2,10,155.0711854,1,2.753606221,0.451896082,6.093450087,1.11E-09,2.98E-08,7.110382599,1,0.635633456,1.235374418,0.51452697,0.60688361,0.74010553,18.41242423,1,-2.013535816,1.196075079,-1.683452696,0.092287489,0.182377229,44.52176531,1,-0.111934525,0.855699511,-0.130810552,0.895925175,0.935798759,25.82000627,1,-0.423683712,0.977931541,-0.433244756,0.664836967,0.761392862,N,-,,SNARE docking complex subunit,P:vesicle docking involved in exocytosis; C:cytosol,IPR027482 (G3DSA:3.40.50.GENE3D); IPR001619 (PIRSF); G3DSA:1.25.40.60 (GENE3D); G3DSA:3.40.50.2060 (GENE3D); G3DSA:3.90.830.10 (GENE3D); IPR001619 (PFAM); PTHR11679:SF2 (PANTHER); PTHR11679:SF2 (PANTHER); IPR001619 (PANTHER); IPR001619 (PANTHER); IPR001619 (PANTHER); IPR001619 (SUPERFAMILY),1.F.1.1.3, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_06357,4457,3190,5259,0,5,0,0,0,0,0,1,0,1,2,0,0,1,0,38.92440181,1,-2.290669015,1.177228524,-1.945815081,0.051676956,0.136345605,11.09436606,0,-0.00630732,1.236475037,-0.005101049,0.995929969,0.997901717,41.99331168,1,-0.855735824,1.061415417,-0.8062214,0.420115201,0.561469581,33.46396961,1,-3.091769842,1.217476096,-2.539491209,0.011101384,0.052795448,36.19087408,1,-1.822057908,1.156907049,-1.574938894,0.11527055,0.212627859,N,-,,exosome-associated family,C:nucleus,IPR007146 (PFAM); PTHR15341:SF3 (PANTHER); IPR011082 (PANTHER),,
RL4_JR_06358,466,626,478,0,0,28,0,1,2,3,5,2,19,44,4,0,3,11,2.33045102,1,0.677209924,1.246638343,0.543228858,0.586972239,0.758977604,0.745553492,1,3.889197515,1.456975328,2.669364018,0.007599504,0.02755073,1.929869064,1,1.240728695,1.214411471,1.021670764,0.306936753,0.448402263,2.22607966,1,0.818504046,1.222521952,0.66952094,0.503163228,0.640176889,1.897147014,1,1.162470955,1.203262324,0.966099355,0.333994467,0.470725777,N,-,,zn 2cys6 transcription factor,F:binding,IPR007219 (SMART); PTHR31944 (PANTHER); PTHR31944:SF80 (PANTHER),,
RL4_JR_06359,555,334,642,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.30178267,0,1.517100645,1.384965513,1.095406803,0.273338455,NA,0.419319571,0,4.719493766,1.613826775,2.924411616,0.003451081,0.016643092,1.081649957,0,2.075850726,1.245980254,1.666038221,0.095705802,0.187800431,1.247325846,0,1.654015119,1.280447236,1.29174797,0.196444439,0.326333051,1.060505003,0,2.000947105,1.222817516,1.636341546,0.101768126,0.193539119,N,-, Effector probability:0.617,like family,,PTHR14194:SF70 (PANTHER); PTHR14194 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06360,802,959,744,0,0,6,0,0,0,0,0,0,0,4,1,0,1,0,0.00781203,1,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,0,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,0,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,0.007662926,1,9.0007212,4.037607722,2.229221316,0.025799183,0.085851084,0.006329724,1,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,N,-,,hypothetical protein MMYC01_204872,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_06361,552,571,634,0,0,4,0,0,0,0,0,2,0,0,0,0,1,0,0.004235441,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001340044,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003452355,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003983613,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003339785,1,10.24113992,1.835951848,5.578109216,2.43E-08,8.07E-07,Y,-,,---NA---,,no IPS match,,
RL4_JR_06362,9303,5723,4559,0,2,0,0,0,0,2,0,0,0,3,3,0,0,0,0.747884595,1,2.316644045,1.704504496,1.359130498,0.17410524,NA,0.236659877,0,5.544375319,1.785280508,3.105604579,0.001898905,0.015023052,0.618165117,1,2.882000193,1.285657632,2.241654482,0.024983712,0.066526854,0.713384668,1,2.459590297,1.376227436,1.787197546,0.073905566,0.156951709,0.61432502,0,2.789313574,1.261589966,2.210950983,0.027039232,0.069443444,N,-,,hypothetical protein MMYC01_204874,P:transmembrane transport; C:membrane; C:integral component of membrane,IPR021765 (PFAM); PTHR33365:SF7 (PANTHER); PTHR33365 (PANTHER),,
RL4_JR_06363,1565,1710,2329,0,5,0,2,0,0,1,0,0,0,0,0,0,0,0,4.656937645,1,-0.321448348,1.239485074,-0.259340233,0.79537274,0.895480377,1.492654814,1,2.887747704,1.380105414,2.092410968,0.036401769,0.092045641,3.854479824,1,0.242750949,1.225407658,0.198098117,0.842968298,0.899189869,4.445688104,0,-0.179316357,1.228972833,-0.145907503,0.883994409,0.928610911,3.775766742,0,0.169530611,1.218586209,0.139120736,0.889354742,0.927556321,N,-,,ABC transporter,F:nucleotide binding; F:ATPase activity; C:membrane; P:transport,IPR003593 (SMART); IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24223:SF229 (PANTHER); PTHR24223 (PANTHER); PTHR24223:SF229 (PANTHER); PTHR24223 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.1.208.40, the atp-binding cassette (abc) superfamily.
RL4_JR_06364,4141,3934,5343,1,4,6,0,0,1,0,0,3,0,1,0,0,3,0,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_06365,3628,2685,2254,0,6,1,0,0,0,3,0,1,0,4,0,0,2,1,18.42474107,1,-2.305846246,1.186025687,-1.94417901,0.051873868,0.13677667,15.28376561,0,1.819796757,1.127147625,1.614515008,0.106415764,0.212328083,15.27297257,1,-1.74386512,1.191717162,-1.463321311,0.143379479,0.253461471,17.61590064,1,-2.16592646,1.189418719,-1.820995773,0.068607499,0.148747523,15.00634452,1,-1.821316947,1.189032506,-1.531763797,0.125580733,0.226586765,N,-,,glycoside hydrolase family 115,F:hydrolase activity,IPR031924 (PFAM); PTHR37842 (PANTHER); PTHR37842:SF2 (PANTHER),,
RL4_JR_06366,11708,8601,8611,1,0,0,0,0,0,0,0,1,1,1,0,0,0,2,8.452226054,1,-1.18169203,1.187005494,-0.99552364,0.319481653,0.508004368,2.700131138,0,2.032497117,1.277882861,1.590519114,0.111717841,0.220860934,7.000225933,1,-0.61845101,1.19260049,-0.5185735,0.604058193,0.721228385,8.075210378,1,-1.04072897,1.189598993,-0.87485697,0.381651735,0.527179238,6.896411377,1,-0.69962775,1.193294521,-0.586299307,0.557674397,0.676708206,N,-,,hypothetical protein FOXB_11270,,IPR031924 (PFAM); IPR029018 (G3DSA:3.30.379.GENE3D); PTHR37842:SF2 (PANTHER); PTHR37842 (PANTHER),,
RL4_JR_06367,944,505,685,0,0,44,0,0,0,0,2,1,1,39,3,0,8,2,170.3444978,1,-1.379661578,0.56638469,-2.435909024,0.01485442,0.052121444,40.42209146,0,-1.871567269,1.194997808,-1.566167951,0.117309303,0.229361555,118.1262789,1,-2.708075155,1.036692653,-2.612225664,0.008995486,0.030105883,129.3229986,1,-3.226104903,1.021915033,-3.156920879,0.001594446,0.010963519,118.5974686,1,-2.920547542,0.981609962,-2.975262738,0.002927377,0.011587057,N,-,,2-dehydropantoate 2-reductase,F:DNA binding; F:NADP binding; F:oxidoreductase activity; P:oxidation-reduction process; F:2-dehydropantoate 2-reductase activity,IPR013332 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013752 (PFAM); IPR013328 (G3DSA:1.10.1040.GENE3D); PTHR21708 (PANTHER); PTHR21708:SF24 (PANTHER); PTHR21708 (PANTHER); PTHR21708:SF24 (PANTHER); PTHR21708 (PANTHER); IPR008927 (SUPERFAMILY),,
RL4_JR_06368,328,216,235,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0.011995548,0,8.278788502,3.994728753,2.072428196,0.038225526,NA,0.003674643,0,11.54805534,3.998155187,2.888345949,0.003872737,0.017716233,0.009795413,0,8.859139625,3.047426446,2.90708891,0.003648095,0.015596838,0.01131933,1,8.43600951,3.995699254,2.111272389,0.034748906,0.099426657,0.00992088,0,8.755100215,1.62018887,5.403752846,6.53E-08,1.59E-06,Y,-, Effector probability:0.66,predicted protein,C:cell; P:cell redox homeostasis,no IPS match,,
RL4_JR_06369,733,1753,975,0,0,0,0,0,0,0,2,1,1,2,0,0,5,0,0.012047471,0,8.273092713,3.994385999,2.07118008,0.03834197,NA,0.00401109,0,11.43263965,3.991205167,2.86445802,0.004177235,0.018371529,0.010113829,1,8.82019535,3.041025661,2.900401487,0.00372685,0.01574077,0.01164654,1,8.398490877,3.993441208,2.103071121,0.035459553,0.099858856,0.00966951,1,8.76562085,1.6165792,5.422326879,5.88E-08,1.50E-06,Y,-, Effector probability:0.83,hypothetical protein TRIVIDRAFT_69582,,no IPS match,,
RL4_JR_06370,469,368,646,0,4,4,0,0,0,0,0,0,0,0,0,0,0,2,0.672714499,1,2.469719661,1.807167917,1.36662434,0.171743084,NA,0.21256894,0,5.699450147,1.836773734,3.102968015,0.001915903,0.015023052,0.554192153,0,3.040682471,1.303069063,2.333477602,0.019623093,0.054842592,0.639577709,0,2.61772383,1.414264293,1.850943875,0.064177628,0.142437195,0.548295691,1,2.954087566,1.268823317,2.328210339,0.019900937,0.054385153,Y,-, Effector probability:0.638,hypothetical protein FVEG_12001,,no IPS match,,
RL4_JR_06371,35,18,28,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0.157319822,0,4.56596471,3.299512762,1.383829989,0.166410518,NA,0.050307275,0,7.778909465,2.410075888,3.227661628,0.001248065,0.015023052,0.130093338,1,5.13280562,1.419972088,3.614722898,0.000300669,0.002328977,0.150061815,0,4.709528287,2.001372892,2.353148833,0.018615182,0.074321259,0.127610933,0,5.057766888,1.276150809,3.963298735,7.39E-05,0.000540004,N,-, Effector probability:0.631,---NA---,,no IPS match,,
RL4_JR_06372,827,740,1053,0,4,0,0,0,0,0,0,0,0,2,0,0,0,0,1.942797889,1,0.939592893,1.267762122,0.741142898,0.458606802,NA,0.622541075,0,4.149345714,1.496272863,2.77312101,0.005552147,0.022004241,1.610226643,0,1.501922554,1.218879668,1.232215611,0.217868553,0.34680837,1.857256388,1,1.079781896,1.231499855,0.876802292,0.380594034,0.526282042,1.582126468,0,1.424272091,1.204676606,1.182285838,0.237092303,0.365942236,Y,-,,glycoside hydrolase family 18,"P:metabolic process; F:hydrolase activity, acting on glycosyl bonds",IPR011583 (SMART); IPR018392 (SMART); IPR018392 (G3DSA:3.10.350.GENE3D); IPR013781 (G3DSA:3.20.20.GENE3D); IPR018392 (G3DSA:3.10.350.GENE3D); IPR001002 (G3DSA:3.30.60.GENE3D); IPR001223 (PFAM); IPR018392 (PFAM); PTHR11177 (PANTHER); PTHR11177:SF185 (PANTHER); IPR001002 (PROSITE_PROFILES); IPR017853 (SUPERFAMILY); IPR029070 (SUPERFAMILY); IPR018392 (SUPERFAMILY); IPR018392 (SUPERFAMILY); IPR001002 (SUPERFAMILY),9.B.29.2.7, the small 4-5 tms putative permease (4-5pp) family.
RL4_JR_06373,576,581,1164,0,0,0,0,0,0,0,0,0,0,3,0,0,2,0,1.472367136,0,1.339339055,1.370060538,0.977576551,0.3282838,NA,0.467657228,0,4.561843028,1.575384051,2.895702178,0.003783112,0.017565442,1.218453108,0,1.903320661,1.246186074,1.527316587,0.126682307,0.231295162,1.405918875,1,1.480893003,1.277109609,1.159566096,0.246225512,0.384891092,1.20772635,1,1.81393003,1.238958175,1.464076889,0.143172941,0.250021736,N,-,,---NA---,,no IPS match,,
RL4_JR_06374,1954,1821,3048,5,2,0,0,0,0,4,2,0,1,0,0,0,0,0,166.9964886,1,1.574168342,0.449281391,3.503747032,0.000458761,0.003131859,11.89031429,0,-0.106204711,1.212096881,-0.087620645,0.930178193,0.960711748,41.97160422,1,-1.798825564,1.193292108,-1.5074478,0.131695914,0.237959921,39.66535369,1,-2.236197393,1.146547007,-1.950375674,0.051131359,0.124880807,49.44827632,0,-0.229562454,0.759356863,-0.302311687,0.76241447,0.834264185,N,-,,programmed cell death 5,F:organic cyclic compound binding; F:heterocyclic compound binding; F:oxidoreductase activity,IPR002836 (G3DSA:1.10.8.GENE3D); IPR002836 (PFAM); IPR002836 (PIRSF); IPR002836 (PANTHER); IPR002836 (SUPERFAMILY),,
RL4_JR_06375,2241,1449,2735,3,1,0,0,0,2,0,0,0,1,3,0,0,0,0,168.4983114,1,0.591819871,0.379887825,1.557880596,0.119261556,0.251080199,20.98843701,1,-0.925989842,1.197609195,-0.773198675,0.43940481,0.600771751,67.37927445,0,-1.75467918,1.026699206,-1.70904893,0.087441886,0.174676728,85.36690472,1,-1.679207002,0.842617608,-1.992845848,0.04627833,0.116820765,65.12195971,0,-1.446550548,0.833930422,-1.734617793,0.082808526,0.165764398,N,-,,succinate-semialdehyde dehydrogenase,F:aldehyde dehydrogenase (NAD) activity; P:reciprocal meiotic recombination; C:integral component of membrane; P:oxidation-reduction process,IPR016162 (G3DSA:3.40.605.GENE3D); IPR016163 (G3DSA:3.40.309.GENE3D); IPR015590 (PFAM); PTHR11699:SF25 (PANTHER); PTHR11699 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_06376,28,9,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,104.7007452,0,1.086354199,0.648322836,1.675637721,0.093809176,0.211309251,11.03379606,0,0.001691275,1.294158512,0.001306853,0.998957283,0.999648603,86.9923692,0,1.167175838,0.65442645,1.783509572,0.074503391,0.15418486,90.05012589,0,1.14580912,0.701971705,1.632272515,0.10262209,0.199778632,27.5613278,0,-2.698393868,1.244123779,-2.168911096,0.030089434,0.075353827,N,-,,phospholipid-translocating p-type ATPase,F:magnesium ion binding; F:ATP binding; P:phospholipid translocation; C:integral component of membrane; F:phospholipid-translocating ATPase activity,PR00119 (PRINTS); IPR023299 (G3DSA:3.40.1110.GENE3D); IPR032631 (PFAM); IPR001757 (TIGRFAM); IPR023214 (G3DSA:3.40.50.GENE3D); IPR008250 (G3DSA:2.70.150.GENE3D); IPR006539 (TIGRFAM); IPR032630 (PFAM); PF13246 (PFAM); IPR026871 (PTHR24092:PANTHER); IPR006539 (PANTHER); SSF81665 (SUPERFAMILY); SSF81653 (SUPERFAMILY); IPR023299 (SUPERFAMILY); IPR023214 (SUPERFAMILY),3.A.3.8.4, the p-type atpase (p-atpase) superfamily.
RL4_JR_06377,3759,1919,2863,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,9.590006213,0,0.316517224,1.143783298,0.276728314,0.781988729,0.887515867,1.84123404,0,2.584860662,1.314606872,1.966261334,0.049268431,0.116408743,17.77310791,1,1.753789399,1.031375701,1.700436996,0.089048758,0.177286336,13.53247372,0,1.238357878,1.014022556,1.221233069,0.221997787,0.357224782,4.705081896,0,-0.147903901,1.197217116,-0.123539748,0.901679701,0.936743995,N,-,,hypothetical protein CMQ_5642,,no IPS match,,
RL4_JR_06378,4323,2418,3110,0,0,2,0,0,0,0,0,5,0,0,0,0,0,0,130.3975604,1,1.505590744,0.477079546,3.155848447,0.00160032,0.008668931,11.48574557,0,-0.056249345,1.223813624,-0.045962345,0.963340262,0.980387104,37.68478378,1,-1.748456261,1.20059792,-1.456321248,0.145303834,0.255835829,82.42623028,0,0.586275212,0.571204167,1.026384691,0.304710291,0.450327207,51.88244734,0,-0.166435746,0.767847125,-0.216756357,0.828398225,0.884854102,N,-,,V-type proton ATPase subunit E,"C:vacuolar proton-transporting V-type ATPase, V1 domain; P:ATP hydrolysis coupled proton transport; C:fungal-type vacuole membrane; F:proton-transporting ATPase activity, rotational mechanism",IPR002842 (PFAM); PTHR12317:SF29 (PANTHER); PTHR12317 (PANTHER); SSF160527 (SUPERFAMILY),3.A.2.2.4," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_06379,2994,2622,3666,0,0,2,0,0,0,1,0,0,0,0,0,0,0,4,35.01310424,1,-0.902491737,1.008266394,-0.895092549,0.370737617,0.563007721,7.427195924,0,0.572708504,1.230908416,0.465273043,0.641735937,0.76681043,34.91649435,1,-0.252082288,1.033258952,-0.243968163,0.807255477,0.873930082,38.22757908,0,0.213834401,0.75053575,0.284909014,0.77571385,0.854900669,61.39577369,1,1.839274846,0.530858051,3.464720637,0.000530783,0.002843478,N,-,,Duf803 domain-containing,C:membrane; P:transport,IPR008521 (PFAM); PTHR12570:SF8 (PANTHER); IPR008521 (PANTHER); SSF103481 (SUPERFAMILY),2.A.7.29.4, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_06380,13,29,29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,130.5218429,0,2.927514718,0.367586942,7.964142321,1.66E-15,1.18E-13,5.36987388,0,1.040624248,1.238388984,0.840304833,0.400737492,0.564412297,72.63353813,0,2.208488484,0.538279498,4.102865686,4.08E-05,0.000610228,43.35395431,0,0.699777073,0.739228918,0.946631086,0.343826798,0.490592775,67.05873968,0,2.480995408,0.47067783,5.271111675,1.36E-07,2.91E-06,N,-,,tetraspanin,P:entry into host; C:integral component of membrane; P:modulation by symbiont of entry into host; P:pathogenesis,no IPS match,8.A.40.2.1, the tetraspanin (tetraspanin) family.
RL4_JR_06381,256,385,484,0,0,1,4,0,0,0,0,0,0,0,0,0,0,0,136.6385579,1,-0.264253766,0.589414356,-0.448332761,0.65391306,0.804703848,20.58462946,1,-0.89797691,1.202330187,-0.746863814,0.455145771,0.614838581,59.83766506,0,-2.586356393,1.190310528,-2.172841734,0.029792231,0.076262085,77.57257825,0,-1.256237242,0.747619064,-1.680317293,0.092895598,0.185260573,67.98585084,0,-1.019925037,0.75182121,-1.356605831,0.174906488,0.291175303,N,-,,C6 transcription factor,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31001 (PANTHER); PTHR31001:SF1 (PANTHER); IPR001138 (SUPERFAMILY),,
RL4_JR_06382,176,137,127,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,55.86300594,0,-1.330543758,0.962065003,-1.383008168,0.166662361,0.318340329,14.02961617,0,-0.34489178,1.256457443,-0.274495393,0.783703944,0.869393146,43.06048959,0,-2.041468796,1.230417145,-1.659168035,0.097081937,0.189777472,42.19499773,0,-3.42616859,1.23746003,-2.768710509,0.005627862,0.030751268,36.14016082,0,-3.089293247,1.240937048,-2.489484259,0.012792858,0.038321111,N,-,,upf0075 domain,"F:ATP binding; P:peptidoglycan turnover; P:amino sugar metabolic process; P:phosphorylation; F:phosphotransferase activity, alcohol group as acceptor; F:kinase activity",G3DSA:3.30.420.40 (GENE3D); IPR005338 (PFAM); PTHR30605 (PANTHER); PTHR30605:SF0 (PANTHER); SSF53067 (SUPERFAMILY),,
RL4_JR_06383,8744,7077,5870,1,2,8,0,0,0,0,6,1,5,12,4,0,1,4,5.664042335,1,1.957274468,1.2167187,1.608649943,0.107692907,0.233845817,0.584472587,0,4.240324639,1.557632523,2.722288202,0.006483158,0.024540958,9.363633358,1,2.546491587,1.229373479,2.071373453,0.03832391,0.092378872,1.754786957,1,1.161714255,1.294636026,0.897328849,0.369543467,0.515233765,1.500610907,1,1.501066064,1.256064695,1.195054737,0.232065645,0.359605855,N,-,,major facilitator superfamily transporter sugar,C:integral component of plasma membrane; P:proton transport; F:sugar:proton symporter activity; P:glucose import; F:glucose transmembrane transporter activity; P:glucose transmembrane transport,IPR003663 (PRINTS); IPR003663 (TIGRFAM); G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR23500:SF4 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.125, the major facilitator superfamily (mfs).
RL4_JR_06384,14186,18842,21314,6,19,71,0,0,0,7,3,5,1,15,8,0,32,3,84.5471607,1,0.776407594,0.490107169,1.584158818,0.113157582,0.242365523,12.26310322,0,-0.150740385,1.212029253,-0.124370253,0.901022125,0.944583723,80.73206343,1,0.608846383,0.615189571,0.989689051,0.322326128,0.464980011,44.69549478,1,-1.497643803,1.01588957,-1.474219095,0.14042261,0.253301074,42.91676615,1,-0.68045116,0.847153858,-0.803220281,0.421847425,0.557598587,N,-, Effector probability:0.593,SRF-type transcription factor,"P:DNA replication initiation; P:regulation of mating type switching; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding, bending; P:negative regulation of arginine catabolic process by negative regulation of transcription from RNA polymerase II promoter; P:transcription from RNA polymerase II promoter; F:protein dimerization activity; P:positive regulation of arginine biosynthetic process by positive regulation of transcription from RNA polymerase II promoter; P:positive regulation of transcription involved in G2/M transition of mitotic cell cycle; F:RNA polymerase II repressing transcription factor binding; F:RNA polymerase II activating transcription factor binding; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; F:RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding; F:DNA replication origin binding; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; P:negative regulation of mating-type specific transcription from RNA polymerase II promoter; C:nuclear chromatin; P:positive regulation of mating-type specific transcription from RNA polymerase II promoter; C:cytosol",IPR002100 (PRINTS); IPR002100 (SMART); IPR002100 (PFAM); PTHR11945 (PANTHER); PTHR11945:SF221 (PANTHER); IPR002100 (PROSITE_PROFILES); IPR002100 (SUPERFAMILY),,
RL4_JR_06385,25578,27643,41317,0,0,6,0,0,2,0,0,1,0,13,0,0,6,0,169.9763053,1,1.66260446,0.590195207,2.817041619,0.004846824,0.021189922,13.78110333,1,-0.319099861,1.205731833,-0.264652431,0.791277226,0.873795221,88.53442665,1,0.654682519,0.572048742,1.144452336,0.252436094,0.388044795,92.00122292,1,0.633645995,0.496533517,1.27613942,0.201906239,0.333219343,58.09782739,1,-0.120099485,0.678987031,-0.176880382,0.859602349,0.906706301,N,-,,rrm domain containing,F:nucleotide binding; C:integral component of membrane; F:copper ion transmembrane transporter activity; P:copper ion transmembrane transport,IPR012677 (G3DSA:3.30.70.GENE3D); IPR007274 (PFAM); PTHR24012 (PANTHER); PTHR24012:SF387 (PANTHER); PTHR24012:SF387 (PANTHER); PTHR24012 (PANTHER); PTHR24012 (PANTHER); PTHR24012:SF387 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),1.A.56.3.2, the copper transporter (ctr) family.
RL4_JR_06386,12153,14324,17520,13,15,20,0,1,4,7,4,12,8,13,8,0,21,7,189.8096379,1,0.706938656,0.726399941,0.97320858,0.330449647,0.520125067,43.49298384,1,0.478075167,0.988661845,0.48355782,0.628699716,0.756232742,102.2901426,1,-0.677019305,0.681366336,-0.993620128,0.320407841,0.463023925,179.957784,1,0.564154896,0.419782078,1.343923253,0.178973206,0.304044247,86.92563402,1,-0.752745773,0.66767087,-1.127420419,0.25956477,0.391376514,N,-,,transporter sec61 subunit gamma,"P:SRP-dependent cotranslational protein targeting to membrane, translocation; C:Ssh1 translocon complex; F:P-P-bond-hydrolysis-driven protein transmembrane transporter activity; C:integral component of membrane; F:structural molecule activity; P:posttranslational protein targeting to membrane, translocation; C:Sec61 translocon complex",IPR001901 (PFAM); IPR023391 (G3DSA:1.20.5.GENE3D); IPR008158 (TIGRFAM); PTHR12309 (PANTHER); IPR023391 (SUPERFAMILY),3.A.5.9.1, the general secretory pathway (sec) family.
RL4_JR_06387,2977,3934,6517,0,0,2,0,0,0,1,2,2,0,3,0,0,0,0,94.05514696,1,0.990532287,0.713793729,1.387701022,0.165228105,0.316638684,11.62628514,0,-0.07376332,1.249247279,-0.059046212,0.952915301,0.975027218,53.60466223,1,-0.311652197,0.888839951,-0.350628025,0.725867429,0.814348609,50.74023466,1,-0.467557271,0.80865917,-0.5781883,0.563136997,0.690855073,29.499234,0,-2.796366231,1.217537619,-2.296739081,0.021633659,0.058240041,N,-,,WD repeat domain-containing,,IPR020472 (PRINTS); IPR001680 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR19847:SF7 (PANTHER); PTHR19847 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_06388,2981,4269,7649,0,0,3,0,0,0,3,2,1,0,2,7,0,1,0,4.883915082,1,-0.390190688,1.202827246,-0.32439462,0.745639292,0.866884045,1.557393718,0,2.826400137,1.334870876,2.117358456,0.034229437,0.087714016,11.88317085,1,1.136470139,1.192359248,0.95312729,0.340525581,0.483992837,13.97323034,1,0.70177413,1.142731067,0.614120111,0.53913596,0.670415463,3.980909952,1,0.093249236,1.199753288,0.077723676,0.93804786,0.959948917,N,-,,hypothetical protein SPSK_09710,C:integral component of membrane,PTHR37019:SF2 (PANTHER); PTHR37019 (PANTHER),,
RL4_JR_06389,215,297,595,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,27.71134501,1,-2.894739744,1.228621631,-2.356087237,0.01846858,0.061449467,8.982557321,0,0.298439195,1.277577896,0.233597651,0.815297352,0.888314294,23.06543089,0,-2.338641957,1.226123168,-1.907346682,0.056475709,0.124052957,79.88661423,1,0.979867122,0.629638191,1.556238387,0.119651416,0.223957056,63.89808444,0,1.194563723,0.613068004,1.948501172,0.051355025,0.114404758,N,-,,myb dna-binding domain-containing,F:DNA binding; P:telomeric loop formation; F:double-stranded telomeric DNA binding; C:nuclear telomere cap complex,IPR001005 (SMART); IPR009057 (G3DSA:1.10.10.GENE3D); IPR001005 (PFAM); PTHR21717:SF26 (PANTHER); PTHR21717 (PANTHER); PTHR21717 (PANTHER); PTHR21717:SF26 (PANTHER); IPR017930 (PROSITE_PROFILES); IPR017930 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY); IPR009057 (SUPERFAMILY),,
RL4_JR_06390,1050,1535,2474,0,0,2,0,0,0,0,0,2,0,3,0,0,0,0,1094.935306,1,-0.440689779,0.7083621,-0.62212501,0.533859671,0.71706681,307.5443411,0,-0.781965784,0.59280706,-1.319089864,0.187139071,0.327380173,670.1479975,1,-1.960279971,0.616440549,-3.179998417,0.001472759,0.007781946,822.7957215,1,-1.393901785,0.634382526,-2.197257533,0.028002059,0.088933766,607.0620519,0,-2.292263904,0.686958815,-3.336828722,0.000847402,0.004181258,N,-,,40s ribosomal s4,F:structural constituent of ribosome; C:ribosome; F:rRNA binding; P:translation,IPR032277 (PFAM); IPR005824 (PFAM); IPR013843 (PFAM); IPR013845 (PFAM); IPR000876 (PIRSF); IPR000876 (PANTHER); IPR013845 (PRODOM),,
RL4_JR_06391,683,307,645,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,175.3333846,0,-0.284271161,0.43305203,-0.656436505,0.511543309,0.697388088,42.25839366,0,-0.655813259,1.10567567,-0.593133481,0.553091825,0.699050953,98.34447685,0,-2.405126854,1.027589888,-2.340551306,0.019255293,0.054248524,177.297231,0,-0.579661084,0.478610672,-1.211132803,0.225844511,0.361586919,125.2212492,0,-0.870869904,0.578059054,-1.506541412,0.131928245,0.234985748,N,-,,d-lactate dehydrogenase,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; C:integral component of membrane; P:oxidation-reduction process",IPR016171 (G3DSA:1.10.45.GENE3D); IPR016167 (G3DSA:3.30.43.GENE3D); IPR006094 (PFAM); IPR016169 (G3DSA:3.30.465.GENE3D); IPR004113 (PFAM); PTHR11748 (PANTHER); PTHR11748:SF81 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY); IPR016164 (SUPERFAMILY),,
RL4_JR_06392,11731,8660,11599,0,0,1,1,0,1,4,0,1,0,0,0,0,0,0,92.12342988,1,-0.828695079,0.715847487,-1.157641947,0.247010184,0.423342243,18.16347671,1,-0.71742684,1.233067189,-0.581822991,0.560685916,0.703864919,61.13483561,1,-1.539565635,1.053842176,-1.460907212,0.144040907,0.254319871,57.96711126,0,-2.83513387,1.165053533,-2.433479485,0.014954483,0.065631958,45.82427065,0,-3.43185207,1.206550381,-2.844350408,0.004450208,0.016275514,N,-,,RNA-dependent RNA polymerase 1,"F:nucleotide binding; P:RNA metabolic process; P:chromatin silencing at centromere; P:cellular localization; C:cytoplasm; F:oxidoreductase activity; P:chromosome organization; P:nuclear division; P:nuclear chromosome segregation; C:chromosome, centromeric region; P:chromatin silencing by small RNA; C:nuclear heterochromatin",IPR007855 (PFAM); IPR007855 (PANTHER); PTHR23079:SF1 (PANTHER),,
RL4_JR_06393,969,938,962,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,0.238687279,0,3.964342942,2.870376965,1.381122755,0.16724122,NA,0.078344219,0,7.140029668,2.322452131,3.074349552,0.002109621,0.015045494,0.199795585,0,4.512878545,1.484103582,3.040811032,0.002359419,0.011285095,0.230218241,1,4.091862737,1.89350591,2.160998133,0.030695484,0.093753174,0.193723193,1,4.451933007,1.356127102,3.282828727,0.001027711,0.004889837,N,-,,---NA---,,no IPS match,,
RL4_JR_06394,1989,1329,1922,0,0,3,0,0,0,0,2,0,0,0,0,0,0,0,25.00601498,1,0.377463525,0.970841763,0.388800255,0.697423912,0.836580544,4.314245251,0,1.356338013,1.329013291,1.020560157,0.307462874,0.469048864,11.2405713,1,-1.301771609,1.250230285,-1.041225464,0.29777092,0.438543842,74.28750135,0,2.303168338,0.635759681,3.62270274,0.000291541,0.002654542,11.1576579,0,-1.393775753,1.265152252,-1.10166642,0.270606721,0.402866203,N,-,,zinc finger,F:nucleic acid binding; F:metal ion binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_06395,573,392,677,0,0,0,0,0,0,0,0,0,2,0,0,0,2,0,72.51246185,0,2.502550506,0.502565122,4.979554685,6.37E-07,1.03E-05,3.772604364,0,1.550028685,1.27513834,1.21557688,0.224146146,0.373159093,22.7452298,0,0.721812114,1.042171826,0.69260375,0.488558257,0.623178,31.30083308,1,1.50082267,0.693558632,2.163944906,0.030468578,0.093257059,24.29178595,1,0.516817571,0.974636933,0.530266763,0.595926988,0.706694865,N,-,,g2-specific kinase nima,C:nucleus; P:regulation of cell septum assembly; P:regulation of exit from mitosis; P:positive regulation of cellular component organization; P:positive regulation of cell cycle process; P:regulation of mitotic cytokinetic process; P:phosphorylation; P:regulation of actomyosin contractile ring contraction; C:mitotic spindle pole body; F:kinase activity; P:positive regulation of mitotic cell cycle,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24362 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_06396,8,8,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28.41701104,0,-0.419239611,1.007388102,-0.416164942,0.677289312,0.82271087,5.299245627,0,1.059765109,1.239485197,0.855004249,0.392548796,0.556729566,13.72967846,0,-1.590158246,1.191173613,-1.334950865,0.181892428,0.303113709,44.09778042,0,0.315545394,0.84495486,0.373446451,0.708816193,0.804932004,13.50910528,0,-1.66959826,1.190924094,-1.401935076,0.160934635,0.272850499,N,-,,btb poz domain-containing,C:cytoplasm,IPR000210 (SMART); IPR002110 (SMART); IPR000210 (PFAM); G3DSA:3.30.710.10 (GENE3D); IPR020683 (PFAM); G3DSA:3.30.710.10 (GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24413:SF79 (PANTHER); PTHR24413:SF79 (PANTHER); PTHR24413 (PANTHER); PTHR24413 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR000210 (PROSITE_PROFILES); IPR000210 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR011333 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR011333 (SUPERFAMILY),8.A.28.1.1, the ankyrin (ankyrin) family.
RL4_JR_06397,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,130.7997537,0,2.421510671,0.411801073,5.880292286,4.10E-09,1.00E-07,6.332051938,0,0.802867945,1.232875792,0.651215597,0.514907323,0.665365922,16.42249041,0,-1.848554478,1.193068055,-1.549412433,0.121282607,0.223654848,37.57024041,0,-0.527781819,1.013867905,-0.520562705,0.602671436,0.72393502,54.77830073,0,1.952815827,0.529329599,3.689224693,0.000224938,0.001375303,N,-,,OPT family small oligopeptide transporter,P:tetrapeptide transmembrane transport; F:tetrapeptide transmembrane transporter activity; C:integral component of membrane; C:endoplasmic reticulum; C:Golgi apparatus; C:plasma membrane,IPR004813 (TIGRFAM); IPR004813 (PFAM); IPR004648 (TIGRFAM); PTHR22601 (PANTHER); PTHR22601:SF0 (PANTHER),2.A.67.1.2, the oligopeptide transporter (opt) family.
RL4_JR_06398,12069,9740,7539,0,1,0,0,0,1,0,1,3,1,6,1,0,8,0,1.004919045,1,1.890503371,1.565941957,1.207262736,0.227330977,NA,0.316690473,1,5.124120474,1.704379457,3.00644346,0.002643232,0.015349618,0.828997246,1,2.458885503,1.283484446,1.915789093,0.055391947,0.122229309,10.26911733,1,2.989364293,1.18520626,2.522231273,0.011661301,0.054713009,8.546293336,1,4.01024581,1.045488396,3.8357631,0.000125175,0.000837118,N,-,,Serine hydrolase,,no IPS match,,
RL4_JR_06399,31833,19168,16601,1,2,12,0,0,0,3,0,4,0,2,0,0,7,0,49.86937334,1,-3.742423704,1.23943029,-3.019470909,0.002532166,0.012625092,15.70241506,0,-0.507450703,1.239046157,-0.409549475,0.682136467,0.798006594,41.12009623,1,-3.172816475,1.224224162,-2.591695682,0.009550421,0.031535702,78.76886334,1,-0.551972428,0.742547075,-0.74335008,0.457269759,0.59933415,52.52400211,1,-1.103758259,0.923966889,-1.194586377,0.232248674,0.359779349,N,-,,exosome complex exonuclease rrp43,P:nuclear-transcribed mRNA catabolic process; P:snRNA 3'-end processing; C:nuclear lumen; C:intracellular non-membrane-bounded organelle; C:cytoplasmic part; P:nuclear RNA surveillance; P:polyadenylation-dependent RNA catabolic process; C:exosome (RNase complex),IPR001247 (PFAM); PTHR11097 (PANTHER); PTHR11097 (PANTHER); IPR033196 (PTHR11097:PANTHER); IPR033196 (PTHR11097:PANTHER); IPR015847 (SUPERFAMILY); IPR020568 (SUPERFAMILY),,
RL4_JR_06400,2227,2201,4097,8,3,5,0,0,2,2,1,1,0,1,0,0,1,0,171.8079851,1,-3.68799354,1.037100344,-3.556062401,0.000376455,0.002637209,69.45872191,1,-0.5579131,0.990108734,-0.563486697,0.573103516,0.713085899,132.1954316,1,-4.857552739,1.202308539,-4.040188173,5.34E-05,0.000762632,207.7778249,1,-1.708856808,0.599835288,-2.848876754,0.004387387,0.025340728,161.5699009,1,-1.571228673,0.645480791,-2.434198964,0.014924789,0.043386014,N,-,,rab geranylgeranyltransferase component a,F:GDP-dissociation inhibitor activity; P:small GTPase mediated signal transduction; F:oxidoreductase activity; P:regulation of catalytic activity; P:oxidation-reduction process; F:transferase activity; C:cellular_component; F:molecular_function; C:intracellular,IPR018203 (PRINTS); G3DSA:3.30.519.10 (GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR018203 (PFAM); IPR017230 (PIRSF); PTHR11787:SF4 (PANTHER); PTHR11787 (PANTHER); SSF54373 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_06401,818,582,1163,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0.769576208,1,2.275566502,1.620349332,1.404367847,0.16020934,NA,0.245106857,0,5.494023388,1.74833647,3.142429093,0.001675523,0.015023052,0.636421307,0,2.840954193,1.251565605,2.269920317,0.023212418,0.062633934,0.734241964,0,2.418503768,1.322445449,1.828811744,0.067427815,0.147323861,0.627695826,0,2.758532383,1.222871746,2.255782254,0.024084271,0.063272768,N,-,,---NA---,,no IPS match,,
RL4_JR_06402,1640,1897,1911,2,0,0,0,0,0,0,0,2,0,4,0,0,3,1,73.86143335,1,3.100642243,0.956811398,3.240599193,0.001192788,0.006785747,2.835389955,0,1.961915954,1.286663386,1.524809033,0.127306736,0.243686195,7.386576296,1,-0.695990451,1.207915011,-0.576191574,0.5644857,0.689138108,12.53525899,1,-0.172502397,1.158046317,-0.148959842,0.881585321,0.92661179,18.8921736,1,1.403906903,0.878548394,1.597984712,0.110046379,0.205093163,N,-,,alpha beta hydrolase domain containing,P:metabolic process; F:hydrolase activity,IPR013094 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR23024 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_06403,952,1357,1546,0,2,0,0,0,0,0,1,5,0,5,3,0,3,0,389.2682097,1,0.662855271,0.366982969,1.806228971,0.070882581,0.172511962,68.98664689,0,-0.541007023,0.981372539,-0.551275893,0.581444561,0.720523917,152.9350435,1,-2.435377185,0.858664762,-2.836237486,0.004564849,0.017727092,298.2222432,1,0.139223458,0.401211218,0.347007889,0.728585392,0.819065026,224.8064368,1,-0.064101282,0.562707108,-0.113915892,0.909304468,0.941959048,N,-,,ATP synthase subunit D,"C:mitochondrial proton-transporting ATP synthase, stator stalk; P:protein complex assembly; F:proton-transporting ATPase activity, rotational mechanism; P:ATP synthesis coupled proton transport; F:proton-transporting ATP synthase activity, rotational mechanism",IPR008689 (PIRSF); PF05873 (PFAM); IPR008689 (PANTHER); PTHR12700:SF12 (PANTHER); IPR008689 (SUPERFAMILY),3.A.2.1.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_06404,1298,1164,1545,0,1,4,0,0,0,1,0,1,4,0,0,0,3,2,384.612775,1,0.367460417,0.355496498,1.033654112,0.301297893,0.48704061,64.13566552,0,-1.392348854,1.114339163,-1.249483909,0.211488135,0.357435783,231.0940227,1,-0.48380422,0.492993384,-0.981360472,0.326415012,0.469407042,313.798231,1,-0.046307428,0.37907546,-0.122158865,0.902773204,0.940485512,210.3295252,1,-0.614081902,0.663959973,-0.924877895,0.355029426,0.492297527,N,-,,nascent polypeptide-associated complex subunit alpha,C:cytoplasm; F:phosphatidylinositol phosphate binding; P:protein transport; F:anion binding; P:cellular process,IPR002715 (SMART); IPR002715 (PFAM); IPR016641 (PIRSF); G3DSA:1.10.8.10 (GENE3D); IPR016641 (PANTHER); IPR002715 (PROSITE_PROFILES),,
RL4_JR_06405,10950,10532,18099,2,12,10,0,1,1,0,0,1,3,11,0,0,5,1,844.6592961,1,-0.052879221,0.458024567,-0.115450623,0.908087956,0.955524513,340.8198435,1,-0.095867098,0.804840092,-0.119113224,0.905185654,0.94671308,402.1037619,1,-3.177353973,0.698012281,-4.552002966,5.31E-06,0.000110013,462.020198,1,-2.908900231,0.574600781,-5.062471764,4.14E-07,8.18E-06,471.4602556,1,-1.402974183,0.617779461,-2.27099519,0.023147269,0.061158184,N,-, Effector probability:0.559,ribosomal l14,C:nucleus; F:structural constituent of ribosome; C:cytosol; C:ribosome; P:translation,IPR014722 (G3DSA:2.30.30.GENE3D); IPR002784 (PFAM); PTHR11127 (PANTHER); IPR008991 (SUPERFAMILY),,
RL4_JR_06406,607,457,595,0,0,1,0,0,3,0,0,0,0,1,0,0,0,0,178.9921352,1,1.805900396,0.65268571,2.766875952,0.005659629,0.02409773,58.56418794,1,1.337584177,0.986565782,1.355798266,0.175163363,0.3112243,119.6189537,0,1.169149659,0.505286827,2.313833641,0.020676849,0.05700774,45.62552809,1,-2.459334172,1.147916721,-2.142432571,0.032158689,0.095907726,35.50522095,0,-3.063773856,1.195889063,-2.561921461,0.010409486,0.032439532,N,-,,glutamic acid rich,"F:2-isopropylmalate synthase activity; F:catalytic activity; P:leucine biosynthetic process; P:carboxylic acid metabolic process; F:transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer",no IPS match,1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_06407,3457,3908,3589,4,0,9,0,0,0,0,1,1,5,4,1,0,9,0,55.83770636,1,3.371049925,0.791128775,4.261063472,2.03E-05,0.000213068,1.966346982,0,2.489978443,1.322122955,1.883318366,0.059657236,0.135514035,226.4281108,1,5.517398551,0.400446927,13.77810185,3.45E-43,1.84E-40,51.31947509,1,3.396183461,0.544060565,6.242289336,4.31E-10,1.48E-08,78.403912,1,4.009272277,1.490156542,2.690504094,0.007134416,0.023990688,Y,-,,GPI anchored serine-rich,C:integral component of membrane,no IPS match,,
RL4_JR_06408,1949,1703,2359,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,23.66219154,1,0.706976481,1.010271955,0.699788286,0.484059531,0.672277435,2.435191207,0,2.18143768,1.289804252,1.691293603,0.090780741,0.187872145,41.46455488,0,2.35341355,0.743620441,3.164804812,0.00155187,0.008099097,7.299539836,1,-0.895188391,1.19782561,-0.747344508,0.454855633,0.59702013,33.27392706,0,2.826787689,0.61051072,4.630201559,3.65E-06,4.36E-05,N,-,,cenp-o kinetochore centromere component,P:centromere complex assembly; C:kinetochore,IPR018464 (PFAM); PTHR14582 (PANTHER),,
RL4_JR_06409,2240,1740,2728,1,0,6,0,0,1,0,0,2,0,0,0,0,1,2,1008.523778,1,1.362551662,0.62176278,2.191433303,0.028420451,0.086771722,92.19263386,1,-3.06105288,1.19734095,-2.556542378,0.010571819,0.035084575,589.4998481,1,0.547842768,0.298301141,1.83654265,0.06627744,0.140610395,532.2562556,0,0.023423979,0.459895047,0.050933314,0.959378659,0.976742979,491.6043356,1,0.291932373,0.345120291,0.845885855,0.397616424,0.534430678,Y,-,,subtilisin ase Spm1,P:mycelium development; P:proteolysis; F:serine-type endopeptidase activity; C:vacuole,IPR015500 (PRINTS); IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (PFAM); IPR010259 (G3DSA:3.30.70.GENE3D); IPR010259 (PFAM); IPR015500 (PANTHER); IPR015500 (PANTHER); PTHR10795:SF414 (PANTHER); IPR015500 (PANTHER); PTHR10795:SF414 (PANTHER); IPR009020 (SUPERFAMILY); IPR000209 (SUPERFAMILY),1.I.3.1.1,The Bacterial (Planctomycetes) Nuclear Pore-like Complex (B-NPC) Family
RL4_JR_06410,3105,4369,4233,0,1,8,0,0,0,1,0,0,3,2,0,0,0,4,297.784403,1,-1.004797051,0.518875827,-1.93648846,0.052807905,0.138746179,66.47835431,0,-2.589283429,1.20898181,-2.141705861,0.032217159,0.08365882,213.6718641,1,-2.090885847,0.698386674,-2.993879931,0.002754543,0.012757088,313.7103785,1,-0.764149782,0.43653005,-1.750509002,0.080030522,0.166524668,206.7852615,1,-1.725810368,0.595152555,-2.89977814,0.003734269,0.014118548,N,-,,beige beach domain-containing,C:membrane part,IPR001680 (SMART); IPR000409 (SMART); IPR000409 (G3DSA:1.10.1540.GENE3D); IPR023362 (G3DSA:2.30.29.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); PF13385 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); IPR023362 (PFAM); IPR000409 (PFAM); PTHR13743:SF84 (PANTHER); PTHR13743 (PANTHER); PTHR13743 (PANTHER); PTHR13743:SF84 (PANTHER); PTHR13743 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR000409 (PROSITE_PROFILES); IPR000409 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR017986 (SUPERFAMILY); IPR011993 (SUPERFAMILY),,
RL4_JR_06411,3983,4199,4082,0,0,3,0,0,0,3,0,2,0,0,0,0,0,0,24.92389421,1,-2.741674688,1.188973088,-2.305918204,0.021115203,0.068793062,7.973403636,0,0.470365021,1.226908492,0.383374167,0.701442355,0.811335792,104.220897,1,2.101295214,0.481540515,4.363693495,1.28E-05,0.000232026,37.12808789,0,-0.86593765,1.01362332,-0.854299258,0.392939198,0.537927174,57.10932295,0,0.712169014,0.665831611,1.069593276,0.284802423,0.419009668,N,-,,NADH-ubiquinone oxidoreductase kDa subunit,C:mitochondrion; C:integral component of membrane,PTHR38488 (PANTHER); PTHR38488:SF1 (PANTHER); PD750912 (PRODOM),,
RL4_JR_06412,3961,2220,1882,1,0,5,0,0,0,0,0,0,1,2,0,0,0,1,63.1243664,1,1.450730808,0.556884612,2.605083311,0.009185192,0.035445979,5.71252579,0,0.951400174,1.239789812,0.767388282,0.442850693,0.604026844,51.31277665,0,1.127818605,0.746203775,1.511408336,0.130684447,0.236893347,36.05858341,1,-0.378401758,1.017631626,-0.371845516,0.710007873,0.805832273,30.06216424,1,0.818154357,0.764692272,1.069913202,0.28465838,0.418929536,Y,-,,dolichyl-diphosphooligosaccharide- glycosyltransferase 48kd subunit,"C:nuclear envelope; C:oligosaccharyltransferase complex; F:transferase activity, transferring glycosyl groups; C:integral component of membrane; P:protein N-linked glycosylation via asparagine; P:mitotic cell cycle",IPR005013 (PFAM); PTHR10830:SF0 (PANTHER); IPR005013 (PANTHER),9.B.142.3.14, the integral membrane glycosyltransferase family 39 (gt39) family.
RL4_JR_06413,3928,2964,2547,5,2,6,2,0,1,2,0,0,0,6,0,0,1,0,123.6788976,1,-1.393759591,0.676260268,-2.060981041,0.039304849,0.111336444,29.92040377,1,-1.437572248,1.206012869,-1.19200407,0.233259649,0.3834125,101.5679739,1,-1.687621585,0.871091231,-1.937364911,0.052700753,0.117805789,127.7738919,1,-0.844602381,0.594315716,-1.421134185,0.155277753,0.272896567,137.699999,1,-0.020981712,0.530710448,-0.03953514,0.968463738,0.979428988,N,-,,acetyl-coenzyme a transporter 1,C:integral component of membrane; F:acetyl-CoA transporter activity; P:acetyl-CoA transport,IPR024371 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR12778:SF9 (PANTHER); PTHR12778 (PANTHER); PTHR12778:SF9 (PANTHER); PTHR12778 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.25.4, the major facilitator superfamily (mfs).
RL4_JR_06414,62712,71527,61497,0,1,5,0,0,2,0,0,2,13,3,1,0,5,2,115.300491,1,-1.261630083,0.668769974,-1.886493312,0.059228509,0.150948508,24.05904039,1,-1.122963974,1.198966303,-0.936610121,0.348959144,0.511907892,132.669681,1,0.364081772,0.485066034,0.750581873,0.452904334,0.59240355,110.8759038,1,-0.664297901,0.568330043,-1.168859379,0.242460292,0.380818527,124.7974987,1,-0.407187741,0.570589177,-0.713626822,0.475457967,0.605459932,N,-,,glutamyl-trna amidotransferase subunit a partial,,IPR025638 (PFAM); IPR001279 (G3DSA:3.60.15.GENE3D); PTHR33835 (PANTHER); PTHR33835:SF1 (PANTHER); IPR001279 (SUPERFAMILY),,
RL4_JR_06415,12296,26862,32592,0,5,14,0,0,0,0,1,2,1,4,0,0,20,1,29.57121037,1,-0.103609718,1.034670178,-0.100137918,0.920234832,0.961623962,4.300746645,0,1.360931712,1.270460978,1.07121095,0.284074589,0.443392905,11.18249623,1,-1.294137092,1.210481247,-1.069109575,0.285020298,0.424407338,12.90307112,1,-1.716772509,1.210655105,-1.418052509,0.156175435,0.274140091,25.7665086,1,0.320893805,0.994307334,0.322731005,0.746898969,0.823369413,N,-,,acetyltransferase,F:transferase activity,IPR016181 (G3DSA:3.40.630.GENE3D); IPR000182 (PFAM); PTHR13256:SF33 (PANTHER); PTHR13256 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_06416,8843,11193,13155,2,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_06417,44258,37476,37714,3,12,23,0,0,0,5,7,18,6,38,10,0,17,16,43.35808998,1,3.390277185,0.696161805,4.869955751,1.12E-06,1.66E-05,1.525408411,0,2.856387657,1.414141502,2.019874004,0.043396458,0.105498605,3.95621009,1,0.205085299,1.253757304,0.163576554,0.870064503,0.91784235,27.20070227,1,2.12332076,0.914896185,2.320832456,0.020295888,0.077428737,3.88841671,1,0.127195368,1.254043271,0.101428213,0.919210541,0.948317251,Y,-,,serine threonine- phosphatase family,P:nucleotide catabolic process; C:cytoplasmic part; F:hydrolase activity,IPR014485 (PIRSF); IPR004843 (PFAM); IPR008334 (G3DSA:3.90.780.GENE3D); IPR029052 (G3DSA:3.60.21.GENE3D); IPR006179 (PANTHER); IPR006179 (PANTHER); PTHR11575:SF22 (PANTHER); PTHR11575:SF22 (PANTHER); IPR008334 (SUPERFAMILY); IPR029052 (SUPERFAMILY),,
RL4_JR_06418,293,336,264,0,0,8,0,0,0,1,0,0,0,0,0,0,0,0,34.00327897,1,0.006959831,0.860079259,0.008092081,0.993543524,0.997603551,15.21048689,0,1.838028678,1.122050891,1.638097427,0.101401372,0.204908102,15.17269132,1,-1.734479548,1.195741849,-1.450546829,0.14690609,0.258073444,64.07098014,0,1.174979536,0.62246929,1.887610449,0.059078266,0.135638877,14.9997848,0,-1.820615401,1.202945362,-1.51346475,0.130161649,0.232472516,N,-,,pre-mrna-splicing factor isy1,C:post-spliceosomal complex; P:generation of catalytic spliceosome for second transesterification step; C:cytoplasm; C:post-mRNA release spliceosomal complex; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome; C:Prp19 complex; P:mRNA 3'-splice site recognition,IPR009360 (PFAM); IPR009360 (PANTHER); SSF140102 (SUPERFAMILY),,
RL4_JR_06419,604,675,797,0,2,6,0,0,0,0,0,0,0,3,0,0,4,8,188.7236395,1,-0.404898738,0.513877794,-0.787928069,0.430738782,0.622051156,51.24847129,0,0.077375789,1.00763228,0.076789709,0.938790838,0.966532768,218.065763,0,0.772046142,0.419904878,1.83862151,0.065970875,0.14014657,251.4743675,1,0.862379418,0.409065986,2.108167014,0.035016545,0.099498352,127.4551147,1,-0.497821359,0.538901248,-0.923771027,0.355605543,0.492814964,N,-,,efr3,C:mitochondrion; P:establishment of protein localization to plasma membrane; C:plasma membrane,PTHR12444 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_06420,495,688,618,0,0,5,0,0,0,0,1,0,4,0,0,0,1,0,65.76131494,1,-0.322898008,0.718362491,-0.449491743,0.653076963,0.804196508,12.10932936,0,-0.132589887,1.225360849,-0.108204769,0.913833262,0.951662713,44.61114253,1,-0.97850388,1.053218094,-0.929061023,0.352857462,0.496294658,71.8006465,1,0.083794745,0.658273977,0.127294634,0.898707207,0.937600255,42.95909301,1,-0.703786188,0.890272952,-0.790528552,0.429219154,0.56380954,N,-,,atp12 chaperone,P:mitochondrial proton-transporting ATP synthase complex assembly; P:proton-transporting ATP synthase complex assembly; C:mitochondrion,IPR011419 (PFAM); G3DSA:3.30.2180.10 (GENE3D); IPR023335 (G3DSA:1.10.3580.GENE3D); IPR011419 (PANTHER); SSF160909 (SUPERFAMILY),,
RL4_JR_06421,5360,4996,4712,4,6,25,0,0,0,0,0,3,0,1,1,0,0,2,13.23675314,1,-1.828673545,1.244976106,-1.468842282,0.141875573,0.285008846,4.23566454,0,1.383000432,1.315419452,1.051375992,0.293085938,0.452228027,10.93846693,1,-1.262223717,1.234026595,-1.022849688,0.306378921,0.448039895,12.61697299,1,-1.684354791,1.23688009,-1.361776945,0.17326829,0.296434712,10.70575691,1,-1.3340531,1.234772855,-1.08040365,0.279962471,0.41357164,N,-,,AMP-binding enzyme,P:metabolic process; F:ligase activity,IPR000873 (PFAM); G3DSA:2.30.38.10 (GENE3D); IPR025110 (PFAM); G3DSA:3.30.300.30 (GENE3D); G3DSA:3.40.50.980 (GENE3D); G3DSA:3.40.50.980 (GENE3D); PTHR24096:SF236 (PANTHER); PTHR24096 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.7, the fatty acid transporter (fat) family.
RL4_JR_06422,194,197,108,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5.231936828,0,-0.489462226,1.294226027,-0.378189139,0.705290093,0.840578025,1.679480256,0,2.71762718,1.426604996,1.90496121,0.056785114,0.130572222,4.326971292,0,0.075886373,1.262734315,0.060096865,0.952078487,0.972469277,4.990267146,0,-0.34607326,1.272387475,-0.271987321,0.785631769,0.861446659,20.24833325,1,0.952917531,1.179037938,0.808216174,0.418966149,0.554731562,N,-,,hypothetical protein CMQ_2465,,no IPS match,,
RL4_JR_06423,3,3,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.232384501,0,4.003060912,2.886055622,1.38703526,0.165431011,NA,0.072672269,0,7.24745515,2.302624226,3.147476287,0.001646865,0.015023052,0.190998068,0,4.576507427,1.454723142,3.145964544,0.001655401,0.008533237,0.220523329,0,4.153539621,1.876264489,2.213728206,0.026847481,0.087153604,0.190705342,0,4.478414777,1.34772179,3.32295197,0.000890702,0.004350392,,,,,,,,
RL4_JR_06424,135,176,105,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,187.1252261,1,-2.432820948,0.699270378,-3.479084807,0.000503129,0.003383783,52.71891839,0,-2.25471468,1.209545058,-1.864101435,0.062307461,0.1403686,188.186291,0,-1.273371847,0.599088677,-2.125514796,0.033543681,0.08378027,260.4993409,1,-0.397582864,0.426079077,-0.933119896,0.350758068,0.497537887,151.7909238,0,-2.747786383,0.850281973,-3.231617826,0.001230916,0.005670164,N,-,,pal1 cell morphology,C:nucleus; C:cell division site; C:cytoplasmic part,IPR013226 (PFAM); PTHR28307 (PANTHER); PTHR28307:SF2 (PANTHER),,
RL4_JR_06425,1362,1215,888,0,0,0,0,0,0,0,0,1,2,7,2,0,0,0,0.087527534,0,5.411563067,3.918938283,1.380874787,0.167317463,NA,0.029067666,0,8.571089034,2.901490219,2.954029959,0.003136536,0.015953775,0.073565889,1,5.95494524,1.79500548,3.317508111,0.000908243,0.005324291,0.084725732,1,5.534110218,2.736415321,2.022394106,0.043135653,0.113059408,0.070752954,0,5.902975644,1.492219025,3.955837276,7.63E-05,0.000553948,N,-,,quinate permease,,no IPS match,,
RL4_JR_06426,289,271,328,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,172.9517819,1,-0.44692619,0.458649023,-0.974440514,0.329837861,0.519262307,39.25698347,0,-0.518163904,1.111627209,-0.466131002,0.641121734,0.766257432,153.1474317,0,0.057165434,0.491615355,0.116280815,0.90742999,0.943145592,164.2531264,1,-0.195238557,0.445293192,-0.438449455,0.661060503,0.769072457,99.38648779,0,-0.979162952,0.624068719,-1.568998609,0.116648263,0.214591434,N,-,,CK1 CK1 kinase,P:regulation of cell shape; P:peptidyl-serine autophosphorylation; C:cell division site; P:regulation of DNA repair; P:peptidyl-tyrosine autophosphorylation; F:protein serine/threonine kinase activity; P:endocytosis; C:nucleus; F:ATP binding; F:protein tyrosine kinase activity; P:peptidyl-threonine autophosphorylation; P:homologous chromosome segregation; C:cytosol; P:Wnt signaling pathway,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR11909:SF18 (PANTHER); PTHR11909 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_06427,6345,4820,4386,1,0,0,0,0,0,0,0,1,0,1,1,0,0,0,221.5917723,1,1.131459407,0.484299239,2.336281614,0.019476569,0.064120198,24.01841759,0,-1.120587407,1.199271537,-0.934390062,0.350102722,0.513064971,109.5845063,1,-0.376324717,1.145822451,-0.328431963,0.742585079,0.827028026,179.383731,1,0.538038515,0.418844957,1.284576799,0.19894021,0.329231724,80.81539129,0,-1.253227081,0.769133133,-1.62940202,0.103227942,0.195645554,N,-,,inositol 5-phosphatase,F:hydrolase activity,IPR000300 (SMART); IPR005135 (G3DSA:3.60.10.GENE3D); PTHR11200:SF173 (PANTHER); PTHR11200 (PANTHER); PTHR11200 (PANTHER); IPR005135 (SUPERFAMILY),,
RL4_JR_06428,2786,2635,2855,1,12,7,0,0,0,1,5,0,5,6,0,0,0,2,48.21014863,1,0.518733403,0.629160906,0.824484481,0.40966433,0.60097853,8.120628715,0,0.443944669,1.234111598,0.35972814,0.719050446,0.824074798,65.27949585,1,0.865346862,1.217368979,0.710833672,0.477187312,0.613621789,41.87810417,1,-0.313841939,0.860111323,-0.364885254,0.715197062,0.809272491,20.64535447,1,-2.28158187,1.196866747,-1.906295647,0.056611859,0.123082471,N,-,,catalytic subunit of the partial,F:ATP binding; F:protein serine/threonine kinase activity; P:protein phosphorylation,IPR000719 (SMART); IPR000961 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24353 (PANTHER); IPR000961 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_06429,175,256,249,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2883.218523,0,-0.344954945,0.349800718,-0.986147045,0.324060961,0.513304017,653.2903044,0,-1.412104693,0.509878701,-2.769491432,0.005614388,0.022181435,1692.487863,0,-1.847634959,0.462543007,-3.994514952,6.48E-05,0.00087859,2002.468045,0,-1.674916912,0.386436219,-4.33426483,1.46E-05,0.000199564,1683.398652,0,-1.77934381,0.970948138,-1.832583781,0.066864492,0.139963403,N,-,,glutamine synthetase,F:ATP binding; C:cytoplasm; P:glutamine biosynthetic process; F:glutamate-ammonia ligase activity,IPR008146 (SMART); IPR008147 (PFAM); IPR014746 (G3DSA:3.30.590.GENE3D); IPR008146 (PFAM); PTHR20852 (PANTHER); PTHR20852:SF57 (PANTHER); IPR008147 (SUPERFAMILY); SSF55931 (SUPERFAMILY),,
RL4_JR_06430,180,252,213,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,86.98489387,1,1.372358072,0.490055758,2.800412093,0.005103741,0.022146977,7.595027589,0,0.540479146,1.221972544,0.442300564,0.658271723,0.780122512,26.19844834,0,-1.149283005,1.188680147,-0.966856398,0.333615826,0.477119173,107.5086824,0,1.560032594,0.495136094,3.150714751,0.001628715,0.011157467,19.40684841,0,-2.192236908,1.191540679,-1.839833878,0.06579263,0.138528689,N,-,,acyl- thioesterase 1,F:palmitoyl-(protein) hydrolase activity; C:cytoplasm; P:macromolecule depalmitoylation; P:protein deacylation,IPR029058 (G3DSA:3.40.50.GENE3D); IPR003140 (PFAM); PTHR10655 (PANTHER); PTHR10655:SF17 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_06431,1092,1000,1161,0,0,6,0,0,0,0,0,1,0,0,0,0,2,0,124.5723086,1,0.994462019,0.978177504,1.016647812,0.309321001,0.497131742,13.08777507,0,-0.244587823,1.230285415,-0.198805757,0.842414693,0.905962762,48.08874198,1,-1.066893214,1.043917009,-1.022009609,0.306776353,0.448232616,81.61067722,0,0.392888594,0.57440339,0.683994211,0.493978821,0.632865439,56.21464111,1,0.212938138,0.642702979,0.331316556,0.740405387,0.81813866,N,-,,TBC domain-containing,F:calcium ion binding,IPR000195 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR000195 (PFAM); G3DSA:1.10.8.270 (GENE3D); PTHR22957:SF289 (PANTHER); PTHR22957 (PANTHER); PTHR22957:SF289 (PANTHER); IPR000195 (PROSITE_PROFILES); IPR000195 (SUPERFAMILY); IPR000195 (SUPERFAMILY); IPR011992 (SUPERFAMILY),8.A.87.1.5, the tbc1 domain (tbc1) family.
RL4_JR_06432,44089,36576,52433,8,4,54,0,0,4,5,10,1,0,24,8,0,45,2,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,Y,-,,---NA---,,no IPS match,,
RL4_JR_06433,4439,3931,4553,3,0,8,0,0,0,1,0,4,0,1,0,0,1,3,217.1809513,1,-1.84032261,0.585073527,-3.145455271,0.001658286,0.008917794,60.5017235,0,-1.293554604,1.118459088,-1.156550667,0.247455988,0.400824053,138.5569749,1,-3.894242749,1.194675779,-3.259664938,0.001115439,0.006293634,164.3367498,1,-2.979140918,0.863624648,-3.449578385,0.000561463,0.004603085,156.6449926,1,-1.53970867,0.599505596,-2.568297411,0.010219943,0.031976799,N,-,,vacuolar membrane pq loop repeat,P:regulation of induction of conjugation upon nitrogen starvation; C:integral component of membrane; P:negative regulation of cAMP biosynthetic process; C:plasma membrane; P:cellular response to nitrogen starvation,IPR006603 (SMART); IPR006603 (PFAM); PTHR16201:SF6 (PANTHER); PTHR16201 (PANTHER),2.A.43.2.7, the lysosomal cystine transporter (lct) family.
RL4_JR_06434,6503,5263,8559,2,0,4,0,0,0,2,1,3,0,2,0,0,2,0,99.92553314,1,1.66722205,0.496517331,3.357832542,0.000785562,0.004895809,6.40060982,0,0.787357465,1.236701145,0.636659445,0.524346695,0.673703636,56.2649516,1,0.971437872,0.741534041,1.310038135,0.190182935,0.313146092,28.73189722,1,-1.332820526,1.14271635,-1.166361649,0.243468257,0.381715099,16.26319826,1,-1.937314942,1.190115298,-1.627838029,0.103559234,0.196024911,N,-,,#NAME?,,IPR032710 (SUPERFAMILY),,
RL4_JR_06435,9169,10382,16696,5,4,0,0,0,0,0,0,0,8,6,3,0,2,7,3.558521095,1,0.066615397,1.252567574,0.053183076,0.95758604,0.978210232,1.130012783,0,3.289188857,1.402068879,2.34595383,0.018978458,0.05515359,10.7799387,0,1.596668067,1.209551851,1.320049294,0.186818561,0.308842441,3.388787793,1,0.212184547,1.231886777,0.172243546,0.863246064,0.915373674,2.897049081,1,0.551871146,1.224466902,0.450703195,0.652203479,0.752028268,N,-,,s1 p1 nuclease,F:nucleic acid binding; P:DNA catabolic process; P:nucleic acid phosphodiester bond hydrolysis; F:endonuclease activity,IPR003154 (PFAM); IPR008947 (G3DSA:1.10.575.GENE3D); PTHR33146 (PANTHER); IPR008947 (SUPERFAMILY),,
RL4_JR_06436,616,574,637,0,7,0,0,0,0,0,0,0,6,0,0,0,0,0,144.5146575,1,5.486843844,2.001929531,2.740777714,0.006129396,0.025603488,23.32953957,0,4.381351797,1.188448518,3.686614718,0.000227257,0.009505354,13.72397228,0,1.742801397,1.258604203,1.384709659,0.166141264,0.283072056,23.12109857,1,3.279763726,0.845565159,3.878782953,0.00010498,0.001109974,2.623663917,0,0.694845628,1.294313589,0.536844884,0.591374765,0.703025654,Y,-,,ribosomal s17,P:biological_process; C:ribosome; C:cellular_component; F:molecular_function,PTHR34587:SF2 (PANTHER); PTHR34587 (PANTHER),,
RL4_JR_06437,2935,2341,1845,0,0,7,0,0,0,0,0,0,0,5,0,0,0,0,1.076161923,1,1.791648521,1.466748594,1.221510304,0.221892867,NA,0.346785949,0,4.993480164,1.67206116,2.986421958,0.002822629,0.015349618,0.894682007,0,2.349495243,1.258266569,1.86724761,0.061867018,0.133485119,1.03170707,1,1.927727265,1.307165804,1.474738139,0.140282958,0.253274777,0.877664818,0,2.273827229,1.231487013,1.846407802,0.064833015,0.136985451,Y,-,,---NA---,,no IPS match,,
RL4_JR_06438,278,209,150,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.781346309,0,-0.3595666,1.253806571,-0.286779961,0.774280807,0.882697432,1.514567961,0,2.866601951,1.375520188,2.084012999,0.037158985,0.093643567,3.942294547,0,0.210032638,1.231416078,0.170561878,0.864568276,0.91375814,4.549225127,0,-0.212717802,1.236565408,-0.172023089,0.863419377,0.915373674,3.894026693,0,0.125133162,1.234812948,0.101337747,0.919282353,0.948317251,N,-,,molybdopterin synthase large subunit,C:cytosol; F:molybdopterin synthase activity; P:Mo-molybdopterin cofactor biosynthetic process; C:molybdopterin synthase complex,IPR003448 (G3DSA:3.90.1170.GENE3D); IPR003448 (PFAM); IPR003448 (PTHR23404:PANTHER); PTHR23404 (PANTHER); IPR003448 (SUPERFAMILY),,
RL4_JR_06439,10715,9251,14557,0,0,30,0,0,0,0,0,0,0,4,0,0,0,0,0.136420119,1,4.771511628,3.499292928,1.363564505,0.17270467,NA,0.043275128,0,7.99569181,2.469996122,3.237127273,0.001207395,0.015023052,0.112634767,0,5.339165577,1.434342129,3.722379388,0.000197354,0.001739686,0.129968688,1,4.916547305,2.097155151,2.344388923,0.019058286,0.075082357,0.1113383,0,5.255084208,1.281298419,4.101374145,4.11E-05,0.000327948,N,-,,Zinc 2-type,,IPR001876 (G3DSA:4.10.1060.GENE3D); IPR001876 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_06440,321,278,191,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,20.45188778,0,-0.060368516,1.027234027,-0.058768026,0.953136876,0.977110943,4.080210262,0,1.436896847,1.262084508,1.138510803,0.25490725,0.409888413,17.08758282,0,-0.253599058,1.198595745,-0.211580142,0.832434603,0.891617427,40.15326652,1,0.702657602,0.858180252,0.818776242,0.412914088,0.556580354,10.43141316,0,-1.296562719,1.203590874,-1.077245389,0.281370653,0.415106784,N,-,,cat eye syndrome critical region 5,F:hydrolase activity,PF13242 (PFAM); IPR006357 (PFAM); IPR006357 (TIGRFAM); IPR023214 (G3DSA:3.40.50.GENE3D); PTHR14269 (PANTHER); PTHR14269:SF18 (PANTHER); IPR023214 (SUPERFAMILY),,
RL4_JR_06441,8366,9127,12791,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,10.44534718,0,2.123554463,1.043871301,2.034306779,0.041920674,0.116799474,0.903880464,0,3.611449713,1.454191025,2.483476828,0.01301068,0.041205914,2.329576161,0,0.969266562,1.231352209,0.78715623,0.431190416,0.571757927,2.686442794,1,0.54739422,1.241333017,0.4409729,0.659232616,0.767651552,13.86075182,0,3.089893704,0.87022766,3.550672824,0.000384248,0.002163798,N,-,,Epidermal growth factor- type 3,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,G3DSA:2.170.300.10 (GENE3D); PTHR17178 (PANTHER); IPR000742 (PROSITE_PROFILES),,
RL4_JR_06442,442,574,458,0,0,6,0,0,0,0,0,0,0,7,0,0,1,2,153.6364551,1,-1.21255364,0.561975686,-2.157662101,0.030954113,0.092839577,54.94208703,0,-0.075184469,1.000385573,-0.075155491,0.940090997,0.967327546,112.9184907,0,-1.956824084,0.862256807,-2.26942144,0.02324271,0.062665564,141.1250197,1,-1.271292917,0.596192476,-2.132353172,0.032977824,0.097153424,141.4306334,1,-0.295747488,0.506218844,-0.584228525,0.559066573,0.677797219,N,-,,chitin synthase activator,,IPR006597 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR006597 (PFAM); PTHR11102:SF81 (PANTHER); PTHR11102 (PANTHER); SSF81901 (SUPERFAMILY),3.A.16.1.4, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_06443,1661,3990,2509,3,0,2,0,0,0,0,0,0,0,0,0,0,0,0,316.5442964,1,-0.262341771,0.430520144,-0.609360037,0.542285821,0.723618138,66.42078544,0,-1.450729113,1.106577642,-1.311005264,0.189855985,0.330932027,378.0679988,0,0.729424744,0.506011434,1.441518305,0.14943831,0.261387949,265.7813569,0,-0.659923237,0.41353375,-1.595814699,0.11053017,0.211499618,192.8775288,0,-1.113635833,0.659923351,-1.687523,0.091502831,0.17847547,N,-,,UPF0041 domain,C:integral component of membrane; P:mitochondrial pyruvate transport; C:mitochondrial inner membrane,IPR005336 (PFAM); PTHR14154:SF2 (PANTHER); PTHR14154 (PANTHER),2.A.105.1.12, the mitochondrial pyruvate carrier (mpc) family.
RL4_JR_06444,52,32,45,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,146.6879286,0,1.283629304,0.46124547,2.782963492,0.005386487,0.023091413,15.05780133,0,-0.44695925,1.204371587,-0.371114077,0.710552567,0.818065333,122.6729536,0,0.908846976,0.521761843,1.741880877,0.081529291,0.165212678,71.85228932,0,-0.79296532,0.748481079,-1.059432686,0.28940277,0.434104155,54.18413922,0,-0.59034641,0.768691517,-0.767988715,0.44249389,0.576015767,N,-, Effector probability:0.761,NADH-ubiquinone oxidoreductase kDa subunit,C:ribosome,IPR007741 (SMART); IPR007741 (PFAM); IPR016464 (PIRSF); IPR012336 (G3DSA:3.40.30.GENE3D); IPR016464 (PANTHER); IPR012336 (SUPERFAMILY),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_06445,2417,2177,3307,2,3,6,0,0,1,0,0,0,0,6,2,0,0,4,47.33164152,1,2.177674052,0.748183583,2.910614591,0.003607187,0.016663323,2.352696532,1,2.231275131,1.340936946,1.663967227,0.096118979,0.196469367,65.26174771,0,3.226017794,0.618744567,5.213811916,1.85E-07,6.02E-06,34.92047048,1,1.531732009,0.882270337,1.736125476,0.082541651,0.169786888,5.926767837,1,-0.481178829,1.218801028,-0.394796868,0.692992806,0.782224322,N,-,,hypothetical protein VFPPC_16116,F:oxidoreductase activity; C:mitochondrion; P:oxidation-reduction process,IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_06446,3244,2420,2907,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,44.10299481,0,0.271902231,0.773601699,0.351475742,0.725231468,0.85460265,6.477158605,0,0.770117965,1.242119408,0.620003166,0.535255703,0.683038102,98.89317479,1,2.485440418,0.500488819,4.966025861,6.83E-07,1.94E-05,81.11548869,1,1.731922756,0.525278918,3.297148805,0.000976717,0.007234282,24.42195563,1,-0.316211569,1.002705234,-0.315358451,0.75248951,0.827607679,N,-,,DUF1687 domain containing,F:oxidoreductase activity; C:mitochondrion; P:oxidation-reduction process,IPR012882 (PFAM); PTHR28071 (PANTHER); PTHR28071:SF1 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_06447,36790,32680,19600,2,5,1,0,0,0,2,3,0,0,1,1,0,0,0,27.50012503,1,0.1466758,0.945438539,0.155140491,0.876710561,0.939966455,5.205510341,0,1.085548402,1.31973526,0.822550125,0.410763871,0.574433808,21.19423591,1,-0.588052898,1.234821791,-0.476224912,0.633914154,0.74443184,15.39145362,1,-1.97118353,1.242576575,-1.58636785,0.112655889,0.21395992,13.00095159,0,-1.614375581,1.237336395,-1.304718416,0.191988748,0.31217056,N,-,,proteophosphoglycan ppg4,,no IPS match,,
RL4_JR_06448,2999,2941,1521,0,0,6,0,0,0,0,0,0,0,0,0,0,1,0,17.39777456,1,1.617308748,0.873809082,1.850871983,0.064187972,0.160153648,1.892106171,0,2.54545059,1.323787699,1.922854089,0.054498377,0.126372321,4.920700197,0,-0.110134154,1.210229596,-0.091002694,0.92749045,0.956881142,5.677170668,0,-0.532603955,1.210456319,-0.440002623,0.659935208,0.768292972,4.867485664,1,-0.196983153,1.21588156,-0.162008504,0.871299157,0.914876165,N,-,,#NAME?,,IPR014710 (G3DSA:2.60.120.GENE3D); PTHR40434 (PANTHER); IPR011051 (SUPERFAMILY),,
RL4_JR_06449,1402,1315,1498,2,0,5,0,0,0,0,0,0,5,5,0,0,5,0,19.99582922,1,-2.423989336,1.190476433,-2.036150628,0.041735232,0.116365787,6.423248177,0,0.782255914,1.242936356,0.629361198,0.529112615,0.677544297,16.59395924,0,-1.863573201,1.196255148,-1.557839232,0.119271363,0.220750143,19.13778935,1,-2.28551207,1.194569435,-1.913251756,0.055715831,0.130978125,31.73257099,1,0.669557621,0.751944499,0.890434895,0.373232412,0.509502248,N,-,,phospholipase c,P:single-organism process,IPR001192 (PRINTS); IPR001711 (SMART); IPR000909 (SMART); IPR001711 (PFAM); IPR000909 (PFAM); IPR017946 (G3DSA:3.20.20.GENE3D); IPR000008 (G3DSA:2.60.40.GENE3D); PTHR10336:SF82 (PANTHER); PTHR10336:SF82 (PANTHER); IPR001192 (PANTHER); PTHR10336:SF82 (PANTHER); IPR001192 (PANTHER); IPR000909 (PROSITE_PROFILES); IPR001711 (PROSITE_PROFILES); IPR017946 (SUPERFAMILY),,
RL4_JR_06450,2272,2048,3042,1,7,5,0,0,0,1,2,0,0,6,5,0,3,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_06451,327,190,299,0,0,120,0,0,0,0,0,0,0,5,2,0,3,0,4.838860659,1,-0.376761088,1.265468828,-0.297724511,0.765913435,0.877722899,1.536737703,0,2.845690696,1.39028057,2.046846339,0.040673174,0.100462145,15.06003066,0,1.154635081,1.223455264,0.943749326,0.345297761,0.489038171,4.603795422,1,-0.229829376,1.246079424,-0.184441996,0.853666727,0.908299245,3.928361365,1,0.112463534,1.240307603,0.090673905,0.927751706,0.953072851,N,-, Effector probability:0.675,hypothetical protein CMQ_4921,F:metal ion binding,no IPS match,,
RL4_JR_06452,373,294,160,4,8,0,0,0,0,0,0,0,0,0,0,0,0,0,8.99104002,1,3.182391335,1.02780946,3.096285314,0.001959617,0.010300616,0.430656959,0,4.680824037,1.580583327,2.961453507,0.003061907,0.015724315,1.12006937,0,2.025000073,1.232707084,1.642726078,0.100439621,0.194571065,1.292310145,0,1.60261251,1.261436026,1.270466736,0.203918424,0.335575281,1.107397343,0,1.939186102,1.221595435,1.587420881,0.112417353,0.208542635,N,-,,high-affinity methionine permease,C:membrane,IPR002293 (PFAM); PTHR11785:SF203 (PANTHER); IPR002293 (PANTHER); PTHR11785:SF203 (PANTHER); IPR002293 (PANTHER),2.A.3.8.4, the amino acid-polyamine-organocation (apc) family.
RL4_JR_06453,33,18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein VP1G_10767,,no IPS match,,
RL4_JR_06454,967,703,873,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,9.16866605,0,0.423346763,1.176088285,0.359961721,0.71887576,0.849940355,1.694318866,0,2.704687555,1.346805333,2.008224565,0.044619434,0.107866708,4.421923884,0,0.044039762,1.222777895,0.036016158,0.971269475,0.983313217,5.102874835,1,-0.378735284,1.2257408,-0.308984807,0.757333084,0.841435035,4.3894931,0,-0.047796096,1.231905642,-0.038798504,0.969051037,0.979752074,N,-,,"D-arabinono-1,4-lactone oxidase","C:integral component of mitochondrial outer membrane; F:D-arabinono-1,4-lactone oxidase activity; P:dehydro-D-arabinono-1,4-lactone biosynthetic process; F:flavin adenine dinucleotide binding; P:cellular response to oxidative stress; P:oxidation-reduction process",IPR016167 (G3DSA:3.30.43.GENE3D); IPR016169 (G3DSA:3.30.465.GENE3D); IPR030654 (TIGRFAM); IPR010031 (PIRSF); IPR006094 (PFAM); IPR007173 (PFAM); PTHR13878:SF63 (PANTHER); PTHR13878 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY),,
RL4_JR_06455,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.673924744,0,-1.376283954,1.203206226,-1.143847102,0.252687052,0.430179668,3.106752939,0,1.830191015,1.292317004,1.416209034,0.156714312,0.28601916,8.019588808,0,-0.814381995,1.205351134,-0.675638801,0.49927,0.632142257,17.27216042,0,0.484012658,1.029649246,0.470075281,0.638301234,0.752275637,19.44096022,0,1.311513883,0.854131664,1.53549381,0.124662576,0.225414457,N,-,,rad21 rec8 n terminal domain containing,"P:attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation; C:nuclear meiotic cohesin complex; C:nuclear pericentric heterochromatin; C:horsetail nucleus; P:meiotic sister chromatid cohesion involved in meiosis I; C:condensed nuclear chromosome inner kinetochore; P:synapsis; P:meiotic sister chromatid cohesion, centromeric",IPR006910 (PFAM); PTHR12585 (PANTHER); PTHR12585:SF28 (PANTHER),,
RL4_JR_06456,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,75.85043764,0,0.223001505,0.597530559,0.373205189,0.708995734,0.843023933,11.62935022,0,-0.074223736,1.212104575,-0.061235423,0.95117172,0.973779725,63.4830035,0,-0.308360083,0.855491467,-0.360447877,0.718512229,0.809604225,52.58931822,0,-0.842253963,0.8605033,-0.978792252,0.327682639,0.47451183,33.8102456,0,-1.888833609,1.133175432,-1.666850123,0.095544211,0.184444829,N,-,,signal recognition particle receptor subunit alpha,F:GTP binding; C:nucleus; P:SRP-dependent cotranslational protein targeting to membrane; F:GTPase activity; C:cytosol; C:signal recognition particle receptor complex; F:signal recognition particle binding,IPR013822 (SMART); IPR003593 (SMART); IPR000897 (SMART); IPR007222 (PFAM); IPR013822 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.20.120.140 (GENE3D); IPR000897 (PFAM); PTHR11564 (PANTHER); PTHR11564:SF16 (PANTHER); IPR013822 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011012 (SUPERFAMILY),3.A.5.8.1, the general secretory pathway (sec) family.
RL4_JR_06457,55,51,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,58.82188511,0,-1.920805855,1.033035497,-1.859380303,0.062973252,0.158125859,14.90902061,0,-0.432651449,1.216318217,-0.355705804,0.722060898,0.825935181,38.86325921,0,-3.091398969,1.20324682,-2.569214328,0.010192939,0.033191804,70.20322324,0,-0.486371693,0.703516644,-0.691343548,0.489349671,0.629460485,42.39083408,0,-2.253101667,1.143715882,-1.96998372,0.048840236,0.109964935,N,-,,er to golgi transport yif1,C:integral component of Golgi membrane; C:ER to Golgi transport vesicle,PF03878 (PFAM); PTHR14083:SF0 (PANTHER); IPR005578 (PANTHER),9.B.135.2.5, the membrane trafficking yip (yip) family.
RL4_JR_06458,849,704,1125,0,4,0,0,0,0,0,0,2,0,0,0,0,0,0,44.71982746,1,2.510070584,0.563323662,4.455823096,8.36E-06,9.92E-05,2.410632149,0,2.196093962,1.287890419,1.70518697,0.088159559,0.183649117,6.254318332,1,-0.455986614,1.19522584,-0.381506657,0.702827333,0.798241596,7.214999415,0,-0.878321722,1.192644227,-0.736449062,0.461457456,0.603728743,6.167668703,0,-0.53851884,1.197403982,-0.449738641,0.652898905,0.752441233,Y,-,,integral membrane Mpv17 PMP22 family,C:membrane; C:integral component of membrane,IPR007248 (PFAM); PTHR11266:SF36 (PANTHER); IPR007248 (PANTHER),,
RL4_JR_06459,214,267,307,0,0,6,0,0,0,0,0,0,0,3,1,0,0,0,187.9347512,1,-2.436292122,0.746458184,-3.263802547,0.001099277,0.006351208,52.61340024,0,-2.251831727,1.229955679,-1.830823472,0.067126896,0.148645469,135.3711376,0,-4.891786807,1.219400852,-4.011631449,6.03E-05,0.000836278,156.0767226,1,-5.313290725,1.223060362,-4.344258786,1.40E-05,0.000191207,151.3731057,0,-2.361999777,0.801828709,-2.945766036,0.00322156,0.012540674,N,-,,histidine kinase m1nbp,P:regulation of cellular process; P:cellular process,IPR004358 (PRINTS); IPR000014 (SMART); IPR003661 (SMART); IPR003594 (SMART); IPR001789 (SMART); IPR003661 (G3DSA:1.10.287.GENE3D); IPR003661 (PFAM); IPR000014 (TIGRFAM); IPR003594 (PFAM); G3DSA:3.40.50.2300 (GENE3D); IPR003594 (G3DSA:3.30.565.GENE3D); IPR000014 (PFAM); IPR001789 (PFAM); G3DSA:3.30.450.20 (GENE3D); PTHR24423 (PANTHER); PTHR24423 (PANTHER); PTHR24423:SF465 (PANTHER); PTHR24423:SF465 (PANTHER); IPR000700 (PROSITE_PROFILES); IPR005467 (PROSITE_PROFILES); IPR001789 (PROSITE_PROFILES); IPR011006 (SUPERFAMILY); IPR000014 (SUPERFAMILY); IPR000014 (SUPERFAMILY); IPR003661 (SUPERFAMILY); IPR003594 (SUPERFAMILY),9.B.259.2.2,The Uncharacterized Archaeal/Bacterial Protein-9 (UABP1) Family
RL4_JR_06460,71,60,58,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46.83399735,0,2.208366726,0.66773843,3.307233231,0.000942224,0.005677391,2.171846686,0,2.346656199,1.306479254,1.796167977,0.072467806,0.157779981,27.75876924,0,1.529186887,1.0308394,1.483438533,0.137957936,0.246459528,10.49258542,0,0.223852136,1.146089118,0.195318263,0.845143801,0.903026697,5.520375326,0,-0.378525819,1.194799856,-0.316811069,0.751386965,0.827057386,N,PKS,,polyketide synthase,F:catalytic activity; P:metabolic process,IPR020841 (SMART); IPR020806 (SMART); SM00822 (SMART); IPR020807 (SMART); IPR020801 (SMART); IPR020843 (SMART); IPR013968 (PFAM); G3DSA:3.30.70.250 (GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR032821 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR014031 (PFAM); IPR020807 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR013149 (PFAM); IPR014030 (PFAM); IPR014043 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR001227 (G3DSA:3.40.366.GENE3D); PTHR11712 (PANTHER); PTHR11712:SF262 (PANTHER); PTHR11712 (PANTHER); PTHR11712:SF262 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR011032 (SUPERFAMILY); IPR016036 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR016035 (SUPERFAMILY),,
RL4_JR_06461,4,10,7,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,2.417068159,1,0.624516533,1.245419224,0.501450854,0.616053858,0.77932821,0.775112267,0,3.833123812,1.455020448,2.634412332,0.008428307,0.029611704,2.003547725,0,1.186680725,1.216423569,0.975548941,0.329288037,0.472330985,2.310839755,0,0.764591595,1.22444109,0.624441307,0.532337805,0.665392775,1.966998143,0,1.110149316,1.203808785,0.922197388,0.356425626,0.493816292,N,-,,multidrug transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF43 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_06462,1,7,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,193.4344933,0,-1.142369117,0.53556529,-2.133015599,0.032923447,0.097315028,45.4423919,0,-2.040476522,1.197549493,-1.70387657,0.088404149,0.18393151,164.5294694,0,-1.542675548,0.682218242,-2.261263995,0.023742914,0.063830793,158.1949489,0,-2.401652298,0.76091096,-3.156285589,0.001597923,0.010976236,144.1723021,0,-1.431962047,0.650628158,-2.200891598,0.027743699,0.070774742,N,-,,phosphoribosylaminoimidazole-succinocarboxamide synthase,C:nucleus; F:ATP binding; P:adenine biosynthetic process; F:phosphoribosylaminoimidazole carboxylase activity; C:cytoplasm; F:phosphoribosylaminoimidazolesuccinocarboxamide synthase activity; P:'de novo' IMP biosynthetic process,G3DSA:3.30.200.20 (GENE3D); IPR028923 (PFAM); IPR001636 (TIGRFAM); IPR013816 (G3DSA:3.30.470.GENE3D); PTHR11609:SF1 (PANTHER); PTHR11609 (PANTHER); PTHR11609:SF1 (PANTHER); PTHR11609 (PANTHER); SSF56104 (SUPERFAMILY),,
RL4_JR_06463,32,25,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.92997281,0,-0.403763165,1.22387313,-0.329906062,0.741470943,0.864165305,1.564969618,0,2.819360545,1.345386606,2.095576493,0.036119776,0.091515488,15.14084622,0,1.125471787,1.201488531,0.936731194,0.348896846,0.4926404,4.697204035,0,-0.258958292,1.214369216,-0.213245106,0.831135788,0.894259752,4.021155713,0,0.078775748,1.215805725,0.064793039,0.948338784,0.96649782,Y,-,,aspartic-type endopeptidase,P:protein metabolic process; P:mycelium development; C:membrane; F:peptidase activity,IPR001461 (PRINTS); IPR033121 (PFAM); IPR021109 (G3DSA:2.40.70.GENE3D); IPR021109 (G3DSA:2.40.70.GENE3D); IPR001461 (PANTHER); PTHR13683:SF231 (PANTHER); IPR033121 (PROSITE_PROFILES); IPR021109 (SUPERFAMILY),8.A.32.1.4,The β-Amyloid Cleaving Enzyme (BACE1) Family
RL4_JR_06464,251,246,164,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41.45277501,0,0.435922654,0.686170456,0.635297906,0.525234139,0.709179097,7.12185005,0,0.633220142,1.229108885,0.515186368,0.606422794,0.739669842,26.35638021,0,-1.059823051,1.195038405,-0.886852713,0.375158203,0.518866346,77.52146584,0,1.554711746,1.385587355,1.12205971,0.261837053,0.402169321,33.03190002,0,-0.416023857,0.981396906,-0.423909892,0.671631529,0.766394835,N,-,,g-patch domain containing,F:binding,IPR000467 (SMART); IPR000467 (PFAM); PTHR13948:SF3 (PANTHER); PTHR13948 (PANTHER); IPR000467 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES),,
RL4_JR_06465,14,15,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,164.2479486,0,0.664891031,0.428829946,1.550477145,0.121027035,0.254010432,99.22441355,0,0.637576209,0.978271903,0.651737218,0.514570709,0.665261188,58.58516449,0,-3.683509923,1.192970959,-3.087677781,0.002017271,0.009899587,160.0704368,0,0.24087565,0.464013154,0.519113839,0.603681358,0.724718254,72.59954151,0,-2.078860211,0.977745797,-2.126176576,0.03348856,0.081960761,N,-,,ectonucleotide pyrophosphatase phosphodiesterase 1,C:membrane,IPR017849 (G3DSA:3.40.720.GENE3D); IPR002591 (PFAM); IPR024873 (PANTHER); IPR017850 (SUPERFAMILY),,
RL4_JR_06466,45,32,35,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.29974651,0,1.455011716,0.74168743,1.96175863,0.049790592,0.132309984,2.910967063,0,1.923975698,1.272718761,1.511705301,0.130608849,0.248127398,7.568093577,0,-0.731081213,1.197104878,-0.610707739,0.541393082,0.669483762,8.731759054,0,-1.153597656,1.195277468,-0.965129593,0.334479906,0.481302288,7.47847349,0,-0.816486081,1.202882736,-0.678774461,0.497280778,0.625151214,N,-,,---NA---,,no IPS match,,
RL4_JR_06467,57,53,68,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,85.96548083,0,-3.51848362,1.198570583,-2.935566474,0.003329393,0.015654862,35.31959648,0,-0.317037193,1.147323686,-0.276327593,0.782296464,0.868531843,67.87881431,0,-3.895927823,1.226277214,-3.177036789,0.001487882,0.007849564,106.2784052,0,-1.930302293,0.910662626,-2.119667854,0.034034066,0.0989162,74.96710122,0,-3.049177857,1.170659365,-2.604667034,0.009196358,0.029373226,N,-,,hypothetical protein F503_01823,,no IPS match,,
RL4_JR_06468,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,134.1031446,0,-0.152876759,0.644047411,-0.237368797,0.812370694,0.904630102,25.12870064,0,-1.185715012,1.221929589,-0.970362795,0.331865687,0.495083932,72.66387742,0,-2.867578059,1.205587804,-2.378572552,0.017379816,0.050214972,100.1149139,0,-1.225544011,0.708200848,-1.730503451,0.083540365,0.171223927,101.7053597,0,-0.165768575,0.567881996,-0.291906727,0.77035794,0.840866121,N,-,,kinase rad3,C:nucleus; F:ATP binding; P:positive regulation of response to DNA damage stimulus; P:mitotic DNA damage checkpoint; P:histone phosphorylation; C:cytoplasmic part; F:protein serine/threonine kinase activity; P:DNA metabolic process; C:intracellular organelle part; P:regulation of cell cycle process,IPR003152 (SMART); IPR000403 (SMART); IPR012993 (SMART); G3DSA:3.30.1010.10 (GENE3D); IPR003151 (PFAM); IPR003152 (PFAM); IPR000403 (G3DSA:1.10.1070.GENE3D); IPR011989 (G3DSA:1.25.10.GENE3D); IPR012993 (PFAM); IPR000403 (PFAM); PTHR11139 (PANTHER); PTHR11139:SF69 (PANTHER); PTHR11139 (PANTHER); PTHR11139:SF69 (PANTHER); IPR000403 (PROSITE_PROFILES); IPR003152 (PROSITE_PROFILES); IPR014009 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR011009 (SUPERFAMILY),,
RL4_JR_06469,5,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29.77828808,0,-2.998551063,1.251427553,-2.396104398,0.01657037,0.056513829,9.364402839,0,0.238253052,1.268749868,0.187785676,0.851044665,0.911496572,83.05148232,0,1.320492855,1.568309247,0.841984996,0.399796352,0.54191167,37.9891062,0,-1.897116896,1.19451138,-1.588194912,0.112242271,0.213378332,39.95653487,0,0.009706788,0.874761103,0.011096501,0.991146455,0.993993448,N,-,,cytochrome c oxidase-assembly factor mitochondrial,P:mitochondrial respiratory chain complex IV assembly; C:integral component of membrane; C:mitochondrial inner membrane,IPR020164 (PFAM); PTHR17130 (PANTHER); IPR020164 (PRODOM),3.D.4.11.1, the proton-translocating cytochrome oxidase (cox) superfamily.
RL4_JR_06470,36,46,57,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,116.3299351,0,-1.394759568,0.668091589,-2.087677185,0.036826964,0.106085584,29.66369466,0,-1.42512143,1.199942048,-1.187658548,0.234967961,0.385406855,124.0000365,0,-0.46796648,0.592337879,-0.790033014,0.429508488,0.570050332,161.1005912,0,-0.017487073,0.464998755,-0.03760671,0.970001258,0.983306241,106.7692714,0,-0.773015822,0.615797223,-1.255309042,0.209366594,0.332540729,N,-,,choline kinase,"C:nucleus; C:membrane; C:integral component of membrane; P:phosphorylation; F:phosphotransferase activity, alcohol group as acceptor; F:kinase activity",PF01633 (PFAM); G3DSA:3.90.1200.10 (GENE3D); IPR007521 (PFAM); G3DSA:3.10.450.110 (GENE3D); PTHR22603 (PANTHER); PTHR22603:SF33 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_06471,3,13,8,0,2,2,0,0,0,0,0,0,0,0,3,0,0,2,2.659288241,1,0.4864059,1.239266938,0.392494857,0.69469261,0.83514623,0.850742861,0,3.698706067,1.435127328,2.577266835,0.009958504,0.033466129,2.205170104,0,1.047853188,1.216471478,0.861387387,0.38902472,0.53273181,2.54367346,1,0.625689637,1.223421188,0.51142619,0.60905266,0.72917798,2.173515531,1,0.966016832,1.211223759,0.797554395,0.425129125,0.560108314,N,-,,---NA---,,no IPS match,,
RL4_JR_06472,1493,1522,1210,0,0,2,0,0,0,0,0,0,2,7,1,0,3,0,0.027342103,1,7.088722786,3.945562112,1.796631908,0.072394075,NA,0.009348662,0,10.20877207,3.943144561,2.588992596,0.009625716,0.032783143,0.02331516,0,7.611672831,3.805304019,2.000279818,0.045470057,0.105172232,0.026820242,1,7.193265127,3.944592199,1.823576371,0.068216142,0.148241862,0.022154035,1,7.576122001,2.314867151,3.272810709,0.001064838,0.005021542,N,-,,hypothetical protein SPI_04504,,no IPS match,,
RL4_JR_06473,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.04032593,0,6.530017453,3.933146892,1.660252625,0.096863642,NA,0.013036867,0,9.728038599,3.151895535,3.086408953,0.0020259,0.015023052,0.033475425,0,7.092559832,1.799785132,3.940781434,8.12E-05,0.001023837,0.038596023,0,6.668662104,3.376402301,1.975079244,0.048259156,0.120173132,0.032599685,0,7.024343688,1.377280562,5.100154523,3.39E-07,5.73E-06,N,-,,hypothetical protein CMQ_4920,,no IPS match,,
RL4_JR_06474,140,147,91,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1042.614624,1,6.319727761,0.941360423,6.713398614,1.90E-11,7.57E-10,13.53000674,0,2.327657256,1.131039101,2.057981243,0.039591934,0.09822293,330.6628782,0,4.871050354,0.315714043,15.42867816,1.05E-53,7.09E-51,443.7360989,1,5.182883173,0.493271713,10.50715667,8.01E-26,1.04E-23,459.2621849,0,5.476451154,0.699452616,7.829624242,4.89E-15,7.18E-13,N,-, Effector probability:0.681,woronin body major,P:positive regulation of translational termination; F:translation elongation factor activity; F:ribosome binding; P:translational frameshifting; P:positive regulation of translational elongation,IPR014722 (G3DSA:2.30.30.GENE3D); G3DSA:2.40.50.140 (GENE3D); IPR001884 (PANTHER); PTHR11673:SF12 (PANTHER); IPR012340 (SUPERFAMILY); IPR008991 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_06475,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.69487948,0,4.101385089,0.751436807,5.45805722,4.81E-08,1.02E-06,0.453365373,0,4.606727268,1.567707351,2.938512258,0.003297916,0.016307527,1.17681352,0,1.953750627,1.228780012,1.589992193,0.111836565,0.210726481,1.357597169,0,1.531524941,1.25388705,1.221421771,0.221926368,0.357224782,1.161374924,0,1.870309894,1.216213889,1.5378133,0.124094271,0.224628113,,,,,,,,
RL4_JR_06476,120,51,62,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.138046111,0,4.754140164,3.563101672,1.334270139,0.18211534,NA,0.044747228,0,7.947575245,2.548445081,3.118597809,0.001817138,0.015023052,0.115273391,0,5.304762467,1.542969132,3.438022418,0.000585979,0.003800418,0.132898704,0,4.884034874,2.207104555,2.212869736,0.026906628,0.087153604,0.113153016,0,5.226681837,1.355733794,3.85524198,0.000115615,0.000782489,N,-,,---NA---,,no IPS match,,
RL4_JR_06477,12091,4962,7505,0,6,10,0,0,0,0,0,0,0,3,0,0,0,0,38.86030842,1,1.817255584,0.563859402,3.222887794,0.001269053,0.007131936,3.884757024,0,1.507720039,1.257724531,1.198768094,0.230618132,0.380677875,16.55493907,0,-0.179233635,1.190286672,-0.150580225,0.880306862,0.925368775,24.92314806,1,0.171021036,1.011101129,0.169143354,0.865683885,0.916519181,17.25825414,0,-0.286485538,1.118995383,-0.256020304,0.797935159,0.863427753,N,-,,hypothetical protein ACRE_065570,,PTHR13856:SF91 (PANTHER); PTHR13856 (PANTHER); PTHR13856 (PANTHER); PTHR13856 (PANTHER); PTHR13856:SF91 (PANTHER),,
RL4_JR_06478,8349,10307,10490,0,3,12,2,0,0,2,4,1,0,3,0,0,1,0,0.174310258,1,4.417719914,3.179562466,1.389411267,0.164707726,NA,0.055439229,1,7.638026038,2.3787641,3.210922023,0.001323098,0.015023052,0.14446283,1,4.978361979,1.430010846,3.481345608,0.000498901,0.003378513,0.166681635,1,4.557116566,1.962016114,2.322670305,0.020196871,0.077185792,0.14334195,1,4.887970915,1.298837063,3.76334419,0.000167656,0.0010737,N,-,,hypothetical protein CMQ_4924,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_06479,633,386,401,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,75.66434209,0,0.33008538,0.575820108,0.573243928,0.566479545,0.743339252,11.01879611,0,0.003654982,1.223941611,0.002986239,0.997617329,0.998987768,41.46682033,0,-0.82335812,1.036682906,-0.794223688,0.427065221,0.567632697,42.46907406,0,-2.114345432,1.146300195,-1.844495395,0.065110976,0.143899171,27.95337408,0,-2.718777006,1.192168791,-2.280530262,0.022576258,0.06013802,Y,-,,pH signal transduction,C:cell tip; C:integral component of membrane; C:plasma membrane,IPR009571 (PFAM); PTHR28013 (PANTHER); PTHR28013:SF3 (PANTHER),,
RL4_JR_06480,226,305,251,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,554.3675512,0,0.984472327,0.510564515,1.928203583,0.053829809,0.14066098,102.5448759,0,-0.280487258,0.852328918,-0.329083353,0.742092686,0.840866693,206.543916,0,-1.970143345,0.667796717,-2.95021418,0.003175537,0.014106686,306.8098467,0,-0.30514568,0.383969189,-0.794713972,0.426779903,0.569471075,384.0728083,0,0.680190492,0.685485736,0.992275194,0.321063301,0.456632381,N,-,,coatamer subunit,"P:ER to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to ER; F:structural molecule activity; C:cytosol; C:Golgi membrane; P:intracellular protein transport; C:COPI vesicle coat",IPR017106 (PIRSF); IPR015873 (G3DSA:3.30.310.GENE3D); IPR011989 (G3DSA:1.25.10.GENE3D); IPR032154 (PFAM); IPR013040 (G3DSA:2.60.40.GENE3D); IPR013040 (PFAM); IPR002553 (PFAM); IPR017106 (PANTHER); IPR009028 (SUPERFAMILY); IPR013041 (SUPERFAMILY); IPR016024 (SUPERFAMILY),9.B.278.1.1, the organellar-targeting adaptor protein complex (o-apc) family.
RL4_JR_06481,125,132,124,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,228.3502267,0,-0.515774762,0.728467971,-0.708026684,0.478928687,0.667929386,41.61853519,0,-1.91362036,1.227871971,-1.558485253,0.119118261,0.232180828,135.741822,0,-1.739579834,0.781464844,-2.226050024,0.026010831,0.06864798,170.1427537,1,-1.129235425,0.589595508,-1.915271419,0.055457899,0.13064477,171.2716431,0,-0.598268724,0.613936216,-0.97448026,0.329818136,0.466528167,N,-,,ribosomal l24e,C:ribosome,PTHR22949 (PANTHER),,
RL4_JR_06482,5,4,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,165.1123086,0,0.052277287,0.444325226,0.117655456,0.906340663,0.954424568,27.92094539,0,-1.33774997,1.209154808,-1.106351281,0.268574504,0.425823832,138.6153914,0,-0.204057637,1.642704339,-0.12422055,0.901140652,0.938981881,99.31135606,0,-1.703792761,0.765038622,-2.227067643,0.025942753,0.086008637,126.7526485,0,-0.248098344,0.54073749,-0.458814764,0.646367191,0.747255973,N,-,,serologically defined colon cancer antigen 1,P:cellular protein metabolic process; C:macromolecular complex; C:cytoplasmic part,IPR021846 (PFAM); G3DSA:2.30.310.10 (GENE3D); IPR008532 (PFAM); PF05833 (PFAM); PTHR15239:SF6 (PANTHER); PTHR15239 (PANTHER),,
RL4_JR_06483,106,128,78,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,458.4328131,0,-2.198312131,0.654418005,-3.359186505,0.000781723,0.004883075,125.6655557,0,-3.50792238,1.222242132,-2.870071557,0.004103789,0.018371529,402.9575425,0,-2.005402501,0.543897908,-3.687093611,0.00022683,0.001909987,405.0382003,0,-2.968165222,0.6646449,-4.465791012,7.98E-06,0.000117059,334.943308,0,-3.990206427,0.879594522,-4.536415731,5.72E-06,6.36E-05,N,-,,zinc finger dhhc domain containing,,PTHR42081 (PANTHER); PTHR42081:SF1 (PANTHER); PTHR42081 (PANTHER); PTHR42081:SF1 (PANTHER),1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_06484,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,147.358518,0,-2.295647441,0.793967099,-2.891363437,0.003835743,0.017488906,38.66742656,0,-1.807555318,1.215549777,-1.487026984,0.137007684,0.257480836,100.7390599,0,-4.46551029,1.212594652,-3.682607606,0.00023086,0.001934793,154.7762336,0,-1.755863899,1.388990427,-1.26412959,0.206183518,0.338238515,119.1883667,0,-1.6836376,0.763697856,-2.204585998,0.027483159,0.070376072,N,-,,abc1 family,C:integral component of membrane; P:phosphorylation; F:kinase activity,IPR004147 (PFAM); PTHR10566 (PANTHER); PTHR10566:SF59 (PANTHER); PTHR10566:SF59 (PANTHER); PTHR10566:SF59 (PANTHER); PTHR10566 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_06485,0,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22.91160348,0,0.887617795,1.061725531,0.836014365,0.403146822,0.595163187,2.183554224,0,2.338710942,1.351677291,1.730228774,0.083589409,0.175975874,61.09746183,0,3.112039599,0.674812156,4.61171242,3.99E-06,8.66E-05,10.59256697,0,0.198407818,1.190690825,0.166632525,0.8676592,0.918169879,5.670543912,0,-0.417283541,1.252256071,-0.333225409,0.73896414,0.817527525,N,-,,hypothetical protein F503_06190,C:membrane,PTHR39136 (PANTHER); PTHR39136 (PANTHER); PTHR39136:SF1 (PANTHER); PTHR39136:SF1 (PANTHER),,
RL4_JR_06486,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,150.8277142,0,-1.232384934,0.597319079,-2.063193657,0.039094233,0.110922399,33.17798099,0,-1.586617457,1.210136607,-1.311106075,0.189821929,0.330929652,98.63204087,0,-2.413311465,1.041448913,-2.317263415,0.020489387,0.056645154,221.2493188,0,0.213150725,0.618325451,0.344722548,0.730302965,0.820132822,99.07626976,0,-2.093987742,0.847722233,-2.470134274,0.013506235,0.039915535,N,-,,myosin class ii heavy chain,P:biological_process; C:cellular_component,PTHR31313 (PANTHER); PTHR31313:SF31 (PANTHER),,
RL4_JR_06487,20,3,27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.41833492,0,2.820932557,0.665383071,4.23956166,2.24E-05,0.000230396,1.384729784,0,2.995928037,1.354391441,2.212010463,0.026965942,0.072670198,3.586281261,0,0.346414088,1.203650947,0.287802779,0.77349771,0.848601085,8.148246881,0,0.871166829,1.14732449,0.759302915,0.447671374,0.589807764,3.530478201,0,0.266236737,1.20032017,0.221804768,0.824465868,0.882165837,Y,-,,neurofilament medium polypeptide,,no IPS match,,
RL4_JR_06488,387,421,429,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,305.395202,0,-0.660362007,0.446938807,-1.477522196,0.139535713,0.281347589,65.73811309,0,-1.434173471,1.117427515,-1.283459958,0.199330979,0.342900777,273.6237137,0,-0.038412861,0.426266336,-0.090114696,0.928196071,0.957027907,343.6028115,0,-0.087377089,0.412737841,-0.211701183,0.832340165,0.894918145,185.3676255,0,-1.320528752,0.551451589,-2.394641305,0.016636632,0.047183724,Y,-,,cell wall,C:integral component of membrane,IPR007567 (PFAM),1.C.105.2.5, the bacillus thuringiensis vegetative insecticidal protein-3 (vip3) family.
RL4_JR_06489,1012,645,829,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.48906504,0,-2.14581543,1.219329335,-1.759832531,0.078436206,0.185473207,5.213064353,0,1.083298011,1.26027609,0.859571977,0.390025028,0.554548859,13.61593846,0,-1.57834092,1.213794424,-1.300336275,0.193485741,0.317479682,23.73694617,0,-0.288179066,1.046350305,-0.275413563,0.782998525,0.860321222,13.52255474,0,-1.671053793,1.226385694,-1.362584219,0.173013585,0.288355975,N,-,,cbp4 domain containing,P:mitochondrial respiratory chain complex III assembly; C:integral component of mitochondrial membrane,IPR012420 (PFAM); PTHR28202:SF1 (PANTHER); PTHR28202 (PANTHER),,
RL4_JR_06490,23862,756,6756,0,0,1,0,0,0,0,0,0,0,3,1,0,0,4,150.387882,1,-0.60858352,0.643750008,-0.945372447,0.344468764,0.534355614,39.62293706,0,-0.538056302,1.14179974,-0.471235264,0.637472739,0.763317547,105.1585272,0,-1.322120479,0.80491895,-1.642551066,0.100475852,0.194571065,186.0733424,1,0.233875143,0.553616424,0.422449791,0.672696741,0.777330003,116.3684382,1,-0.801980604,0.678065623,-1.182747772,0.236909125,0.365823531,N,-,,phosphoserine phosphatase,F:phosphoserine phosphatase activity; P:L-serine biosynthetic process; P:dephosphorylation,TIGR00338 (TIGRFAM); IPR006383 (TIGRFAM); IPR023214 (G3DSA:3.40.50.GENE3D); PF12710 (PFAM); IPR023190 (G3DSA:1.10.150.GENE3D); PTHR10000:SF7 (PANTHER); PTHR10000 (PANTHER); IPR023214 (SUPERFAMILY),,
RL4_JR_06491,506,582,340,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,470.586628,1,-0.488688998,0.393284593,-1.242583632,0.214021305,0.382388481,162.1752461,0,-0.086087388,0.693476971,-0.124138785,0.90120539,0.944583723,282.6352449,0,-2.2663338,0.640450957,-3.538653157,0.000402174,0.002891767,386.5355895,1,-0.981934324,0.549985616,-1.785381826,0.074199405,0.157333816,279.8739929,0,-1.985697625,0.585561434,-3.391100419,0.000696126,0.003572364,N,-,,nascent polypeptide-associated complex subunit beta,"P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; C:intracellular part; P:transport",IPR002715 (SMART); IPR002715 (PFAM); PTHR10351 (PANTHER); IPR002715 (PROSITE_PROFILES),,
RL4_JR_06492,68,90,133,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,32.3794602,0,-3.119369865,1.280992893,-2.435118792,0.014886902,0.052190521,10.15522853,0,0.121293349,1.293873766,0.093744345,0.925312243,0.958747657,26.70658972,0,-2.550192282,1.257494725,-2.027994417,0.042560818,0.10020095,48.16748399,1,-0.679427944,0.960998604,-0.707002009,0.479565229,0.620048263,26.74281679,0,-2.65485849,1.279635798,-2.074698515,0.038014485,0.090415001,N,-,,tRNA-specific adenosine deaminase 1,P:RNA processing; F:adenosine deaminase activity,IPR002466 (SMART); IPR002466 (PFAM); PTHR10910 (PANTHER); IPR002466 (PROSITE_PROFILES),,
RL4_JR_06493,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,620.9754033,0,-0.520342356,0.588055149,-0.884852987,0.376235927,0.567659088,237.0149766,0,-0.003407651,0.588853085,-0.00578693,0.995382724,0.997829394,346.4703777,0,-2.955748959,0.681308414,-4.338342078,1.44E-05,0.000257242,558.674274,0,-0.696744465,0.479818744,-1.452099304,0.146473995,0.261376313,345.7619452,0,-2.592329383,0.595797897,-4.351021371,1.36E-05,0.000129923,N,-,,60S ribosomal L24,C:ribosome,IPR000988 (PFAM); IPR000988 (G3DSA:2.30.170.GENE3D); IPR000988 (PANTHER); PTHR10792:SF1 (PANTHER); SSF57716 (SUPERFAMILY),,
RL4_JR_06494,14,32,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,234.5757164,0,0.809154005,0.631790078,1.280732372,0.200287685,0.363826973,25.8166219,0,-1.224753809,1.207607523,-1.014198558,0.310488016,0.472311347,152.2216525,0,0.280676659,0.551889398,0.508574109,0.611050781,0.726856786,108.3651074,0,-1.260513845,0.700517046,-1.799404958,0.071954646,0.154221166,115.9091819,0,-0.07170192,0.563085911,-0.127337442,0.898673327,0.934447736,N,-,,cdp-alcohol phosphatidyltransferase,"C:integral component of membrane; F:phosphotransferase activity, for other substituted phosphate groups; P:phospholipid biosynthetic process",IPR000462 (PFAM); IPR014472 (PANTHER); PTHR10414:SF37 (PANTHER),4.F.1.1.2, the choline/ethanolaminephosphotransferase 1 (cept1) family.
RL4_JR_06495,45,34,64,0,0,0,0,0,0,0,0,0,0,3,2,0,0,2,73.09428867,0,-0.816745264,0.658491992,-1.240326799,0.214854544,0.383231051,26.65956349,0,0.271604986,1.113811983,0.243851737,0.807345649,0.883358844,70.74835154,0,-0.477261273,0.738739211,-0.646048383,0.518248022,0.648707094,94.31630949,1,0.003623787,0.532562989,0.006804429,0.994570893,0.995948006,47.90359093,1,-2.443889101,1.115664697,-2.190522931,0.028486334,0.072232439,N,-,,bzip transcription factor,"P:regulation of transcription, DNA-templated",IPR004827 (SMART); IPR013910 (PFAM); G3DSA:1.20.5.170 (GENE3D); IPR023167 (G3DSA:1.10.238.GENE3D); PTHR22952 (PANTHER); PTHR22952:SF153 (PANTHER); SSF57959 (SUPERFAMILY); SSF111430 (SUPERFAMILY),,
RL4_JR_06496,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41.76658146,0,-3.486555318,1.188646355,-2.933215,0.003354715,0.015719566,13.38372922,0,-0.276850395,1.214338075,-0.227984612,0.819658204,0.891051481,67.10138414,0,0.210407159,0.674402939,0.311990275,0.755047914,0.835330027,88.23460815,0,0.378831529,0.542032453,0.698909313,0.484608707,0.624853823,41.70649924,0,-1.329355611,0.968160938,-1.373072966,0.169729664,0.28442529,N,-,,hypothetical protein CMQ_5001,,no IPS match,,
RL4_JR_06497,679,580,792,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,23.79512008,0,-2.675031459,1.194680375,-2.239118943,0.025148178,0.079120261,7.586233707,0,0.542094138,1.228805338,0.441155422,0.659100483,0.780868612,56.19209854,0,0.717801137,0.748212545,0.959354587,0.337380145,0.480681715,22.73936292,1,-2.534396813,1.195938487,-2.119169875,0.034076113,0.09891647,27.1971501,0,-0.533279413,0.988714166,-0.539366615,0.589633912,0.701707319,N,-,,ww domain binding 11,P:transmembrane transport; C:integral component of membrane; P:RNA processing,IPR019007 (PFAM); IPR021154 (PANTHER); PTHR23237:SF3 (PANTHER),,
RL4_JR_06498,114,311,94,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,116.7813174,0,2.433316517,0.403706183,6.027444262,1.67E-09,4.37E-08,5.834409663,0,0.920955259,1.239454602,0.743032667,0.457461903,0.616486404,15.0973618,0,-1.727249199,1.192601257,-1.448304023,0.147532043,0.259038225,29.44819694,0,0.154868589,0.854195389,0.181303471,0.856129382,0.910268574,14.84820207,0,-1.806057248,1.192002719,-1.515145242,0.129735627,0.231965716,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11360:SF118 (PANTHER); PTHR11360 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.13.19, the major facilitator superfamily (mfs).
RL4_JR_06499,176,198,97,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,75.14041573,0,1.911717144,0.556038955,3.438099304,0.000585813,0.003823249,4.272322053,0,1.370480596,1.25826992,1.089178541,0.27607516,0.434457831,17.57580404,0,-0.318844364,1.196653508,-0.266446688,0.789895212,0.861085294,35.41371859,0,0.620559493,0.856678468,0.724378534,0.468833375,0.610074811,34.08533686,0,1.806529462,0.648387395,2.786188439,0.005333186,0.018900422,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane; F:transporter activity,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23504:SF31 (PANTHER); PTHR23504 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.73, the major facilitator superfamily (mfs).
RL4_JR_06500,1011,2077,1221,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,170.9467412,0,2.316545897,0.395676132,5.854651589,4.78E-09,1.16E-07,8.26031884,0,0.419362163,1.235799987,0.33934469,0.73435008,0.834241471,78.69621035,0,1.588009117,0.552487022,2.874292161,0.004049342,0.016537127,40.64487918,0,0.059484059,0.758684402,0.07840422,0.937506517,0.963289373,20.92720385,0,-2.301142078,1.193973741,-1.927297057,0.05394262,0.118680797,N,-,,phosphopantothenate-cysteine ligase,C:nucleus; C:cytoplasm; P:coenzyme A biosynthetic process; F:ligase activity; C:CoA-synthesizing protein complex,IPR007085 (G3DSA:3.40.50.GENE3D); PTHR12290 (PANTHER); PTHR12290 (PANTHER); PTHR12290:SF2 (PANTHER); PTHR12290:SF2 (PANTHER); IPR007085 (SUPERFAMILY),,
RL4_JR_06501,10573,10669,6541,0,0,0,0,0,0,0,0,0,0,3,1,0,3,0,228.7268699,0,3.697049713,1.063177081,3.477360244,0.000506377,0.00340282,5.072275457,0,1.122817221,1.275866748,0.880042702,0.378836177,0.542987792,786.231093,0,5.890683236,0.7401828,7.958416809,1.74E-15,1.85E-13,371.6552277,1,4.477692228,0.396545818,11.29173988,1.44E-29,2.25E-27,132.7083964,1,3.374148857,0.516813229,6.528758684,6.63E-11,4.83E-09,N,-,,myosin-crossreactive antigen,F:FAD binding; F:oxidoreductase activity; F:oleate hydratase activity; P:oxidation-reduction process; P:fatty acid metabolic process,IPR010354 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR37417 (PANTHER); PTHR37417:SF1 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_06502,11718,12303,8774,0,0,12,0,0,0,0,0,0,0,0,0,0,0,0,48.58209168,1,-0.897511381,1.200892973,-0.747369999,0.454840249,0.643417159,29.73470218,0,1.547726414,1.299645992,1.190883074,0.23369949,0.383948424,27.77659058,0,-2.606802372,1.815397891,-1.435939958,0.151019427,0.263607014,65.36794541,0,0.296373919,1.022805112,0.289765778,0.77199543,0.851929562,34.1272997,0,-1.679512274,1.351673111,-1.24254323,0.214036201,0.338718824,N,-,,phosphoadenosine phosphosulfate reductase,"P:methionine biosynthetic process; C:nucleus; P:sulfur amino acid metabolic process; F:phosphoadenylyl-sulfate reductase (thioredoxin) activity; C:cytosol; P:sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin)",IPR002500 (PFAM); IPR011800 (TIGRFAM); IPR004511 (TIGRFAM); IPR014729 (G3DSA:3.40.50.GENE3D); PTHR23293 (PANTHER); PTHR23293:SF11 (PANTHER); SSF52402 (SUPERFAMILY),,
RL4_JR_06503,52,175,48,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.621180375,0,-1.03251889,1.277593094,-0.808175071,0.418989806,0.61048738,2.437912938,0,2.179806197,1.381957924,1.577331813,0.114719196,0.225648601,6.332580574,0,-0.473963688,1.259539661,-0.376299137,0.706694521,0.800915183,7.304842118,0,-0.896179629,1.266775032,-0.70744971,0.479287055,0.619846906,6.266838416,0,-0.56159055,1.270337148,-0.442079924,0.658431371,0.756523151,N,-,,nudix domain-containing,P:deadenylation-dependent decapping of nuclear-transcribed mRNA; C:cytoplasmic mRNA processing body; F:m7G(5')pppN diphosphatase activity,IPR015797 (G3DSA:3.90.79.GENE3D); IPR000086 (PFAM); PTHR23114:SF22 (PANTHER); PTHR23114 (PANTHER); IPR000086 (PROSITE_PROFILES); IPR015797 (SUPERFAMILY),,
RL4_JR_06504,641,722,656,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.360787394,0,0.373771542,1.156097331,0.323304563,0.746464599,0.867225605,1.783682895,0,2.630718111,1.345271267,1.955529844,0.050520564,0.1188308,4.603728285,0,-0.013788226,1.212595882,-0.011370834,0.990927583,0.99621844,5.309071728,0,-0.4356305,1.212754054,-0.359207622,0.719439775,0.812459393,11.88195097,0,0.846861353,1.131533118,0.748419414,0.454207216,0.586139187,N,-,,phosphoribosylaminoimidazole-succinocarboxamide synthase,C:membrane; C:integral component of membrane,IPR021840 (PFAM); PTHR37544 (PANTHER); PTHR37544:SF1 (PANTHER),,
RL4_JR_06505,97,133,65,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,99.78752101,0,2.427863862,0.462028243,5.254795346,1.48E-07,2.83E-06,5.644985192,0,0.968567082,1.245254897,0.777806282,0.436683224,0.598346513,54.36022765,0,1.151508677,0.751163654,1.532966445,0.125284123,0.229321363,24.92695039,0,-0.384641713,1.026159511,-0.374836182,0.707782304,0.804207813,21.80095238,1,-0.829232571,1.130899468,-0.733250474,0.463405676,0.594523881,N,-,,rpel repeat,C:integral component of membrane,IPR004018 (SMART); IPR004018 (PFAM); PTHR22793 (PANTHER); IPR004018 (PROSITE_PROFILES); IPR004018 (PROSITE_PROFILES),,
RL4_JR_06506,796,699,362,0,0,0,0,0,0,0,0,0,0,1,0,0,3,0,11.32063831,0,-1.603019571,1.207571972,-1.327473317,0.184352161,0.341816236,3.615306223,0,1.611457116,1.27909681,1.259839837,0.207727146,0.352906037,9.360601603,0,-1.037467867,1.20580814,-0.860392157,0.389572907,0.532905839,10.79803046,1,-1.459727279,1.20500117,-1.211390757,0.22574568,0.361485847,9.196653779,1,-1.114816628,1.20508685,-0.925092352,0.354917871,0.492266225,N,-,,hypothetical protein F503_06216,,no IPS match,,
RL4_JR_06507,400,637,273,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,98.21729707,0,0.307174751,0.617362787,0.49755955,0.61879452,0.781201748,15.87251283,0,-0.522934291,1.222165392,-0.427875224,0.668741966,0.788690362,114.1585778,0,0.692758646,1.116130287,0.620679014,0.53481084,0.663897013,79.85477614,0,-0.843222381,0.768326827,-1.09747877,0.272432156,0.414409341,63.46945211,0,-0.339252381,0.713046662,-0.475778654,0.634232079,0.737352142,Y,-,,FK506-binding 2,C:endoplasmic reticulum membrane; C:endoplasmic reticulum lumen; F:peptidyl-prolyl cis-trans isomerase activity; F:FK506 binding; P:chaperone-mediated protein folding; P:protein peptidyl-prolyl isomerization,G3DSA:3.10.50.40 (GENE3D); IPR001179 (PFAM); IPR023566 (PANTHER); IPR001179 (PROSITE_PROFILES); SSF54534 (SUPERFAMILY),8.A.11.1.2, the immunophilin-like prolyl:peptidyl isomerase regulator (i-ppi) family.
RL4_JR_06508,241,219,433,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.693377297,0,2.425972386,1.850923779,1.310681949,0.18996524,NA,0.217522402,0,5.666018609,1.860662158,3.045162489,0.002325546,0.015159195,0.570459508,0,2.998368889,1.336024374,2.244247146,0.024816504,0.066151208,0.658556549,0,2.575237338,1.459345576,1.76465217,0.077622242,0.162953597,0.568322738,0,2.902094888,1.306853452,2.220673544,0.026373081,0.068206243,N,-,,Cation transporter,F:DNA binding; P:cation transmembrane transport; C:integral component of membrane; F:cation transmembrane transporter activity; P:cellular process,IPR003445 (PFAM); PTHR31064 (PANTHER); PTHR31064:SF6 (PANTHER),2.A.38.2.3, the k(+) transporter (trk) family.
RL4_JR_06509,574,779,568,1,0,0,0,0,0,0,0,0,0,2,3,0,0,0,23.26786472,1,-2.642696847,1.199107379,-2.203886735,0.027532311,0.084577523,7.409433677,0,0.576103226,1.232794553,0.46731487,0.640274619,0.765552374,25.76712804,0,-1.11748492,1.198892081,-0.932098007,0.351285878,0.494771595,38.27686824,1,0.200493979,0.766475054,0.261579262,0.793645834,0.866752677,26.42436934,0,-1.229123324,1.136277002,-1.081710993,0.279380967,0.413074225,N,-, Effector probability:0.561,DNA polymerase kappa subunit,P:DNA repair; F:DNA-directed DNA polymerase activity; F:potassium ion transmembrane transporter activity; P:potassium ion transmembrane transport; C:integral component of membrane; P:DNA biosynthetic process; F:damaged DNA binding,G3DSA:3.30.70.270 (GENE3D); IPR001126 (PFAM); G3DSA:1.10.150.20 (GENE3D); PTHR11076:SF33 (PANTHER); PTHR11076 (PANTHER); IPR001126 (PROSITE_PROFILES); SSF56672 (SUPERFAMILY),,
RL4_JR_06510,1229,1309,1111,2,1,2,0,0,0,0,0,1,0,0,2,0,3,0,161.7613712,1,-0.220721328,1.003828802,-0.219879453,0.825965039,0.912420164,29.68478692,0,-1.426132567,1.191784127,-1.196636651,0.231448208,0.381550287,140.8772695,1,-0.090516331,0.50256257,-0.180109575,0.857066545,0.908961,170.7233782,1,-0.181131508,0.439453534,-0.412174427,0.68021158,0.78245197,162.2213737,1,0.456609821,0.409283864,1.115631133,0.26458006,0.396826018,N,-,,rhodanese-like domain-containing,C:mitochondrion; F:transferase activity; P:tRNA wobble position uridine thiolation,IPR001763 (SMART); IPR001763 (PFAM); IPR001763 (G3DSA:3.40.250.GENE3D); IPR001763 (G3DSA:3.40.250.GENE3D); PTHR11364:SF13 (PANTHER); PTHR11364 (PANTHER); IPR001763 (PROSITE_PROFILES); IPR001763 (PROSITE_PROFILES); IPR001763 (SUPERFAMILY); IPR001763 (SUPERFAMILY),9.B.102.4.1, the yede/yeee (yede/yeee) family.
RL4_JR_06511,6,2,6,12,11,5,0,0,0,4,0,0,0,0,0,0,0,0,21.25674601,1,0.891044991,0.882473388,1.009713158,0.312632737,0.500580543,25.42915253,0,2.751703257,1.125212313,2.445496931,0.014465268,0.044775976,8.094486816,1,-0.827862842,1.206874328,-0.685956129,0.492740774,0.626167471,60.70238046,0,2.759854196,0.530011082,5.207163188,1.92E-07,4.06E-06,7.977803989,0,-0.909670042,1.209806994,-0.751913361,0.452103163,0.584130447,N,-, Effector probability:0.93,anaphase-promoting complex subunit 11,F:ubiquitin protein ligase activity; F:metal ion binding; C:anaphase-promoting complex; F:cullin family protein binding; P:positive regulation of mitotic metaphase/anaphase transition; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process,IPR013083 (G3DSA:3.30.40.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); IPR024991 (PFAM); PTHR11210 (PANTHER); SSF57850 (SUPERFAMILY); SSF57850 (SUPERFAMILY),3.A.20.1.3, the peroxisomal protein importer (ppi) family.
RL4_JR_06512,110,142,126,0,3,0,0,0,1,0,0,0,0,0,0,0,0,0,103.3300937,1,1.980802279,0.413266515,4.793038406,1.64E-06,2.35E-05,7.392795476,1,0.579434677,1.226196682,0.472546277,0.636536918,0.762578611,81.66454598,0,1.91439622,0.509068113,3.760589536,0.000169513,0.001596422,82.25579289,0,1.590443377,1.427339137,1.114271539,0.265162713,0.40608736,18.82638862,0,-2.148444964,1.188578594,-1.807575011,0.07067267,0.145943461,N,-,,syntaxin 1B 2 3,F:zinc ion binding; P:vesicle-mediated transport; P:mycelium development; C:integral component of membrane; F:carbonate dehydratase activity,IPR000727 (SMART); IPR006011 (PFAM); G3DSA:1.20.58.70 (GENE3D); IPR000727 (PFAM); PTHR19957 (PANTHER); PTHR19957:SF71 (PANTHER); IPR000727 (PROSITE_PROFILES); IPR010989 (SUPERFAMILY),8.A.91.1.5, the syntaxin (syntaxin) family.
RL4_JR_06513,13,4,14,0,0,6,0,0,0,0,0,2,0,0,0,0,0,0,185.3024179,1,0.140971587,0.858030561,0.164296697,0.869497582,0.936924185,26.56406342,0,-1.265886918,1.192609294,-1.06144311,0.288488574,0.447933939,88.42036468,1,-1.513218734,0.845964391,-1.788749916,0.0736551,0.152960869,145.165827,0,-0.155304195,0.4561834,-0.340442452,0.733523354,0.822108032,167.568213,0,0.589760252,1.419709895,0.415408989,0.677842528,0.771138952,N,-,,duf52 domain-containing,F:zinc ion binding; P:vesicle-mediated transport; C:integral component of membrane; F:carbonate dehydratase activity,IPR002737 (PFAM); IPR002737 (TIGRFAM); IPR002737 (PANTHER); IPR002737 (PANTHER); PTHR11060:SF0 (PANTHER); PTHR11060:SF0 (PANTHER),,
RL4_JR_06514,0,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,160.8940893,0,-0.969821887,0.544558561,-1.78093222,0.074923524,0.179332178,43.62606312,0,-0.715147962,1.112242648,-0.642978368,0.520238136,0.67065558,313.5511748,0,1.407069222,0.66101398,2.128652742,0.033283001,0.083281539,173.1688048,0,-0.413838987,0.472030586,-0.876720702,0.38063836,0.526282042,221.9135258,0,0.884715644,0.617925826,1.431750555,0.152215223,0.261838112,N,-,,gpr fun34 family,P:plasma membrane acetate transport; F:acetate transmembrane transporter activity; C:integral component of membrane; C:plasma membrane,IPR000791 (PFAM); PTHR31123 (PANTHER); PTHR31123:SF1 (PANTHER),2.A.96.1.3, the acetate uptake transporter (acetr) family.
RL4_JR_06515,13,10,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,187.4386548,0,-0.473346026,0.517877894,-0.914010874,0.360711132,0.552283723,43.5513932,0,-0.713585801,1.133807439,-0.629371246,0.529106038,0.677544297,266.1381205,0,1.102698968,0.427319948,2.58049963,0.009865746,0.032344823,150.581319,0,-0.974919124,0.578266113,-1.685935079,0.091808305,0.183589935,151.2947226,0,0.065845218,0.521152514,0.126345391,0.899458527,0.934916086,N,-,,fumarate reductase,C:membrane; P:oxidation-reduction process; F:succinate dehydrogenase activity,PR00368 (PRINTS); IPR003953 (PFAM); IPR010960 (TIGRFAM); IPR027477 (G3DSA:3.90.700.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR11632 (PANTHER); PTHR11632:SF6 (PANTHER); IPR027477 (SUPERFAMILY); IPR023753 (SUPERFAMILY),3.D.10.1.1, the prokaryotic succinate dehydrogenase (sdh) family.
RL4_JR_06516,3,11,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,982.5433867,0,-0.062249856,0.903365682,-0.068908812,0.945062204,0.972970401,313.0510969,0,-0.418541875,0.618068001,-0.677177713,0.498293207,0.652767881,497.194299,0,-2.402369884,1.670504095,-1.438110742,0.150402635,0.262893004,673.4074039,0,-1.26383121,1.071813793,-1.179151843,0.238337718,0.376327059,597.7751767,0,-0.989825761,0.658254871,-1.503712018,0.132655533,0.235969304,N,-,,40S ribosomal S2,C:small-subunit processome; P:rRNA export from nucleus; P:positive regulation of translational fidelity; F:structural constituent of ribosome; P:mycelium development; C:cytosolic small ribosomal subunit; F:small ribosomal subunit rRNA binding; P:translation,IPR013810 (PFAM); IPR005711 (TIGRFAM); IPR005324 (PFAM); IPR014721 (G3DSA:3.30.230.GENE3D); IPR014720 (G3DSA:3.30.160.GENE3D); IPR000851 (PANTHER); IPR013810 (PROSITE_PROFILES); SSF54768 (SUPERFAMILY); IPR020568 (SUPERFAMILY),,
RL4_JR_06517,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,40.21672725,0,-0.650024401,0.859608733,-0.756186362,0.449537468,0.638384992,9.14531783,0,0.272453509,1.215304401,0.224185405,0.82261304,0.893304279,34.85066531,0,-1.420983026,1.191366777,-1.192733467,0.232973774,0.364660867,47.49579486,0,0.224261193,0.677887833,0.330823452,0.740777845,0.827891456,23.49792129,0,-2.46822077,1.19861867,-2.059221028,0.03947307,0.093096862,N,-, Effector probability:0.767,Duf498 domain,P:biological_process; C:cellular_component; F:molecular_function,IPR007523 (PFAM); IPR007523 (G3DSA:3.40.1230.GENE3D); PTHR21192:SF2 (PANTHER); IPR007523 (PANTHER); IPR007523 (SUPERFAMILY),,
RL4_JR_06518,60,40,41,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,662.0989389,0,-0.795087343,0.519359687,-1.530899224,0.125794301,0.261060775,137.6857744,0,-3.639723412,1.189415729,-3.060093559,0.002212679,0.015045494,368.8214803,0,-5.33203199,1.192347181,-4.471878722,7.75E-06,0.000153015,523.9600952,0,-1.661369324,0.654365148,-2.538902522,0.01112008,0.052859536,432.5616633,0,-1.804368207,0.465184952,-3.878818951,0.000104965,0.000720033,N,-,,60S ribosomal l34,F:RNA binding; F:structural constituent of ribosome; P:mycelium development; P:ribosome biogenesis; C:cytosolic large ribosomal subunit; P:translation,IPR008195 (PRINTS); IPR008195 (PFAM); IPR008195 (PANTHER),,
RL4_JR_06519,219,171,174,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,38.53870993,0,-0.576978315,0.884947761,-0.651991384,0.514406731,0.700055864,8.598472236,0,0.361432561,1.231913527,0.293391178,0.769223168,0.860339989,30.20151284,0,-1.331954126,1.20131407,-1.108747628,0.267539069,0.405700396,41.84476405,0,-0.018540283,0.7734836,-0.023969846,0.980876661,0.988219039,22.07197506,1,-2.377886273,1.208221072,-1.968088728,0.04905783,0.110380116,N,-,,Ribosomal L34e,F:structural constituent of ribosome; C:ribosome; C:intracellular; P:translation,no IPS match,,
RL4_JR_06520,48,52,52,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,64.13308498,0,-0.355608318,0.710140633,-0.500757598,0.61654173,0.779684923,12.33209182,0,-0.158880996,1.223625026,-0.129844513,0.896689444,0.942408473,57.52540241,0,-0.404823389,0.868814947,-0.465948923,0.641252062,0.750177475,49.08806892,0,-0.950983353,0.883825243,-1.075985734,0.281933637,0.425484882,39.5361653,0,-1.246487813,1.003899595,-1.241645897,0.21436724,0.339135672,N,-, Effector probability:0.628,gln pro-rich,,IPR004330 (PFAM),,
RL4_JR_06521,988,920,989,0,0,101,0,0,0,0,0,3,5,14,9,0,22,1,242.6357415,1,0.555349902,0.362750185,1.530943127,0.125783449,0.261060775,52.69877134,0,0.018961188,0.99566601,0.019043724,0.984806225,0.992120268,213.4840157,1,0.553759504,0.41088901,1.347710674,0.177751458,0.29769326,228.4731913,1,0.468429103,0.380501072,1.231084844,0.218291133,0.353292475,150.3789877,1,-0.041348551,0.455268569,-0.090822327,0.927633769,0.953049399,N,-,,nadph oxidase regulator,,IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); G3DSA:3.10.20.240 (GENE3D); IPR001440 (PFAM); PTHR15175 (PANTHER); PTHR15175:SF0 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR000270 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); SSF54277 (SUPERFAMILY),,
RL4_JR_06522,12,7,22,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,225.5508816,1,-1.577897311,0.526174381,-2.9988106,0.002710357,0.013303908,190.6766961,0,0.456070835,0.777100266,0.586888018,0.557278917,0.701501953,137.8330398,0,-4.917781117,1.194103094,-4.118389058,3.82E-05,0.000576509,225.7292195,0,-0.867798968,0.465844773,-1.86285007,0.062483363,0.139934539,153.8361402,0,-2.771694126,0.840616035,-3.297217768,0.000976478,0.00469015,N,-,,heavy-metal-associated domain-containing,C:nucleus; P:superoxide metabolic process; F:oxidoreductase activity; P:positive regulation of catalytic activity; P:intracellular copper ion transport; C:cytosol; P:oxidation-reduction process; F:superoxide dismutase copper chaperone activity; C:mitochondrial inner membrane,IPR001424 (PFAM); IPR006121 (PFAM); IPR001424 (G3DSA:2.60.40.GENE3D); G3DSA:3.30.70.100 (GENE3D); IPR024142 (PTHR10003:PANTHER); IPR024134 (PANTHER); IPR024142 (PTHR10003:PANTHER); IPR024134 (PANTHER); IPR006121 (PROSITE_PROFILES); IPR001424 (SUPERFAMILY); IPR006121 (SUPERFAMILY),3.A.3.5.5, the p-type atpase (p-atpase) superfamily.
RL4_JR_06523,4,5,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,239.7523465,0,-1.305776286,0.983469429,-1.327724328,0.184269194,0.341807203,56.65108721,0,-2.358533123,1.196386176,-1.971381123,0.048680299,0.115396249,258.9916698,0,-0.387738086,0.447092834,-0.8672429,0.385808935,0.529761245,299.8421941,0,-0.388007726,0.395648849,-0.98068711,0.326747062,0.473224718,192.0511394,0,-1.132286835,0.581540985,-1.947045632,0.051529264,0.114717194,N,-,,50S ribosomal l13,F:structural constituent of ribosome; F:mRNA binding; C:mitochondrial large ribosomal subunit; P:translation,IPR005822 (G3DSA:3.90.1180.GENE3D); IPR005822 (PIRSF); IPR005823 (TIGRFAM); IPR005822 (PFAM); IPR005822 (PANTHER); IPR005822 (SUPERFAMILY),,
RL4_JR_06524,42,40,43,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,395.0632298,0,0.902233885,0.386668754,2.333350902,0.019629736,0.0645203,44.4045079,0,-2.007098451,1.220693988,-1.644227358,0.100129248,0.202661117,944.7187605,0,2.878696064,0.51276252,5.614092198,1.98E-08,7.94E-07,212.0313756,0,-1.048442787,0.590044699,-1.776887054,0.075586825,0.159773821,305.1996435,0,0.85383842,0.761723036,1.120930284,0.262317539,0.394294103,N,-,,urate oxidase,C:nucleus; C:peroxisome; P:urate catabolic process; F:urate oxidase activity; C:cytosol; P:oxidation-reduction process; P:purine nucleobase metabolic process,IPR002042 (PRINTS); G3DSA:3.10.270.10 (GENE3D); IPR002042 (PIRSF); IPR002042 (TIGRFAM); IPR002042 (PFAM); PTHR10395 (PANTHER); PTHR10395 (PANTHER); PTHR10395:SF13 (PANTHER); PTHR10395:SF13 (PANTHER); PD003367 (PRODOM); SSF55620 (SUPERFAMILY); SSF55620 (SUPERFAMILY),,
RL4_JR_06525,1458,899,1352,0,3,1,0,0,0,0,0,0,0,0,0,0,0,0,44.69402135,1,-2.508021504,1.145098315,-2.190223731,0.028508015,0.086941453,13.0278092,0,-0.237990038,1.208992032,-0.196849964,0.84394495,0.907028954,40.29952579,0,-1.928175761,1.190479493,-1.619663146,0.105304657,0.201493923,75.92388132,0,-0.252247525,0.669316971,-0.376873045,0.706267954,0.802847539,40.66744092,0,-2.036987152,1.121727608,-1.815937432,0.06937997,0.143897015,N,-, Effector probability:0.552,phosphomethylpyrimidine kinase,F:organic cyclic compound binding; F:heterocyclic compound binding; P:signal transduction; P:thiamine metabolic process; F:kinase activity; F:hydrolase activity,IPR016084 (G3DSA:1.20.910.GENE3D); IPR004305 (PFAM); IPR029056 (G3DSA:3.40.1190.GENE3D); IPR013749 (PFAM); PTHR20858 (PANTHER); PTHR20858:SF17 (PANTHER); IPR016084 (SUPERFAMILY); IPR029056 (SUPERFAMILY),,
RL4_JR_06526,11,5,7,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1359.791733,1,-3.223956006,0.359737227,-8.961974926,3.19E-19,3.66E-17,468.1036369,0,-3.464244219,0.995139388,-3.48116481,0.000499238,0.015023052,1080.368441,0,-3.808510151,0.557534623,-6.83098411,8.43E-12,5.97E-10,1235.980184,0,-3.838683626,0.912086943,-4.208681699,2.57E-05,0.000327551,1097.840163,0,-2.964643646,0.617924102,-4.797747228,1.60E-06,2.13E-05,N,-,,ATP-dependent RNA helicase dbp-2,"C:nucleus; F:ATP binding; F:RNA binding; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:mycelium development; C:cytoplasm; P:RNA secondary structure unwinding; P:rRNA processing; F:ATP-dependent RNA helicase activity",IPR014001 (SMART); IPR001650 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011545 (PFAM); IPR001650 (PFAM); PTHR24031 (PANTHER); PTHR24031:SF253 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_06527,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,258.6461382,0,0.605065789,0.372473527,1.624453136,0.104279134,0.228623805,81.18410182,0,1.272203765,0.684739676,1.857937857,0.06317784,0.141792925,165.0352428,0,-0.446187074,0.542976794,-0.821742436,0.411223502,0.553388663,157.3964881,0,-1.150237077,0.574478782,-2.002227259,0.045260295,0.115278131,122.1437408,0,-0.625391749,0.548319858,-1.140560094,0.254053032,0.385015259,N,-,,c2h2 transcription factor,F:nucleic acid binding; F:metal ion binding,IPR013087 (G3DSA:3.30.160.GENE3D); PTHR36167:SF2 (PANTHER); PTHR36167 (PANTHER); IPR007087 (PROSITE_PROFILES),,
RL4_JR_06528,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,63.97342428,0,-0.708254042,0.830808911,-0.852487296,0.393943687,0.586137625,22.06912244,0,0.713819198,1.155790425,0.617602623,0.536837315,0.68390183,33.20874585,0,-2.864525545,1.227630984,-2.333376709,0.019628383,0.054842592,56.95639088,0,-1.511063299,1.064959416,-1.418892848,0.155930258,0.273763458,33.01356645,0,-2.958753051,1.241258851,-2.383671262,0.017140907,0.048329624,N,-,,aar2 domain containing,P:biological_process; C:cellular_component; F:molecular_function; P:spliceosomal tri-snRNP complex assembly,IPR007946 (PFAM),,
RL4_JR_06529,5,1,1,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,958.1704009,1,-0.51585267,0.375398203,-1.374147949,0.169395756,0.32212834,183.0606441,0,-4.05066635,1.197956884,-3.381312301,0.000721405,0.015023052,502.00744,0,-4.29644234,0.866297465,-4.959546247,7.07E-07,1.99E-05,762.4228293,1,-1.234429883,0.509254738,-2.423992929,0.015350904,0.065943109,540.1856113,0,-2.388090202,0.558534547,-4.275635614,1.91E-05,0.000172762,N,-, Effector probability:0.59,40S ribosomal s16,F:structural constituent of ribosome; C:ribosome; P:translation,IPR000754 (PFAM); IPR014721 (G3DSA:3.30.230.GENE3D); IPR000754 (PANTHER); IPR020568 (SUPERFAMILY),,
RL4_JR_06530,26282,9373,9293,42,74,8,0,0,4,0,0,0,0,2,0,0,0,0,35.44416385,1,0.060012267,0.844125183,0.071094037,0.943322914,0.97203844,5.676163408,1,0.960606567,1.236988216,0.776568891,0.437413161,0.598795783,14.70712633,0,-1.689512327,1.191575782,-1.41788072,0.156225592,0.270363743,30.28848342,1,-0.377489125,1.012053638,-0.3729932,0.709153505,0.805122151,40.7981088,0,1.174925735,0.670949366,1.751139197,0.079921936,0.161132935,N,-,,eap30 vps36 family,,IPR011991 (G3DSA:1.10.10.GENE3D); IPR007286 (PFAM); IPR016689 (PIRSF); IPR011991 (G3DSA:1.10.10.GENE3D); IPR007286 (PANTHER); PTHR12806:SF0 (PANTHER); IPR011991 (SUPERFAMILY); IPR011991 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_06531,0,17,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,189.6338464,0,0.826920784,0.506937324,1.631209117,0.102846202,0.226333779,33.30562916,0,-0.198908029,1.127684319,-0.176386268,0.859990492,0.918156865,69.81940297,0,-2.80283918,1.201065302,-2.333627635,0.019615228,0.054842592,164.9413798,0,0.329786646,1.401022716,0.235389935,0.813906097,0.882218096,72.1398887,0,-2.164639897,0.983312882,-2.201374491,0.027709523,0.070720379,N,-,,integral membrane,C:integral component of membrane,IPR007248 (PFAM); PTHR11266:SF23 (PANTHER); IPR007248 (PANTHER),9.B.192.1.2, the mpv17/pmp22 4 tms putative porin (mpv17) family.
RL4_JR_06532,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,63.51212449,0,-0.036193157,0.69968013,-0.051728148,0.958745309,0.978906038,10.13802522,0,0.123833781,1.229022881,0.100757913,0.919742637,0.955670261,32.80360281,0,-1.566429916,1.200663136,-1.304637303,0.19201638,0.315631406,38.37145481,0,-1.231223655,1.031312514,-1.193841477,0.232539984,0.369709944,25.90218975,0,-2.608748788,1.204115023,-2.166527896,0.030270871,0.075639823,N,-,,alkaline phosphatase,"C:fungal-type vacuole membrane; F:fructose-2,6-bisphosphate 6-phosphatase activity; P:protein dephosphorylation; P:nicotinamide nucleotide metabolic process; C:integral component of membrane; F:alkaline phosphatase activity",IPR001952 (PRINTS); IPR001952 (SMART); IPR001952 (PFAM); IPR017849 (G3DSA:3.40.720.GENE3D); PTHR11596 (PANTHER); PTHR11596:SF47 (PANTHER); IPR017850 (SUPERFAMILY),,
RL4_JR_06533,247,495,185,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,56.4475149,0,0.527317584,0.699083062,0.7542989,0.450669763,0.639513641,7.943572363,0,0.475646671,1.256068202,0.378679016,0.704926238,0.81434186,27.27575589,0,-1.226219216,1.220147796,-1.004975971,0.314908421,0.457211078,32.0026001,0,-0.904102179,1.061007792,-0.852116437,0.39414947,0.538888738,20.67674049,0,-2.283712855,1.237014529,-1.846148773,0.064870607,0.137036281,N,-,,hypothetical protein SPI_01636,,IPR032675 (G3DSA:3.80.10.GENE3D); SSF52047 (SUPERFAMILY),,
RL4_JR_06534,2,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.06513199,0,-2.355296575,1.199954608,-1.962821393,0.049666931,0.132055444,6.063641467,0,0.86527235,1.239188632,0.698257172,0.485016378,0.641324072,15.77931734,0,-1.791090876,1.200509595,-1.491942158,0.135714309,0.243353112,18.20597439,0,-2.21363615,1.199802848,-1.844999912,0.065037551,0.143809829,27.19818242,0,0.312307629,0.871135032,0.358506566,0.719964255,0.80273517,N,-,,dna repair rad9,C:nucleus; P:DNA damage checkpoint; C:cytoplasm; P:mitotic DNA integrity checkpoint,IPR007268 (PFAM); PTHR15237:SF0 (PANTHER); IPR007268 (PANTHER),,
RL4_JR_06535,17,10,21,0,0,14,0,0,0,0,0,0,0,3,0,0,5,0,43.03743536,1,-0.79158353,0.871537323,-0.908261195,0.36374024,0.555275613,10.05603915,0,0.135480439,1.222403282,0.110831213,0.911750193,0.950652603,26.15214153,0,-2.519945804,1.198975497,-2.10174921,0.03557525,0.08722786,30.1726036,1,-2.942422376,1.198978319,-2.454108076,0.014123453,0.063753882,25.86869153,1,-2.606926261,1.20655071,-2.160643759,0.030722868,0.076561418,N,-,,RCC1 domain-containing,C:integral component of membrane,IPR000408 (PRINTS); PF13540 (PFAM); IPR000408 (PFAM); IPR009091 (G3DSA:2.130.10.GENE3D); PTHR22870:SF203 (PANTHER); PTHR22870 (PANTHER); IPR000408 (PROSITE_PROFILES); IPR009091 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_06536,5,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,215.1979585,0,-2.936891121,0.767378773,-3.82717274,0.000129624,0.001064923,88.34605574,0,-0.264446708,0.856431242,-0.308777512,0.757490777,0.852777405,208.978977,0,-1.478378266,0.596498844,-2.478426036,0.013196347,0.040192484,184.8937624,0,-4.579614411,1.15368379,-3.969557733,7.20E-05,0.00081097,162.5866435,0,-4.254095297,1.140383956,-3.730406126,0.000191171,0.001197779,N,-,,prephenate dehydrogenase,C:nucleus; P:histone lysine methylation; P:tyrosine biosynthetic process; F:histone-lysine N-methyltransferase activity; P:oxidation-reduction process; F:prephenate dehydrogenase activity; F:prephenate dehydrogenase (NADP+) activity,IPR016040 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.3660.10 (GENE3D); IPR003099 (PFAM); PTHR21363 (PANTHER); PTHR21363:SF0 (PANTHER); IPR003099 (PROSITE_PROFILES); IPR008927 (SUPERFAMILY); IPR008927 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_06537,2864,2995,3310,0,1,3,0,0,0,3,0,0,0,2,2,0,2,10,123.3167488,1,0.483099107,0.425870315,1.134380797,0.256634851,0.435265512,85.11681811,0,1.495978804,0.838302773,1.784532812,0.074337128,0.1609154,100.699294,1,0.260177488,0.566939285,0.458915963,0.646294515,0.753985443,205.7839128,1,1.285583792,0.355729145,3.613940017,0.000301579,0.002736099,69.26667615,1,-0.512633931,0.669418687,-0.765789694,0.443801448,0.576759917,N,-,,histone-lysine N- H3 lysine-79 specific,"P:histone H3-K79 methylation; C:chromosome, telomeric region; C:nucleus; P:DNA damage checkpoint; F:nucleosomal histone binding; P:transcription, DNA-templated; F:histone methyltransferase activity (H3-K79 specific); P:negative regulation of cell cycle; P:nucleotide-excision repair; P:chromatin silencing at telomere",IPR025789 (PFAM); IPR021162 (PIRSF); IPR029063 (G3DSA:3.40.50.GENE3D); IPR030445 (PANTHER); IPR025789 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_06538,5486,2895,5990,0,4,1,0,0,0,0,0,1,0,0,0,0,1,4,38.9850432,1,0.96274342,0.672536709,1.431510589,0.152283934,0.300225311,5.004156909,0,1.142406018,1.241447273,0.920221135,0.357457212,0.521577325,46.19414006,1,0.908632754,0.848574378,1.070775618,0.284270332,0.423539786,24.61471343,0,-0.982566268,1.142389497,-0.860097428,0.389735339,0.534408221,12.79422887,1,-1.59114109,1.195362244,-1.331095321,0.183157648,0.301638124,N,-,,autophagy 16,C:membrane; P:transport,IPR013923 (PFAM); PTHR19878 (PANTHER),9.A.15.2.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_06539,2700,2002,3969,0,0,0,0,0,0,2,0,0,0,0,0,0,0,1,140.4668706,0,1.16219761,0.392876254,2.958177288,0.003094641,0.014772428,14.07447701,0,-0.349459836,1.209029625,-0.289041582,0.772549557,0.862066485,59.94672933,1,-0.588510193,0.84817079,-0.693858123,0.487771188,0.622487773,58.05204316,0,-0.701517665,0.741338921,-0.946284682,0.344003404,0.490775605,43.51895903,1,-1.403212801,0.965001834,-1.454103766,0.14591754,0.253810914,N,-,,vacuolar sorting-associated,"P:regulation of vacuole fusion, non-autophagic; C:endosome; P:regulation of SNARE complex assembly; F:actin binding; P:vacuole organization; P:endosomal transport; P:intracellular protein transport; C:lysosomal membrane; C:HOPS complex",IPR006925 (PFAM); IPR016534 (PIRSF); IPR015943 (G3DSA:2.130.10.GENE3D); IPR006926 (PFAM); IPR016534 (PTHR12811:PANTHER); PTHR12811 (PANTHER); IPR011044 (SUPERFAMILY),,
RL4_JR_06540,1286,1038,2221,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,130.6113999,1,0.147010776,0.716738578,0.205110735,0.837485609,0.918937779,22.31889453,0,-1.014662979,1.23332146,-0.822707633,0.410674273,0.574387867,97.86760291,0,-0.275385723,0.667565081,-0.41252266,0.679956376,0.779980547,101.3314213,1,-0.781684204,0.66885241,-1.168694607,0.242526696,0.380828597,94.29368018,0,-0.147900638,0.605006813,-0.244461112,0.806873717,0.869938918,N,-,,fha domain containing,P:negative regulation of cell cycle process; P:regulation of mitotic cell cycle phase transition; F:metal ion binding; P:regulation of mitotic nuclear division; P:cell cycle process; C:cell part; P:negative regulation of mitotic cell cycle; P:negative regulation of cellular component organization,IPR000253 (SMART); IPR001841 (SMART); IPR000253 (G3DSA:2.60.200.GENE3D); IPR001841 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR000253 (PFAM); PTHR15067:SF4 (PANTHER); PTHR15067 (PANTHER); IPR001841 (PROSITE_PROFILES); IPR000253 (PROSITE_PROFILES); IPR008984 (SUPERFAMILY); SSF57850 (SUPERFAMILY),1.A.13.2.1, the epithelial chloride channel (e-clc) family.
RL4_JR_06541,32954,30375,45856,3,8,9,0,0,0,0,0,0,3,3,0,0,3,0,233.7621963,1,-0.94082015,0.492022779,-1.912147545,0.055857272,0.144241046,67.96901402,0,-0.512857206,0.984896087,-0.520722148,0.602560343,0.736840531,150.254804,0,-2.40571719,0.861028582,-2.794003871,0.005205986,0.019498852,206.3665021,1,-1.334434047,0.533142276,-2.502960479,0.01231593,0.057148848,153.0507043,1,-1.960122732,0.703747285,-2.78526507,0.005348398,0.018938136,N,-,,mitochondrial-processing peptidase subunit alpha,P:protein processing involved in protein targeting to mitochondrion; F:metal ion binding; C:mitochondrial processing peptidase complex; F:metalloendopeptidase activity,IPR007863 (PFAM); IPR011237 (G3DSA:3.30.830.GENE3D); IPR011237 (G3DSA:3.30.830.GENE3D); IPR011765 (PFAM); PTHR11851:SF49 (PANTHER); PTHR11851 (PANTHER); PTHR11851 (PANTHER); IPR011249 (SUPERFAMILY); IPR011249 (SUPERFAMILY),,
RL4_JR_06542,35,31,31,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,79.74942162,0,-0.644249165,0.622829594,-1.03439074,0.300953532,0.486655879,18.16923051,0,-0.717877867,1.203998164,-0.596244984,0.551011578,0.697167399,73.04648719,0,-0.550923364,0.74294246,-0.74154244,0.458364609,0.596273064,121.6847441,0,0.702896043,0.44068901,1.594993356,0.110713722,0.211713865,46.27080774,0,-3.445799181,1.187525601,-2.90166307,0.003711875,0.014054876,N,-,,hypothetical protein SPI_01644,,IPR029058 (G3DSA:3.40.50.GENE3D); PTHR10351:SF46 (PANTHER); PTHR10351 (PANTHER),,
RL4_JR_06543,657,588,943,0,0,9,0,0,0,0,0,0,0,0,2,0,2,0,630.4343881,1,-3.928561524,0.678271497,-5.792019191,6.95E-09,1.66E-07,214.3194782,0,-1.896351837,0.862311902,-2.199148397,0.027867372,0.074701679,524.450402,0,-3.587212756,0.687043962,-5.221227399,1.78E-07,5.84E-06,597.9611421,1,-3.636011683,0.600841678,-6.051530406,1.43E-09,4.58E-08,548.983325,1,-2.488511894,0.948607274,-2.623332082,0.008707436,0.028113133,N,-,,rRNA biogenesis RRP5,C:small-subunit processome; F:RNA binding; P:RNA processing; C:nucleolus,IPR022967 (SMART); IPR003107 (SMART); G3DSA:2.40.50.140 (GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); G3DSA:2.40.50.140 (GENE3D); G3DSA:2.40.50.140 (GENE3D); IPR003029 (PFAM); PTHR23270:SF10 (PANTHER); PTHR23270 (PANTHER); IPR003029 (PROSITE_PROFILES); IPR003029 (PROSITE_PROFILES); IPR003029 (PROSITE_PROFILES); IPR003029 (PROSITE_PROFILES); IPR003029 (PROSITE_PROFILES); IPR003029 (PROSITE_PROFILES); IPR003029 (PROSITE_PROFILES); IPR003029 (PROSITE_PROFILES); IPR003029 (PROSITE_PROFILES); IPR003029 (PROSITE_PROFILES); IPR003029 (PROSITE_PROFILES); IPR003029 (PROSITE_PROFILES); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY),,
RL4_JR_06544,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,277.2584231,0,-1.746981765,0.559378346,-3.123077209,0.001789708,0.009538487,182.5915852,0,0.447854318,1.616483486,0.277054682,0.781738119,0.868102385,211.0233772,0,-2.422502034,0.775703987,-3.122972261,0.001790346,0.009057717,222.9514156,0,-2.970175835,0.788833696,-3.765275052,0.000166366,0.00164337,171.4848324,0,-5.335725892,1.217730822,-4.38169569,1.18E-05,0.000115534,N,-,,hypothetical protein F503_06075,,PTHR42051 (PANTHER),,
RL4_JR_06545,2,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,168.6407583,0,-1.749110779,0.748044914,-2.338242994,0.019374646,0.063810402,41.1698782,0,-1.897982694,1.255160334,-1.512143622,0.13049733,0.247962074,125.0862312,0,-2.15226509,0.92782445,-2.319689991,0.020357654,0.056327107,163.31183,0,-1.823761263,0.762702318,-2.391183585,0.016794153,0.070283577,125.9288399,0,-1.503868839,0.761915612,-1.973799745,0.048404518,0.109250054,N,-,,hypothetical protein F503_06074,C:integral component of membrane,IPR019415 (SMART); IPR019449 (SMART); IPR019441 (SMART); IPR019443 (PFAM); IPR019449 (PFAM); IPR019439 (PFAM); IPR019415 (PFAM); IPR019409 (PFAM); IPR019441 (PFAM); PTHR15678:SF6 (PANTHER); PTHR15678 (PANTHER); PTHR15678 (PANTHER); PTHR15678:SF6 (PANTHER),,
RL4_JR_06546,33986,34274,24183,8,21,8,0,0,0,2,1,1,4,7,0,0,10,0,3.128414637,1,0.252495771,1.298566378,0.194441944,0.84582985,0.92262066,0.993003323,0,3.475691473,1.45353674,2.391196162,0.016793578,0.050335976,2.579257625,1,0.822272174,1.248462738,0.658627726,0.510134854,0.641565871,2.97606663,1,0.399620604,1.262013869,0.3166531,0.751506839,0.836614266,2.540449269,1,0.741387942,1.245579605,0.595215223,0.551699616,0.671792978,N,-,,HET domain containing partial,C:integral component of membrane,no IPS match,,
RL4_JR_06547,436,364,463,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,541.0925381,0,-1.552693632,0.428336587,-3.624938141,0.000289031,0.002110933,133.0539263,0,-2.567036132,1.104897909,-2.323324274,0.020161739,0.057857293,362.4984556,0,-2.990814843,0.665958772,-4.490990991,7.09E-06,0.000141561,430.8269375,0,-2.381876755,0.4629212,-5.145317943,2.67E-07,5.53E-06,346.869989,0,-2.816455341,0.599489254,-4.698091454,2.63E-06,3.28E-05,N,-,,translation initiation factor 4b,C:polysome; F:nucleotide binding; F:translation initiation factor activity; P:formation of translation preinitiation complex; C:eukaryotic translation initiation factor 4F complex; F:RNA strand-exchange activity; P:cytoplasmic translation; F:RNA strand annealing activity; F:ribosomal small subunit binding; C:cytosol; P:eukaryotic translation initiation factor 4F complex assembly,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR23236 (PANTHER); IPR033107 (PTHR23236:PANTHER); PTHR23236 (PANTHER); IPR033107 (PTHR23236:PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_06548,392,194,380,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,121.6784891,0,-0.787091344,0.636054845,-1.237458293,0.215916989,0.384237907,27.71348565,0,-1.327027666,1.198570206,-1.107175582,0.268218022,0.425680372,72.14896063,0,-3.983935318,1.196007588,-3.331028464,0.000865258,0.005125727,91.27395282,0,-2.684525532,1.025243169,-2.618428108,0.00883359,0.044059164,75.23767656,0,-3.141795291,1.133530634,-2.771689796,0.005576615,0.019598483,N,-,,elongation factor 2,F:GTP binding; F:translation elongation factor activity; P:mycelium development; F:GTPase activity; P:mature ribosome assembly; P:translational elongation; C:intracellular; P:response to stress,IPR000795 (PRINTS); IPR000640 (SMART); G3DSA:3.90.1430.10 (GENE3D); G3DSA:2.40.30.10 (GENE3D); IPR014721 (G3DSA:3.30.230.GENE3D); IPR000640 (G3DSA:3.30.70.GENE3D); IPR009022 (PFAM); IPR000640 (PFAM); IPR004161 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.70.870 (GENE3D); PF00009 (PFAM); PTHR23115:SF13 (PANTHER); PTHR23115:SF13 (PANTHER); PTHR23115:SF13 (PANTHER); PTHR23115:SF13 (PANTHER); PTHR23115 (PANTHER); PTHR23115 (PANTHER); PTHR23115 (PANTHER); PTHR23115 (PANTHER); PTHR23115:SF13 (PANTHER); PTHR23115 (PANTHER); PTHR23115 (PANTHER); PTHR23115:SF13 (PANTHER); IPR000795 (PROSITE_PROFILES); IPR009022 (SUPERFAMILY); IPR009022 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR009000 (SUPERFAMILY); IPR020568 (SUPERFAMILY),,
RL4_JR_06549,21,10,30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,160.9404067,0,-0.143167701,0.554228736,-0.258318797,0.79616088,0.895996753,63.95917784,0,-0.283414769,1.142039322,-0.248165509,0.804006352,0.881420155,98.43469132,0,-0.738785553,0.726369482,-1.017093328,0.309109034,0.450341036,92.07525716,0,-1.599178065,0.808100069,-1.978935686,0.047823248,0.119594863,90.8196329,0,-0.987963197,0.715622694,-1.380564375,0.167412944,0.281430525,N,-,,usp domain-containing,C:cell division site; C:cell tip; F:organic cyclic compound binding; F:heterocyclic compound binding; P:response to stress,IPR014729 (G3DSA:3.40.50.GENE3D); IPR006016 (PFAM); PTHR31964 (PANTHER); PTHR31964:SF45 (PANTHER); SSF52402 (SUPERFAMILY),,
RL4_JR_06550,2730,1210,1673,0,1,2,0,0,0,0,0,1,0,4,2,0,3,1,44.58400974,1,2.541236537,0.742254068,3.423674787,0.000617805,0.003993703,1.386535036,0,2.994061767,1.36205556,2.198193564,0.027935315,0.074863982,16.58428238,1,2.164727184,1.039306186,2.082857981,0.037264171,0.090319,4.13693689,1,-0.075821817,1.20882755,-0.062723435,0.949986735,0.970499011,7.387882115,1,1.197134821,1.129822495,1.059577788,0.289336723,0.423894418,N,-,,---NA---,,no IPS match,,
RL4_JR_06551,479,332,743,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,382.0574398,1,-0.964603742,0.605062202,-1.594222442,0.110886222,0.238431681,102.5618901,0,-1.283181267,0.990815801,-1.295075498,0.195294186,0.338198076,241.8585944,0,-3.171865519,0.870456196,-3.643911703,0.000268526,0.002133872,328.1787393,0,-1.797890538,0.50595529,-3.553457341,0.000380203,0.003312869,242.9898285,0,-2.506711515,0.683283188,-3.668627531,0.000243856,0.001474055,N,-,,eukaryotic translation initiation factor 3 subunit L,F:translation initiation factor activity; P:formation of translation preinitiation complex; C:eukaryotic 43S preinitiation complex; C:integral component of membrane; C:eukaryotic 48S preinitiation complex; P:regulation of translational initiation; C:eukaryotic translation initiation factor 3 complex,IPR019382 (PFAM); IPR019382 (PANTHER),,
RL4_JR_06552,1918,1520,2130,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,112.8188658,0,-2.466807121,0.858419672,-2.873660985,0.004057442,0.018277534,32.47726595,0,-1.555837227,1.201750503,-1.294642459,0.195443598,0.338341047,111.4254688,0,-1.387993885,0.74785335,-1.855970671,0.063457739,0.136313632,114.3230056,0,-2.315227118,0.85699855,-2.701553134,0.006901645,0.036150625,131.8919125,1,-0.358569223,0.50961665,-0.703605785,0.481678308,0.610254272,N,-,,g -coupled receptor,C:integral component of membrane,IPR025969 (PFAM); IPR022535 (PFAM); PTHR15948:SF0 (PANTHER); IPR015672 (PANTHER),1.A.38.1.1, the golgi ph regulator (gphr) family.
RL4_JR_06553,431,36,245,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.83295238,0,5.347096369,0.705777871,7.576174583,3.56E-14,2.07E-12,0.235791068,0,5.549991829,1.771755259,3.13248221,0.001733349,0.015023052,0.611657161,0,2.898638749,1.262944912,2.295142664,0.02172495,0.059384459,12.74042427,0,4.77115225,0.878781468,5.429281819,5.66E-08,1.35E-06,0.602246062,0,2.818480873,1.229968998,2.291505621,0.021934187,0.058830105,Y,-,,Heterokaryon incompatibility,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,1.C.105.2.5, the bacillus thuringiensis vegetative insecticidal protein-3 (vip3) family.
RL4_JR_06554,34457,6803,19100,1,2,3,0,0,1,0,0,1,0,2,0,0,0,0,48.41001875,1,1.518645785,0.608025807,2.497666656,0.012501369,0.045390561,4.145606276,1,1.413974311,1.259171088,1.12294058,0.261462732,0.417762552,36.71462415,1,1.582109486,0.746044273,2.120664339,0.03395006,0.084553605,57.78030545,1,2.359895515,0.503451045,4.687437914,2.77E-06,4.52E-05,18.25439374,0,0.358976729,0.972786184,0.369019149,0.712113452,0.796965701,N,-,,peroxin 11c,C:cellular_component,IPR029058 (G3DSA:3.40.50.GENE3D); PTHR12652:SF25 (PANTHER); PTHR12652 (PANTHER),1.A.101.2.4, the peroxisomal pore-forming pex11 (pex11) family.
RL4_JR_06555,268,183,272,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,70.30320749,0,0.968275312,0.560135782,1.728643918,0.083872844,0.194605991,8.755517657,0,0.335325649,1.228454317,0.272965502,0.784879734,0.869397316,35.75181073,0,-0.501484224,1.042564381,-0.481010318,0.630509165,0.741390235,63.18315988,0,0.323384088,0.686280483,0.471212714,0.637488841,0.751755708,37.18180017,0,-0.709609079,0.983543344,-0.721482265,0.470612849,0.601939754,N,-,,increased rdna silencing 4,F:calcium ion binding,IPR000261 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR11216:SF81 (PANTHER); PTHR11216 (PANTHER); IPR000261 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY),,
RL4_JR_06556,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,22.58539279,1,3.127629248,0.669793522,4.669542398,3.02E-06,4.02E-05,1.114793629,0,3.30876974,1.381580822,2.394915801,0.016624182,0.049931743,2.890188455,0,0.65794233,1.205264248,0.545890522,0.585141194,0.706243377,7.345706316,0,1.182706452,1.147078638,1.031059609,0.302512867,0.448257395,10.56699626,0,2.246115518,0.976938554,2.299136941,0.021497164,0.057918784,N,-,,microtubule associated,P:spindle organization; C:microtubule cytoskeleton; C:cytoskeletal part; P:cytokinesis; F:microtubule binding,PF03999 (PFAM); IPR007145 (PANTHER); PTHR19321:SF0 (PANTHER),,
RL4_JR_06557,8,0,6,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,7.731962154,1,6.982415207,1.130403465,6.176923042,6.54E-10,1.87E-08,0.030724848,0,8.490024215,2.706393352,3.137025225,0.001706714,0.015023052,0.079150497,0,5.847147606,1.584430455,3.690378196,0.000223921,0.0018923,0.091254878,0,5.426423787,2.471548233,2.1955565,0.028123703,0.089208173,0.077661867,0,5.768628816,1.343036042,4.295215194,1.75E-05,0.00015977,N,-,,Cutinase transcription factor 1 beta,,no IPS match,,
RL4_JR_06558,503,597,586,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,127.7909645,1,2.600380129,0.803355545,3.236898214,0.001208365,0.006840973,6.406576636,0,0.785977588,1.23608129,0.635862378,0.524866126,0.674114317,30.97302173,0,-0.045228711,1.036989848,-0.043615385,0.965210988,0.979628676,19.18793552,0,-2.289256344,1.195835146,-1.914357804,0.055574453,0.130813304,58.85770786,0,2.020636065,0.561073268,3.601376467,0.000316537,0.001826174,Y,-,,hypothetical protein SPSK_07704,P:mycelium development; C:membrane,no IPS match,,
RL4_JR_06559,4,12,11,0,0,0,0,0,4,0,0,0,0,2,0,0,0,0,10.6685516,0,-1.517615008,1.214457587,-1.24962372,0.211437034,0.378804721,3.444041518,1,1.681492607,1.304978262,1.288521546,0.197564474,0.341021078,8.866256265,0,-0.959253756,1.216114221,-0.788785905,0.430237149,0.570718147,14.23487941,1,-0.435270019,1.167257884,-0.372899617,0.709223157,0.805122151,16.03598787,0,-0.092535327,1.138568294,-0.08127341,0.93522452,0.957748269,N,-,,glycosyltransferase family 4,C:integral component of membrane; F:transferase activity,IPR001296 (PFAM); IPR028098 (PFAM); G3DSA:3.40.50.2000 (GENE3D); PTHR12526 (PANTHER); PTHR12526 (PANTHER); PTHR12526:SF363 (PANTHER); PTHR12526:SF363 (PANTHER); SSF53756 (SUPERFAMILY),2.A.38.4.5, the k(+) transporter (trk) family.
RL4_JR_06560,183,300,255,0,0,2,0,0,0,0,0,0,0,0,0,0,2,6,107.1298378,1,2.49528938,0.703872566,3.545086851,0.000392484,0.002736652,5.974212172,0,0.886835139,1.262461164,0.702465283,0.482389045,0.639102345,21.89835316,0,-0.793953021,1.204655516,-0.65907059,0.509850441,0.641287844,31.08242756,0,-0.44242787,1.031621191,-0.428866598,0.66802031,0.773816819,48.75058304,1,1.383523089,0.63424935,2.181355155,0.029157158,0.073528325,N,-,,udp-glucose 6-dehydrogenase,F:NAD binding; P:polysaccharide biosynthetic process; F:UDP-glucose 6-dehydrogenase activity; P:oxidation-reduction process,IPR014027 (SMART); IPR017476 (TIGRFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR028357 (PIRSF); IPR017476 (PIRSF); IPR014027 (PFAM); G3DSA:1.20.5.100 (GENE3D); IPR014026 (PFAM); IPR001732 (PFAM); PTHR11374:SF3 (PANTHER); IPR017476 (PANTHER); PTHR11374:SF3 (PANTHER); IPR017476 (PANTHER); IPR016040 (SUPERFAMILY); IPR008927 (SUPERFAMILY); IPR014027 (SUPERFAMILY),,
RL4_JR_06561,167,237,143,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,108.9910263,1,-2.169887056,0.868327773,-2.49892624,0.012457024,0.045283291,36.72591715,0,-0.391979152,1.131700758,-0.346362896,0.729070006,0.831041284,83.5907356,0,-2.135908846,1.046702882,-2.040606636,0.041289942,0.098080566,90.72091511,0,-3.423159231,1.1563922,-2.960206089,0.003074333,0.018991838,80.86033506,0,-1.831817279,0.860446738,-2.1289142,0.03326136,0.081538706,N,-,,c6 zinc finger domain-containing,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31001 (PANTHER); PTHR31001:SF27 (PANTHER); PTHR31001 (PANTHER); PTHR31001:SF27 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_06562,3,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.45983511,0,1.182659029,0.882857693,1.33958059,0.180381738,0.337280361,2.543143449,0,2.118815328,1.298963474,1.631158512,0.102856877,0.206981572,6.623518439,0,-0.538830971,1.210872704,-0.444993904,0.65632416,0.76184289,7.642466387,0,-0.9614317,1.210992259,-0.793920599,0.427241657,0.569861912,6.561767323,0,-0.627866035,1.219465606,-0.514869819,0.606643993,0.714799305,N,-,,hypothetical protein SPBR_03267,C:membrane,no IPS match,,
RL4_JR_06563,5,3,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.88408436,0,-0.337785014,1.023991915,-0.329870782,0.741497601,0.864165305,5.046486925,0,1.130171384,1.253200372,0.901828159,0.367148159,0.531731817,13.13386415,0,-1.526366063,1.204996547,-1.266697458,0.205263489,0.331697935,15.15359491,0,-1.948901465,1.204581956,-1.617906905,0.105682662,0.204439617,13.00276276,0,-1.614538746,1.213961028,-1.329975764,0.183526257,0.302097764,N,-,,XAP5 domain-containing,"C:nucleus; C:nuclear chromatin; P:negative regulation of transcription, DNA-templated; P:DNA-templated transcription, termination",IPR007005 (PFAM); PTHR12722:SF0 (PANTHER); IPR007005 (PANTHER),,
RL4_JR_06564,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.284073836,0,-0.754105131,1.227878233,-0.614153025,0.539114212,0.721704886,1.988654893,0,2.47361733,1.325521392,1.866146669,0.062020848,0.139940933,5.189999654,0,-0.186949536,1.218160213,-0.153468759,0.878028625,0.923549278,34.57221618,0,1.743623851,0.870592772,2.002800744,0.04519868,0.115278131,5.149527964,0,-0.278154395,1.227572214,-0.226589028,0.820743325,0.879833368,N,-,,23S rRNA (adenine1618-N6)-methyltransferase,F:methyltransferase activity; F:transferase activity; P:methylation,IPR010286 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR13393:SF0 (PANTHER); IPR010286 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_06565,18,33,14,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,62.4313083,1,3.782474456,0.852209741,4.438431379,9.06E-06,0.000106367,1.65686406,0,2.737136415,1.347967974,2.030564871,0.042299154,0.103543419,4.277144509,0,0.09244615,1.209454339,0.076436246,0.939072034,0.963531496,8.944209897,0,0.617028697,1.154989195,0.534228977,0.593183123,0.716282274,26.29158304,0,2.25028189,0.843715118,2.66711102,0.007650639,0.025356047,Y,-,,glycoside hydrolase family 3,F:beta-glucosidase activity; C:extracellular region; P:cellulose catabolic process; C:plasma membrane; F:scopolin beta-glucosidase activity,IPR001764 (PRINTS); IPR026891 (SMART); IPR002772 (G3DSA:3.40.50.GENE3D); IPR002772 (PFAM); IPR026891 (PFAM); IPR001764 (PFAM); IPR001764 (G3DSA:3.20.20.GENE3D); PTHR30620:SF1 (PANTHER); IPR026892 (PANTHER); IPR017853 (SUPERFAMILY); IPR002772 (SUPERFAMILY),,
RL4_JR_06566,92,138,124,0,0,3,0,0,0,0,0,0,0,2,0,0,0,0,25.08018231,1,1.32548873,0.73202768,1.810708484,0.070185989,0.171225269,3.133807085,0,1.817611675,1.267117543,1.434445987,0.151445032,0.278653495,8.122917814,0,-0.833048917,1.191679254,-0.699054644,0.484517882,0.620369171,9.370161109,1,-1.255306605,1.1886895,-1.056042478,0.290948808,0.435788612,8.001196538,0,-0.914012281,1.192417387,-0.766520424,0.443366704,0.5766859,N,-,,"3 (2 ),5 -bisphosphate nucleotidase",P:phosphatidylinositol phosphorylation,IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); G3DSA:3.30.540.10 (GENE3D); IPR000760 (PANTHER); IPR000760 (PANTHER); PTHR20854:SF31 (PANTHER); PTHR20854:SF31 (PANTHER); IPR000760 (PANTHER); SSF56655 (SUPERFAMILY),,
RL4_JR_06567,1,5,2,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,44.52989274,0,3.128489952,0.607015626,5.153887012,2.55E-07,4.56E-06,1.926553723,0,2.519608344,1.363197164,1.848308088,0.064557786,0.144146508,4.958104305,0,-0.120610183,1.22716308,-0.098283745,0.921706985,0.954224514,19.04092403,1,1.193494478,1.045547007,1.141502458,0.25366089,0.393250116,4.843936275,0,-0.190040339,1.219805035,-0.155795667,0.876194086,0.917421419,N,-,,Sir2 family,"F:DNA binding; C:chromosome, telomeric region; F:NAD-dependent histone deacetylase activity; P:histone deacetylation; P:chromatin silencing at telomere; P:short-chain fatty acid metabolic process; F:NAD+ binding",IPR003000 (PFAM); IPR029035 (G3DSA:3.40.50.GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); PTHR11085:SF7 (PANTHER); PTHR11085:SF7 (PANTHER); IPR003000 (PANTHER); IPR003000 (PANTHER); IPR003000 (PANTHER); PTHR11085:SF7 (PANTHER); PTHR11085:SF7 (PANTHER); IPR026590 (PROSITE_PROFILES); IPR029035 (SUPERFAMILY),,
RL4_JR_06568,659,450,863,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,187.3154132,0,9.848726411,2.157631678,4.564600395,5.00E-06,6.29E-05,0.067033574,0,7.365178824,2.386528029,3.086148051,0.002027678,0.015023052,660.4280308,0,11.92768984,0.870329521,13.70479749,9.50E-43,4.81E-40,494.5881972,0,11.33430052,0.541253882,20.94082074,2.28E-97,2.88E-94,165.8135845,0,10.03199869,1.533603852,6.541453761,6.09E-11,4.47E-09,Y,-,,hypothetical protein F503_06029,,PTHR34612:SF2 (PANTHER); PTHR34612 (PANTHER),,
RL4_JR_06569,184,107,133,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,631.7176416,0,0.659305877,0.847637463,0.777815877,0.436677567,0.62673552,107.937735,0,-0.66625125,0.848213566,-0.785475824,0.432174639,0.593983211,409.3310981,0,-0.12190142,0.398475256,-0.305919674,0.759665806,0.838628237,543.4733569,0,0.453372092,0.458592446,0.988616574,0.322850774,0.46932722,321.2799528,0,-0.498179802,0.416385547,-1.196438745,0.231525389,0.35915345,N,-, Effector probability:0.579,malate dehydrogenase,P:carbohydrate metabolic process; F:L-malate dehydrogenase activity; P:malate metabolic process; C:mitochondrial matrix; F:mRNA binding; P:tricarboxylic acid cycle; P:replicative cell aging; P:chronological cell aging,IPR001236 (PFAM); IPR022383 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR010097 (TIGRFAM); IPR001557 (PIRSF); IPR015955 (G3DSA:3.90.110.GENE3D); PTHR11540:SF30 (PANTHER); IPR001557 (PANTHER); IPR016040 (SUPERFAMILY); IPR015955 (SUPERFAMILY),,
RL4_JR_06570,79,41,59,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,255.7806845,0,0.168731041,0.483557277,0.348937033,0.727136582,0.855862103,51.03247066,0,-0.998986766,1.131163363,-0.88314986,0.377155308,0.54172925,128.2120154,0,-2.156186828,0.870130094,-2.478005121,0.013211925,0.040227828,183.9898128,0,-0.90025181,1.448440242,-0.621531896,0.534249715,0.666824256,166.9062476,0,-0.353791837,0.762040477,-0.464269088,0.642454968,0.743922295,N,-,,cation-transporting atpase 4,F:ATPase activity; F:ATP binding; P:cation transport; F:metal ion binding; C:integral component of membrane,PR00119 (PRINTS); PF00702 (PFAM); IPR023214 (G3DSA:3.40.50.GENE3D); IPR023299 (G3DSA:3.40.1110.GENE3D); IPR008250 (G3DSA:2.70.150.GENE3D); IPR006544 (TIGRFAM); IPR008250 (PFAM); IPR001757 (TIGRFAM); IPR006544 (PTHR24093:PANTHER); IPR006544 (PTHR24093:PANTHER); PTHR24093 (PANTHER); IPR023214 (SUPERFAMILY); IPR023299 (SUPERFAMILY); SSF81653 (SUPERFAMILY); SSF81665 (SUPERFAMILY),3.A.3.10.3, the p-type atpase (p-atpase) superfamily.
RL4_JR_06571,91,46,50,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.893432879,0,2.060344131,1.657111676,1.243334509,0.213744593,NA,0.281571087,0,5.293835174,1.758753334,3.009992972,0.002612537,0.015349618,0.735516426,0,2.632138163,1.301731832,2.022027962,0.043173463,0.101084214,0.848933859,0,2.209104432,1.384695971,1.595371459,0.110629194,0.21162301,0.729255076,0,2.542382392,1.279317959,1.987295163,0.046889697,0.106615357,N,-,,hypothetical protein PFICI_13583,,IPR027796 (PFAM); PTHR42037 (PANTHER); PTHR42037:SF1 (PANTHER),,
RL4_JR_06572,21,16,25,0,0,0,0,0,0,4,0,0,0,1,0,0,0,0,56.38366983,0,-0.506782705,0.752654496,-0.673327147,0.500739186,0.687419134,11.09081318,0,-0.005819945,1.2125791,-0.004799642,0.996170455,0.997937453,99.12179705,1,1.168466614,0.547301988,2.134957736,0.032764463,0.082289114,42.59501521,1,-2.134017811,1.146256445,-1.86172808,0.062641428,0.140195505,35.8916008,0,-1.812118483,1.129975677,-1.603679194,0.108784784,0.203416185,N,-,,c2hc5 finger,C:cytoplasm,IPR009349 (PFAM); PTHR12963:SF0 (PANTHER); PTHR12963 (PANTHER); PTHR12963 (PANTHER); PTHR12963:SF0 (PANTHER),,
RL4_JR_06573,6,9,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,54.96448271,0,-0.058753253,0.691743425,-0.084935036,0.932313038,0.966922166,86.7430346,0,1.802760519,0.980641507,1.83834817,0.066011117,0.146655955,26.17180336,0,-2.520940693,1.196321062,-2.107244262,0.035096412,0.086388543,43.52058638,0,-1.208832304,1.021286518,-1.183636797,0.236556868,0.374240357,25.82524458,0,-2.60445727,1.200969125,-2.168629663,0.030110811,0.075381735,N,-,,fad binding domain,,PTHR38887:SF1 (PANTHER); PTHR38887:SF1 (PANTHER); PTHR38887:SF1 (PANTHER); PTHR38887 (PANTHER); PTHR38887 (PANTHER); PTHR38887:SF1 (PANTHER); PTHR38887 (PANTHER); PTHR38887 (PANTHER),,
RL4_JR_06574,5,15,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.988259248,0,-1.100284855,1.277505157,-0.861276253,0.389085911,0.581881368,2.603540448,0,2.085115044,1.397495263,1.49203729,0.13568937,0.255430129,6.669432597,0,-0.54854907,1.263248108,-0.434237001,0.664116346,0.76831378,7.687253797,0,-0.969634866,1.270285361,-0.763320507,0.445272275,0.587410622,21.22745868,0,1.109888127,1.041875145,1.065279398,0.286749513,0.421262162,N,-,,Iridoid synthase,,PTHR32487:SF8 (PANTHER); PTHR32487 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06575,7,13,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,264.1102444,0,-2.411106752,0.701190486,-3.438590226,0.000584752,0.003823249,68.74001989,0,-2.637558716,1.205588977,-2.187776072,0.028685918,0.076490743,199.8776528,0,-3.448201709,1.043591032,-3.304169549,0.000952582,0.005535425,232.9234128,0,-3.357378556,0.866946162,-3.872649425,0.000107659,0.001135462,174.7769999,0,-5.363160374,1.205933142,-4.447311537,8.70E-06,8.88E-05,N,-,,nitrate assimilation regulatory nira,"C:nucleus; F:zinc ion binding; F:protein heterodimerization activity; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31944:SF20 (PANTHER); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_06576,11,8,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,247.9106706,0,-1.843625661,0.719769191,-2.561412301,0.010424756,0.03913721,180.6563527,0,0.481882547,1.597829904,0.301585635,0.76296796,0.856371888,181.4912666,0,-4.262183984,1.1878033,-3.588291078,0.000332853,0.002527981,196.6081425,0,-5.646365591,1.186336554,-4.75949727,1.94E-06,3.30E-05,168.1208101,0,-5.307136266,1.193528569,-4.446593409,8.72E-06,8.90E-05,N,-,,aldo keto reductase,,IPR023210 (G3DSA:3.20.20.GENE3D); IPR023210 (PFAM); PTHR11732:SF255 (PANTHER); IPR001395 (PANTHER); IPR001395 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.6, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_06577,5724,8245,6632,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,86.35205163,0,-2.694275397,1.063585827,-2.533199792,0.011302651,0.041779351,25.47755634,0,-1.205612185,1.239940683,-0.972314403,0.33089416,0.493998627,81.16182679,0,-2.018827146,1.065071044,-1.8954859,0.058028058,0.126747801,107.5817821,0,-0.675009396,0.680242967,-0.992306321,0.321048121,0.467444956,71.63651311,0,-2.254206144,1.007556363,-2.23730029,0.02526672,0.065900449,N,-,,Nrm1,,IPR013734 (PFAM); PTHR28246 (PANTHER); PTHR28246:SF1 (PANTHER),,
RL4_JR_06578,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.503523859,0,-0.273533867,1.210986502,-0.225876891,0.821297171,0.90986066,1.433443352,0,2.945974513,1.346355583,2.188110295,0.028661569,0.076466105,3.726797691,0,0.29080569,1.206173471,0.241097733,0.80947937,0.875552258,4.299775256,0,-0.131675441,1.206559157,-0.109133017,0.913096988,0.94724457,3.683542676,0,0.205157383,1.209350282,0.169642647,0.865291181,0.910077049,N,-,,alcohol dehydrogenase 2,F:zinc ion binding; F:oxidoreductase activity; C:membrane; P:oxidation-reduction process,IPR020843 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013149 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR013154 (PFAM); PTHR11695:SF280 (PANTHER); IPR002085 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_06579,766,680,894,0,1,3,0,0,0,1,0,0,0,0,0,0,0,0,2.165346875,1,0.783153503,1.291579475,0.60635332,0.544280159,0.724936741,0.68636445,0,4.008407452,1.48091598,2.706708217,0.006795395,0.025353577,14.78505441,1,3.167131669,1.049435916,3.017937179,0.002545017,0.011995227,2.06275799,0,0.928185191,1.245637439,0.745148758,0.456181796,0.59823677,1.768381481,0,1.264085323,1.227497307,1.029807004,0.303100612,0.438350764,Y,-,,aspartyl protease,P:protein metabolic process; F:peptidase activity,IPR001461 (PRINTS); IPR021109 (G3DSA:2.40.70.GENE3D); IPR021109 (G3DSA:2.40.70.GENE3D); IPR033121 (PFAM); IPR001461 (PANTHER); PTHR13683:SF328 (PANTHER); IPR033121 (PROSITE_PROFILES); IPR021109 (SUPERFAMILY),8.A.32.1.4,The β-Amyloid Cleaving Enzyme (BACE1) Family
RL4_JR_06580,52,57,56,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,238.6665809,0,-0.399362396,0.678755569,-0.588374393,0.556281022,0.734445797,41.278336,0,-1.901791698,1.211449042,-1.569848695,0.116450316,0.228123455,138.0755944,0,-1.723697282,0.765069386,-2.252994715,0.024259482,0.064876672,198.2045258,0,-1.051697402,0.652108848,-1.612763581,0.106795881,0.205963485,123.8467125,1,-2.016308711,0.773072474,-2.608175533,0.009102626,0.029119776,N,-,,L10-interacting MYB domain-containing,,IPR024752 (PFAM); PTHR31704 (PANTHER),,
RL4_JR_06581,95,54,88,0,2,0,0,0,0,0,0,0,0,2,0,0,0,0,126.925651,1,-0.838070932,0.752708397,-1.113407177,0.265533594,0.445510219,24.14382155,0,-1.128058896,1.243144665,-0.907423671,0.364182796,0.52857159,68.74690408,0,-2.80918502,1.223404737,-2.296202504,0.021664305,0.059252781,71.77560658,1,-4.192610708,1.228929926,-3.411594606,0.000645841,0.005145139,88.09252751,0,-0.528622401,0.702499991,-0.752487413,0.451757997,0.583946089,N,-,,alpha beta hydrolase fold,P:metabolic process; F:hydrolase activity,IPR013094 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR23024:SF218 (PANTHER); PTHR23024 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_06582,74,89,94,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,810.787848,0,-1.976658393,0.367607478,-5.377089721,7.57E-08,1.53E-06,239.9880457,0,-1.619327878,0.777636153,-2.082372161,0.037308489,0.093892722,556.8310526,0,-4.017446418,0.750711555,-5.351518023,8.72E-08,3.03E-06,630.8671963,0,-4.532393111,0.748285009,-6.05704118,1.39E-09,4.46E-08,595.2893884,0,-2.41387579,0.999413967,-2.415291231,0.015722633,0.045058493,N,-,,DUF757 domain-containing,C:nucleus; C:cytosol; C:ribosome,IPR023139 (G3DSA:1.10.3560.GENE3D); IPR021148 (PFAM); IPR008476 (PANTHER),,
RL4_JR_06583,651,106,265,12,4,5,0,0,0,1,0,1,0,0,2,0,13,0,60.45409246,1,0.313898627,0.738477983,0.425061592,0.670791776,0.817535882,6.478050012,0,0.770002658,1.237921967,0.622012274,0.533933797,0.682125192,16.74513914,1,-1.876634377,1.193183094,-1.572796654,0.115765911,0.216278664,47.24993788,1,0.03322593,0.849148405,0.039128532,0.968787913,0.982666562,24.16541919,1,-0.282776889,0.970265759,-0.291442717,0.770712748,0.841162723,N,-,,ABC a-pheromone efflux pump,"F:nucleotide binding; P:peptide pheromone export; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:membrane; C:cell part",IPR003593 (SMART); IPR011527 (PFAM); IPR003439 (PFAM); G3DSA:1.20.1560.10 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24221 (PANTHER); PTHR24221 (PANTHER); PTHR24221:SF259 (PANTHER); PTHR24221:SF259 (PANTHER); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.206.1, the atp-binding cassette (abc) superfamily.
RL4_JR_06584,2,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.002549198,0,-0.103448992,1.224854652,-0.084458178,0.932692153,0.966946573,1.272982036,0,3.117220534,1.368678657,2.277540106,0.022753992,0.063764095,3.31243522,0,0.460779271,1.213682972,0.379653733,0.704202469,0.798985296,3.821845212,0,0.038265158,1.216419494,0.031457205,0.974904921,0.98517231,3.277806912,0,0.373499866,1.217491421,0.306778232,0.759012178,0.831913871,N,-,,translin-associated factor,P:biological_process; C:nucleus; F:sequence-specific DNA binding; C:cellular_component; F:molecular_function,IPR016069 (G3DSA:1.20.58.GENE3D); IPR002848 (PFAM); IPR016068 (G3DSA:1.20.58.GENE3D); PTHR10741:SF5 (PANTHER); IPR002848 (PANTHER); IPR002848 (SUPERFAMILY),,
RL4_JR_06585,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,61.6112302,0,2.392663009,0.590237111,4.053731907,5.04E-05,0.000471043,3.310183116,0,1.738502176,1.291202871,1.346420625,0.178166903,0.315638633,8.649814634,0,-0.923824628,1.219603926,-0.757479217,0.448762812,0.588354663,26.0291643,0,1.334544377,0.800564206,1.667004803,0.09551345,0.189325309,20.17586758,0,1.157004314,0.906205227,1.276757494,0.201687876,0.323730144,N,-,,gpi mannosyltransferase,"P:GPI anchor biosynthetic process; F:transferase activity, transferring hexosyl groups; C:integral component of membrane",IPR007704 (PFAM); PTHR12886:SF0 (PANTHER); PTHR12886:SF0 (PANTHER); IPR007704 (PANTHER); IPR007704 (PANTHER),,
RL4_JR_06586,50,57,63,0,0,26,0,0,0,7,5,2,5,30,0,0,2,2,91.58426905,1,0.44989555,0.541697692,0.83052883,0.406239855,0.597890084,12.99993147,0,-0.234902951,1.227540126,-0.19136071,0.848243,0.909814098,46.59802099,1,-1.064547976,1.045360548,-1.018354842,0.308509354,0.449661489,38.7510579,1,-3.303365294,1.201612551,-2.749110179,0.00597573,0.032286159,69.85332507,1,0.033614691,0.696160409,0.048285842,0.961488438,0.97457908,N,-,,hypothetical protein CMQ_2473,,no IPS match,,
RL4_JR_06587,384,111,174,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,1257.948424,0,1.352289162,0.515411046,2.623710089,0.008697778,0.033862717,114.4159154,0,-3.372631924,1.191101327,-2.831523942,0.004632677,0.019672352,339.9325634,0,-2.876638744,0.678406131,-4.240290018,2.23E-05,0.000366287,600.5215367,1,-0.29879293,0.543184981,-0.550075831,0.582267363,0.708134489,344.0465435,1,-2.086352224,0.757685832,-2.753584844,0.005894649,0.020495646,N,-,,nad dependent epimerase dehydratase,F:coenzyme binding; F:catalytic activity,IPR016040 (G3DSA:3.40.50.GENE3D); IPR029903 (PFAM); PTHR10366 (PANTHER); PTHR10366:SF405 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06588,2885,765,1983,0,0,0,0,0,0,0,0,5,0,0,1,0,0,1,415.5871008,0,7.026545706,2.333955274,3.010574275,0.002607542,0.012911966,1.015961063,0,3.44263376,1.399040521,2.460710543,0.013866219,0.043279021,28.04889291,1,3.199530651,0.853658625,3.74802123,0.000178235,0.001640412,63.07183701,1,4.537044347,0.480659359,9.439209408,3.76E-21,3.88E-19,18.04501741,1,3.306751883,0.767811172,4.306725407,1.66E-05,0.000153206,Y,-,,subtilisin-like protease,F:serine-type peptidase activity,IPR015500 (PRINTS); IPR010259 (G3DSA:3.30.70.GENE3D); IPR000209 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); PTHR10795:SF420 (PANTHER); PTHR10795:SF420 (PANTHER); IPR015500 (PANTHER); IPR000209 (SUPERFAMILY),1.I.3.1.1,The Bacterial (Planctomycetes) Nuclear Pore-like Complex (B-NPC) Family
RL4_JR_06589,33597,19231,20679,12,13,9,0,0,1,0,0,1,9,8,2,4,4,0,259.4545503,1,0.744376263,0.435990448,1.707322411,0.087762143,0.200944025,147.2533747,1,1.50769312,1.598212109,0.943362343,0.345495598,0.508670028,274.9429457,1,1.107261426,0.38929616,2.844264958,0.004451401,0.017386326,120.4676094,1,-1.331559637,0.626520233,-2.125325835,0.033559434,0.098176616,201.3012525,1,0.016947241,0.60738183,0.02790212,0.977740217,0.985232852,N,-,,squalene synthetase,C:endoplasmic reticulum membrane; F:geranyltranstransferase activity; F:oxidoreductase activity; C:integral component of membrane; P:ergosterol biosynthetic process; P:oxidation-reduction process; P:isoprenoid biosynthetic process; C:mitochondrial outer membrane; F:farnesyl-diphosphate farnesyltransferase activity; F:squalene synthase activity,IPR002060 (PFAM); IPR008949 (G3DSA:1.10.600.GENE3D); IPR006449 (TIGRFAM); PTHR11626:SF2 (PANTHER); PTHR11626 (PANTHER); IPR008949 (SUPERFAMILY),,
RL4_JR_06590,9264,10437,8500,5,2,13,0,0,1,1,2,5,0,9,4,2,1,0,244.2811294,1,0.399685868,0.512212161,0.780313118,0.435206594,0.625844419,36.56189104,1,-1.72673334,1.194212021,-1.445918572,0.148200042,0.274187686,194.4174268,1,-0.083212055,0.461355366,-0.180364337,0.85686655,0.908844102,176.5012799,1,-0.743329292,0.476476233,-1.560055341,0.118746804,0.222691497,135.6371152,1,-0.444150805,0.513186578,-0.86547627,0.386777435,0.522976747,N,-,,DNAJ domain containing,P:protein import into peroxisome matrix; P:mycelium development; C:cytosol,IPR001623 (PRINTS); IPR001623 (SMART); IPR001623 (G3DSA:1.10.287.GENE3D); IPR026894 (PFAM); IPR001623 (PFAM); PTHR24078 (PANTHER); IPR001623 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_06591,22425,12665,8986,18,2,6,1,0,0,2,0,1,10,6,0,0,0,0,12.9909311,1,-1.801819745,1.192539313,-1.510910144,0.130811346,0.268197778,4.17346059,1,1.404318884,1.265144021,1.110007131,0.266995954,0.424326118,10.78184778,1,-1.241517024,1.198689749,-1.035728406,0.300328866,0.441231961,28.48100182,1,1.045160037,0.756574336,1.381437338,0.167144532,0.288097136,10.58530005,0,-1.317862855,1.19587592,-1.102006348,0.270458912,0.402823843,N,-,,hypothetical protein HMPREF1624_03885,P:biological_process; C:cellular_component; F:molecular_function,PTHR38701 (PANTHER),,
RL4_JR_06592,18,53,107,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,48.71276144,0,1.32092828,0.657283792,2.009677245,0.04446536,0.121809404,5.76409906,0,0.938342593,1.254602095,0.747920473,0.454508128,0.614059166,15.02813693,0,-1.720725682,1.211101999,-1.420793363,0.155376841,0.269263118,34.6764183,0,0.163885542,0.882271507,0.185754091,0.852637608,0.907897583,14.90687817,0,-1.811690695,1.222463807,-1.481999454,0.13834044,0.243896388,N,-,,heme steroid-binding domain,F:binding,IPR001199 (SMART); IPR001199 (PFAM); IPR001199 (G3DSA:3.10.120.GENE3D); PTHR19370 (PANTHER); IPR001199 (PROSITE_PROFILES); IPR001199 (SUPERFAMILY),,
RL4_JR_06593,50,20,37,0,0,1,0,0,0,0,0,0,0,0,5,0,0,0,10.81410029,1,-1.537054709,1.191781333,-1.289712019,0.197150665,0.359650073,3.468198176,0,1.671391682,1.272230681,1.313748919,0.188930713,0.32965983,8.964362659,0,-0.97509892,1.19687533,-0.814703834,0.415241858,0.556869136,10.33922599,1,-1.397116842,1.194605822,-1.169521206,0.242193702,0.380600844,8.800520547,0,-1.051406926,1.192730196,-0.881512792,0.378040333,0.513779648,N,-,,DNA damage response,"P:GPI anchor biosynthetic process; F:transferase activity, transferring hexosyl groups; C:membrane; C:integral component of membrane",IPR032429 (PFAM); IPR000253 (G3DSA:2.60.200.GENE3D); IPR023210 (G3DSA:3.20.20.GENE3D); IPR023210 (PFAM); IPR000253 (PFAM); PTHR12162:SF0 (PANTHER); PTHR12162 (PANTHER); PTHR12162 (PANTHER); PTHR12162:SF0 (PANTHER); IPR000253 (PROSITE_PROFILES); IPR008984 (SUPERFAMILY); IPR023210 (SUPERFAMILY),8.A.5.1.6, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_06594,4358,4197,4202,0,1,5,0,0,0,0,1,0,0,2,3,0,6,3,0.037130691,1,6.650178182,3.935429899,1.689822548,0.091061909,NA,0.012046834,0,9.842532136,3.935018414,2.50126711,0.01237498,0.039576477,0.030706339,1,7.217751826,2.540425827,2.841158262,0.004495,0.017496109,0.03539607,1,6.794208972,3.935484911,1.726396905,0.084276032,0.172139364,0.029533298,1,7.170064943,1.654549561,4.333544979,1.47E-05,0.000138583,N,-,,glycoside hydrolase family 18,"P:metabolic process; F:hydrolase activity, acting on glycosyl bonds",IPR011583 (SMART); IPR001002 (G3DSA:3.30.60.GENE3D); IPR013781 (G3DSA:3.20.20.GENE3D); IPR001223 (PFAM); PTHR11177:SF218 (PANTHER); PTHR11177 (PANTHER); PTHR11177:SF218 (PANTHER); PTHR11177 (PANTHER); PTHR11177:SF218 (PANTHER); IPR001002 (PRODOM); IPR001002 (SUPERFAMILY); IPR017853 (SUPERFAMILY); IPR029070 (SUPERFAMILY),9.B.29.2.7, the small 4-5 tms putative permease (4-5pp) family.
RL4_JR_06595,498,549,685,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,0.477298418,1,2.964587857,2.122893328,1.396484608,0.162568612,NA,0.149804821,0,6.203909685,1.983387901,3.127935631,0.001760387,0.015023052,0.393428489,0,3.533649153,1.355550238,2.606800585,0.009139257,0.030466196,0.454185134,0,3.110951488,1.541259434,2.018447654,0.043544661,0.113446415,0.393124252,1,3.433678496,1.311291565,2.618546926,0.008830515,0.028422815,N,-, Effector probability:0.663,glycoside hydrolase family 18,"F:hydrolase activity, hydrolyzing O-glycosyl compounds; P:organic substance metabolic process",IPR029226 (PFAM); PTHR11177:SF218 (PANTHER); PTHR11177 (PANTHER),,
RL4_JR_06596,2912,3137,4660,1,4,4,0,0,0,0,0,0,0,1,0,0,0,0,0.908256782,1,2.036275282,1.587326513,1.282833283,0.199550491,NA,0.29074795,0,5.247578983,1.73453468,3.025352588,0.002483434,0.015349618,0.754210127,0,2.595296086,1.280636503,2.02656732,0.042706682,0.100377978,0.869972389,1,2.173384607,1.351470697,1.608162583,0.107799576,0.207448821,0.744762034,0,2.510898342,1.256006383,1.999112725,0.045596159,0.10447185,N,-,,IBR finger domain-containing,F:ubiquitin-protein transferase activity; F:zinc ion binding; F:metal ion binding; P:protein ubiquitination,IPR013083 (G3DSA:3.30.40.GENE3D); IPR031127 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),,
RL4_JR_06597,2036,2132,2825,0,2,2,0,0,0,0,0,1,0,4,0,0,3,0,5.68154707,1,1.946552738,1.158448338,1.680310355,0.092896947,0.209688885,0.592892724,0,4.219620388,1.499706083,2.813631575,0.004898533,0.020348467,1.541138173,1,1.564731891,1.220901712,1.281619868,0.199976027,0.325543865,1.778086212,1,1.142308706,1.235767546,0.924371829,0.355292757,0.501511106,1.522512372,1,1.479910673,1.214460534,1.218574529,0.223005721,0.349687615,N,-,,het domain-containing,,IPR010730 (PFAM); PTHR33112 (PANTHER); PTHR33112:SF6 (PANTHER),,
RL4_JR_06598,733,866,1056,0,0,0,0,0,0,0,0,1,0,2,1,0,0,0,30.69127095,0,8.153270278,0.955953717,8.528938306,1.48E-17,1.37E-15,0.045988089,0,7.908937722,2.562734296,3.086132547,0.002027784,0.015023052,175.8063013,1,10.57296693,1.29098617,8.189837483,2.62E-16,3.12E-14,9.7714586,1,5.817210075,1.252448822,4.644668885,3.41E-06,5.46E-05,0.114722142,0,5.211328514,1.376147548,3.786896632,0.000152541,0.000987515,N,-,,Dihydroxyacetone kinase 2,P:glycerol metabolic process; F:ATP binding; F:glycerone kinase activity; P:phosphorylation,IPR004007 (SMART); G3DSA:3.30.1180.20 (GENE3D); G3DSA:3.40.50.10440 (GENE3D); IPR004006 (PFAM); IPR012734 (TIGRFAM); IPR004007 (PFAM); PTHR28629:SF4 (PANTHER); PTHR28629 (PANTHER); IPR004006 (PROSITE_PROFILES); IPR004007 (PROSITE_PROFILES); SSF82549 (SUPERFAMILY); IPR004007 (SUPERFAMILY),,
RL4_JR_06599,1589,2273,2550,0,3,9,0,0,0,0,1,0,0,5,0,0,0,0,130.2343643,1,8.368812972,1.984119742,4.217897132,2.47E-05,0.000250834,0.128419029,0,6.426869507,2.083673105,3.084394328,0.002039671,0.015023052,604.2599855,1,10.83499194,1.487037507,7.286293652,3.19E-13,2.69E-11,74.24151221,1,7.488336803,0.706923179,10.59285794,3.22E-26,4.31E-24,0.325608727,0,3.70621097,1.323110695,2.801134466,0.00509233,0.018180478,N,-,,transketolase,F:transketolase activity; P:metabolic process,IPR005475 (SMART); IPR005474 (PFAM); IPR029061 (G3DSA:3.40.50.GENE3D); IPR009014 (G3DSA:3.40.50.GENE3D); IPR005475 (PFAM); IPR029061 (G3DSA:3.40.50.GENE3D); PTHR11624:SF69 (PANTHER); IPR033247 (PANTHER); PTHR11624:SF69 (PANTHER); IPR033247 (PANTHER); IPR029061 (SUPERFAMILY); IPR009014 (SUPERFAMILY); IPR029061 (SUPERFAMILY),,
RL4_JR_06600,7231,8144,8450,12,2,38,0,0,0,1,1,5,1,25,4,0,15,0,19.32330722,1,7.016570035,0.731638471,9.590214718,8.79E-22,1.38E-19,0.073486262,0,7.231662024,2.232609304,3.239107716,0.001199043,0.015023052,258.1191827,1,10.46741458,0.633070346,16.5343625,2.08E-61,1.91E-58,86.93798947,1,8.581793844,1.919437917,4.470993185,7.79E-06,0.000114579,0.189027377,1,4.488991197,1.268284966,3.539418443,0.00040101,0.002246941,N,-,,MFS hexose transporter,C:integral component of plasma membrane; P:proton transport; F:sugar:proton symporter activity; P:glucose import; F:glucose transmembrane transporter activity; P:glucose transmembrane transport,IPR003663 (TIGRFAM); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500 (PANTHER); PTHR23500:SF1 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.10, the major facilitator superfamily (mfs).
RL4_JR_06601,3332,3750,6501,0,1,4,0,0,0,0,0,2,0,12,0,0,1,0,111.4187615,1,7.389207883,2.028718099,3.642303918,0.000270209,0.001985913,0.213182116,0,5.695336911,2.036269265,2.796946852,0.005158802,0.021097936,632.72376,1,10.15285734,1.686770204,6.019111152,1.75E-09,8.79E-08,19.91428925,1,4.636556055,1.539549424,3.011631833,0.002598475,0.016484689,23.71533089,1,5.904626706,1.009508626,5.849010649,4.95E-09,2.45E-07,N,-,,alcohol dehydrogenase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR013149 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR013154 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR11695:SF511 (PANTHER); IPR002085 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_06602,3688,4064,3478,0,2,0,0,0,0,2,3,0,3,3,3,0,0,0,12.12638016,1,4.708212791,0.993340951,4.739775188,2.14E-06,2.99E-05,0.213502932,0,5.693388121,1.879641442,3.028975629,0.002453845,0.015349618,94.22354308,1,7.484612751,1.058849754,7.068625856,1.56E-12,1.22E-10,9.950051264,1,3.580673223,1.212459472,2.953231266,0.003144663,0.019321193,15.98426808,0,5.511560635,0.878381443,6.27467791,3.50E-10,2.20E-08,N,-,,cellulose-binding,,IPR011483 (PFAM); PTHR33307:SF1 (PANTHER); PTHR33307 (PANTHER),,
RL4_JR_06603,14431,17572,23122,3,1,7,0,0,0,0,0,1,2,0,0,0,0,2,231.6553252,1,4.463747317,2.124063469,2.101513153,0.035595945,0.10319535,3.281664272,0,1.751167493,1.300655052,1.346373499,0.178182093,0.315638633,59.32313403,1,2.729529876,0.604360915,4.516390471,6.29E-06,0.000126858,59.03355427,1,2.240722459,0.609029205,3.679170785,0.000233994,0.002189635,46.88017519,1,2.87926205,0.576549947,4.993950765,5.92E-07,9.19E-06,N,-,,NAD(P)H-dependent D-xylose reductase xyl1,F:oxidoreductase activity; P:oxidation-reduction process,IPR020471 (PRINTS); IPR020471 (PIRSF); IPR023210 (G3DSA:3.20.20.GENE3D); IPR023210 (PFAM); IPR001395 (PANTHER); PTHR11732:SF218 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.5, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_06604,4380,6343,8040,0,1,0,0,0,4,1,0,0,2,3,0,0,3,0,64.97619604,1,0.605018177,0.675573701,0.895562062,0.370486706,0.562731436,25.44958773,1,2.356126531,1.009779855,2.333307126,0.019632032,0.056630215,23.77952791,1,-0.960292365,1.197293554,-0.802052564,0.422522553,0.563883249,27.9523573,1,-0.621546986,1.024554121,-0.606651199,0.544082415,0.674358483,24.32286751,1,-1.062904401,1.124375737,-0.945328475,0.344491205,0.481498268,N,-,,Transcriptional regulatory pro-1,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR37534:SF2 (PANTHER); PTHR37534 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_06605,287,275,353,0,0,16,0,0,0,0,0,0,0,0,0,0,0,0,20.82985358,1,0.973543682,0.848173098,1.147812498,0.251045977,0.428310122,2.999765939,0,1.880673091,1.275703904,1.474223826,0.140421337,0.262628376,7.771727211,0,-0.769332545,1.195761408,-0.643382986,0.519975621,0.650250765,8.964588665,0,-1.191522143,1.193344539,-0.998472866,0.318050115,0.464080908,7.65416078,0,-0.850096467,1.196497934,-0.7104872,0.477402066,0.607019454,N,-,,C6 zinc finger domain-containing,,IPR003480 (PFAM); IPR023213 (G3DSA:3.30.559.GENE3D); IPR021858 (PFAM); IPR023213 (G3DSA:3.30.559.GENE3D); PTHR31313:SF27 (PANTHER); PTHR31313 (PANTHER); SSF52777 (SUPERFAMILY),,
RL4_JR_06606,3227,4923,3352,0,11,11,0,0,0,1,0,3,2,5,2,0,10,4,32.39935693,1,1.882911152,0.699654216,2.691202465,0.007119497,0.028953569,31.14345654,0,4.040468617,0.890279389,4.538427674,5.67E-06,0.000408435,7.826956665,1,-0.779423212,1.216060592,-0.640941099,0.521560952,0.65172588,18.34394726,1,-0.250046959,1.164697462,-0.214688335,0.830010318,0.893741834,22.46178854,1,0.837148767,0.999513096,0.837556577,0.402279789,0.539409729,N,-, Effector probability:0.601,Membrane- eicosanoid glutathione metabolism (MAPEG),C:integral component of membrane,IPR023352 (G3DSA:1.20.120.GENE3D); IPR001129 (PFAM); PTHR35371 (PANTHER); PTHR35371:SF2 (PANTHER); SSF161084 (SUPERFAMILY),,
RL4_JR_06607,43,78,30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.12132464,0,-1.701611345,1.196997914,-1.42156584,0.155152327,0.304207833,3.86961518,0,1.513370926,1.263054215,1.198183663,0.230845524,0.380927433,10.02602914,0,-1.136569248,1.197809017,-0.948873512,0.342684948,0.486158378,48.81493709,0,1.200372072,0.746672074,1.607629525,0.107916342,0.207610291,9.86160433,0,-1.215530359,1.197496401,-1.015059718,0.310077362,0.445766476,N,-,,FAD dependent oxidoreductase,"F:iron ion binding; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:heme binding",IPR023753 (G3DSA:3.50.50.GENE3D); G3DSA:3.30.9.10 (GENE3D); IPR006076 (PFAM); PTHR10961 (PANTHER); PTHR10961:SF21 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_06608,7355,8205,9646,0,0,3,0,0,0,0,3,1,4,1,0,0,2,0,71.40095519,1,3.037753058,0.551378358,5.50938029,3.60E-08,7.94E-07,2.959673236,0,1.900177778,1.324749072,1.434368076,0.151467253,0.278653495,7.619976145,1,-0.740639777,1.22331753,-0.605435432,0.544889714,0.672089205,8.78683399,1,-1.162377762,1.22448,-0.949282767,0.342476816,0.489499365,7.444744191,1,-0.810031201,1.218494017,-0.664780614,0.506190824,0.633051148,N,-,,Tetrapeptide OPT1 isp4,P:transmembrane transport; C:integral component of membrane,IPR004813 (TIGRFAM); IPR004648 (TIGRFAM); IPR004813 (PFAM); PTHR22601 (PANTHER); PTHR22601:SF16 (PANTHER),2.A.67.1.5, the oligopeptide transporter (opt) family.
RL4_JR_06609,650,1007,1203,0,0,3,0,0,0,0,0,0,0,3,0,0,0,0,11.55791062,1,1.020373236,1.147882851,0.888917571,0.374047381,0.56638423,39.4697052,0,4.208247691,1.116506528,3.769120543,0.000163824,0.007337275,2.941052015,0,0.632405573,1.21151661,0.521994967,0.601673835,0.719670122,3.392657933,1,0.210168088,1.214305315,0.173076808,0.862591054,0.915006226,2.900961176,0,0.549573557,1.210060843,0.454170185,0.649706341,0.750003044,Y,-,,poly(3-hydroxybutyrate) depolymerase,C:extracellular region,IPR029058 (G3DSA:3.40.50.GENE3D); IPR010126 (PFAM); PTHR38050 (PANTHER); PTHR38050:SF2 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_06610,77,130,104,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.004235441,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001340044,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003452355,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003983613,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003339785,0,10.24113992,1.835951848,5.578109216,2.43E-08,8.07E-07,N,-,,C6 zinc finger domain,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR021858 (PFAM); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_06611,133,201,151,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0.008470882,0,8.791019641,4.031633903,2.180510397,0.029219649,NA,0.002680088,0,12.01721297,4.032710343,2.979934573,0.0028831,0.015349618,0.006904709,0,9.374372631,4.033343739,2.324218623,0.02011378,0.055743746,0.007967227,0,8.951770626,4.033311655,2.219459191,0.026455501,0.08636862,0.006679571,1,9.335361424,1.822923296,5.121093929,3.04E-07,5.22E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_06612,5194,5412,10796,0,2,8,0,0,5,0,0,0,0,4,0,0,3,0,74.20144007,1,0.807093529,0.504758728,1.598968941,0.109827504,0.236950261,10.04043666,1,0.137759021,1.211797961,0.113681509,0.909490271,0.949547243,54.73253067,0,0.306735297,0.737708942,0.415794468,0.677560408,0.778352612,38.07348087,1,-1.20803822,1.010728784,-1.195215017,0.232003033,0.369112305,52.3561719,1,0.599517298,0.620226378,0.966610449,0.333738809,0.47043094,N,-,,acid phosphatase,C:membrane; C:integral component of membrane; P:attachment of GPI anchor to protein; C:GPI-anchor transamidase complex; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); PTHR42103 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_06613,977,935,1708,0,0,0,0,0,0,1,0,0,0,4,0,0,0,0,57.48341643,0,-0.331667102,0.668575336,-0.496080373,0.619837706,0.781764585,12.26589924,0,-0.151073142,1.209991429,-0.124854721,0.900638565,0.944488746,80.70906328,1,0.352730213,0.666238345,0.529435473,0.596503396,0.715690967,48.73329283,1,-0.920350235,0.853454846,-1.078381872,0.280863374,0.424312393,68.55217548,0,0.335949309,0.620801928,0.54115378,0.588401593,0.700689702,N,-,,patatin-like phospholipase,P:lipid metabolic process; F:hydrolase activity,IPR021771 (PFAM); IPR002641 (PFAM); G3DSA:3.40.1090.10 (GENE3D); PTHR14226:SF33 (PANTHER); PTHR14226 (PANTHER); IPR016035 (SUPERFAMILY),,
RL4_JR_06614,18457,18285,24398,6,23,6,0,0,2,0,4,9,1,0,0,0,5,0,30.11614599,1,-0.024737577,0.857586188,-0.028845587,0.976987743,0.988376241,5.996920952,1,0.88134427,1.247928892,0.706245585,0.480035427,0.637235225,15.48587598,1,-1.76385046,1.197577426,-1.472848787,0.140791814,0.24997831,53.81945879,1,0.875549506,0.677143615,1.293004153,0.196009623,0.325771082,22.91489838,1,-0.170686024,0.97598968,-0.174885071,0.861169941,0.907870562,N,-,,heterokaryon incompatibility het-6,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR010730 (PFAM); PTHR24148 (PANTHER); PTHR24148:SF25 (PANTHER),,
RL4_JR_06615,174,119,255,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0.075220449,1,5.630042256,3.920925116,1.4358964,0.151031823,NA,0.023374337,0,8.882703214,2.883679645,3.080336344,0.00206767,0.015023052,0.061859979,0,6.200421174,1.715967081,3.613368371,0.000302245,0.002337606,0.071443143,0,5.778988952,2.767065588,2.088490051,0.036753652,0.101814152,0.062340297,0,6.092052129,1.428353168,4.26508812,2.00E-05,0.000179522,N,-,,serine threonine variant 2,F:kinase activity,G3DSA:1.10.510.10 (GENE3D); PTHR24055 (PANTHER); PTHR24055:SF229 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_06616,5,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.124779959,0,4.900226738,3.632719608,1.34891411,0.177364555,NA,0.03977323,0,8.117721103,2.513258801,3.229958292,0.001238083,0.015023052,0.10312018,0,5.467495386,1.449319704,3.772456395,0.000161648,0.00155121,0.118965113,0,5.044391779,2.164907796,2.330072342,0.019802328,0.076496975,0.101466658,0,5.388893597,1.282239682,4.202719407,2.64E-05,0.000226868,N,-,,serine threonine CMGC group,F:nucleotide binding; F:protein kinase activity; P:phosphorylation,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); PTHR24055 (PANTHER); PTHR24055:SF199 (PANTHER); PTHR24055:SF199 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_06617,151,132,177,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.00781203,0,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,0,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,0,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,0.007662926,0,9.0007212,4.037607722,2.229221316,0.025799183,0.085851084,0.006329724,0,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,N,-,,carbohydrate-binding module family 35,"F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR013781 (G3DSA:3.20.20.GENE3D); IPR013812 (G3DSA:2.60.40.GENE3D); IPR008979 (G3DSA:2.60.120.GENE3D); IPR006102 (PFAM); PTHR10066 (PANTHER); PTHR10066:SF68 (PANTHER); IPR017853 (SUPERFAMILY); IPR006102 (SUPERFAMILY); IPR008979 (SUPERFAMILY); IPR006102 (SUPERFAMILY),,
RL4_JR_06618,2506,2797,2751,3,1,5,0,0,1,5,0,2,0,6,0,0,0,0,0.418576645,1,3.154016652,2.167902245,1.454870329,0.145705164,NA,0.135309799,1,6.351351266,2.002027267,3.172459921,0.001511534,0.015023052,0.348356447,1,3.710467602,1.322066829,2.80656584,0.005007268,0.018936713,0.401655696,1,3.288793599,1.514574393,2.171430874,0.029898617,0.092069191,0.340978935,0,3.637107181,1.255390009,2.897193027,0.00376518,0.014208889,N,-, Effector probability:0.648,---NA---,,no IPS match,,
RL4_JR_06619,117,48,97,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,198.293078,0,0.637823044,0.494889956,1.288817921,0.197461394,0.359938148,26.06723241,0,-1.238622588,1.247602485,-0.992802277,0.32080632,0.482855252,94.26735584,0,-1.072305905,0.802448092,-1.336293171,0.181453468,0.302641665,150.5134777,0,0.073422346,0.561701694,0.130714127,0.896001457,0.935798759,88.41289044,0,-0.820897625,0.719022859,-1.141685017,0.253584971,0.384478561,N,-,,kelch domain-containing,P:regulation of filamentous growth; C:endoplasmic reticulum; P:positive regulation of cell-substrate adhesion; P:signal transduction involved in conjugation with cellular fusion,IPR015915 (G3DSA:2.120.10.GENE3D); PF13415 (PFAM); PTHR10681:SF102 (PANTHER); PTHR10681 (PANTHER); SSF117281 (SUPERFAMILY),,
RL4_JR_06620,213,127,136,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,945.9271184,0,0.57909519,0.489585721,1.18282696,0.236877733,0.410967464,159.7771111,0,-0.958860706,0.887601246,-1.08028319,0.280016093,0.439089527,443.5627515,0,-1.27335887,0.548782965,-2.320332355,0.020322905,0.056261715,471.0488161,0,-1.874362269,0.798610453,-2.347029469,0.018923758,0.074786514,339.9431665,0,-2.968192934,0.73893544,-4.016850151,5.90E-05,0.000444665,N,-, Effector probability:0.752,mitochondrial peroxiredoxin prx1,C:mitochondrion; F:thioredoxin peroxidase activity; P:cellular oxidant detoxification; P:cellular response to oxidative stress; P:cell redox homeostasis; P:response to cadmium ion; P:oxidation-reduction process,IPR012336 (G3DSA:3.40.30.GENE3D); IPR000866 (PFAM); G3DSA:3.30.1020.10 (GENE3D); IPR024706 (PIRSF); IPR019479 (PFAM); PTHR10681 (PANTHER); PTHR10681:SF99 (PANTHER); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY),,
RL4_JR_06621,1135,939,484,0,0,8,0,0,0,0,1,1,0,0,1,0,0,0,68.69157256,1,0.796528634,0.721166895,1.10449972,0.269376425,0.450506944,8.210529162,0,0.428078715,1.31445542,0.325670014,0.744674034,0.842753866,21.0345635,1,-2.205693212,1.249991214,-1.764566973,0.07763657,0.159172264,36.27955448,1,-0.382686871,0.966842291,-0.395811059,0.692244418,0.792332662,20.49085354,0,-2.270738537,1.251681143,-1.814150951,0.069654489,0.144400431,N,-,,fatty acid transporter,C:lipid particle; C:peroxisome; F:very long-chain fatty acid-CoA ligase activity; P:long-chain fatty acid metabolic process; P:long-chain fatty acid transport; C:integral component of membrane; C:endoplasmic reticulum; P:very long-chain fatty acid metabolic process; P:fatty acid biosynthetic process; C:intrinsic component of the cytoplasmic side of the plasma membrane; F:long-chain fatty acid-CoA ligase activity; F:long-chain fatty acid transporter activity,G3DSA:3.30.300.30 (GENE3D); IPR000873 (PFAM); IPR025110 (PFAM); G3DSA:3.40.50.980 (GENE3D); G3DSA:2.30.38.10 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR030310 (PTHR24096:PANTHER); PTHR24096 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.2, the fatty acid transporter (fat) family.
RL4_JR_06622,2685,2551,2774,0,5,0,0,0,0,1,12,12,0,9,10,0,8,2,32.52130983,1,-0.738312142,1.010864937,-0.730376646,0.46515999,0.653370385,67.2365907,0,2.408296562,0.974005123,2.472570734,0.013414516,0.042115923,23.62332321,1,-0.947314674,1.191465382,-0.795083674,0.426564831,0.567408008,27.78025925,1,-0.605514921,1.016292534,-0.595807704,0.551303697,0.680339751,24.28431757,1,-1.059005569,1.127184229,-0.939514182,0.347466814,0.48485412,N,-,,phosphatidylinositol-glycan biosynthesis class s,F:GPI-anchor transamidase activity; P:attachment of GPI anchor to protein; C:GPI-anchor transamidase complex,IPR019540 (PFAM); IPR019540 (PANTHER),,
RL4_JR_06623,955,808,1080,0,0,2,0,0,0,3,1,0,0,0,0,0,0,0,0.003880053,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,0,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,,,,,,,,
RL4_JR_06624,135,98,286,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.890098862,0,-0.06242427,1.241897487,-0.050265236,0.959911027,0.97972653,1.24593768,0,3.148248015,1.397298611,2.253096075,0.024253092,0.066927425,3.229538274,0,0.497410148,1.227331028,0.405277905,0.685273246,0.783744503,3.725136007,0,0.07529505,1.232861365,0.061073412,0.951300744,0.971282538,3.185387323,0,0.414587153,1.227243698,0.337819745,0.735499029,0.815210489,N,-,,major facilitator superfamily transporter,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23507:SF8 (PANTHER); PTHR23507 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.2.91, the major facilitator superfamily (mfs).
RL4_JR_06625,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.706314319,0,1.126713222,1.288084956,0.87471965,0.381726466,NA,0.544608656,0,4.34220604,1.519299546,2.858031551,0.00426278,0.018590202,1.413076949,0,1.689942642,1.220236135,1.384930829,0.166073619,0.2830428,1.630139806,0,1.267672425,1.23661366,1.025115981,0.305308466,0.451013746,1.393568139,0,1.607432009,1.209937774,1.328524527,0.184004886,0.302590462,Y,-,,glycoside partial,C:membrane,no IPS match,,
RL4_JR_06626,1328,1463,1588,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1.014558193,0,1.876756028,1.484659072,1.264098986,0.2061945,NA,0.326940636,0,5.078532393,1.685091592,3.01380199,0.002579961,0.015349618,0.84306632,0,2.435419982,1.256281274,1.938594511,0.052550733,0.117616005,0.972180404,1,2.013581381,1.307805161,1.539664654,0.123642117,0.229407446,0.826245701,0,2.360962882,1.226763227,1.924546506,0.054286117,0.119229271,N,-,,methylsterol monooxygenase,F:oxidoreductase activity; C:membrane; P:single-organism metabolic process,IPR006694 (PFAM); PTHR11863 (PANTHER),,
RL4_JR_06627,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,60.7518557,0,1.148209882,0.634360589,1.810027138,0.070291579,0.171393133,6.127263992,0,0.850216626,1.25509496,0.67741219,0.498144466,0.652767881,74.61687414,0,1.626961984,0.653426055,2.489894568,0.0127781,0.039154201,18.45993314,0,-2.233544507,1.215158376,-1.838068643,0.066052291,0.145480761,42.53206836,0,1.259459688,0.690127594,1.824966425,0.068006096,0.141883726,N,-,,thioesterase family,P:biological_process; C:cellular_component,IPR029069 (G3DSA:3.10.129.GENE3D); IPR006683 (PFAM); IPR003736 (TIGRFAM); PTHR21660:SF11 (PANTHER); PTHR21660 (PANTHER); IPR029069 (SUPERFAMILY),,
RL4_JR_06628,6200,4477,5859,0,0,0,1,0,0,0,0,1,0,0,0,0,2,1,0.063025282,0,5.885037499,3.923656823,1.499885888,0.133643964,NA,0.020536292,1,9.071378511,2.970087157,3.054246569,0.002256266,0.015081,0.052738989,1,6.432731944,1.749558903,3.676773576,0.000236203,0.001964107,0.060789687,0,6.012433778,2.92705691,2.054088445,0.039967132,0.107481332,0.051616068,1,6.356051999,1.400143787,4.539570905,5.64E-06,6.28E-05,,,,,,,,
RL4_JR_06629,416,295,521,0,1,6,0,0,0,1,2,0,0,0,2,0,0,0,47.40971496,1,-3.66940541,1.223400629,-2.999348964,0.002705572,0.013288416,15.0490758,0,-0.446077363,1.232913728,-0.361807443,0.71749593,0.823038735,39.10542799,1,-3.100286988,1.212824159,-2.556254313,0.010580576,0.03420107,45.12178352,1,-3.522910861,1.215806077,-2.897592739,0.003760385,0.022383247,46.27037357,0,-1.525434409,1.009750724,-1.510703951,0.130863895,0.233315186,N,-, Effector probability:0.676,dead deah box helicase,F:nucleic acid binding; F:ATP binding; F:helicase activity; F:hydrolase activity,G3DSA:2.40.10.10 (GENE3D); PTHR40462 (PANTHER),,
RL4_JR_06630,9780,10187,14647,0,5,1,0,0,0,5,0,1,5,1,0,0,3,0,344.1173922,1,-0.902355444,1.001733563,-0.900793862,0.367697932,0.559537349,74.04296623,0,-2.744772856,1.199560568,-2.288148618,0.022128868,0.06242709,251.5029162,1,-1.430689484,0.550484914,-2.598962202,0.009350607,0.030997231,295.2507754,1,-1.868837519,0.532959472,-3.506528388,0.000453993,0.003859512,237.7992881,1,-1.556506146,0.531028905,-2.93111379,0.00337749,0.013022502,N,-,,membrane-associated progesterone receptor component 1,C:integral component of membrane,IPR001199 (SMART); IPR001199 (G3DSA:3.10.120.GENE3D); IPR001199 (PFAM); PTHR10281 (PANTHER); PTHR10281:SF26 (PANTHER); IPR001199 (SUPERFAMILY),,
RL4_JR_06631,22697,36706,23166,0,0,4,0,0,0,0,0,1,2,14,0,0,3,0,3.508068431,1,0.087045607,1.416805367,0.061437943,0.951010435,0.976014987,1.146167945,0,3.268856224,1.577120869,2.072673242,0.0382027,0.095525624,2.924412201,1,0.641033477,1.332037726,0.481242734,0.630343992,0.741390235,3.370266459,1,0.220102085,1.361726205,0.161634611,0.8715936,0.921078904,2.830391158,1,0.585107541,1.324096469,0.441891927,0.658567413,0.756523151,N,-,,molybdenum cofactor sulfurase,F:catalytic activity,IPR015422 (G3DSA:3.90.1150.GENE3D); IPR015421 (G3DSA:3.40.640.GENE3D); IPR000192 (PFAM); PTHR14237 (PANTHER); PTHR14237:SF19 (PANTHER); PTHR14237:SF19 (PANTHER); PTHR14237 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_06632,794,974,911,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0.246439313,0,3.918215985,2.723596546,1.438618356,0.150258683,NA,0.078496428,0,7.136497033,2.20384884,3.23819715,0.001202877,0.015023052,0.204190555,0,4.47973691,1.358935781,3.296503759,0.000978963,0.005653749,0.235579245,1,4.058138687,1.722872598,2.355449087,0.018500332,0.0741845,0.20211312,0,4.392542187,1.267485009,3.465557506,0.000529133,0.002836144,N,-,,---NA---,,no IPS match,,
RL4_JR_06633,586,909,688,0,0,6,0,0,0,0,0,5,0,0,0,0,4,0,0.316014093,1,3.559572431,2.477891903,1.436532573,0.150850855,NA,0.102586801,0,6.750954301,2.134536305,3.162726389,0.001562992,0.015023052,0.263181308,1,4.115571033,1.369360874,3.005468545,0.00265172,0.012400007,0.30339231,0,3.693779001,1.65246663,2.235312311,0.025396852,0.085851084,0.256484602,1,4.047826001,1.277433713,3.168717061,0.001531134,0.006784564,,,,,,,,
RL4_JR_06634,19922,16628,16222,0,10,26,0,0,2,13,0,9,0,28,0,0,19,1,69.1216343,1,2.706067235,0.458632546,5.900294823,3.63E-09,9.02E-08,31.45177712,1,3.914611613,0.863423796,4.533824098,5.79E-06,0.000408435,45.64492451,1,2.229733544,0.666322143,3.346329652,0.00081889,0.004905586,58.07283462,1,2.177320912,1.538366072,1.415346419,0.156966951,0.275224784,27.73707415,1,1.943690882,0.669170954,2.904625299,0.00367693,0.013932977,N,-,,hypothetical protein CMQ_2469,,no IPS match,,
RL4_JR_06635,7174,6192,8211,0,4,4,0,0,0,0,0,2,0,0,0,0,4,0,1223.66777,1,1.341278916,0.201289731,6.66342444,2.68E-11,1.02E-09,165.4040387,0,-0.144628455,0.637400967,-0.226903413,0.820498848,0.891678048,671.0058635,1,0.526199397,0.378783098,1.389183941,0.164776824,0.281487138,683.1844025,0,0.151700878,0.261461809,0.580202817,0.561777854,0.689872744,456.3041088,1,-0.385692048,0.483424345,-0.797833316,0.424967225,0.560040759,N,-,,---NA---,,PS51257 (PROSITE_PROFILES); IPR017854 (SUPERFAMILY),,
RL4_JR_06636,297,316,376,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0.837163107,1,2.153980303,1.579497648,1.363712257,0.172658145,NA,0.266423043,0,5.373608092,1.726411055,3.112589019,0.001854541,0.015023052,0.692975925,0,2.717476167,1.255432976,2.164572877,0.03042041,0.077595422,0.799525571,0,2.295265163,1.32124342,1.737200828,0.082351729,0.169577233,0.685449849,0,2.631114625,1.23231876,2.135092567,0.03275345,0.080590201,N,-, Effector probability:0.661,hypothetical protein SPI_02579,,no IPS match,,
RL4_JR_06637,485,434,446,0,0,0,0,0,0,0,2,1,0,0,0,0,4,0,88.80256445,0,2.254325867,0.474845185,4.747496523,2.06E-06,2.89E-05,4.179422909,0,1.402244274,1.252178289,1.119843945,0.262780269,0.41920597,121.743057,1,3.475958157,0.412755897,8.421341001,3.72E-17,4.65E-15,31.42771939,0,0.071024065,1.008813638,0.070403554,0.943872463,0.967278207,88.8908856,1,2.48486309,0.504542645,4.924981294,8.44E-07,1.26E-05,N,-,,ligninase h2 precursor,F:oxidoreductase activity; F:binding; P:response to stimulus,IPR002016 (PRINTS); IPR000823 (PRINTS); G3DSA:1.10.520.10 (GENE3D); G3DSA:1.10.420.10 (GENE3D); IPR002016 (PFAM); PTHR31356:SF0 (PANTHER); PTHR31356 (PANTHER); IPR002016 (PROSITE_PROFILES); IPR010255 (SUPERFAMILY),9.A.61.3.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_06638,1427,1347,1309,0,1,3,0,0,0,1,0,2,1,2,5,0,0,0,152.8844725,1,-0.030508948,0.651990219,-0.046793567,0.962677756,0.980954926,60.49529048,0,1.46974863,0.858789716,1.711418526,0.08700388,0.181802904,365.618424,1,2.433876274,0.634696095,3.834711276,0.000125712,0.001331283,242.5284095,1,1.249363196,0.684562615,1.825053207,0.067993,0.148028592,159.1985637,0,1.101454948,0.51601957,2.134521657,0.032800103,0.080665786,N,-,,hypothetical protein CMQ_2395,F:oxygen binding; F:heme binding,IPR012292 (G3DSA:1.10.490.GENE3D); PF11563 (PFAM); PTHR42071:SF1 (PANTHER); PTHR42071 (PANTHER),,
RL4_JR_06639,261,318,229,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,108.2631174,0,0.478237937,0.553014344,0.864783964,0.387157375,0.579954069,32.99470867,0,1.271652214,0.9972501,1.275158773,0.20225305,0.346694734,93.07652425,0,0.604421551,0.592950269,1.019346112,0.30803868,0.449234168,70.8910846,0,0.025268238,0.625489358,0.04039755,0.967776184,0.98193545,48.31006208,0,-0.922726146,0.873480781,-1.056378304,0.290795414,0.425406173,N,-,,pyrroline-5-carboxylate reductase,F:pyrroline-5-carboxylate reductase activity; C:cytoplasm; P:oxidation-reduction process; P:L-proline biosynthetic process,IPR000304 (TIGRFAM); IPR029036 (PFAM); IPR029036 (G3DSA:1.10.3730.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR000304 (PIRSF); IPR028939 (PFAM); IPR000304 (PANTHER); PTHR11645:SF0 (PANTHER); IPR000304 (HAMAP); IPR008927 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_06640,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.477390071,0,0.589137289,1.290886164,0.456382062,0.648115263,0.799897778,0.789369739,0,3.806821637,1.473342113,2.583800194,0.009771839,0.033129495,8.544727725,0,2.118555974,1.214765818,1.744003612,0.08115846,0.164625977,11.67266177,0,1.686634253,1.167249948,1.444964085,0.148467974,0.26428239,5.872120974,0,2.006423463,1.150833608,1.743452267,0.081254645,0.163234778,N,-,,heterokaryon incompatibility,"F:oxidoreductase activity; P:metabolic process; P:lipid metabolic process; P:oxidation-reduction process; F:phosphoric diester hydrolase activity; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",IPR010730 (PFAM); PTHR33112 (PANTHER); PTHR33112:SF7 (PANTHER),,
RL4_JR_06641,620,509,759,0,0,9,0,0,0,0,0,2,0,4,0,0,0,0,31.41346477,1,-0.12260684,0.858956495,-0.142739289,0.886496086,0.944499813,6.379660777,0,0.792018729,1.237455375,0.640038214,0.522147756,0.671561274,36.04295748,1,0.541181701,0.859434958,0.629694773,0.528894303,0.658370334,47.16853492,1,1.212121556,0.598631029,2.024822467,0.042885597,0.112719511,20.1816438,0,-1.012894548,1.13077287,-0.8957542,0.370384056,0.506570115,N,-,,c6 zinc finger domain containing,"C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PR00755 (PRINTS); IPR001138 (SMART); IPR021858 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31263 (PANTHER); PTHR31263:SF4 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_06642,364,471,434,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,82.32053944,0,1.294980368,0.553548829,2.339414883,0.019313972,0.063636262,7.251649114,0,0.607170086,1.23600712,0.491235103,0.623260174,0.752282313,91.94465387,0,2.08186375,0.52052977,3.999509479,6.35E-05,0.000864885,122.0900655,1,2.266346576,1.753959022,1.292131998,0.196311436,0.326165621,118.3584585,0,2.754537813,0.647726671,4.252623734,2.11E-05,0.00018798,N,-,,general amino acid permease agp2,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PIRSF); IPR004841 (PFAM); IPR002293 (PANTHER); PTHR11785:SF347 (PANTHER),2.A.3.10.19, the amino acid-polyamine-organocation (apc) family.
RL4_JR_06643,5178,3211,2435,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.432292325,0,-1.339735575,1.190043736,-1.125786838,0.260255757,0.439852178,3.014084354,0,1.873835608,1.273099546,1.471868884,0.141056288,0.263232254,33.80314475,0,2.041185313,0.741105725,2.754243077,0.005882806,0.021432698,29.06505426,0,1.838604541,0.668356852,2.750932433,0.00594259,0.032133255,7.682401349,0,-0.855282968,1.192433208,-0.717258595,0.47321455,0.603721317,N,-,,hypothetical protein CH63R_06259,,IPR016624 (PFAM); IPR016624 (PIRSF); PTHR35339:SF2 (PANTHER); PTHR35339 (PANTHER); PTHR35339:SF2 (PANTHER); PTHR35339 (PANTHER),,
RL4_JR_06644,1666,5264,2253,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,10.96184083,1,-1.556932007,1.214765473,-1.281672917,0.199957409,0.36338885,3.497726696,0,1.659042225,1.287840954,1.288235337,0.197664055,0.341071398,9.088930822,0,-0.995280905,1.214107829,-0.819763188,0.41235112,0.554475062,10.48534685,0,-1.417639212,1.214439852,-1.16731941,0.243081403,0.381385127,8.987628407,0,-1.081767904,1.221673241,-0.885480558,0.375897501,0.512035813,N,-,,hypothetical protein SPI_06728,,no IPS match,,
RL4_JR_06645,1987,405,674,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0.122352241,1,4.928257948,3.915476795,1.258661002,0.208152803,NA,0.041082853,0,8.071707174,2.881807495,2.800918239,0.005095743,0.02088223,23.63231157,0,7.859914187,1.839846008,4.272050027,1.94E-05,0.000329556,0.11905675,0,5.04317526,2.64550472,1.906318754,0.056608863,0.132401186,46.42548999,1,9.013660982,1.926900447,4.677803151,2.90E-06,3.57E-05,N,-,,cytochrome B5,C:membrane; F:binding,IPR001834 (PRINTS); IPR001199 (PRINTS); IPR001709 (PRINTS); IPR001199 (SMART); G3DSA:2.40.30.10 (GENE3D); IPR001199 (PFAM); IPR001199 (G3DSA:3.10.120.GENE3D); IPR008333 (PFAM); G3DSA:3.40.50.80 (GENE3D); IPR001433 (PFAM); PTHR19370 (PANTHER); PTHR19370:SF94 (PANTHER); PTHR19370 (PANTHER); PTHR19370:SF94 (PANTHER); IPR017927 (PROSITE_PROFILES); IPR001199 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY); IPR017938 (SUPERFAMILY); IPR001199 (SUPERFAMILY),5.B.1.2.2, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_06646,269,118,166,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,11.84397831,1,5.140509758,2.314642944,2.22086511,0.026360099,0.082073568,0.13207117,0,6.386425602,2.845319915,2.244536921,0.024797876,0.068133578,0.33019186,0,3.787692082,2.088863275,1.813279082,0.069788788,0.14643655,28.46102899,0,6.324663415,2.373692531,2.664483008,0.007710676,0.039449518,8.035393024,0,5.186211134,2.317667995,2.237685098,0.025241598,0.06586886,N,-,,Cytochrome P450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR001128 (PRINTS); IPR002403 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24305 (PANTHER); PTHR24305:SF87 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_06647,271,305,428,0,2,0,0,0,0,0,0,0,0,0,0,0,0,3,1.596040333,1,1.223035951,1.308702832,0.934540616,0.350025095,NA,0.509322836,0,4.438820486,1.538719925,2.884748819,0.003917261,0.017836488,1.322118826,0,1.785787953,1.225722166,1.456927192,0.145136479,0.25561991,13.55999049,0,3.663362435,0.863708397,4.241434316,2.22E-05,0.000287928,1.304864587,1,1.702242767,1.215356891,1.400611441,0.161330298,0.27342974,N,-,,nad-dependent 15-hydroxyprostaglandin dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24322:SF633 (PANTHER); IPR002347 (PANTHER); PTHR24322:SF633 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06648,302,429,357,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.211831462,0,2.955341456,1.051349272,2.810998719,0.004938798,0.021545838,0.498546059,0,4.469622119,1.556895096,2.870856316,0.004093616,0.018358696,1.299681522,0,1.810629037,1.242832662,1.456856657,0.145155953,0.25561991,1.49982424,0,1.387904592,1.270521653,1.092389562,0.274661909,0.416996825,1.287165258,0,1.722380845,1.235932002,1.393588678,0.163441849,0.276314698,N,-,,trehalose-6-phosphate hydrolase,P:maltose metabolic process; C:nucleus; F:maltose alpha-glucosidase activity; C:cytosol; F:starch alpha-glucosidase activity; F:dextrin alpha-glucosidase activity; F:sucrose alpha-glucosidase activity,IPR006047 (SMART); IPR013781 (G3DSA:3.20.20.GENE3D); G3DSA:3.90.400.10 (GENE3D); IPR006047 (PFAM); IPR013780 (G3DSA:2.60.40.GENE3D); PTHR10357:SF142 (PANTHER); IPR015902 (PANTHER); IPR017853 (SUPERFAMILY); SSF51011 (SUPERFAMILY),8.A.9.1.2, the rbat transport accessory protein (rbat) family.
RL4_JR_06649,21127,22253,19499,40,78,115,0,0,6,15,5,28,29,85,42,4,54,21,14.89227312,1,0.06492462,1.145767015,0.056664766,0.954812242,0.977334789,2.189623379,1,2.33480753,1.296893066,1.800308437,0.071811949,0.15683461,5.690794492,1,-0.319720741,1.199031876,-0.266649075,0.789739366,0.861008114,6.565800624,1,-0.7422266,1.197298192,-0.619917916,0.53531183,0.667327294,5.619547731,1,-0.40414736,1.202998997,-0.335949872,0.736908668,0.815789213,N,-,,FAD binding domain-containing,F:FAD binding; F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789 (PANTHER); PTHR13789:SF238 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_06650,19403,10644,3557,22,21,2,0,0,5,11,15,53,12,15,13,1,18,5,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,cytochrome P450 oxidoreductase,"P:small molecule metabolic process; F:iron ion binding; C:intracellular membrane-bounded organelle; C:membrane; P:secondary metabolite biosynthetic process; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; P:oxidation-reduction process; F:heme binding",IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24279:SF76 (PANTHER); PTHR24279 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_06651,6836,2977,1838,5,8,2,0,0,4,0,6,1,1,22,7,0,14,5,8.663700908,1,-1.217181814,1.199182602,-1.015009567,0.310101267,0.498091384,2.781748949,1,1.989601215,1.295408224,1.535887435,0.12456599,0.239843438,35.86691951,1,2.163298621,0.751156834,2.879955987,0.003977307,0.016348297,36.54466641,1,1.260058718,0.854823265,1.474057586,0.140466087,0.253334366,7.044628671,1,-0.730348446,1.197509743,-0.609889356,0.541935104,0.664055782,N,-,,C2H2 transcription factor,"F:nucleic acid binding; F:metal ion binding; P:metabolic process; P:regulation of transcription, DNA-templated",IPR007219 (PFAM); PTHR40626:SF2 (PANTHER); PTHR40626 (PANTHER),,
RL4_JR_06652,9925,7880,6994,6,7,19,11,0,1,0,8,5,5,20,2,0,8,2,9.404117755,1,-1.335408678,1.206245628,-1.107078564,0.268259963,0.448915851,3.010080615,1,1.875788667,1.292141039,1.451690343,0.146587726,0.272199773,7.783395505,1,-0.771231613,1.205751946,-0.639627094,0.522415064,0.652477241,12.98937777,1,-0.246940071,1.155411392,-0.213724802,0.830761669,0.894259752,30.0901503,1,1.780035323,0.756045448,2.354402539,0.018552508,0.051506483,N,-,,C2H2 type zinc finger domain-containing,F:binding,IPR015880 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); IPR001138 (SUPERFAMILY),,
RL4_JR_06653,14949,11439,10022,0,5,14,0,0,0,6,9,5,1,14,2,0,2,5,86.35543095,1,-0.041562344,0.610308127,-0.06810059,0.94570556,0.973387076,12.32052593,0,-0.157460747,1.213840093,-0.129721161,0.89678704,0.942408473,212.9588495,1,2.657018123,0.40650725,6.536213377,6.31E-11,3.85E-09,120.2805415,1,0.986002616,0.479143674,2.057843333,0.039605175,0.106832454,142.2212772,1,1.88535499,0.771600675,2.443433566,0.014548248,0.042486591,N,-,,hydroxyneurosporene dehydrogenase,,IPR023374 (G3DSA:2.40.370.GENE3D); IPR010791 (PFAM); SSF159245 (SUPERFAMILY),,
RL4_JR_06654,30,38,26,0,0,24,0,0,0,0,0,0,0,0,0,0,0,0,0.482053088,1,2.950302472,2.007874474,1.469365994,0.141733546,NA,0.154509343,0,6.159739546,1.92446458,3.200754958,0.00137068,0.015023052,0.400065005,0,3.510245529,1.287955028,2.72544107,0.006421564,0.022959612,0.461440845,0,3.088399547,1.437093665,2.149059328,0.031629697,0.095116531,0.393950331,0,3.429399951,1.237701091,2.770782038,0.005592185,0.019632756,N,-,,siderophore iron transporter,P:transmembrane transport; C:membrane; C:integral component of membrane; P:transport; F:transporter activity,IPR010573 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF2 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.47, the major facilitator superfamily (mfs).
RL4_JR_06655,388,455,344,0,0,0,0,0,0,0,0,3,1,2,0,0,0,3,18.0237247,0,-2.274266919,1.185049696,-1.919132105,0.054967617,0.142674458,5.754110694,0,0.940915699,1.231806974,0.763849953,0.444956664,0.606334324,14.9280088,1,-1.711037478,1.189726142,-1.438177592,0.150383672,0.262893004,38.89097662,1,0.592627498,0.737408886,0.803661998,0.421592207,0.56463242,22.08582613,1,-0.859318563,1.121380903,-0.766303903,0.443495496,0.5766859,N,-,,hypothetical protein SPI_03636,,no IPS match,,
RL4_JR_06656,616,555,823,0,1,4,0,0,0,0,0,0,1,0,0,0,0,3,0.471543909,1,2.982048138,2.290865709,1.301712329,0.193014743,NA,0.155662236,0,6.149359873,2.125484913,2.893156209,0.003813916,0.017631542,0.395849144,0,3.526144446,1.4778197,2.386045095,0.017030663,0.049389409,0.456019327,1,3.105693366,1.709416497,1.816814902,0.06924546,0.149618072,7.748466007,1,4.43034511,1.272738198,3.480955564,0.000499628,0.002706655,N,-,,3-hydroxyphenylacetate 6 hydroxylase,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24281:SF5 (PANTHER); PTHR24281 (PANTHER); PTHR24281:SF5 (PANTHER); PTHR24281 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_06657,84,130,141,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.052980331,0,6.136545757,3.926865623,1.562708365,0.118121206,NA,0.016720552,0,9.36808833,3.050966171,3.070531695,0.00213678,0.015045494,0.043514072,0,6.713731957,1.777075021,3.777967659,0.000158113,0.001535778,0.050219654,0,6.288914864,3.109085787,2.022753727,0.043098545,0.113020659,0.042870411,0,6.636706693,1.395704367,4.755094884,1.98E-06,2.57E-05,N,-,,sugar transporter stl1,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,IPR003663 (PRINTS); IPR003663 (TIGRFAM); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500 (PANTHER); PTHR23500:SF9 (PANTHER); PS51257 (PROSITE_PROFILES); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.38, the major facilitator superfamily (mfs).
RL4_JR_06658,2068,2722,3245,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,15.36467873,1,7.953066893,0.991575745,8.020634763,1.05E-15,7.66E-14,0.02837546,0,8.603283819,2.78984193,3.083788987,0.002043825,0.015023052,0.074742894,0,5.927401793,1.672467825,3.544105128,0.000393948,0.002850844,13.41014415,0,7.230522886,1.124852706,6.427973057,1.29E-10,4.87E-09,0.075076194,0,5.821740527,1.419782165,4.100446302,4.12E-05,0.000329006,N,-,,dimethylaniline monooxygenase,"F:NADP binding; F:flavin adenine dinucleotide binding; P:oxidation-reduction process; F:N,N-dimethylaniline monooxygenase activity",PR00419 (PRINTS); PF13738 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PF13450 (PFAM); PTHR23023 (PANTHER); PTHR23023:SF4 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_06659,256,240,217,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0.05257302,0,6.147435353,3.927017524,1.565420912,0.117484248,NA,0.016211359,0,9.411451606,3.927740714,2.396148904,0.016568358,0.049808411,0.042914831,1,6.730968351,2.407986274,2.79526857,0.005185662,0.019451514,0.049576689,0,6.306820254,3.927272883,1.605903242,0.108295171,0.208147926,0.043072544,0,6.627394853,1.696532141,3.906436367,9.37E-05,0.000656774,N,-,,hexose transporter,F:transporter activity,IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500 (PANTHER); PTHR23500:SF145 (PANTHER); PTHR23500:SF145 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.127, the major facilitator superfamily (mfs).
RL4_JR_06660,90235,43674,70310,0,0,4,0,0,0,0,5,34,0,1,3,0,5,0,0.039918619,1,6.544233455,3.933407246,1.663756902,0.09616102,NA,0.012527675,0,9.782914826,3.165977058,3.09001444,0.002001468,0.015023052,0.032876183,1,7.113503469,1.811506728,3.926843527,8.61E-05,0.001062624,28.94380673,1,9.3659115,1.504903798,6.22359483,4.86E-10,1.65E-08,0.032801818,1,7.020325607,1.38896994,5.054339483,4.32E-07,7.04E-06,N,-,,hypothetical protein F503_02304,,IPR010856 (PFAM); IPR027443 (G3DSA:2.60.120.GENE3D); PTHR30613 (PANTHER); PTHR30613:SF1 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_06661,10343,6591,10612,0,3,3,0,0,3,0,0,11,0,0,3,0,1,0,0.04374675,1,6.411986534,3.931080903,1.63110012,0.102869195,NA,0.013358526,1,9.689478646,3.932184005,2.464146803,0.013733985,0.0429264,0.035729296,1,6.993512207,2.503166149,2.793866563,0.005208196,0.019499919,8.064469989,1,8.053487312,2.20554996,3.651464469,0.000260749,0.002404449,0.036343736,1,6.871908157,1.738462107,3.952866232,7.72E-05,0.000559269,N,-,,pantothenate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662 (PANTHER); PTHR11662:SF242 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_06662,1133,1437,1961,0,0,5,0,0,0,0,0,0,1,0,0,0,0,0,23.82046486,1,2.671330345,0.697087646,3.832129803,0.000127039,0.00104685,23.82774016,0,3.793450818,1.130306302,3.356126398,0.000790424,0.015023052,76.74636932,0,4.459476221,0.52582468,8.480918428,2.23E-17,2.83E-15,95.24584824,1,4.267637441,1.377194686,3.098790233,0.001943125,0.012935007,34.72443596,0,3.717034941,0.578164817,6.429023059,1.28E-10,8.85E-09,N,-,,bacterial alpha-L-rhamnosidase domain,F:catalytic activity; P:metabolic process,IPR008979 (G3DSA:2.60.120.GENE3D); IPR016007 (PIRSF); IPR013737 (PFAM); IPR008902 (PFAM); PTHR33307 (PANTHER); PTHR33307:SF5 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_06663,49,24,37,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,9.4425945,0,-1.341579829,1.294972493,-1.035990985,0.300206348,0.486039926,2.957029137,0,1.901230453,1.367103797,1.390699417,0.164316595,0.296838919,7.778942496,1,-0.770732271,1.267302382,-0.608167618,0.543076309,0.670991524,21.01584828,1,1.041508893,0.983715026,1.058750619,0.289713368,0.434441329,7.787133443,0,-0.874844202,1.288664268,-0.678876744,0.497215962,0.625147351,N,-, Effector probability:0.762,rieske domain-containing,F:binding,IPR017941 (G3DSA:2.102.10.GENE3D); IPR017941 (PROSITE_PROFILES); IPR017941 (SUPERFAMILY),,
RL4_JR_06664,709,437,466,0,3,2,0,0,0,0,5,0,0,3,1,0,2,0,1.347870836,1,1.466817354,1.676856387,0.874742385,0.381714093,NA,0.443545398,0,4.638510829,1.805308188,2.569373396,0.010188261,0.03400118,1.130885732,1,2.011527959,1.398035288,1.438824882,0.150200145,0.262629752,5.314553648,1,2.527924655,1.317403487,1.918868957,0.05500092,0.12987041,1.097713195,1,1.951220908,1.372479299,1.42167602,0.155120325,0.26522954,N,-,,Acyl- thioesterase,P:acyl-CoA metabolic process; F:acyl-CoA hydrolase activity,PF13622 (PFAM); IPR029069 (G3DSA:3.10.129.GENE3D); IPR029069 (G3DSA:3.10.129.GENE3D); IPR003703 (PANTHER); PTHR11066:SF35 (PANTHER); IPR029069 (SUPERFAMILY); IPR029069 (SUPERFAMILY),,
RL4_JR_06665,21,18,19,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,57.37656741,1,1.083375329,0.582616472,1.859499998,0.0629563,0.158125859,25.25458856,0,2.398769322,1.009856379,2.375356904,0.017531989,0.051888535,48.68591132,0,0.94356081,0.750899294,1.256574373,0.208907799,0.336191792,39.40435195,0,0.719690328,0.690390202,1.042439951,0.297207752,0.442338453,16.45827609,0,-1.954588291,1.195807403,-1.634534362,0.102146697,0.194076808,N,-,,partial,F:hydrolase activity,IPR017439 (TIGRFAM); IPR017144 (PIRSF); IPR002933 (PFAM); IPR011650 (G3DSA:3.30.70.GENE3D); G3DSA:3.40.630.10 (GENE3D); PTHR30575 (PANTHER); PTHR30575:SF4 (PANTHER); IPR011650 (SUPERFAMILY); SSF53187 (SUPERFAMILY),,
RL4_JR_06666,453,472,379,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,74.86115104,0,2.927330639,0.589884395,4.962549719,6.96E-07,1.11E-05,2.174969455,0,2.344524801,1.300687871,1.802526842,0.071462555,0.15630288,38.90249194,0,2.51657686,0.742930552,3.38736488,0.000705675,0.004350944,38.46443818,0,2.011079778,0.742893119,2.707091676,0.006787551,0.035700756,5.569955594,0,-0.391325885,1.202247481,-0.325495284,0.744806251,0.821746028,N,-,,MFS general substrate transporter,C:membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11360:SF120 (PANTHER); PTHR11360 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.13.14, the major facilitator superfamily (mfs).
RL4_JR_06667,2310,2840,2927,1,1,0,0,0,0,3,0,3,0,6,1,0,2,0,14.07555296,1,-1.917323914,1.206315392,-1.589405165,0.111968949,0.240290826,4.519904435,0,1.289300484,1.274243646,1.011816294,0.311625898,0.473330933,11.66432221,1,-1.35491483,1.207165856,-1.122393268,0.261695266,0.398766235,22.76472389,1,-0.825649671,1.15708308,-0.713561269,0.475498514,0.616285517,11.42472053,1,-1.427868602,1.203487352,-1.186442549,0.235447577,0.364066389,N,-,,c6 zinc finger domain containing,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31944 (PANTHER); PTHR31944:SF57 (PANTHER); PTHR31944 (PANTHER); PTHR31944:SF57 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_06668,21,19,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.98856435,0,-0.097934046,1.269227292,-0.077160369,0.938495969,0.969777845,1.268287877,0,3.122692884,1.409994459,2.214684508,0.026781727,0.07230852,3.290575344,0,0.470886103,1.238459312,0.380219276,0.703782652,0.798867089,3.796536336,0,0.048350338,1.246451633,0.038790385,0.969057511,0.982841561,3.237472054,0,0.391554261,1.236500067,0.316663356,0.751499057,0.827057386,N,-,,alpha-N-arabinofuranosidase C,"P:carbohydrate metabolic process; F:hydrolase activity, acting on glycosyl bonds",IPR010720 (SMART); IPR013781 (G3DSA:3.20.20.GENE3D); IPR010720 (PFAM); PTHR31776:SF4 (PANTHER); PTHR31776 (PANTHER); PTHR31776:SF4 (PANTHER); PTHR31776 (PANTHER); SSF51011 (SUPERFAMILY); IPR017853 (SUPERFAMILY),,
RL4_JR_06669,28595,21647,16201,2,2,11,1,0,0,0,3,4,1,7,2,0,3,2,3.54352011,1,0.072759751,1.242758052,0.058546996,0.953312929,0.977139485,1.128708063,1,3.290894406,1.398529883,2.353109822,0.018617135,0.054353227,2.927473186,1,0.639573327,1.220378877,0.524077677,0.600224514,0.718707627,7.388976598,1,1.163162485,1.163364941,0.999825974,0.317394734,0.463525411,2.881373185,1,0.559689617,1.216384967,0.460125398,0.645426215,0.746679665,N,-,,High-affinity glucose transporter P49374,C:integral component of membrane; P:hexose transmembrane transport; P:glucose transport; F:sugar transmembrane transporter activity,IPR003663 (PRINTS); IPR003663 (TIGRFAM); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF85 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.39, the major facilitator superfamily (mfs).
RL4_JR_06670,2120,1569,1229,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37.38055922,0,-2.224034463,1.150667883,-1.932820492,0.053258315,0.139659702,10.65786578,0,0.051635391,1.214084534,0.042530309,0.96607595,0.982479732,60.94558444,0,-0.182563863,0.854683962,-0.213603941,0.830855925,0.890716113,82.25564213,0,0.52111552,0.583050277,0.893774587,0.371442509,0.517169335,42.51236904,0,-0.48082237,0.856270228,-0.561531108,0.57443553,0.689363487,N,-,,hypothetical protein IQ07DRAFT_560609,,no IPS match,,
RL4_JR_06671,45090,65330,77433,11,8,31,2,0,0,2,0,0,0,21,0,0,10,1,48.42082097,1,0.967120701,0.577875014,1.673581098,0.094212956,0.21196616,6.948214859,1,0.66892261,1.233024725,0.542505431,0.587470367,0.725521603,17.9713549,1,-1.978563165,1.192032861,-1.659822669,0.096950132,0.189629663,20.7286323,1,-2.400649612,1.190073388,-2.017228212,0.043671703,0.113446415,17.6532796,1,-2.055648926,1.189291525,-1.728465126,0.083904868,0.167297517,N,-,,integral membrane,,no IPS match,,
RL4_JR_06672,293,371,310,0,0,2,0,0,1,0,0,0,0,0,1,0,0,0,23.65173951,1,0.575008327,0.883547745,0.650794856,0.515178922,0.700528502,3.89431063,1,1.504206219,1.27694299,1.177974452,0.238806791,0.390564282,10.08293091,0,-1.144718141,1.207133577,-0.948294508,0.342979546,0.486453383,83.08992104,1,2.34124004,0.691894219,3.383812117,0.000714869,0.005576309,9.905346676,0,-1.221919408,1.206760567,-1.012561598,0.31126961,0.44665601,Y,-,,c6 zinc finger domain containing,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_06673,2543,2145,2566,0,1,0,0,0,0,0,0,2,0,0,0,0,0,0,21.6397295,1,1.920196655,0.778592233,2.46624173,0.013653915,0.048683847,2.046573052,0,2.432409131,1.338111903,1.817792014,0.069095928,0.152173407,5.278154226,1,-0.210831896,1.215359815,-0.173472822,0.862279789,0.912768777,6.086992024,0,-0.632710026,1.215698424,-0.52044982,0.602750094,0.723943618,5.167138731,0,-0.283175204,1.20866281,-0.23428801,0.814761394,0.875088481,N,-,,rta1 domain-containing,C:membrane,IPR007568 (PFAM); PTHR31465:SF15 (PANTHER); PTHR31465 (PANTHER),9.A.26.1.3, the lipid-translocating exporter (lte) family.
RL4_JR_06674,3566,6056,3663,0,0,0,0,0,0,0,0,1,0,0,2,0,2,1,15.10268907,0,-2.018986401,1.227539187,-1.644742932,0.100022835,0.22149465,4.780328434,0,1.20839166,1.275987987,0.947024324,0.343626385,0.506950337,12.45109836,1,-1.449194461,1.218826483,-1.189008018,0.234436512,0.366723616,14.36847577,1,-1.871991997,1.220217829,-1.53414575,0.1249938,0.231575888,12.30874121,1,-1.535331242,1.227239118,-1.251044901,0.210918096,0.334567715,N,-,,3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase,C:cellular_component,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); IPR002347 (PANTHER); PTHR24322:SF242 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06675,0,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.711498675,0,-0.33829918,1.215556301,-0.278308112,0.780775849,0.887242075,1.499859225,0,2.880705727,1.346275394,2.13975962,0.032374198,0.083947753,3.893806796,0,0.227916093,1.20779533,0.188704234,0.850324633,0.904368798,4.492371548,0,-0.194542779,1.208288748,-0.161006862,0.872087996,0.921123614,3.838180182,0,0.145972802,1.207390817,0.120899381,0.903770732,0.938242455,N,-,,MFS FHS L-fucose permease,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23514 (PANTHER); PTHR23514:SF8 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.7.25, the major facilitator superfamily (mfs).
RL4_JR_06676,3250,1520,2127,0,0,3,0,0,0,1,0,0,0,3,0,0,6,0,6.837187252,1,-0.875830126,1.237778878,-0.707582058,0.479204838,0.668151268,2.213591249,0,2.319200621,1.361493957,1.703423368,0.088488868,0.184032118,5.693124792,1,-0.320203251,1.233388368,-0.259612673,0.79516256,0.865057571,6.563761348,1,-0.741689208,1.236199689,-0.599975243,0.548522735,0.678284403,5.566624908,1,-0.390744255,1.229277033,-0.31786509,0.750587274,0.826593012,N,-,,heterokaryon incompatibility,C:nucleus; C:membrane; C:integral component of membrane,IPR010730 (PFAM); PTHR33112 (PANTHER); PTHR33112 (PANTHER); PTHR33112:SF6 (PANTHER),,
RL4_JR_06677,8,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,76.29361,0,-0.719507143,0.876016945,-0.821339298,0.411453029,0.602843716,17.44763253,0,-0.659420522,1.300753486,-0.506952723,0.612187991,0.744958745,52.45970583,0,-2.328725191,1.259547838,-1.848858075,0.064478309,0.138008118,59.44280918,0,-2.028719481,1.121964795,-1.808184615,0.070577772,0.151848692,43.38333855,0,-3.352874954,1.262128089,-2.656525104,0.007895057,0.025945295,N,-,,sulfide-quinone oxidoreductase,F:oxidoreductase activity; P:oxidation-reduction process,PR00368 (PRINTS); IPR023753 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR10632:SF2 (PANTHER); PTHR10632 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_06678,9,10,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,111.9916754,0,0.980950566,0.624503182,1.570769523,0.116236194,0.247005696,58.62809377,0,2.782440614,0.737061331,3.775046251,0.000159978,0.007261422,30.30385548,0,-2.732459003,1.20710937,-2.263638301,0.02359637,0.063534482,63.85249569,0,-0.795468513,0.874568073,-0.909555857,0.363056787,0.509275419,29.76197401,0,-2.809222041,1.207669277,-2.326151783,0.020010455,0.054524824,N,-,,alpha-ketoglutarate-dependent sulfonate dioxygenase,F:dioxygenase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process,IPR009836 (PFAM); PTHR24637 (PANTHER); PTHR24637:SF222 (PANTHER); PTHR24637:SF222 (PANTHER); PTHR24637 (PANTHER),,
RL4_JR_06679,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29.77862149,0,1.712665664,0.864712644,1.980618274,0.047634098,0.128250486,1.84538671,0,2.581693055,1.342695807,1.922768389,0.054509144,0.126372321,4.763597659,0,-0.062824421,1.213133951,-0.051786879,0.95869851,0.975757889,5.493920116,0,-0.484790252,1.21341679,-0.399524925,0.689506462,0.789885077,4.667484612,0,-0.136424,1.206326621,-0.113090433,0.90995886,0.942154971,N,-,,Serine carboxypeptidase S28,F:peptidase activity,IPR008758 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR11010 (PANTHER); PTHR11010:SF23 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_06680,0,6,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,93.02864746,0,1.487498908,1.235966491,1.203510709,0.22877875,0.400896276,7.303466607,0,0.596953158,1.291706655,0.462142976,0.643978793,0.768764399,18.80884359,0,-2.044372438,1.233008613,-1.658035813,0.097310238,0.190150328,21.68597641,0,-2.465894791,1.236123641,-1.994860958,0.046058047,0.116438882,18.43269178,0,-2.118032723,1.236318468,-1.71317729,0.086679928,0.171681196,N,-,,c2h2 transcription factor,F:nucleic acid binding; F:metal ion binding,IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_06681,138,121,96,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,333.3107396,0,1.020505458,0.45168122,2.25934888,0.023861692,0.075892273,43.01186415,0,-0.691176276,1.141082762,-0.605719672,0.544700919,0.691169951,190.3765723,0,0.358790576,0.484003426,0.741297597,0.458513019,0.596273064,180.311753,0,-0.260366336,0.512913105,-0.507622701,0.611717967,0.731496928,134.9456346,1,-0.252173997,0.588304763,-0.428645173,0.668181466,0.764444897,N,-,,hypothetical protein SPBR_04172,C:membrane,IPR018830 (PFAM),,
RL4_JR_06682,892,980,931,1,1,1,4,0,0,0,0,1,7,6,0,0,1,1,52.18097283,1,0.752676633,0.692694058,1.08659317,0.277216645,0.460237515,5.893424519,1,0.90637033,1.252505184,0.723645971,0.469283111,0.627722748,15.30502592,1,-1.747049641,1.206494387,-1.448037935,0.147606442,0.259123914,25.67915423,1,-0.451894159,1.03597435,-0.436202073,0.662690124,0.770083497,61.44912383,1,2.17576054,0.642925747,3.384155245,0.000713976,0.003647331,N,-,,golgi transport complex component cog5,C:Golgi transport complex; F:identical protein binding; P:intra-Golgi vesicle-mediated transport; P:CVT pathway,IPR019465 (PFAM); IPR019465 (PANTHER),,
RL4_JR_06683,6,2,4,0,0,3,0,0,0,0,0,0,0,0,0,0,1,0,238.2318952,1,-0.223924297,0.563599853,-0.397310779,0.691138299,0.832103414,39.91745771,0,-1.853451397,1.227058099,-1.510483813,0.130920017,0.248485357,103.94584,0,-4.510716367,1.222568163,-3.689541822,0.000224658,0.001895367,178.6689242,0,-0.731430387,0.589675284,-1.240395192,0.214829259,0.34936496,129.0162254,1,-1.942643901,0.820327289,-2.368132729,0.017878121,0.049914502,N,-,,formyltetrahydrofolate deformylase,"P:'de novo' IMP biosynthetic process; F:amino acid binding; F:hydroxymethyl-, formyl- and related transferase activity; F:formyltetrahydrofolate deformylase activity",IPR004810 (PRINTS); G3DSA:3.30.70.260 (GENE3D); IPR002912 (PFAM); IPR002376 (PFAM); PIRSF036480 (PIRSF); IPR004810 (TIGRFAM); IPR002376 (G3DSA:3.40.50.GENE3D); IPR004810 (PTHR10520:PANTHER); PTHR10520 (PANTHER); IPR002912 (PROSITE_PROFILES); IPR004810 (HAMAP); IPR002376 (SUPERFAMILY); SSF55021 (SUPERFAMILY),,
RL4_JR_06684,2521,3248,4898,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,33.97196507,0,-0.3025671,0.869899196,-0.347818576,0.727976438,0.856109526,7.233109853,0,0.610913371,1.246088979,0.490264645,0.623946642,0.752786194,18.70120399,0,-2.036107084,1.202798882,-1.692807597,0.090492096,0.179741413,41.62617405,1,0.553892016,0.703159046,0.787719392,0.43086086,0.57317911,93.10973537,0,2.214664312,0.478594619,4.627432538,3.70E-06,4.40E-05,N,-,,"endo-1,4-beta-xylanase partial","P:xylan catabolic process; C:integral component of membrane; F:hydrolase activity, acting on glycosyl bonds",PF07264 (PFAM); PTHR34292 (PANTHER); PTHR34292:SF1 (PANTHER),2.A.121.2.9,the sulfate transporter (cysz) family
RL4_JR_06685,7348,4833,4981,5,9,0,0,0,0,0,4,7,10,13,10,0,16,8,34.64116298,1,-0.568871313,1.024052831,-0.555509731,0.578546056,0.75335654,5.994928276,0,0.88179912,1.262366995,0.698528338,0.484846842,0.641267442,50.65956156,1,1.371069353,0.69585842,1.970328033,0.048800788,0.111074455,17.84859273,1,-2.184947427,1.207733074,-1.809131068,0.070430643,0.15159657,15.19557673,1,-1.839434664,1.208355639,-1.522262655,0.127943281,0.229481971,Y,-,,hypothetical protein HMPREF1624_08199,,no IPS match,,
RL4_JR_06686,494,377,408,0,0,1,0,0,0,0,0,5,1,0,4,7,2,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_06687,867,752,885,0,2,5,0,0,0,0,3,6,3,8,0,0,0,0,226.4172566,1,-0.504767013,0.429652479,-1.174826256,0.240064233,0.414836691,40.01909135,0,-1.85709659,1.199017481,-1.548848637,0.121418111,0.235846117,132.3217412,1,-1.686828369,0.745640363,-2.262254637,0.023681675,0.063747216,127.5647936,1,-3.203481973,1.018362591,-3.145718431,0.001656794,0.011334488,102.0397552,0,-4.586780341,1.193937965,-3.841724174,0.000122173,0.000819207,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11360:SF130 (PANTHER); PTHR11360 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.13.4, the major facilitator superfamily (mfs).
RL4_JR_06688,1425,999,1753,0,0,1,0,0,0,0,0,0,0,6,1,0,0,0,50.30151526,1,1.299459323,0.535157698,2.428180194,0.015174802,0.052904287,6.303156083,0,0.809433363,1.226919685,0.659728076,0.509428346,0.661166011,48.84991567,0,1.295171106,0.665075567,1.94740443,0.051486267,0.115869601,18.86891113,1,-2.265202822,1.186693753,-1.908835212,0.056283353,0.131853065,16.13134567,0,-1.925576758,1.192895881,-1.614203544,0.106483284,0.200183909,N,-,,nadph-dependent 1-acyldihydroxyacetone phosphate reductase,F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process; C:intracellular part,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24322:SF484 (PANTHER); IPR002347 (PANTHER); PS51257 (PROSITE_PROFILES); IPR016040 (SUPERFAMILY),,
RL4_JR_06689,5001,6011,3896,0,4,8,2,0,0,0,0,2,1,4,0,0,1,5,18.03223673,1,3.119647586,0.7901177,3.948332743,7.87E-05,0.00069118,10.25425407,1,4.570960221,1.149571038,3.976231194,7.00E-05,0.003597475,2.282048731,1,0.998221976,1.230725682,0.811084054,0.417317402,0.558936247,2.63319382,1,0.575655436,1.241677998,0.463610885,0.642926554,0.755427389,2.262392003,1,0.908378619,1.233178865,0.736615462,0.461356229,0.592495158,Y,-,,Cytochrome P450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; F:metal ion binding; F:oxidoreductase activity; P:oxidation-reduction process; F:monooxygenase activity; C:cellular_component; F:heme binding",IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24286:SF62 (PANTHER); PTHR24286 (PANTHER); IPR001128 (SUPERFAMILY); IPR001128 (SUPERFAMILY),,
RL4_JR_06690,31,15,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.685720419,0,0.015645545,1.210382229,0.012926119,0.989686736,0.994874704,1.175267417,0,3.232506094,1.370745991,2.358209409,0.018363331,0.053767322,3.051067426,0,0.579514584,1.204164876,0.481258502,0.630332787,0.741390235,11.54305461,0,1.883387056,1.016470296,1.852869743,0.063901031,0.142111804,3.010364857,0,0.496319202,1.203372561,0.412440185,0.680016814,0.77274638,N,-,,General amino acid permease AGP2,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR004841 (PFAM); IPR002293 (PIRSF); PTHR11785:SF347 (PANTHER); IPR002293 (PANTHER),2.A.3.10.19, the amino acid-polyamine-organocation (apc) family.
RL4_JR_06691,365,382,202,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.935217433,0,-0.405163952,1.21573979,-0.333265354,0.738933989,0.862653618,1.57819629,0,2.807317217,1.349631282,2.080062351,0.037519814,0.094307316,4.083776321,0,0.159340183,1.210018271,0.131684113,0.895234152,0.934625357,4.710637745,0,-0.262854884,1.21045513,-0.217153761,0.828088518,0.892526745,4.010855301,0,0.082422397,1.204837114,0.068409577,0.945459599,0.965166076,N,-,,fungal specific transcription factor domain-containing,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR007219 (PFAM); PTHR31001 (PANTHER); PTHR31001:SF30 (PANTHER),,
RL4_JR_06692,1136303,1085913,782278,6,3,5,0,4,0,15,26,87,48,47,29,0,2,19,78.47966881,1,0.53429586,0.940110184,0.568333233,0.569808718,0.745983002,11.47588439,1,-0.055031196,1.28892856,-0.042695304,0.965944423,0.98244468,29.98747462,1,-2.717295431,1.253058051,-2.168531162,0.030118296,0.076979963,34.61377517,1,-3.140448382,1.261737558,-2.488987002,0.012810765,0.059051859,29.72132074,1,-2.807188223,1.267353476,-2.215000216,0.02676005,0.068945383,N,-,,glycerol dehydrogenase,P:oxidation-reduction process; F:alcohol dehydrogenase (NADP+) activity,IPR020471 (PRINTS); IPR020471 (PIRSF); IPR023210 (PFAM); IPR023210 (G3DSA:3.20.20.GENE3D); IPR001395 (PANTHER); PTHR11732:SF282 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.4, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_06693,180288,185929,121799,0,0,0,0,0,0,3,4,17,8,8,1,0,3,1,0.839040641,0,2.150689579,1.597340614,1.346418892,0.178167462,NA,0.267394993,0,5.368337809,1.736793064,3.090948438,0.001995183,0.015023052,0.695258542,1,2.712613982,1.26570127,2.143170784,0.032099387,0.080879591,0.802116922,1,2.290520196,1.336214562,1.714185925,0.086494585,0.175572909,0.687816543,1,2.625911838,1.241894513,2.114440326,0.034477677,0.083854546,N,-,,metalloprotease m41,C:membrane; P:proteolysis; C:integral component of membrane; F:peptidase activity; F:metallopeptidase activity,no IPS match,,
RL4_JR_06694,722,647,703,0,1,2,0,0,0,0,0,6,4,0,0,0,0,0,0.549024984,1,2.762491652,2.020296229,1.367369602,0.171509485,NA,0.173970546,0,5.988234554,1.947596548,3.074679178,0.002107291,0.015045485,0.454746717,1,3.324627889,1.356900904,2.450162631,0.01427917,0.042747008,0.524772648,1,2.902448371,1.519543337,1.910079365,0.056122995,0.131568726,0.452911969,0,3.228704534,1.316049178,2.453331219,0.014153994,0.041466781,N,-,,small s,F:thiamine diphosphokinase activity; F:thiamine binding; F:ATP binding; F:cytochrome-c oxidase activity; F:oxidoreductase activity; P:thiamine metabolic process; P:hydrogen ion transmembrane transport; P:oxidation-reduction process; C:mitochondrial envelope; P:thiamine diphosphate biosynthetic process,IPR027417 (G3DSA:3.40.50.GENE3D); IPR031352 (PFAM); PTHR10039:SF5 (PANTHER); PTHR10039 (PANTHER); PTHR10039:SF5 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_06695,202,136,254,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,224.8984799,0,0.520964307,0.466155254,1.117576821,0.263747773,0.443353938,30.79805507,0,-1.479243036,1.237551573,-1.195298093,0.231970585,0.382100286,162.6409704,1,0.028335326,0.57749662,0.049065787,0.960866869,0.977080773,153.8023475,0,-0.505195256,0.571544335,-0.883912629,0.376743379,0.522323253,93.25812488,0,-1.626827334,0.820737419,-1.982153239,0.047462092,0.107626805,N,-,,duf1479 domain-containing,,IPR000675 (SMART); IPR029058 (G3DSA:3.40.50.GENE3D); IPR000675 (PFAM); IPR010856 (PFAM); IPR027443 (G3DSA:2.60.120.GENE3D); PTHR30613 (PANTHER); PTHR30613:SF1 (PANTHER); IPR029058 (SUPERFAMILY); SSF51197 (SUPERFAMILY),,
RL4_JR_06696,1619,1297,1554,3,1,2,0,0,0,1,0,9,5,7,2,0,2,1,229.6429103,1,0.946780522,1.422138526,0.665744233,0.505574596,0.692221146,26.33016081,0,-1.253112256,1.278722165,-0.979972265,0.32709981,0.489561477,89.60974048,1,-1.487018409,0.936891057,-1.587183908,0.112470998,0.211253504,77.71223604,1,-4.307248869,1.263458767,-3.409093341,0.000651792,0.005184125,65.66319554,1,-3.950812025,1.253072876,-3.152898846,0.001616578,0.007110523,N,-,,short chain dehydrogenase reductase,C:membrane; C:integral component of membrane,IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24319:SF36 (PANTHER); PTHR24319 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06697,908,775,817,3,5,2,0,0,1,0,7,1,2,6,1,0,2,2,5.558449851,1,-0.577079901,1.216432815,-0.474403431,0.635212247,0.791837971,1.791276418,1,2.624605614,1.351462663,1.942048187,0.052131267,0.121779987,4.618523275,1,-0.018372663,1.216206404,-0.015106534,0.987947188,0.994620753,33.40694461,1,3.030420742,0.628830708,4.819136063,1.44E-06,2.56E-05,4.525419846,1,-0.092012774,1.209810828,-0.076055506,0.939374939,0.961015586,N,-,,hypothetical protein SPI_06005,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_06698,687,732,1265,0,2,0,0,0,0,0,0,0,1,2,2,0,0,0,56.7907654,1,-2.882289994,1.14807297,-2.510545992,0.012054462,0.044000134,26.41488924,0,0.290994851,1.129516538,0.257627792,0.796694179,0.87691806,58.32160286,0,-1.448512955,1.039546262,-1.393408843,0.163496193,0.279891447,70.7774191,1,-0.673723556,0.694392439,-0.970234579,0.331929578,0.478471951,54.72637827,0,-1.142364798,0.848107198,-1.346958027,0.177993751,0.295005194,N,-,,hypothetical protein SPI_06004,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_06699,16008,15164,23575,0,0,29,0,0,0,0,0,0,1,17,6,0,11,9,337.0969095,1,-0.038472336,0.314240579,-0.122429561,0.902558829,0.952655573,54.65921617,0,-2.306871822,1.188278957,-1.941355444,0.052215179,0.121864106,179.6575996,0,-1.813964689,0.662071169,-2.739833381,0.006147034,0.022170492,195.6602699,1,-1.673163845,0.535666434,-3.123518179,0.001787028,0.012054404,143.6073051,1,-4.110037342,1.119940172,-3.669872235,0.000242672,0.00146865,N,-,,nadh-ubiquinone oxidoreductase 23 kda subunit,"C:membrane; P:oxidation-reduction process; F:oxidoreductase activity, acting on NAD(P)H; F:4 iron, 4 sulfur cluster binding",IPR017896 (PFAM); G3DSA:1.10.1060.10 (GENE3D); IPR010226 (TIGRFAM); PTHR10849:SF20 (PANTHER); PTHR10849 (PANTHER); IPR017896 (PROSITE_PROFILES); IPR017896 (PROSITE_PROFILES); IPR010226 (HAMAP); SSF54862 (SUPERFAMILY),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_06700,7170,6518,7747,0,1,24,3,0,0,0,0,2,2,0,0,0,0,0,302.5253913,1,-0.141155789,0.64448867,-0.219019814,0.826634613,0.912789005,81.09866961,1,-0.080147263,0.857735566,-0.093440527,0.925553595,0.958801913,255.9290679,1,-0.281437378,0.453946612,-0.619979026,0.535271596,0.664185517,238.1094456,1,-0.680555562,0.529717414,-1.284752104,0.198878924,0.329192398,221.7312655,0,-0.57063622,1.61183227,-0.35402953,0.723316753,0.80523168,N,-, Effector probability:0.625,acyl carrier,P:fatty acid biosynthetic process,IPR009081 (PFAM); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR003231 (TIGRFAM); PTHR20863 (PANTHER); PTHR20863:SF5 (PANTHER); IPR003231 (PRODOM); IPR009081 (PROSITE_PROFILES); IPR003231 (HAMAP); IPR009081 (SUPERFAMILY),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_06701,1524,811,820,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,88.87688538,0,-1.618609552,0.789531418,-2.050088843,0.040355762,0.113329537,23.74243114,0,-1.103859056,1.225242436,-0.900931133,0.367624937,0.532117777,61.19800318,0,-3.746422774,1.20744284,-3.102774433,0.001917157,0.009558417,129.1666374,0,-0.268618666,0.561271397,-0.478589622,0.632230603,0.747470207,59.96480446,0,-3.819850005,1.204499123,-3.171318211,0.001517488,0.006735891,N,-,,spindle poison sensitivity,F:metal ion binding,IPR000571 (SMART); IPR000571 (G3DSA:4.10.1000.GENE3D); IPR000571 (PFAM); PTHR11224 (PANTHER); PTHR11224:SF41 (PANTHER); IPR000571 (PROSITE_PROFILES); IPR000571 (PROSITE_PROFILES); IPR000571 (SUPERFAMILY),,
RL4_JR_06702,232,306,151,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.252786772,0,0.725826066,1.298064973,0.559160043,0.5760525,0.751061369,0.713233432,0,3.952920974,1.479459606,2.671868132,0.007543028,0.027424761,1.861401639,0,1.292160289,1.236952524,1.044632081,0.296193046,0.437249694,2.148067376,0,0.869455006,1.253348773,0.693705555,0.487866882,0.628022212,1.847381231,0,1.200857173,1.238092202,0.96992548,0.332083638,0.46868509,N,-,,F-box Skp2,,IPR032675 (G3DSA:3.80.10.GENE3D); IPR001810 (PFAM); IPR001810 (SUPERFAMILY),,
RL4_JR_06703,5709,5703,8520,0,2,21,0,0,0,3,1,1,7,17,7,0,9,0,136.4835175,1,1.325370867,0.527760015,2.511313531,0.012028281,0.043963584,11.14671473,0,-0.013023236,1.242523605,-0.010481279,0.991637303,0.995769125,41.80129949,1,-0.844639712,1.05511956,-0.800515642,0.423412105,0.564549473,33.21784326,1,-3.081095136,1.21082776,-2.544618844,0.010939708,0.052222792,69.71410448,1,0.869127192,0.589789857,1.473621802,0.140583448,0.24673382,N,-,,Ferroporti- partial,C:membrane,IPR002589 (PFAM); IPR009716 (PFAM); PTHR11660 (PANTHER); PTHR11660 (PANTHER); PTHR11660:SF57 (PANTHER); PTHR11660:SF57 (PANTHER); IPR020846 (SUPERFAMILY); SSF52949 (SUPERFAMILY),2.A.100.1.3, the ferroportin (fpn) family.
RL4_JR_06704,839,819,794,0,7,27,0,0,1,2,7,5,5,4,2,0,10,0,155.3984824,1,-1.484009483,0.784861625,-1.890791238,0.058652217,0.149822418,36.21888958,1,-1.713136191,1.250448436,-1.37001746,0.170681451,0.305993208,105.9008711,1,-2.540702247,1.083698453,-2.344473446,0.019053967,0.053808191,188.7959372,1,-0.219816907,0.554359347,-0.396524219,0.691718345,0.791909571,121.4165108,1,-0.943549905,0.713427863,-1.322558248,0.185982327,0.304852041,N,-,,fcp1-like phosphatase,F:phosphoprotein phosphatase activity; P:protein dephosphorylation; C:intracellular part,IPR004274 (SMART); IPR001357 (SMART); IPR011947 (TIGRFAM); G3DSA:2.40.50.100 (GENE3D); IPR004274 (PFAM); IPR001357 (G3DSA:3.40.50.GENE3D); IPR023214 (G3DSA:3.40.50.GENE3D); IPR001357 (PFAM); PTHR23081:SF0 (PANTHER); PTHR23081 (PANTHER); IPR001357 (PROSITE_PROFILES); IPR004274 (PROSITE_PROFILES); IPR023214 (SUPERFAMILY); IPR001357 (SUPERFAMILY),,
RL4_JR_06705,1165,1279,660,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0.16330624,0,4.512258719,3.341716412,1.35028176,0.176925621,NA,0.05234282,0,7.722055481,2.481190934,3.112237505,0.001856751,0.015023052,0.134790612,1,5.082636754,1.52684054,3.328858923,0.000872026,0.005153758,0.1554606,0,4.658946112,2.107688138,2.210453259,0.027073721,0.087411169,0.131322592,0,5.016787277,1.357780828,3.694843213,0.000220023,0.00134932,Y,-,,kinase-like domain,F:nucleotide binding; F:ATP binding; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,G3DSA:1.10.510.10 (GENE3D); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_06706,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.376367149,0,1.436795836,1.412500993,1.017199877,0.309058355,NA,0.434856426,0,4.66675666,1.599897876,2.916909092,0.003535188,0.016928889,1.135551108,0,2.005240555,1.255728772,1.596873942,0.110293809,0.208557065,10.62280126,0,2.534643314,1.171261441,2.164028649,0.030462151,0.093257059,1.126856164,0,1.914267422,1.247933094,1.533950362,0.125041865,0.225918787,N,-,,glycoside hydrolase family 94,P:carbohydrate metabolic process; F:carbohydrate binding; F:hydrolase activity,IPR010383 (PFAM); IPR005196 (G3DSA:2.70.98.GENE3D); IPR033432 (PFAM); G3DSA:2.60.420.10 (GENE3D); PTHR37469:SF1 (PANTHER); PTHR37469 (PANTHER); IPR008928 (SUPERFAMILY); IPR011013 (SUPERFAMILY),,
RL4_JR_06707,59,46,74,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.162944438,0,-1.298289835,1.224991648,-1.059835663,0.289219369,0.473975816,2.905210241,0,1.926768315,1.300725492,1.481302801,0.138525903,0.259755314,14.07794749,0,0.22850422,1.213805209,0.18825444,0.850677198,0.904553719,35.39368481,0,1.578362628,0.779757973,2.024169914,0.042952672,0.112784182,7.523283678,0,-0.825142126,1.230410268,-0.67062357,0.502460363,0.63001996,N,-,,udp-glucuronosyl udp-glucosyltransferase,"F:transferase activity, transferring hexosyl groups; P:metabolic process; F:transferase activity",no IPS match,,
RL4_JR_06708,466,520,609,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0.500387191,1,2.896392349,1.99890725,1.448987865,0.147340971,NA,0.159827604,0,6.110784815,1.923264792,3.177297707,0.001486544,0.015023052,0.415080174,0,3.456611076,1.301627353,2.65560728,0.007916575,0.02714101,0.478832871,1,3.034814108,1.45218168,2.089830873,0.036632995,0.101650752,0.410255355,0,3.371072244,1.254975916,2.68616489,0.007227741,0.024240105,N,-,,---NA---,,no IPS match,,
RL4_JR_06709,418,1582,759,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,2.765390033,1,0.43010073,1.233360635,0.348722602,0.727297574,0.855928103,0.887772145,0,3.637312136,1.431846553,2.540294648,0.011075911,0.036328702,2.294700721,0,0.990717535,1.215365979,0.815159838,0.414980824,0.556606499,6.65813549,0,1.515239379,1.15466827,1.312272467,0.189428218,0.317911605,2.254195849,0,0.913367042,1.205386119,0.757738145,0.448607759,0.580535995,N,-,,chromosome transmission fidelity 1,F:nucleotide binding; F:nucleic acid binding; F:DNA helicase activity; P:chromosome organization; F:ATP-dependent helicase activity; P:single-organism cellular process; P:nucleobase-containing compound metabolic process,IPR006554 (SMART); IPR006555 (SMART); IPR006555 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR010614 (PFAM); IPR013020 (TIGRFAM); PTHR11472 (PANTHER); PTHR11472:SF41 (PANTHER); PTHR11472:SF41 (PANTHER); PTHR11472 (PANTHER); IPR014013 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_06710,770,1217,810,0,1,11,0,0,0,0,0,0,0,0,0,0,3,0,32.12248672,1,2.174340049,0.675417096,3.219255275,0.00128524,0.007206178,2.163569053,0,2.352138686,1.304325224,1.803337575,0.071335215,0.15612001,16.6797501,0,0.66303765,1.19368256,0.555455589,0.578583079,0.700750699,66.68276275,0,3.025076666,0.545603161,5.544463233,2.95E-08,7.54E-07,5.522691979,1,-0.379032825,1.199793273,-0.315915111,0.752066942,0.827340174,N,-,,cell cycle,"P:regulation of cell shape; F:identical protein binding; P:double-strand break repair via break-induced replication; P:positive regulation of meiotic DNA double-strand break formation; P:mitotic DNA replication initiation; C:chromosome, centromeric region; F:protein serine/threonine kinase activity; P:premeiotic DNA replication; P:cell division; C:nucleus; F:ATP binding; P:negative regulation of exit from mitosis; P:negative regulation of DNA binding; P:regulation of chromatin silencing at telomere; C:cytoplasm; P:G1/S transition of mitotic cell cycle; C:Dbf4-dependent protein kinase complex; P:phagocytosis; P:peptidyl-serine phosphorylation; P:negative regulation of transcription by transcription factor catabolism; P:mitotic DNA replication checkpoint",IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); PTHR11909:SF7 (PANTHER); PTHR11909:SF7 (PANTHER); PTHR11909 (PANTHER); PTHR11909 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_06711,4,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,70.09895068,0,2.900404077,0.56533496,5.130416975,2.89E-07,5.06E-06,3.333364132,0,1.728607658,1.278615314,1.35193724,0.176395393,0.313021418,8.613072228,0,-0.917397709,1.199576297,-0.76476812,0.444409634,0.584008715,9.933981242,0,-1.3394053,1.197661768,-1.118350219,0.263417447,0.40410631,8.450977362,0,-0.992915202,1.195165792,-0.830776122,0.406100114,0.543022141,N,-,,condensin complex subunit 1,P:cell division; C:nucleus; P:mitotic chromosome condensation,IPR032682 (PFAM); IPR024324 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR14222:SF2 (PANTHER); IPR026971 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_06712,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_06713,32,12,36,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,118.8040582,1,-0.909423115,0.634913423,-1.432357676,0.152041485,0.299892271,78.81259984,0,2.140389357,0.625221381,3.423410366,0.000618406,0.015023052,84.59546192,0,-0.869820542,0.749310323,-1.160828186,0.245711778,0.379979376,132.6230769,0,0.181770513,0.468979264,0.387587526,0.698321302,0.796855988,87.33198976,0,-1.112672261,0.757056282,-1.469735194,0.141633487,0.248060726,N,-, Effector probability:0.629,nadh:ubiquinone oxidoreductase 14kd subunit,C:integral component of membrane,IPR009346 (PFAM); IPR009346 (PANTHER); PTHR12966:SF0 (PANTHER),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_06714,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,299.7104652,0,5.304858288,1.081377206,4.905650181,9.31E-07,1.43E-05,2.434672408,0,2.181765189,1.286538214,1.695841729,0.089915857,0.186348958,124.8651385,0,4.419491913,0.396835153,11.13684581,8.30E-29,2.27E-26,215.5369586,0,4.640600704,0.378833516,12.24970998,1.69E-34,3.41E-32,82.73791343,0,4.105063523,0.488062834,8.410932438,4.07E-17,7.35E-15,N,-,,methyltransferase type 12,F:transferase activity,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); PTHR10108:SF905 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_06715,14,12,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,95.21167425,0,-0.489993978,0.58036894,-0.844280155,0.398512873,0.590351919,19.12865956,0,-0.792172161,1.197610704,-0.661460488,0.508317046,0.660485897,60.7874284,0,-2.484927596,1.189915571,-2.088322615,0.036768743,0.089396434,96.04360086,0,-0.341555504,0.574982655,-0.594027491,0.552493726,0.68153009,56.83239009,0,-1.864154846,0.978622695,-1.904875961,0.056796197,0.123377278,N,-,,mitochondrial tricarboxylate transporter,P:transmembrane transport; F:structural constituent of ribosome; C:mitochondrion; C:integral component of membrane; P:translation,IPR002067 (PRINTS); IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); PTHR24089 (PANTHER); PTHR24089:SF301 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.7.3, the mitochondrial carrier (mc) family.
RL4_JR_06716,14,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,98.44479133,0,-1.899555166,0.856515777,-2.217770201,0.026570505,0.082536643,22.42048046,0,-1.021253148,1.202644435,-0.849172971,0.395785051,0.559985502,124.6592965,0,0.105548159,1.639587785,0.064374814,0.948671784,0.970234684,96.09412885,0,-1.757226846,0.855989218,-2.052860957,0.040086065,0.107602271,80.69519292,0,-0.594772081,0.653964141,-0.9094873,0.363092959,0.499771099,N,-, Effector probability:0.673,Cytochrome B pre-mRNA-processing 6,C:macromolecular complex,PTHR28250:SF1 (PANTHER); PTHR28250 (PANTHER),,
RL4_JR_06717,63,67,82,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,222.6582294,0,-0.904781696,0.506202441,-1.787391015,0.073874313,0.177568251,47.39952375,0,-2.10129086,1.216676443,-1.7270745,0.084154285,0.176870778,217.2394043,0,-0.352006518,0.507820026,-0.693171794,0.488201747,0.62295872,206.5693073,0,-1.384219511,0.59058545,-2.343809031,0.019087942,0.075140729,158.358514,0,-1.601885445,0.67738041,-2.36482399,0.018038642,0.050286687,N,-,,metal homeostatis bsd2,C:integral component of membrane; P:vacuolar transport; P:metal ion transport; C:intracellular,IPR019325 (PFAM); PTHR13396:SF5 (PANTHER); PTHR13396 (PANTHER),8.A.30.2.3, the nedd4-family interacting protein-2 (nedd4) family.
RL4_JR_06718,1317,1099,1566,0,0,8,0,0,0,0,0,0,0,1,0,0,0,0,62.56061229,1,1.526042173,0.795319333,1.918779175,0.055012286,0.142734832,4.658925521,0,1.245537615,1.266874897,0.983157546,0.325529906,0.487644473,12.04339863,0,-1.401227266,1.204692272,-1.163141243,0.244772201,0.378910362,17.90119398,1,-0.876814493,1.155858969,-0.758582592,0.448102289,0.590083275,19.56009247,0,0.184255007,0.99040896,0.186039317,0.852413929,0.901942839,N,-,,#NAME?,P:cellular protein modification process; F:methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PF01135 (PFAM); IPR000682 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_06719,2628,1710,1715,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,156.9208151,0,-0.569799255,0.631813677,-0.901846978,0.367138161,0.558894031,30.17403201,0,-1.449692943,1.24068128,-1.168465235,0.242619154,0.39494871,97.12321193,0,-1.701708187,0.903948949,-1.882526872,0.059764515,0.129812476,138.1523161,0,-0.799050933,0.619200033,-1.290456864,0.196892079,0.326862159,75.75635991,0,-4.157081117,1.220050938,-3.407301275,0.000656087,0.003397891,N,-,,udp-glucose:sterol glycosyltransferase,"F:transferase activity, transferring glycosyl groups; P:steroid metabolic process",IPR001849 (SMART); IPR004182 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); IPR004276 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR004182 (PFAM); IPR001849 (PFAM); IPR002213 (PANTHER); PTHR11926:SF417 (PANTHER); IPR001849 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); SSF53756 (SUPERFAMILY),9.B.198.2.4, the membrane-anchored lipid-binding protein (lam) family.
RL4_JR_06720,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.82601586,0,0.021764579,1.00347325,0.021689247,0.982695841,0.991333724,3.893449546,0,1.504483943,1.251907855,1.201752939,0.229459264,0.379383644,10.09303434,0,-1.146297177,1.189817614,-0.963422598,0.33533549,0.4785708,19.66617006,0,0.16075008,1.009142084,0.159293802,0.873437404,0.921809518,21.52258579,0,0.9803092,0.838816501,1.168681349,0.242532039,0.371997384,N,-,,wd repeat-containing,F:DNA binding; C:nuclear chromatin; C:cytoplasm; P:cellular response to DNA damage stimulus,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR14773 (PANTHER); IPR033052 (PTHR14773:PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),,
RL4_JR_06721,27,8,30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.6332063,0,0.13714092,0.800671979,0.171282278,0.864001815,0.932961854,7.151945161,0,0.627210582,1.279435682,0.490224394,0.623975121,0.752786194,70.62601266,0,1.606342288,0.640241229,2.508964145,0.012108577,0.03749992,50.13652701,0,-0.054744571,0.89704952,-0.061027367,0.951337414,0.971282538,59.78627812,0,1.649646874,0.597121853,2.76266371,0.00573318,0.020044354,N,-,,short chain dehydrogenase reductase,C:integral component of membrane,IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24320:SF70 (PANTHER); PTHR24320 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06722,443,427,667,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,49.41917775,1,2.932786183,0.750072113,3.910005629,9.23E-05,0.000795914,2.374788355,1,2.217677157,1.336581251,1.659216119,0.097072251,0.198097847,21.84391121,0,1.391320016,1.062521426,1.309451257,0.190381539,0.313351113,100.231648,0,3.565462569,0.612167233,5.824327694,5.73E-09,1.66E-07,13.44363323,0,0.423499869,1.157458451,0.365887751,0.714448837,0.798823481,N,-,,duf895 domain membrane,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); PTHR23294 (PANTHER); PTHR23294:SF19 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.58.5, the major facilitator superfamily (mfs).
RL4_JR_06723,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.60702081,0,-1.115903352,1.056931842,-1.055794998,0.291061884,0.475848267,8.764466956,0,0.333790302,1.260163958,0.264878471,0.791103084,0.873795221,22.85119748,0,-2.32528584,1.224376448,-1.899159236,0.057543543,0.12596126,30.37851411,0,-1.803203038,1.181303401,-1.526452084,0.126897315,0.234287986,22.68372118,0,-2.417380397,1.237334122,-1.953700584,0.050736637,0.113501647,N,-,,hypothetical protein SPBR_04188,,PTHR39468 (PANTHER); PTHR39468:SF1 (PANTHER),,
RL4_JR_06724,3,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.048589606,0,0.862776324,1.359635231,0.634564555,0.525712452,NA,0.660146145,0,4.064653272,1.55474408,2.614355202,0.008939604,0.031009827,1.705382626,0,1.418635586,1.270920786,1.116226598,0.264325152,0.401745659,11.27886462,0,1.95204185,1.193916298,1.634990538,0.102051031,0.198896379,1.677251239,0,1.339775713,1.261234202,1.062273534,0.288111526,0.422527404,N,-,,hypothetical protein SPI_06011,F:thiol-dependent ubiquitin-specific protease activity; C:nucleus; P:protein deubiquitination involved in ubiquitin-dependent protein catabolic process; C:cytoplasm; F:K63-linked polyubiquitin binding,IPR022105 (PFAM); IPR022099 (PFAM); PTHR13367:SF8 (PANTHER); PTHR13367 (PANTHER),,
RL4_JR_06725,674,504,624,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.871628073,0,0.993479773,1.35464089,0.733389772,0.463320736,NA,0.591332552,0,4.223392168,1.535594133,2.750331013,0.005953509,0.023168558,1.542829761,0,1.563340407,1.252897153,1.247780317,0.212111519,0.34015793,1.780558222,0,1.140457977,1.278981936,0.891692013,0.372558036,0.518223672,1.528492148,0,1.474459853,1.248902425,1.180604524,0.237759866,0.36680156,N,-,,aflatoxin biosynthesis ketoreductase nor-1,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06726,232,138,155,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28.35027303,0,1.706777362,0.688623428,2.478535138,0.013192312,0.047265208,2.9410889,0,1.90911432,1.274487256,1.497946967,0.13414703,0.253091563,7.653153733,0,-0.7471913,1.200057049,-0.622629816,0.533527813,0.66306689,8.830447768,0,-1.169789337,1.198742183,-0.975847312,0.329140135,0.475805806,19.1500843,0,1.360812913,0.86450351,1.574097615,0.115464884,0.212831231,N,-,,Short-chain dehydrogenase reductase SDR,P:nucleocytoplasmic transport; F:structural constituent of nuclear pore; C:nuclear pore,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06727,112,248,184,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.657870841,0,-1.216191555,1.205748163,-1.008661337,0.31313708,0.501191348,2.752536203,0,2.004754346,1.285836331,1.559105384,0.11897144,0.232028692,7.152422994,0,-0.649401676,1.203037221,-0.539801815,0.589333715,0.708852861,8.252365921,0,-1.071936036,1.20203986,-0.891764134,0.372519369,0.518223672,7.057114066,0,-0.732750227,1.20674845,-0.607210415,0.543711281,0.665424643,N,-,,Acyl-coenzyme A:6-aminopenicillanic-acid-acyltransferase 40 kDa,"F:transferase activity, transferring acyl groups",IPR005079 (PFAM); PTHR34180 (PANTHER),,
RL4_JR_06728,68,77,68,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34.59885319,0,-0.199864013,1.028932587,-0.194244031,0.845984808,0.922666319,4.594501903,0,1.26552898,1.260216099,1.004215849,0.315274584,0.477201051,19.81388394,0,-0.430837797,1.205117318,-0.357506933,0.720712337,0.8109015,23.12507693,0,-0.863888386,1.15866437,-0.745589844,0.45591522,0.598178256,11.86455762,0,-1.482368972,1.218135932,-1.21691589,0.223636219,0.350350723,N,-,,zinc finger transcription factor 1,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); IPR001138 (PFAM); PTHR31313 (PANTHER); PTHR31313:SF6 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_06729,501,645,601,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0.515272942,1,2.854358055,1.973271118,1.446510836,0.148033975,NA,0.163602935,0,6.077255235,1.907802552,3.1854739,0.001445171,0.015023052,0.425250862,0,3.42298103,1.294016197,2.645238164,0.008163344,0.027808106,0.490672583,0,3.000159043,1.436692051,2.088240859,0.036776113,0.101820658,0.419504353,0,3.340517794,1.247399729,2.677985025,0.007406653,0.024692908,N,-,,hypothetical protein ASPCAL00742,"P:biological_process; F:RNA-directed RNA polymerase activity; P:transcription, RNA-templated; C:cellular_component; F:molecular_function",no IPS match,,
RL4_JR_06730,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.189071024,0,4.300704511,3.052309011,1.409000365,0.15883506,NA,0.059991159,0,7.524588568,2.321880519,3.240730307,0.001192239,0.015023052,0.156027222,0,4.869485627,1.390144664,3.50286251,0.000460287,0.003185199,0.180036192,0,4.446554045,1.876523783,2.369569779,0.017808794,0.072619429,0.154033788,0,4.786844287,1.271747903,3.763988348,0.000167225,0.001072293,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502:SF26 (PANTHER); PTHR23502:SF26 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.36, the major facilitator superfamily (mfs).
RL4_JR_06731,18,5,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.448653183,0,3.054152867,2.120387538,1.440374843,0.149761377,NA,0.143749806,0,6.264151907,1.981386494,3.161499246,0.001569592,0.015023052,0.371091633,0,3.620348861,1.322858076,2.736762866,0.0062047,0.022346633,0.428014691,0,3.197584432,1.503538696,2.126705778,0.033444537,0.098027965,0.363215199,0,3.547985321,1.25893739,2.818238103,0.004828799,0.017417736,N,-,,cation transporter,F:DNA binding; C:membrane; P:cation transmembrane transport; F:cation transmembrane transporter activity; P:cellular process,IPR003445 (PFAM); PTHR31064:SF6 (PANTHER); PTHR31064 (PANTHER); PTHR31064 (PANTHER),2.A.38.2.3, the k(+) transporter (trk) family.
RL4_JR_06732,15,5,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.259452352,0,3.844298177,2.701242493,1.423159227,0.154690002,NA,0.082917528,0,7.058036147,2.21451331,3.187172601,0.00143671,0.015023052,0.21426837,0,4.413121627,1.389231587,3.176663754,0.001489797,0.00785236,0.247160474,0,3.989832644,1.74546889,2.285822834,0.022264625,0.080481732,0.209809837,0,4.34047555,1.285804783,3.375687825,0.000736314,0.003740683,N,-,,---NA---,,no IPS match,,
RL4_JR_06733,447,357,509,2,0,0,0,0,0,0,0,0,1,2,0,0,1,1,0.163484719,1,4.51032157,3.256345625,1.38508687,0.166025906,NA,0.052955716,0,7.704912494,2.405523697,3.203008353,0.00136,0.015023052,0.136146726,0,5.066090044,1.43318418,3.534849264,0.000408008,0.002925405,0.15696399,1,4.644347711,1.992907396,2.330438293,0.019782998,0.076494698,7.854137409,1,6.64882413,1.034586025,6.426555133,1.31E-10,8.93E-09,N,-,,hemerythrin hhe cation binding domain-containing,,G3DSA:1.20.120.520 (GENE3D); IPR012312 (PFAM); PTHR38048:SF2 (PANTHER); PTHR38048 (PANTHER),,
RL4_JR_06734,149,196,207,0,0,0,0,0,0,0,0,0,2,0,0,0,7,2,0.859799212,0,2.115400575,1.703677293,1.241667412,0.214359298,NA,0.27083896,0,5.349654294,1.785564775,2.996057253,0.002734951,0.015349618,0.710214642,0,2.68169485,1.320623942,2.030627164,0.04229283,0.099693999,0.819775468,1,2.258969373,1.414060227,1.597505771,0.110153012,0.211004315,0.709149681,1,2.582153493,1.302613513,1.98228674,0.047447157,0.10761704,N,-,,zn2 cys6 dna-binding,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated",no IPS match,,
RL4_JR_06735,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.268067977,0,1.555019233,1.360996647,1.142559195,0.253221656,NA,0.405976677,0,4.766089878,1.598155678,2.982243811,0.00286144,0.015349618,1.051007745,0,2.117255033,1.229464718,1.722094991,0.085052312,0.170610186,1.21229459,0,1.695089758,1.25872312,1.346674048,0.178085234,0.302752262,1.033901341,0,2.037976926,1.210083269,1.684162552,0.092150258,0.179358201,N,-, Effector probability:0.805,glutathione S-transferase domain-containing,F:transferase activity,IPR010987 (G3DSA:1.20.1050.GENE3D); IPR012336 (G3DSA:3.40.30.GENE3D); IPR004046 (PFAM); IPR004045 (PFAM); PTHR11260 (PANTHER); PTHR11260:SF186 (PANTHER); IPR004045 (PROSITE_PROFILES); IPR010987 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR010987 (SUPERFAMILY),1.A.12.2.2, the intracellular chloride channel (clic) family.
RL4_JR_06736,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.400451549,0,-0.240268992,1.223850334,-0.196322202,0.844357985,0.921878003,1.408023306,0,2.971812127,1.368521883,2.171548855,0.029889708,0.07882846,3.650934339,0,0.320485252,1.217378458,0.26325852,0.792351328,0.863205084,4.21135707,0,-0.101693981,1.219871786,-0.083364483,0.933561728,0.961382476,3.601327729,0,0.23755513,1.217926147,0.195048879,0.845354683,0.896534635,N,-, Effector probability:0.682,NAD-dependent epimerase dehydratase,,IPR016040 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR15020 (PANTHER); PTHR15020:SF24 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06737,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.56388479,0,-1.503448524,1.299594589,-1.156859636,0.247329712,0.423622883,3.457148323,0,1.675998847,1.4055958,1.192376106,0.233113805,0.38329726,8.833116937,0,-0.953909639,1.280846495,-0.744749384,0.456423239,0.595084207,10.17938836,0,-1.374744539,1.290009348,-1.065685719,0.286565736,0.43080595,8.581283457,0,-1.015067314,1.282508471,-0.791470261,0.428669624,0.563380055,N,-,,hypothetical protein MYCTH_2120123,,IPR003615 (PFAM),,
RL4_JR_06738,6710,6683,7199,1,0,10,0,0,0,8,0,0,3,2,4,0,2,1,0.921269475,1,2.015816364,2.315871109,0.870435473,0.384062468,NA,0.310033035,0,5.155200991,2.250748424,2.290438565,0.021995906,0.062152913,0.78052086,1,2.546484911,1.710520914,1.488718958,0.136561391,0.244525561,0.898456736,1,2.127274047,1.915089856,1.110795945,0.266656192,0.407654227,0.748732454,1,2.503240193,1.674737034,1.494706418,0.134991079,0.23929129,,,,,,,,
RL4_JR_06739,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2218.979129,0,-4.244253776,1.635293327,-2.595408241,0.009447863,0.036219767,710.4113494,0,-6.006921798,2.75740966,-2.178465494,0.029371399,0.077891447,1788.662224,0,-8.615584143,2.739201615,-3.145290254,0.001659221,0.008548578,2068.152581,0,-8.013200635,1.872624128,-4.279129226,1.88E-05,0.000246716,1754.282297,0,-5.501064739,1.883513646,-2.920639704,0.003493135,0.01336659,N,-, Effector probability:0.885,glutathione-dependent formaldehyde-activating enzyme,F:zinc ion binding; P:formaldehyde catabolic process; F:S-(hydroxymethyl)glutathione synthase activity,IPR014185 (PIRSF); IPR006913 (PFAM); IPR014185 (TIGRFAM); IPR006913 (G3DSA:3.90.1590.GENE3D); IPR011057 (SUPERFAMILY),,
RL4_JR_06740,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,242.8342623,0,-1.743361548,1.363388509,-1.278697551,0.201003582,0.364883673,58.47734325,0,-2.404294462,1.324870939,-1.814738622,0.069564087,0.152971472,151.9237669,0,-5.058218249,1.321953578,-3.826320631,0.000130073,0.001356816,188.5610972,0,-3.738868097,1.184377383,-3.156821593,0.001594989,0.010963519,150.5749686,0,-5.148120866,1.351437524,-3.809366525,0.000139323,0.000917793,N,-,,dihydroxy-acid dehydratase,F:catalytic activity; P:metabolic process,IPR000581 (PFAM); IPR000581 (PANTHER); PTHR21000:SF14 (PANTHER); SSF143975 (SUPERFAMILY); IPR015928 (SUPERFAMILY),,
RL4_JR_06741,7,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.503483589,0,-1.190200048,1.25819308,-0.945959779,0.344169101,0.534195496,2.708128912,0,2.028284897,1.349246595,1.5032722,0.132768866,0.251052954,7.014458926,0,-0.621186404,1.240928484,-0.500581953,0.616665366,0.730958924,8.092428249,0,-1.043604414,1.245223708,-0.838085885,0.40198247,0.54580562,6.885230476,0,-0.697195128,1.243298217,-0.560762589,0.574959393,0.689663477,N,-,,methyltransferase domain-containing,F:methyltransferase activity,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF905 (PANTHER); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_06742,210,282,291,2,1,38,0,0,0,6,5,23,26,155,4,0,64,12,5.657111448,1,-0.602638285,1.199621169,-0.502357161,0.615416307,0.779196613,1.810959052,0,2.608764803,1.325040989,1.96881819,0.048973973,0.115875304,4.691428967,1,-0.041169666,1.203122503,-0.034219014,0.972702504,0.984173511,5.411429504,1,-0.463335411,1.201819663,-0.385528233,0.699846093,0.797992089,4.620788599,1,-0.122033716,1.202403949,-0.101491447,0.919160347,0.948317251,N,-,,atp-dependent dna helicase pif1,P:DNA metabolic process; P:organelle organization; F:hydrolase activity,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003840 (PFAM); IPR010285 (PFAM); IPR003840 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.7.16.1, the type iv (conjugal dna-protein transfer or virb) secretory pathway (ivsp) family.
RL4_JR_06743,651,870,636,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,36.12904846,0,-0.969793813,1.019118193,-0.951600923,0.341299413,0.531561782,7.716598108,0,0.517512787,1.224145721,0.422754234,0.672474582,0.790935129,46.83824531,1,0.274270646,0.855327225,0.320661658,0.748466807,0.831726132,44.51906068,1,0.159286847,0.752875444,0.211571313,0.832441491,0.894921232,42.31159556,0,0.401232901,0.762230913,0.526392848,0.598615284,0.709052381,N,-,,#NAME?,C:cellular_component,IPR016040 (G3DSA:3.40.50.GENE3D); IPR008030 (PFAM); PTHR14194 (PANTHER); PTHR14194:SF79 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06744,36,43,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.06492052,0,-2.195385023,1.214433338,-1.807744364,0.070646296,0.17214232,5.411606882,0,1.029376292,1.257051117,0.818881808,0.41285385,0.576934945,14.11410164,0,-1.630201833,1.211398324,-1.345719076,0.178393132,0.298422351,48.55811417,0,0.704426374,0.770526979,0.914213769,0.36060453,0.506607586,32.95119033,0,0.880817361,0.797425608,1.104576216,0.269343262,0.401700964,N,-,,short-chain dehydrogenase,,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24322:SF434 (PANTHER); IPR002347 (PANTHER); PTHR24322:SF434 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06745,129,185,125,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.226622686,0,0.74296277,1.254935717,0.592032532,0.553828804,0.732749819,0.713148857,0,3.953323218,1.469646702,2.689982029,0.007145587,0.026320098,1.844525872,0,1.3060314,1.217499022,1.072716591,0.283398294,0.422862834,30.064334,0,3.216788121,0.851704418,3.776883218,0.000158803,0.001582561,1.811701618,0,1.228909007,1.204605214,1.020175733,0.307645125,0.44296173,N,-,,---NA---,,no IPS match,,
RL4_JR_06746,5,5,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.174362181,0,4.417294272,3.173605338,1.391885191,0.163957167,NA,0.055775676,0,7.629485013,2.375396318,3.211878774,0.0013187,0.015023052,0.144781246,0,4.975573299,1.424351129,3.493221016,0.000477231,0.003259104,0.167008845,0,4.554387593,1.954362826,2.330369536,0.019786628,0.076494698,0.143090579,0,4.889735771,1.291115985,3.787216508,0.000152344,0.000986876,N,-,,hypothetical protein CMQ_1032,,no IPS match,,
RL4_JR_06747,622,392,644,0,0,0,0,0,0,0,0,0,2,0,0,0,1,1,0.083084401,0,5.486599783,3.919587132,1.399790232,0.161576144,NA,0.026381831,0,8.70905601,2.751034998,3.165737992,0.001546901,0.015023052,0.068839869,0,6.046972982,1.582936161,3.820099087,0.000133398,0.001376714,0.079433279,1,5.626292421,2.565614353,2.192961079,0.028310183,0.089465864,0.068418651,1,5.954687102,1.335210795,4.459735588,8.21E-06,8.50E-05,N,-, Effector probability:0.946,hypothetical protein CMQ_1032,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_06748,4657,4197,3506,0,0,1,0,0,0,0,0,0,0,18,0,0,1,4,2.193743645,1,0.76408883,1.256823718,0.607952268,0.543219132,0.724232992,0.700916279,0,3.978174445,1.46906411,2.707965171,0.006769713,0.025294585,1.818156067,0,1.326222971,1.218547864,1.088363462,0.276434685,0.415534484,2.0973605,1,0.904009307,1.22910324,0.735503152,0.462033121,0.604169618,1.793252159,1,1.243510908,1.211980398,1.026015693,0.304884187,0.439987513,N,-,,---NA---,,SSF54001 (SUPERFAMILY),,
RL4_JR_06749,207,287,202,0,0,4,0,0,0,0,3,0,2,15,5,0,1,0,1.952182481,1,0.932481457,1.297549301,0.718648191,0.472357713,NA,0.619404158,0,4.156450679,1.49830167,2.77410802,0.00553533,0.021974647,1.613764926,1,1.498149873,1.229964087,1.218043591,0.223207408,0.353307036,1.862119744,1,1.075581885,1.247073485,0.862484768,0.388420812,0.533384617,1.598446335,1,1.409695737,1.227247242,1.148664823,0.250694216,0.381409307,N,-,,xenobiotic compound family,"P:transmembrane transport; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:proteolysis; C:integral component of membrane; P:oxidation-reduction process; F:peptidase activity; F:monooxygenase activity",IPR016215 (TIGRFAM); IPR011251 (PFAM); IPR016215 (PIRSF); IPR011251 (G3DSA:3.20.20.GENE3D); PTHR30011 (PANTHER); PTHR30011:SF16 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_06750,32,58,45,0,0,9,0,0,0,3,1,0,5,6,0,0,4,2,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_06751,8,13,5,0,0,23,0,0,0,0,2,0,6,12,4,0,0,3,23.97428367,1,-0.432176965,1.080176747,-0.400098378,0.689084059,0.831135544,5.250732141,0,1.073071807,1.306555342,0.821298396,0.411476321,0.575350645,85.01197006,1,2.457872076,1.601444017,1.534784887,0.124836676,0.228667724,148.0154379,1,3.237211186,0.530750994,6.09930311,1.07E-09,3.49E-08,103.7277205,1,3.07617089,0.515700884,5.965029315,2.45E-09,1.32E-07,N,-,,alpha beta hydrolase fold family,C:membrane; C:integral component of membrane; F:hydrolase activity,IPR013595 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR000073 (PFAM); PTHR10992 (PANTHER); PTHR10992:SF863 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_06752,142,204,159,0,0,0,0,0,0,0,3,1,1,1,2,0,0,0,0.149889141,0,4.635831248,3.391140907,1.367041764,0.171612215,NA,0.047977198,0,7.847493208,2.455418205,3.19599048,0.001393517,0.015023052,0.123871898,1,5.204096783,1.457710273,3.570048782,0.000356915,0.002645245,0.142878249,1,4.780473326,2.070140086,2.309251127,0.02092965,0.078370083,32.17094481,0,6.849848019,1.028874714,6.657611394,2.78E-11,2.18E-09,N,-,,Peptidase S9 S15,C:membrane; C:integral component of membrane,IPR013901 (PFAM),,
RL4_JR_06753,25,32,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.019781616,0,7.556258757,3.960309894,1.907996838,0.056391625,NA,0.006177465,0,10.80099648,3.666590793,2.94578727,0.003221339,0.016157775,0.016297679,0,8.122821537,2.181397604,3.723677664,0.000196342,0.001734522,0.018818652,0,7.703057059,3.960515312,1.944963332,0.051779392,0.125559168,0.01637629,0,8.021846978,1.492011636,5.376531112,7.59E-08,1.81E-06,N,-,,tat pathway signal sequence,F:GTP binding; P:peptidyl-tyrosine phosphorylation; F:non-membrane spanning protein tyrosine kinase activity; C:extracellular region; C:microtubule; P:microtubule-based process,IPR027417 (G3DSA:3.40.50.GENE3D); IPR022812 (PFAM); PTHR36681 (PANTHER); PTHR36681:SF2 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_06754,210,256,403,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.386071593,0,-0.531427402,1.28584735,-0.413289651,0.679394412,0.824051985,1.699497248,0,2.700382456,1.396774504,1.933298788,0.053199401,0.123846444,4.433406126,0,0.040619304,1.253819923,0.032396442,0.9741559,0.985348619,5.116757574,0,-0.382358652,1.262326426,-0.302899982,0.761966085,0.844685058,4.387448058,0,-0.047022076,1.26139789,-0.037277751,0.970263545,0.980201888,N,-,,siderochrome-iron transporter,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF46 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.16.7, the major facilitator superfamily (mfs).
RL4_JR_06755,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.202198532,0,-0.95081635,1.193140852,-0.796902016,0.42550794,0.616319055,2.29543987,0,2.266726377,1.290775537,1.75609648,0.079071936,0.168818,5.96053398,0,-0.386565638,1.195828045,-0.323261893,0.746496911,0.830315835,16.18879982,0,0.140238011,1.141108359,0.122896313,0.902189205,0.940167322,13.24749182,0,0.464779655,1.124862269,0.413188057,0.679468838,0.772297034,N,-,,hypothetical protein SPI_04853,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_06756,93,74,79,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.77353567,0,-0.96546835,1.006833275,-0.958915815,0.337601157,0.527542736,7.740000686,0,0.513218752,1.229094248,0.417558501,0.676269944,0.793420046,20.01632174,0,-2.134095261,1.191551165,-1.791022764,0.073289642,0.152389471,23.0864349,0,-2.556134379,1.189662414,-2.148621617,0.031664407,0.095162398,41.76572255,0,0.014999662,0.83360697,0.017993686,0.98564389,0.990240563,N,-,,hypothetical protein CMQ_799,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_06757,134,90,143,4,4,2,0,0,0,0,0,0,0,0,0,0,0,0,71.07311952,1,-0.061067356,0.573396134,-0.106501165,0.915184731,0.959033659,23.59134493,0,0.553151106,1.119799764,0.493973229,0.621325086,0.750703759,71.9126909,0,-0.185650008,0.741028875,-0.250530059,0.802177462,0.869979206,66.48636842,0,-0.143292377,0.621558032,-0.230537407,0.8176742,0.884976085,47.74609234,0,-0.883008466,0.838811005,-1.052690608,0.292482815,0.427205496,N,-,,fungal transcriptional regulatory,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31001 (PANTHER); PTHR31001:SF29 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_06758,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35.56842449,0,1.515075312,0.633461086,2.391741726,0.016768638,0.057046934,4.049920123,0,1.447682903,1.263461587,1.14580682,0.251875092,0.40642112,31.31839178,0,1.203802553,0.857077124,1.404544024,0.160156912,0.275472065,12.08606246,0,-1.622305685,1.196246622,-1.356163231,0.175047238,0.29872801,60.4782521,0,2.54405364,1.245590233,2.042448289,0.041107084,0.096144427,N,-,,hypothetical protein SPI_06020,,no IPS match,,
RL4_JR_06759,60,49,66,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,99.31609028,0,0.740856285,0.880884969,0.841036356,0.400327567,0.59207257,41.56556515,0,1.900145347,0.856622165,2.218183727,0.026542308,0.071796162,127.1199,0,1.48468755,1.12730527,1.317023515,0.187830742,0.310110639,129.2157573,0,1.48517442,0.411933202,3.605376821,0.0003117,0.002802811,53.53483781,1,-0.078086206,0.669991472,-0.11654806,0.907218199,0.940567711,Y,-,,hypothetical protein CMQ_786,,no IPS match,,
RL4_JR_06760,2,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0.256557327,0,3.860309911,2.680265475,1.440271476,0.149790608,NA,0.081199121,0,7.087720341,2.186090177,3.242190288,0.001186148,0.015023052,0.21170335,0,4.428504666,1.353773734,3.271229569,0.001070809,0.006083544,0.244307223,0,4.005943663,1.702746235,2.352636923,0.018640825,0.074340352,0.209667306,1,4.341465262,1.266252053,3.428594845,0.000606715,0.003184184,Y,-,,hypothetical protein SPI_06022,,IPR011024 (SUPERFAMILY),,
RL4_JR_06761,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.011783322,0,2.847230469,1.16130667,2.45174728,0.014216447,0.050359433,0.317942828,0,5.118606652,1.670554271,3.064016979,0.002183865,0.015045494,8.670420521,0,3.423601058,1.204666989,2.841948097,0.004483879,0.017459535,0.954776747,0,2.039494129,1.298024314,1.571229527,0.116129344,0.218795982,0.81810056,0,2.376346329,1.229353339,1.933005145,0.053235564,0.117431391,Y,-,,hypothetical protein CMQ_1275,,no IPS match,,
RL4_JR_06762,7,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.866606572,0,3.077223534,1.212404895,2.538115399,0.011145123,0.041365747,0.277569142,0,5.314677471,1.795088478,2.960677168,0.003069635,0.015756008,0.714282659,0,2.674213633,1.315881146,2.032260771,0.042127264,0.099462784,0.823492737,0,2.25283509,1.405546458,1.602817948,0.108974853,0.209249078,0.699602078,0,2.60079409,1.280229447,2.031506224,0.042203669,0.09808429,N,NRPS-Like,,nonribosomal peptide synthetase,F:catalytic activity; P:metabolic process; F:phosphopantetheine binding,IPR013120 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR009081 (PFAM); G3DSA:3.30.300.30 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR000873 (PFAM); PTHR24095 (PANTHER); PTHR24095:SF187 (PANTHER); IPR009081 (PROSITE_PROFILES); SSF56801 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR009081 (SUPERFAMILY),4.C.1.1.7, the fatty acid transporter (fat) family.
RL4_JR_06763,15,27,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_06764,277195,147166,205805,9,42,89,2,2,1,3,11,16,8,32,16,0,35,10,1196.850246,1,2.677797593,0.456308185,5.868397023,4.40E-09,1.07E-07,187.8191826,1,1.552994744,0.610972178,2.541842002,0.011027001,0.036218122,385.1214988,1,0.883911249,0.432108916,2.04557512,0.040798191,0.097208964,557.8747649,1,1.358001685,0.724535283,1.874307183,0.060888098,0.137855991,436.2277091,1,1.189724443,0.393314696,3.024866488,0.002487429,0.010174602,N,-,,glycosyltransferase family 20,"P:cellular response to heat; C:alpha,alpha-trehalose-phosphate synthase complex (UDP-forming); F:trehalose-phosphatase activity; P:trehalose biosynthetic process; F:transferase activity; P:dephosphorylation",IPR023214 (G3DSA:3.40.50.GENE3D); IPR001830 (PFAM); IPR003337 (PFAM); IPR006379 (TIGRFAM); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); IPR003337 (TIGRFAM); PTHR10788:SF45 (PANTHER); PTHR10788 (PANTHER); PTHR10788:SF45 (PANTHER); PTHR10788 (PANTHER); PTHR10788 (PANTHER); SSF53756 (SUPERFAMILY); IPR023214 (SUPERFAMILY),,
RL4_JR_06765,452,199,323,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.64813476,0,-2.725830902,1.210269279,-2.252251586,0.024306378,0.076976487,7.91146051,0,0.481565109,1.253692011,0.384117554,0.700891322,0.810791081,20.47789361,0,-2.167060147,1.211569007,-1.78863947,0.073672897,0.15296645,23.61825503,0,-2.589064787,1.212289072,-2.135682691,0.032705286,0.096909869,20.16869897,0,-2.247873179,1.216068241,-1.848476182,0.064533487,0.136437994,N,-,,nf-x1 finger and helicase domain containing,F:metal ion binding; F:helicase activity; F:hydrolase activity,IPR000571 (SMART); IPR000571 (G3DSA:4.10.1000.GENE3D); IPR032297 (PFAM); IPR000571 (PROSITE_PROFILES); IPR000571 (SUPERFAMILY),,
RL4_JR_06766,31,29,58,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,50.45960835,0,-1.459317665,1.018633793,-1.432622475,0.151965755,0.299815389,10.99662772,0,0.006499479,1.222840128,0.005315069,0.995759209,0.997829394,28.54920998,0,-2.646454003,1.199055008,-2.207116425,0.027305927,0.071285508,60.87117882,0,-0.724749177,0.861605427,-0.841161341,0.400257554,0.544339522,28.1936861,0,-2.731102658,1.204695939,-2.267047285,0.023387337,0.061670812,N,-,,NFX1-type zinc finger-containing 1,F:nucleoside-triphosphatase activity,PTHR22605 (PANTHER); IPR031248 (PTHR22605:PANTHER),,
RL4_JR_06767,4648,4445,5194,0,0,4,0,0,0,0,0,0,2,0,0,0,0,0,23.9423272,1,-2.683883051,1.248178715,-2.150239401,0.031536283,0.094239193,7.754932556,0,0.510415811,1.302139322,0.391982488,0.695071153,0.807240395,26.4635569,0,-1.168628753,1.239314264,-0.942964014,0.34569931,0.489422432,23.01789641,1,-2.551888795,1.246759345,-2.046817459,0.040676011,0.108666124,19.56451626,0,-2.2039996,1.247100947,-1.767298475,0.077178255,0.156536425,Y,-,,tyrosinase central domain-containing,F:metal ion binding; F:oxidoreductase activity; P:metabolic process; P:oxidation-reduction process,IPR002227 (PRINTS); IPR008922 (G3DSA:1.10.1280.GENE3D); IPR002227 (PFAM); PTHR11474 (PANTHER); PTHR11474:SF34 (PANTHER); IPR008922 (SUPERFAMILY),,
RL4_JR_06768,35858,37312,55612,8,6,42,0,0,8,3,1,0,2,10,1,0,21,5,0.039892658,1,6.545145995,3.933424046,1.663981793,0.096116068,NA,0.012359451,1,9.801634471,3.283108473,2.985473843,0.002831394,0.015349618,0.032716975,1,7.119823504,1.94373759,3.662955093,0.000249322,0.002031818,0.037789453,1,6.697972163,3.539346367,1.892431955,0.058433452,0.134982775,0.032927503,1,7.01635456,1.456270669,4.818029168,1.45E-06,1.96E-05,N,-,,---NA---,,no IPS match,,
RL4_JR_06769,3993,3597,2789,0,0,5,0,0,0,2,0,1,2,3,0,0,3,1,122.6069656,1,8.296793607,1.303995035,6.36259601,1.98E-10,6.47E-09,0.131100907,0,6.396476864,1.997923329,3.201562729,0.001366843,0.015023052,0.341954319,1,3.735878326,1.320634942,2.828850128,0.004671557,0.01798967,64.57999676,1,7.467781683,1.532652552,4.872455713,1.10E-06,2.01E-05,15.78156869,1,6.217808823,0.826249168,7.525343526,5.26E-14,7.01E-12,Y,-, Effector probability:0.737,hypothetical protein SPI_06058,,no IPS match,,
RL4_JR_06770,1319,1954,1686,4,1,23,0,0,0,0,0,2,9,6,1,0,11,9,1.017268237,1,1.872866012,1.469887478,1.274156042,0.20260812,NA,0.326916805,0,5.078578305,1.675046418,3.031903027,0.002430173,0.015349618,0.84475854,1,2.432296911,1.249446544,1.946699459,0.051570777,0.115971244,0.974246577,1,2.010386939,1.29803541,1.548792062,0.121431714,0.226259865,0.829891277,1,2.354660044,1.223080733,1.92518775,0.054205874,0.119123749,N,-,,peptidoglycan bound,C:membrane,no IPS match,,
RL4_JR_06771,3595,3309,6527,0,1,2,0,0,0,2,0,1,0,4,5,0,0,0,2.819590724,1,0.402321526,1.237573226,0.325089068,0.745113663,0.866396417,0.904967228,0,3.609676404,1.431683202,2.521281523,0.011692826,0.037861416,2.337581116,1,0.96425032,1.21671503,0.792503007,0.428067439,0.56873422,2.696004872,1,0.542219678,1.222748951,0.443443176,0.657445212,0.766683654,2.293022201,0,0.88889621,1.204833808,0.737774956,0.460651214,0.59181494,N,-,,hypothetical protein F503_03835,,no IPS match,,
RL4_JR_06772,859,862,819,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,11.49724862,1,2.330963805,1.150686576,2.025715649,0.042793932,0.118651995,0.459501585,0,4.587486396,1.576596243,2.909740788,0.003617286,0.017053643,1.187034431,0,1.94200438,1.23285665,1.575206964,0.11520868,0.215436402,1.369052574,1,1.519877834,1.258819096,1.207383839,0.227284356,0.363202984,1.164519059,0,1.866390337,1.211843616,1.540124743,0.12352995,0.22378614,N,-,,hypothetical protein SPBR_04309,,no IPS match,,
RL4_JR_06773,562,464,330,0,0,1,0,0,0,0,0,0,1,6,0,0,2,0,4.12230975,1,-0.145701958,1.213415295,-0.12007592,0.904423007,0.953456484,1.323963914,0,3.060736506,1.372533859,2.2299898,0.02574812,0.070040976,3.419277509,0,0.415476452,1.210124092,0.343333758,0.731347387,0.818772636,3.943459959,1,-0.006486105,1.211173692,-0.005355223,0.995727171,0.996810125,3.354303343,1,0.340085423,1.201475692,0.283056432,0.777133579,0.846163833,N,-,,P-hydroxylaminobenzoate partial,C:integral component of membrane,PTHR42044:SF1 (PANTHER); PTHR42044:SF1 (PANTHER); PTHR42044 (PANTHER); PTHR42044 (PANTHER),,
RL4_JR_06774,46,31,65,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.48359639,0,-1.744206288,1.210371791,-1.441050015,0.149570553,0.296380028,26.27162246,0,2.406008642,1.123326372,2.141860729,0.032204691,0.083647904,10.30504948,0,-1.176290514,1.20628612,-0.97513392,0.329493835,0.472559227,11.89096384,0,-1.598965546,1.205944309,-1.325903307,0.184871728,0.312023044,10.18372463,0,-1.261899449,1.212929049,-1.040373673,0.298166328,0.433443514,N,-,,family,P:glutamine metabolic process; F:transferase activity,IPR032633 (PFAM); IPR029062 (G3DSA:3.40.50.GENE3D); IPR029062 (SUPERFAMILY),,
RL4_JR_06775,1857,1354,2010,4,3,0,0,0,0,0,0,1,0,0,0,0,0,0,4.023907828,1,5.128864697,1.213711263,4.225770044,2.38E-05,0.000243132,0.065342293,0,7.401432681,2.282165991,3.243161414,0.001182112,0.015023052,0.169593405,1,4.749559311,1.375448391,3.45309889,0.000554186,0.003650343,0.195666345,0,4.326541224,1.820054946,2.377148686,0.017447054,0.072043809,0.167043083,0,4.669598544,1.264776845,3.692033549,0.000222468,0.001362668,N,-,,family inorganic phosphate transporter,F:inorganic phosphate transmembrane transporter activity; P:transmembrane transport; P:phosphate ion transport; C:integral component of membrane,IPR001204 (PFAM); IPR001204 (PANTHER); PTHR11101:SF51 (PANTHER); IPR000048 (PROSITE_PROFILES),2.A.20.2.1, the inorganic phosphate transporter (pit) family.
RL4_JR_06776,1669,1343,2048,0,0,5,0,0,1,0,0,0,0,0,1,0,7,0,0.064039522,1,5.8624527,3.923395004,1.494229537,0.135115635,NA,0.020718079,1,9.059140426,2.870024952,3.15646748,0.001596927,0.015023052,0.053263049,0,6.420838898,1.624419256,3.952698095,7.73E-05,0.000981595,0.061409743,1,5.998353274,2.799208555,2.142874729,0.032123159,0.095886492,0.052015152,1,6.348332588,1.329615846,4.774561468,1.80E-06,2.37E-05,N,-,,hypothetical protein CMQ_715,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_06777,4498,5838,6599,0,2,5,0,0,0,1,0,2,2,10,1,0,3,2,5.348026695,1,-0.521566275,1.20520406,-0.432761797,0.66518783,0.813705551,1.705323685,0,2.695424705,1.328057324,2.029599669,0.042397249,0.103683245,4.429496057,1,0.04160805,1.204748511,0.03453671,0.972449169,0.984015531,5.110137555,1,-0.38078205,1.204144613,-0.316226179,0.751830839,0.836882942,4.374907021,1,-0.043063871,1.207871343,-0.035652697,0.971559289,0.980565969,N,-,,---NA---,,no IPS match,,
RL4_JR_06778,2687,3123,3941,0,0,10,0,0,0,0,5,2,0,4,0,0,9,2,190.9860582,1,-2.166958988,0.897155589,-2.415365869,0.015719411,0.054223659,51.45944886,0,-2.219863711,1.249564161,-1.776510386,0.075648832,0.163177917,135.124258,1,-4.889159427,1.25207562,-3.904843565,9.43E-05,0.001128758,168.0358496,1,-3.075051193,0.979644341,-3.138946517,0.001695564,0.011584065,142.5521864,1,-3.356878192,1.087319934,-3.087295732,0.002019865,0.008553382,N,-,,rRNA processing,P:rRNA processing; C:intracellular part,IPR001313 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR13102 (PANTHER); PTHR13102:SF0 (PANTHER); PTHR13102 (PANTHER); PTHR13102 (PANTHER); PTHR13102 (PANTHER); PTHR13102:SF0 (PANTHER); PTHR13102:SF0 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_06779,7747,7323,10976,1,3,5,0,0,1,0,0,0,0,4,0,0,11,1,85.30137289,1,0.737406764,0.544892632,1.353306541,0.17595772,0.331133352,9.503071417,1,0.21710214,1.218382735,0.178188786,0.858574716,0.917202457,24.66333861,0,-2.435378348,1.192628375,-2.042026167,0.041148936,0.09781447,48.50960827,1,0.171275348,0.678743422,0.252341817,0.800776869,0.872188661,47.50167336,1,0.656220641,0.640252392,1.024940554,0.305391238,0.440656446,N,-,,glutamate decarboxylase,F:pyridoxal phosphate binding; P:carboxylic acid metabolic process; F:carboxy-lyase activity,IPR015421 (G3DSA:3.40.640.GENE3D); IPR002129 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); PTHR11999:SF13 (PANTHER); PTHR11999 (PANTHER); PTHR11999:SF13 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_06780,226,229,300,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,22.70425665,1,-0.2868556,1.00933027,-0.284203901,0.776254126,0.884452676,4.81816074,0,1.197028787,1.246085218,0.96063156,0.336737454,0.499700412,23.56002497,0,-0.492024696,1.191573938,-0.412919988,0.679665236,0.779885623,14.40754158,0,-1.876036247,1.191803349,-1.574115603,0.115460726,0.217901184,12.30977252,0,-1.535558796,1.196621329,-1.283245383,0.199406121,0.321187874,N,-,,Ras family,F:GTP binding; P:small GTPase mediated signal transduction; C:intracellular,PR00449 (PRINTS); SM00175 (SMART); SM00174 (SMART); SM00173 (SMART); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); PTHR24073:SF593 (PANTHER); PTHR24073:SF593 (PANTHER); PTHR24073 (PANTHER); PTHR24073 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_06781,10862,11790,17929,0,1,3,0,0,0,0,2,0,2,6,0,0,11,0,15.20727478,1,-2.028978404,1.20458853,-1.684374667,0.092109283,0.208480869,4.823853554,0,1.195294305,1.250043157,0.956202431,0.338969972,0.501891656,19.05729472,1,-0.49985515,1.199916074,-0.416575093,0.676989231,0.778049605,14.49131858,1,-1.884326994,1.201364684,-1.568488752,0.116767113,0.219670572,12.41985185,1,-1.548302204,1.209633367,-1.279976434,0.200553424,0.322318003,N,-,,ammecr1 family,C:nucleus; C:cytoplasm,IPR002733 (PFAM); G3DSA:3.30.1490.150 (GENE3D); IPR023473 (TIGRFAM); IPR027485 (G3DSA:3.30.700.GENE3D); IPR023473 (PANTHER); IPR002733 (PROSITE_PROFILES); IPR002733 (SUPERFAMILY),,
RL4_JR_06782,2553,2726,5730,0,1,0,0,0,0,1,0,0,0,5,0,0,0,0,155.0183705,1,-0.127338055,0.430022057,-0.296119823,0.767138576,0.877722899,27.67962135,0,-1.325218412,1.194269403,-1.109647797,0.267150826,0.424505599,78.23414664,1,-3.013822776,1.185870848,-2.541442671,0.011039605,0.035403036,145.5028119,1,0.008849894,0.430713933,0.020547034,0.983606992,0.9896037,70.6275194,0,-4.055936875,1.185887445,-3.420170179,0.00062582,0.003269569,N,-,,vacuolar sorting-associated 74,"C:nucleus; F:phosphatidylinositol-4-phosphate binding; P:retrograde vesicle-mediated transport, Golgi to ER; P:endoplasmic reticulum unfolded protein response; P:protein localization to Golgi apparatus; C:cytosol; C:extrinsic component of membrane; C:Golgi medial cisterna; P:regulation of phosphatidylinositol dephosphorylation",IPR008628 (PFAM); G3DSA:1.10.3630.10 (GENE3D); IPR008628 (PANTHER); PTHR12704:SF2 (PANTHER),,
RL4_JR_06783,961,965,926,0,0,5,0,0,0,1,0,0,1,1,0,0,0,0,265.9150103,1,-2.295460936,0.612694776,-3.746499935,0.000179319,0.001404878,73.28773213,0,-2.729998249,1.195131883,-2.284265267,0.022355946,0.062874933,190.9358492,1,-5.387960517,1.200900784,-4.486599216,7.24E-06,0.000143942,240.3848043,1,-2.799296035,0.703727502,-3.977812473,6.96E-05,0.000787714,212.1837756,0,-2.338146298,0.693226201,-3.372847557,0.000743951,0.003768137,N,-,,surfeit locus 6,P:ribosomal large subunit biogenesis; P:ribosomal small subunit biogenesis; C:nucleolus,IPR029190 (PFAM); IPR029188 (PFAM); PTHR14369:SF0 (PANTHER); IPR007019 (PANTHER); PTHR14369:SF0 (PANTHER); IPR007019 (PANTHER),1.A.17.6.8, the calcium-dependent chloride channel (ca-clc) family.
RL4_JR_06784,18200,12168,8490,0,4,8,0,0,5,0,3,1,5,6,1,0,3,0,22.83498229,1,-1.04018754,1.164083779,-0.893567592,0.371553292,0.563721733,4.706758361,1,1.230701231,1.262996078,0.97442997,0.329843095,0.492861008,12.26695324,1,-1.427858385,1.210714721,-1.179351634,0.238258186,0.371039205,22.17771789,1,-0.135203522,1.041077774,-0.129868801,0.896670228,0.936122152,56.3560307,1,1.90731058,1.421245251,1.341999615,0.17959612,0.297077392,N,-,,exonuclease 1,C:nucleus; F:DNA binding; P:DNA repair; P:nucleic acid phosphodiester bond hydrolysis; F:5'-3' exodeoxyribonuclease activity,IPR006084 (PRINTS); IPR008918 (SMART); IPR006085 (SMART); IPR006086 (SMART); IPR029060 (G3DSA:3.40.50.GENE3D); IPR006086 (PFAM); G3DSA:1.10.150.20 (GENE3D); IPR006085 (PFAM); IPR032641 (PTHR11081:PANTHER); IPR006084 (PANTHER); IPR020045 (SUPERFAMILY); IPR029060 (SUPERFAMILY),,
RL4_JR_06785,3605,4015,5600,1,5,11,0,0,1,0,0,2,0,5,0,0,0,2,54.64561457,1,-3.874370499,1.278166168,-3.031194689,0.002435881,0.012274194,17.11352194,1,-0.631592607,1.267704043,-0.498217712,0.6183306,0.749246308,44.9743206,1,-3.302065199,1.250190525,-2.64124958,0.008260085,0.028052699,51.92397358,1,-3.725527797,1.260073249,-2.956596215,0.003110552,0.019174726,44.93685898,1,-3.403601928,1.268501111,-2.683168266,0.007292829,0.024385697,N,-,,translation machinery-associated 16,,IPR021346 (PFAM); PTHR13349 (PANTHER),,
RL4_JR_06786,988,709,1093,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.012025636,0,-0.690284351,1.273636291,-0.541979179,0.587832849,0.759749744,1.891738335,0,2.545646417,1.372905287,1.854203958,0.063709986,0.142639345,4.959503745,0,-0.121435187,1.248952065,-0.097229662,0.922544013,0.954602983,5.724784775,0,-0.544596142,1.25600017,-0.433595595,0.664582134,0.771219955,4.946672973,0,-0.220192309,1.263873983,-0.174220145,0.861692454,0.907870562,N,-, Effector probability:0.923,hypothetical protein CMQ_456,,no IPS match,,
RL4_JR_06787,7559,7775,9824,3,1,6,1,0,2,1,6,1,6,11,0,0,4,2,305.352804,1,-0.981055756,0.570478553,-1.71970664,0.08548578,0.197505804,119.7045992,1,-0.30379918,0.865777496,-0.350897524,0.725665229,0.828466439,174.3379653,1,-4.20031816,1.207140894,-3.479559163,0.000502239,0.003394307,223.0845916,1,-2.285303091,0.655646949,-3.485569624,0.00049109,0.004129809,161.7334707,1,-5.251253398,1.21913076,-4.307375033,1.65E-05,0.000153176,N,-,,regulatory suaprga1,C:mitochondrial matrix,IPR003428 (G3DSA:3.10.280.GENE3D); IPR003428 (PFAM); PTHR10826:SF1 (PANTHER); PTHR10826 (PANTHER); IPR003428 (SUPERFAMILY),9.B.103.1.2, the putative ca(2+) uniporter (gc1qr) family.
RL4_JR_06788,317,115,370,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,119.5205959,1,0.82031009,0.649937406,1.262137064,0.20689947,0.372848659,57.35567803,0,1.482617994,1.003797181,1.477009522,0.139673085,0.261422146,32.80074613,0,-2.846634417,1.205738064,-2.360906155,0.018230343,0.052151454,45.84662039,0,-1.551779119,1.037953055,-1.495037866,0.13490456,0.245566249,32.09272637,0,-2.917983972,1.201775759,-2.428060269,0.01517982,0.043887973,N,-,,oxysterol binding,P:mycelium development; P:lipid metabolic process,IPR000648 (PFAM); IPR000648 (PANTHER); PTHR10972:SF65 (PANTHER); IPR000648 (PANTHER); PTHR10972:SF65 (PANTHER); SSF144000 (SUPERFAMILY),2.D.1.1.2, the pi4p/ps counter transporter (p/p-ct) family.
RL4_JR_06789,312,260,655,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,54.94045926,0,2.766670837,0.567195157,4.877811105,1.07E-06,1.61E-05,2.58169366,0,2.097292351,1.329222553,1.57783386,0.114603783,0.22555308,32.6404322,0,2.26025882,0.781392259,2.89260457,0.00382062,0.0159891,15.68585151,1,0.747804607,1.047449775,0.713928844,0.47527118,0.616148617,153.1969748,0,4.552186677,1.882708367,2.417892625,0.015610683,0.044839195,N,-,,cp2 transcription factor,,IPR007604 (PFAM); PTHR11037:SF14 (PANTHER); PTHR11037:SF14 (PANTHER); PTHR11037 (PANTHER); PTHR11037 (PANTHER),,
RL4_JR_06790,25616,30882,39862,6,14,56,0,0,2,8,4,7,6,31,4,0,10,3,378.1516253,1,-0.681498614,0.972070675,-0.701079285,0.483253537,0.671386641,165.2139734,1,-0.111164066,0.767597884,-0.144820703,0.884852436,0.934426328,250.2394348,1,-2.263711831,0.697185148,-3.246930657,0.001166568,0.006525047,324.1508181,1,-1.396096493,0.479913102,-2.909061011,0.003625161,0.021680305,238.8256163,1,-1.67778178,0.713373213,-2.351899049,0.018677843,0.051826024,N,-,,eukaryotic translation initiation factor 2a,F:translation initiation factor activity; C:cytosolic ribosome; P:translational initiation,G3DSA:2.120.10.60 (GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR011387 (PIRSF); IPR013979 (PFAM); PTHR13227:SF0 (PANTHER); PTHR13227 (PANTHER); PTHR13227 (PANTHER); PTHR13227:SF0 (PANTHER); SSF82171 (SUPERFAMILY),,
RL4_JR_06791,4296,5896,4960,6,2,5,0,0,1,0,3,1,0,1,5,0,6,4,0.173802352,1,4.422250457,3.210975637,1.377229527,0.168441296,NA,0.054821811,1,7.654549708,2.40335151,3.184948051,0.0014478,0.015023052,0.142985099,1,4.995661157,1.456921219,3.428916466,0.000605996,0.003890364,0.165026094,1,4.572235792,1.999753636,2.286399539,0.022230895,0.080442001,0.141423577,1,4.910836955,1.315785289,3.732247957,0.000189779,0.001191263,N,-,,Major facilitator superfamily general substrate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23514:SF8 (PANTHER); PTHR23514 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.7.25, the major facilitator superfamily (mfs).
RL4_JR_06792,181,115,75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.17533832,0,-2.2862621,1.249767289,-1.829350248,0.067347156,0.16610572,5.913331545,0,0.901601103,1.320800732,0.682617053,0.494848856,0.649885989,22.99759794,0,-0.770871576,1.239793943,-0.621773949,0.534090519,0.66361468,17.46853218,0,-2.153844332,1.248065993,-1.725745548,0.0843932,0.172274425,26.34028597,0,0.366805973,0.927110751,0.395644181,0.69236754,0.781925281,N,-,,and nb-arc domain-containing,F:ADP binding,IPR029058 (G3DSA:3.40.50.GENE3D); PTHR22731 (PANTHER); PTHR22731:SF7 (PANTHER); IPR027417 (SUPERFAMILY); IPR029058 (SUPERFAMILY),,
RL4_JR_06793,351,243,162,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,107.8365221,0,-0.751593448,0.635132123,-1.183365509,0.236664321,0.410967464,34.2086311,0,-0.252695621,1.131942102,-0.223240765,0.823348126,0.893527365,70.70241959,0,-2.853814236,1.203219751,-2.371814653,0.017700968,0.050910397,82.06959611,0,-2.520157447,1.03600673,-2.432568607,0.014992151,0.065631958,86.30588533,0,-0.738292202,0.667120681,-1.106684626,0.268430305,0.400627482,N,-,,vhs domain-containing,P:vesicle-mediated transport; C:clathrin adaptor complex; C:Golgi apparatus; P:intracellular protein transport,IPR002014 (SMART); IPR000253 (SMART); IPR008152 (SMART); IPR004152 (PFAM); IPR008153 (G3DSA:2.60.40.GENE3D); IPR000253 (G3DSA:2.60.200.GENE3D); IPR002014 (PFAM); IPR004152 (G3DSA:1.20.58.GENE3D); IPR008152 (PFAM); IPR008942 (G3DSA:1.25.40.GENE3D); IPR000253 (PFAM); G3DSA:1.20.5.170 (GENE3D); PTHR13856 (PANTHER); PTHR13856:SF94 (PANTHER); IPR002014 (PROSITE_PROFILES); IPR004152 (PROSITE_PROFILES); IPR008153 (PROSITE_PROFILES); IPR000253 (PROSITE_PROFILES); IPR008984 (SUPERFAMILY); IPR008942 (SUPERFAMILY); SSF89009 (SUPERFAMILY); IPR013041 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_06794,150,125,131,0,0,8,0,0,0,0,0,0,0,1,0,0,0,0,178.1318579,1,-0.046351174,0.822019773,-0.056386933,0.955033566,0.977438695,30.9755796,0,-1.487563378,1.197731552,-1.241983962,0.21424248,0.360836583,91.68460496,0,-3.182197051,1.195383156,-2.662072854,0.007766107,0.026733786,130.4114941,1,-0.873635773,0.565997458,-1.543533033,0.122701499,0.228129767,95.73566947,0,-3.293940613,1.133405729,-2.906232542,0.003658095,0.013882387,N,-,,pre-rRNA-processing TSR3,P:rRNA processing; C:intracellular part,IPR007209 (PFAM); IPR007177 (PFAM); IPR022968 (PANTHER); PTHR20426:SF0 (PANTHER); IPR007177 (PRODOM); IPR022968 (HAMAP),,
RL4_JR_06795,13168,12482,15400,0,5,8,0,0,5,6,0,8,2,8,2,0,10,1,99.38743688,1,-0.368023452,0.569517419,-0.646202276,0.518148366,0.702869034,17.83450719,1,-0.691096429,1.199862076,-0.575979892,0.564628773,0.707237391,60.63084503,1,-1.521269275,1.029592239,-1.477545398,0.139529498,0.248521577,62.71253437,1,-2.816715684,1.140701235,-2.46928433,0.01353836,0.061620201,53.39208454,1,-1.75805363,0.974793361,-1.803514161,0.071307504,0.146894908,N,-,,translation initiation factor IF-2,F:GTP binding; F:translation initiation factor activity; F:translation elongation factor activity; F:GTPase activity; P:translational initiation; P:translational elongation; C:intracellular,IPR006847 (PFAM); G3DSA:2.40.30.10 (GENE3D); IPR023115 (PFAM); IPR000178 (TIGRFAM); G3DSA:2.40.30.10 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR023115 (G3DSA:3.40.50.GENE3D); PF00009 (PFAM); IPR005225 (TIGRFAM); PTHR23115:SF184 (PANTHER); PTHR23115 (PANTHER); IPR000178 (HAMAP); IPR000795 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR009000 (SUPERFAMILY); IPR009000 (SUPERFAMILY); IPR023115 (SUPERFAMILY),,
RL4_JR_06796,3926,3650,3892,1,0,2,0,0,0,0,0,0,3,0,1,0,3,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,Uncharacterised,,no IPS match,,
RL4_JR_06797,1145,1781,1943,0,0,12,0,0,0,0,0,2,0,1,3,0,4,0,82.9836713,1,2.092010964,0.474433333,4.409494057,1.04E-05,0.000120092,5.06772428,0,1.12413849,1.239783968,0.906721267,0.364554214,0.528883153,45.66412777,1,1.604053807,0.674558984,2.377929646,0.017410147,0.05026102,52.58833878,1,1.750772019,0.550375164,3.181052004,0.001467413,0.010204365,13.01298936,1,-1.615659967,1.200832217,-1.345450217,0.178479888,0.295665717,N,-,,hypothetical protein SPSK_10413,C:membrane,no IPS match,,
RL4_JR_06798,40,37,55,6,0,2,0,0,0,0,1,11,0,0,0,0,0,0,294.7736465,1,0.832249048,0.414030283,2.010116367,0.044418874,0.121722934,32.63975847,0,-1.563051434,1.198174392,-1.304527491,0.192053792,0.333787344,84.88288822,1,-4.218416548,1.195338844,-3.52905502,0.000417046,0.002973365,132.9340927,0,-1.334480584,0.628185279,-2.124342338,0.033641528,0.098242279,106.6513749,0,-1.376886343,0.698059149,-1.97244939,0.048558328,0.109450818,N,-,,casein kinase substrate phospho pp28,P:phosphorylation; F:kinase activity,IPR019380 (PFAM); PTHR22055 (PANTHER); PTHR22055:SF0 (PANTHER),,
RL4_JR_06799,4360,2674,2068,1,4,17,0,0,0,0,2,2,6,15,4,0,3,6,25.55086951,1,-2.777698806,1.199547381,-2.315622418,0.020578894,0.067153046,8.119831311,0,0.444008759,1.226837192,0.361913351,0.717416783,0.823038735,21.13880142,1,-2.212923564,1.199138255,-1.84542821,0.064975273,0.138719878,24.39047351,1,-2.635513644,1.198833643,-2.198398134,0.027920747,0.088842727,20.92716724,1,-2.301084443,1.207965707,-1.904925305,0.056789781,0.123377278,N,-,,succinyl-3-ketoacid-coenzyme a transferase,P:metabolic process; F:CoA-transferase activity; F:transferase activity,no IPS match,,
RL4_JR_06800,153,84,103,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,255.5550133,0,-0.489573722,1.153384471,-0.424467066,0.671225219,0.817535882,50.5051699,0,-2.192838673,1.3501127,-1.624189353,0.104335402,0.20920819,162.2965761,0,-2.155853031,1.461202715,-1.475396267,0.140106038,0.249153967,238.3267889,0,-0.723057613,0.75828929,-0.953537948,0.340317579,0.487371356,184.0897576,0,-1.332883175,0.842580484,-1.581906061,0.113671017,0.210290343,N,-,,Coenzyme A transferase,F:3-oxoacid CoA-transferase activity; C:mitochondrion; P:ketone body catabolic process,IPR004165 (SMART); G3DSA:3.40.810.20 (GENE3D); IPR012791 (TIGRFAM); IPR004165 (PFAM); IPR014388 (PIRSF); IPR012792 (TIGRFAM); G3DSA:3.40.1080.10 (GENE3D); IPR004165 (PANTHER); PTHR13707:SF23 (PANTHER); SSF100950 (SUPERFAMILY); SSF100950 (SUPERFAMILY),,
RL4_JR_06801,1213,695,773,4,0,3,0,0,0,0,0,1,0,1,0,0,0,0,245.5856469,1,0.329587203,0.994959386,0.331256941,0.740450413,0.863625206,110.3646309,0,0.07277897,0.993843054,0.073229842,0.941623219,0.968313545,115.7328972,1,-1.839628453,0.860692615,-2.137381477,0.032566977,0.081915049,133.827824,1,-1.174263393,0.603220481,-1.946657036,0.051575866,0.12546988,176.4764942,0,0.468157466,0.442414858,1.058186579,0.289970389,0.424577033,N,-,,ibr domain-containing,C:nucleus; F:ubiquitin-protein transferase activity; F:zinc ion binding; C:site of double-strand break; F:oxidoreductase activity; C:integral component of membrane; C:cytosol; P:oxidation-reduction process; P:histone ubiquitination; P:histone catabolic process,IPR001841 (SMART); IPR002867 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR018957 (PFAM); IPR002867 (PFAM); PTHR11685:SF10 (PANTHER); IPR031127 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); SSF57850 (SUPERFAMILY); SSF57850 (SUPERFAMILY),,
RL4_JR_06802,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,114.1976856,0,1.738745137,0.523107129,3.323879644,0.000887745,0.005424887,26.66112112,0,2.109653794,1.026602598,2.054985831,0.039880373,0.098817415,84.91672506,0,1.796937938,0.573166214,3.135107921,0.001717909,0.00877946,61.56189833,0,0.204519521,0.779631481,0.262328454,0.793068227,0.866402222,27.91289491,0,-0.592344435,1.009428122,-0.5868119,0.557330043,0.676452492,N,-,,tsa family,F:peroxidase activity; C:nucleus; F:ubiquitin-protein transferase activity; F:zinc ion binding; C:site of double-strand break; P:cellular oxidant detoxification; C:cytosol; P:oxidation-reduction process; F:peroxiredoxin activity; P:protein ubiquitination,IPR003746 (SMART); IPR003746 (G3DSA:3.30.1200.GENE3D); IPR003746 (PFAM); IPR013740 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR10430:SF18 (PANTHER); PTHR10430 (PANTHER); IPR003746 (SUPERFAMILY); IPR012336 (SUPERFAMILY),,
RL4_JR_06803,4065,3264,2012,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.32914701,0,2.209208958,0.792341496,2.788203026,0.005300132,0.022769075,1.971182511,0,2.486436408,1.362546054,1.824845773,0.068024306,0.150172743,44.35207368,0,2.975572998,0.740898239,4.016169619,5.92E-05,0.000822598,44.61115585,0,2.905430222,0.657849484,4.416557727,1.00E-05,0.000141419,16.30598727,0,1.421657895,1.02666546,1.384733343,0.166134019,0.279698528,N,-,,DASH complex subunit DAM1,C:spindle midzone; F:identical protein binding; C:kinetochore microtubule; C:DASH complex; F:microtubule plus-end binding; C:mitotic spindle polar microtubule; P:mitotic spindle organization in nucleus; P:mitotic sister chromatid biorientation; F:structural constituent of cytoskeleton; P:positive regulation of microtubule polymerization; P:positive regulation of attachment of spindle microtubules to kinetochore; C:mitotic spindle pole body,IPR013962 (PFAM); PTHR28113 (PANTHER); IPR013962 (PRODOM),,
RL4_JR_06804,11,24,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,184.4621486,0,-2.748506537,0.744210361,-3.693184992,0.000221463,0.001685348,90.97584174,0,-1.33111426,1.104224024,-1.205474822,0.228020052,0.377702019,263.2528838,0,-0.008504705,0.427062509,-0.019914426,0.984111637,0.992246411,210.6119384,0,-1.435261769,0.510823299,-2.809703029,0.004958723,0.027877331,192.0349963,0,-0.728726735,0.488504031,-1.491751734,0.135764241,0.240358969,N,-,,phosphatidylinositol transfer csr1,,IPR001251 (SMART); IPR011074 (SMART); IPR011074 (PFAM); IPR001251 (PFAM); G3DSA:1.10.8.20 (GENE3D); IPR001251 (G3DSA:3.40.525.GENE3D); PTHR10174:SF137 (PANTHER); PTHR10174 (PANTHER); PTHR10174 (PANTHER); PTHR10174:SF137 (PANTHER); IPR001251 (PROSITE_PROFILES); IPR001251 (SUPERFAMILY); IPR011074 (SUPERFAMILY),,
RL4_JR_06805,19,6,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,140.1704493,0,-1.077905334,0.631173968,-1.707778502,0.087677449,0.200806466,163.5868446,0,2.163585009,1.567883973,1.379939489,0.167605277,0.301492911,130.4332048,0,-0.647943665,0.662049437,-0.978693778,0.327731307,0.470765005,96.74032336,0,-2.788234765,1.053164184,-2.647483468,0.008109332,0.040992008,90.86573644,0,-1.952246136,0.884268416,-2.207752873,0.027261505,0.069914574,N,-, Effector probability:0.708,hit family 1,F:hydrolase activity; P:nucleotide metabolic process,IPR001310 (PRINTS); IPR001310 (PFAM); IPR011146 (G3DSA:3.30.428.GENE3D); IPR001310 (PANTHER); PTHR23089:SF7 (PANTHER); IPR011146 (PROSITE_PROFILES); IPR011146 (SUPERFAMILY),,
RL4_JR_06806,241,138,159,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,304.0011456,0,0.626108028,0.471267741,1.328561183,0.183992786,0.341748534,45.25061828,0,-0.781948189,1.111537682,-0.703483293,0.481754615,0.638808481,131.2483986,0,-1.212448481,0.679054563,-1.785494932,0.074181073,0.153793636,161.3636775,0,-1.043829921,0.552453983,-1.889442293,0.058832588,0.135305037,96.23031171,0,-3.513788815,1.133945511,-3.098728096,0.001943533,0.008278617,N,-,,ran-interacting mog1,C:nucleus; P:protein import into nucleus; C:cytosol; F:Ran GTPase binding; P:poly(A)+ mRNA export from nucleus,IPR016123 (G3DSA:3.40.1000.GENE3D); IPR007681 (PFAM); PTHR15837 (PANTHER); PTHR15837:SF0 (PANTHER); IPR016123 (SUPERFAMILY),,
RL4_JR_06807,410,111,196,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35.5082232,0,2.36636042,0.667110021,3.547181645,0.000389376,0.002717305,1.916819906,0,2.526873128,1.322913179,1.910082361,0.05612261,0.129372138,11.45319354,0,0.842284305,1.19579173,0.70437375,0.481200049,0.617526847,52.41998481,0,3.338458951,0.521183186,6.405538476,1.50E-10,5.58E-09,12.58482985,0,1.473291947,0.974701178,1.511531923,0.130652982,0.233103337,N,-,,hmg box-containing,C:nucleus; C:mitotic spindle; C:cellular_component,IPR006640 (SMART); IPR006640 (PFAM); IPR009071 (G3DSA:1.10.30.GENE3D); PTHR23099 (PANTHER); PTHR23099:SF0 (PANTHER); PTHR23099 (PANTHER); IPR009071 (SUPERFAMILY),,
RL4_JR_06808,144,61,134,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1197.762333,0,-0.227064784,0.348361038,-0.651808783,0.514524535,0.700055864,266.8424525,0,-1.18387947,0.761152469,-1.55537756,0.119856175,0.233469279,1014.373568,0,-0.191212656,0.373309468,-0.5122095,0.608504395,0.724849805,1087.837945,0,-0.419109742,0.498860694,-0.840133824,0.400833357,0.544756744,971.9870407,0,-0.174198842,0.675914319,-0.257723261,0.796620493,0.862373836,N,-,,"1,3-beta-glucan synthase component FKS1","F:1,3-beta-D-glucan synthase activity; P:(1->3)-beta-D-glucan biosynthetic process; C:integral component of membrane; C:1,3-beta-D-glucan synthase complex",IPR026899 (SMART); IPR003440 (PFAM); IPR026899 (PFAM); PTHR12741 (PANTHER); PTHR12741 (PANTHER); PTHR12741:SF7 (PANTHER); PTHR12741:SF7 (PANTHER); PTHR12741 (PANTHER),9.B.119.1.1," the glycan synthase, fks1 (fks1) family."
RL4_JR_06809,15,16,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,211.9543481,0,-0.602744641,0.432107425,-1.394895357,0.163047398,0.313712219,83.96047831,0,-0.164862693,0.979518866,-0.16830987,0.86633951,0.922091327,182.4246879,0,-0.097132759,0.470105741,-0.206618959,0.836307453,0.894492905,210.7706457,0,-0.04684834,0.402648768,-0.116350388,0.907374853,0.943338165,211.5667851,0,0.27480083,0.462007212,0.594797706,0.551978701,0.671971185,N,-,,aminotransferase class I and II,F:pyridoxal phosphate binding; P:transmembrane transport; F:serine C-palmitoyltransferase activity; F:transaminase activity; C:integral component of membrane; C:SPOTS complex; P:sphingolipid biosynthetic process,IPR004839 (PFAM); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR13693:SF2 (PANTHER); PTHR13693 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_06810,56,37,102,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.01891545,0,-1.689651024,1.195717354,-1.413085641,0.157630545,0.306762878,3.863768729,0,1.51555269,1.273454825,1.190111075,0.234002738,0.384197196,29.47523962,0,1.269713877,0.863495869,1.470434222,0.141444189,0.250784757,38.15618314,0,1.181100572,0.753152911,1.568208202,0.116832551,0.219752847,17.51689585,0,0.460640078,0.981507482,0.469318968,0.638841659,0.740500492,N,-,,oligopeptide transporter 6,F:pyridoxal phosphate binding; P:transmembrane transport; F:catalytic activity; C:integral component of membrane; P:biosynthetic process,IPR004813 (TIGRFAM); IPR004813 (PFAM); PTHR22601 (PANTHER); PTHR22601:SF9 (PANTHER),2.A.67.1.2, the oligopeptide transporter (opt) family.
RL4_JR_06811,702,821,1841,0,3,2,0,0,0,0,0,0,0,1,0,0,0,0,63.35547351,1,-0.546490899,0.682148702,-0.801131625,0.42305545,0.614654739,14.09041532,0,-0.351160345,1.20513854,-0.291385872,0.770756218,0.861227565,65.26868078,0,-0.592478661,0.851648382,-0.695684597,0.486626374,0.621653679,50.28460121,1,-1.703086086,1.017659191,-1.673532849,0.094222445,0.18735177,36.20091013,0,-3.091734406,1.197810634,-2.581154582,0.009847048,0.030963155,N,-,,sterol o-acyltransferase,C:endoplasmic reticulum membrane; F:ergosterol O-acyltransferase activity; C:integral component of membrane; P:ergosterol metabolic process,IPR004299 (PFAM); IPR014371 (PIRSF); IPR014371 (PANTHER); PTHR10408:SF14 (PANTHER),,
RL4_JR_06812,7228,6962,14438,0,15,3,1,0,0,0,0,2,0,2,0,0,1,1,84.87343085,1,0.371952787,0.529487037,0.702477608,0.482381362,0.670746062,147.4056871,1,3.297517595,1.550846359,2.126269682,0.033480811,0.086232257,63.608704,1,-0.524079192,0.857217825,-0.611372252,0.540953168,0.669103222,94.91510232,1,0.204281759,0.590853584,0.345740069,0.729538068,0.819819416,41.71032021,1,-2.081251669,1.123251078,-1.85288197,0.063899278,0.135379826,N,-,,molecular chaperone,,IPR001623 (PRINTS); IPR001623 (SMART); IPR001623 (PFAM); IPR001623 (G3DSA:1.10.287.GENE3D); PTHR24074 (PANTHER); PTHR24074:SF10 (PANTHER); IPR001623 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_06813,27236,28407,32941,4,7,24,4,0,1,3,2,10,0,1,11,0,11,7,7.913510457,1,-1.08665818,1.188094217,-0.914622902,0.360389632,0.552066029,2.53327629,1,2.124545195,1.287546845,1.650072153,0.098928179,0.200872825,19.55595197,1,1.296173826,1.030756552,1.257497537,0.20857353,0.335760601,20.8888312,1,0.787666359,1.010588189,0.779413779,0.43573601,0.577700632,6.451802626,1,-0.603535137,1.192468045,-0.506122692,0.612770521,0.720257897,N,-,,calcineurin-like phosphoesterase,F:hydrolase activity,IPR029052 (G3DSA:3.60.21.GENE3D); IPR004843 (PFAM); PTHR12905 (PANTHER); PTHR12905:SF16 (PANTHER); PTHR12905 (PANTHER); PTHR12905 (PANTHER); PTHR12905:SF16 (PANTHER); PTHR12905:SF16 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_06814,5564,3274,3064,0,0,2,0,0,0,1,2,3,2,2,0,0,4,4,85.83352014,1,0.354015059,0.57985023,0.610528444,0.541511807,0.723138537,10.91329483,0,0.017543128,1.218375245,0.014398789,0.988511825,0.994208734,52.31220612,1,-0.223015542,0.852250928,-0.261678263,0.7935695,0.864026306,44.61480257,1,-0.750129824,0.856394354,-0.875916359,0.381075506,0.526618423,27.75575274,1,-2.708478923,1.189961761,-2.276105847,0.022839675,0.060638879,N,-,,hypothetical protein SPSK_08928,C:cellular_component,no IPS match,,
RL4_JR_06815,12772,16203,13197,7,19,18,0,0,3,7,8,10,3,11,7,0,7,5,16.51622869,1,-0.238517017,1.165292033,-0.204684328,0.837818765,0.918937779,2.692294298,1,2.036598344,1.295369763,1.572213898,0.115900953,0.227530925,40.23287262,1,1.806299566,0.867183852,2.082948802,0.037255891,0.090319,8.104522799,1,-1.046022817,1.21325069,-0.862165442,0.388596484,0.533384617,6.962326954,1,-0.713282496,1.222277721,-0.583568271,0.559510812,0.678042726,N,-,,DNA primase large subunit,"C:nuclear envelope; F:DNA primase activity; F:DNA binding; C:alpha DNA polymerase:primase complex; F:metal ion binding; C:cytosol; F:4 iron, 4 sulfur cluster binding; C:primosome complex; P:DNA replication, synthesis of RNA primer; P:double-strand break repair",IPR007238 (PFAM); IPR016558 (PIRSF); PTHR10537:SF3 (PANTHER); PTHR10537 (PANTHER),,
RL4_JR_06816,347,419,660,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,84.90514508,0,-1.129025264,0.697067833,-1.619677756,0.105301517,0.230061536,20.97282312,0,-0.924915732,1.204467245,-0.767904429,0.442543966,0.60377814,84.97113891,1,-0.756415732,0.74851664,-1.010552995,0.312230423,0.454169656,117.3498875,0,-0.436772574,0.585505467,-0.745975228,0.455682379,0.597950245,57.44053938,0,-2.727363078,1.12503089,-2.424256172,0.01533978,0.044236764,N,-,,CAMK kinase,F:nucleotide binding; P:regulation of cellular process; F:protein serine/threonine kinase activity; P:protein phosphorylation,G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); IPR020636 (PANTHER); PTHR24347:SF211 (PANTHER); PTHR24347:SF211 (PANTHER); IPR020636 (PANTHER); IPR020636 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.1, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_06817,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20485.36867,0,-2.620706096,0.343639968,-7.626313419,2.42E-14,1.45E-12,6349.957304,0,-3.080596066,0.521692544,-5.905003058,3.53E-09,5.41E-07,16184.11621,0,-3.222546659,0.638244194,-5.049081039,4.44E-07,1.31E-05,17736.25971,0,-4.293303876,1.079457774,-3.977278202,6.97E-05,0.000788567,15337.23684,0,-3.872050178,1.241946618,-3.117726738,0.001822517,0.007829013,N,-,,heat shock 90,F:ATP binding; F:FMN binding; C:cytoplasm; F:oxidoreductase activity; F:unfolded protein binding; P:oxidation-reduction process; P:protein folding; P:response to stress,IPR020575 (PRINTS); IPR003594 (SMART); IPR003594 (G3DSA:3.30.565.GENE3D); IPR001404 (PFAM); IPR001404 (PIRSF); IPR003594 (PFAM); IPR001404 (PANTHER); IPR001404 (HAMAP); IPR003594 (SUPERFAMILY); IPR020568 (SUPERFAMILY); SSF110942 (SUPERFAMILY),,
RL4_JR_06818,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,78.45472171,0,-2.517401186,1.004518166,-2.506078309,0.012207858,0.044520208,22.61400144,0,-1.033615008,1.195162656,-0.864832082,0.38713096,0.551672461,58.63253609,0,-3.684641393,1.18559429,-3.107843404,0.001884579,0.009454647,76.94968729,0,-3.1580988,1.136902178,-2.777810493,0.005472653,0.030049136,57.75760243,0,-3.76571645,1.186524098,-3.173737859,0.001504895,0.006691729,N,-,,50S ribosomal,C:intracellular,no IPS match,,
RL4_JR_06819,2779,572,2634,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,429.7493804,0,-0.049029115,0.314941516,-0.155676888,0.876287716,0.939923479,68.10808779,0,-2.62424797,1.187047015,-2.210736337,0.027054101,0.07284959,286.4931321,0,-0.649761943,0.424249363,-1.531556674,0.125631871,0.229750192,419.2841754,0,0.074264753,0.304714359,0.243719242,0.80744827,0.87708534,262.0938646,0,-0.586901826,0.460815271,-1.27361627,0.202799443,0.325050556,N,-,,transcription initiation factor TFIID subunit 5,"C:nucleus; F:translation initiation factor activity; C:prospore membrane; P:ascospore-type prospore membrane assembly; F:phosphatidylinositol binding; C:cytosol; P:regulation of transcription, DNA-templated; P:translational initiation; P:intracellular protein transport; P:retrograde transport, endosome to Golgi",IPR020472 (PRINTS); IPR001683 (SMART); IPR001680 (SMART); IPR006594 (SMART); IPR007582 (PFAM); IPR015404 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR027267 (G3DSA:1.20.1270.GENE3D); IPR001683 (G3DSA:3.30.1520.GENE3D); IPR001680 (PFAM); IPR001683 (PFAM); IPR006594 (PFAM); PTHR19879 (PANTHER); PTHR19879:SF1 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR006594 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001683 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); SSF103657 (SUPERFAMILY); SSF160897 (SUPERFAMILY); IPR001683 (SUPERFAMILY); IPR017986 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_06820,0,0,2,0,0,3,0,0,0,0,5,4,4,31,8,0,12,1,59.02535749,1,-0.772582723,0.898049217,-0.860289958,0.389629227,0.582373623,10.39582807,0,0.087516716,1.240132909,0.070570433,0.943739643,0.969701824,33.6824387,1,-1.613942717,1.215327861,-1.327989564,0.184181555,0.305480678,67.65721615,1,0.073463278,0.717822146,0.102341894,0.918485303,0.950815523,27.0279043,1,-2.670147353,1.229830882,-2.171150027,0.029919833,0.075021871,N,-,,Mediator subunit Med11,C:mediator complex; F:RNA polymerase II transcription cofactor activity; P:regulation of transcription from RNA polymerase II promoter,IPR019404 (PFAM),,
RL4_JR_06821,47,36,100,0,1,57,0,0,0,7,33,17,35,118,45,2,70,27,90.18857273,1,-0.106583642,0.592000342,-0.180039832,0.857121298,0.928096512,40.05334582,0,0.239153461,1.109527506,0.21554532,0.829342182,0.897722336,65.63574923,1,-0.937383495,0.856552917,-1.09436729,0.273793924,0.412544975,127.5586166,1,0.649958556,0.44908376,1.447299175,0.14781315,0.26328209,68.04184542,1,-0.797504414,0.757178355,-1.053258336,0.292222608,0.426887016,N,-,,peptidase family m28 family,C:membrane; F:peptidase activity,G3DSA:3.40.630.10 (GENE3D); IPR007484 (PFAM); PTHR12147 (PANTHER); PTHR12147:SF6 (PANTHER); PTHR12147:SF6 (PANTHER); PTHR12147:SF6 (PANTHER); PTHR12147 (PANTHER); PTHR12147 (PANTHER); SSF53187 (SUPERFAMILY),,
RL4_JR_06822,593,679,1450,0,2,4,0,0,0,0,0,0,0,0,0,0,1,0,1083.319042,1,-2.409116957,0.323722858,-7.441911808,9.92E-14,5.55E-12,292.270919,0,-4.725644874,1.194126234,-3.957408135,7.58E-05,0.003815511,912.0636094,0,-2.157645251,0.452055257,-4.772967941,1.82E-06,4.53E-05,1049.294616,0,-2.147693405,0.451911279,-4.752466919,2.01E-06,3.39E-05,835.2097875,1,-2.73340535,0.53683821,-5.091674359,3.55E-07,5.98E-06,N,-,,branchpoint-bridging,F:RNA binding; F:metal ion binding; C:membrane; C:U2-type spliceosomal complex,IPR001878 (SMART); IPR001878 (PFAM); IPR001878 (G3DSA:4.10.60.GENE3D); IPR004088 (G3DSA:3.30.1370.GENE3D); IPR032570 (PFAM); PTHR11208 (PANTHER); IPR031150 (PTHR11208:PANTHER); IPR001878 (PROSITE_PROFILES); IPR001878 (PROSITE_PROFILES); IPR001878 (SUPERFAMILY); IPR004088 (SUPERFAMILY),1.G.7.1.1, the reovirus fast fusion protein (r-fast) famly.
RL4_JR_06823,550,658,1189,0,1,0,0,0,0,0,0,2,0,0,0,0,6,0,64.13988661,1,3.372405345,0.845537226,3.988476488,6.65E-05,0.000592895,39.70968066,0,4.914424248,0.768618454,6.393841079,1.62E-10,3.09E-08,5.681912934,1,-0.317219964,1.198934023,-0.264585005,0.791329173,0.862340333,19.87782789,0,0.995053255,1.01453033,0.98080188,0.326690451,0.473210417,27.68062042,1,1.832995617,0.836105769,2.192301124,0.028357771,0.071996597,N,-,,endosomal spry domain-containing,C:membrane,no IPS match,,
RL4_JR_06824,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,362.9534539,0,-2.528788992,0.54002051,-4.682764716,2.83E-06,3.78E-05,100.9082971,0,-3.191390111,1.195908068,-2.668591505,0.007617003,0.027584723,392.7866043,0,-1.01930747,0.425258133,-2.396914699,0.016533772,0.048141475,351.7543097,0,-2.717509999,0.587118685,-4.628553087,3.68E-06,5.85E-05,277.4997726,0,-3.319136785,0.777214326,-4.270555334,1.95E-05,0.000175957,N,-,,saccharopine dehydrogenase,"F:saccharopine dehydrogenase (NADP+, L-glutamate-forming) activity; C:cytoplasm; P:oxidation-reduction process; P:lysine biosynthetic process via aminoadipic acid",IPR016040 (G3DSA:3.40.50.GENE3D); IPR005097 (PFAM); G3DSA:3.30.360.10 (GENE3D); IPR032095 (PFAM); G3DSA:1.10.1870.10 (GENE3D); PTHR11133 (PANTHER); SSF55347 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_06825,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,58.41009148,0,-0.310283058,0.730748191,-0.424610094,0.671120934,0.817535882,9.800250784,0,0.172726743,1.214719959,0.142194702,0.886926216,0.936030358,39.72307022,0,-0.653962284,1.026724457,-0.636940397,0.524163668,0.654090099,134.1179198,0,1.746189565,0.399786951,4.367800298,1.26E-05,0.000172653,51.28486934,0,0.391156211,0.660099513,0.59257158,0.553467904,0.673217507,N,-,,hypothetical protein CMQ_6268,,no IPS match,1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_06826,4,14,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.840327563,0,2.148636957,1.620417331,1.325977522,0.184847143,NA,0.265627134,0,5.377876653,1.740443667,3.089945831,0.00200193,0.015023052,0.693396058,0,2.71679812,1.272305926,2.135334014,0.032733736,0.082252754,0.80022905,0,2.294112862,1.346536814,1.703713436,0.088434637,0.178687028,0.687827506,0,2.626631177,1.250977473,2.09966305,0.035758492,0.086162478,N,-, Effector probability:0.912,---NA---,,no IPS match,,
RL4_JR_06827,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,92.656547,0,-2.702826166,1.042734466,-2.592056035,0.009540423,0.036540268,26.08834674,0,-1.239788062,1.229791805,-1.008128413,0.313392819,0.475230279,86.63854636,0,-1.487233441,0.886019933,-1.678555285,0.093238747,0.183790708,130.8588794,0,-0.12567583,0.585356903,-0.214699492,0.830001618,0.893741834,65.61685317,0,-3.949790317,1.206833945,-3.272853183,0.001064678,0.005021542,N,-,,glucan 4-alpha-glucosidase,P:biological_process; C:cellular_component,PTHR23196 (PANTHER); PTHR23196:SF13 (PANTHER),,
RL4_JR_06828,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,89.80627372,0,0.81952395,0.502678161,1.630315406,0.103034853,0.226626674,12.67166084,0,-0.198020447,1.205740156,-0.164231444,0.869548948,0.924826569,81.84843403,0,0.558844032,0.611409656,0.914025527,0.360703433,0.504596042,57.23678197,0,-1.532230706,1.011430611,-1.51491431,0.129794106,0.238505503,36.3253219,0,-2.004360035,1.122762608,-1.785203765,0.074228272,0.151555001,N,-,,DNA-binding SAP,,IPR003034 (SMART); IPR003034 (G3DSA:1.10.720.GENE3D); IPR003034 (PFAM); PTHR12381 (PANTHER); IPR003034 (PROSITE_PROFILES); SSF68906 (SUPERFAMILY),,
RL4_JR_06829,2162,2777,1610,0,3,0,0,0,0,1,0,0,0,0,2,0,4,0,30.78582904,1,1.791815491,0.74051374,2.419692432,0.015533639,0.053764714,21.04306814,0,3.907992527,1.00474557,3.889534471,0.000100437,0.004864212,5.914559756,1,-0.375339321,1.201741277,-0.312329557,0.75479008,0.835227322,10.83336069,1,0.149401541,1.149148496,0.130010648,0.896558002,0.936122152,13.18305395,1,0.480653426,1.125823348,0.426935031,0.669426649,0.765007013,N,-,,Methyltransferase domain-containing,C:cytoplasm; F:S-adenosylmethionine-dependent methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR029063 (SUPERFAMILY),,
RL4_JR_06830,2,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,117.2435344,0,1.044246026,0.529793078,1.971045053,0.048718723,0.130103515,23.2898871,0,0.584283942,1.116176466,0.523469147,0.600647816,0.735335897,96.20128987,0,0.833000022,0.547278515,1.522076965,0.127989797,0.233135787,100.2973962,0,0.336901669,0.54865143,0.614054117,0.539179567,0.670415463,55.01342424,0,-0.15596371,0.695234246,-0.224332606,0.822498507,0.881155156,N,-,,calcineurin-like phosphoesterase,F:phosphoprotein phosphatase activity; P:endoplasmic reticulum unfolded protein response; P:protein dephosphorylation; C:integral component of membrane; P:traversing start control point of mitotic cell cycle,IPR004843 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); PTHR32440:SF0 (PANTHER); PTHR32440 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_06831,4,7,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,96.44185348,0,-0.092152737,0.607069112,-0.151799416,0.879345143,0.941268208,17.92222901,0,-0.698166141,1.229097436,-0.568031566,0.570013534,0.71081397,54.22728129,0,-2.384806837,1.209393225,-1.971903586,0.048620614,0.110828278,208.446116,0,1.365086521,0.567868142,2.403879385,0.016222125,0.068954245,45.67810542,0,-3.427236455,1.212586419,-2.826385321,0.00470766,0.017023234,N,-,,endosomal spry domain,P:protein transport; C:integral component of membrane; C:endosome membrane,IPR003877 (SMART); IPR003877 (PFAM); PTHR12864:SF24 (PANTHER); PTHR12864 (PANTHER); IPR001870 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),,
RL4_JR_06832,1068,1179,796,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,137.3901019,0,-2.778549605,0.855873358,-3.246449465,0.001168542,0.006694498,40.31916487,0,-1.867874701,1.198211385,-1.55888579,0.119023414,0.232040639,145.53356,0,-1.370093287,0.670391353,-2.043721597,0.040981058,0.09752991,166.0584679,1,-1.611464654,0.615782381,-2.616938554,0.008872231,0.044186591,121.4358921,0,-2.375885032,0.844129467,-2.814597907,0.00488383,0.017559935,N,-,,importin beta-2 subunit,C:nuclear envelope; C:mitotic spindle midzone; C:cellular bud tip; C:cellular bud neck; P:mRNA-binding (hnRNP) protein import into nucleus; C:cytosol; P:transcription factor import into nucleus; C:nuclear periphery; P:exit from mitosis; F:Ran GTPase binding; F:nuclear localization sequence binding,IPR011989 (G3DSA:1.25.10.GENE3D); IPR001494 (PFAM); PF13513 (PFAM); PTHR10527 (PANTHER); PTHR10527:SF3 (PANTHER); PTHR10527 (PANTHER); IPR016024 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_06833,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.12671516,0,-1.578411866,1.219076143,-1.294760689,0.195402797,0.357260425,3.52777985,0,1.646658627,1.282692123,1.283752037,0.19922873,0.342841416,9.20217558,0,-1.013160515,1.214904158,-0.83394275,0.404313245,0.54657061,18.64194818,0,0.277769038,1.04501323,0.265804327,0.790389911,0.864571956,9.131853026,0,-1.104683826,1.226148781,-0.900937834,0.367621374,0.504017117,N,-,,hypothetical protein CMQ_6253,P:proteasome assembly,IPR032157 (PFAM),,
RL4_JR_06834,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.82842143,0,-1.156541457,1.155049261,-1.001291889,0.316685713,0.504988672,5.08449163,0,1.119344326,1.246665242,0.897870806,0.36925443,0.533636971,24.31148783,0,-0.576352962,1.199078619,-0.480663197,0.630755892,0.741497057,51.23875254,0,1.102515396,0.684956873,1.609612866,0.107482398,0.207011466,20.47840127,0,-0.689161211,1.138778903,-0.605175604,0.545062324,0.666435941,N,-,,methyltransferase family,C:nucleus; C:cytosol; F:methyltransferase activity; P:methylation,IPR012901 (SMART); IPR029063 (G3DSA:3.40.50.GENE3D); IPR012901 (PFAM); PTHR12303 (PANTHER); PTHR12303 (PANTHER); PTHR12303:SF6 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_06835,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,167.6503483,0,2.4939874,1.358590284,1.835717088,0.066399509,0.164646565,74.869323,0,2.996410119,0.787905993,3.803004602,0.000142952,0.006577078,215.7384697,0,3.12353011,1.243760154,2.51136049,0.012026681,0.037314778,272.0007566,0,3.33999932,0.379819816,8.793641565,1.45E-18,1.17E-16,183.4874769,0,3.169942596,0.470795673,6.733160009,1.66E-11,1.38E-09,N,-,,nadph-dependent beta-ketoacyl reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); PTHR24322:SF628 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06836,3,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,70.17593716,0,1.836579814,0.562701762,3.263860073,0.001099054,0.006351208,3.900405116,0,1.501913679,1.25222444,1.199396555,0.230373786,0.380450942,10.11046574,0,-1.148758949,1.190091752,-0.96526923,0.33440998,0.47771506,20.97540575,0,-0.622089241,1.137949428,-0.546675648,0.584601587,0.709886439,36.26893316,0,1.717157229,0.664288481,2.584957108,0.009739111,0.030700031,Y,-,,ubiquitin family,C:membrane; C:integral component of membrane,PTHR12943 (PANTHER); PTHR12943:SF27 (PANTHER),,
RL4_JR_06837,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,80.28628142,0,0.557710859,0.760878785,0.732982533,0.463569083,0.651696808,12.13986822,0,-0.136225108,1.225437681,-0.111164452,0.91148594,0.950652603,76.56777554,0,0.603295891,0.646781032,0.932766827,0.350940372,0.494491347,48.56810693,0,-0.93324666,0.888707452,-1.050116839,0.293664397,0.438191544,46.49513567,0,-0.68074596,0.879688942,-0.773848491,0.439020393,0.573115198,N,-,,phosphatidylserine decarboxylase,C:integral component of mitochondrial inner membrane; P:positive regulation of mitochondrial fusion; F:phosphatidylserine decarboxylase activity; P:phospholipid biosynthetic process; P:positive regulation of protein processing; P:phosphatidylcholine biosynthetic process,IPR033177 (TIGRFAM); IPR003817 (PFAM); PTHR10067:SF6 (PANTHER); PTHR10067:SF6 (PANTHER); IPR033177 (PANTHER); PTHR10067:SF6 (PANTHER); IPR033177 (PANTHER); IPR033661 (HAMAP),2.A.25.1.6, the alanine or glycine:cation symporter (agcs) family.
RL4_JR_06838,3,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,857.2893355,0,-1.169487961,0.674764252,-1.733180083,0.083063666,0.193581826,223.5589221,0,-2.015756371,0.955311486,-2.110051434,0.034853926,0.088909133,523.5917908,0,-4.394058829,0.925781026,-4.746326297,2.07E-06,5.02E-05,679.9473712,0,-2.416145109,0.602208191,-4.012142551,6.02E-05,0.000697051,600.8862274,0,-2.231958418,0.563186188,-3.963091543,7.40E-05,0.000540004,N,-, Effector probability:0.691,nitroreductase family,F:oxidoreductase activity; P:oxidation-reduction process,IPR000415 (G3DSA:3.40.109.GENE3D); IPR029479 (PFAM); PTHR23026 (PANTHER); IPR033877 (PTHR23026:PANTHER); IPR000415 (SUPERFAMILY),,
RL4_JR_06839,217,215,177,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,241.2151729,0,-0.304991696,0.582031106,-0.524012707,0.600269702,0.76883364,43.20185359,0,-1.967490896,1.274084632,-1.544238778,0.122530498,0.237278305,176.9065673,0,-0.809528681,1.735801265,-0.466371754,0.640949426,0.74991247,184.0048145,0,-1.032138004,0.654888432,-1.576051664,0.115013897,0.217219867,229.3495017,0,0.142337261,0.704754703,0.201967097,0.839942447,0.892102935,N,-,,fad binding domain-containing,F:oxidoreductase activity; P:oxidation-reduction process,IPR001709 (PRINTS); IPR003097 (PFAM); IPR023173 (G3DSA:1.20.990.GENE3D); IPR001433 (PFAM); G3DSA:3.40.50.80 (GENE3D); G3DSA:2.40.30.10 (GENE3D); PTHR19384:SF17 (PANTHER); PTHR19384 (PANTHER); PTHR19384 (PANTHER); IPR017927 (PROSITE_PROFILES); IPR017938 (SUPERFAMILY); SSF52343 (SUPERFAMILY),,
RL4_JR_06840,75,52,65,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,290.7465951,0,-1.746472552,0.909715652,-1.919800488,0.054883105,0.14261292,70.52083291,0,-2.674453535,1.258025077,-2.125914328,0.033510394,0.086264548,290.4932253,1,-0.71007684,1.901782871,-0.373374295,0.708869888,0.802571991,357.0886501,0,-0.53730737,0.551923812,-0.973517284,0.330296274,0.476979453,266.594813,0,-0.695434367,0.599435807,-1.16014819,0.245988477,0.3762286,N,-,,c6 zinc finger domain containing,"C:nucleus; F:zinc ion binding; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR021858 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31263 (PANTHER); PTHR31263:SF7 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_06841,166,144,175,0,0,7,0,0,9,0,0,0,0,7,0,0,0,0,17.90312539,1,1.49477685,0.88285538,1.693116318,0.090433329,0.205789427,2.078250263,1,2.410201312,1.340521495,1.797957975,0.072183668,0.157398338,5.360262408,0,-0.233320169,1.218103689,-0.191543767,0.848099594,0.902761044,6.181133375,1,-0.655070902,1.218752951,-0.537492772,0.590927276,0.714831382,5.256412692,0,-0.308032843,1.214233186,-0.25368508,0.799738861,0.864824946,N,-,,cytochrome P450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR002403 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24279 (PANTHER); PTHR24279:SF39 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_06842,87,76,75,0,0,4,0,0,0,0,0,0,0,3,0,0,0,0,4.223514298,1,-0.180885828,1.228762352,-0.147209774,0.882966446,0.942955919,1.339866314,0,3.043331295,1.362826384,2.233102712,0.025542172,0.069611703,3.491213741,0,0.384986401,1.215519794,0.316725736,0.751451719,0.833357798,4.028529828,1,-0.037673195,1.218425778,-0.030919565,0.975333687,0.98517231,3.458503861,0,0.296147586,1.220999023,0.242545309,0.808357653,0.870704387,N,-,,hypothetical protein SPI_07354,,no IPS match,,
RL4_JR_06843,369,370,316,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.98425418,0,-0.307006239,1.162904065,-0.263999627,0.791780206,0.893161355,2.828028049,0,1.965694545,1.291940228,1.521505796,0.128132958,0.244781558,7.361378427,0,-0.690987427,1.210273551,-0.570934915,0.568043762,0.692459368,17.80666033,0,-0.162380024,1.158144168,-0.14020709,0.88849637,0.931630491,7.276099631,0,-0.776845893,1.216586566,-0.638545514,0.523118637,0.647424055,N,-,,hypothetical protein SPI_07355,,PTHR35391 (PANTHER); PTHR35391:SF2 (PANTHER),,
RL4_JR_06844,2,0,3,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,748.5605122,0,-0.131843164,0.414920335,-0.317755368,0.750670508,0.870005683,274.2698843,0,-0.074843857,0.592055893,-0.126413499,0.899404618,0.944130759,332.869113,0,-6.189826092,1.197574912,-5.168633739,2.36E-07,7.55E-06,488.5462227,1,-1.605415591,0.517317551,-3.103346458,0.001913455,0.012779506,472.104991,0,-1.147424225,1.866207867,-0.614842669,0.538658628,0.66101693,N,-,,60S ribosomal l17,F:structural constituent of ribosome; C:large ribosomal subunit; P:translation,IPR001063 (PFAM); IPR005721 (TIGRFAM); IPR001063 (G3DSA:3.90.470.GENE3D); IPR005721 (PANTHER); IPR001063 (SUPERFAMILY),,
RL4_JR_06845,42,64,66,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,644.3099882,0,-3.479596585,0.606940685,-5.733009292,9.87E-09,2.32E-07,183.8994762,0,-4.057261397,1.201935188,-3.375607467,0.000736529,0.015023052,495.0492858,0,-4.891234408,1.051315124,-4.652491243,3.28E-06,7.38E-05,599.8712856,0,-3.282143561,0.566257571,-5.796202518,6.78E-09,1.92E-07,521.2087485,0,-2.911829727,0.819353575,-3.553813416,0.000379688,0.002142891,N,-,,rRNA 2 -O-methyltransferase fibrillarin,C:small-subunit processome; P:tRNA processing; C:Cajal body; C:ribosome; P:regulation of transcription from RNA polymerase I promoter; C:box C/D snoRNP complex; F:rRNA methyltransferase activity; P:box C/D snoRNA 3'-end processing; F:RNA binding; P:histone glutamine methylation; F:histone-glutamine methyltransferase activity; P:rRNA methylation; C:90S preribosome,IPR000692 (PRINTS); IPR000692 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR029063 (G3DSA:3.40.50.GENE3D); IPR000692 (PFAM); IPR000692 (PIRSF); PTHR10335 (PANTHER); IPR000692 (HAMAP); IPR029063 (SUPERFAMILY),,
RL4_JR_06846,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.111259376,0,1.745236748,1.591354267,1.096699072,0.272772962,NA,0.350960923,0,4.975829274,1.720151115,2.892669854,0.003819826,0.017638812,0.919138483,0,2.309811184,1.315281665,1.756134253,0.079065488,0.16125282,1.060818808,0,1.887125522,1.386995823,1.360584863,0.173644918,0.29692171,0.916947252,0,2.211282413,1.304457057,1.695174556,0.090042312,0.176442503,N,-,,---NA---,,no IPS match,,
RL4_JR_06847,4165,4360,4709,0,1,0,0,0,0,0,2,8,0,0,0,0,7,0,255.1271158,1,-1.766812106,0.549469899,-3.215484797,0.001302244,0.007286492,65.53567391,0,-2.568694225,1.208133643,-2.126167283,0.033489333,0.086232264,180.7714232,1,-4.256077775,1.206221386,-3.528438331,0.000418019,0.002974018,230.403899,0,-2.339447556,0.652059478,-3.587782459,0.000333502,0.002964628,167.1791926,1,-5.29903949,1.212181605,-4.371489775,1.23E-05,0.000119908,N,-,,zinc finger,"F:nucleic acid binding; C:nucleus; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding",IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR10032:SF195 (PANTHER); IPR027775 (PANTHER); SSF57667 (SUPERFAMILY),,
RL4_JR_06848,1156,1062,1438,0,5,2,0,0,0,0,0,7,4,0,0,0,0,0,2.024199445,1,0.880055755,1.294488261,0.679848386,0.496600466,NA,0.647038065,0,4.09353298,1.502705985,2.724107723,0.006447547,0.024424429,1.679024188,1,1.44095458,1.234491826,1.167245136,0.243111388,0.376779544,1.93683978,1,1.018794921,1.251768818,0.813884246,0.415711266,0.559568808,1.657665928,0,1.356857162,1.228097399,1.104844911,0.269226796,0.40163862,N,-,,carboxymuconolactone decarboxylase,C:intracellular membrane-bounded organelle; C:cytoplasmic part,IPR029032 (G3DSA:1.20.1290.GENE3D); PTHR28180 (PANTHER); PTHR28180:SF2 (PANTHER); IPR029032 (SUPERFAMILY),,
RL4_JR_06849,25,7,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,112.0550103,0,1.180647518,0.735352179,1.605553844,0.108371974,0.234757982,21.84794185,0,0.742387771,1.113879692,0.66648829,0.505099046,0.65856202,143.1526998,0,1.596122807,0.449246707,3.552887049,0.000381028,0.002789246,109.2599335,0,0.940735668,0.464528918,2.025139084,0.042853085,0.112668782,92.25104029,0,1.284450203,0.462193116,2.779033608,0.005452088,0.019227584,N,-,,E3 ubiquitin- ligase synoviolin,F:catalytic activity; C:Hrd1p ubiquitin ligase complex; P:cellular process,IPR001841 (SMART); IPR024766 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR22763 (PANTHER); PTHR22763 (PANTHER); IPR032832 (PTHR22763:PANTHER); IPR032832 (PTHR22763:PANTHER); PTHR22763 (PANTHER); IPR032832 (PTHR22763:PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),3.A.16.1.4, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_06850,1620,2006,1534,0,0,0,0,0,0,3,0,0,0,0,0,1,0,0,41.68598628,0,0.395639219,0.723505289,0.546836664,0.584490952,0.757803362,7.15677866,0,0.626133557,1.238294718,0.505641789,0.61310814,0.745533431,18.66882981,1,-2.033658606,1.206085669,-1.686164307,0.091764157,0.181645631,216.9312702,0,3.117565072,0.390441105,7.98472557,1.41E-15,9.14E-14,37.10848074,1,0.103124996,0.872644866,0.118175217,0.905928827,0.939808337,N,-,,ubiquitin carboxyl-terminal hydrolase 2,F:thiol-dependent ubiquitin-specific protease activity; P:protein deubiquitination; C:cytoplasm; C:proteasome complex; C:nuclear periphery; P:ubiquitin-dependent protein catabolic process,IPR001578 (PRINTS); IPR001578 (G3DSA:3.40.532.GENE3D); IPR001578 (PFAM); IPR017390 (PIRSF); IPR001578 (PANTHER); PTHR10589:SF16 (PANTHER); SSF54001 (SUPERFAMILY),,
RL4_JR_06851,525,544,699,0,0,1,0,0,0,0,0,0,0,0,0,0,4,0,0.556134311,1,2.743911945,2.030706103,1.351210764,0.176627927,NA,0.178478492,0,5.951533475,1.964831102,3.029030571,0.002453399,0.015349618,0.462794628,0,3.299694331,1.371449936,2.405989636,0.016128722,0.047165565,0.533778777,0,2.878053663,1.538130474,1.871137535,0.06132602,0.138290858,0.457334386,1,3.214185478,1.322984398,2.429496132,0.015119826,0.043772973,N,-,,inner membrane yieg,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR006043 (PFAM); IPR006043 (PANTHER); IPR006043 (PANTHER); PTHR11119:SF15 (PANTHER); PTHR11119:SF15 (PANTHER); PTHR11119:SF15 (PANTHER),2.A.40.7.1, the nucleobase/ascorbate transporter (nat) or nucleobase:cation symporter-2 (ncs2) family.
RL4_JR_06852,1558,1341,1138,0,0,0,0,0,0,5,0,0,0,0,1,0,0,1,0.325976338,0,3.514900264,2.402550109,1.462987286,0.143470858,NA,0.104280151,0,6.727158725,2.08115626,3.232414046,0.001227491,0.015023052,0.269738855,1,4.080262752,1.320591778,3.089722972,0.002003433,0.009860356,0.31113866,1,3.657481237,1.575884601,2.320906769,0.020291876,0.077428737,0.2647929,1,4.003950458,1.244915837,3.216241886,0.001298813,0.005923263,N,-,,hypothetical protein HMPREF1624_00620,P:biological_process; C:cellular_component; F:molecular_function,IPR029063 (G3DSA:3.40.50.GENE3D); IPR029063 (SUPERFAMILY),,
RL4_JR_06853,54390,59156,55031,9,17,7,0,0,0,9,14,13,14,44,18,0,17,7,7.666400486,1,8.595903269,1.567061418,5.485364626,4.13E-08,8.93E-07,0.009207564,0,10.22995802,3.943680144,2.594013117,0.009486287,0.032395477,0.023885656,1,7.580325093,2.772177658,2.734429761,0.006248843,0.022473635,0.027569539,1,7.155170506,3.943611069,1.814370226,0.069620746,0.150228434,0.023329259,1,7.516043272,1.804251974,4.165739255,3.10E-05,0.000259905,N,-,,g- coupled receptor,F:transmembrane signaling receptor activity; P:signal transduction; C:membrane,IPR022343 (PRINTS); IPR000276 (PFAM); G3DSA:1.20.1070.10 (GENE3D); PTHR23112 (PANTHER); PTHR23112:SF0 (PANTHER); IPR017981 (PROSITE_PROFILES); IPR017452 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY),9.A.14.5.2, the g-protein-coupled receptor (gpcr) family.
RL4_JR_06854,4864,4035,5401,0,0,8,0,0,0,3,0,0,0,0,0,0,0,1,170.5679138,1,-1.385566534,0.582458157,-2.378825872,0.017367878,0.058548409,43.37609273,0,-1.973330351,1.19212576,-1.655303842,0.09786288,0.19910916,119.2265797,1,-3.665933597,1.19096311,-3.078125229,0.002083074,0.010173197,182.7085106,0,-1.159356591,0.515615967,-2.248488536,0.024545055,0.084731907,160.4907215,1,-0.791169872,0.519913045,-1.521734991,0.128075496,0.229556453,Y,-,,zinc carboxypeptidase,P:fungal-type cell wall organization; F:zinc ion binding; F:metallocarboxypeptidase activity; P:proteolysis; C:endoplasmic reticulum; C:fungal-type vacuole,IPR000834 (PRINTS); IPR000834 (SMART); IPR000834 (PFAM); IPR003146 (G3DSA:3.30.70.GENE3D); G3DSA:3.40.630.10 (GENE3D); PTHR11705:SF61 (PANTHER); PTHR11705 (PANTHER); PTHR11705:SF61 (PANTHER); PTHR11705 (PANTHER); SSF53187 (SUPERFAMILY),,
RL4_JR_06855,7,9,1,0,0,18,0,0,0,0,1,3,0,4,0,0,0,5,42.84448029,1,-2.186776496,1.147400257,-1.905853238,0.056669249,0.145838403,10.42063409,0,0.084103356,1.212971235,0.069336645,0.944721657,0.97033501,27.10968297,1,-2.571809236,1.193524999,-2.154801314,0.031177385,0.079107732,131.3206263,1,1.478056021,0.718593972,2.056872279,0.039698513,0.106957809,26.80806753,1,-2.658366014,1.200686911,-2.21403764,0.02682619,0.06900792,N,-, Effector probability:0.613,abhydrolase domain-containing,F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); PTHR10992 (PANTHER); PTHR10992:SF744 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_06856,76,79,74,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,29.97714765,0,-1.864227464,1.148165038,-1.623658099,0.104448798,0.228715056,8.34067875,0,0.405378759,1.225755149,0.330717565,0.740857833,0.8400317,21.62867652,1,-2.245830896,1.194349014,-1.880380751,0.060056205,0.130390097,38.59866475,0,-0.933699822,1.017733771,-0.917430323,0.358917189,0.504797408,21.29320352,0,-2.326061061,1.195969507,-1.944916695,0.051785005,0.11510937,N,-, Effector probability:0.656,40S ribosomal s3ae,F:GTP binding; C:intracellular ribonucleoprotein complex; C:cytoplasm; P:small GTPase mediated signal transduction,PR00449 (PRINTS); SM00174 (SMART); SM00173 (SMART); SM00175 (SMART); IPR005225 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001806 (PFAM); PTHR24073 (PANTHER); PTHR24073:SF285 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_06857,2,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,1531.036958,1,-0.450030948,0.419926407,-1.07169004,0.283859276,0.467054643,307.1941185,0,-3.765053749,1.113388378,-3.381617614,0.000720604,0.015023052,833.4740758,0,-3.055717789,0.496483571,-6.154720856,7.52E-10,3.95E-08,1096.66538,0,-1.752879913,0.834571737,-2.10033462,0.035699416,0.10034633,862.219507,0,-2.242304577,0.648638699,-3.456939251,0.000546348,0.002916064,N,-,,40s ribosomal s1,F:GTP binding; F:structural constituent of ribosome; C:cytosolic small ribosomal subunit; P:small GTPase mediated signal transduction; P:translation,IPR001593 (SMART); IPR001593 (PFAM); PTHR11830 (PANTHER); IPR027500 (HAMAP),,
RL4_JR_06858,1480,2107,1569,0,0,2,0,0,0,0,0,2,2,18,0,0,2,5,43.29971802,1,3.361045908,0.614733263,5.467486652,4.56E-08,9.75E-07,1.160476357,0,3.250809597,1.385019115,2.34712255,0.018919031,0.055123325,28.99966321,1,3.415190199,0.751794996,4.542714724,5.55E-06,0.000114507,31.54686898,1,3.677961998,0.594538399,6.186248024,6.16E-10,2.05E-08,39.78539453,1,3.501079609,0.681071437,5.140546816,2.74E-07,4.93E-06,N,-,,hypothetical protein SPI_07368,,no IPS match,,
RL4_JR_06859,2026,3084,962,0,0,3,0,0,0,7,53,71,7,59,18,0,41,66,235.1204812,1,-0.245058915,1.239052358,-0.197779306,0.843217738,0.921089646,243.0881555,0,2.249366166,1.780173461,1.263565723,0.206385943,0.351276024,115.7381133,1,-3.620549339,1.207319471,-2.998832889,0.002710159,0.012576077,264.6855274,1,0.292304239,0.423711364,0.689866414,0.490278199,0.630117639,137.2383498,1,-1.463038077,0.656177502,-2.229637669,0.025771507,0.066992685,N,-,,GTP cyclohydrolase II,F:GTP cyclohydrolase II activity,IPR032677 (PFAM); IPR022163 (PFAM); PTHR21327:SF16 (PANTHER); PTHR21327 (PANTHER); IPR032677 (SUPERFAMILY),,
RL4_JR_06860,1641,1909,659,0,3,1,0,0,0,2,8,25,0,2,1,0,5,16,54.37020004,1,-0.029623172,0.687663921,-0.043077978,0.965639374,0.982763976,9.887512119,0,0.159910902,1.218938094,0.131188699,0.895626036,0.941970775,51.09781803,1,-0.083545149,0.855360093,-0.097672488,0.922192362,0.954446809,77.77480437,1,1.230224485,0.588655859,2.08988744,0.036627912,0.101650752,40.78088064,1,0.024144265,0.765539507,0.031538889,0.974839779,0.983288779,N,-, Effector probability:0.816,transcription elongation factor,F:translation elongation factor activity; P:translational elongation,IPR007808 (PFAM); PTHR20934:SF0 (PANTHER); IPR007808 (PANTHER); SSF57783 (SUPERFAMILY),,
RL4_JR_06861,277,315,178,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,117.030928,0,1.480878369,0.797069589,1.857903488,0.063182721,0.158460354,10.96890309,0,0.010166299,1.207702325,0.008417885,0.993283579,0.996480454,28.47406869,1,-2.642607616,1.187413778,-2.225515372,0.02604666,0.068649449,72.82124619,0,0.25230267,0.607052509,0.415619187,0.677688685,0.780301756,39.30989618,1,-1.048344651,0.970143108,-1.080608255,0.279871409,0.413497449,N,-,,uracil phosphoribosyltransferase,"F:transferase activity, transferring glycosyl groups",IPR029057 (PFAM); IPR029057 (G3DSA:3.40.50.GENE3D); PTHR10285 (PANTHER); IPR029057 (SUPERFAMILY),,
RL4_JR_06862,98,71,65,0,0,0,0,0,0,0,0,5,0,0,0,0,4,0,128.4456025,0,-0.131594667,0.522970209,-0.251629375,0.801327551,0.899570577,21.69351903,0,-0.973648298,1.221028803,-0.797399943,0.425218792,0.588114572,55.93454472,1,-3.616669998,1.202467264,-3.007707658,0.002632262,0.012326097,184.9234265,0,0.788088022,0.562381309,1.401341064,0.161112107,0.280622756,81.82739361,1,-0.310546594,0.616330446,-0.50386379,0.614357098,0.721703865,N,-,,Wings apart,,IPR022771 (PFAM),,
RL4_JR_06863,213,384,204,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,53.77219029,0,-2.60219976,1.144412424,-2.2738304,0.022976186,0.073631632,14.0409541,0,-0.34602409,1.218461645,-0.283984393,0.776422341,0.86457062,55.77324675,0,-0.591354887,0.859737868,-0.687831616,0.491558824,0.625272212,69.77499908,0,-1.075924541,0.855323372,-1.257915516,0.208422312,0.341137392,35.62143194,1,-3.068493411,1.192423853,-2.573324412,0.010072674,0.031584338,N,-, Effector probability:0.894,GTP-binding rhb1,F:GTP binding; C:nucleus; P:small GTPase mediated signal transduction; F:GTPase activity; C:membrane; F:GDP binding; P:regulation of L-arginine import; C:cytosol,PR00449 (PRINTS); SM00174 (SMART); SM00175 (SMART); SM00173 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); IPR001806 (PFAM); IPR020849 (PANTHER); IPR020849 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_06864,2,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.803883193,0,2.212685864,1.717478496,1.288333955,0.197629738,NA,9.639263862,0,6.317408886,1.21409738,5.203379062,1.96E-07,2.18E-05,0.668535561,0,2.770592045,1.317268272,2.103286099,0.035440768,0.086982384,0.770703262,0,2.348927786,1.41368512,1.661563634,0.0966003,0.190956274,0.650594312,0,2.705987496,1.272628017,2.126298855,0.033478383,0.081955665,N,-,,kinase-like domain,F:ATP binding; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_06865,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.566124197,0,2.718656961,1.931744332,1.40735858,0.159321087,NA,0.179851689,0,5.940737241,1.897479374,3.130857348,0.001742968,0.015023052,0.466838324,0,3.288746175,1.311446026,2.507725145,0.012151114,0.037597152,0.538639549,0,2.865791546,1.448243403,1.978805179,0.047837945,0.119594863,0.459456091,0,3.209259183,1.264576096,2.537814208,0.011154719,0.034297457,N,-,,polysaccharide deacetylase,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; P:carbohydrate metabolic process",IPR002509 (G3DSA:3.20.20.GENE3D); IPR011330 (SUPERFAMILY),,
RL4_JR_06866,18,18,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,336.0944928,0,0.094429236,0.355651909,0.265510275,0.790616396,0.892347509,64.15478829,0,-1.392256848,1.107066826,-1.257608679,0.208533313,0.35388156,159.6512192,0,-3.136702792,1.030322864,-3.044388221,0.002331541,0.011176381,213.3406099,0,-1.23607905,0.484121167,-2.553243145,0.010672496,0.051140097,165.9195619,0,-2.405506601,0.748126099,-3.215375861,0.001302738,0.005933524,N,-,,seryl-tRNA synthetase,F:ATP binding; C:cytosol; F:serine-tRNA ligase activity; P:seryl-tRNA aminoacylation,IPR002317 (PRINTS); IPR002317 (PIRSF); IPR015866 (G3DSA:1.10.287.GENE3D); IPR002314 (PFAM); IPR015866 (PFAM); G3DSA:3.30.930.10 (GENE3D); IPR002317 (TIGRFAM); PTHR11778:SF7 (PANTHER); IPR002317 (PANTHER); IPR006195 (PROSITE_PROFILES); SSF55681 (SUPERFAMILY); IPR010978 (SUPERFAMILY),,
RL4_JR_06867,64,121,85,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,41.63687748,0,1.487633619,0.603177986,2.466326117,0.013650699,0.048683847,4.778756653,1,1.208882043,1.259004576,0.96018876,0.336960223,0.499957692,12.3723857,0,-1.440138612,1.201607756,-1.198509751,0.230718629,0.361970464,52.16550575,0,0.904024708,0.752008176,1.202147445,0.229306407,0.365799176,12.18234778,0,-1.520571707,1.203819204,-1.263122985,0.206544985,0.329428099,N,-,,peptidase family c78,P:biological_process; C:cytoplasm,IPR012462 (PFAM),,
RL4_JR_06868,5,9,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,70.42424818,0,0.083716233,0.640054406,0.130795495,0.895937087,0.948632537,11.0898056,0,-0.005699708,1.216418303,-0.004685648,0.996261407,0.997937453,28.88568299,0,-2.663356384,1.198241074,-2.222721656,0.026234575,0.069112369,46.6544402,0,-1.351223434,1.024340068,-1.319116059,0.187130315,0.315099691,28.60458738,0,-2.751947715,1.20686715,-2.280240799,0.022593411,0.060167881,N,-, Effector probability:0.749,Inosine triphosphate pyrophosphatase,F:nucleotide binding; C:nucleus; C:cytoplasm; F:metal ion binding; P:deoxyribonucleoside triphosphate catabolic process; F:nucleoside-triphosphate diphosphatase activity; P:nucleotide metabolic process,IPR002637 (PFAM); IPR029001 (G3DSA:3.90.950.GENE3D); PTHR11067:SF9 (PANTHER); IPR002637 (PANTHER); IPR027502 (HAMAP); IPR029001 (SUPERFAMILY),,
RL4_JR_06869,961,836,1352,0,0,7,0,0,0,0,0,0,0,1,0,0,0,0,93.70700699,1,-2.600683882,1.072076201,-2.425838649,0.015273059,0.053155979,24.49907431,0,-1.149183051,1.230718847,-0.933749454,0.350433148,0.513474859,77.13945942,0,-2.004315915,1.075137592,-1.864241313,0.062287824,0.1341843,102.9386074,1,-1.845368038,0.909082832,-2.029922877,0.042364379,0.111790289,63.89692183,0,-3.91145519,1.238754881,-3.157569951,0.001590901,0.007021092,N,-,,dTMP kinase,"F:ATPase activity; C:nucleus; F:adenylate kinase activity; F:ATP binding; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nucleotide phosphorylation; C:cytoplasm; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:cellular response to oxidative stress",PF13238 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR12595 (PANTHER); PTHR12595:SF0 (PANTHER); IPR020618 (HAMAP); IPR027417 (SUPERFAMILY),,
RL4_JR_06870,15,10,16,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,371.0509551,1,-0.297821566,0.320201325,-0.930107223,0.352315571,0.542812168,104.7556294,0,-0.016121444,0.757572094,-0.02128041,0.983021971,0.99097747,290.9443579,0,-0.544301353,1.825181876,-0.298217597,0.765537092,0.842332086,269.535305,0,-1.760660545,0.505823209,-3.480782444,0.000499951,0.004190404,228.5492078,0,-1.022520666,0.523456296,-1.953402173,0.050771959,0.113536931,N,-,,myosin MYO2,P:vesicle transport along actin filament; P:budding cell apical bud growth; P:mitochondrion inheritance; F:ATP binding; P:unidimensional cell growth; P:vesicle-mediated transport; P:peroxisome inheritance; C:myosin complex; C:fungal-type vacuole membrane; P:metabolic process; C:mating projection tip; P:membrane addition at site of cytokinesis; F:microfilament motor activity; F:actin filament binding; P:vacuole inheritance; P:establishment of mitotic spindle orientation; C:incipient cellular bud site; C:cellular bud tip; F:calmodulin binding; C:Myo2p-Vac17p-Vac8p transport complex; P:Golgi inheritance; C:cellular bud neck; C:actin filament bundle; C:transport vesicle; C:filamentous actin,IPR001609 (PRINTS); IPR000048 (SMART); IPR002710 (SMART); IPR001609 (SMART); IPR001609 (PFAM); G3DSA:1.20.5.190 (GENE3D); IPR002710 (PFAM); IPR000048 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR13140:SF414 (PANTHER); PTHR13140 (PANTHER); IPR000048 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); IPR002710 (PROSITE_PROFILES); IPR001609 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR008989 (SUPERFAMILY); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_06871,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,829.1021456,0,-0.249026637,0.63781612,-0.390436412,0.696213867,0.83586648,197.1534239,0,-0.521567602,0.648392726,-0.804400761,0.421165562,0.584618461,380.5656014,0,-4.506422981,1.04028655,-4.331905456,1.48E-05,0.000262557,480.5013434,0,-2.850792363,0.527508836,-5.40425519,6.51E-08,1.54E-06,380.8829703,0,-3.517728126,0.728830246,-4.82653971,1.39E-06,1.89E-05,N,-,,D-3-phosphoglycerate dehydrogenase,F:NAD binding; F:phosphoglycerate dehydrogenase activity; P:L-serine biosynthetic process; P:oxidation-reduction process; F:amino acid binding,IPR006140 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.70.260 (GENE3D); IPR006139 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR029015 (PTHR10996:PANTHER); PTHR10996 (PANTHER); IPR002912 (PROSITE_PROFILES); SSF55021 (SUPERFAMILY); IPR016040 (SUPERFAMILY); SSF52283 (SUPERFAMILY),,
RL4_JR_06872,4,8,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,976.6030475,0,-0.609014393,0.300178152,-2.028843166,0.042474267,0.117898969,195.309267,0,-3.155652977,1.110213794,-2.842383146,0.004477764,0.019176787,565.664301,0,-2.450407116,0.478929428,-5.116426292,3.11E-07,9.67E-06,707.3573045,0,-1.83908291,0.343189008,-5.358804813,8.38E-08,1.93E-06,581.2387503,0,-1.822198371,0.461633583,-3.947282948,7.90E-05,0.000570023,N,-,,nucleosome assembly,C:nucleus; P:nucleosome assembly,IPR002164 (PFAM); PTHR11875:SF7 (PANTHER); IPR002164 (PANTHER); PTHR11875:SF7 (PANTHER); SSF143113 (SUPERFAMILY),,
RL4_JR_06873,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,280.7000926,0,0.205604864,0.349663823,0.588007253,0.556527425,0.734533365,44.85690134,0,-2.021732093,1.198033401,-1.687542343,0.091499115,0.188972464,116.081257,0,-4.670006484,1.190858445,-3.921546262,8.80E-05,0.001074667,175.2942508,0,-1.223197581,0.523500862,-2.336572239,0.019461437,0.075787328,235.2278185,0,0.444313106,0.398250405,1.115662659,0.26456656,0.396826018,N,-,,alpha-ketoglutarate dehydrogenase complex subunit,F:thiamine pyrophosphate binding; C:mitochondrial oxoglutarate dehydrogenase complex; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; P:tricarboxylic acid cycle; C:mitochondrial nucleoid,IPR005475 (SMART); IPR001017 (PFAM); IPR032106 (PFAM); IPR011603 (PIRSF); IPR029061 (G3DSA:3.40.50.GENE3D); IPR031717 (PFAM); IPR005475 (PFAM); IPR029061 (G3DSA:3.40.50.GENE3D); IPR011603 (TIGRFAM); IPR011603 (PANTHER); PTHR23152:SF4 (PANTHER); IPR029061 (SUPERFAMILY); IPR029061 (SUPERFAMILY),,
RL4_JR_06874,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,187.4722203,0,-0.456919705,0.454620109,-1.00505828,0.314868787,0.503074729,55.7295715,0,-0.103507099,0.993292498,-0.104206062,0.917005824,0.954060707,177.5709205,0,-0.003956437,0.470349938,-0.008411687,0.993288524,0.997327483,227.7261579,0,0.018339209,0.395396885,0.046381775,0.963005962,0.978772417,97.65291847,0,-3.534689506,1.118885956,-3.159115088,0.00158249,0.006987662,N,-,,p-type ATPase,C:integral component of plasma membrane; F:ATP binding; F:cation-transporting ATPase activity; F:metal ion binding; C:intracellular membrane-bounded organelle; P:cation transmembrane transport; P:cellular calcium ion homeostasis,PR00119 (PRINTS); IPR008250 (G3DSA:2.70.150.GENE3D); IPR006544 (TIGRFAM); IPR023299 (G3DSA:3.40.1110.GENE3D); IPR006068 (PFAM); IPR008250 (PFAM); IPR023214 (G3DSA:3.40.50.GENE3D); IPR001757 (TIGRFAM); IPR006544 (PFAM); PTHR24093 (PANTHER); PTHR24093:SF84 (PANTHER); PTHR24093:SF84 (PANTHER); PTHR24093 (PANTHER); IPR023299 (SUPERFAMILY); SSF81653 (SUPERFAMILY); IPR023214 (SUPERFAMILY); SSF81665 (SUPERFAMILY),3.A.3.10.8, the p-type atpase (p-atpase) superfamily.
RL4_JR_06875,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,109.8348294,0,-0.026460688,0.584721194,-0.045253513,0.963905241,0.981715225,20.18071706,0,-0.869413725,1.206368133,-0.720686912,0.471102166,0.629255229,113.9511247,0,0.294632172,0.570804008,0.516170467,0.605735355,0.722656697,107.2044215,0,-0.610092083,0.637840007,-0.956497046,0.338821176,0.48605333,93.7404774,0,0.137983812,0.565878644,0.243839935,0.80735479,0.870146606,N,-,,hypothetical protein HMPREF1624_00641,C:integral component of membrane,PTHR36987:SF1 (PANTHER); PTHR36987 (PANTHER),,
RL4_JR_06876,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,101.0786132,0,0.928990434,0.454348712,2.044663952,0.040888,0.114399835,12.26109305,0,-0.150513799,1.204958389,-0.124912031,0.900593194,0.944488746,86.74648311,0,0.810443865,1.3857595,0.584837315,0.558657111,0.684809855,44.7636144,0,-1.498433213,1.011673071,-1.481143717,0.13856828,0.250715482,46.87332402,0,-0.279120752,0.75278973,-0.370781827,0.710800038,0.795727644,N,-,,serine threonine- kinase bur1,"F:ATP binding; P:peptidyl-serine autophosphorylation; P:peptidyl-threonine autophosphorylation; F:RNA polymerase II carboxy-terminal domain kinase activity; P:transcription, DNA-templated; C:cyclin-dependent protein kinase holoenzyme complex; C:P-TEFb-cap methyltransferase complex; P:positive regulation of histone H3-K4 methylation; P:peptidyl-tyrosine autophosphorylation; F:cyclin-dependent protein serine/threonine kinase activity; P:regulation of cell cycle; P:phosphorylation of RNA polymerase II C-terminal domain serine 2 residues involved in positive regulation of transcription elongation from RNA polymerase II promoter",IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24056:SF215 (PANTHER); PTHR24056 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_06877,5,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,94.53077382,0,3.849415828,0.522456209,7.367920532,1.73E-13,9.36E-12,2.270638385,0,2.282500537,1.320371299,1.728680818,0.083866236,0.176375243,121.6679715,0,4.430996935,0.451557814,9.812690189,9.93E-23,1.83E-20,70.79576781,0,3.493782792,0.490864974,7.117604584,1.10E-12,5.20E-11,25.04211867,0,2.483354296,0.692820098,3.584414344,0.000337835,0.001932533,N,-,,pheromone-regulated membrane,C:integral component of membrane,IPR031606 (PFAM); PTHR36424 (PANTHER),1.A.88.1.4, the fungal potassium channel (f-kch) family.
RL4_JR_06878,3,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,543.981073,0,-0.918998387,0.562806014,-1.632886579,0.102492853,0.225733047,138.4897389,0,-1.145583657,0.869211967,-1.317956609,0.187518174,0.32793002,325.6890163,0,-2.837869784,0.701428727,-4.045841974,5.21E-05,0.000749743,454.6369411,0,-1.546231047,0.442148642,-3.497084234,0.000470373,0.003972085,376.8984101,0,-1.293573563,0.616033857,-2.099841668,0.035742771,0.086145099,N,-,,elongation factor Tu,F:GTP binding; F:translation elongation factor activity; F:GTPase activity; C:mitochondrion; P:mitochondrial translational elongation,IPR000795 (PRINTS); IPR004541 (TIGRFAM); G3DSA:2.40.30.10 (GENE3D); IPR004161 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR004160 (PFAM); IPR005225 (TIGRFAM); PF00009 (PFAM); G3DSA:2.40.30.10 (GENE3D); PTHR23115 (PANTHER); PTHR23115:SF177 (PANTHER); IPR000795 (PROSITE_PROFILES); IPR004541 (HAMAP); IPR009001 (SUPERFAMILY); IPR009000 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_06879,4,4,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,377.0331218,0,-1.032029126,0.431494853,-2.391753041,0.016768121,0.057046934,83.76835741,0,-2.92283431,1.192658453,-2.450688461,0.01425833,0.044257227,240.2580265,0,-3.745637337,1.039161782,-3.604479497,0.000312779,0.002398921,352.4675618,0,-1.03798514,0.497545311,-2.086212285,0.036959398,0.102104749,306.4456419,0,-0.936558752,0.474631445,-1.973233677,0.048468945,0.109371088,N,-, Effector probability:0.799,40S ribosomal S29,P:positive regulation of macroautophagy; F:zinc ion binding; C:cytosolic small ribosomal subunit; P:negative regulation of septation initiation signaling; C:endoplasmic reticulum; C:Golgi trans cisterna; C:fungal-type vacuole; P:re-entry into mitotic cell cycle after pheromone arrest; P:translation; C:nuclear envelope; F:RNA binding; F:structural constituent of ribosome; P:asymmetric protein localization to old mitotic spindle pole body; P:intra-S DNA damage checkpoint; C:old mitotic spindle pole body,G3DSA:4.10.830.10 (GENE3D); IPR001209 (PFAM); PTHR12010:SF2 (PANTHER); PTHR12010 (PANTHER),,
RL4_JR_06880,5,2,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,326.2186532,0,1.824676483,0.38405761,4.751048891,2.02E-06,2.84E-05,119.2018885,0,1.524128603,0.761514782,2.001443229,0.045344646,0.109100786,310.8006047,0,1.947015882,0.366548939,5.311748788,1.09E-07,3.71E-06,222.8619144,0,1.287707593,0.506399286,2.54287008,0.01099461,0.052410747,111.2601127,0,0.229429225,0.682428025,0.336195491,0.736723453,0.815789213,Y,-,,disulfide-isomerase erp38,F:protein disulfide isomerase activity; C:integral component of membrane; C:endoplasmic reticulum; P:cell redox homeostasis; P:protein folding; P:response to endoplasmic reticulum stress,PR00421 (PRINTS); IPR012336 (G3DSA:3.40.30.GENE3D); IPR013766 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR011679 (PFAM); IPR005788 (TIGRFAM); IPR011679 (G3DSA:1.20.1150.GENE3D); PTHR18929:SF87 (PANTHER); PTHR18929 (PANTHER); IPR013766 (PROSITE_PROFILES); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY); IPR011679 (SUPERFAMILY),8.A.88.1.3, the calciquestrin (casq) family.
RL4_JR_06881,5,1,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.56485695,0,0.318609123,1.208485532,0.263643308,0.792054784,0.893347564,1.813144708,0,2.606980724,1.376475036,1.893954236,0.058231085,0.13326137,4.731928822,0,-0.053428144,1.245007842,-0.042913902,0.965770167,0.979803304,17.49608339,0,1.785248173,0.933423372,1.912581392,0.055801664,0.131149453,4.686752532,0,-0.142237135,1.253262052,-0.113493531,0.909639292,0.942016757,N,-,,heat shock factor-binding,,IPR009643 (PFAM),,
RL4_JR_06882,24,10,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46.52695502,0,-1.483400269,1.027401517,-1.443836945,0.148784847,0.295109842,48.51455451,0,2.58885675,0.768145267,3.370269739,0.000750946,0.015023052,66.53862372,0,0.490665285,0.686926099,0.714291225,0.475047117,0.611724372,74.02165209,0,0.245623413,0.637492948,0.38529589,0.700018206,0.797992089,73.30198425,0,0.882656566,0.582763359,1.514605462,0.129872348,0.232037679,Y,-,,ring finger ubiquitin ligase,F:catalytic activity; C:membrane,IPR001841 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR024766 (PFAM); PTHR22763:SF71 (PANTHER); PTHR22763 (PANTHER); PTHR22763 (PANTHER); PTHR22763:SF71 (PANTHER); PTHR22763:SF71 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),3.A.16.1.4, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_06883,4,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,151.1750986,0,0.406585985,0.857738514,0.474020903,0.635485001,0.791837971,22.34686799,0,-1.016494321,1.222107709,-0.831755101,0.405547192,0.569419986,66.06269294,0,-2.712650979,1.212789031,-2.236704744,0.025305644,0.067224964,139.751656,0,-0.011497304,0.548236444,-0.020971433,0.983268444,0.989523208,113.7051745,0,0.179968788,0.573226707,0.313957438,0.753553365,0.828237931,N,-,,phosphoglycolate phosphatase,P:metabolic process; F:hydrolase activity,IPR023214 (PFAM); IPR006439 (TIGRFAM); IPR023214 (G3DSA:3.40.50.GENE3D); PTHR18901 (PANTHER); PTHR18901:SF39 (PANTHER); IPR023214 (SUPERFAMILY),,
RL4_JR_06884,1,3,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.87451378,0,-2.091054126,1.22214548,-1.710969897,0.08708667,0.199789948,5.024063034,0,1.136568373,1.26691957,0.897111703,0.369659315,0.533973056,13.12067452,0,-1.5249084,1.216843817,-1.253166906,0.210144971,0.337806873,24.77690622,0,-0.995162878,1.168950958,-0.851329879,0.394586132,0.539161212,35.13226662,0,0.643591601,0.889061726,0.723899794,0.469127256,0.60049475,N,-,,tRNA A64-2 -O-ribosylphosphate transferase,F:transferase activity,IPR033449 (PFAM); IPR033421 (PFAM); IPR007306 (PIRSF); PTHR31811 (PANTHER); PTHR31811:SF0 (PANTHER); PTHR31811 (PANTHER); PTHR31811:SF0 (PANTHER),,
RL4_JR_06885,10,7,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.569568024,0,1.24733072,1.302495276,0.95764702,0.338240781,NA,0.501893678,0,4.460100259,1.540830236,2.894608474,0.003796317,0.01760253,1.300078908,0,1.810474419,1.221600073,1.482051662,0.138326549,0.246900209,1.499660811,0,1.388233173,1.240529966,1.119064603,0.26311258,0.403760968,1.279431669,0,1.730731818,1.206678641,1.434293904,0.151488409,0.260986923,N,-,,C6 zinc finger domain-containing,"C:nucleus; F:zinc ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR021858 (PFAM),,
RL4_JR_06886,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.21533007,0,1.382796162,0.854384664,1.618470252,0.105561293,0.230459138,2.287648924,0,2.271661501,1.297713388,1.750510954,0.080030186,0.170247587,5.939226288,0,-0.381220833,1.200753563,-0.317484657,0.75087588,0.833172666,6.852179216,0,-0.803665503,1.199243175,-0.670143904,0.502766059,0.63996725,5.855410451,0,-0.463429186,1.202531354,-0.385378048,0.699957344,0.787714584,N,-,,flavin-containing monoamine oxidase A,F:oxidoreductase activity; P:oxidation-reduction process,IPR001613 (PRINTS); G3DSA:1.10.405.10 (GENE3D); IPR002937 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR10742 (PANTHER); PTHR10742:SF281 (PANTHER); SSF54373 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_06887,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.649825844,0,-1.372688874,1.235906586,-1.110673646,0.26670885,0.446806076,3.059953078,0,1.852018966,1.311048119,1.412624707,0.1577661,0.287368808,7.956589112,0,-0.803084044,1.224575564,-0.655806034,0.511948934,0.643145417,9.181100394,0,-1.225767018,1.22657481,-0.999341424,0.317629325,0.463801113,7.848515486,0,-0.886104066,1.230163201,-0.720314236,0.471331542,0.602478457,N,-,,---NA---,,no IPS match,,
RL4_JR_06888,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,155.578637,0,0.520908687,0.438351972,1.188334308,0.234701726,0.408337957,21.48348602,0,-0.959617469,1.20636091,-0.795464658,0.426343261,0.589206035,55.69169154,0,-3.6103773,1.194933974,-3.021403173,0.002516061,0.011886421,96.34021097,0,-0.361314125,0.577420015,-0.625738831,0.531486259,0.66464374,77.96583686,0,-0.514822574,0.640223125,-0.804129925,0.421321943,0.557194968,N,-,,intracellular transport,P:biological_process; C:cellular_component; F:molecular_function,IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR18937:SF245 (PANTHER); PTHR18937:SF245 (PANTHER); PTHR18937 (PANTHER); PTHR18937:SF245 (PANTHER); PTHR18937 (PANTHER); PTHR18937 (PANTHER); PTHR18937:SF245 (PANTHER); PTHR18937:SF245 (PANTHER); PTHR18937 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_06889,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.206044853,0,-0.951606688,1.238833584,-0.768147313,0.442399671,0.632032937,2.275043428,0,2.279502753,1.325655054,1.719529334,0.085518031,0.17917895,5.94745776,0,-0.383469421,1.226318067,-0.312699806,0.754508743,0.835098559,6.864188726,0,-0.806431777,1.229083847,-0.656124299,0.511744151,0.64678686,5.91181808,0,-0.477325614,1.238378598,-0.385444011,0.699908481,0.787714584,N,-,,2-dehydropantoate 2-reductase family,F:oxidoreductase activity; C:intracellular part; P:single-organism metabolic process,IPR013328 (G3DSA:1.10.1040.GENE3D); IPR013752 (PFAM); IPR013332 (PFAM); IPR003710 (TIGRFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR21708 (PANTHER); PTHR21708:SF33 (PANTHER); IPR008927 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_06890,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,78.08205014,0,1.256556861,0.589876031,2.130204983,0.033154694,0.09778597,27.71565687,0,1.935150291,1.010334602,1.915355851,0.055447137,0.128194592,75.90875395,0,1.068115319,0.634899258,1.682338268,0.092503264,0.18269376,138.9464002,0,2.304279568,0.579801063,3.974258955,7.06E-05,0.000796074,53.68709945,0,1.132139012,0.595544711,1.9010143,0.05730014,0.124078014,N,-,,ammonium transporter,F:ammonium transmembrane transporter activity; P:ammonium transmembrane transport; C:integral component of membrane,IPR002229 (PRINTS); IPR024041 (PFAM); IPR001905 (TIGRFAM); IPR029020 (G3DSA:1.10.3430.GENE3D); IPR001905 (PANTHER); PTHR11730:SF17 (PANTHER); IPR024041 (SUPERFAMILY),1.A.11.3.3, the ammonium transporter channel (amt) family.
RL4_JR_06891,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.681832105,0,0.474624368,1.307938259,0.362879795,0.71669468,0.848021123,0.848259526,0,3.702908211,1.469644213,2.519595001,0.011748993,0.038015671,2.2102575,0,1.04484512,1.24736311,0.837643114,0.402231171,0.544337438,2.550693729,0,0.622001879,1.263489455,0.492288936,0.622515101,0.739784671,2.185650606,0,0.958436764,1.246613363,0.768832416,0.441992802,0.575733581,N,-,,DNA polymerase,F:DNA binding; P:DNA repair; C:nucleus; F:DNA-directed DNA polymerase activity; F:DNA polymerase activity; P:DNA biosynthetic process,IPR001357 (G3DSA:3.40.50.GENE3D); IPR001357 (SUPERFAMILY),,
RL4_JR_06892,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,207.414775,0,-2.646801167,0.810110946,-3.267208252,0.001086138,0.00629759,76.631133,0,-0.764854316,1.032284726,-0.740933482,0.458733773,0.617460539,151.6297698,0,-5.055425473,1.235123607,-4.093052261,4.26E-05,0.000634773,183.0560769,0,-3.78117299,1.083901606,-3.488483614,0.000485769,0.004088451,181.4837265,0,-1.823673917,0.736819251,-2.475062799,0.013321275,0.039564416,N,-,,serine threonine- kinase psk1,F:nucleotide binding; F:protein serine/threonine kinase activity; P:protein phosphorylation,IPR000961 (SMART); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24351 (PANTHER); IPR000961 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_06893,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44.5498822,0,-2.341930695,1.160723676,-2.017647045,0.043628034,0.120283034,11.5941226,0,-0.069865,1.222486229,-0.057149928,0.954425765,0.975729481,30.22022831,0,-2.728520214,1.203705973,-2.266766366,0.023404502,0.063068186,50.91751093,0,-0.456828433,0.77898791,-0.586438413,0.557580937,0.686383828,56.98346525,0,0.530743234,0.657036729,0.807783204,0.419215396,0.554843906,N,-,,U4 U6 small nuclear ribonucleo PRP4,"F:U6 snRNA binding; C:U4/U6 x U5 tri-snRNP complex; C:viral nucleocapsid; P:phosphorylation; F:kinase activity; F:U4 snRNA binding; P:mRNA splicing, via spliceosome",IPR020472 (PRINTS); IPR001680 (SMART); IPR014906 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR014906 (PFAM); IPR027106 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR014906 (SUPERFAMILY); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_06894,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,81.10671043,0,2.170331086,0.474432589,4.574582646,4.77E-06,6.04E-05,4.388910974,0,1.331656223,1.244813385,1.069763741,0.284725667,0.444272114,87.1228026,0,2.823574268,0.484191701,5.831521408,5.49E-09,2.46E-07,21.15277857,0,-0.013005098,1.009785854,-0.012879066,0.989724277,0.993657756,18.58249969,0,-0.467492911,1.119864847,-0.41745476,0.676345808,0.770044002,N,-,,Duf962 domain-containing,C:integral component of membrane; C:endoplasmic reticulum; P:sphingoid catabolic process,IPR009305 (PFAM); PTHR28026 (PANTHER); PTHR28026:SF4 (PANTHER),,
RL4_JR_06895,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34.02364574,0,-0.005671386,0.915415982,-0.006195419,0.995056802,0.997870116,5.819948753,0,0.924512838,1.27706468,0.723935798,0.469105152,0.627722748,15.14466527,0,-1.731712296,1.224324998,-1.414422068,0.157238014,0.271558795,25.49948289,0,-0.447964773,1.061972229,-0.421823435,0.673153899,0.777535616,14.94963791,0,-1.815769064,1.232341274,-1.473430374,0.140635025,0.246781565,N,-,,lysine decarboxylase,"F:hydrolase activity, hydrolyzing N-glycosyl compounds; P:cytokinin biosynthetic process; C:nucleus; C:cytosol",IPR005269 (TIGRFAM); G3DSA:3.40.50.450 (GENE3D); IPR031100 (PFAM); PTHR31223:SF11 (PANTHER); PTHR31223:SF11 (PANTHER); PTHR31223 (PANTHER); PTHR31223 (PANTHER); SSF102405 (SUPERFAMILY),,
RL4_JR_06896,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.012706323,0,8.20293094,3.990270723,2.055732934,0.039808266,NA,0.004020132,0,11.42967648,3.991033794,2.863838561,0.004185413,0.018371529,0.010357064,0,8.787173804,3.991470463,2.201487869,0.027701505,0.072039566,0.01195084,0,8.36455496,3.991447685,2.095619339,0.036115972,0.100959199,0.010019356,0,8.741909568,1.949319774,4.484594926,7.31E-06,7.74E-05,N,-,,---NA---,,no IPS match,,
RL4_JR_06897,5,4,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,65.87898064,0,2.098449357,0.483342637,4.34153579,1.41E-05,0.000156618,4.9319132,0,1.163359582,1.239131252,0.938850973,0.347807264,0.510564209,12.81088432,0,-1.4903311,1.192329749,-1.249931993,0.211324391,0.339271826,73.69937192,0,1.829039482,0.537063441,3.405630214,0.000660115,0.005234902,43.52602962,0,2.005411498,0.568080765,3.530152083,0.000415321,0.002319428,N,-,,proteasome subunit alpha type-1,"C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:proteasome core complex, alpha-subunit complex; F:threonine-type endopeptidase activity; C:proteasome storage granule; P:proteasomal ubiquitin-independent protein catabolic process",IPR000426 (SMART); IPR001353 (PFAM); IPR029055 (G3DSA:3.60.20.GENE3D); IPR000426 (PFAM); PTHR11599 (PANTHER); PTHR11599:SF12 (PANTHER); IPR023332 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY),,
RL4_JR_06898,1,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,131.3419243,0,1.272483007,0.46131405,2.758387711,0.005808726,0.024524381,11.53401243,0,-0.06234641,1.216385414,-0.051255474,0.959121948,0.978272787,36.4841661,0,-1.755476395,1.196189815,-1.467556715,0.142224673,0.251992053,53.8651886,0,-1.391623977,1.021360233,-1.362520228,0.173033765,0.296190511,37.01289611,0,-1.867258676,1.132565646,-1.648697966,0.099209527,0.189850021,N,-,,vacuolar sorting 55 superfamily,C:fungal-type vacuole membrane; C:late endosome; C:integral component of membrane; C:Vps55/Vps68 complex; C:Golgi apparatus; P:late endosome to vacuole transport via multivesicular body sorting pathway,IPR007262 (PFAM); IPR007262 (PANTHER); PTHR12050:SF0 (PANTHER); PS51257 (PROSITE_PROFILES),,
RL4_JR_06899,130,168,162,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,78.11289435,0,-0.512489155,0.695623086,-0.736733967,0.461284147,0.6494919,14.11316459,0,-0.353501558,1.21674337,-0.29053091,0.771410107,0.86142479,36.74275912,0,-3.010456987,1.201555764,-2.505465894,0.012229019,0.037791999,54.4288143,0,-1.142365524,0.878551439,-1.300283026,0.193503983,0.322839084,36.38696595,0,-3.099136521,1.209969723,-2.561333943,0.010427108,0.032474458,N,-,,aminodeoxychorismate synthase,F:oxo-acid-lyase activity; P:para-aminobenzoic acid biosynthetic process; F:4-amino-4-deoxychorismate synthase activity; P:biosynthetic process,PR00097 (PRINTS); IPR017926 (PFAM); IPR029062 (G3DSA:3.40.50.GENE3D); IPR006805 (PFAM); IPR005801 (G3DSA:3.60.120.GENE3D); IPR015890 (PFAM); IPR010117 (TIGRFAM); PTHR11236:SF18 (PANTHER); PTHR11236:SF18 (PANTHER); PTHR11236 (PANTHER); PTHR11236 (PANTHER); IPR017926 (PROSITE_PROFILES); IPR029062 (SUPERFAMILY); IPR005801 (SUPERFAMILY),,
RL4_JR_06900,1779,2120,3611,0,0,1,0,0,0,2,0,1,5,2,1,0,0,0,51.83175725,1,-2.740657041,1.151624754,-2.379817759,0.017321202,0.058463536,24.76436497,0,0.438072604,1.128913916,0.388047838,0.697980633,0.808347822,85.97090212,1,0.029916283,0.679588625,0.044021165,0.964887533,0.979398575,53.88642953,1,-1.824514834,1.025676818,-1.778839886,0.075266016,0.159228669,81.47452843,0,0.781077249,0.547780079,1.425895682,0.153898456,0.263837092,N,-,,hypercellular,C:intracellular membrane-bounded organelle; C:endomembrane system; C:cytoplasmic part; P:Golgi vesicle transport,IPR013935 (PFAM); PTHR21512:SF5 (PANTHER); IPR013935 (PANTHER),,
RL4_JR_06901,189,178,234,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,52.80186876,0,-0.822547855,0.874646934,-0.94043416,0.346994907,0.536539888,10.44446295,0,0.080811354,1.222706615,0.066092187,0.947304431,0.971687824,55.89862703,0,0.239798908,0.76029666,0.315401765,0.752456627,0.833942535,80.68898068,0,0.551803523,0.602966222,0.915148317,0.360113773,0.506168615,38.52354446,0,-0.476561729,0.875317747,-0.544444267,0.586135791,0.698766617,N,-,,glycosyl hydrolase family 31,"P:metabolic process; F:hydrolase activity, acting on glycosyl bonds",IPR010730 (PFAM); IPR025887 (PFAM); IPR007150 (PFAM); IPR000322 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR22762:SF7 (PANTHER); PTHR22762 (PANTHER); SSF57850 (SUPERFAMILY); IPR017853 (SUPERFAMILY); IPR011013 (SUPERFAMILY),,
RL4_JR_06902,7373,5440,6901,0,0,0,0,0,2,1,0,0,0,0,0,0,0,0,41.23467343,0,2.07832238,0.668231114,3.110184987,0.001869702,0.009898082,3.390673943,1,1.703847593,1.289881113,1.320933825,0.18652343,0.326544391,8.842164081,1,-0.95559195,1.217731729,-0.784731092,0.432611249,0.573191504,36.8507525,0,1.356088571,0.779747319,1.739138484,0.082010407,0.169116557,8.774022372,0,-1.047025318,1.228945307,-0.851970638,0.394230389,0.530866164,N,-, Effector probability:0.613,Electron transport complex subunit C,C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_06903,468,433,474,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,258.4017391,0,0.121922235,0.486595399,0.250561832,0.802152894,0.900058795,40.35710133,0,-1.869221204,1.248811778,-1.496799788,0.134445361,0.253559894,169.2910607,0,-0.682188819,0.638627598,-1.068210677,0.285425489,0.424698362,253.9092424,0,0.342589915,0.626114037,0.547168559,0.584262934,0.709753926,128.1074903,0,-1.27331611,0.728776735,-1.74719643,0.080603271,0.162087014,N,-,,Cytokinesis sepA,F:actin binding; F:Rho GTPase binding; P:actin cytoskeleton organization,IPR010472 (SMART); IPR010473 (SMART); IPR015425 (SMART); IPR015425 (PFAM); IPR010473 (PFAM); IPR010472 (PFAM); PTHR23213 (PANTHER); PTHR23213 (PANTHER); PTHR23213:SF258 (PANTHER); PTHR23213 (PANTHER); PTHR23213:SF258 (PANTHER); PTHR23213:SF258 (PANTHER); PTHR23213 (PANTHER); PTHR23213:SF258 (PANTHER); IPR015425 (PROSITE_PROFILES); IPR014767 (PROSITE_PROFILES); IPR014768 (PROSITE_PROFILES); SSF101447 (SUPERFAMILY); IPR016024 (SUPERFAMILY),1.A.14.3.14, the calcium transporter a (cata) (formerly the testis-enhanced gene transfer (tegt) family.
RL4_JR_06904,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.8954093,0,0.717257484,0.686726036,1.04445943,0.29627288,0.481856889,5.919516898,0,0.899996685,1.243078701,0.724006199,0.469061929,0.627722748,21.8752769,0,-0.791994764,1.198865624,-0.660620129,0.508855957,0.640379141,25.76223294,0,-0.454919544,1.027302145,-0.442829353,0.65788917,0.766715365,22.91382135,0,-0.176552254,0.993370875,-0.177730451,0.85893467,0.906284048,N,-,,multiple myeloma tumor-associated 2,P:phosphorylation; F:kinase activity,IPR019315 (PFAM); PTHR14580:SF0 (PANTHER); PTHR14580 (PANTHER),,
RL4_JR_06905,105,74,91,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.927502828,0,-0.670001641,1.204286241,-0.556347501,0.57797332,0.752971311,1.900268425,0,2.539321244,1.327163241,1.91334507,0.055703891,0.128641293,4.919029764,0,-0.109503988,1.207093864,-0.090717044,0.927717427,0.956881142,19.32050048,0,1.203032551,1.022445822,1.176622296,0.239346295,0.377387964,4.842000432,0,-0.189524132,1.206128838,-0.157134235,0.875139057,0.916625828,N,-,,hypothetical protein TGAM01_05092,,no IPS match,,
RL4_JR_06906,6360,4889,5622,0,0,2,0,0,0,0,0,0,0,7,0,0,0,0,1.786450093,1,1.060294959,1.378190267,0.769338592,0.441692333,NA,0.569424009,0,4.277799689,1.566767772,2.730334238,0.006327014,0.024095091,1.481706442,0,1.621191312,1.267683549,1.278861206,0.200945936,0.32638804,1.709441806,1,1.19890069,1.299403656,0.922654546,0.35618726,0.502283567,1.468156537,0,1.532041615,1.262813501,1.213197051,0.225054491,0.351864843,N,-,,---NA---,,no IPS match,,
RL4_JR_06907,2555,2323,2093,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.01654235,0,-1.563991684,1.257645156,-1.243587412,0.213651452,0.381894948,40.97866643,0,4.210187787,0.840952019,5.006454225,5.54E-07,5.06E-05,9.084734574,0,-0.994592944,1.241466639,-0.801143513,0.423048568,0.564362064,10.48680471,0,-1.417802661,1.246051274,-1.137836533,0.255188747,0.3947122,9.062221145,0,-1.093616516,1.258796621,-0.868779355,0.384967827,0.521026501,N,-,,Mediator of RNA polymerase II transcription subunit 6,C:core mediator complex; P:RNA polymerase II transcriptional preinitiation complex assembly; C:mediator complex; F:RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly; P:positive regulation of transcription from RNA polymerase II promoter,IPR007018 (PFAM); IPR007018 (PANTHER); PTHR13104:SF0 (PANTHER),,
RL4_JR_06908,466,327,246,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,125.4859524,0,-5.073712559,1.319160064,-3.84616901,0.000119979,0.000995053,39.17289645,0,-1.826288316,1.273146107,-1.434468759,0.151438538,0.278653495,103.1571779,0,-4.499719871,1.270740553,-3.541021698,0.000398581,0.002876145,123.1248811,0,-3.982251601,1.240017574,-3.211447712,0.00132068,0.009339603,103.2732286,0,-4.604101048,1.296261151,-3.551831391,0.00038256,0.002156692,N,-,,DEAH-box RNA helicase,F:organic cyclic compound binding; F:heterocyclic compound binding; F:hydrolase activity,IPR001650 (SMART); IPR014001 (SMART); IPR007502 (SMART); IPR011545 (PFAM); IPR001650 (PFAM); IPR007502 (PFAM); IPR011709 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR18934 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_06909,1,1,4,0,0,0,0,0,0,7,0,2,1,6,0,0,0,0,51.7088521,0,1.422155453,0.82063334,1.732997409,0.083096129,0.193581826,5.454339239,0,1.018009543,1.300665842,0.782683384,0.433813062,0.59520714,14.31073459,1,-1.650141089,1.244082588,-1.326391917,0.184709915,0.306106265,32.56570437,1,0.572123218,0.860969889,0.664510136,0.506363864,0.642402915,25.51729866,0,-0.069467347,1.051972743,-0.06603531,0.947349713,0.966188757,N,-,,proteasome assembly chaperone 3,C:proteasome complex,PTHR31051:SF1 (PANTHER); PTHR31051 (PANTHER),,
RL4_JR_06910,1015,976,1188,3,1,0,0,0,0,0,0,0,0,1,0,0,0,0,38.4719188,1,-0.778101078,1.130673162,-0.688175066,0.491342544,0.679154943,7.082226233,0,0.641238982,1.330754294,0.481861291,0.629904486,0.756782577,18.57349136,0,-2.026261246,1.27181307,-1.593206811,0.111113804,0.209841514,21.43769107,1,-2.449324475,1.281341641,-1.911531162,0.055936356,0.131283172,18.56465899,0,-2.128276832,1.295031207,-1.64341741,0.1002966,0.19156821,N,-,,---NA---,,no IPS match,,
RL4_JR_06911,402,437,480,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5224.424893,0,-2.21707037,1.352758655,-1.63892529,0.10122882,0.2236795,1534.65397,0,-3.846197825,1.622153591,-2.371044176,0.017737911,0.052329681,3655.496497,0,-8.681936415,1.790662124,-4.848450358,1.24E-06,3.27E-05,4225.022175,0,-7.307117317,1.565828589,-4.66661381,3.06E-06,4.95E-05,3512.911496,0,-7.767410396,1.86832067,-4.157428927,3.22E-05,0.000267113,N,-,,formate dehydrogenase,P:formate catabolic process; F:NAD binding; F:phosphoglycerate dehydrogenase activity; F:formate dehydrogenase (NAD+) activity; C:cytosol; P:oxidation-reduction process; P:serine family amino acid biosynthetic process,IPR016040 (G3DSA:3.40.50.GENE3D); IPR006139 (PFAM); IPR006140 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10996 (PANTHER); PTHR10996:SF163 (PANTHER); IPR033689 (HAMAP); SSF52283 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_06912,7,28,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,285.9034783,0,0.317562537,0.834563093,0.380513517,0.703564265,0.839727461,85.67642967,0,-0.205930677,1.004381452,-0.205032338,0.83754686,0.902934212,171.3955373,0,-0.711479831,0.586607603,-1.21287182,0.225178831,0.355482689,361.237646,0,0.912497354,0.380505173,2.39812076,0.016479431,0.069610783,137.7488261,0,-1.037123724,0.601319897,-1.724745397,0.084573366,0.168299003,N,-,,copii coat assembly sec16,C:intracellular membrane-bounded organelle; C:membrane; C:endomembrane system; C:cytoplasmic part; C:intracellular organelle part; P:transport,IPR024298 (PFAM); IPR024468 (PFAM); IPR024340 (PFAM); IPR024880 (PANTHER); PTHR13402:SF6 (PANTHER); IPR024880 (PANTHER); IPR024880 (PANTHER); PTHR13402:SF6 (PANTHER),,
RL4_JR_06913,1306,642,1231,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.675766863,1,2.46304276,1.705386091,1.444272809,0.148662251,NA,0.216349738,0,5.674118779,1.793336212,3.164001676,0.001556159,0.015023052,0.560143824,0,3.025113882,1.256829031,2.406941444,0.016086749,0.04707708,0.646103615,0,2.602962533,1.342452702,1.938960329,0.052506169,0.126216752,0.551121772,0,2.945543064,1.220947659,2.412505601,0.015843294,0.045365767,N,-,,---NA---,,no IPS match,,
RL4_JR_06914,1032,1026,1051,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,90.90279981,0,0.672041622,0.544846124,1.233452147,0.21740712,0.385308794,13.05355756,0,-0.24080869,1.236223835,-0.194793761,0.845554407,0.907796108,60.97325668,1,-0.071283286,0.768762433,-0.092724727,0.926122253,0.956161556,186.0338158,0,1.787679105,0.725003148,2.465753575,0.013672536,0.062133944,63.79285704,0,0.602194413,0.596287212,1.009906637,0.312540022,0.447971082,N,-,,phospholipid-translocating P-type ATPase,F:magnesium ion binding; F:ATP binding; P:vesicle-mediated transport; P:phospholipid translocation; C:integral component of membrane; C:Golgi apparatus part; F:phospholipid-translocating ATPase activity,PR00119 (PRINTS); IPR023214 (G3DSA:3.40.50.GENE3D); IPR032630 (PFAM); IPR032631 (PFAM); IPR001757 (TIGRFAM); IPR008250 (G3DSA:2.70.150.GENE3D); PF00702 (PFAM); IPR006539 (TIGRFAM); IPR023299 (G3DSA:3.40.1110.GENE3D); PTHR24092:SF5 (PANTHER); PTHR24092:SF5 (PANTHER); IPR006539 (PANTHER); IPR006539 (PANTHER); IPR023214 (SUPERFAMILY); IPR023299 (SUPERFAMILY); SSF81653 (SUPERFAMILY); SSF81665 (SUPERFAMILY),3.A.3.8.18, the p-type atpase (p-atpase) superfamily.
RL4_JR_06915,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28.99731883,0,-0.28436018,1.020011914,-0.278781234,0.780412717,0.887208326,4.804069195,0,1.201196701,1.247508068,0.9628769,0.335609303,0.498757505,26.84538579,0,0.365859856,1.039314437,0.352020373,0.724822984,0.813670603,14.42690864,0,-1.878004315,1.198977063,-1.566338817,0.117269318,0.22032879,19.7400792,0,-0.60604868,1.13620806,-0.533395864,0.59375958,0.705115617,N,-,,cytochrome c mitochondrial import factor,P:cytochrome c-heme linkage; F:oxidoreductase activity; C:mitochondrion; C:membrane; C:integral component of membrane; P:oxidation-reduction process; C:extrinsic component of mitochondrial inner membrane; P:mitochondrial membrane organization,IPR001834 (PRINTS); G3DSA:3.40.50.80 (GENE3D); IPR008333 (PFAM); G3DSA:2.40.30.10 (GENE3D); PTHR19370 (PANTHER); PTHR19370 (PANTHER); PTHR19370:SF88 (PANTHER); PTHR19370:SF88 (PANTHER); PTHR19370 (PANTHER); PTHR19370:SF88 (PANTHER); PTHR19370:SF88 (PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY); IPR017938 (SUPERFAMILY),,
RL4_JR_06916,2588,2190,3571,4,0,7,0,0,0,7,0,0,0,11,0,0,8,1,16.63283321,1,1.802503801,0.899551634,2.003780254,0.045093605,0.123158229,1.639234169,0,2.752371763,1.349475083,2.039586946,0.041391483,0.101888277,4.278265939,1,0.091689846,1.222533622,0.074999856,0.940214826,0.964508552,33.19694632,1,2.023454264,0.872806865,2.318329913,0.020431398,0.077565768,11.96767084,1,1.65424013,1.018477383,1.624228635,0.104327022,0.19710974,N,-,,FMI1 partial,,IPR009737 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR31902 (PANTHER); IPR030108 (PTHR31902:PANTHER); IPR030108 (PTHR31902:PANTHER); PTHR31902 (PANTHER); IPR012336 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_06917,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,106.8919341,0,-0.513914836,0.712848932,-0.72093092,0.470952018,0.659915246,27.29704652,0,0.21704828,1.143194377,0.189861221,0.849417881,0.910253245,53.38130501,0,-2.400222854,1.219733006,-1.967826437,0.049088011,0.111532106,100.0310952,0,-0.430536641,0.676908961,-0.636033301,0.524754717,0.659035166,65.93006388,0,-0.594382403,0.779847073,-0.762178154,0.445953683,0.578511344,N,-,,amino acid permease,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PFAM); PTHR11785:SF72 (PANTHER); IPR002293 (PANTHER); PTHR11785:SF72 (PANTHER),2.A.3.8.29, the amino acid-polyamine-organocation (apc) family.
RL4_JR_06918,11,4,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22.91745487,0,-0.326597755,1.057211035,-0.308923899,0.757379416,0.872574676,32.97289041,0,3.351700115,0.896132224,3.740184793,0.000183885,0.008022776,12.59952718,0,-1.466295786,1.216767206,-1.205075036,0.228174336,0.359035899,32.19815798,0,0.417609339,0.889585129,0.469442806,0.638753157,0.752394531,12.45701868,0,-1.552607449,1.225128009,-1.267302223,0.205047246,0.327580717,N,-,,kinase-like domain,F:catalytic activity,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); IPR011009 (SUPERFAMILY),,
RL4_JR_06919,66,116,126,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,5.502459564,0,-0.562654455,1.203990684,-0.467324592,0.640267665,0.795507708,1.756094943,0,2.653107588,1.325923975,2.000950008,0.045397778,0.109142431,4.558972464,0,5.54E-05,1.204545516,4.60E-05,0.999963278,0.999963278,24.52988995,1,1.322555517,1.017230459,1.30015328,0.19354844,0.322839084,35.38485206,0,3.480965499,0.586668018,5.933450251,2.97E-09,1.56E-07,N,-,,leucyl-tRNA synthetase,F:nucleotide binding; P:leucyl-tRNA aminoacylation; F:leucine-tRNA ligase activity; C:mitochondrion; C:cytosol,IPR002302 (PRINTS); IPR009080 (G3DSA:1.10.730.GENE3D); IPR002300 (PFAM); IPR014729 (G3DSA:3.40.50.GENE3D); IPR002302 (TIGRFAM); IPR009008 (G3DSA:3.90.740.GENE3D); IPR013155 (PFAM); IPR025709 (PFAM); IPR015413 (PFAM); PTHR11946 (PANTHER); IPR002302 (PTHR11946:PANTHER); IPR002302 (PTHR11946:PANTHER); IPR002302 (PTHR11946:PANTHER); PTHR11946 (PANTHER); IPR002302 (PTHR11946:PANTHER); PTHR11946 (PANTHER); PTHR11946 (PANTHER); IPR002302 (HAMAP); SSF52374 (SUPERFAMILY); IPR009008 (SUPERFAMILY); IPR009080 (SUPERFAMILY),,
RL4_JR_06920,740,791,1544,0,0,0,0,0,0,0,3,5,3,5,0,0,4,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,hypothetical protein COLAER_00127,,no IPS match,,
RL4_JR_06921,2558,4885,2770,4,0,5,0,0,0,0,0,0,3,14,0,0,7,0,37.54201959,1,1.448595044,0.933425376,1.551913073,0.120683024,0.253591646,2.313711424,0,2.255227511,1.346573435,1.674789842,0.093975473,0.193023485,13.89347136,0,0.553649686,1.2300729,0.45009502,0.652641928,0.759028935,16.61901174,1,0.123474331,1.187341151,0.103992295,0.917175463,0.950015505,6.009460755,1,-0.500925628,1.252109642,-0.400065307,0.689108416,0.779643933,N,-,,family methyltransferase,P:metabolic process; F:methyltransferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); IPR025714 (PFAM); G3DSA:1.10.8.10 (GENE3D); PTHR18895:SF74 (PANTHER); PTHR18895 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_06922,220,194,156,0,0,0,0,0,0,0,0,1,0,0,0,0,6,0,18.82456122,0,1.278720764,0.926820615,1.379685285,0.167683566,0.319692108,24.65113214,0,3.170590173,1.146848778,2.7646105,0.00569908,0.022411068,6.101604185,1,-0.420427198,1.233847516,-0.340744859,0.733295665,0.820318819,7.040585837,0,-0.843083445,1.237435405,-0.681315115,0.495672121,0.634304217,20.78989012,1,1.201021982,1.02312073,1.173880997,0.240442695,0.369645048,N,-,,hypothetical protein CMQ_1370,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_06923,5,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.14671911,0,-1.061576599,1.192597721,-0.890138041,0.373391769,0.565774526,4.750873156,0,1.21722056,1.288001392,0.945045998,0.344635393,0.508068665,23.51332868,0,-0.486640895,1.225963169,-0.396945771,0.691407451,0.788840091,18.37430849,0,-0.92714147,1.186262819,-0.781564974,0.434470278,0.576541489,27.83924056,0,1.003501336,0.85634066,1.171848287,0.241257972,0.370560826,N,-,,transport sec22,"P:ER to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to ER; C:ER to Golgi transport vesicle membrane; C:integral component of membrane; F:SNAP receptor activity; C:SNARE complex; C:endoplasmic reticulum; C:Golgi apparatus; P:vesicle fusion with Golgi apparatus",IPR010908 (SMART); IPR001388 (PFAM); IPR010908 (G3DSA:3.30.450.GENE3D); G3DSA:1.20.5.110 (GENE3D); IPR010908 (PFAM); PTHR21136 (PANTHER); PTHR21136:SF69 (PANTHER); IPR010908 (PROSITE_PROFILES); IPR001388 (PROSITE_PROFILES); IPR011012 (SUPERFAMILY); SSF58038 (SUPERFAMILY),1.F.1.1.2, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_06924,4,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.80310094,0,0.587009202,1.147856025,0.511396194,0.60907366,0.775199598,1.524296215,0,2.857331503,1.336989121,2.137138933,0.032586693,0.084380278,3.963323623,0,0.202134766,1.204259611,0.167849826,0.866701423,0.915356338,16.60756833,0,2.080995198,0.859835486,2.420224836,0.015510913,0.066517576,3.915965833,0,0.1169516,1.207338164,0.09686731,0.92283177,0.950332757,N,-,,proline-rich early nodulin,,IPR028020 (PFAM),,
RL4_JR_06925,16,10,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.29864695,0,2.210209286,1.022146448,2.162321546,0.0305934,0.09185902,0.848331965,0,3.702842234,1.430728843,2.588081068,0.009651226,0.032836878,47.69197123,0,4.664993678,0.586248458,7.957366227,1.76E-15,1.85E-13,6.550617393,0,1.575444941,1.152860824,1.366552587,0.171765587,0.294417906,2.168116041,0,0.970015716,1.207647937,0.803227237,0.421843405,0.557598587,N,-,,proteasome component region PCI domain-containing,,no IPS match,,
RL4_JR_06926,43,28,55,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,27.8050737,0,2.301015185,0.84261713,2.73079564,0.006318164,0.026311168,1.205194287,0,3.196249259,1.367442152,2.337392667,0.019418776,0.056193705,3.125915824,0,0.54461102,1.202631383,0.4528495,0.650657117,0.757329576,3.606030681,1,0.122309289,1.202828122,0.10168476,0.919006899,0.951231329,3.081189077,0,0.462739215,1.200357477,0.385501172,0.699866138,0.787714584,N,-,,---NA---,,no IPS match,,
RL4_JR_06927,168,167,264,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.461250034,0,0.598541739,1.324731037,0.45182133,0.651397702,0.802855787,0.78122784,0,3.821749201,1.495127606,2.556135801,0.01058418,0.03510258,2.029245953,0,1.168324953,1.253320879,0.932183428,0.351241738,0.494771595,2.341439291,0,0.745654349,1.27250712,0.585972634,0.557893905,0.686685605,20.59032277,0,3.318431289,0.892455405,3.718316085,0.000200555,0.001248077,N,-,,kinase-like domain,F:ATP binding; C:membrane; C:integral component of membrane; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,G3DSA:3.90.1200.10 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR011009 (SUPERFAMILY),,
RL4_JR_06928,641,495,813,0,0,4,0,0,0,0,0,0,0,3,0,0,1,0,36.75010164,1,0.722701183,0.767450529,0.941690905,0.346350913,0.535848805,5.585364355,0,0.98377251,1.270497555,0.774320663,0.438741187,0.600126797,22.43904664,0,-0.716850411,1.219299896,-0.587919685,0.556586203,0.683145878,60.9721733,1,1.861237159,0.692784643,2.686602798,0.007218273,0.037460286,18.37574906,1,-0.84643881,1.167681326,-0.724888539,0.468520413,0.599945514,N,-,,hypothetical protein SPI_01832,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_06929,69,41,65,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.307317147,0,-0.971495497,1.204822223,-0.806339291,0.420047241,0.611598139,2.325099892,0,2.248230114,1.298064335,1.731986662,0.083275937,0.175534993,6.038668569,0,-0.405182639,1.202438861,-0.336967352,0.736141511,0.82249578,10.97868013,0,0.119072934,1.150536762,0.103493376,0.917571406,0.950144337,13.67641234,0,1.177085148,0.986934304,1.192668188,0.232999349,0.360776634,N,-,,hypothetical protein SPI_01833,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_06930,610,381,673,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,329.746669,0,7.621873222,1.249446252,6.100200959,1.06E-09,2.89E-08,0.537304199,0,4.36157212,1.560928316,2.794216798,0.005202559,0.021136905,1.404025143,0,1.699199711,1.259845753,1.348736309,0.177421679,0.297191363,5.63207064,0,2.220312615,1.19167758,1.863182334,0.062436617,0.139909847,24.20135942,0,4.511826369,0.754374618,5.980883053,2.22E-09,1.22E-07,Y,-,,small secreted,,PTHR38849 (PANTHER),,
RL4_JR_06931,594,641,880,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,5.094189293,0,-0.451371592,1.244124211,-0.362802675,0.716752293,0.848021123,1.614013611,0,2.774731155,1.36072704,2.039153389,0.041434721,0.101969912,4.212735962,0,0.113929998,1.228787011,0.09271745,0.926128034,0.956161556,14.49668389,1,0.643863262,1.171077545,0.549804123,0.582453731,0.708134489,4.183738987,0,0.021438618,1.238116002,0.017315516,0.986184907,0.990587519,N,-,,heterokaryon incompatibility,C:nucleus; C:membrane; C:integral component of membrane,PTHR33112 (PANTHER); PTHR33112:SF6 (PANTHER),,
RL4_JR_06932,145,152,200,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29.64362762,0,-0.838393018,1.021372604,-0.82084933,0.411732096,0.602967694,16.39045951,0,1.571853062,1.126510764,1.395328933,0.162916671,0.294787727,18.22581742,0,-1.999025192,1.198152451,-1.668423072,0.095231771,0.186991166,30.33939271,0,-1.471165087,1.149459431,-1.279875607,0.200588888,0.331585713,18.01730534,0,-2.08510636,1.20536736,-1.729851354,0.083656836,0.167019839,Y,-,,hypothetical protein SPI_04303,,IPR003615 (PFAM),,
RL4_JR_06933,1331,1210,1959,0,0,3,0,0,0,0,0,3,0,1,0,0,0,0,0.781089812,1,2.254244064,1.648055277,1.367820664,0.171368218,NA,0.248332306,0,5.475208465,1.760674569,3.109722013,0.001872635,0.015023052,0.644898197,1,2.822249284,1.267752691,2.226182838,0.026001937,0.068642402,10.05633573,1,3.351915249,1.163951568,2.879772098,0.003979627,0.023385796,0.635572649,0,2.740851727,1.237144022,2.215466978,0.026728029,0.068930537,Y,-,,lipase 1 precursor,P:lipid catabolic process; F:triglyceride lipase activity; C:cellular_component; F:hydrolase activity,IPR005152 (PFAM); IPR005152 (PIRSF); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR34853 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_06934,604,285,960,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.047427184,0,6.295229349,3.929195975,1.602167311,0.109118617,NA,0.015362424,0,9.490051181,3.077312212,3.083876619,0.002043223,0.015023052,0.039575248,0,6.846862609,1.770221938,3.867798981,0.000109822,0.001229911,0.045627439,0,6.426359845,3.189603331,2.014783401,0.043927349,0.113902079,0.038830934,0,6.766635627,1.37724688,4.913160976,8.96E-07,1.32E-05,N,-, Effector probability:0.667,hypothetical protein V496_05717,,no IPS match,,
RL4_JR_06935,4947,2827,4160,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1.31535896,0,1.502438613,1.432066906,1.049139957,0.294113708,NA,0.417827215,0,4.724586408,1.621556028,2.913612805,0.003572727,0.016958421,1.085165805,0,2.071461677,1.259788723,1.64429292,0.100115711,0.194170778,1.252080111,1,1.648758636,1.300584671,1.267705727,0.204903059,0.336738106,1.069108625,0,1.990344205,1.242777366,1.601529171,0.109259764,0.204086097,N,-,,alpha-ketoglutarate-dependent sulfonate,F:dioxygenase activity; P:oxidation-reduction process,IPR003819 (PFAM); G3DSA:3.60.130.10 (GENE3D); PTHR30468 (PANTHER); PTHR30468:SF2 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_06936,5010,3276,4312,0,0,4,0,0,0,0,0,0,2,2,0,0,0,0,17.26197876,1,-2.211888232,1.190264097,-1.85831719,0.063123984,0.158402172,5.494796733,0,1.007420948,1.233221469,0.816901889,0.413984498,0.577820062,14.28022717,0,-1.647040152,1.19212874,-1.381595877,0.167095821,0.284267869,34.13409522,1,0.243527285,0.850619856,0.286293911,0.774653022,0.854024591,14.10438408,0,-1.731828698,1.198132034,-1.44544061,0.148334164,0.25694907,N,-,,vitamin h transporter,P:transmembrane transport; C:integral component of membrane,IPR019519 (PFAM); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF242 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_06937,308,716,397,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.043876557,0,6.407820903,3.931011013,1.630069436,0.103086823,NA,0.014199646,0,9.60413278,3.08267072,3.115523406,0.001836188,0.015023052,0.036525337,0,6.964420449,1.74610146,3.988554278,6.65E-05,0.000893778,0.042111731,0,6.542425881,3.241893537,2.018087826,0.043582115,0.113446415,0.035715309,0,6.889310002,1.362720129,5.055557525,4.29E-07,7.01E-06,,,,,,,,
RL4_JR_06938,23,13,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.510375398,0,2.867954652,1.978171261,1.449800989,0.147114024,NA,0.161689178,0,6.093993477,1.907388297,3.194941213,0.001398593,0.015023052,0.42179693,0,3.433478555,1.294297193,2.652774473,0.007983319,0.027315781,0.486742825,0,3.011213106,1.438316942,2.093567153,0.036298556,0.1010789,0.418437968,0,3.343508084,1.253591097,2.667144088,0.007649887,0.025356047,N,-, Effector probability:0.73,DOC family,P:phosphorylation; F:kinase activity,IPR006440 (TIGRFAM); IPR003812 (PFAM); IPR003812 (G3DSA:1.10.3290.GENE3D); PTHR39426:SF1 (PANTHER); PTHR39426 (PANTHER); IPR003812 (PROSITE_PROFILES); IPR003812 (SUPERFAMILY),,
RL4_JR_06939,221,125,173,0,0,3,0,0,0,0,0,0,0,0,0,0,3,0,50.83069064,1,-0.138546016,0.756832948,-0.183060233,0.854750758,0.92758379,8.687782427,0,0.346506607,1.23240252,0.2811635,0.778584998,0.866026083,22.53678389,0,-2.30529152,1.200488192,-1.920295039,0.054820643,0.12131239,34.02022564,0,-1.007072916,1.029027427,-0.978664795,0.327745632,0.474535182,22.23861316,1,-2.388807423,1.205653191,-1.98133878,0.047553294,0.107793949,N,-,,u4 tri-snrnp-associated,C:nucleus,IPR013957 (PFAM); PTHR31077 (PANTHER),,
RL4_JR_06940,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30.17963016,0,-1.878555309,1.198015359,-1.568056114,0.116868037,0.247831933,170.3065011,0,4.031052382,0.660196614,6.105836198,1.02E-09,1.78E-07,220.2975375,0,3.15940699,1.327382034,2.380179111,0.017304225,0.050025121,109.3392099,0,1.827372429,1.696798188,1.076953312,0.281501124,0.425080232,44.49674489,0,0.779952328,0.737590009,1.057433423,0.290313825,0.424956986,Y,-,,integral membrane,C:membrane,IPR005018 (SMART); IPR015920 (G3DSA:2.60.40.GENE3D); IPR015920 (PFAM); PTHR23130 (PANTHER); PTHR23130:SF61 (PANTHER); IPR005018 (PROSITE_PROFILES); SSF49344 (SUPERFAMILY),5.B.2.3.1, the eukaryotic cytochrome b561 (cytb561) family.
RL4_JR_06941,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,369.8049017,0,-0.07329343,0.842408374,-0.087004631,0.930667831,0.966567557,186.6721497,0,0.158312621,0.753784587,0.210023691,0.833649183,0.900418847,355.7960902,0,0.342734604,0.404647362,0.846995768,0.39699748,0.539356369,347.5292811,0,-0.03411262,0.487552582,-0.069967058,0.944219879,0.967373791,288.0102008,0,-0.075675547,0.433561655,-0.174543911,0.861438024,0.907870562,N,-,,atp synthase h chain,,IPR019711 (PFAM); PTHR28207:SF1 (PANTHER); PTHR28207 (PANTHER),3.A.2.1.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_06942,717,1004,860,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,147.7426172,1,-1.600363602,0.656435816,-2.437958993,0.014770449,0.051938503,36.21834511,0,-1.713115794,1.220614388,-1.403486483,0.16047182,0.291196802,147.9617933,0,-0.732108201,0.612918748,-1.194462077,0.232297267,0.363714434,235.2366505,0,0.348901637,0.466836218,0.747374825,0.454837338,0.59702013,132.4493001,0,-0.987521716,0.61146928,-1.614998085,0.10631111,0.200036386,N,-,,serine threonine- kinase sck1,P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:regulation of protein localization; C:fungal-type vacuole membrane; P:regulation of sphingolipid biosynthetic process; F:protein serine/threonine kinase activity; P:replicative cell aging; P:age-dependent response to oxidative stress involved in chronological cell aging; P:positive regulation of transcription from RNA polymerase III promoter; P:positive regulation of ribosomal protein gene transcription from RNA polymerase II promoter; P:positive regulation of transcription from RNA polymerase I promoter; P:regulation of response to osmotic stress; C:nucleus; F:ATP binding; P:peptidyl-serine phosphorylation; P:intracellular signal transduction,no IPS match,,
RL4_JR_06943,6,14,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,226.1943401,0,-2.259210612,0.683205908,-3.306778507,0.000943755,0.005677841,59.06057225,0,-2.418594722,1.229594748,-1.966985242,0.049184912,0.116292848,180.4979195,0,-2.245153189,0.791670286,-2.835970009,0.004568674,0.017735142,263.8236182,0,-1.174731965,0.595935794,-1.971239145,0.048696528,0.120875791,199.8486239,0,-1.480611096,1.525265818,-0.970723318,0.331686077,0.468319834,N,-,,serine threonine- kinase sck1,"F:nucleotide binding; C:cytoplasm; P:positive regulation of transcription, DNA-templated; C:intracellular membrane-bounded organelle; P:cellular response to oxidative stress; F:protein kinase activity; P:phosphorylation; P:cell aging; P:regulation of transcription from RNA polymerase II promoter",IPR000008 (SMART); IPR000008 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR000008 (SUPERFAMILY),,
RL4_JR_06944,37,27,36,0,0,0,0,0,3,0,0,0,3,0,0,0,0,0,17.10357778,0,0.04767258,1.278569178,0.037285882,0.970257062,0.984504494,2.304282981,1,2.261301392,1.485201987,1.522554785,0.127870129,0.244438423,47.51098389,0,2.784858013,0.831849639,3.347790133,0.000814587,0.00488559,16.08220902,1,0.177250043,1.263626348,0.14027093,0.888445932,0.931630491,5.684389657,0,-0.420864075,1.315355955,-0.319962117,0.748997049,0.825118199,N,-,,hypothetical protein CMQ_587,,no IPS match,,
RL4_JR_06945,17901,21620,12348,0,0,12,0,0,0,0,2,1,0,4,2,0,0,0,25.55209458,1,-1.1022736,1.170096979,-0.942036105,0.346174155,0.535778554,4.912981795,0,1.168919954,1.267214902,0.922432298,0.356303129,0.520568746,12.77655282,1,-1.486397264,1.21254817,-1.225845951,0.220256652,0.349620311,18.75423246,1,-0.963330296,1.165507475,-0.826532919,0.408501852,0.552205823,12.60948147,0,-1.570153563,1.218712023,-1.288371274,0.197616753,0.319067075,N,-,,hypothetical protein CMQ_1080,,no IPS match,,
RL4_JR_06946,3541,4099,5018,0,0,0,0,0,0,1,0,0,5,1,0,0,0,3,20.64417002,0,-2.470135173,1.188548676,-2.078278511,0.037683715,0.107866361,6.597620977,0,0.743558599,1.231571331,0.603747895,0.546011266,0.692398651,17.11062915,1,-1.907913828,1.19315229,-1.599053067,0.109808812,0.207872926,19.73800125,1,-2.33017649,1.191433172,-1.955776072,0.050491539,0.123963829,16.87232957,1,-1.990400211,1.196904561,-1.662956492,0.096321145,0.18554773,N,-,,hypothetical protein SPI_00286,,no IPS match,,
RL4_JR_06947,31097,35005,34645,66,144,201,20,1,31,48,2,22,9,25,10,0,38,3,134.9867397,1,-2.173168543,0.781133046,-2.782072216,0.005401302,0.023142763,35.33064564,1,-1.677364073,1.206206875,-1.390610605,0.164343539,0.296838919,115.6184701,1,-1.926449924,0.872087683,-2.209009439,0.027173984,0.071032641,153.7920661,1,-1.636460871,0.700094676,-2.337485094,0.019413975,0.075748169,95.16459911,1,-3.49800545,1.146538826,-3.050926293,0.002281366,0.00949397,N,-,,cytosolic fe-s cluster assembly factor nar-1,C:intracellular part,IPR004108 (PFAM); G3DSA:3.40.50.1780 (GENE3D); PTHR11615 (PANTHER); PTHR11615 (PANTHER); PTHR11615:SF6 (PANTHER); PTHR11615:SF6 (PANTHER); IPR009016 (SUPERFAMILY),,
RL4_JR_06948,19,2,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.953432833,0,-1.417734258,1.208850421,-1.172795437,0.240877848,0.415626372,3.181903906,0,1.795588394,1.289559361,1.392404606,0.16379991,0.296174115,21.25394312,0,0.959150498,1.049967798,0.913504681,0.360977173,0.504909215,17.54740921,0,0.438165116,1.036980828,0.422539264,0.672631448,0.777330003,37.61311127,0,1.728507683,0.776304306,2.226585205,0.025975009,0.067366025,N,-,,hypothetical protein CMQ_832,,PTHR39605 (PANTHER),,
RL4_JR_06949,25,37,45,0,0,0,3,0,0,5,1,0,21,140,17,0,98,18,171.4266205,0,0.933564619,0.391529335,2.384405297,0.01710675,0.057883397,19.48426051,1,-0.818737208,1.196457247,-0.684301266,0.493784948,0.649100136,69.51883166,1,-1.645784043,1.02796073,-1.601018399,0.109372844,0.207280171,71.70738592,1,-2.160501231,1.011251626,-2.136462554,0.03264173,0.096778189,68.54458704,1,-1.334595321,0.841466527,-1.58603495,0.112731381,0.20893378,N,-,,zinc finger,C:intracellular part,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR19818 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_06950,34,26,48,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,160.9691679,0,0.015498452,0.41976278,0.03692193,0.970547254,0.984504494,27.02001577,0,-1.290442767,1.195606658,-1.079320493,0.28044488,0.439310715,100.1013088,0,-1.119385798,0.738664429,-1.515418577,0.129666436,0.23551184,92.86942293,0,-2.058218775,0.85096383,-2.418691256,0.015576455,0.066742109,80.30583452,0,-2.346855213,0.970788998,-2.417471991,0.015628737,0.044865597,N,-,,ran GTPase activating 1,"C:chromosome, telomeric region; C:nucleus; P:rRNA export from nucleus; P:ribosomal subunit export from nucleus; P:RNA import into nucleus; P:rRNA metabolic process; P:protein import into nucleus; F:GTPase activator activity; C:cytosol; P:tRNA metabolic process; P:chromatin silencing at telomere; P:positive regulation of GTPase activity",SM00368 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); IPR001611 (PFAM); IPR027038 (PANTHER); SSF52047 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_06951,1362,1234,1183,0,0,2,0,0,0,0,0,0,0,2,0,0,1,0,404.6021493,1,-0.020983861,1.155465781,-0.018160521,0.985510797,0.992445017,143.2214021,0,-0.428527169,1.503719365,-0.284978154,0.775660879,0.864102951,555.1694195,0,1.216132067,0.823153318,1.477406505,0.139566703,0.248544117,262.0595744,1,-1.758815572,0.909603141,-1.933607628,0.053161389,0.126947892,365.6260534,1,0.435005439,0.832508932,0.52252345,0.601305924,0.710493929,N,-,,hypothetical protein CMQ_364,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_06952,8036,9075,5579,0,0,4,0,0,0,0,0,0,0,9,0,1,0,8,18.77877435,1,-0.580954777,1.144186647,-0.507744762,0.611632352,0.776912733,3.444377838,0,1.681328334,1.269669851,1.324224824,0.185428389,0.325217015,21.91243526,0,0.852411011,1.034898418,0.823666358,0.41012916,0.552367649,18.30654515,1,0.336128542,1.018063868,0.330164494,0.741275674,0.827955455,12.62170032,1,-0.114622758,1.122698007,-0.102095806,0.91868063,0.948082905,Y,-,,chitinase 1,F:chitinase activity; P:carbohydrate metabolic process; F:chitin binding; P:chitin catabolic process; C:extracellular region,IPR011583 (SMART); IPR013781 (G3DSA:3.20.20.GENE3D); IPR001223 (PFAM); IPR029070 (G3DSA:3.10.50.GENE3D); PTHR11177:SF222 (PANTHER); PTHR11177 (PANTHER); PTHR11177 (PANTHER); PTHR11177:SF222 (PANTHER); IPR017853 (SUPERFAMILY); IPR029070 (SUPERFAMILY),9.B.29.2.7, the small 4-5 tms putative permease (4-5pp) family.
RL4_JR_06953,5080,6393,4021,0,2,0,0,0,0,0,0,0,6,2,2,0,0,0,15.68482442,1,5.883606074,0.771932282,7.621919964,2.50E-14,1.49E-12,0.13162941,0,6.390967581,1.984079815,3.221124237,0.001276888,0.015023052,0.340739724,0,3.741881451,1.297345761,2.884259203,0.003923357,0.016218891,31.69834468,1,6.368445316,0.692688911,9.193802896,3.79E-20,3.73E-18,19.63808174,0,6.572481026,0.716345637,9.17501369,4.52E-20,1.06E-17,Y,-,,---NA---,,no IPS match,,
RL4_JR_06954,5,1,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,85.25969002,0,1.526351851,1.087910995,1.403011697,0.160613351,0.310346688,6.758756024,0,0.708767377,1.223722466,0.579189643,0.562461219,0.705481097,17.53084788,0,-1.942843509,1.187588436,-1.635956911,0.101848606,0.196455392,20.22378698,0,-2.365169709,1.185174518,-1.995629903,0.045974222,0.116343164,17.27629298,0,-2.024482223,1.190182958,-1.700984046,0.088945983,0.174835581,N,-,,ABC transporter,"F:FAD binding; F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process",IPR003593 (SMART); IPR003439 (PFAM); G3DSA:1.20.1560.10 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011527 (PFAM); PTHR24221 (PANTHER); PTHR24221:SF18 (PANTHER); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.210.2, the atp-binding cassette (abc) superfamily.
RL4_JR_06955,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26.2430841,0,3.13826828,0.932834237,3.364229307,0.000767577,0.004803162,0.708806782,0,3.962217367,1.544149068,2.565955224,0.010289211,0.034259011,1.828973053,0,1.318445457,1.27089158,1.037417729,0.299541219,0.440458287,2.109531497,0,0.896270581,1.297021239,0.691022286,0.489551536,0.629583298,1.788358013,0,1.247777589,1.256759498,0.99285312,0.320781539,0.45629574,Y,-,,cell surface glyco,,IPR011658 (G3DSA:3.90.182.GENE3D); IPR018871 (PFAM),,
RL4_JR_06956,16,4,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,87.72599633,0,-1.561743685,0.734665559,-2.125788621,0.033520864,0.098616375,23.14527419,0,-1.067124835,1.195561235,-0.892572295,0.372086261,0.536668564,71.08318152,0,-2.756440739,1.186412427,-2.323341088,0.020160836,0.055858868,139.2169822,0,0.167668353,0.439357354,0.38162182,0.702741897,0.800456937,141.2253063,0,0.640584475,0.431170969,1.485685543,0.137362316,0.242763738,N,-,,cleft lip and palate transmembrane 1,C:integral component of membrane,IPR008429 (PFAM); PTHR21347:SF0 (PANTHER); IPR008429 (PANTHER),,
RL4_JR_06957,15,9,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,118.9779852,0,-0.06218057,0.63615166,-0.097744883,0.922134874,0.962237952,17.84055693,0,-0.691542901,1.250427867,-0.553045017,0.580232585,0.71930364,45.8393484,0,-3.329515798,1.221671567,-2.72537717,0.006422807,0.022959612,72.90531143,0,-0.779231687,0.763237472,-1.020955751,0.307275403,0.452994097,52.47868938,0,-1.741549114,1.011632219,-1.72152397,0.085155786,0.169324889,N,-,,ATPase subunit c domain,C:cellular_component,IPR003594 (G3DSA:3.30.565.GENE3D); IPR022155 (PFAM); PTHR15600 (PANTHER); PTHR15600:SF29 (PANTHER); PTHR15600:SF29 (PANTHER); PTHR15600 (PANTHER); IPR003594 (SUPERFAMILY),,
RL4_JR_06958,0,5,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,44.02528428,0,-1.375813944,1.018060418,-1.351406969,0.176565103,0.331893573,10.23678817,0,0.109776952,1.215969687,0.090279349,0.92806523,0.959733049,26.63641915,1,-2.546411823,1.195492776,-2.130010213,0.03317077,0.08304176,42.76784045,1,-0.670487439,0.864369281,-0.775695589,0.437928745,0.57968735,26.35166436,0,-2.633599923,1.203164734,-2.18889388,0.028604554,0.072441498,N,-,,short chain dehydrogenase reductase,,IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24322:SF323 (PANTHER); PTHR24322:SF323 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_06959,1420,1680,1348,1,2,3,0,0,0,0,0,1,0,6,0,0,0,2,106.352394,1,-0.126216581,0.616676695,-0.204672208,0.837828236,0.918937779,26.91594199,0,0.248255405,1.140994286,0.217578132,0.827757825,0.896773807,45.51694127,1,-3.319378758,1.211820738,-2.739166491,0.006159517,0.022207604,79.15331573,1,-1.006961807,0.783937621,-1.284492261,0.19896977,0.329231724,48.8234641,1,-2.47629296,1.14944046,-2.154346438,0.031213014,0.077610944,N,-,,phosphoserine aminotransferase,F:O-phospho-L-serine:2-oxoglutarate aminotransferase activity; C:cytosol; P:L-serine biosynthetic process; P:purine nucleobase biosynthetic process,IPR015422 (G3DSA:3.90.1150.GENE3D); IPR000192 (PFAM); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR21152 (PANTHER); PTHR21152:SF1 (PANTHER); PTHR21152 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_06960,3204,2455,3328,12,0,1,0,0,0,2,0,5,2,5,3,0,0,0,157.5872164,1,0.860722235,0.482982356,1.782098712,0.074733136,0.179157485,16.0341485,0,-0.537531846,1.211932351,-0.44353288,0.657380342,0.779491956,85.81869707,1,0.220558924,0.61866721,0.356506568,0.721461234,0.811383418,73.16400231,1,-0.566605314,0.675472623,-0.838827949,0.401565865,0.545459402,56.1610001,0,-0.648959395,0.746610722,-0.869207172,0.384733825,0.520779409,N,-,,serine threonine- phosphatase 2b catalytic subunit,F:phosphoprotein phosphatase activity; F:L-ascorbic acid binding; F:trimethyllysine dioxygenase activity; F:calmodulin binding; F:iron ion binding; P:protein dephosphorylation; P:oxidation-reduction process; P:carnitine biosynthetic process,IPR006186 (PRINTS); IPR006186 (SMART); IPR029052 (G3DSA:3.60.21.GENE3D); IPR004843 (PFAM); PTHR11668 (PANTHER); PTHR11668:SF118 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_06961,1632,1315,1883,0,1,0,0,0,0,0,0,0,0,4,2,0,1,0,11.81423434,1,-1.664619107,1.201861959,-1.385033526,0.166042216,0.317676454,3.761992774,0,1.554042588,1.265599265,1.22791047,0.219480579,0.367082356,22.76050306,0,0.719949905,1.040191369,0.692132166,0.488854333,0.623351445,96.68916972,1,2.546484165,0.593076109,4.293688664,1.76E-05,0.000232582,9.618455437,1,-1.17949953,1.202897205,-0.980548899,0.326815245,0.463186499,N,-,,trimethyllysine dioxygenase,F:dioxygenase activity; F:metal ion binding; P:cellular metabolic process; P:organic substance metabolic process,IPR010376 (PFAM); IPR003819 (PFAM); G3DSA:3.60.130.10 (GENE3D); PTHR10696:SF3 (PANTHER); PTHR10696:SF3 (PANTHER); PTHR10696 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_06962,10436,5554,10394,0,0,0,0,0,0,0,0,1,0,3,0,0,1,2,0.281359793,0,3.726991107,2.611795385,1.426984337,0.153584409,NA,0.089002121,0,6.955057677,2.175827513,3.196511504,0.001391003,0.015023052,0.232734316,1,4.290521414,1.382347775,3.103793049,0.001910569,0.009547188,0.26858997,1,3.868743171,1.709259133,2.263403538,0.023610825,0.083034578,0.231728047,1,4.19570683,1.300448173,3.226354513,0.00125378,0.005770235,Y,-,,gpi transamidase component pig,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_06963,1866,1610,1322,0,1,4,0,0,0,0,0,0,0,0,0,0,3,2,8.496271511,1,-1.189249361,1.194028729,-0.995997276,0.319251469,0.507987806,2.705817675,0,2.02941744,1.27763735,1.588414302,0.112192686,0.221540063,53.28282704,0,2.781592707,0.61268452,4.540008137,5.63E-06,0.000115516,33.79308553,0,1.995352075,0.669535697,2.980202677,0.002880577,0.017970329,6.943603024,1,-0.709435807,1.201072969,-0.590668365,0.554742648,0.674443962,N,-,,alkaline phosphatase family,F:chitinase activity; F:chitin binding; P:chitin catabolic process; C:integral component of membrane; C:extracellular region,IPR018946 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); PTHR11177 (PANTHER); PTHR11177:SF166 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_06964,14282,16904,15217,14,2,4,0,0,0,0,0,0,0,3,0,0,3,0,64.07991788,1,0.108649235,0.673885021,0.16122815,0.871913711,0.938895466,136.2043418,0,2.574638824,0.768923654,3.348367308,0.000812892,0.015023052,86.2820911,0,0.872549368,0.603286101,1.446327649,0.148085324,0.259739401,43.61662514,1,-1.464831481,1.039472742,-1.409206247,0.158774191,0.277409609,38.31996279,1,-1.191627347,1.008020208,-1.182146289,0.23714766,0.365968612,Y,-, Effector probability:0.844,endosomal cargo receptor,C:endoplasmic reticulum membrane; C:integral component of membrane; P:transport,IPR009038 (SMART); IPR009038 (PFAM); IPR015720 (PANTHER); PTHR22811:SF46 (PANTHER); IPR009038 (PROSITE_PROFILES); IPR009038 (SUPERFAMILY),9.B.188.1.2, the transmembrane emp24 domain-containing protein (tmed) family.
RL4_JR_06965,70,39,45,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,75.19249516,0,-4.334862609,1.221991539,-3.547375305,0.00038909,0.002717305,23.78569929,0,-1.106551492,1.215940635,-0.910037431,0.36280277,0.527552024,75.12011112,0,-1.954187879,1.0579841,-1.847086245,0.064734642,0.13829363,120.6563351,0,-0.474756488,0.597686597,-0.794323465,0.427007147,0.569624159,81.01440029,0,-0.984660464,0.756882265,-1.300942709,0.193278066,0.313863739,N,-,,transcriptional regulator cwf13,"P:mRNA cis splicing, via spliceosome; P:generation of catalytic spliceosome for second transesterification step; C:post-mRNA release spliceosomal complex; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome; C:Prp19 complex; C:mitotic spindle pole body",IPR004015 (PFAM); IPR017862 (PANTHER),,
RL4_JR_06966,167,81,121,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,81.03219084,0,-3.342404595,1.146286547,-2.915854334,0.003547161,0.016436672,23.25417391,0,-1.07389746,1.197402419,-0.896855931,0.369795798,0.533973056,93.58719726,0,-1.308389194,0.848782521,-1.541489323,0.12319774,0.226279738,180.2631804,0,0.741930134,0.382179795,1.94131177,0.052220473,0.125807414,111.8098684,0,-0.008876234,0.525739512,-0.016883331,0.986529691,0.990835544,N,-,,glycoside hydrolase family 16,"P:carbohydrate metabolic process; C:integral component of membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR013320 (G3DSA:2.60.120.GENE3D); PTHR10963:SF33 (PANTHER); PTHR10963 (PANTHER); PTHR10963:SF33 (PANTHER); PTHR10963 (PANTHER); IPR000757 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),,
RL4_JR_06967,796,582,1248,0,0,2,0,0,0,0,0,0,0,0,0,0,5,0,55.29585317,1,-1.318885751,0.975684479,-1.351754363,0.176453908,0.331848984,13.77674656,0,-0.318708494,1.26027684,-0.252887687,0.800355005,0.878654377,36.15854751,0,-2.987319966,1.238877284,-2.411312245,0.015895234,0.046630932,53.7751556,0,-1.159683783,0.953485634,-1.216257216,0.223886954,0.359248084,36.11377664,1,-3.088255016,1.256776959,-2.457281694,0.013999287,0.041096775,N,-,,mitochondrial import inner membrane translocase subunit tim22,F:mitochondrion targeting sequence binding; F:protein channel activity; C:integral component of membrane; P:protein import into mitochondrial inner membrane; C:mitochondrial inner membrane protein insertion complex,IPR003397 (PFAM); PTHR14110 (PANTHER); PTHR14110 (PANTHER); PTHR14110:SF0 (PANTHER),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_06968,786,830,888,7,7,184,0,0,2,2,3,6,13,39,10,0,48,3,562.9803273,1,-0.912249053,0.311628952,-2.927356545,0.003418567,0.0159515,161.1158118,1,-1.725183791,0.986636929,-1.748549785,0.080368873,0.170794401,420.3391706,1,-1.499423345,0.455441009,-3.292244914,0.00099391,0.005727004,416.0555332,1,-2.067624915,0.452453521,-4.569806217,4.88E-06,7.49E-05,370.9082909,1,-1.70157861,0.446408125,-3.811710662,0.000138008,0.000909723,N,-,,ubiquitin carboxyl-terminal hydrolase,,IPR002083 (SMART); IPR024729 (PFAM); IPR002083 (PFAM); IPR001394 (PFAM); IPR029346 (PFAM); G3DSA:2.20.210.10 (GENE3D); PTHR24006 (PANTHER); PTHR24006 (PANTHER); PTHR24006:SF445 (PANTHER); IPR002083 (PROSITE_PROFILES); IPR028889 (PROSITE_PROFILES); IPR008974 (SUPERFAMILY); SSF54001 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_06969,87,57,86,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,50.84517442,0,-0.482670668,0.900168846,-0.536200148,0.591820232,0.76236688,17.85300652,0,1.297285978,1.143593787,1.134394042,0.256629297,0.412056114,22.10897368,0,-2.277588198,1.214542402,-1.875264456,0.060756351,0.131571614,25.51538311,0,-2.700486894,1.216451831,-2.219970265,0.026420786,0.08636862,21.9044839,0,-2.366904947,1.224985535,-1.93219012,0.053336044,0.117550598,N,-,,pyruvate dehydrogenase,P:negative regulation of catalytic activity; C:mitochondrion; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity; P:peptidyl-serine phosphorylation; P:carbon utilization,IPR003594 (G3DSA:3.30.565.GENE3D); IPR018955 (PFAM); IPR018955 (G3DSA:1.20.140.GENE3D); PTHR11947 (PANTHER); PTHR11947:SF20 (PANTHER); IPR018955 (SUPERFAMILY); IPR003594 (SUPERFAMILY),,
RL4_JR_06970,263,301,325,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,386.8090823,0,0.849499092,0.48388806,1.755569445,0.079161953,0.186810302,54.67681923,0,-1.118338447,1.109207057,-1.008232358,0.313342927,0.475230279,124.1685523,0,-3.727815582,1.192107456,-3.127080165,0.001765518,0.008968441,280.8932488,0,-0.030645408,0.378193681,-0.081030989,0.935417308,0.962317601,175.7262444,0,-0.813732742,0.517584334,-1.572174211,0.115910155,0.21349651,N,-,,cell division control 12,C:septin filament array; P:septin ring assembly; F:1-phosphatidylinositol binding; C:cellular bud neck septin ring; F:GTP binding; F:protein complex scaffold; F:phosphatidylinositol-4-phosphate binding; P:positive regulation of protein kinase activity; F:GTPase activity; P:mitotic cytokinesis; C:mating projection; F:phosphatidylinositol-5-phosphate binding; P:maintenance of cell polarity; C:septin complex,IPR027417 (G3DSA:3.40.50.GENE3D); IPR016491 (PIRSF); IPR027417 (G3DSA:3.40.50.GENE3D); IPR030379 (PFAM); PTHR18884:SF58 (PANTHER); IPR016491 (PANTHER); IPR030379 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_06971,8379,9921,12046,0,1,3,0,5,0,0,0,0,0,0,1,0,1,0,123.7409657,1,-5.053513428,1.250156791,-4.042303707,5.29E-05,0.000490115,38.94525591,1,-1.817887141,1.22693628,-1.481647556,0.138434098,0.259631266,102.0202781,0,-4.483736593,1.226714772,-3.655076711,0.000257105,0.00206746,149.7091329,1,-2.130117612,0.811958374,-2.623432038,0.008704881,0.043545909,124.0689366,1,-1.95712755,0.833248794,-2.348791338,0.018834458,0.052189078,N,-,,periodic tryptophan 2,,IPR020472 (PRINTS); IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR007148 (PFAM); IPR027145 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR017986 (SUPERFAMILY); IPR011044 (SUPERFAMILY),8.A.92.1.1,The G-Protein αβγ Complex (GPC) Family
RL4_JR_06972,3107,3622,4915,0,3,4,0,0,0,0,0,0,0,7,0,0,0,1,5.51505554,1,-0.565960507,1.213168798,-0.466514229,0.640847465,0.795743321,1.758312838,0,2.651262486,1.332416513,1.989815092,0.046611308,0.111542474,4.569176009,0,-0.003205232,1.210595101,-0.00264765,0.997887484,0.999239715,9.282921707,1,0.520617037,1.157260557,0.449870199,0.652804037,0.76270954,4.51633518,1,-0.08898249,1.214940944,-0.073240177,0.941614995,0.963025735,N,-,,DUF4243 domain,,IPR025337 (PFAM); PTHR35870 (PANTHER); PTHR35870:SF1 (PANTHER),,
RL4_JR_06973,143,155,185,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,134.038821,0,-0.97217372,0.628393215,-1.547078639,0.121844284,0.255192181,32.03210002,0,-1.535902743,1.211377351,-1.267897853,0.204834431,0.349811727,136.7146197,0,-0.762288103,0.628827331,-1.212237549,0.225421462,0.355699327,146.0511864,0,-0.589985933,0.524409195,-1.125048796,0.260568357,0.400781883,99.59762219,0,-2.031263304,0.845439988,-2.402610868,0.016278499,0.046388912,N,-,,endonuclease Exonuclease phosphatase,C:cell part; P:primary metabolic process; P:cellular metabolic process; P:organic substance metabolic process; F:hydrolase activity,PR01217 (PRINTS); IPR000300 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR005135 (G3DSA:3.60.10.GENE3D); PTHR11200:SF30 (PANTHER); PTHR11200 (PANTHER); IPR011047 (SUPERFAMILY); IPR005135 (SUPERFAMILY),,
RL4_JR_06974,1369,1820,2313,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,254.5898678,0,-0.167509638,0.443641998,-0.377578404,0.70574381,0.840750292,86.86337384,0,-0.268079829,0.978919588,-0.273852758,0.784197778,0.869397316,226.0881168,0,-0.040698191,0.447348269,-0.090976524,0.927511245,0.956881142,245.07048,0,-0.033733744,0.378786353,-0.089057443,0.929036259,0.957988809,261.8430096,0,0.817075409,0.36693818,2.2267386,0.025964749,0.06735667,N,-,,hypothetical protein MYCTH_2302201,C:integral component of membrane,IPR031833 (PFAM); PTHR41800 (PANTHER),,
RL4_JR_06975,2244,3586,2388,2,1,3,6,0,0,0,0,0,0,0,0,0,0,2,145.4913797,1,-3.429189982,1.023185097,-3.351485467,0.000803793,0.004990365,61.22156636,1,-0.299022905,0.982159563,-0.304454506,0.760781647,0.855150676,141.8274943,0,-1.773870825,0.750040093,-2.36503467,0.018028383,0.051705198,181.0650888,0,-1.286411954,0.548744411,-2.344282563,0.019063723,0.075082357,147.7569346,1,-0.864014248,0.602793729,-1.433349762,0.151757908,0.261317826,N,-,,Calcium homeostasis endoplasmic reticulum,C:membrane; C:integral component of membrane; C:cellular_component,IPR006903 (PFAM); PTHR12323 (PANTHER); IPR006569 (PROSITE_PROFILES),,
RL4_JR_06976,1928,3031,2140,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,123.5888569,1,0.490355063,0.546590676,0.897115676,0.369657195,0.561680647,17.01136361,0,-0.622876169,1.241642589,-0.501654964,0.615910249,0.747690518,76.96612825,0,-0.824012591,0.88143143,-0.934857282,0.349861855,0.493480433,98.62663681,0,-0.167555454,1.575341373,-0.106361362,0.915295648,0.948798246,99.95400266,1,0.892415413,0.540095782,1.652328054,0.098467693,0.188680052,N,-,,serine threonine phosphatase 2a,"P:cellular bud neck septin ring organization; P:signal transduction; P:protein dephosphorylation; C:kinetochore; C:protein phosphatase type 2A complex; F:protein phosphatase type 2A regulator activity; C:condensed nuclear chromosome, centromeric region; P:septin ring disassembly; P:establishment of protein localization to chromosome; C:cellular bud neck; C:spindle pole body; P:sister chromatid biorientation; P:regulation of protein phosphatase type 2A activity; P:mitotic spindle orientation checkpoint; P:meiotic sister chromatid cohesion, centromeric",IPR002554 (PFAM); IPR002554 (PIRSF); IPR002554 (PANTHER); PTHR10257:SF24 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_06977,6351,5952,6904,2,0,6,0,0,0,0,0,3,0,5,0,0,0,0,36.57077131,1,0.934693485,0.741335195,1.260824377,0.207372129,0.373406994,4.133512245,0,1.418146724,1.258556779,1.12680393,0.259825389,0.415996547,10.70961717,1,-1.231937099,1.197008462,-1.029179942,0.303395126,0.444768644,21.66555706,1,-0.704265601,1.145794059,-0.614652865,0.538783994,0.670252849,10.55057396,0,-1.313095742,1.199099882,-1.09506786,0.273486908,0.406317673,N,-,,transcription factor tau subunit sfc1,P:transcription initiation from RNA polymerase III promoter; C:intracellular part,IPR019136 (PFAM); PTHR13230 (PANTHER),,
RL4_JR_06978,11491,12999,9025,0,3,7,0,0,0,0,0,2,1,4,0,0,9,0,4.01050096,1,-0.106060531,1.237696055,-0.085691903,0.931711339,0.966629651,1.270756222,0,3.11976198,1.374089789,2.270420758,0.023182066,0.06469503,3.311051305,1,0.46158096,1.218945989,0.3786722,0.7049313,0.79954341,23.87874084,1,3.048950111,0.706984971,4.312609514,1.61E-05,0.000216143,3.277501619,1,0.373787253,1.223093362,0.305608112,0.759903043,0.832235621,N,-,,hypothetical protein SPI_03519,,no IPS match,,
RL4_JR_06979,4540,5004,6509,0,0,9,0,0,0,0,1,4,1,4,4,0,1,3,100.3614557,1,-0.906807886,0.614985605,-1.474518881,0.140341938,0.282781574,22.02736782,0,-0.995725691,1.196964292,-0.831875853,0.405479023,0.569419986,57.19229874,1,-3.648793149,1.189363361,-3.067854004,0.002156019,0.010448798,94.88569859,1,-1.739856896,0.847480647,-2.052975372,0.040074966,0.107602271,68.03197791,1,-1.530022071,0.847863683,-1.804561395,0.071143344,0.146705979,N,-,,60kDa lysophospholipase,P:mycelium development; P:cellular amino acid metabolic process,IPR006034 (PRINTS); IPR006034 (SMART); IPR002110 (SMART); IPR027474 (G3DSA:3.40.50.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PIRSF500176 (PIRSF); IPR006034 (PIRSF); IPR027474 (PFAM); IPR027473 (G3DSA:3.40.50.GENE3D); IPR020683 (PFAM); PTHR11707 (PANTHER); PTHR11707:SF28 (PANTHER); PTHR11707:SF28 (PANTHER); PTHR11707 (PANTHER); IPR006034 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR006034 (SUPERFAMILY); IPR020683 (SUPERFAMILY),1.A.4.7.2, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_06980,2902,7485,10633,0,0,0,0,0,0,0,0,0,0,6,0,0,1,0,17.08076453,0,0.381183826,1.023810496,0.372318732,0.709655553,0.843500368,3.001299523,0,1.879862946,1.275309213,1.474044825,0.140469523,0.26265658,7.811319532,0,-0.776752561,1.201751252,-0.646350532,0.518052369,0.648542375,9.012849155,1,-1.199337545,1.200655797,-0.998902057,0.31784214,0.463978037,37.19131108,1,1.797514568,0.765433639,2.348361081,0.018856232,0.052218196,N,-,,nap family,C:nucleus; P:nucleosome assembly,IPR002164 (PFAM); PTHR11875:SF61 (PANTHER); IPR002164 (PANTHER); SSF143113 (SUPERFAMILY),,
RL4_JR_06981,21514,14467,14124,2,2,0,0,0,0,0,0,7,0,4,3,0,4,0,48.928894,1,0.037849498,0.660558946,0.057299198,0.954306859,0.977185309,9.554794682,0,0.209326816,1.218515023,0.171788457,0.863603841,0.920631709,57.93557847,1,-0.022109918,0.846063234,-0.026132702,0.979151494,0.988623688,67.20207262,1,0.66915081,0.568054862,1.177968635,0.238809111,0.376904322,24.30781091,1,-2.517148266,1.186605092,-2.121302431,0.03389636,0.082718883,N,-,,arginine rich,C:Set1C/COMPASS complex; F:histone methyltransferase activity (H3-K4 specific); P:histone H3-K4 methylation,PF05205 (PFAM),1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_06982,3063,3423,3660,1,0,0,0,0,0,0,0,0,2,0,2,0,0,0,60.40147365,1,-1.969259185,1.011042719,-1.947750721,0.051444798,0.135820926,15.46092284,0,-0.485057505,1.200740956,-0.403965154,0.686238343,0.800770086,70.74260493,0,-0.318127599,0.741026648,-0.429306558,0.667700145,0.771578161,76.04628896,1,-0.260326099,0.616519145,-0.422251444,0.672841496,0.777330003,43.53282644,0,-2.293732916,1.124109839,-2.040488247,0.04130172,0.096510482,N,-,,NADH-ubiquinone oxidoreductase 14 kDa subunit,C:integral component of membrane,PTHR39218 (PANTHER),,
RL4_JR_06983,5969,10970,13276,0,2,2,0,0,0,0,0,1,1,3,0,0,2,0,127.9593129,1,0.751223965,0.512134857,1.466847949,0.142417423,0.285745532,26.6388631,0,0.272681987,1.121294512,0.243184983,0.807862099,0.883444333,60.61483216,1,-1.476105795,1.041866418,-1.416789878,0.15654437,0.270684065,75.12131649,1,-1.396075056,0.865188253,-1.613608427,0.106612388,0.20582108,63.78334471,1,-0.487791124,0.718216058,-0.679170451,0.497029868,0.624996384,N,-,,translation initiation factor eif-2b subunit delta,F:translation initiation factor activity; P:negative regulation of translational initiation; P:L-methionine biosynthetic process from methylthioadenosine; F:guanyl-nucleotide exchange factor activity; P:regulation of catalytic activity; F:S-methyl-5-thioribose-1-phosphate isomerase activity; C:eukaryotic translation initiation factor 2B complex; P:translational initiation,G3DSA:3.40.50.10470 (GENE3D); IPR000649 (PFAM); PTHR10233:SF14 (PANTHER); PTHR10233 (PANTHER); SSF100950 (SUPERFAMILY),,
RL4_JR_06984,2164,3016,3293,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,20.24261578,0,-2.441710855,1.219313181,-2.002529698,0.045227792,0.123400779,6.402616274,0,0.786770397,1.252697194,0.628061116,0.529963904,0.678337714,23.22208188,1,-0.913112644,1.211945099,-0.753427399,0.451193123,0.590623116,28.61191367,0,-1.345399179,1.167092301,-1.152778729,0.249001217,0.388106115,24.33496608,0,-0.314583242,1.020185794,-0.308358775,0.757809347,0.831176966,N,-,,translation initiation factor if-3,F:translation initiation factor activity; P:translational initiation,IPR019815 (G3DSA:3.30.110.GENE3D); IPR019815 (PFAM); IPR001288 (PANTHER); PTHR10938:SF0 (PANTHER); IPR019815 (SUPERFAMILY),,
RL4_JR_06985,3935,4017,5081,0,2,3,0,0,0,1,0,0,0,1,0,0,7,1,15.29487942,1,-0.677428695,1.172736338,-0.57764791,0.563501854,0.740384623,3.639724918,0,1.601590486,1.284342633,1.247011853,0.212393151,0.358606085,31.63386754,1,0.78189357,1.051755975,0.743417284,0.457229083,0.595499424,61.52820265,1,1.906746053,0.677666512,2.813693785,0.004897586,0.027564233,9.422499356,1,-1.149892857,1.228454551,-0.936048352,0.349248293,0.486669277,N,-, Effector probability:0.595,mitochondrial inner membrane protease subunit,P:protein processing involved in protein targeting to mitochondrion; C:integral component of membrane; F:serine-type peptidase activity; C:mitochondrial inner membrane,IPR000223 (PRINTS); IPR000223 (TIGRFAM); IPR019759 (PFAM); IPR028360 (G3DSA:2.10.109.GENE3D); IPR026730 (PTHR12383:PANTHER); IPR000223 (PANTHER); IPR015927 (SUPERFAMILY),1.E.43.3.9, the putative transglycosylase-associated holin (t-a hol) family
RL4_JR_06986,10395,7924,7615,1,3,8,0,0,0,1,1,1,1,6,1,0,0,5,84.903137,1,-1.511139128,0.745242945,-2.027713429,0.042589504,0.118138448,22.23481454,0,-1.00924239,1.198823212,-0.841860902,0.399865818,0.56368071,79.87361239,1,-1.254198117,0.850542545,-1.474585985,0.140323885,0.249409939,126.7231727,1,-0.001390137,1.428956822,-0.000972833,0.999223792,0.999460773,56.90402969,1,-3.744250301,1.192979151,-3.138571448,0.001697735,0.007387009,N,-,,vacuolar 8,"C:nucleus; P:vacuole inheritance; C:Myo2p-Vac17p-Vac8p transport complex; P:CVT vesicle assembly; C:nucleus-vacuole junction; F:protein anchor; C:fungal-type vacuole membrane; P:nucleus-vacuole junction assembly; P:vacuole fusion, non-autophagic; C:Golgi apparatus; P:macroautophagy",IPR000225 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR000225 (PFAM); PTHR23315 (PANTHER); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_06987,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,66.05176846,0,-0.088932949,0.618629467,-0.143758023,0.885691551,0.944154115,34.80067796,0,0.747850464,1.118396268,0.668681115,0.503698917,0.657354362,38.78145983,0,-1.86186137,1.191530711,-1.562579423,0.118151551,0.219520335,57.29216175,0,-0.216272433,0.678049674,-0.318962521,0.749754934,0.835214952,54.14576578,0,-0.272489043,0.739030959,-0.36871127,0.712342948,0.797134432,N,-,,chitin synthase,P:chitin biosynthetic process; C:integral component of membrane; F:chitin synthase activity; C:chitosome; C:plasma membrane,IPR013616 (PFAM); IPR004834 (PFAM); PTHR22914:SF9 (PANTHER); IPR004835 (PANTHER); IPR004834 (PRODOM); IPR029044 (SUPERFAMILY),4.D.1.1.12, the putative vectorial glycosyl polymerization (vgp) family.
RL4_JR_06988,623,640,647,0,0,5,0,0,0,1,8,12,22,46,7,0,22,11,319.7031223,1,0.025888309,0.474254076,0.054587425,0.956467157,0.978015059,49.20594043,0,-2.155268007,1.195238711,-1.803211348,0.071355029,0.156129616,128.071909,1,-4.811837022,1.196226702,-4.022512635,5.76E-05,0.000808524,159.8066228,1,-2.938023595,0.868021546,-3.38473579,0.000712468,0.005569688,126.7405197,1,-4.899516212,1.205725842,-4.06354085,4.83E-05,0.000378192,N,-,,homoserine kinase,,PR00958 (PRINTS); IPR000870 (PIRSF); IPR013750 (PFAM); IPR013750 (G3DSA:3.30.70.GENE3D); IPR000870 (TIGRFAM); IPR006204 (PFAM); IPR014721 (G3DSA:3.30.230.GENE3D); PTHR20861 (PANTHER); PTHR20861 (PANTHER); PTHR20861:SF4 (PANTHER); IPR000870 (HAMAP); IPR020568 (SUPERFAMILY); IPR013750 (SUPERFAMILY),,
RL4_JR_06989,258,270,413,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36.99734043,0,1.897868883,0.78406215,2.42055924,0.015496654,0.053693135,3.337890772,0,1.726668006,1.36445263,1.265465703,0.205704436,0.35064342,8.551624461,0,-0.907128573,1.252162738,-0.724449423,0.468789867,0.605669808,17.8807473,0,0.365051418,1.094585497,0.333506537,0.738751956,0.826169223,59.87749211,0,2.674538016,1.562111924,1.712129569,0.086872793,0.1719959,N,-,,pyridine nucleotide-disulfide oxidoreductase,C:cytoplasm,PR00411 (PRINTS); PR00368 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (PFAM); IPR023753 (SUPERFAMILY),,
RL4_JR_06990,52,48,69,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,963.3594752,0,0.310175919,0.730056512,0.424865629,0.670934632,0.817535882,201.8310174,0,-0.272033545,0.626847527,-0.433970836,0.66430962,0.785076375,2568.281421,0,2.66074159,0.657429234,4.047190867,5.18E-05,0.00074756,1384.222257,0,1.256960161,1.003279669,1.252851223,0.210259856,0.343867072,1584.389768,0,1.851982844,1.150968466,1.609064799,0.107602173,0.201791444,N,-,,hypothetical protein F503_00961,C:membrane,no IPS match,,
RL4_JR_06991,19,26,44,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,42.88281375,0,-0.860357214,1.017956259,-0.845180926,0.39800983,0.590249808,7.283653988,0,0.600908667,1.239850312,0.484662271,0.627915934,0.755379734,98.25227014,1,1.805123963,0.560783365,3.218932792,0.001286686,0.007022325,29.74825525,0,-0.746172748,1.025055994,-0.727933647,0.466654205,0.608170141,48.66006634,0,1.079904855,0.625620016,1.726135396,0.084323057,0.167899893,N,-,,actin,,IPR004000 (PRINTS); IPR004000 (SMART); G3DSA:3.30.420.40 (GENE3D); IPR004000 (PFAM); G3DSA:3.90.640.10 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR029909 (PTHR11937:PANTHER); IPR004000 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_06992,97,59,153,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,270.3188292,0,-1.854908312,0.805231445,-2.303571629,0.021246702,0.069111082,67.1473298,0,-2.603730348,1.275664345,-2.041077936,0.041243081,0.101572376,203.1118167,0,-2.41646015,1.297319967,-1.862655483,0.062510753,0.134529845,236.496712,0,-2.491928321,1.547679664,-1.610106006,0.107374716,0.206922155,174.3462333,0,-3.661854925,1.085757642,-3.372626434,0.000744549,0.003769279,N,-,,hypothetical protein CMQ_603,,IPR022024 (PFAM); PTHR34693 (PANTHER); PTHR34693:SF2 (PANTHER),,
RL4_JR_06993,1170,1657,1885,0,2,0,0,0,0,0,0,0,0,2,0,0,0,0,12.73490594,1,-1.773204406,1.221279839,-1.451923097,0.14652299,0.29232708,4.078946634,0,1.437288935,1.292332063,1.112166893,0.2660664,0.423114548,10.57562736,0,-1.213794126,1.220406413,-0.994581897,0.319939656,0.462591984,12.19855672,1,-1.635929272,1.221437321,-1.339347704,0.180457506,0.306004045,10.43656864,0,-1.29741939,1.226900657,-1.057477133,0.290293885,0.424956986,N,-,,CMGC SRPK kinase,F:nucleotide binding; F:protein kinase activity; P:phosphorylation,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24055:SF229 (PANTHER); PTHR24055 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_06994,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,140.5148557,0,0.328552833,0.514707181,0.638329608,0.523259143,0.707239648,21.39863178,0,-0.953901102,1.237063076,-0.771101427,0.440646815,0.602082487,96.71983065,0,-0.205093727,0.66375666,-0.308989332,0.757329642,0.836848428,115.465133,0,-0.143334693,0.582786639,-0.245947115,0.805723171,0.875692047,61.50366656,0,-2.002792641,1.000498778,-2.001794191,0.045306871,0.103950163,N,-,,hypothetical protein SPI_00275,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_06995,159,133,127,0,2,2,0,0,0,0,108,92,0,1,0,0,26,0,56.91643959,1,0.001898518,0.750933359,0.002528212,0.997982781,0.999396344,8.031697162,0,0.459850984,1.242334693,0.370150642,0.711270251,0.818773738,61.06478103,1,1.207525583,0.636961842,1.895758117,0.057992036,0.126696456,52.48678895,1,-0.262742276,0.860071188,-0.305488987,0.759993756,0.843188339,49.79314636,1,0.393207409,0.752952844,0.522220498,0.601516816,0.710660182,N,-,,ifrd domain-containing,C:cytosol,IPR007701 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR12354 (PANTHER); PTHR12354:SF1 (PANTHER); PTHR12354:SF1 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_06996,16,26,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,233.5095524,0,0.370257254,0.496425566,0.745846466,0.455760167,0.644494963,35.09662998,0,-1.667720392,1.228281049,-1.357767746,0.174537392,0.310650164,107.8934132,0,-2.481195131,1.0563661,-2.348802305,0.018833904,0.05350137,159.5262267,0,-0.618081871,0.562031602,-1.099727967,0.271450665,0.413174682,163.3226205,0,0.031093949,0.49545823,0.062757962,0.949959241,0.967446095,N,-,,fha domain containing,C:membrane; C:integral component of membrane,IPR000253 (SMART); IPR000253 (G3DSA:2.60.200.GENE3D); IPR000253 (PFAM); PTHR15715 (PANTHER); IPR000253 (PROSITE_PROFILES); IPR008984 (SUPERFAMILY),9.B.321.1.1, the actinobacterial nutrient-sensing signal transduction pathway controlling glutamate metabolism (sigt) family.
RL4_JR_06997,70,127,102,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.21332896,0,0.78511854,1.224941117,0.640943902,0.521559131,0.705969701,1.370139463,0,3.011281329,1.479527829,2.035298877,0.041820809,0.102720269,3.510946699,0,0.377140898,1.280949778,0.29442286,0.7684348,0.844327536,4.046742487,0,-0.043947037,1.29597598,-0.033910379,0.972948616,0.984716587,3.422334984,0,0.311019391,1.275442352,0.243852174,0.807345311,0.870146606,N,-,,hypothetical protein SPSK_09824,,no IPS match,,
RL4_JR_06998,65,54,55,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.36962322,0,-2.044436299,1.215129426,-1.682484397,0.092474948,0.209035918,4.872353318,0,1.180810452,1.261939711,0.935710669,0.349422176,0.512438607,19.20846328,0,-0.517223279,1.209230388,-0.42772931,0.668848208,0.772136448,33.93692644,0,-0.143667086,1.036766368,-0.138572286,0.889788145,0.932233543,28.05419885,0,1.004146563,0.811053116,1.238077437,0.215687349,0.340638654,N,-,,WD-repeat pop3,F:protein kinase activator activity; C:Golgi membrane; P:TOR signaling; P:microtubule cytoskeleton organization; P:transport; P:fungal-type cell wall organization; C:nucleus; C:TORC2 complex; P:regulation of cell growth; P:mitotic sister chromatid segregation; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; P:activation of protein kinase activity; C:endosome membrane; P:establishment or maintenance of actin cytoskeleton polarity; P:mitochondria-nucleus signaling pathway; C:TORC1 complex,IPR020472 (PRINTS); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR19842 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),3.A.20.1.2, the peroxisomal protein importer (ppi) family.
RL4_JR_06999,2,1,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,90.96455862,0,1.183999302,1.099774096,1.076584098,0.281666112,0.464771873,8.577374898,0,0.365008742,1.222280041,0.298629389,0.765222839,0.857951607,41.14939998,0,-0.458678186,1.030804776,-0.444970956,0.656340744,0.76184289,44.59984597,0,-0.965270275,1.013413397,-0.952494093,0.34084646,0.487783803,48.91234438,0,1.034811835,0.588850831,1.757341216,0.078859667,0.159595068,N,-,,SCY1 kinase,F:ATP binding; F:protein kinase activity; P:protein phosphorylation,G3DSA:1.10.510.10 (GENE3D); IPR011989 (G3DSA:1.25.10.GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); PTHR12984:SF3 (PANTHER); PTHR12984 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR011009 (SUPERFAMILY),,
RL4_JR_07000,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,70.33214029,0,0.818220317,0.589133938,1.388852796,0.164877517,0.316263998,10.2387724,0,0.109506636,1.215926016,0.090060279,0.928239314,0.959733049,65.82918816,0,0.601354424,0.677851289,0.887148012,0.374999218,0.518859106,30.70543643,0,-2.967677358,1.193659738,-2.486200433,0.012911522,0.059427429,33.67113293,0,-1.695285992,1.129615634,-1.500763571,0.133416724,0.236865567,N,-,,hypothetical protein CMQ_1158,,no IPS match,,
RL4_JR_07001,4,11,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,407.3118955,0,-2.425015161,0.606148981,-4.000691642,6.32E-05,0.000569245,113.4757514,0,-3.360733108,1.192236764,-2.818847069,0.004819647,0.020167206,314.8421707,0,-3.618056354,0.8644111,-4.185573686,2.84E-05,0.000452078,366.1426738,0,-3.404838376,0.686073556,-4.962789114,6.95E-07,1.33E-05,324.1947301,0,-4.38904405,1.000022426,-4.388945624,1.14E-05,0.000112732,N,-,,aconitate hydratase,"C:nucleus; F:metal ion binding; C:mitochondrion; P:tricarboxylic acid cycle; F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity",IPR001030 (PRINTS); IPR015931 (G3DSA:3.30.499.GENE3D); IPR006248 (TIGRFAM); IPR015931 (G3DSA:3.30.499.GENE3D); IPR015932 (G3DSA:3.40.1060.GENE3D); IPR001030 (PFAM); IPR015928 (G3DSA:3.20.19.GENE3D); IPR000573 (PFAM); IPR015937 (PANTHER); PTHR11670:SF33 (PANTHER); IPR015928 (SUPERFAMILY); IPR001030 (SUPERFAMILY),,
RL4_JR_07002,288,22,51,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.681566363,0,0.292623769,1.163538126,0.251494783,0.801431595,0.899570577,1.87626282,0,2.557741855,1.338807853,1.910462245,0.056073723,0.129316535,4.85148376,0,-0.089189889,1.213396765,-0.073504308,0.941404816,0.965142517,13.61917824,0,1.206769423,1.035197141,1.165738752,0.243720087,0.381977908,4.760134245,0,-0.164693175,1.20872311,-0.136253848,0.891620608,0.929009712,N,-,,dna repair and recombination rhm52,P:double-strand break repair via homologous recombination,IPR007232 (PFAM); IPR004585 (TIGRFAM); IPR004585 (PTHR12132:PANTHER); IPR007232 (PANTHER); SSF54768 (SUPERFAMILY),,
RL4_JR_07003,9324,709,1547,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,844.9820929,0,0.418888074,0.538626898,0.777696166,0.436748153,0.62673552,229.6027003,0,0.258830968,0.663796966,0.389924904,0.696592078,0.807453971,511.8554033,0,-0.527516569,0.470683082,-1.120746823,0.262395645,0.399472709,688.2869992,0,-0.11912792,0.438948958,-0.271393559,0.786088355,0.861659045,438.7159811,0,-0.885621195,0.554328449,-1.597647022,0.110121555,0.205186004,N,-,,zz type zinc finger domain-containing,F:zinc ion binding; C:Golgi apparatus,IPR000433 (SMART); IPR032350 (PFAM); IPR000433 (PFAM); PTHR20930 (PANTHER); PTHR20930:SF0 (PANTHER); PTHR20930:SF0 (PANTHER); PTHR20930 (PANTHER); IPR000433 (PROSITE_PROFILES); IPR000433 (PROSITE_PROFILES); IPR000433 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); SSF57850 (SUPERFAMILY); SSF57850 (SUPERFAMILY); SSF57850 (SUPERFAMILY),,
RL4_JR_07004,928,336,393,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,109.615264,0,-3.882105245,1.176488808,-3.299738357,0.00096775,0.005775351,33.4458825,0,-1.598267016,1.210065282,-1.320810571,0.186564534,0.326544391,110.8273346,0,-1.849250781,0.8779769,-2.106263595,0.035181462,0.086534771,104.7598034,1,-3.736106001,1.165783981,-3.204801285,0.001351558,0.00952961,98.16733244,0,-2.170188935,0.894310216,-2.426662355,0.01523843,0.044007161,N,-,,RNA binding Rnp24,C:intracellular part,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR24012 (PANTHER); PTHR24012:SF447 (PANTHER); PTHR24012:SF447 (PANTHER); PTHR24012 (PANTHER); PTHR24012 (PANTHER); PTHR24012:SF447 (PANTHER); PTHR24012:SF447 (PANTHER); PTHR24012 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_07005,499,811,1004,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,81.40377591,0,-1.11331978,0.762043522,-1.460966136,0.144024735,0.288402992,17.27959882,0,-0.645450566,1.22466311,-0.527043365,0.598163475,0.733358853,51.05773711,0,-2.326850413,1.201726656,-1.93625597,0.052836359,0.118049492,55.39520619,1,-2.764088708,1.156220972,-2.390623224,0.016819804,0.070314003,43.66484024,0,-3.362213135,1.198445719,-2.805478032,0.005024201,0.017975276,N,-,,nuclear envelope cut8,C:nucleus; C:cytoplasm; C:viral envelope; P:double-strand break repair via single-strand annealing; P:nucleus-associated proteasomal ubiquitin-dependent protein catabolic process; P:protein transport; P:proteasome localization; P:DNA recombinase assembly,IPR013868 (PFAM); PTHR28032 (PANTHER); PTHR28032:SF1 (PANTHER),,
RL4_JR_07006,77,128,141,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,50.62332476,0,-2.565082794,1.149266496,-2.231930369,0.025619565,0.080232021,13.70766318,0,-0.311367788,1.224815161,-0.254216144,0.799328579,0.878023957,101.0962563,0,0.866883604,0.560350101,1.547039256,0.12185378,0.22450367,73.41047198,0,-0.628282783,0.755299968,-0.831832133,0.405503704,0.5491874,53.68310883,0,-0.416497642,0.757245563,-0.550016616,0.582307977,0.695021604,N,-,,upf0052 domain containing,P:biological_process; F:transferase activity; C:cellular_component; F:molecular_function,IPR018545 (SMART); IPR002882 (PFAM); G3DSA:3.40.50.10680 (GENE3D); IPR018545 (PFAM); PTHR31240 (PANTHER); SSF142338 (SUPERFAMILY),,
RL4_JR_07007,53231,57194,77775,7,13,45,0,1,0,0,9,0,2,19,6,0,15,0,9.639720094,1,0.302867288,1.163567546,0.26029197,0.794638567,0.894787714,46.47394584,1,4.252732761,0.989019671,4.299947601,1.71E-05,0.001041703,4.80730949,1,-0.076154907,1.211111992,-0.062880153,0.949861939,0.971235243,17.58142287,1,1.794047185,0.875520159,2.049121504,0.040450235,0.108205715,4.741879632,1,-0.1590841,1.213132507,-0.131134975,0.895668534,0.932160143,N,-,,fmHP,,IPR032801 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR032801 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_07008,67497,62929,77854,2,30,77,0,0,11,1,7,7,6,38,8,0,20,4,199.2790898,1,-4.716826084,1.139479515,-4.139456673,3.48E-05,0.000338503,69.7620384,1,-1.532514397,1.10254115,-1.389983854,0.16453378,0.297076512,156.6322759,1,-5.10225175,1.186361154,-4.3007576,1.70E-05,0.000297114,192.7277033,1,-3.215741211,0.845659524,-3.80264293,0.000143161,0.001451192,227.01495,1,-0.60676904,0.503790972,-1.204406339,0.228432563,0.355772912,N,-,,atp-dependent helicase nam7,"F:DNA binding; F:ATP binding; F:zinc ion binding; P:intracellular mRNA localization; C:cytoplasm; F:ribosomal small subunit binding; P:DNA recombination; P:nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay; F:helicase activity; P:chromatin silencing at silent mating-type cassette; P:protein ubiquitination",IPR014001 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13087 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PF13086 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR018999 (PFAM); PTHR10887 (PANTHER); PTHR10887:SF364 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_07009,5691,3296,7234,6,7,9,0,0,0,0,1,1,2,6,3,0,1,1,93.3915915,1,-3.645331546,1.231910327,-2.95908839,0.003085506,0.014754723,28.08611373,0,-1.346296401,1.251608472,-1.075652994,0.282082477,0.441167928,73.7113884,1,-4.014838829,1.246110565,-3.221896147,0.001273453,0.006985447,89.10847572,1,-3.495342045,1.210583162,-2.887320883,0.003885378,0.022925086,88.95870838,1,-1.588260917,0.899898881,-1.76493265,0.077575086,0.157309782,N,-,,U3 small nucleolar ribonucleo IMP4,C:small-subunit processome; F:snoRNA binding; P:ribosomal small subunit biogenesis; C:Mpp10 complex; C:viral nucleocapsid; F:rRNA primary transcript binding; F:single-stranded telomeric DNA binding; P:rRNA processing,IPR007109 (SMART); IPR007109 (PFAM); IPR007109 (G3DSA:3.40.50.GENE3D); PTHR22734 (PANTHER); PTHR22734:SF2 (PANTHER); IPR007109 (PROSITE_PROFILES); IPR004154 (SUPERFAMILY),,
RL4_JR_07010,3784,3461,2305,0,0,3,0,0,0,0,0,3,2,1,0,0,1,0,224.071048,1,-0.58152923,1.12173617,-0.518418899,0.604166032,0.772004859,143.6650111,0,0.207743392,0.840138346,0.247272836,0.80469708,0.881986339,213.6581806,1,-0.051888249,0.421340084,-0.123150517,0.901987909,0.939477942,242.1164906,1,-0.128551541,0.365239342,-0.35196521,0.724864354,0.816652006,187.3543559,1,-0.216458038,0.626288295,-0.345620443,0.729627981,0.810119893,N,-,,syntaxin psy1,C:endosome; P:vesicle-mediated transport; C:cell division site; C:cell tip; C:prospore membrane leading edge; P:ascospore-type prospore membrane assembly; C:integral component of membrane; C:Golgi apparatus; C:plasma membrane raft,IPR000727 (SMART); IPR006011 (SMART); IPR000727 (PFAM); IPR006011 (PFAM); G3DSA:1.20.58.70 (GENE3D); PTHR19957 (PANTHER); PTHR19957:SF114 (PANTHER); IPR000727 (PROSITE_PROFILES); IPR010989 (SUPERFAMILY),8.A.91.1.5, the syntaxin (syntaxin) family.
RL4_JR_07011,4,4,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,315.0782441,0,0.497044573,0.315981097,1.57301996,0.115714197,0.246088742,41.94467105,0,-1.924904589,1.190225028,-1.617261059,0.105821941,0.211351557,179.9417116,0,-0.747133372,0.532831948,-1.402193271,0.16085754,0.276343957,199.1209139,0,-0.937139764,0.47966892,-1.95372209,0.050734092,0.124288092,151.5739917,0,-1.40521914,0.634442857,-2.214886847,0.026767832,0.068945383,N,-,,mitochondrial import receptor subunit tom-70,P:protein transmembrane transport; F:P-P-bond-hydrolysis-driven protein transmembrane transporter activity; C:integral component of membrane; C:mitochondrial outer membrane; P:intracellular protein transport,IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR019734 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR005687 (TIGRFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PF13432 (PFAM); PTHR22904:SF178 (PANTHER); PTHR22904 (PANTHER); PTHR22904:SF178 (PANTHER); PTHR22904 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_07012,35,14,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,133.2730521,0,0.388863826,0.561648849,0.69236112,0.488710576,0.676453192,16.45679499,0,-0.575057582,1.21784399,-0.472193143,0.636788933,0.762790247,121.9435634,0,0.783641442,0.523483946,1.496973208,0.13440023,0.241552978,217.8708233,0,1.789692549,0.357705818,5.003252555,5.64E-07,1.09E-05,116.7341659,0,1.128464496,0.438815414,2.571615445,0.010122526,0.031701384,N,-,,aminodeoxychorismate lyase,F:catalytic activity; P:metabolic process,IPR001544 (PFAM); G3DSA:3.20.10.10 (GENE3D); PTHR11825:SF30 (PANTHER); IPR001544 (PANTHER); IPR001544 (SUPERFAMILY),,
RL4_JR_07013,1878,1661,1578,2,0,4,0,0,0,0,0,0,0,2,0,0,5,0,7.532144392,1,-1.015167418,1.235826181,-0.821448383,0.411390914,0.602843716,2.405405345,0,2.199315739,1.33539634,1.64693857,0.099570673,0.20197482,6.223327031,0,-0.448499727,1.225466613,-0.36598282,0.714377895,0.806823049,25.80347081,1,0.892876007,1.045463259,0.854048193,0.393078287,0.537971598,6.105423318,1,-0.523776809,1.224253038,-0.427833783,0.668772139,0.764762876,N,-,,eukaryotic aspartyl protease,F:aspartic-type endopeptidase activity; P:proteolysis,IPR001461 (PRINTS); IPR033121 (PFAM); IPR021109 (G3DSA:2.40.70.GENE3D); IPR021109 (G3DSA:2.40.70.GENE3D); IPR001461 (PANTHER); PTHR13683:SF328 (PANTHER); IPR033121 (PROSITE_PROFILES); IPR021109 (SUPERFAMILY),8.A.32.1.4,The β-Amyloid Cleaving Enzyme (BACE1) Family
RL4_JR_07014,10354,13145,15299,5,5,10,0,0,0,0,2,1,2,7,0,0,4,2,0.161633147,1,4.526966575,3.296219404,1.373381447,0.169633794,NA,0.052151991,0,7.727256613,2.432495335,3.176678903,0.001489719,0.015023052,0.134023317,1,5.090426848,1.460070545,3.486425274,0.000489522,0.003336184,0.154536243,1,4.66732066,2.033777639,2.294902142,0.021738733,0.080037533,0.130573662,1,5.023409131,1.300572817,3.86245896,0.000112251,0.000763808,N,-,,hypothetical protein HMPREF1624_01317,,no IPS match,,
RL4_JR_07015,13247,9580,10321,0,3,2,0,0,0,1,3,4,1,13,0,0,0,0,0.252503616,1,3.883283445,2.679627941,1.449187548,0.147285214,NA,0.081036644,0,7.090973592,2.183841433,3.247018527,0.001166208,0.015023052,0.209365453,1,4.445452737,1.340091319,3.317275975,0.000908998,0.005325633,0.241468844,1,4.023046157,1.686805956,2.385008271,0.017078737,0.070957003,0.205447723,0,4.369030625,1.247607274,3.501927824,0.000461905,0.002537594,Y,-,,tripeptidyl-peptidase 1,F:serine-type peptidase activity,IPR015366 (SMART); IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (PFAM); IPR015366 (PFAM); PTHR14218 (PANTHER); PTHR14218:SF9 (PANTHER); IPR030400 (PROSITE_PROFILES); IPR009020 (SUPERFAMILY); IPR000209 (SUPERFAMILY),,
RL4_JR_07016,5555,9167,12544,0,0,4,0,0,0,0,0,2,0,0,0,0,5,0,1.001126628,1,1.896246568,1.551646868,1.222086421,0.221674948,NA,0.317721858,0,5.119724571,1.70375015,3.004973805,0.002656037,0.015349618,0.82557837,1,2.465944569,1.275387205,1.933486991,0.053176234,0.118632921,0.952599446,0,2.043148303,1.337715536,1.527341387,0.126676143,0.233922296,0.813684626,1,2.384348151,1.251640095,1.904979044,0.056782795,0.123377278,N,-,,hypothetical protein SPI_01205,P:signal transduction; P:regulation of GTPase activity,no IPS match,,
RL4_JR_07017,1448,1495,2396,2,5,8,0,0,0,0,4,2,0,0,0,0,0,0,226.6201959,1,-0.665627111,0.686066157,-0.970208345,0.331942652,0.521767389,53.48508428,0,-1.083324363,1.155144892,-0.937825524,0.348334082,0.51113911,114.9468332,1,-4.655830481,1.233778763,-3.773634805,0.000160886,0.00154683,219.1937956,0,-0.715198368,0.562565681,-1.271315318,0.203616495,0.335440451,113.6184092,0,-4.741829252,1.24606855,-3.805432096,0.000141557,0.000931901,N,-,,branched-chain amino acid aminotransferase,F:L-leucine transaminase activity; F:L-valine transaminase activity; P:cellular amino acid biosynthetic process; P:branched-chain amino acid biosynthetic process; F:L-isoleucine transaminase activity,G3DSA:3.20.10.10 (GENE3D); IPR001544 (PFAM); G3DSA:3.30.470.10 (GENE3D); IPR005786 (PIRSF); PTHR11825:SF31 (PANTHER); IPR001544 (PANTHER); IPR001544 (SUPERFAMILY),,
RL4_JR_07018,47808,28721,39014,1,20,41,0,0,2,2,2,18,3,11,1,0,19,10,40.01374912,1,0.390707577,0.818111883,0.477572304,0.632954647,0.791363067,5.857606566,1,0.915209565,1.277305229,0.716515947,0.473672824,0.631189617,15.24063908,1,-1.74082429,1.224539214,-1.421615796,0.155137817,0.268936179,17.58694633,1,-2.163572541,1.226801112,-1.763588669,0.077801257,0.16312647,53.8742999,1,1.376287185,0.687349941,2.002309308,0.045251476,0.103846598,N,-,,ethanolamine-phosphate cytidylyltransferase,C:nucleus; F:nucleotidyltransferase activity; C:cytosol; P:biosynthetic process,IPR004821 (PFAM); IPR014729 (G3DSA:3.40.50.GENE3D); IPR004821 (TIGRFAM); PTHR10739 (PANTHER); PTHR10739 (PANTHER); PTHR10739:SF23 (PANTHER); PTHR10739 (PANTHER); PTHR10739:SF23 (PANTHER); PTHR10739:SF23 (PANTHER); SSF52374 (SUPERFAMILY); SSF52374 (SUPERFAMILY),,
RL4_JR_07019,2387,2461,3706,0,0,1,0,0,0,0,1,4,0,0,0,0,8,0,45.41330181,1,-3.607388762,1.228600371,-2.936177496,0.003322841,0.015642089,14.32601146,0,-0.375105795,1.232830954,-0.304263771,0.760926944,0.855213101,43.97025583,1,-2.076979648,1.216558742,-1.707258003,0.087774108,0.175263719,89.95442427,0,0.37820046,0.601845843,0.628400885,0.529741358,0.663077172,67.44049511,1,0.047330705,0.698337887,0.067776224,0.94596377,0.965415097,N,-,,Poly(A)+ RNA export,P:mitotic spindle assembly checkpoint; P:regulation of mRNA export from nucleus in response to heat stress; F:RNA binding; P:nuclear pore distribution; F:ubiquitin binding; P:protein import into nucleus; C:membrane; C:cytosol; P:posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery; P:poly(A)+ mRNA export from nucleus; C:nuclear pore,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR10971:SF11 (PANTHER); PTHR10971 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_07020,7706,6395,6097,0,12,4,0,0,0,0,0,1,2,10,0,0,0,3,60.79101688,1,0.085473157,0.65593659,0.130307043,0.896323508,0.948632537,9.305479854,0,0.247457934,1.214399639,0.203769769,0.838533418,0.903339516,69.82904151,1,1.004929077,0.606733098,1.656295133,0.097662066,0.190656823,66.35961179,1,-0.081086905,0.732170254,-0.110748702,0.911815625,0.946206129,23.74254447,1,-2.483173573,1.18719204,-2.091635968,0.036471092,0.087566946,N,-,,hypothetical protein CMQ_544,P:biological_process; C:cellular_component; F:molecular_function,PTHR37332 (PANTHER); PTHR37332:SF1 (PANTHER),,
RL4_JR_07021,9497,11519,11761,1,0,4,0,0,0,0,1,0,1,5,4,0,1,3,102.4555798,1,0.180812804,0.604583003,0.299070274,0.764886427,0.877161421,23.60561377,0,0.550245153,1.138962806,0.48311073,0.629017115,0.756515326,76.66204412,1,-0.175403597,0.771099886,-0.227471953,0.820056776,0.883970912,159.5093663,1,1.398891574,0.451429759,3.098802297,0.001943046,0.012935007,67.29946523,1,0.420585734,0.642724585,0.654379409,0.512867397,0.638709245,N,-,,hypothetical protein F503_01089,,no IPS match,,
RL4_JR_07022,47569,32715,32664,8,9,5,0,4,2,2,0,12,0,3,0,0,5,3,80.27059637,1,1.09471861,0.713640084,1.533992603,0.125031473,0.260073114,7.963210853,1,0.472223823,1.2911174,0.365748167,0.714553,0.82111474,20.43666928,1,-2.164052551,1.232559353,-1.755739021,0.079132981,0.161357965,31.58384103,1,-0.884350466,1.075101834,-0.822573674,0.410750474,0.55451314,27.63125151,1,-0.57752087,1.025500551,-0.56315998,0.573325952,0.688672294,N,-,,Autophagy-related 13,P:autophagy,IPR018731 (PFAM); PTHR13430:SF4 (PANTHER); PTHR13430 (PANTHER); PTHR13430:SF4 (PANTHER); PTHR13430:SF4 (PANTHER); PTHR13430 (PANTHER); PTHR13430 (PANTHER),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_07023,877,1390,2258,4,0,3,0,0,0,1,1,0,0,1,0,0,6,3,177.89184,1,-1.781508336,0.607556328,-2.932252129,0.003365134,0.015759337,46.60303112,0,-2.076815995,1.208497276,-1.71851111,0.08570343,0.179493092,160.5830072,1,-1.328804894,0.636723906,-2.086940481,0.036893515,0.089635216,172.0545355,1,-1.639200447,0.602669062,-2.719901437,0.006530138,0.034634701,185.5537034,1,-0.486657605,0.463552138,-1.049844377,0.293789668,0.42874321,N,-,,chromatin remodelling complex ATPase chain ISW1,F:ATPase activity; F:DNA binding; F:ATP binding; F:nucleosome binding; P:ATP-dependent chromatin remodeling; F:helicase activity; C:NURF complex,IPR014001 (SMART); IPR001005 (SMART); IPR001650 (SMART); IPR015195 (PFAM); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR009057 (G3DSA:1.10.10.GENE3D); IPR000330 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR009057 (G3DSA:1.10.10.GENE3D); IPR015194 (PFAM); IPR029915 (PTHR10799:PANTHER); PTHR10799 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR017884 (PROSITE_PROFILES); IPR015194 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR009057 (SUPERFAMILY); IPR009057 (SUPERFAMILY),,
RL4_JR_07024,1291,1935,1982,0,0,22,0,0,0,6,0,2,13,34,2,0,9,10,4.030150611,1,5.080655286,1.225326611,4.146368193,3.38E-05,0.000330023,0.068495406,0,7.333672491,2.286310393,3.207645171,0.001338265,0.015023052,0.176124417,1,4.694778589,1.39330861,3.369518106,0.000752997,0.004597917,0.203059335,1,4.272931053,1.825605729,2.340555239,0.01925509,0.0755065,0.172121136,1,4.622712372,1.273954334,3.628632713,0.000284926,0.001679207,Y,-,,phospholipase d1,P:biological_process; F:catalytic activity; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,PS51257 (PROSITE_PROFILES),,
RL4_JR_07025,238,329,348,0,0,25,0,0,0,0,0,1,0,0,0,0,4,0,205.7568529,1,-0.449407654,0.649710826,-0.691704119,0.48912316,0.676775227,55.58459687,0,-0.112559946,1.031948723,-0.109075135,0.913142897,0.951496026,163.791789,1,-0.398977642,0.576693769,-0.691836228,0.489040183,0.623418608,265.2007091,0,0.515354992,0.426285577,1.208943066,0.226684719,0.362359139,107.9102982,1,-2.24437549,0.881141807,-2.547121782,0.010861552,0.033590987,N,-,,ADA HAT complex component 1,,PTHR13585:SF10 (PANTHER); PTHR13585:SF10 (PANTHER); PTHR13585 (PANTHER); PTHR13585 (PANTHER),,
RL4_JR_07026,171,274,400,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47.58228684,1,-3.674698172,1.195222473,-3.074488855,0.002108636,0.010935952,15.12028805,0,-0.452935261,1.204514683,-0.376031333,0.706893603,0.815590681,39.34316392,0,-3.109093477,1.193321119,-2.605412263,0.009176377,0.030579869,45.39497847,0,-3.531678463,1.193437331,-2.959249196,0.003083896,0.019039298,38.90927349,0,-3.195814427,1.20012728,-2.662896244,0.00774713,0.025603425,N,-,,DNA RNA-binding Alba,F:nucleic acid binding,IPR002775 (PFAM),,
RL4_JR_07027,231,353,399,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,88.48193554,0,3.437218021,0.761776762,4.512106688,6.42E-06,7.87E-05,2.092855748,1,2.400110697,1.35023319,1.777552733,0.075477343,0.162930617,18.42000156,0,1.562248635,1.066785366,1.464445131,0.143072365,0.253085125,10.26737579,0,0.272720794,1.179113557,0.231293069,0.817087131,0.884435236,5.327299703,0,-0.327061918,1.229477065,-0.266017095,0.790226043,0.857101091,N,-,,vacuolar transporter chaperone 1,"C:cell division site; C:vacuolar transporter chaperone complex; P:small GTPase mediated signal transduction; C:fungal-type vacuole membrane; P:vacuole fusion, non-autophagic; C:endoplasmic reticulum; P:vacuolar transport; P:polyphosphate metabolic process; P:regulation of establishment or maintenance of cell polarity regulating cell shape; P:regulation of catalytic activity; C:integral component of membrane; C:intrinsic component of vacuolar membrane; F:mRNA binding; F:GTPase regulator activity; P:lysosomal microautophagy",IPR003807 (PFAM),9.B.51.1.6, the uncharacterized duf202/yidh (yidh) family.
RL4_JR_07028,3839,3579,3582,13,18,171,0,0,0,1,10,1,3,38,2,0,15,1,68.69699731,1,1.475759374,0.581700513,2.53697451,0.01118151,0.04146307,7.159697644,0,0.625639306,1.241882561,0.503782987,0.614413884,0.746321533,18.58342083,1,-2.026902315,1.20350611,-1.68416454,0.092149874,0.182140829,127.2094964,1,2.55865623,0.461596071,5.543063283,2.97E-08,7.58E-07,72.35267725,1,1.787248001,1.324038918,1.349845519,0.17706554,0.294092617,N,-, Effector probability:0.883,dynein light chain,,IPR005334 (PFAM); IPR005334 (PANTHER); PTHR21255:SF4 (PANTHER),,
RL4_JR_07029,47,24,62,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,190.6569063,0,-2.836798886,0.851705941,-3.330725723,0.000866199,0.005329149,103.3670765,0,-0.668248606,1.046571241,-0.638512297,0.523140252,0.672528543,249.3550841,0,-0.2810154,0.683476421,-0.411155954,0.680958183,0.780605841,164.4784849,0,-5.388931146,1.24363006,-4.333226834,1.47E-05,0.000200237,196.5611071,0,-0.842465684,0.692075387,-1.217303345,0.223488822,0.35017399,N,-,,f-box domain containing,P:biological_process; C:cellular_component; F:molecular_function,G3DSA:1.20.1280.50 (GENE3D); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY),,
RL4_JR_07030,1850,466,851,2,0,0,0,0,0,0,0,1,0,0,0,0,3,0,114.004212,1,0.578790907,0.548411237,1.055395782,0.291244351,0.476051176,13.71473871,0,-0.312105994,1.24331875,-0.251026532,0.801793596,0.879851993,63.99138961,1,-0.138506119,0.7770363,-0.178249225,0.858527252,0.909842971,67.35863357,0,-0.639990829,0.781699144,-0.818717576,0.412947566,0.556580354,67.87046803,1,-0.047449618,0.70517136,-0.067288068,0.946352376,0.965519731,N,-,,choline-phosphate cytidylyltransferase,C:nuclear envelope; F:choline-phosphate cytidylyltransferase activity; P:CDP-choline pathway,IPR004821 (TIGRFAM); IPR004821 (PFAM); IPR014729 (G3DSA:3.40.50.GENE3D); PTHR10739 (PANTHER); PTHR10739:SF13 (PANTHER); SSF52374 (SUPERFAMILY),,
RL4_JR_07031,1078,833,976,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,164.5288422,0,-0.139686788,0.566976026,-0.246371595,0.805394593,0.901661738,26.00842942,0,-1.23536939,1.220131016,-1.01248913,0.311304242,0.472984319,132.2235686,0,-0.053131579,0.56593206,-0.093883318,0.925201846,0.955956798,119.8803908,0,-1.206072469,0.700037248,-1.722868994,0.084912219,0.173159358,106.4021408,1,-0.706995967,0.646481532,-1.093605822,0.274127895,0.406961345,N,-,,ring-15,C:intracellular part,IPR001841 (SMART); IPR018957 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR12983 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),3.A.20.1.2, the peroxisomal protein importer (ppi) family.
RL4_JR_07032,263,218,199,1,0,19,0,0,0,0,0,0,0,1,0,0,0,0,960.9783211,1,-1.646723166,0.384679182,-4.280770169,1.86E-05,0.000198098,281.6227362,0,-1.548822665,0.750284874,-2.064312795,0.038988069,0.097010135,867.8445109,0,-1.201302536,0.725150998,-1.656623985,0.09759552,0.190597424,769.372778,1,-3.318009709,0.540233205,-6.141810016,8.16E-10,2.70E-08,650.6289306,0,-3.499421642,0.657419482,-5.32296614,1.02E-07,2.28E-06,N,-,,5 -AMP-activated kinase subunit beta-2,P:signal transduction; P:phosphorylation; F:kinase activity,IPR032640 (PFAM); PTHR10343 (PANTHER); PTHR10343:SF53 (PANTHER); PTHR10343 (PANTHER); PTHR10343:SF53 (PANTHER); IPR014756 (SUPERFAMILY),,
RL4_JR_07033,6369,6163,5820,0,4,17,0,0,0,0,1,2,0,12,5,0,2,0,89.7893424,1,1.937952217,0.537950368,3.602474002,0.000315203,0.002249716,6.006702605,0,0.878863665,1.248908095,0.703705636,0.48161611,0.638747152,145.2469798,1,3.111645702,0.440546846,7.06314375,1.63E-12,1.25E-10,94.67013651,1,2.003568445,0.51369609,3.900299193,9.61E-05,0.001037045,30.64576181,1,0.332290915,0.881894791,0.376792015,0.706328175,0.792330243,N,-,,amidohydrolase family,,G3DSA:3.20.20.140 (GENE3D); IPR006680 (PFAM); PTHR21240 (PANTHER); PTHR21240:SF1 (PANTHER); IPR032466 (SUPERFAMILY),,
RL4_JR_07034,3651,4241,2938,0,0,9,0,0,0,0,0,3,0,8,2,0,0,0,111.8735964,1,0.138949807,0.554680775,0.250504098,0.802197536,0.900058795,17.41103851,0,-0.656438752,1.212420326,-0.541428363,0.588212362,0.725729586,81.88261632,1,-0.175208066,0.690430758,-0.253766311,0.799676102,0.868567842,80.92170107,1,-1.386962717,0.866443831,-1.60075318,0.109431597,0.209966823,91.20578114,0,0.594479444,0.658865918,0.902276818,0.366909837,0.503446177,N,-,,gtp-binding,P:positive regulation of sexual sporulation resulting in formation of a cellular spore,PTHR40625 (PANTHER); PTHR40625:SF2 (PANTHER); IPR014756 (SUPERFAMILY),,
RL4_JR_07035,952,952,1382,0,4,2,0,0,0,0,7,5,0,4,1,0,1,1,70.16269582,1,2.454890008,0.565363278,4.3421462,1.41E-05,0.000156396,2.564427726,0,2.106908434,1.288115796,1.635651422,0.101912562,0.205630649,6.638346892,1,-0.541845871,1.195710716,-0.453157995,0.650434977,0.757158067,59.1989373,1,2.369557686,0.608906896,3.891494255,9.96E-05,0.001067451,6.530633935,1,-0.621083686,1.193896116,-0.520215853,0.602913138,0.711562597,N,-,,Tumor susceptibility,P:negative regulation of protein polyubiquitination; F:ubiquitin binding; C:ESCRT I complex; P:cellular protein modification process; P:late endosome to vacuole transport; P:protein targeting to membrane; P:protein targeting to vacuole; C:cytoplasmic side of plasma membrane,IPR008883 (PFAM); IPR016135 (G3DSA:3.10.110.GENE3D); IPR017916 (PFAM); PTHR23306 (PANTHER); PTHR23306 (PANTHER); PTHR23306:SF3 (PANTHER); PTHR23306:SF3 (PANTHER); IPR017916 (PROSITE_PROFILES); IPR008883 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY); SSF140111 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_07036,5023,3822,4142,0,0,5,0,0,0,0,0,2,0,2,0,0,0,2,234.2100827,1,1.443572366,0.464083905,3.110584856,0.001867172,0.009891164,28.92928369,0,0.092777083,1.123098506,0.082608144,0.934163125,0.963775268,231.1082158,1,1.855046754,0.476159882,3.895848482,9.79E-05,0.001146631,250.8594818,1,1.639758799,0.450774608,3.637646777,0.00027514,0.002523366,202.5144653,1,1.702246498,0.599187294,2.840925561,0.004498281,0.016424485,N,-,,"indoleamine 2,3-dioxygenase",F:dioxygenase activity; P:oxidation-reduction process; F:heme binding,IPR000898 (PFAM); PTHR28657:SF1 (PANTHER); PTHR28657:SF1 (PANTHER); PTHR28657 (PANTHER); PTHR28657 (PANTHER); SSF140959 (SUPERFAMILY),,
RL4_JR_07037,1125,709,726,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.703168962,1,2.405680987,1.770988358,1.358383287,0.174342095,NA,0.228217237,0,5.597269558,1.841327881,3.039800579,0.002367348,0.015214845,0.585725488,0,2.961068946,1.309953594,2.260438049,0.023794077,0.063947767,0.675225779,0,2.539538952,1.415983949,1.793480041,0.072896199,0.155514964,0.571215605,0,2.893248898,1.262804759,2.291129232,0.02195594,0.058872854,Y,-,,---NA---,,no IPS match,,
RL4_JR_07038,3983,5410,5732,0,1,4,0,0,0,5,0,0,3,4,3,0,4,4,28.79200607,1,0.847280092,0.755584544,1.121357099,0.26213589,0.441513763,4.342258776,0,1.347097257,1.266167967,1.06391671,0.287366433,0.446854501,11.22407233,1,-1.299566651,1.201628475,-1.081504539,0.279472743,0.418671507,22.25705396,1,-0.771068984,1.150851142,-0.669998887,0.5028585,0.63996725,11.0304869,1,-1.377297963,1.201064028,-1.146731507,0.251492605,0.382279331,N,-,,isoflavone reductase family,,IPR016040 (G3DSA:3.40.50.GENE3D); IPR008030 (PFAM); G3DSA:3.90.25.10 (GENE3D); PTHR14194 (PANTHER); PTHR14194:SF49 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_07039,1214,1909,3091,0,3,9,0,0,0,0,0,0,0,2,1,0,0,0,198.3062839,1,-2.167148347,0.639888994,-3.386756717,0.000707241,0.004476082,62.21805638,0,-1.341332182,1.12001401,-1.197603039,0.231071593,0.381082487,178.5709469,0,-1.512367985,0.636347788,-2.37663745,0.017471251,0.050392861,241.8530781,1,-0.811470084,0.456920578,-1.775954342,0.075740443,0.159964953,173.1398804,0,-1.260627368,0.578065266,-2.18076996,0.029200436,0.073564173,N,-,,phosphatidylethanolamine methyltransferase,P:metabolic process,SSF57997 (SUPERFAMILY),,
RL4_JR_07040,6136,5542,4764,0,4,14,0,0,0,2,0,5,0,4,1,0,0,0,1.007539817,1,1.886911407,1.507995236,1.251271464,0.210835453,NA,0.319305477,0,5.112442475,1.67852859,3.045788142,0.002320713,0.015159195,0.831517407,1,2.45512343,1.256893556,1.953326452,0.050780925,0.114576796,4.971109253,1,2.977740206,1.175073129,2.534089268,0.011274001,0.053440664,0.822314961,0,2.369038442,1.238110127,1.913431115,0.055692884,0.121582353,N,-,,hypothetical protein MMYC01_205693,,no IPS match,,
RL4_JR_07041,92780,53310,54935,1,19,13,0,0,0,3,4,5,3,2,4,0,5,2,78.49477317,1,0.287698736,0.609358892,0.472133483,0.636831514,0.792787296,9.775995572,0,0.176266262,1.215335391,0.145035077,0.884683177,0.934426328,94.37304022,1,1.65818797,0.48901332,3.390885078,0.000696673,0.004311197,98.26798209,1,1.508974263,0.441803165,3.415489936,0.000636674,0.005087863,62.17850828,1,0.663083608,0.618608321,1.071895713,0.283766876,0.418032827,N,-,,b-zip transcription factor idi-4,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR004827 (SMART); IPR004827 (PFAM); G3DSA:1.20.5.170 (GENE3D); PTHR11462 (PANTHER); PTHR11462:SF40 (PANTHER); PTHR11462:SF40 (PANTHER); PTHR11462 (PANTHER); IPR004827 (PROSITE_PROFILES); SSF57959 (SUPERFAMILY),,
RL4_JR_07042,10915,8273,9811,2,4,8,0,1,1,0,1,6,1,10,1,0,4,0,469.0980035,1,6.861669325,1.197145883,5.731690198,9.94E-09,2.33E-07,66.94963673,1,6.427900519,0.641998881,10.01232355,1.35E-23,9.73E-21,3.374830947,1,0.43387922,1.225596259,0.354014804,0.723327789,0.812670129,3.893160669,1,0.011609951,1.230502038,0.009435134,0.992471964,0.995125632,3.334681239,1,0.34855653,1.227888027,0.283866707,0.776512532,0.845578553,Y,-,,glycoside hydrolase family 18,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR013781 (G3DSA:3.20.20.GENE3D); IPR001223 (PFAM); PTHR11177 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_07043,2216,5279,7042,0,2,1,0,0,0,0,0,0,0,0,0,0,1,0,48.70221454,1,-3.708280989,1.196743885,-3.098642103,0.001944097,0.010238828,15.48563711,0,-0.487385808,1.206735733,-0.403887773,0.686295248,0.800770086,46.79336859,0,-2.181783546,1.195077389,-1.825642059,0.067904196,0.143251111,54.51499628,0,-1.843281773,1.023476512,-1.801000561,0.071702791,0.153811602,39.86639713,1,-3.230882227,1.202386463,-2.687058053,0.007208442,0.024185889,N,-, Effector probability:0.584,tom core complex subunit,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_07044,17341,12767,16785,0,0,4,0,0,1,0,1,6,0,0,0,0,3,1,28.10574548,1,1.699982194,0.756604439,2.246857284,0.024649149,0.077910795,2.848243332,1,1.955326221,1.306571153,1.496532521,0.13451494,0.253643856,7.444317101,1,-0.707335146,1.223715045,-0.578022758,0.563248754,0.688354707,8.591464137,0,-1.130250333,1.225813659,-0.922040903,0.356507241,0.502594794,22.13185225,1,0.908303451,1.015094764,0.894796705,0.370895772,0.507132976,N,-,,meiotic recombination dmc1,C:holo TFIIH complex,IPR031349 (PFAM); PTHR37781 (PANTHER); PTHR37781 (PANTHER); PTHR37781:SF1 (PANTHER),,
RL4_JR_07045,3221,1318,1921,3,4,2,0,0,0,0,0,1,0,0,0,0,2,0,43.85608089,1,1.968311607,0.760122705,2.589465615,0.009612502,0.036764554,2.567186347,0,2.105380565,1.356790825,1.551735556,0.120725511,0.23477111,6.6586595,1,-0.546099824,1.244596078,-0.438776751,0.660823308,0.765816754,7.682634887,0,-0.968644958,1.249562023,-0.775187578,0.438228827,0.580008742,13.91073593,1,0.3197727,1.172643512,0.272693872,0.785088546,0.85308237,Y,-,,glycoside hydrolase family 16,P:metabolic process; F:beta-glucanase activity,IPR013320 (G3DSA:2.60.120.GENE3D); IPR000757 (PFAM); PTHR10963 (PANTHER); PTHR10963:SF36 (PANTHER); IPR000757 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),,
RL4_JR_07046,1572,797,1040,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,375.4339164,0,-2.851430378,0.615481617,-4.632844099,3.61E-06,4.71E-05,146.6388754,0,-1.534986863,0.985158286,-1.558111915,0.119206721,0.232308515,349.1939917,0,-1.487168456,0.497433476,-2.9896831,0.00279267,0.012892381,409.1493008,0,-1.339214312,0.462507961,-2.895548669,0.003784963,0.022489879,294.2542324,0,-2.459720356,0.678153978,-3.627082395,0.000286642,0.001688335,N,-, Effector probability:0.827,zinc knuckle,F:nucleic acid binding; F:zinc ion binding,IPR001878 (SMART); IPR001878 (PFAM); IPR001878 (G3DSA:4.10.60.GENE3D); IPR001878 (G3DSA:4.10.60.GENE3D); PTHR23002 (PANTHER); IPR001878 (PROSITE_PROFILES); IPR001878 (PROSITE_PROFILES); IPR001878 (PROSITE_PROFILES); IPR001878 (PROSITE_PROFILES); IPR001878 (PROSITE_PROFILES); IPR001878 (PROSITE_PROFILES); IPR001878 (PROSITE_PROFILES); IPR001878 (SUPERFAMILY); IPR001878 (SUPERFAMILY); IPR001878 (SUPERFAMILY),1.G.7.1.1, the reovirus fast fusion protein (r-fast) famly.
RL4_JR_07047,4173,4464,4847,5,7,3,0,0,2,0,0,1,4,3,1,0,0,0,2.678761679,1,0.476355991,1.25358233,0.379995777,0.70394855,0.839727461,0.853924886,1,3.693386328,1.438208326,2.568046828,0.010227334,0.034098107,24.35418121,1,2.875876051,1.038045446,2.7704722,0.005597508,0.020636988,26.62395934,1,3.895639344,0.643647622,6.052441137,1.43E-09,4.57E-08,9.900349596,0,2.626943759,0.989963095,2.653577465,0.007964349,0.02610089,N,-,,hypothetical protein SPI_01218,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_07048,93989,66857,46617,15,7,12,0,0,5,0,7,5,5,12,2,0,4,5,72.11106466,1,-0.2934209,0.864317558,-0.339482748,0.734246091,0.859641161,14.21222949,1,-0.363595891,1.273277776,-0.285558971,0.775215932,0.86389251,37.35491298,1,-3.034268087,1.25014405,-2.427134768,0.015218601,0.045020321,59.17357929,1,-0.827711786,0.888130332,-0.931971082,0.35135147,0.497891342,37.33371789,1,-3.136180683,1.269424789,-2.470552577,0.013490449,0.039892171,N,-,,Prp8 binding,C:integral component of membrane,IPR020472 (PRINTS); IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22847:SF501 (PANTHER); PTHR22847:SF501 (PANTHER); PTHR22847 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.15.2.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_07049,17942,17728,13057,12,14,2,0,0,0,6,6,2,4,5,9,0,3,1,48.5858388,1,1.262539802,0.590560707,2.137866247,0.0325276,0.096419743,5.64227583,0,0.96928408,1.243669064,0.7793746,0.435759081,0.597339304,81.03342485,1,2.100124794,1.638579001,1.281674422,0.199956881,0.325543865,16.85753536,1,-2.10239565,1.194515433,-1.760040592,0.078400924,0.164077999,18.22881139,1,-0.828510832,1.125067373,-0.736409972,0.461481238,0.592580537,N,-,,BET3 family,,IPR016721 (PIRSF); G3DSA:3.30.1380.20 (GENE3D); IPR007194 (PFAM); IPR016721 (PANTHER); IPR024096 (SUPERFAMILY),,
RL4_JR_07050,3967,3112,5440,7,7,10,0,0,2,0,0,0,0,4,0,0,0,1,371.1241857,1,-1.14535107,0.526623503,-2.174895466,0.029637951,0.089451129,94.77292269,1,-2.035792899,1.145980064,-1.776464498,0.075656388,0.163177917,278.8959984,0,-1.785678711,0.60862542,-2.933953548,0.003346743,0.014699534,377.4877073,1,-1.028332953,0.497871599,-2.065458153,0.038879671,0.105480449,222.5024461,1,-4.007074563,1.020193921,-3.927757735,8.57E-05,0.000609644,N,-,,som1,P:phosphorylation; F:kinase activity,PTHR12610:SF12 (PANTHER); PTHR12610 (PANTHER); PTHR12610 (PANTHER); PTHR12610:SF12 (PANTHER),3.A.2.1.9," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_07051,17571,17033,17496,1,1,12,0,0,0,0,0,2,2,2,0,0,4,3,0.015598098,1,7.897226533,3.974462125,1.986992525,0.046923225,NA,0.005173869,0,11.06112819,3.972197013,2.784637357,0.005358762,0.021575731,0.013163741,1,8.434663406,2.923591714,2.885034652,0.003913706,0.016192218,0.015162248,1,8.01507741,3.973383284,2.01719211,0.043675469,0.113446415,0.012785134,1,8.357399562,1.610627411,5.188909306,2.12E-07,4.23E-06,N,-,,hypothetical protein SPSK_09155,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_07052,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,105.3353686,0,-1.726189117,0.76032492,-2.270330844,0.023187517,0.074075846,26.09124205,0,-1.239951508,1.206586052,-1.027652778,0.304113188,0.465047637,67.56179353,0,-3.889123181,1.196110974,-3.25147354,0.001148085,0.006446594,144.0909717,0,-0.697133878,0.597118978,-1.167495764,0.243010218,0.381385127,122.1777707,0,-0.153499341,0.534377449,-0.287248913,0.773921736,0.843755527,N,-,,ATP dependent RNA helicase,C:nucleus; F:ATP binding; C:mitochondrion; P:RNA processing; F:ATP-dependent RNA helicase activity; F:poly(A) RNA binding,IPR007502 (SMART); IPR014001 (SMART); IPR001650 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR011545 (PFAM); IPR007502 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011709 (PFAM); PTHR18934:SF132 (PANTHER); PTHR18934 (PANTHER); PTHR18934:SF132 (PANTHER); PTHR18934 (PANTHER); PTHR18934:SF132 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.A.53.1.4, the hepatitis c virus p7 viroporin cation-selective channel (hcv-p7) family.
RL4_JR_07053,172,250,171,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27.72838009,0,-1.73498241,1.152245317,-1.505740474,0.132133809,0.270230037,7.695014717,0,0.521622264,1.246461321,0.418482511,0.675594371,0.792854054,19.86549532,0,-2.123211314,1.203127165,-1.764743891,0.077606818,0.159143494,22.90916948,0,-2.545045437,1.202553343,-2.116368019,0.03431352,0.099341681,19.49750027,0,-2.199061033,1.202297756,-1.829048604,0.067392327,0.14089352,N,-,,translational activator gcn1,P:regulation of translation; F:protein kinase binding; P:regulation of protein kinase activity; C:intracellular ribonucleoprotein complex; F:ribosome binding; P:cellular response to stress; P:positive regulation of kinase activity; F:protein kinase regulator activity,IPR011989 (G3DSA:1.25.10.GENE3D); IPR022716 (PFAM); IPR026827 (PANTHER); IPR033173 (PTHR23346:PANTHER),,
RL4_JR_07054,35282,41254,52082,8,14,2,0,0,2,2,1,3,0,13,3,0,21,0,239.6554167,1,-1.937838773,0.736243706,-2.63206158,0.008486848,0.033278288,111.8327343,1,0.315995861,0.734283901,0.43034562,0.666944246,0.787358253,196.0938589,1,-2.780131332,0.870854491,-3.192417747,0.001410871,0.007537856,318.3142484,1,-0.67531255,0.518564049,-1.302274137,0.192822689,0.322113468,194.6632556,1,-1.884345105,0.624609227,-3.016838405,0.002554259,0.010407194,N,-,,translational activator gcn1,F:protein kinase binding; P:regulation of translational elongation; P:regulation of protein kinase activity; C:cytosolic ribosome; F:structural constituent of ribosome; F:ribosome binding; C:mitochondrion; P:cellular response to stress; P:positive regulation of kinase activity; F:protein kinase regulator activity; P:translation,SM01349 (SMART); PF13513 (PFAM); IPR000357 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR011989 (G3DSA:1.25.10.GENE3D); IPR026827 (PANTHER); IPR033173 (PTHR23346:PANTHER); IPR021133 (PROSITE_PROFILES); IPR021133 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_07055,274,260,181,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,927.3161908,0,-0.424691246,0.912181956,-0.465577337,0.641518068,0.796091329,170.7128029,0,-3.949916889,1.199191861,-3.293815625,0.000988373,0.015023052,460.3643182,1,-4.782969219,1.047496875,-4.566094022,4.97E-06,0.000103723,649.5322294,0,-1.724221755,0.460818567,-3.741649924,0.000182816,0.001781533,547.0869667,0,-1.735087792,0.611655487,-2.836707639,0.004558133,0.016585631,N,-,,60s ribosomal l19,F:structural constituent of ribosome; C:cytosolic large ribosomal subunit; P:translation,IPR000196 (SMART); IPR015972 (G3DSA:1.10.1650.GENE3D); IPR015974 (G3DSA:1.10.1200.GENE3D); IPR000196 (PFAM); PTHR10722 (PANTHER); IPR000196 (SUPERFAMILY),,
RL4_JR_07056,64,57,83,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,207.3506917,0,-0.13546919,0.564611038,-0.239933654,0.81038169,0.903772226,47.04588013,0,-0.852059302,1.107280623,-0.769506197,0.441592867,0.602968164,163.1118713,0,-0.438175706,0.515049914,-0.850744159,0.394911487,0.538059334,319.4497947,0,0.786765244,0.661385247,1.189571809,0.234214732,0.37152188,127.5642413,0,-0.946163896,0.588126021,-1.608777477,0.107665007,0.201871889,N,-,,serine hydroxymethyltransferase,F:pyridoxal phosphate binding; P:L-serine metabolic process; F:glycine hydroxymethyltransferase activity; P:tetrahydrofolate interconversion; F:methyltransferase activity; P:glycine metabolic process; P:methylation,IPR015421 (G3DSA:3.40.640.GENE3D); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR001085 (PFAM); IPR001085 (PIRSF); IPR001085 (PANTHER); IPR001085 (HAMAP); IPR015424 (SUPERFAMILY),,
RL4_JR_07057,910,808,1009,0,0,0,7,0,0,0,0,2,0,0,4,0,2,1,45.19221481,0,0.197066715,0.754656405,0.261134357,0.793988898,0.894416104,6.838087602,1,0.691876795,1.228758919,0.563069602,0.57338749,0.713294354,33.48550113,1,-0.140468261,1.036578395,-0.135511469,0.892207497,0.93284196,20.53813996,1,-2.387480082,1.195869936,-1.996437916,0.045886277,0.116236817,17.60837491,1,-2.051944935,1.204777663,-1.703173123,0.088535675,0.174265884,N,-,,ureidoglycolate hydrolase,C:intracellular part; F:hydrolase activity,IPR024060 (G3DSA:2.60.120.GENE3D); IPR007247 (PFAM); PTHR21221:SF1 (PANTHER); IPR007247 (PANTHER); IPR011051 (SUPERFAMILY),,
RL4_JR_07058,1145,1705,1755,0,0,4,0,0,0,0,0,1,0,0,0,0,0,0,28.95306197,1,-2.957902599,1.184869513,-2.496395229,0.012546273,0.045524882,9.239807601,0,0.257669488,1.213934091,0.212259867,0.831904304,0.899156043,23.96178593,1,-2.393658172,1.187246541,-2.016142469,0.04378508,0.102138284,36.95480341,0,-1.86705445,1.137731179,-1.641033035,0.100790558,0.19689454,23.60547632,0,-2.474806415,1.189110854,-2.081224308,0.03741338,0.089342092,N,-,,ureidoglycolate hydrolase,F:hydrolase activity,IPR009097 (G3DSA:3.90.1140.GENE3D); IPR009097 (SUPERFAMILY),,
RL4_JR_07059,7665,8949,6207,4,0,18,0,0,0,4,0,1,5,7,0,0,7,3,589.6538925,1,-0.198228699,0.544409846,-0.364116668,0.71577089,0.847794399,103.3090374,0,-3.2253191,1.193329122,-2.702790907,0.006875999,0.025587815,308.2059258,1,-2.73557214,0.691229073,-3.957547864,7.57E-05,0.000969179,458.0552102,1,-0.936984401,0.479372879,-1.954604532,0.050629766,0.124152672,357.4988767,1,-1.176883772,0.528387056,-2.227313779,0.02592631,0.06727419,N,-,,60S ribosomal l44,F:structural constituent of ribosome; P:mycelium development; C:cytosolic large ribosomal subunit; P:translation,IPR000552 (G3DSA:3.10.450.GENE3D); IPR000552 (PFAM); IPR000552 (PANTHER); PTHR10369:SF3 (PANTHER); IPR000552 (PRODOM); IPR011332 (SUPERFAMILY),,
RL4_JR_07060,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,592.3101872,0,-2.856328062,0.481969008,-5.926372893,3.10E-09,7.77E-08,179.0286875,0,-3.024665547,1.126141451,-2.685866454,0.0072342,0.026578791,516.9986842,0,-2.722605301,0.578787024,-4.703984694,2.55E-06,5.94E-05,555.838567,0,-3.640453946,0.65050005,-5.596393033,2.19E-08,5.70E-07,483.7222284,0,-2.51690615,0.623424867,-4.037224503,5.41E-05,0.000415789,N,-,,GTPase activating,P:biological regulation,IPR001936 (SMART); IPR000008 (SMART); IPR000008 (PFAM); G3DSA:1.10.494.10 (GENE3D); IPR001936 (G3DSA:1.10.506.GENE3D); IPR000008 (G3DSA:2.60.40.GENE3D); IPR001936 (PFAM); PTHR10194 (PANTHER); IPR001936 (PROSITE_PROFILES); IPR008936 (SUPERFAMILY); IPR000008 (SUPERFAMILY),,
RL4_JR_07061,3368,4110,4822,1,1,7,0,1,0,1,0,0,0,1,0,0,0,2,1295.878517,1,-1.982435296,0.425095266,-4.663508286,3.11E-06,4.13E-05,345.1897064,1,-3.250272534,1.004874677,-3.234505364,0.001218536,0.015023052,943.206678,1,-2.959502634,0.515940066,-5.736136477,9.69E-09,4.09E-07,1091.211155,1,-3.23552384,0.84767523,-3.816938051,0.000135118,0.001379103,862.6580846,1,-4.336928147,0.75381528,-5.753303573,8.75E-09,4.22E-07,N,-,,peptidyl-prolyl cis-trans isomerase,F:peptidyl-prolyl cis-trans isomerase activity; P:protein peptidyl-prolyl isomerization; P:protein folding,IPR002130 (PRINTS); IPR019734 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR002130 (PFAM); IPR024936 (PANTHER); PTHR11071:SF263 (PANTHER); IPR002130 (PROSITE_PROFILES); IPR029000 (SUPERFAMILY); IPR011990 (SUPERFAMILY),3.D.1.8.1, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_07062,2334,2959,4979,0,1,0,0,0,0,0,0,0,0,6,0,0,0,0,5.891715976,1,-0.661229846,1.197168785,-0.552328004,0.580723647,0.754866717,1.880975907,0,2.554013465,1.314540168,1.942894958,0.052028851,0.12162495,4.880852644,0,-0.098321867,1.200060549,-0.081930755,0.934701777,0.960990232,5.630552358,1,-0.520648288,1.198321183,-0.434481419,0.663938885,0.771073196,26.91136047,0,2.051838164,0.843864014,2.431479635,0.015037294,0.0436004,N,-, Effector probability:0.704,D-tyrosyl-tRNA(Tyr) deacylase,F:D-tyrosyl-tRNA(Tyr) deacylase activity; C:cytoplasm; F:aminoacyl-tRNA editing activity; P:tRNA metabolic process,IPR023509 (G3DSA:3.50.80.GENE3D); IPR003732 (PFAM); IPR003732 (PANTHER); IPR023509 (SUPERFAMILY),,
RL4_JR_07063,24670,31906,46322,16,4,67,0,0,8,1,0,0,0,14,0,0,13,0,212.985719,1,-2.774598049,0.744060161,-3.728996919,0.000192244,0.001484514,55.20740038,1,-2.321275214,1.19286047,-1.945973794,0.051657888,0.120953305,191.281809,1,-1.565290873,0.615604677,-2.542688401,0.011000328,0.035298675,220.6798811,1,-1.840587753,0.569884416,-3.229756248,0.001238958,0.008884171,182.5039951,1,-1.438597821,0.554923056,-2.592427554,0.009530125,0.030182207,N,-,,ccr4-not transcription complex,"C:nucleus; C:cytoplasmic mRNA processing body; C:cytosol; P:regulation of transcription, DNA-templated; C:CCR4-NOT core complex; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",IPR007207 (PFAM); IPR007282 (PFAM); PTHR23326:SF1 (PANTHER); PTHR23326 (PANTHER),,
RL4_JR_07064,6898,6392,6772,0,3,8,0,0,0,3,2,10,5,2,5,0,10,4,2.027096278,1,0.878061545,1.441859469,0.608978589,0.542538631,NA,0.636486959,0,4.117032704,1.588909674,2.591105569,0.009566814,0.032626445,1.672892155,1,1.446110924,1.305755937,1.107489449,0.268082371,0.406114908,1.931221146,1,1.022922549,1.34567755,0.76015428,0.44716237,0.589290511,1.674470989,1,1.342570985,1.311649929,1.023574168,0.306036452,0.441210177,N,-,,transcription factor C2H2,F:nucleic acid binding; F:metal ion binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR14596:SF38 (PANTHER); PTHR14596 (PANTHER); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_07065,14757,10847,19328,4,5,1,0,0,0,0,2,0,0,0,0,0,0,1,809.7825573,1,-1.388768983,0.483377699,-2.873051416,0.004065279,0.018292637,192.430789,0,-4.122677186,1.233655465,-3.341838386,0.000832255,0.015023052,634.3190279,1,-1.849333814,0.512122304,-3.611117497,0.00030488,0.002352599,879.8095888,0,-0.827219595,0.468341399,-1.766274768,0.077349763,0.162550093,617.6643977,1,-1.672534992,0.724064877,-2.309924214,0.02089235,0.0565753,N,-,,isocitrate dehydrogenase,,IPR024084 (SMART); IPR004790 (TIGRFAM); IPR024084 (PFAM); IPR024084 (G3DSA:3.40.718.GENE3D); IPR004790 (PIRSF); IPR004790 (PANTHER); SSF53659 (SUPERFAMILY),,
RL4_JR_07066,6583,3652,5906,1,2,6,0,0,0,0,0,1,0,0,0,0,4,0,78.47871216,1,-0.363021248,0.6357714,-0.570993359,0.568004144,0.744860603,14.99476792,0,-0.440916079,1.207206885,-0.365236551,0.714934836,0.821124522,52.02548958,1,-1.278987664,1.038591589,-1.23146353,0.218149549,0.3471465,53.05457152,0,-1.797360786,1.023765552,-1.755637101,0.079150393,0.16510048,73.36570455,1,0.516541465,0.592296201,0.872099912,0.383153874,0.519196062,N,-,,hypothetical protein CMQ_1720,C:nucleus; P:chromatin remodeling; C:Ino80 complex,IPR032742 (PFAM),,
RL4_JR_07067,5,17,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,64.72797698,0,-3.085738925,1.179607844,-2.615902345,0.008899201,0.034472782,19.24000665,0,-0.800552532,1.222028951,-0.655101118,0.512402653,0.663143781,63.2266669,0,-1.648064297,1.060064559,-1.55468295,0.120021597,0.221854784,65.99277282,0,-2.173371393,1.050941155,-2.068023868,0.038637779,0.104959993,57.17976789,0,-2.612166814,1.152134594,-2.267241021,0.023375506,0.061666754,N,-,,MYG1,,IPR003226 (PFAM); IPR003226 (PANTHER),,
RL4_JR_07068,5877,4911,5382,0,0,9,0,0,0,3,5,2,5,20,1,0,21,8,113.4143022,1,-2.257408148,0.850046368,-2.655629427,0.007916055,0.031502037,28.51731883,0,-1.36826452,1.195551314,-1.144463231,0.252431578,0.406929835,113.7406451,1,-1.189832447,0.740360902,-1.607097896,0.108032895,0.205394371,104.0302222,1,-2.700636064,1.013252787,-2.665313235,0.007691664,0.039372144,91.65801582,1,-1.8825068,0.845108246,-2.227533348,0.02591165,0.067253384,N,-,,camp-regulated phospho family,,IPR006760 (PFAM); PTHR10358:SF6 (PANTHER); PTHR10358 (PANTHER),,
RL4_JR_07069,210,197,204,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0.185139047,0,4.331028568,3.099598013,1.39728718,0.162327229,NA,0.058487412,0,7.561094026,2.347918848,3.220338741,0.001280392,0.015023052,0.152537277,0,4.90187956,1.41492872,3.464400356,0.000531415,0.003534852,0.176041124,1,4.478873417,1.918215476,2.334916735,0.019547771,0.075899004,0.150994612,0,4.815966205,1.289852796,3.733733199,0.000188662,0.001184991,N,-,,hypothetical protein SPSK_08523,,no IPS match,,
RL4_JR_07070,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.68998191,0,-2.163239746,1.192969796,-1.813323148,0.069781995,0.17064127,5.307844416,0,1.057359234,1.236050372,0.855433774,0.392311053,0.556591725,20.29921998,0,-0.635936509,1.19226152,-0.533386759,0.593765881,0.712997958,15.92272444,0,-2.020262306,1.192153123,-1.694633237,0.090145018,0.181094902,28.36567779,0,0.006229634,0.977130528,0.006375437,0.994913172,0.995896774,N,-,,tubulin gamma chain,"C:interphase microtubule organizing center; C:equatorial microtubule organizing center; P:microtubule nucleation; C:gamma-tubulin complex; C:mitotic spindle pole body; C:microtubule; C:inner plaque of spindle pole body; F:GTP binding; C:nucleus; C:outer plaque of spindle pole body; P:mitotic cytokinesis, site selection; P:mitotic spindle midzone assembly; F:GTPase activity; P:mitotic spindle organization in nucleus; P:cytoplasmic microtubule organization",IPR002454 (PRINTS); IPR000217 (PRINTS); IPR003008 (SMART); IPR018316 (SMART); IPR003008 (G3DSA:3.40.50.GENE3D); IPR003008 (PFAM); IPR018316 (PFAM); IPR018316 (G3DSA:3.30.1330.GENE3D); IPR023123 (G3DSA:1.10.287.GENE3D); IPR002454 (PTHR11588:PANTHER); IPR000217 (PANTHER); IPR003008 (SUPERFAMILY); IPR008280 (SUPERFAMILY),,
RL4_JR_07071,2020,2359,3034,0,2,4,1,0,0,1,0,4,1,11,0,0,10,2,94.66106204,1,-2.837662069,1.060117864,-2.676742055,0.007434184,0.029920117,28.12807673,1,-1.348396039,1.235048923,-1.091775406,0.274931832,0.433062558,144.0355484,1,0.132689805,0.556956103,0.238241047,0.811694142,0.877479071,102.3400476,1,-2.643543354,1.047849033,-2.522828452,0.011641518,0.054645511,109.225527,1,-0.272971443,0.651078549,-0.419260385,0.675025845,0.768714057,N,-,,phospholipase d1,P:regulation of localization; P:regulation of cellular process; F:catalytic activity; P:phosphorus metabolic process; P:single-organism cellular process; P:organic substance metabolic process; C:intracellular,IPR001736 (SMART); IPR001736 (PFAM); IPR001683 (PFAM); IPR025202 (PFAM); G3DSA:3.30.870.10 (GENE3D); IPR016555 (PIRSF); PTHR18896:SF76 (PANTHER); PTHR18896:SF76 (PANTHER); IPR015679 (PANTHER); PTHR18896:SF76 (PANTHER); IPR015679 (PANTHER); IPR001736 (PROSITE_PROFILES); IPR001736 (PROSITE_PROFILES); SSF56024 (SUPERFAMILY); SSF56024 (SUPERFAMILY),,
RL4_JR_07072,1168,1530,1194,0,1,3,0,0,0,0,0,0,0,2,0,0,0,0,122.5050553,1,2.738091877,0.74865279,3.657358808,0.000254828,0.001895062,42.00164837,0,3.886762632,0.761536712,5.103841441,3.33E-07,3.40E-05,11.68129943,0,-1.357233706,1.198855573,-1.132107767,0.25758913,0.39411098,29.52493595,1,0.927045222,0.759210541,1.221064739,0.222061509,0.357224782,11.55630447,0,-1.444349175,1.206727228,-1.196914383,0.231339928,0.35897575,N,-,,c2h2 finger domain containing,F:metal ion binding,IPR007219 (PFAM),,
RL4_JR_07073,49008,37831,26383,14,33,11,0,0,1,2,5,5,6,2,0,0,9,0,2.598064525,1,0.520202654,1.342749278,0.387416074,0.698448206,0.837070731,0.81686291,1,3.757176842,1.494035826,2.514783633,0.011910545,0.038431158,2.140434593,1,1.090808619,1.265404619,0.862023579,0.388674543,0.532468345,2.470772218,1,0.667657799,1.287214751,0.51868408,0.603981065,0.724992091,2.131807174,1,0.994322689,1.271275963,0.782145434,0.434129108,0.568856894,N,-,,hypothetical protein CMQ_1420,,no IPS match,,
RL4_JR_07074,5370,6229,4938,1,0,119,7,0,7,8,12,31,58,83,40,2,63,62,7.19172489,1,1.089894438,1.160881017,0.938851116,0.347807191,0.537693966,1.071156334,1,3.366271161,1.390730093,2.420506451,0.015498904,0.047388757,2.788510317,1,0.709242936,1.214323193,0.58406439,0.559176992,0.685126409,32.91076146,1,3.580731991,0.632203804,5.66388872,1.48E-08,3.98E-07,2.759181767,1,0.622094911,1.216761927,0.511270855,0.60916141,0.717264714,N,-,,dna mismatch repair msh-2,F:protein kinase activity; P:protein phosphorylation; C:cellular_component,IPR032054 (PFAM),,
RL4_JR_07075,883,1226,1005,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,815.8761831,0,-1.126882422,0.398077173,-2.830813968,0.004642972,0.020529736,181.7360292,0,-4.04018596,1.209515228,-3.340334927,0.000836774,0.015023052,529.1685241,1,-2.88688545,0.585816626,-4.927967771,8.31E-07,2.29E-05,643.7989644,0,-2.547700786,0.474493512,-5.369305846,7.90E-08,1.83E-06,619.6725604,0,-1.417409805,0.533943611,-2.654605798,0.007940114,0.02605953,N,-, Effector probability:0.592,multi -bridging factor 1,C:nucleus; F:transcription coactivator activity; C:mitochondrion; F:sequence-specific DNA binding; P:positive regulation of transcription from RNA polymerase II promoter,IPR001387 (SMART); IPR001387 (PFAM); IPR010982 (G3DSA:1.10.260.GENE3D); IPR013729 (PFAM); PTHR10245 (PANTHER); IPR001387 (PROSITE_PROFILES); IPR010982 (SUPERFAMILY),,
RL4_JR_07076,3451,4056,5002,0,0,2,0,0,0,2,0,3,0,0,1,0,0,0,7.61153025,1,-1.030677307,1.274800577,-0.808500816,0.418802337,0.610323234,2.41005173,0,2.19632697,1.367755667,1.605788975,0.108320284,0.215152652,6.300572152,1,-0.466702684,1.254809576,-0.371931082,0.709944162,0.803428873,59.27732097,1,2.9667265,0.645346075,4.597109389,4.28E-06,6.67E-05,6.273973061,0,-0.563181496,1.270165207,-0.443392318,0.657481991,0.756134162,N,-,,cyclopropane-fatty-acyl-phospholipid synthase,C:membrane; C:integral component of membrane; F:molecular_function,IPR010775 (PFAM); PTHR33973:SF2 (PANTHER); PTHR33973 (PANTHER),,
RL4_JR_07077,528,646,849,0,0,0,0,0,0,0,0,0,3,1,0,0,0,0,98.64267945,0,1.608745017,0.636199656,2.528679482,0.011449253,0.042202452,30.63594472,0,1.346476531,1.175415257,1.14553263,0.251988587,0.406474658,72.46417304,0,0.957127886,0.773284216,1.237743984,0.215811005,0.344508138,33.05023515,1,-0.981615558,1.100559946,-0.891923753,0.372433802,0.518193245,21.41486375,0,-2.334291861,1.261054423,-1.851063537,0.064160413,0.135799237,N,-, Effector probability:0.936,glutathione-dependent formaldehyde-activating enzyme,F:carbon-sulfur lyase activity; P:metabolic process,IPR006913 (PFAM); IPR006913 (G3DSA:3.90.1590.GENE3D); PTHR33337 (PANTHER); PTHR33337:SF9 (PANTHER); IPR011057 (SUPERFAMILY),,
RL4_JR_07078,514,549,435,0,1,10,0,0,0,0,3,0,1,1,0,0,2,0,66.30568741,1,0.447190188,0.603732166,0.740709562,0.45886956,0.647142558,28.72378208,0,1.782663168,1.006457123,1.771226143,0.076523104,0.164696333,58.36084276,1,0.622346289,0.695643026,0.894634555,0.370982473,0.515263792,112.3608949,1,1.266772779,0.633311953,2.000235071,0.045474886,0.115502582,44.48712434,1,0.021414093,0.774527059,0.02764796,0.97794293,0.985339055,Y,-,,GPI anchored,,PTHR39599 (PANTHER); PTHR39599:SF2 (PANTHER),,
RL4_JR_07079,17665,18275,14831,19,28,8,0,0,5,0,3,14,0,0,2,0,7,3,72.43086372,1,-2.431643737,1.110224542,-2.190226972,0.02850778,0.086941453,20.34382029,1,-0.881047331,1.248461302,-0.70570656,0.48037064,0.637379431,53.39193099,1,-3.549586643,1.23800366,-2.867185903,0.004141397,0.016730846,74.95981029,1,-2.235637179,1.080559275,-2.068963019,0.038549557,0.10492319,53.29356069,1,-3.649666233,1.253972422,-2.91048365,0.003608698,0.013733113,N,-,,RNA methyltransferase,F:RNA methyltransferase activity; P:rRNA modification; P:RNA methylation,IPR013123 (SMART); IPR001537 (PFAM); IPR029026 (G3DSA:3.40.1280.GENE3D); IPR013123 (PFAM); IPR029064 (G3DSA:3.30.1330.GENE3D); PTHR12029:SF58 (PANTHER); PTHR12029 (PANTHER); PTHR12029 (PANTHER); PTHR12029:SF58 (PANTHER); IPR029064 (SUPERFAMILY); IPR029028 (SUPERFAMILY),,
RL4_JR_07080,896,1155,1349,0,0,3,0,0,0,0,0,1,1,0,0,0,0,4,107.7596841,1,-1.573192087,0.717881189,-2.191437958,0.028420115,0.086771722,28.53834535,0,-1.369284201,1.217958344,-1.124245511,0.260908887,0.417206912,91.14412307,1,-2.186160204,1.044909738,-2.092200049,0.036420624,0.0887205,100.8930921,1,-1.739379929,0.778576646,-2.234050993,0.025479718,0.085851084,79.39179968,1,-3.148699039,1.12820332,-2.790896803,0.005256223,0.018666873,N,-,,SNF2 family domain-containing,,IPR014001 (SMART); IPR001965 (SMART); IPR001650 (SMART); IPR000330 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PF15446 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001650 (PFAM); PTHR10799:SF655 (PANTHER); PTHR10799:SF655 (PANTHER); PTHR10799 (PANTHER); PTHR10799 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR016197 (SUPERFAMILY); IPR011011 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_07081,1464,1231,2072,0,0,4,0,0,0,0,0,0,0,2,0,0,0,1,144.5277624,1,-0.885248022,0.708728439,-1.249065189,0.211641232,0.378966016,28.0135946,0,-1.342521553,1.23694284,-1.08535456,0.277764649,0.436777036,137.7733621,0,-0.159025319,0.606617457,-0.262150911,0.793205098,0.863856326,182.4507406,1,0.421553308,0.488976772,0.862113156,0.388625253,0.533384617,175.3863171,1,0.791247241,0.491154237,1.610995449,0.107180714,0.201224686,N,-,,hypothetical protein SPI_00859,,no IPS match,1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_07082,2049,1989,1605,0,3,0,0,0,1,0,1,1,2,10,0,0,1,2,28.49506875,1,-2.935013313,1.206813107,-2.432036324,0.015014202,0.052523952,9.032552526,1,0.290316858,1.228342074,0.236348542,0.813162223,0.886942675,23.55239438,1,-2.368888796,1.203727899,-1.967960365,0.049072598,0.111532106,73.73951849,1,0.686078232,1.560719061,0.439591115,0.660233277,0.768374935,23.35247761,1,-2.45927618,1.214120498,-2.025561864,0.042809703,0.099141867,N,-,,U1 small nuclear ribonucleo C,C:commitment complex; F:zinc ion binding; P:mRNA 5'-splice site recognition; F:pre-mRNA 5'-splice site binding; F:U1 snRNA binding; C:viral nucleocapsid; F:mRNA binding; C:U2-type prespliceosome; C:U1 snRNP; P:spliceosomal snRNP assembly,IPR003604 (SMART); IPR013085 (PFAM); IPR017340 (PANTHER); IPR000690 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_07083,6477,4650,4653,2,7,9,0,0,0,0,6,8,1,3,2,0,4,0,132.2276025,1,1.356233314,0.432345222,3.136922173,0.001707314,0.009145286,12.73318914,0,-0.20504553,1.210112014,-0.16944343,0.865447866,0.92194673,91.63627669,1,0.90302904,1.392258777,0.648607181,0.516592313,0.647654216,82.23107833,1,0.250626842,0.587692541,0.426459116,0.669773333,0.775200617,70.68807424,1,0.647765839,0.575674759,1.125228836,0.260492077,0.392249,Y,-, Effector probability:0.646,endoplasmic reticulum vesicle 25,C:endoplasmic reticulum membrane; P:ER to Golgi vesicle-mediated transport; C:integral component of membrane; C:ER to Golgi transport vesicle,IPR009038 (SMART); IPR009038 (PFAM); PTHR22811:SF58 (PANTHER); IPR015720 (PANTHER); PS51257 (PROSITE_PROFILES); IPR009038 (PROSITE_PROFILES),9.B.188.1.4, the transmembrane emp24 domain-containing protein (tmed) family.
RL4_JR_07084,6077,7043,6560,0,8,15,0,0,0,5,0,4,2,6,5,0,3,9,39.99590598,1,-0.4045507,0.879116343,-0.460178796,0.64538789,0.79800127,7.712988532,0,0.51815969,1.233689115,0.420008318,0.674479377,0.79200467,89.35819827,1,1.849171565,0.56491848,3.273342317,0.001062837,0.006048431,32.52535716,1,-1.612904279,1.157173219,-1.393831323,0.163368547,0.283674591,19.94480441,1,-2.231705394,1.215082131,-1.836670409,0.066258566,0.139213111,N,-,,tpr repeat,"P:protein-FAD linkage; C:mitochondrial matrix; C:mitochondrion; P:mitochondrial electron transport, succinate to ubiquinone",IPR005631 (PFAM); IPR005631 (G3DSA:1.10.150.GENE3D); PTHR12469 (PANTHER); PTHR12469 (PANTHER); PTHR12469:SF2 (PANTHER); IPR005631 (SUPERFAMILY),,
RL4_JR_07085,477071,307885,384733,164,295,83,10,6,47,78,109,118,90,256,90,0,152,47,46.286659,1,-0.341169351,0.740522226,-0.460714532,0.645003427,0.79800127,9.88522266,1,0.160245706,1.211205293,0.13230268,0.894744888,0.941631083,69.93708454,1,0.342199624,0.736464894,0.464651644,0.642180942,0.750830334,56.24752053,1,-0.182787971,0.736046752,-0.248337447,0.803873328,0.8746204,25.29866428,1,-2.574745756,1.191319475,-2.161255491,0.030675609,0.076462467,N,-,,mis12-mtw1 family,P:chromosome segregation; C:condensed chromosome kinetochore,IPR013218 (PFAM); PTHR14778 (PANTHER),,
RL4_JR_07086,2113,2492,1806,11,9,3,0,0,3,0,0,0,0,6,0,0,4,2,266.0040308,1,-2.321246176,0.580446122,-3.999072593,6.36E-05,0.00057197,79.42181229,1,-1.747415594,1.113111979,-1.569847085,0.116450691,0.228123455,220.0335482,0,-1.91868943,0.627521718,-3.057566574,0.002231421,0.010762698,269.480128,1,-1.562290503,0.476987099,-3.275330732,0.001055383,0.007720923,216.3749962,1,-1.527934958,0.554638528,-2.754830185,0.00587226,0.020438858,N,-,,bzip transcription factor,"C:nucleus; F:transcription factor activity, sequence-specific DNA binding; P:positive regulation of nucleobase-containing compound metabolic process; P:cellular macromolecule metabolic process; P:positive regulation of macromolecule metabolic process; P:negative regulation of transcription, DNA-templated; P:cellular response to stress; F:sequence-specific DNA binding; P:single-organism cellular process; P:primary metabolic process; P:regulation of transcription from RNA polymerase II promoter",IPR002112 (PRINTS); IPR004827 (SMART); IPR021755 (PFAM); IPR020956 (PFAM); IPR021756 (PFAM); IPR004827 (PFAM); G3DSA:1.20.5.170 (GENE3D); PTHR19304 (PANTHER); PTHR19304:SF5 (PANTHER); IPR004827 (PROSITE_PROFILES); SSF57959 (SUPERFAMILY),,
RL4_JR_07087,4455,4041,3588,0,3,7,0,0,0,0,2,0,2,7,0,3,3,0,3.144838398,1,0.244812988,1.237454247,0.197835991,0.843173386,0.921089646,1.010916054,0,3.449963211,1.420974571,2.427885257,0.015187147,0.046611372,2.6085472,1,0.806017482,1.2197225,0.660820376,0.508727514,0.640352772,3.008323129,1,0.384084292,1.225265964,0.313470139,0.753923504,0.83863867,2.556033478,1,0.732204732,1.208046499,0.606106415,0.544444092,0.66607396,N,-,,hypothetical protein PFICI_14774,,no IPS match,,
RL4_JR_07088,1561,1843,1751,0,0,4,0,0,0,0,0,0,0,1,0,0,0,0,8.875159702,1,-1.252237066,1.188806428,-1.053356574,0.292177599,0.477194165,2.842871704,0,1.958193152,1.280646685,1.529065882,0.126248112,0.242298709,15.2019627,0,0.271243022,1.191683116,0.22761338,0.819946817,0.8839465,8.488144557,1,-1.112668777,1.192988202,-0.932673748,0.350988443,0.497706799,11.10058304,0,0.160375512,1.122482051,0.142875792,0.886388278,0.925387606,N,-,,Transcription factor,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR007219 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); IPR001138 (PFAM); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07089,1594,1128,1501,2,2,0,0,0,0,1,0,0,0,0,0,0,0,0,26.06132626,1,-1.325048071,1.157119705,-1.145126183,0.252156891,0.429546025,5.735412308,0,0.94554998,1.245779091,0.75900293,0.447850804,0.608802825,26.00680338,1,-0.750150828,1.2018421,-0.624167541,0.532517561,0.66214785,17.23465099,0,-2.134538871,1.20395788,-1.772934839,0.076239505,0.160750726,14.79605169,0,-1.800923463,1.213910141,-1.483572303,0.137922422,0.243343395,N,-,,chromosome condensation,,no IPS match,,
RL4_JR_07090,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27.12687814,0,-0.682324696,1.068520267,-0.638569728,0.52310288,0.707237868,6.15660999,0,0.843288628,1.268087001,0.665008494,0.50604506,0.659141436,22.60053044,0,-0.858475749,1.221329054,-0.702902912,0.482116256,0.618232423,18.58341796,0,-2.243217415,1.226396593,-1.829112563,0.067382747,0.147258864,16.02404704,0,-1.91594204,1.239170361,-1.54614902,0.122068582,0.222012645,N,-,,hypothetical protein SPI_03519,,no IPS match,,
RL4_JR_07091,1432,1554,2146,0,0,3,3,0,0,0,0,4,4,1,0,0,8,3,30.23503409,1,-1.624567367,1.161841668,-1.398269155,0.162032257,0.312422394,7.152500847,1,0.627080419,1.259470945,0.49789193,0.618560216,0.749246308,37.97304418,1,0.375395779,0.882115154,0.425563235,0.670426135,0.773227864,40.57849996,1,-0.681521612,1.03810997,-0.656502328,0.51150097,0.646560215,41.32012817,1,1.049841121,0.681637813,1.540174417,0.123517844,0.22378614,N,-,,Enolase,F:lyase activity,IPR000941 (PRINTS); IPR020811 (SMART); IPR020810 (SMART); IPR020811 (PFAM); IPR029065 (G3DSA:3.20.20.GENE3D); IPR000941 (PIRSF); IPR020810 (PFAM); IPR029017 (G3DSA:3.30.390.GENE3D); IPR000941 (PANTHER); PTHR11902:SF6 (PANTHER); IPR000941 (HAMAP); IPR029017 (SUPERFAMILY); IPR029065 (SUPERFAMILY),,
RL4_JR_07092,3487,2501,3523,0,2,12,0,0,0,0,0,1,0,2,1,0,0,0,86.900472,1,-2.482931599,1.047320882,-2.370745816,0.017752235,0.059597832,22.54710634,0,-1.02938838,1.222843076,-0.841799246,0.399900334,0.56368071,58.71762177,1,-3.686766041,1.213492679,-3.038144443,0.002380398,0.011362165,81.39463182,1,-2.373511058,1.046888675,-2.267204828,0.023377716,0.082704184,58.2006996,0,-3.776753783,1.222269104,-3.089952752,0.002001883,0.008495,N,-,,chromosome condensation,C:membrane; C:integral component of membrane,IPR003691 (PFAM); PTHR28259 (PANTHER); PTHR28259 (PANTHER); PTHR28259:SF1 (PANTHER); PTHR28259:SF1 (PANTHER); PTHR28259 (PANTHER); PTHR28259:SF1 (PANTHER),1.A.43.2.6, the camphor resistance or fluoride exporter (fluc) family.
RL4_JR_07093,7173,6642,7456,1,0,5,0,0,3,0,0,1,1,11,0,0,0,1,24.19365715,1,4.767296416,0.706031629,6.752241992,1.46E-11,5.91E-10,0.40782073,1,4.759342815,1.62617001,2.926719093,0.003425581,0.016598245,1.062220242,1,2.101209827,1.262317001,1.664565894,0.095999394,0.18813354,9.248766119,1,3.386938082,1.059171273,3.197724645,0.001385165,0.009725931,1.053042107,1,2.011538584,1.251654257,1.607104017,0.108031552,0.202334345,N,-,,hypothetical protein SAPIO_CDS6396,,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_07094,1738,1757,1440,2,0,1,0,0,4,0,0,0,0,3,0,0,0,2,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,Y,-,,tat pathway signal sequence,,IPR001148 (SMART); IPR001148 (G3DSA:3.10.200.GENE3D); IPR001148 (PFAM); PTHR18952:SF86 (PANTHER); IPR023561 (PANTHER); IPR001148 (PROSITE_PROFILES); IPR001148 (SUPERFAMILY),,
RL4_JR_07095,3,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,114.3068089,0,6.361574724,0.670721489,9.484674083,2.43E-21,3.61E-19,0.478849479,0,4.528043545,1.59661072,2.836034788,0.004567747,0.019450877,15.57743038,0,3.704169163,1.060417413,3.493123667,0.000477405,0.003259104,49.27863036,0,4.608080352,0.723281096,6.371078101,1.88E-10,6.79E-09,1.209527422,0,1.811961931,1.234242786,1.468075772,0.142083642,0.248720068,N,-,,salicylate hydroxylase,F:FAD binding; F:oxidoreductase activity; P:oxidation-reduction process,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789:SF183 (PANTHER); PTHR13789 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_07096,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.556846205,0,3.279989879,1.202346078,2.727991499,0.006372125,0.02650882,0.238451003,0,5.533983817,1.803267601,3.06886444,0.002148741,0.015045494,0.61335317,0,2.894838619,1.286947613,2.249383417,0.024488113,0.065396374,0.707212474,0,2.47291144,1.377782685,1.794848685,0.072677812,0.155402214,0.599010635,0,2.825093112,1.243151135,2.272525867,0.023054767,0.060963573,N,-,,glutathione s-transferase,F:transferase activity,IPR012336 (G3DSA:3.40.30.GENE3D); IPR010987 (G3DSA:1.20.1050.GENE3D); IPR004045 (PFAM); IPR012336 (SUPERFAMILY); IPR010987 (SUPERFAMILY),,
RL4_JR_07097,4211,3985,4440,0,7,8,0,0,0,0,0,0,0,0,0,0,2,0,0.512178298,1,2.862934804,1.953136469,1.465814012,0.142698963,NA,0.162721126,0,6.084942995,1.894808711,3.211375882,0.00132101,0.015023052,0.423360265,0,3.428670851,1.279284138,2.680148022,0.007358961,0.025575737,0.488485206,0,3.006287391,1.41467412,2.125074141,0.033580427,0.098209654,0.418558471,1,3.34328551,1.237057876,2.702610423,0.006879733,0.023281182,N,-,,serine threonine kinase,C:membrane; C:integral component of membrane; P:phosphorylation; F:kinase activity,G3DSA:3.90.1200.10 (GENE3D); IPR002575 (PFAM); PTHR21310 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_07098,74,85,71,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.063406631,0,5.876504249,3.92355742,1.497749012,0.134198473,NA,0.020877261,0,9.048377021,2.968505371,3.048125534,0.002302737,0.015159195,0.053179023,0,6.42244755,1.758687435,3.65184138,0.000260367,0.00208871,0.061269047,0,6.001503663,2.921595548,2.054187024,0.039957594,0.107481332,0.05153962,0,6.357736027,1.412433503,4.501263963,6.76E-06,7.24E-05,N,-,,integral membrane,C:bicellular tight junction; C:membrane; C:integral component of membrane; F:structural molecule activity; C:plasma membrane,IPR009571 (PFAM); PTHR28019:SF1 (PANTHER); PTHR28019 (PANTHER),1.H.1.4.1, the claudin tight junction (claudin1) family.
RL4_JR_07099,3488,2877,3375,0,0,1,0,0,0,0,0,1,0,0,0,0,5,0,0.034946441,1,6.734755543,3.937153863,1.710564478,0.087161541,NA,0.010673917,0,10.01146553,3.9385137,2.541940004,0.011023909,0.036218122,0.02870297,1,7.307321952,2.727957383,2.678678926,0.007391323,0.025644193,0.03317433,0,6.88469245,3.937336611,1.748565879,0.080366089,0.166879953,0.029489242,1,7.170875884,1.8901677,3.793777603,0.000148373,0.000966092,Y,-,,tat pathway signal sequence,P:lipid metabolic process; C:membrane; C:integral component of membrane; F:phosphoric diester hydrolase activity; F:hydrolase activity,IPR017946 (G3DSA:3.20.20.GENE3D); PTHR13593:SF51 (PANTHER); PTHR13593 (PANTHER); IPR000909 (PROSITE_PROFILES); IPR017946 (SUPERFAMILY),,
RL4_JR_07100,2383,3013,2550,0,1,2,0,0,1,0,0,2,0,1,0,0,0,2,59.71702021,1,-2.094982654,1.055109477,-1.985559507,0.047082256,0.127226581,16.48194144,1,-0.577353664,1.223291595,-0.471967327,0.63695011,0.762802771,57.38287097,1,-1.419297308,1.056216728,-1.343755756,0.179027381,0.299087988,75.02936327,1,-0.641776249,0.722681348,-0.888048724,0.374514543,0.520180339,46.61759144,1,-2.404058788,1.154255467,-2.082778776,0.037271393,0.089104217,N,-,,impact family,P:mycelium development; P:regulation of primary metabolic process; P:regulation of cellular metabolic process,IPR001498 (PFAM); IPR001498 (G3DSA:3.30.230.GENE3D); IPR016135 (G3DSA:3.10.110.GENE3D); IPR023582 (PANTHER); PTHR16301:SF7 (PANTHER); IPR020568 (SUPERFAMILY),,
RL4_JR_07101,1964,1485,1557,1,0,0,6,0,0,0,0,1,0,0,5,0,0,0,18.67276523,1,0.154053289,1.030054118,0.149558442,0.881112998,0.94187837,3.550656444,1,1.637512422,1.289601928,1.269781307,0.204162541,0.348958669,9.155741677,1,-1.005561347,1.20808843,-0.832357403,0.405207239,0.547559808,10.55850356,1,-1.42739202,1.207201927,-1.182397068,0.237048186,0.374797263,16.32977285,0,-0.142104247,1.130446077,-0.125706347,0.899964377,0.935233549,N,-, Effector probability:0.588,disease resistance,C:membrane; C:integral component of membrane,IPR009288 (PFAM); IPR013024 (G3DSA:3.10.490.GENE3D); PTHR31544 (PANTHER); PTHR31544:SF2 (PANTHER); IPR013024 (SUPERFAMILY),,
RL4_JR_07102,7882,4838,5388,0,3,4,0,0,0,0,2,0,1,13,0,0,10,1,145.0509871,1,-0.785101096,0.703729719,-1.115628734,0.264581087,0.444400352,49.35442356,0,0.133377025,1.091033085,0.122248378,0.902702314,0.945092348,84.77890269,1,-3.139781658,1.252042868,-2.507726962,0.012151052,0.037597152,117.1972058,1,-1.783081105,0.850466426,-2.096591999,0.036029708,0.100941006,76.03958602,1,-4.162471278,1.25245243,-3.323456586,0.000889093,0.004344625,N,-,,abc-2 type transporter,,IPR001278 (PRINTS); IPR008909 (SMART); IPR003593 (SMART); IPR003439 (PFAM); IPR008909 (PFAM); IPR001278 (PFAM); IPR010929 (PFAM); IPR013525 (PFAM); IPR014729 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001278 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005148 (G3DSA:3.30.1360.GENE3D); IPR029481 (PFAM); IPR009080 (G3DSA:1.10.730.GENE3D); PTHR19241 (PANTHER); PTHR19241 (PANTHER); PTHR19241 (PANTHER); PTHR19241:SF216 (PANTHER); PTHR19241:SF216 (PANTHER); PTHR19241:SF216 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); SSF52374 (SUPERFAMILY); IPR005148 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR009080 (SUPERFAMILY),3.A.1.205.27, the atp-binding cassette (abc) superfamily.
RL4_JR_07103,2667,2424,2174,1,3,11,0,0,0,2,0,7,5,2,3,0,0,6,40.0510265,1,-0.631197973,0.840541507,-0.750942062,0.452687525,0.641707181,9.138144351,0,0.273626274,1.214682331,0.225265707,0.821772576,0.892678902,23.68678753,1,-2.377043642,1.186774815,-2.002944124,0.045183286,0.104748246,35.34702873,1,-1.069654681,1.008214323,-1.060939779,0.28871727,0.433208827,23.33208328,1,-2.45803339,1.188421947,-2.068317063,0.038610218,0.091530897,Y,-,,Chitin- domain 3,C:viral capsid; F:hydrolase activity,PTHR36182 (PANTHER); PTHR36182:SF2 (PANTHER),,
RL4_JR_07104,1802,1748,1773,0,0,1,0,0,0,0,2,1,1,3,1,0,4,0,750.1352011,1,-3.276698311,1.055484906,-3.104448289,0.001906342,0.010065982,222.7432821,0,-4.333717933,1.234034566,-3.511828642,0.000445035,0.015023052,573.5664426,1,-6.974825286,1.227332849,-5.682912578,1.32E-08,5.52E-07,684.6064661,1,-5.056695792,0.903135374,-5.599045214,2.16E-08,5.64E-07,599.887844,1,-3.383539748,0.682274688,-4.959204564,7.08E-07,1.08E-05,N,-,,histone acetylase complex subunit,P:DNA repair; C:SAGA-type complex; P:histone acetylation; P:phosphorylation; F:kinase activity,IPR000403 (SMART); IPR003152 (SMART); IPR003151 (PFAM); IPR000403 (G3DSA:1.10.1070.GENE3D); IPR000403 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR11139 (PANTHER); IPR033317 (PTHR11139:PANTHER); PTHR11139 (PANTHER); IPR033317 (PTHR11139:PANTHER); IPR033317 (PTHR11139:PANTHER); IPR033317 (PTHR11139:PANTHER); IPR033317 (PTHR11139:PANTHER); PTHR11139 (PANTHER); PTHR11139 (PANTHER); IPR033317 (PTHR11139:PANTHER); PTHR11139 (PANTHER); IPR014009 (PROSITE_PROFILES); IPR000403 (PROSITE_PROFILES); IPR003152 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_07105,1190,969,1298,0,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0.072025209,0,5.692913715,3.921554658,1.451698169,0.146585549,NA,0.022384303,1,8.945621359,2.920408287,3.063140657,0.002190271,0.015045494,0.059090892,1,6.268095291,1.73313776,3.616616887,0.000298479,0.002316709,0.06824319,0,5.845522339,2.826570525,2.068061733,0.038634218,0.104959993,0.059273911,0,6.166602562,1.420303807,4.34174895,1.41E-05,0.000134007,N,-,,glycoside hydrolase family 18,"P:macromolecule metabolic process; C:membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds; P:primary metabolic process",IPR011583 (SMART); IPR001002 (G3DSA:3.30.60.GENE3D); IPR013781 (G3DSA:3.20.20.GENE3D); IPR001223 (PFAM); PTHR11177:SF218 (PANTHER); PTHR11177 (PANTHER); IPR001002 (PRODOM); IPR001002 (SUPERFAMILY); IPR017853 (SUPERFAMILY),9.B.29.2.7, the small 4-5 tms putative permease (4-5pp) family.
RL4_JR_07106,4726,4703,2704,0,2,5,0,0,0,0,0,2,0,1,0,0,1,2,0.01945219,1,7.578995213,3.961154526,1.913329854,0.055705838,NA,0.006172944,0,10.80242385,3.961531915,2.726829944,0.006394599,0.024293008,0.016176062,1,8.134334048,2.743339398,2.965121287,0.003025636,0.013662596,0.018666501,1,7.714042116,3.960923314,1.947536346,0.051470467,0.125322509,0.016201367,1,8.027987584,1.556646785,5.157231339,2.51E-07,4.63E-06,N,-, Effector probability:0.63,hypothetical protein AUD_9490,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_07107,2339,2540,1721,0,0,6,0,0,0,3,1,2,14,16,2,2,0,17,0.091070088,1,5.354241684,3.918464797,1.366413114,0.171809335,NA,0.028048055,0,8.619667445,2.887423734,2.985245062,0.002833512,0.015349618,0.074667712,1,5.929474011,1.787812616,3.316608216,0.000911173,0.005332205,0.086266727,1,5.506990124,2.719859265,2.024733483,0.042894738,0.112719511,0.07567741,1,5.812221317,1.521073099,3.821132148,0.00013284,0.000879666,N,-, Effector probability:0.934,hypothetical protein MAPG_03108,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_07108,4168,2899,4926,9,0,0,0,0,0,1,0,1,0,0,0,0,0,0,4.717859704,1,-0.340267732,1.215496227,-0.279941413,0.779522454,0.886566873,1.514428957,0,2.866839284,1.35969895,2.108436786,0.034993225,0.089174254,3.910555873,1,0.221862012,1.211653653,0.183106791,0.854714228,0.907901833,14.14541347,0,0.750618252,1.15260158,0.651238264,0.514892693,0.649711929,3.83383702,0,0.147407598,1.203632188,0.122468973,0.902527617,0.937432511,N,-,,ABC integral membrane type 1,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003593 (SMART); IPR011527 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); G3DSA:1.20.1560.10 (GENE3D); PTHR24223:SF257 (PANTHER); PTHR24223 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR011527 (SUPERFAMILY); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.208.41, the atp-binding cassette (abc) superfamily.
RL4_JR_07109,5569,7722,4791,0,4,5,0,0,1,5,0,0,2,9,1,0,0,0,6.234882198,1,-0.742947158,1.201702513,-0.618245489,0.536413529,0.719628608,1.996983405,1,2.467693716,1.319048983,1.870812797,0.061371033,0.138598304,5.172403026,1,-0.181981604,1.205081561,-0.151011857,0.879966363,0.925185616,5.966096523,1,-0.604116227,1.203978969,-0.501766428,0.615831831,0.73478947,5.094368407,0,-0.262804233,1.205044654,-0.218086717,0.827361547,0.884308808,N,-,,destruxin partial,F:RNA binding; F:catalytic activity; P:metabolic process; F:methyltransferase activity; F:phosphopantetheine binding; P:methylation,G3DSA:3.30.300.30 (GENE3D); IPR001242 (PFAM); PTHR24095 (PANTHER); PTHR24095:SF198 (PANTHER); SSF56801 (SUPERFAMILY); SSF52777 (SUPERFAMILY),,
RL4_JR_07110,1759,890,1654,0,1,3,0,0,0,0,0,1,1,7,0,0,0,1,2.889098899,1,0.366770635,1.264513335,0.290048847,0.771778868,0.880706673,0.926950847,0,3.574932771,1.447369887,2.469951048,0.013513154,0.042373032,2.399893141,1,0.925764609,1.234085031,0.750162741,0.453156696,0.59258052,2.767972535,1,0.503765295,1.244605812,0.404758912,0.685654733,0.786836017,2.364198948,1,0.84462852,1.229771439,0.68681748,0.492197753,0.620688149,N,-,,nonribosomal peptide synthase,F:catalytic activity; P:metabolic process; F:phosphopantetheine binding,G3DSA:2.30.38.10 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR000873 (PFAM); SSF56801 (SUPERFAMILY),,
RL4_JR_07111,454,449,327,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.609216191,0,0.045695287,1.242957692,0.036763348,0.970673698,0.984504494,1.155767035,0,3.256629859,1.405047947,2.317806924,0.020459817,0.058534275,2.995932736,0,0.605720916,1.226407242,0.493898678,0.621377738,0.734738171,3.455705104,0,0.183599725,1.232466777,0.14896931,0.88157785,0.92661179,2.954888919,0,0.522944312,1.225535819,0.426706673,0.66959299,0.765007013,N,-,,nonribosomal peptide synthase,F:catalytic activity; P:metabolic process; F:phosphopantetheine binding,IPR009081 (PFAM); IPR001242 (PFAM); IPR009081 (G3DSA:1.10.1200.GENE3D); PTHR24095:SF198 (PANTHER); PTHR24095 (PANTHER); IPR009081 (PROSITE_PROFILES); SSF52777 (SUPERFAMILY); IPR009081 (SUPERFAMILY),,
RL4_JR_07112,422,309,411,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.739207758,0,-0.85515697,1.213728004,-0.704570519,0.48107755,0.669500594,2.160985522,0,2.353817236,1.325876917,1.775290908,0.075849866,0.163490703,5.595594293,0,-0.2954486,1.214286153,-0.243310524,0.807764852,0.874164764,6.453948356,0,-0.71751384,1.21453081,-0.590774507,0.554671518,0.68363349,9.372450699,0,0.552193125,1.143314235,0.482975815,0.629112908,0.732879696,N,-,,nonribosomal peptide,F:catalytic activity; F:binding,SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY),,
RL4_JR_07113,1187,963,934,0,0,7,0,0,0,0,0,0,1,0,0,0,0,0,5.677282485,1,-0.607756911,1.200906982,-0.506081587,0.612799376,0.777846166,1.819659875,0,2.601863217,1.327834717,1.959478228,0.050056807,0.117968569,20.39604188,0,1.777458355,1.036495858,1.714872608,0.086368586,0.172907962,5.432702229,1,-0.468960303,1.203386079,-0.389700622,0.696757937,0.795699764,4.635279609,0,-0.126576428,1.202647403,-0.105248162,0.916178895,0.946417202,N,-,,peptide synthetase,F:catalytic activity; P:nitrogen compound metabolic process; P:metabolic process; F:phosphopantetheine binding; F:glutamate-ammonia ligase activity,IPR001242 (PFAM); PTHR24095:SF198 (PANTHER); PTHR24095 (PANTHER); SSF52777 (SUPERFAMILY),,
RL4_JR_07114,560,269,336,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,2.306992394,1,0.691869519,1.330904658,0.519849048,0.603168791,0.77127047,0.730504808,0,3.918549903,1.502444467,2.608116299,0.009104202,0.031419274,1.901367317,0,1.262118057,1.252941199,1.007324253,0.313778979,0.45616002,24.83023845,0,3.174026888,0.894819967,3.547112273,0.000389479,0.003387861,1.877523428,0,1.177717103,1.248704278,0.943151332,0.345603503,0.48278635,N,-,,3-hydroxyacyl- dehyrogenase,F:3-hydroxyacyl-CoA dehydrogenase activity; F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:NAD+ binding; P:fatty acid metabolic process,IPR006108 (PFAM); IPR013328 (G3DSA:1.10.1040.GENE3D); IPR006176 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR23309:SF20 (PANTHER); PTHR23309 (PANTHER); IPR008927 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_07115,303,285,326,0,0,0,0,0,2,2,0,0,0,2,0,0,0,0,343.9134238,0,-2.031273186,0.847693973,-2.396234079,0.016564508,0.056513829,117.7313588,1,-0.917297188,1.00895912,-0.909151986,0.363269905,0.527881402,367.9139507,1,-0.768505635,0.6299175,-1.220009978,0.222461093,0.352456354,487.6377198,1,-0.303159289,0.579516661,-0.523124372,0.600887706,0.722602894,310.1106826,0,-1.853566925,0.80756199,-2.295262716,0.021718073,0.058420693,N,-,,fungal transcriptional regulatory,"P:regulation of transcription, DNA-templated; F:binding",IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR021858 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07116,3013,3847,3295,1,3,14,0,0,0,0,0,5,0,9,0,0,0,0,531.0380242,1,1.401974619,0.521763295,2.68699357,0.007209834,0.029182168,57.38518773,0,-1.203338436,1.125289163,-1.069359304,0.284907797,0.444487781,411.255604,1,1.214861797,0.350654919,3.464550852,0.000531118,0.003534852,504.8340711,1,1.250124991,0.388670832,3.216410616,0.00129805,0.009223517,243.0463525,0,0.235130875,0.454813058,0.516983562,0.605167634,0.71380735,N,-, Effector probability:0.81,glutathione peroxidase,C:nucleus; F:glutathione peroxidase activity; C:mitochondrion; F:thioredoxin peroxidase activity; P:cellular oxidant detoxification; C:cytosol; P:cell redox homeostasis; P:oxidation-reduction process; P:cellular response to hydrogen peroxide; P:hydrogen peroxide catabolic process,IPR000889 (PRINTS); IPR000889 (PFAM); IPR000889 (PIRSF); IPR012336 (G3DSA:3.40.30.GENE3D); IPR000889 (PANTHER); IPR000889 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY),,
RL4_JR_07117,2366,2111,1852,0,4,5,0,0,0,0,0,0,1,1,4,0,1,0,116.1470097,1,0.934491175,0.535486356,1.745126024,0.080962934,0.190064359,77.79063193,0,2.246357128,0.844492519,2.660008322,0.007813872,0.028086652,63.38940364,0,0.195734514,0.750089972,0.260948048,0.794132571,0.864308552,53.94460508,1,-0.333998509,0.755577782,-0.442043846,0.658457478,0.7671901,35.67865332,1,-1.055434902,0.990518983,-1.065537279,0.286632865,0.421213028,N,-,,fad dependent oxidoreductase,F:oxidoreductase activity; C:membrane; P:oxidation-reduction process,IPR023753 (G3DSA:3.50.50.GENE3D); IPR006076 (PFAM); PTHR13847 (PANTHER); PTHR13847:SF150 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_07118,2004,1814,1796,0,1,2,0,0,0,0,0,1,2,9,1,0,0,2,37.8433222,1,3.965869378,0.517510397,7.663361741,1.81E-14,1.12E-12,1.108877823,0,3.316422699,1.379750747,2.403638996,0.016232795,0.049061913,15.87432994,1,2.484791608,1.032296898,2.407051317,0.01608191,0.04707708,3.318846178,1,0.242139189,1.20536023,0.200885331,0.840788238,0.900653926,18.27768158,1,3.191977363,0.75351518,4.236115541,2.27E-05,0.000200577,N,-,,dihydrodipicolinate synthase,P:metabolic process; F:lyase activity,IPR002220 (PRINTS); IPR002220 (SMART); IPR002220 (PFAM); IPR002220 (PIRSF); IPR013785 (G3DSA:3.20.20.GENE3D); IPR002220 (PANTHER); PTHR12128:SF24 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_07119,1744,1287,1464,0,0,0,0,0,0,0,0,0,0,4,2,0,3,0,5.198162289,0,-0.48031163,1.247911545,-0.384892368,0.70031716,0.838694568,1.641597679,0,2.750321256,1.358578455,2.024411064,0.042927874,0.104627003,4.287119048,0,0.088850267,1.228928718,0.072298959,0.942363993,0.96563695,4.947828768,1,-0.334080438,1.233238213,-0.270896924,0.786470311,0.861704567,4.253865212,1,-0.002434608,1.237519838,-0.001967328,0.9984303,0.998660594,N,-,,d-galacturonic acid reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR016040 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.360.10 (GENE3D); IPR000683 (PFAM); PTHR22604:SF133 (PANTHER); PTHR22604 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_07120,16798,16912,22240,10,11,28,0,0,2,1,4,0,3,24,6,0,16,8,15.47014446,1,-2.053673756,1.195288282,-1.71814096,0.085770907,0.197996339,4.91985063,1,1.166889002,1.242190583,0.93938001,0.347535673,0.510399093,41.42515712,1,0.925983845,0.851907579,1.086953406,0.277057402,0.41603814,14.7526978,1,-1.910093175,1.193700812,-1.600143985,0.109566645,0.210186109,16.4833398,1,-0.642019668,1.129935106,-0.568191629,0.569904855,0.686041423,N,-,,anaphase-promoting complex subunit 6,F:ubiquitin-protein transferase activity; P:negative regulation of DNA-dependent DNA replication initiation; C:anaphase-promoting complex; P:anaphase-promoting complex-dependent catabolic process; C:cytosol; P:positive regulation of mitotic metaphase/anaphase transition; P:protein ubiquitination,IPR019734 (SMART); IPR019734 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); PF13432 (PFAM); PF12895 (PFAM); PTHR12558 (PANTHER); PTHR12558:SF9 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY),8.A.95.1.1, the transmembrane and tpr repeat-containing protein 3 (tmtc3) family.
RL4_JR_07121,18489,15131,16692,2,5,1,0,0,0,0,0,0,3,9,3,0,18,2,72.97936107,1,-4.291754691,1.231877577,-3.483913314,0.00049414,0.003340704,23.02139784,0,-1.059429259,1.222739318,-0.866439186,0.386249363,0.550960548,60.20824197,0,-3.722924159,1.217180211,-3.058646636,0.002223392,0.010729087,88.11548648,1,-2.378063579,1.051557831,-2.261467233,0.02373034,0.083109543,63.72629303,1,-2.890125686,1.161028585,-2.489280387,0.012800197,0.038321111,N,-,,nucleolar 16,P:ribosome biogenesis; C:intracellular part,IPR019002 (PFAM); PTHR13243 (PANTHER),,
RL4_JR_07122,76,68,118,0,0,0,0,0,0,0,0,1,2,8,2,0,0,1,85.17310778,0,0.906717907,0.639991425,1.416765712,0.156551437,0.306049994,7.942273248,0,0.475908082,1.226006379,0.388177493,0.697884688,0.808347822,50.70189338,1,0.640545782,0.752720401,0.850974387,0.394783581,0.537998246,79.73102635,1,0.962838337,0.589540758,1.633200629,0.102426808,0.199513549,20.46313774,1,-2.268732188,1.206648117,-1.8801937,0.060081684,0.12888285,N,-,,chaperone-binding,,no IPS match,,
RL4_JR_07123,82,82,102,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.643871577,0,1.180351293,1.323260507,0.892002207,0.372391749,NA,0.524629782,0,4.396068807,1.542757736,2.849487449,0.004378973,0.018901479,1.362534973,0,1.742216334,1.235148458,1.410531926,0.158382676,0.272930419,1.57185463,0,1.320007778,1.258086894,1.049218289,0.294077663,0.43851787,1.346116634,0,1.657251309,1.226343217,1.351376422,0.176574883,0.293422072,N,-,,multidrug resistance fnx1,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501:SF60 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.48.3, the major facilitator superfamily (mfs).
RL4_JR_07124,248,250,261,2,0,0,0,0,0,0,0,2,3,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_07125,1162,2367,1575,0,4,0,0,0,0,2,0,0,0,1,0,0,0,0,12.98475649,1,-0.350889814,1.141514966,-0.307389587,0.758546853,0.872779853,2.938736621,0,1.910374363,1.281135684,1.491156937,0.135920297,0.255674641,7.599068402,1,-0.736744056,1.196238221,-0.615884063,0.537971041,0.66663633,12.7762644,1,-0.211652772,1.144491301,-0.184931744,0.853282572,0.908176815,7.464858025,0,-0.813954818,1.192369104,-0.682636623,0.494836487,0.623006643,Y,-, Effector probability:0.779,glycoside hydrolase family 45,P:polysaccharide catabolic process; F:cellulase activity,IPR009009 (PFAM); IPR009009 (G3DSA:2.40.40.GENE3D); IPR007112 (PROSITE_PROFILES); IPR009009 (SUPERFAMILY),,
RL4_JR_07126,140,99,131,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,8.949069072,1,0.482679986,1.194056276,0.404235542,0.68603952,0.828896683,1.620845505,0,2.768618571,1.370589421,2.020020385,0.043381273,0.105498605,17.23597286,0,1.91605768,1.071121933,1.788832457,0.073641802,0.152960869,58.33145958,0,3.838978909,0.614993896,6.242304088,4.31E-10,1.48E-08,4.217168529,1,0.009978546,1.248372994,0.007993241,0.993622384,0.995368843,Y,-,,glycosyl hydrolase family 76,"F:mannan endo-1,6-alpha-mannosidase activity; P:carbohydrate catabolic process; C:integral component of membrane",IPR014480 (PIRSF); IPR012341 (G3DSA:1.50.10.GENE3D); IPR005198 (PFAM); PTHR12145:SF16 (PANTHER); PTHR12145 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_07127,4391,3325,3974,1,0,7,0,0,0,2,6,5,6,5,7,0,4,4,65.98110201,1,-1.107677876,0.834436559,-1.327456071,0.184357862,0.341816236,15.99557968,0,-0.53413869,1.230163794,-0.434201277,0.664142286,0.785076375,78.90344165,1,-0.066234155,0.720971976,-0.091867864,0.926803024,0.956468279,52.30069243,1,-2.675748389,1.175246333,-2.27675536,0.022800839,0.081316834,53.19173561,1,-1.120505887,0.910014268,-1.231305845,0.218208497,0.343762413,N,-,,Ribosome biogenesis Alb1,P:biological_process; C:cellular_component; F:molecular_function,IPR022784 (PFAM); PTHR28280 (PANTHER),,
RL4_JR_07128,17743,15874,19162,3,4,9,0,0,0,0,0,6,1,1,0,0,6,0,85.34610115,1,-2.045289161,0.923093261,-2.215690709,0.026712692,0.082860129,23.42630577,0,-1.084582388,1.223349095,-0.886568186,0.375311428,0.540000324,76.82127466,1,-1.919997777,1.061268299,-1.809153989,0.070427083,0.147532069,78.57022116,1,-2.458967106,1.056392639,-2.327701855,0.019927941,0.076714457,72.30145936,1,-1.664132815,0.90659298,-1.835589786,0.066418349,0.139404184,N,-,,ubiquitin carboxyl-terminal hydrolase,F:thiol-dependent ubiquitin-specific protease activity; P:protein deubiquitination; C:cytoplasm; C:membrane; C:integral component of membrane; C:endoplasmic reticulum; P:ubiquitin-dependent protein catabolic process; F:thiol-dependent ubiquitinyl hydrolase activity; F:hydrolase activity,IPR001394 (PFAM); PTHR24006 (PANTHER); PTHR24006 (PANTHER); PTHR24006 (PANTHER); PTHR24006:SF461 (PANTHER); PTHR24006:SF461 (PANTHER); IPR028889 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY),,
RL4_JR_07129,493,581,532,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,167.7429997,0,-4.511674886,1.142963409,-3.947348488,7.90E-05,0.00069318,52.55358933,0,-2.250191708,1.197592944,-1.878928662,0.060254235,0.136563673,180.342188,0,-1.493350022,0.618590594,-2.414116926,0.0157734,0.046327211,268.7251143,0,-0.500063159,0.391725418,-1.276565512,0.201755684,0.333025155,133.7184163,1,-4.976845472,1.191998338,-4.175211755,2.98E-05,0.000252032,N,-,,mediator of rna polymerase ii transcription subunit 19,C:mediator complex; F:RNA polymerase II transcription cofactor activity; P:regulation of transcription from RNA polymerase II promoter,IPR013942 (PFAM),,
RL4_JR_07130,2075,1894,2185,0,0,7,0,0,1,0,0,2,0,0,4,0,2,0,65.25600582,1,0.98441471,0.696849687,1.412664349,0.157754439,0.306930768,55.49672862,1,3.243460078,0.718071819,4.516902061,6.28E-06,0.000432085,52.37534172,1,0.52750097,0.764609239,0.68989615,0.490259497,0.624403969,95.27071678,1,1.790903685,0.609569644,2.937980428,0.003303579,0.020113491,33.25431193,1,-0.696728947,0.991897575,-0.702420254,0.482417118,0.610864597,N,-,,hypothetical protein HMPREF1624_04529,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_07131,3288,3434,3358,1,2,1,0,0,4,1,0,4,3,3,1,0,1,1,139.9508216,1,-0.856342984,0.505253243,-1.694878749,0.090098425,0.205199036,50.53826126,1,0.1187135,0.983162236,0.120746603,0.903891745,0.945946262,184.0317753,1,0.448491804,0.419174618,1.069940271,0.284646195,0.424037386,307.3274962,1,1.099005798,0.295047043,3.724849392,0.000195432,0.001884522,140.5947832,1,-0.29839674,0.483090513,-0.617682882,0.536784398,0.659667909,N,-,,fungal specific transcription factor,,IPR001138 (SMART); IPR007219 (SMART); IPR001138 (PFAM); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31001 (PANTHER); PTHR31001:SF31 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07132,3666,4655,4703,0,2,15,0,0,0,0,5,2,4,8,0,0,2,1,42.48478191,1,2.673365275,0.595034875,4.492787542,7.03E-06,8.56E-05,2.593964451,0,2.09042372,1.30105989,1.606708297,0.108118373,0.214835919,6.714596562,1,-0.55812562,1.206211138,-0.462709722,0.643572449,0.751762918,11.75711246,1,-0.033904492,1.155149618,-0.029350736,0.976584863,0.985736391,28.69271937,1,1.601362577,0.848953208,1.886278963,0.059257373,0.127438593,N,-,,topoisomerase 1-associated factor 1,,IPR006906 (PFAM); IPR007725 (PFAM); PTHR22940:SF4 (PANTHER); PTHR22940 (PANTHER),,
RL4_JR_07133,999,876,1342,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,36.06509538,0,0.786130018,0.757658208,1.037578699,0.299466239,0.485212627,5.359623844,0,1.043324971,1.265186064,0.824641529,0.409575136,0.573484511,29.68184568,1,0.206915157,1.058453947,0.195488106,0.845010848,0.900514718,90.01098031,1,2.057287661,0.576946199,3.565822366,0.000362717,0.003179662,142.0839199,0,3.133404311,2.124673562,1.474769756,0.140274455,0.246319607,N,-,,3-hydroxybutyryl- dehydrogenase,F:3-hydroxyacyl-CoA dehydrogenase activity; F:3-hydroxybutyryl-CoA dehydrogenase activity; P:oxidation-reduction process; F:NAD+ binding; P:fatty acid metabolic process,IPR006176 (PFAM); IPR022694 (PIRSF); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013328 (G3DSA:1.10.1040.GENE3D); IPR006108 (PFAM); PTHR23309 (PANTHER); IPR016040 (SUPERFAMILY); IPR008927 (SUPERFAMILY),,
RL4_JR_07134,7303,7843,10937,1,3,6,0,0,0,0,0,0,3,2,6,0,2,2,24.76216374,1,2.371464035,0.752496468,3.151462014,0.001624553,0.008782706,1.80575607,0,2.612819133,1.359367711,1.922084151,0.05459517,0.126542778,4.699383077,0,-0.043743686,1.231499556,-0.035520667,0.971664567,0.983518274,5.42181681,1,-0.466196521,1.235411482,-0.377361331,0.7059051,0.802615287,19.38645882,1,1.57637189,1.014231936,1.554251877,0.120124348,0.219462111,N,-,,anion exchange 4,,IPR011531 (PFAM); G3DSA:1.10.287.570 (GENE3D); PTHR11453:SF21 (PANTHER); PTHR11453:SF21 (PANTHER); IPR003020 (PANTHER),2.A.31.3.2, the anion exchanger (ae) family.
RL4_JR_07135,4091,3381,3465,0,0,0,0,0,0,0,0,1,0,5,0,0,3,0,9.354418709,0,-1.327831545,1.265220709,-1.049486099,0.29395445,0.478945557,92.25331266,0,4.843373533,1.364679416,3.549092539,0.000386561,0.014476338,7.740891302,1,-0.763348575,1.248954628,-0.611189996,0.541073805,0.669170682,8.927177746,1,-1.18523612,1.253980506,-0.945179063,0.344567467,0.49137262,14.91988305,1,0.112943652,1.173211912,0.096268756,0.923307125,0.950435608,N,-,,homeobox domain-containing,,IPR001356 (SMART); IPR001356 (PFAM); IPR009057 (G3DSA:1.10.10.GENE3D); PTHR24326:SF229 (PANTHER); PTHR24326 (PANTHER); IPR001356 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_07136,3841,4585,4051,7,7,5,0,0,2,0,1,11,1,4,3,0,5,3,450.7796979,1,-1.108645622,0.428696632,-2.586084284,0.009707319,0.037057702,117.8480217,1,-1.531659149,1.00840815,-1.51888811,0.128790662,0.24573404,361.4875289,1,-1.277785557,1.297671007,-0.984676047,0.324783222,0.467857903,337.182477,1,-3.14392157,0.698386837,-4.501690761,6.74E-06,0.000100527,309.0093414,1,-1.747520485,0.538742834,-3.243700655,0.001179877,0.005467392,N,-,,mitochondrial inner membrane aaa protease,F:zinc ion binding; P:cristae formation; P:protein complex assembly; P:cytoplasmic translation; P:mitochondrial fusion; P:signal peptide processing; F:ATP-dependent peptidase activity; F:metalloendopeptidase activity; P:replicative cell aging; C:m-AAA complex; P:protein import into mitochondrial intermembrane space; F:ATP binding; C:mitochondrial inner boundary membrane; P:mitochondrial protein processing,IPR003593 (SMART); G3DSA:1.10.8.60 (GENE3D); IPR000642 (PFAM); IPR011546 (PFAM); IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005936 (TIGRFAM); PTHR23076 (PANTHER); PTHR23076:SF10 (PANTHER); IPR005936 (HAMAP); SSF140990 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.29.1.1, the mitochondrial inner membrane i-aaa protease complex (mimp) familly.
RL4_JR_07137,161,129,75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.132045653,0,-0.718469925,1.240228889,-0.579304297,0.562383867,0.739272894,1.966423297,0,2.490050667,1.359821373,1.831160119,0.067076647,0.148566701,5.074881641,0,-0.154139877,1.22876635,-0.125442788,0.900173015,0.938263318,5.853140771,0,-0.576163707,1.231542211,-0.467839187,0.639899595,0.753278265,4.966967109,0,-0.226085231,1.223976041,-0.184713771,0.853453544,0.902476985,N,-,,HXT2-Hexose facilitator of moderately low affinity for glucose,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,IPR003663 (PRINTS); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); IPR003663 (TIGRFAM); PTHR23500 (PANTHER); PTHR23500:SF161 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.68, the major facilitator superfamily (mfs).
RL4_JR_07138,2490,2241,2132,2,27,6,2,0,0,0,0,0,4,4,1,0,0,4,6.409700903,1,-0.782353211,1.251605525,-0.625079704,0.531918748,0.71571716,2.045332927,1,2.433263697,1.362212395,1.786258667,0.074057386,0.160412767,11.79155428,0,0.747009099,1.225102126,0.609752512,0.542025763,0.669938814,6.105732663,1,-0.637143471,1.238980237,-0.514248292,0.607078408,0.727244307,5.192135885,1,-0.28999703,1.233992333,-0.235007157,0.814203178,0.874767315,N,-,,glycoside hydrolase family 32,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:hydrolase activity",IPR001362 (SMART); IPR023296 (G3DSA:2.115.10.GENE3D); IPR013148 (PFAM); PTHR30175 (PANTHER); PTHR30175:SF0 (PANTHER); IPR023296 (SUPERFAMILY),,
RL4_JR_07139,3120,3284,3869,4,0,41,0,0,2,0,2,0,2,10,2,0,13,0,5.172011033,1,-0.472777842,1.213688547,-0.389538027,0.696878186,0.836135226,1.65120378,1,2.742058158,1.340821334,2.045058569,0.040849084,0.100847422,4.277393112,1,0.092476052,1.208292348,0.076534501,0.938993866,0.963531496,23.55884796,1,1.417447625,1.020551511,1.388903557,0.164862079,0.285240695,4.205829463,1,0.013970708,1.204940432,0.011594522,0.990749117,0.993693394,N,-,,DAL81-transcriptional activator,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR007219 (SMART); IPR007219 (PFAM); PTHR31668 (PANTHER); PTHR31668:SF7 (PANTHER),,
RL4_JR_07140,0,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46.02346671,0,0.833321025,0.735970425,1.132275152,0.257518773,0.436311143,4.465740235,0,1.306603047,1.247081541,1.04772864,0.294763648,0.454391735,11.58523305,0,-1.34533327,1.192982781,-1.127705522,0.259444305,0.396111317,13.36452988,0,-1.767642051,1.190751156,-1.484476452,0.137682566,0.249469574,11.42596905,0,-1.42805385,1.196619539,-1.193406763,0.232710108,0.360383885,N,-,,dihydroxyacetone kinase,P:glycerol metabolic process; F:ATP binding; F:glycerone kinase activity; P:phosphorylation,IPR004007 (SMART); IPR004006 (PFAM); IPR004007 (PFAM); G3DSA:3.30.1180.20 (GENE3D); G3DSA:3.40.50.10440 (GENE3D); IPR012734 (TIGRFAM); PTHR28629 (PANTHER); PTHR28629:SF3 (PANTHER); IPR004007 (PROSITE_PROFILES); IPR004006 (PROSITE_PROFILES); IPR004007 (SUPERFAMILY); SSF82549 (SUPERFAMILY),,
RL4_JR_07141,127,138,307,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.826458723,0,0.518317584,1.182006367,0.438506592,0.661019093,0.810238699,1.585024028,0,2.800876669,1.360400701,2.058861529,0.039507505,0.098061542,4.138937262,0,0.139435368,1.227948475,0.113551481,0.909593351,0.944678199,4.776433232,0,-0.283370908,1.232198594,-0.229971783,0.818113696,0.885330774,4.111439534,0,0.046610783,1.237441631,0.037667056,0.969953143,0.980201888,N,-,,---NA---,,no IPS match,,
RL4_JR_07142,2515,3349,3523,0,1,6,0,0,0,0,1,0,1,2,0,0,0,3,0.043469247,1,6.42090492,3.931231211,1.633306355,0.102404581,NA,0.013690453,0,9.654521714,3.132390562,3.082157708,0.002055059,0.015023052,0.035926095,1,6.983858195,1.804618853,3.86999071,0.00010884,0.001228418,0.041468766,1,6.563755678,3.30892245,1.983653524,0.047294478,0.118822975,0.035917442,1,6.885729319,1.394959814,4.936148876,7.97E-07,1.20E-05,N,-,,3-hydroxyisobutyryl- hydrolase,P:branched-chain amino acid catabolic process; C:mitochondrion; P:valine catabolic process; F:3-hydroxyisobutyryl-CoA hydrolase activity,IPR032259 (PFAM); IPR014748 (G3DSA:1.10.12.GENE3D); IPR029045 (G3DSA:3.90.226.GENE3D); PTHR11941 (PANTHER); PTHR11941:SF53 (PANTHER); IPR029045 (SUPERFAMILY),,
RL4_JR_07143,1193,802,1651,0,1,5,0,0,0,0,0,0,0,6,0,0,0,0,60.83216969,1,-0.952623109,0.833479704,-1.142946978,0.253060606,0.430635883,33.5162516,0,1.198872877,1.053035169,1.138492723,0.254914796,0.409888413,57.39868366,0,-0.667839881,0.905419031,-0.737603096,0.460755673,0.598497618,43.69714416,1,-3.476628917,1.227702262,-2.831817636,0.004628424,0.026386706,66.78411726,0,-0.163356527,0.725100533,-0.225288108,0.82175515,0.880731544,N,-,,gata transcription factor,"P:regulation of transcription, DNA-templated; P:single-organism cellular process; F:binding; P:chromatin organization",IPR013088 (G3DSA:3.30.50.GENE3D); PTHR39147 (PANTHER); PTHR39147:SF1 (PANTHER); PTHR39147:SF1 (PANTHER); PTHR39147 (PANTHER); PTHR39147 (PANTHER); PTHR39147:SF1 (PANTHER); SSF57716 (SUPERFAMILY),,
RL4_JR_07144,403,240,315,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,24.98416214,1,0.497127255,1.042496475,0.476862289,0.633460187,0.791550676,2.831957843,0,1.963627898,1.301187552,1.509104429,0.131272098,0.249013526,15.23883649,0,0.263928759,1.213385694,0.217514316,0.827807552,0.888802071,8.535570245,0,-1.120768189,1.220969262,-0.917933173,0.358653853,0.504568387,7.340369942,0,-0.789567532,1.230532217,-0.641647185,0.521102289,0.645401918,N,-, Effector probability:0.64,Replication factor A 3,C:nucleus; F:DNA binding; P:DNA repair; P:DNA replication; P:DNA recombination,IPR013970 (PFAM); G3DSA:2.40.50.140 (GENE3D); PTHR15114 (PANTHER); IPR012340 (SUPERFAMILY),,
RL4_JR_07145,65,33,43,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.359756021,0,3.372722463,2.336572653,1.443448573,0.148894149,NA,0.114327608,0,6.594388768,2.064509914,3.194166676,0.001402351,0.015023052,0.296720859,0,3.942731749,1.340608875,2.941000781,0.003271537,0.014438117,0.342353148,0,3.519613728,1.580158981,2.227379505,0.025921921,0.085995888,0.292013923,0,3.863560159,1.268809701,3.045027284,0.002326592,0.009630721,N,-,,---NA---,,no IPS match,,
RL4_JR_07146,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,85.50400571,0,-1.567141562,0.816575573,-1.919162922,0.054963718,0.142674458,22.24448401,0,-1.009905467,1.217926158,-0.8292009,0.406990736,0.570826138,73.75093067,0,-1.845784922,1.055823042,-1.74819534,0.080430208,0.163509122,93.65413608,0,-1.358821313,0.783290187,-1.734761057,0.082783136,0.170085077,103.9902839,0,0.193997125,0.714598361,0.271477147,0.786024074,0.853824026,Y,-,,60S ribosomal mitochondrial precursor,C:nucleus; F:DNA binding; P:DNA repair; F:RNA binding; C:cytosolic ribosome; F:structural constituent of ribosome; P:DNA replication; P:DNA recombination; C:mitochondrial large ribosomal subunit; P:translation,IPR002136 (PFAM); IPR023574 (G3DSA:3.40.1370.GENE3D); PTHR10746:SF6 (PANTHER); PTHR10746:SF6 (PANTHER); IPR013005 (PANTHER); IPR023574 (SUPERFAMILY),,
RL4_JR_07147,1356,1037,1625,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,54.50615961,0,-1.921665647,1.0037931,-1.91440412,0.055568539,0.143776767,14.9722344,0,-0.438699229,1.202417186,-0.36484777,0.715225044,0.821364636,54.51047776,0,-1.265798035,1.026926552,-1.232608148,0.217721996,0.346629577,44.78676062,1,-3.512215515,1.185386604,-2.962928299,0.003047275,0.018872784,42.12437504,1,-2.241166411,1.118473739,-2.003772046,0.045094485,0.103533256,N,-,,nuclear snf4,F:AMP binding; F:protein serine/threonine kinase activator activity; P:peroxisome organization; P:protein phosphorylation; C:nuclear envelope lumen; P:replicative cell aging; C:plasma membrane; P:positive regulation of gluconeogenesis; P:regulation of transcription from RNA polymerase II promoter; F:ATP binding; F:catalytic activity; C:cytosol; P:positive regulation of protein serine/threonine kinase activity; C:nucleotide-activated protein kinase complex,IPR000644 (SMART); IPR013785 (G3DSA:3.20.20.GENE3D); G3DSA:3.10.580.10 (GENE3D); IPR000644 (PFAM); PTHR13780 (PANTHER); PTHR13780:SF35 (PANTHER); IPR000644 (PROSITE_PROFILES); IPR000644 (PROSITE_PROFILES); IPR000644 (PROSITE_PROFILES); IPR000644 (PROSITE_PROFILES); SSF54631 (SUPERFAMILY); SSF54631 (SUPERFAMILY),1.C.126.1.2, the hlyc hlyc) family of haemolysins.
RL4_JR_07148,30,29,37,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.080569451,0,1.785997636,1.440129922,1.240164244,0.214914651,NA,0.346068123,0,4.996501319,1.65225711,3.024045887,0.002494186,0.015349618,0.894869328,0,2.349734829,1.242321474,1.891406435,0.05857011,0.127683849,1.032170179,0,1.927422431,1.284675407,1.500318618,0.133531889,0.243781171,4.73903166,0,3.202828084,1.135285202,2.821166063,0.004784943,0.017271852,N,-,,GTPase GAP,P:signal transduction,IPR000198 (SMART); IPR000198 (PFAM); IPR000198 (G3DSA:1.10.555.GENE3D); IPR000198 (PROSITE_PROFILES); IPR008936 (SUPERFAMILY),,
RL4_JR_07149,100,46,57,0,0,0,1,0,0,0,0,0,0,0,0,0,4,0,182.535674,0,-0.984439897,0.582536062,-1.689920953,0.091043078,0.206715679,49.80700055,1,-0.955753046,1.128438822,-0.846969306,0.39701223,0.561094358,112.1427078,0,-3.572298455,1.212104822,-2.947186077,0.003206802,0.014215184,150.1838055,0,-2.592804223,0.882052732,-2.939511584,0.0032873,0.02002642,135.1468679,1,-1.445728428,0.694781701,-2.080838379,0.037448702,0.089363212,N,-,,ribosomal 35,C:ribosome,IPR008914 (G3DSA:3.90.280.GENE3D); IPR008914 (PFAM); PTHR11362 (PANTHER); PTHR11362:SF25 (PANTHER); IPR008914 (SUPERFAMILY),,
RL4_JR_07150,585,480,739,0,0,0,0,0,0,0,0,2,1,1,0,0,0,0,223.7904924,0,-1.208576209,0.498486677,-2.424490493,0.015329885,0.053217532,50.32022943,0,-2.187530309,1.207761557,-1.811226974,0.070105724,0.153928447,166.9706752,1,-1.694833385,0.687814664,-2.464084403,0.013736376,0.041415838,201.8276337,1,-1.370839759,0.53948161,-2.541031487,0.011052597,0.052612854,131.1795885,0,-3.976224718,1.127055844,-3.52797489,0.000418752,0.002334726,N,-,,c-x8-c-x5-c-x3-h type zinc finger,F:metal ion binding,IPR000571 (G3DSA:4.10.1000.GENE3D); IPR000571 (PROSITE_PROFILES); IPR000571 (SUPERFAMILY),,
RL4_JR_07151,7,11,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51.26463993,0,-0.953780257,0.881503698,-1.081992349,0.279255927,0.46257256,11.28306732,0,-0.030631981,1.222673247,-0.025053285,0.980012462,0.989593589,29.43020327,0,-2.690296019,1.204071926,-2.234331654,0.025461259,0.067514349,33.9617269,0,-3.113070768,1.205218772,-2.582992266,0.009794752,0.047806532,29.18753177,0,-2.78105281,1.214307136,-2.290238382,0.022007502,0.058979871,N,-,,monothiol glutaredoxin-5,F:glutathione disulfide oxidoreductase activity; F:protein disulfide oxidoreductase activity; C:mitochondrial matrix; F:electron carrier activity; P:response to osmotic stress; P:cellular response to oxidative stress; P:cell redox homeostasis; P:oxidation-reduction process,IPR012336 (G3DSA:3.40.30.GENE3D); IPR002109 (PFAM); IPR004480 (TIGRFAM); IPR004480 (PANTHER); IPR002109 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY),,
RL4_JR_07152,57,63,54,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51.24126531,0,1.232880798,0.631759992,1.951501856,0.050997376,0.134947873,5.006904611,0,1.141585622,1.245015714,0.91692467,0.359182116,0.523189146,13.01654186,0,-1.513284744,1.198114947,-1.263054725,0.206569513,0.333382712,15.01859195,0,-1.935849919,1.196944648,-1.617326182,0.105807891,0.204642768,12.8517015,0,-1.597607744,1.203611527,-1.327345001,0.184394584,0.303083631,N,-,,gamma-glutamyltranspeptidase,P:glutathione metabolic process; F:gamma-glutamyltransferase activity,IPR000101 (PRINTS); IPR000101 (PFAM); PTHR11686:SF8 (PANTHER); IPR000101 (PANTHER); IPR029055 (SUPERFAMILY),,
RL4_JR_07153,743,818,914,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,93.79508739,1,-0.590592313,0.732704843,-0.80604396,0.420217502,0.611729904,57.48541742,0,0.137924433,1.147497762,0.120195819,0.90432803,0.946305005,50.19668915,1,-3.46056554,1.23215848,-2.808539321,0.00497668,0.018865759,79.28795922,0,-1.186610973,0.829809438,-1.429980089,0.152722734,0.269675215,57.79394977,0,-1.916292457,1.050780339,-1.823685108,0.068199692,0.14212747,N,-,,peptide chain release factor 1,"P:translational termination; C:cytoplasm; P:mitochondrial translation; F:translation release factor activity, codon specific",IPR005139 (SMART); IPR005139 (PFAM); IPR000352 (PFAM); IPR014720 (G3DSA:3.30.160.GENE3D); PTHR11075:SF9 (PANTHER); PTHR11075 (PANTHER); SSF75620 (SUPERFAMILY),,
RL4_JR_07154,8626,8414,10079,0,9,7,0,3,0,0,1,1,2,12,0,0,0,1,231.3376777,1,-0.733453811,1.307805245,-0.560828008,0.574914791,0.750296858,73.91662482,1,0.129619661,0.858617407,0.150963235,0.880004718,0.931615043,340.3753075,1,0.99647152,0.470365523,2.118504593,0.034132356,0.08481227,187.7022917,1,-1.107612867,0.514989958,-2.150746535,0.031496211,0.094938713,189.0754664,1,-0.309483199,0.47040753,-0.657904433,0.510599542,0.636991173,N,-,,msf1 domain-containing,C:mitochondrial intermembrane space; P:positive regulation of phosphatidylcholine biosynthetic process; P:phospholipid transport; P:cardiolipin metabolic process; F:phosphatidic acid transporter activity; C:extrinsic component of mitochondrial inner membrane,IPR006797 (PFAM); PTHR11158:SF29 (PANTHER); PTHR11158 (PANTHER); IPR006797 (PROSITE_PROFILES),,
RL4_JR_07155,3120,3758,5454,0,0,5,0,0,0,1,0,0,2,6,3,0,0,2,0.403199306,1,3.20821338,2.215924337,1.447799154,0.147673229,NA,0.127849838,0,6.433008092,2.011980255,3.197351503,0.001386958,0.015023052,0.332487746,1,3.778120852,1.323740789,2.854124375,0.004315563,0.016980475,0.38365831,1,3.355132988,1.528656326,2.194824913,0.02817616,0.089290647,0.328057051,1,3.695553314,1.262495861,2.927180538,0.003420503,0.013158278,N,-,,kinesin light chain 1,F:ADP binding,IPR027417 (G3DSA:3.40.50.GENE3D); IPR002182 (PFAM); IPR010730 (PFAM); PTHR10622:SF11 (PANTHER); PTHR10622 (PANTHER); PTHR10622:SF11 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_07156,2828,3270,2948,0,0,4,0,0,2,0,0,1,0,4,0,0,1,0,251.3951144,1,-2.543759378,0.634654298,-4.00810234,6.12E-05,0.000556678,107.7879768,1,-1.726725343,1.121996747,-1.538975356,0.123810313,0.238797254,244.2760149,1,-1.394769584,1.481312271,-0.941577013,0.346409243,0.490153344,210.7733428,1,-4.772433733,1.152363598,-4.141430485,3.45E-05,0.000422054,195.1992461,1,-2.459639419,0.700256488,-3.512483585,0.000443939,0.002453752,N,-,,retinoblastoma-binding,F:pre-mRNA binding; F:zinc ion binding; C:mRNA cleavage and polyadenylation specificity factor complex; C:cytosol; P:mRNA polyadenylation; P:mRNA cleavage; P:protein ubiquitination,IPR001878 (SMART); IPR014891 (SMART); IPR025829 (PFAM); IPR001878 (G3DSA:4.10.60.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); IPR014891 (PFAM); PTHR15439:SF0 (PANTHER); PTHR15439 (PANTHER); IPR014891 (PROSITE_PROFILES); IPR001878 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR001878 (SUPERFAMILY),,
RL4_JR_07157,198,201,259,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,100.5253177,0,-4.753747305,1.231060096,-3.861507104,0.00011269,0.000946779,31.72709834,0,-1.522156464,1.216676859,-1.251077025,0.210906377,0.356631197,82.91191112,0,-4.184532483,1.214799816,-3.444627196,0.000571848,0.003735087,95.69254101,0,-4.607524995,1.219311698,-3.778791758,0.000157591,0.00157358,86.20387044,0,-3.349883241,1.1587914,-2.89084234,0.003842108,0.014450723,N,-,,helicase associated domain-containing,F:nucleotide binding; P:ribosome biogenesis; F:helicase activity,IPR001650 (SMART); IPR014001 (SMART); IPR007502 (SMART); IPR011709 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011545 (PFAM); IPR007502 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); PTHR18934 (PANTHER); PTHR18934 (PANTHER); PTHR18934:SF142 (PANTHER); PTHR18934:SF142 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_07158,1212,946,1306,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,19.94711095,0,-0.454546433,1.166540459,-0.38965338,0.696792874,0.836135226,3.128407317,0,1.820038477,1.286848329,1.414337988,0.157262688,0.286695005,8.154108106,0,-0.838584503,1.212419715,-0.691661883,0.489149689,0.623425265,9.409780768,1,-1.261376526,1.212878981,-1.039985477,0.298346648,0.443511938,15.43814183,1,0.012390534,1.147343042,0.010799329,0.99138355,0.994132757,N,-,,acn9 family,C:mitochondrial intermembrane space; P:regulation of gluconeogenesis; P:carbon utilization,PF13233 (PFAM); PTHR13137:SF6 (PANTHER); IPR008381 (PANTHER),,
RL4_JR_07159,54830,32494,32000,2,12,18,0,0,0,0,9,6,3,12,1,0,4,1,303.6546125,1,1.513422307,0.37076741,4.08186444,4.47E-05,0.000424291,63.82186774,0,1.338114109,0.757068482,1.767494146,0.077145509,0.165753946,214.4581477,1,1.215926178,0.403467266,3.013692259,0.002580895,0.012130444,149.301997,1,0.262368205,0.432067418,0.607239042,0.543692286,0.674039965,121.0003264,1,0.211251578,0.647371096,0.326322227,0.744180573,0.82132421,N,-,,plasma membrane snare,P:ascospore formation; P:ascospore-type prospore assembly,G3DSA:1.20.5.110 (GENE3D); PTHR19305 (PANTHER); PTHR19305 (PANTHER); PTHR19305:SF8 (PANTHER); SSF58038 (SUPERFAMILY),,
RL4_JR_07160,1607,1448,1440,1,0,0,0,0,0,0,0,3,0,1,0,0,0,2,56.59632513,1,1.119165384,0.67092368,1.668096413,0.095296589,0.213696969,4.615700177,0,1.258927451,1.244478837,1.011610172,0.31172448,0.473409631,31.49100029,1,1.006690701,0.854752154,1.17775743,0.238893324,0.371685264,29.8848675,1,0.89500072,0.749715505,1.193787128,0.232561248,0.369709944,54.31632654,1,2.491805389,0.557527501,4.469385611,7.84E-06,8.20E-05,N,-,,GTP-binding,C:cellular_component,IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:2.40.30.10 (GENE3D); PTHR23115:SF147 (PANTHER); PTHR23115 (PANTHER); PTHR23115 (PANTHER); PTHR23115 (PANTHER); PTHR23115:SF147 (PANTHER); PTHR23115:SF147 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_07161,16207,12889,24376,4,1,5,0,0,0,0,0,1,4,10,1,0,4,5,39.84511114,1,0.525752086,0.712295684,0.738109325,0.460448018,0.64865048,25.34387034,0,2.381695816,1.002363819,2.376079194,0.017497707,0.05180222,40.69231318,1,0.497063276,0.867193967,0.57318581,0.566518891,0.690859495,105.5531323,1,1.800732244,0.656227598,2.744066613,0.006068322,0.032681789,32.45116781,1,0.582649943,0.793656144,0.734133979,0.462867086,0.594058721,N,-,,---NA---,,no IPS match,,
RL4_JR_07162,362,315,254,0,0,5,0,1,0,1,0,3,1,1,0,0,14,1,22.70024386,1,-1.394626319,1.155275116,-1.207181129,0.227362396,0.398792087,6.02086547,1,0.875499215,1.246144422,0.702566411,0.482326001,0.639102345,28.64407855,1,0.03792673,1.045720664,0.036268509,0.971068259,0.983207826,60.74503512,1,1.501665108,0.573185903,2.619857015,0.008796664,0.043918257,37.56499479,1,0.3807017,0.862750365,0.441265186,0.659021027,0.75678665,N,-,,proliferating cell nuclear antigen,C:PCNA complex; C:nucleus; F:DNA polymerase processivity factor activity; C:membrane; P:leading strand elongation; P:mismatch repair; F:binding; P:translesion synthesis,IPR026859 (PFAM); IPR000730 (PANTHER); PTHR11352:SF3 (PANTHER),,
RL4_JR_07163,19,24,29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,95.86482472,0,1.882098403,0.52126079,3.610665598,0.000305412,0.002210783,25.48503799,0,2.349847333,1.005853297,2.336173019,0.019482226,0.056294345,55.39752599,0,1.200158583,0.693414833,1.730794505,0.083488422,0.168236786,24.23693331,0,-1.419121175,1.15866206,-1.224792995,0.220653225,0.356060481,32.07281214,0,-0.331747525,0.993275293,-0.333993534,0.738384438,0.817064747,N,-,,proliferating cell nuclear antigen,C:PCNA complex; C:nucleus; F:DNA binding; F:DNA polymerase processivity factor activity; P:UV-damage excision repair; P:DNA strand elongation involved in DNA replication; P:positive regulation of DNA-directed DNA polymerase activity; C:cytosol; P:postreplication repair,IPR000730 (PRINTS); G3DSA:3.70.10.10 (GENE3D); IPR000730 (TIGRFAM); IPR022648 (PFAM); IPR022649 (PFAM); IPR000730 (PANTHER); PTHR11352:SF0 (PANTHER); SSF55979 (SUPERFAMILY); SSF55979 (SUPERFAMILY),,
RL4_JR_07164,7,9,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,114.4570905,0,-0.621370661,0.895074161,-0.694211372,0.487549662,0.675285253,39.84219771,0,0.709057806,0.987113909,0.718314066,0.472563659,0.630569418,99.16797902,0,-0.746095113,0.748868219,-0.996296937,0.319105892,0.461716171,63.33272166,0,-4.01208513,1.195763028,-3.355251028,0.00079293,0.006095988,54.3079505,0,-3.676866808,1.201791369,-3.059488445,0.002217153,0.009249558,N,-,,pyridoxine kinase,F:pyridoxal kinase activity; C:cytosol; P:pyridoxal 5'-phosphate salvage; P:phosphorylation,IPR013749 (PFAM); IPR029056 (G3DSA:3.40.1190.GENE3D); PTHR10534:SF2 (PANTHER); IPR004625 (PANTHER); PTHR10534:SF2 (PANTHER); IPR004625 (PANTHER); PTHR10534:SF2 (PANTHER); IPR029056 (SUPERFAMILY),,
RL4_JR_07165,24,16,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.00537682,0,-0.114896283,1.011581471,-0.113580849,0.909570069,0.956076847,4.258499997,0,1.375170463,1.246975378,1.102804825,0.270111932,0.427399247,11.05650094,0,-1.277836725,1.192276906,-1.071761701,0.283827079,0.423110509,60.75058348,0,2.02559995,0.536350649,3.776633725,0.000158962,0.001582589,10.90471647,0,-1.360602228,1.19586907,-1.137751834,0.255224123,0.386278177,N,-,,dUTP diphosphatase,F:dUTP diphosphatase activity; P:deoxyribonucleotide catabolic process; P:deoxyribose phosphate catabolic process; P:organonitrogen compound catabolic process; P:pyrimidine deoxyribonucleoside triphosphate catabolic process; C:intracellular part; P:dUTP metabolic process,IPR029054 (G3DSA:2.70.40.GENE3D); IPR008181 (TIGRFAM); IPR008180 (PFAM); PTHR11241:SF0 (PANTHER); PTHR11241 (PANTHER); IPR029054 (SUPERFAMILY),,
RL4_JR_07166,926,569,1497,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,119.7708482,1,2.101956624,1.185501708,1.77305238,0.076220028,0.181483434,7.850724544,0,0.49271252,1.270971138,0.387666175,0.69826309,0.808489934,51.60594913,0,0.675492968,0.792453221,0.852407372,0.39398803,0.537131001,31.35411177,0,-0.862993055,1.057399335,-0.816146773,0.414416195,0.558048142,19.83794797,0,-2.224029343,1.221879741,-1.820170405,0.068733059,0.143013849,N,-,,agmatinase 1,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines; F:metal ion binding",IPR006035 (PRINTS); IPR006035 (PIRSF); IPR006035 (PFAM); IPR023696 (G3DSA:3.40.800.GENE3D); PTHR11358:SF30 (PANTHER); IPR006035 (PANTHER); IPR006035 (PROSITE_PROFILES); SSF52768 (SUPERFAMILY),,
RL4_JR_07167,12,25,12,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,564.0410478,0,2.504743117,0.613263238,4.084287078,4.42E-05,0.00042136,293.744919,0,3.220592589,0.584305969,5.51182558,3.55E-08,4.79E-06,671.0131367,0,3.158455789,0.333817915,9.461612595,3.03E-21,5.03E-19,197.1856255,0,0.722446172,0.443336091,1.629567695,0.103192897,0.200504333,182.8640758,1,1.049412631,0.709668223,1.478736961,0.13921063,0.244918788,Y,-,,hypothetical protein CMQ_416,,no IPS match,,
RL4_JR_07168,16231,15192,19601,0,4,7,0,0,0,0,1,2,1,6,2,0,1,0,88.93548816,1,3.329835293,0.483850232,6.881954523,5.90E-12,2.66E-10,2.391558149,0,2.207508308,1.291327247,1.709487903,0.087360611,0.18228491,6.222620423,1,-0.448698566,1.20163941,-0.373405334,0.70884679,0.802571991,48.44040878,1,2.202474601,0.675130178,3.26229618,0.001105136,0.008021149,10.01456456,1,0.393967441,1.135957345,0.346815347,0.728730047,0.809655627,N,-,,hd domain-containing,,IPR003607 (SMART); IPR006674 (G3DSA:1.10.3210.GENE3D); PTHR33594 (PANTHER); PTHR33594 (PANTHER); PTHR33594:SF1 (PANTHER); PTHR33594:SF1 (PANTHER); SSF109604 (SUPERFAMILY),,
RL4_JR_07169,6662,4653,6620,0,9,3,0,0,0,0,0,1,0,13,0,0,17,3,9.424329236,1,0.357221995,1.159419645,0.308104142,0.758003089,0.87260239,1.77883245,0,2.634515,1.324698752,1.988765367,0.046727107,0.111681648,4.632531721,1,-0.022987933,1.208743409,-0.019018042,0.984826712,0.992670812,38.26286745,1,2.302962174,0.753016289,3.058316544,0.002225843,0.014412615,16.1667494,1,2.079801849,0.873070264,2.382170068,0.017210947,0.048473112,N,-,,acid phosphatase,F:metal ion binding; P:dephosphorylation; F:acid phosphatase activity,IPR004843 (PFAM); IPR015914 (G3DSA:2.60.40.GENE3D); IPR029052 (G3DSA:3.60.21.GENE3D); IPR015914 (PFAM); IPR025733 (PFAM); PTHR22953 (PANTHER); PTHR22953 (PANTHER); PTHR22953:SF16 (PANTHER); IPR008963 (SUPERFAMILY); IPR029052 (SUPERFAMILY),,
RL4_JR_07170,5900,5202,7418,0,6,5,0,0,0,0,1,3,0,6,0,0,5,1,31.40824069,1,-0.13315764,0.879283361,-0.151438826,0.879629564,0.941301297,6.325230175,0,0.804338665,1.237372822,0.650037443,0.515668036,0.665951791,58.16455378,1,1.542101879,0.634286157,2.431240003,0.015047243,0.044640184,19.02112593,1,-2.27678179,1.201547714,-1.894874223,0.058109067,0.134694836,16.32684795,1,-1.942928094,1.211410932,-1.603855507,0.108745906,0.203408886,N,-,,phosphoglycerate mutase,F:molecular_function,IPR013078 (SMART); IPR029033 (G3DSA:3.40.50.GENE3D); IPR013078 (PFAM); PTHR23029 (PANTHER); PTHR23029:SF37 (PANTHER); IPR029033 (SUPERFAMILY),,
RL4_JR_07171,1236,1202,1961,6,0,0,0,0,0,0,0,0,0,3,0,0,3,0,15.10209861,1,0.694880366,1.087205231,0.639143692,0.522729459,0.707148923,2.354047444,0,2.230229665,1.345874871,1.657085449,0.097502201,0.198566325,14.00773582,0,0.526481689,1.231693367,0.42744542,0.669054931,0.772168276,7.11541354,1,-0.858317094,1.246670628,-0.68848746,0.491145865,0.630512474,17.72561454,1,1.624968599,0.940892974,1.72704935,0.084158801,0.167638768,N,-,,DUF1716 domain containing,,IPR013180 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR013180 (PFAM); PTHR14978 (PANTHER); PTHR14978:SF0 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_07172,5643,4978,7208,0,2,5,0,0,0,1,4,0,0,1,0,0,1,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_07173,43,62,83,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,119.8102966,0,0.302280372,0.976040585,0.309700618,0.756788633,0.872432934,18.64684427,0,-0.755334824,1.223154837,-0.617530014,0.53688519,0.68390183,83.04547273,0,-0.576874061,0.771162708,-0.748057518,0.454425465,0.593702852,78.53509947,0,-1.500990539,0.880816399,-1.704090138,0.088364249,0.178637851,47.75781784,0,-3.491428745,1.212599251,-2.879293172,0.003985676,0.014852769,N,-,,vacuolar ATPase,"C:nucleus; P:proton transport; P:transmembrane transport; C:vacuolar proton-transporting V-type ATPase complex; C:cytosol; F:hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances",IPR005124 (TIGRFAM); PF03179 (PFAM); IPR005124 (PANTHER),3.A.2.2.4," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_07174,1819,2214,2726,0,4,8,0,0,0,2,0,0,2,5,1,0,5,0,12.33229256,1,-1.72668179,1.240816144,-1.391569411,0.164052827,0.315002698,3.887085624,0,1.50675674,1.29641121,1.162252169,0.245133049,0.398080656,10.16241851,1,-1.156241891,1.228485238,-0.94119315,0.346605886,0.49022604,58.6138707,1,1.592159597,0.748195973,2.127998084,0.033337242,0.097850963,10.09302473,1,-1.249013169,1.241533388,-1.006024631,0.314403722,0.449878135,Y,-,,cytochrome c oxidase assembly partial,C:integral component of membrane,IPR031568 (PFAM); PTHR28163 (PANTHER),,
RL4_JR_07175,2195,1895,4148,0,0,8,0,0,0,0,0,0,1,0,0,0,3,0,31.39047412,1,-1.698196389,1.157056736,-1.467686359,0.142189438,0.285358286,7.415479621,0,0.574910331,1.232270395,0.4665456,0.640825016,0.766083714,32.32408451,0,-0.266583221,1.044835968,-0.255143611,0.798612182,0.867691536,22.3013175,1,-2.506319626,1.202027089,-2.08507749,0.037062267,0.102305195,19.15152081,1,-2.173155751,1.212077219,-1.792918566,0.072985946,0.149591641,N,-,,benomyl methotrexate resistance,P:transmembrane transport; C:membrane; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); PTHR23502:SF23 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.35, the major facilitator superfamily (mfs).
RL4_JR_07176,839,850,1378,1,0,2,0,0,0,0,0,0,3,0,0,0,4,0,467.5428035,1,-0.741730371,0.318987714,-2.325263135,0.020057894,0.065636703,92.41850208,0,-3.064596604,1.186929,-2.581954443,0.009824255,0.033197402,273.6983243,0,-2.578548865,0.668117329,-3.859425213,0.000113654,0.001251467,339.4626823,1,-1.743507071,0.444497668,-3.922421184,8.77E-05,0.000955429,296.9538993,1,-1.613271173,0.479172715,-3.366784299,0.000760501,0.003832886,N,-,,DNA-directed RNA polymerase II subunit RPB2,"F:DNA binding; F:RNA binding; F:DNA-directed RNA polymerase activity; F:ribonucleoside binding; P:transcription, RNA-templated; C:nuclear pericentric heterochromatin; C:cytosol; P:transcription from RNA polymerase II promoter; P:chromatin silencing by small RNA; C:DNA-directed RNA polymerase II, core complex",G3DSA:3.90.1100.10 (GENE3D); IPR007642 (G3DSA:3.90.1110.GENE3D); IPR014724 (G3DSA:2.40.50.GENE3D); IPR007120 (G3DSA:2.40.270.GENE3D); IPR007641 (PFAM); IPR007644 (PFAM); IPR007647 (PFAM); IPR007646 (PFAM); IPR007645 (PFAM); IPR007642 (PFAM); IPR007120 (PFAM); PTHR20856:SF7 (PANTHER); IPR015712 (PANTHER); IPR015712 (PANTHER); PTHR20856:SF7 (PANTHER); IPR015712 (PANTHER); SSF64484 (SUPERFAMILY),,
RL4_JR_07177,4018,3946,4019,4,5,18,0,0,0,2,0,4,0,3,0,0,7,6,2.651627223,1,0.490558561,1.284265581,0.381975946,0.702479206,0.839189539,0.841572872,0,3.714211471,1.455870101,2.551197026,0.010735362,0.035487698,2.194262137,1,1.05479143,1.237938409,0.852054854,0.394183647,0.537325333,2.531947942,1,0.632206902,1.251467032,0.505172638,0.613437586,0.732713144,2.176978999,1,0.963883719,1.240625991,0.776933359,0.437198089,0.571916104,N,-,,pheromone receptor 2,,IPR000366 (PRINTS); IPR027458 (G3DSA:1.10.287.GENE3D); IPR000366 (PFAM); PTHR28009 (PANTHER),9.B.45.1.3, the fungal mating-type pheromone receptor (mat-pr) family.
RL4_JR_07178,5257,3309,3459,0,1,5,0,0,0,0,0,0,2,4,0,0,0,0,0.388057191,1,3.263301945,2.228787969,1.464159889,0.143150267,NA,0.122956939,0,6.489114262,2.008862022,3.230243885,0.001236847,0.015023052,0.32048332,0,3.830115714,1.308591176,2.926900154,0.003423588,0.0149077,0.369824393,1,3.40771104,1.514121158,2.250619788,0.024409629,0.08458162,0.31744166,0,3.742484808,1.252127686,2.988900293,0.002799835,0.011200581,,,,,,,,
RL4_JR_07179,3757,2979,3175,0,0,8,0,0,0,0,1,5,0,11,4,0,4,2,51.99274569,1,-0.627737394,0.810181776,-0.774810558,0.43845161,0.628516646,11.60515317,0,-0.071240187,1.230340168,-0.057902838,0.953826023,0.975510458,30.31625646,1,-2.733083339,1.211046036,-2.256795578,0.024020851,0.064420423,63.0686798,1,0.288440172,0.661966897,0.435732019,0.663031172,0.770391395,33.97272854,1,-1.898227881,1.154193885,-1.64463519,0.100045065,0.191268181,N,-,,GTP-binding guf1,F:GTP binding; P:positive regulation of translation; F:GTPase activity; F:ribosome binding; C:mitochondrial ribosome; C:mitochondrial inner membrane; P:translation,IPR000795 (PRINTS); IPR006297 (TIGRFAM); PF00009 (PFAM); IPR000640 (G3DSA:3.30.70.GENE3D); G3DSA:3.30.70.870 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); IPR013842 (PFAM); IPR000640 (PFAM); G3DSA:2.40.30.10 (GENE3D); PTHR23115:SF97 (PANTHER); PTHR23115 (PANTHER); IPR000795 (PROSITE_PROFILES); IPR006297 (HAMAP); IPR009022 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR009022 (SUPERFAMILY); IPR009000 (SUPERFAMILY),,
RL4_JR_07180,31039,19761,29975,7,13,13,0,0,5,3,1,0,0,3,0,2,1,0,73.89856286,1,0.049841737,0.679197243,0.073383302,0.941501105,0.971334924,14.01203666,1,-0.343041448,1.24494867,-0.27554666,0.782896283,0.868911862,53.62104234,1,-1.156198815,1.055948852,-1.094938275,0.273543679,0.412536304,54.89213022,1,-1.668893739,1.044286718,-1.598118323,0.110016647,0.210889539,54.1921176,1,-0.445190785,0.780300598,-0.570537542,0.568313167,0.685020335,N,-,,MIT domain containing,F:nucleotide binding; F:GTP binding; F:GTPase activity,IPR007330 (PFAM); IPR007330 (G3DSA:1.20.58.GENE3D); PTHR37327 (PANTHER); IPR007330 (SUPERFAMILY),,
RL4_JR_07181,2970,3769,4191,3,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0.493789021,1,2.915594871,2.010953459,1.449856961,0.147098411,NA,0.156501746,0,6.141018065,1.922355467,3.194527845,0.001400598,0.015023052,0.408268337,0,3.480387613,1.299525263,2.678199271,0.007401917,0.025663358,0.471124126,0,3.058214823,1.451761502,2.106554567,0.035156208,0.099540439,0.405128064,0,3.390005688,1.257060623,2.696771838,0.007001522,0.023622264,N,-,,hypothetical protein SMAC_10001,,no IPS match,,
RL4_JR_07182,4634,3429,3464,0,0,3,0,0,0,0,2,6,0,2,0,0,8,0,5.122548779,1,-0.459411777,1.261914359,-0.364059394,0.715813658,0.847794399,1.625650155,0,2.764369012,1.381577397,2.000878863,0.045405446,0.109142431,4.241437987,1,0.104141795,1.241893693,0.083857254,0.933169926,0.96020046,20.94057425,1,2.346996383,0.827194798,2.837295869,0.004549743,0.026040784,4.213167429,1,0.011282384,1.251856071,0.009012525,0.992809143,0.994872582,N,-,,"tagatose 1,6-diphosphate aldolase",F:aldehyde-lyase activity; P:carbohydrate metabolic process; F:zinc ion binding,IPR013785 (G3DSA:3.20.20.GENE3D); IPR000771 (PFAM); IPR000771 (PIRSF); PTHR30304:SF7 (PANTHER); PTHR30304 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_07183,3595,3035,3556,0,0,8,0,0,0,2,0,0,1,13,0,0,5,4,1.318716361,1,1.498473667,1.35137824,1.10884845,0.267495565,NA,0.422497358,0,4.708539044,1.589795047,2.96172708,0.003059188,0.015724315,1.093511287,1,2.059980293,1.230090644,1.674657313,0.094001487,0.185006038,1.261285587,1,1.637881156,1.258000392,1.301971897,0.192925993,0.322179726,1.075672976,1,1.98072253,1.211412746,1.635051749,0.1020382,0.193953693,N,-,,---NA---,,no IPS match,,
RL4_JR_07184,5275,3870,4946,0,1,0,0,0,0,0,0,1,0,1,1,0,2,1,0.250518986,1,3.894539544,2.745852362,1.418335377,0.156092873,NA,0.078827128,0,7.130128604,2.226251852,3.202750218,0.00136122,0.015023052,0.20668766,1,4.461837396,1.3973927,3.192973168,0.00140816,0.007534997,0.238581229,1,4.039735539,1.769560109,2.282903824,0.022436034,0.080726669,0.206207017,1,4.364809385,1.306847202,3.339953883,0.000837923,0.004141085,N,-,,Ankyrin repeat-containing,"P:RNA phosphodiester bond hydrolysis, endonucleolytic; F:ribonuclease III activity; P:RNA phosphodiester bond hydrolysis; F:RNA binding; F:cytoskeletal adaptor activity; F:spectrin binding; C:cytoplasm; F:catalytic activity; P:protein targeting to plasma membrane; P:nucleoside metabolic process; P:RNA processing",IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); PTHR24198 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY),8.A.28.1.2, the ankyrin (ankyrin) family.
RL4_JR_07185,369468,41307,224751,1,7,47,0,0,0,5,0,4,2,9,4,0,3,10,3.655880785,1,0.027320159,1.208076953,0.022614585,0.981957709,0.991069033,1.168906096,0,3.240363468,1.374900106,2.356799198,0.018433211,0.053893982,3.029523455,1,0.589787945,1.204442891,0.48967697,0.624362501,0.73700231,3.494633616,1,0.167565177,1.205188228,0.13903652,0.889421291,0.932042079,2.984374179,1,0.508715515,1.200947831,0.423595015,0.671861191,0.766394835,N,-,,plays a role in the entry into g0,,PR01036 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501:SF73 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.3.79, the major facilitator superfamily (mfs).
RL4_JR_07186,25130,12515,19638,16,2,4,0,0,2,0,4,0,0,2,6,0,6,0,4.570584658,1,3.25578876,1.17809592,2.763602441,0.005716714,0.024277437,0.240638757,1,5.520703534,1.76762752,3.12322787,0.001788792,0.015023052,16.30837252,1,4.699422095,1.045345645,4.495567681,6.94E-06,0.000139099,0.717972262,1,2.451132767,1.338213811,1.831645098,0.067004313,0.146685118,0.611112222,1,2.797059654,1.225013551,2.283288745,0.022413366,0.059830036,N,-,,dynamin family,F:GTP binding; F:nucleotide binding; F:GTPase activity,IPR022812 (PRINTS); IPR001401 (SMART); IPR022812 (PFAM); IPR000375 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11566:SF70 (PANTHER); PTHR11566:SF70 (PANTHER); IPR022812 (PANTHER); IPR022812 (PANTHER); IPR030381 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_07187,483,587,695,1,3,0,0,0,0,2,0,0,2,0,1,0,0,1,0.012376897,1,8.237661038,3.992283311,2.063395906,0.039075029,NA,0.004015611,0,11.43115744,3.991119401,2.864148198,0.004181323,0.018371529,0.010235446,1,8.805715205,3.038577053,2.897973312,0.003755825,0.015764501,0.01179869,1,8.381441139,3.992433907,2.099331219,0.035787713,0.10034633,0.009844433,1,8.758432769,1.618956569,5.409924478,6.31E-08,1.56E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_07188,3750,2769,4301,0,0,0,0,0,1,0,0,2,0,6,1,0,5,4,3.683937196,0,0.016665172,1.257670029,0.01325083,0.989427677,0.994793072,1.170191502,1,3.23879916,1.404110744,2.306655065,0.021074057,0.060020148,3.039937689,1,0.585128269,1.229302516,0.475983951,0.634085812,0.744460716,3.507535446,1,0.162530106,1.236268032,0.13146834,0.89540483,0.935504479,2.996368023,1,0.503233674,1.227969501,0.409809587,0.681945633,0.774069455,N,-,,amidase,"F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (PFAM); IPR023631 (G3DSA:3.90.1300.GENE3D); PTHR11895:SF34 (PANTHER); IPR000120 (PANTHER); IPR023631 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_07189,6496,4235,7280,0,0,0,0,0,1,1,0,2,0,0,0,0,0,2,204.365537,0,0.031073362,0.448975982,0.069209409,0.944822934,0.972846838,32.83351283,1,-1.57155532,1.221062195,-1.287039535,0.198080508,0.341504157,147.1057935,1,-0.244534804,0.556144736,-0.439696338,0.660157055,0.765307458,176.6932006,0,-0.608878823,0.593140438,-1.026533993,0.304639949,0.450288976,124.1401926,1,-0.674240232,0.576181787,-1.170186645,0.241925866,0.371305047,N,-,,exocyst complex component,C:cellular bud; C:site of polarized growth; P:cellular localization; P:cellular component organization; F:binding; C:intracellular part; P:exocytosis,IPR028258 (SMART); IPR028258 (PFAM); IPR019160 (PFAM); PTHR16092:SF14 (PANTHER); PTHR16092 (PANTHER); PTHR16092 (PANTHER); PTHR16092 (PANTHER); PTHR16092:SF14 (PANTHER); PTHR16092:SF14 (PANTHER),1.F.2.1.2, the octameric exocyst (exocyst) family.
RL4_JR_07190,9149,11379,14311,0,0,5,1,0,0,0,0,0,3,6,2,0,4,0,6.552321482,1,-0.814082776,1.206059658,-0.674993787,0.499679712,0.686954346,2.090311014,1,2.401844454,1.312221629,1.830364933,0.067195388,0.148672693,5.418140596,0,-0.24864265,1.20390845,-0.206529533,0.836377298,0.894492905,6.250461725,1,-0.670966976,1.202796757,-0.55783903,0.576954308,0.703574868,5.331292726,1,-0.328139601,1.202600053,-0.272858462,0.784962018,0.853036431,N,-,,glutathione S-transferase,F:transferase activity,IPR010987 (G3DSA:1.20.1050.GENE3D); IPR004045 (PFAM); IPR016639 (PIRSF); PF13410 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR016639 (PANTHER); PTHR32419:SF23 (PANTHER); IPR010987 (SUPERFAMILY),,
RL4_JR_07191,12433,13480,18370,0,6,32,0,0,1,8,3,4,5,14,2,0,4,0,1.692791803,1,1.138372318,1.30754782,0.870616203,0.383963747,NA,0.538517091,1,4.358441698,1.525834326,2.856431806,0.00428432,0.018621961,1.39909,1,1.704539381,1.225895815,1.390443918,0.164394118,0.281088676,1.61421201,1,1.282027082,1.244924604,1.029802992,0.303102496,0.44876932,1.380515387,1,1.621353783,1.216125574,1.333212473,0.182462087,0.300933154,N,-,,Spastin,F:nucleotide binding; P:biological_process; F:ATP binding; F:nucleoside-triphosphatase activity; C:cellular_component; F:molecular_function; F:hydrolase activity,IPR003593 (SMART); IPR003959 (PFAM); G3DSA:1.10.8.60 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23074 (PANTHER); PTHR23074:SF88 (PANTHER); IPR027417 (SUPERFAMILY),3.A.29.1.1, the mitochondrial inner membrane i-aaa protease complex (mimp) familly.
RL4_JR_07192,31653,23111,34566,0,14,13,1,0,1,0,2,6,0,10,1,2,9,11,2.559502166,1,0.541918428,1.311708483,0.413139379,0.679504499,0.824051985,0.827534778,1,3.738793091,1.504299523,2.485404691,0.012940423,0.040996233,2.126482373,1,1.100854021,1.255480564,0.87683876,0.380574223,0.524464449,2.45177321,1,0.679243223,1.273371312,0.533421176,0.593742062,0.716609653,2.07399836,1,1.033654357,1.239859671,0.83368657,0.404457628,0.541254756,N,-,,hypothetical protein SAMD00023353_4700910,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_07193,20934,31164,33280,1,1,8,0,0,0,0,0,1,1,3,2,0,8,0,0.01625695,1,7.841892454,3.971935915,1.97432502,0.048344798,NA,0.005182911,0,11.05900183,3.759459354,2.941646868,0.00326472,0.016208996,0.013406975,1,8.413847212,2.242522468,3.751956706,0.00017546,0.001628189,0.015466548,1,7.98848385,3.972176633,2.011109925,0.044313847,0.114176173,0.01313498,1,8.343198162,1.511882806,5.518415931,3.42E-08,1.07E-06,N,-,,duf227 domain containing,P:phosphorylation; F:transferase activity; F:kinase activity,IPR015897 (SMART); G3DSA:3.90.1200.10 (GENE3D); IPR004119 (PFAM); IPR011009 (SUPERFAMILY),1.C.59.5.2, the clostridium perfringens enterotoxin (cpe) family
RL4_JR_07194,1561,2898,2338,0,2,1,0,0,0,0,1,1,0,3,1,0,0,1,0.012376897,1,8.237661038,3.992283311,2.063395906,0.039075029,NA,0.004015611,0,11.43115744,3.991119401,2.864148198,0.004181323,0.018371529,0.010235446,1,8.805715205,3.038577053,2.897973312,0.003755825,0.015764501,0.01179869,1,8.381441139,3.992433907,2.099331219,0.035787713,0.10034633,0.009844433,1,8.758432769,1.618956569,5.409924478,6.31E-08,1.56E-06,N,-,,integral membrane,C:membrane; C:integral component of membrane,PTHR33048 (PANTHER),2.A.1.7.25, the major facilitator superfamily (mfs).
RL4_JR_07195,15993,11436,13479,0,5,2,0,0,0,0,8,1,3,2,4,0,3,0,0.295917689,1,3.654150208,2.602411188,1.404140216,0.1602771,NA,0.093825978,0,6.878893198,2.19254415,3.137402364,0.00170452,0.015023052,0.245214789,1,4.21516067,1.418409576,2.97175142,0.002961063,0.013479228,0.282968557,1,3.793442029,1.743944265,2.175208293,0.029614511,0.091584277,0.244239782,1,4.119414957,1.334381,3.087135501,0.002020955,0.008554417,N,-,,hypothetical protein F503_06748,P:nucleocytoplasmic transport; P:biological_process; F:structural constituent of nuclear pore; C:cellular_component; F:molecular_function; C:nuclear pore,IPR029032 (G3DSA:1.20.1290.GENE3D); IPR025340 (PFAM),,
RL4_JR_07196,1424,900,1047,0,1,2,0,0,0,0,0,1,0,1,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,CFEM domain-containing,F:chitin binding,IPR008427 (SMART); IPR008427 (PFAM); PTHR37928 (PANTHER),9.B.87.1.15, the selenoprotein p receptor (selp-receptor) family.
RL4_JR_07197,2118,1641,1997,0,0,2,0,0,0,0,3,0,0,4,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,Pectin lyase fold virulence factor,F:catalytic activity,IPR012334 (G3DSA:2.160.20.GENE3D); IPR024535 (PFAM); PTHR31375 (PANTHER); PTHR31375:SF6 (PANTHER); IPR011050 (SUPERFAMILY); IPR011050 (SUPERFAMILY),,
RL4_JR_07198,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.008470882,0,8.791019641,4.031633903,2.180510397,0.029219649,NA,0.002680088,0,12.01721297,4.032710343,2.979934573,0.0028831,0.015349618,0.006904709,0,9.374372631,4.033343739,2.324218623,0.02011378,0.055743746,0.007967227,0,8.951770626,4.033311655,2.219459191,0.026455501,0.08636862,0.006679571,0,9.335361424,1.822923296,5.121093929,3.04E-07,5.22E-06,N,-, Effector probability:0.571,Pectin lyase fold virulence factor,C:membrane; F:lyase activity; C:integral component of membrane; F:hydrolase activity,no IPS match,,
RL4_JR_07199,14269,7042,8109,15,30,0,0,0,0,2,0,0,0,0,0,0,7,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,Pectin lyase fold virulence factor,"F:chitinase activity; P:carbohydrate metabolic process; F:chitin binding; P:chitin catabolic process; P:metabolic process; C:membrane; F:lyase activity; C:integral component of membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:hydrolase activity; F:hydrolase activity, acting on glycosyl bonds",no IPS match,,
RL4_JR_07200,12974,11753,10505,1,3,5,0,0,0,0,1,0,3,9,5,0,11,0,0.039641116,1,6.55398527,3.933587322,1.666159852,0.09568158,NA,0.012859602,0,9.746913473,3.165792817,3.078822285,0.002078206,0.015023052,0.033072982,1,7.106495302,1.814228528,3.917089382,8.96E-05,0.001090575,0.038128118,1,6.685540686,3.400309938,1.966156264,0.049280563,0.121802535,0.032375524,1,7.028677554,1.384689217,5.075996453,3.85E-07,6.42E-06,N,-,,alkaline serine protease,C:extracellular space; F:metal ion binding; P:proteolysis; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:peptidase activity; C:extracellular region; P:pathogenesis; F:hydrolase activity,IPR015366 (SMART); IPR000209 (G3DSA:3.40.50.GENE3D); IPR015366 (PFAM); PTHR14218:SF13 (PANTHER); PTHR14218 (PANTHER); IPR030400 (PROSITE_PROFILES); IPR000209 (SUPERFAMILY); IPR009020 (SUPERFAMILY),,
RL4_JR_07201,3837,3551,3130,0,2,12,0,1,0,0,3,2,0,1,0,0,2,5,0.31978705,1,3.542242572,2.505541498,1.413763282,0.157431418,NA,0.102516534,1,6.751372115,2.15379298,3.134643012,0.001720634,0.015023052,0.265957661,1,4.098512801,1.399096665,2.929399307,0.003396178,0.014839408,0.306763906,1,3.677120451,1.694250895,2.170351782,0.029980207,0.09220826,0.262901138,1,4.012510059,1.316004798,3.049008684,0.002295978,0.009546933,N,-, Effector probability:0.61,---NA---,,no IPS match,,
RL4_JR_07202,28104,29387,37467,2,4,33,0,0,9,4,3,0,1,25,2,0,20,4,0.40084465,1,3.216729928,2.237790189,1.437458232,0.150587833,NA,0.128046413,1,6.431029351,2.030449049,3.167294129,0.001538646,0.015023052,0.331076351,1,3.78501194,1.339118647,2.826494835,0.00470605,0.018094969,0.381907891,1,3.362027013,1.551256624,2.167292607,0.03021255,0.092725695,0.324460713,1,3.711143876,1.26933886,2.92368255,0.003459173,0.013285841,Y,-, Effector probability:0.868,hypothetical protein PFICI_11276,C:virion; P:evasion or tolerance by virus of host immune response,no IPS match,,
RL4_JR_07203,15198,8880,7957,3,6,15,0,0,4,6,5,9,4,11,1,0,4,2,0.471144843,1,2.983526112,2.04616868,1.458103694,0.144811963,NA,0.14990344,1,6.2034696,1.938408056,3.200290868,0.00137289,0.015023052,0.389081532,1,3.551404087,1.296058553,2.740157132,0.006140982,0.022156557,0.448899516,1,3.128587519,1.454881138,2.150407642,0.031522984,0.094951224,0.383237064,1,3.470955813,1.243977645,2.790207545,0.005267426,0.018693548,N,-,,domain-containing,C:membrane; C:integral component of membrane,IPR021842 (PFAM),,
RL4_JR_07204,1344,2182,1707,0,0,9,0,0,0,0,0,0,0,0,1,0,3,0,0.04775661,1,6.285501174,3.92904566,1.599752642,0.109653469,NA,0.015366945,0,9.48965832,3.026215585,3.135817015,0.001713761,0.015023052,97.52069192,0,11.29507582,1.87110387,6.03658407,1.57E-09,7.97E-08,0.04577959,1,6.421750063,3.127671753,2.05320461,0.040052737,0.107597232,0.039005857,1,6.76311975,1.350984576,5.00606733,5.56E-07,8.71E-06,N,-,,maltose permease,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); IPR003663 (TIGRFAM); PTHR23500 (PANTHER); PTHR23500:SF87 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.11, the major facilitator superfamily (mfs).
RL4_JR_07205,17968,19354,23333,7,5,23,0,1,3,4,4,16,6,23,12,0,16,4,0.57540477,1,2.69476068,2.02066218,1.333602769,0.182334075,NA,0.183473868,1,5.911593047,1.959449092,3.016966897,0.002553177,0.015349618,6.976589237,1,4.213984466,1.27240067,3.311837666,0.000926853,0.005408335,0.551300044,1,2.831372739,1.541650911,1.836584871,0.066271202,0.14577361,0.47441555,1,3.161537326,1.333823004,2.370282501,0.017774498,0.049687133,N,-,,hypothetical protein NECHADRAFT_48150,"P:regulation of transcription, DNA-templated",PTHR31944 (PANTHER); PTHR31944:SF57 (PANTHER),,
RL4_JR_07206,4335,3356,3272,0,1,7,0,0,5,0,1,2,0,2,3,0,3,3,27.34992296,1,6.062049156,0.633476553,9.569492553,1.07E-21,1.65E-19,0.197867075,1,5.803019729,1.835813441,3.161007323,0.001572245,0.015023052,196.8188092,1,8.604166485,1.553762127,5.537634323,3.07E-08,1.17E-06,0.591321314,1,2.731109861,1.380363567,1.978543861,0.047867386,0.11960225,0.503917056,1,3.075656154,1.233297376,2.493847967,0.012636666,0.037921233,N,-,,endoglucanase family 5 glycoside hydrolase,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR001547 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR31297:SF13 (PANTHER); PTHR31297 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_07207,242,306,370,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0.023358204,0,7.315437055,3.952125779,1.851013218,0.064167652,NA,0.007508467,1,10.52125751,3.951891025,2.662334929,0.007760062,0.027959129,0.019506799,0,7.865462077,2.651210638,2.966743557,0.003009719,0.01361501,0.022497964,0,7.445332924,3.951772468,1.884048989,0.059558349,0.136354635,0.019366229,0,7.768283252,1.545930068,5.024990078,5.03E-07,7.99E-06,N,-,,aryl-alcohol dehydrogenase,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; P:oxidation-reduction process",IPR007867 (PFAM); IPR000172 (PFAM); IPR012132 (PIRSF); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR11552 (PANTHER); PTHR11552:SF128 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_07208,11875,12345,13218,19,6,125,0,0,1,4,16,37,9,66,7,0,63,10,5.397238585,1,2.18479941,1.168223248,1.870189978,0.061457441,0.155267092,0.508214693,1,4.442106161,1.561542879,2.844690479,0.00444546,0.019058426,1.311205477,1,1.798235785,1.237049991,1.453648436,0.146043801,0.256870646,1.512076315,1,1.376361132,1.261128485,1.091372646,0.275108944,0.417553541,1.285592354,1,1.723369079,1.217462987,1.415541251,0.156909863,0.267190104,N,-,,amidase family,"F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (PFAM); IPR023631 (G3DSA:3.90.1300.GENE3D); IPR000120 (PANTHER); PTHR11895:SF38 (PANTHER); IPR023631 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_07209,692,666,1035,0,1,1,3,0,0,0,0,1,2,0,0,0,0,0,0.008115494,1,8.845278576,4.03634189,2.191409652,0.028422161,NA,0.002507343,1,12.10167175,4.040174693,2.995333784,0.002741447,0.015349618,0.006623884,1,9.426891884,3.299070491,2.857438757,0.00427075,0.016940088,0.007651472,1,9.002876608,4.037800151,2.229648886,0.025770762,0.085851084,0.006630333,0,9.341240721,1.70468121,5.479758129,4.26E-08,1.17E-06,N,-,,Cis-aconitate decarboxylase,F:lyase activity; C:cellular_component,IPR005656 (PFAM); G3DSA:3.30.1330.120 (GENE3D); PTHR16943:SF8 (PANTHER); IPR005656 (PANTHER); IPR005656 (SUPERFAMILY),,
RL4_JR_07210,2044,2620,2149,2,3,19,0,0,0,0,0,2,1,4,1,0,2,0,0.015901563,1,7.871528,3.973277037,1.981117331,0.047578117,NA,0.005010166,0,11.10419825,3.765442626,2.948975554,0.003188292,0.016079667,0.01312615,1,8.436770725,2.240862621,3.76496562,0.000166572,0.001577526,0.015150793,1,8.016170674,3.973433359,2.017441832,0.043649426,0.113446415,0.013085742,1,8.344620785,1.511525422,5.520661885,3.38E-08,1.07E-06,N,-, Effector probability:0.607,pfs domain-containing,F:catalytic activity; F:binding,IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (SUPERFAMILY),,
RL4_JR_07211,9724,10049,13141,0,0,1,0,0,0,0,0,0,0,5,0,0,0,0,15.06819521,1,0.52707994,1.15997366,0.454389576,0.649548454,0.800939584,1.599192324,0,2.788256634,1.35618078,2.055962358,0.039786145,0.098632221,4.137817088,0,0.140384245,1.215715268,0.115474609,0.908068945,0.943482143,4.773035776,1,-0.28183471,1.217204449,-0.231542623,0.816893277,0.884319943,33.87995027,0,3.019142129,0.689255385,4.380295311,1.19E-05,0.000116054,N,-,,5-oxoprolinase (ATP-hydrolysing),,PTHR33266 (PANTHER),,
RL4_JR_07212,4135,3596,3505,1,3,0,0,1,0,0,0,0,2,1,0,0,4,0,5.139472634,1,-0.463995277,1.194525334,-0.388434857,0.697694253,0.836658786,1.643264208,1,2.748970579,1.328436742,2.069327422,0.038515372,0.096096133,4.257955817,0,0.098800291,1.198306453,0.082449937,0.934288928,0.960961201,4.91164974,1,-0.323424173,1.196219576,-0.270371911,0.786874147,0.862053748,4.192621418,1,0.01833432,1.196060121,0.015328928,0.987769764,0.991785885,N,-,,hypothetical protein CMQ_527,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:heme binding",IPR003615 (PFAM),,
RL4_JR_07213,3335,3056,2769,0,2,2,0,0,2,5,3,2,0,4,0,0,4,2,0.016612338,1,7.812771892,3.97064423,1.967633321,0.049110243,NA,0.005355656,1,11.01441033,3.970129233,2.774320352,0.005531718,0.021974647,0.013687801,1,8.385893671,2.919029933,2.872835792,0.004068055,0.016555546,0.015782304,1,7.96124824,3.970963317,2.004865723,0.044977404,0.115138395,0.013184218,1,8.339720293,1.621041499,5.144667981,2.68E-07,4.88E-06,,,,,,,,
RL4_JR_07214,8570,10016,10970,7,0,18,0,0,0,0,0,2,9,8,5,0,1,3,0.574113135,1,2.698519977,2.020566635,1.335526347,0.181704138,NA,0.182082583,0,5.923022973,1.955616691,3.02872388,0.00245589,0.015349618,0.47242451,1,3.271740117,1.370374289,2.387479204,0.016964363,0.049229616,0.545114841,1,2.848660895,1.532229398,1.85916084,0.063004344,0.140696731,0.464091603,1,3.194702097,1.318669464,2.422670869,0.015406878,0.044404965,N,-,,allantoate permease,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF296 (PANTHER); PTHR11662:SF296 (PANTHER); PTHR11662 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.36, the major facilitator superfamily (mfs).
RL4_JR_07215,6162,6815,7706,4,2,0,0,0,0,0,2,0,0,4,1,0,0,0,41.51455574,1,4.320619005,0.739961659,5.83897686,5.25E-09,1.27E-07,0.400643627,0,4.785159659,1.599346257,2.991947265,0.002772041,0.015349618,1.037928031,1,2.135352961,1.228599092,1.738038856,0.082203967,0.166346785,1.197273038,1,1.713102367,1.258064312,1.361696974,0.173293537,0.296434712,1.021591738,0,2.055419945,1.20981245,1.698957508,0.08932719,0.175448652,N,-,,short-chain dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); SM00822 (SMART); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24320 (PANTHER); PTHR24320:SF39 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_07216,3434,2804,3751,0,0,1,0,0,0,2,5,6,1,5,0,0,1,0,0.00781203,1,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,0,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,1,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,0.007662926,1,9.0007212,4.037607722,2.229221316,0.025799183,0.085851084,0.006329724,1,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_07217,77790,68156,72278,89,131,73,3,1,18,9,19,15,14,31,13,0,9,12,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,RNA polymerase 2 mediator complex component,"C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PR00755 (PRINTS); IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07218,1107,1094,1016,0,0,1,0,0,0,0,0,0,1,0,0,0,1,2,8.497184437,1,3.833052549,1.043684876,3.672614826,0.000240081,0.001800168,0.276397601,0,5.320877834,1.734879904,3.067000673,0.002162184,0.015045494,0.71302984,0,2.677619449,1.26270475,2.120542786,0.033960297,0.0845583,0.822311761,1,2.255407767,1.329082259,1.696966272,0.089703037,0.180529368,0.698214256,1,2.604422362,1.227329228,2.122024232,0.033835703,0.082650542,Y,-,,tannase subunit,P:biological_process; C:cellular_component; F:molecular_function; F:hydrolase activity,IPR011118 (PFAM); IPR011118 (PANTHER); PTHR33938:SF7 (PANTHER),,
RL4_JR_07219,2555,2302,2299,0,0,1,0,0,0,0,2,1,0,10,0,0,0,3,4.824131726,1,2.834485378,1.208051543,2.346328179,0.018959406,0.062742899,0.322590082,0,5.097947943,1.710233894,2.980848387,0.002874511,0.015349618,0.832252477,1,2.454688987,1.276434474,1.923082646,0.054469671,0.120667605,0.959866611,1,2.032380327,1.337958455,1.51901602,0.128758464,0.236860364,8.179695489,1,3.322790005,1.153288715,2.881143259,0.003962355,0.014806123,N,-,,tannase subunit,F:hydrolase activity,IPR011118 (PFAM); IPR011118 (PANTHER); PTHR33938:SF7 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_07220,1958,1166,1948,0,0,4,0,0,0,0,0,1,0,1,0,0,0,0,0.090896431,1,5.356954601,3.918486786,1.367097784,0.171594658,NA,0.029052877,0,8.570193908,2.710601782,3.161731083,0.001568343,0.015023052,0.075501343,1,5.914134967,1.569016856,3.769325322,0.000163689,0.001561915,0.087096206,1,5.493494209,2.48896295,2.207141817,0.027304153,0.087982757,0.074748376,0,5.825730832,1.331892897,4.374023501,1.22E-05,0.000118638,N,-,,glycoside hydrolase,"C:membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds",no IPS match,,
RL4_JR_07221,15679,5833,11596,0,5,2,0,0,0,0,1,4,0,0,0,0,0,3,141.4268148,1,-1.771554898,0.952843127,-1.859230389,0.062994489,0.158125859,42.20311506,0,-0.657810482,1.165191286,-0.564551495,0.572378865,0.712612448,168.1352285,1,0.13615656,0.600008407,0.22692442,0.820482513,0.884215978,121.1766055,0,-1.427733805,0.7459428,-1.913999042,0.055620278,0.130813304,108.4275781,1,-1.340945383,0.741942393,-1.807344337,0.070708607,0.145987897,N,-,,AGC kinase,F:ATP binding; P:phosphorelay signal transduction system; P:cellular response to stress; F:protein serine/threonine kinase activity; P:protein phosphorylation; C:intracellular part,IPR000719 (SMART); IPR001789 (SMART); G3DSA:3.40.50.2300 (GENE3D); IPR001789 (PFAM); G3DSA:3.30.450.20 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24356:SF1 (PANTHER); PTHR24356:SF1 (PANTHER); PTHR24356 (PANTHER); PTHR24356 (PANTHER); PTHR24356:SF1 (PANTHER); IPR000961 (PROSITE_PROFILES); IPR000014 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR001789 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR000014 (SUPERFAMILY); IPR011006 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_07222,471,335,352,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_07223,1888,1454,1348,0,0,3,0,0,0,0,2,0,0,0,0,0,0,0,1.4139504,1,1.397670169,1.440323899,0.970386015,0.331854117,NA,0.454051552,0,4.604531802,1.633180352,2.81936517,0.004811874,0.020143007,16.86170199,1,3.779809554,1.077284821,3.508644585,0.000450396,0.003130151,1.356069007,0,1.533074376,1.323837851,1.158052986,0.246842414,0.385512794,1.159319303,0,1.872546639,1.264934056,1.480351192,0.138779548,0.24433019,N,-,,1-acyl-sn-glycerol-3-phosphate acyltransferase,"F:transferase activity, transferring acyl groups; P:mycelium development; P:metabolic process; C:integral component of membrane",IPR002123 (SMART); IPR032098 (PFAM); IPR002123 (PFAM); PTHR10983:SF30 (PANTHER); PTHR10983 (PANTHER); SSF69593 (SUPERFAMILY),,
RL4_JR_07224,3862,3357,3447,0,0,13,0,0,0,0,0,0,1,4,0,0,0,3,155.5907384,1,-0.483892,0.59150844,-0.818064406,0.413320412,0.604385718,98.43626002,0,0.76748857,0.904336617,0.848675765,0.396061735,0.560220358,140.7439298,0,-0.2153176,0.624774928,-0.344632268,0.730370844,0.818131713,276.131229,1,0.994505865,0.446442924,2.22762152,0.025905764,0.085970457,108.7804966,1,-1.25795948,0.72919662,-1.725130705,0.08450392,0.168226935,N,-,,bzip-type transcription factor,"F:transcription factor activity, sequence-specific DNA binding; C:cytoplasm; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding; P:translation",IPR023167 (G3DSA:1.10.238.GENE3D); G3DSA:1.20.5.170 (GENE3D); PTHR40621:SF2 (PANTHER); PTHR40621 (PANTHER); IPR004827 (PROSITE_PROFILES); SSF57959 (SUPERFAMILY),,
RL4_JR_07225,523,455,397,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,28.2568125,0,-1.768402778,1.181927829,-1.496201997,0.134601024,0.273602232,7.91978022,0,0.48009272,1.281855947,0.374529385,0.708010498,0.816578807,33.35712437,0,-0.348529961,1.074386466,-0.324399061,0.745635931,0.829726337,42.74287158,1,-0.80727745,1.059172464,-0.762177527,0.445954057,0.588004274,19.9013523,1,-2.228632322,1.226668697,-1.816816821,0.069245166,0.143728436,N,-,,C6 transcription,"P:negative regulation of asexual sporulation resulting in formation of a cellular spore; F:zinc ion binding; P:asexual sporulation resulting in formation of a cellular spore; P:tRNA processing; P:regulation of secondary metabolite biosynthetic process; P:regulation of transcription, DNA-templated; C:cellular_component; F:molecular_function; F:transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter; F:DNA binding; C:nucleus; P:diterpenoid biosynthetic process",IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31845 (PANTHER); PTHR31845:SF7 (PANTHER),,
RL4_JR_07226,5888,4322,2947,0,4,19,0,0,0,0,0,2,1,5,0,0,5,2,25.8237776,1,-1.615101291,1.150587192,-1.403719164,0.160402494,0.310141058,16.46100692,0,1.556458212,1.141124689,1.363968572,0.172577457,0.308090018,73.18002651,1,1.610780664,1.409422071,1.142866071,0.253094202,0.388761295,33.11458962,1,-0.131733805,0.873957123,-0.150732572,0.880186678,0.926401674,25.29760398,1,-1.142761006,1.128429624,-1.012700289,0.31120334,0.44665601,N,-,,zinc-binding oxidoreductase,F:zinc ion binding; F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process,IPR020843 (SMART); IPR013149 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013154 (PFAM); IPR002085 (PANTHER); IPR002085 (PANTHER); PTHR11695:SF570 (PANTHER); PTHR11695:SF570 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_07227,1080,1072,2138,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.077435706,0,-0.925656771,1.231664526,-0.751549428,0.452322065,0.641300558,2.289271011,0,2.270697853,1.35182157,1.679731928,0.093009485,0.191466749,5.891102751,0,-0.369523506,1.229065865,-0.30065395,0.763678388,0.84110966,16.10454119,0,0.162171984,1.174701294,0.138053806,0.890197894,0.932373402,5.763408604,0,-0.440861286,1.225074671,-0.359864828,0.71894822,0.802043932,N,-,,snf2 family helicase,F:ATP binding; F:helicase activity,IPR014001 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000330 (PFAM); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10799:SF585 (PANTHER); PTHR10799:SF585 (PANTHER); PTHR10799 (PANTHER); PTHR10799:SF585 (PANTHER); PTHR10799 (PANTHER); PTHR10799 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_07228,15568,16338,20278,13,1,21,0,0,2,5,1,0,0,5,0,0,4,0,1.839177073,1,1.018534377,1.411326853,0.721685678,0.470487749,NA,0.598914224,1,4.205262174,1.609178696,2.613297197,0.008967329,0.031052788,1.534273574,1,1.571598951,1.291611486,1.21677375,0.22369031,0.353905407,1.768472009,1,1.150411079,1.32858714,0.865890572,0.386550174,0.53169685,1.49381244,1,1.506813635,1.271266907,1.185285031,0.23590477,0.364606288,N,-,,---NA---,,no IPS match,,
RL4_JR_07229,3067,2785,3482,1,1,11,0,0,1,0,2,5,0,4,0,0,0,0,86.72617217,1,2.230515068,0.536605847,4.156710334,3.23E-05,0.000317722,5.091433729,1,1.117492744,1.286473525,0.86864807,0.385039653,0.54962225,24.17862566,1,-0.561648151,1.214096376,-0.462605904,0.643646876,0.751762918,90.58459678,1,2.092920874,0.658401261,3.178792323,0.0014789,0.010277188,12.83044179,0,-1.595364538,1.216214548,-1.311745975,0.189605859,0.309438962,N,-,,Co-chaperone Hsc20,F:chaperone binding; P:protein folding; P:protein oligomerization,IPR032675 (G3DSA:3.80.10.GENE3D); PTHR24006 (PANTHER); PTHR24006:SF459 (PANTHER); PTHR24006 (PANTHER); PTHR24006:SF459 (PANTHER); PTHR24006:SF459 (PANTHER); PTHR24006 (PANTHER); SSF52047 (SUPERFAMILY),,
RL4_JR_07230,244,298,211,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,8.360981826,0,4.082581829,1.043718889,3.911572236,9.17E-05,0.000792443,0.230271709,0,5.584133729,1.779670583,3.137734467,0.00170259,0.015023052,0.59793177,0,2.931275241,1.265355765,2.316562126,0.020527597,0.056704335,0.68986609,0,2.508607424,1.349260947,1.859245559,0.06299234,0.140696731,0.589362452,1,2.849738092,1.232780179,2.311635229,0.020797794,0.056334312,N,-,,thioredoxin reductase,,no IPS match,,
RL4_JR_07231,507,406,376,0,0,0,0,0,0,0,0,0,2,3,0,0,0,0,1.741269006,0,1.097604301,1.365413702,0.803862082,0.421476631,NA,56.82140905,0,7.451361073,0.687393057,10.84002958,2.22E-27,2.25E-24,1.435611549,0,1.667184082,1.253308675,1.330226236,0.183443742,0.304956395,1.656837289,1,1.244307498,1.281702509,0.970823954,0.331635952,0.47818485,1.423111698,0,1.577523847,1.248742761,1.263289683,0.206485093,0.329428099,N,-,,calcineurin-like phosphoesterase,F:hydrolase activity,IPR004843 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); PTHR37844 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_07232,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.36731691,0,-2.044226145,1.186786001,-1.722489263,0.084980926,0.196617809,4.901774508,0,1.172195736,1.238867967,0.94618294,0.344055286,0.507388396,20.5669025,0,-0.518797553,1.189095823,-0.436295833,0.662622105,0.767286536,14.67884903,0,-1.902958455,1.188515761,-1.601121768,0.109349952,0.209889718,12.55402307,0,-1.563859068,1.19520864,-1.30844023,0.190724035,0.310812949,N,-,,Fe-S assembly co-chaperone,P:cellular process,IPR001623 (G3DSA:1.10.287.GENE3D); IPR004640 (TIGRFAM); IPR009073 (G3DSA:1.20.1280.GENE3D); IPR009073 (PFAM); IPR004640 (PANTHER); PTHR14021:SF15 (PANTHER); IPR004640 (PANTHER); PTHR14021:SF15 (PANTHER); IPR009073 (SUPERFAMILY); IPR001623 (SUPERFAMILY),,
RL4_JR_07233,3417,3000,3040,4,0,9,0,0,0,0,0,0,2,8,4,0,10,0,10.73997948,1,-1.527252695,1.236035727,-1.235605623,0.216605193,0.384897662,3.387458832,0,1.705226814,1.298222973,1.313508426,0.189011684,0.329698265,15.35422824,0,0.004109155,1.220058296,0.003367999,0.997312731,0.999239715,10.22081441,1,-1.380696152,1.227255762,-1.125027231,0.260577495,0.400781883,8.797216973,1,-1.050771667,1.237686876,-0.848980212,0.395892303,0.53274981,N,-,,n-glutamine methyltransferase mtq2,F:nucleic acid binding; P:regulation of translation; F:protein methyltransferase activity; C:eRF1 methyltransferase complex; C:cytosol; P:peptidyl-glutamine methylation; F:S-adenosylmethionine-dependent methyltransferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PTHR18895:SF71 (PANTHER); PTHR18895 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_07234,4068,3990,6797,0,12,4,0,0,0,0,0,0,0,0,0,0,10,1,133.7370913,1,-1.58344382,0.785184605,-2.016651637,0.04373188,0.120406574,30.1647327,0,-1.449307437,1.232221196,-1.176174734,0.239525059,0.391296424,90.11526417,0,-3.153839893,1.228494498,-2.567239738,0.010251171,0.033359967,91.24333475,0,-4.538839605,1.236566062,-3.670519308,0.000242058,0.002254682,90.33414887,1,-2.05340492,0.936612788,-2.192373354,0.028352559,0.071996597,N,-,,small nuclear ribonucleo Sm D1,"C:commitment complex; P:vacuolar proton-transporting V-type ATPase complex assembly; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP; C:integral component of membrane; C:cytosol; C:viral nucleocapsid; F:mRNA binding; C:U2-type prespliceosome; C:U1 snRNP; P:mRNA splicing, via spliceosome",IPR001163 (SMART); IPR001163 (PFAM); G3DSA:2.30.30.100 (GENE3D); IPR027141 (PANTHER); IPR010920 (SUPERFAMILY),,
RL4_JR_07235,3389,4416,4320,0,2,0,0,0,0,2,0,2,5,4,2,0,8,1,78.92455353,1,1.679905558,0.509840897,3.294960386,0.000984356,0.005844522,27.86870645,0,1.914226344,1.110520059,1.723720637,0.084758288,0.177988102,36.56074963,1,0.167869911,1.027763579,0.163335142,0.870254566,0.91785157,63.52113953,1,0.992673297,0.663508596,1.496097116,0.134628349,0.245208138,25.79675535,1,0.461213168,0.844888544,0.545886403,0.585144026,0.6979952,N,-,,small nuclear ribonucleo,P:vacuolar proton-transporting V-type ATPase complex assembly; P:mycelium development; C:integral component of endoplasmic reticulum membrane; P:response to toxic substance,IPR013945 (PFAM); PTHR28251 (PANTHER),,
RL4_JR_07236,5612,4154,5027,0,0,5,0,0,0,0,0,2,1,4,0,0,5,2,140.5455605,1,-2.12355536,0.734525887,-2.891055849,0.003839499,0.017488906,123.9653394,0,0.993553872,0.746710966,1.330573565,0.183329366,0.322813944,118.6194301,1,-1.481052321,0.738590224,-2.005242248,0.044937156,0.104320973,111.7635657,1,-2.996109623,1.01197567,-2.96065381,0.003069868,0.018975832,142.5977137,1,-0.205217522,0.665443825,-0.308391955,0.757784103,0.831176966,N,-,,F-box domain-containing,,IPR011989 (G3DSA:1.25.10.GENE3D); IPR016024 (SUPERFAMILY),,
RL4_JR_07237,2077,748,1653,5,7,4,0,0,1,6,0,9,6,31,0,0,97,9,2.36623305,1,0.655096612,1.278729749,0.512302629,0.608439226,0.774722523,0.763228292,1,3.855457922,1.486567221,2.593530833,0.009499602,0.032430008,1.965856439,1,1.214070576,1.235334034,0.98278728,0.325712143,0.468795812,2.266822214,1,0.792316392,1.249047701,0.634336376,0.525861322,0.659933798,1.923428741,1,1.142265015,1.219882114,0.936373279,0.349081031,0.486503157,N,-,,transcription factor c2h2,P:biological_process,no IPS match,,
RL4_JR_07238,2635,2291,2382,0,0,5,0,0,0,0,1,2,5,6,0,0,5,0,67.08471838,1,1.872456027,0.591804853,3.163975454,0.001556299,0.008469839,26.65939917,0,2.27479501,1.137463341,1.999884242,0.045512765,0.109347308,24.2444049,1,0.512403176,1.054712087,0.485822797,0.62709281,0.739078883,20.99679609,1,-0.009892232,1.042644204,-0.009487639,0.992430073,0.995125632,11.03639394,1,-1.377923319,1.212128767,-1.136779653,0.255630411,0.386725815,N,-,,anaphase-promoting complex subunit 2,P:ubiquitin-dependent protein catabolic process,IPR016158 (SMART); IPR014786 (SMART); IPR011991 (G3DSA:1.10.10.GENE3D); IPR001373 (PFAM); G3DSA:4.10.1030.10 (GENE3D); G3DSA:1.20.1310.10 (GENE3D); IPR014786 (PFAM); PTHR11932 (PANTHER); IPR016158 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY); IPR016158 (SUPERFAMILY),,
RL4_JR_07239,81,65,84,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,468.5759222,0,-1.415376275,0.707454653,-2.00066007,0.045429035,0.123825616,109.4193752,0,-3.308200545,1.241233408,-2.665252581,0.007693052,0.027832988,306.7433679,0,-3.156297236,0.829812155,-3.803628588,0.000142592,0.001422267,395.8895267,0,-2.173572669,0.604210763,-3.597374959,0.000321445,0.002872577,284.910376,0,-4.32988631,1.029473723,-4.205922125,2.60E-05,0.000224442,N,-,,C3h4 type zinc finger,F:zinc ion binding,IPR001841 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001841 (PFAM); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_07240,1467,1276,827,0,0,7,0,0,1,0,0,1,2,6,1,0,2,0,153.6407179,1,2.821611882,1.311680889,2.151142023,0.031464991,0.094062943,6.389933254,1,0.789739379,1.228069697,0.643073744,0.52017625,0.67065558,73.92347687,1,1.95866263,0.530224902,3.694022337,0.000220734,0.001871955,105.7759349,1,2.344842208,0.399714585,5.866291345,4.46E-09,1.33E-07,116.2658529,1,2.688660477,0.583987974,4.603965483,4.15E-06,4.87E-05,N,-,,acyl- dehydrogenase family member 11,F:transferase activity,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); PTHR19959:SF130 (PANTHER); PTHR19959 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_07241,967,1109,1808,0,0,2,0,0,0,3,6,29,1,21,6,1,30,4,665.5406212,1,-2.28642094,0.694001676,-3.294546712,0.000985806,0.005847451,294.5003706,0,-1.00149803,1.527887345,-0.655478975,0.512159419,0.66300933,506.3814954,1,-3.531892841,0.694046654,-5.088840673,3.60E-07,1.09E-05,629.0837418,1,-2.341589442,0.440527632,-5.315420132,1.06E-07,2.37E-06,538.6083476,1,-2.216156073,0.644783276,-3.437055761,0.000588075,0.003104408,N,-,,eukaryotic translation initiation factor 3 subunit D,"C:nucleus; F:translation initiation factor activity; P:formation of translation preinitiation complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; P:mycelium development; C:eukaryotic 43S preinitiation complex; C:eukaryotic translation initiation factor 3 complex, eIF3e; C:cytosol; C:eukaryotic 48S preinitiation complex; P:regulation of translational initiation",IPR007783 (PFAM); IPR007783 (PIRSF); IPR007783 (PANTHER); IPR007783 (HAMAP),,
RL4_JR_07242,3880,3653,3048,0,0,0,0,0,0,0,0,0,4,0,3,0,1,1,5.417559476,0,-0.53992361,1.204989779,-0.448073187,0.654100379,0.804727928,1.723339631,0,2.680281321,1.322340495,2.026922212,0.042670369,0.104124752,4.479326965,0,0.025622931,1.202171579,0.021313872,0.982995278,0.991515811,5.168097383,1,-0.396889024,1.201211544,-0.330407267,0.741092251,0.827955455,4.423523283,1,-0.058866869,1.205173144,-0.048845155,0.961042697,0.97432235,N,-,,snf2 family helicase,C:macromolecular complex; C:cytoplasmic part,IPR019193 (PFAM); PTHR31531:SF2 (PANTHER); PTHR31531 (PANTHER); PTHR31531:SF2 (PANTHER); PTHR31531 (PANTHER),,
RL4_JR_07243,10180,7843,9487,2,2,12,0,0,0,0,0,7,7,10,0,0,5,3,99.36401118,1,0.677012757,0.531588353,1.273565821,0.202817332,0.367358746,10.02569629,0,0.139915252,1.214663398,0.115188498,0.908295716,0.948789395,40.30175896,1,-0.686519921,1.026979886,-0.668484291,0.503824506,0.636237907,52.58070785,1,-0.612077184,0.843389563,-0.725734833,0.468001343,0.609336654,41.5627193,1,-1.655458934,1.114413976,-1.485497283,0.137412143,0.242809414,N,-,,cell cycle checkpoint rad17,,IPR027417 (G3DSA:3.40.50.GENE3D); PF03215 (PFAM); IPR004582 (PANTHER); PTHR12172:SF0 (PANTHER); IPR004582 (PANTHER); PTHR12172:SF0 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_07244,6412,3984,8805,0,3,0,0,0,1,2,4,6,0,0,0,0,0,0,2.675196478,1,0.478135874,1.255606887,0.380800614,0.703351203,0.839696806,0.849450376,1,3.700880403,1.433728407,2.581298093,0.009842955,0.033200076,2.209696482,1,1.045104835,1.220080887,0.856586515,0.391673441,0.535056256,12.18494094,0,1.573112729,1.153341587,1.363960813,0.172579899,0.295563512,9.548703322,0,1.897225956,1.137772082,1.667492098,0.095416594,0.18435366,N,-,,haloacid dehalogenase-like hydrolase,,PF12710 (PFAM); IPR023214 (G3DSA:3.40.50.GENE3D); PTHR28181:SF1 (PANTHER); PTHR28181 (PANTHER); IPR023214 (SUPERFAMILY),,
RL4_JR_07245,3725,2795,3450,1,3,1,0,0,0,0,0,5,4,7,4,0,1,3,54.16413022,1,0.937962731,0.663073322,1.414568644,0.157195008,0.306720132,7.477464491,0,0.562891287,1.24088783,0.453619799,0.650102501,0.773702236,19.51511853,1,-2.097620214,1.209090692,-1.734874173,0.082763095,0.167144139,34.55524292,1,-0.235799883,0.889713177,-0.2650291,0.790987044,0.864875143,27.09103292,1,-0.533438702,1.012446716,-0.526880767,0.598276391,0.70889533,N,-,,transcription initiation factor iif,"F:transcription factor activity, core RNA polymerase II binding; F:translation initiation factor activity; P:transcriptional start site selection at RNA polymerase II promoter; F:catalytic activity; P:translational initiation; C:transcription factor TFIIF complex; C:mitotic spindle pole body; P:regulation of transcription from RNA polymerase II promoter; P:transcription elongation from RNA polymerase II promoter",IPR011991 (G3DSA:1.10.10.GENE3D); IPR003196 (PFAM); PTHR10445:SF0 (PANTHER); IPR003196 (PANTHER); IPR011039 (SUPERFAMILY); IPR011991 (SUPERFAMILY),,
RL4_JR_07246,60,29,53,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,148.0010985,0,-1.851971014,0.661921885,-2.797869442,0.00514409,0.02225185,35.84883722,0,-1.698336138,1.194251555,-1.422092466,0.15499941,0.283605211,92.92882634,0,-4.34907917,1.188053927,-3.660674884,0.000251552,0.002044019,125.8212422,0,-3.030499401,1.010164321,-3.000006372,0.00269974,0.017073619,113.6630057,0,-2.200167627,0.838872614,-2.622767259,0.008721883,0.028141831,N,-,,CCCH zinc finger,F:binding,IPR000571 (SMART); IPR000571 (PFAM); IPR000571 (G3DSA:4.10.1000.GENE3D); PTHR23102 (PANTHER); IPR000571 (PROSITE_PROFILES); IPR000571 (PROSITE_PROFILES); IPR000571 (PROSITE_PROFILES); IPR000571 (PROSITE_PROFILES); IPR000571 (SUPERFAMILY); IPR000571 (SUPERFAMILY),,
RL4_JR_07247,261,239,548,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9.402398606,1,2.792630351,1.048000251,2.664722979,0.007705177,0.030858532,0.565058766,0,4.289174421,1.541622476,2.782246943,0.005398395,0.02171483,1.460563324,0,1.642988648,1.240519208,1.324436283,0.185358191,0.306879204,5.696271916,0,2.166503098,1.172902906,1.847129107,0.064728431,0.143251445,1.43228047,0,1.568138111,1.223445959,1.281738764,0.199934302,0.321701155,N,-,,Extradiol ring-cleavage class III subunit B,F:transition metal ion binding; F:oxidoreductase activity; P:metabolic process,IPR004183 (PFAM); IPR004183 (G3DSA:3.40.830.GENE3D); IPR014436 (PIRSF); PTHR30096:SF0 (PANTHER); IPR014436 (PANTHER); IPR004183 (SUPERFAMILY),,
RL4_JR_07248,10676,7816,8925,0,3,10,0,0,0,0,0,2,2,3,3,0,6,2,3.481783213,1,0.09785832,1.216234214,0.080460095,0.935871333,0.968396542,1.108998385,0,3.316237807,1.379480147,2.403976464,0.016217817,0.049031287,2.880407577,1,0.662607715,1.205777009,0.549527575,0.582643446,0.704152113,3.32314213,1,0.240178057,1.207513583,0.198902986,0.842338634,0.901625458,2.84270431,1,0.579069825,1.204938951,0.480580219,0.630814877,0.734222396,N,-,,xenobiotic compound family,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity",IPR011251 (G3DSA:3.20.20.GENE3D); IPR011251 (PFAM); IPR016215 (TIGRFAM); IPR016215 (PIRSF); PTHR30011:SF30 (PANTHER); PTHR30011 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_07249,2859,2727,2064,0,1,31,0,0,0,0,0,0,0,3,2,0,6,1,5.283232611,1,-0.503982813,1.226341595,-0.410964461,0.681098594,0.825249121,1.68021549,0,2.716774296,1.345045276,2.019838547,0.043400137,0.105498605,15.44427406,0,1.021330981,1.206820198,0.846299211,0.397385848,0.539511107,5.047032454,1,-0.362885811,1.220468103,-0.297333302,0.766212059,0.847926701,4.33259765,1,-0.029036526,1.225047095,-0.023702376,0.981090011,0.987527226,N,-,,gamma-glutamyltranspeptidase,P:glutathione metabolic process; F:transferase activity; C:cellular_component; F:gamma-glutamyltransferase activity,IPR000101 (PRINTS); IPR000101 (PFAM); IPR000101 (PANTHER); PTHR11686:SF8 (PANTHER); IPR000101 (PANTHER); PTHR11686:SF8 (PANTHER); IPR029055 (SUPERFAMILY),,
RL4_JR_07250,2249,2887,3408,2,0,2,0,0,0,0,2,0,0,4,0,0,1,3,19.58683707,1,1.127106899,0.945693704,1.191830816,0.23332759,0.406899663,2.560559761,0,2.108922725,1.335220457,1.579456571,0.11423137,0.224995122,14.55121427,1,0.404637296,1.230135867,0.328937077,0.742203249,0.826993803,17.37839214,1,-0.025541673,1.187499958,-0.021508778,0.982839801,0.989190158,6.685170008,1,-0.654706347,1.254360286,-0.521944416,0.601709032,0.710721413,N,-,,hypothetical protein CMQ_1605,C:integral component of membrane,PTHR40623 (PANTHER); PTHR40623:SF2 (PANTHER),,
RL4_JR_07251,7156,6734,7098,0,1,3,0,0,0,3,0,0,0,0,0,0,0,0,16.25531224,1,-0.792867918,1.168789446,-0.678366767,0.497539175,0.684357543,3.944511066,0,1.485662691,1.274873307,1.165341437,0.243880813,0.396492384,10.26208347,1,-1.170231741,1.211094849,-0.966259366,0.333914413,0.477343903,96.62381895,0,2.577652607,0.584425281,4.410576834,1.03E-05,0.000144777,10.1343132,0,-1.254878856,1.217318913,-1.030854645,0.302608988,0.438015155,N,-,,DNA repair rad51,"F:DNA-dependent ATPase activity; P:reciprocal meiotic recombination; F:double-stranded telomeric DNA binding; P:telomere maintenance; P:meiotic DNA repair synthesis; F:single-stranded telomeric DNA binding; C:chromosome, centromeric region; F:endodeoxyribonuclease activity; F:four-way junction DNA binding; P:DNA recombinase assembly; P:strand invasion; P:chromosome organization involved in meiotic cell cycle; P:mitotic recombination; P:mating type switching; C:nucleoplasm; C:nuclear envelope; C:linear element; F:ATP binding; F:recombinase activity; P:mitotic recombination-dependent replication fork processing; P:response to ionizing radiation",IPR003593 (SMART); IPR016467 (PIRSF); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.150.20 (GENE3D); IPR013632 (PFAM); IPR011941 (TIGRFAM); PTHR22942:SF39 (PANTHER); PTHR22942 (PANTHER); IPR020587 (PROSITE_PROFILES); IPR020588 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR010995 (SUPERFAMILY),,
RL4_JR_07252,10487,8828,7704,0,0,2,0,0,0,0,0,0,3,3,0,0,0,0,37.87809005,1,-3.345633166,1.218165312,-2.746452499,0.006024361,0.02525526,11.96933642,0,-0.115810825,1.228831738,-0.094244657,0.924914812,0.958737823,37.7594234,0,-1.815537309,1.209466802,-1.501105534,0.133328268,0.240137944,57.42471606,1,-0.489584634,0.78500221,-0.623672938,0.532842399,0.665872022,31.0335732,0,-2.869525595,1.221652601,-2.348888377,0.018829551,0.052189078,N,-,,DNA repair partial,C:nuclear envelope,PF11715 (PFAM); PTHR21286 (PANTHER),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_07253,1157,1152,1116,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_07254,831,1240,1519,0,2,2,0,0,0,0,0,0,0,3,0,0,0,0,55.34504588,1,-0.706393221,0.733456232,-0.963102078,0.335496299,0.525634493,12.80247234,0,-0.212812183,1.206024142,-0.176457648,0.859934419,0.918156865,65.08884599,0,-0.039861249,0.734677264,-0.054256816,0.956730555,0.974749656,127.5315179,1,1.251098311,0.40749183,3.070241459,0.002138858,0.013944581,44.24629453,0,-0.733728689,0.834154363,-0.879607806,0.379071809,0.514766908,N,-,,Vacuolar sorting-associated 26,"C:nucleus; P:protein retention in Golgi apparatus; C:endosome; C:cytosol; C:retromer, cargo-selective complex; P:intracellular protein transport; P:retrograde transport, endosome to Golgi",IPR028934 (PFAM); PTHR12233 (PANTHER); PTHR12233:SF1 (PANTHER),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_07255,420,418,684,0,0,0,0,0,0,0,0,4,0,0,2,0,0,0,541.4153097,0,-0.58426055,0.553241784,-1.056067288,0.290937474,0.475808507,134.7308719,0,-1.089270919,0.857815342,-1.269819816,0.204148821,0.348958669,283.9819189,1,-4.965477971,1.199103118,-4.140993294,3.46E-05,0.000532281,412.1459011,1,-1.726789666,0.451246947,-3.826706591,0.000129869,0.001332759,312.5389848,0,-2.430949395,0.60327011,-4.029620159,5.59E-05,0.000426265,N,-, Effector probability:0.642,60s ribosomal l9,F:structural constituent of ribosome; C:ribosome; F:rRNA binding; P:translation,IPR020040 (G3DSA:3.90.930.GENE3D); IPR020040 (PFAM); IPR000702 (PIRSF); IPR020040 (G3DSA:3.90.930.GENE3D); IPR000702 (PANTHER); PTHR11655:SF16 (PANTHER); IPR020040 (SUPERFAMILY); IPR020040 (SUPERFAMILY),,
RL4_JR_07256,168,141,283,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,63.744966,0,2.850350115,0.571075615,4.991195635,6.00E-07,9.73E-06,3.021869996,0,1.869967749,1.296198532,1.442655352,0.149117582,0.275482418,7.886879015,0,-0.790658256,1.218272406,-0.648999561,0.51633866,0.647517973,53.40748837,0,2.320058034,0.618362623,3.751937694,0.000175473,0.001721575,7.830919078,0,-0.882951529,1.229857254,-0.71793009,0.472800393,0.603670111,Y,-,,hypothetical protein UCRPA7_6705,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_07257,19,18,29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,109.9100319,0,2.468104665,0.381629308,6.467282807,9.98E-11,3.46E-09,6.582899613,0,0.746818182,1.227177187,0.608565894,0.542812217,0.689205377,17.05473124,0,-1.903089148,1.187768593,-1.602238988,0.109102772,0.206884521,37.00852044,0,-0.011163218,0.843510491,-0.013234238,0.989440914,0.993657756,16.7868528,0,-1.983039583,1.187913308,-1.669347055,0.09504862,0.18383329,N,-,,V-ATPase subunit H,"C:vacuolar proton-transporting V-type ATPase, V1 domain; P:ATP hydrolysis coupled proton transport; C:fungal-type vacuole membrane; F:proton-transporting ATPase activity, rotational mechanism",IPR011987 (PFAM); IPR004908 (PIRSF); PF03224 (PFAM); IPR011987 (G3DSA:1.25.40.GENE3D); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR10698:SF0 (PANTHER); PTHR10698:SF0 (PANTHER); IPR004908 (PANTHER); IPR004908 (PANTHER); IPR016024 (SUPERFAMILY),3.A.2.2.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_07258,6798,4161,4835,0,0,0,0,0,0,0,1,1,0,2,0,0,0,0,75.40253985,0,-3.316121922,1.14008266,-2.908667975,0.003629721,0.016738986,22.9179244,0,-1.052858251,1.201276643,-0.876449448,0.380785747,0.545087446,108.2451414,1,-0.290895289,0.610496823,-0.476489439,0.633725729,0.744383256,142.9032131,1,0.081103865,1.798814637,0.045087394,0.964037649,0.979221629,58.28942066,0,-3.7789467,1.18549138,-3.187662738,0.001434277,0.006422847,N,-,,hypothetical protein CMQ_1060,,no IPS match,,
RL4_JR_07259,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.489375101,0,2.928683662,2.039403829,1.436048918,0.150988422,NA,0.154548806,0,6.159211572,1.93641095,3.180735769,0.001469015,0.015023052,0.403459869,0,3.498193904,1.310569176,2.669217289,0.007602825,0.026278934,0.465637122,0,3.075430262,1.471172082,2.090462632,0.036576262,0.101605701,0.40004483,0,3.408973234,1.265089602,2.694649636,0.007046268,0.023749489,Y,-,,hypothetical protein H113_03922,,no IPS match,,
RL4_JR_07260,26222,27430,35097,0,0,12,0,0,1,0,2,6,5,11,0,0,3,5,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,GPN-loop GTPase 3 like,C:nucleus; P:mycelium development; C:cytosol; P:RNA polymerase II complex import to nucleus; P:RNA polymerase III complex localization to nucleus,IPR004130 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR004130 (PANTHER); IPR030228 (PTHR21231:PANTHER); IPR004130 (PANTHER); IPR030228 (PTHR21231:PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_07261,844,836,943,0,0,0,0,0,0,0,0,0,0,4,0,0,2,0,61.61101263,0,0.884209662,0.647880778,1.364772181,0.172324665,0.326246605,8.667433906,0,0.349855972,1.234937168,0.283298601,0.77694795,0.864870466,29.05902952,0,-1.345019859,1.204505049,-1.116657717,0.264140703,0.401585896,26.02957866,1,-2.729342271,1.206154246,-2.262846796,0.023645135,0.083034578,33.56731514,1,-0.716802793,0.998135235,-0.718141959,0.472669761,0.603579434,N,-,,hypothetical protein SPI_02252,C:membrane,IPR024316 (PFAM),,
RL4_JR_07262,131,85,161,0,17,0,0,0,3,0,0,0,0,0,0,0,0,0,43.48008053,1,-3.544639638,1.219562116,-2.906485526,0.003655138,0.016818171,13.74885005,1,-0.315783749,1.227162963,-0.257328292,0.796925354,0.876986805,58.10101422,0,-0.573367895,0.881188648,-0.650675535,0.515255959,0.646400413,41.44985264,0,-3.400518634,1.214322333,-2.800342662,0.005104839,0.028478966,35.68508422,0,-3.071025973,1.223465488,-2.510104293,0.012069551,0.036577134,N,-,,mitochondrial chaperone BCS1,P:protein insertion into mitochondrial membrane from inner side; P:protein transmembrane transport; F:ATP binding; F:protein transmembrane transporter activity; P:mitochondrial respiratory chain complex III assembly; P:chaperone-mediated protein complex assembly; P:aerobic respiration; C:mitochondrial inner membrane,IPR003593 (SMART); IPR014851 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR014851 (PFAM); IPR003959 (PFAM); PTHR23070 (PANTHER); IPR027243 (PTHR23070:PANTHER); IPR027243 (PTHR23070:PANTHER); PTHR23070 (PANTHER); IPR027417 (SUPERFAMILY),3.A.28.1.1," the aaa-atpase, bcs1 (bcs1) family."
RL4_JR_07263,3399,3191,2889,0,0,7,0,0,0,0,0,0,2,4,0,0,7,0,159.2599269,1,-0.944092004,0.583335315,-1.618437936,0.105568252,0.230459138,35.66847277,0,-1.691094166,1.206768553,-1.40134093,0.161112147,0.292044619,99.58668919,0,-3.389757476,1.205912327,-2.810948524,0.004939569,0.018765519,136.7952217,1,-1.496712334,0.66245091,-2.259355842,0.023861259,0.0833662,92.37216115,1,-4.443166087,1.217549476,-3.649269435,0.000262987,0.001574657,N,-,,mitochondrial ribosomal subunit s18,"P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:structural constituent of ribosome; F:mRNA 5'-UTR binding; P:ribosomal small subunit assembly; C:mitochondrial small ribosomal subunit; F:small ribosomal subunit rRNA binding; P:translation",IPR001971 (PFAM); IPR001971 (G3DSA:3.30.420.GENE3D); PTHR11759:SF3 (PANTHER); IPR001971 (PANTHER); SSF53137 (SUPERFAMILY),,
RL4_JR_07264,755,715,549,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,463.471667,1,-2.423766226,0.475953578,-5.092442499,3.53E-07,6.07E-06,164.4009905,0,-0.951733649,0.788045733,-1.207713726,0.227157396,0.376932322,334.0865001,0,-5.204951064,1.199875671,-4.33790866,1.44E-05,0.000257294,377.791591,0,-6.588623722,1.198926273,-5.495436932,3.90E-08,9.58E-07,355.755988,0,-2.66510191,0.58762269,-4.535396532,5.75E-06,6.38E-05,N,-,,mitochondrial inner membrane translocase subunit TIM44,"P:protein import into mitochondrial matrix; F:chaperone binding; C:presequence translocase-associated import motor; F:protein binding, bridging",IPR007379 (SMART); IPR007379 (PFAM); IPR017303 (PIRSF); PTHR10721 (PANTHER); IPR032710 (SUPERFAMILY),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_07265,5580,3945,4942,3,6,8,0,0,1,0,0,0,0,3,3,0,6,2,0.027316142,1,7.090035941,3.945597266,1.796948716,0.072343762,NA,0.009180438,1,10.23403782,3.943784179,2.594979177,0.009459665,0.032349004,0.023155952,0,7.621026569,2.772153144,2.749136204,0.005975255,0.021690026,0.026656637,1,7.201741858,3.94481403,1.825622654,0.067907121,0.147894085,0.022279721,1,7.563746413,1.77582487,4.259286229,2.05E-05,0.000183431,,,,,,,,
RL4_JR_07266,767,645,820,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.85234486,0,0.831681989,1.172287086,0.709452487,0.478043726,0.667102415,1.285344597,0,3.103420635,1.384390993,2.241722643,0.024979304,0.068450087,3.332367505,0,0.452687987,1.221210605,0.370687894,0.710870008,0.804199829,13.15671054,0,0.981926431,1.160415684,0.846185074,0.397449507,0.541637462,3.278013446,0,0.37359782,1.217762484,0.306790384,0.759002928,0.831913871,N,-,,vacuolar ABC heavy metal transporter,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003593 (SMART); G3DSA:1.20.1560.10 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); IPR011527 (PFAM); PTHR24221 (PANTHER); PTHR24221:SF18 (PANTHER); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY),3.A.1.210.2, the atp-binding cassette (abc) superfamily.
RL4_JR_07267,1551,1166,1854,0,3,1,0,0,0,0,0,0,0,1,0,0,0,2,163.1966622,1,1.606547495,0.475117392,3.38136958,0.000721255,0.004561237,12.04232649,0,-0.124555214,1.23083583,-0.101195636,0.919395161,0.955641561,61.38793261,0,-0.358606881,0.874984104,-0.409843881,0.681920474,0.781465971,197.5623648,1,2.216162745,0.503642649,4.400268229,1.08E-05,0.000150576,61.63227618,1,0.499951612,0.652296753,0.766448108,0.443409717,0.5766859,N,-,,glycine cleavage system t,F:transaminase activity; F:glycine dehydrogenase (decarboxylating) activity; P:oxidation-reduction process; F:aminomethyltransferase activity; P:glycine catabolic process; P:one-carbon metabolic process; P:methylation,IPR013977 (G3DSA:2.40.30.GENE3D); IPR013977 (PFAM); IPR006223 (TIGRFAM); G3DSA:3.30.70.1400 (GENE3D); IPR028896 (PIRSF); IPR027266 (G3DSA:3.30.1360.GENE3D); IPR006222 (PFAM); PTHR13847:SF212 (PANTHER); PTHR13847 (PANTHER); SSF103025 (SUPERFAMILY); IPR029043 (SUPERFAMILY),,
RL4_JR_07268,7650,7158,6169,0,0,6,0,0,0,0,0,3,2,1,0,0,2,1,296.7453626,1,0.382995743,0.730272728,0.524455766,0.599961578,0.76883364,84.6596324,0,-0.179380287,0.992615526,-0.18071477,0.856591465,0.915566928,246.6834438,1,0.61877638,0.509365955,1.214797287,0.224443416,0.354653551,181.1759886,1,-1.295554254,0.637780542,-2.031348042,0.042219701,0.111553882,117.1752661,1,-1.989434364,0.779186768,-2.553218875,0.01067324,0.033118773,Y,-,,calcineurin-like phosphoesterase,F:pyrophosphatase activity; C:vacuolar membrane; P:polyphosphate metabolic process,IPR012358 (PIRSF); IPR004843 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); PTHR10340 (PANTHER); PTHR10340:SF36 (PANTHER); PTHR10340:SF36 (PANTHER); PTHR10340:SF36 (PANTHER); PTHR10340 (PANTHER); PTHR10340 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_07269,1014,1437,1432,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,270.8073665,0,0.796349558,0.326212362,2.441199815,0.014638553,0.051541352,31.59589949,0,-1.516162309,1.191579325,-1.272397294,0.203231995,0.347602949,156.2517859,1,0.095051547,0.474420419,0.200352985,0.841204526,0.897781428,231.1216791,1,0.769728526,0.368826865,2.086964369,0.036891356,0.102000266,104.1886939,0,-1.076505369,0.636769824,-1.690572211,0.090918536,0.177746703,N,-,,hypothetical protein SPI_07591,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,1.G.20.2.1, the hantavirus gc envelope fusion glycoprotein (gc-efg) family.
RL4_JR_07270,3203,2514,3260,0,0,2,0,0,0,0,0,1,0,4,0,0,2,0,225.7647555,1,-2.791397507,0.829984104,-3.363193939,0.000770462,0.004816422,63.72765005,0,-2.528337369,1.238087928,-2.042130701,0.041138568,0.101412557,166.5838804,1,-5.191115841,1.242832435,-4.176842908,2.96E-05,0.000466119,208.3280099,1,-2.973996696,0.869853004,-3.418964677,0.000628599,0.005039243,165.2522263,1,-5.282304184,1.260736226,-4.189856749,2.79E-05,0.000238297,N,-,,periodic tryptophan 1,P:mycelium development; C:cytosol; P:rRNA processing; C:nucleolus,IPR020472 (PRINTS); IPR001680 (SMART); PF11715 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR14091 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_07271,505,387,599,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,115.1224653,0,-2.493080034,0.847318949,-2.942315921,0.003257674,0.015388595,33.09580043,0,-1.583047711,1.192133765,-1.327911143,0.184207463,0.323818677,98.81175358,0,-2.412729745,1.026515181,-2.350408246,0.01875283,0.053359656,152.2900919,1,-0.923968171,0.527343798,-1.752117262,0.079753647,0.16605093,99.26227117,0,-2.632314268,0.965829462,-2.725444161,0.006421504,0.022047381,N,-,,pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16,"F:ATP binding; C:cytoplasm; C:U2-type spliceosomal complex; F:ATP-dependent RNA helicase activity; F:poly(A) RNA binding; P:mRNA splicing, via spliceosome",IPR007502 (SMART); IPR001650 (SMART); IPR014001 (SMART); IPR007502 (PFAM); IPR011709 (PFAM); IPR001650 (PFAM); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR18934 (PANTHER); PTHR18934:SF91 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.A.53.1.4, the hepatitis c virus p7 viroporin cation-selective channel (hcv-p7) family.
RL4_JR_07272,3984,4311,3397,2,7,2,0,0,1,9,2,0,0,1,0,0,5,2,26.76382383,1,0.265497639,0.849459457,0.312548924,0.754623388,0.871491732,4.877628653,1,1.179328106,1.238160496,0.952484036,0.340851559,0.503905086,12.66488753,1,-1.473813051,1.190551806,-1.237924333,0.215744119,0.344455679,23.92358763,1,-0.947107995,1.139642165,-0.831057348,0.405941233,0.549602999,16.35510583,1,-0.626848399,1.123964522,-0.557711908,0.577041125,0.690771032,N,-,,acylphosphatase,F:hydrolase activity,G3DSA:3.30.70.100 (GENE3D); IPR001792 (PFAM); PTHR10029 (PANTHER); IPR001792 (PROSITE_PROFILES); IPR001792 (SUPERFAMILY),,
RL4_JR_07273,16975,15025,12175,10,2,29,0,0,1,1,4,4,2,18,1,0,5,0,59.80281271,1,-0.638112039,0.739547326,-0.862841385,0.388224682,0.581232695,12.24349762,1,-0.148429246,1.211956566,-0.122470764,0.902526199,0.945005709,31.73495805,1,-2.799054974,1.190751158,-2.35066324,0.018739986,0.053338098,64.86657422,1,-0.889944744,0.848152902,-1.049273948,0.294052053,0.43851787,31.27267757,1,-2.88063683,1.193095616,-2.414422441,0.015760178,0.045153311,N,-,,mRNA splicing factor RNA helicase,F:organic cyclic compound binding; F:heterocyclic compound binding; F:hydrolase activity,IPR010756 (PFAM),,
RL4_JR_07274,521,365,487,0,0,5,0,0,0,0,0,0,0,1,0,0,0,1,24.14177589,1,-2.695695069,1.186548869,-2.271878672,0.023093839,0.073882173,7.702364685,0,0.520233106,1.22084455,0.426125592,0.670016333,0.789052394,19.97573154,0,-2.131157835,1.188689351,-1.79286357,0.072994742,0.151932312,41.99196223,1,-0.813641495,1.00881996,-0.806527951,0.419938498,0.562789847,19.67756617,1,-2.212226459,1.190604028,-1.858070699,0.063158975,0.134103789,N,-,,glycine-rich rna-binding,F:nucleotide binding; F:nucleic acid binding; C:membrane,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR24012 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),9.A.60.1.1, the small nuclear rna exporter (snrna-e).
RL4_JR_07275,5,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.087709078,0,-1.117870461,1.19846807,-0.932749473,0.350949334,0.541218274,2.576886816,0,2.099904941,1.28649017,1.632274378,0.102621698,0.206710436,6.687142948,0,-0.552324643,1.198419977,-0.460877367,0.644886591,0.752863451,7.714837418,0,-0.974725892,1.196571722,-0.814598802,0.415301996,0.559092237,6.589820729,0,-0.633911435,1.199852116,-0.528324638,0.597274034,0.707960617,N,-,,cation transport,C:nucleus; C:cytosol; F:gamma-glutamylcyclotransferase activity; P:glutathione catabolic process,IPR013024 (G3DSA:3.10.490.GENE3D); IPR006840 (PFAM); IPR006840 (PANTHER); PTHR12192:SF2 (PANTHER),,
RL4_JR_07276,610,575,927,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,71.5568009,1,0.439163766,0.617348506,0.711370905,0.476854424,0.666126437,8.828525559,0,0.32336045,1.217415764,0.265612176,0.790537907,0.87373468,22.90250883,0,-2.328415541,1.189668219,-1.957197397,0.050324265,0.113673105,63.81479522,0,0.958605167,0.541592702,1.769974305,0.076731421,0.161486076,30.28554157,0,-0.740156828,0.973083777,-0.760630118,0.446878026,0.57933931,N,-,,calcium-binding modulator,C:site of polarized growth; P:cellular bud site selection; F:calcium ion binding; P:cell budding,IPR002048 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR002048 (PFAM); IPR002048 (PFAM); IPR002048 (PFAM); PTHR10183 (PANTHER); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY),3.A.5.9.1, the general secretory pathway (sec) family.
RL4_JR_07277,207,275,253,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,14.4554072,0,-1.955969408,1.245095007,-1.570939885,0.116196613,0.246985922,4.673835768,0,1.240923064,1.321840211,0.938784472,0.347841413,0.510564209,12.04604547,0,-1.401541327,1.240473663,-1.129843679,0.2585421,0.394953831,13.88918145,1,-1.823114585,1.24395213,-1.465582591,0.142762037,0.256652277,11.81761541,1,-1.476725285,1.244769184,-1.186344668,0.235486213,0.364070531,N,-,,beta-lactamase superfamily,P:biological_process; C:cellular_component; F:molecular_function,PF13483 (PFAM); IPR001279 (G3DSA:3.60.15.GENE3D),,
RL4_JR_07278,12706,12269,9403,1,0,22,0,0,5,2,0,2,1,9,1,0,13,5,135.0778736,1,0.650132139,0.739599644,0.87903252,0.379383644,0.571457121,16.65477274,1,-0.592328953,1.244811988,-0.475838085,0.634189734,0.76075711,76.10780015,1,-0.792675671,0.886100982,-0.894565843,0.371019218,0.515263792,61.49665375,1,-1.38195635,0.910341603,-1.518063489,0.128998394,0.237258627,42.02257839,1,-3.30690594,1.216681522,-2.717971697,0.006568346,0.022482622,N,-,,transcription factor,,no IPS match,,
RL4_JR_07279,12199,23549,25660,0,1,2,4,0,2,0,1,7,0,18,0,0,0,0,39.812152,1,-0.024518792,0.774466699,-0.031658936,0.974744043,0.987085638,7.788410322,1,0.504169605,1.230078745,0.409867748,0.681902965,0.797944718,33.26068909,1,-0.334142531,1.042201269,-0.320612285,0.748504226,0.831726132,58.69798368,1,0.730807253,0.635446318,1.150069222,0.250115362,0.389423041,20.02144689,0,-2.237216236,1.206461652,-1.854361663,0.063687436,0.135015763,N,-,,golgi apparatus membrane TVP23,P:vesicle-mediated transport; C:integral component of Golgi membrane; C:endoplasmic reticulum; P:protein secretion,IPR008564 (PFAM); IPR008564 (PANTHER),,
RL4_JR_07280,12430,10023,6882,0,13,27,6,2,0,1,7,5,1,1,3,0,11,2,19.46171094,1,1.20223472,0.846502603,1.420237477,0.155538557,0.304727076,2.554843486,1,2.112271127,1.282009344,1.647625375,0.09942957,0.201729025,6.629393647,1,-0.539997526,1.194206919,-0.452180872,0.651138687,0.757724558,15.6709657,1,0.765454606,1.0125993,0.755930412,0.449690919,0.59154483,6.53797292,1,-0.622621294,1.196682483,-0.520289469,0.602861835,0.711562597,N,-,,citrate lyase subunit beta,F:metal ion binding; F:lyase activity,IPR011206 (PIRSF); IPR015813 (G3DSA:3.20.20.GENE3D); IPR005000 (PFAM); IPR011206 (PANTHER); PTHR32308:SF0 (PANTHER); IPR015813 (SUPERFAMILY),,
RL4_JR_07281,4426,4866,4567,1,2,6,0,0,2,0,2,2,0,3,0,0,2,0,3.547335238,1,0.07103164,1.228113843,0.057837993,0.953877675,0.977184938,1.127280231,1,3.292640105,1.382469575,2.381708911,0.017232513,0.051256979,2.931292927,1,0.637399523,1.211629997,0.526067797,0.598841103,0.717921094,3.382161731,1,0.214839751,1.214860332,0.176843169,0.85963158,0.912687748,2.895408089,1,0.552640725,1.212159997,0.455914011,0.648451814,0.748810974,Y,-,,Kin of IRRE 3,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_07282,7955,11186,3922,1,4,5,0,0,3,0,0,1,0,3,0,0,0,0,210.178957,1,-0.671237644,0.542643553,-1.236977092,0.216095587,0.384329012,40.09382075,1,-1.859774389,1.210437972,-1.536447494,0.124428666,0.239624611,142.6706369,1,-1.357032212,0.690621847,-1.96494249,0.049420894,0.112057588,179.6585445,1,-0.7656536,0.500904055,-1.528543426,0.12637767,0.233456287,143.198455,0,-0.814183708,0.542319566,-1.50129879,0.133278298,0.236702818,N,-,,duf726 domain,C:cytoplasm; C:membrane,IPR029058 (G3DSA:3.40.50.GENE3D); IPR007941 (PFAM); PTHR17920:SF3 (PANTHER); IPR007941 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_07283,2656,2312,2553,0,0,7,0,0,0,0,0,5,1,1,0,0,0,1,180.6401192,1,0.196115925,0.511609768,0.38333108,0.701474297,0.838858189,25.52418217,0,-1.208245351,1.232456898,-0.980355056,0.326910887,0.489351079,121.1459039,1,-0.218703339,0.618860739,-0.353396694,0.723791064,0.813010178,256.2190667,1,1.229221783,0.42560927,2.888146171,0.003875197,0.022892827,82.78730158,1,-1.691473603,0.867414251,-1.950018232,0.051173946,0.114166986,N,-,,PH domain-containing,F:catalytic activity,IPR001849 (SMART); IPR001849 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR001849 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY),,
RL4_JR_07284,896,949,892,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,13.37312779,0,-1.843624672,1.223482485,-1.50686642,0.1318449,0.269909836,4.328735544,0,1.351636573,1.30469269,1.035980797,0.300211101,0.460406143,11.12904489,0,-1.287225895,1.223802387,-1.051824959,0.292879866,0.43330641,24.86579285,1,0.564774384,0.910583739,0.620233329,0.535104182,0.667232739,14.73324767,0,-0.428439194,1.150953313,-0.37224724,0.709708777,0.79471371,N,-,,serine threonine- kinase,F:kinase activity,IPR000719 (SMART); IPR000253 (G3DSA:2.60.200.GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24362 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR000253 (PROSITE_PROFILES); IPR008984 (SUPERFAMILY); IPR011009 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_07285,1972,2176,2656,2,1,10,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_07286,611,576,697,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,89.92809094,0,-2.792176337,1.15223218,-2.423275782,0.015381245,0.053373117,25.77037851,0,-1.222148293,1.268131183,-0.963739642,0.335176474,0.498553456,67.64755537,1,-3.890985515,1.259045196,-3.090425607,0.001998699,0.00984663,82.11162843,0,-3.372471681,1.22579068,-2.751262296,0.005936609,0.032126223,71.30479818,0,-3.065572923,1.209917127,-2.533704874,0.011286374,0.034586725,N,-,,rrna-processing utp23,"C:small-subunit processome; P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:mitochondrion; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:nucleolus; F:small ribosomal subunit rRNA binding",IPR006984 (PFAM); IPR029060 (G3DSA:3.40.50.GENE3D); PTHR12416:SF3 (PANTHER); PTHR12416 (PANTHER); IPR029060 (SUPERFAMILY),,
RL4_JR_07287,67,91,85,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,83.95594301,0,0.259497553,0.560664985,0.462838879,0.643479861,0.797070863,11.59346138,0,-0.069716316,1.209200894,-0.057654866,0.954023546,0.975515338,37.89329953,0,-1.758557023,1.186902761,-1.481635296,0.138437362,0.247054443,38.67574265,0,-2.195081634,1.138352191,-1.928297456,0.053818138,0.127765932,48.90653665,0,0.130533985,0.671365042,0.194430715,0.845838641,0.896860011,N,-,,rrna-processing utp23,C:small-subunit processome; F:catalytic activity,IPR001932 (G3DSA:3.60.40.GENE3D); IPR001932 (PFAM); PTHR12320:SF13 (PANTHER); PTHR12320 (PANTHER); PTHR12320:SF13 (PANTHER); IPR001932 (SUPERFAMILY),,
RL4_JR_07288,3064,2597,2880,0,5,0,0,0,0,2,0,3,1,4,3,0,0,4,23.50750171,1,-1.103800963,1.167568768,-0.945384112,0.344462811,0.534355614,4.930755036,0,1.163638077,1.268157313,0.917581805,0.358837847,0.522838159,12.83723048,1,-1.493405208,1.214306101,-1.229842464,0.218756103,0.347838352,14.81130983,1,-1.91593379,1.214981402,-1.576924377,0.114812927,0.217042734,24.30066757,1,0.596216558,0.896028224,0.665399306,0.505795129,0.632857604,N,-,,binuclear zinc transcription factor,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR007219 (PFAM); PTHR31313:SF44 (PANTHER); PTHR31313 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07289,1790,2140,2440,0,0,12,0,0,3,0,2,1,3,5,0,0,4,1,2.27237034,1,0.713229336,1.30928793,0.544745979,0.585928237,0.758426055,0.721300543,1,3.936688088,1.490495789,2.641193701,0.008261447,0.029217138,1.880805143,1,1.277127246,1.245102149,1.02572086,0.305023179,0.44638973,21.44081204,1,2.616525492,1.044831301,2.504256418,0.012270907,0.057033942,1.866391833,1,1.185941793,1.245964273,0.951826484,0.341184988,0.478396068,N,-,,family transcriptional regulator,,IPR008030 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR14194 (PANTHER); PTHR14194:SF46 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_07290,7216,6518,5665,1,2,4,0,0,4,1,0,1,1,1,0,0,9,7,3.738015763,1,-0.004809184,1.217468822,-0.00395015,0.996848245,0.999175326,1.199242696,1,3.203418887,1.384346715,2.314029319,0.020666114,0.05904104,3.102295514,1,0.555560746,1.21214196,0.45832977,0.646715539,0.754302779,3.578081631,1,0.133532583,1.214401157,0.109957555,0.912443037,0.946760171,3.051147958,1,0.476660357,1.20691798,0.394940141,0.692887065,0.782192166,N,-,,#NAME?,P:biological_process; F:oxidoreductase activity; P:oxidation-reduction process; C:cellular_component; F:molecular_function,IPR016040 (G3DSA:3.40.50.GENE3D); IPR008030 (PFAM); PTHR10366:SF373 (PANTHER); PTHR10366 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_07291,2491,2078,3127,0,0,7,0,0,0,0,0,2,0,0,0,0,1,0,110.8567867,1,-1.820551301,0.756159107,-2.407629934,0.016056447,0.055136771,27.76216842,0,-1.329524495,1.199264418,-1.108616645,0.267595595,0.425012178,115.6376544,1,-0.582057538,0.622705261,-0.934723976,0.349930568,0.493480577,111.2341778,0,-0.909308403,0.596360105,-1.524763973,0.127317979,0.234850526,89.99663036,1,-1.448844484,0.757199694,-1.913424551,0.055693724,0.121582353,N,-, Effector probability:0.783,atp synthase subunit e,"C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); F:hydrogen ion transmembrane transporter activity; C:integral component of membrane; P:ATP synthesis coupled proton transport",IPR008386 (PFAM); PTHR12427 (PANTHER),,
RL4_JR_07292,26232,15148,16342,21,31,21,0,0,11,3,0,3,6,7,2,0,7,0,69.29054131,1,0.787575591,0.571873702,1.377184488,0.168455216,0.320880572,9.836535685,1,0.167415252,1.233586878,0.135714197,0.892047224,0.939475809,36.50378994,1,-1.517818921,1.199646457,-1.26522186,0.205791808,0.332286486,91.16002731,1,0.720773315,0.628771693,1.146319599,0.251662937,0.391230959,24.95631834,1,-2.555095677,1.198975922,-2.131065044,0.033083784,0.081146636,N,-,,cytoplasmic dynein 1 intermediate chain 2,F:organic cyclic compound binding; F:heterocyclic compound binding,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR12442 (PANTHER); PTHR12442:SF22 (PANTHER); PTHR12442:SF22 (PANTHER); PTHR12442 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),,
RL4_JR_07293,994,1169,1454,0,2,2,0,0,0,0,0,0,0,7,0,0,2,0,162.3564311,1,1.225230518,0.523573414,2.34013127,0.019276963,0.063539986,16.94817641,0,-0.617518649,1.222829699,-0.504991536,0.61356478,0.745558548,109.1501879,0,0.710401063,0.54915726,1.293620452,0.195796555,0.32049221,94.03311284,1,0.007065565,0.587345553,0.012029656,0.990401954,0.994153778,50.58567413,1,-2.410359485,1.136051336,-2.121699441,0.033862986,0.082677292,N,-,,oligosaccharyl transferase stt3 subunit,C:oligosaccharyltransferase complex; C:integral component of membrane; P:protein N-linked glycosylation; F:oligosaccharyl transferase activity,IPR003674 (PFAM); PTHR13872 (PANTHER); PTHR13872:SF1 (PANTHER),9.B.142.3.5, the integral membrane glycosyltransferase family 39 (gt39) family.
RL4_JR_07294,23000,24902,32252,0,0,5,2,0,0,0,0,0,0,12,0,0,0,0,0.012021509,1,8.275938237,3.994557068,2.071803731,0.038283749,NA,0.003842866,1,11.4894157,3.940199092,2.915948011,0.003546096,0.016928889,0.009954621,0,8.839817482,2.38250595,3.710302374,0.000207012,0.001791132,0.011482935,1,8.417149062,3.994556965,2.107154594,0.035104181,0.099498352,0.009795195,0,8.760474239,1.567861258,5.587531547,2.30E-08,8.07E-07,N,-,,---NA---,,no IPS match,,
RL4_JR_07295,2676,1874,1510,16,4,0,0,0,0,7,2,7,0,5,2,0,17,5,0.052243594,1,6.156297049,3.927141982,1.567627827,0.116968014,NA,0.016206838,0,9.411448006,3.159956845,2.978347006,0.002898077,0.015349618,0.042793213,1,6.734147284,1.884518412,3.573404877,0.000352369,0.002628877,0.049424539,1,6.311098588,3.245286851,1.944696687,0.051811494,0.125559168,0.042897621,1,6.634748039,1.457566699,4.551934428,5.32E-06,5.97E-05,N,-,,---NA---,,no IPS match,,
RL4_JR_07296,1257,754,742,0,0,2,0,0,0,0,8,3,4,15,2,0,18,0,1.709728638,1,1.123671514,1.337791284,0.839945309,0.400939052,NA,0.543800973,0,4.344231143,1.542052667,2.8171743,0.004844823,0.020239081,23.55578418,1,3.523751767,1.048418035,3.361017884,0.000776558,0.004702173,1.633553802,1,1.264399193,1.268492707,0.996772931,0.31887474,0.464949128,1.402558683,1,1.598094121,1.238324409,1.290529452,0.196866893,0.31816078,N,-,,zinc finger DNA-binding,F:binding,IPR000571 (PROSITE_PROFILES),,
RL4_JR_07297,3474,2238,3569,4,1,4,0,0,0,0,2,2,0,4,2,0,7,0,14.40661851,1,-1.951132426,1.201308376,-1.624172831,0.104338928,0.228638249,4.586469656,0,1.268073099,1.254526178,1.010798436,0.312112912,0.473786277,11.9291219,1,-1.387571504,1.202414711,-1.153987464,0.248505308,0.38310762,32.71067744,1,-0.060717795,1.023457944,-0.059326126,0.952692352,0.971988116,11.80121973,1,-1.474658811,1.210332341,-1.218391644,0.223075179,0.349742364,N,-,,tubulin-specific chaperone e,P:biological_process; C:cellular_component,SM00364 (SMART); IPR000938 (SMART); IPR000938 (PFAM); IPR000938 (G3DSA:2.30.30.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR15140 (PANTHER); PTHR15140:SF6 (PANTHER); IPR000938 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY); IPR000938 (SUPERFAMILY),8.A.43.1.11, the neat-domain containing methaemoglobin heme sequestration (n-mhs) family.
RL4_JR_07298,665,1123,1229,0,0,0,0,0,2,1,0,0,0,2,0,0,0,0,160.6645252,0,5.284016598,2.049733106,2.577904695,0.009940141,0.037752174,39.6339131,1,4.031625213,1.193533061,3.377891526,0.000730439,0.015023052,33.40229917,1,3.248378338,0.853472716,3.806071683,0.000141191,0.001415819,141.3291688,1,5.077487607,0.607621893,8.356327615,6.47E-17,4.82E-15,36.64514443,0,3.368343205,0.822414859,4.095674062,4.21E-05,0.000335329,N,-,,peroxisomal dehydratase,F:isomerase activity,IPR029069 (G3DSA:3.10.129.GENE3D); IPR002539 (PFAM); IPR029069 (G3DSA:3.10.129.GENE3D); PTHR13078 (PANTHER); IPR029069 (SUPERFAMILY); IPR029069 (SUPERFAMILY),,
RL4_JR_07299,2189,2130,2382,3,0,3,0,0,0,0,2,4,1,3,0,0,2,2,165.1647507,1,0.698909479,0.73436125,0.951724343,0.3412368,0.531561782,22.1268995,0,-1.002186942,1.206221623,-0.830848098,0.406059447,0.569902069,150.2404997,1,0.752823716,0.460327844,1.635407733,0.101963602,0.196532541,242.3688497,1,1.581935419,0.372261125,4.24953161,2.14E-05,0.000278786,200.2646318,1,1.578735604,0.346574534,4.555255654,5.23E-06,5.90E-05,N,-,,casein kinase ii beta 2 subunit,P:phosphorylation; F:kinase activity,PTHR42342:SF1 (PANTHER); PTHR42342:SF1 (PANTHER); PTHR42342 (PANTHER),,
RL4_JR_07300,9534,10392,11438,0,2,9,0,0,0,1,3,1,7,2,3,0,8,7,24.81946718,1,-0.483938866,1.028110859,-0.470706891,0.637850063,0.793591706,5.466615488,0,1.014882965,1.246504781,0.81418297,0.41554014,0.579352245,28.53630221,1,0.182992594,1.040120179,0.175934087,0.860345725,0.910977931,24.40017809,1,-0.339205767,1.026692524,-0.330386907,0.741107633,0.827955455,21.71298232,1,-0.056131103,0.988917982,-0.056760119,0.954736283,0.970227926,N,-,,1-phosphatidylinositol phosphodiesterase,P:lipid metabolic process; F:phosphoric diester hydrolase activity,IPR000909 (SMART); IPR017946 (G3DSA:3.20.20.GENE3D); PTHR13593 (PANTHER); PTHR13593:SF37 (PANTHER); PTHR13593 (PANTHER); PTHR13593:SF37 (PANTHER); IPR000909 (PROSITE_PROFILES); IPR017946 (SUPERFAMILY),,
RL4_JR_07301,3272,3257,3166,0,0,6,1,0,0,5,0,1,2,7,3,0,13,0,0.915453809,1,2.02488071,1.602827332,1.263318057,0.2064749,NA,0.291564013,1,5.24344485,1.737660927,3.017530502,0.002548434,0.015349618,0.758998694,1,2.585994784,1.287861356,2.00797607,0.044645835,0.103763643,0.875683512,1,2.163853085,1.361653417,1.589136456,0.112029589,0.213174138,0.752299374,1,2.4965847,1.266986783,1.970489932,0.048782248,0.109882149,Y,-,,hypothetical protein SPSK_00919,,no IPS match,,
RL4_JR_07302,482,601,977,0,0,2,0,0,0,1,0,0,0,0,0,0,0,0,4.296901172,1,-0.20554467,1.25116662,-0.164282412,0.869508827,0.936924185,1.358881334,0,3.023029185,1.378590771,2.192840144,0.028318899,0.07571154,3.544056969,1,0.363515071,1.228042581,0.29601178,0.767221085,0.843665135,4.08999391,0,-0.059328245,1.233498203,-0.048097553,0.961638496,0.978355082,7.37107204,0,1.202244818,1.158940702,1.037365256,0.299565664,0.43472873,N,-,,mitochondrial chaperone BCS1,,IPR012664 (TIGRFAM); G3DSA:3.40.220.10 (GENE3D); IPR019261 (PFAM); PTHR35596 (PANTHER); SSF52949 (SUPERFAMILY),,
RL4_JR_07303,2017,2678,2789,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,292.7884135,1,-2.514883774,0.659402649,-3.813881821,0.000136801,0.001117139,97.53860597,0,-1.198761643,1.003151594,-1.194995502,0.232088788,0.382232787,205.6233896,0,-5.494874744,1.213053037,-4.529789364,5.90E-06,0.000120271,245.3291483,0,-4.206058802,1.049269108,-4.008560598,6.11E-05,0.000704538,203.8872152,0,-5.58540699,1.227435647,-4.550468289,5.35E-06,6.00E-05,N,-,,valyl-trna synthetase,"P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:ATP binding; P:mitochondrial respiratory chain complex III assembly; C:mitochondrion; F:5S rRNA binding; C:cytosol; F:7S RNA binding; C:nucleolus; P:ribosomal large subunit assembly; P:assembly of large subunit precursor of preribosome; P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",IPR007109 (SMART); IPR007109 (PFAM); PTHR12728:SF0 (PANTHER); PTHR12728:SF0 (PANTHER); PTHR12728 (PANTHER); PTHR12728 (PANTHER); IPR007109 (PROSITE_PROFILES),,
RL4_JR_07304,4748,6066,9858,6,0,7,0,0,0,0,0,0,0,0,0,0,3,1,62.21636442,1,-2.913390919,1.139108166,-2.557606912,0.010539515,0.039495346,17.28213253,0,-0.645697263,1.197759844,-0.539087419,0.589826536,0.727189305,98.95540606,0,0.33110081,0.564139988,0.5869125,0.557262474,0.683654411,87.07046976,0,-0.409105757,0.607290328,-0.67365762,0.500529011,0.638349445,71.27176131,1,0.021761605,0.585623374,0.037159727,0.970357649,0.980201888,N,-,,c6 zinc finger domain containing,"C:nucleus; F:zinc ion binding; F:structural constituent of ribosome; P:regulation of transcription, DNA-templated; C:ribosome; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter; P:translation",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR021858 (PFAM); PTHR31263 (PANTHER); PTHR31263 (PANTHER); PTHR31263:SF9 (PANTHER); PTHR31263 (PANTHER); PTHR31263:SF9 (PANTHER); PTHR31263 (PANTHER); PTHR31263:SF9 (PANTHER); PTHR31263:SF9 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07305,3730,4426,2916,1,1,2,0,0,0,0,0,0,0,0,0,0,1,0,145.5811346,1,0.607990952,0.45645002,1.33199896,0.18286053,0.340331164,18.00926828,0,-0.705189283,1.202350133,-0.58650909,0.557533455,0.701671592,53.37182634,0,-2.39993899,1.194281204,-2.009525882,0.044481393,0.103476475,121.5310511,0,0.26087718,1.757314135,0.148452218,0.881985893,0.926936596,53.73510993,1,-2.512883608,1.130599426,-2.222611785,0.026241989,0.067936624,N,-,,cystathionine gamma-lyase,F:pyridoxal phosphate binding; F:identical protein binding; P:cysteine biosynthetic process via cystathionine; P:transsulfuration; F:cystathionine gamma-lyase activity,IPR015421 (G3DSA:3.40.640.GENE3D); IPR000277 (PIRSF); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR000277 (PFAM); IPR000277 (PANTHER); PTHR11808:SF15 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_07306,2151,2446,2432,0,0,7,0,0,0,0,5,0,1,5,2,0,3,3,74.2443355,1,-0.750189828,0.704551602,-1.064776272,0.286977185,0.4709921,16.25167776,0,-0.556973411,1.217358781,-0.457526096,0.64729295,0.771810488,48.61707054,1,-2.245557647,1.199500545,-1.872077222,0.061195921,0.132268895,123.0900639,1,0.323677437,0.540602351,0.598734794,0.549349751,0.678750073,49.14360367,1,-1.620973225,0.985772091,-1.644369159,0.100099972,0.191300908,N,-,,GPI inositol-deacylase,"F:hydrolase activity, acting on ester bonds",IPR013887 (PFAM); PTHR37988:SF1 (PANTHER); PTHR37988:SF1 (PANTHER); PTHR37988 (PANTHER); PTHR37988 (PANTHER),,
RL4_JR_07307,20791,21344,21045,13,4,18,0,0,0,0,1,2,5,3,2,0,2,2,90.67890543,1,-3.599164705,1.201940275,-2.994462186,0.002749291,0.013470702,27.35045063,0,-1.308003274,1.230755337,-1.062764657,0.287888691,0.447444062,118.3945016,1,-0.383834274,0.662270116,-0.579573598,0.562202201,0.6875737,123.8581503,1,-1.270946998,0.753764847,-1.686131959,0.091770386,0.183558901,104.8081478,1,-0.859971155,0.714586263,-1.203453243,0.228800975,0.356237101,N,-,,glutaredoxin domain containing,C:intracellular membrane-bounded organelle; C:endomembrane system,IPR014025 (PRINTS); IPR012336 (G3DSA:3.40.30.GENE3D); IPR011899 (TIGRFAM); IPR002109 (PFAM); PTHR10168:SF88 (PANTHER); PTHR10168 (PANTHER); IPR002109 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY),,
RL4_JR_07308,252,210,263,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,98.73181775,0,-4.727763365,1.254261436,-3.769360382,0.000163666,0.001302625,31.18672148,0,-1.497348127,1.236611408,-1.210847739,0.225953765,0.375489084,81.29838565,0,-4.156162592,1.229702771,-3.379810707,0.000725358,0.004458726,103.4605698,0,-3.624004059,1.190027696,-3.045310686,0.002324401,0.014942575,80.39880202,0,-4.242875872,1.238988502,-3.424467512,0.000616005,0.00322662,N,-,,hypothetical protein SPI_02249,,no IPS match,,
RL4_JR_07309,652,1106,799,0,2,0,0,0,0,0,0,3,2,1,0,0,0,0,33.50115686,1,-1.820021152,1.180686291,-1.541494269,0.123196537,0.257306028,8.118245066,0,0.444383687,1.261725994,0.352203005,0.724686023,0.82753519,70.56300068,1,1.404142745,0.629816044,2.229448992,0.025784046,0.068191369,24.27257481,1,-2.628375479,1.22103057,-2.152587776,0.03135109,0.094726884,24.53451099,0,-1.355582998,1.153077784,-1.175621468,0.239746173,0.368966408,Y,-,,"arabinogalactan endo-1,4-beta-galactosidase","P:carbohydrate metabolic process; F:arabinogalactan endo-1,4-beta-galactosidase activity; F:glucosidase activity",IPR013781 (G3DSA:3.20.20.GENE3D); IPR011683 (PFAM); PTHR34983 (PANTHER); PTHR34983:SF2 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_07310,967,1674,1276,0,1,3,0,0,0,0,6,1,0,2,2,0,0,1,914.8653962,1,0.038866798,0.506771188,0.076694963,0.938866212,0.969777845,164.9144964,0,-2.088121584,0.997346965,-2.09367618,0.036288836,0.091817974,454.056826,1,-2.255464323,0.537484024,-4.196337424,2.71E-05,0.000433854,601.7593464,1,-1.271598533,0.463295505,-2.744681354,0.006056968,0.032655377,476.9957192,1,-1.61205273,0.655484179,-2.459331255,0.013919612,0.040945982,N,-,,40S ribosomal s15,P:rRNA export from nucleus; F:RNA binding; F:structural constituent of ribosome; P:mycelium development; C:cytosolic small ribosomal subunit; P:ribosomal small subunit assembly; P:translation,IPR002222 (PRINTS); IPR023575 (G3DSA:3.30.860.GENE3D); IPR002222 (PIRSF); IPR005713 (TIGRFAM); IPR002222 (PFAM); IPR002222 (PANTHER); PTHR11880:SF2 (PANTHER); IPR023575 (SUPERFAMILY),,
RL4_JR_07311,255,322,300,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,67.05478659,0,-0.397164978,0.854529773,-0.464776056,0.642091836,0.79631882,11.33288345,0,-0.036878378,1.272627169,-0.028978148,0.976882019,0.98791086,29.10114489,0,-2.673977665,1.22858097,-2.176476545,0.029519646,0.075659973,33.55127561,1,-3.095443091,1.232362682,-2.511795542,0.012011866,0.056081049,35.72745416,0,-1.79903418,1.155160727,-1.557388629,0.119378244,0.218414298,N,-,,set domain containing,,IPR001214 (SMART); G3DSA:2.170.270.10 (GENE3D); IPR001214 (PFAM); IPR001214 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY),,
RL4_JR_07312,147,123,111,2,0,0,0,0,0,0,0,0,0,2,0,0,0,0,274.1361225,1,1.221151459,0.4977654,2.453267058,0.014156519,0.050190737,43.28434277,0,0.492516188,0.983027065,0.501019967,0.61635707,0.747963825,92.31074855,0,-1.390846057,0.848696984,-1.638801696,0.101254566,0.195630005,109.5584808,1,-0.372919358,0.531498341,-0.70163786,0.482905034,0.62317276,86.00140958,0,-0.709697511,0.636676599,-1.114690743,0.264982969,0.397180246,N,-,,NADH-ubiquinone oxidoreductase kDa subunit,P:biological_process; F:NADH dehydrogenase activity; F:oxidoreductase activity; C:mitochondrion; C:membrane; C:integral component of membrane; F:NADH dehydrogenase (ubiquinone) activity; P:oxidation-reduction process; C:mitochondrial inner membrane,PTHR42100 (PANTHER); PTHR42100:SF1 (PANTHER),,
RL4_JR_07313,2609,2504,2840,0,3,2,0,0,0,0,0,6,1,0,0,0,9,0,121.9412225,1,2.995441642,0.427634837,7.004671707,2.48E-12,1.15E-10,4.202492416,0,1.394275531,1.258214863,1.108137864,0.267802281,0.425273719,68.19568523,1,2.162652373,0.626777816,3.45042903,0.000559696,0.003679458,39.89103052,1,1.051477647,0.753554945,1.395356308,0.16290842,0.283069805,10.77005579,1,-1.34265744,1.20499406,-1.114244033,0.26517451,0.397349699,Y,-,,nucleotide exchange factor sil1,"P:SRP-dependent cotranslational protein targeting to membrane, translocation; P:regulation of catalytic activity; C:endoplasmic reticulum; F:adenyl-nucleotide exchange factor activity; C:intracellular",IPR031884 (PFAM); PTHR19316 (PANTHER); PTHR19316:SF6 (PANTHER),,
RL4_JR_07314,1570,1428,1284,0,0,0,0,0,0,0,0,2,2,0,0,0,1,1,12.38613692,0,-1.732788223,1.19358988,-1.451745069,0.146572503,0.29232708,3.957398201,0,1.481011074,1.259689194,1.175695625,0.239716527,0.391482848,24.59122846,1,0.653607376,1.033665078,0.632320265,0.527177625,0.656475556,15.8349022,1,-0.643539244,1.145346983,-0.561872737,0.57420273,0.700795883,10.07890237,1,-1.246986436,1.194586478,-1.043864516,0.296548077,0.431586788,N,-,,set and mynd domain,P:biological_process; F:metal ion binding,IPR001214 (SMART); IPR002893 (PFAM); G3DSA:2.170.270.10 (GENE3D); IPR001214 (PFAM); PTHR12197 (PANTHER); IPR001214 (PROSITE_PROFILES); IPR002893 (PROSITE_PROFILES); SSF144232 (SUPERFAMILY); SSF82199 (SUPERFAMILY),,
RL4_JR_07315,24753,28204,34106,2,0,8,0,0,0,0,1,2,6,9,5,12,9,5,12.73030904,1,1.23085138,1.129459258,1.089770499,0.275814252,0.458872454,1.625506052,0,2.764731111,1.441549302,1.917888695,0.055125126,0.127537491,4.200989254,1,0.118501107,1.27320949,0.093072749,0.925845767,0.956065131,32.9272331,1,3.059348773,0.780724836,3.918600552,8.91E-05,0.000969655,4.111134788,1,0.046798354,1.272387541,0.036779953,0.970660458,0.98031006,N,-,,spc7 kinetochore domain-containing,P:fusion of virus membrane with host plasma membrane; C:viral envelope; F:host cell surface receptor binding,no IPS match,,
RL4_JR_07316,425,319,673,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.08599279,0,1.778811783,1.447582116,1.228815805,0.219140874,NA,0.346585131,0,4.994313309,1.651080649,3.024875443,0.002487355,0.015349618,0.898012111,0,2.344640855,1.244313073,1.884285318,0.059526392,0.129378531,1.03594437,0,1.922147186,1.287667476,1.49273568,0.13550639,0.246452703,0.883163881,0,2.265914632,1.220992228,1.855797751,0.063482391,0.134637455,N,-, Effector probability:0.699,---NA---,,no IPS match,,
RL4_JR_07317,1646,2888,3091,0,0,6,0,0,0,0,0,0,0,2,0,0,0,0,135.0787993,1,-2.080923343,0.820578924,-2.53592102,0.011215202,0.041550237,33.81243436,0,-1.613995991,1.219659245,-1.323317145,0.185729932,0.325646696,102.7813408,0,-2.459085846,1.063837252,-2.311524476,0.020803903,0.057280041,130.1576174,1,-1.2780476,0.691581568,-1.84800703,0.064601326,0.14306396,102.6647682,0,-2.660011359,1.019194629,-2.609915008,0.009056472,0.029008788,N,-,,RNA exonuclease 1,F:nucleic acid binding; P:nucleic acid phosphodiester bond hydrolysis; P:biological_process; F:exonuclease activity,IPR013520 (SMART); IPR013520 (PFAM); IPR012337 (G3DSA:3.30.420.GENE3D); PTHR12801 (PANTHER); PTHR12801:SF68 (PANTHER); PTHR12801:SF68 (PANTHER); PTHR12801:SF68 (PANTHER); PTHR12801:SF68 (PANTHER); PTHR12801 (PANTHER); PTHR12801 (PANTHER); IPR012337 (SUPERFAMILY),,
RL4_JR_07318,11563,10235,11376,4,3,10,0,0,2,4,4,2,3,5,3,0,1,5,174.2067974,1,-0.153872427,0.519472875,-0.296208781,0.767070643,0.877722899,32.06849382,1,-1.537584568,1.19272418,-1.289136746,0.197350551,0.340867409,102.7874132,1,-1.787830646,0.850771534,-2.101422738,0.035603874,0.087255777,152.1092669,1,-0.573552092,0.48884828,-1.173272191,0.240686671,0.379115205,82.23193198,1,-4.275409966,1.194135112,-3.580340218,0.000343147,0.001958492,N,-,,zinc finger transcription factor,P:biological_process; F:metal ion binding; C:cellular_component,IPR000571 (G3DSA:4.10.1000.GENE3D); IPR019496 (PFAM); IPR000571 (PROSITE_PROFILES),,
RL4_JR_07319,31501,32525,45456,21,10,60,0,0,2,0,3,5,1,26,8,5,15,2,29.70374416,1,-1.584695026,1.204514903,-1.31562924,0.188298515,0.34715012,6.822840118,1,0.69505367,1.282628605,0.541897839,0.587888885,0.725705672,17.89562816,1,-1.972629626,1.23807731,-1.593300846,0.111092717,0.209841514,47.95121606,1,0.343199378,0.822947237,0.417036916,0.676651406,0.779715494,25.22570699,1,-1.12630151,1.184389754,-0.950955128,0.341627155,0.478683184,N,-,,rna polymerase iii subunit rpc25,F:RNA polymerase III activity; P:transcription initiation from RNA polymerase III type 2 promoter; C:nuclear chromatin; C:cytosol; P:tRNA transcription from RNA polymerase III promoter; C:DNA-directed RNA polymerase III complex,G3DSA:2.40.50.140 (GENE3D); IPR005576 (G3DSA:3.30.1490.GENE3D); IPR005576 (PFAM); IPR013238 (PFAM); PTHR12709 (PANTHER); PTHR12709:SF1 (PANTHER); IPR012340 (SUPERFAMILY); IPR005576 (SUPERFAMILY),,
RL4_JR_07320,12753,8999,6918,0,5,0,0,0,2,0,0,4,7,12,3,0,8,7,99.56695539,1,0.343722051,0.632489648,0.543442968,0.586824849,0.758927888,15.5019444,1,-0.488917071,1.235488444,-0.395727757,0.692305876,0.804999435,40.57586344,1,-3.153599631,1.22101138,-2.582776609,0.009800876,0.032184259,119.3993392,1,0.515244246,0.568398495,0.906484185,0.364679632,0.511082862,59.3370426,1,-0.656194709,0.824411278,-0.795955522,0.426057888,0.560775355,N,-, Effector probability:0.727,transmembrane 111,C:cytosol; C:ER membrane protein complex; P:protein folding in endoplasmic reticulum,IPR002809 (SMART); IPR008568 (PIRSF); IPR002809 (PFAM); IPR008568 (PANTHER),3.A.27.1.1, the c-terminal tail-anchored membrane protein biogenesis/ insertion complex-2 (tamp-b2) family.
RL4_JR_07321,4758,3262,2716,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,42.69530926,0,1.834456411,0.612880727,2.993170336,0.002760956,0.0134913,3.733053852,0,1.56510254,1.264346963,1.237874243,0.215762694,0.362481326,17.56803358,0,-0.131024469,1.20065883,-0.109127144,0.913101646,0.947155847,19.24518249,0,0.204559264,1.030072885,0.198587175,0.842585687,0.901625458,28.92974602,1,1.71934439,0.720059876,2.387779749,0.016950497,0.047956856,N,-,,signal peptidase complex,C:membrane,IPR009582 (PFAM); PTHR13085:SF0 (PANTHER); PTHR13085 (PANTHER),,
RL4_JR_07322,2080,2119,2030,0,5,3,0,0,0,3,0,0,0,4,0,0,3,0,205.91548,1,-1.634485711,0.569012917,-2.872493157,0.004072469,0.018314885,52.49948793,0,-2.248728487,1.193582281,-1.884016311,0.059562769,0.135390602,136.5945701,1,-4.904773807,1.194937633,-4.104627447,4.05E-05,0.000606492,204.314269,1,-1.453791987,0.532178395,-2.731775662,0.006299402,0.033666761,150.1121816,1,-2.781274763,0.860534492,-3.232031706,0.001229134,0.005664535,N,-,,DNA repair transcription,,IPR024687 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); PF14500 (PFAM); PTHR12891 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_07323,3174,3102,2152,0,0,16,0,0,0,0,0,0,0,10,0,0,5,0,249.9871445,1,-0.161788291,0.601990348,-0.268755623,0.788117745,0.890526979,39.87797681,0,-1.852033267,1.210204798,-1.530346988,0.125930863,0.241873282,104.1672751,0,-4.513784576,1.210545523,-3.728719399,0.000192455,0.00171552,120.2180927,1,-4.936702058,1.214249937,-4.065639129,4.79E-05,0.000569246,110.8168108,1,-3.666099871,1.154204815,-3.176299236,0.00149167,0.006644592,N,-,,methylenetetrahydrofolate dehydrogenase,C:nucleus; P:folic acid-containing compound biosynthetic process; C:cytosol; P:oxidation-reduction process; P:purine nucleobase biosynthetic process; F:methylenetetrahydrofolate dehydrogenase (NAD+) activity; P:one-carbon metabolic process; F:methylenetetrahydrofolate dehydrogenase (NADP+) activity; F:hydrolase activity,IPR000672 (PRINTS); IPR020631 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR020630 (PFAM); G3DSA:3.40.192.10 (GENE3D); PTHR10025 (PANTHER); PTHR10025:SF5 (PANTHER); PTHR10025:SF5 (PANTHER); IPR016040 (SUPERFAMILY); SSF53223 (SUPERFAMILY),,
RL4_JR_07324,43,28,45,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,570.2527615,0,-1.232127312,0.462506062,-2.664024135,0.007721202,0.030907541,153.3381256,0,-1.331577276,0.876249598,-1.519632396,0.128603391,0.245513041,375.7280877,0,-2.750340162,0.654806369,-4.200234288,2.67E-05,0.000427805,470.7124532,0,-2.036976406,0.490476556,-4.1530556,3.28E-05,0.000407066,373.3992183,0,-2.365365345,0.597550924,-3.958433079,7.54E-05,0.000549145,N,-,,nucleic acid-binding,F:organic cyclic compound binding; F:heterocyclic compound binding,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR24012 (PANTHER); IPR006311 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_07325,2860,2952,4466,0,0,6,0,0,0,0,0,1,0,0,2,0,0,0,10.66202197,1,-1.516718729,1.29782813,-1.168659158,0.242540983,0.41743657,3.340591077,0,1.725339065,1.364632632,1.264324936,0.206113423,0.350989244,8.765003047,1,-0.942812713,1.268664778,-0.743153534,0.457388732,0.595499424,28.74362854,1,0.436852884,1.10598062,0.394991445,0.692849201,0.792666459,8.733508572,0,-1.040289276,1.287348333,-0.808086863,0.419040579,0.554757566,N,-,,hypothetical protein CMQ_7908,,no IPS match,,
RL4_JR_07326,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,229.9286452,0,-2.145020812,0.647382521,-3.313374619,0.000921774,0.005578512,55.31333666,0,-2.324034255,1.191985521,-1.94971685,0.051209877,0.120043162,156.5770951,0,-3.156903794,1.033139186,-3.055642296,0.00224579,0.010821694,181.6934993,0,-2.685799777,0.748737027,-3.587106931,0.000334367,0.002969709,141.5431692,0,-5.058875878,1.195373481,-4.232046268,2.32E-05,0.00020318,N,-,,hlh transcription factor,F:organic cyclic compound binding; F:heterocyclic compound binding; F:protein dimerization activity,IPR011598 (SMART); IPR011598 (G3DSA:4.10.280.GENE3D); IPR011598 (PFAM); PTHR22934 (PANTHER); IPR011598 (PROSITE_PROFILES); IPR011598 (SUPERFAMILY),,
RL4_JR_07327,11318,9008,11425,3,31,12,0,0,5,0,4,2,0,2,1,0,2,0,29.34676411,1,2.317511353,0.71401444,3.245748576,0.001171422,0.006701588,1.918998877,1,2.52509455,1.328672916,1.900463628,0.057372304,0.131653244,5.003282827,1,-0.133981026,1.217157327,-0.110076999,0.912348309,0.946547439,5.773796933,1,-0.556777604,1.218742644,-0.456845919,0.647781798,0.758592494,4.955670624,1,-0.222745889,1.224504267,-0.181906993,0.855655717,0.903861672,N,-,,polysaccharide export,C:membrane; C:integral component of membrane; F:transferase activity,IPR021047 (PFAM); PTHR34144 (PANTHER); PTHR34144:SF5 (PANTHER),,
RL4_JR_07328,11456,11167,8170,1,3,13,0,0,1,2,0,5,7,10,8,0,4,0,41.51824881,1,1.132622015,0.66713055,1.697751686,0.089554638,0.204302779,4.492650762,1,1.298000552,1.252272092,1.036516393,0.299961296,0.460380324,11.62742731,1,-1.350358895,1.193875103,-1.131072163,0.25802472,0.394356627,13.41204254,1,-1.772509859,1.191628539,-1.487468453,0.136891129,0.248391162,18.79267614,1,-0.494300594,1.119511588,-0.44153236,0.658827639,0.75668409,N,-,,peroxisomal membrane 4,C:integral component of membrane,IPR003397 (PFAM); IPR019531 (PIRSF); PTHR15460 (PANTHER),1.B.69.1.4, the peroxysomal membrane porin 4 (pxmp4) family.
RL4_JR_07329,1696,1456,1910,0,0,9,0,0,0,0,0,0,3,0,1,0,2,2,2.439616693,1,0.610779135,1.356121914,0.450386598,0.652431707,0.803523228,0.771438932,0,3.839684167,1.516578687,2.531806758,0.011347651,0.036970234,2.018021792,0,1.175555897,1.27324485,0.923275596,0.355863602,0.499274267,2.328961955,1,0.752758024,1.298246011,0.57982695,0.562031322,0.690016628,5.870842172,1,2.003516755,1.198325615,1.671930175,0.094538092,0.182985697,N,-, Effector probability:0.681,kinase-like (PK-like),P:nucleocytoplasmic transport; F:ATP binding; F:structural constituent of nuclear pore; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity; C:nuclear pore,no IPS match,,
RL4_JR_07330,2100,1512,2087,0,0,4,0,0,2,2,0,0,0,3,0,0,2,0,9.725267607,1,-1.384228391,1.189718519,-1.163492346,0.244629802,0.420145247,3.116446613,1,1.825637892,1.275804561,1.430969874,0.15243885,0.280033763,30.2059248,1,1.007341913,1.030772572,0.977268838,0.328436076,0.471309261,31.93954717,1,1.076278721,0.850016983,1.266184961,0.205446871,0.337358022,37.39714137,1,1.742670756,0.743051085,2.345290642,0.019012253,0.05250929,N,-,,phytanoyl- dioxygenase,F:dioxygenase activity; P:oxidation-reduction process,G3DSA:2.60.120.620 (GENE3D); IPR008775 (PFAM); PTHR31630 (PANTHER); PTHR31630:SF6 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_07331,21579,13916,11067,2,4,2,0,3,0,6,4,3,5,28,1,0,3,4,3.196401891,1,0.22100743,1.256529708,0.175887151,0.8603826,0.930655165,1.03010477,1,3.422770958,1.4368426,2.382147465,0.017212003,0.051221071,2.658232177,1,0.778440242,1.233612562,0.631024899,0.528024244,0.657448954,3.065352839,1,0.356677599,1.242353792,0.28709825,0.774037092,0.853624394,2.609019922,1,0.702422684,1.22612533,0.572880004,0.566725944,0.683675172,N,-,,---NA---,,no IPS match,,
RL4_JR_07332,3972,3889,3070,0,2,22,0,0,0,3,5,4,3,5,2,0,6,2,107.7953986,1,0.844145072,0.465094123,1.814998363,0.069524161,0.170170449,14.75241101,0,-0.417331934,1.214678111,-0.343574096,0.731166608,0.832025678,115.7500846,1,1.079640032,0.495222484,2.180111097,0.029249227,0.07511902,126.4961894,1,0.725254046,0.474314534,1.529057183,0.126250269,0.233263498,79.19743662,1,0.636859805,0.518027438,1.229393964,0.218924132,0.344728902,N,-,,peroxisomal targeting signal receptor,"C:peroxisomal membrane; F:peroxisome matrix targeting signal-1 binding; P:protein import into peroxisome matrix, docking; C:cytosol",IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); PF13432 (PFAM); PTHR10130:SF0 (PANTHER); PTHR10130:SF0 (PANTHER); IPR024111 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY),3.A.20.1.5, the peroxisomal protein importer (ppi) family.
RL4_JR_07333,2439,2503,4312,0,0,3,0,0,0,0,0,0,1,1,1,0,1,1,83.67880775,1,-4.489142857,1.202566689,-3.732967907,0.000189237,0.00146888,26.91481858,0,-1.284801397,1.215899611,-1.056667331,0.29066344,0.449724142,104.7062449,0,-0.795197776,0.690813272,-1.15110379,0.249689539,0.384348015,84.18993898,1,-3.406081137,1.157296805,-2.943135349,0.003249063,0.019865197,68.28960504,1,-4.007396882,1.2014004,-3.335604752,0.000851141,0.004192577,N,-,,chromatin spt2,,IPR013256 (SMART); IPR013256 (PFAM); PTHR22691 (PANTHER),,
RL4_JR_07334,1739,1879,2754,0,3,7,0,0,0,0,2,2,2,4,14,0,10,0,954.5938637,1,-0.067719664,0.651920266,-0.103877219,0.917266786,0.960708991,315.0028094,0,0.122846359,0.576747889,0.212998368,0.831328236,0.898925692,490.8905239,1,-2.342894092,0.56490366,-4.147422395,3.36E-05,0.000520503,655.1730211,1,-1.346494085,0.436835331,-3.082383656,0.0020535,0.013483584,590.3723248,1,-0.982310834,0.769666688,-1.276280823,0.201856267,0.323949073,N,-,,60S acidic ribosomal P2,"F:structural constituent of ribosome; P:cytoplasmic translation; C:cytosolic large ribosomal subunit; F:large ribosomal subunit rRNA binding; P:fatty acid biosynthetic process; P:translational elongation; F:ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process; C:preribosome, large subunit precursor",PF00428 (PFAM); PTHR21141 (PANTHER),,
RL4_JR_07335,3878,4618,7364,3,2,1,0,0,0,0,0,1,5,0,0,0,2,0,34.37349664,1,1.670038712,0.617569562,2.704211498,0.00684667,0.028121781,3.650487483,0,1.597402967,1.255095032,1.272734674,0.203112209,0.347456782,9.483516391,1,-1.05652821,1.193126464,-0.885512343,0.375880365,0.519723138,10.94124984,1,-1.478989172,1.190871179,-1.241938841,0.214259128,0.348814049,9.362764104,1,-1.14068027,1.19805414,-0.952110787,0.341040799,0.478326374,N,-,,TTK kinase,P:cell cycle process; F:protein kinase activity; P:phosphorylation; P:regulation of cell cycle,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR22974 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_07336,7086,5011,8444,2,0,3,0,0,0,0,0,0,0,4,0,0,5,0,159.8285605,1,-0.597049568,0.516359213,-1.156267872,0.247571606,0.423859215,30.00447346,0,-1.441621467,1.197099287,-1.204262239,0.228488237,0.378272479,128.9191539,0,-0.68607794,0.621614347,-1.103703515,0.26972177,0.408109879,150.1389263,1,-0.356913047,0.491398304,-0.726321283,0.467641835,0.609065292,84.63704623,1,-3.249323534,1.132271717,-2.86973832,0.004108116,0.015224992,N,-,,BAF1 ABF1 chromatin reorganising factor,,IPR028909 (PFAM); PTHR21349 (PANTHER); IPR028909 (SUPERFAMILY),,
RL4_JR_07337,4206,5148,5828,0,1,4,1,0,0,0,0,0,0,3,0,0,3,2,28.44082982,1,-0.764801464,1.039608344,-0.735663069,0.46193577,0.650184958,6.596271084,1,0.743789724,1.243420804,0.598180215,0.549719692,0.696054881,17.20144517,0,-1.915573641,1.207323955,-1.586627709,0.112596988,0.211411703,19.84936772,1,-2.338299396,1.20764617,-1.936245445,0.052837647,0.126562852,31.79228759,1,-0.305576114,0.998198825,-0.306127503,0.759507568,0.83219415,N,-,,tRNA splicing endonuclease subunit,"P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:nucleic acid phosphodiester bond hydrolysis; C:mitochondrial membrane; F:endonuclease activity; C:tRNA-intron endonuclease complex; C:mitochondrial outer membrane; P:tRNA-type intron splice site recognition and cleavage",IPR024336 (PFAM); IPR024337 (PANTHER),,
RL4_JR_07338,4131,4609,5125,9,3,2,0,0,0,0,0,2,0,13,0,0,1,4,20.49766573,1,-2.459801126,1.186392605,-2.073344958,0.038140187,0.108830254,73.50734838,0,2.974427772,0.848293455,3.506366521,0.000454269,0.015023052,17.00162488,1,-1.898620156,1.192616114,-1.591979292,0.111389358,0.210079332,19.60957696,1,-2.320681389,1.190600766,-1.949168399,0.051275318,0.125099419,20.57795309,1,-1.046777626,1.121021449,-0.933771273,0.350421891,0.487566531,N,-,,---NA---,,no IPS match,,
RL4_JR_07339,14638,19063,22003,6,23,48,2,3,10,10,14,16,6,31,7,1,13,5,9.168864251,1,-1.299224085,1.245657924,-1.043002304,0.296947226,0.482664967,2.905139032,1,1.926795628,1.324423279,1.454818606,0.145719486,0.270985235,38.95908725,1,2.090562473,0.802740732,2.604281045,0.009206723,0.030630582,12.76711731,1,-0.213253349,1.18773123,-0.179546806,0.857508369,0.91123764,7.543800602,1,-0.8290852,1.248299367,-0.66417177,0.50658038,0.633460089,N,-, Effector probability:0.851,peptidyl-prolyl cis-trans isomerase-like 3,F:peptidyl-prolyl cis-trans isomerase activity; P:protein peptidyl-prolyl isomerization; P:protein folding,IPR002130 (PRINTS); IPR002130 (PFAM); IPR029000 (G3DSA:2.40.100.GENE3D); IPR024936 (PIRSF); IPR024936 (PANTHER); PTHR11071:SF256 (PANTHER); IPR002130 (PROSITE_PROFILES); IPR029000 (SUPERFAMILY),3.D.1.8.1, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_07340,6376,7170,13203,4,0,5,0,2,3,3,0,1,2,7,0,0,0,0,53.97755749,1,-0.067136128,0.757431175,-0.088636605,0.929370716,0.96586144,8.41017746,1,0.393409631,1.243563232,0.316356757,0.751731736,0.848464388,45.77722078,1,0.15596365,0.866575631,0.179976962,0.857170654,0.908976192,29.04746458,1,-1.726763228,1.155798103,-1.494000746,0.135175424,0.245939114,21.3054411,0,-2.326989781,1.202109745,-1.935754861,0.052897732,0.116889903,N,-,,heat shock transcription factor,P:regulation of cellular process,IPR000232 (PRINTS); IPR000232 (SMART); IPR011991 (G3DSA:1.10.10.GENE3D); IPR000232 (PFAM); IPR027725 (PANTHER); PTHR10015:SF205 (PANTHER); PTHR10015:SF205 (PANTHER); IPR027725 (PANTHER); IPR011991 (SUPERFAMILY),,
RL4_JR_07341,2458,2597,2559,0,2,4,0,0,0,0,0,1,0,3,0,0,0,2,35.90094475,1,-3.268367994,1.188234231,-2.750609189,0.005948456,0.024975557,11.48254101,0,-0.05585822,1.214914861,-0.045977065,0.96332853,0.980387104,29.76441918,1,-2.706575639,1.192039679,-2.270541567,0.023174744,0.062556508,128.7484169,1,1.143752215,0.611423563,1.870638104,0.061395259,0.138354552,40.56114639,1,-1.111028023,0.974593037,-1.139991751,0.254289738,0.385201016,N,-,,peptidyl-prolyl isomerase cwc27,P:cellular macromolecule metabolic process; P:primary metabolic process; C:intracellular part; F:isomerase activity,IPR002130 (PRINTS); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); PTHR11071:SF152 (PANTHER); PTHR11071:SF152 (PANTHER); IPR024936 (PANTHER); IPR024936 (PANTHER); IPR002130 (PROSITE_PROFILES); IPR029000 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_07342,11937,16908,16753,8,5,64,3,0,0,4,0,12,0,20,6,0,6,5,379.088647,1,1.295272003,0.58002403,2.233135069,0.025540039,0.080075186,55.42383555,1,-0.091049121,0.992020824,-0.091781461,0.926871674,0.959634629,101.6311018,1,-3.421069271,1.195969128,-2.860499649,0.00422974,0.016940088,141.846072,1,-1.138283153,0.582593416,-1.953820833,0.05072241,0.124288092,135.0940795,1,-0.850991497,0.566551577,-1.502054767,0.133082965,0.236480348,N,-,,V-type proton ATPase subunit B,"C:vacuolar proton-transporting V-type ATPase, V1 domain; F:ATP binding; P:proteasome storage granule assembly; P:ATP hydrolysis coupled proton transport; C:fungal-type vacuole membrane; P:ATP metabolic process; F:proton-transporting ATPase activity, rotational mechanism; P:vacuolar acidification; P:cellular calcium ion homeostasis",IPR022879 (PIRSF); IPR004100 (PFAM); IPR005723 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000194 (PFAM); PTHR15184:SF11 (PANTHER); PTHR15184 (PANTHER); IPR022879 (HAMAP); IPR027417 (SUPERFAMILY),3.A.2.2.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_07343,850,677,879,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,565.2183462,0,1.516615142,0.3453808,4.391139124,1.13E-05,0.000129016,75.98607656,0,0.06953009,0.85200685,0.081607431,0.934958892,0.964104921,196.0751413,0,-0.636462982,0.504438128,-1.261726556,0.207047198,0.333940709,244.6076981,0,-0.229163106,0.501429874,-0.457019251,0.647657208,0.758592494,152.5745213,0,-1.897984113,0.691682743,-2.744009637,0.006069376,0.020966369,Y,-,,pci domain-containing,,PTHR38118 (PANTHER); PTHR38118:SF1 (PANTHER),,
RL4_JR_07344,108,71,105,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.72549933,0,-3.089821037,1.188424503,-2.599930436,0.009324266,0.035870723,10.15951007,0,0.120801691,1.220454288,0.098980922,0.921153417,0.956566852,86.2458683,0,0.896118665,0.614518464,1.458245304,0.14477294,0.25516995,39.62466091,0,-1.999469563,1.142465816,-1.750135134,0.080094999,0.166590358,25.8154071,0,-2.603938299,1.188606288,-2.19074922,0.028469945,0.072208967,N,-,,ring finger,F:ubiquitin-protein transferase activity; F:ubiquitin protein ligase activity; F:zinc ion binding; F:ubiquitin conjugating enzyme binding; C:ubiquitin ligase complex; C:cytoplasm; F:metal ion binding; P:protein polyubiquitination; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; F:ligase activity; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; P:protein ubiquitination,IPR002867 (SMART); IPR002867 (PFAM); IPR031127 (PANTHER); SSF57850 (SUPERFAMILY); SSF57850 (SUPERFAMILY); SSF57850 (SUPERFAMILY),,
RL4_JR_07345,3802,3991,3170,0,0,10,0,0,0,4,2,0,1,6,0,0,2,0,2225.840998,1,-1.925043214,0.742836384,-2.591476745,0.0095565,0.036584668,564.6087381,0,-5.675586298,1.228269241,-4.62079983,3.82E-06,0.000288752,1454.979961,1,-8.31778943,1.226011735,-6.784428884,1.17E-11,7.97E-10,1792.776359,1,-3.847253851,0.491774263,-7.823211062,5.15E-15,3.22E-13,1435.081672,1,-6.228180103,0.933978619,-6.668439698,2.59E-11,2.05E-09,N,-,,zinc finger zpr1,F:zinc ion binding; P:mycelium development,IPR004457 (SMART); IPR004457 (TIGRFAM); IPR004457 (PFAM); PTHR10876 (PANTHER); PTHR10876:SF0 (PANTHER),,
RL4_JR_07346,2568,2486,2538,0,4,2,0,0,0,0,0,0,1,3,0,0,7,0,104.2114163,1,-4.805713826,1.201023422,-4.001348963,6.30E-05,0.000569245,33.53193671,0,-1.601933776,1.212625051,-1.321046249,0.186485944,0.326544391,86.57276026,0,-4.246854497,1.200695908,-3.536994228,0.000404709,0.002907927,99.8377284,1,-4.668695683,1.201947024,-3.884277419,0.000102635,0.001090426,84.97096463,1,-4.322697262,1.199249125,-3.60450316,0.000312751,0.00180742,N,-,,rnase p rpr2 rpp21 snm1 subunit domain-containing,,IPR007175 (PFAM),,
RL4_JR_07347,209,189,322,0,0,0,0,0,2,0,0,1,1,0,0,0,0,0,13.89745911,0,-1.899111647,1.204708722,-1.576407319,0.114931963,0.244872017,4.40723188,1,1.325578367,1.253845099,1.05721063,0.290415469,0.44960517,11.48316417,1,-1.332564923,1.202762117,-1.107920597,0.267896109,0.406015002,21.27382164,1,-0.034918827,1.029392491,-0.033921782,0.972939524,0.984716587,11.37215101,0,-1.421176971,1.211858278,-1.172725389,0.240905947,0.370188604,N,-,,DUF866 domain,C:nucleus; C:cytosol,IPR008584 (PFAM); IPR008584 (PANTHER); PTHR12857:SF0 (PANTHER); SSF141678 (SUPERFAMILY),,
RL4_JR_07348,8582,7605,8347,0,1,8,0,0,0,4,1,0,0,1,0,0,0,3,169.7151877,1,-1.575521017,0.598685173,-2.631635269,0.008497503,0.033296173,40.75169615,0,-1.883297853,1.19592185,-1.574766656,0.115310316,0.226635148,119.1023986,1,-2.722050377,1.039319138,-2.619070772,0.008816965,0.029635776,191.9511828,1,-1.162528638,0.573695395,-2.026386558,0.042725187,0.112420094,105.0097099,1,-4.628158709,1.20490622,-3.841094545,0.000122487,0.000820768,N,-,,pentatricopeptide repeat domain-containing,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_07349,1645,1540,2441,0,0,3,0,0,2,0,0,1,4,0,0,0,0,0,63.2453086,1,-2.175376287,1.020597479,-2.131473309,0.033050169,0.097577906,17.67291655,1,-0.677982079,1.20104769,-0.564492222,0.572419192,0.712612448,73.3123598,1,-0.516799435,0.747383664,-0.691478099,0.489265139,0.623451261,89.65049002,1,-0.695446986,0.672956262,-1.033420781,0.301407026,0.447124662,45.44692607,0,-3.419881941,1.198562436,-2.853319809,0.004326506,0.015923617,N,-,,glycerophosphodiester phosphodiesterase gde1,C:cell; F:glycerophosphocholine phosphodiesterase activity; P:glycerophospholipid catabolic process; P:phosphorylation; F:glycerophosphodiester phosphodiesterase activity; F:kinase activity; P:cellular phosphate ion homeostasis,IPR002110 (PRINTS); IPR002110 (SMART); PF13637 (PFAM); IPR030395 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR004331 (PFAM); IPR017946 (G3DSA:3.20.20.GENE3D); PTHR22958 (PANTHER); IPR033506 (PTHR22958:PANTHER); IPR033506 (PTHR22958:PANTHER); PTHR22958 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR004331 (PROSITE_PROFILES); IPR030395 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR017946 (SUPERFAMILY); IPR020683 (SUPERFAMILY),1.A.4.7.2, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_07350,2643,2733,3689,2,0,0,1,0,0,0,0,0,0,2,0,0,2,0,161.9501323,1,-0.202826151,0.754748891,-0.268733287,0.788134934,0.890526979,25.53349699,1,-1.208770063,1.210591268,-0.998495606,0.318039094,0.479831824,90.01938906,0,-1.4468014,0.859732475,-1.682850704,0.092403997,0.182536207,125.4934891,1,-0.156405876,0.518727535,-0.301518361,0.763019251,0.84522926,79.76256265,1,-1.716261306,0.843775628,-2.034025693,0.041949005,0.097639925,N,-,,ww domain-containing,P:biological_process; C:cellular_component; F:molecular_function,PR01228 (PRINTS); IPR001202 (SMART); IPR001202 (PFAM); G3DSA:2.20.70.10 (GENE3D); IPR001202 (PROSITE_PROFILES); IPR001202 (SUPERFAMILY),,
RL4_JR_07351,389,314,762,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11.95397599,1,-1.681849079,1.193491081,-1.409184455,0.158780633,0.308055413,3.805268091,0,1.537475745,1.254814241,1.225261632,0.22047666,0.36826151,9.891779995,0,-1.11737834,1.195573943,-0.934595762,0.349996664,0.493505045,11.41253553,0,-1.539873059,1.193733124,-1.289964255,0.197063069,0.32709239,9.774712369,0,-1.202819049,1.201796872,-1.00085054,0.316899071,0.452170673,Y,-,,hypothetical protein CMQ_7921,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_07352,53457,27711,46012,1,0,2,0,0,2,0,0,1,0,3,0,0,5,1,18.27093754,1,0.215895064,1.01044886,0.213662534,0.83081023,0.915664666,3.403459634,1,1.698568001,1.268702602,1.338822824,0.180628359,0.319134272,28.30344432,1,1.453295016,0.852751056,1.704242998,0.088335699,0.176124327,48.84133107,1,2.157058999,0.572566895,3.767348442,0.000164991,0.001631377,16.02068979,1,-0.093557438,1.119180445,-0.083594597,0.933378763,0.956395178,N,-,,ATP-binding cassette sub-family D member 1,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; C:integral component of peroxisomal membrane; P:fatty acid transmembrane transport",IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); IPR011527 (PFAM); PTHR11384 (PANTHER); IPR031238 (PTHR11384:PANTHER); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.203.15, the atp-binding cassette (abc) superfamily.
RL4_JR_07353,7531,5243,7184,0,4,4,0,0,0,0,2,0,0,2,0,0,0,0,0.493948041,1,2.915290936,1.980801705,1.471773236,0.141082123,NA,0.158075761,0,6.126949146,1.911318146,3.205614492,0.001347744,0.015023052,21.24941149,1,5.884655402,0.868045725,6.779199798,1.21E-11,8.16E-10,0.471747599,1,3.056953887,1.421497259,2.150516906,0.03151435,0.094951224,15.84389344,0,6.004106211,0.775379489,7.743442142,9.68E-15,1.34E-12,N,-,,---NA---,,no IPS match,,
RL4_JR_07354,2254,2191,4113,0,1,1,0,0,0,0,0,4,0,1,0,0,0,0,4.22335648,1,4.147363933,1.234979097,3.35824626,0.000784387,0.004892749,0.129718384,0,6.412368301,2.031355711,3.15669396,0.001595687,0.015023052,19.83092452,1,6.162503438,0.906557032,6.797700778,1.06E-11,7.37E-10,0.386066564,1,3.346434758,1.553465633,2.154173666,0.031226555,0.094548108,0.327374205,0,3.697961149,1.270587288,2.910434555,0.003609265,0.013733113,Y,-,,lustrin a,C:extracellular space; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_07355,4287,5311,6963,0,2,3,0,0,0,1,0,0,0,0,0,0,0,0,1498.017318,1,-0.607790037,0.254802878,-2.385334266,0.017063609,0.05783337,402.9510956,0,-1.105276714,0.559432494,-1.97571061,0.048187563,0.114442635,858.530297,1,-2.739662928,0.464967417,-5.892161103,3.81E-09,1.79E-07,1100.697467,0,-1.944622867,0.321449195,-6.04954965,1.45E-09,4.62E-08,829.1524818,0,-2.790114711,0.852656988,-3.272259246,0.001066917,0.005026773,N,-,,5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase,C:nucleus; P:L-methionine biosynthetic process from homoserine via O-acetyl-L-homoserine and cystathionine; F:zinc ion binding; P:adenine biosynthetic process; C:cytosol; F:5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity; P:methylation,G3DSA:3.20.20.210 (GENE3D); IPR002629 (PFAM); G3DSA:3.20.20.210 (GENE3D); IPR006276 (TIGRFAM); IPR013215 (PFAM); IPR006276 (PIRSF); PTHR30519:SF0 (PANTHER); PTHR30519 (PANTHER); IPR006276 (HAMAP); SSF51726 (SUPERFAMILY); SSF51726 (SUPERFAMILY),,
RL4_JR_07356,948,864,2093,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,18.59139823,1,0.163661682,1.031976758,0.158590472,0.873991536,0.939103212,3.481385527,0,1.665777267,1.272925759,1.308620911,0.190662794,0.332052443,42.27491052,0,1.43519913,0.862426389,1.664141019,0.096084251,0.188244325,10.45936767,1,-1.414078048,1.206036892,-1.172499828,0.240996441,0.379544092,8.97770722,0,-1.080129164,1.215338377,-0.888747681,0.3741387,0.510257857,N,-,,Kinetochore fta7,F:DNA binding,IPR025212 (PFAM),,
RL4_JR_07357,73412,105242,161133,13,24,67,1,0,0,8,5,8,5,45,8,0,26,2,260.346362,1,0.233478254,0.434567419,0.537265897,0.591083958,0.762020059,108.4232832,1,0.306828481,0.839306003,0.365574034,0.714682954,0.82111474,166.3488614,1,-0.928305463,0.567483921,-1.6358269,0.101875821,0.196455392,244.7896648,1,-0.009333625,0.366405581,-0.02547348,0.979677301,0.987381314,211.0035804,1,-0.055194713,0.617836274,-0.089335501,0.928815281,0.953681647,Y,-,,peptidyl-tRNA hydrolase,C:membrane; C:integral component of membrane; F:hydrolase activity,no IPS match,,
RL4_JR_07358,8135,10424,12391,0,5,8,0,0,0,1,0,0,0,1,0,0,5,0,2.179841352,1,0.773232345,1.265984454,0.610775545,0.541348185,0.723138537,0.695536792,0,3.989259675,1.473281329,2.707737889,0.00677435,0.025302573,1.806160487,1,1.335681963,1.222453947,1.092623543,0.274559122,0.413144552,2.08364437,1,0.913409995,1.234475512,0.739917468,0.459350074,0.601360163,1.783713517,1,1.251235037,1.217592649,1.027630249,0.30412379,0.439345691,N,-,,centromere-localized 2,P:chromosome segregation; C:Mis6-Sim4 complex,IPR018565 (PFAM); PTHR28064 (PANTHER),,
RL4_JR_07359,1550,1389,1072,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,71.28918271,1,0.833997223,0.512341116,1.627816305,0.103563842,0.227483528,28.53657289,0,1.819245068,0.982745657,1.851186067,0.064142789,0.143386333,44.87831756,0,-0.072316108,0.847042137,-0.085374865,0.931963375,0.959251445,33.29393118,0,-1.951649618,1.138452581,-1.714300315,0.086473585,0.175565481,25.0291044,0,-2.559295003,1.191004023,-2.148855045,0.031645892,0.078533005,N,-,,Chromatin modification-related eaf3,"P:nucleic acid metabolic process; P:negative regulation of transcription, DNA-templated; P:histone modification; F:transferase activity; P:cellular response to DNA damage stimulus; C:histone acetyltransferase complex; C:Sin3-type complex",IPR008676 (PIRSF); IPR025995 (PFAM); IPR026541 (PFAM); G3DSA:2.30.30.270 (GENE3D); PTHR10880:SF15 (PANTHER); IPR008676 (PANTHER); IPR026541 (PROSITE_PROFILES); IPR016197 (SUPERFAMILY),,
RL4_JR_07360,9321,11340,12782,0,1,2,0,0,0,2,0,0,2,6,0,0,0,0,71.76397378,1,0.8786196,0.932811627,0.941904641,0.346241464,0.535781082,7.488432735,0,0.560776027,1.247177356,0.449636152,0.652972816,0.776387977,19.56807201,1,-2.101516752,1.214251392,-1.730709774,0.083503541,0.168236786,26.59522352,1,-1.578973053,1.169188782,-1.350485976,0.176860149,0.301060695,41.89485413,0,0.430366298,0.799595341,0.538230123,0.590418186,0.70221827,N,-,,ribosomal L30,F:structural constituent of ribosome; C:intracellular membrane-bounded organelle; C:large ribosomal subunit; P:translation,IPR016082 (G3DSA:3.30.1390.GENE3D); IPR005996 (TIGRFAM); IPR016082 (PFAM); PTHR15892 (PANTHER); PTHR15892:SF2 (PANTHER); IPR005996 (HAMAP); IPR016082 (SUPERFAMILY),,
RL4_JR_07361,10253,8669,11292,0,2,4,0,3,0,1,0,2,0,5,0,0,0,0,646.4581608,1,0.399030033,0.4123244,0.967757505,0.333165491,0.52288651,136.2647121,1,-0.161250979,0.758458599,-0.212603534,0.831636215,0.899147807,287.4943529,1,-2.05489378,0.649714681,-3.162763349,0.001562793,0.008147126,538.0412002,1,0.099056507,0.61351605,0.161457075,0.871733417,0.921078904,439.5822364,0,0.038175173,0.549811521,0.069433199,0.944644804,0.964846347,N,-,,ATP-citrate synthase subunit 1,C:nucleus; F:structural constituent of ribosome; F:ATP citrate synthase activity; F:cofactor binding; F:lyase activity; C:cytosol; C:large ribosomal subunit; F:ligase activity; P:translation,PR01798 (PRINTS); IPR003781 (SMART); IPR002020 (PFAM); IPR016143 (G3DSA:1.10.230.GENE3D); IPR016102 (G3DSA:3.40.50.GENE3D); IPR005811 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR016142 (G3DSA:1.10.580.GENE3D); IPR003781 (PFAM); PTHR23118 (PANTHER); PTHR23118:SF2 (PANTHER); IPR002020 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_07362,3009,2596,4939,0,0,5,0,0,0,2,0,0,0,4,0,0,2,2,596.0505382,1,0.767642389,0.572670769,1.340460225,0.180095767,0.33706135,71.22983564,0,-2.688896506,1.222580514,-2.199361494,0.027852228,0.074680862,304.397699,1,-0.694089005,0.521902671,-1.329920392,0.183544502,0.304973664,464.8842708,1,0.316016804,0.619979306,0.509721537,0.610246563,0.730175661,278.8341339,1,-0.631800262,0.611879985,-1.032555858,0.301811795,0.437163553,N,-,,atp-citrate synthase subunit 2,C:nucleus; F:ATP binding; F:lyase activity; C:cytosol,IPR032263 (PFAM); IPR016102 (G3DSA:3.40.50.GENE3D); IPR013650 (PFAM); IPR013816 (G3DSA:3.30.470.GENE3D); PTHR23118 (PANTHER); SSF56059 (SUPERFAMILY); IPR016102 (SUPERFAMILY),,
RL4_JR_07363,4717,3284,4313,0,0,6,0,0,0,0,0,2,6,5,0,0,0,1,197.1845943,1,3.886845029,1.060276108,3.665880048,0.000246489,0.001843136,4.193807151,0,1.397265824,1.247121373,1.120392814,0.262546406,0.419097101,17.37864674,1,-0.292798174,1.188567661,-0.246345399,0.805414869,0.872554322,94.25099128,1,2.942723762,0.405215548,7.262119568,3.81E-13,1.91E-11,44.04503779,1,1.623676262,0.666686733,2.435441087,0.014873646,0.043287057,Y,-,,"1,3-beta-glucanosyltransferase gel2",P:carbohydrate metabolic process; C:fungal-type cell wall; C:integral component of membrane; F:transferase activity; C:plasma membrane; C:anchored component of membrane; F:hydrolase activity,IPR004886 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR31468:SF4 (PANTHER); PTHR31468 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_07364,802,764,1034,0,0,0,0,0,0,0,0,1,0,5,0,0,3,2,97.08329834,0,3.795395734,0.554634413,6.843058505,7.75E-12,3.40E-10,11.73083777,0,3.144560823,1.166123288,2.696593796,0.007005267,0.025982891,6.125756764,1,-0.426117076,1.231791655,-0.345932752,0.729393254,0.817398418,11.07931015,1,0.095984565,1.182672591,0.081159034,0.935315478,0.962317601,20.80423412,1,1.195544758,1.019192293,1.173031591,0.240783137,0.370056051,N,-,,integral membrane,C:membrane; C:integral component of membrane,IPR019595 (G3DSA:3.20.180.GENE3D); IPR019595 (PFAM); PTHR37783 (PANTHER),,
RL4_JR_07365,631,828,942,5,3,36,0,0,1,0,0,5,0,6,0,5,11,0,85.18299982,1,1.502594228,0.578637597,2.596779465,0.009410232,0.036117517,7.006577173,1,0.656765948,1.274840475,0.515175005,0.606430734,0.739669842,18.20240373,1,-1.997146799,1.226396815,-1.628467046,0.103425891,0.19862962,29.02114709,1,-0.714570838,1.065905747,-0.67038839,0.502610234,0.639955812,18.00561718,1,-2.084187858,1.236724806,-1.68524788,0.091940757,0.179088142,N,-,,cfem domain-containing,C:membrane; C:integral component of membrane,PTHR33048 (PANTHER),9.B.313.1.4, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_07366,86,131,145,0,0,4,0,0,0,0,0,1,0,0,2,0,0,0,512.1322685,1,-1.491535416,0.411399942,-3.62551197,0.00028839,0.002108138,132.6881133,0,-2.5638298,1.118670348,-2.291854615,0.021914034,0.061976488,359.3936416,1,-2.753803293,0.656389062,-4.195382665,2.72E-05,0.000434999,405.5942257,1,-3.491804636,0.692764881,-5.040389214,4.65E-07,9.08E-06,328.267014,0,-4.037864003,0.887725746,-4.548548941,5.40E-06,6.04E-05,N,-,,hypothetical protein CMQ_4150,,no IPS match,,
RL4_JR_07367,132,227,174,0,2,7,0,0,0,0,0,0,0,4,0,0,4,0,16.36352209,1,4.473121324,0.773011126,5.786619591,7.18E-09,1.71E-07,0.345669224,0,4.997972121,1.645923087,3.036576959,0.00239281,0.015242306,0.899870807,0,2.340970084,1.245204554,1.879988373,0.060109662,0.130394305,5.049933931,1,2.864021283,1.166554991,2.455110393,0.014084133,0.06368369,0.89003392,1,2.25471573,1.229299631,1.834146592,0.066632237,0.139708303,N,-, Effector probability:0.68,Histone-fold domain-containing new1,F:DNA binding; F:protein heterodimerization activity; P:kinetochore assembly; P:mitotic nuclear division,IPR009072 (G3DSA:1.10.20.GENE3D); PTHR34832 (PANTHER); IPR009072 (SUPERFAMILY),,
RL4_JR_07368,3189,2566,2885,0,0,9,0,5,0,0,4,0,0,4,0,0,3,0,51.35866837,1,-0.601889116,0.809081883,-0.743916195,0.456927177,0.645473924,11.44890606,1,-0.051617331,1.235056459,-0.041793499,0.966663318,0.982682143,36.26659216,1,-1.74487762,1.209107081,-1.443112564,0.148988765,0.261000835,50.3947425,1,-0.444018932,0.793686244,-0.559438866,0.575862242,0.702651868,44.45645918,1,-0.583347378,0.876683372,-0.665402581,0.505793035,0.632857604,N,-,,prefoldin subunit 4,C:nucleus; P:amine metabolic process; F:copper ion binding; F:quinone binding; C:prefoldin complex; F:primary amine oxidase activity; C:cytosol; F:unfolded protein binding; P:oxidation-reduction process; P:protein folding,IPR016661 (PIRSF); IPR002777 (PFAM); IPR009053 (G3DSA:1.10.287.GENE3D); PTHR21100 (PANTHER); IPR016661 (PTHR21100:PANTHER); IPR009053 (SUPERFAMILY),,
RL4_JR_07369,4294,3737,3172,0,0,5,0,0,0,0,0,6,0,4,0,0,0,0,21.68296485,1,-1.314589179,1.157425253,-1.135787538,0.256045494,0.434446576,5.708323045,0,0.952502863,1.254038433,0.759548382,0.447524584,0.608576356,14.77437186,1,-1.695932179,1.203232734,-1.409479755,0.158693356,0.27327973,21.05433363,1,-1.171751432,1.155099749,-1.014415797,0.31038439,0.456381345,14.51028227,0,-1.77273976,1.202800598,-1.473843431,0.140523752,0.246671807,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23502:SF40 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.77, the major facilitator superfamily (mfs).
RL4_JR_07370,3115,2610,2953,0,2,3,0,0,0,1,0,16,2,9,3,0,1,5,0.205792029,1,4.178192328,3.068827623,1.361494629,0.17335743,NA,0.067637428,0,7.351965398,2.406048729,3.055617831,0.002245973,0.015045494,0.1725416,1,4.724035988,1.528675268,3.090280903,0.001999673,0.009846638,0.198805784,1,4.303339722,2.003183206,2.148250699,0.031693845,0.095194358,0.16752968,1,4.661085051,1.384005933,3.367821582,0.000757646,0.003826018,N,-,,c6 zinc finger domain containing,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_07371,470,206,383,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,220.2127079,0,-3.116597844,0.824055968,-3.782022053,0.00015556,0.001247842,66.00837853,0,-2.579058886,1.220922545,-2.11238534,0.034653411,0.088479115,194.5375173,0,-2.818025495,0.88896821,-3.169995804,0.001524411,0.007967548,215.2083797,0,-3.879989866,1.048930332,-3.698996728,0.000216453,0.002048216,190.6736418,0,-2.183133761,0.722063414,-3.023465418,0.002498976,0.010210707,N,-,,c6 zinc finger domain containing,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR007219 (PFAM); PTHR31001 (PANTHER); PTHR31001:SF50 (PANTHER); PTHR31001 (PANTHER); PTHR31001:SF50 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07372,71320,32100,40825,1,2,11,0,0,0,0,2,6,1,4,0,0,9,1,19.60052276,1,2.500809811,0.740817124,3.375745148,0.000736161,0.004641112,1.379429224,0,3.001426496,1.347862918,2.226803969,0.025960378,0.070485769,10.07980841,1,1.310176853,1.192488855,1.098691067,0.27190284,0.410595167,16.16609959,1,2.23139237,0.852826187,2.616467933,0.008884471,0.04421039,3.533128555,1,0.265316715,1.201828854,0.220760813,0.825278677,0.88273258,N,-,,Chl4 family chromosome segregation,C:nucleus; P:sister chromatid cohesion; P:macromolecular complex subunit organization; P:mitotic sister chromatid segregation; C:condensed chromosome kinetochore,IPR007902 (PFAM); PTHR12309 (PANTHER); IPR027715 (PTHR12309:PANTHER); IPR027715 (PTHR12309:PANTHER),,
RL4_JR_07373,22909,6067,7790,0,3,7,0,0,0,0,0,8,0,3,1,0,5,0,25.42073321,1,-0.131039431,1.030694463,-0.127137029,0.898831945,0.950562931,4.317136216,0,1.355444574,1.26371649,1.072585967,0.283456924,0.442906913,11.22147287,1,-1.299158969,1.205873163,-1.077359551,0.281319667,0.420544109,20.97082604,1,-0.003183985,1.033551194,-0.003080627,0.997542019,0.998254564,11.07223668,1,-1.382580573,1.210883693,-1.141794692,0.253539369,0.384466993,N,-,,family hydrolase,"F:hydrolase activity, acting on ester bonds",G3DSA:3.20.20.140 (GENE3D); IPR001130 (PFAM); IPR001130 (PANTHER); IPR001130 (PANTHER); PTHR10060:SF15 (PANTHER); IPR001130 (PANTHER); PTHR10060:SF15 (PANTHER); PTHR10060:SF15 (PANTHER); IPR032466 (SUPERFAMILY),,
RL4_JR_07374,43690,14732,15642,4,4,7,0,0,3,1,0,1,1,0,0,0,0,0,147.7487859,1,0.592476685,0.455245367,1.301444734,0.19310627,0.354093269,17.38075051,1,-0.653864264,1.21102315,-0.539927138,0.589247281,0.726563647,111.3788055,1,0.467566871,1.534165665,0.304769479,0.760541729,0.839024132,126.9679276,1,0.916181498,0.46222449,1.982113708,0.047466516,0.119055056,44.15161718,0,-3.378167587,1.1905804,-2.837412396,0.004548083,0.01657047,N,-,,ribonucleoside-diphosphate reductase large chain,"F:ATP binding; F:ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; P:DNA replication; P:oxidation-reduction process",IPR000788 (PRINTS); IPR013509 (PFAM); IPR000788 (PFAM); G3DSA:3.20.70.20 (GENE3D); IPR013346 (TIGRFAM); IPR005144 (PFAM); PTHR11573 (PANTHER); IPR005144 (PROSITE_PROFILES); SSF51998 (SUPERFAMILY); IPR008926 (SUPERFAMILY),,
RL4_JR_07375,58421,32908,39601,18,31,13,2,0,1,2,0,2,0,6,0,0,5,3,100.5353552,1,-4.753877502,1.231369086,-3.860643859,0.000113089,0.000948509,41.2280792,1,-0.612260679,1.136941197,-0.538515695,0.590221073,0.727509586,105.0302762,1,-2.341888698,1.055997153,-2.217703608,0.026575048,0.069821478,95.65108712,1,-4.606883494,1.219051755,-3.779071294,0.000157414,0.001573367,81.85901463,1,-4.26884233,1.221371254,-3.495122648,0.000473844,0.00258774,N,-,,CFEM domain,C:membrane; C:integral component of membrane,IPR008427 (PFAM),,
RL4_JR_07376,20768,11214,14926,6,3,10,0,0,0,0,1,3,2,1,0,0,1,3,9.035593319,1,3.12718374,1.049017283,2.981060266,0.002872523,0.013890954,0.442851481,0,4.640483517,1.584387642,2.928881413,0.003401842,0.016514841,1.155049062,1,1.980600312,1.245160995,1.590637933,0.111691082,0.210491534,1.332915069,1,1.557962522,1.277882417,1.219175177,0.222777711,0.357978785,1.145145645,1,1.890963085,1.237297517,1.528301042,0.126437811,0.227507169,N,-, Effector probability:0.739,endoribonuclease l-psp,,IPR006175 (PFAM); IPR006056 (TIGRFAM); IPR013813 (G3DSA:3.30.1330.GENE3D); IPR006175 (PANTHER); PTHR11803:SF22 (PANTHER); IPR013813 (SUPERFAMILY),,
RL4_JR_07377,12778,15087,21823,1,6,5,0,0,0,3,0,0,3,5,2,0,5,3,0.800006454,1,2.219446047,1.628523992,1.362857445,0.172927443,NA,0.254207985,0,5.441263049,1.750078822,3.109153132,0.001876244,0.015023052,0.662110378,1,2.783038632,1.267522405,2.195652417,0.028116831,0.072820364,0.763965895,1,2.360813584,1.343103052,1.757730787,0.078793327,0.164716097,0.656042236,1,2.694361846,1.244023558,2.165844714,0.030323055,0.07573284,N,-,,---NA---,,no IPS match,,
RL4_JR_07378,5285,4569,4294,0,0,2,0,0,0,0,0,3,1,2,0,0,0,0,1.734089803,1,1.103781186,1.366609663,0.807678459,0.419275707,NA,0.55309331,0,4.320038364,1.562437796,2.764934627,0.00569342,0.022397513,1.432046098,1,1.671419163,1.255589193,1.331183139,0.183128758,0.304642553,1.65202641,1,1.248952228,1.284093073,0.972633725,0.330735375,0.477312696,1.405895787,0,1.595092275,1.240277146,1.286077293,0.198416088,0.32005144,N,-,,Fungal trichothecene efflux pump,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR010573 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF2 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.47, the major facilitator superfamily (mfs).
RL4_JR_07379,5790,6942,9798,0,0,19,0,0,0,3,0,0,0,3,0,0,0,1,227.0870903,1,-0.045449206,0.491097672,-0.092546165,0.926264114,0.964696123,262.3000596,0,2.511894467,1.835556775,1.3684646,0.171166695,0.306728172,100.8801148,1,-4.467502078,1.20888674,-3.695550567,0.000219411,0.001863519,200.598478,1,-0.458071939,0.494124359,-0.927037762,0.353906929,0.500182531,166.7432729,1,-0.16064732,0.49284366,-0.325960002,0.744454618,0.821447581,N,-,,Calcium calmodulin-dependent calcium-dependent partial,F:ATP binding; P:positive regulation of cellular process; C:cell cortex of cell tip; F:protein kinase activity; P:single-organism cellular process; P:protein phosphorylation; P:regulation of cell cycle process,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR020636 (PANTHER); IPR020636 (PANTHER); PTHR24347:SF1 (PANTHER); PTHR24347:SF1 (PANTHER); IPR020636 (PANTHER); PTHR24347:SF1 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.1, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_07380,20398,16848,21585,1,5,8,0,0,0,0,3,7,0,0,4,0,0,2,756.1690872,1,-0.375473692,1.049245742,-0.357851052,0.720454783,0.850820805,182.9840273,0,-0.754054702,0.738095545,-1.021622075,0.306959805,0.468493237,355.4834445,1,-6.284652641,1.217869351,-5.160366864,2.46E-07,7.82E-06,586.4699433,1,-1.086585229,0.657461543,-1.652697774,0.098392388,0.193591707,421.9949611,1,-1.978987027,0.661393521,-2.992147585,0.002770223,0.011121534,N,-,,40S ribosomal s0,F:structural constituent of ribosome; C:cytosolic small ribosomal subunit; P:ribosomal small subunit assembly; P:translation,IPR001865 (PRINTS); IPR005707 (TIGRFAM); G3DSA:3.40.50.10490 (GENE3D); IPR001865 (PFAM); PTHR11489:SF9 (PANTHER); IPR005707 (PANTHER); IPR027498 (HAMAP); IPR023591 (SUPERFAMILY),,
RL4_JR_07381,519454,221700,285135,27,37,25,3,0,13,0,0,5,0,6,7,0,36,8,82.68142677,1,-3.461922341,1.23704862,-2.798533771,0.00513352,0.022228905,24.7114126,1,-1.161629087,1.258654533,-0.922913362,0.356052357,0.520352578,120.329304,1,-0.333699469,1.620074015,-0.205977916,0.836808162,0.894598293,110.9792395,1,-1.1682719,0.793625729,-1.472069084,0.141002223,0.254075015,81.04298749,1,-2.986086601,1.207414398,-2.473124891,0.013393733,0.0396757,N,-,,ribosomal S15,F:structural constituent of ribosome; C:ribosome; P:translation,IPR000589 (SMART); IPR009068 (G3DSA:1.10.287.GENE3D); IPR000589 (PFAM); PTHR23321 (PANTHER); PD157043 (PRODOM); IPR009068 (SUPERFAMILY),,
RL4_JR_07382,11714,8193,7467,3,3,7,0,0,0,0,0,3,0,0,1,0,2,0,159.7638784,1,1.532310381,0.464495521,3.298870092,0.000970748,0.005789009,13.21351859,0,-0.258473205,1.216969642,-0.21239084,0.831802131,0.899156043,76.13305595,1,0.477047548,0.639846261,0.745565892,0.455929694,0.594619836,67.69393273,1,-0.989908346,0.868364488,-1.139968711,0.254299337,0.393769042,34.13843115,1,-3.007091823,1.211335657,-2.482459594,0.013047886,0.038868863,N,-,,vacuolar ATP synthase subunit d,"C:nucleus; P:ATP hydrolysis coupled proton transport; C:fungal-type vacuole membrane; C:proton-transporting V-type ATPase, V0 domain; F:proton-transporting ATPase activity, rotational mechanism; P:vacuolar transport",IPR016727 (PIRSF); IPR002843 (PFAM); IPR016727 (PANTHER); IPR002843 (SUPERFAMILY),3.A.2.2.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_07383,41767,41001,55097,27,42,11,0,0,3,0,1,0,5,6,1,0,2,1,886.8939123,1,-2.562426629,0.415985858,-6.1598888,7.28E-10,2.07E-08,254.6709644,1,-3.555586801,1.112719907,-3.195401447,0.001396365,0.015023052,675.5878838,1,-3.984737598,0.687528676,-5.795740217,6.80E-09,2.96E-07,739.8028598,1,-6.603642903,1.15056895,-5.739458643,9.50E-09,2.63E-07,680.0599005,1,-3.240265457,0.853321922,-3.797236862,0.000146318,0.000955891,N,-,,nucleolar nop-58,"C:box C/D snoRNP complex; C:small-subunit processome; P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:snRNA binding; C:90S preribosome",IPR012976 (SMART); IPR012974 (PFAM); IPR002687 (PFAM); PTHR10894:SF1 (PANTHER); PTHR10894:SF1 (PANTHER); PTHR10894 (PANTHER); IPR002687 (PROSITE_PROFILES); IPR002687 (SUPERFAMILY),,
RL4_JR_07384,6538,5686,5923,0,1,3,0,0,3,0,0,0,1,2,1,0,4,0,44.99265322,1,-0.677300194,0.8963952,-0.755582129,0.449899774,0.638754326,53.89491106,1,1.933713193,0.996054883,1.941372132,0.052213156,0.121864106,24.21704419,0,-2.409014858,1.211858609,-1.987867925,0.046826299,0.107669646,46.57345025,1,-1.071018869,1.040987356,-1.028849067,0.303550605,0.449137788,53.50644881,1,0.184290777,0.800354756,0.230261363,0.817888682,0.87770248,N,-,,ubiquitin ( ),,G3DSA:3.10.20.90 (GENE3D); PTHR13042:SF0 (PANTHER); PTHR13042 (PANTHER); IPR029071 (SUPERFAMILY),,
RL4_JR_07385,84,92,109,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.028880864,0,1.856723349,1.464327578,1.267969938,0.204808686,NA,0.329197431,0,5.068598852,1.66653864,3.041392938,0.002354863,0.015193819,0.851682517,0,2.421114434,1.244610457,1.945278879,0.051741423,0.116225907,0.982395522,0,1.998734864,1.290818875,1.548423953,0.121520258,0.226383185,0.836450943,0,2.344127976,1.218146742,1.924339568,0.054312034,0.119260322,N,-,,hypothetical protein SPI_04939,"F:transferase activity, transferring acyl groups other than amino-acyl groups; C:membrane; C:integral component of membrane",no IPS match,,
RL4_JR_07386,14039,9324,14533,4,1,7,0,0,3,0,1,0,2,2,6,0,6,2,2.092180868,1,0.832797207,1.29890675,0.64115242,0.521423659,NA,0.663521911,1,4.0572642,1.490597707,2.721904227,0.006490695,0.024560305,1.726935753,1,1.400785983,1.232376431,1.136654311,0.255682826,0.391608613,1.992718563,1,0.978106045,1.248841052,0.783210997,0.433503218,0.575786447,1.706713667,1,1.31533376,1.22770141,1.071379204,0.283998959,0.418313859,N,-,,Methylated-DNA-- -cysteine methyltransferase,P:DNA repair; F:methyltransferase activity; P:methylation,IPR014048 (TIGRFAM); IPR014048 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); PTHR10815 (PANTHER); PTHR10815:SF5 (PANTHER); IPR014048 (SUPERFAMILY),,
RL4_JR_07387,2362,2055,2792,0,0,2,1,0,0,1,3,1,0,3,0,0,6,1,369.1017966,1,-2.428179891,0.524576814,-4.628835713,3.68E-06,4.78E-05,103.3206717,1,-3.225468244,1.198658931,-2.690897435,0.00712601,0.026267106,280.5908884,1,-4.057198186,1.041840309,-3.894261097,9.85E-05,0.001151095,382.0065064,1,-1.893593631,0.467177224,-4.053266161,5.05E-05,0.000598115,297.5793504,1,-2.54603724,0.610807096,-4.168316406,3.07E-05,0.000257623,N,-,,regulatory cys-3,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",no IPS match,,
RL4_JR_07388,4302,3421,5631,0,2,7,0,0,0,1,0,0,1,5,0,0,1,0,665.1670507,1,-1.705577611,0.35134136,-4.854474323,1.21E-06,1.78E-05,190.6501637,0,-1.704422219,0.869971634,-1.959169877,0.050092896,0.118026138,442.7648847,1,-4.693507956,1.03818633,-4.52087243,6.16E-06,0.000124449,550.3405467,1,-3.183770003,0.554976533,-5.736765098,9.65E-09,2.66E-07,413.894844,1,-6.606903705,1.204180523,-5.486638905,4.10E-08,1.17E-06,N,-,,regulatory cys-3,"C:nucleus; F:RNA polymerase II regulatory region sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding",IPR004827 (SMART); G3DSA:1.20.5.170 (GENE3D); IPR004827 (PFAM); PTHR13044 (PANTHER); IPR004827 (PROSITE_PROFILES); SSF57959 (SUPERFAMILY),,
RL4_JR_07389,1616,1913,1834,0,7,7,0,0,0,0,0,0,1,0,0,0,0,0,113.3943769,1,-0.14208741,0.737344894,-0.192701423,0.847192809,0.923399489,21.59591386,0,-0.967144208,1.199082579,-0.806570144,0.41991418,0.583584346,84.58217991,0,-1.204887647,0.845701263,-1.42472017,0.154238106,0.267875239,141.1104288,1,0.157003118,0.458496775,0.342430148,0.732027204,0.821133092,73.98986437,0,-1.074086577,0.738052556,-1.455298228,0.145586717,0.253406483,N,-,,aminotransferase class i and ii,F:pyridoxal phosphate binding; F:transaminase activity; P:biosynthetic process,IPR015422 (G3DSA:3.90.1150.GENE3D); IPR004839 (PFAM); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR11751:SF427 (PANTHER); PTHR11751 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_07390,4950,5348,4876,8,1,2,0,0,0,2,2,3,4,4,1,6,0,2,28.06815362,1,0.941865611,0.731762319,1.287119583,0.198052611,0.360811344,4.094132163,0,1.43198303,1.252342187,1.143443896,0.252854336,0.407359552,10.60277265,1,-1.217385715,1.190929808,-1.022214497,0.306679391,0.448232616,12.23010891,1,-1.63955711,1.188085247,-1.379999553,0.167586782,0.288623265,10.43441207,1,-1.297098025,1.190452146,-1.089584348,0.275896281,0.408817481,N,-,,von willebrand factor,,IPR002035 (SMART); IPR002035 (G3DSA:3.40.50.GENE3D); PTHR34706 (PANTHER); IPR002035 (PROSITE_PROFILES); IPR002035 (SUPERFAMILY),,
RL4_JR_07391,703,805,632,0,0,0,0,0,0,0,0,0,0,0,0,4,0,2,0.237312829,0,3.972851778,2.770390587,1.434040311,0.15156076,NA,0.076371968,0,7.176670457,2.227265492,3.22218904,0.001272152,0.015023052,0.196800954,0,4.535407382,1.3668995,3.31802549,0.000906562,0.0053206,0.226949561,0,4.112711525,1.747201911,2.353884516,0.018578382,0.074262186,0.192460456,1,4.463404491,1.260732873,3.540325302,0.000399634,0.002241715,N,-,,hypothetical protein CMQ_3747,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_07392,10544,15667,21695,0,0,1,0,0,3,0,0,0,0,3,0,0,5,3,102.5687058,1,-1.676478653,0.744549874,-2.251667366,0.0243433,0.077063502,25.17745135,1,-1.188560582,1.197674789,-0.992390082,0.321007275,0.483014069,65.36431905,0,-3.841472361,1.191119197,-3.225094827,0.001259309,0.006925176,79.41789959,1,-3.316694284,1.143980103,-2.899258716,0.003740461,0.022277746,68.37976731,1,-2.995441711,1.125272307,-2.661970523,0.007768468,0.025645823,N,-,,rna splicing factor pad-1,F:nucleotide binding; C:nucleus; F:RNA binding; F:U1 snRNP binding; P:mRNA processing,IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR029123 (PFAM); IPR006509 (TIGRFAM); PTHR24012 (PANTHER); PTHR24012:SF286 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_07393,4228,6168,8776,0,0,0,0,0,0,0,0,0,0,2,0,0,7,2,53.38449297,0,-3.840711926,1.188232976,-3.232288619,0.00122803,0.006942665,17.01360198,0,-0.623121849,1.199751297,-0.519375849,0.603498669,0.737577099,44.19112551,0,-3.27673788,1.1890243,-2.755820785,0.005854507,0.021382043,74.26468573,1,-1.377789292,0.84838918,-1.624006204,0.104374484,0.202295493,51.35195478,1,-1.692796023,0.97673873,-1.733110371,0.083076053,0.166201352,N,-,,RNA splicing factor,F:nucleotide binding; C:nucleus; F:RNA binding; F:U1 snRNP binding; P:mRNA processing,IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR24012:SF286 (PANTHER); PTHR24012 (PANTHER); PTHR24012:SF286 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_07394,76,61,282,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,717.400578,0,1.143618693,0.618372792,1.849400084,0.064400063,0.160518092,70.70933669,0,-2.678296183,1.199136631,-2.233520446,0.025514644,0.069574144,922.0589589,0,2.033000163,0.798426074,2.546259733,0.010888414,0.035039511,430.5272793,0,-0.071322378,0.522763098,-0.136433459,0.891478624,0.933232121,394.6110459,0,0.423621128,0.699508264,0.605598461,0.544781425,0.666298684,N,-,,inositolphosphorylceramide-B C-26 hydroxylase,C:endoplasmic reticulum membrane; F:iron ion binding; F:fatty acid alpha-hydroxylase activity; C:integral component of membrane; P:oxidation-reduction process; P:fatty acid biosynthetic process; P:mannosyl-inositol phosphorylceramide metabolic process; F:heme binding,IPR001199 (PRINTS); IPR001199 (SMART); IPR014430 (PIRSF); IPR006694 (PFAM); IPR001199 (PFAM); IPR001199 (G3DSA:3.10.120.GENE3D); PTHR12863:SF1 (PANTHER); PTHR12863 (PANTHER); IPR001199 (PROSITE_PROFILES); IPR001199 (SUPERFAMILY),1.A.105.1.2,The Mixed Lineage Kinase Domain-like (MLKL) Family
RL4_JR_07395,94,254,390,0,0,0,0,0,0,0,0,0,7,5,0,0,6,0,241.851154,0,-1.818425692,0.747763784,-2.431818352,0.01502324,0.052533042,63.5608124,0,-2.524566296,1.189451331,-2.122462879,0.033798887,0.086808508,250.6727966,0,-1.167140673,0.520471713,-2.24246706,0.024931202,0.066404496,277.3915185,1,-0.985314302,0.426821862,-2.308490709,0.020971859,0.078455086,231.4520508,1,-0.879883288,0.476659877,-1.845935288,0.064901602,0.137069482,N,-,,DNA-directed RNA polymerase III subunit RPC2,F:DNA binding; F:DNA-directed RNA polymerase activity; F:ribonucleoside binding; P:tRNA transcription from RNA polymerase III promoter; C:DNA-directed RNA polymerase III complex,IPR007646 (PFAM); G3DSA:3.90.1100.10 (GENE3D); IPR007642 (G3DSA:3.90.1110.GENE3D); IPR007645 (PFAM); IPR007120 (G3DSA:2.40.270.GENE3D); IPR007644 (PFAM); IPR007647 (PFAM); IPR014724 (G3DSA:2.40.50.GENE3D); IPR007641 (PFAM); IPR007642 (PFAM); IPR007120 (PFAM); PTHR20856:SF8 (PANTHER); IPR015712 (PANTHER); SSF64484 (SUPERFAMILY),,
RL4_JR_07396,95,56,87,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33.36072023,0,0.060874136,0.847886345,0.07179516,0.942764925,0.971842636,5.642675559,0,0.969121595,1.231087384,0.787207803,0.43116023,0.593109355,38.18416251,0,0.724610329,0.847698942,0.854796784,0.392663659,0.535902788,16.90779167,0,-2.106857619,1.188231566,-1.77310356,0.076211548,0.16072525,22.18463247,0,-0.09990543,0.97709931,-0.102246956,0.918560658,0.948055725,N,-,,DNA repair RAD57,P:DNA repair; P:DNA recombination; P:cellular component organization; F:binding; C:intracellular part,IPR003593 (SMART); IPR013632 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR22942 (PANTHER); PTHR22942 (PANTHER); PTHR22942:SF24 (PANTHER); PTHR22942 (PANTHER); PTHR22942:SF24 (PANTHER); PTHR22942:SF24 (PANTHER); IPR020588 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_07397,1550,1815,2101,0,0,0,0,0,0,0,0,3,0,0,0,0,2,0,200.9007998,0,-0.950993706,0.980604618,-0.969803415,0.332144491,0.521886509,45.10948212,0,-2.029825872,1.218944473,-1.665232434,0.095866392,0.196151127,116.1923888,1,-4.671377633,1.207219939,-3.869533201,0.000109044,0.001229229,167.3612445,0,-1.604045764,0.627911836,-2.554571632,0.010631855,0.050987486,333.0542936,1,1.063083211,0.98426413,1.080079196,0.280106915,0.413724656,N,-,,choline Carnitine O-acyltransferase,"F:transferase activity, transferring acyl groups; C:mitochondrion; P:alcohol metabolic process; P:carnitine metabolic process",IPR000542 (PFAM); IPR000542 (PANTHER); PTHR22589:SF29 (PANTHER); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY),4.C.2.1.1, the carnitine o-acyl transferase (crat) family.
RL4_JR_07398,9458,10515,13538,1,2,9,0,2,0,0,0,4,0,6,2,0,0,0,0.193303214,1,4.268460277,3.115559076,1.37004633,0.17067244,NA,0.060766532,1,7.505248054,2.392496145,3.136994836,0.001706891,0.015023052,0.159721234,1,4.833015125,1.493831966,3.235313767,0.001215091,0.006744289,0.184377962,1,4.411299182,1.993648854,2.212676105,0.026919984,0.087153604,0.15999682,0,4.730187721,1.368462816,3.456570151,0.000547097,0.002918522,Y,-,,major facilitator superfamily transporter,P:transmembrane transport; C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_07399,4441,4505,5960,0,0,17,0,0,0,1,4,2,1,4,1,0,0,2,6.757600394,1,-0.859007642,1.194499527,-0.719136025,0.472057113,0.661236594,2.166228149,0,2.350359365,1.3076225,1.797429582,0.072267448,0.157445353,5.605340102,1,-0.297851824,1.200286473,-0.248150613,0.804017876,0.871320593,6.465211072,1,-0.719931179,1.198234923,-0.600826403,0.547955617,0.677748671,13.23429497,1,1.291375926,0.977477564,1.321131015,0.186457683,0.305384025,N,-,,hypothetical protein SPI_05053,,no IPS match,,
RL4_JR_07400,4187,3808,5199,0,0,12,0,0,0,0,0,0,0,4,0,0,0,1,87.03746756,1,-0.742570136,0.864883748,-0.858577974,0.390573395,0.583464155,14.77952728,0,-0.420066767,1.224600261,-0.343023582,0.73158072,0.832309772,94.58998207,0,0.545838769,0.613475313,0.889748549,0.373600919,0.517559217,63.18673115,1,-1.743119695,1.042335446,-1.67232123,0.094460995,0.187640173,45.71741143,1,-2.234929859,1.152042552,-1.939971622,0.052383139,0.115980599,N,-,,dna-directed rna polymerase iii 130 kda polypeptide,F:DNA-directed RNA polymerase activity; P:RNA biosynthetic process,IPR031342 (PFAM); PTHR19932:SF13 (PANTHER); PTHR19932 (PANTHER),,
RL4_JR_07401,2935,2019,3617,0,2,3,0,0,0,0,0,0,0,0,0,0,1,0,484.593127,1,0.047641847,0.766097247,0.062187728,0.950413335,0.975770449,78.10392751,0,-2.821804734,1.186419515,-2.378420701,0.017386976,0.051595126,314.7661914,0,-0.670230168,0.407711772,-1.643882305,0.100200516,0.194298032,418.6558639,0,-0.400962583,0.316391758,-1.267297816,0.205048821,0.336868297,246.2241584,1,-1.556938057,0.653692138,-2.381760415,0.017230103,0.04851357,N,-, Effector probability:0.838,GTP-binding ypt1,"P:protein complex assembly; P:COPII-coated vesicle budding; C:Golgi membrane; C:Golgi stack; C:endoplasmic reticulum membrane; F:GTP binding; C:trans-Golgi network; F:GTPase activity; C:cytosol; C:cytoplasmic vesicle; P:macroautophagy; C:pre-autophagosomal structure membrane; P:retrograde vesicle-mediated transport, Golgi to ER; P:small GTPase mediated signal transduction; P:SNARE complex disassembly; P:regulation of endoplasmic reticulum unfolded protein response; F:SNARE binding; P:pre-mRNA catabolic process; C:nucleus; C:mitochondrion; P:Golgi vesicle docking; P:early endosome to Golgi transport; P:negative regulation of G0 to G1 transition; P:Golgi vesicle budding; P:CVT pathway; P:endocytic recycling",PR00449 (PRINTS); SM00175 (SMART); SM00173 (SMART); SM00174 (SMART); SM00176 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001806 (PFAM); IPR005225 (TIGRFAM); PTHR24073 (PANTHER); PTHR24073:SF455 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_07402,2003,1403,2005,0,0,1,0,0,0,0,1,1,2,3,0,0,0,0,19.50600137,1,1.190573205,0.853198923,1.39542277,0.162888389,0.313554383,2.564791098,0,2.106641516,1.282324653,1.642830083,0.100418094,0.203123891,6.663022914,1,-0.547343087,1.196591728,-0.457418411,0.647370333,0.754831248,7.687116449,1,-0.969789987,1.194475014,-0.81189642,0.416851069,0.560879345,6.579601322,0,-0.631761299,1.201107998,-0.525982093,0.598900649,0.709141512,N,-,,amino-acid N-acetyltransferase subunit Mak10,C:intracellular part,IPR007244 (PFAM); PTHR21373 (PANTHER),,
RL4_JR_07403,146,173,204,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,hypothetical protein BN1708_009330,,no IPS match,,
RL4_JR_07404,245,105,106,0,0,0,0,0,0,0,6,2,0,0,0,0,13,0,368.702574,0,0.807450333,0.600844495,1.343859084,0.178993959,0.335840092,88.63640999,0,-0.318137484,0.990066255,-0.321329489,0.747960711,0.84571697,205.4467656,1,-0.258635025,0.501255656,-0.515974276,0.605872375,0.722734998,326.7166239,0,0.698088867,0.533130342,1.309415,0.190393813,0.319234043,143.6261769,1,-1.785503435,0.726720295,-2.456933495,0.014012863,0.041124705,N,-,,mitochondrial ATP synthase epsilon chain domain-containing,"C:mitochondrial proton-transporting ATP synthase complex, catalytic core F(1); P:ATP hydrolysis coupled proton transport; C:integral component of membrane; C:proton-transporting V-type ATPase, V0 domain; F:proton-transporting ATPase activity, rotational mechanism; P:ATP synthesis coupled proton transport; F:proton-transporting ATP synthase activity, rotational mechanism",IPR006721 (G3DSA:1.10.1620.GENE3D); IPR006721 (PFAM); IPR006721 (PANTHER); IPR006721 (SUPERFAMILY),3.A.2.1.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_07405,4940,5492,6419,12,19,10,0,0,1,0,0,0,0,0,0,0,0,0,579.075636,1,-0.063764543,0.272545671,-0.233959111,0.815016722,0.906040195,101.2354444,1,-2.137754115,1.102546474,-1.938924269,0.05251056,0.122439966,330.8068576,0,-1.422256621,0.463091222,-3.07122345,0.002131835,0.010356383,465.8361584,0,-0.496684379,0.300949643,-1.650390327,0.098863128,0.194198091,312.3167056,0,-1.697633555,0.482052746,-3.521675935,0.000428828,0.002388275,N,-,,cytochrome b-c1 complex subunit 2,"F:ATPase activity, coupled to transmembrane movement of ions, rotational mechanism; F:zinc ion binding; F:cation-transporting ATPase activity; C:mitochondrial crista; F:ubiquinol-cytochrome-c reductase activity; P:hydrogen ion transmembrane transport; C:mitochondrial respiratory chain complex III; P:protein processing; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:aerobic respiration; F:metalloendopeptidase activity",IPR007863 (PFAM); IPR011237 (G3DSA:3.30.830.GENE3D); IPR011237 (G3DSA:3.30.830.GENE3D); IPR011765 (PFAM); PTHR11851 (PANTHER); IPR011249 (SUPERFAMILY); IPR011249 (SUPERFAMILY),,
RL4_JR_07406,1303,1224,1193,1,0,1,0,0,0,1,0,0,1,3,1,0,0,0,7.872226086,1,-1.078948127,1.225740923,-0.88024158,0.378728453,0.570575571,2.497121352,0,2.145248519,1.311590104,1.635608955,0.101921455,0.205630649,6.495109396,1,-0.510305176,1.216735872,-0.419405056,0.67492013,0.77681803,7.494634772,1,-0.932971433,1.217738472,-0.766150905,0.443586516,0.585798028,6.412020118,0,-0.594441204,1.221640684,-0.486592508,0.626547134,0.730682991,N,-,,DNA-directed RNA polymerase III subunit RPC3,"P:hyphal growth; C:nucleus; P:transcription, DNA-templated; P:conidium formation; C:intracellular organelle part; P:pathogenesis",IPR008806 (PFAM); IPR013197 (PFAM); PTHR12949 (PANTHER),,
RL4_JR_07407,3193,2209,2997,0,0,1,0,0,0,0,0,3,0,0,0,0,0,0,40.57270424,1,-0.159563096,0.849346278,-0.187865774,0.850981874,0.92564135,6.619103779,0,0.738858192,1.230587073,0.600411144,0.548232263,0.69469291,62.67009716,1,1.699511204,0.585177855,2.904264386,0.003681172,0.015684377,56.74676519,0,0.724404689,0.670454849,1.080467522,0.279934042,0.423350586,28.53434083,0,0.202804294,0.853209209,0.237695857,0.812116997,0.873081822,N,-,,hypothetical protein HMPREF1624_03492,P:biological_process; C:cellular_component; F:molecular_function,PTHR38119 (PANTHER); PTHR38119:SF1 (PANTHER),,
RL4_JR_07408,10570,9886,10352,6,2,6,0,0,0,0,2,3,4,9,0,0,2,0,20.36398935,1,2.250719033,0.766397973,2.936749718,0.003316717,0.015640332,1.621247333,0,2.768444615,1.340576801,2.065114518,0.038912166,0.096916571,4.206415624,1,0.116552026,1.208798618,0.096419721,0.92318723,0.954975735,4.8529038,1,-0.305869886,1.209147889,-0.252963172,0.800296672,0.871947036,4.142996086,1,0.035713268,1.207832806,0.029568056,0.976411542,0.984456654,N,-,,flap structure-specific endonuclease,P:nucleic acid metabolic process; F:nuclease activity,IPR006084 (PRINTS); IPR006085 (SMART); IPR006086 (SMART); G3DSA:1.10.150.20 (GENE3D); IPR006085 (PFAM); IPR006086 (PFAM); IPR029060 (G3DSA:3.40.50.GENE3D); PTHR11081:SF24 (PANTHER); IPR006084 (PANTHER); IPR020045 (SUPERFAMILY); IPR029060 (SUPERFAMILY),,
RL4_JR_07409,3597,3425,2501,2,1,1,0,0,0,0,0,1,0,0,0,0,5,0,0.495195934,1,2.911689173,2.033110557,1.43213519,0.152105135,NA,0.159771562,0,6.111741846,1.950473806,3.133465226,0.001727554,0.015023052,0.410938862,1,3.473011193,1.319752549,2.631562406,0.008499326,0.02877295,0.473840098,0,3.050773382,1.480208425,2.061043114,0.039298927,0.106248768,0.401018622,1,3.404255831,1.257349029,2.707486746,0.006779478,0.023003422,N,-,,---NA---,,no IPS match,,
RL4_JR_07410,376,373,613,0,0,3,2,0,1,0,0,4,0,0,0,0,0,2,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,Actin-related 10,,IPR004000 (SMART); IPR004000 (PFAM); G3DSA:3.30.420.40 (GENE3D); IPR004000 (PANTHER); IPR027127 (PTHR11937:PANTHER); IPR027127 (PTHR11937:PANTHER); IPR004000 (PANTHER); IPR027127 (PTHR11937:PANTHER); IPR004000 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_07411,1418,1520,1627,1,0,0,0,0,0,1,0,1,1,2,4,0,0,0,601.7505017,1,-3.165141178,0.610587039,-5.183767384,2.17E-07,3.99E-06,198.4146243,0,-1.777706468,0.880826292,-2.018225935,0.043567736,0.105804373,439.6182284,1,-6.591115048,1.200945665,-5.488270816,4.06E-08,1.51E-06,575.0541775,1,-2.631192984,0.483277339,-5.444478302,5.20E-08,1.25E-06,536.3744785,0,-1.757368248,0.436048064,-4.030216835,5.57E-05,0.000425826,N,-,,hypothetical protein CMQ_3614,,no IPS match,,
RL4_JR_07412,3438,4025,4438,2,1,8,0,0,0,0,7,3,0,7,0,0,5,0,0.999565453,1,1.898482425,1.514492941,1.253543265,0.210008064,NA,0.320386314,0,5.107804328,1.69477809,3.013848455,0.002579566,0.015349618,0.827395995,1,2.463069102,1.262276858,1.951290707,0.051022474,0.114993661,0.954304221,1,2.040719379,1.318015213,1.548327636,0.121543434,0.226384707,0.810624123,1,2.389384847,1.231831319,1.93970133,0.052415998,0.116016419,N,-,,---NA---,,no IPS match,,
RL4_JR_07413,1121,664,1038,0,0,2,0,0,0,0,0,0,0,0,1,0,0,0,0.920516939,1,2.017051104,1.603935415,1.257563793,0.208549554,NA,0.290290558,0,5.249686801,1.728240026,3.037591262,0.002384772,0.015223444,0.759670907,0,2.584798877,1.285072919,2.011402496,0.04428296,0.103109633,0.876809078,1,2.162072182,1.35773261,1.592413827,0.111291751,0.212408856,0.756103626,0,2.489872733,1.268826427,1.96234306,0.049722557,0.111677216,N,-,,---NA---,,no IPS match,,
RL4_JR_07414,441,821,653,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,144.2036494,0,-0.614997484,0.622840337,-0.987407924,0.323442701,0.512856279,25.88137228,0,-1.228295117,1.233146866,-0.996065555,0.319218294,0.481180577,156.6150159,0,0.308222989,0.551015277,0.559372855,0.575907283,0.698261717,151.4644856,1,0.010970472,0.533932877,0.020546538,0.983607388,0.9896037,95.25562221,0,-0.746993628,0.66341755,-1.125978093,0.260174792,0.391994788,N,-,,serine threonine- kinase ksg1,F:ATP binding; C:integral component of membrane; F:protein serine/threonine kinase activity; P:protein phosphorylation,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); G3DSA:3.30.200.20 (GENE3D); PTHR24356:SF163 (PANTHER); PTHR24356 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_07415,3574,3478,2780,2,0,7,0,0,0,3,4,0,0,0,2,0,0,1,125.9442939,1,-1.716684359,0.67452811,-2.5450153,0.010927295,0.040684537,32.0317384,0,-1.535923597,1.191868985,-1.288668147,0.197513481,0.340991208,128.1211563,1,-0.785037495,0.611771732,-1.283219628,0.199415141,0.324787466,133.7215124,1,-0.903252105,0.542278512,-1.665660884,0.095780977,0.189744158,127.0416892,1,-0.647735098,0.553053997,-1.171196847,0.241519663,0.370848553,N,-,,26S proteasome regulatory subunit N6,C:SWI/SNF superfamily-type complex,IPR019835 (SMART); IPR003121 (G3DSA:1.10.245.GENE3D); IPR003121 (PFAM); PTHR13844 (PANTHER); PTHR13844:SF7 (PANTHER); IPR003121 (SUPERFAMILY),,
RL4_JR_07416,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.58235514,0,-0.917388621,0.897660354,-1.021977429,0.306791583,0.49345539,10.80299563,0,0.032091113,1.228516138,0.026121849,0.97916015,0.989243725,43.88304814,0,-0.80381623,1.050649213,-0.765066227,0.444232109,0.583927016,49.87527095,0,-0.743982917,0.881639583,-0.843862879,0.398746033,0.543086305,47.29147118,0,0.164344082,0.743698348,0.22098218,0.825106309,0.882641455,N,-,,short-chain dehydrogenase reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_07417,5349,5874,5505,0,0,1,0,0,0,0,0,2,0,9,0,0,5,0,15.97966985,1,-2.100540864,1.222107772,-1.718785291,0.085653475,0.197837216,5.049206349,0,1.129371082,1.264349978,0.893242457,0.371727346,0.536291932,13.19255829,1,-1.532768563,1.215807202,-1.260700348,0.207416828,0.334377065,19.23709694,1,-1.010229837,1.169481226,-0.863827323,0.387682756,0.532803793,13.10645037,1,-1.625961215,1.228780777,-1.323231324,0.185758462,0.304644072,N,-,,---NA---,,no IPS match,,
RL4_JR_07418,3644,3027,7021,2,3,0,0,0,0,0,2,0,2,3,1,0,6,1,361.5066795,1,-0.842851199,0.469572887,-1.794931572,0.072664603,0.175617847,119.26866,0,0.149572222,0.748888776,0.199725548,0.841695232,0.905381417,209.9446107,1,-2.943667313,0.881717487,-3.338560657,0.000842136,0.00501517,253.9541105,1,-2.263149104,0.622507444,-3.635537417,0.000277402,0.002541803,182.4827868,1,-5.425405278,1.210530791,-4.481839966,7.40E-06,7.82E-05,N,-,,flocculation suppression,"C:nucleus; P:negative regulation of gene expression; F:transcription factor activity, sequence-specific DNA binding; F:sequence-specific DNA binding; P:negative regulation of flocculation; P:negative regulation of filamentous growth; P:regulation of transcription from RNA polymerase II promoter",IPR000232 (PRINTS); IPR000232 (SMART); IPR000232 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); IPR027722 (PTHR10015:PANTHER); IPR027725 (PANTHER); IPR011991 (SUPERFAMILY),,
RL4_JR_07419,3567,3300,3297,3,0,8,0,0,0,0,0,0,2,10,1,0,3,0,30.1837749,1,2.66251912,0.66945196,3.977162335,6.97E-05,0.000620458,1.544029445,0,2.838829115,1.336151536,2.124631106,0.033617406,0.086408173,21.57537471,0,2.011609734,1.031294453,1.950567783,0.051108483,0.115161869,4.622345033,1,-0.235735649,1.20069744,-0.196332266,0.844350108,0.902750248,27.11212558,1,3.286933162,0.631981797,5.200993409,1.98E-07,4.01E-06,N,-,,chromosome transmission fidelity 4,"P:Okazaki fragment processing involved in mitotic DNA replication; P:DNA repair; P:chromatin silencing at centromere central core; C:nuclear chromatin; C:chromosome, centromeric core domain; C:nuclear replication fork; C:nucleoplasm",IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); IPR022100 (PFAM); PTHR19932 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),8.A.92.1.3,The G-Protein αβγ Complex (GPC) Family
RL4_JR_07420,59294,54504,80788,9,12,73,0,4,0,3,4,5,4,26,8,0,37,0,33.64260361,1,1.545243914,0.711855037,2.170728358,0.029951712,0.090203633,3.283603969,1,1.750140385,1.282456633,1.364678025,0.172354269,0.307901503,15.06273345,1,0.052297259,1.208031467,0.043291305,0.965469322,0.979792644,21.91716149,1,0.953916175,0.887169315,1.075235763,0.282269188,0.425800883,8.495369388,1,-1.00044173,1.222763492,-0.818180896,0.413253902,0.549395451,N,-,,WD repeat,C:intracellular part,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR22844 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),8.A.92.1.4,The G-Protein αβγ Complex (GPC) Family
RL4_JR_07421,3383,3017,1640,0,0,1,0,0,3,0,0,0,4,0,0,0,1,3,2.132802126,1,0.80521476,1.321504208,0.609316834,0.542314451,0.723618138,0.680103254,1,4.021791939,1.511741104,2.660370833,0.007805466,0.028076378,152.8872964,0,6.378553643,0.438550937,14.54461297,6.32E-48,4.00E-45,84.87934787,1,5.187764574,0.533003523,9.733077463,2.18E-22,2.37E-20,58.92692437,1,5.521723194,0.541144613,10.20378483,1.91E-24,6.44E-22,N,-,,gastric mucin,,no IPS match,,
RL4_JR_07422,12,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,76.35182693,0,1.887809163,0.865781745,2.180467738,0.029222808,0.088591477,6.093865249,0,0.85820012,1.236621464,0.693987728,0.487689905,0.643842253,44.46727499,0,1.028779447,0.743167307,1.384317418,0.166261283,0.283181229,204.5657199,0,3.512493679,0.329594594,10.65701241,1.62E-26,2.27E-24,149.5237949,0,3.244472147,0.453719022,7.150840037,8.62E-13,9.10E-11,N,-,,peroxisomal membrane pmp47a,C:integral component of membrane; P:transport,IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); PTHR24089:SF377 (PANTHER); PTHR24089 (PANTHER); PTHR24089:SF377 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.6.1, the mitochondrial carrier (mc) family.
RL4_JR_07423,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.05078639,0,-0.271679833,1.005123703,-0.270294922,0.786933372,0.890032226,4.817611998,0,1.197247905,1.24934278,0.958302177,0.337910407,0.500926938,25.4560405,0,0.370028262,1.032545867,0.358364964,0.720070207,0.810556225,67.66513611,0,1.861324625,0.538617707,3.455743472,0.000548777,0.004510041,41.70056976,0,1.112586216,0.736419387,1.510805167,0.130838098,0.233310275,N,-,,ARS binding 2,C:nucleus; F:DNA replication origin binding; C:mitotic spindle pole body,G3DSA:1.20.1000.10 (GENE3D); IPR018562 (PFAM); PTHR42048:SF1 (PANTHER); PTHR42048 (PANTHER); PTHR42048:SF1 (PANTHER); PTHR42048 (PANTHER); PTHR42048:SF1 (PANTHER); PTHR42048 (PANTHER),,
RL4_JR_07424,572,757,759,0,0,3,2,0,0,0,0,0,0,0,0,0,0,0,30.93524601,1,-1.915538909,1.138671082,-1.682258327,0.092518758,0.209077016,8.647845092,1,0.353182441,1.215153208,0.290648487,0.771320173,0.86142479,48.4333732,0,0.519127531,0.737800954,0.703614611,0.48167281,0.617904128,41.93230606,0,-0.000758818,0.737742661,-0.001028567,0.999179322,0.999460773,22.11819005,0,-2.380917209,1.190621907,-1.999725686,0.045529893,0.104367255,N,-,,regulator of V-ATPase,F:nucleotide binding; P:isoleucyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation; P:biological_process; F:ATP binding; F:aminoacyl-tRNA ligase activity; F:isoleucine-tRNA ligase activity; C:cytoplasm; P:regulation of translational fidelity; F:aminoacyl-tRNA editing activity; C:cellular_component; F:molecular_function,IPR013665 (PFAM),,
RL4_JR_07425,1026,1743,2138,3,0,8,0,0,0,2,0,0,3,2,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,kxY xW signal peptide domain,,no IPS match,,
RL4_JR_07426,8922,25776,30222,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,8.72874823,0,0.548842686,1.153032891,0.475999159,0.634074977,0.791550676,1.560898248,0,2.823096443,1.334956089,2.114748541,0.034451385,0.088199705,4.059426321,0,0.16757977,1.204964884,0.139074402,0.889391356,0.930948735,16.71853186,1,2.045451307,0.861572493,2.374090774,0.017592225,0.072271927,4.011654746,0,0.082130404,1.208424852,0.067964842,0.945813622,0.965359165,N,-, Effector probability:0.906,hypothetical protein SPI_05066,,PTHR34561 (PANTHER),,
RL4_JR_07427,206705,113443,117830,27,28,21,0,0,0,10,4,13,2,6,4,0,24,7,57.31096114,1,1.585219705,0.536605335,2.954163146,0.003135182,0.014905152,5.200499043,0,1.086853393,1.234907163,0.880109393,0.378800051,0.542987792,13.50558184,1,-1.566546375,1.190510623,-1.315860896,0.188220736,0.310703853,24.89360339,1,-1.039828347,1.139853085,-0.912247693,0.361638343,0.507754463,13.32712802,1,-1.650042267,1.195169251,-1.380592971,0.167404146,0.281430525,N,-,,conidiophore development hyma,"P:regulation of cell shape; C:incipient cellular bud site; C:cellular bud; C:integral component of membrane; C:mating projection tip; P:regulation of transcription, DNA-templated; P:budding cell apical bud growth",IPR011989 (G3DSA:1.25.10.GENE3D); IPR013878 (PFAM); IPR013878 (PANTHER); IPR028637 (PTHR10182:PANTHER); IPR028637 (PTHR10182:PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_07428,4743,1348,2961,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.304789772,0,-1.320158274,1.211312065,-1.089858107,0.275775653,0.458872454,2.955670862,0,1.902030349,1.286348756,1.47862727,0.13923996,0.260852652,7.683029583,0,-0.752638485,1.206952288,-0.623585947,0.532899542,0.662414428,31.50099245,0,1.150774603,0.865066044,1.330273695,0.183428111,0.31010346,11.44254551,0,0.092647993,1.140144227,0.081259889,0.935235272,0.957748269,N,-,,carbon-nitrogen hydrolase,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; C:nucleus; P:nitrogen compound metabolic process",IPR003010 (G3DSA:3.60.110.GENE3D); IPR003010 (PFAM); PTHR23088 (PANTHER); PTHR23088:SF27 (PANTHER); IPR003010 (PROSITE_PROFILES); IPR003010 (SUPERFAMILY),,
RL4_JR_07429,4664,4380,5696,0,2,0,0,0,0,0,3,0,0,4,0,0,0,7,159.6427315,1,-1.690744826,0.604299752,-2.797857884,0.005144274,0.02225185,57.07829711,0,-0.149306776,0.978124745,-0.152645945,0.878677491,0.931058686,130.7389934,1,-1.621583038,0.736380638,-2.20209896,0.027658319,0.072039566,197.1511561,1,-0.666609059,0.455463926,-1.463582562,0.14330804,0.257222816,116.870014,1,-1.907423321,0.744575949,-2.561757902,0.010414389,0.032444826,N,-,,Transcription initiation factor TFIID component TAF4,P:cellular nitrogen compound biosynthetic process; P:gene expression; P:primary metabolic process; P:cellular macromolecule biosynthetic process,IPR007900 (PFAM),,
RL4_JR_07430,2907,2151,4288,1,0,3,0,0,0,2,0,0,0,1,0,0,1,0,169.8783901,1,0.304259058,0.395913702,0.768498429,0.442191123,0.631878645,24.02860409,0,-1.121142461,1.199433508,-0.934726647,0.349929191,0.512884921,76.53621219,1,-1.947197289,1.028325,-1.893562141,0.058283153,0.12711302,180.9131712,1,0.545238068,0.398565895,1.367999807,0.171312137,0.29369038,68.53296154,1,-2.915509729,1.1147758,-2.615332814,0.008914055,0.028652319,N,-,,metallo-beta-lactamase superfamily,"P:RNA phosphodiester bond hydrolysis, endonucleolytic; F:RNA binding; C:mRNA cleavage and polyadenylation specificity factor complex; F:metal ion binding; P:snoRNA splicing; P:termination of RNA polymerase II transcription; P:mRNA polyadenylation; F:endoribonuclease activity; P:mRNA cleavage; P:snoRNA 3'-end processing",IPR001279 (SMART); IPR022712 (SMART); IPR021718 (SMART); IPR001279 (PFAM); IPR011108 (PFAM); IPR001279 (G3DSA:3.60.15.GENE3D); IPR021718 (PFAM); IPR022712 (PFAM); PTHR11203 (PANTHER); PTHR11203:SF11 (PANTHER); PTHR11203 (PANTHER); PTHR11203 (PANTHER); PTHR11203:SF11 (PANTHER); IPR001279 (SUPERFAMILY),,
RL4_JR_07431,9151,5428,3921,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,239.409201,0,-2.624466961,0.71456233,-3.672831397,0.000239878,0.001800168,63.38358342,0,-2.520539542,1.190413772,-2.117364231,0.034228947,0.087714016,177.8820384,0,-3.357381879,1.036697654,-3.238535233,0.001201452,0.006686915,190.2433649,0,-5.598891201,1.193604258,-4.69074332,2.72E-06,4.45E-05,182.343359,0,-2.357158454,0.711013363,-3.315209777,0.000915744,0.004440568,N,-,,mitochondrial GTP GDP carrier 1,P:cellular iron ion homeostasis; C:cell; P:guanine nucleotide transmembrane transport; F:guanine nucleotide transmembrane transporter activity; C:integral component of membrane; P:mitochondrial genome maintenance,IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089:SF105 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.21.1, the mitochondrial carrier (mc) family.
RL4_JR_07432,998,836,1231,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,169.5050307,0,1.792838467,1.313765953,1.364655906,0.172361225,0.326246605,12.71712126,0,-0.203136876,1.227932511,-0.165430001,0.868605542,0.92392027,52.35028368,0,-0.45095938,0.868664165,-0.519141226,0.603662261,0.721069644,41.90501386,1,-2.324556856,1.154328892,-2.013773433,0.044033326,0.113902079,32.21218097,0,-2.923308909,1.197900191,-2.440361002,0.014672591,0.042751075,N,-,,chromosome segregation atpase,C:mitotic spindle; C:DASH complex; P:attachment of spindle microtubules to kinetochore; C:cellular_component,SSF57997 (SUPERFAMILY),,
RL4_JR_07433,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,84.83260895,0,2.520478935,0.469016646,5.373964775,7.70E-08,1.55E-06,4.63925431,0,1.251561621,1.24790043,1.002933881,0.315892764,0.4775189,19.92109487,0,-0.443678094,1.197221858,-0.370589704,0.710943152,0.804199829,89.72652849,0,2.011168572,0.581939879,3.455973109,0.00054831,0.004509861,19.31969036,0,-0.556252996,1.13577891,-0.489754644,0.624307529,0.729499565,N,-,,seryl-tRNA synthetase,F:nucleotide binding; F:aminoacyl-tRNA ligase activity; C:cytoplasm; P:growth of unicellular organism as a thread of attached cells; P:seryl-tRNA aminoacylation,IPR002317 (PRINTS); IPR015866 (G3DSA:1.10.287.GENE3D); IPR002317 (PIRSF); IPR002314 (PFAM); G3DSA:3.30.930.10 (GENE3D); IPR002317 (PANTHER); PTHR11778:SF0 (PANTHER); IPR006195 (PROSITE_PROFILES); IPR010978 (SUPERFAMILY); SSF55681 (SUPERFAMILY),,
RL4_JR_07434,2727,2440,3365,2,3,10,0,0,0,0,1,3,0,2,0,0,2,0,0.072510404,1,5.683385737,3.921457487,1.449304437,0.147252582,NA,0.023398168,0,8.883771553,2.811490656,3.159808315,0.00157873,0.015023052,0.060167758,1,6.245994163,1.600099603,3.903503352,9.48E-05,0.001128758,0.06937697,1,5.822605766,2.681127543,2.171700403,0.029878268,0.092062527,0.058694722,1,6.176301487,1.324272864,4.663919089,3.10E-06,3.78E-05,N,-,,retinitis pigmentosa 1-like 1 isoform X2,,no IPS match,,
RL4_JR_07435,803,1536,2807,0,0,0,0,0,0,0,0,0,0,3,0,0,7,0,8.707435945,0,-1.224726118,1.207312385,-1.014423553,0.310380691,0.498397557,2.802875257,0,1.978648957,1.306709739,1.514222248,0.129969481,0.247250939,7.235874638,0,-0.666201753,1.210980666,-0.550134095,0.582227403,0.703733313,8.344458228,1,-1.08803301,1.210431838,-0.898880033,0.368716565,0.514901709,7.102538474,1,-0.742252013,1.208963805,-0.613957183,0.539243621,0.661638592,N,-,,mechanosensitive ion channel,P:cellular homeostasis; C:membrane; P:phosphorylation; F:kinase activity,IPR011992 (G3DSA:1.10.238.GENE3D); IPR006685 (PFAM); PTHR31323 (PANTHER); PTHR31323:SF1 (PANTHER); IPR002048 (PROSITE_PROFILES); IPR010920 (SUPERFAMILY); IPR011992 (SUPERFAMILY),1.A.23.4.9, the small conductance mechanosensitive ion channel (mscs) family.
RL4_JR_07436,20205,27836,29713,5,2,8,0,0,0,2,0,4,4,6,0,0,12,3,71064.87983,1,-3.240019771,0.524164416,-6.18130432,6.36E-10,1.83E-08,21857.85656,0,-4.338555911,0.471342686,-9.204674305,3.43E-20,1.58E-17,55935.76263,1,-4.464931963,0.796467631,-5.605917664,2.07E-08,8.22E-07,62819.82207,1,-5.791393754,0.905558318,-6.395384636,1.60E-10,5.92E-09,54161.98336,1,-4.746943795,1.016675769,-4.669083241,3.03E-06,3.70E-05,N,-,,hsp70,"C:nucleus; F:ATP binding; P:SRP-dependent cotranslational protein targeting to membrane, translocation; P:mycelium development; C:cytoplasm; F:unfolded protein binding; P:protein folding",IPR013126 (PRINTS); G3DSA:3.30.30.30 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR029048 (G3DSA:1.20.1270.GENE3D); IPR013126 (PFAM); G3DSA:3.90.640.10 (GENE3D); IPR029047 (G3DSA:2.60.34.GENE3D); G3DSA:3.30.420.40 (GENE3D); PTHR19375:SF140 (PANTHER); PTHR19375 (PANTHER); IPR029047 (SUPERFAMILY); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY); IPR029048 (SUPERFAMILY),1.A.33.1.3, the cation channel-forming heat shock protein-70 (hsp70) family.
RL4_JR_07437,15186,7337,6727,0,8,1,0,0,0,0,0,2,0,0,0,0,0,0,23.58867321,1,-2.662288334,1.191846168,-2.233751641,0.025499419,0.080040116,7.508361934,0,0.557016313,1.223026551,0.4554409,0.648792076,0.772807092,32.49914022,1,-0.276598188,1.032781995,-0.267818561,0.788838983,0.860304413,34.53447765,0,-0.215598833,0.855556217,-0.251998441,0.801042269,0.872383885,19.23908598,0,-2.179709083,1.196458051,-1.821801509,0.068485109,0.142589292,N,-,,Early meiotic induction,,IPR021475 (PFAM); PTHR28052 (PANTHER); PTHR28052:SF1 (PANTHER),,
RL4_JR_07438,1819,2170,3599,0,0,0,0,0,0,2,0,1,0,6,0,0,3,0,126.4455741,0,0.628178095,0.727371705,0.863627347,0.387792637,0.580692425,17.65281324,0,-0.676279954,1.2091907,-0.559283125,0.57596851,0.715507273,110.8939578,1,0.498667896,0.544897448,0.91515917,0.360108076,0.50393507,60.77478348,1,-2.024386828,1.021073235,-1.982606887,0.047411357,0.11896902,52.68943434,1,-1.736013599,0.975806439,-1.779055282,0.075230699,0.153138486,N,-,,mitochondrial escape 2,F:nucleotide binding; F:nucleic acid binding; C:integral component of mitochondrial inner membrane; P:mitochondrial genome maintenance,IPR000504 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR018850 (PFAM); PTHR32198:SF2 (PANTHER); PTHR32198:SF2 (PANTHER); PTHR32198 (PANTHER); PTHR32198 (PANTHER); IPR012677 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_07439,18306,5284,11183,3,0,7,0,0,0,0,7,0,0,0,0,0,1,0,51.95934264,1,-2.744261886,1.148175521,-2.390106596,0.016843483,0.057229961,60.05834565,0,1.192175971,0.988276346,1.20631843,0.227694734,0.377329093,39.88530757,1,-3.128753367,1.195001789,-2.618199734,0.008839505,0.029681972,77.95128348,0,-0.804397951,0.750232722,-1.072197903,0.283631152,0.427727944,50.71379528,1,-0.999262687,0.843707522,-1.18437096,0.23626625,0.364886484,N,-,,cupin domain-containing,"P:chromosome organization; C:chromosome, centromeric region",IPR028929 (PFAM); IPR025974 (PFAM); IPR014710 (G3DSA:2.60.120.GENE3D); IPR028386 (PANTHER); IPR011051 (SUPERFAMILY),,
RL4_JR_07440,56467,25032,62731,7,13,7,0,1,1,0,2,2,1,4,4,0,0,0,44.65983749,1,2.013373741,0.626237372,3.21503288,0.001304296,0.007288276,2.927853022,1,1.915720166,1.283369861,1.492726473,0.135508801,0.255232616,36.22555885,1,1.679949416,0.854847664,1.965203261,0.049390717,0.112014251,30.09920364,1,1.564661616,0.751866068,2.081037677,0.037430458,0.102872797,11.32346467,0,0.116362132,1.128550994,0.103107553,0.91787761,0.947760164,N,-,,ribonuclease h2 subunit a,P:RNA metabolic process; F:nuclease activity,IPR024567 (PFAM); IPR004649 (TIGRFAM); IPR023160 (G3DSA:1.10.10.GENE3D); IPR012337 (G3DSA:3.30.420.GENE3D); IPR001352 (PANTHER); PTHR10954:SF7 (PANTHER); IPR012337 (SUPERFAMILY),,
RL4_JR_07441,58610,12655,33786,4,4,3,0,0,0,3,0,1,0,0,1,0,3,0,206.1774194,1,0.680662629,0.360470133,1.888263594,0.058990572,0.150436101,34.21364382,0,-0.251696202,1.115292054,-0.225677392,0.821452343,0.892426813,107.2760164,1,-0.412636777,0.611633358,-0.674647272,0.499899892,0.632623313,86.14376483,1,-1.93339215,0.851931692,-2.269421561,0.023242702,0.082358448,97.88699578,1,-0.131487457,0.519642817,-0.2530343,0.800241708,0.86511119,N,-,,SEY1,C:endoplasmic reticulum membrane; F:GTP binding; F:GTPase activity; C:integral component of membrane; P:endoplasmic reticulum membrane fusion; C:cortical endoplasmic reticulum; P:endoplasmic reticulum inheritance,IPR027417 (G3DSA:3.40.50.GENE3D); IPR008803 (PFAM); PTHR14187:SF52 (PANTHER); PTHR14187 (PANTHER); IPR030386 (PROSITE_PROFILES); IPR008803 (HAMAP); IPR027417 (SUPERFAMILY),1.N.5.1.6," the endoplasmic reticulum fusion gtpase, atlastin (atlastin) family."
RL4_JR_07442,7889,8369,10756,2,2,2,0,0,1,0,0,3,1,4,0,0,1,0,66.39638715,1,1.641557066,0.595092674,2.758489791,0.005806912,0.024524381,5.624462273,1,0.9738275,1.293068009,0.753113907,0.451381468,0.611549086,81.53748778,1,2.161404172,0.603325724,3.582483038,0.000340344,0.002569456,16.70671064,1,-2.089561912,1.227991591,-1.7016093,0.088828633,0.17937573,14.20056763,1,-1.741731974,1.227881472,-1.418485426,0.156049091,0.266306598,N,-,,phosphotransferase enzyme family,P:phosphorylation; F:kinase activity,IPR016477 (PIRSF); IPR016477 (PFAM); PTHR12149:SF8 (PANTHER); PTHR12149 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_07443,2335,3287,5461,0,0,0,0,0,0,0,3,0,1,4,0,0,0,1,352.03974,0,0.748668044,1.096862744,0.682553991,0.494888715,0.682322484,43.28229187,0,-1.970177372,1.889316009,-1.042799279,0.297041265,0.456868514,214.928877,1,-0.085583838,1.441215141,-0.05938311,0.952646965,0.972629879,125.8515374,1,-5.002741332,1.853164937,-2.699566149,0.006942995,0.036310861,104.9166856,1,-4.626870848,1.822959889,-2.538108971,0.011145327,0.034278992,N,-,,hypothetical protein CMQ_610,,no IPS match,,
RL4_JR_07444,234,187,251,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,623.3690035,0,0.969915575,0.304072315,3.189752988,0.001423944,0.007870284,104.8514846,0,-0.01879542,0.758518937,-0.024779104,0.980231158,0.989715689,436.9371723,0,0.644048837,0.502804674,1.280912589,0.20022437,0.325738635,462.8274013,0,0.252976221,0.34616325,0.730800342,0.464901115,0.606509958,274.2887618,0,-0.397755127,0.433522748,-0.917495399,0.358883103,0.496134819,N,-,,succinyl- ligase [GDP-forming] subunit mitochondrial,F:ATP binding; F:metal ion binding; C:mitochondrion; F:succinate-CoA ligase (ADP-forming) activity; P:succinyl-CoA metabolic process,IPR016102 (G3DSA:3.40.50.GENE3D); IPR005811 (PFAM); IPR005809 (PIRSF); IPR013815 (G3DSA:3.30.1490.GENE3D); IPR013816 (G3DSA:3.30.470.GENE3D); IPR013650 (PFAM); IPR005809 (TIGRFAM); PTHR11815:SF1 (PANTHER); IPR005809 (PANTHER); IPR011761 (PROSITE_PROFILES); IPR016102 (SUPERFAMILY); SSF56059 (SUPERFAMILY),,
RL4_JR_07445,19,14,39,0,0,3,0,0,0,0,0,2,0,0,0,0,0,0,0.008115494,1,8.845278576,4.03634189,2.191409652,0.028422161,NA,0.002507343,0,12.10167175,4.040174693,2.995333784,0.002741447,0.015349618,0.006623884,1,9.426891884,3.299070491,2.857438757,0.00427075,0.016940088,0.007651472,0,9.002876608,4.037800151,2.229648886,0.025770762,0.085851084,0.006630333,0,9.341240721,1.70468121,5.479758129,4.26E-08,1.17E-06,N,-, Effector probability:0.891,---NA---,,no IPS match,,
RL4_JR_07446,315,206,281,0,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.843,---NA---,,no IPS match,,
RL4_JR_07447,1956,2025,2082,7,26,19,0,0,6,2,0,0,0,0,3,0,1,1,3.91518428,1,-0.071366176,1.307361694,-0.054587935,0.956466751,0.978015059,1.23118907,1,3.165352742,1.434776308,2.20616463,0.027372475,0.073530836,3.223108349,1,0.500425608,1.260280224,0.397074871,0.69131225,0.788840091,3.720481679,1,0.077251282,1.273735111,0.060649409,0.951638423,0.971304338,3.204779651,1,0.406146289,1.269391671,0.319953485,0.749003592,0.825118199,N,-, Effector probability:0.687,---NA---,,no IPS match,,
RL4_JR_07448,1489,1653,1743,2,1,4,0,0,0,0,0,2,0,2,0,0,0,1,1.008615624,1,1.885167199,1.467265652,1.284816554,0.198856396,NA,0.323059149,0,5.095641073,1.670786636,3.049845482,0.002289591,0.015101794,0.836739374,1,2.445828624,1.245505018,1.963724424,0.049562059,0.112251965,0.965134116,1,2.023820502,1.2931689,1.565008641,0.117580883,0.220791254,0.824091503,1,2.364939793,1.222330932,1.934778653,0.053017464,0.117128916,N,-,,triacylglycerol lipase,F:hydrolase activity,IPR002018 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR11559 (PANTHER); PTHR11559:SF206 (PANTHER); IPR029058 (SUPERFAMILY),8.A.117.1.3, the neuroligin (nlg) family.
RL4_JR_07449,1477,1292,932,0,0,3,0,0,2,0,0,2,7,2,3,0,9,3,0.099037887,1,5.23326286,3.917524985,1.335859473,0.18159521,NA,0.031728444,1,8.443308557,2.649823038,3.186366953,0.001440717,0.015023052,0.082284435,1,5.790554001,1.527189884,3.791639835,0.000149656,0.001477113,0.094911282,1,5.369658063,2.388915111,2.247739168,0.024592827,0.084867884,0.081253023,1,5.705290762,1.313054791,4.345051555,1.39E-05,0.000132681,N,-, Effector probability:0.713,---NA---,,no IPS match,,
RL4_JR_07450,4345,3719,4043,5,5,6,0,0,0,0,0,0,5,13,3,0,0,0,5.632623597,1,-0.596293471,1.214091712,-0.49114368,0.62332483,0.78413014,1.813171402,0,2.607053188,1.346609465,1.936012821,0.052866131,0.123183926,4.6801833,0,-0.037585374,1.214768802,-0.030940352,0.975317109,0.985920676,5.397203419,1,-0.459416553,1.215265454,-0.378038026,0.705402346,0.802352684,4.592733238,0,-0.113321886,1.210248893,-0.093635191,0.925398954,0.951718071,N,-,,kinase-like domain,F:ATP binding; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,G3DSA:1.10.510.10 (GENE3D); IPR001245 (PFAM); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_07451,2463,3163,2575,2,0,7,0,0,0,0,0,0,0,7,0,0,12,4,21.44146481,1,0.86375227,0.882921245,0.978289145,0.327931337,0.517290234,3.167087193,0,1.802328019,1.27909754,1.40906222,0.158816771,0.28886673,8.244379482,0,-0.854444736,1.206604766,-0.708139699,0.478858509,0.6152238,9.513225653,1,-1.27712768,1.206233119,-1.058773516,0.289702938,0.434441329,12.01139112,1,-0.011917435,1.142421225,-0.010431735,0.991676831,0.994328373,N,-,,arp2 3 complex subunit,C:medial cortex; C:mating projection tip; F:structural molecule activity; P:actin cortical patch assembly; C:Arp2/3 protein complex; P:mitochondrion inheritance; C:nucleus; C:actomyosin contractile ring; P:Arp2/3 complex-mediated actin nucleation; C:cytosol; F:mRNA binding; C:extrinsic component of mitochondrial outer membrane; C:actin cortical patch,IPR006789 (PFAM); IPR006789 (PIRSF); IPR006789 (G3DSA:1.25.40.GENE3D); PTHR12644:SF0 (PANTHER); IPR006789 (PANTHER); IPR006789 (PANTHER); PTHR12644:SF0 (PANTHER); IPR006789 (SUPERFAMILY),,
RL4_JR_07452,1332,1577,2664,0,0,0,0,0,0,0,0,1,2,2,0,0,1,0,0.07524641,0,5.629551976,3.920920313,1.435773116,0.151066912,NA,0.023542561,0,8.872650343,2.839262494,3.124984169,0.001778146,0.015023052,0.062019187,1,6.196828357,1.659047871,3.735171519,0.000187587,0.001692633,0.071606748,1,5.775768693,2.710536165,2.130858377,0.033100811,0.097397767,0.062214612,1,6.094426257,1.382774022,4.407391345,1.05E-05,0.000104548,N,-,,hypothetical protein CMQ_1236,,no IPS match,,
RL4_JR_07453,9584,4916,5407,3,1,1,0,0,0,0,2,1,0,2,0,0,4,0,97.1411966,1,1.178457897,0.557686068,2.113120563,0.03459045,0.101106733,46.29947604,0,2.907919094,0.776462251,3.745087529,0.000180331,0.007936127,22.91037014,1,-2.32901606,1.204163523,-1.934136034,0.053096405,0.118507055,77.97956033,1,0.61192963,0.643155218,0.951449376,0.341376306,0.488266011,64.11718817,1,1.185854001,0.593746964,1.997238003,0.045799335,0.104842474,N,-,,methyltransferase type 11,F:methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR13090 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_07454,7792,3914,4165,0,4,1,0,0,2,0,0,0,0,0,1,0,0,0,134.4099958,1,-0.098274849,0.552363181,-0.177917088,0.858788091,0.929176823,34.5800437,1,-0.273337105,1.122028159,-0.243609845,0.807533003,0.883373135,156.8057841,0,0.560847914,0.474790142,1.181254337,0.237501701,0.370202806,145.7212518,1,-0.068513418,0.48120608,-0.142378537,0.886781015,0.930355796,90.55309775,0,-0.714496462,0.619389614,-1.15354931,0.24868499,0.378921825,N,-,,ap-2 complex subunit alpha,P:vesicle-mediated transport; C:clathrin adaptor complex; F:protein transporter activity; P:intracellular protein transport,IPR008152 (SMART); IPR003164 (PFAM); IPR008152 (PFAM); IPR017104 (PIRSF); IPR013038 (G3DSA:2.60.40.GENE3D); IPR002553 (PFAM); IPR015873 (G3DSA:3.30.310.GENE3D); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR22780:SF4 (PANTHER); PTHR22780 (PANTHER); IPR009028 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR013041 (SUPERFAMILY),9.B.278.1.1, the organellar-targeting adaptor protein complex (o-apc) family.
RL4_JR_07455,36710,23737,27928,7,12,19,0,0,0,2,0,5,0,1,3,0,10,0,33.1426686,1,-1.045750385,1.008185569,-1.037259824,0.299614784,0.485356912,26.91212085,0,2.077765762,0.991856102,2.09482581,0.03618648,0.091638616,38.71000514,1,-0.388174546,1.030541904,-0.376670318,0.706418624,0.800696874,28.3986728,1,-1.688061834,1.142474862,-1.477548338,0.139528711,0.252182827,28.20221207,1,-1.360395445,1.122690102,-1.211728367,0.225616377,0.352471195,N,-,,family pyridoxal phosphate enzyme,F:pyridoxal phosphate binding,IPR011078 (TIGRFAM); IPR029066 (G3DSA:3.20.20.GENE3D); IPR001608 (PFAM); IPR011078 (PIRSF); IPR011078 (PANTHER); IPR029066 (SUPERFAMILY),,
RL4_JR_07456,2986,2251,4466,0,0,2,0,0,0,2,0,0,1,1,0,0,3,0,115.9379394,1,1.527967545,0.460746956,3.31628354,0.000912232,0.00552952,20.39887704,0,0.919447489,1.129955083,0.813702688,0.415815294,0.579496407,104.1170566,1,1.201024921,0.551044667,2.179541866,0.029291438,0.075208349,54.17694254,1,-0.343285973,0.752957001,-0.4559171,0.648449592,0.759023367,31.78086567,1,-1.786717767,1.121226026,-1.593539328,0.111039253,0.206440036,N,-,,involucrin repeat,,SM01160 (SMART); IPR029191 (PFAM); IPR013861 (PFAM); IPR022764 (G3DSA:1.20.1540.GENE3D); PTHR12917:SF11 (PANTHER); PTHR12917 (PANTHER); SSF144091 (SUPERFAMILY); SSF57997 (SUPERFAMILY),,
RL4_JR_07457,5075,3388,4396,0,1,1,0,0,0,0,0,2,4,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_07458,1447,1290,1563,2,1,16,0,0,0,0,3,0,0,0,0,0,1,0,33.66716174,1,0.410917012,0.742874589,0.553144525,0.58016445,0.754387825,117.4348157,0,4.219344392,1.383497021,3.049767601,0.002290185,0.015101794,36.08215439,1,0.663773949,0.852307685,0.778796157,0.436099802,0.576531,69.7704795,0,1.179892617,0.618482884,1.907720728,0.056427321,0.132129192,37.84093777,1,1.109894066,0.681587081,1.628396571,0.103440824,0.195837387,N,-,,dehydrodolichyl diphosphate synthase,P:protein glycosylation; F:dehydrodolichyl diphosphate synthase activity,IPR001441 (TIGRFAM); IPR001441 (PFAM); IPR001441 (G3DSA:3.40.1180.GENE3D); PTHR10291:SF0 (PANTHER); IPR001441 (PANTHER); IPR001441 (PANTHER); PTHR10291:SF0 (PANTHER); IPR001441 (SUPERFAMILY); IPR001441 (SUPERFAMILY),,
RL4_JR_07459,178909,255294,200657,0,3,1,1,0,2,0,3,0,0,12,0,0,6,0,114.4266972,1,-2.417566783,0.843104029,-2.86745965,0.004137816,0.018578255,31.56471576,1,-1.514718972,1.193282183,-1.269371984,0.204308424,0.349149057,167.7452458,1,-0.160452312,0.506560545,-0.316748537,0.751434416,0.833357798,98.40578322,1,-3.640302153,1.138170031,-3.19838166,0.001382012,0.009714382,88.34260325,1,-2.576052931,0.969373059,-2.657442258,0.007873608,0.025908443,N,-,,phd-finger domain-containing,C:nucleus; P:negative regulation of chromatin silencing; F:binding,IPR001965 (SMART); IPR024610 (SMART); IPR024610 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR028651 (PANTHER); IPR028651 (PANTHER); PTHR10333:SF62 (PANTHER); PTHR10333:SF62 (PANTHER); IPR019787 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY),,
RL4_JR_07460,7830,9261,10502,0,3,7,6,0,0,0,0,1,1,6,0,0,7,2,220.0188039,1,-0.474298107,0.613489899,-0.773114778,0.439454456,0.629622313,41.68922572,1,-1.91608484,1.23957842,-1.545755241,0.12216369,0.236918687,134.9242833,1,-1.758044324,0.806262208,-2.180487075,0.029221376,0.075104648,161.4505953,1,-1.349030371,0.664738775,-2.029414293,0.042416111,0.111868486,109.5368087,1,-3.710362443,1.16607525,-3.181923673,0.001463004,0.006531266,N,-,,leucine rich repeat domain containing,C:membrane,IPR032675 (G3DSA:3.80.10.GENE3D); PTHR24006 (PANTHER); PTHR24006:SF484 (PANTHER); PTHR24006 (PANTHER); PTHR24006:SF484 (PANTHER); SSF52047 (SUPERFAMILY),,
RL4_JR_07461,2407,2868,5168,0,4,0,0,0,0,1,0,0,1,2,2,0,0,0,276.3877601,1,-0.101205032,0.897066499,-0.112817759,0.910175039,0.956240562,47.79722744,0,-2.113328979,1.190147236,-1.775687003,0.075784521,0.163384647,147.4326973,1,-2.355121194,0.844655911,-2.788261071,0.005299182,0.019752916,218.0409563,1,-0.498921022,0.406489154,-1.227390735,0.219675767,0.354909389,141.3396461,0,-1.913718426,0.672429547,-2.845976109,0.004427552,0.016213006,N,-,,V-type proton ATPase subunit A,"C:vacuolar proton-transporting V-type ATPase, V0 domain; F:hydrogen ion transmembrane transporter activity; P:ATP hydrolysis coupled proton transport; C:integral component of membrane",IPR002490 (PFAM); IPR026028 (PIRSF); PTHR11629:SF64 (PANTHER); IPR002490 (PANTHER); IPR002490 (PANTHER); PTHR11629:SF64 (PANTHER),3.A.2.2.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_07462,1411,1300,2490,1,0,0,0,0,0,0,0,2,2,3,0,0,0,1,248.1305817,1,-0.862637341,0.596006594,-1.447362074,0.147795542,0.293575854,51.8977075,0,-2.23207006,1.267933174,-1.760400395,0.078339942,0.167644164,240.335801,1,-0.400008974,0.602770047,-0.663617869,0.506934918,0.638731687,298.0222362,1,-0.214527656,0.642765026,-0.333757512,0.738562547,0.826169223,147.6276295,1,-2.687687568,0.932482456,-2.882292907,0.003947926,0.014770447,N,-,,cyclic-AMP-mediated signaling,C:nucleus; P:cAMP-mediated signaling,IPR008862 (PFAM); IPR008862 (PANTHER),,
RL4_JR_07463,962,1348,1874,0,0,0,6,0,0,0,1,0,0,0,0,0,0,0,30.83607964,0,1.985995692,0.748034969,2.654950334,0.007932009,0.031519399,2.381364488,1,2.213612239,1.327546896,1.667445607,0.095425832,0.195368177,19.22650405,1,1.361223577,1.069027849,1.273328454,0.202901514,0.328720584,19.22427567,0,1.39849316,0.914142473,1.529841574,0.126055948,0.233008674,6.194233058,0,-0.544643348,1.242731485,-0.438263096,0.661195574,0.758495202,Y,-,,transmembrane 167 precursor,C:integral component of membrane; C:Golgi membrane; F:methyltransferase activity; P:methylation,IPR009653 (PFAM); IPR009653 (PANTHER),,
RL4_JR_07464,8124,5742,5564,2,0,1,0,0,0,2,2,7,2,5,3,0,0,0,11.50295704,1,-1.626371513,1.25795498,-1.29286941,0.196056229,0.358175354,3.631056387,0,1.605009605,1.322272445,1.213826705,0.224813906,0.373901801,22.50508102,1,0.746636754,1.088658952,0.68583164,0.492819282,0.626167471,14.98492546,1,-0.539659016,1.199105602,-0.450051284,0.652673462,0.762644986,9.478640071,0,-1.158461722,1.260711183,-0.918895412,0.35815028,0.495595406,N,-,,transcription initiation factor TFIID subunit 13,F:translation initiation factor activity; P:RNA polymerase II transcriptional preinitiation complex assembly; C:transcription factor TFIID complex; F:protein heterodimerization activity; P:translational initiation,IPR009072 (G3DSA:1.10.20.GENE3D); IPR003195 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); IPR003195 (PANTHER); PTHR11380:SF5 (PANTHER); IPR009072 (SUPERFAMILY); IPR009072 (SUPERFAMILY),,
RL4_JR_07465,2742,1897,2956,0,3,2,0,0,0,0,0,0,1,3,5,0,0,0,57.41150965,1,0.010177395,0.713897353,0.014256104,0.98862566,0.994272677,11.05588132,0,-0.001243882,1.248282914,-0.000996474,0.999204929,0.999651886,28.65656625,0,-2.651852171,1.216368293,-2.180139179,0.029247146,0.07511902,102.2509533,1,0.849038234,0.737791893,1.150782819,0.249821595,0.389085317,50.36876399,0,-0.476655252,0.883329342,-0.539612157,0.589464531,0.701707319,N,-,,integral membrane DUF6,P:cellular nitrogen compound biosynthetic process; F:hydrolase activity,IPR000620 (PFAM); PTHR22911:SF6 (PANTHER); PTHR22911 (PANTHER); PTHR22911 (PANTHER); SSF103481 (SUPERFAMILY); SSF103481 (SUPERFAMILY),2.A.7.28.12, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_07466,13900,12142,15259,0,1,2,0,0,2,2,0,0,0,0,2,0,3,0,210.2253574,1,-1.394441615,0.499800326,-2.789997409,0.005270846,0.022681743,50.97203723,1,-2.206122585,1.193637218,-1.848235421,0.064568293,0.144146508,132.2132421,1,-4.857746681,1.190717396,-4.079680617,4.51E-05,0.000664583,171.1413968,1,-3.536957801,1.01358452,-3.489553887,0.000483827,0.004075502,161.2675413,1,-1.375162144,0.585003245,-2.350691482,0.018738564,0.051980262,N,-,,-like helicase 1,"F:ATP binding; P:DNA repair; C:R2TP complex; F:ATP-dependent 5'-3' DNA helicase activity; P:box C/D snoRNP assembly; P:transcription, DNA-templated; P:DNA duplex unwinding; C:Swr1 complex; P:histone exchange; C:Ino80 complex; P:regulation of transcription from RNA polymerase II promoter",IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.8.60 (GENE3D); IPR010339 (PFAM); IPR027238 (PANTHER); IPR027417 (SUPERFAMILY),9.B.307.1.3,The FtsH AAA(+) Zinc Metaloprotease (FtsH) Family
RL4_JR_07467,54448,58902,55925,30,31,82,4,0,7,17,20,19,18,30,26,0,15,28,6.628888804,1,-0.831063677,1.19812051,-0.693639472,0.487908333,0.675552645,2.110087187,1,2.388191209,1.299680522,1.837521735,0.066132911,0.146853496,18.47996307,1,1.553940724,1.033350406,1.503788758,0.132635767,0.239086185,6.325347773,1,-0.688404549,1.196473674,-0.575361216,0.565047028,0.692627259,5.412444071,1,-0.349978014,1.201803246,-0.291210741,0.770890148,0.841265655,N,-,,hmg box,,IPR009071 (SMART); IPR009071 (PFAM); IPR009071 (G3DSA:1.10.30.GENE3D); PTHR10270 (PANTHER); PTHR10270:SF237 (PANTHER); IPR009071 (PROSITE_PROFILES); IPR009071 (SUPERFAMILY),,
RL4_JR_07468,1919,1771,3441,0,0,1,0,0,0,0,3,0,4,0,0,0,1,0,22.68633248,1,0.666943515,0.934714055,0.713526786,0.475519844,0.665021292,3.54967096,0,1.637810782,1.306490016,1.253596094,0.209988852,0.355792962,72.49040398,1,2.634717538,0.631411795,4.172740453,3.01E-05,0.00047312,24.00216592,1,0.292478393,1.057126605,0.276673004,0.782031203,0.859631519,31.60484541,1,1.516887189,0.810969903,1.870460522,0.061419894,0.131142225,N,-,,galactose-proton symport,F:methyltransferase activity; F:transferase activity; P:methylation,G3DSA:2.170.270.10 (GENE3D); PTHR12350 (PANTHER); IPR003616 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY),,
RL4_JR_07469,2547,2110,4237,0,1,6,0,0,0,0,0,0,1,7,0,0,3,0,150.8067753,1,-0.097516566,0.680522195,-0.143296672,0.886055884,0.944154115,22.5660907,0,-1.030548231,1.199321039,-0.859276372,0.390188057,0.554624843,92.26321803,0,-0.539714982,0.663968164,-0.812862742,0.416296758,0.557854186,214.7817299,1,0.90926208,0.367639933,2.473240796,0.013389389,0.061066472,88.00866981,1,-0.338367164,0.569664504,-0.593976212,0.552528023,0.672316577,N,-,,hypothetical protein CMQ_1198,C:integral component of membrane,PTHR42055:SF1 (PANTHER); PTHR42055 (PANTHER),,
RL4_JR_07470,29,15,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,418.9670368,0,-0.641331869,0.417671765,-1.535492515,0.124662894,0.259536617,83.86778942,0,-2.92454623,1.197308892,-2.442599608,0.014581905,0.045068105,256.9923547,0,-2.442555354,0.692956643,-3.524831427,0.000423752,0.003001533,419.1703304,0,-0.506433943,0.378622975,-1.337567913,0.18103733,0.30676875,224.3719893,0,-4.016353325,1.010569028,-3.974348326,7.06E-05,0.000521184,N,-,,60s ribosomal l26,F:structural constituent of ribosome; C:large ribosomal subunit; P:translation,IPR005824 (SMART); IPR014722 (G3DSA:2.30.30.GENE3D); IPR005756 (PFAM); IPR005756 (TIGRFAM); IPR005824 (PFAM); IPR005756 (PANTHER); IPR005756 (HAMAP); IPR008991 (SUPERFAMILY),,
RL4_JR_07471,86,42,50,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,7.074021733,0,-0.92486555,1.202764267,-0.768949973,0.441923009,0.631716823,2.27521471,0,2.279585596,1.316344764,1.731754217,0.083317333,0.175585685,5.872132649,0,-0.364803899,1.206656702,-0.30232617,0.76240343,0.840070998,6.771957699,1,-0.78667185,1.20547654,-0.652581634,0.514026029,0.648860933,5.758144358,0,-0.439513979,1.201116205,-0.36592128,0.714423817,0.798823481,N,-,,hypothetical protein SPSK_08390,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_07472,32,16,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27.8149151,0,-2.900043374,1.222819596,-2.371603616,0.01771108,0.059484146,8.910711363,0,0.310028669,1.259917966,0.24607052,0.805627643,0.882815092,23.00851741,0,-2.335036938,1.216940826,-1.918776072,0.055012679,0.121604446,50.60760236,0,0.473732473,0.702381888,0.674465674,0.500015302,0.638077325,26.38911935,0,-1.479096368,1.147090916,-1.289432553,0.19724775,0.318623719,N,-,,dynactin 1,C:dynactin complex; P:transport along microtubule; F:dynein binding,IPR000938 (SMART); IPR000938 (PFAM); IPR022157 (PFAM); IPR000938 (G3DSA:2.30.30.GENE3D); IPR027663 (PTHR18916:PANTHER); IPR027663 (PTHR18916:PANTHER); PTHR18916 (PANTHER); PTHR18916 (PANTHER); IPR000938 (PROSITE_PROFILES); IPR000938 (SUPERFAMILY),,
RL4_JR_07473,199,221,374,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_07474,188,152,282,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,65.43537276,0,0.084691812,0.70623846,0.11991957,0.904546862,0.953456484,10.76088803,0,0.037724515,1.245695613,0.030283895,0.975840641,0.987449662,42.50635903,0,-0.808602878,1.066521659,-0.758168267,0.448350256,0.587889909,46.15505804,0,-1.313758706,1.055988092,-1.244103713,0.213461395,0.347866831,35.396971,1,-1.780200513,1.165172806,-1.527842482,0.126551652,0.227631102,N,-,,signal recognition particle sec65,P:SRP-dependent cotranslational protein targeting to membrane; C:signal recognition particle,IPR002778 (PFAM); IPR002778 (G3DSA:3.30.56.GENE3D); PTHR17453:SF0 (PANTHER); IPR002778 (PANTHER); IPR002778 (SUPERFAMILY),3.A.5.9.1, the general secretory pathway (sec) family.
RL4_JR_07475,39,50,73,0,0,5,0,0,0,2,0,0,0,2,0,0,0,0,59.4396603,1,-0.62779267,0.751985567,-0.834846701,0.403804027,0.595702216,12.05413198,0,-0.125975475,1.208475977,-0.10424326,0.916976305,0.954060707,50.85141861,1,-0.379880493,0.855811024,-0.443883617,0.65712673,0.762580355,75.50622208,1,0.321581293,0.5816758,0.552853142,0.580363976,0.706640706,45.72901943,0,-1.178075624,0.978085718,-1.204470735,0.228407686,0.355772912,N,-,,c-x8-c-x5-c-x3-h zinc finger,F:metal ion binding,IPR000571 (G3DSA:4.10.1000.GENE3D); PTHR37543 (PANTHER); PTHR37543:SF1 (PANTHER); IPR000571 (PROSITE_PROFILES); IPR000571 (SUPERFAMILY),,
RL4_JR_07476,425,407,385,0,8,0,0,0,0,0,0,3,0,13,0,0,2,3,198.0779462,1,-1.672186551,0.565224096,-2.958448802,0.003091916,0.014768062,58.65520294,0,-1.239641874,1.107131667,-1.119687848,0.262846805,0.419246039,141.1554873,1,-2.993522009,1.035355091,-2.89129984,0.003836519,0.016016484,176.7754724,1,-2.898663759,0.852636959,-3.399645919,0.000674732,0.005333066,145.9490285,1,-1.988540093,0.704592231,-2.822256626,0.0047687,0.017219361,N,-,,fungal specific transcription factor domain-containing,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR001138 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31944:SF35 (PANTHER); PTHR31944 (PANTHER); PTHR31944:SF35 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07477,6288,5710,4908,2,7,10,0,0,0,0,0,2,1,3,1,1,16,2,93.24647017,1,-4.645313743,1.239323747,-3.748264935,0.000178062,0.001398105,29.38934237,0,-1.411740653,1.223512517,-1.153842428,0.248564776,0.402105268,95.82760146,1,-2.24164964,1.063194098,-2.108410537,0.034995494,0.086240817,124.8806759,1,-0.773274251,0.68726445,-1.125148044,0.260526306,0.400781883,76.53683472,1,-4.171860575,1.234200647,-3.380212597,0.000724298,0.003694466,N,-,,Orotidine 5 -phosphate decarboxylase,P:nucleobase-containing small molecule metabolic process; F:catalytic activity; P:single-organism biosynthetic process; P:pyrimidine-containing compound biosynthetic process,IPR001754 (SMART); IPR013785 (G3DSA:3.20.20.GENE3D); IPR001754 (PFAM); PTHR19278:SF9 (PANTHER); PTHR19278 (PANTHER); PTHR19278 (PANTHER); PTHR19278:SF9 (PANTHER); PTHR19278:SF9 (PANTHER); IPR011060 (SUPERFAMILY),,
RL4_JR_07478,4598,4513,4831,3,5,129,0,1,0,8,16,12,8,38,2,0,15,5,116.2089236,1,0.670750768,0.43621472,1.53766193,0.124131297,0.258820625,62.79645299,1,2.385803495,0.677742461,3.520221368,0.000431187,0.015023052,118.0375372,1,0.965619045,0.481035107,2.007377487,0.044709484,0.103887725,122.194945,1,0.820501602,0.430543477,1.905734603,0.056684647,0.132423019,63.73988496,1,-0.063378484,0.615713439,-0.102935034,0.918014532,0.947781905,N,-,,CDP-diacylglycerol--inositol 3-phosphatidyltransferase,"C:integral component of membrane; F:phosphotransferase activity, for other substituted phosphate groups; P:phospholipid biosynthetic process",IPR000462 (PFAM); PTHR15362:SF4 (PANTHER); PTHR15362 (PANTHER); PTHR15362:SF4 (PANTHER); PTHR15362 (PANTHER),4.F.1.1.8, the choline/ethanolaminephosphotransferase 1 (cept1) family.
RL4_JR_07479,5210,4554,5200,0,3,8,0,0,0,0,0,4,0,5,1,0,0,1,1.809573117,1,1.04231702,1.37966123,0.75548765,0.44995644,NA,0.578714556,0,4.254749098,1.570355583,2.709417627,0.006740144,0.025230672,1.4952565,1,1.609148098,1.265859514,1.271190112,0.203661023,0.329687272,11.360032,1,2.141747184,1.186322353,1.805366963,0.071017277,0.152664529,23.56081216,1,3.79842082,0.891911725,4.258740764,2.06E-05,0.000183717,N,-,,---NA---,,no IPS match,,
RL4_JR_07480,1403,1438,1524,1,0,6,0,0,0,0,2,1,2,9,4,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hydroxyproline-rich glyco,,IPR011989 (G3DSA:1.25.10.GENE3D),,
RL4_JR_07481,54,62,82,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.196779207,0,4.243027563,3.030676354,1.400026617,0.161505348,NA,0.061989309,0,7.477058191,2.327696072,3.212214121,0.001317162,0.015023052,0.162051864,0,4.814086858,1.416938605,3.397526781,0.000679979,0.004231168,0.187044699,0,4.391264154,1.893639784,2.318954318,0.020397513,0.077534994,0.160866254,0,4.724381006,1.298328123,3.638818973,0.000273891,0.001627435,Y,-,,---NA---,,no IPS match,,
RL4_JR_07482,4154,3863,4696,9,3,11,1,0,0,0,4,8,4,3,3,0,13,1,39.77035177,1,1.058139851,0.741195052,1.427613215,0.153403218,0.301557458,3.805233251,1,1.537503639,1.258861816,1.221344249,0.221955706,0.370243187,9.877143577,1,-1.115244711,1.196460301,-0.932120113,0.351274455,0.494771595,15.40598066,1,-0.590604588,1.146224244,-0.515260946,0.606370686,0.72665442,9.748459459,1,-1.198986507,1.201008427,-0.998316481,0.318125918,0.453473873,N,-,,phosphatase 2c domain containing,"P:positive regulation of autophagosome maturation; C:fungal-type vacuole membrane; P:protein dephosphorylation; P:regulation of aerobic respiration; P:mitophagy; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; F:magnesium-dependent protein serine/threonine phosphatase activity; C:mitochondrial matrix; F:metal ion binding; P:positive regulation of catalytic activity; P:regulation of stress-activated MAPK cascade; P:positive regulation of vacuole fusion, non-autophagic; P:macroautophagy",IPR001932 (SMART); IPR001932 (PFAM); IPR001932 (G3DSA:3.60.40.GENE3D); PTHR13832:SF321 (PANTHER); IPR015655 (PANTHER); PTHR13832:SF321 (PANTHER); IPR015655 (PANTHER); IPR001932 (PROSITE_PROFILES); IPR001932 (SUPERFAMILY),,
RL4_JR_07483,132,148,216,0,0,12,0,0,0,1,0,0,0,0,0,0,0,0,105.432434,1,1.631256409,0.495067979,3.295014988,0.000984164,0.005844522,7.672822163,0,0.525723644,1.22809706,0.428079882,0.668592963,0.788690362,64.25566346,1,0.941376922,1.230680964,0.764923608,0.444317035,0.583962828,31.0730038,0,-0.832369268,1.02659245,-0.810807899,0.417475998,0.561021494,19.75744258,0,-2.21807238,1.206714329,-1.838108926,0.066046356,0.138853687,Y,-,,heterokaryon incompatibility het-c,,IPR010816 (PFAM); PTHR14905 (PANTHER); PTHR14905:SF7 (PANTHER),,
RL4_JR_07484,829,749,545,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19.53224351,1,-0.675439671,1.17302006,-0.575812549,0.56474189,0.741611955,3.728285362,0,1.567079144,1.313280368,1.193255593,0.232769288,0.383041901,9.58544784,0,-1.071794957,1.224040137,-0.875620762,0.381236235,0.52504906,15.06309054,0,-0.548266881,1.176425035,-0.466044894,0.641183366,0.75397801,24.09394885,0,0.560047259,0.998437609,0.560923641,0.574849593,0.689663477,N,-,,RNA-binding,F:RNA binding,PTHR12537 (PANTHER); PTHR12537:SF13 (PANTHER),,
RL4_JR_07485,2424,1919,1888,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,57.5591013,1,-2.779079417,1.179616619,-2.355917484,0.018477022,0.061449467,16.03426939,0,-0.537532341,1.251639436,-0.429462611,0.667586598,0.787840916,41.20079328,0,-3.175588733,1.220312185,-2.602275689,0.009260737,0.030769841,60.82570039,0,-1.860912515,1.055076841,-1.763769655,0.077770768,0.16312647,63.00948268,1,-0.329052796,0.727577252,-0.452258225,0.651082967,0.7513352,N,-,,RNA-binding,F:RNA binding,IPR001313 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR001313 (PFAM); PTHR12537 (PANTHER); PTHR12537:SF13 (PANTHER); PTHR12537 (PANTHER); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR033133 (PROSITE_PROFILES); IPR001313 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),,
RL4_JR_07486,1344,1667,1233,0,0,0,0,0,0,0,2,3,0,0,2,0,5,0,856.681833,0,-0.222674605,0.820592103,-0.271358455,0.786115352,0.889847237,157.6293517,0,-2.830407197,1.129484897,-2.50592744,0.012213068,0.039219757,478.5879771,1,-2.213771491,0.585382255,-3.781753668,0.000155727,0.001520332,646.0896126,1,-1.05287948,0.585749939,-1.797489697,0.072257912,0.15480562,504.0675332,1,-1.489123709,0.939985167,-1.584199157,0.113148405,0.209521261,N,-,,60S ribosomal L15,F:structural constituent of ribosome; P:cytoplasmic translation; C:cytosolic large ribosomal subunit,IPR000439 (SMART); IPR024794 (G3DSA:3.40.1120.GENE3D); IPR000439 (PFAM); IPR000439 (PANTHER); IPR012678 (SUPERFAMILY),,
RL4_JR_07487,8097,8632,4835,0,0,2,0,0,0,3,1,1,1,8,0,0,1,2,21.168835,1,-0.131121662,1.008349305,-0.130035952,0.896537983,0.948632537,4.339474034,0,1.348045342,1.256045526,1.073245606,0.283160933,0.442581063,11.21984983,1,-1.298929359,1.194130323,-1.087761808,0.276700274,0.415799942,16.95229821,1,-0.773788132,1.143661663,-0.676588327,0.498667187,0.636536217,11.02095703,1,-1.376014259,1.190940194,-1.155401645,0.247925988,0.378106738,N,-,,arginine-tRNA- transferase 1,C:cytoplasm; F:transferase activity,IPR007472 (PFAM); IPR007471 (PFAM); IPR030700 (PANTHER); IPR016181 (SUPERFAMILY),,
RL4_JR_07488,6961,8531,11176,0,2,22,0,0,2,2,1,0,1,3,1,0,5,1,19.48555473,1,0.058435951,1.0137849,0.057641371,0.954034295,0.977184938,3.787581633,1,1.544289042,1.262123972,1.223563672,0.221116871,0.369140742,9.807010426,1,-1.104698617,1.195302289,-0.924200202,0.355382091,0.49894443,38.60635101,1,1.205874986,0.742464637,1.624151408,0.104343499,0.202274157,17.00710774,1,-0.24883766,1.121196187,-0.221939446,0.824361023,0.882165837,N,-,,nudix family,F:hydrolase activity,IPR015797 (G3DSA:3.90.79.GENE3D); IPR000086 (PFAM); PTHR12629:SF0 (PANTHER); PTHR12629 (PANTHER); IPR000086 (PROSITE_PROFILES); IPR015797 (SUPERFAMILY),,
RL4_JR_07489,344,331,608,0,0,4,0,0,0,0,0,2,0,0,0,0,0,0,45.72280767,1,1.534614005,0.562712375,2.727173015,0.006387953,0.026561124,4.724626176,0,1.225310582,1.240620164,0.987659735,0.323319321,0.485554624,12.2573309,1,-1.426659616,1.189948785,-1.198925226,0.230557022,0.361772983,14.14011664,0,-1.848995774,1.187369794,-1.557219817,0.119418305,0.22366081,12.08594312,0,-1.509042565,1.193238347,-1.264661473,0.205992706,0.328971002,N,-,,hypothetical protein CMQ_800,P:transmembrane transport; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_07490,3774,4184,6247,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,19.66553493,1,-2.399853164,1.202183601,-1.996245134,0.045907247,0.124712394,15.70122513,0,1.719931574,1.145080812,1.502017636,0.133092554,0.251430167,16.30881127,0,-1.838504447,1.204337298,-1.526569384,0.126868125,0.23155091,26.83122176,1,-0.541484676,1.032706102,-0.524335699,0.600045072,0.722236846,15.97063907,1,-1.911152524,1.200598542,-1.59183312,0.111422206,0.207037959,N,-,,ubiquitin conjugating enzyme,"F:transferase activity, transferring glycosyl groups; F:transferase activity; F:NAD+ ADP-ribosyltransferase activity",SM00212 (SMART); IPR016135 (G3DSA:3.10.110.GENE3D); IPR012317 (G3DSA:3.90.228.GENE3D); IPR000608 (PFAM); IPR012317 (PFAM); PTHR21328:SF2 (PANTHER); PTHR21328:SF2 (PANTHER); PTHR21328 (PANTHER); PTHR21328:SF2 (PANTHER); PTHR21328 (PANTHER); IPR000608 (PROSITE_PROFILES); SSF56399 (SUPERFAMILY); IPR016135 (SUPERFAMILY),3.A.20.1.1, the peroxisomal protein importer (ppi) family.
RL4_JR_07491,36375,34314,36448,8,17,44,0,0,1,0,11,5,0,2,4,0,0,0,92.9683524,1,-4.640993222,1.196053519,-3.880255479,0.000104347,0.000888582,29.56034892,1,-1.420088439,1.194964994,-1.188393339,0.234678479,0.385119256,76.84991423,1,-4.07499226,1.191923587,-3.418836833,0.000628894,0.003996829,88.6684272,1,-4.497535732,1.192257544,-3.772285404,0.000161759,0.001605697,102.9270302,0,-0.778263905,0.613463572,-1.268639151,0.204569794,0.327111365,N,-,,ribose-phosphate pyrophosphokinase,F:magnesium ion binding; P:fungal-type cell wall organization; P:nucleotide biosynthetic process; F:ribose phosphate diphosphokinase activity; P:phosphorylation; F:kinase activity; C:ribose phosphate diphosphokinase complex; P:5-phosphoribose 1-diphosphate biosynthetic process,SM01400 (SMART); IPR005946 (TIGRFAM); IPR029099 (PFAM); IPR029057 (G3DSA:3.40.50.GENE3D); IPR029057 (G3DSA:3.40.50.GENE3D); IPR005946 (PFAM); PTHR10210:SF36 (PANTHER); PTHR10210 (PANTHER); IPR029057 (SUPERFAMILY),,
RL4_JR_07492,1702,1389,1630,16,7,1,1,0,0,3,3,7,0,13,3,0,5,2,38.23110202,1,-3.358995384,1.21496593,-2.76468278,0.005697818,0.024222405,12.09407026,1,-0.130748277,1.226296291,-0.106620462,0.915090085,0.952642378,38.04137481,1,-1.828470022,1.20676481,-1.515183411,0.129725963,0.235577695,56.45912771,1,-0.215003165,0.723327975,-0.2972416,0.766282064,0.847926701,38.61624874,1,-1.94064724,1.146059264,-1.693321891,0.090394214,0.17696083,N,-,,RNA polymerase III subunit C17,"F:nucleotide binding; F:DNA-directed RNA polymerase activity; P:transcription, DNA-templated",IPR006590 (SMART); IPR005574 (PFAM); PTHR15561:SF0 (PANTHER); PTHR15561 (PANTHER); IPR010997 (SUPERFAMILY),,
RL4_JR_07493,63,73,53,3,30,11,0,0,4,2,3,19,0,1,0,0,9,0,100.6366698,1,-0.276353781,0.683312352,-0.404432584,0.685894643,0.828896683,15.35418048,1,-0.475077043,1.213709448,-0.391425678,0.695482615,0.807240395,40.01236853,1,-3.133406915,1.201557235,-2.607788312,0.009112929,0.030417322,50.18433773,1,-2.609863893,1.156481167,-2.256728401,0.024025051,0.08365596,47.33542873,1,-1.561018652,0.998701945,-1.563047574,0.118041405,0.216398557,N,-, Effector probability:0.599,Rho-like small,F:GTP binding; P:small GTPase mediated signal transduction; C:intracellular,PR00449 (PRINTS); SM00175 (SMART); SM00174 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001806 (PFAM); PTHR24072:SF172 (PANTHER); PTHR24072 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_07494,8820,8452,7908,1,2,14,0,0,0,1,0,6,1,0,0,0,4,2,88.34631876,1,-1.667726063,0.926584054,-1.799864843,0.071881982,0.17421664,19.60229181,0,-0.827483885,1.237762635,-0.668531964,0.503794086,0.657393804,67.04941384,1,-1.668434538,1.075179328,-1.551773267,0.120716485,0.2228138,79.34560432,1,-0.957204048,0.782078796,-1.223922772,0.220981362,0.356449943,78.22069478,1,-0.304618761,0.748348591,-0.407054633,0.683967863,0.775582328,N,-,,pseudouridylate synthase 3,P:pseudouridine synthesis,IPR001406 (TIGRFAM); IPR020097 (PFAM); IPR020094 (G3DSA:3.30.70.GENE3D); IPR020095 (G3DSA:3.30.70.GENE3D); PTHR11142:SF5 (PANTHER); IPR001406 (PANTHER); IPR020103 (SUPERFAMILY),,
RL4_JR_07495,641,691,992,0,0,9,0,0,0,0,0,0,0,0,0,0,2,0,12.22920225,1,-1.714615124,1.221695411,-1.403471854,0.160476179,0.310155098,3.865221168,0,1.514879979,1.276506378,1.18673906,0.235330563,0.385751572,10.0934485,0,-1.146466346,1.215103956,-0.943512972,0.345418583,0.48909339,39.90847108,0,0.788356715,0.875509653,0.900454625,0.367878362,0.514328696,10.0186252,1,-1.238349652,1.226768364,-1.009440484,0.312763431,0.448227847,N,-,,GPI- c transferase complex,"F:transferase activity, transferring glycosyl groups; C:membrane; C:integral component of membrane; F:phosphatidylinositol N-acetylglucosaminyltransferase activity; C:endoplasmic reticulum; F:transferase activity",IPR019328 (PFAM),,
RL4_JR_07496,2,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.12648379,0,-0.12027057,0.893714241,-0.134573854,0.892948815,0.947661823,6.324016718,0,0.804744409,1.266973986,0.635170428,0.525317268,0.674386325,16.3044444,0,-1.838111557,1.211752153,-1.516903891,0.129290951,0.234956307,32.12680341,0,-0.524536362,1.03879528,-0.504946809,0.613596196,0.732713144,39.11403714,0,1.246265698,0.667993261,1.865686035,0.062085305,0.132311873,N,-,,WD g-beta repeat,C:nucleus; F:ligand-dependent nuclear receptor transcription coactivator activity; F:transcription factor binding; P:positive regulation of sequence-specific DNA binding transcription factor activity; P:positive regulation of transcription from RNA polymerase II promoter; F:RNA polymerase II transcription cofactor activity,IPR015943 (G3DSA:2.130.10.GENE3D); PTHR15528:SF11 (PANTHER); PTHR15528 (PANTHER); PTHR15528 (PANTHER); PTHR15528:SF11 (PANTHER); IPR017986 (SUPERFAMILY),,
RL4_JR_07497,4,9,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42.38571968,0,2.009199545,0.568770502,3.532531202,0.000411602,0.002848046,26.08926637,0,2.472642885,1.117772817,2.212115779,0.026958666,0.072669938,9.808103754,0,-1.105134977,1.199078941,-0.921653228,0.356709484,0.50018377,38.28561911,0,1.205417862,0.748746401,1.609914732,0.107416472,0.206956253,40.56929937,0,2.371210953,0.591159297,4.011120125,6.04E-05,0.000454582,N,-,,hypothetical protein SPI_01800,,no IPS match,,
RL4_JR_07498,7736,8518,13409,0,2,5,0,0,0,0,0,0,0,4,3,0,5,7,33.33041316,1,-2.038092451,1.143522149,-1.782293813,0.074701331,0.17913388,9.399064111,0,0.232965759,1.214868991,0.191762042,0.847928605,0.90966967,47.95519571,0,-0.012321399,0.851783037,-0.014465419,0.988458668,0.994648201,73.13322889,1,0.692886128,0.575631052,1.203698316,0.228706203,0.365071781,27.99250176,1,-1.576820153,1.127576075,-1.398415759,0.161988254,0.274315281,N,-,,charged multivesicular body 3,P:protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; C:ESCRT III complex; P:intralumenal vesicle formation,IPR005024 (PFAM); PTHR10476:SF9 (PANTHER); PTHR10476:SF9 (PANTHER); PTHR10476 (PANTHER),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_07499,222,169,250,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,3326.022341,1,-3.263883054,0.337782468,-9.662677514,4.34E-22,7.54E-20,1258.365326,0,-1.969065788,0.688624922,-2.859416971,0.004244205,0.018549155,2635.197299,0,-4.025579571,0.555373529,-7.248418156,4.22E-13,3.50E-11,3063.932403,0,-3.974381965,0.669441544,-5.936861852,2.91E-09,8.92E-08,2569.379945,0,-4.199301079,0.626763666,-6.699975294,2.08E-11,1.70E-09,N,-,,Hsp90 binding co-chaperone Sba1,,IPR008978 (G3DSA:2.60.40.GENE3D); IPR007052 (PFAM); PTHR22932 (PANTHER); PTHR22932:SF1 (PANTHER); IPR007052 (PROSITE_PROFILES); IPR008978 (SUPERFAMILY),,
RL4_JR_07500,1526,1318,2032,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,660.0539176,0,-0.772911395,0.419225947,-1.843663066,0.065232259,0.162126461,128.9542544,0,-3.545198594,1.192874607,-2.971979263,0.002958867,0.01548137,488.5116169,0,-1.013085638,0.410370741,-2.46870826,0.013560172,0.041053583,533.9383293,1,-1.222420697,0.346988843,-3.522939486,0.000426789,0.003674521,386.6253677,0,-2.03603216,0.514654795,-3.956112287,7.62E-05,0.000553709,N,-,,RNA annealing,F:nucleotide binding; F:RNA binding; P:transcription-coupled nucleotide-excision repair; F:ATP-dependent RNA helicase inhibitor activity; C:transcription export complex; P:negative regulation of ATP-dependent RNA helicase activity; P:poly(A)+ mRNA export from nucleus,IPR025715 (SMART); IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR19965 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_07501,6374,5528,6293,2,2,51,0,0,1,6,4,1,0,37,7,0,28,3,33.13926252,1,-0.239647196,0.854677137,-0.280395001,0.779174472,0.886370752,25.69777683,1,2.307960048,0.998451444,2.311539598,0.020803069,0.059331829,54.48312633,1,1.164576981,0.67062858,1.736545409,0.082467443,0.16669293,20.71241353,1,-2.399510077,1.191306059,-2.014184397,0.043990177,0.113902079,44.66423957,1,1.352848113,0.580275134,2.33139081,0.019732762,0.054052085,N,-, Effector probability:0.695,Dolichyl-diphosphooligosaccharide-- glycosyltransferase subunit 4,C:integral component of membrane,IPR018943 (PFAM); IPR018943 (SUPERFAMILY),9.B.142.3.14, the integral membrane glycosyltransferase family 39 (gt39) family.
RL4_JR_07502,6865,5087,6309,1,1,0,0,0,0,1,2,6,0,4,0,0,0,2,354.2793905,1,-2.560289448,0.532517501,-4.807897285,1.53E-06,2.21E-05,94.2946071,0,-3.093576863,1.191811912,-2.595692182,0.009440059,0.032313927,274.0745483,1,-2.919779985,0.741356429,-3.938429441,8.20E-05,0.001030777,345.7182093,1,-2.255867955,0.507835301,-4.442125135,8.91E-06,0.000128656,310.8375075,1,-1.601305171,0.464110011,-3.450270694,0.000560025,0.002978073,N,-,,translation machinery-associated 46,F:DNA binding; C:cytoplasm; F:metal ion binding; P:cytoplasmic translation,IPR000571 (SMART); IPR032378 (PFAM); IPR000571 (G3DSA:4.10.1000.GENE3D); IPR032297 (PFAM); PTHR12681 (PANTHER); IPR000571 (PROSITE_PROFILES); IPR000571 (PROSITE_PROFILES); IPR000571 (SUPERFAMILY),,
RL4_JR_07503,16462,12523,13299,2,14,7,0,0,2,0,0,2,5,9,5,1,13,3,65.04174408,1,0.520399126,0.568911781,0.914727279,0.36033482,0.552066029,18.92666238,1,1.127369548,1.115751345,1.010412896,0.312297512,0.473995414,24.76390035,1,-2.441154839,1.188028419,-2.054794986,0.039898811,0.095447911,28.56821657,1,-2.863489219,1.186368544,-2.413659089,0.015793232,0.067556497,43.69861436,1,0.408932848,0.672578385,0.608007717,0.543182355,0.665262048,N,-,,short chain dehydrogenase,,IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); PTHR24322:SF315 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_07504,124,104,138,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,4.365373858,0,-0.22865832,1.274361112,-0.179429769,0.857600259,0.928384144,1.383674086,0,2.996864273,1.40414604,2.13429671,0.0328185,0.084871962,38.75041599,1,3.167349851,0.793324032,3.992504607,6.54E-05,0.00088489,4.169250988,0,-0.087252661,1.255689321,-0.069485867,0.944602882,0.967537094,18.32272347,0,1.958826945,1.030147101,1.901502167,0.057236269,0.124078014,N,-,,c2h2 finger domain-containing,F:nucleic acid binding; F:DNA binding; P:biological_process; F:metal ion binding,IPR015880 (SMART),,
RL4_JR_07505,1844,2016,1611,1,2,2,0,0,0,0,2,3,3,5,1,0,4,0,322.9268955,1,0.587079389,0.526102358,1.115903361,0.264463503,0.444355448,61.79555478,0,-0.332784629,1.019651225,-0.326371038,0.744143647,0.842341981,166.934975,1,-0.803437995,0.588373695,-1.365523308,0.172088633,0.290807097,174.4549582,1,-1.675402695,0.663018193,-2.526933216,0.011506338,0.05426254,161.295231,1,-0.751183938,0.547727565,-1.37145542,0.170233031,0.285035463,N,-,,serine threonine- kinase nrc-2,C:nucleus; F:ATP binding; C:cytoplasm; P:conidium formation; F:protein serine/threonine kinase activity; P:protein phosphorylation; C:plasma membrane; P:sporulation resulting in formation of a cellular spore; P:intracellular signal transduction,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); PTHR24351 (PANTHER); PTHR24351:SF29 (PANTHER); PTHR24351 (PANTHER); PTHR24351:SF29 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_07506,14,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.49596272,0,0.318892662,1.025216124,0.311049207,0.755763214,0.872067369,3.14208696,0,1.813827651,1.278504779,1.418710106,0.15598355,0.284993771,8.149176103,0,-0.837550277,1.201539,-0.697064579,0.48576238,0.621177003,13.41299907,0,-0.313244763,1.151199113,-0.272103027,0.785542802,0.861446659,8.023003624,0,-0.917824847,1.20252876,-0.763245652,0.445316908,0.578055601,N,-,,DASH complex subunit DAD3,P:transmembrane transport; C:mitotic spindle; C:DASH complex; P:attachment of spindle microtubules to kinetochore; C:integral component of membrane,IPR013965 (PFAM); PTHR28017 (PANTHER),,
RL4_JR_07507,19911,12605,11410,1,6,8,0,0,2,0,0,1,1,5,12,0,5,0,176.8668903,1,-0.147483595,0.629033234,-0.234460736,0.814627312,0.90602994,40.51818931,1,-0.580660877,1.148915036,-0.505399319,0.613278397,0.745558548,140.3226448,1,-0.357834654,0.629091577,-0.568811708,0.569483929,0.693810768,131.454923,1,-1.479126089,1.40914905,-1.049659076,0.293874886,0.438344611,99.92285322,1,-2.023958375,0.918532722,-2.203468996,0.02756171,0.070488081,N,-,,37S ribosomal s5,F:RNA binding; F:structural constituent of ribosome; C:mitochondrion; C:small ribosomal subunit; P:translation,IPR014720 (G3DSA:3.30.160.GENE3D); IPR013810 (PFAM); IPR014721 (G3DSA:3.30.230.GENE3D); IPR005324 (PFAM); IPR000851 (PANTHER); IPR013810 (PROSITE_PROFILES); SSF54768 (SUPERFAMILY); IPR020568 (SUPERFAMILY),,
RL4_JR_07508,3055,2524,3691,0,0,4,0,0,0,0,4,5,0,0,1,0,2,2,46.73178636,1,6.097662449,0.706879571,8.626168732,6.34E-18,6.16E-16,0.28903557,0,5.256144339,1.696046282,3.09905714,0.001941376,0.015023052,0.751506744,1,2.600965427,1.246880568,2.085977995,0.036980616,0.089800381,20.9250241,1,5.203804764,0.689939603,7.542406238,4.61E-14,2.61E-12,16.18449462,1,5.114841921,0.776504012,6.587012874,4.49E-11,3.35E-09,N,-,,hypothetical protein CH63R_10197,C:integral component of membrane,no IPS match,,
RL4_JR_07509,553,634,596,0,0,8,1,0,0,0,0,1,1,0,0,0,0,0,0.718815905,1,2.374025632,1.823103572,1.302189118,0.192851744,NA,0.225730891,1,5.61263007,1.847177353,3.038490084,0.002377669,0.015223444,0.591332844,1,2.946681703,1.331593345,2.212899091,0.026904603,0.070547061,4.694209976,1,3.465316212,1.230154906,2.816975483,0.004847823,0.027365184,0.588235764,0,2.852447014,1.302769425,2.189525605,0.02855866,0.072379582,N,-,,hypothetical protein SPI_01007,,no IPS match,,
RL4_JR_07510,30,21,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,121.2969744,0,0.473907735,0.571776622,0.828833702,0.407198515,0.598545132,17.76248735,0,-0.68520908,1.251783968,-0.547386049,0.584113538,0.72261027,45.63159771,0,-3.322950213,1.222614874,-2.717904291,0.006569684,0.023363675,64.64491531,0,-1.476775293,0.921279077,-1.602961937,0.108943058,0.209249078,55.73225521,0,-1.710735739,1.004984705,-1.702250523,0.088708415,0.174571955,N,-,,Ras guanyl-nucleotide exchange factor,P:biological regulation,IPR001895 (SMART); G3DSA:1.20.870.10 (GENE3D); IPR001806 (PFAM); IPR001895 (PFAM); IPR001895 (G3DSA:1.10.840.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000651 (PFAM); PTHR23113:SF226 (PANTHER); PTHR23113:SF226 (PANTHER); PTHR23113 (PANTHER); PTHR23113 (PANTHER); IPR001895 (PROSITE_PROFILES); IPR000651 (PROSITE_PROFILES); IPR023578 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_07511,730,755,802,1,0,19,0,0,0,0,0,9,5,7,1,0,2,0,42.77068647,1,3.680238966,0.878120612,4.191040404,2.78E-05,0.000278978,0.882800419,0,3.645526264,1.518940934,2.400044784,0.016393066,0.049428244,2.263641839,1,1.010604661,1.270850378,0.795219232,0.426485987,0.567377678,21.88007528,1,2.372293411,1.075975022,2.204784834,0.027469197,0.088070176,6.06409126,1,1.872325695,1.177930812,1.589503963,0.11194666,0.207844552,N,-,,---NA---,,no IPS match,,
RL4_JR_07512,3851,2181,2516,1,7,4,0,0,1,1,6,22,16,48,11,4,4,20,31.62560745,1,-3.085441847,1.184337262,-2.605205415,0.009181919,0.035445979,10.12026232,1,0.12635119,1.215916463,0.103914367,0.917237305,0.954190751,26.21682392,1,-2.523464548,1.189395834,-2.121635604,0.03386835,0.08444681,78.41716746,1,0.567407311,1.549790922,0.366118618,0.714276565,0.80877323,25.8153933,1,-2.60397124,1.190567474,-2.187168133,0.028730252,0.0726508,N,-,,FAD dependent oxidoreductase superfamily,F:oxidoreductase activity; P:single-organism metabolic process,IPR016040 (G3DSA:3.40.50.GENE3D); IPR023209 (PIRSF); G3DSA:3.30.9.10 (GENE3D); IPR006076 (PFAM); IPR023209 (PANTHER); PTHR11530:SF3 (PANTHER); SSF51971 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_07513,1551,1328,1108,0,0,4,0,0,0,0,0,0,1,4,0,0,1,0,453.7803382,1,-1.610175643,0.423458597,-3.802439378,0.000143278,0.001161893,128.7569256,0,-2.34526066,1.111425428,-2.110137667,0.0348465,0.088909133,344.6498292,0,-1.788524407,0.500444106,-3.573874459,0.000351738,0.002628851,463.0233758,1,-0.904975776,0.397293085,-2.277854336,0.022735258,0.081168718,321.4860552,1,-1.952678073,0.728347514,-2.680970326,0.007340903,0.024514063,Y,-,,fibronectin type 3 domain containing,C:membrane; C:integral component of membrane,IPR003961 (SMART); IPR003961 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013892 (PFAM); PTHR22977:SF5 (PANTHER); PTHR22977 (PANTHER); IPR003961 (PROSITE_PROFILES); IPR003961 (SUPERFAMILY),,
RL4_JR_07514,915,599,892,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,342.1868878,0,-0.624189205,1.110319489,-0.562170809,0.573999648,0.749950213,130.9848256,0,0.780871821,0.635124994,1.229477391,0.218892869,0.366523346,203.00908,1,-2.104617429,0.712780136,-2.952688105,0.003150201,0.014031074,210.1003955,0,-3.912190146,1.038132139,-3.768489576,0.000164238,0.001625526,229.5731022,0,-1.158470395,0.551305835,-2.101320757,0.035612819,0.085913698,N,-,,saccharopine dehydrogenase,"F:magnesium ion binding; F:saccharopine dehydrogenase (NAD+, L-lysine-forming) activity; F:tRNA guanylyltransferase activity; C:cytoplasm; F:mRNA binding; P:oxidation-reduction process; P:tRNA modification; P:lysine biosynthetic process via aminoadipic acid",IPR007698 (SMART); IPR007886 (SMART); IPR027281 (PIRSF); IPR007886 (PFAM); G3DSA:3.40.50.1770 (GENE3D); PTHR11133 (PANTHER); IPR016040 (SUPERFAMILY); SSF52283 (SUPERFAMILY),,
RL4_JR_07515,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,118.7929076,0,-0.631915439,0.573742788,-1.101391516,0.270726296,0.452300865,84.20393311,0,1.764578149,0.711937834,2.478556505,0.013191521,0.041596443,62.8759565,0,-3.785444572,1.202749946,-3.147324665,0.001647719,0.008497966,166.4191872,0,0.339572251,0.459622423,0.738806972,0.460024217,0.602164861,119.1906416,0,0.42477541,0.554764353,0.765686202,0.443863039,0.576759917,N,-,,nuclear elongation and deformation 1,F:phosphatidate phosphatase activity; C:nucleus; P:fatty acid catabolic process; F:transcription coactivator activity; P:triglyceride biosynthetic process; P:dephosphorylation; P:positive regulation of transcription from RNA polymerase II promoter,IPR031315 (SMART); IPR007651 (PFAM); IPR013209 (PFAM); IPR023214 (G3DSA:3.40.50.GENE3D); PTHR12181:SF12 (PANTHER); PTHR12181 (PANTHER); IPR023214 (SUPERFAMILY),,
RL4_JR_07516,919,806,737,0,0,21,0,0,1,0,0,0,0,5,0,0,0,0,36.49300516,1,-0.990221057,1.047035467,-0.945737836,0.344282319,0.534269576,7.801941848,1,0.501656213,1.247523114,0.402121778,0.687594406,0.801442802,20.33830493,0,-2.15714611,1.21321789,-1.778036846,0.075397804,0.155685777,39.51731456,1,0.102802167,0.79785253,0.128848581,0.897477464,0.936694855,27.85156908,0,-0.589785451,1.014863876,-0.581147349,0.561141149,0.679367947,Y,-,,penicillin-binding,P:proteolysis; F:aminopeptidase activity; P:transport; C:intracellular,IPR021860 (PFAM); IPR012338 (G3DSA:3.40.710.GENE3D); IPR001466 (PFAM); PTHR22935 (PANTHER); PTHR22935:SF68 (PANTHER); IPR012338 (SUPERFAMILY),9.B.306.1.3, The Putative Calcium Binding Protein with Similarity to the C-termini of Anoctamins (1.A.17.5) (CBP) Family
RL4_JR_07517,2002,1914,3733,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,450.0187154,0,0.030566013,0.47386371,0.064503806,0.948569077,0.974462042,225.8732601,0,0.957067664,0.606180621,1.578848995,0.114370697,0.225138117,211.8819593,1,-2.988869568,0.877265129,-3.407031089,0.000656736,0.004122009,310.3679174,1,-1.361284244,0.486474402,-2.798264901,0.005137796,0.02859823,255.0447414,0,-1.797647423,0.609479165,-2.949481339,0.003183078,0.012409959,N,-,,nuclear transport factor 2,C:nuclear envelope; P:protein import into nucleus,IPR032710 (G3DSA:3.10.450.GENE3D); IPR002075 (PFAM); PTHR12612 (PANTHER); IPR018222 (PROSITE_PROFILES); IPR032710 (SUPERFAMILY),,
RL4_JR_07518,998,215,166,9,6,12,0,0,0,1,0,0,0,0,0,0,0,0,204.1625595,1,-0.330417414,0.407409673,-0.811020052,0.417354156,0.608865379,172.802059,0,1.773240891,1.550936776,1.143335382,0.25289937,0.407359552,193.490762,1,-0.313595989,0.487590075,-0.643154988,0.520123537,0.650250765,151.9243627,0,-1.581487548,0.609168265,-2.59614238,0.009427699,0.046328835,136.5638321,0,-1.573511259,0.680191384,-2.313336064,0.020704169,0.056140791,Y,-,,glycoside hydrolase family 47,"P:glycoprotein metabolic process; P:cellular macromolecule catabolic process; C:membrane; P:cellular protein metabolic process; F:hydrolase activity, acting on glycosyl bonds; P:ERAD pathway",IPR001382 (PRINTS); IPR001382 (G3DSA:1.50.10.GENE3D); IPR001382 (PFAM); PTHR11742 (PANTHER); PTHR11742 (PANTHER); PTHR11742:SF25 (PANTHER); PTHR11742 (PANTHER); PTHR11742:SF25 (PANTHER); IPR001382 (SUPERFAMILY),,
RL4_JR_07519,36582,33263,33982,4,4,37,1,0,4,14,5,7,4,37,5,0,21,6,9.270234329,1,2.514342695,1.150106087,2.186183278,0.028802199,0.087740232,0.404478677,1,4.771461261,1.607045541,2.969089015,0.002986841,0.015566036,1.04533911,1,2.125170292,1.234665779,1.721251474,0.085205201,0.170883014,1.205624748,1,1.703114105,1.266154411,1.345107745,0.178590443,0.303444912,1.026516896,1,2.048150172,1.212597849,1.689059711,0.091207988,0.1780719,N,-,,hypothetical protein SPI_04364,C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_07520,1435,1649,2753,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,458.9605249,0,-1.937683127,0.568132838,-3.410616316,0.000648162,0.004170117,121.6133901,0,-3.460634384,1.210026961,-2.859964692,0.004236882,0.018533154,359.294612,0,-2.943641675,0.693478058,-4.244750994,2.19E-05,0.000362571,384.3022076,1,-4.19806866,0.869900712,-4.825917029,1.39E-06,2.49E-05,322.3781879,0,-3.968129175,0.863096349,-4.597550646,4.27E-06,5.01E-05,Y,-,,c6 zinc finger domain-containing,"C:nucleus; F:zinc ion binding; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31845 (PANTHER); PTHR31845:SF12 (PANTHER); IPR001138 (PROSITE_PROFILES); PS51257 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07521,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.458232206,0,-1.344072753,1.235566828,-1.087818742,0.276675134,0.459885033,3.00873349,0,1.876271987,1.316002305,1.425736095,0.153944534,0.282031958,7.837324509,0,-0.781556162,1.228590475,-0.636140503,0.524684849,0.654579101,21.07740168,0,1.066840038,0.915439914,1.165385103,0.243863145,0.382038425,7.772060102,0,-0.872112182,1.239534272,-0.703580532,0.481694039,0.610254272,N,-,,hypothetical protein SPI_04362,,no IPS match,,
RL4_JR_07522,3807,5102,3346,5,18,15,0,0,3,0,3,4,0,2,0,0,0,0,86.81651399,1,3.379106017,0.498797903,6.774499248,1.25E-11,5.14E-10,2.872970849,1,1.943063334,1.307738658,1.485819297,0.137326924,0.257984991,18.48596489,1,0.26037552,1.206459121,0.215817938,0.829129665,0.889771967,179.8340358,1,4.419751983,0.381038719,11.59922015,4.16E-31,7.26E-29,52.16800883,0,2.850736876,0.567046789,5.027339777,4.97E-07,7.98E-06,N,-,,fungal specific transcription factor domain-containing,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR007219 (PFAM); PTHR19444 (PANTHER); PTHR19444:SF29 (PANTHER); PTHR19444:SF29 (PANTHER); PTHR19444 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07523,1636,1506,1922,0,0,0,0,0,1,4,0,1,1,1,1,0,0,0,2261.293506,0,-0.582786871,0.323231177,-1.803003279,0.0713877,0.173534224,474.2676086,1,-2.75673602,0.822787303,-3.350484396,0.000806704,0.015023052,1336.99471,1,-2.487120797,0.918801367,-2.706918913,0.006791084,0.024039488,1625.816006,1,-1.984244647,0.360797677,-5.499604834,3.81E-08,9.42E-07,1264.121335,0,-2.667193717,0.997040589,-2.67511047,0.007470463,0.024872447,N,-,,Thioredoxin reductase,C:nucleus; P:removal of superoxide radicals; F:thioredoxin-disulfide reductase activity; C:cytosol; P:oxidation-reduction process,IPR000103 (PRINTS); PR00368 (PRINTS); IPR005982 (TIGRFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR22912:SF167 (PANTHER); PTHR22912 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_07524,3901,6339,4720,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,97.27642062,0,-2.106346713,0.854360282,-2.465408047,0.01368573,0.048775965,63.89033911,0,-0.285634247,1.116246293,-0.255888193,0.798037172,0.87792752,121.4240362,0,-0.437705232,0.618832643,-0.707307925,0.479375142,0.61565317,101.5111224,0,-1.239932244,0.679145961,-1.825722768,0.067892032,0.147894085,68.69322295,0,-3.002054781,1.120181851,-2.679970916,0.007362856,0.024571165,N,-,,EF hand domain-containing,F:metal ion binding,IPR000433 (SMART); IPR002048 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR000433 (PFAM); PTHR23055:SF68 (PANTHER); IPR028846 (PANTHER); PTHR23055:SF68 (PANTHER); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR000433 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR011992 (SUPERFAMILY),8.A.66.1.1, the dystrophin (dystrophin) family.
RL4_JR_07525,93484,118072,171563,2,0,35,0,0,2,3,0,2,5,8,1,0,34,0,59.18206241,1,-0.861829963,0.770709556,-1.118229242,0.263469098,0.443234406,14.05161977,1,-0.347161819,1.221279848,-0.284260663,0.776210629,0.864429969,52.11586223,1,-1.173548449,1.043240447,-1.124906968,0.260628459,0.397559517,50.04484452,1,-1.700793893,1.031195983,-1.649341076,0.099077779,0.194524435,43.64963665,1,-1.417829903,0.991871959,-1.429448519,0.152875362,0.262499561,N,-,,aldehyde dehydrogenase,P:metabolic process; F:aminobutyraldehyde dehydrogenase activity; F:4-trimethylammoniobutyraldehyde dehydrogenase activity,IPR016163 (G3DSA:3.40.309.GENE3D); IPR015590 (PFAM); IPR016162 (G3DSA:3.40.605.GENE3D); PTHR11699 (PANTHER); PTHR11699:SF155 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_07526,296,353,1226,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.420396348,0,0.622206275,1.276100245,0.487584167,0.625844413,0.785845578,0.779049515,0,3.82576703,1.47938048,2.586060234,0.009707996,0.032974611,2.011975656,0,1.180250347,1.235428407,0.955336902,0.339407352,0.482810177,2.320239783,0,0.758424123,1.248922483,0.607262767,0.543676544,0.674039965,1.976311425,0,1.103064457,1.225382595,0.900179635,0.368024662,0.504497527,N,-,,duf1772 domain containing,P:biological_process; F:molecular_function,IPR001214 (SMART); G3DSA:2.170.270.10 (GENE3D); IPR001214 (PFAM); PTHR12197 (PANTHER); IPR001214 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY),,
RL4_JR_07527,2664,3102,3035,0,0,4,0,0,0,1,0,0,1,8,0,0,2,0,15.70336961,1,-2.075296721,1.198366724,-1.731770983,0.083314346,0.193861505,4.98781894,0,1.147076267,1.243024891,0.922810375,0.356106033,0.520355892,35.11576788,1,0.323108386,1.034205475,0.312421849,0.754719948,0.835227322,33.59649206,1,-0.185238944,1.01857169,-0.181861469,0.855691443,0.910070994,16.68487691,1,-0.665184742,1.133923052,-0.586622471,0.557457288,0.676525834,N,-,,general substrate transporter,P:transmembrane transport; C:membrane; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); PTHR23507:SF1 (PANTHER); PTHR23507:SF1 (PANTHER); PTHR23507 (PANTHER); PTHR23507 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.2.91, the major facilitator superfamily (mfs).
RL4_JR_07528,591,664,647,0,1,1,0,0,1,0,0,0,0,2,0,0,0,0,263.3405108,1,-1.0648509,0.635830093,-1.674741273,0.093985006,0.211569999,53.18729089,1,-2.267508547,1.18957091,-1.90615669,0.056629879,0.130274464,138.2374089,0,-4.922027151,1.190391642,-4.134796463,3.55E-05,0.000544962,275.2545909,1,-0.669416751,0.424244877,-1.577901793,0.114588173,0.216822927,148.1371854,0,-2.808666096,0.856166018,-3.280515738,0.001036175,0.004918551,N,-,,GTP cyclohydrolase 1,C:cytoplasm; F:GTP cyclohydrolase I activity; P:tetrahydrofolate biosynthetic process,IPR020602 (PFAM); G3DSA:1.10.286.10 (GENE3D); G3DSA:3.30.1130.10 (GENE3D); IPR001474 (TIGRFAM); IPR001474 (PANTHER); IPR001474 (HAMAP); SSF55620 (SUPERFAMILY),,
RL4_JR_07529,1868,1691,2466,0,0,2,0,0,0,0,0,1,0,1,0,0,4,0,28.0567505,1,-1.758453306,1.214759899,-1.447572732,0.147736582,0.293546989,7.688655248,0,0.522808294,1.295621286,0.403519377,0.686566183,0.800901568,67.01989671,1,1.264235616,1.395156156,0.906160655,0.364850825,0.508981586,79.05154199,1,1.437691409,0.63549443,2.262319449,0.023677674,0.083097555,31.21938039,1,-0.051295797,0.940259149,-0.054554956,0.956493025,0.971265859,N,-,,amidase,"F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (G3DSA:3.90.1300.GENE3D); IPR023631 (PFAM); PTHR11895:SF79 (PANTHER); IPR000120 (PANTHER); IPR023631 (SUPERFAMILY),,
RL4_JR_07530,2764,2430,3031,0,1,9,0,0,0,1,0,1,0,1,0,0,2,2,31.86941889,1,-0.989756552,1.05157096,-0.941217083,0.346593624,0.536122636,7.831920321,0,0.496179539,1.270240528,0.390618571,0.696079197,0.807389704,20.17202106,1,-2.14530273,1.219238033,-1.759543807,0.078485186,0.160392416,23.25864079,1,-2.56688656,1.220678392,-2.102836076,0.035480101,0.099871011,19.75916332,1,-2.218290142,1.219637401,-1.818811182,0.068940242,0.14330116,N,-,,methyltransferase type 11,C:nucleus; C:cytosol; F:methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR025714 (PFAM); PTHR10108 (PANTHER); PTHR10108:SF911 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_07531,452,225,229,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21.30091563,1,0.886805826,0.878241485,1.009751692,0.31261427,0.500580543,3.163677267,0,1.804000787,1.297062677,1.390835477,0.164275322,0.296821637,8.162072902,0,-0.839787523,1.209003808,-0.694611148,0.487299024,0.622277411,29.47099905,0,1.747892149,0.70696023,2.472405201,0.01342073,0.061159719,7.993376762,0,-0.912603347,1.20413484,-0.757891324,0.448516045,0.580496607,N,-,,signal transducer,F:DNA binding; P:biological_process; F:molecular_function,IPR001357 (G3DSA:3.40.50.GENE3D); PTHR14625:SF3 (PANTHER); IPR022047 (PANTHER); IPR001357 (PROSITE_PROFILES); IPR001357 (SUPERFAMILY),,
RL4_JR_07532,4637,3730,3514,3,4,4,0,0,5,0,0,0,5,4,0,0,4,4,63.25570536,1,0.976776969,0.606108684,1.611554157,0.107058993,0.232792375,7.859871168,1,0.491065327,1.265160482,0.388144693,0.697908959,0.808347822,115.4588748,0,2.351562984,0.510623426,4.605278298,4.12E-06,8.89E-05,192.5170925,1,2.861306269,0.407251524,7.025894557,2.13E-12,9.62E-11,80.46384132,1,2.041461532,0.510740195,3.997064561,6.41E-05,0.000479221,Y,-,,lysophospholipase,F:lysophospholipase activity; P:phospholipid catabolic process,IPR002642 (SMART); IPR002642 (PFAM); G3DSA:3.40.1090.10 (GENE3D); PTHR10728:SF33 (PANTHER); PTHR10728 (PANTHER); IPR002642 (PROSITE_PROFILES); IPR016035 (SUPERFAMILY),,
RL4_JR_07533,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49.28443097,0,4.79196745,0.627512213,7.636452881,2.23E-14,1.36E-12,0.506661112,0,4.44641339,1.556625849,2.856443245,0.004284166,0.018621961,1.317740913,0,1.791064759,1.242377062,1.441643454,0.149402983,0.261371315,1.520506476,0,1.368381393,1.269316627,1.078045749,0.28101334,0.424475618,1.300962357,0,1.707083371,1.231976762,1.385645755,0.1658551,0.279368305,N,-,,Tyrosine- phosphatase non-receptor type 6,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_07534,6974,5086,5950,0,5,19,0,0,0,2,1,2,0,4,3,0,0,1,76.86906612,1,-0.828723155,0.756272026,-1.095800356,0.273166153,0.455363772,14.34656539,0,-0.377076109,1.216629394,-0.309935064,0.756610337,0.85207052,43.60899347,1,-2.062912875,1.194677427,-1.726753036,0.084212026,0.169259987,42.80537378,1,-3.446851684,1.194750904,-2.884996089,0.003914185,0.023054756,36.43945238,1,-3.101198397,1.192656284,-2.600244879,0.009315726,0.029679586,N,-,,phospholipase carboxylesterase,C:membrane; C:integral component of membrane,PTHR38695:SF1 (PANTHER); PTHR38695 (PANTHER),,
RL4_JR_07535,1589,1443,1211,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,16.741294,0,4.013383756,0.818857907,4.901196802,9.53E-07,1.45E-05,0.469599058,0,4.55592992,1.60507813,2.838447447,0.004533358,0.019345132,1.21829611,0,1.903618684,1.265101272,1.504716441,0.132396994,0.238843045,5.416883719,1,2.425326465,1.192718956,2.03344338,0.042007748,0.111196981,12.78485148,0,3.991393188,0.912174809,4.3756889,1.21E-05,0.000118061,N,-,,eukaryotic aspartyl protease,F:aspartic-type endopeptidase activity; P:proteolysis,IPR001461 (PRINTS); IPR021109 (G3DSA:2.40.70.GENE3D); IPR021109 (G3DSA:2.40.70.GENE3D); IPR033121 (PFAM); PTHR13683:SF328 (PANTHER); IPR001461 (PANTHER); IPR033121 (PROSITE_PROFILES); IPR021109 (SUPERFAMILY),8.A.32.1.4,The β-Amyloid Cleaving Enzyme (BACE1) Family
RL4_JR_07536,432,445,562,0,0,3,0,0,0,5,0,0,0,1,0,0,0,0,91.20696437,1,-0.57492371,0.672464525,-0.854950244,0.392578693,0.584960179,15.00420687,0,-0.441803309,1.205708361,-0.366426346,0.714046963,0.820978445,68.99302689,1,-0.273195409,0.744935219,-0.366737136,0.713815103,0.806457327,44.95250173,1,-3.517561087,1.191293528,-2.952724081,0.003149834,0.019328525,38.47546196,0,-3.179656994,1.196586269,-2.657273508,0.00787755,0.025912995,N,-,,WSS1 involved in sister chromatid separation and segregation,C:nuclear envelope; F:zinc ion binding; F:metal ion binding; P:protein sumoylation; P:response to UV-C; P:cellular response to DNA damage stimulus; P:response to UV-B,IPR013536 (PFAM); PTHR23153 (PANTHER); IPR013536 (PROSITE_PROFILES); IPR001876 (PROSITE_PROFILES); IPR001876 (SUPERFAMILY),,
RL4_JR_07537,16,18,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,663.4732848,0,-0.138624655,0.729036987,-0.190147629,0.849193448,0.924435568,127.9882907,0,-1.66248829,0.983194919,-1.69090407,0.090855126,0.18794923,404.0071245,0,-1.321654827,0.452711103,-2.919422158,0.00350681,0.015224246,426.2261039,0,-1.745489693,0.427561517,-4.082429363,4.46E-05,0.000531501,338.0091962,0,-1.897861611,0.525962231,-3.608361016,0.000308138,0.00178688,N,-,,histidine biosynthesis trifunctional,C:nucleus; F:ATP binding; F:phosphoribosyl-ATP diphosphatase activity; F:zinc ion binding; F:phosphoribosyl-AMP cyclohydrolase activity; F:NAD binding; C:cytosol; P:oxidation-reduction process; P:histidine biosynthetic process; F:histidinol dehydrogenase activity,IPR012131 (PRINTS); IPR012131 (TIGRFAM); IPR002496 (PFAM); IPR021130 (PFAM); IPR016298 (PIRSF); G3DSA:3.40.50.1980 (GENE3D); IPR012131 (PFAM); IPR008179 (TIGRFAM); PTHR21256:SF2 (PANTHER); PTHR21256:SF2 (PANTHER); PTHR21256 (PANTHER); PTHR21256 (PANTHER); IPR002496 (PRODOM); IPR012131 (HAMAP); SSF101386 (SUPERFAMILY); SSF141734 (SUPERFAMILY); IPR016161 (SUPERFAMILY),,
RL4_JR_07538,56,77,124,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,30.46086447,1,-0.051112946,0.857310357,-0.05962012,0.952458194,0.976893618,6.056821166,0,0.866918064,1.233293538,0.70292922,0.482099861,0.639053796,15.73692434,0,-1.787202699,1.194592599,-1.496077156,0.13463355,0.241800614,88.96802948,0,1.569528056,0.551444021,2.84621466,0.004424236,0.025466395,27.12822646,0,0.32567166,0.85732988,0.379867385,0.704043859,0.790380759,N,-,,transcription initiation factor TFIID subunit 9B,"F:translation initiation factor activity; F:ubiquitin-protein transferase activity; P:mycelium development; F:protein heterodimerization activity; C:cytosol; P:transcription from RNA polymerase II promoter; P:DNA-templated transcription, initiation; P:chromatin organization; P:translational initiation; C:SAGA complex; P:protein ubiquitination",IPR009072 (G3DSA:1.10.20.GENE3D); IPR003162 (PFAM); PTHR12595 (PANTHER); PTHR12595:SF6 (PANTHER); PTHR12595 (PANTHER),,
RL4_JR_07539,1291,1381,1274,1,3,3,0,0,0,0,0,1,2,0,0,0,0,0,61.88760835,1,1.08822385,0.544714218,1.997788589,0.045739585,0.124464154,7.308063718,0,0.595995533,1.221835561,0.487787024,0.625700703,0.753789874,18.99361488,1,-2.058531374,1.191465247,-1.727730942,0.084036473,0.169041378,37.95993204,1,0.234062637,0.746241887,0.313655184,0.753782942,0.83863867,18.76269542,0,-2.143563626,1.197740616,-1.789672653,0.073506551,0.15038469,N,-,,---NA---,,no IPS match,,
RL4_JR_07540,1147,1212,2052,2,0,0,0,0,0,0,0,1,0,0,0,0,1,0,32.91321265,1,-0.223207846,0.852001314,-0.261980636,0.793336371,0.894051404,6.888546412,0,0.681356708,1.237568182,0.550560945,0.581934688,0.720707563,30.80024531,1,-0.145721284,1.035444136,-0.14073312,0.888080779,0.930352836,103.5210881,0,2.137030795,0.433443099,4.930360639,8.21E-07,1.54E-05,55.37774613,1,1.570563098,0.542773805,2.893586766,0.00380869,0.014357033,N,-,,guanine nucleotide exchange factor synembryn,P:G-protein coupled receptor signaling pathway; F:G-protein alpha-subunit binding; F:guanyl-nucleotide exchange factor activity; F:GTPase activator activity; C:cytosol,IPR019318 (PFAM); PTHR12425 (PANTHER); PTHR12425:SF5 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_07541,103,89,85,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,52.62800551,0,0.630457695,0.682938504,0.923154416,0.35592674,0.546826808,8.363458292,0,0.401474622,1.26485192,0.317408398,0.750933736,0.847847325,21.51497146,0,-2.238229257,1.215940576,-1.840739014,0.065659814,0.139651251,44.86540663,0,0.327472524,0.739522208,0.442816349,0.657898577,0.766715365,24.87496553,0,-1.378474929,1.143142882,-1.20586407,0.227869906,0.3551151,N,-,,telomere length regulator,C:nuclear lumen; C:intracellular non-membrane-bounded organelle,IPR022031 (PFAM); IPR028566 (PANTHER),,
RL4_JR_07542,83,45,77,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,460.925371,0,1.474837837,0.391769609,3.764553973,0.000166847,0.00132368,38.16584708,0,-1.788683756,1.198361671,-1.492607615,0.135539929,0.255243751,202.5137732,0,-0.132356477,0.494099055,-0.267874378,0.788796017,0.860304413,174.2777011,0,-0.696955623,0.486158239,-1.433598295,0.15168693,0.268314146,104.9217744,0,-3.586793604,1.126081776,-3.185198163,0.001446549,0.006469218,N,-,,glucose-6-phosphate 1-epimerase,P:carbohydrate metabolic process; F:carbohydrate binding; C:intracellular part; F:isomerase activity,IPR025532 (PIRSF); IPR008183 (PFAM); IPR014718 (G3DSA:2.70.98.GENE3D); PTHR11122 (PANTHER); PTHR11122:SF13 (PANTHER); IPR011013 (SUPERFAMILY),,
RL4_JR_07543,523,627,581,0,0,1,0,0,0,0,0,0,0,0,0,0,7,0,73.27119523,1,-0.599717922,0.825869391,-0.726165576,0.467737272,0.656199599,12.45467499,0,-0.173152782,1.249448577,-0.13858336,0.889779393,0.938063064,45.49988653,0,-1.023386131,1.074153621,-0.952737216,0.340723232,0.484201805,37.50519468,0,-3.256248343,1.22928068,-2.64890549,0.008075291,0.040840321,32.29424759,1,-2.926995419,1.237934586,-2.364418486,0.018058401,0.050314947,N,-,,phospho-2-dehydro-3-deoxyheptonate aldolase,P:aromatic amino acid family biosynthetic process; F:3-deoxy-7-phosphoheptulonate synthase activity,IPR002480 (PFAM); IPR002480 (PANTHER); PTHR21337:SF0 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_07544,187,143,160,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,87.6626446,0,0.576510924,0.590486788,0.976331623,0.328900154,0.518186067,9.460046716,0,0.223678917,1.216552214,0.183862981,0.854120946,0.913806971,40.24149402,0,-0.604710839,1.031343871,-0.586332896,0.557651829,0.683991654,37.96493952,1,-1.901881042,1.14273756,-1.664320058,0.096048486,0.190199672,24.20636664,0,-2.511060231,1.19448486,-2.102211852,0.035534722,0.085827543,N,-,,hypothetical protein SPSK_01291,,no IPS match,,
RL4_JR_07545,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44.58727709,0,0.251107655,0.679912532,0.369323469,0.711886634,0.844759376,17.48939412,0,1.362546596,1.117486456,1.219295848,0.222731924,0.371232099,73.29011598,0,1.418973246,0.574960759,2.467947983,0.013589006,0.041116289,65.72372053,0,1.237627673,0.523844765,2.362584788,0.01814799,0.073563223,28.53028776,0,-0.625816838,0.980229324,-0.638439212,0.523187812,0.64743053,Y,-,,serine kinase,,PTHR35204:SF1 (PANTHER); PTHR35204 (PANTHER),,
RL4_JR_07546,5839,5778,9262,6,4,6,0,0,0,3,8,21,2,4,0,0,13,1,83.10250907,1,-0.919111026,0.681859328,-1.347948158,0.177675057,0.333826144,18.45868183,0,-0.740725913,1.207667947,-0.613352301,0.539643418,0.686598574,67.38282928,1,-0.992145532,0.860329433,-1.153215842,0.248821803,0.383362035,59.25165757,1,-2.868017727,1.148296277,-2.497628692,0.012502707,0.057882905,62.33209187,1,-1.264840015,0.852581577,-1.48354134,0.137930641,0.243343395,N,-,,duf1776 domain containing,C:cytoplasm; C:integral component of membrane,IPR016040 (G3DSA:3.40.50.GENE3D); IPR013952 (PFAM); IPR016040 (SUPERFAMILY),,
RL4_JR_07547,1995,1543,2688,0,0,0,0,0,0,0,0,2,0,1,0,0,1,0,24.57652924,0,-0.458891198,1.016755237,-0.451329073,0.651752394,0.803171606,14.77143072,0,1.950831518,1.123347554,1.736623284,0.082453687,0.174091827,20.51925271,1,-0.658814867,1.194058905,-0.551744025,0.581123742,0.703000808,40.24551164,1,1.240462768,0.630788379,1.966527619,0.049237695,0.121802535,21.57996608,1,-0.041799109,0.987129647,-0.042344092,0.966224396,0.97810658,N,-,,mrna 3 -end-processing yth-1,F:RNA binding; C:mRNA cleavage and polyadenylation specificity factor complex; F:metal ion binding; C:cytosol; P:mRNA polyadenylation; P:mRNA cleavage,IPR000571 (SMART); IPR000571 (G3DSA:4.10.1000.GENE3D); IPR000571 (PFAM); PTHR23102 (PANTHER); IPR000571 (PROSITE_PROFILES); IPR000571 (PROSITE_PROFILES); IPR000571 (PROSITE_PROFILES); IPR000571 (PROSITE_PROFILES); IPR000571 (PROSITE_PROFILES); IPR000571 (SUPERFAMILY); IPR000571 (SUPERFAMILY),,
RL4_JR_07548,1893,1823,1811,0,0,1,0,0,4,3,2,0,0,3,0,0,12,0,1.369132773,1,1.44462217,1.377465974,1.048753433,0.294291615,NA,0.437015647,1,4.659851621,1.593403928,2.924463495,0.003450505,0.016643092,1.131908898,1,2.01071891,1.241401366,1.619717011,0.10529308,0.201493923,1.305754959,1,1.58825847,1.27286475,1.247782587,0.212110687,0.346174058,1.11251487,1,1.93279633,1.222378014,1.581177269,0.113837511,0.21048298,N,-,,---NA---,,no IPS match,,
RL4_JR_07549,1196,976,1171,0,0,0,0,0,0,0,0,0,1,1,5,0,0,0,13.87912173,0,-1.897103612,1.197629017,-1.584049472,0.113182461,0.242365523,4.411588658,0,1.324200349,1.249166328,1.060067278,0.289113993,0.448560981,11.46931019,0,-1.330735878,1.197055186,-1.111674628,0.266278073,0.404167797,32.5038631,1,-0.007989693,1.017278093,-0.007853991,0.993733486,0.99563127,22.90785428,0,0.781689206,0.859403641,0.909571671,0.363048444,0.499771099,N,-,,methyltransferase domain-containing,F:methyltransferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); PTHR10108:SF923 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_07550,1931,1939,1804,0,0,14,0,0,0,1,0,0,0,0,0,0,0,0,0.256687134,1,3.859589163,2.658011793,1.452058705,0.146485283,NA,0.08204024,0,7.073126547,2.172449893,3.255829545,0.001130616,0.015023052,0.212499391,1,4.423848668,1.333689156,3.317001304,0.000909892,0.005327788,0.245125248,0,4.001324458,1.672672262,2.392174815,0.016748863,0.070191323,0.209038879,0,4.344770911,1.245963212,3.487078004,0.000488329,0.002655387,N,-,,---NA---,,no IPS match,,
RL4_JR_07551,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,128.6084883,0,-0.320921787,0.828203288,-0.387491563,0.69839233,0.837070731,69.7122737,0,0.4807902,0.975807277,0.492710201,0.622217369,0.751292402,91.25590088,0,-1.025653277,0.750828127,-1.366029375,0.171929744,0.290587099,116.7047675,0,-0.402062396,0.536237318,-0.749784439,0.453384542,0.595475222,120.2708143,0,-0.10845869,0.547014966,-0.198273717,0.842830914,0.894326452,N,-,,succinate dehydrogenase (ubiquinone) membrane anchor subunit,C:mitochondrion; C:membrane,PF05328 (PFAM); G3DSA:1.20.1300.10 (GENE3D); PTHR13337:SF2 (PANTHER); IPR007992 (PANTHER); SSF81343 (SUPERFAMILY),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_07552,3,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,163.5188618,0,-1.693156568,0.882588497,-1.918398634,0.055060484,0.142734832,41.69535258,0,-1.916319081,1.245723331,-1.538318368,0.123970791,0.238970166,120.5087067,0,-3.623203847,1.244202072,-2.912070257,0.003590419,0.015446947,155.7128162,0,-1.774383885,0.755847063,-2.347543532,0.018897665,0.07474174,128.4741477,0,-1.866390847,0.856219082,-2.179805245,0.029271901,0.073707535,N,-,,tyrosyl-tRNA synthetase,F:tyrosine-tRNA ligase activity; F:ATP binding; P:tyrosyl-tRNA aminoacylation; F:RNA binding; C:mitochondrion; C:cytosol,IPR002307 (PRINTS); IPR002307 (TIGRFAM); G3DSA:1.10.240.10 (GENE3D); IPR002305 (PFAM); IPR014729 (G3DSA:3.40.50.GENE3D); IPR032005 (PFAM); IPR002942 (G3DSA:3.10.290.GENE3D); PTHR11766:SF0 (PANTHER); IPR024088 (PANTHER); IPR024088 (PANTHER); PTHR11766:SF0 (PANTHER); SSF52374 (SUPERFAMILY),,
RL4_JR_07553,60,67,93,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,100.6412437,0,0.767274642,0.491231019,1.561942575,0.118301518,0.249897405,32.20846659,0,1.355115741,0.993331539,1.364212942,0.172500556,0.308090018,41.4751185,0,-1.977586717,1.195764579,-1.653826138,0.098162843,0.1913421,44.36491397,0,-2.415088917,1.149485422,-2.101017439,0.035639435,0.100263763,50.0291149,0,-0.430297195,0.774791101,-0.555371886,0.578640319,0.691622385,N,-,,nitrogen permease regulator,P:nitrogen compound transport; C:Seh1-associated complex; C:intracellular membrane-bounded organelle; C:cytoplasmic part; P:cellular response to starvation; P:single-organism transport; P:regulation of TOR signaling; P:organic substance transport,IPR009348 (PFAM); PTHR12991:SF10 (PANTHER); IPR009348 (PANTHER),,
RL4_JR_07554,4222,3112,2472,0,4,7,0,0,2,0,1,1,3,5,3,0,12,3,673.6438405,1,-1.047287578,0.511412211,-2.047834517,0.040576217,0.113713768,164.7232112,1,-2.094139017,1.018048592,-2.057012832,0.039684992,0.098405557,487.1238461,1,-1.683601408,0.508751824,-3.309278369,0.000935368,0.005448599,462.4269251,1,-3.781267268,0.72781043,-5.195401323,2.04E-07,4.30E-06,442.3690857,1,-2.118106178,0.56301564,-3.762073426,0.000168511,0.001078489,N,-,,deubiquitination-protection dph1,"F:polyubiquitin binding; C:cytosol; P:negative regulation of protein catabolic process; P:spindle pole body duplication; P:ER-associated ubiquitin-dependent protein catabolic process; F:protein binding, bridging; C:cellular_component; F:molecular_function",IPR015940 (SMART); IPR000626 (SMART); IPR015940 (PFAM); G3DSA:1.10.8.10 (GENE3D); G3DSA:3.10.20.90 (GENE3D); IPR000626 (PFAM); IPR015496 (PANTHER); IPR015496 (PANTHER); PTHR10677:SF3 (PANTHER); PTHR10677:SF3 (PANTHER); IPR000626 (PROSITE_PROFILES); IPR015940 (PROSITE_PROFILES); IPR009060 (SUPERFAMILY); IPR029071 (SUPERFAMILY),8.A.52.1.5, the ubiquitin-related protein degradation (upd) family.
RL4_JR_07555,1268,1073,1378,0,0,2,0,0,0,0,1,0,1,0,0,0,2,1,100.1859893,1,0.524793231,0.456641965,1.149244422,0.250455208,0.427718985,16.01646476,0,-0.535959313,1.199681828,-0.446751214,0.6550547,0.777823852,72.91039971,1,-0.363302794,0.734981959,-0.494301649,0.621093161,0.734573266,185.4948789,1,1.576083492,0.333124355,4.731216638,2.23E-06,3.73E-05,144.4062614,1,1.403848694,0.734195947,1.912089953,0.055864657,0.121902943,N,-,,alcohol dehydrogenase,F:zinc ion binding; F:thioredoxin-disulfide reductase activity; P:cellular oxidant detoxification; P:oxidation-reduction process,IPR020843 (SMART); IPR011032 (G3DSA:3.90.180.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013149 (PFAM); PTHR11695:SF31 (PANTHER); IPR002085 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_07556,1187,1365,2001,0,0,5,0,0,0,1,1,0,6,5,0,0,1,0,87.64741841,1,0.222673671,0.50477574,0.44113386,0.659116092,0.808457753,59.64061548,0,1.219070157,0.973249614,1.252577077,0.210359661,0.356084486,94.30131797,1,0.3916293,1.520553478,0.257557071,0.796748764,0.866317742,83.93954269,1,0.014745646,0.564108806,0.026139719,0.979145896,0.987238817,64.71055399,1,-0.230912788,0.667728725,-0.345818262,0.7294793,0.810119893,N,-,,golgi apparatus membrane TVP18,P:vesicle-mediated transport; C:integral component of Golgi membrane,IPR019365 (SMART); IPR019365 (PFAM); IPR019365 (PANTHER),1.A.55.4.1," the synaptic vesicle-associated ca(2+) channel, flower (flower) family."
RL4_JR_07557,2156,2833,2789,0,0,5,0,0,0,2,0,0,0,0,0,0,0,0,1083.367163,1,-1.480053308,0.350844475,-4.218545296,2.46E-05,0.000250427,338.6801535,0,-2.285363819,0.866342942,-2.637943599,0.008341045,0.029387,678.5945943,1,-4.756957231,0.872138127,-5.454362199,4.91E-08,1.80E-06,954.0596582,0,-2.001236111,0.395333634,-5.062144826,4.15E-07,8.18E-06,818.6393478,0,-2.022435647,0.517796058,-3.905853694,9.39E-05,0.000657903,N,-,,altered inheritance of mitochondria 21,P:biological_process; C:cellular_component; F:molecular_function,IPR021582 (PFAM),,
RL4_JR_07558,896,1265,1451,0,0,1,0,0,0,0,0,0,2,1,0,0,0,0,143.5945987,1,-1.203753355,0.604480917,-1.991383551,0.046438736,0.125886538,43.91291427,0,-0.727522898,1.116654267,-0.651520277,0.514710692,0.665261188,102.9895496,0,-2.485617324,1.044267467,-2.3802497,0.01730091,0.050025121,135.9349906,1,-1.073980798,0.601317705,-1.78604553,0.074091887,0.157153744,89.1659811,0,-4.392202318,1.20951715,-3.631368368,0.000281922,0.001665382,N,-,,Bromodomain containing,,IPR001487 (SMART); IPR001487 (PFAM); IPR001487 (G3DSA:1.20.920.GENE3D); IPR001487 (G3DSA:1.20.920.GENE3D); PTHR16062 (PANTHER); PTHR16062:SF14 (PANTHER); IPR001487 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); IPR001487 (SUPERFAMILY); IPR001487 (SUPERFAMILY),,
RL4_JR_07559,2336,3558,7063,0,1,3,0,0,0,2,0,0,0,0,0,0,3,0,0.730954154,1,2.349760196,1.649292869,1.424707668,0.154241722,NA,0.234046761,0,5.560669318,1.767805914,3.145520261,0.001657917,0.015023052,40.9426907,1,6.308845658,0.628843849,10.03245189,1.10E-23,2.10E-21,47.40471651,0,6.368879629,0.530436622,12.00686258,3.27E-33,6.25E-31,46.922962,1,6.902559078,0.573783436,12.02990301,2.47E-33,1.79E-30,Y,-,,hypersensitive response-inducing,,no IPS match,,
RL4_JR_07560,7094,7218,9242,3,10,0,0,0,0,0,0,2,0,4,3,0,1,1,4.466626757,1,-0.261483602,1.198656537,-0.218147229,0.8273144,0.913168837,1.4288011,0,2.95074385,1.34681765,2.190900788,0.028458973,0.076005731,3.700536222,1,0.301293558,1.200301385,0.251014921,0.801802573,0.86985097,4.268562981,1,-0.120897286,1.198981471,-0.100833323,0.919682774,0.951639048,3.641516492,1,0.221654477,1.196127258,0.185310112,0.852985807,0.902265075,N,-,,NACHT and Ankyrin domain partial,C:integral component of membrane,IPR002110 (PRINTS); IPR002110 (SMART); PF05729 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24123 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR007111 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR020683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_07561,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.532745019,0,-0.570546007,1.235004944,-0.461978723,0.644096578,0.797479603,1.781797774,0,2.632201133,1.368185279,1.923863071,0.054371749,0.126140464,4.601645635,0,-0.013263073,1.229204913,-0.010789961,0.991391024,0.996346293,5.306582809,0,-0.435070723,1.232287199,-0.353059516,0.724043822,0.816152533,4.521508735,0,-0.09076067,1.227996549,-0.073909548,0.941082358,0.962665071,N,-,,subtilisin-like serine protease,P:proteolysis; C:integral component of membrane; F:peptidase activity,PTHR34414 (PANTHER); PTHR34414:SF2 (PANTHER),,
RL4_JR_07562,185,148,208,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,55.04333522,0,-3.884874738,1.19716618,-3.245058876,0.001174263,0.006713133,17.56445754,0,-0.669096167,1.209782065,-0.553071653,0.580214346,0.71930364,45.61520904,0,-3.322497915,1.197029139,-2.775619913,0.005509658,0.020352142,52.62306156,0,-3.74484486,1.197596341,-3.12696752,0.001766194,0.011945703,59.78915934,0,-1.715241798,0.98246638,-1.745852921,0.080836512,0.162427007,N,-,,hypothetical protein FPOA_12898,,IPR003615 (PFAM),,
RL4_JR_07563,9496,10614,15490,4,3,15,0,0,6,2,0,3,0,4,0,0,6,0,12.68974828,1,-1.767807934,1.190195808,-1.485308486,0.137462125,0.278128972,4.044020032,1,1.449732032,1.250209466,1.15959131,0.246215241,0.399325536,10.49629457,1,-1.202805222,1.192226945,-1.008872705,0.313035687,0.455210183,12.10932137,1,-1.625203352,1.189901873,-1.365829729,0.171992413,0.294720704,58.42300173,1,1.838226553,1.577272865,1.165446128,0.243838455,0.373391463,N,-,,carboxypeptidase s,"F:peptidase activity, acting on L-amino acid peptides",G3DSA:3.40.630.10 (GENE3D); IPR011650 (G3DSA:3.30.70.GENE3D); IPR002933 (PFAM); IPR011650 (PFAM); IPR017141 (PIRSF); PTHR11014 (PANTHER); PTHR11014:SF16 (PANTHER); PTHR11014:SF16 (PANTHER); PTHR11014 (PANTHER); IPR011650 (SUPERFAMILY); SSF53187 (SUPERFAMILY),,
RL4_JR_07564,194,251,244,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,34.69280469,0,-3.21897186,1.193882569,-2.696221508,0.007013101,0.028620751,11.06311846,0,-0.002202279,1.21666154,-0.0018101,0.99855575,0.999345591,28.73923258,1,-2.656029592,1.195366093,-2.221938206,0.026287482,0.069215726,45.19007359,0,-0.779836266,0.864182202,-0.902397972,0.366845498,0.513262286,88.38296992,0,1.335685508,0.50162151,2.662735713,0.007750826,0.025604279,N,-,,serine threonine- kinase partial,P:phosphorylation; F:kinase activity,no IPS match,,
RL4_JR_07565,1035,1124,780,0,0,1,0,0,0,0,1,0,2,4,2,0,2,0,33.86729706,1,1.033389871,0.686824215,1.504591494,0.132429134,0.270630481,116.256718,0,4.542062029,1.382136341,3.286261922,0.001015266,0.015023052,67.61572654,1,1.995974783,0.619503867,3.221892372,0.00127347,0.006985447,43.4709266,1,1.450665894,0.627496633,2.311830562,0.020787023,0.078120428,12.0876708,1,-1.509227712,1.204873007,-1.25260314,0.210350171,0.333823744,N,-,,hypothetical protein PFICI_01923,,no IPS match,,
RL4_JR_07566,434,312,491,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.722504412,0,2.366654561,1.673820895,1.413923418,0.157384389,NA,0.229917178,0,5.586329529,1.773527955,3.149840132,0.001633598,0.015023052,0.597126884,0,2.933029525,1.25885649,2.32991572,0.019810606,0.055193656,0.68893028,0,2.510468429,1.339549999,1.87411327,0.060914815,0.137885647,0.58891413,0,2.850717933,1.227569166,2.322246283,0.020219678,0.054974286,N,-,,Amidase signature domain partial,"F:transferase activity; F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (G3DSA:3.90.1300.GENE3D); PTHR11895:SF78 (PANTHER); IPR000120 (PANTHER); IPR023631 (SUPERFAMILY),,
RL4_JR_07567,632,877,462,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.121229332,0,4.941934551,3.692072377,1.338525913,0.180725059,NA,0.038610452,0,8.160640981,2.542083478,3.210217545,0.001326345,0.015023052,0.100070268,0,5.511398149,1.474910078,3.736768925,0.0001864,0.001686429,0.115449405,0,5.087819494,2.209787261,2.302402401,0.02131249,0.079217679,0.098351033,0,5.434653962,1.295076399,4.196396417,2.71E-05,0.000232109,N,-,,hypothetical protein LY89DRAFT_646248,F:methyltransferase activity; F:transferase activity; P:methylation,PTHR34598 (PANTHER); PTHR34598:SF3 (PANTHER),,
RL4_JR_07568,2324,1438,2920,1,0,2,0,0,0,3,0,0,0,1,0,0,0,2,0.012021509,1,8.275938237,3.994557068,2.071803731,0.038283749,NA,0.003842866,0,11.4894157,3.940199092,2.915948011,0.003546096,0.016928889,0.009954621,1,8.839817482,2.38250595,3.710302374,0.000207012,0.001791132,0.011482935,1,8.417149062,3.994556965,2.107154594,0.035104181,0.099498352,0.009795195,1,8.760474239,1.567861258,5.587531547,2.30E-08,8.07E-07,N,-,,tetratricopeptide repeat domain-containing partial,F:nucleic acid binding; F:DNA binding; F:zinc ion binding; F:ADP binding,IPR027417 (G3DSA:3.40.50.GENE3D); IPR002182 (PFAM); IPR027417 (SUPERFAMILY),,
RL4_JR_07569,198,77,144,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.038956302,0,6.57833285,3.934042234,1.672156133,0.094493538,NA,0.012682336,0,9.76611336,3.933565893,2.482763382,0.013036765,0.041249809,0.032670539,0,7.122985254,2.483542477,2.868074664,0.004129781,0.0167079,0.037660212,0,6.702829433,3.933728286,1.703938083,0.088392655,0.178637851,0.032151363,0,7.039022583,1.628694707,4.321879695,1.55E-05,0.000145171,N,-,,Magnesium transport transmembrane region,P:transmembrane transport; F:actin binding; C:membrane; C:integral component of membrane; F:metal ion transmembrane transporter activity; P:metal ion transport,G3DSA:1.20.58.340 (GENE3D); IPR002523 (PFAM); SSF144083 (SUPERFAMILY),,
RL4_JR_07570,699,242,382,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.004235441,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001340044,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003452355,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003983613,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003339785,0,10.24113992,1.835951848,5.578109216,2.43E-08,8.07E-07,N,-,,oxaloacetate hydrolase class,"F:methylisocitrate lyase activity; P:metabolic process; F:2,3-dimethylmalate lyase activity; F:hydrolase activity",PF13714 (PFAM); IPR015813 (G3DSA:3.20.20.GENE3D); PTHR21631:SF12 (PANTHER); PTHR21631 (PANTHER); IPR015813 (SUPERFAMILY),,
RL4_JR_07571,501,571,531,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.023739554,0,7.293271016,3.951438118,1.845725733,0.064932039,NA,0.007849436,0,10.46050377,3.590523679,2.913364373,0.003575571,0.016958421,0.019946832,0,7.837352665,2.157725522,3.632228744,0.000280984,0.002210804,0.022977324,0,7.416384117,3.950883384,1.877145791,0.060498115,0.137403188,0.019289782,0,7.769566241,1.492133271,5.207018966,1.92E-07,3.89E-06,N,-,,aconitase family,F:hydro-lyase activity; P:metabolic process,IPR001030 (PRINTS); IPR015931 (G3DSA:3.30.499.GENE3D); IPR000573 (PFAM); IPR015931 (G3DSA:3.30.499.GENE3D); IPR015932 (G3DSA:3.40.1060.GENE3D); IPR001030 (PFAM); IPR015928 (G3DSA:3.20.19.GENE3D); IPR015937 (PANTHER); PTHR11670:SF34 (PANTHER); PTHR11670:SF34 (PANTHER); IPR015937 (PANTHER); IPR015928 (SUPERFAMILY); IPR001030 (SUPERFAMILY),,
RL4_JR_07572,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.049429704,0,6.237031868,3.928311576,1.58771313,0.112351223,NA,0.015557774,0,9.472442104,3.228345487,2.934147582,0.003344651,0.016402404,0.040464161,0,6.819461298,1.957121387,3.484434509,0.000493178,0.003355467,0.046703946,0,6.39392023,3.35367708,1.906540218,0.056580153,0.132364614,0.039754787,0,6.745956097,1.505835931,4.479874571,7.47E-06,7.89E-05,N,-,,SET domain-containing 5,F:metal ion binding,IPR001214 (SMART); IPR001214 (PFAM); G3DSA:2.170.270.10 (GENE3D); PTHR12197:SF181 (PANTHER); PTHR12197 (PANTHER); IPR001214 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY),,
RL4_JR_07573,109,72,78,0,0,0,0,0,0,0,0,0,0,6,0,0,20,0,0.008470882,0,8.791019641,4.031633903,2.180510397,0.029219649,NA,0.002680088,0,12.01721297,4.032710343,2.979934573,0.0028831,0.015349618,0.006904709,0,9.374372631,4.033343739,2.324218623,0.02011378,0.055743746,0.007967227,1,8.951770626,4.033311655,2.219459191,0.026455501,0.08636862,0.006679571,1,9.335361424,1.822923296,5.121093929,3.04E-07,5.22E-06,N,-,,trihydroxytoluene oxygenase,,no IPS match,,
RL4_JR_07574,33,30,47,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.17535046,0,4.409232911,3.141763571,1.403426073,0.160489823,NA,0.055789239,0,7.629138239,2.348397557,3.248657033,0.001159512,0.015023052,0.145146098,0,4.972326208,1.391678846,3.572897744,0.000353053,0.002629723,0.167465296,0,4.550592486,1.912706643,2.379137702,0.017353192,0.071802644,0.143615349,0,4.885994655,1.27036079,3.846147248,0.00011999,0.000806703,N,-,,hypothetical protein F503_07292,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_07575,916,453,849,6,5,0,1,0,0,0,3,2,0,0,7,0,4,0,58.3375912,1,0.043165079,0.615906917,0.07008377,0.944126984,0.972375702,11.33480094,1,-0.037132461,1.214422227,-0.030576237,0.975607494,0.987312443,29.33869915,1,-2.685694285,1.189326185,-2.258164596,0.0239354,0.064242308,33.84166653,1,-3.107853279,1.187924341,-2.61620473,0.008891323,0.044216426,44.2825248,1,-0.147564786,0.740480415,-0.199282497,0.84204177,0.893676407,N,-,,ankyrin repeat,P:transmembrane transport; C:membrane; P:proteolysis; C:integral component of membrane; F:serine-type endopeptidase activity,IPR031359 (PFAM); PTHR10039 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_07576,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.015979003,0,0.305092311,1.242864886,0.245475043,0.80608863,0.901743694,0.957489563,0,3.528134412,1.410241235,2.501794959,0.012356547,0.039545871,8.990534463,0,1.833389433,1.201334528,1.526127312,0.126978162,0.231709969,12.51047768,0,1.39945162,1.152025994,1.214774343,0.224452169,0.360040908,2.463697791,0,0.785591441,1.216998168,0.645515713,0.518593039,0.643657353,N,-,,thiopurine s-methyltransferase family,F:methyltransferase activity,IPR008854 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10259 (PANTHER); PTHR10259:SF15 (PANTHER); IPR008854 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_07577,62,61,48,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,318.4227864,0,5.587893083,0.277315108,20.14997712,2.69E-90,2.20E-86,318.6660079,0,7.552055211,0.694960725,10.86688058,1.66E-27,1.86E-24,3160.271707,0,9.212810908,0.760090147,12.12068192,8.21E-34,3.08E-31,300.2161753,0,5.688580236,0.401808698,14.15743427,1.68E-45,6.30E-43,233.0089412,0,5.473506113,2.05861959,2.658823485,0.007841403,0.025819255,Y,-,,Pectate lyase B,P:polysaccharide catabolic process; F:lyase activity; C:extracellular region,IPR002022 (SMART); IPR002022 (PFAM); IPR012334 (G3DSA:2.160.20.GENE3D); PTHR31683 (PANTHER); PTHR31683:SF6 (PANTHER); IPR011050 (SUPERFAMILY),,
RL4_JR_07578,30,60,46,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,81.89830675,0,0.554398134,0.581962236,0.952635926,0.340774568,0.530947083,37.73396882,0,2.382295534,0.860949385,2.767056432,0.005656496,0.022298256,181.7484836,0,2.689359044,0.379112617,7.09382627,1.30E-12,1.03E-10,56.64222076,0,-0.53778486,0.849923568,-0.632744967,0.5269002,0.660664337,24.53040354,0,-2.530308277,1.195215844,-2.117030401,0.034257268,0.083418672,N,-,,general substrate transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR003663 (PRINTS); IPR003663 (TIGRFAM); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF21 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.83, the major facilitator superfamily (mfs).
RL4_JR_07579,13191,9306,11608,1,2,4,0,0,0,2,0,0,9,7,0,0,9,7,0.140455941,1,4.72945247,3.474200655,1.361306654,0.173416801,NA,0.04545177,0,7.925566832,2.479104562,3.196947379,0.001388903,0.015023052,0.116761545,1,5.288694077,1.459027174,3.624808483,0.000289176,0.002265955,0.134618176,1,4.866162143,2.103949654,2.312870051,0.020729785,0.078054694,0.113874736,1,5.219164891,1.290144069,4.045412459,5.22E-05,0.000404931,N,-,,allantoate permease,"P:transmembrane transport; C:integral component of membrane; F:phosphotransferase activity, for other substituted phosphate groups; P:phospholipid biosynthetic process",IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF301 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.4, the major facilitator superfamily (mfs).
RL4_JR_07580,11328,13926,9684,0,1,15,0,0,6,4,4,3,9,21,3,0,24,5,0.19081875,1,4.287237879,3.068851607,1.397017004,0.162408458,NA,0.060121989,1,7.520880541,2.340963161,3.212729131,0.001314802,0.015023052,0.157513798,1,4.853613375,1.424181994,3.4080008,0.000654407,0.004110999,0.181809519,1,4.43178989,1.913475739,2.316094111,0.020553131,0.07779456,0.157028909,1,4.757913644,1.306711407,3.641135771,0.000271438,0.001615702,N,-,,integral membrane PTH11,C:membrane; C:integral component of membrane,PTHR33048 (PANTHER),9.B.313.1.4, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_07581,2346,2395,4917,0,2,6,0,0,1,1,0,2,2,9,0,0,5,0,0.00781203,1,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,1,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,1,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,0.007662926,1,9.0007212,4.037607722,2.229221316,0.025799183,0.085851084,0.006329724,1,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,N,-,,15-hydroxyprostaglandin dehydrogenase [NAD+],,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24322:SF644 (PANTHER); IPR002347 (PANTHER); PTHR24322:SF644 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_07582,645,1034,819,0,0,13,0,0,0,1,0,3,11,13,0,0,7,6,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_07583,14468,13102,10300,0,0,9,0,0,0,0,0,4,1,11,1,0,7,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,alpha beta hydrolase,F:catalytic activity,G3DSA:1.20.1440.110 (GENE3D); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR17630:SF54 (PANTHER); PTHR17630 (PANTHER); PTHR17630 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_07584,1133,1044,1350,0,0,1,0,0,0,0,0,5,0,0,0,0,0,0,0.071877513,1,5.695819613,3.921584421,1.452428152,0.146382593,NA,0.02355735,0,8.874230252,2.873442435,3.08836194,0.002012632,0.015023052,0.060083732,1,6.247280626,1.683855068,3.710105902,0.000207173,0.001791132,0.069236274,0,5.825382506,2.759673988,2.110895175,0.034781323,0.099426657,0.058219191,0,6.183716455,1.37275385,4.504606893,6.65E-06,7.15E-05,N,-,,alcohol dehydrogenase -like domain-containing,F:metal ion binding,IPR020843 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); IPR013149 (PFAM); PTHR11695:SF460 (PANTHER); IPR002085 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_07585,5372,9367,14605,0,1,6,0,0,0,0,4,0,0,1,0,0,1,0,1.529165781,1,1.284721799,1.332774116,0.963945641,0.33507318,NA,0.489405187,0,4.496384852,1.560562617,2.881258851,0.003960902,0.018018989,1.268557261,1,1.845431018,1.235289928,1.493925415,0.135195115,0.242612306,1.463264998,1,1.423360288,1.260271361,1.129407786,0.25872585,0.398600004,1.250646701,1,1.763252312,1.222485048,1.442350821,0.14920343,0.257928074,N,HYBRID,,beta-ketoacyl synthase domain-containing,F:catalytic activity,IPR020841 (SMART); IPR020801 (SMART); IPR020806 (SMART); SM00822 (SMART); IPR020807 (SMART); G3DSA:3.40.50.980 (GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR001242 (PFAM); IPR014043 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); G3DSA:3.30.70.250 (GENE3D); IPR020807 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR009081 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.300.30 (GENE3D); IPR013217 (PFAM); IPR010071 (TIGRFAM); IPR000873 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR001227 (G3DSA:3.40.366.GENE3D); G3DSA:2.30.38.10 (GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR013968 (PFAM); IPR014030 (PFAM); IPR032821 (PFAM); IPR014031 (PFAM); IPR013120 (PFAM); PTHR11712 (PANTHER); PTHR11712:SF258 (PANTHER); PTHR11712:SF258 (PANTHER); PTHR11712 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR009081 (PROSITE_PROFILES); IPR016040 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016039 (SUPERFAMILY); SSF56801 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY); IPR029063 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR016036 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016035 (SUPERFAMILY),4.C.1.1.4, the fatty acid transporter (fat) family.
RL4_JR_07586,5431,5626,3929,6,21,17,0,0,4,2,4,5,0,0,0,0,0,0,1.32150429,1,1.49538919,1.352349454,1.105771282,0.268825528,NA,0.422978199,1,4.706869502,1.588704632,2.962708994,0.003049447,0.015692173,1.095681132,1,2.05697922,1.230519506,1.671634793,0.094596359,0.185959911,1.263842575,0,1.634870609,1.258633986,1.29892457,0.193969817,0.323385505,1.078941495,0,1.976359261,1.213411917,1.628762034,0.103363405,0.195764024,N,-,,fusarin C cluster-transporter,C:membrane,PR01036 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501 (PANTHER); PTHR23501:SF83 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_07587,57,79,52,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.249308999,0,4.309941276,1.071184949,4.023526732,5.73E-05,0.000526123,0.193898463,0,5.831873622,1.854134739,3.145334316,0.001658971,0.015023052,0.506251209,0,3.170017666,1.29677965,2.444530701,0.014504074,0.043200718,0.584211095,0,2.747759998,1.415426885,1.941294197,0.052222603,0.125807414,0.50295951,0,3.077814144,1.264348784,2.434307829,0.0149203,0.043385422,N,-,,C6 zinc finger domain,"C:membrane; P:regulation of transcription, DNA-templated; F:binding",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07588,422,653,360,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,58.51871617,0,5.826302921,0.878885921,6.629191324,3.38E-11,1.27E-09,0.399370555,0,4.789884032,1.632565414,2.933961476,0.003346657,0.016404294,1.029277398,0,2.147861654,1.251438862,1.716313693,0.086104644,0.172447757,1.186938754,0,1.725875766,1.290381062,1.3374931,0.181061733,0.30676875,1.007140304,0,2.075744969,1.224641669,1.694981497,0.090078931,0.176480104,Y,-,,beta-glucosidase,F:beta-glucosidase activity; P:cellulose catabolic process; F:scopolin beta-glucosidase activity,IPR001764 (PRINTS); IPR026891 (SMART); IPR002772 (PFAM); IPR001764 (PFAM); IPR002772 (G3DSA:3.40.50.GENE3D); IPR001764 (G3DSA:3.20.20.GENE3D); IPR026891 (PFAM); IPR026892 (PANTHER); IPR026892 (PANTHER); PTHR30620:SF32 (PANTHER); IPR002772 (SUPERFAMILY); IPR017853 (SUPERFAMILY),,
RL4_JR_07589,4,13,9,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0.028252498,0,7.04353146,3.944371419,1.785717092,0.074145077,NA,0.008857553,0,10.28360247,3.420675565,3.006307459,0.002644415,0.015349618,0.023202388,1,7.618643572,1.993864006,3.821044739,0.000132888,0.001376714,0.026785879,0,7.19512172,3.944640674,1.824024623,0.06814835,0.148228151,0.02305586,0,7.533048591,1.433860751,5.253682121,1.49E-07,3.15E-06,N,-,,hypothetical protein SBOR_3004,"F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (G3DSA:3.90.1300.GENE3D); IPR023631 (SUPERFAMILY),,
RL4_JR_07590,28,35,25,0,0,3,0,0,0,0,0,1,0,2,0,0,0,0,28.5544188,1,0.078452005,0.89990194,0.087178393,0.930529714,0.966547161,5.416176514,0,1.028154506,1.258419551,0.817020448,0.413916743,0.577805167,27.13294136,1,0.181925409,1.056389278,0.172214365,0.863269005,0.913345265,16.31213173,1,-2.055166434,1.213687203,-1.69332463,0.090393692,0.181450463,43.85127264,0,1.233888338,0.723950099,1.704383133,0.088309533,0.173888375,N,-,,cyclin-dependent kinase regulatory subunit,"P:cell division; F:protein disulfide isomerase activity; F:cyclin-dependent protein serine/threonine kinase regulator activity; P:regulation of protein kinase activity; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; C:endoplasmic reticulum; P:oxidation-reduction process; P:phosphorylation; F:kinase activity; P:cell cycle",IPR000789 (PRINTS); IPR000789 (SMART); IPR000789 (PFAM); IPR000789 (G3DSA:3.30.170.GENE3D); PTHR23415 (PANTHER); PTHR23415:SF12 (PANTHER); IPR000789 (SUPERFAMILY),,
RL4_JR_07591,49,53,55,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,122.5063564,0,2.399470851,0.455442114,5.268443067,1.38E-07,2.66E-06,14.82151209,0,1.936665809,1.13691044,1.703446235,0.088484591,0.184032118,51.92698876,0,1.519518186,0.678423754,2.239777391,0.025105378,0.066812255,177.0691791,0,3.324737017,0.353724562,9.39922577,5.50E-21,5.62E-19,110.6118261,0,2.944875814,0.432975699,6.801480585,1.04E-11,8.81E-10,Y,-,,endoplasmic oxidoreductin-1,"P:cell division; F:protein disulfide isomerase activity; F:cyclin-dependent protein serine/threonine kinase regulator activity; P:regulation of protein kinase activity; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; C:endoplasmic reticulum; P:oxidation-reduction process; P:protein folding; F:thiol oxidase activity; P:cell cycle",IPR007266 (PFAM); IPR007266 (PIRSF); PTHR12613:SF0 (PANTHER); IPR007266 (PANTHER); IPR007266 (PANTHER); SSF110019 (SUPERFAMILY),,
RL4_JR_07592,3771,2319,2356,1,4,3,0,0,0,4,7,1,1,12,0,0,5,0,32.93704414,1,1.852019397,0.632152238,2.92970472,0.003392842,0.015861781,31.35400429,0,3.948897218,0.879361888,4.490639485,7.10E-06,0.000485648,43.46037847,1,1.958993856,0.751083871,2.608222505,0.009101377,0.030399981,48.28165016,1,2.232209094,0.590569427,3.779757283,0.000156981,0.001572142,40.23358013,1,0.748646846,0.977211509,0.766105228,0.443613692,0.576731977,N,-,,family UPF0406,P:RNA processing; F:hydrolase activity,IPR027521 (PFAM); IPR027521 (PANTHER),,
RL4_JR_07593,395,357,433,2,0,0,2,0,0,0,0,0,0,0,0,0,0,1,263.1586264,1,-0.447755024,0.666881005,-0.671416671,0.501955128,0.68857406,56.84086331,1,-1.191773178,1.192757569,-0.999174693,0.317710073,0.479406881,530.7785284,0,1.75268442,0.546092967,3.209498248,0.001329669,0.007202549,732.5913302,0,2.080014802,0.48687355,4.2721869,1.94E-05,0.000253866,420.3075548,1,1.422259369,0.810857825,1.754018184,0.079427391,0.160519429,N,-,,calcium-dependent kinase,F:ATP binding; C:membrane; C:integral component of membrane; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); IPR013226 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR11042:SF38 (PANTHER); PTHR11042 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_07594,620,812,777,0,3,3,0,0,0,0,0,0,0,0,0,0,0,1,24.61779063,1,2.392300535,0.778380427,3.07343357,0.002116108,0.010967731,1.748789724,0,2.659016434,1.368926961,1.942409281,0.052087573,0.121706004,4.569467906,0,-0.003321219,1.239510939,-0.002679459,0.997862104,0.999239715,18.59715357,0,1.310081378,1.05922102,1.236834762,0.216148434,0.350835284,4.544743668,1,-0.097981135,1.251066439,-0.078318091,0.937575027,0.959665644,N,-,,hypothetical protein F503_03123,,PR01217 (PRINTS),,
RL4_JR_07595,6,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,75.28420367,0,-0.287912563,0.778038126,-0.370049427,0.711345663,0.844759376,12.42402569,0,-0.169609966,1.246081222,-0.136114695,0.891730611,0.939240088,62.56365102,0,-0.017063646,0.79856487,-0.021367889,0.982952188,0.991515811,37.55416032,0,-3.258123658,1.229672361,-2.649586801,0.008059027,0.040819232,43.99491961,0,-0.767582498,0.925765075,-0.829133134,0.407029076,0.543492219,N,-,,hypothetical protein CMQ_1668,C:membrane; C:integral component of membrane,no IPS match,1.G.20.2.1, the hantavirus gc envelope fusion glycoprotein (gc-efg) family.
RL4_JR_07596,9,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.043093338,0,-0.697537619,1.196544698,-0.582959935,0.559920272,0.737103369,1.92586027,0,2.520009031,1.308442609,1.92596069,0.054109282,0.125634524,20.68544169,0,1.691363648,1.030127866,1.641896802,0.100611393,0.194796278,5.767827679,0,-0.555236639,1.195430097,-0.464466003,0.642313911,0.754808304,4.930862456,0,-0.215533,1.199052159,-0.179752814,0.857346629,0.905175664,N,-,,4-coumarate- ligase,P:metabolic process; F:ligase activity,G3DSA:3.40.50.980 (GENE3D); G3DSA:3.30.300.30 (GENE3D); G3DSA:3.40.50.980 (GENE3D); G3DSA:2.30.38.10 (GENE3D); IPR025110 (PFAM); IPR000873 (PFAM); PTHR24096:SF194 (PANTHER); PTHR24096 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.7, the fatty acid transporter (fat) family.
RL4_JR_07597,33531,30766,21561,3,13,2,0,0,0,5,1,30,10,19,8,0,34,1,2.646336877,1,0.493603785,1.231802439,0.400716681,0.688628728,0.830794612,0.848352221,0,3.702826416,1.434488149,2.581287561,0.009843255,0.033200076,2.194685734,1,1.054991276,1.212756035,0.869912204,0.384348385,0.528113878,21.15587772,1,2.375851272,1.014901622,2.340967066,0.019233864,0.075464879,21.46037612,1,3.903127921,0.681485415,5.727382914,1.02E-08,4.87E-07,N,-,,rhamnolipids biosynthesis 3-oxoacyl-[acyl-carrier- ] reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); SM00822 (SMART); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); PTHR24322:SF513 (PANTHER); PTHR24322:SF513 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_07598,15,64,12,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0.174891226,0,4.412975675,3.196773744,1.380446672,0.167449159,NA,0.054943599,1,7.650706778,2.393628953,3.196279344,0.001392123,0.015023052,0.14422844,0,4.980603361,1.453569599,3.426463629,0.000611496,0.003918216,0.166495121,0,4.55870211,1.989378033,2.291521287,0.021933282,0.080296448,0.144068852,0,4.882434089,1.323982611,3.687687472,0.000226301,0.001382801,N,-,,acyl- dehydrogenase family member 10,F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; P:oxidation-reduction process,IPR013786 (PFAM); G3DSA:2.40.110.10 (GENE3D); G3DSA:1.20.140.10 (GENE3D); IPR006091 (PFAM); IPR013786 (G3DSA:1.10.540.GENE3D); IPR009075 (PFAM); PTHR10909:SF281 (PANTHER); PTHR10909 (PANTHER); IPR009075 (SUPERFAMILY); IPR009100 (SUPERFAMILY),,
RL4_JR_07599,66,78,60,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,sirQ,P:biological_process; C:cellular_component; F:molecular_function,IPR016040 (G3DSA:3.40.50.GENE3D); PTHR32487 (PANTHER); PTHR32487:SF8 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_07600,243,264,221,4,0,3,0,0,0,0,0,0,0,1,0,0,1,0,1.821608983,1,1.032265346,1.353273585,0.762791321,0.445587858,NA,0.588952003,0,4.229371155,1.565322172,2.701917364,0.006894089,0.025645709,1.516884819,0,1.587810686,1.261241455,1.258926814,0.208056768,0.335236995,1.748969195,1,1.166239006,1.289177023,0.904638374,0.365656999,0.511859133,1.486092993,1,1.514232372,1.24495925,1.216290712,0.223874198,0.350579711,N,-,,4-hydroxyacetophenone monooxygenase,"F:NADP binding; F:flavin adenine dinucleotide binding; P:oxidation-reduction process; F:N,N-dimethylaniline monooxygenase activity",IPR023753 (G3DSA:3.50.50.GENE3D); IPR020946 (PFAM); PTHR23023 (PANTHER); PTHR23023:SF140 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_07601,397,218,284,0,0,13,0,0,0,0,0,3,0,5,2,0,6,0,16.66927651,1,-2.161540073,1.271283301,-1.700281967,0.089077901,0.203385814,5.363766343,0,1.042249638,1.337136439,0.779463941,0.435706471,0.597339304,13.88024654,1,-1.60603626,1.258797384,-1.275849696,0.202008656,0.327483689,16.00740616,1,-2.027908208,1.265192064,-1.602846133,0.108968629,0.209249078,13.68480747,1,-1.688333179,1.270262757,-1.329121215,0.183807982,0.30241401,N,-,,nitrogen assimilation transcription factor nit-4,F:binding,IPR001138 (SMART); IPR007219 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); PTHR31313:SF34 (PANTHER); PTHR31313 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07602,4,8,5,0,0,0,0,0,0,0,1,2,1,0,0,0,10,0,8.144769258,0,5.74120508,1.230342966,4.66634527,3.07E-06,4.08E-05,0.042411403,0,8.024073065,2.521119243,3.182742383,0.001458874,0.015023052,0.11123064,1,5.354859808,1.50170318,3.565857673,0.000362668,0.002678084,0.128389913,1,4.933534114,2.17725464,2.265942634,0.023454896,0.082861417,0.111092111,1,5.256810948,1.335556748,3.936044616,8.28E-05,0.000591891,N,-, Effector probability:0.884,---NA---,,no IPS match,,
RL4_JR_07603,1,0,0,0,0,3,0,0,0,0,0,2,0,0,0,0,0,0,155.0239373,1,0.168516184,0.430246534,0.391673542,0.695299442,0.835383335,33.87280685,0,-0.231983531,1.118256698,-0.207451054,0.835657614,0.901377491,80.9009457,1,-1.970894589,1.031349279,-1.910986539,0.056006311,0.123235794,144.4682901,0,0.355883595,0.445947942,0.798038427,0.424848191,0.567566689,89.21934482,0,-0.46319702,0.577620019,-0.801906105,0.422607274,0.558238571,N,-,,cleavage and polyadenylation specificity factor subunit,C:mRNA cleavage and polyadenylation specificity factor complex; C:mitochondrion; C:cytosol; F:mRNA binding; P:termination of RNA polymerase II transcription; P:mRNA polyadenylation; P:mRNA cleavage,PF10433 (PFAM); IPR004871 (PFAM); PTHR10644 (PANTHER); PTHR10644:SF2 (PANTHER),,
RL4_JR_07604,297,274,214,2,0,0,0,0,0,0,1,0,0,0,2,0,6,0,30.42070631,1,-0.201941925,1.017637011,-0.198442002,0.842699258,0.920863894,13.95467677,0,2.187532121,1.127329647,1.940454708,0.052324453,0.122034129,66.53118127,1,2.242755204,0.584305243,3.838328051,0.000123875,0.001321506,21.75069958,1,-0.083092128,1.023146688,-0.081212332,0.935273093,0.962317601,41.56579932,1,1.486844616,0.687077246,2.16401376,0.030463293,0.076026829,N,-,,lysosomal cobalamin transporter,F:cobalamin binding; C:integral component of membrane; P:transport; C:lysosomal membrane,IPR006876 (PFAM); PTHR16130 (PANTHER); PTHR16130:SF2 (PANTHER),9.A.54.1.3, the lysosomal cobalamin (b12) transporter (l-b12t) family.
RL4_JR_07605,5,33,30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.78556324,0,1.750032458,0.758905139,2.305996322,0.021110838,0.068793062,2.409441763,0,2.196737302,1.299096117,1.690973649,0.090841836,0.18794923,17.34211131,0,0.501539471,1.200974569,0.417610401,0.676231991,0.777528043,15.26002165,0,0.836764071,1.031437429,0.811260138,0.417216296,0.560915594,13.5750805,0,0.389620344,1.140981823,0.341478134,0.732743663,0.812599079,N,-,,zinc fyve domain containing,,SSF57845 (SUPERFAMILY),,
RL4_JR_07606,5,5,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42.55160146,0,-2.43057709,1.148297548,-2.116678811,0.034287116,0.100436013,12.32268373,0,-0.157728792,1.210654547,-0.130283897,0.89634182,0.942408473,32.01212722,0,-2.811551638,1.192817027,-2.357068665,0.01841984,0.052622534,50.58102267,0,-1.499588968,1.017137985,-1.474322059,0.140394899,0.253298705,31.58315549,0,-2.894837226,1.196876431,-2.418660065,0.01557779,0.04477325,Y,-,,conserved glycine-rich,C:membrane,PTHR42091 (PANTHER),,
RL4_JR_07607,2994,3656,5692,1,0,6,0,0,0,0,0,1,0,6,3,0,1,1,11.0266656,1,1.842591787,1.065526535,1.729278179,0.08375932,0.194397876,1.071289796,0,3.36600916,1.418272366,2.373316467,0.017629152,0.052099935,2.799701336,1,0.703355898,1.237814049,0.5682242,0.569882741,0.693985712,3.231109415,1,0.280499044,1.247916421,0.224773903,0.822155169,0.888211811,2.783050039,1,0.6096275,1.245026543,0.489650203,0.624381445,0.729501746,N,-,,g u mismatch-specific uracil dna glycosylase,F:deaminated base DNA N-glycosylase activity,IPR005122 (SMART); SM00987 (SMART); IPR005122 (PFAM); IPR005122 (G3DSA:3.40.470.GENE3D); IPR015637 (PANTHER); IPR005122 (SUPERFAMILY),,
RL4_JR_07608,1126,1482,1508,0,0,18,0,0,0,0,10,31,1,1,0,0,6,3,61.22873641,1,0.969209553,0.613543862,1.579690732,0.114177709,0.243874008,6.957047384,0,0.667030641,1.239391474,0.538192052,0.590444466,0.727685242,44.09321286,1,0.819989768,0.765065367,1.071790469,0.283814155,0.423110509,20.88316692,1,-2.411434173,1.203394262,-2.003860453,0.045085011,0.115278131,48.04902202,1,1.120622334,0.65228722,1.717989101,0.085798603,0.170201971,N,-,,udp-n-acetylglucosamine pyrophosphorylase,C:nucleus; P:carbohydrate metabolic process; F:UDP-N-acetylglucosamine diphosphorylase activity; P:UDP-N-acetylglucosamine biosynthetic process,IPR029044 (G3DSA:3.90.550.GENE3D); IPR002618 (PFAM); IPR002618 (PANTHER); PTHR11952:SF2 (PANTHER); IPR029044 (SUPERFAMILY),,
RL4_JR_07609,373,618,750,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,77.75367872,0,0.261118285,0.67984182,0.384086824,0.700914097,0.838793781,10.07857228,0,0.132245396,1.236965789,0.106911118,0.914859493,0.952500286,52.31652701,0,0.272947891,0.784929318,0.34773563,0.728038736,0.816422703,30.37803575,0,-2.952167262,1.214959102,-2.429849085,0.015105111,0.065631958,26.12089321,0,-2.620893319,1.224271413,-2.14077801,0.032291944,0.079725904,N,-, Effector probability:0.579,integral membrane mpv17 pmp22,C:integral component of membrane; P:ethanol metabolic process; C:mitochondrial inner membrane,IPR007248 (PFAM); IPR007248 (PANTHER),9.B.192.1.2, the mpv17/pmp22 4 tms putative porin (mpv17) family.
RL4_JR_07610,1911,2300,3094,2,4,0,0,0,2,0,0,0,2,2,0,0,2,0,6.057578256,1,-0.701248055,1.267767888,-0.553135998,0.580170289,0.754387825,1.915666897,1,2.527524205,1.372170038,1.841990523,0.065476536,0.145715264,27.14974569,0,1.71408305,1.073287918,1.59703936,0.110256934,0.208526284,5.781654473,1,-0.55889166,1.253548937,-0.4458475,0.655707407,0.765218707,4.988149385,1,-0.232290953,1.260470653,-0.184289061,0.853786695,0.902725445,N,-,,hypothetical protein F503_03052,P:mycelium development; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_07611,535,1009,787,0,0,0,0,0,3,0,0,1,0,0,0,0,0,0,67.91887415,0,3.439807011,0.89354654,3.849611471,0.000118305,0.000984832,2.1707292,1,2.347291543,1.29805997,1.808307472,0.07055866,0.154784685,21.32946235,1,1.516447919,1.0335862,1.467171214,0.142329486,0.252001349,25.45882246,0,1.01280471,1.014338597,0.998487796,0.318042879,0.464080908,13.29782972,0,1.271917411,0.986497726,1.289326247,0.19728469,0.318632555,N,-,,nadph oxidase,F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process,IPR013121 (PFAM); IPR013112 (PFAM); G3DSA:3.40.50.80 (GENE3D); IPR013130 (PFAM); G3DSA:2.40.30.10 (GENE3D); PTHR11972 (PANTHER); PTHR11972:SF39 (PANTHER); PTHR11972:SF39 (PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY); IPR017938 (SUPERFAMILY),5.B.1.1.3, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_07612,5321,5190,4456,6,14,14,0,1,0,3,0,3,1,1,7,0,2,0,0.502112207,1,2.891489532,1.967906665,1.469322495,0.141745338,NA,0.160354881,1,6.106097971,1.904717882,3.205775526,0.00134699,0.015023052,0.416165885,1,3.453140046,1.281842161,2.693888649,0.007062375,0.02473175,0.480084437,1,3.031190314,1.421262467,2.132744925,0.032945656,0.097138839,0.410752915,1,3.369536766,1.236594319,2.724852213,0.006433027,0.022079459,N,-,,---NA---,,no IPS match,,
RL4_JR_07613,4198,4611,5318,0,0,9,0,0,0,0,0,0,1,0,0,0,5,0,179.4637237,1,0.277011044,0.436250421,0.634981723,0.525440336,0.709340106,46.97925651,0,0.28293852,1.001543108,0.282502588,0.777558162,0.865169146,126.2017588,0,-0.195964938,0.56135564,-0.349092312,0.727020008,0.815370617,172.6480302,1,0.113202201,0.439466117,0.257590282,0.79672313,0.868895055,90.78612788,1,-1.149276392,0.683174836,-1.682258086,0.092518805,0.179799021,N,-,,Myosin-1,C:myosin complex; F:ATP binding; F:actin binding; P:mycelium development; C:actin cortical patch; F:motor activity,IPR001609 (PRINTS); IPR001452 (SMART); IPR001609 (SMART); IPR001452 (PFAM); IPR010926 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:2.30.30.40 (GENE3D); IPR001609 (PFAM); PTHR13140 (PANTHER); IPR010926 (PROSITE_PROFILES); IPR001609 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR001452 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_07614,9570,13349,15718,3,1,0,0,0,0,0,0,0,4,2,0,0,4,0,0.649057651,1,2.521267501,1.741920668,1.447406617,0.147783074,NA,0.206841895,0,5.738907202,1.805611767,3.17837273,0.001481042,0.015023052,0.53691269,0,3.086226506,1.259192421,2.450957021,0.014247696,0.042688274,0.619424068,1,2.663817572,1.351130243,1.971547589,0.048661275,0.120850936,0.529443268,1,3.004083704,1.224565522,2.453183313,0.014159816,0.041471836,Y,-,,---NA---,,no IPS match,,
RL4_JR_07615,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,palmitoyltransferase pfa4,F:transferase activity,IPR001594 (PFAM); PTHR22883 (PANTHER); IPR033682 (PTHR22883:PANTHER); IPR001594 (PROSITE_PROFILES); IPR033682 (HAMAP),8.A.114.1.3, the huntington-interacting protein 14 (hip14) family.
RL4_JR_07616,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,81.69884221,0,0.733958782,0.611050134,1.201143311,0.229695615,0.401942691,9.655096691,0,0.194272728,1.245526104,0.155976441,0.876051591,0.928925357,24.96612536,0,-2.452845117,1.209348075,-2.028237501,0.042536014,0.100194185,80.98623065,0,0.51590055,0.674629776,0.764716544,0.444440353,0.586687755,39.92893012,0,0.061545527,0.785749613,0.078327149,0.937567822,0.959665644,N,-,,importin-beta domain-containing,C:nuclear part; P:nucleocytoplasmic transport; P:intracellular protein transport,IPR001494 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR001494 (PFAM); PTHR10997:SF7 (PANTHER); PTHR10997 (PANTHER); PTHR10997:SF7 (PANTHER); PTHR10997 (PANTHER); IPR001494 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_07617,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_07618,291,374,270,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,146.865353,0,0.148026744,0.431375834,0.343150293,0.731485397,0.858256561,24.45561947,0,-1.146560559,1.19638897,-0.958350994,0.337885798,0.500926938,69.91250347,0,-2.835927444,1.18784925,-2.387447265,0.016965837,0.049229616,109.4378582,0,-1.162370669,0.662227919,-1.755242622,0.079217816,0.165207083,62.45296749,0,-3.87846781,1.188426275,-3.263532531,0.001100326,0.005150622,N,-,,adenine phosphoribosyltransferase,P:AMP salvage; F:adenine phosphoribosyltransferase activity; C:cytosol; P:adenine salvage,IPR029057 (G3DSA:3.40.50.GENE3D); IPR000836 (PFAM); PTHR32315 (PANTHER); IPR005764 (HAMAP); IPR029057 (SUPERFAMILY),,
RL4_JR_07619,9280,10027,12942,4,1,15,1,0,0,3,0,3,1,4,2,0,4,1,47.14870873,1,-0.396360465,0.765237321,-0.517957572,0.604487872,0.772101465,10.21751769,1,0.112540311,1.230632029,0.091449197,0.927135672,0.959634629,26.45800703,1,-2.536688863,1.200733606,-2.112615863,0.03463366,0.085749859,44.16384884,1,-1.223865714,1.026837067,-1.191879173,0.233308626,0.370580062,26.05930007,1,-2.617545871,1.20359969,-2.174764495,0.029647769,0.074468782,N,-,,conserved fungal,C:membrane,IPR011989 (G3DSA:1.25.10.GENE3D); PTHR40467:SF1 (PANTHER); PTHR40467 (PANTHER); PTHR40467:SF1 (PANTHER); PTHR40467 (PANTHER); SSF101447 (SUPERFAMILY),,
RL4_JR_07620,8375,10313,11387,0,1,2,1,0,0,0,0,0,0,0,0,0,5,0,94.21670763,1,0.625568531,0.556292231,1.124532208,0.260787315,0.440411017,14.16763237,1,-0.359012666,1.220517059,-0.294148012,0.768644805,0.859883147,51.02945137,0,-1.187243879,1.041634599,-1.139789212,0.254374129,0.390135386,72.00950054,0,-0.142083931,0.642286534,-0.221215802,0.824924406,0.890253636,47.71588392,1,-0.893047177,0.861031025,-1.037183506,0.299650343,0.434789299,N,-,,Peroxisomal biogenesis factor 2,C:membrane,IPR006845 (PFAM),3.A.20.1.1, the peroxisomal protein importer (ppi) family.
RL4_JR_07621,3551,4695,5075,0,12,2,0,0,4,0,0,0,0,3,0,0,0,1,13.03671159,1,-1.806692082,1.203987738,-1.500590102,0.133461613,0.27211001,4.182634709,1,1.401179945,1.27445115,1.099437939,0.27157709,0.429247862,55.08033719,0,1.834498458,1.251665635,1.465645782,0.142744812,0.252692512,16.46814325,1,-0.719518108,1.156027842,-0.622405518,0.533675253,0.666418761,10.5852621,1,-1.317757407,1.201496481,-1.096763434,0.272744818,0.40551267,N,-,,DNA replication licensing factor mcm10,P:cell division; C:nucleus; P:DNA replication,IPR015408 (PFAM); PTHR13454 (PANTHER),,
RL4_JR_07622,1191,1273,1735,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,2.859141061,1,0.382310703,1.233673972,0.30989606,0.756639999,0.872432934,0.913522049,0,3.596065424,1.420364989,2.531789682,0.011348204,0.036970234,2.36603864,0,0.946771225,1.212333238,0.780949656,0.434832105,0.575230659,21.35386734,1,2.268513598,1.015915899,2.232973812,0.025550671,0.085851084,2.326769198,0,0.868057992,1.204137227,0.720896234,0.47097336,0.602133153,N,-,,ribonuclease subunit b,C:nucleus,IPR019024 (PFAM); PTHR13383:SF11 (PANTHER); PTHR13383 (PANTHER),,
RL4_JR_07623,26730,21799,19309,5,5,4,0,0,0,1,2,6,1,8,4,0,2,2,12.61261092,1,-0.29112474,1.141374149,-0.255065125,0.7986728,0.897559449,2.803270733,0,1.978399178,1.273567687,1.553430727,0.120320267,0.234117982,7.276845808,1,-0.674374279,1.193355941,-0.565107405,0.572000712,0.6956914,8.395053932,1,-1.096772889,1.190747837,-0.921079053,0.357009156,0.502952234,18.758826,1,1.446439407,0.846577389,1.708573162,0.087530044,0.172891473,N,-,,DASH complex subunit Duo1,C:membrane; C:intracellular non-membrane-bounded organelle; C:intracellular organelle part,IPR013960 (PFAM); PTHR28216 (PANTHER),,
RL4_JR_07624,579,486,602,0,0,0,0,0,0,0,0,1,0,0,5,0,0,0,2.888699942,0,0.367407246,1.236453349,0.297146064,0.766354997,0.877722899,0.919650626,0,3.586362601,1.415092689,2.534365861,0.011265105,0.036770522,2.388021067,1,0.933242608,1.212580995,0.769633214,0.441517497,0.5813896,2.755112517,1,0.510777103,1.217834154,0.419414336,0.674913349,0.778480024,2.354956829,0,0.850748427,1.208893694,0.703741307,0.481593891,0.610254272,N,-,,---NA---,,no IPS match,,
RL4_JR_07625,2980,2262,2907,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0.220926072,1,4.076054345,2.843426252,1.433500989,0.151714716,NA,0.070347938,0,7.294892542,2.241989562,3.253758477,0.001138891,0.015023052,0.182597938,0,4.642627622,1.356653163,3.422118306,0.000621353,0.003961319,0.210664988,0,4.219892075,1.763790933,2.392512626,0.016733452,0.070155779,0.179953903,1,4.561734772,1.256183688,3.631423346,0.000281862,0.001665382,N,-,,5 3 -nucleotidase,P:pathogenesis,IPR004344 (PFAM); IPR002828 (G3DSA:3.40.1210.GENE3D); IPR002828 (TIGRFAM); IPR002828 (PFAM); IPR027746 (PTHR12241:PANTHER); PTHR12241 (PANTHER); PTHR12241 (PANTHER); IPR027746 (PTHR12241:PANTHER); IPR004344 (PROSITE_PROFILES); IPR002828 (SUPERFAMILY); SSF56059 (SUPERFAMILY),,
RL4_JR_07626,9163,8106,8945,0,5,4,0,0,0,3,0,4,8,5,0,0,1,0,1.824476649,1,1.030382926,1.29410121,0.796215101,0.425907022,NA,0.582017146,0,4.246436416,1.512592685,2.807389231,0.004994485,0.020659657,1.50874277,1,1.59594077,1.224912173,1.302902205,0.192608151,0.316333479,1.740516257,1,1.173525859,1.241472666,0.945269188,0.344521465,0.49137262,1.484786698,1,1.516275746,1.212523568,1.25051239,0.211112432,0.334823523,N,-, Effector probability:0.574,Shikimate kinase,P:phosphorylation; F:kinase activity,no IPS match,,
RL4_JR_07627,171,88,91,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,501.8274419,0,0.787337411,0.323682327,2.432438675,0.014997531,0.052489632,214.986154,0,1.060891753,1.56104169,0.679605009,0.496754597,0.651854656,223.1683432,0,-1.304797323,0.544948114,-2.394351479,0.016649785,0.048395758,468.360761,0,0.750155308,0.477214241,1.57194661,0.115962934,0.218645196,312.2255911,0,0.28542904,0.509453426,0.560265229,0.575298541,0.689663477,N,-,,calcium-translocating p-type atpase,C:integral component of plasma membrane; F:ATP binding; F:metal ion binding; C:fungal-type vacuole membrane; P:calcium ion transmembrane transport; F:calcium-transporting ATPase activity; P:cellular calcium ion homeostasis,PR00119 (PRINTS); IPR004014 (PFAM); IPR001757 (TIGRFAM); IPR008250 (G3DSA:2.70.150.GENE3D); IPR006408 (TIGRFAM); IPR023298 (G3DSA:1.20.1110.GENE3D); IPR023299 (G3DSA:3.40.1110.GENE3D); PF00702 (PFAM); IPR006068 (PFAM); IPR008250 (PFAM); PTHR24093:SF346 (PANTHER); PTHR24093 (PANTHER); PTHR24093:SF346 (PANTHER); PTHR24093 (PANTHER); IPR023299 (SUPERFAMILY); IPR023214 (SUPERFAMILY); SSF81653 (SUPERFAMILY); SSF81665 (SUPERFAMILY),3.A.3.2.27, the p-type atpase (p-atpase) superfamily.
RL4_JR_07628,6324,10576,15715,0,0,4,0,0,0,0,0,0,0,9,0,0,4,0,8.385900028,1,-1.170492265,1.220687895,-0.958879226,0.337619591,0.527542736,2.668180583,0,2.049575258,1.306295197,1.568998541,0.116648279,0.228333762,6.945834552,0,-0.607371173,1.21709134,-0.499034997,0.61775473,0.731564965,8.013933004,1,-1.029893004,1.218002915,-0.845558735,0.397798954,0.542015127,6.880514576,1,-0.696326775,1.225947024,-0.567990917,0.570041135,0.686041423,N,-,,ubiquitin-like autophagy Apg12,P:late nucleophagy; C:pre-autophagosomal structure membrane; F:dipeptidase activity; C:Atg12-Atg5-Atg16 complex; F:enzyme activator activity; P:C-terminal protein lipidation; P:mitophagy; F:metallopeptidase activity; P:autophagosome assembly; C:nucleus; P:piecemeal microautophagy of nucleus; F:metal ion binding; P:positive regulation of catalytic activity; P:proteolysis; C:cytosol; F:protein tag; F:Atg8 ligase activity; P:CVT pathway,G3DSA:3.10.20.90 (GENE3D); IPR007242 (PFAM); IPR007242 (PANTHER); IPR029071 (SUPERFAMILY),9.A.15.2.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_07629,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,126.4130179,0,1.720766295,0.5651968,3.044543588,0.002330337,0.011830047,48.08634323,0,2.630984016,0.791958203,3.322124837,0.000893347,0.015023052,60.03943802,0,0.525618086,0.712120146,0.738103099,0.460451801,0.598256421,68.06653118,0,0.051179382,0.703687599,0.07273026,0.942020768,0.965967215,27.30942088,0,-2.685116059,1.219389976,-2.202015854,0.027664189,0.070643105,N,-,,3-methyl-2-oxobutanoate hydroxymethyltransferase,P:pantothenate biosynthetic process; F:3-methyl-2-oxobutanoate hydroxymethyltransferase activity; C:mitochondrion; F:methyltransferase activity; P:methylation,IPR003700 (TIGRFAM); IPR003700 (PFAM); IPR015813 (G3DSA:3.20.20.GENE3D); PTHR20881:SF0 (PANTHER); IPR003700 (PANTHER); IPR003700 (HAMAP); IPR015813 (SUPERFAMILY),,
RL4_JR_07630,72,45,148,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.01625695,0,7.841892454,3.971935915,1.97432502,0.048344798,NA,0.005182911,0,11.05900183,3.759459354,2.941646868,0.00326472,0.016208996,6.512139979,0,9.386434345,1.417516712,6.621745104,3.55E-11,2.27E-09,0.015466548,0,7.98848385,3.972176633,2.011109925,0.044313847,0.114176173,0.01313498,0,8.343198162,1.511882806,5.518415931,3.42E-08,1.07E-06,Y,-,,glycoside hydrolase family 7,"F:lyase activity; C:extracellular region; F:hydrolase activity, hydrolyzing O-glycosyl compounds; P:cellulose catabolic process; F:cellulose binding",IPR001722 (PRINTS); IPR001722 (PFAM); IPR001722 (G3DSA:2.70.100.GENE3D); PTHR33753:SF2 (PANTHER); PTHR33753 (PANTHER); IPR013320 (SUPERFAMILY),,
RL4_JR_07631,14072,8238,14781,3,4,44,0,0,2,2,1,1,4,9,1,0,3,2,3.985732182,1,-0.097309421,1.214206901,-0.080142371,0.936124024,0.968535166,1.28016782,1,3.10923396,1.376792768,2.258316598,0.023925928,0.066316157,3.308360553,1,0.462874141,1.21122452,0.382153873,0.702347234,0.79804303,50.37689069,1,3.51312841,1.517652773,2.314843338,0.020621507,0.077838716,3.249780062,1,0.385667168,1.204587668,0.320165296,0.748843029,0.825118199,N,-,,Six-bladed beta-,,no IPS match,,
RL4_JR_07632,4257,3243,3256,0,7,0,0,0,0,0,5,3,1,1,1,0,0,0,2.696610479,1,0.466333735,1.238800578,0.376439714,0.706590026,0.841512618,0.859770708,0,3.683440104,1.427600507,2.580161666,0.009875407,0.033264183,2.233253932,1,1.029519717,1.214748684,0.847516635,0.396707219,0.539239268,2.576428944,1,0.607176219,1.221293339,0.497158381,0.619077368,0.736996867,2.205661011,0,0.944974729,1.212583984,0.779306622,0.435799115,0.570528321,N,-,,Ankyrin repeats 3 copy,"F:chitinase activity; P:biological_process; P:carbohydrate metabolic process; F:chitin binding; P:chitin catabolic process; C:membrane; C:integral component of membrane; C:extracellular region; F:hydrolase activity, hydrolyzing O-glycosyl compounds; C:cellular_component; F:molecular_function",IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PF13857 (PFAM); PTHR24198 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),8.A.28.1.1, the ankyrin (ankyrin) family.
RL4_JR_07633,14468,17410,19003,14,11,36,0,0,0,0,2,4,0,13,0,0,1,4,70.24770513,1,0.634925131,0.755622501,0.840267634,0.400758344,0.592602243,6.958799686,0,0.666598577,1.245724602,0.535109105,0.592574414,0.729333441,18.16316522,1,-1.994051618,1.210779106,-1.646916112,0.09957529,0.193344886,24.9718796,1,-1.471094511,1.164838622,-1.262917012,0.206619006,0.338678555,21.89253551,1,-1.158394393,1.153624132,-1.004135022,0.315313537,0.45073409,N,-,,hypothetical protein F503_02810,,no IPS match,,
RL4_JR_07634,13777,13828,19156,0,0,19,0,0,3,1,1,0,0,13,3,0,4,3,227.0413264,1,-1.242933113,0.487495635,-2.549629216,0.010783754,0.04024422,47.76335468,1,-2.112297855,1.195455611,-1.766939596,0.077238345,0.16589913,240.7496534,1,0.048067768,0.406645834,0.118205485,0.905904844,0.9422006,203.5583085,1,-1.006583285,0.466104469,-2.159565834,0.030806296,0.093949923,234.1058582,1,0.166112423,0.368500009,0.450779971,0.652148138,0.752028268,N,-,,ubiquitin-conjugating enzyme,F:ubiquitin-protein transferase activity; F:ATP binding; P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:cytoplasm; P:negative regulation of gluconeogenesis; F:ligase activity; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process,SM00212 (SMART); IPR016135 (G3DSA:3.10.110.GENE3D); IPR000608 (PFAM); PTHR24067 (PANTHER); PTHR24067:SF0 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_07635,595,783,764,5,0,6,0,0,0,1,0,1,3,6,0,0,0,1,43.87499285,1,-3.557713166,1.207473964,-2.946409838,0.003214861,0.015239302,13.99418554,0,-0.341273175,1.224669563,-0.278665516,0.780501529,0.867395309,36.37000022,1,-2.99574064,1.205538116,-2.484982102,0.012955795,0.039615493,58.00485913,1,-0.727165771,0.784485585,-0.926933248,0.353961193,0.500189404,35.96708737,1,-3.082402438,1.212771588,-2.54161828,0.011034061,0.033998741,N,-,,duf455 domain,,IPR007590 (PFAM); IPR007590 (PANTHER); PTHR12111:SF2 (PANTHER); IPR007590 (PANTHER); IPR007590 (PANTHER); PTHR12111:SF2 (PANTHER),2.A.1.82.2, the major facilitator superfamily (mfs).
RL4_JR_07636,427,357,449,0,2,22,0,0,1,0,0,1,6,6,0,0,2,5,24.65868322,1,0.479665683,0.848399891,0.56537688,0.571817447,0.747937587,4.22874684,1,1.385336838,1.255142294,1.103728912,0.26971075,0.426948166,10.93965977,1,-1.262412036,1.193093997,-1.058099395,0.29001013,0.42956292,21.93044013,1,-0.735137009,1.141506075,-0.644006217,0.519571402,0.653985635,10.7492609,1,-1.339956747,1.190118717,-1.125901751,0.260207108,0.391994788,Y,-,,glycosyl hydrolase family 92,F:catalytic activity,IPR014718 (G3DSA:2.70.98.GENE3D); IPR012939 (PFAM); G3DSA:1.20.1050.60 (GENE3D); G3DSA:1.20.1610.10 (GENE3D); G3DSA:3.30.2080.10 (GENE3D); PTHR12143 (PANTHER); PTHR12143:SF22 (PANTHER); PTHR12143 (PANTHER); PTHR12143:SF22 (PANTHER); IPR008928 (SUPERFAMILY),1.C.96.1.3," the haemolytic lectin, cel-iii (cel-iii) family"
RL4_JR_07637,14416,12221,17361,7,4,9,0,0,1,3,4,3,3,15,4,0,13,4,21.92796608,1,0.297180693,1.022784434,0.290560438,0.771387521,0.880495372,3.248183882,1,1.765965729,1.293358315,1.365411045,0.172123894,0.307598527,8.378061294,1,-0.877492401,1.207254876,-0.726849333,0.467318258,0.604254959,18.97409305,1,-0.348365598,1.155199579,-0.301563127,0.76298512,0.84522926,8.205394018,1,-0.950403927,1.202137462,-0.79059505,0.429180336,0.56380954,N,-,,major facilitator superfamily transporter,F:molybdate ion transmembrane transporter activity; C:membrane; C:integral component of membrane; P:molybdate ion transport,IPR008509 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23516 (PANTHER); PTHR23516:SF1 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.40.2, the major facilitator superfamily (mfs).
RL4_JR_07638,1601,1799,1550,2,4,10,0,0,1,0,0,1,0,3,0,0,0,0,4.875763637,1,-0.387927925,1.20690875,-0.321422746,0.747890048,0.86813987,1.566346698,1,2.818188128,1.350812538,2.086291065,0.036952266,0.093204792,10.54401063,1,1.134732082,1.198868073,0.946502879,0.343892155,0.487409236,4.665386268,1,-0.249063376,1.20750479,-0.206262848,0.836585598,0.897764451,18.70002096,0,1.783525138,0.972640583,1.833693934,0.06669944,0.13974379,N,-,,Sir2 family,F:NAD+ binding,IPR003000 (PFAM); IPR029035 (G3DSA:3.40.50.GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); PTHR11085:SF17 (PANTHER); IPR003000 (PANTHER); IPR026590 (PROSITE_PROFILES); IPR029035 (SUPERFAMILY),,
RL4_JR_07639,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1166.131978,0,2.982676452,0.627811871,4.750908016,2.03E-06,2.84E-05,127.6956368,0,1.23936243,0.625753763,1.980591254,0.047637131,0.113534974,535.8571757,0,1.974953687,0.289990962,6.810397385,9.73E-12,6.84E-10,581.4477617,0,1.897301081,0.677550232,2.800236782,0.005106513,0.028478966,453.9916498,0,1.745126288,0.967188998,1.8043281,0.071179887,0.146721571,Y,-,,glycoside hydrolase family 16,"P:carbohydrate metabolic process; C:ascospore wall; C:membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds; P:ascospore wall assembly",IPR000757 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); IPR017168 (PIRSF); PTHR10963:SF27 (PANTHER); PTHR10963 (PANTHER); IPR000757 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),1.C.105.2.5, the bacillus thuringiensis vegetative insecticidal protein-3 (vip3) family.
RL4_JR_07640,66,67,80,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,17.19112703,0,-0.351652759,1.139612048,-0.308572342,0.757646863,0.872595179,2.926990708,0,1.916087158,1.270097169,1.50861462,0.131397296,0.24915763,7.598357981,0,-0.736777221,1.193000816,-0.617583166,0.536850144,0.665654729,8.765936718,0,-1.159176712,1.19037931,-0.973787685,0.330161969,0.476942493,7.495578685,1,-0.819783846,1.196274965,-0.68528045,0.493166966,0.621445617,N,-,,mfs transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF276 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_07641,2092,1916,2258,0,1,4,0,0,0,0,2,2,0,5,1,0,3,0,4.81820421,1,-0.370732283,1.217891313,-0.304405064,0.76081931,0.87398931,1.530105865,0,2.851850041,1.342210456,2.124741339,0.033608202,0.086406457,3.980491891,1,0.195987204,1.209125292,0.16209007,0.871234926,0.918598457,4.592869332,1,-0.22661576,1.209958252,-0.187292214,0.851431527,0.907255758,3.933446681,1,0.110575141,1.212373487,0.091205509,0.927329298,0.95292897,N,-,,kinase-like domain,P:phosphorylation; F:transferase activity; F:kinase activity,G3DSA:3.90.1200.10 (GENE3D); IPR011009 (SUPERFAMILY),,
RL4_JR_07642,783,775,1670,0,0,0,0,0,0,0,0,2,0,4,1,0,0,0,10.65904102,0,-1.516266392,1.304570698,-1.162272304,0.245124873,0.420646018,3.350774463,0,1.720996819,1.375458428,1.251216892,0.210855357,0.356604499,8.758839382,1,-0.941733097,1.273319004,-0.739589289,0.459549243,0.597467129,29.38099977,1,0.442412848,1.112579941,0.397645897,0.690891224,0.791141556,8.682469635,0,-1.031822783,1.288727695,-0.800652292,0.423332969,0.558614142,N,-,,2OG-Fe(II) oxygenase,F:metal ion binding; P:cell communication; P:regulation of amino acid import; P:cellular response to stimulus; C:intracellular part,PR00682 (PRINTS); IPR027443 (G3DSA:2.60.120.GENE3D); IPR026992 (PFAM); IPR005123 (PFAM); PTHR10209:SF131 (PANTHER); PTHR10209 (PANTHER); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_07643,1956,1561,2592,0,0,1,0,0,1,1,0,0,1,0,0,0,0,0,215.9882864,1,-2.65683129,0.676496821,-3.927337438,8.59E-05,0.000748614,253.5320709,1,1.490153869,1.849783171,0.805582996,0.420483333,0.583991809,263.3172675,1,-0.822995997,0.494076608,-1.665725484,0.095768104,0.187825704,280.6929962,1,-0.969205176,1.932995388,-0.501400667,0.616089171,0.734860145,216.5459179,0,-1.250611516,0.499839421,-2.502026576,0.012348465,0.037266233,N,-,,dihydrodipicolinate synthetase,P:metabolic process; F:lyase activity,IPR002220 (PRINTS); IPR002220 (SMART); IPR013785 (G3DSA:3.20.20.GENE3D); IPR002220 (PFAM); PTHR12128:SF26 (PANTHER); IPR002220 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_07644,316,293,287,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4.147358828,0,-0.154742999,1.215678682,-0.127289391,0.898711357,0.950562931,1.331190469,0,3.052825392,1.37262731,2.224074495,0.026143433,0.070906705,3.442867184,1,0.405285983,1.212589784,0.334231731,0.738204701,0.823898622,13.60609594,0,0.933737958,1.152009665,0.810529621,0.417635848,0.561040594,18.116571,0,2.016651833,0.97956373,2.058724482,0.03952064,0.093187349,N,-,,tyrosinase precursor,F:oxidoreductase activity; F:metal ion binding; P:metabolic process; P:oxidation-reduction process,IPR002227 (PRINTS); IPR008922 (G3DSA:1.10.1280.GENE3D); IPR002227 (PFAM); PTHR11474 (PANTHER); PTHR11474 (PANTHER); PTHR11474:SF32 (PANTHER); IPR008922 (SUPERFAMILY),,
RL4_JR_07645,20,11,40,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,127.9822921,0,-0.55763222,0.628743669,-0.886899141,0.375133204,0.566938992,27.00781648,0,-1.289762707,1.23303052,-1.046010368,0.295556246,0.455345558,98.10421182,0,-1.50805074,0.881338449,-1.711091513,0.087064221,0.174094049,123.1101931,0,-0.661409296,0.607302345,-1.089093928,0.276112467,0.418885036,83.30863639,0,-1.413949194,0.793795691,-1.78125078,0.074871491,0.152530216,N,-,,transcriptional activator dal81,"C:nucleus; F:DNA binding; F:zinc ion binding; P:RNA polymerase II transcriptional preinitiation complex assembly; P:positive regulation of gamma-aminobutyric acid catabolic process; P:nitrogen utilization; P:nitrogen catabolite activation of transcription from RNA polymerase II promoter; F:RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly; P:positive regulation of transcription from RNA polymerase II promoter; P:positive regulation of urea catabolic process; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; F:transcription factor activity, RNA polymerase II transcription factor recruiting",IPR001138 (SMART); IPR007219 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); IPR001138 (G3DSA:4.10.240.GENE3D); IPR000757 (PFAM); PTHR31668 (PANTHER); PTHR31668:SF4 (PANTHER); PTHR31668 (PANTHER); PTHR31668:SF4 (PANTHER); IPR000757 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY); IPR013320 (SUPERFAMILY),,
RL4_JR_07646,858,1149,1098,0,2,7,0,0,0,2,2,11,3,13,0,0,6,2,74.48529231,1,1.119835501,0.573953396,1.951091341,0.051046181,0.134986951,54.18713748,0,3.499015275,0.693334279,5.046649761,4.50E-07,4.25E-05,105.7657356,1,2.099884571,0.509103369,4.124672313,3.71E-05,0.000565213,40.54733103,1,-0.732336857,1.023246673,-0.715699231,0.474177086,0.61509544,18.81459442,1,-2.147549121,1.208816279,-1.776571972,0.075638691,0.153845268,N,-,,endo-1 3(4)-beta glucanase,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_07647,1017,938,920,2,0,0,0,0,0,0,0,0,0,2,0,0,3,0,13.23956629,1,-0.393706529,1.193528996,-0.329867586,0.741500016,0.864165305,31.16264981,0,4.006620839,0.937275032,4.27475469,1.91E-05,0.001139308,7.799995785,0,-0.77431495,1.23466876,-0.627143874,0.53056493,0.660287566,22.31926676,1,0.540226385,1.061025741,0.509154834,0.610643699,0.73056451,7.620311067,1,-0.84360496,1.232182591,-0.684642817,0.493569342,0.621874146,N,-,,dna replication atp-dependent helicase dna2,F:helicase activity,IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR014808 (PFAM); PF13087 (PFAM); PF13086 (PFAM); IPR022765 (PFAM); PTHR10887:SF355 (PANTHER); PTHR10887:SF355 (PANTHER); PTHR10887 (PANTHER); PTHR10887 (PANTHER); PTHR10887:SF355 (PANTHER); PTHR10887 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_07648,300,262,295,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,114.4878666,0,-0.710396107,0.536872677,-1.323211512,0.185765049,0.343488501,47.77106577,0,-0.282655537,1.10625998,-0.255505525,0.798332677,0.87792752,88.18977776,0,-2.028013085,1.026652449,-1.975364776,0.048226767,0.110139362,122.4363099,0,-0.954483785,0.606434831,-1.573926392,0.115504468,0.217943111,72.85232914,0,-2.269192403,0.972107447,-2.334302048,0.019579912,0.053801151,N,-,,NADH:ubiquinone oxidoreductase subunit,C:integral component of membrane,IPR019329 (PFAM); PTHR40637 (PANTHER); PTHR40637:SF1 (PANTHER),3.D.1.6.3, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_07649,136,181,226,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,323.4332582,1,1.447151084,0.376611702,3.842554749,0.00012176,0.001006403,72.6311158,0,1.688303299,0.681688432,2.476649478,0.013262208,0.041754298,86.24967932,0,-1.469404252,0.853762894,-1.721091725,0.085234181,0.170907278,94.33933762,0,-1.981759178,0.853564387,-2.321745387,0.020246649,0.077328301,114.5892318,0,-0.16382479,0.527697788,-0.310451916,0.756217319,0.830354664,N,-,,branched-chain amino acid aminotransferase,F:L-leucine transaminase activity; F:L-valine transaminase activity; P:cellular amino acid biosynthetic process; P:branched-chain amino acid biosynthetic process; F:L-isoleucine transaminase activity,IPR001544 (PFAM); G3DSA:3.30.470.10 (GENE3D); G3DSA:3.20.10.10 (GENE3D); IPR005786 (PIRSF); IPR005786 (TIGRFAM); PTHR11825:SF44 (PANTHER); IPR001544 (PANTHER); IPR001544 (SUPERFAMILY),,
RL4_JR_07650,440,228,247,0,0,0,0,0,0,0,1,1,0,0,0,0,1,0,58.073027,0,0.005042671,0.689769458,0.007310661,0.994166988,0.997713653,9.850449715,0,0.165354172,1.239116164,0.133445255,0.893841257,0.940810219,44.92112434,1,-0.081996627,0.871443595,-0.094092867,0.925035386,0.955956798,85.33790057,0,1.123544387,0.53034927,2.118498978,0.034132831,0.098985751,24.94921565,1,-2.554755684,1.202207492,-2.12505387,0.033582118,0.082150023,N,-,,SCY1 kinase,P:phosphorylation; F:kinase activity,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR011989 (G3DSA:1.25.10.GENE3D); IPR000719 (PFAM); PTHR12984 (PANTHER); PTHR12984 (PANTHER); PTHR12984 (PANTHER); PTHR12984:SF6 (PANTHER); PTHR12984:SF6 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_07651,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein SPBR_00315,,no IPS match,,
RL4_JR_07652,97843,72849,88167,9,28,81,0,0,1,10,5,17,16,35,12,1,15,2,195.8105885,1,0.856669405,0.663212877,1.291695977,0.196462451,0.358715461,21.68543706,1,-0.97311365,1.266666257,-0.768247867,0.442339941,0.603581138,88.07271408,1,-0.509301576,0.776629048,-0.655784865,0.511962556,0.643145417,130.6848695,1,0.037392481,0.630229052,0.059331573,0.952688014,0.971988116,54.12882154,1,-3.672126968,1.236081587,-2.970780413,0.002970441,0.011725425,N,-,,NAD-dependent histone deacetylase SIR2,"F:NAD-dependent histone deacetylase activity (H3-K9 specific); C:nuclear rDNA heterochromatin; P:histone H3-K9 modification; F:histone deacetylase activity (H3-K4 specific); P:chromatin silencing at telomere; P:chromatin silencing at centromere outer repeat region; C:mating-type region heterochromatin; C:chromosome, telomeric region; F:DNA binding; P:histone H3-K4 deacetylation; C:chromosome, centromeric outer repeat region; F:protein binding; F:NAD-dependent histone deacetylase activity (H4-K16 specific); P:regulation of histone H3-K9 methylation; P:histone H4-K16 deacetylation; C:nuclear pericentric heterochromatin; P:protein localization to chromosome, telomeric region; P:histone H4-K12 deacetylation; F:histone deacetylase activity (H3-K14 specific); P:chromatin silencing at silent mating-type cassette; C:nuclear subtelomeric heterochromatin; P:histone H3-K9 deacetylation; F:NAD+ binding",IPR003000 (PFAM); IPR029035 (G3DSA:3.40.50.GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); PTHR11085:SF15 (PANTHER); PTHR11085:SF15 (PANTHER); IPR003000 (PANTHER); IPR026590 (PROSITE_PROFILES); IPR029035 (SUPERFAMILY),,
RL4_JR_07653,5100,4341,4278,8,0,4,0,0,1,0,0,3,0,24,3,0,7,3,51.59920637,1,2.147176363,0.512862588,4.186650411,2.83E-05,0.000283727,4.292711975,1,1.36367734,1.25392077,1.087530706,0.276802336,0.435466777,17.60790152,1,-0.32276989,1.191315088,-0.270935786,0.786440421,0.858706085,22.12637162,1,-0.75731042,1.141822245,-0.663247212,0.507172239,0.643256785,10.91816265,1,-1.36241916,1.190829016,-1.144093016,0.252585064,0.383709493,N,-,,g1 s regulator,F:nucleic acid binding; C:intracellular organelle; P:regulation of nuclear division; P:positive regulation of protein kinase activity; P:DNA-dependent DNA replication; P:regulation of cell cycle process,IPR006572 (SMART); IPR006572 (PFAM); IPR013939 (PFAM); PTHR15375:SF22 (PANTHER); PTHR15375 (PANTHER); PTHR15375:SF22 (PANTHER); PTHR15375:SF22 (PANTHER); PTHR15375 (PANTHER); PTHR15375 (PANTHER); IPR006572 (PROSITE_PROFILES); IPR001357 (SUPERFAMILY),,
RL4_JR_07654,1383,1596,1397,2,0,5,3,0,0,0,1,1,0,0,0,0,0,0,51.0030863,1,-0.370820364,0.897035462,-0.413384286,0.679325086,0.824051985,7.867391882,1,0.489551033,1.251081393,0.391302305,0.695573796,0.807240395,20.57280515,1,-2.173755898,1.218350412,-1.784179556,0.074394493,0.154117014,42.36839472,0,-0.830731704,1.048770533,-0.792100538,0.428302056,0.570862408,20.46134837,0,-2.268599492,1.232626513,-1.840459756,0.065700767,0.138414538,N,-,,metallopeptidase family m24,C:nucleus; F:aminopeptidase activity; F:manganese ion binding; P:protein processing; C:extrinsic component of mitochondrial inner membrane; P:protein stabilization,IPR007865 (SMART); IPR029149 (G3DSA:3.40.350.GENE3D); IPR000994 (PFAM); IPR000994 (G3DSA:3.90.230.GENE3D); IPR007865 (PFAM); PTHR10804 (PANTHER); PTHR10804:SF17 (PANTHER); IPR000994 (SUPERFAMILY); IPR028980 (SUPERFAMILY),,
RL4_JR_07655,26,27,47,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,91.77100489,0,-3.537349698,1.172402377,-3.017180592,0.002551378,0.012699291,27.06456919,0,-1.292800831,1.231566203,-1.049720939,0.293846434,0.453125168,82.70002396,0,-2.121137776,1.061768619,-1.997740127,0.045744841,0.105678334,131.0859904,0,-0.370999179,0.575019848,-0.645193693,0.518801673,0.653382439,68.2549747,0,-4.006664677,1.212191245,-3.305307388,0.000948723,0.004576379,N,-,,helix-loop-helix dna-binding domain-containing,F:DNA binding; P:mycelium development; F:protein dimerization activity,IPR011598 (SMART); IPR011598 (PFAM); IPR011598 (G3DSA:4.10.280.GENE3D); PTHR12565:SF142 (PANTHER); PTHR12565:SF142 (PANTHER); PTHR12565 (PANTHER); IPR011598 (PROSITE_PROFILES); IPR011598 (SUPERFAMILY),,
RL4_JR_07656,2673,2652,3252,4,1,6,0,0,0,0,1,1,0,1,0,0,3,0,2.947888502,1,0.337857242,1.335195427,0.253039544,0.800237655,0.898601348,0.959469655,0,3.525316935,1.517401334,2.323259414,0.020165221,0.057857293,2.46030823,1,0.890189187,1.278083335,0.696503242,0.486113728,0.621390831,22.10651063,1,2.258750027,1.086330251,2.079248023,0.03759456,0.103099924,2.399250363,1,0.82333618,1.267257125,0.649699389,0.515886419,0.641689188,N,-,,hypothetical protein CMQ_6163,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_07657,4408,2062,1848,0,0,1,0,0,0,0,2,2,0,0,0,0,0,0,4.803311958,1,-0.366430797,1.216927786,-0.301111374,0.763329568,0.876089282,1.525201192,0,2.856443994,1.341316711,2.129582051,0.033206134,0.085764861,3.970804518,1,0.19934204,1.209311496,0.164839283,0.869070483,0.917080423,4.581745933,0,-0.223273138,1.210207929,-0.184491551,0.853627855,0.908299245,3.929444177,0,0.111977873,1.214386938,0.092209385,0.926531682,0.952205976,N,-,,porphobilinogen deaminase,F:methyltransferase activity; F:transferase activity; P:methylation,PF13649 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR35897 (PANTHER); PTHR35897:SF1 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_07658,2851,2578,3483,0,1,8,0,0,0,0,2,1,0,11,2,0,0,4,17.40290829,1,-0.919182022,1.154133567,-0.796426036,0.42578445,0.616424054,4.33758663,0,1.348674779,1.26263026,1.068147044,0.285454188,0.445065818,11.23396818,1,-1.300685189,1.201292755,-1.082737895,0.278924778,0.418036189,70.12485223,1,1.657306893,0.635485137,2.607939661,0.009108901,0.045099082,11.04244646,1,-1.378704376,1.200958052,-1.148003774,0.250967006,0.381652288,N,-,,"DOPA 4,5-dioxygenase",F:magnesium ion binding; F:dioxygenase activity; P:oxidation-reduction process; F:terpene synthase activity,IPR014980 (PFAM); IPR023389 (G3DSA:3.30.70.GENE3D); PTHR36423 (PANTHER); PTHR36423:SF2 (PANTHER); IPR023389 (SUPERFAMILY),,
RL4_JR_07659,19208,13224,18167,0,4,7,5,0,0,2,1,1,2,0,4,0,12,5,0.486317741,1,2.937762032,2.021224641,1.45345647,0.146097057,NA,0.156582282,1,6.140772749,1.937988076,3.168632886,0.001531577,0.015023052,0.403434911,1,3.499465179,1.301827323,2.688117784,0.007185605,0.025096191,0.465229907,1,3.077153552,1.456515236,2.112682021,0.034627993,0.099426657,0.394541185,1,3.427728273,1.242555161,2.75861256,0.005804731,0.020238603,N,-,,---NA---,,no IPS match,,
RL4_JR_07660,8335,5760,6970,0,7,1,0,0,0,0,2,0,0,3,0,0,1,3,53.2026765,1,0.244927869,0.647896452,0.378035516,0.705404211,0.840591228,9.619736961,0,0.199490882,1.217653616,0.163832209,0.869863235,0.924869293,39.37051596,1,-0.63493853,1.036404533,-0.612635809,0.540117175,0.668314139,46.2148348,1,-0.567935857,0.85969275,-0.660626552,0.508851837,0.644211184,40.18221155,1,0.055017756,0.771628454,0.071300839,0.943158327,0.964009496,N,-,,phosphopantothenoylcysteine decarboxylase,F:catalytic activity,IPR003382 (G3DSA:3.40.50.GENE3D); IPR003382 (PFAM); PTHR14359:SF21 (PANTHER); PTHR14359:SF21 (PANTHER); PTHR14359 (PANTHER); PTHR14359 (PANTHER); PTHR14359:SF21 (PANTHER); PTHR14359 (PANTHER); IPR003382 (SUPERFAMILY); SSF140860 (SUPERFAMILY),,
RL4_JR_07661,1342,968,1435,0,0,2,0,0,0,1,0,0,1,0,0,0,2,2,26.53323638,1,0.258860377,0.902388333,0.286861397,0.77421845,0.882697432,4.795610443,0,1.20383232,1.272459881,0.946067014,0.344114407,0.507388396,34.62996946,1,0.956194958,0.877289897,1.089941832,0.275738768,0.414673097,14.35881538,1,-1.870961087,1.213853811,-1.541339714,0.123234128,0.228860152,12.25224039,1,-1.528688774,1.216955362,-1.256158461,0.209058524,0.332190451,N,-,,transferase hexapeptide domain-containing,P:biological_process; C:dynactin complex; F:transferase activity; C:cellular_component,G3DSA:2.160.10.10 (GENE3D); IPR001451 (PFAM); IPR027777 (PANTHER); IPR011004 (SUPERFAMILY),,
RL4_JR_07662,749,776,826,0,1,0,0,0,0,0,0,0,0,0,2,0,2,3,308.8007839,1,-0.479101951,0.42670118,-1.122804374,0.261520587,0.440984901,61.39854303,0,-2.474618728,1.192806286,-2.074619121,0.038021849,0.095238097,159.2073339,0,-5.125783534,1.191306365,-4.302657726,1.69E-05,0.000295085,245.6172208,1,-1.500053139,0.489669248,-3.063400745,0.002188368,0.01421246,164.3192712,1,-4.272934349,1.125573559,-3.796228433,0.000146914,0.000958444,N,-,,NADH-ubiquinone oxidoreductase 51 kDa subunit,"P:transmembrane transport; F:FMN binding; F:NAD binding; C:integral component of membrane; F:NADH dehydrogenase (ubiquinone) activity; P:oxidation-reduction process; F:4 iron, 4 sulfur cluster binding",IPR019575 (SMART); IPR019575 (PFAM); IPR019554 (PFAM); IPR011537 (TIGRFAM); IPR011538 (PFAM); PTHR11780 (PANTHER); SSF142984 (SUPERFAMILY); SSF140490 (SUPERFAMILY); SSF142019 (SUPERFAMILY),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_07663,5760,6601,8824,2,2,13,1,0,0,6,0,6,3,19,0,0,4,0,5.149649309,1,-0.4667674,1.217860253,-0.383268441,0.701520736,0.838858189,1.634110131,1,2.756956542,1.334928628,2.0652464,0.038899692,0.096909349,63.45906235,1,3.733434428,0.58703325,6.359834692,2.02E-10,1.13E-08,51.15012203,1,3.010736111,0.627228158,4.800065289,1.59E-06,2.76E-05,18.93887339,1,1.707967685,0.987559845,1.729482718,0.083722737,0.167019839,N,-,,ex11b,P:peroxisome fission; C:integral component of peroxisomal membrane; C:membrane; C:integral component of membrane,IPR008733 (PFAM); PTHR12652 (PANTHER); PTHR12652 (PANTHER); PTHR12652 (PANTHER); PTHR12652:SF23 (PANTHER); PTHR12652:SF23 (PANTHER),,
RL4_JR_07664,4745,3664,2962,0,2,5,0,0,0,1,1,1,2,0,0,0,4,0,114.5883269,1,-3.855453387,1.184175899,-3.255811397,0.001130688,0.006514234,33.00018201,0,-1.578919429,1.215525332,-1.29896053,0.193957475,0.336401227,94.10668684,1,-3.279916113,1.213788014,-2.702214947,0.006887922,0.024255068,136.4891329,1,-1.590251125,0.719971342,-2.208770035,0.02719064,0.087676826,112.7607198,1,-1.023954673,0.711125679,-1.43990676,0.14989378,0.258723922,N,-,,mms4,C:nuclear lumen,IPR007718 (PFAM); PTHR23216 (PANTHER),,
RL4_JR_07665,19529,6245,7625,5,33,4,0,0,5,0,0,4,0,0,0,0,0,0,24.99301725,1,0.44157788,0.851912271,0.518337269,0.604222974,0.772004859,4.312585619,1,1.356960838,1.245804671,1.089224394,0.276054944,0.434457831,11.19714656,1,-1.296081818,1.191880995,-1.087425526,0.276848795,0.415909574,20.9412615,0,0.008989591,1.013180974,0.008872641,0.992920749,0.995249435,14.90472955,0,-0.448871498,1.124705144,-0.39910149,0.689818425,0.779945455,N,-,,cecr1 family adenosine deaminase,C:extracellular space; F:deaminase activity,G3DSA:3.20.20.140 (GENE3D); IPR013659 (PFAM); IPR001365 (PFAM); PTHR11409 (PANTHER); PTHR11409:SF37 (PANTHER); IPR032466 (SUPERFAMILY),,
RL4_JR_07666,7315,3025,5077,0,0,0,0,0,0,0,0,0,1,0,0,0,5,1,1589.144803,0,-1.074006341,0.289875907,-3.705055565,0.000211344,0.00161437,519.3786113,0,-0.933330437,1.696844697,-0.550038809,0.582292755,0.721058251,1085.74273,0,-2.172820464,0.369658457,-5.877913588,4.15E-09,1.92E-07,1514.025934,1,-0.969031567,0.408251062,-2.37361677,0.017614822,0.072301852,1024.581749,1,-2.240893252,0.574246853,-3.902316992,9.53E-05,0.000666671,N,-,,cross-pathway control 1,"P:negative regulation of transcription from RNA polymerase II promoter; F:transcription factor activity, sequence-specific DNA binding; F:transcription factor activity, RNA polymerase II transcription factor binding; P:cellular response to nutrient levels; P:positive regulation of transcription initiation from RNA polymerase II promoter; F:sequence-specific DNA binding",IPR004827 (PFAM); G3DSA:1.20.5.170 (GENE3D); PTHR11462 (PANTHER); IPR004827 (PROSITE_PROFILES); SSF57959 (SUPERFAMILY),,
RL4_JR_07667,1968,797,828,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,60.13877983,0,-4.012587409,1.212319084,-3.309844299,0.000933479,0.005636714,37.87054257,0,0.842835213,1.007470056,0.836585869,0.402825391,0.566620152,49.78607773,0,-3.448723568,1.20680162,-2.857738596,0.004266717,0.016940088,105.7622898,0,-0.153916154,0.583176681,-0.26392714,0.791836062,0.865523063,60.92353778,0,-1.355049447,0.886452472,-1.528620529,0.126358544,0.227406748,N,-,,translation initiation regulator,F:ATP binding; P:regulation of translational elongation; C:cytosolic ribosome; P:sulfate transmembrane transport; F:ATPase-coupled sulfate transmembrane transporter activity; P:monosaccharide transport; F:monosaccharide-transporting ATPase activity,IPR003593 (SMART); IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR032781 (PFAM); PTHR19211 (PANTHER); PTHR19211:SF45 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.121.9, the atp-binding cassette (abc) superfamily.
RL4_JR_07668,528,641,808,0,0,1,0,0,0,0,0,2,0,0,0,0,2,0,49.40292401,1,0.483313622,0.705766994,0.684806213,0.493466214,0.681184578,7.044423494,0,0.649099802,1.258402467,0.515812563,0.605985327,0.739515499,24.66920239,1,-1.032647588,1.207279889,-0.855350609,0.392357078,0.535773275,57.23853897,0,0.650974841,0.698679428,0.931721781,0.351480327,0.497934562,17.78546579,1,-2.066408812,1.206080133,-1.713326301,0.086652526,0.171660503,N,-,,hypothetical protein SPI_02209,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_07669,2576,2362,1839,0,3,16,0,0,0,0,0,3,0,5,0,0,1,2,1089.647546,1,1.767453599,0.769917867,2.295639151,0.021696522,0.070321903,79.08363776,0,-2.839796077,1.210593002,-2.345789273,0.018986839,0.055162107,439.4866271,1,0.150063065,0.406548445,0.369114842,0.712042127,0.805139616,540.9063543,1,0.411669169,0.917121772,0.448870784,0.653524873,0.7632875,330.0117916,1,-0.428859288,0.665660626,-0.644261161,0.519406096,0.644167899,N,-,,Tubulin beta chain,F:GTP binding; C:cytoplasm; F:GTPase activity; P:response to antibiotic; F:structural constituent of cytoskeleton; C:microtubule; P:microtubule-based process,IPR002453 (PRINTS); IPR000217 (PRINTS); IPR018316 (SMART); IPR003008 (SMART); IPR023123 (G3DSA:1.10.287.GENE3D); IPR018316 (PFAM); IPR018316 (G3DSA:3.30.1330.GENE3D); IPR003008 (G3DSA:3.40.50.GENE3D); IPR003008 (PFAM); IPR000217 (PANTHER); IPR008280 (SUPERFAMILY); IPR003008 (SUPERFAMILY),,
RL4_JR_07670,428,339,267,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,77.93817735,0,0.909336971,0.539170973,1.686546601,0.091690567,0.207751511,8.467463247,1,0.383596988,1.225923225,0.312904577,0.75435316,0.850190701,21.92354409,0,-2.265457669,1.192837659,-1.899217092,0.057535938,0.12596126,46.6344344,0,0.035402438,0.746190799,0.047444216,0.962159189,0.978688145,21.5797105,0,-2.34542886,1.193972458,-1.964391091,0.049484755,0.111192443,N,-,,hypothetical protein F503_01998,,no IPS match,,
RL4_JR_07671,13730,14265,17672,5,6,27,0,0,0,3,8,2,5,5,0,0,11,1,12.5928033,1,-1.756981035,1.257253123,-1.397475976,0.162270486,0.312733906,4.002477996,0,1.464540998,1.324461451,1.1057634,0.26882894,0.426035155,61.21676638,1,2.003814332,0.755289852,2.653040188,0.007977037,0.027311994,118.8193825,1,3.051160941,0.688294659,4.432928397,9.30E-06,0.000133131,10.36912931,1,-1.288032231,1.260076988,-1.022185345,0.306693185,0.441842416,N,-,,hypothetical protein F503_01997,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_07672,4633,3307,2952,0,0,2,0,0,0,1,2,1,0,3,1,0,1,1,164.7581206,1,-0.046461814,0.416842704,-0.111461263,0.911250581,0.956734502,72.88119602,0,0.308619593,0.975089226,0.316503951,0.751620027,0.848464388,100.5732968,1,-1.186428544,0.739275804,-1.604852395,0.108526292,0.205990558,228.9659675,1,0.704236602,0.348979685,2.017987385,0.043592575,0.113446415,87.23069742,1,-1.873062455,0.839133244,-2.232139495,0.025605745,0.066630215,N,-,,phosphatase pp2a regulatory subunit b,P:positive regulation of protein localization to nucleus; P:negative regulation of GTPase activity; P:positive regulation of transcription by transcription factor localization; C:fungal-type vacuole membrane; P:protein dephosphorylation; P:negative regulation of septation initiation signaling; P:regulation of mitotic cell cycle spindle assembly checkpoint; C:mating projection tip; C:protein phosphatase type 2A complex; F:protein phosphatase type 2A regulator activity; C:nucleus; P:negative regulation of exit from mitosis; C:cellular bud tip; C:mitotic spindle; C:cellular bud neck; C:cytosol; P:regulation of protein phosphatase type 2A activity; P:positive regulation of G2/M transition of mitotic cell cycle,IPR000009 (PRINTS); IPR001680 (SMART); IPR000009 (PIRSF); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR000009 (PANTHER); IPR017986 (SUPERFAMILY),,
RL4_JR_07673,7081,4595,5483,0,0,3,0,0,0,1,3,1,0,1,0,0,6,0,86.8541213,1,0.599327535,0.568786044,1.053695923,0.292022156,0.477035793,37.3473467,0,2.448802424,0.848077209,2.887475808,0.003883465,0.017754485,23.9112724,1,-2.390670583,1.187523555,-2.013156347,0.044098184,0.102703017,58.24467652,1,0.238083583,0.660984601,0.360195356,0.718701048,0.812024373,53.04808412,1,0.170735537,0.74208391,0.230075783,0.818032882,0.877764194,N,-,,udp-n-acetylglucosamine transporter yea4,P:UDP-glucose transport; C:cell tip; P:mycelium development; P:fungal-type cell wall chitin biosynthetic process; P:UDP-N-acetylglucosamine transmembrane transport; C:integral component of membrane; F:UDP-N-acetylglucosamine transmembrane transporter activity; C:endoplasmic reticulum,IPR013657 (PFAM); PTHR10778:SF4 (PANTHER); PTHR10778 (PANTHER); PTHR10778:SF4 (PANTHER); PTHR10778 (PANTHER); SSF103481 (SUPERFAMILY),2.A.7.10.1, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_07674,2566,1651,3150,0,2,2,0,0,0,0,0,0,0,3,0,0,0,0,334.8760823,1,-0.460286254,0.341609236,-1.347405766,0.177849584,0.333956979,62.17972131,0,-2.492846465,1.188777518,-2.096983184,0.035995064,0.091278881,183.393548,0,-3.315492622,1.027054239,-3.228157282,0.001245905,0.00687761,213.3179276,1,-2.834328931,0.735408109,-3.854089851,0.000116161,0.001213756,196.7449621,0,-1.615563823,0.54794306,-2.948415525,0.003194074,0.012448037,N,-,,AMP deaminase,F:AMP deaminase activity; P:IMP salvage; C:membrane; P:transport,IPR001365 (PFAM); IPR006329 (TIGRFAM); G3DSA:3.20.20.140 (GENE3D); IPR006329 (PANTHER); IPR032466 (SUPERFAMILY),,
RL4_JR_07675,35629,18349,24209,10,11,20,0,0,1,5,17,5,6,14,5,0,27,1,3.374783684,1,0.142792065,1.250625223,0.114176543,0.909097846,0.955724256,1.089582878,1,3.341837577,1.429261579,2.338156727,0.019379119,0.056108537,2.806256022,1,0.700434469,1.231434876,0.568795381,0.56949501,0.693810768,3.235773097,1,0.278768198,1.238864426,0.225019132,0.82196439,0.888202467,2.746902883,1,0.628143944,1.221078412,0.514417369,0.606960218,0.715005493,N,-,,aldo keto reductase,C:intracellular part,IPR023210 (G3DSA:3.20.20.GENE3D); IPR023210 (PFAM); PTHR11732:SF124 (PANTHER); IPR001395 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.6, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_07676,3364,3031,4766,0,0,0,0,0,0,0,0,0,0,3,0,0,1,0,148.2889391,0,1.318776769,0.511102588,2.580258447,0.00987264,0.037548249,23.58615971,0,0.552722255,1.131537318,0.488470196,0.625216832,0.753565702,83.95684153,0,0.381472262,1.256404658,0.303622133,0.761415788,0.839530977,125.0914517,1,0.787162671,0.506054363,1.555490335,0.119829335,0.224181821,55.40915766,1,-0.494380282,0.78098765,-0.633019334,0.526721018,0.650451312,N,-,,amino acid permease,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PIRSF); IPR004841 (PFAM); PTHR11785:SF263 (PANTHER); IPR002293 (PANTHER),2.A.3.10.18, the amino acid-polyamine-organocation (apc) family.
RL4_JR_07677,2868,3907,3700,1,1,9,0,0,1,0,0,2,4,6,2,0,0,0,93.65905673,1,-0.942269826,0.710484631,-1.32623534,0.184761757,0.342197339,28.72163372,1,0.106507464,1.146813836,0.092872497,0.926004856,0.959171219,86.31429589,1,-0.311798953,0.70524839,-0.442112251,0.658407979,0.763804559,65.43195012,1,-2.157485083,1.046605404,-2.061412138,0.039263738,0.106215744,116.3757567,0,0.779080636,0.494860847,1.574342848,0.115408209,0.212808666,N,-,,SH3 domain-containing,C:nucleus; F:protein binding; C:cell cortex; P:actin filament organization; C:intracellular organelle part,IPR001452 (PRINTS); IPR001452 (SMART); IPR001452 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR007131 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR001452 (PFAM); G3DSA:2.30.30.40 (GENE3D); PTHR11216 (PANTHER); PTHR11216 (PANTHER); IPR029922 (PTHR11216:PANTHER); IPR029922 (PTHR11216:PANTHER); PD936484 (PRODOM); IPR001452 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY); IPR001452 (SUPERFAMILY); IPR001452 (SUPERFAMILY),8.A.23.1.12, the basigin (basigin) family.
RL4_JR_07678,11204,8270,8410,0,0,0,0,0,0,0,2,4,0,14,6,0,12,2,106.0585912,0,0.349837759,0.841908012,0.415529671,0.677754199,0.823153008,16.87177188,0,-0.610991546,1.209370649,-0.505214465,0.613408212,0.745558548,43.6193796,1,-3.257892157,1.190641183,-2.736250186,0.006214376,0.02237032,138.1340855,1,0.53947329,0.470451974,1.146712777,0.251500348,0.391038241,65.65376781,1,-0.394615305,0.666615476,-0.591968412,0.553871741,0.673627793,N,-,,transmembrane 56,C:integral component of membrane,IPR006634 (SMART); IPR006634 (PFAM); PTHR13439 (PANTHER); PTHR13439:SF0 (PANTHER); PTHR13439 (PANTHER); IPR006634 (PROSITE_PROFILES),9.B.311.1.3,The 6-7 TMS TRAM-LAG (TRAM-LAG) Family
RL4_JR_07679,147,116,174,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.48005327,0,2.194339323,0.760544713,2.885220666,0.003911394,0.017733515,2.020181298,0,2.450897327,1.341321281,1.827226155,0.067665773,0.149479038,5.278816058,0,-0.211476833,1.230043731,-0.171926272,0.863495492,0.913429503,6.092072024,0,-0.634337568,1.233510719,-0.514253795,0.607074561,0.727244307,5.24830279,0,-0.305610695,1.241764156,-0.246110096,0.805597008,0.868932535,N,-,,dor1-like family,C:Golgi transport complex; P:intra-Golgi vesicle-mediated transport; P:CVT pathway,IPR007255 (PFAM); IPR007255 (PANTHER); IPR007255 (PANTHER); PTHR21311:SF0 (PANTHER); PTHR21311:SF0 (PANTHER); IPR007255 (PANTHER),,
RL4_JR_07680,434,534,390,0,0,3,0,0,0,0,0,0,0,3,0,0,0,2,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_07681,42,21,55,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,58.24932837,0,0.000994349,0.826069223,0.001203711,0.999039577,0.999802078,64.61106742,0,3.514879241,0.704212486,4.991219714,6.00E-07,5.37E-05,21.71959181,0,-2.252015998,1.220964282,-1.844456904,0.065116581,0.138845886,25.05956914,0,-2.674543276,1.223453417,-2.186060571,0.028811174,0.090174077,21.53469874,0,-2.34238998,1.232688321,-1.900228907,0.057403086,0.124242465,N,-,,solute carrier family 25 member 38,F:structural constituent of ribosome; C:integral component of membrane; P:heme biosynthetic process; P:transport; C:mitochondrial inner membrane; F:transporter activity; P:translation,IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089:SF107 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR030847 (HAMAP); IPR023395 (SUPERFAMILY),2.A.29.5.6, the mitochondrial carrier (mc) family.
RL4_JR_07682,5504,10090,6368,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,345.5126613,1,-1.323379518,0.888323479,-1.489749567,0.136290096,0.276237169,119.1713709,0,-0.299960553,0.76316229,-0.393049495,0.694282925,0.806834876,349.0239526,0,-0.550097445,0.419545383,-1.311175065,0.189798625,0.312747604,377.3482024,0,-0.838326929,0.362664085,-2.31157968,0.020800857,0.078120428,317.0445618,0,-0.87924671,0.417253435,-2.107224617,0.035098114,0.084924529,N,-,,Reticulocyte-binding 2 a,,no IPS match,1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_07683,26525,43248,27243,1,8,18,0,0,0,8,5,2,3,78,0,0,14,3,52.32656772,1,-2.550143363,1.174654094,-2.170973886,0.029933146,0.090203633,35.66229431,0,0.653885157,1.128634107,0.579359735,0.562346467,0.70542458,50.55539578,1,-1.110098995,1.05506874,-1.052157981,0.292727074,0.433143657,84.54915646,1,0.175367532,0.622502587,0.28171374,0.778163018,0.856681588,84.44478063,1,1.029848322,0.611418855,1.684358135,0.092112476,0.17932612,N,-,,prefoldin subunit 1,"C:nucleus; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; C:prefoldin complex; C:integral component of membrane; C:cytosol; F:unfolded protein binding; P:ceramide metabolic process; P:protein folding",IPR009053 (G3DSA:1.10.287.GENE3D); IPR002777 (PFAM); PTHR20903 (PANTHER); IPR009053 (SUPERFAMILY),,
RL4_JR_07684,28844,52181,34478,12,11,30,0,0,1,10,3,3,11,64,0,0,13,7,26.41961711,1,0.265314955,1.013751971,0.261715846,0.793540523,0.894157954,3.328545919,1,1.7306898,1.277244224,1.355018694,0.175411601,0.311548733,24.29570335,1,0.907605251,1.036790276,0.875399078,0.381356802,0.525126829,17.95420304,1,0.384418942,1.022662935,0.375899946,0.70699128,0.803399182,8.454453693,1,-0.99344836,1.196816413,-0.830075816,0.40649592,0.54318498,N,-,,alkaline phytoceramidase,C:membrane; P:cellular process,IPR008901 (PFAM); PTHR12956 (PANTHER); PTHR12956:SF4 (PANTHER),,
RL4_JR_07685,630,529,437,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,35.5744384,1,0.049572575,0.843879408,0.058743672,0.953156275,0.977110943,5.727610112,0,0.947612271,1.239511131,0.76450485,0.444566448,0.60596574,14.82037423,0,-1.700522389,1.191960674,-1.42665981,0.153677975,0.267325743,74.86834029,0,2.244615608,0.468260173,4.793522353,1.64E-06,2.84E-05,14.57381153,0,-1.779144769,1.19093389,-1.493907247,0.135199864,0.239610965,N,-,,m repeat,P:mycelium development,IPR022091 (PFAM); IPR022092 (PFAM); PTHR18937 (PANTHER),,
RL4_JR_07686,9165,8579,16034,1,0,1,0,0,0,0,0,0,1,6,0,0,8,4,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,recognition complex subunit 1,F:binding,no IPS match,,
RL4_JR_07687,16928,11759,12301,11,0,0,0,0,0,0,0,2,3,7,0,0,3,0,51.51859522,1,0.271481196,0.72721688,0.373315312,0.708913782,0.843023933,9.055487166,0,0.286712826,1.246804686,0.229958091,0.818124335,0.890148825,50.34119272,1,0.047387438,0.880865496,0.053796451,0.957097337,0.975010409,35.24033304,1,-1.082758055,1.051469899,-1.029756588,0.303124284,0.44876932,27.17504996,1,-1.529091652,1.154321721,-1.324666793,0.185281692,0.304146746,N,-,,ankyrin repeat domain-containing,C:nucleus; C:proteasome regulatory particle; P:proteolysis; P:proteasome regulatory particle assembly; C:cytosol,IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24198 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),8.A.28.1.2, the ankyrin (ankyrin) family.
RL4_JR_07688,18854,13346,13267,3,1,8,0,0,0,2,0,6,3,2,5,0,3,1,95.70463888,1,-0.363784604,0.759425438,-0.479026097,0.631920063,0.790713081,28.75038147,0,0.104927378,1.137854471,0.092215112,0.926527131,0.95951582,50.65100554,1,-3.473565377,1.216180113,-2.856127427,0.00428843,0.016940088,76.11611559,1,-1.591273614,0.898351098,-1.771327065,0.076506329,0.161125824,54.23521374,1,-2.641040244,1.160285359,-2.276198888,0.022834108,0.060638879,N,-,,pre-mRNA-splicing factor prp46,"C:catalytic step 2 spliceosome; C:precatalytic spliceosome; C:DNA replication factor A complex; C:Prp19 complex; C:Cul4-RING E3 ubiquitin ligase complex; P:mRNA splicing, via spliceosome",IPR020472 (PRINTS); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR19923:SF0 (PANTHER); PTHR19923 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_07689,2100,1427,1716,0,0,0,0,0,0,0,0,0,0,0,1,0,2,0,4.641151272,0,-0.316901232,1.200014112,-0.264081254,0.791717308,0.893161355,1.480824894,0,2.899102814,1.33900836,2.16511181,0.030379124,0.079807291,3.842777406,0,0.246708577,1.200269662,0.205544291,0.837146898,0.894865927,8.444713932,1,0.771435658,1.144469894,0.674055004,0.500276345,0.638187979,3.789968185,1,0.164049562,1.200371376,0.136665673,0.891295064,0.928946134,N,-,,origin recognition complex subunit 1,F:ATPase activity; C:nuclear pre-replicative complex; F:DNA replication origin binding; F:ATP binding; P:DNA replication initiation; C:DNA replication preinitiation complex; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; F:chromatin binding; C:nuclear origin of replication recognition complex; P:chromatin silencing at silent mating-type cassette,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.8.60 (GENE3D); IPR003959 (PFAM); PTHR10763:SF23 (PANTHER); PTHR10763 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_07690,17718,15483,14585,12,7,7,0,0,2,2,6,8,7,5,5,0,6,7,79.75845439,1,1.037770982,0.52157967,1.989669155,0.046627393,0.126248347,19.40930195,1,1.055948796,1.119133923,0.94354105,0.345404229,0.508670028,32.54363381,1,-1.552126219,1.19199699,-1.3021226,0.192874479,0.316682002,55.73020019,1,0.103711722,0.67511792,0.153620159,0.877909241,0.92447541,25.68129714,1,-2.596393014,1.196039678,-2.170825152,0.029944392,0.07506486,N,-, Effector probability:0.727,alpha subunit,C:prefoldin complex; F:unfolded protein binding; P:protein folding,IPR004127 (PFAM); IPR009053 (G3DSA:1.10.287.GENE3D); IPR011599 (TIGRFAM); PTHR12674 (PANTHER); PTHR12674:SF2 (PANTHER); IPR009053 (SUPERFAMILY),,
RL4_JR_07691,1204,718,1126,5,5,1,2,0,0,1,1,0,0,0,0,0,0,1,10.36577599,1,4.585223493,1.216013612,3.770700795,0.00016279,0.001298181,0.096848261,1,6.833578886,2.174668151,3.142354793,0.001675948,0.015023052,0.250259224,1,4.186591932,1.399479334,2.991535373,0.002775784,0.012831979,0.288588219,0,3.765356922,1.7113905,2.200174024,0.027794551,0.088524638,0.246322715,1,4.106034409,1.308624579,3.137671778,0.001702955,0.007403355,N,-, Effector probability:0.593,---NA---,,no IPS match,,
RL4_JR_07692,1639,1722,1429,0,3,2,0,0,0,0,3,0,0,2,0,0,2,0,9.143741982,1,-1.295304267,1.20616043,-1.073907114,0.282864314,0.466183248,2.910806659,0,1.924029235,1.285022493,1.497272807,0.134322288,0.25337499,7.571379468,1,-0.731767141,1.206191152,-0.606675932,0.544065998,0.671640551,31.69458158,1,1.171440744,0.862921712,1.357528415,0.174613371,0.298188629,7.490971762,1,-0.818951719,1.213548089,-0.674840764,0.499776939,0.627665778,N,-,,Vacuolar sorting-associated 37C,,IPR009851 (PFAM); PTHR13678 (PANTHER); IPR009851 (PROSITE_PROFILES); SSF140111 (SUPERFAMILY),,
RL4_JR_07693,290,315,355,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,43.36085982,0,-3.540698905,1.219019725,-2.904546032,0.003677861,0.016867004,23.33518388,0,0.576852276,1.153429858,0.500119077,0.616991234,0.748168653,73.93479923,1,0.157494539,0.719040252,0.219034384,0.826623263,0.888212048,61.64794876,0,-0.424123615,0.748629778,-0.566533188,0.571031379,0.697810057,47.04449353,0,-0.881576734,0.892663585,-0.987580035,0.323358368,0.459380311,N,-,,hypothetical protein SPI_05178,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_07694,16175,25958,19231,0,3,18,0,0,0,0,0,4,0,3,0,0,6,0,413.9486849,1,-2.788298051,0.5688641,-4.901518745,9.51E-07,1.45E-05,118.7536615,0,-3.426314346,1.20434649,-2.844957307,0.004441738,0.019050679,344.4320368,1,-3.244494087,0.762655969,-4.254204017,2.10E-05,0.000350487,437.8891318,1,-1.988678985,0.478562643,-4.155524909,3.25E-05,0.00040418,364.1356826,1,-1.99481158,0.531391137,-3.753942137,0.000174075,0.0011078,N,-,,F-box domain-containing,P:biological_process; C:cellular_component; F:molecular_function,G3DSA:1.20.1280.50 (GENE3D); IPR001810 (PFAM); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY),,
RL4_JR_07695,1166,881,1350,0,0,0,0,0,0,0,0,0,0,3,0,0,4,0,168.8149864,0,0.431403578,0.482722397,0.893688755,0.371488443,0.563721733,23.30782807,0,-1.077213403,1.227826588,-0.877333504,0.380305519,0.544631079,60.12510689,0,-3.720913449,1.210204352,-3.074615822,0.002107739,0.010263947,184.1279238,1,0.561526715,0.475733914,1.180337787,0.237865895,0.375782835,93.37498564,1,-0.232221856,0.608347221,-0.381725844,0.702664729,0.789708112,N,-,,hmg-i hmg- dna-binding,F:DNA binding; P:biological_process; C:cellular_component; F:molecular_function,PTHR22934:SF24 (PANTHER); PTHR22934 (PANTHER),,
RL4_JR_07696,1137,1353,1549,0,1,3,0,0,0,0,2,1,0,0,0,0,1,0,111.2603504,1,0.651463898,0.461755558,1.410841487,0.158291358,0.307508978,14.94942668,0,-0.43646055,1.214338303,-0.359422534,0.71927902,0.824243432,96.00314887,1,0.732481978,0.545542198,1.342667863,0.179379545,0.299626879,60.60841464,0,-0.793924393,0.752564234,-1.054958975,0.291444088,0.435993125,45.64249305,1,-1.487992634,0.969673267,-1.534529913,0.12489934,0.225701556,N,-,,V-ATPase subunit C,"F:hydrogen ion transmembrane transporter activity; P:ATP hydrolysis coupled proton transport; C:cytosol; C:proton-transporting V-type ATPase, V1 domain",G3DSA:3.30.70.1180 (GENE3D); IPR004907 (PFAM); G3DSA:3.30.70.100 (GENE3D); PTHR10137:SF0 (PANTHER); IPR004907 (PANTHER); IPR004907 (SUPERFAMILY),3.A.2.2.3," the h(+)- or na(+)-translocating f-type, v-type and a-type atpase (f-atpase) superfamily."
RL4_JR_07697,2010,1708,1589,0,0,5,0,0,0,0,0,3,3,3,0,0,0,0,9.994013146,1,-1.423564268,1.215889335,-1.17080085,0.241678836,0.416655948,3.215759846,0,1.78037041,1.306084864,1.36313532,0.172839867,0.308388002,21.30606579,1,0.948227885,1.05821607,0.896062639,0.370219309,0.514919671,9.581746598,1,-1.287546257,1.217859844,-1.057220388,0.290411017,0.435218162,8.166610104,0,-0.943629279,1.21864256,-0.774328183,0.438736742,0.57296653,N,-,,dna mismatch repair,F:ATP binding; P:mismatch repair; F:mismatched DNA binding,IPR000432 (SMART); IPR007696 (SMART); IPR000432 (PFAM); G3DSA:1.10.1420.10 (GENE3D); IPR007696 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11361 (PANTHER); PTHR11361:SF20 (PANTHER); PTHR11361 (PANTHER); PTHR11361:SF20 (PANTHER); IPR027417 (SUPERFAMILY); IPR007696 (SUPERFAMILY),,
RL4_JR_07698,1638,1255,1964,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27.70917631,1,-2.894703295,1.20200487,-2.408229256,0.016030111,0.055108996,8.817956931,0,0.325019614,1.229298427,0.264394395,0.79147603,0.873795221,48.9382453,0,0.478084269,0.763782457,0.625942982,0.531352341,0.661025867,26.471125,0,-2.753611029,1.201870358,-2.291104869,0.021957349,0.080296448,22.70782892,0,-2.418908993,1.21027389,-1.998645936,0.045646676,0.104543758,N,-,,hmg box,,IPR009071 (SMART); IPR009071 (G3DSA:1.10.30.GENE3D); IPR009071 (PFAM); PTHR10270:SF222 (PANTHER); PTHR10270 (PANTHER); IPR009071 (PROSITE_PROFILES); IPR009071 (SUPERFAMILY),,
RL4_JR_07699,8201,7844,10948,1,0,16,0,0,0,0,0,1,0,0,0,0,0,0,177.9081587,1,-0.069040501,0.434909459,-0.158746837,0.873868335,0.939103212,30.72769897,0,-1.475932395,1.20959279,-1.220189477,0.222393055,0.370789409,79.34352401,1,-4.121049372,1.197240048,-3.442124558,0.000577164,0.003764957,156.190245,0,-0.260732351,0.480259693,-0.542898675,0.587199568,0.712279337,104.5322789,0,-1.007123696,0.633055168,-1.590894045,0.111633423,0.207354322,N,-,,phd finger domain,F:metal ion binding,IPR001965 (SMART); IPR019787 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR14296 (PANTHER); PTHR14296 (PANTHER); PTHR14296:SF3 (PANTHER); IPR011011 (SUPERFAMILY),,
RL4_JR_07700,14053,13835,12407,0,5,6,0,0,0,0,0,0,0,2,2,0,3,0,119.4041327,1,-1.857577727,0.892962919,-2.080240611,0.037503469,0.107616356,32.61664939,0,-1.562000142,1.277249575,-1.222940428,0.221352197,0.369419117,89.98836985,0,-3.232730024,1.253441513,-2.579083261,0.009906291,0.032415756,140.2212005,1,-1.089723862,0.72230979,-1.508665501,0.131384286,0.240728537,123.5531172,1,-0.456727768,0.801028478,-0.570176693,0.568557862,0.685070612,N,-,,ion transporter,F:calcium channel activity; F:calcium ion binding; P:ion transmembrane transport; P:calcium ion transport; C:integral component of membrane; P:regulation of ion transmembrane transport; F:voltage-gated ion channel activity; C:plasma membrane,IPR002077 (PRINTS); IPR011992 (G3DSA:1.10.238.GENE3D); IPR027359 (G3DSA:1.20.120.GENE3D); IPR005821 (PFAM); PTHR10037:SF62 (PANTHER); PTHR10037 (PANTHER); PTHR10037:SF62 (PANTHER); PTHR10037 (PANTHER); PTHR10037:SF62 (PANTHER); PTHR10037 (PANTHER); IPR002048 (PROSITE_PROFILES); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY),1.A.1.11.17, the voltage-gated ion channel (vic) superfamily.
RL4_JR_07701,9017,7082,10168,2,3,1,0,0,1,0,1,1,0,2,1,0,0,0,125.060213,1,2.671868748,1.210555305,2.207143067,0.027304066,0.08408704,5.802658224,1,0.928845619,1.237073818,0.7508409,0.452748411,0.612335572,54.77536715,1,1.42531275,0.664971823,2.143418263,0.032079528,0.080849674,45.40890566,1,1.369922818,0.576702109,2.375442703,0.017527913,0.072113013,18.6298607,0,-0.867745744,1.118472501,-0.775831095,0.437848722,0.572249685,N,-,,cyclin B,C:nucleus,IPR004367 (SMART); IPR013763 (SMART); IPR006671 (PFAM); IPR013763 (G3DSA:1.10.472.GENE3D); PIRSF001771 (PIRSF); IPR013763 (G3DSA:1.10.472.GENE3D); IPR004367 (PFAM); PTHR10177:SF223 (PANTHER); PTHR10177 (PANTHER); IPR013763 (SUPERFAMILY); IPR013763 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_07702,32749,28027,43583,10,9,60,0,0,0,3,10,0,4,22,0,0,19,1,120.5390221,1,-2.08112963,0.866479108,-2.401823207,0.016313591,0.055777985,41.15197893,0,-0.610330082,1.157111277,-0.527460145,0.597874086,0.73318167,96.36559745,1,-2.385828862,1.08961094,-2.189615371,0.028552143,0.07368389,100.247901,1,-3.672190487,1.200255015,-3.059508556,0.002217005,0.014379994,83.23586242,1,-4.292913809,1.254930841,-3.420836963,0.000624287,0.003264933,N,-,,50S ribosomal l2,F:RNA binding; F:structural constituent of ribosome; P:mitochondrial translation; F:transferase activity; C:mitochondrial large ribosomal subunit,IPR002171 (SMART); IPR022669 (SMART); IPR022666 (PFAM); IPR014722 (G3DSA:2.30.30.GENE3D); IPR005880 (TIGRFAM); IPR022669 (PFAM); G3DSA:2.40.50.140 (GENE3D); IPR014726 (G3DSA:4.10.950.GENE3D); IPR005880 (PTHR13691:PANTHER); IPR002171 (PANTHER); IPR002171 (PANTHER); IPR012340 (SUPERFAMILY); IPR008991 (SUPERFAMILY),,
RL4_JR_07703,2160,1830,3009,0,4,4,0,0,2,0,0,0,1,3,0,0,0,1,96.71034413,1,0.18833714,0.523121963,0.360025297,0.718828216,0.849940355,16.62823211,1,-0.590068185,1.200564445,-0.491492304,0.623078294,0.752152474,58.91327613,0,-1.420643581,1.031630797,-1.377085277,0.168485884,0.285865598,126.596404,1,0.930093018,0.428398755,2.171091789,0.029924235,0.092092059,58.14197708,1,-0.725893688,0.76065259,-0.95430384,0.339929865,0.477297169,N,-,,pap2 domain containing,C:integral component of membrane; P:single-organism cellular process,IPR000326 (PFAM); IPR000326 (G3DSA:1.20.144.GENE3D); PTHR10165 (PANTHER); PTHR10165:SF101 (PANTHER); PTHR10165:SF101 (PANTHER); PTHR10165 (PANTHER); IPR000326 (SUPERFAMILY); IPR000326 (SUPERFAMILY),9.B.105.3.2, the lead resistance fusion protein (pbrbc) family.
RL4_JR_07704,7534,7857,6885,7,10,7,1,0,2,0,1,3,4,7,1,0,7,3,148.5990199,1,0.113583739,0.479000825,0.237126394,0.812558736,0.904716005,22.08862525,1,-0.999745381,1.204880417,-0.829746559,0.406682091,0.570696815,116.666877,1,0.160079488,0.554728538,0.288572658,0.772908422,0.848230337,150.2000994,1,0.443576677,0.449498634,0.986825417,0.323728232,0.470130286,56.76572802,1,-3.740737036,1.202901234,-3.109762408,0.001872379,0.008015046,N,-,,Casein kinase II subunit beta-2,C:protein kinase CK2 complex; F:protein serine/threonine kinase inhibitor activity; C:UTP-C complex; P:protein phosphorylation; P:cellular response to DNA damage stimulus; P:negative regulation of protein serine/threonine kinase activity; F:kinase activity; P:regulation of transcription from RNA polymerase III promoter; P:regulation of transcription from RNA polymerase I promoter; C:CURI complex,IPR000704 (PRINTS); IPR000704 (SMART); IPR016149 (G3DSA:1.10.1820.GENE3D); IPR000704 (PFAM); IPR016150 (G3DSA:2.20.25.GENE3D); PTHR22746 (PANTHER); PTHR22746:SF13 (PANTHER); IPR000704 (SUPERFAMILY),,
RL4_JR_07705,5402,2151,1646,0,0,1,0,1,0,0,1,1,0,0,0,0,10,0,172.0921878,1,-1.201599001,0.567784671,-2.116293488,0.034319854,0.100495826,40.3514043,1,-1.869009969,1.219085236,-1.533124932,0.125245076,0.240830292,103.9423682,1,-4.510641598,1.206299305,-3.739239159,0.000184578,0.001680457,177.6316799,0,-0.646933791,0.569053921,-1.136858507,0.25559744,0.395007148,169.0478588,1,-0.375043285,0.499520904,-0.750805985,0.452769427,0.584714594,N,-,,zinc finger,"F:nucleic acid binding; C:nucleus; F:transcription factor activity, sequence-specific DNA binding; P:transcription, DNA-templated; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR10032:SF195 (PANTHER); IPR027775 (PANTHER); IPR027775 (PANTHER); IPR027775 (PANTHER); PTHR10032:SF195 (PANTHER); SSF57667 (SUPERFAMILY),,
RL4_JR_07706,4491,3976,2727,2,1,7,0,2,0,0,2,4,2,13,0,5,12,1,35.96075214,1,-2.163791302,1.182851152,-1.829301429,0.067354465,0.16610572,10.15885324,1,0.120778779,1.24582228,0.096947037,0.922768455,0.957582689,33.05820507,1,-1.580441317,1.218460736,-1.297080218,0.194603587,0.319003678,38.67532325,1,-1.257523527,1.059152866,-1.187291814,0.235112536,0.372537469,48.51785594,1,-0.369574657,0.899394,-0.410915191,0.681134723,0.773495858,N,-,,ethanolamine kinase,P:phosphorylation; F:kinase activity,G3DSA:3.10.450.110 (GENE3D); G3DSA:3.90.1200.10 (GENE3D); PF01633 (PFAM); PTHR22603 (PANTHER); PTHR22603:SF24 (PANTHER); PTHR22603 (PANTHER); PTHR22603:SF24 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_07707,5960,6398,4975,2,8,2,0,0,0,3,0,2,0,6,0,0,0,1,5.978373583,1,1.732785121,1.17079361,1.480009035,0.138870835,0.28021476,0.685174546,0,4.01091146,1.476627483,2.716264938,0.006602306,0.024846353,1.783808787,1,1.353895007,1.226437264,1.103925204,0.269625585,0.408025324,2.05832938,1,0.931258953,1.240351076,0.750802713,0.452771396,0.594824236,1.764216319,1,1.267467321,1.223276241,1.036125185,0.300143744,0.435193385,N,-,,---NA---,,no IPS match,,
RL4_JR_07708,343,266,414,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0.036697419,1,6.666597314,3.935756776,1.693853989,0.090293032,NA,0.011369418,0,9.9235784,3.936644663,2.520821473,0.011708124,0.037898826,0.029947889,0,7.250911946,2.510153204,2.888633225,0.003869201,0.016080373,0.034589501,0,6.826466122,3.936131857,1.734308293,0.082863397,0.170215438,0.029861116,0,7.159096239,1.622205026,4.413188298,1.02E-05,0.000102147,N,-,,efflux pump antibiotic resistance,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501:SF77 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.79, the major facilitator superfamily (mfs).
RL4_JR_07709,5957,3838,5899,0,3,15,2,0,0,2,0,3,2,0,4,0,0,0,1.158889365,1,1.684994949,1.408257449,1.196510589,0.231497369,NA,0.371941987,1,4.892482993,1.633187619,2.995665002,0.002738471,0.015349618,0.960809648,1,2.247061071,1.239731912,1.812537895,0.069903124,0.146643023,1.108133569,1,1.824911977,1.277172734,1.428868569,0.153042013,0.26990949,0.94259657,0,2.171375546,1.214519045,1.787848083,0.073800521,0.150941177,N,-,,Transcription fungi,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31944:SF80 (PANTHER); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07710,3201,2257,3034,1,1,9,0,0,0,0,3,2,1,1,1,0,0,1,2.898407221,1,0.362341398,1.223228066,0.296217368,0.767064086,0.877722899,0.928711449,0,3.572254052,1.416713405,2.521507907,0.011685305,0.037851326,2.403292737,1,0.923983031,1.210050907,0.763590214,0.445111483,0.584670548,2.772007246,1,0.501879727,1.214006042,0.413407932,0.679307764,0.781678726,2.363473245,1,0.845153615,1.20183335,0.703220305,0.481918467,0.610385849,N,-,,pantothenate,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662:SF242 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_07711,94,92,94,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2.938373071,0,0.342452496,1.310420996,0.261330135,0.793837929,0.894369538,45.55196533,0,5.267821858,1.015690254,5.186445216,2.14E-07,2.33E-05,2.428273597,0,0.90862557,1.255325827,0.723816519,0.469178387,0.606012818,2.802531941,0,0.485748602,1.271825485,0.381930232,0.702513115,0.800376426,2.417932714,1,0.812477766,1.262598118,0.643496735,0.519901833,0.644469307,N,-,,Peptidase renal dipeptidase,P:autophagosome assembly; C:cytoplasm; F:metal ion binding; F:dipeptidase activity; P:proteolysis; F:metallopeptidase activity,G3DSA:3.20.20.140 (GENE3D); IPR008257 (PFAM); IPR008257 (PANTHER); PTHR10443:SF24 (PANTHER); PTHR10443:SF24 (PANTHER); IPR008257 (PROSITE_PROFILES); IPR032466 (SUPERFAMILY),,
RL4_JR_07712,1593,1680,2075,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,35.89766951,1,-1.951221016,1.167185991,-1.67173101,0.094577376,0.212493042,8.950150424,0,0.303661357,1.252524748,0.242439407,0.808439703,0.883636834,42.59041563,0,0.053507454,0.882715396,0.06061688,0.95166433,0.972469277,26.63503548,0,-2.762365018,1.211858252,-2.279445647,0.022640587,0.081088061,22.60635288,0,-2.412430042,1.208915697,-1.995532069,0.04598488,0.105172105,N,-,,thiol-specific monooxygenase,F:nucleotide binding; F:coenzyme binding; F:monooxygenase activity,IPR000960 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); PF13450 (PFAM); IPR020946 (PFAM); PTHR23023:SF125 (PANTHER); PTHR23023 (PANTHER); PTHR23023:SF125 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_07713,10377,17239,24898,3,0,11,0,0,0,0,4,4,1,0,0,0,0,1,32.14806374,1,-3.109077438,1.195311458,-2.601060517,0.009293606,0.035796235,10.30191089,0,0.100674063,1.227532803,0.082013338,0.934636107,0.963917721,34.52233983,1,-1.586915542,1.197898641,-1.324749431,0.185254272,0.30675732,30.77268474,1,-2.97080577,1.198333791,-2.479113742,0.01317093,0.060341929,63.10512434,1,0.360879732,0.692992961,0.520755263,0.602537271,0.71149869,N,-,,fungal specific transcription factor domain-containing,"P:regulation of transcription, DNA-templated; F:binding",IPR001138 (SMART); IPR007219 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); IPR001138 (PFAM); PTHR31944 (PANTHER); PTHR31944:SF72 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07714,38155,24345,27334,9,4,3,0,0,0,0,7,4,0,5,0,0,0,2,0.011995548,1,8.278788502,3.994728753,2.072428196,0.038225526,NA,0.003674643,0,11.54805534,3.998155187,2.888345949,0.003872737,0.017716233,0.009795413,1,8.859139625,3.047426446,2.90708891,0.003648095,0.015596838,0.01131933,1,8.43600951,3.995699254,2.111272389,0.034748906,0.099426657,0.00992088,1,8.755100215,1.62018887,5.403752846,6.53E-08,1.59E-06,N,-, Effector probability:0.583,isocitrate lyase,C:cytosol; F:isocitrate lyase activity; P:carboxylic acid metabolic process,IPR015813 (G3DSA:3.20.20.GENE3D); IPR006254 (PFAM); PTHR21631 (PANTHER); IPR015813 (SUPERFAMILY),,
RL4_JR_07715,2656,2570,2409,0,7,12,0,0,1,0,5,9,0,5,1,0,4,0,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-, Effector probability:0.828,isocitrate lyase,F:lyase activity,IPR006254 (PFAM); IPR015813 (G3DSA:3.20.20.GENE3D); PTHR21631 (PANTHER); PTHR21631:SF13 (PANTHER); IPR015813 (SUPERFAMILY),,
RL4_JR_07716,5532,5438,8298,0,0,0,0,0,2,0,0,0,0,5,0,0,0,2,0.015901563,0,7.871528,3.973277037,1.981117331,0.047578117,NA,0.005010166,1,11.10419825,3.765442626,2.948975554,0.003188292,0.016079667,0.01312615,0,8.436770725,2.240862621,3.76496562,0.000166572,0.001577526,0.015150793,1,8.016170674,3.973433359,2.017441832,0.043649426,0.113446415,0.013085742,1,8.344620785,1.511525422,5.520661885,3.38E-08,1.07E-06,N,-,,mfs general substrate transporter,P:transmembrane transport; F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662 (PANTHER); PTHR11662:SF303 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.4, the major facilitator superfamily (mfs).
RL4_JR_07717,2203,2230,2698,0,0,3,0,0,0,0,2,0,0,4,1,0,1,1,13.32123509,1,3.286996864,0.878715152,3.740685315,0.000183519,0.001425857,0.592027773,0,4.221676732,1.506690217,2.801954035,0.005079411,0.020840615,1.542034353,1,1.563779984,1.229382561,1.272004366,0.203371568,0.329271351,1.779334361,1,1.141220247,1.247345311,0.914919259,0.360234019,0.506227542,16.25775716,1,3.171867103,0.991141613,3.200215852,0.001373247,0.006196135,N,-,,Nipped-B B,,no IPS match,,
RL4_JR_07718,1162,1324,1439,0,0,4,0,0,1,0,0,0,4,6,0,0,0,0,0.047019874,1,6.307349279,3.929384661,1.605174811,0.108455339,NA,9.393415911,1,10.42443854,1.29306191,8.06182477,7.52E-16,2.62E-13,238.0260558,0,12.58945359,1.664370935,7.564091225,3.91E-14,3.59E-12,28.62781996,1,8.79545638,0.980302491,8.972186096,2.91E-19,2.65E-17,27.06278285,0,9.740763726,1.546562191,6.298333029,3.01E-10,1.94E-08,N,-,,MFS sugar transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,IPR003663 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); IPR003663 (TIGRFAM); PTHR23500:SF34 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.73, the major facilitator superfamily (mfs).
RL4_JR_07719,758,723,1019,0,0,2,0,0,0,0,0,0,0,2,0,0,0,0,5.463159587,1,-0.55185346,1.230592674,-0.448445267,0.653831879,0.804703848,1.735472081,0,2.67020372,1.345055863,1.985199123,0.047122322,0.112440392,59.18772728,0,3.81665856,0.576942022,6.615324271,3.71E-11,2.36E-09,42.45209494,1,2.378457526,0.771129354,3.084382036,0.002039755,0.01341944,4.446799922,0,-0.066382547,1.219995826,-0.05441211,0.956606831,0.971284012,N,-,,C6 transcription factor,,IPR007219 (SMART); IPR007219 (PFAM); PTHR31944:SF38 (PANTHER); PTHR31944:SF38 (PANTHER); PTHR31944 (PANTHER); PTHR31944 (PANTHER),,
RL4_JR_07720,214,254,159,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,2.457799893,0,0.600323464,1.249190313,0.480570061,0.630822098,0.790149958,0.781714711,0,3.820762206,1.442224621,2.64921438,0.008067914,0.02880544,28.02711101,1,3.980416378,0.749357966,5.311768952,1.09E-07,3.71E-06,2.344676366,0,0.743321994,1.223301403,0.607636018,0.543428907,0.673981306,2.007319752,0,1.081137473,1.212200566,0.891880027,0.372457241,0.508718409,N,-,,NAD-binding Rossmann fold oxidoreductase,,IPR000683 (PFAM); G3DSA:3.30.360.10 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR22604 (PANTHER); PTHR22604:SF111 (PANTHER); IPR016040 (SUPERFAMILY); SSF55347 (SUPERFAMILY),,
RL4_JR_07721,714,805,688,0,0,2,0,0,0,0,5,2,0,0,0,0,0,0,1.430400576,1,1.381182141,1.333931927,1.035421758,0.300471989,NA,0.455727098,0,4.599225164,1.563590367,2.941451457,0.00326678,0.016208996,1.183886282,1,1.945154389,1.227273483,1.584939638,0.112980049,0.212012979,1.365845788,0,1.522824458,1.251655159,1.216648569,0.223737955,0.359179768,1.169005557,0,1.861025178,1.215687818,1.530841347,0.125808608,0.226737657,N,-,,cinnamoyl- reductase,"F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; P:single-organism metabolic process",IPR016040 (G3DSA:3.40.50.GENE3D); IPR001509 (PFAM); PTHR10366 (PANTHER); PTHR10366:SF377 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_07722,1295,1689,1360,0,0,2,0,0,0,0,0,0,0,2,1,0,0,0,1.063041896,1,1.809651312,1.467720986,1.232966844,0.217588135,NA,0.339585857,0,5.023777509,1.663644623,3.019741981,0.002529901,0.015349618,0.879104554,0,2.375458553,1.250138456,1.900156371,0.057412602,0.125810645,1.01408937,1,1.952976603,1.297148773,1.505591836,0.132171985,0.241778747,0.863595519,0,2.298227701,1.224731749,1.876515165,0.060584574,0.129686853,N,-,,Siderophore iron transporter mirB,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF50 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.16.8, the major facilitator superfamily (mfs).
RL4_JR_07723,1949,2479,3029,0,0,0,0,0,0,2,0,0,0,0,0,0,0,2,7.828800172,0,-1.070893648,1.194226188,-0.896725979,0.369865155,0.56189198,2.503880935,0,2.141404148,1.29166161,1.657867766,0.09734416,0.198452685,6.481903004,1,-0.507276018,1.197257602,-0.423698306,0.671785851,0.77421002,7.476873179,0,-0.929446362,1.194912692,-0.777836212,0.436665577,0.578417344,6.37207069,1,-0.585489897,1.194274949,-0.490247155,0.623959016,0.729257311,N,-,,rna polymerase ii mediator complex subunit,C:mediator complex; F:RNA polymerase II transcription cofactor activity; P:regulation of transcription from RNA polymerase II promoter,IPR019095 (PFAM); PTHR13321 (PANTHER); PTHR13321:SF2 (PANTHER),,
RL4_JR_07724,1768,1820,3468,1,0,1,0,0,0,0,3,1,2,0,0,0,0,1,0.023384166,1,7.313912602,3.95207815,1.850649791,0.064219952,NA,0.007676691,0,10.49078673,3.950953353,2.655254516,0.007924859,0.028414957,0.019666007,1,7.855152288,2.683181743,2.927551333,0.003416427,0.014889386,0.022661569,1,7.435381089,3.951464833,1.881677151,0.059879864,0.136569486,0.019240544,1,7.773765358,1.580101908,4.919787338,8.66E-07,1.28E-05,N,-,,o-methyltransferase,,IPR001077 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR11746:SF87 (PANTHER); PTHR11746 (PANTHER); IPR016461 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY); IPR029063 (SUPERFAMILY),,
RL4_JR_07725,1362,1697,2161,0,11,6,0,0,0,0,0,0,0,3,2,0,0,0,0.073980628,1,5.653610531,3.921157912,1.441821691,0.149352682,NA,0.023860924,0,8.8542018,3.921032505,2.258130171,0.023937545,0.066327904,0.061851133,0,6.202569352,2.32633136,2.666244998,0.007670377,0.02647627,0.071325356,1,5.781715202,3.921027447,1.474540865,0.140336024,0.253280256,0.061263549,0,6.112876611,1.755591235,3.481947556,0.000497781,0.002698091,N,-,,nacht domain containing,,PF05729 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR10039 (PANTHER); PTHR10039:SF8 (PANTHER); PTHR10039:SF8 (PANTHER); IPR007111 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011990 (SUPERFAMILY),,
RL4_JR_07726,2988,2168,3324,3,1,7,0,0,0,0,0,1,0,1,0,0,0,2,56.68188053,1,1.247181492,0.555642854,2.24457398,0.024795495,0.078282371,7.116698326,0,0.634274507,1.22916107,0.516022287,0.605838843,0.739515499,26.32747918,1,-1.057564852,1.194055951,-0.885691203,0.37578395,0.519660799,49.26153671,1,-0.105798516,0.853295497,-0.123988133,0.901324671,0.939363077,22.11756322,1,-1.174607729,1.131037945,-1.038521947,0.299027123,0.434196131,N,-,,zinc finger domain-containing,,no IPS match,,
RL4_JR_07727,74,50,56,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,31.84904426,0,-0.161816495,0.874244994,-0.185092847,0.853156212,0.926866435,6.507435342,0,0.763468682,1.243260616,0.614085793,0.539158636,0.6862019,32.54607333,0,-0.061981053,1.040304048,-0.059579748,0.952490348,0.972568057,23.46149607,1,-1.362185441,1.152154984,-1.18229358,0.237089232,0.374797263,20.43893599,0,-1.035362639,1.130653224,-0.915720768,0.359813369,0.497217192,N,-,,mitochondrial cytochrome b2 partial,F:catalytic activity,IPR001199 (SMART); IPR000262 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); IPR001199 (PFAM); IPR001199 (G3DSA:3.10.120.GENE3D); PTHR10578 (PANTHER); PTHR10578:SF64 (PANTHER); IPR012133 (PROSITE_PROFILES); IPR001199 (PROSITE_PROFILES); IPR001199 (SUPERFAMILY); SSF51395 (SUPERFAMILY),,
RL4_JR_07728,79,61,85,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,409.935313,0,3.542757222,0.736382255,4.811030139,1.50E-06,2.18E-05,38.26304488,0,2.304109544,0.862463465,2.67154452,0.007550306,0.027441362,127.7160795,0,2.177510922,0.432254815,5.037563134,4.71E-07,1.38E-05,194.1199088,0,2.435333951,0.393589747,6.18749338,6.11E-10,2.04E-08,161.8972267,0,2.762453819,0.369124659,7.483796473,7.22E-14,9.49E-12,N,-,,trehalose synthase,F:transferase activity,G3DSA:3.40.50.2000 (GENE3D); IPR001296 (PFAM); PTHR12526 (PANTHER); PTHR12526:SF402 (PANTHER); SSF53756 (SUPERFAMILY),,
RL4_JR_07729,171,194,213,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,11.92104244,0,-1.677914889,1.238286753,-1.355029346,0.175408207,0.330251594,3.82599826,0,1.529654015,1.316981733,1.161484611,0.245444878,0.398308512,95.87123881,1,3.04143505,0.563530855,5.397104745,6.77E-08,2.42E-06,11.43036977,0,-1.542079242,1.236401423,-1.247231857,0.212312495,0.346384791,24.50509051,0,0.51034635,1.021521435,0.499594362,0.617360728,0.724056223,Y,-,,hypothetical protein SPI_06539,,PTHR35204 (PANTHER); PTHR35204:SF1 (PANTHER),,
RL4_JR_07730,242,158,151,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,367.2143097,0,1.75608326,0.404899934,4.337079645,1.44E-05,0.000159178,36.52279721,0,-0.381206702,1.131207956,-0.336990825,0.736123817,0.835881229,208.0870477,0,0.902374077,1.269424577,0.710852849,0.477175427,0.613621789,270.5834589,0,1.356263671,0.432268801,3.137546978,0.00170368,0.011623825,199.8963739,0,1.017143787,0.591549785,1.71945593,0.085531386,0.169900737,N,-, Effector probability:0.726,superoxide dismutase,P:age-dependent response to reactive oxygen species involved in chronological cell aging; C:mitochondrial matrix; P:removal of superoxide radicals; F:manganese ion binding; P:oxidation-reduction process; F:superoxide dismutase activity; P:replicative cell aging,IPR001189 (PRINTS); IPR019832 (PFAM); IPR019831 (PFAM); G3DSA:1.10.287.990 (GENE3D); IPR001189 (PIRSF); PTHR11404:SF26 (PANTHER); IPR001189 (PANTHER); IPR019831 (SUPERFAMILY); IPR019832 (SUPERFAMILY),,
RL4_JR_07731,47,34,33,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.71269701,0,0.41545714,1.081007575,0.384323986,0.700738332,0.838793781,47.48455075,0,3.644086217,1.014048532,3.593601393,0.000326139,0.012945786,7.491255106,0,-0.716396063,1.235515239,-0.579835877,0.562025301,0.6875737,8.646566638,0,-1.139463906,1.239363148,-0.919394698,0.357889162,0.503771412,29.55970314,0,1.4625787,0.914594529,1.599155313,0.109786097,0.204749352,N,-,,dna replication complex gins psf3,C:nucleus; P:DNA replication,IPR021151 (PFAM); IPR010492 (PANTHER); SSF158573 (SUPERFAMILY); SSF160059 (SUPERFAMILY),,
RL4_JR_07732,285,179,191,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.45669072,0,-1.488868524,1.220978703,-1.219405811,0.222690206,0.392716536,3.338444173,0,1.726284251,1.298417718,1.329529186,0.183673443,0.323216724,8.673382501,0,-0.927763521,1.219019919,-0.761073307,0.446613283,0.586020551,10.00573512,0,-1.350088678,1.219991319,-1.106637938,0.268450498,0.409692228,15.94197805,0,-0.07394977,1.153398914,-0.064114652,0.948878935,0.966928263,N,-,,hypothetical protein SPI_06542,,no IPS match,,
RL4_JR_07733,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,874.3458785,0,0.997783933,0.974654547,1.023730856,0.305962417,0.492682199,158.2135107,0,-0.484082211,0.768464089,-0.62993472,0.528737295,0.677367283,362.1395551,0,-0.948204141,0.43747801,-2.167432691,0.030201877,0.077171471,711.8606889,0,0.654808456,0.747591895,0.875890256,0.381089697,0.526618423,378.5857837,0,-0.583261354,0.813261052,-0.717188352,0.473257885,0.603721317,N,-,,Amino-acid permease INDA1,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PIRSF); IPR004841 (PFAM); IPR002293 (PANTHER); PTHR11785:SF391 (PANTHER),2.A.3.10.21, the amino acid-polyamine-organocation (apc) family.
RL4_JR_07734,446,373,418,0,0,2,0,0,0,0,3,0,1,0,0,0,3,1,143.165596,1,0.784642805,0.389291203,2.015567779,0.043845192,0.120596452,36.97993789,0,0.91940429,0.98765186,0.930899164,0.351905727,0.515408736,151.3379849,1,1.251018334,0.419181481,2.984431307,0.00284106,0.013074041,86.51358751,1,-0.092404735,0.543485671,-0.170022395,0.864992525,0.916401518,92.03650001,1,0.479268753,0.488384754,0.981334388,0.32642787,0.462721803,N,-,,caspase domain-containing,C:nucleus; P:misfolded or incompletely synthesized protein catabolic process; P:apoptotic process; P:positive regulation of apoptotic process; C:cytosol; F:calcium-dependent cysteine-type endopeptidase activity,IPR029030 (G3DSA:3.40.50.GENE3D); PF00656 (PFAM); PTHR31773:SF9 (PANTHER); PTHR31773 (PANTHER); IPR029030 (SUPERFAMILY),,
RL4_JR_07735,19926,19168,16087,0,5,7,0,0,0,1,1,1,0,3,1,0,4,0,99.94000404,1,0.025563036,0.66236101,0.038593811,0.969214237,0.984173481,18.46697721,0,-0.741381676,1.199276762,-0.618190645,0.536449676,0.683871992,89.64632778,1,0.006601782,0.614310639,0.010746651,0.991425578,0.996346293,91.29659167,1,-0.758488803,0.667591542,-1.136156999,0.255890864,0.395194477,58.9421003,1,-1.277422266,0.84926043,-1.504158466,0.132540569,0.235806232,N,-,,hypothetical protein F503_07117,F:nucleotide binding; F:nucleic acid binding,IPR001202 (SMART); G3DSA:2.20.70.10 (GENE3D); IPR001202 (PFAM); PTHR23181:SF9 (PANTHER); IPR015767 (PANTHER); IPR001202 (PROSITE_PROFILES); IPR001202 (SUPERFAMILY),,
RL4_JR_07736,13007,11687,13439,0,1,0,0,0,0,0,4,2,6,7,0,0,0,4,28.41443239,1,-2.930890113,1.197173113,-2.44817569,0.014358162,0.05077325,9.147929936,0,0.272116478,1.239370733,0.219560193,0.826213696,0.89567688,23.59585873,1,-2.371443989,1.201012162,-1.974537863,0.048320617,0.110328805,43.25684763,1,-0.092769842,0.769242988,-0.120598879,0.904008757,0.94125928,37.85546149,1,-0.756723288,0.97574616,-0.77553294,0.438024809,0.572312908,N,-,,hypothetical protein HMPREF1541_05753,"F:zinc ion binding; P:ATP hydrolysis coupled proton transport; F:hydrogen ion transmembrane transporter activity; P:metabolic process; P:regulation of transcription, DNA-templated; P:histidine biosynthetic process; F:histidinol dehydrogenase activity; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter; C:nucleus; F:NAD binding; F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process; C:proton-transporting V-type ATPase, V0 domain",IPR001138 (SMART); IPR001138 (PFAM); IPR021858 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07737,881,955,1132,0,0,3,0,0,0,3,1,0,0,13,0,0,1,1,1.77351481,1,1.071059598,1.427494463,0.750307357,0.453069613,NA,0.577288716,0,4.258349365,1.622119529,2.625176067,0.008660417,0.030230354,1.478130244,1,1.625497267,1.295902576,1.25433601,0.209719901,0.337284237,1.703774094,1,1.204265722,1.33566641,0.901621627,0.367257898,0.513688084,1.437359327,1,1.562462366,1.273778612,1.226635736,0.219959531,0.346090172,N,-,,hypothetical HRQ family 1,C:membrane; F:transferase activity,IPR021848 (PFAM),,
RL4_JR_07738,1377,1332,1844,3,2,0,0,0,0,0,0,0,0,8,1,0,0,2,0.158867929,1,4.551582761,3.296508558,1.380728332,0.167362507,NA,0.051274703,0,7.751218875,2.418137857,3.205449537,0.001348517,0.015023052,0.132254338,0,5.107058035,1.437260707,3.553327528,0.000380391,0.002786595,4.164089157,1,5.628126001,1.213965007,4.636151756,3.55E-06,5.65E-05,0.129802704,1,5.02921657,1.289062634,3.901452448,9.56E-05,0.000668594,Y,-,,alkaline phosphatase,P:dephosphorylation; F:alkaline phosphatase activity,IPR001952 (PRINTS); IPR001952 (PFAM); IPR017849 (G3DSA:3.40.720.GENE3D); PTHR11596 (PANTHER); PTHR11596:SF47 (PANTHER); IPR017850 (SUPERFAMILY),,
RL4_JR_07739,7989,5734,9191,0,3,2,0,0,0,0,0,0,2,5,1,0,0,2,0.533363576,1,2.804505207,1.923193728,1.458254135,0.144770507,NA,0.171603737,0,6.008552974,1.893791181,3.172764259,0.001509951,0.015023052,0.442570126,0,3.365629085,1.285356456,2.618440253,0.008833276,0.029670897,4.521966127,1,3.889889073,1.177171862,3.304435994,0.000951677,0.007096145,0.433448566,1,3.291872532,1.233164841,2.669450525,0.007597547,0.025237913,N,-,,alkaline phosphatase,F:hydrolase activity,IPR001952 (SMART); IPR017849 (G3DSA:3.40.720.GENE3D); IPR001952 (PFAM); PTHR11596 (PANTHER); PTHR11596:SF47 (PANTHER); PTHR11596 (PANTHER); PTHR11596:SF47 (PANTHER); IPR017850 (SUPERFAMILY),,
RL4_JR_07740,213,105,197,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,58.31299601,0,-1.607967032,1.017064498,-1.58098826,0.113880722,0.243395056,12.13419234,0,-0.135534494,1.210348124,-0.111979762,0.910839454,0.950652603,44.57485344,0,-0.972959268,1.036877489,-0.938355088,0.348061958,0.491555982,52.48095974,0,-0.506360835,0.757085879,-0.668828793,0.503604697,0.640577583,38.9594422,0,-1.214517909,0.987621255,-1.229740553,0.218794276,0.344578012,N,-,,hypothetical protein SPI_02995,,no IPS match,,
RL4_JR_07741,680,920,1340,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,133.5229857,0,2.606390682,0.355329337,7.335140698,2.21E-13,1.17E-11,6.150849304,0,0.844759128,1.232352707,0.685484864,0.493038009,0.648542004,15.92540948,0,-1.804255749,1.189132614,-1.517287246,0.129194177,0.234883841,36.99402501,0,-0.486923396,1.008311728,-0.482909583,0.629159937,0.745144972,15.66741875,0,-1.883505623,1.188393102,-1.584918004,0.112984965,0.209327132,N,-,,hypothetical protein CMQ_2562,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_07742,2425,2614,3553,0,3,19,0,0,0,2,1,2,1,1,2,0,8,5,69.35103717,1,-1.949524707,1.052403021,-1.852450694,0.063961132,0.159765741,15.94194802,0,-0.529207503,1.251301338,-0.422925707,0.672349466,0.790879872,40.97059876,1,-3.167516352,1.220031028,-2.596258847,0.009424504,0.031201332,51.2466726,1,-2.644021415,1.177621653,-2.245221466,0.024753919,0.085162564,55.45404493,1,-0.658629485,0.805803387,-0.817357554,0.413724125,0.549876184,Y,-,,DUF907 domain containing,P:calcium ion import; P:regulation of localization; P:regulation of cellular process; P:cellular localization; C:integral component of membrane; P:cellular component organization; P:single-organism localization; P:cell wall organization or biogenesis; C:cytoplasmic part; P:single-organism cellular process; C:plasma membrane,IPR032800 (SMART); IPR010308 (PFAM); IPR032800 (PFAM); PTHR31145 (PANTHER); PTHR31145:SF2 (PANTHER),1.A.4.9.3, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_07743,9217,8000,7591,0,1,16,0,0,0,5,7,2,7,26,4,0,13,23,54.97037323,1,-1.09965796,0.897035657,-1.225879877,0.220243882,0.389412569,51.04834212,0,0.729117773,1.147517617,0.635386998,0.525176046,0.674386325,67.82478705,1,-0.010800076,0.781956638,-0.013811605,0.988980284,0.995046175,37.68798161,1,-3.263187411,1.218894549,-2.677169584,0.007424704,0.038218166,39.28329948,1,-1.971879497,1.142307942,-1.726224099,0.084307104,0.167899893,N,-,,ent-kaurene oxidase,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; F:oxidoreductase activity; F:metal ion binding; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR002403 (PRINTS); IPR001128 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24279:SF78 (PANTHER); PTHR24279 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_07744,15352,19330,23477,0,0,3,0,0,5,1,1,0,1,1,0,0,6,0,1.853225492,1,1.007677632,1.406339028,0.716525398,0.473666991,NA,0.602067617,1,4.197719604,1.603054944,2.618575002,0.008829788,0.03070371,1.542844913,1,1.563728817,1.287749367,1.214311463,0.22462881,0.354891085,11.0907704,1,2.099364135,1.206282202,1.74035904,0.081795993,0.16884388,1.500968142,1,1.500054142,1.266379449,1.184521861,0.236206548,0.364849931,N,-,,cfem domain-containing,C:membrane; C:integral component of membrane,PTHR33048 (PANTHER); PTHR33048:SF37 (PANTHER),9.B.313.1.4, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_07745,3260,3548,4044,0,0,2,0,0,0,0,0,0,0,1,0,0,3,0,1079.853704,1,-2.339112376,0.733602675,-3.1885276,0.001429994,0.007898367,439.9825538,0,-1.096844896,1.774262103,-0.618197781,0.536444972,0.683871992,905.4761923,0,-2.066191427,0.536950161,-3.848013423,0.00011908,0.001292134,918.5455073,1,-3.886311731,0.743101854,-5.229850672,1.70E-07,3.63E-06,776.1807833,1,-3.365980862,0.678545588,-4.960581754,7.03E-07,1.08E-05,N,-,,bacterial hemoglobin,F:oxidoreductase activity; F:binding,IPR008333 (PFAM); IPR000971 (PFAM); IPR012292 (G3DSA:1.10.490.GENE3D); G3DSA:3.40.50.80 (GENE3D); IPR001433 (PFAM); G3DSA:2.40.30.10 (GENE3D); PTHR22924:SF49 (PANTHER); PTHR22924 (PANTHER); IPR000971 (PROSITE_PROFILES); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY); IPR017938 (SUPERFAMILY); IPR009050 (SUPERFAMILY),3.D.5.1.1, the na(+)-translocating nadh:quinone dehydrogenase (na-ndh or nqr) family.
RL4_JR_07746,3664,3166,3830,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0.565999212,0,2.718849264,1.858077511,1.463259335,0.14339643,NA,0.180628288,0,5.934475309,1.857620307,3.194665393,0.00139993,0.015023052,0.468232029,0,3.284038672,1.269298675,2.587285985,0.009673527,0.031879813,9.852420768,0,3.81284731,1.155927407,3.298517958,0.000971967,0.007217807,0.460898932,1,3.204207969,1.22695155,2.611519558,0.009014083,0.028910352,N,-,,fungal transcriptional regulatory,"C:nucleus; F:zinc ion binding; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07747,100,80,75,0,0,0,0,0,0,0,3,0,0,0,0,0,0,1,3.971846551,0,-0.092023345,1.254953724,-0.073328078,0.941545049,0.971334924,1.256857135,0,3.13564387,1.389615435,2.25648319,0.024040387,0.066497238,3.275911773,1,0.477063716,1.22883929,0.388223033,0.697850989,0.794121078,3.780437443,0,0.054256187,1.235155731,0.043926596,0.964962915,0.979768303,3.242213203,1,0.389430305,1.232787367,0.31589414,0.75208286,0.827340174,N,-,,mesaconyl-c4 hydratase,,IPR029069 (G3DSA:3.10.129.GENE3D); PTHR28152 (PANTHER); PTHR28152:SF2 (PANTHER); IPR029069 (SUPERFAMILY),,
RL4_JR_07748,167,219,227,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17.15150577,0,3.474821205,1.030580674,3.371711982,0.000747025,0.004695094,0.358560473,0,4.945157819,1.642295217,3.011125994,0.002602808,0.015349618,0.933795111,1,2.287712343,1.250488739,1.829454574,0.067331538,0.142428854,1.07753896,0,1.865035459,1.295029327,1.440149208,0.14982519,0.265947456,0.923633905,0,2.201335462,1.235104775,1.782306657,0.074699238,0.152240294,N,-,,acyl- dehydrogenase,F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; P:oxidation-reduction process,IPR013786 (PFAM); IPR006091 (PFAM); IPR013786 (G3DSA:1.10.540.GENE3D); G3DSA:2.40.110.10 (GENE3D); G3DSA:1.20.140.10 (GENE3D); IPR009075 (PFAM); PTHR10909:SF241 (PANTHER); PTHR10909 (PANTHER); IPR009075 (SUPERFAMILY); IPR009100 (SUPERFAMILY),,
RL4_JR_07749,2,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,205.6767818,0,0.382185051,0.486910252,0.784918884,0.432501129,0.623162171,27.44987905,0,-1.313252261,1.217024134,-1.07906838,0.280557246,0.439393539,100.3841051,0,-1.554849629,0.880653227,-1.765563995,0.077469025,0.158957521,125.8190776,0,-0.709691661,0.607970447,-1.16731276,0.243084088,0.381385127,71.31645089,0,-4.069942471,1.225689587,-3.320532795,0.000898458,0.004377713,N,-,,Aromatic amino acid aminotransferase,P:metabolic process; F:transferase activity,IPR015421 (G3DSA:3.40.640.GENE3D); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR004839 (PFAM); PTHR11751:SF377 (PANTHER); PTHR11751:SF377 (PANTHER); PTHR11751 (PANTHER); PTHR11751 (PANTHER); PTHR11751 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_07750,24,78,60,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.507285981,0,1.305950497,1.366823014,0.955464229,0.339342987,NA,0.483000441,0,4.515569031,1.582293676,2.853812221,0.004319806,0.018725049,1.247577464,0,1.870444716,1.246916968,1.500055548,0.133600014,0.240370809,1.438949926,0,1.448198412,1.276638704,1.134383915,0.256633543,0.39591873,1.222541898,0,1.796544062,1.22617913,1.465156287,0.142878283,0.249593273,N,-,,unnamed protein product,P:austinol biosynthetic process; P:dehydroaustinol biosynthetic process,IPR032710 (G3DSA:3.10.450.GENE3D); IPR032710 (SUPERFAMILY),,
RL4_JR_07751,3946,4811,4333,0,10,5,0,0,0,1,10,8,3,13,4,0,6,2,2.635285694,1,0.499813558,1.310992779,0.38124814,0.703019131,0.839588651,0.852427651,0,3.696034518,1.501609908,2.46138128,0.013840319,0.043224842,2.189896842,1,1.058445247,1.256487949,0.842383923,0.399573089,0.541681569,2.524840947,1,0.636865963,1.274048029,0.499875946,0.617162431,0.735706605,2.135382413,1,0.991568536,1.24124112,0.798852471,0.424375961,0.559625763,N,PKS,,beta-ketoacyl synthase domain-containing,F:catalytic activity,IPR020801 (SMART); IPR020841 (SMART); IPR001227 (G3DSA:3.40.366.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR014043 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR032821 (PFAM); IPR014031 (PFAM); G3DSA:3.30.70.250 (GENE3D); IPR014030 (PFAM); PTHR11712 (PANTHER); PTHR11712 (PANTHER); PTHR11712:SF268 (PANTHER); PTHR11712:SF268 (PANTHER); IPR016035 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR016036 (SUPERFAMILY),,
RL4_JR_07752,34,44,29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.4981899,0,-2.656817725,1.209883785,-2.195928037,0.028097095,0.085945293,7.58885625,0,0.54168608,1.262271812,0.429135845,0.667824368,0.78802964,19.53515369,0,-2.098978164,1.211989476,-1.731845206,0.083301127,0.167929233,22.52478746,0,-2.520593283,1.212368078,-2.079066027,0.037611282,0.103117853,19.10588369,0,-2.169780352,1.209139543,-1.794482999,0.07273611,0.14923062,N,-,,beta-ketoacyl synthase domain-containing,P:nucleic acid phosphodiester bond hydrolysis; F:catalytic activity; F:endonuclease activity; P:metabolic process; F:phosphopantetheine binding; F:transferase activity,SM00822 (SMART); IPR013968 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR020807 (PFAM); PTHR11712:SF268 (PANTHER); PTHR11712:SF268 (PANTHER); PTHR11712 (PANTHER); PTHR11712 (PANTHER); IPR016040 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR029063 (SUPERFAMILY),,
RL4_JR_07753,276,210,218,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,547.0279739,1,1.133350943,1.707786029,0.663637554,0.506922315,0.693638418,100.1726085,0,-0.64739862,0.998003832,-0.648693521,0.516536493,0.666800457,405.6887592,0,0.937578859,0.383436183,2.445201837,0.01447711,0.043161268,861.1696287,0,2.108132366,0.621478289,3.392125523,0.000693527,0.005456066,289.0640992,0,0.348451451,0.612480623,0.568918326,0.569411568,0.685854404,N,-,,oligopeptide transporter 2,P:mycelium development; C:membrane,IPR004648 (TIGRFAM); IPR004813 (PFAM); IPR004813 (TIGRFAM); PTHR22601:SF20 (PANTHER); PTHR22601 (PANTHER); PTHR22601:SF20 (PANTHER); PTHR22601 (PANTHER),2.A.67.1.4, the oligopeptide transporter (opt) family.
RL4_JR_07754,9,11,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.83187972,0,0.450463033,0.866755507,0.519711763,0.603264487,0.77127047,13.67556805,0,2.277247668,1.142717972,1.992834386,0.046279585,0.110900085,22.17856632,0,-0.32286996,1.200438799,-0.26895995,0.787960502,0.859902137,49.41759773,0,1.357306497,0.684210886,1.983754606,0.047283203,0.118822975,10.92015348,0,-1.362793571,1.204021115,-1.131868498,0.257689725,0.389244885,N,-,,CCCH zinc finger DNA binding,F:DNA binding; F:metal ion binding,IPR000571 (SMART); PTHR37543:SF1 (PANTHER); PTHR37543 (PANTHER); PTHR37543 (PANTHER); PTHR37543:SF1 (PANTHER); IPR000571 (PROSITE_PROFILES); IPR000571 (PROSITE_PROFILES),,
RL4_JR_07755,752,489,809,0,1,0,0,0,0,0,0,0,1,0,0,0,0,3,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_07756,3188,2945,3550,0,0,11,1,0,0,0,1,0,1,1,0,0,0,3,82.81313548,1,-0.589366492,0.705111562,-0.835848571,0.403240098,0.595193182,24.54177702,1,0.457806069,1.145778178,0.399559075,0.689481304,0.803098937,193.5150627,1,1.9726554,0.425936265,4.631339384,3.63E-06,8.01E-05,284.4788271,1,2.366741931,0.370932193,6.380524461,1.76E-10,6.43E-09,274.0388407,1,2.444063502,0.435640888,5.610271142,2.02E-08,8.07E-07,N,-,,nape-hydrolyzing phospholipase d,F:hydrolase activity,IPR001279 (PFAM); IPR001279 (G3DSA:3.60.15.GENE3D); IPR024884 (PIRSF); PTHR15032 (PANTHER); PTHR15032:SF5 (PANTHER); PTHR15032:SF5 (PANTHER); PTHR15032 (PANTHER); IPR001279 (SUPERFAMILY),,
RL4_JR_07757,8623,8596,11167,2,0,8,0,0,0,0,0,0,2,7,0,0,3,1,0.826636211,1,2.172405761,1.60636955,1.352369859,0.176257027,NA,0.26215811,0,5.396943775,1.736519084,3.107909279,0.001884159,0.015023052,0.682432485,0,2.740174871,1.261759832,2.171708752,0.029877638,0.076461377,0.787463602,1,2.317518501,1.332221272,1.739589774,0.081931076,0.16905485,0.674660134,1,2.65464054,1.236968067,2.146086558,0.031866074,0.078943967,N,-,,flavin-binding monooxygenase,P:oxidation-reduction process; F:monooxygenase activity,PF13738 (PFAM); IPR032710 (G3DSA:3.10.450.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR23023:SF100 (PANTHER); PTHR23023 (PANTHER); IPR032710 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_07758,15,11,28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.374936412,0,0.655280883,1.171083055,0.559551161,0.575785625,0.750840654,1.445614607,0,2.933718953,1.361190836,2.155259113,0.031141563,0.081527405,3.768451814,0,0.274702492,1.220600756,0.225055155,0.821936367,0.884832342,52.52486303,0,3.362106209,1.527337658,2.201285479,0.02771582,0.088451852,25.83305058,0,2.43750684,0.875135175,2.785291816,0.005347957,0.018938136,N,-,,DNA polymerase alpha subunit B,,PTHR28180:SF1 (PANTHER); PTHR28180 (PANTHER); IPR029032 (SUPERFAMILY),,
RL4_JR_07759,247,302,298,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,80.44349032,0,1.106598386,1.023171058,1.081538006,0.279457864,0.462719151,7.796351094,0,0.502691847,1.245665058,0.403552981,0.686541467,0.800901568,48.90736446,1,0.666942146,0.767339861,0.869161346,0.384758887,0.52853446,36.65256173,0,-0.836032462,1.034811856,-0.807907696,0.419143721,0.562245651,19.96182553,0,-2.232988369,1.213705334,-1.839810955,0.065795997,0.138528689,N,-,,c6 zinc finger domain containing,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31944 (PANTHER); PTHR31944:SF50 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07760,718,955,979,0,0,7,0,0,0,3,0,0,0,0,0,0,0,0,60.84428006,1,2.061470127,0.538861189,3.825605127,0.000130451,0.001070645,4.572782905,0,1.272427456,1.268160739,1.003364492,0.31568503,0.477347456,236.8388773,1,4.271727596,1.35912145,3.143006533,0.001672221,0.008602422,17.6791136,0,-0.853826185,1.159104268,-0.736625866,0.461349901,0.603666031,23.26276856,0,0.729423935,0.874681461,0.833930943,0.4043199,0.541141967,N,-,,deoxyribose-phosphate aldolase,F:deoxyribose-phosphate aldolase activity; C:cytoplasm; P:deoxyribonucleotide catabolic process; P:carbohydrate catabolic process,IPR002915 (SMART); IPR011343 (PIRSF); IPR002915 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); IPR011343 (TIGRFAM); IPR011343 (PANTHER); PTHR10889:SF7 (PANTHER); IPR028581 (HAMAP); SSF51569 (SUPERFAMILY),,
RL4_JR_07761,307,306,458,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5.595379589,0,-0.586613032,1.192736721,-0.491821054,0.622845851,0.783890227,1.789784243,0,2.625753779,1.319549192,1.989886997,0.046603385,0.111542474,4.63634418,0,-0.024013584,1.197577839,-0.020051794,0.984002056,0.992234742,21.3943882,0,2.273001644,0.740544774,3.069364235,0.002145149,0.013976597,11.92942239,1,0.829803207,1.120303411,0.740695064,0.458878353,0.590586414,N,-,,alcohol dehydrogenase,F:zinc ion binding; P:folic acid-containing compound biosynthetic process; P:oxidation-reduction process; F:methylenetetrahydrofolate dehydrogenase (NADP+) activity,IPR020843 (SMART); IPR011032 (G3DSA:3.90.180.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013154 (PFAM); IPR013149 (PFAM); IPR002085 (PANTHER); PTHR11695:SF535 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_07762,273,189,367,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,62.47966695,0,5.719677096,0.954083281,5.994945315,2.04E-09,5.29E-08,0.44144579,0,4.645347553,1.620137816,2.867254567,0.004140498,0.018371529,12.21221497,0,2.960163003,1.220707435,2.42495697,0.015310201,0.045242405,40.00011394,0,5.08381962,0.638396821,7.963416256,1.67E-15,1.07E-13,23.21701761,0,4.178126899,0.881742464,4.738488921,2.15E-06,2.76E-05,N,-,,ammonium transporter,F:ammonium transmembrane transporter activity; P:ammonium transmembrane transport; C:integral component of membrane; P:pseudohyphal growth; P:nitrogen utilization; C:plasma membrane,IPR029020 (G3DSA:1.10.3430.GENE3D); IPR024041 (PFAM); IPR001905 (TIGRFAM); IPR001905 (PANTHER); PTHR11730:SF35 (PANTHER); IPR024041 (SUPERFAMILY),1.A.11.3.5, the ammonium transporter channel (amt) family.
RL4_JR_07763,5259,6228,6576,0,0,7,0,0,0,0,0,0,1,1,0,0,4,2,1.280868394,1,1.540291199,1.443430138,1.067104779,0.285924524,NA,0.408975693,0,4.755306197,1.636066116,2.906548916,0.003654398,0.017196565,1.062726612,0,2.100600137,1.267977483,1.656654132,0.097589421,0.190597424,1.225974319,1,1.678478057,1.312829585,1.278519372,0.201066359,0.332103896,1.051287695,1,2.013789236,1.254723833,1.604966115,0.108501262,0.203026294,Y,-,,alpha beta-hydrolase,F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR000073 (PFAM); IPR029058 (SUPERFAMILY),,
RL4_JR_07764,8521,13373,20076,2,4,1,0,0,0,0,0,0,0,3,0,0,7,0,455.8883203,1,-2.786879634,0.509693636,-5.467754428,4.56E-08,9.75E-07,133.2299183,0,-2.569119467,1.105341462,-2.324276755,0.020110666,0.057780346,422.36173,0,-1.72352373,0.452047813,-3.812702287,0.000137456,0.001401411,555.0614158,1,-1.086590728,0.38518832,-2.820933739,0.004788409,0.027100416,405.4657936,1,-1.794835234,0.443136606,-4.050297831,5.12E-05,0.000398557,N,-,,adenylosuccinate lyase,"F:N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity; P:'de novo' AMP biosynthetic process; P:'de novo' IMP biosynthetic process; F:(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity",IPR019468 (SMART); IPR004769 (TIGRFAM); IPR024083 (G3DSA:1.10.275.GENE3D); G3DSA:1.20.200.10 (GENE3D); IPR022761 (PFAM); IPR019468 (PFAM); PTHR11444:SF2 (PANTHER); IPR000362 (PANTHER); IPR008948 (SUPERFAMILY),,
RL4_JR_07765,1496,1236,1512,2,0,0,0,0,1,0,0,0,0,1,1,0,0,0,0.65672855,1,2.504194641,1.885366493,1.328226978,0.184103134,NA,0.205924761,1,5.744931885,1.876758514,3.061092752,0.002205308,0.015045494,0.541071693,0,3.074172597,1.340058123,2.294059148,0.021787101,0.05950165,0.624652414,1,2.651228601,1.470789587,1.80258864,0.071452842,0.15347052,0.540833498,0,2.973393388,1.311646538,2.26691666,0.023395317,0.061670812,N,-,,hypothetical protein CMQ_7382,C:membrane; C:integral component of membrane,PTHR33048 (PANTHER),,
RL4_JR_07766,725,970,1381,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,0.015624059,0,7.894997458,3.974358507,1.986483465,0.046979667,NA,0.005342092,0,11.01782189,3.970278013,2.775075663,0.005518887,0.021974647,0.013322949,0,8.419138269,3.972556748,2.119324859,0.034063022,0.084689105,0.015325853,0,8.000645136,3.972725723,2.013893154,0.044020753,0.113902079,0.012659449,1,8.375900661,2.059145617,4.067658253,4.75E-05,0.000372148,N,-,,aminoglycoside phosphotransferase,P:phosphorylation; F:transferase activity; F:kinase activity,IPR015897 (SMART); IPR004119 (PFAM); G3DSA:3.90.1200.10 (GENE3D); PTHR11012 (PANTHER); IPR011009 (SUPERFAMILY),1.C.59.5.2, the clostridium perfringens enterotoxin (cpe) family
RL4_JR_07767,4097,3737,6689,0,1,7,0,0,0,0,0,7,0,8,1,0,0,0,39.54014428,1,0.879313173,0.749071892,1.173870203,0.240447019,0.415146409,5.131941048,0,1.105913266,1.27467999,0.867600711,0.385612957,0.550285401,21.26677308,1,-0.5960629,1.220134105,-0.488522448,0.625179829,0.737683052,23.516222,1,-0.273639837,1.06032172,-0.258072462,0.796350984,0.868832448,28.79994013,0,0.904578726,0.840527114,1.0762041,0.281835987,0.415551094,N,-,,vacuolar fusion mon1,C:late endosome membrane; F:phosphatidylinositol phosphate binding; P:single-organism cellular process; P:protein targeting to vacuole,IPR004353 (PRINTS); IPR004353 (PFAM); PTHR13027:SF7 (PANTHER); IPR004353 (PANTHER),,
RL4_JR_07768,279,204,171,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,559.6137803,0,1.619110265,0.609609139,2.655980956,0.007907808,0.031484577,187.8823252,0,1.205418844,0.63837294,1.888267449,0.058990055,0.134481382,258.4000308,0,0.451689046,0.389288621,1.160293473,0.245929341,0.380178447,333.0639216,0,0.745517386,0.448980812,1.660466029,0.096820737,0.191279992,295.8967599,0,0.943700735,0.496780414,1.899633539,0.057481228,0.124331859,Y,-,,disulfide isomerase,C:endoplasmic reticulum lumen; F:protein disulfide isomerase activity; P:cell redox homeostasis; P:protein folding; P:response to endoplasmic reticulum stress,PR00421 (PRINTS); PF13848 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR012336 (G3DSA:3.40.30.GENE3D); IPR005792 (TIGRFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR013766 (PFAM); IPR005788 (TIGRFAM); PTHR18929:SF74 (PANTHER); PTHR18929:SF74 (PANTHER); PTHR18929 (PANTHER); IPR013766 (PROSITE_PROFILES); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY),8.A.88.1.3, the calciquestrin (casq) family.
RL4_JR_07769,356,287,209,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,52.47656716,1,1.082588209,0.614058238,1.763005758,0.077899518,0.184417955,6.973904151,0,0.663560976,1.236930975,0.536457562,0.591642358,0.728639536,25.95545625,0,-1.02808754,1.198702136,-0.85766723,0.39107624,0.534601115,57.00187091,0,1.402421009,0.574801598,2.439834915,0.014693975,0.065631958,17.8576017,0,-2.072198042,1.204286675,-1.72068502,0.085307996,0.169560946,N,-,,hypothetical protein CMQ_3925,,PTHR37849 (PANTHER); PTHR37849:SF1 (PANTHER),,
RL4_JR_07770,656,548,407,0,0,0,0,0,0,0,0,0,0,0,0,0,6,1,12.43340232,0,-1.738507864,1.216311822,-1.429327442,0.152910142,0.30095077,160.1169972,0,5.308444064,1.633162609,3.250407544,0.001152397,0.015023052,10.26545878,0,-1.170846714,1.211219629,-0.966667552,0.333710253,0.477186808,15.858256,0,-0.647826928,1.163359429,-0.556858794,0.57762391,0.704180169,10.18240565,1,-1.261744314,1.222053651,-1.032478658,0.30184794,0.437163553,N,-,,hit finger domain,,IPR007529 (PFAM); PTHR13093 (PANTHER),,
RL4_JR_07771,1920,2784,2738,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,85.5002747,1,-1.20618571,0.764061233,-1.578650582,0.114416226,0.244030854,18.31014337,1,-0.729100482,1.206530504,-0.604295109,0.545647458,0.692196758,47.68306713,0,-3.386459306,1.19811127,-2.826498165,0.004706001,0.018094969,99.97144004,0,-0.273269689,0.595092391,-0.459205484,0.646086613,0.757555062,51.0784113,0,-2.545907258,1.136649657,-2.239834625,0.025101661,0.06557129,N,-,,Kelch repeats,,IPR013536 (PFAM); IPR025183 (PFAM); PF13415 (PFAM); IPR015915 (G3DSA:2.120.10.GENE3D); PTHR23244 (PANTHER); PTHR23244:SF304 (PANTHER); IPR013536 (PROSITE_PROFILES); SSF117281 (SUPERFAMILY),,
RL4_JR_07772,5612,6320,6652,0,0,0,0,0,0,0,0,0,2,5,0,0,0,0,1.675613135,0,1.152954364,1.33064466,0.866463,0.386236308,NA,0.531078228,0,4.378412527,1.535194856,2.852023969,0.004344182,0.018791374,1.384089366,0,1.719722915,1.235631545,1.391776474,0.163990096,0.280540002,1.597163269,1,1.297091182,1.258711705,1.030491078,0.302779538,0.448521262,1.37091066,0,1.631347349,1.230313587,1.325960606,0.184852746,0.303617307,N,-,,---NA---,,no IPS match,,
RL4_JR_07773,12000,12143,8907,0,4,1,0,0,0,0,0,3,2,0,0,0,8,0,281.1054082,1,0.464142314,0.423580329,1.095759842,0.273183887,0.455363772,92.65617226,0,1.42020976,0.663182588,2.141506404,0.032233223,0.083674694,204.9957051,1,0.254516499,0.526119946,0.483761356,0.628555244,0.740026491,244.7191845,1,0.220144198,0.433504823,0.507824103,0.611576705,0.731421466,208.2245103,1,0.600786308,0.642628456,0.934889052,0.34984548,0.487233216,N,-,,aminopeptidase 2,F:zinc ion binding; P:peptide catabolic process; P:proteolysis; C:cytosol; F:metalloaminopeptidase activity; F:peptide binding; C:plasma membrane,IPR014782 (PRINTS); G3DSA:1.10.390.10 (GENE3D); IPR014782 (PFAM); IPR024571 (PFAM); PTHR11533:SF190 (PANTHER); IPR001930 (PANTHER); SSF55486 (SUPERFAMILY); SSF63737 (SUPERFAMILY),3.A.1.145.1, the atp-binding cassette (abc) superfamily.
RL4_JR_07774,10057,7655,11589,6,2,11,0,0,2,0,0,0,0,2,0,0,0,0,7507.999739,1,2.475680542,0.66406015,3.72809683,0.000192931,0.001487649,806.3833095,1,0.446922486,0.971727766,0.459925611,0.645569617,0.770294979,2322.865032,0,0.557258246,0.411788051,1.353264728,0.175971073,0.295199858,2788.235243,1,0.631953936,0.345101458,1.831212012,0.067068905,0.146745735,1945.434788,0,0.136368731,1.14121551,0.119494284,0.904883768,0.939109077,N,-,,enolase,F:magnesium ion binding; F:phosphopyruvate hydratase activity; P:glycolytic process; C:phosphopyruvate hydratase complex,IPR000941 (PRINTS); IPR020811 (SMART); IPR020810 (SMART); IPR029017 (G3DSA:3.30.390.GENE3D); IPR029065 (G3DSA:3.20.20.GENE3D); IPR020810 (PFAM); IPR020811 (PFAM); IPR000941 (PIRSF); IPR000941 (TIGRFAM); IPR000941 (PANTHER); IPR000941 (HAMAP); IPR029065 (SUPERFAMILY); IPR029017 (SUPERFAMILY),,
RL4_JR_07775,5071,3889,3559,11,2,3,0,0,2,0,2,1,0,3,2,0,1,3,81.45934749,1,-0.18580175,0.684372389,-0.271492178,0.786012515,0.889847237,16.25466606,1,-0.557233758,1.22835499,-0.45364228,0.650086317,0.773702236,66.14258149,1,-0.79896928,0.875280521,-0.912815105,0.361339793,0.505276804,77.9067521,1,-0.3518082,0.665200713,-0.528875259,0.596891986,0.719676898,63.4079636,1,-1.036540956,0.862470872,-1.201827203,0.229430484,0.356997641,N,-,,Checkpoint serine threonine- kinase bub1,P:mitotic spindle assembly checkpoint; C:nucleus; P:sister chromatid segregation; P:nuclear division; C:intracellular non-membrane-bounded organelle; C:protein complex; F:protein serine/threonine kinase activity; P:protein phosphorylation; C:intracellular organelle part; P:cellular protein localization,IPR000719 (SMART); IPR013212 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR012572 (PFAM); IPR013212 (PFAM); G3DSA:3.30.200.20 (GENE3D); IPR015661 (PANTHER); PTHR14030:SF4 (PANTHER); PTHR14030:SF4 (PANTHER); PTHR14030:SF4 (PANTHER); IPR015661 (PANTHER); IPR013212 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_07776,8,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.67860857,0,0.845154467,0.85509438,0.988375654,0.322968707,0.512204259,3.259404262,0,1.760928532,1.266812535,1.390046659,0.164514709,0.297076512,62.0118466,0,2.739067366,0.57479244,4.765315575,1.89E-06,4.67E-05,21.7892649,0,0.991156972,0.854227717,1.160295964,0.245928327,0.384559739,12.19051209,0,-0.041939784,1.124875348,-0.037283939,0.970258611,0.980201888,N,-,,dna-(apurinic or apyrimidinic site) lyase 1,P:nucleic acid metabolic process; F:catalytic activity; F:binding,IPR001719 (SMART); IPR013022 (G3DSA:3.20.20.GENE3D); IPR013022 (PFAM); IPR001719 (TIGRFAM); IPR001719 (PANTHER); PTHR21445:SF0 (PANTHER); IPR001719 (PROSITE_PROFILES); IPR013022 (SUPERFAMILY),,
RL4_JR_07777,15314,14625,17737,0,1,0,0,0,0,0,0,3,0,3,0,0,0,0,0.641294294,1,2.538498482,1.773949871,1.430986593,0.152434058,NA,0.203942625,0,5.75912341,1.819946761,3.16444609,0.001553784,0.015023052,0.530811289,1,3.101917553,1.27348645,2.435768007,0.014860212,0.044157553,0.612446508,1,2.679783842,1.374464173,1.949693483,0.051212663,0.125006803,0.52548542,0,3.014505623,1.241441411,2.428230278,0.015172706,0.043887973,N,-,,dihydrouridine synthase,F:tRNA dihydrouridine synthase activity; P:tRNA dihydrouridine synthesis; F:flavin adenine dinucleotide binding; P:oxidation-reduction process,IPR001269 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); IPR001269 (PANTHER); IPR001269 (PANTHER); PTHR11082:SF4 (PANTHER); SSF51395 (SUPERFAMILY),,
RL4_JR_07778,359,373,526,0,0,8,0,0,0,0,0,0,0,8,0,0,9,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_07779,5487,6022,7713,0,0,2,0,0,0,0,0,1,0,2,0,0,0,0,4.875778576,1,-0.388099924,1.234365377,-0.314412516,0.753207752,0.870775614,1.544554734,0,2.838207186,1.353564262,2.09683963,0.036007774,0.091278881,4.029589951,1,0.178075597,1.220993426,0.145844845,0.884043873,0.927755797,16.68482348,1,2.040565819,0.889142659,2.294981349,0.021734193,0.080037533,3.997943156,0,0.087014591,1.229030041,0.070799401,0.943557409,0.964222725,N,-,,phosphatase methylesterase 1,C:intracellular membrane-bounded organelle; P:cellular protein modification process; C:ribosome; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR016812 (PIRSF); IPR000073 (PFAM); IPR016812 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_07780,9397,7873,8882,0,1,1,0,0,0,1,4,4,4,10,0,0,3,2,1.819350273,1,1.034205479,1.277384474,0.809627407,0.418154352,NA,0.580207093,0,4.250855732,1.50346254,2.827377218,0.004693101,0.019834475,1.50604571,1,1.598048688,1.218254704,1.311752528,0.189603647,0.312541441,1.737446925,1,1.175722399,1.232470203,0.953956044,0.340105893,0.487329156,9.206737262,1,3.182157019,0.98284266,3.237707467,0.001204943,0.005568255,N,-,,---NA---,,no IPS match,,
RL4_JR_07781,1311,1012,1861,2,0,1,0,0,0,0,0,2,0,6,4,0,0,0,4.574648362,1,-0.295763463,1.20586548,-0.245270694,0.806246842,0.901743694,1.463903344,0,2.915761194,1.350020314,2.159790608,0.030788883,0.08077892,3.788288381,1,0.267651688,1.20406907,0.222289315,0.82408867,0.886429419,8.381277834,1,0.792487512,1.148311676,0.690132765,0.4901107,0.629982333,3.722683304,0,0.189934536,1.198115541,0.158527729,0.874040972,0.916304084,Y,-,,transient receptor potential ion channel,C:membrane,IPR032800 (SMART); IPR010308 (PFAM); IPR032800 (PFAM); PTHR31145:SF5 (PANTHER); PTHR31145 (PANTHER),1.A.4.9.3, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_07782,6046,4681,5438,2,5,15,0,0,0,1,0,4,2,7,0,0,0,1,30.74839092,1,-1.905859871,1.143387496,-1.666853868,0.095543466,0.214015265,8.636382663,0,0.355139271,1.229184214,0.28892274,0.772640502,0.862066485,22.32049058,1,-2.29124433,1.193633722,-1.919553954,0.054914265,0.121466467,41.79013898,1,-0.00164427,0.751616013,-0.002187646,0.998254512,0.998846421,21.90779182,1,-2.36716801,1.190301909,-1.988712269,0.046732971,0.106330636,N,-,,c2h2 finger domain-containing,F:metal ion binding,IPR015880 (SMART),,
RL4_JR_07783,14838,11780,11131,2,7,4,0,0,0,0,6,1,0,2,3,0,3,2,60.84025964,1,-0.94698567,0.890023371,-1.064000903,0.287328291,0.471255367,11.6769254,0,-0.080072144,1.231399859,-0.065025299,0.948153857,0.972362041,54.4370121,1,-0.328636749,0.875027906,-0.375572878,0.707234457,0.801347694,131.8602067,1,1.32396388,0.509056179,2.600820761,0.009300103,0.045866315,29.97707044,1,-2.819540549,1.213827145,-2.322851785,0.020187116,0.054900497,N,-,,UPF0136 domain,C:mitochondrion; C:integral component of membrane; C:endoplasmic reticulum,IPR005349 (PFAM); IPR005349 (PANTHER); PTHR12668:SF15 (PANTHER),2.A.126.1.9, the fatty acid exporter (fax) family.
RL4_JR_07784,2952,3001,4326,1,0,7,0,0,1,0,0,0,3,3,0,0,9,0,21.92666815,1,-2.557039229,1.207245864,-2.118076612,0.03416858,0.10019672,6.97174861,1,0.663932651,1.242275434,0.534448829,0.593031044,0.729714114,44.1475083,0,0.813858786,0.770128776,1.056782725,0.29061076,0.430263723,38.60299995,1,-0.106872246,0.875722987,-0.122038872,0.902868233,0.940487743,82.08096056,1,1.624744407,1.807946746,0.898668288,0.368829373,0.505057804,N,-, Effector probability:0.837,cmc1- cytochrome c oxidase biogenesis,C:mitochondrion,IPR013892 (PFAM); PTHR22977 (PANTHER); PTHR22977:SF1 (PANTHER),,
RL4_JR_07785,2961,3879,4813,0,1,5,0,0,0,0,0,1,0,3,0,0,5,0,55.89425007,1,-0.355396309,0.797227456,-0.445790354,0.65574869,0.805662322,11.58910848,0,-0.069244387,1.247512491,-0.055505967,0.955735377,0.976575155,62.8423902,1,0.373725703,0.746489005,0.500644619,0.616621255,0.730958924,108.2393974,1,0.8853842,0.692195991,1.279094667,0.200863722,0.331877477,37.58558551,1,-1.887964141,1.168863961,-1.615212895,0.106264599,0.200023994,N,-, Effector probability:0.596,prefoldin subunit 2,F:tubulin binding; P:tubulin complex assembly; C:cytoplasm; C:prefoldin complex; C:integral component of membrane; F:unfolded protein binding; P:protein folding,IPR002777 (PFAM); IPR009053 (G3DSA:1.10.287.GENE3D); IPR027235 (PANTHER); IPR009053 (SUPERFAMILY),,
RL4_JR_07786,9156,7400,7757,2,7,16,0,0,0,5,7,0,4,6,0,0,3,0,10.17384334,1,-1.448918029,1.209550637,-1.197897785,0.230956812,0.403630179,3.253526048,0,1.763582677,1.289505516,1.367642601,0.171423975,0.306901084,8.416150914,1,-0.884004445,1.207764335,-0.73193455,0.464208517,0.601414833,50.64860742,1,2.014734223,0.638978332,3.153055626,0.00161571,0.011083378,15.98186915,1,0.703810494,0.989977065,0.71093616,0.477123797,0.606894277,N,-,,nuclear transcription factor Y subunit B-3,C:CCAAT-binding factor complex; F:protein heterodimerization activity; P:transcription from RNA polymerase II promoter; F:sequence-specific DNA binding; P:carbon catabolite activation of transcription from RNA polymerase II promoter; P:regulation of cellular respiration,no IPS match,,
RL4_JR_07787,6359,6102,4696,3,5,7,1,0,0,2,0,1,3,6,4,0,5,0,79.40803821,1,1.06347938,0.561088593,1.895385851,0.058041302,0.148665915,9.168926382,1,0.268814357,1.246804439,0.215602663,0.82929748,0.897722336,23.69786694,1,-2.377625531,1.208699893,-1.967093358,0.049172449,0.111647423,35.35751868,1,-1.084641795,1.041423183,-1.041499568,0.297643754,0.442766856,23.23361422,1,-2.451902242,1.207866403,-2.029944897,0.042362141,0.098366948,N,-, Effector probability:0.698,nuclear transcription Y subunit beta,C:CCAAT-binding factor complex; F:protein heterodimerization activity; P:transcription from RNA polymerase II promoter; F:sequence-specific DNA binding; P:carbon catabolite activation of transcription from RNA polymerase II promoter; P:regulation of cellular respiration,PR00615 (PRINTS); IPR009072 (G3DSA:1.10.20.GENE3D); IPR003958 (PFAM); PTHR11064 (PANTHER); IPR009072 (SUPERFAMILY),,
RL4_JR_07788,4013,3211,3048,0,5,3,0,0,4,0,0,5,1,6,0,0,2,0,248.0079459,1,-3.578302471,0.855491618,-4.182744043,2.88E-05,0.000287941,71.35168395,1,-2.691355958,1.188741832,-2.264037394,0.023571815,0.065569395,191.7251985,1,-4.382361227,1.190297139,-3.681737175,0.00023165,0.001936603,258.6466564,1,-2.22961117,0.571875264,-3.89877183,9.67E-05,0.001041387,198.0798764,1,-2.823223115,0.761634901,-3.706793254,0.0002099,0.001299046,N,-,,RNA polymerase I-specific transcription initiation factor RRN3,"C:nucleus; F:translation initiation factor activity; P:transcription from RNA polymerase I promoter; C:cytosol; P:translational initiation; F:transcription factor activity, RNA polymerase I CORE element sequence-specific binding; P:regulation of transcription from RNA polymerase I promoter",IPR007991 (PFAM); IPR007991 (PANTHER),,
RL4_JR_07789,4538,4162,4315,4,15,1,0,0,3,0,2,2,8,1,8,0,0,2,31.18497392,1,-0.275572339,1.019046218,-0.270421826,0.78683575,0.890032226,23.61224352,1,2.818811272,1.010958304,2.788256707,0.005299253,0.021421343,23.62331746,1,-0.499071775,1.198688936,-0.416348029,0.677155352,0.778152189,68.09799525,1,1.852265469,0.557566602,3.322052401,0.000893579,0.006718958,12.31905485,1,-1.536567998,1.199192549,-1.281335511,0.200075845,0.321856996,N,-,,alanine racemase,,G3DSA:1.20.5.170 (GENE3D); PTHR40621 (PANTHER); SSF57959 (SUPERFAMILY),,
RL4_JR_07790,3359,2722,2759,0,11,2,0,0,1,0,0,2,1,0,0,0,1,0,10.54634936,1,-1.501162285,1.211340581,-1.239256993,0.21525034,0.38346339,3.352631276,1,1.72014196,1.280273874,1.343573431,0.179086366,0.316796959,40.10182324,1,1.887591195,0.765688961,2.465219288,0.013692942,0.041344273,22.10752566,1,0.928647862,0.882991743,1.051706168,0.29293438,0.437650967,8.647829673,1,-1.02612973,1.218949148,-0.841815044,0.39989149,0.537203308,Y,-,,glycosyltransferase family 17,F:transferase activity,IPR006813 (PFAM); IPR006813 (PANTHER); PS51257 (PROSITE_PROFILES),,
RL4_JR_07791,137531,137067,133103,220,510,103,1,14,51,28,13,7,1,12,3,0,14,10,47.9786288,1,0.021686968,0.734811648,0.029513643,0.976454938,0.988082286,7.782322685,1,0.505355319,1.224915847,0.412563296,0.679926597,0.796379339,31.21462953,1,-1.181473401,1.188437093,-0.994140462,0.320154489,0.462836505,27.24802496,1,-1.618020951,1.139983933,-1.419336627,0.155800899,0.273583784,27.17098934,1,-1.288418898,1.115947403,-1.154551635,0.248274082,0.378523578,N,-,,threonine aldolase,C:cytosol; P:glycine biosynthetic process; P:threonine catabolic process; F:L-allo-threonine aldolase activity,IPR023603 (PIRSF); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR015421 (G3DSA:3.40.640.GENE3D); IPR001597 (PFAM); PTHR10289 (PANTHER); PTHR10289:SF5 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_07792,2107,2042,2681,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,50.74983175,0,2.555066613,0.681493706,3.749215277,0.000177389,0.001394159,91.09624916,0,5.19429596,0.736746659,7.050314916,1.79E-12,4.63E-10,91.95438034,0,3.648583915,0.628935838,5.801202119,6.58E-09,2.87E-07,265.8964273,0,5.27533874,0.438406193,12.03299321,2.38E-33,4.64E-31,151.5864318,0,4.566925076,0.502390647,9.090386348,9.87E-20,2.22E-17,Y,-,,trehalase,"P:trehalose metabolic process; F:alpha,alpha-trehalase activity",IPR001661 (PRINTS); IPR001661 (PFAM); IPR001661 (PANTHER); PTHR23403:SF1 (PANTHER); IPR001661 (PANTHER); IPR001661 (PANTHER); PTHR23403:SF1 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_07793,831,959,671,2,0,0,0,0,0,0,0,0,1,0,0,0,0,0,22.61246749,1,1.909436493,0.876901135,2.177482063,0.029444619,0.089139743,1.555355902,0,2.828191246,1.347176975,2.099346484,0.035786369,0.090852677,4.054415688,0,0.169335775,1.216266376,0.139225895,0.889271646,0.930948735,4.678672774,1,-0.253414126,1.21849901,-0.207972369,0.835250542,0.896714212,4.016152207,0,0.080525127,1.222577142,0.065865069,0.947485251,0.966188757,N,-,,acetyltransferase,F:transferase activity; F:N-acetyltransferase activity,IPR016181 (G3DSA:3.40.630.GENE3D); IPR000182 (PFAM); PTHR13256 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_07794,2319,2073,3040,0,0,2,0,0,0,0,0,0,5,4,0,0,0,0,42.00991537,1,-1.281985215,1.032499585,-1.241632669,0.214372122,0.38281816,9.558815364,0,0.2086406,1.226648759,0.170089929,0.864939414,0.921816506,48.98401065,0,-0.042872991,0.867639236,-0.049413385,0.960589862,0.976995355,62.13492944,1,0.623456005,0.615260447,1.013320469,0.310907114,0.456950867,39.76361764,0,-0.331183152,0.871206962,-0.380142913,0.703839333,0.790238772,N,-,,copii-coated vesicle membrane,P:ER to Golgi vesicle-mediated transport; C:integral component of Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:ER to Golgi transport vesicle,IPR012936 (PFAM); PF13850 (PFAM); PTHR10984 (PANTHER),,
RL4_JR_07795,4895,4033,3332,0,0,1,0,1,0,0,0,1,0,0,3,0,4,1,88.36951349,1,1.883561871,0.473346346,3.979246668,6.91E-05,0.000615715,5.381556675,1,1.037518028,1.238378571,0.837803602,0.402141015,0.565814756,50.99984966,1,1.53041899,0.663875751,2.305279244,0.021150939,0.058061852,105.9779687,1,2.502339275,0.416594989,6.006647568,1.89E-09,5.97E-08,48.45647461,1,2.073876954,0.517541794,4.007168074,6.15E-05,0.00046191,N,-,,cell cycle inhibitor,C:cell division site; C:growing cell tip; C:cytosol; P:negative regulation of cyclin-dependent protein kinase activity; F:protein kinase inhibitor activity; P:negative regulation of G2/M transition of mitotic cell cycle,IPR006597 (SMART); IPR006597 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR11102:SF100 (PANTHER); PTHR11102 (PANTHER); PTHR11102:SF100 (PANTHER); PTHR11102 (PANTHER); SSF81901 (SUPERFAMILY),3.A.16.1.4, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_07796,3842,4747,6691,0,4,6,0,0,5,0,1,0,4,2,0,0,8,4,54.18954735,1,-1.606470596,1.020482714,-1.574226172,0.115435171,0.245751598,12.13093185,1,-0.135152767,1.214588406,-0.111274541,0.911398644,0.950652603,42.64878861,1,-1.830166955,1.197181725,-1.528729446,0.126331529,0.230779574,36.43626619,1,-3.214543881,1.198043029,-2.683162293,0.007292959,0.037693318,31.25991287,1,-2.880022852,1.205834597,-2.38840622,0.016921626,0.04789809,N,-, Effector probability:0.585,proteasome component PUP1,"C:nuclear envelope; P:proteasome-mediated ubiquitin-dependent protein catabolic process; F:threonine-type endopeptidase activity; C:proteasome core complex, beta-subunit complex; C:proteasome storage granule; P:proteasomal ubiquitin-independent protein catabolic process",IPR000243 (PRINTS); IPR029055 (G3DSA:3.60.20.GENE3D); IPR024689 (PFAM); IPR001353 (PFAM); PTHR11599:SF44 (PANTHER); PTHR11599 (PANTHER); IPR023333 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY),,
RL4_JR_07797,19318,18487,18529,0,4,6,0,0,2,4,4,3,9,16,6,0,13,3,217.6869157,1,-0.631335321,0.547486874,-1.153151521,0.248848198,0.425687481,122.8789156,1,-0.396446034,0.979063227,-0.404923832,0.6855335,0.800065731,148.312923,1,-2.301774412,0.846465613,-2.71927693,0.006542481,0.023311485,187.3257908,1,-1.592802789,0.565569377,-2.816281879,0.004858302,0.027373571,171.4864695,1,-0.5475765,0.490422797,-1.116539654,0.264191206,0.396580573,N,-,,nuclear pore complex subunit,C:nuclear part; P:nuclear export; P:macromolecule localization,IPR015943 (G3DSA:2.130.10.GENE3D); IPR024977 (PFAM); PTHR23193 (PANTHER); SSF117289 (SUPERFAMILY),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_07798,4065,5362,6876,1,0,3,0,0,0,0,0,0,0,0,0,0,1,0,39.4527005,1,0.013411152,0.747764193,0.017935002,0.985690706,0.992495256,7.697268035,0,0.521163575,1.22055995,0.426987281,0.669388592,0.788825193,53.20320048,0,0.285533587,0.84802323,0.336704912,0.73633936,0.82249578,126.9380638,0,2.091500236,0.40775405,5.129318119,2.91E-07,5.94E-06,38.67467423,1,0.401682227,0.751779606,0.534308491,0.593128119,0.704696339,Y,-,,mn2+ homeostasis per1,P:GPI anchor biosynthetic process; C:fungal-type vacuole membrane; C:integral component of membrane; C:endoplasmic reticulum; C:Golgi apparatus; P:cellular manganese ion homeostasis,IPR007217 (PFAM); PTHR13148:SF0 (PANTHER); IPR007217 (PANTHER),9.B.132.1.1, the post-gpi attachment protein-3 (p-gap3) family.
RL4_JR_07799,14458,15241,20729,1,1,3,2,0,0,0,0,0,2,3,0,0,2,4,57.15868134,1,3.075917635,0.821175748,3.745748266,0.000179857,0.001405433,2.388890965,1,2.20907638,1.319444657,1.674247091,0.094082048,0.193151862,12.72299765,0,0.512606109,1.214458418,0.422086176,0.672962118,0.775093115,26.12933195,1,0.887992756,1.039643373,0.854132079,0.393031812,0.537971598,6.171554662,1,-0.539437144,1.231094195,-0.438176986,0.66125799,0.758495202,N,-,,hypothetical protein SPI_04127,,no IPS match,,
RL4_JR_07800,342,361,345,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,125.5994716,0,-0.191226708,0.511706768,-0.373703691,0.708624779,0.842882935,29.77991401,0,0.032485207,1.108557522,0.029304033,0.97662211,0.987831897,59.48723576,0,-2.576852845,1.188209156,-2.168686239,0.030106513,0.076969277,91.79163079,0,-0.910424037,0.665114035,-1.368823974,0.171054305,0.293373884,74.40290183,0,-1.390848695,0.841112691,-1.653581867,0.098212499,0.188405653,N,-,,ubiquitin conjugating enzyme,F:ATP binding; F:ligase activity,SM00212 (SMART); IPR000608 (PFAM); IPR016135 (G3DSA:3.10.110.GENE3D); PTHR24067 (PANTHER); PTHR24067:SF159 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),3.A.20.1.1, the peroxisomal protein importer (ppi) family.
RL4_JR_07801,58045,61092,76876,2,4,40,2,0,0,0,4,11,8,14,0,0,25,8,138.6103718,1,2.047816068,0.419758611,4.87855642,1.07E-06,1.61E-05,17.56255384,1,1.349006915,1.125965158,1.198089395,0.230882217,0.380927433,36.922035,1,-0.395022545,1.036457026,-0.381127761,0.703108449,0.798280331,72.49472832,1,1.080454353,0.554369476,1.948978794,0.051297957,0.125103619,76.69401204,1,1.512865652,0.534269627,2.831651987,0.004630822,0.016765927,N,-,,trans-2-enoyl- reductase,F:zinc ion binding; C:mitochondrion; P:fatty acid biosynthetic process; P:aerobic respiration; F:enoyl-[acyl-carrier-protein] reductase activity,IPR020843 (SMART); IPR013149 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR11695:SF590 (PANTHER); IPR002085 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_07802,79516,44587,55717,10,7,10,0,0,0,2,2,6,1,17,2,0,12,3,13.58537988,1,0.368383256,1.146621618,0.321277089,0.748000417,0.868144459,1.787722518,0,2.627408869,1.332613625,1.971620895,0.0486529,0.115358317,24.12277558,1,2.379183838,0.861660007,2.761163124,0.00575959,0.021111546,5.336257989,1,-0.443123604,1.205920662,-0.367456681,0.713278399,0.808275746,19.28354875,1,1.58860904,0.977788961,1.624695209,0.104227519,0.197032044,N,-,,hypothetical protein SPSK_06562,P:mycelium development,no IPS match,,
RL4_JR_07803,5863,4183,4239,0,0,7,0,0,0,0,1,2,0,0,0,0,0,0,402.3120558,1,1.819025434,0.997914314,1.822827279,0.068329555,0.167951946,103.8683979,0,1.338743812,0.797631246,1.678399409,0.093269153,0.191884221,97.74944586,1,-1.181278125,0.807912877,-1.462135533,0.143704073,0.253902275,224.7536817,0,0.640599576,0.700562914,0.914406918,0.360503068,0.506535326,100.345647,0,-1.358793535,0.827502153,-1.642042297,0.100581239,0.192003213,N,-,,dienelactone hydrolase,F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR002925 (PFAM); PTHR17630:SF43 (PANTHER); PTHR17630 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_07804,31636,38110,55829,3,5,68,1,0,1,3,2,0,8,27,0,0,33,1,35.55312655,1,2.245709387,0.601963899,3.730637984,0.000190996,0.001478312,2.80493808,1,1.97752843,1.278916777,1.546252629,0.122043568,0.236743003,7.291736516,1,-0.677296958,1.199647213,-0.564580112,0.572359396,0.695929499,36.67297664,1,1.234659115,0.851773077,1.449516483,0.147193401,0.262290247,7.200290856,1,-0.761743363,1.204363293,-0.632486367,0.527069114,0.650801803,N,-,,homocitrate synthase,,IPR019339 (SMART); IPR019339 (PFAM); PTHR22093 (PANTHER),,
RL4_JR_07805,49438,53941,80018,5,8,55,10,1,10,0,0,2,1,36,0,0,11,4,150.7783726,1,-2.144881619,0.719426558,-2.981376757,0.002869555,0.013884835,41.76704973,1,-1.918802189,1.197897291,-1.601808605,0.10919794,0.216598382,147.8021281,1,-1.189998101,0.641904769,-1.853854586,0.063759967,0.136730756,125.5568146,1,-4.999387699,1.199776707,-4.166931788,3.09E-05,0.000386864,115.4591474,1,-3.004057274,0.997447647,-3.011744309,0.002597513,0.010566419,N,-,,ATP-dependent rRNA helicase spb4,,IPR025313 (SMART); IPR014001 (SMART); IPR001650 (SMART); IPR001650 (PFAM); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR025313 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24031:SF2 (PANTHER); PTHR24031 (PANTHER); PTHR24031 (PANTHER); IPR014014 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_07806,2491,2409,3996,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,127.7077874,1,-3.165145662,1.005119809,-3.149023265,0.001638172,0.008844608,35.71140128,0,-1.692793468,1.194602467,-1.417034968,0.156472704,0.285732764,130.4296224,0,-1.198887773,0.665265979,-1.802117967,0.071526848,0.149646167,210.3204434,1,-0.036357854,0.398719899,-0.091186454,0.927344438,0.956926461,117.8566108,0,-1.229468816,0.622419006,-1.975307316,0.048233284,0.108960731,N,-,,phosphatidate cytidylyltransferase,C:integral component of endoplasmic reticulum membrane; F:diacylglycerol kinase activity; P:phosphorylation; P:phosphatidic acid biosynthetic process,PTHR31303:SF1 (PANTHER); PTHR31303 (PANTHER),,
RL4_JR_07807,40,26,46,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.94785344,0,-1.680834557,1.216403554,-1.381806681,0.167031067,0.318883993,3.818658656,0,1.532517649,1.287315575,1.190475497,0.233859555,0.384102199,9.878400135,0,-1.115143812,1.212641753,-0.919598727,0.357782492,0.501209274,15.40650776,0,-0.591535066,1.16430091,-0.508060297,0.611411058,0.731309741,13.55397016,0,-0.26192784,1.141368719,-0.229485736,0.818491406,0.878163133,N,-,,---NA---,,no IPS match,,
RL4_JR_07808,285,348,375,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33.01169389,0,-3.147307655,1.198592766,-2.625835684,0.008643653,0.033706942,10.5123701,0,0.071455913,1.221062008,0.058519479,0.953334847,0.975106641,27.33714069,0,-2.583876091,1.198760299,-2.155456845,0.031126102,0.079026542,31.53964848,0,-3.006346723,1.19881512,-2.507765105,0.01214974,0.056637257,27.03909069,0,-2.670765953,1.206188962,-2.214218532,0.02681375,0.06900792,N,-,,hypothetical protein CMQ_7018,,no IPS match,,
RL4_JR_07809,2297,1956,1673,0,1,3,0,0,0,0,1,1,0,0,0,0,0,0,11.70638238,1,1.589576958,1.040406359,1.527842409,0.12655167,0.262101935,1.291478259,0,3.096475302,1.373591492,2.254291264,0.024177851,0.066756193,9.858186764,1,1.402614269,1.205705155,1.163314483,0.244701932,0.378910362,7.887956276,0,0.964151822,1.162431231,0.829426978,0.406862841,0.550512664,3.318033847,0,0.356090992,1.219425617,0.292015345,0.770274892,0.840866121,N,-,,hypothetical protein SPBR_07833,,no IPS match,,
RL4_JR_07810,2494,2246,2652,0,0,3,0,0,0,0,5,5,1,14,6,0,9,6,7.591322767,1,-1.026842107,1.22708072,-0.836817082,0.402695394,0.594604349,2.44969606,0,2.172951464,1.339281996,1.622474932,0.104701696,0.209693425,6.316757013,1,-0.470236764,1.22582608,-0.38360806,0.701268965,0.797086225,7.283802366,1,-0.891922946,1.22742307,-0.726663013,0.467432416,0.608949204,17.77718792,1,1.636222425,0.891246566,1.835880761,0.066375294,0.139371598,N,-,,guanine nucleotide exchange factor lte1,C:cellular bud; P:vesicle-mediated transport; P:small GTPase mediated signal transduction; F:guanyl-nucleotide exchange factor activity; C:membrane; F:scavenger receptor activity; P:receptor-mediated endocytosis; P:positive regulation of GTPase activity; C:intracellular,IPR000651 (SMART); IPR001895 (SMART); IPR001895 (PFAM); IPR000651 (PFAM); G3DSA:1.20.870.10 (GENE3D); IPR001895 (G3DSA:1.10.840.GENE3D); PTHR23113:SF216 (PANTHER); PTHR23113 (PANTHER); PTHR23113 (PANTHER); PTHR23113 (PANTHER); PTHR23113:SF216 (PANTHER); PTHR23113:SF216 (PANTHER); IPR000651 (PROSITE_PROFILES); IPR001895 (PROSITE_PROFILES); IPR023578 (SUPERFAMILY),,
RL4_JR_07811,4952,3742,3660,0,0,2,0,0,0,6,1,7,0,6,0,0,4,1,0.907571968,1,2.037353892,1.601832321,1.271889614,0.203412342,NA,0.290570684,0,5.248450453,1.742326054,3.012323923,0.002592558,0.015349618,0.753807684,1,2.596054019,1.287353806,2.016581617,0.043739193,0.102064907,0.869504483,1,2.174151303,1.361239576,1.597184904,0.110224497,0.211088146,0.744537874,1,2.51133057,1.262599193,1.989016454,0.046699387,0.106292685,N,-,,---NA---,,no IPS match,,
RL4_JR_07812,2964,2723,2526,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,332.8024408,0,1.296683121,0.370853712,3.496481437,0.000471437,0.003210338,41.19294661,0,-0.610975696,1.14139902,-0.535286683,0.592451633,0.729271,215.5165131,0,0.737263047,0.443594761,1.662019283,0.096508908,0.188912642,208.6042383,1,0.17818862,0.468459682,0.380371304,0.703669813,0.800973227,109.6034875,0,-1.569194287,0.775418293,-2.023674578,0.043003646,0.099522149,N,-,,sphingosine kinase,P:phosphorylation; F:kinase activity,IPR001206 (SMART); IPR001206 (PFAM); PTHR12358 (PANTHER); PTHR12358:SF31 (PANTHER); PTHR12358:SF31 (PANTHER); PTHR12358 (PANTHER); IPR001206 (PROSITE_PROFILES); IPR016064 (SUPERFAMILY),,
RL4_JR_07813,2355,1929,2097,7,1,3,0,0,0,0,0,0,0,1,3,0,1,0,188.6088758,1,-1.279229549,0.585613384,-2.184426762,0.028930903,0.088000862,54.32577347,0,-1.108033408,1.120915447,-0.988507573,0.322904128,0.485219059,117.2287366,0,-4.684201846,1.20568138,-3.88510756,0.000102285,0.0011763,170.6010519,1,-1.805910378,0.653877902,-2.761846472,0.00574755,0.031287066,154.7740002,1,-1.007998274,0.674386821,-1.494688572,0.134995738,0.23929129,N,-,,ribosomal rna-processing 1,"P:rRNA processing; F:molecular_function; C:preribosome, small subunit precursor; C:preribosome, large subunit precursor",IPR010301 (PFAM); IPR010301 (PANTHER),,
RL4_JR_07814,1465,1677,2028,0,0,3,0,0,0,0,0,0,0,1,0,0,0,6,142.7202273,1,3.321603128,0.911936747,3.642361312,0.000270149,0.001985913,3.933705509,0,1.489640626,1.256083661,1.185940612,0.235645753,0.38608066,36.18457511,0,1.656640404,0.741792861,2.233292461,0.025529664,0.067660294,19.77676024,1,0.145118144,1.013415481,0.143197087,0.886134531,0.929848909,10.03251824,1,-1.240448872,1.193270136,-1.039537348,0.298554898,0.433759268,N,-,,hypothetical protein SPBR_02680,C:membrane; C:integral component of membrane,PTHR42354 (PANTHER),,
RL4_JR_07815,4851,1923,1618,1,2,0,0,0,0,3,17,47,4,28,1,0,19,13,282.9062341,1,0.394775469,0.762928955,0.517447223,0.604844002,0.772207834,40.7622596,0,-1.883660645,1.194310846,-1.577194624,0.11475075,0.225666813,120.3732495,1,-2.717643339,1.035361487,-2.624825604,0.008669336,0.029217162,167.758428,1,-0.959075564,0.518660343,-1.849139957,0.064437606,0.142818692,195.5357483,1,-0.172795243,0.465195257,-0.3714467,0.710304848,0.79529322,N,-,,nmda receptor-regulated 1,C:cytoplasm; P:positive regulation of catalytic activity; C:integral component of membrane; F:acetyltransferase activator activity; F:transferase activity; P:positive regulation of N-terminal peptidyl-serine acetylation,IPR019734 (SMART); IPR021183 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR021183 (PIRSF); PF13432 (PFAM); IPR011990 (PFAM); PTHR22767 (PANTHER); PTHR22767:SF2 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY),,
RL4_JR_07816,1133,931,1568,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12.07910379,0,-1.696769363,1.218077487,-1.392989675,0.163622913,0.314374876,3.820735699,0,1.531595685,1.273669189,1.202506662,0.229167286,0.379024718,9.968883536,1,-1.128527165,1.212182202,-0.930988067,0.351859737,0.495125201,11.50448701,0,-1.55137815,1.21267308,-1.279304518,0.200789842,0.331809557,9.883626544,0,-1.218766894,1.222518219,-0.996931477,0.318797772,0.454175804,N,-,,caffeine-induced death cid2,"F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:NAD binding; P:metabolic process; P:oxidation-reduction process",IPR019171 (PFAM); PTHR31905 (PANTHER),,
RL4_JR_07817,366,206,242,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.586939737,0,-1.204416082,1.240320085,-0.971052631,0.33152207,0.521310148,2.711136854,0,2.026559618,1.317145202,1.538600008,0.123901977,0.238889264,7.077520274,0,-0.634296405,1.227105933,-0.516904359,0.605222925,0.722130453,8.168310157,0,-1.057246494,1.229738133,-0.859733032,0.389936222,0.53453889,7.016387861,0,-0.724421231,1.237347758,-0.58546292,0.558236492,0.677227952,N,-,,D-isomer specific 2-hydroxyacid dehydrogenase,"F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; C:intracellular membrane-bounded organelle; C:cytoplasmic part; P:single-organism metabolic process",IPR006139 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR006140 (PFAM); PTHR10996:SF145 (PANTHER); PTHR10996 (PANTHER); IPR016040 (SUPERFAMILY); SSF52283 (SUPERFAMILY),,
RL4_JR_07818,4740,3903,7583,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,97.86036705,0,-1.587733138,0.763115526,-2.080593414,0.037471137,0.107561414,23.78599876,0,-1.106490517,1.213322971,-0.911950522,0.361794764,0.526309951,69.29931073,1,-2.790677427,1.19866454,-2.328155488,0.019903849,0.05540461,70.88282828,0,-4.174517298,1.19960142,-3.47992027,0.000501563,0.004196995,71.85092511,1,-1.626094886,0.851094212,-1.910593284,0.056056868,0.122138108,N,-, Effector probability:0.648,c6 zinc finger domain containing,"P:regulation of transcription, DNA-templated",no IPS match,,
RL4_JR_07819,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38.00880711,0,-0.802802778,1.033221296,-0.776990159,0.437164577,0.62711247,7.017158016,0,0.654674715,1.252216921,0.522812545,0.601104709,0.735467207,18.17111982,0,-1.994505738,1.208014089,-1.651061653,0.098725986,0.192138535,20.96206078,0,-2.416807476,1.208212852,-2.000315981,0.045466154,0.115502582,17.85012401,0,-2.071602926,1.20909505,-1.713349935,0.086648181,0.171660503,N,-,,c6 zinc finger domain containing,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_07820,5276,5057,5749,0,4,7,0,0,1,2,0,2,4,4,5,0,0,3,1354.878303,1,-0.17004068,0.307254462,-0.553419724,0.579976036,0.754375718,246.1738276,1,-2.729120428,1.005643008,-2.713806398,0.006651503,0.02499128,630.697566,1,-3.882007404,0.706092809,-5.497871322,3.84E-08,1.44E-06,743.0335507,1,-3.682838666,0.584336492,-6.302599132,2.93E-10,1.03E-08,650.3792105,1,-2.800242521,0.58725024,-4.768397403,1.86E-06,2.43E-05,N,-,,adenosylhomocysteinase,P:S-adenosylmethionine cycle; P:mycelium development; C:cytosol; P:triglyceride metabolic process; P:S-adenosylhomocysteine catabolic process; F:adenosylhomocysteinase activity; P:phosphatidylcholine biosynthetic process; P:one-carbon metabolic process,IPR015878 (SMART); IPR000043 (SMART); G3DSA:3.40.50.1480 (GENE3D); IPR000043 (PIRSF); G3DSA:3.40.50.1480 (GENE3D); IPR000043 (TIGRFAM); IPR015878 (PFAM); IPR000043 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR000043 (PANTHER); IPR000043 (HAMAP); IPR016040 (SUPERFAMILY); SSF52283 (SUPERFAMILY),,
RL4_JR_07821,72898,38680,17418,0,0,2,1,0,1,0,4,8,0,0,2,0,9,0,149.0412605,1,-2.928433871,0.897030157,-3.264587984,0.001096234,0.006342608,43.57961803,1,-1.98008677,1.201574703,-1.647909835,0.099371175,0.201650969,131.1729306,1,-2.812951312,1.04433574,-2.693531594,0.007069944,0.024749695,155.1657877,1,-1.803389718,0.664083107,-2.715608484,0.00661541,0.035013604,134.6288403,1,-2.475796409,0.872827662,-2.836523769,0.004560758,0.016585779,N,-,,eukaryotic translation initiation factor 3 subunit H,,PTHR10410 (PANTHER); IPR027524 (PTHR10410:PANTHER); IPR027524 (PTHR10410:PANTHER); IPR027524 (HAMAP),,
RL4_JR_07822,1313,1137,1033,0,0,3,0,0,0,0,0,0,0,5,0,0,0,2,28.24234808,1,2.14869298,0.84928452,2.530003701,0.011406132,0.042066559,1.340745489,0,3.042458507,1.352653881,2.249251305,0.024496512,0.067418422,3.483399895,0,0.388408042,1.204015536,0.322593879,0.74700283,0.83069603,32.92477098,1,2.296776218,0.848191769,2.707850161,0.006772059,0.035637784,3.438576591,1,0.304531035,1.204931754,0.252737165,0.800471327,0.865247377,N,-,,hypothetical protein F503_05643,,PTHR36986 (PANTHER); IPR011008 (SUPERFAMILY),,
RL4_JR_07823,984,1017,854,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,33.79924993,0,-2.061520445,1.155474548,-1.784133151,0.074402032,0.178678768,9.516826708,0,0.215017858,1.222520186,0.175880825,0.86038757,0.918192232,62.63038799,1,0.702384147,0.683268477,1.027976806,0.303960738,0.445339871,57.93962643,1,0.426225068,0.638611862,0.667424289,0.504501156,0.641315028,47.27282808,0,0.399261317,0.700179744,0.570226888,0.568523821,0.685070612,N,-,,mitochondrial carrier,P:transmembrane transport; C:membrane; C:integral component of membrane; P:transport,IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089:SF285 (PANTHER); PTHR24089:SF285 (PANTHER); PTHR24089 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.18.1, the mitochondrial carrier (mc) family.
RL4_JR_07824,2271,2358,2204,0,0,1,0,0,0,0,0,0,2,2,0,0,0,0,5.632586786,1,-0.596288231,1.237425432,-0.481878112,0.629892536,0.789227969,1.783610998,0,2.630588096,1.345142442,1.955620471,0.05050988,0.1188308,4.65606075,0,-0.030394719,1.224920165,-0.024813633,0.980203617,0.989291339,5.373097436,1,-0.45317892,1.228007789,-0.369035868,0.71210099,0.807483763,4.623740736,0,-0.122814208,1.234760739,-0.099463972,0.920769892,0.949464829,N,-,,---NA---,,no IPS match,,
RL4_JR_07825,40,36,61,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.47848667,0,-2.309979854,1.211756962,-1.906306238,0.056610485,0.145779148,5.899545937,0,0.904963287,1.259942033,0.718257875,0.472598299,0.630569418,15.27293842,0,-1.743820543,1.208589259,-1.44285623,0.149060975,0.26102537,17.61842568,0,-2.166096084,1.208566956,-1.792284716,0.07308737,0.155726644,22.72030595,0,-0.158934249,0.996160046,-0.159546901,0.87323801,0.916059102,N,-,,dipeptidyl peptidase III,,PF03571 (PFAM); PTHR23422 (PANTHER); PTHR23422:SF11 (PANTHER),,
RL4_JR_07826,2649,2914,4872,0,1,7,0,0,0,0,0,0,0,2,2,0,0,0,0.80549304,1,2.209755948,1.582597636,1.39628412,0.162628954,NA,0.257808502,0,5.421216549,1.735075589,3.124484365,0.00178117,0.015023052,0.667278009,0,2.77289066,1.248215576,2.221483783,0.026318212,0.069260613,0.769683852,1,2.350602984,1.312942212,1.790332402,0.07340049,0.156163052,0.656026691,0,2.694416495,1.216923903,2.214120774,0.026820472,0.06900792,N,-,,pth11-like integral membrane,C:integral component of membrane,PTHR33048 (PANTHER),9.B.313.1.1, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_07827,135,159,220,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.13261795,0,4.812315098,3.540143783,1.359355832,0.17403386,NA,0.0426125,0,8.01846199,2.48622528,3.225155039,0.001259045,0.015023052,0.109940862,0,5.375408553,1.441355007,3.729413313,0.000191926,0.001713457,0.126791645,0,4.952533413,2.118458529,2.337800502,0.0193976,0.075713452,0.107670697,0,5.301399012,1.278189824,4.14758349,3.36E-05,0.000276588,N,-,,flavin-binding monooxygenase,"F:NADP binding; F:flavin adenine dinucleotide binding; P:oxidation-reduction process; F:N,N-dimethylaniline monooxygenase activity",IPR023753 (G3DSA:3.50.50.GENE3D); IPR020946 (PFAM); PTHR23023 (PANTHER); PTHR23023:SF127 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_07828,1455,984,1488,0,0,1,0,0,0,0,0,2,0,1,1,0,0,0,0.168474786,1,4.467043056,3.267750852,1.367008459,0.171622654,NA,0.052795308,0,7.708453316,2.429949501,3.172268935,0.001512529,0.015023052,0.13853106,1,5.039920908,1.478880303,3.407930241,0.000654576,0.004110999,0.159931611,1,4.617071985,2.04147731,2.261632771,0.023720102,0.083109543,0.138061764,0,4.945084504,1.336115265,3.701091242,0.000214674,0.001324544,N,-,,serine threonine CMGC group,,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24055 (PANTHER); PTHR24055:SF199 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_07829,271,270,279,0,0,0,0,0,0,1,0,5,1,0,2,0,1,0,11.76137446,0,5.832060238,1.025196989,5.68872158,1.28E-08,2.97E-07,0.097653492,0,6.822102939,2.192202521,3.11198572,0.001858335,0.015023052,0.252122653,1,4.178460063,1.423487416,2.93536846,0.003331518,0.014645372,0.290828072,1,3.755232378,1.740048676,2.158119156,0.030918569,0.094093931,11.8279796,1,6.258691088,0.973353436,6.430029271,1.28E-10,8.85E-09,N,-, Effector probability:0.67,predicted protein,,no IPS match,,
RL4_JR_07830,192,120,123,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.182680545,0,4.350446336,3.141857035,1.38467355,0.16615231,NA,0.058011092,0,7.573297038,2.379483039,3.182748906,0.001458841,0.015023052,0.150489049,0,4.922837072,1.448336264,3.39896003,0.000676426,0.004214238,0.173636286,0,4.4991429,1.963554576,2.291325617,0.021944588,0.080296448,0.147901015,0,4.846002749,1.310043187,3.69911679,0.000216351,0.001330027,N,-,,thermostable alkaline protease precursor,P:proteolysis; C:membrane; C:integral component of membrane; F:serine-type endopeptidase activity; F:peptidase activity,IPR000209 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (SUPERFAMILY),,
RL4_JR_07831,24883,23413,36364,0,5,38,0,0,5,2,0,0,2,18,5,0,16,0,0.155187495,1,4.585428205,3.317224644,1.382308616,0.166876962,NA,0.049270806,1,7.80825598,2.412624626,3.236415602,0.00121041,0.015023052,0.128408386,1,5.148680729,1.420675427,3.624107681,0.000289961,0.002267697,0.148167284,1,4.727129922,2.009397156,2.352511503,0.018647113,0.074340352,0.127315506,1,5.059866953,1.283411871,3.942512195,8.06E-05,0.000580245,N,-,,Pfs NB-ARC and ankyrin-domain-containing,F:catalytic activity; P:nucleoside metabolic process,IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24188 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR020683 (SUPERFAMILY),1.A.4.7.1, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_07832,1701,1087,1953,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0.27245889,0,3.773547017,2.612325858,1.444516199,0.148593827,NA,0.086209287,0,7.001326892,2.160555173,3.240522148,0.00119311,0.015023052,0.2248295,1,4.341635549,1.347925177,3.220976672,0.001277545,0.006995062,0.259458017,0,3.919111161,1.673426336,2.341968138,0.019182352,0.075367217,0.222753048,0,4.254026848,1.265574805,3.361339711,0.000775654,0.003887868,,,,,,,,
RL4_JR_07833,95,37,76,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,239.6231444,0,-1.99255718,0.585070137,-3.405672338,0.000660013,0.004236341,61.63206,0,-2.480113835,1.197134558,-2.071708496,0.038292635,0.095703221,173.6499209,0,-3.322190137,1.046398915,-3.174879187,0.001498989,0.0078776,212.3547915,0,-2.827668156,0.762102932,-3.710349397,0.000206973,0.001978853,173.9121016,0,-3.528299214,0.996459881,-3.540834188,0.000398864,0.002238636,N,-,,amidophosphoribosyltransferase,F:identical protein binding; C:cytoplasm; P:'de novo' IMP biosynthetic process; P:nucleoside metabolic process; F:amidophosphoribosyltransferase activity; P:purine nucleobase biosynthetic process; P:adenine metabolic process,PF13522 (PFAM); IPR005854 (PIRSF); IPR029055 (G3DSA:3.60.20.GENE3D); IPR000836 (PFAM); IPR005854 (TIGRFAM); PTHR11907:SF0 (PANTHER); PTHR11907 (PANTHER); IPR017932 (PROSITE_PROFILES); IPR029057 (SUPERFAMILY); IPR029055 (SUPERFAMILY),,
RL4_JR_07834,149,233,198,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0.206398959,0,4.173984237,2.998015155,1.392249212,0.163846945,NA,0.067310023,0,7.358879048,2.344038185,3.139402377,0.001692928,0.015023052,0.172466419,1,4.724644311,1.456117706,3.24468571,0.001175803,0.006569443,0.198782875,0,4.303505126,1.91326539,2.24929858,0.024493506,0.084669352,0.168130897,0,4.655873782,1.322362928,3.520874402,0.000430126,0.002394188,N,-,,vanillyl-alcohol oxidase,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; P:oxidation-reduction process",no IPS match,,
RL4_JR_07835,3838,3987,2702,0,0,2,0,0,0,0,8,0,0,5,0,0,0,0,0.8550493,1,2.123538198,1.543706636,1.375609943,0.168942427,NA,0.273642725,0,5.335169437,1.715079946,3.11074096,0.001866186,0.015023052,0.708779867,1,2.68545661,1.245691394,2.15579607,0.031099593,0.078989532,0.817563979,1,2.263335562,1.30445444,1.73508211,0.082726262,0.17002022,0.697776298,0,2.605142864,1.217901998,2.139041456,0.032432311,0.080013925,N,-,,Vanillyl-alcohol oxidase,F:flavin adenine dinucleotide binding; P:oxidation-reduction process; F:vanillyl-alcohol oxidase activity,IPR016167 (G3DSA:3.30.43.GENE3D); IPR004113 (PFAM); IPR016170 (G3DSA:3.40.462.GENE3D); IPR016171 (G3DSA:1.10.45.GENE3D); IPR016169 (G3DSA:3.30.465.GENE3D); IPR006094 (PFAM); PTHR11748 (PANTHER); PTHR11748:SF92 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY); IPR016164 (SUPERFAMILY),,
RL4_JR_07836,1076,1120,1007,0,0,2,0,0,0,0,0,0,1,2,0,0,6,1,188.244286,1,1.150895875,0.400789675,2.871570666,0.004084375,0.018358307,47.32614775,0,1.379597951,0.866595352,1.591974787,0.11139037,0.220302107,96.05414712,0,-0.29593509,0.680509732,-0.434872679,0.663654847,0.768043172,65.53488008,1,-2.151914251,1.027613927,-2.09408825,0.03625212,0.101052846,68.45597976,1,-0.622393937,0.703604777,-0.884578896,0.376383793,0.51249138,N,-,,flavin-binding monooxygenase,F:nucleotide binding; F:coenzyme binding; P:oxidation-reduction process; F:monooxygenase activity,IPR025700 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR23023 (PANTHER); PTHR23023:SF130 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_07837,8,10,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.40038036,0,6.133903301,0.75399294,8.135226444,4.11E-16,3.16E-14,0.157291345,0,6.134324936,1.96398728,3.123403597,0.001787724,0.015023052,0.405044682,0,3.494039978,1.330380634,2.626346092,0.008630701,0.029135452,0.467101528,0,3.07153497,1.498552054,2.04966852,0.040396789,0.108119875,0.395437828,0,3.424991804,1.267220857,2.702758391,0.006876671,0.023281182,N,-,,short-chain dehydrogenase reductase sdr,C:integral component of membrane,PTHR33048 (PANTHER); PTHR33048:SF11 (PANTHER),9.B.313.1.1, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_07838,65,58,43,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.397601396,0,0.635985883,1.239008024,0.513302473,0.607739754,0.773952688,0.765627592,0,3.850792013,1.445851952,2.663337701,0.007736972,0.027939221,1.985906889,0,1.199024059,1.211833184,0.98942996,0.322452822,0.465096505,6.302502995,0,1.72346732,1.149323744,1.499549042,0.133731256,0.243881298,1.957852101,0,1.116919488,1.205654043,0.926401313,0.354237462,0.491591873,N,-,,hypothetical protein SPBR_03657,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_07839,459,293,340,0,0,18,0,0,0,0,0,0,0,0,0,0,2,1,12.07166135,1,-1.695720617,1.195168485,-1.418813028,0.155953533,0.305246863,3.846652824,0,1.521932284,1.25804422,1.209760563,0.226370783,0.375935204,9.98112011,0,-1.130146151,1.195805116,-0.945092253,0.34461178,0.488360815,11.51498386,0,-1.552541104,1.193912398,-1.300381089,0.193470388,0.322839084,9.834342429,1,-1.211529259,1.197849807,-1.011420005,0.31181545,0.44722198,N,-,,hypothetical protein SPI_04986,,no IPS match,,
RL4_JR_07840,491,441,458,0,0,3,1,0,0,0,1,3,7,2,4,0,3,3,1.909865354,1,0.964115851,1.271972215,0.75796927,0.44846938,NA,0.608919001,1,4.181159219,1.493356724,2.799839551,0.005112801,0.020935184,1.581107019,1,1.5278027,1.21830903,1.25403544,0.209829124,0.337356925,1.82406377,1,1.105475973,1.231544661,0.897633685,0.369380874,0.515077999,31.02243229,1,4.093896736,0.751576065,5.447082374,5.12E-08,1.36E-06,N,-,,hypothetical protein AFUB_092770,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_07841,1123,841,1686,0,0,0,0,0,1,0,0,1,2,0,1,0,1,1,30.25154117,0,-0.184631775,1.018467533,-0.181283909,0.856144736,0.927670176,4.536662914,1,1.283835148,1.256232569,1.021972507,0.306793913,0.468381295,33.93003177,1,0.463266795,1.038557318,0.446067623,0.655548399,0.761359641,13.60194351,1,-1.793064486,1.201353516,-1.492536928,0.135558444,0.246503097,41.47232867,1,1.499228248,0.696218368,2.153387954,0.031288202,0.077778797,N,-,,4-amino-4-deoxychorismate lyase,F:branched-chain-amino-acid transaminase activity,IPR001544 (PFAM); G3DSA:3.20.10.10 (GENE3D); G3DSA:3.30.470.10 (GENE3D); PTHR11825:SF32 (PANTHER); IPR001544 (PANTHER); IPR001544 (SUPERFAMILY),,
RL4_JR_07842,74204,18248,28810,1,1,9,0,0,0,5,10,22,5,9,1,0,7,6,0.882954482,1,2.077206612,1.555876173,1.335071934,0.181852804,NA,0.284509923,0,5.279089677,1.72638671,3.05788364,0.002229061,0.015045494,0.733649518,1,2.636006608,1.261540422,2.089514185,0.036661462,0.089220913,0.846008815,1,2.214144546,1.324899463,1.671179291,0.094686269,0.187980094,0.718974089,1,2.56155015,1.22811381,2.085759585,0.037000406,0.088606696,N,-,,kinase-like domain,P:phosphorylation; F:transferase activity; F:kinase activity,G3DSA:3.90.1200.10 (GENE3D); IPR002575 (PFAM); IPR011009 (SUPERFAMILY),,
RL4_JR_07843,192,119,120,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.200317237,0,1.634356627,1.411787283,1.157650764,0.247006584,NA,0.381468758,0,4.855862962,1.619137913,2.999042221,0.002708298,0.015349618,0.99154979,0,2.201307785,1.240783188,1.774127668,0.076042035,0.156792172,1.144054641,0,1.77872193,1.278032666,1.391765623,0.163993383,0.28434866,0.978710262,0,2.117753953,1.224605774,1.729335267,0.083749108,0.167019839,N,-,,hypothetical protein THITE_2121873,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_07844,10,12,33,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.051852897,0,1.824926504,1.491269438,1.223740297,0.221050213,NA,0.33474721,0,5.044436004,1.672148536,3.016739181,0.002555096,0.015349618,0.868559537,0,2.392755676,1.257395106,1.902946548,0.05704752,0.125118955,1.002081257,0,1.970104848,1.308526535,1.505590293,0.132172382,0.241778747,0.855079205,0,2.312693439,1.234264855,1.873741628,0.060966045,0.130310578,N,-,,hypothetical protein K432DRAFT_343507,,no IPS match,,
RL4_JR_07845,1242,1264,1547,0,0,0,0,0,1,0,1,2,2,0,0,0,0,0,0.040222084,0,6.533637034,3.93321294,1.661145006,0.096684327,NA,0.012363972,1,9.80171897,3.934233164,2.491392493,0.012724347,0.040476379,0.032838593,1,7.116338704,2.484285351,2.864541588,0.004176133,0.01683088,0.037941604,1,6.692455676,3.933535761,1.701384221,0.088870862,0.17942522,0.033102426,0,7.008466872,1.653008577,4.239824867,2.24E-05,0.000197981,N,-,,uracil phosphoribosyltransferase,,PF13207 (PFAM); IPR029057 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PF12710 (PFAM); IPR023214 (G3DSA:3.40.50.GENE3D); IPR029057 (G3DSA:3.40.50.GENE3D); PTHR10285:SF84 (PANTHER); PTHR10285 (PANTHER); IPR027417 (SUPERFAMILY); IPR029057 (SUPERFAMILY); IPR023214 (SUPERFAMILY),,
RL4_JR_07846,600,543,502,0,1,1,0,0,0,0,1,0,0,0,0,0,0,0,71.69550962,1,-3.242297925,1.184534131,-2.737192487,0.006196602,0.02585774,21.92416407,0,-0.988900416,1.24427447,-0.794760673,0.426752731,0.589624781,56.36663947,1,-3.627759071,1.221136096,-2.970806516,0.002970188,0.013488722,64.99172994,0,-4.049345187,1.225335682,-3.304682339,0.000950841,0.007096145,54.99812231,0,-3.695102924,1.216819384,-3.036689729,0.002391915,0.009852784,N,-,,Rieske domain-containing,,IPR001663 (PRINTS); IPR015879 (G3DSA:3.90.380.GENE3D); IPR017941 (G3DSA:2.102.10.GENE3D); IPR017941 (PFAM); IPR015879 (PFAM); PTHR21266:SF2 (PANTHER); PTHR21266 (PANTHER); IPR017941 (PROSITE_PROFILES); SSF55961 (SUPERFAMILY); IPR017941 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_07847,18439,25654,31471,9,0,10,0,0,0,0,0,3,3,2,0,0,2,0,14.17746668,1,-0.530027944,1.184271487,-0.447556113,0.654473582,0.804822955,3.310608328,0,1.73849494,1.315087433,1.321961489,0.186180975,0.326098604,8.559949731,1,-0.908456217,1.22539919,-0.741355327,0.458478023,0.596273064,21.90879836,1,0.942811631,0.910726575,1.035230175,0.30056143,0.446149315,8.391363482,1,-0.98262066,1.225183343,-0.802019278,0.422541807,0.558224921,N,-,,C6 transcription factor,"C:nucleus; F:DNA binding; F:zinc ion binding; F:oxidoreductase activity; P:transcription, DNA-templated; P:oxidation-reduction process; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (PFAM); PTHR31313 (PANTHER); PTHR31313:SF24 (PANTHER),,
RL4_JR_07848,434,486,737,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,28.35818493,1,-1.774965487,1.193160899,-1.487616204,0.136852138,0.277032193,7.889885777,0,0.48557161,1.28514369,0.37783449,0.705553551,0.814787569,20.32069965,0,-2.15581714,1.230435868,-1.752075989,0.079760742,0.162311107,33.06962586,0,-1.623060606,1.186078489,-1.368425969,0.17117878,0.293511456,19.84104274,0,-2.224190834,1.230140358,-1.808078906,0.070594221,0.145840948,N,-,,fructosyl amino acid oxidase,F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process,IPR023753 (G3DSA:3.50.50.GENE3D); IPR006076 (PFAM); PTHR10961:SF7 (PANTHER); PTHR10961 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_07849,588,828,428,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.042024985,0,6.47212479,3.932112565,1.645966305,0.099770696,NA,0.01339592,0,9.689232654,3.932179686,2.464086951,0.013736278,0.0429264,0.034401928,0,7.053744206,2.715659547,2.597433178,0.009392339,0.031125382,0.039683985,0,6.629481544,3.932396084,1.685863123,0.091822166,0.183589935,0.03322293,0,7.00195609,1.936581842,3.615626223,0.000299622,0.001745499,Y,-,,beta-ig-h3 fasciclin,C:membrane; C:integral component of membrane,IPR000782 (SMART); IPR000782 (PFAM); IPR000782 (G3DSA:2.30.180.GENE3D); IPR000782 (G3DSA:2.30.180.GENE3D); PTHR10900 (PANTHER); IPR000782 (PROSITE_PROFILES); IPR000782 (SUPERFAMILY); IPR000782 (SUPERFAMILY),,
RL4_JR_07850,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.27791927,0,-1.581745876,1.198198756,-1.320103087,0.186800602,0.345067357,6.856369867,0,0.688123271,1.290451023,0.533242454,0.593865757,0.730212487,17.72102675,0,-1.958322249,1.232906403,-1.588378683,0.112200735,0.210953486,20.44158689,0,-2.380540449,1.23625906,-1.925600001,0.054154339,0.128320308,17.35605691,0,-2.031118331,1.235583185,-1.643853976,0.100206369,0.191431978,N,-,,dimethylglycine mitochondrial precursor,F:oxidoreductase activity; P:oxidation-reduction process,IPR032503 (PFAM); G3DSA:3.30.9.10 (GENE3D); IPR013977 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR006076 (PFAM); IPR027266 (G3DSA:3.30.1360.GENE3D); IPR013977 (G3DSA:2.40.30.GENE3D); G3DSA:3.30.70.1400 (GENE3D); IPR006222 (PFAM); PTHR13847:SF181 (PANTHER); PTHR13847 (PANTHER); IPR023753 (SUPERFAMILY); SSF103025 (SUPERFAMILY); SSF54373 (SUPERFAMILY); IPR029043 (SUPERFAMILY),,
RL4_JR_07851,1225,1385,1531,0,0,7,0,0,0,0,0,0,0,0,0,0,1,0,0.123158789,1,4.918873372,3.678751288,1.337104084,0.181188664,NA,0.039918849,0,8.112564911,2.549275359,3.182302328,0.001461092,0.015023052,0.102671301,0,5.472671914,1.494891359,3.660916147,0.000251315,0.002044019,0.118367967,0,5.051348875,2.21536659,2.280141308,0.022599309,0.080997621,0.100466357,1,5.397965686,1.307411703,4.128742057,3.65E-05,0.000296875,Y,-, Effector probability:0.703,---NA---,,no IPS match,,
RL4_JR_07852,528,300,758,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,36.52728377,0,1.196429966,0.698801843,1.712116214,0.086875254,0.199417297,4.206984157,0,1.39265414,1.260974666,1.10442674,0.269408066,0.426618969,18.79985893,0,-0.303155162,1.202443618,-0.252115906,0.800951476,0.869272542,45.55999154,1,1.065546137,0.760361679,1.401367489,0.161104209,0.280622756,18.21915608,0,-0.41569781,1.14233548,-0.363901689,0.715931423,0.799713297,N,-, Effector probability:0.771,ubiquitin-conjugating enzyme,C:cellular_component,SM00212 (SMART); IPR000608 (PFAM); IPR016135 (G3DSA:3.10.110.GENE3D); PTHR24068 (PANTHER); PTHR24068:SF74 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),3.A.20.1.1, the peroxisomal protein importer (ppi) family.
RL4_JR_07853,13,27,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,117.6098739,0,3.013565721,0.551804049,5.461296858,4.73E-08,1.00E-06,4.836082583,0,1.191686551,1.238873947,0.961911059,0.336094283,0.499038628,58.25698865,0,1.947919488,0.607125617,3.208429088,0.001334622,0.007221654,104.5533361,0,2.223883863,0.494456984,4.497628583,6.87E-06,0.000102165,12.36094835,0,-1.541471584,1.191202665,-1.294046453,0.195649376,0.31669863,N,-,,cofilin tropomyosin-type actin-binding,F:actin binding; C:intracellular,IPR002108 (SMART); IPR029006 (G3DSA:3.40.20.GENE3D); IPR002108 (PFAM); PTHR10829 (PANTHER); IPR002108 (PROSITE_PROFILES); SSF55753 (SUPERFAMILY),,
RL4_JR_07854,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,138.6718324,0,-0.385215443,0.598145478,-0.644016309,0.519564858,0.70385422,27.1159446,0,-1.295524361,1.240445784,-1.044402245,0.296299326,0.456073871,82.75991695,0,-2.124460787,1.070835506,-1.983928226,0.047263842,0.108429444,96.48904869,0,-1.689820356,0.823511563,-2.051969192,0.040172657,0.107719319,68.09062314,0,-4.003171226,1.217913036,-3.286910565,0.00101293,0.004837696,N,-,,transcriptional corepressor of histone genes,,IPR011990 (G3DSA:1.25.40.GENE3D); G3DSA:1.10.601.10 (GENE3D); PTHR15502 (PANTHER); IPR033053 (PTHR15502:PANTHER); IPR033053 (PTHR15502:PANTHER); PTHR15502 (PANTHER); IPR033053 (PTHR15502:PANTHER); IPR033053 (PTHR15502:PANTHER); PTHR15502 (PANTHER),,
RL4_JR_07855,159,227,211,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,147.6020062,0,0.645444674,0.431775762,1.49486083,0.134950767,0.274067303,19.58099816,0,-0.825885224,1.196913255,-0.690012597,0.490186265,0.645966069,63.88209711,0,-1.659875111,1.031091583,-1.609823161,0.107436467,0.204490843,66.73077398,0,-2.175873621,1.014498809,-2.14477691,0.031970688,0.095572329,92.00378805,0,0.204494309,0.532756233,0.383842171,0.70109543,0.788398531,N,-,,bud site selection,,IPR015374 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR31975:SF1 (PANTHER); PTHR31975 (PANTHER); PTHR31975:SF1 (PANTHER); PTHR31975 (PANTHER); IPR011990 (SUPERFAMILY),,
RL4_JR_07856,2458,3523,4190,6,0,40,0,0,2,0,0,1,1,6,0,0,5,1,9.268354524,1,0.399319383,1.144061441,0.349036659,0.727061789,0.855862103,1.741545665,1,2.665190382,1.323958891,2.013046176,0.044109772,0.106966725,4.511539456,1,0.015503168,1.199127236,0.012928709,0.98968467,0.9954861,5.20424976,1,-0.40672617,1.197188184,-0.339734534,0.734056452,0.822341401,4.438819647,1,-0.063880763,1.195887012,-0.053417055,0.957399616,0.971796603,N,-,,GTPase activating,C:cytosol,IPR000195 (SMART); G3DSA:1.10.8.270 (GENE3D); IPR000195 (PFAM); PTHR22957 (PANTHER); PTHR22957:SF148 (PANTHER); PTHR22957 (PANTHER); PTHR22957:SF148 (PANTHER); PTHR22957 (PANTHER); PTHR22957:SF148 (PANTHER); IPR000195 (PROSITE_PROFILES); IPR000195 (SUPERFAMILY); IPR000195 (SUPERFAMILY),8.A.87.1.5, the tbc1 domain (tbc1) family.
RL4_JR_07857,5294,7459,10013,0,0,6,0,0,0,0,3,1,0,1,3,1,2,2,264.7272379,1,-0.667294406,0.666343843,-1.001426535,0.316620641,0.504983615,121.5367391,0,-0.059851403,0.86837791,-0.068923222,0.945050734,0.97033501,203.0417694,1,-1.14906482,0.587020635,-1.957452176,0.050294329,0.113638551,254.5739054,1,-0.573270588,0.60687639,-0.944624963,0.344850378,0.491706813,241.3566022,1,-0.212409968,0.477817144,-0.444542375,0.656650499,0.7553495,N,-,,---NA---,,no IPS match,,
RL4_JR_07858,1,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.145780257,0,4.675484319,3.484977083,1.341611209,0.17972209,NA,0.046913602,0,7.879109034,2.521218168,3.125119886,0.001777326,0.015023052,0.121457241,0,5.228861665,1.530379454,3.416709269,0.000633829,0.004015574,0.140070816,0,4.808064602,2.167825336,2.217920661,0.026560243,0.086566351,0.119859796,0,5.144380765,1.353874645,3.799746736,0.000144844,0.000947728,N,-,,mfs maltose permease,C:membrane,no IPS match,2.A.1.1.11, the major facilitator superfamily (mfs).
RL4_JR_07859,7363,6686,8877,0,0,10,2,0,0,0,0,0,2,1,0,0,5,2,0.362800314,1,3.360332074,2.280881623,1.473260182,0.140680893,NA,0.115926017,1,6.574172148,2.029948986,3.238589834,0.001201222,0.015023052,0.300724442,0,3.921889336,1.30463407,3.00612212,0.002646027,0.012384826,0.346904341,1,3.499988808,1.52322035,2.297756072,0.021575676,0.079756744,0.296648836,1,3.838968999,1.241820628,3.091403791,0.001992125,0.008460683,N,-,,mfs maltose permease,F:transporter activity,G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR23500:SF162 (PANTHER); PTHR23500 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.1.11, the major facilitator superfamily (mfs).
RL4_JR_07860,2101,2442,3876,0,4,0,0,0,0,1,0,0,0,1,0,0,7,3,5.802634311,1,-0.638824239,1.302280884,-0.490542591,0.623749999,0.784404528,1.847994915,0,2.579640154,1.419827514,1.816868689,0.069237222,0.15241826,4.783098759,1,-0.068750245,1.267552766,-0.054238567,0.956745094,0.974749656,5.518114055,1,-0.491168555,1.277512051,-0.384472737,0.700628099,0.798588258,4.688351495,1,-0.142746551,1.2688914,-0.112497059,0.910429302,0.942545673,N,-,,---NA---,,no IPS match,,
RL4_JR_07861,12139,20773,25792,0,0,0,0,0,2,0,0,0,0,0,0,0,4,0,164.3883077,0,-0.326548523,0.465207475,-0.701941693,0.482715526,0.670981984,31.51915483,1,-1.512621061,1.207928414,-1.252243961,0.210480982,0.356149866,136.0362114,0,-0.532035475,0.587223602,-0.906018548,0.364926035,0.508981586,167.0882579,0,-0.616564245,0.556842359,-1.107250974,0.268185434,0.409462697,117.4336706,1,-0.805010407,0.584759137,-1.376652978,0.168619563,0.283035987,N,-,,pheromone-regulated membrane,C:membrane; C:integral component of membrane,IPR010619 (PFAM); IPR024528 (PFAM); PTHR31082 (PANTHER); PTHR31082:SF4 (PANTHER),2.A.79.1.10, the threonine/serine exporter (thre) family.
RL4_JR_07862,703,453,649,0,0,2,1,0,0,0,0,1,0,0,0,0,0,0,1820.230035,1,-2.362792847,0.607001335,-3.892566145,9.92E-05,0.000850881,543.77125,1,-2.739224379,0.922618668,-2.968966999,0.002988027,0.015566036,1943.282921,1,-0.900526984,0.720555038,-1.249768493,0.211384129,0.339291176,1822.63949,0,-2.070740103,0.574075486,-3.607086792,0.000309654,0.002797804,1554.070229,0,-1.897735191,0.675370648,-2.809916596,0.004955434,0.01778581,N,-,,helix-loop-helix dna-binding domain-containing,F:binding,IPR011598 (SMART); IPR011598 (G3DSA:4.10.280.GENE3D); IPR011598 (PFAM); PTHR12565:SF142 (PANTHER); PTHR12565:SF142 (PANTHER); PTHR12565 (PANTHER); PTHR12565 (PANTHER); PTHR12565:SF142 (PANTHER); PTHR12565:SF142 (PANTHER); PTHR12565 (PANTHER); PTHR12565 (PANTHER); IPR011598 (PROSITE_PROFILES); IPR011598 (SUPERFAMILY),,
RL4_JR_07863,1662,1696,2054,3,4,6,0,0,0,0,1,0,1,2,0,0,3,3,69.34718384,1,-4.218111485,1.302628714,-3.238153313,0.001203061,0.006825156,22.5791227,0,-1.031395659,1.304387875,-0.790712394,0.429111842,0.591725227,57.97511038,1,-3.668380121,1.274473356,-2.878349793,0.003997616,0.01637703,76.13900468,1,-3.128477753,1.241911792,-2.51908209,0.011766122,0.05505175,56.69582953,1,-3.738969555,1.280174891,-2.920670904,0.003492786,0.01336659,N,-,,---NA---,,no IPS match,,
RL4_JR_07864,2805,2836,3564,1,2,8,0,0,0,0,0,0,6,1,2,0,3,0,10.5798336,1,0.087134761,1.159415647,0.075154032,0.940092158,0.970425386,2.150773589,0,2.360675911,1.311094799,1.800537926,0.071775741,0.156812874,5.585417274,0,-0.292581625,1.207198897,-0.242364059,0.808498081,0.87467777,14.46738674,1,1.005593858,1.029060037,0.977196491,0.328471885,0.475179002,46.90563547,1,3.238348407,0.566187232,5.719571593,1.07E-08,5.08E-07,N,-, Effector probability:0.582,microsomal signal peptidase 18 kda subunit,C:integral component of membrane; F:serine-type peptidase activity; P:signal peptide processing; P:protein targeting to ER; C:signal peptidase complex,IPR001733 (PRINTS); IPR001733 (TIGRFAM); IPR028360 (G3DSA:2.10.109.GENE3D); IPR019759 (PFAM); IPR001733 (PANTHER); IPR015927 (SUPERFAMILY),,
RL4_JR_07865,856,880,1016,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,9.820899376,0,-1.398411568,1.193924662,-1.171272873,0.241489112,0.416416862,118.146908,0,4.847583944,1.552588336,3.122259669,0.001794686,0.015023052,8.141426096,0,-0.836430432,1.19859701,-0.697841247,0.485276481,0.620879873,27.04993642,1,1.053453934,0.856143542,1.230464148,0.218523345,0.353555268,15.74944825,0,0.746809229,0.984289173,0.758729497,0.448014388,0.580100008,N,-,,btb poz,P:biological_process; C:cellular_component,IPR000210 (PFAM); G3DSA:3.30.710.10 (GENE3D); PTHR26379:SF150 (PANTHER); PTHR26379 (PANTHER); PTHR26379:SF150 (PANTHER); IPR000210 (PROSITE_PROFILES); IPR011333 (SUPERFAMILY),,
RL4_JR_07866,652,769,987,0,0,3,0,0,0,2,0,0,0,0,0,0,2,3,65.37597992,1,1.830561519,0.694988295,2.633945828,0.008439895,0.033156332,3.571264656,0,1.629004484,1.275688926,1.27696059,0.201616161,0.345949955,15.79615142,1,-0.06624356,1.205460698,-0.054952899,0.956175988,0.974445963,10.72735384,0,-1.450573865,1.20880732,-1.200004203,0.230137708,0.366778576,16.57361397,1,-0.178009588,1.145022153,-0.155463882,0.876455626,0.917600374,N,-,,phosphotransferase enzyme family,P:phosphorylation; F:transferase activity; F:kinase activity,G3DSA:3.90.1200.10 (GENE3D); IPR011009 (SUPERFAMILY),,
RL4_JR_07867,3572,4982,7056,0,0,1,0,0,0,0,1,2,4,2,0,0,4,1,130.8008663,1,-4.143456797,1.145788117,-3.616250452,0.000298901,0.002177175,40.43422477,0,-1.872006221,1.191248079,-1.571466308,0.116074374,0.227645612,105.0751952,1,-4.526306527,1.189835598,-3.804144485,0.000142295,0.001420706,152.5330235,1,-1.898102517,0.668631498,-2.838787167,0.004528535,0.025948737,111.5081995,1,-2.944530941,0.98108802,-3.001291302,0.002688372,0.010874859,N,-,,transcription initiation factor iib,"F:zinc ion binding; P:regulation of transcription, DNA-templated; P:negative regulation of protein homodimerization activity; C:transcription factor TFIIIB complex; P:translational initiation; F:RNA polymerase III core binding; F:TFIIIC-class transcription factor binding; P:DNA-templated transcriptional open complex formation; F:DNA binding; F:translation initiation factor activity; P:transposon integration; F:TBP-class protein binding; P:RNA polymerase III transcriptional preinitiation complex assembly",IPR013763 (SMART); IPR013150 (PFAM); IPR011665 (PFAM); IPR013763 (G3DSA:1.10.472.GENE3D); IPR013763 (G3DSA:1.10.472.GENE3D); G3DSA:1.20.5.650 (GENE3D); IPR000812 (PANTHER); IPR000812 (PANTHER); IPR029529 (PTHR11618:PANTHER); IPR013763 (SUPERFAMILY); IPR013763 (SUPERFAMILY),,
RL4_JR_07868,3436,3161,4090,1,0,7,0,0,0,0,0,2,0,4,0,0,5,0,124.4010915,1,-0.257404561,0.565403974,-0.455257785,0.648923793,0.800411295,40.39046734,0,0.65693135,1.026791248,0.639790562,0.522308769,0.671682043,97.37083751,1,-0.219492177,0.653966648,-0.335632065,0.737148341,0.823033199,126.965904,1,0.297668052,0.539119691,0.552137228,0.580854337,0.707123983,87.77458445,1,-0.705581094,0.700807168,-1.006812039,0.314025108,0.449590529,N,-,,phospholipid-transporting atpase 1,F:nucleotide binding; F:transition metal ion binding; F:oxidoreductase activity; C:membrane; P:metabolic process; P:phospholipid transport; P:cellular process; F:hydrolase activity,IPR032630 (PFAM); IPR023299 (G3DSA:3.40.1110.GENE3D); IPR008250 (G3DSA:2.70.150.GENE3D); IPR032631 (PFAM); IPR023214 (G3DSA:3.40.50.GENE3D); IPR008250 (PFAM); PF00702 (PFAM); IPR006539 (TIGRFAM); IPR001757 (TIGRFAM); IPR023299 (G3DSA:3.40.1110.GENE3D); PF13246 (PFAM); IPR006539 (PANTHER); PTHR24092:SF8 (PANTHER); IPR006539 (PANTHER); PTHR24092:SF8 (PANTHER); IPR006539 (PANTHER); PTHR24092:SF8 (PANTHER); PTHR24092:SF8 (PANTHER); IPR006539 (PANTHER); SSF81653 (SUPERFAMILY); IPR023214 (SUPERFAMILY); SSF81665 (SUPERFAMILY); IPR023299 (SUPERFAMILY),3.A.3.8.20, the p-type atpase (p-atpase) superfamily.
RL4_JR_07869,6800,7363,9016,1,6,23,0,0,1,3,2,0,0,11,3,0,2,5,0.062210661,1,5.903431683,3.923873097,1.50449098,0.132454994,NA,0.019517907,1,9.143175263,3.92418945,2.329952562,0.019808659,0.057074649,0.051540506,1,6.464608184,2.392176569,2.702395914,0.006884173,0.024255068,0.059503757,1,6.042808751,3.923850791,1.540020014,0.123555475,0.229323045,0.052020333,1,6.350193021,1.774330453,3.578923538,0.000345012,0.00196692,,,,,,,,
RL4_JR_07870,1664,1378,2786,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0.11156248,1,5.061580317,3.916319235,1.292433025,0.196207226,NA,0.034571009,0,8.318570904,2.718122198,3.060410937,0.002210335,0.015045494,0.091527042,0,5.636610622,1.663816514,3.387759752,0.00070466,0.004349984,0.105716889,0,5.213939577,2.466808005,2.113638178,0.034546182,0.099426657,0.092152176,0,5.528317992,1.443737044,3.829172365,0.000128575,0.000857025,,,,,,,,
RL4_JR_07871,40802,41345,40130,1,2,20,0,0,1,2,0,0,0,10,0,0,12,0,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,hypothetical protein OIDMADRAFT_34131,,IPR032675 (G3DSA:3.80.10.GENE3D); SSF52047 (SUPERFAMILY),,
RL4_JR_07872,6269,8039,7792,4,3,12,0,0,0,0,0,2,3,4,9,0,3,2,1.040071607,1,1.841055954,1.570779729,1.172065007,0.241170958,NA,0.327657133,0,5.075114579,1.706216899,2.974483832,0.002934819,0.0154422,0.856542478,1,2.412222242,1.289743595,1.870311473,0.061440577,0.132712696,0.988643101,1,1.989216134,1.356304628,1.466644066,0.142472906,0.25631453,0.850268068,1,2.320770457,1.273705016,1.822062745,0.068445466,0.142536063,N,-,,cytochrome P450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305:SF71 (PANTHER); PTHR24305 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_07873,164,136,151,0,0,7,0,0,0,0,0,0,0,1,0,0,0,0,6.532313659,1,-0.81000573,1.221102619,-0.663339606,0.507113076,0.693666747,2.108639326,0,2.389278932,1.344897476,1.776550982,0.075642147,0.163177917,5.43181197,0,-0.252395112,1.220719734,-0.206759263,0.836197872,0.894492905,6.263240226,1,-0.674055792,1.221686205,-0.551742165,0.581125017,0.707283423,5.318147893,0,-0.324870702,1.215468867,-0.26728015,0.789253469,0.856321407,N,-,,serine threonine- kinase chk2,F:ATP binding; P:cell cycle checkpoint; F:protein serine/threonine kinase activity; P:protein phosphorylation,IPR000253 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); IPR000253 (PFAM); G3DSA:3.30.200.20 (GENE3D); IPR000253 (G3DSA:2.60.200.GENE3D); IPR020636 (PANTHER); PTHR24347:SF253 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR000253 (PROSITE_PROFILES); IPR008984 (SUPERFAMILY); IPR011009 (SUPERFAMILY),8.A.104.1.1, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_07874,138,118,219,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,5.484880367,1,-0.557700227,1.218806961,-0.4575788,0.647255077,0.799198868,1.740302813,0,2.666137721,1.330398642,2.004014163,0.045068543,0.108666936,4.529668354,0,0.009530196,1.2105148,0.007872846,0.993718443,0.997462375,13.24989733,0,1.306715421,1.031007846,1.267415593,0.205006727,0.3368538,4.478282083,0,-0.076588424,1.215100832,-0.063030509,0.94974221,0.967418499,N,-,,hypothetical protein PFICI_02503,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_07875,256,275,286,0,0,0,0,0,0,0,4,0,0,3,0,0,0,0,4.206858326,0,-0.174873311,1.259824551,-0.138807671,0.889602132,0.945788685,1.33327375,0,3.050543582,1.3921388,2.191263962,0.028432696,0.075955596,9.967679693,1,1.356433968,1.218805042,1.112921199,0.265742275,0.403536042,16.03767904,1,2.248582153,0.905420631,2.483466885,0.013011043,0.059790422,3.424765044,0,0.310413896,1.23495732,0.251355971,0.801538906,0.866031525,N,-,,hypothetical protein HMPREF1541_02202,,IPR009784 (PFAM); PTHR35332:SF1 (PANTHER); PTHR35332 (PANTHER); IPR013320 (SUPERFAMILY),,
RL4_JR_07876,1690,1276,1582,0,0,0,0,0,0,0,0,1,0,0,2,0,0,0,11.15696114,0,-1.582157683,1.240434177,-1.275487013,0.202136918,0.366370357,3.519999624,0,1.649885118,1.302180923,1.267016809,0.20514928,0.349961587,22.19081909,1,0.799345725,1.070803731,0.746491352,0.455370653,0.594240449,31.95758695,1,1.270315018,0.803965365,1.58006187,0.114092698,0.216165526,9.118072784,0,-1.102442388,1.239413803,-0.889486938,0.37374144,0.510059588,N,-, Effector probability:0.619,acetyltransferase,F:acetyltransferase activity,IPR024688 (SMART); IPR024688 (PFAM); G3DSA:2.160.10.10 (GENE3D); IPR001451 (PFAM); IPR001451 (PFAM); PTHR23416:SF60 (PANTHER); PTHR23416 (PANTHER); IPR011004 (SUPERFAMILY),,
RL4_JR_07877,4152,4185,3713,3,0,5,0,0,0,1,0,3,1,5,0,0,0,3,8.182432876,1,4.489125922,1.048354901,4.282066994,1.85E-05,0.000197203,0.172927766,0,5.997182528,1.87844996,3.192622989,0.001409869,0.015023052,0.450258242,1,3.339998122,1.282962013,2.603349194,0.009231787,0.030693798,0.519558998,1,2.917398199,1.411039902,2.067551878,0.038682181,0.105001899,8.16637533,1,4.914906401,1.007671049,4.877490927,1.07E-06,1.54E-05,Y,-,,hypothetical protein SPI_02493,,no IPS match,,
RL4_JR_07878,250,526,461,0,0,1,0,0,0,0,0,1,0,2,0,0,0,0,0.033172753,1,6.813211161,3.938845228,1.729748382,0.08367524,NA,0.010374863,0,10.05689312,3.939524965,2.552818731,0.010685509,0.035334441,0.027057185,1,7.399408913,2.619741123,2.824480956,0.004735726,0.018195253,0.031237398,1,6.974350322,3.93928866,1.77045932,0.076650655,0.161382384,0.026619807,0,7.325599184,1.702644184,4.302483896,1.69E-05,0.000155177,N,-,,serine threonine kinase,F:nucleotide binding; F:ATP binding; F:protein kinase activity; P:phosphorylation; F:protein serine/threonine kinase activity; P:protein phosphorylation; C:cellular_component; F:kinase activity,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_07879,468,637,862,3,0,3,0,0,0,0,2,2,0,2,3,0,3,0,5.677714053,1,1.948423133,1.189776968,1.637637292,0.101497379,0.223969601,0.596334721,0,4.211478389,1.541941074,2.731283614,0.006308815,0.024070045,8.037840316,1,2.529618464,1.218064407,2.076752634,0.037824396,0.091392407,1.775124046,1,1.145287822,1.270381151,0.901530868,0.367306129,0.513688084,1.506794321,1,1.494886087,1.229377851,1.215969595,0.223996505,0.350579711,N,-,,ABC transporter,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003593 (SMART); IPR003439 (PFAM); IPR011527 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.20.1560.10 (GENE3D); PTHR24223:SF257 (PANTHER); PTHR24223 (PANTHER); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY),3.A.1.208.41, the atp-binding cassette (abc) superfamily.
RL4_JR_07880,48737,36349,45482,2,11,21,0,1,2,1,3,5,2,5,0,0,4,2,205.3085148,1,0.414521208,1.045789518,0.396371546,0.691830954,0.832347952,66.46493392,1,1.152122799,0.833015928,1.383074153,0.16664213,0.299973615,75.94446268,1,-4.057902339,1.235221935,-3.285160525,0.001019243,0.005839737,103.7145464,1,-1.833195644,0.856387533,-2.140614587,0.032305131,0.096169659,98.93089689,1,-1.084235608,0.794444652,-1.364771737,0.172324805,0.287539329,N,-,,omega-6 fatty acid desaturase (delta-12 desaturase),P:lipid metabolic process; C:integral component of membrane,IPR005804 (PFAM); PTHR32100:SF19 (PANTHER); PTHR32100 (PANTHER),,
RL4_JR_07881,3973,4401,5903,0,0,1,0,0,0,0,0,0,0,3,0,0,0,1,53.73706516,1,0.703391299,0.656133738,1.072024282,0.283709126,0.466974817,7.10941709,0,0.635713628,1.237844112,0.513565175,0.607556033,0.740747069,68.06757642,0,1.592796034,0.602096625,2.645415981,0.008159055,0.027805617,21.39903906,1,-2.446734241,1.205906185,-2.028959028,0.042462464,0.111961574,33.47710698,1,0.092191652,0.875781709,0.105267844,0.916163278,0.946417202,N,-,,hypothetical protein SPSK_07215,C:membrane,PTHR12459:SF5 (PANTHER); IPR026749 (PANTHER); PTHR12459:SF5 (PANTHER); IPR026749 (PANTHER); PTHR12459:SF5 (PANTHER); PTHR12459:SF5 (PANTHER); IPR026749 (PANTHER),1.B.69.2.3, the peroxysomal membrane porin 4 (pxmp4) family.
RL4_JR_07882,479,491,653,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,563.8622513,0,-1.628811368,1.151228052,-1.414846837,0.157113408,0.306720132,154.7475369,0,-1.990166518,1.013196798,-1.964244775,0.049501713,0.116905351,394.2920023,1,-3.114495511,0.706620239,-4.407594544,1.05E-05,0.000194167,433.8837682,0,-3.242632903,0.655467969,-4.947050132,7.53E-07,1.43E-05,354.0301759,0,-4.693638095,1.012332938,-4.636456957,3.54E-06,4.25E-05,N,-,,topoisomerase ii-associated partial,,no IPS match,,
RL4_JR_07883,262,282,339,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0.182177461,1,4.354374372,3.180586848,1.369047468,0.170984437,NA,0.059011393,0,7.549075592,2.419075922,3.120644344,0.001804558,0.015023052,0.151201063,0,4.916443531,1.491874528,3.295480577,0.000982535,0.005671142,0.174313615,0,4.493657597,2.016672486,2.228253536,0.025863613,0.085915053,0.146797057,0,4.854214603,1.333877118,3.639176756,0.000273511,0.001627085,N,-, Effector probability:0.596,NAD(P)-binding domain,,IPR008030 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR14194:SF64 (PANTHER); PTHR14194 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_07884,1796,1849,2453,0,0,3,0,0,0,0,0,0,0,2,2,0,2,0,17.68746101,1,1.554827481,0.863440693,1.800734541,0.071744731,0.174080178,1.982443247,0,2.47822765,1.309891388,1.891933693,0.058499816,0.133567194,20.83680859,0,1.648516276,1.034921726,1.592889814,0.111184912,0.20992694,17.9776468,1,1.70254238,0.860711644,1.978063608,0.047921531,0.119679876,28.24643228,1,2.912960833,0.645065107,4.51576252,6.31E-06,6.90E-05,N,-,,syntaxin,,G3DSA:1.20.5.110 (GENE3D); IPR019529 (PFAM); PTHR15959 (PANTHER); PTHR15959:SF0 (PANTHER); PTHR15959 (PANTHER); PTHR15959:SF0 (PANTHER); IPR000727 (PROSITE_PROFILES),,
RL4_JR_07885,4589,4372,4297,3,0,10,0,0,2,0,1,4,0,13,3,0,0,1,277.6459983,1,0.908405012,0.697765001,1.301878155,0.192958041,0.353980594,31.05523311,1,-1.49122971,1.202152095,-1.240466757,0.214802803,0.361468656,216.4570764,1,0.540020691,0.458023234,1.179024667,0.238388354,0.371184819,337.57628,1,1.501775269,0.386073081,3.889873036,0.000100297,0.001072338,331.2828673,1,1.619797957,0.327925041,4.939537252,7.83E-07,1.19E-05,N,-,,aspartate aminotransferase,F:pyridoxal phosphate binding; F:L-phenylalanine:2-oxoglutarate aminotransferase activity; P:cellular amino acid metabolic process; P:biosynthetic process; F:L-aspartate:2-oxoglutarate aminotransferase activity,IPR000796 (PRINTS); IPR015421 (G3DSA:3.40.640.GENE3D); IPR004839 (PFAM); IPR000796 (PANTHER); IPR015424 (SUPERFAMILY),9.A.70.1.1, the aspartate amino transferase (aat) family.
RL4_JR_07886,3404,3861,5212,0,3,0,0,0,0,0,0,0,1,0,0,0,0,0,11.81165099,1,-0.156392681,1.185036872,-0.13197284,0.895005774,0.948391329,2.58372224,0,2.096102789,1.348782989,1.55406971,0.120167789,0.233911224,6.656479572,0,-0.545810299,1.234051665,-0.442291287,0.658278435,0.763741792,17.31029193,1,-0.013395954,1.181276565,-0.011340235,0.990951995,0.994389391,43.35162803,0,2.411721931,0.751994493,3.20710052,0.001340801,0.006071384,N,-,,hypothetical protein COCSADRAFT_157409,,no IPS match,,
RL4_JR_07887,49,38,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.46426696,0,1.858346492,1.012633549,1.835161884,0.066481707,0.164750232,1.095493014,0,3.333906078,1.383458628,2.409834317,0.015959766,0.048395673,36.1020726,0,3.504333363,0.743440696,4.713669,2.43E-06,5.72E-05,3.285272495,0,0.25673251,1.211509039,0.211911345,0.832176199,0.894836875,2.811881066,0,0.594843628,1.208783078,0.492101221,0.622647789,0.728400793,N,-,,cyclopropane-fatty-acyl-phospholipid synthase,C:cytoplasm; C:integral component of membrane; F:S-adenosylmethionine-dependent methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR029063 (PFAM); PTHR10108:SF90 (PANTHER); PTHR10108 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_07888,7583,8754,12508,11,5,16,0,0,0,0,0,0,0,1,0,0,5,3,0.411016158,1,3.180330188,2.159235594,1.472896332,0.140778991,NA,0.132138602,0,6.385479906,1.987558792,3.212725044,0.001314821,0.015023052,0.341338965,0,3.739666211,1.3004728,2.875620475,0.004032342,0.016494317,0.393654105,1,3.317771078,1.486729659,2.231590025,0.025642071,0.085851084,0.33520119,1,3.662149011,1.239132014,2.955414732,0.00312249,0.012225526,N,-,,hypothetical protein SPI_02729,,no IPS match,,
RL4_JR_07889,598,644,825,0,0,8,0,0,0,0,0,0,0,1,0,0,0,0,96.20688371,1,-1.741109149,0.765903246,-2.273275584,0.023009578,0.073670383,25.87999954,0,-1.228260263,1.206228142,-1.018265301,0.308551894,0.469991138,67.11865379,0,-3.879678198,1.197445262,-3.239962879,0.001195453,0.006658056,100.7054569,1,-1.976041506,0.861453407,-2.293846063,0.021799342,0.080144641,85.50950647,0,-1.053131673,0.705134275,-1.493519333,0.135301297,0.239707023,N,-,,c6 transcription factor,"C:nucleus; F:zinc ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31263 (PANTHER); PTHR31263:SF4 (PANTHER); PTHR31263:SF4 (PANTHER); PTHR31263 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07890,4397,7017,9507,0,0,2,0,0,0,1,0,0,0,0,0,0,3,0,51.11903218,1,-0.946965396,0.877387223,-1.079301558,0.280453319,0.463708588,39.39868646,0,2.14498581,0.872816039,2.457546279,0.013988979,0.043594963,57.92443233,1,-0.266554001,0.863407138,-0.308723416,0.75753193,0.836980603,137.5181962,0,1.400410069,0.701277911,1.996940225,0.045831677,0.116156628,28.90964277,1,-2.767230018,1.206427741,-2.293738716,0.021805511,0.058578085,N,-,,tetratricopeptide repeat 1,,IPR011990 (G3DSA:1.25.40.GENE3D); PTHR22904:SF352 (PANTHER); PTHR22904 (PANTHER); PTHR22904 (PANTHER); IPR011990 (SUPERFAMILY),,
RL4_JR_07891,2324,2576,3750,0,0,8,0,0,0,0,4,2,1,2,0,0,0,0,19.84271042,1,2.42323764,0.739984384,3.274714564,0.001057688,0.006198719,1.458111396,0,2.921436854,1.342247418,2.176526335,0.029515927,0.078156662,3.780929427,1,0.270310341,1.200288639,0.225204448,0.821820229,0.884832342,75.6385898,1,4.038214058,0.461251536,8.754906465,2.04E-18,1.64E-16,7.584693518,0,1.119573508,1.12424297,0.995846572,0.319324698,0.454622407,N,-,,vacuolar calcium ion transporter,,IPR004837 (PFAM); PTHR31503:SF18 (PANTHER); PTHR31503:SF18 (PANTHER); PTHR31503 (PANTHER); PTHR31503 (PANTHER),2.A.19.2.2, the ca(2+):cation antiporter (caca) family.
RL4_JR_07892,9348,14135,19572,0,1,1,0,0,0,0,2,0,0,7,3,0,3,0,1.208497548,1,1.624450059,1.388787515,1.169689417,0.242125979,NA,0.388112657,0,4.831062313,1.620480042,2.981253818,0.002870708,0.015349618,1.002629923,1,2.185406612,1.237515051,1.765963662,0.077401945,0.158916507,1.156340905,1,1.763359879,1.271967666,1.386324454,0.165647853,0.286306677,0.984094807,1,2.109025075,1.213904092,1.737390201,0.08231832,0.164978818,N,-,,methyltransferase domain-containing,F:methyltransferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); PTHR10108:SF923 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_07893,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.015624059,0,7.894997458,3.974358507,1.986483465,0.046979667,NA,0.005342092,0,11.01782189,3.970278013,2.775075663,0.005518887,0.021974647,0.013322949,0,8.419138269,3.972556748,2.119324859,0.034063022,0.084689105,0.015325853,0,8.000645136,3.972725723,2.013893154,0.044020753,0.113902079,0.012659449,0,8.375900661,2.059145617,4.067658253,4.75E-05,0.000372148,N,-,,integral membrane,C:membrane; C:integral component of membrane,PTHR33048 (PANTHER),9.B.313.1.6, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_07894,457,230,241,2,3,0,0,0,0,0,2,0,0,2,4,0,2,6,6.235479179,1,-0.742968731,1.39894821,-0.531090948,0.595355757,0.765712165,1.987805126,0,2.474251444,1.514276749,1.633949306,0.102269495,0.206168459,5.182342207,1,-0.184769941,1.339552523,-0.137934077,0.890292518,0.931320671,5.978946001,1,-0.607205413,1.361388334,-0.446019257,0.655583336,0.765218707,5.154058507,1,-0.279544892,1.359465735,-0.205628495,0.837081118,0.890054219,N,-,,sterigmatocystin 8-o-methyltransferase,F:O-methyltransferase activity,IPR011991 (G3DSA:1.10.10.GENE3D); IPR029063 (G3DSA:3.40.50.GENE3D); IPR001077 (PFAM); PTHR11746 (PANTHER); PTHR11746:SF87 (PANTHER); IPR016461 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY); IPR011991 (SUPERFAMILY),,
RL4_JR_07895,11190,8180,6371,0,2,13,0,0,0,0,6,7,0,14,6,0,4,7,65.68949033,1,0.095459154,0.610818313,0.156280766,0.875811717,0.939867402,12.41073644,0,-0.168038704,1.213569095,-0.138466532,0.889871719,0.938063064,84.25162667,1,0.793547845,1.278443869,0.620713873,0.5347879,0.663897013,61.29026371,1,0.030522373,0.640746656,0.047635634,0.962006632,0.978631282,71.08182931,1,0.497150502,0.608457332,0.817067157,0.413890051,0.549946892,N,-,,hypothetical protein PMG11_07322,,PTHR40081 (PANTHER),,
RL4_JR_07896,3041,3531,3806,0,7,2,0,0,0,0,5,14,1,3,16,0,8,3,178.6282037,1,-1.849357436,0.587920655,-3.145590172,0.001657521,0.008917794,99.04296313,0,0.466625137,0.75119831,0.621174369,0.534484901,0.682570801,274.28075,1,0.377515681,0.549601758,0.686889508,0.492152359,0.625791319,186.6672782,1,-1.340720659,0.523356547,-2.561772979,0.010413937,0.05002334,127.9288277,1,-3.938695281,1.124205564,-3.503536547,0.000459124,0.002525055,N,-,,mannitol 2-dehydrogenase,F:NADP binding; F:mannitol 2-dehydrogenase activity; F:NAD binding; P:mannitol metabolic process; P:oxidation-reduction process; C:extracellular region,IPR000669 (PRINTS); IPR013328 (G3DSA:1.10.1040.GENE3D); IPR013131 (PFAM); IPR013118 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR30562 (PANTHER); PTHR30562:SF8 (PANTHER); IPR008927 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_07897,306,317,243,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,16.18217864,0,4.723063109,0.795965843,5.933750989,2.96E-09,7.50E-08,0.292605666,0,5.238693439,1.730569532,3.027149932,0.002468715,0.015349618,0.753522746,0,2.597911965,1.270631154,2.044583873,0.040895901,0.097407232,0.868909374,0,2.175886615,1.336248824,1.628354372,0.103449767,0.20088778,0.736591686,1,2.52704548,1.234700457,2.046687085,0.040688818,0.095408588,N,-,,histidinol dehydrogenase,F:zinc ion binding; F:NAD binding; P:oxidation-reduction process; P:histidine biosynthetic process; F:histidinol dehydrogenase activity,IPR012131 (PRINTS); IPR012131 (TIGRFAM); G3DSA:3.40.50.1980 (GENE3D); IPR022695 (PIRSF); IPR012131 (PFAM); PTHR21256 (PANTHER); PTHR21256:SF11 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_07898,2053,1989,1523,0,1,12,0,0,0,2,2,1,0,0,5,0,4,0,22.42815633,1,1.750781734,0.779699684,2.245456513,0.024738841,0.078133745,2.267262289,0,2.284500178,1.305040884,1.750520008,0.080028625,0.170247587,18.90521362,1,1.442928804,1.046678393,1.378578954,0.168024609,0.285272705,10.82880724,1,0.149701873,1.158800019,0.129186978,0.8972097,0.936520434,5.849060575,1,-0.461893937,1.217421987,-0.379403315,0.70438839,0.790592223,N,-,,short chain type dehydrogenase,,IPR002347 (PRINTS); IPR002347 (PRINTS); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_07899,137,130,169,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11.63796088,1,6.612240667,0.970577384,6.812687763,9.58E-12,4.11E-10,0.057670123,0,7.581630531,2.379887045,3.185710241,0.001443991,0.015023052,0.150049016,0,4.92656393,1.447905828,3.402544444,0.000667615,0.004172181,0.173156926,0,4.50298862,1.96551674,2.290994795,0.021963715,0.080296448,32.19771751,0,7.016719578,1.508838194,4.650412222,3.31E-06,4.02E-05,N,-,,salicylate hydroxylase,F:FAD binding; C:integral component of membrane; F:lyase activity; P:oxidation-reduction process; F:monooxygenase activity,PR00420 (PRINTS); IPR023375 (G3DSA:2.40.400.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR010451 (PFAM); IPR002938 (PFAM); PTHR13789:SF186 (PANTHER); PTHR13789 (PANTHER); SSF54373 (SUPERFAMILY); SSF160104 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_07900,544,621,623,0,0,1,0,0,0,0,0,0,0,5,0,0,0,0,9.308033443,1,0.384975978,1.202652643,0.32010571,0.748888197,0.868556996,1.735024574,0,2.670538645,1.375606696,1.941353333,0.052215435,0.121864106,4.522128702,0,0.01203601,1.240909749,0.009699343,0.992261165,0.996889157,14.85408792,1,0.543496707,1.184155745,0.458974007,0.646252832,0.757555062,19.91436959,0,2.481598961,0.844265616,2.93935808,0.003288929,0.012734379,N,-,,alcohol dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); PTHR24322:SF574 (PANTHER); PTHR24322:SF574 (PANTHER); PTHR24322:SF574 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_07901,827,1982,1379,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.18041873,0,8.402732904,0.784113738,10.71621691,8.54E-27,2.79E-24,0.027726396,0,8.637491223,2.699836614,3.199264422,0.001377787,0.015023052,0.072413841,0,5.974820757,1.537951263,3.884922038,0.000102363,0.0011763,0.083569043,0,5.55329869,2.485360075,2.234404079,0.025456498,0.085851084,0.07193336,0,5.884573587,1.314471998,4.476758422,7.58E-06,7.97E-05,N,-,,6-hydroxy-d-nicotine oxidase,F:oxidoreductase activity,IPR016169 (G3DSA:3.30.465.GENE3D); IPR006094 (PFAM); IPR016167 (G3DSA:3.30.43.GENE3D); PTHR11748 (PANTHER); PTHR11748:SF75 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY),,
RL4_JR_07902,1974,2750,3972,0,0,1,3,0,0,0,1,0,1,3,1,0,1,1,0.016941764,1,7.786237146,3.969489371,1.961521097,0.049818266,NA,0.005360177,1,11.01327471,3.970079784,2.774068863,0.005535996,0.021974647,0.013809418,1,8.370946466,3.970412799,2.108331524,0.035002323,0.086240817,0.015934454,1,7.948319201,3.970395183,2.001896243,0.045295892,0.115278131,0.013359141,1,8.321812604,2.097869539,3.966792239,7.28E-05,0.000534084,N,-,,RTA1 domain,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_07903,30291,26417,36499,6,7,31,0,0,1,11,7,8,2,6,0,0,9,6,15.57383158,1,6.209900322,1.001941098,6.197869648,5.72E-10,1.69E-08,0.09381571,1,6.878775423,2.232050485,3.081818923,0.0020574,0.015023052,6.746004865,1,5.161979276,1.296061329,3.982820227,6.81E-05,0.000903627,0.285491181,1,3.780539522,1.808797219,2.090084772,0.036610185,0.101650752,0.248410127,1,4.095603361,1.387674368,2.9514153,0.003163213,0.012351535,N,-, Effector probability:0.662,hypothetical protein MAPG_09836,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_07904,2041,2142,1218,0,0,3,0,0,0,0,0,0,1,0,0,0,0,0,18.96108654,1,2.732877662,0.739910842,3.693522931,0.000221169,0.001684681,1.177419665,0,3.229916801,1.372468244,2.353363594,0.018604432,0.054331813,3.051904212,0,0.579367792,1.20331835,0.481475074,0.630178891,0.741390235,11.54377637,1,1.884141742,1.015214242,1.855905546,0.063467022,0.141511474,17.73585981,0,2.183455533,0.969604015,2.251904384,0.024328315,0.063764999,N,-,,acyl esterase,P:proteolysis; F:dipeptidyl-peptidase activity,IPR013736 (SMART); IPR013736 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR000383 (PFAM); IPR005674 (TIGRFAM); IPR008979 (G3DSA:2.60.120.GENE3D); PTHR11731:SF106 (PANTHER); PTHR11731:SF106 (PANTHER); PTHR11731 (PANTHER); PTHR11731 (PANTHER); IPR008979 (SUPERFAMILY); IPR029058 (SUPERFAMILY),,
RL4_JR_07905,8483,8630,8643,4,4,11,0,0,3,5,0,0,1,29,0,0,6,0,0.643757726,1,2.533352274,1.940158198,1.30574521,0.191639218,NA,0.204495239,1,5.755573896,1.919441592,2.998566834,0.002712527,0.015349618,0.5299448,1,3.105991368,1.364483548,2.276312801,0.022827294,0.061742861,0.611444008,1,2.683025655,1.507681256,1.779570877,0.075146216,0.159041688,0.519894862,1,3.030770179,1.31730091,2.300742492,0.021406191,0.057719755,N,-,,transcription factor Pig1p,F:binding,IPR015880 (SMART); IPR001138 (SMART); PF12874 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR007219 (PFAM); PTHR31986 (PANTHER); PTHR31986:SF11 (PANTHER); PTHR31986:SF11 (PANTHER); PTHR31986 (PANTHER); PTHR31986:SF11 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR001138 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY); SSF57667 (SUPERFAMILY),,
RL4_JR_07906,22001,27775,39162,0,0,4,0,0,1,2,7,0,3,5,2,0,5,0,11.70917471,1,6.030121465,1.183274568,5.096130372,3.47E-07,5.98E-06,0.079600712,1,7.11667837,2.383963632,2.985229419,0.002833657,0.015349618,0.207699768,1,4.457358881,1.567190088,2.844172456,0.004452694,0.017386326,0.239756031,1,4.03358395,1.992505787,2.024377533,0.042931322,0.112757362,0.205032393,1,4.373978707,1.445853602,3.025187821,0.002484788,0.010169149,N,-,,cupin domain,F:FAD binding; F:oxidoreductase activity; F:lyase activity; P:oxidation-reduction process,IPR013096 (PFAM); IPR014710 (G3DSA:2.60.120.GENE3D); PTHR36156 (PANTHER); PTHR36156:SF2 (PANTHER); IPR011051 (SUPERFAMILY),,
RL4_JR_07907,2739,2104,2380,3,3,7,0,0,0,6,0,3,5,16,8,0,0,0,0.09267337,1,5.329396068,3.918265322,1.360141703,0.173785086,NA,0.029916601,0,8.529147862,2.686918245,3.17432355,0.001501862,0.015023052,0.076905471,1,5.891814344,1.544534791,3.814620673,0.000136392,0.001394783,8.111851263,1,7.186285528,1.094750224,6.564315196,5.23E-11,2.06E-09,0.074994565,0,5.822772243,1.311559458,4.439579318,9.01E-06,9.18E-05,N,-,,aromatic ring-opening dioxygenase family,"F:dioxygenase activity; P:cellular aromatic compound metabolic process; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen; F:zinc ion binding; F:ferrous iron binding; P:oxidation-reduction process",IPR004183 (PFAM); IPR004183 (G3DSA:3.40.830.GENE3D); IPR014436 (PIRSF); IPR014436 (PANTHER); PTHR30096:SF1 (PANTHER); PTHR30096:SF1 (PANTHER); IPR004183 (SUPERFAMILY),,
RL4_JR_07908,9074,8697,12249,2,9,4,0,0,0,1,3,3,0,0,0,0,2,0,4.391378535,1,3.639779186,1.338417784,2.719464154,0.006538778,0.027064106,0.182797394,0,5.917519237,2.003647355,2.953373618,0.003143213,0.015971687,0.471855592,1,3.273699493,1.41201345,2.318461975,0.020424227,0.056480436,0.544311688,0,2.850912529,1.590660139,1.792282625,0.073087705,0.155726644,0.460642979,1,3.205241845,1.35351705,2.368083833,0.017880484,0.049914502,N,-,,NAD-dependent aldehyde dehydrogenase,"P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",IPR016163 (G3DSA:3.40.309.GENE3D); IPR015590 (PFAM); IPR016162 (G3DSA:3.40.605.GENE3D); PTHR11699:SF155 (PANTHER); PTHR11699 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_07909,277,497,512,0,0,0,0,0,0,1,0,2,1,0,1,0,3,4,7.706700455,0,7.432397207,1.199592337,6.195769159,5.80E-10,1.70E-08,0.022076208,0,8.967602421,2.913638335,3.077802181,0.002085333,0.015023052,0.057201873,1,6.319904336,1.718981749,3.676539521,0.000236419,0.001964107,0.066001958,1,5.89490373,2.828070809,2.084425789,0.037121454,0.102428443,7.777125996,1,7.894670823,1.109450755,7.115837079,1.11E-12,1.14E-10,Y,-,,ferric-chelate reductase,F:catalytic activity; P:metabolic process,IPR013112 (PFAM); G3DSA:3.40.50.80 (GENE3D); IPR013121 (PFAM); IPR013130 (PFAM); PTHR32361 (PANTHER); PTHR32361:SF9 (PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY),5.B.1.5.3, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_07910,502,420,371,0,0,2,0,0,0,0,0,3,0,1,0,0,0,0,1.039565208,1,1.841919416,1.563780086,1.177863455,0.238851046,NA,0.333983331,0,5.047903179,1.72136996,2.932491735,0.003362539,0.016450274,0.860508146,1,2.406528607,1.291726366,1.863032813,0.06245765,0.134471764,0.992389938,1,1.98432307,1.357447766,1.461804365,0.143794828,0.257913663,0.840425638,0,2.337251083,1.259191585,1.856152083,0.063431884,0.134574806,N,-, Effector probability:0.677,hypothetical protein CMQ_395,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_07911,10744,23900,34588,0,2,8,0,0,0,0,0,0,0,3,0,0,6,2,30.13707018,1,0.695830407,0.779093403,0.893128352,0.371788441,0.563973616,4.741967629,0,1.219981653,1.26332922,0.96568783,0.334200411,0.497548489,35.84974346,0,0.975339137,0.870969015,1.119832188,0.26278528,0.399885491,23.84914087,1,-0.905161818,1.158701994,-0.781186036,0.434693085,0.576761563,16.04088134,1,-0.591832296,1.145641818,-0.51659453,0.605439235,0.713878218,N,-,,aldehyde dehydrogenase,F:oxidoreductase activity; P:metabolic process,IPR016162 (G3DSA:3.40.605.GENE3D); IPR015590 (PFAM); IPR016163 (G3DSA:3.40.309.GENE3D); PTHR11699:SF184 (PANTHER); PTHR11699 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_07912,2691,2534,4166,2,2,0,0,0,0,5,7,2,6,2,3,0,2,9,2.513099167,1,0.568025238,1.284409685,0.44224615,0.658311094,0.807715732,0.796376451,0,3.793846912,1.459150952,2.600037308,0.009321363,0.031950841,2.077670223,1,1.133573639,1.23496295,0.917900929,0.358670735,0.502377217,22.45549801,1,3.710343873,0.723012957,5.131780606,2.87E-07,5.88E-06,2.061781925,1,1.042391641,1.237379273,0.842418863,0.399553538,0.536820538,N,-, Effector probability:0.638,hypothetical protein VE01_08982,,no IPS match,,
RL4_JR_07913,2877,4957,4754,2,7,35,0,0,0,1,3,4,0,1,0,0,0,3,0.130234082,1,4.838185243,3.634023851,1.331357592,0.183071376,NA,0.042076181,0,8.036281579,2.560793506,3.138199765,0.00169989,0.015023052,0.108611916,1,5.390432645,1.53369855,3.514662411,0.000440313,0.003082802,0.125235778,1,4.96967746,2.228905937,2.229648806,0.025770767,0.085851084,0.106823291,1,5.309800415,1.342399423,3.955454929,7.64E-05,0.000554437,N,-,,hypothetical protein CMQ_1304,,IPR025332 (PFAM),,
RL4_JR_07914,10361,6871,10037,0,0,5,0,0,0,0,2,1,2,0,3,0,4,1,1.49655953,1,1.316100599,1.378308491,0.954866496,0.339645215,NA,0.473681538,0,4.54344629,1.574093492,2.886389095,0.003896901,0.017783446,1.23469645,1,1.884722395,1.247701387,1.510555663,0.130901697,0.23715918,1.42484248,1,1.461960577,1.278999912,1.143049787,0.253017921,0.392854845,1.222310553,1,1.797021014,1.239186878,1.45016143,0.147013508,0.255275556,N,-,,tat pathway signal sequence,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,IPR021765 (PFAM); PTHR33365 (PANTHER),,
RL4_JR_07915,12,7,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.008141456,0,8.841220392,4.035983802,2.190598582,0.028480854,NA,0.002675567,0,12.01934062,4.032893235,2.980327006,0.002879408,0.015349618,0.006783092,0,9.399044527,3.291065204,2.855927776,0.004291127,0.016940088,0.007815077,0,8.97609272,4.035428601,2.224322026,0.026126786,0.086108719,0.006504647,0,9.346543544,1.704039324,5.484934187,4.14E-08,1.17E-06,N,-,,hypothetical protein Micbo1qcDRAFT_168462,C:membrane; C:integral component of membrane,PTHR35896:SF3 (PANTHER); PTHR35896 (PANTHER),,
RL4_JR_07916,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.74,telomerase-binding EST1A partial,,no IPS match,,
RL4_JR_07917,149,79,129,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,90.53517359,0,5.17363487,1.104714395,4.683232963,2.82E-06,3.78E-05,90.11153901,0,6.313320024,0.741331124,8.516194476,1.65E-17,6.68E-15,635.9612279,0,8.113032934,0.523667618,15.49271455,3.89E-54,2.81E-51,481.7201207,0,7.615557916,0.38252888,19.90845216,3.44E-88,3.48E-85,62.55481898,0,5.140530645,0.457494376,11.23627067,2.71E-29,1.30E-26,Y,-,,alpha beta hydrolase,F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR000073 (PFAM); PTHR10992 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_07918,4443,5523,3924,0,3,28,0,0,1,6,13,51,10,23,22,4,92,35,14.28817438,1,-1.938932222,1.20196211,-1.61313922,0.106714265,0.232277207,4.55030796,1,1.279578151,1.256265084,1.018557442,0.308413117,0.469861164,24.80432636,1,0.445468746,1.041170152,0.427853935,0.668757467,0.772136448,68.20608186,1,1.771810387,0.593793967,2.98388075,0.002846177,0.017799592,38.65279539,1,1.927864623,0.61435648,3.138022771,0.001700917,0.007397672,N,-,,methyltransferase type 12,F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108 (PANTHER); PTHR10108 (PANTHER); PTHR10108:SF905 (PANTHER); PTHR10108:SF905 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_07919,3049,2237,3461,3,2,10,0,0,0,0,3,2,1,6,0,0,3,9,0.023713592,1,7.294775898,3.951484475,1.846084919,0.064879876,NA,22.31957552,0,11.42532863,1.287324794,8.875249421,6.98E-19,2.94E-16,0.019787624,1,7.846564413,2.051149954,3.8254465,0.000130535,0.001356816,0.02281372,1,7.426217697,3.95118342,1.879492017,0.060177342,0.136951133,0.019415467,1,7.764816771,1.447934094,5.362686605,8.20E-08,1.94E-06,N,-,,iron permease ftr1 family,C:membrane; C:cell part,IPR004923 (PFAM); PTHR31632:SF2 (PANTHER); IPR004923 (PANTHER),2.A.108.1.3, the iron/lead transporter (ilt) family.
RL4_JR_07920,31531,25071,23248,1,5,3,0,0,0,2,0,4,3,2,3,0,22,2,20.95915361,1,-2.491844412,1.214169503,-2.052303575,0.040140169,0.112879523,6.629261658,0,0.736606273,1.244918077,0.591690559,0.55405782,0.699568308,25.14197871,1,-0.961897939,1.207079183,-0.796880563,0.4255204,0.566465291,67.17117747,1,0.779213139,0.7041527,1.106596821,0.268468283,0.409692228,21.01539768,1,-1.086199735,1.15055365,-0.944067002,0.34513541,0.482332095,N,-,,c6 transcription,,IPR021858 (PFAM); PTHR36206:SF1 (PANTHER); PTHR36206 (PANTHER),,
RL4_JR_07921,5144,7753,5822,3,2,21,4,0,0,0,0,4,2,14,0,2,14,2,30.96904588,1,3.028116841,0.83956723,3.606759214,0.000310045,0.002232434,1.009508294,1,3.452034673,1.500919376,2.299946772,0.021451236,0.060871715,33.96286008,1,3.641515865,0.828413913,4.3957686,1.10E-05,0.000203552,21.6117753,1,2.180303571,1.080375961,2.018097079,0.043581152,0.113446415,29.54598375,1,4.048469469,0.73494696,5.508519239,3.62E-08,1.13E-06,N,-,,c6 zinc finger domain-containing,"F:DNA binding; C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR021858 (PFAM); PTHR37534 (PANTHER); PTHR37534:SF2 (PANTHER); PTHR37534:SF2 (PANTHER); PTHR37534 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07922,1851,1683,2268,3,0,0,0,0,0,0,0,0,1,0,0,0,3,1,74.06642562,1,2.606065006,0.488056415,5.339679848,9.31E-08,1.84E-06,12.90782236,0,2.562384353,1.12516848,2.277333928,0.022766292,0.063780906,28.67608541,0,1.391964159,0.856962658,1.624299666,0.104311869,0.200047993,26.63820141,1,1.278667996,0.753155337,1.697748039,0.089555327,0.180375509,31.88091394,1,1.83408392,0.69185102,2.650981017,0.008025835,0.026255761,N,-,,WD repeat,C:intracellular part,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR19854 (PANTHER); PTHR19854:SF1 (PANTHER); PTHR19854 (PANTHER); PTHR19854:SF1 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),,
RL4_JR_07923,3697,3897,3659,0,0,18,0,0,0,0,0,0,0,1,0,0,5,0,27.59751752,1,-1.440432455,1.177946936,-1.222833059,0.221392756,0.390935521,6.19515574,0,0.834287341,1.261751055,0.661213904,0.508475146,0.660606524,16.18816032,0,-1.827984694,1.219350341,-1.499146416,0.133835652,0.24070921,27.99437682,1,-1.29781019,1.172885457,-1.106510599,0.268505579,0.409692228,16.09455581,1,-1.922277523,1.233408659,-1.558508211,0.119112823,0.21796807,N,-,,ribonuclease p subunit p29,F:RNA binding; P:RNA phosphodiester bond hydrolysis; P:tRNA processing; F:ribonuclease activity; C:nucleolus; C:ribonuclease P complex,IPR002730 (SMART); IPR002730 (PFAM); IPR002730 (G3DSA:2.30.30.GENE3D); PTHR13348 (PANTHER); IPR023534 (SUPERFAMILY),,
RL4_JR_07924,115,72,49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.228053287,0,4.030182826,2.796790671,1.44100267,0.149583928,NA,0.072841718,0,7.24461064,2.222317577,3.259934905,0.001114378,0.015023052,0.188856969,0,4.593541884,1.345548525,3.41388051,0.000640447,0.004037286,0.217860009,0,4.171305131,1.734691665,2.404637789,0.016188502,0.068869153,0.186059466,0,4.51248535,1.250069669,3.609787089,0.000306448,0.001778103,Y,-,,---NA---,,PS51257 (PROSITE_PROFILES),,
RL4_JR_07925,8,12,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37.92746214,0,-0.533065116,0.864746476,-0.616440923,0.537603551,0.720514173,8.443745828,0,0.387664347,1.226715793,0.316018062,0.751988799,0.848613869,21.88904546,0,-2.263089358,1.194955021,-1.89386991,0.058242279,0.127051247,41.29810002,0,0.023856586,0.755296178,0.031585736,0.974802419,0.98517231,28.90678419,0,-1.407942403,1.124543505,-1.252012391,0.210565349,0.334112859,N,-,,glycerol-3-phosphate acyltransferase,F:O-acyltransferase activity; P:cellular lipid metabolic process,IPR002123 (SMART); IPR002123 (PFAM); IPR022284 (PANTHER); PTHR12563:SF10 (PANTHER); SSF69593 (SUPERFAMILY),,
RL4_JR_07926,36,34,46,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,63.79111822,0,0.400294897,0.726017445,0.551357132,0.581388881,0.755334732,10.49737991,0,0.073524088,1.24203544,0.059196449,0.952795638,0.975027218,67.1111894,0,0.259678034,0.780920004,0.332528342,0.739490343,0.824878826,66.94250764,0,0.286040824,0.676814918,0.422627836,0.672566814,0.777330003,27.16605543,0,-2.677490876,1.227375422,-2.181476693,0.029148177,0.073523988,N,-,,pantoate-beta-alanine ligase,P:pantothenate biosynthetic process; C:cytosol; F:pantoate-beta-alanine ligase activity,IPR014729 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.1300.10 (GENE3D); IPR003721 (PFAM); IPR003721 (TIGRFAM); PTHR21299 (PANTHER); IPR003721 (PTHR21299:PANTHER); PTHR21299 (PANTHER); IPR003721 (HAMAP); SSF52374 (SUPERFAMILY),,
RL4_JR_07927,1,2,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0.062540087,0,5.895968442,3.923785015,1.502622702,0.132936366,NA,0.019522428,0,9.142111047,3.124309543,2.926122051,0.003432163,0.016607314,0.051662123,0,6.459527314,1.914302533,3.374350294,0.000739901,0.004528877,0.059655908,1,6.038784177,3.11915529,1.936031911,0.052863793,0.12659553,0.052195256,0,6.345953758,1.539573043,4.121891967,3.76E-05,0.00030462,,,,,,,,
RL4_JR_07928,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.449665429,0,0.11105817,1.329009642,0.083564608,0.933402607,0.967083853,1.084613561,0,3.348124827,1.463171927,2.288264808,0.022122105,0.062425409,2.846462443,0,0.679458293,1.271262194,0.534475339,0.593012707,0.712385016,3.285812738,0,0.256283656,1.288990554,0.198825085,0.842399573,0.901625458,2.843387732,0,0.578662953,1.283227767,0.450943291,0.652030421,0.752015259,Y,-,,antigenic cell wall galactomanno,,IPR021054 (PFAM),,
RL4_JR_07929,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.051558779,0,6.174888086,3.927405567,1.572256285,0.115891127,NA,0.016029572,0,9.426607218,3.082272918,3.058329833,0.002225744,0.015045494,0.042390771,0,6.745395478,1.809659205,3.727439652,0.000193435,0.00172237,0.048956633,0,6.324285988,3.159118617,2.001914697,0.045293907,0.115278131,0.04267346,0,6.639962161,1.427809745,4.650453033,3.31E-06,4.02E-05,,,,,,,,
RL4_JR_07930,15,9,4,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0.055438833,1,6.070182866,3.925964172,1.546163592,0.122065064,NA,0.017196872,0,9.325093967,3.062843706,3.044586947,0.002330001,0.015159195,0.0455623,0,6.641157849,1.81490804,3.659225538,0.000252979,0.002044019,0.052624492,0,6.219985665,3.101454869,2.00550578,0.044909003,0.115085715,0.045964008,0,6.532481827,1.447193787,4.51389571,6.36E-06,6.91E-05,,,,,,,,
RL4_JR_07931,307,226,342,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15.40811596,1,-2.048070198,1.194254912,-1.714935545,0.086357045,0.198730824,4.948696717,0,1.158494376,1.257699203,0.921121977,0.356986748,0.521191383,12.79226263,0,-1.488236306,1.20003168,-1.240164181,0.214914674,0.343564844,14.75347987,0,-1.91019756,1.198490772,-1.593835852,0.110972805,0.212023317,12.57166132,0,-1.56596774,1.199501025,-1.305515967,0.191717214,0.311879304,N,-,,high-affinity nicotinic acid transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662:SF191 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.3, the major facilitator superfamily (mfs).
RL4_JR_07932,3261,2183,3174,3,0,13,0,0,1,0,3,5,1,2,3,0,7,0,2060.966915,1,-2.953365184,0.398345963,-7.414070827,1.22E-13,6.80E-12,669.6561803,1,-4.015729026,1.046627826,-3.836826163,0.000124635,0.005895102,1741.472446,1,-2.84133076,0.479843,-5.921375867,3.19E-09,1.51E-07,2045.335347,1,-2.537914067,0.553192307,-4.587760953,4.48E-06,6.94E-05,1802.459601,1,-2.15914327,0.625995388,-3.449136064,0.000562383,0.00298591,N,-,,pentatricopeptide repeat,P:negative regulation of mitochondrial translation; C:integral component of mitochondrial membrane,IPR002885 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR002885 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR002885 (TIGRFAM); PTHR24015 (PANTHER); PTHR24015:SF203 (PANTHER); PTHR24015:SF203 (PANTHER); PTHR24015:SF203 (PANTHER); PTHR24015 (PANTHER); PTHR24015 (PANTHER); PTHR24015:SF203 (PANTHER); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); SSF81901 (SUPERFAMILY),,
RL4_JR_07933,207,156,199,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,371.4094472,0,-1.915732785,0.531048429,-3.607454014,0.000309216,0.002228434,96.83591203,0,-3.131961507,1.196061585,-2.618562076,0.008830122,0.03070371,340.8149696,0,-1.626586375,0.516716224,-3.14792975,0.001644312,0.008489044,375.399932,0,-1.490732859,0.47562019,-3.134292633,0.00172269,0.011729814,335.039062,0,-1.412189017,0.545869848,-2.587043455,0.009680338,0.030533777,N,-,,nonsense-mediated mRNA decay 3,C:nucleus; F:ATP binding; P:ribosomal large subunit export from nucleus; F:ribosomal large subunit binding; C:cytosolic large ribosomal subunit,IPR013750 (G3DSA:3.30.70.GENE3D); IPR006204 (PFAM); IPR007064 (PFAM); IPR014721 (G3DSA:3.30.230.GENE3D); IPR013750 (PFAM); PTHR12746:SF2 (PANTHER); PTHR12746 (PANTHER); IPR020568 (SUPERFAMILY); IPR013750 (SUPERFAMILY),,
RL4_JR_07934,683,692,671,0,0,1,0,0,0,0,0,0,0,2,0,0,0,1,52.10121532,1,-3.805573986,1.267448192,-3.002547962,0.002677298,0.013181249,16.35143284,0,-0.565864247,1.261447036,-0.448583437,0.653732184,0.77665225,42.87127172,0,-3.232967326,1.242775383,-2.60140921,0.009284164,0.030820137,53.50272664,1,-2.713114138,1.205772689,-2.250104155,0.024442334,0.084615276,46.5607969,1,-2.404819599,1.191352725,-2.018562219,0.043532741,0.100586263,N,-,,pre-rrna-processing esf2,"P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:organic cyclic compound binding; F:heterocyclic compound binding; P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:intracellular part",IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR12311 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_07935,150,252,124,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,242.5588139,0,0.991325384,0.479862682,2.065852214,0.038842436,0.110486957,54.46132331,0,0.919929019,0.873068292,1.05367361,0.292032375,0.451007035,258.2477939,0,1.495840535,1.533177405,0.975647391,0.329239231,0.472327898,169.6582481,0,0.356631771,0.463335693,0.769704938,0.44147494,0.583466097,97.7128818,0,-0.79859449,0.657057981,-1.215409466,0.224209959,0.3507611,N,-,,aldehyde dehydrogenase,,IPR016163 (G3DSA:3.40.309.GENE3D); IPR016162 (G3DSA:3.40.605.GENE3D); IPR015590 (PFAM); PTHR11699 (PANTHER); PTHR11699:SF65 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_07936,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.69283946,0,-2.542398614,1.138445918,-2.233218613,0.025534531,0.080075186,13.38314775,0,-0.27679976,1.207180581,-0.22929441,0.818640098,0.890606007,140.0810834,0,1.488612283,0.448446928,3.319483736,0.000901841,0.005299033,58.61622548,0,-1.608899287,1.008791166,-1.594878446,0.11073942,0.211713865,48.84213164,0,-1.324294461,0.963743685,-1.374114801,0.169406045,0.284026529,N,-,,hypothetical protein CMQ_5590,,no IPS match,,
RL4_JR_07937,857,704,478,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,148.0134863,0,-5.311912601,1.254097399,-4.235645977,2.28E-05,0.000234153,46.6130153,0,-2.077158998,1.227913087,-1.691617281,0.090718969,0.187782701,121.9006623,0,-4.740577642,1.228209036,-3.859748222,0.000113504,0.001251467,140.7030953,0,-5.163692444,1.234712033,-4.182102634,2.89E-05,0.000365545,121.0729041,0,-4.833510073,1.243957894,-3.885589776,0.000102082,0.000705996,N,-,,ATP-dependent RNA helicase DBP7,F:organic cyclic compound binding; F:heterocyclic compound binding; F:hydrolase activity,IPR001650 (SMART); IPR014001 (SMART); IPR025313 (SMART); IPR011545 (PFAM); IPR001650 (PFAM); IPR025313 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24031:SF282 (PANTHER); PTHR24031 (PANTHER); PTHR24031 (PANTHER); PTHR24031:SF282 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_07938,7370,7859,5652,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,114.7526231,0,0.480673991,0.73420962,0.654682229,0.512672369,0.698227243,13.43345583,0,-0.282299743,1.221332162,-0.231140841,0.817205388,0.889722807,63.74525483,0,-0.127130707,0.768869202,-0.165347638,0.868670365,0.91677247,48.4854679,0,-1.650193277,1.040387161,-1.586133834,0.112708953,0.213984277,42.51482967,0,-1.377216625,1.008707317,-1.36532828,0.172149894,0.287394643,N,-,,general amino acid permease (Agp2),F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:amino acid transport,IPR004841 (PFAM); IPR002293 (PIRSF); PTHR11785:SF326 (PANTHER); IPR002293 (PANTHER),2.A.3.10.19, the amino acid-polyamine-organocation (apc) family.
RL4_JR_07939,54670,71754,63359,0,0,0,0,0,0,0,0,3,0,2,0,0,0,0,8.372012545,0,-1.168057726,1.231199461,-0.948715267,0.342765447,0.532929392,2.652790268,0,2.057891954,1.312614543,1.567780858,0.116932284,0.228756973,6.92417529,1,-0.60286792,1.223387495,-0.492785747,0.622163983,0.735410176,7.990312363,1,-1.025629381,1.225346415,-0.837011777,0.402585948,0.546372283,6.877145476,0,-0.695588579,1.235126458,-0.563171953,0.5733178,0.688672294,N,-,,heterokaryon incompatibility,P:biological_process; F:metal ion binding; C:cellular_component; F:molecular_function; F:hydrolase activity,IPR010730 (PFAM); PTHR33112:SF6 (PANTHER); PTHR33112 (PANTHER); PTHR33112:SF6 (PANTHER); PTHR33112 (PANTHER),,
RL4_JR_07940,9,42,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37.24363083,0,4.221855949,0.535933977,7.877567254,3.34E-15,2.27E-13,0.921942187,0,3.582784823,1.422589521,2.51849516,0.01178575,0.038089197,2.386507011,0,0.933955359,1.21451749,0.768992926,0.44189751,0.581613415,2.752633848,0,0.51187703,1.219825961,0.419631198,0.674754894,0.778389861,9.714156055,0,1.789508795,1.128827005,1.585281701,0.112902345,0.209212343,N,-,,MFS general substrate transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF242 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_07941,31,83,60,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,132.9907259,0,-0.576555019,0.782537542,-0.736776178,0.461258472,0.6494919,23.87904991,0,-1.112182344,1.211249325,-0.918210908,0.358508459,0.522514654,139.0907282,0,0.243898524,0.556203025,0.438506289,0.661019312,0.765868565,92.93128768,0,-1.473721018,0.770869674,-1.911764165,0.05590645,0.131283172,76.78635526,0,-1.265945705,0.78997993,-1.60250363,0.109044286,0.203816391,N,-,,mfs transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23512 (PANTHER); PTHR23512:SF3 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.53.5, the major facilitator superfamily (mfs).
RL4_JR_07942,3,5,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.112200639,0,-0.714052129,1.190908976,-0.599585814,0.548782303,0.728808365,1.954354606,0,2.498844514,1.309260306,1.908592586,0.056314669,0.129690799,38.27371111,0,2.264530357,0.845047659,2.679766441,0.007367355,0.025594883,5.841147416,0,-0.573455629,1.193493451,-0.480484939,0.63088261,0.746312235,4.985633125,0,-0.231584504,1.194583862,-0.193862073,0.846283881,0.897144205,N,-,,hypothetical protein NECHADRAFT_53561,,no IPS match,,
RL4_JR_07943,17,21,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.027974995,0,7.057164904,3.944726748,1.789012358,0.073612825,NA,0.00918948,0,10.233268,3.441762488,2.973263853,0.00294651,0.0154422,0.023399187,0,7.608647542,2.028930759,3.750077478,0.00017678,0.001628499,0.026960938,0,7.186064547,3.944404775,1.821837503,0.068479645,0.148587944,0.022629567,0,7.543781739,1.445745696,5.21791748,1.81E-07,3.72E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_07944,825,1405,777,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,107.2045122,0,-1.057994199,0.670290174,-1.578412217,0.11447094,0.244081007,20.75631956,0,-0.909986677,1.196696515,-0.760415582,0.447006212,0.608098869,76.07689077,0,-1.734503877,1.029328863,-1.685082328,0.091972689,0.181897148,111.5119244,1,-0.441733288,0.572450283,-0.771653541,0.440319654,0.582243241,68.7166016,0,-1.044084238,0.758903415,-1.37578013,0.168889715,0.283348528,N,-,,serine threonine- kinase partial,P:cellular macromolecule metabolic process; F:organic cyclic compound binding; F:heterocyclic compound binding; P:phosphorylation; P:primary metabolic process; F:kinase activity,G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR11909:SF149 (PANTHER); PTHR11909 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_07945,7,6,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.30861154,0,-2.129776241,1.199804506,-1.77510272,0.075880928,0.18111077,5.234240465,0,1.077604872,1.259613079,0.85550467,0.39227182,0.556591725,13.51518799,0,-1.567409787,1.202041997,-1.303955927,0.19224861,0.315910554,52.83650132,0,0.782079378,0.757817296,1.032015741,0.302064744,0.447921138,13.24755004,0,-1.641438816,1.19845185,-1.369632677,0.170801594,0.285892897,N,HYBRID,,lovastatin nonaketide synthase,,IPR020841 (SMART); IPR020807 (SMART); IPR020806 (SMART); IPR020801 (SMART); SM00822 (SMART); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR000873 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR014030 (PFAM); G3DSA:3.30.300.30 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR020807 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013217 (PFAM); IPR001242 (PFAM); IPR009081 (PFAM); IPR013120 (PFAM); IPR032821 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR013968 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR014031 (PFAM); G3DSA:2.30.38.10 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR001227 (G3DSA:3.40.366.GENE3D); IPR014043 (PFAM); PTHR11712:SF258 (PANTHER); PTHR11712 (PANTHER); PTHR11712 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR009081 (PROSITE_PROFILES); IPR016040 (SUPERFAMILY); IPR009081 (SUPERFAMILY); SSF52777 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR016039 (SUPERFAMILY); SSF52777 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR029063 (SUPERFAMILY); IPR016036 (SUPERFAMILY); IPR016035 (SUPERFAMILY); SSF56801 (SUPERFAMILY),4.C.1.1.4, the fatty acid transporter (fat) family.
RL4_JR_07946,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_07947,50,38,78,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.581060191,0,2.680926136,1.850003577,1.449146461,0.147296685,NA,0.184451844,0,5.904118296,1.851445284,3.188923998,0.001428034,0.015023052,0.480000487,0,3.247690328,1.27456838,2.548070688,0.010832052,0.03488031,0.553855653,0,2.825161093,1.389024543,2.033917332,0.041959931,0.111128512,0.474514625,0,3.162398809,1.237320594,2.555844317,0.01059305,0.032910289,N,-,,zinc-binding dehydrogenase family,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR013149 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR11695:SF460 (PANTHER); IPR002085 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_07948,61,51,71,0,0,20,0,0,0,0,0,0,0,0,0,0,1,0,2.221655373,1,0.746245639,1.460855949,0.510827669,0.609471733,0.775432064,0.717261961,0,3.945150315,1.625034384,2.427733441,0.015193506,0.046616751,1.840449939,0,1.309352165,1.325476567,0.987835016,0.323233456,0.46608966,2.122060168,0,0.887667433,1.366956893,0.649374854,0.516096113,0.650698396,1.78834317,1,1.247645881,1.310152929,0.952290266,0.340949793,0.478275253,N,-,,2og-fe oxygenase,F:iron ion binding; F:oxidoreductase activity; P:cell communication; P:regulation of amino acid import; P:cellular response to stimulus; P:oxidation-reduction process; C:intracellular part,PR00682 (PRINTS); IPR005123 (PFAM); IPR026992 (PFAM); IPR027443 (G3DSA:2.60.120.GENE3D); PTHR10209 (PANTHER); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_07949,11,20,28,0,0,10,0,0,0,0,0,0,0,0,0,0,3,0,7.381521504,1,-0.986192158,1.189563429,-0.829037052,0.407083441,0.598483819,2.356212811,0,2.229056146,1.288807534,1.729549282,0.083710834,0.176158225,6.110794005,0,-0.422386041,1.193814782,-0.353812038,0.723479751,0.812750666,7.049415816,0,-0.844700225,1.190915357,-0.709286533,0.478146684,0.61881846,6.021479945,1,-0.503859498,1.19449019,-0.421819704,0.673156623,0.767448576,N,-,,cation transporter,P:cation transport; P:transmembrane transport; C:membrane,IPR003445 (PFAM); PTHR31064:SF6 (PANTHER); PTHR31064 (PANTHER); PTHR31064 (PANTHER),2.A.38.2.5, the k(+) transporter (trk) family.
RL4_JR_07950,25024,24038,37422,0,1,5,0,0,0,2,2,1,3,13,5,0,2,1,0.298686158,1,3.641080153,2.513406259,1.448663598,0.147431551,NA,0.095267937,0,6.857564059,2.128457855,3.221846297,0.001273674,0.015023052,0.246742111,1,4.209007002,1.342969561,3.134104543,0.001723794,0.008805093,0.284645627,1,3.785938677,1.63517162,2.315315794,0.020595656,0.077838716,0.242387494,1,4.132140001,1.259050199,3.281950159,0.001030918,0.004900492,N,-,,glycerophosphoinositol transporter,P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane,IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR24064:SF269 (PANTHER); PTHR24064 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.9.7, the major facilitator superfamily (mfs).
RL4_JR_07951,1368,1167,1892,2,0,1,0,0,0,0,0,1,2,2,0,0,3,0,2.688217653,1,0.471007115,1.280504123,0.367829441,0.713000415,0.845486894,0.850163299,0,3.699589617,1.446341324,2.55789526,0.010530781,0.034971313,2.218710389,1,1.039017712,1.233375323,0.842418113,0.399553958,0.541681569,2.560500973,1,0.616208803,1.245707179,0.494665852,0.62083601,0.73865624,2.200467534,1,0.948603563,1.235932668,0.767520422,0.442772156,0.576169807,N,-,,#NAME?,C:integral component of membrane,IPR018946 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); PTHR11177 (PANTHER); PTHR11177:SF166 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_07952,14276,14476,11972,1,0,31,1,0,1,3,0,0,2,9,0,0,6,1,17.06692706,1,0.042773539,1.166400558,0.036671398,0.970747015,0.984504494,2.234206155,1,2.305822477,1.326607694,1.738134406,0.082187134,0.173601454,16.85582649,1,0.618516099,1.208039405,0.511999937,0.608651054,0.724870104,28.0215552,1,1.948264266,0.775465189,2.512381333,0.011991943,0.056030651,5.683927426,1,-0.420554414,1.215387834,-0.346024867,0.729324026,0.810119893,N,-,,hypothetical protein SPI_03677,,no IPS match,,
RL4_JR_07953,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,60.11783135,0,1.801570829,0.81237484,2.217659558,0.026578054,0.082536643,3.885199649,0,1.507596291,1.285146231,1.173093189,0.240758437,0.392614291,10.01474778,0,-1.134996425,1.208180877,-0.939425914,0.347512113,0.491096125,11.54845999,0,-1.55674734,1.207284827,-1.28946153,0.197237682,0.327274915,29.11001824,0,1.704895443,0.70087841,2.432512428,0.014994477,0.043526112,N,-,,C6 zinc finger domain containing,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_07954,13873,8132,18498,0,1,15,0,0,0,3,0,1,0,4,2,3,9,5,98.22314912,1,3.943699102,1.131996377,3.483844279,0.000494267,0.003340704,30.24013004,0,4.567274257,0.870136188,5.248918867,1.53E-07,1.76E-05,46.49873776,1,2.578954688,0.743324604,3.469486512,0.000521454,0.003484622,66.49284549,1,3.068609528,0.546776575,5.612181777,2.00E-08,5.27E-07,90.94269564,1,4.116894316,0.438789135,9.382398038,6.45E-21,1.59E-18,N,-,,family Taurine catabolism dioxygenase,F:sulfonate dioxygenase activity; P:sulfur compound catabolic process; P:oxidation-reduction process,IPR003819 (PFAM); G3DSA:3.60.130.10 (GENE3D); PTHR30468:SF12 (PANTHER); PTHR30468 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_07955,4809,3896,5490,0,0,0,0,0,0,0,0,0,0,0,5,0,2,0,9.798403397,0,2.010931288,1.158981676,1.735084626,0.082725817,0.193208479,0.575461701,0,4.262857467,1.534866343,2.777347673,0.005480452,0.021974647,1.48400958,0,1.619841817,1.234996869,1.311616132,0.189649687,0.312553058,1.711368118,1,1.197906776,1.254851867,0.954620069,0.339769864,0.487000266,1.453351976,1,1.546621578,1.215924478,1.271971743,0.203383159,0.325676813,N,-,,hypothetical protein CMQ_5760,,no IPS match,,
RL4_JR_07956,1565,1070,1083,2,2,3,0,0,0,0,0,0,0,0,0,0,1,0,1.14937346,1,1.696963963,1.415579182,1.19877714,0.230614614,NA,0.367294169,0,4.910593763,1.632196652,3.008579731,0.002624719,0.015349618,0.951031926,0,2.261863209,1.239137915,1.825352272,0.067947887,0.143313418,37.05702522,0,4.90089991,0.678431192,7.223871734,5.05E-13,2.51E-11,0.934829186,1,2.183768282,1.216483773,1.795147893,0.07263014,0.14907362,Y,-,,dna-directed rna polymerase,F:catalytic activity,PTHR36182 (PANTHER); PTHR36182:SF2 (PANTHER),,
RL4_JR_07957,5,14,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,94.84624647,0,2.026126882,0.716725999,2.82691975,0.00469981,0.02069134,7.007467742,0,0.656639189,1.224293506,0.536341315,0.591722682,0.728639536,413.0491653,0,4.48999629,0.262219666,17.12303412,9.99E-66,1.26E-62,332.3450579,0,4.028258685,0.312140545,12.90527217,4.20E-38,1.12E-35,218.5786827,0,3.756323205,0.44909088,8.364282983,6.05E-17,1.02E-14,N,-,,integral membrane,C:integral component of membrane,IPR026841 (PFAM); PTHR31310 (PANTHER); PTHR31310 (PANTHER); PTHR31310:SF9 (PANTHER); PTHR31310:SF9 (PANTHER),,
RL4_JR_07958,383,352,330,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,69.16203389,0,0.090198161,0.692913431,0.130172338,0.896430079,0.948632537,12.05359207,0,-0.125925251,1.24145106,-0.101433923,0.919206009,0.955641561,88.89091003,0,1.012519489,0.605307265,1.672736389,0.094379202,0.185677233,155.3340315,0,1.74687104,0.488071589,3.579128716,0.000344742,0.00304582,107.1188685,0,1.625519455,0.557237134,2.917105405,0.003532964,0.013497874,N,-,,mannosyl phosphorylinositol ceramide synthase sur1,C:membrane,IPR007577 (PFAM); PTHR32385 (PANTHER); PTHR32385:SF2 (PANTHER); IPR029044 (SUPERFAMILY),,
RL4_JR_07959,4271,3932,7554,0,0,2,0,0,0,0,0,1,0,9,0,0,0,0,40.73224423,1,4.387049845,0.7099027,6.179790341,6.42E-10,1.84E-08,0.805887306,0,3.776810042,1.463355376,2.580924705,0.009853607,0.033223921,19.66909942,1,2.944854385,1.053958747,2.794088851,0.005204618,0.019498852,11.73612744,1,1.647980001,1.169073382,1.409646328,0.15864414,0.27727808,2.078575345,0,1.030904211,1.237318017,0.833176432,0.404745232,0.541568056,N,-,,hypothetical protein FOQG_16251,P:glycogen biosynthetic process; F:glycogen (starch) synthase activity,no IPS match,,
RL4_JR_07960,50,88,54,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,64.97450151,0,-1.274915275,0.87960603,-1.449416251,0.147221373,0.293149124,14.31173174,0,-0.373666447,1.218255885,-0.306722464,0.75905463,0.853898657,60.84830453,0,-0.623370207,0.871993033,-0.714879803,0.474683318,0.611333661,51.08731893,0,-1.738827401,1.037391047,-1.676154238,0.093707985,0.186555644,48.59386393,0,-0.938649094,0.88324232,-1.062731113,0.287903907,0.422284088,N,-,,fructose-bisphosphate aldolase,F:aldehyde-lyase activity; P:carbohydrate metabolic process; F:zinc ion binding,IPR000771 (PIRSF); IPR000771 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR30304:SF7 (PANTHER); PTHR30304 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_07961,99,83,140,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,26.63359254,0,0.956763619,1.032997581,0.926201219,0.354341419,0.545212618,2.061262456,0,2.421959577,1.32249498,1.831356348,0.067047372,0.148566701,5.366388772,0,-0.234959932,1.215407287,-0.193317857,0.846710043,0.902042995,6.192431263,1,-0.657671679,1.216482515,-0.540633894,0.588759951,0.713321719,12.67037388,0,0.617736035,1.145216154,0.539405625,0.589607001,0.701707319,N,-,,C6 transcription factor,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR007219 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR007219 (PFAM); PTHR31313 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_07962,210,291,239,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,163.8156703,0,0.994305041,0.959898045,1.035844427,0.300274727,0.486039926,16.55994407,0,-0.584082122,1.231817409,-0.474162906,0.635383743,0.761738037,208.0577868,0,2.085301205,0.506669892,4.115699863,3.86E-05,0.000582404,179.9132993,0,1.217293944,0.512754104,2.374030621,0.017595091,0.072271927,113.0253818,0,1.014650723,0.487449976,2.081548413,0.037383738,0.089292367,Y,-,,non-classical export,P:plasma membrane organization; C:cytoplasm; C:membrane,IPR008253 (PFAM); PTHR28165:SF1 (PANTHER); PTHR28165 (PANTHER),9.A.27.1.7, the non-classical protein exporter (ncpe) family.
RL4_JR_07963,9,6,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,124.0058722,0,1.558951792,0.432330915,3.605922539,0.000311046,0.002237665,9.954879503,0,0.150075023,1.213137879,0.123708133,0.901546372,0.944583723,110.8180869,0,1.743457202,1.122787648,1.552793358,0.12047251,0.22252576,142.7346629,0,1.893517364,0.402219883,4.707667237,2.51E-06,4.14E-05,37.17344946,0,-0.392825034,0.856105715,-0.458851082,0.646341109,0.747255973,N,-,,hypothetical protein HMPREF1624_04655,,PTHR28230 (PANTHER),,
RL4_JR_07964,31,41,23,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,281.2150304,1,-0.622742068,0.649432908,-0.958901313,0.337608463,0.527542736,76.32705048,0,-0.734931506,0.974135062,-0.754445184,0.450581949,0.610874697,213.3927573,0,-1.213164716,0.53728794,-2.257941461,0.023949309,0.064262605,255.8764461,0,-0.930275645,0.420383177,-2.212923108,0.026902947,0.087153604,163.1088288,0,-2.517264601,0.762781934,-3.300110411,0.000966468,0.004650897,N,-,,eukaryotic translation initiation factor 2 beta subunit,C:multi-eIF complex; F:translation initiation factor activity; P:formation of translation preinitiation complex; C:eukaryotic 43S preinitiation complex; F:mRNA binding; F:translation initiation factor binding; C:eukaryotic translation initiation factor 2 complex,IPR002735 (SMART); IPR016189 (G3DSA:3.30.30.GENE3D); IPR002735 (PFAM); PTHR23001:SF3 (PANTHER); PTHR23001 (PANTHER); IPR016189 (SUPERFAMILY); IPR016190 (SUPERFAMILY),,
RL4_JR_07965,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,64.04851927,0,0.170161554,0.613151088,0.277519778,0.781381021,0.887242075,10.44284473,0,0.081085398,1.211231617,0.066944585,0.946625819,0.971385497,44.66388266,0,-0.746248102,1.0280329,-0.725899047,0.467900661,0.60482971,52.60546862,0,-0.268014414,0.738927551,-0.362707296,0.716823549,0.810388391,48.79917562,0,-0.423740466,0.836830735,-0.506363411,0.612601555,0.720142894,N,-,,fad dependent oxidoreductase,,IPR023753 (G3DSA:3.50.50.GENE3D); IPR006076 (PFAM); PTHR13847 (PANTHER); PTHR13847:SF129 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_07966,613,564,572,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,75.45334896,0,1.6466918,0.547347862,3.00849225,0.002625475,0.012965269,6.742661921,0,0.712257834,1.270180335,0.560753315,0.574965716,0.714963511,45.98919228,0,0.492251494,0.877335155,0.561075765,0.574745888,0.697521862,52.09829349,0,1.2686144,0.643521428,1.971363104,0.048682358,0.120870249,31.68966901,0,-0.301512901,0.989823521,-0.304612787,0.76066108,0.832705529,N,-,,PX domain-containing,C:membrane,IPR003114 (SMART); IPR001683 (G3DSA:3.30.1520.GENE3D); IPR013937 (PFAM); IPR003114 (PFAM); PTHR21660 (PANTHER); PTHR21660:SF14 (PANTHER); PTHR21660:SF14 (PANTHER); PTHR21660 (PANTHER); PTHR21660:SF14 (PANTHER); PTHR21660:SF14 (PANTHER); PTHR21660 (PANTHER); PTHR21660 (PANTHER); IPR003114 (PROSITE_PROFILES); IPR001683 (SUPERFAMILY),,
RL4_JR_07967,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_07968,13,9,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,86.42000258,0,-0.086933831,0.540367553,-0.160879073,0.872188645,0.938943648,25.94242618,0,0.332346064,1.11909883,0.296976509,0.766484444,0.858700115,57.20495463,0,-1.410543682,1.031686727,-1.367220926,0.171556068,0.290197767,78.80909862,0,-0.354834666,0.61905999,-0.573183005,0.56652079,0.693761853,42.15948108,0,-3.311595607,1.189538665,-2.783932716,0.005370417,0.018991407,N,-,,camk camkl ampk kinase,P:pseudohyphal growth; P:cell adhesion; P:invasive growth in response to glucose limitation; C:fungal-type vacuole; P:protein phosphorylation; P:positive regulation of filamentous growth of a population of unicellular organisms in response to starvation; C:nuclear envelope lumen; C:mitotic spindle pole body; P:replicative cell aging; P:positive regulation of gluconeogenesis; P:cellular response to nitrogen starvation; F:ATP binding; F:AMP-activated protein kinase activity; C:cytosol; P:fungal-type cell wall assembly; P:negative regulation of translation; P:single-species surface biofilm formation; P:intracellular signal transduction; C:nucleotide-activated protein kinase complex,IPR000719 (SMART); IPR000719 (PFAM); IPR032270 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR013896 (PFAM); PTHR24343 (PANTHER); PTHR24343:SF15 (PANTHER); PTHR24343 (PANTHER); PTHR24343:SF15 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR028375 (SUPERFAMILY); IPR011009 (SUPERFAMILY),8.A.104.1.1, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_07969,103,84,147,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,28.98516832,0,-2.95964495,1.213143373,-2.43964977,0.014701507,0.05174068,9.213329662,0,0.261735087,1.239005654,0.211246079,0.832695256,0.899812254,36.9971019,1,-0.581481013,1.055286861,-0.551017012,0.581622013,0.703116832,27.6913178,0,-2.818616703,1.211585589,-2.326386786,0.019997926,0.076714457,54.6736176,0,1.023162828,0.65860547,1.553529199,0.120296759,0.219658194,N,-,,UV radiation resistance autophagy-related 14,P:positive regulation of autophagy,IPR018791 (PFAM); PTHR15157:SF13 (PANTHER); PTHR15157:SF13 (PANTHER); PTHR15157 (PANTHER); PTHR15157:SF13 (PANTHER); PTHR15157 (PANTHER); PTHR15157 (PANTHER),,
RL4_JR_07970,314,158,354,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,29.89243218,0,1.55034991,0.758160973,2.044882243,0.040866469,0.114399835,2.673108717,0,2.047054765,1.29473829,1.58105679,0.113865054,0.22444831,6.923416477,0,-0.602325395,1.20387049,-0.50032408,0.616846902,0.73100293,24.03300365,1,1.680688412,0.762143865,2.205211495,0.027439257,0.088070176,6.806039341,0,-0.680499953,1.202470224,-0.56591834,0.571449293,0.687082781,N,-,,hypothetical protein SPSK_04428,,no IPS match,,
RL4_JR_07971,3937,3408,3799,9,2,41,4,0,2,12,34,5,8,22,4,0,43,2,12.38670473,1,-0.255077955,1.161781595,-0.21955758,0.826215732,0.912449971,2.717105512,1,2.023358634,1.289493707,1.569110902,0.1166221,0.228326672,7.082102575,1,-0.635372258,1.208565154,-0.525724455,0.59907967,0.717921094,17.48447917,1,-0.107062285,1.156082836,-0.092607797,0.926215149,0.956655996,7.018484743,1,-0.724902352,1.217701781,-0.59530368,0.551640496,0.671792978,N,-,,CMGC CK2 kinase,F:nucleotide binding; F:ATP binding; F:protein kinase activity; P:phosphorylation; F:protein serine/threonine kinase activity; P:protein phosphorylation; F:kinase activity,IPR024526 (PFAM),,
RL4_JR_07972,3,1,6,2,0,0,0,0,0,0,0,0,2,1,0,0,0,0,116.1079613,1,-0.919153289,0.576857399,-1.593380426,0.111074874,0.238711492,25.81587334,0,-1.224689293,1.194899932,-1.024930423,0.305396018,0.466739921,87.89356315,0,-1.473095331,0.850442898,-1.732150781,0.08324672,0.167872297,93.40406981,1,-1.585837039,0.746433272,-2.124552989,0.03362393,0.098223396,66.20549204,0,-3.962662771,1.194125607,-3.318463943,0.00090514,0.004403913,N,-,,casein kinase ii subunit alpha,F:ATP binding; F:protein serine/threonine kinase activity; P:protein phosphorylation,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); PTHR24054 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_07973,185,241,174,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,69.01748276,1,0.878241978,0.638171476,1.376184944,0.168764382,0.321244096,7.45163367,0,0.567880596,1.245449571,0.455964343,0.648415619,0.772603048,19.45793689,0,-2.093387919,1.212417686,-1.726622717,0.084235443,0.169273447,34.48980975,0,-0.235116258,0.896209453,-0.262345211,0.793055309,0.866402222,19.32623077,0,-2.18626202,1.225132356,-1.78451088,0.074340688,0.151692525,N,-,,myb-like dna-binding domain,F:DNA binding; C:nucleus; F:histone binding,IPR018465 (PFAM),,
RL4_JR_07974,18,53,31,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,59.88489184,0,1.723624123,0.578903025,2.977396986,0.002907073,0.014033079,14.92529361,0,1.909501263,1.132626038,1.685906203,0.091813867,0.189467882,30.15091862,0,0.15899984,1.045717832,0.152048511,0.879148674,0.924535284,77.2233772,0,1.510961068,0.607077318,2.48891043,0.012813524,0.059051859,14.34115556,0,-1.755847065,1.216234623,-1.443674626,0.148830522,0.257547263,N,-,,autophagy apg6,"P:autophagy; C:phosphatidylinositol 3-kinase complex, class III; P:endosomal transport; C:cytoplasmic part; P:phosphatidylinositol biosynthetic process; P:protein targeting to vacuole",IPR007243 (PFAM); IPR007243 (PANTHER),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_07975,27,28,36,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1107.469354,0,-2.216641452,0.404960128,-5.473727658,4.41E-08,9.46E-07,309.5479423,0,-3.084252243,1.006914079,-3.063073909,0.002190759,0.015045494,827.9600633,0,-3.529931148,0.62210086,-5.674210361,1.39E-08,5.76E-07,903.7041071,0,-4.373562529,0.684425506,-6.390122067,1.66E-10,6.06E-09,810.5484365,0,-3.371411445,0.960995936,-3.508247348,0.000451069,0.002488871,N,-,,inosine-5 -monophosphate dehydrogenase imd2,F:nucleotide binding; F:metal ion binding; C:cytosol; F:IMP dehydrogenase activity; P:oxidation-reduction process; P:GMP biosynthetic process,SM01240 (SMART); IPR000644 (SMART); IPR013785 (G3DSA:3.20.20.GENE3D); IPR005990 (TIGRFAM); IPR001093 (PFAM); IPR005990 (PIRSF); IPR000644 (PFAM); IPR005990 (PTHR11911:PANTHER); PTHR11911 (PANTHER); PTHR11911 (PANTHER); IPR005990 (PTHR11911:PANTHER); IPR005990 (HAMAP); IPR000644 (PROSITE_PROFILES); IPR000644 (PROSITE_PROFILES); SSF54631 (SUPERFAMILY); SSF51412 (SUPERFAMILY),,
RL4_JR_07976,11,22,29,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,52.40382226,1,0.578719268,0.674507708,0.857987627,0.390899296,0.58363039,6.616130188,0,0.73956132,1.233389812,0.599616855,0.548761611,0.695189616,74.42773176,0,1.508007936,0.617750736,2.441126895,0.014641509,0.043584427,49.15504632,1,0.964812657,0.622485262,1.549936547,0.121156747,0.225897426,24.59998714,0,-0.322601161,0.976828285,-0.330253706,0.74120827,0.818757771,N,-,,Ras GTPase activating,P:small GTPase mediated signal transduction; F:GTPase activator activity; C:intracellular; P:positive regulation of GTPase activity,IPR001715 (SMART); IPR001936 (SMART); IPR000048 (SMART); IPR000593 (PFAM); IPR000048 (PFAM); IPR001715 (PFAM); G3DSA:1.20.5.190 (GENE3D); IPR001936 (G3DSA:1.10.506.GENE3D); IPR001936 (PFAM); IPR001715 (G3DSA:1.10.418.GENE3D); PTHR14149 (PANTHER); PTHR14149:SF14 (PANTHER); IPR000048 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); IPR001936 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); IPR000048 (PROSITE_PROFILES); IPR001715 (PROSITE_PROFILES); IPR001715 (SUPERFAMILY); SSF143885 (SUPERFAMILY); IPR008936 (SUPERFAMILY),,
RL4_JR_07977,100,106,136,0,0,44,1,0,0,1,0,1,0,4,1,0,4,0,302.836651,1,-1.787023391,0.514101747,-3.476011123,0.000508931,0.003414359,78.04928197,1,-2.820805825,1.195139601,-2.360231242,0.018263547,0.053521604,254.8530089,1,-1.848091239,0.591440229,-3.124730357,0.001779681,0.009017764,233.7693845,1,-5.896130004,1.196953096,-4.925949082,8.40E-07,1.57E-05,200.0963947,1,-5.558336231,1.205430707,-4.611079009,4.01E-06,4.72E-05,N,-,,major facilitator superfamily transporter,C:membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23504 (PANTHER); PTHR23504:SF8 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.96, the major facilitator superfamily (mfs).
RL4_JR_07978,1110,1099,1338,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,181.0447197,0,0.774360638,0.67578322,1.145871361,0.251848383,0.42919973,61.65979898,0,-0.156436266,1.105592749,-0.14149538,0.887478609,0.93624486,213.7140767,0,1.202089681,0.395021557,3.043098941,0.002341553,0.011208457,223.8608673,0,1.316877552,0.485639856,2.711634011,0.006695247,0.035343784,161.6096426,0,0.424058116,0.462818611,0.916251217,0.359535148,0.496900542,N,-,,pa domain-containing,C:membrane,G3DSA:3.40.630.10 (GENE3D); IPR007484 (PFAM); IPR007365 (G3DSA:1.20.930.GENE3D); IPR003137 (PFAM); G3DSA:3.50.30.30 (GENE3D); IPR007365 (PFAM); PTHR10404 (PANTHER); IPR031054 (PTHR10404:PANTHER); SSF53187 (SUPERFAMILY); IPR007365 (SUPERFAMILY); SSF52025 (SUPERFAMILY),9.B.229.1.4," the transferrin receptor, cd71, (tfr) family."
RL4_JR_07979,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,2.881553266,1,0.371086798,1.252909475,0.296180056,0.767092579,0.877722899,0.918117964,0,3.588815489,1.428676321,2.5119864,0.012005372,0.038724784,2.381119513,0,0.937611248,1.221415401,0.767643217,0.442699179,0.582178784,2.747037578,0,0.515170594,1.229035903,0.419166432,0.675094503,0.778556294,2.343730458,0,0.85767477,1.215346396,0.705703964,0.480372255,0.609494873,N,-,,hypothetical protein CMQ_5547,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_07980,124,139,127,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.47199739,0,1.069647599,1.040009389,1.028498021,0.303715621,0.489956899,1.875678379,0,2.558212262,1.349978623,1.895002053,0.05809213,0.133003514,4.837193871,0,-0.084947624,1.218356593,-0.069723121,0.944414039,0.966961881,5.57848566,0,-0.506836813,1.219413868,-0.415639699,0.677673673,0.780301756,4.734586809,0,-0.157034279,1.211320358,-0.129638934,0.896852099,0.93292916,N,-,,chromatin assembly factor 1 subunit B,P:carbohydrate metabolic process,no IPS match,,
RL4_JR_07981,1029,879,1542,0,0,0,0,0,0,3,0,0,0,5,0,0,0,0,12.67770033,0,-1.766427403,1.19301254,-1.480644455,0.138701342,0.279993653,4.066654061,0,1.441738267,1.264505807,1.140159467,0.254219871,0.409030922,10.50843765,1,-1.204372379,1.197446755,-1.005783659,0.31451965,0.456865853,12.12000065,1,-1.626377082,1.195410603,-1.360517531,0.173666209,0.29692171,10.31227242,0,-1.280095482,1.193409548,-1.072637205,0.283433925,0.417663876,N,-,,chromatin assembly factor 1 subunit B,"C:nucleus; F:histone binding; C:CAF-1 complex; C:cytosol; C:chromosome, centromeric region; P:DNA replication-dependent nucleosome assembly",IPR001680 (SMART); IPR001680 (PFAM); IPR024977 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR15271 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_07982,10116,7050,8052,3,5,4,0,0,1,0,0,0,0,1,0,0,1,1,454.8194941,1,-0.552616514,0.343938111,-1.606732421,0.108113078,0.234383867,341.2512191,1,1.237762028,0.519560478,2.382325217,0.017203697,0.051216417,236.604533,0,-3.160045119,0.854951461,-3.69616904,0.000218877,0.001861114,333.4589732,1,-1.554774887,0.439174646,-3.540220052,0.000399794,0.003462711,231.1877211,1,-2.715314814,0.68080655,-3.988379394,6.65E-05,0.000494551,Y,-,,multidrug resistance-associated 1,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011527 (PFAM); IPR003439 (PFAM); G3DSA:1.20.1560.10 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24223 (PANTHER); PTHR24223 (PANTHER); PTHR24223:SF227 (PANTHER); PTHR24223:SF227 (PANTHER); PTHR24223:SF227 (PANTHER); PTHR24223 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY); IPR011527 (SUPERFAMILY),3.A.1.208.12, the atp-binding cassette (abc) superfamily.
RL4_JR_07983,244,230,234,1,6,9,0,0,0,1,0,0,1,8,5,0,2,2,108.0419896,1,-0.532300153,0.620834606,-0.857394461,0.391226919,0.583905819,19.81958366,0,-0.843375372,1.208781215,-0.697707212,0.485360317,0.641695027,82.23435091,1,-0.683653436,0.761938255,-0.897255692,0.369582494,0.514175233,119.7975152,1,0.153976761,1.448511232,0.106300012,0.915344322,0.948798246,55.04562112,1,-2.662612654,1.140917577,-2.333746721,0.019608988,0.053863539,N,-,,heat shock DNAj,C:membrane; C:integral component of membrane,IPR024586 (PFAM); IPR001623 (G3DSA:1.10.287.GENE3D); IPR001623 (PROSITE_PROFILES); IPR001623 (SUPERFAMILY),,
RL4_JR_07984,1409,1819,3260,0,0,4,0,0,0,0,0,0,0,10,0,0,0,0,235.0835793,1,1.135824419,0.907623075,1.251427437,0.210778572,0.378168373,24.70851568,0,-1.161398506,1.198575654,-0.968982227,0.332554057,0.495891598,141.6226618,0,0.187151682,0.50840184,0.368117633,0.712785523,0.805743707,256.8726423,1,1.460297092,0.31589345,4.622752043,3.79E-06,5.98E-05,92.49888889,0,-1.247369373,0.742164288,-1.680718667,0.092817573,0.180275835,N,-,,NADH-cytochrome b5 reductase,"F:cytochrome-b5 reductase activity, acting on NAD(P)H; C:integral component of membrane; P:oxidation-reduction process; C:mitochondrial outer membrane; P:cellular process",IPR001834 (PRINTS); IPR001709 (PRINTS); IPR001433 (PFAM); G3DSA:2.40.30.10 (GENE3D); G3DSA:3.40.50.80 (GENE3D); IPR008333 (PFAM); PTHR19370:SF90 (PANTHER); PTHR19370 (PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY); IPR017938 (SUPERFAMILY),5.B.1.3.2, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_07985,2591,2764,3980,0,5,8,0,0,0,0,0,0,0,2,0,0,0,0,49.14474837,1,-1.214687788,1.013072401,-1.199013799,0.23052258,0.402957619,9.289662608,0,0.24988531,1.226952246,0.203663436,0.838616517,0.903339516,59.25114483,0,0.737744462,0.679099911,1.086356293,0.27732139,0.416311055,97.28624698,1,1.106160194,0.529345366,2.089675787,0.036646933,0.101657589,23.71569161,0,-2.481588564,1.199512079,-2.068831658,0.038561887,0.091437729,N,-,,sh3 domain-containing,P:response to heat; C:cytoplasm; P:hyperosmotic response; P:inactivation of MAPK activity involved in cell wall organization or biogenesis,IPR001452 (SMART); G3DSA:2.30.30.40 (GENE3D); IPR001452 (PFAM); PTHR10663 (PANTHER); PTHR10663:SF215 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY),,
RL4_JR_07986,1832,2186,1729,0,0,10,0,0,0,2,1,0,1,3,6,0,8,9,73.10321669,1,-1.800780645,0.955993529,-1.883674512,0.059609016,0.151773953,19.39826205,0,-0.812386623,1.238013804,-0.656201587,0.511694428,0.66297924,76.24164193,1,-1.065044154,0.89938266,-1.184194673,0.236336011,0.368840106,88.36623095,1,-0.649270424,0.71676956,-0.905828679,0.365026539,0.511259331,50.65014858,1,-3.576270835,1.241975428,-2.879502086,0.003983037,0.014848563,N,-,,RNA polymerase II subunit A domain phosphatase SSU72,"P:negative regulation of chromosome condensation; P:snoRNA transcription; F:CTD phosphatase activity; P:transcription elongation from RNA polymerase II promoter; P:mRNA cleavage; P:termination of RNA polymerase II transcription, poly(A)-coupled; P:transcriptional start site selection at RNA polymerase II promoter; C:mRNA cleavage and polyadenylation specificity factor complex; F:protein tyrosine phosphatase activity; P:termination of RNA polymerase II transcription, exosome-dependent; P:dephosphorylation of RNA polymerase II C-terminal domain; C:cytosol; P:mRNA 3'-end processing; P:transcription antitermination; P:peptidyl-tyrosine dephosphorylation",IPR006811 (PFAM); IPR006811 (PANTHER),,
RL4_JR_07987,1832,1250,3155,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,60.78864641,0,0.516106063,0.571714403,0.902734057,0.366667056,0.558513285,9.581836051,0,0.205250535,1.223514605,0.167754871,0.866776127,0.922362065,44.26820791,1,-0.039184379,0.853733409,-0.045897675,0.963391807,0.978468966,75.92271875,0,1.017389408,0.518939796,1.960515297,0.049935592,0.122892747,43.6372138,0,0.413460378,0.671143552,0.616053565,0.537859168,0.660476567,N,-,,cell polarity,,IPR013724 (SMART); IPR013724 (PFAM); PTHR21601 (PANTHER),,
RL4_JR_07988,6287,5161,7541,0,0,12,0,0,0,2,4,0,5,5,0,0,1,0,48.22504103,1,-2.628797566,1.163664342,-2.259068592,0.023879118,0.075899793,14.08793175,0,-0.350878862,1.219548985,-0.287711987,0.773567213,0.862854831,36.65148057,1,-3.006805319,1.202856692,-2.499720323,0.012429139,0.038281898,55.61548667,1,-1.694352434,1.031641118,-1.642385521,0.100510134,0.196498892,43.9222654,1,-1.430537188,0.997280115,-1.434438697,0.151447111,0.260960177,N,-,,F-box domain-containing,,IPR001810 (SMART); IPR001810 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); G3DSA:1.20.1280.50 (GENE3D); PTHR13252:SF9 (PANTHER); PTHR13252:SF9 (PANTHER); PTHR13252 (PANTHER); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY),9.A.27.1.4, the non-classical protein exporter (ncpe) family.
RL4_JR_07989,557,640,766,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,24.6602988,1,4.382177804,0.622375897,7.041046779,1.91E-12,9.10E-11,0.558410066,0,4.306161182,1.516332658,2.839852561,0.004513439,0.019276384,1.447321247,0,1.655801927,1.220599771,1.356547794,0.174924939,0.293883187,1.66960633,1,1.233453604,1.236504525,0.997532624,0.318506046,0.464545335,1.424643353,0,1.575833497,1.207749378,1.304768627,0.191971645,0.31217056,N,-,,hypothetical protein SPI_00396,,IPR006640 (PFAM),,
RL4_JR_07990,71,57,86,0,0,0,0,0,0,0,0,0,0,8,0,0,6,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_07991,2647,2572,3480,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8.102248848,0,-1.120452948,1.199287938,-0.934265169,0.350167127,0.540216229,2.5970474,0,2.088718722,1.297504906,1.609796397,0.107442312,0.21387042,6.712540756,1,-0.557691996,1.201773004,-0.464057683,0.642606419,0.751067581,7.742190023,0,-0.979738143,1.200052103,-0.816413005,0.414263961,0.557917346,6.58742445,0,-0.633485652,1.197089213,-0.529188339,0.596674805,0.707340052,N,-,,serine threonine- kinase chk1,F:ATP binding; P:mitotic G2 DNA damage checkpoint; C:nuclear chromatin; C:site of double-strand break; P:replication fork protection; P:signal transduction involved in mitotic DNA damage checkpoint; C:cytosol; P:negative regulation of transcription from RNA polymerase II promoter by transcription factor localization involved in response to DNA damage checkpoint signaling; F:protein serine/threonine kinase activity; P:peptidyl-serine phosphorylation,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24347:SF152 (PANTHER); PTHR24347:SF152 (PANTHER); IPR020636 (PANTHER); IPR020636 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_07992,113,130,128,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,40.5986207,0,1.427128179,0.643710947,2.217032637,0.026620861,0.082638123,4.298706501,0,1.361643428,1.260785179,1.079996379,0.280143793,0.4392007,56.05988971,0,2.111816362,0.628741025,3.3588016,0.000782812,0.004731459,22.17823393,0,-0.76205937,1.151249806,-0.661940932,0.508009078,0.643834261,34.14461847,0,1.796490995,0.651710493,2.756578288,0.005840963,0.020350911,N,-,,ubiquitin-conjugating enzyme,F:ATP binding; C:cytoplasm; F:ligase activity,SM00212 (SMART); IPR016135 (G3DSA:3.10.110.GENE3D); IPR000608 (PFAM); PTHR24067:SF44 (PANTHER); PTHR24067 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),3.A.20.1.1, the peroxisomal protein importer (ppi) family.
RL4_JR_07993,883,1590,1316,0,0,58,0,0,1,1,0,1,0,15,0,0,3,0,851.7942678,1,-0.129707329,0.619748831,-0.209290156,0.834221736,0.917340408,181.9102387,1,-2.773843692,1.12454659,-2.466632967,0.013639008,0.04271474,389.0833413,1,-4.541400028,1.056497004,-4.298545108,1.72E-05,0.00029881,580.7483823,1,-1.403889092,0.776597186,-1.807744243,0.070646315,0.151931593,513.2719169,1,-1.169398797,0.730195851,-1.601486498,0.109269208,0.204086097,N,-,,60S ribosomal L31,F:structural constituent of ribosome; C:ribosome; P:translation,IPR000054 (SMART); IPR023621 (G3DSA:3.10.440.GENE3D); IPR000054 (PFAM); IPR000054 (PANTHER); IPR000054 (PRODOM); IPR023621 (SUPERFAMILY),,
RL4_JR_07994,353,304,283,0,0,3,0,0,0,0,0,0,0,1,1,0,3,1,145.3709755,1,1.314155554,0.456681919,2.877616782,0.004006916,0.018069883,88.81758508,0,1.523809164,0.971090966,1.569172424,0.116607768,0.228326672,31.54033072,0,-2.790169733,1.187731431,-2.349158791,0.018815881,0.05350137,87.92965994,1,0.119962668,0.607140087,0.197586472,0.84336862,0.902209631,31.12274314,1,-2.873665968,1.192109346,-2.410572468,0.015927507,0.045568241,N,-,,regulator of g- signaling domain-containing,C:integral component of membrane,IPR016137 (SMART); IPR016137 (PFAM); G3DSA:1.10.167.10 (GENE3D); PTHR13155 (PANTHER); IPR016137 (PROSITE_PROFILES); IPR016137 (SUPERFAMILY),,
RL4_JR_07995,2126,1750,2118,0,0,6,1,0,0,2,4,1,1,4,0,0,6,3,29.04159116,1,-0.792737435,1.007896663,-0.7865265,0.4315591,0.622464487,29.15641779,1,1.614340622,1.114053265,1.449069512,0.147318171,0.273005223,52.87979618,1,0.865794362,0.740966265,1.168466639,0.242618588,0.376094103,63.48330295,1,1.334695016,0.541216337,2.466102603,0.01365922,0.062129202,28.71090701,1,-0.364591303,0.973352515,-0.374572724,0.707978262,0.793741546,N,-,,cop9 signalosome subunit 7,,SM00753 (SMART); IPR000717 (SMART); PTHR15350 (PANTHER),,
RL4_JR_07996,6442,10514,9186,1,15,40,0,0,3,4,0,12,0,14,0,0,2,0,169.70801,1,0.889856737,0.390185485,2.280599282,0.02257217,0.072526097,27.60948877,1,0.194092548,1.117955261,0.173613877,0.862168925,0.919584753,58.2308986,1,-2.408730489,1.18958559,-2.024848409,0.042882933,0.100566785,118.2921597,1,-0.037898614,0.541979822,-0.069926246,0.944252363,0.967373791,69.52261475,1,-0.255976018,0.616168802,-0.415431643,0.677825946,0.771138952,N,-,,heavy metal translocating p-type atpase,F:nucleotide binding; P:cellular iron ion homeostasis; P:copper ion export; F:copper ion binding; F:cation-transporting ATPase activity; C:integral component of membrane; C:trans-Golgi network transport vesicle membrane,PR00119 (PRINTS); PR00942 (PRINTS); IPR006122 (TIGRFAM); IPR008250 (G3DSA:2.70.150.GENE3D); IPR023214 (G3DSA:3.40.50.GENE3D); IPR023299 (G3DSA:3.40.1110.GENE3D); PF00702 (PFAM); IPR006121 (PFAM); IPR008250 (PFAM); G3DSA:3.30.70.100 (GENE3D); G3DSA:3.30.70.100 (GENE3D); IPR001757 (TIGRFAM); IPR027256 (TIGRFAM); PTHR24093 (PANTHER); PTHR24093:SF352 (PANTHER); PTHR24093 (PANTHER); PTHR24093:SF352 (PANTHER); IPR006121 (PROSITE_PROFILES); IPR006121 (PROSITE_PROFILES); IPR006121 (PROSITE_PROFILES); IPR006121 (PROSITE_PROFILES); SSF81665 (SUPERFAMILY); IPR006121 (SUPERFAMILY); IPR006121 (SUPERFAMILY); SSF81653 (SUPERFAMILY); IPR006121 (SUPERFAMILY); IPR006121 (SUPERFAMILY); IPR023214 (SUPERFAMILY),3.A.3.5.3, the p-type atpase (p-atpase) superfamily.
RL4_JR_07997,1955,3089,1915,0,1,16,0,0,1,0,0,4,0,3,2,0,0,1,80.74876967,1,-0.072043976,0.62345045,-0.115556859,0.908003755,0.955524513,101.7053868,1,2.469742389,0.744887436,3.315591417,0.000914494,0.015023052,40.21587501,1,-1.865995809,1.192750728,-1.564447428,0.11771253,0.218784956,69.44119443,1,0.429483086,0.567807269,0.756388848,0.449416092,0.591260127,31.98737122,1,-2.913218478,1.199138593,-2.429426002,0.015122752,0.043772973,N,-,,sad1-interacting factor 3,P:cation transport; F:metal ion binding; C:membrane,IPR003734 (PFAM); PTHR16255 (PANTHER); PTHR16255 (PANTHER); PTHR16255:SF4 (PANTHER); PTHR16255:SF4 (PANTHER),,
RL4_JR_07998,191,246,281,0,0,0,0,0,3,1,4,8,0,12,1,0,4,0,278.3802002,0,0.733893594,0.526765742,1.393206762,0.163557276,0.314374876,44.41454368,1,-0.749200597,1.128203515,-0.664065115,0.506648636,0.659418477,102.5832587,1,-3.365139172,1.210754455,-2.779373769,0.005446382,0.020167947,125.6737557,1,-1.760418664,0.736133336,-2.391439945,0.016782429,0.07027382,90.84943647,1,-4.419183472,1.223001578,-3.613391473,0.000302218,0.001758595,N,-,,tyrosyl-tRNA synthetase,C:nucleus; F:tyrosine-tRNA ligase activity; F:ATP binding; P:tyrosyl-tRNA aminoacylation; C:cytoplasm,IPR002307 (PRINTS); IPR014729 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.240.10 (GENE3D); IPR002305 (PFAM); IPR023617 (PIRSF); IPR002307 (TIGRFAM); PTHR11946:SF80 (PANTHER); PTHR11946 (PANTHER); SSF52374 (SUPERFAMILY),,
RL4_JR_07999,49674,98613,45706,0,0,203,4,0,0,0,0,2,3,21,0,0,13,4,60.35641891,1,0.345809389,0.756582116,0.457067887,0.647622251,0.799498368,6.393522811,1,0.788907322,1.23259633,0.640037052,0.522148511,0.671561274,36.10352671,1,0.536731646,0.857079383,0.626233294,0.531161932,0.660949287,28.79600324,1,-1.337358699,1.145840642,-1.167141965,0.243153043,0.381385127,46.91053115,1,1.456896376,0.596446135,2.442628581,0.014580735,0.042556915,N,-, Effector probability:0.743,ribonuclease p complex subunit,,PTHR28139:SF1 (PANTHER); PTHR28139 (PANTHER),,
RL4_JR_08000,1968,2814,3079,2,7,0,0,0,0,0,0,0,0,0,0,0,0,0,29.00734177,1,-2.960715729,1.238165149,-2.391212295,0.01679284,0.057081661,9.14558657,0,0.27236313,1.257743767,0.21654898,0.82855985,0.897378751,62.94031403,0,0.968082402,0.709717927,1.364038253,0.172555527,0.291357804,37.27625425,0,-1.861649562,1.183701743,-1.572735339,0.115780113,0.218422517,23.85979826,0,-2.490285597,1.242968272,-2.003498924,0.045123763,0.103576989,N,-,,RNAse P subunit P30,C:nucleus; F:carbon-sulfur lyase activity; P:RNA phosphodiester bond hydrolysis; C:intracellular ribonucleoprotein complex; P:tRNA processing; F:ribonuclease activity,G3DSA:3.20.20.140 (GENE3D); IPR002738 (PFAM); IPR002738 (PANTHER); IPR016195 (SUPERFAMILY),,
RL4_JR_08001,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,83.4661783,0,1.1950986,0.465158816,2.569227024,0.010192566,0.038415541,10.02022984,0,0.140663283,1.211560221,0.116100942,0.907572542,0.94832758,58.49486099,0,0.625941143,0.666299846,0.939428617,0.347510726,0.491096125,49.26591293,0,-1.193845831,1.009116916,-1.183059972,0.23678538,0.374484844,29.5055418,0,-1.664084378,1.121409018,-1.483922771,0.13782941,0.243305939,Y,-,,unnamed protein product,,no IPS match,,
RL4_JR_08002,47,31,64,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.947999324,0,0.337725144,1.273099355,0.265277917,0.790795375,0.892347509,0.934626772,0,3.562908371,1.434914133,2.483011554,0.013027686,0.041233971,2.438204838,0,0.902742768,1.234743288,0.731117777,0.464707217,0.601546587,2.813553805,0,0.480082686,1.245847111,0.38534639,0.699980796,0.797992089,2.419950863,0,0.811265257,1.239052719,0.65474636,0.512631072,0.638597884,N,-, Effector probability:0.743,glutathione-dependent formaldehyde-activating enzyme,F:carbon-sulfur lyase activity; P:metabolic process,IPR006913 (G3DSA:3.90.1590.GENE3D); IPR006913 (PFAM); PTHR33337 (PANTHER); PTHR33337:SF3 (PANTHER); IPR011057 (SUPERFAMILY),,
RL4_JR_08003,59244,74815,91283,5,29,7,0,1,1,1,1,2,0,4,0,0,12,0,0.043191743,1,6.429875606,3.931383335,1.635524969,0.101939045,NA,0.01402238,1,9.621464695,3.227538731,2.98105321,0.002872589,0.015349618,0.036122894,1,6.977751362,1.908527644,3.656091325,0.00025609,0.002060935,0.041643826,1,6.557930765,3.416908514,1.919258516,0.054951625,0.129784279,0.035491148,1,6.895282941,1.432728017,4.812694986,1.49E-06,2.01E-05,N,-,,---NA---,,no IPS match,,
RL4_JR_08004,2742,5334,4838,0,0,0,0,0,0,0,2,0,0,1,0,0,0,0,30.72086176,0,-0.100108741,0.912428726,-0.109716779,0.912633993,0.956988186,6.113481541,0,0.853534046,1.264122762,0.6751987,0.499549532,0.653811326,41.88486363,1,1.000828825,0.786072876,1.273201067,0.202946702,0.328741186,30.3695904,1,0.054876657,0.901069017,0.060901725,0.951437476,0.971282538,19.52912705,0,-0.95558683,1.152608124,-0.829064805,0.407067738,0.543492219,N,-,,monosaccharide-p-dolichol utilization,C:integral component of membrane,IPR006603 (SMART); IPR006603 (PFAM); IPR016817 (PIRSF); PTHR12226:SF2 (PANTHER); IPR016817 (PANTHER),2.A.43.3.1, the lysosomal cystine transporter (lct) family.
RL4_JR_08005,2905,2741,3393,0,0,2,0,0,0,0,0,2,0,0,0,0,2,1,104.8488542,1,0.928086147,0.576183277,1.610748148,0.107234627,0.233036784,12.33857094,0,-0.159545604,1.265465177,-0.126076645,0.899671255,0.944164458,31.68232979,1,-2.796594677,1.225002233,-2.282930269,0.022434476,0.061005155,111.0264949,0,0.782955265,0.605452049,1.293174687,0.195950648,0.325771082,50.20381547,1,0.016242046,0.752063163,0.021596652,0.982769705,0.988530028,N,-,,choline-sulfatase,F:sulfuric ester hydrolase activity; C:mediator complex; P:metabolic process; F:RNA polymerase II transcription cofactor activity; P:regulation of transcription from RNA polymerase II promoter,G3DSA:3.30.1120.10 (GENE3D); IPR017785 (TIGRFAM); IPR025863 (PFAM); IPR017849 (G3DSA:3.40.720.GENE3D); IPR000917 (PFAM); PTHR10342:SF207 (PANTHER); PTHR10342 (PANTHER); IPR017850 (SUPERFAMILY),2.A.127.1.6, the enterobacterial cardiolipin transporter (clt) family.
RL4_JR_08006,155,235,175,0,0,1,0,0,0,0,1,0,3,0,2,0,0,0,23.57886082,1,-0.906566829,1.164093365,-0.778775016,0.436112257,0.626731603,4.286162703,0,1.365742126,1.266592691,1.078280442,0.280908623,0.439875785,11.17627105,1,-1.293528377,1.210740831,-1.068377596,0.285350219,0.424698362,16.90812958,1,-0.770356443,1.163042081,-0.662363345,0.507738389,0.643571757,11.08554444,0,-1.384383781,1.221690939,-1.133170212,0.257142781,0.388708667,N,-,,rna polymerase ii mediator complex component med8,F:sulfuric ester hydrolase activity; C:mediator complex; P:metabolic process; F:RNA polymerase II transcription cofactor activity; P:regulation of transcription from RNA polymerase II promoter,IPR019364 (PFAM); PTHR13074 (PANTHER); IPR020178 (PRODOM),,
RL4_JR_08007,7600,6933,11014,0,0,17,0,0,0,1,0,0,7,9,4,0,6,0,34.30250065,1,-3.202627846,1.187787107,-2.696297869,0.007011494,0.028620751,11.00463724,0,0.005500356,1.220447508,0.004506835,0.996404078,0.997981603,28.46049333,1,-2.641907339,1.192795133,-2.214887759,0.02676777,0.070224643,32.82531558,1,-3.063928194,1.191706488,-2.571042638,0.010139284,0.049059272,72.52548082,1,0.726918606,0.576646108,1.260597438,0.207453922,0.330158906,N,-,,beta-lactamase-type transpeptidase fold domain containing,P:transport; C:intracellular,no IPS match,,
RL4_JR_08008,3045,2484,4911,0,1,10,0,0,0,0,3,3,1,2,2,0,2,1,673.4698807,1,8.907472022,2.484572181,3.585112998,NA,NA,0.45132597,0,4.613410153,1.58886163,2.903594665,0.003689054,0.01730334,20.66091112,1,4.368854656,0.869434243,5.024939715,5.04E-07,1.46E-05,14.66707993,1,3.282989505,1.028331072,3.192541385,0.001410267,0.009867973,5.001845987,1,2.824685241,1.136395307,2.485653737,0.012931372,0.038645838,Y,-,,accumulation-associated protein,,no IPS match,,
RL4_JR_08009,172,149,181,0,0,151,0,0,0,0,0,0,0,2,0,0,9,0,47.28646502,1,5.410825827,0.70399686,7.685866421,1.52E-14,9.46E-13,0.470363036,0,4.553795715,1.576080355,2.889316969,0.003860797,0.017716233,1.214082771,0,1.909510898,1.235878791,1.545063247,0.122330966,0.225096092,13.43493661,1,3.782774769,0.874356745,4.326351678,1.52E-05,0.000205206,28.2138119,1,5.225883588,0.605870672,8.625411045,6.39E-18,1.24E-15,Y,-,,---NA---,,no IPS match,,
RL4_JR_08010,94,52,102,0,0,73,0,0,0,0,0,0,0,0,0,0,1,0,5.631210572,1,-0.595531743,1.200830737,-0.495933128,0.619941593,0.781764585,1.798257403,0,2.618960357,1.322162713,1.980815471,0.047611971,0.113501736,4.659670707,0,-0.031083316,1.200654702,-0.025888639,0.979346162,0.988721633,17.41003621,0,1.850270946,0.85602944,2.161457141,0.030660044,0.093673189,4.584955184,1,-0.110577939,1.198003223,-0.092301871,0.926458202,0.952205976,N,-,,alpha beta hydrolase,P:mycelium development; F:catalytic activity; F:binding,IPR000639 (PRINTS); IPR029058 (G3DSA:3.40.50.GENE3D); IPR000073 (PFAM); PTHR10992 (PANTHER); PTHR10992:SF778 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_08011,320,230,227,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,94.08334767,0,3.224119327,1.085544578,2.970047839,0.002977534,0.014310886,3.233538239,0,1.772465685,1.278910053,1.385918956,0.165771652,0.298831818,14.85363709,0,0.08828499,1.195137247,0.073870168,0.941113693,0.965074824,37.71713379,0,2.205050996,0.590872962,3.731852934,0.000190076,0.001838132,15.92123702,0,0.719844768,0.973976323,0.739078303,0.459859451,0.591322954,N,-,,tenascin Y variant,C:membrane; C:integral component of membrane,SSF101447 (SUPERFAMILY),,
RL4_JR_08012,1347,1580,1774,0,1,7,0,0,0,0,0,0,0,0,0,0,0,0,5.990474616,1,-0.685216894,1.197973311,-0.5719801,0.567335457,0.744103321,1.919415222,0,2.524865541,1.320061106,1.912688382,0.055787957,0.128771215,4.969018934,0,-0.124059877,1.202486069,-0.103169492,0.917828453,0.950792516,9.742987374,0,0.400647355,1.148765374,0.348763433,0.727266918,0.818175283,4.890430209,0,-0.203868672,1.200827859,-0.169773436,0.865188318,0.910077049,N,-,,heterokaryon incompatibility (het-6OR allele),F:DNA binding,IPR010730 (PFAM); PTHR24148 (PANTHER); PTHR24148:SF25 (PANTHER),,
RL4_JR_08013,415,561,539,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.320372223,0,0.166076298,1.224985596,0.135574083,0.892157995,0.947068956,1.063045341,0,3.377305638,1.3997651,2.412765998,0.01583198,0.048137971,2.75422716,0,0.72713448,1.213872243,0.599020601,0.549159147,0.676475447,3.176913333,0,0.30499772,1.21767972,0.250474501,0.802220421,0.873479059,2.713568409,0,0.645854302,1.210246319,0.53365525,0.593580075,0.704985133,N,-,,GDSL-like Lipase Acylhydrolase,C:membrane; F:hydrolase activity,IPR013830 (PFAM); IPR013830 (G3DSA:3.40.50.GENE3D); PTHR30383:SF4 (PANTHER); PTHR30383 (PANTHER); IPR013830 (SUPERFAMILY),,
RL4_JR_08014,95,82,90,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,117.2604784,1,4.191248885,1.235191186,3.393198503,0.000690816,0.00440976,2.078760089,0,2.409841372,1.321512903,1.823547365,0.06822053,0.150474658,75.70927115,0,3.747711308,0.532599255,7.036643921,1.97E-12,1.49E-10,172.1951778,0,4.835226038,0.378382519,12.77867182,2.16E-37,5.33E-35,128.1204941,0,4.051496473,0.572263953,7.079768795,1.44E-12,1.42E-10,N,-,,oligopeptide transporter,P:oligopeptide transport; C:integral component of membrane; F:transporter activity,IPR000109 (PFAM); G3DSA:1.20.1250.20 (GENE3D); IPR000109 (PANTHER); IPR000109 (PANTHER); PTHR11654:SF127 (PANTHER); IPR020846 (SUPERFAMILY),2.A.17.2.4, the proton-dependent oligopeptide transporter (pot/ptr) family.
RL4_JR_08015,81,48,40,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,5.160792605,0,-0.470174869,1.203265424,-0.39074909,0.69598271,0.835711944,1.648715088,0,2.744150004,1.333107751,2.058460766,0.039545924,0.098132836,4.277139467,1,0.092139047,1.204258165,0.076511042,0.939012529,0.963531496,4.933982062,0,-0.330143649,1.203509586,-0.274317424,0.783840696,0.86067336,4.219059219,0,0.009223918,1.205342114,0.007652531,0.993894223,0.995368843,N,-,,major facilitator superfamily transporter,F:arylformamidase activity; P:tryptophan catabolic process to kynurenine,G3DSA:3.50.30.50 (GENE3D); IPR007325 (PFAM); PTHR34861 (PANTHER); PTHR34861 (PANTHER); PTHR34861:SF3 (PANTHER); SSF102198 (SUPERFAMILY),,
RL4_JR_08016,75,64,77,0,0,22,0,0,0,0,0,0,0,0,0,0,0,0,5.12368624,1,-0.459469583,1.197233015,-0.383776238,0.701144301,0.838858189,1.641673998,0,2.75039935,1.334341989,2.061240201,0.03928013,0.097664818,4.247172931,0,0.102572276,1.200801207,0.085419864,0.931927602,0.959251445,4.898769922,0,-0.319519352,1.199113066,-0.266463072,0.789882596,0.8642275,4.174600856,0,0.024505281,1.195556261,0.02049697,0.983646929,0.98901938,N,-,,Mandelate racemase muconate lactonizing enzyme domain-containing,P:cellular amino acid catabolic process; F:catalytic activity,IPR013342 (SMART); IPR029065 (G3DSA:3.20.20.GENE3D); IPR029065 (PFAM); IPR029017 (G3DSA:3.30.390.GENE3D); IPR013341 (PFAM); PTHR13794:SF4 (PANTHER); IPR001354 (PANTHER); IPR029017 (SUPERFAMILY); IPR029065 (SUPERFAMILY),,
RL4_JR_08017,3,2,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.235214735,0,-0.184664825,1.272745517,-0.145091711,0.884638462,0.943876612,1.336913631,0,3.046544291,1.399200605,2.177346321,0.029454737,0.078047344,3.489773912,0,0.385817829,1.240956262,0.310903648,0.755873871,0.835878435,32.93349723,0,2.342021064,0.896503182,2.612395707,0.008991012,0.044646394,3.458679881,0,0.296167686,1.247206823,0.237464774,0.812296244,0.873089116,N,-,,tubulin-tyrosine ligase,P:lipid storage; C:actomyosin contractile ring; C:cytoplasm; C:membrane; P:mitotic actomyosin contractile ring assembly; C:integral component of membrane; C:cytosol; C:endoplasmic reticulum; F:ligase activity,IPR009617 (PFAM); PTHR21212:SF0 (PANTHER); PTHR21212:SF0 (PANTHER); PTHR21212 (PANTHER); PTHR21212 (PANTHER),1.R.1.1.1, the membrane contact site (mcs) family.
RL4_JR_08018,3271,3133,3182,1,3,0,0,0,0,0,0,2,1,6,3,0,9,4,87.20966151,1,2.869891986,0.737435714,3.891718198,9.95E-05,0.000852964,3.90379549,0,1.500680556,1.260597817,1.190451495,0.233868984,0.384102199,32.25574841,1,0.681509388,1.032113955,0.660304402,0.509058506,0.640530489,30.29396822,1,0.172379892,1.01544212,0.169758461,0.865200096,0.916460443,17.67298017,1,0.439299788,0.977847374,0.449251898,0.653249954,0.752593771,N,-,,SH3 domain-containing,P:cell division; C:cytoplasmic part,PR00499 (PRINTS); IPR001452 (PRINTS); IPR001452 (SMART); IPR001060 (SMART); G3DSA:1.20.58.70 (GENE3D); G3DSA:2.30.30.40 (GENE3D); IPR001060 (PFAM); IPR001452 (PFAM); PTHR23065:SF7 (PANTHER); PTHR23065 (PANTHER); PTHR23065 (PANTHER); PTHR23065:SF7 (PANTHER); PTHR23065:SF7 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR031160 (PROSITE_PROFILES); SSF103657 (SUPERFAMILY); IPR001452 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_08019,460,522,882,0,0,0,0,0,1,0,0,1,0,7,0,0,0,0,145.2086914,0,-0.069188095,0.564443569,-0.122577525,0.902441653,0.952655151,22.85109257,1,-1.048670742,1.21614906,-0.862288001,0.388529054,0.553251916,73.73438017,1,-1.883169597,1.05043038,-1.792760028,0.073011304,0.151935547,97.89998276,1,-0.848407792,0.662983867,-1.279680899,0.200657385,0.331644796,58.58264477,0,-3.786168623,1.210294816,-3.128302769,0.00175819,0.007594569,N,-,,mitochondrial intermembrane space import and assembly 40,C:membrane,PTHR38402 (PANTHER); PTHR38402:SF1 (PANTHER),9.B.235.1.8, the mitochondrial outer membrane protein-14 (om14) family.
RL4_JR_08020,5820,4466,5391,2,0,13,0,0,0,2,2,0,3,19,0,0,9,0,76.8635654,1,-0.416256675,0.827493128,-0.503033392,0.614940795,0.778967874,15.73671815,0,-0.510599382,1.256532512,-0.406355886,0.684481128,0.799648263,41.30918386,1,-3.179434949,1.238984715,-2.56616156,0.010283092,0.033431607,51.69968802,1,-2.659309307,1.201245501,-2.213793354,0.026842997,0.087153604,63.69470403,1,-0.657086089,0.84963182,-0.773377449,0.439299032,0.573331103,N,-,,small nuclear ribonucleo E,"C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP; C:cytosol; C:viral nucleocapsid; C:U2-type prespliceosome; C:U2 snRNP; C:U1 snRNP; P:mRNA splicing, via spliceosome",IPR001163 (SMART); IPR001163 (PFAM); G3DSA:2.30.30.100 (GENE3D); IPR027078 (PANTHER); IPR010920 (SUPERFAMILY),,
RL4_JR_08021,361,336,592,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,148.3350859,0,-0.459226855,0.500211662,-0.918065071,0.3585848,0.549978341,27.07672806,0,-1.293493926,1.196070094,-1.08145328,0.279495532,0.438612989,84.74499364,0,-2.126701736,1.033752882,-2.057263175,0.039660918,0.095013519,111.8872777,0,-1.321528856,0.674366767,-1.959658928,0.050035669,0.123053472,138.3711525,1,0.462964807,0.511819242,0.904547482,0.365705169,0.502099923,N,-,,phosphatidate cytidylyltransferase,C:Golgi to plasma membrane transport vesicle; P:phosphatidylserine metabolic process; F:phosphatidate cytidylyltransferase activity; C:integral component of membrane; C:endoplasmic reticulum; P:phosphatidylinositol metabolic process; P:CDP-diacylglycerol biosynthetic process,PF01148 (PFAM); IPR016720 (PIRSF); PTHR13773:SF8 (PANTHER); PTHR13773 (PANTHER),9.B.273.1.1,The Phosphatidate Cytidylyltransferase (PCT) Family
RL4_JR_08022,6205,6218,6947,2,3,6,0,0,0,0,3,0,1,3,1,0,0,2,86.26527482,1,-3.520547555,1.148230955,-3.066062224,0.002168982,0.011192001,26.381375,0,-1.25593686,1.204255984,-1.042915191,0.296987573,0.456855352,74.87778871,1,-2.94472091,1.19505492,-2.464088353,0.013736225,0.041415838,90.90969443,1,-2.030943778,0.865596049,-2.346295112,0.018961088,0.074881699,86.70320513,1,-1.073602929,0.697035788,-1.540240757,0.123501678,0.22378614,N,-,,DNA repair,C:cellular_component; F:molecular_function,IPR022093 (PFAM),,
RL4_JR_08023,2268,2400,4075,0,0,1,3,0,0,0,0,0,2,5,0,0,0,0,139.7149765,1,-1.71011545,0.678270126,-2.521289652,0.011692556,0.042948164,32.64926219,1,-1.56346004,1.204030468,-1.298521991,0.194108025,0.336547007,84.53513925,0,-4.212504053,1.195364856,-3.52403204,0.000425033,0.003004911,145.4994324,1,-0.912376269,0.554539074,-1.645287612,0.099910513,0.195669866,83.22914556,0,-4.292813038,1.19683161,-3.586814554,0.000334742,0.001919512,N,-,,hypothetical protein SPSK_08634,"P:regulation of transcription, DNA-templated",no IPS match,,
RL4_JR_08024,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41.36303047,0,-1.251906462,1.001601912,-1.249904225,0.211334536,0.378773167,28.19333737,0,1.869908076,0.985041644,1.898303576,0.057656103,0.132154682,55.83631361,0,0.400464122,0.736011981,0.544100005,0.586372657,0.7068644,130.985118,0,1.62719181,0.454245068,3.582189274,0.000340727,0.003020892,35.68628497,0,-0.297417849,0.83826825,-0.354800327,0.722739183,0.804854183,Y,-,,glycoside catalytic core,P:carbohydrate metabolic process; C:integral component of membrane; F:hydrolase activity,IPR024655 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR34154 (PANTHER); PTHR34154:SF2 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_08025,1961,2012,4006,0,0,0,0,0,1,0,0,0,0,1,8,0,0,0,144.8956454,0,2.017765525,1.246402316,1.618871772,0.105474856,0.230378547,9.722454963,1,0.18423675,1.220688303,0.150928578,0.880032057,0.931615043,276.5292636,0,3.237582397,0.333121037,9.718937088,2.50E-22,4.37E-20,382.163428,1,3.657423038,0.261808662,13.96983208,2.38E-44,8.61E-42,148.1905321,0,2.541898876,0.361129741,7.038741449,1.94E-12,1.87E-10,N,-,,3-ketoacyl- thiolase,"F:transferase activity, transferring acyl groups other than amino-acyl groups; P:metabolic process",IPR020617 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR020616 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR002155 (PIRSF); IPR002155 (TIGRFAM); PTHR18919:SF97 (PANTHER); PTHR18919 (PANTHER); IPR016039 (SUPERFAMILY); IPR016039 (SUPERFAMILY),,
RL4_JR_08026,3573,6089,4564,8,0,10,0,0,0,0,4,5,0,4,2,0,22,5,444.0036806,1,-5.940832202,1.207310037,-4.920717975,8.62E-07,1.35E-05,142.3878919,0,-3.68815919,1.243395823,-2.966198794,0.003015055,0.015636999,411.3555236,1,-3.150164803,0.748287164,-4.209834076,2.56E-05,0.000413302,438.9521342,1,-4.447026062,0.925428506,-4.805369655,1.54E-06,2.70E-05,356.3776167,1,-6.39104479,1.241709316,-5.146973374,2.65E-07,4.85E-06,N,-,,transcriptional regulator medusa,C:nucleus; P:positive regulation of conidium formation,PTHR39463 (PANTHER),,
RL4_JR_08027,835,912,1344,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,439.9727953,0,-2.708573163,0.532002772,-5.091276413,3.56E-07,6.10E-06,124.5350862,0,-3.49490024,1.193925102,-2.927235749,0.003419895,0.016584684,385.2426678,0,-2.506964347,0.592979827,-4.227739689,2.36E-05,0.000384827,460.3656495,0,-1.962421181,0.445788586,-4.402134203,1.07E-05,0.000149492,390.7992738,0,-2.097338787,0.58474321,-3.586768947,0.000334801,0.001919512,N,-,,gyf domain containing,C:cytosol,IPR003169 (SMART); IPR019734 (SMART); IPR003169 (G3DSA:3.30.1490.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR003169 (PFAM); PTHR16193 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR003169 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR003169 (SUPERFAMILY); IPR011990 (SUPERFAMILY),,
RL4_JR_08028,1022,1349,1983,0,0,3,0,0,0,0,0,1,0,4,0,0,0,0,0.285191174,1,3.707699702,2.558773856,1.44901422,0.147333612,NA,0.090397643,0,6.932997733,2.1399595,3.239779881,0.00119622,0.015023052,0.235345772,1,4.276172454,1.340526206,3.189920818,0.001423118,0.007594963,0.271572462,1,3.853426925,1.647712826,2.338652018,0.01935345,0.075643466,0.232646719,0,4.191466966,1.260172448,3.326105862,0.000880685,0.004313949,N,-,,hypothetical protein CMQ_2418,,no IPS match,,
RL4_JR_08029,1304,1679,2272,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,109.0213739,1,1.183867542,0.449150145,2.635794632,0.008394052,0.033061029,57.20512049,0,1.486996405,0.988242168,1.504688277,0.132404238,0.250597551,39.00720354,0,-1.87195437,1.194177508,-1.567567935,0.116982,0.21786714,56.76268186,0,-1.509654013,1.018211701,-1.482652391,0.13816679,0.250123145,43.50504077,1,-0.706106682,0.844796513,-0.835830488,0.403250272,0.540210242,N,-,,sulfate transporter,"F:secondary active sulfate transmembrane transporter activity; P:nucleotide catabolic process; C:integral component of membrane; P:sulfate transmembrane transport; P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; F:hydrolase activity",IPR002645 (PFAM); IPR011547 (PFAM); IPR002645 (G3DSA:3.30.750.GENE3D); IPR001902 (PANTHER); PTHR11814:SF125 (PANTHER); IPR002645 (PROSITE_PROFILES); IPR002645 (SUPERFAMILY),2.A.53.1.11, the sulfate permease (sulp) family.
RL4_JR_08030,4165,5065,5798,1,3,6,0,0,2,0,0,1,2,8,0,0,0,3,104.5306757,1,0.937144451,0.592831478,1.580794012,0.113925144,0.243426224,11.90975836,1,-0.108623518,1.246281278,-0.087158108,0.930545838,0.960826785,67.69947441,1,0.36040719,0.727927351,0.49511423,0.62051949,0.734152076,58.6155438,1,-0.858750863,0.903286944,-0.950695533,0.341758956,0.488675248,34.90656214,1,-1.943517089,1.170815837,-1.659968227,0.096920845,0.186350845,N,-,,flagellar associated,"F:nucleotide binding; F:secondary active sulfate transmembrane transporter activity; P:nucleotide catabolic process; C:integral component of membrane; P:sulfate transmembrane transport; P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; F:hydrolase activity",IPR006179 (PRINTS); IPR029052 (G3DSA:3.60.21.GENE3D); IPR004843 (PFAM); IPR008334 (G3DSA:3.90.780.GENE3D); IPR008334 (PFAM); PTHR11575:SF24 (PANTHER); IPR006179 (PANTHER); IPR008334 (SUPERFAMILY); IPR029052 (SUPERFAMILY),,
RL4_JR_08031,10489,24467,19100,3,2,67,0,0,0,2,5,9,0,12,0,0,11,2,41.13080643,1,-0.471536818,0.88559392,-0.532452637,0.594412537,0.764981461,8.065036589,0,0.453789624,1.236144858,0.367100685,0.713543916,0.820737673,47.02580476,1,0.600917436,0.77213346,0.77825592,0.436418156,0.576725939,56.2182516,1,0.127818199,0.769330883,0.166142036,0.868045174,0.918482327,20.83486575,1,-2.29467955,1.216597753,-1.886144819,0.059275442,0.127450382,N,-,,n-acetyltransferase ats1,C:nucleus; F:tyramine N-feruloyltransferase activity; C:cytosol; F:N-acetyltransferase activity,IPR000182 (PFAM); IPR016181 (G3DSA:3.40.630.GENE3D); PTHR10545 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_08032,5518,6973,7017,10,0,18,0,0,0,4,1,9,9,26,6,0,4,4,32.48661391,1,0.070116342,1.088962796,0.064388188,0.948661135,0.974462042,3.885166773,0,1.507419112,1.321590554,1.140609781,0.254032345,0.408891491,10.19449839,1,-1.160866234,1.246969088,-0.93095029,0.351879279,0.495125201,23.80272409,1,0.667073098,0.953220187,0.699810083,0.484045917,0.62432674,10.18071597,1,-1.261532706,1.265961199,-0.996501873,0.319006358,0.454404851,N,-,,LYR motif,,IPR008011 (PFAM),,
RL4_JR_08033,1387,1284,922,0,0,4,0,0,0,0,3,0,0,0,0,0,2,0,62.89595398,1,-4.077215059,1.185857429,-3.438200038,0.000585595,0.003823249,58.49423837,0,0.05551482,1.111796424,0.049932541,0.960176146,0.978544397,86.73850123,1,-0.688269484,0.739746855,-0.93041218,0.352157714,0.495379283,112.4674093,0,-0.045002489,0.509632021,-0.088303888,0.929635149,0.958118474,58.60017641,1,-2.659813909,1.115075426,-2.385321968,0.01706418,0.04812669,N,-,,start control cdc10,C:SBF transcription complex; F:DNA binding; C:nuclear chromatin; C:cytoplasm; P:positive regulation of reciprocal meiotic recombination; C:MBF transcription complex; P:positive regulation of transcription involved in G1/S transition of mitotic cell cycle; P:positive regulation of transcription from RNA polymerase II promoter in response to heat stress; F:RNA polymerase II transcription coactivator activity,IPR002110 (SMART); IPR018004 (SMART); IPR018004 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PF13637 (PFAM); IPR003163 (G3DSA:3.10.260.GENE3D); IPR032468 (PTHR11707:PANTHER); PTHR11707 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR003163 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR003163 (SUPERFAMILY),1.C.63.1.1, the ╬▒-latrotoxin (latrotoxin) family.
RL4_JR_08034,28106,16907,20558,29,23,15,0,0,0,6,8,6,0,2,4,4,1,4,48.54209297,1,-0.011612164,0.754187682,-0.015396915,0.987715524,0.993857747,7.941277316,0,0.476111438,1.231125463,0.386728609,0.698957134,0.809015907,33.62071042,1,-0.359395893,1.04119343,-0.345176874,0.729961403,0.817763555,43.84947157,1,0.418335172,0.69444018,0.602406347,0.546903686,0.676903082,20.37142544,1,-2.262279255,1.205191362,-1.877112071,0.060502735,0.129621285,N,-,,FYVE zinc finger,F:DNA binding; P:vacuole inheritance; P:DNA repair; P:mycelium development; C:cytoplasmic side of endosome membrane; F:metal ion binding; P:vesicle fusion; P:vesicle docking involved in exocytosis; C:cytosol; C:Golgi apparatus; F:phosphatidylinositol-3-phosphate binding; P:Golgi to endosome transport,IPR000306 (SMART); IPR006642 (SMART); IPR021565 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR000306 (PFAM); PTHR13510:SF21 (PANTHER); PTHR13510:SF21 (PANTHER); PTHR13510 (PANTHER); PTHR13510 (PANTHER); PTHR13510 (PANTHER); PTHR13510:SF21 (PANTHER); IPR017455 (PROSITE_PROFILES); SSF140125 (SUPERFAMILY); IPR011011 (SUPERFAMILY); IPR011011 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_08035,12806,12668,11194,6,4,43,0,2,0,0,2,4,7,16,3,0,12,1,7.012001759,1,-0.912167464,1.244916295,-0.732713893,0.463732949,0.651702566,2.211657087,1,2.320284999,1.333293494,1.740265748,0.081812365,0.173135012,13.62511642,1,0.619016546,1.220535471,0.50716801,0.612036939,0.727602392,6.673633598,1,-0.765764722,1.233137505,-0.620988916,0.534606916,0.66700406,5.744973147,1,-0.435999905,1.241368038,-0.351225335,0.725419305,0.80695127,N,-,,siroheme synthase,F:ferrochelatase activity; P:siroheme biosynthetic process; P:oxidation-reduction process; F:precorrin-2 dehydrogenase activity; P:sulfate assimilation,IPR028162 (G3DSA:1.10.3280.GENE3D); IPR006367 (TIGRFAM); IPR028281 (PFAM); IPR028162 (PFAM); G3DSA:3.30.160.110 (GENE3D); IPR006367 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR35330 (PANTHER); SSF75615 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_08036,1505,1296,1689,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,5.85757604,1,-0.65287111,1.234122445,-0.529016479,0.596794018,0.766715843,46.48857745,0,4.251857265,1.002380658,4.241759087,2.22E-05,0.00126825,4.853492534,0,-0.09029835,1.225341014,-0.073692424,0.941255127,0.965086784,13.62289438,0,1.198280411,1.051348556,1.139755606,0.254388134,0.39383484,12.17316529,1,0.761531146,1.15594858,0.658793271,0.510028529,0.636671046,Y,-,,Glycoside Hydrolase Family 18,"P:carbohydrate metabolic process; F:transaminase activity; C:extracellular region; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:cellulose binding",IPR013781 (G3DSA:3.20.20.GENE3D); PTHR11177 (PANTHER); PTHR11177:SF185 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_08037,1648,1306,1683,0,3,0,0,0,0,6,0,0,1,0,0,0,0,2,151.0414828,1,1.018835652,0.663066484,1.536551275,0.124403232,0.259162811,17.46315215,0,-0.660693034,1.279798636,-0.516247647,0.605681456,0.739515499,593.3013818,1,3.624426534,1.349706032,2.685345141,0.007245494,0.025285551,219.1862405,1,1.573762892,0.597922077,2.632053491,0.00848705,0.042626156,419.2860071,1,3.191036229,0.815825758,3.911418826,9.18E-05,0.000645604,N,-,,N-acetylglucosaminyl-phosphatidylinositol biosynthetic,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_08038,10637,9431,7503,2,1,4,0,0,0,1,0,1,3,16,5,0,0,9,312.2042291,1,-1.477139276,0.562214474,-2.62735903,0.008605049,0.033636794,152.1275785,0,-1.081135405,1.003898142,-1.07693735,0.281508255,0.440678404,196.4962127,1,-5.429367807,1.211632871,-4.481033767,7.43E-06,0.000147458,285.3457914,1,-2.087170324,0.601919785,-3.467522378,0.00052528,0.004354344,247.2273122,1,-1.495662675,0.57156379,-2.616790463,0.008876081,0.028548386,N,-,,ribosome biogenesis ssf1,,IPR007109 (SMART); IPR007109 (PFAM); PTHR12661 (PANTHER); IPR007109 (PROSITE_PROFILES),,
RL4_JR_08039,2808,2311,2332,0,2,9,0,0,0,0,0,0,0,6,0,0,7,1,208.5115144,1,-0.977592592,0.788197726,-1.240288521,0.214868697,0.383231051,69.70954717,0,0.278023533,0.84195388,0.330212307,0.741239548,0.840182162,130.1417567,0,-2.15806795,0.848257323,-2.544119443,0.010955362,0.035187843,200.0170054,1,-1.050744767,0.519514138,-2.022552787,0.043119276,0.113045746,106.5528904,1,-4.649208632,1.193819855,-3.894397143,9.84E-05,0.000685043,N,-,,cell cycle control cwf19,F:catalytic activity; C:U2-type spliceosomal complex,IPR006768 (PFAM); IPR006767 (PFAM); PTHR12072:SF5 (PANTHER); PTHR12072 (PANTHER); IPR011146 (SUPERFAMILY),,
RL4_JR_08040,5692,4558,6838,1,1,3,0,0,2,0,3,0,0,1,0,0,0,0,123.7021061,1,-2.623845922,0.876637112,-2.993081042,0.002761764,0.0134913,101.2948003,1,1.689227982,0.593521479,2.846110954,0.004425677,0.019044014,120.1391166,1,-1.531456094,0.752543882,-2.035038928,0.041846956,0.099057894,169.6853561,1,-0.85737467,0.531272854,-1.613812307,0.106568144,0.20582108,126.5827426,0,-0.747849173,0.610763344,-1.224449995,0.220782519,0.346965303,N,-,,atpase npa3,F:ATPase activity; F:GTPase activity; P:mitotic sister chromatid cohesion; C:cytosol; P:RNA polymerase II complex import to nucleus,IPR027417 (G3DSA:3.40.50.GENE3D); IPR004130 (PFAM); IPR004130 (PANTHER); IPR030230 (PTHR21231:PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_08041,526,639,501,4,2,17,0,0,2,0,0,0,0,1,0,0,0,1,175.3411338,1,-1.788898889,0.623906708,-2.867253816,0.004140508,0.018579903,45.80914496,1,-2.052069514,1.197010826,-1.714328284,0.086468451,0.180945558,119.3223719,0,-4.709743326,1.198012331,-3.931297872,8.45E-05,0.001049524,137.6869327,1,-5.132436901,1.199298622,-4.279532059,1.87E-05,0.00024659,125.4840659,1,-3.860495757,1.137793954,-3.392965609,0.000691403,0.003554783,N,-, Effector probability:0.867,dna directed rna polymerase,,IPR006591 (SMART); IPR006591 (PFAM); IPR006591 (G3DSA:2.20.28.GENE3D); PTHR12056 (PANTHER); PD012151 (PRODOM); IPR029040 (SUPERFAMILY),,
RL4_JR_08042,391,305,364,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,118.6581506,1,-2.011913464,0.737104526,-2.729481902,0.006343393,0.026402755,31.65050293,0,-1.51864333,1.191689118,-1.274362003,0.202535152,0.346877959,110.7670448,0,-1.759114525,0.844607562,-2.082759619,0.03727314,0.090319117,145.3209956,0,-1.049694167,0.563445906,-1.862990138,0.062463654,0.139921348,103.7995815,0,-1.316595305,0.67425096,-1.952678428,0.050857711,0.113687501,N,-,,upf0171 domain,C:Seh1-associated complex; C:cytoplasmic part; P:single-organism cellular process; P:regulation of TOR signaling,IPR005365 (PFAM); IPR005365 (PANTHER),,
RL4_JR_08043,1621,1752,1485,0,0,2,0,0,0,0,0,2,0,6,0,0,0,1,179.2160067,1,-0.159579534,0.469599767,-0.339820301,0.733991859,0.859641161,49.679339,0,0.150986668,1.001819969,0.150712377,0.88020261,0.931615043,86.53599723,1,-3.171830127,1.199006324,-2.645382317,0.008159866,0.027805617,119.2845698,1,-1.822038962,0.75828461,-2.402843126,0.016268165,0.069049765,124.7594511,1,-0.215815385,0.546018766,-0.395252688,0.692656412,0.782096214,N,-,,hlh transcription factor,F:DNA binding; F:protein dimerization activity,IPR011598 (SMART); IPR011598 (G3DSA:4.10.280.GENE3D); IPR011598 (PFAM); PTHR12565:SF3 (PANTHER); PTHR12565 (PANTHER); PTHR12565 (PANTHER); PTHR12565:SF3 (PANTHER); IPR011598 (PROSITE_PROFILES); IPR011598 (SUPERFAMILY),3.A.16.1.4, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_08044,591,706,627,0,1,0,0,0,0,0,0,0,0,2,0,0,0,0,120.2883088,1,-0.46840954,0.546590858,-0.856965558,0.391463919,0.58404584,22.04848331,0,-0.997082494,1.206327105,-0.826544053,0.408495539,0.572210331,70.06359091,0,-1.826468381,1.036039114,-1.762933809,0.077911654,0.159510129,96.80270781,1,-1.017897167,0.675244776,-1.507449154,0.131695568,0.241124344,75.45589881,0,-0.802285912,0.685065419,-1.171108467,0.241555181,0.370848553,N,-,,transport SFT2,P:vesicle-mediated transport; C:integral component of membrane; C:cytoplasmic part,IPR007305 (PFAM); PTHR23137:SF3 (PANTHER); IPR011691 (PANTHER),,
RL4_JR_08045,911,1155,908,0,0,1,0,0,0,0,0,0,0,3,0,0,0,0,455.5636314,1,-1.660129255,0.590307635,-2.812312017,0.004918676,0.021469536,134.7309133,0,-1.083557084,0.847618494,-1.278354698,0.20112439,0.345329179,353.9277056,0,-2.083536493,0.537640578,-3.875333404,0.000106479,0.001212589,381.9129054,1,-1.943980514,0.439611925,-4.422037723,9.78E-06,0.000138457,291.6695511,0,-3.083120754,0.689122176,-4.473982786,7.68E-06,8.06E-05,N,-,,La domain family,C:cytosol,IPR006630 (SMART); IPR011991 (G3DSA:1.10.10.GENE3D); IPR006630 (PFAM); PTHR22792:SF67 (PANTHER); PTHR22792 (PANTHER); IPR006630 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY),,
RL4_JR_08046,1010,1143,1657,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.511867058,0,1.301313171,1.311331647,0.992360075,0.321021908,NA,0.482819218,0,4.515963872,1.548466167,2.91641107,0.003540836,0.016928889,1.252035615,0,1.864619324,1.222490195,1.525263214,0.127193459,0.232019204,1.444323764,0,1.442355898,1.24295513,1.160424752,0.245875914,0.384537169,1.233800661,0,1.783132697,1.209024758,1.474852094,0.140252312,0.246319607,Y,-,,hypothetical protein SPSK_07996,,no IPS match,,
RL4_JR_08047,6535,6693,10904,0,2,7,0,0,0,0,0,1,0,3,0,0,5,2,375.1109508,1,-0.505352275,0.367301277,-1.375852214,0.168867392,0.321273364,133.3800826,0,-0.370920083,0.840917151,-0.441089924,0.659147898,0.780868612,341.0487028,1,0.037153192,0.344457851,0.107859909,0.91410682,0.948004245,363.7690492,1,-0.446969457,0.340879416,-1.311224546,0.189781912,0.318399645,319.132684,1,0.000319446,0.41436498,0.000770929,0.999384888,0.999384888,N,-,,hypothetical protein CMQ_744,,no IPS match,1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_08048,12,20,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,92.24440612,0,-0.971518806,0.677716317,-1.433518394,0.151709746,0.299527616,22.04570272,0,-0.996947974,1.208706428,-0.824805719,0.409481899,0.573433285,57.3909187,0,-3.65379895,1.201662069,-3.040621024,0.002360908,0.011285095,134.4521145,0,-0.014542646,0.527604578,-0.027563533,0.978010267,0.986585031,90.86535098,0,-0.33782159,0.624213538,-0.541195551,0.588372803,0.700689702,N,-,,pre-mRNA-splicing factor clf-1,C:prespliceosome; C:catalytic step 2 spliceosome; C:post-mRNA release spliceosomal complex; C:precatalytic spliceosome; C:catalytic step 1 spliceosome; C:Prp19 complex; P:spliceosomal complex assembly,IPR003107 (SMART); IPR003107 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PF13428 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR11246 (PANTHER); PTHR11246:SF3 (PANTHER); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY),,
RL4_JR_08049,9147,9589,9306,0,5,6,0,0,2,1,3,0,0,3,0,1,3,1,126.5379429,1,-0.595546066,0.610277339,-0.975861347,0.329133179,0.518283347,68.37849762,1,0.576381862,0.995978699,0.578709025,0.562785526,0.70571297,62.06058867,1,-3.766647078,1.213447132,-3.104088326,0.001908663,0.009542375,151.7465606,1,-0.149024309,0.604907188,-0.246358966,0.805404368,0.875495903,61.67696877,1,-3.860440711,1.224487032,-3.152700363,0.001617678,0.007111684,N,-,,pre-mrna-processing factor 31,C:U4/U6 x U5 tri-snRNP complex; C:viral nucleocapsid; P:spliceosomal tri-snRNP complex assembly,IPR012976 (SMART); IPR002687 (PFAM); IPR019175 (PFAM); IPR027105 (PANTHER); PTHR13904:SF0 (PANTHER); PTHR13904:SF0 (PANTHER); IPR002687 (PROSITE_PROFILES); IPR002687 (SUPERFAMILY),,
RL4_JR_08050,86,110,83,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,684.9101399,1,2.144716015,0.631102461,3.398364208,0.000677901,0.004337503,68.00912823,0,0.338859792,0.840918623,0.402963833,0.686974831,0.801091518,374.1740359,0,1.447490015,0.549088047,2.636171055,0.008384745,0.028409358,233.6298699,0,-0.184135433,0.394897859,-0.466286228,0.641010635,0.75397801,144.3200316,0,-0.6918177,0.52365393,-1.321135315,0.18645625,0.305384025,N,-,,acetate kinase,F:magnesium ion binding; P:organic acid metabolic process; F:ATP binding; P:acetyl-CoA biosynthetic process; P:phosphorylation; C:intracellular; F:acetate kinase activity,IPR000890 (PRINTS); IPR004372 (PIRSF); G3DSA:3.30.420.40 (GENE3D); IPR000890 (PFAM); G3DSA:3.30.420.40 (GENE3D); IPR000890 (PANTHER); PTHR21060:SF11 (PANTHER); IPR004372 (HAMAP); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_08051,9684,5820,3960,7,0,4,0,0,0,0,2,0,0,1,0,0,0,0,3.051230545,1,0.288116473,1.297931832,0.221981206,0.824328514,0.911334452,0.963162258,0,3.519482455,1.4475157,2.431395014,0.015040807,0.046232324,2.519886243,1,0.855231004,1.248876828,0.684800122,0.493470058,0.626758358,2.90833567,1,0.432311278,1.26316487,0.342244538,0.73216687,0.821133092,2.508287021,0,0.759585731,1.25627152,0.604635001,0.545421545,0.666611346,N,-,,Metallophosphoesterase domain,,IPR004843 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); PTHR12905 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_08052,1894,1510,2091,0,0,0,0,0,0,3,2,0,0,0,3,0,0,0,69.45113958,0,1.85168175,0.627157434,2.952499088,0.00315213,0.014976748,49.10485429,0,3.002307961,1.020268079,2.94266578,0.003253995,0.016208996,22.60822726,1,-0.37743529,1.218272034,-0.309811995,0.756703929,0.836339583,42.21127869,1,0.614032148,0.89143237,0.688815179,0.490939582,0.630407517,33.7230341,0,1.217586776,0.784866507,1.551329769,0.120822676,0.220578723,N,-,,acetate kinase,P:phosphorylation; F:kinase activity,no IPS match,,
RL4_JR_08053,1814,798,1148,0,0,1,0,0,0,0,0,0,0,1,0,0,2,1,92.77642863,1,1.162307082,0.479370882,2.424650987,0.01532311,0.053216659,10.32338311,0,0.097709494,1.221418344,0.079996747,0.936239843,0.964737829,65.732014,0,0.840230173,0.628670818,1.336518491,0.181379861,0.302568744,87.83283051,1,1.06117148,0.503544949,2.107401697,0.035082775,0.099498352,34.01374271,1,-0.961848009,0.976141142,-0.985357513,0.324448491,0.460605857,N,-,,phosphate transporter,P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane,IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR24064 (PANTHER); PTHR24064:SF296 (PANTHER); PTHR24064:SF296 (PANTHER); PTHR24064 (PANTHER); PTHR24064 (PANTHER); PTHR24064:SF296 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.9.2, the major facilitator superfamily (mfs).
RL4_JR_08054,143,170,188,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,72.37751597,0,0.079846384,0.709781076,0.112494383,0.910431424,0.956386757,13.48539879,0,-0.287763267,1.250261759,-0.230162416,0.817965565,0.890086483,34.70721942,1,-2.928134509,1.216565204,-2.406886618,0.016089164,0.04707708,61.36814684,1,-0.642796538,0.796779058,-0.806743766,0.419814123,0.562697644,57.05926717,0,0.145158134,0.68753325,0.211128893,0.832786695,0.886921772,N,-,,RAB6A-GEF complex partner 1,F:molecular_function,IPR015943 (G3DSA:2.130.10.GENE3D); IPR009771 (PFAM); PTHR22746 (PANTHER); SSF101908 (SUPERFAMILY),,
RL4_JR_08055,69,119,122,0,2,0,0,0,0,0,0,1,0,0,1,0,0,0,53.93251928,1,1.373619581,0.628372108,2.18599706,0.02881582,0.08774896,4.568972887,0,1.273596805,1.253846607,1.015751686,0.309747648,0.471326774,18.37362428,1,-0.419213335,1.198800085,-0.349694115,0.726568271,0.815044562,17.7115203,1,-0.856825131,1.152066252,-0.743729043,0.457040415,0.599111109,38.4068146,0,1.713284935,0.651498545,2.629760184,0.008544512,0.027684219,N,-,,wd domain-containing,,IPR020472 (PRINTS); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR22839 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_08056,10765,11271,17220,1,0,0,0,0,0,0,0,0,0,1,1,0,2,0,188.2928936,1,-0.93871181,0.612993048,-1.531358003,0.125680938,0.260958282,37.42552947,0,-1.760425502,1.215196311,-1.448675812,0.147428138,0.273114451,169.0621956,0,-0.558693189,0.576568242,-0.968997508,0.332546433,0.475925938,135.5132354,1,-1.572216579,0.668368258,-2.352320836,0.018656675,0.074340352,118.0501301,1,-1.327712694,0.66971918,-1.982491668,0.047424239,0.107606944,N,-,,C6 transcription factor Prf,F:binding,IPR007219 (SMART); IPR001138 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31313:SF44 (PANTHER); PTHR31313 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_08057,1325,1706,2038,0,0,11,0,0,0,0,0,0,0,1,0,0,0,0,50.11474267,1,-2.474188763,1.160854608,-2.131351114,0.033060227,0.097577906,12.92484355,0,-0.226519026,1.239790025,-0.182707572,0.855027474,0.914378034,80.88290322,0,0.539963348,0.645321411,0.836735524,0.402741247,0.544809244,80.10983937,1,0.536890015,0.58553323,0.916924928,0.35918198,0.50509966,40.29185617,0,-1.276006947,0.991059847,-1.287517551,0.197913956,0.319445052,N,-,,methyltransferase domain-containing,P:metabolic process; F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); IPR013216 (PFAM); PTHR10108 (PANTHER); PTHR10108:SF826 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_08058,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,110.8776123,0,-0.209324274,0.599587032,-0.349114078,0.727003668,0.855862103,21.04730155,0,-0.93007344,1.209493062,-0.768977904,0.441906428,0.603191991,54.84721652,0,-3.588370986,1.202720874,-2.983544281,0.002849308,0.013100088,63.29190316,0,-4.011138961,1.204614273,-3.329811916,0.000869047,0.006586151,65.87633495,0,-1.488495805,0.877195499,-1.69688035,0.089719284,0.175945719,N,-,,Translation machinery-associated 22,F:translation initiation factor activity; C:mitochondrion; C:ribosome; P:translational initiation,IPR001950 (PFAM); IPR001950 (G3DSA:3.30.780.GENE3D); PTHR12789 (PANTHER); IPR001950 (PROSITE_PROFILES); IPR001950 (SUPERFAMILY),,
RL4_JR_08059,2599,4763,7768,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,39.96263415,0,2.601909371,0.593093634,4.387012811,1.15E-05,0.000131119,2.24001987,0,2.302088413,1.314505767,1.751295787,0.079894973,0.170037199,5.787687526,0,-0.343793522,1.205703394,-0.285139383,0.775537359,0.850654412,35.5812187,1,1.574948242,0.857185268,1.837348705,0.066158434,0.145620466,5.677094565,0,-0.418919462,1.200299559,-0.349012427,0.72707998,0.808265788,N,-,,Borealin partial,P:biological_process; C:cellular_component; F:molecular_function,IPR018851 (PFAM); PTHR16040:SF7 (PANTHER); PTHR16040 (PANTHER),,
RL4_JR_08060,2231,3274,3843,0,1,7,6,0,0,0,0,4,1,1,0,0,5,0,103.8877378,1,0.871831974,0.486970413,1.790318161,0.073402778,0.176747304,21.11669762,1,0.829423985,1.114932842,0.743922821,0.456923168,0.616334796,56.51857861,1,0.07175836,0.747506461,0.095996976,0.923522975,0.955092923,113.5511878,1,1.349206167,0.4349586,3.101918588,0.001922708,0.012824388,37.53697119,1,-1.893482407,1.127524695,-1.679326772,0.093088376,0.18066318,N,-,,von Willebrand factor type A domain-containing,"C:nucleus; C:proteasome regulatory particle, base subcomplex; F:structural molecule activity; C:cytosol; F:K48-linked polyubiquitin binding; P:ubiquitin-dependent protein catabolic process",IPR002035 (SMART); IPR002035 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); IPR027040 (PANTHER); IPR003903 (PROSITE_PROFILES); IPR002035 (PROSITE_PROFILES); IPR002035 (SUPERFAMILY),,
RL4_JR_08061,11018,10178,13937,3,4,16,0,0,1,1,1,2,3,4,0,2,8,1,60.0180173,1,-0.117294459,0.794058684,-0.147715101,0.882567614,0.94282897,8.852116088,1,0.319426972,1.233620971,0.258934454,0.795685814,0.876284606,23.10535568,1,-2.341232835,1.207731947,-1.93853681,0.052557764,0.117616005,108.0408625,1,1.812229438,0.490009759,3.698353765,0.000217002,0.002051492,30.64954545,1,-0.776098251,1.010471698,-0.768055407,0.442454268,0.576015767,N,-, Effector probability:0.743,sybindin-like family,,IPR007233 (SMART); IPR007233 (PFAM); G3DSA:3.30.450.70 (GENE3D); PTHR23249:SF15 (PANTHER); PTHR23249:SF15 (PANTHER); IPR007233 (PANTHER); IPR011012 (SUPERFAMILY),,
RL4_JR_08062,1798,1747,1977,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,67.6634836,0,-3.153540254,1.177770072,-2.677551697,0.007416241,0.029862632,20.16620669,1,-0.868394948,1.219030659,-0.712365141,0.476238695,0.633441271,52.68453426,0,-3.530344762,1.211579851,-2.913835815,0.003570176,0.015394895,83.43996031,0,-1.620954403,0.885513672,-1.830524422,0.067171558,0.14692418,52.31853716,0,-3.623024472,1.222066419,-2.964670671,0.003030071,0.011942184,N,-,,DNA-directed RNA polymerase II subunit RPB4,"P:positive regulation of translational initiation; C:cytoplasmic mRNA processing body; P:transcription initiation from RNA polymerase II promoter; C:DNA-directed RNA polymerase II, core complex; F:single-stranded DNA binding; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; F:nucleotide binding; F:DNA-directed RNA polymerase activity; P:transcription, RNA-templated; F:single-stranded RNA binding; P:recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex; P:mRNA export from nucleus in response to heat stress; F:translation initiation factor binding",IPR006590 (SMART); IPR005574 (PFAM); PTHR21297 (PANTHER); IPR010997 (SUPERFAMILY),,
RL4_JR_08063,391,265,266,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,31.37464098,1,-3.073896879,1.228333009,-2.502494728,0.012332146,0.044913236,28.66645846,0,1.783801133,1.02520473,1.739946256,0.081868455,0.173182937,38.91208093,1,-0.69488898,1.066693654,-0.651441937,0.514761247,0.645939869,29.90873917,0,-2.929734724,1.222577035,-2.396360016,0.016558817,0.069741274,25.78337471,0,-2.602145863,1.233706592,-2.109209661,0.034926488,0.08468168,N,-,,hypothetical protein CMQ_471,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_08064,4875,4502,5364,6,2,4,1,0,0,0,4,3,0,1,0,0,0,2,322.5181221,1,-2.367149483,0.648698406,-3.649075536,0.000263186,0.001948339,83.44686526,1,-2.917281456,1.215972146,-2.399135099,0.01643385,0.049521712,224.7705955,1,-4.619201319,1.22460882,-3.771981097,0.000161957,0.001551228,263.9699386,1,-3.738076047,0.924325619,-4.044111696,5.25E-05,0.000618353,224.3026504,1,-4.730599573,1.174473682,-4.027846384,5.63E-05,0.000428524,N,-,,pumilio domain containing,"P:ribosomal large subunit biogenesis; F:translation repressor activity, nucleic acid binding; C:large ribosomal subunit; C:nucleolus; P:negative regulation of translation; F:mRNA 3'-UTR binding",IPR001313 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR012959 (PFAM); PTHR13389 (PANTHER); IPR033133 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY),,
RL4_JR_08065,1274,1827,1673,0,0,3,0,0,0,0,0,1,1,0,0,0,0,1,67.47074252,1,-0.04233121,0.710121638,-0.059611209,0.95246529,0.976893618,12.89429166,0,-0.22315854,1.232659026,-0.181038337,0.856337485,0.915392124,62.23215274,1,-0.460690956,0.878455125,-0.524433113,0.59997733,0.718496628,52.0906571,1,-1.568257172,1.043945327,-1.502240714,0.133034954,0.243136987,33.22346282,1,-2.967888914,1.220043565,-2.432608966,0.01499048,0.043526112,N,-,,rwd domain containing,C:cytoplasm,IPR006575 (SMART); IPR032378 (PFAM); IPR006575 (PFAM); IPR016135 (G3DSA:3.10.110.GENE3D); PTHR12292 (PANTHER); IPR006575 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),,
RL4_JR_08066,164,114,104,2,0,20,0,0,0,0,0,0,1,2,0,0,7,3,206.7452899,1,-2.372406215,0.699408408,-3.392018436,0.000693798,0.004419822,61.63043456,0,-1.324554657,1.111356714,-1.191835745,0.233325657,0.383458727,136.1059842,0,-4.899608199,1.198219568,-4.089073763,4.33E-05,0.000642917,165.0764995,1,-3.601556158,1.028241354,-3.502636946,0.000460677,0.003903225,146.3231144,1,-2.798752963,0.874995017,-3.198593029,0.001381,0.006217262,N,-,,tpr domain-containing,C:nucleus; P:ER-associated ubiquitin-dependent protein catabolic process; C:nucleolus,IPR019734 (SMART); IPR019734 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY),,
RL4_JR_08067,123,121,113,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,312.3565515,0,-1.216951212,0.718557607,-1.69360285,0.090340776,0.205636175,98.06786708,0,-0.497155381,0.886951975,-0.560521195,0.575123987,0.715072472,383.8923249,0,0.215614055,0.704721015,0.305956613,0.759637681,0.838628237,336.8805442,1,-0.840390543,0.458626484,-1.832407357,0.066890753,0.146626731,229.344493,0,-1.333110844,0.522445912,-2.551672457,0.010720725,0.033238258,N,-,,integral membrane,C:membrane; C:cytoplasmic part,IPR032800 (SMART); PF13589 (PFAM); IPR010308 (PFAM); IPR032800 (PFAM); IPR003594 (G3DSA:3.30.565.GENE3D); PTHR31145:SF6 (PANTHER); PTHR31145:SF6 (PANTHER); PTHR31145 (PANTHER); IPR003594 (SUPERFAMILY),1.A.4.9.4, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_08068,89,64,95,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,149.3318217,0,0.163202439,0.475968321,0.342885087,0.731684911,0.8583672,23.83086191,1,-1.109243751,1.204774211,-0.920706752,0.35720355,0.521357511,199.9356577,0,1.276434006,0.419068815,3.045881634,0.002319991,0.011136839,128.1312503,0,-0.155279147,0.514192125,-0.30198663,0.762662255,0.845222782,80.07454059,0,-1.235481584,0.768067557,-1.608558483,0.107712919,0.201924329,N,-, Effector probability:0.555,"6,7-dimethyl-8-ribityllumazine synthase","C:mitochondrial intermembrane space; F:6,7-dimethyl-8-ribityllumazine synthase activity; P:riboflavin biosynthetic process; F:riboflavin binding; F:transferase activity; C:riboflavin synthase complex",IPR002180 (G3DSA:3.40.50.GENE3D); IPR002180 (PFAM); IPR002180 (TIGRFAM); IPR002180 (PANTHER); IPR002180 (SUPERFAMILY),,
RL4_JR_08069,19,16,36,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,294.1088625,0,0.032014334,0.522595819,0.061260218,0.951151972,0.976037458,48.48267864,0,-2.133868411,1.259600536,-1.694083442,0.090249428,0.187001988,233.579404,0,-0.355495356,0.674149922,-0.527323886,0.59796869,0.717210525,355.5342766,0,0.53820661,0.480020449,1.121216005,0.262195929,0.402598389,147.8871236,0,-1.5547179,0.765302166,-2.031508558,0.042203432,0.09808429,N,-,,hypothetical protein SPI_09215,P:biological_process; C:cellular_component; F:molecular_function,PTHR42068 (PANTHER),,
RL4_JR_08070,19,9,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,244.9385597,0,0.849962557,0.322509922,2.635461734,0.00840229,0.03306603,29.34153896,0,-1.409331818,1.198560946,-1.175853279,0.239653512,0.391443093,75.92358598,0,-4.057474854,1.188346939,-3.414385751,0.00063926,0.004032317,147.4585516,0,-0.914133581,0.572050731,-1.597993903,0.110044334,0.210902684,82.35250513,0,-2.463259888,0.965361824,-2.551644188,0.010721595,0.033238258,N,-,,cation efflux family,P:mycelium development; P:cation transmembrane transport; C:integral component of membrane; F:cation transmembrane transporter activity,IPR027470 (PFAM); IPR027469 (G3DSA:1.20.1510.GENE3D); IPR027470 (G3DSA:3.30.70.GENE3D); IPR002524 (PFAM); IPR002524 (PANTHER); PTHR11562:SF41 (PANTHER); PTHR11562:SF41 (PANTHER); SSF160240 (SUPERFAMILY); SSF161111 (SUPERFAMILY),2.A.4.5.3, the cation diffusion facilitator (cdf) family.
RL4_JR_08071,153,112,251,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37.7362458,0,-0.526520301,0.871674003,-0.604033502,0.545821369,0.725807082,8.345391242,0,0.404479774,1.224155606,0.330415326,0.741086163,0.840102379,21.73163378,0,-2.252817153,1.198185512,-1.880190613,0.060082104,0.130394305,33.09840701,0,-0.953623565,1.025888791,-0.929558421,0.352599764,0.499043207,33.09659592,0,-0.148791802,0.868747564,-0.171271619,0.864010195,0.909649914,N,-,,BTB POZ fold,F:protein heterodimerization activity; P:transcription from RNA polymerase II promoter,IPR000210 (SMART); G3DSA:3.30.710.10 (GENE3D); IPR000210 (PFAM); IPR000210 (PROSITE_PROFILES); IPR011333 (SUPERFAMILY),,
RL4_JR_08072,159,149,188,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,63.44807981,0,0.803632654,0.630203525,1.275195427,0.20224008,0.366475915,9.220536505,0,0.260608731,1.22362569,0.212980762,0.831341968,0.898925692,42.94280304,1,-0.568559439,1.040105322,-0.546636409,0.58462855,0.705961288,55.66556737,1,-0.47486398,0.863384382,-0.550002977,0.582317332,0.708134489,31.52626381,0,-0.826016982,0.998015254,-0.827659676,0.407863262,0.543906247,N,-, Effector probability:0.859,U6 snRNA-associated Sm LSm6,"F:RNA binding; P:maturation of SSU-rRNA; C:U4/U6 x U5 tri-snRNP complex; C:cytoplasmic mRNA processing body; C:spliceosomal complex; C:nucleolus; C:U6 snRNP; C:small nucleolar ribonucleoprotein complex; P:mRNA splicing, via spliceosome",IPR001163 (SMART); IPR001163 (PFAM); IPR016487 (PIRSF); G3DSA:2.30.30.100 (GENE3D); PTHR11021 (PANTHER); PTHR11021:SF1 (PANTHER); IPR010920 (SUPERFAMILY),,
RL4_JR_08073,123,110,128,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,184.2732382,0,-0.841999326,0.474910301,-1.772964966,0.076234512,0.181483434,48.04621417,0,-0.889859958,1.107065436,-0.803800687,0.421512093,0.584858863,100.4295525,0,-4.461070259,1.189396273,-3.750701393,0.000176341,0.001628499,115.8631379,0,-4.883475863,1.189228492,-4.10642353,4.02E-05,0.000483776,106.8753232,0,-2.878049248,0.979353896,-2.938722417,0.003295681,0.012755646,N,-,,methyltransferase type 11,P:biological_process; P:metabolic process; F:methyltransferase activity; F:transferase activity; C:cellular_component; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR013216 (PFAM); IPR029063 (SUPERFAMILY),,
RL4_JR_08074,1,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33964.33476,0,-2.47046882,0.81984481,-3.013337147,0.002583917,0.012837755,10509.88757,0,-3.031691616,1.077170132,-2.814496545,0.00488537,0.020316236,26401.85084,0,-3.310083566,0.502192719,-6.591261566,4.36E-11,2.73E-09,29953.65292,0,-3.591148199,1.031042676,-3.483025759,0.000495781,0.004165792,24466.95072,0,-4.439475849,0.962251662,-4.613632822,3.96E-06,4.67E-05,N,-,,heat shock 30,C:cytoplasm,IPR008978 (G3DSA:2.60.40.GENE3D); IPR002068 (PFAM); PTHR11527:SF134 (PANTHER); IPR031107 (PANTHER); IPR031107 (PANTHER); PTHR11527:SF134 (PANTHER); IPR031107 (PANTHER); IPR002068 (PROSITE_PROFILES); IPR008978 (SUPERFAMILY),,
RL4_JR_08075,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1252.08077,0,-1.902721511,0.847035414,-2.24633053,0.024682844,0.077987082,340.3910864,0,-3.283200707,1.157369383,-2.836778607,0.00455712,0.019413791,1025.150285,0,-2.065037606,0.645125559,-3.20098557,0.001369584,0.007371434,1025.314794,0,-3.666663768,0.746295144,-4.913155066,8.96E-07,1.66E-05,867.3561079,0,-3.991166496,0.926637675,-4.307148956,1.65E-05,0.000153193,N,-,,yt521-b-like splicing,F:nucleotide binding; F:RNA binding,IPR007275 (PFAM); PTHR12357:SF3 (PANTHER); PTHR12357 (PANTHER); PTHR12357:SF3 (PANTHER); PTHR12357 (PANTHER); IPR007275 (PROSITE_PROFILES),,
RL4_JR_08076,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.7644823,0,0.122023196,0.776367489,0.157171955,0.87510933,0.939731725,8.646742367,0,0.353392942,1.281023589,0.275867631,0.782649737,0.868733483,22.22564987,0,-2.285163546,1.228453724,-1.860195058,0.062857934,0.135168591,25.62321031,0,-2.70656176,1.231376128,-2.197997589,0.027949278,0.088851717,21.72468546,0,-2.355096966,1.228760027,-1.916645166,0.055283026,0.120946551,N,-,,NADH dehydrogenase,,IPR032675 (G3DSA:3.80.10.GENE3D),,
RL4_JR_08077,42,26,33,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,398.177728,1,0.902354904,0.293711803,3.072245975,0.002124546,0.010990516,62.64992332,0,-0.34792372,0.985257416,-0.353129765,0.723991159,0.827021613,230.0491581,0,-0.100919168,0.447403438,-0.225566367,0.821538702,0.884832342,347.8692387,0,0.786881899,0.292983785,2.685752384,0.00723667,0.037488272,231.5906096,0,0.357976672,0.366052171,0.977938937,0.328104526,0.464493613,N,-,,phosphoglucomutase 2,F:magnesium ion binding; F:phosphoglucomutase activity; P:glycogen biosynthetic process; P:galactose catabolic process; C:cytosol; P:glucose metabolic process,IPR005841 (PRINTS); IPR016055 (G3DSA:3.40.120.GENE3D); IPR005846 (PFAM); IPR005843 (G3DSA:3.30.310.GENE3D); IPR005843 (PFAM); IPR016055 (G3DSA:3.40.120.GENE3D); IPR005845 (PFAM); IPR005844 (PFAM); IPR016055 (G3DSA:3.40.120.GENE3D); PTHR22573:SF2 (PANTHER); PTHR22573 (PANTHER); IPR005843 (SUPERFAMILY); IPR016055 (SUPERFAMILY); IPR016055 (SUPERFAMILY); IPR016055 (SUPERFAMILY),,
RL4_JR_08078,159,106,216,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,142.3731837,0,1.700184341,0.947675554,1.794057401,0.072804007,0.175876545,29.11833878,0,1.715921488,1.035173949,1.657616567,0.097394884,0.198516112,54.00010059,0,0.261296742,0.779278495,0.335305984,0.737394281,0.82317562,30.74073348,0,-2.96923177,1.213857118,-2.446113077,0.01444057,0.064924855,26.05774165,0,-2.617458723,1.209284904,-2.164468203,0.030428434,0.075958555,N,-,,hypothetical protein SPI_09235,F:oxygen binding; F:heme binding,PS51257 (PROSITE_PROFILES),,
RL4_JR_08079,36,38,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,510.2723249,0,0.034264519,1.091622516,0.031388615,0.97495962,0.987181405,81.55772011,0,-2.884233275,1.188324677,-2.427142455,0.015218279,0.046678612,498.9662434,0,0.371619377,0.718029948,0.517554146,0.604769382,0.721759427,614.7369372,0,0.618275675,0.268454648,2.303091712,0.021273684,0.079131538,326.1537661,0,-0.496489025,0.428046275,-1.159895679,0.246091282,0.376272158,N,-, Effector probability:0.557,nucleosome binding,"C:nucleus; F:DNA binding; P:DNA repair; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; C:chromosome",PR00886 (PRINTS); IPR009071 (SMART); IPR009071 (PFAM); IPR009071 (G3DSA:1.10.30.GENE3D); PTHR13711 (PANTHER); IPR009071 (PROSITE_PROFILES); IPR009071 (SUPERFAMILY),,
RL4_JR_08080,184,229,137,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33.14013447,0,2.710307669,0.882166476,3.072331292,0.002123939,0.010990516,0.931978048,0,3.567080081,1.42971872,2.49495235,0.012597405,0.040148277,2.429209566,0,0.908411176,1.229776741,0.73867975,0.460101485,0.59803151,12.11556314,0,1.437497524,1.164117311,1.234839059,0.216890408,0.351611513,2.404915556,0,0.820464275,1.231301928,0.666338821,0.505194557,0.632400404,N,-,,Centromere Cenp-H,P:kinetochore assembly; C:kinetochore,IPR008426 (PFAM); PTHR42116 (PANTHER),,
RL4_JR_08081,1158,1193,1284,0,1,7,0,0,0,0,0,0,0,12,4,0,7,0,100.1561823,1,-0.960150789,0.631716745,-1.519907136,0.128534317,0.265195487,22.80520714,0,-1.045741712,1.211181815,-0.863406054,0.387914252,0.552634491,82.41416496,0,-1.281543195,0.858708914,-1.492407,0.135592481,0.243177729,71.92367275,1,-3.165954506,1.148891677,-2.755659709,0.00585739,0.031816564,77.05102814,1,-0.838869885,0.679338414,-1.234833579,0.216892448,0.342114976,N,-,,Autophagy-related 11,C:intracellular membrane-bounded organelle; C:membrane; C:cytoplasmic part; P:organelle organization; P:macroautophagy; P:cellular protein localization; P:cellular response to nitrogen starvation,IPR019460 (PFAM); PTHR23160 (PANTHER); PTHR23160:SF1 (PANTHER); SSF57997 (SUPERFAMILY),9.A.15.1.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_08082,0,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_08083,133,143,152,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,77.14480823,0,-1.865438587,0.903829765,-2.063926925,0.039024645,0.110773507,74.82919587,0,1.299362929,0.86270444,1.506150738,0.132028482,0.250120213,83.00975153,0,-0.759358871,0.77178794,-0.983895745,0.325166776,0.468343781,92.38268316,0,-0.721838423,0.667979043,-1.080630343,0.279861579,0.423350586,53.91039932,0,-3.666274785,1.217981668,-3.010123124,0.002611418,0.010618718,N,-,,fructose-bisphosphate aldolase,C:intracellular,IPR020070 (G3DSA:3.40.5.GENE3D); IPR020070 (PFAM); IPR009027 (SUPERFAMILY),,
RL4_JR_08084,19,9,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26.19806961,0,1.990994389,0.842304092,2.363747733,0.018091127,0.060387648,2.246388978,0,2.297920839,1.380457703,1.66460793,0.095991002,0.196320143,21.53383199,0,1.466769368,1.091181061,1.344203469,0.1788826,0.29899413,6.748676645,0,-0.78169466,1.263762117,-0.618545729,0.536215664,0.66804277,5.771032932,0,-0.442499291,1.264036169,-0.350068536,0.726287263,0.807650581,N,-,,Alcohol acetyltransferase,P:response to drug; F:N-acetyltransferase activity,IPR010828 (PFAM); PTHR28037:SF1 (PANTHER); PTHR28037 (PANTHER); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY),,
RL4_JR_08085,12,12,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,184.3638167,0,1.548496327,0.932925371,1.659828722,0.096948914,0.216450257,15.93288722,0,-0.528376606,1.222956838,-0.43204845,0.6657062,0.78617176,54.14594426,0,-1.356730487,1.044886049,-1.298448274,0.19413334,0.318284362,80.84068542,0,-0.096230386,0.609616416,-0.157853993,0.874571852,0.922592207,92.95883814,0,0.687859065,0.512643216,1.341789072,0.179664397,0.297141786,N,-,,hypothetical protein CMQ_4848,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_08086,309,267,320,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,IPR008385 (PFAM),,
RL4_JR_08087,525,807,487,0,3,2,0,0,0,0,0,0,0,0,0,0,0,0,149.2814274,1,4.163962494,0.628660632,6.623545809,3.51E-11,1.31E-09,11.64417185,0,3.200926264,1.13680595,2.815719135,0.004866819,0.02028401,117.9319522,0,4.425568601,0.434388004,10.18805436,2.24E-24,4.54E-22,49.34419152,0,2.290050046,0.683117625,3.35235099,0.000801284,0.006155536,21.84270798,0,0.482590282,1.135785437,0.424895642,0.670912752,0.766091433,N,-,,hypothetical protein F503_07015,,no IPS match,,
RL4_JR_08088,1222,982,1047,0,1,5,0,0,0,1,0,3,1,0,1,0,2,0,7.080660395,1,-0.926388692,1.208403657,-0.766621887,0.443306358,0.632406938,2.277671379,0,2.277994736,1.321661736,1.723583784,0.084783008,0.177988102,5.882660933,1,-0.367516872,1.211436652,-0.303372753,0.761605808,0.839649047,6.784117304,1,-0.789390801,1.211020297,-0.651839447,0.514504751,0.649303328,9.637486609,1,0.48490226,1.136697968,0.426588481,0.669679089,0.765007013,N,-,,ankyrin repeat-containing,F:catalytic activity; C:membrane; C:integral component of membrane; P:nucleoside metabolic process,IPR002110 (SMART); IPR020683 (PFAM); PF05729 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR002110 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24123 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR027417 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_08089,279,294,280,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,225.104035,0,0.720292497,0.437856547,1.645042198,0.099961109,0.221418064,28.21131546,0,-1.352656833,1.231478123,-1.098401025,0.272029415,0.429607273,72.62156414,0,-3.993318651,1.214415788,-3.288263123,0.001008076,0.005792145,153.2269113,1,0.067466846,0.64665896,0.104331418,0.916906346,0.949833922,93.75575295,0,-1.144214333,0.717317753,-1.595128977,0.110683397,0.20589186,N,-,,phosphatidylinositol 3,P:phosphatidylinositol-mediated signaling; P:phosphatidylinositol phosphorylation; F:1-phosphatidylinositol 4-kinase activity; C:intracellular; C:plasma membrane,IPR000403 (SMART); IPR001263 (SMART); IPR001263 (PFAM); IPR000403 (PFAM); IPR001263 (G3DSA:1.25.40.GENE3D); IPR000403 (G3DSA:1.10.1070.GENE3D); G3DSA:3.30.1010.10 (GENE3D); IPR015433 (PANTHER); PTHR10048:SF15 (PANTHER); PTHR10048:SF15 (PANTHER); IPR015433 (PANTHER); IPR015433 (PANTHER); PTHR10048:SF15 (PANTHER); IPR001263 (PROSITE_PROFILES); IPR000403 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR016024 (SUPERFAMILY),,
RL4_JR_08090,30,21,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,136.3051611,0,0.337414916,0.430631544,0.783535068,0.433312969,0.623937114,22.58802146,0,-1.031960745,1.197417637,-0.861821902,0.388785531,0.553408401,110.7037065,0,-0.270213371,0.606406069,-0.445598065,0.655887609,0.761491531,108.9277184,0,-0.22457964,0.508625563,-0.441542182,0.658820531,0.767348197,72.73908084,0,-1.548932834,0.835742036,-1.853362361,0.063830438,0.135290598,N,-, Effector probability:0.616,proteasome component c5,"C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:cytosol; F:threonine-type endopeptidase activity; C:proteasome core complex, beta-subunit complex; P:proteasomal ubiquitin-independent protein catabolic process",IPR029055 (G3DSA:3.60.20.GENE3D); IPR001353 (PFAM); PTHR11599 (PANTHER); PTHR11599:SF59 (PANTHER); IPR023333 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY),,
RL4_JR_08091,2982,3228,2476,0,0,22,0,0,0,0,0,2,0,0,0,0,4,0,98.64963412,1,-1.121797837,0.710319344,-1.579286623,0.114270329,0.243908253,113.6584737,0,1.56149216,0.799172967,1.953885111,0.050714806,0.119213949,95.35048098,1,-0.666555062,0.717639373,-0.928816181,0.352984358,0.496300353,133.9445735,0,0.143718385,0.602272507,0.238626839,0.811394951,0.880250068,69.15766334,1,-2.192977678,0.995323153,-2.203282092,0.027574872,0.070499965,N,-,,vps9 domain,F:phosphatidylinositol binding,PF13857 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR003123 (PFAM); PTHR10489 (PANTHER); PTHR10489 (PANTHER); PTHR10489:SF564 (PANTHER); PD127710 (PRODOM); IPR003123 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR001683 (SUPERFAMILY); SSF109993 (SUPERFAMILY); IPR020683 (SUPERFAMILY),8.A.28.1.1, the ankyrin (ankyrin) family.
RL4_JR_08092,1558,1530,1486,0,9,4,0,0,0,0,0,0,0,4,0,0,0,0,29.68126655,1,3.83706893,0.589133978,6.513066759,7.36E-11,2.61E-09,67.87473597,0,5.77290658,0.8422154,6.854430091,7.16E-12,1.69E-09,2.441121753,0,0.901245983,1.211041595,0.744190775,0.456761068,0.595167213,12.45175092,1,1.428389319,1.146482828,1.245888106,0.212805477,0.34713315,2.411644467,0,0.816323778,1.210248205,0.67450939,0.499987518,0.627774507,N,-,,sialidase,,no IPS match,,
RL4_JR_08093,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30.38389949,0,-1.497252715,1.144461156,-1.308259967,0.190785149,0.350704201,6.483822896,0,0.768642572,1.232834945,0.623475653,0.532971997,0.681251263,29.8314873,0,-0.065268056,1.036012409,-0.0629993,0.949767062,0.971235243,23.43174756,0,-1.359791054,1.146289879,-1.186254086,0.235521973,0.372894444,16.61994204,0,-1.968646195,1.200594805,-1.639725732,0.101062206,0.192485861,N,-,,UPF0326 hag1,,IPR008580 (SMART); IPR008580 (PFAM); PTHR12378 (PANTHER); PTHR12378:SF10 (PANTHER),,
RL4_JR_08094,138,143,140,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,702.3793768,1,-2.04566385,0.391508631,-5.22507983,1.74E-07,3.27E-06,335.5089447,0,-0.202271047,1.623199452,-0.124612565,0.900830281,0.944500114,544.6484939,0,-2.529454085,1.604345859,-1.57662643,0.114881508,0.214958862,606.669163,0,-3.166639232,0.542018591,-5.842307414,5.15E-09,1.50E-07,503.160035,1,-3.163189065,0.607558246,-5.206396405,1.93E-07,3.90E-06,N,-,,gtp-binding,F:GTP binding; F:ATPase activity; C:nucleus; F:ATP binding; F:ribosome binding; C:cytosol; F:ribosomal large subunit binding,IPR006073 (PRINTS); IPR004396 (TIGRFAM); IPR004396 (PIRSF); IPR027417 (G3DSA:3.40.50.GENE3D); IPR023192 (G3DSA:1.10.150.GENE3D); IPR006073 (PFAM); IPR013029 (PFAM); IPR012675 (G3DSA:3.10.20.GENE3D); PTHR23305:SF11 (PANTHER); PTHR23305 (PANTHER); IPR031167 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR012676 (SUPERFAMILY),,
RL4_JR_08095,714,627,481,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.833278273,0,-0.64686088,1.19983772,-0.539123641,0.589801544,0.760847723,1.861387732,0,2.569105588,1.316768869,1.951067988,0.051048959,0.119749145,11.3308215,0,0.877858076,1.194955869,0.734636398,0.462560965,0.599842091,43.79254024,0,2.247243224,0.741165212,3.032040883,0.002429063,0.01553649,4.769300492,0,-0.167594401,1.204244726,-0.13916972,0.889316036,0.927556321,N,-,,hypothetical protein UCRPA7_2030,,no IPS match,,
RL4_JR_08096,10,0,26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.01230271,0,-0.143285652,1.143156903,-0.125342069,0.900252748,0.951329264,2.546310146,0,2.11711941,1.294497253,1.63547617,0.101949266,0.20564577,77.17915334,0,3.437303785,1.591719675,2.159490669,0.03081212,0.078377364,44.85301399,0,1.803960801,0.745816213,2.418773915,0.015572916,0.066742109,6.489287395,0,-0.611947568,1.200485239,-0.509750181,0.610226492,0.717955307,N,-,,F-box-like domain-containing,,no IPS match,,
RL4_JR_08097,26,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,148.6760813,0,-0.056348217,0.508450851,-0.110823331,0.911756443,0.956734502,21.28217688,0,-0.946074612,1.20070614,-0.787931852,0.430736569,0.592782536,120.2312834,0,0.311681182,1.386736245,0.224758806,0.822166914,0.884832342,161.7992743,0,0.902732111,0.40293229,2.240406477,0.025064546,0.08557795,100.1406343,0,0.228591649,0.51904936,0.440404453,0.6596442,0.757330483,N,-,,ubiquitin carboxyl-terminal hydrolase 16,,IPR001394 (PFAM); PTHR24006:SF470 (PANTHER); PTHR24006 (PANTHER); PTHR24006:SF470 (PANTHER); PTHR24006 (PANTHER); IPR028889 (PROSITE_PROFILES); SSF54001 (SUPERFAMILY),,
RL4_JR_08098,2,7,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,160.8355009,0,0.240030629,0.551782174,0.435009757,0.663555346,0.812073884,44.18442992,0,0.41850721,1.04099076,0.402027786,0.687663578,0.801442802,78.3961155,0,-2.030749099,1.068580212,-1.900418027,0.057378283,0.125762662,79.41964801,0,-3.318907226,1.178132168,-2.817092443,0.004846058,0.027365184,63.83121127,0,-3.909980286,1.215468113,-3.216851388,0.001296057,0.005916476,N,-,,Oxysterol-binding,,IPR000648 (PFAM); IPR000648 (PANTHER); PTHR10972:SF27 (PANTHER); SSF144000 (SUPERFAMILY),2.D.1.1.4, the pi4p/ps counter transporter (p/p-ct) family.
RL4_JR_08099,547,490,634,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1.520772719,1,1.292924221,1.429851911,0.904236453,0.365870035,NA,0.493120338,0,4.48571482,1.631323376,2.749739804,0.00596426,0.023186611,1.265142173,0,1.850095419,1.282293567,1.442801762,0.149076323,0.26102537,1.458499938,0,1.428592668,1.323733105,1.079215034,0.280491879,0.423814397,1.232228356,0,1.784643655,1.25698591,1.419780159,0.155671693,0.265886621,N,-,,---NA---,,no IPS match,,
RL4_JR_08100,187,147,182,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0.111822094,0,5.058264051,3.822934484,1.323136473,0.185789997,NA,0.036253248,0,8.25174534,2.588673017,3.187635242,0.001434414,0.015023052,0.093119123,1,5.614483424,1.501748392,3.738631221,0.000185025,0.001681223,0.107352937,0,5.192489094,2.281453424,2.27595665,0.022848604,0.081458492,0.090895323,0,5.542917455,1.302314868,4.256203774,2.08E-05,0.000185649,N,-,,glycosyltransferase family 31,"F:transferase activity, transferring glycosyl groups; C:membrane; C:integral component of membrane; F:transferase activity",IPR003378 (PFAM); PTHR23033:SF14 (PANTHER); PTHR23033 (PANTHER); PTHR23033 (PANTHER); PTHR23033:SF14 (PANTHER),,
RL4_JR_08101,5459,5745,6829,4,1,78,0,0,0,3,4,6,4,26,11,0,3,1,5.835074306,1,-0.647060651,1.235940847,-0.523536909,0.600600673,0.768942293,1.886394034,0,2.549992048,1.369864239,1.86149253,0.062674654,0.141009071,4.851287591,1,-0.089242209,1.229858559,-0.072562986,0.942153882,0.965617119,5.593464504,1,-0.510807893,1.232623633,-0.414407025,0.678576045,0.781014261,4.738719185,1,-0.15841465,1.222612859,-0.129570574,0.896906186,0.93292916,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:membrane; P:polyamine transport,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23502:SF38 (PANTHER); PTHR23502 (PANTHER); PTHR23502:SF38 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.64, the major facilitator superfamily (mfs).
RL4_JR_08102,8808,8534,16318,4,0,23,2,0,0,5,0,0,9,27,2,0,6,10,1.76801533,1,1.075518702,1.314438646,0.818234236,0.41322345,NA,0.569888091,1,4.276887259,1.542076893,2.773459144,0.00554638,0.022001033,1.46882478,1,1.634543875,1.238782029,1.31947658,0.187009835,0.309057716,1.693748556,1,1.212732556,1.260119399,0.962394958,0.335851246,0.482750406,1.438369289,1,1.561412922,1.219811621,1.280044308,0.200529553,0.322318003,N,-,,retinitis pigmentosa 1-like 1 isoform X2,,no IPS match,,
RL4_JR_08103,122,81,95,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.364906679,0,3.352083373,2.271296848,1.475845562,0.139985356,NA,0.116794263,0,6.563578924,2.02611441,3.239490767,0.001197433,0.015023052,0.302250186,0,3.915595377,1.300138389,3.011675842,0.002598099,0.012199978,0.348635267,0,3.493157671,1.514739037,2.306111868,0.021104382,0.078712841,0.297069948,0,3.837470017,1.235009283,3.107239817,0.001888431,0.008067666,N,-,,oxidoreductase family,F:oxidoreductase activity; P:oxidation-reduction process,IPR016040 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.360.10 (GENE3D); IPR000683 (PFAM); PTHR22604:SF106 (PANTHER); PTHR22604:SF106 (PANTHER); PTHR22604 (PANTHER); IPR016040 (SUPERFAMILY); SSF55347 (SUPERFAMILY),,
RL4_JR_08104,485,645,830,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.64371419,0,1.07752457,0.750545921,1.435654421,0.151100701,0.29890386,3.747121545,0,1.559682567,1.257783285,1.240024881,0.214966192,0.361683476,9.751045924,0,-1.096681008,1.198503336,-0.915042099,0.360169529,0.50393507,33.88719354,0,0.80375207,0.855547145,0.939459707,0.34749477,0.494668839,13.50451033,0,-0.254092593,1.135121938,-0.223846077,0.822877075,0.881310793,N,-,,oligoribonuclease,P:nucleic acid phosphodiester bond hydrolysis; F:exonuclease activity; C:intracellular membrane-bounded organelle; C:cytoplasmic part,IPR013520 (SMART); IPR012337 (G3DSA:3.30.420.GENE3D); IPR013520 (PFAM); PTHR11046 (PANTHER); IPR012337 (SUPERFAMILY),,
RL4_JR_08105,37718,48491,50982,8,14,66,0,0,6,2,2,12,4,11,6,0,14,2,148.6970794,1,-2.045000637,0.694250647,-2.945622946,0.00322305,0.015269248,39.84651834,1,-1.850876203,1.195417684,-1.548309205,0.121547869,0.236007584,151.8088303,1,-0.887856786,0.58439836,-1.519266389,0.128695456,0.234210462,123.581236,1,-3.982029944,1.147981277,-3.46872377,0.000522937,0.004343507,102.3784943,1,-4.591544998,1.200791688,-3.823764808,0.000131429,0.000874324,N,-,,mRNA cleavage and polyadenylation specificity factor complex subunit,P:mRNA metabolic process; C:mRNA cleavage factor complex; P:RNA processing; P:termination of RNA polymerase II transcription,IPR032460 (PFAM); IPR021850 (PTHR15245:PANTHER); PTHR15245 (PANTHER),,
RL4_JR_08106,2,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,132.227833,0,0.812627879,0.513220035,1.583390796,0.11333242,0.242476181,17.39936774,0,-0.655490495,1.206505719,-0.543296633,0.586925582,0.725025719,64.20103306,0,-1.483368504,1.037752777,-1.429404515,0.152888002,0.266271827,77.93560637,0,-0.700359352,0.688686571,-1.016949337,0.309177531,0.454871041,60.26691236,0,-0.806884358,0.77904493,-1.03573533,0.300325635,0.435394767,N,-, Effector probability:0.778,Cytochrome oxidase assembly mitochondrial,C:integral component of membrane,PTHR15642 (PANTHER),,
RL4_JR_08107,4159,5420,5120,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,152.1839239,1,-1.881049414,0.667018276,-2.820086766,0.004801067,0.021046266,36.44877875,0,-1.722280204,1.190981818,-1.446101173,0.148148827,0.274143039,107.6038223,0,-2.553881927,1.028264612,-2.483681629,0.0130032,0.039712519,149.4389487,0,-1.479806223,0.606906119,-2.438278636,0.014757394,0.065631958,93.29011051,1,-4.457428928,1.190944146,-3.742769083,0.000182003,0.001146011,N,-,,transcriptional regulatory,P:negative regulation of transcription from RNA polymerase II promoter; C:nuclear chromatin; P:negative regulation of chromatin silencing; C:histone deacetylase complex; P:positive regulation of transcription from RNA polymerase II promoter; P:cellular process,IPR013907 (SMART); IPR013907 (PFAM); PTHR21964 (PANTHER); IPR033487 (PTHR21964:PANTHER); IPR033487 (PTHR21964:PANTHER),,
RL4_JR_08108,347,1173,621,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,179.8156007,0,-5.592701825,1.258666561,-4.443354576,8.86E-06,0.000104467,56.61671206,0,-2.357651145,1.227894216,-1.920076758,0.054848205,0.127071075,148.0639086,0,-5.02109004,1.231151076,-4.078370347,4.54E-05,0.000667367,216.8213897,1,-2.082320458,0.695532611,-2.993850218,0.002754811,0.01733528,166.3469098,0,-2.274205448,0.818113858,-2.779815334,0.005438982,0.019188046,N,-,,nucleolar 12,"F:nucleotide binding; P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:nucleic acid binding; C:preribosome; C:nucleolus",IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR24012 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY),,
RL4_JR_08109,2069,2622,3516,0,0,16,0,0,0,0,0,0,0,4,2,0,6,0,971.7152851,1,2.346050701,0.903263255,2.597305589,0.009395829,0.036088123,133.1470761,0,0.960083992,0.723884231,1.326294939,0.184742023,0.324364051,188.4473828,0,-1.236977271,0.670848469,-1.84389967,0.065197763,0.138904507,445.67312,1,0.953420902,0.441855234,2.157767585,0.030945906,0.094120547,255.7249677,1,0.134095497,0.587269731,0.228337151,0.819384145,0.878841575,N,-,,Tubulin alpha chain,F:GTP binding; C:cytoplasm; F:GTPase activity; F:structural constituent of cytoskeleton; C:microtubule; P:microtubule-based process,IPR002452 (PRINTS); IPR000217 (PRINTS); IPR003008 (SMART); IPR018316 (SMART); IPR023123 (G3DSA:1.10.287.GENE3D); IPR003008 (PFAM); IPR003008 (G3DSA:3.40.50.GENE3D); IPR018316 (PFAM); IPR018316 (G3DSA:3.30.1330.GENE3D); IPR000217 (PANTHER); PTHR11588:SF73 (PANTHER); IPR003008 (SUPERFAMILY); IPR008280 (SUPERFAMILY),,
RL4_JR_08110,2945,2513,2069,5,2,13,0,0,5,1,0,3,2,6,1,0,1,0,6.005746686,1,1.708421383,1.280953378,1.333710822,0.182298647,0.339852002,0.693226301,1,3.99420929,1.601519453,2.494012348,0.012630815,0.040229424,1.799263978,1,1.34192942,1.313789279,1.021419067,0.307055935,0.448446955,2.076165682,1,0.919169337,1.353249585,0.679231198,0.496991382,0.635588349,1.768061945,1,1.264340033,1.306307738,0.967873034,0.333107783,0.469803079,N,-,,valyl-tRNA synthetase,F:valine-tRNA ligase activity; F:ATP binding; P:nucleocytoplasmic transport; P:valyl-tRNA aminoacylation; P:regulation of translational fidelity; C:mitochondrion; F:aminoacyl-tRNA editing activity; F:structural constituent of nuclear pore; C:nuclear pore,IPR002303 (PRINTS); IPR009080 (G3DSA:1.10.730.GENE3D); IPR009008 (G3DSA:3.90.740.GENE3D); IPR014729 (G3DSA:3.40.50.GENE3D); IPR002303 (TIGRFAM); IPR002300 (PFAM); IPR013155 (PFAM); PTHR11946 (PANTHER); IPR002303 (PTHR11946:PANTHER); IPR009080 (SUPERFAMILY); SSF52374 (SUPERFAMILY); IPR009008 (SUPERFAMILY),,
RL4_JR_08111,6346,6266,4925,0,0,2,0,0,6,0,0,1,4,0,0,0,8,0,18.92183437,1,-2.344394578,1.184452631,-1.97930632,0.047781528,0.128520181,6.039881631,1,0.870990671,1.228950154,0.708727419,0.478493646,0.635907712,22.16841712,1,-0.819193038,1.187819222,-0.689661375,0.490407161,0.624430276,58.04818994,1,1.113904477,0.606050159,1.83797407,0.066066226,0.145480761,15.45079895,1,-1.863394688,1.192481376,-1.56261953,0.118142112,0.216480084,N,-,,hypothetical protein SPSK_09216,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_08112,4205,3519,3040,12,15,13,0,0,0,4,1,1,2,1,0,0,0,2,4.457288768,1,-0.258691487,1.326069815,-0.195081348,0.845329264,0.922395985,1.442713013,0,2.936736811,1.475900902,1.989792679,0.046613778,0.111542474,3.718556454,1,0.294125743,1.286160797,0.228685047,0.819113717,0.883142415,4.287366146,1,-0.127386198,1.301787027,-0.097854868,0.922047538,0.953891011,3.650763397,1,0.217847872,1.287948133,0.169143358,0.865683881,0.910370721,N,-,,hypothetical protein CMQ_4869,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_08113,1414,1220,1416,0,2,3,0,0,1,0,1,1,4,1,2,0,4,1,8.980940003,1,3.154038752,1.130294726,2.790456931,0.00526337,0.022670842,0.424398675,1,4.702031556,1.670242346,2.815179227,0.004875004,0.020298144,1.105663233,1,2.044353081,1.303061054,1.568885106,0.116674713,0.217575022,1.276030851,1,1.621357298,1.359557542,1.192562468,0.233040772,0.37035596,1.092027735,1,1.959697441,1.288506963,1.520905588,0.128283531,0.229888629,Y,-,,aldose 1-epimerase,P:carbohydrate metabolic process; F:carbohydrate binding; F:isomerase activity,IPR014718 (G3DSA:2.70.98.GENE3D); IPR008183 (PFAM); PTHR10091 (PANTHER); PTHR10091:SF6 (PANTHER); IPR011013 (SUPERFAMILY),,
RL4_JR_08114,33700,31489,42868,7,0,31,0,0,5,1,0,0,1,1,0,0,6,0,8.257087822,1,-1.147927422,1.204228101,-0.953247496,0.340464687,0.530565599,2.622171107,1,2.07471257,1.285242539,1.614257626,0.106471557,0.212397537,6.823032553,1,-0.581506667,1.202090594,-0.483746126,0.628566054,0.740026491,7.872739626,1,-1.004120254,1.2010204,-0.836055952,0.403123427,0.54666776,14.4664639,1,0.995502278,0.992137283,1.003391663,0.315671925,0.451055355,N,-,,sister chromatid cohesion,C:Ctf18 RFC-like complex; P:mitotic sister chromatid cohesion,IPR018607 (PFAM); PTHR28605 (PANTHER),,
RL4_JR_08115,1511,2097,3336,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,69.35114949,0,0.503237985,0.675222378,0.745292219,0.456095084,0.644676253,20.45094551,0,0.912579016,1.128943118,0.808348093,0.418890224,0.58273871,28.88357317,0,-2.663231804,1.204906714,-2.210321989,0.027082824,0.070812631,42.64429364,0,-2.134620907,1.158993892,-1.841787883,0.065506183,0.144624968,28.63536585,0,-2.753490577,1.214862383,-2.266504104,0.023420536,0.06170516,N,-,,diphthamide biosynthesis 1,P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine,IPR016435 (PFAM); IPR016435 (TIGRFAM); IPR016435 (PANTHER); PTHR10762:SF1 (PANTHER),,
RL4_JR_08116,533,758,1104,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,889.5608687,1,-0.71838562,0.558613089,-1.286016448,0.198437321,0.361270178,255.99038,0,-2.343005437,0.989716679,-2.367349654,0.017915998,0.052793516,481.1361388,0,-4.857078638,1.045573897,-4.645370978,3.39E-06,7.57E-05,655.7606862,0,-2.00526008,0.644577556,-3.110967892,0.001864752,0.012518134,651.1494611,0,-1.082526952,0.569403256,-1.901160452,0.057280999,0.124078014,N,-,,40S ribosomal s6,F:structural constituent of ribosome; C:cytosolic small ribosomal subunit; P:ribosomal small subunit biogenesis; P:rRNA processing; P:translation,IPR001377 (SMART); IPR001377 (PFAM); IPR014401 (PIRSF); IPR001377 (PANTHER),,
RL4_JR_08117,15055,11287,7702,0,9,17,0,0,0,0,6,3,1,4,2,0,6,2,296.9786119,1,-2.820686248,0.681106312,-4.141330361,3.45E-05,0.000336267,92.07391716,0,-1.987519899,1.119841054,-1.774823215,0.075927082,0.163609324,236.6350921,1,-3.165173162,0.879993843,-3.596812851,0.00032214,0.002457684,265.0841176,1,-3.301464921,0.792531096,-4.16572288,3.10E-05,0.000387481,225.2051274,1,-3.975751333,1.011682194,-3.929842154,8.50E-05,0.000605233,N,-,,ribose-phosphate pyrophosphokinase 3,F:magnesium ion binding; P:ribonucleoside monophosphate biosynthetic process; P:nucleotide biosynthetic process; F:ribose phosphate diphosphokinase activity; C:cytosol; P:phosphorylation; F:kinase activity,SM01400 (SMART); IPR029057 (G3DSA:3.40.50.GENE3D); IPR029057 (G3DSA:3.40.50.GENE3D); IPR005946 (PFAM); IPR005946 (TIGRFAM); IPR029099 (PFAM); PTHR10210 (PANTHER); IPR029057 (SUPERFAMILY),,
RL4_JR_08118,13760,11319,8939,3,10,13,0,0,3,1,3,3,10,3,1,0,10,3,960.3380348,1,-1.640653646,0.367025532,-4.470134912,7.82E-06,9.38E-05,263.4022715,1,-2.25738883,0.90541097,-2.4932201,0.012659035,0.040306622,711.839509,1,-2.371552001,0.505450019,-4.691961448,2.71E-06,6.21E-05,810.3706264,1,-2.655315184,0.458586107,-5.790221601,7.03E-09,1.98E-07,676.5514083,1,-2.555514886,0.50842908,-5.026295673,5.00E-07,7.99E-06,N,-,,E3 ubiquitin- ligase HUWE1,F:ubiquitin-protein transferase activity; C:nucleus; C:cytoplasm; F:ligase activity; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; P:protein ubiquitination,IPR000569 (SMART); IPR000569 (PFAM); IPR010314 (PFAM); IPR010309 (PFAM); G3DSA:3.30.2160.10 (GENE3D); IPR025527 (PFAM); PTHR11254 (PANTHER); PTHR11254:SF291 (PANTHER); PTHR11254 (PANTHER); PTHR11254:SF291 (PANTHER); IPR000569 (PROSITE_PROFILES); IPR000569 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_08119,2864,3193,3155,0,6,5,0,0,1,1,6,0,0,9,0,0,4,3,36.11332602,1,0.227111801,0.748983498,0.303226708,0.761717096,0.874854015,34.8246647,1,2.895893943,0.874661667,3.31087328,0.000930053,0.015023052,85.71631776,1,2.066856763,0.51879527,3.983954528,6.78E-05,0.000901674,75.48256483,1,1.215537378,0.578992689,2.099400219,0.035781635,0.10034633,47.83818876,1,1.59389956,0.553391142,2.880240465,0.00397372,0.014830045,N,-,,microtubule binding,C:membrane,IPR008636 (PFAM); SSF116907 (SUPERFAMILY),,
RL4_JR_08120,4849,3083,6156,0,3,6,0,0,1,1,0,3,0,2,0,0,3,0,192.5066556,1,0.176801624,0.444615788,0.397650351,0.69088794,0.832103414,27.09960983,1,-1.294686605,1.192298657,-1.085874414,0.277534558,0.436550862,125.7863029,1,-0.316531836,0.564838961,-0.560393064,0.575211361,0.697835809,109.2380131,1,-0.854143731,0.572010137,-1.493231807,0.135376519,0.246260735,84.1175766,1,-2.345637123,0.969066713,-2.420511499,0.015498689,0.044618774,Y,-,,ase propeptide,C:integral component of membrane,IPR010259 (G3DSA:3.30.70.GENE3D); PTHR28288:SF1 (PANTHER); PTHR28288 (PANTHER); IPR009020 (SUPERFAMILY),,
RL4_JR_08121,5813,4817,6754,0,1,5,0,0,0,2,0,1,1,2,0,0,3,0,2.306110994,1,0.691929778,1.30459112,0.530380567,0.595848097,0.765983103,0.734811661,0,3.909952307,1.490903244,2.622539272,0.008727721,0.030420796,8.410339568,1,2.215261539,1.220047258,1.815717813,0.06941367,0.145888311,21.4760069,1,2.593324605,1.044731173,2.482288911,0.013054139,0.059942473,28.56103362,1,4.325603574,0.693934303,6.233448259,4.56E-10,2.83E-08,Y,-,,glycosyl hydrolase family 11,"P:xylan catabolic process; F:endo-1,4-beta-xylanase activity",IPR001137 (PRINTS); IPR033123 (PFAM); IPR013319 (G3DSA:2.60.120.GENE3D); PTHR10587 (PANTHER); IPR033123 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),,
RL4_JR_08122,2206,2444,3019,0,0,3,0,0,0,0,0,0,0,2,0,0,2,0,74.75437466,1,2.218292379,0.607331672,3.652522141,0.000259677,0.001925861,4.435191673,0,1.316421095,1.292370599,1.018609597,0.308388346,0.469861164,11.58849466,0,-1.345772353,1.229666997,-1.094420161,0.273770746,0.412544975,33.4313159,1,1.201321569,0.766305914,1.567678845,0.116956101,0.219944377,15.38683547,1,-0.514343012,1.175063143,-0.437715211,0.661592741,0.75868559,N,-,,hypothetical protein SPSK_09456,,no IPS match,,
RL4_JR_08123,5230,4104,3543,1,3,2,0,0,0,0,0,1,0,1,0,0,0,6,1087.912215,1,-0.55603501,0.654684843,-0.849317066,0.395704887,0.588007371,208.6438738,0,-4.239385631,1.199024771,-3.535694787,0.000406704,0.014915438,690.0066574,1,-1.837303539,0.413402547,-4.444344992,8.82E-06,0.00016966,962.3230256,1,-0.814271574,0.528037972,-1.54207011,0.123056557,0.228614247,679.6761804,1,-1.718454939,0.80578431,-2.132648798,0.032953547,0.080944848,N,-, Effector probability:0.609,40S ribosomal S23,F:structural constituent of ribosome; C:cytosolic small ribosomal subunit; P:translation,IPR006032 (PIRSF); G3DSA:2.40.50.140 (GENE3D); IPR005680 (TIGRFAM); IPR006032 (PFAM); IPR006032 (PANTHER); IPR012340 (SUPERFAMILY),,
RL4_JR_08124,2802,6573,5840,0,0,12,0,0,0,2,1,0,3,16,0,0,9,0,115.6894325,1,2.441596182,0.564697145,4.323726805,1.53E-05,0.000166875,5.082485572,0,1.1199061,1.280370189,0.874673676,0.381751487,0.546160926,27.58869903,1,0.27963798,1.065691039,0.262400611,0.793012601,0.863739599,24.59715015,1,-1.00783754,1.176705646,-0.856490783,0.391726369,0.536629615,13.14405435,1,-1.630139162,1.236392038,-1.318464623,0.18734816,0.3064459,N,-,,4-hydroxybenzoate polyprenyl transferase,C:integral component of mitochondrial inner membrane; F:4-hydroxybenzoate octaprenyltransferase activity; P:isoprenoid biosynthetic process; P:ubiquinone biosynthetic process,IPR000537 (PFAM); IPR006370 (TIGRFAM); PTHR11048:SF28 (PANTHER); PTHR11048 (PANTHER); IPR031103 (HAMAP),,
RL4_JR_08125,876,675,1157,0,1,5,0,0,0,0,0,0,2,0,1,0,0,0,77.44772865,1,-0.4905788,0.695899534,-0.704956357,0.480837397,0.669411263,14.07878986,0,-0.349889914,1.232631803,-0.283855984,0.776520749,0.864585086,36.28666933,0,-2.992342399,1.204225896,-2.484868004,0.012959948,0.039615493,45.85647692,1,-2.467964025,1.158645152,-2.130043026,0.033168061,0.097485704,94.79093532,0,0.772477737,0.556267344,1.388680723,0.164929859,0.277994809,N,-,,transcription factor jumonji,F:DNA binding; P:regulation of gene expression,IPR003347 (SMART); IPR003347 (PFAM); IPR018866 (PFAM); G3DSA:2.60.120.650 (GENE3D); PTHR32031 (PANTHER); PTHR32031:SF108 (PANTHER); IPR003347 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_08126,1289,978,1581,0,0,8,0,0,0,0,1,0,0,1,0,0,1,0,25.70658455,1,-1.295226288,1.166860511,-1.110009531,0.26699492,0.447165788,15.09880368,0,1.863064163,1.162832563,1.602177495,0.109116365,0.216478998,47.21721725,1,1.425999224,0.721786543,1.975652271,0.048194174,0.110139362,35.60081354,1,-0.350147376,1.043434336,-0.335572028,0.73719362,0.824978935,14.40497202,1,-1.762351461,1.215109134,-1.450364755,0.14695683,0.255268071,N,-,,mitochondrial carrier pet8,,no IPS match,,
RL4_JR_08127,3,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,491.422147,0,-4.202020837,0.918947117,-4.572647065,4.82E-06,6.06E-05,151.727493,0,-3.779817044,1.287909377,-2.934847057,0.003337121,0.016389297,417.7463865,0,-3.59821256,0.881358348,-4.082576136,4.45E-05,0.00065827,484.5296188,0,-3.256509817,0.784209251,-4.152603161,3.29E-05,0.000407373,392.1911141,0,-3.976626214,0.959774588,-4.143291834,3.42E-05,0.000281132,N,-,,hypothetical protein SPSK_09860,,IPR027915 (PFAM); PTHR39615 (PANTHER),,
RL4_JR_08128,3921,4020,3286,1,3,3,0,0,0,0,0,0,0,4,0,0,0,0,66.45434993,1,1.231619548,0.653884467,1.883543057,0.05962681,0.151773953,33.43632388,0,3.213752544,0.907506068,3.541301439,0.000398158,0.014708611,20.15071752,0,-0.620221273,1.209893334,-0.512624754,0.608213834,0.724588945,70.3260815,1,1.580880833,0.627012187,2.521292035,0.011692477,0.054808485,13.36245568,0,-1.653973422,1.209654491,-1.367310612,0.171527967,0.28669482,N,-,,rna polymerase ii holoenzyme cyclin-like subunit,P:negative regulation of transcription from RNA polymerase II promoter; F:cyclin-dependent protein serine/threonine kinase regulator activity; P:regulation of protein kinase activity; C:mediator complex; P:positive regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle; P:positive regulation of transcription by galactose,IPR013763 (SMART); IPR006671 (PFAM); IPR013763 (G3DSA:1.10.472.GENE3D); PTHR10026:SF7 (PANTHER); PTHR10026 (PANTHER); IPR013763 (SUPERFAMILY); IPR013763 (SUPERFAMILY),,
RL4_JR_08129,11480,11374,11259,4,1,6,0,0,0,3,1,0,6,5,4,0,14,0,252.8067446,1,-1.090322971,0.772716096,-1.411026606,0.158236769,0.307508978,52.43041694,0,-2.246819499,1.188201789,-1.890941016,0.058632218,0.133804435,298.3133147,1,0.179312276,0.368176474,0.487028066,0.626238442,0.738329799,191.705481,1,-2.010953136,0.608069923,-3.307108376,0.000942644,0.007054155,172.8872771,1,-1.125903785,0.557832747,-2.018353692,0.043554439,0.100613436,N,-,,calcium dependent mitochondrial carrier,F:structural constituent of ribosome; C:membrane; P:nucleoside transport; P:purine ribonucleotide transport; P:adenine nucleotide transport; P:translation,IPR002067 (PRINTS); IPR002048 (SMART); IPR002048 (PFAM); IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); PTHR24089 (PANTHER); PTHR24089:SF57 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY); IPR011992 (SUPERFAMILY),2.A.29.23.2, the mitochondrial carrier (mc) family.
RL4_JR_08130,1781,1722,1800,0,0,0,0,0,0,0,0,0,1,4,0,0,4,0,316.2998525,0,0.012002999,0.518028383,0.023170543,0.981514235,0.991069033,136.6283157,0,0.538725295,0.741699135,0.726339387,0.467630739,0.626405606,244.0869451,0,0.145501469,0.388111087,0.37489645,0.707737479,0.801738194,364.9770208,1,0.788903525,0.55919387,1.410787149,0.158307385,0.276974729,162.7743568,1,-1.055017572,0.516852642,-2.041234747,0.041227499,0.096359287,N,-,,hypothetical protein F503_07050,,no IPS match,,
RL4_JR_08131,1713,1116,1455,0,0,1,0,0,0,0,2,0,0,3,0,0,0,0,5.083176663,1,-0.448115251,1.229573988,-0.36444757,0.715523819,0.847794399,1.6412705,0,2.750794092,1.373657699,2.002532432,0.045227499,0.108972326,4.226384564,1,0.109654111,1.224737094,0.089532776,0.928658507,0.957309716,12.89641704,1,1.400768822,1.047654846,1.337051823,0.181205721,0.306909991,4.135717008,0,0.03789119,1.217394108,0.031124834,0.975169985,0.983362079,N,-,,Pyrethroid hydrolase,F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR029058 (SUPERFAMILY),,
RL4_JR_08132,3188,3412,3798,2,5,4,2,0,0,0,0,0,4,9,1,0,4,1,2.914599398,1,0.354652595,1.313663267,0.269972225,0.787181622,0.890189586,0.934106946,1,3.564004991,1.484016798,2.401593429,0.01632384,0.049248855,2.410150997,0,0.920273636,1.257430789,0.731868222,0.464249004,0.601414833,2.779810147,1,0.498163908,1.273863477,0.391065383,0.695748908,0.794816393,2.356993726,1,0.849413167,1.246934021,0.681201373,0.495744079,0.62391657,N,-,,major facilitator superfamily transporter monocarboxylate,P:ion transmembrane transport; C:integral component of fungal-type vacuolar membrane; F:transporter activity,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11360 (PANTHER); PTHR11360:SF155 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.13.4, the major facilitator superfamily (mfs).
RL4_JR_08133,7892,6073,9843,5,1,5,0,0,0,0,0,0,1,14,0,0,5,0,30.65048562,1,-0.217416362,1.029335765,-0.21122006,0.832715558,0.916665376,4.693311532,0,1.234984903,1.275351262,0.96834883,0.332870186,0.496143722,46.71498441,0,1.421612211,0.764796102,1.858812052,0.063053783,0.135560948,17.98563371,1,-0.885738217,1.16150428,-0.762578523,0.445714797,0.587841907,23.09425408,1,0.19523063,0.987092135,0.197783594,0.843214383,0.894545853,N,-,,c6 zinc finger domain containing,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR007219 (SMART); IPR001138 (PFAM); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31944:SF31 (PANTHER); PTHR31944:SF31 (PANTHER); PTHR31944 (PANTHER); PTHR31944 (PANTHER); PTHR31944:SF31 (PANTHER); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_08134,73,97,40,1,0,0,0,0,0,0,0,0,0,4,0,0,0,0,26.27618044,1,0.302142372,0.867650467,0.348230518,0.72766707,0.856109526,14.08562744,0,2.146874906,1.125388391,1.907674651,0.05643328,0.129910771,29.8217121,0,0.399128366,1.036452017,0.385091022,0.700169979,0.796015819,41.10881255,1,0.884239665,0.750296032,1.178521047,0.238588947,0.376631288,58.32184508,0,1.921619601,0.598138737,3.21266536,0.001315094,0.005976359,N,-,,acid phosphatase,C:membrane; C:integral component of membrane,IPR029033 (G3DSA:3.40.50.GENE3D); PTHR11567 (PANTHER); PTHR11567:SF36 (PANTHER); PTHR11567:SF36 (PANTHER); PTHR11567 (PANTHER); IPR029033 (SUPERFAMILY),,
RL4_JR_08135,218,190,486,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.534114951,0,2.802354923,1.929305516,1.452520039,0.146357061,NA,0.169538614,0,6.025637646,1.886491729,3.194097039,0.00140269,0.015023052,0.441743762,0,3.366851665,1.286148924,2.617777462,0.00885045,0.029708872,0.509720149,0,2.944673701,1.418602406,2.075756878,0.037916442,0.103648294,0.437727749,0,3.278327203,1.247094085,2.628772954,0.008569355,0.027755829,N,-,,pp-loop family,"F:nucleotide binding; F:ATP binding; F:ligase activity, forming carbon-nitrogen bonds; C:cytoplasm; P:tRNA processing; C:mitochondrion",IPR014729 (G3DSA:3.40.50.GENE3D); IPR011063 (PFAM); PTHR11807 (PANTHER); IPR012094 (PTHR11807:PANTHER); SSF52402 (SUPERFAMILY),,
RL4_JR_08136,25045,32385,38860,4,17,20,0,0,5,2,0,3,1,7,2,0,2,0,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_08137,18272,14921,21574,4,9,16,0,0,3,4,5,15,11,17,2,4,20,0,4.056681585,1,-0.122643616,1.202800155,-0.101965082,0.918784391,0.961445874,1.298798451,1,3.088376598,1.361760682,2.267929041,0.023333532,0.065010187,3.362229478,1,0.439605203,1.202742682,0.365502288,0.714736499,0.807047994,3.87818901,1,0.017460362,1.202360361,0.014521737,0.988413737,0.993220434,3.30727743,1,0.360497193,1.19735744,0.30107734,0.76335552,0.834731212,N,-,,F-box cyclin,,IPR032675 (G3DSA:3.80.10.GENE3D); SSF52047 (SUPERFAMILY),,
RL4_JR_08138,4555,3840,5615,2,13,6,0,0,2,0,4,2,1,4,1,0,1,0,25.0431657,1,1.843478433,0.88866325,2.074439821,0.038038482,0.108688817,1.645543686,1,2.746879464,1.353636932,2.029258658,0.042431952,0.1037293,4.29284833,1,0.086966888,1.224852816,0.071001909,0.943396236,0.966401244,24.22474735,1,1.423738126,1.039679184,1.369401396,0.170873838,0.29318719,4.253948142,1,-0.00244817,1.232004413,-0.001987144,0.99841449,0.998660594,N,-,,PET8 related,P:mycelium development; C:integral component of membrane; P:transport,IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); PTHR24089:SF45 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.18.1, the mitochondrial carrier (mc) family.
RL4_JR_08139,2319,2371,4347,0,2,3,0,0,0,0,8,1,0,1,0,0,1,0,78.797519,1,-1.028713288,0.757731746,-1.357622,0.174583659,0.329383323,19.07705479,0,-0.788219637,1.230393509,-0.640624021,0.521766989,0.671561274,62.34401903,1,-1.622092664,1.058583176,-1.532324244,0.125442441,0.229486678,126.1201296,1,0.211973893,1.307034795,0.162179227,0.871164717,0.920820833,71.21567335,1,-0.592392362,0.716681697,-0.826576657,0.408477053,0.544403075,N,-,,WD repeat-containing 5B,,IPR020472 (PRINTS); IPR001680 (SMART); IPR021772 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR19862 (PANTHER); PTHR19862 (PANTHER); PTHR19862:SF14 (PANTHER); PTHR19862:SF14 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_08140,117,145,134,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,236.4835401,1,-1.916918351,0.640870968,-2.991114351,0.002779614,0.013537964,59.00529152,0,-2.417269374,1.217519702,-1.98540473,0.04709946,0.112440392,154.1991007,0,-5.079665522,1.221698331,-4.157872195,3.21E-05,0.000500321,199.3208097,0,-2.798900731,0.807312061,-3.466937836,0.000526424,0.004358168,168.5089506,0,-2.61900696,0.849529097,-3.082892591,0.002049991,0.008644799,N,-,,atp-dependent rna helicase has1,"C:nuclear envelope; P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:ATP binding; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:RNA binding; P:snoRNA release from pre-rRNA; C:nucleolus; C:preribosome, large subunit precursor; F:ATP-dependent RNA helicase activity",IPR001650 (SMART); IPR025313 (SMART); IPR014001 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR025313 (PFAM); PTHR24031:SF301 (PANTHER); PTHR24031 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_08141,4117,3984,5789,1,0,1,0,0,0,1,2,0,0,1,0,0,0,0,46.94663274,1,-1.676961305,1.025405606,-1.635412655,0.101962571,0.224874468,12.47862747,0,-0.175916831,1.211330586,-0.145226112,0.88453235,0.934426328,119.8424083,1,1.448852596,0.481217202,3.010807993,0.002605536,0.01222356,118.4045553,1,1.0662676,0.4678074,2.279287584,0.022649976,0.081093,32.15863684,0,-2.920904034,1.204098658,-2.425801253,0.015274633,0.044086561,N,-,,"fructose-2,6- partial","F:ATP binding; P:fructose 2,6-bisphosphate metabolic process; F:fructose-2,6-bisphosphate 2-phosphatase activity; P:fructose metabolic process; P:glucose metabolic process; P:dephosphorylation; P:carbohydrate phosphorylation; F:6-phosphofructo-2-kinase activity",IPR003094 (PRINTS); IPR013078 (SMART); IPR013078 (PFAM); PIRSF000709 (PIRSF); IPR013079 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR029033 (G3DSA:3.40.50.GENE3D); IPR003094 (PANTHER); IPR027417 (SUPERFAMILY); IPR029033 (SUPERFAMILY),,
RL4_JR_08142,448,528,623,0,0,0,0,0,0,0,0,2,0,4,0,0,0,0,16.11331006,0,1.984455225,0.846395402,2.344595944,0.019047709,0.062911422,1.488651161,0,2.891540843,1.34037929,2.157255684,0.030985748,0.081222717,16.85459995,1,2.062137946,1.030898185,2.000331339,0.045464497,0.105172232,8.460936611,1,0.766542134,1.143379983,0.670417661,0.502591579,0.639955812,11.1622109,0,1.095393965,1.12025069,0.977811462,0.328167581,0.464517931,N,-,,Transmembrane 53-B,C:membrane; C:integral component of membrane,IPR008547 (PFAM); PTHR12265:SF8 (PANTHER); IPR008547 (PANTHER),,
RL4_JR_08143,1274,1864,881,0,6,1,0,0,0,0,0,0,0,0,0,0,0,0,2361.906131,1,-1.066532019,0.791439125,-1.347585664,0.177791684,0.333956979,556.5131167,0,-2.642800146,0.71492023,-3.696636401,0.000218475,0.009214179,1537.824419,0,-2.538818815,0.427701422,-5.935960661,2.92E-09,1.42E-07,2105.378164,0,-1.329363756,0.469357599,-2.832304749,0.004621378,0.026376242,1572.253323,0,-2.14393389,0.727897035,-2.945380718,0.003225575,0.012541838,N,-,,thiazole biosynthetic enzyme,C:nucleus; F:identical protein binding; F:ferrous iron binding; F:oxidoreductase activity; C:cytosol; P:oxidation-reduction process; P:thiazole biosynthetic process; P:response to stress; P:thiamine biosynthetic process; P:mitochondrial genome maintenance,PF01946 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR002922 (TIGRFAM); PTHR10617:SF115 (PANTHER); PTHR10617 (PANTHER); IPR027495 (HAMAP); IPR023753 (SUPERFAMILY),,
RL4_JR_08144,2998,3170,7371,2,4,3,0,0,0,4,0,0,0,0,0,0,0,0,56.4236334,1,-1.533677301,1.018659524,-1.505583824,0.132174044,0.270244573,11.65142543,0,-0.076910107,1.227981264,-0.062631336,0.950060076,0.973626414,56.131864,1,0.085074942,0.762571447,0.111563241,0.91116972,0.945874227,42.78122196,0,-1.426220015,1.029427225,-1.385450065,0.165914891,0.286670354,48.23605941,0,-0.579598149,0.85279993,-0.679641413,0.496731541,0.624848659,N,-,,snare complex subunit,F:protein binding; P:vesicle-mediated transport; F:organic cyclic compound binding; F:heterocyclic compound binding; C:cell part; P:single-organism cellular process; C:membrane part,IPR000727 (SMART); IPR000727 (PFAM); G3DSA:1.20.5.110 (GENE3D); PTHR19957 (PANTHER); PTHR19957:SF124 (PANTHER); PTHR19957:SF124 (PANTHER); PTHR19957 (PANTHER); IPR000727 (PROSITE_PROFILES); SSF58038 (SUPERFAMILY),1.F.1.1.5, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_08145,279,248,252,0,0,3,0,0,0,0,0,0,0,1,0,0,0,0,1.680728015,1,1.148462757,1.292758071,0.888381812,0.374335406,NA,0.537573214,0,4.360981026,1.526822352,2.856246519,0.004286821,0.018622836,1.393196454,0,1.710385941,1.222862387,1.398674094,0.161910736,0.277615421,5.618655745,1,2.234559967,1.154569698,1.935405,0.052940616,0.12668961,1.372600392,0,1.62913281,1.21079688,1.345504631,0.178462327,0.295665717,N,-,,WD domain-containing,F:ubiquitin-protein transferase activator activity; P:regulation of catalytic activity; F:anaphase-promoting complex binding; C:cellular_component; F:molecular_function,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR033010 (PANTHER); IPR033010 (PANTHER); PTHR19918:SF5 (PANTHER); PTHR19918:SF5 (PANTHER); IPR033010 (PANTHER); PTHR19918:SF5 (PANTHER); IPR017986 (SUPERFAMILY),,
RL4_JR_08146,57,100,84,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,491.8312383,0,-2.39015573,0.900897925,-2.653081622,0.007976058,0.031663592,130.2491174,0,-3.559612223,1.190889346,-2.989036921,0.002798583,0.015349618,337.7037467,1,-6.210627399,1.190068963,-5.218712183,1.80E-07,5.90E-06,425.5199297,0,-3.574795335,0.66443591,-5.380195867,7.44E-08,1.74E-06,386.8419125,0,-2.191410012,0.783796199,-2.795892624,0.005175659,0.018451954,N,-,,kh domain-containing,F:nucleic acid binding; F:RNA binding,IPR004087 (SMART); IPR004088 (PFAM); IPR004088 (G3DSA:3.30.1370.GENE3D); IPR004088 (G3DSA:3.30.1370.GENE3D); IPR004088 (G3DSA:3.30.1370.GENE3D); PTHR10288 (PANTHER); PTHR10288:SF145 (PANTHER); PTHR10288 (PANTHER); PTHR10288:SF145 (PANTHER); IPR004088 (PROSITE_PROFILES); IPR004088 (PROSITE_PROFILES); IPR004088 (PROSITE_PROFILES); IPR004088 (SUPERFAMILY); IPR004088 (SUPERFAMILY); IPR004088 (SUPERFAMILY),,
RL4_JR_08147,7045,4184,4951,0,0,0,0,0,0,0,0,2,0,2,3,0,0,0,56.21300249,0,0.098966084,0.668598827,0.148020128,0.882326883,0.94282897,9.151795117,0,0.271432702,1.214248629,0.22353964,0.823115535,0.893527365,36.77834563,1,-0.562532159,1.03131983,-0.545448796,0.585444888,0.706264822,46.06093861,1,-1.06322574,1.012153047,-1.050459457,0.293506922,0.438168468,31.20922956,0,-0.800283884,0.979429086,-0.817092217,0.41387573,0.549946892,N,-,,geranylgeranyl transferase type-2 subunit alpha,C:intracellular organelle; F:protein prenyltransferase activity; P:intracellular transport; P:protein prenylation; C:cytoplasmic part,G3DSA:1.25.40.120 (GENE3D); IPR002088 (PFAM); IPR032955 (PTHR11129:PANTHER); IPR032955 (PTHR11129:PANTHER); PTHR11129 (PANTHER); PTHR11129 (PANTHER); IPR002088 (PROSITE_PROFILES); IPR002088 (PROSITE_PROFILES); IPR002088 (PROSITE_PROFILES); IPR002088 (PROSITE_PROFILES); IPR002088 (PROSITE_PROFILES); SSF48439 (SUPERFAMILY),,
RL4_JR_08148,10326,9498,15771,2,9,7,0,0,2,0,0,0,0,7,2,0,0,0,8.668321335,1,-1.2182301,1.221807714,-0.997071868,0.318729627,0.507454391,2.748651227,1,2.006688552,1.300322499,1.543223742,0.122776499,0.237482079,7.169105141,0,-0.653013389,1.216525069,-0.536785806,0.591415577,0.710934612,8.272685811,1,-1.075731281,1.217501867,-0.883556166,0.376935851,0.522380758,7.113439071,0,-0.744320449,1.227148138,-0.606544903,0.544152974,0.665806509,N,-,,SET domain-containing,P:biological_process; F:molecular_function,G3DSA:3.90.1410.10 (GENE3D); IPR001214 (PFAM); PTHR13271:SF23 (PANTHER); PTHR13271 (PANTHER); SSF82199 (SUPERFAMILY),,
RL4_JR_08149,1183,2496,2096,0,0,34,0,0,0,0,0,0,0,8,0,0,2,0,108.3569629,1,0.254107831,0.748501868,0.339488573,0.734241704,0.859641161,15.9410232,0,-0.529129686,1.294851795,-0.408641118,0.682803051,0.7982597,99.49897556,0,0.635528586,0.676472228,0.939474763,0.347487044,0.491096125,102.5632026,1,0.044626781,0.707400655,0.063085581,0.949698356,0.970365168,62.48065205,1,-0.338266541,0.79660051,-0.424637615,0.671100868,0.766134465,N,-,,hypothetical protein SPBR_08728,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_08150,5136,4384,4257,5,0,13,0,0,0,0,3,4,4,1,3,0,1,0,51.15939465,1,-1.123730664,0.875328388,-1.283781812,0.199218309,0.362368554,12.61369342,0,-0.191408936,1.214629086,-0.157586327,0.874782778,0.92815003,190.8688799,1,2.392642676,0.537210457,4.453827439,8.44E-06,0.000164545,147.0134874,1,1.475072294,0.44640551,3.304332635,0.000952028,0.007096145,106.031506,1,1.218484051,1.711054297,0.712124713,0.476387552,0.606262439,N,-,,hypothetical protein CMQ_4495,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_08151,311,280,339,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,81.59653593,0,0.841630922,0.683300841,1.231713575,0.218056097,0.386046363,9.913728691,0,0.156134866,1.307713224,0.119395341,0.904962152,0.946577132,418.9294877,0,3.99045432,0.731246481,5.457057812,4.84E-08,1.78E-06,126.3898577,0,1.561175212,0.616183923,2.533618867,0.011289144,0.053487407,91.3094618,0,1.504341004,0.702449006,2.141566137,0.032228411,0.079646732,N,-,,heat shock 30,C:intracellular,IPR008978 (G3DSA:2.60.40.GENE3D); IPR002068 (PROSITE_PROFILES); IPR008978 (SUPERFAMILY),,
RL4_JR_08152,292,360,442,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.4589498,0,1.352657336,1.512164945,0.894517056,0.371045308,NA,0.476614166,0,4.534816062,1.691329804,2.681213357,0.007335573,0.026863484,1.218662849,0,1.903871086,1.32115418,1.441066542,0.149565885,0.261565904,1.404499435,0,1.482859648,1.377268177,1.076667328,0.281628914,0.425151745,1.184383652,0,1.841603385,1.29525231,1.42181054,0.155081259,0.26522954,N,-,,---NA---,,no IPS match,,
RL4_JR_08153,733,501,743,0,0,2,0,0,0,2,2,0,3,0,0,0,0,2,18.40984984,1,-0.213638748,1.143666245,-0.186801656,0.851816149,0.926054923,2.673746678,0,2.046663134,1.291055672,1.585263268,0.112906531,0.222732393,45.9149812,1,2.790239644,0.627849126,4.444124437,8.83E-06,0.00016966,7.984693035,1,-1.024524049,1.19887672,-0.854569975,0.392789255,0.537794619,6.814622124,1,-0.682518331,1.200861283,-0.568357345,0.569792348,0.686041423,N,-,,hypothetical protein SPI_06854,,no IPS match,,
RL4_JR_08154,648,981,1010,0,1,17,0,0,0,0,0,4,1,2,12,0,1,3,55.90523384,1,-1.658022709,1.039734528,-1.594659661,0.110788363,0.238346906,12.69531049,0,-0.200752435,1.233002706,-0.162815891,0.870663396,0.925331257,39.54440954,1,-1.89566521,1.210558245,-1.565943,0.117361962,0.218333793,51.45059188,1,-1.544358263,1.042579806,-1.481285418,0.138530533,0.250691983,32.73699664,1,-2.946644002,1.220770354,-2.413757831,0.015788953,0.045222955,N,-,,24-dehydrocholesterol reductase precursor,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; P:steroid metabolic process; P:oxidation-reduction process; F:delta24(24-1) sterol reductase activity",IPR006094 (PFAM); IPR016169 (G3DSA:3.30.465.GENE3D); PTHR10801:SF3 (PANTHER); PTHR10801 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY),,
RL4_JR_08155,17826,15118,11489,0,1,4,0,0,0,2,4,12,2,9,4,0,8,12,145.5046287,1,-5.287267716,1.191102127,-4.43897093,9.04E-06,0.000106254,46.60488526,0,-2.076889338,1.198250242,-1.733268448,0.083047966,0.175090921,120.6845169,1,-4.726116588,1.192282872,-3.963922235,7.37E-05,0.00094965,148.838144,1,-4.19846994,1.144758823,-3.667558489,0.000244878,0.002274665,118.8134048,1,-4.806345084,1.194525563,-4.023643557,5.73E-05,0.000434614,N,-,,alcohol dehydrogenase (NADP+),F:zinc ion binding; P:oxidation-reduction process; F:geraniol dehydrogenase activity; F:alcohol dehydrogenase (NADP+) activity,IPR020843 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013149 (PFAM); IPR013154 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR002085 (PANTHER); PTHR11695:SF487 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_08156,1719,1937,2391,0,0,1,0,0,0,0,0,0,1,2,1,0,1,0,9.740863124,1,-1.38618961,1.208029082,-1.14748033,0.251183158,0.428334491,47.72535616,0,3.508231404,0.989678026,3.544820953,0.00039288,0.014566777,8.047813847,0,-0.819499253,1.205111451,-0.680019473,0.496492131,0.62934649,9.284822947,1,-1.241937719,1.204329499,-1.031227517,0.30243414,0.448257395,7.925838777,1,-0.900242389,1.206911302,-0.745906006,0.455724197,0.587442953,N,-,,interferon-induced GTP-binding Mx,F:GTP binding; F:nucleotide binding; F:GTPase activity,IPR022812 (PRINTS); IPR001401 (SMART); IPR000375 (PFAM); IPR022812 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR022812 (PANTHER); IPR022812 (PANTHER); PTHR11566:SF66 (PANTHER); IPR030381 (PROSITE_PROFILES); IPR020850 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_08157,1270,1287,1265,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.817376669,1,2.188618105,1.629213729,1.343358496,0.179155919,NA,0.25862786,0,5.416438307,1.74613458,3.101959248,0.001922444,0.015023052,0.674488501,0,2.756827888,1.269669914,2.171294963,0.029908883,0.076521994,0.77837405,0,2.334142915,1.345032327,1.735380532,0.082673426,0.169963135,0.668259144,0,2.668344055,1.24640584,2.140830835,0.032287682,0.079725904,N,-,,cadmium resistance transporter,P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane,IPR004676 (PFAM); G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR23500 (PANTHER); PTHR23500:SF168 (PANTHER); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.77.1.2, the cadmium resistance (cadd) family.
RL4_JR_08158,1345,1466,2615,0,0,0,0,0,0,0,0,0,1,1,0,0,2,0,204.6528787,0,-0.598765025,0.631818119,-0.947685745,0.34328946,0.533337539,80.66661152,0,-1.009433308,1.134554634,-0.889717672,0.373617503,0.538251688,128.4852068,0,-2.185775114,0.884759542,-2.470473625,0.013493427,0.040875959,156.9737778,1,-1.954000834,0.711832218,-2.745030056,0.006050536,0.032638078,159.2658069,1,-0.723216688,0.544776659,-1.327547126,0.184327762,0.303022989,N,-,,sit4 phosphatase-associated,C:nucleus; C:nuclear pericentric heterochromatin; C:membrane; C:integral component of membrane; C:cytosol; P:regulation of mitotic sister chromatid segregation,no IPS match,,
RL4_JR_08159,988,823,1575,0,0,0,0,0,0,0,0,0,0,0,1,0,5,0,287.4287154,0,-1.664564035,0.537369622,-3.097614687,0.001950849,0.010261138,69.79559412,0,-2.659539612,1.217111389,-2.185124251,0.028879738,0.076926501,199.3723749,0,-2.90951893,0.887920118,-3.27678005,0.001049981,0.005988738,227.4690899,1,-2.732503369,0.73374721,-3.724039197,0.00019606,0.001888784,180.1200563,1,-4.446850727,1.145043443,-3.883565078,0.000102936,0.000709964,N,-,,sit4 phosphatase-associated,C:nucleus,IPR007587 (PFAM); PTHR12634:SF8 (PANTHER); PTHR12634:SF8 (PANTHER); IPR007587 (PANTHER); IPR007587 (PANTHER),,
RL4_JR_08160,416,328,475,0,1,5,0,0,0,0,0,2,0,2,0,0,1,0,0.304396644,1,3.613421977,2.564558726,1.408983908,0.158839926,NA,0.098688456,0,6.806549354,2.185451651,3.114481783,0.001842683,0.015023052,0.254067586,1,4.165114985,1.415496702,2.94251126,0.003255619,0.014386683,0.292910497,1,3.74401029,1.728106373,2.166539252,0.030270004,0.09284574,0.249110521,1,4.089576467,1.320994554,3.095831434,0.001962619,0.00834587,N,-,,Heterokaryon partial,,IPR010730 (PFAM); PTHR24148 (PANTHER); PTHR24148:SF25 (PANTHER),,
RL4_JR_08161,14583,12611,15092,16,43,17,0,0,2,2,3,7,3,10,3,0,19,4,41.93785459,1,3.950339914,0.775992049,5.090696377,3.57E-07,6.10E-06,0.539360382,1,4.356234658,1.554072789,2.803108509,0.005061264,0.020783007,1.3932451,1,1.710387586,1.242375855,1.37670704,0.168602841,0.285966689,11.24202171,1,2.24010733,1.163797716,1.924825336,0.054251213,0.128519778,1.368768931,1,1.632893401,1.226851173,1.330962905,0.183201217,0.30166081,N,-,,allantoate permease,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF256 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.38, the major facilitator superfamily (mfs).
RL4_JR_08162,16172,16155,17769,1,11,10,2,0,1,1,2,4,1,7,2,0,6,4,2.8167834,1,0.403724384,1.225057612,0.329555427,0.741735907,0.864200334,0.899556937,1,3.618257643,1.416076227,2.555129148,0.010614841,0.035182587,2.331756752,1,0.967655182,1.20782025,0.801158271,0.423040026,0.564362064,2.689856615,1,0.545362091,1.211663152,0.450093815,0.652642796,0.762644986,2.295994591,1,0.887203027,1.20125523,0.7385633,0.460172216,0.591574872,N,-,,acyl- synthetase,F:catalytic activity,G3DSA:3.30.300.30 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR025110 (PFAM); IPR000873 (PFAM); G3DSA:3.40.50.980 (GENE3D); G3DSA:2.30.38.10 (GENE3D); PTHR24095 (PANTHER); PTHR24095:SF197 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.4, the fatty acid transporter (fat) family.
RL4_JR_08163,49303,48998,62373,8,1,26,0,0,0,3,0,1,4,7,5,0,3,0,74.89552177,1,-4.329162528,1.235419926,-3.504203255,0.000457976,0.00313174,23.82772664,0,-1.109083742,1.233211134,-0.899346196,0.368468288,0.532805145,62.07126196,1,-3.766893708,1.223075765,-3.079853119,0.002071027,0.010129023,71.61701962,1,-4.18943535,1.228324813,-3.410690158,0.000647987,0.005157914,61.56531178,1,-3.857835363,1.232969609,-3.128897366,0.001754636,0.007585521,Y,-, Effector probability:0.926,hypothetical protein CMQ_4252,,no IPS match,,
RL4_JR_08164,2051,2924,3052,0,0,6,0,0,0,0,6,3,0,1,0,0,2,0,23.15885414,1,1.583817565,0.824421522,1.921125931,0.054715833,0.142392604,2.514780335,0,2.135155173,1.335179082,1.599152654,0.109786688,0.217595624,6.510803072,1,-0.513666264,1.228029448,-0.418284973,0.675738775,0.777270581,7.510945301,1,-0.936001301,1.230414184,-0.760720506,0.446824024,0.588921276,6.39114569,1,-0.589756849,1.228154384,-0.48019765,0.631086858,0.734454533,N,-,,---NA---,,no IPS match,,
RL4_JR_08165,2560,3063,4715,0,4,2,0,0,0,0,0,0,0,0,0,0,0,0,613.9055992,1,-0.138923982,0.285715103,-0.486232545,0.626802299,0.786564091,113.3826137,0,-2.318111239,1.117920208,-2.07359275,0.038117149,0.095382394,353.1793558,0,-1.623510088,1.65149873,-0.98305258,0.325581561,0.468674495,539.6332401,0,-0.470527598,0.321107887,-1.46532557,0.142832114,0.256687105,368.8899169,0,-1.037659017,0.408583208,-2.539651647,0.011096293,0.034159308,N,-,,vacuolar sorting-associated 13,P:protein retention in Golgi apparatus; C:endosome; C:prospore membrane; P:ascospore-type prospore membrane assembly; C:mitochondrion; P:late endosome to vacuole transport; C:extrinsic component of membrane; P:protein targeting to vacuole; P:protein catabolic process in the vacuole,SM01349 (SMART); IPR000467 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR009543 (PFAM); IPR031645 (PFAM); IPR026854 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR031646 (PFAM); IPR022783 (PFAM); IPR022159 (PFAM); IPR013094 (PFAM); IPR031642 (PFAM); IPR000467 (PFAM); PTHR16166:SF93 (PANTHER); IPR026847 (PANTHER); IPR000467 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR029058 (SUPERFAMILY),,
RL4_JR_08166,650,482,1195,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_08167,94,88,126,1,5,3,0,0,0,0,0,0,0,0,0,0,0,0,10.75869198,1,-1.529953861,1.204474341,-1.270225367,0.204004364,0.368853636,3.451520953,0,1.678283653,1.285558994,1.305489411,0.191726251,0.333560177,101.7047828,0,3.401016585,1.20558008,2.82106236,0.00478649,0.018341568,29.25115818,0,0.359655088,1.027634749,0.349983386,0.726351167,0.81787206,39.67938816,0,2.495878573,0.609465989,4.095189262,4.22E-05,0.000335768,Y,-, Effector probability:0.947,hypothetical protein SPI_06563,F:binding,IPR005089 (PFAM),,
RL4_JR_08168,27569,20888,23874,0,0,0,0,0,0,0,0,3,0,3,3,0,8,0,10.60906075,0,2.027137692,1.077933247,1.880578133,0.060029329,0.152513006,0.946492766,0,3.544727995,1.462397432,2.423915632,0.015354172,0.047038417,2.464046483,1,0.887562505,1.252121909,0.708846717,0.478419603,0.614737919,2.842863862,1,0.465149166,1.267242706,0.367056101,0.713577172,0.808452969,24.53894341,1,3.068715754,0.906309991,3.385944969,0.000709336,0.003630972,N,-,,kinase-like domain,F:ATP binding; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24362:SF160 (PANTHER); PTHR24362 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.1, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_08169,6266,3939,3822,0,16,11,0,0,0,0,0,2,2,0,0,0,1,2,0.121480874,1,4.938964965,3.775906945,1.308020838,0.190866242,NA,0.038110301,0,8.178976254,2.622637513,3.118607209,0.00181708,0.015023052,0.099714261,1,5.515565658,1.578076013,3.495120395,0.000473848,0.003250627,0.115110741,1,5.091875857,2.326653579,2.188497636,0.028633373,0.089817459,0.098903012,1,5.427571673,1.372574934,3.954298989,7.68E-05,0.000556329,N,-,,CFEM domain-containing,C:membrane; C:integral component of membrane,PTHR33048:SF34 (PANTHER); PTHR33048 (PANTHER),9.B.313.1.4, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_08170,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.166423595,0,4.484902486,3.264922016,1.373662974,0.169546337,NA,0.052828182,0,7.70831464,2.421813967,3.18286819,0.00145824,0.015023052,0.137082074,0,5.057477034,1.461734782,3.459914271,0.000540347,0.003584847,0.158169738,0,4.633725615,2.023598297,2.289844591,0.022030327,0.080406536,0.134766035,0,4.980375124,1.312576641,3.794349959,0.000148031,0.000964486,N,-,,c6 zinc finger domain containing,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR007219 (PFAM); PTHR19444:SF29 (PANTHER); PTHR19444 (PANTHER); PTHR19444 (PANTHER); PTHR19444:SF29 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_08171,3400,3372,3945,0,0,8,0,0,0,0,1,2,0,4,0,0,0,0,0.219478559,1,4.085429105,2.864139389,1.42640722,0.153750831,NA,0.069488734,0,7.312270277,2.253119033,3.24539901,0.001172862,0.015023052,0.181315428,1,4.651319823,1.371475429,3.391471495,0.000695184,0.004304613,0.209238363,1,4.229286874,1.786406255,2.367483243,0.017909531,0.072971429,0.179882637,0,4.561945421,1.272113485,3.586115133,0.000335641,0.001922702,N,-,,short chain dehydrogenase reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); IPR002347 (PANTHER); PTHR24322:SF512 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_08172,414,273,392,1,4,26,0,0,0,0,8,9,1,17,4,0,33,0,0.29087895,1,3.679075737,2.552022305,1.441631497,0.149406358,NA,0.094214609,0,6.873654049,2.155596144,3.188748537,0.001428901,0.015023052,0.242270382,1,4.234473242,1.364136974,3.104140803,0.001908325,0.009542375,0.27931557,1,3.812864499,1.669825112,2.283391519,0.022407316,0.080726669,0.236872184,1,4.16220109,1.271176452,3.274290587,0.001059276,0.005004746,N,-,,lipase esterase family,P:metabolic process; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR013094 (PFAM); PTHR23024 (PANTHER); PTHR23024:SF24 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_08173,1657,1519,3431,0,0,5,0,0,0,2,0,1,0,1,0,0,0,0,0.032487939,1,6.84226532,3.939495098,1.736838135,0.082415746,NA,0.010197597,0,10.08094702,3.360745911,2.999615944,0.002703202,0.015349618,0.026654743,1,7.419931303,1.967412785,3.771415618,0.000162324,0.001552218,0.030769492,1,6.995399016,3.77549234,1.852844182,0.063904696,0.142111804,0.026395646,0,7.338604919,1.431658124,5.125947874,2.96E-07,5.19E-06,N,-,,duf1446 domain containing,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated",IPR010839 (PFAM); PTHR13943:SF48 (PANTHER); PTHR13943 (PANTHER),,
RL4_JR_08174,7077,7822,7060,0,3,8,0,0,0,2,0,3,1,6,1,0,1,0,0.05658288,1,6.041345947,3.925585139,1.538966991,0.123812355,NA,0.018219778,0,9.244833451,2.953367767,3.130268284,0.001746467,0.015023052,0.0468824,1,6.60652857,1.679999875,3.932457774,8.41E-05,0.001045754,0.054062572,1,6.182531851,2.956289749,2.091314579,0.036499874,0.1014442,0.045734665,1,6.537557176,1.34652578,4.855129603,1.20E-06,1.69E-05,N,-,,c6 zinc finger domain containing,"F:metal ion binding; C:membrane; P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR007219 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_08175,4106,3136,3016,0,0,5,0,0,0,0,3,0,7,3,0,0,11,1,12.86021014,1,1.230687961,1.035554898,1.188433335,0.23466273,0.408337957,1.661397605,0,2.733029607,1.341712499,2.036971117,0.041652937,0.102357617,4.324115063,1,0.076294089,1.215169066,0.062784752,0.949937908,0.971235243,4.989096018,1,-0.346229531,1.216692848,-0.284566093,0.775976591,0.855018281,4.281124114,1,-0.011787775,1.221241315,-0.00965229,0.992298707,0.994647992,N,-, Effector probability:0.915,acetoacetate- ligase,F:acetoacetate-CoA ligase activity; P:lipid metabolic process,G3DSA:3.30.300.30 (GENE3D); PTHR24095:SF183 (PANTHER); PTHR24095 (PANTHER); SSF56801 (SUPERFAMILY),,
RL4_JR_08176,9169,8673,5742,0,2,9,0,0,1,0,0,0,0,0,2,0,5,4,26.93064732,1,-1.685132062,1.14020629,-1.47791858,0.139429572,0.281203078,29.67606215,1,1.50732847,1.108036631,1.360359782,0.173716099,0.309569428,26.96392794,0,-1.106329788,1.18804837,-0.931216116,0.351741783,0.495069347,26.07120287,1,-1.543116946,1.139606172,-1.354079141,0.17571113,0.299558039,18.86324851,1,-2.151260206,1.193360951,-1.802690296,0.071436867,0.147081444,N,-,,SET domain-containing,F:metal ion binding; P:peptidyl-lysine monomethylation; F:protein-lysine N-methyltransferase activity,IPR015353 (PFAM); IPR001214 (PFAM); IPR015353 (G3DSA:3.90.1420.GENE3D); IPR002893 (PFAM); G3DSA:3.90.1410.10 (GENE3D); PTHR13271 (PANTHER); PTHR13271:SF36 (PANTHER); IPR002893 (PROSITE_PROFILES); IPR001214 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY); SSF144232 (SUPERFAMILY); IPR015353 (SUPERFAMILY),,
RL4_JR_08177,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.937315829,0,1.990863094,1.554834151,1.280434375,0.200392411,NA,0.298441499,0,5.209834937,1.711220868,3.044513443,0.00233057,0.015159195,0.77666291,0,2.552842278,1.269812138,2.010409415,0.044387875,0.103306401,0.896069484,0,2.13068026,1.333780095,1.597474926,0.110159882,0.211004315,0.769222461,0,2.464556997,1.25003506,1.971590298,0.048656396,0.109647453,N,-,,flavin-binding monooxygenase-like family,F:nucleotide binding; F:coenzyme binding; F:monooxygenase activity,PF13450 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR23023 (PANTHER); PTHR23023:SF29 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_08178,423,370,608,0,0,7,0,0,0,0,0,3,0,1,0,0,0,0,113.7004804,1,0.063227787,0.472628514,0.133779036,0.893577305,0.948082151,18.81539516,0,-0.76830618,1.199815488,-0.640353611,0.521942735,0.671561274,94.94724183,1,-0.268683246,0.659965853,-0.40711689,0.683922139,0.782906799,125.4221936,1,0.070988194,0.498677973,0.142352776,0.886801362,0.930355796,51.83460155,0,-2.567162011,1.114902821,-2.302588138,0.021302027,0.05750014,N,-,,vacuolar membrane,C:membrane,IPR022127 (PFAM); PTHR31735 (PANTHER); PTHR31735 (PANTHER); PTHR31735:SF1 (PANTHER); PTHR31735:SF1 (PANTHER),8.A.65.1.3, the endoplasmic reticulum (er)-plasma membrane (pm) junctional competence regulator (tmem110) family.
RL4_JR_08179,12890,3128,8352,0,0,2,0,0,0,0,0,0,0,1,0,0,0,1,50.31277835,1,2.959854473,0.681374753,4.343945034,1.40E-05,0.000155968,1.306592969,0,3.079755064,1.36769361,2.251787273,0.024335718,0.067100556,3.387097863,0,0.429151262,1.210223496,0.354604966,0.722885555,0.812443757,3.90744552,1,0.006798433,1.211824081,0.005610083,0.995523825,0.996705105,3.333143623,1,0.349518564,1.206466613,0.289704299,0.772042467,0.842341593,N,-,,cell division control 18,P:DNA replication initiation; P:mitotic cell cycle process; F:purine ribonucleoside binding; P:regulation of DNA-dependent DNA replication initiation; P:protein autophosphorylation; P:regulation of mitotic cell cycle; P:cell division; P:peptidyl-amino acid modification; F:purine ribonucleoside triphosphate binding; C:nucleoplasm part; C:protein-DNA complex; F:nucleoside-triphosphatase activity; F:purine ribonucleotide binding; P:regulation of cell cycle process,IPR003593 (SMART); G3DSA:1.10.8.60 (GENE3D); IPR016314 (PIRSF); IPR003593 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10763:SF26 (PANTHER); PTHR10763:SF26 (PANTHER); PTHR10763 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_08180,20,54,57,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,53.97615484,0,-2.804580523,1.164696196,-2.407993203,0.01604048,0.055121412,16.17635432,0,-0.550257551,1.235641877,-0.445321222,0.656087633,0.778421992,54.64959063,0,-1.37673098,1.05516105,-1.304759098,0.191974891,0.315614452,123.4961425,0,0.302103732,0.647062751,0.466884753,0.640582335,0.753735751,104.2199555,0,0.827870754,0.516766721,1.602020254,0.109151131,0.203978442,N,-,,pH-response regulator palF RIM8,P:protein processing; P:invasive growth in response to glucose limitation; P:meiotic nuclear division; C:cytoplasmic side of plasma membrane,IPR011022 (SMART); IPR011021 (PFAM); PTHR11188 (PANTHER); PTHR11188 (PANTHER); PTHR11188:SF80 (PANTHER); PTHR11188:SF80 (PANTHER); PTHR11188 (PANTHER); PTHR11188:SF80 (PANTHER); IPR014756 (SUPERFAMILY),,
RL4_JR_08181,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.166034875,0,0.78290801,1.325357531,0.590714574,0.554711681,0.733323269,0.692996954,0,3.994735277,1.517149166,2.633053734,0.008462096,0.029683219,1.790761186,0,1.348906037,1.249939592,1.079176983,0.280508838,0.419784417,2.065579091,0,0.926647513,1.270430252,0.729396606,0.465759093,0.607550995,1.754620678,0,1.275288719,1.236121943,1.031685204,0.302219611,0.437639239,N,-,,hypothetical protein CMQ_6860,C:membrane,no IPS match,,
RL4_JR_08182,160,665,466,0,0,2,0,0,0,0,0,7,1,0,0,0,0,0,53.83459882,1,-1.20588532,0.853314879,-1.413177422,0.157603563,0.306762878,13.51895344,0,-0.291416398,1.206677204,-0.241503193,0.809165142,0.883821039,114.0232859,1,1.057536564,0.511911399,2.065858596,0.038841833,0.093404922,60.55042851,1,-0.33564721,0.675579735,-0.496828416,0.619310055,0.737100541,34.64716878,0,-3.028455885,1.195170571,-2.533911023,0.011279737,0.03457685,N,-,,arsenite efflux transporter,P:transmembrane transport; C:integral component of membrane,PTHR10283 (PANTHER); PTHR10283:SF21 (PANTHER); PTHR10283 (PANTHER); PTHR10283:SF21 (PANTHER),,
RL4_JR_08183,872,870,985,0,0,3,0,0,0,8,9,64,8,1,24,0,4,6,162.4356025,1,-1.9954762,0.721865523,-2.764332326,0.005703941,0.024235809,40.14119028,0,-1.861525427,1.204803805,-1.545085946,0.122325476,0.237106122,112.5069109,1,-3.558856235,1.2042559,-2.955232551,0.003124335,0.013934257,128.7977366,1,-3.227067243,1.03852945,-3.107343025,0.001887772,0.012641331,103.7954143,1,-4.611381255,1.215824297,-3.792802354,0.000148957,0.000968649,N,-,,Phosphoribosylaminoimidazole carboxylase,F:ATP binding; F:phosphoribosylaminoimidazole carboxylase activity; C:cytoplasm; F:metal ion binding; P:'de novo' IMP biosynthetic process; P:purine nucleobase metabolic process,IPR000031 (SMART); IPR013815 (G3DSA:3.30.1490.GENE3D); IPR000031 (TIGRFAM); IPR016185 (G3DSA:3.40.50.GENE3D); IPR013816 (G3DSA:3.30.470.GENE3D); IPR000031 (PFAM); IPR005875 (TIGRFAM); IPR000031 (G3DSA:3.40.50.GENE3D); IPR003135 (PFAM); PTHR11609:SF5 (PANTHER); PTHR11609 (PANTHER); IPR033747 (HAMAP); IPR011761 (PROSITE_PROFILES); IPR005875 (HAMAP); SSF56059 (SUPERFAMILY); IPR000031 (SUPERFAMILY); IPR011054 (SUPERFAMILY); IPR016185 (SUPERFAMILY),,
RL4_JR_08184,1527,895,1763,0,0,4,1,0,0,0,0,1,0,0,0,0,1,3,45.77624789,1,0.005002543,0.796213627,0.006282916,0.994986991,0.997870116,17.12448139,1,1.426423497,1.152701295,1.237461521,0.215915791,0.362678334,20.04236265,1,-2.135916288,1.214200973,-1.759112648,0.078558377,0.160477201,23.11995584,0,-2.558173132,1.215374954,-2.104842726,0.035305001,0.099766434,19.66626341,1,-2.211399889,1.215335361,-1.819579978,0.068822993,0.143086818,N,-,,molybdenum cofactor sulfurase,F:catalytic activity; F:ion binding,IPR000192 (PFAM); IPR005303 (PFAM); IPR015421 (G3DSA:3.40.640.GENE3D); IPR005302 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); PTHR14237:SF21 (PANTHER); PTHR14237 (PANTHER); PTHR14237:SF21 (PANTHER); PTHR14237 (PANTHER); IPR005302 (PROSITE_PROFILES); IPR028886 (HAMAP); IPR015424 (SUPERFAMILY); IPR011037 (SUPERFAMILY); SSF141673 (SUPERFAMILY),,
RL4_JR_08185,1054,1349,2289,0,0,0,0,0,0,0,5,0,0,0,0,0,6,0,115.8289347,0,1.675909546,0.681304896,2.459852493,0.013899413,0.049408022,9.762197855,0,0.178245885,1.226836763,0.145288999,0.8844827,0.934426328,25.45134041,1,-2.480755698,1.203970187,-2.060479341,0.039352739,0.094409272,37.39213063,0,-1.185716208,1.03525367,-1.145338812,0.252068834,0.391737715,41.2602247,1,-1.632710072,1.143492984,-1.427826926,0.153341681,0.263149918,N,-, Effector probability:0.679,UMP-CMP kinase,C:nucleus; F:cytidylate kinase activity; F:ATP binding; F:uridylate kinase activity; P:nucleotide phosphorylation; P:'de novo' pyrimidine nucleobase biosynthetic process; C:cytoplasm; C:integral component of membrane; P:pyrimidine nucleotide biosynthetic process,IPR000850 (PRINTS); IPR027417 (G3DSA:3.40.50.GENE3D); IPR006266 (TIGRFAM); PF00406 (PFAM); IPR000850 (PANTHER); PTHR23359:SF107 (PANTHER); IPR000850 (HAMAP); IPR006266 (HAMAP); IPR027417 (SUPERFAMILY),,
RL4_JR_08186,2745,1835,1794,0,5,8,0,0,1,0,0,3,1,2,0,0,0,0,358.9562442,1,-1.617368264,0.495825563,-3.261970311,0.001106407,0.00638336,89.96985097,1,-3.025868813,1.191891753,-2.538711091,0.011126166,0.036462632,290.9985255,1,-2.04864354,0.591237615,-3.465008805,0.000530214,0.00353383,286.2933032,1,-3.401524791,0.763784807,-4.453511982,8.45E-06,0.000123424,239.5168866,0,-4.110082272,0.999472972,-4.112249543,3.92E-05,0.000315528,N,-,,Eukaryotic translation initiation factor 3 subunit M,C:nucleus; F:translation initiation factor activity; P:formation of translation preinitiation complex; C:eukaryotic 43S preinitiation complex; P:cytoplasmic translational initiation; C:cytosol; C:eukaryotic 48S preinitiation complex; P:regulation of translational initiation; C:eukaryotic translation initiation factor 3 complex,IPR000717 (SMART); SM00753 (SMART); IPR000717 (PFAM); PTHR15350:SF2 (PANTHER); PTHR15350 (PANTHER),,
RL4_JR_08187,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.31554004,0,2.197398268,1.031218766,2.13087498,0.033099443,0.097658321,0.853920365,0,3.693394072,1.437559194,2.569211819,0.010193013,0.034005827,2.21408955,0,1.042540918,1.219373551,0.854980754,0.392561802,0.535880503,2.55427834,0,0.620129774,1.227320503,0.505271258,0.613368327,0.732713144,2.179103306,0,0.962747156,1.212186988,0.794223305,0.427065444,0.561563327,Y,-,,sterol esterase precursor,F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR002018 (PFAM); PTHR11559 (PANTHER); PTHR11559:SF162 (PANTHER); IPR029058 (SUPERFAMILY),8.A.117.1.3, the neuroligin (nlg) family.
RL4_JR_08188,94505,110443,143382,67,108,120,0,4,14,18,32,80,13,71,61,0,38,28,29.19422135,1,-1.819747367,1.136336157,-1.601416409,0.109284721,0.236233374,8.125910599,1,0.443011929,1.223093574,0.36220608,0.717198036,0.823038735,43.17539282,1,-0.377011629,1.027290071,-0.366996275,0.713621797,0.806418916,62.94577354,1,0.902323725,0.567997901,1.588603979,0.112149829,0.213282686,20.69342423,1,-2.284917677,1.188554539,-1.922434017,0.054551169,0.119707539,N,-,,serine threonine- kinase chk2,F:ATP binding; P:cell cycle checkpoint; F:protein serine/threonine kinase activity; P:protein phosphorylation,IPR000719 (SMART); IPR000253 (SMART); IPR000253 (PFAM); IPR000253 (G3DSA:2.60.200.GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR020636 (PANTHER); PTHR24347:SF253 (PANTHER); PTHR24347:SF253 (PANTHER); IPR020636 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR000253 (PROSITE_PROFILES); IPR008984 (SUPERFAMILY); IPR011009 (SUPERFAMILY),8.A.104.1.3, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_08189,5857,6635,8410,0,2,5,0,0,0,0,0,1,0,2,0,0,4,1,27.20417518,1,0.195284109,0.903593378,0.216119455,0.828894635,0.914541849,5.09117367,0,1.11758858,1.290959623,0.865703744,0.386652646,0.551278876,20.93520477,1,-0.559785079,1.216658896,-0.460100264,0.645444255,0.753167085,15.09516351,1,-1.94313754,1.22072426,-1.591790712,0.111431738,0.212475771,12.78667057,1,-1.590410546,1.216537634,-1.307325398,0.191102222,0.311278957,Y,-,,---NA---,,no IPS match,,
RL4_JR_08190,87,39,82,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,139.2461798,0,-0.682741549,0.675090436,-1.011333464,0.311856855,0.5000252,27.03656073,0,-1.29129845,1.237416405,-1.043543988,0.296696419,0.456546238,114.9891401,0,-0.349311182,0.664146299,-0.525955173,0.598919353,0.717921094,84.13862685,0,-3.406362216,1.176177543,-2.896129275,0.003777967,0.022474688,79.4448943,0,-1.814264964,0.885176113,-2.049609042,0.040402597,0.095001463,N,-,,arf GTPase activator,F:GTPase activator activity; P:positive regulation of GTPase activity,IPR001164 (SMART); IPR001849 (SMART); IPR027267 (G3DSA:1.20.1270.GENE3D); IPR001849 (PFAM); IPR001164 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); PF16746 (PFAM); PTHR23180 (PANTHER); PTHR23180 (PANTHER); PTHR23180:SF203 (PANTHER); PTHR23180:SF203 (PANTHER); PTHR23180 (PANTHER); PTHR23180:SF203 (PANTHER); IPR001849 (PROSITE_PROFILES); IPR001164 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY); SSF103657 (SUPERFAMILY); SSF57863 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_08191,2173,2530,1650,6,9,18,0,0,0,0,0,2,0,0,0,0,5,3,59.14470051,1,-0.70624412,0.784995718,-0.899678946,0.368291131,0.560231036,12.8204258,0,-0.214818094,1.245448487,-0.17248252,0.863058202,0.920146948,44.06707377,1,-1.893465613,1.21079587,-1.563819022,0.117860076,0.219018981,58.10418233,0,-0.285174871,0.732894199,-0.389107829,0.697196382,0.795975132,51.57387399,1,-0.025930428,0.719867972,-0.036021089,0.971265544,0.980367224,N,-,,c2 domain containing,F:magnesium ion binding; F:inorganic diphosphatase activity; C:endoplasmic reticulum; P:phosphate-containing compound metabolic process,IPR000008 (SMART); IPR008528 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR000008 (PFAM); IPR019558 (PFAM); PTHR10774 (PANTHER); IPR014772 (PROSITE_PROFILES); IPR014770 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (SUPERFAMILY),1.F.1.2.1, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_08192,28064,30301,34629,7,18,104,6,0,5,8,1,7,8,50,4,0,9,9,621.0496348,1,0.273966739,0.708360079,0.386761969,0.698932434,0.837360613,91.57589504,1,-3.051395121,1.193630809,-2.556397757,0.010576215,0.035087658,294.4408869,1,-2.079872835,0.592467621,-3.510525743,0.000447222,0.003122531,414.8037118,1,-0.854812376,0.384430983,-2.22357826,0.026176833,0.086220049,361.0092614,1,-0.614615162,0.493524942,-1.245357854,0.213000238,0.337394776,N,-,,inorganic pyrophosphatase,F:magnesium ion binding; C:nucleus; F:inorganic diphosphatase activity; C:cytoplasm; P:phosphate-containing compound metabolic process,IPR008162 (PFAM); IPR008162 (G3DSA:3.90.80.GENE3D); IPR008162 (PANTHER); IPR008162 (SUPERFAMILY),,
RL4_JR_08193,26,45,44,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,59.8674227,0,-4.006040335,1.198110966,-3.343630471,0.000826898,0.00511048,47.148534,0,1.399371578,0.855036696,1.636621661,0.101709547,0.205407828,79.51826674,0,-0.618516017,0.749985653,-0.824703798,0.409539775,0.551794075,70.7516403,0,-2.128107051,1.02098671,-2.084363127,0.037127149,0.102428443,52.82408631,0,-2.597925758,1.132054833,-2.294876257,0.021740217,0.058433686,N,-, Effector probability:0.791,mitochondrial ribosomal l44,F:structural constituent of ribosome; P:mitochondrial translation; C:mitochondrial large ribosomal subunit,IPR019716 (PFAM); PTHR28236:SF1 (PANTHER); PTHR28236 (PANTHER),,
RL4_JR_08194,33902,23328,23515,0,9,8,1,0,5,0,5,5,1,7,4,0,5,1,57.67949035,1,-0.356124017,0.693162282,-0.51376716,0.607414791,0.773659619,12.28484396,1,-0.153332933,1.213521832,-0.126353666,0.899451977,0.944130759,38.44430116,1,-1.846826809,1.195541066,-1.544762335,0.122403761,0.225189111,65.43965008,1,-0.891315736,0.856189208,-1.041026595,0.297863205,0.44292333,62.47556509,1,0.656932401,0.601656012,1.091873741,0.274888601,0.407682303,N,-,,Sec20 domain-containing,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,IPR005606 (PFAM); PTHR12825:SF0 (PANTHER); PTHR12825 (PANTHER),,
RL4_JR_08195,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,284.4819862,0,0.587302308,0.628130613,0.935000295,0.349788147,0.539953526,63.39967591,0,0.472866752,0.920082426,0.513939555,0.607294252,0.740517096,555.43091,0,2.390400484,0.508500576,4.700880584,2.59E-06,6.02E-05,348.8167645,0,1.129661204,0.623015556,1.813215084,0.069798654,0.150492201,285.7610865,0,1.244678531,0.473199006,2.630348997,0.008529725,0.027662866,N,-,,pt repeat family,,no IPS match,,
RL4_JR_08196,3058,3301,4337,0,0,5,0,0,0,0,0,1,2,2,7,0,1,0,8.801402429,1,3.340306533,1.185033475,2.818744452,0.004821188,0.021089145,9.760467833,0,5.761546559,1.274276329,4.521426342,6.14E-06,0.000425847,0.97385777,1,2.227443259,1.363787846,1.633276954,0.102410762,0.197036593,1.122170426,1,1.806652552,1.44767442,1.24796883,0.212042472,0.346174058,0.943718179,1,2.169266221,1.330405632,1.630529944,0.102989542,0.195275115,N,-,,---NA---,,no IPS match,,
RL4_JR_08197,437,476,699,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,108.1083355,1,3.406594933,0.523920463,6.502122314,7.92E-11,2.78E-09,2.782509456,0,1.989219584,1.321161359,1.505659827,0.132154522,0.250265308,33.15841964,0,2.152495529,0.779719376,2.760602846,0.005769479,0.021140139,30.89612961,0,1.256881127,0.8784826,1.430741062,0.15250444,0.26943072,14.36982565,0,0.215327945,1.138665887,0.189105468,0.850010156,0.900246112,N,-,,septin,F:GTP binding,IPR027417 (G3DSA:3.40.50.GENE3D); IPR030379 (PFAM); PTHR18884:SF70 (PANTHER); IPR016491 (PANTHER); IPR016491 (PANTHER); IPR030379 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_08198,7034,4131,6062,0,2,3,0,0,0,0,5,3,2,3,0,0,3,1,73.71434955,1,4.013634263,0.79231794,5.065686464,4.07E-07,6.89E-06,1.355633614,0,3.026615615,1.567730329,1.930571578,0.053536056,0.124544232,25.60382112,1,2.282583103,1.149705082,1.985364019,0.047103986,0.108136226,3.991457609,1,-0.024131532,1.367407916,-0.017647647,0.985919946,0.991501733,3.370204714,1,0.333191556,1.339692557,0.248707477,0.803587065,0.867596399,N,-,,response regulator receiver domain-containing,,IPR009783 (PFAM); IPR032710 (G3DSA:3.10.450.GENE3D); PTHR31757:SF0 (PANTHER); PTHR31757 (PANTHER); PTHR31757:SF0 (PANTHER); PTHR31757 (PANTHER); IPR032710 (SUPERFAMILY); IPR032710 (SUPERFAMILY),,
RL4_JR_08199,1096,1628,1177,8,1,0,0,0,0,0,0,1,2,2,7,5,0,5,212.3362102,1,-0.859603675,0.438517516,-1.960249348,0.049966653,0.132648212,45.96951527,0,-2.057092715,1.193564087,-1.723487442,0.084800414,0.177988102,147.8598076,1,-2.295608346,0.849164242,-2.70337378,0.006863951,0.024212767,173.6331737,1,-1.27673729,0.530370603,-2.407255007,0.016072942,0.068435047,129.1284024,1,-2.588936399,0.849270487,-3.048423839,0.002300452,0.009561608,N,-,,transmembrane pft27,C:cis-Golgi network; C:integral component of membrane; C:fungal-type vacuole; C:Golgi medial cisterna; P:cellular calcium ion homeostasis,IPR001727 (PFAM); PTHR12608:SF1 (PANTHER); IPR001727 (PANTHER); PTHR12608:SF1 (PANTHER),2.A.106.2.5, the ca(2+):h(+) antiporter-2 (caca2) family.
RL4_JR_08200,5341,3896,5037,0,0,11,0,0,0,0,2,5,3,0,0,0,1,1,0.517384129,1,2.848390971,1.940334831,1.467989403,0.142107101,NA,0.166088899,0,6.055642145,1.89761941,3.191178438,0.001416937,0.015023052,0.428966352,1,3.410609093,1.280181367,2.664160862,0.007718065,0.026631795,0.494736378,1,2.988299836,1.413262673,2.114468806,0.034475246,0.099396379,0.420739879,1,3.335021292,1.229217052,2.713126445,0.006665167,0.022729813,N,-,,---NA---,,no IPS match,,
RL4_JR_08201,2391,2579,4049,0,0,0,0,0,0,0,0,0,1,2,0,0,0,0,8.994174171,0,0.471181736,1.178958395,0.399659341,0.689407443,0.831135544,1.636160645,0,2.755100925,1.351255611,2.038919137,0.041458099,0.102002643,4.271242135,0,0.094161552,1.223735631,0.076945992,0.93866651,0.963506007,14.56459232,1,0.623460522,1.166314626,0.534556035,0.592956892,0.716174225,4.237532378,0,0.003102807,1.232087028,0.002518334,0.997990662,0.99848374,N,-,,hypothetical protein CMQ_8102,,no IPS match,,
RL4_JR_08202,2702,2262,4587,3,0,2,0,0,0,0,0,0,0,5,0,0,0,0,1.534665541,1,1.280037856,1.468231177,0.8718231,0.383304891,NA,0.487832395,0,4.501176704,1.634858979,2.753250747,0.005900668,0.023030924,1.264641805,0,1.850765917,1.293239679,1.431108206,0.152399206,0.265603298,1.459098771,1,1.428102501,1.339389071,1.066234249,0.286317764,0.430624979,1.242001319,0,1.773970228,1.276743551,1.389449139,0.164696217,0.27765237,N,-,,hypothetical protein CMQ_8271,,no IPS match,,
RL4_JR_08203,66716,31024,54259,4,23,15,3,0,8,6,10,14,5,12,5,0,3,8,0.084809417,1,5.457384388,3.919330498,1.39242771,0.163792918,NA,44.65069772,1,10.36890755,1.046867836,9.904695886,3.97E-23,2.51E-20,0.06992558,1,6.028212854,1.555214549,3.87612941,0.000106131,0.001209992,0.080684845,1,5.604610312,2.52703077,2.217863897,0.026564114,0.086566351,0.068916211,1,5.94877668,1.316856162,4.517408091,6.26E-06,6.85E-05,N,-,,hypothetical protein CMQ_8089,,no IPS match,,
RL4_JR_08204,40677,28839,40669,7,9,27,0,0,2,0,1,2,3,12,2,0,6,5,0.149304922,1,4.640982944,3.497180004,1.32706436,0.184487394,NA,0.047908156,1,7.848682089,2.551547107,3.07604828,0.002097639,0.015023052,0.124347944,1,5.194706619,1.574426179,3.299428509,0.000968819,0.005604756,0.143422919,1,4.773844051,2.209565488,2.160535217,0.03073126,0.093834141,0.123101106,1,5.106363052,1.394221574,3.662519034,0.000249747,0.001507865,Y,-,,hypothetical protein CMQ_8200,,no IPS match,,
RL4_JR_08205,945,484,1294,7,1,5,0,0,0,0,0,0,0,0,0,0,0,0,203.7532109,1,1.442628737,0.528018553,2.732155391,0.006292146,0.026216202,19.12791695,0,-0.792084762,1.198529421,-0.660880532,0.508688932,0.660799457,132.3197773,0,0.704079371,0.477809643,1.473556219,0.140601117,0.249814971,174.8624109,0,1.235910081,0.35270939,3.504046438,0.000458245,0.003889133,56.57397465,0,-1.852957034,0.968327087,-1.913565218,0.055675733,0.121582353,N,-,,sh3 domain containing,"P:propionate catabolic process, 2-methylcitrate cycle; C:cytoplasm; C:membrane; F:lyase activity; C:integral component of membrane; F:2-methylcitrate dehydratase activity; F:2 iron, 2 sulfur cluster binding",IPR001452 (PRINTS); IPR001452 (SMART); G3DSA:2.30.30.40 (GENE3D); IPR001452 (PFAM); PTHR10663 (PANTHER); PTHR10663:SF216 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY),8.A.23.1.12, the basigin (basigin) family.
RL4_JR_08206,330,419,381,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.010701897,0,0.307795323,1.317428654,0.23363339,0.815269603,0.906040195,0.953205036,0,3.534674997,1.469965997,2.404596436,0.016190334,0.04896282,2.480129972,0,0.878753379,1.257351473,0.698892393,0.484619282,0.620420538,2.861994614,0,0.455957614,1.273867265,0.357931809,0.720394346,0.813244816,2.447148377,0,0.795373187,1.256203962,0.633156089,0.526631718,0.650451312,N,-,,---NA---,,no IPS match,,
RL4_JR_08207,63,18,20,0,0,0,0,0,0,0,0,0,0,0,2,0,6,0,2.601960595,0,0.51834593,1.287768991,0.402514685,0.687305283,0.829811529,0.834176123,0,3.72723141,1.474384153,2.527992045,0.011471695,0.037329975,2.153526292,0,1.082726671,1.239331015,0.873638001,0.382315424,0.526034433,2.483812205,1,0.660612338,1.252937302,0.527250914,0.598019356,0.720569557,2.108756621,1,1.009957756,1.226763124,0.823270391,0.410354248,0.546257791,N,-,,hypothetical protein SPSK_03119,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_08208,34808,30113,29008,1,4,6,0,0,0,10,1,8,3,9,2,0,3,5,1.067214091,1,1.80388549,1.490777619,1.210029898,0.226267421,NA,0.337842393,0,5.031005691,1.66491541,3.02177856,0.002512943,0.015349618,0.880532061,1,2.372413157,1.258411576,1.885244226,0.059396872,0.129180223,1.016129217,1,1.949676568,1.309660841,1.488688145,0.136569508,0.248118836,0.871618753,1,2.28499074,1.242058646,1.839680233,0.065815197,0.138540306,N,-,,c6 zinc finger domain containing,"F:DNA binding; C:nucleus; F:zinc ion binding; F:carboxypeptidase activity; P:proteolysis; F:serine-type carboxypeptidase activity; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31001 (PANTHER); PTHR31001 (PANTHER); PTHR31001:SF4 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_08209,3056,3431,2507,0,0,9,0,0,0,0,4,0,0,4,0,0,0,0,34.72056571,1,-3.220111027,1.210802434,-2.659485095,0.007826019,0.031265752,11.0419214,0,0.000544821,1.23127145,0.000442487,0.999646947,0.999866719,35.25061889,1,-1.694871725,1.20710085,-1.404084609,0.160293656,0.275656322,33.17386103,1,-3.079218929,1.209421599,-2.546026076,0.010895705,0.05207089,28.48751756,0,-2.746049571,1.217515366,-2.255453727,0.024104864,0.063310439,N,-,,5-methylcytosine g t mismatch-specific dna,,no IPS match,,
RL4_JR_08210,2384,2203,1735,0,1,6,0,0,0,1,0,1,1,2,0,0,0,4,41.1735075,1,-3.466001109,1.242312288,-2.789959612,0.005271462,0.022681743,12.97139411,0,-0.231809876,1.248875929,-0.185614816,0.852746834,0.912614026,57.51187823,1,-0.487705341,0.906457602,-0.538034366,0.590553323,0.710151068,62.50698063,1,-0.978964931,0.910263472,-1.075474256,0.282162452,0.42576674,41.24030858,1,-2.051824849,1.173377024,-1.748649247,0.080351668,0.161705382,N,-,,exosome complex exonuclease rrp40,"C:cytoplasmic exosome (RNase complex); C:nuclear exosome (RNase complex); F:RNA binding; P:nuclear polyadenylation-dependent rRNA catabolic process; F:exonuclease activity; P:nuclear-transcribed mRNA catabolic process, exonucleolytic; F:manganese ion binding; P:nuclear polyadenylation-dependent tRNA catabolic process; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",IPR004088 (PFAM); PTHR21321:SF1 (PANTHER); IPR026699 (PANTHER); IPR012340 (SUPERFAMILY); IPR004088 (SUPERFAMILY),,
RL4_JR_08211,0,0,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36.31920813,0,-2.177733093,1.150193375,-1.893362578,0.058309668,0.149252583,87.0489234,0,1.763112555,0.984539045,1.790800033,0.07332539,0.159338686,50.46916282,0,-0.153429168,0.861616032,-0.178071394,0.858666907,0.909895726,52.42536531,0,-0.266186928,0.758846583,-0.350778317,0.725754665,0.817382201,26.6025373,0,-2.647294858,1.203776886,-2.19915741,0.027866732,0.071032667,N,-,,zinc finger 2,F:nucleic acid binding; F:metal ion binding; C:integral component of membrane,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY),,
RL4_JR_08212,1768,2341,2104,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,344.8940595,0,-0.54582659,0.544138732,-1.003101889,0.315811703,0.50408763,65.17976966,0,-2.560827346,1.218226594,-2.102094437,0.035545004,0.090307864,190.0987647,0,-3.361608766,1.054107077,-3.18905815,0.001427372,0.007609642,225.7608272,0,-2.010146066,0.647949562,-3.102318736,0.001920111,0.012815507,179.9987848,0,-2.69576637,0.800650699,-3.366969357,0.000759991,0.003832886,N,-,,sulfate adenylyltransferase,P:methionine biosynthetic process; F:ATP binding; P:hydrogen sulfide biosynthetic process; P:sulfur amino acid metabolic process; C:cytoplasm; P:cysteine biosynthetic process; F:adenylylsulfate kinase activity; F:sulfate adenylyltransferase (ATP) activity; P:phosphorylation; P:sulfate assimilation,IPR002650 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR002891 (TIGRFAM); IPR014729 (G3DSA:3.40.50.GENE3D); IPR024951 (PFAM); PF01583 (PFAM); G3DSA:3.10.400.10 (GENE3D); IPR025980 (PFAM); PTHR11055 (PANTHER); IPR027535 (HAMAP); IPR027417 (SUPERFAMILY); SSF52374 (SUPERFAMILY); IPR015947 (SUPERFAMILY),,
RL4_JR_08213,6524,3322,4657,0,1,20,1,1,1,12,13,4,42,60,12,0,115,12,130.7668967,1,1.20576981,1.082159782,1.114225302,0.265182543,0.445044063,12.6411823,1,-0.194506261,1.288986411,-0.150898612,0.880055695,0.931615043,51.87481333,1,-0.448441602,0.933505284,-0.480384642,0.630953913,0.741643726,66.69176785,1,-0.011176504,0.747021277,-0.014961427,0.988062954,0.992966492,35.36693759,1,-1.965017545,1.17398163,-1.673806042,0.094168724,0.182445146,N,-,,transcription mediator subunit med12,P:regulation of transcription from RNA polymerase II promoter,IPR019035 (SMART); IPR019035 (PFAM); PTHR13992 (PANTHER),,
RL4_JR_08214,4837,5242,4264,0,10,18,0,0,0,0,2,9,11,27,2,0,26,11,123.1679837,1,1.191877838,0.694711586,1.715644104,0.086227201,0.198667424,13.35319323,0,-0.273653984,1.224292712,-0.223520063,0.82313077,0.893527365,47.86731976,1,-1.120310768,1.054820048,-1.062087102,0.288196145,0.427752202,79.24758199,1,0.153911244,0.62299423,0.247050834,0.804868883,0.875305242,87.95545475,1,1.080576823,0.568723354,1.900004307,0.057432554,0.124279678,N,-, Effector probability:0.562,family UPF0139,C:integral component of membrane,IPR005351 (PFAM); PTHR28038:SF1 (PANTHER); PTHR28038 (PANTHER),,
RL4_JR_08215,82,65,118,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,413.829227,0,-4.058673995,0.794647411,-5.107515532,3.26E-07,5.67E-06,126.378981,0,-3.516104437,1.196878126,-2.937729717,0.003306251,0.016316858,337.1060206,0,-5.21231509,1.202295038,-4.335304502,1.46E-05,0.000259443,464.0431526,1,-1.888456196,0.494437481,-3.819403401,0.000133775,0.001368152,380.0680885,0,-2.181936657,0.819728356,-2.661780137,0.007772863,0.025651968,N,-,,hsp70 chaperone,F:ATP binding,IPR013126 (PRINTS); G3DSA:3.90.640.10 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR013126 (PFAM); G3DSA:3.30.30.30 (GENE3D); G3DSA:3.30.420.40 (GENE3D); PTHR19375:SF177 (PANTHER); PTHR19375 (PANTHER); PTHR19375:SF177 (PANTHER); PTHR19375 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),1.A.33.1.6, the cation channel-forming heat shock protein-70 (hsp70) family.
RL4_JR_08216,19,9,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,92.89450857,0,-0.321865726,0.624580187,-0.515331311,0.606321523,0.772991246,170.3270845,0,2.970353935,1.732779276,1.714213677,0.08648949,0.180952174,77.50895184,0,-0.849477685,0.86874769,-0.97781864,0.32816403,0.471052409,103.7715425,0,0.177127906,0.554851836,0.319234604,0.749548618,0.835076998,67.10712568,0,-0.233651375,0.69377629,-0.336782012,0.736281234,0.815628829,N,-,,Nucleoporin NUP53,C:nucleus; C:nuclear membrane; F:protein binding; C:membrane; P:protein transport; P:transport; P:mRNA transport; C:nuclear pore,no IPS match,1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_08217,2054,2450,3896,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0.125109386,1,4.896465465,3.640581595,1.344967923,0.178635594,NA,0.039777751,0,8.117559146,2.523430194,3.216874858,0.001295951,0.015023052,0.103241797,0,5.46602912,1.46464218,3.73198942,0.000189973,0.001705046,0.119117264,1,5.042617291,2.18050463,2.312591876,0.020745089,0.07808328,0.101641581,0,5.387231055,1.291773189,4.170415598,3.04E-05,0.000255685,N,-, Effector probability:0.838,---NA---,,no IPS match,,
RL4_JR_08218,710,723,1220,0,0,1,0,0,0,3,0,0,0,0,0,0,0,0,96.87758487,1,2.549270164,0.780189076,3.267503021,0.001085007,0.006295511,138.80832,0,4.752567517,1.554291977,3.057705751,0.002230385,0.015045494,12.87783421,1,-1.497806762,1.24510218,-1.20295891,0.228992222,0.359987151,92.37216178,0,2.646501181,0.754441913,3.507892569,0.000451671,0.00385461,91.67837179,0,2.88399667,0.580871158,4.964950712,6.87E-07,1.06E-05,N,-,,2-methylcitrate dehydratase,,IPR012705 (TIGRFAM); G3DSA:3.30.1330.120 (GENE3D); IPR005656 (PFAM); PTHR16943:SF19 (PANTHER); IPR005656 (PANTHER); IPR005656 (SUPERFAMILY),,
RL4_JR_08219,6544,4907,4731,5,4,8,5,0,0,3,4,3,2,2,3,0,1,4,7.387497519,1,1.006615911,1.19037123,0.845631922,0.397758112,0.590198377,1.155900798,1,3.256608449,1.442915917,2.256963424,0.02401036,0.066469157,2.971231123,1,0.618024539,1.244587967,0.496569592,0.619492601,0.733316088,26.70770727,1,2.533411978,0.895539278,2.828923353,0.004670488,0.026581616,2.902752088,1,0.548543161,1.234465792,0.444356713,0.656784705,0.755418055,N,-,,allantoate permease,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF256 (PANTHER); PTHR11662:SF256 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.43, the major facilitator superfamily (mfs).
RL4_JR_08220,1584,1846,1989,0,12,36,0,0,3,0,4,2,1,26,3,0,29,2,0.888100318,1,2.06885812,1.53317086,1.349398279,0.177209073,NA,0.285358858,1,5.274770465,1.71282485,3.079573761,0.00207297,0.015023052,0.7369891,1,2.629491857,1.250927333,2.102034056,0.035550293,0.087187782,0.849958065,1,2.207450562,1.309115791,1.686214907,0.091754414,0.183558901,0.723215699,1,2.553281274,1.219574941,2.093582927,0.03629715,0.08722265,N,-,,family Taurine catabolism dioxygenase,F:dioxygenase activity; P:metabolic process,IPR003819 (PFAM); G3DSA:3.60.130.10 (GENE3D); PTHR30468:SF12 (PANTHER); PTHR30468 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_08221,1741,2057,1738,0,8,18,0,0,0,0,0,0,0,1,2,0,2,0,0.608973447,1,2.613225372,1.877732284,1.391692199,0.164015626,NA,0.197501432,0,5.805861784,1.889953552,3.071960038,0.002126582,0.015045494,0.506818226,0,3.170063293,1.318357119,2.404555828,0.016192133,0.047310001,0.584275202,1,2.74836954,1.446011389,1.900655528,0.057347147,0.133419087,0.493903584,1,3.103154089,1.264203401,2.454631974,0.014102889,0.041340981,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF242 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_08222,2345,2381,4088,0,0,1,0,0,0,0,0,2,0,0,0,0,0,1,4.511251764,1,-0.275598944,1.27779437,-0.21568333,0.829234596,0.914669529,1.435746678,0,2.943791089,1.410475595,2.08709112,0.036879899,0.093068645,3.721163467,1,0.293478545,1.246762589,0.235392486,0.813904117,0.879140943,12.31633069,0,1.572717008,1.074500538,1.46367261,0.143283423,0.257222816,3.655638524,1,0.216263996,1.245286876,0.173666004,0.862127956,0.908140403,N,-,,xenobiotic compound family,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity",IPR016215 (TIGRFAM); IPR016215 (PIRSF); IPR011251 (G3DSA:3.20.20.GENE3D); IPR011251 (PFAM); PTHR30011 (PANTHER); PTHR30011:SF30 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_08223,195,200,186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.21808622,0,4.094804772,2.879552147,1.422028344,0.155018023,NA,0.06953065,0,7.311934953,2.266037999,3.226748606,0.001252054,0.015023052,0.180109677,0,4.66329554,1.3809926,3.376770839,0.000733421,0.004497369,0.207780791,0,4.240039307,1.801141228,2.354084867,0.018568371,0.074262186,0.176936754,0,4.586583217,1.270393641,3.610363804,0.000305768,0.00177619,N,-,,hypothetical protein SPBR_06321,"C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); F:hydrogen ion transmembrane transporter activity; C:membrane; C:integral component of membrane; P:ATP synthesis coupled proton transport",no IPS match,,
RL4_JR_08224,134,94,98,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,FAD NAD(P)-binding domain-containing,F:nucleotide binding; F:coenzyme binding; F:monooxygenase activity,IPR000960 (PRINTS); IPR020946 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR23023:SF76 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_08225,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.555264921,0,1.260689143,1.324341049,0.951936923,0.341128973,NA,0.497134341,0,4.473892309,1.552368857,2.881977624,0.003951878,0.01798602,1.287000772,0,1.825375395,1.229471228,1.484683297,0.137627738,0.245956439,1.484585403,0,1.40303172,1.251792289,1.120818312,0.262365208,0.40279723,1.264848666,0,1.747508051,1.212514649,1.441226341,0.149520749,0.25821006,N,-,,alpha-ketoglutarate-dependent sulfonate dioxygenase,F:dioxygenase activity; P:oxidation-reduction process,IPR003819 (PFAM); G3DSA:3.60.130.10 (GENE3D); PTHR30468:SF16 (PANTHER); PTHR30468 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_08226,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.16710868,0,3.08350043,0.738497672,4.175369193,2.98E-05,0.000296341,0.92388966,0,3.579733865,1.410177487,2.538498804,0.011132918,0.036468414,2.395534495,0,0.928600959,1.206723545,0.769522534,0.441583173,0.5813896,2.763434659,0,0.506318247,1.209978124,0.418452398,0.675616384,0.779024699,2.360176814,0,0.847355258,1.201402045,0.705305323,0.480620248,0.60965673,Y,-,,triacylglycerol lipase,,IPR029058 (G3DSA:3.40.50.GENE3D); IPR002018 (PFAM); PTHR11559:SF206 (PANTHER); PTHR11559:SF206 (PANTHER); PTHR11559 (PANTHER); IPR029058 (SUPERFAMILY),8.A.117.1.3, the neuroligin (nlg) family.
RL4_JR_08227,53,48,87,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29.43315024,0,0.000647318,0.91035395,0.000711062,0.999432655,0.999877636,5.81821202,0,0.924982946,1.289052955,0.717567841,0.473023792,0.630791386,87.97740913,0,2.281087461,0.570330311,3.99959009,6.35E-05,0.000864885,58.19952848,0,1.188222757,0.679371225,1.749003658,0.080290387,0.166791171,18.50469624,0,-0.858223542,1.153354614,-0.744110729,0.456809489,0.58838156,N,-,,homeobox transcription factor,,IPR001356 (SMART); IPR009057 (G3DSA:1.10.10.GENE3D); IPR001356 (PFAM); PTHR24341 (PANTHER); IPR001356 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY),,
RL4_JR_08228,380,466,309,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,195.5159089,0,-0.98758599,0.576699226,-1.712480173,0.086808215,0.199417297,44.16800297,0,-1.999392478,1.220956872,-1.637561919,0.101513112,0.20505203,192.7710598,0,-0.496089561,0.545870502,-0.908804486,0.363453338,0.507567331,177.9407063,0,-1.211087025,0.575712405,-2.103631978,0.035410562,0.099858856,177.0187181,0,-1.04551871,0.581032764,-1.799414379,0.071953157,0.147954044,N,-,,map kinase kinase kinase wis4,F:ATP binding; P:activation of MAPKK activity; C:cytoplasm; F:MAP kinase kinase kinase activity; P:stress-activated MAPK cascade,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24361 (PANTHER); PTHR24361:SF358 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_08229,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,64.57160727,0,1.516597942,0.533635193,2.842012596,0.004482972,0.019865337,5.534816596,0,0.997025156,1.243671,0.801679187,0.422738558,0.585837854,27.30781572,0,0.169912838,1.03315575,0.164460042,0.869369,0.917299818,20.51673105,0,-1.124787511,1.143234117,-0.983864543,0.32518212,0.471700424,28.78856404,0,-0.044046805,0.966379389,-0.045579205,0.963645644,0.976081647,N,-,,DNA replication regulator SLD3,P:DNA replication initiation; C:nuclear chromatin; C:DNA replication preinitiation complex,IPR013948 (PFAM); PTHR28067 (PANTHER),,
RL4_JR_08230,1646,1491,1464,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,117.4853727,0,1.253965974,0.784280939,1.598873454,0.109848724,0.236950261,12.32423714,1,-0.157947948,1.213563115,-0.130152232,0.896445987,0.942408473,56.10298162,0,-0.40507883,0.858092534,-0.472068937,0.636877584,0.74661286,67.61894139,0,-0.186266913,0.680858703,-0.273576459,0.784410127,0.860934151,46.75502931,0,-0.688491432,0.856925284,-0.803443946,0.421718183,0.557573336,N,-,,hypothetical protein F503_02320,C:TRAPPII protein complex; P:intra-Golgi vesicle-mediated transport,IPR024662 (PFAM); PTHR28159 (PANTHER),,
RL4_JR_08231,709,662,742,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,76.10005696,0,1.705393374,0.838924827,2.032832167,0.042069482,0.117036118,6.556101564,0,0.752681189,1.354531901,0.555676237,0.578432204,0.717687028,40.40723123,0,0.522470298,0.966135271,0.540783795,0.588656613,0.708290891,55.56274024,0,1.133153616,1.318396462,0.859493824,0.390068126,0.534647323,16.5538716,0,-1.962925759,1.28602779,-1.526347856,0.126923256,0.228177907,Y,-,,hypothetical protein CMQ_8298,C:membrane,no IPS match,,
RL4_JR_08232,9003,10692,12054,0,3,5,0,0,0,0,0,2,0,2,0,0,0,2,30.39730882,1,6.658810124,0.978662281,6.803991787,1.02E-11,4.30E-10,0.064110474,0,7.428352306,2.351697963,3.158718688,0.001584644,0.015023052,0.16701954,1,4.769031281,1.456163543,3.275065705,0.001056374,0.006018419,0.192695308,1,4.347802446,1.930827234,2.251782226,0.024336037,0.084384376,0.165823803,1,4.677447863,1.331578385,3.512709365,0.000443562,0.002453752,N,-,,f-box domain containing,,G3DSA:1.20.1280.50 (GENE3D); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY),,
RL4_JR_08233,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34.99922748,0,-3.231503221,1.195531676,-2.702984193,0.006872001,0.028185916,11.17845213,0,-0.017095091,1.220560307,-0.014005938,0.988825244,0.994326358,40.0213934,0,-1.704719918,1.19430596,-1.427372864,0.153472448,0.267105908,52.66777267,0,-1.34248893,1.018608999,-1.317962959,0.187516048,0.31548687,32.32324334,0,-1.81466653,1.124254696,-1.61410625,0.106504382,0.200183909,N,-,,and NB-ARC domain-containing,F:microtubule motor activity; C:kinesin complex,IPR029058 (G3DSA:3.40.50.GENE3D); PTHR22731:SF5 (PANTHER); PTHR22731 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_08234,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.55826538,0,1.38860943,1.193850006,1.163135589,0.244774495,0.420305268,0.87383745,0,3.660178835,1.466914442,2.495154952,0.012590214,0.040137998,2.262668903,0,1.011340981,1.242244041,0.814124236,0.415573783,0.557180371,2.610245518,0,0.588944771,1.256051,0.468886033,0.6391511,0.752663979,2.221663345,0,0.934828205,1.233853978,0.757648977,0.448661151,0.580535995,N,-,,NCS1 nucleoside transporter,P:transmembrane transport; C:membrane; C:integral component of membrane; P:transport; F:transporter activity,IPR001248 (PFAM); PTHR30618:SF1 (PANTHER); PTHR30618 (PANTHER),2.A.39.3.13, the nucleobase:cation symporter-1 (ncs1) family.
RL4_JR_08235,36,67,64,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.162722021,0,4.516991166,3.258746698,1.386113001,0.165712401,NA,0.052273779,0,7.723208624,2.401592626,3.215869562,0.001300499,0.015023052,0.135266659,0,5.074109236,1.426519523,3.556985484,0.000375135,0.002760077,0.15600527,0,4.652847339,1.989850235,2.338290217,0.019372198,0.075643466,0.133218937,0,4.992303952,1.285191142,3.884483631,0.000102548,0.00070825,N,-,,hypothetical protein SPI_03805,,no IPS match,,
RL4_JR_08236,12,16,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.776632041,0,2.262582979,1.695802962,1.334225161,0.182130076,NA,0.248225307,0,5.475985677,1.790906003,3.057662248,0.002230708,0.015045494,0.6417194,0,2.829863891,1.291283438,2.191512574,0.028414721,0.073385366,0.740229857,0,2.407254795,1.380256627,1.744063204,0.081148069,0.167918292,0.628931952,0,2.755834161,1.253181025,2.199071089,0.027872868,0.071032667,N,-,,ATPase,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003593 (SMART); IPR010929 (PFAM); IPR003439 (PFAM); IPR029481 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR013525 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR19241 (PANTHER); PTHR19241 (PANTHER); PTHR19241:SF179 (PANTHER); PTHR19241:SF179 (PANTHER); PTHR19241:SF179 (PANTHER); PTHR19241 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.205.5, the atp-binding cassette (abc) superfamily.
RL4_JR_08237,172,159,154,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.073524645,0,5.663671475,3.921258449,1.444350468,0.148640416,NA,0.023579955,0,8.87289306,2.873531801,3.087800545,0.002016438,0.015023052,0.060691818,0,6.234875802,1.689820773,3.689666918,0.000224548,0.001895367,0.069997026,0,5.810198669,2.757444833,2.107095162,0.035109332,0.099498352,0.059093806,0,6.170182433,1.381682611,4.465701735,7.98E-06,8.31E-05,Y,-,,kinase-like domain partial,P:phosphorylation; F:kinase activity,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); PTHR21310 (PANTHER); PTHR21310:SF6 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_08238,115,95,160,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.79362035,0,0.460456292,0.820991716,0.560853761,0.574897234,0.750296858,6.563023345,0,0.751175676,1.292266444,0.581285446,0.561048088,0.704232235,17.052272,0,-1.902852442,1.236764672,-1.538572766,0.123908631,0.227337982,33.00042891,0,-0.588649135,1.071825054,-0.549202627,0.582866402,0.708466065,24.15932835,0,-1.039698552,1.172423414,-0.886794429,0.375189588,0.511415532,N,-,,c6 zinc finger domain,"C:nucleus; F:zinc ion binding; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; C:nuclear chromatin; P:proteolysis; P:positive regulation of pyrimidine-containing compound salvage; P:transcription from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; F:peptidase activity; P:positive regulation of transcription from RNA polymerase II promoter; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_08239,2654,3255,3413,7,5,5,0,0,0,1,0,0,0,1,0,0,3,1,82.37665687,1,-0.110330673,0.652509673,-0.169086647,0.865728488,0.934208069,13.12005494,0,-0.248152806,1.240510374,-0.200040896,0.841448597,0.905212318,55.93730855,1,-1.050613388,1.049646207,-1.000921435,0.316864793,0.459655991,59.02850385,1,-0.314886505,0.725548311,-0.433997986,0.664289904,0.77111504,44.31706074,1,-1.284050514,0.989049292,-1.298267462,0.194195443,0.315100779,N,-,,chromatin structure-remodeling complex RSC7,C:SWI/SNF complex,IPR013933 (PFAM); PTHR22597 (PANTHER); IPR013933 (PRODOM),,
RL4_JR_08240,5593,5185,5629,4,4,8,0,0,0,0,0,2,2,1,0,0,3,0,21.12785459,1,-2.503494073,1.208731151,-2.071175275,0.038342419,0.109293311,6.710903316,0,0.718940073,1.243976556,0.577936996,0.563306657,0.706104022,17.48422962,1,-1.939101067,1.207168808,-1.60632138,0.108203315,0.205563964,45.53286405,1,0.665431331,0.704999555,0.943874824,0.345233619,0.491991034,17.32944392,1,-2.028939828,1.217600622,-1.666342634,0.09564519,0.184528877,N,-,,cbf nf-y family transcription factor,C:nucleus; F:protein heterodimerization activity,IPR003958 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); PTHR11064:SF31 (PANTHER); PTHR11064 (PANTHER); IPR009072 (SUPERFAMILY),,
RL4_JR_08241,4347,2135,2028,4,0,8,0,0,0,0,5,3,1,12,0,0,0,0,169.6178132,1,-4.469272098,1.152935319,-3.876429167,0.000106001,0.000900785,95.32471127,0,-0.534752029,0.975108061,-0.548402839,0.583415327,0.722099528,138.3710841,1,-3.892220999,1.19337758,-3.261516778,0.001108179,0.006260715,212.8320818,1,-1.108422768,0.483105153,-2.294371653,0.02176916,0.08009184,157.3424508,0,-1.569199457,0.628234225,-2.497793649,0.012496891,0.037579752,N,-,,mitotic control dis3,"C:cytoplasmic exosome (RNase complex); F:nucleic acid binding; C:nuclear exosome (RNase complex); P:RNA phosphodiester bond hydrolysis, exonucleolytic; F:3'-5'-exoribonuclease activity; F:endonuclease activity; P:rRNA catabolic process; P:rRNA processing; P:mRNA catabolic process",IPR002716 (SMART); SM00955 (SMART); IPR029060 (G3DSA:3.40.50.GENE3D); IPR033771 (PFAM); IPR002716 (PFAM); PF00773 (PFAM); IPR033770 (PFAM); PTHR23355:SF35 (PANTHER); PTHR23355 (PANTHER); PTHR23355:SF35 (PANTHER); PTHR23355 (PANTHER); IPR029060 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY),,
RL4_JR_08242,455,485,500,0,0,1,0,0,0,0,0,2,0,2,0,0,0,0,36.88547605,1,-3.307283563,1.201434475,-2.752778975,0.005909178,0.024836203,11.70875991,0,-0.084017424,1.216384285,-0.069071448,0.944932748,0.97033501,38.30593472,1,-1.778208658,1.197209788,-1.48529412,0.137465929,0.245840852,57.78620871,1,-0.83758749,0.861680816,-0.972039152,0.331031071,0.477652785,44.83254298,0,-1.132708541,0.983478283,-1.151737218,0.249429074,0.379884081,N,-,,transcription factor,P:biological_process; C:cellular_component; F:molecular_function,IPR029052 (G3DSA:3.60.21.GENE3D); PTHR10351:SF51 (PANTHER); PTHR10351 (PANTHER); PTHR10351:SF51 (PANTHER); PTHR10351 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_08243,2416,3422,3147,0,7,10,0,0,0,0,1,0,3,5,0,0,2,2,154.4757451,1,0.313078613,0.510002768,0.613876302,0.539297071,0.721704886,22.78404984,0,-1.044479754,1.21775667,-0.857708095,0.391053669,0.555387293,121.3866568,1,-0.252885622,0.666063432,-0.37967198,0.704188922,0.798985296,91.99569809,1,-1.795473179,0.886496122,-2.025359316,0.042830482,0.112638605,74.23991586,1,-1.59609283,0.890979783,-1.791390625,0.073230632,0.149941386,Y,-,,rhomboid family,C:membrane; P:protein processing; F:peptidase activity,IPR022764 (G3DSA:1.20.1540.GENE3D); IPR022764 (PFAM); PTHR22936:SF13 (PANTHER); PTHR22936:SF13 (PANTHER); IPR002610 (PANTHER); IPR002610 (PANTHER); SSF144091 (SUPERFAMILY),9.B.104.1.6, the rhomboid protease (rhomboid) family.
RL4_JR_08244,2143,1648,2019,0,1,1,0,0,0,0,2,0,0,4,0,0,11,0,19.28814576,1,-2.37203218,1.244079153,-1.906656963,0.056565023,0.145708071,6.079720811,0,0.861416,1.280311757,0.672817378,0.501063481,0.655012857,22.42421461,1,-0.842586544,1.229568265,-0.685270243,0.493173406,0.626538783,31.70546232,1,-0.490818203,1.066384724,-0.460263722,0.645326937,0.756943378,15.8750879,1,-1.902466448,1.249977003,-1.52200116,0.12800879,0.229518151,N,-,,secondary alcohol dehydrogenase,F:zinc ion binding; F:oxidoreductase activity; F:metal ion binding; P:oxidation-reduction process; C:cellular_component; F:molecular_function,PTHR40422 (PANTHER),,
RL4_JR_08245,1467,1222,1519,0,8,13,0,0,0,0,5,3,0,2,2,0,10,2,89.54139112,1,-0.218603225,0.731689516,-0.298765008,0.765119351,0.877161421,33.17941544,0,1.245192023,1.017747168,1.223478741,0.221148929,0.369140742,37.70645826,1,-3.047795847,1.215014548,-2.508443913,0.012126422,0.037543698,132.4535497,1,1.058637303,0.494294834,2.141712251,0.032216644,0.096023999,37.491664,1,-3.142273386,1.227657811,-2.559567786,0.010480241,0.032579811,N,-,,Mitochondrial carrier,,IPR022036 (PFAM); PTHR35020:SF1 (PANTHER); PTHR35020 (PANTHER),,
RL4_JR_08246,5764,4627,5728,4,4,0,0,0,0,0,0,1,0,4,0,0,4,0,58.55577094,1,-0.504859703,0.928643961,-0.543652599,0.586680557,0.75886158,8.946211047,0,0.304161414,1.256287132,0.242111382,0.808693859,0.883777832,23.41741081,1,-2.360593181,1.225206533,-1.926690005,0.054018274,0.120008999,44.68650826,1,-0.480015765,0.908838953,-0.528163723,0.597385706,0.720101467,23.32275357,1,-2.457442165,1.240875351,-1.98041017,0.047657458,0.107959094,N,-,,serine threonine- kinase psk1,F:dihydroneopterin aldolase activity; P:folic acid-containing compound metabolic process; P:phosphorylation; F:kinase activity,IPR006157 (SMART); G3DSA:3.30.1130.10 (GENE3D); IPR006157 (PFAM); SSF55620 (SUPERFAMILY),,
RL4_JR_08247,2240,4717,4041,0,0,3,0,0,0,0,0,1,0,0,0,0,0,0,69.27235999,1,0.331029511,0.531935787,0.622311036,0.533737366,0.71706681,12.39530691,0,-0.166186616,1.209996703,-0.137344685,0.890758352,0.938703205,54.28213874,1,-0.408023999,0.847155049,-0.481640285,0.630061503,0.741390235,61.09299953,0,0.059251657,0.613405336,0.096594622,0.923048327,0.954341296,42.81288009,0,-1.218218468,0.965838971,-1.261305978,0.207198628,0.329908179,N,-,,sir2 family histone deacetylase,,IPR029035 (G3DSA:3.40.50.GENE3D); IPR003000 (PFAM); IPR026591 (G3DSA:3.30.1600.GENE3D); PTHR11085:SF23 (PANTHER); IPR003000 (PANTHER); IPR003000 (PANTHER); PTHR11085:SF23 (PANTHER); IPR026590 (PROSITE_PROFILES); IPR029035 (SUPERFAMILY),,
RL4_JR_08248,102,196,159,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,99.02817404,1,0.922564374,0.457216282,2.017785478,0.043613608,0.120283034,13.13538928,0,-0.249830771,1.213155874,-0.205934601,0.836841997,0.902366538,141.0876111,1,1.725390177,0.497474983,3.468295365,0.000523771,0.003497797,63.25663215,0,-0.028979106,0.6215578,-0.046623348,0.962813423,0.978772417,59.68747655,0,-0.027833056,0.663146617,-0.041971195,0.966521661,0.978159281,N,-,,RNA polymerase II Mediator complex subunit Sin4,F:oxidoreductase activity; P:oxidation-reduction process,IPR021665 (PFAM),,
RL4_JR_08249,3403,2724,3485,0,1,10,0,0,0,1,4,1,0,2,0,0,3,0,125.7290778,1,1.208931129,0.471930979,2.561669359,0.010417044,0.039126263,12.44844476,0,-0.17242108,1.215499064,-0.141852088,0.88719684,0.93621835,38.93618792,1,-1.868842701,1.199237829,-1.558358697,0.119148242,0.220610992,96.17125086,1,0.998288062,0.506895661,1.969415284,0.048905422,0.121283975,39.8412928,1,-1.257696675,0.996436531,-1.262194465,0.20687882,0.329555784,N,-,,crossover junction endonuclease MUS81,P:nucleic acid phosphodiester bond hydrolysis; P:reciprocal meiotic recombination; C:intracellular membrane-bounded organelle; F:endonuclease activity; P:double-strand break repair via homologous recombination; P:mitotic DNA integrity checkpoint,IPR006166 (SMART); IPR023366 (G3DSA:2.40.30.GENE3D); IPR001783 (TIGRFAM); IPR026017 (PFAM); IPR027421 (G3DSA:1.10.150.GENE3D); IPR006166 (PFAM); IPR020819 (G3DSA:3.40.50.GENE3D); PTHR13451 (PANTHER); IPR033309 (PTHR13451:PANTHER); IPR026017 (PROSITE_PROFILES); IPR026017 (PROSITE_PROFILES); IPR011335 (SUPERFAMILY); IPR017938 (SUPERFAMILY); IPR017938 (SUPERFAMILY); IPR010996 (SUPERFAMILY),,
RL4_JR_08250,3218,3718,3856,5,0,20,0,0,0,1,2,4,2,8,0,0,4,1,344.5532667,1,-1.605082482,0.542273441,-2.959913505,0.003077254,0.014732535,84.09213902,0,-2.928397033,1.207908913,-2.424352534,0.01533571,0.047010315,219.7621384,1,-5.590814639,1.216702398,-4.595055164,4.33E-06,9.26E-05,301.775533,1,-1.961110423,0.714109458,-2.74623225,0.006028407,0.032536046,309.8724215,1,-0.918798567,0.636369194,-1.44381371,0.148791384,0.25752355,N,-,,hnrnp arginine n-methyltransferase,"F:protein-arginine omega-N asymmetric methyltransferase activity; P:mRNA export from nucleus; P:positive regulation of transcription elongation from RNA polymerase II promoter; C:nucleus; F:identical protein binding; P:peptidyl-arginine methylation, to asymmetrical-dimethyl arginine; F:protein-arginine omega-N monomethyltransferase activity; P:negative regulation of DNA-templated transcription, termination",G3DSA:2.70.160.11 (GENE3D); IPR029063 (G3DSA:3.40.50.GENE3D); PF06325 (PFAM); IPR025799 (PANTHER); IPR025799 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_08251,5511,6078,7908,0,3,23,0,0,2,0,4,1,6,10,1,0,6,0,67.04622977,1,1.015800754,0.574607725,1.767816042,0.077091662,0.183036606,45.97312217,1,1.457033279,1.117250623,1.304123934,0.19219133,0.333852864,19.83055448,1,-2.120625643,1.198722339,-1.769071597,0.076881927,0.158073239,55.15083895,1,0.204711005,0.752273292,0.272123186,0.785527302,0.861446659,19.54705998,1,-2.202615063,1.202487724,-1.831715218,0.06699386,0.140176242,Y,-,,mannosyl-oligosaccharide glucosidase,C:endoplasmic reticulum membrane; P:fungal-type cell wall biogenesis; P:protein N-linked glycosylation; F:mannosyl-oligosaccharide glucosidase activity; P:oligosaccharide metabolic process,IPR031631 (PFAM); IPR031335 (PFAM); PTHR10412:SF11 (PANTHER); IPR004888 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_08252,2591,3930,2484,0,1,13,0,0,0,0,3,0,0,4,0,0,0,0,129.1403948,1,0.442969574,0.439862493,1.007063755,0.313904137,0.50224638,28.13304478,0,0.153211617,1.118541654,0.136974441,0.891050998,0.93877623,83.64465606,1,-0.585085274,0.740960107,-0.789631276,0.429743137,0.570287,144.2415812,1,0.788878551,0.416542602,1.893872435,0.058241944,0.134804147,78.17919608,0,-0.068346106,0.570608032,-0.11977768,0.904659263,0.938972326,N,-,,GTPase-activating GYP7,"C:nucleus; P:regulation of vacuole fusion, non-autophagic; P:vesicle-mediated transport; P:mycelium development; C:cytosol",IPR000195 (SMART); G3DSA:1.10.8.270 (GENE3D); IPR000195 (PFAM); PTHR22957:SF34 (PANTHER); PTHR22957 (PANTHER); PTHR22957:SF34 (PANTHER); PTHR22957 (PANTHER); IPR000195 (PROSITE_PROFILES); IPR000195 (SUPERFAMILY); IPR000195 (SUPERFAMILY),8.A.87.1.4, the tbc1 domain (tbc1) family.
RL4_JR_08253,378,417,423,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,41.15912478,0,2.017754324,0.64473637,3.129580427,0.001750561,0.009358506,3.240637781,0,1.769133884,1.288935801,1.372553918,0.169891066,0.304792161,8.46027724,1,-0.891890551,1.216628253,-0.733083872,0.463507276,0.600838369,21.79806696,1,0.966993628,0.895336817,1.080033357,0.280127327,0.423571054,15.76647126,0,-0.043762484,1.154866931,-0.037893963,0.969772227,0.980130145,N,-,,major facilitator superfamily transporter sugar,,IPR028095 (PFAM),,
RL4_JR_08254,3152,2128,1646,0,0,0,0,0,0,0,0,0,4,4,0,0,5,3,94.48236892,0,1.094405514,0.542506486,2.017313233,0.043662835,0.120297674,9.973780222,0,0.14732778,1.22882067,0.119893637,0.904567405,0.946457646,39.01335024,0,-0.696695991,1.050529928,-0.663185286,0.507211894,0.638964643,38.04607789,1,-1.218915669,1.038659814,-1.173546577,0.24057669,0.379000932,25.78518243,1,-2.602229826,1.216044011,-2.139914184,0.032361703,0.079878654,N,-,,tRNA modification GTPase,C:cytoplasm; P:tRNA modification; F:hydrolase activity,IPR018948 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR025867 (PFAM); IPR027266 (G3DSA:3.30.1360.GENE3D); IPR006073 (PFAM); IPR027368 (G3DSA:1.20.120.GENE3D); PTHR11649:SF56 (PANTHER); PTHR11649 (PANTHER); IPR004520 (HAMAP); IPR027417 (SUPERFAMILY),,
RL4_JR_08255,47766,48010,64222,3,15,80,3,0,4,5,11,0,4,39,2,0,18,2,15.0303406,1,-2.012277068,1.217325161,-1.65303169,0.098324414,0.218802665,4.817045351,1,1.197344528,1.28038089,0.93514714,0.349712475,0.512647397,12.48336838,1,-1.453040259,1.217496713,-1.193465447,0.232687137,0.364268528,14.39868615,1,-1.875139174,1.218241481,-1.539217966,0.123751093,0.229567574,16.17282888,1,-0.608014033,1.153838271,-0.526949096,0.598228939,0.70889533,N,-,,hypothetical protein,,no IPS match,,
RL4_JR_08256,8163,8251,9356,3,0,11,0,0,1,0,0,2,2,3,5,0,3,4,2.601338638,1,0.518242496,1.381300735,0.375184406,0.707523327,0.84225526,0.847597207,1,3.7041546,1.563310571,2.369429766,0.017815538,0.052528075,2.173474078,1,1.068956451,1.298577872,0.823174701,0.410408653,0.552552358,2.505220039,1,0.647837823,1.327295734,0.48808853,0.625487135,0.742358135,2.120983,1,1.00116343,1.288035581,0.777279328,0.436993989,0.571796864,N,-,,---NA---,,no IPS match,,
RL4_JR_08257,6095,3932,4073,0,4,1,0,0,0,0,1,1,0,1,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,glycoside hydrolase family 18,F:hydrolase activity,IPR001223 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR11177 (PANTHER); PTHR11177:SF160 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_08258,35,14,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.152994685,0,-1.129437697,1.204142479,-0.937960181,0.348264874,0.538197545,2.61157021,0,2.080676731,1.300679457,1.599684473,0.109668598,0.217404142,19.74852599,0,1.251881376,1.042174614,1.201220371,0.229665729,0.360765841,7.786811545,0,-0.988015729,1.20340623,-0.821015967,0.411637174,0.555265971,28.72089744,0,1.592083154,0.844287958,1.885711076,0.059333899,0.127548988,N,-,,aminotransferase class 3,"P:carbohydrate metabolic process; F:transaminase activity; C:membrane; C:integral component of membrane; F:transferase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds",no IPS match,,
RL4_JR_08259,1235,601,1593,0,0,3,0,0,0,0,0,0,4,6,0,0,0,0,91.7516548,1,2.123935114,1.008954907,2.10508428,0.035283972,0.102490197,6.140074691,0,0.84730626,1.236804404,0.685077008,0.493295328,0.648711876,15.89452812,0,-1.801379768,1.192622498,-1.510435843,0.130932248,0.23715918,22.34595403,1,-1.276355392,1.143107498,-1.116566372,0.264179777,0.404897119,27.20520334,0,0.327069909,0.84059619,0.38909278,0.697207514,0.785728517,Y,-,,wsc domain containing,P:biological_process; C:cellular_component; F:molecular_function,IPR018535 (PFAM); PTHR32208:SF33 (PANTHER); PTHR32208 (PANTHER); PTHR32208 (PANTHER),,
RL4_JR_08260,1008,1072,848,3,0,8,0,0,0,0,0,2,0,5,0,0,0,2,76.3416642,1,-1.432343635,0.841684817,-1.70175772,0.088800795,0.202866672,16.0493186,0,-0.538925208,1.200926878,-0.44875772,0.653606441,0.776594013,52.69699534,1,-2.228696033,1.186920051,-1.877713694,0.060420342,0.130956015,129.3967482,1,1.005773911,0.406349006,2.475147952,0.013318099,0.060850972,71.92065995,1,0.318090532,0.553835953,0.574340706,0.565737269,0.682834381,N,-,,ubiquitin-conjugating enzyme,F:ATP binding,SM00212 (SMART); IPR000608 (PFAM); IPR016135 (G3DSA:3.10.110.GENE3D); PTHR24067:SF154 (PANTHER); PTHR24067 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_08261,1336,1434,1365,0,1,1,0,0,0,0,0,0,2,0,1,0,0,0,101.0787161,1,0.683169349,0.877326324,0.778694689,0.436159586,0.626731603,80.91553601,0,1.873721026,0.837062897,2.238447115,0.025191913,0.068898281,42.77039204,0,-2.030025772,1.186757798,-1.710564511,0.087161535,0.174219819,83.57132816,1,0.465442707,0.509352341,0.913793202,0.360825519,0.506847722,91.5427471,0,0.73445449,0.516911659,1.420851083,0.155360057,0.26553352,N,-,,uba ts-n domain-containing,P:mycelium development,IPR011990 (G3DSA:1.25.40.GENE3D); IPR001623 (G3DSA:1.10.287.GENE3D); G3DSA:1.10.8.10 (GENE3D); PTHR23172 (PANTHER); IPR015940 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR001623 (SUPERFAMILY); IPR009060 (SUPERFAMILY),,
RL4_JR_08262,1505,1768,1673,2,8,7,0,0,0,0,0,0,2,0,0,0,10,0,42.94305914,1,-1.100964841,1.023566644,-1.075616178,0.282098949,0.465147866,8.537855176,0,0.371585865,1.225349065,0.303248989,0.761700118,0.855518042,113.629734,0,2.006265279,0.502121385,3.995578243,6.45E-05,0.000875828,33.69481628,1,-0.988832407,1.028896454,-0.961061147,0.336521424,0.483507793,29.75649521,1,-0.714260893,0.997140046,-0.716309505,0.473800259,0.604161634,N,-,,serine threonine phosphatase 2b catalytic subunit,C:membrane; C:integral component of membrane,PTHR38644 (PANTHER),,
RL4_JR_08263,60,72,120,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,72.64435014,0,-0.516048611,0.711894145,-0.724895147,0.468516359,0.657066607,15.72415131,0,-0.509445831,1.220225889,-0.417501248,0.676311812,0.793420046,41.05871856,0,-3.170665107,1.208339765,-2.623984742,0.008690768,0.029265836,60.70833895,1,-1.85807171,1.039760581,-1.787018803,0.07393445,0.156969239,44.61821572,1,-2.334672792,1.150393913,-2.029455097,0.042411958,0.09842335,N,-, Effector probability:0.638,small nuclear ribonucleo sm d3,C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP; C:viral nucleocapsid; C:U2-type prespliceosome; P:RNA processing; C:U1 snRNP,IPR001163 (SMART); G3DSA:2.30.30.100 (GENE3D); IPR001163 (PFAM); IPR027141 (PANTHER); IPR010920 (SUPERFAMILY),,
RL4_JR_08264,2847,3687,5962,0,0,0,0,0,0,0,0,0,0,3,2,0,3,0,63.26263463,0,-0.325467792,0.749835091,-0.434052494,0.664250322,0.812680582,10.00682837,0,0.142646077,1.224320727,0.116510383,0.907248057,0.948282201,106.7538909,0,1.640930228,0.496725537,3.303494801,0.000954877,0.005539931,94.2435851,1,1.35790337,0.472059559,2.876550942,0.004020473,0.023598428,48.25999186,1,0.351884774,0.677873059,0.519101281,0.603690115,0.71223053,N,-,,platelet-activating factor acetylhydrolase,C:nucleus; F:1-alkyl-2-acetylglycerophosphocholine esterase activity; P:phospholipid catabolic process; C:cytosol; P:cellular response to oxidative stress,IPR005065 (PFAM); IPR016715 (PIRSF); IPR029058 (G3DSA:3.40.50.GENE3D); IPR005065 (PANTHER); PTHR10272:SF7 (PANTHER); IPR005065 (PANTHER); IPR005065 (PANTHER); PTHR10272:SF7 (PANTHER); PTHR10272:SF7 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_08265,11187,11817,17070,0,1,1,0,0,2,0,0,0,3,2,2,0,6,1,4.812862006,1,-0.36908318,1.212671382,-0.304355479,0.760857082,0.87398931,1.530658199,1,2.851352795,1.339994686,2.127883659,0.033346731,0.085974429,26.11755512,0,2.028511803,1.033667539,1.962441236,0.049711136,0.112514093,4.5892278,1,-0.225413688,1.206156338,-0.186885962,0.851750046,0.907461592,3.925778474,1,0.113397743,1.207551328,0.093907183,0.925182888,0.951592518,N,-,,duf580 domain containing,C:integral component of membrane,IPR007603 (PFAM); PTHR12385:SF4 (PANTHER); IPR007603 (PANTHER),2.A.92.1.8, the choline transporter-like (ctl) family.
RL4_JR_08266,58,65,69,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.67969884,0,2.454670311,1.703005663,1.441375307,0.149478682,NA,0.217853485,0,5.664144246,1.793459174,3.15822313,0.00158734,0.015023052,0.563633769,0,3.0162032,1.258207973,2.397221497,0.016519934,0.048115021,0.650098683,0,2.594089894,1.343780677,1.930441432,0.053552165,0.127520149,0.554160949,0,2.937492829,1.221448711,2.404925235,0.016175775,0.046161139,N,-,,---NA---,,no IPS match,,
RL4_JR_08267,590,750,893,0,0,17,0,0,0,0,0,0,0,1,0,0,3,0,3.578403068,1,0.058583352,1.248960682,0.046905681,0.9625884,0.980954926,1.149621032,0,3.264486173,1.415425388,2.306364009,0.021090301,0.060049516,2.965279764,0,0.621158789,1.227898554,0.505871424,0.612946914,0.728256609,3.419781931,1,0.199202864,1.234163994,0.161407126,0.871772754,0.921078904,2.902321008,1,0.549030941,1.217566155,0.450924936,0.652043651,0.752015259,N,-,,P-loop containing nucleoside triphosphate hydrolase,F:nucleotide binding; P:biological_process; F:ATP binding; F:hydrolase activity,IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23077:SF81 (PANTHER); PTHR23077 (PANTHER); IPR027417 (SUPERFAMILY),3.A.16.1.1, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_08268,11476,12222,15870,4,10,29,0,0,2,0,2,1,1,20,6,0,19,3,7.531309488,1,-1.015436959,1.220019655,-0.832311967,0.405232878,0.596960812,30.55771666,1,4.345217493,0.904871715,4.802025991,1.57E-06,0.000134733,20.60192581,1,1.362188126,1.055474254,1.290593419,0.196844699,0.321843627,15.2428413,1,0.833610155,1.047141105,0.796081971,0.425984393,0.568632099,28.25229122,1,1.714535763,0.870574134,1.969431086,0.048903609,0.110082046,N,-,,tat pathway signal sequence,,IPR021765 (PFAM); PTHR33365 (PANTHER); PTHR33365:SF4 (PANTHER),,
RL4_JR_08269,13364,11753,18127,6,8,23,0,0,1,0,3,10,5,16,4,0,16,1,46.66403256,1,1.275060383,0.738815086,1.725818012,0.084380158,0.195505064,4.16273836,1,1.407971196,1.315623228,1.070193325,0.284532298,0.444038841,18.60948,1,-0.277783585,1.229525952,-0.225927386,0.821257897,0.88479461,54.96930195,1,1.469028569,0.7548855,1.946028331,0.051651337,0.125559168,10.60178765,1,-1.320089112,1.240941917,-1.063779936,0.287428403,0.421881921,Y,-,,hypothetical protein SPI_06362,,no IPS match,,
RL4_JR_08270,31956,31718,46758,7,14,58,0,5,1,0,4,1,0,8,1,0,21,4,204.6676364,1,-2.259433896,0.703746897,-3.21057742,0.001324686,0.00738673,49.73884889,1,-2.170788098,1.193500266,-1.818841738,0.068935579,0.151853303,129.2562082,1,-4.825101856,1.192951823,-4.044674532,5.24E-05,0.000752419,158.4446186,1,-4.297732948,1.145876199,-3.750608443,0.000176406,0.00172738,127.5800014,1,-4.909035537,1.199091869,-4.093961158,4.24E-05,0.000337287,N,-,,h aca ribonucleo complex subunit 3,C:box H/ACA snoRNP complex; P:rRNA pseudouridine synthesis; F:snoRNA binding; P:snRNA pseudouridine synthesis; C:viral nucleocapsid; P:cleavage involved in rRNA processing,G3DSA:2.20.28.40 (GENE3D); IPR007264 (PFAM); PTHR13305:SF0 (PANTHER); IPR007264 (PANTHER); IPR007264 (SUPERFAMILY),,
RL4_JR_08271,4132,3000,3771,0,5,25,2,0,0,2,7,1,0,1,0,0,0,0,143.0795254,1,-0.357832019,0.62358742,-0.573828156,0.566084093,0.742939838,27.36092593,1,-1.308563927,1.224214051,-1.068901247,0.28511417,0.444604164,101.5737767,1,-1.542387586,0.887946127,-1.737028339,0.082382169,0.166640775,86.64321431,1,-3.451048402,1.180237686,-2.924028308,0.003455333,0.020836956,75.06700838,0,-3.140751484,1.16576272,-2.694160166,0.007056625,0.023768571,N,-,,20S-pre-rRNA D-site endonuclease NOB1,"P:RNA phosphodiester bond hydrolysis, endonucleolytic; C:nucleus; P:maturation of SSU-rRNA; C:proteasome complex; P:cleavage involved in rRNA processing; F:endoribonuclease activity",IPR017117 (PIRSF); IPR033411 (PFAM); IPR014881 (PFAM); PTHR12814:SF2 (PANTHER); PTHR12814 (PANTHER); IPR014881 (SUPERFAMILY),,
RL4_JR_08272,407,560,576,0,0,13,0,0,0,4,6,20,1,9,0,0,19,0,0.941419891,1,1.984780496,1.548760567,1.281528299,0.200008166,NA,0.297887376,0,5.212552839,1.701274303,3.063910875,0.00218464,0.015045494,0.776887822,1,2.552917846,1.263079959,2.021184666,0.043260652,0.101194742,0.896544048,1,2.130224061,1.324407278,1.608435786,0.107739769,0.207388815,0.769753012,1,2.4642843,1.244355346,1.980370244,0.047661941,0.107959094,N,-,,kinase-like domain,,G3DSA:3.90.1200.10 (GENE3D); IPR002575 (PFAM); PTHR21310 (PANTHER); PTHR21310:SF20 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_08273,623,550,742,0,2,0,0,0,0,2,0,2,0,0,0,0,7,0,461.6863221,1,2.902950706,0.513105097,5.657614242,1.53E-08,3.52E-07,37.01748806,0,0.914661049,0.992221295,0.921831706,0.356616366,0.520800875,115.6803446,1,0.616785621,0.510191862,1.208928773,0.226690211,0.357491312,445.188822,0,2.941209055,0.317613533,9.260339218,2.04E-20,2.04E-18,119.0913708,1,1.156870363,0.465447696,2.485500247,0.01293695,0.038650521,Y,-,,allergen Asp f 4,,PTHR42039 (PANTHER),,
RL4_JR_08274,26849,22415,22529,7,25,118,0,0,0,11,16,16,3,38,8,2,26,17,10.03473584,1,-1.429405499,1.241701569,-1.151166701,0.249663662,0.426724523,3.180700598,0,1.796064332,1.315235711,1.365583611,0.172069693,0.307555966,8.304570657,1,-0.865098733,1.232173292,-0.702091775,0.482621932,0.618581687,9.583168946,1,-1.287849337,1.235251325,-1.042580818,0.297142477,0.442306319,8.254476054,1,-0.958971004,1.24561347,-0.769878479,0.441371981,0.575306899,N,-,,---NA---,,no IPS match,,
RL4_JR_08275,15545,20977,15084,0,5,13,0,0,0,2,0,3,6,10,2,0,6,2,86.70875902,1,0.952974033,0.481276142,1.980098222,0.047692493,0.128323007,28.89112397,0,1.76732006,0.984216309,1.795662238,0.072548251,0.157921161,61.46403807,1,0.614814813,0.66196709,0.928769454,0.353008578,0.496300353,61.62446751,1,0.102180432,0.660242526,0.154761967,0.877008976,0.92394929,90.09921975,1,1.701868501,0.437755584,3.887713975,0.000101193,0.000701285,N,-,,gamma-butyrobetaine dioxygenase,P:ascospore formation; P:conidium formation; P:pathogenesis,IPR003819 (PFAM); G3DSA:3.60.130.10 (GENE3D); PTHR10696:SF25 (PANTHER); PTHR10696 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_08276,2067,2181,1962,0,0,0,0,0,0,0,9,2,1,1,0,0,0,5,2.614576031,0,0.511241441,1.23372905,0.41438713,0.678590613,0.823800925,0.8354329,0,3.724965942,1.431991716,2.601248249,0.009288521,0.031888626,2.16437236,1,1.075214601,1.210620947,0.888151327,0.374459357,0.518395532,2.496704856,1,0.652939368,1.216092872,0.53691571,0.591325839,0.715057222,2.129646019,1,0.995728641,1.202165998,0.828278826,0.407512612,0.543656685,N,-,,peptidase s9 prolyl oligopeptidase active site domain containing,P:proteolysis; F:serine-type peptidase activity; F:serine-type endopeptidase activity,IPR011042 (G3DSA:2.120.10.GENE3D); IPR029058 (G3DSA:3.40.50.GENE3D); IPR001375 (PFAM); PTHR11731:SF75 (PANTHER); PTHR11731 (PANTHER); IPR029058 (SUPERFAMILY); SSF82171 (SUPERFAMILY),8.A.51.1.3, the dipeptidyl-aminopeptidase-like protein 6 beta subunit of kv4 channels (dpp6) family.
RL4_JR_08277,1289,1622,1557,1,2,5,0,0,0,2,1,1,1,0,1,0,4,0,18.71512318,1,-1.055223601,1.198235544,-0.880647888,0.378508431,0.570349423,14.06593222,0,2.149955104,1.165262927,1.845038621,0.065031921,0.144893925,12.27601548,1,-1.42886046,1.232842317,-1.15899693,0.246457436,0.380646085,22.1933088,1,-0.149965264,1.072820069,-0.139786035,0.888829047,0.931638858,12.22028,1,-1.524951481,1.248592879,-1.221336039,0.221958813,0.348546889,N,-,,gdsl-like lipase acylhydrolase,P:RNA phosphodiester bond hydrolysis; F:endonuclease activity,IPR013830 (G3DSA:3.40.50.GENE3D); IPR013830 (PFAM); IPR013830 (SUPERFAMILY),,
RL4_JR_08278,6168,7516,9947,1,0,5,0,0,0,0,3,0,0,7,1,0,8,4,58.2927731,1,1.326279267,0.561008309,2.36409915,0.018073975,0.060387648,6.15321155,0,0.844122726,1.233106371,0.684549805,0.493628051,0.648980793,29.01079637,1,0.006348854,1.038047326,0.006116151,0.995120048,0.998095149,97.30920676,1,1.77189592,0.573930001,3.087303188,0.002019815,0.013305546,15.84287273,1,-1.899529367,1.205077029,-1.576272157,0.114963095,0.21209937,N,-,,heterokaryon incompatibility partial,C:membrane,no IPS match,,
RL4_JR_08279,6223,6413,6129,0,5,0,0,0,0,0,4,6,1,5,1,3,4,0,350.6008447,1,-4.072813477,0.866058403,-4.702700723,2.57E-06,3.48E-05,101.9025521,0,-3.205531704,1.191050087,-2.691349204,0.007116366,0.026241114,352.7491032,1,-1.46428774,0.466688452,-3.137612972,0.001703296,0.008722393,394.1497309,1,-1.748634331,0.434384106,-4.025548601,5.68E-05,0.000661531,307.3629395,1,-1.960908132,0.566347568,-3.462375833,0.000535429,0.002864751,N,-,,tRNA-splicing endonuclease subunit,P:nucleic acid phosphodiester bond hydrolysis; P:RNA metabolic process; F:nuclease activity,IPR006678 (PFAM); IPR011856 (G3DSA:3.40.1350.GENE3D); IPR006677 (PFAM); PTHR21227:SF0 (PANTHER); IPR006676 (PANTHER); PTHR21227:SF0 (PANTHER); IPR006676 (PANTHER); IPR006677 (SUPERFAMILY),,
RL4_JR_08280,860,1307,1200,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,258.8916773,1,-0.077442571,0.369271015,-0.209717438,0.833888214,0.917340408,40.27762088,0,-1.866380653,1.196671744,-1.559642954,0.11884428,0.231825362,123.7738837,0,-2.112157463,0.851258819,-2.481216541,0.01309348,0.039939258,137.9371462,0,-2.624287927,0.849953626,-3.087566011,0.002018029,0.01330244,106.4724219,1,-3.664411965,1.119695855,-3.272685121,0.001065311,0.005021542,N,-,,phosphoacetylglucosamine mutase,F:magnesium ion binding; C:nucleus; P:fungal-type cell wall chitin biosynthetic process; C:cytosol; F:phosphoacetylglucosamine mutase activity,IPR016657 (PIRSF); IPR016055 (G3DSA:3.40.120.GENE3D); IPR016055 (G3DSA:3.40.120.GENE3D); IPR005844 (PFAM); IPR005843 (PFAM); IPR005843 (G3DSA:3.30.310.GENE3D); PTHR22573 (PANTHER); PTHR22573 (PANTHER); PTHR22573:SF15 (PANTHER); PTHR22573:SF15 (PANTHER); IPR016055 (SUPERFAMILY); IPR005843 (SUPERFAMILY); IPR016055 (SUPERFAMILY); IPR016055 (SUPERFAMILY),,
RL4_JR_08281,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,315.2366774,0,-1.812347264,0.623876704,-2.904976659,0.003672805,0.016867004,76.93773723,0,-2.800094122,1.231189947,-2.274299046,0.022948013,0.064130255,238.0336852,0,-2.065331715,0.696253519,-2.966350129,0.003013572,0.013626352,264.5245758,0,-2.78251545,0.733367049,-3.794164809,0.000148141,0.001495444,204.6845735,0,-3.3347177,0.90959355,-3.666162432,0.000246218,0.001487442,N,-,,sgt1 and cs domain containing,P:cellular process,IPR007699 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR008978 (G3DSA:2.60.40.GENE3D); IPR007052 (PFAM); PTHR22904:SF344 (PANTHER); PTHR22904 (PANTHER); IPR007052 (PROSITE_PROFILES); IPR007699 (PROSITE_PROFILES); IPR008978 (SUPERFAMILY); IPR011990 (SUPERFAMILY),,
RL4_JR_08282,279,558,347,0,1,8,0,0,0,0,0,0,2,1,0,0,0,0,100.8351814,1,0.014197724,0.538642058,0.026358365,0.978971502,0.989524162,36.08089734,0,0.985988448,1.004308569,0.981758474,0.326218851,0.488531914,107.9337777,0,0.141731643,0.628073058,0.225661078,0.821465033,0.884832342,95.90710949,1,-0.180913242,0.586672541,-0.308371757,0.75779947,0.841803151,58.60530489,0,-1.683702116,0.970267632,-1.735296593,0.082688285,0.165589178,N,-,,ceramide glucosyltransferase,C:membrane; F:transferase activity,IPR029044 (G3DSA:3.90.550.GENE3D); PF13641 (PFAM); PTHR12726 (PANTHER); PTHR12726:SF0 (PANTHER); IPR029044 (SUPERFAMILY),4.D.1.4.2, the putative vectorial glycosyl polymerization (vgp) family.
RL4_JR_08283,1325,1474,1788,0,1,2,0,0,1,0,0,0,0,2,4,0,0,0,38.44919792,1,-2.269521982,1.154268057,-1.966200111,0.0492755,0.13128332,10.98980696,1,0.007369539,1.216345562,0.006058754,0.995165843,0.997728671,63.76376853,0,0.177098062,0.753015077,0.23518528,0.81406493,0.879197072,57.1011185,1,0.197781462,0.647409247,0.305496813,0.759987797,0.843188339,77.11084386,0,1.047462136,0.552867807,1.894597809,0.058145705,0.125474268,N,-,,lanosterol synthase,F:intramolecular transferase activity,IPR018333 (TIGRFAM); IPR008930 (G3DSA:1.50.10.GENE3D); IPR008930 (G3DSA:1.50.10.GENE3D); IPR032696 (PFAM); IPR032697 (PFAM); PTHR11764 (PANTHER); PTHR11764:SF20 (PANTHER); IPR008930 (SUPERFAMILY); IPR008930 (SUPERFAMILY),,
RL4_JR_08284,8891,9280,7009,6,1,5,0,0,2,2,6,10,3,22,4,0,6,3,2.741668541,1,0.442699029,1.251905667,0.353620118,0.723623596,0.853821419,0.870476552,1,3.665595475,1.428026183,2.566896545,0.010261322,0.034188645,2.26484855,1,1.009493502,1.21891083,0.82819307,0.407561168,0.549713464,2.613307358,1,0.58688995,1.226751163,0.47840994,0.63235846,0.747534082,13.82005941,1,3.116427207,0.870049803,3.581895193,0.000341111,0.001947967,N,-,,type IIB DNA topoisomerase,,G3DSA:3.40.1360.10 (GENE3D); IPR002815 (SUPERFAMILY),,
RL4_JR_08285,2515,2854,4220,0,2,3,0,0,0,0,0,2,0,4,2,0,3,0,133.7568199,1,-1.946476208,0.8385516,-2.321236055,0.020274107,0.06626449,32.16237285,0,-1.541822276,1.216310035,-1.267622754,0.204932702,0.349884082,106.1798353,1,-2.361892045,1.055772239,-2.237122703,0.025278321,0.067170007,96.98796566,1,-4.626932138,1.218895769,-3.796003115,0.000147048,0.001485886,87.39799288,1,-3.370701433,1.159362166,-2.907375737,0.003644751,0.013850127,N,-,,ankyrin repeat containing yar1,,IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); PTHR24193 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),8.A.28.1.1, the ankyrin (ankyrin) family.
RL4_JR_08286,966,1496,806,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.33129498,0,-0.976591386,1.241037323,-0.786915404,0.43133139,0.622420481,2.328924201,0,2.245746184,1.335903036,1.681069751,0.092749367,0.191164548,6.071527411,0,-0.413299194,1.231141383,-0.335704087,0.737094023,0.823033199,7.005672543,0,-0.83591389,1.234305387,-0.677234256,0.498257337,0.636371087,6.025533145,0,-0.504898924,1.241942791,-0.406539599,0.684346167,0.775924406,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502:SF51 (PANTHER); PTHR23502 (PANTHER); PTHR23502 (PANTHER); PTHR23502:SF51 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.31, the major facilitator superfamily (mfs).
RL4_JR_08287,408,608,274,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0.644723186,0,2.5307846,1.765828154,1.433199825,0.15180074,NA,0.206446674,0,5.741629903,1.822253679,3.150840066,0.001628016,0.015023052,0.535013248,0,3.090791183,1.273934768,2.42617696,0.015258828,0.045116932,0.617118905,0,2.668916333,1.373900982,1.942582739,0.052066594,0.125807414,0.527420639,1,3.008611886,1.237052049,2.43208189,0.015012313,0.043555661,N,-,,---NA---,,no IPS match,,
RL4_JR_08288,9,20,29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.1503723,0,2.291811445,1.021841158,2.242825537,0.024908067,0.078576957,0.806511799,0,3.77577956,1.451451598,2.601381655,0.009284909,0.031888626,2.086016959,0,1.128135187,1.219842711,0.924820206,0.355059438,0.498629734,2.405916021,0,0.706130321,1.228301149,0.57488371,0.565369948,0.692855328,2.051294925,0,1.049408102,1.210661736,0.866805377,0.386048656,0.522349678,N,-,,zinc c2h2 type domain containing partial,F:nucleic acid binding,IPR015880 (SMART); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007219 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_08289,15816,13534,11531,0,1,4,0,0,0,0,5,2,2,14,3,0,1,2,0.011692083,1,8.312151371,3.996763216,2.079720745,0.037551154,NA,0.003838345,0,11.49092626,3.994647088,2.876581086,0.004020089,0.018157671,0.009833003,1,8.854297471,3.046863773,2.906036545,0.003660387,0.015609839,0.011330785,1,8.434549956,3.995610333,2.110954085,0.034776259,0.099426657,0.009620272,1,8.767548331,1.615958211,5.425603379,5.78E-08,1.50E-06,N,-,,hypothetical protein SPI_03356,C:membrane; C:integral component of membrane; P:protein glycosylation at cell surface; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_08290,15,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.055265175,0,6.074600055,3.9260229,1.547265569,0.121799221,NA,0.018201694,0,9.246116499,3.064060826,3.017602138,0.002547832,0.015349618,0.046395931,0,6.618703438,1.823187334,3.630292572,0.0002831,0.002221787,0.05345397,0,6.19820231,3.094694207,2.002848067,0.045193599,0.115278131,0.045034973,0,6.551465597,1.43560452,4.56355877,5.03E-06,5.71E-05,N,-,,hypothetical protein SPI_03356,,no IPS match,,
RL4_JR_08291,8266,6953,8157,4,3,4,0,0,1,0,8,2,4,7,1,0,6,0,14.23222594,1,0.213953522,1.179460346,0.181399504,0.856054008,0.927670176,1.974298521,1,2.484056907,1.346002153,1.845507381,0.064963766,0.144805822,5.149859288,1,-0.175807716,1.230070976,-0.142924855,0.886349529,0.929457419,5.942471631,1,-0.598482695,1.23353377,-0.48517739,0.627550519,0.743673807,5.112750354,1,-0.267897222,1.240323607,-0.215989779,0.828995714,0.885239929,N,-,,major facilitator superfamily transporter,P:biological_process; P:transmembrane transport; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11360 (PANTHER); PTHR11360:SF130 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.13.19, the major facilitator superfamily (mfs).
RL4_JR_08292,5481,5826,7617,1,6,23,0,0,0,0,6,0,6,8,2,0,3,1,0.251984387,1,3.88621176,3.082684643,1.260658228,0.20743201,NA,0.077672166,0,7.15125241,2.505909933,2.853754764,0.004320587,0.018725049,0.20618129,1,4.466191032,1.684595663,2.651194664,0.00802076,0.027426988,0.238196747,1,4.042249118,2.149461927,1.880586517,0.060028187,0.136796173,0.207961429,1,4.352774189,1.56366931,2.78369228,0.0053744,0.018991407,N,-, Effector probability:0.879,hypothetical protein SPI_02215,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_08293,2447,1778,2116,0,0,6,0,0,0,4,0,0,0,2,1,0,0,0,24.6066528,1,5.035405921,0.881831493,5.710167943,1.13E-08,2.62E-07,0.185393372,0,5.896867626,1.878875237,3.138509419,0.001698095,0.015023052,6.97786448,1,4.211205531,1.221847767,3.446587738,0.000567714,0.003716147,10.18783958,1,3.77977138,1.173199604,3.221763259,0.001274044,0.009090692,0.471136667,0,3.171041741,1.250690295,2.535433236,0.011230833,0.034468684,N,-,,GNAT family,F:transferase activity,IPR000182 (PFAM); IPR016181 (G3DSA:3.40.630.GENE3D); PTHR21471:SF61 (PANTHER); PTHR21471 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_08294,124412,136457,142095,26,77,102,2,0,10,3,18,28,9,58,15,0,72,12,39.80753854,1,-0.926132744,1.017375107,-0.910315907,0.362655932,0.554035036,7.564195717,1,0.546328488,1.227568306,0.445049359,0.656284084,0.778496133,128.605547,1,2.425276927,0.453081608,5.352847883,8.66E-08,3.02E-06,169.1008521,1,2.556752141,0.387670493,6.595168292,4.25E-11,1.71E-09,102.5469812,1,2.473692993,0.43795479,5.648283911,1.62E-08,7.46E-07,N,-,,maltose permease MAL31,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR003663 (TIGRFAM); IPR005828 (PFAM); PTHR23500:SF98 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.10, the major facilitator superfamily (mfs).
RL4_JR_08295,1852,2038,2048,4,0,6,0,0,0,0,0,1,1,2,7,0,0,0,31.25506124,1,3.141036208,0.620604911,5.06124936,4.17E-07,7.02E-06,1.327258022,0,3.05712919,1.363068571,2.242828611,0.024907869,0.068361564,3.436601197,1,0.408232907,1.206357545,0.338401255,0.735060829,0.821810462,3.964202534,1,-0.013992555,1.206845585,-0.011594321,0.990749277,0.994284511,3.378539507,0,0.329936455,1.200699689,0.274786825,0.783480021,0.851700152,N,-, Effector probability:0.927,hypothetical protein SPSK_06776,,no IPS match,,
RL4_JR_08296,3986,3315,2846,0,10,1,0,0,0,0,1,1,2,6,0,0,6,0,9.442035037,1,-1.341462242,1.195420768,-1.122167422,0.261791261,0.441167757,3.033980829,0,1.864361194,1.28728871,1.448285205,0.147537304,0.273114451,7.836139561,1,-0.781100315,1.201161852,-0.650287315,0.51550665,0.646634781,9.037289181,1,-1.2030235,1.199314548,-1.003092559,0.315816204,0.46201629,11.55109344,1,0.073009921,1.125687365,0.06485808,0.948286998,0.96649782,N,-,,hypothetical protein CMQ_8289,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_08297,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.365973882,0,-1.166815989,1.188820992,-0.981490062,0.326351133,0.515663867,2.679871113,0,2.043397008,1.285021287,1.590165882,0.111797419,0.220975097,6.934219585,0,-0.604680252,1.195128235,-0.505954285,0.612888742,0.728256609,7.998143128,0,-1.026778552,1.192378647,-0.861117862,0.389173132,0.533781897,6.816876596,0,-0.682945251,1.192013887,-0.572933972,0.566689401,0.683675172,N,-,,---NA---,,no IPS match,,
RL4_JR_08298,15219,12250,12321,3,3,1,0,0,1,0,0,1,0,3,0,0,7,0,10.46657338,1,-1.490263263,1.199277363,-1.242634364,0.214002601,0.382388481,3.350360939,1,1.72118591,1.278373842,1.346386991,0.178177744,0.315638633,8.683055015,1,-0.92933814,1.203305552,-0.772320994,0.439924334,0.579921088,10.01572233,1,-1.351508681,1.202052749,-1.124333921,0.260871393,0.401112051,8.559016911,1,-1.011302641,1.20627663,-0.8383671,0.401824561,0.539084892,N,-,,Peptidase cysteine trypsin,,G3DSA:2.40.10.10 (GENE3D); IPR009003 (SUPERFAMILY),,
RL4_JR_08299,1711,1721,1550,4,4,2,0,0,0,3,0,1,0,0,1,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_08300,229,345,310,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0.099341351,0,5.228904905,3.917492575,1.334758089,0.181955535,NA,0.031564741,0,8.450553888,2.634933102,3.207122746,0.001340698,0.015023052,0.082246844,1,5.791033066,1.508638041,3.838583483,0.000123746,0.001321506,0.094899828,0,5.369824868,2.369476372,2.266249595,0.023436106,0.082852853,0.081553631,0,5.702056001,1.305853898,4.366534427,1.26E-05,0.000122425,N,-,,---NA---,,no IPS match,,
RL4_JR_08301,137,372,288,0,0,37,1,0,0,1,0,0,0,5,0,0,0,0,0.282555764,1,3.720936598,2.557500476,1.4549114,0.145693791,NA,0.090361475,1,6.933563523,2.139736287,3.240382268,0.001193696,0.015023052,0.234372833,1,4.281292432,1.335844512,3.204933204,0.001350938,0.007296223,0.270355259,1,3.859611043,1.641819483,2.350813279,0.018732431,0.074407951,0.231247334,0,4.197919023,1.254494653,3.346302843,0.000818969,0.004072721,N,-,,fungal transcriptional regulatory,F:binding,IPR001138 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31313 (PANTHER); PTHR31313:SF37 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_08302,114,72,84,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.61863637,0,-1.032047043,1.236174013,-0.834871978,0.403789794,0.595702216,2.418344148,0,2.191387799,1.326810402,1.651620907,0.098611855,0.200431566,6.306769256,0,-0.468139898,1.227467347,-0.381386844,0.702916221,0.798241596,7.277328428,0,-0.890798786,1.230074197,-0.724182971,0.468953412,0.610074811,25.20725088,0,2.036694622,0.815144146,2.498569892,0.012469555,0.037509351,N,-,,glycosyltransferase family 71,C:membrane; F:transferase activity,IPR022751 (PFAM); PTHR31392 (PANTHER); IPR029044 (SUPERFAMILY),,
RL4_JR_08303,280,474,433,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32.00425883,0,4.930685795,0.703629613,7.007501826,2.43E-12,1.14E-10,0.468620518,0,4.55901822,1.61676264,2.81984387,0.004804702,0.020121305,1.211169645,0,1.912263467,1.270065411,1.505641718,0.132159173,0.238626622,23.06679506,0,4.196445798,0.804833635,5.214053703,1.85E-07,3.92E-06,1.191487513,0,1.832995211,1.253750895,1.462009094,0.143738718,0.250836697,Y,-,,hypothetical protein CMQ_1931,,no IPS match,,
RL4_JR_08304,9,12,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.052891608,0,0.859736105,1.379744399,0.623112589,0.533210537,NA,0.659243801,0,4.06657137,1.565010565,2.598430618,0.009365097,0.032079022,27.70253819,0,4.204874808,0.830390883,5.063729496,4.11E-07,1.23E-05,1.969456123,0,0.994746563,1.31135539,0.758563674,0.44811361,0.590083275,1.684646047,0,1.333500113,1.274018244,1.046688397,0.295243317,0.430182557,N,-,,hypothetical protein FOYG_15645,C:membrane,IPR025509 (PFAM),,
RL4_JR_08305,911,1197,1079,0,0,2,0,0,0,0,0,1,3,0,0,0,0,0,84.0652666,1,-0.935497784,0.663116325,-1.410759695,0.158315483,0.307508978,18.82298561,0,-0.768880516,1.205156209,-0.637992412,0.52347862,0.672844519,67.6044831,1,-1.589813065,1.029251719,-1.544629983,0.122435789,0.22520711,69.80784258,1,-2.104419683,1.012354781,-2.078737338,0.037641499,0.103172761,59.08559668,0,-1.817731625,0.965228356,-1.883214075,0.059671362,0.128138398,N,-,,guanine nucleotide exchange factor,P:intracellular transport; P:endosomal transport; P:protein localization to vacuole,IPR003123 (SMART); IPR003892 (SMART); IPR003123 (PFAM); IPR003892 (PFAM); G3DSA:1.10.8.10 (GENE3D); PTHR23101 (PANTHER); PTHR23101:SF25 (PANTHER); PTHR23101:SF25 (PANTHER); PTHR23101 (PANTHER); IPR003892 (PROSITE_PROFILES); IPR003123 (PROSITE_PROFILES); SSF109993 (SUPERFAMILY); IPR009060 (SUPERFAMILY),1.F.1.1.5, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_08306,265,251,183,0,0,2,0,0,0,0,0,0,0,0,0,0,3,0,1.643556724,1,1.180814207,1.304936245,0.90488268,0.365527544,NA,0.527936992,0,4.387158831,1.541908382,2.845278541,0.00443726,0.019050679,1.36387813,0,1.74140052,1.228525361,1.417472178,0.156344923,0.270477785,1.57296088,0,1.31940423,1.248453352,1.05683102,0.290588714,0.435367081,1.338886386,1,1.664867265,1.210874706,1.374929426,0.169153325,0.283743774,N,-,,alpha beta-hydrolase,P:metabolic process; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR013094 (PFAM); PTHR23024:SF156 (PANTHER); PTHR23024 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_08307,10401,9514,8177,1,1,6,0,0,2,0,0,3,1,6,0,0,11,1,14.84522875,1,0.074792664,1.148536591,0.065119966,0.948078483,0.97410885,2.177196396,1,2.342989008,1.30291666,1.798264678,0.072135074,0.157360177,38.86915021,1,2.109473091,0.854035589,2.470006071,0.013511076,0.04091718,6.529083778,1,-0.734286432,1.202210311,-0.610780348,0.541345005,0.672282372,17.17518363,1,1.796905571,0.864813738,2.077794897,0.037728254,0.089903171,N,-,,carbohydrate purine kinase,,IPR029056 (G3DSA:3.40.1190.GENE3D); IPR011611 (PFAM); PTHR10584 (PANTHER); PTHR10584:SF185 (PANTHER); IPR029056 (SUPERFAMILY),,
RL4_JR_08308,14225,13054,17606,0,10,15,0,0,1,1,8,24,5,12,0,0,12,0,28.26010441,1,-2.922981877,1.200233865,-2.435343613,0.014877654,0.052180526,8.97505893,1,0.299581319,1.223434234,0.244869165,0.806557738,0.883358844,23.34192135,1,-2.355865691,1.197645264,-1.967081373,0.04917383,0.111647423,26.9328193,1,-2.778471943,1.197379766,-2.320460076,0.020316002,0.077430677,23.05505998,1,-2.440757629,1.203667445,-2.027767419,0.042583991,0.098749886,N,-,,allantoin permease,P:nucleobase transport; C:plasma membrane; F:nucleobase transmembrane transporter activity,IPR001248 (PFAM); PTHR30618 (PANTHER); PTHR30618:SF10 (PANTHER); PTHR30618 (PANTHER); PTHR30618:SF10 (PANTHER),2.A.39.3.10, the nucleobase:cation symporter-1 (ncs1) family.
RL4_JR_08309,3491,3680,4681,3,1,16,0,0,0,4,5,0,2,2,0,0,4,0,35.76698853,1,2.205902491,0.608725935,3.62380238,0.000290303,0.002116439,2.887656881,0,1.935677199,1.288310912,1.50249228,0.13297002,0.251245575,42.65825038,1,2.425038642,0.678761072,3.572742669,0.000353262,0.002629723,20.6587602,1,1.161943812,0.866964939,1.340243139,0.180166311,0.305660841,7.34673231,1,-0.790801428,1.200676806,-0.658629719,0.510133574,0.636723673,N,-,,#NAME?,,IPR023606 (G3DSA:3.40.50.GENE3D); IPR003673 (PFAM); G3DSA:3.30.1540.10 (GENE3D); PTHR24023 (PANTHER); PTHR24023:SF593 (PANTHER); IPR023606 (SUPERFAMILY),,
RL4_JR_08310,800,515,509,0,5,0,0,0,0,3,0,4,3,0,0,0,0,0,11.41173381,1,-1.614974381,1.188816056,-1.358472888,0.17431368,0.329026145,3.651229625,0,1.597136805,1.262281575,1.265277761,0.205771776,0.35064342,9.460950832,1,-1.053083361,1.194857052,-0.881346734,0.378130178,0.52183614,10.91316183,1,-1.475282055,1.192524244,-1.237108648,0.21604675,0.350781485,9.319698349,0,-1.134126027,1.196340829,-0.947995754,0.343131616,0.480128194,N,-,,caib baif family enzyme,F:zinc ion binding; F:metal ion binding; F:catalytic activity; C:membrane; C:integral component of membrane; F:transferase activity,IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR019787 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY),,
RL4_JR_08311,1309,1765,2025,0,2,2,0,0,0,0,3,9,3,6,1,0,2,0,34.0358773,1,-3.191346595,1.251878576,-2.549246114,0.010795608,0.040254833,10.7091628,0,0.044670917,1.264584624,0.035324577,0.971820926,0.98535224,41.08375829,1,-0.815608033,1.086891972,-0.750403954,0.45301145,0.592467113,42.05563341,1,-2.090390767,1.195169056,-1.749033542,0.080285222,0.166791171,28.03258532,1,-2.722810158,1.253885075,-2.171498977,0.029893474,0.074992921,N,-,,asparagine synthase,P:alpha-amino acid metabolic process; P:cellular amino acid metabolic process,IPR017932 (PFAM); IPR001962 (PFAM); IPR014729 (G3DSA:3.40.50.GENE3D); IPR029055 (G3DSA:3.60.20.GENE3D); PTHR11772 (PANTHER); PTHR11772 (PANTHER); PTHR11772:SF3 (PANTHER); PTHR11772:SF3 (PANTHER); IPR017932 (PROSITE_PROFILES); SSF52402 (SUPERFAMILY); IPR029055 (SUPERFAMILY),,
RL4_JR_08312,1809,1343,848,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,0.004235441,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001340044,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003452355,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003983613,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003339785,0,10.24113992,1.835951848,5.578109216,2.43E-08,8.07E-07,,,,,,,,
RL4_JR_08313,489,395,608,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,2.47438627,1,0.590633039,1.249408479,0.472730135,0.636405724,0.792413799,0.786902143,0,3.811221907,1.441304115,2.64428712,0.008186318,0.029049239,2.045707585,0,1.15625931,1.21538331,0.951353618,0.341424897,0.484761134,10.38347135,0,2.457160474,1.023500578,2.400741659,0.016361883,0.069228612,2.020629655,0,1.071613488,1.212417389,0.883865159,0.376769007,0.51263662,N,-,,mfs general substrate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501:SF77 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_08314,1915,1525,1561,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,8113.791835,0,2.441918497,0.724289046,3.371469594,0.000747683,0.00469561,1082.666935,0,0.857747447,0.833504918,1.029085046,0.303439712,0.464310925,2705.985694,0,0.679598907,0.323388034,2.101496766,0.035597382,0.087255777,2963.018464,0,0.529939641,0.481188137,1.101314851,0.27075965,0.412308837,1659.72969,1,-0.646912742,0.814159923,-0.794576992,0.426859606,0.561438492,N,-,,phosphoglycerate kinase,F:ATP binding; C:cytoplasm; F:phosphoglycerate kinase activity; P:glycolytic process,IPR001576 (PRINTS); IPR001576 (PFAM); IPR001576 (PIRSF); IPR015901 (G3DSA:3.40.50.GENE3D); IPR015824 (G3DSA:3.40.50.GENE3D); IPR001576 (PANTHER); PTHR11406:SF6 (PANTHER); IPR001576 (SUPERFAMILY),,
RL4_JR_08315,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,682.8112631,0,-0.041166155,0.696771017,-0.059081325,0.952887333,0.977080803,207.0530479,0,-0.678016776,0.830574499,-0.81632265,0.414315623,0.578054047,360.2192481,0,-1.790959815,0.660463549,-2.711670945,0.006694501,0.023730788,392.8117889,0,-2.09663625,0.677727508,-3.093627196,0.001977258,0.013119092,360.0716637,0,-1.637606843,0.572327577,-2.861310388,0.004218938,0.015578682,N,-,,transcription factor TFIIB,"F:zinc ion binding; F:RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly; F:transcription factor activity, core RNA polymerase II recruiting; P:translational initiation; F:RNA polymerase II core binding; P:transcriptional open complex formation at RNA polymerase II promoter; P:regulation of transcription from RNA polymerase II promoter; C:nucleus; C:transcriptional preinitiation complex; F:translation initiation factor activity; P:RNA polymerase II transcriptional preinitiation complex assembly; P:transcriptional start site selection at RNA polymerase II promoter; P:positive regulation of transcription regulatory region DNA binding; C:integral component of membrane; F:TBP-class protein binding",IPR000812 (PRINTS); IPR013763 (SMART); IPR013763 (G3DSA:1.10.472.GENE3D); IPR013137 (PFAM); G3DSA:2.20.25.10 (GENE3D); IPR013150 (PFAM); IPR000812 (PANTHER); IPR013137 (PROSITE_PROFILES); SSF57783 (SUPERFAMILY); IPR013763 (SUPERFAMILY); IPR013763 (SUPERFAMILY),,
RL4_JR_08316,289,526,382,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,90.58832464,0,-1.985717216,0.902990298,-2.199046014,0.027874651,0.085328855,23.04477609,0,-1.060897715,1.217706654,-0.871226014,0.383630758,0.548090739,60.20614795,1,-3.722880481,1.212400574,-3.070668687,0.0021358,0.010365695,104.4761178,0,-0.8481739,0.667270335,-1.271109857,0.203689569,0.335466307,63.68633353,0,-2.888739323,1.155257349,-2.500515859,0.012401258,0.037380988,N,-,,chromatin structure-remodeling complex rsc7,F:DNA-dependent ATPase activity; P:protein import into nucleus; P:ATP-dependent chromatin remodeling; C:RSC complex; P:cellular response to DNA damage stimulus; P:nucleosome disassembly; P:transcription elongation from RNA polymerase II promoter,IPR013933 (PFAM); PTHR22597:SF3 (PANTHER); PTHR22597 (PANTHER); IPR013933 (PRODOM),,
RL4_JR_08317,104,101,134,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,60.59186144,1,0.218902145,0.727638789,0.300839027,0.763537247,0.876204369,8.706206904,0,0.343516194,1.27454149,0.26952139,0.787528484,0.871568261,75.92802008,0,1.331131076,0.653862988,2.035795113,0.041770933,0.098921387,104.6274624,0,1.41403192,0.578591513,2.44392095,0.01452861,0.065233779,21.84703856,0,-2.363196637,1.221910435,-1.934017887,0.053110929,0.117233083,N,-,,cyclin,F:protein kinase binding; C:intracellular part; P:regulation of cyclin-dependent protein serine/threonine kinase activity,IPR013922 (PFAM); PTHR15615 (PANTHER); PTHR15615 (PANTHER); PTHR15615:SF27 (PANTHER); IPR013763 (SUPERFAMILY),,
RL4_JR_08318,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.4972656,0,-2.31154232,1.201067795,-1.924572725,0.054282834,0.141572686,5.870137551,0,0.912086643,1.238089833,0.736688582,0.461311752,0.619840304,28.27700943,0,0.073464167,1.040659523,0.070593854,0.943721002,0.966636121,30.9545963,0,-0.432515701,1.022933948,-0.422818797,0.672427472,0.777330003,26.33532995,0,-0.153040309,0.987624161,-0.154958045,0.876854393,0.917922945,N,-,,NEFA-interacting nuclear NIP30,,IPR019331 (PFAM); PTHR13495:SF0 (PANTHER); PTHR13495 (PANTHER),,
RL4_JR_08319,379,364,600,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,105.3931935,1,-0.628894213,0.658297963,-0.955333675,0.339408983,0.529223716,20.86007168,0,-0.917202299,1.222409688,-0.75032316,0.453060097,0.612511594,92.36698388,0,-0.73740223,0.778412641,-0.947315333,0.34347812,0.487026959,62.94857786,0,-4.003305177,1.219376498,-3.283075558,0.001026811,0.007561066,54.22233857,0,-3.674591857,1.226803134,-2.995257964,0.002742128,0.011031967,N,-,,mitochondrial import inner membrane translocase subunit tim-54,P:protein import into mitochondrial inner membrane; C:mitochondrial inner membrane protein insertion complex,IPR021056 (PFAM); PTHR12358 (PANTHER),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_08320,873,856,680,0,0,0,0,0,0,0,0,0,0,2,0,0,3,0,162.5164355,0,0.706003917,0.407424394,1.732846455,0.083122964,0.193581826,29.87595674,0,0.025135374,1.116797237,0.022506658,0.982043801,0.990676395,70.62076685,0,-1.715423717,1.030437763,-1.664752379,0.095962168,0.188096997,105.1778777,1,-0.426196741,0.572557139,-0.744374162,0.456650146,0.598677033,70.73455418,1,-1.398016225,0.833983293,-1.676312028,0.09367709,0.181562124,N,-,,AGC NDR kinase,F:identical protein binding; P:establishment or maintenance of bipolar cell polarity regulating cell shape; C:mating projection tip; P:cell separation after cytokinesis; P:microtubule cytoskeleton organization; F:protein serine/threonine kinase activity; P:protein phosphorylation; P:budding cell apical bud growth; P:regulation of fungal-type cell wall organization; C:nucleus; F:ATP binding; C:incipient cellular bud site; C:cellular bud tip; P:cellular response to osmotic stress; C:cellular bud neck; C:cell cortex of cell tip; P:maintenance of protein location in cell cortex of cell tip; P:positive regulation of bipolar cell growth; C:cytosol; P:regulation of establishment or maintenance of bipolar cell polarity regulating cell shape; P:fungal-type cell wall assembly; P:establishment or maintenance of actin cytoskeleton polarity,IPR000961 (SMART); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24356 (PANTHER); PTHR24356:SF184 (PANTHER); IPR000961 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_08321,2625,2874,3660,2,0,5,0,0,0,3,0,0,0,2,1,0,1,0,30.14766953,1,-3.016349669,1.25901227,-2.395806411,0.016583847,0.056534712,9.501861043,0,0.217232911,1.278493309,0.169913217,0.865078387,0.921816506,37.90574663,1,-0.644040798,1.094296633,-0.58854316,0.556167773,0.682833196,28.75008946,1,-2.872732558,1.249221645,-2.299617982,0.021469872,0.079539868,24.86355248,1,-2.549743575,1.261602299,-2.021035929,0.043276046,0.10006165,N,-, Effector probability:0.583,splicing factor 3A subunit 2,F:zinc ion binding; F:RNA binding; C:catalytic step 2 spliceosome; C:cytosol; C:U2-type prespliceosome; C:U2 snRNP; P:spliceosomal complex assembly,IPR003604 (SMART); SM01050 (SMART); PF12874 (PFAM); IPR031781 (PFAM); PTHR23205:SF0 (PANTHER); PTHR23205 (PANTHER); PTHR23205:SF0 (PANTHER); IPR000690 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_08322,3495,3200,5100,0,1,1,0,0,0,0,0,0,1,4,0,0,1,0,47.10631043,1,-2.44131935,1.145237198,-2.131715031,0.03303028,0.097560111,12.52850103,0,-0.181622236,1.218760313,-0.149022112,0.881536185,0.932578309,54.5793231,0,-0.998327727,1.03505964,-0.964512275,0.334789158,0.477998461,49.45107387,1,-0.954318214,0.864323203,-1.104121942,0.269540244,0.41087461,31.93896514,1,-2.911060635,1.196953113,-2.432059036,0.01501326,0.043555661,Y,-,,hypothetical protein SPI_04657,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_08323,632,568,690,1,1,5,0,0,0,0,0,0,0,0,0,0,0,0,270.5933163,1,-2.13938174,0.548130437,-3.903052258,9.50E-05,0.000818274,70.23592459,0,-2.668615078,1.196223567,-2.230866496,0.025689974,0.069920385,192.8273295,0,-4.35508904,1.193660272,-3.648516367,0.000263759,0.002106699,298.8943518,0,-1.295775136,0.454563991,-2.850589049,0.004363833,0.02524789,298.7871467,0,-0.332171285,0.40465914,-0.820866877,0.4117221,0.547574709,N,-,,stress response nst1,C:cytoplasm,IPR025279 (PFAM); PTHR31780:SF1 (PANTHER); PTHR31780 (PANTHER),1.F.2.1.1, the octameric exocyst (exocyst) family.
RL4_JR_08324,18632,10762,11401,1,0,4,0,0,0,0,0,0,0,0,0,0,3,1,98.13604837,1,0.339903009,0.528796301,0.642786283,0.520362785,0.70481813,24.45000377,0,0.46875118,1.115932878,0.420053204,0.674446588,0.79200467,124.6375604,0,1.049086052,0.497664117,2.108020279,0.035029235,0.086265137,123.9024467,0,0.891864664,0.457147887,1.950932485,0.051065078,0.124827115,60.86403869,1,-0.951386394,0.852255316,-1.116316175,0.26428682,0.3966135,N,-, Effector probability:0.67,gtp-binding rho2,F:GTP binding; C:nucleus; C:site of polarized growth; C:cell division site; C:cell tip; P:small GTPase mediated signal transduction; F:GTPase activity; P:regulation of alpha-glucan biosynthetic process; P:establishment or maintenance of cell polarity regulating cell shape; C:cytosol; P:establishment or maintenance of actin cytoskeleton polarity,PR00449 (PRINTS); SM00173 (SMART); SM00175 (SMART); SM00174 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); IPR001806 (PFAM); PTHR24072:SF28 (PANTHER); PTHR24072 (PANTHER); PS51420 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_08325,578,583,530,0,5,0,0,0,0,2,0,0,0,1,0,0,0,0,79.34504545,1,0.034251432,0.688088487,0.049777656,0.960299573,0.979877913,14.09760391,0,-0.351921305,1.243207136,-0.283075358,0.777119071,0.864870724,88.8596174,1,0.590396921,1.368304175,0.431480757,0.666118842,0.770190401,84.45805064,1,-0.323204562,0.734473166,-0.440049517,0.659901244,0.768292972,36.70184334,0,-3.111563744,1.238551093,-2.51226111,0.011996029,0.036370126,N,-,,vacuolar membrane,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; P:nitrogen compound metabolic process; C:integral component of membrane; C:fungal-type vacuole",IPR007248 (PFAM); PTHR11266:SF8 (PANTHER); IPR007248 (PANTHER),9.B.192.1.2, the mpv17/pmp22 4 tms putative porin (mpv17) family.
RL4_JR_08326,216,202,185,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,67.46279202,0,-0.135648545,0.609920548,-0.222403632,0.823999685,0.91111269,12.88091356,0,-0.221657563,1.205653818,-0.183848431,0.854132361,0.913806971,100.4739915,0,0.951128894,0.533196372,1.783824768,0.074452144,0.154157721,89.60113206,0,0.737702629,0.487379197,1.513611237,0.130124469,0.239022397,56.13510386,0,0.227375366,0.627541251,0.362327362,0.717107413,0.800675587,N,-,,26 proteasome complex subunit Sem1,C:proteasome complex,IPR007834 (SMART); IPR007834 (PFAM),,
RL4_JR_08327,10831,10174,14858,0,2,9,0,0,0,3,0,2,0,3,1,0,7,0,29.34767963,1,1.833457612,0.87609204,2.092768258,0.036369847,0.105065584,1.683704664,0,2.713801584,1.34019856,2.024925011,0.042875065,0.104534188,4.389559748,1,0.05478318,1.216930053,0.045017526,0.96409334,0.978985052,13.08867296,1,1.348320147,1.039143989,1.297529661,0.194449006,0.323868431,11.71366286,1,0.904917499,1.146806702,0.789075873,0.430067663,0.564484714,N,-,,mitochondrial outer membrane iml2,C:membrane; C:cytoplasmic part,IPR019412 (PFAM); PTHR31859 (PANTHER); PTHR31859:SF1 (PANTHER); PTHR31859 (PANTHER); PTHR31859:SF1 (PANTHER); PTHR31859:SF1 (PANTHER),,
RL4_JR_08328,329,441,458,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,246.3629574,0,-2.251276105,0.601616175,-3.742047173,0.000182527,0.001420856,65.46999715,0,-2.567255057,1.200041441,-2.139305335,0.032410948,0.083968164,176.4575336,1,-4.258267388,1.200482217,-3.547130752,0.000389451,0.002830441,238.7572239,0,-1.938656531,0.571085545,-3.394686745,0.000687072,0.005413697,255.2053913,0,-0.55685279,0.503033717,-1.106988997,0.268298685,0.400497879,N,-,,TPR Domain containing,F:protein complex scaffold; P:response to heat; C:TRC complex; P:posttranslational protein targeting to membrane,IPR019734 (SMART); PF13432 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR001440 (PFAM); IPR032374 (PFAM); PTHR22904 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY),3.A.21.1.1, the c-terminal tail-anchored membrane protein biogenesis/ insertion complex (tamp-b) family.
RL4_JR_08329,1823,1557,2228,0,0,5,0,0,0,0,1,0,0,14,0,0,0,2,76.25207965,1,-0.277960737,0.646261217,-0.43010586,0.667118637,0.81521178,15.7911061,0,-0.515556736,1.217836376,-0.423338263,0.672048481,0.790704326,47.53963823,1,-2.208255456,1.202154109,-1.836915449,0.066222378,0.140552486,126.0046082,1,0.90331403,0.479593091,1.883500924,0.059632515,0.136354635,59.5283262,1,-0.648469991,0.780005916,-0.831365478,0.405767195,0.542648639,N,-,,E3 ubiquitin- ligase MARCH5,F:zinc ion binding; F:metal ion binding; C:membrane; C:integral component of membrane,IPR011016 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR011016 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),,
RL4_JR_08330,5890,4964,6883,0,5,14,0,2,0,0,0,0,2,4,6,0,0,2,91.47337271,1,2.057597373,0.426147329,4.828370931,1.38E-06,2.01E-05,16.30754174,1,1.589132397,1.1265056,1.41067421,0.158340699,0.28810436,24.43147425,0,-1.013767075,1.191682425,-0.85070238,0.394934701,0.538059334,20.68387632,1,-2.397648359,1.190831393,-2.013423877,0.044070056,0.113919494,17.64174981,1,-2.054756527,1.192854993,-1.722553486,0.084969303,0.16898727,N,-,,Galactokinase,F:ATP binding; C:cytoplasm; P:galactose metabolic process; P:carbohydrate phosphorylation; F:galactokinase activity,IPR000705 (PRINTS); IPR006206 (PRINTS); IPR013750 (G3DSA:3.30.70.GENE3D); IPR014721 (G3DSA:3.30.230.GENE3D); IPR006204 (PFAM); IPR019539 (PFAM); IPR000705 (PIRSF); IPR000705 (TIGRFAM); IPR013750 (PFAM); PTHR10457:SF7 (PANTHER); IPR006206 (PANTHER); IPR006206 (PANTHER); PTHR10457:SF7 (PANTHER); IPR013750 (SUPERFAMILY); IPR020568 (SUPERFAMILY),,
RL4_JR_08331,701,701,887,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,147.8501149,1,-3.518579383,1.042233125,-3.37600034,0.000735478,0.004641112,44.42859606,0,-2.007924086,1.20012914,-1.67309002,0.094309576,0.193552621,135.3068054,0,-2.269115636,0.870163554,-2.607688664,0.009115582,0.030417322,229.3099761,0,-0.313527437,0.43787402,-0.716022013,0.473977757,0.614944232,145.6153212,0,-1.239327874,0.648371887,-1.911446037,0.055947285,0.122004364,N,-,,snf5 smarcb1 ini1,"F:zinc ion binding; P:regulation of nuclear cell cycle DNA replication; C:nuclear chromosome; P:regulation of transcription, DNA-templated; P:chromosome segregation; F:sequence-specific DNA binding; P:galactose metabolic process; P:carbohydrate phosphorylation; P:nucleosome disassembly; F:galactokinase activity; P:double-strand break repair; P:transcription elongation from RNA polymerase II promoter; F:ATP binding; F:transcription factor activity, sequence-specific DNA binding; P:G2/M transition of mitotic cell cycle; P:ATP-dependent chromatin remodeling; C:cytosol; P:chromatin remodeling at centromere; C:RSC complex",IPR013088 (G3DSA:3.30.50.GENE3D); IPR006939 (PFAM); IPR000679 (PFAM); PTHR10019:SF5 (PANTHER); PTHR10019:SF5 (PANTHER); IPR006939 (PANTHER); SSF57716 (SUPERFAMILY),,
RL4_JR_08332,5650,4878,10159,0,0,1,0,0,1,0,0,0,3,0,0,0,0,1,588.0352374,1,-0.121398583,0.614123667,-0.197677747,0.843297201,0.921089646,105.5333521,1,-2.204693883,1.114938396,-1.977413183,0.047994945,0.114149981,281.1298376,0,-2.961911653,0.765546542,-3.869015781,0.000109276,0.001229229,388.8201018,1,-1.355739548,0.440712632,-3.076243908,0.002096263,0.013711022,285.9679847,1,-2.289031592,0.614209703,-3.726791646,0.000193933,0.001212828,N,-,,acetolactate synthase,F:magnesium ion binding; F:acetolactate synthase activity; F:thiamine pyrophosphate binding; P:isoleucine biosynthetic process; P:mycelium development; F:flavin adenine dinucleotide binding; P:valine biosynthetic process; C:acetolactate synthase complex,IPR029035 (G3DSA:3.40.50.GENE3D); IPR029061 (G3DSA:3.40.50.GENE3D); IPR012001 (PFAM); IPR029061 (G3DSA:3.40.50.GENE3D); IPR012846 (TIGRFAM); IPR012000 (PFAM); IPR011766 (PFAM); PTHR18968 (PANTHER); PTHR18968:SF13 (PANTHER); IPR029061 (SUPERFAMILY); IPR029035 (SUPERFAMILY); IPR029061 (SUPERFAMILY),,
RL4_JR_08333,6952,7334,5154,1,0,12,0,0,0,0,1,0,1,4,0,0,8,1,8.162446819,1,4.518188055,1.113894489,4.056208284,4.99E-05,0.000467686,0.165969181,0,6.056514271,1.942932156,3.117203168,0.001825757,0.015023052,0.432445241,1,3.39881832,1.336534386,2.543008512,0.010990255,0.035277534,20.55701406,1,5.939353867,0.787295516,7.543995546,4.56E-14,2.59E-12,0.427309909,1,3.313987382,1.287901605,2.573168143,0.010077224,0.03158882,N,-,,FAD dependent oxidoreductase,"F:NADP binding; F:flavin adenine dinucleotide binding; P:oxidation-reduction process; F:N,N-dimethylaniline monooxygenase activity",PR00419 (PRINTS); PF13450 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR020946 (PFAM); PTHR23023:SF40 (PANTHER); PTHR23023 (PANTHER); PTHR23023:SF40 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_08334,1745,1911,3832,0,0,0,0,0,0,0,0,9,0,0,1,0,4,0,0.265310535,0,3.811709245,2.668165478,1.428588023,0.153122679,NA,0.085165001,0,7.018977637,2.200398371,3.189866767,0.001423384,0.015023052,0.220601006,1,4.368378647,1.383486373,3.157514762,0.001591202,0.008261193,0.25443226,1,3.947063028,1.729408502,2.282319662,0.022470475,0.080821867,0.217587584,1,4.285087676,1.288110304,3.326646533,0.000878978,0.004308593,N,-,,het-s domain,F:ATP binding; C:membrane; C:integral component of membrane; F:protein kinase activity; F:transferase activity; P:protein phosphorylation; C:cellular_component,G3DSA:1.10.510.10 (GENE3D); PTHR37542 (PANTHER); IPR011009 (SUPERFAMILY),1.C.104.2.1, the heterokaryon incompatibility prion/amyloid protein (het-s) family
RL4_JR_08335,6400,8088,8805,0,0,6,0,0,0,0,1,6,3,11,0,0,6,1,2.693806341,1,0.468153973,1.229686714,0.380709955,0.703418481,0.839696806,0.860815656,0,3.681781854,1.425742559,2.582360911,0.009812691,0.033196543,2.230199908,1,1.031962645,1.209412663,0.853275872,0.393506337,0.536618825,35.49007569,1,3.349736311,0.738434212,4.536269119,5.73E-06,8.73E-05,16.92561922,1,2.637004755,0.970396169,2.717451737,0.006578675,0.022495469,N,-,,serine threonine kinase,F:binding,IPR000719 (SMART); IPR002110 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR020683 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR000719 (PFAM); PTHR24198 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR011009 (SUPERFAMILY),1.A.4.7.2, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_08336,241,183,243,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22.41630863,0,-2.588770423,1.26613017,-2.044632127,0.04089114,0.114399835,7.058023282,0,0.646230267,1.297875331,0.497913976,0.618544676,0.749246308,31.43678384,0,-0.210718335,1.096984947,-0.19208863,0.847672781,0.902496502,29.30658702,0,-0.745822225,1.095351222,-0.680897788,0.495936168,0.634489979,18.27670442,0,-2.105682177,1.260782,-1.670139784,0.09489171,0.183635047,N,-,,acid ase,F:aspartic-type endopeptidase activity; P:proteolysis,IPR000250 (PRINTS); IPR000250 (PFAM); PTHR37536 (PANTHER); PTHR37536:SF1 (PANTHER); IPR013320 (SUPERFAMILY),,
RL4_JR_08337,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.117196761,0,4.991230053,3.915865036,1.274617487,0.202444665,NA,0.03699848,0,8.222668829,3.05955151,2.687540576,0.007198036,0.026484375,0.095701833,0,5.576526057,2.03680762,2.737875684,0.006183745,0.022287017,0.110441762,0,5.152341882,2.869427187,1.795599451,0.072558243,0.155219145,0.093191351,0,5.512105126,1.770375263,3.11352358,0.001848677,0.007927937,N,-,,major facilitator superfamily transporter,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF6 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.37, the major facilitator superfamily (mfs).
RL4_JR_08338,4,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.17355081,0,4.424322368,3.168304011,1.396432398,0.162584325,NA,0.055321962,0,7.64173029,2.36612049,3.229645457,0.001239438,0.015023052,0.143341106,0,4.992713732,1.407814654,3.546428302,0.000390491,0.002833929,0.165364759,0,4.569408898,1.937940934,2.357867992,0.018380228,0.074009818,0.140871598,0,4.915621804,1.275518459,3.853822553,0.000116288,0.000786516,N,-,,Nitrilotriacetate monooxygenase component A pristinamycin IIA synthase subunit A,F:oxidoreductase activity,IPR011251 (PFAM); IPR011251 (G3DSA:3.20.20.GENE3D); PTHR30011 (PANTHER); PTHR30011:SF30 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_08339,1055,888,1330,7,12,226,0,0,1,11,12,16,14,63,5,2,85,12,83.72641564,1,1.700114887,0.91689995,1.854198909,0.063710708,0.159335364,7.235503,1,0.61047108,1.235174941,0.494238556,0.621137713,0.75061556,25.22607964,1,-1.076198958,1.194716081,-0.900798923,0.36769524,0.512042175,21.60216563,1,-2.460192379,1.194486576,-2.059623296,0.039434567,0.106530148,26.12120391,1,-0.447016292,0.9765341,-0.457757995,0.647126317,0.74801901,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501 (PANTHER); PTHR23501:SF8 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.52, the major facilitator superfamily (mfs).
RL4_JR_08340,120,102,134,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,3.961012354,1,5.654999835,1.29792183,4.356964883,1.32E-05,0.000147987,0.04564712,0,7.919492445,2.514762742,3.149200643,0.001637177,0.015023052,0.117650457,0,5.278882536,1.512372323,3.490464917,0.000482181,0.003289488,0.135694683,0,4.855057977,2.158728496,2.249035942,0.024510209,0.084669352,0.114798589,0,5.210970835,1.332035432,3.912036204,9.15E-05,0.000644852,N,-, Effector probability:0.732,luciferase-like monooxygenase,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity",IPR011251 (PFAM); IPR011251 (G3DSA:3.20.20.GENE3D); PTHR30011:SF21 (PANTHER); PTHR30011 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_08341,18,5,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.813627145,0,0.405009994,1.307756585,0.309698302,0.756790394,0.872432934,0.890754101,0,3.632238264,1.46659179,2.476652528,0.013262094,0.041754298,2.327260714,0,0.969903801,1.252915903,0.77411724,0.438861463,0.579022185,2.685705145,0,0.547161819,1.269457873,0.431020068,0.666453779,0.772594975,2.314531539,0,0.875497795,1.258545885,0.695642333,0.486652848,0.615074283,N,-,,Amino acid permease,P:transmembrane transport; C:membrane; C:integral component of membrane; F:amino acid transmembrane transporter activity; P:transport; P:amino acid transport; P:amino acid transmembrane transport,no IPS match,,
RL4_JR_08342,1086,929,1019,0,0,7,0,0,0,0,0,1,1,1,0,0,0,1,14.00667527,1,2.797781584,0.949285925,2.947248568,0.003206154,0.015215708,0.809197153,0,3.770778002,1.498043355,2.517135428,0.011831334,0.038199925,2.112330553,1,1.109683343,1.263639354,0.878164596,0.379854402,0.523858597,30.37428216,1,3.075454068,0.912416809,3.370667922,0.000749862,0.005808991,2.099720798,1,1.015968216,1.267531513,0.801532905,0.422823203,0.558387201,N,-,,aminopeptidase,P:proteolysis; F:aminopeptidase activity,IPR016117 (G3DSA:3.60.70.GENE3D); IPR005321 (PFAM); PTHR36512:SF1 (PANTHER); PTHR36512 (PANTHER); IPR016117 (SUPERFAMILY),,
RL4_JR_08343,15,9,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,224.4513942,0,6.238366439,2.119574623,2.943216234,0.003248215,0.015370611,0.949437624,0,3.540414797,1.411822894,2.507690456,0.012152307,0.039086198,72.8253919,0,5.024092401,0.495406836,10.14134654,3.62E-24,7.19E-22,63.69342818,0,4.035901271,0.576118315,7.005334085,2.46E-12,1.10E-10,9.787921474,0,1.745023699,1.126420231,1.549176454,0.121339308,0.221202826,N,-,,hypothetical protein V500_08946,"P:carbohydrate metabolic process; F:oxidoreductase activity; P:oxidation-reduction process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR001362 (SMART); IPR013189 (G3DSA:2.60.120.GENE3D); IPR013189 (PFAM); IPR013148 (PFAM); PTHR30175 (PANTHER); PTHR30175 (PANTHER); PTHR30175:SF10 (PANTHER); PTHR30175:SF10 (PANTHER); IPR023296 (SUPERFAMILY); IPR013320 (SUPERFAMILY),,
RL4_JR_08344,3291,2590,2701,1,2,4,0,0,0,0,0,2,0,0,1,0,0,0,0.023765515,1,7.291767558,3.951391854,1.845366855,0.064984191,NA,0.00801766,0,10.43077191,3.949162813,2.641261555,0.008259793,0.029217138,0.02010604,1,7.826608423,2.804730448,2.790502891,0.005262623,0.019647061,0.023140929,1,7.406611064,3.950587192,1.874812706,0.060818495,0.137784371,0.019164096,0,7.780288866,1.717906591,4.528935918,5.93E-06,6.54E-05,N,-,,#NAME?,F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); IPR002877 (PFAM); IPR029063 (SUPERFAMILY),,
RL4_JR_08345,17074,15653,15161,10,6,56,1,0,2,3,1,1,3,19,2,2,45,3,9.711605108,1,-1.381900014,1.30315157,-1.060429229,0.288949371,0.473681866,3.085462052,1,1.840084817,1.388606512,1.325130482,0.185127878,0.324928798,7.995408717,1,-0.810062009,1.272961546,-0.636360157,0.524541704,0.654481169,9.224950483,1,-1.232608887,1.281923475,-0.961530787,0.336285353,0.483237185,15.56465495,1,0.747555889,1.084920086,0.689042353,0.490796615,0.619383738,N,-,,Nitrogen assimilation transcription factor nirA,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR007219 (PFAM); PTHR31313 (PANTHER),,
RL4_JR_08346,13965,9860,8357,8,0,5,0,0,0,0,2,2,2,7,0,0,2,8,0.164213384,1,4.503977376,3.329135856,1.352896839,0.176088589,NA,0.05128704,0,7.750120926,2.466231255,3.142495624,0.001675142,0.015023052,0.134919497,1,5.077741777,1.513083495,3.355890004,0.0007911,0.00477016,0.155784392,1,4.654880277,2.094792272,2.222120226,0.026275182,0.08636862,0.134847664,1,4.978931382,1.363390905,3.651873694,0.000260334,0.001563393,N,-, Effector probability:0.662,phenylacetaldoxime dehydratase,,IPR025702 (PFAM); IPR025702 (PRODOM),,
RL4_JR_08347,8516,5987,7303,2,2,11,0,0,0,6,0,0,0,4,0,0,3,6,0.087597346,1,5.410434154,3.918928776,1.38059007,0.167405038,NA,0.027389948,0,8.654589625,2.751858824,3.144997683,0.001660881,0.015023052,0.072095425,1,5.980560659,1.60929525,3.71626068,0.000202193,0.001769232,0.083241833,1,5.558779575,2.556870934,2.174055601,0.02970096,0.091712247,7.793256097,1,7.528432658,1.087686919,6.921507032,4.47E-12,4.08E-10,N,-,,Phenylacetaldoxime dehydratase,,G3DSA:3.30.70.900 (GENE3D); IPR025702 (PFAM); IPR025702 (PRODOM); PS51257 (PROSITE_PROFILES); IPR011008 (SUPERFAMILY),,
RL4_JR_08348,42055,28930,26328,0,2,14,0,0,0,2,4,4,0,8,0,0,1,2,44.72069214,1,-1.405586016,1.047873785,-1.341369577,0.17980049,0.336733792,10.40860265,0,0.085742372,1.238118882,0.069252132,0.944788928,0.97033501,33.68499521,1,-1.614092971,1.213151917,-1.330495339,0.183355121,0.304909206,49.99840565,1,-1.235282862,1.044829616,-1.18228163,0.237093972,0.374797263,34.73618804,1,-1.016418368,1.021454112,-0.995070024,0.319702209,0.455080116,N,-, Effector probability:0.743,hypothetical protein MMYC01_200195,,PTHR42470 (PANTHER),,
RL4_JR_08349,9970,7161,13498,1,1,2,0,0,0,0,0,0,0,0,4,0,5,0,0.01164016,1,8.317974459,3.997123045,2.080990344,0.03743479,NA,0.003501898,0,11.6103591,4.002138943,2.901038485,0.003719282,0.017380689,0.009514587,0,8.898423346,3.998182413,2.22561715,0.026039836,0.068649449,0.011003575,1,8.472850999,3.997973129,2.11928663,0.034066251,0.0989162,0.009871642,1,8.75387984,1.939189559,4.514195015,6.36E-06,6.91E-05,N,-,,General substrate transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF133 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.119, the major facilitator superfamily (mfs).
RL4_JR_08350,533,377,828,0,2,0,0,0,0,3,2,1,0,1,0,0,0,0,0.100788864,1,5.208288775,3.917340571,1.329547095,0.183667539,NA,0.032423945,0,8.412899385,2.634923179,3.192844274,0.001408789,0.015023052,0.083529354,1,5.772482331,1.513135753,3.81491371,0.000136231,0.001394538,0.096326453,1,5.349128863,2.363525549,2.263199086,0.02362342,0.083034578,0.081624897,0,5.701367224,1.301125134,4.381874636,1.18E-05,0.000115534,N,-,,aliphatic nitrilase,P:nitrogen compound metabolic process; F:nitrilase activity,IPR003010 (G3DSA:3.60.110.GENE3D); IPR003010 (PFAM); PTHR23088:SF2 (PANTHER); PTHR23088 (PANTHER); IPR003010 (PROSITE_PROFILES); IPR003010 (SUPERFAMILY),,
RL4_JR_08351,10178,7839,7779,0,5,2,0,0,0,0,0,2,11,5,0,0,2,1,7.693205472,1,7.641415562,1.499240351,5.096858257,3.45E-07,5.97E-06,0.017205914,0,9.325143116,3.926525791,2.374909427,0.017553257,0.051921118,0.045805534,1,6.63609232,2.408443235,2.755345122,0.005863026,0.021397718,32.14563392,1,9.339065247,2.515382515,3.712781333,0.000204994,0.00196195,0.046313854,1,6.521762285,1.738980234,3.750337214,0.000176597,0.001120071,Y,-,,secreted,,IPR011089 (PFAM); PTHR24094:SF14 (PANTHER); PTHR24094 (PANTHER),,
RL4_JR_08352,389,319,375,0,0,5,0,0,0,0,0,0,0,1,0,0,0,0,20.22629163,1,7.044787181,1.079495265,6.526001,6.75E-11,2.42E-09,0.031070338,0,8.474343327,2.67969987,3.162422562,0.001564623,0.015023052,71.56577519,0,9.861021662,1.69097303,5.831566493,5.49E-09,2.46E-07,96.44473196,1,10.00339083,2.02661063,4.936020114,7.97E-07,1.50E-05,0.077760343,0,5.767006694,1.322064825,4.362120967,1.29E-05,0.000124563,N,-,,sugar transporter stl1,"C:nucleus; F:DNA binding; F:zinc ion binding; F:substrate-specific transmembrane transporter activity; P:transmembrane transport; P:transcription, DNA-templated; C:integral component of membrane; P:carbohydrate transport",IPR003663 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); IPR003663 (TIGRFAM); PTHR23500 (PANTHER); PTHR23500:SF64 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.125, the major facilitator superfamily (mfs).
RL4_JR_08353,16773,11878,15456,7,5,5,0,0,1,0,8,10,4,8,11,0,7,2,27.73262058,1,3.522847794,0.868906767,4.054344988,5.03E-05,0.000470348,0.527938498,1,4.387215478,1.556622768,2.818419189,0.004826076,0.020177422,84.63595627,1,5.890380606,0.527554064,11.16545395,6.02E-29,1.69E-26,1.572772987,1,1.319883244,1.265414205,1.043044434,0.296927714,0.442051625,1.336443844,1,1.667980749,1.221699416,1.365295528,0.172160184,0.287394643,N,-,,3-carboxy-muconate cycloisomerase,,IPR007219 (SMART); IPR007219 (PFAM); PTHR31944 (PANTHER),,
RL4_JR_08354,1083,1195,1855,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,102.51835,0,5.169678872,0.710506826,7.276043925,3.44E-13,1.76E-11,0.768738304,0,3.844816444,1.532526664,2.508808841,0.012113902,0.039000291,343.9811375,0,7.420104603,1.585065787,4.681259708,2.85E-06,6.49E-05,20.9498569,1,2.546188967,1.088475485,2.339224908,0.019323797,0.075572463,52.19142894,0,4.863203474,1.41064092,3.4475134,0.000565772,0.003000757,N,-,,"3-carboxy-cis,cis-muconate cycloisomerase",,IPR000362 (PRINTS); PR00145 (PRINTS); IPR019468 (SMART); IPR019468 (PFAM); IPR024083 (G3DSA:1.10.275.GENE3D); G3DSA:1.10.40.30 (GENE3D); IPR022761 (PFAM); G3DSA:1.20.200.10 (GENE3D); PTHR11444:SF21 (PANTHER); IPR000362 (PANTHER); IPR008948 (SUPERFAMILY),,
RL4_JR_08355,6120,6296,11680,2,0,9,0,0,1,0,0,4,0,14,4,0,4,3,1.165958157,1,1.675963964,1.422785524,1.177945611,0.23881829,NA,0.372969977,1,4.888332743,1.635367861,2.989133429,0.002797699,0.015349618,0.967233578,1,2.236571275,1.247387733,1.793004064,0.072972274,0.151916781,1.115717692,1,1.81453477,1.288210916,1.408569628,0.158962465,0.277616636,0.954199998,1,2.153517139,1.229640678,1.751338563,0.079887609,0.161115573,N,-,,MFS transporter,P:transmembrane transport; C:membrane; C:integral component of membrane; P:phosphorylation; F:kinase activity,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); PTHR23502:SF30 (PANTHER); PTHR23502:SF30 (PANTHER); PTHR23502 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.2.33, the major facilitator superfamily (mfs).
RL4_JR_08356,19314,21388,29950,4,8,22,2,0,3,2,1,3,4,20,0,0,5,4,0.151211668,1,4.622869082,3.438797587,1.344327186,0.178842608,NA,0.049613,1,7.799270319,2.514875894,3.101254553,0.001927026,0.015023052,0.126548112,1,5.171875695,1.540903033,3.356392703,0.000789664,0.004767176,0.145819719,1,4.750684632,2.152945997,2.20659721,0.027342212,0.088025404,0.122718868,1,5.109577673,1.360192227,3.756511448,0.000172298,0.001098958,N,-,,integral membrane,C:membrane; C:integral component of membrane,IPR019595 (PFAM); IPR019595 (G3DSA:3.20.180.GENE3D); PTHR37783 (PANTHER),,
RL4_JR_08357,1861,1754,4557,0,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0.088082541,0,5.402573765,3.918862784,1.378607536,0.168015792,NA,0.028403812,0,8.603726413,2.692223373,3.195769897,0.001394583,0.015023052,0.073172291,0,5.962419852,1.528561767,3.900673156,9.59E-05,0.001133378,0.084375613,1,5.539971679,2.469166805,2.243660359,0.024854262,0.085333811,0.071605542,0,5.88821386,1.302317699,4.521334437,6.15E-06,6.77E-05,N,-,,choline dehydrogenase,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; F:oxidoreductase activity; P:oxidation-reduction process; C:cellular_component",IPR000172 (PFAM); IPR012132 (PIRSF); IPR007867 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR11552 (PANTHER); PTHR11552:SF127 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_08358,27880,28881,37433,4,5,43,4,0,3,0,2,3,6,31,2,0,6,2,0.487861027,1,2.933251039,2.017255069,1.454080391,0.14592402,NA,0.155931991,1,6.14669976,1.930543557,3.183921822,0.001452942,0.015023052,0.403406165,1,3.499609723,1.297231601,2.697752444,0.006980933,0.024502222,0.465336239,1,3.076857093,1.449739979,2.122350999,0.033808274,0.098534477,0.395918541,1,3.423684324,1.242597429,2.755264292,0.005864474,0.020418776,N,-,,Salicylaldehyde dehydrogenase,F:oxidoreductase activity,IPR016163 (G3DSA:3.40.309.GENE3D); IPR016162 (G3DSA:3.40.605.GENE3D); IPR015590 (PFAM); PTHR11699 (PANTHER); PTHR11699:SF155 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_08359,5748,5799,8883,11,1,9,0,0,0,2,8,0,2,3,0,0,7,3,0.07182559,1,5.696845866,3.921594947,1.452685946,0.146310971,NA,0.023220902,0,8.89439216,2.805484099,3.170359142,0.001522506,0.015023052,0.059765315,1,6.253954191,1.589468338,3.934620175,8.33E-05,0.001041502,0.068909064,1,5.83198749,2.67575644,2.179565899,0.029289655,0.09099655,0.058470561,1,6.179098685,1.320784964,4.678353292,2.89E-06,3.57E-05,N,-,,Major facilitator superfamily,,PR01036 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501:SF83 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.33, the major facilitator superfamily (mfs).
RL4_JR_08360,4735,4182,4586,0,0,5,0,0,1,0,0,4,2,6,0,0,1,0,4.679295987,1,-0.328886492,1.25273768,-0.262534206,0.792909617,0.893712096,1.496136365,1,2.884208223,1.38909939,2.076315232,0.037864805,0.094986169,3.884216728,1,0.231111294,1.236887197,0.186849128,0.851778927,0.905535005,4.480622331,1,-0.191111637,1.242797345,-0.153775382,0.877786845,0.92447541,3.838897705,1,0.14541294,1.241034213,0.117170774,0.906724726,0.940152366,N,-,,C6 zinc finger domain partial,"F:DNA binding; C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_08361,3641,3560,3213,0,0,0,0,0,0,0,0,5,2,5,1,0,2,0,1.500822331,0,1.311681756,1.395991319,0.939605954,0.347419721,NA,0.483674846,0,4.513427582,1.605929253,2.81047722,0.004946809,0.020495948,1.248855874,1,1.868131172,1.265701885,1.475964596,0.139953397,0.248926245,5.451720423,1,2.390280566,1.193731063,2.002361034,0.045245916,0.115278131,1.227099165,1,1.790482605,1.248740287,1.433831056,0.15162048,0.261170017,N,-,,P-loop containing nucleoside triphosphate hydrolase,,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003959 (PFAM); PTHR23077:SF81 (PANTHER); PTHR23077 (PANTHER); IPR027417 (SUPERFAMILY),3.A.29.1.2, the mitochondrial inner membrane i-aaa protease complex (mimp) familly.
RL4_JR_08362,2001,1619,2351,0,0,0,0,0,0,2,1,1,0,0,0,0,2,0,0.569876014,0,2.708850822,1.866656899,1.451177677,0.146730391,NA,0.181230916,0,5.929459707,1.860138765,3.187643749,0.001434371,0.015023052,0.471645215,1,3.272424704,1.278292127,2.559997543,0.01046729,0.033867321,0.544180409,0,2.850309666,1.396899985,2.040453645,0.041305163,0.109854158,0.466812726,1,3.185356833,1.241343815,2.566055267,0.010286244,0.032131745,N,-,,hypothetical protein CMQ_7231,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_08363,1674,1358,1524,6,0,10,0,0,0,0,0,0,0,3,0,0,0,0,2.535113596,1,0.555364708,1.381306264,0.402057619,0.687641622,0.829851172,0.805240035,0,3.777852998,1.539859164,2.453375664,0.014152246,0.044022443,2.101635806,0,1.117049771,1.290821384,0.86537904,0.386830781,0.530804395,2.425023268,1,0.694488704,1.319455137,0.526345068,0.598648475,0.721070165,21.39275113,0,3.840190139,0.858467758,4.473307357,7.70E-06,8.06E-05,N,-,,hypothetical protein CFIO01_01306,F:nucleotide binding; P:DNA repair; F:ATP binding; F:DNA helicase activity; P:DNA duplex unwinding; P:telomere maintenance; F:helicase activity,IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (SUPERFAMILY),,
RL4_JR_08364,1211,902,1239,5,0,3,0,0,0,0,0,1,2,1,0,0,6,0,0.071166738,1,5.709910512,3.921729596,1.455967418,0.145401627,NA,0.02321186,0,8.894901148,2.872021833,3.097086884,0.001954326,0.015023052,0.059522081,1,6.258834796,1.678196925,3.729499621,0.00019186,0.001713457,0.068604764,1,5.838121653,2.761571218,2.114057974,0.034510316,0.099426657,0.058120715,1,6.185178745,1.371775688,4.508884941,6.52E-06,7.04E-05,N,-,,Demethylmenaquinone methyltransferase,,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF854 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_08365,2484,1983,1958,7,6,7,0,0,0,0,4,4,0,4,0,0,0,0,0.206702424,1,4.171886781,2.970353892,1.404508329,0.160167533,NA,0.06714632,0,7.362339964,2.319126837,3.174617208,0.001500343,0.015023052,0.172428828,1,4.724941519,1.425703727,3.314111781,0.000919347,0.005370729,0.19877142,1,4.303587709,1.875392205,2.294766768,0.021746494,0.080037533,0.168431505,0,4.653409809,1.298074943,3.584854506,0.000337266,0.001930367,N,-,,hypothetical protein BcDW1_7868,,no IPS match,,
RL4_JR_08366,1375,893,1747,10,14,0,0,0,0,4,20,88,15,18,15,0,10,11,131.6856853,1,-5.143277653,1.276868293,-4.028040857,5.62E-05,0.000519044,42.59356327,0,-1.947029812,1.265089941,-1.539044576,0.123793414,0.238797254,109.2927665,1,-4.583053947,1.248696303,-3.670271096,0.000242293,0.001989439,126.0076705,1,-5.004537219,1.258362575,-3.977023249,6.98E-05,0.000788567,106.31843,1,-4.64603226,1.250577448,-3.715109581,0.000203116,0.001263235,N,-,,ABC drug exporter,F:ATP binding; P:sterol import; P:transmembrane transport; P:cellular response to drug; C:integral component of membrane; F:xenobiotic-transporting ATPase activity; C:plasma membrane,IPR003593 (SMART); IPR013525 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR029481 (PFAM); IPR010929 (PFAM); PTHR19241 (PANTHER); PTHR19241 (PANTHER); PTHR19241:SF298 (PANTHER); PTHR19241:SF298 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.205.7, the atp-binding cassette (abc) superfamily.
RL4_JR_08367,6270,964,1124,0,1,2,0,0,2,0,0,0,1,6,0,0,0,1,8.893986133,1,3.02830234,1.155875545,2.619920764,0.00879502,0.034117819,0.282401095,1,5.289781928,1.709424216,3.094481685,0.001971571,0.015023052,0.731347,0,2.640808944,1.248480007,2.11521925,0.034411265,0.085352921,0.843641582,1,2.218355135,1.306449685,1.698002733,0.089507246,0.180350421,0.719061499,1,2.562403967,1.219602716,2.101015301,0.035639623,0.08593741,N,-,,histidyl-tRNA synthetase,F:histidine-tRNA ligase activity; F:ATP binding; P:histidyl-tRNA aminoacylation; C:mitochondrion; C:cytosol; P:mitochondrial translation,IPR015807 (TIGRFAM); G3DSA:3.30.930.10 (GENE3D); PF13393 (PFAM); IPR004516 (PIRSF); IPR004154 (G3DSA:3.40.50.GENE3D); IPR004154 (PFAM); IPR004516 (PANTHER); PTHR11476:SF7 (PANTHER); IPR006195 (PROSITE_PROFILES); IPR004154 (SUPERFAMILY); SSF55681 (SUPERFAMILY),,
RL4_JR_08368,770,328,831,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.196657473,0,4.243911313,2.996671044,1.416208603,0.156714438,NA,0.06333058,0,7.446799088,2.305508371,3.230003059,0.001237889,0.015023052,0.163203911,0,4.805260825,1.384489908,3.47078068,0.000518948,0.003474753,0.188201387,0,4.382710193,1.848175005,2.371371857,0.017722191,0.072499872,0.159685849,0,4.732235252,1.263487012,3.745377046,0.000180123,0.001136795,N,-,,choline transporter,P:transport,IPR002293 (PFAM); IPR002293 (PANTHER); PTHR11785:SF312 (PANTHER),2.A.3.4.1, the amino acid-polyamine-organocation (apc) family.
RL4_JR_08369,561,400,427,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0.594579565,1,2.647986325,2.002568382,1.322295083,0.186069909,NA,0.188437314,0,5.873518566,1.948479877,3.014410687,0.00257479,0.015349618,0.489124632,0,3.221573225,1.372542228,2.347157821,0.01891724,0.053661569,0.564401398,0,2.79848329,1.530377585,1.828622764,0.06745614,0.147323861,0.480692054,1,3.143970888,1.322710861,2.376914699,0.017458125,0.0489819,N,-,,GNAT family acetyltransferase,"F:transferase activity, transferring acyl groups",IPR016181 (G3DSA:3.40.630.GENE3D); IPR000182 (PFAM); PTHR21471 (PANTHER); PTHR21471:SF65 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_08370,1253,1658,1499,0,5,11,0,0,0,3,0,1,0,2,0,0,0,1,3.593365305,1,0.052617268,1.295406731,0.040618337,0.967600165,0.983636405,1.145415995,0,3.26974373,1.445439373,2.262110602,0.023690571,0.065841833,2.965380215,1,0.621084236,1.252214491,0.495988698,0.619902385,0.733598647,3.420969874,1,0.198683338,1.264363506,0.157140994,0.875133731,0.922800356,2.909618438,1,0.545580692,1.247427861,0.437364523,0.661847008,0.758826969,N,-,,integral membrane,C:membrane,PTHR38794 (PANTHER); PTHR38794:SF1 (PANTHER); PS51257 (PROSITE_PROFILES),2.A.1.7.25, the major facilitator superfamily (mfs).
RL4_JR_08371,854,1102,855,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.11594061,0,1.177722744,1.017893311,1.157019828,0.24726426,0.423599712,2.443118349,0,2.17687469,1.411981273,1.541716403,0.123142524,0.237871876,6.314616504,0,-0.46953882,1.27611484,-0.367944017,0.712914978,0.805800071,11.29609413,0,0.049839708,1.231046084,0.040485655,0.967705943,0.98193545,6.178083298,0,-0.540861983,1.279834094,-0.4226032,0.672584792,0.766969368,N,-,,amino acid permease,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PFAM); PTHR11785:SF416 (PANTHER); IPR002293 (PANTHER),2.A.3.4.2, the amino acid-polyamine-organocation (apc) family.
RL4_JR_08372,3226,4904,4277,1,0,10,0,0,0,6,0,1,2,1,1,0,4,1,0.247124127,1,3.914258457,2.709556034,1.444612478,0.148566766,NA,0.078673693,0,7.133302536,2.193036066,3.252706441,0.001143115,0.015023052,0.204592997,1,4.477227544,1.345982224,3.326364541,0.000879868,0.005191164,0.23604715,1,4.055388236,1.704030916,2.379879495,0.0173183,0.071687568,0.202337281,1,4.391369925,1.257404456,3.492408432,0.000478686,0.002609958,N,-,,Spastin,F:ATP binding; F:nucleoside-triphosphatase activity,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.8.60 (GENE3D); IPR003959 (PFAM); PTHR23074:SF88 (PANTHER); PTHR23074 (PANTHER); IPR027417 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_08373,31,60,82,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,53.56462304,0,9.11161539,1.695631823,5.37358126,7.72E-08,1.55E-06,0.032754646,0,8.397129249,2.714354268,3.093601063,0.001977432,0.015023052,0.08602646,0,5.727812924,1.629481917,3.515112912,0.000439567,0.003079707,0.099328438,0,5.304403026,2.470286546,2.147282482,0.0317708,0.095284166,30.97000426,0,8.803106921,1.412734612,6.231253095,4.63E-10,2.86E-08,N,-,,catechol o-methyltransferase,F:O-methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); IPR001077 (PFAM); PTHR11746 (PANTHER); PTHR11746:SF87 (PANTHER); IPR016461 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY); IPR011991 (SUPERFAMILY),,
RL4_JR_08374,1916,1550,2376,0,0,0,0,0,0,0,0,1,0,4,0,0,0,1,7.733531402,0,6.970004517,1.132641022,6.153763089,7.57E-10,2.14E-08,0.030242781,0,8.512201126,2.696452211,3.156815126,0.001595024,0.015023052,0.079280959,1,5.845203675,1.574899771,3.711476617,0.000206054,0.001791132,0.091524815,1,5.422345886,2.461915869,2.202490327,0.027630692,0.088405467,0.078913539,1,5.753420498,1.345181306,4.277059511,1.89E-05,0.000171815,N,-,,integral membrane,C:membrane,PTHR33048 (PANTHER); PTHR33048:SF41 (PANTHER),9.B.313.1.6, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_08375,7559,7372,8319,0,0,18,0,0,0,0,4,5,0,6,6,0,9,7,63.76069316,1,10.18643457,0.912986427,11.15726834,6.60E-29,2.83E-26,0.017052479,0,9.340767828,3.037171746,3.075482261,0.002101624,0.015023052,0.043710871,1,6.708311092,1.758192912,3.815457932,0.000135931,0.001394287,4.061982854,1,7.238585631,1.276497481,5.6706619,1.42E-08,3.85E-07,7.40792951,1,7.585658589,1.222300371,6.206051123,5.43E-10,3.26E-08,N,-,,Thiol-specific monooxygenase,"F:NADP binding; F:flavin adenine dinucleotide binding; P:oxidation-reduction process; F:N,N-dimethylaniline monooxygenase activity",IPR000960 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); PF13450 (PFAM); IPR020946 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR23023 (PANTHER); PTHR23023:SF125 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_08376,668,934,834,0,0,3,1,0,0,0,0,0,0,8,2,0,0,0,0.016282912,1,7.839735781,3.971839371,1.973830019,0.048401074,NA,0.005351135,1,11.01554673,3.970178753,2.774571981,0.00552744,0.021974647,0.013566183,0,8.397347712,2.840476149,2.956316924,0.00311337,0.013891475,0.015630153,1,7.974278064,3.97154097,2.007854917,0.044658711,0.114728762,0.013009295,0,8.347323895,1.562419104,5.342563895,9.16E-08,2.07E-06,Y,-,,rhamnogalacturonate lyase,P:biological_process; P:carbohydrate metabolic process; F:catalytic activity; F:lyase activity; F:carbohydrate binding; C:cellular_component; F:molecular_function,IPR014766 (G3DSA:2.60.40.GENE3D); IPR029411 (PFAM); IPR008979 (G3DSA:2.60.120.GENE3D); PTHR32018 (PANTHER); PTHR32018:SF1 (PANTHER); IPR013784 (SUPERFAMILY); IPR011013 (SUPERFAMILY); IPR008979 (SUPERFAMILY),,
RL4_JR_08377,1916,1974,1875,3,1,11,0,0,0,0,3,6,0,15,0,0,0,0,52.57811727,1,6.327419809,0.688759296,9.186692422,4.05E-20,5.42E-18,0.155643769,0,6.149004676,1.939544058,3.170335136,0.001522632,0.015023052,0.40468552,1,3.493069295,1.311509272,2.663396569,0.007735619,0.026665102,0.466870576,1,3.07125844,1.471604249,2.087013844,0.036886883,0.102000266,0.400536608,0,3.405727733,1.264048567,2.694301329,0.007053636,0.023766412,N,-,,siderophore iron transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF50 (PANTHER); PTHR23501:SF50 (PANTHER); PTHR23501 (PANTHER); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.16.8, the major facilitator superfamily (mfs).
RL4_JR_08378,6759,6560,7493,9,0,3,0,0,0,0,0,3,3,7,1,0,1,13,25.38477759,1,1.756240818,0.909836268,1.930282271,0.053571872,0.140166561,1.750480997,0,2.657705686,1.36704691,1.944121791,0.051880766,0.121415866,4.569500106,1,-0.00307658,1.237425079,-0.002486276,0.998016241,0.999239715,14.58607412,1,0.527907322,1.180968138,0.447012332,0.654866156,0.76455409,16.11043861,1,2.074904285,0.920171485,2.254910437,0.024138951,0.063383527,N,-,,lipase,P:metabolic process; F:hydrolase activity,IPR013094 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR23024:SF119 (PANTHER); PTHR23024 (PANTHER); IPR029058 (SUPERFAMILY),8.A.117.1.3, the neuroligin (nlg) family.
RL4_JR_08379,8097,7921,10982,3,0,6,0,0,1,1,4,28,1,8,3,0,27,4,11.98963663,1,-1.68608308,1.198215463,-1.407161844,0.159379403,0.308714105,3.809420176,1,1.53589413,1.256559398,1.222301255,0.221593725,0.369700294,9.9126865,1,-1.120401331,1.198212078,-0.935060956,0.349756887,0.493480433,11.43753166,1,-1.542996865,1.196820951,-1.289246201,0.197312508,0.327345427,9.80353999,1,-1.207042947,1.205493382,-1.00128542,0.31668884,0.451934391,N,-,,kinase-like domain,,IPR011009 (SUPERFAMILY),,
RL4_JR_08380,11078,7559,7923,1,7,4,0,0,1,1,13,10,0,5,3,0,13,2,23.68902387,1,1.623933543,0.875396277,1.855083903,0.063584246,0.159067856,1.903200078,1,2.537106313,1.329143337,1.908828223,0.056284255,0.129680269,4.943466639,1,-0.116422842,1.212768831,-0.095997555,0.923522515,0.955092923,5.703686372,1,-0.538957487,1.213456073,-0.444150801,0.65693356,0.766260618,4.873749022,1,-0.198658802,1.214418054,-0.163583538,0.870059005,0.913931025,N,-,,Alcohol partial,P:alcohol metabolic process; F:transferase activity; F:alcohol O-acetyltransferase activity,IPR010828 (PFAM); PTHR28037 (PANTHER); PTHR28037:SF1 (PANTHER); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY),,
RL4_JR_08381,34575,37620,54777,10,2,94,0,3,4,0,10,0,0,45,1,0,32,8,2.252248018,1,0.726525419,1.277767144,0.568589842,0.56963452,0.745983002,0.716720639,1,3.946062619,1.472696529,2.67948117,0.007373635,0.026983346,14.85805296,1,3.110822152,1.046013262,2.973979647,0.002939646,0.013430042,2.146626713,1,0.870930718,1.238525676,0.703199566,0.481931389,0.622159961,1.833412411,1,1.212015456,1.218372079,0.994782691,0.319841966,0.455197422,N,-,,salicylate hydroxylase,F:FAD binding; F:oxidoreductase activity; P:oxidation-reduction process,PR00420 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789 (PANTHER); PTHR13789:SF174 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_08382,2129,2296,2763,0,0,3,0,0,0,1,0,0,0,5,0,0,0,0,0.130029641,1,4.840921503,3.620652324,1.337030201,0.181212779,NA,0.041295061,0,8.063735984,2.542461824,3.171625198,0.001515885,0.015023052,0.107096594,1,5.413913169,1.508679246,3.588511729,0.000332571,0.00252774,0.123568783,1,4.989927022,2.205968732,2.262011673,0.023696682,0.083109543,0.105205527,0,5.338106547,1.324608678,4.029949854,5.58E-05,0.000425989,N,NRPS-Like,,transferase family,C:membrane; F:transferase activity,G3DSA:3.40.50.980 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR023213 (G3DSA:3.30.559.GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR007817 (PFAM); IPR003480 (PFAM); IPR000873 (PFAM); IPR009081 (PFAM); G3DSA:3.30.300.30 (GENE3D); IPR023213 (G3DSA:3.30.559.GENE3D); PTHR37285 (PANTHER); PTHR37285:SF2 (PANTHER); IPR009081 (PROSITE_PROFILES); SSF56801 (SUPERFAMILY); IPR009081 (SUPERFAMILY),,
RL4_JR_08383,33544,33667,40925,2,9,36,0,0,0,1,0,0,1,23,1,0,11,5,2.802814545,1,0.410943516,1.227704668,0.334725057,0.737832498,0.862354945,0.896419839,0,3.623325422,1.420739208,2.550310009,0.010762717,0.035554902,8.819722982,1,1.936405179,1.194939778,1.62050441,0.105123968,0.201224249,2.677266227,1,0.552222017,1.214012216,0.454873526,0.64920023,0.759638545,2.282400926,1,0.895739259,1.200915472,0.745880356,0.455739693,0.587442953,N,-,,major facilitator superfamily transporter,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502:SF33 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.86, the major facilitator superfamily (mfs).
RL4_JR_08384,1778,2513,2447,0,0,3,0,0,0,0,1,0,0,4,0,0,0,0,0.339408075,1,3.456516779,2.481748396,1.392774862,0.163687882,NA,0.106066937,0,6.701952999,2.145451807,3.123795639,0.001785344,0.015023052,0.279110347,1,4.029062368,1.415298811,2.846792731,0.004416211,0.017319652,0.322268059,1,3.606090989,1.703214333,2.117226775,0.034240606,0.099223279,0.279217125,0,3.92775332,1.344698879,2.920916631,0.003490032,0.013364816,N,-,,hypothetical protein UCRPA7_4048,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_08385,3103,2483,4164,1,0,4,0,0,0,1,1,1,0,3,0,0,2,0,0.035024326,1,6.73165076,3.937088788,1.709804153,0.087302095,NA,0.011178589,0,9.947190664,3.937135766,2.526504357,0.011520396,0.037446836,0.029180594,1,7.284814901,2.506730411,2.906102255,0.003659618,0.015609839,0.033665144,1,6.8642193,3.936907493,1.743556158,0.081236514,0.167963999,0.029112186,1,7.18418011,1.601417859,4.486137125,7.25E-06,7.73E-05,N,-,,fad binding domain-containing,F:FAD binding; F:oxidoreductase activity; P:oxidation-reduction process; C:cellular_component,PR00420 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR002938 (PFAM); PTHR13789 (PANTHER); PTHR13789:SF213 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_08386,10105,7871,8480,2,6,18,0,0,2,3,6,7,1,15,6,0,9,4,0.102380822,1,5.185274418,3.917173423,1.323728581,0.185593203,NA,0.031545431,1,8.450065113,2.827034233,2.989021149,0.002798728,0.015349618,0.084060682,1,5.758185403,1.767786032,3.257286402,0.001124829,0.006334356,0.097118151,1,5.33589887,2.620280782,2.036384385,0.041711772,0.110673924,0.08537413,1,5.637568762,1.530409703,3.683699047,0.000229874,0.001400867,N,-,,---NA---,,no IPS match,,
RL4_JR_08387,15340,13625,12518,4,0,5,1,3,0,0,0,0,2,12,0,0,1,2,320.8569038,1,8.665690053,0.96077287,9.019499119,1.89E-19,2.27E-17,56.52774546,1,8.19214837,1.37576401,5.954617442,2.61E-09,4.19E-07,56.04644241,0,6.277426626,0.821170013,7.644490824,2.10E-14,1.97E-12,0.750893081,1,2.386165833,1.596436286,1.494682785,0.134997249,0.245659085,12.21218996,1,4.849086957,1.084298205,4.472097189,7.75E-06,8.10E-05,N,-,,cytochrome P450 55A1,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR002397 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24286 (PANTHER); PTHR24286:SF69 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_08388,12189,14401,18054,0,0,16,0,0,0,3,5,6,4,11,5,0,10,1,0.180322638,1,4.368986209,3.096290194,1.411038996,0.158233116,NA,0.057642997,0,7.58230286,2.329507846,3.254894751,0.001134344,0.015023052,0.149319312,1,4.932786703,1.377263589,3.581585066,0.000341516,0.002572884,0.172244024,1,4.510337265,1.881110124,2.397699745,0.016498383,0.069610783,0.146927924,1,4.853300452,1.258716335,3.855753927,0.000115373,0.000781899,Y,-,,glycosyl hydrolase,"P:carbohydrate metabolic process; C:membrane; C:integral component of membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:hydrolase activity",IPR001764 (PRINTS); IPR026891 (SMART); IPR001764 (PFAM); IPR026891 (PFAM); IPR002772 (PFAM); IPR002772 (G3DSA:3.40.50.GENE3D); IPR001764 (G3DSA:3.20.20.GENE3D); IPR026892 (PANTHER); IPR017853 (SUPERFAMILY); IPR002772 (SUPERFAMILY),,
RL4_JR_08389,11270,14023,9048,6,14,22,0,0,0,8,44,61,4,1,4,0,8,22,0.015624059,1,7.894997458,3.974358507,1.986483465,0.046979667,NA,0.005342092,0,11.01782189,3.970278013,2.775075663,0.005518887,0.021974647,0.013322949,1,8.419138269,3.972556748,2.119324859,0.034063022,0.084689105,0.015325853,1,8.000645136,3.972725723,2.013893154,0.044020753,0.113902079,0.012659449,1,8.375900661,2.059145617,4.067658253,4.75E-05,0.000372148,N,-,,---NA---,,no IPS match,,
RL4_JR_08390,3075,3605,3504,0,0,1,0,0,0,0,0,1,0,2,3,0,0,1,11.29460749,1,-1.599851287,1.198940579,-1.334387471,0.182076904,0.339516202,3.588716026,0,1.622016324,1.26077907,1.286519076,0.198261966,0.341591073,9.334324698,1,-1.033614688,1.198283575,-0.862579368,0.388368778,0.532292644,10.77014128,1,-1.456197755,1.196849129,-1.216692831,0.223721108,0.359179768,9.224029653,1,-1.119111824,1.204425322,-0.929166635,0.352802735,0.490138268,N,-,,FAD dependent oxidoreductase superfamily,F:oxidoreductase activity; F:1-alkyl-2-acetylglycerophosphocholine esterase activity; P:lipid catabolic process; P:oxidation-reduction process,IPR006076 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13847:SF188 (PANTHER); PTHR13847 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_08391,110380,96360,98424,6,5,10,0,2,0,0,7,2,0,17,0,0,19,4,36.58171684,1,-2.19225786,1.198347431,-1.829400892,0.067339574,0.16610572,10.46025844,1,0.078708747,1.271392762,0.061907499,0.950636495,0.973667236,27.04827958,1,-2.568423545,1.230593978,-2.087141325,0.036875361,0.089634132,40.51400102,1,-2.035856461,1.187968974,-1.713728645,0.086578573,0.175672957,26.50347778,1,-2.641870153,1.233197104,-2.142293509,0.032169871,0.079540889,N,-,,Zn(2)-C6 fungal-type DNA-binding domain,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PTHR31845 (PANTHER),,
RL4_JR_08392,8435,9609,8695,1,10,16,0,0,5,5,1,2,4,2,1,0,9,0,2.994904116,1,0.315448277,1.332926954,0.236658338,0.812921858,0.90481012,0.954758333,1,3.532423933,1.491950782,2.367654466,0.017901246,0.052765407,2.470652652,1,0.884454587,1.267638144,0.697718503,0.485353255,0.620889102,2.850209592,1,0.462046893,1.28638141,0.359183435,0.719457868,0.812459393,2.422198175,1,0.810115359,1.260903451,0.642488018,0.520556366,0.645120344,N,-,,hypothetical protein FGSG_08078,"F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (PFAM); PIRSF001221 (PIRSF); IPR023631 (G3DSA:3.90.1300.GENE3D); IPR000120 (PANTHER); PTHR11895:SF45 (PANTHER); IPR023631 (SUPERFAMILY),,
RL4_JR_08393,2087,3446,4528,0,2,2,0,0,1,0,0,0,2,0,0,0,0,0,1.826101178,1,1.029198823,1.483121531,0.69394099,0.487719216,NA,0.580894774,1,4.249309063,1.637708588,2.594667388,0.00946825,0.032366641,1.503845529,0,1.600804241,1.317373002,1.215148814,0.224309339,0.354607705,1.73501504,1,1.178221353,1.364104949,0.863732188,0.387735027,0.532803793,1.473665183,0,1.527129152,1.30379836,1.171292432,0.241481252,0.370847517,N,-,,retrograde regulation 2,C:membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662:SF210 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_08394,43259,41861,59275,7,16,48,0,0,0,1,1,1,3,34,5,0,12,3,18.10540348,1,-2.280834589,1.191829292,-1.913725904,0.055655187,0.143864074,5.787249173,0,0.932621698,1.240445142,0.751844371,0.452144655,0.6117842,15.00983047,1,-1.718941189,1.196186553,-1.43701765,0.150712979,0.263176451,25.33770402,1,-0.41708562,1.020741603,-0.408610385,0.682825608,0.78447853,14.80394191,1,-1.80172943,1.200330898,-1.501027286,0.133348504,0.236785971,N,-,,major facilitator superfamily transporter multidrug resistance,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR001958 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23504:SF15 (PANTHER); PTHR23504 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.96, the major facilitator superfamily (mfs).
RL4_JR_08395,1578,1299,1566,1,0,2,0,0,0,0,0,0,1,1,0,0,3,2,36.00103327,1,-1.204254383,1.020838185,-1.179672156,0.238130632,0.41236886,9.017124197,0,0.292799612,1.219320624,0.240133404,0.810226839,0.884354687,23.46347908,0,-2.363434953,1.195561383,-1.976841161,0.048059587,0.109881496,35.09543813,1,-1.062563477,1.022198886,-1.039488001,0.298577836,0.443790456,23.21224185,1,-2.450589158,1.203420937,-2.036352437,0.041714978,0.097229316,N,-,,conserved hypothetical protein,,SSF54001 (SUPERFAMILY),,
RL4_JR_08396,5530,7351,5732,1,4,19,0,0,1,0,1,0,9,0,1,0,1,1,0.015901563,1,7.871528,3.973277037,1.981117331,0.047578117,NA,0.005010166,1,11.10419825,3.765442626,2.948975554,0.003188292,0.016079667,0.01312615,1,8.436770725,2.240862621,3.76496562,0.000166572,0.001577526,0.015150793,1,8.016170674,3.973433359,2.017441832,0.043649426,0.113446415,0.013085742,1,8.344620785,1.511525422,5.520661885,3.38E-08,1.07E-06,N,-,,phosphatase 2C,F:catalytic activity,IPR001932 (SMART); IPR001932 (PFAM); IPR001932 (G3DSA:3.60.40.GENE3D); IPR015655 (PANTHER); PTHR13832:SF10 (PANTHER); PTHR13832:SF10 (PANTHER); IPR015655 (PANTHER); PTHR13832:SF10 (PANTHER); IPR015655 (PANTHER); IPR015655 (PANTHER); PTHR13832:SF10 (PANTHER); IPR001932 (PROSITE_PROFILES); IPR001932 (SUPERFAMILY),,
RL4_JR_08397,2211,3084,2615,0,3,2,0,0,0,0,0,1,0,2,0,0,0,0,0.719069018,1,2.373320085,1.792271052,1.324197075,0.185437602,NA,0.226283788,0,5.608949739,1.82964016,3.065602658,0.002172318,0.015045494,0.593408239,1,2.940891349,1.318965816,2.229694898,0.025767705,0.068184068,0.684974196,1,2.518176349,1.42934205,1.761773083,0.078107644,0.163531824,0.592225404,0,2.842261754,1.29464863,2.195392393,0.028135462,0.071575768,N,-, Effector probability:0.601,alpha-galactosidase a partial,"F:ATP binding; C:membrane; P:phosphorylation; F:phosphotransferase activity, alcohol group as acceptor; F:kinase activity",no IPS match,,
RL4_JR_08398,1686,1609,3029,0,2,4,0,0,0,0,0,1,0,2,0,0,0,0,106.7166809,1,-0.327316971,0.600052062,-0.545480953,0.585422777,0.758426055,17.62851374,0,-0.674282486,1.216452871,-0.554302187,0.579372054,0.718500849,45.5537159,1,-3.32046883,1.197189551,-2.773553132,0.005544779,0.020472406,314.8683855,1,2.242063695,0.331443408,6.764544543,1.34E-11,5.53E-10,82.5779044,0,0.210820577,0.555422989,0.379567612,0.704266407,0.790542945,N,-,,arsenite resistance Ars2,P:mycelium development; F:metal ion binding; C:nuclear lumen; C:macromolecular complex,IPR025239 (SMART); IPR025239 (PFAM); IPR021933 (PFAM); PTHR21032 (PANTHER); PTHR21032:SF2 (PANTHER); PTHR21032:SF2 (PANTHER); PTHR21032 (PANTHER),,
RL4_JR_08399,1509,1305,1970,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,312.4130123,0,0.067411048,0.536133577,0.125735546,0.899941263,0.951246544,50.72039975,0,-2.199002246,1.21068935,-1.81632245,0.069320923,0.152569338,173.6041605,0,-2.008833841,0.777747136,-2.582888123,0.009797709,0.032184259,222.0014684,0,-0.926998359,0.534843285,-1.733214914,0.083057477,0.170475767,158.3765688,1,-1.803755488,0.709666944,-2.541692979,0.011031703,0.033998741,N,-,,t-complex 1 subunit delta,C:nucleus; C:chaperonin-containing T-complex; F:ATP binding; P:mycelium development; F:unfolded protein binding; P:protein folding,IPR017998 (PRINTS); IPR027413 (G3DSA:1.10.560.GENE3D); IPR027409 (G3DSA:3.50.7.GENE3D); IPR002423 (PFAM); IPR027410 (G3DSA:3.30.260.GENE3D); PTHR11353:SF26 (PANTHER); PTHR11353:SF26 (PANTHER); PTHR11353 (PANTHER); PTHR11353 (PANTHER); SSF54849 (SUPERFAMILY); IPR027409 (SUPERFAMILY); SSF48592 (SUPERFAMILY),,
RL4_JR_08400,2593,2109,3227,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,168.9952571,1,0.976491455,0.366698216,2.662929385,0.007746367,0.030977873,18.01977021,0,-0.705990314,1.19769089,-0.589459534,0.55555305,0.70046188,88.37957174,0,-0.21182089,0.660188112,-0.320849295,0.748324601,0.831709107,117.9644359,0,0.521897957,0.441685716,1.181604789,0.237362552,0.37516326,61.52020078,0,-0.82601083,0.744450904,-1.109557159,0.267189901,0.399441033,N,-,,26s protease regulatory subunit 7,"C:nucleus; F:ATP binding; C:proteasome regulatory particle, base subcomplex; P:proteasome regulatory particle assembly; C:cytosol; F:nucleoside-triphosphatase activity; P:positive regulation of protein catabolic process; F:peptidase activity; P:ubiquitin-dependent protein catabolic process; P:positive regulation of RNA polymerase II transcriptional preinitiation complex assembly",IPR003593 (SMART); IPR005937 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.8.60 (GENE3D); IPR003959 (PFAM); PTHR23073 (PANTHER); IPR027417 (SUPERFAMILY),9.B.307.1.2, the ftsh aaa(+) zinc metaloprotease (ftsh) family.
RL4_JR_08401,14567,13181,19783,1,1,2,0,0,3,0,5,2,0,1,0,0,0,1,27.2260052,1,-2.869321224,1.206164889,-2.378879746,0.01736534,0.058548409,8.656702339,1,0.351640569,1.233464901,0.285083563,0.775580122,0.864102951,22.53907539,1,-2.305455122,1.204864853,-1.913455368,0.055689782,0.122726024,26.00569833,1,-2.728018864,1.20537235,-2.263216726,0.023622333,0.083034578,33.55136504,1,-0.715802725,0.99751151,-0.717588436,0.47301109,0.603721317,N,-,,hypothetical protein SPI_05246,,no IPS match,,
RL4_JR_08402,4836,4321,5082,0,4,9,3,0,0,0,6,1,6,7,7,0,4,1,74.42040213,1,-1.300236034,0.784739322,-1.656901849,0.097539321,0.217470833,18.84731719,1,-0.770803972,1.214642561,-0.634593251,0.525693731,0.674538485,49.00582628,1,-3.425934108,1.203023818,-2.847769145,0.004402685,0.017276272,79.17416431,1,-1.520331784,0.871312405,-1.744875633,0.08100652,0.16769393,67.07071237,1,-1.286453883,0.866945204,-1.483892958,0.13783732,0.243305939,N,-, Effector probability:0.604,pre-mrna branch site p14,F:nucleotide binding; F:nucleic acid binding,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR12785 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_08403,1187,1371,1355,0,1,4,0,0,0,3,0,0,0,0,1,0,0,0,90.99832911,1,-0.798196004,0.718684182,-1.110635275,0.266725373,0.446806076,36.30312261,0,0.965805014,1.008722175,0.957453934,0.338338187,0.501302074,91.16068984,1,0.128755581,1.157514706,0.111234509,0.911430387,0.945906841,52.69211994,1,-3.746735688,1.208667547,-3.099889377,0.001935929,0.012904071,52.59668367,0,-2.474388983,1.144529606,-2.161926585,0.030623835,0.076352212,Y,-,,---NA---,,no IPS match,,
RL4_JR_08404,3859,3569,3545,5,1,10,0,0,0,0,3,0,0,4,0,0,2,0,17.88780264,1,-2.263137637,1.245269796,-1.8173874,0.069157816,0.169426264,5.682776834,0,0.95895213,1.293511405,0.74135576,0.458477761,0.617362232,21.24450834,1,-0.731370499,1.229124124,-0.595033882,0.551820823,0.679005252,35.63819664,1,-0.339440214,1.064602387,-0.318842244,0.749846142,0.835224664,45.38751868,1,1.704923134,0.70435405,2.420548492,0.015497112,0.044618774,N,-,,methyltransferase type 12,F:methyltransferase activity; F:transferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF818 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_08405,7664,4383,5320,0,1,14,0,0,0,0,1,5,1,4,1,0,6,2,0.03109235,1,6.903208781,3.940901152,1.751682804,0.079828365,NA,0.009674842,0,10.15397018,3.941794771,2.575976368,0.009995748,0.033549109,0.025690649,1,7.467241431,2.615936117,2.854519796,0.004310195,0.016972544,0.029670076,1,7.045872517,3.940934463,1.787868482,0.073797229,0.156842347,0.026073009,1,7.346841463,1.688059511,4.352240792,1.35E-05,0.000129325,N,-,,glucose dehydrogenase,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; C:integral component of membrane; P:oxidation-reduction process",PTHR33048:SF15 (PANTHER); PTHR33048 (PANTHER),9.B.313.1.1, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_08406,12026,10904,15882,0,7,6,0,0,2,0,2,1,0,5,4,0,3,2,0.649628867,1,2.519727097,1.992688841,1.264485977,0.206055651,NA,0.204652253,1,5.753818633,1.950208415,2.950360889,0.003174029,0.016079667,0.537403272,1,3.083801358,1.40136178,2.200574756,0.027766142,0.07211504,0.620312023,1,2.661147179,1.559081221,1.706868855,0.087846431,0.177711311,0.53803991,1,2.980351565,1.368923905,2.177149186,0.029469438,0.074075984,N,-,,short chain dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); SM00822 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24322:SF361 (PANTHER); IPR002347 (PANTHER); PTHR24322:SF361 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_08407,4640,4943,4582,0,0,6,0,0,0,0,0,4,0,12,2,0,0,0,0.198908283,1,4.22735204,3.032269107,1.39412166,0.16328087,NA,0.062461108,0,7.465755727,2.33580505,3.196223815,0.001392391,0.015023052,0.163978474,1,4.795640649,1.436098194,3.339354278,0.000839734,0.005006753,0.189297386,1,4.373558805,1.910585079,2.289120152,0.022072372,0.080442001,0.163784927,0,4.697420131,1.321163481,3.555517691,0.000377236,0.002132613,N,-,,heterokaryon incompatibility partial,P:transmembrane transport; C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_08408,41287,47015,58290,0,5,1,0,0,3,1,2,2,2,5,0,0,18,0,72.57030103,1,0.654988198,0.552006053,1.186559813,0.235401296,0.409380467,10.80579698,1,0.03173725,1.213356039,0.026156585,0.979132444,0.989243725,73.61465042,1,0.98472749,0.593503119,1.659178289,0.097079871,0.189777472,97.31564923,1,0.714321947,0.550276608,1.298114324,0.194248053,0.323693472,62.56761286,1,0.996489069,0.583900082,1.706608888,0.087894772,0.173352678,N,-,,hyphal anastamosis-8,C:integral component of membrane,PTHR42069 (PANTHER),,
RL4_JR_08409,22455,12702,17625,4,1,5,0,3,0,2,1,1,0,3,1,0,0,0,491.2485052,1,-0.301157241,0.375893282,-0.801177501,0.423028894,0.614654739,85.51058887,1,-2.952532263,1.198079623,-2.464387348,0.01372477,0.042916936,288.2042331,1,-1.633579141,0.55170038,-2.960989699,0.003066522,0.013767301,341.7478482,1,-1.32253986,0.489677522,-2.700838412,0.006916493,0.036209666,240.4241604,0,-2.823886128,0.75361684,-3.747111236,0.000178883,0.001131285,N,-,,eukaryotic translation initiation factor 2 subunit gamma,F:GTP binding; C:multi-eIF complex; F:translation initiation factor activity; P:formation of translation preinitiation complex; P:positive regulation of translational fidelity; C:eukaryotic 43S preinitiation complex; F:GTPase activity; C:eukaryotic 48S preinitiation complex; F:tRNA binding; F:translation initiation factor binding; C:eukaryotic translation initiation factor 2 complex,IPR000795 (PRINTS); G3DSA:2.40.30.10 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR015256 (PFAM); IPR004161 (PFAM); PF00009 (PFAM); G3DSA:2.40.30.10 (GENE3D); PTHR23115:SF164 (PANTHER); PTHR23115 (PANTHER); IPR000795 (PROSITE_PROFILES); IPR009001 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR009000 (SUPERFAMILY),,
RL4_JR_08410,13777,11480,6328,3,0,3,0,0,0,0,0,3,3,1,1,0,6,0,60.6177093,1,-0.748904289,0.755386594,-0.99141856,0.321481241,0.509944384,13.07918833,0,-0.243726698,1.207945921,-0.201769545,0.840096892,0.9042387,40.53129642,1,-1.938112716,1.193446421,-1.623962905,0.104383726,0.200109987,52.59111295,1,-1.58794473,1.018775099,-1.558680352,0.119072054,0.223186244,56.82466499,1,0.179113375,0.653176581,0.274218917,0.783916391,0.852083034,N,-,,hypothetical protein CMQ_8203,C:nucleus; C:cytosol,IPR031355 (PFAM); PTHR38698:SF1 (PANTHER); PTHR38698 (PANTHER),,
RL4_JR_08411,184,339,251,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,80.43545738,0,-1.062496376,0.749499482,-1.417607885,0.156305277,0.305715284,19.39744872,0,-0.812324883,1.21558187,-0.668260117,0.503967567,0.657459143,57.14304288,0,-2.51157435,1.207726145,-2.079589284,0.037563221,0.090869784,117.3656564,0,-0.136183143,0.585399144,-0.232632973,0.816046421,0.883734679,50.26556809,0,-3.565273202,1.217889935,-2.927418233,0.003417889,0.013153222,N,-,,nuclear pore complex Nup62,,IPR007758 (PFAM); PTHR12084:SF0 (PANTHER); IPR026010 (PANTHER),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_08412,31745,30267,34884,9,5,6,0,0,1,2,0,3,1,8,2,0,6,1,230.0970746,1,0.408373235,0.489977551,0.83345295,0.404589323,0.596537086,53.0864118,1,0.008449773,0.980533084,0.00861753,0.993124291,0.996480454,358.4498266,1,1.585764286,0.32550038,4.871773996,1.11E-06,2.93E-05,404.3601927,1,1.47501659,0.3481672,4.236517939,2.27E-05,0.000292697,110.7277346,1,-1.438334301,0.681848829,-2.109462158,0.034904709,0.084649145,N,-,,ATPase mitochondria,P:negative regulation of ATPase activity; F:ATPase inhibitor activity; C:mitochondrion,IPR007648 (PFAM),,
RL4_JR_08413,6150,6982,8690,0,0,9,0,0,0,0,0,0,0,2,0,0,1,0,3.77437396,1,-0.018793413,1.349075415,-0.013930587,0.988885359,0.994370363,1.204564437,0,3.196894624,1.49332133,2.140794858,0.032290585,0.083763531,3.134939222,0,0.540278279,1.291799851,0.418236833,0.675773968,0.777270581,7.628210447,1,1.059142261,1.238464165,0.855206223,0.392436992,0.537457668,3.109564178,1,0.449404775,1.299948496,0.345709678,0.729560911,0.810119893,N,-,,---NA---,,no IPS match,,
RL4_JR_08414,8880,5475,5506,3,5,3,0,1,0,0,0,5,0,4,0,0,3,2,834.4442979,1,0.640797647,1.037628412,0.61755985,0.536865517,0.719998174,104.8451158,1,-3.246597138,1.187018303,-2.735085996,0.006236398,0.023876729,436.2095385,1,-0.687549722,0.355005952,-1.93672731,0.052778686,0.117953954,483.6502796,1,-0.717773514,0.512424267,-1.400740674,0.161291635,0.280838831,467.1057558,1,-0.230441557,0.452361152,-0.509419422,0.610458266,0.718123613,N,-,,tyrosine 3-monooxygenase tryptophan 5-monooxygenase activation,F:protein domain specific binding; P:oxidation-reduction process; F:monooxygenase activity,IPR000308 (PRINTS); IPR023410 (SMART); G3DSA:1.20.190.20 (GENE3D); IPR000308 (PIRSF); IPR023410 (PFAM); IPR000308 (PANTHER); PTHR18860:SF25 (PANTHER); IPR023410 (SUPERFAMILY),8.A.98.1.8, the 14-3-3 protein (14-3-3) family.
RL4_JR_08415,410,309,364,4,0,0,0,0,0,0,0,2,0,0,0,0,1,0,12.73515378,1,-1.773167925,1.254536205,-1.413405144,0.157536634,0.306762878,4.016106532,0,1.459603744,1.31202558,1.112481164,0.265931325,0.422966195,32.66042137,1,0.645497107,1.0763397,0.599715041,0.548696162,0.676037477,69.95448933,0,2.181112485,1.723021629,1.265864832,0.205561479,0.337491483,10.49106882,1,-1.304865933,1.258311856,-1.036997249,0.299737139,0.434790621,N,-,,Diphthamide biosynthesis 4,,IPR007872 (PFAM); IPR001623 (PFAM); IPR001623 (G3DSA:1.10.287.GENE3D); PTHR21454:SF8 (PANTHER); PTHR21454 (PANTHER); PTHR21454:SF8 (PANTHER); PTHR21454 (PANTHER); IPR001623 (PROSITE_PROFILES); IPR007872 (PROSITE_PROFILES); SSF144217 (SUPERFAMILY); IPR001623 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_08416,19941,18177,28112,1,3,22,0,0,2,0,3,0,5,5,1,0,5,1,56.34880922,1,-1.998802737,1.055828978,-1.893112217,0.058342948,0.149252583,15.39369964,1,-0.478807658,1.224077336,-0.391158013,0.695680442,0.807240395,40.21906071,1,-3.140860052,1.211233175,-2.593109334,0.009511253,0.031426868,68.08657568,1,-0.853584777,0.788522049,-1.082512249,0.279024976,0.422430694,59.2592297,1,-0.356670953,0.755520523,-0.472086385,0.63686513,0.739118203,N,-,,60S ribosomal,F:structural constituent of ribosome; C:mitochondrial large ribosomal subunit,PTHR28041 (PANTHER),,
RL4_JR_08417,9433,7130,8845,0,0,3,0,0,0,0,1,3,1,2,0,0,7,3,127.808131,1,-1.461906382,0.623041817,-2.346401706,0.018955665,0.062742899,32.30128062,0,-1.547992407,1.203038435,-1.28673562,0.198186453,0.341591073,103.0564847,1,-1.794399698,0.857230629,-2.093251965,0.036326668,0.088576876,140.3595012,1,-1.082122239,0.580634069,-1.86369057,0.06236517,0.139855449,128.1438299,1,-0.249758001,0.511014144,-0.488749683,0.625018925,0.729657168,N,-,,pre-mrna-splicing atp-dependent rna helicase prp28,"F:nucleic acid binding; P:RNA splicing, via transesterification reactions; F:ATP binding; C:catalytic step 2 spliceosome; C:cytoplasm; C:U5 snRNP; P:RNA secondary structure unwinding; P:mRNA processing; F:ATP-dependent RNA helicase activity",IPR001650 (SMART); IPR014001 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR011545 (PFAM); PTHR24031 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_08418,53,70,61,0,0,5,0,0,0,0,0,0,0,3,0,0,0,0,91.35253148,1,-0.499620714,0.569963321,-0.876583976,0.380712646,0.572930043,19.2720804,0,-0.80293225,1.196417181,-0.671113941,0.502147946,0.656111167,50.02511862,0,-3.455619665,1.18689701,-2.911473899,0.00359728,0.015464484,81.78091596,1,-0.580869083,0.612945444,-0.94766849,0.343298247,0.490253138,64.7913908,0,-0.927835652,0.74920467,-1.23842748,0.215557596,0.340486843,N,-,,amino-acid transporter Arg-13,P:mitochondrial ornithine transport; P:L-ornithine transmembrane transport; F:L-ornithine transmembrane transporter activity; P:arginine biosynthetic process; F:structural constituent of ribosome; C:integral component of membrane; C:mitochondrial inner membrane; P:translation,IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089:SF234 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.9.1, the mitochondrial carrier (mc) family.
RL4_JR_08419,1198,992,1042,0,3,3,0,0,0,0,0,4,1,9,0,0,2,0,223.5566676,1,1.892954458,0.3851641,4.914670031,8.89E-07,1.38E-05,51.95813814,0,2.179469178,0.794208922,2.744201326,0.006065832,0.02345535,346.9377872,1,3.108590058,0.653431281,4.757332787,1.96E-06,4.79E-05,337.1772384,1,2.722685422,0.804235498,3.385433036,0.00071066,0.005560616,106.0840004,1,1.076654006,1.520439648,0.708120186,0.478870625,0.608373811,N,-,,benzodiazapine receptor,C:membrane,IPR004307 (PFAM); IPR004307 (PIRSF); PTHR10057:SF0 (PANTHER); IPR004307 (PANTHER),9.A.24.1.7, the mitochondrial cholesterol/porphyrin uptake translocator protein (tspo) family.
RL4_JR_08420,1864,2541,2451,0,2,7,0,0,0,0,0,2,0,2,3,0,0,2,74.19864388,1,-1.673063581,0.892368375,-1.874857546,0.060812324,0.154031293,27.90262485,0,0.170276512,1.127585521,0.151009843,0.879967952,0.931615043,185.506314,1,1.580378275,0.612262072,2.581212111,0.009845407,0.03229906,280.6954892,1,1.902256107,0.404489953,4.702851312,2.57E-06,4.23E-05,108.2259686,1,0.670173513,0.533068144,1.257200453,0.208681059,0.331798952,N,-,,phosphopantothenoylcysteine decarboxylase,F:catalytic activity; C:membrane,IPR003382 (PFAM); IPR003382 (G3DSA:3.40.50.GENE3D); PTHR14359 (PANTHER); PTHR14359:SF6 (PANTHER); IPR003382 (SUPERFAMILY),,
RL4_JR_08421,277,298,296,0,0,5,0,0,0,0,0,0,0,1,0,0,2,0,0.823320808,1,2.177979576,1.601441349,1.360012077,0.173826102,NA,0.263562394,0,5.389244616,1.743719018,3.090661144,0.001997114,0.015023052,0.683246849,0,2.737953608,1.264795862,2.164739537,0.030407637,0.077595422,0.788111363,1,2.316031139,1.336077869,1.733455207,0.083014792,0.170422703,0.673851004,1,2.655228217,1.236844566,2.146775991,0.03181112,0.078827114,N,-,,retrograde regulation 2,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF289 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.3, the major facilitator superfamily (mfs).
RL4_JR_08422,12,4,8,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,9.060277301,1,3.11104898,1.026889025,3.029586356,0.002448889,0.012316914,0.452560422,0,4.609264162,1.566658695,2.942098477,0.003259962,0.016208996,1.176990418,0,1.953570216,1.23029037,1.587893609,0.112310399,0.211069329,1.357996347,0,1.531138168,1.256245948,1.218820383,0.222912373,0.358138334,1.163402735,0,1.868071463,1.219899688,1.531332027,0.125687354,0.226611871,N,-,,gibberellin 2-oxidase,F:iron ion binding; F:oxidoreductase activity; P:oxidation-reduction process,PR00682 (PRINTS); IPR026992 (PFAM); IPR027443 (G3DSA:2.60.120.GENE3D); IPR005123 (PFAM); PTHR10209 (PANTHER); PTHR10209:SF186 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_08423,1440,1837,1732,0,2,24,0,0,0,0,1,1,0,0,0,0,11,0,11.20783396,1,-0.04402045,1.206718878,-0.036479457,0.970900059,0.984537312,24.68397752,0,3.156479594,1.169603197,2.698761087,0.006959812,0.02585219,28.25350278,1,1.428286633,1.075020441,1.328613465,0.183975527,0.305238977,19.08547857,0,1.413377601,0.940039108,1.50353064,0.132702262,0.242642714,5.971541087,1,-0.491838473,1.2433524,-0.395574475,0.69241897,0.781925281,N,-,,hypothetical protein F503_04813,C:membrane; C:integral component of membrane,IPR032805 (PFAM); PTHR31595 (PANTHER); PTHR31595:SF4 (PANTHER),,
RL4_JR_08424,1116,842,707,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,14.63748678,0,0.805503888,1.043435603,0.771972784,0.440130547,0.630169365,2.243025854,0,2.300164461,1.330532943,1.728754235,0.08385309,0.176375243,5.794025839,0,-0.345352017,1.216987344,-0.283776178,0.776581911,0.851447936,14.70600351,1,0.947566908,1.042275308,0.909133029,0.36327991,0.509447242,5.678112912,1,-0.419132304,1.212683966,-0.345623687,0.729625542,0.810119893,N,-,,telomerase reverse transcriptase,,IPR003545 (PRINTS); IPR021891 (SMART); IPR021891 (PFAM); IPR000477 (PFAM); IPR003545 (PTHR12066:PANTHER); PTHR12066 (PANTHER); IPR000477 (PROSITE_PROFILES); SSF56672 (SUPERFAMILY),,
RL4_JR_08425,1787,1591,1247,0,2,19,0,0,0,0,0,1,1,1,0,0,3,3,133.0317555,1,-0.857960008,0.649754384,-1.320437428,0.186689014,0.344962396,28.51544183,0,-1.368132164,1.252957526,-1.091922221,0.27486729,0.433028281,79.64619098,1,-3.041941873,1.230990097,-2.471134317,0.013468522,0.040824945,112.2606601,1,-2.028925656,0.919472201,-2.206619901,0.027340625,0.088025404,75.12614653,1,-3.141618645,1.160995664,-2.705969318,0.006810534,0.023096861,N,-,,Rho guanyl nucleotide exchange,,IPR000219 (SMART); IPR027267 (G3DSA:1.20.1270.GENE3D); IPR000219 (PFAM); IPR004148 (PFAM); IPR000219 (G3DSA:1.20.900.GENE3D); PTHR22834:SF20 (PANTHER); PTHR22834:SF20 (PANTHER); PTHR22834 (PANTHER); PTHR22834:SF20 (PANTHER); PTHR22834:SF20 (PANTHER); PTHR22834 (PANTHER); PTHR22834 (PANTHER); IPR000219 (PROSITE_PROFILES); IPR000219 (SUPERFAMILY); SSF103657 (SUPERFAMILY),,
RL4_JR_08426,8725,5889,6685,0,3,0,0,0,1,0,0,2,1,0,0,0,3,0,0.229809086,1,4.018964635,2.896515637,1.387516982,0.165284177,NA,0.075154938,1,7.19982838,2.322337383,3.100250822,0.001933568,0.015023052,0.192291634,1,4.567598528,1.471434157,3.104181391,0.001908063,0.009542375,0.221608049,1,4.146665302,1.890980783,2.192864856,0.028317117,0.089465864,0.187245755,1,4.500740786,1.344606713,3.347254437,0.000816163,0.004065045,N,-,,fungal specific transcription factor domain-containing,"F:zinc ion binding; P:transcription, DNA-templated; P:transcription from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:positive regulation of transcription from RNA polymerase II promoter; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter; F:DNA binding; C:nucleus; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; C:nuclear chromatin; C:mitotic spindle; F:metal ion binding",IPR007219 (PFAM); PTHR31001 (PANTHER); PTHR31001:SF46 (PANTHER),,
RL4_JR_08427,624,532,854,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,60.26600397,1,-2.798753825,1.172879372,-2.386224783,0.017022343,0.057717487,15.96966169,0,-0.531787519,1.228273281,-0.432955375,0.66504719,0.785576806,41.58547671,0,-3.189066426,1.212107779,-2.63100896,0.008513179,0.028780844,61.30461373,0,-1.875905258,1.04468973,-1.795657795,0.072548958,0.155219145,41.21479009,0,-3.27888151,1.221524918,-2.684252659,0.007269215,0.024330843,N,-,,fungal specific transcription factor domain containing,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_08428,1282,1037,1666,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,101.7355273,1,-0.770492058,0.641005615,-1.202005162,0.229361528,0.401530332,22.4203716,0,-1.02126194,1.208556643,-0.845026127,0.398096251,0.562197041,89.85143338,0,-0.856081391,0.766434694,-1.116965866,0.26400892,0.40150613,131.3820733,0,-0.312495961,0.596941965,-0.523494709,0.600630032,0.722511474,65.34240884,0,-2.832946557,1.142343222,-2.47994342,0.013140323,0.039073648,N,-,,uroporphyrinogen decarboxylase,,G3DSA:3.20.20.210 (GENE3D); IPR006361 (TIGRFAM); IPR000257 (PFAM); PTHR21091:SF2 (PANTHER); PTHR21091 (PANTHER); SSF51726 (SUPERFAMILY),,
RL4_JR_08429,420,467,687,0,0,0,0,0,0,0,0,0,1,0,2,0,0,0,103.977636,0,-1.200782163,0.856126364,-1.402575851,0.160743357,0.31045083,23.59158041,0,-1.094660012,1.302338522,-0.840534158,0.400608958,0.564412297,86.26658716,0,-0.954497332,0.890113789,-1.072331812,0.283571023,0.42299588,88.08965872,1,-2.328149262,1.127642352,-2.064616727,0.038959279,0.105612504,58.43403406,0,-3.782529764,1.270225864,-2.977840296,0.002902872,0.011508418,N,-,,gcn5-related n-acetyltransferase,"F:transferase activity, transferring acyl groups other than amino-acyl groups; F:transferase activity; F:N-acetyltransferase activity",IPR016181 (G3DSA:3.40.630.GENE3D); IPR013653 (PFAM); PTHR20958 (PANTHER); PTHR20958:SF6 (PANTHER); IPR016181 (SUPERFAMILY),,
RL4_JR_08430,500,401,387,0,0,15,0,0,0,0,0,0,0,1,0,0,0,3,1356.403872,1,-5.254496642,0.846475851,-6.207497395,5.38E-10,1.60E-08,422.5909742,0,-5.257597235,1.211971226,-4.338054503,1.44E-05,0.000903747,1099.180288,0,-6.941092888,1.208989213,-5.741236408,9.40E-09,3.98E-07,1268.295353,1,-7.373372999,1.159244769,-6.360497109,2.01E-10,7.22E-09,1070.228096,1,-7.977481999,1.219532722,-6.541425132,6.09E-11,4.47E-09,N,-,,hypothetical protein CMQ_8136,P:biological_process; C:cellular_component; F:molecular_function,IPR022024 (PFAM); PTHR34693:SF1 (PANTHER); PTHR34693 (PANTHER),,
RL4_JR_08431,833,761,858,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,119.214105,1,-1.435414924,0.663645293,-2.162924892,0.030546957,0.091787136,31.01192636,0,-1.489210974,1.214931838,-1.22575681,0.220290205,0.368010802,79.97113382,0,-4.132409182,1.201153029,-3.440368613,0.000580922,0.003777302,114.8569549,0,-2.227441511,0.867097525,-2.568847731,0.010203728,0.049219985,109.2312249,0,-0.645061603,0.590937504,-1.091590224,0.275013255,0.40776463,N,-,,developmental regulator,"C:nucleus; C:cytoplasm; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:sporulation resulting in formation of a cellular spore",IPR021740 (PFAM); PTHR33572 (PANTHER); PTHR33572:SF2 (PANTHER),,
RL4_JR_08432,596,524,367,0,1,8,0,0,0,0,0,0,1,1,0,0,0,0,502.3446604,1,-0.169196511,0.603057217,-0.280564606,0.779044366,0.886370752,88.39314719,0,-3.000340805,1.197462843,-2.505581549,0.01222502,0.039243355,328.7718221,0,-1.065179064,0.519954821,-2.048599264,0.040501317,0.09656979,414.4727549,1,-0.915503912,0.387811393,-2.360693699,0.01824079,0.073727743,410.599604,0,-0.128714459,0.682579772,-0.188570574,0.850429398,0.900595927,N,-,,involucrin repeat,,PTHR40641:SF2 (PANTHER); PTHR40641 (PANTHER); PTHR40641 (PANTHER); PTHR40641:SF2 (PANTHER),,
RL4_JR_08433,22,22,7,0,0,49,0,0,0,1,43,48,15,62,11,0,41,1,702.7682598,1,-7.559233983,1.247045732,-6.06171353,1.35E-09,3.57E-08,360.5441931,0,-1.315725768,0.783157049,-1.680027997,0.092951869,0.191426005,680.3628498,1,-2.518042438,0.588379043,-4.27962632,1.87E-05,0.000320692,740.8630278,1,-3.653197002,0.747378363,-4.88801547,1.02E-06,1.87E-05,612.8247516,1,-3.438546821,0.721448113,-4.766173424,1.88E-06,2.45E-05,N,-,,hmg box,,IPR009071 (SMART); IPR001660 (SMART); IPR009071 (PFAM); IPR013761 (G3DSA:1.10.150.GENE3D); IPR001660 (PFAM); IPR009071 (G3DSA:1.10.30.GENE3D); PTHR13711:SF225 (PANTHER); PTHR13711 (PANTHER); PTHR13711 (PANTHER); PTHR13711:SF225 (PANTHER); IPR009071 (PROSITE_PROFILES); IPR001660 (PROSITE_PROFILES); IPR009071 (SUPERFAMILY); IPR013761 (SUPERFAMILY),,
RL4_JR_08434,20973,18111,23578,4,4,81,0,0,3,8,12,3,4,45,9,0,15,8,333.8174259,1,-3.929561669,0.985154183,-3.988778342,6.64E-05,0.000592789,109.1561798,1,-2.263376793,1.187826563,-1.905477503,0.056718029,0.130447601,256.8496251,1,-5.815791262,1.263471633,-4.6030248,4.16E-06,8.96E-05,296.116777,1,-6.237201218,1.271605083,-4.904982924,9.34E-07,1.72E-05,251.8082602,1,-5.889965515,1.278563586,-4.606705198,4.09E-06,4.81E-05,N,-,,Amidase,"F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",PIRSF001221 (PIRSF); IPR023631 (PFAM); IPR023631 (G3DSA:3.90.1300.GENE3D); IPR000120 (PANTHER); IPR000120 (PANTHER); PTHR11895:SF45 (PANTHER); IPR023631 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_08435,12954,10306,9032,1,5,20,0,0,1,0,1,2,0,15,0,0,16,0,106.6478474,1,-3.846322791,1.264382659,-3.042055951,0.002349682,0.011913429,33.34569516,1,-1.593912277,1.295675346,-1.23017875,0.218630176,0.36614405,85.87536307,1,-4.235190292,1.276245285,-3.318476738,0.000905099,0.005315092,99.00394706,1,-4.656599239,1.29141596,-3.605808959,0.000311182,0.002802811,84.26609516,1,-4.310672165,1.286703553,-3.350167296,0.000807628,0.004028192,N,-,,2-dehydropantoate 2-reductase,F:oxidoreductase activity; P:single-organism metabolic process,IPR013328 (G3DSA:1.10.1040.GENE3D); IPR013332 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR003710 (TIGRFAM); IPR013752 (PFAM); PTHR21708:SF33 (PANTHER); PTHR21708 (PANTHER); IPR008927 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_08436,44,87,91,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,151.6359962,0,-0.304279242,0.590400522,-0.515377664,0.606289138,0.772991246,27.36769409,0,-1.308865416,1.240760255,-1.054889863,0.291475699,0.450636478,70.34371909,0,-3.947356571,1.221515702,-3.231523396,0.001231322,0.006821062,136.3295873,0,-0.775101403,0.640920396,-1.209356742,0.22652582,0.362219509,72.58274154,0,-3.088396291,1.15023865,-2.685004797,0.007252877,0.024306274,N,-,,Fungal transcriptional regulatory N-terminal,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR021858 (PFAM); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_08437,2717,2532,3486,1,0,3,0,0,0,4,0,4,1,0,0,0,0,1,48.56661456,1,-0.622379388,0.883057384,-0.704800616,0.480934325,0.669418567,9.273540054,0,0.252421854,1.256883416,0.200831558,0.840830286,0.904694812,23.90249539,1,-2.39010947,1.214168899,-1.968514819,0.049008833,0.111472798,27.56132351,1,-2.811765409,1.215404009,-2.313440953,0.020698408,0.077965542,23.42940338,1,-2.464081896,1.214224295,-2.02934656,0.042423004,0.098426425,N,-,,FMN-binding split barrel,F:FMN binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR012349 (G3DSA:2.30.110.GENE3D); IPR024747 (PFAM); PTHR34071 (PANTHER); PTHR34071:SF2 (PANTHER); IPR012349 (SUPERFAMILY),,
RL4_JR_08438,2204,2840,2846,0,1,4,0,2,0,0,0,0,1,1,0,0,0,0,17.70667114,1,-2.248553776,1.200699098,-1.872703811,0.061109297,0.154487029,5.703975745,1,0.953606682,1.261899495,0.755691468,0.449834201,0.610351445,14.70598499,0,-1.689293433,1.204915822,-1.402001204,0.160914887,0.276343957,16.95835413,1,-2.111060282,1.203990672,-1.753385912,0.079535788,0.165733659,22.12569373,0,-0.097040674,0.985522311,-0.098466237,0.92156208,0.949701381,N,-,,hypothetical protein CMQ_8268,,no IPS match,,
RL4_JR_08439,1048,489,470,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,335.4198393,0,-1.531970558,0.648711666,-2.361558512,0.0181983,0.06069572,93.46482219,0,-2.013200455,1.141625124,-1.763451429,0.077824382,0.166858377,338.4438817,0,-0.76319186,0.505524246,-1.50970377,0.131119029,0.23734115,372.061709,0,-1.123716502,0.472843595,-2.376507822,0.017477391,0.072063371,252.8777098,1,-2.198790999,0.643292781,-3.418025297,0.000630772,0.003293745,N,-,,sensor gacs,F:phosphorelay sensor kinase activity; P:phosphorelay signal transduction system; C:integral component of membrane; P:signal transduction by protein phosphorylation; C:intracellular,IPR004358 (PRINTS); IPR003660 (SMART); IPR001789 (SMART); IPR003661 (SMART); IPR003594 (SMART); IPR003660 (PFAM); IPR001789 (PFAM); IPR003594 (PFAM); IPR003661 (PFAM); IPR003661 (G3DSA:1.10.287.GENE3D); IPR003594 (G3DSA:3.30.565.GENE3D); G3DSA:3.40.50.2300 (GENE3D); PTHR24423:SF525 (PANTHER); PTHR24423 (PANTHER); PTHR24423 (PANTHER); PTHR24423:SF525 (PANTHER); PTHR24423:SF525 (PANTHER); PTHR24423 (PANTHER); IPR005467 (PROSITE_PROFILES); IPR003660 (PROSITE_PROFILES); IPR003660 (PROSITE_PROFILES); IPR003660 (PROSITE_PROFILES); IPR003660 (PROSITE_PROFILES); IPR003660 (PROSITE_PROFILES); IPR003660 (PROSITE_PROFILES); IPR001789 (PROSITE_PROFILES); IPR003594 (SUPERFAMILY); IPR003661 (SUPERFAMILY); SSF58104 (SUPERFAMILY); IPR011006 (SUPERFAMILY); SSF58104 (SUPERFAMILY),9.B.238.3.1,The Uncharacterized Bacterial 5 TMS Protein-1 (UBP1) Family
RL4_JR_08440,21422,14041,18260,1,5,0,0,0,0,2,0,0,3,0,0,0,0,0,24.8962572,1,-0.48268908,1.009348921,-0.478218255,0.632494871,0.790909435,184.03339,0,5.010422123,1.703305082,2.941588196,0.003265338,0.016208996,14.31793517,1,-1.650745518,1.194440627,-1.382023921,0.166964356,0.284091957,24.53677196,1,-0.347240402,1.017596112,-0.341235976,0.732925942,0.821711346,14.06675882,0,-1.72806742,1.192365532,-1.449276563,0.147260364,0.255606781,N,-,,condensin complex component cnd2,C:nucleus; P:mitotic chromosome condensation; P:mycelium development; C:condensin complex,IPR022816 (PFAM); IPR022816 (PIRSF); PTHR13108 (PANTHER),,
RL4_JR_08441,16456,16146,18877,0,0,11,0,3,0,1,0,0,0,0,0,0,0,0,231.33707,1,1.714001639,0.301612949,5.682785319,1.33E-08,3.06E-07,56.39989333,1,1.81797734,0.754527235,2.409425738,0.015977647,0.048435384,263.2171631,1,2.007470691,0.345324398,5.813289487,6.13E-09,2.72E-07,124.7786879,0,0.568201455,0.429785976,1.322056761,0.186149251,0.313917582,94.07736466,0,0.553078726,0.473278998,1.16861033,0.242560665,0.371997384,N,-,,sodium calcium exchanger,,IPR004837 (PFAM); PTHR12266:SF0 (PANTHER); PTHR12266:SF0 (PANTHER); PTHR12266 (PANTHER); PTHR12266 (PANTHER); PTHR12266:SF0 (PANTHER); PTHR12266 (PANTHER),2.A.19.4.4, the ca(2+):cation antiporter (caca) family.
RL4_JR_08442,8658,6192,4812,0,0,2,0,0,0,0,2,0,0,8,0,0,2,0,76.67634738,1,1.830812271,0.78600285,2.329269252,0.019844806,0.065069907,5.739851774,0,0.944403612,1.344030824,0.702665143,0.482264455,0.639102345,15.12862615,1,-1.730307796,1.277317384,-1.354642015,0.17553164,0.294804633,21.47952163,1,-1.212745217,1.239743054,-0.978223039,0.327964024,0.474715617,22.54959411,1,-0.883700693,1.229727043,-0.71861532,0.472377971,0.603359021,N,-,,hypothetical protein SPSK_06638,,no IPS match,,
RL4_JR_08443,354,331,443,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,241.9472595,0,1.106122471,0.943977445,1.171767904,0.241290252,0.416161919,25.45628128,0,-1.204456758,1.211499478,-0.994186774,0.320131946,0.48227051,80.71826437,0,-2.043612702,1.050721204,-1.944961892,0.051779565,0.116269392,153.1772707,0,-0.07818423,0.513877122,-0.15214577,0.879071965,0.925411068,111.7132838,0,0.008435165,0.597578705,0.014115572,0.988737777,0.992390322,N,-,,phosphomannomutase,C:cytoplasm; F:phosphomannomutase activity; P:GDP-mannose biosynthetic process,IPR023214 (G3DSA:3.40.50.GENE3D); IPR005002 (PFAM); IPR006379 (TIGRFAM); IPR005002 (PANTHER); IPR023214 (SUPERFAMILY),,
RL4_JR_08444,141,187,212,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,98.08196844,0,0.763561576,0.603139827,1.265977707,0.205521064,0.370703145,11.07137689,0,-0.003212875,1.235499775,-0.002600466,0.997925131,0.999073169,28.56041574,1,-2.64694911,1.202424777,-2.201342788,0.027711766,0.072047745,58.29373148,0,-0.038591724,0.697807876,-0.055304226,0.955896096,0.974373097,43.44556169,0,-0.121654176,0.767971105,-0.158409835,0.874133864,0.916306592,N,-,,ww domain-containing,,IPR001202 (SMART); G3DSA:2.20.70.10 (GENE3D); IPR001202 (PFAM); PTHR10351 (PANTHER); PTHR10351 (PANTHER); PTHR10351:SF48 (PANTHER); PTHR10351:SF48 (PANTHER); IPR001202 (PROSITE_PROFILES); IPR001202 (SUPERFAMILY),,
RL4_JR_08445,12976,8401,10872,5,7,1,0,0,0,0,4,0,6,0,2,0,3,1,34.95089776,1,0.872581163,0.775974833,1.124496731,0.260802357,0.440411017,5.087962307,0,1.118501581,1.297383525,0.862120999,0.388620937,0.553251916,13.12253656,1,-1.52487386,1.226964252,-1.24280219,0.213940735,0.342494624,23.15775093,1,-0.241190418,1.064059317,-0.226670087,0.820680289,0.887281145,12.83154637,1,-1.595381834,1.226205955,-1.301071674,0.193233923,0.313842391,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:mitochondrion; C:integral component of membrane; C:fungal-type vacuole,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR20772 (PANTHER); PTHR20772:SF2 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.44.3, the major facilitator superfamily (mfs).
RL4_JR_08446,8588,4202,6034,2,4,0,0,0,0,0,0,1,0,0,0,0,7,0,34.07966295,1,0.360890792,0.771762422,0.467619026,0.640057056,0.795367169,5.987694965,0,0.883459741,1.244368823,0.709966148,0.477725128,0.635084548,15.57416396,1,-1.772211131,1.203078148,-1.473064018,0.140733774,0.2499257,21.9800722,0,-1.248308934,1.155297056,-1.080509059,0.279915555,0.423350586,19.2700069,1,-0.930769101,1.141548919,-0.815356298,0.414868392,0.550890815,N,-,,histone deacetylase phd1,"F:histone deacetylase activity (H4-K16 specific); C:Rpd3L-Expanded complex; P:transcription, DNA-templated; F:NAD-dependent histone deacetylase activity (H3-K14 specific); C:cytosol; P:regulation of transcription, DNA-templated; C:Set3 complex; P:histone H4 deacetylation; P:negative regulation of meiotic nuclear division; P:positive regulation of stress-activated MAPK cascade; F:NAD-independent histone deacetylase activity; P:histone H3 deacetylation",IPR000286 (PRINTS); IPR003084 (PRINTS); IPR023801 (PFAM); IPR003084 (PIRSF); IPR023801 (G3DSA:3.40.800.GENE3D); IPR000286 (PANTHER); PTHR10625:SF132 (PANTHER); SSF52768 (SUPERFAMILY),,
RL4_JR_08447,55425,53217,48950,8,8,9,0,0,4,1,2,1,1,2,1,0,21,0,99.15498394,1,-1.827809006,0.824064867,-2.218040205,0.026552091,0.082536643,26.53615077,1,-1.264412981,1.216675425,-1.039236065,0.298694961,0.458923861,77.15761644,1,-2.964332334,1.212495926,-2.444818388,0.01449251,0.043178979,79.99234296,1,-4.348992937,1.216911561,-3.5737954,0.000351844,0.003103153,80.10146945,1,-2.340312083,1.012322778,-2.31182399,0.020787385,0.056334312,N,-,,phd-finger domain-containing,P:regulation of response to DNA damage stimulus; F:zinc ion binding; C:NuA4 histone acetyltransferase complex; P:cellular macromolecule metabolic process; P:chromatin organization; P:primary metabolic process; P:positive regulation of transcription from RNA polymerase II promoter,IPR024610 (SMART); IPR001965 (SMART); IPR024610 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR028651 (PANTHER); IPR019787 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY),,
RL4_JR_08448,1851,1614,1579,4,0,0,0,0,0,0,0,0,3,0,0,0,2,0,771.3507795,1,0.181769435,0.312389192,0.581868513,0.560655251,0.737594829,124.2427281,0,-2.461751967,1.122462329,-2.193171123,0.028295052,0.075667772,350.1258253,0,-2.405996578,0.608145874,-3.956282006,7.61E-05,0.000971869,470.9969388,1,-1.314583574,0.429036269,-3.06403833,0.002183709,0.014191307,376.7222815,1,-1.433433266,0.512932951,-2.794582145,0.005196684,0.018486069,N,-,,utp-glucose-1-phosphate uridylyltransferase,P:UDP-glucose metabolic process; F:UTP:glucose-1-phosphate uridylyltransferase activity,IPR002618 (PFAM); IPR029044 (G3DSA:3.90.550.GENE3D); IPR016267 (PIRSF); IPR002618 (PANTHER); IPR029044 (SUPERFAMILY),,
RL4_JR_08449,315,278,411,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37.92531064,0,-3.347421564,1.192550524,-2.806943184,0.005001406,0.021784021,12.19224116,0,-0.142335625,1.224571947,-0.116232962,0.907467914,0.948316149,47.16215213,0,-0.962758797,1.037660501,-0.927816754,0.353502632,0.496787985,109.1892373,0,0.861577733,0.502265298,1.715383756,0.086274892,0.175301633,30.87398787,0,-2.86213951,1.192879541,-2.399353339,0.016424058,0.046685453,N,-,,chromodomain helicase,C:nucleus; P:regulation of macromolecule metabolic process; F:organic cyclic compound binding; F:heterocyclic compound binding; F:nucleoside-triphosphatase activity; P:chromatin organization; P:regulation of primary metabolic process; P:regulation of cellular metabolic process; P:regulation of cellular component organization,no IPS match,,
RL4_JR_08450,671,764,1191,0,4,5,0,0,0,0,0,0,0,4,0,0,3,0,231.2335523,1,-2.366599978,0.630263645,-3.754936522,0.000173385,0.001370181,61.6318164,0,-2.480072451,1.204502196,-2.059002017,0.039494045,0.098061542,165.5697747,0,-4.162738736,1.198061347,-3.474562257,0.000511688,0.003437509,219.5513314,1,-1.729818616,0.572480955,-3.021617751,0.002514278,0.016030899,179.731432,1,-2.981827553,0.848928369,-3.512460724,0.000443978,0.002453752,N,-,,chromodomain helicase dna binding,P:negative regulation of histone exchange; F:chromatin DNA binding; F:DNA-dependent ATPase activity; F:methylated histone binding; F:helicase activity; P:termination of RNA polymerase I transcription; P:termination of RNA polymerase II transcription; C:SAGA complex; P:transcription elongation from RNA polymerase II promoter; P:nucleosome mobilization; P:regulation of transcriptional start site selection at RNA polymerase II promoter; F:ATP binding; C:SLIK (SAGA-like) complex; P:histone H2B conserved C-terminal lysine ubiquitination; F:rDNA binding; P:ATP-dependent chromatin remodeling; C:mitochondrion; P:negative regulation of histone H3-K14 acetylation; P:negative regulation of histone H3-K9 acetylation; P:chromatin organization involved in regulation of transcription; P:nucleosome positioning; F:nucleosome-dependent ATPase activity; P:negative regulation of DNA-dependent DNA replication; C:nucleolar chromatin,IPR001650 (SMART); IPR025260 (SMART); IPR000953 (SMART); IPR014001 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR000330 (PFAM); IPR025260 (PFAM); IPR023780 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:2.40.50.40 (GENE3D); PTHR10799 (PANTHER); PTHR10799:SF70 (PANTHER); PTHR10799:SF70 (PANTHER); PTHR10799 (PANTHER); IPR000953 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR000953 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR016197 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR016197 (SUPERFAMILY),,
RL4_JR_08451,4074,2687,3391,0,4,5,0,0,0,0,0,2,0,0,0,0,0,5,25.21435523,1,-2.758481159,1.192315172,-2.31355033,0.020692401,0.067496444,8.102575002,0,0.447185872,1.236485027,0.361658946,0.717606909,0.823072763,27.41847043,1,-1.235958976,1.195852701,-1.033537805,0.301352288,0.442542873,43.39680736,0,-0.872938414,1.019320083,-0.856392834,0.391780527,0.536631201,20.5175243,1,-2.272608918,1.193274073,-1.904515458,0.056843085,0.123452647,N,-,,chromodomain-helicase-DNA-binding 1,,no IPS match,,
RL4_JR_08452,25995,29877,33978,15,27,139,0,0,0,1,4,0,6,43,3,0,13,0,381.5010431,1,-3.566320583,0.743044599,-4.799605013,1.59E-06,2.29E-05,157.2683302,0,-1.669142716,0.995831982,-1.676128852,0.093712957,0.192601532,328.4529529,1,-3.176678835,0.77619997,-4.092603655,4.27E-05,0.000635067,396.5713247,1,-2.169924648,0.599528917,-3.619382796,0.000295307,0.002683353,325.9659716,1,-2.496397446,0.726481421,-3.436285327,0.00058975,0.003110007,N,-,,translation initiation factor rli1,,IPR013283 (PRINTS); IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR007209 (PFAM); G3DSA:3.30.70.20 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); IPR017896 (PFAM); IPR013283 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR017896 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF54862 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.31.3, the atp-binding cassette (abc) superfamily.
RL4_JR_08453,271,225,302,0,0,108,0,0,0,1,1,1,3,8,0,0,4,0,319.6322627,1,-2.111684487,0.703830596,-3.000273785,0.00269737,0.013256113,78.79155452,0,-2.834462136,1.186435466,-2.389057152,0.016891674,0.050570106,217.7003159,1,-3.668307867,1.031954063,-3.554720118,0.000378382,0.002777908,274.3869219,1,-3.159776794,0.738106527,-4.280922439,1.86E-05,0.000245373,228.7809204,1,-2.387065657,0.640429443,-3.727289057,0.00019355,0.001211186,N,-,,FF domain-containing,C:nuclear part; C:intracellular ribonucleoprotein complex,IPR002713 (SMART); IPR001202 (SMART); IPR002713 (G3DSA:1.10.10.GENE3D); IPR001202 (PFAM); IPR002713 (PFAM); G3DSA:2.20.70.10 (GENE3D); PTHR11864:SF19 (PANTHER); PTHR11864 (PANTHER); PTHR11864 (PANTHER); PTHR11864:SF19 (PANTHER); IPR002713 (PROSITE_PROFILES); IPR002713 (PROSITE_PROFILES); IPR002713 (PROSITE_PROFILES); IPR001202 (PROSITE_PROFILES); IPR002713 (PROSITE_PROFILES); IPR001202 (PROSITE_PROFILES); IPR002713 (SUPERFAMILY); IPR002713 (SUPERFAMILY); IPR002713 (SUPERFAMILY); IPR001202 (SUPERFAMILY); IPR002713 (SUPERFAMILY); IPR001202 (SUPERFAMILY); IPR002713 (SUPERFAMILY),,
RL4_JR_08454,9044,7149,9070,7,1,21,0,3,0,10,2,10,0,6,0,6,4,1,32.35943419,1,2.92142355,0.569045692,5.133899774,2.84E-07,4.99E-06,1.797105456,1,2.619862696,1.317156554,1.989029086,0.046697993,0.111641806,50.37309671,1,3.376601311,0.609933362,5.536016753,3.09E-08,1.18E-06,9.386815488,1,0.493833147,1.142772004,0.432136196,0.665642429,0.771763643,20.0314698,1,2.499790771,0.748713799,3.338780152,0.000841471,0.004156047,N,-,,pre-mrna-processing prp40,C:nucleus; C:membrane; C:integral component of membrane; C:U1 snRNP,no IPS match,,
RL4_JR_08455,9581,9474,9484,1,4,23,0,0,0,5,4,2,3,5,2,0,11,0,2.099264233,1,0.827934832,1.27499655,0.649362409,0.516104155,NA,0.667861633,0,4.047895144,1.479233002,2.736482446,0.006209991,0.023854849,1.734824456,1,1.394287151,1.221727936,1.141241933,0.253769259,0.389443683,2.001561087,1,0.97177171,1.234461229,0.787203103,0.431162981,0.573355028,1.711261769,1,1.311470429,1.214724764,1.079644104,0.280300694,0.413769822,N,-,,kinase domain-containing,F:ATP binding; F:protein kinase activity; P:protein phosphorylation,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); PTHR24055 (PANTHER); PTHR24055:SF213 (PANTHER); PTHR24055:SF213 (PANTHER); PTHR24055 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_08456,1251,980,1019,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,3.987447554,0,-0.097744803,1.205241566,-0.081099761,0.935362615,0.968241015,1.27745966,0,3.112291873,1.366418732,2.277699946,0.022744461,0.063755036,11.14803033,0,1.426284975,1.193287286,1.195256995,0.231986636,0.363284255,7.823732793,1,0.989358217,1.146948135,0.862600659,0.388357068,0.533384617,22.19574123,0,3.006971708,0.743675943,4.043389783,5.27E-05,0.000408129,N,-,,helix-loop-helix DNA-binding domain-containing,F:DNA binding; F:protein dimerization activity,IPR011598 (SMART); IPR011598 (PFAM); IPR011598 (G3DSA:4.10.280.GENE3D); PTHR12565:SF51 (PANTHER); PTHR12565 (PANTHER); PTHR12565:SF51 (PANTHER); IPR011598 (PROSITE_PROFILES); IPR011598 (SUPERFAMILY),3.A.16.1.4, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_08457,1391,1159,2016,0,0,8,0,0,0,0,0,0,1,2,0,0,0,0,42.91393541,1,-1.065282071,1.080871769,-0.985576737,0.324340858,0.513581662,8.485720374,0,0.380465576,1.276436509,0.298068547,0.765650847,0.858146149,22.13748361,0,-2.279421403,1.23534799,-1.845165429,0.065013478,0.138742928,33.57289641,1,-1.003627812,1.08083079,-0.928570708,0.353111608,0.499407044,58.7373037,0,0.793318258,1.362773698,0.582134994,0.560475756,0.678887071,N,-,,delta-1-pyrroline-5-carboxylate dehydrogenase,,IPR005931 (TIGRFAM); IPR015590 (PFAM); IPR016162 (G3DSA:3.40.605.GENE3D); IPR016163 (G3DSA:3.40.309.GENE3D); PTHR11699:SF18 (PANTHER); PTHR11699 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_08458,969,902,827,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,257.4149719,0,-5.143454846,1.178272469,-4.365250808,1.27E-05,0.000143275,99.04825339,0,-1.224937414,1.000021099,-1.22491157,0.220608541,0.368420994,220.2789038,0,-4.558016961,1.209181125,-3.769507203,0.00016357,0.001561915,281.5399724,0,-2.05447968,0.638744898,-3.216432234,0.001297952,0.009223517,226.3031606,0,-2.731095672,0.757502456,-3.605395139,0.000311678,0.001803282,N,-,,Nuclear GTP-binding,"F:GTP binding; P:ribosomal large subunit export from nucleus; F:RNA binding; F:GTPase activity; P:positive regulation of growth rate; P:rRNA processing; C:nucleolus; C:preribosome, large subunit precursor",IPR006073 (PRINTS); IPR023179 (G3DSA:1.10.1580.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR014813 (PFAM); IPR006073 (PFAM); PTHR11089:SF30 (PANTHER); PTHR11089 (PANTHER); PTHR11089:SF30 (PANTHER); PTHR11089:SF30 (PANTHER); PTHR11089 (PANTHER); IPR030378 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_08459,3,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,193.615138,0,3.518719141,0.927720042,3.792867442,0.000148918,0.001200465,14.59854654,0,1.995536096,1.15575373,1.726610128,0.084237706,0.177009354,170.3091652,0,3.629177029,0.646456309,5.613955625,1.98E-08,7.94E-07,44.5745066,0,0.376592594,0.889808071,0.423229015,0.672128179,0.777215374,17.26113879,0,-0.730388817,1.157855033,-0.630811972,0.528163475,0.65159683,N,-,,Haloacid dehalogenase-like hydrolase,P:metabolic process; F:hydrolase activity,IPR023214 (G3DSA:3.40.50.GENE3D); IPR023198 (G3DSA:1.10.150.GENE3D); IPR006439 (TIGRFAM); IPR023214 (PFAM); PTHR18901:SF2 (PANTHER); PTHR18901 (PANTHER); IPR023214 (SUPERFAMILY),,
RL4_JR_08460,26,31,63,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,78.58134709,0,3.150763665,0.492069457,6.403087248,1.52E-10,5.05E-09,2.250740786,0,2.295184853,1.305767625,1.757728412,0.078793731,0.16834322,5.820288573,0,-0.351927107,1.200385542,-0.293178395,0.769385797,0.8450973,10.72481598,0,0.172963014,1.147572252,0.150720805,0.880195961,0.926401674,5.715470694,0,-0.428644538,1.195539577,-0.358536468,0.719941882,0.80273517,N,-, Effector probability:0.57,glutathione s-transferase ii,F:transferase activity,IPR004045 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR010987 (G3DSA:1.20.1050.GENE3D); IPR004046 (PFAM); PTHR11260:SF149 (PANTHER); PTHR11260 (PANTHER); IPR010987 (PROSITE_PROFILES); IPR004045 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR010987 (SUPERFAMILY),,
RL4_JR_08461,89,49,91,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.159829927,0,-0.158976468,1.203992671,-0.132041059,0.894951815,0.948391329,1.332643539,0,3.051255752,1.360783444,2.242278715,0.024943365,0.068416136,3.449359973,0,0.402628041,1.204336661,0.334315192,0.738141728,0.823898622,12.00177503,0,1.706062887,1.018184632,1.675592847,0.093817971,0.186658863,3.39331308,0,0.323390332,1.199559308,0.269590949,0.787474964,0.854792735,N,-, Effector probability:0.797,---NA---,,no IPS match,,
RL4_JR_08462,143,144,179,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,32.06348933,1,-0.168566077,0.85845423,-0.196360005,0.844328398,0.921878003,6.601288289,0,0.742768963,1.239193251,0.599397199,0.548908045,0.695201105,47.12481867,0,0.914844481,0.750159051,1.219534017,0.222641573,0.352687104,19.72063063,0,-2.328883394,1.195849391,-1.947472158,0.051478155,0.125322509,24.55986276,0,-0.321523463,0.983298999,-0.326984431,0.743679661,0.820950345,N,-,,pre-mrna splicing factor,P:negative regulation of gene expression; F:RNA binding; F:protein binding; P:cellular macromolecule metabolic process; P:negative regulation of nitrogen compound metabolic process; P:negative regulation of cellular macromolecule biosynthetic process; P:gene expression; P:cellular nitrogen compound metabolic process; P:primary metabolic process; C:intracellular part; P:regulation of transcription from RNA polymerase II promoter,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); PTHR24012 (PANTHER); PTHR24012:SF380 (PANTHER); PTHR24012 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_08463,11,19,5,0,0,8,0,0,0,0,5,21,0,0,1,0,0,0,0.00781203,1,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,0,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,1,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,0.007662926,1,9.0007212,4.037607722,2.229221316,0.025799183,0.085851084,0.006329724,0,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_08464,22,53,24,0,0,34,0,0,0,0,19,70,0,4,6,0,0,0,8.807514359,1,-1.240929086,1.205059584,-1.02976575,0.303119982,0.489415953,2.830329438,0,1.96463207,1.301270523,1.509779892,0.131099598,0.24873292,7.303528957,1,-0.679444345,1.207041339,-0.562900642,0.573502543,0.696513885,8.42293255,1,-1.101346146,1.206000944,-0.913221628,0.361125991,0.507199426,7.155569189,0,-0.752884153,1.201692325,-0.626519898,0.53097399,0.654505922,N,-,,intermediate filament,P:mycelium development; C:membrane,IPR001683 (SMART); IPR016137 (SMART); IPR003114 (SMART); IPR001683 (PFAM); IPR016137 (PFAM); IPR001683 (G3DSA:3.30.1520.GENE3D); IPR003114 (PFAM); IPR013937 (PFAM); PTHR22775:SF30 (PANTHER); PTHR22775 (PANTHER); PTHR22775:SF30 (PANTHER); PTHR22775:SF30 (PANTHER); PTHR22775 (PANTHER); PTHR22775 (PANTHER); IPR001683 (PROSITE_PROFILES); IPR003114 (PROSITE_PROFILES); IPR016137 (PROSITE_PROFILES); IPR001683 (SUPERFAMILY); IPR016137 (SUPERFAMILY),,
RL4_JR_08465,20,14,24,0,0,5,0,0,0,0,13,24,0,0,9,0,0,0,508.2399395,1,0.80864493,0.655791479,1.233082398,0.217545024,0.385308794,60.0187648,0,-2.441825805,1.216252685,-2.007663239,0.04467909,0.107907837,227.2369649,1,-1.40677493,0.644564407,-2.182520341,0.029071152,0.074775493,662.175294,1,1.462938592,0.841827433,1.737812923,0.082243783,0.169423866,334.2676848,0,0.397503363,0.797101447,0.498686039,0.618000582,0.724554874,N,-,,hydroxymethylglutaryl- synthase,P:ergosterol biosynthetic process; P:isoprenoid biosynthetic process; F:hydroxymethylglutaryl-CoA synthase activity,IPR016039 (G3DSA:3.40.47.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR013528 (PFAM); IPR010122 (TIGRFAM); IPR013746 (PFAM); PTHR11877:SF26 (PANTHER); PTHR11877 (PANTHER); IPR016039 (SUPERFAMILY); IPR016039 (SUPERFAMILY),,
RL4_JR_08466,15,91,61,0,0,29,0,0,0,0,11,84,0,0,2,0,6,0,16.64428856,1,0.453482632,1.014181896,0.44714132,0.654773026,0.805056549,2.868292494,0,1.945284094,1.274017125,1.526890068,0.12678835,0.243013004,7.454149765,1,-0.709212567,1.196754033,-0.592613475,0.553439859,0.680309025,8.60001038,1,-1.131686348,1.194805052,-0.947172383,0.343550946,0.49036422,7.363833679,1,-0.794218838,1.202113681,-0.6606853,0.508814153,0.63562533,N,-,,f-box domain-containing,,IPR001810 (PFAM); G3DSA:1.20.1280.50 (GENE3D); IPR001810 (SUPERFAMILY),,
RL4_JR_08467,39,83,43,0,0,3,0,0,0,0,2,12,1,0,0,0,4,0,495.2678919,1,-3.912347473,0.740051323,-5.286589392,1.25E-07,2.44E-06,150.0044694,0,-3.763340158,1.229832988,-3.060041643,0.002213062,0.015045494,769.6542843,1,0.031548125,0.649691943,0.04855859,0.961271071,0.977197342,766.567055,1,-0.523791494,0.615215783,-0.851394759,0.394550102,0.539161212,626.8764158,1,-0.454034864,0.64828432,-0.700363791,0.483700143,0.61210648,N,-,,fad binding domain-containing,F:FAD binding; P:mycelium development; P:secondary metabolite biosynthetic process; P:oxidation-reduction process; F:monooxygenase activity,PR00420 (PRINTS); G3DSA:3.30.9.10 (GENE3D); G3DSA:3.40.30.20 (GENE3D); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR012941 (PFAM); PTHR13789 (PANTHER); PTHR13789:SF228 (PANTHER); IPR023753 (SUPERFAMILY); IPR012336 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_08468,1033,814,695,0,0,58,0,0,0,0,4,3,4,3,0,0,10,0,28.2332591,1,-2.921627622,1.245171833,-2.346365012,0.018957532,0.062742899,9.141687718,0,0.273110338,1.291530246,0.211462596,0.832526317,0.89972575,23.46071328,1,-2.363138863,1.236920789,-1.910501372,0.05606869,0.123319447,27.04776887,1,-2.784576225,1.241253152,-2.243358835,0.024873684,0.085359821,46.00706369,1,0.679492358,0.7402599,0.917910531,0.358665708,0.496105231,N,-,,wd40 repeat,,no IPS match,,
RL4_JR_08469,2042,1561,1605,2,3,0,0,0,2,0,0,1,0,2,0,0,0,1,15.98262693,1,-0.759197443,1.138577107,-0.666794931,0.504903131,0.691571482,80.5575731,1,3.170749188,0.97433967,3.254254432,0.001136904,0.015023052,23.07489795,1,0.676407782,1.030249548,0.656547516,0.511471905,0.642927933,27.67135651,1,1.15214697,0.740944682,1.554970294,0.119953144,0.22428912,17.29927414,1,-0.291835268,1.122029549,-0.260095884,0.794789813,0.86103647,N,-,,carbohydrate contains domain,F:catalytic activity,IPR029056 (G3DSA:3.40.1190.GENE3D); IPR011611 (PFAM); PTHR10584 (PANTHER); PTHR10584:SF201 (PANTHER); PTHR10584 (PANTHER); IPR029056 (SUPERFAMILY),,
RL4_JR_08470,840,681,827,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,2.157456788,1,0.788240157,1.251150181,0.630012423,0.528686456,0.712896547,0.690620725,0,3.999571227,1.471147955,2.718673682,0.006554423,0.024747198,1.788565763,0,1.350097763,1.215654329,1.110593473,0.266743374,0.404813358,2.063055808,0,0.927954199,1.225326702,0.75731166,0.448863167,0.590839777,1.760565664,0,1.270017341,1.205741512,1.053308133,0.292199793,0.426887016,N,-, Effector probability:0.587,indigoidine synthase A like,,IPR029056 (G3DSA:3.40.1190.GENE3D); IPR029056 (SUPERFAMILY),,
RL4_JR_08471,582,911,865,0,0,6,0,0,3,0,0,0,1,0,0,0,0,2,163.8607539,1,0.469926545,0.402048189,1.168831394,0.242471569,0.417431998,126.1661861,1,1.987420409,0.666174746,2.983331958,0.002851286,0.015349618,167.6072678,0,0.927873107,0.42814821,2.167177358,0.030221333,0.077184858,471.5516683,1,2.662069561,0.230556571,11.54627493,7.71E-31,1.32E-28,115.3625457,1,0.609623073,0.450823276,1.352244007,0.17629727,0.293056946,N,-,,indigoidine synthase A like,"C:cytoplasm; F:hydrolase activity, acting on glycosyl bonds",IPR007342 (PFAM); PTHR10584:SF201 (PANTHER); PTHR10584 (PANTHER); SSF110581 (SUPERFAMILY),,
RL4_JR_08472,934,1111,971,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,183.6112714,0,-5.622839843,1.245181931,-4.515677349,6.31E-06,7.75E-05,57.8720528,0,-2.389293585,1.218502735,-1.960843843,0.049897242,0.117674716,194.3409635,0,-1.661715565,0.678586018,-2.44879134,0.014333646,0.042869669,239.5157821,1,-1.668731326,0.617682605,-2.701600002,0.006900673,0.036150625,161.890171,0,-2.981308443,0.926642557,-3.217323033,0.001293928,0.005912014,N,-,,utp18 possible u3 snornp involved in maturation of pre-18s rrna,"P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:preribosome; P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR18359 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),,
RL4_JR_08473,873,856,554,0,3,10,0,0,0,0,0,0,0,0,0,0,0,0,12.20652906,1,-1.711961335,1.25142924,-1.368004902,0.171310542,0.325011953,3.840218264,0,1.524216648,1.307567667,1.165688542,0.243740394,0.396327754,10.06530816,0,-1.142452064,1.237058953,-0.923522732,0.355734859,0.499274267,11.61848966,0,-1.565636224,1.240970651,-1.261622282,0.207084735,0.339322127,10.03356829,0,-1.24051375,1.253785697,-0.989414502,0.322460382,0.458361838,N,-, Effector probability:0.599,hypothetical protein CMQ_8240,,PTHR38846 (PANTHER); PTHR38846:SF1 (PANTHER),,
RL4_JR_08474,315,243,332,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,9.8816721,1,0.243594434,1.16255577,0.209533547,0.83403175,0.917340408,1.932438045,1,2.515023318,1.328068797,1.893744755,0.058258898,0.133294883,5.023717082,0,-0.140019191,1.213917494,-0.115344899,0.908171752,0.943492131,5.795813368,0,-0.562435625,1.214642591,-0.463046191,0.643331259,0.755584188,4.968596695,0,-0.226668841,1.219541984,-0.185863909,0.852551485,0.901994126,N,-,,Cytochrome P450,F:oxidoreductase activity; F:metal ion binding; C:membrane; P:single-organism metabolic process,IPR002403 (PRINTS); IPR001128 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24286 (PANTHER); PTHR24286 (PANTHER); PTHR24286:SF77 (PANTHER); PTHR24286:SF77 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_08475,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.221742099,0,-1.141889532,1.211204245,-0.942772069,0.345797501,0.535334072,2.608821244,0,2.082031825,1.292120055,1.611330013,0.107107813,0.213498479,6.797770894,0,-0.576270483,1.208141563,-0.476989205,0.633369809,0.744224227,15.86710218,0,0.719986331,1.032799046,0.697121414,0.485726814,0.625936616,21.46612766,0,1.032404075,0.993008716,1.039672723,0.298491978,0.433737846,N,-,,trascription factor,F:binding,IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); PTHR31001:SF40 (PANTHER); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_08476,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26.92727659,0,-2.853317319,1.214305886,-2.349751699,0.018785938,0.062349749,8.699603201,0,0.344620643,1.261712105,0.273137304,0.784747672,0.869397316,22.38040307,0,-2.295134114,1.214615021,-1.889597999,0.058811745,0.128109434,25.80495262,0,-2.716720137,1.215694747,-2.234705828,0.025436668,0.085851084,21.86681224,0,-2.364492162,1.211479084,-1.951739979,0.050969083,0.113823263,N,PKS-Like,,polyketide synthase,"P:secondary metabolic process; F:transferase activity, transferring acyl groups; F:oxidoreductase activity; P:oxidation-reduction process; F:phosphopantetheine binding",IPR020841 (SMART); IPR020843 (SMART); IPR020807 (SMART); SM00822 (SMART); IPR014031 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR013968 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); IPR020807 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR032821 (PFAM); IPR014030 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); PTHR11712:SF228 (PANTHER); PTHR11712 (PANTHER); PTHR11712 (PANTHER); IPR016040 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR029063 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_08477,2637,2361,2874,0,2,7,0,0,0,0,2,2,0,2,0,0,5,1,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,Y,-,,---NA---,,no IPS match,,
RL4_JR_08478,3331,2763,3525,0,0,5,0,0,0,3,2,0,0,3,0,0,2,4,10.36744905,1,-1.476316295,1.224077368,-1.206064529,0.22779261,0.399383648,3.352830264,0,1.720219268,1.318761489,1.304420308,0.192090315,0.333787344,21.61898732,1,0.893385508,1.065409843,0.838536938,0.401729211,0.544021741,17.96353012,1,0.368882205,1.055460769,0.349498737,0.726714919,0.817997129,8.421278035,1,-0.987913146,1.219241866,-0.810268392,0.417785938,0.553541222,N,-,,MFS drug efflux transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF12 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_08479,1790,1456,1418,0,0,3,0,0,0,0,0,0,3,2,0,0,2,0,23.75078486,1,1.828057042,1.070332496,1.707933795,0.087648628,0.200796828,1.150559059,0,3.263250345,1.443045273,2.261363802,0.023736738,0.065922607,15.98218118,0,2.42061132,1.080915119,2.239409253,0.0251293,0.066826643,3.443699995,1,0.189088176,1.265094254,0.149465683,0.881186186,0.92661179,2.934914606,1,0.5331113,1.250287406,0.426391002,0.669822957,0.76502622,N,-,,calcium-transporting ATPase,F:nucleotide binding; F:cation-transporting ATPase activity; C:membrane; P:cation transmembrane transport,PR00119 (PRINTS); IPR004014 (SMART); IPR023298 (G3DSA:1.20.1110.GENE3D); IPR008250 (PFAM); IPR023299 (G3DSA:3.40.1110.GENE3D); IPR001757 (TIGRFAM); IPR006414 (TIGRFAM); IPR004014 (PFAM); IPR006068 (PFAM); PF13246 (PFAM); IPR008250 (G3DSA:2.70.150.GENE3D); PTHR24093 (PANTHER); PTHR24093 (PANTHER); PTHR24093:SF334 (PANTHER); PTHR24093 (PANTHER); PTHR24093:SF334 (PANTHER); PTHR24093:SF334 (PANTHER); IPR023214 (SUPERFAMILY); SSF81665 (SUPERFAMILY); IPR023299 (SUPERFAMILY); SSF81653 (SUPERFAMILY),3.A.3.9.5, the p-type atpase (p-atpase) superfamily.
RL4_JR_08480,3,4,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,220.6332041,0,6.212876209,2.150986667,2.888384342,0.003872264,0.017598847,0.942819341,0,3.550513164,1.496524226,2.372506307,0.017667862,0.052173222,110.9074069,0,5.486124902,1.34270901,4.085862878,4.39E-05,0.000649968,115.8321727,0,5.440205038,0.525522152,10.35199947,4.10E-25,5.00E-23,52.60000495,0,4.602924878,1.377951717,3.340410858,0.000836545,0.004141085,Y,-,,natterin,,IPR023307 (G3DSA:2.170.15.GENE3D); PS51257 (PROSITE_PROFILES); SSF56973 (SUPERFAMILY),,
RL4_JR_08481,9,12,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.51246708,0,-1.49641199,1.189796086,-1.257704583,0.208498614,0.374819677,3.372416809,0,1.711777077,1.272729826,1.344965005,0.178636536,0.316222283,8.719841574,0,-0.935283711,1.196419182,-0.781735803,0.434369856,0.57481188,10.05714011,0,-1.357304861,1.194046718,-1.136726763,0.255652528,0.395007148,8.567740461,0,-1.012786609,1.193586443,-0.848523887,0.396146275,0.532949912,N,-,,fatty-acid amide hydrolase,"C:nucleus; F:zinc ion binding; F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; F:hydrolase activity; P:regulation of transcription from RNA polymerase II promoter",IPR023631 (G3DSA:3.90.1300.GENE3D); IPR023631 (PFAM); IPR021858 (PFAM); PTHR11895:SF36 (PANTHER); IPR000120 (PANTHER); IPR023631 (SUPERFAMILY),,
RL4_JR_08482,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,121.5183623,0,-5.027349196,1.305234057,-3.851684048,0.000117308,0.000977529,38.50400439,0,-1.801413037,1.273189976,-1.414881574,0.157103221,0.286522308,99.96514745,0,-4.454354711,1.262131534,-3.529231773,0.000416768,0.002973365,115.3509931,0,-4.8770568,1.275158363,-3.824667542,0.000130949,0.001341959,98.26855159,0,-4.532433939,1.273488266,-3.559070044,0.00037217,0.002107508,N,-,,benzoate 4-monooxygenase cytochrome p450,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:membrane; P:regulation of transcription, DNA-templated; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24305:SF62 (PANTHER); PTHR24305 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_08483,47,28,30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.030670487,0,0.458766547,1.221143527,0.375686016,0.707150335,0.841934097,1.656011899,0,2.737867751,1.410443096,1.94114017,0.052241278,0.121896315,4.295248116,0,0.086446985,1.256512085,0.068799167,0.945149481,0.967511966,4.955814398,0,-0.336119609,1.265459196,-0.265610784,0.790538979,0.864571956,4.221431909,0,0.00863234,1.25786324,0.006862702,0.994524399,0.995606045,N,-,,hypothetical protein SPI_03556,P:transmembrane transport; C:membrane; C:integral component of membrane,IPR031818 (PFAM),,
RL4_JR_08484,8875,6644,4550,2,6,13,0,0,0,0,1,3,4,9,0,0,6,0,0.004235441,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001340044,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003452355,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003983613,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003339785,1,10.24113992,1.835951848,5.578109216,2.43E-08,8.07E-07,N,-, Effector probability:0.652,Maltose permease,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR005828 (PFAM); PTHR23500 (PANTHER); PTHR23500:SF98 (PANTHER),2.A.1.1.11, the major facilitator superfamily (mfs).
RL4_JR_08485,47664,22373,24523,17,35,31,0,0,4,3,9,4,2,1,9,0,3,3,0.07382811,1,5.657824108,3.921199932,1.442880803,0.149054052,NA,0.023416252,1,8.882625675,2.9003261,3.062629983,0.002194012,0.015045494,0.060654228,1,6.235420048,1.726970931,3.610610888,0.000305477,0.002353612,0.069985571,1,5.810408735,2.791885443,2.081177346,0.037417676,0.102865591,0.059394414,1,6.164701453,1.416010187,4.353571401,1.34E-05,0.00012877,N,-,,Maltose permease,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500 (PANTHER); PTHR23500 (PANTHER); PTHR23500:SF98 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.10, the major facilitator superfamily (mfs).
RL4_JR_08486,3297,1545,1488,0,4,3,0,0,0,0,0,0,0,3,0,0,0,0,0.003880053,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,6.501904533,0,11.2828501,2.764961727,4.080653267,4.49E-05,0.000662772,0.003667858,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,0,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-, Effector probability:0.668,general alpha-glucoside permease,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,IPR005828 (PFAM); PTHR23500 (PANTHER); PTHR23500:SF98 (PANTHER); IPR020846 (PROSITE_PROFILES),2.A.1.1.11, the major facilitator superfamily (mfs).
RL4_JR_08487,1634,1541,2006,0,1,1,1,1,0,0,0,1,0,2,0,0,0,1,0.145624488,1,4.67701399,3.51081376,1.332173767,0.182803095,NA,0.045904259,1,7.909795083,2.539746399,3.114403503,0.001843172,0.015023052,0.120501992,1,5.239197813,1.5568976,3.365152476,0.000765014,0.00464607,0.139089187,1,4.817903898,2.199648147,2.19030662,0.028502007,0.089621994,0.120613908,1,5.137404518,1.388573644,3.699771013,0.000215794,0.001328216,N,-,,hypothetical protein H634G_09932,,no IPS match,,
RL4_JR_08488,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.875971713,0,2.088568042,1.552189475,1.345562559,0.178443633,NA,0.280278425,0,5.300539351,1.717648234,3.085928333,0.002029177,0.015023052,0.726639304,0,2.64918759,1.255805929,2.109551745,0.034896984,0.086175829,0.838178867,0,2.227205365,1.317900241,1.689965064,0.091034639,0.182483808,0.716546492,0,2.56667491,1.230040151,2.086659454,0.036918929,0.088474356,N,-,,FAD dependent oxidoreductase superfamily,F:oxidoreductase activity; P:oxidation-reduction process; C:cellular_component,IPR023753 (G3DSA:3.50.50.GENE3D); IPR006076 (PFAM); PTHR13847:SF185 (PANTHER); PTHR13847 (PANTHER); SSF51971 (SUPERFAMILY),,
RL4_JR_08489,377,230,372,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.040629395,0,6.519518409,3.932956239,1.657663603,0.097385384,NA,0.012873165,0,9.745468895,3.165782515,3.078375994,0.002081321,0.015023052,0.033437834,0,7.093855841,1.819035928,3.899788746,9.63E-05,0.001133378,0.038584569,0,6.669085625,3.392387647,1.965897273,0.049310478,0.121802535,0.032900293,0,7.018393941,1.38996904,5.049316738,4.43E-07,7.16E-06,N,-,,nucleotide sugar dehydrogenase,F:oxidoreductase activity,IPR001732 (PFAM); IPR014026 (PFAM); IPR017476 (PIRSF); IPR016040 (G3DSA:3.40.50.GENE3D); IPR028359 (PIRSF); IPR013328 (G3DSA:1.10.1040.GENE3D); IPR017476 (PANTHER); PTHR11374:SF4 (PANTHER); IPR016040 (SUPERFAMILY); IPR008927 (SUPERFAMILY),,
RL4_JR_08490,142,129,156,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.012021509,0,8.275938237,3.994557068,2.071803731,0.038283749,NA,0.003842866,0,11.4894157,3.940199092,2.915948011,0.003546096,0.016928889,0.009954621,0,8.839817482,2.38250595,3.710302374,0.000207012,0.001791132,0.011482935,0,8.417149062,3.994556965,2.107154594,0.035104181,0.099498352,0.009795195,0,8.760474239,1.567861258,5.587531547,2.30E-08,8.07E-07,N,-,,chitin synthase,C:membrane,PF03142 (PFAM); IPR004835 (PANTHER); IPR029044 (SUPERFAMILY),4.D.1.1.12, the putative vectorial glycosyl polymerization (vgp) family.
RL4_JR_08491,105,74,75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.871862828,0,2.09526784,1.624807636,1.289548247,0.197207554,NA,0.27921483,0,5.30596607,1.755386636,3.022676578,0.002505499,0.015349618,0.724224647,0,2.653807426,1.289763435,2.057592388,0.039629278,0.094960192,0.835371434,0,2.231928545,1.367885939,1.63166276,0.102750549,0.199913396,0.715201526,0,2.569299864,1.263486575,2.033499932,0.04200204,0.097718442,N,-,,hypothetical protein AK830_g1384,C:membrane; C:integral component of membrane,IPR012334 (G3DSA:2.160.20.GENE3D); IPR024535 (PFAM); IPR011050 (SUPERFAMILY),,
RL4_JR_08492,1160,1628,2053,1,2,4,0,0,0,4,1,1,0,0,0,0,5,1,359.5120663,1,2.825943735,1.288547067,2.193124184,0.028298433,0.086496297,33.24693813,0,1.237213123,1.021144841,1.211594158,0.225667772,0.3750754,185.5707515,1,2.016060718,0.434469007,4.640286618,3.48E-06,7.72E-05,610.8269279,0,3.756871641,0.425221921,8.835084596,1.00E-18,8.30E-17,316.2620737,1,3.059020682,0.513263135,5.959946225,2.52E-09,1.36E-07,N,-,,acyl- oxidase,F:acyl-CoA dehydrogenase activity; F:acyl-CoA oxidase activity; P:fatty acid beta-oxidation; F:flavin adenine dinucleotide binding; C:peroxisomal matrix,G3DSA:2.40.110.10 (GENE3D); G3DSA:1.20.140.10 (GENE3D); IPR029320 (PFAM); IPR012258 (PIRSF); G3DSA:1.20.140.10 (GENE3D); IPR013786 (G3DSA:1.10.540.GENE3D); IPR002655 (PFAM); IPR006091 (PFAM); PTHR10909 (PANTHER); PTHR10909:SF313 (PANTHER); PTHR10909 (PANTHER); PTHR10909:SF313 (PANTHER); PTHR10909:SF313 (PANTHER); PTHR10909 (PANTHER); IPR009075 (SUPERFAMILY); IPR009100 (SUPERFAMILY); IPR009075 (SUPERFAMILY),,
RL4_JR_08493,9,2,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.072354636,0,5.686441013,3.921488577,1.450072059,0.147038426,NA,0.022388824,0,8.945439032,3.043962066,2.938748525,0.003295403,0.016303066,0.05921251,0,6.265829328,1.858836291,3.370834407,0.000749409,0.004578766,0.068395341,0,5.8424531,2.973909359,1.964569997,0.049464027,0.122062705,0.059448834,0,6.162303894,1.506195831,4.091303247,4.29E-05,0.000340641,N,-, Effector probability:0.681,kinase-like domain,F:ATP binding; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,no IPS match,,
RL4_JR_08494,2900,4874,3979,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,38.30448342,0,8.452976255,1.923339504,4.394947557,1.11E-05,0.000127131,0.03712931,0,8.216829927,2.908392886,2.825213185,0.004724917,0.019923787,0.097188409,0,5.55312444,1.865043664,2.977476906,0.002906315,0.013313818,0.112215089,0,5.128861142,2.685983935,1.909490625,0.05619883,0.131685525,0.096186472,1,5.466818943,1.603433376,3.409445647,0.00065095,0.003378203,Y,-,,CFEM domain-containing,C:membrane; C:integral component of membrane,IPR008427 (PFAM); PTHR33048:SF34 (PANTHER); PTHR33048 (PANTHER),9.B.313.1.4, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_08495,22051,15570,20328,1,0,27,0,0,0,0,1,8,4,2,3,0,7,3,57.23895126,1,1.082498114,0.608317701,1.779494683,0.075158696,0.179702415,5.630057028,0,0.972392848,1.242175008,0.782814693,0.433735938,0.59520714,27.56405253,1,0.144134732,1.033593152,0.139450161,0.889094437,0.930948735,49.71849313,1,0.644698084,0.741219993,0.869779674,0.384420821,0.529703432,22.04576081,1,-0.084899976,0.973698959,-0.087193249,0.930517905,0.954655364,N,-,,multicopper oxidase,F:oxidoreductase activity,IPR008972 (G3DSA:2.60.40.GENE3D); IPR011706 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); IPR008972 (G3DSA:2.60.40.GENE3D); IPR011707 (PFAM); IPR001117 (PFAM); PTHR11709 (PANTHER); PTHR11709:SF49 (PANTHER); PTHR11709:SF49 (PANTHER); PTHR11709 (PANTHER); PTHR11709:SF49 (PANTHER); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY),2.A.108.1.7, the iron/lead transporter (ilt) family.
RL4_JR_08496,435,319,118,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.328461568,0,0.678467941,1.257388689,0.539584893,0.589483338,0.760557499,0.741726258,0,3.896577335,1.456901927,2.674563924,0.007482651,0.027264,1.925001527,0,1.244276043,1.217462675,1.022023976,0.306769553,0.448232616,2.220859176,0,0.821826211,1.226936003,0.669819949,0.502972575,0.640014744,1.897091892,0,1.162704696,1.210421428,0.960578415,0.336764186,0.473772042,N,-,,MFS transporter,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23504 (PANTHER); PTHR23504:SF16 (PANTHER); IPR020846 (SUPERFAMILY); IPR027417 (SUPERFAMILY),2.A.1.2.96, the major facilitator superfamily (mfs).
RL4_JR_08497,21,15,26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,402.0397543,0,9.148689945,1.45349128,6.29428609,NA,NA,9.608593829,0,6.501036784,1.147677164,5.664516981,1.47E-08,2.13E-06,0.595826684,0,2.935801351,1.25603498,2.337356362,0.019420662,0.054615218,0.687268081,0,2.513748129,1.334954497,1.883021582,0.059697443,0.136410881,0.586689368,0,2.85519195,1.222929193,2.33471567,0.019558279,0.053768009,Y,-,,6-hydroxy-D-nicotine oxidase,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; P:oxidation-reduction process",IPR016169 (G3DSA:3.30.465.GENE3D); IPR016167 (G3DSA:3.30.43.GENE3D); IPR006094 (PFAM); IPR012951 (PFAM); PTHR11748:SF96 (PANTHER); PTHR11748 (PANTHER); IPR016166 (PROSITE_PROFILES); PS51257 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY),,
RL4_JR_08498,37,24,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,80.51760736,0,8.104581238,1.09515755,7.400379281,1.36E-13,7.44E-12,0.10391083,0,6.731900465,2.077300062,3.240697186,0.001192378,0.015023052,0.270869424,0,4.072700295,1.323407978,3.077433688,0.002087913,0.010191914,0.312573323,0,3.650348328,1.579639881,2.310873745,0.02083983,0.078120428,0.26834,0,3.984986634,1.256253676,3.172119382,0.001513308,0.00672323,N,-,,integral membrane,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component,PTHR31740:SF6 (PANTHER); PTHR31740 (PANTHER),2.A.1.7.25, the major facilitator superfamily (mfs).
RL4_JR_08499,920,826,840,0,4,7,0,0,3,1,0,4,0,0,5,0,5,0,0.015572136,1,7.899458556,3.974566037,1.987502153,0.046866778,NA,0.005005645,1,11.10559461,3.974227246,2.79440352,0.005199555,0.021136506,0.013004533,1,8.449602389,2.844306081,2.970707845,0.002971143,0.013488722,0.014998643,1,8.029635455,3.97405316,2.020515361,0.043329958,0.113246213,0.012910819,1,8.3508871,1.560789616,5.350424565,8.77E-08,2.01E-06,,,,,,,,
RL4_JR_08500,29820,25895,29647,28,44,65,0,0,6,4,19,30,8,32,16,0,27,10,5.35166808,1,-0.522148275,1.222374665,-0.427158947,0.669263561,0.816661642,1.721030954,1,2.682352092,1.357101721,1.976529873,0.048094796,0.114275944,4.438080959,1,0.039287092,1.217669998,0.032264154,0.974261395,0.98535688,5.118134156,1,-0.382583921,1.218896627,-0.313877249,0.75361427,0.838591547,15.92603622,1,2.161623942,0.864713771,2.499814406,0.012425838,0.037432792,N,-,,hypothetical protein SPI_09357,,no IPS match,,
RL4_JR_08501,67,58,85,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,64.02931052,0,1.342461561,0.697820256,1.923792766,0.054380565,0.141691679,6.832954194,0,0.692918783,1.278432716,0.542006454,0.58781406,0.725705672,17.89060489,0,-1.972234772,1.23404974,-1.598180939,0.110002715,0.208162146,47.29656768,0,0.341096656,0.816209168,0.417903485,0.676017684,0.779398662,17.83150901,0,-2.070137594,1.251412392,-1.654240926,0.098078571,0.188219395,N,-,,hypothetical protein F503_03604,"F:identical protein binding; C:fungal-type vacuole membrane; P:vacuole fusion, non-autophagic; F:phospholipid binding",PTHR38407 (PANTHER),,
RL4_JR_08502,1149,1026,1088,4,3,3,0,0,0,0,10,5,1,0,1,3,4,2,2.980075022,1,0.322078236,1.330939673,0.241993114,0.808785499,0.902858546,0.944238883,0,3.548114085,1.483560388,2.391620936,0.016774157,0.050292658,2.467175055,1,0.885710589,1.269238954,0.697828085,0.485284713,0.620879873,2.84708767,1,0.462998762,1.288788115,0.359251266,0.719407128,0.812459393,2.455232796,1,0.79031673,1.276235512,0.619256181,0.535747606,0.658946126,Y,-,,beta-lactamase family,,IPR012338 (G3DSA:3.40.710.GENE3D); IPR001466 (PFAM); PTHR22935:SF64 (PANTHER); PTHR22935 (PANTHER); PTHR22935:SF64 (PANTHER); PTHR22935 (PANTHER); IPR012338 (SUPERFAMILY),,
RL4_JR_08503,7861,5970,3840,5,3,2,0,0,4,1,12,31,4,3,13,0,13,7,18.89808002,1,0.127702149,1.023515613,0.124768149,0.900707104,0.951686123,12.96573324,1,2.538532501,1.132413466,2.241701089,0.024980697,0.068450087,15.80624405,1,-0.0675087,1.196829192,-0.056406294,0.955018143,0.974156451,24.06182888,1,0.282886455,1.020270113,0.277266237,0.781575683,0.859317384,9.168264591,1,-1.110340271,1.201581545,-0.924065683,0.355452119,0.492727238,N,-,,transcription factor cys6,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_08504,2975,3705,4540,0,6,4,0,0,2,2,1,4,0,7,0,0,3,0,0.677686504,1,2.458901937,1.906856076,1.289505783,0.197222307,NA,0.22185469,1,5.638121258,1.923864351,2.930623073,0.00338283,0.016488617,8.40944538,1,3.971363593,1.277175972,3.109488184,0.001874118,0.009425518,0.652807997,1,2.58822951,1.512731906,1.710963786,0.087087798,0.176458667,0.549745117,1,2.948500699,1.321022134,2.231984326,0.025615999,0.066639771,N,-,,glycoside hydrolase,P:carbohydrate metabolic process; C:beta-galactosidase complex; F:beta-galactosidase activity,IPR013529 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); IPR017853 (SUPERFAMILY),,
RL4_JR_08505,170,255,189,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0.507196304,0,2.877000052,2.050003148,1.403412505,0.160493866,NA,0.165063924,0,6.064715248,1.971365036,3.076403983,0.002095138,0.015023052,0.42292402,1,3.430979224,1.347890183,2.545444182,0.010913881,0.035104773,0.487492298,1,3.009541708,1.515857151,1.9853729,0.047102999,0.118473832,0.411753917,1,3.365239175,1.283548533,2.621824643,0.008746042,0.028192829,N,-,,hypothetical protein,,no IPS match,,
RL4_JR_08506,1786,1351,1871,0,0,3,0,0,0,0,0,3,0,7,0,0,1,0,2.865709847,1,0.378717779,1.250855373,0.30276704,0.762067403,0.875133147,0.923547005,0,3.580355119,1.444609571,2.478424061,0.01319642,0.041598929,2.381049385,1,0.937510694,1.226946559,0.764100674,0.44480725,0.584446361,2.745689448,1,0.515729713,1.235336261,0.417481239,0.676326444,0.77948836,2.332782271,1,0.863881705,1.215021067,0.711001421,0.477083355,0.606894277,N,-,,c6 zinc finger domain containing,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_08507,1483,1957,2269,2,3,4,0,0,0,0,6,4,0,25,0,0,22,2,0.559813174,1,2.734622123,1.861488084,1.46905164,0.141818783,NA,0.179429341,0,5.944091521,1.862007719,3.192302299,0.001411435,0.015023052,71.95027222,1,7.325911488,1.55474212,4.711978528,2.45E-06,5.75E-05,0.535421484,1,2.874078999,1.384695971,2.075602919,0.037930691,0.103656747,0.456383923,1,3.217527266,1.225246298,2.626024882,0.00863885,0.027918404,N,-,,hexose transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR003663 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR23500:SF145 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.83, the major facilitator superfamily (mfs).
RL4_JR_08508,769,806,777,0,0,0,0,0,0,0,0,4,0,5,0,0,0,0,129.4249489,0,-1.397521481,1.131534669,-1.235067311,0.216805454,0.384996487,30.91225958,0,-1.484583099,1.930785643,-0.768901045,0.441952057,0.603191991,79.03687876,1,-4.1154512,1.91346235,-2.150787655,0.031492964,0.079756559,124.7739391,1,-1.223884475,1.074144857,-1.139403562,0.254534871,0.393881334,118.1467382,0,-0.761392661,1.030060306,-0.739172898,0.459802016,0.591322954,N,-,,salicylate hydroxylase,F:FAD binding; P:oxidation-reduction process; F:monooxygenase activity,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789 (PANTHER); PTHR13789:SF187 (PANTHER); SSF54373 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_08509,19620,18800,28117,0,1,0,5,0,0,3,0,0,0,3,0,0,3,1,150.2198406,1,-4.296651752,1.210357135,-3.549904096,0.000385372,0.002696279,46.18257695,1,-2.063752667,1.253409499,-1.646511111,0.099658574,0.202072133,118.6380649,1,-4.701435509,1.239337256,-3.793507767,0.000148534,0.001471388,136.764792,1,-5.122733775,1.246863495,-4.108496074,3.98E-05,0.000480026,115.9499487,1,-4.771150182,1.243480181,-3.836933033,0.00012458,0.000833693,N,-,,Amino acid polyamine transporter partial,P:transmembrane transport; C:membrane; C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transport; P:amino acid transmembrane transport,IPR002293 (PIRSF); IPR002293 (PFAM); IPR002293 (PANTHER); PTHR11785:SF308 (PANTHER),2.A.3.4.2, the amino acid-polyamine-organocation (apc) family.
RL4_JR_08510,11928,8949,14279,0,0,3,0,0,0,0,0,0,0,23,1,0,0,2,19.51485284,1,-2.388826238,1.224961602,-1.950123362,0.051161417,0.135204031,6.317862377,0,0.806142148,1.287871253,0.62594933,0.531348177,0.679765704,16.23284051,0,-1.831806233,1.224102744,-1.496448106,0.134536921,0.241686508,18.71511241,1,-2.253270197,1.225584963,-1.838526309,0.065984889,0.14545983,15.84115724,1,-1.899439245,1.221429255,-1.555095587,0.119923306,0.219173912,N,-,,Cytochrome P450,F:oxidoreductase activity; F:metal ion binding; C:membrane; P:metabolic process,IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305 (PANTHER); PTHR24305:SF69 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_08511,61515,24772,45869,1,0,4,0,0,0,0,0,0,0,1,1,0,0,0,74.88375399,1,-2.181626913,1.017224171,-2.144686466,0.031977924,0.095210183,18.18409894,0,-0.719096912,1.21246108,-0.593088656,0.553121822,0.699050953,47.12802454,0,-3.369556559,1.197475829,-2.813882733,0.004894708,0.018685529,54.36122876,1,-3.791717673,1.197977093,-3.165100315,0.001550295,0.010707187,46.45570304,0,-3.451586415,1.200208247,-2.875822944,0.004029757,0.01497295,N,-,,NAD dependent epimerase,F:coenzyme binding; F:catalytic activity,IPR029903 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR10366 (PANTHER); PTHR10366:SF405 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_08512,11,9,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.036367992,0,6.679190678,3.936010002,1.696944539,0.089707146,NA,0.011364897,0,9.923974403,3.304196637,3.003445464,0.002669414,0.015349618,0.029826272,0,7.256289866,1.93461134,3.750773974,0.00017629,0.001628499,0.03443735,0,6.832645641,3.627452579,1.883593373,0.059619999,0.136354635,0.029686193,0,7.168275379,1.426437213,5.025300317,5.03E-07,7.99E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_08513,3473,3007,2851,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,Y,-,,hydrophobic surface binding a,,IPR021054 (PFAM),,
RL4_JR_08514,5,13,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.94205024,0,0.616039076,0.760458503,0.810089011,0.41788902,0.609327697,5.14231152,0,1.103104956,1.24870004,0.883402675,0.377018746,0.54172925,26.35737578,0,0.266989202,1.041749535,0.256289245,0.797727501,0.867102557,19.42602223,0,-1.026742384,1.152122685,-0.891174523,0.37283555,0.518538454,24.75934029,0,0.560948612,0.863966222,0.649271462,0.516162928,0.641954262,N,-,,integral membrane,C:integral component of membrane,IPR009732 (PFAM); PTHR38446:SF1 (PANTHER); PTHR38446 (PANTHER),,
RL4_JR_08515,454,554,526,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,74.6720338,1,0.617303888,0.609388467,1.012989123,0.311065356,0.49914854,7.850480507,0,0.49273475,1.222782732,0.402961816,0.686976315,0.801091518,20.35112372,0,-2.158105264,1.190142801,-1.813316236,0.069783061,0.14643655,23.47569598,1,-2.580344606,1.188303712,-2.171452113,0.029897013,0.092069191,20.05515116,0,-2.239709789,1.192810826,-1.877673928,0.060425786,0.129483826,N,-,,---NA---,,no IPS match,,
RL4_JR_08516,18,26,32,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0.395984454,1,3.233872966,2.538394838,1.273983432,0.202669288,NA,0.123157373,0,6.486145146,2.240406301,2.89507539,0.003790675,0.017584423,0.326476061,0,3.802472577,1.554769333,2.445682776,0.014457815,0.043126375,0.377046943,0,3.379279236,1.85318411,1.823498927,0.068227859,0.148241862,0.330198283,0,3.684906339,1.489592234,2.473768495,0.01336963,0.039639093,N,-,,duf895 domain membrane,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23294:SF24 (PANTHER); PTHR23294 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.58.5, the major facilitator superfamily (mfs).
RL4_JR_08517,5568,5118,5152,0,0,1,0,0,0,1,0,0,0,3,0,0,0,0,0.454422158,1,3.035348853,2.212831431,1.371703606,0.170155725,NA,0.142745547,0,6.273450094,2.03603275,3.081212763,0.002061593,0.015023052,0.375240213,1,3.601653148,1.393904494,2.583859341,0.009770163,0.032125083,0.433179105,1,3.17911536,1.605088109,1.980648503,0.047630706,0.119312443,0.375802081,0,3.498303058,1.34481661,2.601323506,0.009286484,0.029614377,N,-,,Salicylate hydroxylase (Salicylate 1-monooxygenase),F:oxidoreductase activity,PR00420 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_08518,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.39945151,0,7.427562589,1.096305302,6.775085899,1.24E-11,5.14E-10,0.0400542,0,8.106764784,2.728506042,2.971136827,0.002966996,0.015504352,0.104279495,0,5.44838159,1.706553603,3.192622594,0.001409871,0.007537856,0.120293444,0,5.027449406,2.45665672,2.046459875,0.040711146,0.108690715,0.103636401,0,5.354927667,1.480748552,3.616365289,0.000298769,0.001743501,N,-,,salicylate hydroxylase,F:oxidoreductase activity,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789 (PANTHER); PTHR13789:SF183 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_08519,1676,1378,1672,0,4,0,0,0,0,2,0,1,0,0,0,0,2,0,102.3721321,1,1.063393449,0.5821115,1.826786533,0.067731872,0.166834725,11.38922436,0,-0.0440994,1.245885916,-0.035396017,0.97176396,0.98535224,48.6145402,1,-0.869271155,1.061676056,-0.818772497,0.412916225,0.55501379,91.90798085,0,0.7703619,0.586873233,1.312654687,0.189299333,0.317800654,56.42439654,1,0.52474356,0.704430324,0.744919039,0.456320665,0.587892446,N,-,,pantothenate kinase,F:ATP binding; P:coenzyme A biosynthetic process; F:pantothenate kinase activity; P:phosphorylation,IPR004567 (PFAM); IPR004567 (TIGRFAM); PTHR12280:SF20 (PANTHER); PTHR12280:SF20 (PANTHER); PTHR12280 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_08520,4517,5663,3314,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,45.89350542,1,-1.263493535,1.003848163,-1.258650045,0.208156762,0.374452672,9.57630331,0,0.206078167,1.220936668,0.168786942,0.865964229,0.922091327,31.27095672,0,-1.479856592,1.189837407,-1.243746905,0.213592727,0.342208066,56.50903531,0,-0.533865741,0.847010879,-0.630293842,0.528502351,0.661935466,39.4375973,0,-0.305472282,0.835337632,-0.365687202,0.714598497,0.798823481,N,-,,ell-associated factor,F:translation elongation factor activity; P:translational elongation,IPR019194 (PFAM),,
RL4_JR_08521,8329,10108,6159,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,312.7832717,0,1.521020287,0.813748383,1.869153069,0.061601522,0.155498815,35.02608994,0,-0.305234206,1.213722782,-0.251485932,0.801438437,0.879748385,81.18820877,0,-2.018369758,1.121039666,-1.800444551,0.071790472,0.150135661,92.82391142,0,-1.974285357,0.98043184,-2.013689557,0.044042137,0.113902079,67.39455674,0,-2.978824079,1.201232694,-2.479806031,0.013145387,0.03907723,N,-,,respiratory complex assembly rmp1,P:biological_process; C:cell cortex; F:molecular_function,IPR019448 (PFAM); PTHR21456 (PANTHER); PTHR21456 (PANTHER); PTHR21456:SF1 (PANTHER),,
RL4_JR_08522,287,290,439,0,1,0,0,0,0,0,0,0,0,2,0,0,1,0,127.5079447,1,2.621280141,0.801969435,3.268553671,0.001080987,0.006294531,6.309402659,0,0.808008111,1.233574753,0.655013496,0.512459065,0.663143781,97.74079453,0,2.158247778,0.522593002,4.129882663,3.63E-05,0.000553387,69.95756214,1,1.75312542,0.508144556,3.450052551,0.000560477,0.004602461,43.20481717,1,1.453494683,0.611286,2.37776537,0.017417905,0.048892788,Y,-,,hypothetical protein CMQ_5272,,no IPS match,,
RL4_JR_08523,335,424,444,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,107.9381238,1,0.275865667,0.892038781,0.309252998,0.757129082,0.872432934,17.37747648,0,-0.653602643,1.222520062,-0.534635515,0.592901921,0.72964781,45.01633538,0,-3.303354526,1.204501907,-2.74250668,0.006097221,0.022045809,51.93153854,0,-3.72568686,1.206171373,-3.088853661,0.002009304,0.013270842,44.24094367,1,-3.381074172,1.204842806,-2.806236761,0.005012385,0.017950086,N,-,,copper amine oxidase 1,P:ion transport; P:amine metabolic process; F:copper ion binding; F:quinone binding; F:primary amine oxidase activity; C:membrane; P:oxidation-reduction process,G3DSA:3.10.450.40 (GENE3D); IPR015800 (PFAM); IPR015798 (G3DSA:2.70.98.GENE3D); IPR015798 (PFAM); G3DSA:3.10.450.40 (GENE3D); IPR015798 (G3DSA:2.70.98.GENE3D); IPR000269 (PANTHER); IPR000269 (PANTHER); PTHR10638:SF32 (PANTHER); IPR016182 (SUPERFAMILY); IPR015798 (SUPERFAMILY); IPR016182 (SUPERFAMILY),,
RL4_JR_08524,211,223,174,0,0,3,0,0,0,0,0,0,0,41,2,0,5,0,0.05617557,1,6.051550552,3.925718407,1.54151417,0.123191697,NA,0.017710585,0,9.284190563,2.951382381,3.145709151,0.001656847,0.015023052,0.046283159,0,6.62168671,1.672202777,3.959858696,7.50E-05,0.000962282,0.053419607,1,6.199129413,2.960761361,2.093761927,0.036281193,0.1010789,0.045936798,1,6.534385818,1.348333965,4.84626657,1.26E-06,1.76E-05,N,-,,mfs transporter,P:transmembrane transport; C:membrane; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF259 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_08525,101,72,108,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,74.86063206,0,-0.783469514,0.741938843,-1.055975868,0.29097924,0.475808507,16.4235647,0,-0.572156011,1.233058243,-0.464013775,0.642637876,0.767706902,55.57405248,0,-1.409544479,1.060042579,-1.329705529,0.183615312,0.30499121,49.12033719,0,-3.645399124,1.215538474,-2.998999376,0.002708679,0.017108778,76.60458785,0,0.361120011,0.64293221,0.561676652,0.574336345,0.689326161,N,-,,fructosyl amino acid oxidase,F:oxidoreductase activity; P:oxidation-reduction process,IPR006076 (PFAM); G3DSA:3.30.9.10 (GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR10961 (PANTHER); PTHR10961:SF26 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_08526,40425,33511,39719,2,5,10,0,0,0,0,1,0,0,10,1,0,1,1,134.4707393,1,1.278939926,0.649326555,1.96964057,0.048879579,0.130443857,11.85223808,0,-0.101549667,1.249515092,-0.081271261,0.935226229,0.96418414,30.75301023,1,-2.753630288,1.219603443,-2.2578079,0.023957638,0.064267921,53.14043287,1,-0.871367535,0.901348473,-0.966737684,0.333675184,0.480304412,30.2563618,1,-2.832922632,1.223811955,-2.314834907,0.020621969,0.055962861,N,-,,MFS general substrate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR010291 (PFAM); PTHR23294 (PANTHER); PTHR23294:SF4 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.58.5, the major facilitator superfamily (mfs).
RL4_JR_08527,25169,13811,19263,2,2,7,1,0,0,0,0,1,0,6,0,0,0,2,1.832725265,1,1.023676702,1.326891838,0.771484662,0.44041971,NA,0.580039712,1,4.251178477,1.520878566,2.795212302,0.005186564,0.021136506,20.42585762,1,3.421566763,1.047499675,3.266413198,0.001089192,0.006170665,11.3812008,1,2.120112762,1.163487374,1.822205217,0.068423853,0.148587944,1.499527076,1,1.501988346,1.235779169,1.215418081,0.224206675,0.3507611,N,-,,Salicylate hydroxylase (Salicylate 1-monooxygenase),,PR00420 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_08528,12,12,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.044154061,0,6.398978377,3.930863317,1.62788117,0.103550085,NA,0.013867719,0,9.636780322,3.109842576,3.098800048,0.001943061,0.015023052,0.036328538,0,6.970788528,1.777263294,3.922203621,8.77E-05,0.001074667,0.041936672,0,6.548218794,3.276223825,1.998709229,0.045639824,0.115844376,0.036141603,0,6.881600617,1.378593909,4.991753242,5.98E-07,9.23E-06,N,-,,hypothetical protein GGTG_07348,C:membrane; C:integral component of membrane,no IPS match,1.A.1.7.7, the voltage-gated ion channel (vic) superfamily.
RL4_JR_08529,2938,2744,3862,0,4,3,0,0,0,0,0,3,2,8,0,0,8,0,88.67612179,1,0.750206012,0.550559048,1.362625889,0.173000445,0.327077087,12.21540676,0,-0.145080273,1.228022827,-0.118141348,0.905955662,0.947322645,55.71200744,1,-0.387648869,0.867856178,-0.44667409,0.655110392,0.76093823,36.50544071,1,-3.217172296,1.203438489,-2.673316772,0.007510529,0.038542376,38.82475387,1,-1.20894949,0.989608401,-1.221644328,0.221842158,0.348456694,N,-,,methylmalonate-semialdehyde dehydrogenase,F:methylmalonate-semialdehyde dehydrogenase (acylating) activity; P:oxidation-reduction process; F:malonate-semialdehyde dehydrogenase (acetylating) activity,IPR016163 (G3DSA:3.40.309.GENE3D); IPR010061 (TIGRFAM); IPR015590 (PFAM); IPR016162 (G3DSA:3.40.605.GENE3D); PTHR11699 (PANTHER); IPR010061 (PTHR11699:PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_08530,279,321,327,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,23.32181791,0,-1.443604673,1.194362832,-1.208681846,0.226785099,0.398216279,6.221590367,0,0.828282274,1.289221693,0.642466907,0.520570069,0.670724318,16.09887372,0,-1.819815576,1.230090497,-1.47941601,0.139029164,0.247804798,18.5716456,1,-2.242129871,1.232916972,-1.818557066,0.068979033,0.149137884,15.78766213,1,-1.894468437,1.233198933,-1.536222897,0.124483722,0.225151427,N,-,,duf1688 domain,,IPR012469 (PFAM); PTHR31687 (PANTHER); PTHR31687:SF4 (PANTHER),,
RL4_JR_08531,672,191,651,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.533211419,0,1.280931127,1.348144581,0.950143735,0.342039223,NA,0.487385275,0,4.502254477,1.559557355,2.886879704,0.00389083,0.017776207,1.268947071,0,1.844788734,1.239608539,1.488202667,0.136697454,0.244684165,1.464128665,0,1.422391656,1.266615648,1.122986013,0.261443435,0.401797283,1.256675115,0,1.756612956,1.232441582,1.425311334,0.154067225,0.26403701,Y,-,,---NA---,,no IPS match,,
RL4_JR_08532,15,15,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.090816414,0,4.717027911,1.294289307,3.644492685,0.00026792,0.001977999,0.087610556,0,6.978785761,2.237920604,3.118424196,0.001818209,0.015023052,0.225262266,0,4.341109609,1.431897894,3.031717295,0.002431668,0.011567947,0.259765734,0,3.91818425,1.787005135,2.192598205,0.028336341,0.089465864,0.219326452,0,4.275775153,1.320920386,3.236966587,0.001208076,0.005580185,N,-, Effector probability:0.641,peroxidase,F:peroxidase activity; P:cellular oxidant detoxification; P:oxidation-reduction process; F:peroxiredoxin activity,IPR029032 (G3DSA:1.20.1290.GENE3D); IPR004675 (TIGRFAM); IPR010195 (TIGRFAM); IPR003779 (PFAM); PTHR35446:SF2 (PANTHER); PTHR35446 (PANTHER); IPR029032 (SUPERFAMILY),,
RL4_JR_08533,1,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.024043018,0,7.275864843,3.950905398,1.841568985,0.065538221,NA,0.007685733,0,10.48932229,3.438867284,3.050225969,0.002286692,0.015101794,0.019909242,0,7.839781561,1.975830508,3.967841133,7.25E-05,0.000937752,0.02296587,0,7.41710638,3.950905352,1.877318163,0.0604745,0.137403188,0.01959039,0,7.76041061,1.430427943,5.425237004,5.79E-08,1.50E-06,N,-,,major facilitator superfamily transporter sugar,,G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR23500 (PANTHER); PTHR23500:SF133 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.39, the major facilitator superfamily (mfs).
RL4_JR_08534,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.114176751,0,5.027973382,3.864900713,1.300932095,0.193281699,NA,0.036056672,0,8.25809846,2.646694741,3.120155238,0.001807558,0.015023052,0.094530518,0,5.589147705,1.588465338,3.51858336,0.000433857,0.003050469,0.109103355,0,5.168215481,2.366384042,2.184013832,0.028961232,0.090448017,0.094491661,0,5.489293543,1.381708395,3.972830711,7.10E-05,0.000524135,N,-,,methyltransferase type 12,F:transferase activity,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); PTHR10108:SF905 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_08535,3,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.040248046,0,6.532731296,3.933196397,1.660921713,0.096729171,NA,0.012532196,0,9.7824915,3.261558999,2.999329922,0.002705741,0.015349618,0.032997801,0,7.109466016,1.917231194,3.70819442,0.000208742,0.001800092,0.038105209,0,6.68641608,3.510525445,1.904676717,0.056822107,0.132532559,0.032976741,0,7.015702979,1.431546882,4.900784646,9.55E-07,1.38E-05,N,-,,major facilitator superfamily transporter,C:membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502:SF64 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.78, the major facilitator superfamily (mfs).
RL4_JR_08536,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein BN1723_012000,F:DNA binding; F:metal ion binding; P:DNA integration; P:DNA recombination,no IPS match,,
RL4_JR_08537,1227,1048,1070,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.791,"hypothetical protein MMYC01_210518, partial",F:DNA binding; P:DNA integration; P:DNA recombination,IPR021842 (PFAM),,
RL4_JR_08538,979,651,1129,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,"hypothetical protein MMYC01_210518, partial",F:DNA binding; F:metal ion binding; P:DNA integration; P:DNA recombination,IPR021842 (PFAM),,
RL4_JR_08539,25,4,2,0,0,0,0,0,0,0,3,0,0,0,0,0,12,0,0.444795841,0,3.066461876,2.071952177,1.479986802,0.138876769,NA,0.14218606,0,6.27972109,1.945649818,3.227570055,0.001248465,0.015023052,0.368320969,1,3.63017461,1.282473577,2.830603824,0.004646023,0.017925433,0.424868594,0,3.207802203,1.443881438,2.221652083,0.026306827,0.08636862,0.362422213,1,3.550652849,1.229505545,2.887870545,0.003878595,0.014553576,Y,-, Effector probability:0.67,hypothetical protein CMQ_7356,P:protein-FAD linkage; C:mitochondrial matrix; C:mitochondrion,no IPS match,,
RL4_JR_08540,93,5,1,0,0,3,0,0,0,0,0,0,0,7,0,0,2,0,16.61854973,1,-2.15699208,1.217980637,-1.770957611,0.076567751,0.182057625,5.262332716,0,1.069788906,1.260537185,0.848676992,0.396061052,0.560220358,13.70830983,0,-1.587992144,1.211735287,-1.31051077,0.190023103,0.313015603,37.48912518,1,0.70209465,0.779870344,0.900270993,0.367976054,0.514394249,20.92380562,1,-0.735553319,1.147987942,-0.640732618,0.521696418,0.646058737,N,-,,hypothetical protein CMQ_7375,,no IPS match,,
RL4_JR_08541,135,114,151,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0.837799249,0,2.153032825,1.565655524,1.375163817,0.169080663,NA,0.266828532,0,5.371523279,1.720681708,3.121741374,0.001797848,0.015023052,0.692818295,0,2.718469727,1.247711523,2.178764624,0.029349158,0.075318347,0.79930811,1,2.296014175,1.309612248,1.753201513,0.079567423,0.165765465,0.683302134,0,2.636062162,1.221593889,2.157887483,0.030936581,0.07705606,N,-,,fmn-dependent dehydrogenase family,F:FMN binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR000262 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR10578 (PANTHER); PTHR10578:SF65 (PANTHER); IPR012133 (PROSITE_PROFILES); SSF51395 (SUPERFAMILY),,
RL4_JR_08542,100,133,160,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0.724784434,1,2.362168951,1.718816843,1.374299397,0.169348753,NA,0.229780601,0,5.587175462,1.793874516,3.114585447,0.001842036,0.015023052,0.597818997,0,2.931477611,1.28099956,2.288429834,0.022112502,0.060260288,0.689831727,0,2.508655588,1.37297668,1.827165474,0.067674893,0.147578784,0.590264277,0,2.847635261,1.249095257,2.279758285,0.022622028,0.060180777,N,-, Effector probability:0.897,ribonuclease H,"P:RNA phosphodiester bond hydrolysis, endonucleolytic; F:nucleic acid binding; F:RNA-DNA hybrid ribonuclease activity; C:nucleus; C:nuclear chromatin; C:nucleolus; P:RNA catabolic process",IPR002156 (PFAM); IPR017290 (PIRSF); IPR012337 (G3DSA:3.30.420.GENE3D); IPR011320 (PFAM); IPR011320 (G3DSA:3.40.970.GENE3D); PTHR10642 (PANTHER); PTHR10642:SF0 (PANTHER); IPR002156 (PROSITE_PROFILES); IPR012337 (SUPERFAMILY); IPR009027 (SUPERFAMILY),,
RL4_JR_08543,513,560,646,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,54.10046269,1,0.079310949,0.701717301,0.113024076,0.910011468,0.956202596,9.123660842,0,0.275840848,1.225603337,0.225065354,0.821928433,0.892752399,31.62069032,0,-1.420834629,1.200641366,-1.183396366,0.236652097,0.369162685,61.14215733,0,0.694657076,0.60966699,1.139404113,0.254534641,0.393881334,46.72645919,0,0.676029976,0.678461922,0.996415501,0.319048305,0.454404851,N,-, Effector probability:0.699,kinase domain-containing,F:organic cyclic compound binding; F:heterocyclic compound binding; P:phosphorylation; F:kinase activity,G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_08544,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003880053,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,0,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,glycoside hydrolase family 3,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",no IPS match,,
RL4_JR_08545,790,738,632,0,0,0,0,0,0,0,2,2,2,0,1,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,Spherulin-1B,,no IPS match,,
RL4_JR_08546,762,891,684,0,0,0,0,0,0,0,0,0,0,1,0,0,2,2,20.81601977,0,1.379228795,1.010568273,1.364805162,0.172314296,0.326246605,1.526394774,0,2.855342977,1.336385947,2.136615536,0.032629275,0.084468931,3.967683213,0,0.200497862,1.20350061,0.166595563,0.867688285,0.916099301,4.577693768,1,-0.221988108,1.203090636,-0.184514866,0.853609566,0.908299245,3.920048768,1,0.115406702,1.206518874,0.095652629,0.923796465,0.950649376,N,-,,hypothetical protein SPI_01267,,no IPS match,,
RL4_JR_08547,3526,2815,3289,4,0,2,0,0,0,0,9,17,0,4,7,0,2,14,35.12464125,1,0.755210038,0.853343867,0.885000839,0.376156179,0.567659088,3.528142774,0,1.64658728,1.260467402,1.306330714,0.191440117,0.333176902,9.170770145,1,-1.008090552,1.196505423,-0.842529029,0.399491898,0.541681569,10.58103383,1,-1.430619707,1.194767131,-1.197404641,0.231148876,0.368100404,46.59434029,1,2.335767241,0.588577169,3.968497866,7.23E-05,0.00053259,N,-,,hypothetical protein SPI_01268,,no IPS match,,
RL4_JR_08548,46,32,43,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.59695013,0,6.977736509,0.97933274,7.124990544,1.04E-12,5.05E-11,0.04445599,0,7.956787892,2.507942997,3.172635064,0.001510623,0.015023052,0.116171148,0,5.294967996,1.499700409,3.530683837,0.000414487,0.002963464,0.134092998,0,4.871600949,2.154610273,2.261012588,0.023758478,0.083143865,0.115153617,0,5.207688668,1.329911957,3.915814607,9.01E-05,0.000636606,N,-,,MFS transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23502:SF4 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.33, the major facilitator superfamily (mfs).
RL4_JR_08549,1512,1355,1644,0,0,0,0,0,0,0,0,0,0,3,1,0,0,1,38.82509673,0,-0.583421079,1.009031189,-0.578199252,0.563129604,0.740014708,5.956945538,0,0.890909695,1.231876825,0.723213293,0.469548853,0.627909758,28.47398286,0,0.056681121,1.033302392,0.05485434,0.956254508,0.974445963,17.85513188,1,-2.185561684,1.191352178,-1.834521919,0.066576557,0.146191204,15.28638099,1,-1.84795825,1.199093145,-1.54112986,0.123285184,0.223535949,N,-,,bola,,IPR002634 (PIRSF); IPR002634 (G3DSA:3.30.300.GENE3D); IPR002634 (PFAM); PTHR12735:SF3 (PANTHER); PTHR12735 (PANTHER); IPR002634 (SUPERFAMILY),,
RL4_JR_08550,77,22,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,42.82306779,0,0.365168997,0.730152134,0.500127275,0.616985462,0.779762571,6.129986733,0,0.849645556,1.231283742,0.690048546,0.490163659,0.645966069,45.9101834,0,1.022160536,0.737095849,1.386740324,0.16552096,0.282347801,18.32066745,0,-2.222625322,1.186774083,-1.87282934,0.061091955,0.137947378,15.6397196,1,-1.880954016,1.190385019,-1.580122386,0.114078842,0.210698335,N,-,,hypothetical protein CMQ_7968,,no IPS match,,
RL4_JR_08551,2,7,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,261.2527673,0,-1.767131913,0.87730603,-2.014270793,0.043981111,0.120913799,144.5931936,0,-0.93072556,1.002414874,-0.92848339,0.35315688,0.516927486,188.3425798,0,-3.448644268,1.047316122,-3.292839855,0.000991809,0.005718155,341.0946247,0,-0.558712795,0.39530536,-1.413370147,0.157546918,0.27597968,212.8605077,0,-1.898637052,0.600709821,-3.160655919,0.001574143,0.006956875,N,-,,1-phosphatidylinositol-3-phosphate 5-kinase FAB1,C:mitochondrion; C:endomembrane system; C:protein complex; P:single-organism cellular process; C:vacuolar membrane; C:membrane part; F:binding; P:primary metabolic process; F:kinase activity; P:organic substance metabolic process; P:phosphate-containing compound metabolic process,IPR000306 (SMART); IPR002498 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR027409 (G3DSA:3.50.7.GENE3D); IPR002423 (PFAM); IPR027483 (G3DSA:3.30.810.GENE3D); IPR019411 (PFAM); IPR002498 (PFAM); IPR000306 (PFAM); IPR027484 (G3DSA:3.30.800.GENE3D); PTHR11353:SF57 (PANTHER); PTHR11353:SF57 (PANTHER); PTHR11353 (PANTHER); PTHR11353:SF57 (PANTHER); PTHR11353 (PANTHER); PTHR11353 (PANTHER); IPR017455 (PROSITE_PROFILES); IPR002498 (PROSITE_PROFILES); IPR027532 (HAMAP); SSF56104 (SUPERFAMILY); IPR011011 (SUPERFAMILY); IPR027409 (SUPERFAMILY),9.A.58.1.1, the maintenance of mitochondrial morphology (mmm) family.
RL4_JR_08552,6,3,14,0,0,4,0,0,0,0,0,0,1,1,0,0,0,0,35.73344945,1,0.223146843,0.798463317,0.279470375,0.77988387,0.88684494,6.475269802,0,0.770537964,1.247605038,0.6176137,0.536830012,0.68390183,16.8796038,0,-1.888244663,1.209209462,-1.561553,0.118393329,0.219756716,19.47915219,1,-2.311056889,1.209804081,-1.910273676,0.056097985,0.131552854,16.71198545,0,-1.976551413,1.218666883,-1.621896386,0.104825535,0.197903094,N,-,,vacuolar sorting-associated 28,P:protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; C:ESCRT I complex; P:telomere maintenance; F:protein complex binding; P:protein targeting to membrane,IPR007143 (PIRSF); IPR007143 (PFAM); IPR007143 (PANTHER); IPR017899 (PROSITE_PROFILES); IPR017898 (PROSITE_PROFILES); SSF140111 (SUPERFAMILY); SSF140427 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_08553,0,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,276.4186109,0,-3.223115146,0.830580966,-3.880555028,0.000104218,0.000888415,76.51072236,0,-2.792083928,1.211815979,-2.304049439,0.021219868,0.060332922,199.8125754,0,-5.453516884,1.219339179,-4.472518378,7.73E-06,0.000152856,242.6458535,0,-3.604450738,0.912918861,-3.948270641,7.87E-05,0.000871728,202.0607789,0,-4.617732425,1.167102984,-3.956576658,7.60E-05,0.000553031,N,-,,nucleolar complex 2,"C:Noc complex; C:preribosome, large subunit precursor",IPR005343 (PFAM); PTHR12687:SF4 (PANTHER); IPR005343 (PANTHER); PTHR12687:SF4 (PANTHER); IPR005343 (PANTHER),,
RL4_JR_08554,2,3,5,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,8.555224647,0,3.731572974,1.06127481,3.516123193,0.000437898,0.003012116,0.291280028,0,5.245040143,1.715967873,3.056607426,0.002238572,0.015045494,0.757457782,0,2.59003024,1.267574119,2.043296878,0.041023058,0.097561063,0.874015137,1,2.167261258,1.33254247,1.626410645,0.103862328,0.201457101,0.747512166,0,2.506755543,1.243220756,2.016339842,0.043764451,0.101006399,N,-,,short chain dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); PTHR24322:SF290 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_08555,0,3,8,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,47.50611345,0,-0.430869058,0.795503428,-0.541630674,0.588072956,0.759939677,10.20977202,0,0.113613773,1.229565815,0.092401538,0.926379017,0.959460597,40.93753494,0,-0.723867588,1.048366266,-0.690472033,0.489897391,0.624021287,40.3259086,1,-2.015394348,1.15970275,-1.737854245,0.0822365,0.169423866,56.8378744,0,0.7505354,0.636085359,1.179928746,0.238028556,0.36693653,N,-,,nitric oxide dioxygenase,F:oxygen binding; F:dioxygenase activity; F:oxidoreductase activity; P:oxidation-reduction process; F:heme binding,IPR000971 (PFAM); G3DSA:2.40.30.10 (GENE3D); IPR012292 (G3DSA:1.10.490.GENE3D); G3DSA:3.40.50.80 (GENE3D); G3DSA:2.40.30.10 (GENE3D); PTHR22924 (PANTHER); PTHR22924:SF49 (PANTHER); PTHR22924 (PANTHER); PTHR22924:SF49 (PANTHER); IPR000971 (PROSITE_PROFILES); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY); IPR009050 (SUPERFAMILY); IPR017938 (SUPERFAMILY),1.A.107.1.4, the pore-forming globin (globin) family.
RL4_JR_08556,405,434,337,0,0,5,1,0,0,0,1,10,0,1,9,0,8,0,12.17692581,1,-1.708227067,1.196539528,-1.427639478,0.153395654,0.301557458,3.88306017,1,1.508354595,1.260391248,1.196735218,0.231409775,0.381549071,50.40567995,1,2.254451704,0.622121784,3.623810905,0.000290294,0.002267697,27.66240262,1,1.145852574,0.752916758,1.521884806,0.128037947,0.235877768,9.912929451,1,-1.223012897,1.198015919,-1.020865313,0.307318255,0.442616975,N,-,,MFS allantoate transporter,"F:allantoate transmembrane transporter activity; F:hydrogen ion transmembrane transporter activity; F:dipeptide transporter activity; P:ATP hydrolysis coupled proton transport; P:allantoate transport; P:dipeptide transport; P:tripeptide transport; C:integral component of membrane; C:proton-transporting V-type ATPase, V0 domain; C:plasma membrane",G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662 (PANTHER); PTHR11662:SF230 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.4, the major facilitator superfamily (mfs).
RL4_JR_08557,481,594,1301,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,98.8399834,0,1.583223512,0.479172007,3.304081811,0.00095288,0.005715136,27.13512133,0,2.034403753,1.003550292,2.027206578,0.042641291,0.104078887,73.92626968,0,1.374418604,0.589905851,2.329894849,0.019811709,0.055193656,83.64587304,1,1.077439002,0.562641651,1.914964879,0.055496983,0.130706432,47.31667744,0,0.308717215,0.754669648,0.409075965,0.682483914,0.774460257,N,-,,NAD dependent epimerase dehydratase family,C:membrane,IPR016040 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR15020 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_08558,215,54,72,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0.039589193,0,6.555822483,3.933621383,1.666612479,0.095591486,NA,0.012523154,0,9.783407598,3.165980796,3.090166438,0.002000444,0.015023052,0.032754566,0,7.11771988,1.809882802,3.932696565,8.40E-05,0.001045754,0.037800908,1,6.69748772,3.406103088,1.966319734,0.049261689,0.121802535,0.032626895,0,7.023781385,1.387191293,5.063311327,4.12E-07,6.81E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_08559,1973,1540,1541,1,1,5,0,0,2,1,1,2,0,5,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein SPBR_06432,,no IPS match,,
RL4_JR_08560,502,594,607,6,0,2,0,0,0,1,2,1,3,1,0,0,0,0,32.03420125,1,-1.738293121,1.14980614,-1.511814089,0.130581164,0.26790913,7.678697904,0,0.524631361,1.234776638,0.424879565,0.670924472,0.789662501,19.92157742,1,-2.127350892,1.199633412,-1.773334146,0.076173354,0.156967034,32.2928349,1,-1.599086535,1.151292706,-1.388948724,0.164848343,0.285240695,19.65925941,0,-2.210950876,1.204861929,-1.835024264,0.066502094,0.13952211,N,-,,male barren-2,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_08561,1244,1303,953,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1.573753049,0,1.243535727,1.413765378,0.879591301,0.379080753,NA,0.50984089,0,4.437603793,1.618034683,2.742588795,0.006095697,0.023522929,1.308656246,0,1.801321973,1.277411698,1.410134239,0.158500049,0.273000652,1.508719591,1,1.3797663,1.31584669,1.048576791,0.294372942,0.438782563,1.275098768,0,1.735337231,1.2529601,1.384990018,0.16605552,0.279612862,N,-,,g-patch domain-containing,F:nucleic acid binding,no IPS match,,
RL4_JR_08562,250,429,308,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33.05039378,0,1.837720324,0.629638651,2.918690461,0.003515051,0.016339478,3.228799881,0,1.774469633,1.268117146,1.399294725,0.161724621,0.292997425,8.392891707,0,-0.880348737,1.198275904,-0.734679496,0.462534711,0.599842091,38.26590757,0,1.031526349,0.851210896,1.211834051,0.225575911,0.361271132,23.02578922,0,0.724984725,0.980486342,0.739413385,0.459656017,0.591322954,N,-,,hypothetical protein F503_05882,C:membrane,no IPS match,,
RL4_JR_08563,249,345,286,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,62.00407853,0,1.682144325,0.625389571,2.689754358,0.007150463,0.029021631,3.783746286,0,1.545658614,1.254971807,1.231628157,0.218088018,0.365417467,16.33512654,0,-0.147499278,1.193128912,-0.123623924,0.901613049,0.939303531,15.36028619,1,-0.584736634,1.145358429,-0.510527202,0.609682162,0.72975906,36.38836865,0,1.993139796,0.636792526,3.129967321,0.001748258,0.007564576,N,-,,rna recognition motif-containing,"F:nucleic acid binding; C:nucleus; P:mRNA splicing, via spliceosome",PTHR23189:SF41 (PANTHER); PTHR23189 (PANTHER),1.G.20.2.1, the hantavirus gc envelope fusion glycoprotein (gc-efg) family.
RL4_JR_08564,2381,2718,3286,0,0,1,0,0,0,3,0,0,1,3,3,0,2,1,62.56704493,1,-0.836288261,0.817736359,-1.022686898,0.306455908,0.493105043,13.60569287,0,-0.300684986,1.237006049,-0.24307479,0.80794746,0.883444333,35.59160757,1,-2.964526256,1.219416184,-2.431102928,0.015052938,0.044640184,49.10128507,1,-1.680345932,1.060226604,-1.584893196,0.112990603,0.214398398,35.41961611,1,-3.06025434,1.233139382,-2.481677566,0.013076554,0.038941209,N,-, Effector probability:0.806,mitochondrial 37s ribosomal s8,F:structural constituent of ribosome; C:mitochondrial small ribosomal subunit; P:translation,IPR000630 (PFAM); G3DSA:3.30.1370.30 (GENE3D); G3DSA:3.30.1490.10 (GENE3D); IPR000630 (PANTHER); IPR000630 (SUPERFAMILY),,
RL4_JR_08565,1878,1843,1688,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,90.36899964,1,0.182802405,0.59116074,0.309226226,0.757149445,0.872432934,13.92751967,0,-0.334309314,1.241346089,-0.269311932,0.787689651,0.87156902,50.19055117,0,-1.155220606,1.054285396,-1.095738032,0.273193434,0.412130878,91.90833306,0,-0.008898246,0.677224957,-0.013139276,0.989516676,0.993657756,57.1464652,0,-0.800907307,0.860195745,-0.931075644,0.351814437,0.489030476,N,-,,c6 zinc finger domain containing,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); IPR001138 (PFAM); PTHR31001 (PANTHER); PTHR31001:SF47 (PANTHER); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_08566,910,1203,914,0,0,3,0,0,0,0,0,0,0,1,7,0,0,0,135.322438,1,-1.935883119,0.67718217,-2.858733152,0.004253364,0.018966711,65.1860497,0,0.442814001,0.844432908,0.524392165,0.600005805,0.734905464,118.3635772,0,-2.569885645,1.028705515,-2.498174267,0.012483481,0.03840254,191.9226998,1,-0.502069162,0.447114397,-1.122909854,0.261475782,0.401797283,106.5767527,0,-2.282413007,0.850840071,-2.682540568,0.007306529,0.024423442,N,-,,DNA polymerase gamma,F:DNA binding; F:DNA-directed DNA polymerase activity; P:DNA replication; P:DNA biosynthetic process; C:gamma DNA polymerase complex,IPR002297 (PRINTS); IPR001098 (SMART); G3DSA:3.30.70.370 (GENE3D); G3DSA:1.10.150.20 (GENE3D); IPR001098 (PFAM); IPR012337 (G3DSA:3.30.420.GENE3D); IPR002297 (PANTHER); PTHR10267:SF0 (PANTHER); SSF56672 (SUPERFAMILY); IPR012337 (SUPERFAMILY),,
RL4_JR_08567,584,575,425,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,74.60633474,1,7.78E-05,0.613845941,0.000126664,0.999898937,0.999898937,49.37751932,0,2.481370157,0.765997342,3.23939787,0.001197824,0.015023052,109.6606683,0,1.250082776,0.516009791,2.422595072,0.015410093,0.045444737,56.80173645,0,-0.452627566,0.747593639,-0.605445984,0.544882705,0.675102471,49.58240171,0,0.088702091,0.685172791,0.129459447,0.896994111,0.93292916,N,-,,zinc ring-type containing,F:zinc ion binding; F:ubiquitin protein ligase activity; P:DNA recombination; P:negative regulation of protein sumoylation; C:SUMO-targeted ubiquitin ligase complex; P:protein ubiquitination,IPR001841 (SMART); PF13920 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR23041 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),3.A.20.1.4, the peroxisomal protein importer (ppi) family.
RL4_JR_08568,873,1469,1410,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,89.12545601,0,-2.724928905,1.016480704,-2.680748285,0.007345775,0.029637404,44.8549056,0,0.398828468,0.993817906,0.401309401,0.688192343,0.801966716,112.988069,0,-0.274917796,0.585726146,-0.469362342,0.638810661,0.748359076,109.9459378,0,-0.625725881,0.562563658,-1.11227569,0.266019633,0.406988332,66.28632471,0,-3.964420004,1.188540684,-3.335535804,0.000851352,0.004192577,N,-,,nuclear pore complex subunit,C:nuclear pore nuclear basket; P:nuclear pore organization; C:cytosol; F:structural constituent of nuclear pore; C:nuclear periphery; C:nuclear pore inner ring; C:mitotic spindle pole body,IPR021827 (PFAM); PTHR31344 (PANTHER); PTHR31344:SF0 (PANTHER); PTHR31344:SF0 (PANTHER),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_08569,339,426,408,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,117.230512,0,-1.045242322,0.622283959,-1.679687073,0.093018216,0.209856916,27.74657211,0,-1.328690482,1.216831713,-1.091926244,0.274865521,0.433028281,71.5721751,0,-3.972317295,1.202262577,-3.304034719,0.00095304,0.005535425,113.199808,0,-1.346907436,0.694732198,-1.93874336,0.052532596,0.126250305,104.8328515,0,-0.3329573,0.579515916,-0.574543841,0.565599842,0.682834381,N,-,,phosphotidylinositol kinase,F:ATP binding; P:DNA damage checkpoint; P:DNA repair; F:ubiquitin protein ligase binding; P:replicative senescence; P:telomere maintenance; P:histone phosphorylation; F:protein serine/threonine kinase activity; P:ubiquitin-dependent protein catabolic process; P:response to ionizing radiation,IPR021668 (SMART); IPR000403 (SMART); IPR003152 (SMART); IPR003152 (PFAM); IPR000403 (G3DSA:1.10.1070.GENE3D); IPR003151 (PFAM); G3DSA:3.30.1010.10 (GENE3D); IPR000403 (PFAM); IPR021668 (PFAM); IPR015519 (PTHR11139:PANTHER); PTHR11139 (PANTHER); IPR015519 (PTHR11139:PANTHER); PTHR11139 (PANTHER); IPR000403 (PROSITE_PROFILES); IPR014009 (PROSITE_PROFILES); IPR003152 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_08570,789,457,469,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.989519524,0,0.31798971,1.255572223,0.253262779,0.800065157,0.898531326,0.959751081,0,3.524911147,1.437860173,2.451497867,0.014226303,0.044198477,2.476911371,0,0.880821086,1.227188758,0.717755179,0.472908254,0.60943523,2.856646796,0,0.458804331,1.235374696,0.371388804,0.710347963,0.8061279,21.72858715,0,3.716551042,0.708220225,5.247733556,1.54E-07,3.25E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_08571,7343,3188,2886,0,0,6,0,0,0,0,1,0,0,2,0,0,0,0,62.59842576,1,0.449774416,0.623419377,0.721463646,0.4706243,0.659569325,8.707363573,0,0.343332838,1.233822861,0.278267529,0.780807001,0.867485783,62.82061368,1,1.093047395,0.628734361,1.738488401,0.082124792,0.166286279,25.93081677,1,-2.723717877,1.195483811,-2.278339406,0.022706364,0.081131698,60.65451414,0,1.509728585,0.524604263,2.877842768,0.004004047,0.014898661,N,-,,ubiquitin ligase subunit,"P:transcription-coupled nucleotide-excision repair; P:negative regulation of mitotic DNA replication initiation; C:chromosome, centromeric region; F:protein serine/threonine kinase activity; P:protein phosphorylation; P:chromatin silencing at telomere; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; P:negative regulation of transcription from RNA polymerase II promoter; C:chromosome, telomeric region; F:ATP binding; F:ubiquitin protein ligase binding; P:chromatin silencing at centromere; P:heterochromatin assembly; P:regulation of histone H3-K9 methylation; C:CLRC ubiquitin ligase complex; P:mitotic sister chromatid segregation; C:cytosol; C:COP9 signalosome; P:chromatin silencing at silent mating-type cassette; F:ligase activity; P:chromatin silencing by small RNA; P:cellular protein localization; P:positive regulation of meiotic cell cycle",IPR016158 (SMART); IPR019559 (SMART); IPR019559 (PFAM); G3DSA:1.20.1310.10 (GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); IPR001373 (PFAM); G3DSA:1.20.1310.10 (GENE3D); G3DSA:1.20.1310.10 (GENE3D); G3DSA:1.20.1310.10 (GENE3D); G3DSA:4.10.1030.10 (GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); PTHR11932 (PANTHER); PTHR11932 (PANTHER); PTHR11932:SF77 (PANTHER); IPR016158 (PROSITE_PROFILES); IPR016158 (SUPERFAMILY); IPR011991 (SUPERFAMILY); IPR016159 (SUPERFAMILY),,
RL4_JR_08572,3829,2335,2992,0,8,3,0,0,5,0,0,0,0,0,3,0,0,0,185.3175983,1,-2.21358422,0.758945205,-2.916658812,0.003538026,0.016427554,46.53908288,1,-2.074881472,1.217466257,-1.704261995,0.088332152,0.183857298,132.818859,0,-3.776994287,1.218978155,-3.098492184,0.001945081,0.009634051,144.5301085,1,-4.216908382,1.178157597,-3.579239647,0.000344595,0.00304582,147.101857,0,-2.175873363,0.820416227,-2.652157883,0.007997913,0.026181336,N,-,,mrna turnover 4,"F:structural constituent of ribosome; P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process; C:cytosolic large ribosomal subunit; P:rRNA processing; C:nucleolus; F:large ribosomal subunit rRNA binding; P:ribosomal large subunit assembly; C:preribosome, large subunit precursor",IPR001790 (PFAM); IPR033867 (PTHR21141:PANTHER); PTHR21141 (PANTHER); IPR033867 (PTHR21141:PANTHER); PTHR21141 (PANTHER); SSF160369 (SUPERFAMILY),,
RL4_JR_08573,508,525,397,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,181.9307764,1,-2.460111736,0.732820623,-3.357044902,0.000787803,0.004902287,51.60625886,0,-2.223973916,1.199391735,-1.854251494,0.063703188,0.142639345,134.4564211,0,-4.882012565,1.20116074,-4.064412366,4.82E-05,0.00070246,186.137681,0,-2.256733902,0.692004284,-3.261155971,0.00110959,0.008047706,144.6764387,0,-2.783560406,0.880172171,-3.162518081,0.00156411,0.006919924,N,-,,u1 small nuclear ribonucleo,,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); IPR022023 (PFAM); PTHR13952:SF5 (PANTHER); PTHR13952 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),9.A.60.1.1, the small nuclear rna exporter (snrna-e).
RL4_JR_08574,2691,1236,1759,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,86.71545705,1,0.157550778,0.599452032,0.262824662,0.792685726,0.893695399,13.81379904,0,-0.322580601,1.221409586,-0.264105182,0.791698871,0.873795221,36.03743384,0,-2.98249038,1.206449919,-2.472121165,0.013431398,0.040736812,51.22119913,0,-2.453516005,1.161537864,-2.112299634,0.034660757,0.099426657,35.75882625,0,-3.074007016,1.216960393,-2.525971293,0.011537891,0.035261438,N,-, Effector probability:0.841,mitochondrial 54s ribosomal l51,C:mitochondrion; P:mitochondrial translation; C:ribosome; P:aerobic respiration,IPR007741 (SMART); IPR007741 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR21396 (PANTHER); IPR012336 (SUPERFAMILY),3.D.1.6.1, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_08575,11331,6622,8247,11,10,10,0,0,1,1,6,7,0,8,5,0,11,1,0.405050879,1,3.20151331,2.178019514,1.469919479,0.141583563,NA,0.128653563,1,6.423887257,1.987674372,3.231860987,0.001229869,0.015023052,0.334611154,1,3.768363875,1.298601413,2.901863371,0.003709503,0.01574077,0.386086056,1,3.345804119,1.489198434,2.246714771,0.024658262,0.084922906,0.33054943,1,3.684208069,1.242991494,2.96398494,0.003036831,0.011959517,N,-,,caf1 family ribonuclease,"F:nucleic acid binding; P:RNA phosphodiester bond hydrolysis, exonucleolytic; C:nucleus; F:3'-5'-exoribonuclease activity; P:ncRNA 3'-end processing; P:heterochromatin assembly involved in chromatin silencing by small RNA",IPR012337 (G3DSA:3.30.420.GENE3D); IPR006941 (PFAM); PTHR15092 (PANTHER); IPR012337 (SUPERFAMILY),,
RL4_JR_08576,1655,1137,1850,1,2,2,0,0,0,0,0,0,0,2,0,0,12,0,132.9419303,1,-0.294652293,0.838652763,-0.351340037,0.725333261,0.85460265,21.03400541,0,-0.929184452,1.226359026,-0.757677346,0.448644164,0.609145034,61.50538381,0,-2.630783877,1.218214262,-2.159541191,0.030808205,0.078377364,67.49612141,1,-3.070592276,1.177398663,-2.607946121,0.009108729,0.045099082,54.72754194,1,-3.687975601,1.230900139,-2.996161495,0.002734016,0.011006724,N,-,,50S ribosomal subunit l30,C:ribosome; F:hydrolase activity,IPR021757 (PFAM); IPR015797 (G3DSA:3.90.79.GENE3D); PTHR13124 (PANTHER); IPR000086 (PROSITE_PROFILES); IPR015797 (SUPERFAMILY),,
RL4_JR_08577,10950,6618,14071,7,1,9,0,0,0,0,0,0,2,10,0,0,1,3,92.81144875,1,-0.631008953,0.669277587,-0.942820984,0.345772476,0.535334072,18.22686352,0,-0.722519639,1.221191586,-0.591651341,0.554084087,0.699568308,55.31382323,0,-2.418229447,1.208870124,-2.000404674,0.045456584,0.105172232,92.99042131,1,-1.007578073,0.777200745,-1.296419335,0.194831054,0.324302741,89.15806926,1,0.369409651,0.606125431,0.609460735,0.542219091,0.664323366,N,-,,phd and ring finger domain,F:metal ion binding; C:cytoplasmic part,IPR001965 (SMART); IPR001841 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR019787 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001841 (PFAM); IPR019787 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY); SSF57850 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_08578,2253,1485,1914,0,0,3,0,0,0,0,0,0,0,5,0,0,6,7,563.9445241,1,-0.602319592,0.710426083,-0.847828656,0.396533401,0.588809517,110.3794087,0,-3.320818915,1.203192424,-2.760006503,0.005780021,0.022667715,332.1910329,0,-3.117254605,0.777674109,-4.008433055,6.11E-05,0.000844214,567.4350374,1,-0.476997151,0.365337752,-1.305633346,0.191677275,0.320729203,358.6732698,1,-1.665211705,0.93209336,-1.786528879,0.074013666,0.151238822,N,-,,60S ribosomal L43,,IPR011331 (G3DSA:2.20.25.GENE3D); IPR002674 (TIGRFAM); IPR002674 (PFAM); IPR011332 (SUPERFAMILY),,
RL4_JR_08579,1947,1224,1503,0,2,0,0,0,0,0,2,3,0,0,0,0,0,0,1104.316335,1,2.436608995,0.507891305,4.797500907,1.61E-06,2.31E-05,138.4116731,0,1.29842972,0.703555468,1.845525732,0.064961099,0.144805822,202.0186746,1,-1.009813384,0.631455795,-1.599183018,0.109779942,0.207857142,308.1440422,0,-0.136727606,0.53018413,-0.257887021,0.796494102,0.868832448,248.4549433,0,-0.117317536,0.565696408,-0.207386036,0.835708387,0.888818006,N,-, Effector probability:0.589,triosephosphate isomerase,P:gluconeogenesis; P:pentose-phosphate shunt; P:glycolytic process; F:triose-phosphate isomerase activity,IPR013785 (G3DSA:3.20.20.GENE3D); IPR000652 (PFAM); IPR000652 (TIGRFAM); IPR000652 (PANTHER); IPR022896 (HAMAP); IPR000652 (PROSITE_PROFILES); IPR000652 (SUPERFAMILY),,
RL4_JR_08580,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28.99245358,0,-0.804623596,1.045055976,-0.769933491,0.441339346,0.631411026,16.16150521,0,1.618738285,1.141304734,1.418322589,0.156096605,0.28514886,28.69440404,0,-0.988673972,1.206510264,-0.819449284,0.412530126,0.55456845,77.96549668,0,1.524919918,0.554346879,2.750840628,0.005944256,0.032133255,25.09896158,0,-0.373524146,1.002674328,-0.372527884,0.709499855,0.794676225,N,-,,saccharopine dehydrogenase,C:membrane,IPR005097 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR12286 (PANTHER); PTHR12286:SF5 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_08581,11486,8867,10963,5,4,5,0,0,0,0,2,2,0,2,0,0,0,0,102.9462856,1,-1.68340736,0.761466448,-2.210743972,0.027053572,0.08353635,34.56067859,0,-0.271703208,1.11414872,-0.243866194,0.807334452,0.883358844,100.7450682,1,-0.70807797,0.679609909,-1.041888826,0.297463225,0.438357743,96.99683489,1,-1.549186341,0.75753833,-2.045027004,0.040852196,0.1089643,64.89262245,0,-3.933761622,1.203280871,-3.269196509,0.001078534,0.005069529,N,-,,sporulation rmd1,C:membrane,IPR003734 (PFAM); PTHR16255:SF11 (PANTHER); PTHR16255:SF11 (PANTHER); PTHR16255 (PANTHER); PTHR16255 (PANTHER),,
RL4_JR_08582,1629,1507,1806,0,0,8,0,0,0,0,0,5,0,0,0,0,0,0,60.90433986,1,0.289820327,0.604271417,0.479619454,0.631498011,0.790591212,10.8969235,0,0.019692394,1.21709057,0.016179892,0.987090877,0.993726257,34.75633438,1,-1.669739357,1.192762523,-1.39989254,0.1615455,0.277154151,40.62234964,0,-1.329113223,1.019116859,-1.304181372,0.19217175,0.321185039,65.71443218,0,0.895494252,0.553318646,1.618406064,0.105575116,0.198948083,N,-,,hmg box,,IPR009071 (G3DSA:1.10.30.GENE3D),,
RL4_JR_08583,213,179,301,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,346.569834,1,-0.050341032,0.461642546,-0.109047645,0.913164701,0.95740828,58.40358453,1,-2.402490678,1.197265949,-2.006647463,0.044787214,0.108143172,201.1636992,0,-1.6492703,0.636107534,-2.592753919,0.009521087,0.031449097,219.7832089,0,-1.456758981,0.607340969,-2.398585071,0.016458553,0.069579477,154.6805517,0,-4.221874298,1.14379184,-3.691121191,0.000223268,0.001366739,N,-,,T-complex 1 subunit theta,C:chaperonin-containing T-complex; F:ATP binding; F:unfolded protein binding; P:protein folding,IPR017998 (PRINTS); IPR027409 (G3DSA:3.50.7.GENE3D); IPR002423 (PFAM); IPR012721 (TIGRFAM); IPR027413 (G3DSA:1.10.560.GENE3D); IPR027410 (G3DSA:3.30.260.GENE3D); PTHR11353 (PANTHER); PTHR11353:SF19 (PANTHER); SSF54849 (SUPERFAMILY); SSF48592 (SUPERFAMILY); IPR027409 (SUPERFAMILY),,
RL4_JR_08584,298,283,341,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,40.7712948,0,-1.221511574,1.031997087,-1.183638588,0.236556158,0.410967464,9.320896512,0,0.245104234,1.249027561,0.196236049,0.844425413,0.907028954,69.50728775,0,1.055665528,1.159538233,0.910418905,0.362601632,0.506551527,90.30522341,1,1.223481357,0.540891058,2.261973719,0.023699027,0.083109543,57.52512601,0,0.94402137,0.605199674,1.559851089,0.118795075,0.21742591,N,-,,von willebrand factor type a domain-containing,F:zinc ion binding,IPR002035 (SMART); PF15411 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR002035 (G3DSA:3.40.50.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); IPR002035 (PFAM); PTHR10166 (PANTHER); IPR001841 (PROSITE_PROFILES); IPR002035 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR011993 (SUPERFAMILY); IPR002035 (SUPERFAMILY),1.A.13.2.1, the epithelial chloride channel (e-clc) family.
RL4_JR_08585,393,462,372,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.72496804,0,1.117126979,0.676548562,1.651214772,0.098694728,0.219267862,4.554400186,0,1.278267948,1.262015716,1.012877995,0.31111844,0.472984319,24.78026225,0,0.44806081,1.041981235,0.430008522,0.667189442,0.771178908,61.76623869,0,1.722661209,1.559462733,1.104650449,0.269311082,0.410597004,41.0536551,0,1.206200749,0.756348224,1.594769064,0.110763887,0.20600374,N,-,,siderophore iron transporter mirC,P:transmembrane transport; C:fungal-type vacuole membrane; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF87 (PANTHER); PTHR23501:SF87 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.16.6, the major facilitator superfamily (mfs).
RL4_JR_08586,1525,3915,3592,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,8.053932602,1,-1.112061932,1.196206948,-0.929656807,0.352548805,0.542966424,2.563054887,0,2.107616475,1.28223707,1.643702655,0.100237637,0.202839937,6.662011752,0,-0.547095593,1.19728547,-0.456946657,0.647709387,0.755027039,7.686293628,0,-0.969598526,1.195356288,-0.81113768,0.417286609,0.560915594,6.580836746,0,-0.631999343,1.202287364,-0.525664131,0.599121589,0.709154325,N,-,,nuclear division rft1,"C:nucleus; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:pathogenesis; P:sporulation resulting in formation of a cellular spore",IPR021740 (PFAM); PTHR33572:SF4 (PANTHER); PTHR33572 (PANTHER),,
RL4_JR_08587,72,52,87,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.08749322,0,-2.356930171,1.238076799,-1.90370272,0.056948912,0.146373416,6.014610694,0,0.876952919,1.273216362,0.688769753,0.490968173,0.646828042,37.93422609,0,0.614438924,0.897461541,0.684640953,0.493570518,0.626807316,39.52572932,0,0.491311247,0.811035069,0.605782988,0.544658868,0.674907727,15.68668747,0,-1.885233939,1.243785607,-1.515722588,0.129589513,0.231818697,N,-,,hypothetical protein CMQ_8014,,no IPS match,,
RL4_JR_08588,45,24,70,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,79.12529236,0,-1.528184137,0.890921962,-1.715283944,0.086293181,0.198695955,17.45702849,0,-0.660272531,1.218623684,-0.541818233,0.58794373,0.725705672,45.55055037,0,-3.320451972,1.20811355,-2.74846017,0.005987591,0.02171923,88.52397608,0,-0.674222593,0.70775696,-0.952618809,0.340783244,0.487762276,45.2120704,0,-3.412417508,1.218398153,-2.800740875,0.005098544,0.018196249,Y,-,,u3 snoRNA associated,,IPR011989 (G3DSA:1.25.10.GENE3D),,
RL4_JR_08589,10943,5568,7472,4,4,15,0,0,0,4,0,6,1,6,3,0,4,0,10.02956335,1,2.366537672,1.013416666,2.335206981,0.019532611,0.064252838,0.764778656,0,3.852399984,1.448265162,2.660010118,0.00781383,0.028086652,25.51145797,1,3.610335271,0.852390507,4.235541389,2.28E-05,0.000372906,89.79189821,1,5.110983227,0.460542566,11.09774341,1.29E-28,1.94E-26,1.95361049,1,1.119977712,1.205927422,0.928727295,0.353030432,0.490387313,Y,-,,C6 transcription factor,C:membrane,PTHR39460:SF1 (PANTHER); PTHR39460 (PANTHER),,
RL4_JR_08590,10809,4742,4746,0,0,39,0,0,0,0,2,1,0,0,0,0,0,0,0.138497272,1,4.74948684,3.550101262,1.337845455,0.180946821,NA,0.043410479,0,7.990312636,2.531217367,3.156707416,0.001595614,0.015023052,124.9344006,1,10.13137068,1.466634345,6.907904967,4.92E-12,3.61E-10,9.767178723,0,5.843404303,1.227807613,4.759218172,1.94E-06,3.30E-05,73.46468633,0,9.446389641,1.700200238,5.55604536,2.76E-08,9.10E-07,Y,-,,glycosyl hydrolase family 35,"P:metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR001944 (PRINTS); IPR018954 (SMART); IPR018954 (PFAM); IPR008979 (G3DSA:2.60.120.GENE3D); IPR025972 (G3DSA:2.60.390.GENE3D); IPR025300 (PFAM); IPR025972 (PFAM); IPR031330 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); IPR018954 (G3DSA:2.102.20.GENE3D); IPR008979 (G3DSA:2.60.120.GENE3D); IPR001944 (PANTHER); PTHR23421:SF64 (PANTHER); SSF51011 (SUPERFAMILY); IPR017853 (SUPERFAMILY); IPR025972 (SUPERFAMILY); IPR008979 (SUPERFAMILY); IPR008979 (SUPERFAMILY),,
RL4_JR_08591,573,412,406,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,215.4891426,0,0.396562745,0.725298919,0.546757667,0.58454523,0.757803362,31.87061955,0,-1.528638875,1.192430493,-1.281952184,0.19985942,0.343459601,147.2928632,0,-0.354975204,0.532910137,-0.666107059,0.505342673,0.63728067,184.9444686,1,-0.066216508,0.411209833,-0.161028513,0.872070943,0.921123614,120.0984088,0,-0.382256452,0.531197282,-0.719612967,0.471763326,0.602878162,N,-,,UV excision repair RAD23,C:nuclear part; P:proteasome-mediated ubiquitin-dependent protein catabolic process; F:protein binding; P:cellular protein modification process; P:cellular response to stress; C:protein complex,IPR004806 (PRINTS); IPR015940 (SMART); IPR000626 (SMART); IPR006636 (SMART); G3DSA:1.10.8.10 (GENE3D); IPR004806 (TIGRFAM); IPR015940 (PFAM); IPR015360 (PFAM); G3DSA:1.10.8.10 (GENE3D); G3DSA:3.10.20.90 (GENE3D); IPR015360 (G3DSA:1.10.10.GENE3D); IPR000626 (PFAM); PTHR10621:SF0 (PANTHER); PTHR10621:SF0 (PANTHER); PTHR10621 (PANTHER); IPR015940 (PROSITE_PROFILES); IPR015940 (PROSITE_PROFILES); IPR000626 (PROSITE_PROFILES); IPR015360 (SUPERFAMILY); IPR009060 (SUPERFAMILY); IPR009060 (SUPERFAMILY); IPR029071 (SUPERFAMILY),8.A.52.1.6, the ubiquitin-related protein degradation (upd) family.
RL4_JR_08592,5214,4002,4035,0,0,1,0,0,1,0,1,1,0,5,0,0,3,0,170.8550927,1,-2.575931374,0.750788028,-3.43097023,0.000601427,0.003902237,46.92426341,1,-2.086761429,1.194202284,-1.747410348,0.080566184,0.17110594,134.8970533,1,-2.921284855,1.035292999,-2.821698647,0.004777004,0.018332976,144.6439229,1,-4.215978788,1.145859514,-3.679315602,0.000233861,0.002189635,120.4084963,1,-4.82557852,1.199679815,-4.02238869,5.76E-05,0.000435957,N,-,,transcription factor tfiiib component,P:regulation of nucleobase-containing compound metabolic process; P:regulation of macromolecule metabolic process,IPR001005 (SMART); PF15963 (PFAM); IPR030701 (PANTHER); IPR009057 (SUPERFAMILY),,
RL4_JR_08593,13864,13747,15182,4,9,14,0,0,0,0,4,1,0,8,0,0,1,0,312.9740428,1,-2.014321666,0.480416578,-4.192864608,2.75E-05,0.000277084,79.84587111,0,-2.853626909,1.189638097,-2.398735309,0.016451802,0.049546308,213.4459235,1,-4.542339382,1.189269554,-3.819436367,0.000133757,0.001377574,309.3496487,1,-1.736711046,0.465092156,-3.734122419,0.000188371,0.001825124,219.9022987,1,-4.650690718,1.123496663,-4.13947889,3.48E-05,0.000284921,N,-,,E3 ubiquitin- ligase BRE1,,IPR001841 (SMART); PF13923 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR013956 (PFAM); PTHR23163 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),3.A.20.1.1, the peroxisomal protein importer (ppi) family.
RL4_JR_08594,11598,12662,17567,2,2,26,0,0,3,5,3,6,2,15,0,0,22,0,51.92131311,1,1.600992562,0.602751618,2.656139799,0.007904084,0.031484577,3.908546916,1,1.498879331,1.251395998,1.197765802,0.231008204,0.381073182,10.13947924,1,-1.153003355,1.190842547,-0.968224857,0.332932083,0.476410517,43.00224373,1,1.476103439,0.660894942,2.233491808,0.02551653,0.085851084,25.43910293,1,1.37537448,0.749988997,1.833859544,0.066674846,0.139739768,Y,-,,DUF1183 domain,C:integral component of membrane,IPR009567 (PFAM); IPR009567 (PANTHER),8.A.111.1.3, the store-operated ca2+ entry-associated regulatory factor (saraf) family.
RL4_JR_08595,7865,5130,5452,0,0,4,0,0,0,0,0,0,0,5,4,0,0,0,42.88655,1,-3.524743827,1.208852639,-2.91577626,0.003548048,0.016436672,13.78300224,0,-0.319254821,1.235265431,-0.258450381,0.796059339,0.876314587,35.54616752,0,-2.962587037,1.2065457,-2.455428781,0.014071663,0.042223331,53.02867611,1,-1.098769073,0.887634137,-1.237862568,0.215767024,0.350608428,50.23149122,0,-0.439001412,0.775281044,-0.566248091,0.571225142,0.687039581,N,-,,leptomycin b resistance pmd1,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:drug transmembrane transport; C:integral component of membrane; C:vacuole; C:plasma membrane",IPR003593 (SMART); IPR003439 (PFAM); IPR011527 (PFAM); G3DSA:1.20.1560.10 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24221:SF225 (PANTHER); PTHR24221 (PANTHER); PTHR24221:SF225 (PANTHER); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY); IPR011527 (SUPERFAMILY),3.A.1.201.10, the atp-binding cassette (abc) superfamily.
RL4_JR_08596,156,159,250,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,IS481 family,,no IPS match,,
RL4_JR_08597,3633,2119,2960,5,5,3,0,0,0,0,0,2,0,0,0,0,5,3,85.4216585,1,-0.126347497,0.786901621,-0.16056327,0.872437386,0.939046053,15.11349629,0,-0.452226208,1.324599488,-0.341405996,0.732797962,0.83322635,51.58922627,1,-1.284730249,1.135939009,-1.130985237,0.258061305,0.394356627,44.47112652,0,-3.501975133,1.288569683,-2.717722742,0.006573289,0.034827083,37.4777403,1,-3.141769801,1.279300039,-2.455850625,0.014055157,0.041224931,N,-,,hypothetical protein SPI_09048,,IPR017956 (PFAM),,
RL4_JR_08598,13195,8341,6356,0,5,1,0,0,0,0,0,2,3,11,1,0,8,0,152.1666752,1,-0.926639614,0.531834509,-1.742345781,0.081447957,0.190934608,30.26495297,0,-1.454048693,1.198758251,-1.212962407,0.225144194,0.374352165,78.35403359,1,-4.102954524,1.189608223,-3.448996438,0.000562674,0.003694237,98.40012867,1,-2.798244301,1.014423619,-2.758457364,0.005807488,0.031562435,80.96347523,1,-3.252026373,1.11906891,-2.90601083,0.003660688,0.013887023,N,-,,histone h3 lysine 36 methyltransferase,"C:intracellular organelle; P:histone lysine methylation; P:transcription, DNA-templated; P:negative regulation of macromolecule metabolic process; P:regulation of histone acetylation; F:histone-lysine N-methyltransferase activity; P:regulation of transcription, DNA-templated; P:negative regulation of cellular component organization; P:negative regulation of cellular metabolic process",IPR006560 (SMART); IPR001202 (SMART); IPR003616 (SMART); IPR001214 (SMART); G3DSA:2.20.70.10 (GENE3D); G3DSA:2.170.270.10 (GENE3D); IPR013257 (PFAM); IPR001214 (PFAM); IPR017923 (PFAM); PTHR22884 (PANTHER); IPR001214 (PROSITE_PROFILES); IPR006560 (PROSITE_PROFILES); IPR025788 (PROSITE_PROFILES); IPR003616 (PROSITE_PROFILES); IPR001202 (PROSITE_PROFILES); IPR001202 (SUPERFAMILY); SSF82199 (SUPERFAMILY),,
RL4_JR_08599,11,22,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,350.2423878,0,-1.126470493,0.894545363,-1.259265924,0.207934297,0.374217515,83.2458421,0,-1.828476219,1.171761164,-1.56045129,0.118653272,0.231524549,279.3769154,0,-1.159190056,0.680189141,-1.704217234,0.088340511,0.176124327,249.8731878,0,-2.853539538,0.824323307,-3.461675189,0.000536825,0.004433943,197.8512141,0,-4.590727246,1.223512584,-3.752088295,0.000175368,0.001115325,N,-,,4-aminobutyrate aminotransferase,F:pyridoxal phosphate binding; F:identical protein binding; P:glutamate metabolic process; F:4-aminobutyrate transaminase activity; C:mitochondrion; P:gamma-aminobutyric acid catabolic process; C:cytosol,IPR005814 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR004631 (TIGRFAM); IPR005814 (PIRSF); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR11986:SF7 (PANTHER); IPR005814 (PANTHER); IPR005814 (PANTHER); PTHR11986:SF7 (PANTHER); IPR015424 (SUPERFAMILY),9.B.313.1.2, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_08600,84,111,149,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2.089753214,0,0.834239426,1.344836227,0.620327895,0.535041933,NA,0.658940967,0,4.067104497,1.5160621,2.682676716,0.007303555,0.026775294,1.724224482,0,1.402612821,1.256062395,1.116674479,0.264133533,0.401585896,1.990098848,1,0.979674945,1.280153879,0.765279051,0.444105396,0.586330308,1.715670518,0,1.307616921,1.258184258,1.03928889,0.2986704,0.433864821,N,-,,---NA---,,no IPS match,,
RL4_JR_08601,689,578,1037,0,0,0,0,0,0,0,0,1,2,2,0,0,0,0,287.6285468,0,0.204288355,0.409184969,0.499256744,0.617598524,0.780295611,54.30172182,0,-1.106096021,1.10578918,-1.000277486,0.31717624,0.478886918,248.4662125,1,0.228348058,0.396299334,0.576200963,0.564479354,0.689138108,234.0897868,1,-0.783925052,0.527564506,-1.485932134,0.137297073,0.24890472,137.7748849,0,-2.136396672,0.756533795,-2.823927612,0.00474391,0.017141732,N,-,,helix-loop-helix dna binding,,IPR011598 (SMART); IPR011598 (G3DSA:4.10.280.GENE3D); IPR011598 (PFAM); PTHR12565 (PANTHER); PTHR12565:SF122 (PANTHER); IPR011598 (PROSITE_PROFILES); IPR011598 (SUPERFAMILY),,
RL4_JR_08602,46,29,51,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,114.2660984,0,2.724597134,0.560403203,4.861851465,1.16E-06,1.72E-05,5.514351663,0,1.002267506,1.256238328,0.797832293,0.424967819,0.587961217,20.84120083,0,-0.691566396,1.206554948,-0.57317439,0.566526623,0.690859495,40.6166646,0,1.177956861,0.67057016,1.756649686,0.078977538,0.164943807,14.19404695,0,-1.741018643,1.21756797,-1.42991495,0.152741431,0.262353462,N,-,,negative regulation of gluconeogenesis,P:cellular protein metabolic process; P:negative regulation of cellular process; C:intracellular part,IPR013144 (SMART); IPR006595 (SMART); IPR024964 (PFAM); PTHR12170:SF2 (PANTHER); PTHR12170 (PANTHER); PTHR12170:SF2 (PANTHER); PTHR12170 (PANTHER); IPR006595 (PROSITE_PROFILES); IPR006594 (PROSITE_PROFILES),,
RL4_JR_08603,263,207,222,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,71.38939931,0,-0.885642075,0.749634849,-1.1814313,0.23743143,0.411682381,42.67309129,0,1.786424998,0.855318353,2.088608284,0.036742999,0.092769427,55.3704658,0,-1.226287112,1.033996155,-1.185968735,0.235634647,0.368142772,60.94923216,1,-1.162309594,0.857390862,-1.355635622,0.175215132,0.298964141,60.53585998,0,0.030178181,0.650402827,0.046399216,0.962992062,0.975749495,N,-,,CAF1 family ribonuclease,"F:nucleic acid binding; F:poly(A)-specific ribonuclease activity; P:positive regulation of transcription elongation from RNA polymerase II promoter; C:nucleus; P:RNA phosphodiester bond hydrolysis, exonucleolytic; F:metal ion binding; C:cytoplasmic mRNA processing body; C:cytosol; C:CCR4-NOT core complex; P:nuclear-transcribed mRNA poly(A) tail shortening; P:transcription elongation from RNA polymerase II promoter",IPR012337 (G3DSA:3.30.420.GENE3D); IPR006941 (PFAM); PTHR10797 (PANTHER); PTHR10797 (PANTHER); PTHR10797:SF0 (PANTHER); IPR012337 (SUPERFAMILY),,
RL4_JR_08604,517,608,564,1,0,4,0,0,0,1,0,0,0,3,5,0,0,0,114.3034325,1,0.183528839,0.494642642,0.371033193,0.710612809,0.844331386,57.33681307,0,1.754385111,0.744806587,2.355490864,0.018498252,0.054052917,67.16980059,1,-1.672892648,1.028585545,-1.626401087,0.10386436,0.199378608,110.7604725,1,0.114124982,0.488195064,0.233769226,0.815164141,0.883298045,58.17305333,0,-2.646530261,1.121238729,-2.360362867,0.018257067,0.050812261,N,-,,NADH-ubiquinone oxidoreductase b12,C:mitochondrial respiratory chain complex I; C:integral component of membrane; P:electron transport chain,IPR012576 (PFAM); IPR012576 (PANTHER); PTHR15082:SF2 (PANTHER),,
RL4_JR_08605,921,898,771,1,0,13,0,0,0,0,0,0,0,0,0,0,0,0,10.41276209,1,-1.482693334,1.195006557,-1.240740752,0.214701535,0.383184231,3.345928925,0,1.723157102,1.280612929,1.345572158,0.178440536,0.315985847,8.643482274,0,-0.922602899,1.200981421,-0.76820747,0.442363936,0.582000324,22.0031658,0,0.953563283,0.865392722,1.101885027,0.270511659,0.411993163,15.85156867,0,-0.064091646,1.125197444,-0.056960355,0.954576776,0.970227926,N,-,,hypothetical protein HMPREF1624_00332,,no IPS match,,
RL4_JR_08606,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,288.4584894,0,0.281273611,0.44846726,0.627188729,0.53053553,0.714327258,52.22800813,0,-1.039326193,1.124062496,-0.924616022,0.355165676,0.519356685,129.4584129,0,-2.790453146,1.051797906,-2.653031661,0.007977239,0.027311994,161.0760913,0,-2.279562412,0.7775013,-2.931908167,0.003368863,0.02038837,118.8001817,0,-3.054645661,1.016789565,-3.004206344,0.002662747,0.010788439,N,-,,Eukaryotic translation initiation factor 6,,IPR002769 (SMART); IPR002769 (PFAM); IPR002769 (TIGRFAM); IPR002769 (PIRSF); G3DSA:3.75.10.10 (GENE3D); IPR002769 (PANTHER); SSF55909 (SUPERFAMILY),,
RL4_JR_08607,5079,5998,6614,4,0,2,0,0,6,0,0,4,0,9,3,0,0,4,132.3895004,1,0.731051121,0.443823672,1.647165682,0.099523996,0.220629553,63.52279471,1,2.296973619,0.71193885,3.226363638,0.00125374,0.015023052,42.95021796,1,-3.235604484,1.197157432,-2.702739336,0.006877065,0.02424772,57.55595822,1,-1.935683235,1.025848499,-1.886909457,0.059172505,0.135793656,80.76884774,1,0.551293815,0.550899909,1.000715023,0.316964602,0.45220045,N,-,,eukaryotic translation initiation factor 6,F:translation initiation factor activity; F:ribosome binding; C:membrane; C:integral component of membrane; P:mature ribosome assembly; P:translational initiation,no IPS match,,
RL4_JR_08608,622,575,714,0,5,66,0,0,0,0,6,11,9,7,10,0,16,2,53.54851206,1,-1.748853034,1.038933606,-1.683315491,0.092314033,0.20878788,22.57684373,0,0.659183094,1.129183596,0.583769633,0.559375311,0.703004333,34.43991475,1,-2.917057947,1.205990972,-2.41880579,0.015571551,0.045827438,58.36940061,1,-1.582983586,1.034828146,-1.529706736,0.126089336,0.233008674,45.73671687,1,-0.824045054,0.885931162,-0.930145693,0.352295656,0.489568146,N,-,,sumo activating enzyme,C:nucleus; P:cellular protein modification process; F:small protein activating enzyme activity,IPR000594 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10953:SF162 (PANTHER); PTHR10953 (PANTHER); PTHR10953 (PANTHER); IPR000594 (SUPERFAMILY),3.A.16.1.3, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_08609,4625,4653,5754,0,2,5,0,0,0,1,0,0,2,5,0,0,2,0,47.9813783,1,-3.686783932,1.203645858,-3.063013848,0.002191199,0.011270998,15.40195614,0,-0.479525474,1.22620062,-0.391066083,0.69574839,0.807240395,52.85053531,1,-1.311789542,1.049670487,-1.249715561,0.211403471,0.339291176,53.9875903,1,-1.832602838,1.036839813,-1.767488878,0.07714639,0.162223717,46.94910408,1,-1.54549906,0.994522224,-1.554011586,0.120181653,0.219487597,N,-,,hypothetical protein CMQ_5787,,no IPS match,,
RL4_JR_08610,5942,4810,6887,2,1,0,0,0,0,6,0,0,0,0,3,0,6,0,118.9136044,1,-4.996115084,1.241264601,-4.025020194,5.70E-05,0.000523384,37.99353075,0,-1.782179815,1.233206074,-1.445159777,0.148413012,0.274481364,98.71170925,1,-4.436175992,1.225966943,-3.618511915,0.000296302,0.002305734,113.8722383,1,-4.858465137,1.232043172,-3.943421178,8.03E-05,0.000886005,105.3803662,1,-2.87568349,1.037342058,-2.772165139,0.005568478,0.01957668,N,-,,25S rRNA (uridine-N(3))-methyltransferase,P:ncRNA metabolic process; P:gene expression; F:S-adenosylmethionine-dependent methyltransferase activity; C:intracellular part,IPR019446 (PFAM); PTHR11538 (PANTHER); PTHR11538 (PANTHER); PTHR11538:SF26 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_08611,14513,8532,14207,2,3,8,0,0,0,3,2,7,3,2,3,0,2,4,93.40213611,1,0.720078509,0.90015166,0.799952432,0.423738358,0.615124366,12.86617639,0,-0.21994672,1.247508116,-0.176308849,0.860051311,0.918156865,93.14246879,1,0.782532614,0.617923407,1.266390956,0.205373147,0.331769226,70.15437096,1,-0.518891756,0.785109744,-0.660916209,0.50866605,0.644183084,39.74157396,1,-1.992940899,1.139606734,-1.748797054,0.080326106,0.161690224,N,-,,hypothetical protein CMQ_5598,,IPR021264 (PFAM); PTHR36102:SF1 (PANTHER); PTHR36102 (PANTHER),,
RL4_JR_08612,1454,964,1221,0,6,0,0,0,0,0,0,0,0,1,0,0,2,0,256.1185404,1,0.610578152,0.409259483,1.491909603,0.135722845,0.275224203,32.97713848,0,-1.577853111,1.206315505,-1.307993726,0.190875437,0.332308424,113.8481198,0,-1.404218789,0.749491629,-1.873561672,0.060990865,0.131966556,119.5673975,1,-1.924378092,0.752969189,-2.555719569,0.010596848,0.050849805,91.26707206,1,-2.628770805,0.97309536,-2.701452409,0.006903736,0.023346803,N,-,,multidrug resistance-associated 1,"F:phytochelatin transmembrane transporter ATPase activity; F:glutathione S-conjugate-exporting ATPase activity; P:phytochelatin 2 import into vacuole; C:fungal-type vacuole membrane; P:vacuole fusion, non-autophagic; C:Golgi apparatus; P:cell redox homeostasis; F:ATP binding; P:glutathione metabolic process; C:integral component of membrane; P:glutathione transmembrane import into vacuole; P:bilirubin transport; P:cellular detoxification of cadmium ion; F:bilirubin transmembrane transporter activity",IPR003593 (SMART); IPR011527 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); G3DSA:1.20.1560.10 (GENE3D); PTHR24223 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR011527 (SUPERFAMILY); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.208.11, the atp-binding cassette (abc) superfamily.
RL4_JR_08613,8834,9145,5244,0,6,4,0,0,0,0,0,3,1,5,2,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_08614,1010,979,1056,0,0,2,0,0,0,0,0,0,0,2,0,0,3,0,62.99315604,1,2.094441764,0.77712247,2.695124441,0.007036235,0.028679942,3.515668579,0,1.651711718,1.31153641,1.259371608,0.20789614,0.353074618,42.36615102,0,1.439377887,0.893065676,1.611726803,0.107021403,0.203892488,10.56639461,1,-1.428544008,1.234380448,-1.157296367,0.247151297,0.385876158,9.046544913,1,-1.091068391,1.239756032,-0.880067016,0.378823006,0.51456707,N,-, Effector probability:0.756,upf0047 domain,C:nucleus; C:integral component of membrane; C:cytosol,IPR001602 (PIRSF); IPR001602 (TIGRFAM); IPR001602 (G3DSA:2.60.120.GENE3D); IPR001602 (PFAM); PTHR30615:SF5 (PANTHER); PTHR30615 (PANTHER); IPR001602 (SUPERFAMILY),,
RL4_JR_08615,2555,1363,1639,1,0,3,0,0,0,0,5,2,0,0,3,0,7,2,45.23237024,1,1.105164715,0.697814848,1.583750644,0.113250475,0.242365523,5.876129841,0,0.910669065,1.266390973,0.719105777,0.472075748,0.630222992,15.26362065,1,-1.742979824,1.215970405,-1.433406452,0.151741715,0.264681976,68.18744801,1,1.395445024,0.630716039,2.212477465,0.026933692,0.087153604,29.77130469,1,-0.122138766,1.000985156,-0.122018559,0.90288432,0.937696939,N,-,,cleavage and polyadenylation specificity factor subunit 5,C:mRNA cleavage factor complex; F:mRNA binding; P:mRNA polyadenylation,IPR016706 (PFAM); IPR016706 (PANTHER),,
RL4_JR_08616,731,406,732,0,0,11,0,0,0,0,2,0,0,4,8,0,0,1,29.03409725,1,0.070028055,0.842268364,0.083142212,0.933738461,0.967199448,5.618968091,0,0.9752386,1.234093834,0.790246716,0.429383698,0.591725227,60.04871344,1,1.945499179,0.569502347,3.416138999,0.000635158,0.004020165,16.79263305,1,-2.096889873,1.185813415,-1.768313503,0.077008508,0.162001068,22.04915591,1,-0.083036991,0.967653014,-0.085812775,0.931615251,0.955297186,N,-,,tat pathway signal sequence,,IPR001841 (SMART); IPR031790 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027370 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR022812 (PFAM); PTHR13063 (PANTHER); IPR016818 (PTHR13063:PANTHER); PTHR13063 (PANTHER); IPR016818 (PTHR13063:PANTHER); IPR016818 (PTHR13063:PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR027417 (SUPERFAMILY); SSF57850 (SUPERFAMILY),,
RL4_JR_08617,2292,1480,3187,0,2,0,0,0,0,0,0,0,0,1,0,0,0,0,53.64428528,1,1.854896118,0.613334095,3.024283394,0.002492229,0.012481032,14.34733567,0,2.067539005,1.144620427,1.806309721,0.070869974,0.155303286,72.89690686,0,2.323587175,0.570328918,4.074117764,4.62E-05,0.000675749,14.81002218,1,-1.915730115,1.204412457,-1.590593076,0.111701184,0.212709138,42.7943619,0,1.625715074,0.641846028,2.532873933,0.011313163,0.034647846,Y,-,,mitochondrial carrier,"P:biological_process; F:transferase activity, transferring acyl groups; F:zinc ion binding; F:metal ion binding; C:membrane; C:integral component of membrane; F:transferase activity; C:cellular_component; P:transport; F:N-acetyltransferase activity; F:molecular_function",PR01217 (PRINTS); IPR023395 (G3DSA:1.50.40.GENE3D),,
RL4_JR_08618,231,103,183,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,73.36558005,0,-1.753837235,0.855367905,-2.05038934,0.040326453,0.113286226,19.84683493,0,-0.84530981,1.207416158,-0.700098143,0.483866016,0.640304852,84.61762142,0,-0.668266394,0.745037212,-0.896957069,0.369741826,0.514326222,75.28851294,1,-1.205459042,0.753594309,-1.59961272,0.109684525,0.210372384,76.49101466,0,-0.936244718,0.746911037,-1.253488932,0.210027825,0.333364434,N,-,,SAGA-associated factor 73,P:macromolecule metabolic process; P:biological regulation; C:nucleoplasm part; C:protein complex; P:chromatin organization,IPR013243 (PFAM); PTHR15117:SF11 (PANTHER); PTHR15117 (PANTHER); IPR013243 (PROSITE_PROFILES),,
RL4_JR_08619,106,171,189,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,64.14137573,0,-1.013666246,0.766586549,-1.322311547,0.186064429,0.343886184,15.584548,0,-0.496558441,1.212150576,-0.40965079,0.682062134,0.798006594,40.48942528,0,-3.150534845,1.19753324,-2.630853775,0.008517067,0.028780844,58.74571185,0,-1.277813591,0.870441802,-1.468005773,0.142102655,0.255875757,51.59326612,0,-1.041978892,0.864815885,-1.204856328,0.22825877,0.35561164,N,-,,negative regulator of the pho system,P:positive regulation of macroautophagy; P:negative regulation of phosphate metabolic process; P:regulation of protein localization; P:negative regulation of glycogen biosynthetic process; P:negative regulation of calcium-mediated signaling; C:cyclin-dependent protein kinase holoenzyme complex; P:traversing start control point of mitotic cell cycle; P:negative regulation of sequence-specific DNA binding transcription factor activity; F:cyclin-dependent protein serine/threonine kinase activity; P:protein phosphorylation; P:cellular response to DNA damage stimulus; C:ascospore-type prospore; P:negative regulation of transcription from RNA polymerase II promoter; C:nucleus; F:ATP binding; P:regulation of establishment or maintenance of cell polarity; P:regulation of protein stability; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; C:cytosol; P:negative regulation of macroautophagy,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); PTHR24056:SF46 (PANTHER); PTHR24056 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_08620,675,725,915,0,0,5,0,0,0,0,0,0,0,0,0,0,3,0,40.42672932,1,0.899179328,0.86924983,1.034431411,0.300934526,0.486655879,3.2909015,0,1.747053415,1.297751311,1.346215874,0.178232907,0.315673401,8.502566893,0,-0.898969374,1.21268743,-0.741303448,0.458509471,0.596273064,9.805537228,0,-1.320844821,1.212436346,-1.089413746,0.275971472,0.418733876,12.21594442,1,-0.047875246,1.142192375,-0.041915221,0.966566283,0.978159281,N,-,,CMGC CDK CDK5 kinase,P:regulation of cellular process; P:negative regulation of biological process,no IPS match,,
RL4_JR_08621,602,779,775,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49.67374941,0,-3.736783578,1.193107822,-3.131974753,0.001736348,0.009294703,149.6880532,0,3.072517971,1.546386707,1.986901438,0.04693332,0.112148033,73.61146557,0,-0.039892237,0.678457708,-0.058798413,0.953112672,0.972811039,47.43880869,0,-3.595224774,1.19288122,-3.013900055,0.002579128,0.016372205,40.64217828,0,-3.258690015,1.198989204,-2.717864351,0.006570477,0.022482622,N,-,,DEAD DEAH box helicase,F:nucleic acid binding; P:biological_process; F:ATP binding; F:helicase activity; C:cellular_component; F:hydrolase activity,IPR001650 (SMART); IPR014001 (SMART); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011545 (PFAM); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_08622,1116,954,1564,2,0,0,0,0,0,0,1,0,1,0,0,0,0,0,57.87163371,1,-2.730297155,1.155017611,-2.363857598,0.018085763,0.060387648,15.17093081,0,-0.457768569,1.208641239,-0.378746442,0.704876162,0.81434186,52.51421683,1,-1.297534391,1.041088639,-1.246324609,0.212645247,0.340797923,74.9681237,1,-0.248793085,0.639479271,-0.389055747,0.697234909,0.795975132,58.43149461,0,-0.299975726,0.713810889,-0.420245376,0.674306209,0.768413097,N,-,,malonyl -acyl carrier transacylase,C:mitochondrion; P:metabolic process; F:transferase activity,IPR020801 (SMART); G3DSA:3.30.70.250 (GENE3D); IPR001227 (G3DSA:3.40.366.GENE3D); IPR014043 (PFAM); PTHR10982 (PANTHER); PTHR10982:SF13 (PANTHER); IPR016036 (SUPERFAMILY); IPR016035 (SUPERFAMILY),,
RL4_JR_08623,33,50,45,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.612816215,0,2.604010688,1.807124827,1.440968908,0.149593467,NA,0.195753447,0,5.818312541,1.838325981,3.16500588,0.001550798,0.015023052,14.84982067,0,4.984369998,1.049598162,4.74883644,2.05E-06,4.97E-05,0.586162899,0,2.743106383,1.384003115,1.982008821,0.047478253,0.119055056,0.501751895,0,3.080764416,1.239420827,2.485648417,0.012931565,0.038645838,Y,-,,glycoside hydrolase family 6,"F:hydrolase activity, hydrolyzing O-glycosyl compounds; P:cellulose catabolic process",IPR016288 (PRINTS); IPR016288 (G3DSA:3.20.20.GENE3D); IPR016288 (PFAM); IPR016288 (PIRSF); PTHR34876:SF2 (PANTHER); PTHR34876 (PANTHER); IPR016288 (SUPERFAMILY),,
RL4_JR_08624,12,18,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41.33815652,0,-0.105023007,0.763895187,-0.137483531,0.89064861,0.946205412,17.66362934,0,1.331486105,1.122893947,1.185763009,0.235715903,0.386133092,34.53159656,0,-0.420815083,1.037703389,-0.405525401,0.685091351,0.783624996,50.52761383,0,0.375218619,0.68168146,0.550431016,0.58202378,0.708036859,47.56830881,0,0.618801273,0.687558415,0.899998109,0.368121257,0.504497527,Y,-,,OST3 OST6 family,F:zinc ion binding; P:metabolic process; C:integral component of membrane; F:transferase activity,IPR021149 (PFAM); PTHR12692 (PANTHER); PTHR12692:SF0 (PANTHER),1.A.76.1.14, the magnesium transporter1 (magt1) family.
RL4_JR_08625,35,48,28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.87884531,0,0.565800199,1.157188973,0.488943649,0.624881593,0.785174421,1.564433883,0,2.81998182,1.362973175,2.068992898,0.038546753,0.096148407,4.036581503,0,0.17610502,1.215692633,0.144859823,0.884821548,0.928475679,33.5611284,0,2.102227554,0.864570683,2.431527688,0.015035299,0.065631958,3.953883403,0,0.10291689,1.207510807,0.085230616,0.932078051,0.955578196,N,-,,viral a-type inclusion,,no IPS match,,
RL4_JR_08626,18,30,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,183.6765266,0,3.193468112,0.365318424,8.741601578,2.30E-18,2.34E-16,33.49877025,0,3.222226393,0.860913857,3.742797685,0.000181983,0.007974153,26.87806408,0,0.214620305,1.030076525,0.208353749,0.834952767,0.893825473,48.10315047,0,1.673830312,0.542605022,3.084804312,0.002036861,0.013409115,35.74751928,0,0.541023092,0.832367514,0.649981028,0.515704477,0.641620524,N,-,,short-chain dehydrogenase,,IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24320 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_08627,19,11,11,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,78.06802298,0,-0.720189449,0.688146887,-1.046563549,0.295300921,0.480467673,16.06553043,0,-0.540422406,1.205296329,-0.448373062,0.65388398,0.77674142,63.96480613,0,-1.364750097,1.03546071,-1.318012439,0.187499484,0.309664727,77.95304669,0,-0.327362024,0.633716615,-0.516574785,0.605453021,0.72590656,59.97993724,1,-1.060402284,0.85588509,-1.238954033,0.215362522,0.340231788,N,-,,ribosomal rna large subunit methyltransferase j,,IPR029063 (G3DSA:3.40.50.GENE3D); IPR002877 (PFAM); IPR015507 (PANTHER); IPR015507 (HAMAP); IPR029063 (SUPERFAMILY),,
RL4_JR_08628,57,46,114,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,774.7961333,0,-1.081697172,0.569477339,-1.899456041,0.057504541,0.14747628,217.6041493,0,-2.284713434,1.003498765,-2.276747629,0.022801301,0.063861307,481.4861461,0,-3.463115819,0.718303109,-4.821245757,1.43E-06,3.65E-05,589.4630853,0,-2.442361298,0.718621551,-3.398675276,0.000677131,0.005343685,498.0348195,0,-2.523736298,0.721598768,-3.497423237,0.000469776,0.002571071,N,-,,60S ribosomal L18,F:RNA binding; F:structural constituent of ribosome; C:cytosolic large ribosomal subunit; P:translation,G3DSA:3.100.10.10 (GENE3D); IPR021131 (PFAM); IPR000039 (PANTHER); IPR021131 (SUPERFAMILY),,
RL4_JR_08629,112,99,106,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.983684865,0,-1.269670862,1.206666564,-1.052213511,0.292701602,0.477763039,2.850328526,0,1.954322327,1.280932188,1.525703191,0.127083799,0.243440995,7.423782379,0,-0.703301196,1.204177847,-0.584050934,0.559186045,0.685126409,21.89012263,0,0.608763692,1.024246426,0.594352761,0.552276197,0.681344766,7.348767858,0,-0.791224589,1.212096087,-0.652773816,0.513902106,0.639692504,N,-,,mitochondrial carrier,F:structural constituent of ribosome; C:mitochondrion; C:integral component of membrane; F:3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity; F:5'-adenylyl sulfate transmembrane transporter activity; P:5'-adenylyl sulfate transmembrane transport; P:translation; P:3'-phospho-5'-adenylyl sulfate transmembrane transport,IPR002067 (PRINTS); IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); PTHR24089:SF92 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.23.9, the mitochondrial carrier (mc) family.
RL4_JR_08630,411,277,418,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,306.246153,0,-1.903518795,0.488024815,-3.900454932,9.60E-05,0.000826231,117.7683571,0,-1.924492581,1.105024655,-1.741583387,0.08158137,0.172863017,274.8718317,0,-1.672968755,0.541567888,-3.089121035,0.002007496,0.009875555,256.8509782,0,-4.179980801,1.014087401,-4.121913749,3.76E-05,0.00045561,219.4297654,0,-2.989024061,0.772233332,-3.870622954,0.000108558,0.000741664,N,-,,pre-mrna splicing factor,F:nucleotide binding; F:nucleic acid binding,IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR23147:SF1 (PANTHER); PTHR23147 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),,
RL4_JR_08631,1481,630,544,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,600.5533481,0,-1.30536213,0.894076788,-1.460011207,0.144286994,0.288845703,192.5663183,0,-0.574110686,0.787272366,-0.729240237,0.465854722,0.62471933,1402.265261,0,1.602053068,0.661919131,2.420315403,0.01550705,0.045677445,814.7728856,0,0.014530954,0.493974528,0.029416403,0.976532491,0.985736391,824.0312779,0,0.529920041,0.9378621,0.565029807,0.57205349,0.687645921,N,-,,mboat family,C:endoplasmic reticulum membrane; F:ergosterol O-acyltransferase activity; P:ergosterol metabolic process,IPR004299 (PFAM); PTHR10408:SF9 (PANTHER); PTHR10408:SF9 (PANTHER); IPR014371 (PANTHER); IPR014371 (PANTHER),,
RL4_JR_08632,200,12,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,784.3499315,0,-0.047955849,0.546401548,-0.087766679,0.930062122,0.966266756,164.6641312,0,-0.972024077,0.81564627,-1.19172258,0.233370041,0.383469408,448.2195972,0,-1.596881428,0.508352605,-3.141287,0.001682071,0.008644309,510.7934768,0,-1.477297003,0.426054019,-3.467393657,0.000525532,0.004354344,458.9707294,0,-0.992916981,0.759702084,-1.306982041,0.191218811,0.311348144,N,-,,fimbrin,"P:mitotic actomyosin contractile ring assembly; P:endocytosis; P:ascospore formation; P:actin crosslink formation; P:negative regulation of actin filament depolymerization; C:actomyosin contractile ring; F:actin binding; C:actin filament bundle; P:establishment or maintenance of cell polarity regulating cell shape; F:protein binding, bridging; C:actin cortical patch; P:actin filament bundle assembly; P:actin cortical patch localization",IPR001715 (SMART); IPR001715 (G3DSA:1.10.418.GENE3D); IPR011992 (G3DSA:1.10.238.GENE3D); IPR001715 (G3DSA:1.10.418.GENE3D); IPR001715 (PFAM); PTHR19961 (PANTHER); PTHR19961:SF36 (PANTHER); IPR001715 (PROSITE_PROFILES); IPR001715 (PROSITE_PROFILES); IPR001715 (PROSITE_PROFILES); IPR001715 (PROSITE_PROFILES); IPR011992 (SUPERFAMILY); IPR001715 (SUPERFAMILY),8.A.66.1.2, the dystrophin (dystrophin) family.
RL4_JR_08633,473602,2375,64013,0,10,8,0,0,0,0,0,0,1,0,0,0,0,5,69.7634855,1,-0.029497373,0.695937834,-0.042385069,0.966191731,0.982922264,10.19646105,0,0.115489045,1.230228295,0.093876109,0.925207573,0.958737823,26.47556925,0,-2.537667668,1.203126805,-2.109227104,0.034924983,0.086197107,30.54216787,1,-2.959975578,1.203550824,-2.459368993,0.013918148,0.063052015,26.15448648,1,-2.62279114,1.209512071,-2.168470412,0.030122913,0.075381735,N,-,,ring finger partial,P:biological_process; F:zinc ion binding; F:metal ion binding; F:electron carrier activity; C:cellular_component; F:heme binding,no IPS match,,
RL4_JR_08634,20577,4398,21505,6,0,0,0,0,0,0,0,0,1,1,0,0,0,0,118.0222014,1,0.425618431,0.516987067,0.823267076,0.410356132,0.601739769,26.3420649,0,0.297799712,1.120498267,0.265774362,0.79041299,0.87373468,50.64423743,0,-2.313417851,1.19822252,-1.930708039,0.053519168,0.119161658,60.57393385,1,-2.747205504,1.15245518,-2.383785115,0.017135605,0.071105738,87.82613463,0,0.064426024,1.39522766,0.046175994,0.963169976,0.975749495,N,-,,DDHD domain-containing,C:mitochondrion; C:membrane,IPR004177 (SMART); IPR004177 (PFAM); PTHR23509 (PANTHER); PTHR23509:SF10 (PANTHER); PTHR23509 (PANTHER); PTHR23509:SF10 (PANTHER); PTHR23509 (PANTHER); PTHR23509:SF10 (PANTHER); PTHR23509:SF10 (PANTHER); IPR004177 (PROSITE_PROFILES),,
RL4_JR_08635,531,983,584,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,510.0593803,0,-1.620196107,0.436906417,-3.708336716,0.000208625,0.001598088,130.4530126,0,-2.537019605,1.113191034,-2.279051419,0.022664009,0.063582344,360.89737,0,-2.705071492,0.640413023,-4.223948287,2.40E-05,0.000390106,401.0798243,0,-2.849337869,0.57921988,-4.919268085,8.69E-07,1.61E-05,357.3250203,0,-2.318188435,0.573892295,-4.039413764,5.36E-05,0.000412898,N,-,,DNA-directed RNA polymerase III subunit RPC1,F:DNA binding; F:DNA-directed RNA polymerase activity; C:cytoplasm; P:tRNA transcription from RNA polymerase III promoter; C:DNA-directed RNA polymerase III complex,IPR006592 (SMART); G3DSA:2.40.40.20 (GENE3D); IPR007066 (PFAM); IPR007080 (PFAM); IPR007083 (PFAM); IPR007081 (PFAM); G3DSA:3.30.1490.180 (GENE3D); IPR000722 (PFAM); PTHR19376:SF32 (PANTHER); PTHR19376 (PANTHER); SSF64484 (SUPERFAMILY),,
RL4_JR_08636,516,399,503,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,579.951038,0,-1.485908266,1.120564986,-1.326034889,0.184828141,0.342221511,148.3139457,0,-2.735580308,1.113886084,-2.455888754,0.014053666,0.043756137,672.6027531,0,-0.166560241,0.32023695,-0.520115623,0.60298299,0.720646888,533.3495449,0,-1.558845065,0.471407095,-3.306791691,0.00094371,0.007056919,619.9170451,0,-0.273379241,0.717017282,-0.381272876,0.703000778,0.789822778,N,-,,mitochondrial distribution and morphology 34,C:integral component of membrane; C:mitochondrial membrane part; C:mitochondrial outer membrane; P:mitochondrion organization,PTHR28185 (PANTHER); PTHR28185:SF1 (PANTHER); IPR027536 (HAMAP),9.A.58.1.1, the maintenance of mitochondrial morphology (mmm) family.
RL4_JR_08637,1727,1958,2387,0,1,1,0,0,0,1,2,0,1,3,0,0,2,2,20.78860233,1,0.469172201,1.006290267,0.46623943,0.641044129,0.795866383,2.856198097,0,1.951411672,1.27200104,1.534127419,0.124998309,0.24049285,7.414563137,1,-0.701436079,1.193198422,-0.587862058,0.556624886,0.683145878,8.553931944,1,-1.123837272,1.190586959,-0.943935479,0.34520262,0.491991034,7.313755648,1,-0.784346559,1.196303223,-0.655641934,0.512054538,0.638255841,N,-,,serine threonine- kinase,,G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24362 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_08638,1276,1109,1903,0,0,0,0,0,0,0,0,0,2,1,1,0,3,1,2.479207501,0,0.587749276,1.243181093,0.472778487,0.636371224,0.792413799,0.789364276,0,3.806713229,1.439008446,2.645372402,0.008160106,0.029019308,2.051115295,0,1.152375538,1.213183256,0.949877549,0.342174476,0.485586542,2.366425033,1,0.729948605,1.22045164,0.598097115,0.549775135,0.679003811,2.025510757,1,1.068049456,1.20996482,0.882711165,0.377392348,0.513149248,N,-,,hypothetical protein FAVG1_09620,,IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (SUPERFAMILY),,
RL4_JR_08639,191,192,172,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,10.48995497,0,1.537757423,1.15620469,1.330004485,0.183516794,0.34134291,0.793890026,0,3.798478006,1.457984508,2.605293804,0.009179551,0.031625396,2.057609349,0,1.147720367,1.22564871,0.936418697,0.349057655,0.492779056,2.373400732,1,0.725609832,1.236227248,0.586955055,0.557233893,0.686040025,25.19176932,0,4.223384669,0.666909602,6.332769324,2.41E-10,1.57E-08,N,-,,Inositol-pentakisphosphate 2-kinase,P:inositol phosphate biosynthetic process; P:biological_process; F:ATP binding; F:inositol pentakisphosphate 2-kinase activity; C:cytosol; P:phosphorylation; F:kinase activity,IPR009286 (PFAM),,
RL4_JR_08640,17,9,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.47340225,0,3.708042416,0.870439216,4.259967093,2.04E-05,0.000213668,0.465056832,0,4.570115452,1.593632149,2.867735477,0.00413421,0.018371529,1.199692434,0,1.926295104,1.248225315,1.543227078,0.12277569,0.225791296,1.383424503,0,1.504527556,1.279481292,1.175888671,0.239639367,0.37770059,1.176724405,0,1.850915269,1.227935995,1.507338556,0.131723899,0.234683175,N,-,,---NA---,,no IPS match,,
RL4_JR_08641,7,4,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47.33742852,0,0.629948521,0.680317101,0.925963083,0.354465166,0.545268562,6.323690289,0,0.804700438,1.234642601,0.651767918,0.514550901,0.665261188,22.94183493,0,-0.888746061,1.196225763,-0.742958468,0.457506825,0.595500013,46.9077771,0,0.06570957,0.856200881,0.076745506,0.938826003,0.963977274,27.84093878,0,0.257376471,0.864566127,0.297694373,0.765936438,0.837122888,N,-,,nucleoside transporter,P:nucleobase transport; C:fungal-type vacuole membrane; C:integral component of membrane; P:nucleoside transmembrane transport; P:nicotinamide riboside transport; F:nicotinamide riboside transmembrane transporter activity; F:nucleobase transmembrane transporter activity,IPR002259 (PRINTS); IPR002259 (PIRSF); IPR002259 (PFAM); IPR002259 (PANTHER); PTHR10332:SF10 (PANTHER); PTHR10332:SF10 (PANTHER); IPR002259 (PANTHER); IPR020846 (SUPERFAMILY),2.A.57.3.1, the equilibrative nucleoside transporter (ent) family.
RL4_JR_08642,192,154,204,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.238171301,0,3.967699923,2.783398604,1.425487502,0.15401633,NA,0.075544412,0,7.192101399,2.233374835,3.220284068,0.001280636,0.015023052,6.695102769,0,5.501819805,1.231040358,4.469244059,7.85E-06,0.000154611,0.226587988,0,4.114921052,1.764682731,2.331819187,0.019710205,0.076371876,0.193613652,0,4.4569547,1.277160304,3.489737886,0.000483495,0.002631926,N,-,,---NA---,,no IPS match,,
RL4_JR_08643,141,144,204,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,56.40405871,0,0.083758724,0.703560323,0.119049812,0.905235892,0.953753637,9.171220394,0,0.268336648,1.228392323,0.218445397,0.827082098,0.896234343,57.12335126,0,0.038174084,0.865906703,0.044085678,0.964836109,0.979398575,36.90687638,0,-1.862334096,1.157302812,-1.609202083,0.107572161,0.207144947,23.71146614,0,-2.481287281,1.214431617,-2.043167559,0.041035854,0.096022191,N,-,,Pinin SDK partial,P:single-organism process,IPR006786 (PFAM),3.A.22.1.1, the transcription-coupled trex/tap nuclear mrna export complex (trex) family.
RL4_JR_08644,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.92831718,0,-1.794622491,1.193808699,-1.503274764,0.132768205,0.271187535,4.122728766,0,1.421944341,1.254247015,1.133703588,0.256918904,0.4123249,34.22078674,0,1.179785087,0.852371749,1.384120353,0.166321606,0.283236322,43.63993147,0,1.398867634,0.670116584,2.087498901,0.03684306,0.1019224,10.52881263,0,-1.309978137,1.196214289,-1.095103234,0.273471412,0.406317673,N,-, Effector probability:0.971,pre-mRNA splicing factor ini1,P:response to xenobiotic stimulus; C:U2 snRNP; P:spliceosomal complex assembly,IPR005345 (PIRSF); IPR005345 (PFAM); IPR005345 (PANTHER),,
RL4_JR_08645,1370,1762,908,0,0,2,0,0,0,0,0,11,5,19,1,0,12,6,32.52373613,1,-0.218277507,0.891477081,-0.244849264,0.806573147,0.901743694,6.707045866,0,0.719780732,1.249945283,0.575849793,0.564716714,0.707258424,48.82533833,1,0.888374761,0.772983156,1.14928088,0.25044018,0.385444874,33.4607894,1,-0.623686242,1.037355923,-0.601226858,0.547688898,0.677501539,39.37943365,1,0.228686774,0.875611466,0.2611738,0.793958481,0.860467656,N,-,,peroxin 26,C:membrane,no IPS match,,
RL4_JR_08646,11,17,9,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,46.39261556,0,2.063602401,0.538935434,3.829034557,0.000128647,0.001059033,3.721561261,0,1.569643073,1.258371596,1.247360539,0.212265329,0.35848161,9.64394109,0,-1.080542744,1.192673351,-0.905983808,0.364944423,0.508981586,47.22924679,0,2.360675439,0.520790487,4.532869738,5.82E-06,8.86E-05,24.93322785,1,1.452310672,0.746796482,1.944720826,0.051808588,0.115128706,N,-,,Cytochrome b561 ferric reductase transmembrane,C:membrane; C:integral component of membrane; P:oxidation-reduction process,IPR006593 (SMART); PTHR15459 (PANTHER); PTHR15459:SF2 (PANTHER),5.B.2.3.5, the eukaryotic cytochrome b561 (cytb561) family.
RL4_JR_08647,1,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.190338003,0,-0.948209776,1.221042763,-0.776557386,0.437419952,0.627368489,2.283709224,0,2.274145387,1.31410937,1.73056021,0.083530234,0.175924475,5.935398971,0,-0.380274346,1.21333836,-0.313411624,0.753967954,0.834956418,6.848433038,0,-0.802865074,1.21384872,-0.661421033,0.508342341,0.644014791,5.855137549,0,-0.46335266,1.216721036,-0.380820785,0.703336235,0.790077162,N,-,,mind kinetochore complex component,,IPR007128 (PFAM),,
RL4_JR_08648,263,561,511,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,226.7269528,0,2.55050142,0.649014823,3.929804574,8.50E-05,0.000742561,47.34416629,0,2.742011259,0.782717344,3.503194709,0.000459713,0.015023052,31.99472993,0,-1.521365209,1.200290931,-1.267497045,0.20497762,0.331394669,79.02124634,0,0.645280794,0.596106456,1.082492544,0.279033727,0.422430694,32.46143657,0,-1.626865576,1.132032615,-1.437118997,0.150684184,0.259733974,N,-,,PH domain-containing,,IPR011993 (G3DSA:2.30.29.GENE3D); PTHR37283:SF1 (PANTHER); PTHR37283 (PANTHER); IPR011993 (SUPERFAMILY),,
RL4_JR_08649,572,561,668,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,643.1550227,0,-1.723880772,0.475689168,-3.623964741,0.000290121,0.002116439,158.4994029,0,-3.842817397,1.205565711,-3.187563616,0.001434769,0.015023052,456.4176361,0,-3.08743146,0.648462016,-4.761160077,1.92E-06,4.73E-05,523.6611696,1,-3.363139582,0.598548157,-5.618828731,1.92E-08,5.08E-07,439.5317423,1,-2.951682952,0.697339874,-4.232775238,2.31E-05,0.000202698,N,-,,ntf2 and rrm domain-containing,F:organic cyclic compound binding; F:heterocyclic compound binding,IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR032710 (G3DSA:3.10.450.GENE3D); IPR002075 (PFAM); PTHR10693 (PANTHER); PTHR10693:SF20 (PANTHER); IPR018222 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR032710 (SUPERFAMILY); IPR012677 (SUPERFAMILY),,
RL4_JR_08650,2214,1876,1944,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,0.647228789,1,2.525274643,1.757185291,1.437113465,0.150685756,NA,0.205641722,0,5.747192795,1.810610543,3.174173937,0.001502636,0.015023052,0.535190146,0,3.090342918,1.266247407,2.440552219,0.014664826,0.043628179,0.617518083,0,2.668026318,1.36251471,1.958163313,0.050210853,0.123454318,0.52944845,1,3.00399618,1.234549411,2.43327335,0.014963,0.043484608,N,-,,---NA---,,no IPS match,,
RL4_JR_08651,4070,3333,3693,0,0,7,0,0,1,2,0,2,0,6,0,0,3,0,0.581094225,1,2.68084228,1.842640165,1.454891916,0.145699186,NA,0.186802458,1,5.886088692,1.858345672,3.167380956,0.001538187,0.015023052,0.482107784,1,3.242056559,1.275679466,2.54143509,0.011039844,0.035403036,0.55599397,1,2.819875609,1.389086477,2.030021641,0.04235434,0.111790289,0.472580108,1,3.16718706,1.228546434,2.577995404,0.009937532,0.031228278,N,-, Effector probability:0.746,---NA---,,no IPS match,,
RL4_JR_08652,1038,1148,964,0,0,6,0,0,0,0,1,2,0,0,0,0,13,0,91.77882501,1,-1.26583809,0.687597499,-1.84095796,0.06562772,0.162881332,23.29439648,0,-1.076360758,1.207536229,-0.891369329,0.372731066,0.537287125,501.6316544,1,2.917380331,0.596822906,4.888184252,1.02E-06,2.75E-05,380.1396303,0,2.057852177,0.437790835,4.70053736,2.59E-06,4.26E-05,85.77289649,1,-0.602914528,0.620599967,-0.971502674,0.331298022,0.4679903,N,-,,rta1 domain,C:integral component of membrane; P:response to stress,IPR007568 (PFAM); PTHR31465 (PANTHER); PTHR31465:SF1 (PANTHER),9.A.26.1.1, the lipid-translocating exporter (lte) family.
RL4_JR_08653,3386,3643,3449,0,0,15,0,0,3,0,1,13,0,15,3,0,5,0,159.4804364,1,4.182673048,0.792659795,5.276756905,1.31E-07,2.55E-06,381.2710894,1,6.924728818,0.488069053,14.18801043,1.09E-45,3.67E-42,10280.22218,1,10.41883647,0.479211657,21.74161734,8.29E-105,2.80E-101,4108.276663,1,8.891344387,0.25009915,35.55127785,7.94E-277,8.04E-273,1188.820765,1,7.346254315,0.696508282,10.54726054,5.23E-26,1.96E-23,Y,-, Effector probability:0.778,NPP1 domain,P:biological_process; C:cellular_component; F:molecular_function,IPR008701 (PFAM); IPR008701 (PIRSF); PTHR33657 (PANTHER); PTHR33657:SF8 (PANTHER),,
RL4_JR_08654,16,22,26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,146.1441266,0,-1.067695057,0.536050693,-1.991780014,0.0463952,0.125828471,33.02847067,0,-1.580100057,1.199982347,-1.316769419,0.187915926,0.328398655,112.7547254,0,-1.409175814,0.742314917,-1.898353088,0.057649585,0.126111581,224.0588602,0,0.331638263,0.36929594,0.898028457,0.369170378,0.514987936,128.8284327,0,-0.677965274,0.536623718,-1.263390438,0.206448899,0.329428099,N,-,,C6 zinc finger domain-containing,"C:nucleus; F:zinc ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; P:transport; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PTHR38791 (PANTHER),,
RL4_JR_08655,69,84,97,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,64.34488256,1,0.231044845,0.675727387,0.341920202,0.732410946,0.858724992,8.429094325,0,0.390107564,1.218118801,0.320254119,0.748775701,0.846203649,21.92006775,1,-2.265241664,1.192699968,-1.899255239,0.057530925,0.12596126,29.3028142,0,-1.740694429,1.14450021,-1.520921022,0.128279658,0.236280068,21.66133943,0,-2.350808377,1.199323485,-1.960112018,0.049982699,0.112087448,N,-,,monolysocardiolipin acyltransferase,"F:transferase activity, transferring acyl groups; P:phospholipid metabolic process",IPR000872 (PRINTS); IPR002123 (SMART); IPR002123 (PFAM); IPR000872 (PANTHER); PTHR12497:SF0 (PANTHER); SSF69593 (SUPERFAMILY),,
RL4_JR_08656,106,44,66,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7.08592054,1,-0.927382057,1.230888637,-0.753424826,0.451194669,0.640125733,2.240919543,0,2.301309367,1.319763594,1.743728481,0.081206447,0.172176718,5.85252701,0,-0.360278446,1.221141907,-0.295034053,0.767967867,0.844036593,6.754157773,0,-0.783142422,1.223048083,-0.640320223,0.521964436,0.656752816,5.812494658,0,-0.452891159,1.232087425,-0.367580376,0.71318615,0.797901632,N,-,,Trafficking particle complex subunit 2,P:ER to Golgi vesicle-mediated transport; C:cytoplasm,G3DSA:3.30.450.70 (GENE3D); IPR006722 (PFAM); IPR006722 (PANTHER); IPR011012 (SUPERFAMILY),,
RL4_JR_08657,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37.5725412,0,-0.25314166,0.878252752,-0.288233267,0.773168185,0.882045316,83.61988033,0,2.342261252,0.985223884,2.37738984,0.01743565,0.051694098,24.61789419,0,-1.028755761,1.203333064,-0.854921876,0.392594399,0.535880503,36.95509549,0,0.282203017,0.77727007,0.363069451,0.716553005,0.810388391,32.69678641,0,-0.381810945,0.995029596,-0.38371818,0.701187337,0.788398531,N,-,,O-glucosyltransferase rumi,C:membrane; C:endomembrane system; F:glucosyltransferase activity; P:glycolipid metabolic process,IPR006598 (SMART); IPR006598 (PFAM); PTHR12203:SF25 (PANTHER); PTHR12203:SF25 (PANTHER); PTHR12203 (PANTHER),,
RL4_JR_08658,14254,15967,9634,28,67,57,4,0,5,11,5,14,6,10,32,8,27,10,193.3851655,1,-0.50507577,0.48457637,-1.042303755,0.297270872,0.483094775,36.66462392,1,-1.730775572,1.20693514,-1.434025338,0.151565032,0.278782711,107.7521798,1,-2.559004461,1.040199687,-2.460108856,0.013889488,0.041769555,221.6485934,1,0.210959726,0.405242472,0.520576545,0.602661792,0.72393502,119.9817669,1,-1.063283581,0.603734176,-1.761178386,0.078208215,0.15843501,N,-,,nuclear pore complex subunit nup133,"P:macromolecular complex subunit organization; C:nuclear pore outer ring; C:nuclear membrane; P:negative regulation of transcription, DNA-templated; C:nuclear periphery; P:organelle organization; P:single-organism process; P:poly(A)+ mRNA export from nucleus",IPR015943 (G3DSA:2.130.10.GENE3D); IPR014908 (PFAM); IPR007187 (PFAM); PTHR13405 (PANTHER); PTHR13405:SF11 (PANTHER); SSF117289 (SUPERFAMILY),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_08659,2498,1450,2255,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,182.8358241,0,-0.627350375,0.977916157,-0.641517547,0.521186484,0.705699475,65.80580131,0,0.419123607,0.844044253,0.496565915,0.619495194,0.749794375,119.8603777,0,-2.013413402,0.845393747,-2.38162798,0.0172363,0.049885736,163.7156926,0,-0.805110016,0.480390361,-1.675949564,0.093748072,0.186556453,137.6522932,0,-0.883295725,0.542182361,-1.629148768,0.103281529,0.195645554,N,-,,CK1 CK1 CK1-G kinase,F:ATP binding; F:protein serine/threonine kinase activity; P:protein phosphorylation,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR11909 (PANTHER); PTHR11909 (PANTHER); PTHR11909:SF155 (PANTHER); PTHR11909:SF155 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_08660,3046,2234,3371,0,2,0,0,0,0,0,0,0,3,0,0,0,0,0,111.5256153,1,0.477529741,0.744264919,0.641612588,0.521124758,0.705699475,16.33419206,0,-0.564361523,1.234262823,-0.457245825,0.647494364,0.771959712,76.59233661,0,-0.108575013,0.729375909,-0.148860158,0.881663981,0.926169183,146.6264431,1,0.985906718,0.541234627,1.821588398,0.068517463,0.148615962,70.1658623,0,-0.710736107,0.821694233,-0.864964215,0.38705843,0.52301703,Y,-,,emp24 gp25l p24 family gold,C:endoplasmic reticulum membrane; C:integral component of membrane; C:Golgi apparatus; P:transport,IPR009038 (SMART); IPR009038 (PFAM); IPR015720 (PANTHER); PTHR22811:SF14 (PANTHER); IPR009038 (PROSITE_PROFILES),9.B.188.1.4, the transmembrane emp24 domain-containing protein (tmed) family.
RL4_JR_08661,2944,1211,1885,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,131.4538456,0,-1.111451058,0.680531711,-1.633209797,0.10242488,0.22565006,51.36028206,0,-0.465545453,1.137534251,-0.409258405,0.682350037,0.798006594,111.1849333,1,-1.227889753,0.79157287,-1.551202422,0.120853182,0.222984803,158.9108245,0,-0.582358936,0.683356949,-0.852203138,0.394101356,0.538888738,83.45020986,0,-2.508842544,1.037588455,-2.417955338,0.015607992,0.044839195,N,-,,swr1-complex 4,P:cellular macromolecule metabolic process; C:nuclear lumen; C:protein complex; P:chromatin organization; P:primary metabolic process,IPR032563 (PFAM); IPR027109 (PANTHER); IPR027109 (PANTHER); PTHR12855:SF10 (PANTHER),,
RL4_JR_08662,1,3,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,162.0265357,0,-1.43588712,0.783104184,-1.833583767,0.066715804,0.165129711,41.30114009,0,-1.902574058,1.237394073,-1.537565194,0.124154963,0.239234064,153.1742735,0,-1.144405422,1.328085565,-0.861695551,0.388855075,0.532643245,217.4071449,0,-0.587891431,0.735005671,-0.799846115,0.423799961,0.566562905,134.39609,0,-1.113577325,0.679803522,-1.63808702,0.101403542,0.193027047,N,-,,nodulation l,"C:nucleus; F:zinc ion binding; F:acetyltransferase activity; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR024688 (SMART); IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001451 (PFAM); G3DSA:2.160.10.10 (GENE3D); IPR001138 (PFAM); IPR024688 (PFAM); PTHR23416 (PANTHER); PTHR23416:SF54 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR011004 (SUPERFAMILY); IPR001138 (SUPERFAMILY),,
RL4_JR_08663,32,25,47,0,0,32,0,0,0,0,0,0,0,16,0,0,4,0,8.838471026,1,-1.245924976,1.218430464,-1.022565516,0.306513321,0.493105043,2.814196416,0,1.972835318,1.301482084,1.515837477,0.129560453,0.246741118,7.299453042,0,-0.678663836,1.212572551,-0.559689262,0.575691408,0.698250847,12.43299417,1,-0.155174986,1.162858069,-0.133442756,0.893843233,0.934644505,7.183607997,1,-0.758382143,1.214015429,-0.624689048,0.532175162,0.655507727,N,-,,fungal specific transcription factor domain-containing,"F:DNA binding; C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; F:copper ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR007219 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31001:SF35 (PANTHER); PTHR31001 (PANTHER); PTHR31001:SF35 (PANTHER); PTHR31001:SF35 (PANTHER); PTHR31001:SF35 (PANTHER); PTHR31001 (PANTHER); PTHR31001 (PANTHER); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_08664,101,71,83,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.65034586,0,-0.644644834,1.010339444,-0.638047775,0.523442581,0.707239648,159.557963,0,4.418095017,1.722036856,2.565621637,0.01029911,0.034269426,35.05246407,0,0.003395986,1.029995831,0.003297087,0.99736931,0.999239715,49.27980712,0,0.80432831,0.668204455,1.203715875,0.228699414,0.365071781,15.92091538,0,-1.906585853,1.196318147,-1.593711386,0.111000693,0.206406247,N,-,,adaptor complexes medium subunit family,C:AP-type membrane coat adaptor complex; P:vesicle-mediated transport; P:intracellular protein transport,G3DSA:3.30.450.60 (GENE3D); G3DSA:2.60.40.1170 (GENE3D); IPR028565 (PFAM); IPR001392 (PIRSF); PTHR10529 (PANTHER); PTHR10529:SF212 (PANTHER); IPR028565 (PROSITE_PROFILES); IPR028565 (SUPERFAMILY); IPR011012 (SUPERFAMILY),9.B.278.1.1, the organellar-targeting adaptor protein complex (o-apc) family.
RL4_JR_08665,255,240,208,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.81402424,0,-1.537333226,1.197134935,-1.284177064,0.199080009,0.36219775,3.445184281,0,1.680885647,1.266035968,1.327676061,0.184285145,0.323821535,34.94920046,0,1.839500253,0.751931291,2.446367476,0.014430384,0.043057237,10.3305808,0,-1.396205932,1.197869995,-1.165573841,0.243786789,0.381977908,23.58075292,0,0.632419309,0.982035623,0.643988154,0.519583116,0.644234148,N,-, Effector probability:0.718,exosome complex exonuclease,P:nucleic acid phosphodiester bond hydrolysis; F:exonuclease activity; C:integral component of membrane,IPR028036 (PFAM); PTHR28048:SF1 (PANTHER); PTHR28048 (PANTHER),,
RL4_JR_08666,129,122,106,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.25815187,1,-1.461060143,1.239394619,-1.178849836,0.238457976,0.412760485,3.233822539,0,1.772173438,1.304074376,1.3589512,0.174162053,0.31009117,19.5300045,0,0.069983751,1.220727563,0.057329541,0.954282688,0.973710737,9.764611507,0,-1.314847288,1.230249688,-1.068764578,0.285175764,0.429417141,8.413442874,0,-0.98642832,1.241297913,-0.79467492,0.426802625,0.561436479,N,-,,exosome complex exonuclease rrp4,"C:cytoplasmic exosome (RNase complex); C:nuclear exosome (RNase complex); P:polyadenylation-dependent snoRNA 3'-end processing; F:RNA binding; P:U4 snRNA 3'-end processing; P:nuclear polyadenylation-dependent rRNA catabolic process; F:exonuclease activity; C:membrane; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'",IPR025721 (PFAM); IPR026699 (PANTHER); PTHR21321:SF4 (PANTHER); IPR026699 (PANTHER); PTHR21321:SF4 (PANTHER); IPR026699 (PANTHER); PTHR21321:SF4 (PANTHER); SSF110324 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR004088 (SUPERFAMILY),,
RL4_JR_08667,384,337,308,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein BN1723_001165,,no IPS match,,
RL4_JR_08668,811,1124,1174,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,55.88217183,0,2.586045382,0.770270172,3.357322502,0.000787013,0.004901106,3.203916617,1,1.785606498,1.294228644,1.379668505,0.167688734,0.30158944,52.61554434,0,2.220729456,1.298571905,1.710132067,0.087241454,0.174345141,21.6517828,0,0.989602177,0.893779978,1.107210053,0.268203122,0.409462697,30.70498678,0,1.666978653,0.790160709,2.109670393,0.034886756,0.084625877,N,-,,kinase-like domain,P:phosphorylation; F:kinase activity,no IPS match,,
RL4_JR_08669,14,20,17,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,145.4823013,1,2.999808571,0.696602312,4.306343113,1.66E-05,0.000179342,53.29587973,0,2.641881003,0.995277486,2.654416524,0.007944569,0.02841517,173.4986656,0,3.538074015,0.391352846,9.040624215,1.56E-19,2.32E-17,288.6900552,0,4.138418226,0.597954132,6.920962673,4.49E-12,1.94E-10,117.6798974,0,2.930643627,0.741128677,3.954297973,7.68E-05,0.000556329,N,-,,fatty aldehyde dehydrogenase,,IPR016162 (G3DSA:3.40.605.GENE3D); IPR016163 (G3DSA:3.40.309.GENE3D); IPR015590 (PFAM); PTHR11699 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_08670,7,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,105.2824863,0,-0.258944815,0.653341391,-0.396339216,0.691854801,0.832347952,64.38272287,0,0.854053057,1.010745526,0.844973373,0.398125706,0.562197041,83.59479721,0,-0.68112553,0.794487251,-0.857314612,0.391271035,0.534769368,115.849105,0,-0.308379478,0.680550642,-0.4531323,0.650453478,0.760625445,66.54431321,0,-1.398862052,0.912432189,-1.53311344,0.125247907,0.226139241,N,-,,37S ribosomal,F:structural constituent of ribosome; C:mitochondrion; P:mitochondrial translation; C:ribosome,IPR019349 (PFAM); PTHR13490 (PANTHER),,
RL4_JR_08671,447,375,519,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.284529053,0,-0.201614852,1.272318022,-0.158462624,0.87409227,0.939103212,1.352134299,0,3.030112433,1.397426626,2.168351723,0.030131936,0.07934325,3.538103733,0,0.365697234,1.243064973,0.294189959,0.768612753,0.844431417,4.083556944,0,-0.057270108,1.251609992,-0.045757151,0.963503811,0.978974018,3.522366626,0,0.269725286,1.253750951,0.215134661,0.829662331,0.885461702,N,-,,glycosyltransferase family 28 domain-containing,,IPR007235 (PFAM); G3DSA:3.40.50.2000 (GENE3D); PTHR12867 (PANTHER); PTHR12867:SF6 (PANTHER); SSF53756 (SUPERFAMILY),,
RL4_JR_08672,7196,13509,20343,0,0,7,0,0,0,0,0,0,0,3,0,0,2,0,149.6634341,1,1.063882855,0.532792427,1.996805513,0.045846314,0.124671411,14.00427023,0,-0.342272025,1.223973421,-0.27964008,0.779753654,0.866847621,62.38752512,0,-0.190318008,0.772504168,-0.246365025,0.805399678,0.872554322,97.36561932,1,0.707173768,0.535962065,1.319447429,0.187019575,0.31497203,35.89148012,1,-3.07932632,1.209407758,-2.546144012,0.010892024,0.033642998,N,-,,WD domain-containing,C:nucleus; P:actin filament depolymerization; C:mating projection tip; C:actin cortical patch,IPR020472 (PRINTS); IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR19856:SF0 (PANTHER); PTHR19856 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR011044 (SUPERFAMILY); IPR017986 (SUPERFAMILY),1.A.4.1.14, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_08673,2560,2089,2814,4,0,4,0,0,0,0,0,0,0,5,0,0,6,0,119.1809188,1,0.635424509,0.568164272,1.118381673,0.263404018,0.443234406,16.96578095,0,-0.619076014,1.208845341,-0.512121768,0.608565791,0.741710166,72.84135192,0,-0.860897681,0.861918744,-0.998815361,0.317884143,0.460540794,75.07648965,1,-0.434883348,0.655162983,-0.663778876,0.506831847,0.642905594,70.78482036,1,-0.004657336,0.641558272,-0.007259412,0.994207878,0.995527725,N,-, Effector probability:0.707,polyadenylate-binding 2,C:polysome; F:nucleotide binding; C:nuclear chromatin; C:cytoplasm; F:poly(A) binding; C:nucleolus; C:Mmi1 nuclear focus complex; P:nuclear-transcribed mRNA poly(A) tail shortening; C:nucleoplasm,IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR24012:SF436 (PANTHER); PTHR24012 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),9.A.60.1.1, the small nuclear rna exporter (snrna-e).
RL4_JR_08674,1338,1073,1365,0,0,2,0,0,0,1,0,0,0,0,0,0,0,0,189.1447922,1,-3.159500618,0.88102037,-3.58618339,0.000335553,0.002380193,53.9891224,0,-2.289067027,1.21865048,-1.878362225,0.060331629,0.136647293,260.1035711,1,-0.348022367,0.549384855,-0.633476448,0.526422556,0.656072876,312.8426889,0,-0.125432821,0.444681829,-0.282073187,0.777887392,0.856564421,240.9881125,0,-0.150682064,0.460749376,-0.327036935,0.74363995,0.820950345,N,-,,e3 ubiquitin- ligase hula,C:Golgi apparatus; P:positive regulation of transcription from RNA polymerase II promoter; P:positive regulation of fatty acid biosynthetic process; P:ubiquitin-dependent endocytosis; F:ubiquitin binding; P:regulation of phosphate metabolic process; P:regulation of ergosterol biosynthetic process; P:cellular response to UV; C:extrinsic component of cytoplasmic side of plasma membrane; P:regulation of rRNA processing; P:regulation of dolichol biosynthetic process; P:regulation of tRNA export from nucleus; P:regulation of mRNA export from nucleus; P:positive regulation of receptor-mediated endocytosis; F:ligase activity; P:regulation of multivesicular body size; P:regulation of ubiquinone biosynthetic process; P:protein autoubiquitination; P:regulation of tRNA processing; P:regulation of protein localization; P:protein polyubiquitination; F:phosphatidylinositol binding; P:chromatin assembly or disassembly; P:protein monoubiquitination; P:mitochondrion organization; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; C:nucleus; F:ubiquitin-protein transferase activity; C:cellular bud tip; P:regulation of actin cytoskeleton organization; P:ribophagy; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:response to drug; C:endosome membrane; P:regulation of nitrogen utilization; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:regulation of ribosomal large subunit export from nucleus,IPR000008 (SMART); IPR000569 (SMART); IPR001202 (SMART); G3DSA:2.20.70.10 (GENE3D); IPR000008 (G3DSA:2.60.40.GENE3D); IPR000569 (PFAM); IPR001202 (PFAM); IPR000008 (PFAM); IPR024928 (PIRSF); G3DSA:3.30.2160.10 (GENE3D); PTHR11254 (PANTHER); PTHR11254:SF67 (PANTHER); IPR001202 (PROSITE_PROFILES); IPR001202 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000569 (PROSITE_PROFILES); IPR001202 (PROSITE_PROFILES); IPR000008 (SUPERFAMILY); IPR001202 (SUPERFAMILY); IPR001202 (SUPERFAMILY); IPR001202 (SUPERFAMILY); IPR000569 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_08675,1020,1294,1480,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,197.4884345,0,-0.798976844,0.98569538,-0.810571765,0.417611637,0.609132082,79.80564838,0,0.660589662,0.745639673,0.885936848,0.375651559,0.540259317,109.7908273,1,-4.589642117,1.189413962,-3.858742427,0.000113972,0.001251467,143.9942807,0,-2.699188159,0.850691222,-3.172935242,0.001509062,0.010444013,138.5260188,0,-1.472535159,0.629626032,-2.338745675,0.0193486,0.053278372,N,-,,mitochondrial nadh-ubiquinone oxidoreductase 20 kd subunit,"P:cristae formation; F:quinone binding; C:mitochondrial crista junction; F:metal ion binding; F:NADH dehydrogenase (ubiquinone) activity; P:oxidation-reduction process; C:MICOS complex; F:4 iron, 4 sulfur cluster binding",IPR006138 (TIGRFAM); IPR006137 (G3DSA:3.40.50.GENE3D); IPR006137 (PFAM); PTHR11995:SF19 (PANTHER); PTHR11995 (PANTHER); SSF56770 (SUPERFAMILY),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_08676,7158,7095,7378,3,0,10,0,0,0,0,0,1,2,11,0,0,0,0,79.43768081,1,-2.298241898,1.009087526,-2.277544651,0.022753721,0.073023155,96.21118574,0,0.838676889,0.971918997,0.862908217,0.388187932,0.55294656,146.7158824,1,0.818607888,0.474389056,1.725604499,0.084418589,0.169540528,67.87761289,1,-2.949888137,1.140780369,-2.585851068,0.009713889,0.047467726,50.11284965,0,-3.56088194,1.192909245,-2.985040107,0.002835411,0.011311262,N,-,,hypothetical protein F503_05143,C:membrane part; F:binding; C:mitochondrial inner membrane,IPR031463 (PFAM),,
RL4_JR_08677,15625,18733,23402,0,1,7,0,0,0,0,0,0,0,5,0,0,6,0,64.05307882,1,-2.219117689,1.077148385,-2.060178263,0.039381502,0.111514854,71.78378273,0,1.533420237,0.879764446,1.742989551,0.08133544,0.172377999,57.61625686,0,-2.389843698,1.221325634,-1.956762088,0.050375446,0.113763332,111.0317036,1,0.120559023,0.602151471,0.200213781,0.84131339,0.900930521,57.9197825,1,-1.280072831,0.91907766,-1.392779835,0.163686378,0.276540644,N,-,,50S ribosomal l17,F:structural constituent of ribosome; P:mitochondrial translation; C:mitochondrial large ribosomal subunit; P:mitochondrial genome maintenance,IPR000456 (G3DSA:3.90.1030.GENE3D); IPR000456 (PFAM); IPR000456 (TIGRFAM); IPR000456 (PANTHER); PTHR14413:SF16 (PANTHER); IPR000456 (SUPERFAMILY),,
RL4_JR_08678,1148,951,1627,0,1,0,0,0,0,0,0,0,0,2,0,0,0,6,132.9395132,1,-2.461643268,0.965646284,-2.549218392,0.010796467,0.040254833,34.21877674,0,-1.631229385,1.236089425,-1.319669397,0.186945422,0.327097936,113.2681174,0,-1.888484843,0.915528626,-2.062726156,0.039138653,0.094029361,107.6038029,1,-3.778227194,1.19667957,-3.157258875,0.001592599,0.010961974,101.0652319,1,-2.243041247,0.948220849,-2.365526184,0.01800447,0.050205249,N,-,,U3 small nucleolar RNA-associated 25,C:nucleus; F:RNA binding; C:intracellular ribonucleoprotein complex; P:ribosomal small subunit biogenesis; P:rRNA processing,IPR027417 (G3DSA:3.40.50.GENE3D); IPR010678 (PFAM); IPR010678 (PANTHER),,
RL4_JR_08679,2515,4104,7072,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,224.52051,0,-0.728256126,0.541804259,-1.344131415,0.178905895,0.33575208,46.23636212,0,-2.065467,1.210437144,-1.706381046,0.087937157,0.183223529,128.6437089,0,-3.765715664,1.211805376,-3.107525136,0.001886609,0.009455462,139.4143985,0,-5.150426878,1.215780461,-4.23631325,2.27E-05,0.000292697,120.0232566,0,-4.820950869,1.226467364,-3.930761642,8.47E-05,0.000603772,N,-,,eukaryotic translation initiation factor 3 subunit F,"C:nucleus; F:translation initiation factor activity; P:formation of translation preinitiation complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:eukaryotic 43S preinitiation complex; C:eukaryotic translation initiation factor 3 complex, eIF3e; C:integral component of membrane; P:cytoplasmic translational initiation; C:cytosol; C:eukaryotic 48S preinitiation complex; P:regulation of translational initiation",IPR000555 (SMART); IPR024969 (PFAM); IPR000555 (PFAM); PTHR10540 (PANTHER); PTHR10540:SF6 (PANTHER); IPR027531 (HAMAP),,
RL4_JR_08680,356,394,761,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,145.1372619,0,-0.954133681,0.542948367,-1.757319367,0.078863388,0.186321322,30.75017977,0,-1.476987212,1.204859069,-1.225858899,0.220251778,0.368007345,115.9939652,0,-0.981937745,0.674378589,-1.456063051,0.145375191,0.255872467,144.3039352,0,-0.656024162,0.521280698,-1.258485427,0.208216254,0.340855226,104.0024388,0,-1.563877462,0.745154532,-2.098729049,0.035840792,0.086340239,N,-,,r3h domain,F:nucleic acid binding,IPR001374 (G3DSA:3.30.1370.GENE3D); IPR001374 (PFAM); IPR024771 (PFAM); PTHR15672:SF8 (PANTHER); PTHR15672 (PANTHER); PTHR15672 (PANTHER); IPR001374 (PROSITE_PROFILES); IPR024771 (PROSITE_PROFILES); IPR001374 (SUPERFAMILY),,
RL4_JR_08681,12347,16810,20214,2,9,4,0,1,2,1,0,0,2,4,0,0,0,0,29.55038687,1,-0.005722333,0.904656091,-0.006325423,0.994953076,0.997870116,5.721817335,1,0.948956262,1.256806402,0.75505365,0.450216792,0.610461402,14.94545984,1,-1.712750694,1.21399401,-1.410839493,0.158291947,0.272850968,17.24802278,1,-2.135633858,1.215035894,-1.757671414,0.078803434,0.164716097,22.56711705,0,-0.152122789,1.01978012,-0.149172146,0.881417798,0.921618524,N,-,,zinc knuckle-domain-containing,,PF13917 (PFAM),,
RL4_JR_08682,3949,3264,2642,2,7,1,2,0,0,0,0,0,0,2,0,0,0,0,59.17160051,1,-1.864787883,1.073603118,-1.736943431,0.082397156,0.192772011,14.25356898,1,-0.367792276,1.244603786,-0.295509527,0.767604675,0.859574568,37.34420745,0,-3.033862513,1.226849921,-2.472888055,0.013402612,0.04068607,90.45769984,1,0.373166325,0.628346022,0.593886667,0.552587917,0.681563243,37.207694,0,-3.13130292,1.241930768,-2.521318419,0.0116916,0.035655858,N,-,,bcas2 family,,IPR008409 (PFAM); IPR008409 (PTHR13296:PANTHER); PTHR13296 (PANTHER),,
RL4_JR_08683,824,655,517,0,3,6,0,0,0,0,0,4,0,2,0,0,38,0,18.41332008,1,-2.305056563,1.266671996,-1.81977384,0.068793453,0.168874936,5.780763787,0,0.934157193,1.304348714,0.716186694,0.473876078,0.631377341,71.92219463,1,1.72131938,0.715407614,2.406068019,0.016125262,0.047165565,17.52794357,1,-2.158844893,1.25472451,-1.720572824,0.085328368,0.173867927,15.17683775,1,-1.837569018,1.269580689,-1.447382616,0.147789792,0.256271903,N,-,,cwf18 pre-mrna splicing factor,C:spliceosomal complex,IPR013169 (PFAM); PTHR31551 (PANTHER),,
RL4_JR_08684,15776,19010,25206,0,2,32,4,0,0,4,1,0,5,5,3,0,11,0,57.46436046,1,-0.387184577,0.751907025,-0.514936773,0.606597203,0.773215364,12.14115662,1,-0.136382368,1.230817873,-0.110806295,0.911769953,0.950652603,31.70862373,1,-2.797873793,1.211896563,-2.308673759,0.020961692,0.057620463,105.4703689,1,0.725116566,0.56590584,1.28133784,0.200075027,0.330898342,42.72729405,1,-1.211857151,1.009918622,-1.199955249,0.230156721,0.357823117,N,-,,pentatricopeptide repeat,,IPR002885 (PFAM); IPR002885 (TIGRFAM); IPR002885 (PFAM); PTHR24015 (PANTHER); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES); IPR002885 (PROSITE_PROFILES),,
RL4_JR_08685,8,19,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.9920615,0,1.065870515,1.015269407,1.04984008,0.293791645,0.478945557,1.920471384,0,2.524107053,1.333938511,1.892221442,0.058461483,0.133567194,4.959567204,0,-0.121223584,1.209888573,-0.100194007,0.920190304,0.952946669,5.71961559,0,-0.54311143,1.209438047,-0.449060977,0.65338767,0.763215293,4.868649452,0,-0.197476393,1.205469601,-0.163816983,0.869875222,0.913924107,N,-,,hypothetical protein CTHT_0052040,,no IPS match,,
RL4_JR_08686,2251,1280,1021,0,0,0,0,0,0,0,1,0,0,0,0,0,3,0,198.6857038,0,-1.794193629,0.591320352,-3.034215926,0.002411618,0.012166961,48.61465304,0,-2.13778678,1.208431576,-1.76905902,0.076884026,0.165262287,143.0080433,1,-2.95617741,1.040782491,-2.840341219,0.00450653,0.017534247,276.792542,0,-0.200955065,0.427632879,-0.469924262,0.63840913,0.752315228,138.0671169,1,-2.644675494,0.850679074,-3.108899203,0.001877858,0.008032661,N,-,,polarized growth,P:regulation of cellular process; C:cell division site; C:cell tip; C:cell cortex region,IPR001849 (SMART); IPR001660 (SMART); IPR001452 (SMART); IPR001452 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR001849 (PFAM); IPR013761 (G3DSA:1.10.150.GENE3D); IPR001660 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); PTHR10663 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR001660 (PROSITE_PROFILES); IPR013761 (SUPERFAMILY); IPR001452 (SUPERFAMILY); IPR011993 (SUPERFAMILY),8.A.23.1.12, the basigin (basigin) family.
RL4_JR_08687,7804,4958,6651,0,0,8,0,0,1,0,0,1,0,2,0,0,6,0,104.4980319,1,3.300812219,0.526851708,6.265163747,3.72E-10,1.13E-08,25.8084179,1,2.588611101,1.135807532,2.279093093,0.022661532,0.063582344,9.07095572,1,-0.992153203,1.214892648,-0.816659155,0.414123239,0.55604558,41.44773815,1,1.632171289,0.704908418,2.315437363,0.020589009,0.077838716,23.65814083,1,0.627145781,0.995026704,0.630280352,0.528511175,0.651866933,N,-,,"Delta(3,5)-Delta(2,4)-dienoyl- isomerase",P:metabolic process; F:isomerase activity,IPR029045 (G3DSA:3.90.226.GENE3D); IPR001753 (PFAM); IPR014748 (G3DSA:1.10.12.GENE3D); PTHR11941:SF43 (PANTHER); PTHR11941 (PANTHER); IPR029045 (SUPERFAMILY),,
RL4_JR_08688,6812,8044,9508,0,1,19,0,0,0,1,0,0,1,7,0,1,0,0,8.346452354,1,-1.163516277,1.206582263,-0.964307459,0.334891802,0.524989878,21.40585613,0,3.697913235,0.997333033,3.707801819,0.000209066,0.008891461,6.897257076,1,-0.597166372,1.204007081,-0.495982442,0.619906799,0.733598647,11.97022284,1,-0.073307964,1.153298846,-0.063563719,0.949317621,0.970207017,18.40730024,1,1.506559034,0.871177249,1.729336981,0.083748802,0.167019839,N,-,,RNA polymerase II transcription factor B subunit 5,P:phosphorylation of RNA polymerase II C-terminal domain; C:core TFIIH complex; C:cytosol; P:nucleotide-excision repair; P:transcription from RNA polymerase II promoter; C:holo TFIIH complex,IPR009400 (SMART); IPR009400 (G3DSA:3.30.70.GENE3D); IPR009400 (PFAM); PTHR28580:SF1 (PANTHER); PTHR28580 (PANTHER); IPR009400 (SUPERFAMILY),,
RL4_JR_08689,4666,4122,5208,0,4,3,0,0,0,0,1,1,1,0,0,0,2,0,16.18928658,1,-2.119428265,1.207733649,-1.754880528,0.079279745,0.18687205,5.202722639,0,1.086255213,1.27005924,0.855279171,0.392396616,0.556591725,46.66266525,1,0.8710557,0.870896504,1.000182795,0.317222054,0.459976522,97.53747392,1,2.600709408,0.476969217,5.452572866,4.96E-08,1.20E-06,50.41574231,1,1.588300252,0.653314828,2.431140675,0.015051369,0.043617343,N,-,,phenylalanyl-tRNA beta subunit,F:binding,no IPS match,,
RL4_JR_08690,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,223.2074851,0,-1.751453063,0.568263569,-3.08211393,0.002055362,0.010703749,53.31456734,0,-2.270963178,1.19376854,-1.902347986,0.057125676,0.131206284,138.7177134,0,-4.927033668,1.195243085,-4.122202193,3.75E-05,0.000568605,227.6401848,0,-1.291623418,0.500751341,-2.579370862,0.009898046,0.048158441,182.8402557,0,-1.118956887,0.546369075,-2.047987227,0.040561251,0.095206417,N,-,,phenylalanyl-trna synthetase beta chain,F:magnesium ion binding; C:nucleus; F:ATP binding; F:RNA binding; F:phenylalanine-tRNA ligase activity; C:integral component of membrane; C:cytosol; P:phenylalanyl-tRNA aminoacylation; C:phenylalanine-tRNA ligase complex,IPR005146 (SMART); IPR005147 (SMART); IPR020825 (G3DSA:3.50.40.GENE3D); G3DSA:3.30.930.10 (GENE3D); IPR004531 (TIGRFAM); IPR005146 (PFAM); IPR005147 (G3DSA:3.30.56.GENE3D); IPR005147 (PFAM); PTHR10947 (PANTHER); IPR005147 (PROSITE_PROFILES); IPR009061 (SUPERFAMILY); IPR020825 (SUPERFAMILY); SSF55681 (SUPERFAMILY),,
RL4_JR_08691,1275,1160,1551,2,3,6,0,0,0,0,0,5,1,7,0,0,0,0,360.5357281,1,-1.642187166,0.454777884,-3.610965314,0.000305059,0.002210191,82.86391176,0,-2.907148477,1.191628058,-2.439644197,0.014701734,0.045348304,240.5386744,1,-2.740557166,0.744737003,-3.679899287,0.000233326,0.001947398,328.0555026,1,-1.658843228,0.446571971,-3.714615636,0.000203513,0.001951295,230.0621745,0,-3.017387786,0.749430277,-4.026242173,5.67E-05,0.000430486,N,-,,1 domain-containing,C:intracellular organelle; P:nucleocytoplasmic transport; P:cellular component organization; P:single-organism cellular process; P:intracellular protein transport,IPR000156 (SMART); IPR011993 (G3DSA:2.30.29.GENE3D); IPR000156 (PFAM); PTHR38697 (PANTHER); PTHR38697:SF1 (PANTHER); IPR000156 (PROSITE_PROFILES); IPR011993 (SUPERFAMILY),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_08692,7137,8874,9609,11,3,15,0,0,0,0,0,0,1,4,1,0,4,1,306.5216669,1,3.541730457,0.880496798,4.022422872,5.76E-05,0.000528002,7.964046006,0,0.472002039,1.279709181,0.368835393,0.712250422,0.819529245,180.4142507,0,2.811784945,0.662729831,4.242731827,2.21E-05,0.000364093,488.569132,1,4.279819687,0.403734659,10.60057537,2.96E-26,4.05E-24,354.3289106,1,3.960487573,0.495281371,7.996439613,1.28E-15,1.94E-13,N,-, Effector probability:0.814,lipid transfer,,IPR003033 (G3DSA:3.30.1050.GENE3D); IPR003033 (PFAM); PTHR10094:SF12 (PANTHER); PTHR10094 (PANTHER); IPR003033 (SUPERFAMILY),,
RL4_JR_08693,1964,1791,2653,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,290.891561,0,-1.029604938,0.404692843,-2.544163943,0.010953966,0.04073038,64.26310495,0,-2.540390822,1.195096947,-2.125677609,0.033530113,0.086271428,222.7973543,0,-1.377365691,0.548940137,-2.509136421,0.012102673,0.03749992,277.2684927,0,-0.868003158,0.664545982,-1.306159666,0.191498266,0.320668746,170.7803551,0,-4.332225139,1.119869614,-3.868508518,0.000109503,0.00074611,N,-,,cAMP-dependent kinase regulatory subunit,F:identical protein binding; P:positive regulation of protein export from nucleus; P:positive regulation of adenylate cyclase activity; F:cAMP-dependent protein kinase regulator activity; P:protein localization to bud neck; C:plasma membrane; C:cAMP-dependent protein kinase complex; F:cAMP-dependent protein kinase inhibitor activity; C:nucleus; P:negative regulation of Ras protein signal transduction; C:cytosol; F:cAMP binding; P:phosphorylation; P:negative regulation of protein serine/threonine kinase activity; F:kinase activity; P:negative regulation of meiotic cell cycle,PR00103 (PRINTS); IPR000595 (SMART); IPR014710 (G3DSA:2.60.120.GENE3D); IPR000595 (PFAM); IPR012198 (PIRSF); IPR014710 (G3DSA:2.60.120.GENE3D); PTHR11635 (PANTHER); IPR000595 (PROSITE_PROFILES); IPR000595 (PROSITE_PROFILES); IPR018490 (SUPERFAMILY); IPR018490 (SUPERFAMILY),1.A.1.5.31, the voltage-gated ion channel (vic) superfamily.
RL4_JR_08694,24484,4468,10125,1,0,24,0,0,0,3,0,0,1,8,5,2,3,2,213.8924146,1,-0.051427977,0.577921861,-0.088987769,0.929091631,0.96586144,77.26950999,0,0.109711196,0.986232853,0.111242691,0.911423899,0.950652603,130.7743692,1,-1.058284298,0.681577429,-1.55269857,0.120495164,0.222527005,166.2420025,1,-0.247104807,0.473495328,-0.521873802,0.6017582,0.723267068,131.7269591,1,-0.654639168,0.572894167,-1.142687788,0.253168242,0.384191914,N,-,,lem3 cdc50 family,C:integral component of membrane; C:endoplasmic reticulum,IPR005045 (PIRSF); IPR005045 (PFAM); IPR005045 (PANTHER); PTHR10926:SF0 (PANTHER),8.A.27.1.2, the cdc50 p-type atpase lipid flippase subunit (cdc50) family.
RL4_JR_08695,10394,7177,8733,10,5,0,0,2,0,2,0,1,1,6,0,0,14,5,241.2729021,1,-1.73391415,0.567213671,-3.056897673,0.002236406,0.011424296,59.71955184,1,-2.434614223,1.210332615,-2.011524926,0.04427004,0.107207936,190.999035,1,-1.944328369,0.698316762,-2.784307174,0.005364221,0.01992931,239.6196687,1,-1.137522212,0.579126637,-1.964202886,0.049506568,0.122137915,159.3597489,1,-4.223757796,1.140573504,-3.703187721,0.000212907,0.001316047,N,-,,transcription elongation complex subunit,P:DNA repair; C:FACT complex; C:nuclear chromatin; F:metal ion binding; P:DNA-dependent DNA replication; P:chromatin organization involved in regulation of transcription; C:replication fork protection complex; C:mitotic spindle pole body; P:DNA replication-independent nucleosome organization; P:nucleosome assembly; P:transcription elongation from RNA polymerase II promoter; P:positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,IPR013719 (SMART); IPR013953 (SMART); IPR029148 (SMART); IPR013953 (PFAM); IPR029148 (PFAM); IPR029149 (G3DSA:3.40.350.GENE3D); IPR000994 (PFAM); IPR013719 (PFAM); IPR000994 (G3DSA:3.90.230.GENE3D); PTHR13980:SF15 (PANTHER); PTHR13980 (PANTHER); IPR000994 (SUPERFAMILY),,
RL4_JR_08696,1586,2599,1973,3,5,5,0,0,2,1,1,7,2,0,2,0,2,0,538.3661233,1,-2.559508165,0.998755376,-2.56269776,0.010386242,0.03902854,167.1188482,1,-2.152999885,1.115930585,-1.92933137,0.053689738,0.124815692,450.3905872,1,-2.34305871,0.738913953,-3.170949339,0.001519416,0.007952848,509.5042515,1,-2.731134097,0.738327021,-3.699084578,0.000216378,0.002048216,376.207913,1,-6.469166815,1.310495904,-4.936426581,7.96E-07,1.20E-05,N,-,,glutamate-cysteine ligase,F:ATP binding; C:glutamate-cysteine ligase complex; P:chromatin remodeling; P:glutathione biosynthetic process; C:Ino80 complex; F:glutamate-cysteine ligase activity,IPR004308 (PFAM); IPR004308 (PANTHER); SSF55931 (SUPERFAMILY),,
RL4_JR_08697,332,634,581,0,0,5,0,0,0,0,5,0,2,5,0,0,1,1,24.32800146,1,-2.706992494,1.184348046,-2.285639347,0.022275366,0.071827051,7.78095052,0,0.505575731,1.223188421,0.413326125,0.679367691,0.79599025,28.00669508,1,-1.18295627,1.188856595,-0.995036975,0.319718282,0.462470051,39.30544694,1,0.150990312,0.741750791,0.203559354,0.838697858,0.899270975,71.42043412,1,1.419405228,1.542323857,0.920302971,0.357414457,0.494888219,N,-,,GATA zinc finger domain-containing 10,"F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR000679 (SMART); IPR000679 (PFAM); IPR013088 (G3DSA:3.30.50.GENE3D); PTHR10071:SF180 (PANTHER); PTHR10071 (PANTHER); PTHR10071 (PANTHER); PTHR10071:SF180 (PANTHER); IPR000679 (PROSITE_PROFILES); SSF57716 (SUPERFAMILY),,
RL4_JR_08698,13727,12145,15448,0,1,3,0,1,0,0,12,5,0,6,3,0,11,2,245.6226915,1,2.580971523,0.658915146,3.917001361,8.97E-05,0.00077811,29.58271905,1,1.66865286,0.993081327,1.680278155,0.092903209,0.19136473,162.9515216,1,2.291457195,0.386975262,5.921456533,3.19E-09,1.51E-07,137.2836336,1,1.844795237,0.377974549,4.880739306,1.06E-06,1.93E-05,111.746135,1,2.067105878,0.516806779,3.999765412,6.34E-05,0.000474135,N,-,,glycoside hydrolase family 72,"P:fungal-type cell wall organization; C:fungal-type cell wall; P:fungal-type cell wall (1->3)-beta-D-glucan biosynthetic process; C:anchored component of external side of plasma membrane; C:integral component of membrane; F:1,3-beta-glucanosyltransferase activity; F:hydrolase activity",IPR013781 (G3DSA:3.20.20.GENE3D); IPR004886 (PFAM); PTHR31468 (PANTHER); PTHR31468:SF5 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_08699,9500,5227,8587,2,2,3,6,0,0,2,4,0,0,2,0,0,2,1,75.74930077,1,-0.127582529,0.610538197,-0.208967317,0.834473753,0.917347645,31.6205199,1,1.423833219,0.982534086,1.44914384,0.147297417,0.273005223,47.74070722,1,-1.050288894,1.028533382,-1.021151975,0.307182442,0.448540217,114.4656341,1,1.017699034,0.445343991,2.285197631,0.022301242,0.080484515,48.04732748,1,-0.743499863,0.842347882,-0.882651787,0.377424439,0.513149248,N,-,,actin polymerization,C:cell division site; C:cell tip; P:response to salt stress; F:metal ion binding; P:positive regulation of catalytic activity; P:actin nucleation; C:mating projection tip; F:enzyme activator activity; P:endocytosis; C:plasma membrane; C:actin cortical patch; P:intracellular signal transduction,IPR020454 (PRINTS); IPR002219 (SMART); IPR001452 (SMART); IPR001060 (SMART); G3DSA:2.30.30.40 (GENE3D); IPR001060 (PFAM); IPR001452 (PFAM); G3DSA:3.30.60.20 (GENE3D); IPR002219 (PFAM); PTHR10663 (PANTHER); PTHR10663:SF178 (PANTHER); PTHR10663:SF178 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR031160 (PROSITE_PROFILES); IPR002219 (PROSITE_PROFILES); SSF103657 (SUPERFAMILY); SSF57889 (SUPERFAMILY); IPR001452 (SUPERFAMILY); IPR001452 (SUPERFAMILY),1.F.1.1.3, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_08700,8022,8999,11222,12,4,10,0,0,1,0,4,1,3,4,1,0,1,0,286.8870752,1,-0.238603566,0.358453813,-0.66564661,0.505637007,0.692221146,164.3188687,1,1.527858239,0.554946127,2.753164972,0.005902215,0.023030924,159.0931887,1,-2.035266276,0.745459714,-2.73021632,0.006329278,0.022698409,164.0001474,1,-2.972012401,0.856545923,-3.469764225,0.000520915,0.004333828,174.2925599,1,-1.30270175,0.540760265,-2.409018993,0.015995466,0.045711004,N,-,,ATP-dependent RNA helicase DBP5,P:protein transport; F:inositol hexakisphosphate binding; C:nuclear pore cytoplasmic filaments; F:ATP-dependent RNA helicase activity; C:polysome; P:mRNA export from nucleus; F:ATP binding; C:cellular bud tip; C:nuclear membrane; P:translational termination; F:RNA binding; C:cytoplasm; P:RNA secondary structure unwinding,IPR001650 (SMART); IPR014001 (SMART); IPR001650 (PFAM); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24031:SF284 (PANTHER); PTHR24031 (PANTHER); IPR014014 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_08701,534,501,456,1,1,3,0,0,0,0,0,1,2,7,0,0,2,0,9.184507191,1,-1.301481509,1.215947568,-1.070343445,0.284464746,0.467781374,2.962535115,0,1.898773498,1.314694845,1.444269371,0.148663218,0.274793479,7.628306472,1,-0.742254971,1.216537574,-0.610137317,0.541770849,0.669869086,8.796137102,1,-1.163942549,1.216675901,-0.956657847,0.338739981,0.486052571,7.459325395,1,-0.812908631,1.211205797,-0.67115649,0.502120843,0.629771245,N,-,,"hypothetical protein THITE_39109, partial",C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_08702,73682,46471,42743,16,22,55,0,0,6,14,19,26,6,44,24,2,74,17,43.88098476,1,0.46797071,0.859162556,0.544682385,0.585971982,0.758426055,4.365184829,1,1.339513652,1.258280508,1.064558851,0.287075609,0.446630697,11.31459988,1,-1.31101987,1.199360839,-1.09309878,0.274350431,0.412891894,25.08754128,1,0.564518289,0.865706575,0.65208964,0.514343347,0.649180552,11.13225785,1,-1.39038415,1.200042107,-1.158612803,0.246614048,0.376749497,N,-, Effector probability:0.664,GAF,C:cytoplasm; P:cellular response to oxidative stress; P:oxidation-reduction process; F:methionine-R-sulfoxide reductase activity,IPR003018 (PFAM); IPR029016 (G3DSA:3.30.450.GENE3D); PTHR21021 (PANTHER); PTHR21021:SF15 (PANTHER); IPR029016 (SUPERFAMILY),,
RL4_JR_08703,11245,9422,10017,5,2,6,2,0,0,0,2,10,4,14,0,0,6,12,90.53869712,1,3.131226809,1.058697531,2.957621716,0.003100223,0.014790422,3.302370355,1,1.741989069,1.26554082,1.376477978,0.168673701,0.302984064,74.99213191,1,2.869359418,1.635436012,1.754492011,0.079346238,0.161630042,47.46120922,1,1.417985617,0.739257978,1.918120142,0.055095779,0.13000344,8.459698364,1,-0.994409346,1.199550341,-0.828985089,0.407112845,0.543492219,N,-,,neutral ceramidase,C:integral component of membrane,IPR031331 (PFAM); IPR031329 (PFAM); IPR006823 (PANTHER); PTHR12670:SF5 (PANTHER),,
RL4_JR_08704,1184,881,944,0,0,0,0,0,0,0,0,3,2,2,0,0,2,0,120.0428289,0,0.617332768,0.460541702,1.340449225,0.180099341,0.33706135,39.53945377,0,0.280730565,1.106015889,0.253821458,0.799633495,0.878134016,267.4061865,1,2.201411994,0.479886692,4.587357872,4.49E-06,9.59E-05,97.04571836,1,0.304135465,0.494911633,0.614524785,0.5388686,0.670275747,66.98158626,1,-0.443653637,0.678065526,-0.654293162,0.51292295,0.638709245,N,-,,coatomer subunit epsilon,"P:retrograde vesicle-mediated transport, Golgi to ER; F:structural molecule activity; C:cytosol",IPR011990 (G3DSA:1.25.40.GENE3D); PF04733 (PFAM); IPR006822 (PIRSF); IPR006822 (PANTHER); IPR011990 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_08705,3489,3258,4339,0,0,5,0,0,0,2,0,1,0,2,0,0,0,0,301.9584802,1,0.749955529,0.40908699,1.833242188,0.066766563,0.165173809,35.33304969,0,-1.677405424,1.22614384,-1.368033154,0.171301699,0.306833444,121.0533777,1,-1.499708007,0.778266423,-1.926985365,0.053981454,0.11995352,181.5468271,1,-0.530302004,0.525935906,-1.008301578,0.313309706,0.459415028,125.8126379,0,-1.375491293,0.724511324,-1.898509032,0.057629059,0.124624994,N,-,,phosphatidylserine decarboxylase,P:phosphatidylethanolamine biosynthetic process; F:calcium ion binding; F:phosphatidylserine decarboxylase activity; C:Golgi membrane; C:endosome membrane; P:protein autoprocessing; C:Golgi stack,IPR000008 (SMART); IPR011992 (G3DSA:1.10.238.GENE3D); IPR033177 (TIGRFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR000008 (PFAM); IPR000008 (G3DSA:2.60.40.GENE3D); IPR003817 (PFAM); IPR033177 (PANTHER); PTHR10067:SF2 (PANTHER); PTHR10067:SF2 (PANTHER); IPR033177 (PANTHER); PTHR10067:SF2 (PANTHER); IPR000008 (PROSITE_PROFILES); IPR033179 (HAMAP); IPR000008 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR000008 (SUPERFAMILY); IPR011992 (SUPERFAMILY); IPR000008 (SUPERFAMILY),2.A.25.1.6, the alanine or glycine:cation symporter (agcs) family.
RL4_JR_08706,4118,3055,3376,0,2,7,6,0,0,2,0,1,5,2,0,0,0,1,40.84373441,1,-2.095435337,1.151093115,-1.820387343,0.068700039,0.168710089,28.66048416,1,1.789008556,1.014253305,1.763867613,0.077754271,0.166778709,67.22510402,1,0.910065052,0.634934361,1.433321472,0.151765989,0.264681976,91.2812323,1,0.712941414,0.626704048,1.137604609,0.255285621,0.394801728,62.9193138,1,1.046247254,0.557466166,1.87679059,0.060546801,0.12966082,N,-,,ste12 interacting,,no IPS match,,
RL4_JR_08707,696,621,661,0,0,0,0,0,0,0,0,2,1,1,0,0,0,0,56.58123258,0,0.762613354,0.852159375,0.894918693,0.370830553,0.563044045,5.187788629,0,1.090322539,1.275921004,0.854537652,0.392807157,0.557017938,13.51806142,1,-1.567950541,1.221489582,-1.283638079,0.199268619,0.324653283,25.23274507,1,-1.037350578,1.174072288,-0.883549155,0.376939636,0.522380758,13.40861791,0,-1.658889293,1.233432689,-1.344937027,0.178645572,0.295843378,N,-,,DUF159 domain,,IPR003738 (G3DSA:3.90.1680.GENE3D); IPR003738 (PFAM); IPR003738 (PANTHER); PTHR13604:SF0 (PANTHER); PTHR13604:SF0 (PANTHER); IPR003738 (PANTHER); IPR003738 (SUPERFAMILY),,
RL4_JR_08708,2808,3024,2665,4,0,3,0,0,0,1,0,2,0,3,0,0,0,0,8.340655545,1,-1.162256692,1.196655951,-0.971253844,0.331421887,0.521298212,2.667726882,0,2.049964769,1.289317486,1.589961193,0.111843553,0.221023124,6.904658338,1,-0.59841468,1.198786747,-0.499183596,0.617650049,0.731526568,7.964489921,1,-1.020581692,1.196753715,-0.852791747,0.393774801,0.538561375,6.785207745,0,-0.67611339,1.195829015,-0.56539303,0.571806464,0.687430593,N,-,,meiotic chromosome segregation,F:metal ion binding; P:metal ion transport,IPR018959 (PFAM); PTHR31527 (PANTHER); PTHR31527:SF0 (PANTHER),,
RL4_JR_08709,555,672,900,0,1,0,0,0,0,3,0,0,0,0,0,0,0,0,334.361427,1,7.285449213,2.271650139,3.207117631,0.001340722,0.007465943,0.680377814,0,4.021053879,1.487011854,2.704116895,0.006848619,0.025523462,1.772058019,1,1.363515764,1.233905967,1.105040255,0.269142147,0.407415534,119.525692,0,6.06476417,0.540317736,11.22444029,3.09E-29,4.75E-27,99.99316604,0,6.146370179,0.463130301,13.27136266,3.39E-40,3.82E-37,Y,-,,alkaline ase,P:proteolysis; F:serine-type endopeptidase activity; C:extracellular region,IPR015500 (PRINTS); IPR010259 (G3DSA:3.30.70.GENE3D); IPR000209 (PFAM); IPR010259 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); PTHR10795:SF420 (PANTHER); IPR015500 (PANTHER); IPR000209 (SUPERFAMILY); IPR009020 (SUPERFAMILY),1.I.3.1.1,The Bacterial (Planctomycetes) Nuclear Pore-like Complex (B-NPC) Family
RL4_JR_08710,4845,6019,5514,0,0,5,0,0,0,1,0,3,5,2,0,0,1,0,1326.957914,1,1.530964252,0.404738708,3.782599049,0.000155199,0.001247405,286.1515031,0,0.883176463,1.523163348,0.579830432,0.562028973,0.705288528,584.2552839,1,0.127502923,0.318627277,0.400163239,0.689036288,0.786937958,909.1464205,1,0.900859046,0.279405336,3.224201289,0.001263246,0.009039126,485.3290413,1,-0.220471909,0.380402378,-0.579575527,0.5622009,0.679879117,N,-,,fructose-bisphosphate aldolase,C:nucleus; P:gluconeogenesis; F:zinc ion binding; C:fungal-type cell wall; C:mitochondrion; P:glycolytic process; C:cytosol; F:fructose-bisphosphate aldolase activity; C:plasma membrane,IPR000771 (TIGRFAM); IPR000771 (PFAM); IPR000771 (PIRSF); IPR013785 (G3DSA:3.20.20.GENE3D); IPR006411 (TIGRFAM); PTHR30559 (PANTHER); PTHR30559:SF0 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_08711,1770287,1219503,1425529,84,167,181,4,9,27,17,51,149,21,4,68,0,158,49,0.988436514,1,1.914344315,1.550495827,1.234665893,0.216954874,NA,0.312175937,1,5.144854167,1.698451287,3.029144377,0.002452474,0.015349618,0.816105485,1,2.481451987,1.274154722,1.947527992,0.051471467,0.115869601,0.941886679,1,2.05879149,1.336888801,1.539987087,0.123563501,0.229323045,0.811409325,1,2.387992336,1.25965307,1.895753993,0.057992582,0.125250617,N,-,,methyltransferase type 11,C:integral component of membrane; F:methyltransferase activity; P:methylation,IPR013216 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF792 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_08712,5812,5719,6158,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0.004235441,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001340044,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003452355,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003983613,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003339785,0,10.24113992,1.835951848,5.578109216,2.43E-08,8.07E-07,N,-,,Asparagine synthetase,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_08713,16517,16815,20146,7,11,15,0,0,0,2,7,5,5,18,10,0,15,4,0.03953727,1,6.557661918,3.933655529,1.667065626,0.095501356,NA,0.012186706,0,9.821089237,3.33286412,2.946741566,0.003211415,0.016148008,0.03243615,1,7.130624811,2.006648818,3.553499121,0.000380142,0.002786595,0.037473698,1,6.709648819,3.600010671,1.863785814,0.062351789,0.139855449,0.032878265,1,7.016831476,1.513287719,4.636812543,3.54E-06,4.24E-05,N,-, Effector probability:0.611,methyltransferase domain-containing,F:transferase activity,no IPS match,,
RL4_JR_08714,2045,2400,3811,1,2,0,0,0,0,0,0,1,2,2,1,0,0,0,0.100814825,1,5.207921283,3.917337881,1.329454196,0.183698168,NA,0.032592169,0,8.405616429,2.655240585,3.165670364,0.00154726,0.015023052,0.083688563,1,5.76998541,1.540700612,3.745039994,0.000180365,0.001652082,0.096490058,1,5.346753935,2.39067321,2.236505564,0.025318673,0.085851084,0.081499212,0,5.702703581,1.314910476,4.33695197,1.44E-05,0.000136836,N,-,,monocarboxylate transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11360:SF118 (PANTHER); PTHR11360 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.13.19, the major facilitator superfamily (mfs).
RL4_JR_08715,4027,4584,5329,0,0,9,1,0,0,0,0,3,1,9,3,0,2,2,0.102388894,1,5.185157005,3.917172577,1.323698893,0.185603066,NA,0.033727821,1,8.355914591,2.774008462,3.012216691,0.002593474,0.015349618,6.584741774,1,6.688992271,1.325556071,5.046178294,4.51E-07,1.32E-05,9.734377421,1,6.270131976,1.29825355,4.82966673,1.37E-06,2.45E-05,11.66517235,1,7.778891231,1.067331296,7.288169341,3.14E-13,3.79E-11,N,-,,CVNH domain-containing,P:phosphorylation; F:kinase activity; C:outer membrane,IPR018392 (SMART); IPR011058 (SMART); IPR011058 (PFAM); IPR011058 (G3DSA:2.30.60.GENE3D); IPR018392 (PFAM); IPR018392 (G3DSA:3.10.350.GENE3D); IPR008816 (PFAM); PTHR37014 (PANTHER); IPR011058 (SUPERFAMILY); IPR018392 (SUPERFAMILY),,
RL4_JR_08716,76006,69585,83540,3,10,15,0,0,0,0,8,14,4,27,3,0,15,4,16.92176978,1,1.734344977,0.88151407,1.96746148,0.049130033,0.130938519,1.738579984,0,2.667627123,1.336632525,1.995781991,0.045957658,0.110285304,4.514716987,1,0.014476215,1.211935054,0.011944712,0.990469725,0.996077828,41.16887634,1,2.655469242,0.686241266,3.869585488,0.000109021,0.001147436,26.54658492,1,2.174507384,0.857330806,2.536369122,0.01120086,0.034407982,N,-,,aldo keto reductase,C:nucleus; C:cytoplasm; F:alditol:NADP+ 1-oxidoreductase activity; P:cellular response to oxidative stress; P:oxidation-reduction process; P:arabinose catabolic process; P:D-xylose catabolic process,IPR020471 (PRINTS); IPR023210 (PFAM); IPR023210 (G3DSA:3.20.20.GENE3D); IPR020471 (PIRSF); PTHR11732:SF246 (PANTHER); IPR001395 (PANTHER); IPR023210 (SUPERFAMILY),,
RL4_JR_08717,573,596,541,0,0,15,0,0,4,0,0,0,1,1,0,0,0,3,0.003880053,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,1,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,1,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,Amino acid permease,F:polyamine transmembrane transporter activity; P:positive regulation of (R)-carnitine transmembrane transport; P:polyamine transmembrane transport; C:fungal-type vacuole membrane; P:response to osmotic stress; F:amino acid transmembrane transporter activity; P:positive regulation of polyamine transmembrane transport; P:amino acid transmembrane transport; P:fatty acid metabolic process; P:carnitine transmembrane transport; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; F:carnitine transmembrane transporter activity,IPR002293 (PIRSF); IPR004841 (PFAM); IPR002293 (PANTHER); PTHR11785:SF326 (PANTHER),2.A.3.10.19, the amino acid-polyamine-organocation (apc) family.
RL4_JR_08718,27666,21258,30389,0,3,6,0,0,0,5,3,8,3,3,1,0,3,1,0.250144138,1,3.897145126,2.864808048,1.360351221,0.173718807,NA,0.079615501,0,7.116787683,2.331311173,3.052697454,0.002267945,0.0150814,0.205764313,1,4.471753838,1.509897691,2.961627045,0.003060182,0.013767301,0.237385557,1,4.048232719,1.91695441,2.111804379,0.034703232,0.099426657,0.201036971,1,4.402335531,1.388365972,3.170875417,0.001519803,0.00674321,N,-, Effector probability:0.606,iron-sulfur cluster-binding,F:oxidoreductase activity; F:metal ion binding; C:membrane; P:metabolic process; F:iron-sulfur cluster binding,IPR001663 (PRINTS); IPR017941 (PFAM); IPR017941 (G3DSA:2.102.10.GENE3D); PTHR21266 (PANTHER); PTHR21266:SF2 (PANTHER); IPR017941 (PROSITE_PROFILES); IPR017941 (SUPERFAMILY),,
RL4_JR_08719,2600,2500,2551,2,0,2,0,0,0,0,1,1,1,7,7,0,3,2,7.852182702,1,-1.075204012,1.208866487,-0.889431565,0.373771187,0.566139128,2.516395145,0,2.134242546,1.308815069,1.630667767,0.102960441,0.207148795,6.502149606,1,-0.511724624,1.208101252,-0.423577596,0.671873898,0.77421002,27.55749578,1,2.080699201,0.70005696,2.972185578,0.002956879,0.018423631,6.376511855,1,-0.58650802,1.203709087,-0.487250638,0.626080724,0.730334456,N,-,,C6 finger domain,F:transition metal ion binding; F:oxidoreductase activity; P:metabolic process,IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR015879 (PFAM); IPR021858 (PFAM); PTHR21266:SF2 (PANTHER); PTHR21266 (PANTHER); IPR001138 (PROSITE_PROFILES); SSF55961 (SUPERFAMILY); IPR001138 (SUPERFAMILY),,
RL4_JR_08720,52,68,90,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.5367684,0,1.599877682,0.84589183,1.891350201,0.058577611,0.149710575,1.943626717,0,2.506797763,1.310077294,1.913473177,0.055687504,0.128641293,5.03563399,0,-0.143111616,1.196348568,-0.119623678,0.904781262,0.941515623,5.808786314,0,-0.565335927,1.193726299,-0.473589237,0.635792852,0.75062997,12.32160785,0,0.710820968,1.119439082,0.634979589,0.525441727,0.649505248,N,-,,shikimate quinate 5-dehydrogenase,,IPR003462 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR023401 (G3DSA:3.30.1780.GENE3D); PTHR13812 (PANTHER); PTHR13812:SF19 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_08721,8260,6784,5111,0,1,1,0,0,0,0,0,3,1,11,0,0,0,0,0.043824634,1,6.409485777,3.931038922,1.630481383,0.102999797,NA,0.013863198,0,9.637213424,3.082152025,3.126780686,0.001767317,0.015023052,0.03620692,1,6.97451837,1.741577292,4.00471366,6.21E-05,0.000852952,0.041784522,1,6.55323706,3.246406824,2.018612397,0.043527522,0.113446415,0.03596668,0,6.884945061,1.364876316,5.044372873,4.55E-07,7.32E-06,N,-,,dimethylaniline monooxygenase,F:nucleotide binding; F:coenzyme binding; C:membrane; F:monooxygenase activity,IPR020946 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR23023 (PANTHER); PTHR23023:SF1 (PANTHER); PTHR23023 (PANTHER); PTHR23023:SF1 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_08722,3002,3324,3605,0,1,11,0,0,0,1,4,1,0,0,2,0,1,0,0.019781616,1,7.556258757,3.960309894,1.907996838,0.056391625,NA,0.006177465,0,10.80099648,3.666590793,2.94578727,0.003221339,0.016157775,0.016297679,1,8.122821537,2.181397604,3.723677664,0.000196342,0.001734522,0.018818652,1,7.703057059,3.960515312,1.944963332,0.051779392,0.125559168,0.01637629,1,8.021846978,1.492011636,5.376531112,7.59E-08,1.81E-06,N,-,,short-chain dehydrogenase reductase family,F:ATP binding; F:oxidoreductase activity; C:integral component of membrane; F:protein kinase activity; P:oxidation-reduction process; P:protein phosphorylation,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); PTHR24321 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_08723,672,510,604,0,2,2,0,0,2,0,0,0,0,1,0,0,0,1,0.004235441,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001340044,1,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003452355,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003983613,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003339785,1,10.24113992,1.835951848,5.578109216,2.43E-08,8.07E-07,N,-,,short chain dehydrogenase reductase,F:oxidoreductase activity; P:oxidation-reduction process; C:cellular_component,IPR002347 (PRINTS); IPR002347 (PRINTS); SM00822 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); PTHR24322:SF242 (PANTHER); PTHR24322:SF242 (PANTHER); PTHR24322:SF242 (PANTHER); IPR002347 (PANTHER); IPR002347 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_08724,3582,3097,4264,2,0,14,0,0,1,0,6,2,5,3,0,0,5,0,0.003880053,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,1,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,1,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,proline permease,P:transmembrane transport; C:membrane; P:amino acid transport,IPR002293 (PIRSF); IPR004841 (PFAM); IPR002293 (PANTHER); PTHR11785:SF408 (PANTHER),2.A.3.10.3, the amino acid-polyamine-organocation (apc) family.
RL4_JR_08725,5672,3292,5085,1,0,8,0,0,0,0,1,0,5,3,10,0,0,0,2.511919385,1,0.569166559,1.28068404,0.444423871,0.656736158,0.806389762,0.803731019,0,3.780850043,1.470232009,2.571600958,0.01012295,0.033880684,2.077835417,1,1.134337929,1.233526565,0.91958938,0.357787379,0.501209274,2.396712583,1,0.712106322,1.246217375,0.571414214,0.567718896,0.694972044,2.037784688,0,1.059410258,1.221818335,0.867076739,0.385899964,0.522218276,N,-,,arginine metabolism regulation ii,"C:nucleus; F:zinc ion binding; F:oxidoreductase activity; P:regulation of transcription, DNA-templated; P:oxidation-reduction process; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR021858 (PFAM),,
RL4_JR_08726,11484,8964,11111,0,0,3,0,0,0,1,3,1,3,2,1,0,1,2,1.105204761,1,1.753539287,1.517600975,1.15546795,0.24789885,NA,0.356005286,0,4.955776691,1.695955605,2.922114633,0.003476636,0.016733478,0.916250611,1,2.31589413,1.281501107,1.807172945,0.070735318,0.14808196,1.056566092,1,1.893870259,1.339024272,1.414365893,0.157254499,0.27561049,0.89438119,1,2.247278262,1.249924796,1.797930779,0.072187978,0.148316412,N,-,,arginine metabolism regulation II,"F:DNA binding; C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR021858 (PFAM),,
RL4_JR_08727,828,722,1246,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,44.79560642,0,0.490929732,0.711791116,0.689710395,0.490376328,0.678394112,160.1558119,0,4.28801391,1.731869531,2.475945117,0.0132884,0.041810752,28.84201479,0,-1.000846788,1.204408107,-0.830986425,0.405981298,0.548166799,64.63619607,1,1.628243098,0.624308581,2.608074191,0.009105322,0.045099082,17.62766267,0,-2.053533452,1.21757551,-1.686575851,0.091684939,0.178761796,N,-,,kinase-like domain partial,F:nucleotide binding; F:ATP binding; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); PTHR24055 (PANTHER); PTHR24055:SF213 (PANTHER); PTHR24055 (PANTHER); PTHR24055:SF213 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_08728,1204,1137,1673,0,0,1,0,0,0,1,0,0,3,2,0,0,0,1,0.011718044,1,8.30924678,3.99658426,2.0790871,0.037609346,NA,0.004006569,0,11.4341231,3.991291091,2.864768027,0.004173148,0.018371529,0.009992212,1,8.834284459,3.994251091,2.211749902,0.02698395,0.070608817,0.011494389,1,8.415706565,3.9944702,2.106839241,0.035131517,0.099498352,0.009494587,1,8.783878684,1.912952289,4.591791826,4.39E-06,5.09E-05,N,-, Effector probability:0.674,C2H2 and C2HC zinc finger,,no IPS match,,
RL4_JR_08729,1765,2783,1980,0,0,37,0,1,3,14,0,6,11,24,5,0,21,11,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,hypothetical protein F503_01673,,no IPS match,,
RL4_JR_08730,1001,1001,1047,5,0,2,0,0,0,0,0,0,1,0,0,0,3,2,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,isoflavone reductase family,,PTHR14194 (PANTHER); PTHR14194:SF58 (PANTHER),,
RL4_JR_08731,2846,2526,4244,0,0,11,0,0,0,1,1,4,0,3,0,0,2,1,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-, Effector probability:0.721,isoflavone reductase family,,no IPS match,,
RL4_JR_08732,73330,33780,44738,5,4,45,0,0,3,0,1,2,0,13,5,3,10,3,87.10086332,1,-1.032415418,0.882590467,-1.169755913,0.24209921,0.417028158,17.34229745,1,-0.650761176,1.240167095,-0.52473669,0.599766248,0.734830182,45.43520788,1,-3.316786746,1.227229233,-2.70266276,0.00687865,0.02424772,56.45556528,1,-2.795602914,1.187460909,-2.354269427,0.018559154,0.074262186,45.28649482,1,-3.414787192,1.241969685,-2.749493191,0.00596875,0.020694557,N,-,,major facilitator superfamily transporter,F:pantothenate transmembrane transporter activity; C:integral component of membrane; P:endocytosis; C:plasma membrane; P:pantothenate transmembrane transport,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF240 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_08733,17024,9661,6442,3,6,8,0,0,0,6,0,0,1,7,2,4,15,0,115.0030612,1,2.783825166,1.18129803,2.35658157,0.018444016,0.061414811,4.996846794,0,1.144436234,1.24535997,0.91896019,0.358116395,0.522263319,98.83344437,1,2.808531492,1.084310399,2.59015453,0.009593286,0.031646277,15.00614646,1,-1.934791079,1.198734234,-1.614028384,0.10652127,0.205786654,70.77952706,1,2.373472468,1.370669152,1.731615879,0.083341977,0.166503062,N,-,,major facilitator superfamily transporter,C:integral component of plasma membrane; F:substrate-specific transmembrane transporter activity,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23514:SF6 (PANTHER); PTHR23514 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.7.13, the major facilitator superfamily (mfs).
RL4_JR_08734,28553,12770,13086,5,3,0,0,0,0,0,14,0,9,9,3,0,12,6,201.9422538,1,-1.765980535,0.601842197,-2.934291651,0.003343099,0.015692176,118.5812149,0,0.007310155,0.855249629,0.008547394,0.99318025,0.996480454,164.7000633,1,-2.063752089,0.763702086,-2.702299923,0.006886161,0.024255068,200.3597914,1,-1.771791144,0.605357385,-2.926851456,0.003424124,0.020673377,156.3084239,1,-2.059686573,0.725464058,-2.839129728,0.004523676,0.016505305,N,-,,eukaryotic translation initiation factor 4e-1,F:translation initiation factor activity; C:cytoplasm; P:translational initiation,IPR001040 (PFAM); IPR023398 (G3DSA:3.30.760.GENE3D); IPR001040 (PANTHER); IPR023398 (SUPERFAMILY),,
RL4_JR_08735,684,438,495,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,74.94211042,1,1.871562575,0.543788909,3.441707883,0.000578054,0.003793858,4.963649045,0,1.15417831,1.264232916,0.912947523,0.361270142,0.525701031,23.87438758,0,-0.527705401,1.199868494,-0.439802698,0.660080013,0.765305778,18.77777647,0,-0.964838594,1.153678448,-0.836315002,0.402977716,0.546570579,12.54721308,0,-1.563141555,1.198698106,-1.304032723,0.192222426,0.31240001,N,-,,AMP-binding enzyme,P:metabolic process; F:ligase activity,IPR000873 (PFAM); G3DSA:2.30.38.10 (GENE3D); G3DSA:3.30.300.30 (GENE3D); IPR025110 (PFAM); G3DSA:3.40.50.980 (GENE3D); G3DSA:3.40.50.980 (GENE3D); PTHR24095:SF202 (PANTHER); PTHR24095 (PANTHER); PTHR24095 (PANTHER); PTHR24095:SF202 (PANTHER); SSF56801 (SUPERFAMILY),4.C.1.1.4, the fatty acid transporter (fat) family.
RL4_JR_08736,304,311,443,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,149.4023051,0,-4.342825501,1.179138623,-3.683049148,0.000230461,0.001742445,46.0296179,0,-2.058990908,1.20890963,-1.70318017,0.088534357,0.184088898,143.622954,0,-2.309345833,0.880010571,-2.624225105,0.008684637,0.029258989,196.2253933,0,-1.244263943,0.562364123,-2.212559251,0.026928047,0.087153604,119.0281419,0,-4.808936646,1.221356684,-3.937372848,8.24E-05,0.000589759,N,-,,dna-directed rna polymerase ii subunit rpb1,F:nucleic acid binding; F:DNA-directed RNA polymerase activity; C:membrane; C:integral component of membrane; P:RNA biosynthetic process,no IPS match,,
RL4_JR_08737,572,806,843,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,67.08389378,1,-0.814816605,0.761062672,-1.070630101,0.284335783,0.467663573,13.80018284,0,-0.321103971,1.211730477,-0.264996199,0.79101239,0.873795221,51.55878657,0,-1.151406576,1.037744219,-1.109528297,0.267202344,0.40532762,65.45993266,1,-0.124247236,0.642898428,-0.193261067,0.846754516,0.90382391,101.7001092,0,0.940791376,1.653415072,0.568998911,0.569356879,0.685854404,N,-,,tRNA(His) guanylyltransferase,F:magnesium ion binding; F:GTP binding; F:tRNA guanylyltransferase activity; F:identical protein binding; C:cytosol; P:tRNA modification,IPR025845 (PFAM); IPR024956 (PFAM); IPR007537 (PIRSF); PTHR12729:SF6 (PANTHER); IPR007537 (PANTHER); IPR007537 (PANTHER),,
RL4_JR_08738,30545,29782,40458,5,15,46,4,1,2,0,0,0,2,19,1,0,37,0,20.10347843,1,-1.180492575,1.146612894,-1.029547619,0.303222415,0.489415953,5.178061511,1,1.093066015,1.23768243,0.883155475,0.377152274,0.54172925,13.46635914,0,-1.562382883,1.194541327,-1.307935395,0.190895223,0.314079108,15.53735469,1,-1.98493373,1.19298493,-1.663838059,0.096144796,0.19035316,13.30940406,1,-1.648123295,1.201351209,-1.37189132,0.170097273,0.284917379,N,-,,SET1 complex component swd1,"C:Set1C/COMPASS complex; C:chromosome, telomeric region; C:cytosol; P:telomere maintenance; P:chromatin silencing at telomere; P:histone H3-K4 methylation",IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR22847:SF461 (PANTHER); PTHR22847 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_08739,39122,45806,60198,4,2,2,0,0,0,0,2,0,2,7,0,0,12,0,932.4741651,1,-3.227795094,0.602108391,-5.36082065,8.28E-08,1.65E-06,297.7537696,0,-3.713055196,1.127613023,-3.292845257,0.00099179,0.015023052,798.8014289,1,-2.922024039,0.566401699,-5.158925274,2.48E-07,7.86E-06,1075.213731,1,-1.670335959,0.35064001,-4.76367759,1.90E-06,3.25E-05,744.2576849,1,-3.599759281,0.577934711,-6.228660801,4.70E-10,2.89E-08,N,-,,DNA-directed RNA polymerase subunit 1,"F:DNA binding; F:DNA-directed RNA polymerase activity; P:transcription, RNA-templated; C:cytosol; P:transcription from RNA polymerase II promoter; P:translesion synthesis; C:DNA-directed RNA polymerase II, core complex",PR01217 (PRINTS); IPR006592 (SMART); IPR007083 (PFAM); IPR007080 (PFAM); IPR007075 (PFAM); IPR007066 (PFAM); G3DSA:3.30.1490.180 (GENE3D); IPR007081 (PFAM); IPR000722 (PFAM); IPR007073 (PFAM); G3DSA:2.40.40.20 (GENE3D); PTHR19376 (PANTHER); PTHR19376:SF37 (PANTHER); PTHR19376:SF37 (PANTHER); PTHR19376 (PANTHER); SSF64484 (SUPERFAMILY),,
RL4_JR_08740,82,53,146,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.24506702,0,1.415124554,1.028189467,1.37632664,0.168720529,0.321244096,23.77587346,0,3.840080748,1.118063732,3.434581265,0.00059347,0.015023052,324.9333395,0,6.411809333,1.599330791,4.009057645,6.10E-05,0.000843135,27.67471417,0,2.161980025,0.857677656,2.520737262,0.011710926,0.054844183,99.56231085,0,5.043186837,0.607146512,8.306375372,9.87E-17,1.64E-14,N,-,,hypothetical protein SPI_04909,,no IPS match,,
RL4_JR_08741,20109,12562,18715,0,3,7,0,0,0,1,0,0,2,4,0,0,0,0,0.992847184,1,1.907794268,1.636840325,1.165534743,0.243802605,NA,0.313564206,0,5.138366333,1.749260672,2.937450327,0.003309232,0.016323608,0.821155611,1,2.472373909,1.318091928,1.87572191,0.060693476,0.131491707,0.947731839,1,2.049732948,1.398774806,1.46537737,0.142817988,0.256687105,0.819115806,0,2.37405784,1.303810746,1.820860772,0.068628024,0.142857471,N,-,,hypothetical protein SPI_07721,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_08742,186,125,198,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.673977688,0,0.478486263,1.256768593,0.38072742,0.703405521,0.839696806,0.850028894,0,3.699830242,1.436362867,2.57583256,0.009999906,0.033549568,2.212761561,0,1.04273212,1.223172793,0.852481454,0.393946928,0.537131001,2.553109538,0,0.62023503,1.232409062,0.503270423,0.614774158,0.733945095,2.190699651,0,0.954846171,1.223890171,0.780173086,0.435289002,0.570151533,N,-,,hypothetical protein VM1G_00854,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_08743,2982,3328,3450,0,1,17,0,0,1,6,4,2,1,6,4,0,8,4,12.5390071,1,-1.750492091,1.191368,-1.469312665,0.141748003,0.284822712,4.0038903,1,1.46415147,1.255729159,1.165977121,0.243623696,0.396265314,10.37538254,1,-1.186003736,1.193764977,-0.993498518,0.320467072,0.463023925,11.96879973,1,-1.608269375,1.191497417,-1.349788386,0.177083871,0.301309407,29.51210391,1,1.663114481,0.676739375,2.457540587,0.0139892,0.041080878,N,-,,major facilitator superfamily transporter,,no IPS match,,
RL4_JR_08744,1573,1631,2459,0,0,5,0,0,0,0,0,0,4,13,11,0,1,2,11.611684,1,-1.640021939,1.202773211,-1.36353381,0.172714336,0.326763348,3.703312657,0,1.576649785,1.270199881,1.241261166,0.214509286,0.361204833,9.622019983,0,-1.077510773,1.204512172,-0.894561964,0.371021292,0.515263792,29.72504394,1,0.25042399,1.025026157,0.244309853,0.806990853,0.876693389,28.81259619,1,1.738952936,0.716902992,2.425646084,0.015281164,0.044092844,N,-,,NADH-ubiquinone oxidoreductase assembly factor N7BML,F:electron carrier activity; C:membrane; F:NADH dehydrogenase (ubiquinone) activity; P:oxidation-reduction process,IPR007763 (PFAM); PTHR12910:SF1 (PANTHER); IPR007763 (PANTHER),,
RL4_JR_08745,61,21,59,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,146.9936833,0,-1.110832269,0.595341188,-1.865875049,0.062058849,0.15640287,39.77616532,0,-0.543662938,1.120259033,-0.485301097,0.627462777,0.755014055,138.7881079,0,-0.291071229,0.556676909,-0.522872826,0.601062756,0.71932704,145.7314473,0,-0.968948468,0.586372127,-1.652446328,0.098443598,0.193654834,146.5370779,0,0.293452853,0.604034761,0.485821136,0.627093988,0.731152306,N,-,,calponin domain containing,C:cell part; P:single-organism cellular process,IPR003096 (PRINTS); IPR001715 (SMART); IPR001715 (G3DSA:1.10.418.GENE3D); IPR001715 (PFAM); PTHR18959 (PANTHER); IPR001715 (PROSITE_PROFILES); IPR001715 (SUPERFAMILY),,
RL4_JR_08746,26,31,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,107.3965928,0,-3.850943795,1.167505157,-3.298438361,0.000972242,0.005793683,33.34294791,0,-1.593767222,1.221477909,-1.304785957,0.191965742,0.333787344,119.7616976,0,-1.107986969,0.703244228,-1.575536527,0.115132654,0.215373797,191.063707,0,-0.039832774,0.482331361,-0.082583836,0.934182454,0.961826047,114.5779938,0,-0.915979855,0.619752614,-1.47797659,0.139414044,0.245234051,N,-,,udp- transferase,P:metabolic process,IPR004276 (PFAM); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); IPR002213 (PANTHER); PTHR11926:SF164 (PANTHER); SSF53756 (SUPERFAMILY),,
RL4_JR_08747,0,6,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,33.86423565,1,0.924686175,0.848116788,1.090281655,0.275589094,0.4587341,3.135471984,0,1.816799339,1.269098803,1.431566506,0.152267921,0.279770539,8.143310694,0,-0.836786412,1.196465389,-0.699382046,0.484313305,0.620185669,9.394636194,0,-1.259192023,1.194464603,-1.054189484,0.291796174,0.436272336,15.76188274,0,0.744766798,0.983896044,0.756956797,0.449075746,0.580923972,N,-,,abc1 domain containing,P:ribosomal large subunit biogenesis; C:membrane; C:integral component of membrane; P:translational initiation,IPR019191 (PFAM); PTHR18829:SF0 (PANTHER); PTHR18829 (PANTHER),,
RL4_JR_08748,10837,10059,13213,0,0,9,0,0,0,0,0,1,1,6,2,0,7,3,191.0585228,1,-3.305015084,0.882257718,-3.746088036,0.000179614,0.001404878,57.03219492,0,-2.368196412,1.195022349,-1.981717257,0.047510895,0.113287462,148.3635228,1,-5.024006379,1.196729269,-4.198114402,2.69E-05,0.000431146,196.5474526,1,-2.411805116,0.686647086,-3.512437705,0.000444016,0.003797013,165.9014132,1,-2.206814708,0.715673893,-3.083547869,0.002045482,0.008632974,N,-,,g-patch domain containing,F:nucleic acid binding; P:box C/D snoRNA 3'-end processing; P:positive regulation of catalytic activity; F:enzyme activator activity; P:negative regulation of telomere maintenance via telomerase; C:nucleolus; F:telomerase inhibitor activity; P:negative regulation of telomerase activity; C:nucleoplasm,IPR000467 (SMART); IPR000467 (PFAM); PTHR23149:SF13 (PANTHER); PTHR23149 (PANTHER); IPR000467 (PROSITE_PROFILES),,
RL4_JR_08749,2466,2485,3253,1,0,0,0,0,0,0,0,0,1,1,9,0,0,0,3.269352587,1,0.188797328,1.288263006,0.146551851,0.883485761,0.943016726,150.106736,0,7.227555581,0.587436447,12.3035532,8.67E-35,1.46E-31,53.47299879,0,3.939869945,0.717698763,5.489587206,4.03E-08,1.50E-06,19.15581795,1,3.009481085,0.814884848,3.693136636,0.000221505,0.002090156,25.83094388,0,3.784530895,0.731561797,5.173221063,2.30E-07,4.41E-06,Y,-,,Pectinesterase,P:pectin catabolic process; C:cell wall; F:aspartyl esterase activity; C:extracellular region; P:cell wall modification; F:pectinesterase activity,IPR012334 (G3DSA:2.160.20.GENE3D); IPR000070 (PFAM); PTHR31321:SF1 (PANTHER); PTHR31321 (PANTHER); IPR011050 (SUPERFAMILY),,
RL4_JR_08750,1956,2388,2166,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0.023739554,1,7.293271016,3.951438118,1.845725733,0.064932039,NA,0.007849436,0,10.46050377,3.590523679,2.913364373,0.003575571,0.016958421,0.019946832,0,7.837352665,2.157725522,3.632228744,0.000280984,0.002210804,0.022977324,1,7.416384117,3.950883384,1.877145791,0.060498115,0.137403188,0.019289782,0,7.769566241,1.492133271,5.207018966,1.92E-07,3.89E-06,Y,-,,carbohydrate-binding module family 18,,no IPS match,,
RL4_JR_08751,68788,66392,89134,17,16,88,1,0,0,4,2,5,7,44,0,0,24,5,14.48625129,1,-1.95904127,1.186673611,-1.650867813,0.098765569,0.219345343,4.620983595,1,1.257301596,1.241736691,1.012534787,0.311282423,0.472984319,27.68020558,1,0.428781946,1.028665639,0.416833157,0.676800448,0.777920951,29.88340069,1,0.901047795,0.740562274,1.216707664,0.223715462,0.359179768,23.05900467,1,0.198728996,0.973166406,0.204208648,0.838190453,0.89089632,N,-,,hypothetical protein UCREL1_8362,P:biological_process; C:cellular_component,PTHR38795 (PANTHER); PTHR38795:SF1 (PANTHER),,
RL4_JR_08752,337,254,317,0,4,2,0,0,0,0,0,4,0,7,0,0,0,5,8.182934281,1,4.413044564,1.245040593,3.544498541,0.000393361,0.002740424,0.172415842,0,6.001090906,2.051698911,2.924937414,0.003445255,0.016643092,0.452219288,1,3.332761671,1.451076205,2.296751651,0.021632941,0.059192404,0.521930851,1,2.910286477,1.654089963,1.759448725,0.078501322,0.164220224,0.452468829,1,3.230122464,1.405956467,2.297455532,0.021592797,0.058160966,N,-,,hypothetical protein Z518_06398,C:membrane,PTHR35043 (PANTHER); PTHR35043:SF2 (PANTHER),,
RL4_JR_08753,10548,13239,8955,0,0,27,9,0,0,0,0,1,3,18,4,0,4,2,14.22334611,1,-1.932501531,1.196372768,-1.6153005,0.106245635,0.231566095,4.520041434,1,1.289146079,1.246051226,1.034585138,0.300862698,0.461134498,11.75674296,1,-1.366491781,1.196315562,-1.142250276,0.253350003,0.389036165,40.21280838,1,0.943446661,0.746642756,1.2635851,0.206378984,0.338418015,30.56612205,1,1.161821724,0.762638597,1.523423713,0.127652733,0.229180092,N,-,,abhydrolase domain-containing 12,C:membrane,IPR029058 (G3DSA:3.40.50.GENE3D); IPR000073 (PFAM); PTHR12277 (PANTHER); PTHR12277 (PANTHER); PTHR12277:SF50 (PANTHER); PTHR12277:SF50 (PANTHER); IPR029058 (SUPERFAMILY),1.C.57.3.4, the clostridial cytotoxin (cct) family.
RL4_JR_08754,2200,2773,2770,0,1,4,0,0,0,1,1,1,0,12,0,0,4,0,442.9239593,1,0.871905426,0.465367003,1.873586699,0.060987413,0.154238016,97.7919169,0,-0.524532975,0.988913198,-0.530413566,0.595825222,0.731514459,705.7098836,1,2.140550309,0.299456584,7.14811569,8.80E-13,7.18E-11,527.1130705,1,1.363046815,0.321534834,4.239188641,2.24E-05,0.000290452,403.5769457,1,1.256422236,0.470964037,2.667766829,0.007635723,0.025331486,Y,-,,xyloglucan-specific endoglucanase,"P:carbohydrate metabolic process; C:membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR013319 (G3DSA:2.60.120.GENE3D); IPR002594 (PFAM); PTHR34002:SF3 (PANTHER); PTHR34002 (PANTHER); IPR013320 (SUPERFAMILY),,
RL4_JR_08755,2696,2786,3114,1,0,19,0,0,0,0,0,0,3,3,0,0,1,1,806.7132032,1,0.069366695,0.484047052,0.143305685,0.886048766,0.944154115,307.0102301,0,0.515622061,0.532365794,0.968548442,0.332770538,0.496068245,767.8203029,0,0.549293195,0.517796301,1.060828736,0.28876774,0.42816119,695.0408344,1,-0.124313276,0.255109084,-0.487294588,0.626049583,0.742849742,612.2704954,1,0.033014698,0.665159409,0.049634264,0.960413841,0.973947415,N,-,,glycosyl family 2,C:integral component of membrane; F:transferase activity,IPR029044 (G3DSA:3.90.550.GENE3D); PF13641 (PFAM); PTHR10587:SF87 (PANTHER); PTHR10587:SF87 (PANTHER); PTHR10587 (PANTHER); PTHR10587 (PANTHER); IPR029044 (SUPERFAMILY),4.D.3.1.12, the glycan glucosyl transferase (opgh) family.
RL4_JR_08756,6885,5069,4888,3,1,6,0,0,0,0,0,0,0,6,10,0,7,0,1.843247275,1,1.01565937,1.303663622,0.779080856,0.435932087,NA,0.588577495,0,4.230296526,1.518201849,2.786386099,0.005329935,0.021493864,1.524274731,0,1.581277009,1.230245921,1.28533408,0.198675566,0.323947726,1.758356696,1,1.158894715,1.248302817,0.928376272,0.353212423,0.499479857,1.498140657,1,1.503349984,1.216381357,1.235919949,0.216488321,0.341637196,N,-,,aaa atpase domain containing,F:GTP binding; F:hydrolase activity,IPR027417 (G3DSA:3.40.50.GENE3D); PTHR32046 (PANTHER); PTHR32046:SF0 (PANTHER); IPR027417 (SUPERFAMILY),1.C.125.1.3,the pore-forming stonustoxin (stonustoxin) family
RL4_JR_08757,4224,3256,3458,1,0,0,0,0,0,0,0,3,3,0,0,0,0,0,0.081614178,1,5.513015502,3.919823675,1.406444769,0.159592094,NA,0.025919074,0,8.735950776,2.802255303,3.117471405,0.001824096,0.015023052,0.067156494,1,6.088056579,1.642878781,3.705724762,0.000210787,0.001811552,0.077484893,1,5.663404695,2.637744299,2.147063571,0.031788221,0.095308184,0.065849824,0,6.015368611,1.367939188,4.397394756,1.10E-05,0.000108966,N,-,,hypothetical protein CMQ_2898,,no IPS match,,
RL4_JR_08758,88,72,40,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0.091555283,0,5.346677449,3.918403704,1.36450398,0.172409002,NA,0.029061919,1,8.569747969,2.672166977,3.207040594,0.001341081,0.015023052,0.075744578,0,5.910048383,1.520443796,3.887054817,0.000101468,0.001171335,0.087400506,0,5.48864414,2.437060565,2.252157464,0.024312323,0.084347946,0.075098222,0,5.821593984,1.306790369,4.454879775,8.39E-06,8.65E-05,N,-,,P-loop containing nucleoside triphosphate hydrolase,F:nucleotide binding,IPR001270 (PRINTS); G3DSA:1.10.8.60 (GENE3D); IPR019489 (PFAM); IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11638 (PANTHER); IPR027417 (SUPERFAMILY),3.A.9.1.2, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_08759,34,62,44,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.49000864,0,2.481819723,0.694279214,3.574670929,0.000350669,0.002470427,78.3864415,0,4.354643667,0.978964159,4.448215622,8.66E-06,0.000580417,4.459202601,0,0.032175997,1.206834795,0.026661476,0.97872974,0.988358486,9.156714858,0,0.556155852,1.15318479,0.482278171,0.629608352,0.745501645,8.265075575,0,0.876560734,1.136850646,0.771043001,0.440681444,0.574616821,N,-,,kinase-like domain,P:phosphorylation; F:transferase activity; F:kinase activity,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); IPR011009 (SUPERFAMILY),,
RL4_JR_08760,13188,14934,14693,4,5,22,0,0,1,1,0,1,1,10,0,0,1,3,5.714627365,1,1.918531703,1.196234822,1.603808606,0.108756247,0.235340441,0.599451184,1,4.203618667,1.525869019,2.75490138,0.005870983,0.022944436,1.56625296,1,1.541155431,1.249574543,1.233344133,0.217447399,0.346301316,1.807574395,1,1.118400258,1.274021087,0.877850664,0.380024766,0.525936407,1.55656456,1,1.447980208,1.249275677,1.159055791,0.246433444,0.376572116,N,-, Effector probability:0.764,ubiquitin carboxyl-terminal hydrolase,P:proteolysis; F:thiol-dependent ubiquitinyl hydrolase activity,IPR001578 (G3DSA:3.40.532.GENE3D); IPR001578 (PFAM); IPR001578 (PANTHER); PTHR10589:SF26 (PANTHER); SSF54001 (SUPERFAMILY),,
RL4_JR_08761,1428,987,1327,0,0,7,0,0,0,0,0,0,2,0,2,0,0,0,0.673602182,1,2.467909652,1.913334366,1.289847554,0.197103593,NA,0.212474279,0,5.700181529,1.902245899,2.996553458,0.002730504,0.015349618,0.553678515,0,3.042351127,1.361633762,2.234338786,0.02546079,0.067514349,0.639021585,1,2.619161356,1.49924736,1.746984137,0.08064009,0.167208843,0.546699955,0,2.958254044,1.321716617,2.238190854,0.025208612,0.065810671,N,-,,aldehyde dehydrogenase,"P:amine metabolic process; F:copper ion binding; F:quinone binding; F:primary amine oxidase activity; P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",IPR016162 (G3DSA:3.40.605.GENE3D); IPR015590 (PFAM); IPR016163 (G3DSA:3.40.309.GENE3D); PTHR11699:SF206 (PANTHER); PTHR11699 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_08762,2553,2571,3628,0,3,3,0,0,0,0,0,0,1,1,0,0,0,0,13.58983664,1,3.087361142,0.888486474,3.474854409,0.000511131,0.003426298,0.676673314,0,4.028856389,1.483473261,2.715826766,0.00661105,0.024866982,1.764093189,0,1.369629026,1.231860703,1.111837582,0.26620799,0.404165772,33.98403354,1,3.698174851,0.762852395,4.847824922,1.25E-06,2.26E-05,1.748746436,0,1.280017395,1.231186993,1.039661239,0.298497315,0.433737846,N,-,,AT hook motif family,F:DNA binding,no IPS match,,
RL4_JR_08763,4995,4953,9587,0,2,0,0,0,0,0,0,2,0,0,3,0,0,0,0.048744889,1,6.256684928,3.928606276,1.592596582,0.111250721,NA,0.015380508,0,9.488430747,3.077335274,3.083326938,0.002047001,0.015023052,0.040061718,1,6.832510421,1.776243216,3.846607469,0.000119765,0.001296788,0.04623604,1,6.408014646,3.182720225,2.01337667,0.044075018,0.113919494,0.039530626,0,6.753702613,1.384829372,4.876920397,1.08E-06,1.54E-05,N,-,,Transcription fungi,"F:FAD binding; C:nucleus; F:DNA binding; F:zinc ion binding; F:oxidoreductase activity; P:transcription, DNA-templated; C:membrane; P:oxidation-reduction process; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (PFAM),,
RL4_JR_08764,18639,16840,16947,6,4,18,0,0,4,0,0,18,3,3,3,0,13,1,1.494175425,1,1.318380355,1.506390086,0.875191869,0.381469516,NA,0.486467779,1,4.505336387,1.683720151,2.675822573,0.00745461,0.027180643,1.24449596,1,1.873823773,1.318170343,1.421533858,0.155161618,0.268936179,1.434449523,1,1.452575627,1.372639704,1.058235182,0.289948235,0.43472914,1.20823828,1,1.813038096,1.291598085,1.403716928,0.16040316,0.272040534,N,-,,hypothetical protein F503_08336,,no IPS match,,
RL4_JR_08765,31293,38347,40866,17,23,8,0,0,6,0,1,1,2,5,2,0,5,0,55.23322895,1,0.120442947,0.754559306,0.159620253,0.873180224,0.939103212,7.379634805,1,0.581972068,1.227992289,0.473921598,0.635555817,0.761763881,41.35117604,1,0.335118073,0.85557944,0.391685514,0.695290595,0.792158674,57.43022554,1,0.813859706,0.624006041,1.304249722,0.192148452,0.321185039,22.7632911,1,-1.224528799,1.128968547,-1.084643857,0.278079422,0.411570553,N,-, Effector probability:0.754,cytochrome c oxidase assembly subunit 17,P:mitochondrial respiratory chain complex IV assembly; C:mitochondrial intermembrane space; P:intracellular copper ion transport; P:protein farnesylation; C:cytosol; F:copper chaperone activity,IPR007745 (PFAM); IPR009069 (G3DSA:1.10.810.GENE3D); IPR007745 (PANTHER); IPR007745 (PRODOM); IPR009069 (SUPERFAMILY),,
RL4_JR_08766,45173,49692,50554,19,10,32,0,0,1,2,2,7,5,14,5,0,16,6,20.84021812,1,-2.483501474,1.197265575,-2.074311269,0.038050412,0.108688817,6.654273461,1,0.731277988,1.238951744,0.590239282,0.55503024,0.700193732,17.23632621,1,-1.918306909,1.197378819,-1.602088561,0.109136027,0.206908828,29.19563978,1,-1.390417063,1.148248249,-1.210902838,0.225932645,0.361652089,16.94668717,1,-1.996668093,1.197502195,-1.667360696,0.095442704,0.18435366,N,-,,telomere length regulation,F:telomeric DNA binding; P:telomere maintenance via telomerase; C:nuclear telomere cap complex; P:protein localization to chromosome,IPR019337 (PFAM); PTHR15830 (PANTHER),,
RL4_JR_08767,12914,10331,11793,2,6,19,0,0,0,0,0,0,1,8,0,0,18,7,28.12395369,1,4.896624895,0.619436383,7.904968178,2.68E-15,1.88E-13,0.442516259,0,4.641605254,1.577130813,2.943069285,0.003249757,0.016208996,1.152430338,0,1.983880684,1.236962049,1.603833105,0.108750845,0.206294465,1.329760934,1,1.561381209,1.266451655,1.232878652,0.217621041,0.352602503,1.140876825,1,1.896289129,1.227810647,1.544447536,0.122479952,0.222481075,N,-,,methyltransferase type 12,F:transferase activity,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF852 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_08768,10323,9682,8748,3,0,11,0,0,2,0,3,9,4,8,5,0,1,0,94.23044858,1,1.905069407,0.516449964,3.688778273,0.000225333,0.00170843,5.950069833,1,0.892593035,1.229826074,0.725788023,0.46796873,0.626719634,21.95846443,1,-0.799702572,1.190354127,-0.671819045,0.501698903,0.634186502,65.83122105,1,1.541374252,0.538749737,2.86102089,0.004222792,0.024572283,15.26159046,1,-1.845577401,1.196906129,-1.54195668,0.123084121,0.223284633,N,-,,nedd8-activating enzyme e1 catalytic subunit,F:ATP binding; F:NEDD8 activating enzyme activity; P:protein neddylation; F:acid-amino acid ligase activity,IPR014929 (SMART); IPR023318 (G3DSA:1.10.10.GENE3D); IPR014929 (G3DSA:3.10.20.GENE3D); IPR000594 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR014929 (PFAM); IPR030468 (PTHR10953:PANTHER); PTHR10953 (PANTHER); IPR000594 (SUPERFAMILY),3.A.25.1.1, the symbiont-specific erad-like machinery (selma) family.
RL4_JR_08769,4243,5385,6252,0,1,10,0,0,0,0,7,1,0,2,4,0,7,2,209.9158269,1,-2.236980338,0.7038696,-3.178117566,0.001482346,0.008137942,55.08009595,0,-2.317954776,1.214534281,-1.908513257,0.056324911,0.129690799,183.4941613,1,-2.130657744,0.783941096,-2.717879895,0.006570168,0.023363675,173.9680618,1,-3.693230136,1.056942372,-3.494258755,0.00047538,0.004011019,174.0166344,1,-2.14727461,0.753925076,-2.848127325,0.004397733,0.016144686,N,-,,rna polymerase rpb3 insert domain-containing,F:RNA polymerase III activity; F:DNA binding; C:DNA-directed RNA polymerase I complex; F:RNA polymerase I activity; P:transcription from RNA polymerase I promoter; C:cytosol; F:protein dimerization activity; P:tRNA transcription from RNA polymerase III promoter; C:DNA-directed RNA polymerase III complex,IPR011263 (SMART); G3DSA:3.30.1360.10 (GENE3D); IPR011262 (G3DSA:2.170.120.GENE3D); IPR011262 (PFAM); IPR009025 (PFAM); PTHR11800:SF13 (PANTHER); PTHR11800 (PANTHER); IPR011262 (SUPERFAMILY); IPR009025 (SUPERFAMILY),,
RL4_JR_08770,3000,3044,3577,0,4,8,0,0,0,0,7,0,0,2,0,0,4,0,289.5718968,1,-0.089315959,0.397099491,-0.224920859,0.822040842,0.909928731,71.20073087,0,-1.222974667,1.11046787,-1.10131477,0.270759685,0.428290285,140.2181576,1,-2.984447817,1.04168375,-2.865022917,0.004169791,0.016812011,259.0138605,1,-0.403460057,0.414801973,-0.972657036,0.330723785,0.477312696,288.1946939,1,0.637230538,0.466976304,1.364588592,0.172382392,0.287588025,N,-,,nadh-ubiquinone oxidoreductase 49 kda subunit,"F:quinone binding; F:NAD binding; P:oxidation-reduction process; F:oxidoreductase activity, acting on NAD(P)H",IPR001135 (PFAM); IPR029014 (G3DSA:1.10.645.GENE3D); IPR022885 (TIGRFAM); PTHR11993 (PANTHER); PTHR11993:SF10 (PANTHER); IPR022885 (HAMAP); IPR029014 (SUPERFAMILY),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_08771,688,568,506,3,0,15,0,0,0,2,2,12,3,9,0,0,5,0,3.460489159,1,0.10647981,1.244098828,0.085587903,0.931794015,0.966629651,1.099366585,0,3.328733533,1.397840488,2.381340047,0.01724978,0.051263146,2.8634756,1,0.670848735,1.222597823,0.548707614,0.58320612,0.704663893,68.48986688,1,4.25079704,1.740884146,2.44174608,0.014616423,0.06554087,2.837001111,1,0.581860412,1.226619695,0.474360892,0.635242576,0.738133087,N,-,,hypothetical protein F503_08331,,no IPS match,,
RL4_JR_08772,23121,27184,36878,6,14,6,0,0,3,0,4,1,6,7,4,0,18,3,127.9401783,1,2.667120833,0.597420193,4.46439686,8.03E-06,9.58E-05,14.53537901,1,2.015104328,1.127480071,1.787263811,0.07389486,0.160197853,50.49033091,1,1.580626546,0.68221719,2.316896394,0.020509376,0.056681774,32.82687395,1,0.329911716,0.863775536,0.381941491,0.702504764,0.800376426,17.13983802,1,-0.715781418,1.137829013,-0.629076434,0.529299018,0.652679644,N,-,,ubiquinone biosynthesis monooxygenase Coq6,"F:FAD binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; P:oxidation-reduction process; C:extrinsic component of mitochondrial inner membrane; P:ubiquinone biosynthetic process",PR00420 (PRINTS); IPR010971 (TIGRFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR002938 (PFAM); PTHR13789:SF240 (PANTHER); PTHR13789 (PANTHER); IPR000689 (HAMAP); IPR023753 (SUPERFAMILY),,
RL4_JR_08773,19603,19309,27168,2,4,16,0,0,0,2,0,0,1,18,2,0,12,6,164.1401104,1,0.43916778,0.57982879,0.757409407,0.448804622,0.637703494,43.00215476,0,0.027416056,1.151853187,0.023801693,0.981010789,0.990206543,295.8511201,1,2.157061771,0.426264309,5.060385606,4.18E-07,1.24E-05,160.2723556,1,0.541975519,0.721702472,0.750968079,0.452671867,0.594770653,149.6722714,1,1.139138311,0.500485925,2.276064628,0.022842142,0.060638879,N,-,,sphingolipid long chain base-responsive LSP1,C:prospore membrane leading edge; C:prospore membrane spindle pole body attachment site; P:ascospore-type prospore-specific spindle pole body remodeling; C:meiotic spindle pole body,IPR028245 (PFAM); PTHR31962:SF4 (PANTHER); PTHR31962 (PANTHER),,
RL4_JR_08774,4905,6852,6888,4,13,28,0,2,2,10,11,8,3,26,2,0,13,0,2.464141744,1,0.596876058,1.365840067,0.437002891,0.662109251,0.810691961,0.788272144,1,3.808905664,1.536668024,2.478678286,0.013187019,0.041595203,2.035064627,1,1.164357824,1.277789968,0.911227865,0.362175325,0.506095651,2.34736205,1,0.742126324,1.303224124,0.569454103,0.56904801,0.696096195,1.990220362,1,1.093490331,1.266319483,0.863518524,0.387852439,0.523935368,N,-,,---NA---,,no IPS match,,
RL4_JR_08775,293,568,566,0,0,1,0,0,0,0,0,0,0,3,0,0,0,0,112.8809368,1,0.752554568,0.739241822,1.018008648,0.308673846,0.496189406,15.09681846,0,-0.450657663,1.223574694,-0.368312343,0.71264035,0.819884704,108.2877158,0,1.010038993,0.53711594,1.880485977,0.060041876,0.130386948,65.36848355,1,-0.530601915,0.722948527,-0.733941484,0.462984402,0.604944777,69.29485616,0,0.190815397,0.636872371,0.299613244,0.764472181,0.835612742,Y,-,,oligosaccharyltransferase alpha subunit,C:endoplasmic reticulum membrane; F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; C:integral component of membrane; P:protein glycosylation,IPR007676 (PFAM); IPR007676 (PANTHER),9.B.142.3.14, the integral membrane glycosyltransferase family 39 (gt39) family.
RL4_JR_08776,2404,2671,3607,0,1,1,0,0,4,0,4,1,0,3,3,0,4,4,609.3773898,1,0.4954022,0.664863419,0.745118751,0.456199935,0.644676253,87.26937161,1,-1.903219673,1.147306219,-1.658859371,0.097144133,0.198124706,412.2285502,1,0.109113536,0.641221503,0.170165123,0.86488028,0.913897083,441.8650783,1,-0.172858973,0.707030347,-0.244485931,0.806854497,0.876639316,266.0474265,1,-1.494285647,0.643700601,-2.321398559,0.020265343,0.055068868,N,-,,hexokinase,P:glycolytic process; F:glucokinase activity; P:fructose 6-phosphate metabolic process; P:mannose metabolic process; P:fructose metabolic process; P:glucose metabolic process; P:carbohydrate phosphorylation; F:fructokinase activity; F:glucose binding; C:nucleus; F:ATP binding; P:glucose 6-phosphate metabolic process; P:cellular glucose homeostasis; C:cytosol; F:mannokinase activity,PR00475 (PRINTS); IPR022673 (PFAM); IPR022672 (PFAM); G3DSA:3.40.367.20 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR001312 (PANTHER); PTHR19443:SF21 (PANTHER); IPR001312 (PROSITE_PROFILES); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_08777,4108,6751,6694,0,1,19,0,0,0,0,1,0,4,4,2,0,5,5,45.07243035,1,-3.596535536,1.222844752,-2.941121946,0.003270258,0.015439098,14.25909925,0,-0.368354793,1.230163492,-0.29943564,0.764607672,0.857505226,43.74939834,1,-2.068462781,1.213669151,-1.704305312,0.088324063,0.176124327,74.93742733,1,-0.687638577,0.788179225,-0.872439357,0.382968738,0.528205758,37.02382706,1,-3.124162731,1.226551889,-2.547110121,0.010861915,0.033590987,N,-,,arginine n-methyltransferase 2,C:nucleus; C:cytoplasm; F:protein-arginine N-methyltransferase activity; P:peptidyl-arginine N-methylation,IPR017408 (PIRSF); IPR029063 (G3DSA:3.40.50.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR32379:SF1 (PANTHER); PTHR32379 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR026480 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY); IPR020683 (SUPERFAMILY),,
RL4_JR_08778,1123,1035,1831,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,64.07755548,0,0.778760143,0.719388946,1.082530038,0.279017076,0.462451086,7.900337338,0,0.483644082,1.300145812,0.371992185,0.709898668,0.817566767,55.61557331,0,0.957028305,0.758362974,1.261966022,0.206961013,0.333854891,130.6676728,1,2.006378977,0.60333516,3.325479949,0.000882664,0.006679356,34.74809567,1,-0.517159608,1.03417081,-0.500071751,0.617024556,0.723745787,N,-,,vacuolar transporter chaperone 4,"C:vacuolar transporter chaperone complex; C:integral component of membrane; C:intrinsic component of vacuolar membrane; P:vacuole fusion, non-autophagic; C:endoplasmic reticulum; P:vacuolar transport; P:phosphorylation; F:polyphosphate kinase activity; P:polyphosphate metabolic process; P:lysosomal microautophagy",IPR018966 (PFAM); IPR003807 (PFAM); PTHR10783 (PANTHER); PTHR10783:SF3 (PANTHER); IPR004331 (PROSITE_PROFILES),4.E.1.1.3, the vacuolar (acidocalcisome) polyphosphate polymerase (v-ppp) family.
RL4_JR_08779,133,127,132,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32.61787026,0,-0.213602485,0.871265709,-0.245163425,0.806329895,0.901743694,6.776414922,0,0.705051848,1.244977562,0.566316911,0.571178366,0.711878091,43.51400223,0,0.869068858,0.75894475,1.145101613,0.252167067,0.387690112,56.16708863,0,0.699168745,0.683900316,1.022325518,0.30662686,0.452367325,44.21391637,0,1.372722808,0.60271599,2.277561621,0.022752709,0.060464877,N,-,,cell division control 54,P:negative regulation of ATP-dependent DNA helicase activity; P:mitotic DNA replication initiation; F:chromatin binding; C:MCM complex; C:MCM core complex; F:single-stranded DNA binding; P:cell division; F:ATP binding; F:RNA helicase activity; P:DNA duplex unwinding; F:single-stranded RNA binding; F:single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity; F:3'-5' DNA/RNA helicase activity; C:rDNA protrusion,IPR008047 (PRINTS); IPR001208 (PRINTS); IPR031327 (SMART); IPR033762 (PFAM); IPR027925 (PFAM); IPR004039 (G3DSA:2.20.28.GENE3D); G3DSA:2.40.50.140 (GENE3D); IPR001208 (PFAM); G3DSA:3.30.1640.10 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11630:SF66 (PANTHER); PTHR11630 (PANTHER); PTHR11630 (PANTHER); PTHR11630:SF66 (PANTHER); IPR001208 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR012340 (SUPERFAMILY),,
RL4_JR_08780,525,636,629,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,57.912872,1,0.038470148,0.645088184,0.059635487,0.952445954,0.976893618,119.1232433,0,3.205271168,0.620937869,5.161983714,2.44E-07,2.59E-05,51.06566702,0,-0.833645797,1.03353831,-0.806593997,0.419900433,0.561345832,59.05707947,0,-0.049965273,0.680137382,-0.073463501,0.941437288,0.965760135,62.98058944,0,0.8327057,0.576444316,1.444555314,0.148582832,0.257250543,N,-,,coatomer subunit zeta,"P:retrograde vesicle-mediated transport, Golgi to ER; P:protein transport; C:COPI vesicle coat",IPR022775 (PFAM); G3DSA:3.30.450.60 (GENE3D); PTHR11043 (PANTHER); PTHR11043:SF0 (PANTHER); IPR011012 (SUPERFAMILY),,
RL4_JR_08781,569,996,827,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,55.13893936,0,-0.064938289,0.687539472,-0.09445027,0.924751484,0.963735642,38.27980323,0,2.300459062,0.86449063,2.661057253,0.007789571,0.028039132,26.37652689,0,-2.53227079,1.197290221,-2.115001648,0.034429807,0.085352921,34.44289104,0,-2.008020917,1.150199523,-1.745802251,0.08084532,0.167497209,66.77158672,0,0.626018574,0.646488195,0.968337208,0.332875988,0.469595986,N,-,,translation initiation sua5,P:regulation of biological quality; F:nucleotidyltransferase activity; F:RNA binding; C:cytoplasm; P:tRNA processing; P:tRNA threonylcarbamoyladenosine metabolic process,IPR005145 (PFAM); IPR006070 (PFAM); IPR017945 (G3DSA:3.90.870.GENE3D); PTHR17490:SF3 (PANTHER); PTHR17490 (PANTHER); IPR006070 (PROSITE_PROFILES); IPR017945 (SUPERFAMILY),,
RL4_JR_08782,5030,6261,5462,3,2,11,0,0,0,0,0,0,0,8,0,0,6,0,97.40337116,1,0.099554923,0.649604936,0.153254566,0.878197528,0.940772371,17.77502674,0,-0.686237098,1.209235133,-0.567496824,0.570376684,0.711176728,78.44972547,0,-0.199087772,0.675151702,-0.294878576,0.768086639,0.844036593,82.37387198,1,-0.456730279,0.621836342,-0.734486309,0.462652402,0.604667041,45.15175684,1,-3.410521126,1.188857077,-2.86873939,0.004121112,0.015267567,N,-,,STE STE20 YSK kinase,C:cell part; F:kinase activity; P:cellular process,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24362 (PANTHER); PTHR24362:SF288 (PANTHER); PTHR24362:SF288 (PANTHER); PTHR24362 (PANTHER); PTHR24362:SF288 (PANTHER); PTHR24362 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_08783,452,526,828,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,109.327736,0,-3.814955849,1.145674047,-3.329878913,0.000868838,0.005340789,32.45199112,0,-1.554692064,1.201867205,-1.293563928,0.195816089,0.338812043,83.9281245,0,-4.202074576,1.19178792,-3.525857667,0.000422114,0.002992633,145.4458799,0,-0.899282788,0.543212062,-1.655491197,0.097824901,0.192774838,113.3073236,0,-0.690206872,0.556366545,-1.240561421,0.214767811,0.339504151,N,-,,DNA repair RAD16,"F:nucleic acid binding; F:ATP binding; F:zinc ion binding; F:ATP-dependent helicase activity; P:regulation of transcription, DNA-templated",IPR001841 (SMART); IPR001650 (SMART); IPR014001 (SMART); IPR018957 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000330 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR10799 (PANTHER); PTHR10799:SF598 (PANTHER); PTHR10799 (PANTHER); PTHR10799:SF598 (PANTHER); PTHR10799:SF598 (PANTHER); PTHR10799 (PANTHER); PTHR10799:SF598 (PANTHER); PTHR10799 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF57850 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_08784,2078,2751,2139,0,1,11,0,0,2,3,0,3,3,21,0,0,8,0,31.35978805,1,0.54926072,0.833759439,0.658776013,0.510039612,0.696096331,5.070666822,1,1.123264415,1.276269686,0.880115251,0.378796878,0.542987792,28.94735306,1,0.284821812,1.065593313,0.267289414,0.789246337,0.860655958,27.34116966,1,0.307796092,0.914973367,0.336398963,0.736570031,0.824427545,13.18055507,1,-1.634083861,1.238040744,-1.319895059,0.186870058,0.305812079,N,-,,short-chain dehydrogenase oxidoreductase,P:single-organism metabolic process,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24320:SF80 (PANTHER); PTHR24320 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_08785,150,264,252,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,105.9243098,0,-0.470940769,0.574762328,-0.819366102,0.412577569,0.603624069,21.51515565,0,-0.961728328,1.216574654,-0.790521424,0.429223315,0.591725227,105.597383,0,0.009395662,0.598569692,0.015696856,0.987476235,0.994252552,92.12947754,0,-0.551134016,0.619375274,-0.889822439,0.373561236,0.519191148,61.78618989,0,-2.74507392,1.124296849,-2.441591757,0.014622672,0.042654726,N,-,,DNA repair,P:primary metabolic process; P:cellular metabolic process; P:organic substance metabolic process,IPR013088 (G3DSA:3.30.50.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR24006:SF493 (PANTHER); PTHR24006 (PANTHER); SSF52047 (SUPERFAMILY),,
RL4_JR_08786,9204,15231,21564,0,1,4,0,0,2,0,0,0,0,2,0,0,6,1,15.32361944,1,-2.039896808,1.200680674,-1.698950314,0.089328546,0.203843993,4.874590068,1,1.180244717,1.249629326,0.944475847,0.344926539,0.508149809,23.73022044,0,-0.511396693,1.196675787,-0.42734774,0.669126065,0.772168276,14.6068283,1,-1.895698726,1.198170609,-1.582160931,0.113612837,0.215336947,12.48392008,1,-1.555711811,1.203185777,-1.292993851,0.196013186,0.317236814,N,-,,l-serine dehydratase,P:alpha-amino acid catabolic process; P:cellular amino acid catabolic process; C:mitochondrion; F:ammonia-lyase activity,IPR001926 (PFAM); G3DSA:3.40.50.1100 (GENE3D); PTHR10314 (PANTHER); PTHR10314:SF85 (PANTHER); IPR001926 (SUPERFAMILY),,
RL4_JR_08787,2731,2479,3962,0,1,0,0,0,0,0,0,0,0,4,0,0,7,0,43.96218173,1,1.544494932,0.600335227,2.572720811,0.010090257,0.038115088,4.046632408,0,1.448810367,1.249594288,1.159424608,0.246283151,0.399371685,10.49001184,0,-1.20195869,1.189591249,-1.010396378,0.312305422,0.454213489,34.73702835,1,0.6946633,0.842344603,0.824678282,0.409554265,0.553340931,17.69759944,1,-0.349227839,1.118276557,-0.31229112,0.754819288,0.829179265,N,-,,DNA polymerase subunit delta-2,"F:transferase activity, transferring acyl groups; C:cytoplasm; F:ligase activity; P:translation",IPR000182 (PFAM); IPR016181 (G3DSA:3.40.630.GENE3D); PTHR13256 (PANTHER); PTHR13256:SF16 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_08788,1152,1060,1225,4,1,5,0,0,0,0,8,2,0,2,0,0,0,1,27.73319633,1,-1.452186716,1.160887197,-1.250928358,0.210960617,0.378411766,6.272634003,0,0.816463936,1.248018652,0.65420812,0.512977731,0.66364527,41.6979308,1,0.57460331,0.865706822,0.663738919,0.506857425,0.638713539,46.08420591,1,0.475460272,0.764209516,0.622159581,0.533836941,0.66647337,16.04772318,1,-1.918023874,1.208777345,-1.58674704,0.112569948,0.20867278,N,-,,methionyl-tRNA synthetase,F:nucleotide binding; F:methionine-tRNA ligase activity; C:mitochondrion; P:methionyl-tRNA aminoacylation; C:cytosol,IPR033911 (PRINTS); IPR014758 (TIGRFAM); G3DSA:2.170.220.10 (GENE3D); IPR009080 (G3DSA:1.10.730.GENE3D); IPR014729 (G3DSA:3.40.50.GENE3D); IPR015413 (PFAM); PTHR11946:SF88 (PANTHER); PTHR11946 (PANTHER); PTHR11946:SF88 (PANTHER); SSF52374 (SUPERFAMILY); IPR009080 (SUPERFAMILY),,
RL4_JR_08789,1032,1913,1609,0,1,2,0,0,0,0,0,0,0,2,0,0,0,0,15.72559311,1,-2.077483443,1.214951971,-1.70993051,0.087278724,0.200117996,4.991924502,0,1.145838889,1.26266662,0.907475394,0.364155456,0.52857159,13.01275787,0,-1.513001149,1.212323018,-1.248018166,0.212024405,0.340072096,15.01522306,1,-1.935662134,1.212868494,-1.595937353,0.110502781,0.211499618,12.90628334,0,-1.603788619,1.223495215,-1.310825411,0.189916755,0.309846462,N,-,,nuclear transport factor 2 domain-containing,F:transferase activity; F:molecular_function,IPR032710 (G3DSA:3.10.450.GENE3D); IPR018222 (PROSITE_PROFILES),,
RL4_JR_08790,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,233.7419922,0,-0.171567643,0.411304912,-0.417130061,0.676583278,0.821975634,49.20541735,0,-0.932521757,1.107582077,-0.841943705,0.399819465,0.56368071,186.2619448,0,-0.499593693,0.517524135,-0.965353419,0.334367824,0.47771506,216.9233334,0,-0.013859615,0.415777881,-0.033334181,0.973408097,0.984893994,144.8384788,0,-0.660864417,0.607722421,-1.087444521,0.276840405,0.409976466,N,-,,mevalonate kinase,"F:ATP binding; P:farnesyl diphosphate biosynthetic process, mevalonate pathway; P:cellular macromolecule metabolic process; P:isopentenyl diphosphate biosynthetic process, mevalonate pathway; P:ergosterol biosynthetic process; F:mevalonate kinase activity; F:protein geranylgeranyltransferase activity; P:phosphorylation; C:ribosome",IPR006206 (PRINTS); IPR013750 (G3DSA:3.30.70.GENE3D); IPR013750 (PFAM); IPR002088 (PFAM); IPR006205 (TIGRFAM); G3DSA:1.25.40.120 (GENE3D); IPR006204 (PFAM); IPR014721 (G3DSA:3.30.230.GENE3D); IPR006206 (PANTHER); IPR006205 (PTHR10457:PANTHER); IPR002088 (PROSITE_PROFILES); IPR002088 (PROSITE_PROFILES); IPR002088 (PROSITE_PROFILES); IPR002088 (PROSITE_PROFILES); IPR002088 (PROSITE_PROFILES); SSF48439 (SUPERFAMILY); IPR013750 (SUPERFAMILY); IPR020568 (SUPERFAMILY),,
RL4_JR_08791,1163,1287,1417,0,2,9,0,0,0,0,0,0,4,3,1,0,8,0,4.14275052,1,-0.153014866,1.2450661,-0.122896982,0.902188676,0.952511352,1.310937294,0,3.074795478,1.376252161,2.234180309,0.025471212,0.069511891,3.42167797,0,0.414008744,1.224871017,0.33800191,0.735361748,0.821994296,3.948708649,1,-0.008793773,1.229992273,-0.007149454,0.994295609,0.995770826,3.395616065,1,0.322636701,1.232089164,0.261861488,0.793428232,0.860021502,N,-,,dimeric alpha-beta barrel,,PTHR42052:SF1 (PANTHER); PTHR42052 (PANTHER),,
RL4_JR_08792,2983,2460,3644,6,1,7,0,0,0,0,0,1,0,0,2,0,0,1,346.3363741,1,0.010446654,0.681314094,0.015333095,0.987766439,0.993857747,142.1102318,0,0.612683831,0.749595549,0.817352546,0.413726986,0.577692115,147.9750184,1,-5.020228496,1.236769911,-4.059145078,4.93E-05,0.000716429,230.9934435,1,-1.374816974,1.516754311,-0.90642035,0.364713406,0.511082862,166.8701475,1,-2.291450203,0.839053397,-2.730994487,0.006314353,0.021716312,N,-,,60S ribosomal L38,F:structural constituent of ribosome; P:cytoplasmic translation; C:cytosolic large ribosomal subunit,IPR002675 (PFAM); IPR002675 (PANTHER); IPR002675 (PRODOM),,
RL4_JR_08793,3528,2926,4695,1,2,2,0,0,0,0,0,0,0,3,0,0,0,0,4.897055087,1,-0.394189545,1.285301394,-0.306690358,0.759079069,0.873023023,1.541336715,0,2.841242752,1.39904079,2.030850547,0.042270158,0.103497469,15.10206291,0,1.139159562,1.233752035,0.923329429,0.355835556,0.499274267,16.68887133,1,2.012164815,0.940706463,2.138993293,0.032436212,0.096393191,52.08029958,0,3.259763545,1.692397375,1.926121839,0.054089162,0.118925683,N,-,,hypothetical protein MAPG_03870,C:integral component of membrane,no IPS match,,
RL4_JR_08794,4061,4402,3481,0,0,1,0,0,1,3,0,2,0,2,0,0,11,0,183.7447861,1,0.834356733,0.674721964,1.236593407,0.216238069,0.384329012,22.69132627,1,-1.038550436,1.218648329,-0.852215042,0.394094749,0.558218172,169.2956121,1,0.853619915,0.516235493,1.653547513,0.098219485,0.191409829,135.4884464,1,0.30557112,0.53905674,0.566862628,0.570807517,0.697661288,183.1244456,1,1.407806307,0.489199256,2.877776876,0.004004883,0.014898661,N,-,,peptidase family M48,C:nuclear inner membrane; F:structural constituent of ribosome; P:CAAX-box protein processing; C:integral component of endoplasmic reticulum membrane; P:peptide pheromone maturation; C:ribosome; F:metalloendopeptidase activity; P:translation,G3DSA:3.30.2010.10 (GENE3D); IPR001915 (PFAM); IPR032456 (PFAM); IPR027057 (PTHR10120:PANTHER); PTHR10120 (PANTHER),9.B.1.1.3, the integral membrane caax protease (caax protease) family.
RL4_JR_08795,2160,2752,3317,0,2,1,0,0,0,0,2,2,4,3,0,0,3,0,42.16224215,1,-0.19139029,0.832647903,-0.22985741,0.818202572,0.907531826,8.482760074,0,0.380904517,1.252317179,0.30415978,0.761006165,0.855213101,64.63659307,1,0.874363136,0.72265209,1.209936494,0.226303262,0.356979469,25.61668201,1,-2.706254476,1.224037451,-2.210924571,0.027041061,0.087339591,22.0882045,1,-2.378975365,1.236027853,-1.924693978,0.054267654,0.11921458,N,-,,ribosomal l34,C:membrane; P:proteolysis; P:cellular protein metabolic process; P:gene expression; F:peptidase activity; C:intracellular,IPR000271 (PFAM); IPR000271 (TIGRFAM); IPR000271 (PANTHER); PTHR14503:SF0 (PANTHER),,
RL4_JR_08796,824,662,1202,0,0,8,0,0,0,0,0,0,2,2,0,0,0,0,352.6038399,1,2.244152997,1.614254528,1.39021013,0.164465078,0.315547062,19.88552476,0,-0.848156413,1.20029007,-0.706626202,0.479798802,0.637088216,51.66268017,0,-3.502101724,1.191707139,-2.938726814,0.003295634,0.014523764,98.93091108,1,-0.398108769,0.579901699,-0.686510783,0.492391067,0.631400787,51.03162933,0,-3.587106188,1.196647462,-2.997629881,0.002720879,0.010966918,Y,-,,glycoside hydrolase family 3,F:beta-glucosidase activity; P:cellulose catabolic process; C:plasma membrane; F:scopolin beta-glucosidase activity,IPR001764 (PRINTS); IPR026891 (SMART); IPR002772 (PFAM); IPR001764 (G3DSA:3.20.20.GENE3D); IPR002772 (G3DSA:3.40.50.GENE3D); IPR001764 (PFAM); IPR026891 (PFAM); PTHR30620:SF42 (PANTHER); IPR026892 (PANTHER); IPR026892 (PANTHER); PTHR30620:SF42 (PANTHER); IPR017853 (SUPERFAMILY); IPR002772 (SUPERFAMILY),,
RL4_JR_08797,15213,8120,7846,4,6,12,0,0,0,3,0,5,1,24,3,0,7,0,172.419822,1,5.282945854,2.023253475,2.611114188,0.009024775,0.034926052,1.405790334,0,2.974222341,1.384952338,2.147526857,0.031751361,0.082767778,3.638822806,1,0.325800261,1.226892411,0.26554917,0.790586437,0.861746026,13.83292868,1,0.855915589,1.166927781,0.733477773,0.46326708,0.605093231,3.572471813,1,0.249456652,1.222423197,0.204067341,0.838300875,0.89092016,Y,-,,lipase,P:lipid metabolic process; P:lipid catabolic process; C:cellular_component; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR002921 (PFAM); PTHR21493 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_08798,1601,1219,1840,1,0,4,0,0,0,0,0,1,0,2,0,0,2,0,42.01733755,1,2.03825613,0.588959623,3.460773964,0.000538625,0.003572071,3.651647904,0,1.59698874,1.266109216,1.261335688,0.207187928,0.352463229,23.81969719,1,0.765974947,1.037951245,0.737968138,0.460533811,0.598286193,14.946477,1,-0.531214596,1.150153106,-0.461864245,0.644178676,0.756034438,16.70506707,1,-0.201240517,1.129809447,-0.178118989,0.858629529,0.906057737,N,-,,DNA polymerase delta subunit 2,F:DNA binding; F:DNA-directed DNA polymerase activity; P:DNA replication; P:DNA biosynthetic process,IPR007185 (PFAM); PTHR10416:SF0 (PANTHER); PTHR10416:SF0 (PANTHER); IPR024826 (PANTHER); PTHR10416:SF0 (PANTHER); IPR024826 (PANTHER),,
RL4_JR_08799,564,403,520,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,157.7779365,0,-1.870360608,1.121965495,-1.667039331,0.095506584,0.213991408,46.07172817,0,-0.820297698,1.189261074,-0.689754097,0.49034884,0.646096193,96.64584285,0,-4.405657292,1.268060682,-3.474326863,0.000512137,0.003438244,111.5941356,1,-4.829304297,1.282734311,-3.764851579,0.000166648,0.001644553,104.5237106,0,-2.885981033,1.110749648,-2.598228176,0.00937062,0.029826322,N,-,,ribosome biogenesis ytm1,P:ribosomal large subunit biogenesis; C:preribosome; P:rRNA processing; C:nucleolus,IPR020472 (PRINTS); IPR001680 (SMART); IPR001680 (PFAM); IPR012972 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR19855 (PANTHER); PTHR19855 (PANTHER); PTHR19855:SF11 (PANTHER); PTHR19855:SF11 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR028599 (HAMAP); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_08800,162,91,198,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.92559961,0,-0.025396647,0.764984032,-0.033198925,0.973515956,0.986576791,30.13984653,0,1.420592008,1.114279846,1.274896977,0.202345709,0.346731551,36.06741825,0,-0.335865131,1.037714063,-0.323658648,0.746196481,0.830164085,62.05847286,0,0.186495387,0.753634619,0.247461279,0.804551255,0.875158501,20.17301149,0,-2.248121146,1.205983005,-1.86413999,0.062302048,0.132578444,N,-,,3 -5 exonuclease,F:exonuclease activity; P:nucleobase-containing compound metabolic process,IPR002562 (SMART); IPR012337 (G3DSA:3.30.420.GENE3D); IPR002562 (PFAM); PTHR13620:SF0 (PANTHER); PTHR13620 (PANTHER); IPR012337 (SUPERFAMILY),,
RL4_JR_08801,631,743,1393,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,58.54403519,0,0.972971852,0.631368566,1.541052095,0.123304108,0.257464784,7.529998321,1,0.552788631,1.244395499,0.444222621,0.656881639,0.779022372,61.30115056,0,1.038130392,0.703283232,1.476119926,0.139911701,0.248904031,30.71749348,0,-0.818367484,1.046058098,-0.782334639,0.434017935,0.576016725,38.83462503,0,0.677469799,0.75316883,0.899492612,0.368390329,0.504797954,N,-,,U6 snRNA-associated Sm LSm5,C:intracellular ribonucleoprotein complex; C:viral nucleocapsid,IPR001163 (SMART); IPR001163 (PFAM); G3DSA:2.30.30.100 (GENE3D); PTHR20971 (PANTHER); IPR010920 (SUPERFAMILY),,
RL4_JR_08802,4918,9601,16910,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,58.94528673,0,-1.070744362,0.867228874,-1.234673331,0.216952105,0.384996487,12.4077158,0,-0.167681396,1.213300878,-0.138202649,0.890080261,0.938185193,38.8020199,0,-1.862851688,1.196835427,-1.556481072,0.11959374,0.221185061,37.27445341,1,-3.247317075,1.19769678,-2.711301499,0.006701966,0.035360814,31.9522007,0,-2.91160453,1.20453417,-2.417203764,0.015640259,0.044885947,N,-, Effector probability:0.605,DNA-directed RNA polymerase II subunit RPB11,"F:L-histidine transmembrane transporter activity; F:L-lysine transmembrane transporter activity; P:L-histidine transmembrane export from vacuole; C:endoplasmic reticulum; F:protein dimerization activity; C:vacuolar membrane; P:termination of RNA polymerase II transcription; C:DNA-directed RNA polymerase II, core complex; F:L-arginine transmembrane transporter activity; P:L-lysine transmembrane export from vacuole; F:DNA binding; F:DNA-directed RNA polymerase activity; P:transcription, RNA-templated; C:integral component of membrane; C:cytosol; P:L-arginine transmembrane export from vacuole",IPR009025 (PFAM); G3DSA:3.30.1360.10 (GENE3D); PTHR13946:SF16 (PANTHER); PTHR13946 (PANTHER); IPR009025 (SUPERFAMILY),,
RL4_JR_08803,1055,1031,2282,0,0,9,0,0,0,0,0,0,0,4,0,0,1,1,105.7764685,1,0.917959485,0.452076605,2.030539682,0.042301712,0.117536516,12.50398897,0,-0.178760865,1.215549045,-0.147061828,0.883083219,0.933922092,76.69733012,0,0.579542576,0.615698617,0.941276398,0.346563235,0.49022604,67.94580819,1,-0.19755375,0.669301582,-0.295164027,0.767868581,0.849226585,39.47081932,1,-1.230929226,0.967392587,-1.272419535,0.203224097,0.325525072,N,-,,vacuolar amino acid transporter 3,F:L-histidine transmembrane transporter activity; F:L-lysine transmembrane transporter activity; C:integral component of membrane; P:L-histidine transmembrane export from vacuole; C:endoplasmic reticulum; C:vacuolar membrane; P:L-arginine transmembrane export from vacuole; F:L-arginine transmembrane transporter activity; P:L-lysine transmembrane export from vacuole,IPR013057 (PFAM); PTHR22950 (PANTHER); PTHR22950:SF168 (PANTHER),2.A.18.7.3, the amino acid/auxin permease (aaap) family.
RL4_JR_08804,1670,909,3113,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,33.22849037,1,1.091530268,0.69536772,1.569716622,0.116481052,0.24733275,4.520883052,0,1.288971644,1.26157627,1.021715194,0.306915718,0.468493237,11.69711691,0,-1.358963451,1.20083675,-1.131680431,0.257768812,0.394147628,21.51573593,0,-0.059346154,1.026134596,-0.057834668,0.953880323,0.972808045,11.48672432,0,-1.435629103,1.199178968,-1.197176686,0.231237695,0.358927129,N,-,,solute carrier family 12 (potassium chloride transporters) member 9,F:potassium:chloride symporter activity; P:vacuolar transmembrane transport; P:potassium ion homeostasis; P:chloride transmembrane transport; F:potassium ion symporter activity; P:L-arginine import across plasma membrane; P:L-lysine transmembrane transport; C:integral component of vacuolar membrane,IPR004841 (PFAM); IPR018491 (PFAM); PTHR11827:SF65 (PANTHER); PTHR11827 (PANTHER); PTHR11827 (PANTHER); PTHR11827 (PANTHER); PTHR11827:SF65 (PANTHER); PTHR11827 (PANTHER); PTHR11827:SF65 (PANTHER); PTHR11827:SF65 (PANTHER),2.A.30.1.6, the cation-chloride cotransporter (ccc) family.
RL4_JR_08805,976138,10043,114053,28,70,22,0,0,9,0,1,0,2,2,0,0,0,2,3.083179558,1,0.273106223,1.220424202,0.22377975,0.822928687,0.910354463,0.984279055,1,3.488357619,1.400974815,2.489950271,0.012776097,0.040564509,2.553842757,1,0.836116182,1.20808744,0.69209906,0.488875122,0.623351445,2.946116058,1,0.413820506,1.211223927,0.341654831,0.732610668,0.821488114,2.518850697,1,0.753417447,1.205210971,0.625133246,0.531883609,0.655387799,N,-,,hypothetical protein SPBR_07549,,no IPS match,,
RL4_JR_08806,13213,10141,8410,0,16,8,2,0,0,3,0,5,12,15,7,0,7,1,57.0071932,1,1.281410257,0.58676908,2.183840799,0.028973948,0.088003551,5.624839026,1,0.973657976,1.235537584,0.788043997,0.430670971,0.592782536,57.66132351,1,1.719501241,0.621328879,2.76745746,0.005649542,0.02078353,50.26945359,1,1.407402541,0.587715959,2.394698526,0.016634036,0.069939175,14.47463118,1,-1.769207962,1.203734874,-1.469765477,0.141625282,0.248060726,N,-,,vitamin b12 biosynthesis cobw,,IPR003495 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011629 (G3DSA:3.30.1220.GENE3D); PTHR13748 (PANTHER); PTHR13748:SF42 (PANTHER); PTHR13748:SF42 (PANTHER); PTHR13748 (PANTHER); IPR027417 (SUPERFAMILY),9.B.10.1.1, the putative tripartite zn(2+) transporter (tzt) family.
RL4_JR_08807,60,52,57,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,143.9498126,0,0.604722829,0.632948888,0.95540547,0.339372689,0.529223716,54.86656673,0,1.93494148,0.76260884,2.537265999,0.011172203,0.036549786,129.500706,0,0.849218082,0.486024673,1.747273604,0.080589889,0.16378116,130.6028367,0,0.238624159,0.529072878,0.451023231,0.651972805,0.762002153,73.5641411,0,-0.737649019,0.735076829,-1.003499214,0.315620056,0.451044893,N,-,,hypothetical protein CMQ_720,,no IPS match,,
RL4_JR_08808,3986,3421,2695,0,2,9,0,0,0,0,1,3,4,1,11,0,8,0,190.9939467,1,-0.079373168,0.582119553,-0.136352004,0.891543015,0.946655162,28.33180279,0,-1.35882032,1.197345326,-1.134860838,0.256433631,0.411872613,73.49400495,1,-4.010554116,1.190636382,-3.3684122,0.000756025,0.004608064,140.6602418,1,-0.670164778,1.63347876,-0.410268437,0.681609042,0.783525381,72.39587347,1,-4.091605579,1.1918798,-3.432901184,0.00059716,0.003142537,N,-,,duf1754 domain containing,C:nucleus,IPR013865 (PFAM); PTHR13282:SF6 (PANTHER); IPR013865 (PANTHER),,
RL4_JR_08809,1163,1074,1552,1,0,1,0,0,0,0,1,1,0,0,0,0,0,1,366.3801627,1,-1.641764427,0.903858497,-1.816395413,0.069309738,0.169747477,162.9006583,0,0.47455958,0.681317173,0.696532538,0.486095387,0.642331268,226.3510232,1,-5.633428044,1.213937315,-4.640625158,3.47E-06,7.72E-05,280.2644439,0,-4.292438139,1.043445706,-4.11371489,3.89E-05,0.000470417,229.3803037,1,-4.048469522,1.008013749,-4.016284031,5.91E-05,0.000445402,N,-,,a-agglutinin core aga1,C:integral component of membrane,no IPS match,,
RL4_JR_08810,362,359,578,0,0,3,0,0,0,0,0,0,2,0,1,0,2,0,71.99996497,1,0.3998968,0.560520011,0.713438936,0.475574187,0.665021292,10.44802183,0,0.080361529,1.211596507,0.066326973,0.947117509,0.97159455,33.58651975,0,-1.608827343,1.187181945,-1.355164935,0.175365014,0.294573652,47.29352657,1,-0.272852302,0.738464926,-0.369485797,0.711765658,0.807284338,57.57674594,1,0.941362987,0.550538301,1.709895542,0.087285191,0.172542475,N,-,,phosphatidate cytidylyltransferase,C:endoplasmic reticulum membrane; F:nucleotidyltransferase activity; C:membrane; C:integral component of membrane; P:protein glycosylation; C:endoplasmic reticulum; P:phosphorylation; F:transferase activity; F:dolichol kinase activity,PTHR13205:SF15 (PANTHER); PTHR13205:SF15 (PANTHER); IPR032974 (PANTHER); PTHR13205:SF15 (PANTHER); IPR032974 (PANTHER); IPR032974 (PANTHER),,
RL4_JR_08811,3265,4398,6566,3,2,1,0,0,1,0,0,1,2,2,2,0,5,0,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_08812,896,1465,1437,0,0,2,0,0,3,0,0,0,0,2,1,0,0,0,14.75026513,1,-1.984944611,1.18339916,-1.677324674,0.09347901,0.210663471,4.716462153,1,1.227836715,1.242758927,0.987992674,0.323156236,0.485525816,12.21838647,0,-1.421973093,1.189216771,-1.195722367,0.23180492,0.363080297,55.03474332,1,1.473289323,0.603935559,2.439481002,0.014708376,0.065631958,12.02620795,0,-1.501896581,1.189066783,-1.263088501,0.206557376,0.329428099,N,-,,origin recognition complex subunit 2,P:macromolecular complex subunit organization; P:cellular macromolecule metabolic process; C:nuclear lumen; C:macromolecular complex; P:primary metabolic process; C:chromosomal part,IPR017956 (PRINTS); IPR017956 (SMART); IPR007220 (PFAM); IPR007220 (PANTHER); PTHR14052:SF0 (PANTHER),,
RL4_JR_08813,471,382,527,0,0,0,0,0,0,0,0,0,0,0,2,0,8,0,44.33674628,0,2.863421689,0.661741557,4.327099697,1.51E-05,0.000165367,1.368851194,0,3.012540272,1.351271951,2.229410793,0.025786585,0.070107927,3.550585767,0,0.360775865,1.202304937,0.300070186,0.76412362,0.841508488,12.11906632,1,1.664810118,1.016169753,1.638318906,0.101355186,0.197786286,3.500714858,1,0.278531972,1.201413763,0.231836842,0.816664741,0.87666778,N,-, Effector probability:0.725,had superfamily phosphatase,C:mitochondrion; F:phosphatidylglycerophosphatase activity; P:dephosphorylation; P:cardiolipin biosynthetic process,IPR023214 (G3DSA:3.40.50.GENE3D); IPR010021 (TIGRFAM); IPR027706 (PFAM); PTHR19288 (PANTHER); PTHR19288:SF25 (PANTHER); IPR023214 (SUPERFAMILY),,
RL4_JR_08814,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.180600141,0,4.366793003,3.10610305,1.405875122,0.15976121,NA,0.057311071,0,7.590454559,2.33711558,3.24778741,0.001163061,0.015023052,0.149122513,0,4.93439742,1.3893766,3.551519019,0.000383014,0.002801761,0.172068965,0,4.511748547,1.896961968,2.378407487,0.017387599,0.071906876,0.147354218,0,4.850505478,1.269305236,3.821386172,0.000132704,0.000879464,N,-,,copper homeostasis cutc,F:copper ion binding; P:copper ion homeostasis,no IPS match,,
RL4_JR_08815,379,652,800,3,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1.517636141,1,1.296006603,1.40018487,0.925596777,0.354655569,NA,0.480273534,0,4.523553199,1.586259251,2.851711155,0.004348459,0.01880184,1.251079734,1,1.865919201,1.258615888,1.482516802,0.138202836,0.246766405,1.443747971,1,1.443089434,1.2934561,1.115684896,0.264557038,0.405301863,1.236888974,0,1.779962416,1.248486374,1.42569631,0.153956022,0.263891099,N,-,,copper homeostasis cutc,F:copper ion binding; P:copper ion homeostasis,IPR005627 (PFAM); IPR023648 (G3DSA:3.20.20.GENE3D); IPR005627 (PANTHER); PTHR12598:SF0 (PANTHER); IPR023648 (SUPERFAMILY),9.B.158.1.1, the cut copper homeostasis (cut) family.
RL4_JR_08816,596,406,856,0,0,3,1,0,0,0,0,0,0,0,0,0,0,2,110.0216035,1,-0.521632149,0.580252916,-0.898973767,0.368666634,0.560697688,29.42672075,1,0.0564601,1.125307769,0.050173029,0.959984504,0.978544397,93.4527967,0,-0.10635077,0.624602152,-0.170269619,0.864798103,0.913897083,115.8706216,0,0.071824951,1.38452793,0.051876853,0.958626818,0.976481804,62.3645838,1,-1.374546082,0.842262376,-1.631968994,0.102686018,0.194845565,N,-,,rho-gtpase-activating 8,C:integral component of membrane; C:intracellular; P:intracellular signal transduction,IPR000591 (SMART); IPR001060 (SMART); IPR000198 (SMART); IPR000198 (G3DSA:1.10.555.GENE3D); IPR011991 (G3DSA:1.10.10.GENE3D); IPR000591 (PFAM); IPR001060 (PFAM); IPR000198 (PFAM); PTHR23065 (PANTHER); PTHR23065:SF17 (PANTHER); PTHR23065:SF17 (PANTHER); PTHR23065 (PANTHER); IPR031160 (PROSITE_PROFILES); IPR000198 (PROSITE_PROFILES); IPR000591 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY); IPR008936 (SUPERFAMILY); SSF103657 (SUPERFAMILY),,
RL4_JR_08817,912,1024,1851,1,0,0,0,0,0,1,0,0,0,1,0,0,4,0,123.9191301,1,1.847458503,0.568180388,3.251535152,0.001147836,0.006594398,9.941962384,0,0.152011923,1.215886459,0.125021479,0.900506546,0.944488746,25.77419342,1,-2.498823061,1.190098636,-2.099677276,0.03575724,0.0875257,49.0038653,1,-1.179347655,1.011753891,-1.165646769,0.24375729,0.381977908,85.36464061,1,1.502748746,0.472255532,3.182067005,0.00146228,0.006530915,Y,-,,membrane dipeptidase,F:metal ion binding; F:dipeptidase activity; P:proteolysis; C:integral component of membrane; F:metallopeptidase activity,IPR008257 (PFAM); G3DSA:3.20.20.140 (GENE3D); PTHR10443:SF12 (PANTHER); IPR008257 (PANTHER); IPR008257 (PROSITE_PROFILES); IPR032466 (SUPERFAMILY),,
RL4_JR_08818,357,381,460,0,1,0,0,0,0,0,0,0,0,3,0,0,0,0,36.43583412,1,-1.243191787,1.062491865,-1.170071817,0.241972069,0.416995296,9.087112069,0,0.281624986,1.245096789,0.226187224,0.821055807,0.892091765,36.75985448,0,-0.569103354,1.06373492,-0.535004861,0.592646496,0.712160608,27.42569101,1,-2.804686821,1.219845881,-2.299214076,0.021492786,0.07956263,23.62491605,0,-2.476003718,1.230921185,-2.011504675,0.044272177,0.101922645,N,-, Effector probability:0.585,mitochondrial 37s ribosomal sws2,F:RNA binding; F:structural constituent of ribosome; P:regulation of sporulation resulting in formation of a cellular spore; C:cytosol; P:ribosome biogenesis; C:small ribosomal subunit; P:translation,G3DSA:1.10.8.50 (GENE3D); IPR027437 (G3DSA:4.10.910.GENE3D); IPR001892 (PFAM); PTHR10871:SF1 (PANTHER); PTHR10871 (PANTHER); IPR001892 (PROSITE_PROFILES); IPR010979 (SUPERFAMILY),,
RL4_JR_08819,200,236,227,0,0,2,0,0,0,0,0,7,0,1,0,0,0,0,7.810886552,1,-1.067966478,1.259507401,-0.84792394,0.396480331,0.588809517,2.469069993,0,2.16141531,1.346858435,1.604782845,0.108541603,0.215465405,12.95739039,1,0.459300199,1.23438195,0.372089205,0.709826433,0.803385445,7.453903796,1,-0.925368582,1.248405066,-0.741240649,0.45854754,0.600549421,6.432237994,0,-0.599104617,1.25822177,-0.476151845,0.633966204,0.737127677,N,-,,Methyltransferase 25,,IPR025714 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR12496:SF0 (PANTHER); PTHR12496 (PANTHER); PTHR12496 (PANTHER); PTHR12496:SF0 (PANTHER); PTHR12496 (PANTHER); PTHR12496:SF0 (PANTHER),,
RL4_JR_08820,314,292,338,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,32.06399303,1,1.245194586,0.965802709,1.289284628,0.197299153,0.359840486,2.575288396,0,2.100834403,1.392946444,1.50819467,0.131504711,0.249314607,13.1791677,0,0.410995276,1.25726441,0.326896453,0.743746204,0.828075065,7.708138736,0,-0.973438609,1.277145294,-0.762198799,0.445941363,0.588004274,14.28374953,0,1.00744699,1.076519092,0.93583755,0.349356835,0.486753537,N,-,,hypothetical protein CMQ_1479,C:membrane; C:integral component of membrane,G3DSA:3.30.2130.10 (GENE3D); IPR027795 (PFAM); PTHR31131 (PANTHER); PTHR31131:SF6 (PANTHER); PTHR31131 (PANTHER); PTHR31131:SF6 (PANTHER); SSF55021 (SUPERFAMILY),,
RL4_JR_08821,145,266,198,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,42.2756613,0,0.035973095,0.851328932,0.042255225,0.966295239,0.982922264,15.24128839,0,1.829553505,1.136020251,1.610493742,0.107290111,0.213751109,21.63770468,0,-0.769353812,1.195990557,-0.643277497,0.520044055,0.650250765,25.48265813,0,-0.429638125,1.022303986,-0.42026455,0.674292204,0.77811814,22.57266837,1,-0.137633555,0.975478115,-0.141093432,0.887796132,0.926407899,N,-,,DUF3433 domain,C:membrane; C:integral component of membrane,IPR021840 (PFAM); PTHR37544:SF3 (PANTHER); PTHR37544 (PANTHER),,
RL4_JR_08822,1258,1085,2100,0,0,5,0,0,0,0,1,0,0,11,0,0,1,0,286.9022165,1,0.024777802,0.575493084,0.043054909,0.965657763,0.982763976,163.3875601,0,0.923090455,1.599817026,0.576997519,0.563941131,0.706549342,260.0154231,1,-0.032757541,0.413236697,-0.079270648,0.936817353,0.962067081,244.6851613,1,-0.395722235,0.388633361,-1.018240517,0.308563669,0.454099876,176.336786,1,-0.677246433,0.462119954,-1.465520862,0.142778865,0.249505697,Y,-,,transient receptor potential ion channel,P:fungal-type cell wall biogenesis; P:Golgi calcium ion export; F:calcium channel activity; C:integral component of Golgi membrane; P:establishment of protein localization to plasma membrane; C:endoplasmic reticulum; P:fungal-type cell wall organization; C:integral component of plasma membrane; C:cytosol; C:plasma membrane of cell tip; P:regulation of intracellular protein transport; P:cell wall repair; P:regulation of exocytosis; P:regulation of fungal-type cell wall biogenesis,IPR032800 (SMART); IPR032800 (PFAM); IPR010308 (PFAM); PTHR31145:SF2 (PANTHER); PTHR31145 (PANTHER),1.A.4.9.3, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_08823,522,653,645,0,0,0,0,0,0,0,0,0,0,1,0,0,2,0,50.97728376,0,-1.440880962,1.085651825,-1.327203555,0.184441357,0.34189334,20.55354965,0,0.895555948,1.181650015,0.757885953,0.44851926,0.609063744,28.86386901,0,-2.662154941,1.238312678,-2.149824507,0.031569099,0.07992137,33.29423394,1,-3.084335413,1.244062028,-2.479245683,0.013166058,0.060341929,28.2422048,1,-2.733545648,1.241045219,-2.202615672,0.027621848,0.070555997,N,-,,developmental regulatory,,PTHR22934:SF23 (PANTHER); PTHR22934 (PANTHER),,
RL4_JR_08824,95,146,184,3,0,78,0,0,0,0,0,0,0,1,0,0,4,1,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_08825,376,321,584,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32.4098697,0,-1.029954967,1.072875132,-0.959995191,0.337057635,0.527169515,7.888126507,0,0.4858696,1.270137118,0.382533187,0.702065917,0.811689555,33.43786502,0,-0.353484695,1.071370255,-0.329937007,0.74144756,0.826492974,23.58188793,1,-2.586727352,1.226834785,-2.108456153,0.034991552,0.099498352,34.80987318,0,-0.534309909,1.009694187,-0.52917994,0.596680631,0.707340052,N,-,,---NA---,,no IPS match,,
RL4_JR_08826,1828,1490,2205,0,0,2,0,0,1,0,0,0,1,0,0,0,0,0,26.66987985,1,1.011719686,0.895511843,1.129766952,0.258574437,0.437736098,12.96541616,1,2.534164237,1.190417032,2.128803746,0.033270501,0.085865377,9.410519166,0,-1.045436504,1.254044641,-0.833651746,0.404477257,0.546646342,10.86257945,1,-1.468607405,1.26034884,-1.165238828,0.243922333,0.382058555,16.76660342,0,-0.197732962,1.199130456,-0.164896956,0.869025089,0.913203235,N,-,,pal1,C:membrane,no IPS match,,
RL4_JR_08827,52,76,66,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,38.15648835,0,2.252362289,0.662708856,3.398720674,0.000677018,0.004335255,2.068824719,0,2.416679465,1.301698292,1.856558836,0.063373945,0.142107016,11.87064416,0,0.725137318,1.192082137,0.608294761,0.542991995,0.670969237,18.23214251,1,1.645932577,0.853201015,1.92912637,0.053715176,0.127668112,16.52788624,0,1.357165734,0.976634308,1.389635529,0.164639581,0.277644197,N,-,,ph-response regulator,C:membrane,IPR009571 (PFAM); PTHR28013:SF1 (PANTHER); PTHR28013 (PANTHER),,
RL4_JR_08828,6,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,110.7131056,0,0.411668231,0.560481979,0.734489683,0.462650346,0.650966113,15.76617926,0,-0.513302579,1.227664596,-0.418113042,0.67586447,0.793079082,41.2072719,0,-3.175882873,1.214484005,-2.615005929,0.008922591,0.029881676,95.87484733,0,0.115319743,0.602204325,0.191496039,0.848136984,0.904871719,40.96822959,0,-3.270212069,1.226767624,-2.665714357,0.007682494,0.025438181,N,-,,sulfate transporter,C:membrane,IPR031563 (PFAM); PTHR31970:SF0 (PANTHER); PTHR31970 (PANTHER); PTHR31970:SF0 (PANTHER); PTHR31970 (PANTHER),2.A.53.5.1, the sulfate permease (sulp) family.
RL4_JR_08829,82,136,108,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,55.94442888,0,-2.85926738,1.150738667,-2.484723475,0.01296521,0.046674295,16.63379052,0,-0.590554526,1.210618977,-0.487812051,0.625682975,0.753789874,73.18033699,0,-0.82522759,0.857991729,-0.96181299,0.336143552,0.479312298,59.14603379,0,-2.715849014,1.150413496,-2.360759,0.018237578,0.073727743,42.66875892,0,-3.328903138,1.202096012,-2.769248965,0.005618568,0.019711713,N,-,,forkhead domain containing,"F:DNA binding; C:nucleus; F:transcription factor activity, sequence-specific DNA binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR001766 (SMART); IPR000253 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); IPR000253 (G3DSA:2.60.200.GENE3D); IPR001766 (PFAM); IPR001766 (PROSITE_PROFILES); IPR008984 (SUPERFAMILY); IPR011991 (SUPERFAMILY),,
RL4_JR_08830,1329,1343,1645,0,0,0,0,0,0,0,0,0,0,2,1,0,0,0,14.70618859,0,-1.980608945,1.1988625,-1.652073482,0.098519572,0.219117412,4.728202801,0,1.224293772,1.266079848,0.966995703,0.333546182,0.496931771,25.19715401,0,0.397676695,1.043637288,0.38104876,0.703167068,0.798280331,51.64134866,1,0.926503492,0.75415709,1.228528518,0.219248631,0.354388951,26.68471177,0,0.19464112,0.974828073,0.199667126,0.841740926,0.893457625,N,-, Effector probability:0.728,cytochrome b5,F:metal ion binding; F:heme binding,IPR001199 (PRINTS); IPR001199 (SMART); IPR001199 (PFAM); IPR001199 (G3DSA:3.10.120.GENE3D); PTHR19359 (PANTHER); PTHR19359:SF33 (PANTHER); IPR001199 (PROSITE_PROFILES); IPR001199 (SUPERFAMILY),,
RL4_JR_08831,5,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,136.2289102,0,-0.914924138,0.743166126,-1.231116578,0.218279266,0.386357616,25.77205306,0,-1.222211981,1.230735668,-0.993074316,0.32067374,0.48273548,66.50951923,0,-3.866509588,1.214661219,-3.183199995,0.00145657,0.007724626,76.6950325,0,-4.288250395,1.218020509,-3.520671747,0.000430455,0.003696657,65.2963376,0,-3.942732134,1.214884956,-3.245354315,0.001173046,0.005440718,N,-,,Thiol methyltransferase,,no IPS match,,
RL4_JR_08832,36,36,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.595891912,0,-0.302958734,1.22860799,-0.24658698,0.805227882,0.901661738,1.471444026,0,2.908250223,1.369685291,2.123298134,0.033728877,0.086650683,3.81453027,0,0.257255353,1.221251228,0.210649002,0.833161172,0.892301249,4.399962432,0,-0.164890119,1.224210535,-0.134690982,0.892856203,0.934191284,3.762434391,0,0.174412761,1.222235265,0.142699827,0.886527253,0.925387606,N,-,,hypothetical protein SPBR_06542,,no IPS match,,
RL4_JR_08833,2481,1744,2602,0,2,2,0,0,0,0,0,0,0,2,0,0,0,0,81.16102318,1,-1.33033882,0.747367049,-1.780034082,0.075070383,0.179570653,19.64348301,0,-0.830465958,1.1978518,-0.69329608,0.488123762,0.644254625,92.69940358,0,-0.082096259,0.613247168,-0.133871403,0.893504264,0.933522928,135.1156859,1,0.29136861,0.466654837,0.624377135,0.532379938,0.665392775,96.30729454,0,0.46047188,0.50705725,0.908126016,0.363811647,0.500284249,N,-, Effector probability:0.84,Synaptobrevin like ykt6,"C:endosome; P:vesicle fusion; F:palmitoyltransferase activity; C:mitochondrion; C:integral component of membrane; F:SNAP receptor activity; C:SNARE complex; P:vacuole fusion, non-autophagic; C:Golgi apparatus; C:fungal-type vacuole",IPR001388 (PRINTS); IPR010908 (SMART); IPR001388 (G3DSA:1.10.3840.GENE3D); IPR010908 (G3DSA:3.30.450.GENE3D); IPR010908 (PFAM); IPR001388 (PFAM); PTHR21136 (PANTHER); PTHR21136:SF5 (PANTHER); IPR010908 (PROSITE_PROFILES); IPR001388 (PROSITE_PROFILES); SSF58038 (SUPERFAMILY); IPR011012 (SUPERFAMILY),,
RL4_JR_08834,1712,3052,1739,0,0,1,0,3,5,15,0,5,0,21,0,0,6,0,14.54857615,1,-1.965191905,1.215105492,-1.617301476,0.105813221,0.230808624,4.604442156,1,1.262403892,1.261873115,1.000420626,0.317106992,0.478853793,18.51618294,1,-0.436404047,1.208062581,-0.361242913,0.717917865,0.809376443,13.86838331,1,-1.821017276,1.211205492,-1.503475082,0.132716578,0.242642714,11.92580462,1,-1.489769806,1.222344646,-1.218780489,0.222927519,0.349619134,N,-,,major facilitator superfamily transporter quinate,F:substrate-specific transmembrane transporter activity; P:chromatin remodeling; P:regulation of cellular process; P:transmembrane transport; C:integral component of membrane; C:intracellular part,IPR013272 (SMART); IPR013272 (PFAM); PTHR31200 (PANTHER); IPR029525 (PTHR31200:PANTHER),,
RL4_JR_08835,14129,15528,19368,0,5,35,0,3,1,1,15,10,5,26,1,0,14,10,56.50009201,1,2.125742099,0.621694559,3.419270878,0.000627892,0.004052486,2.739065877,1,2.011839508,1.280300746,1.571380407,0.116094314,0.227645612,7.111352957,1,-0.641092306,1.197677005,-0.535279799,0.592456393,0.712016681,21.52829605,1,0.670870661,1.015617327,0.660554564,0.508898015,0.644211184,7.011877062,1,-0.723480183,1.200147321,-0.602826145,0.546624352,0.667378701,N,-,,mitochondrial outer membrane,C:mitotic spindle; C:DASH complex; P:attachment of spindle microtubules to kinetochore,IPR033468 (PFAM); IPR012336 (PFAM); IPR013959 (PFAM); PTHR28222 (PANTHER),,
RL4_JR_08836,11945,8055,8114,0,3,3,0,0,0,2,0,5,0,15,7,0,3,4,138.2188702,1,0.316874602,0.598326712,0.529601297,0.596388395,0.766436126,39.30852779,0,0.718702419,1.059939537,0.678059826,0.497733761,0.652598592,73.58674976,1,-1.138097339,0.908576301,-1.25261614,0.210345438,0.338050022,64.82124524,1,-3.00924229,1.190051692,-2.528665191,0.011449719,0.054096317,77.3457385,1,-0.942944986,0.804411543,-1.172217124,0.241109895,0.370389575,N,-,,SPRY domain-containing,,IPR003877 (SMART); IPR006595 (SMART); IPR013144 (SMART); IPR006594 (SMART); IPR024964 (PFAM); IPR006594 (PFAM); IPR003877 (PFAM); PTHR12864:SF14 (PANTHER); PTHR12864:SF14 (PANTHER); PTHR12864 (PANTHER); PTHR12864:SF14 (PANTHER); PTHR12864 (PANTHER); PTHR12864 (PANTHER); IPR001870 (PROSITE_PROFILES); IPR006595 (PROSITE_PROFILES); IPR006594 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),1.A.3.1.5," the ryanodine-inositol 1,4,5-triphosphate receptor ca(2+) channel (rir-cac) family."
RL4_JR_08837,20622,13312,11720,2,2,2,0,0,0,0,2,2,1,3,7,0,0,7,199.4514738,1,0.146294982,0.401420314,0.364443396,0.715526935,0.847794399,30.4019132,0,-1.460569014,1.204291746,-1.212803308,0.22520503,0.374367764,130.9056173,1,-0.482646511,0.584306795,-0.826015571,0.408795259,0.551010944,197.5408062,1,0.071551443,0.498212171,0.143616409,0.885803383,0.929744,99.90107853,1,-1.561981882,0.754283792,-2.07081459,0.038376126,0.091168062,N,-,,duf1711 domain containing,C:nucleus; P:chromatin remodeling; C:cytosol; C:Ino80 complex,IPR013175 (PFAM); PTHR28061 (PANTHER),,
RL4_JR_08838,924,587,243,1,0,0,0,0,0,2,0,3,1,0,0,0,0,0,36.44746103,1,-2.183721319,1.157139882,-1.887171424,0.059137272,0.150763084,10.47448603,0,0.076762061,1.236962248,0.062056915,0.950517507,0.973667236,27.03616843,1,-2.567767624,1.202921641,-2.134609219,0.032792944,0.082311149,79.32025657,1,1.115518472,0.640302544,1.742174042,0.081477995,0.168378638,38.06727595,0,-0.442872907,0.857107253,-0.516706521,0.605361043,0.713878218,N,-,,"indoleamine 2,3-dioxygenase",F:dioxygenase activity; P:oxidation-reduction process; F:heme binding,IPR000898 (PFAM); PTHR28657:SF3 (PANTHER); PTHR28657:SF3 (PANTHER); PTHR28657 (PANTHER); SSF140959 (SUPERFAMILY),,
RL4_JR_08839,960,1517,1369,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,37.08331053,1,1.46950629,0.868961528,1.691106273,0.090816507,0.206316087,2.220824954,0,2.314483026,1.334277346,1.734634132,0.08280563,0.174652758,5.72563897,0,-0.328427368,1.217063555,-0.269852274,0.787273905,0.859513661,45.28482243,1,2.764406472,0.613734382,4.504239215,6.66E-06,9.95E-05,5.611467307,0,-0.40232293,1.212772675,-0.331738123,0.740087011,0.81813866,Y,-,,transcription factor c2h2,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_08840,1814,1457,1904,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,153.3457666,0,3.944382309,0.376493611,10.47662483,1.11E-25,3.11E-23,2.951881709,0,1.903952575,1.287330975,1.478992281,0.139142378,0.260718095,14.13125376,0,0.218831765,1.197423078,0.182752253,0.854992414,0.908005182,32.87309788,0,2.114770692,0.635979764,3.325216949,0.000883498,0.006680667,26.79475408,0,2.10511212,0.683541162,3.07971522,0.002071986,0.008730278,N,-,,cell division control,P:cell division,IPR012535 (PFAM); PTHR34065 (PANTHER); PTHR34065:SF1 (PANTHER); PTHR34065:SF1 (PANTHER),,
RL4_JR_08841,8416,7407,12135,0,2,2,0,0,0,0,3,0,2,0,3,0,1,0,64.03878531,1,1.741259498,0.526986674,3.304181271,0.000952542,0.005715136,4.707331627,0,1.230611014,1.240040709,0.992395657,0.321004557,0.483014069,46.80974905,1,1.404914529,0.734586788,1.912523547,0.055809075,0.122908653,79.92147961,1,1.904378302,0.531237987,3.584793157,0.000337345,0.002993534,39.0595157,1,1.904721714,0.580041496,3.283768017,0.001024292,0.004878154,N,-,,Geranylgeranyl pyrophosphate synthase,P:isoprenoid biosynthetic process; F:transferase activity,IPR008949 (G3DSA:1.10.600.GENE3D); IPR000092 (PFAM); PTHR12001 (PANTHER); PTHR12001:SF44 (PANTHER); IPR008949 (SUPERFAMILY),5.B.14.1.1, the flavin-based extracellular electron transfer (f-eet) family.
RL4_JR_08842,917,613,973,0,0,0,0,0,0,0,0,2,0,2,0,0,0,4,55.566162,0,-0.556115985,0.744017655,-0.747449984,0.454791983,0.643417159,11.5286651,0,-0.06165412,1.21314225,-0.050821839,0.959467488,0.978272787,49.41096731,1,-0.311752039,0.854837862,-0.364691426,0.715341759,0.807461252,54.56726721,1,-0.107124543,0.678623001,-0.15785575,0.874570467,0.922592207,44.60147897,1,-0.585183845,0.847613054,-0.690390317,0.489948765,0.618625917,N,-,,integral peroxisomal membrane,C:membrane,IPR010482 (PFAM); PTHR28304:SF2 (PANTHER); PTHR28304 (PANTHER); PTHR28304:SF2 (PANTHER),3.A.20.1.5, the peroxisomal protein importer (ppi) family.
RL4_JR_08843,4841,4724,5730,0,9,10,0,0,0,1,1,0,1,1,0,0,1,2,59.71411675,1,-1.424406658,0.911137436,-1.563327992,0.117975468,0.249337789,15.26841368,0,-0.467020096,1.225443988,-0.381102768,0.703126994,0.812819944,39.87845526,1,-3.128596917,1.211799033,-2.581778688,0.009829259,0.032256539,50.0329737,1,-2.605945331,1.168686925,-2.229806183,0.025760313,0.085851084,69.43830492,1,-0.262919736,0.730536891,-0.359899327,0.71892242,0.802043932,N,-,,cysteine synthase A,C:mitochondrion; C:membrane,IPR001926 (PFAM); G3DSA:3.40.50.1100 (GENE3D); G3DSA:3.40.50.1100 (GENE3D); PTHR10314 (PANTHER); PTHR10314:SF35 (PANTHER); IPR001926 (SUPERFAMILY),,
RL4_JR_08844,7255,6250,7672,3,1,10,0,0,0,0,3,1,0,3,0,0,1,1,112.8122227,1,-1.113289634,0.639455147,-1.740997221,0.081684066,0.191323172,25.22423728,0,-1.19125309,1.199216409,-0.993359564,0.32053476,0.482661832,127.0686419,1,-0.026412132,0.561091921,-0.047072737,0.962455256,0.977910178,150.4191296,1,0.135389864,0.463780027,0.291926897,0.770342518,0.850661794,72.69225614,1,-2.271702048,0.989600664,-2.295574498,0.021700222,0.058388188,N,-,,transcription elongation factor S-II,"F:zinc ion binding; P:transcription elongation from RNA polymerase I promoter; F:transcription factor activity, core RNA polymerase II recruiting; P:translational elongation; P:tRNA transcription from RNA polymerase III promoter; F:RNA polymerase II core binding; P:mRNA cleavage; P:positive regulation of RNA polymerase II transcriptional preinitiation complex assembly; P:positive regulation of transcription elongation from RNA polymerase II promoter; C:nucleus; F:RNA polymerase II regulatory region DNA binding; P:RNA polymerase II transcriptional preinitiation complex assembly; F:translation elongation factor activity; P:maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter; P:transcription antitermination; P:regulation of mRNA 3'-end processing",IPR003617 (SMART); IPR003618 (SMART); IPR001222 (SMART); IPR003618 (G3DSA:1.10.472.GENE3D); IPR003618 (PFAM); IPR016492 (PIRSF); IPR006289 (TIGRFAM); IPR017923 (PFAM); IPR001222 (PFAM); IPR017923 (G3DSA:1.20.930.GENE3D); G3DSA:2.20.25.10 (GENE3D); PTHR11477 (PANTHER); IPR017923 (PROSITE_PROFILES); IPR003618 (PROSITE_PROFILES); IPR001222 (PROSITE_PROFILES); SSF57783 (SUPERFAMILY); IPR017923 (SUPERFAMILY); IPR003618 (SUPERFAMILY),,
RL4_JR_08845,28611,15018,7037,1,23,2,0,2,0,3,6,47,2,0,5,0,37,8,31.89069044,1,-0.300411938,1.088120846,-0.276083249,0.782484126,0.887825894,4.981246475,1,1.148913457,1.306098868,0.879652747,0.379047455,0.543213697,50.94492869,1,1.618673384,0.758094438,2.135186994,0.032745739,0.082262496,24.40555875,1,-0.986828777,1.200429468,-0.822063106,0.411040982,0.55475739,13.04977076,1,-1.619708676,1.264248502,-1.281163216,0.200136343,0.321903174,N,-,,aspartyl-tRNA synthetase,F:nucleotide binding; P:tRNA aminoacylation for protein translation; F:aminoacyl-tRNA ligase activity; C:cytoplasm,IPR002312 (PRINTS); G3DSA:2.40.50.140 (GENE3D); IPR004364 (PFAM); G3DSA:3.30.930.10 (GENE3D); IPR004115 (G3DSA:3.30.1360.GENE3D); IPR004524 (TIGRFAM); IPR018150 (PANTHER); IPR004524 (PTHR22594:PANTHER); IPR004524 (PTHR22594:PANTHER); IPR018150 (PANTHER); IPR006195 (PROSITE_PROFILES); SSF55681 (SUPERFAMILY),9.B.111.1.5,The 6 TMS Lysyl tRNA Synthetase (LysS) Family
RL4_JR_08846,884,955,843,0,1,0,0,0,0,0,0,2,0,2,0,0,1,0,44.64916497,1,0.744527297,0.620024363,1.200803294,0.229827514,0.402001041,6.952903357,0,0.667894839,1.231411602,0.542381473,0.58755574,0.725538514,18.02286481,1,-1.9828383,1.193745913,-1.661022064,0.096709016,0.18923117,20.78960024,1,-2.405050147,1.192135259,-2.017430596,0.043650597,0.113446415,25.12869709,1,-1.129720425,1.125060106,-1.004142285,0.315310036,0.45073409,N,-,,enth domain-containing,C:cytoplasmic part; F:phospholipid binding,IPR013809 (SMART); IPR008942 (G3DSA:1.25.40.GENE3D); IPR011417 (PFAM); IPR014712 (G3DSA:1.20.58.GENE3D); PTHR22951:SF5 (PANTHER); PTHR22951 (PANTHER); IPR013809 (PROSITE_PROFILES); IPR008942 (SUPERFAMILY); SSF89009 (SUPERFAMILY),,
RL4_JR_08847,39,28,36,0,0,4,0,0,0,0,0,0,0,3,2,0,5,0,44.02212323,1,-2.235684978,1.164664306,-1.919596029,0.054908946,0.14261292,10.74940177,0,0.039270292,1.225642739,0.03204057,0.974439697,0.986927705,28.0484041,0,-2.620915475,1.205599691,-2.173951681,0.029708764,0.076106156,32.36808444,1,-3.043730961,1.206851291,-2.522043092,0.011667541,0.054716932,27.82473295,1,-2.712065706,1.216236503,-2.229883497,0.025755178,0.066967432,N,-,,CDK-activating kinase assembly factor MAT1,P:DNA repair; P:phosphorylation; C:holo TFIIH complex; P:regulation of transcription from RNA polymerase II promoter,IPR001841 (PFAM); IPR015877 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR12683:SF13 (PANTHER); IPR004575 (PANTHER); IPR004575 (PANTHER); PTHR12683:SF13 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),,
RL4_JR_08848,1711,1713,1866,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,281.9693629,1,-0.527602402,0.483538619,-1.091127741,0.275216678,0.458301216,51.9824804,0,-2.234453094,1.217063951,-1.835937291,0.066366932,0.147188011,223.1057919,0,-0.725048954,0.565873616,-1.281291322,0.20009136,0.325626897,213.2205762,0,-1.863006003,0.693337071,-2.687013402,0.007209406,0.037433454,164.1475509,0,-1.798429921,0.697448968,-2.578582813,0.009920652,0.031184911,N,-,,nuclear movement,,IPR008978 (G3DSA:2.60.40.GENE3D); IPR007052 (PFAM); PTHR12356:SF3 (PANTHER); PTHR12356 (PANTHER); IPR007052 (PROSITE_PROFILES); IPR008978 (SUPERFAMILY),,
RL4_JR_08849,165,253,128,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,50.03713128,1,-3.747278225,1.226557069,-3.055119341,0.00224971,0.011477882,15.80092197,0,-0.516477778,1.228936431,-0.420264031,0.674292583,0.79196908,41.31478357,0,-3.179639692,1.215762039,-2.615347075,0.008913683,0.029871607,55.70586309,0,-1.893435918,1.05541587,-1.794018805,0.072810167,0.155447875,41.08736217,0,-3.274399802,1.228353961,-2.66568099,0.007683256,0.025438181,N,-,,p450 monooxygenase,"F:iron ion binding; F:metal ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR024325 (PFAM); PF13758 (PFAM),,
RL4_JR_08850,6126,5556,6441,0,0,4,0,0,0,1,0,0,2,8,2,0,6,8,3.044643806,1,0.291463435,1.292069075,0.225578833,0.821529005,0.90986066,0.961042036,0,3.522750332,1.442502073,2.442111106,0.014601652,0.045101594,2.509676375,1,0.861373344,1.243340526,0.692789567,0.488441621,0.623107733,2.896503275,1,0.438430402,1.256395382,0.348958941,0.727120135,0.818101052,2.489229082,1,0.770732714,1.247185465,0.617977627,0.536590087,0.659661805,N,-,,NADH:flavin oxidoreductase NADH oxidase,F:FMN binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR001155 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR22893:SF6 (PANTHER); PTHR22893 (PANTHER); SSF51395 (SUPERFAMILY),,
RL4_JR_08851,6325,3974,3485,4,2,2,0,0,0,0,0,0,0,5,0,0,2,0,27.03114529,1,3.122320026,0.649830328,4.804823493,1.55E-06,2.24E-05,1.324296125,0,3.060320922,1.382867247,2.21302582,0.026895866,0.072539289,22.33536477,0,2.243793503,1.043935208,2.149360886,0.031605803,0.079974295,3.94698988,1,-0.008033675,1.22178182,-0.006575376,0.994753647,0.996032504,7.223992931,1,1.264968002,1.139827991,1.109788505,0.267090174,0.399392706,N,-,,thioesterase superfamily,P:transmembrane transport; C:membrane; C:integral component of membrane,IPR029069 (G3DSA:3.10.129.GENE3D); PTHR12418:SF26 (PANTHER); PTHR12418 (PANTHER); PTHR12418:SF26 (PANTHER); PTHR12418 (PANTHER); IPR029069 (SUPERFAMILY),,
RL4_JR_08852,2476,2330,3262,0,1,1,0,0,0,0,0,0,0,3,0,0,0,0,16.95837035,1,-0.312734003,1.155673198,-0.270607646,0.786692815,0.890006931,2.883858027,0,1.937590472,1.306994428,1.48247799,0.138213156,0.259312987,37.46117995,0,2.115710907,0.763132873,2.772401743,0.005564432,0.020537479,8.571925588,1,-1.1267331,1.210279006,-0.930969714,0.351869231,0.498415775,7.280128885,0,-0.777861746,1.206084315,-0.644948065,0.518960842,0.643952068,N,-,,hypothetical protein F503_05327,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_08853,5190,3108,5518,0,5,3,0,0,1,0,0,0,2,2,0,0,1,0,2.682804066,1,0.474081807,1.265474889,0.374627589,0.707937451,0.842613141,0.851340302,1,3.697683867,1.439883257,2.568044214,0.010227411,0.034098107,2.214842634,0,1.041816848,1.225103112,0.850391153,0.395107653,0.538077735,2.555652313,1,0.619168936,1.234990898,0.50135506,0.616121261,0.734860145,2.18792989,1,0.956930322,1.223042385,0.782417955,0.433968985,0.56872068,N,-,,family hydrolase,"F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; P:DNA metabolic process; C:intracellular part",IPR001130 (PFAM); G3DSA:3.20.20.140 (GENE3D); PTHR10060:SF15 (PANTHER); IPR001130 (PANTHER); IPR001130 (PANTHER); IPR032466 (SUPERFAMILY),,
RL4_JR_08854,4696,3800,4001,8,1,5,0,0,0,0,4,2,1,4,0,0,4,0,12.32261586,1,0.752180665,1.256784559,0.598496106,0.549508956,0.729379601,1.363627484,0,3.018110342,1.486761271,2.029989886,0.042357567,0.103611237,3.545644293,1,0.363112815,1.295845723,0.280212998,0.779314095,0.85368707,4.091721357,1,-0.05973526,1.314896047,-0.045429645,0.963764852,0.979049977,3.491333805,1,0.282598462,1.300223545,0.217346058,0.827938666,0.884617103,N,-,,Proline iminopeptidase,P:proteolysis; F:peptidase activity,IPR000073 (PRINTS); IPR000073 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR10992 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_08855,846,1094,999,0,0,0,0,0,0,0,0,2,4,0,5,0,0,0,31.54671299,0,3.108444196,0.615620284,5.049288133,4.43E-07,7.44E-06,1.551558933,0,2.831878801,1.365481237,2.07390532,0.038088105,0.095356863,16.99882933,1,2.00483817,1.048985653,1.911216005,0.055976828,0.123197697,14.24952357,1,0.718002108,1.157410502,0.620352162,0.53502596,0.667217372,3.921348004,0,0.114675664,1.208970187,0.094854005,0.924430791,0.951012168,N,-,,major facilitator superfamily transporter,"C:nucleus; F:zinc ion binding; P:transmembrane transport; C:integral component of membrane; F:transporter activity; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662:SF258 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_08856,21,15,35,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.047123719,0,6.304244525,3.929336175,1.60440447,0.108624926,NA,0.015526127,0,9.475263839,3.228410469,2.934962555,0.003335879,0.016389297,0.039612839,0,6.845968582,1.949662942,3.511360058,0.00044582,0.003117046,0.045638894,0,6.426024449,3.366661363,1.90872314,0.056297816,0.13185644,0.038530325,0,6.775864108,1.487636125,4.554785942,5.24E-06,5.91E-05,N,-,,stress response,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_08857,668,647,811,0,0,0,0,0,0,1,2,3,0,4,1,0,0,0,34.40627077,0,10.15674516,1.00398904,10.11639047,4.67E-24,1.03E-21,0.012686857,0,9.765559455,3.26153446,2.994161054,0.002752006,0.015349618,0.032792157,1,7.116805952,1.914943771,3.716456881,0.000202036,0.001769232,0.037812363,1,6.697087938,3.515929551,1.904784451,0.056808096,0.132530408,0.032326286,0,7.030567879,1.422269688,4.943203062,7.68E-07,1.17E-05,Y,-,,starch binding domain-containing,F:starch binding,IPR002044 (SMART); IPR002044 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR004302 (PFAM); PTHR15048 (PANTHER); IPR002044 (PROSITE_PROFILES); IPR013784 (SUPERFAMILY),,
RL4_JR_08858,2467,2824,4060,0,0,7,0,3,1,1,4,2,0,2,0,0,2,0,0.272819099,1,3.771426455,2.662681175,1.416401817,0.156657892,NA,0.08799975,1,6.971821411,2.212178102,3.151564246,0.001623984,0.015023052,0.227300071,1,4.325421161,1.40713457,3.073921465,0.00211265,0.01028292,0.262106641,1,3.904230035,1.751620464,2.228924653,0.025818918,0.085851084,0.2236167,1,4.245385404,1.308018499,3.245661591,0.00117178,0.00543734,N,-,,---NA---,,no IPS match,,
RL4_JR_08859,5149,5140,8585,0,0,0,0,0,0,0,0,2,0,5,3,0,5,0,0.377591862,0,3.302630657,2.290035158,1.442174652,0.14925311,NA,0.12226389,0,6.497593162,2.057949565,3.157314092,0.001592297,0.015023052,0.314637787,1,3.857084417,1.348634059,2.859993333,0.004236499,0.016940088,0.362755372,1,3.435649736,1.576234407,2.179656604,0.029282926,0.09099655,0.308029404,1,3.783480251,1.273968637,2.96983783,0.00297957,0.011752297,N,-,,---NA---,,no IPS match,,
RL4_JR_08860,5437,6283,6488,0,1,0,0,0,0,3,0,0,3,11,4,0,4,5,4.657383832,1,-0.32206608,1.203816695,-0.267537476,0.789055363,0.891276415,1.486892629,0,2.893190692,1.342534091,2.155022141,0.031160102,0.081527405,3.858456575,1,0.240759234,1.203537441,0.200042995,0.841446955,0.897850862,8.462707901,1,0.76525155,1.148072695,0.666553219,0.505057559,0.641672753,25.90312269,1,2.391554879,0.845219226,2.829508376,0.004661958,0.016870023,N,-,,fungal specific transcription factor domain-containing,"F:DNA binding; C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; P:response to xenobiotic stimulus; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR007219 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31944 (PANTHER); PTHR31944:SF76 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_08861,2539,2739,5753,0,0,3,0,0,0,0,0,0,0,3,0,0,0,0,0.139771127,1,4.736423347,3.477390911,1.362062382,0.173178199,NA,0.045274504,0,7.931076793,2.477859955,3.200776854,0.001370576,0.015023052,0.116359102,0,5.29294197,1.456585919,3.63380004,0.000279277,0.002205463,0.13415027,1,4.870992516,2.102406696,2.316865013,0.020511086,0.077696516,0.113650575,0,5.220993353,1.290066894,4.047071803,5.19E-05,0.000402689,N,-,,MFS transporter,P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane; P:anion transport,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF278 (PANTHER); PTHR11662 (PANTHER); PTHR11662 (PANTHER); PTHR11662:SF278 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.38, the major facilitator superfamily (mfs).
RL4_JR_08862,33380,28622,28748,7,9,15,2,0,0,7,2,4,1,10,2,0,8,6,44.02884134,1,2.833256022,0.814290237,3.479417897,0.000502504,0.003382368,1.19360257,1,3.210167042,1.396244982,2.299143118,0.021496814,0.060983954,10.95071637,1,1.514971306,1.21235727,1.249607969,0.211442791,0.339300493,3.586189685,1,0.130414997,1.234645859,0.105629477,0.915876336,0.949156622,17.80273634,1,2.169464521,1.00128794,2.166673975,0.030259722,0.075639823,N,-,,haloacid dehalogenase,P:metabolic process; F:hydrolase activity,IPR006439 (PRINTS); IPR023214 (PFAM); IPR023214 (G3DSA:3.40.50.GENE3D); PTHR12725:SF62 (PANTHER); PTHR12725 (PANTHER); IPR023214 (SUPERFAMILY),,
RL4_JR_08863,1551,2408,2721,0,3,0,0,0,1,0,0,0,0,0,0,0,0,0,1.786339962,1,1.060847593,1.392924108,0.761597553,0.446300236,NA,0.564538922,1,4.290343346,1.566853552,2.738190394,0.00617783,0.023767387,1.471344,0,1.631983748,1.268214893,1.286835344,0.198151685,0.32335391,1.698023285,0,1.209073455,1.300718586,0.929542691,0.352607911,0.499043207,1.454908633,0,1.545684472,1.261201355,1.225565186,0.220362346,0.346454775,N,-,,hypothetical protein SPI_01516,,no IPS match,,
RL4_JR_08864,10330,12348,12812,9,3,34,0,0,1,0,0,1,8,8,4,0,4,6,20.0091161,1,-1.172754002,1.157158611,-1.013477315,0.310832226,0.49897074,5.134615885,1,1.105216815,1.246452424,0.886689932,0.37524586,0.53998274,13.37156927,1,-1.552158717,1.201786027,-1.291543322,0.196515343,0.321396158,15.42961416,1,-1.974854244,1.201157863,-1.644125476,0.100150287,0.195984084,13.22964281,1,-1.639435654,1.209941673,-1.354970815,0.175426856,0.291945581,N,-,,O- family 2,F:methyltransferase activity,IPR010730 (PFAM),,
RL4_JR_08865,6980,9093,14939,0,0,0,0,0,0,0,0,0,3,1,0,0,2,2,1.625139979,0,1.196951424,1.359562241,0.880394724,0.378645514,NA,0.514605773,0,4.42380307,1.554964198,2.844954936,0.004441771,0.019050679,1.343183594,0,1.762762611,1.248044934,1.412419187,0.15782657,0.272250161,1.550033818,1,1.340133327,1.276477114,1.049868668,0.293778499,0.438265404,1.333505722,1,1.671111131,1.244266488,1.343049215,0.179256038,0.296660246,N,-,,glycoside hydrolase family 18,"P:metabolic process; F:hydrolase activity, acting on glycosyl bonds",IPR011583 (SMART); IPR018392 (SMART); IPR018392 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); IPR018392 (G3DSA:3.10.350.GENE3D); IPR001002 (G3DSA:3.30.60.GENE3D); IPR001223 (PFAM); IPR029070 (G3DSA:3.10.50.GENE3D); PTHR11177:SF218 (PANTHER); PTHR11177 (PANTHER); IPR001002 (PRODOM); IPR001002 (SUPERFAMILY); IPR017853 (SUPERFAMILY); IPR018392 (SUPERFAMILY); IPR029070 (SUPERFAMILY),9.B.29.2.7, the small 4-5 tms putative permease (4-5pp) family.
RL4_JR_08866,469,363,553,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0.550923658,0,2.757565527,2.000766517,1.378254535,0.168124715,NA,0.173493,0,5.992140377,1.930810788,3.103432203,0.001912901,0.015023052,0.454998797,0,3.323802847,1.344483456,2.472178317,0.013429251,0.040736812,0.525194735,1,2.901296797,1.50082037,1.933140604,0.053218879,0.12702526,0.454338563,0,3.224553608,1.307560954,2.466082822,0.013659975,0.040311059,N,-,,FAR-17a AIG1,C:membrane,PTHR12242 (PANTHER),,
RL4_JR_08867,9246,8553,7044,0,0,9,0,0,0,3,1,2,2,8,0,0,1,2,52.64796476,1,1.126729451,0.559617657,2.013391531,0.044073456,0.12102028,6.293578557,0,0.811652335,1.230724152,0.659491677,0.509580089,0.661193394,22.80157813,1,-0.876294245,1.188195569,-0.73750001,0.460818337,0.598502225,82.70200426,1,1.48908738,0.534849819,2.784122434,0.005367277,0.029582841,23.41514419,1,-0.984706713,1.118059407,-0.880728436,0.378464822,0.514218508,N,-,,glycerol:H+ symporter (Gup1),C:integral component of membrane,IPR004299 (PFAM); PTHR13285 (PANTHER); PTHR13285:SF18 (PANTHER); PTHR13285:SF18 (PANTHER),2.A.50.1.1, the glycerol uptake (gup) or membrane-bound acyl transfeerase (mboat) family.
RL4_JR_08868,10894,11567,10443,8,0,11,2,0,0,5,7,1,7,11,1,0,19,11,36.30013023,1,1.799590641,0.685552048,2.62502409,0.008664284,0.033755122,2.802051995,1,1.978961208,1.281670683,1.54404812,0.122576676,0.237322324,7.29622437,1,-0.678334862,1.203626907,-0.563575688,0.573042936,0.696196152,8.418813907,1,-1.100965771,1.202811231,-0.915327146,0.360019912,0.506137408,22.66475875,1,1.82453131,0.783522114,2.328627713,0.019878797,0.054339313,N,-,,F-box pof7,P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; C:SCF ubiquitin ligase complex; P:cellular response to methylmercury,IPR001810 (PFAM); G3DSA:1.20.1280.50 (GENE3D); PTHR12874 (PANTHER); PTHR12874:SF9 (PANTHER); PTHR12874 (PANTHER); PTHR12874:SF9 (PANTHER); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY),,
RL4_JR_08869,9480,11117,12770,0,1,1,0,0,2,0,4,0,3,4,1,0,10,0,48.76131074,1,-0.627269863,0.906015736,-0.692338817,0.488724579,0.676453192,18.50780001,1,1.189501752,1.148344238,1.035840747,0.300276445,0.460406143,23.88142381,1,-2.388898527,1.220430322,-1.957423119,0.050297743,0.113638551,43.60920548,1,-0.140188232,0.816144467,-0.171768894,0.863619221,0.915373674,23.76484663,1,-2.484531183,1.235008643,-2.011752061,0.04424608,0.10188573,N,-,,U4 U6 small nuclear ribonucleo,"C:mitotic spindle; C:U4/U6 x U5 tri-snRNP complex; C:viral nucleocapsid; P:mRNA splicing, via spliceosome",IPR013881 (PFAM); IPR010541 (PFAM); IPR027104 (PANTHER),,
RL4_JR_08870,5702,4058,3391,0,6,6,0,0,0,3,0,0,0,0,5,0,11,2,156.7472672,1,0.056459557,0.983108197,0.057429647,0.954202947,0.977185309,23.92496136,0,-1.114897382,1.205324078,-0.924977275,0.354977728,0.519156851,154.2543313,1,0.39887634,0.49807258,0.80083979,0.423224401,0.564483541,105.9943863,1,-0.874972209,0.618905596,-1.413740987,0.157437966,0.275884287,144.2228736,1,0.90899409,0.407121568,2.232733814,0.025566503,0.066545204,N,-,,solute carrier family 25 member 40,F:pyridoxal phosphate binding; F:structural constituent of ribosome; P:manganese ion transport; C:mitochondrion; C:integral component of membrane; F:metallochaperone activity; P:translation,IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089:SF25 (PANTHER); PTHR24089:SF25 (PANTHER); PTHR24089 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.14.8, the mitochondrial carrier (mc) family.
RL4_JR_08871,1181,898,1159,0,2,2,0,0,0,0,0,0,1,0,0,0,0,0,27.7013801,1,2.349430289,0.851778837,2.75826328,0.005810938,0.024524381,1.173707065,0,3.234511424,1.381876242,2.340666499,0.019249353,0.055812648,25.22311407,0,2.992902478,0.855396541,3.498848,0.000467273,0.003220334,30.79864199,1,2.896896865,0.745601022,3.885317725,0.000102196,0.001086908,32.44837267,0,3.153914107,0.745410888,4.231108184,2.33E-05,0.000203676,N,-,,uracil-DNA glycosylase,C:nucleus; F:uracil DNA N-glycosylase activity; P:base-excision repair; C:mitochondrion,IPR005122 (SMART); SM00987 (SMART); IPR005122 (G3DSA:3.40.470.GENE3D); IPR002043 (TIGRFAM); IPR005122 (PFAM); IPR002043 (PANTHER); PTHR11264:SF0 (PANTHER); IPR002043 (HAMAP); IPR005122 (SUPERFAMILY),,
RL4_JR_08872,262,337,402,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,114.1021011,0,2.632451461,0.766524084,3.434271039,0.00059415,0.003868375,5.724484209,0,0.94843222,1.266069961,0.749115175,0.45378779,0.613331554,29.14039852,0,0.121620127,1.051813156,0.115629022,0.907946561,0.943451809,100.3815014,1,2.392074723,0.477565852,5.008889791,5.47E-07,1.06E-05,41.53568671,0,1.590994413,0.637428031,2.495959284,0.012561702,0.037752221,N,-,,morphogenesis,C:cell division site; C:mitochondrion; C:cytosol; P:establishment of cell polarity,IPR012965 (PFAM); PTHR28093 (PANTHER),,
RL4_JR_08873,5700,5081,6516,0,2,4,0,0,0,0,0,0,0,0,3,0,3,0,207.8531647,1,-1.141956914,0.556059584,-2.053659258,0.040008682,0.112626236,44.59770509,0,-2.013372211,1.21647565,-1.655086324,0.097906989,0.19915887,193.5118299,0,-0.538940234,1.673220774,-0.322097503,0.74737883,0.830840372,295.3582048,1,0.116437403,0.473756192,0.245774947,0.805856452,0.875742897,135.01687,1,-2.486195047,0.864101153,-2.877203716,0.004012165,0.014918534,N,-,,zinc cadmium resistance,P:cation transport; P:transmembrane transport; C:membrane,IPR002524 (TIGRFAM); IPR027469 (G3DSA:1.20.1510.GENE3D); IPR002524 (PFAM); PTHR11562:SF17 (PANTHER); IPR002524 (PANTHER); PTHR11562:SF17 (PANTHER); IPR002524 (PANTHER); SSF160240 (SUPERFAMILY); SSF161111 (SUPERFAMILY),2.A.4.2.8, the cation diffusion facilitator (cdf) family.
RL4_JR_08874,716,689,961,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,1.159199504,1,1.684776462,1.669717133,1.00901909,0.312965479,NA,0.365475633,0,4.917708705,1.770454909,2.777652614,0.005475312,0.021966353,0.952172285,0,2.260059944,1.356038177,1.66666395,0.095581245,0.1876046,1.098954243,0,1.836940875,1.440617307,1.275106766,0.202271455,0.333658925,0.939513835,1,2.17673329,1.336057915,1.629220758,0.103266294,0.195645554,N,-,,glycoside hydrolase family 3,F:beta-glucosidase activity; P:cellulose catabolic process; F:scopolin beta-glucosidase activity,IPR001764 (PRINTS); IPR011658 (SMART); IPR026891 (SMART); IPR026891 (PFAM); IPR002772 (PFAM); IPR002772 (G3DSA:3.40.50.GENE3D); IPR001764 (G3DSA:3.20.20.GENE3D); IPR001764 (PFAM); IPR011658 (PFAM); IPR026892 (PANTHER); PTHR30620:SF20 (PANTHER); IPR002772 (SUPERFAMILY); IPR017853 (SUPERFAMILY),,
RL4_JR_08875,2617,2414,2420,0,0,5,0,0,0,3,0,0,2,5,0,0,0,0,58.73626381,1,-0.506735966,0.740771099,-0.684065518,0.493933795,0.681466582,20.5781768,0,0.897060756,1.117804251,0.802520437,0.422251971,0.585484172,98.76262888,1,1.158535781,0.534541183,2.167346162,0.030208469,0.077171471,82.76813436,1,0.451870897,0.570222315,0.792446884,0.428100151,0.570706259,51.73132252,0,0.439609325,0.62021302,0.708803767,0.47844626,0.607971664,N,-,,cell division control 1,P:single-organism cellular process,IPR029052 (G3DSA:3.60.21.GENE3D); IPR004843 (PFAM); PTHR13315:SF0 (PANTHER); IPR033308 (PANTHER); IPR033308 (PANTHER); PTHR13315:SF0 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_08876,3701,3863,4576,0,1,1,0,0,0,1,0,3,0,5,1,0,1,0,4.265811836,1,-0.194870637,1.218236352,-0.159961273,0.872911581,0.939046053,45.98688233,0,4.693479735,0.988631636,4.747450481,2.06E-06,0.00016952,3.529253119,1,0.369881127,1.20996279,0.305696283,0.759835904,0.83870243,4.071128588,1,-0.052365499,1.211132359,-0.04323681,0.965512763,0.980228289,3.468615233,1,0.292001476,1.20458039,0.242409289,0.808463037,0.870725269,N,-,,hypothetical protein NECHADRAFT_75613,C:membrane; C:integral component of membrane,IPR021514 (PFAM); PTHR37576:SF2 (PANTHER); PTHR37576 (PANTHER),,
RL4_JR_08877,4276,3678,5672,0,3,13,0,0,1,0,2,0,0,1,2,0,5,0,3.033907194,1,0.296221057,1.239184603,0.23904514,0.81107058,0.904262969,0.970783672,1,3.508266028,1.419374472,2.471698694,0.01344728,0.042205696,2.516765247,1,0.85714195,1.2199925,0.702579688,0.482317724,0.618412442,2.903084766,1,0.434985945,1.226349132,0.354699925,0.722814407,0.815249624,2.48177946,1,0.774668559,1.216916777,0.636583022,0.524396487,0.648366426,N,-,,mitochondrial chaperone BCS1,,IPR019261 (PFAM); G3DSA:3.40.220.10 (GENE3D); PTHR35596 (PANTHER); SSF52949 (SUPERFAMILY),,
RL4_JR_08878,1381,1385,2315,0,0,0,0,0,0,0,0,1,1,0,0,0,2,0,1.070729005,0,1.79888556,1.588778915,1.132244104,0.257531823,NA,0.337142935,0,5.033761922,1.716206956,2.933073954,0.003356239,0.016427396,0.884147736,1,2.365798776,1.306749091,1.810446085,0.070226638,0.147230169,1.02055579,1,1.942959943,1.377653505,1.410340072,0.158439292,0.277063528,0.882729803,1,2.266287511,1.296081386,1.748568828,0.080365578,0.161705382,N,-,,hypothetical protein GGTG_12645,F:metal ion binding; F:NAD+ ADP-ribosyltransferase activity,IPR012317 (PFAM); IPR012317 (G3DSA:3.90.228.GENE3D); SSF56399 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_08879,871,720,1295,0,0,1,0,0,0,2,0,0,5,1,0,0,0,0,262.8865064,1,3.492563702,0.737374711,4.736484248,2.17E-06,3.01E-05,6.649678859,0,0.732277434,1.276432627,0.573690627,0.566177172,0.708211238,79.85426394,1,1.89387293,1.543278797,1.227174853,0.219756879,0.348881706,48.63389013,1,0.042751685,0.888253583,0.048130045,0.961612602,0.978355082,39.89918687,0,1.161843083,0.689774873,1.684380119,0.09210823,0.17932612,N,-,,hypothetical protein SPBR_04591,C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_08880,5966,5016,6464,0,0,4,0,0,0,0,2,1,0,15,0,0,0,0,1.680043438,1,1.149087184,1.536503134,0.747858666,0.454545412,NA,0.524073388,0,4.397382147,1.663014514,2.644223553,0.008187856,0.029049239,1.381665555,1,1.722143553,1.336449808,1.288595757,0.197538659,0.322676338,1.595436787,1,1.298575642,1.393591269,0.931819588,0.35142977,0.497932608,1.385601099,0,1.615897366,1.339485899,1.206356384,0.227680106,0.35496131,N,-,,hypothetical protein SPSK_06358,"F:oxidoreductase activity, acting on CH-OH group of donors; F:catalytic activity; F:flavin adenine dinucleotide binding; F:oxidoreductase activity; P:oxidation-reduction process",IPR021833 (PFAM); PTHR38116 (PANTHER),,
RL4_JR_08881,3463,3276,2976,0,1,5,1,0,0,0,0,1,0,5,0,0,2,2,0.007786068,1,8.896911713,4.040984052,2.201669593,0.027688656,NA,0.002502822,1,12.10389348,4.040376809,2.995733828,0.002737853,0.015349618,0.006502266,1,9.448056946,3.305547956,2.858242286,0.00425995,0.016940088,0.007499321,1,9.02784755,4.040049892,2.234588134,0.025444401,0.085851084,0.00645541,1,9.348501478,1.703823852,5.486776974,4.09E-08,1.17E-06,N,-,,short-chain dehydrogenase reductase family,,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24320 (PANTHER); PTHR24320:SF60 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_08882,11781,11196,15822,3,13,8,0,0,0,0,0,0,0,3,0,0,0,0,2.605843791,1,0.516018548,1.248671996,0.41325388,0.679420616,0.824051985,0.837449518,0,3.721549336,1.45049077,2.565717351,0.010296269,0.034269426,2.161560626,0,1.077190616,1.221228669,0.882054806,0.377747171,0.521520384,2.492862114,1,0.655227244,1.229468149,0.532935517,0.594078218,0.716929911,2.118922491,0,1.002746627,1.207932182,0.830134872,0.406462533,0.54318498,N,-,,major facilitator superfamily transporter,P:transmembrane transport; P:mycelium development; C:integral component of membrane,PR01036 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501:SF59 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_08883,1211,831,520,0,0,7,0,0,0,0,0,0,0,2,0,0,0,7,15.10143335,1,0.711163154,1.046996664,0.679241089,0.496985117,0.684172221,2.361607346,0,2.225667761,1.309131262,1.700110467,0.089110149,0.184999714,6.160827416,0,-0.434253304,1.215743821,-0.357191455,0.720948483,0.810983929,7.109767842,1,-0.857084507,1.216770852,-0.704392701,0.48118825,0.621511805,6.107183566,1,-0.524203271,1.224861894,-0.427969287,0.668673481,0.764748559,N,-,,Pre translocase Sec Sec61-beta subunit,C:integral component of membrane; P:intracellular protein transport; C:Sec61 translocon complex,IPR016482 (PFAM); IPR030671 (PANTHER),3.A.5.8.1, the general secretory pathway (sec) family.
RL4_JR_08884,38742,33639,33721,29,27,8,0,0,7,14,112,182,17,5,83,0,151,89,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_08885,1869,2111,1678,2,0,0,0,0,0,6,0,2,0,2,0,0,4,2,74.42512374,1,-2.151605311,1.045097783,-2.058759807,0.039517254,0.111860429,18.22985655,0,-0.722692625,1.243977771,-0.580953006,0.561272126,0.704426096,53.41131676,1,-2.401118346,1.217412936,-1.972312167,0.048573982,0.11075743,86.1812886,1,-0.190581033,0.675508638,-0.282129676,0.777844079,0.856564421,60.63257111,1,-1.733052228,0.99876595,-1.735193543,0.08270653,0.165592963,N,-,,serine threonine- phosphatase dullard,P:biological_process; F:phosphatase activity; P:dephosphorylation; C:cellular_component,IPR004274 (SMART); IPR004274 (PFAM); IPR011948 (TIGRFAM); IPR023214 (G3DSA:3.40.50.GENE3D); PTHR12210:SF29 (PANTHER); PTHR12210 (PANTHER); IPR004274 (PROSITE_PROFILES); IPR023214 (SUPERFAMILY),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_08886,23782,19173,8304,2,5,1,0,0,0,0,4,0,0,0,4,0,2,0,75.0550215,1,-0.199089329,0.590453716,-0.337180245,0.735981029,0.860807632,15.50312244,0,-0.488954831,1.213553841,-0.402911527,0.687013311,0.801091518,54.44345728,1,-1.31489299,1.035421372,-1.269911001,0.204116334,0.33021313,105.4941716,1,0.187252401,0.546254899,0.342793083,0.73175413,0.821133092,92.41465997,1,0.845685413,0.48660573,1.737927364,0.082223613,0.164886925,N,-,,peroxisomal ABC transporter,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:fatty acid beta-oxidation; P:long-chain fatty acid catabolic process; C:integral component of peroxisomal membrane; P:transmembrane transport; P:fatty-acyl-CoA transport; P:very long-chain fatty acid catabolic process; P:peroxisomal long-chain fatty acid import; F:peroxisomal fatty-acyl-CoA transporter activity",IPR003593 (SMART); IPR003439 (PFAM); IPR011527 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11384 (PANTHER); PTHR11384:SF35 (PANTHER); PTHR11384 (PANTHER); PTHR11384:SF35 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.203.6, the atp-binding cassette (abc) superfamily.
RL4_JR_08887,1254,707,1248,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.568073114,0,2.713365794,1.90611774,1.423503772,0.154590169,NA,0.180198968,0,5.937592638,1.880872262,3.156829286,0.001594947,0.015023052,6.968814883,0,4.237051511,1.224149166,3.46122158,0.00053773,0.003569822,0.542438028,0,2.854783504,1.431649707,1.994051681,0.046146407,0.116604036,0.466692222,0,3.185659297,1.264317596,2.519666978,0.011746591,0.035791223,N,-,,tat pathway signal sequence,"F:nucleotide binding; F:ATPase activity; P:biological_process; F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:membrane; C:integral component of membrane; C:cellular_component; P:transport; F:molecular_function",no IPS match,,
RL4_JR_08888,7205,5064,4275,2,2,10,0,0,0,0,2,4,3,6,0,0,2,0,236.0872671,1,3.221779661,1.241266036,2.595559347,0.009443709,0.036219767,16.92049572,0,1.46649258,1.131465869,1.296099706,0.194941136,0.337760045,65.03456134,1,1.506538868,0.601482662,2.504708721,0.012255227,0.037861435,155.6083214,1,2.772957382,0.398397285,6.96028183,3.40E-12,1.49E-10,115.7343907,1,2.427068613,1.669373224,1.453880162,0.145979534,0.253871999,N,-,,aldo keto reductase,P:cellular response to osmotic stress; P:galactose catabolic process; F:mRNA binding; P:cellular response to oxidative stress; P:oxidation-reduction process; P:arabinose catabolic process; F:D-xylose:NADP reductase activity; F:glucose 1-dehydrogenase (NADP+) activity; P:D-xylose catabolic process,IPR020471 (PRINTS); IPR020471 (PIRSF); IPR023210 (G3DSA:3.20.20.GENE3D); IPR023210 (PFAM); PTHR11732:SF218 (PANTHER); IPR001395 (PANTHER); IPR001395 (PANTHER); PTHR11732:SF218 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.4, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_08889,2509,1838,1900,2,1,1,0,0,0,0,1,5,1,0,2,0,0,4,82.21276612,1,-0.741666895,0.737840038,-1.005186567,0.314807022,0.503074571,13.4373583,0,-0.282623787,1.21137461,-0.23330833,0.815521991,0.888463415,65.32793365,1,-0.109188177,0.740845711,-0.147383153,0.882829603,0.926865799,144.4683164,1,1.115579994,0.642594946,1.736054729,0.082554158,0.169786888,34.1574849,1,-3.007920105,1.186320182,-2.535504454,0.01122855,0.034468684,N,-,,phosphatase 1 regulatory subunit sds22,P:positive regulation of mitotic sister chromatid separation; P:regulation of catalytic activity; C:cell part,SM00364 (SMART); IPR003591 (SMART); SM00365 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); IPR001611 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR24365 (PANTHER); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR032675 (SUPERFAMILY),8.A.43.1.12, the neat-domain containing methaemoglobin heme sequestration (n-mhs) family.
RL4_JR_08890,10844,9560,6685,2,4,19,0,0,0,1,0,1,0,9,2,0,8,6,2.133452798,1,0.804497526,1.258663397,0.639168127,0.522713564,0.707148923,0.679471331,0,4.023008153,1.468918739,2.738754736,0.006167236,0.023735652,1.764837104,1,1.369337437,1.215563812,1.126503951,0.259952269,0.396707382,2.036109566,1,0.946919739,1.225854216,0.772457056,0.439843772,0.581743097,1.74171832,1,1.285880971,1.209568185,1.063090933,0.287740716,0.42216704,N,-,,btb poz domain containing,,G3DSA:3.30.710.10 (GENE3D); IPR000210 (PFAM); PTHR26379:SF150 (PANTHER); PTHR26379 (PANTHER); PTHR26379 (PANTHER); PTHR26379:SF150 (PANTHER); IPR000210 (PROSITE_PROFILES); IPR011333 (SUPERFAMILY),,
RL4_JR_08891,562,235,261,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,13.86606183,1,-1.895794338,1.20736998,-1.570185087,0.116372058,0.247230013,4.395126268,0,1.329562321,1.256570753,1.058087909,0.290015366,0.449334108,11.44997524,0,-1.328343956,1.204237697,-1.103057943,0.270002003,0.408409755,21.23573179,0,-0.031627187,1.031495876,-0.030661477,0.975539514,0.98517231,11.33284117,0,-1.416164661,1.212725288,-1.16775388,0.242906056,0.372414267,N,-,,cop9 signalosome complex subunit 12,C:nucleus; C:cytosol; P:cellular process,IPR011991 (G3DSA:1.10.10.GENE3D); IPR000717 (PFAM); PTHR12732 (PANTHER),,
RL4_JR_08892,1134,1011,1716,0,0,0,0,0,0,0,0,1,0,0,2,0,4,0,652.9056676,0,-0.854719652,0.444841461,-1.921402852,0.054680939,0.142383372,137.291624,0,-3.635591743,1.199464513,-3.031012343,0.002437353,0.015349618,420.803063,1,-2.839801316,0.653758174,-4.343810034,1.40E-05,0.000251364,468.7941791,1,-2.498793606,0.749854294,-3.332372203,0.00086109,0.006540538,399.8592845,1,-2.513475097,0.59346885,-4.23522666,2.28E-05,0.000201022,N,-,,60S ribosomal l20,F:structural constituent of ribosome; C:cytosolic large ribosomal subunit; P:translation,G3DSA:3.10.20.10 (GENE3D); IPR021138 (PIRSF); IPR023573 (PFAM); PTHR10052:SF1 (PANTHER); PTHR10052 (PANTHER); SSF160374 (SUPERFAMILY),,
RL4_JR_08893,2067,2400,2228,0,8,0,0,0,0,1,1,0,1,0,1,0,7,0,32.60792869,1,2.088548581,0.869366812,2.402379011,0.016288822,0.05571665,1.429494153,0,2.949969401,1.375267489,2.145015006,0.031951647,0.083203273,19.39321042,1,2.123012276,1.051908734,2.018247598,0.043565481,0.101790199,4.276347832,1,-0.123790583,1.227027869,-0.100886529,0.919640537,0.951639048,3.658431297,1,0.214859539,1.224874251,0.175413548,0.860754696,0.907543611,N,-,,hydroxyproline-rich glyco dz-hrgp,,PTHR39611 (PANTHER); PTHR39611:SF2 (PANTHER),1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_08894,2608,2267,3185,0,0,10,0,0,0,0,5,0,0,0,0,0,0,1,63.85200136,1,-0.161700227,0.730045521,-0.221493348,0.824708316,0.911402119,11.10020809,0,-0.006976157,1.261958551,-0.005528039,0.995589285,0.997829394,41.57879205,1,-0.836819079,1.069640761,-0.782336566,0.434016803,0.574527473,32.95379561,0,-3.069562946,1.224427807,-2.506936651,0.012178254,0.056717947,42.7225808,1,-1.016570744,1.004278726,-1.012239648,0.311423483,0.446813486,N,-,,hypothetical protein SPI_03877,,no IPS match,,
RL4_JR_08895,25826,27971,35554,0,1,11,0,0,0,0,0,3,1,4,0,2,0,0,99.65913524,1,-0.633965929,0.694168354,-0.913274028,0.361098438,0.552456227,20.47001609,0,-0.889963807,1.241122576,-0.717063588,0.473334862,0.630988473,53.4406386,1,-3.550910725,1.228560014,-2.890303024,0.003848706,0.016036854,105.7947922,1,-0.042124103,0.739084741,-0.056994957,0.954549212,0.973294136,68.56767859,1,-1.095694073,0.855664982,-1.280517604,0.200363157,0.322165629,N,-,,histone acetyltransferase GCN5,"P:histone H3 acetylation; F:H3 histone acetyltransferase activity; P:reciprocal meiotic recombination; C:Ada2/Gcn5/Ada3 transcription activator complex; C:chromosome, centromeric region; C:SAGA complex; P:negative regulation of leucine import; P:negative regulation of transcription from RNA polymerase II promoter; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:chromatin remodeling; C:SLIK (SAGA-like) complex; F:lysine-acetylated histone binding; C:cytosol; P:chromatin organization involved in regulation of transcription",IPR001487 (PRINTS); IPR001487 (SMART); IPR001487 (G3DSA:1.20.920.GENE3D); IPR016181 (G3DSA:3.40.630.GENE3D); IPR000182 (PFAM); IPR001487 (PFAM); PTHR22880 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY); IPR001487 (SUPERFAMILY),,
RL4_JR_08896,468,567,421,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,15.30895934,1,-0.019470304,1.149004634,-0.016945366,0.986480201,0.992930966,2.320161121,0,2.251262854,1.293872473,1.739941841,0.081869231,0.173182937,38.52639551,0,2.729782381,0.676990043,4.032234169,5.52E-05,0.000782296,10.97214553,1,0.120390287,1.148843668,0.104792576,0.916540401,0.949649157,9.819690072,0,0.440645079,1.133316495,0.388810258,0.697416512,0.785728517,N,-,,DNA repair,P:DNA repair; P:mitotic G2 DNA damage checkpoint; C:site of double-strand break; C:integral component of membrane; C:cytosol; P:intra-S DNA damage checkpoint; C:checkpoint clamp complex; P:mitotic DNA replication checkpoint,no IPS match,,
RL4_JR_08897,44469,23468,24408,6,22,63,2,0,7,3,12,12,17,20,10,0,17,10,64.95908158,1,1.717218829,0.57448414,2.98914924,0.002797555,0.013592882,4.217927563,1,1.388982123,1.247869473,1.113082861,0.265672844,0.422856204,18.79434252,1,-0.302253218,1.190436902,-0.253901082,0.799571979,0.868567842,42.3278282,1,1.616369203,0.614266129,2.631382598,0.008503824,0.042687764,25.53190314,1,0.339602609,0.972270683,0.34928813,0.726873009,0.808124433,N,-,,dna repair exonuclease rad1,P:DNA repair; P:mitotic G2 DNA damage checkpoint; P:nucleic acid phosphodiester bond hydrolysis; C:site of double-strand break; F:exonuclease activity; C:cytosol; P:intra-S DNA damage checkpoint; C:checkpoint clamp complex; P:mitotic DNA replication checkpoint,IPR003021 (PRINTS); IPR003021 (PFAM); G3DSA:3.70.10.10 (GENE3D); IPR003021 (PANTHER); SSF55979 (SUPERFAMILY),,
RL4_JR_08898,6552,8603,11280,0,0,1,0,0,0,0,3,0,0,1,0,0,3,0,115.3737456,1,-3.212453989,1.246349819,-2.577489834,0.009952081,0.037762405,33.58856608,0,-1.604407734,1.320566491,-1.214939001,0.224389357,0.37344115,99.87896346,1,-3.321863934,1.309259411,-2.537208369,0.011174042,0.035707308,139.4833155,1,-1.590450463,0.904918795,-1.757561532,0.078822144,0.164721198,93.37624855,1,-3.478660372,1.280386167,-2.716883751,0.006589975,0.022511301,N,-, Effector probability:0.552,---NA---,,no IPS match,,
RL4_JR_08899,5480,4016,3923,2,0,2,0,0,0,0,0,1,0,1,0,0,0,0,15.69686777,1,-2.074650976,1.19704899,-1.733137902,0.083071161,0.193581826,5.043217444,0,1.131238944,1.260116127,0.897725947,0.369331673,0.533672404,20.86059551,1,-0.551502948,1.198585185,-0.460128287,0.645424141,0.753167085,15.0129843,1,-1.935222012,1.199340719,-1.613571507,0.106620401,0.20582108,12.7596965,0,-1.587336974,1.19669508,-1.326433943,0.184696002,0.303480529,N,-,,hypothetical protein SPI_03900,P:regulation of mitotic metaphase/anaphase transition; C:anaphase-promoting complex; P:anaphase-promoting complex-dependent catabolic process,no IPS match,,
RL4_JR_08900,4279,3057,3338,0,1,0,0,0,0,3,0,5,1,1,2,0,3,1,21.95927801,1,1.835072935,0.802316054,2.287219513,0.022183014,0.071670901,2.15184842,0,2.360051258,1.348926838,1.749576917,0.080191346,0.170524538,18.54096727,1,1.531591193,1.061831967,1.442404487,0.149188299,0.26113111,16.02794653,1,0.249274021,1.16955299,0.21313615,0.831220769,0.894259752,5.418994904,1,-0.351824645,1.218476323,-0.28874147,0.772779225,0.842782168,N,-,,rhoptry partial,C:nucleus; C:cytoplasm; P:mitotic spindle organization; P:mitotic sister chromatid segregation; F:structural molecule activity; C:mitotic spindle pole body; P:cellular protein localization; F:microtubule binding,no IPS match,,
RL4_JR_08901,394,542,512,0,0,1,2,0,0,0,0,0,0,3,0,0,0,0,54.41660044,1,0.576670923,0.625804609,0.921487178,0.356796133,0.547749878,8.791872342,1,0.329330279,1.224052229,0.269049205,0.787891818,0.871684445,69.70338953,0,1.286404644,0.593155497,2.168747739,0.030101841,0.076969277,67.3267848,1,0.571206527,0.630457728,0.906018758,0.364925924,0.511189123,29.95561214,0,-1.475001081,1.132580673,-1.302336439,0.1928014,0.313224726,Y,-,,oligosaccharyltransferase subunit ribophorin ii,C:oligosaccharyltransferase complex; F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; C:integral component of membrane; P:protein N-linked glycosylation,IPR008814 (PFAM); PTHR12640 (PANTHER); IPR008814 (PTHR12640:PANTHER),9.B.142.3.14, the integral membrane glycosyltransferase family 39 (gt39) family.
RL4_JR_08902,15341,15166,16767,1,0,0,0,0,1,0,0,0,0,3,0,0,15,2,38.95387739,1,0.900560389,0.748580032,1.20302486,0.2289667,0.401011237,4.215430956,1,1.389783839,1.253000104,1.109164983,0.267359016,0.424703069,53.40268575,0,1.885127247,0.675806514,2.789448177,0.005279795,0.019695151,20.66912956,1,0.035395287,1.022566738,0.034614158,0.972387412,0.984640718,37.50529177,1,1.831713317,0.645428104,2.837981962,0.004539975,0.016546884,N,-,,glutaminyl-peptide cyclotransferase,F:metal ion binding; P:proteolysis; F:peptidase activity; F:transferase activity,G3DSA:3.40.630.10 (GENE3D); IPR007484 (PFAM); PTHR12283:SF2 (PANTHER); PTHR12283 (PANTHER); SSF53187 (SUPERFAMILY),,
RL4_JR_08903,4099,7305,10985,0,0,1,0,0,0,0,0,0,0,1,0,0,4,0,87.27683455,1,0.522069491,0.807016023,0.646913415,0.517687983,0.702478138,13.24186421,0,-0.261480776,1.231934677,-0.212252144,0.831910328,0.899156043,34.26829186,0,-2.909765834,1.206232391,-2.412276321,0.015853262,0.046521281,39.53004187,1,-3.332011721,1.207628748,-2.759135808,0.005795444,0.031513896,63.10259833,1,-0.320651655,0.770052955,-0.416402084,0.677115804,0.770682283,N,-,,ABC transporter,"F:nucleotide binding; F:ATPase activity; F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:membrane; C:integral component of membrane; P:transport",IPR003593 (SMART); G3DSA:1.20.1560.10 (GENE3D); IPR003439 (PFAM); IPR011527 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24223 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY),3.A.1.208.41, the atp-binding cassette (abc) superfamily.
RL4_JR_08904,11402,10862,12763,0,0,22,1,2,0,0,5,9,5,13,1,0,17,1,1.778130093,1,1.067239536,1.299154292,0.821487904,0.411368411,NA,0.572026113,1,4.271449538,1.530419138,2.79103249,0.00525402,0.02127033,1.476579233,1,1.626828226,1.231551087,1.320958783,0.186515108,0.308441514,1.702834691,1,1.204928359,1.250335341,0.963684157,0.335204299,0.481892941,1.448546722,1,1.551233795,1.214555684,1.277202698,0.201530695,0.323631766,N,-,,---NA---,,no IPS match,,
RL4_JR_08905,10766,10052,12076,3,12,15,0,0,0,3,4,1,1,4,5,0,0,6,20.3694181,1,1.55952091,1.074637678,1.451206246,0.146722438,0.292441156,1.377987821,0,3.002983233,1.420038287,2.114719906,0.034453827,0.088199705,3.582727181,1,0.348095529,1.252893302,0.277833339,0.781140298,0.854577953,8.14580847,1,0.868984131,1.199966791,0.724173484,0.468959235,0.610074811,3.531633591,1,0.266066485,1.254819281,0.2120357,0.832079183,0.886687544,N,-,,succinate-semialdehyde dehydrogenase,"P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",IPR016162 (G3DSA:3.40.605.GENE3D); IPR015590 (PFAM); IPR016163 (G3DSA:3.40.309.GENE3D); PTHR11699 (PANTHER); PTHR11699:SF162 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_08906,4876,4132,3776,3,6,1,0,0,0,4,2,3,9,14,3,0,8,6,4.458599007,1,-0.258638632,1.236796512,-0.209119794,0.834354723,0.917340408,1.426951016,0,2.952682149,1.379224063,2.140828476,0.032287873,0.083763531,3.68856053,1,0.306232611,1.222516303,0.250493683,0.802205589,0.869979206,13.56685402,1,0.836023362,1.162822985,0.718960128,0.472165487,0.613221595,3.617140795,1,0.231484647,1.216209051,0.190332943,0.849048241,0.899660137,N,-,,---NA---,,no IPS match,,
RL4_JR_08907,539,804,521,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,23.78713595,0,0.053110136,1.015304254,0.052309577,0.958282023,0.978676107,3.841863473,0,1.523779737,1.273525483,1.196505102,0.231499509,0.381572713,9.918536099,0,-1.121029718,1.200888459,-0.933500284,0.350561724,0.494026572,30.06343786,1,0.204342024,1.020334358,0.200269669,0.841269683,0.900930521,40.60946435,0,2.387745159,0.563293277,4.238902282,2.25E-05,0.000198492,N,-,,---NA---,,no IPS match,,
RL4_JR_08908,15,17,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,82.03192523,0,4.292367739,0.582272246,7.371753972,1.68E-13,9.16E-12,1.577443246,0,2.807957105,1.349363033,2.080950076,0.037438476,0.094126243,38.67842732,0,2.989127339,0.750002658,3.985488992,6.73E-05,0.000900612,27.34125441,0,2.06212752,0.858123275,2.403066764,0.016258219,0.069049765,15.59279884,0,2.280551195,0.856869567,2.661491648,0.007779527,0.025657235,Y,-,,cdp-alcohol phosphatidyltransferase,C:membrane; C:integral component of membrane; F:transferase activity,PTHR38118:SF2 (PANTHER); PTHR38118 (PANTHER),,
RL4_JR_08909,23,21,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32.50830807,0,0.130981819,0.853620296,0.153442719,0.878049159,0.940772371,5.372929768,0,1.039822411,1.238187579,0.839793928,0.401023938,0.564635457,20.44143239,0,-0.650606214,1.1915169,-0.54603188,0.585044023,0.706210289,41.76700398,0,1.007187784,0.670858014,1.501342703,0.133266945,0.243385249,21.46133437,0,-0.026025871,0.977589702,-0.026622489,0.978760836,0.985672714,N,-,,cholinephosphotransferase 1,"C:integral component of membrane; F:phosphotransferase activity, for other substituted phosphate groups; P:phospholipid biosynthetic process",IPR000462 (PFAM); IPR014472 (PIRSF); IPR014472 (PANTHER); PTHR10414:SF44 (PANTHER); PTHR10414:SF44 (PANTHER); IPR014472 (PANTHER),4.F.1.1.2, the choline/ethanolaminephosphotransferase 1 (cept1) family.
RL4_JR_08910,60,105,83,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,78.81035278,0,-0.078818652,0.620647495,-0.126994233,0.898944963,0.950562931,12.60344322,0,-0.190192086,1.222640749,-0.155558439,0.876381087,0.928969459,40.38737975,0,-1.873532786,1.195109409,-1.567666334,0.116959022,0.217864424,41.54411755,0,-2.310376292,1.148133253,-2.012289327,0.044189447,0.114079079,31.92973616,0,-2.910648302,1.192291177,-2.441222712,0.014637625,0.042686045,N,-,,PX domain-containing,C:endosome; P:vesicle organization; F:phosphatidylinositol binding; C:extrinsic component of membrane; P:endocytosis,IPR001683 (SMART); IPR001683 (G3DSA:3.30.1520.GENE3D); IPR001683 (PFAM); PTHR10555:SF158 (PANTHER); PTHR10555 (PANTHER); PTHR10555 (PANTHER); PTHR10555:SF158 (PANTHER); IPR001683 (PROSITE_PROFILES); IPR001683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_08911,6960,14941,12670,0,8,6,0,0,1,0,0,0,3,5,4,0,0,0,24.74887142,1,-0.478981264,1.030023539,-0.465019726,0.641917331,0.796223443,5.429707983,1,1.024572101,1.24406119,0.823570504,0.410183641,0.573939565,14.14695601,0,-1.633544452,1.20227322,-1.358713165,0.174237499,0.293252692,33.65955442,1,0.253636021,0.867580768,0.292348598,0.770020105,0.85049128,14.01446631,0,-1.722609221,1.211904869,-1.421406304,0.155198675,0.265302479,N,-,,IQ calmodulin-binding domain-containing,,IPR000048 (SMART); IPR000048 (PFAM); PTHR31250:SF1 (PANTHER); PTHR31250:SF1 (PANTHER); PTHR31250 (PANTHER); PTHR31250 (PANTHER); IPR000048 (PROSITE_PROFILES),,
RL4_JR_08912,1040,1934,1608,1,0,3,0,0,0,0,0,0,0,0,0,1,4,1,96.49152423,1,-1.036851757,0.649579333,-1.59618957,0.110446476,0.237736767,51.53401778,0,1.100359126,0.854282645,1.288050427,0.19772841,0.341071398,152.7513531,0,0.423473735,0.499319405,0.848101898,0.396381225,0.538942187,130.4482963,0,-0.411016626,0.554504775,-0.741231897,0.458552847,0.600549421,71.44081628,1,-2.147986186,0.983552156,-2.183906744,0.028969101,0.073218211,N,-,,iq calmodulin-binding domain-containing,C:intracellular organelle part,IPR029184 (PFAM); PTHR38422 (PANTHER),,
RL4_JR_08913,2776,3316,5290,0,0,0,0,0,0,0,0,1,2,7,0,0,4,2,224.5263529,0,-0.814976001,0.464064609,-1.756169261,0.079059512,0.186676554,45.53983454,0,-2.043522992,1.209385495,-1.68972011,0.091081514,0.18825019,133.1747523,1,-2.862863741,1.041693726,-2.748277799,0.005990923,0.021723532,212.709924,1,-1.004410393,0.539556193,-1.861549188,0.062666661,0.140220982,115.1584501,1,-4.761269197,1.196664257,-3.978784499,6.93E-05,0.000513805,N,-,,transcription initiation factor TFIID subunit 2,C:cell part,PTHR15137 (PANTHER); SSF55486 (SUPERFAMILY); SSF63737 (SUPERFAMILY),,
RL4_JR_08914,2414,2378,2480,0,3,2,0,0,0,0,5,1,0,0,4,0,0,0,39.76260585,1,1.041265323,0.717946104,1.450339123,0.146963974,0.292851026,5.333057226,0,1.050461315,1.267011865,0.829085618,0.407055961,0.570826138,13.92977927,1,-1.611233762,1.218610054,-1.322189782,0.186104963,0.308014818,40.14491919,1,1.198592115,0.699957355,1.712378771,0.086826889,0.176059813,13.84353472,0,-1.704917277,1.232114005,-1.38373338,0.166440109,0.280120695,Y,-,,Anaphase-promoting subunit CDC26,,IPR018860 (PFAM),,
RL4_JR_08915,2837,4542,3728,3,2,3,0,0,1,3,0,1,6,8,3,0,8,0,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,RNA-binding 8A,F:nucleotide binding; C:nucleus; F:RNA binding; C:cytoplasm; P:RNA processing,IPR008111 (PRINTS); IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR008111 (PTHR23139:PANTHER); PTHR23139 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_08916,2692,2108,1322,0,6,2,0,0,0,0,0,0,0,2,0,0,2,0,82.3809434,1,-2.506982442,1.033799087,-2.425019013,0.015307585,0.053200039,22.75654057,0,-1.042662229,1.226059755,-0.850417139,0.395093211,0.559105146,66.45485707,0,-2.722322191,1.206619987,-2.256155393,0.024060901,0.064493662,146.2391864,1,0.305001559,0.497310088,0.613302578,0.539676289,0.670856325,65.06325603,1,-2.09131711,0.989002345,-2.114572448,0.034466404,0.083847271,N,-,,hypothetical protein SPI_03917,C:mitochondrion; C:membrane,PTHR10351 (PANTHER); PTHR10351:SF42 (PANTHER),,
RL4_JR_08917,13836,11946,10380,1,0,6,0,0,0,0,1,5,1,6,0,0,8,5,75.33945902,1,-1.694197288,0.859078442,-1.972110118,0.048597037,0.12994252,19.17128891,0,-0.795342914,1.213483184,-0.655421455,0.512196442,0.66300933,56.05537916,1,-2.480231233,1.196263493,-2.073315158,0.038142959,0.092030342,116.3964729,1,-0.115569037,0.552622714,-0.209128279,0.834348099,0.896099043,75.72398415,1,-0.130288771,0.603310521,-0.215956405,0.829021729,0.885239929,Y,-,,pheromone processing endoprotease,C:integral component of membrane; F:serine-type endopeptidase activity; P:protein processing,IPR015500 (PRINTS); IPR000209 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); IPR002884 (PFAM); IPR008979 (G3DSA:2.60.120.GENE3D); IPR015500 (PANTHER); PTHR10795:SF416 (PANTHER); PTHR10795:SF416 (PANTHER); IPR015500 (PANTHER); IPR000209 (SUPERFAMILY); IPR008979 (SUPERFAMILY),1.I.3.1.1,The Bacterial (Planctomycetes) Nuclear Pore-like Complex (B-NPC) Family
RL4_JR_08918,24,15,14,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,99.74097351,1,-0.193757952,0.554334033,-0.349532845,0.726689317,0.855813965,19.59479536,0,-0.826845337,1.211842797,-0.682304124,0.495046666,0.650001603,114.5285396,0,0.507262993,0.525859114,0.964636687,0.334726817,0.477998461,151.0601432,0,0.731853745,0.428265775,1.708877496,0.087473644,0.177098709,68.67288174,0,-0.931459943,0.749640919,-1.242541488,0.214036843,0.338718824,N,-,,sorting nexin-4,C:endosome; P:vesicle organization; F:phosphatidylinositol binding; C:extrinsic component of membrane; P:endocytosis,IPR001683 (SMART); IPR027267 (G3DSA:1.20.1270.GENE3D); IPR001683 (G3DSA:3.30.1520.GENE3D); IPR001683 (PFAM); PTHR10555:SF24 (PANTHER); PTHR10555:SF24 (PANTHER); PTHR10555:SF24 (PANTHER); PTHR10555 (PANTHER); PTHR10555 (PANTHER); PTHR10555 (PANTHER); IPR001683 (PROSITE_PROFILES); SSF103657 (SUPERFAMILY); IPR001683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_08919,12904,7424,8263,2,8,2,0,0,2,2,1,6,7,13,4,0,2,1,184.4824785,1,0.009532588,0.443194075,0.021508835,0.982839756,0.991333724,27.99190432,1,-1.341390978,1.208262696,-1.11018157,0.266920793,0.424273283,138.0032489,1,-0.163606009,0.552768305,-0.295975742,0.767248607,0.843665135,122.067821,1,-0.885950063,0.588353228,-1.505813211,0.132115131,0.241761377,101.4405204,1,-0.650675316,0.585285377,-1.111723172,0.266257193,0.398500234,N,-,,mitochondrial distribution and morphology 38,F:ribosome binding; C:mitochondrion; C:integral component of membrane,IPR011685 (PFAM); PTHR14009:SF1 (PANTHER); PTHR14009 (PANTHER); PTHR14009 (PANTHER); PTHR14009:SF1 (PANTHER); IPR033122 (PROSITE_PROFILES),2.A.97.1.4, the mitochondrial inner membrane k(+)/h(+) and ca(2+)/h(+) exchanger (letm1) family.
RL4_JR_08920,3516,3666,4722,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.88840947,0,-1.331130356,1.154299981,-1.153192739,0.248831283,0.425687481,5.744443269,0,0.943285841,1.242011238,0.759482533,0.447563959,0.608576356,37.0929891,0,0.120481288,1.038609467,0.116002493,0.907650566,0.943241052,58.83660363,0,0.944452986,0.68371109,1.381362683,0.167167474,0.288097136,37.2550209,0,0.82482877,0.771450274,1.069192401,0.284982982,0.419214397,N,-,,adenylate kinase,F:GTP binding; F:adenylate kinase activity; F:ATP binding; P:nucleotide phosphorylation; P:ITP metabolic process; C:mitochondrial matrix; P:ADP biosynthetic process; P:AMP metabolic process; P:GTP metabolic process; C:mitochondrial inner membrane; F:nucleoside triphosphate adenylate kinase activity,IPR000850 (PRINTS); PF00406 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR007862 (PFAM); IPR000850 (PANTHER); IPR028586 (HAMAP); IPR000850 (HAMAP); IPR007862 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_08921,436,710,479,7,0,3,0,0,0,0,0,2,0,1,0,0,0,0,1.98641001,1,0.907656462,1.272036303,0.713546036,0.475507937,NA,0.633440764,0,4.124263962,1.488252153,2.771213166,0.005584785,0.022098982,1.642970153,1,1.472852594,1.218831308,1.208413817,0.226888128,0.357623447,1.895399202,1,1.050450123,1.231461386,0.853011012,0.393653197,0.538467796,1.618284215,0,1.392017756,1.208871116,1.151502205,0.249525688,0.379952785,N,-,,short-chain dehydrogenase reductase,,IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24320:SF99 (PANTHER); PTHR24320:SF99 (PANTHER); PTHR24320 (PANTHER); PTHR24320 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_08922,1537,2183,1869,0,1,10,0,0,0,0,0,0,3,17,1,0,14,0,53.96498602,1,1.783023346,0.668857889,2.665773065,0.007681152,0.030777427,4.997531538,0,1.144240907,1.252215293,0.913773305,0.360835976,0.525144752,32.52497024,0,0.882446288,0.871681584,1.012349354,0.311371045,0.453167267,142.0470699,1,2.895453917,0.584380727,4.954738893,7.24E-07,1.38E-05,99.79306668,1,2.755603193,0.501981382,5.489452985,4.03E-08,1.17E-06,N,-,,Oxoglutarate iron-dependent dioxygenase,F:oxidoreductase activity; F:metal ion binding,PR00682 (PRINTS); IPR027443 (G3DSA:2.60.120.GENE3D); IPR005123 (PFAM); IPR026992 (PFAM); PTHR10209 (PANTHER); PTHR10209:SF146 (PANTHER); PTHR10209 (PANTHER); PTHR10209:SF146 (PANTHER); IPR005123 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),,
RL4_JR_08923,20836,12276,9745,0,1,3,0,1,1,0,2,14,0,0,0,0,13,1,81.67974132,1,1.069465585,0.54008652,1.980174556,0.047683918,0.128323007,123.4263319,1,3.440016529,1.586583976,2.168190642,0.030144185,0.07935486,57.03176296,1,0.564211998,0.756131467,0.746182407,0.455557234,0.594337814,49.32961783,0,0.580586622,0.653012148,0.889090078,0.373954671,0.519595313,29.38008435,1,-0.68923743,0.996561968,-0.691615225,0.489178998,0.617881406,Y,-,,glycosyl hydrolase,F:hydrolase activity,IPR005198 (PFAM); IPR012341 (G3DSA:1.50.10.GENE3D); PTHR12145 (PANTHER); PTHR12145:SF24 (PANTHER); PTHR12145:SF24 (PANTHER); PTHR12145 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_08924,4641,3036,2954,4,2,4,0,0,0,0,2,2,2,2,0,0,1,4,788.6401399,1,0.243776972,0.440299266,0.553661999,0.579810187,0.754280259,117.5714749,0,-3.411888842,1.19794154,-2.84812633,0.004397746,0.018960415,322.1023128,1,-4.245707704,1.047290073,-4.053994032,5.04E-05,0.000728236,484.5276957,1,-1.269448151,0.787794247,-1.61139556,0.107093534,0.206419577,349.9635337,1,-2.236150197,0.76720147,-2.914684453,0.003560483,0.013573002,N,-,,40S ribosomal s11,F:structural constituent of ribosome; C:ribosome; P:translation,IPR000266 (PRINTS); IPR000266 (PFAM); IPR028333 (TIGRFAM); IPR032440 (PFAM); G3DSA:2.40.50.140 (GENE3D); IPR000266 (PANTHER); IPR000266 (PRODOM); IPR000266 (HAMAP); IPR012340 (SUPERFAMILY),,
RL4_JR_08925,8403,5851,5950,2,7,2,0,0,0,2,3,3,0,1,4,0,1,5,56.75301808,1,-3.928965457,1.230571917,-3.192796295,0.001409023,0.007798542,46.03530108,0,1.464340938,0.895248951,1.635680151,0.101906546,0.205630649,86.52686478,1,-0.512125664,0.783420387,-0.653704796,0.513302013,0.644348367,83.73007006,1,-0.51891229,0.691693933,-0.750205062,0.45313121,0.595219707,46.55646187,1,-3.454683809,1.229595955,-2.809608957,0.004960173,0.017796509,N,-,,autophagy-related 6,,no IPS match,,
RL4_JR_08926,67677,43111,74167,5,11,23,0,0,5,0,23,12,1,7,3,0,3,5,8.125589702,1,-1.124777092,1.216303101,-0.924750657,0.355095623,0.546064108,40.90987569,1,3.02615568,1.11926999,2.703686962,0.006857486,0.025536723,6.708567527,1,-0.557108464,1.21037418,-0.460277882,0.645316775,0.753167085,15.7646382,1,0.737803968,1.035779069,0.712317897,0.476267944,0.617124768,6.642918986,1,-0.645512573,1.218482485,-0.529767626,0.596273054,0.707022447,N,-,,at hook domain-containing,,no IPS match,,
RL4_JR_08927,1286,1375,2096,4,0,8,0,0,0,3,4,10,4,5,2,0,2,1,0.154320951,1,4.593425725,3.464313935,1.325926521,0.184864037,NA,0.047915973,0,7.847655728,2.541726693,3.087529336,0.002018278,0.015023052,0.126891486,1,5.164876948,1.585655007,3.257251373,0.001124968,0.006334356,0.146554145,1,4.742518803,2.203631963,2.152137418,0.031386533,0.094771274,0.127971142,1,5.05345735,1.427489122,3.540102179,0.000399972,0.002242369,N,-,,mRNA 3 -end-processing YTH1,F:transferase activity,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_08928,3539,4748,5416,3,0,7,0,0,0,0,3,2,1,0,2,0,12,0,49.43438001,1,0.894733835,0.585825053,1.527305517,0.126685058,0.262308808,7.255989462,0,0.60638493,1.22953091,0.493183965,0.621882607,0.751226562,25.28974556,1,-1.081104514,1.191197351,-0.907578004,0.36410122,0.508178796,44.31221727,1,-0.14380632,0.849820064,-0.169219728,0.865623813,0.916519181,18.47766034,1,-2.121457674,1.191425863,-1.780604014,0.074977164,0.1527145,Y,-,,mannosylphosphorylation,,IPR007074 (PFAM); IPR009644 (PANTHER); PTHR15407:SF32 (PANTHER),,
RL4_JR_08929,719,610,674,5,1,1,0,0,0,0,0,0,2,1,3,0,0,0,65.73980883,1,0.865784404,0.541734509,1.598171039,0.110004917,0.237161764,46.06133762,0,2.962045377,0.754052616,3.928168026,8.56E-05,0.004205809,49.53665602,0,0.534817499,0.742535972,0.720258033,0.471366138,0.608067124,62.53750933,1,0.35372842,0.667431229,0.529984821,0.596122455,0.719093393,48.93977456,0,1.024513049,0.599757688,1.708211616,0.087597084,0.172955134,N,-,,er lumen retaining receptor,C:integral component of membrane; C:endoplasmic reticulum; F:ER retention sequence binding; P:protein retention in ER lumen,IPR000133 (PRINTS); IPR000133 (PFAM); PTHR10585:SF30 (PANTHER); IPR000133 (PANTHER),9.B.191.1.7, the endoplasmic reticulum retention receptor (kdelr) family.
RL4_JR_08930,4345,4443,6677,3,13,10,0,0,1,2,16,5,2,12,13,3,25,1,15.46732504,1,-0.696876328,1.146586772,-0.607783332,0.543331186,0.724264022,3.722820869,1,1.569170834,1.264565452,1.240877514,0.214651001,0.361273267,42.13362716,1,2.054226081,0.675573822,3.040712965,0.002360187,0.011285095,38.41376204,1,1.230816769,0.744504127,1.653203421,0.09828947,0.193539651,24.91931863,1,1.450988238,0.752493502,1.928240223,0.053825253,0.118474063,N,-,,chromosome segregation,,SM01315 (SMART); IPR013253 (SMART); IPR013253 (PFAM); PF15402 (PFAM); IPR028972 (PFAM); IPR033338 (PANTHER); PTHR28260:SF1 (PANTHER),,
RL4_JR_08931,83,51,42,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.384730698,0,1.428058679,1.455702449,0.981010014,0.326587804,NA,0.449621508,0,4.618935418,1.654977374,2.790935689,0.005255591,0.02127033,1.153189097,0,1.983688103,1.286281461,1.542188209,0.123027865,0.226092134,1.329368765,0,1.562272197,1.333033483,1.171967709,0.241210021,0.379703274,1.123436855,0,1.91786104,1.259169446,1.523115929,0.127729704,0.229180092,N,-,,hypothetical protein CMQ_5796,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_08932,1332,939,1118,0,0,4,0,0,0,0,0,0,1,0,0,0,0,0,0.426443848,1,3.127300529,2.261676907,1.382735314,0.16674604,NA,0.138881964,0,6.314024314,2.075103905,3.042750919,0.002344263,0.015170793,0.35509468,0,3.683685776,1.39984639,2.631492856,0.008501065,0.02877295,0.409287675,1,3.262039622,1.624416489,2.008130085,0.04462947,0.114728762,0.344434042,0,3.62326155,1.319127746,2.746710136,0.006019631,0.020830063,N,-,,hypothetical protein CMQ_5796,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_08933,15646,10681,15104,1,1,4,0,0,1,0,2,4,1,9,4,0,8,1,21.13463283,1,-0.147078593,1.05579486,-0.139306032,0.889208323,0.945660475,4.364031908,1,1.339933569,1.303979401,1.02757265,0.304150895,0.465047637,11.21908471,1,-1.29881212,1.223537642,-1.061521996,0.288452742,0.427944836,12.93534274,1,-1.720353569,1.224598362,-1.404830859,0.16007158,0.279002367,10.9518203,1,-1.366939976,1.219769392,-1.120654433,0.262434986,0.394412087,N,-,,5-oxoprolinase (ATP-hydrolysing),C:cytosol; F:hydrolase activity,IPR008040 (PFAM); IPR003692 (PFAM); IPR002821 (PFAM); PTHR11365:SF11 (PANTHER); PTHR11365 (PANTHER),,
RL4_JR_08934,64,90,97,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,5-oxoprolinase (5-oxo-l-prolinase) (pyroglutamase) (5-opase),,no IPS match,,
RL4_JR_08935,2648,2225,2791,4,0,2,0,0,0,0,3,7,0,10,3,0,2,4,9.320342861,1,-1.322568165,1.309479698,-1.009995166,0.312497606,0.500580543,2.965711636,0,1.897202312,1.399066706,1.356048503,0.175083736,0.311184825,7.675893279,1,-0.751213586,1.277443883,-0.58805995,0.556492054,0.683145878,8.855711958,1,-1.173666698,1.287112415,-0.911860289,0.361842268,0.507923606,7.519583562,1,-0.824363882,1.283852954,-0.64210148,0.520807295,0.645352327,N,-,,adenosine deaminase family,C:cytosol; P:adenosine catabolic process; P:hypoxanthine salvage; P:inosine biosynthetic process; F:adenosine deaminase activity,IPR001365 (PFAM); G3DSA:3.20.20.140 (GENE3D); PTHR11409 (PANTHER); PTHR11409 (PANTHER); PTHR11409:SF39 (PANTHER); PTHR11409:SF39 (PANTHER); IPR032466 (SUPERFAMILY),,
RL4_JR_08936,372,242,410,0,8,105,0,0,7,0,0,0,0,0,0,0,0,0,6.246786946,1,-0.745262474,1.212750504,-0.614522502,0.538870108,0.721500467,2.006592978,1,2.460865507,1.333543108,1.845358798,0.064985363,0.144822069,13.02146607,0,0.778533104,1.203648525,0.646810999,0.517754273,0.648329531,5.972299953,0,-0.605261583,1.21141806,-0.499630642,0.617335178,0.735787955,5.073438756,0,-0.256766408,1.204968202,-0.213089779,0.831256937,0.88631808,N,-,,mismatched base pair and cruciform DNA recognition,,IPR008462 (G3DSA:1.10.1470.GENE3D); PTHR40460 (PANTHER); IPR008462 (SUPERFAMILY),,
RL4_JR_08937,3765,3491,4951,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,309.1769231,0,-2.056390802,0.494282136,-4.160358329,3.18E-05,0.000313924,81.01872422,0,-2.874672027,1.185960088,-2.423919706,0.015354,0.047038417,233.9366378,1,-3.118974773,0.849696242,-3.670693852,0.000241893,0.001987763,407.1518945,1,-0.673165863,0.352917756,-1.90742985,0.056464947,0.132186726,278.8556416,0,-1.293441518,0.464663114,-2.783611353,0.005375741,0.018991407,N,-,,cysteine desulfurase,C:L-cysteine desulfurase complex; F:cysteine desulfurase activity; P:cellular iron ion homeostasis; C:nucleus; F:pyridoxal phosphate binding; P:mitochondrial tRNA thio-modification; P:[2Fe-2S] cluster assembly; C:mitochondrion; P:tRNA wobble uridine modification,IPR015421 (G3DSA:3.40.640.GENE3D); IPR000192 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR010240 (TIGRFAM); PTHR11601 (PANTHER); PTHR11601:SF34 (PANTHER); IPR010240 (HAMAP); IPR015424 (SUPERFAMILY),,
RL4_JR_08938,602,610,1051,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,112.8884329,1,-0.632330894,0.585188507,-1.080559318,0.279893187,0.463157935,43.96213533,0,-0.044738288,1.123438803,-0.03982263,0.968234534,0.983587184,68.9100669,0,-1.798186141,1.041011764,-1.727344687,0.084105778,0.169147179,81.81709024,0,-1.727611168,0.864421458,-1.998575061,0.045654351,0.115852206,69.61424043,1,-2.004685761,0.973815687,-2.058588486,0.039533677,0.093196386,N,-,,bar adaptor,"F:identical protein binding; C:mating projection tip; P:lipid tube assembly; C:chromosome, centromeric region; P:endocytosis; P:cellular response to DNA damage stimulus; P:chromatin silencing at telomere; C:chromosome, telomeric region; P:chromatin silencing at centromere; P:establishment or maintenance of cell polarity regulating cell shape; F:cytoskeletal protein binding; C:actin cortical patch; P:actin cortical patch localization",IPR001452 (PRINTS); IPR001452 (SMART); IPR004148 (SMART); IPR027267 (G3DSA:1.20.1270.GENE3D); G3DSA:2.30.30.40 (GENE3D); IPR001452 (PFAM); IPR004148 (PFAM); PTHR10663:SF177 (PANTHER); PTHR10663 (PANTHER); PTHR10663 (PANTHER); PTHR10663:SF177 (PANTHER); PTHR10663 (PANTHER); PTHR10663:SF177 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR004148 (PROSITE_PROFILES); IPR001452 (SUPERFAMILY); SSF103657 (SUPERFAMILY),8.A.34.2.1, the endophilin (endophilin) family.
RL4_JR_08939,469,937,587,2,1,2,0,0,0,0,0,0,0,0,0,0,0,1,40.23378882,1,2.838773848,0.683829626,4.151288185,3.31E-05,0.000324172,1.398529025,0,2.981567927,1.364583948,2.184964825,0.028891426,0.076937388,3.628068057,0,0.329535882,1.214627229,0.271306187,0.786155548,0.858487625,4.185133975,0,-0.092695573,1.216638656,-0.076189897,0.939268021,0.964218667,3.580173995,1,0.246072669,1.215513929,0.202443315,0.839570169,0.891801087,N,-,,f-box domain containing,P:biological_process; C:cellular_component; F:molecular_function,IPR001810 (PFAM); G3DSA:1.20.1280.50 (GENE3D); IPR001810 (PROSITE_PROFILES),,
RL4_JR_08940,23203,23497,33873,3,2,2,2,0,0,0,4,8,1,16,3,0,8,0,59.03912621,1,3.181681926,0.539441564,5.898103035,3.68E-09,9.09E-08,24.06944855,1,3.578288927,1.123458716,3.185064904,0.001447215,0.015023052,4.541698988,1,0.005914092,1.204003653,0.004912022,0.996080789,0.99854658,9.249747008,1,0.530759482,1.149634376,0.461676767,0.644313135,0.7561046,4.457842615,1,-0.070201597,1.197448607,-0.058625979,0.953250018,0.969528522,N,-,,mosc domain-containing,F:oxidoreductase activity; F:metal ion binding; P:metabolic process; F:iron-sulfur cluster binding,IPR000951 (PRINTS); IPR015808 (G3DSA:2.40.33.GENE3D); IPR001041 (PFAM); G3DSA:2.40.30.10 (GENE3D); IPR012675 (G3DSA:3.10.20.GENE3D); IPR005302 (PFAM); G3DSA:3.40.50.80 (GENE3D); PTHR30212:SF2 (PANTHER); PTHR30212 (PANTHER); IPR005302 (PROSITE_PROFILES); IPR017927 (PROSITE_PROFILES); IPR001041 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY); IPR001041 (SUPERFAMILY); IPR017938 (SUPERFAMILY); IPR011037 (SUPERFAMILY),,
RL4_JR_08941,196,252,218,0,0,0,0,0,0,2,0,0,0,6,0,0,2,0,12.07438267,0,-0.202241494,1.175396044,-0.172062425,0.863388453,0.932574881,2.610296253,0,2.081229984,1.305212394,1.594552729,0.110812291,0.219456468,6.81125273,1,-0.579019744,1.217850001,-0.47544422,0.634470383,0.744739496,40.77802082,1,1.758934245,0.774726039,2.270395156,0.023183618,0.082218611,49.21831236,1,3.220924692,0.661677702,4.867815074,1.13E-06,1.61E-05,N,-,,MFS transporter,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23506:SF1 (PANTHER); PTHR23506:SF1 (PANTHER); PTHR23506 (PANTHER); PTHR23506 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.2.28, the major facilitator superfamily (mfs).
RL4_JR_08942,2122,3328,5927,0,0,7,0,0,0,0,0,0,0,4,0,0,0,0,103.0415575,1,-2.251130703,0.893455512,-2.519577833,0.011749566,0.043099352,27.64842226,0,-1.323644496,1.208810411,-1.094997597,0.273517689,0.431506554,83.22409096,0,-3.022245476,1.205948311,-2.506115268,0.012206582,0.037745704,83.26837033,1,-4.406892578,1.209167126,-3.644568633,0.000267841,0.002460877,71.57313266,0,-4.075122882,1.215806595,-3.351785473,0.000802922,0.004008672,N,-,,meiotic recombination dmc1,C:nuclear part; P:ribosome biogenesis; C:protein complex; P:cellular process,IPR024326 (PFAM); IPR024326 (PANTHER),,
RL4_JR_08943,1380,1620,1395,0,1,6,0,0,0,6,0,0,0,0,0,0,1,0,49.02248191,1,1.362579052,0.574118055,2.373342974,0.017627887,0.059277947,5.925962742,0,0.89852819,1.247874604,0.72004686,0.471496144,0.629698374,15.30982325,1,-1.747300364,1.197721671,-1.458853427,0.144605454,0.255005333,21.66927138,0,-1.222475866,1.148714248,-1.06421233,0.287232523,0.431488025,15.01799771,1,-1.822409143,1.194253856,-1.525981377,0.127014502,0.228301409,N,-,,nima interactive,,IPR021622 (PFAM); PTHR21736 (PANTHER); PTHR21736:SF12 (PANTHER),,
RL4_JR_08944,30297,17740,18127,3,2,16,0,0,1,1,2,5,8,10,1,0,2,0,13.02898379,1,-1.80588316,1.190463556,-1.516957954,0.1292773,0.266164997,4.178789958,1,1.402489413,1.260441644,1.112696823,0.265838661,0.422885262,17.29965986,1,-0.282188179,1.19353597,-0.236430393,0.813098714,0.878622199,24.49220017,1,0.636350792,0.85762564,0.741991334,0.458092586,0.600257207,10.60366768,1,-1.320309316,1.191881981,-1.107751722,0.267969055,0.400352174,N,-,,f-box domain containing,,IPR001810 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); IPR001810 (PFAM); IPR001810 (SUPERFAMILY),,
RL4_JR_08945,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,75.45746088,0,-0.72635272,0.827139574,-0.878150124,0.379862255,0.572072415,13.7143946,0,-0.312163674,1.23031966,-0.253725665,0.799707505,0.878134016,35.84893511,0,-2.974917375,1.214235076,-2.450034127,0.014284268,0.042747243,58.70928094,0,-1.09263037,0.894096927,-1.222049128,0.221689049,0.357079482,39.49904729,0,-2.141631971,1.158370702,-1.848831266,0.064482181,0.136386481,N,-,,phosphotransferase enzyme family partial,P:phosphorylation; F:transferase activity; F:kinase activity,G3DSA:3.90.1200.10 (GENE3D); IPR002575 (PFAM); PTHR21310:SF21 (PANTHER); PTHR21310 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_08946,6325,7658,6324,0,2,2,0,0,0,0,0,0,4,0,3,0,3,6,1.327768276,1,1.488453045,1.499112669,0.992889377,0.320763867,NA,0.418791249,0,4.720929675,1.654549871,2.853301528,0.004326755,0.018731997,1.09716961,0,2.054466125,1.294776716,1.586733913,0.112572922,0.211405725,1.266354949,1,1.631658649,1.348534078,1.209949882,0.226298125,0.361969749,1.094441166,1,1.956074087,1.289352341,1.517098177,0.129241898,0.231360364,N,-, Effector probability:0.888,hypothetical protein SPSK_10676,,no IPS match,,
RL4_JR_08947,2448,1658,1888,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,112.6914954,1,0.801437342,0.508381008,1.576450202,0.114922087,0.244872017,13.50322843,0,-0.289679492,1.233869182,-0.234773262,0.814384722,0.887893382,47.79901608,0,-1.116131162,1.049365309,-1.063624986,0.287498619,0.427092592,117.997063,0,0.747125326,0.530430071,1.40852747,0.158974939,0.277616636,49.16875523,0,-0.794261641,0.85565429,-0.928250639,0.353277572,0.490595998,N,-,,dual specificity kinase pom1,F:nucleotide binding; P:phosphorylation; F:kinase activity,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24058:SF22 (PANTHER); PTHR24058 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_08948,21113,14305,15055,0,0,10,0,0,5,2,0,1,10,8,0,0,6,1,54.73829099,1,-3.876862841,1.185735088,-3.269585997,0.00107705,0.00628061,17.49922624,1,-0.663703511,1.202629577,-0.551876924,0.58103268,0.720119112,45.36536324,1,-3.314561343,1.18894011,-2.787828684,0.00530626,0.019772018,65.9773835,1,-2.002553346,1.012175562,-1.978464429,0.047876338,0.11960225,44.70763009,1,-3.396246748,1.190925477,-2.851771008,0.004347641,0.01598978,N,-,,cog1565 domain containing,F:transferase activity,IPR003788 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR003788 (PANTHER); PTHR12049:SF5 (PANTHER); IPR003788 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_08949,39674,38871,56231,6,2,82,0,0,0,0,2,0,5,20,1,0,20,4,1560.370513,1,-2.383023205,0.440462534,-5.410274475,6.29E-08,1.30E-06,424.8411303,0,-5.265259668,1.229119263,-4.283766292,1.84E-05,0.001107129,1185.970765,1,-3.525822268,0.541512036,-6.511069074,7.46E-11,4.47E-09,1416.543797,1,-3.069046653,0.442710563,-6.932399872,4.14E-12,1.81E-10,1091.954466,1,-5.787822784,0.921695902,-6.279536199,3.40E-10,2.15E-08,N,-,,alanyl-tRNA synthetase,F:nucleic acid binding; F:ATP binding; F:zinc ion binding; F:alanine-tRNA ligase activity; C:mitochondrion; P:mitochondrial alanyl-tRNA aminoacylation,IPR002318 (PRINTS); IPR012947 (SMART); G3DSA:3.30.930.10 (GENE3D); IPR012947 (PFAM); IPR002318 (TIGRFAM); IPR018164 (PFAM); PTHR11777 (PANTHER); PTHR11777:SF9 (PANTHER); IPR023033 (HAMAP); IPR018165 (PROSITE_PROFILES); IPR018162 (SUPERFAMILY); IPR009000 (SUPERFAMILY); IPR018163 (SUPERFAMILY); SSF55681 (SUPERFAMILY),,
RL4_JR_08950,8785,9668,11119,0,3,17,0,0,1,0,5,4,2,6,17,0,8,0,2399.224295,1,-0.487202857,0.797048359,-0.611258841,0.541028234,0.722966148,476.0186858,1,-3.792158077,1.161550921,-3.264736834,0.001095658,0.015023052,1297.230671,1,-3.086561393,0.692841837,-4.454929291,8.39E-06,0.000164018,1455.711929,1,-3.644963694,0.958544598,-3.802602091,0.000143184,0.001451192,1232.643924,1,-3.297168066,1.308852332,-2.519129154,0.01176455,0.035833144,N,-,,hypothetical protein HMPREF1624_00469,,no IPS match,,
RL4_JR_08951,1547,1690,2148,0,2,2,0,0,0,0,2,0,0,0,0,0,0,0,16.30306742,1,-0.203799848,1.147671672,-0.177576787,0.859055356,0.929342739,2.637679812,0,2.066231398,1.282563986,1.61101623,0.107176185,0.213592704,6.854876404,1,-0.588163747,1.198806404,-0.490624462,0.623692082,0.7366144,19.94371352,0,1.290814035,0.859372699,1.502042171,0.133086218,0.243186782,6.767045125,0,-0.672211708,1.202961293,-0.558797454,0.57629996,0.690210208,N,-,,DNA repair Dds20,C:nucleus; C:site of double-strand break; P:double-strand break repair via homologous recombination; C:cytosol; P:positive regulation of DNA binding; P:intra-S DNA damage checkpoint; P:strand invasion; P:mating type switching; F:ligase activity; C:Swi5-Sfr1 complex,no IPS match,,
RL4_JR_08952,2312,2408,2506,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0.043876557,0,6.407820903,3.931011013,1.630069436,0.103086823,NA,0.014199646,0,9.60413278,3.08267072,3.115523406,0.001836188,0.015023052,0.036525337,0,6.964420449,1.74610146,3.988554278,6.65E-05,0.000893778,0.042111731,1,6.542425881,3.241893537,2.018087826,0.043582115,0.113446415,0.035715309,0,6.889310002,1.362720129,5.055557525,4.29E-07,7.01E-06,N,-,,NAD dependent epimerase dehydratase,F:coenzyme binding; F:catalytic activity,IPR016040 (G3DSA:3.40.50.GENE3D); IPR001509 (PFAM); PTHR10366 (PANTHER); PTHR10366:SF267 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_08953,24068,24023,33388,4,7,44,0,0,0,0,5,0,0,20,7,0,16,4,15.87124053,1,-0.127021415,1.142917693,-0.11113785,0.911507035,0.956734502,2.515083354,0,2.134967118,1.292222933,1.65216625,0.098500664,0.200286003,6.509391378,1,-0.513376359,1.197640787,-0.428656375,0.668173312,0.771860636,7.508472149,1,-0.935526892,1.195340694,-0.78264456,0.433835867,0.57585057,6.397537301,1,-0.59125244,1.194316992,-0.495054867,0.620561391,0.726698391,N,-,,efflux pump antibiotic resistance,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF32 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_08954,52063,38771,41261,1,3,8,0,0,1,5,3,0,5,1,0,0,12,1,219.4473377,1,-5.880055124,1.19196678,-4.933069631,8.09E-07,1.27E-05,70.33681057,1,-2.670675525,1.195905369,-2.233182987,0.02553688,0.069611703,181.863961,1,-5.3177198,1.192121631,-4.460719159,8.17E-06,0.000160267,241.0669173,1,-2.689329416,0.670891166,-4.008592681,6.11E-05,0.000704538,178.5940981,1,-5.394325234,1.190203218,-4.532272434,5.84E-06,6.46E-05,N,PKS,,polyketide synthase,F:oxidoreductase activity; P:oxidation-reduction process; F:phosphopantetheine binding; F:transferase activity,SM00822 (SMART); IPR020806 (SMART); IPR020843 (SMART); IPR020807 (SMART); IPR020841 (SMART); IPR020801 (SMART); IPR014031 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR014030 (PFAM); IPR013968 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR014043 (PFAM); IPR032821 (PFAM); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR020807 (PFAM); IPR013154 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR009081 (PFAM); PF13602 (PFAM); IPR013217 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR001227 (G3DSA:3.40.366.GENE3D); PTHR11712 (PANTHER); PTHR11712:SF262 (PANTHER); PTHR11712 (PANTHER); PTHR11712:SF262 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016035 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR011032 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR016036 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_08955,92307,66675,97496,10,16,12,0,0,2,0,4,10,4,0,8,0,7,0,0.031777164,1,6.873008086,3.940197018,1.744331072,0.081101377,NA,0.009852108,1,10.12815714,3.400240156,2.978659353,0.002895124,0.015349618,0.026093092,1,7.4450293,2.01112645,3.701920036,0.000213974,0.001828079,0.030137982,1,7.02413952,3.833853765,1.832135483,0.066931238,0.146670023,0.02629717,1,7.340400824,1.46365278,5.015124436,5.30E-07,8.40E-06,N,-, Effector probability:0.652,fad dependent oxidoreductase,"F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process; P:biosynthetic process; F:hydroxymethyl-, formyl- and related transferase activity",no IPS match,,
RL4_JR_08956,501,427,548,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0.314462735,0,3.566589317,2.443460266,1.459646947,0.14438713,NA,0.101054702,0,6.772333355,2.100569147,3.224046857,0.001263927,0.015023052,0.261261965,0,4.124985568,1.330708777,3.099840956,0.001936246,0.009606687,0.301311265,0,3.703314153,1.60006652,2.314475121,0.020641674,0.077838716,0.256916078,1,4.045569981,1.25284512,3.229106228,0.001241778,0.005717598,N,NRPS-Like,,nonribosomal peptide synthetase 11,F:catalytic activity; P:metabolic process,G3DSA:3.30.300.30 (GENE3D); G3DSA:2.30.38.10 (GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR000873 (PFAM); IPR001242 (PFAM); G3DSA:3.40.50.980 (GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); PTHR24095 (PANTHER); PTHR24095:SF137 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR009081 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF56801 (SUPERFAMILY),4.C.1.1.16, the fatty acid transporter (fat) family.
RL4_JR_08957,15102,12478,15692,4,0,0,0,0,0,2,0,4,2,2,3,0,5,3,3.141326864,1,0.246302686,1.222923788,0.201404771,0.840382085,0.919624667,1.000399048,0,3.464915612,1.396143008,2.481777005,0.013072906,0.041312505,2.598665874,1,0.811093588,1.207817838,0.671536355,0.501878908,0.634334839,2.998115698,1,0.388659499,1.210918569,0.320962539,0.748238779,0.834352163,2.565022619,1,0.727370803,1.206318852,0.602967285,0.546530453,0.667378701,N,-,,8-amino-7-oxononanoate synthase,F:pyridoxal phosphate binding; P:biosynthetic process; F:transferase activity,IPR015422 (G3DSA:3.90.1150.GENE3D); IPR004839 (PFAM); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR13693:SF53 (PANTHER); PTHR13693 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_08958,123,105,284,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003880053,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,0,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-, Effector probability:0.741,GNAT family,F:transferase activity; F:N-acetyltransferase activity,IPR016181 (G3DSA:3.40.630.GENE3D); PTHR13256:SF22 (PANTHER); PTHR13256 (PANTHER); IPR016181 (SUPERFAMILY),,
RL4_JR_08959,66381,33813,50087,5,6,30,0,0,0,3,10,4,11,39,5,0,26,4,19.55674527,1,2.484453512,0.791825217,3.137628681,0.001703205,0.009129268,1.368633898,0,3.012872129,1.383312982,2.178011895,0.029405151,0.077956768,3.540904692,1,0.365168774,1.223141365,0.298549934,0.765283471,0.842180032,52.26093891,1,3.45726649,1.56218631,2.213094857,0.026891107,0.087153604,3.475235803,1,0.2892568,1.217584895,0.237566022,0.812217707,0.873089116,N,-,,NACHT and WD domain,"F:hydrolase activity, acting on ester bonds; F:DNA binding; F:pyridoxal phosphate binding; F:zinc ion binding; F:catalytic activity; P:biosynthetic process",IPR001680 (SMART); IPR029058 (G3DSA:3.40.50.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR22731:SF5 (PANTHER); PTHR22731 (PANTHER); IPR029058 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011047 (SUPERFAMILY),,
RL4_JR_08960,3574,3437,4811,0,2,4,0,0,0,0,0,2,0,2,0,0,9,0,1.348336917,1,1.466690864,1.376255997,1.065710789,0.286554399,NA,0.430656395,0,4.681002499,1.595217508,2.934397645,0.003341958,0.016397137,1.115087159,1,2.032322015,1.239677904,1.639395208,0.101130979,0.195477751,1.286316251,1,1.609894087,1.271006307,1.266629503,0.205287798,0.33720619,4.95627518,1,2.883929091,1.139672118,2.53049017,0.011390328,0.03486308,N,-, Effector probability:0.68,DRAP deaminase,"F:hydrolase activity, acting on ester bonds; F:zinc ion binding",IPR002125 (PFAM); G3DSA:3.40.140.10 (GENE3D); PTHR11079 (PANTHER); PTHR11079:SF92 (PANTHER); IPR002125 (PROSITE_PROFILES); IPR016193 (SUPERFAMILY),,
RL4_JR_08961,3570,5210,6417,0,0,1,0,0,0,0,0,2,0,2,0,0,0,1,0.007760107,1,8.901087564,4.041366561,2.202494486,0.027630398,NA,0.002334598,0,12.18995876,4.048442383,3.01102439,0.002603679,0.015349618,0.006343058,1,9.480780804,4.042868098,2.345063102,0.01902386,0.053738157,0.007335717,1,9.055356819,4.042572319,2.23999872,0.025091006,0.08557795,0.006581095,1,9.341867313,1.819064456,5.135533973,2.81E-07,4.95E-06,N,-,,-ribulosamine 3- chloroplastic,P:phosphorylation; F:kinase activity,IPR016477 (PFAM); PTHR12149:SF8 (PANTHER); PTHR12149 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_08962,7484,6471,8439,0,3,0,0,0,0,3,0,1,2,0,0,0,1,2,74.00590491,1,0.690066618,0.54342082,1.269856789,0.204135648,0.368927473,10.62591196,0,0.056002573,1.214073749,0.046127818,0.963208374,0.980387104,47.09644449,1,-0.195673761,0.855409457,-0.228748653,0.819064278,0.883142415,102.4774624,1,1.280715207,0.463624106,2.762399947,0.005737814,0.031250872,61.97136836,1,1.049077761,0.558110563,1.879695225,0.060149627,0.129001265,N,-,,ubiquitin- ligase sel1,C:integral component of membrane; F:ligase activity,IPR006597 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR006597 (PFAM); PTHR11102 (PANTHER); PTHR11102:SF98 (PANTHER); PTHR11102 (PANTHER); PTHR11102:SF98 (PANTHER); SSF81901 (SUPERFAMILY); SSF81901 (SUPERFAMILY); SSF81901 (SUPERFAMILY),3.A.16.1.4, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_08963,10,18,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.63664321,0,-0.946183199,1.187149819,-0.797020885,0.425438902,0.616319055,4.363183714,0,1.340028752,1.2862143,1.041839414,0.297486137,0.457274819,11.41333402,0,-1.323794862,1.226230255,-1.079564672,0.28033608,0.419592324,13.17257893,0,-1.746767814,1.228626863,-1.421723606,0.155106504,0.272695495,11.35923049,0,-1.419561555,1.241220328,-1.143682167,0.252755471,0.383901121,N,-,,wd domain-containing,C:nucleus; C:cytosol,IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),,
RL4_JR_08964,1240,1334,1597,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,48.93019188,0,0.83823533,0.703465673,1.191579578,0.233426137,0.406899663,7.00840701,0,0.656358816,1.251943103,0.524272081,0.600089312,0.734918817,18.31575714,1,-2.006089218,1.215998234,-1.64974682,0.09899473,0.192512994,29.1620832,0,-0.718190958,1.051458069,-0.68304289,0.494579741,0.633394874,18.19430573,1,-2.099172414,1.229087862,-1.707910784,0.087652898,0.172965424,N,-,,frg1-like family,F:actin filament binding; C:catalytic step 2 spliceosome; C:striated muscle dense body; C:nucleolus,G3DSA:2.80.10.50 (GENE3D); IPR010414 (PFAM); PTHR12928:SF0 (PANTHER); IPR010414 (PANTHER); IPR008999 (SUPERFAMILY),,
RL4_JR_08965,9163,7252,5288,0,0,2,0,0,0,0,5,5,1,0,1,0,10,0,135.1417307,1,-1.817383348,0.816353687,-2.226220542,0.025999413,0.081141243,30.07155292,0,-1.444847116,1.203230149,-1.200806943,0.229826098,0.379804043,100.5852803,1,-1.698256939,0.866841404,-1.959132237,0.050097302,0.113312129,94.4819722,1,-3.580311898,1.157093131,-3.094229671,0.001973247,0.013109661,164.3877301,1,0.100261555,0.534824894,0.187466133,0.851295175,0.901135771,N,-,,116 kda u5 small nuclear ribonucleo component,F:GTP binding; C:intracellular ribonucleoprotein complex; F:translation elongation factor activity; F:GTPase activity; C:viral nucleocapsid; P:translational elongation,IPR000795 (PRINTS); IPR005517 (SMART); IPR000640 (SMART); IPR004161 (PFAM); IPR014721 (G3DSA:3.30.230.GENE3D); G3DSA:3.30.70.870 (GENE3D); IPR031950 (PFAM); IPR005225 (TIGRFAM); IPR000640 (PFAM); PF00009 (PFAM); IPR005517 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:2.40.30.10 (GENE3D); IPR000640 (G3DSA:3.30.70.GENE3D); G3DSA:3.90.1430.10 (GENE3D); PTHR23115:SF5 (PANTHER); PTHR23115 (PANTHER); PTHR23115 (PANTHER); PTHR23115 (PANTHER); PTHR23115 (PANTHER); PTHR23115:SF5 (PANTHER); PTHR23115:SF5 (PANTHER); PTHR23115:SF5 (PANTHER); PTHR23115 (PANTHER); IPR000795 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR009022 (SUPERFAMILY); IPR020568 (SUPERFAMILY); IPR009022 (SUPERFAMILY); IPR009000 (SUPERFAMILY),,
RL4_JR_08966,1012,1111,1411,8,3,1,0,0,4,0,0,0,0,4,0,0,0,0,125.5167339,1,-1.435234519,0.635337383,-2.2590116,0.023882663,0.075899793,31.30395811,1,-1.502785142,1.195347715,-1.257194977,0.208683042,0.353995266,89.26291374,0,-3.196550739,1.192906537,-2.679632175,0.00737031,0.025594883,122.2002487,1,-2.245216529,0.852430309,-2.633900396,0.008441025,0.042435638,88.22727382,0,-2.57974436,0.985921356,-2.616582291,0.008881495,0.028556729,N,-,,cytoplasmic required for cell,C:nucleus; P:establishment of mitotic sister chromatid cohesion; C:cytosol; P:iron-sulfur cluster assembly,IPR002744 (PFAM); PTHR12377:SF0 (PANTHER); PTHR12377 (PANTHER); SSF117916 (SUPERFAMILY),,
RL4_JR_08967,136,204,310,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,229.9114326,0,-1.096345597,0.563594287,-1.945274502,0.051741949,0.136472946,54.17976821,0,-2.294150326,1.214242073,-1.889368173,0.058842512,0.134205478,152.6122884,0,-3.12071941,1.050764138,-2.969952341,0.00297846,0.013509823,274.1739421,0,-0.610200704,0.595145291,-1.025297039,0.305223053,0.450953365,144.0415482,0,-4.071962445,1.132901187,-3.594278557,0.000325292,0.00187348,N,-,,lipase regulator 1,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR007219 (PFAM); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR19444 (PANTHER); PTHR19444:SF30 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_08968,245,259,340,0,0,1,0,0,0,0,0,0,0,5,1,0,0,0,14.60756722,1,-1.971057194,1.260589782,-1.563599215,0.117911719,0.249313078,4.603375433,0,1.262715627,1.311802224,0.962580794,0.33575794,0.498758712,12.06665449,0,-1.404090973,1.245519733,-1.12731331,0.259610037,0.396244839,13.92784954,1,-1.827192114,1.250575155,-1.461081413,0.143993101,0.258132107,12.04276592,0,-1.503873659,1.264332325,-1.189460737,0.234258413,0.362504421,N,-,,paired amphipathic helix,C:membrane,no IPS match,,
RL4_JR_08969,51541,35115,56409,8,6,31,0,0,0,0,4,4,5,6,3,0,15,13,230.640808,1,4.165571488,1.254184992,3.321337374,0.000895872,0.005454121,3.998886229,0,1.465827612,1.271045005,1.153246035,0.248809413,0.402243872,10.42842389,1,-1.193618098,1.211517082,-0.985225975,0.324513084,0.467535288,20.05685693,1,0.098934346,1.041198788,0.095019652,0.924299218,0.955341933,14.20544508,1,-0.35666192,1.15247923,-0.309473621,0.756961275,0.830721105,Y,-,,hypothetical protein TSTA_098780,,no IPS match,,
RL4_JR_08970,598,368,958,0,0,0,0,0,0,0,0,0,3,6,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,Y,-,,hypothetical protein SPI_08829,,no IPS match,,
RL4_JR_08971,1211,3024,2274,1,3,10,1,0,0,4,0,1,0,2,0,0,0,0,146.4254047,1,-1.007141382,0.685354984,-1.46951785,0.141692384,0.284781096,43.79404875,1,-0.722357788,1.114213366,-0.648311904,0.516783237,0.66703391,89.56374614,1,-4.295877904,1.196876214,-3.589241604,0.000331641,0.002524464,130.309347,1,-1.985057646,0.754644062,-2.630455529,0.008527053,0.042783155,88.63380382,0,-4.3835684,1.204872743,-3.63820032,0.00027455,0.001629436,N,-,,hypothetical protein VE00_04976,F:zinc ion binding,no IPS match,,
RL4_JR_08972,2823,1969,3048,0,2,5,0,0,2,0,0,5,8,2,0,0,3,1,0.329171577,1,3.500785952,2.3817453,1.469840605,0.141604929,NA,0.105270184,1,6.713461239,2.069333291,3.244262907,0.00117755,0.015023052,0.272507941,1,4.065163018,1.310767573,3.101360686,0.001926335,0.009579507,0.314338613,1,3.642592123,1.558543637,2.33717686,0.01942999,0.075752271,0.267859287,1,3.987068095,1.23909109,3.21773607,0.001292067,0.005906173,N,-,,neutral trehalase,"P:ascospore formation; C:cytoplasm; F:calcium ion binding; P:conidium formation; P:trehalose catabolic process; P:pathogenesis; F:alpha,alpha-trehalase activity",IPR001661 (PRINTS); IPR001661 (PFAM); IPR001661 (PANTHER); PTHR23403:SF6 (PANTHER); PTHR23403:SF6 (PANTHER); IPR001661 (PANTHER); IPR001661 (PANTHER); PTHR23403:SF6 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_08973,3435,4555,8269,0,0,2,0,0,0,0,0,0,1,1,0,0,0,0,0.424329411,1,3.13439996,2.116921901,1.480640338,0.13870244,NA,0.135831329,0,6.345693169,1.964531148,3.230131105,0.001237335,0.015023052,0.351620847,0,3.697053395,1.28638794,2.873980144,0.004053344,0.016540129,0.405582036,1,3.274794514,1.459137456,2.244335858,0.0248108,0.085296029,0.345821762,0,3.617993992,1.230487615,2.940292895,0.003279021,0.012700876,N,-,,kinesin family,F:nucleotide binding,no IPS match,,
RL4_JR_08974,8501,7589,6010,0,0,5,0,0,0,1,0,1,0,4,0,0,0,1,0.359983173,1,3.371453349,2.357234779,1.430257766,0.152643051,NA,0.114712282,0,6.589127583,2.081502072,3.165563788,0.001547827,0.015023052,0.298637046,1,3.931167499,1.362772233,2.884684178,0.003918065,0.016203632,0.344541905,1,3.509518538,1.61156186,2.177712582,0.029427442,0.091256615,0.296129249,1,3.841293672,1.294901916,2.966474622,0.003012352,0.011876973,N,-,,recQ family helicase,F:nucleic acid binding; F:ATP binding; F:helicase activity; F:hydrolase activity,IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),2.A.16.2.2, the telurite-resistance/dicarboxylate transporter (tdt) family.
RL4_JR_08975,9920,5771,6024,5,0,2,0,0,0,3,0,5,3,13,2,0,10,9,0.003906015,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,1,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,N,-,,heterokaryon incompatibility,,no IPS match,,
RL4_JR_08976,2032,2035,3077,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0.008141456,0,8.841220392,4.035983802,2.190598582,0.028480854,NA,0.002675567,0,12.01934062,4.032893235,2.980327006,0.002879408,0.015349618,0.006783092,0,9.399044527,3.291065204,2.855927776,0.004291127,0.016940088,0.007815077,1,8.97609272,4.035428601,2.224322026,0.026126786,0.086108719,0.006504647,0,9.346543544,1.704039324,5.484934187,4.14E-08,1.17E-06,N,-,,high-affinity nicotinic acid transporter,P:transmembrane transport; C:membrane; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF191 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_08977,2860,3163,4005,1,5,11,0,0,0,0,0,9,3,4,0,0,6,2,0.047323338,1,6.298315691,3.929243874,1.602933259,0.10894939,NA,0.014689528,0,9.552066482,3.162366049,3.020544217,0.002523209,0.015349618,0.038938416,1,6.866988551,1.878165693,3.656220841,0.000255961,0.002060935,0.04497302,1,6.446471801,3.296839741,1.955348852,0.050541909,0.124027345,0.039333675,1,6.75656719,1.464780122,4.612683561,3.98E-06,4.69E-05,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF217 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.38, the major facilitator superfamily (mfs).
RL4_JR_08978,1673,1814,2611,0,1,2,0,0,0,0,8,1,1,0,0,0,0,0,106.8815483,1,5.434339303,0.38060464,14.27817408,2.99E-46,4.88E-43,0.816947505,0,3.757196458,1.432019927,2.623704034,0.008697933,0.030327413,37.25681346,1,3.930671251,0.73932663,5.316555754,1.06E-07,3.64E-06,11.75720375,1,1.632186145,1.143098302,1.427861577,0.153331705,0.27025804,9.810475402,0,2.691222198,0.979011362,2.748918248,0.00597923,0.020718583,N,-,,dimethylaniline monooxygenase,F:nucleotide binding; F:coenzyme binding; P:oxidation-reduction process; F:monooxygenase activity,PR00419 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR020946 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR23023 (PANTHER); PTHR23023:SF4 (PANTHER); PTHR23023 (PANTHER); PTHR23023:SF4 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_08979,2410,2562,2770,0,0,4,0,0,0,4,0,0,2,2,0,0,0,0,0.015598098,1,7.897226533,3.974462125,1.986992525,0.046923225,NA,0.005173869,0,11.06112819,3.972197013,2.784637357,0.005358762,0.021575731,0.013163741,1,8.434663406,2.923591714,2.885034652,0.003913706,0.016192218,0.015162248,1,8.01507741,3.973383284,2.01719211,0.043675469,0.113446415,0.012785134,0,8.357399562,1.610627411,5.188909306,2.12E-07,4.23E-06,,,,,,,,
RL4_JR_08980,20005,17539,16982,0,5,2,0,0,1,0,0,6,1,8,2,0,10,0,10.19730002,1,0.170725262,1.157405942,0.147506813,0.882732002,0.94282897,2.033066158,1,2.44179566,1.317351894,1.853563706,0.063801604,0.142781304,5.284268611,1,-0.212957061,1.209360543,-0.176090631,0.860222741,0.910972284,6.096393449,1,-0.635375143,1.20925959,-0.525424936,0.599287823,0.721754396,5.22434333,1,-0.299071336,1.214679176,-0.246214261,0.805516376,0.868932535,Y,-,,carboxypeptidase Y,F:hydrolase activity,IPR001563 (PRINTS); IPR029058 (G3DSA:3.40.50.GENE3D); IPR001563 (PFAM); IPR001563 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_08981,294,268,222,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.671657979,0,2.471709017,1.75083246,1.411733602,0.158028415,NA,0.215286143,0,5.681137812,1.817524,3.125756695,0.001773482,0.015023052,0.557729167,0,3.030756916,1.280965207,2.36599472,0.017981701,0.05165025,0.643296182,0,2.608947549,1.379831147,1.890773051,0.058654646,0.135095153,0.549776807,0,2.948639809,1.244739593,2.368880869,0.017841999,0.049848301,Y,-,,---NA---,,no IPS match,,
RL4_JR_08982,804,666,751,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0.720735545,0,2.370132026,1.663317363,1.424942755,0.154173749,NA,0.231235843,0,5.578179797,1.776342496,3.140261413,0.001687971,0.015023052,0.597670845,1,2.931847326,1.257125545,2.332183399,0.019691045,0.05494822,0.689326216,0,2.509678146,1.336061771,1.878414756,0.060324448,0.137255065,0.586859109,1,2.854846623,1.220493517,2.339092,0.019330673,0.053243488,N,-,,mg2+ transporter,C:membrane; P:transport,G3DSA:1.20.58.340 (GENE3D),1.A.35.1.1, the cora metal ion transporter (mit) family.
RL4_JR_08983,1403,1211,1918,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0.003880053,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,0,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,fad binding domain containing,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; P:oxidation-reduction process",IPR016169 (G3DSA:3.30.465.GENE3D); IPR006094 (PFAM); IPR016167 (G3DSA:3.30.43.GENE3D); PTHR11748 (PANTHER); PTHR11748:SF88 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY),,
RL4_JR_08984,1325,1225,2352,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0.019478151,1,7.57718263,3.961086708,1.912905015,0.055760213,NA,0.006341168,0,10.76585697,3.960170739,2.718533538,0.006557201,0.024747198,0.01633527,1,8.122024615,2.743094565,2.960898512,0.00306743,0.013767301,0.018830106,0,7.702177146,3.960482763,1.944757144,0.051804214,0.125559168,0.016075682,0,8.032689633,1.553673371,5.170127636,2.34E-07,4.41E-06,N,-,,integral membrane,C:integral component of membrane,PTHR31740:SF6 (PANTHER); PTHR31740 (PANTHER),9.B.313.1.3, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_08985,2345,1368,1874,0,1,0,0,0,0,0,0,3,0,0,2,0,6,0,6.331774666,1,1.514533076,1.170086198,1.294377353,0.195535109,0.357422232,0.806816316,0,3.775331979,1.464959826,2.577089086,0.009963627,0.03347223,141.9606864,1,6.165231469,0.452014759,13.63944726,2.33E-42,1.12E-39,119.4182982,1,5.779452858,0.414945355,13.92822644,4.27E-44,1.49E-41,90.83255961,1,5.554721104,1.627310488,3.413436554,0.000641491,0.003344539,Y,-,,minor extracellular protease vpr,C:cell wall; C:membrane; P:proteolysis; F:serine-type endopeptidase activity,IPR015500 (PRINTS); IPR010435 (PFAM); IPR010259 (G3DSA:3.30.70.GENE3D); IPR000209 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); PTHR10795:SF363 (PANTHER); IPR015500 (PANTHER); IPR015500 (PANTHER); PTHR10795:SF363 (PANTHER); IPR015500 (PANTHER); IPR000209 (SUPERFAMILY); IPR009020 (SUPERFAMILY),2.A.7.3.49, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_08986,5944,4095,7814,0,2,0,0,0,0,0,0,0,0,1,1,0,0,0,140.9855557,1,5.366023051,1.321504589,4.06054061,4.90E-05,0.000461212,1.125956585,0,3.29441844,1.383300287,2.3815642,0.017239286,0.051259028,2.914281966,0,0.645989837,1.205281494,0.535965947,0.591982085,0.711531121,3.361520868,1,0.223830836,1.206388269,0.185537975,0.852807098,0.907897583,2.865297006,0,0.56752536,1.198067573,0.473700627,0.635713407,0.738480753,Y,-,,gpi anchored serine-threonine rich,C:membrane; C:integral component of membrane,IPR018466 (PFAM); PTHR40633 (PANTHER); PTHR40633:SF1 (PANTHER),,
RL4_JR_08987,107,74,142,0,0,6,0,0,0,0,0,0,0,2,0,0,0,0,0.031855048,1,6.869599497,3.94011846,1.743500752,0.081246183,NA,0.010356779,0,10.05972386,3.29154909,3.056227808,0.002241409,0.015045494,0.026570716,0,7.4235516,1.892858295,3.92187393,8.79E-05,0.001074667,0.030628796,1,7.001724368,3.702391942,1.891135373,0.058606276,0.135014457,0.025920114,0,7.349611104,1.404773655,5.231882785,1.68E-07,3.49E-06,N,-,,methyltransferase type 11,P:metabolic process; F:transferase activity,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); PTHR10108:SF818 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_08988,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.558,conserved hypothetical protein,,no IPS match,,
RL4_JR_08989,123,152,95,4,0,19,0,0,0,0,1,1,1,0,4,0,0,0,1.433811579,1,1.377727839,1.335566559,1.031568087,0.302274497,NA,0.460245311,0,4.585096231,1.574120345,2.912799042,0.00358205,0.016974492,1.189877121,1,1.938163299,1.232025736,1.573151633,0.115683712,0.216204891,1.372329292,1,1.516162073,1.257568867,1.205629459,0.227960395,0.364110901,1.169257629,0,1.860252828,1.213490229,1.532977178,0.125281478,0.226139241,N,-,,hypothetical protein FOVG_12100,,no IPS match,,
RL4_JR_08990,76,63,45,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0.019833539,1,7.552685693,3.960178349,1.907157968,0.056500135,NA,0.006513913,0,10.72948069,3.659267997,2.932138532,0.003366365,0.016450773,0.016616095,0,8.100945958,2.184121524,3.709017959,0.000208065,0.001795777,0.019145861,0,7.679570666,3.959653204,1.939455369,0.052445914,0.126101847,0.016124919,0,8.029345281,1.489227061,5.391619244,6.98E-08,1.68E-06,N,-,,intracellular serine protease,P:proteolysis; F:serine-type endopeptidase activity,IPR015500 (PRINTS); IPR000209 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (SUPERFAMILY),,
RL4_JR_08991,37,41,50,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.068171118,0,5.772308038,3.922389708,1.471630426,0.141120705,NA,0.021385228,0,9.011969626,2.870544217,3.13946379,0.001692573,0.015023052,0.056078571,0,6.344285547,1.649860103,3.845347575,0.000120382,0.001297917,0.064738937,0,5.921775675,2.782802037,2.127990276,0.03333789,0.097850963,0.055857678,0,6.252461566,1.35463708,4.615599011,3.92E-06,4.64E-05,N,-,,ankyrin unc44,F:ubiquitin-protein transferase activity; P:protein ubiquitination,IPR002110 (SMART); IPR003877 (SMART); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR003877 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24123 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR001870 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY),8.A.28.1.2, the ankyrin (ankyrin) family.
RL4_JR_08992,10,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.86714546,0,0.892343137,0.774098963,1.15275072,0.249012717,0.425790347,5.335073332,0,1.050067021,1.329910465,0.78957723,0.429774711,0.591867569,13.66962091,0,-1.583881611,1.246843326,-1.270313261,0.203973066,0.330086849,41.43815001,0,0.992974814,0.780868714,1.271628376,0.20350519,0.335311643,28.0408833,0,0.068783763,1.028975003,0.066846874,0.946703607,0.965780757,N,-,,zinc c6 transcription factor,"C:nucleus; F:zinc ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PTHR31845:SF14 (PANTHER); PTHR31845 (PANTHER),,
RL4_JR_08993,1,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,62.62976899,0,2.05439655,0.741478193,2.770676965,0.005593989,0.023843137,3.424867963,0,1.689377332,1.336143085,1.264368578,0.206097766,0.350989244,8.981811492,0,-0.978093522,1.251269175,-0.781681145,0.434401985,0.57481188,51.30935548,0,1.927290114,0.725697313,2.655776836,0.007912596,0.040295857,8.950340245,0,-1.07567354,1.268526351,-0.847970985,0.39645413,0.53329322,N,-, Effector probability:0.595,thioesterase superfamily,P:transmembrane transport; C:membrane; C:integral component of membrane,IPR006683 (PFAM); IPR029069 (G3DSA:3.10.129.GENE3D); PTHR12418 (PANTHER); PTHR12418:SF26 (PANTHER); IPR029069 (SUPERFAMILY),,
RL4_JR_08994,3658,3450,5974,0,0,2,0,0,0,0,1,1,1,4,0,0,1,0,44.60267368,1,2.650608472,0.832963465,3.182142535,0.001461899,0.008052781,20.12822863,0,4.638138951,1.022361374,4.53669228,5.71E-06,0.000408435,3.582708249,1,0.347699938,1.231169315,0.282414395,0.777625778,0.852483311,4.134866597,1,-0.075218226,1.237209451,-0.060796679,0.951521135,0.971282538,3.558914395,1,0.254886415,1.239721112,0.205599801,0.837103533,0.890054219,N,-,,copper-containing nitrite reductase,F:nitrite reductase (NO-forming) activity; F:copper ion binding; P:nitrogen compound metabolic process; C:integral component of membrane; P:oxidation-reduction process,IPR001287 (PRINTS); IPR008972 (G3DSA:2.60.40.GENE3D); IPR008972 (G3DSA:2.60.40.GENE3D); IPR011707 (PFAM); PTHR11709 (PANTHER); PTHR11709:SF84 (PANTHER); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY),,
RL4_JR_08995,1047,952,751,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,29.2435062,1,1.920680717,0.962548317,1.995412264,0.045997934,0.124849126,1.698466299,0,2.701356315,1.449872053,1.86316876,0.062438527,0.140632569,4.354340913,0,0.066531918,1.275639961,0.052155718,0.958404617,0.975556841,5.01896205,0,-0.354585213,1.287087864,-0.275494178,0.782936598,0.860321222,8.107607545,1,0.924228902,1.198213538,0.771339058,0.440505987,0.574462019,N,-,,major facilitator superfamily transporter,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),,
RL4_JR_08996,11492,7581,4361,0,4,5,0,0,2,0,0,1,1,2,1,0,0,0,31.79542607,1,-0.969029113,1.012017185,-0.95752239,0.338303651,0.528272823,17.07491331,1,1.438152597,1.117957316,1.286411007,0.198299659,0.341591073,31.06715223,1,-1.171032245,1.19061199,-0.98355489,0.325334414,0.468451943,32.38303044,1,-1.605779723,1.142557263,-1.405426033,0.15989463,0.278872069,41.84835565,0,0.016775322,0.845196207,0.019847843,0.984164752,0.989343538,N,-,,2-dehydropantoate 2-reductase,P:pantothenate biosynthetic process; F:NADP binding; C:cytoplasm; P:oxidation-reduction process; F:2-dehydropantoate 2-reductase activity,IPR016040 (G3DSA:3.40.50.GENE3D); IPR013752 (PFAM); IPR003710 (TIGRFAM); IPR013328 (G3DSA:1.10.1040.GENE3D); IPR013332 (PFAM); PTHR21708 (PANTHER); PTHR21708:SF30 (PANTHER); IPR008927 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_08997,2425,2223,2502,0,0,3,0,0,0,0,0,0,0,2,0,0,0,0,0.131707556,1,4.822135331,3.6214128,1.331561906,0.18300419,NA,0.043103609,0,8.002254923,2.562947354,3.12228611,0.001794524,0.015023052,0.110053635,0,5.373696937,1.542696809,3.483313706,0.000495248,0.003367285,0.126826008,1,4.952101814,2.227734282,2.222931996,0.026220386,0.086316686,0.106768872,0,5.310414629,1.344917821,3.948504918,7.86E-05,0.000568246,N,-,,intracellular serine protease,P:proteolysis; F:serine-type endopeptidase activity; F:peptidase activity; P:cytolysis in other organism; C:extracellular region,IPR015500 (PRINTS); IPR000209 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (SUPERFAMILY),,
RL4_JR_08998,78120,44316,50567,0,0,16,0,0,0,0,0,0,0,1,2,0,8,1,0.05696423,1,6.031855032,3.92546203,1.536597472,0.124391912,NA,0.018560747,0,9.218760341,3.127981892,2.947191084,0.00320675,0.016140587,0.047322434,0,6.59383054,1.882133688,3.503380542,0.000459393,0.003183362,0.054541932,1,6.170115459,3.161777219,1.951470655,0.051001084,0.12470079,0.045658218,1,6.538909791,1.452126839,4.502988042,6.70E-06,7.20E-05,N,-,,ankyrin unc44,,no IPS match,,
RL4_JR_08999,2,6,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.55440477,0,1.261132819,1.324195028,0.952376948,0.340905846,NA,0.498450274,0,4.470004665,1.556671387,2.871514632,0.004085099,0.018328621,1.29010502,0,1.821271402,1.233384355,1.476645455,0.1397707,0.248819865,1.487996158,0,1.399270748,1.256941636,1.113234463,0.265607745,0.406582545,1.269756378,0,1.741304521,1.218613429,1.428922807,0.153026422,0.262697952,N,-,,ankyrin unc44,,IPR002110 (PRINTS); IPR002110 (SMART); IPR003877 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR003877 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR002110 (PFAM); PTHR24123 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR001870 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY); IPR013320 (SUPERFAMILY),8.A.28.1.2, the ankyrin (ankyrin) family.
RL4_JR_09000,2,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.310860185,0,3.583232876,2.446547496,1.464607935,0.143027916,NA,0.099555476,0,6.793845194,2.095963361,3.241395017,0.001189462,0.015023052,0.257893637,0,4.143636105,1.321061731,3.136595366,0.001709218,0.008748295,0.297468348,0,3.721823274,1.589907353,2.340905756,0.019237022,0.075464879,0.254051824,0,4.06223174,1.246444105,3.259056481,0.001117834,0.005220512,N,-,,Serine threonine- phosphatase 6 regulatory ankyrin repeat subunit A,F:catalytic activity; P:nucleoside metabolic process,IPR002110 (SMART); IPR002110 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); PTHR24198 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),3.A.23.6.1, the type vi symbiosis/virulence secretory system (t6ss) family.
RL4_JR_09001,2,5,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.008470882,0,8.791019641,4.031633903,2.180510397,0.029219649,NA,0.002680088,0,12.01721297,4.032710343,2.979934573,0.0028831,0.015349618,0.006904709,0,9.374372631,4.033343739,2.324218623,0.02011378,0.055743746,0.007967227,0,8.951770626,4.033311655,2.219459191,0.026455501,0.08636862,0.006679571,0,9.335361424,1.822923296,5.121093929,3.04E-07,5.22E-06,N,-,,glutamyl-trna subunit a,"F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (PFAM); IPR023631 (G3DSA:3.90.1300.GENE3D); IPR000120 (PANTHER); PTHR11895:SF72 (PANTHER); IPR023631 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_09002,422,416,337,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,9.44345222,0,-1.341417865,1.19630284,-1.121302918,0.262158944,0.441513763,3.016648681,0,1.872618697,1.278316115,1.464910498,0.142945338,0.266413683,7.813735739,0,-0.776880239,1.197800796,-0.648588848,0.516604166,0.647654216,9.013576008,1,-1.19912101,1.195804969,-1.002773062,0.315970369,0.462111799,7.684168026,0,-0.855591019,1.196394873,-0.715140994,0.474521925,0.604800414,N,-,,Ketopantoate reductase domain,F:oxidoreductase activity,IPR013332 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR016040 (SUPERFAMILY),,
RL4_JR_09003,581,426,557,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.916237647,0,2.023749028,1.548798757,1.306657187,0.191329165,NA,0.290796455,0,5.24726487,1.705395999,3.07686008,0.002091935,0.015023052,0.757848224,0,2.588276331,1.260479069,2.053406831,0.040033137,0.095724016,0.874472967,0,2.165929379,1.322078899,1.638275431,0.10136425,0.197786286,0.751206379,0,2.499047373,1.241854578,2.012351058,0.044182944,0.101786645,N,-, Effector probability:0.692,hypothetical protein Micbo1qcDRAFT_208403,,no IPS match,,
RL4_JR_09004,290,171,266,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.596317836,0,1.222794612,1.30993994,0.933473799,0.350575392,NA,0.50899091,0,4.439751373,1.538122251,2.886474966,0.003895837,0.017783446,1.321922027,0,1.785986156,1.225810371,1.456984047,0.145120784,0.25561991,1.52505101,0,1.363705868,1.246175822,1.094312572,0.273817913,0.415840164,1.305290881,0,1.701822799,1.216123976,1.399382656,0.161698265,0.273915833,N,-,,HET-domain-containing partial,,IPR010730 (PFAM); PTHR33112 (PANTHER); PTHR33112:SF6 (PANTHER),,
RL4_JR_09005,347,217,344,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.15413657,0,-2.696596548,1.194467909,-2.257571365,0.023972396,0.07613634,7.683077521,0,0.52378402,1.22409314,0.42789556,0.66872716,0.788690362,19.98533621,0,-2.131972111,1.195263444,-1.783683858,0.074475051,0.154157721,23.05863578,0,-2.554506665,1.194352821,-2.138820808,0.032450184,0.096393191,19.76497084,0,-2.21865049,1.202918219,-1.84439013,0.065126305,0.137461713,N,-,,hypothetical protein CMQ_1572,,no IPS match,,
RL4_JR_09006,660,420,614,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,23.84749946,0,-2.678180651,1.229964655,-2.177445214,0.029447365,0.089139743,7.60187842,0,0.539110908,1.268090164,0.425136101,0.670737462,0.789534201,19.77814065,0,-2.116926207,1.224911878,-1.728227348,0.083947472,0.16892948,22.81790771,0,-2.539349192,1.227601321,-2.068545503,0.038588756,0.104945248,19.59281629,1,-2.206057885,1.236352881,-1.784327047,0.074370538,0.151692525,N,-,,heterokaryon incompatibility -domain-containing,P:transmembrane transport; C:membrane; C:integral component of membrane; P:transport; F:transporter activity,IPR010730 (PFAM); PTHR24148 (PANTHER),,
RL4_JR_09007,532,400,491,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,311.9639636,0,0.433205487,0.435499864,0.994731623,0.31986681,0.508371992,59.29871653,0,-0.241734734,1.006876528,-0.240083791,0.8102653,0.884354687,209.5843719,1,-0.097121183,1.180246384,-0.082288905,0.934416977,0.960970512,130.8342196,0,-4.000271564,1.163707215,-3.43752407,0.000587059,0.004762795,146.6209766,0,-0.745523919,0.68785669,-1.08383611,0.278437471,0.412040251,N,-,,amino acid transporter,C:integral component of membrane,IPR013057 (PFAM); PTHR22950:SF8 (PANTHER); PTHR22950 (PANTHER),2.A.18.4.1, the amino acid/auxin permease (aaap) family.
RL4_JR_09008,130,237,205,0,0,0,0,0,0,0,0,0,2,1,0,0,0,0,11.27495243,0,-1.597351281,1.198282775,-1.333033666,0.182520756,0.339955326,3.582815009,0,1.624388012,1.260271185,1.288919426,0.1974261,0.340898496,9.319064716,0,-1.031265088,1.19788497,-0.860904939,0.389290401,0.532735336,14.76408695,1,-0.506963618,1.147885297,-0.441650066,0.658742448,0.767345523,9.209648183,0,-1.116864479,1.204123555,-0.927533121,0.353649804,0.490978234,Y,-,,glycoside hydrolase family 16,"P:carbohydrate metabolic process; F:carbohydrate binding; F:hydrolase activity, acting on glycosyl bonds",IPR000757 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); PTHR38121 (PANTHER); PTHR38121:SF1 (PANTHER); IPR000757 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),,
RL4_JR_09009,14084,38956,15920,2,0,11,0,0,3,5,2,10,12,15,5,4,3,1,0.661436119,1,2.493780714,1.813099417,1.375424144,0.168999988,NA,0.211910554,1,5.703871644,1.850421502,3.082471555,0.002052893,0.015023052,0.549579538,1,3.051809279,1.309303235,2.330865149,0.019760471,0.05512676,4.645501925,1,3.572500137,1.206301742,2.961531111,0.003061136,0.018933414,0.542725362,1,2.967290558,1.272213859,2.332383456,0.019680528,0.053986817,N,-,,MFS multidrug transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23502:SF60 (PANTHER); PTHR23502:SF60 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.86, the major facilitator superfamily (mfs).
RL4_JR_09010,10082,15010,12360,5,14,57,0,0,1,8,12,16,18,17,13,0,14,9,2.266283435,1,0.717427758,1.2955268,0.553772996,0.579734211,0.754280259,0.717615349,1,3.94416382,1.477281593,2.669879485,0.007587848,0.027538255,1.870124918,1,1.285756596,1.234233136,1.041745323,0.29752977,0.438391994,6.169679501,1,1.808378975,1.171662227,1.543430294,0.122726408,0.228129767,1.851061099,1,1.198156175,1.232447549,0.9721762,0.330962899,0.467783053,N,-,,glycerate kinase,P:organic acid phosphorylation; F:glycerate kinase activity,IPR018193 (G3DSA:3.90.1510.GENE3D); IPR004381 (TIGRFAM); IPR004381 (PFAM); IPR004381 (PIRSF); IPR004381 (PANTHER); PTHR21599:SF5 (PANTHER); IPR004381 (SUPERFAMILY),,
RL4_JR_09011,2606,2464,3489,5,3,2,3,0,0,2,0,2,1,3,0,0,2,0,0.125287865,1,4.89393701,3.857697732,1.268615986,0.20457806,NA,0.040390647,1,8.094954023,2.729649339,2.965565543,0.00302127,0.015639935,0.104597911,1,5.444350061,1.707968876,3.187616669,0.001434506,0.007639403,0.120620654,1,5.023639492,2.456812786,2.044779122,0.040876639,0.109000782,0.10338503,1,5.357893553,1.479066488,3.622483233,0.000291788,0.0017112,N,-,,hypothetical protein CMQ_5571,,no IPS match,,
RL4_JR_09012,276,285,307,0,0,9,0,0,0,0,0,2,0,0,0,0,4,0,2.011868013,1,0.889337836,1.307145756,0.680366235,0.496272595,NA,0.646578702,0,4.094770289,1.518645673,2.696330264,0.007010812,0.025989957,1.667498008,1,1.451775145,1.239528601,1.171231664,0.241505671,0.374770603,24.55917665,0,3.358843307,0.875134236,3.838089252,0.000123995,0.001285009,1.631956331,1,1.379625353,1.222113732,1.128884585,0.258946524,0.390677032,N,-,,NACHT domain,F:nucleotide binding; P:biological_process; F:ATP binding; F:protein kinase activity; P:protein phosphorylation; C:cellular_component; F:molecular_function,G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); PTHR10039 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_09013,307,433,558,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.851523063,0,2.129745096,1.608760737,1.32384204,0.185555511,NA,0.271595123,0,5.346110535,1.743268436,3.066716763,0.002164238,0.015045494,0.703457761,0,2.697150357,1.271298901,2.121570588,0.033873814,0.08444681,0.81152085,0,2.274506348,1.343119591,1.693450355,0.090369777,0.181438428,0.691097327,0,2.619895836,1.239451173,2.113754775,0.034536217,0.083976754,N,-,,SNF2 family domain-containing,F:binding,IPR027417 (G3DSA:3.40.50.GENE3D); IPR000330 (PFAM); PTHR10799 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_09014,1116,1317,1426,0,0,0,0,0,0,2,0,1,0,0,0,0,1,0,2.012406767,0,0.888535497,1.274906537,0.696941675,0.485839295,NA,0.643091494,0,4.10238178,1.491325193,2.750829799,0.005944452,0.023160024,1.668312695,1,1.450252699,1.224136904,1.184714466,0.236130361,0.36863281,1.92449642,0,1.028066819,1.238130066,0.830338303,0.406347538,0.549962414,1.645925151,1,1.367150431,1.216793213,1.123568423,0.261196158,0.393140585,N,-,,oxidoreductase containing,F:oxidoreductase activity; F:ion binding,IPR006620 (SMART); G3DSA:2.60.120.620 (GENE3D); IPR005123 (PFAM); PTHR10869 (PANTHER); PTHR10869:SF86 (PANTHER); PTHR10869 (PANTHER); PTHR10869:SF86 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_09015,4407,5452,8421,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0.77408601,0,2.267374003,1.989087777,1.139906458,0.254325274,NA,0.244008878,0,5.50062763,1.968709132,2.794027589,0.005205604,0.021136905,0.634814058,0,2.845166218,1.44592145,1.967718383,0.049100449,0.111532106,0.732668467,1,2.421947365,1.599428912,1.514257587,0.129960521,0.238767969,0.624586583,1,2.765877291,1.406955744,1.965859482,0.049314845,0.110859858,N,-,,short-chain dehydrogenase reductase family,,IPR002347 (PRINTS); SM00822 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24320 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09016,1909,1783,2573,2,5,0,0,0,0,0,3,1,1,2,4,0,0,0,1.518981379,1,1.294618551,1.354672505,0.955669024,0.339239477,NA,0.48151289,0,4.519794391,1.560624374,2.896144944,0.003777779,0.017556495,1.254156813,1,1.862112143,1.238761123,1.503205185,0.132786141,0.23928923,1.447211203,1,1.439452032,1.266079403,1.136936616,0.255564784,0.395007148,1.240900642,0,1.775205844,1.230316756,1.442885204,0.149052812,0.257755716,N,-,,conserved hypothetical protein,P:ribosomal large subunit export from nucleus; C:cell; P:ribosomal large subunit biogenesis; P:actin cytoskeleton organization,PTHR37540 (PANTHER),,
RL4_JR_09017,144,106,163,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.728085091,0,2.355344022,1.679310207,1.40256637,0.160746186,NA,0.232496578,0,5.570137979,1.779958278,3.12936435,0.001751849,0.015023052,0.603656318,0,2.916504316,1.268167245,2.299778935,0.021460747,0.058800706,0.696377124,0,2.494520668,1.35246203,1.844429354,0.065120593,0.143899171,0.596265584,0,2.831843937,1.238079442,2.287287747,0.022179033,0.059329646,N,-,,---NA---,,no IPS match,,
RL4_JR_09018,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.004235441,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001340044,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003452355,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003983613,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003339785,0,10.24113992,1.835951848,5.578109216,2.43E-08,8.07E-07,N,-,,related to integral membrane pth11,C:membrane,PTHR33048:SF29 (PANTHER); PTHR33048 (PANTHER),9.B.313.1.4, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_09019,825,741,723,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0.02046643,1,7.509973426,3.958630497,1.897114023,0.057812891,NA,0.006354731,0,10.76296664,3.960064592,2.717876537,0.006570235,0.024762936,0.016700122,0,8.094399799,2.742530175,2.951435091,0.00316301,0.014069558,0.019286557,1,7.669675312,3.959294103,1.937132002,0.05272921,0.126422133,0.016600451,0,8.012578593,1.566709906,5.114270715,3.15E-07,5.36E-06,N,-,,Short-chain dehydrogenase reductase SDR,F:oxidoreductase activity; F:cholestenol delta-isomerase activity; C:integral component of membrane; P:oxidation-reduction process; P:sterol metabolic process,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24322:SF361 (PANTHER); PTHR24322:SF361 (PANTHER); IPR002347 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09020,348,327,615,0,0,1,0,0,0,0,0,2,1,11,0,0,0,0,0.015875601,1,7.873726156,3.973377595,1.981620414,0.047521741,NA,0.004841942,0,11.15004198,3.976319002,2.804111535,0.005045545,0.020752135,0.012966942,1,8.453583283,2.925374836,2.889743624,0.003855561,0.016036854,0.014987188,1,8.030738991,3.97410421,2.020767088,0.043303881,0.113246213,0.013211428,0,8.338311818,1.621864357,5.141189386,2.73E-07,4.92E-06,N,-,,Glucose 1-dehydrogenase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); PF13561 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); PTHR24322:SF494 (PANTHER); PTHR24322:SF494 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09021,3094,3711,5903,0,0,4,0,0,0,1,0,4,0,1,0,0,3,0,0.031855048,1,6.869599497,3.94011846,1.743500752,0.081246183,NA,0.010356779,0,10.05972386,3.29154909,3.056227808,0.002241409,0.015045494,0.026570716,1,7.4235516,1.892858295,3.92187393,8.79E-05,0.001074667,0.030628796,1,7.001724368,3.702391942,1.891135373,0.058606276,0.135014457,0.025920114,1,7.349611104,1.404773655,5.231882785,1.68E-07,3.49E-06,N,-,,Major facilitator superfamily general substrate transporter,C:integral component of plasma membrane; F:sugar:proton symporter activity; P:hexose transmembrane transport; P:glucose import; F:glucose transmembrane transporter activity,IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF176 (PANTHER); PTHR23500:SF176 (PANTHER); PTHR23500 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.82, the major facilitator superfamily (mfs).
RL4_JR_09022,5655,4398,8550,0,0,3,0,0,0,0,2,0,0,2,0,0,3,0,89.04143148,1,0.826600959,0.533289357,1.550004604,0.121140411,0.254117632,10.87001286,0,0.023248062,1.223806901,0.018996511,0.984843888,0.992120268,50.36403566,1,-0.795499097,1.039239003,-0.765463088,0.443995838,0.58369223,48.60996465,1,-0.351455845,0.768565867,-0.457287865,0.647464151,0.758483689,27.81685128,1,-2.711635476,1.203108576,-2.253857658,0.024205124,0.06349142,N,-,,L-asparaginase precursor,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding; F:hydrolase activity",IPR000246 (PFAM); IPR000246 (PANTHER); PTHR10188:SF24 (PANTHER); IPR029055 (SUPERFAMILY),,
RL4_JR_09023,15213,12110,13714,0,0,1,0,0,0,0,4,2,4,9,4,0,0,0,4.051743549,1,-0.120615063,1.221453966,-0.098747122,0.921339054,0.961964073,1.297753882,0,3.089590527,1.376174491,2.245057256,0.024764457,0.068060232,3.355059099,1,0.442940238,1.212497928,0.365312161,0.714878402,0.807118205,3.869808392,1,0.020823271,1.214384921,0.017147175,0.986319204,0.99170625,3.292531769,0,0.367095037,1.204728458,0.30471185,0.760585624,0.832705529,N,-,,CMGC kinase,P:metabolic process; F:kinase activity,G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR011009 (SUPERFAMILY),,
RL4_JR_09024,1783,2641,2299,0,0,10,0,0,5,0,3,1,1,15,0,0,1,1,4.213478862,1,-0.177194744,1.209050899,-0.146556893,0.88348178,0.943016726,1.351067146,1,3.031493468,1.364411083,2.221832925,0.026294599,0.071240345,3.492392308,1,0.384972404,1.206732082,0.31902061,0.749710885,0.832701371,4.028048237,1,-0.037077987,1.206994527,-0.030719267,0.975493426,0.98517231,3.428663598,1,0.308526011,1.198884032,0.257344332,0.796912972,0.86259823,N,-,,CMGC kinase,F:nucleotide binding; F:ATP binding; F:protein kinase activity; P:phosphorylation; F:protein serine/threonine kinase activity; P:protein phosphorylation; F:kinase activity,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24055:SF0 (PANTHER); PTHR24055 (PANTHER); PTHR24055:SF0 (PANTHER); PTHR24055 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.2, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_09025,8522,8035,8252,1,0,8,0,0,2,0,8,6,6,15,10,0,4,6,0.224499409,1,4.052599066,2.936438672,1.380106829,0.167553755,NA,0.071114269,1,7.278611998,2.331125271,3.12235987,0.001794075,0.015023052,0.186048715,1,4.613235329,1.475414778,3.126737917,0.001767574,0.008974384,0.214702457,1,4.191688679,1.912615193,2.191600639,0.028408356,0.08952213,0.185567088,1,4.515666163,1.361934575,3.315626348,0.00091438,0.004436079,N,-,,N2227-like,C:integral component of membrane; F:methyltransferase activity; P:methylation,IPR012901 (SMART); IPR012901 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR12303 (PANTHER); PTHR12303:SF10 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_09026,628,775,614,0,0,9,0,0,0,0,0,0,0,1,0,0,0,3,0.024017057,1,7.277353383,3.950950707,1.841924621,0.065486177,NA,0.007517509,0,10.51930317,3.508544607,2.998195646,0.002715833,0.015349618,0.019750033,0,7.848844754,2.050648851,3.827493308,0.000129455,0.00135673,0.022802265,1,7.426944679,3.951205681,1.879665418,0.060153691,0.136951133,0.019716075,1,7.757103381,1.450896594,5.346420561,8.97E-08,2.04E-06,Y,-,,di-copper centre,F:metal ion binding; P:oxidation-reduction process; F:monooxygenase activity,IPR002227 (PRINTS); IPR002227 (PFAM); IPR008922 (G3DSA:1.10.1280.GENE3D); PTHR11474 (PANTHER); IPR008922 (SUPERFAMILY),,
RL4_JR_09027,991,1437,1808,0,0,5,0,0,0,0,2,0,0,4,6,8,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-, Effector probability:0.657,Protein of unknown function DUF3328,C:integral component of membrane,IPR021765 (PFAM); PTHR33365:SF3 (PANTHER); PTHR33365 (PANTHER),,
RL4_JR_09028,495,315,619,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,0.020162965,1,7.530309459,3.959361818,1.901899802,0.057184255,NA,0.006518434,0,10.72863192,3.595247881,2.984114664,0.002844002,0.015349618,0.016737713,0,8.093068843,2.110155252,3.835295453,0.000125413,0.001330907,0.019298012,0,7.668814375,3.959262975,1.936929783,0.052753927,0.126422133,0.016299842,1,8.024147024,1.467629563,5.467419861,4.57E-08,1.23E-06,Y,-,,conserved Plasmodium,C:membrane; C:integral component of membrane,no IPS match,2.A.120.1.3, the putative amino acid permease (paap) family.
RL4_JR_09029,760,1057,492,0,0,0,4,0,0,0,0,0,0,0,0,0,0,1,63.83825484,0,-1.914748796,1.047830674,-1.827345623,0.06764782,0.166678017,15.22013723,1,-0.462370885,1.233970765,-0.374701653,0.707882363,0.816545331,39.47004006,0,-3.113665432,1.212173398,-2.568663392,0.010209157,0.033233925,55.17247543,0,-2.583584107,1.168366003,-2.211279771,0.027016469,0.087337724,38.82050293,1,-3.192507899,1.214741819,-2.628136983,0.008585394,0.027798884,N,-,,SAM-dependent methyltransferase,C:integral component of membrane; F:methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PF13649 (PFAM); IPR029063 (SUPERFAMILY),,
RL4_JR_09030,31080,19461,26989,2,10,11,0,0,2,1,12,0,3,1,1,0,9,3,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,Pth11-like integral membrane,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,PTHR33048 (PANTHER); PTHR33048:SF27 (PANTHER); PTHR33048 (PANTHER); PTHR33048:SF27 (PANTHER),9.B.313.1.1, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_09031,498,634,387,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.031066388,0,6.90436961,3.940928509,1.751965202,0.079779792,NA,0.009506618,0,10.17823344,3.942386122,2.581744436,0.009830235,0.033197402,0.025531441,0,7.475901505,2.747094914,2.721384495,0.00650091,0.023198876,0.029506471,0,7.053544786,3.941115862,1.789732917,0.073496858,0.156335229,0.026198695,0,7.341603062,1.845391492,3.978344483,6.94E-05,0.000514379,N,-,,enoyl- hydratase isomerase family,"F:transferase activity, transferring acyl groups other than amino-acyl groups; F:isomerase activity",IPR003480 (PFAM); IPR023213 (G3DSA:3.30.559.GENE3D); IPR023213 (G3DSA:3.30.559.GENE3D); PTHR31642:SF31 (PANTHER); PTHR31642 (PANTHER); SSF52777 (SUPERFAMILY),,
RL4_JR_09032,438,710,436,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2.890799805,0,0.366238759,1.235336051,0.296468931,0.76687199,0.877722899,0.91938953,0,3.586732328,1.412555783,2.539179246,0.011111288,0.036432931,2.390030126,1,0.931840386,1.212150562,0.768749704,0.442041912,0.581727845,6.769147897,0,1.455913381,1.152413453,1.263360279,0.206459732,0.338472278,17.09159522,0,2.537392331,0.979940062,2.589334215,0.009616171,0.030407163,N,-,,NIT3 Nitrilase,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; P:nitrogen compound metabolic process",IPR003010 (G3DSA:3.60.110.GENE3D); IPR003010 (PFAM); PTHR23088 (PANTHER); PTHR23088:SF6 (PANTHER); IPR003010 (PROSITE_PROFILES); IPR003010 (SUPERFAMILY),,
RL4_JR_09033,395,484,407,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1.713011513,0,1.121144928,1.28490625,0.872549985,0.382908412,NA,0.546989691,0,4.33594194,1.517760935,2.856801649,0.004279332,0.018621961,1.418335874,0,1.684765679,1.218684266,1.382446403,0.166834677,0.283966756,1.6361701,1,1.262475652,1.23433943,1.022794558,0.306404992,0.452105879,1.397378274,0,1.603569038,1.206925778,1.328639314,0.183966995,0.302590462,N,-,,kinesin light chain 1,F:ADP binding,IPR011990 (G3DSA:1.25.40.GENE3D); IPR010730 (PFAM); PF13424 (PFAM); PTHR10622:SF11 (PANTHER); PTHR10622 (PANTHER); IPR027417 (SUPERFAMILY); IPR011990 (SUPERFAMILY),,
RL4_JR_09034,1199,1013,1291,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,1.831959252,1,1.024470174,1.29021749,0.794029055,0.427178517,NA,0.584683672,0,4.239844384,1.510554898,2.80681251,0.005003435,0.020667464,1.515282627,0,1.589699241,1.223576247,1.299223685,0.193867175,0.318002476,9.771203315,0,2.890383963,1.026134668,2.816768648,0.004850945,0.027365184,1.490941499,0,1.510281174,1.210927455,1.247210283,0.212320404,0.336423175,Y,-,,aspartic-type endopeptidase,C:membrane,IPR021109 (G3DSA:2.40.70.GENE3D); IPR021109 (G3DSA:2.40.70.GENE3D); IPR033121 (PFAM); IPR033121 (PROSITE_PROFILES); IPR021109 (SUPERFAMILY),,
RL4_JR_09035,353,331,574,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3.921316434,1,-0.073874612,1.268068395,-0.058257592,0.953543446,0.977139485,1.241513363,0,3.153261952,1.404157425,2.245661274,0.024725712,0.067972206,3.242706763,0,0.491429405,1.239606816,0.396439741,0.691780653,0.789047694,3.742128328,0,0.068656684,1.248252105,0.055002258,0.956136665,0.974520207,3.223242358,0,0.397717265,1.248058472,0.318668776,0.749977694,0.826011548,Y,-,,DUF563 domain-containing,"P:biological_process; F:transferase activity, transferring glycosyl groups; C:membrane; C:integral component of membrane; F:transferase activity; C:cellular_component",IPR007657 (PFAM); PTHR20961 (PANTHER); PTHR20961:SF0 (PANTHER),,
RL4_JR_09036,3,2,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.007227433,0,-0.911299249,1.310597945,-0.6953309,0.486847954,0.674542392,2.200756822,0,2.327354931,1.403580392,1.658155773,0.097286029,0.198374131,5.784163215,0,-0.343331682,1.277052532,-0.268846953,0.78804746,0.859904342,6.677295888,0,-0.766625565,1.288025653,-0.595194329,0.55171358,0.68073361,5.790245403,0,-0.447395363,1.297483259,-0.344817831,0.730231327,0.810700897,N,-,,geranylgeranyl pyrophosphate synthetase,F:metal ion binding,PTHR35179:SF2 (PANTHER); PTHR35179 (PANTHER),,
RL4_JR_09037,5066,3654,2653,0,0,4,0,0,2,0,0,3,0,0,0,0,2,3,0.18255556,1,4.351072132,3.108450732,1.399755861,0.161586439,NA,0.058787691,1,7.553857006,2.353433299,3.209717909,0.001328653,0.015023052,7.994846309,1,5.866905336,1.232613685,4.759727567,1.94E-06,4.75E-05,12.20991555,0,6.765065226,0.919187275,7.359833422,1.84E-13,9.61E-12,0.149343856,1,4.827303469,1.284699749,3.757534376,0.000171596,0.001095465,N,-,,methyltransferase type 12,F:methyltransferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_09038,549,716,976,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,194.9877917,1,-3.967003589,1.119466324,-3.543656028,0.00039462,0.00274217,60.38192987,0,-2.450530495,1.251251753,-1.958463187,0.050175687,0.118193693,156.0457257,1,-5.096841008,1.246901444,-4.087605344,4.36E-05,0.000646052,189.5824954,0,-4.561431463,1.208143234,-3.775571749,0.000159641,0.001587786,153.5973996,0,-5.176796991,1.259017028,-4.111776786,3.93E-05,0.000315753,N,-,,High-affinity nicotinic acid transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF249 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_09039,22,39,28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.221208397,0,4.073943404,2.924395047,1.393089285,0.163592793,NA,0.07163373,0,7.268750649,2.320127347,3.132910207,0.001730824,0.015023052,0.184590884,0,4.625763032,1.453843294,3.181748027,0.001463891,0.007747221,0.212822798,0,4.204763346,1.886620837,2.228727291,0.025832055,0.085866566,0.181194611,0,4.54838676,1.329856482,3.420208737,0.000625731,0.003269569,Y,-,,cellobiose dehydrogenase,"F:oxidoreductase activity, acting on CH-OH group of donors",IPR007867 (PFAM); IPR000172 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR11552 (PANTHER); PTHR11552:SF57 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_09040,5098,4532,8021,0,0,4,0,0,0,0,2,0,2,2,0,0,12,0,51.40563708,1,-3.786208714,1.216865323,-3.111444333,0.001861746,0.009875242,16.26741268,0,-0.55845231,1.220565284,-0.457535797,0.647285979,0.771810488,42.4734865,1,-3.219546097,1.209017385,-2.662944419,0.007746021,0.026673712,49.01565078,1,-3.642388641,1.211678103,-3.006069542,0.002646485,0.016747286,42.17720385,1,-3.312169729,1.219939667,-2.715027487,0.006627027,0.022622606,N,-,,exosome complex exonuclease rrp41,"P:U4 snRNA 3'-end processing; P:U1 snRNA 3'-end processing; C:nucleolus; C:ribosome; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:mitotic spindle pole body; C:cytoplasmic exosome (RNase complex); P:nuclear-transcribed mRNA catabolic process, non-stop decay; P:nuclear polyadenylation-dependent mRNA catabolic process; C:nuclear exosome (RNase complex); P:polyadenylation-dependent snoRNA 3'-end processing; F:exonuclease activity; P:nonfunctional rRNA decay; P:nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay; P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent CUT catabolic process; C:cytosol; P:U5 snRNA 3'-end processing; P:nuclear polyadenylation-dependent tRNA catabolic process",IPR027408 (G3DSA:3.30.230.GENE3D); IPR001247 (PFAM); PTHR11953:SF0 (PANTHER); PTHR11953 (PANTHER); IPR020568 (SUPERFAMILY); IPR015847 (SUPERFAMILY),,
RL4_JR_09041,3975,3558,4194,0,0,2,0,0,0,0,2,0,0,0,0,0,1,0,154.9821792,1,-0.510997427,0.562786861,-0.907976824,0.363890467,0.555401015,31.24528781,0,-1.500085457,1.206945972,-1.242877056,0.213913142,0.360629787,171.5275464,1,0.010341833,0.529683675,0.019524546,0.984422656,0.992458193,153.0107745,0,-0.825429826,0.578868239,-1.425937321,0.153886435,0.27097394,107.909228,1,-0.916025591,0.676464365,-1.354137243,0.175692596,0.292291741,Y,-,,disulfide isomerase,F:protein disulfide isomerase activity; F:protein disulfide oxidoreductase activity; F:protein-disulfide reductase (glutathione) activity; P:cell redox homeostasis; P:oxidation-reduction process; C:fungal-type vacuole; P:protein folding,PR00421 (PRINTS); IPR012336 (G3DSA:3.40.30.GENE3D); IPR013766 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR18929 (PANTHER); PTHR18929:SF103 (PANTHER); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY),8.A.88.1.3, the calciquestrin (casq) family.
RL4_JR_09042,91,97,81,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,34.18341344,0,-3.197609002,1.215924508,-2.629775929,0.008544116,0.033446689,20.22383128,0,0.941772971,1.138218991,0.827409293,0.408005115,0.571760733,28.28339832,0,-2.632964748,1.211200236,-2.173847619,0.029716581,0.076106923,97.82539481,0,0.736774077,0.593642153,1.241108087,0.214565822,0.348992603,28.06635814,1,-2.724555972,1.222369836,-2.228912963,0.025819696,0.067066297,N,-,,DUF605 domain containing,,PF04652 (PFAM); IPR023175 (G3DSA:1.25.40.GENE3D); G3DSA:1.20.5.420 (GENE3D); PTHR12741 (PANTHER),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_09043,8275,9201,14604,0,3,8,0,0,1,0,0,1,2,0,1,0,4,2,0.922697938,1,2.013595377,1.610518932,1.250277371,0.211198242,NA,0.291098804,1,5.245653792,1.732450345,3.027881177,0.002462749,0.015349618,0.761915933,1,2.580444582,1.289471547,2.001164422,0.045374674,0.105095675,0.879388975,1,2.157771759,1.363758995,1.582223668,0.113598519,0.215336947,0.758770928,1,2.484690619,1.273529097,1.951027758,0.051053744,0.113984379,Y,-,,"2,6-dihydropseudooxynicotine hydrolase",P:proteolysis; F:aminopeptidase activity; F:hydrolase activity,G3DSA:1.20.1440.110 (GENE3D); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR17630:SF54 (PANTHER); PTHR17630 (PANTHER); PTHR17630:SF54 (PANTHER); PTHR17630 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_09044,14060,13927,11034,2,3,6,0,0,0,1,0,4,3,6,0,0,1,0,0.031829087,1,6.870734861,3.940144606,1.743777335,0.081197924,NA,0.010188555,0,10.08215548,3.266315815,3.086705651,0.002023879,0.015023052,11.09639653,1,8.388563647,1.312035844,6.393547619,1.62E-10,9.22E-09,0.030465191,1,7.009140538,3.678357594,1.905508195,0.056714043,0.132423019,0.0260458,1,7.3468273,1.393610729,5.271793008,1.35E-07,2.91E-06,N,-,,DUF563 domain-containing,"F:transferase activity, transferring glycosyl groups; C:membrane; C:integral component of membrane; F:transferase activity",IPR007657 (PFAM); PTHR20961 (PANTHER),,
RL4_JR_09045,2477,2588,3861,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0.18298401,1,4.348071114,3.17182363,1.370842651,0.170424012,NA,0.057847389,0,7.57728492,2.406766146,3.148326203,0.001642083,0.015023052,0.150451459,0,4.922982534,1.482577446,3.320556742,0.000898381,0.005284839,0.173624832,0,4.499206658,2.006197946,2.242653407,0.024919173,0.085411859,0.148201624,0,4.843222886,1.339355246,3.616085352,0.000299092,0.001743501,N,-,,---NA---,,no IPS match,,
RL4_JR_09046,1099,1378,1450,0,3,3,0,0,0,0,0,0,0,0,0,0,0,0,11.43775271,1,-1.617910703,1.227254973,-1.318316681,0.187397659,0.345958385,3.635318328,0,1.603465628,1.294641392,1.23854037,0.215515763,0.362246853,32.96629382,0,1.360458375,0.883415921,1.539997574,0.123560945,0.226753368,10.88874542,0,-1.471847167,1.220148899,-1.20628488,0.227707666,0.363811022,9.29313407,0,-1.12986209,1.222812929,-0.923986052,0.355493578,0.492727238,N,-,,alcohol dehydrogenase,F:metal ion binding,IPR020843 (SMART); IPR011032 (G3DSA:3.90.180.GENE3D); IPR013154 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013149 (PFAM); IPR002085 (PANTHER); PTHR11695:SF498 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_09047,3772,3760,7773,1,0,6,0,1,0,0,0,0,1,3,0,0,2,0,28.79159873,1,2.642477308,0.605814857,4.36185623,1.29E-05,0.000144964,30.01821602,1,4.732701851,0.861621026,5.492788253,3.96E-08,5.27E-06,17.87114164,0,1.72434334,1.031682984,1.671388756,0.094644915,0.186004629,5.621594261,1,-0.518146869,1.195446202,-0.433433866,0.664699602,0.771267874,39.53929543,1,3.586748531,0.52186751,6.872910198,6.29E-12,5.69E-10,N,-,,beta-galactosidase,"P:metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR006101 (PRINTS); IPR004199 (SMART); IPR013781 (G3DSA:3.20.20.GENE3D); IPR008979 (G3DSA:2.60.120.GENE3D); IPR006104 (PFAM); IPR013812 (G3DSA:2.60.40.GENE3D); IPR006103 (PFAM); IPR004199 (PFAM); IPR006102 (PFAM); IPR014718 (G3DSA:2.70.98.GENE3D); PTHR10066 (PANTHER); PTHR10066:SF72 (PANTHER); PTHR10066 (PANTHER); PTHR10066:SF72 (PANTHER); PTHR10066 (PANTHER); IPR011013 (SUPERFAMILY); IPR017853 (SUPERFAMILY); IPR008979 (SUPERFAMILY); IPR006102 (SUPERFAMILY); IPR006102 (SUPERFAMILY),,
RL4_JR_09048,12840,9603,13505,0,11,0,0,0,3,0,15,16,2,8,0,0,11,4,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,Uncharacterised,,no IPS match,,
RL4_JR_09049,24,41,35,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,340.9622794,0,0.851171268,0.350816957,2.426254634,0.015255562,0.053117745,40.55810591,0,-1.876422512,1.193810189,-1.571793012,0.115998563,0.22760148,720.9980698,0,2.553711894,1.41918501,1.799421411,0.071952045,0.150318305,244.4407877,0,-0.113671531,0.397234547,-0.286157214,0.774757713,0.854047016,230.5029934,0,0.56195627,0.65912378,0.852580786,0.393891821,0.530551376,N,-,,sugar transporter,C:integral component of plasma membrane; P:proton transport; F:sugar:proton symporter activity; P:glucose import; F:glucose transmembrane transporter activity; P:glucose transmembrane transport,IPR003663 (PRINTS); G3DSA:3.20.20.210 (GENE3D); IPR003663 (TIGRFAM); IPR005828 (PFAM); IPR002629 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500 (PANTHER); PTHR23500:SF103 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); SSF51726 (SUPERFAMILY),2.A.1.1.82, the major facilitator superfamily (mfs).
RL4_JR_09050,21458,16020,16557,0,3,3,0,1,0,0,0,10,0,1,0,0,5,0,9.657084684,1,2.589081472,1.065639819,2.429602784,0.015115378,0.052787353,0.649498129,1,4.088106665,1.534307171,2.664464288,0.007711105,0.027875715,1.679709667,1,1.440491936,1.255028412,1.147776355,0.251060901,0.386106723,1.937163748,1,1.018640888,1.278529047,0.79672878,0.425608566,0.568357521,1.653331726,1,1.360500617,1.245420369,1.092402735,0.274656122,0.407456884,N,-,,---NA---,,no IPS match,,
RL4_JR_09051,5950,8051,11130,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,39.27579832,0,1.046392863,0.848412303,1.233354182,0.217443651,0.385308794,2.916321616,0,1.921418828,1.288416645,1.491302394,0.135882121,0.255674641,7.534785554,0,-0.724536155,1.20046274,-0.603547391,0.546144599,0.673467469,8.689902063,0,-1.146486636,1.198510172,-0.956593163,0.338772641,0.486052571,7.397761813,1,-0.800983014,1.196799882,-0.669270633,0.503322857,0.630867037,N,-,,trans-aconitate 2-methyltransferase,F:methyltransferase activity,PF13649 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); IPR023149 (G3DSA:1.10.150.GENE3D); PTHR10108:SF890 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_09052,617,859,988,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,416.5380553,1,-1.783828188,0.415114528,-4.297195275,1.73E-05,0.000185441,102.1107275,0,-3.208465046,1.191011561,-2.693899161,0.007062153,0.026103757,314.0945184,0,-2.234813296,0.573902166,-3.894066673,9.86E-05,0.001151095,366.5161916,0,-2.232766127,0.486628264,-4.588237662,4.47E-06,6.94E-05,320.6927529,1,-1.74727731,0.469565866,-3.721048388,0.000198397,0.001236169,N,-,,histone deacetylase rpd3,P:negative regulation of chromatin silencing at rDNA; P:positive regulation of macroautophagy; P:transfer RNA gene-mediated silencing; P:regulation of DNA-dependent DNA replication initiation; P:negative regulation of chromatin silencing at silent mating-type cassette; P:regulation of transcription involved in G2/M transition of mitotic cell cycle; P:positive regulation of transcription from RNA polymerase II promoter; P:replicative cell aging; P:negative regulation of reciprocal meiotic recombination; P:transcription elongation from RNA polymerase II promoter; P:negative regulation of transcription involved in meiotic cell cycle; F:transcription coactivator activity; F:histone deacetylase activity; F:transcription corepressor activity; P:negative regulation of chromatin silencing at telomere; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; C:Rpd3L complex; P:chromatin organization involved in regulation of transcription; C:Rpd3S complex; P:histone H4 deacetylation; P:protein localization to nucleolar rDNA repeats; P:negative regulation of transcription from RNA polymerase I promoter; P:histone H3 deacetylation,IPR000286 (PRINTS); IPR003084 (PRINTS); IPR023801 (PFAM); IPR023801 (G3DSA:3.40.800.GENE3D); PTHR10625:SF109 (PANTHER); IPR000286 (PANTHER); SSF52768 (SUPERFAMILY),,
RL4_JR_09053,7399,6324,6812,9,3,28,0,0,4,3,2,15,2,13,0,0,14,0,180.2617796,1,1.085424109,0.372492903,2.913945739,0.003568919,0.01650524,19.21186973,1,-0.798436828,1.19797789,-0.666487116,0.505099796,0.65856202,81.85323332,1,-0.630162465,0.741802147,-0.849502078,0.395601975,0.538481901,109.7723662,1,0.351680313,0.606766622,0.579597328,0.562186195,0.690123088,64.78666404,1,-0.93478627,0.761016304,-1.228339347,0.219319606,0.345190582,N,-,,26S proteasome regulatory subunit rpn11,"F:thiol-dependent ubiquitin-specific protease activity; P:protein deubiquitination; P:peroxisome fission; P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:mitochondrion; C:proteasome regulatory particle, lid subcomplex; C:nuclear periphery; C:proteasome storage granule; P:mitochondrial fission",IPR000555 (SMART); IPR024969 (PFAM); IPR000555 (PFAM); G3DSA:3.40.140.10 (GENE3D); PTHR10410 (PANTHER); PTHR10410:SF5 (PANTHER); SSF102712 (SUPERFAMILY),,
RL4_JR_09054,1164,1057,1409,1,4,0,0,0,0,0,0,3,0,4,0,0,11,0,14.779847,1,0.087725893,1.139786135,0.076966976,0.938649816,0.969777845,2.169126192,0,2.348433029,1.305028061,1.799526845,0.071935381,0.156992223,5.61374181,1,-0.299992086,1.19849966,-0.250306359,0.802350439,0.869979206,73.92200746,1,3.322859186,1.753828954,1.894631274,0.058141269,0.134694836,5.521701646,1,-0.378998105,1.195983435,-0.316892436,0.751325221,0.827057386,N,-,,hypothetical protein SPI_04413,,no IPS match,,
RL4_JR_09055,1554,1431,2222,0,0,5,0,0,2,0,3,0,3,0,6,0,4,0,38.01023421,1,0.20317206,0.842061821,0.241279268,0.809338678,0.902858546,5.164604691,1,1.096894137,1.243907733,0.881813102,0.377877885,0.542409926,32.27500134,1,0.27566629,1.029130693,0.267863248,0.788804584,0.860304413,46.71730033,1,1.077908334,0.665118228,1.620626662,0.105097731,0.20350249,24.71796926,1,0.578344752,0.838279871,0.689918454,0.49024547,0.618765319,N,-,,amidohydrolase family,F:hydrolase activity,IPR011059 (G3DSA:2.30.40.GENE3D); IPR013108 (PFAM); IPR011059 (G3DSA:2.30.40.GENE3D); G3DSA:3.20.20.140 (GENE3D); PTHR22642 (PANTHER); PTHR22642:SF4 (PANTHER); IPR032466 (SUPERFAMILY); IPR011059 (SUPERFAMILY),,
RL4_JR_09056,1627,1206,1912,0,0,1,0,0,0,0,0,2,2,6,0,0,0,3,54.93413008,1,-0.540332294,0.772678261,-0.699297912,0.484365872,0.672588388,49.76359398,0,0.879593606,1.133959846,0.775683204,0.437936059,0.599268459,58.17069643,1,0.122725687,0.768837883,0.159624922,0.873176545,0.919879224,72.54480164,1,0.016223894,1.384055196,0.011721999,0.990647412,0.994280833,44.01913059,1,-0.559304051,0.86308042,-0.648032371,0.516964014,0.642634824,N,-,,calcium calmodulin-dependent,,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24347:SF138 (PANTHER); IPR020636 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.2, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_09057,1351,1858,2085,4,0,9,0,0,2,0,4,1,0,1,0,0,0,2,1.481180339,1,1.330666971,1.376880377,0.96643615,0.333825982,NA,0.474141946,1,4.542059494,1.588553705,2.859242014,0.004246547,0.018551379,1.229617267,1,1.890303376,1.253287659,1.508275743,0.131483969,0.237822589,1.418345834,1,1.468270857,1.286180413,1.141574574,0.253630898,0.393250116,1.213586427,1,1.806619768,1.240962191,1.455821766,0.145441897,0.253241481,N,-,,hypothetical protein MGU_09924,,no IPS match,,
RL4_JR_09058,4823,5109,6680,0,6,0,0,0,2,4,0,0,0,0,0,0,0,0,101.294213,1,2.433986547,0.613771499,3.965623281,7.32E-05,0.000649838,4.19230626,1,1.397840653,1.267717007,1.102644081,0.27018176,0.427442915,30.32076639,1,1.152904708,0.862068163,1.337370706,0.181101662,0.302164637,50.37906381,0,1.092770868,0.74816011,1.460610975,0.144122233,0.258228515,10.61414254,0,-1.32173757,1.195806911,-1.105310195,0.269025202,0.401397019,N,-,,hypothetical protein VP1G_04786,,no IPS match,,
RL4_JR_09059,1016,1120,1200,0,0,2,0,0,0,0,0,0,3,5,0,0,0,0,73.03075375,1,7.419300408,1.131096157,6.559389637,5.40E-11,1.99E-09,0.15529621,0,6.152491988,2.025498539,3.037519836,0.002385337,0.015223444,11.46938666,0,4.473907224,1.263584539,3.540647329,0.000399147,0.002878178,45.87699271,1,6.966040219,0.72894069,9.55638821,1.22E-21,1.29E-19,52.66079252,0,7.237306702,0.672349985,10.76419552,5.08E-27,2.06E-24,N,-,,carboxylic acid transport,P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane,IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23508 (PANTHER); PTHR23508:SF9 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.12.2, the major facilitator superfamily (mfs).
RL4_JR_09060,2753,1465,1894,0,0,25,0,0,0,0,4,0,0,2,0,0,0,0,1.068487946,1,1.802210291,1.459351381,1.234939244,0.216853117,NA,0.339706419,0,5.023154302,1.653608187,3.037693174,0.002383966,0.015223444,0.882648203,1,2.369236513,1.245645704,1.902014759,0.057169225,0.12533158,1.018385322,1,1.946639433,1.290882731,1.507990917,0.131556852,0.240928063,0.870760984,0,2.286416951,1.225964987,1.864993678,0.06218229,0.132434937,N,-,,thiol-specific monooxygenase,F:oxidoreductase activity,PR00419 (PRINTS); PF13738 (PFAM); PF13450 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR23023:SF40 (PANTHER); PTHR23023:SF40 (PANTHER); PTHR23023 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_09061,7615,5208,7982,17,33,12,9,1,3,15,20,43,0,15,6,0,26,2,14.70444397,1,0.783486689,1.062550757,0.737364012,0.460901014,0.649176532,2.246127897,1,2.297972425,1.336285654,1.719671553,0.085492162,0.179161834,12.35225317,1,0.601200047,1.22101475,0.492377383,0.622452585,0.735665418,14.77716348,1,0.924456757,1.059576974,0.872477205,0.382948098,0.528205758,5.806710736,1,-0.451534151,1.239523527,-0.36428042,0.71564862,0.799596366,N,-,,hypothetical protein SPI_01886,,IPR003615 (PFAM),,
RL4_JR_09062,560,575,748,1,7,4,0,0,0,0,0,0,4,1,0,0,1,0,1.544835499,1,1.270049168,1.6331609,0.777663222,0.436767579,NA,0.480631826,0,4.522138464,1.735374223,2.605857805,0.00916445,0.03158412,1.271553485,0,1.841822442,1.380044392,1.334611011,0.182003692,0.303209706,1.468471463,1,1.418116498,1.4547271,0.974833354,0.329642929,0.476396611,1.28152614,1,1.728460581,1.384019053,1.248870511,0.211712439,0.335669973,N,-,,ectomycorrhiza-induced ankyrin-domain nacht-domain containing,,IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR002110 (PFAM); IPR001810 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),1.A.4.6.4, the transient receptor potential ca(2+) channel (trp-cc) family.
RL4_JR_09063,396,438,568,0,0,1,0,0,0,0,0,0,0,1,3,0,3,0,0.219071248,1,4.088079537,2.894711307,1.412258116,0.157873974,NA,0.068979542,0,7.322678741,2.277181039,3.215677022,0.001301372,0.015023052,0.180716186,0,4.655666588,1.403263729,3.317741698,0.000907484,0.005322923,0.208595398,1,4.233580178,1.828693705,2.31508435,0.020608316,0.077838716,0.18008477,1,4.560483526,1.300508706,3.506692038,0.000453714,0.002502099,N,-,,terpenoid synthase,F:magnesium ion binding; P:terpenoid biosynthetic process; F:terpene synthase activity,IPR008949 (G3DSA:1.10.600.GENE3D); IPR008949 (SUPERFAMILY),,
RL4_JR_09064,1374,1552,2065,0,0,3,0,0,0,0,2,4,0,0,0,0,0,0,11.88914098,1,-0.167375332,1.146673545,-0.145965984,0.883948242,0.943386938,2.577292688,0,2.099704486,1.28877366,1.629226722,0.103265032,0.207514126,30.7451135,1,1.857736599,0.852084052,2.180226931,0.029240644,0.07511902,7.703160107,0,-0.972471989,1.19583037,-0.81321901,0.416092502,0.560007522,6.569417328,0,-0.629456113,1.196554223,-0.526057324,0.598848379,0.709141512,N,-,,rnase h domain,"P:RNA phosphodiester bond hydrolysis, endonucleolytic; F:nucleic acid binding; F:RNA-DNA hybrid ribonuclease activity; F:metal ion binding",IPR002156 (PFAM); IPR012337 (G3DSA:3.30.420.GENE3D); IPR002893 (PFAM); PTHR10642 (PANTHER); IPR002156 (PROSITE_PROFILES); IPR012337 (SUPERFAMILY); SSF144232 (SUPERFAMILY),,
RL4_JR_09065,488,455,936,0,0,2,0,0,0,0,1,0,0,0,0,0,3,0,2.014414216,1,0.887535612,1.280983299,0.692854944,0.488400587,NA,19.4004885,0,5.736713908,1.009186993,5.684490532,1.31E-08,1.92E-06,1.666286891,1,1.452709952,1.22415531,1.186703958,0.235344413,0.367802847,11.55745015,0,1.981254616,1.1519178,1.719961803,0.085439385,0.174024094,1.63816485,1,1.374400946,1.211775113,1.134204631,0.256708722,0.388110469,Y,-,,Acid sphingomyelinase,F:hydrolase activity,IPR029052 (G3DSA:3.60.21.GENE3D); IPR004843 (PFAM); IPR011160 (PIRSF); PTHR10340:SF34 (PANTHER); PTHR10340 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_09066,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,672.0043666,0,-0.976860914,0.396776955,-2.461990049,0.01381685,0.049157376,145.8467639,0,-3.722787899,1.217787987,-3.057008229,0.002235581,0.015045494,476.1836056,0,-1.949090745,0.501375133,-3.887489861,0.000101286,0.001170573,475.9820248,0,-3.681729413,0.715857132,-5.143106419,2.70E-07,5.58E-06,427.4816815,0,-2.576043779,0.632408434,-4.073386189,4.63E-05,0.00036452,N,-,,bifunctional catalase-peroxidase cat2,P:response to oxidative stress; C:cytoplasm; F:metal ion binding; F:catalase activity; P:cellular oxidant detoxification; P:oxidation-reduction process; C:extracellular region; F:heme binding; P:hydrogen peroxide catabolic process,IPR002016 (PRINTS); IPR000763 (PRINTS); G3DSA:1.10.520.10 (GENE3D); IPR000763 (TIGRFAM); G3DSA:1.10.420.10 (GENE3D); IPR002016 (PFAM); G3DSA:1.10.420.10 (GENE3D); PTHR30555 (PANTHER); PTHR30555:SF0 (PANTHER); IPR002016 (PROSITE_PROFILES); IPR010255 (SUPERFAMILY); IPR010255 (SUPERFAMILY),,
RL4_JR_09067,3708,5899,4960,0,0,16,0,0,0,1,3,0,2,1,0,0,0,0,47.93087067,1,-1.350779259,1.016170165,-1.32928451,0.183754123,0.341628563,32.4485982,0,1.047141621,1.111629244,0.941988191,0.346198686,0.509334753,37.44498013,1,-1.570358139,1.193537527,-1.31571744,0.188268899,0.310732691,61.09169369,1,0.094540023,0.677027171,0.139639925,0.888944494,0.931638858,40.80802066,0,-0.927607717,0.979999338,-0.946539125,0.343873676,0.480834273,N,-,,nuclear distribution pac-1a,P:cell division; P:establishment of mitotic spindle orientation; C:cytoplasm; F:oxidoreductase activity; C:spindle pole; P:mitotic nuclear division; P:oxidation-reduction process; P:transport; C:microtubule associated complex; F:dynein binding; C:microtubule,IPR020472 (PRINTS); IPR001680 (SMART); IPR001680 (PFAM); IPR017252 (PIRSF); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22847 (PANTHER); PTHR22847:SF452 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017252 (HAMAP); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); SSF109925 (SUPERFAMILY); IPR017986 (SUPERFAMILY),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_09068,669,1058,1350,0,0,0,0,0,0,0,0,0,4,0,1,0,0,0,76.45074874,0,1.293644635,0.570196766,2.268768804,0.023282389,0.074290953,119.820588,0,3.730140773,1.410131259,2.645243661,0.008163211,0.029019308,42.34410617,0,0.162971754,0.87437265,0.186387067,0.852141234,0.905729958,43.43824985,1,-0.903469435,1.034645273,-0.873216607,0.382545025,0.527980967,21.24952642,0,-2.323102222,1.215125872,-1.911820228,0.055899256,0.121952159,N,-,,nuclear migration,C:microtubule cytoskeleton; C:cytoskeletal part; P:metabolic process; P:cell cycle,G3DSA:3.30.360.10 (GENE3D); IPR000683 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR22604 (PANTHER); PTHR22604:SF111 (PANTHER); IPR016040 (SUPERFAMILY); SSF55347 (SUPERFAMILY),,
RL4_JR_09069,1682,1698,2479,0,1,0,0,0,0,0,0,2,0,0,0,0,0,0,41.81398306,1,2.773541866,0.554249185,5.004142439,5.61E-07,9.17E-06,2.269140282,0,2.283448498,1.310054067,1.743018517,0.08133038,0.172377999,5.862972803,1,-0.362464067,1.203108378,-0.301272997,0.76320633,0.840772675,6.762104462,0,-0.784471436,1.201491347,-0.652914761,0.513811232,0.648860933,5.752389139,0,-0.43796282,1.197524837,-0.365723371,0.714571505,0.798823481,N,-,,carbohydrate esterase family 9,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; C:membrane; P:metabolic process",IPR013108 (PFAM); IPR011059 (G3DSA:2.30.40.GENE3D); G3DSA:3.20.20.140 (GENE3D); IPR011059 (G3DSA:2.30.40.GENE3D); PTHR11113 (PANTHER); IPR032466 (SUPERFAMILY); IPR011059 (SUPERFAMILY),,
RL4_JR_09070,23785,22037,26662,8,5,15,0,0,0,0,1,4,2,11,0,0,8,4,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_09071,206,164,297,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,57.48978731,0,0.282049756,0.827201885,0.340968463,0.733127323,0.859100276,8.088809739,0,0.449506902,1.303635147,0.344810358,0.730236945,0.831707102,53.77556885,0,0.864486033,0.81116089,1.065739292,0.28654151,0.426042427,37.89440222,0,-0.907931119,1.10196103,-0.823923074,0.409983269,0.553846644,21.31359461,0,-2.327476515,1.28168723,-1.815947339,0.069378451,0.143897015,N,-,,c2h2 finger domain containing,F:DNA binding; P:biological_process; F:metal ion binding,IPR015880 (SMART); PTHR23215 (PANTHER); IPR003656 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY),,
RL4_JR_09072,26,31,40,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46.33317656,0,-1.060043701,1.023724566,-1.035477448,0.300445993,0.486220673,8.401697761,0,0.394892458,1.241683869,0.318029789,0.750462341,0.84759873,53.07281092,0,0.574095919,0.761558568,0.753843424,0.450943246,0.590372355,62.42260731,0,1.010503383,0.581393666,1.73807085,0.08219833,0.169399165,21.27276171,0,-2.324707978,1.199623312,-1.937864956,0.0526397,0.116395931,N,-,,glycosyltransferase family 2 partial,C:integral component of membrane; F:transferase activity,IPR029044 (G3DSA:3.90.550.GENE3D); PF13641 (PFAM); IPR029044 (SUPERFAMILY),,
RL4_JR_09073,2382,2680,4140,0,0,4,0,0,0,0,0,0,0,7,0,0,1,0,13.2225023,1,-1.827219553,1.217418327,-1.500897032,0.133382196,0.272032989,4.269729791,0,1.371450018,1.296268648,1.057998294,0.29005622,0.449334108,17.48485976,0,-0.306731878,1.214547196,-0.25254834,0.800617255,0.869030673,22.30270764,1,-0.737632374,1.168346025,-0.631347528,0.527813317,0.661563486,10.73440045,1,-1.338013431,1.213879159,-1.102262462,0.270347584,0.40271727,N,-,,kinesin family,F:organic cyclic compound binding; F:heterocyclic compound binding; P:mitotic cell cycle process; F:nucleoside-triphosphatase activity; P:microtubule cytoskeleton organization,IPR001752 (PRINTS); IPR001752 (SMART); IPR001752 (PFAM); IPR001752 (G3DSA:3.40.850.GENE3D); IPR027640 (PANTHER); IPR027640 (PANTHER); PTHR24115:SF372 (PANTHER); IPR027640 (PANTHER); IPR027640 (PANTHER); PTHR24115:SF372 (PANTHER); PTHR24115:SF372 (PANTHER); IPR001752 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_09074,4709,3265,2868,0,0,8,0,0,0,1,0,1,1,1,0,0,3,1,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_09075,36,33,55,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_09076,413,278,601,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,65.6490062,0,1.528583601,0.557234537,2.743160196,0.006085099,0.025483695,6.054943176,0,0.867464726,1.262613049,0.687039253,0.492057993,0.647757966,50.78552366,0,1.359950086,0.693683485,1.960476377,0.049940136,0.113007139,43.67449976,1,0.832596598,0.70155685,1.186784218,0.235312745,0.372679735,26.4992315,0,-0.168958212,0.983255325,-0.171835542,0.863566822,0.909372239,Y,-,,immunoglobulin I-set domain-containing,F:oxidoreductase activity; C:membrane; F:binding,IPR031924 (PFAM); IPR029018 (G3DSA:3.30.379.GENE3D); PTHR37842 (PANTHER); PTHR37842:SF2 (PANTHER),,
RL4_JR_09077,120,99,111,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,hypothetical protein XPE_0776,,no IPS match,,
RL4_JR_09078,15,16,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.07669076,0,-1.435149978,1.238110751,-1.159145074,0.246397056,0.42248024,3.24416507,0,1.76776625,1.329869383,1.329278103,0.183756236,0.323306209,8.352237636,0,-0.873018989,1.230851975,-0.709280244,0.478150586,0.614548245,22.95537289,0,0.44146346,1.057111177,0.417613085,0.676230028,0.77948836,8.155516038,0,-0.941556362,1.227490486,-0.767057972,0.443047049,0.576365331,N,-,,c6 zinc finger domain-containing,F:binding,IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); IPR001138 (PFAM); PTHR31001 (PANTHER); PTHR31001:SF50 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09079,318,274,323,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.51475916,0,-1.496485819,1.208679891,-1.238115923,0.215673081,0.383994106,3.349648466,0,1.721544275,1.280687048,1.344234939,0.178872427,0.316584491,16.53064537,0,0.03195046,1.20184945,0.026584411,0.978791207,0.988358486,38.9286767,0,0.994402613,0.862788688,1.152544797,0.249097273,0.388196073,8.551250839,0,-1.009822497,1.207178604,-0.836514575,0.402865481,0.540052031,N,-,,Amid-like NADH,F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process,PR00368 (PRINTS); PR00411 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR22912 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_09080,61,70,56,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,56.02354159,1,0.472940697,0.662850224,0.713495568,0.475539154,0.665021292,7.105104915,0,0.636649954,1.221482468,0.521210881,0.602219875,0.736636807,24.94923743,1,-1.054846238,1.188297828,-0.887695167,0.374704746,0.518664322,107.9634124,0,2.185087163,0.408205973,5.352903451,8.66E-08,1.99E-06,58.89309057,0,1.130469428,0.619282724,1.825449642,0.067933204,0.141790082,N,-,,maintenance of telomere capping 1,C:cytoplasmic part,IPR018814 (PFAM); PTHR28265 (PANTHER),,
RL4_JR_09081,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,66.62513509,0,-4.160327092,1.199337917,-3.468853134,0.000522685,0.003490789,88.38568123,0,1.284708981,0.864942766,1.485310972,0.137461467,0.258141923,55.32332695,0,-3.600813726,1.200231883,-3.000098378,0.002698924,0.012556943,75.83296331,0,-1.730412708,0.87569623,-1.976042203,0.048149998,0.119967179,92.46055058,0,0.075590103,0.547219091,0.138134989,0.890133734,0.928122168,N,-,,hypothetical protein CMQ_1602,,no IPS match,,
RL4_JR_09082,234,370,310,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,775.8302836,0,-0.116684419,0.787947554,-0.14808653,0.88227448,0.94282897,130.8313601,0,-3.566053185,1.189335784,-2.998356926,0.002714396,0.015349618,385.6781585,0,-2.813270252,0.622232069,-4.521255643,6.15E-06,0.000124449,587.8959151,0,-0.87165262,0.33265443,-2.620294639,0.008785383,0.043905231,439.6234426,0,-1.438136436,0.843579462,-1.704802572,0.088231252,0.173787544,N,-, Effector probability:0.771,60S ribosomal l23,F:structural constituent of ribosome; C:cytosolic large ribosomal subunit; F:large ribosomal subunit rRNA binding; P:translation,IPR000218 (SMART); IPR000218 (G3DSA:2.40.150.GENE3D); IPR000218 (PFAM); IPR000218 (PANTHER); PTHR11761:SF10 (PANTHER); IPR000218 (SUPERFAMILY),,
RL4_JR_09083,10041,8661,6697,4,3,10,0,0,0,0,3,6,6,1,2,0,5,3,55.18596266,1,1.037516512,0.669090654,1.550636683,0.120988776,0.25399548,4.841574893,0,1.190020384,1.240229502,0.959516269,0.337298728,0.500351283,12.58210178,1,-1.46435644,1.193225889,-1.227224831,0.219738099,0.348881706,18.52824497,1,-0.939690341,1.143520595,-0.821752004,0.411218055,0.554848455,12.42302929,1,-1.548679034,1.198629377,-1.292041613,0.196342734,0.317617859,N,-,,zip family zinc transporter,P:transmembrane transport; C:membrane; F:metal ion transmembrane transporter activity; P:metal ion transport,IPR003689 (PFAM); PTHR11040:SF60 (PANTHER); PTHR11040 (PANTHER); PTHR11040 (PANTHER); PTHR11040:SF60 (PANTHER),2.A.5.1.14, the zinc (zn(2+))-iron (fe(2+)) permease (zip) family.
RL4_JR_09084,494,605,531,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26.15890966,0,2.110357115,0.66858804,3.156438626,0.001597085,0.008662912,2.255008254,0,2.292359855,1.295744907,1.769144407,0.076869779,0.165262287,5.852801186,0,-0.36030551,1.197935552,-0.300772032,0.763588337,0.841101983,14.77508069,0,0.943360616,1.016629634,0.927929488,0.353444147,0.499737745,20.50594023,0,1.244108957,0.974909733,1.276127333,0.201910511,0.323956435,N,-, Effector probability:0.674,hypothetical protein SPI_08333,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09085,122,147,153,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.825199647,0,-1.070267488,1.221541323,-0.876161508,0.380942239,0.573143552,2.487029347,0,2.151114447,1.310059737,1.641997221,0.10059058,0.203432138,25.95582771,0,1.893552318,0.876394511,2.16061636,0.030724987,0.078254029,28.80010876,0,1.78960432,0.773366053,2.314045611,0.02066522,0.077869503,6.366871827,0,-0.58424291,1.216955643,-0.480085624,0.63116651,0.73446281,N,-,,ydg sra domain-containing,F:histone binding,IPR003105 (SMART); IPR003105 (PFAM); IPR003105 (G3DSA:2.30.280.GENE3D); PTHR14140 (PANTHER); IPR003105 (PROSITE_PROFILES); IPR015947 (SUPERFAMILY),,
RL4_JR_09086,265,228,144,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,60.71073146,0,0.914840624,0.670496598,1.36442247,0.17243464,0.326309857,33.42874017,0,3.246052411,0.851825571,3.810700828,0.000138573,0.006434128,28.09814761,0,0.229080311,1.031222053,0.222144504,0.824201394,0.886456487,33.20686769,0,0.297201507,0.850851611,0.34929887,0.726864946,0.817997129,50.41425687,0,1.302605694,0.680719502,1.913571876,0.055674881,0.121582353,Y,-,,serine carboxypeptidase s28,P:proteolysis; F:serine-type carboxypeptidase activity; F:dipeptidyl-peptidase activity,IPR008758 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR11010:SF11 (PANTHER); PTHR11010:SF11 (PANTHER); PTHR11010 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_09087,1,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.464984767,0,3.002429251,2.031323815,1.478065304,0.1393903,NA,0.148872718,0,6.213460057,1.930841813,3.218005751,0.001290852,0.015023052,0.38521789,0,3.565604273,1.281063929,2.783314861,0.005380656,0.019961071,0.44433021,0,3.14324054,1.433076312,2.193351821,0.028282041,0.089465864,0.37859637,0,3.487514831,1.228581015,2.838652714,0.004530443,0.016518092,N,-,,hypothetical protein SPBR_04208,,no IPS match,,
RL4_JR_09088,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27.66479104,0,-1.730458114,1.140997848,-1.51661821,0.129363105,0.266164997,7.624507168,0,0.534865715,1.226373646,0.436136016,0.662738048,0.783763818,19.76726861,0,-2.116120361,1.192434005,-1.774622622,0.075960219,0.156687299,42.86006459,0,0.492525967,0.676102224,0.728478549,0.466320695,0.608066016,23.34547622,0,-1.268077942,1.125122753,-1.127057416,0.259718206,0.391549559,Y,-,,"Mannan endo-1,6-alpha-mannosidase",,IPR012341 (G3DSA:1.50.10.GENE3D); IPR014480 (PIRSF); IPR005198 (PFAM); PTHR12145:SF23 (PANTHER); PTHR12145 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_09089,25,12,38,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34.17004924,0,-0.17257729,1.005607249,-0.171615002,0.863740213,0.93280284,4.502864761,0,1.294722262,1.254428979,1.032120816,0.302015523,0.462560489,27.32735211,0,0.472143763,1.032261308,0.457387833,0.647392308,0.754831248,13.42687061,0,-1.774168845,1.191846628,-1.488588216,0.136595837,0.248122147,11.43431765,0,-1.429136439,1.191033133,-1.199913251,0.230173033,0.357823117,N,-,,nad-dependent malic enzyme,P:malate metabolic process; F:metal ion binding; F:NAD binding; C:mitochondrion; F:malate dehydrogenase (decarboxylating) (NAD+) activity; P:cellular amino acid metabolic process; P:oxidation-reduction process; P:pyruvate metabolic process,IPR001891 (PRINTS); IPR012302 (SMART); IPR012301 (SMART); IPR001891 (PIRSF); IPR012301 (G3DSA:3.40.50.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR012302 (PFAM); IPR012301 (PFAM); PTHR23406 (PANTHER); PTHR23406:SF34 (PANTHER); IPR016040 (SUPERFAMILY); SSF53223 (SUPERFAMILY),,
RL4_JR_09090,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,104.7368292,0,1.814630826,0.802140104,2.262236754,0.02368278,0.07538202,6.518359656,0,0.761068068,1.24525344,0.611175238,0.541083574,0.688132673,46.86404565,0,0.937072741,0.75171414,1.246581235,0.212551086,0.3407549,19.41812919,0,-2.306421126,1.196894784,-1.927004075,0.053979122,0.128024973,16.51132345,0,-1.959174518,1.194789105,-1.639765972,0.101053836,0.192485861,N,-,,Oligopeptide transporter,P:oligopeptide transport; C:integral component of membrane; F:transporter activity,G3DSA:1.20.1250.20 (GENE3D); IPR000109 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11654:SF118 (PANTHER); IPR000109 (PANTHER); IPR020846 (SUPERFAMILY),2.A.17.2.4, the proton-dependent oligopeptide transporter (pot/ptr) family.
RL4_JR_09091,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35.7515994,0,-3.262273349,1.204651352,-2.708064324,0.00676769,0.027898342,11.53262073,0,-0.062090166,1.241052675,-0.050030243,0.960098288,0.978544397,49.20568746,0,-0.308353052,0.877241455,-0.351503056,0.725210981,0.813882714,47.58172354,0,-1.390265819,1.034744847,-1.343583226,0.179083197,0.304180065,29.07884967,0,-2.775719596,1.203155424,-2.307033273,0.021052965,0.056934101,N,-,,c6 zinc finger domain containing,"P:regulation of transcription, DNA-templated; F:binding",IPR001138 (SMART); IPR007219 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); IPR001138 (PFAM); PTHR31001:SF32 (PANTHER); PTHR31001:SF32 (PANTHER); PTHR31001 (PANTHER); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09092,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29.77727422,0,-1.596406186,1.143906292,-1.395574268,0.162842736,0.313540486,6.947689063,0,0.669016,1.229951796,0.543936764,0.586484989,0.724658332,24.50577362,0,-1.019632017,1.19140268,-0.855824848,0.392094669,0.535559421,108.8834656,0,2.421278878,0.428858744,5.645865715,1.64E-08,4.40E-07,17.7209197,0,-2.0611188,1.193077825,-1.72756442,0.084066346,0.167527107,Y,-,,secreted aspartic ase precursor,,IPR001461 (PRINTS); IPR021109 (G3DSA:2.40.70.GENE3D); IPR021109 (G3DSA:2.40.70.GENE3D); IPR033121 (PFAM); IPR001461 (PANTHER); PTHR13683:SF345 (PANTHER); IPR033121 (PROSITE_PROFILES); IPR021109 (SUPERFAMILY),8.A.32.1.4,The β-Amyloid Cleaving Enzyme (BACE1) Family
RL4_JR_09093,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.726208042,0,0.450508528,1.294607888,0.3479884,0.727848895,0.856109526,0.877299609,0,3.654371756,1.47986845,2.469389598,0.013534377,0.042426438,2.267649858,0,1.007572847,1.249865881,0.806144773,0.420159378,0.561469581,10.63830589,0,2.29055553,1.066955519,2.146814454,0.031808056,0.095311207,2.230865391,0,0.928337476,1.24408915,0.746198514,0.455547505,0.587442953,N,-, Effector probability:0.647,gaba permease,F:putrescine transmembrane transporter activity; F:gamma-aminobutyric acid:proton symporter activity; C:fungal-type vacuole membrane; C:integral component of membrane; P:putrescine transport; P:gamma-aminobutyric acid transport; P:amino acid transmembrane transport,no IPS match,2.A.3.4.3, the amino acid-polyamine-organocation (apc) family.
RL4_JR_09094,5,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,344.5428457,0,-0.983070521,0.579980534,-1.695006061,0.090074271,0.205199036,70.50317291,0,-2.674091077,1.209838759,-2.210287162,0.027085239,0.072894653,181.8810684,0,-5.317862582,1.205438426,-4.411558871,1.03E-05,0.000191474,217.7618701,0,-4.022719583,1.03709986,-3.87881605,0.000104966,0.001109974,197.6757507,0,-2.492025165,0.719037053,-3.465781292,0.000528693,0.002835285,N,-,,DUF221 domain-containing,C:membrane,IPR032880 (PFAM); IPR027815 (PFAM); IPR003864 (PFAM); IPR022257 (PFAM); PTHR13018 (PANTHER); PTHR13018:SF53 (PANTHER); PTHR13018 (PANTHER),1.A.17.5.8, the calcium-dependent chloride channel (ca-clc) family.
RL4_JR_09095,34,13,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,243.9161674,0,-2.032535667,0.631529657,-3.21843265,0.001288932,0.007221916,63.67019487,0,-2.527036104,1.224012004,-2.064551733,0.038965434,0.096977656,245.1420858,0,-1.038568972,0.569463077,-1.823768764,0.068187038,0.143698079,360.2755955,0,-0.192276953,0.488577109,-0.393544743,0.693917184,0.793440033,174.2071121,0,-3.582389479,1.023373182,-3.50057002,0.000464264,0.002547294,N,-,,hypothetical protein CMQ_1188,,no IPS match,,
RL4_JR_09096,28,45,26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.171721385,0,0.421270942,1.194175468,0.352771392,0.724259833,0.854201491,1.707637752,0,2.693426794,1.379665532,1.952231704,0.050910702,0.119520529,35.81270904,0,2.863157956,0.799894109,3.579421232,0.000344356,0.002588167,14.75851891,0,0.569676284,1.183250743,0.481450181,0.630196579,0.745936447,15.9789384,0,2.115770167,0.923161585,2.291874143,0.021912907,0.058819772,N,-,,camk kinase,F:protein kinase activity; P:phosphorylation,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24362 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.1, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_09097,673,1193,1210,0,2,0,0,0,0,0,0,0,0,2,0,0,0,0,0.30709205,1,3.600843588,2.668676226,1.349299534,0.177240775,NA,0.101243462,0,6.770135824,2.27655998,2.973844697,0.002940939,0.0154422,0.257307029,0,4.148053454,1.51262342,2.74229091,0.006101228,0.022052421,0.296429622,1,3.727275888,1.854008985,2.010387176,0.044390227,0.11425872,0.248449703,0,4.093703811,1.400294003,2.923460218,0.003461645,0.013285841,N,-,,---NA---,,no IPS match,,
RL4_JR_09098,9721,11470,12219,3,1,6,0,0,0,6,0,6,8,28,8,0,15,6,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,Y,-,,expression library immunization antigen 1,C:membrane; C:integral component of membrane,PTHR34992 (PANTHER); PTHR34992:SF2 (PANTHER),,
RL4_JR_09099,1714,1891,2059,0,0,6,0,0,0,1,0,0,5,5,0,0,0,1,58.13749582,1,-0.206627026,0.714970456,-0.289000789,0.772580774,0.881498455,11.2454408,0,-0.025703371,1.24676014,-0.020616131,0.983551872,0.991189969,36.79373253,1,-1.704707361,1.208876507,-1.4101584,0.158492916,0.273000652,33.38248495,1,-3.088166791,1.210987798,-2.550122136,0.010768519,0.051527056,28.30410703,1,-2.736751016,1.206174523,-2.268951104,0.023271299,0.061407847,N,-,,aldo-keto reductase,,IPR005025 (PFAM); IPR023210 (G3DSA:3.20.20.GENE3D); IPR029039 (G3DSA:3.40.50.GENE3D); IPR023210 (PFAM); IPR001395 (PANTHER); PTHR11732:SF255 (PANTHER); PTHR11732:SF255 (PANTHER); IPR001395 (PANTHER); IPR001395 (PANTHER); PTHR11732:SF255 (PANTHER); IPR023210 (SUPERFAMILY); IPR029039 (SUPERFAMILY),8.A.5.1.6, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_09100,3004,3734,3745,0,0,0,0,0,1,0,0,1,5,5,1,0,3,0,139.0111628,0,-1.139226149,0.662941334,-1.718441875,0.085716048,0.197925706,27.95740828,1,-1.33961394,1.21677533,-1.100954225,0.27091658,0.428471504,72.08389123,1,-3.982601156,1.201846403,-3.313735555,0.000920585,0.005374859,111.2071906,1,-0.933848162,0.627700526,-1.487728818,0.136822425,0.248355513,86.03099851,1,-1.453907472,0.765266235,-1.89987145,0.057449991,0.124290847,N,-,,cyclic nucleotide-binding domain-containing,,IPR000595 (SMART); IPR006553 (SMART); IPR001611 (PFAM); PF16643 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); IPR000595 (PFAM); IPR014710 (G3DSA:2.60.120.GENE3D); IPR001810 (PFAM); IPR014710 (G3DSA:2.60.120.GENE3D); PTHR24006 (PANTHER); PTHR24006:SF443 (PANTHER); PTHR24006:SF443 (PANTHER); PTHR24006 (PANTHER); IPR000595 (PROSITE_PROFILES); IPR000595 (PROSITE_PROFILES); SSF52047 (SUPERFAMILY); IPR018490 (SUPERFAMILY); IPR001810 (SUPERFAMILY); IPR018490 (SUPERFAMILY),1.A.1.5.16, the voltage-gated ion channel (vic) superfamily.
RL4_JR_09101,1613,1030,708,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1092.130812,0,-1.76034043,0.382073155,-4.607338698,4.08E-06,5.25E-05,318.7184383,0,-1.775613877,0.772702072,-2.297928195,0.021565876,0.061162734,792.4763213,0,-2.875445699,0.528931579,-5.436328273,5.44E-08,1.96E-06,954.817256,0,-2.571215089,0.458619033,-5.606429094,2.07E-08,5.42E-07,752.0330196,0,-3.167110068,0.572906893,-5.528140973,3.24E-08,1.06E-06,N,-,,bax inhibitor family,C:integral component of membrane,PF01027 (PFAM); IPR006214 (PANTHER); PTHR23291:SF32 (PANTHER),1.A.14.1.5, the calcium transporter a (cata) (formerly the testis-enhanced gene transfer (tegt) family.
RL4_JR_09102,2582,2788,4234,0,0,7,0,0,0,0,0,0,3,5,0,1,4,0,37.06417158,1,-0.751752986,1.013894919,-0.74145059,0.45842028,0.646687298,6.712635126,0,0.718601355,1.233909316,0.582377769,0.560312252,0.703627286,23.93365449,0,-0.973231784,1.195948834,-0.813773764,0.415774568,0.557375758,72.30174466,1,0.997978359,0.632033202,1.57899673,0.114336807,0.216526231,28.80372198,1,0.175683671,0.861918107,0.203828728,0.838487342,0.891024805,Y,-, Effector probability:0.786,peptide methionine sulfoxide reductase,P:protein repair; C:nucleus; P:mycelium development; C:cytoplasm; P:cellular response to oxidative stress; F:peptide-methionine (S)-S-oxide reductase activity; P:oxidation-reduction process,IPR002569 (PFAM); IPR002569 (G3DSA:3.30.1060.GENE3D); IPR002569 (TIGRFAM); IPR028427 (PANTHER); PTHR10173:SF6 (PANTHER); IPR002569 (SUPERFAMILY),,
RL4_JR_09103,2531,3135,4006,0,0,10,0,0,0,2,0,2,10,4,0,0,3,4,28.47428692,1,0.894495373,0.735641741,1.215938851,0.224008217,0.394321247,4.226127314,0,1.386223866,1.252917253,1.106396981,0.268554732,0.425823832,40.96464166,1,1.560419968,0.738674929,2.112458279,0.034647161,0.085762312,40.69646844,1,1.830154073,0.574073853,3.188011547,0.001432548,0.010010041,32.84844916,1,0.884949444,0.831686889,1.064041595,0.287309857,0.421840531,N,-,,nucleopolyhedrovirus p10 family,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09104,30,17,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,48.96711283,0,-0.036082482,0.764761181,-0.047181373,0.962368673,0.980885012,26.87270057,0,2.075465333,1.016058372,2.042663484,0.041085762,0.101308181,21.01536668,0,-2.204439922,1.205584496,-1.828523782,0.06747098,0.142604635,24.23912228,0,-2.626503259,1.205640913,-2.178512051,0.029367936,0.091155841,20.70290912,0,-2.285587235,1.209510178,-1.889680035,0.058800766,0.126511991,N,-,,WD domain-containing,C:Seh1-associated complex; C:extrinsic component of fungal-type vacuolar membrane,IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22850 (PANTHER); PTHR22850 (PANTHER); PTHR22850:SF124 (PANTHER); PTHR22850:SF124 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.15.2.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_09105,42,83,111,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.015927524,0,7.869332732,3.973176761,1.980614809,0.047634487,NA,0.00517839,0,11.06015741,3.759614657,2.941832721,0.003262761,0.016208996,0.013285358,0,8.423639838,2.241829332,3.757484888,0.00017163,0.001605896,0.015314398,0,8.001728236,3.972774847,2.014140882,0.043994744,0.113902079,0.012960057,0,8.348352688,1.510574778,5.526606699,3.26E-08,1.06E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_09106,4837,4337,7973,0,0,6,0,0,0,0,0,2,0,2,0,0,2,0,4.722048001,1,-0.342009942,1.211244251,-0.282362489,0.777665575,0.885318973,1.512701129,0,2.868386001,1.352888977,2.120193194,0.033989756,0.08724185,3.917972021,1,0.218715361,1.210303655,0.180711147,0.856594309,0.90874576,13.83141342,1,0.74697383,1.151498063,0.648697427,0.516533968,0.651133768,3.859102877,1,0.137803825,1.209023325,0.113979459,0.909254076,0.941959048,Y,-,,cytochrome p450,F:oxidoreductase activity; F:metal ion binding,IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24305:SF81 (PANTHER); PTHR24305 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_09107,28,23,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.494512781,0,-0.270551183,1.243215154,-0.217622172,0.827723507,0.913496804,1.421416288,0,2.958073049,1.366759883,2.164296074,0.030441634,0.079930018,3.710622898,0,0.297098846,1.224624112,0.242604113,0.808312095,0.874570017,4.282253637,0,-0.125742826,1.229047401,-0.102309176,0.918511272,0.950815523,3.682180061,0,0.205762953,1.232339252,0.166969406,0.867394121,0.9119798,N,-,,siderophore iron transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501 (PANTHER); PTHR23501:SF3 (PANTHER); PTHR23501:SF3 (PANTHER); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.16.8, the major facilitator superfamily (mfs).
RL4_JR_09108,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.493484227,0,-0.269983473,1.323820998,-0.203942582,0.838398369,0.918937779,1.419189064,0,2.960461668,1.448411609,2.043936716,0.040959799,0.101046817,35.60674726,0,3.123898253,0.82497681,3.786649778,0.000152692,0.001499374,8.277454053,0,0.822289006,1.223273512,0.672203721,0.501454012,0.63888535,3.648978877,0,0.218888499,1.279803031,0.171032959,0.86419785,0.90974682,N,-, Effector probability:0.675,nudix domain containing,F:hydrolase activity,IPR020476 (PRINTS); IPR000086 (PFAM); IPR015797 (G3DSA:3.90.79.GENE3D); PTHR16099 (PANTHER); PTHR16099:SF5 (PANTHER); IPR000086 (PROSITE_PROFILES); IPR015797 (SUPERFAMILY),,
RL4_JR_09109,0,1,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,61.28774258,0,-0.070177708,0.613102219,-0.114463308,0.908870531,0.955724256,30.99282644,0,1.496285198,0.981847214,1.52394912,0.127521422,0.24395612,64.25992896,0,0.337124105,0.666034143,0.506166401,0.612739839,0.728256609,36.64746688,0,-3.222869536,1.186279796,-2.716787005,0.006591901,0.034907428,65.02148127,0,0.328013416,0.617929214,0.530826846,0.595538775,0.706468672,N,-,,hypothetical protein CMQ_6212,C:nucleus,SM01050 (SMART); IPR018816 (PFAM); IPR019134 (PFAM); PTHR21737:SF4 (PANTHER); PTHR21737 (PANTHER),,
RL4_JR_09110,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51.64175512,0,-0.588496676,0.768349939,-0.765922721,0.443722286,0.632736655,11.7138586,0,-0.084594149,1.233749426,-0.068566718,0.945334512,0.970453948,30.21548919,0,-2.728218526,1.202158166,-2.269433925,0.023241951,0.062665564,38.85521904,0,-2.203638951,1.155666285,-1.906812529,0.056544868,0.13231264,41.20398929,0,-0.604514964,0.857331735,-0.705112081,0.480740489,0.609709223,Y,-,,---NA---,,no IPS match,,
RL4_JR_09111,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0979198,0,5.249434488,3.917646109,1.339946065,0.18026288,NA,0.030873762,0,8.481719657,2.817301306,3.010583085,0.002607466,0.015349618,0.081123543,0,5.809599503,1.727064346,3.363858165,0.00076861,0.004662319,0.093636807,0,5.388627971,2.612470898,2.062655694,0.039145352,0.106060126,0.08135668,0,5.704969897,1.469176764,3.883106538,0.00010313,0.00071082,N,-,,XLF family,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:DNA recombination; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:double-strand break repair; P:regulation of transcription from RNA polymerase II promoter",IPR015381 (PFAM); IPR009089 (G3DSA:2.170.210.GENE3D); PTHR32235 (PANTHER),,
RL4_JR_09112,32,46,39,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,175.1601669,0,-2.404348326,0.741206435,-3.243830886,0.001179337,0.006727996,50.36878901,0,-2.188931218,1.220156562,-1.793975696,0.072817048,0.15830201,136.3028157,0,-3.869407836,1.209920363,-3.198068199,0.001383516,0.007430616,206.9814599,0,-1.356076188,0.568132825,-2.386899906,0.016991117,0.070796319,149.9856527,0,-1.986202978,0.71722101,-2.769303952,0.00561762,0.019711713,N,-,,c6 zinc finger domain containing,,IPR001138 (SMART); IPR007219 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); IPR001138 (PFAM); PTHR31001 (PANTHER); PTHR31001:SF59 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09113,5,3,4,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,67.07980802,0,2.804369086,0.53803096,5.212281995,1.87E-07,3.46E-06,2.302465246,0,2.262380909,1.297238762,1.743997308,0.081159559,0.172113358,36.52502768,1,2.435572714,0.739365532,3.294138837,0.000987237,0.005695037,6.87321468,0,-0.808089434,1.193300736,-0.677188415,0.498286417,0.636371087,5.858975303,0,-0.464471678,1.192667724,-0.389439295,0.696951208,0.785728517,N,-,,Structure-specific endonuclease subunit SLX4,P:cellular process,IPR018574 (PFAM); IPR027784 (HAMAP),,
RL4_JR_09114,56,21,69,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0.385811203,0,3.271577378,2.291481372,1.42771284,0.153374529,NA,0.125444129,0,6.460635757,2.068056804,3.124012717,0.001784027,0.015023052,6.820631507,1,4.786435161,1.24848142,3.833805682,0.000126176,0.00133277,16.41741383,0,6.058637729,0.856073707,7.07723842,1.47E-12,6.89E-11,15.04512778,0,5.467195663,1.031581536,5.299819233,1.16E-07,2.56E-06,Y,-,,nudix domain-containing,F:hydrolase activity,IPR015797 (G3DSA:3.90.79.GENE3D); PTHR12318:SF0 (PANTHER); PTHR12318 (PANTHER); IPR000086 (PROSITE_PROFILES); IPR015797 (SUPERFAMILY),,
RL4_JR_09115,46,60,48,0,0,7,0,0,0,0,1,29,0,0,0,0,0,0,8.747517675,1,-1.231334334,1.24029601,-0.992774567,0.320819827,0.509383973,2.765792802,0,1.997699382,1.317891098,1.515830393,0.129562245,0.246741118,7.229813396,1,-0.665171008,1.229592178,-0.540968802,0.588529086,0.708221618,16.36694145,0,0.61810045,1.062967672,0.581485653,0.560913185,0.689145249,7.191737725,0,-0.760110716,1.243167963,-0.611430425,0.540914666,0.663126406,N,-,,kinase partial,P:phosphorylation; F:kinase activity,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); PTHR21310 (PANTHER); PTHR21310:SF13 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_09116,3,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37.32334639,0,1.922601203,0.679858792,2.827941957,0.00468483,0.020636524,3.422149265,0,1.690702275,1.315772213,1.284950585,0.198809552,0.342294657,8.802035953,0,-0.948741393,1.222590916,-0.776008868,0.43774375,0.577874263,14.1604888,0,-0.425169043,1.174422762,-0.362023844,0.717334212,0.810694151,24.03836908,0,1.564897071,0.797686712,1.961794082,0.049786463,0.111746384,N,-,,Zn(2)-C6 fungal-type DNA-binding domain,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR021858 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09117,159,118,118,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21.1188341,1,-2.502708917,1.258126259,-1.989235102,0.046675259,0.12633602,6.767043656,0,0.707048203,1.308205563,0.54047179,0.58887171,0.726219462,23.95143922,0,-0.974510844,1.240329302,-0.78568719,0.43205077,0.57278232,41.47661655,0,0.33580172,0.840081486,0.399725176,0.689358947,0.789885077,17.05154244,0,-2.005590367,1.246325141,-1.609203169,0.107571924,0.201774992,N,-,,aldehyde dehydrogenase,"P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",IPR016163 (G3DSA:3.40.309.GENE3D); IPR016162 (G3DSA:3.40.605.GENE3D); IPR015590 (PFAM); PTHR11699 (PANTHER); PTHR11699:SF196 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_09118,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,102.4023733,0,1.73478383,1.066522497,1.626579687,0.103826396,0.227947504,8.37889877,0,0.398816387,1.255562379,0.317639644,0.750758299,0.847743809,21.59044374,0,-2.243264454,1.210379809,-1.853355812,0.063831376,0.136854904,48.96731751,0,0.581222208,0.680718501,0.853836362,0.393195664,0.537987311,21.11479193,0,-2.31397744,1.207172383,-1.916857503,0.055256037,0.120928847,N,-,,amino acid permease family,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PFAM); IPR002293 (PIRSF); PTHR11785:SF369 (PANTHER); IPR002293 (PANTHER),2.A.3.4.2, the amino acid-polyamine-organocation (apc) family.
RL4_JR_09119,1,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,58.64294345,0,-0.033659703,0.704197344,-0.047798679,0.961876689,0.980643887,11.40676468,0,-0.04626355,1.239529902,-0.037323464,0.970227097,0.984659342,62.73671383,0,-0.260927734,0.874107269,-0.298507681,0.765315715,0.842180032,102.7600182,0,1.251019258,0.511393414,2.446295206,0.014433277,0.064920892,48.29200918,0,0.127248398,0.722377716,0.176152165,0.8601744,0.907026224,N,-,,primary-amine oxidase,P:amine metabolic process; F:copper ion binding; F:quinone binding; F:primary amine oxidase activity; P:oxidation-reduction process,G3DSA:3.10.450.40 (GENE3D); IPR015800 (PFAM); IPR015802 (PFAM); IPR015798 (G3DSA:2.70.98.GENE3D); G3DSA:3.10.450.40 (GENE3D); IPR015798 (PFAM); IPR000269 (PANTHER); PTHR10638:SF18 (PANTHER); IPR016182 (SUPERFAMILY); IPR015798 (SUPERFAMILY); IPR016182 (SUPERFAMILY),,
RL4_JR_09120,386,489,367,1,0,0,0,0,0,0,0,0,0,0,0,0,2,3,18.29633209,1,-0.513949464,1.154253073,-0.44526584,0.656127651,0.805885182,3.263782866,0,1.758907092,1.270727283,1.384173549,0.166305321,0.299580433,8.500468139,0,-0.898679926,1.202966569,-0.747053118,0.455031498,0.594034673,9.808628548,0,-1.321351571,1.202143529,-1.099162903,0.271697017,0.413487493,8.414546461,1,-0.986615587,1.211114151,-0.814634678,0.415281454,0.551294706,N,-,,unnamed protein product,C:membrane,no IPS match,,
RL4_JR_09121,441,400,444,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.33532646,0,1.613682515,0.909619292,1.774019667,0.076059897,0.181378732,1.903045265,0,2.537298656,1.373645222,1.847128076,0.06472858,0.144408792,4.893237383,0,-0.101723394,1.232894492,-0.082507786,0.934242927,0.960961201,5.641589796,0,-0.523224758,1.236101356,-0.423286291,0.672086395,0.777215374,4.781408292,0,-0.171385515,1.226680794,-0.139714843,0.888885298,0.927257742,N,-,,hypothetical protein PV04_04406,,IPR010730 (PFAM); PTHR39596 (PANTHER); PTHR39596:SF2 (PANTHER),,
RL4_JR_09122,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.192001038,0,1.084992606,1.246504307,0.870428285,0.384066395,0.576806636,1.06668851,0,3.372406701,1.489017498,2.264853641,0.023521662,0.065462268,10.61863675,0,1.678201661,1.252732737,1.339632638,0.180364807,0.301173233,12.83847425,0,1.251250364,1.213547464,1.031068336,0.302508775,0.448257395,10.10265865,0,1.581845963,1.195460015,1.323211101,0.185765185,0.304644072,N,-,,NAD(P)-binding,,IPR016040 (G3DSA:3.40.50.GENE3D); IPR008030 (PFAM); PTHR14194 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09123,28,74,39,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47.43771259,0,3.42062072,0.660394777,5.179660472,2.22E-07,4.04E-06,10.52588133,0,4.181053562,1.161335436,3.600211818,0.000317958,0.012771315,10.80863535,0,1.582210782,1.211782818,1.30568841,0.191658541,0.315186338,3.42022099,0,0.198584215,1.234301677,0.160887908,0.872181686,0.921126481,2.916124771,0,0.541926628,1.223477296,0.442939668,0.657809374,0.756167111,Y,-,,hypothetical protein AK830_g801,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,IPR032675 (SUPERFAMILY),,
RL4_JR_09124,106,101,106,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.211911975,1,1.620630736,1.46368472,1.107226654,0.268195946,NA,0.385763549,0,4.839822486,1.648049015,2.936698145,0.003317268,0.016335522,1.000262647,0,2.189150721,1.265083593,1.73043958,0.083551767,0.168300456,10.78929925,0,2.720244971,1.175069651,2.314964877,0.020614854,0.077838716,0.983586782,0,2.110634085,1.24397596,1.696683981,0.089756423,0.175953011,N,-,,hypothetical protein F503_04064,P:proteolysis; F:serine-type endopeptidase activity,no IPS match,,
RL4_JR_09125,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26.14076515,0,0.321171726,1.041147142,0.308478709,0.757718099,0.872595179,3.273655761,0,1.754671358,1.321799588,1.327486688,0.184347741,0.323840304,8.424756382,0,-0.885633002,1.22541272,-0.722722221,0.469850561,0.606488249,113.5848254,0,3.355098608,0.484388788,6.92645803,4.32E-12,1.88E-10,74.88812782,0,3.064422417,0.603686896,5.076178457,3.85E-07,6.42E-06,N,-,,ankyrin repeat domain-containing,P:metabolic process; F:peptidase activity,IPR015500 (PRINTS); IPR000209 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); IPR015500 (PANTHER); IPR000209 (SUPERFAMILY),1.I.3.1.1,The Bacterial (Planctomycetes) Nuclear Pore-like Complex (B-NPC) Family
RL4_JR_09126,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,61.66629116,0,1.382442849,0.635395727,2.175719461,0.029576244,0.089340956,6.014737183,0,0.877062943,1.299367709,0.674992103,0.499680782,0.653811326,15.45017194,0,-1.760546797,1.230720355,-1.430501081,0.152573256,0.265839875,109.1463663,0,2.488179478,0.516587273,4.81657139,1.46E-06,2.58E-05,41.39993114,0,1.104549583,0.735344895,1.502083702,0.133075493,0.236480348,N,-,,serine threonine kinase,P:regulation of Rho protein signal transduction; P:nucleoside metabolic process; F:protein kinase activity; F:Rho guanyl-nucleotide exchange factor activity; F:protein serine/threonine kinase activity; P:protein phosphorylation; P:positive regulation of GTPase activity; F:nucleotide binding; F:ATP binding; F:catalytic activity; F:metal ion binding; P:phosphorylation; F:kinase activity,no IPS match,,
RL4_JR_09127,78,78,58,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0.59019957,1,2.658192065,1.914434192,1.388500099,0.164984815,NA,0.190376412,0,5.858587279,1.904044299,3.076917529,0.002091532,0.015023052,0.491527921,0,3.213125608,1.327764117,2.419952134,0.01552255,0.045709802,0.566792919,0,2.791635169,1.464754917,1.905871854,0.056666834,0.132423019,0.483172871,0,3.134627626,1.280377472,2.448205857,0.01435696,0.042012781,Y,-,,hypothetical protein PMG11_05765,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09128,82,105,62,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,542.5744933,1,-0.190458301,0.46075982,-0.41335701,0.679345067,0.824051985,121.746362,0,-0.910803126,0.873960851,-1.04215552,0.297339581,0.457118961,252.1428286,0,-4.781728852,1.209567181,-3.953256113,7.71E-05,0.000980538,354.179734,0,-1.975230565,0.533036808,-3.705617576,0.000210876,0.002006694,333.1697685,1,-1.084862109,0.533299106,-2.034247004,0.041926698,0.097610442,N,-, Effector probability:0.832,40S ribosomal s21,C:nucleus; F:structural constituent of ribosome; P:ribosomal small subunit biogenesis; C:cytosol; P:rRNA processing; C:ribosome; P:translation,IPR001931 (PFAM); IPR001931 (PIRSF); IPR001931 (PANTHER); IPR001931 (PRODOM),,
RL4_JR_09129,9,4,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,55.77302678,0,0.110636893,0.670903132,0.164907403,0.869016865,0.936747787,10.56414919,0,0.06446537,1.239755652,0.051998448,0.95852993,0.978048382,187.4708919,0,2.697712807,0.458927723,5.87829558,4.15E-09,1.92E-07,44.74545567,0,-1.26567678,1.031939715,-1.226502635,0.220009584,0.355278635,104.4667012,0,1.863745843,0.591361387,3.151619103,0.001623679,0.007131711,Y,-,,"endo-beta-1,4-glucanase celB",,IPR001722 (PRINTS); IPR001722 (PFAM); IPR001722 (G3DSA:2.70.100.GENE3D); PTHR33753 (PANTHER); PTHR33753:SF1 (PANTHER); IPR013320 (SUPERFAMILY),,
RL4_JR_09130,11724,7727,5836,4,0,0,0,0,1,1,1,10,0,6,0,0,3,2,0.984663557,1,1.919968049,1.502901395,1.277507663,0.201423077,NA,0.312246204,1,5.144657568,1.677785385,3.06633829,0.00216698,0.015045494,7.312062136,1,3.448152215,1.208047771,2.854317766,0.004312937,0.016976739,0.938515084,1,2.064200897,1.304254617,1.582667119,0.113497357,0.215238946,0.804992789,1,2.399614833,1.233536221,1.945313637,0.051737242,0.115053717,N,-,,high affinity methionine permease,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PFAM); IPR002293 (PIRSF); IPR002293 (PANTHER); PTHR11785:SF203 (PANTHER),2.A.3.8.4, the amino acid-polyamine-organocation (apc) family.
RL4_JR_09131,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.075504815,0,1.792525923,1.49442503,1.199475308,0.23034318,NA,0.340397962,0,5.020018726,1.666186024,3.012880107,0.002587811,0.015349618,0.888753716,0,2.358425384,1.263515051,1.866558996,0.061963198,0.133613508,1.025642236,0,1.93587546,1.316221771,1.47078213,0.141350047,0.254611141,0.882615782,0,2.266543115,1.250717931,1.812193668,0.069956277,0.144818505,N,-,,S-adenosyl-L-methionine-dependent methyltransferase,F:O-methyltransferase activity; F:S-adenosylmethionine-dependent methyltransferase activity; P:aromatic compound biosynthetic process; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR001077 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); PTHR11746 (PANTHER); PTHR11746:SF87 (PANTHER); IPR016461 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY); IPR029063 (SUPERFAMILY),,
RL4_JR_09132,150,70,137,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,22.73776331,0,-2.609425533,1.216352649,-2.145287006,0.031929907,0.095136662,7.21147389,0,0.615147489,1.248368624,0.492761094,0.622181404,0.751292402,18.81021274,1,-2.044554526,1.212650439,-1.686021346,0.091791688,0.181645631,85.74671868,0,1.789283343,0.532214895,3.361956533,0.000773923,0.005963448,22.52904078,0,-1.20858319,1.155372561,-1.046054953,0.295535662,0.430484617,N,-,,uv radiation resistance-associated,P:positive regulation of autophagy; F:molecular_function,IPR018791 (PFAM); PTHR15157 (PANTHER); PTHR15157 (PANTHER); PTHR15157:SF5 (PANTHER); PTHR15157:SF5 (PANTHER),9.B.313.1.6, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_09133,11129,7217,5968,0,3,9,3,0,0,0,1,8,3,17,9,0,2,3,154.2353561,1,0.067389898,0.564640929,0.119350006,0.904998068,0.953626225,23.46109152,1,-1.086686619,1.247884166,-0.870823309,0.383850636,0.548171732,67.16446665,1,-2.77204299,1.229162072,-2.255229846,0.024118905,0.064632027,118.1384836,1,-0.635384984,1.606164963,-0.395591361,0.692406511,0.792428611,75.16796225,1,-1.258045843,0.84373172,-1.4910496,0.135948473,0.240600995,N,-,,3 exoribonuclease family,,PTHR42085:SF1 (PANTHER); PTHR42085 (PANTHER),,
RL4_JR_09134,2893,1573,1669,0,0,1,0,0,0,0,0,2,0,0,2,0,0,0,315.3832474,1,-1.360945304,0.442176843,-3.077830341,0.002085136,0.010834738,71.39265533,0,-2.692203237,1.189468989,-2.263365638,0.023613159,0.065662746,203.171109,1,-3.521923217,1.034058988,-3.405920993,0.000659413,0.004136241,226.1719321,1,-3.468593882,0.859719158,-4.03456623,5.47E-05,0.000641797,195.017894,0,-3.238108072,0.863440758,-3.750237688,0.000176667,0.001120071,N,-,,NLI interacting factor-like phosphatase,F:mitochondrion targeting sequence binding; C:mitochondrial inner membrane presequence translocase complex; F:identical protein binding; P:protein import into mitochondrial matrix; C:integral component of membrane; F:transferase activity; P:regulation of mitochondrial membrane permeability,IPR004274 (SMART); IPR023214 (G3DSA:3.40.50.GENE3D); IPR004274 (PFAM); IPR027111 (PTHR12210:PANTHER); PTHR12210 (PANTHER); IPR004274 (PROSITE_PROFILES); IPR023214 (SUPERFAMILY),3.A.8.1.1, the mitochondrial protein translocase (mpt) family.
RL4_JR_09135,2230,1588,1693,0,0,1,0,0,1,0,7,0,0,3,0,0,0,1,61.72053216,1,0.406427776,0.685327595,0.593041604,0.55315331,0.732212348,9.710763817,1,0.185865245,1.246424883,0.149118689,0.881459979,0.932578309,46.24502564,1,-0.081024998,0.892044985,-0.090830619,0.92762718,0.956881142,58.2278496,1,-0.521418557,0.896132941,-0.581854023,0.560665012,0.689091192,44.21461368,1,0.022239019,0.81919079,0.027147545,0.978342053,0.98545197,N,-,,polarized growth,P:mycelium development; C:membrane,IPR033307 (PTHR13315:PANTHER); IPR033307 (PTHR13315:PANTHER); IPR033308 (PANTHER); IPR033308 (PANTHER); IPR033307 (PTHR13315:PANTHER); IPR033307 (PTHR13315:PANTHER); IPR033308 (PANTHER); IPR033308 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_09136,802,477,496,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,24.51846793,0,-1.193445945,1.180232372,-1.011195739,0.311922755,0.500032587,5.216381353,0,1.082370254,1.271616786,0.851176444,0.394671346,0.558800303,13.63771368,0,-1.580659629,1.221698659,-1.293821203,0.195727187,0.32049221,19.75093205,1,-1.058563188,1.17625497,-0.899943647,0.368150241,0.514495678,36.72796236,0,1.434344224,0.735943212,1.948987641,0.051296901,0.114300423,N,-,,hypothetical protein SPI_08369,C:membrane,PTHR37852:SF1 (PANTHER); PTHR37852 (PANTHER),,
RL4_JR_09137,233,125,103,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,174.2501462,0,-0.519026685,0.568373487,-0.913178916,0.361148451,0.552456227,35.73423455,0,-1.693713862,1.205420599,-1.405081234,0.159997124,0.290439542,130.649499,0,-1.51161826,0.756687346,-1.997678787,0.045751495,0.105678334,123.1448384,0,-2.07251364,0.773935717,-2.677888608,0.007408785,0.038155621,102.7492162,0,-2.751702469,0.988902278,-2.7825828,0.00539281,0.019045066,N,-,,proline oxidase,F:proline dehydrogenase activity; C:mitochondrion; P:oxidation-reduction process; P:proline catabolic process to glutamate,IPR029041 (G3DSA:3.20.20.GENE3D); IPR002872 (PFAM); IPR015659 (PANTHER); IPR029041 (SUPERFAMILY),,
RL4_JR_09138,1752,1076,1122,0,6,6,0,0,0,1,0,0,0,2,7,0,0,0,55.09066579,1,1.093022544,0.596019606,1.833870117,0.066673276,0.165074534,6.342712077,0,0.800362498,1.232724889,0.649262869,0.516168482,0.666410379,16.5141925,1,-1.856730748,1.197944927,-1.549929973,0.121158325,0.223466365,23.06672627,1,-1.332621271,1.149781598,-1.159021221,0.246447535,0.385133708,20.20370112,0,-1.015207531,1.136373885,-0.89337457,0.371656616,0.5079675,N,-,,Kinase binding CGI-121,P:nucleic acid metabolic process; C:nucleus; P:cellular macromolecule metabolic process,IPR013926 (PFAM); IPR013926 (PANTHER); SSF143870 (SUPERFAMILY),,
RL4_JR_09139,50,68,62,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,67.68638502,1,4.960003363,0.648569293,7.647607459,2.05E-14,1.26E-12,67.47724573,0,6.594834278,0.870735282,7.573868216,3.62E-14,1.15E-11,1.411765061,0,1.691485958,1.252453198,1.350538256,0.176843391,0.296368563,1.629225349,0,1.26864959,1.281003668,0.990355939,0.322000174,0.468359684,1.39720843,0,1.604068288,1.245855987,1.28752304,0.197912044,0.319445052,N,-,,alcohol dehydrogenase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); PTHR11695:SF566 (PANTHER); IPR002085 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_09140,100,154,180,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,1.167980244,0,1.673828949,1.460014768,1.146446588,0.251610416,NA,0.370662785,1,4.897347472,1.645321407,2.976529358,0.002915312,0.01539889,0.963660551,0,2.242662992,1.257833645,1.782956753,0.074593343,0.15430793,1.111933909,0,1.819931418,1.303668307,1.396008024,0.162712079,0.282874278,0.95074609,0,2.159672073,1.239779198,1.741981215,0.081511731,0.163556536,N,-,,hypothetical protein SPI_08390,F:arylformamidase activity; P:tryptophan catabolic process to kynurenine,G3DSA:3.50.30.50 (GENE3D); IPR007325 (PFAM); PTHR34861 (PANTHER); PTHR34861:SF1 (PANTHER); SSF102198 (SUPERFAMILY),,
RL4_JR_09141,1261,1159,1426,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17.68499817,0,-0.950765157,1.183431589,-0.803396804,0.421745421,0.613625673,13.82655665,0,2.225498583,1.170482041,1.901352183,0.057255898,0.131475545,63.59775384,1,1.860116582,0.721689736,2.577446357,0.009953333,0.032537146,56.57448581,0,1.931565012,0.621292128,3.108948148,0.001877547,0.012581178,48.05187531,0,1.619491631,0.736741563,2.198181441,0.027936179,0.071122406,N,-, Effector probability:0.634,glutathione S-transferase,C:mitochondrion; F:transferase activity; P:cellular process,IPR010987 (G3DSA:1.20.1050.GENE3D); IPR012336 (G3DSA:3.40.30.GENE3D); IPR004046 (PFAM); IPR004045 (PFAM); PTHR11260:SF282 (PANTHER); PTHR11260 (PANTHER); IPR010987 (PROSITE_PROFILES); IPR004045 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR010987 (SUPERFAMILY),,
RL4_JR_09142,617,872,1195,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,57.6800876,0,4.719273624,0.690269393,6.836857712,8.09E-12,3.53E-10,0.630331072,0,4.131417707,1.541972287,2.679307367,0.007377464,0.0269876,1.63497341,1,1.480119722,1.260073654,1.174629528,0.240142964,0.373285333,91.14175421,0,5.518436855,0.563596616,9.791465557,1.23E-22,1.35E-20,8.973303129,0,2.343401586,1.162957915,2.015035588,0.04390092,0.101298272,N,-,,glyoxalase family,F:dioxygenase activity; P:biological_process; P:oxidation-reduction process; C:cellular_component; F:molecular_function,IPR025870 (PFAM); PTHR40265:SF1 (PANTHER); PTHR40265 (PANTHER),,
RL4_JR_09143,5242,7163,11621,3,0,2,0,0,0,1,0,0,0,0,0,0,3,0,25.53245762,1,1.707425214,0.85806334,1.989859179,0.04660645,0.126248347,55.82696651,0,4.812176081,0.861683719,5.584619939,2.34E-08,3.25E-06,4.71589774,1,-0.048309248,1.207573158,-0.040005235,0.968088952,0.981231383,13.46249378,0,1.251346793,1.026917176,1.218546951,0.223016194,0.358248289,4.627105878,1,-0.123854515,1.201543521,-0.103079508,0.917899869,0.947760164,N,-, Effector probability:0.589,isochorismatase,F:catalytic activity,IPR000868 (G3DSA:3.40.50.GENE3D); IPR000868 (PFAM); PTHR11080:SF17 (PANTHER); PTHR11080 (PANTHER); IPR000868 (SUPERFAMILY),,
RL4_JR_09144,1338,1477,1534,3,2,4,1,0,0,2,0,0,4,0,1,0,3,0,68.01844987,1,-1.107430691,0.740452457,-1.4956135,0.134754403,0.273736658,16.87324978,1,-0.611146573,1.204671202,-0.507314006,0.611934513,0.744739827,65.8640484,1,-1.43166687,1.029314476,-1.390893555,0.164257708,0.280902877,102.4421354,1,0.20776018,0.51244887,0.405426164,0.685164282,0.78654063,43.07252915,1,-3.342497847,1.191013655,-2.806431172,0.005009361,0.017950086,N,-,,cyclohexanone monooxygenase,F:oxidoreductase activity,PF13450 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR23023 (PANTHER); PTHR23023:SF76 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_09145,9591,8141,9423,0,4,0,4,0,0,0,2,2,0,2,0,0,14,0,41.50683353,1,-3.477679882,1.191130458,-2.919646508,0.003504286,0.016308025,13.26093265,1,-0.263610049,1.21219348,-0.217465325,0.827845727,0.896773807,42.24702324,1,-1.953775224,1.193184639,-1.63744584,0.101537347,0.196026716,39.68745512,1,-3.337843576,1.193128706,-2.797555335,0.005149095,0.028629645,33.94225404,1,-2.998811154,1.197516933,-2.504191023,0.012273175,0.037083228,N,-,,fungal specific transcription factor domain containing,F:binding,IPR001138 (SMART); IPR007219 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR007219 (PFAM); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09146,243,188,160,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,106.9797135,0,2.975666754,0.575030337,5.174799588,2.28E-07,4.14E-06,4.519992928,0,1.289163689,1.244673018,1.035744866,0.300321185,0.460406143,11.75310486,0,-1.36605146,1.194954495,-1.143182829,0.25296269,0.388677231,36.84275603,0,0.533787905,0.851631052,0.626783046,0.530801458,0.66399367,11.61258527,0,-1.451353456,1.201232631,-1.208220139,0.226962597,0.354137201,N,-,,salicylate hydroxylase (salicylate 1-monooxygenase),F:FAD binding; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789 (PANTHER); PTHR13789:SF186 (PANTHER); SSF54373 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_09147,1017,1391,964,3,1,4,1,0,0,0,0,2,0,2,0,0,0,0,15.29702056,1,3.133375775,1.015646954,3.085103306,0.002034815,0.010613822,0.450194176,1,4.616832968,1.568643449,2.943201001,0.003248374,0.016208996,1.169796038,1,1.962341364,1.229720252,1.59576242,0.110541847,0.20898705,1.349595578,1,1.540034586,1.255528865,1.226602295,0.219972106,0.355274777,1.155597178,0,1.877613036,1.218413119,1.541031532,0.123309112,0.223535949,N,-,,allantoate permease,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662 (PANTHER); PTHR11662:SF241 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.20, the major facilitator superfamily (mfs).
RL4_JR_09148,39767,24916,19636,2,12,4,0,0,0,0,0,4,0,6,5,0,1,1,314.2594089,1,8.117071098,2.244772465,3.615988358,0.000299204,0.002177435,0.364909839,0,4.919997451,1.633783161,3.01141398,0.002600341,0.015349618,0.943351077,1,2.273420278,1.236878901,1.838029798,0.066058015,0.140291869,1.088040442,1,1.851250915,1.27398994,1.453112663,0.146192476,0.260965941,12.50793099,1,4.398548738,0.85318111,5.155468967,2.53E-07,4.67E-06,Y,-,,isoamyl alcohol,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_09149,1678,1617,1698,0,0,35,0,0,0,0,4,4,5,10,0,0,3,12,0.84570223,1,2.139560069,1.702059794,1.25704166,0.20873855,NA,0.266372366,0,5.373890033,1.784064976,3.012160491,0.002593954,0.015349618,13.69344478,1,4.519466703,1.089984997,4.146356801,3.38E-05,0.000522131,0.803317874,1,2.288801542,1.403515191,1.63076364,0.102940202,0.200205446,0.690123534,1,2.62198019,1.286886383,2.037460512,0.041603915,0.097037466,N,-,,3-oxoacyl-[acyl-carrier ] reductase,F:oxidoreductase activity; P:metabolic process,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); PTHR24322:SF487 (PANTHER); IPR002347 (PANTHER); PTHR24322:SF487 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09150,40960,44090,56290,0,3,20,0,3,0,0,5,0,2,13,2,0,16,2,0.288091021,1,3.693037326,2.595173168,1.42304081,0.154724325,NA,0.093733769,1,6.881221001,2.187414456,3.145824048,0.001656196,0.015023052,0.240100537,1,4.248091762,1.395735395,3.043622579,0.002337482,0.011194261,0.276758582,1,3.826366558,1.716683453,2.228929597,0.025818589,0.085851084,4.094139348,1,5.108015433,1.188419464,4.298158678,1.72E-05,0.000158092,N,-,,3-isopropylmalate dehydrogenase,F:magnesium ion binding; C:cytoplasm; F:NAD binding; P:leucine biosynthetic process; P:oxidation-reduction process; P:branched-chain amino acid biosynthetic process; F:3-isopropylmalate dehydrogenase activity,IPR024084 (SMART); IPR004429 (TIGRFAM); IPR024084 (PFAM); IPR024084 (G3DSA:3.40.718.GENE3D); IPR001804 (PANTHER); PTHR11835:SF35 (PANTHER); SSF53659 (SUPERFAMILY),,
RL4_JR_09151,401,443,509,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.65407626,0,-2.323904105,1.189411341,-1.953827094,0.050721669,0.134390184,5.967502213,0,0.888383934,1.23815665,0.71750528,0.47306238,0.630791386,26.53705172,0,-0.800429377,1.19272704,-0.671091834,0.502162029,0.63461259,17.84133783,0,-2.184420056,1.192762162,-1.83139617,0.067041433,0.146734653,19.10335536,0,-0.913995968,1.126920336,-0.811056416,0.417333274,0.553293099,N,-,,Transcription factor,F:binding,IPR001138 (SMART); IPR015880 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY); SSF57667 (SUPERFAMILY),,
RL4_JR_09152,2694,2531,2601,6,0,2,0,0,0,0,1,1,2,1,0,1,0,0,2.775895961,1,0.424585519,1.227995308,0.345755001,0.729526846,0.857173155,0.886054582,0,3.640028025,1.418921543,2.56534834,0.010307227,0.034285163,2.299158239,1,0.987673277,1.209905511,0.816322653,0.414315621,0.556156371,2.652327023,1,0.565377093,1.214607695,0.465481238,0.64158687,0.75421654,2.267788812,1,0.904903999,1.206107242,0.750268274,0.453093146,0.584999759,N,-,,P-loop containing nucleoside triphosphate hydrolase,F:metal ion binding,IPR027417 (G3DSA:3.40.50.GENE3D); PTHR13884:SF8 (PANTHER); PTHR13884 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_09153,183,232,252,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,111.8291141,0,-4.907454066,2.243182689,-2.187719302,0.028690055,0.087431255,37.69266712,0,-1.7706782,2.290658268,-0.77299972,0.439522546,0.60078963,101.3114717,0,-3.416208945,1.977027089,-1.727952522,0.083996737,0.168995024,109.1318223,1,-4.797077236,2.261952489,-2.120768345,0.033941302,0.098780018,90.88246333,1,-4.419687429,2.240362646,-1.972755365,0.048523441,0.109438879,N,-,,ATP-binding cassette sub-family G member 5,F:ATPase activity; F:ATP binding; C:integral component of membrane,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); IPR013525 (PFAM); PTHR19241:SF277 (PANTHER); PTHR19241 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.1.204.23, the atp-binding cassette (abc) superfamily.
RL4_JR_09154,1650,1642,2633,0,0,8,0,0,0,0,0,0,0,3,0,0,2,0,14.25364331,1,0.853814842,1.12738833,0.757338726,0.448846956,0.637703494,2.151044999,0,2.36059607,1.429221315,1.651665872,0.098602683,0.200431566,5.506386783,0,-0.271977856,1.274406887,-0.213415243,0.831003092,0.890716113,64.15892909,1,3.119789181,1.757800103,1.774825918,0.075926635,0.160224507,5.347999971,1,-0.332849301,1.270562389,-0.261970057,0.793344527,0.860021502,N,-,,hypothetical protein VFPBJ_09823,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09155,9748,8319,10008,0,4,1,0,0,0,0,0,0,2,0,0,0,0,3,11.25012439,1,-1.594172818,1.234388451,-1.291467703,0.196541547,0.35877958,3.642509633,0,1.600669564,1.325895149,1.207236911,0.227340919,0.377050291,20.42593325,0,-0.074996539,1.224547144,-0.061244305,0.951164646,0.972096797,26.8329106,1,1.208707805,0.824349967,1.466255661,0.14257865,0.256413646,9.125026451,1,-1.103680325,1.227208913,-0.899341842,0.368470607,0.504839634,N,-,,hypothetical protein NCU06614,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR021858 (PFAM); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31263 (PANTHER); PTHR31263:SF4 (PANTHER); PTHR31263:SF4 (PANTHER); PTHR31263:SF4 (PANTHER); PTHR31263 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09156,140,175,123,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,41.98792215,1,1.90041592,0.787113145,2.414412631,0.015760602,0.05434277,3.629130871,0,1.605925286,1.330600357,1.206917822,0.227463793,0.377069852,31.56427136,0,0.804855904,1.07711955,0.747229872,0.454924815,0.593971992,30.9323133,1,1.483357854,0.792558624,1.871606477,0.061261067,0.138205949,9.275503224,0,-1.127132818,1.249030924,-0.902405855,0.366841312,0.503424815,N,-,,ammonium transporter,F:ammonium transmembrane transporter activity; C:integral component of plasma membrane; P:organic cation transport; P:ammonium transmembrane transport; P:nitrogen utilization,IPR029020 (G3DSA:1.10.3430.GENE3D); IPR024041 (PFAM); IPR001905 (PANTHER); PTHR11730:SF41 (PANTHER); IPR024041 (SUPERFAMILY),1.A.11.3.3, the ammonium transporter channel (amt) family.
RL4_JR_09157,269,279,322,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.016282912,0,7.839735781,3.971839371,1.973830019,0.048401074,NA,0.005351135,0,11.01554673,3.970178753,2.774571981,0.00552744,0.021974647,0.013566183,0,8.397347712,2.840476149,2.956316924,0.00311337,0.013891475,0.015630153,0,7.974278064,3.97154097,2.007854917,0.044658711,0.114728762,0.013009295,0,8.347323895,1.562419104,5.342563895,9.16E-08,2.07E-06,N,-,,Alpha-ketoglutarate-dependent sulfonate dioxygenase,F:dioxygenase activity; F:oxidoreductase activity; P:oxidation-reduction process,IPR003819 (PFAM); G3DSA:3.60.130.10 (GENE3D); PTHR30468:SF1 (PANTHER); PTHR30468 (PANTHER); PTHR30468:SF1 (PANTHER); PTHR30468 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_09158,428,336,564,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,DUF895 domain membrane,C:membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23294 (PANTHER); PTHR23294:SF24 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.58.5, the major facilitator superfamily (mfs).
RL4_JR_09159,487,550,1005,0,0,3,0,0,0,0,1,0,0,0,1,0,0,0,0.012376897,1,8.237661038,3.992283311,2.063395906,0.039075029,NA,0.004015611,0,11.43115744,3.991119401,2.864148198,0.004181323,0.018371529,0.010235446,1,8.805715205,3.038577053,2.897973312,0.003755825,0.015764501,0.01179869,1,8.381441139,3.992433907,2.099331219,0.035787713,0.10034633,0.009844433,0,8.758432769,1.618956569,5.409924478,6.31E-08,1.56E-06,N,-,,ankyrin repeat,P:biological_process; C:cellular_component; F:molecular_function,IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); PF13857 (PFAM); PTHR24198 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),8.A.28.1.1, the ankyrin (ankyrin) family.
RL4_JR_09160,781,1180,1131,0,0,1,0,0,0,0,0,0,1,2,7,0,0,0,52.44687611,1,-3.815144434,1.201891059,-3.174284728,0.001502063,0.008218704,16.65438871,0,-0.592362269,1.208684168,-0.490088548,0.624071241,0.75281243,43.3766027,0,-3.249903472,1.198558648,-2.711509761,0.006697757,0.023734019,68.67510028,1,-1.921894888,1.025209791,-1.874635714,0.060842856,0.137784371,46.81995373,0,-2.409608054,1.137445164,-2.118438877,0.034137916,0.083188063,N,-,,catechol o-methyltransferase,F:binding; F:transferase activity,PF13578 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10509:SF25 (PANTHER); PTHR10509 (PANTHER); IPR002935 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_09161,2375,2930,4173,0,0,0,0,0,0,0,0,1,1,3,0,0,0,0,0.004235441,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001340044,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003452355,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003983613,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003339785,0,10.24113992,1.835951848,5.578109216,2.43E-08,8.07E-07,N,-,,potassium sodium efflux P-type fungal-type,F:ATP binding; F:cation-transporting ATPase activity; F:metal ion binding; P:cation transmembrane transport; C:integral component of membrane,IPR008250 (PFAM); IPR008250 (G3DSA:2.70.150.GENE3D); IPR004813 (PFAM); PTHR24093:SF334 (PANTHER); PTHR24093 (PANTHER); SSF81653 (SUPERFAMILY),3.A.3.9.5, the p-type atpase (p-atpase) superfamily.
RL4_JR_09162,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.099917247,0,-1.120011366,1.206167901,-0.928570032,0.353111959,0.543731098,2.581983544,0,2.097076346,1.295274115,1.619021272,0.105442686,0.21084152,6.695297309,0,-0.554019695,1.20397474,-0.460158902,0.645402168,0.753167085,11.73564639,0,-0.029793776,1.152803003,-0.025844638,0.979381258,0.987377799,25.89273039,0,2.281027118,0.697583703,3.269897374,0.001075865,0.005059514,N,-,,hypothetical protein SPI_06728,,no IPS match,,
RL4_JR_09163,3309,3289,3406,0,0,4,0,0,0,1,1,2,2,8,4,0,3,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,potassium sodium efflux P-type fungal-type,F:ATP binding; F:cation-transporting ATPase activity; F:metal ion binding; P:cation transmembrane transport; C:integral component of membrane,PR00119 (PRINTS); IPR023299 (G3DSA:3.40.1110.GENE3D); PF13246 (PFAM); IPR023298 (G3DSA:1.20.1110.GENE3D); PF00702 (PFAM); IPR001757 (TIGRFAM); PTHR24093:SF334 (PANTHER); PTHR24093 (PANTHER); IPR023299 (SUPERFAMILY); IPR023214 (SUPERFAMILY),3.A.3.9.5, the p-type atpase (p-atpase) superfamily.
RL4_JR_09164,25443,24165,34467,4,4,35,0,0,3,0,0,1,6,9,0,0,6,2,158.4000549,1,6.521974898,0.847320894,7.697172283,1.39E-14,8.80E-13,0.595458483,1,4.21359214,1.666808286,2.527940481,0.01147338,0.037329975,1.521634527,1,1.583424082,1.332086764,1.18867939,0.234565854,0.36681259,1.75352398,1,1.162577917,1.381711037,0.841404524,0.400121352,0.544227389,5.339627873,1,2.443744501,1.227693511,1.990516754,0.04653404,0.106022883,N,-,,cytochrome P450,F:FMN binding; F:iron ion binding; F:NADPH-hemoprotein reductase activity; F:aromatase activity; P:oxidation-reduction process; F:[methionine synthase] reductase activity; F:heme binding,IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (PFAM); G3DSA:3.40.50.80 (GENE3D); G3DSA:2.40.30.10 (GENE3D); IPR008254 (PFAM); IPR029039 (G3DSA:3.40.50.GENE3D); IPR001433 (PFAM); IPR003097 (PFAM); IPR023173 (G3DSA:1.20.990.GENE3D); IPR023206 (PIRSF); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR19384 (PANTHER); PTHR19384:SF70 (PANTHER); IPR017927 (PROSITE_PROFILES); IPR008254 (PROSITE_PROFILES); IPR017938 (SUPERFAMILY); IPR029039 (SUPERFAMILY); IPR001128 (SUPERFAMILY); SSF52343 (SUPERFAMILY),,
RL4_JR_09165,693,621,1083,0,2,10,0,0,0,0,0,0,2,4,1,0,0,0,21.43710564,1,-0.209961074,1.135933556,-0.1848357,0.853357906,0.926866435,4.378408166,0,1.33514801,1.354064932,0.986029531,0.324118622,0.486273676,19.20148181,0,-0.35482773,1.257608783,-0.282144761,0.777832512,0.852525317,25.14078411,1,0.495359698,0.985772423,0.502509186,0.615309392,0.734410892,64.49415994,0,2.655059053,0.672444014,3.948371906,7.87E-05,0.000568246,N,-,,methyltransferase type 12,F:transferase activity,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF818 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_09166,1737,1663,1743,0,4,15,0,0,0,0,0,0,1,2,0,0,0,0,202.5834538,1,-5.764694065,1.308354324,-4.406064899,1.05E-05,0.000121293,64.82324491,0,-2.552912657,1.269216283,-2.011408686,0.044282307,0.107207936,167.1823429,0,-5.196280999,1.265656252,-4.105602126,4.03E-05,0.000605149,196.845569,1,-4.676719944,1.230795315,-3.799754425,0.00014484,0.0014665,163.1991955,0,-5.264269332,1.275181588,-4.128250739,3.66E-05,0.000297271,N,-,,ferric reductase like transmembrane component,C:membrane,IPR013130 (PFAM); IPR013112 (PFAM); G3DSA:3.40.50.80 (GENE3D); IPR013121 (PFAM); PTHR11972:SF82 (PANTHER); PTHR11972 (PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY); IPR017938 (SUPERFAMILY),5.B.1.5.3, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_09167,6161,5983,5716,0,0,1,0,0,0,1,4,1,8,0,0,0,0,0,0.498639465,1,2.901521993,1.969432913,1.473277903,0.140676116,NA,0.159696774,0,6.11210937,1.906696237,3.205602051,0.001347802,0.015023052,0.413593598,1,3.462383309,1.279993221,2.705001287,0.006830412,0.024111261,0.477059543,1,3.040426431,1.419070303,2.142548135,0.0321494,0.095907726,0.407260235,0,3.381648938,1.232191712,2.744417858,0.006061832,0.020947458,N,-,,UDP-glycosyltransferase 84B2,"F:transferase activity, transferring hexosyl groups; P:metabolic process",IPR002213 (PFAM); G3DSA:3.40.50.2000 (GENE3D); PTHR11926:SF394 (PANTHER); IPR002213 (PANTHER); SSF53756 (SUPERFAMILY),,
RL4_JR_09168,28,43,51,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.039233805,0,6.56842602,3.933856213,1.669716854,0.094975398,NA,0.012350409,0,9.802636223,3.283143771,2.985746865,0.002828867,0.015349618,0.03247374,0,7.128711554,1.941149078,3.672418382,0.000240266,0.001976672,0.037485153,0,6.709174874,3.545096953,1.892522253,0.058421432,0.134982775,0.032577657,0,7.024994113,1.450913835,4.841772091,1.29E-06,1.79E-05,Y,-,,hypothetical protein CMQ_4145,P:suppression by virus of host apoptotic process; C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09169,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.204054119,0,4.1905923,3.144149164,1.332822357,0.182590107,NA,0.063310044,0,7.446192361,2.448598099,3.041002263,0.002357921,0.015201829,0.167318056,0,4.767264583,1.570525924,3.035457428,0.002401711,0.011458494,0.193246636,0,4.343929619,2.074373418,2.094092405,0.03625175,0.101052846,0.168026538,0,4.66094302,1.438300283,3.240591048,0.001192822,0.005514758,N,-,,"alpha-1,3-mannosyltransferase CMT1",F:transferase activity,IPR021047 (PFAM); PTHR34144:SF3 (PANTHER); PTHR34144 (PANTHER),,
RL4_JR_09170,2231,1721,2897,0,0,9,0,0,0,0,0,1,0,0,0,0,1,1,0.491818965,1,2.921590753,2.013128364,1.451268983,0.146704975,NA,0.157603962,0,6.131358016,1.931485491,3.174426132,0.001501331,0.015023052,0.407055319,1,3.486702589,1.299872324,2.682342355,0.00731086,0.025450611,4.481083053,0,4.010748314,1.185450182,3.383312411,0.000716171,0.005582165,0.398832033,1,3.41284572,1.243400266,2.744768369,0.006055362,0.020932244,N,-,,peptidase M61 domain-containing,,IPR001478 (G3DSA:2.30.42.GENE3D); IPR001478 (PROSITE_PROFILES); IPR001478 (SUPERFAMILY),,
RL4_JR_09171,2935,2996,4981,0,0,0,0,0,0,0,2,1,0,0,0,0,0,0,2.413657156,0,0.626578799,1.241356315,0.504753383,0.613732062,0.778424465,0.770594053,0,3.841506273,1.445919917,2.656790482,0.007888845,0.02831592,1.997556886,1,1.190885992,1.211914122,0.982648828,0.325780304,0.468827263,2.304356251,0,0.768565321,1.218886618,0.630547017,0.528336751,0.661902237,1.96674607,0,1.110565787,1.203643127,0.922670319,0.356179038,0.493542187,N,-,,cell division cycle ATPase,F:nucleotide binding; P:cell division; F:ATP binding,IPR003593 (SMART); IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23077:SF85 (PANTHER); PTHR23077 (PANTHER); IPR027417 (SUPERFAMILY),3.A.25.2.1, the symbiont-specific erad-like machinery (selma) family.
RL4_JR_09172,7640,8206,12395,0,2,8,0,0,0,0,0,1,1,5,0,0,0,0,2.054057012,1,0.859493789,1.338569483,0.642098748,0.520809069,NA,0.655734363,0,4.074456419,1.528750713,2.665219636,0.007693806,0.027832988,1.696686814,1,1.426747353,1.252921899,1.138736066,0.254813255,0.390690504,1.957244524,1,1.004359201,1.275746748,0.787271614,0.431122883,0.573355028,1.664479466,0,1.35144323,1.239764316,1.090080761,0.27567757,0.408553191,N,-,,hypothetical protein SAPIO_CDS1649,P:biological_process; C:cellular_component; F:molecular_function,PTHR40619 (PANTHER); PTHR40619:SF2 (PANTHER),,
RL4_JR_09173,38464,30259,29957,1,4,7,0,0,4,0,0,1,0,0,0,0,7,1,1.240868747,1,1.58642871,1.412427963,1.123192653,0.261355682,NA,0.39383725,1,4.809813474,1.614690023,2.978784415,0.002893943,0.015349618,1.02451,1,2.154103055,1.244600553,1.730758556,0.083494837,0.168236786,5.193736537,0,2.677204809,1.169226216,2.289723555,0.022037347,0.080406536,1.011987611,1,2.069530467,1.229872407,1.682719651,0.092429376,0.17965971,N,-,,hydantoinase,F:hydrolase activity,IPR008040 (PFAM); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR022751 (PFAM); IPR024071 (G3DSA:2.40.390.GENE3D); IPR002821 (PFAM); IPR027479 (G3DSA:3.40.1610.GENE3D); IPR029044 (G3DSA:3.90.550.GENE3D); IPR010318 (PFAM); PTHR11365 (PANTHER); PTHR11365:SF10 (PANTHER); IPR029044 (SUPERFAMILY); SSF160991 (SUPERFAMILY); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_09174,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32.3849375,0,-0.192888297,0.862206006,-0.223714861,0.822979181,0.910354463,6.657145014,0,0.730564206,1.228993058,0.594441279,0.552217006,0.698517937,23.81492084,0,-0.963371852,1.19422715,-0.80669063,0.419844744,0.561345508,85.48792496,0,1.286388438,0.61381031,2.095742638,0.036105027,0.100959199,28.70572039,0,0.184302231,0.861209845,0.21400386,0.830544047,0.885744521,N,-,,C6 transcription factor,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); PTHR19444 (PANTHER); PTHR19444:SF23 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09175,283,401,317,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,6.574272794,1,-0.819277356,1.219119304,-0.672023938,0.501568457,0.688159346,2.084309955,0,2.405848423,1.315265869,1.829172702,0.067373741,0.149029065,36.80591156,0,2.571400911,0.763372487,3.368474703,0.000755853,0.004608064,14.2937375,1,1.041279366,1.036744789,1.00437386,0.315198445,0.461516161,101.1892105,0,4.507466656,0.633647637,7.113522394,1.13E-12,1.15E-10,N,-,,glycerol kinase,P:carbohydrate metabolic process; P:glycerol-3-phosphate metabolic process; F:glycerol kinase activity; P:phosphorylation,IPR018484 (PFAM); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR000577 (PIRSF); IPR005999 (TIGRFAM); IPR018485 (PFAM); PTHR10196 (PANTHER); PTHR10196:SF75 (PANTHER); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_09176,2262,3395,3831,5,6,7,0,0,0,2,1,0,10,17,0,0,6,1,13.58124034,1,0.372573069,1.173097919,0.317597588,0.750790204,0.870020808,1.773091845,0,2.639151219,1.353332761,1.950112563,0.051162704,0.119960364,42.48637619,1,3.123797739,0.708590917,4.408464271,1.04E-05,0.000193745,38.7073266,1,3.042771064,0.639357278,4.75910914,1.94E-06,3.30E-05,54.76023159,1,3.695953878,1.314167182,2.812392463,0.004917446,0.017661988,Y,-,,aquaglyceroporin,C:integral component of membrane; P:transport; F:transporter activity,IPR000425 (PRINTS); PR02019 (PRINTS); IPR000425 (PFAM); IPR023271 (G3DSA:1.20.1080.GENE3D); IPR000425 (TIGRFAM); IPR000425 (PANTHER); PTHR19139:SF100 (PANTHER); IPR023271 (SUPERFAMILY),1.A.8.9.18, the major intrinsic protein (mip) family.
RL4_JR_09177,12564,8198,10512,6,13,2,2,0,0,0,5,16,0,1,6,0,4,0,124.3687655,1,1.51381331,0.831983753,1.819522683,0.068831725,0.168880967,9.652217425,1,0.194689773,1.222695375,0.15922999,0.873487676,0.927359163,24.95814007,1,-2.452434434,1.191508898,-2.058259438,0.039565236,0.094863247,193.9788274,1,2.550316292,0.33528842,7.606335739,2.82E-14,1.63E-12,36.10445845,1,-0.322499379,0.838718041,-0.384514656,0.700597035,0.788171664,N,-,,Glycerol-3-phosphate dehydrogenase,P:small molecule metabolic process; P:organophosphate metabolic process; P:oxidation-reduction process; C:cytoplasmic part; F:sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity; P:single-organism cellular process; P:primary metabolic process; P:phosphate-containing compound metabolic process,IPR000447 (PRINTS); IPR006076 (PFAM); IPR031656 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR11985 (PANTHER); PTHR11985:SF15 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_09178,7720,7791,9291,7,5,16,0,0,0,0,2,9,5,20,1,0,6,0,204.6725835,1,0.476574196,0.617060525,0.772329741,0.439919155,0.630066795,63.40563148,0,-0.25949767,1.109995018,-0.233782734,0.815153655,0.888253342,111.2095829,1,-0.68156977,0.669836919,-1.017515981,0.308908034,0.450112973,216.2186695,1,1.083922552,0.68130441,1.59095191,0.111620399,0.212635285,79.07916576,1,-1.700820394,0.843245142,-2.016994003,0.043696139,0.10087173,N,-, Effector probability:0.624,hypothetical protein CMQ_6666,C:integral component of membrane,no IPS match,,
RL4_JR_09179,9228,20233,20809,0,1,4,0,0,0,0,0,0,0,4,0,0,0,0,2.025872711,1,0.879077732,1.330646645,0.660639498,0.508843532,NA,0.639796901,0,4.109676351,1.510410442,2.720900383,0.006510438,0.024625804,1.671675025,0,1.447336077,1.246849586,1.160794448,0.245725502,0.379979376,1.929312578,1,1.024483223,1.268835279,0.80742019,0.419424439,0.562324211,1.660278008,0,1.355013664,1.246949097,1.086663174,0.277185695,0.410307772,N,-,,aspartate aminotransferase,P:metabolic process; F:transferase activity,IPR000796 (PRINTS); IPR015421 (G3DSA:3.40.640.GENE3D); IPR004839 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); PTHR11879:SF15 (PANTHER); PTHR11879:SF15 (PANTHER); IPR000796 (PANTHER); IPR000796 (PANTHER); IPR015424 (SUPERFAMILY),9.A.70.1.1, the aspartate amino transferase (aat) family.
RL4_JR_09180,8406,8501,8976,0,0,3,0,0,0,0,0,2,4,4,0,0,0,2,0.291685499,1,3.675127864,2.511370826,1.463395141,0.143359287,NA,0.093050605,0,6.891296498,2.116199828,3.256448851,0.001128153,0.015023052,0.241520777,1,4.238385262,1.319872217,3.211208787,0.001321779,0.007175167,0.278626787,1,3.816282012,1.608728838,2.372234476,0.017680866,0.072425666,0.238276751,1,4.155574871,1.244214835,3.339917474,0.000838033,0.004141085,N,-, Effector probability:0.559,aldolase,P:phosphorylation; F:kinase activity,IPR015813 (G3DSA:3.20.20.GENE3D); IPR005000 (PFAM); PTHR30502 (PANTHER); IPR015813 (SUPERFAMILY),,
RL4_JR_09181,1189,1238,1397,0,0,3,0,0,0,0,0,0,1,0,0,0,1,0,21.86649957,1,-2.552869232,1.205669959,-2.117386448,0.034227063,0.100332154,6.976323543,0,0.663091155,1.245402152,0.532431354,0.594427274,0.730459253,18.0732491,0,-1.986716003,1.203432534,-1.650874433,0.098764217,0.192138535,28.87262537,1,-0.690023226,1.032397966,-0.668369417,0.503897813,0.64086991,17.76610789,1,-2.064793246,1.204469217,-1.714276477,0.086477961,0.171381749,N,-,,Major facilitator superfamily general substrate transporter,F:binding,IPR007219 (SMART); G3DSA:1.20.1250.20 (GENE3D); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR11662 (PANTHER); PTHR11662:SF259 (PANTHER); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_09182,3407,2735,3451,1,0,3,0,0,0,0,0,0,2,0,1,0,0,0,2.620680998,1,0.507607083,1.278899051,0.396909422,0.691434256,0.832196708,0.829671937,0,3.734764198,1.449113699,2.577274786,0.009958275,0.033466129,2.165147246,0,1.074135946,1.232735075,0.871343704,0.383566514,0.527254228,2.498593757,1,0.651405411,1.245205084,0.523131025,0.600883077,0.722602894,2.148523048,0,0.982990415,1.235636015,0.795533962,0.426302964,0.560924952,N,-,,Hydantoinase oxoprolinase,P:metabolic process; F:hydrolase activity,IPR003692 (PFAM); IPR002821 (PFAM); IPR008040 (PFAM); PTHR11365 (PANTHER); PTHR11365:SF9 (PANTHER),,
RL4_JR_09183,1900,2045,2077,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0.047453146,0,6.29445874,3.929184031,1.601976057,0.109160904,NA,0.015530648,0,9.474937641,3.105551037,3.050968259,0.002281047,0.015100664,0.039734457,0,6.842112287,1.812445425,3.775072171,0.000159961,0.00154377,0.045791044,1,6.421391854,3.220750428,1.993756423,0.04617868,0.11664321,0.038705248,0,6.769722845,1.402228161,4.827832614,1.38E-06,1.88E-05,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662:SF158 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_09184,603,714,698,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38.25771991,0,9.473926365,0.864803696,10.95500217,6.29E-28,2.33E-25,0.023393647,0,8.884036428,2.816249043,3.154563497,0.001607384,0.015023052,0.060046141,0,6.248355269,1.605898221,3.890878755,9.99E-05,0.001160969,4.080812961,0,6.774200233,1.243334825,5.44841188,5.08E-08,1.22E-06,15.50066253,0,8.759184605,0.867542074,10.09655309,5.72E-24,1.81E-21,N,-,,hypothetical protein SPSK_10326,,PTHR37592:SF1 (PANTHER); PTHR37592 (PANTHER),,
RL4_JR_09185,2130,2387,2386,0,5,1,0,0,0,0,0,0,1,7,0,0,2,0,82.20317718,1,-1.984425652,0.9266721,-2.141453974,0.032237446,0.095853321,22.33332725,0,-1.0156557,1.221755503,-0.831308471,0.40579939,0.569695066,66.23985215,0,-2.71706381,1.215464767,-2.235411412,0.025390352,0.067379271,99.66991035,1,-1.336350068,0.786299702,-1.69954289,0.08921694,0.179872864,77.36971494,1,-0.904849204,0.769869343,-1.175328271,0.239863408,0.369034646,N,-,,dead deah box helicase,F:nucleic acid binding; F:ATP binding; F:helicase activity,IPR001650 (SMART); IPR014001 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011545 (PFAM); PTHR24031:SF232 (PANTHER); PTHR24031 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_09186,1721,743,1182,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.441156181,0,-1.341240652,1.199663357,-1.118014187,0.263560934,0.443234406,3.000639343,0,1.880216728,1.27278615,1.477244805,0.139610027,0.26135245,7.803123455,0,-0.775120666,1.198902814,-0.64652502,0.517939399,0.648481137,9.003302431,0,-1.197685962,1.197409314,-1.000231038,0.317198712,0.463372812,7.709158979,0,-0.860276081,1.204431809,-0.714258852,0.475067131,0.605190577,N,-,,hypothetical protein CMQ_5252,,no IPS match,,
RL4_JR_09187,5855,3230,3861,0,9,3,0,0,0,3,0,0,0,3,0,0,0,0,0.133813921,1,4.79944804,3.914733418,1.225996135,0.220200129,NA,0.043971854,0,7.973749026,2.86186201,2.786210165,0.005332828,0.021496969,0.111579379,1,5.35447699,1.849653168,2.894854605,0.003793342,0.015900997,4.140145075,1,5.866431792,1.468521815,3.994786956,6.48E-05,0.000739142,0.107189984,0,5.307272075,1.591416058,3.334936862,0.000853188,0.004199575,N,-,,c6 zinc finger domain containing,"C:nucleus; F:zinc ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_09188,1645,2163,2307,0,0,4,0,0,0,0,0,2,0,4,2,0,0,0,7.665412207,1,8.752372238,1.210762578,7.228809673,4.87E-13,2.44E-11,0.009194001,0,10.23263417,3.417489009,2.994196657,0.002751685,0.015349618,0.023520804,1,7.602821568,1.997858148,3.805486178,0.000141526,0.001415819,0.027113088,1,7.178283977,3.944203294,1.819957908,0.068765415,0.148866758,0.02280449,0,7.539230421,1.431110837,5.268096799,1.38E-07,2.93E-06,N,-,,dimethylaniline monooxygenase,F:nucleotide binding; F:coenzyme binding; F:monooxygenase activity,PR00419 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR020946 (PFAM); PTHR23023 (PANTHER); PTHR23023:SF125 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_09189,661,611,731,0,0,3,0,0,0,0,0,0,0,2,0,0,0,0,7.665030858,1,8.761144838,1.199735948,7.302560909,2.82E-13,1.46E-11,0.008853032,0,10.28426816,3.352162312,3.067950536,0.002155323,0.015045494,0.023080771,0,7.624423634,1.916489159,3.978328601,6.94E-05,0.000910129,0.026633728,1,7.202981497,3.888516563,1.85237259,0.063972338,0.142168553,0.022880937,0,7.537421664,1.41260086,5.335846719,9.51E-08,2.14E-06,N,-,,DUF1479 domain,,IPR027443 (G3DSA:2.60.120.GENE3D); IPR010856 (PFAM); PTHR30613 (PANTHER); PTHR30613:SF1 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_09190,251,301,333,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.805256397,0,6.126982229,1.238092074,4.948729061,7.47E-07,1.19E-05,0.053355458,0,7.6942294,2.504481929,3.072184036,0.002124987,0.015045494,0.138167785,0,5.046635392,1.567437275,3.219672948,0.001283369,0.007011781,0.159421304,0,4.622624017,2.142853479,2.157228229,0.030987886,0.094165438,0.135263594,0,4.974866902,1.400774672,3.551511175,0.000383026,0.002158117,N,-,,hexose transporter,P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR23500:SF145 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.127, the major facilitator superfamily (mfs).
RL4_JR_09191,12452,9386,9326,1,8,3,0,0,0,0,5,0,2,8,1,0,7,2,0.36454804,1,3.353298446,2.325138464,1.442193013,0.149247931,NA,0.116056847,0,6.572328456,2.061625276,3.187935524,0.001432925,0.015023052,0.302211018,1,3.914028762,1.345604715,2.908750778,0.00362876,0.015553585,0.348677668,1,3.492329014,1.583471575,2.20548892,0.027419804,0.088070176,0.299643957,1,3.824405584,1.280914245,2.985684326,0.002829446,0.011296584,N,-, Effector probability:0.594,beta transducin,P:biological_process; C:cellular_component; F:molecular_function,PTHR10622:SF10 (PANTHER); PTHR10622 (PANTHER),,
RL4_JR_09192,7648,7236,4809,5,4,5,0,0,0,1,4,2,3,14,10,0,1,2,0.071062892,1,5.71198323,3.92175107,1.456487964,0.145257775,NA,0.022538964,0,8.93596298,2.851853892,3.133387374,0.001728012,0.015023052,0.058885248,1,6.271856462,1.646426745,3.809374746,0.000139319,0.001412278,0.067950344,1,5.851442975,2.742031236,2.133981152,0.032844324,0.097077583,0.058623456,1,6.177374354,1.357713893,4.549835121,5.37E-06,6.01E-05,N,-,,cytochrome b b6 petb,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09193,1503,978,866,0,0,0,0,0,0,0,0,0,0,3,0,0,1,0,0.007786068,0,8.896911713,4.040984052,2.201669593,0.027688656,NA,0.002502822,0,12.10389348,4.040376809,2.995733828,0.002737853,0.015349618,0.006502266,0,9.448056946,3.305547956,2.858242286,0.00425995,0.016940088,0.007499321,1,9.02784755,4.040049892,2.234588134,0.025444401,0.085851084,0.00645541,1,9.348501478,1.703823852,5.486776974,4.09E-08,1.17E-06,N,-,,methyltransferase type 12,F:methyltransferase activity; F:transferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF818 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_09194,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.10024397,0,1.759834663,1.415525121,1.24323803,0.213780132,NA,0.351008021,0,4.975930298,1.634512357,3.044290414,0.002332299,0.015159195,0.910771831,0,2.323710218,1.233452183,1.883907824,0.059577445,0.129433916,1.050692568,0,1.901406743,1.27118099,1.495779719,0.134711068,0.24531467,0.897998255,0,2.241561858,1.214376537,1.845854057,0.064913399,0.137069482,N,-,,arylsulfatase A,F:sulfuric ester hydrolase activity; P:metabolic process,IPR017849 (G3DSA:3.40.720.GENE3D); IPR000917 (PFAM); PTHR10342 (PANTHER); PTHR10342:SF22 (PANTHER); IPR017850 (SUPERFAMILY),,
RL4_JR_09195,3295,7366,9851,0,0,2,0,0,0,0,0,0,0,1,0,0,1,0,4.927707145,1,-0.40348832,1.208808552,-0.333790094,0.738537959,0.862613513,1.571500775,0,2.813324621,1.339124106,2.100869223,0.035652448,0.090558112,4.08184278,0,0.159514207,1.20682764,0.132176462,0.894844719,0.934441251,4.709041401,1,-0.262864078,1.206853484,-0.217809437,0.827577591,0.892356029,4.031747379,1,0.074773126,1.209575118,0.061817679,0.950708025,0.968110103,N,-,,transcription factor,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:proteolysis; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; F:metallopeptidase activity; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR007219 (PFAM); PTHR31944 (PANTHER),,
RL4_JR_09196,3127,2745,3203,0,5,2,0,0,0,0,1,0,0,1,0,0,5,0,7.067391554,1,-0.923267592,1.202567633,-0.767746916,0.442637557,0.632032937,2.254185877,0,2.292948788,1.302504427,1.76041535,0.078337409,0.167644164,12.34304054,1,0.603939227,1.196175904,0.504891651,0.613634939,0.72889317,6.742158338,1,-0.780234899,1.200074761,-0.650155244,0.515591948,0.650297773,5.752616975,1,-0.437879584,1.200919923,-0.364620135,0.715394983,0.799401192,N,-, Effector probability:0.601,hypothetical protein SPI_03629,P:pseudouridine synthesis; C:membrane; C:integral component of membrane; P:ribosome biogenesis,no IPS match,,
RL4_JR_09197,1295,922,1684,0,1,0,0,0,0,0,0,0,0,0,0,0,3,0,133.8128063,1,0.709101664,0.835676512,0.848536072,0.396139492,0.588545981,15.03527415,0,-0.444816723,1.220759475,-0.364377039,0.715576479,0.821667052,70.62921634,0,-0.280968388,0.77507439,-0.36250506,0.716974643,0.808493126,45.3052899,0,-3.52882159,1.210412753,-2.915386989,0.003552477,0.021346489,38.96875781,1,-3.198018874,1.218746866,-2.624022233,0.008689811,0.02806518,N,-,,hypothetical protein SPI_03630,F:DNA binding; C:membrane; C:integral component of membrane; F:hydrolase activity,no IPS match,,
RL4_JR_09198,179,136,257,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,metalloprotease m41,P:transmembrane transport; F:oxidoreductase activity; C:membrane; P:proteolysis; C:integral component of membrane; P:oxidation-reduction process; F:peptidase activity; F:metallopeptidase activity,no IPS match,,
RL4_JR_09199,358,262,317,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,385.8571933,0,1.814654829,0.487000163,3.726189364,0.000194396,0.001497531,27.17183499,0,-1.298493776,1.230110332,-1.05559131,0.291154973,0.45034698,82.96332289,0,-2.126135611,1.059967294,-2.005850202,0.044872233,0.104218051,205.5783212,0,0.669222088,0.459892243,1.455171507,0.145621787,0.260176565,72.23418642,0,-3.080249366,1.139607781,-2.702903066,0.006873679,0.023281182,N,-,,cellular morphogenesis regulator,C:trans-Golgi network; C:endosome; P:cell morphogenesis; C:mitochondrion; C:cytosol; C:Golgi membrane; P:endoplasmic reticulum organization; P:Golgi to endosome transport,IPR007249 (PFAM); PTHR14042:SF24 (PANTHER); PTHR14042 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_09200,6328,7800,7589,0,2,2,0,0,0,1,0,5,0,7,0,0,3,1,11.71987169,1,-1.653149572,1.200409048,-1.377155208,0.168464267,0.320880572,3.723171422,0,1.568958441,1.260191681,1.245015711,0.213125975,0.359723382,20.7535456,1,-0.124791604,1.195637081,-0.104372477,0.916873763,0.95028972,15.18474968,1,-0.562395396,1.149520197,-0.489243597,0.624669247,0.741648233,16.93267529,1,-0.235473584,1.132550163,-0.207914485,0.835295739,0.888472461,N,-,,trimethylguanosine synthase,P:metabolic process,IPR019012 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR14741 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_09201,2479,2936,2220,0,1,8,0,0,0,1,0,0,0,1,6,0,0,0,19.11533591,1,0.07607313,1.082988816,0.070243689,0.943999701,0.972375702,3.645152348,0,1.599573016,1.317506386,1.214091281,0.224712869,0.373856618,20.53209324,1,-0.091264078,1.227248047,-0.074364818,0.940720102,0.964831356,24.56443167,1,0.260842905,1.062842525,0.245420087,0.806131177,0.875947432,9.311228998,0,-1.132676042,1.239058728,-0.914142338,0.360642059,0.498027711,N,-,,GRASP55 65 family,C:nucleus; P:ER to Golgi vesicle-mediated transport; C:cis-Golgi network; C:cell division site; C:cell tip; C:cytosol; C:Golgi membrane; P:protein secretion; C:COPII vesicle coat,IPR024958 (PFAM); PTHR12893:SF0 (PANTHER); IPR007583 (PANTHER); IPR001478 (SUPERFAMILY),9.A.48.1.1, the unconventional protein secretion (ups) system.
RL4_JR_09202,3681,5363,4151,0,6,16,0,0,0,0,5,4,0,6,2,0,0,1,55.98459509,1,1.562261089,0.737512008,2.118285632,0.034150885,0.100180841,5.651479967,0,0.966905185,1.268373443,0.762319008,0.445869632,0.60708803,32.25118948,1,0.139838353,1.055982178,0.132424917,0.894648207,0.934332417,102.0466131,1,2.137860653,0.708490826,3.017485301,0.002548814,0.016200089,22.1913922,1,-0.112850734,1.013059102,-0.111396003,0.91130233,0.943116893,N,-,,dad family,C:oligosaccharyltransferase complex; F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; C:integral component of membrane; P:protein N-linked glycosylation,IPR003038 (PIRSF); IPR003038 (PFAM); IPR003038 (PANTHER),9.B.142.3.14, the integral membrane glycosyltransferase family 39 (gt39) family.
RL4_JR_09203,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,516.3931873,0,-5.311992794,1.011328607,-5.252489408,1.50E-07,2.86E-06,167.837219,0,-2.924964218,1.109848002,-2.635463788,0.008402239,0.029540627,410.7245942,0,-6.493035805,1.191222238,-5.450734211,5.02E-08,1.83E-06,473.8041559,0,-6.915322937,1.188853955,-5.816797686,6.00E-09,1.74E-07,404.3500811,0,-6.573242044,1.196923364,-5.491781882,3.98E-08,1.17E-06,Y,-,,cytosolic cu zn superoxide dismutase,F:transition metal ion binding; P:superoxide metabolic process,IPR001424 (PFAM); IPR001424 (G3DSA:2.60.40.GENE3D); PTHR10003:SF37 (PANTHER); IPR024134 (PANTHER); IPR001424 (SUPERFAMILY),,
RL4_JR_09204,1,5,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32.10120454,0,0.599921743,0.855660236,0.701121448,0.483227226,0.671386641,3.93235059,0,1.490193915,1.269419202,1.173917893,0.240427915,0.392282406,10.16065485,0,-1.155797397,1.199758139,-0.963358663,0.335367563,0.4785708,21.3542711,0,-0.627635739,1.148375276,-0.546542365,0.584693175,0.709886439,9.967921906,0,-1.23107471,1.195824624,-1.029477639,0.303255282,0.438511816,N,-,,ankyrin repeat,,IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR002110 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24128:SF12 (PANTHER); PTHR24128:SF12 (PANTHER); PTHR24128 (PANTHER); PTHR24128 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_09205,140,106,184,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,123.1374748,0,-0.353043049,0.523779106,-0.674030416,0.500291977,0.687278712,24.33107137,0,-1.139242167,1.197329816,-0.951485674,0.341357888,0.504265111,159.7542195,1,0.375801305,0.50172335,0.749020959,0.453844573,0.593247037,244.5042427,0,1.17128815,0.346788963,3.377524306,0.000731415,0.005683481,69.96776187,0,-2.946169575,1.129278121,-2.608896356,0.009083475,0.029076884,N,-,,hypothetical protein CMQ_3784,"P:RNA phosphodiester bond hydrolysis, endonucleolytic; C:integral component of membrane; P:rRNA transcription; F:endoribonuclease activity",IPR026770 (PANTHER),,
RL4_JR_09206,1178,962,1477,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,1.852149814,0,1.008259536,1.350558281,0.746550186,0.455335127,NA,0.586532809,0,4.235043636,1.536576939,2.756154625,0.005848534,0.022883209,1.531598953,0,1.573369781,1.253732683,1.254948366,0.209497505,0.337033647,1.767468323,1,1.150721321,1.280080696,0.898944359,0.368682299,0.514901709,1.521915036,0,1.480366297,1.252761981,1.18168201,0.237331899,0.366197116,N,-, Effector probability:0.572,hypothetical protein SPBR_00989,C:membrane,IPR003807 (PFAM); PTHR38646 (PANTHER); PTHR38646:SF1 (PANTHER),,
RL4_JR_09207,183,518,308,0,0,41,0,1,0,0,3,1,2,8,9,0,1,4,0.070785388,1,5.717526495,3.921808651,1.457880025,0.144873615,NA,0.022870891,1,8.915580374,2.911900027,3.0617742,0.002200294,0.015045494,0.059082047,1,6.2681074,1.718199453,3.648067394,0.00026422,0.002107933,0.068125404,1,5.847889243,2.814449147,2.077809524,0.037726906,0.10337887,0.058197163,1,6.184454381,1.394024374,4.436403334,9.15E-06,9.27E-05,N,-,,Halotolerance 9,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09208,6422,5346,5471,0,2,21,0,0,0,3,1,8,8,23,1,1,16,9,7.530441521,1,0.953126149,1.149678538,0.82903709,0.40708342,0.598483819,1.187697798,0,3.217415137,1.37850718,2.333985042,0.019596505,0.05654385,9.572458533,1,1.531169305,1.195701316,1.280561696,0.200347661,0.325886845,47.67294492,1,4.256008474,0.516992561,8.23224316,1.84E-16,1.34E-14,10.38618318,1,1.4257742,1.122805998,1.2698313,0.204144729,0.326534815,N,-,,hypothetical protein SPSK_03191,P:biological_process; C:cellular_component; F:molecular_function,PTHR38702 (PANTHER); PTHR38702:SF1 (PANTHER),,
RL4_JR_09209,1198,1598,1478,0,0,2,0,0,0,0,1,1,0,2,0,0,2,0,55.56607587,1,0.143639395,0.638380481,0.225005932,0.82197466,0.909928731,19.86947351,0,0.990263197,1.132775008,0.874192306,0.382013535,0.546458593,66.07556134,1,0.818852428,0.635942686,1.287619852,0.197878325,0.322959885,56.91624528,1,0.043756865,0.684872846,0.063890495,0.94905742,0.970207017,33.91835803,1,-1.710286071,1.121834652,-1.524543807,0.127372922,0.22886439,N,-,,karyogamy,,IPR013889 (PFAM); PTHR37271 (PANTHER),,
RL4_JR_09210,81,48,102,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37.28340876,0,1.530404221,0.962925676,1.589327462,0.111986482,0.240290826,2.281699518,0,2.275521984,1.396029571,1.629995547,0.103102438,0.207352052,5.869228963,0,-0.363987554,1.258501169,-0.289223056,0.77241069,0.847810587,10.77972643,0,0.157153203,1.210863352,0.129786076,0.896735679,0.936122152,5.721163452,0,-0.430066037,1.255833302,-0.342454716,0.732008717,0.812228851,N,-,,helicase musn,P:DNA double-strand break processing; P:mitotic cell cycle process; P:recombinational repair; P:meiotic cell cycle process; P:negative regulation of cell cycle; P:telomere maintenance; C:chromosome; F:ATP-dependent DNA helicase activity; P:mitotic recombination; P:cellular developmental process; P:maintenance of rDNA; F:nucleotide binding; P:DNA duplex unwinding; C:membrane; P:nuclear division; C:nuclear lumen; P:replication fork processing; P:nuclear chromosome segregation; P:regulation of reciprocal meiotic recombination,IPR018982 (SMART); IPR014001 (SMART); IPR001650 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR032284 (PFAM); IPR018982 (PFAM); IPR011991 (G3DSA:1.10.10.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR004589 (TIGRFAM); IPR011545 (PFAM); PTHR13710 (PANTHER); PTHR13710 (PANTHER); PTHR13710:SF70 (PANTHER); PTHR13710 (PANTHER); PTHR13710:SF70 (PANTHER); PTHR13710:SF70 (PANTHER); IPR002121 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR011991 (SUPERFAMILY); IPR010997 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),2.A.16.2.2, the telurite-resistance/dicarboxylate transporter (tdt) family.
RL4_JR_09211,257,379,435,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,8.567461586,0,-1.201139156,1.24105179,-0.967839671,0.333124448,0.52288651,2.704795686,0,2.029938158,1.318082173,1.540069504,0.123543412,0.23846423,7.061185005,0,-0.630961743,1.227615702,-0.513973341,0.60727063,0.723973614,8.149480051,0,-1.053915907,1.230324666,-0.856616092,0.391657089,0.536607311,7.000312179,1,-0.721111801,1.237897272,-0.582529599,0.56021001,0.678646369,N,-,,duf1275 domain,F:nucleic acid binding; F:ATP binding; P:DNA repair; F:ATP-dependent 3'-5' DNA helicase activity; P:DNA replication; P:DNA duplex unwinding; C:integral component of membrane; P:DNA recombination; C:intracellular,IPR010699 (PFAM); PTHR37488 (PANTHER); PTHR37488:SF2 (PANTHER),9.B.143.5.1, the 6 tms duf1275/pf06912 (duf1275) family.
RL4_JR_09212,14913,21125,26177,0,4,3,0,0,2,0,0,0,0,2,0,0,0,0,1061.069325,1,-6.400658467,1.057795633,-6.05094053,1.44E-09,3.79E-08,335.6786239,1,-4.925415869,1.225480282,-4.019171863,5.84E-05,0.003127808,939.9000922,0,-3.585537509,0.605436876,-5.92223178,3.18E-09,1.51E-07,1051.580331,1,-4.020769939,0.597366464,-6.730826357,1.69E-11,6.92E-10,889.2991697,0,-3.986661357,0.842550183,-4.731660428,2.23E-06,2.85E-05,N,-,,nitrate transporter,F:nitrite transmembrane transporter activity; F:nitrate transmembrane transporter activity; P:transmembrane transport; P:nitrite transport; C:integral component of membrane; P:nitrate transport,IPR004737 (TIGRFAM); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662:SF272 (PANTHER); PTHR11662 (PANTHER); PTHR11662 (PANTHER); PTHR11662:SF272 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.8.5, the major facilitator superfamily (mfs).
RL4_JR_09213,4306,4309,4932,0,1,0,0,0,0,1,3,3,0,4,2,0,7,0,1.462452101,1,1.34950566,1.440578265,0.936780523,0.348871466,NA,0.463141183,0,4.576013025,1.615708609,2.83220192,0.004622865,0.019644263,1.20491977,1,1.920346227,1.274169065,1.507136125,0.131775769,0.238061721,1.390426659,1,1.497507522,1.316013985,1.137911557,0.255157415,0.3947122,1.188853698,1,1.837130916,1.260908581,1.45698978,0.145119201,0.252810033,N,-,,pre-mRNA splicing factor,P:DNA repair,IPR011257 (G3DSA:1.10.340.GENE3D); PTHR15074 (PANTHER); IPR011257 (SUPERFAMILY),,
RL4_JR_09214,4149,4360,5676,5,1,8,0,0,0,0,0,1,0,0,7,0,0,1,499.1968149,1,-0.400792092,0.358383334,-1.118333509,0.263424581,0.443234406,159.3276162,0,-0.835414676,0.851680241,-0.980901794,0.326641173,0.489019664,361.1211758,1,-0.909855089,0.436046017,-2.086603371,0.036924002,0.089687764,418.5973258,1,-1.064346906,0.400597435,-2.656898957,0.007886308,0.040205873,323.8795066,1,-1.309739224,0.57607113,-2.273572056,0.022991729,0.060844552,N,-,,cytochrome c1,"F:electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity; C:mitochondrial respiratory chain complex III; P:mitochondrial electron transport, ubiquinol to cytochrome c; F:heme binding",IPR002326 (PRINTS); IPR009056 (G3DSA:1.10.760.GENE3D); G3DSA:1.20.5.100 (GENE3D); IPR002326 (PFAM); PTHR10266:SF3 (PANTHER); IPR002326 (PANTHER); IPR009056 (PROSITE_PROFILES); IPR009056 (SUPERFAMILY); IPR021157 (SUPERFAMILY),3.D.3.3.1, the proton-translocating quinol:cytochrome c reductase (qcr) superfamily.
RL4_JR_09215,3709,4946,4001,0,1,4,0,0,0,0,0,1,3,2,4,0,2,0,210.6676261,1,-1.60609094,0.622126445,-2.581614965,0.009833923,0.037418445,61.0396353,0,-1.309582998,1.130215695,-1.158701834,0.246577743,0.399657312,146.0832086,1,-3.926180216,1.216331751,-3.227885987,0.001247087,0.006880384,183.1203308,1,-2.574289603,0.791823923,-3.251088438,0.001149641,0.008308433,175.8375134,1,-1.261156991,0.630052913,-2.001668376,0.04532041,0.103957668,N,-,,phospho-2-dehydro-3-deoxyheptonate aldolase,C:nucleus; P:aromatic amino acid family biosynthetic process; C:mitochondrion; F:3-deoxy-7-phosphoheptulonate synthase activity; P:chorismate biosynthetic process; P:cellular amino acid biosynthetic process,IPR006219 (TIGRFAM); IPR006219 (PIRSF); IPR013785 (G3DSA:3.20.20.GENE3D); IPR006218 (PFAM); IPR006219 (PANTHER); PTHR21225:SF0 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_09216,4575,7367,9739,0,0,1,0,0,0,0,1,6,4,1,0,0,3,3,5.796975616,1,-0.637618677,1.238881537,-0.514672838,0.606781657,0.773215364,1.831863415,0,2.592113636,1.341611161,1.932090095,0.053348387,0.12416472,32.12153166,1,2.74090382,0.776441251,3.530085266,0.000415426,0.002968081,61.71886203,1,3.100516708,0.63400014,4.890403822,1.01E-06,1.85E-05,31.76770774,1,3.170419726,0.685132771,4.62745304,3.70E-06,4.40E-05,N,-,,integral membrane,C:integral component of membrane; C:endoplasmic reticulum,IPR006838 (PFAM); PTHR10989 (PANTHER); PTHR10989:SF16 (PANTHER),9.B.203.1.3, the aig1 lipid hydrolase (aig1) family.
RL4_JR_09217,5036,10266,9170,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,37.05962358,0,-0.222602603,0.896495623,-0.248303056,0.803899935,0.901349047,6.764909871,0,0.707385827,1.250274122,0.565784586,0.571540226,0.712016021,68.53182865,0,1.664139253,0.616876382,2.697686768,0.006982311,0.024502222,34.03256972,1,-0.641119703,1.042299953,-0.615100961,0.538488047,0.67004934,36.11664467,0,0.184469237,0.883165394,0.20887281,0.834547531,0.888236492,N,-,,cyclophilin-type peptidyl-prolyl cis-trans isomerase,"C:nucleus; F:peptidyl-prolyl cis-trans isomerase activity; F:zinc ion binding; P:protein peptidyl-prolyl isomerization; P:protein folding; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR001680 (PFAM); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR11071:SF213 (PANTHER); IPR024936 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR029000 (SUPERFAMILY),3.D.1.8.1, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_09218,1665,2769,1871,0,1,0,0,0,0,0,3,4,0,0,0,0,1,0,89.91958075,1,-1.628520653,0.772606581,-2.107826534,0.035045997,0.102036132,23.86883286,0,-1.111509754,1.209753754,-0.918790085,0.35820538,0.522292546,88.51934737,1,-1.345736994,0.85888633,-1.56683946,0.117152221,0.218063815,107.5272933,0,-1.119049929,0.68122324,-1.642706624,0.100443648,0.19644426,97.84118418,1,-0.613502745,0.628667855,-0.975877388,0.329125229,0.465743248,N,-,,c6 zinc finger domain containing,"C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PR00755 (PRINTS); IPR001138 (SMART); IPR021858 (PFAM); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR12526 (PANTHER); PTHR12526:SF232 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09219,33463,32546,49562,9,12,70,0,0,2,0,6,4,5,24,2,0,20,3,177.0117541,1,-0.043573789,0.417484929,-0.104372125,0.916874043,0.960557139,136.580334,1,1.417658946,0.684695852,2.070494427,0.038406067,0.095915671,147.3801406,1,-0.185025715,0.513196842,-0.360535568,0.718446663,0.809604225,228.9492414,1,0.744283374,0.489893468,1.51927597,0.128693046,0.236826079,102.8141755,1,-2.021975063,0.833337634,-2.426357552,0.015251236,0.044031584,N,-,,actin binding,F:actin binding; C:intracellular,PR00499 (PRINTS); IPR001452 (PRINTS); IPR001452 (SMART); IPR002108 (SMART); G3DSA:2.30.30.40 (GENE3D); G3DSA:2.30.30.40 (GENE3D); IPR029006 (G3DSA:3.40.20.GENE3D); IPR002108 (PFAM); IPR001452 (PFAM); PTHR10829 (PANTHER); PTHR10829 (PANTHER); PTHR10829:SF25 (PANTHER); PTHR10829:SF25 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR002108 (PROSITE_PROFILES); SSF55753 (SUPERFAMILY); IPR001452 (SUPERFAMILY); IPR001452 (SUPERFAMILY),8.A.34.1.1, the endophilin (endophilin) family.
RL4_JR_09220,3702,3116,1896,0,4,0,0,0,0,0,0,0,0,0,0,0,0,1,251.6913186,1,-1.237512298,0.47599093,-2.599865293,0.009326036,0.035870723,55.7534531,0,-2.33548225,1.194974394,-1.95442033,0.050651528,0.119092862,215.7907506,0,-1.153743012,0.547567256,-2.107034341,0.035114603,0.086410698,314.4352468,0,0.040558368,0.474393015,0.085495289,0.931867641,0.959907346,207.7457342,1,-0.655635734,0.515545677,-1.271731611,0.203468495,0.325761941,N,-, Effector probability:0.801,hypothetical protein CMQ_3502,,PTHR31568 (PANTHER),,
RL4_JR_09221,6420,5600,7238,13,4,9,0,0,2,2,0,1,0,9,0,0,6,0,305.1873994,1,-0.560671966,0.430369266,-1.30276953,0.192653456,0.353580854,54.95179533,1,-2.314583153,1.200344313,-1.928266021,0.053822046,0.125065828,161.9619915,1,-2.566243376,0.864327228,-2.969064602,0.002987078,0.013536785,176.369928,1,-3.091968101,0.869248318,-3.557059629,0.000375029,0.003270602,185.0236191,1,-1.590521383,0.609042667,-2.611510605,0.009014319,0.028910352,N,-,,monothiol glutaredoxin-4,F:glutathione disulfide oxidoreductase activity; P:cellular iron ion homeostasis; C:nucleus; F:protein disulfide oxidoreductase activity; F:electron carrier activity; C:cytosol; P:cell redox homeostasis; P:oxidation-reduction process,IPR013766 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR002109 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); IPR004480 (PANTHER); PTHR10293:SF40 (PANTHER); IPR002109 (PROSITE_PROFILES); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY),,
RL4_JR_09222,916,1204,1170,5,3,9,0,0,0,4,0,2,0,2,2,0,0,0,4.572684417,1,-0.295536355,1.241194025,-0.238106492,0.8117985,0.904486774,1.476649743,0,2.903251352,1.393406368,2.083564004,0.037199844,0.093689182,3.80491743,1,0.26110974,1.231726479,0.211986788,0.832117342,0.891371915,4.387276138,1,-0.160535514,1.236269377,-0.129854801,0.896681305,0.936122152,3.728274768,0,0.187485024,1.226024347,0.152921126,0.878460476,0.919224092,N,-,,---NA---,,no IPS match,,
RL4_JR_09223,985,1110,989,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,5.093356525,0,-0.450806725,1.220478643,-0.369368795,0.711852854,0.844759376,1.638571662,0,2.753183632,1.360272474,2.023994225,0.042970746,0.104681081,4.225374346,1,0.110130071,1.2164806,0.090531711,0.927864695,0.956881142,4.872769918,1,-0.311723319,1.217666329,-0.256000607,0.797950369,0.869952351,4.137013233,0,0.037555905,1.208268666,0.031082413,0.975203816,0.983362079,N,-,,diphenol oxidase,F:metal ion binding; C:membrane,IPR008972 (G3DSA:2.60.40.GENE3D); IPR011707 (PFAM); IPR001117 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); IPR011706 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); PTHR11709:SF114 (PANTHER); PTHR11709:SF114 (PANTHER); PTHR11709 (PANTHER); PTHR11709 (PANTHER); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY),2.A.108.1.7, the iron/lead transporter (ilt) family.
RL4_JR_09224,319,639,294,0,0,2,0,0,0,0,0,0,0,7,0,0,0,0,12.24333509,1,4.496888379,0.94500187,4.758602622,1.95E-06,2.75E-05,0.248346432,0,5.474786663,1.783836404,3.069108047,0.002146989,0.015045494,0.65024526,0,2.809029516,1.298790881,2.162803541,0.030556293,0.07788316,0.750519702,1,2.386377876,1.390693516,1.715962467,0.086168912,0.175157646,0.647755264,0,2.712965074,1.27757044,2.123534631,0.033709077,0.082400869,Y,-,,hypothetical protein CMQ_3458,,no IPS match,,
RL4_JR_09225,82,102,86,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,156.8078856,0,-0.625844169,0.92839811,-0.674111852,0.500240205,0.687278712,37.86708125,0,-0.451174001,1.134726767,-0.39760585,0.690920748,0.804312801,142.3996124,0,-0.02572964,0.545467936,-0.047169849,0.962377858,0.977910178,183.0979295,0,-0.003988243,0.550390137,-0.007246211,0.994218411,0.995770826,98.55532392,0,-0.897872496,0.644657525,-1.392789909,0.163683331,0.276540644,N,-,,fungal specific transcription factor domain-containing,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR007219 (PFAM); PTHR31001:SF35 (PANTHER); PTHR31001 (PANTHER),,
RL4_JR_09226,6306,8221,12314,0,3,1,0,0,0,0,1,1,0,7,0,0,0,2,66.42134948,1,-3.01817724,1.165047607,-2.590604214,0.009580761,0.036660341,46.99398929,0,1.384214942,0.904453934,1.530442723,0.125907181,0.241873282,56.42686822,1,-2.451620625,1.20978084,-2.026499795,0.042713594,0.100377978,76.07815861,1,-0.842293702,0.731223167,-1.151896903,0.249363441,0.388541495,47.58205907,1,-3.486156907,1.207460015,-2.887182071,0.003887092,0.014576596,N,-,,f-box domain containing,,IPR001810 (SUPERFAMILY),,
RL4_JR_09227,8123,7526,9539,2,0,14,0,0,0,0,0,3,3,7,0,0,0,0,131.7529658,1,-0.727398856,0.567709584,-1.281286905,0.200092911,0.363554112,28.22912146,0,-1.353615136,1.202145272,-1.125999633,0.260165675,0.41628153,105.9924476,1,-0.882438388,0.690759488,-1.277490073,0.201429283,0.326910879,107.7697604,1,-2.107175789,0.863770274,-2.4395095,0.014707216,0.065631958,76.55448827,0,-3.168391307,1.136484611,-2.787887558,0.005305295,0.018814752,N,-,,dynamin central region,"F:GTP binding; P:mitochondrion inheritance; C:peroxisome; P:peroxisome fission; F:protein homodimerization activity; P:mitochondrial membrane fission; C:cell division site; F:GTPase activity; P:protein homooligomerization; P:establishment of mitochondrion localization, microtubule-mediated; C:mitochondrial outer membrane; P:chronological cell aging",IPR022812 (PRINTS); IPR003130 (SMART); IPR001401 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000375 (PFAM); IPR003130 (PFAM); IPR022812 (PFAM); PTHR11566:SF21 (PANTHER); IPR022812 (PANTHER); PTHR11566:SF21 (PANTHER); IPR022812 (PANTHER); IPR020850 (PROSITE_PROFILES); IPR030381 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.N.6.1.2, the mitochondrial inner/outer membrane fusion (mmf) family.
RL4_JR_09228,1281,1381,2794,0,1,0,0,0,0,0,0,0,0,2,2,0,0,1,63.82814979,1,0.23289005,0.852393252,0.273219021,0.784684859,0.889119538,7.441966533,0,0.569764423,1.24794643,0.456561603,0.647986183,0.772455087,19.44434983,0,-2.092351107,1.214509991,-1.72279448,0.084925697,0.170389964,22.4411737,1,-2.515308941,1.216124575,-2.068298752,0.038611939,0.104959993,26.67584143,1,-1.244362086,1.155433384,-1.076965668,0.281495604,0.415230622,N,-, Effector probability:0.863,cytochrome c oxidase assembly cox19,C:mitochondrion; C:membrane; C:endomembrane system; F:binding; C:intracellular organelle part; P:transport; P:single-organism metabolic process; P:cellular process,PTHR21107 (PANTHER),,
RL4_JR_09229,2974,3484,5878,0,2,9,0,0,0,0,0,0,4,4,2,0,3,1,2.852987487,1,0.385460806,1.251431441,0.30801592,0.758070219,0.87260239,0.913620669,0,3.595955648,1.436320094,2.503589321,0.012294064,0.039429822,2.361691684,0,0.949544793,1.22255169,0.776690917,0.437341147,0.577528629,2.724048975,1,0.527379196,1.230241568,0.428679383,0.668156567,0.773816819,2.31688201,1,0.874160728,1.211793024,0.721377917,0.470677029,0.601945803,N,-,,succinyl- synthetase subunit alpha,P:organic acid metabolic process; C:cytoplasmic part; F:binding; P:primary metabolic process; F:succinate-CoA ligase activity,PR01798 (PRINTS); IPR003781 (SMART); IPR005811 (PFAM); IPR013816 (G3DSA:3.30.470.GENE3D); IPR016102 (G3DSA:3.40.50.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR003781 (PFAM); IPR016102 (G3DSA:3.40.50.GENE3D); PTHR11117:SF6 (PANTHER); PTHR11117 (PANTHER); IPR016102 (SUPERFAMILY); IPR016102 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_09230,800,951,1191,0,1,6,0,0,0,0,1,0,0,2,0,0,5,0,26.9511345,1,-2.854686628,1.182755714,-2.413589377,0.015796253,0.054419693,8.614318578,0,0.358786649,1.217385917,0.294718909,0.768208617,0.859715247,38.01524496,1,-0.467778058,1.026984711,-0.455486876,0.648759007,0.755989432,25.75778042,1,-2.714163593,1.185718245,-2.289045989,0.02207668,0.080442001,37.44018195,1,0.240599241,0.744687847,0.323087374,0.746629072,0.823308577,N,-,,major facilitator superfamily transporter,C:membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11360 (PANTHER); PTHR11360:SF78 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.13.18, the major facilitator superfamily (mfs).
RL4_JR_09231,11667,13635,15974,1,0,8,0,0,0,0,0,0,2,7,0,0,2,1,133.03003,1,1.824761248,0.389690481,4.682591273,2.83E-06,3.78E-05,37.12022362,0,2.477319587,0.861688793,2.874958578,0.004040805,0.018171436,23.24388411,0,-2.349755169,1.189494052,-1.975424059,0.048220045,0.110139362,38.84478385,1,-0.465610773,0.85046431,-0.547478322,0.58405016,0.70964933,22.84551773,1,-2.427646212,1.187194944,-2.044858954,0.040868766,0.095741844,N,-,,lim domain-containing,P:regulation of cellular process,IPR001781 (SMART); IPR001781 (G3DSA:2.10.110.GENE3D); IPR001781 (PFAM); IPR001781 (G3DSA:2.10.110.GENE3D); IPR001781 (G3DSA:2.10.110.GENE3D); PTHR24216:SF8 (PANTHER); PTHR24216:SF8 (PANTHER); PTHR24216 (PANTHER); IPR001781 (PROSITE_PROFILES); IPR001781 (PROSITE_PROFILES); IPR001781 (PROSITE_PROFILES); SSF57716 (SUPERFAMILY); SSF57716 (SUPERFAMILY),,
RL4_JR_09232,8116,9352,14141,4,9,3,0,0,0,0,0,0,0,0,0,0,0,1,179.294363,1,-1.171759127,0.575342152,-2.036630068,0.041687127,0.116353992,81.3033068,0,-0.064117487,0.979360466,-0.065468731,0.947800802,0.972098462,134.5306764,0,-1.238975222,0.682621546,-1.815025075,0.069520056,0.146020964,127.3097139,0,-2.49746412,0.862415734,-2.895893501,0.003780807,0.022478373,97.913633,1,-3.539638775,1.131316516,-3.128778484,0.001755346,0.007585521,N,-,,ubiquitin-like modifier,F:identical protein binding; P:protein sumoylation; P:mitotic sister chromatid segregation; F:protein tag; C:condensed nuclear chromosome; C:septin ring,IPR000626 (SMART); G3DSA:3.10.20.90 (GENE3D); IPR022617 (PFAM); PTHR10562 (PANTHER); IPR000626 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY),,
RL4_JR_09233,26388,29309,43421,4,12,10,0,0,3,1,4,1,6,7,1,0,7,3,3.916991829,1,-0.072081692,1.236559925,-0.058292114,0.953515949,0.977139485,1.24127073,1,3.153615626,1.375328302,2.292991151,0.021848514,0.061825737,3.234977888,1,0.495045372,1.218189294,0.406378036,0.684464856,0.783173847,3.733008488,1,0.072327347,1.222299147,0.059173196,0.952814159,0.972014444,3.20385142,1,0.406553498,1.222792307,0.3324796,0.739527141,0.818060997,N,-, Effector probability:0.966,DUF1903 domain-containing,C:mitochondrial intermembrane space,IPR009069 (G3DSA:1.10.810.GENE3D); IPR027179 (PFAM); PTHR15590 (PANTHER); IPR027179 (PTHR15590:PANTHER); IPR009069 (SUPERFAMILY),,
RL4_JR_09234,430,972,1254,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,24.89040479,0,-0.488204538,1.024155705,-0.476689761,0.633583055,0.791550676,5.509144179,0,1.003734602,1.248637655,0.803863793,0.421475643,0.584858863,14.26902506,0,-1.64572614,1.19907651,-1.372494687,0.169909492,0.28784533,83.7256502,1,1.989941233,0.503976936,3.948476787,7.87E-05,0.000871728,14.02739066,0,-1.723903564,1.199034466,-1.437743128,0.150506951,0.259514834,N,-,,nuclear pore complex,P:mycelium development; P:macromolecule localization; C:nuclear pore; P:organic substance transport,IPR007252 (PFAM); IPR007252 (PANTHER),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_09235,12956,15100,15228,4,2,0,0,0,0,0,0,2,0,4,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_09236,383,512,618,0,1,4,0,0,0,0,0,0,0,0,0,0,0,0,53.21431162,1,1.691783349,0.656954699,2.575190272,0.010018496,0.037943773,3.666073119,0,1.591261029,1.275373365,1.2476825,0.212147352,0.358370411,31.68216445,0,0.771334592,1.044421757,0.738527885,0.460193728,0.598074622,38.94768179,0,0.863232626,0.869528054,0.992759949,0.320826952,0.467257321,13.29067039,0,-0.222505985,1.145744376,-0.194202118,0.846017624,0.896955858,N,-,,prolyl-tRNA synthetase,F:ATP binding; F:proline-tRNA ligase activity; C:mitochondrion; P:prolyl-tRNA aminoacylation,IPR002316 (PRINTS); G3DSA:3.30.930.10 (GENE3D); IPR002314 (PFAM); IPR004154 (G3DSA:3.40.50.GENE3D); IPR004154 (PFAM); PTHR11451 (PANTHER); IPR004500 (PTHR11451:PANTHER); IPR006195 (PROSITE_PROFILES); SSF55681 (SUPERFAMILY); IPR004154 (SUPERFAMILY),,
RL4_JR_09237,1168,1226,1105,0,2,3,0,0,0,0,0,0,0,0,0,0,0,1,123.2152845,1,-0.096584241,0.929069733,-0.103958011,0.917202671,0.960708991,22.49732457,0,-1.026131817,1.240810412,-0.826985176,0.408245464,0.571939181,70.88053351,0,-1.854474264,1.067932211,-1.736509345,0.082473813,0.16669293,118.7505422,0,-0.219276598,0.594824274,-0.368640972,0.712395352,0.807727093,56.50883041,1,-3.734193725,1.214842267,-3.073809521,0.002113443,0.00887173,N,-,,tpr mlp1 mlp2,P:mitotic spindle assembly checkpoint; P:mycelium development; P:protein import into nucleus; P:metabolic process; C:viral nucleocapsid; F:nucleocytoplasmic transporter activity; C:nuclear pore; F:hydrolase activity,IPR012929 (PFAM); PTHR18898:SF2 (PANTHER); PTHR18898 (PANTHER),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_09238,182,126,308,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_09239,895,715,825,0,0,0,0,0,0,2,0,0,2,1,0,0,0,4,57.50124442,0,-1.324116098,0.850768447,-1.556376595,0.119618567,0.251507287,14.76286016,0,-0.418346417,1.211669252,-0.345264532,0.729895509,0.831420475,38.16940461,1,-3.06532454,1.190471838,-2.574882028,0.010027428,0.032737079,97.31946256,1,0.246194812,0.540663625,0.455356714,0.648852631,0.759319566,64.51042795,1,0.269805622,0.57442228,0.46969909,0.638570018,0.740355862,N,-,,transcription factor bzip,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",G3DSA:1.20.5.170 (GENE3D); PTHR39607 (PANTHER); PTHR39607:SF1 (PANTHER); SSF57959 (SUPERFAMILY),,
RL4_JR_09240,344,202,257,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.621579536,0,1.200077558,1.316044171,0.911882431,0.361830611,NA,0.51763955,0,4.415437063,1.540809518,2.865660557,0.004161402,0.018371529,14.34133666,0,3.579456604,1.04376956,3.429355235,0.000605017,0.003889011,1.550303931,0,1.339960379,1.25237121,1.069938664,0.284646918,0.428876495,1.326898119,0,1.678011754,1.221020454,1.374269979,0.169357883,0.283992806,Y,-,,hypothetical protein SPBR_01918,C:membrane; C:integral component of membrane,PTHR39599 (PANTHER); PTHR39599:SF1 (PANTHER),,
RL4_JR_09241,4340,3518,3634,0,2,12,0,0,0,1,6,3,3,4,4,0,7,2,10.00347727,1,2.369617999,1.043576316,2.270670543,0.02316693,0.07405792,0.753417618,0,3.873886935,1.46945964,2.636266306,0.008382392,0.029501589,8.458878175,1,2.179069989,1.210809093,1.799680893,0.07191104,0.150263646,2.261501222,1,0.795175898,1.246347255,0.638005094,0.523470364,0.657965581,5.800812941,1,2.057827999,1.153753357,1.783594375,0.0744896,0.151876418,N,-,,ADP-ribosylation factor,F:ATP binding; P:transmembrane transport; C:membrane; C:integral component of membrane; F:metal ion transmembrane transporter activity; P:metal ion transport; P:mismatch repair; F:mismatched DNA binding,IPR002523 (PFAM); G3DSA:1.20.58.340 (GENE3D); SSF143865 (SUPERFAMILY),1.A.35.3.2, the cora metal ion transporter (mit) family.
RL4_JR_09242,8550,5603,6843,0,0,0,0,0,0,0,2,3,0,1,0,0,0,0,7.494743945,0,-1.00805253,1.19229251,-0.845474178,0.397846144,0.590221648,2.400497102,0,2.202239388,1.295955638,1.699316955,0.08925948,0.185216165,6.210078964,1,-0.445494172,1.197127553,-0.372135928,0.709791648,0.803385445,37.82220956,1,2.183079816,0.666416212,3.275850402,0.001053443,0.007712303,6.102150601,0,-0.523113468,1.193012508,-0.438481126,0.661037549,0.758414185,Y,-,,hypothetical protein HMPREF1624_03634,,no IPS match,1.C.105.2.10, the bacillus thuringiensis vegetative insecticidal protein-3 (vip3) family.
RL4_JR_09243,29240,37845,57214,8,9,80,5,0,5,3,2,5,4,17,8,0,36,6,31.1123385,1,-0.093082373,0.845365474,-0.110109031,0.912322906,0.956988186,6.269846088,1,0.817077469,1.226536331,0.666166544,0.505304655,0.658685604,38.41271946,1,-0.00727278,1.026148453,-0.007087454,0.994345077,0.997776897,26.79606046,1,-0.529030138,1.010146971,-0.523716007,0.60047608,0.722511474,16.05067762,1,-1.918335302,1.192891845,-1.608138499,0.107804849,0.202021858,N,-,,thioesterase family,C:mitochondrion; C:membrane; C:integral component of membrane,IPR029069 (G3DSA:3.10.129.GENE3D); IPR006683 (PFAM); PTHR12418:SF16 (PANTHER); PTHR12418 (PANTHER); IPR029069 (SUPERFAMILY),,
RL4_JR_09244,892,897,1077,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,48.15081149,1,0.914946203,0.707142612,1.293863767,0.195712482,0.357666314,5.221958368,0,1.08089375,1.25465842,0.8615044,0.388960299,0.553501496,110.139332,0,2.834035248,0.488247807,5.804501743,6.46E-09,2.83E-07,107.6745045,0,2.619968188,0.47289503,5.540274319,3.02E-08,7.68E-07,20.82148517,0,-0.72539593,1.143930063,-0.634126118,0.525998519,0.650034786,N,-,,hypothetical protein F503_01960,,no IPS match,,
RL4_JR_09245,7035,7057,9554,1,5,4,0,0,0,2,2,2,3,8,0,0,0,1,281.9280048,1,-4.332411008,1.092303355,-3.966307517,7.30E-05,0.000648683,82.39414055,0,-2.898965299,1.22062859,-2.374977386,0.017550025,0.051921118,237.8226702,1,-3.713046535,1.073838142,-3.457733889,0.000544739,0.003602181,282.3401222,1,-2.530614787,0.688355388,-3.676320153,0.000236623,0.002212191,218.3931481,1,-4.73313124,1.183167158,-4.000390992,6.32E-05,0.000473233,N,-,,ribosome biogenesis mak21,"C:nuclear part; P:ribosomal large subunit biogenesis; C:preribosome, large subunit precursor",IPR005612 (PFAM); G3DSA:1.10.601.10 (GENE3D); PTHR12048 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_09246,1524,1414,2284,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,7.497661982,1,-1.008806079,1.202472316,-0.838943289,0.401501134,0.593336787,2.382605934,0,2.212924257,1.291313836,1.713699796,0.086583874,0.181074789,21.88483151,0,1.381141703,1.035896108,1.333282066,0.182439257,0.303735411,11.16400128,0,0.081008146,1.149594641,0.070466704,0.943822201,0.967278207,13.49486267,1,0.406953744,1.133118398,0.359144944,0.719486661,0.802467773,N,-,,Alpha beta hydrolase fold-3,P:metabolic process; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR013094 (PFAM); PTHR23024 (PANTHER); PTHR23024:SF182 (PANTHER); IPR029058 (SUPERFAMILY),8.A.117.1.1, the neuroligin (nlg) family.
RL4_JR_09247,1897,1530,1703,0,0,0,3,0,0,0,0,0,0,0,0,0,1,0,4.879450701,0,-0.389279475,1.203776038,-0.323381977,0.746405977,0.867225605,1.557698802,1,2.826071137,1.337716072,2.112609093,0.03463424,0.088460201,4.042616271,0,0.173485632,1.203838863,0.144110343,0.885413337,0.928807857,14.29886554,0,0.700789734,1.145529884,0.611760325,0.540696343,0.671576176,11.35449971,1,1.025680046,1.128965661,0.908513059,0.363607218,0.500138986,N,-,,TPR MLP1 MLP2,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09248,707,506,1099,0,0,0,0,0,0,0,4,0,0,1,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,major facilitator superfamily transporter,C:nucleus; P:DNA repair; P:transmembrane transport; F:transmembrane transporter activity; F:nuclease activity; C:integral component of membrane; F:binding; P:anion transport,G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF253 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.3, the major facilitator superfamily (mfs).
RL4_JR_09249,2681,1814,2055,0,3,1,0,0,0,1,0,2,0,1,0,0,0,0,0.031881009,1,6.868464964,3.940092353,1.743224358,0.081294432,NA,0.010525003,0,10.03744526,3.395130433,2.956424048,0.003112289,0.015916638,0.026729924,1,7.416284522,2.018065453,3.674947466,0.000237898,0.001965084,0.030792401,1,6.99431031,3.814832404,1.83345153,0.06673545,0.146413095,0.025794429,0,7.353888809,1.456150082,5.050227238,4.41E-07,7.16E-06,N,-,,30S ribosomal S17P,C:ribosome,IPR029030 (G3DSA:3.40.50.GENE3D); IPR024983 (PFAM),,
RL4_JR_09250,3215,2524,3261,0,0,0,0,0,0,0,0,0,6,0,4,0,1,1,0.023991096,0,7.278843323,3.950996105,1.842280561,0.065434122,NA,0.007349285,0,10.55064835,3.952814198,2.669148567,0.007604381,0.02755073,0.019590825,0,7.860208691,2.683050839,2.929578738,0.003394218,0.014837247,0.02263866,1,7.436844232,3.951509931,1.88202595,0.059832492,0.136569486,0.01984176,1,7.75009228,1.597955263,4.850005791,1.23E-06,1.73E-05,N,-,,hypothetical protein SPI_06070,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09251,8287,10726,9617,4,6,46,0,0,2,0,0,1,0,8,0,0,5,3,270.2908645,1,-2.953150052,0.691677177,-4.269549653,1.96E-05,0.000206713,75.82341162,1,-2.77906626,1.190614439,-2.334144597,0.019588152,0.056535863,216.1805708,1,-3.606656946,1.036048802,-3.481165114,0.000499238,0.003378531,243.6607859,1,-3.150539649,0.758566811,-4.153279054,3.28E-05,0.000407066,202.3623799,1,-4.584323642,1.134568787,-4.040586779,5.33E-05,0.000411778,N,-,,ATP-dependent RNA helicase mak5,F:organic cyclic compound binding; F:heterocyclic compound binding; P:rRNA processing,IPR014001 (SMART); IPR001650 (SMART); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); PTHR24031 (PANTHER); PTHR24031:SF91 (PANTHER); IPR014014 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.18.1.1, the nuclear mrna exporter (mrna-e) family.
RL4_JR_09252,10574,13221,13717,7,22,44,0,0,3,0,5,5,0,18,3,0,2,3,74.20903107,1,-1.622476695,0.937605712,-1.730446683,0.083550499,0.194141112,27.15043302,1,0.228125503,1.153706424,0.197732714,0.843254193,0.906672927,46.57903873,1,-3.352649476,1.229418293,-2.727020978,0.006390898,0.022870784,65.80197883,1,-1.516249902,0.936627463,-1.618839892,0.105481716,0.204167918,46.42112455,1,-3.450484688,1.244096883,-2.773485518,0.005545931,0.019504709,N,-,,trna (uridine-2 -o-)-methyltransferase trm7,P:tRNA nucleoside ribose methylation; C:cytoplasm; F:tRNA methyltransferase activity; P:cytoplasmic translation,IPR002877 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10920:SF12 (PANTHER); IPR015507 (PANTHER); PTHR10920:SF12 (PANTHER); IPR028590 (HAMAP); IPR015507 (HAMAP); IPR029063 (SUPERFAMILY),,
RL4_JR_09253,2712,2734,2462,0,0,0,0,0,0,4,2,0,1,0,0,0,0,0,72.51152678,0,-0.660849913,0.774747169,-0.852987839,0.393666048,0.585918576,14.85059939,0,-0.426988457,1.241807606,-0.343844292,0.730963388,0.831981493,38.89886474,1,-3.092704208,1.225397562,-2.523837409,0.01160816,0.036227193,48.91159484,1,-2.571376613,1.184855017,-2.17020359,0.029991426,0.092214756,38.74477373,0,-3.189703644,1.240017653,-2.572305028,0.010102384,0.031657889,N,-,,gcn5-related n-acetyltransferase,F:transferase activity; F:N-acetyltransferase activity,IPR000182 (PFAM); IPR016181 (G3DSA:3.40.630.GENE3D); IPR016181 (SUPERFAMILY),,
RL4_JR_09254,168502,153099,115147,22,28,7,0,0,0,0,0,0,7,10,1,0,3,0,104.9996149,1,-0.07260248,0.505861872,-0.143522341,0.885877668,0.944154115,18.51357905,0,-0.744998299,1.196683673,-0.622552406,0.533578696,0.681843651,79.42315439,0,-0.573396634,0.736433764,-0.778612635,0.436207934,0.576598658,115.3195982,1,-0.259497335,0.566969131,-0.457692175,0.64717361,0.758267423,73.3470958,1,-0.845278755,0.741788461,-1.139514565,0.254488597,0.385386935,N,-,,glycosyltransferase family 69,C:membrane,IPR021047 (PFAM); PTHR34144 (PANTHER); PTHR34144:SF4 (PANTHER),,
RL4_JR_09255,10593,7308,8217,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28.69997638,0,0.576846237,1.058742552,0.544840892,0.585862952,0.758426055,2.712755614,0,2.025754134,1.32551896,1.528272469,0.126444902,0.242584401,7.062203098,0,-0.631071008,1.229936975,-0.513092151,0.607886862,0.724293437,8.149646528,0,-1.05385479,1.232849801,-0.854811989,0.39265524,0.537683839,21.70623679,0,0.993736441,1.01493262,0.979115679,0.327522825,0.463892604,N,-,,histone transcription regulator,P:cellular process,no IPS match,,
RL4_JR_09256,970,1073,1434,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,34.64379772,0,-2.100886299,1.144949021,-1.834916891,0.066518004,0.164790125,54.43834788,0,1.835862652,0.977071941,1.878943172,0.060252253,0.136563673,31.98429078,0,-1.520814422,1.190638305,-1.277310176,0.201492763,0.326961489,37.42632728,1,-1.178770757,1.015715716,-1.160532164,0.245832206,0.384537169,25.13510969,0,-2.565380311,1.194938893,-2.146871548,0.031803509,0.078827114,N,-,,histone transcription regulator,"C:nucleus; P:transcription, DNA-templated; C:integral component of membrane; P:regulation of transcription, DNA-templated",IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR011494 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR019015 (PFAM); IPR001680 (PFAM); IPR031120 (PANTHER); PTHR13831:SF0 (PANTHER); IPR031120 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR017986 (SUPERFAMILY),8.A.92.1.1,The G-Protein αβγ Complex (GPC) Family
RL4_JR_09257,9297,9800,13024,1,2,4,0,0,0,0,0,2,6,1,1,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_09258,4073,4406,5422,0,0,2,0,0,0,0,1,3,1,2,2,0,0,0,5.997901804,1,1.717775169,1.189503475,1.444111098,0.148707727,0.295028608,0.699772531,0,3.980533838,1.511649052,2.633239398,0.008457471,0.029683219,8.309984995,1,2.293318263,1.22200057,1.876691647,0.060560368,0.131231414,2.088987436,1,0.909766702,1.268366244,0.717274452,0.473204768,0.61433495,1.784238388,0,1.250608416,1.240903037,1.007821222,0.313540296,0.449086928,N,-,,cytochrome p450,F:oxidoreductase activity; F:binding,IPR002403 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24279 (PANTHER); PTHR24279:SF68 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_09259,7027,7050,5741,5,4,0,0,0,0,1,0,2,1,10,0,0,2,1,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_09260,937,891,1165,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,92.05765145,0,-0.532225921,0.696548822,-0.764089901,0.44481367,0.633797644,19.14032508,0,-0.792993717,1.254436897,-0.632151142,0.527288119,0.676027334,55.64022391,0,-2.46806679,1.22563745,-2.013700535,0.044040984,0.102602396,60.66581716,0,-2.90682827,1.18532235,-2.452352535,0.014192554,0.064008734,55.27052064,0,-2.555745941,1.152501472,-2.217564145,0.026584565,0.068630474,N,-,,sec7 domain-containing,P:biological regulation,IPR000904 (SMART); PF15410 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR000904 (PFAM); IPR023394 (G3DSA:1.10.1000.GENE3D); PTHR10663:SF206 (PANTHER); PTHR10663:SF206 (PANTHER); PTHR10663:SF206 (PANTHER); PTHR10663 (PANTHER); PTHR10663 (PANTHER); PTHR10663 (PANTHER); IPR000904 (PROSITE_PROFILES); IPR000904 (SUPERFAMILY); IPR011993 (SUPERFAMILY),,
RL4_JR_09261,899,913,839,0,0,2,0,0,0,0,0,3,2,5,0,0,0,1,0.086990416,1,5.420320839,3.91901229,1.383083399,0.166639295,NA,0.027717354,0,8.637957712,2.729042213,3.165197545,0.001549777,0.015023052,0.072170606,1,5.979017015,1.573919974,3.798806237,0.000145395,0.001445949,0.083264742,1,5.558365142,2.52431062,2.201933905,0.027669978,0.088418139,0.071583513,1,5.888737595,1.332230094,4.420210608,9.86E-06,9.92E-05,N,-,,hypothetical protein F503_06902,,no IPS match,,
RL4_JR_09262,41,44,38,0,0,0,0,0,0,0,1,2,0,0,0,0,4,0,14.60679388,0,-1.970951924,1.377156404,-1.431175078,0.152380044,0.300342209,4.804760533,0,1.201077647,1.463946458,0.820438234,0.411966327,0.575876697,12.26079934,1,-1.427005407,1.338460274,-1.066154472,0.286353819,0.425954461,14.12678068,0,-1.847556169,1.356325799,-1.362177266,0.173141949,0.296325596,11.91814543,1,-1.488929238,1.352240507,-1.101083151,0.270860469,0.403066175,N,-,,sugar transporter,C:integral component of plasma membrane; P:proton transport; F:sugar:proton symporter activity; P:glucose import; F:glucose transmembrane transporter activity; P:glucose transmembrane transport,IPR003663 (PRINTS); IPR005828 (PFAM); IPR003663 (TIGRFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF107 (PANTHER); PTHR23500 (PANTHER); PS51257 (PROSITE_PROFILES); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.125, the major facilitator superfamily (mfs).
RL4_JR_09263,31,45,24,0,0,1,0,0,0,0,0,3,0,0,0,0,0,0,288.5328074,1,-0.590965899,1.336248206,-0.442257581,0.658302823,0.807715732,188.4236735,0,1.141350495,0.784167261,1.455493683,0.145532638,0.270737247,812.9251336,1,2.166155194,0.510796339,4.240741423,2.23E-05,0.000366145,1467.535588,0,2.932806718,0.507070311,5.783826533,7.30E-09,2.05E-07,1200.050211,0,2.89778026,0.731216708,3.962956845,7.40E-05,0.000540004,N,-,,ABC-2 type transporter,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003593 (SMART); IPR010929 (PFAM); IPR003439 (PFAM); IPR013525 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR029481 (PFAM); PTHR19241 (PANTHER); PTHR19241:SF179 (PANTHER); PTHR19241:SF179 (PANTHER); PTHR19241:SF179 (PANTHER); PTHR19241 (PANTHER); PTHR19241:SF179 (PANTHER); PTHR19241 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.205.4, the atp-binding cassette (abc) superfamily.
RL4_JR_09264,67372,77418,81729,15,30,52,3,0,5,1,9,4,10,16,8,0,21,1,6.252545715,1,-0.746929915,1.235835481,-0.604392677,0.545582603,0.725807082,2.020300116,1,2.450998355,1.363724486,1.797282647,0.07229076,0.157462249,5.204713443,1,-0.190854557,1.231363785,-0.154994453,0.87682569,0.922854971,15.63646672,1,0.340850703,1.175541655,0.289952042,0.771852928,0.851912495,5.099667647,1,-0.264359128,1.228389758,-0.215207858,0.829605265,0.885461702,N,-,,MATE efflux family,P:drug transmembrane transport; F:antiporter activity; C:integral component of membrane; F:drug transmembrane transporter activity,IPR002528 (PFAM); IPR002528 (TIGRFAM); PTHR11206:SF95 (PANTHER); PTHR11206 (PANTHER),2.A.66.1.5, the multidrug/oligosaccharidyl-lipid/polysaccharide (mop) flippase superfamily.
RL4_JR_09265,856,737,1157,0,0,2,0,0,0,3,0,0,0,0,0,0,0,0,0.103299289,1,5.172543196,3.917082096,1.320509264,0.186665045,NA,0.033236712,0,8.376602249,2.617762063,3.199909712,0.001374706,0.015023052,0.085895998,1,5.729428185,1.503509643,3.810702652,0.000138572,0.001409181,0.099058501,0,5.308149377,2.335842753,2.27247719,0.023057704,0.081973053,0.084467123,0,5.64896194,1.300840597,4.34254739,1.41E-05,0.000133772,N,-,,---NA---,,no IPS match,,
RL4_JR_09266,10743,9753,12054,1,5,21,3,0,0,2,3,2,2,11,6,1,2,11,0.124502456,1,4.903400526,3.640439101,1.346925574,0.178004204,NA,0.040105157,1,8.106026025,2.521669107,3.214547857,0.001306501,0.015023052,0.103316979,1,5.465127327,1.459449454,3.744649953,0.000180645,0.001652082,0.119140173,1,5.0423411,2.174517603,2.318832044,0.020404145,0.077534994,7.822111731,1,7.051956536,1.034083242,6.819525012,9.13E-12,8.04E-10,N,-,,Aldolase-type TIM barrel,F:FMN binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR001155 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR22893:SF70 (PANTHER); PTHR22893 (PANTHER); SSF51395 (SUPERFAMILY),,
RL4_JR_09267,187,148,212,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.689099838,0,7.872267591,1.1297496,6.96815258,3.21E-12,1.48E-10,0.016706989,0,9.369241243,2.969723936,3.154919934,0.001605422,0.015023052,160.045433,0,11.89558452,1.303328385,9.127081601,7.04E-20,1.10E-17,45.00196944,0,9.838818399,0.718178023,13.69969295,1.02E-42,3.33E-40,50.22930952,0,10.43171152,1.447832834,7.205052459,5.80E-13,6.39E-11,Y,-,,"galactan 1,3-beta-galactosidase","P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:carbohydrate binding",IPR008979 (G3DSA:2.60.120.GENE3D); IPR023296 (G3DSA:2.115.10.GENE3D); IPR006710 (PFAM); IPR006710 (PANTHER); PTHR22925:SF43 (PANTHER); IPR005084 (PROSITE_PROFILES); IPR023296 (SUPERFAMILY); IPR008979 (SUPERFAMILY),,
RL4_JR_09268,2409,2498,2754,1,0,8,0,0,2,0,0,3,0,1,0,0,0,0,443.4577708,1,-5.148430918,1.026999448,-5.013080514,5.36E-07,8.85E-06,138.5953296,1,-3.649225192,1.192020981,-3.061376646,0.002203218,0.015045494,490.2341232,1,-1.558429066,0.43300378,-3.59911192,0.000319306,0.002439737,467.2885521,1,-2.708250446,0.513217077,-5.277007656,1.31E-07,2.88E-06,387.2910881,0,-2.8821226,0.658612568,-4.37605163,1.21E-05,0.000117993,N,-,,aconitase a isopropylmalate dehydratase,"F:metal ion binding; F:homoaconitate hydratase activity; C:mitochondrion; F:4 iron, 4 sulfur cluster binding; P:lysine biosynthetic process via aminoadipic acid",IPR001030 (PRINTS); IPR015931 (G3DSA:3.30.499.GENE3D); IPR015931 (G3DSA:3.30.499.GENE3D); IPR015928 (G3DSA:3.20.19.GENE3D); IPR001030 (PFAM); IPR000573 (PFAM); IPR015932 (G3DSA:3.40.1060.GENE3D); IPR004418 (TIGRFAM); IPR015937 (PANTHER); IPR004418 (PTHR11670:PANTHER); IPR015928 (SUPERFAMILY); IPR001030 (SUPERFAMILY),,
RL4_JR_09269,1521,1723,2697,0,6,0,0,0,0,0,0,0,0,1,0,0,2,2,61.72091755,1,-1.009182743,0.853208347,-1.182809271,0.236884746,0.410967464,12.07442621,0,-0.128365148,1.219240634,-0.105282866,0.916151358,0.953636914,66.40768866,0,0.049200952,0.749004428,0.065688466,0.947625855,0.969458787,59.35045776,1,-0.875542211,0.857065323,-1.021558319,0.306989994,0.452771112,50.09762767,1,0.059934614,0.691834659,0.086631413,0.930964496,0.95482329,N,-,,fungal specific transcription factor domain containing,F:binding,IPR001138 (SMART); IPR007219 (SMART); IPR001138 (PFAM); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31944 (PANTHER); PTHR31944:SF64 (PANTHER); PTHR31944 (PANTHER); PTHR31944:SF64 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09270,15489,28366,26278,9,16,38,0,0,5,2,0,5,6,46,3,1,31,10,9.247719089,1,-1.311428901,1.207082492,-1.086445135,0.277282102,0.460237515,2.979976126,1,1.890291153,1.30401431,1.449593873,0.147171806,0.272933862,7.681337666,1,-0.752284492,1.210321079,-0.621557787,0.534232685,0.663709867,8.85769354,1,-1.174037053,1.20961755,-0.970585333,0.331754812,0.478288121,7.522237799,1,-0.82505199,1.205424002,-0.684449611,0.493691298,0.621874146,N,-,,hexose transporter,C:integral component of membrane; P:hexose transmembrane transport; P:glucose transport; F:sugar transmembrane transporter activity,IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF117 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.69, the major facilitator superfamily (mfs).
RL4_JR_09271,11808,22768,21374,10,7,56,0,0,0,4,7,3,2,41,7,0,17,4,36.70630686,1,-1.250970872,1.048429818,-1.193185133,0.232796876,0.406323687,9.199236498,0,0.263971654,1.236076509,0.21355608,0.830893252,0.898699862,23.97976291,1,-2.394771329,1.208861627,-1.981013604,0.047589748,0.108954909,27.67287767,1,-2.817590448,1.210191484,-2.328218704,0.019900493,0.076700608,23.73882615,1,-2.482928137,1.217957318,-2.038600286,0.041489937,0.096797826,N,-,,glycerate dehydrogenase,"F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; P:metabolic process",IPR016040 (G3DSA:3.40.50.GENE3D); IPR006140 (PFAM); IPR006139 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10996 (PANTHER); PTHR10996:SF135 (PANTHER); IPR016040 (SUPERFAMILY); SSF52283 (SUPERFAMILY),,
RL4_JR_09272,1039,1088,1155,0,2,44,0,0,0,0,0,1,3,11,1,0,1,4,0.040629395,1,6.519518409,3.932956239,1.657663603,0.097385384,NA,0.012873165,0,9.745468895,3.165782515,3.078375994,0.002081321,0.015023052,0.033437834,1,7.093855841,1.819035928,3.899788746,9.63E-05,0.001133378,0.038584569,1,6.669085625,3.392387647,1.965897273,0.049310478,0.121802535,0.032900293,1,7.018393941,1.38996904,5.049316738,4.43E-07,7.16E-06,N,-,,MFS general substrate transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF313 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.3, the major facilitator superfamily (mfs).
RL4_JR_09273,637,401,826,0,5,13,0,0,1,0,0,0,0,1,0,0,0,2,4.560051329,1,-0.291533145,1.208156959,-0.241304032,0.809319486,0.902858546,1.464084571,1,2.915561081,1.357569208,2.147633478,0.031742884,0.082766993,3.784731787,0,0.268781326,1.2086579,0.222379985,0.824018091,0.886429419,8.376619826,1,0.793357841,1.153111483,0.688014865,0.49144342,0.630814482,3.718927091,1,0.191144356,1.203351144,0.158843375,0.873792275,0.916138219,N,-,,modin,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09274,2091,1122,2322,2,3,5,0,0,0,0,0,0,0,2,0,0,0,0,598.9617515,1,-2.452948833,0.931978149,-2.631981056,0.00848886,0.033278288,178.7758764,0,-2.86070587,1.285821137,-2.224808557,0.026094093,0.070810833,410.2256985,0,-6.491278668,1.3699292,-4.738404487,2.15E-06,5.16E-05,492.9205388,1,-4.814285554,1.799165975,-2.67584293,0.007454157,0.038350274,407.4121717,0,-6.584119653,1.422577041,-4.628304452,3.69E-06,4.39E-05,N,-,,hypothetical protein HMPREF1624_04634,,no IPS match,,
RL4_JR_09275,33251,25061,38824,2,6,15,0,0,1,0,0,6,3,2,0,0,3,0,6.046606202,1,1.688417745,1.166760081,1.447099342,0.147869102,0.293650471,0.716022226,1,3.947565868,1.485347277,2.657672001,0.007868243,0.028262014,1.847597262,1,1.303707687,1.228041127,1.061615656,0.288410203,0.427944836,2.130772616,1,0.881716916,1.240859831,0.710569312,0.477351166,0.617974754,23.90654591,1,3.465860733,0.84925754,4.081047937,4.48E-05,0.000354084,N,-,,het domain containing,,IPR010730 (PFAM); PTHR24148 (PANTHER),,
RL4_JR_09276,75,90,107,0,0,4,0,0,0,0,0,0,0,1,0,0,0,0,2.228918918,1,0.741215657,1.248866273,0.593510829,0.552839338,0.732105307,0.711486492,0,3.956587497,1.460885933,2.708348002,0.006761908,0.025274753,1.846102165,0,1.304288483,1.214270728,1.074133184,0.282762993,0.422163773,6.141262545,1,1.828580362,1.150788511,1.588980377,0.112064823,0.213201115,1.820795819,0,1.221621106,1.207890759,1.01136721,0.311840709,0.44722198,N,-,,hypothetical protein F503_03701,C:membrane; C:integral component of membrane,IPR028005 (PFAM),,
RL4_JR_09277,2227,3582,3148,0,0,4,0,0,0,0,0,1,0,4,0,0,2,1,0.242593294,1,3.940921565,2.858587029,1.378625708,0.168010186,NA,0.079679742,0,7.115643781,2.321430982,3.065197216,0.002175265,0.015045494,0.203126322,1,4.489009401,1.488621957,3.01554695,0.002565162,0.012078931,0.234049704,1,4.068046225,1.893604692,2.148308061,0.031689291,0.095194358,0.196888055,1,4.428586103,1.361519683,3.252678723,0.001143227,0.005319472,N,-,,---NA---,,no IPS match,,
RL4_JR_09278,1369,1736,1331,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0.092369905,1,5.334065516,3.91830255,1.361320482,0.173412433,NA,0.030080304,0,8.521457244,2.721631564,3.131010589,0.001742059,0.015023052,0.076943062,0,5.890936596,1.590736894,3.703275266,0.000212834,0.001819872,0.088686436,1,5.468346341,2.496232882,2.190639496,0.028477891,0.089620303,0.074693956,0,5.826513809,1.337508573,4.356244085,1.32E-05,0.000127669,N,-,,nadp-dependent leukotriene b4 12-hydroxydehydrogenase,P:biological_process; F:zinc ion binding; C:cytoplasm; F:oxidoreductase activity; P:oxidation-reduction process; C:cellular_component,IPR020843 (SMART); PF16884 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013149 (PFAM); PTHR11695:SF595 (PANTHER); IPR002085 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_09279,32,9,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.13461575,0,1.691612698,0.857311614,1.973159667,0.048477374,0.12981974,1.812907089,0,2.607178705,1.321784644,1.972468599,0.048556138,0.115209851,4.705438663,0,-0.045551911,1.203395797,-0.037852809,0.969805039,0.982616715,5.428224208,0,-0.467880261,1.202338409,-0.389141907,0.697171174,0.795975132,4.643952596,0,-0.12918778,1.205740386,-0.107143944,0.914674786,0.945394263,N,-,,vacuolar h+-atpase assembly,C:membrane; C:integral component of membrane,IPR021013 (PFAM); PTHR31394 (PANTHER); PTHR31394:SF1 (PANTHER),9.B.206.2.2, the tmem199 (tmem199) family.
RL4_JR_09280,22248,11918,17412,0,0,4,0,0,0,1,0,2,2,0,0,0,6,0,73.96180731,1,-0.232516577,0.689446022,-0.337251314,0.735927458,0.860807632,13.47012565,0,-0.286224174,1.230065507,-0.232690188,0.816001989,0.888795022,41.69374996,1,-1.986548241,1.212705904,-1.638112122,0.101398307,0.195795624,103.2274417,1,0.551547417,0.584506068,0.943612816,0.34536754,0.492097713,42.66871753,1,-1.387176191,1.019446077,-1.36071561,0.17360358,0.289196486,N,-,,decaprenyl-diphosphate synthase subunit 1,F:trans-hexaprenyltranstransferase activity; P:isoprenoid biosynthetic process; C:extrinsic component of mitochondrial inner membrane; P:ubiquinone biosynthetic process,IPR008949 (G3DSA:1.10.600.GENE3D); IPR000092 (PFAM); PTHR12001 (PANTHER); PTHR12001:SF47 (PANTHER); PTHR12001:SF47 (PANTHER); PTHR12001 (PANTHER); IPR008949 (SUPERFAMILY); IPR008949 (SUPERFAMILY),5.B.14.1.1, the flavin-based extracellular electron transfer (f-eet) family.
RL4_JR_09281,348,335,399,0,0,4,0,0,0,0,0,1,0,3,0,0,0,0,167.5208542,1,0.654499971,0.530256898,1.234307321,0.217088409,0.384996487,22.57094361,0,-1.030847609,1.238421748,-0.832388167,0.405189879,0.569392191,69.10620175,1,-2.708081123,1.216224806,-2.226628753,0.025972096,0.068581507,70.92643151,1,-3.146252094,1.173969051,-2.680012808,0.007361934,0.037974382,109.6503365,0,0.293951864,0.545113845,0.539248574,0.589715348,0.701712057,N,-,,Allantoinase,"P:heterocycle metabolic process; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides; F:transition metal ion binding; P:organic cyclic compound metabolic process; P:cellular nitrogen compound metabolic process",IPR017593 (TIGRFAM); IPR006680 (PFAM); IPR011059 (G3DSA:2.30.40.GENE3D); G3DSA:3.20.20.140 (GENE3D); PTHR11647:SF4 (PANTHER); PTHR11647 (PANTHER); IPR032466 (SUPERFAMILY); IPR011059 (SUPERFAMILY); IPR011059 (SUPERFAMILY),3.D.8.1.2, the na(+)- or h(+)-pumping formyl methanofuran dehydrogenase (fmf-dh) family.
RL4_JR_09282,897,1278,1205,0,1,1,0,0,0,0,0,0,0,2,0,0,0,0,160.4104736,1,2.673103968,0.716193089,3.732378893,0.00018968,0.001470303,6.587753339,0,0.745791837,1.311263479,0.568758186,0.569520255,0.710542245,48.26073685,0,0.936614661,0.82542766,1.134702295,0.256500075,0.392682105,51.56175343,1,1.240784411,0.736627942,1.684411274,0.092102213,0.184040835,24.15944738,0,-0.304823588,1.036883849,-0.293980457,0.768772837,0.839588499,N,-,,c6 zinc finger domain containing,"P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR021858 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR12526 (PANTHER); PTHR12526:SF323 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09283,4512,4882,4123,5,3,5,0,0,0,6,0,0,1,14,1,0,0,0,0.023687631,1,7.296282206,3.951530923,1.846444416,0.064827703,NA,0.007512988,0,10.52011027,3.508613538,2.998366778,0.002714308,0.015349618,0.019628416,1,7.855683688,2.049267543,3.833410486,0.000126379,0.00133277,0.022650115,1,7.436112476,3.951487371,1.88185151,0.05985618,0.136569486,0.019541152,0,7.761609809,1.449154076,5.355958994,8.51E-08,1.99E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_09284,5874,10050,9027,0,0,0,0,0,1,2,0,0,0,0,0,0,0,0,14.69049646,0,-0.597270647,1.145625682,-0.521348863,0.602123768,0.770529521,3.483428824,1,1.665072557,1.272202847,1.308810589,0.190598519,0.331997627,35.00172398,1,1.832482162,0.74891148,2.446860825,0.014410647,0.043023708,66.2621443,0,2.358849107,1.635789802,1.442024583,0.149295439,0.265475293,8.842954199,0,-1.058301841,1.19376844,-0.886521879,0.375336369,0.511477892,N,-,,ATPase prokaryote,C:membrane,IPR027417 (G3DSA:3.40.50.GENE3D); PTHR36168:SF1 (PANTHER); PTHR36168 (PANTHER); PTHR36168:SF1 (PANTHER); PTHR36168 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_09285,94,107,149,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,97.17110105,1,-3.699886414,1.150144039,-3.216889615,0.001295884,0.007255886,29.70738166,0,-1.427261911,1.196607354,-1.192757095,0.232964518,0.383238559,108.6264986,0,-1.258151269,0.748523009,-1.680845151,0.092792996,0.183161687,107.7575799,0,-2.759089627,1.018095628,-2.710049578,0.006727315,0.035457608,76.38402801,0,-4.168982052,1.199923098,-3.474374366,0.000512046,0.002762103,N,-,,myb DNA-binding domain containing,F:DNA binding,no IPS match,,
RL4_JR_09286,63,52,86,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.34475067,0,-1.728342774,1.202601738,-1.437169695,0.150669782,0.29819604,3.954220989,0,1.48210909,1.273510039,1.163798513,0.244505675,0.39738061,16.74409046,0,-0.206233734,1.203108075,-0.171417463,0.863895525,0.91367006,21.12976207,0,-0.639178152,1.155340171,-0.553238057,0.58010041,0.706460988,13.95843558,0,-0.320875694,1.139117448,-0.281687981,0.778182771,0.847032956,N,-,,hypothetical protein S7711_09045,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,PTHR37577:SF2 (PANTHER); PTHR37577 (PANTHER),,
RL4_JR_09287,119,187,123,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.57706624,0,-2.393564703,1.195151853,-2.002728522,0.045206436,0.123383775,15.63579436,0,1.735858418,1.130705412,1.535199532,0.124734823,0.240122838,22.73107608,0,-0.870114555,1.197314367,-0.726721885,0.467396344,0.604254959,18.724839,0,-2.254159876,1.197627088,-1.882188452,0.059810433,0.136569486,30.74679265,0,-0.223671146,0.981362063,-0.227919087,0.819709144,0.879003927,N,-,,myb DNA-binding domain containing,,no IPS match,,
RL4_JR_09288,12755,9416,8163,0,7,13,10,0,0,0,0,0,5,7,1,0,10,4,7.911470171,1,5.473707418,1.059650991,5.165575706,2.40E-07,4.31E-06,0.08734946,1,6.9823342,2.156411184,3.237941935,0.001203953,0.015023052,0.227271325,0,4.325292996,1.345802027,3.213914758,0.001309385,0.007119344,0.262212973,1,3.903614471,1.666496996,2.342407145,0.019159801,0.075307836,0.224994057,1,4.237940055,1.263752188,3.353458134,0.000798085,0.003988455,N,-,,MYND finger,F:metal ion binding,IPR002893 (PFAM); IPR002893 (PROSITE_PROFILES); SSF144232 (SUPERFAMILY),,
RL4_JR_09289,29726,28749,49573,10,0,59,0,0,5,0,0,0,1,32,4,0,14,2,0.00781203,1,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,1,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,0,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,0.007662926,1,9.0007212,4.037607722,2.229221316,0.025799183,0.085851084,0.006329724,1,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,N,-, Effector probability:0.641,hypothetical protein FOXB_11166,,no IPS match,,
RL4_JR_09290,4099,4987,10755,0,0,1,0,0,0,5,0,0,3,2,0,1,0,0,23.50134142,1,-1.454339986,1.155772539,-1.258327168,0.20827346,0.37449744,50.91561691,0,2.490975354,0.993377359,2.507582171,0.012156031,0.039086198,16.28151749,1,-1.836076894,1.201846111,-1.527713805,0.126583611,0.231156652,22.79258251,1,-1.311790224,1.15379915,-1.136931176,0.255567058,0.395007148,15.98836807,1,-1.912693107,1.201135836,-1.592403665,0.111294033,0.206837755,N,-,,Fungal specific transcription factor domain-containing,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated",IPR007219 (SMART); IPR007219 (PFAM); PTHR31944 (PANTHER); PTHR31944:SF20 (PANTHER),,
RL4_JR_09291,2770,3308,4353,6,1,13,0,0,0,0,2,4,3,0,0,0,0,0,3.661232741,1,0.025443719,1.207744579,0.021067136,0.983192101,0.991333724,1.170047775,0,3.238981185,1.373672947,2.357898358,0.018378724,0.053796833,3.0317053,1,0.58893797,1.20305989,0.489533376,0.624464131,0.73700231,26.77935793,1,2.486884551,0.845890459,2.939960516,0.003282541,0.02001105,2.984172645,0,0.508938887,1.198067534,0.424799832,0.670982601,0.766091433,N,-,,Tat pathway signal sequence,,IPR027417 (G3DSA:3.40.50.GENE3D); IPR022812 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR36681 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_09292,55987,63980,72633,1,6,15,0,0,1,0,4,1,0,1,0,0,13,0,68.79840579,1,0.003231356,0.587754411,0.0054978,0.995613412,0.998267888,13.44696379,1,-0.283657015,1.210900127,-0.234253023,0.814788554,0.888142337,66.19295849,1,-0.10855634,0.743027528,-0.146100024,0.883842427,0.927640549,62.80319361,1,-1.033808012,0.849563726,-1.216869294,0.22365395,0.359179768,38.09948739,1,-2.080792118,1.118446771,-1.860430172,0.062824689,0.133522246,N,-,,mosc domain containing,F:pyridoxal phosphate binding; F:catalytic activity; F:molybdenum ion binding; C:membrane; C:integral component of membrane,IPR005303 (PFAM); IPR005302 (PFAM); PTHR14237 (PANTHER); PTHR14237 (PANTHER); PTHR14237:SF30 (PANTHER); PTHR14237:SF30 (PANTHER); IPR005302 (PROSITE_PROFILES); IPR011037 (SUPERFAMILY); SSF141673 (SUPERFAMILY),,
RL4_JR_09293,1828,2270,3245,0,1,2,2,0,0,0,0,0,2,0,0,0,0,4,2.061447157,1,0.854229146,1.310824432,0.651673195,0.514612018,NA,0.654584485,1,4.076879107,1.50217046,2.71399233,0.006647771,0.024986533,8.200017276,0,2.384514763,1.212531083,1.9665597,0.049233993,0.111758957,11.27527246,1,1.952056762,1.164638052,1.676105945,0.093717443,0.186555644,23.77452283,1,3.589046297,0.870134519,4.124702812,3.71E-05,0.000301648,N,-,,FAD binding domain,F:oxidoreductase activity,IPR006094 (PFAM); IPR016169 (G3DSA:3.30.465.GENE3D); PTHR10801 (PANTHER); PTHR10801:SF3 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY),,
RL4_JR_09294,84,94,78,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,499.4807806,0,-1.4600119,0.670838351,-2.176398975,0.02952544,0.089243625,122.3792977,0,-2.437567409,1.114716953,-2.186714218,0.028763393,0.07667713,304.6130833,0,-5.046641925,1.199446039,-4.207477253,2.58E-05,0.000416969,367.5873051,0,-4.084965956,0.861684754,-4.740673358,2.13E-06,3.58E-05,304.9575471,0,-3.504400019,0.789620535,-4.43808116,9.08E-06,9.21E-05,Y,-,,ferrooxidoreductase Fet3,F:copper ion binding; F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process,IPR001117 (PFAM); IPR011707 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); IPR008972 (G3DSA:2.60.40.GENE3D); IPR011706 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); PTHR11709:SF105 (PANTHER); PTHR11709 (PANTHER); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY); IPR008972 (SUPERFAMILY),2.A.108.1.1, the iron/lead transporter (ilt) family.
RL4_JR_09295,135,189,197,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,212.2391534,0,-5.831870956,1.217417401,-4.79036274,1.66E-06,2.38E-05,67.37611753,0,-2.608648776,1.202561256,-2.169243988,0.030064165,0.079226628,190.8659317,0,-3.439014761,1.04856788,-3.279725448,0.001039082,0.005939956,225.4141019,0,-3.35674161,0.872447213,-3.847501099,0.000119329,0.00124173,176.7512899,0,-4.418934736,1.144189447,-3.862065629,0.000112432,0.000764525,N,-,,high-affinity iron transporter,C:high-affinity iron permease complex; F:iron ion transmembrane transporter activity; P:high-affinity iron ion transmembrane transport; C:integral component of membrane,IPR004923 (PFAM); PTHR31632:SF2 (PANTHER); IPR004923 (PANTHER),2.A.108.1.3, the iron/lead transporter (ilt) family.
RL4_JR_09296,30211,21899,28808,0,2,8,0,0,0,0,0,2,4,9,0,0,5,2,157.7218186,1,-2.322713077,0.765469234,-3.034365032,0.002410426,0.012166961,39.89520925,0,-1.852646691,1.198014446,-1.54643101,0.12200051,0.236704842,110.3834815,1,-3.548065659,1.197469209,-2.962970266,0.00304686,0.013722896,190.3620628,1,-1.138639887,0.565312242,-2.014178719,0.043990773,0.113902079,145.2458301,1,-0.694696476,0.644146618,-1.078475702,0.28082152,0.414477826,N,-,,"Mannan endo-1,6-alpha-mannosidase","F:mannan endo-1,6-alpha-mannosidase activity; P:carbohydrate catabolic process; C:integral component of membrane",IPR012341 (G3DSA:1.50.10.GENE3D); IPR014480 (PIRSF); IPR005198 (PFAM); PTHR12145:SF23 (PANTHER); PTHR12145 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_09297,47541,35877,43644,4,9,12,0,0,3,2,0,0,2,2,4,0,0,0,0.061043902,1,5.932044165,3.924215019,1.511651155,0.130622631,NA,0.018891448,1,9.191107491,3.924776705,2.341816664,0.019190139,0.055672854,0.04981954,1,6.516324082,2.377127391,2.741259936,0.006120407,0.022098784,0.057543916,1,6.091999638,3.924442071,1.552322477,0.120585082,0.225304292,0.049752115,0,6.418916953,1.727989594,3.714673384,0.000203466,0.001264639,N,-,,c6 transcription,"C:membrane; P:regulation of transcription, DNA-templated",PTHR38793:SF2 (PANTHER); PTHR38793 (PANTHER),,
RL4_JR_09298,5552,5721,5581,0,0,12,0,0,0,2,0,1,4,5,2,0,3,1,0.023635708,1,7.299299107,3.951624096,1.847164338,0.064723326,NA,0.00717654,0,10.58314818,3.953856896,2.676664447,0.007435906,0.027132749,0.01931,1,7.879034022,2.805765386,2.808158537,0.004982569,0.018871504,0.022322905,1,7.456088369,3.952107313,1.886610808,0.059212692,0.135855089,0.019792523,1,7.750360769,1.737762779,4.459964768,8.20E-06,8.50E-05,N,-,,hypothetical protein MAPG_04770,,no IPS match,,
RL4_JR_09299,1121,992,1086,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,65.5767668,1,4.036459957,0.91864271,4.393938921,1.11E-05,0.000127543,1.427548741,0,2.952032553,1.368456064,2.157199366,0.030990134,0.081222717,3.701174944,0,0.301233037,1.218357641,0.247245166,0.804718493,0.871986516,13.90520592,0,0.830288372,1.158888293,0.716452464,0.47371201,0.614756998,3.641135352,0,0.222015188,1.215690227,0.182624803,0.855092421,0.903455157,N,-,,cytochrome b5-like Heme Steroid binding domain-containing,F:oxidoreductase activity; P:oxidation-reduction process; F:heme binding,IPR001709 (PRINTS); IPR001199 (SMART); IPR001199 (PFAM); G3DSA:2.40.30.10 (GENE3D); IPR000898 (PFAM); IPR001199 (G3DSA:3.10.120.GENE3D); IPR001433 (PFAM); G3DSA:3.40.50.80 (GENE3D); PTHR19384:SF17 (PANTHER); PTHR19384 (PANTHER); PTHR19384:SF17 (PANTHER); PTHR19384 (PANTHER); IPR001199 (PROSITE_PROFILES); IPR017938 (SUPERFAMILY); SSF52343 (SUPERFAMILY); SSF140959 (SUPERFAMILY); IPR001199 (SUPERFAMILY),,
RL4_JR_09300,22,22,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_09301,6647,5636,7494,0,2,2,0,0,0,0,0,0,0,1,0,0,1,0,0.23895671,1,3.96273063,2.758752281,1.436421333,0.150882486,NA,0.075829902,0,7.186303782,2.214451028,3.245185236,0.001173742,0.015023052,0.197650698,0,4.526727467,1.359742228,3.329107073,0.000871249,0.005152176,0.228068469,1,4.104909792,1.736069054,2.36448532,0.018055143,0.073416997,0.195958318,1,4.43787445,1.267970897,3.499981316,0.000465291,0.00255066,N,-,,cytochrome P450 oxidoreductase,"F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity; F:heme binding",IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305:SF81 (PANTHER); PTHR24305 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_09302,4302,3995,5067,0,0,0,0,0,0,0,0,0,0,1,2,0,2,0,233.1669501,0,9.96940053,2.242587238,4.44549062,8.77E-06,0.000103981,0.077349664,0,7.15853908,2.351479343,3.04427045,0.002332454,0.015159195,0.196904881,0,4.534106444,1.510620819,3.001485473,0.002686659,0.012517134,0.226866138,1,4.113105407,1.933375476,2.127421941,0.033385041,0.097949446,0.190481883,1,4.476461803,1.376643947,3.251720835,0.001147086,0.005332529,Y,-,,FAD linked N-terminal,"F:D-arabinono-1,4-lactone oxidase activity; F:flavin adenine dinucleotide binding; C:membrane; P:oxidation-reduction process",IPR007173 (PFAM); IPR006094 (PFAM); IPR016169 (G3DSA:3.30.465.GENE3D); IPR016167 (G3DSA:3.30.43.GENE3D); PTHR13878 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY),,
RL4_JR_09303,19717,18817,16415,15,37,13,0,0,0,1,39,65,8,5,13,1,44,4,15.55908214,1,6.353945943,0.868239636,7.318193822,2.51E-13,1.31E-11,0.092010841,0,6.907564956,2.191852587,3.151473323,0.00162449,0.015023052,45.72854493,1,7.688182528,1.366460822,5.626346839,1.84E-08,7.45E-07,28.85658867,1,6.22185532,0.91636297,6.789728006,1.12E-11,4.72E-10,4.093821893,1,5.109060504,1.196513709,4.269955677,1.96E-05,0.000176274,Y,-,,GEgh16,,IPR021476 (PFAM); PTHR34618 (PANTHER); PTHR34618:SF3 (PANTHER),,
RL4_JR_09304,15144,15317,19541,0,0,11,0,0,0,5,3,1,5,10,0,0,10,4,42.09597753,1,9.241015481,0.847569891,10.90295394,1.12E-27,3.96E-25,0.02906644,0,8.569531336,2.672197341,3.206923083,0.001341629,0.015023052,6.574599199,1,6.866519088,1.24957365,5.495089536,3.91E-08,1.46E-06,37.98265452,1,8.255476768,0.815802463,10.11945556,4.53E-24,5.40E-22,0.075273145,1,5.819692754,1.308055556,4.449117416,8.62E-06,8.83E-05,N,-,,gEgh 16,,IPR021476 (PFAM); PTHR34618:SF3 (PANTHER); PTHR34618 (PANTHER),,
RL4_JR_09305,1377,1409,1641,0,1,2,0,0,0,0,3,0,0,0,0,0,2,0,3.428867808,1,0.120203767,1.228221274,0.097868169,0.922036976,0.962237952,1.094872964,0,3.334815097,1.394177308,2.3919591,0.01675871,0.050261233,2.836245293,1,0.68526858,1.212452456,0.565192125,0.571943092,0.6956914,3.27181706,0,0.262965487,1.215792091,0.216291493,0.82876054,0.892870873,2.789089542,1,0.606608415,1.206185689,0.502914618,0.615024303,0.722236264,N,-,,major facilitator superfamily transporter,C:membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),,
RL4_JR_09306,14643,10650,9665,0,0,16,0,0,0,0,0,0,1,6,0,0,53,2,18.68918839,1,0.149519978,1.036117656,0.144307914,0.885257329,0.944154115,3.528814741,0,1.646392084,1.283483647,1.282752677,0.199578738,0.343210328,9.136913095,0,-1.00257158,1.207926011,-0.829994197,0.406542065,0.548704421,63.97980696,1,2.784018708,0.541333616,5.142889014,2.71E-07,5.58E-06,24.41839391,1,1.514662682,0.777147945,1.94900172,0.051295219,0.114300423,N,-,,serine peptidase,P:proteolysis; F:serine-type peptidase activity,IPR008758 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR11010:SF23 (PANTHER); PTHR11010 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_09307,13,8,28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.016941764,0,7.786237146,3.969489371,1.961521097,0.049818266,NA,0.005360177,0,11.01327471,3.970079784,2.774068863,0.005535996,0.021974647,0.013809418,0,8.370946466,3.970412799,2.108331524,0.035002323,0.086240817,0.015934454,0,7.948319201,3.970395183,2.001896243,0.045295892,0.115278131,0.013359141,0,8.321812604,2.097869539,3.966792239,7.28E-05,0.000534084,N,-,,salicylate hydroxylase,F:FAD binding; F:oxidoreductase activity; P:oxidation-reduction process,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789:SF187 (PANTHER); PTHR13789 (PANTHER); PS51257 (PROSITE_PROFILES); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_09308,627,496,569,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,10.08547428,0,8.496075239,1.359614786,6.248884113,4.13E-10,1.25E-08,0.006181986,0,10.80045294,3.961457679,2.726383522,0.006403255,0.024293008,0.016419296,0,8.115760534,2.742902141,2.958822487,0.003088169,0.013803367,0.018970802,0,7.692145024,3.960113045,1.942405415,0.05208804,0.125807414,0.016551213,1,8.01449721,1.56545604,5.119592634,3.06E-07,5.23E-06,N,-,,Vanillyl-alcohol oxidase,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; P:oxidation-reduction process",IPR016171 (G3DSA:1.10.45.GENE3D); IPR004113 (PFAM); IPR016169 (G3DSA:3.30.465.GENE3D); IPR016167 (G3DSA:3.30.43.GENE3D); IPR016170 (G3DSA:3.40.462.GENE3D); IPR006094 (PFAM); PTHR11748 (PANTHER); PTHR11748:SF92 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY); IPR016164 (SUPERFAMILY),,
RL4_JR_09309,2981,3478,5258,4,0,0,0,0,0,2,1,4,2,0,0,0,0,1,0.007760107,1,8.901087564,4.041366561,2.202494486,0.027630398,NA,0.002334598,0,12.18995876,4.048442383,3.01102439,0.002603679,0.015349618,0.006343058,1,9.480780804,4.042868098,2.345063102,0.01902386,0.053738157,19.27790483,1,11.3070848,3.920474909,2.884110996,0.003925204,0.023106214,0.006581095,1,9.341867313,1.819064456,5.135533973,2.81E-07,4.95E-06,N,-,,cytochrome b5,C:endoplasmic reticulum; C:organelle part; C:membrane part; F:binding,IPR001199 (PRINTS); IPR001199 (SMART); IPR001199 (PFAM); IPR001199 (G3DSA:3.10.120.GENE3D); PTHR19359 (PANTHER); IPR001199 (PROSITE_PROFILES); IPR001199 (SUPERFAMILY),,
RL4_JR_09310,19112,20121,21945,4,2,48,0,0,0,0,6,10,7,13,7,0,12,0,0.247808942,1,3.910312603,2.702172179,1.44709972,0.147868996,NA,0.078850959,0,7.13011687,2.18797122,3.258780008,0.001118924,0.015023052,0.20499544,1,4.474798577,1.340138401,3.339057051,0.000840633,0.005009163,0.236515056,1,4.052655271,1.695227112,2.390626744,0.016819643,0.070314003,0.202561441,1,4.390271516,1.252640296,3.504814215,0.000456926,0.002515702,N,-,,---NA---,,no IPS match,,
RL4_JR_09311,642,606,767,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0.051029734,1,6.189399885,3.927613678,1.57586779,0.115056276,NA,0.01686165,0,9.356290358,3.208137479,2.91642438,0.003540685,0.016928889,0.042943576,0,6.729678684,1.954045447,3.443972448,0.000573234,0.003741729,0.049470357,0,6.30976484,3.301414724,1.911230599,0.055974953,0.131312883,0.041695187,0,6.662517364,1.511019873,4.409285067,1.04E-05,0.000103866,N,-,,hypothetical protein FAVG1_02512,"C:nucleus; F:DNA binding; F:zinc ion binding; F:copper ion binding; F:oxidoreductase activity; P:transcription, DNA-templated; C:integral component of membrane; F:methyltransferase activity; P:oxidation-reduction process; P:methylation",IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108:SF818 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_09312,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.400447452,0,1.411886796,1.354550452,1.042328689,0.297259316,NA,0.445457444,0,4.632148227,1.574364394,2.942233859,0.003258537,0.016208996,1.157325989,0,1.978263688,1.232469373,1.605121986,0.108466962,0.205987529,1.335280922,0,1.555731962,1.259906818,1.234799225,0.216905236,0.351611513,1.141888791,0,1.895204046,1.21916511,1.554509746,0.120062874,0.219389388,N,-,,fumarylacetoacetate hydrolase,P:metabolic process; F:hydrolase activity,IPR011234 (PFAM); IPR011234 (G3DSA:3.90.850.GENE3D); PTHR11820:SF81 (PANTHER); PTHR11820 (PANTHER); IPR011234 (SUPERFAMILY),,
RL4_JR_09313,8538,11739,14460,6,3,38,2,0,0,1,6,5,5,32,2,0,2,3,1.353967947,1,1.460704,1.388177336,1.052245965,0.292686716,NA,0.432519195,1,4.674792302,1.601278671,2.919412085,0.003506923,0.016855211,1.119503607,1,2.026677761,1.245367421,1.627373357,0.103657827,0.199019882,1.291399281,1,1.604245138,1.278751171,1.254540503,0.209645613,0.343028739,1.099401918,1,1.949880932,1.225086192,1.591627548,0.111468416,0.207085819,N,-,,hypothetical protein PV04_02114,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09314,23273,22778,25916,13,10,21,0,0,1,4,2,5,8,17,5,2,6,3,0.031829087,1,6.870734861,3.940144606,1.743777335,0.081197924,NA,0.010188555,1,10.08215548,3.266315815,3.086705651,0.002023879,0.015023052,0.026411508,1,7.430367819,1.855946036,4.003547342,6.24E-05,0.000854851,0.030465191,1,7.009140538,3.678357594,1.905508195,0.056714043,0.132423019,0.0260458,1,7.3468273,1.393610729,5.271793008,1.35E-07,2.91E-06,N,-,,heterokaryon incompatibility,P:mycelium development,IPR010730 (PFAM); PTHR24148 (PANTHER),,
RL4_JR_09315,491,760,705,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.56942771,0,4.19964211,0.812755835,5.167163282,2.38E-07,4.28E-06,0.41567356,0,4.732178789,1.635342471,2.893692835,0.003807404,0.017621649,1.072324269,0,2.088921441,1.262675763,1.654360924,0.098054201,0.19123497,1.236731525,0,1.666719546,1.304466069,1.277702491,0.201354347,0.332525324,4.909726802,0,2.945140204,1.155158838,2.549554317,0.010786071,0.033397237,N,-,,"2,4-dichlorophenol 6-monooxygenase","F:FAD binding; F:phenol 2-monooxygenase activity; P:oxidation-reduction process; F:2,4-dichlorophenol 6-monooxygenase activity",PR00420 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR002938 (PFAM); PTHR13789:SF252 (PANTHER); PTHR13789 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_09316,1778,1461,1959,0,2,1,0,0,0,0,0,7,0,2,3,0,3,0,0.659746881,1,2.497464942,1.928501012,1.295029107,0.195310189,NA,0.207354946,0,5.734884433,1.90733499,3.006752596,0.002640546,0.015349618,0.544916067,1,3.063730982,1.368600606,2.238586604,0.025182827,0.066933824,0.629040002,1,2.640983164,1.510632359,1.748263334,0.080418439,0.166920192,0.545594096,1,2.960387184,1.339413197,2.210212046,0.027090449,0.0695111,N,-,,multidrug resistance fnx1,P:transmembrane transport; C:integral component of membrane,PR01036 (PRINTS); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF73 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.65, the major facilitator superfamily (mfs).
RL4_JR_09317,367,473,426,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0.187397931,1,4.313381088,3.049479834,1.414464539,0.157225552,NA,22.37169463,0,8.454097556,1.146528428,7.373648444,1.66E-13,4.94E-11,0.155259927,0,4.875455999,1.377294554,3.539878948,0.000400311,0.002882464,0.179111836,0,4.453665242,1.862612329,2.391085452,0.016798643,0.070283577,7.51877025,0,5.728732894,1.156801368,4.95221829,7.34E-07,1.12E-05,N,-,,ankyrin repeat,,IPR002110 (SMART); IPR020683 (PFAM); PF05729 (PFAM); IPR002110 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR031359 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24188 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_09318,48,47,28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.926078158,0,2.008388496,1.533267153,1.30987512,0.190238085,NA,0.293831076,0,5.232315549,1.696736324,3.083752893,0.002044073,0.015023052,39.98037559,0,5.71956381,0.691926519,8.266143377,1.38E-16,1.69E-14,4.894964146,0,3.096287003,1.170780663,2.64463456,0.008177918,0.041297468,0.758334271,0,2.485570079,1.236012004,2.010959499,0.044329735,0.102008765,N,-,,metallophosphoesterase domain-containing,F:catalytic activity; C:membrane,IPR029052 (G3DSA:3.60.21.GENE3D); IPR004843 (PFAM); PTHR12905 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_09319,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.907217402,0,6.338769004,1.283168278,4.939935872,7.81E-07,1.23E-05,0.027908183,0,8.628363193,2.727231645,3.163780829,0.00155734,0.015023052,0.072937901,0,5.966282005,1.577263218,3.782679984,0.000155149,0.00151761,0.084189099,0,5.543055286,2.520191597,2.199457888,0.02784538,0.08865864,0.072332444,0,5.879506702,1.335428916,4.402710345,1.07E-05,0.000106434,N,-,,SSS family solute:Na+ symporter,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR001734 (PFAM); PTHR11819:SF131 (PANTHER); IPR001734 (PANTHER); IPR001734 (PROSITE_PROFILES),2.A.21.6.1, the solute:sodium symporter (sss) family.
RL4_JR_09320,49981,43175,39126,6,0,3,0,0,3,0,0,0,3,10,0,0,12,8,11.30947952,1,1.727871078,1.064302976,1.623476695,0.104487541,0.228715056,1.160739037,1,3.250401224,1.405581426,2.312495857,0.020750373,0.059231607,3.028130387,0,0.590491697,1.234060096,0.47849509,0.632297868,0.743050913,3.49466949,1,0.167619259,1.242383634,0.134917472,0.892677125,0.934100444,3.00010429,1,0.501398324,1.238532772,0.404832504,0.685600634,0.776998704,N,-, Effector probability:0.754,endoribonuclease l-psp,,IPR013813 (G3DSA:3.30.1330.GENE3D); IPR006175 (PFAM); IPR006056 (TIGRFAM); PTHR11803:SF22 (PANTHER); IPR006175 (PANTHER); IPR013813 (SUPERFAMILY),,
RL4_JR_09321,82,99,67,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34.9773866,0,6.371565616,0.647830404,9.835237085,7.94E-23,1.54E-20,0.193431185,0,5.835426674,1.840261113,3.170977548,0.001519269,0.015023052,13.50191222,0,4.9899951,1.055203633,4.72894041,2.26E-06,5.36E-05,0.582110558,0,2.753104262,1.391877247,1.977979214,0.047931052,0.119679876,12.08182281,0,5.271089667,0.891146622,5.914952194,3.32E-09,1.73E-07,Y,-,,chitin binding,P:biological_process; C:viral capsid; F:molecular_function,IPR004302 (PFAM); PTHR36575:SF2 (PANTHER); PTHR36575 (PANTHER),,
RL4_JR_09322,57,64,110,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.111917867,0,5.057042144,3.916289264,1.291284122,0.196605174,NA,0.034743754,0,8.31155507,2.706438765,3.071030159,0.002133216,0.015045494,0.091807867,0,5.632601424,1.648860218,3.416057566,0.000635348,0.004020165,0.106032644,0,5.209768711,2.450728007,2.125804535,0.033519538,0.098116602,0.092201414,0,5.52784644,1.428325708,3.870158193,0.000108765,0.000742578,,,,,,,,
RL4_JR_09323,7744,7379,4841,4,2,2,0,0,0,4,5,1,5,7,0,0,4,2,114.5666224,1,-1.09570011,0.703520617,-1.557452735,0.119363034,0.251164207,25.24830528,0,-1.192575305,1.234504978,-0.966035234,0.33402655,0.497500992,97.81068463,1,-0.728316941,0.735667268,-0.990008626,0.322169903,0.464820877,79.35881801,1,-3.317752556,1.178341835,-2.815611275,0.004868453,0.027415512,64.0584647,1,-3.915090194,1.219676073,-3.209942609,0.001327615,0.006019749,N,-,,copper amine oxidase 1,P:amine metabolic process; F:copper ion binding; F:quinone binding; F:primary amine oxidase activity; P:oxidation-reduction process,IPR015798 (G3DSA:2.70.98.GENE3D); IPR015800 (PFAM); IPR015798 (PFAM); G3DSA:3.10.450.40 (GENE3D); G3DSA:3.10.450.40 (GENE3D); PTHR10638:SF27 (PANTHER); IPR000269 (PANTHER); IPR016182 (SUPERFAMILY); IPR016182 (SUPERFAMILY); IPR015798 (SUPERFAMILY),,
RL4_JR_09324,7669,8127,9337,1,0,4,0,0,0,1,1,4,0,7,1,0,4,4,33.84126726,1,1.012000104,0.722309894,1.401060836,0.161195882,0.311177473,4.739313286,0,1.220915948,1.278257823,0.955140603,0.339506598,0.502373239,12.22320089,1,-1.422440768,1.21109816,-1.174504938,0.240192835,0.373305537,51.34564267,1,0.945878109,0.775712572,1.21936674,0.222705028,0.357918795,19.32863197,1,-0.557423509,1.135434407,-0.490934136,0.623473033,0.729077515,N,-,,Ankyrin repeat-containing,,IPR002110 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PF05729 (PFAM); PF13857 (PFAM); PTHR24198 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR027417 (SUPERFAMILY),8.A.28.1.1, the ankyrin (ankyrin) family.
RL4_JR_09325,2358,2398,3804,0,0,3,0,0,0,0,2,0,1,2,0,0,5,0,3.391034242,1,0.136023015,1.239939555,0.109701327,0.912646248,0.956988186,1.092095022,0,3.338533188,1.417233393,2.355669296,0.01848937,0.054042565,10.6580054,1,1.657993524,1.207580517,1.372987972,0.169756086,0.287633576,3.246215751,1,0.274249842,1.229234173,0.223106263,0.823452804,0.889208785,2.755785787,1,0.623593169,1.212194775,0.514433144,0.606949192,0.715005493,N,-,,short-chain dehydrogenase,C:cellular_component,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24320:SF72 (PANTHER); PTHR24320 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09326,1030,1163,1812,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,18.88520529,0,0.121252042,1.04245802,0.116313597,0.90740401,0.955051208,3.632959397,0,1.604428707,1.303431233,1.230927008,0.218350165,0.365735624,20.426397,0,-0.075145235,1.212321073,-0.061984599,0.950575097,0.971592356,66.6619247,1,2.306377618,1.659847774,1.389511528,0.164677258,0.285018331,9.15988795,0,-1.109222158,1.21492695,-0.91299494,0.361245203,0.498583381,N,-,,hypothetical protein V494_04482,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,IPR021858 (PFAM); PTHR37540 (PANTHER),,
RL4_JR_09327,24082,16206,15846,5,8,6,0,0,5,0,3,0,1,5,1,0,0,0,13.49501376,1,0.396698186,1.184735407,0.334841167,0.737744905,0.862354945,11.15666642,1,3.547225503,1.188197459,2.98538385,0.002832227,0.015349618,4.567094273,1,-0.002199695,1.241385455,-0.001771968,0.998586175,0.999474685,5.265213347,1,-0.423606526,1.246391699,-0.339866293,0.733957222,0.822321221,4.457658936,0,-0.070238509,1.234736704,-0.056885414,0.954636473,0.970227926,N,-,,glutathione S-transferase,F:transferase activity,IPR012336 (PFAM); PTHR12289 (PANTHER); PTHR12289:SF35 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_09328,370,415,423,1,0,4,0,0,0,1,0,1,0,0,0,0,6,0,19.43941483,1,1.164448686,0.924505593,1.259536659,0.207836558,0.374124148,2.588797687,0,2.093315641,1.356279839,1.543424581,0.122727793,0.237478632,26.14565982,1,1.842697008,0.907634166,2.03021997,0.042334185,0.099765197,7.665825813,0,-0.965582142,1.239765535,-0.778842543,0.436072474,0.57783455,25.08270809,1,1.617775785,0.887095059,1.823678048,0.06820076,0.14212747,N,-,,nacht and wd40 domain,,PTHR38117:SF2 (PANTHER); PTHR38117 (PANTHER),,
RL4_JR_09329,754,705,1141,0,1,4,0,0,0,0,0,1,0,3,0,0,0,0,3.989764685,1,5.375250426,1.436875589,3.740929604,0.000183341,0.001425829,0.052939701,0,7.70398799,2.550338822,3.020770386,0.002521325,0.015349618,0.140382488,1,5.01993249,1.625559879,3.088125239,0.002014236,0.009899088,67.28613511,1,8.615549931,1.528383312,5.637034808,1.73E-08,4.62E-07,7.507067046,0,5.873420796,1.303593294,4.505562299,6.62E-06,7.14E-05,N,-,,hypothetical protein SPSK_08149,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_09330,147,226,155,0,0,0,0,0,0,6,5,7,2,4,5,0,11,2,54.81808978,0,0.828317292,0.765825368,1.08160075,0.279429971,0.462719151,7.788968673,0,0.504141632,1.286437247,0.391889797,0.695139642,0.807240395,20.07917161,1,-2.138565185,1.231707919,-1.736259994,0.082517873,0.166715416,23.15749943,1,-2.560519136,1.235087003,-2.073148798,0.038158434,0.104090739,35.06106573,1,0.355391076,0.830848742,0.427744616,0.668837063,0.764762876,N,-,,OPT family small oligopeptide transporter,P:transmembrane transport; C:integral component of membrane,IPR004813 (PFAM); IPR004648 (TIGRFAM); IPR004813 (TIGRFAM); PTHR22601:SF19 (PANTHER); PTHR22601 (PANTHER),2.A.67.1.5, the oligopeptide transporter (opt) family.
RL4_JR_09331,1520,1699,1531,0,0,15,0,0,0,0,2,2,7,23,3,0,8,14,0.792314416,1,2.233402545,1.675727247,1.332795984,0.182598764,NA,0.256574614,0,5.428206599,1.79228996,3.028643087,0.002456547,0.015349618,7.158714916,1,3.750377445,1.231976671,3.044195182,0.002333037,0.011178263,0.760906814,1,2.367008646,1.382786447,1.711767317,0.086939557,0.176193559,0.645592106,1,2.716624183,1.256073699,2.162790436,0.030557302,0.076223867,N,-,,ankyrin repeat-containing,C:membrane; C:integral component of membrane,IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR016181 (G3DSA:3.40.630.GENE3D); IPR000182 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY); IPR020683 (SUPERFAMILY),8.A.114.1.1, the huntington-interacting protein 14 (hip14) family.
RL4_JR_09332,1338,1232,1182,0,2,0,0,0,0,0,0,2,4,4,0,0,0,4,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_09333,2138,2232,2400,0,0,1,0,0,0,0,0,4,0,4,0,0,0,0,143.5531508,1,0.941177194,0.676657235,1.390921644,0.164249189,0.315206982,94.25045963,0,0.996080895,0.977198955,1.019322513,0.308049879,0.469654137,79.40758046,1,-0.182669129,0.668686173,-0.273176172,0.784717795,0.857379987,200.4204265,1,1.453364704,0.34856057,4.169618792,3.05E-05,0.00038328,52.27414608,0,-2.468630565,1.120601424,-2.20295148,0.027598169,0.070527879,N,-,,iron-sulfur clusters transporter atm1,F:ATP binding; P:lipid transport; P:transmembrane transport; P:carbohydrate derivative transport; C:integral component of membrane; F:lipopolysaccharide-transporting ATPase activity,IPR003593 (SMART); IPR020843 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013149 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR003439 (PFAM); IPR013154 (PFAM); IPR011527 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.20.1560.10 (GENE3D); PTHR24221 (PANTHER); PTHR24221:SF253 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.210.1, the atp-binding cassette (abc) superfamily.
RL4_JR_09334,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,290.0892137,0,-1.793212572,0.581829759,-3.082022781,0.002055991,0.010703749,80.8232704,0,-1.778718025,1.149231469,-1.547745665,0.121683543,0.236225704,216.241916,0,-2.22581229,0.750897087,-2.964204188,0.003034669,0.013685071,235.9151387,0,-2.542951025,0.730796706,-3.479696892,0.000501981,0.004196995,187.4279091,0,-3.751469484,1.02507008,-3.65972001,0.000252491,0.001522615,Y,-,,tripeptidyl-peptidase I,P:proteolysis; F:serine-type endopeptidase activity,IPR015366 (SMART); IPR000209 (G3DSA:3.40.50.GENE3D); IPR015366 (PFAM); PTHR14218:SF18 (PANTHER); PTHR14218 (PANTHER); IPR030400 (PROSITE_PROFILES); IPR009020 (SUPERFAMILY); IPR000209 (SUPERFAMILY),,
RL4_JR_09335,360,394,473,0,0,1,0,0,0,0,0,0,0,3,0,0,0,0,459.600408,1,-1.932180395,0.495916757,-3.896178881,9.77E-05,0.000840061,130.2299068,0,-2.535755226,1.131668969,-2.240721708,0.025044107,0.068601535,398.3472355,0,-1.821210891,0.513490506,-3.546727484,0.000390048,0.002832743,414.7976464,1,-2.933994445,0.629264586,-4.662576774,3.12E-06,5.03E-05,307.0517761,0,-6.176122843,1.21652017,-5.076876648,3.84E-07,6.42E-06,N,-,,hypothetical protein CMQ_3632,,no IPS match,,
RL4_JR_09336,1268,1307,1504,1,1,6,0,0,0,0,0,0,1,0,0,0,0,0,38.25905061,1,1.501281877,0.742822642,2.021050239,0.043274565,0.119567496,3.49806584,0,1.659022517,1.335195493,1.242531544,0.21404051,0.360665563,15.48388781,0,-0.01673109,1.230217948,-0.013600102,0.989149023,0.995046175,10.35837194,1,-1.399890935,1.238568258,-1.130249323,0.258371182,0.398235381,8.774001934,0,-1.047123636,1.233964304,-0.84858503,0.39611224,0.532949912,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11360 (PANTHER); PTHR11360:SF148 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.13.4, the major facilitator superfamily (mfs).
RL4_JR_09337,621,862,832,0,0,0,0,0,0,0,0,0,2,1,0,0,1,0,39.51063353,0,-0.628990317,0.886844381,-0.709245422,0.478172191,0.667167562,8.912116704,0,0.309686295,1.232722278,0.251221464,0.801642891,0.879851993,96.13571815,0,1.520869699,1.112595238,1.366956865,0.171638826,0.290289254,45.41352096,1,-1.015828946,1.03193285,-0.984394426,0.324921617,0.471486447,30.7300983,1,-0.779510224,1.005524631,-0.775227379,0.438205313,0.572346335,N,-,,mitochondrial Fmp26,C:mitochondrion,IPR002838 (PFAM); IPR002838 (G3DSA:3.60.160.GENE3D); PTHR36959 (PANTHER); PTHR36959:SF2 (PANTHER); IPR016031 (SUPERFAMILY),,
RL4_JR_09338,10127,9200,10681,0,4,2,0,0,2,0,4,0,3,4,4,0,3,1,38.21051534,1,2.483738817,0.689064929,3.604506211,0.000312747,0.00224008,2.299883176,1,2.263815946,1.33995042,1.689477395,0.09112798,0.18825019,25.51557626,1,1.98657267,0.905619357,2.193606679,0.028263698,0.073069887,10.95900659,1,0.12042511,1.188053374,0.101363384,0.919262002,0.951398116,5.99441875,1,-0.497373695,1.250717656,-0.397670644,0.69087298,0.780876191,N,-,,kinesin family member 22,F:organic cyclic compound binding; F:heterocyclic compound binding,IPR001752 (PRINTS); IPR001752 (SMART); IPR001752 (PFAM); IPR001752 (G3DSA:3.40.850.GENE3D); IPR027640 (PANTHER); IPR027640 (PANTHER); PTHR24115:SF485 (PANTHER); PTHR24115:SF485 (PANTHER); PTHR24115:SF485 (PANTHER); IPR027640 (PANTHER); IPR001752 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR010994 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_09339,6638,5907,6209,4,3,8,0,0,0,0,1,1,0,8,8,0,0,1,0.042888278,1,6.439748449,3.931551847,1.63796605,0.101428776,NA,0.014186083,0,9.605093655,3.930744385,2.443581346,0.014542291,0.044986879,0.036160485,1,6.977415608,2.504961702,2.785438037,0.005345546,0.019896435,0.04165528,1,6.557644251,3.931154943,1.668121544,0.095291601,0.18892255,0.03519054,1,6.908527702,1.71452294,4.029416894,5.59E-05,0.000426313,N,-, Effector probability:0.802,---NA---,,no IPS match,,
RL4_JR_09340,15046,15096,19755,0,5,0,0,0,0,0,0,2,0,0,0,0,5,0,2.607831455,1,0.514581392,1.357957762,0.378937701,0.704734127,0.840182933,0.843306554,0,3.711400408,1.537924322,2.41325295,0.015810842,0.048102526,2.174205684,1,1.068325281,1.284179244,0.831912902,0.405458109,0.547752588,2.506871987,0,0.646775598,1.309438103,0.493933693,0.621353008,0.739097652,2.134537089,1,0.992007991,1.277826298,0.776324601,0.437557351,0.57201655,N,-,,hypothetical protein AFLA70_393g001031,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09341,3339,3732,2790,0,0,34,0,0,0,0,0,3,0,1,0,0,0,0,0.190211821,1,4.29178092,3.064640696,1.400418955,0.161387897,NA,0.060449394,0,7.513208427,2.337870148,3.213697919,0.001310375,0.015023052,0.15758898,1,4.852933917,1.416590679,3.425784166,0.000613027,0.003922224,0.181832428,1,4.431600621,1.905000118,2.326299394,0.020002584,0.076714457,0.156427692,0,4.762102072,1.296078392,3.674239229,0.000238559,0.001448088,,,,,,,,
RL4_JR_09342,1082,1084,1492,0,4,10,0,0,0,0,1,0,4,0,4,0,0,1,76.02639938,1,0.689362954,0.828170856,0.832392193,0.405187608,0.596960812,11.02444537,0,0.002904652,1.273286233,0.002281224,0.998179848,0.999073169,47.85194974,1,-0.251154954,0.912314637,-0.275294229,0.783090198,0.856318052,40.71435499,1,-1.356007277,1.072807044,-1.263980587,0.206236995,0.338271436,35.46494474,1,-1.056571895,1.026596462,-1.029198848,0.303386244,0.438575916,N,-,,Integral membrane,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,1.B.12.3.1, the autotransporter-1 (at-1) family.
RL4_JR_09343,7,7,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,67.33275816,0,-3.144643413,1.155982758,-2.720320343,0.00652187,0.027007825,20.46378177,0,-0.889453645,1.222096705,-0.727809543,0.466730182,0.625561825,63.82634433,0,-2.570475781,1.20234063,-2.137893137,0.032525417,0.081846479,79.46065311,0,-2.200433344,1.029706269,-2.13695246,0.032601858,0.096716618,51.67417488,0,-3.605178274,1.198106689,-3.009062803,0.002620549,0.010647296,Y,-,,Carbohydrate-binding WSC,,IPR002889 (PROSITE_PROFILES),,
RL4_JR_09344,900,591,693,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,61.67813277,0,1.256341809,0.603283418,2.082506781,0.037296204,0.10724795,5.852318923,0,0.91653386,1.261962342,0.726276712,0.467669153,0.626405606,28.10829196,0,0.087268405,1.050032646,0.083110183,0.933763929,0.960616402,61.40912371,0,1.383337752,0.607367026,2.277597717,0.022750557,0.081194708,22.20216558,0,-0.868082568,1.135341839,-0.764600174,0.444509665,0.577303792,N,-,,glutaryl- dehydrogenase,F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; P:oxidation-reduction process,IPR013786 (G3DSA:1.10.540.GENE3D); IPR009075 (PFAM); IPR006091 (PFAM); IPR013786 (PFAM); G3DSA:2.40.110.10 (GENE3D); G3DSA:1.20.140.10 (GENE3D); PTHR10909 (PANTHER); PTHR10909:SF307 (PANTHER); IPR009075 (SUPERFAMILY); IPR009100 (SUPERFAMILY),,
RL4_JR_09345,7563251,4528402,4002965,223,429,296,12,9,43,19,74,250,13,40,87,4,363,63,1269.383587,1,-0.219166402,0.429366992,-0.510440733,0.609742726,0.77565588,221.0368416,1,-4.322627633,1.202570738,-3.594489285,0.000325029,0.012945786,711.7966758,1,-2.069227433,0.520929341,-3.972184456,7.12E-05,0.000925541,902.0686948,1,-1.471259075,0.756880417,-1.943846137,0.051914008,0.125748644,694.0538605,1,-1.95335936,0.502826425,-3.884758764,0.000102432,0.000707931,N,-, Effector probability:0.795,ubiquitin-conjugating enzyme e2-16 kda,F:ATP binding; F:transferase activity; F:ligase activity; P:protein ubiquitination,SM00212 (SMART); IPR016135 (G3DSA:3.10.110.GENE3D); IPR000608 (PFAM); PTHR24068 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),3.A.20.1.1, the peroxisomal protein importer (ppi) family.
RL4_JR_09346,1739,2018,2126,0,0,0,0,0,0,0,0,2,0,3,0,0,0,0,114.439366,0,4.169507728,0.809471422,5.150901705,2.59E-07,4.63E-06,2.163871501,0,2.35197206,1.320920252,1.780555683,0.074985065,0.162109959,49.92619821,1,2.85681469,0.683338288,4.180674108,2.91E-05,0.000460485,92.49583639,1,3.960231046,0.449631105,8.807733732,1.28E-18,1.04E-16,82.71313431,0,3.946221519,1.546609897,2.551529979,0.01072511,0.033238976,N,-,,NADPH oxidase isoform 2,F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process,IPR000778 (PRINTS); G3DSA:2.40.30.10 (GENE3D); IPR013121 (PFAM); IPR013130 (PFAM); G3DSA:3.40.50.80 (GENE3D); IPR013112 (PFAM); PTHR11972:SF72 (PANTHER); PTHR11972 (PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY); IPR017938 (SUPERFAMILY),5.B.1.1.1, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_09347,4275,5093,4385,1,0,16,0,0,0,2,3,3,0,2,0,0,2,0,36.95835922,1,-0.73016238,1.036825205,-0.704229002,0.481290172,0.669571151,6.639594721,0,0.734343589,1.249587304,0.587668894,0.556754558,0.701365232,17.31861959,1,-1.925369309,1.211623289,-1.589082454,0.112041779,0.210916877,19.98455281,1,-2.348092358,1.212484569,-1.936595663,0.052794788,0.126490117,24.55208739,1,-1.077034584,1.151556296,-0.935286088,0.349640883,0.487054937,N,-,,Mitochondrial carrier,C:membrane; P:transport,IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089:SF270 (PANTHER); PTHR24089 (PANTHER); PTHR24089:SF270 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.8.5, the mitochondrial carrier (mc) family.
RL4_JR_09348,4179,4272,3537,0,0,1,2,0,0,0,0,0,3,1,0,0,3,0,1.045691142,1,1.833017426,1.478843264,1.23949405,0.215162591,NA,0.334204865,1,5.04663063,1.67091948,3.020271586,0.002525481,0.015349618,0.867368954,0,2.393684875,1.25608753,1.905667255,0.05669339,0.124450105,1.000561133,1,1.971648202,1.30664269,1.508942128,0.131313573,0.24064252,15.5874702,1,4.006901318,0.99624027,4.022023039,5.77E-05,0.000436308,N,-,,---NA---,,no IPS match,,
RL4_JR_09349,699,848,735,0,3,3,0,0,0,2,0,1,1,3,0,0,1,0,45.82107091,1,2.272599912,0.694586592,3.271874145,0.001068371,0.00624339,12.12991605,0,2.916858166,1.189338453,2.452504717,0.014186552,0.044102693,7.173438841,1,-0.653854138,1.250225287,-0.522989052,0.600981872,0.71932704,40.22523882,1,1.707619029,0.828456868,2.061204506,0.039283534,0.106235518,21.85531129,1,0.978376296,1.044809101,0.936416323,0.349058877,0.486503157,N,-,,hypothetical protein SPBR_02696,,no IPS match,,
RL4_JR_09350,6793,6377,6183,3,8,9,0,0,1,0,3,3,0,3,0,0,9,0,247.4301605,1,-0.461898712,0.542469019,-0.851474823,0.394505643,0.586759715,43.67652401,1,-1.983267967,1.212199443,-1.636090479,0.101820653,0.205591192,125.9588341,1,-2.814789731,1.049414066,-2.682248906,0.007312903,0.025450611,161.2626808,1,-2.00520054,0.697480653,-2.874919229,0.004041309,0.023684757,114.9876437,1,-3.780852824,1.138283422,-3.32153904,0.000895225,0.004368264,N,-,,DNA damage-inducible 1,F:aspartic-type endopeptidase activity; F:ubiquitin binding; P:proteolysis; P:transport,IPR015940 (SMART); IPR000626 (PFAM); IPR019103 (PFAM); G3DSA:1.10.8.10 (GENE3D); G3DSA:3.10.20.90 (GENE3D); IPR015940 (PFAM); PTHR12917 (PANTHER); IPR033322 (PTHR12917:PANTHER); IPR033322 (PTHR12917:PANTHER); PTHR12917 (PANTHER); IPR000626 (PROSITE_PROFILES); IPR001995 (PROSITE_PROFILES); IPR015940 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY); IPR021109 (SUPERFAMILY); IPR009060 (SUPERFAMILY),,
RL4_JR_09351,2010,1025,1342,1,2,6,0,0,0,3,1,4,0,0,0,0,0,0,198.8544789,1,-0.980925823,0.65454595,-1.49863554,0.133968208,0.272818931,79.80878167,0,-0.978001286,1.142755547,-0.855827205,0.392093365,0.556551541,108.5997671,1,-4.573895901,1.231138094,-3.715176977,0.000203062,0.001773766,141.4042913,0,-2.343646155,0.846920804,-2.767255386,0.005653045,0.030872212,108.0463951,0,-4.669285134,1.24792565,-3.741637281,0.000182825,0.00115047,N,-,,ribosomal rna-processing 8,F:methyltransferase activity; F:transferase activity; C:nucleolus; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR007823 (PFAM); IPR007823 (PANTHER); PTHR12787:SF0 (PANTHER); PTHR12787:SF0 (PANTHER); IPR007823 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_09352,23833,6388,2478,7,18,2,0,0,0,6,5,0,0,0,0,0,0,0,7.709621063,1,-1.049004676,1.259739778,-0.832715371,0.405005274,0.596960812,2.425758307,0,2.186969985,1.342077106,1.629541235,0.103198493,0.207421594,6.352569415,1,-0.478474619,1.240546224,-0.385696727,0.699721287,0.795693992,7.332746096,0,-0.901636271,1.245415024,-0.723964505,0.469087527,0.610084934,6.322750896,0,-0.57426396,1.254699898,-0.45769029,0.647174965,0.74801901,N,-,,Fe-containing alcohol,F:oxidoreductase activity,G3DSA:3.40.50.1970 (GENE3D); IPR001670 (PFAM); G3DSA:1.20.1090.10 (GENE3D); PTHR11496:SF70 (PANTHER); PTHR11496 (PANTHER); SSF56796 (SUPERFAMILY),,
RL4_JR_09353,15463,19089,18081,17,11,40,0,0,4,5,4,27,9,13,13,0,15,6,167.3201204,1,-0.186428646,0.58761653,-0.317262426,0.751044485,0.870021756,51.69172813,1,-0.474194379,1.170085398,-0.40526476,0.685282907,0.799928652,192.5148838,1,0.774164502,0.582340197,1.32940248,0.18371522,0.305107101,90.83244478,1,-3.523593564,1.199734401,-2.936978018,0.003314276,0.020166493,123.1348498,1,-0.086983292,0.663527295,-0.13109226,0.895702324,0.932160143,N,-,,c6 zinc finger domain containing,"P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR021858 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31313:SF20 (PANTHER); PTHR31313 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY); SSF101447 (SUPERFAMILY),,
RL4_JR_09354,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,110.3616313,0,0.936012806,0.423322779,2.211108999,0.02702829,0.083489886,14.14433086,0,-0.356641708,1.202267931,-0.296640789,0.766740767,0.858841192,36.7032795,0,-3.008885717,1.186792134,-2.53530979,0.011234792,0.035707308,97.39354434,0,0.739395286,0.464222152,1.592761747,0.11121365,0.212379895,63.22129317,0,0.312295052,0.584604927,0.534198461,0.593204234,0.704704079,N,-,,proteasome component pup2,"C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:proteasome core complex, alpha-subunit complex; F:threonine-type endopeptidase activity; C:proteasome storage granule; P:proteasomal ubiquitin-independent protein catabolic process",IPR000426 (SMART); IPR029055 (G3DSA:3.60.20.GENE3D); IPR001353 (PFAM); IPR000426 (PFAM); PTHR11599 (PANTHER); PTHR11599:SF14 (PANTHER); IPR023332 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY),,
RL4_JR_09355,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,63.76558279,0,-1.067483306,0.876246723,-1.218245133,0.223130833,0.393323539,12.68002043,0,-0.198934901,1.227134717,-0.162113335,0.871216606,0.925682236,39.34152497,0,-1.886672343,1.201932568,-1.569698993,0.116485156,0.217301587,78.82795563,0,0.050569013,0.64340823,0.078595533,0.937354341,0.963234127,54.72813738,0,-0.299467821,0.763941223,-0.392003745,0.695055446,0.784290248,N,-,,spindle pole body component alp4,C:interphase microtubule organizing center; C:equatorial microtubule organizing center; P:microtubule nucleation; F:gamma-tubulin binding; C:gamma-tubulin complex; C:mitotic spindle pole body; C:microtubule; C:nucleus; P:nuclear migration by microtubule mediated pushing forces; P:establishment or maintenance of cell polarity regulating cell shape; C:cytosol; P:microtubule anchoring at spindle pole body; P:cytoplasmic microtubule organization; P:mitotic spindle assembly,IPR007259 (PFAM); PTHR19302:SF13 (PANTHER); IPR007259 (PANTHER); IPR007259 (PANTHER); IPR007259 (PANTHER); PTHR19302:SF13 (PANTHER); PTHR19302:SF13 (PANTHER),,
RL4_JR_09356,190,347,439,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38.65994065,0,-1.990598616,1.140739198,-1.745007641,0.080983539,0.190064359,18.52153419,0,1.189454459,1.121336025,1.060747566,0.288804637,0.44821842,36.70095905,0,-0.55821633,1.032960209,-0.540404485,0.588918115,0.708521331,82.89620447,0,0.755605135,0.573161011,1.318312169,0.187399169,0.315395044,53.18182277,0,0.493533865,0.675055821,0.731100821,0.464717573,0.595754042,N,-,,phosphatidylinositol 4-kinase type ii subunit alpha,P:phosphorylation; F:kinase activity,IPR000403 (PFAM); PTHR12865:SF1 (PANTHER); PTHR12865 (PANTHER); PTHR12865 (PANTHER); PTHR12865:SF1 (PANTHER),,
RL4_JR_09357,94,69,90,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.354150952,0,3.395306904,2.32152996,1.462529867,0.143596066,NA,0.112633032,0,6.615855176,2.048342448,3.229857967,0.001238517,0.015023052,0.292463619,0,3.963173596,1.316411074,3.010589682,0.002607409,0.012226685,0.337433724,0,3.540325452,1.548313399,2.286569021,0.022220991,0.080442001,0.288225816,0,3.882183618,1.24907982,3.108034855,0.001883359,0.008052789,N,-,,---NA---,,no IPS match,,
RL4_JR_09358,10,5,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.511284815,0,0.569401632,1.241802225,0.458528436,0.646572838,0.79868454,0.804378578,0,3.779649908,1.446013604,2.613841182,0.008953064,0.031045878,9.923388005,0,2.094438154,1.196871154,1.749927841,0.080130766,0.162965824,2.399621069,0,0.710231053,1.221958713,0.581223445,0.561089868,0.689278684,2.043370064,0,1.055293872,1.203288949,0.877007865,0.380482366,0.516095678,N,-,,umta methyltransferase,C:membrane; C:integral component of membrane; F:methyltransferase activity; F:transferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF811 (PANTHER); PTHR10108 (PANTHER); PTHR10108:SF811 (PANTHER); PTHR10108 (PANTHER); PTHR10108:SF811 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_09359,579,391,442,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.61891226,0,-2.157197015,1.204553658,-1.790868344,0.073314425,0.176638829,5.282909816,0,1.064115368,1.249617788,0.851552673,0.394462416,0.558582622,13.75438643,0,-1.592961873,1.204325259,-1.322700708,0.185934928,0.307783717,19.88158782,0,-1.069227008,1.156408428,-0.924610182,0.355168715,0.501475817,35.71764364,0,0.566239804,0.866020039,0.653841456,0.513213955,0.638993027,N,-,,Aspartyl glutamyl-tRNA amidotransferase subunit B-related partial,"F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023168 (G3DSA:1.10.10.GENE3D); G3DSA:1.10.1510.10 (GENE3D); IPR019004 (PFAM); PTHR28055:SF1 (PANTHER); PTHR28055 (PANTHER); IPR003789 (SUPERFAMILY),,
RL4_JR_09360,656,876,957,0,0,3,0,0,0,0,0,0,0,0,0,0,1,0,103.8388025,1,-2.961487999,1.009471496,-2.933701457,0.003349462,0.015703972,30.83984833,0,-1.481191121,1.200323409,-1.233993364,0.217205377,0.364421155,124.1547255,0,-0.723749341,0.614938008,-1.176946833,0.239216728,0.37205853,132.9649477,0,-1.232629943,0.613943728,-2.007724626,0.044672562,0.114728762,85.81134387,1,-3.273800529,1.118130007,-2.927924756,0.003412326,0.013136807,N,-,,---NA---,,no IPS match,,
RL4_JR_09361,4,4,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,251.8835606,0,0.498019901,0.49465324,1.006806103,0.314027961,0.50224638,31.93115961,0,-1.531358153,1.232584298,-1.242396285,0.214090386,0.360689561,141.9729331,0,-0.22926167,0.603632124,-0.379803628,0.704091189,0.798985296,235.1444413,0,0.737796116,0.503728576,1.464669966,0.143010983,0.256962946,115.0524268,0,-0.584910907,0.650985308,-0.898500933,0.368918548,0.505096337,N,-,,c6 finger domain-containing,,PTHR35392:SF1 (PANTHER); PTHR35392 (PANTHER); IPR000909 (PROSITE_PROFILES),,
RL4_JR_09362,1958,1993,2998,5,0,5,0,0,4,0,0,0,2,1,3,0,5,3,293.6876356,1,1.447344956,0.952551329,1.519440383,0.128651684,0.265303447,34.47291149,1,-0.270687724,1.169272265,-0.231501021,0.816925592,0.889609558,88.47333341,0,-1.414399788,0.906217886,-1.560772315,0.118577482,0.219900019,103.1519611,1,-1.841732882,0.917564303,-2.007197616,0.044728625,0.114768711,115.4536069,1,0.027640007,0.592250841,0.046669427,0.962776698,0.975689527,N,-,,ring finger,F:zinc ion binding; C:cytoplasm; F:metal ion binding; F:hydrolase activity,IPR001607 (SMART); IPR001841 (SMART); IPR011422 (PFAM); IPR001841 (PFAM); IPR001607 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR24007:SF7 (PANTHER); PTHR24007 (PANTHER); IPR011422 (PRODOM); IPR001607 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); SSF57850 (SUPERFAMILY),8.A.112.1.6, the respiratory supercomplex factor (rcf) family.
RL4_JR_09363,7154,6545,5891,1,0,12,0,0,1,3,0,9,5,6,0,0,5,1,4.566862575,1,-0.29327588,1.254113794,-0.233851092,0.815100584,0.906040195,1.452427105,1,2.927103289,1.384927637,2.113542405,0.03455437,0.088390025,3.768565194,1,0.275185037,1.231679801,0.223422546,0.823206659,0.885763016,22.97253135,1,1.615691944,1.044791103,1.546425826,0.122001761,0.227088972,3.708592475,1,0.195531082,1.230707412,0.158876984,0.873765794,0.916138219,N,-,,nucleic acid- OB-fold,C:cellular_component,G3DSA:2.40.50.140 (GENE3D),,
RL4_JR_09364,2253,1828,2310,0,0,2,0,0,2,1,0,1,0,1,0,0,0,1,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_09365,3092,2948,2519,2,1,14,0,0,1,4,4,0,1,3,0,0,1,0,64.51936258,1,2.33886283,0.719698374,3.249782011,0.001154935,0.006625851,2.663001388,1,2.052555752,1.335695387,1.536694498,0.124368139,0.239553626,40.05871425,1,1.851333052,0.8813446,2.100577973,0.035678029,0.087416353,11.90812332,1,-0.063199257,1.175456719,-0.053765703,0.957121835,0.975426128,6.690150973,1,-0.655925386,1.219681098,-0.537784333,0.59072595,0.70250179,N,-,,piwi domain-containing,F:nucleic acid binding; F:translation initiation factor activity; C:membrane; C:integral component of membrane; P:translational initiation; P:transport; F:transporter activity,IPR003165 (SMART); IPR014811 (SMART); IPR032472 (PFAM); IPR003165 (PFAM); G3DSA:3.40.50.2300 (GENE3D); IPR014811 (PFAM); G3DSA:2.170.260.10 (GENE3D); IPR012337 (G3DSA:3.30.420.GENE3D); PTHR22891 (PANTHER); PTHR22891:SF55 (PANTHER); IPR003165 (PROSITE_PROFILES); IPR003100 (SUPERFAMILY); IPR012337 (SUPERFAMILY),,
RL4_JR_09366,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,154.0365112,0,1.33440343,0.384796315,3.467817589,0.000524703,0.00349146,52.26237719,0,2.162588446,0.773482299,2.795912007,0.005175349,0.021131457,60.29640321,0,-0.656454736,0.854780007,-0.76798092,0.44249852,0.582101744,96.60891782,0,0.404412552,0.520234404,0.777366028,0.436942849,0.578679985,41.26419467,0,-2.208370686,1.118506557,-1.974392257,0.048337158,0.109171029,N,-,,transporter smf2,C:membrane,IPR001046 (PRINTS); IPR001046 (TIGRFAM); IPR001046 (PFAM); PTHR11706:SF50 (PANTHER); IPR001046 (PANTHER); IPR001046 (PANTHER); PTHR11706:SF50 (PANTHER),2.A.55.1.5, the metal ion (mn(2+)-iron) transporter (nramp) family.
RL4_JR_09367,1595,1307,1708,0,0,4,5,0,0,0,1,2,0,1,5,0,4,1,19.45331231,1,0.055041182,1.030949284,0.053388835,0.957422101,0.978165247,3.749109424,1,1.558935367,1.264473869,1.232872743,0.217623246,0.364880321,9.75822608,1,-1.097663109,1.203179403,-0.912302111,0.361609703,0.505514587,11.25988795,1,-1.520325369,1.202430136,-1.264377301,0.206094636,0.338147495,17.36854627,1,0.477728345,0.99638367,0.479462239,0.631609826,0.734809777,N,-,,methylene-fatty-acyl-phospholipid synthase,C:mitochondrion; C:integral component of membrane; F:phosphatidyl-N-dimethylethanolamine N-methyltransferase activity; P:phospholipid metabolic process; P:phosphatidylcholine biosynthetic process; F:phosphatidyl-N-methylethanolamine N-methyltransferase activity; P:methylation,IPR007318 (PFAM); IPR024960 (PIRSF); IPR024960 (PANTHER); IPR024960 (PROSITE_PROFILES),,
RL4_JR_09368,8411,7566,8732,0,1,2,0,0,0,6,0,3,0,1,0,0,2,0,109.0450087,1,2.008722608,0.39927518,5.030922802,4.88E-07,8.14E-06,8.111079388,0,0.445628456,1.218245813,0.365795188,0.714517911,0.82111474,27.5287386,1,-1.243631366,1.186679818,-1.047992345,0.294642134,0.435391121,129.0998251,1,2.017220789,0.399286854,5.052059108,4.37E-07,8.61E-06,35.80824744,1,-0.072780313,0.836368531,-0.087019431,0.930656067,0.954700373,N,-,,spermine spermidine synthase,C:membrane,PF01564 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR12176:SF29 (PANTHER); PTHR12176 (PANTHER); IPR029063 (SUPERFAMILY),2.A.1.86.3, the major facilitator superfamily (mfs).
RL4_JR_09369,14765,6821,10991,0,8,7,0,0,0,0,1,3,1,7,0,0,1,0,3.737758282,1,-0.004319625,1.314046248,-0.00328727,0.997377143,0.999337107,1.180666671,0,3.225908116,1.449590397,2.225392857,0.026054877,0.070723374,3.076692995,1,0.567717071,1.262843142,0.449554701,0.653031557,0.759394841,3.550753076,1,0.144797871,1.277311778,0.113361415,0.909744029,0.944820274,3.040571633,1,0.482076843,1.266099691,0.380757413,0.703383263,0.790077162,N,-,,flavin-nucleotide-binding,F:FMN binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR024747 (PFAM); IPR012349 (G3DSA:2.30.110.GENE3D); PTHR34071 (PANTHER); PTHR34071:SF2 (PANTHER); IPR012349 (SUPERFAMILY),,
RL4_JR_09370,12419,11995,12968,0,2,29,0,0,0,0,3,0,1,14,1,0,5,0,66.27548382,1,0.298951682,0.722104663,0.414000487,0.67887375,0.824022028,11.52124914,0,-0.060658226,1.259794827,-0.04814929,0.961597264,0.979598179,51.78280925,1,-0.85576079,1.06149067,-0.806187764,0.420134593,0.561469581,78.16406177,1,0.408726194,0.645653003,0.633043124,0.526705482,0.660583798,28.93700853,1,-2.768636281,1.217481249,-2.274068931,0.022961842,0.060829057,N,-,,hypothetical protein F503_05584,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09371,20201,11747,7862,3,4,7,0,0,0,5,5,2,6,3,8,0,1,2,1331.677923,1,-1.795694126,0.665935921,-2.69649687,0.007007306,0.028620751,548.4110857,0,-0.889108659,0.848674073,-1.047644422,0.294802463,0.454391735,1053.817721,1,-2.120570044,0.822553317,-2.578033546,0.009936435,0.0324924,1083.943518,1,-3.512870152,0.90568588,-3.878684907,0.000105023,0.001109974,937.3947843,1,-2.812257284,0.97610605,-2.881098099,0.003962923,0.014806123,N,-,,glucosamine-6-phosphate isomerase,P:carbohydrate metabolic process; P:cellular nitrogen compound biosynthetic process; F:isomerase activity,G3DSA:3.40.50.1360 (GENE3D); IPR004547 (TIGRFAM); IPR006148 (PFAM); IPR004547 (PANTHER); SSF100950 (SUPERFAMILY),,
RL4_JR_09372,448,571,872,0,1,4,0,0,0,0,0,2,0,3,0,0,0,0,35.72766414,1,0.829032564,1.107823889,0.748343281,0.454253125,0.643144219,3.859811431,0,1.517036678,1.475339324,1.028262891,0.303826182,0.464832015,9.818179931,1,-1.10645712,1.334325473,-0.829225809,0.406976643,0.54910683,11.31076928,1,-1.526802046,1.35155068,-1.129666885,0.258616616,0.398492351,9.501777948,0,-1.162053854,1.343104782,-0.865199699,0.38692919,0.522976747,N,-,,---NA---,,no IPS match,,
RL4_JR_09373,806,625,1471,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,53.06597019,0,-3.832056865,1.35395606,-2.830266784,0.00465092,0.020551688,36.25132607,0,0.909949583,1.180325655,0.770930954,0.440747858,0.602139266,122.9600544,1,0.828665602,1.848696485,0.448243186,0.653977699,0.760145835,51.30212535,1,-3.708125764,1.333406754,-2.780941189,0.005420156,0.029858038,57.86093298,0,-1.583489845,1.122433643,-1.410764775,0.158313984,0.26921886,N,-,,hexokinase-1,"F:nucleotide binding; P:carbohydrate metabolic process; P:phosphorylation; P:single-organism cellular process; F:phosphotransferase activity, alcohol group as acceptor; F:kinase activity",PR00475 (PRINTS); G3DSA:3.40.367.20 (GENE3D); IPR022673 (PFAM); IPR022672 (PFAM); G3DSA:3.30.420.40 (GENE3D); PTHR19443:SF24 (PANTHER); IPR001312 (PANTHER); PTHR19443:SF24 (PANTHER); IPR001312 (PANTHER); IPR001312 (PROSITE_PROFILES); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_09374,3440,1896,3359,0,0,6,0,0,0,0,0,0,7,1,0,0,0,3,126.3531728,1,0.054935425,0.648297748,0.084737954,0.932469721,0.966946573,20.70931813,0,-0.906675217,1.288936759,-0.703428784,0.481788574,0.638808481,76.56898461,0,-1.129508401,0.94874544,-1.190528411,0.23383877,0.36584511,61.13210496,1,-3.96103932,1.26701433,-3.126278231,0.00177034,0.011957765,70.26963815,1,-1.367314962,0.93409222,-1.463790119,0.143251303,0.250115441,N,-,,acid phosphatase ( ),"F:DNA binding; F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated",IPR024061 (PFAM); IPR024061 (G3DSA:2.60.40.GENE3D); PTHR35144 (PANTHER); PTHR35144:SF3 (PANTHER); PTHR35144 (PANTHER); PTHR35144:SF3 (PANTHER); IPR024061 (PROSITE_PROFILES); IPR008967 (SUPERFAMILY),,
RL4_JR_09375,13853,11408,14721,2,0,8,0,0,0,0,0,0,2,0,0,0,8,0,28.53694617,1,-2.937119111,1.209521331,-2.428331801,0.015168459,0.052904287,18.59509298,0,1.175562075,1.15346922,1.019153398,0.308130147,0.469654137,23.73430987,0,-2.379900508,1.211505801,-1.964415282,0.049481952,0.112145799,41.01352492,1,-1.066005532,1.040480512,-1.024531954,0.305584086,0.451157607,61.70787176,1,0.515753065,0.698172138,0.738719059,0.46007761,0.591528356,N,-,,glycoside hydrolase family 3,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR001764 (G3DSA:3.20.20.GENE3D); IPR016181 (G3DSA:3.40.630.GENE3D); IPR002772 (G3DSA:3.40.50.GENE3D); IPR001764 (PFAM); PTHR30480:SF2 (PANTHER); PTHR30480:SF2 (PANTHER); PTHR30480:SF2 (PANTHER); PTHR30480 (PANTHER); PTHR30480 (PANTHER); PTHR30480 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_09376,502,536,618,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_09377,607,1118,1063,0,0,3,0,0,0,3,3,1,1,1,0,0,2,2,445.0010687,1,-0.744228612,0.520449569,-1.429972577,0.15272489,0.300803875,130.3558209,0,-0.832345204,0.94466424,-0.881101633,0.378262814,0.54255012,372.09542,1,-0.591229058,0.591879367,-0.99890128,0.317842516,0.460540794,562.1905847,1,0.145558601,0.454547645,0.320227379,0.74879597,0.834697699,279.0218691,1,-1.881507644,0.681405006,-2.761217817,0.005758626,0.02011725,N,-,,N-acetylglucosamine-6-phosphate deacetylase,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds",IPR011059 (G3DSA:2.30.40.GENE3D); IPR006680 (PFAM); IPR011059 (G3DSA:2.30.40.GENE3D); G3DSA:3.20.20.140 (GENE3D); PTHR11113 (PANTHER); PTHR11113:SF1 (PANTHER); PTHR11113 (PANTHER); PTHR11113:SF1 (PANTHER); IPR011059 (SUPERFAMILY); IPR032466 (SUPERFAMILY),,
RL4_JR_09378,6208,5502,5913,4,5,0,0,0,0,0,1,4,6,6,7,0,6,1,2.372999775,1,0.65076952,1.402528943,0.463997212,0.642649743,0.796362353,0.772905026,0,3.837233423,1.585156858,2.420727895,0.015489467,0.047388757,1.98286582,1,1.201343474,1.305002071,0.920568251,0.357275884,0.500730095,2.285560376,1,0.780204814,1.338003831,0.583111046,0.559818548,0.68857787,1.936306072,1,1.132570185,1.293759242,0.875410314,0.38135069,0.517098665,N,-,,24-dehydrocholesterol reductase,P:mycelium development; F:oxidoreductase activity,IPR016169 (G3DSA:3.30.465.GENE3D); IPR006094 (PFAM); PTHR10801:SF3 (PANTHER); PTHR10801 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY),,
RL4_JR_09379,19511,18420,28379,3,6,20,0,0,0,1,1,3,5,18,5,0,2,0,8.738510442,1,3.474491357,1.041946475,3.334615971,0.000854173,0.005263098,0.349452091,0,4.982210795,1.645374283,3.028010615,0.002461694,0.015349618,0.910544709,1,2.323624327,1.248484708,1.861155616,0.062722204,0.134905374,21.1086184,1,4.914692099,0.7045913,6.975238129,3.05E-12,1.35E-10,0.902075305,1,2.235107121,1.234651064,1.810314822,0.07024698,0.145262449,N,-,,lipase esterase,P:metabolic process; F:hydrolase activity,IPR013094 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR23024 (PANTHER); PTHR23024:SF203 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_09380,690,552,526,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,348.3426488,0,-1.476205533,0.643046466,-2.295643645,0.021696265,0.070321903,85.95366178,0,-2.959970497,1.222899697,-2.420452392,0.015501209,0.047388757,356.5355413,0,-0.698623566,0.514358381,-1.358242798,0.174386655,0.29325746,357.4558211,0,-1.250816665,0.491325463,-2.545800614,0.010902744,0.05207089,315.7940165,0,-1.022587838,0.58342692,-1.752726523,0.079648961,0.160806725,N,-,,peroxisomal membrane anchor,C:peroxisome; C:Pex17p-Pex14p docking complex,IPR006785 (PFAM); IPR025655 (PANTHER),3.A.20.1.5, the peroxisomal protein importer (ppi) family.
RL4_JR_09381,2182,2927,1777,0,0,0,0,0,0,0,0,0,0,6,0,0,1,0,90.71435108,0,-0.907320194,0.634092602,-1.43089541,0.152460193,0.300427597,21.78618622,0,-0.979798935,1.210751233,-0.809248761,0.418372073,0.582338025,143.6668915,0,0.770870514,0.469714021,1.641148611,0.10076657,0.195022129,92.97935163,1,-0.556034537,0.601698907,-0.924107607,0.355430293,0.501546851,70.67433762,1,-1.091812698,0.751632387,-1.452588683,0.14633799,0.254320657,N,-,,hec ndc80p family,F:identical protein binding; C:Ndc80 complex; P:microtubule nucleation; P:protein localization to kinetochore; C:condensed nuclear chromosome kinetochore; P:chromosome segregation; F:structural constituent of cytoskeleton,IPR005550 (PFAM); IPR005550 (PANTHER); PTHR10643:SF2 (PANTHER); PTHR10643:SF2 (PANTHER); IPR005550 (PANTHER),,
RL4_JR_09382,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30.65302383,0,-3.040234349,1.191963024,-2.550611292,0.010753418,0.04016776,9.838153337,0,0.167178657,1.228024297,0.136136278,0.891713549,0.939240088,25.41303111,0,-2.478451713,1.195146202,-2.073764455,0.038101192,0.091981001,41.34442398,0,-0.600877016,0.862446597,-0.696712142,0.485982958,0.626187001,39.66036432,0,-0.869099569,0.968721355,-0.897161568,0.36963271,0.505747457,N,-,,cutinase transcription factor 1 beta,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR001138 (SMART); IPR001138 (PFAM); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR19444:SF29 (PANTHER); PTHR19444 (PANTHER); PTHR19444:SF29 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09383,2043,2461,4056,0,2,4,0,0,0,0,1,1,0,1,1,0,0,1,13.7042762,1,-1.879029181,1.220064655,-1.540106234,0.123534461,0.257879767,4.400230874,0,1.327924807,1.290258467,1.029192864,0.303389055,0.4643036,11.38931502,1,-1.320705974,1.22013978,-1.082421863,0.279065118,0.418184614,13.13575203,1,-1.742694025,1.221073295,-1.427182162,0.153527395,0.270529912,11.21928969,1,-1.401761546,1.22503199,-1.144265258,0.252513647,0.383658565,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:membrane; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); PTHR23502:SF9 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.77, the major facilitator superfamily (mfs).
RL4_JR_09384,2821,2946,3717,1,0,3,0,0,0,0,0,3,0,5,2,0,0,2,5.432488516,1,-0.544192568,1.241571424,-0.438309515,0.661161929,0.810238699,1.743215855,0,2.663738977,1.3712533,1.942557935,0.052069594,0.121692086,4.514309821,1,0.014303613,1.232474197,0.011605608,0.990740272,0.99621844,23.83120587,1,1.357633558,1.048435281,1.294914034,0.195349887,0.325037063,23.39669302,1,2.532341297,0.805379115,3.144284784,0.001664933,0.007272411,N,-,,kinase-like domain,C:membrane; C:integral component of membrane; F:protein kinase activity; P:phosphorylation; F:protein serine/threonine kinase activity; P:protein phosphorylation; F:kinase activity,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); PTHR21310 (PANTHER); PTHR21310:SF16 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_09385,11264,12575,14891,2,0,6,0,0,1,0,0,2,0,0,3,0,5,0,5.306061533,1,-0.510235224,1.216222446,-0.419524591,0.674832787,0.820826878,1.701878595,1,2.698386002,1.348327556,2.001283732,0.045361822,0.109114154,4.405477092,1,0.049537089,1.21495784,0.040772682,0.967477118,0.980945252,23.7057398,1,1.379521339,1.028131009,1.341775831,0.179668691,0.305021042,4.337760739,1,-0.030886424,1.214405908,-0.025433361,0.979709302,0.986425092,N,-, Effector probability:0.656,hypothetical protein LEMA_P119770.1,,no IPS match,,
RL4_JR_09386,5521,6849,10998,0,0,0,0,0,0,1,1,0,0,9,0,0,0,0,1.604375123,0,1.215913117,1.548255618,0.785343908,0.432251959,NA,0.506949614,0,4.445670055,1.684084616,2.639813946,0.008295155,0.029265794,14.31596789,1,3.587403809,1.137137137,3.154767964,0.001606258,0.008330818,13.55637559,1,3.585489133,1.02228156,3.507340125,0.00045261,0.003857474,1.298421939,0,1.709838385,1.324890129,1.290551079,0.196859389,0.31816078,N,-,,Helix-loop-helix DNA-binding,F:protein dimerization activity,IPR011598 (G3DSA:4.10.280.GENE3D); IPR011598 (PFAM); IPR011598 (PROSITE_PROFILES); IPR011598 (SUPERFAMILY),,
RL4_JR_09387,4006,4230,4185,0,4,9,0,0,5,2,2,6,0,9,4,0,6,0,24.67404544,1,4.240216359,0.812361774,5.219615811,1.79E-07,3.34E-06,0.561238784,1,4.298962586,1.604718034,2.678951999,0.007385298,0.027006498,354.1739094,1,7.938568328,1.318291633,6.021860514,1.72E-09,8.68E-08,1.676600624,1,1.227646391,1.328396369,0.924156689,0.355404742,0.501546851,9.146508905,1,3.2170766,1.058104595,3.040414545,0.002362527,0.009759522,N,-,,transaldolase,P:carbohydrate metabolic process; F:catalytic activity,IPR001585 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); IPR001585 (PANTHER); PTHR10683:SF5 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_09388,131,202,114,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,12.26744429,0,-0.237540644,1.209351968,-0.196419777,0.844281618,0.921878003,2.680413809,0,2.043097312,1.351067818,1.512209295,0.130480627,0.247962074,54.01909694,0,2.784787262,1.36625167,2.038268149,0.041523123,0.098472734,26.656956,1,0.746732615,1.069946267,0.697915996,0.48522973,0.625375638,6.852775799,1,-0.69037036,1.249047934,-0.552717267,0.580457028,0.692975759,N,-,,transporter (major facilitator superfamily),"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:substrate-specific transmembrane transporter activity; P:transmembrane transport; P:nitrogen compound metabolic process; C:integral component of membrane",IPR003663 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR003663 (TIGRFAM); IPR005828 (PFAM); PTHR23500 (PANTHER); PTHR23500:SF117 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.69, the major facilitator superfamily (mfs).
RL4_JR_09389,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.04775185,0,4.923797011,0.915851943,5.376193222,7.61E-08,1.53E-06,0.187716477,0,5.87862762,1.865519541,3.15120131,0.001626004,0.015023052,0.489831913,0,3.217564064,1.29793129,2.478994142,0.013175347,0.040152683,10.20052485,0,3.746010004,1.17611137,3.185081021,0.001447135,0.010091075,0.486408297,0,3.12601245,1.263591943,2.473909769,0.013364345,0.039639093,N,-,,mannose-6-phosphate isomerase,P:carbohydrate metabolic process; F:mannose-6-phosphate isomerase activity; F:isomerase activity,IPR014710 (G3DSA:2.60.120.GENE3D); IPR014710 (G3DSA:2.60.120.GENE3D); PTHR18964 (PANTHER); PTHR18964:SF118 (PANTHER); IPR011051 (SUPERFAMILY),,
RL4_JR_09390,10,18,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.914615244,0,-0.892193763,1.19303704,-0.747834085,0.45456024,0.643397229,2.209755511,0,2.321621664,1.299101695,1.787097709,0.073921698,0.160221718,50.00996773,0,2.72413002,1.169906304,2.328502728,0.019885425,0.055368547,25.23441471,0,0.989714202,1.012159332,0.97782451,0.328161127,0.474797286,17.23006504,0,1.790385197,0.849660093,2.107178166,0.035102139,0.084924529,N,-,,DNA ligase 1,F:nucleotide binding; P:DNA repair; F:DNA ligase activity; P:cellular macromolecule biosynthetic process,IPR012309 (PFAM); G3DSA:3.30.1490.70 (GENE3D); G3DSA:3.30.470.30 (GENE3D); IPR012308 (G3DSA:1.10.3260.GENE3D); G3DSA:2.40.50.140 (GENE3D); IPR000977 (TIGRFAM); IPR012308 (PFAM); IPR012310 (PFAM); PTHR10459:SF38 (PANTHER); PTHR10459 (PANTHER); PTHR10459 (PANTHER); PTHR10459:SF38 (PANTHER); IPR012310 (PROSITE_PROFILES); SSF56091 (SUPERFAMILY); IPR012308 (SUPERFAMILY); IPR012340 (SUPERFAMILY),,
RL4_JR_09391,1020,837,1132,0,3,1,0,0,0,0,0,0,0,1,0,0,0,0,46.44962632,1,2.671194597,0.605938664,4.408358069,1.04E-05,0.000120247,49.27229598,0,5.095199619,0.722073244,7.056347341,1.71E-12,4.55E-10,308.2322347,0,5.673995602,0.538797119,10.53085736,6.23E-26,1.43E-23,58.05295531,1,2.505254792,0.655712178,3.820662293,0.000133094,0.001362563,48.60461188,0,3.365599149,0.651985992,5.162072793,2.44E-07,4.55E-06,N,-,,aldose 1-epimerase,P:carbohydrate metabolic process; F:carbohydrate binding; F:isomerase activity,IPR008183 (PFAM); IPR014718 (G3DSA:2.70.98.GENE3D); PTHR10091:SF0 (PANTHER); PTHR10091 (PANTHER); IPR011013 (SUPERFAMILY),,
RL4_JR_09392,1647,2019,2371,5,1,6,0,0,0,4,0,0,0,2,0,0,0,0,12.3650271,1,1.368949698,1.048803411,1.30524909,0.191808043,0.352108465,1.505426151,0,2.875249022,1.367648507,2.102330391,0.035524344,0.090278035,43.62600211,1,3.060651235,0.768888821,3.98061612,6.87E-05,0.000908475,8.531151642,1,0.741618724,1.171964583,0.632799605,0.526864515,0.660664337,3.879111075,0,0.130437322,1.231403626,0.105925725,0.915641283,0.94620004,N,-,,hypothetical protein SPSK_07341,P:biological_process; C:cellular_component; F:molecular_function,IPR012942 (PFAM),,
RL4_JR_09393,1274,874,733,0,1,0,0,0,0,0,0,0,0,1,0,0,0,2,2.996565324,1,0.314191131,1.290307857,0.243500905,0.807617384,0.902441818,0.970148936,0,3.509319333,1.475009534,2.37918417,0.017351005,0.051518589,2.496155356,0,0.869271216,1.252186268,0.694202803,0.487555035,0.622368828,2.877900924,1,0.447773106,1.266226144,0.353628069,0.723617636,0.815882914,2.442650023,1,0.797459567,1.242344173,0.641899068,0.520938719,0.645380506,N,-,,glucanase b,P:biological_process; C:cellular_component; F:molecular_function; F:hydrolase activity,IPR032477 (PFAM); PTHR38165 (PANTHER); PTHR38165:SF1 (PANTHER),,
RL4_JR_09394,5357,4076,2928,0,1,0,0,0,0,0,0,0,1,1,0,0,4,1,44.09326836,1,4.706321567,0.847112093,5.555724687,2.76E-08,6.15E-07,0.66435041,0,4.055603385,1.557298426,2.604255753,0.009207402,0.031670173,1.72212475,0,1.405211323,1.276946799,1.100446255,0.271137734,0.409823592,1.98689835,1,0.982619271,1.306845634,0.75190156,0.45211026,0.594186965,1.691460082,1,1.328272413,1.266499753,1.048774316,0.294282001,0.429214241,Y,-,,ammonium transporter,F:ammonium transmembrane transporter activity; C:integral component of plasma membrane; P:organic cation transport; P:ammonium transmembrane transport; P:pseudohyphal growth; P:nitrogen utilization,IPR029020 (G3DSA:1.10.3430.GENE3D); IPR024041 (PFAM); IPR001905 (TIGRFAM); PTHR11730:SF21 (PANTHER); IPR001905 (PANTHER); IPR024041 (SUPERFAMILY),1.A.11.3.3, the ammonium transporter channel (amt) family.
RL4_JR_09395,31939,31992,53735,3,7,79,0,0,1,4,6,0,7,31,1,0,29,1,93.48528598,1,3.016273042,0.575161832,5.244216274,1.57E-07,2.98E-06,41.23944156,1,4.124879635,0.809439966,5.095967346,3.47E-07,3.46E-05,27.31231089,1,0.731610878,1.061804174,0.689026184,0.49080679,0.624629534,32.91570458,1,1.188629891,0.798776115,1.488063887,0.136734046,0.248239594,68.97230746,1,2.674056295,0.643422831,4.155986024,3.24E-05,0.000268141,N,-,,methylglutaconyl- hydratase,F:catalytic activity; P:metabolic process,IPR001753 (PFAM); IPR029045 (G3DSA:3.90.226.GENE3D); PTHR11941 (PANTHER); PTHR11941:SF61 (PANTHER); PTHR11941:SF61 (PANTHER); PTHR11941 (PANTHER); PTHR11941:SF61 (PANTHER); PTHR11941 (PANTHER); IPR029045 (SUPERFAMILY),,
RL4_JR_09396,1229,1084,1067,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,10.87820777,1,0.025833236,1.139569494,0.022669294,0.981914069,0.991069033,2.260428249,0,2.288953583,1.298348847,1.762972708,0.077905093,0.166925349,18.84905227,0,1.460535375,1.031488825,1.41594881,0.156790492,0.2709708,14.77271243,1,0.945419165,1.013741588,0.932603709,0.351024617,0.497706799,17.33777591,0,1.767706978,0.840628188,2.102840475,0.035479717,0.085715135,N,-,,ram signaling pathway,,IPR003591 (SMART); SM00364 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); IPR019487 (PFAM); IPR001611 (PFAM); PTHR23155 (PANTHER); SSF52075 (SUPERFAMILY),1.A.25.3.1, the gap junction-forming innexin (innexin) family.
RL4_JR_09397,959,1051,941,0,0,2,0,0,0,0,0,0,0,2,2,0,0,1,2.589466914,1,0.524886871,1.265964859,0.414614092,0.67842443,0.823800925,0.821338365,0,3.749352026,1.443325341,2.597717866,0.009384557,0.032134804,2.140608645,0,1.090586412,1.225852152,0.889655747,0.373650762,0.517559217,6.48166851,1,1.613563368,1.165268736,1.384713516,0.166140085,0.286912563,2.121269634,1,1.001393266,1.227293815,0.815936048,0.414536713,0.550594808,N,-,,Polyketide KR,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PTHR31944 (PANTHER); PTHR31944:SF61 (PANTHER),,
RL4_JR_09398,1230,1130,1343,0,1,6,0,0,0,0,0,0,0,0,0,0,0,0,8.968877963,1,0.480528833,1.147331324,0.418823075,0.67534544,0.821205559,1.651806512,0,2.741544463,1.339294089,2.047007066,0.040657391,0.100447671,23.76564214,0,2.496893549,0.85713479,2.913069892,0.003578945,0.015411841,4.924242342,0,-0.326917625,1.202982316,-0.271755969,0.785809663,0.861540102,4.191409922,0,0.018726575,1.197357119,0.015639925,0.987521654,0.991635104,N,-,,phosphoinositide 3-kinase regulatory subunit 4,C:membrane; P:metabolic process,IPR005804 (PFAM); PTHR36459 (PANTHER),,
RL4_JR_09399,1820,1738,1339,0,0,0,0,0,1,0,0,0,0,2,0,0,0,0,356.2978114,0,3.238846196,0.541921789,5.976593416,2.28E-09,5.90E-08,29.37170814,1,1.659391183,1.09491038,1.515549778,0.129633234,0.246775477,513.7463099,0,4.165929954,0.533902743,7.802788068,6.06E-15,5.95E-13,79.2106064,1,0.779033351,0.706969416,1.101933596,0.270490541,0.411993163,214.5344743,0,2.91550444,0.66152812,4.407226769,1.05E-05,0.000104548,N,-,,L-xylulose reductase,P:oxidation-reduction process; F:L-xylulose reductase (NADP+) activity,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); PTHR24322:SF447 (PANTHER); PTHR24322:SF447 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09400,6759,7701,8750,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,1.364882758,0,1.448896991,1.386865536,1.044727808,0.296148789,NA,0.432363872,0,4.675090322,1.589179174,2.941827076,0.003262821,0.016208996,1.126991769,0,2.016215037,1.243826491,1.620977726,0.105022416,0.201067877,1.300512945,0,1.593560654,1.277009463,1.247884766,0.21207326,0.346174058,8.837301777,1,3.586272647,1.009101647,3.553926065,0.000379526,0.002142891,N,-,,hypothetical protein THAR02_01537,,IPR032675 (G3DSA:3.80.10.GENE3D),,
RL4_JR_09401,2351,3270,3917,0,0,0,0,0,0,0,0,1,0,5,0,0,0,1,11.19690515,0,-1.587412782,1.20723527,-1.314915842,0.188538188,0.347513451,3.550642357,0,1.637362151,1.267882927,1.291414306,0.196560052,0.33992497,9.252830317,1,-1.021041543,1.204878569,-0.847422778,0.396759513,0.539239268,10.67705635,1,-1.443750553,1.204346907,-1.198782962,0.230612349,0.367303765,9.166019756,1,-1.110036616,1.214015895,-0.914350974,0.360532454,0.498006971,N,-,,hypothetical protein F503_02134,,no IPS match,,
RL4_JR_09402,3161,4048,4890,2,4,0,0,0,0,0,0,0,0,1,0,0,2,0,2.504803277,1,0.57273624,1.288098924,0.444636844,0.656582217,0.806322103,0.807067148,0,3.774788181,1.485160039,2.541670986,0.011032397,0.036218122,2.08349174,0,1.129839645,1.243451313,0.908631993,0.363544413,0.507588421,2.402614532,1,0.708077234,1.25857968,0.562600243,0.573707127,0.700528782,2.046244183,1,1.052904856,1.234243337,0.853077205,0.393616492,0.530251061,N,-,,NB-ARC and Ankyrin domain partial,F:catalytic activity; P:nucleoside metabolic process,PTHR10039 (PANTHER),,
RL4_JR_09403,3714,4187,7737,1,2,0,0,0,0,0,2,0,0,5,0,0,7,0,1.303546714,1,1.515318731,1.358120949,1.115746527,0.264530649,NA,0.416383188,0,4.729581066,1.590436344,2.973763197,0.00294172,0.0154422,1.078916251,1,2.079633653,1.229132353,1.691952577,0.090655016,0.180004667,9.267773322,1,3.381917458,1.023519148,3.304205365,0.00095246,0.007096145,1.061745609,1,2.000000182,1.210818351,1.651775578,0.098580309,0.188788657,N,-,,kinase,F:ATP binding; F:protein kinase activity; P:protein phosphorylation,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR24055:SF210 (PANTHER); PTHR24055 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_09404,772,946,1342,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0.300893118,0,3.630360747,2.478189002,1.464924888,0.142941412,NA,0.096244407,0,6.842777279,2.105681704,3.249673141,0.001155377,0.015023052,0.249146345,0,4.194400056,1.318113459,3.182123683,0.001461994,0.007745277,0.287389129,1,3.771874633,1.596050681,2.363254926,0.018115204,0.073513299,0.244929111,0,4.116083597,1.241007153,3.316728341,0.000910781,0.004428082,N,-,,domain,C:cellular_component; F:molecular_function,IPR018392 (PFAM); PTHR21666 (PANTHER); PTHR21666:SF212 (PANTHER); IPR018392 (SUPERFAMILY),,
RL4_JR_09405,1766,1866,1255,0,0,3,0,0,0,0,0,0,1,1,0,0,6,0,22.42799933,1,-1.408318408,2.091761793,-0.673269018,0.50077616,0.687419134,5.864608059,0,0.913498021,1.826830962,0.500045182,0.617043264,0.748168653,15.18557841,0,-1.735619274,2.438327688,-0.711807229,0.476584156,0.613235637,17.52572564,1,-2.158557017,2.438680676,-0.885133113,0.376084842,0.521553079,14.801785,1,-1.801463408,2.430843949,-0.741085584,0.45864155,0.590356686,N,-,,zinc-regulated transporter 1,C:integral component of membrane; C:endoplasmic reticulum; F:high-affinity zinc uptake transmembrane transporter activity; C:plasma membrane; P:high-affinity zinc II ion transport,IPR004698 (TIGRFAM); IPR003689 (PFAM); PTHR11040 (PANTHER); PTHR11040:SF32 (PANTHER),2.A.5.1.1, the zinc (zn(2+))-iron (fe(2+)) permease (zip) family.
RL4_JR_09406,1016,808,1146,0,0,8,1,0,0,0,0,0,1,2,1,0,8,0,89.43482199,1,-1.218786733,0.687884412,-1.771790016,0.076429421,0.181781695,22.38808586,1,-1.019174216,1.198147222,-0.850625196,0.394977588,0.559077493,107.1058229,0,-0.51699981,0.670331428,-0.771259989,0.440552843,0.580673999,75.18280168,1,-2.372090305,1.019371763,-2.327011981,0.019964628,0.076714457,57.53860485,1,-3.760240133,1.198020979,-3.138709755,0.001696934,0.007386698,N,-,,"hypothetical protein FLAG1_12020, partial",,no IPS match,,
RL4_JR_09407,2352,2176,2863,0,0,1,0,0,0,0,3,0,0,4,3,0,1,0,3.93932899,1,-0.080193928,1.221823004,-0.065634652,0.9476687,0.973933139,1.266681196,0,3.124560461,1.385447248,2.255272054,0.024116258,0.066640666,3.268584393,1,0.480528033,1.214987374,0.395500434,0.692473602,0.789660142,3.769476971,1,0.058629715,1.217375442,0.04816075,0.96158813,0.978355082,3.203478473,1,0.406446139,1.205387043,0.337191395,0.735972623,0.815376169,N,-, Effector probability:0.559,MFS general substrate transporter,P:transmembrane transport; C:membrane; C:integral component of membrane,PTHR23502:SF30 (PANTHER); PTHR23502 (PANTHER); PTHR23502 (PANTHER); PTHR23502:SF30 (PANTHER),2.A.1.2.33, the major facilitator superfamily (mfs).
RL4_JR_09408,291439,189410,273845,11,16,22,0,6,7,0,9,11,1,11,14,0,16,7,302.5955438,1,8.35526943,2.251804814,3.71047676,NA,NA,0.29551482,1,5.224302405,1.731856367,3.016591044,0.002556344,0.015349618,16.45281703,1,4.398316281,1.067008089,4.122102099,3.75E-05,0.000568605,110.1981583,1,7.016316566,0.51305548,13.67555135,1.42E-42,4.36E-40,42.86494142,1,6.333522231,0.611990222,10.34905789,4.23E-25,1.48E-22,Y,-,,gegh16,,IPR021476 (PFAM); PTHR34618:SF3 (PANTHER); PTHR34618 (PANTHER),,
RL4_JR_09409,35307,29483,36231,15,7,13,0,0,0,3,3,15,3,18,5,0,11,2,2398.857049,1,-5.12545521,0.492235203,-10.4126141,2.17E-25,5.91E-23,751.149449,0,-6.087435185,1.213871169,-5.014893953,5.31E-07,4.88E-05,1986.689208,1,-5.569924969,0.705406891,-7.896045591,2.88E-15,2.91E-13,2519.882995,1,-2.92766268,0.40609496,-7.209305622,5.62E-13,2.78E-11,1982.548885,1,-4.808016091,0.574756152,-8.365314701,6.00E-17,1.02E-14,Y,-,,Interferon-induced GTP-binding Mx2,F:nucleotide binding; F:catalytic activity; C:membrane,IPR022812 (PRINTS); IPR001401 (SMART); IPR013781 (G3DSA:3.20.20.GENE3D); IPR000375 (PFAM); IPR024655 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR029044 (G3DSA:3.90.550.GENE3D); IPR022812 (PFAM); IPR001173 (PFAM); PTHR35408 (PANTHER); IPR029044 (SUPERFAMILY); IPR017853 (SUPERFAMILY); IPR027417 (SUPERFAMILY),4.D.3.2.1, the glycan glucosyl transferase (opgh) family.
RL4_JR_09410,1820,1903,1679,0,0,3,0,0,2,0,3,2,0,0,0,0,7,0,967.2116576,1,-7.067327646,1.151604585,-6.136939482,8.41E-10,2.37E-08,325.3570371,1,-3.152653164,0.986266177,-3.19655407,0.001390798,0.015023052,854.5997597,1,-3.639667439,0.564256432,-6.450378289,1.12E-10,6.38E-09,1047.442637,0,-2.822056571,0.400440193,-7.047385898,1.82E-12,8.35E-11,836.61987,1,-3.915311414,0.593758901,-6.594109848,4.28E-11,3.23E-09,N,-,,beta- -glucan-binding,"P:carbohydrate metabolic process; C:integral component of membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR000757 (PFAM); IPR013320 (G3DSA:2.60.120.GENE3D); PTHR10963 (PANTHER); PTHR10963:SF28 (PANTHER); IPR000757 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),,
RL4_JR_09411,25912,23508,24147,2,4,2,0,0,0,0,3,1,0,4,5,0,5,7,0.706325346,1,2.399323809,1.681844189,1.426602907,0.153694386,NA,0.225238939,0,5.616022288,1.779081271,3.156697999,0.001595665,0.015023052,0.584197533,1,2.964711208,1.256649132,2.359219556,0.018313417,0.052359513,0.673954546,1,2.54221617,1.338118642,1.899843624,0.057453644,0.133605454,0.575402094,1,2.884070413,1.22331915,2.357578079,0.018394587,0.051143006,Y,-,,PAN domain-containing,,no IPS match,,
RL4_JR_09412,2354,2530,2582,0,2,5,0,0,1,0,0,0,0,0,0,0,5,0,4.94382135,1,-0.408173374,1.266739423,-0.322223629,0.747283285,0.867929533,1.567693315,1,2.816734576,1.388091964,2.029213228,0.042436577,0.1037293,4.092408346,0,0.155736483,1.244312631,0.125158645,0.900397956,0.938401164,4.722411199,0,-0.266968372,1.251522633,-0.213314857,0.831081386,0.894259752,4.06736549,1,0.06209877,1.254601116,0.049496823,0.960523369,0.973947415,N,-, Effector probability:0.649,---NA---,,no IPS match,,
RL4_JR_09413,341,238,522,0,0,0,0,0,0,2,0,2,0,0,0,0,0,2,58.33997842,0,0.313636708,0.736742786,0.4257072,0.670321215,0.817411132,6.418228824,0,0.783317595,1.226862494,0.638472199,0.523166346,0.672528543,23.16655195,1,-0.908305318,1.189646254,-0.763508745,0.445160049,0.584670548,74.78273051,0,1.260262391,0.568170978,2.218104128,0.026547733,0.086566351,16.45349151,1,-1.954101417,1.196030748,-1.633822057,0.10229622,0.194251542,N,-,,autophagy 5,C:cytoplasm; C:membrane; P:transport,IPR007239 (PFAM); PTHR13040:SF2 (PANTHER); IPR007239 (PANTHER),9.A.15.2.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_09414,14507,9024,9913,7,2,27,0,0,2,0,3,5,0,2,4,0,6,4,51.06750901,1,-0.57345225,0.781349362,-0.733925536,0.462994123,0.651225181,11.4959561,1,-0.05748682,1.236399505,-0.046495343,0.962915446,0.980250441,37.50555599,1,-1.739730517,1.203367019,-1.445718962,0.148256044,0.259903755,71.60296292,1,0.553197092,0.591546955,0.935170214,0.349700586,0.496316013,40.62945516,1,-0.577216322,0.859328143,-0.671706526,0.501770546,0.629466829,N,-,,c6 zinc finger domain containing,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR12439 (PANTHER); PTHR12439 (PANTHER); PTHR12439:SF12 (PANTHER); PTHR12439:SF12 (PANTHER); PTHR12439 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09415,721,918,813,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,20.20647692,1,-0.025692235,1.010361234,-0.025428762,0.97971297,0.989985897,4.005482484,0,1.463512351,1.250202042,1.170620669,0.241751286,0.393916052,10.40405394,0,-1.190203775,1.193008248,-0.997649243,0.318449474,0.461161847,106.097717,1,2.63123366,0.482315634,5.455418556,4.89E-08,1.18E-06,14.13253548,0,-0.34454313,1.127252943,-0.305648464,0.759872316,0.832235621,N,-,,membrane,C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_09416,5482,7221,12115,0,4,12,0,0,1,0,5,3,4,0,0,0,1,2,28.57309256,1,-0.775298983,1.04294848,-0.743372274,0.457256326,0.645715268,6.631278847,1,0.736150789,1.244749483,0.591404776,0.554249241,0.699602297,34.87170678,1,-0.097805338,1.048756346,-0.0932584,0.92569828,0.956010343,47.26113744,1,0.388286252,0.772137593,0.50287184,0.615054381,0.734193068,24.89187278,1,-0.359293381,1.011632814,-0.355161849,0.722468344,0.804800036,N,-,,dna excision repair ercc-8,P:DNA repair; C:membrane; C:intracellular part,IPR020472 (PRINTS); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR22850 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_09417,66,75,86,0,0,12,0,0,0,0,0,0,0,5,0,0,4,0,26.06499422,1,0.362028909,1.093015195,0.33122038,0.740478027,0.863625206,3.168766871,0,1.801469705,1.348695549,1.335712649,0.181643213,0.320596095,8.303474538,0,-0.864895336,1.255733393,-0.688757136,0.490976114,0.624766488,13.59543323,1,-0.345116686,1.211719729,-0.284815604,0.775785417,0.854900669,8.28706525,1,-0.964646587,1.274240565,-0.757036476,0.44902801,0.580923972,N,-,,F-box domain containing,,no IPS match,,
RL4_JR_09418,32,66,81,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,38.19987992,0,1.236328707,0.641474009,1.927324709,0.053939176,0.14085653,4.918410709,0,1.167387908,1.263924152,0.923621806,0.355683256,0.519913592,12.68901639,0,-1.476446455,1.202240797,-1.228078816,0.219417382,0.348614836,86.23317053,1,2.29178807,0.491119635,4.666455806,3.06E-06,4.95E-05,24.01656894,0,0.650432837,0.85219081,0.763247889,0.445315574,0.578055601,N,-,,DNA partial,F:DNA binding; P:DNA repair; P:DNA catabolic process; P:nucleic acid phosphodiester bond hydrolysis; F:zinc ion binding; F:deoxyribonuclease activity; F:endonuclease activity; F:lyase activity; C:intracellular,IPR005135 (G3DSA:3.60.10.GENE3D); IPR010666 (PFAM); IPR005135 (PFAM); IPR004808 (PANTHER); PTHR22748:SF4 (PANTHER); IPR004808 (PROSITE_PROFILES); IPR005135 (SUPERFAMILY),,
RL4_JR_09419,5873,4665,3142,0,4,9,0,0,0,0,0,0,0,3,0,0,1,1,125.7743198,1,0.340446732,0.582364103,0.584594295,0.558820545,0.736606561,19.99328523,0,-0.85589368,1.237789694,-0.691469386,0.489270613,0.645095368,103.4176123,0,0.117924916,1.301910601,0.090578352,0.927827634,0.956881142,156.5782084,1,0.787281088,0.475308981,1.65635643,0.097649659,0.192504439,87.77742594,1,-0.141743398,0.620230499,-0.228533421,0.819231577,0.878771026,N,-,,PA domain containing,F:metal ion binding; C:intracellular membrane-bounded organelle; C:membrane; C:cytoplasmic part,IPR001841 (SMART); G3DSA:3.50.30.30 (GENE3D); IPR001841 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR003137 (PFAM); PTHR22765:SF55 (PANTHER); PTHR22765 (PANTHER); PTHR22765:SF55 (PANTHER); PTHR22765 (PANTHER); PTHR22765:SF55 (PANTHER); IPR001841 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); SSF52025 (SUPERFAMILY),3.A.16.1.4, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_09420,308,229,141,0,5,0,0,0,0,0,0,0,0,0,2,0,1,0,653.4273499,1,0.61980821,0.381405708,1.625062753,0.104149188,0.228523152,136.1723927,0,0.279434709,0.670912534,0.416499461,0.677044561,0.793911614,607.9802976,0,0.946191905,0.337857224,2.800567333,0.005101286,0.019201401,450.3339314,1,-0.105508567,0.386609166,-0.272907567,0.78492427,0.861035561,400.2571784,1,0.10427491,0.597685571,0.174464492,0.861500434,0.907870562,N,-, Effector probability:0.69,cytochrome c oxidase subunit,F:cytochrome-c oxidase activity; C:integral component of membrane; P:hydrogen ion transmembrane transport; C:mitochondrial respiratory chain complex IV; P:cellular process,IPR001349 (PFAM); IPR001349 (G3DSA:4.10.95.GENE3D); PTHR11504:SF0 (PANTHER); IPR001349 (PANTHER); IPR001349 (PRODOM); IPR001349 (SUPERFAMILY),3.D.4.8.1, the proton-translocating cytochrome oxidase (cox) superfamily.
RL4_JR_09421,2818,2336,2764,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0.898797729,0,2.051844965,1.624591682,1.26299118,0.206592349,NA,0.286512874,0,5.268998762,1.75066911,3.00970568,0.00261501,0.015349618,0.741836104,0,2.620581161,1.290186087,2.031165262,0.042238233,0.099669214,0.855808504,1,2.197906012,1.366244766,1.608720536,0.107677463,0.207308294,0.728059126,0,2.54472261,1.258380918,2.022219643,0.043153666,0.099801477,N,-,,---NA---,,no IPS match,,
RL4_JR_09422,30173,24359,28704,3,9,5,1,0,0,0,3,7,3,22,3,0,13,0,5.469994552,1,-0.553670479,1.205607917,-0.459245889,0.646057601,0.798449075,1.742418049,1,2.664439901,1.324535528,2.011603195,0.044261782,0.107207936,4.522509663,1,0.011945803,1.202600656,0.009933308,0.992074497,0.996800537,5.217592687,1,-0.410473436,1.201590958,-0.341608293,0.732645695,0.821488114,4.457671368,1,-0.06992618,1.202778242,-0.058137217,0.953639329,0.96982706,N,-, Effector probability:0.715,HMG mating type,,IPR009071 (SMART); IPR009071 (PFAM); IPR009071 (G3DSA:1.10.30.GENE3D); PTHR10270:SF237 (PANTHER); PTHR10270 (PANTHER); IPR009071 (PROSITE_PROFILES); IPR009071 (SUPERFAMILY),,
RL4_JR_09423,14187,14707,22856,0,16,2,0,0,7,0,0,5,1,1,0,0,8,4,0.045930999,1,6.343508749,3.929957056,1.614142002,0.106496629,NA,0.014731443,1,9.551956986,3.929879871,2.430597702,0.015073941,0.04630605,0.037732665,1,6.920274808,2.57682804,2.685578821,0.007240429,0.025276589,0.043515448,1,6.496267866,3.930142116,1.652934595,0.098344175,0.193560037,0.036387792,1,6.870024111,1.824800153,3.764809039,0.000166676,0.001069454,N,-,,alpha box,P:cellular process,IPR006856 (PFAM),,
RL4_JR_09424,7805,5481,5662,0,3,5,1,0,4,0,0,0,5,7,2,0,13,1,0.061069864,1,5.931441515,3.924207748,1.511500383,0.130661011,NA,0.019059672,1,9.178558371,3.105632403,2.955455502,0.003122077,0.015928259,0.049978748,0,6.512502019,1.873928174,3.475321044,0.000510242,0.003430075,0.057707521,1,6.088150153,3.111262756,1.956810026,0.050369808,0.123754988,0.049626429,1,6.424727638,1.47579868,4.353390285,1.34E-05,0.00012877,N,-,,---NA---,,no IPS match,,
RL4_JR_09425,1448,2271,2420,0,1,1,0,0,0,0,0,0,0,4,0,0,2,0,0.123054944,1,4.920076857,3.663852584,1.342869765,0.179314148,NA,0.039245953,0,8.136478362,2.529945979,3.216068022,0.0012996,0.015023052,0.102034469,0,5.480220225,1.467755976,3.733740701,0.000188657,0.001699253,0.117713547,1,5.059045022,2.191573486,2.30840766,0.020976473,0.078455086,0.100969098,1,5.393149231,1.295428104,4.163217714,3.14E-05,0.000261926,N,-,,---NA---,,no IPS match,,
RL4_JR_09426,14546,19258,23997,4,7,32,6,0,2,0,1,2,5,6,2,2,3,3,206.4787495,1,-0.027358626,0.902307209,-0.030320744,0.975811253,0.987675955,35.53389301,1,-1.685587672,1.204392843,-1.399533118,0.161653174,0.292920413,211.0191852,1,0.307421362,0.432812194,0.710288126,0.477525482,0.613900695,309.2516167,1,1.101468998,0.35428881,3.108957906,0.001877485,0.012581178,135.3816832,1,-0.624317598,0.52114779,-1.197966507,0.230930056,0.358504572,N,-,,cytoskeleton assembly control sla2,"C:incipient cellular bud site; F:actin binding; P:actin filament organization; F:clathrin binding; F:phospholipid binding; P:endocytosis; F:protein binding, bridging; C:actin cortical patch",IPR002558 (SMART); IPR013809 (SMART); IPR008942 (G3DSA:1.25.40.GENE3D); IPR011417 (PFAM); IPR002558 (G3DSA:1.20.1410.GENE3D); IPR002558 (PFAM); IPR030224 (PANTHER); PTHR10407:SF15 (PANTHER); IPR002558 (PRODOM); IPR013809 (PROSITE_PROFILES); IPR002558 (PROSITE_PROFILES); IPR002558 (SUPERFAMILY); IPR008942 (SUPERFAMILY),,
RL4_JR_09427,9831,9388,11326,0,5,11,6,0,0,6,0,4,0,4,2,0,0,5,42.41005454,1,-0.173832544,0.781235025,-0.222509921,0.823916951,0.91111269,85.36885307,1,2.030087366,0.997620679,2.034929115,0.041858006,0.102763361,44.6507706,1,0.10476883,0.869104011,0.120548092,0.904048986,0.941043793,51.27076976,1,0.306233761,0.700808352,0.436972191,0.662131516,0.770023202,44.47280442,1,0.252225579,0.760968386,0.331453427,0.740302014,0.81813866,N,-,,DNA polymerase zeta catalytic,F:organic cyclic compound binding; F:heterocyclic compound binding; F:transferase activity; P:DNA metabolic process,IPR006172 (PRINTS); IPR006172 (SMART); IPR006133 (PFAM); G3DSA:1.10.287.690 (GENE3D); IPR025687 (PFAM); IPR023211 (G3DSA:3.90.1600.GENE3D); IPR006134 (PFAM); IPR012337 (G3DSA:3.30.420.GENE3D); PTHR10322 (PANTHER); IPR030559 (PTHR10322:PANTHER); IPR030559 (PTHR10322:PANTHER); PTHR10322 (PANTHER); IPR012337 (SUPERFAMILY); SSF56672 (SUPERFAMILY),,
RL4_JR_09428,118,98,99,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.405602635,1,3.199406034,2.259678394,1.41586787,0.156814194,NA,0.127425039,0,6.437323643,2.039143416,3.15687636,0.001594689,0.015023052,59.00078593,0,7.404324668,0.649247161,11.40447754,3.97E-30,1.22E-27,17.72153675,0,5.643620367,0.928507333,6.078164563,1.22E-09,3.93E-08,8.055096631,0,5.308755192,1.071921478,4.952559775,7.32E-07,1.12E-05,N,-, Effector probability:0.774,---NA---,,no IPS match,,
RL4_JR_09429,37824,29331,27237,0,3,15,0,0,0,2,3,0,2,1,0,0,2,1,58.9205479,1,6.372825802,0.559965532,11.38074657,5.22E-30,2.66E-27,331.4626853,0,10.41406159,0.467436105,22.27911254,5.89E-110,5.96E-106,951.73194,1,10.34807171,0.334524087,30.93371182,4.21E-210,4.26E-206,619.6031248,1,9.553543646,0.510862439,18.70081438,4.88E-78,3.80E-75,263.9075288,1,8.631916697,0.735966897,11.72867521,9.09E-32,5.41E-29,Y,-,,glycosyl hydrolase family 18,F:chitinase activity; P:carbohydrate metabolic process; F:chitin binding; P:chitin catabolic process,IPR001002 (SMART); IPR011583 (SMART); IPR001002 (G3DSA:3.30.60.GENE3D); IPR013781 (G3DSA:3.20.20.GENE3D); IPR001223 (PFAM); IPR001002 (PFAM); PTHR11177:SF207 (PANTHER); PTHR11177 (PANTHER); PTHR11177 (PANTHER); PTHR11177:SF207 (PANTHER); IPR001002 (PROSITE_PROFILES); IPR017853 (SUPERFAMILY); IPR001002 (SUPERFAMILY),9.B.87.1.15, the selenoprotein p receptor (selp-receptor) family.
RL4_JR_09430,806,516,1063,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0.019426228,0,7.580809812,3.961222504,1.913755111,0.055651454,NA,0.00600472,0,10.83982954,3.962959958,2.735286163,0.006232607,0.023876729,0.016016853,0,8.147263859,2.853492395,2.855190318,0.004301105,0.016956535,0.018502896,1,7.725994189,3.961370727,1.950333539,0.051136378,0.124880807,0.016327052,0,8.023085814,1.667298077,4.81202847,1.49E-06,2.01E-05,N,-,,hypothetical protein PV05_00873,C:cellular_component,IPR021889 (PFAM); PTHR37489 (PANTHER); PTHR37489:SF1 (PANTHER),,
RL4_JR_09431,767,856,601,0,4,12,0,0,0,1,0,0,4,19,6,0,4,4,0.040629395,1,6.519518409,3.932956239,1.657663603,0.097385384,NA,0.012873165,0,9.745468895,3.165782515,3.078375994,0.002081321,0.015023052,0.033437834,1,7.093855841,1.819035928,3.899788746,9.63E-05,0.001133378,4.05017271,1,7.621196343,1.28876596,5.913561174,3.35E-09,1.02E-07,0.032900293,1,7.018393941,1.38996904,5.049316738,4.43E-07,7.16E-06,N,-, Effector probability:0.625,hypothetical protein SPBR_07947,,no IPS match,,
RL4_JR_09432,141626,90629,108080,22,51,72,0,0,4,16,0,5,8,29,14,0,37,2,0.05556864,1,6.066877715,3.925920345,1.545338973,0.122264293,NA,0.018037991,1,9.258758986,2.968023334,3.119503435,0.001811561,0.015023052,0.04635834,1,6.619694082,1.695987657,3.903149916,9.49E-05,0.001128758,0.053442516,1,6.198509343,2.979354757,2.080487169,0.037480871,0.102975775,0.045335581,1,6.543866354,1.355370867,4.8281002,1.38E-06,1.88E-05,N,-,,salicylate hydroxylase,F:FAD binding; P:transmembrane transport; C:integral component of membrane; P:oxidation-reduction process; F:monooxygenase activity,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789 (PANTHER); PTHR13789:SF147 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_09433,7573,6079,6249,1,0,2,0,1,0,3,2,1,1,4,0,0,1,0,3.26434435,1,0.190625002,1.22601321,0.155483645,0.876440047,0.939923479,1.04416171,1,3.403151742,1.401004258,2.429080228,0.015137182,0.046472114,2.706951162,1,0.752079658,1.213738232,0.619639094,0.535495423,0.664300411,3.122500642,1,0.329894894,1.217732329,0.270909202,0.786460867,0.861704567,2.668686332,1,0.669940242,1.210861791,0.553275565,0.58007473,0.692768038,N,-, Effector probability:0.806,duf567 domain containing,,IPR007612 (PFAM); PTHR31087 (PANTHER); IPR025659 (SUPERFAMILY),,
RL4_JR_09434,4108,2782,4144,0,0,4,0,0,0,0,2,0,0,2,0,0,2,0,7.664268159,1,8.51743021,3.919560507,2.173057462,0.029775993,0.089810576,0.008171095,0,10.39483299,3.948125313,2.632852851,0.008467102,0.029683219,0.022200703,1,7.679165548,3.823608138,2.008355791,0.044605497,0.103693698,0.025675008,1,7.253586273,3.946199217,1.838119637,0.066044778,0.145480761,0.023033832,1,7.527792441,2.33788432,3.219916562,0.001282279,0.005874695,N,-,,arylsulfotransferase (ASST) domain,F:transferase activity,PF14269 (PFAM); PTHR35340 (PANTHER); PTHR35340:SF4 (PANTHER); IPR011048 (SUPERFAMILY),,
RL4_JR_09435,254,154,200,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.888314064,0,-1.254449147,1.201927021,-1.043698266,0.296625012,0.482333436,2.833209281,0,1.963025843,1.284403084,1.528356532,0.126424041,0.242584401,7.362543441,0,-0.691409556,1.203465307,-0.574515569,0.565618968,0.690085133,47.03516454,0,2.00581414,1.338457379,1.498601428,0.133977062,0.244285567,7.27676872,0,-0.777108307,1.209445347,-0.642532802,0.520527298,0.645120344,N,-,,Heterokaryon incompatibility OR allele,,IPR010730 (PFAM); PTHR24148 (PANTHER),,
RL4_JR_09436,1106,1308,1506,0,0,0,0,0,0,2,0,0,2,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_09437,12928,12841,16032,6,4,1,0,0,0,0,0,0,2,5,8,0,3,0,0.241123071,1,3.949841155,2.948192818,1.339749941,0.180326655,NA,0.079216985,0,7.124229244,2.391039919,2.979552615,0.002886696,0.015349618,0.201442947,0,4.501678468,1.556852474,2.891525397,0.003833766,0.016016484,0.232101317,1,4.080397144,1.988898957,2.051585944,0.040209919,0.107734397,0.194319228,1,4.448546722,1.416237525,3.14110214,0.001683133,0.007332928,N,-,,short chain dehydrogenase reductase family,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); SM00822 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); PTHR24322:SF290 (PANTHER); PTHR24322:SF290 (PANTHER); IPR002347 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09438,1289,2885,1800,0,0,1,0,0,0,0,6,0,3,7,0,0,3,0,1.655196884,1,1.17062186,1.301359626,0.899537558,0.3683664,NA,0.53143889,0,4.377611993,1.538546613,2.845290455,0.004437094,0.019050679,1.373392717,1,1.731336701,1.227219854,1.410779573,0.158309619,0.272850968,1.583964455,1,1.309323583,1.246515918,1.050386573,0.293540417,0.438168468,1.348758029,1,1.654277834,1.210205487,1.366939625,0.171644231,0.286781821,N,-,,C6 zinc finger domain-containing,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR021858 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31313:SF27 (PANTHER); PTHR31313 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09439,2750,1528,1809,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,3.502067913,1,0.089480562,1.220769514,0.07329849,0.941568593,0.971334924,1.114175549,0,3.309504975,1.38007352,2.398064252,0.016481974,0.049593776,2.895993242,0,0.654800365,1.207931406,0.542084064,0.587760597,0.707801627,3.341283453,0,0.23230789,1.210272268,0.1919468,0.847783878,0.904701914,2.860184558,0,0.570247472,1.208233895,0.471967782,0.636949785,0.739118203,N,-,,Sugar transporter STL1,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,IPR003663 (PRINTS); IPR003663 (TIGRFAM); G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR23500:SF122 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.73, the major facilitator superfamily (mfs).
RL4_JR_09440,893,889,668,0,0,3,0,0,0,0,0,0,0,5,0,0,0,0,0.138700142,1,4.747780355,3.914453358,1.212884641,0.225173929,NA,0.043138551,0,8.000179296,2.853563022,2.803575472,0.00505394,0.020778222,0.11332688,0,5.330917102,1.847766443,2.885060026,0.00391339,0.016192218,0.130870136,1,4.906799422,2.596452279,1.889809207,0.058783482,0.135238072,0.112688447,0,5.237859141,1.614106577,3.245051606,0.001174293,0.005444011,Y,-,,phosphoglycerate mutase,P:nucleocytoplasmic transport; F:structural constituent of nuclear pore; P:dephosphorylation; F:acid phosphatase activity; C:nuclear pore,IPR000560 (PFAM); IPR029033 (G3DSA:3.40.50.GENE3D); PTHR20963:SF22 (PANTHER); PTHR20963 (PANTHER); IPR029033 (SUPERFAMILY),,
RL4_JR_09441,2592,1918,1566,0,2,6,0,0,0,0,8,5,8,14,4,0,10,3,0.091581245,1,5.34627348,3.91840045,1.364402017,0.172441073,NA,0.029230143,0,8.561672753,2.666375963,3.210977323,0.001322844,0.015023052,0.075903786,1,5.907519228,1.511653494,3.907985032,9.31E-05,0.001117712,0.087564111,1,5.486046682,2.427423954,2.260028238,0.023819498,0.083277769,0.074972537,1,5.822926003,1.30005652,4.478979116,7.50E-06,7.90E-05,N,-,,hypothetical protein CH063_07162,F:metal ion binding,IPR027377 (SMART); IPR027377 (PFAM),,
RL4_JR_09442,102,151,144,0,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0.41489296,1,3.166628055,2.237780004,1.415075677,0.157046309,NA,0.132741231,0,6.378612179,2.040871783,3.125435038,0.001775423,0.015023052,0.344752151,0,3.724236362,1.364651756,2.72907454,0.006351235,0.022736881,0.39768012,0,3.302635187,1.581466505,2.088337108,0.036767436,0.101820658,0.341114984,0,3.637080469,1.302597816,2.79217455,0.005235511,0.018612902,N,-,,methyltransferase type 12,F:methyltransferase activity; F:transferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108 (PANTHER); PTHR10108:SF905 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_09443,3677,4105,3371,0,4,0,0,0,0,0,0,1,0,0,0,0,0,0,368.3890936,1,5.611590496,1.192833102,4.704422174,2.55E-06,3.46E-05,11.71082415,0,3.160158094,1.12574034,2.807182067,0.004997699,0.020664504,133.5104392,1,4.544636263,0.436612331,10.40885917,2.26E-25,4.97E-23,26.24561657,0,0.909627938,1.008046957,0.902366633,0.36686214,0.513262286,20.68768872,0,1.195472074,0.967918915,1.235095271,0.216795049,0.342014626,N,-,,alcohol dehydrogenase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR013154 (PFAM); IPR013149 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002085 (PANTHER); PTHR11695:SF280 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_09444,144,78,148,0,0,4,0,0,0,0,0,0,0,1,0,0,3,0,4.532514665,1,-0.282869672,1.214703748,-0.232871326,0.815861325,0.90616701,1.443867667,0,2.935514077,1.350392863,2.173822269,0.029718485,0.078520102,3.75315234,0,0.280602117,1.20949685,0.231999047,0.816538754,0.881116856,4.330047275,1,-0.141832346,1.210479835,-0.11717035,0.906725062,0.943020072,3.710008988,1,0.194775467,1.212812127,0.160598218,0.872409858,0.915447178,N,-,,---NA---,,no IPS match,,
RL4_JR_09445,3933,3338,4522,2,3,0,0,0,0,0,3,1,0,0,0,0,0,0,152.707992,1,-1.113589062,0.722014158,-1.542336878,0.122991752,0.2569441,80.92382978,0,-0.047958334,0.980776671,-0.048898322,0.961000326,0.979088606,101.1017108,1,-3.413044731,1.199749645,-2.844797451,0.004443967,0.017386326,109.1663514,0,-4.79757646,1.201874622,-3.991744539,6.56E-05,0.000747006,101.4240856,0,-2.803383821,0.999473546,-2.80486045,0.005033837,0.017997033,N,-,,Fungal transcriptional regulatory,"F:DNA binding; C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PR00755 (PRINTS); IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY); IPR001138 (SUPERFAMILY),,
RL4_JR_09446,25471,26200,34357,8,27,6,0,0,2,6,1,7,4,8,3,0,9,3,229.5001541,1,-2.871472212,0.798306127,-3.59695625,0.000321963,0.002293948,67.39000636,1,-2.608952646,1.224138568,-2.131255981,0.033068059,0.08545185,174.7817749,1,-5.260429132,1.224443926,-4.29617806,1.74E-05,0.000301238,201.6046594,1,-5.682570769,1.228216794,-4.626683822,3.72E-06,5.90E-05,210.1270812,1,-1.931581892,0.672926312,-2.870421112,0.004099255,0.015208851,N,-,,regulatory alcR,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31001 (PANTHER); PTHR31001:SF62 (PANTHER); PTHR31001:SF62 (PANTHER); PTHR31001 (PANTHER); PTHR31001 (PANTHER); PTHR31001:SF62 (PANTHER); PTHR31001 (PANTHER); PTHR31001:SF62 (PANTHER); PTHR31001 (PANTHER); PTHR31001:SF62 (PANTHER),,
RL4_JR_09447,1560,1351,1853,0,0,3,0,0,0,0,0,0,2,1,5,0,3,0,2.273373365,1,0.712838133,1.325449342,0.537808659,0.590709153,0.761657227,0.717193845,0,3.944943115,1.494561277,2.639532535,0.008302045,0.029279897,1.87451831,0,1.282216461,1.249693467,1.026024777,0.304879905,0.44629904,2.163506219,1,0.85927311,1.269941735,0.676624042,0.498644521,0.636536217,1.861724426,1,1.189814305,1.251298089,0.950863999,0.341673419,0.478683184,N,-,,60S ribosomal L37,F:structural constituent of ribosome; C:ribosome; C:intracellular; P:translation,no IPS match,,
RL4_JR_09448,1786,1752,2206,0,2,6,0,0,0,0,0,0,0,4,0,0,0,0,0.930169153,1,2.002156567,1.498964686,1.335692952,0.181649654,NA,0.296908837,0,5.217457597,1.687200254,3.092376015,0.001985612,0.015023052,0.769761356,0,2.566675976,1.241225721,2.067855937,0.038653572,0.0930406,0.887994546,1,2.144286644,1.29222923,1.659370175,0.097041222,0.191640799,0.75799609,0,2.486242098,1.216129134,2.044389883,0.040915046,0.095828092,N,-,,ankyrin repeat,"P:RNA phosphodiester bond hydrolysis, endonucleolytic; F:ribonuclease III activity; P:RNA phosphodiester bond hydrolysis; F:RNA binding; F:catalytic activity; P:nucleoside metabolic process; P:RNA processing",IPR002110 (SMART); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24198 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR020683 (SUPERFAMILY),8.A.28.1.2, the ankyrin (ankyrin) family.
RL4_JR_09449,2025,1645,1696,0,0,3,0,0,0,0,0,2,4,9,1,0,6,2,0.882417365,1,2.078064841,1.533467758,1.355140876,0.175372678,NA,0.28315961,0,5.285879846,1.711859644,3.087799789,0.002016443,0.015023052,0.732254236,1,2.638511421,1.249673913,2.111359926,0.034741387,0.08586958,0.844547826,1,2.216512136,1.307805893,1.694832657,0.090107171,0.181094902,0.719804648,1,2.560053705,1.220464445,2.097606133,0.035939953,0.086517362,N,-,,beta-lactamase family,,IPR001466 (PFAM); IPR012338 (G3DSA:3.40.710.GENE3D); PTHR22935 (PANTHER); PTHR22935:SF77 (PANTHER); IPR012338 (SUPERFAMILY),9.B.306.1.3, The Putative Calcium Binding Protein with Similarity to the C-termini of Anoctamins (1.A.17.5) (CBP) Family
RL4_JR_09450,2662,2204,1589,0,0,7,0,0,0,0,0,0,0,5,0,0,1,0,0.307080727,1,3.600702079,2.599570289,1.385114338,0.166017508,NA,0.098496401,0,6.809040729,2.211303076,3.079198325,0.002075585,0.015023052,0.255600598,0,4.155786542,1.446998361,2.872005009,0.004078765,0.016563847,0.294813065,1,3.734414769,1.772393843,2.106989247,0.035118512,0.099498352,0.252881782,1,4.068598521,1.355920342,3.000617657,0.002694326,0.010888771,N,-,,steroid monooxygenase,"F:NADP binding; F:flavin adenine dinucleotide binding; P:oxidation-reduction process; F:N,N-dimethylaniline monooxygenase activity",PR00411 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR020946 (PFAM); PTHR23023 (PANTHER); PTHR23023 (PANTHER); PTHR23023:SF91 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_09451,8781,10882,10157,8,23,20,0,0,0,7,0,4,3,8,0,0,0,1,0.715054163,1,2.381301357,1.820683981,1.307915806,0.190901868,NA,0.230089643,0,5.58516771,1.864214464,2.995989903,0.002735555,0.015349618,0.595367383,1,2.936504868,1.339457906,2.192308437,0.028357243,0.073274305,0.686607003,1,2.514891057,1.458488637,1.724313096,0.084651336,0.172696913,0.58688572,1,2.854378648,1.301973216,2.192348209,0.028354373,0.071996597,N,-,,Methylglyoxal reductase (NADPH-dependent),F:catalytic activity,G3DSA:3.90.1200.10 (GENE3D); IPR000058 (G3DSA:4.10.1110.GENE3D); IPR002575 (PFAM); PTHR21310:SF3 (PANTHER); PTHR21310 (PANTHER); SSF118310 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR011009 (SUPERFAMILY),,
RL4_JR_09452,3151,2112,4640,3,0,1,0,0,0,0,0,2,0,0,0,0,0,0,0.207023778,1,4.169673558,2.985385307,1.396695277,0.162505225,NA,0.064968451,0,7.408992326,2.320156121,3.193316286,0.001406488,0.015023052,6.669335361,1,5.696655705,1.250022835,4.557241313,5.18E-06,0.000107747,0.196948858,0,4.316417701,1.890618502,2.283071755,0.022426142,0.080726669,0.17041526,0,4.640254265,1.322228222,3.509420073,0.000449085,0.002479272,N,-,,DNase I,P:nucleic acid phosphodiester bond hydrolysis; F:exonuclease activity; F:endonuclease activity,PTHR15822 (PANTHER); IPR005135 (SUPERFAMILY); IPR005135 (SUPERFAMILY),,
RL4_JR_09453,2211,2592,2599,5,0,2,0,0,0,0,2,0,0,0,1,0,0,0,21.51932893,1,-0.905169901,1.172578943,-0.771947941,0.440145261,0.630169365,4.320516831,0,1.354271428,1.288634416,1.050935325,0.293288295,0.452471288,11.21356589,1,-1.298300925,1.220811505,-1.063473697,0.287567187,0.427131779,12.93520472,1,-1.720524972,1.221985918,-1.407974468,0.159138631,0.277806661,22.65999383,0,0.792578423,0.901985422,0.87870425,0.379561654,0.515362981,N,-,,hypothetical protein VF21_09363,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; F:oxidoreductase activity; P:metabolic process; P:regulation of transcription, DNA-templated; P:oxidation-reduction process; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR007219 (PFAM); PTHR31001 (PANTHER); PTHR31001:SF42 (PANTHER),,
RL4_JR_09454,1879,2119,2366,0,0,5,0,0,1,0,5,2,1,8,0,0,2,0,1.398230848,1,1.414260815,1.498109062,0.944030613,0.345154005,NA,0.441245536,1,4.645841229,1.652237884,2.811847661,0.004925783,0.020433923,1.150542264,1,1.986869441,1.296194487,1.532848241,0.125313251,0.229333217,1.327871682,1,1.563852449,1.348313349,1.159858315,0.246106497,0.384778919,1.137718344,1,1.900545022,1.283794056,1.480412698,0.138763143,0.24433019,N,-,,stress responsive A B Barrel domain-containing,F:lyase activity,IPR013097 (SMART); IPR013097 (PFAM); G3DSA:3.30.70.900 (GENE3D); IPR013097 (PROSITE_PROFILES); IPR011008 (SUPERFAMILY),,
RL4_JR_09455,5140,3895,5461,1,0,4,0,0,0,0,0,3,0,1,0,0,2,1,29.05462315,1,1.343264067,0.784130582,1.713061698,0.086701189,0.199297916,3.038101983,0,1.862318246,1.291139049,1.442383953,0.149194088,0.27557346,14.41034486,1,0.166812813,1.208480516,0.138035169,0.890212622,0.931320671,31.76572446,1,1.111035625,0.874085263,1.271083809,0.203698835,0.335466307,30.2748521,1,1.744665788,0.782622334,2.229256324,0.025796855,0.067040546,N,-,,Malate L-lactate dehydrogenase,F:L-malate dehydrogenase activity; P:oxidation-reduction process,IPR003767 (PFAM); G3DSA:1.10.1530.10 (GENE3D); G3DSA:3.30.1370.60 (GENE3D); IPR003767 (PANTHER); PTHR11091:SF0 (PANTHER); IPR003767 (SUPERFAMILY),,
RL4_JR_09456,1349,1220,1676,0,0,2,0,0,1,0,0,1,0,6,0,0,2,0,32.15943126,1,-3.109468319,1.211300288,-2.567049929,0.010256784,0.038613219,10.19041848,1,0.116355254,1.22946188,0.094639172,0.924601435,0.958737823,26.53705295,1,-2.540951715,1.205372605,-2.108021788,0.035029105,0.086265137,51.96934172,1,-0.24950125,0.773732366,-0.322464538,0.747100798,0.833266753,26.24067593,1,-2.627484667,1.212919167,-2.166248782,0.030292181,0.075674398,N,-,,major facilitator superfamily transporter,C:membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); IPR007065 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502:SF64 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.40, the major facilitator superfamily (mfs).
RL4_JR_09457,102,133,105,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.298835425,0,3.639954863,2.652005456,1.372529176,0.169898763,NA,0.095147938,0,6.858753334,2.238719293,3.063695102,0.002186216,0.015045494,0.248180674,0,4.19800757,1.468830812,2.858060666,0.004262389,0.016940088,0.286343569,0,3.776359439,1.810552178,2.085750129,0.037001263,0.102192523,0.246879875,0,4.103630701,1.377593563,2.978839921,0.002893419,0.011484072,N,-, Effector probability:0.568,---NA---,,no IPS match,,
RL4_JR_09458,986,1184,1292,0,0,0,0,0,0,0,0,0,0,0,2,0,3,0,4.245503734,0,-0.188299788,1.343689219,-0.140136413,0.888552211,0.945579042,1.388040976,0,2.992593441,1.504054037,1.98968479,0.046625669,0.111544558,3.545732423,0,0.363011369,1.296608659,0.279969879,0.779500614,0.853799007,4.086271738,1,-0.057889512,1.3146805,-0.044033141,0.964877987,0.979768303,3.441184827,1,0.30314001,1.289652705,0.235055538,0.814165628,0.874767315,N,-,,hypothetical protein SPSK_07051,,no IPS match,,
RL4_JR_09459,21,22,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,228.7743216,0,2.070065076,0.68899695,3.004461887,0.002660511,0.013122399,15.18100789,0,-0.458641405,1.226069983,-0.37407441,0.708348957,0.81661824,247.6853656,0,2.462741316,0.366585495,6.718054443,1.84E-11,1.23E-09,61.19104726,0,-0.825053114,0.772175286,-1.068479048,0.285304477,0.429423382,42.21284611,0,-2.245171548,1.126879299,-1.992379796,0.046329402,0.10567362,N,-,,glycoside hydrolase family 3,C:integral component of membrane; F:beta-glucosidase activity; P:cellulose catabolic process; F:scopolin beta-glucosidase activity,IPR001764 (PRINTS); IPR026891 (SMART); IPR011658 (SMART); IPR001764 (PFAM); IPR026891 (PFAM); IPR002772 (G3DSA:3.40.50.GENE3D); IPR002772 (PFAM); IPR001764 (G3DSA:3.20.20.GENE3D); IPR011658 (PFAM); PTHR30620:SF18 (PANTHER); IPR026892 (PANTHER); PTHR30620:SF18 (PANTHER); IPR026892 (PANTHER); IPR002772 (SUPERFAMILY); SSF56988 (SUPERFAMILY); IPR017853 (SUPERFAMILY),,
RL4_JR_09460,5628,6512,7578,0,0,13,2,0,0,0,0,4,1,8,0,0,3,6,1.689964846,1,1.140714449,1.290723,0.883779439,0.376815288,NA,0.54149991,1,4.350551023,1.527595982,2.847972287,0.004399876,0.018960415,1.400739573,1,1.702980057,1.222180457,1.393394934,0.163500397,0.279891447,1.615635394,1,1.280831872,1.239181377,1.033611298,0.301317915,0.4470756,1.376503821,1,1.625106753,1.206215846,1.347276906,0.177891067,0.294979864,N,-,,---NA---,,no IPS match,,
RL4_JR_09461,6178,10644,16432,0,0,8,0,0,0,1,0,0,1,5,0,0,5,0,0.552377672,1,2.754072475,1.923347624,1.431916125,0.152167827,NA,0.175481545,0,5.976174866,1.888605978,3.164331225,0.001554398,0.015023052,0.455797992,1,3.323073429,1.295535042,2.565020104,0.010316983,0.03349876,0.525905048,1,2.90020302,1.428141995,2.030752566,0.042280101,0.111655196,0.449163336,1,3.241942659,1.250389704,2.592745804,0.009521311,0.03017317,N,-,,phosphotransferase enzyme family,F:catalytic activity,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); PTHR21310 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_09462,3439,2898,4262,0,3,9,0,0,2,0,0,1,0,1,0,0,4,0,0.128530206,1,4.857464735,3.700062694,1.312806062,0.189248307,NA,0.04009941,1,8.105117914,2.603578203,3.11306874,0.001851529,0.015023052,0.105495668,1,5.432911164,1.57874825,3.441277712,0.000578974,0.003771709,0.121814947,1,5.009827005,2.296552648,2.181455326,0.029149755,0.090701067,0.105385632,1,5.33524392,1.385724941,3.85014642,0.000118047,0.000796288,N,-, Effector probability:0.843,---NA---,,no IPS match,,
RL4_JR_09463,42808,26244,45941,2,16,18,0,0,2,0,8,7,1,4,0,0,10,4,0.948285403,1,1.974147973,2.323513237,0.849639219,0.3955257,NA,0.319941847,1,5.109841696,2.25999171,2.261000194,NA,NA,0.803472745,1,2.504730263,1.722273804,1.45431595,0.14585873,0.256589711,0.924766672,1,2.085672932,1.92670655,1.082506795,0.279027398,0.422430694,4.628624003,1,3.371560176,1.547725917,2.178396148,0.029376556,0.073883415,N,-,,---NA---,,no IPS match,,
RL4_JR_09464,4110,3998,4429,0,1,11,0,0,0,0,4,0,4,13,5,0,2,13,44.01725986,1,-3.562284368,2.94900733,-1.2079605,NA,NA,14.98752264,0,-0.440154262,2.984151655,-0.147497283,NA,NA,37.47702426,1,-3.038904233,2.963843866,-1.025325345,NA,NA,43.11875252,1,-3.457377636,2.962435922,-1.167072547,NA,NA,35.71264288,1,-3.072107803,2.946406865,-1.042662451,NA,NA,N,-,,oxalate decarboxylase,P:oxalate metabolic process; F:nutrient reservoir activity,IPR006045 (SMART); IPR006045 (PFAM); IPR017774 (TIGRFAM); IPR014710 (G3DSA:2.60.120.GENE3D); PTHR31238:SF32 (PANTHER); PTHR31238 (PANTHER); IPR011051 (SUPERFAMILY),,
RL4_JR_09465,3923,3610,4232,1,0,8,2,0,0,5,0,0,1,5,1,0,3,2,637.552556,1,7.169470026,1.009759777,7.100173912,1.25E-12,6.01E-11,38.89701286,1,5.550420784,0.816336784,6.799180056,1.05E-11,2.32E-09,118.4765901,1,4.912922256,0.575499107,8.536802567,1.38E-17,1.77E-15,13.47807704,1,0.867500533,1.178969171,0.735812737,0.461844669,0.60415727,15.16874685,1,2.410948485,0.920591222,2.618913181,0.008821039,0.02840745,N,-,,amino acid,C:integral component of membrane,IPR013057 (PFAM); PTHR22950 (PANTHER); PTHR22950:SF330 (PANTHER),2.A.18.4.1, the amino acid/auxin permease (aaap) family.
RL4_JR_09466,71709,52865,73691,8,18,18,0,2,1,0,3,0,12,12,4,6,16,2,0.0292927,1,6.993412351,3.943093381,1.773585273,0.076131775,NA,0.009207564,1,10.22995802,3.943680144,2.594013117,0.009486287,0.032395477,0.023885656,1,7.580325093,2.772177658,2.734429761,0.006248843,0.022473635,0.027569539,1,7.155170506,3.943611069,1.814370226,0.069620746,0.150228434,0.023329259,1,7.516043272,1.804251974,4.165739255,3.10E-05,0.000259905,N,-,,glycoside hydrolase family 18,"F:chitinase activity; P:carbohydrate metabolic process; F:chitin binding; P:chitin catabolic process; P:metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:hydrolase activity, acting on glycosyl bonds; F:hydrolase activity",no IPS match,,
RL4_JR_09467,7907,7861,11514,0,1,7,0,0,1,0,0,2,0,8,0,0,0,0,0.048467386,1,6.264718056,3.928727887,1.594591999,0.110803503,NA,0.015712435,1,9.458823105,3.069218295,3.081834589,0.002057291,0.015023052,0.040258517,1,6.826639983,1.766009032,3.865574784,0.000110828,0.001235706,0.0464111,1,6.402752539,3.170645825,2.019384344,0.043447287,0.113446415,0.039104332,0,6.761682509,1.372139387,4.927839383,8.31E-07,1.25E-05,N,-,,glycoside hydrolase family 18,"F:hydrolase activity, hydrolyzing O-glycosyl compounds; P:organic substance metabolic process",IPR018392 (SMART); IPR018392 (G3DSA:3.10.350.GENE3D); IPR001002 (G3DSA:3.30.60.GENE3D); IPR001223 (PFAM); IPR018392 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR11177:SF185 (PANTHER); PTHR11177 (PANTHER); PTHR11177 (PANTHER); IPR001002 (SUPERFAMILY); IPR018392 (SUPERFAMILY); IPR018392 (SUPERFAMILY); IPR017853 (SUPERFAMILY),,
RL4_JR_09468,66,54,63,0,0,0,0,0,0,0,1,5,2,7,0,0,12,0,0.051940129,0,6.164505167,3.927257941,1.569671577,0.116491537,NA,0.016370541,0,9.397405453,2.992854183,3.139947648,0.00168978,0.015023052,0.042830804,1,6.732538653,1.694588096,3.97296468,7.10E-05,0.000923699,0.049435993,1,6.310733005,3.048209506,2.070308157,0.038423496,0.104636337,0.042597013,1,6.642344925,1.354849392,4.902644503,9.46E-07,1.38E-05,N,-,,hypothetical protein V492_05772,,no IPS match,,
RL4_JR_09469,384,356,376,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.061780639,0,5.91506149,3.924011261,1.507401762,0.131707707,NA,0.019405161,0,9.153436031,3.1395566,2.915518718,0.003550978,0.016938266,0.050540399,0,6.498061815,1.925660659,3.374458415,0.000739611,0.004528877,0.058339031,0,6.072925515,3.146105268,1.930299528,0.053569735,0.127531994,0.049724905,0,6.421734889,1.528915856,4.200188561,2.67E-05,0.000228836,Y,-,,hypothetical protein V501_06320,"F:chitinase activity; P:carbohydrate metabolic process; F:chitin binding; P:chitin catabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",no IPS match,,
RL4_JR_09470,597,327,468,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.369867534,0,3.332467569,2.3695874,1.406349295,0.159620429,NA,0.11590096,0,6.57401634,2.090600231,3.144559271,0.001663372,0.015023052,0.304716969,0,3.902115617,1.386876974,2.813598964,0.00489903,0.018693888,0.351797439,0,3.479468124,1.640006008,2.121619132,0.033869734,0.098678874,0.304814602,0,3.800884983,1.32587799,2.866692872,0.004147853,0.015349786,Y,-,,duf1620 domain-containing,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09471,4771,3639,5411,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,96.49390563,0,-4.694703478,1.18508185,-3.96150146,7.45E-05,0.00065901,30.79589536,0,-1.479148764,1.191727085,-1.241180789,0.21453897,0.361204833,79.89306165,0,-4.131022442,1.186122408,-3.482796054,0.000496206,0.003371538,92.16554023,0,-4.553349004,1.185171785,-3.841931661,0.00012207,0.001266349,78.7637541,1,-4.213242049,1.188924889,-3.543741147,0.000394492,0.002216557,N,-,,efflux pump antibiotic resistance,C:membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF8 (PANTHER); PTHR23501 (PANTHER); PTHR23501 (PANTHER); PTHR23501:SF8 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.52, the major facilitator superfamily (mfs).
RL4_JR_09472,972,1070,1124,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0.906677891,0,2.038948245,1.534157016,1.329034919,0.18383645,NA,0.287994579,0,5.261288385,1.699479394,3.095823582,0.001962671,0.015023052,0.749700174,0,2.604102676,1.250989438,2.081634422,0.037375875,0.090503075,0.865036714,0,2.181718516,1.308888362,1.666848433,0.095544547,0.18934988,0.741881534,1,2.517219434,1.230915135,2.044998361,0.04085502,0.095731792,N,-,,kinesin light chain,F:catalytic activity; P:lipid metabolic process; P:nucleoside metabolic process; F:ADP binding,IPR011990 (G3DSA:1.25.40.GENE3D); PF13424 (PFAM); IPR011990 (SUPERFAMILY),,
RL4_JR_09473,2931,2366,3408,0,0,0,0,0,0,0,0,0,0,3,0,0,6,5,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-, Effector probability:0.747,isoflavone reductase family,,PTHR14194 (PANTHER); PTHR14194:SF58 (PANTHER),,
RL4_JR_09474,1124,1095,1481,0,0,5,5,0,0,3,2,1,1,5,0,0,0,0,0.032869288,1,6.826014905,3.939130018,1.732873725,0.083118115,NA,0.010538566,1,10.03568073,3.395030033,2.955991738,0.003116654,0.015916638,0.027094776,1,7.400163553,2.021875483,3.660049105,0.000252167,0.002044019,0.031248852,1,6.973915455,3.802010328,1.834270518,0.066613848,0.146209671,0.026319198,0,7.339903947,1.463932978,5.013825126,5.34E-07,8.42E-06,N,-, Effector probability:0.681,isoflavone reductase family,,IPR016040 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR14194:SF58 (PANTHER); PTHR14194 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09475,52,64,64,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,54.06938874,0,2.242111326,0.579520691,3.868906425,0.000109325,0.000922306,3.592503126,0,1.620528349,1.280722489,1.265323567,0.205755362,0.35064342,9.341276775,0,-1.034581777,1.211124475,-0.854232409,0.39297623,0.53625709,10.77855465,0,-1.457216221,1.211297083,-1.203021324,0.228968069,0.365374578,9.219163214,0,-1.118329266,1.216428717,-0.919354542,0.357910158,0.495398544,N,-,,DUF952 domain,,IPR009297 (PFAM); PTHR34129:SF1 (PANTHER); PTHR34129 (PANTHER); SSF56399 (SUPERFAMILY),,
RL4_JR_09476,8,13,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37.04824855,0,0.53744025,0.869925744,0.617800143,0.536707089,0.71990405,4.12649164,0,1.420551412,1.260099848,1.12733242,0.25960196,0.415708122,10.7495993,0,-1.237283325,1.204493215,-1.027223158,0.304315396,0.445730478,12.40433632,0,-1.660005851,1.204001371,-1.378740831,0.167974676,0.289045478,10.63893531,0,-1.32500496,1.212822886,-1.092496666,0.274614855,0.407455364,N,-,,hypothetical protein ASPCAL13307,,IPR011483 (PFAM); PTHR33307:SF1 (PANTHER); PTHR33307 (PANTHER),,
RL4_JR_09477,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,27.02374978,0,13.94375812,3.98881809,3.495711714,0.000472799,0.002583428,N,-,,integral membrane,C:membrane,PTHR33048 (PANTHER),9.B.313.1.4, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_09478,6,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,64.98435,0,10.09054075,1.117209691,9.031913023,1.69E-19,2.09E-17,0.022067166,0,8.96822044,2.848882243,3.147978636,0.001644037,0.015023052,13.05442465,0,8.149398719,1.111979917,7.328728328,2.32E-13,2.03E-11,58.01874022,0,9.812516553,0.642193767,15.27968203,1.04E-52,5.88E-50,23.21891888,0,9.390338621,0.781760474,12.01178485,3.08E-33,2.08E-30,N,-,,short chain dehydrogenase reductase,,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24322:SF633 (PANTHER); PTHR24322:SF633 (PANTHER); IPR002347 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09479,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.204077866,0,0.711064688,1.16432148,0.610711646,0.541390494,0.723138537,1.390741555,0,2.989578931,1.356927388,2.203197429,0.027580836,0.07401199,68.83323714,0,4.313701481,0.533862358,8.080175379,6.47E-16,7.36E-14,4.181212562,0,-0.091283827,1.216641976,-0.075029325,0.940191379,0.964906893,22.89086508,0,3.141897503,0.723002858,4.345622522,1.39E-05,0.000132533,Y,-,,glycosyl hydrolase family 12,P:polysaccharide catabolic process; F:cellulase activity,IPR000254 (SMART); IPR000254 (PFAM); IPR002594 (PFAM); IPR013319 (G3DSA:2.60.120.GENE3D); PTHR34002:SF5 (PANTHER); PTHR34002 (PANTHER); IPR000254 (PROSITE_PROFILES); IPR000254 (SUPERFAMILY); IPR013320 (SUPERFAMILY),,
RL4_JR_09480,4,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.441608147,0,-0.997977985,1.204748183,-0.828370608,0.407460647,0.598606871,2.363554079,0,2.224501349,1.293366386,1.719931315,0.085444928,0.179099929,6.151469191,0,-0.432087464,1.202811086,-0.359231361,0.719422017,0.810170023,7.097836845,0,-0.854698635,1.201800241,-0.711181947,0.476971494,0.617767649,6.084620887,0,-0.518880474,1.209290553,-0.429078415,0.66786616,0.764256879,N,-,,argonaute PNH1,F:transferase activity,G3DSA:3.30.710.10 (GENE3D); PTHR22743 (PANTHER); PTHR22743:SF140 (PANTHER),,
RL4_JR_09481,1,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.00781203,0,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,0,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,0,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,0.007662926,0,9.0007212,4.037607722,2.229221316,0.025799183,0.085851084,0.006329724,0,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,N,-, Effector probability:0.575,Vanillyl-alcohol oxidase,"F:oxidoreductase activity, acting on CH-OH group of donors; F:oxidoreductase activity; F:catalytic activity; F:flavin adenine dinucleotide binding; P:oxidation-reduction process",IPR016170 (G3DSA:3.40.462.GENE3D); PTHR11748 (PANTHER); PTHR11748:SF92 (PANTHER),,
RL4_JR_09482,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.237483236,0,3.971559355,2.829226633,1.403761476,0.160389889,NA,0.074802475,0,7.205636159,2.268396412,3.176533044,0.001490468,0.015023052,0.19620898,0,4.536532347,1.426802239,3.179510253,0.001475242,0.007790999,0.226478238,0,4.114700926,1.827432179,2.251629895,0.02434567,0.084388877,0.196012738,0,4.437415407,1.328282603,3.34071635,0.000835625,0.00413929,Y,-,,hypothetical protein TD95_002308,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_09483,14,12,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35.58929198,0,-2.144401379,1.14194716,-1.877846413,0.060402179,0.153221696,10.19115687,0,0.116290374,1.223083816,0.095079644,0.924251566,0.958728669,26.36166233,0,-2.531396715,1.193572635,-2.120856863,0.03393385,0.084536745,40.04007595,0,-2.003640475,1.14504438,-1.749836522,0.080146527,0.166663295,25.92144406,0,-2.609900822,1.193183063,-2.187343169,0.028717482,0.072636648,Y,-,,feruloyl esterase B precursor,P:cell wall macromolecule catabolic process; C:extracellular region; F:feruloyl esterase activity,IPR011118 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR031246 (PTHR33938:PANTHER); IPR011118 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_09484,2977,3029,2827,0,0,6,0,0,0,0,0,0,0,0,0,0,4,0,0.313777921,1,3.569698606,2.45955404,1.451360104,0.146679613,NA,0.100877436,0,6.774823523,2.112397419,3.20717279,0.001340465,0.015023052,22.40082957,0,5.962479427,1.057955027,5.635853391,1.74E-08,7.11E-07,0.30084336,0,3.70546896,1.620739853,2.286282375,0.022237744,0.080442001,0.256691917,1,4.046699691,1.264259385,3.200846076,0.001370247,0.006190875,N,-, Effector probability:0.614,---NA---,,no IPS match,,
RL4_JR_09485,210,250,293,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,15.56739726,0,2.136626167,0.896910285,2.382207233,0.01720921,0.058157719,1.328412243,0,3.055922123,1.40555889,2.174168685,0.029692469,0.078481643,3.418721857,1,0.415669231,1.230890715,0.337697918,0.735590844,0.822068849,51.47224163,1,3.128482825,0.711987535,4.39401348,1.11E-05,0.00015434,18.784859,0,2.930442552,0.793236679,3.694285237,0.000220506,0.001351468,Y,-,,"indoleamine 2,3-dioxygenase",F:dioxygenase activity; P:oxidation-reduction process; F:heme binding,IPR000898 (PFAM); PTHR28657 (PANTHER); PTHR28657:SF1 (PANTHER); SSF140959 (SUPERFAMILY),,
RL4_JR_09486,617,481,510,12,11,27,2,0,29,17,104,331,4,40,10,0,59,0,85.48087494,1,1.031494354,0.917656141,1.124053235,0.260990443,0.440455116,10.20100184,1,0.114909981,1.253918992,0.091640674,0.926983534,0.959634629,26.43071185,1,-2.535103905,1.218473923,-2.080556553,0.037474514,0.090698537,66.77530093,1,0.115373347,0.720551855,0.160118035,0.872788095,0.921478567,25.96499218,1,-2.612249468,1.221337274,-2.138843646,0.032448333,0.080033952,N,-,,kynureninase,F:pyridoxal phosphate binding; P:tryptophan catabolic process; P:quinolinate biosynthetic process; P:'de novo' NAD biosynthetic process from tryptophan; P:mycelium development; C:cytoplasm; F:kynureninase activity; P:anthranilate metabolic process; P:L-kynurenine catabolic process,IPR015421 (G3DSA:3.40.640.GENE3D); IPR000192 (PFAM); IPR010111 (TIGRFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR010111 (PIRSF); PTHR14084:SF2 (PANTHER); IPR010111 (PANTHER); IPR010111 (HAMAP); IPR015424 (SUPERFAMILY),,
RL4_JR_09487,2667,2117,2741,0,6,1,0,0,3,5,3,12,3,0,0,0,0,0,35.35054484,1,-3.245976879,1.19157746,-2.724100605,0.006447686,0.026754946,11.3580719,1,-0.040086501,1.224951269,-0.032724977,0.973893906,0.986762174,40.39866636,1,-1.723421129,1.194727472,-1.442522391,0.14915506,0.261118074,45.85906552,1,-0.808181191,0.863500446,-0.935936043,0.349306118,0.495990505,43.50016736,0,-1.07545772,0.969290812,-1.1095305,0.267201394,0.399441033,N,-,,C6 transcription factor,F:binding,IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31313 (PANTHER); PTHR31313:SF24 (PANTHER); IPR001138 (SUPERFAMILY),,
RL4_JR_09488,15,12,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42.0087971,0,-3.495009225,1.188557929,-2.940545967,0.003276344,0.015458886,13.39757013,0,-0.278405619,1.206448216,-0.230764665,0.817497633,0.889945262,41.28806618,0,-1.969845421,1.190142186,-1.655134524,0.097897213,0.190965585,95.18659093,0,0.807185909,0.478535116,1.686785111,0.091644679,0.183379917,41.71009084,0,-2.081021986,1.124226335,-1.851070306,0.064159439,0.135799237,N,-,,aldo keto reductase,C:membrane,IPR001138 (SMART); IPR007219 (SMART); IPR023210 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR023210 (G3DSA:3.20.20.GENE3D); IPR007219 (PFAM); PTHR11732:SF285 (PANTHER); PTHR11732:SF285 (PANTHER); IPR001395 (PANTHER); IPR001395 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY); IPR023210 (SUPERFAMILY),8.A.5.1.6, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_09489,12,12,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.79100049,0,-1.887859918,1.212538295,-1.556948696,0.119482666,0.251318915,4.382024232,0,1.333931958,1.267167609,1.05268786,0.292484075,0.451505842,58.44242526,0,2.077972391,1.256474795,1.653811442,0.09816583,0.1913421,13.13567812,0,-1.742533143,1.207967922,-1.44253263,0.149152173,0.265313731,18.9464743,0,0.257870559,1.000192623,0.257820897,0.796545136,0.862373836,N,-,,amino acid permease,P:transmembrane transport; C:membrane; P:amino acid transport,IPR004841 (PFAM); IPR002293 (PIRSF); PTHR11785:SF263 (PANTHER); IPR002293 (PANTHER),2.A.3.10.18, the amino acid-polyamine-organocation (apc) family.
RL4_JR_09490,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.09099079,0,2.103487541,1.05070557,2.001976196,0.045287292,0.123521807,0.935787099,0,3.56109214,1.444654998,2.465012161,0.01370086,0.042868657,46.72579546,0,3.999182168,1.337987698,2.988952869,0.002799353,0.012905579,2.822723363,0,0.475405166,1.256790745,0.378269149,0.705230661,0.802298926,2.432106869,0,0.804074323,1.249544777,0.643493805,0.519903734,0.644469307,N,-, Effector probability:0.678,4fe-4s iron-sulfur binding,C:integral component of membrane,IPR023811 (TIGRFAM),,
RL4_JR_09491,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.76981559,0,1.294200549,0.879161702,1.472084767,0.140997989,0.283734976,2.456353477,0,2.16889636,1.308742534,1.657236854,0.097471598,0.198552529,29.93205702,0,1.919516577,0.875512784,2.192448371,0.028347147,0.073266918,28.73559472,0,1.800420004,0.777501337,2.315648757,0.020577454,0.077828437,6.350153134,0,-0.580571839,1.226228725,-0.473461294,0.635884109,0.738549373,N,-,,hypothetical protein ALT_2522,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:N-acetyltransferase activity,IPR016181 (G3DSA:3.40.630.GENE3D); IPR000182 (PFAM); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_09492,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.49888598,0,3.451286391,1.040498469,3.316954799,0.000910043,0.005523909,0.755946896,0,3.869173976,1.67650999,2.307874096,0.02100614,0.059860403,1.972856545,0,1.208872375,1.37875897,0.876782963,0.380604535,0.524464449,10.30047889,0,2.436583028,1.213705562,2.007556943,0.044690394,0.114728762,1.948955144,0,1.123736897,1.38059265,0.813952543,0.415672139,0.551668686,Y,-,,---NA---,,no IPS match,,
RL4_JR_09493,10,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.874297626,0,0.99156459,1.486371971,0.667103935,0.504705747,NA,0.592177909,0,4.221464718,1.632931978,2.585205493,0.009732098,0.033023229,1.540805534,0,1.565604945,1.319844942,1.186203693,0.235541868,0.368054618,1.778173535,0,1.142655175,1.366819519,0.835995652,0.403157349,0.54666776,1.518458447,0,1.483950407,1.311569619,1.131430909,0.257873768,0.389464783,N,-,,hypothetical protein THITE_2131416,,no IPS match,,
RL4_JR_09494,142,100,142,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.751499353,0,-0.626137358,1.321226873,-0.473906012,0.635566932,0.791837971,1.811735619,0,2.608130617,1.429130937,1.824976668,0.06800455,0.15016188,24.22424997,0,2.321730278,0.954813918,2.43160498,0.015032091,0.044615917,5.457164198,0,-0.475267329,1.290679141,-0.368230425,0.712701426,0.807893186,8.538342225,0,0.784127708,1.213718925,0.646053787,0.518244522,0.643436639,N,-,,FAD dependent oxidoreductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR023753 (G3DSA:3.50.50.GENE3D); IPR006076 (PFAM); PTHR13847 (PANTHER); PTHR13847:SF186 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_09495,119,96,116,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,78.33556962,0,0.284565905,0.597523794,0.476241964,0.633902007,0.791550676,12.50376052,0,-0.178779474,1.222322835,-0.146262075,0.883714504,0.934199291,32.52418858,0,-2.834444124,1.202826038,-2.356487167,0.018448705,0.052686796,37.52883697,0,-3.257096826,1.203920125,-2.705409403,0.006822025,0.03584484,39.83892298,0,-1.257723926,0.996859273,-1.261686539,0.207061602,0.329793727,N,-,,methyltransferase type 11,P:metabolic process; F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108 (PANTHER); PTHR10108:SF818 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_09496,45,38,71,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,30.47993781,1,-1.640070337,1.162971882,-1.410240748,0.158468608,0.307733135,7.137640545,0,0.630077152,1.2434007,0.506737009,0.612339359,0.745053371,18.54803302,0,-2.024169862,1.205645725,-1.678909334,0.093169715,0.183690398,30.71337399,0,-1.495439611,1.158027076,-1.291368433,0.196575951,0.3264444,22.15400746,0,-1.178174619,1.140978028,-1.032600621,0.301790838,0.437163553,N,-,,S-adenosyl-L-methionine-dependent methyltransferase,F:methyltransferase activity,no IPS match,,
RL4_JR_09497,119,108,82,0,0,15,0,0,0,0,0,0,0,0,0,0,0,0,0.008141456,1,8.841220392,4.035983802,2.190598582,0.028480854,NA,0.002675567,0,12.01934062,4.032893235,2.980327006,0.002879408,0.015349618,0.006783092,0,9.399044527,3.291065204,2.855927776,0.004291127,0.016940088,0.007815077,0,8.97609272,4.035428601,2.224322026,0.026126786,0.086108719,0.006504647,0,9.346543544,1.704039324,5.484934187,4.14E-08,1.17E-06,N,-,,hypothetical protein K441DRAFT_659674,,no IPS match,,
RL4_JR_09498,1,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.53733133,0,2.793806571,1.997916611,1.398359949,0.162005004,NA,0.169079152,0,6.029511112,1.924182321,3.133544595,0.001727087,0.015023052,0.442482311,0,3.364887412,1.327915431,2.533962128,0.011278092,0.035707308,0.510750838,0,2.941957801,1.481854552,1.985321566,0.047108706,0.118473832,0.439854036,0,3.272004493,1.286936323,2.542475829,0.011007021,0.033967111,N,-,,hypothetical protein K441DRAFT_659674,F:zinc ion binding; F:metal ion binding,no IPS match,,
RL4_JR_09499,1232,1131,1932,0,0,3,0,0,0,0,0,2,0,0,0,0,2,3,17.58140922,1,3.325854185,0.879377614,3.782054638,0.000155539,0.001247842,0.72483069,0,3.929618971,1.524435828,2.577752963,0.009944506,0.033441294,1.900112299,1,1.262623379,1.273886909,0.99115814,0.321608367,0.464209169,2.193431361,0,0.839433524,1.300894858,0.645273919,0.518749691,0.653382439,1.893126157,1,1.165653028,1.278316413,0.911865808,0.361839363,0.498789775,N,-,,hypothetical protein K441DRAFT_661459,,no IPS match,,
RL4_JR_09500,1636,1298,1301,7,2,5,0,0,1,0,4,1,4,14,7,0,6,10,1.348398656,1,1.466577935,1.430591261,1.025155105,0.305290008,NA,0.426796288,1,4.693861088,1.614576545,2.907177801,0.003647058,0.017178001,1.111668607,1,2.03637321,1.261021914,1.614859495,0.106341126,0.203080734,1.282857641,1,1.613549239,1.30154615,1.239717269,0.215079987,0.349716536,1.098980104,1,1.950561334,1.248321416,1.562547361,0.118159098,0.216480084,N,-,,f-box domain containing,,no IPS match,,
RL4_JR_09501,976,692,846,0,0,6,0,0,3,2,0,2,2,5,0,2,0,0,120.1323656,1,-5.010810514,1.343348682,-3.730089276,0.000191412,0.001480131,37.42813858,1,-1.760554094,1.290764108,-1.363962698,0.172579306,0.308090018,98.66891125,1,-4.435541951,1.286476421,-3.44782219,0.000565126,0.003707929,117.9514096,1,-3.919261291,1.258616511,-3.113943966,0.001846045,0.012411162,106.2310347,1,-3.583754187,1.245151255,-2.878167751,0.003999924,0.014894898,N,-,,zinc finger transcription factor,F:metal ion binding,IPR007087 (PROSITE_PROFILES),,
RL4_JR_09502,19027,10196,7186,7,4,4,0,0,1,15,7,29,14,48,28,0,23,29,50.9448101,1,0.771514159,0.623816352,1.236764885,0.216174382,0.384329012,7.683545531,1,0.523706113,1.227117478,0.426777486,0.669541406,0.788825193,43.53261446,1,0.276063085,0.860302072,0.320890876,0.748293088,0.831709107,49.7297455,1,0.177070906,0.754445331,0.234703428,0.814438927,0.882606672,19.78677832,1,-2.220214691,1.206178647,-1.840701372,0.065665333,0.13837907,Y,-,,anaphase-promoting complex,F:inorganic phosphate transmembrane transporter activity; P:transmembrane transport; P:phosphate ion transport; C:anaphase-promoting complex; C:membrane; C:integral component of membrane,IPR026000 (PFAM); PTHR12830 (PANTHER),,
RL4_JR_09503,409,319,664,0,0,5,0,0,0,0,0,0,1,1,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,short-chain dehydrogenase reductase family,,no IPS match,,
RL4_JR_09504,2432,2628,4844,0,4,1,0,0,0,0,3,1,0,0,0,0,3,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,primary-amine oxidase,P:amine metabolic process; F:copper ion binding; F:quinone binding; F:primary amine oxidase activity; P:oxidation-reduction process,IPR015802 (PFAM); G3DSA:3.10.450.40 (GENE3D); IPR000269 (PANTHER); PTHR10638:SF18 (PANTHER); IPR016182 (SUPERFAMILY),,
RL4_JR_09505,469,495,545,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.748,---NA---,,no IPS match,,
RL4_JR_09506,243,201,218,0,0,0,0,0,0,0,0,0,2,0,0,0,5,0,8.945801942,0,-1.263424199,1.291453417,-0.978296377,0.327927761,0.517290234,2.824154651,0,1.967702638,1.374243101,1.431844655,0.152188284,0.279720414,7.357832235,0,-0.690225261,1.263242498,-0.546391736,0.58479669,0.706009208,8.491686266,1,-1.113164724,1.271152923,-0.875712673,0.381186254,0.52667997,7.265888019,1,-0.77483494,1.273723457,-0.608322738,0.542973443,0.665167104,N,-,,glycoside hydrolase,"C:membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds",no IPS match,,
RL4_JR_09507,10,11,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.9412249,0,0.923146757,1.129020191,0.817653009,0.413555349,0.604620886,1.995751088,0,2.468620054,1.409511257,1.751401446,0.079876784,0.170034239,5.187810505,0,-0.186004862,1.268129981,-0.146676496,0.883387371,0.927271504,5.986536729,0,-0.608777687,1.277889868,-0.476392921,0.633794477,0.748794525,5.109230499,0,-0.266767463,1.274255104,-0.209351693,0.834173701,0.888064554,N,-,,ubiquitin-like modifier,C:nucleus; P:protein sumoylation; P:mitotic sister chromatid segregation; F:protein tag; C:septin ring,G3DSA:3.10.20.90 (GENE3D); IPR022617 (PFAM); PTHR10562 (PANTHER); IPR000626 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY),,
RL4_JR_09508,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.629563301,0,-1.211440893,1.268957289,-0.954674286,0.339742438,0.529642424,2.75582496,0,2.003113387,1.363276067,1.469338042,0.141741123,0.264266651,7.122866452,0,-0.6433018,1.249331316,-0.514916893,0.606611095,0.723290478,8.216524423,0,-1.065552988,1.254733016,-0.849226866,0.395755066,0.539989691,6.974351961,0,-0.715766811,1.250763714,-0.572263812,0.567143262,0.683860995,N,-,,---NA---,,no IPS match,,
RL4_JR_09509,210,110,138,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,major facilitator superfamily transporter,P:transmembrane transport; P:tyrosine biosynthetic process; C:membrane; C:integral component of membrane; P:oxidation-reduction process; F:prephenate dehydrogenase activity; F:prephenate dehydrogenase (NADP+) activity,PTHR23502:SF30 (PANTHER); PTHR23502 (PANTHER),,
RL4_JR_09510,1895,682,1644,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,119.1692214,0,-2.949714565,1.064462358,-2.771083959,0.005587002,0.023825803,31.45440703,0,-1.509665478,1.225629416,-1.231747099,0.21804357,0.365403479,81.68226023,0,-4.162950405,1.217271116,-3.419904037,0.000626432,0.003986173,94.24663625,0,-4.585537584,1.221926008,-3.752712976,0.000174931,0.001717922,80.44622046,0,-4.243725484,1.221634099,-3.473810601,0.000513123,0.002764966,Y,-,,FMN-binding split barrel-related,F:FMN binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR012349 (G3DSA:2.30.110.GENE3D); PF13883 (PFAM); PTHR37273 (PANTHER); PTHR37273:SF1 (PANTHER); IPR012349 (SUPERFAMILY),,
RL4_JR_09511,9,7,18,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_09512,6762,6387,5915,0,6,8,0,0,1,1,0,1,0,13,2,0,7,0,1.807692288,1,1.043299644,1.355321215,0.769780354,0.441430196,NA,0.572828793,1,4.269153816,1.542991651,2.766802926,0.005660896,0.022298256,1.495308005,1,1.607952751,1.254761918,1.281480357,0.200024995,0.32557123,1.725543106,1,1.185347094,1.282122991,0.924519023,0.355216152,0.501475817,1.485472824,1,1.515308511,1.253097513,1.209250274,0.226566709,0.353737537,N,-,,"phthalate 4,5-dioxygenase oxygenase reductase subunit",F:catalytic activity; F:ion binding,IPR015808 (G3DSA:2.40.33.GENE3D); G3DSA:3.40.50.80 (GENE3D); IPR001041 (PFAM); IPR012675 (G3DSA:3.10.20.GENE3D); G3DSA:2.40.30.10 (GENE3D); IPR005302 (PFAM); PTHR30212:SF2 (PANTHER); PTHR30212 (PANTHER); IPR017927 (PROSITE_PROFILES); IPR005302 (PROSITE_PROFILES); IPR001041 (PROSITE_PROFILES); IPR017938 (SUPERFAMILY); SSF52343 (SUPERFAMILY); IPR001041 (SUPERFAMILY); IPR011037 (SUPERFAMILY),,
RL4_JR_09513,1006,1252,1332,0,2,0,0,0,1,2,0,5,0,2,0,0,2,3,0.101618124,1,5.19592895,3.917250474,1.326422445,0.184699808,NA,0.030863494,1,8.481276687,3.130947493,2.708853057,0.006751623,0.025262323,0.083180615,1,5.773747494,2.073893775,2.784013126,0.005369086,0.019940069,0.096159431,1,5.350136755,2.980815068,1.794856988,0.072676488,0.155402214,0.085527025,1,5.634556979,1.804495272,3.122511356,0.001793152,0.007719244,,,,,,,,
RL4_JR_09514,593,518,791,3,1,0,0,0,0,1,0,0,0,2,0,0,0,1,4.531176643,1,-0.282056142,1.46689011,-0.192281712,0.847521543,0.923478128,1.428618537,0,2.950940517,1.585729667,1.860935428,0.062753296,0.14112172,3.715953179,1,0.295402699,1.36660926,0.216157396,0.828865062,0.889582305,4.288715137,1,-0.127597892,1.399038911,-0.091203962,0.927330527,0.956926461,3.655121131,1,0.216419989,1.377556185,0.157104292,0.875162655,0.916625828,N,-,,major facilitator superfamily transporter,"F:hydrogen ion transmembrane transporter activity; P:ATP hydrolysis coupled proton transport; C:integral component of membrane; C:proton-transporting V-type ATPase, V0 domain",G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662 (PANTHER); PTHR11662:SF209 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.4, the major facilitator superfamily (mfs).
RL4_JR_09515,2788,3384,3482,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,18.83126633,1,-2.33735371,1.217191225,-1.92028472,0.054821945,0.14261292,6.080253793,0,0.861453176,1.278704189,0.673692308,0.500506953,0.654538938,15.64274974,0,-1.778364311,1.217269728,-1.460945155,0.144030493,0.254319871,26.05990411,1,-0.488939,1.051095588,-0.465170823,0.641809131,0.754302664,22.6452277,0,-0.909253894,1.141873942,-0.796282199,0.42586803,0.560717009,N,-,,Transcription fungi,F:binding,IPR007219 (SMART); IPR001138 (SMART); IPR007219 (PFAM); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31944:SF20 (PANTHER); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09516,227,230,394,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,80.14549562,1,3.372268847,0.736230283,4.580453866,4.64E-06,5.89E-05,1.859183223,0,2.570852465,1.346879515,1.908747171,0.056294715,0.129680269,38.64674187,0,3.052652994,0.698977664,4.367311221,1.26E-05,0.000228627,15.18141056,0,0.452897098,1.162089289,0.389726591,0.696738731,0.795699764,12.45271705,0,1.503192181,1.002861443,1.498903156,0.133898758,0.237513126,N,-,,mfs multidrug transporter,C:membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23502 (PANTHER); PTHR23502:SF55 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.86, the major facilitator superfamily (mfs).
RL4_JR_09517,1428,2008,2021,0,3,4,0,0,0,0,0,4,0,0,0,0,4,2,0.045220224,1,6.365454488,3.930311469,1.619580162,0.105322494,NA,0.014385954,0,9.586000496,3.185012744,3.009721237,0.002614876,0.015349618,0.037171014,1,6.943037689,1.889327531,3.674872448,0.000237968,0.001965084,0.042883937,0,6.517184829,3.350131674,1.945351844,0.051732646,0.125559168,0.036289316,1,6.877091181,1.446264954,4.755070058,1.98E-06,2.57E-05,N,-,,methyltransferase type 11,F:methyltransferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF852 (PANTHER); PTHR10108 (PANTHER); PTHR10108:SF852 (PANTHER); PTHR10108:SF852 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_09518,1910,2614,3448,3,1,2,0,0,0,0,0,4,0,0,0,0,0,0,22.16914528,1,-2.572759245,1.255253875,-2.049592753,0.040404188,0.113387467,7.000484952,0,0.658055303,1.2891475,0.510457728,0.609730823,0.742861746,18.24758024,1,-2.000623683,1.238680038,-1.615125474,0.106283526,0.2030599,21.05947801,0,-2.423554978,1.243279328,-1.9493246,0.051256673,0.125084071,18.03953893,0,-2.086834383,1.250047626,-1.669403901,0.095037361,0.18383329,N,-,,General amino acid permease AGP2,P:metabolic process; C:integral component of membrane; F:lyase activity; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PIRSF); IPR004841 (PFAM); IPR002293 (PANTHER); PTHR11785:SF347 (PANTHER),2.A.3.10.19, the amino acid-polyamine-organocation (apc) family.
RL4_JR_09519,446,330,752,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,2.967250431,0,0.328658373,1.275450558,0.257680215,0.796653717,0.896427727,0.939041842,0,3.556196965,1.433780685,2.480293536,0.013127426,0.041458911,2.447519459,1,0.897627174,1.233278499,0.727838176,0.466712652,0.603664701,12.4597395,0,1.427102572,1.167308716,1.222557968,0.221496697,0.356942099,2.42241265,0,0.810016786,1.234570409,0.656112264,0.511751894,0.638088096,N,-,,proline oxidase,"F:oxidoreductase activity, acting on the CH-NH group of donors; P:single-organism metabolic process",IPR002872 (PFAM); IPR029041 (G3DSA:3.20.20.GENE3D); IPR015659 (PANTHER); PTHR13914:SF7 (PANTHER); IPR029041 (SUPERFAMILY),,
RL4_JR_09520,524,521,662,0,0,16,0,0,0,0,2,0,1,0,1,0,2,0,8.379753191,1,0.64961177,1.248752133,0.520208737,0.602918096,0.77127047,1.44618389,0,2.933325642,1.456654789,2.013741117,0.044036721,0.106815166,3.754263929,1,0.280656402,1.278896381,0.219452026,0.826297946,0.888050999,4.33198787,1,-0.142032853,1.293544178,-0.109801316,0.912566947,0.946791714,3.691305093,1,0.202243987,1.281290439,0.157843983,0.874579739,0.916489325,N,-,,Pyrroline-5-carboxylate reductase,F:pyrroline-5-carboxylate reductase activity; P:proline biosynthetic process; P:oxidation-reduction process,IPR028939 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR000304 (TIGRFAM); IPR029036 (G3DSA:1.10.3730.GENE3D); IPR029036 (PFAM); IPR000304 (PIRSF); PTHR11645:SF27 (PANTHER); IPR000304 (PANTHER); IPR016040 (SUPERFAMILY); IPR008927 (SUPERFAMILY),,
RL4_JR_09521,44,34,48,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.522363105,0,1.291523241,1.408128596,0.917191259,0.359042426,NA,0.491188777,0,4.491374037,1.613128361,2.784263265,0.005364947,0.021592045,1.263242099,0,1.852406866,1.26968929,1.458945019,0.144580241,0.255005289,1.45660061,0,1.430578225,1.306983843,1.094564582,0.273707439,0.415811972,1.232539928,0,1.784499269,1.245368407,1.432908735,0.151883921,0.261460306,N,-,,1-pyrroline-5-carboxylate dehydrogenase,"F:1-pyrroline-5-carboxylate dehydrogenase activity; P:glutamate biosynthetic process; P:proline biosynthetic process; P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",IPR005931 (TIGRFAM); IPR016163 (G3DSA:3.40.309.GENE3D); IPR015590 (PFAM); IPR016162 (G3DSA:3.40.605.GENE3D); PTHR11699 (PANTHER); PTHR11699:SF18 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_09522,8468,6838,6639,3,1,14,0,0,2,0,1,7,4,8,2,0,5,0,0.696382669,1,2.419987666,1.884042773,1.284465353,0.198979179,NA,0.221043046,1,5.643289754,1.891086225,2.984152537,0.00284365,0.015349618,0.573178047,1,2.992770576,1.357431103,2.204731105,0.027472969,0.07164616,0.661347907,1,2.569807433,1.488038103,1.726976902,0.084171812,0.172004328,0.562716035,1,2.916543778,1.314542496,2.218675917,0.026508781,0.068489857,N,-,,hypothetical protein AFLA70_51g004481,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,PTHR37845 (PANTHER),,
RL4_JR_09523,50,54,58,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.410155013,0,1.402065424,1.557292707,0.900322347,0.367948732,NA,0.445544849,0,4.631927584,1.693484841,2.735145584,0.006235269,0.023876729,1.159376738,0,1.976004438,1.32679029,1.489311802,0.136405281,0.244317439,1.337983885,0,1.553021406,1.388966799,1.118112692,0.263518867,0.404200655,1.142769787,0,1.894126946,1.311739104,1.44398146,0.148744191,0.257485883,N,-,,FAD dependent oxidoreductase,F:oxidoreductase activity; P:oxidation-reduction process,PR00420 (PRINTS); IPR006076 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR10961 (PANTHER); PTHR10961:SF21 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_09524,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.867603105,0,2.102659194,1.547885105,1.358407796,0.174334322,NA,0.277218185,0,5.316503296,1.714575879,3.100768746,0.00193019,0.015023052,0.717940025,0,2.667485255,1.248624661,2.136338756,0.032651812,0.082087645,22.17520583,0,4.968413361,0.755041697,6.580316528,4.69E-11,1.87E-09,0.705926519,0,2.588987762,1.219351913,2.123249025,0.03373299,0.082439421,N,-,,flavin depend monooxygenase that catalyses the oxidation of rubrofusarin to 9-hydroxyrubrofusarin,F:oxidoreductase activity,IPR000960 (PRINTS); IPR020946 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR012143 (PIRSF); PTHR23023 (PANTHER); PTHR23023:SF125 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_09525,2296,3091,2096,0,5,3,0,0,0,0,0,0,0,1,5,0,4,0,0.140811329,1,4.725846505,3.487086476,1.355242131,0.175340426,NA,0.045624515,0,7.920205054,2.494269269,3.175360877,0.001496503,0.015023052,0.11704237,0,5.285600196,1.479630733,3.572242774,0.000353937,0.002632813,0.134933931,1,4.862895578,2.126267249,2.287057556,0.022192464,0.080442001,0.113923974,1,5.218881698,1.302666123,4.006307991,6.17E-05,0.00046325,N,-,,Fe-containing alcohol dehydrogenase,F:oxidoreductase activity; F:metal ion binding; P:oxidation-reduction process,G3DSA:1.20.1090.10 (GENE3D); IPR001670 (PFAM); G3DSA:3.40.50.1970 (GENE3D); PTHR11496 (PANTHER); PTHR11496:SF62 (PANTHER); PTHR11496:SF62 (PANTHER); PTHR11496 (PANTHER); PTHR11496:SF62 (PANTHER); SSF56796 (SUPERFAMILY),,
RL4_JR_09526,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.189530257,0,4.297242915,3.053454943,1.407337916,0.159327211,NA,0.060836799,0,7.504804917,2.329474337,3.221673147,0.001274444,0.015023052,0.15694488,0,4.862188518,1.398863311,3.475813883,0.000509306,0.003430075,0.181006367,0,4.439098135,1.883979658,2.356234642,0.018461252,0.074129552,0.153580285,0,4.789758893,1.271337946,3.767494637,0.000164894,0.001060033,N,-,,dead deah box DNA helicase,F:organic cyclic compound binding; F:heterocyclic compound binding; F:hydrolase activity,IPR001650 (SMART); IPR014001 (SMART); IPR004179 (SMART); G3DSA:1.10.3380.10 (GENE3D); IPR004179 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR011545 (PFAM); PTHR24031 (PANTHER); PTHR24031:SF122 (PANTHER); PTHR24031:SF122 (PANTHER); PTHR24031 (PANTHER); PTHR24031:SF122 (PANTHER); PTHR24031 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF158702 (SUPERFAMILY),,
RL4_JR_09527,6034,6548,6530,0,4,10,0,0,0,0,0,1,2,2,1,0,0,0,9.917840629,1,-1.412237014,1.194054103,-1.182724477,0.23691836,0.410967464,12.5607406,0,2.71108816,1.13761063,2.383142428,0.017165552,0.051167225,21.21984535,1,0.96854479,1.037092835,0.933903656,0.350353593,0.493802001,13.4948521,1,-0.325516867,1.147734448,-0.283616884,0.776703997,0.855726656,8.069117054,0,-0.926234271,1.194222284,-0.775596205,0.437987442,0.572312908,N,-,,nucleotide-sugar transporter,F:UDP-galactose transmembrane transporter activity; P:proton transport; C:integral component of Golgi membrane; F:sugar:proton symporter activity; P:UDP-galactose transmembrane import into Golgi lumen,TIGR00803 (TIGRFAM); IPR007271 (PFAM); IPR007271 (PIRSF); PTHR10231:SF36 (PANTHER); IPR007271 (PANTHER); PTHR10231:SF36 (PANTHER); IPR007271 (PANTHER); SSF103481 (SUPERFAMILY); SSF103481 (SUPERFAMILY),2.A.7.12.16, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_09528,3072,2057,2877,0,0,4,0,0,0,0,0,0,0,1,1,0,0,0,6.610392125,1,1.362861591,1.167924099,1.166909384,0.243246966,0.418386833,0.88711271,0,3.638321898,1.429384649,2.545376362,0.010916001,0.035959106,2.305791912,0,0.983810154,1.220828469,0.805854532,0.420326731,0.561619087,2.660448263,1,0.56123259,1.228890569,0.45669859,0.647887705,0.758628774,2.275556694,0,0.900271795,1.217917978,0.739189183,0.459792128,0.591322954,Y,-,,acid ase,F:aspartic-type endopeptidase activity; P:proteolysis,IPR000250 (PRINTS); IPR000250 (PFAM); PTHR37536:SF1 (PANTHER); PTHR37536 (PANTHER); IPR013320 (SUPERFAMILY),,
RL4_JR_09529,4238,2881,3981,0,1,11,0,0,0,0,1,1,0,5,1,0,3,0,0.395435949,1,3.236100238,2.2270837,1.453066285,0.146205351,NA,0.124950568,0,6.465817082,2.011717383,3.214078248,0.00130864,0.015023052,8.1693499,1,4.763564471,1.220475688,3.903039215,9.50E-05,0.001128758,8.399857031,1,5.091160442,1.058626665,4.809212358,1.52E-06,2.67E-05,0.324099202,1,3.712489993,1.265517187,2.933575326,0.003350823,0.012944329,N,-,,GNAT family N-acetyltransferase,P:biological_process; C:nucleus; C:cytosol; F:transferase activity; F:N-acetyltransferase activity,IPR016181 (G3DSA:3.40.630.GENE3D); IPR000182 (PFAM); PTHR10545:SF38 (PANTHER); PTHR10545 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_09530,1130,1205,907,0,0,0,0,0,0,4,0,0,0,1,0,0,0,0,30.73152075,0,-0.905880158,1.016832657,-0.89088421,0.372991292,0.565377734,7.392584309,0,0.579489139,1.234521068,0.469404009,0.638780883,0.764116074,106.3824144,1,1.946993154,0.522542012,3.726003097,0.00019454,0.001729168,122.3805482,1,2.308822499,0.407246207,5.669352987,1.43E-08,3.87E-07,56.67249349,0,1.466335064,0.545397772,2.688560788,0.007176077,0.024098766,Y,-,,glycoside hydrolase family 16,P:carbohydrate metabolic process; F:beta-glucanase activity,IPR013320 (G3DSA:2.60.120.GENE3D); IPR000757 (PFAM); PTHR10963:SF34 (PANTHER); PTHR10963 (PANTHER); IPR000757 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),,
RL4_JR_09531,228,255,229,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,40.56641859,0,-0.053673374,0.750860532,-0.071482481,0.943013767,0.971842636,17.47753723,0,1.363860266,1.128275742,1.208800487,0.226739505,0.376485772,20.98087566,0,-2.202070647,1.195999735,-1.841196601,0.065592753,0.139567262,33.8358723,1,-1.6741666,1.147274451,-1.459255542,0.144494787,0.258710825,43.83159121,0,0.890261148,0.642730918,1.385122643,0.166014969,0.279591078,N,-,,galactosyl transferase GMA12 MNN10 family,"P:cell wall mannoprotein biosynthetic process; P:barrier septum assembly; P:mannosylation; F:alpha-1,6-mannosyltransferase activity; P:protein N-linked glycosylation; P:cell budding; C:alpha-1,6-mannosyltransferase complex",IPR008630 (PFAM); PTHR31306 (PANTHER); PTHR31306:SF5 (PANTHER),,
RL4_JR_09532,692,708,797,0,0,1,0,0,0,0,0,0,0,0,0,0,3,0,144.9182512,1,1.439531675,0.699900992,2.056764731,0.039708862,0.112295893,11.75155418,0,-0.089267213,1.228384294,-0.072670428,0.942068381,0.968574521,52.71070146,0,-0.907354784,1.046459081,-0.867071442,0.385902867,0.529818365,83.45177482,0,0.337754228,1.497594228,0.225531203,0.821566054,0.88804914,30.18713433,1,-2.829615225,1.212199408,-2.334281972,0.019580962,0.053801151,N,-, Effector probability:0.785,hypothetical protein VP1G_10615,,no IPS match,,
RL4_JR_09533,212,252,256,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,71.05299683,0,-4.253155404,1.217421936,-3.493575464,0.000476598,0.003237376,22.96484105,0,-1.055809695,1.234361002,-0.8553492,0.392357858,0.556591725,59.07701717,0,-3.695523619,1.21352388,-3.04528298,0.002324615,0.011153744,68.11574403,0,-4.117085825,1.216431027,-3.384561668,0.00071292,0.005569688,84.75550726,0,-0.412122096,0.652119421,-0.631973351,0.527404291,0.651136257,N,-,,glycoprotease family,C:membrane; P:proteolysis; C:integral component of membrane; P:tRNA threonylcarbamoyladenosine modification; F:peptidase activity; F:transferase activity; C:cellular_component; F:metalloendopeptidase activity,no IPS match,,
RL4_JR_09534,16,20,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,93.46115672,0,2.019602206,0.683474829,2.954903559,0.003127668,0.014895222,5.666067843,0,0.963077497,1.262193243,0.763019056,0.445452031,0.606721123,14.80665049,0,-1.699293789,1.217532448,-1.395686655,0.162808875,0.278896286,26.400375,0,-1.169442189,1.170400737,-0.999181009,0.317707014,0.463847659,18.57864072,0,-0.86603652,1.161975881,-0.74531368,0.456082113,0.587734682,N,-,,glycoprotease family,F:endopeptidase activity; P:tRNA modification; P:tRNA threonylcarbamoyladenosine metabolic process,IPR017861 (PRINTS); IPR000905 (PFAM); G3DSA:3.30.420.40 (GENE3D); PTHR11735:SF6 (PANTHER); PTHR11735 (PANTHER); PTHR11735:SF6 (PANTHER); PTHR11735 (PANTHER); IPR022450 (HAMAP); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_09535,138,167,149,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,223.3524893,0,1.508108366,0.323957277,4.655269295,3.24E-06,4.26E-05,36.25332128,0,0.980704642,0.980984873,0.999714336,0.317448772,0.479105174,68.90578605,0,-0.905928816,0.844734606,-1.072441936,0.283521581,0.422984451,98.58839069,0,-0.414499368,0.603046072,-0.687342787,0.491866742,0.630957907,67.87454769,0,-0.204122108,0.61671541,-0.330982662,0.740657582,0.818328025,N,-,,proteasome component PRE2,"C:nuclear envelope; C:endoplasmic reticulum membrane; P:proteasome-mediated ubiquitin-dependent protein catabolic process; F:threonine-type endopeptidase activity; C:proteasome core complex, beta-subunit complex; C:proteasome storage granule; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome core complex assembly",IPR000243 (PRINTS); IPR029055 (G3DSA:3.60.20.GENE3D); IPR001353 (PFAM); PTHR11599 (PANTHER); PTHR11599:SF63 (PANTHER); IPR023333 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY),,
RL4_JR_09536,16942,16383,14617,8,10,39,0,4,0,2,2,4,6,45,5,0,27,7,203.2706717,1,0.463514142,0.400126224,1.158419803,0.246692762,0.422887067,36.36451575,1,-0.371202238,1.11022937,-0.334347341,0.738117471,0.837675192,76.68709612,1,-2.98240186,1.192370872,-2.501236762,0.012376041,0.038153179,133.1702044,1,-1.018477294,0.623788519,-1.632728502,0.10252611,0.199630166,92.55509071,1,-0.863788783,0.652005615,-1.324818013,0.185231519,0.304146746,N,-,,mannan polymerase complexes MNN9 subunit,"C:cis-Golgi network; P:mannosylation; F:alpha-1,6-mannosyltransferase activity; P:protein N-linked glycosylation; C:endoplasmic reticulum; P:negative regulation of G0 to G1 transition; C:alpha-1,6-mannosyltransferase complex",PF03452 (PFAM); PTHR24319 (PANTHER); PTHR24319:SF35 (PANTHER),,
RL4_JR_09537,697,509,904,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37.08310103,0,2.786677991,0.584067607,4.771156557,1.83E-06,2.59E-05,1.966921461,0,2.489623088,1.315206245,1.892952605,0.058364173,0.133384998,5.097085203,0,-0.160517309,1.201831175,-0.133560614,0.893750031,0.933683347,5.879941891,0,-0.582804273,1.200367126,-0.485521688,0.627306332,0.743645547,12.73602061,0,1.427734048,0.979266392,1.457962878,0.144850776,0.252472732,N,-,,ubiquitin-conjugating enzyme,F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; C:cytoplasm; C:cellular_component; P:protein ubiquitination,SM00212 (SMART); IPR016135 (G3DSA:3.10.110.GENE3D); IPR000608 (PFAM); PTHR24067 (PANTHER); PTHR24067:SF143 (PANTHER); PTHR24067 (PANTHER); PTHR24067:SF143 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),3.A.20.1.5, the peroxisomal protein importer (ppi) family.
RL4_JR_09538,2655,2056,3659,0,4,16,0,0,4,0,0,5,2,2,1,0,0,0,339.3281776,1,-0.636948089,0.351213268,-1.813564997,0.069744723,0.17064127,198.8388777,1,1.034631655,1.555643538,0.665082733,0.505997578,0.659141436,231.1229432,1,-1.2255383,0.522241597,-2.346688403,0.018941088,0.053699124,294.8168,1,-0.820236557,0.387566653,-2.116375469,0.034312887,0.099341681,234.3027976,0,-0.805826943,0.612198696,-1.316283337,0.188078961,0.307392976,N,-,,cell wall proline rich,P:mycelium development,no IPS match,,
RL4_JR_09539,1,2,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,98.24418348,0,-2.902341479,1.076378031,-2.696396059,0.007009427,0.028620751,28.58766182,0,-1.371843752,1.222372369,-1.122279746,0.261743515,0.417947288,81.29262239,1,-3.074087473,1.218908314,-2.522000579,0.011668952,0.036372065,98.35985986,0,-2.189000928,0.916991007,-2.387156374,0.016979267,0.070776074,78.29089606,0,-3.204594417,1.165175027,-2.750311621,0.005953861,0.020666043,N,-,,rRNA-processing CGR1,"P:rRNA processing; C:nucleolus; C:preribosome, large subunit precursor",IPR005579 (PFAM),,
RL4_JR_09540,386,291,321,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,15.00333914,0,-2.009617248,1.239897079,-1.620793598,0.105061912,0.229599538,14.11237169,0,2.135949617,1.161771104,1.838528785,0.065984524,0.146629057,12.39058667,0,-1.44230893,1.229830855,-1.172770161,0.240887987,0.374041408,14.30093727,1,-1.865329858,1.232732336,-1.513166973,0.130237251,0.239102841,23.92254031,0,0.623773417,0.929772213,0.670888427,0.50229161,0.62988637,N,-,,septum formation initiator domain-containing,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_09541,224,191,261,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.007786068,0,8.896911713,4.040984052,2.201669593,0.027688656,NA,0.002502822,0,12.10389348,4.040376809,2.995733828,0.002737853,0.015349618,0.006502266,0,9.448056946,3.305547956,2.858242286,0.00425995,0.016940088,0.007499321,0,9.02784755,4.040049892,2.234588134,0.025444401,0.085851084,0.00645541,0,9.348501478,1.703823852,5.486776974,4.09E-08,1.17E-06,,,,,,,,
RL4_JR_09542,1554,1490,2473,4,1,0,0,0,0,0,0,0,0,1,0,0,1,0,42.56698767,1,1.263066221,0.758088364,1.666120047,0.095689506,0.214234853,3.369648362,0,1.712989164,1.281866664,1.336323982,0.181443401,0.320350621,8.713423633,0,-0.934086633,1.203419635,-0.776193612,0.437634677,0.577805618,23.37435873,1,0.378599971,1.024124507,0.369681585,0.711619754,0.807209278,8.551772634,1,-1.009956662,1.200514731,-0.841269695,0.400196864,0.537399635,N,-, Effector probability:0.648,px domain-containing,F:phosphatidylinositol binding,IPR024555 (PFAM); IPR001683 (G3DSA:3.30.1520.GENE3D); IPR001683 (PFAM); IPR001683 (PROSITE_PROFILES); IPR001683 (SUPERFAMILY),,
RL4_JR_09543,12992,12241,12001,3,5,2,0,0,0,2,3,11,0,8,3,0,12,9,80.81807374,1,0.337675555,0.684602223,0.493243439,0.621840588,0.783190707,13.6613513,0,-0.306467052,1.227946635,-0.249576849,0.802914604,0.880700219,48.29305148,1,-1.135773696,1.046591222,-1.085212328,0.277827625,0.416800369,52.74462826,1,-1.083850794,0.878680232,-1.233498552,0.217389817,0.352284234,38.46442528,1,-2.096973773,1.129775223,-1.856098213,0.06343956,0.134574806,N,-,,px domain-containing,F:succinate dehydrogenase (ubiquinone) activity; F:flavin adenine dinucleotide binding; F:phosphatidylinositol binding; P:tricarboxylic acid cycle; P:electron transport chain; C:mitochondrial inner membrane,IPR024554 (PFAM); IPR001683 (G3DSA:3.30.1520.GENE3D); PTHR11632 (PANTHER),,
RL4_JR_09544,3860,2664,4514,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,550.6803988,0,-0.542753468,0.499157206,-1.087339743,0.276886691,0.46004921,141.3475325,0,-0.679222384,0.814784298,-0.833622329,0.404493839,0.568729912,409.8242454,0,-0.814793699,0.715422144,-1.138899188,0.254745204,0.390645327,500.5511156,1,-0.66847115,0.394698467,-1.693624897,0.090336584,0.181407757,314.8532344,0,-1.828587811,0.555580049,-3.291312951,0.000997209,0.004776132,N,-,,succinate dehydrogenase flavo subunit,F:succinate dehydrogenase (ubiquinone) activity; F:flavin adenine dinucleotide binding; F:phosphatidylinositol binding; P:tricarboxylic acid cycle; P:electron transport chain; C:mitochondrial inner membrane,IPR015939 (PFAM); IPR011281 (TIGRFAM); IPR027477 (G3DSA:3.90.700.GENE3D); IPR003953 (PFAM); IPR014006 (TIGRFAM); IPR030664 (PIRSF); IPR023753 (G3DSA:3.50.50.GENE3D); IPR015939 (G3DSA:1.20.58.GENE3D); G3DSA:4.10.80.40 (GENE3D); PTHR11632:SF51 (PANTHER); PTHR11632 (PANTHER); IPR015939 (SUPERFAMILY); IPR023753 (SUPERFAMILY); IPR027477 (SUPERFAMILY),3.D.10.1.6, the prokaryotic succinate dehydrogenase (sdh) family.
RL4_JR_09545,1147,1104,1043,0,0,3,0,0,0,0,0,0,1,0,0,0,0,0,17.75552049,1,0.283280192,1.02071204,0.277531939,0.781371685,0.887242075,3.226730431,0,1.775478958,1.27377325,1.393873641,0.163355765,0.295477997,29.20694227,0,1.528552455,0.8566325,1.784373643,0.074362971,0.154083241,76.45287238,1,2.312848218,0.594209698,3.89230978,9.93E-05,0.001064995,60.86090405,0,2.982962173,0.501779726,5.944764246,2.77E-09,1.48E-07,N,-,,hypothetical protein CMQ_5867,,PF11274 (PFAM); PTHR40370 (PANTHER),,
RL4_JR_09546,952,868,697,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,753.0119244,1,1.220078526,0.33132388,3.682434616,0.000231017,0.001745035,71.84329533,0,-2.701278099,1.197368105,-2.256013075,0.024069812,0.066548659,482.5524721,0,0.69475727,0.367996809,1.887943736,0.059033504,0.128488576,308.0028873,1,-1.161639308,0.465942597,-2.493095322,0.012663484,0.05846684,389.2229542,0,0.261385919,0.976753087,0.267606955,0.789001877,0.856231941,N,-,,cytochrome p450 51,F:iron ion binding; C:integral component of membrane; P:ergosterol biosynthetic process; C:endoplasmic reticulum; F:methyltransferase activity; P:oxidation-reduction process; F:sterol 14-demethylase activity; P:demethylation; C:plasma membrane; F:heme binding; P:methylation,IPR002403 (PRINTS); IPR001128 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24286 (PANTHER); PTHR24286:SF24 (PANTHER); PTHR24286 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_09547,461,388,369,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,9.845323503,0,0.252625294,1.156533253,0.21843323,0.827091577,0.913046426,1.926002598,0,2.5198682,1.326261369,1.899978585,0.05743593,0.131739516,19.33924189,1,1.688363736,1.043341244,1.618227732,0.105613528,0.201932268,17.79973171,0,1.738572764,0.874296883,1.988538215,0.046752197,0.117782034,23.87976203,1,2.394364592,0.773107221,3.09706665,0.001954459,0.008318159,N,-,,hypothetical protein SPSK_08799,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_09548,11417,9563,12340,12,30,176,0,1,5,9,25,20,7,85,5,0,78,6,107.1325869,1,2.583976617,0.386963443,6.677572941,2.43E-11,9.48E-10,72.4492986,1,3.221426613,0.842242318,3.824821604,0.000130867,0.006161088,38.34331385,1,0.76164693,0.845982601,0.900310395,0.36795509,0.512333563,16.46692281,1,-2.068639517,1.186636272,-1.7432802,0.081284682,0.168029279,21.76441251,1,-0.053983232,0.967300562,-0.055808126,0.955494661,0.970738857,N,-,,kinesin-ii 85 kda subunit,F:ATPase activity; F:ATP binding; F:microtubule motor activity; C:kinesin complex; P:microtubule-based movement; C:microtubule; F:microtubule binding,IPR001752 (PRINTS); IPR001752 (SMART); IPR001752 (PFAM); IPR001752 (G3DSA:3.40.850.GENE3D); IPR027640 (PANTHER); IPR027640 (PANTHER); IPR027640 (PANTHER); PTHR24115:SF545 (PANTHER); PTHR24115:SF545 (PANTHER); IPR001752 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_09549,731,724,840,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,25.86478691,1,2.171702839,0.66935282,3.244481495,0.001176647,0.006717343,2.158490409,0,2.355498248,1.297791612,1.815004987,0.069523143,0.15293182,5.602097183,0,-0.296967924,1.196624616,-0.248171331,0.804001847,0.871320593,10.47455145,0,0.227847947,1.143435247,0.199266156,0.842054552,0.901533503,12.88864582,0,0.555429621,1.123679257,0.494295518,0.62109749,0.727091234,N,-,,sulfate transporter family,P:sulfate transport; P:biological_process; F:secondary active sulfate transmembrane transporter activity; P:transmembrane transport; C:fungal-type vacuole membrane; P:sulfate transmembrane transport; C:Golgi apparatus; C:endoplasmic reticulum; C:fungal-type vacuole; C:cellular_component; F:molecular_function; C:membrane; C:integral component of membrane; P:phosphorylation; F:kinase activity; F:sulfate transmembrane transporter activity,IPR018865 (PFAM); PTHR15243:SF0 (PANTHER); PTHR15243 (PANTHER); PTHR15243 (PANTHER),,
RL4_JR_09550,334,410,458,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.019426228,0,7.580809812,3.961222504,1.913755111,0.055651454,NA,0.00600472,0,10.83982954,3.962959958,2.735286163,0.006232607,0.023876729,0.016016853,0,8.147263859,2.853492395,2.855190318,0.004301105,0.016956535,0.018502896,0,7.725994189,3.961370727,1.950333539,0.051136378,0.124880807,0.016327052,0,8.023085814,1.667298077,4.81202847,1.49E-06,2.01E-05,N,-,,---NA---,,no IPS match,,
RL4_JR_09551,417,1172,1048,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,107.9216778,0,2.06269412,0.829408364,2.486946371,0.012884482,0.046509559,7.471410432,0,0.564099824,1.22744827,0.459571159,0.645824065,0.770422061,25.94653642,0,-1.130793092,1.196654824,-0.944961797,0.34467838,0.488386833,74.44665524,1,1.370152669,0.532931677,2.570972469,0.010141339,0.049059272,49.40597778,0,1.017524029,0.643787255,1.580528383,0.113985912,0.210565109,N,-,,sterol-4-alpha-carboxylate 3-dehydrogenase,F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; F:sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity; P:oxidation-reduction process; P:steroid biosynthetic process,IPR016040 (G3DSA:3.40.50.GENE3D); IPR002225 (PFAM); PTHR10366:SF242 (PANTHER); PTHR10366 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09552,17872,15369,14897,0,1,4,0,5,0,7,0,4,0,0,10,0,4,6,27.91498367,1,1.213866753,0.910538741,1.333130265,0.182489059,0.339955326,2.555196112,1,2.111955549,1.332930167,1.584445758,0.113092316,0.223055421,6.678615874,1,-0.550775142,1.235553408,-0.445772023,0.655761933,0.761432941,63.90705521,1,2.639955627,0.673808746,3.917959869,8.93E-05,0.000971191,6.644704771,1,-0.645987571,1.249312496,-0.517074449,0.605104189,0.71380735,N,-,,arf gtpase activator,F:GTPase activator activity; P:positive regulation of GTPase activity,no IPS match,,
RL4_JR_09553,403,286,351,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,233.6146818,0,-0.777956348,1.138277635,-0.683450438,0.494322258,0.681887213,67.28960354,0,-0.50141946,1.007250854,-0.497809913,0.618618028,0.749246308,195.5279122,0,-0.684048205,0.555843282,-1.230649406,0.218454018,0.347576376,248.7170208,1,-0.331437872,0.499861669,-0.663059187,0.507292648,0.643328916,247.9759371,1,0.095116104,0.598280998,0.158982325,0.8736828,0.916138219,N,-,,HMG box,P:evasion or tolerance of host immune response,IPR009071 (SMART); IPR009071 (G3DSA:1.10.30.GENE3D); IPR009071 (PFAM); IPR009071 (PROSITE_PROFILES); IPR009071 (SUPERFAMILY),,
RL4_JR_09554,8959,6608,5301,1,0,9,0,0,0,2,0,1,1,6,1,0,4,0,391.7940995,1,-1.09802764,0.394931893,-2.780296194,0.005430934,0.023257511,86.55890424,0,-2.970094991,1.188992624,-2.497992781,0.012489874,0.039843209,224.8593704,1,-5.623890535,1.192407575,-4.716416309,2.40E-06,5.68E-05,323.3264008,1,-2.284902644,0.551485007,-4.143181796,3.43E-05,0.000419857,295.6835419,1,-1.625374927,0.499172683,-3.25613757,0.00112939,0.005267193,N,-,,pre-mrna-processing atp-dependent rna helicase prp5,F:nucleic acid binding; P:U2-type prespliceosome assembly; F:ATP binding; P:mycelium development; F:U1 snRNP binding; F:U2 snRNP binding; P:regulation of gene expression; P:RNA secondary structure unwinding; C:cytosol; C:U2-type prespliceosome; C:mitotic spindle pole body; F:ATP-dependent RNA helicase activity,IPR001650 (SMART); IPR014001 (SMART); IPR011545 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); PTHR24031 (PANTHER); PTHR24031:SF25 (PANTHER); PTHR24031:SF25 (PANTHER); PTHR24031 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_09555,1686,1682,2389,0,5,3,0,0,5,3,6,1,2,0,0,0,0,0,15.30913843,1,2.173912995,1.008302697,2.156012279,0.031082706,0.093156767,1.215020005,1,3.184528437,1.474420238,2.159851279,0.030784184,0.08077892,3.168763365,1,0.525171436,1.281599736,0.409778046,0.681968772,0.781465971,3.657271738,1,0.102148503,1.29974122,0.078591416,0.937357616,0.963234127,10.49848838,0,1.388241391,1.202286127,1.154668061,0.248226383,0.378507851,N,-,,hypothetical protein CMQ_5904,,no IPS match,,
RL4_JR_09556,790,1002,539,0,0,1,0,0,3,0,0,0,1,1,0,0,0,0,132.9270697,1,2.465940507,0.675325125,3.651486398,0.000260727,0.001931889,6.083724492,1,0.860585565,1.302633046,0.660650801,0.508836282,0.66090605,67.92381824,0,1.417197966,0.755700373,1.875343741,0.060745449,0.131571614,84.06728659,1,1.649778934,0.718333962,2.296674001,0.021637374,0.07983907,27.13396499,0,0.286983594,0.93647494,0.306450906,0.759261354,0.832072866,N,-,,zinc finger 664,F:nucleic acid binding; P:biological_process; F:metal ion binding,IPR015880 (SMART); IPR007087 (PFAM); IPR013087 (G3DSA:3.30.160.GENE3D); IPR013087 (G3DSA:3.30.160.GENE3D); PF13894 (PFAM); PTHR24409 (PANTHER); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); IPR007087 (PROSITE_PROFILES); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY); SSF57667 (SUPERFAMILY),,
RL4_JR_09557,6685,6000,7274,0,1,7,1,0,0,2,0,0,1,2,3,0,2,0,553.8538391,1,-0.663797059,0.603914158,-1.099157969,0.271699169,0.453369159,129.1491882,1,-1.679600764,0.987962408,-1.700065459,0.089118613,0.184999714,293.9610954,1,-5.016450187,1.200105622,-4.18000724,2.91E-05,0.000461116,355.7595162,1,-3.1347117,0.653412033,-4.797450218,1.61E-06,2.79E-05,349.8799413,1,-1.708985744,0.681023819,-2.509436081,0.01209241,0.036624484,N,-,,60S ribosomal l35,"P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:structural constituent of ribosome; F:mRNA binding; C:cytosolic large ribosomal subunit; P:translation",IPR001854 (PFAM); IPR001854 (TIGRFAM); IPR001854 (G3DSA:1.10.287.GENE3D); PTHR13872 (PANTHER); IPR001854 (SUPERFAMILY),,
RL4_JR_09558,7051,5712,7425,12,10,11,0,0,5,0,0,3,1,2,0,0,5,4,25.23426794,1,-0.525542693,1.044980761,-0.502920927,0.615019867,0.778967874,15.00389285,1,1.887944446,1.150620781,1.640805101,0.100837879,0.203850811,44.62964355,1,1.140499162,0.775547142,1.470573612,0.141406465,0.250761788,16.84418872,1,-2.101455981,1.215133813,-1.729402934,0.083737005,0.171458184,18.28619248,1,-0.836441435,1.152567875,-0.725719893,0.468010504,0.599444194,N,-, Effector probability:0.562,vesicle transport v-snare,P:ER to Golgi vesicle-mediated transport; C:cis-Golgi network; P:vesicle fusion; P:protein transport; C:integral component of membrane; F:SNAP receptor activity; C:SNARE complex; C:Golgi membrane; C:Golgi medial cisterna,IPR023601 (PIRSF); PF12352 (PFAM); IPR023601 (PANTHER),,
RL4_JR_09559,3156,2114,2401,0,2,3,0,0,0,0,0,3,3,7,0,0,0,0,41.8207007,1,-1.042598096,1.018779144,-1.023379897,0.30612826,0.492777101,26.970406,0,2.065045836,0.997935712,2.069317503,0.038516302,0.096096133,82.7613951,1,1.59346063,0.566655805,2.812043249,0.004922788,0.018750305,24.64618677,1,-2.650563246,1.198622336,-2.211341443,0.027012202,0.087337724,21.13149507,0,-2.315113081,1.206944932,-1.918159659,0.05509077,0.1206302,N,-,,F1F0 ATP synthase assembly Atp10,C:mitochondrial membrane,IPR007849 (PFAM); PTHR28106:SF1 (PANTHER); PTHR28106 (PANTHER),,
RL4_JR_09560,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27.64831162,0,-2.891409925,1.190925821,-2.427867358,0.015187897,0.052927323,8.799128117,0,0.328146843,1.2164576,0.269756088,0.787347908,0.871568261,22.86003816,0,-2.325780104,1.191036833,-1.952735665,0.050850925,0.114709173,46.43252623,0,0.28394704,0.674186416,0.421169921,0.673631007,0.777823001,26.42164395,0,-1.479518921,1.1254821,-1.314564595,0.188656275,0.308087869,N,-,,prolyl aminopeptidase,P:proteolysis; F:aminopeptidase activity; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR029058 (SUPERFAMILY),,
RL4_JR_09561,8220,4729,3744,9,1,8,0,0,0,0,0,5,5,5,0,0,0,0,203.6847095,1,4.288513752,0.523787509,8.187506729,2.67E-16,2.07E-14,22.19810518,0,3.317316319,1.006284159,3.29659996,0.000978628,0.015023052,8.919615038,1,-0.967866921,1.202511728,-0.804871086,0.420894075,0.562080414,115.9550756,1,3.307788942,1.462547377,2.261662764,0.023718247,0.083109543,64.19458299,0,2.627542825,0.576067198,4.561174175,5.09E-06,5.76E-05,N,-,,alkanesulfonate monooxygenase,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity",IPR011251 (PFAM); IPR011251 (G3DSA:3.20.20.GENE3D); PTHR30011 (PANTHER); PTHR30011:SF20 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_09562,1131,1152,1061,0,0,10,0,0,0,0,0,1,1,0,0,0,0,0,0.941442711,1,1.984947707,1.845433628,1.075599619,0.282106358,NA,0.295949504,0,5.222118868,1.882223761,2.77444105,0.005529665,0.021974647,0.772184225,1,2.562333928,1.41036174,1.816792001,0.069248968,0.145632595,0.891325602,1,2.139035648,1.53150817,1.396685757,0.162508089,0.282616696,0.762752004,0,2.477475511,1.383142514,1.791193234,0.073262292,0.14997588,N,-,,lysR family regulatory,"F:transferase activity, transferring acyl groups other than amino-acyl groups",IPR023213 (G3DSA:3.30.559.GENE3D); IPR023213 (G3DSA:3.30.559.GENE3D),,
RL4_JR_09563,1609,1716,2929,1,2,0,0,0,0,0,0,0,2,0,0,0,0,0,8.841989359,1,0.505666551,1.331538484,0.379761124,0.704122743,0.839727461,1.571898979,0,2.812966422,1.535551939,1.831892723,0.066967405,0.148454681,10.61808511,0,1.108397001,1.314502491,0.843206467,0.399112982,0.541337072,4.755906457,1,-0.276872204,1.368661186,-0.202294189,0.839686743,0.899950066,4.091962576,0,0.053529624,1.359184111,0.039383645,0.968584519,0.979428988,N,-,,2-oxoisovalerate dehydrogenase E2 component (dihydrolipoyl transacylase),F:transferase activity,IPR023213 (G3DSA:3.30.559.GENE3D); IPR000089 (PFAM); IPR001078 (PFAM); G3DSA:2.40.50.100 (GENE3D); IPR004167 (G3DSA:4.10.320.GENE3D); IPR004167 (PFAM); PTHR23151 (PANTHER); IPR000089 (PROSITE_PROFILES); IPR011053 (SUPERFAMILY); IPR004167 (SUPERFAMILY); SSF52777 (SUPERFAMILY),,
RL4_JR_09564,9353,5546,6118,0,1,0,0,0,0,0,0,2,2,8,0,0,0,0,105.0676558,1,-2.981376315,1.013268075,-2.942337164,0.003257451,0.015388595,31.04790367,0,-1.490904183,1.192743392,-1.249978993,0.211307221,0.357249323,88.43524718,1,-3.181786329,1.187984968,-2.678305211,0.007399576,0.025663358,96.98921624,1,-3.618628295,1.140469433,-3.172928788,0.001509095,0.010444013,79.46770843,0,-4.226070592,1.191117083,-3.547989239,0.000388184,0.002184749,N,-, Effector probability:0.591,thermoresistant gluconokinase,C:nucleus; F:ATP binding; P:D-gluconate catabolic process; C:cytosol; P:phosphorylation; F:gluconokinase activity,IPR027417 (G3DSA:3.40.50.GENE3D); IPR006001 (TIGRFAM); IPR031322 (PFAM); PTHR11603 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_09565,380,177,184,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,197.7933138,0,1.645599848,0.359186311,4.58146593,4.62E-06,5.87E-05,38.40372818,0,0.381327906,1.115028794,0.34198929,0.732358952,0.832914305,91.23198015,0,0.429344017,0.578483084,0.742189407,0.457972586,0.595963029,90.80888485,1,0.097087659,0.550633182,0.176320029,0.860042527,0.912876674,52.62282961,0,-1.069125399,0.845998031,-1.263744548,0.20632173,0.329340614,N,-,,dipeptidyl-peptidase 3,C:nucleus; C:cytoplasm; F:metal ion binding; P:proteolysis; F:dipeptidyl-peptidase activity,IPR005317 (PIRSF); PF03571 (PFAM); PTHR23422 (PANTHER); PTHR23422:SF11 (PANTHER),,
RL4_JR_09566,349,367,486,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,661.6168615,0,-0.522486488,0.456392448,-1.144818436,0.252284377,0.429673475,146.6441225,0,-1.89097023,0.985751787,-1.918302614,0.055072651,0.127445216,425.8318844,0,-2.123627239,0.576520951,-3.683521363,0.000230034,0.001931065,541.4068123,0,-1.14270151,0.70835029,-1.613187044,0.106703877,0.205903708,432.5153463,0,-1.376601121,0.727740164,-1.891610754,0.058542862,0.126116272,N,-,,60S ribosomal l6,F:structural constituent of ribosome; P:cytoplasmic translation; C:cytosolic large ribosomal subunit; C:nucleolus; P:ribosomal large subunit assembly,IPR000915 (PFAM); IPR014722 (G3DSA:2.30.30.GENE3D); IPR000915 (PANTHER); IPR008991 (SUPERFAMILY),,
RL4_JR_09567,1034,1290,1052,0,0,1,0,0,0,0,0,0,2,0,4,0,0,0,162.7453925,1,1.446103686,0.831868291,1.738380585,0.082143775,0.192289504,24.56846175,0,0.457500276,1.116173393,0.409882801,0.681891923,0.797944718,56.89725619,0,-1.283798964,1.028192205,-1.248598227,0.211812061,0.339839193,81.96983275,1,-0.472753772,0.662432298,-0.713663529,0.475435263,0.616282428,53.78469382,0,-0.973601454,0.834563601,-1.166599469,0.243372158,0.373039497,N,-,,26S proteasome complex ubiquitin subunit Rpn13,F:nucleic acid binding; C:nuclear part; C:intracellular ribonucleoprotein complex; C:cytoplasm,IPR006773 (PFAM); IPR006773 (PANTHER),,
RL4_JR_09568,46,44,31,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,93.22515367,0,1.876235089,0.576869326,3.252443846,0.001144172,0.00658262,5.58654327,0,0.98358145,1.250740883,0.786399056,0.431633737,0.593452415,14.5022588,0,-1.669155224,1.203464757,-1.386958126,0.165454532,0.282288377,53.98095902,0,0.684749888,0.762412477,0.898135731,0.369113192,0.514987936,29.01927004,0,-0.056995032,0.984806933,-0.057874321,0.953848738,0.9699426,N,-,,nuclear mRNA splicing factor-associated,F:nucleic acid binding; C:nuclear part; C:intracellular ribonucleoprotein complex,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR15608 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); IPR012677 (SUPERFAMILY),,
RL4_JR_09569,2125,2519,2918,0,0,6,0,0,0,0,1,1,1,2,0,0,4,0,128.9663299,1,-0.033293626,0.890217002,-0.03739945,0.970166511,0.984504494,22.92866282,0,-1.053557123,1.198424896,-0.879118188,0.379337197,0.543551969,108.9377724,1,-0.078558064,0.568101413,-0.138281761,0.89001774,0.931320671,168.2156216,1,0.752642126,0.378828143,1.986764024,0.046948553,0.118188488,99.56156805,1,-0.346705376,0.573480597,-0.604563394,0.545469136,0.666611346,N,-,,hypothetical protein F503_06403,C:integral component of membrane,PTHR38695 (PANTHER); PTHR38695:SF1 (PANTHER),,
RL4_JR_09570,985,1543,1210,0,0,3,0,0,0,0,2,1,0,0,0,0,0,0,500.6015682,1,-0.875442291,0.631694821,-1.385862702,0.165788832,0.317489505,101.8667956,0,-3.205036703,1.200075953,-2.670694879,0.007569442,0.027481309,273.6013174,1,-4.903191619,1.207201274,-4.061618991,4.87E-05,0.000709897,346.8016332,0,-2.39531925,0.633150861,-3.783173011,0.000154842,0.00155225,285.6699534,0,-3.693130156,0.890389992,-4.14776692,3.36E-05,0.000276588,N,-,,bifunctional purine biosynthesis ADE17,F:IMP cyclohydrolase activity; P:'de novo' IMP biosynthetic process; C:cytosol; F:phosphoribosylaminoimidazolecarboxamide formyltransferase activity,IPR011607 (SMART); IPR002695 (SMART); IPR024051 (G3DSA:3.40.140.GENE3D); IPR002695 (PFAM); IPR002695 (TIGRFAM); IPR024050 (G3DSA:1.10.287.GENE3D); IPR024051 (G3DSA:3.40.140.GENE3D); IPR002695 (PIRSF); IPR011607 (G3DSA:3.40.50.GENE3D); IPR011607 (PFAM); IPR002695 (PANTHER); PTHR11692:SF0 (PANTHER); IPR011607 (SUPERFAMILY); IPR016193 (SUPERFAMILY),,
RL4_JR_09571,16879,13706,17553,2,3,19,0,0,0,0,0,0,2,6,2,0,0,1,23.52048468,1,-1.106200343,1.156058464,-0.956872319,0.338631705,0.528415732,4.918251078,0,1.167319554,1.248284061,0.935139357,0.349716486,0.512647397,12.81132058,0,-1.490426979,1.202069375,-1.239884328,0.215018182,0.343676045,34.8411827,1,1.102340527,0.698185246,1.578865398,0.114366934,0.216526231,28.12258155,1,1.011153065,0.785601967,1.287106076,0.198057318,0.319574557,N,-,,hypothetical protein CMQ_5893,C:membrane,IPR021822 (PFAM); PTHR36205 (PANTHER); PTHR36205:SF1 (PANTHER); PTHR36205:SF1 (PANTHER); PTHR36205 (PANTHER),,
RL4_JR_09572,355,424,507,0,0,0,0,0,0,3,0,4,1,2,3,0,0,2,184.044278,0,1.829006348,0.537208272,3.404650384,0.000662488,0.004248882,13.68871066,0,-0.309426527,1.21925202,-0.253783895,0.799662516,0.878134016,69.50679007,1,0.162396395,0.696463776,0.23317278,0.815627242,0.880320916,115.9476349,1,1.198209857,0.530310754,2.259448536,0.023855498,0.0833662,58.46570834,1,0.08928211,0.683513049,0.130622393,0.896074027,0.932451133,Y,-, Effector probability:0.777,endosomal p24b,C:endoplasmic reticulum membrane; P:ER to Golgi vesicle-mediated transport; P:vesicle organization; C:integral component of membrane; C:ER to Golgi transport vesicle; P:protein retention in ER lumen,IPR009038 (SMART); IPR009038 (PFAM); IPR015720 (PANTHER); PTHR22811:SF31 (PANTHER); IPR009038 (PROSITE_PROFILES); IPR009038 (SUPERFAMILY),9.B.188.1.2, the transmembrane emp24 domain-containing protein (tmed) family.
RL4_JR_09573,6535,7695,11960,1,0,0,0,0,0,0,1,0,0,2,3,0,7,0,972.6964408,1,0.697703491,0.576650059,1.209925292,0.226307561,0.397805879,129.3534823,0,-2.523197987,1.104753374,-2.283946849,0.022374655,0.062910071,404.5924878,1,-1.68627016,0.455126543,-3.705057827,0.000211343,0.001813247,659.1127494,1,-0.160647761,0.330992621,-0.485351488,0.627427038,0.743673807,368.6140439,1,-1.936509561,0.83015045,-2.332721209,0.019662782,0.053953079,N,-, Effector probability:0.664,ADP-ribosylation factor,F:GTP binding; P:small GTPase mediated signal transduction; C:intracellular; F:hydrolase activity,IPR006689 (PRINTS); SM00178 (SMART); SM00175 (SMART); SM00177 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR006689 (PFAM); IPR005225 (TIGRFAM); PTHR11711 (PANTHER); PTHR11711:SF181 (PANTHER); IPR024156 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_09574,1034,1125,1220,0,0,3,0,0,0,0,0,0,0,2,0,0,1,0,1794.544533,1,1.335228974,0.743447829,1.795995526,0.072495228,0.175494384,421.6012259,0,0.576564337,0.682759483,0.84446185,0.398411373,0.562503707,564.9968368,0,-1.509857105,0.554020047,-2.725275218,0.006424791,0.022959612,620.4766862,1,-1.968085764,0.881507941,-2.23263532,0.025573003,0.085851084,412.1126368,1,-6.600676491,1.273269775,-5.184036108,2.17E-07,4.29E-06,N,-,,heat shock chaperonin,F:ATPase activity; P:protein import into mitochondrial matrix; F:peptidase activity; P:protein refolding; P:protein unfolding; P:mitochondrial genome maintenance; F:ATP binding; P:cellular response to heat; C:mitochondrial matrix; P:proteolysis; P:protein stabilization; P:positive regulation of mitochondrial translation in response to stress; F:misfolded protein binding,IPR001270 (PRINTS); IPR003593 (SMART); IPR019489 (SMART); IPR003959 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.8.60 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR019489 (PFAM); G3DSA:1.10.8.60 (GENE3D); IPR003959 (PFAM); PTHR11638:SF114 (PANTHER); PTHR11638 (PANTHER); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.9.1.2, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_09575,92567,82827,91036,16,30,32,8,0,0,7,11,6,14,67,10,0,25,8,1369.555735,1,-0.142624891,0.555030072,-0.256967861,0.797203583,0.896831455,229.8141463,1,-4.378810067,1.209443995,-3.62051495,0.000294017,0.011904171,673.9209642,1,-2.924849235,0.586693499,-4.985310454,6.19E-07,1.77E-05,833.0930879,1,-2.133432519,0.706933627,-3.017868212,0.002545596,0.016192865,744.4643868,1,-1.808917538,0.851508046,-2.124369282,0.033639276,0.08226997,N,-,,elongation factor 1-beta,F:translation elongation factor activity; P:translational elongation; C:eukaryotic translation elongation factor 1 complex,IPR018940 (SMART); IPR014038 (SMART); IPR018940 (PFAM); IPR010987 (G3DSA:1.20.1050.GENE3D); IPR014717 (G3DSA:3.30.70.GENE3D); IPR014038 (PFAM); PTHR11595 (PANTHER); IPR014038 (SUPERFAMILY); IPR010987 (SUPERFAMILY),,
RL4_JR_09576,4822,3758,6543,0,0,0,0,0,2,0,0,0,2,5,1,0,3,0,814.1310179,0,0.019847759,0.272194201,0.072917642,0.941871655,0.971524714,194.6640018,1,-0.176918288,0.605962411,-0.29196248,0.770315311,0.860990678,413.804727,0,-2.060400295,0.503069276,-4.09565917,4.21E-05,0.000628597,412.6232783,1,-3.588305299,0.683748938,-5.247986653,1.54E-07,3.33E-06,369.1062466,1,-3.059046028,0.659137834,-4.640980794,3.47E-06,4.17E-05,N,-,,argininosuccinate synthase,"C:nucleus; F:DNA binding; F:ATP binding; P:tRNA aminoacylation for protein translation; F:aminoacyl-tRNA ligase activity; F:zinc ion binding; P:arginine biosynthetic process; P:transcription, DNA-templated; F:argininosuccinate synthase activity",IPR001518 (PFAM); IPR014729 (G3DSA:3.40.50.GENE3D); IPR024074 (G3DSA:3.90.1260.GENE3D); PTHR11587 (PANTHER); PTHR11587:SF2 (PANTHER); SSF69864 (SUPERFAMILY); SSF52402 (SUPERFAMILY),,
RL4_JR_09577,1939,2077,1432,0,2,3,0,0,0,0,0,1,2,2,1,0,0,0,58.67068164,1,1.141732515,0.660154236,1.729493583,0.083720794,0.194363756,6.10708467,0,0.854946501,1.265400449,0.675633157,0.499273584,0.653770662,38.16309896,1,0.594241607,0.890772412,0.667108231,0.504703003,0.636842137,45.73596981,1,0.504721726,0.794993526,0.634875266,0.52550977,0.659574367,23.26226966,0,-0.961920786,1.16501618,-0.825671611,0.408990401,0.544943783,N,-,,DNA replication complex GINS PSF1,P:double-strand break repair via break-induced replication; C:GINS complex; C:cytosol; P:mitotic DNA replication initiation; P:DNA strand elongation involved in mitotic DNA replication; C:replication fork protection complex,IPR021151 (PFAM); PTHR12914:SF2 (PANTHER); IPR005339 (PANTHER); PTHR12914:SF2 (PANTHER); IPR005339 (PANTHER); SSF158573 (SUPERFAMILY),,
RL4_JR_09578,14311,23555,24335,19,8,153,0,0,0,8,11,9,1,66,3,0,25,4,222.3197237,1,-0.769893963,0.439026658,-1.7536383,0.079492504,0.187251553,86.12398055,0,0.461849728,0.742353239,0.622142807,0.533847969,0.682101634,171.7123668,1,-1.174656038,0.578074398,-2.032015331,0.042152104,0.099498228,192.6454922,1,-1.328142945,0.510505922,-2.601621032,0.009278432,0.045815218,136.15969,1,-2.67334505,0.850449681,-3.143448824,0.001669696,0.007283788,N,-,,sulfate transporter family,C:integral component of plasma membrane; F:secondary active sulfate transmembrane transporter activity; C:fungal-type vacuole membrane; P:sulfate transmembrane transport; C:endoplasmic reticulum; C:Golgi apparatus,IPR000595 (SMART); IPR002645 (G3DSA:3.30.750.GENE3D); IPR002645 (PFAM); IPR014710 (G3DSA:2.60.120.GENE3D); IPR011547 (PFAM); IPR000595 (PFAM); IPR001902 (PANTHER); PTHR11814:SF59 (PANTHER); IPR000595 (PROSITE_PROFILES); IPR002645 (PROSITE_PROFILES); IPR018490 (SUPERFAMILY); IPR002645 (SUPERFAMILY),2.A.53.3.7, the sulfate permease (sulp) family.
RL4_JR_09579,2439,1888,2296,0,5,3,0,0,0,0,0,0,1,3,0,0,0,0,18.25822566,1,-1.007902826,1.159882866,-0.868969493,0.384863817,0.57789785,4.657931267,0,1.245878621,1.279971345,0.973364463,0.330372194,0.493437709,19.84757885,0,-0.434710344,1.207992678,-0.359861737,0.718950532,0.809909334,13.84252543,1,-1.818202981,1.210633071,-1.501861318,0.133132928,0.243228239,11.75977469,0,-1.469661196,1.208598897,-1.216004085,0.223983366,0.350579711,N,-,,rho-type GTPase-activating 1,F:zinc ion binding; P:signal transduction,IPR001781 (SMART); IPR000198 (SMART); IPR000198 (PFAM); IPR001781 (PFAM); IPR001781 (G3DSA:2.10.110.GENE3D); IPR001781 (G3DSA:2.10.110.GENE3D); IPR000198 (G3DSA:1.10.555.GENE3D); PTHR24215:SF10 (PANTHER); PTHR24215 (PANTHER); IPR001781 (PROSITE_PROFILES); IPR001781 (PROSITE_PROFILES); IPR001781 (PROSITE_PROFILES); IPR000198 (PROSITE_PROFILES); SSF57716 (SUPERFAMILY); SSF57716 (SUPERFAMILY); SSF57716 (SUPERFAMILY); IPR008936 (SUPERFAMILY),9.A.1.1.1, the non abc multidrug exporter (n-mde) family.
RL4_JR_09580,1091,592,1501,0,0,0,0,0,0,4,0,1,0,5,9,0,0,0,34.91314319,0,1.612047841,0.606560195,2.657688148,0.007867866,0.031402177,3.843588272,0,1.523086762,1.25876207,1.209987811,0.22628357,0.375852034,9.950474428,1,-1.125797245,1.192981488,-0.94368375,0.34533128,0.489038171,35.54687478,1,1.746598573,0.616721708,2.832069229,0.004624783,0.026380807,13.6509191,0,-0.274867722,1.121089105,-0.245179193,0.806317687,0.869502049,N,-,,mitochondrial integral membrane,C:cytoplasm; C:membrane,IPR019431 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR029058 (SUPERFAMILY),,
RL4_JR_09581,7736,6559,7827,3,1,10,2,0,0,0,1,3,5,10,6,0,2,1,66.54185582,1,-4.158527587,1.234643727,-3.368200475,0.000756606,0.004740698,20.97681194,1,-0.925250294,1.226937658,-0.754113534,0.450781051,0.611062783,54.88004767,1,-3.589245559,1.219353826,-2.943563618,0.003244571,0.014356661,79.3893146,1,-1.342916705,0.819903028,-1.637896993,0.101443183,0.197845138,54.58246474,1,-3.684140864,1.231386354,-2.991864294,0.002772795,0.01112264,N,-, Effector probability:0.743,60S ribosome subunit biogenesis nip7,"P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:nucleus; F:RNA binding; C:cytoplasm; P:ribosome assembly; P:assembly of large subunit precursor of preribosome; C:preribosome, large subunit precursor",IPR002478 (SMART); IPR005155 (PFAM); IPR016686 (PIRSF); IPR015947 (G3DSA:2.30.130.GENE3D); PTHR23415:SF4 (PANTHER); PTHR23415 (PANTHER); IPR002478 (PROSITE_PROFILES); IPR015947 (SUPERFAMILY); SSF88802 (SUPERFAMILY),,
RL4_JR_09582,2309,2275,2638,5,0,2,0,0,3,0,0,0,2,3,0,0,0,4,131.1719077,1,-0.080742884,0.939466826,-0.085945434,0.931509794,0.966629651,21.44960279,1,-0.957357736,1.440716951,-0.664500918,0.506369762,0.659309844,55.87359704,0,-3.615093181,1.804770129,-2.003076803,0.045169045,0.104739216,64.49531289,1,-4.038287639,1.80562689,-2.236501717,0.025318925,0.085851084,54.98749814,1,-3.694802198,1.804576346,-2.04746239,0.040612706,0.095274246,N,-,,zinc-regulated transporter 1,C:integral component of membrane; C:endoplasmic reticulum; F:high-affinity zinc uptake transmembrane transporter activity; C:plasma membrane; P:high-affinity zinc II ion transport,IPR003689 (PFAM); IPR004698 (TIGRFAM); PTHR11040:SF32 (PANTHER); PTHR11040 (PANTHER),2.A.5.1.1, the zinc (zn(2+))-iron (fe(2+)) permease (zip) family.
RL4_JR_09583,15481,16319,16822,5,5,13,0,0,0,2,0,0,0,2,2,0,6,2,23.2946324,1,-2.644182827,1.267621714,-2.085939991,0.036984059,0.106454303,44.94555189,0,3.080572872,0.889273575,3.464145294,0.000531919,0.015023052,25.71186208,1,-1.11316679,1.2458604,-0.893492393,0.371593544,0.515980392,22.16403062,1,-2.49726666,1.255141014,-1.989630354,0.04663167,0.11756615,18.81162209,1,-2.147305899,1.254627514,-1.711508695,0.086987247,0.172121532,N,-,,mitochondrial phosphate carrier,P:transmembrane transport; C:integral component of membrane,IPR002067 (PRINTS); IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089 (PANTHER); PTHR24089:SF215 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.4.3, the mitochondrial carrier (mc) family.
RL4_JR_09584,363,244,238,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.767622361,0,2.279044991,1.650328782,1.380964215,0.167289964,NA,0.244683284,0,5.496397175,1.764235022,3.115456335,0.001836605,0.015023052,0.636092468,0,2.840915982,1.268438425,2.239695617,0.02511069,0.066812255,0.733850823,0,2.418856059,1.34791892,1.794511541,0.072731558,0.155402214,0.629143849,0,2.754528651,1.241527555,2.218660906,0.026509803,0.068489857,N,-, Effector probability:0.905,---NA---,,no IPS match,,
RL4_JR_09585,3983,2739,4470,5,0,14,0,0,1,0,6,0,3,4,4,0,3,1,148.9678658,1,0.668766304,0.632292974,1.057684226,0.290199429,0.474999067,17.20380832,1,-0.639111439,1.259638512,-0.507376865,0.611890415,0.744739827,113.946288,1,0.710357187,0.593320369,1.197257375,0.231206253,0.36251078,73.55015547,1,-1.357510599,0.910413647,-1.491092103,0.135937315,0.247103289,70.11591166,1,-0.023684284,0.699702064,-0.033849099,0.972997483,0.981821758,N,-,,hypothetical protein SPI_07507,,no IPS match,,
RL4_JR_09586,6122,5004,3822,1,2,2,0,0,1,0,3,2,0,2,0,0,8,5,44.34414281,1,2.692399482,0.536404536,5.019345101,5.18E-07,8.60E-06,11.79480471,1,3.108620232,1.132107935,2.74586913,0.006035083,0.023385719,29.78800356,1,1.952020609,0.852021821,2.291045325,0.021960792,0.059895221,26.49030641,1,0.863222423,1.013258311,0.851927306,0.39425444,0.538926179,10.02425312,1,0.392306951,1.125946083,0.348424278,0.727521572,0.808490387,N,-,,alanyl-tRNA synthetase,F:nucleotide binding; F:aminoacyl-tRNA ligase activity; P:regulation of translational fidelity; F:Ser-tRNA(Ala) hydrolase activity; F:tRNA binding; P:tRNA aminoacylation,IPR012947 (SMART); IPR012947 (PFAM); PTHR11777:SF7 (PANTHER); PTHR11777 (PANTHER); IPR009000 (SUPERFAMILY); IPR018163 (SUPERFAMILY),,
RL4_JR_09587,4824,4159,4160,0,0,14,0,0,0,0,0,0,4,3,4,0,4,1,8.839861598,1,-1.246425571,1.205876299,-1.033626394,0.301310855,0.48704061,2.805944593,0,1.976958935,1.281798297,1.542332315,0.12299286,0.237764272,7.307516782,0,-0.680554966,1.203970389,-0.56525889,0.571897686,0.6956914,31.06809138,1,1.221293433,0.860453099,1.41936084,0.155793843,0.273583784,7.234335361,1,-0.768596053,1.21196714,-0.634172354,0.525968348,0.650034786,N,-,,hypothetical protein FPOA_06481,,no IPS match,,
RL4_JR_09588,448,406,752,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,4.964191813,1,-0.414038017,1.203950445,-0.34389955,0.73092183,0.858001443,1.593229243,0,2.793603671,1.345213722,2.076698762,0.037829371,0.094986169,4.119455714,0,0.146519276,1.206331933,0.121458507,0.903327878,0.940486573,4.751152105,0,-0.275488536,1.205778771,-0.228473533,0.81927813,0.886143688,4.048574696,0,0.068634507,1.201644685,0.057117139,0.954451884,0.970227926,N,-,,glucosyl glucuronosyl,"P:carbohydrate metabolic process; F:transferase activity, transferring hexosyl groups; P:lipid glycosylation",IPR003903 (SMART); IPR002213 (PFAM); IPR003903 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR004276 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR002213 (PANTHER); PTHR11926:SF164 (PANTHER); IPR003903 (PROSITE_PROFILES); SSF53756 (SUPERFAMILY),,
RL4_JR_09589,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.015624059,0,7.894997458,3.974358507,1.986483465,0.046979667,NA,0.005342092,0,11.01782189,3.970278013,2.775075663,0.005518887,0.021974647,0.013322949,0,8.419138269,3.972556748,2.119324859,0.034063022,0.084689105,0.015325853,0,8.000645136,3.972725723,2.013893154,0.044020753,0.113902079,0.012659449,0,8.375900661,2.059145617,4.067658253,4.75E-05,0.000372148,N,-,,non-ribosomal peptide synthetase,F:catalytic activity; P:metabolic process; F:phosphopantetheine binding,no IPS match,,
RL4_JR_09590,2250,1427,2932,0,4,0,0,0,6,0,0,0,0,0,0,0,0,0,0.338020558,1,3.462352842,2.36997703,1.460922531,0.144036703,NA,0.10772657,1,6.679878875,2.068304646,3.229639738,0.001239463,0.015023052,0.280094341,0,4.023939917,1.323932033,3.03938557,0.002370612,0.011320792,0.323143356,0,3.602190121,1.570993337,2.292937874,0.021851582,0.080257454,0.277085656,0,3.93743174,1.25673377,3.133067506,0.001729897,0.007504371,N,-,,NACHT nucleoside triphosphatase,,PTHR10039 (PANTHER); PTHR10039:SF5 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_09591,21128,22401,20065,1,0,21,0,0,4,1,12,5,4,12,5,1,7,9,1.472850587,1,1.338880488,1.376567819,0.972622249,0.330741081,NA,0.475050037,1,4.539432008,1.597881837,2.840905943,0.004498558,0.019229055,1.22521503,1,1.895857228,1.255224358,1.510373198,0.130948223,0.23715918,1.412813188,1,1.474154328,1.28833068,1.144235988,0.252525782,0.392300156,1.201846351,1,1.820433695,1.235727155,1.473167994,0.140705743,0.246820105,N,-,,metalloproteases (zincins) catalytic,F:zinc ion binding; P:proteolysis; F:metallopeptidase activity,PTHR15910:SF1 (PANTHER); PTHR15910:SF1 (PANTHER); PTHR15910 (PANTHER); PTHR15910 (PANTHER); SSF55486 (SUPERFAMILY),,
RL4_JR_09592,2593,3347,4628,1,0,0,1,0,0,0,2,0,2,4,1,0,11,1,52.19481349,1,0.021275131,0.761915449,0.027923218,0.97772339,0.98879844,7.797112699,1,0.502540302,1.237501711,0.406092612,0.684674554,0.799708728,20.25002685,1,-2.150948945,1.20298209,-1.788014106,0.073773732,0.15311301,23.3607903,1,-2.573282687,1.202833703,-2.139350336,0.032407306,0.096337044,50.89221592,1,1.302372068,0.619183864,2.103368875,0.035433537,0.085624001,N,-,,NADH:flavin oxidoreductase NADH oxidase,F:catalytic activity,IPR013785 (G3DSA:3.20.20.GENE3D); IPR001155 (PFAM); PTHR22893:SF6 (PANTHER); PTHR22893 (PANTHER); SSF51395 (SUPERFAMILY),,
RL4_JR_09593,859,944,785,0,2,0,0,0,0,0,2,0,0,2,0,0,0,0,6.077317203,1,1.668985543,1.161438428,1.436998726,0.150718355,0.298219826,0.725356099,0,3.928866466,1.476685731,2.66059757,0.007800212,0.028067455,1.872847877,1,1.28408721,1.223592484,1.049440257,0.293975538,0.434603275,14.19472776,1,3.158088838,0.871513669,3.623682509,0.000290438,0.002646882,1.836239194,0,1.209377386,1.208801459,1.000476444,0.317079992,0.452240931,N,-,,aminotriazole resistance,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF8 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.52, the major facilitator superfamily (mfs).
RL4_JR_09594,1631,1356,1484,1,0,2,0,0,0,0,0,0,0,12,1,0,0,0,0.928142352,1,2.005510575,1.623760751,1.235102261,0.216792448,NA,0.296056886,0,5.221744001,1.750580391,2.982864441,0.002855644,0.015349618,0.766040176,0,2.5742868,1.29658578,1.985435009,0.047096094,0.108136226,0.883705253,1,2.151651241,1.372852971,1.567284543,0.117048197,0.219994986,0.751137014,0,2.499657184,1.264756352,1.976394251,0.048110142,0.108803929,N,-,,kinase-like domain,"F:transferase activity, transferring phosphorus-containing groups",IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_09595,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1929.083248,0,-2.252529857,0.401944082,-5.604087623,2.09E-08,4.72E-07,500.5274767,0,-5.501787585,1.206499754,-4.560123255,5.11E-06,0.000377718,1350.471787,0,-4.757834207,0.659738089,-7.211701561,5.53E-13,4.55E-11,1698.408141,0,-2.825805881,0.453329924,-6.233442211,4.56E-10,1.56E-08,1467.5259,0,-2.729240181,0.910848642,-2.996370697,0.002732141,0.01100355,N,-,,karyopherin kap123,"C:nuclear membrane; P:protein import into nucleus, translocation; P:NLS-bearing protein import into nucleus; C:cytosol; F:protein transporter activity; C:nuclear periphery; F:Ran GTPase binding; P:protein import into nucleus, docking; F:nuclear localization sequence binding; P:ribosomal protein import into nucleus",IPR001494 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); PF13513 (PFAM); IPR001494 (PFAM); PTHR10527 (PANTHER); PTHR10527 (PANTHER); PTHR10527:SF6 (PANTHER); PTHR10527:SF6 (PANTHER); IPR021133 (PROSITE_PROFILES); IPR001494 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_09596,1658,2782,2667,0,0,6,0,0,0,1,2,0,0,2,0,0,1,0,73.87848822,1,0.729344526,0.561078346,1.299897833,0.193635988,0.354666006,8.359067327,0,0.402178142,1.215882227,0.33077064,0.74081774,0.8400317,53.05525923,1,0.57454456,0.735277931,0.781397802,0.434568563,0.574957153,25.01415961,1,-2.671886411,1.184729925,-2.255270466,0.024116357,0.083910006,21.372978,1,-2.331488634,1.18984968,-1.959481667,0.050056405,0.112227879,N,-,,dihydroxyacid dehydratase,F:ubiquitin-protein transferase activity; F:zinc ion binding; P:protein ubiquitination,IPR002867 (PFAM); IPR002035 (G3DSA:3.40.50.GENE3D); PTHR11685:SF136 (PANTHER); IPR031127 (PANTHER); IPR031127 (PANTHER); PTHR11685:SF136 (PANTHER); IPR002035 (SUPERFAMILY); SSF57850 (SUPERFAMILY),,
RL4_JR_09597,4017,4166,7217,0,0,9,0,0,1,0,0,0,0,2,1,0,1,0,0.709694243,1,2.392435446,1.698370514,1.408665204,0.158934189,NA,0.22522415,1,5.616012859,1.78303806,3.149687596,0.001634451,0.015023052,0.586132988,0,2.959566761,1.265152672,2.339296139,0.019320112,0.054392886,0.67632502,1,2.536981761,1.351205792,1.877568743,0.060440185,0.137403188,0.579397516,1,2.874258801,1.235440715,2.326504839,0.019991635,0.054515298,N,-,,---NA---,,no IPS match,,
RL4_JR_09598,381,356,424,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,25.91853923,0,-2.798287566,1.26869685,-2.205639249,0.027409269,0.084347346,8.147038252,0,0.439158465,1.292737301,0.33971207,0.734073371,0.834114354,21.39277782,0,-2.23013653,1.250054449,-1.784031513,0.074418545,0.1541353,24.69509168,1,-2.653395521,1.25700583,-2.110885612,0.034782145,0.099426657,21.3885586,0,-2.332546621,1.271054385,-1.835127316,0.066486827,0.13951899,N,-,,hypothetical protein CMQ_5897,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (SUPERFAMILY),,
RL4_JR_09599,2302,2773,2776,1,0,10,0,0,1,0,0,1,0,4,1,0,0,0,0.849254428,1,2.133306238,1.614800013,1.321096247,0.186469274,NA,0.268588192,1,5.361831799,1.737901726,3.085233024,0.002033927,0.015023052,0.701460082,1,2.699817735,1.273502165,2.119994618,0.034006499,0.084650989,0.809524607,1,2.277280179,1.347111704,1.690490975,0.090934063,0.182426668,0.69667682,0,2.607959327,1.253786921,2.080065825,0.037519496,0.089489963,N,-,,Fungal transcriptional regulatory partial,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09600,35,13,28,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.362896087,1,3.3599593,2.329347436,1.442446605,0.149176424,NA,0.114416523,0,6.592785599,2.057249233,3.204660617,0.001352218,0.015023052,0.299413186,0,3.927678514,1.341687758,2.927416227,0.003417911,0.014889386,0.345584048,0,3.505306062,1.57968633,2.218988666,0.026487496,0.086427939,0.297954927,0,3.833802652,1.28120104,2.992350562,0.002768382,0.01111855,N,-,,RTA1 domain,P:fatty acid transport; P:phospholipid translocation; C:integral component of membrane; C:endoplasmic reticulum; F:phospholipid-translocating ATPase activity; C:plasma membrane; P:response to stress,IPR007568 (PFAM); PTHR31465 (PANTHER),9.A.26.1.2, the lipid-translocating exporter (lte) family.
RL4_JR_09601,748,607,941,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,27.55179982,0,-2.886360354,1.21395881,-2.377642742,0.017423698,0.05871232,8.73128136,0,0.339309181,1.23771304,0.274142043,0.783975466,0.869393146,22.73079392,0,-2.317582219,1.207779306,-1.918878894,0.054999662,0.121602224,26.22992648,1,-2.740312807,1.208782731,-2.267001948,0.023390107,0.082719116,22.46596075,0,-2.403414598,1.215281135,-1.977661406,0.047966917,0.108552757,N,-,,regulator of g,C:integral component of membrane,G3DSA:1.10.167.10 (GENE3D); PTHR39466 (PANTHER); IPR016137 (SUPERFAMILY),,
RL4_JR_09602,4675,2457,3787,0,0,0,0,0,1,0,4,1,0,5,0,0,3,0,37.70794453,0,-1.286716968,1.016395614,-1.265960764,0.20552713,0.370703145,9.573033995,1,0.206500083,1.216166007,0.169795967,0.865170599,0.921816506,47.02830432,1,-0.617417922,1.032259994,-0.598122494,0.549758202,0.676851762,36.7377924,1,-1.146168574,1.019089086,-1.124699096,0.260716565,0.400934875,24.60105608,1,-2.53442991,1.200186199,-2.111697261,0.034712424,0.084321144,Y,-,,gpi transamidase component gpi16,F:GPI-anchor transamidase activity; P:attachment of GPI anchor to protein; C:GPI-anchor transamidase complex,IPR007245 (PFAM); IPR007245 (PANTHER); PTHR12959:SF11 (PANTHER); PTHR12959:SF11 (PANTHER); IPR007245 (PANTHER),,
RL4_JR_09603,34510,23457,35322,0,2,7,0,0,0,2,1,1,5,9,0,0,8,4,57.93699357,1,0.206333002,0.699931171,0.294790417,0.768153988,0.878290151,9.748221692,0,0.180304338,1.242813472,0.145077553,0.884649641,0.934426328,25.4765958,1,-2.482182914,1.216666627,-2.040150406,0.041335348,0.098144182,41.43676629,1,-0.629685239,0.906799894,-0.694403741,0.487429048,0.627650911,25.33084708,1,-2.576601067,1.230149696,-2.094542701,0.036211663,0.087109311,N,-,,u1 snrnp splicing complex subunit,P:mRNA splice site selection; C:cytosol; F:mRNA binding; C:U2-type prespliceosome; C:U1 snRNP,IPR004882 (PFAM); PTHR12375:SF30 (PANTHER); IPR004882 (PANTHER),,
RL4_JR_09604,7816,4635,5704,5,1,10,0,0,0,0,0,0,5,5,5,0,7,1,74.89531828,1,-0.377963608,0.607189796,-0.622480171,0.533626179,0.71706681,15.30788795,0,-0.470655354,1.207285286,-0.389846012,0.696650418,0.807453971,47.45222212,0,-2.1569596,1.188068184,-1.815518359,0.069444287,0.145908403,108.2973588,1,0.508368181,0.483646813,1.051114506,0.293206003,0.437963364,53.66734356,1,-1.515743278,0.962790406,-1.574323205,0.115412748,0.212808666,N,-,,hypothetical protein SPI_07493,,no IPS match,1.G.20.2.1, the hantavirus gc envelope fusion glycoprotein (gc-efg) family.
RL4_JR_09605,4138,3970,3515,1,3,8,0,0,0,0,4,4,0,4,0,0,2,0,1.733839897,1,1.10363868,1.337657643,0.825053171,0.409341404,NA,0.548755941,0,4.331141124,1.533793554,2.823809705,0.004745655,0.019954733,1.43182151,1,1.670734838,1.241201477,1.34606256,0.178282342,0.298335608,1.652344748,1,1.248034085,1.265329851,0.986331022,0.323970702,0.470414937,1.420143187,1,1.580412565,1.237736519,1.276857021,0.20165273,0.32372505,N,-, Effector probability:0.706,hypothetical protein HMPREF1624_00749,F:nucleoside deoxyribosyltransferase activity; F:deoxyribonucleoside 5'-monophosphate N-glycosidase activity; P:deoxyribonucleoside monophosphate catabolic process,PF15891 (PFAM),,
RL4_JR_09606,1054,608,851,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,22.33330992,0,1.775314722,0.770885457,2.302955265,0.02128136,0.06916866,2.240261256,0,2.30176883,1.302719848,1.766894727,0.07724586,0.16589913,5.835649666,1,-0.356102972,1.207477937,-0.294914682,0.768059056,0.844036593,16.04594551,0,0.171891313,1.153262198,0.149047903,0.881515834,0.92661179,21.22123118,0,2.143509166,0.788309495,2.719121334,0.006545559,0.022412508,N,-,,hypothetical protein SPI_07492,,no IPS match,,
RL4_JR_09607,2258,1816,2886,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0.088360044,0,5.398099443,3.91882538,1.377478943,0.168364221,NA,0.028071886,0,8.62017846,2.686227051,3.209028238,0.001331844,0.015023052,0.072975492,1,5.965663164,1.520514789,3.923449614,8.73E-05,0.001074055,0.084200553,0,5.542863866,2.463561021,2.249939749,0.02445277,0.084615276,0.072031835,0,5.883635947,1.302189146,4.518265235,6.23E-06,6.83E-05,,,,,,,,
RL4_JR_09608,9426,7084,7407,2,3,10,0,0,0,0,0,0,1,9,2,0,5,1,9.783046217,1,0.268295427,1.148050625,0.233696512,0.815220596,0.906040195,1.914617647,0,2.528497326,1.325947379,1.906936404,0.056528823,0.13007155,4.950245628,0,-0.118539039,1.205145723,-0.098360752,0.921645839,0.954224514,9.720888764,1,0.406115733,1.151563188,0.352664741,0.724339796,0.816208485,4.865232517,1,-0.196446052,1.201655255,-0.163479543,0.870140878,0.913931025,N,-,,decarboxylase_GME10520,C:integral component of membrane,PTHR33048 (PANTHER); PTHR33048:SF29 (PANTHER),9.B.313.1.6, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_09609,11476,9076,4393,0,0,5,0,0,0,0,0,1,3,4,0,0,11,0,1.184597232,1,1.653188559,1.514380169,1.091660201,0.274982485,NA,0.385068151,0,4.842514001,1.699196661,2.849884367,0.004373513,0.018894022,0.987654555,1,2.207107806,1.295879551,1.703173573,0.088535591,0.176403624,1.138500641,1,1.785778747,1.354067745,1.318825261,0.187227537,0.315158572,0.962881573,1,2.140179052,1.265810301,1.690758127,0.090883008,0.177711559,N,-,,sugar transporter 4,C:integral component of plasma membrane; P:proton transport; F:sugar:proton symporter activity; P:glucose import; F:glucose transmembrane transporter activity; P:glucose transmembrane transport,G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR23500 (PANTHER); PTHR23500:SF19 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.117, the major facilitator superfamily (mfs).
RL4_JR_09610,1514,1553,1456,0,0,28,0,0,0,1,2,2,0,7,0,0,1,0,5.006057606,1,-0.426184645,1.223191828,-0.348420121,0.727524693,0.856071895,1.612483141,0,2.776281852,1.36596967,2.032462295,0.042106877,0.103222526,4.161260509,1,0.131937619,1.220331936,0.108116173,0.913903539,0.947890526,8.810252316,1,0.655830609,1.166383181,0.562277148,0.573927205,0.700713005,4.083311835,1,0.056271997,1.215609299,0.046291187,0.963078164,0.975749495,N,-,,cytochrome p450,"P:small molecule metabolic process; F:iron ion binding; C:intracellular membrane-bounded organelle; P:secondary metabolite biosynthetic process; C:integral component of membrane; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; P:oxidation-reduction process; F:heme binding",IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (PFAM); IPR001128 (G3DSA:1.10.630.GENE3D); PTHR24279:SF80 (PANTHER); PTHR24279 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_09611,5894,6387,13144,0,1,3,0,0,1,0,0,2,0,1,0,0,0,0,28.49191808,1,2.954215673,0.846819818,3.488600066,0.000485557,0.003287282,0.769257024,1,3.843965482,1.449545855,2.651841244,0.008005417,0.028602483,1.994486129,1,1.192743159,1.21507363,0.981622125,0.326286044,0.469354917,10.32388896,1,2.494383307,1.022181707,2.440254302,0.014676926,0.065631958,1.96602375,0,1.110806117,1.208757293,0.91896539,0.358113675,0.495595406,Y,-,,dj-1 family,,IPR029062 (G3DSA:3.40.50.GENE3D); IPR002818 (PFAM); PTHR11019 (PANTHER); PTHR11019:SF82 (PANTHER); PTHR11019 (PANTHER); PTHR11019:SF82 (PANTHER); PS51257 (PROSITE_PROFILES); IPR029062 (SUPERFAMILY),,
RL4_JR_09612,3887,4209,4966,1,0,9,0,0,0,0,2,0,1,12,2,0,4,0,0.579950178,1,2.683644263,1.82978455,1.466644946,0.142472667,NA,0.185779551,0,5.893909376,1.848127259,3.189125286,0.00142704,0.015023052,0.480787683,1,3.245581461,1.266130199,2.563386818,0.010365649,0.033602892,8.577732172,1,4.545632295,1.032177323,4.403925754,1.06E-05,0.000148466,0.47280945,1,3.166606371,1.223945433,2.587212049,0.009675603,0.030528351,N,-,,retinol dehydrogenase 13,C:cellular_component,IPR002347 (PRINTS); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR24320:SF56 (PANTHER); PTHR24320 (PANTHER); PTHR24320:SF56 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09613,5773,4655,6974,2,5,5,0,0,0,1,2,5,1,9,4,0,0,0,15.20483592,1,0.488031058,1.158950669,0.421097353,0.673683995,0.820040888,1.647613351,0,2.74523946,1.356216892,2.024189108,0.042950698,0.10465743,4.255863353,1,0.099808343,1.215886659,0.08208688,0.934577626,0.960970512,4.908620885,1,-0.32224321,1.217115812,-0.264759694,0.791194588,0.865008661,4.171761131,0,0.025618224,1.209264128,0.02118497,0.983098104,0.988663399,N,-,,salicylate hydroxylase,F:FAD binding; P:secondary metabolite biosynthetic process; P:oxidation-reduction process; F:monooxygenase activity,PR00420 (PRINTS); IPR003953 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR002938 (PFAM); PTHR13789 (PANTHER); PTHR13789:SF187 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_09614,12639,10222,8373,0,3,6,0,0,0,0,0,0,0,12,1,0,6,6,1.177118052,1,1.662626479,1.44069146,1.15404757,0.248480667,NA,0.375534305,0,4.878602024,1.640415665,2.974003557,0.002939417,0.0154422,0.972756583,0,2.229395534,1.252059515,1.780582718,0.074980645,0.154950817,5.133768291,1,2.752798943,1.174781275,2.343243803,0.019116886,0.07516834,0.955966674,1,2.151670844,1.229601372,1.749893009,0.080136777,0.161437499,N,-,,aldehyde dehydrogenase,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); PTHR31944 (PANTHER); PTHR31944:SF20 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09615,2219,2021,3844,0,0,1,0,0,0,0,0,1,0,2,0,0,0,3,25.16936782,1,4.014344199,0.620294706,6.471672508,9.69E-11,3.38E-09,0.72282822,0,3.933863321,1.46446821,2.68620602,0.007226851,0.026561434,1.870338138,1,1.285946342,1.215665462,1.057812682,0.29014085,0.429693676,2.15735711,1,0.863750845,1.224611411,0.705326471,0.480607091,0.621078085,1.83794955,1,1.208169707,1.203589804,1.003805203,0.315472516,0.450897689,N,-,,Aldehyde dehydrogenase,F:retinal dehydrogenase activity; P:oxidation-reduction process,IPR016162 (G3DSA:3.40.605.GENE3D); IPR015590 (PFAM); IPR016163 (G3DSA:3.40.309.GENE3D); PTHR11699:SF204 (PANTHER); PTHR11699 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_09616,146,182,211,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0.101374654,1,5.199339792,3.91727526,1.32728477,0.1844145,NA,0.033546034,0,8.363242196,3.916922464,2.135156433,0.032748234,0.08475521,0.08548471,0,5.73664485,2.330830716,2.461201841,0.013847244,0.041685845,0.098472808,0,5.316676009,3.917102572,1.357298133,0.1746865,0.298225536,0.083166214,0,5.671918467,1.877274333,3.021358343,0.002516434,0.010273746,N,-,,Amidohydrolase 2,F:o-pyrocatechuate decarboxylase activity; F:hydrolase activity,G3DSA:3.20.20.140 (GENE3D); IPR006680 (PFAM); PTHR21240:SF14 (PANTHER); PTHR21240 (PANTHER); IPR032466 (SUPERFAMILY),,
RL4_JR_09617,15215,12187,17882,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.079915123,1,5.542916328,3.920096686,1.413974392,0.157369422,NA,0.025560021,0,8.755483587,2.731488066,3.205389654,0.001348798,0.015023052,0.066229991,0,6.105101409,1.535670362,3.975528577,7.02E-05,0.000916158,0.076396931,0,5.683055684,2.548756017,2.229737035,0.025764906,0.085851084,0.065226579,0,6.024135704,1.303525044,4.62141923,3.81E-06,4.52E-05,N,-,,hypothetical protein SPI_07484,,IPR032710 (G3DSA:3.10.450.GENE3D); IPR009959 (PFAM); IPR032710 (SUPERFAMILY),,
RL4_JR_09618,6968,5476,5201,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.26727483,0,1.965388268,1.048598981,1.874299234,0.060889193,0.154169471,1.051294747,0,3.393486091,1.458953543,2.325972687,0.020020008,0.057568897,13.77114213,0,1.717506153,1.223970442,1.403225188,0.160549699,0.275866455,3.114200557,0,0.334103874,1.258511402,0.265475445,0.790643224,0.864592574,2.636117863,0,0.687584663,1.234702584,0.556882825,0.57760749,0.69104051,N,-,,9-cis-epoxycarotenoid dioxygenase,"F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:nucleotidyltransferase activity; P:oxidation-reduction process; P:biosynthetic process",IPR004294 (PFAM); IPR004294 (PANTHER); PTHR10543:SF33 (PANTHER); IPR011047 (SUPERFAMILY),,
RL4_JR_09619,12,28,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,131.6885646,0,2.414041071,0.396639473,6.086235072,1.16E-09,3.10E-08,35.05839966,0,2.854404,0.860030976,3.318954873,0.00090355,0.015023052,305.6152535,0,3.981869271,0.353583849,11.26145688,2.03E-29,5.88E-27,451.2514887,0,4.382934489,0.468735734,9.350544817,8.72E-21,8.83E-19,190.2377964,0,3.541831687,0.347883655,10.18108105,2.41E-24,7.87E-22,N,-,,Zinc-type alcohol dehydrogenase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR013149 (PFAM); PF16884 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); PTHR11695:SF528 (PANTHER); IPR002085 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_09620,2244,2205,1957,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,195.507068,0,1.152699555,0.370167124,3.113997651,0.00184571,0.009802929,36.79909658,0,0.934253792,0.986490943,0.94704751,0.34361457,0.506950337,59.75725475,0,-1.53758024,1.029929459,-1.492898594,0.135463733,0.242989872,117.3392467,0,0.615544195,0.445060316,1.383057919,0.166647107,0.287444968,91.63903617,0,0.488492671,0.493629836,0.989593082,0.322373053,0.458315059,N,-,,mannose-1-phosphate guanyltransferase,C:nucleus; F:nucleotidyltransferase activity; C:cytosol; P:biosynthetic process,IPR001451 (PFAM); G3DSA:2.160.10.10 (GENE3D); IPR029044 (G3DSA:3.90.550.GENE3D); IPR005835 (PFAM); PTHR22572:SF104 (PANTHER); PTHR22572 (PANTHER); IPR011004 (SUPERFAMILY); IPR029044 (SUPERFAMILY),,
RL4_JR_09621,1344,1392,1405,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,17.8000467,1,-2.256017163,1.212496941,-1.860637406,0.062795399,0.157917652,5.700999298,0,0.954366749,1.266484294,0.753555929,0.451115916,0.611352966,53.94401871,1,1.455601435,0.705726368,2.062557814,0.039154659,0.094045497,83.14385834,0,1.553064015,0.639096071,2.430094762,0.015094876,0.065631958,55.83531777,0,1.844729984,0.576494057,3.19991154,0.001374698,0.006197583,N,-,,dynamin family,F:nucleotide binding,IPR022812 (PRINTS); IPR001401 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR022812 (PFAM); IPR022812 (PANTHER); PTHR11566:SF44 (PANTHER); PTHR11566:SF44 (PANTHER); IPR020850 (PROSITE_PROFILES); IPR030381 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_09622,0,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,412.0440263,0,-0.914105989,0.333400455,-2.741765868,0.006110988,0.025552764,165.1727535,0,-1.330657682,0.98272902,-1.354043337,0.175722552,0.311991523,267.6193475,0,-2.508379848,0.66777933,-3.756300525,0.000172444,0.001606614,378.5409481,0,-1.328628587,0.398908931,-3.330656404,0.000866415,0.006571123,262.8070617,0,-2.50996023,0.623078541,-4.028320772,5.62E-05,0.000427982,N,-,,cell division control,P:cell division; F:ubiquitin-protein transferase activity; P:G2/M transition of mitotic cell cycle; F:ubiquitin binding; P:G1/S transition of mitotic cell cycle; C:nuclear matrix; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; C:nuclear SCF ubiquitin ligase complex; P:meiotic nuclear division; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process,IPR020472 (PRINTS); IPR001680 (SMART); IPR001810 (SMART); IPR001810 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); G3DSA:1.20.1280.50 (GENE3D); IPR001680 (PFAM); PTHR22844:SF166 (PANTHER); PTHR22844 (PANTHER); PTHR22844 (PANTHER); PTHR22844:SF166 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001810 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR001810 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_09623,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.78032066,0,-1.886937976,1.203519064,-1.567850508,0.116916024,0.247869264,4.373240614,0,1.336743216,1.253973062,1.066006326,0.286420782,0.445971521,11.3924019,0,-1.321140901,1.202399352,-1.098753837,0.271875453,0.410595167,13.1455547,0,-1.743808661,1.201667734,-1.451157098,0.14673612,0.2617518,11.28296037,0,-1.409830729,1.211549989,-1.163658736,0.244562338,0.374386706,N,-,,---NA---,,no IPS match,,
RL4_JR_09624,10,13,31,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42.31143241,0,-1.500592429,1.036648233,-1.447542552,0.147745028,0.293546989,10.98465332,0,0.008042228,1.221476205,0.006584023,0.994746747,0.9975061,28.64404566,0,-2.651228388,1.202588104,-2.204602207,0.027482021,0.07164616,57.12392348,0,0.185879918,0.662062674,0.280758794,0.77889541,0.857301449,28.39360061,0,-2.741262085,1.212331866,-2.261148256,0.023750078,0.062492084,N,-,,hypothetical protein SPI_07479,C:late endosome membrane; P:regulation of macromolecule metabolic process; C:membrane raft; P:positive regulation of intracellular signal transduction; P:cellular process; P:regulation of cellular metabolic process,IPR028209 (SMART); IPR028209 (PFAM),,
RL4_JR_09625,0,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20.72325873,0,-2.475626348,1.190279523,-2.079869728,0.037537483,0.107676086,6.646060673,0,0.733033049,1.238839266,0.591709569,0.554045087,0.699568308,55.06679836,0,1.228721838,0.676038811,1.817531505,0.069135769,0.145455221,57.08288702,0,0.423665443,0.747890388,0.566480663,0.571067075,0.697810057,40.07915685,0,1.184637024,0.635340367,1.864570687,0.062241605,0.132505519,N,-,,f-box domain-containing,,IPR001810 (SMART); G3DSA:1.20.1280.50 (GENE3D); IPR001810 (PFAM); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY),,
RL4_JR_09626,105,98,86,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.33779105,0,0.189701135,1.050930793,0.180507733,0.856753984,0.927960568,3.398456789,0,1.70054483,1.291616455,1.316602017,0.187972062,0.328440051,28.35418536,0,1.434729692,0.886352226,1.618690235,0.105513929,0.201779943,19.53317798,0,-0.428348779,1.168080271,-0.366711766,0.713834029,0.808452969,28.08884653,0,1.827957918,0.756690244,2.415728144,0.015703781,0.04505112,N,-,,Zinc finger 830,F:metal ion binding,PTHR13278 (PANTHER); SSF57667 (SUPERFAMILY),,
RL4_JR_09627,263,221,241,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.07378131,0,2.873714447,0.765107142,3.755963435,0.000172676,0.001366334,1.258600784,0,3.133536342,1.400576523,2.237318911,0.025265504,0.069062229,3.28969088,0,0.47069099,1.239037173,0.379884478,0.70403117,0.798985296,3.796567169,0,0.047834784,1.24746417,0.038345618,0.96941212,0.98290584,3.271606051,0,0.376258416,1.248103623,0.301464084,0.763060634,0.834717428,N,-,,mediator of RNA polymerase II transcription subunit 7,C:nucleoplasm part; C:protein complex; P:regulation of transcription from RNA polymerase II promoter,IPR009244 (PFAM); IPR009244 (PANTHER); PTHR21428:SF11 (PANTHER); SSF140718 (SUPERFAMILY),,
RL4_JR_09628,204,174,362,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,90.01283152,0,-1.128285544,0.679744606,-1.659866858,0.09694124,0.216450257,136.3343695,1,2.103349881,1.596407101,1.317552321,0.187653555,0.328104518,74.81454647,0,-1.199791441,0.858690536,-1.397233801,0.162343275,0.278145764,73.12482623,0,-3.072947479,1.147055889,-2.678986708,0.007384533,0.038069446,66.14694915,0,-1.484387623,0.854500397,-1.73714094,0.082362297,0.165034287,N,-,,phd finger domain,"F:zinc ion binding; P:transcription, DNA-templated",IPR001965 (SMART); IPR003618 (SMART); IPR003618 (G3DSA:1.10.472.GENE3D); IPR003618 (PFAM); IPR019787 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR012921 (PFAM); PTHR11477 (PANTHER); PTHR11477:SF11 (PANTHER); PTHR11477:SF11 (PANTHER); PTHR11477 (PANTHER); PTHR11477:SF11 (PANTHER); IPR003618 (PROSITE_PROFILES); IPR003618 (SUPERFAMILY); IPR011011 (SUPERFAMILY),,
RL4_JR_09629,2361,2758,1800,0,1,0,0,0,0,0,0,3,0,0,0,0,0,0,130.5178495,1,1.58007281,0.551676021,2.864131753,0.00418154,0.018733117,58.9431214,0,2.789396268,0.673204355,4.14346141,3.42E-05,0.001871764,86.15108316,1,0.837741201,1.38288491,0.605792423,0.544652602,0.672059308,95.11390006,0,1.096073579,0.444489275,2.465916817,0.013666307,0.062133523,30.78877372,0,-2.858099115,1.187976948,-2.405854019,0.016134711,0.046056934,N,-, Effector probability:0.565,proteasome subunit alpha type-4,"C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:nuclear outer membrane-endoplasmic reticulum membrane network; C:proteasome core complex, alpha-subunit complex; F:threonine-type endopeptidase activity; C:proteasome storage granule; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome core complex assembly",IPR000426 (SMART); IPR000426 (PFAM); IPR029055 (G3DSA:3.60.20.GENE3D); IPR001353 (PFAM); PTHR11599:SF13 (PANTHER); PTHR11599 (PANTHER); IPR023332 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY),,
RL4_JR_09630,3060,2118,2893,0,0,0,0,0,0,0,1,0,0,0,0,0,0,5,98.20732209,0,0.853408778,0.476300192,1.79174561,0.073173725,0.17635192,13.49683032,0,-0.289030308,1.202643568,-0.240329151,0.810075098,0.884354687,70.16114676,1,-0.115958164,0.735101045,-0.157744524,0.874658115,0.921056663,85.67707695,0,-0.040439391,0.605189831,-0.066821003,0.946724203,0.968827831,38.39241942,1,-2.093126805,1.118932511,-1.870646161,0.061394142,0.131114889,N,-,,pap2 superfamily,F:phosphatidate phosphatase activity; C:fungal-type vacuole membrane; C:integral component of membrane; C:endoplasmic reticulum; F:diacylglycerol diphosphate phosphatase activity; P:phospholipid metabolic process; P:dephosphorylation,IPR000326 (SMART); IPR000326 (PFAM); IPR000326 (G3DSA:1.20.144.GENE3D); PTHR10165 (PANTHER); PTHR10165:SF97 (PANTHER); PTHR10165:SF97 (PANTHER); IPR000326 (SUPERFAMILY),9.B.105.3.2, the lead resistance fusion protein (pbrbc) family.
RL4_JR_09631,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,98.72619728,0,0.353264954,0.527630954,0.669530382,0.503157207,0.689759115,25.47951248,0,0.373206555,1.118781873,0.333582947,0.738694288,0.838207084,76.99982026,0,-0.058822465,0.677404178,-0.086835109,0.93080258,0.958641437,66.86731827,0,-1.872628042,1.019407771,-1.836976424,0.066213376,0.14567806,48.66975249,0,-2.346296913,1.129121308,-2.077984797,0.037710759,0.089882636,N,-,,eukaryotic membrane family,C:intracellular membrane-bounded organelle; C:integral component of membrane; C:cytoplasmic part,IPR008010 (PFAM); IPR008010 (PANTHER); PTHR13317:SF4 (PANTHER),9.B.314.1.1, the eukaryotic 9 tms duf747 (duf747) family.
RL4_JR_09632,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44.1523318,0,-0.379068199,0.89544215,-0.423330753,0.67205396,0.818300926,7.697535777,0,0.521041339,1.250829525,0.416556636,0.677002733,0.793911614,20.10212214,0,-2.140378023,1.216651671,-1.759236496,0.078537348,0.160466621,31.22129674,0,-0.852926676,1.052873943,-0.810093822,0.417886255,0.561202212,19.97522953,0,-2.233921185,1.23003225,-1.816148466,0.069347601,0.143897015,N,-,,WW domain-containing,C:intracellular part,IPR001202 (SMART); IPR001202 (PFAM); IPR002713 (PFAM); G3DSA:2.20.70.10 (GENE3D); IPR002713 (G3DSA:1.10.10.GENE3D); PTHR11864 (PANTHER); IPR001202 (PROSITE_PROFILES); IPR001202 (SUPERFAMILY); IPR001202 (SUPERFAMILY); IPR002713 (SUPERFAMILY),,
RL4_JR_09633,1,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.206191268,0,4.175418042,2.952546009,1.414175437,0.157310398,NA,0.065964232,0,7.387477265,2.29573253,3.217917231,0.001291251,0.015023052,0.171192754,0,4.733975647,1.396490736,3.389908379,0.00069916,0.004323943,0.197474036,0,4.312672458,1.843638613,2.339217908,0.019324159,0.075572463,0.169136379,0,4.648648084,1.282461543,3.624785562,0.000289201,0.001700443,N,-,,aminotransferase class-III,F:pyridoxal phosphate binding; F:transaminase activity; C:mitochondrion; C:cytosol,IPR015422 (G3DSA:3.90.1150.GENE3D); IPR005814 (PFAM); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR11986:SF87 (PANTHER); IPR005814 (PANTHER); IPR015424 (SUPERFAMILY),9.B.313.1.2, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_09634,134,141,192,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,7.656611899,1,9.212078698,1.353311953,6.807062241,9.96E-12,4.23E-10,0.006509392,0,10.7300969,3.9588721,2.710392412,0.006720365,0.025175252,0.016494478,0,8.109867811,2.851793459,2.843778109,0.004458208,0.017386326,4.030581852,0,8.623403176,1.429782727,6.031268256,1.63E-09,5.16E-08,0.015949996,1,8.040879118,1.654939983,4.858713428,1.18E-06,1.67E-05,N,-,,methanesulfonate monooxygenase,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity",IPR011251 (PFAM); IPR011251 (G3DSA:3.20.20.GENE3D); PTHR30011 (PANTHER); PTHR30011:SF21 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_09635,4,1,7,0,0,0,0,0,1,0,3,33,1,0,2,0,7,0,11.66296006,0,-1.646354526,1.227881535,-1.340808929,0.179982496,0.336997293,3.728571279,1,1.566845554,1.301959819,1.203451544,0.228801632,0.378605545,9.680743189,1,-1.086261092,1.224784101,-0.886900059,0.37513271,0.518866346,11.16724199,1,-1.508508958,1.226452403,-1.22997758,0.218705501,0.353736932,9.568484513,1,-1.172127222,1.232979667,-0.950646028,0.341784095,0.478705763,N,-,,MSF membrane transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23502:SF59 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.79, the major facilitator superfamily (mfs).
RL4_JR_09636,355,531,471,0,0,0,0,0,0,0,2,6,4,0,0,0,0,0,274.9483476,0,-0.744878016,0.956696174,-0.77859412,0.436218844,0.626731603,54.85700882,0,-2.312078656,1.323043164,-1.747545899,0.08054269,0.171091944,2088.630307,1,3.809093733,0.781286426,4.875412657,1.09E-06,2.89E-05,738.4260329,1,1.821215006,0.79491804,2.291072683,0.02195921,0.080296448,994.5376667,0,2.680558131,1.207767383,2.219432457,0.026457318,0.068406624,N,-,,major facilitator superfamily transporter monosaccharide,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR003663 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR003663 (TIGRFAM); IPR005828 (PFAM); PTHR23500:SF79 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.58, the major facilitator superfamily (mfs).
RL4_JR_09637,182,199,233,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,15.40196519,0,7.545289917,0.836771542,9.01714451,1.93E-19,2.27E-17,0.041431638,0,8.059089364,2.525585363,3.190978805,0.001417917,0.015023052,0.106404481,1,5.422003035,1.479090362,3.665768619,0.000246597,0.002019246,0.122667335,0,5.000093186,2.177454625,2.296301897,0.021658626,0.079874461,0.10385538,0,5.350716988,1.298022934,4.122205278,3.75E-05,0.00030445,N,-,,---NA---,,no IPS match,,
RL4_JR_09638,114,108,136,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.37791713,0,-0.647410775,1.187182585,-0.545333787,0.58552397,0.758426055,3.570543131,0,1.629256463,1.301002936,1.25230806,0.210457633,0.356149866,31.48240967,0,0.810792423,1.063763969,0.762192034,0.4459454,0.585418987,10.78266506,0,-1.457962398,1.232029829,-1.183382386,0.236657635,0.374341283,9.300603059,0,-1.131087795,1.244197396,-0.909090309,0.363302458,0.49992148,N,-,,aminotransferase class I and II,P:metabolic process; F:transferase activity,IPR004839 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR13693 (PANTHER); PTHR13693:SF53 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_09639,81,103,80,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,54.4822304,0,-1.934329223,1.0360706,-1.866985921,0.061903554,0.156204514,33.70267424,0,1.197449645,1.008409605,1.187463545,0.235044828,0.385470471,45.21709102,0,-2.124121721,1.201163727,-1.768386501,0.076996312,0.158269053,116.874398,0,0.805160957,1.513715317,0.531910425,0.594788037,0.717615452,38.05960143,0,-3.16394882,1.201836894,-2.632594186,0.008473553,0.027515946,N,-,,bifunctional dethiobiotin synthetase adenosylmethionine-8-amino-7-oxononanoate aminotransferase,F:catalytic activity; F:binding,IPR015422 (G3DSA:3.90.1150.GENE3D); IPR015421 (G3DSA:3.40.640.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PF13500 (PFAM); IPR005814 (PFAM); PTHR11986:SF8 (PANTHER); PTHR11986:SF8 (PANTHER); PTHR11986:SF8 (PANTHER); IPR005814 (PANTHER); IPR005814 (PANTHER); IPR005814 (PANTHER); IPR004472 (HAMAP); IPR015424 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_09640,647,681,623,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.327883417,0,-0.97572594,1.223611796,-0.797414624,0.425210269,0.616192795,2.367181385,0,2.222437708,1.339728109,1.658872195,0.097141549,0.198124706,13.93468857,0,0.544060974,1.21457076,0.447945062,0.654192846,0.760308618,19.05867313,0,1.440613075,0.898790619,1.602835015,0.108971084,0.209249078,28.40728977,0,2.138213337,0.774864548,2.759467241,0.005789569,0.020199651,Y,-,,FAD-binding domain containing,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; P:oxidation-reduction process",IPR006094 (PFAM); IPR016169 (G3DSA:3.30.465.GENE3D); IPR012951 (PFAM); PTHR13878:SF50 (PANTHER); PTHR13878 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY),,
RL4_JR_09641,4,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.084783456,0,5.457820364,3.91933429,1.3925376,0.163759664,NA,0.026740884,0,8.690164018,2.746494814,3.164092636,0.001555673,0.015023052,0.069766372,0,6.030901466,1.582668546,3.810590335,0.000138635,0.001409181,0.080521241,0,5.607424442,2.556129177,2.193717162,0.028255749,0.089465864,0.069041896,0,5.946862578,1.333529058,4.459492309,8.22E-06,8.50E-05,N,-,,plasma membrane H+-ATPase Pma1,"F:ATP binding; F:metal ion binding; C:integral component of membrane; P:hydrogen ion transmembrane transport; F:hydrogen-exporting ATPase activity, phosphorylative mechanism; P:ATP biosynthetic process",PR00119 (PRINTS); IPR001757 (PRINTS); IPR004014 (SMART); IPR004014 (PFAM); IPR023299 (G3DSA:3.40.1110.GENE3D); IPR008250 (G3DSA:2.70.150.GENE3D); IPR001757 (TIGRFAM); IPR023298 (G3DSA:1.20.1110.GENE3D); PF00702 (PFAM); IPR023299 (G3DSA:3.40.1110.GENE3D); IPR008250 (PFAM); IPR006534 (TIGRFAM); PTHR24093 (PANTHER); PTHR24093:SF271 (PANTHER); IPR023214 (SUPERFAMILY); SSF81653 (SUPERFAMILY); SSF81665 (SUPERFAMILY),3.A.3.3.10, the p-type atpase (p-atpase) superfamily.
RL4_JR_09642,10,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,111.4020997,0,1.518727201,1.141340382,1.330652297,0.183303446,0.341023834,10.08864578,0,0.130907443,1.289665903,0.101504927,0.919149647,0.955641561,25.90687313,0,-2.506226331,1.23870027,-2.023270998,0.043045215,0.100861501,29.86996507,0,-2.927761331,1.243752409,-2.3539744,0.01857389,0.074262186,25.22952174,0,-2.570832696,1.237806364,-2.076926384,0.037808354,0.090051655,N,-,,acyl- dehydrogenase,"F:oxidoreductase activity, acting on the CH-CH group of donors; F:flavin adenine dinucleotide binding; P:oxidation-reduction process",IPR013786 (PFAM); IPR009075 (PFAM); G3DSA:2.40.110.10 (GENE3D); G3DSA:1.20.140.10 (GENE3D); IPR013786 (G3DSA:1.10.540.GENE3D); PTHR10909 (PANTHER); PTHR10909:SF240 (PANTHER); IPR009100 (SUPERFAMILY); IPR009075 (SUPERFAMILY),,
RL4_JR_09643,1880,1546,2171,0,0,9,0,0,0,0,1,0,3,0,0,0,1,0,10.60744887,1,-1.509251927,1.207529169,-1.249867884,0.211347813,0.378773167,3.366258143,0,1.714344172,1.272549389,1.347172996,0.177924523,0.315403156,21.75691348,1,0.875491247,1.043696116,0.838837315,0.401560608,0.543938935,14.11890152,1,-0.418081843,1.154768087,-0.362048318,0.717315924,0.810694151,20.23831994,1,1.163566272,0.871389826,1.335299354,0.18177839,0.30000101,N,-,,"sedoheptulose-1,7- partial","P:carbohydrate metabolic process; F:fructose 1,6-bisphosphate 1-phosphatase activity; P:dephosphorylation",IPR023079 (PRINTS); G3DSA:3.30.540.10 (GENE3D); IPR000146 (PIRSF); IPR033391 (PFAM); G3DSA:3.40.190.80 (GENE3D); PTHR11556:SF2 (PANTHER); IPR000146 (PANTHER); SSF56655 (SUPERFAMILY),,
RL4_JR_09644,1519,1952,1596,0,0,3,0,0,0,0,2,0,0,1,0,0,1,0,3.70551026,1,0.008265346,1.304772461,0.006334703,0.994945672,0.997870116,1.18643499,0,3.219016618,1.457070878,2.209238181,0.027158078,0.073051839,3.062116266,1,0.574796754,1.260176524,0.456123997,0.648300815,0.755629455,3.531902626,1,0.15265949,1.273445499,0.119879092,0.904578927,0.941301299,2.994573459,1,0.503997503,1.253368852,0.402114272,0.68759993,0.778520641,N,-,,metallo ase,C:intracellular membrane-bounded organelle; C:cytoplasmic part; F:peptidase activity,IPR024079 (G3DSA:3.40.390.GENE3D); IPR024077 (G3DSA:1.10.1370.GENE3D); IPR024080 (G3DSA:1.20.1050.GENE3D); IPR001567 (PFAM); PTHR11804 (PANTHER); PTHR11804:SF40 (PANTHER); PTHR11804:SF40 (PANTHER); PTHR11804 (PANTHER); SSF55486 (SUPERFAMILY),,
RL4_JR_09645,2878,2420,2605,15,26,5,0,0,3,0,3,12,12,13,0,0,20,8,0.012047471,1,8.273092713,3.994385999,2.07118008,0.03834197,NA,0.00401109,1,11.43263965,3.991205167,2.86445802,0.004177235,0.018371529,0.010113829,1,8.82019535,3.041025661,2.900401487,0.00372685,0.01574077,0.01164654,1,8.398490877,3.993441208,2.103071121,0.035459553,0.099858856,0.00966951,1,8.76562085,1.6165792,5.422326879,5.88E-08,1.50E-06,N,-, Effector probability:0.747,DUF3328 domain,C:membrane,no IPS match,,
RL4_JR_09646,1247,601,1161,0,0,0,0,0,0,4,2,4,0,0,0,0,0,2,0.06781573,0,5.779714252,3.922469964,1.473488466,0.140619372,NA,0.021212483,0,9.023265794,2.884218381,3.128496043,0.001757034,0.015023052,0.055797746,1,6.350385573,1.668125128,3.806900014,0.00014072,0.001415819,0.064423182,0,5.928564926,2.802054475,2.115792173,0.034362487,0.099376683,0.05580844,1,6.252937782,1.369581428,4.565583072,4.98E-06,5.67E-05,N,-, Effector probability:0.553,hscarg dehydrogenase,,IPR016040 (G3DSA:3.40.50.GENE3D); IPR008030 (PFAM); PTHR14194 (PANTHER); PTHR14194:SF54 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09647,5235,8274,7766,5,16,27,0,0,1,11,2,0,6,26,3,0,7,14,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,metallo-beta-lactamase superfamily,,IPR001279 (SMART); IPR001279 (G3DSA:3.60.15.GENE3D); IPR001279 (PFAM); PTHR23200 (PANTHER); PTHR23200:SF37 (PANTHER); PTHR23200 (PANTHER); IPR001279 (SUPERFAMILY),,
RL4_JR_09648,570,592,1119,0,0,2,2,0,0,0,0,0,0,0,0,0,0,3,19.00459447,1,2.693495419,0.77467826,3.476921397,0.000507206,0.003405589,1.202510443,1,3.19955052,1.404531414,2.278019906,0.022725392,0.063719228,84.44510094,0,4.567618537,0.549246994,8.316146629,9.09E-17,1.12E-14,26.53413067,0,2.462788755,0.870047594,2.830636819,0.004645544,0.026455054,10.75889458,1,2.145266879,0.994755162,2.156577781,0.031038577,0.077272091,N,-,,NADPH2:quinone reductase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR013154 (PFAM); IPR013149 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002085 (PANTHER); PTHR11695:SF605 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_09649,956,596,1082,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0.87191318,0,2.095390617,1.530353235,1.369220236,0.170930442,NA,0.27849823,0,5.30977929,1.705962885,3.112482304,0.001855211,0.015023052,13.71957767,0,4.477698499,1.039911301,4.305846562,1.66E-05,0.000291369,53.02101855,0,5.577029788,0.623278908,8.947887878,3.62E-19,3.25E-17,8.432583861,1,4.244085864,0.985766024,4.305368376,1.67E-05,0.000154007,N,-, Effector probability:0.56,diacetyl reductase,F:oxidoreductase activity; P:single-organism metabolic process,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); IPR002347 (PANTHER); PTHR24322:SF460 (PANTHER); IPR002347 (PANTHER); PTHR24322:SF460 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09650,26363,25575,21719,5,4,130,2,0,2,2,3,11,10,79,2,0,32,2,0.008141456,1,8.841220392,4.035983802,2.190598582,0.028480854,NA,0.002675567,1,12.01934062,4.032893235,2.980327006,0.002879408,0.015349618,0.006783092,1,9.399044527,3.291065204,2.855927776,0.004291127,0.016940088,0.007815077,1,8.97609272,4.035428601,2.224322026,0.026126786,0.086108719,0.006504647,1,9.346543544,1.704039324,5.484934187,4.14E-08,1.17E-06,N,-,,phenylacetone monooxygenase,"F:NADP binding; F:flavin adenine dinucleotide binding; P:oxidation-reduction process; F:N,N-dimethylaniline monooxygenase activity",IPR023753 (G3DSA:3.50.50.GENE3D); PF13450 (PFAM); PTHR23023 (PANTHER); PTHR23023:SF133 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_09651,5054,4377,4804,0,6,10,0,0,2,2,3,9,0,8,0,0,8,2,0.171773872,1,4.439001813,3.173096616,1.398949465,0.161828138,NA,0.054458237,1,7.663935317,2.360124675,3.247258671,0.001165224,0.015023052,0.141936978,1,5.004746975,1.397842063,3.580337942,0.00034315,0.002582938,0.163785983,1,4.582693761,1.931188843,2.372991009,0.017644693,0.072328956,0.14062541,1,4.91729538,1.274203901,3.859111855,0.0001138,0.000772268,N,-, Effector probability:0.578,carboxymuconolactone decarboxylase,P:cellular oxidant detoxification; P:oxidation-reduction process; F:peroxiredoxin activity,IPR029032 (G3DSA:1.20.1290.GENE3D); IPR003779 (PFAM); PTHR33570:SF3 (PANTHER); PTHR33570 (PANTHER); IPR029032 (SUPERFAMILY),,
RL4_JR_09652,4713,4271,5525,0,0,11,0,0,0,0,2,4,3,2,0,0,3,0,19.12523144,1,9.388988379,2.160632785,4.345480844,1.39E-05,0.000155092,0.010029373,0,10.10405046,3.940608674,2.564083697,0.01034486,0.034399037,0.026495534,1,7.427006646,2.544362124,2.919005347,0.003511502,0.015238082,0.030605887,1,7.002782822,3.939933251,1.777386157,0.075504727,0.15963361,0.026521331,1,7.331048385,1.595151307,4.595832605,4.31E-06,5.05E-05,N,-,,family taurine,F:oxidoreductase activity; P:oxidation-reduction process,G3DSA:3.60.130.10 (GENE3D); IPR003819 (PFAM); PTHR30468:SF10 (PANTHER); PTHR30468:SF10 (PANTHER); PTHR30468 (PANTHER); PTHR30468 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_09653,2836,2197,2070,0,0,0,0,0,0,0,0,0,0,4,0,0,0,2,11.4839661,0,9.322087462,1.064796589,8.754805905,2.04E-18,2.14E-16,0.009194001,0,10.23263417,3.417489009,2.994196657,0.002751685,0.015349618,0.023520804,0,7.602821568,1.997858148,3.805486178,0.000141526,0.001415819,69.36888371,1,11.47937469,0.746049262,15.38688565,2.00E-53,1.19E-50,14.75377527,1,9.240623637,1.139154348,8.11182756,4.99E-16,7.89E-14,N,-,,MFS general substrate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662:SF309 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.38, the major facilitator superfamily (mfs).
RL4_JR_09654,216,138,89,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.011583712,0,1.881148253,1.46261247,1.286156307,0.198388516,NA,0.323664509,0,5.093035172,1.667212704,3.054820276,0.002251954,0.015075583,0.837592273,0,2.44507906,1.241388664,1.969632179,0.048880541,0.111230972,0.966145313,0,2.022733929,1.287061606,1.571590607,0.116045526,0.218760185,0.823042564,0,2.367364972,1.215322755,1.947931085,0.05142321,0.114531456,N,NRPS-Like,,nonribosomal peptide synthetase,F:catalytic activity; P:metabolic process; C:membrane; C:integral component of membrane; F:phosphopantetheine binding,G3DSA:3.40.50.980 (GENE3D); IPR013120 (PFAM); IPR000873 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.300.30 (GENE3D); G3DSA:3.40.50.980 (GENE3D); PTHR24095:SF187 (PANTHER); PTHR24095 (PANTHER); PTHR24095:SF187 (PANTHER); PTHR24095:SF187 (PANTHER); PTHR24095:SF187 (PANTHER); PTHR24095 (PANTHER); PTHR24095 (PANTHER); SSF56801 (SUPERFAMILY); IPR016040 (SUPERFAMILY),4.C.1.1.8, the fatty acid transporter (fat) family.
RL4_JR_09655,18,9,13,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0.553432339,0,2.750983779,2.071427563,1.328061781,0.184157698,NA,0.180684712,0,5.934116168,2.001077306,2.96546073,0.003022299,0.015639935,0.463050496,0,3.299556757,1.4007094,2.355632623,0.018491195,0.052778364,0.533687316,1,2.878609484,1.577303612,1.825019269,0.067998122,0.148028592,0.451879979,0,3.231077004,1.340963124,2.409519656,0.015973536,0.045674117,Y,-,,sugar transport,P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane; P:carbohydrate transport,IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.64, the major facilitator superfamily (mfs).
RL4_JR_09656,51,45,37,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,3.877777006,0,6.897881896,1.604505761,4.299069572,1.72E-05,0.000184839,0.019873665,0,9.119886623,3.231149325,2.822489989,0.004765231,0.020005669,0.050045084,0,6.510382717,2.037531038,3.195231186,0.001397189,0.0074842,0.057612643,1,6.090364852,3.259464496,1.868517009,0.061690042,0.138820742,0.047948464,0,6.462545187,1.62524249,3.976357514,7.00E-05,0.000517558,N,-,,Nitrilotriacetate monooxygenase component A pristinamycin IIA synthase subunit A,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity",IPR016215 (PIRSF); IPR016215 (TIGRFAM); IPR011251 (PFAM); IPR011251 (G3DSA:3.20.20.GENE3D); PTHR30011 (PANTHER); PTHR30011:SF30 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_09657,2863,2855,3842,2,0,0,0,0,0,0,0,2,0,4,0,0,2,0,32.04473975,1,12.85205837,3.966881597,3.239839167,0.001195971,0.006799118,0.001340044,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,205.9417066,1,15.82802883,2.257422201,7.011550085,2.36E-12,1.77E-10,138.2635192,1,15.00807315,2.00994285,7.466915365,8.21E-14,4.44E-12,65.27686043,1,14.2872591,2.221006376,6.432786169,1.25E-10,8.75E-09,N,-, Effector probability:0.637,Alcohol dehydrogenase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013154 (PFAM); IPR013149 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); PTHR11695:SF526 (PANTHER); IPR002085 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_09658,1683,1512,1608,4,4,11,0,0,0,0,0,0,2,0,0,0,0,0,0.874283981,1,2.091427503,1.591995825,1.313714189,0.188942404,NA,0.282666433,0,5.288501761,1.747578695,3.026188049,0.002476582,0.015349618,33.22108425,0,5.767881217,0.72196895,7.989098721,1.36E-15,1.46E-13,57.03830653,1,5.820329722,0.64235254,9.060958529,1.29E-19,1.23E-17,11.93751224,0,4.254705087,1.002803783,4.242809169,2.21E-05,0.000195537,N,-,,hypothetical protein NECHADRAFT_75926,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR021833 (PFAM); PTHR38116 (PANTHER),,
RL4_JR_09659,5601,3581,3138,2,0,0,0,0,0,0,0,0,0,1,0,0,4,0,59.51598637,1,5.315336693,0.901719756,5.894665892,3.75E-09,9.21E-08,0.383710023,0,4.847604564,1.710833027,2.833476141,0.004604475,0.019582559,120.6046808,0,6.960870475,1.20424519,5.78027675,7.46E-09,3.21E-07,67.28882759,1,5.557150333,0.743933456,7.469956203,8.02E-14,4.38E-12,20.26152051,1,4.996616252,0.804003245,6.214671746,5.14E-10,3.12E-08,N,-,,acetoacetate decarboxylase,F:lyase activity,IPR023375 (G3DSA:2.40.400.GENE3D); IPR010451 (PFAM); SSF160104 (SUPERFAMILY),,
RL4_JR_09660,4175,3229,2407,0,1,2,0,1,0,2,0,2,0,0,0,0,0,1,4.560746325,1,-0.291747917,1.300700479,-0.224300615,0.822523398,0.910176433,1.434961587,1,2.944318216,1.419203,2.074627953,0.038021029,0.095238097,23.26044382,1,2.657193855,0.929156412,2.859791766,0.004239193,0.016940088,4.345128156,0,-0.146827207,1.274342852,-0.115217978,0.908272349,0.943883561,3.758591534,1,0.176064381,1.276765026,0.137898812,0.890320389,0.928181007,N,-,,maltose permease,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.57, the major facilitator superfamily (mfs).
RL4_JR_09661,214,155,93,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,short chain dehydrogenase reductase family,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); IPR002347 (PANTHER); IPR002347 (PANTHER); PTHR24322:SF567 (PANTHER); PTHR24322:SF567 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09662,70246,98314,52325,7,13,3,0,4,0,1,9,13,0,2,6,0,10,2,15.84959124,1,5.29862422,0.945390852,5.604691658,2.09E-08,4.71E-07,0.181199549,1,5.929841142,1.955255472,3.032770514,0.002423198,0.015349618,6.971567224,1,4.232237157,1.269412178,3.334013356,0.000856025,0.00508075,0.545754388,1,2.846715614,1.536511205,1.852713865,0.063923382,0.142122143,0.467665913,1,3.183636567,1.326038804,2.400862296,0.01635649,0.046571841,Y,-,,NPP1 domain,C:extracellular region,IPR008701 (PFAM); IPR008701 (PIRSF); PTHR33657:SF8 (PANTHER); PTHR33657 (PANTHER),,
RL4_JR_09663,44,50,47,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0.011692083,0,8.312151371,3.996763216,2.079720745,0.037551154,NA,0.003838345,0,11.49092626,3.994647088,2.876581086,0.004020089,0.018157671,0.009833003,0,8.854297471,3.046863773,2.906036545,0.003660387,0.015609839,0.011330785,1,8.434549956,3.995610333,2.110954085,0.034776259,0.099426657,0.009620272,0,8.767548331,1.615958211,5.425603379,5.78E-08,1.50E-06,Y,-,,exopolysaccharide inner membrane,F:lyase activity; C:periplasmic space,IPR008397 (G3DSA:1.50.10.GENE3D); IPR008929 (SUPERFAMILY),,
RL4_JR_09664,238,361,390,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,62.48411508,0,5.685198731,1.040845729,5.462095459,4.71E-08,1.00E-06,57.53128406,0,6.854071313,0.935583394,7.325986502,2.37E-13,6.86E-11,314.3296925,0,8.116980673,0.47579831,17.05970891,2.96E-65,3.33E-62,193.7660922,0,7.301938711,0.577012265,12.65473743,1.05E-36,2.48E-34,232.4021283,0,7.730266423,1.610258118,4.800638069,1.58E-06,2.11E-05,Y,-,,glycosyl hydrolase family 18,F:chitinase activity; P:carbohydrate metabolic process; P:chitin catabolic process,IPR011583 (SMART); IPR001223 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR11177 (PANTHER); IPR017853 (SUPERFAMILY),9.B.29.2.7, the small 4-5 tms putative permease (4-5pp) family.
RL4_JR_09665,73,99,110,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,49.81852014,1,-0.041808509,0.867630412,-0.048187003,0.961567209,0.980643887,6.25341262,0,0.820905961,1.245156071,0.659279571,0.509716258,0.661276492,35.7114859,0,0.568503432,0.866363251,0.656195229,0.511698518,0.643049186,40.37704389,0,0.465867144,0.761470128,0.611799632,0.540670333,0.671576176,15.9573658,0,-1.909878728,1.203372187,-1.587105592,0.112488732,0.208598609,N,-,,trihydroxytoluene oxygenase,,no IPS match,,
RL4_JR_09666,5675,6074,10050,6,3,9,0,0,0,2,0,1,1,6,1,0,0,0,0.306720517,1,3.60256864,2.505308736,1.437973926,0.150441452,NA,0.096705938,0,6.835350148,2.127545332,3.212787077,0.001314537,0.015023052,0.253130027,1,4.169734049,1.359411619,3.067307937,0.002159962,0.010460143,9.927448998,1,4.697500844,1.186165574,3.960240413,7.49E-05,0.000834996,0.252018129,0,4.075349194,1.286913145,3.166763205,0.001541458,0.006827323,N,-,,Methyltransferase type 11,P:metabolic process; C:membrane; C:integral component of membrane; F:methyltransferase activity; F:transferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D),,
RL4_JR_09667,123,149,102,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.142919843,0,1.705204456,1.720833018,0.990918025,0.32172561,NA,0.360689169,0,4.936772386,1.806090353,2.733402777,0.006268363,0.023960863,0.938364444,0,2.281213801,1.380836009,1.65205266,0.098523816,0.19192902,1.082965933,0,1.858135071,1.474936003,1.25980725,0.207738904,0.340183794,0.923881293,0,2.200921862,1.358766039,1.619794577,0.105276412,0.198490432,N,-,,catechol -dioxygenase 1,"F:ferric iron binding; F:catechol 1,2-dioxygenase activity; P:oxidation-reduction process; P:catechol-containing compound metabolic process",IPR000627 (PFAM); IPR007535 (PFAM); IPR015889 (G3DSA:2.60.130.GENE3D); PTHR33711:SF5 (PANTHER); PTHR33711 (PANTHER); IPR015889 (SUPERFAMILY),,
RL4_JR_09668,276,233,147,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.232427887,0,0.205329828,1.333528771,0.153974802,0.877629604,0.940704547,1.033040763,0,3.418752106,1.49000099,2.294462976,0.021763919,0.061655301,2.668485613,0,0.773325898,1.271789962,0.608061017,0.543147006,0.670996984,45.63083621,0,3.497071203,0.781338299,4.475745281,7.61E-06,0.00011257,2.611029903,0,0.701768205,1.264730941,0.554875493,0.578979826,0.691824451,N,-,,fungal specific transcription factor,F:binding,IPR007219 (SMART); IPR007219 (PFAM); PTHR31944:SF82 (PANTHER); PTHR31944 (PANTHER),,
RL4_JR_09669,2502,1795,1578,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.518698914,0,-0.27804137,1.435801414,-0.193648904,0.846450803,0.922969553,1.43781726,0,2.941736523,1.56310717,1.881980058,0.059838723,0.135804385,27.24485836,0,2.702314465,1.327286884,2.035968635,0.041753505,0.098903248,4.287066781,0,-0.126984627,1.376124748,-0.092276973,0.926477983,0.956812482,18.71648808,0,2.406975245,1.028703308,2.33981482,0.019293303,0.053172894,N,-,,ABC-2 type transporter,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); IPR013525 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR010929 (PFAM); PTHR19241:SF279 (PANTHER); PTHR19241 (PANTHER); PTHR19241 (PANTHER); PTHR19241:SF279 (PANTHER); PTHR19241:SF279 (PANTHER); PTHR19241 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.205.7, the atp-binding cassette (abc) superfamily.
RL4_JR_09670,15773,15639,11588,0,0,98,2,0,0,5,9,21,22,108,6,0,29,5,12.25023206,1,1.379260495,1.114674821,1.237365793,0.215951312,0.384237907,1.487429244,1,2.892838379,1.449570537,1.995652026,0.045971812,0.110293123,3.822991332,1,0.254550299,1.268312978,0.200699909,0.840933231,0.897586508,8.419819632,1,0.775474936,1.216400525,0.637516114,0.523788717,0.658148519,3.724006265,1,0.18938022,1.261758207,0.150092323,0.880691777,0.920987837,N,-,,hydantoinase b oxoprolinase,F:hydrolase activity,IPR008040 (PFAM); IPR002821 (PFAM); IPR003692 (PFAM); PTHR11365:SF11 (PANTHER); PTHR11365 (PANTHER),,
RL4_JR_09671,1331,901,1124,0,0,3,0,0,1,1,0,0,1,2,2,0,0,0,0.607586102,1,2.616694755,1.955739056,1.337956998,0.180910455,NA,0.191729073,1,5.84838057,1.917642326,3.049776535,0.002290117,0.015101794,0.499685762,1,3.190353539,1.351189347,2.36114468,0.018218621,0.052132652,0.57669894,1,2.76718146,1.497706908,1.847612137,0.064658473,0.143127905,0.493635265,0,3.105664903,1.307808229,2.374709712,0.017562756,0.049219702,N,-,,dihydrodipicolinate synthetase family,P:metabolic process; F:lyase activity,IPR002220 (PRINTS); IPR002220 (SMART); IPR002220 (PIRSF); IPR013785 (G3DSA:3.20.20.GENE3D); IPR002220 (PFAM); IPR002220 (PANTHER); PTHR12128:SF24 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_09672,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.669262279,0,0.022272053,1.211391666,0.018385509,0.985331312,0.992386771,1.169868057,0,3.239173787,1.371744988,2.361352741,0.018208402,0.053375454,10.87886703,0,1.548659966,1.192305442,1.298878552,0.193985611,0.318125873,3.502386624,0,0.164483477,1.204685095,0.136536492,0.891397178,0.933232121,10.35847426,0,1.43947188,1.124541716,1.280052006,0.200526846,0.322318003,N,-,,l-galactonate dehydratase,P:cellular amino acid catabolic process; F:catalytic activity,IPR013342 (SMART); IPR029065 (G3DSA:3.20.20.GENE3D); IPR029017 (G3DSA:3.30.390.GENE3D); IPR029065 (PFAM); PTHR13794:SF58 (PANTHER); IPR001354 (PANTHER); IPR029065 (SUPERFAMILY); IPR029017 (SUPERFAMILY),,
RL4_JR_09673,5076,3017,3719,2,1,2,0,0,1,5,6,8,7,17,11,7,11,11,1.472746914,1,1.339161001,1.357462268,0.986518029,0.323878973,NA,0.466945149,1,4.56409577,1.565846991,2.914777623,0.003559421,0.016954568,12.28644676,1,2.86746846,1.203623245,2.382363809,0.017201894,0.049814637,1.40370721,1,1.48340243,1.265898395,1.171817925,0.241270165,0.379738911,1.204212242,1,1.818450563,1.229594813,1.478902272,0.139166436,0.244918788,N,-, Effector probability:0.647,NAD dependent epimerase dehydratase,F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; F:coenzyme binding; P:oxidation-reduction process; P:steroid biosynthetic process,IPR016040 (G3DSA:3.40.50.GENE3D); IPR001509 (PFAM); PTHR10366:SF345 (PANTHER); PTHR10366 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09674,54,73,79,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.020821818,0,7.486458809,3.957797453,1.891571991,0.058548031,NA,22.31842178,0,11.82945442,2.167045063,5.458794848,4.79E-08,6.14E-06,0.016980947,0,8.072889215,2.849937382,2.832654944,0.004616319,0.017851647,19.29017143,0,9.836945905,2.478917671,3.968242278,7.24E-05,0.000813835,11.59825674,0,9.879030214,2.139179928,4.618138981,3.87E-06,4.59E-05,Y,-,,CAS1 appressorium specific partial,,IPR021476 (PFAM); PTHR34618 (PANTHER),,
RL4_JR_09675,341,306,497,0,0,1,0,0,0,0,0,0,0,0,5,0,0,3,32.30340019,1,6.638446747,0.844406483,7.861671934,3.79E-15,2.53E-13,0.08284274,0,7.058534826,2.194689637,3.21618816,0.001299056,0.015023052,0.216923107,0,4.39233239,1.378017385,3.187428865,0.001435438,0.007639403,8.273556201,1,5.672735278,1.077521803,5.264612988,1.40E-07,3.06E-06,0.216051449,1,4.297619499,1.292699578,3.324530752,0.000885675,0.004334198,N,-,,siderophore iron transporter mirB,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF3 (PANTHER); PTHR23501:SF3 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.16.8, the major facilitator superfamily (mfs).
RL4_JR_09676,2291,1465,2376,0,7,0,0,0,0,0,2,2,1,1,0,0,0,0,120.6581483,1,1.469497001,0.476147581,3.086221708,0.002027176,0.010593958,19.556808,0,1.033163516,1.142340223,0.904427154,0.365768945,0.530189498,75.7959171,1,1.090005684,0.603128729,1.807252136,0.070722975,0.14808196,117.1556904,1,1.395210771,0.491989091,2.835857127,0.004570289,0.026120901,74.1939719,0,1.037386848,0.572811393,1.811044369,0.070133984,0.145109466,N,-,,Nipped-B B,,IPR024436 (PFAM); PTHR35487:SF2 (PANTHER); PTHR35487 (PANTHER); PTHR35487 (PANTHER); PTHR35487:SF2 (PANTHER),1.Q.1.1.1, the fungal septal pore (fsp) family.
RL4_JR_09677,1370,885,1334,0,2,8,0,0,0,0,3,31,0,1,0,0,3,0,70.5737257,1,-0.262213376,0.646391068,-0.405657486,0.684994284,0.828896683,41.98906909,0,1.848053201,0.869580339,2.125224224,0.033567908,0.086346725,62.0063776,1,-0.17159951,0.761728201,-0.225276561,0.821764133,0.884832342,41.5461922,1,-3.403878417,1.199894204,-2.836815451,0.004556594,0.026065263,35.60830964,1,-3.06793509,1.206017399,-2.543856408,0.010963614,0.033853796,N,-,,ATP-dependent RNA helicase DHX8,F:nucleic acid binding; F:ATP binding; F:ATP-dependent helicase activity,IPR007502 (SMART); IPR001650 (SMART); IPR014001 (SMART); IPR001650 (PFAM); IPR007502 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011709 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR18934 (PANTHER); PTHR18934:SF83 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.A.53.1.5, the hepatitis c virus p7 viroporin cation-selective channel (hcv-p7) family.
RL4_JR_09678,485,435,479,0,0,0,0,0,0,0,0,0,0,4,0,0,0,1,97.36965802,0,1.245886109,0.427505968,2.914312788,0.003564725,0.016504557,11.37187591,0,-0.041865171,1.212425998,-0.034530084,0.972454453,0.98570677,89.50464489,0,1.129834682,0.536023329,2.107808785,0.035047533,0.086289207,64.95133337,1,-0.062303433,0.663192238,-0.093944756,0.925153041,0.956029245,44.42695573,1,-0.156386038,0.743073369,-0.210458408,0.83330991,0.887385659,N,-,,chaperone dnaj 2,C:endoplasmic reticulum lumen; F:heat shock protein binding; F:metal ion binding; F:chaperone binding; F:unfolded protein binding; P:ER-associated ubiquitin-dependent protein catabolic process; P:response to unfolded protein; P:protein folding in endoplasmic reticulum,IPR001623 (PRINTS); IPR001623 (SMART); IPR001623 (G3DSA:1.10.287.GENE3D); G3DSA:2.60.260.20 (GENE3D); IPR001305 (G3DSA:2.10.230.GENE3D); G3DSA:2.60.260.20 (GENE3D); IPR002939 (PFAM); IPR001305 (PFAM); IPR001623 (PFAM); PTHR24078 (PANTHER); PTHR24078:SF207 (PANTHER); IPR001305 (PROSITE_PROFILES); IPR001623 (PROSITE_PROFILES); IPR001305 (SUPERFAMILY); IPR008971 (SUPERFAMILY); IPR001623 (SUPERFAMILY); IPR008971 (SUPERFAMILY),1.P.1.1.1, the polyoma virus sv40 er penitration channel (vpec) family.
RL4_JR_09679,97,150,95,0,0,16,0,0,0,1,0,0,2,5,0,0,0,3,182.4008677,1,1.564402672,0.947239797,1.651538159,0.098628736,0.219256275,32.6865923,0,1.309036864,0.982307356,1.332614334,0.182658399,0.321934235,362.9231959,1,3.193325385,1.207547747,2.644471321,0.008181864,0.027852452,111.1038589,1,0.891784419,0.453413572,1.96682339,0.049203575,0.121802535,138.9169604,1,1.90730298,0.544869344,3.500477686,0.000464425,0.002547294,N,-,,dihydroceramide delta(4)-desaturase,F:sphingolipid delta-4 desaturase activity; C:integral component of membrane; P:oxidation-reduction process; P:sphingolipid biosynthetic process,IPR013866 (SMART); IPR011388 (PIRSF); IPR005804 (PFAM); IPR013866 (PFAM); PTHR12879 (PANTHER); PTHR12879:SF8 (PANTHER),,
RL4_JR_09680,119,69,135,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.428202454,0,0.120377057,1.216043007,0.098990789,0.921145583,0.961964073,1.09373458,0,3.336277198,1.384055043,2.410509042,0.015930276,0.048335209,2.836485372,0,0.684980515,1.205658522,0.568138077,0.569941214,0.693985712,3.272229072,0,0.262638598,1.207327379,0.217537184,0.827789732,0.892394702,2.793986189,0,0.604043319,1.201527864,0.502729348,0.615154573,0.722250329,N,-, Effector probability:0.74,zinc knuckle transcription factor,F:nucleic acid binding; F:zinc ion binding,IPR001878 (SMART); IPR001878 (PFAM); IPR001878 (G3DSA:4.10.60.GENE3D); IPR001878 (G3DSA:4.10.60.GENE3D); PTHR23002 (PANTHER); IPR001878 (PROSITE_PROFILES); IPR001878 (PROSITE_PROFILES); IPR001878 (PROSITE_PROFILES); IPR001878 (PROSITE_PROFILES); IPR001878 (PROSITE_PROFILES); IPR001878 (PROSITE_PROFILES); IPR001878 (SUPERFAMILY); IPR001878 (SUPERFAMILY); IPR001878 (SUPERFAMILY); IPR001878 (SUPERFAMILY),1.G.7.1.1, the reovirus fast fusion protein (r-fast) famly.
RL4_JR_09681,31081,31777,34061,4,2,3,0,0,1,3,7,2,13,11,2,2,9,3,50.97944211,1,-1.819464637,1.029434322,-1.767441204,0.077154368,0.183078921,58.43110159,1,1.351722673,0.986897919,1.369668177,0.170790507,0.306134498,132.3971886,1,1.538166873,0.472806129,3.253271859,0.001140843,0.006413045,83.87259218,1,-0.311625443,0.686585145,-0.453877346,0.649917109,0.760125994,50.34869034,1,-0.842887776,0.853430704,-0.987646416,0.323325846,0.459380311,N,-,,voltage-gated potassium channel subunit beta-2,,IPR005399 (PRINTS); IPR023210 (G3DSA:3.20.20.GENE3D); IPR023210 (PFAM); IPR001395 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.3, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_09682,34,44,87,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.96847354,0,-1.906294559,1.23228015,-1.546965241,0.121871628,0.255192181,4.451744781,0,1.311197264,1.293828591,1.013424246,0.310857563,0.472802442,11.53102702,0,-1.338351217,1.223585292,-1.09379479,0.27404499,0.412668994,13.30276606,0,-1.76072767,1.225240584,-1.437046481,0.150704787,0.267043396,11.32410116,0,-1.415045192,1.225999561,-1.154197143,0.248419353,0.378631033,N,-,,methyltransferase domain-containing,F:transferase activity,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108 (PANTHER); PTHR10108 (PANTHER); PTHR10108:SF876 (PANTHER); PTHR10108:SF876 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_09683,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,116.8189928,0,-0.354707999,0.549084923,-0.645998432,0.518280371,0.702893668,31.56016969,0,-0.088803008,1.115852414,-0.079583112,0.936568827,0.964880373,144.3137762,0,0.613749523,0.490192541,1.252058063,0.210548707,0.338241052,74.6821953,0,-2.364712081,1.027172219,-2.302157357,0.0213263,0.079239921,64.91828309,0,-2.088831427,0.99246734,-2.104685306,0.03531871,0.085387283,N,-,,initiation factor 2 subunit family,P:regulation of catalytic activity; C:cytoplasmic part; P:cellular metabolic process,IPR000649 (PFAM); G3DSA:3.40.50.10470 (GENE3D); PTHR10233 (PANTHER); PTHR10233:SF9 (PANTHER); PTHR10233 (PANTHER); SSF100950 (SUPERFAMILY),,
RL4_JR_09684,1064,1075,1945,0,1,4,0,0,0,0,1,0,0,2,0,0,4,0,462.7958435,1,2.036377188,0.414947696,4.907551506,9.22E-07,1.42E-05,59.87871975,0,0.307500243,1.015415615,0.302831903,0.762017969,0.855685144,301.5730202,1,1.687274876,1.189621664,1.418328976,0.156094741,0.270275895,110.9457233,1,-1.677514796,0.782775969,-2.143033081,0.032110442,0.095876799,113.069629,1,-0.205807819,0.580025956,-0.354825189,0.722720557,0.804854183,N,-,,RING finger domain-containing,,no IPS match,,
RL4_JR_09685,11602,12258,10981,15,4,62,0,3,3,1,6,13,6,31,2,0,30,9,80.14352102,1,-0.728854751,0.726883535,-1.002711873,0.3159999,0.504289355,27.47235444,1,0.203710405,1.133553402,0.179709579,0.857380573,0.916313606,79.76563825,1,-0.256364606,0.72001891,-0.356052601,0.721801173,0.811659159,100.1506925,1,-0.449158194,0.661991763,-0.67849514,0.497457804,0.63589178,46.97194719,1,-3.467505596,1.223138212,-2.834925409,0.004583639,0.016634172,N,-,,N-terminal acetyltransferase A complex catalytic subunit ard1,C:nucleus; F:peptide-serine-N-acetyltransferase activity; C:NatA complex; C:cytosolic ribosome; F:peptide-glutamate-N-acetyltransferase activity; P:N-terminal peptidyl-serine acetylation; P:N-terminal peptidyl-glutamic acid acetylation; P:histone acetylation,IPR016181 (G3DSA:3.40.630.GENE3D); IPR000182 (PFAM); PTHR23091 (PANTHER); PTHR23091:SF4 (PANTHER); IPR000182 (PROSITE_PROFILES); IPR016181 (SUPERFAMILY),,
RL4_JR_09686,1510,2046,1898,0,0,8,0,0,0,0,1,0,0,9,0,0,0,0,134.3231888,1,2.763139051,0.837279849,3.300138007,0.000966373,0.005775351,6.045585763,0,0.86961031,1.232325837,0.705665891,0.480395937,0.637379431,509.1696018,1,4.982941476,1.30845966,3.808249981,0.000139954,0.001415819,26.16149221,1,-0.483532045,1.019522765,-0.474272926,0.635305295,0.750141821,42.55352655,0,1.512771872,0.6112812,2.47475609,0.01333272,0.039564416,N,-,,3-oxoacyl-[acyl-carrier- ] reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR002347 (PRINTS); IPR002347 (PRINTS); SM00822 (SMART); IPR002347 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PANTHER); IPR002347 (PANTHER); PTHR24322:SF644 (PANTHER); PTHR24322:SF644 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09687,810,961,1340,0,0,0,7,0,0,0,0,0,0,1,0,0,0,0,331.9079435,0,-0.000338565,0.405839224,-0.000834233,0.999334378,0.999877636,92.29525198,1,-0.015987474,0.842889708,-0.018967456,0.984867067,0.992120268,167.8326243,0,-2.040717529,0.745827149,-2.736180269,0.006215697,0.02237032,185.0310295,1,-2.241293259,0.674463784,-3.323074288,0.000890312,0.006717145,168.505384,0,-1.957747131,0.70121106,-2.791951301,0.005239124,0.018619211,N,-,,methionyl-tRNA synthetase,F:ATP binding; F:methionine-tRNA ligase activity; P:methionyl-tRNA aminoacylation; C:cytosol,IPR033911 (PRINTS); IPR009080 (G3DSA:1.10.730.GENE3D); IPR014758 (TIGRFAM); IPR014729 (G3DSA:3.40.50.GENE3D); IPR015413 (PFAM); IPR029038 (G3DSA:2.20.28.GENE3D); PTHR11946 (PANTHER); PTHR11946:SF86 (PANTHER); IPR009080 (SUPERFAMILY); SSF52374 (SUPERFAMILY); IPR029038 (SUPERFAMILY),,
RL4_JR_09688,4340,4098,6016,0,3,1,0,0,0,0,0,0,0,4,3,0,1,0,33.4294457,1,0.420839607,0.757269841,0.555732691,0.578393605,0.753278261,5.772107404,0,0.936402868,1.235026051,0.758204952,0.448328297,0.608961222,15.00442022,0,-1.718342192,1.195144387,-1.437769537,0.150499455,0.263016828,17.31194259,1,-2.14088566,1.193781653,-1.79336452,0.072914657,0.155521572,14.81552182,1,-1.802769368,1.200769023,-1.501345665,0.13326618,0.236702818,N,-,,DUF1715 domain-containing,C:cytosol,IPR019191 (PFAM); PTHR28532 (PANTHER),,
RL4_JR_09689,114,132,173,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,181.1332389,0,0.337707025,0.424456586,0.795622064,0.426251738,0.616765634,83.36815502,0,1.876076133,0.623610179,3.008411657,0.002626171,0.015349618,152.5912039,0,-0.095159089,0.553651797,-0.171875336,0.863535537,0.913429503,457.1641551,0,2.149627914,0.286005603,7.516034262,5.65E-14,3.18E-12,135.9557882,0,-0.035440554,1.651699266,-0.021457026,0.982881084,0.988543853,N,-, Effector probability:0.698,nadh-ubiquinone oxidoreductase,,IPR016813 (PIRSF); PTHR37325:SF1 (PANTHER); PTHR37325 (PANTHER),,
RL4_JR_09690,7233,10857,10431,8,5,12,0,0,6,1,11,2,8,8,3,0,24,3,76.17560063,1,1.730711999,0.44612977,3.879391417,0.000104718,0.000890814,7.011316154,1,0.655828494,1.222261403,0.536569749,0.591564845,0.728639536,18.19055877,1,-1.996178754,1.187893483,-1.680435815,0.092872553,0.183211559,20.98488289,1,-2.418520043,1.185617623,-2.039881996,0.04136208,0.109918914,32.66632714,1,-0.394527581,0.967911513,-0.407607075,0.683562169,0.775295952,N,-,,peroxiredoxin Q BCP,C:nucleus; F:thioredoxin peroxidase activity; P:cellular oxidant detoxification; P:cellular response to oxidative stress; P:cell redox homeostasis; P:oxidation-reduction process,IPR012336 (G3DSA:3.40.30.GENE3D); IPR000866 (PFAM); PTHR10681 (PANTHER); PTHR10681:SF119 (PANTHER); IPR013766 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY),,
RL4_JR_09691,70649,105854,107799,233,428,155,1,0,45,38,37,103,79,106,56,0,129,70,146.9154681,1,0.07241548,0.716572411,0.101058147,0.919504301,0.961460663,20.6607232,1,-0.903279488,1.200269667,-0.752563788,0.451712085,0.611669528,140.8401941,1,0.730307458,0.459716178,1.588605087,0.112149579,0.210923711,135.0529602,1,0.444782925,0.428639595,1.037661779,0.299427545,0.444596552,71.21044961,1,-1.411776981,0.830914587,-1.699063903,0.089307144,0.175443312,N,-,,ubiquitin interaction domain-containing,,PTHR39597:SF2 (PANTHER); PTHR39597 (PANTHER); PTHR39597 (PANTHER),,
RL4_JR_09692,3706,5223,3689,0,0,8,0,0,0,1,0,2,1,5,0,0,0,3,198.5944638,1,-1.819088935,0.573071614,-3.174278557,0.001502095,0.008218704,58.39307206,0,-1.232344574,1.112759667,-1.107466968,0.268092086,0.425667152,157.3576689,1,-1.976403431,0.743138153,-2.659537023,0.007824813,0.026919362,159.8926897,1,-3.485110173,1.013656781,-3.438156028,0.00058569,0.004758944,162.1037712,1,-1.443685054,0.572424481,-2.522053306,0.011667203,0.035606961,N,-,,ubiquitin-conjugating enzyme,F:ubiquitin protein ligase activity; F:protein homodimerization activity; P:protein sumoylation; P:protein polyubiquitination; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; C:nucleus; F:ATP binding; F:ubiquitin protein ligase binding; P:G2/M transition of mitotic cell cycle; C:cytoplasm; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; C:SCF ubiquitin ligase complex; F:SUMO transferase activity; P:protein autoubiquitination,SM00212 (SMART); IPR000608 (PFAM); IPR016135 (G3DSA:3.10.110.GENE3D); PTHR24067 (PANTHER); PTHR24067:SF157 (PANTHER); IPR000608 (PROSITE_PROFILES); IPR016135 (SUPERFAMILY),3.A.16.1.2, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_09693,781,890,877,0,0,3,0,0,0,0,6,1,0,3,0,0,1,0,34.92421711,1,-0.073123801,0.907379622,-0.080587881,0.935769705,0.968396542,73.03809445,0,3.109294165,0.876492269,3.547429082,0.00038901,0.014476338,22.38897262,1,-0.839261539,1.217117553,-0.689548463,0.490478186,0.624430276,35.99554173,1,0.08179007,0.896148028,0.091268482,0.927279261,0.956926461,15.70142676,1,-1.886556354,1.228028463,-1.536248068,0.124477551,0.225151427,N,-,,methionine adenosyltransferase 2 subunit beta,P:DNA ligation involved in DNA repair; F:oxidoreductase activity; F:DNA ligase activity,IPR029903 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR005913 (PANTHER); PTHR10491:SF4 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09694,51,43,67,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.50566359,0,-0.547040837,1.043973103,-0.523998976,0.600279252,0.76883364,5.765867296,0,0.938048326,1.276851804,0.734657164,0.462548314,0.621273094,14.84057183,0,-1.702412845,1.214664289,-1.401550091,0.16104964,0.276490851,17.11223421,0,-2.124069432,1.21491504,-1.748327548,0.080407326,0.166920192,22.22459736,0,-0.111363847,0.998567381,-0.111523618,0.911201138,0.943116893,N,-,,hypothetical protein SPI_06155,,G3DSA:3.10.20.90 (GENE3D); PTHR38700:SF1 (PANTHER); PTHR38700 (PANTHER); PTHR38700:SF1 (PANTHER); PTHR38700 (PANTHER); IPR029071 (SUPERFAMILY),,
RL4_JR_09695,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,186.3351139,0,1.721363302,0.500220442,3.441209427,0.00057912,0.003794748,14.37681791,0,-0.380189112,1.215472376,-0.31279124,0.754439271,0.850193086,94.78533564,0,0.593843009,0.593627779,1.000362567,0.317135078,0.459954073,101.8272193,0,0.295354343,0.577246692,0.511660521,0.608888621,0.729087949,92.86105247,0,0.694931163,0.571317768,1.216365398,0.223845759,0.350579711,N,-,,farnesyl pyrophosphate synthase,F:geranyltranstransferase activity; F:dimethylallyltranstransferase activity; C:integral component of membrane; P:ergosterol biosynthetic process; P:isoprenoid biosynthetic process,IPR008949 (G3DSA:1.10.600.GENE3D); IPR000092 (PFAM); PTHR11525 (PANTHER); IPR008949 (SUPERFAMILY),5.B.14.1.1, the flavin-based extracellular electron transfer (f-eet) family.
RL4_JR_09696,344,342,537,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,35.58841558,0,1.573385928,0.68869205,2.284600101,0.022336287,0.071966599,3.264734577,0,1.758579977,1.275948377,1.378253234,0.168125117,0.302213183,21.46753672,0,0.924821658,1.040712181,0.888643061,0.374194941,0.518171192,17.79499729,1,0.406358624,1.025658694,0.396192833,0.691962778,0.792099845,8.341746192,0,-0.974033227,1.203391629,-0.809406683,0.418281259,0.554114582,N,-,,anaphase-promoting complex subunit 8,C:nucleus; P:regulation of mitotic metaphase/anaphase transition; P:cellular protein metabolic process; C:intracellular organelle part,IPR019734 (SMART); IPR007192 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR019734 (PFAM); PF13432 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR12558:SF10 (PANTHER); PTHR12558 (PANTHER); PTHR12558:SF10 (PANTHER); PTHR12558 (PANTHER); PTHR12558:SF10 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY),3.A.20.1.2, the peroxisomal protein importer (ppi) family.
RL4_JR_09697,147,141,167,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,77.03071276,0,7.044414897,1.046580223,6.730888608,1.69E-11,6.78E-10,0.210390228,0,5.714454677,1.809785995,3.157530611,0.001591115,0.015023052,33.75529821,0,5.488288116,0.862922732,6.360115353,2.02E-10,1.13E-08,8.652298504,0,4.362271232,1.037539589,4.204438344,2.62E-05,0.000332918,0.536543951,1,2.985105771,1.229378725,2.428141719,0.015176412,0.043887973,Y,-,,rds1p-like stress response,,PF13668 (PFAM); PTHR31694:SF8 (PANTHER); PTHR31694 (PANTHER); PS51257 (PROSITE_PROFILES); IPR009078 (SUPERFAMILY),,
RL4_JR_09698,383,398,359,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,423.2254599,0,-0.712831739,0.442006769,-1.612716793,0.10680605,0.23241498,115.4736826,0,-0.827578353,0.905067156,-0.914383366,0.360515439,0.524753706,424.6427355,0,-0.125264634,0.422361571,-0.296581515,0.766786025,0.843431304,382.9319784,1,-1.17082767,0.485710311,-2.41054728,0.015928607,0.067995882,285.3849943,0,-1.392751291,0.855276185,-1.628422861,0.103435254,0.195837387,N,-,,cell wall biogenesis phosphatase,"C:nucleus; C:cytoplasmic stress granule; F:mRNA 5'-UTR binding; P:intracellular mRNA localization; C:cellular bud neck; F:translation repressor activity, nucleic acid binding; C:cytoplasmic mRNA processing body; P:negative regulation of translation; P:regulation of fungal-type cell wall organization; F:mRNA 3'-UTR binding",SM00955 (SMART); PF00773 (PFAM); PTHR23355 (PANTHER); PTHR23355 (PANTHER); PTHR23355:SF9 (PANTHER); PTHR23355 (PANTHER); PTHR23355:SF9 (PANTHER); PTHR23355:SF9 (PANTHER); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY); IPR012340 (SUPERFAMILY),,
RL4_JR_09699,2394,2288,2033,0,0,1,0,0,0,0,0,0,0,4,0,0,0,0,65.1788512,1,0.721230302,0.636911745,1.132386563,0.257471951,0.436311143,8.970467868,0,0.300263026,1.23856478,0.242428196,0.808448388,0.883636834,31.27710635,0,-1.399823914,1.210604225,-1.156301857,0.247557709,0.381937556,35.0682344,1,-1.071762167,1.046931906,-1.023717169,0.305968883,0.451659855,42.57945227,0,0.42380597,0.754111408,0.561993846,0.574120212,0.689148446,N,-,,RNA export mediator Gle1,C:nuclear envelope; P:mRNA transport,IPR012476 (PFAM); PTHR12960:SF0 (PANTHER); PTHR12960:SF0 (PANTHER); IPR012476 (PANTHER); IPR012476 (PANTHER),1.I.1.1.2, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_09700,2290,3577,3277,0,3,0,0,0,0,1,0,2,1,5,7,0,0,0,36.27235746,1,0.78517491,0.732193836,1.072359356,0.283558656,0.466950246,5.435156021,0,1.023135658,1.253368196,0.816308935,0.414323465,0.578054047,40.17319202,1,1.169346805,0.77335767,1.512038801,0.130523992,0.236662525,25.6743925,1,-1.107847752,1.161148273,-0.954096714,0.340034689,0.48731086,14.05319508,0,-1.726567075,1.219845659,-1.415397974,0.156951843,0.267216649,N,-,,SNARE domain-containing,C:trans-Golgi network; C:endosome; P:vesicle fusion; C:integral component of membrane; F:SNAP receptor activity; P:endocytosis; P:Golgi vesicle transport,IPR000727 (SMART); G3DSA:1.20.5.110 (GENE3D); G3DSA:1.20.58.90 (GENE3D); IPR015260 (PFAM); PTHR19957:SF100 (PANTHER); PTHR19957 (PANTHER); IPR000727 (PROSITE_PROFILES); IPR010989 (SUPERFAMILY); SSF58038 (SUPERFAMILY),1.F.1.1.5, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_09701,1764,1401,2346,0,0,0,0,0,0,0,0,4,0,2,1,4,0,0,0.008470882,0,8.791019641,4.031633903,2.180510397,0.029219649,NA,0.002680088,0,12.01721297,4.032710343,2.979934573,0.0028831,0.015349618,0.006904709,1,9.374372631,4.033343739,2.324218623,0.02011378,0.055743746,0.007967227,1,8.951770626,4.033311655,2.219459191,0.026455501,0.08636862,0.006679571,1,9.335361424,1.822923296,5.121093929,3.04E-07,5.22E-06,,,,,,,,
RL4_JR_09702,2126,2681,4418,0,0,5,0,0,0,0,0,5,7,2,0,0,0,1,116.4169092,1,1.374130661,0.467982975,2.936283442,0.003321707,0.015642089,9.923218664,0,0.154675199,1.218626332,0.126925863,0.898999077,0.944130759,25.83108294,1,-2.502078211,1.197213654,-2.089917871,0.036625178,0.089154436,56.45367328,1,-0.191758662,0.754223182,-0.254246577,0.799305069,0.870960377,48.70959146,1,0.571772008,0.660784093,0.86529324,0.38687786,0.522976747,N,-,,DUF410 domain-containing,C:nucleus; P:protein insertion into ER membrane; C:TRC complex; P:posttranslational protein targeting to membrane,IPR007317 (PFAM); PTHR12875:SF0 (PANTHER); IPR007317 (PANTHER),3.A.21.1.1, the c-terminal tail-anchored membrane protein biogenesis/ insertion complex (tamp-b) family.
RL4_JR_09703,795,991,740,0,0,0,0,0,0,0,0,0,0,3,3,0,2,0,23.44853878,0,1.560271078,0.77669254,2.008865797,0.044551368,0.122004048,2.59255836,0,2.091098437,1.292647907,1.617686012,0.105730282,0.211251859,14.59289837,0,0.395850391,1.201754942,0.329393604,0.741858202,0.826791329,7.788792759,1,-0.988619002,1.206928559,-0.819119735,0.412718103,0.556501637,14.04100536,1,0.285109237,1.139701171,0.250161397,0.802462537,0.866751994,N,-,,UPF0220 domain,,no IPS match,,
RL4_JR_09704,2242,2897,1964,0,3,7,0,0,0,0,0,0,0,2,0,0,0,0,39.94018723,1,0.543089863,0.677692957,0.801380415,0.42291145,0.614654739,45.01533294,0,1.650601413,1.117851603,1.476583662,0.139787274,0.2615875,17.27032695,0,-1.921146584,1.194551409,-1.608257769,0.107778736,0.205065198,43.9893501,1,0.941705814,0.62890905,1.497364068,0.134298552,0.244739533,66.43130232,0,2.061743012,0.476449869,4.327303131,1.51E-05,0.000142038,N,-,,DNA polymerase delta catalytic subunit,"F:nucleotide binding; F:DNA binding; P:nucleic acid phosphodiester bond hydrolysis; F:DNA-directed DNA polymerase activity; F:3'-5'-exodeoxyribonuclease activity; P:DNA-dependent DNA replication maintenance of fidelity; P:RNA-dependent DNA biosynthetic process; P:DNA replication, removal of RNA primer",IPR006172 (PRINTS); IPR006172 (SMART); IPR006133 (PFAM); TIGR00592 (TIGRFAM); G3DSA:1.10.287.690 (GENE3D); IPR025687 (PFAM); IPR012337 (G3DSA:3.30.420.GENE3D); IPR006134 (PFAM); IPR023211 (G3DSA:3.90.1600.GENE3D); PTHR10322 (PANTHER); PTHR10322:SF23 (PANTHER); IPR012337 (SUPERFAMILY); SSF56672 (SUPERFAMILY),,
RL4_JR_09705,16909,19087,19868,0,3,0,0,0,0,0,0,1,0,4,3,0,4,0,1907.768273,1,-0.389668787,0.453169768,-0.859873746,0.389858642,0.582609782,369.4439588,0,-3.375449616,1.06329927,-3.17450572,0.001500919,0.015023052,980.5578064,1,-3.513248445,0.610139015,-5.758111445,8.51E-09,3.63E-07,1387.343554,1,-1.54615398,0.477887368,-3.23539412,0.001214749,0.008729125,948.2180169,1,-3.636849567,1.019039239,-3.56890042,0.000358483,0.002035691,N,-,,NADP-specific glutamate dehydrogenase,C:cytosol; P:cellular amino acid metabolic process; P:oxidation-reduction process; F:glutamate dehydrogenase (NADP+) activity,IPR006095 (PRINTS); IPR006096 (SMART); IPR006097 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); G3DSA:3.40.192.10 (GENE3D); IPR006096 (PFAM); G3DSA:1.10.285.10 (GENE3D); IPR014362 (PIRSF); PTHR11606:SF4 (PANTHER); PTHR11606 (PANTHER); SSF53223 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_09706,1243,1420,1107,0,2,0,0,0,2,1,0,0,3,4,1,0,0,0,15.72788509,1,0.610629846,1.008722498,0.605349685,0.544946675,0.72558756,2.594005811,1,2.090372802,1.290720826,1.619539067,0.105331328,0.210704289,6.710211715,1,-0.557359725,1.197515259,-0.465430165,0.641623437,0.750525208,11.75109266,1,-0.032348403,1.145240833,-0.02824594,0.977465997,0.986232508,6.596664566,0,-0.635619292,1.194808958,-0.531984036,0.594737052,0.70586087,N,-,,cholesterol oxidase,,IPR000172 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR007867 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR10668 (PANTHER); PTHR10668:SF78 (PANTHER); PTHR10668:SF78 (PANTHER); IPR023753 (SUPERFAMILY); IPR029058 (SUPERFAMILY),,
RL4_JR_09707,841,682,1127,0,0,0,0,0,0,0,4,0,0,3,0,0,0,0,267.7144984,0,-1.224026801,0.443596678,-2.759323641,0.005792114,0.024495628,72.77834669,0,-1.60378693,1.114894343,-1.438510241,0.150289334,0.277191807,192.5507673,1,-2.34833936,0.748912642,-3.135665268,0.001714648,0.00876722,283.872155,1,-1.133301318,0.453542524,-2.498776318,0.012462294,0.057748618,190.7783463,0,-2.290587394,0.676498974,-3.385943636,0.00070934,0.003630972,N,-,,Histone-lysine N- H3 lysine-4 specific,"C:nucleus; P:histone lysine methylation; F:organic cyclic compound binding; F:heterocyclic compound binding; P:regulation of transcription, DNA-templated; P:single-organism cellular process; C:intracellular organelle part; F:protein-lysine N-methyltransferase activity",IPR003616 (SMART); IPR001214 (SMART); IPR024657 (SMART); IPR024657 (PFAM); G3DSA:2.170.270.10 (GENE3D); IPR024636 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR001214 (PFAM); PTHR22884:SF357 (PANTHER); PTHR22884 (PANTHER); PTHR22884:SF357 (PANTHER); PTHR22884 (PANTHER); IPR017111 (PROSITE_PROFILES); IPR003616 (PROSITE_PROFILES); IPR001214 (PROSITE_PROFILES); IPR012677 (SUPERFAMILY); SSF82199 (SUPERFAMILY),,
RL4_JR_09708,2061,2047,1959,0,2,2,0,0,0,1,0,0,0,1,0,0,0,1,70.80970006,1,3.104674365,0.509151193,6.097745441,1.08E-09,2.91E-08,2.501516092,0,2.142758177,1.301734954,1.646078697,0.099747558,0.202131087,6.485811817,1,-0.508146515,1.206781419,-0.421075853,0.673699694,0.775589686,32.84100234,1,2.103353615,0.689749951,3.049443662,0.002292656,0.014766632,17.608177,1,1.090202419,0.984742077,1.10709438,0.268253125,0.400497879,N,-,,hypothetical protein CMQ_3363,,no IPS match,,
RL4_JR_09709,362,731,728,2,1,4,1,1,3,6,0,3,6,29,9,3,10,8,509.8409588,1,1.144758381,0.427418827,2.678305934,0.00739956,0.029810177,118.7159116,1,0.011805703,0.863453195,0.013672661,0.989091134,0.994396152,241.3103883,1,-0.226124857,0.579912994,-0.389928936,0.696589096,0.793191768,217.1986153,1,-0.938279331,0.577400627,-1.625005735,0.104161337,0.201998379,222.7963837,1,-0.355736352,0.492674084,-0.722052091,0.470262452,0.601719616,N,-,,actin lateral binding,,IPR000533 (PFAM); G3DSA:1.20.5.340 (GENE3D); PTHR19269 (PANTHER); SSF57997 (SUPERFAMILY),,
RL4_JR_09710,325,396,506,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,65.55978855,1,-1.830471668,1.057269418,-1.731319981,0.08339471,0.193993168,14.33486544,0,-0.375997954,1.231990261,-0.305195557,0.760217216,0.854741965,37.49026296,0,-3.039496949,1.216540045,-2.498476694,0.012472834,0.038388862,89.51123863,0,-0.109012601,0.672054248,-0.162208038,0.87114203,0.920820833,37.28366469,0,-3.13424552,1.229431306,-2.549345788,0.010792523,0.033407,N,-,,nucleolar 12,C:cytoplasm; P:rRNA processing,IPR019186 (PFAM); PTHR14577:SF0 (PANTHER); IPR019186 (PANTHER),,
RL4_JR_09711,1962,2494,3081,0,1,1,0,0,0,1,0,2,1,6,0,0,2,1,115.4343022,1,0.577804714,0.525642313,1.099235544,0.271665339,0.453369159,26.39833123,0,0.293321972,1.116549595,0.262703935,0.792778784,0.874510337,83.9836427,1,-0.444971295,0.74849707,-0.594486355,0.552186866,0.679016134,64.41017007,1,-1.967396705,1.02134275,-1.926284496,0.05406886,0.128179127,97.79842197,1,0.512926272,1.399447319,0.366520601,0.713976643,0.79869777,Y,-,,er big1,C:membrane; C:integral component of membrane,PTHR28285 (PANTHER); PTHR28285:SF1 (PANTHER),8.A.107.2.1," the v-type atpase assembly factor, atp6ap1 (atp6ap1) family."
RL4_JR_09712,1480,1304,1420,4,2,4,0,0,0,1,0,4,0,8,6,0,9,0,27.9253171,1,-2.905855969,1.236444793,-2.350170411,0.018764818,0.062305,8.796201723,0,0.328562187,1.256173902,0.261557884,0.793662318,0.875008167,23.03241023,1,-2.336665254,1.225026495,-1.907440585,0.056463558,0.124052957,38.61991312,1,-0.492719886,0.922489289,-0.534119899,0.593258583,0.716282274,22.93368385,1,-2.433163907,1.240528425,-1.961393111,0.049833183,0.111823592,N,-,,multifunctional methyltransferase subunit TRM112,C:nucleus; C:tRNA (m2G10) methyltransferase complex; P:maturation of LSU-rRNA; P:maturation of SSU-rRNA; C:eRF1 methyltransferase complex; C:cytosol; P:peptidyl-glutamine methylation; F:methyltransferase activity; P:rRNA (guanine-N7)-methylation; P:tRNA methylation,IPR005651 (PFAM); PTHR12773 (PANTHER); PTHR12773:SF0 (PANTHER); SSF158997 (SUPERFAMILY),,
RL4_JR_09713,2938,2682,3952,0,2,0,0,0,0,1,0,0,0,0,0,0,0,0,229.8358697,1,0.647470395,1.35847617,0.476615202,0.633636156,0.791550676,150.5673583,0,1.307860119,0.778817432,1.679289735,0.093095591,0.191566084,84.03118652,1,-3.100708598,1.209090405,-2.564496901,0.01033255,0.033527801,148.0900936,0,-0.408442892,1.462285283,-0.279318199,0.780000641,0.858238045,121.5939626,0,-0.180329387,0.699683869,-0.257729805,0.796615442,0.862373836,Y,-, Effector probability:0.871,Peptidyl-prolyl cis-trans isomerase B,C:endoplasmic reticulum lumen; F:peptidyl-prolyl cis-trans isomerase activity; C:integral component of membrane; F:peptide binding; P:protein peptidyl-prolyl isomerization; P:protein folding,IPR002130 (PRINTS); IPR002130 (PFAM); IPR029000 (G3DSA:2.40.100.GENE3D); IPR024936 (PANTHER); IPR002130 (PROSITE_PROFILES); IPR029000 (SUPERFAMILY),3.D.1.8.1, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_09714,12744,11002,12374,0,2,15,0,2,0,2,0,1,4,3,0,0,12,1,246.21335,1,-1.010549294,0.448084147,-2.255266784,0.024116588,0.076405098,48.69905372,1,-2.140291075,1.191499256,-1.796300806,0.07244669,0.157767942,132.6813122,1,-3.828579114,1.186407829,-3.227034599,0.001250803,0.006889626,145.5570981,1,-5.212614091,1.185137456,-4.398320267,1.09E-05,0.000151725,139.6415956,1,-2.255830288,0.743252235,-3.035080396,0.002404716,0.009893436,N,-,,iron sulfur cluster assembly 1,"P:cellular iron ion homeostasis; F:iron-sulfur transferase activity; P:[2Fe-2S] cluster assembly; C:mitochondrial matrix; F:ferrous iron binding; C:protein complex; F:4 iron, 4 sulfur cluster binding; P:protein maturation by iron-sulfur cluster transfer; F:2 iron, 2 sulfur cluster binding",IPR011339 (TIGRFAM); IPR002871 (PFAM); G3DSA:3.90.1010.10 (GENE3D); PTHR10093 (PANTHER); SSF82649 (SUPERFAMILY),,
RL4_JR_09715,1808,2024,2202,0,0,4,0,0,0,3,0,0,4,7,4,0,3,1,18.79465673,1,2.746841099,0.825844949,3.326097837,0.00088071,0.00540213,1.114488725,0,3.309118583,1.420973006,2.32876949,0.019871281,0.057206229,2.902084532,1,0.65198394,1.23901419,0.526211843,0.598741027,0.717921094,3.3489549,1,0.229194179,1.248849846,0.183524208,0.854386726,0.908874301,2.86773406,1,0.566534936,1.240431681,0.456724014,0.647869428,0.748336851,N,-, Effector probability:0.591,hypothetical protein NEUTE1DRAFT_116190,,no IPS match,,
RL4_JR_09716,608,452,832,0,0,13,0,0,0,0,0,1,1,0,1,0,0,0,27.36354972,1,0.182275032,0.900623233,0.202387664,0.839613672,0.919624667,5.030030073,0,1.134866618,1.260023951,0.900670671,0.367763447,0.532242152,13.1341753,1,-1.526365076,1.212454914,-1.258904606,0.20806479,0.335236995,44.06351726,1,0.412167118,0.877363662,0.469779107,0.638512843,0.752349881,13.03817555,0,-1.618422467,1.224507069,-1.321693037,0.186270388,0.305176,N,-, Effector probability:0.759,Apc13 domain-containing,,IPR008401 (PFAM); PTHR28526:SF1 (PANTHER); PTHR28526 (PANTHER),,
RL4_JR_09717,5075,4933,6008,1,5,3,0,0,1,0,0,1,2,3,0,0,0,3,37.96856626,1,1.745209504,0.633003127,2.757031411,0.005832875,0.024591521,3.45752197,1,1.675717103,1.266812855,1.32278189,0.185907922,0.325733076,8.993399876,1,-0.980050452,1.201011749,-0.816020704,0.414488295,0.556166931,10.37624242,1,-1.402567776,1.199827898,-1.168974132,0.242414054,0.380818527,8.89557052,1,-1.066868863,1.208302455,-0.882948519,0.377264087,0.513137948,N,-,,trafficking particle complex subunit 5,C:nuclear envelope; P:ER to Golgi vesicle-mediated transport; C:TRAPPI protein complex; C:cytosol; C:TRAPPII protein complex; C:TRAPPIII protein complex,IPR016696 (PIRSF); IPR007194 (PFAM); G3DSA:3.30.1380.20 (GENE3D); IPR016696 (PANTHER); PTHR20902:SF0 (PANTHER); IPR024096 (SUPERFAMILY),,
RL4_JR_09718,1858,2367,2168,5,4,8,0,0,1,0,2,0,3,5,0,0,3,6,57.68558855,1,1.083063646,0.542541182,1.996279144,0.045903547,0.124712394,7.312788496,1,0.595069271,1.221878169,0.487011951,0.626249862,0.754055235,30.06408195,1,-1.096785146,1.189428122,-0.922111329,0.356470508,0.49998775,40.53768365,1,-0.73948843,1.011371826,-0.73117365,0.464673093,0.606446902,48.5706307,1,0.810849065,0.675987517,1.199503016,0.230332413,0.357882173,N,-,,cral trio domain-containing,F:oxidoreductase activity; P:oxidation-reduction process,IPR011074 (SMART); IPR001251 (SMART); IPR011074 (PFAM); IPR001251 (G3DSA:3.40.525.GENE3D); IPR001251 (PFAM); PTHR10174 (PANTHER); PTHR10174:SF127 (PANTHER); IPR001251 (PROSITE_PROFILES); IPR001251 (SUPERFAMILY); IPR011074 (SUPERFAMILY),,
RL4_JR_09719,530,386,482,0,1,0,0,0,0,0,0,3,0,0,0,0,0,2,503.9611161,1,-1.043709543,0.637224634,-1.637898925,0.10144278,0.223947954,112.0072744,0,-3.341931549,1.187308265,-2.814712613,0.004882087,0.020316236,325.823794,1,-2.853259031,0.665956342,-4.284453577,1.83E-05,0.000315409,360.9752891,0,-3.371492327,0.663545732,-5.081024813,3.75E-07,7.50E-06,302.0184874,1,-3.47318929,0.761673842,-4.559942981,5.12E-06,5.78E-05,N,-,,fe-s cluster assembly dre2,"C:mitochondrial intermembrane space; F:metal ion binding; F:electron carrier activity; P:negative regulation of apoptotic process; P:apoptotic process; F:2 iron, 2 sulfur cluster binding; P:hydrogen peroxide-mediated programmed cell death; P:iron-sulfur cluster assembly",IPR007785 (PFAM); IPR031838 (PFAM); IPR007785 (PANTHER),,
RL4_JR_09720,4693,9080,7812,19,15,1,3,0,1,0,0,4,3,2,11,0,0,4,48.42691817,1,2.098127715,0.641952518,3.268353434,0.001081752,0.006294531,2.782451015,1,1.989174211,1.290165737,1.541797425,0.123122828,0.237871876,22.91257367,1,1.160285262,1.041905907,1.113618086,0.265443064,0.403202638,20.37263836,1,1.207107041,0.873159999,1.382458017,0.166831113,0.287713339,18.70657802,1,1.446602456,0.867332359,1.667875573,0.09534043,0.184292067,N,-,,DNA polymerase alpha subunit B,C:nuclear part; F:DNA binding; F:DNA-directed DNA polymerase activity; P:DNA-dependent DNA replication; P:DNA biosynthetic process,IPR016722 (PIRSF); IPR007185 (PFAM); IPR013627 (PFAM); PTHR23061:SF12 (PANTHER); PTHR23061 (PANTHER),,
RL4_JR_09721,630,751,820,0,0,7,0,0,0,0,0,0,2,0,1,0,0,0,37.9023593,1,0.638919163,0.755887172,0.845257316,0.397967187,0.590249808,5.939573604,0,0.89507384,1.258980471,0.710951329,0.477114397,0.634439296,59.80448385,0,1.329088934,1.32054003,1.006473794,0.314187712,0.456688642,25.94049436,1,-0.479711115,1.051592365,-0.45617592,0.64826348,0.758893251,15.42798461,0,-1.861236245,1.23029765,-1.512834107,0.130321803,0.232562494,N,-,,cdp-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase,C:nucleus; C:mitochondrial membrane; C:cytosol; F:CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity; P:cardiolipin biosynthetic process,IPR001736 (SMART); G3DSA:3.30.870.10 (GENE3D); IPR016270 (PANTHER); PTHR12586:SF1 (PANTHER); IPR001736 (PROSITE_PROFILES); SSF56024 (SUPERFAMILY),,
RL4_JR_09722,9202,10236,13502,0,0,5,0,0,0,0,0,6,0,0,0,0,2,0,2.622230785,1,0.50689198,1.27506209,0.397542978,0.6909671,0.832103414,0.830150988,0,3.733975972,1.44609726,2.582105696,0.00981995,0.033197402,2.164635186,1,1.074659132,1.229600905,0.873990193,0.382123595,0.525841956,2.497983777,0,0.651906348,1.241222142,0.525213276,0.599434937,0.721845711,2.144653912,1,0.985690324,1.230808032,0.800848141,0.423219565,0.558537291,N,-,,cdp-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase,C:nucleus; C:mitochondrial membrane; C:cytosol; F:CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity; P:cardiolipin biosynthetic process,no IPS match,,
RL4_JR_09723,9758,8284,9919,0,2,0,0,0,0,0,4,1,0,9,7,0,5,1,125.1396662,1,-0.219326134,0.712310222,-0.307908166,0.758152212,0.87260239,18.71196639,0,-0.760374066,1.200471597,-0.633396132,0.52647499,0.675238197,48.60378018,1,-3.414007417,1.19083761,-2.866895863,0.004145194,0.016732832,101.3482322,1,-0.508101611,0.616986291,-0.823521718,0.410211372,0.554080862,67.25413498,1,-0.575868139,0.68720563,-0.837985188,0.402039023,0.539301153,N,-,,NADH-ubiquinone oxidoreductase subunit,F:electron carrier activity; C:membrane; F:NADH dehydrogenase (ubiquinone) activity; P:oxidation-reduction process,IPR007763 (PFAM); IPR007763 (PANTHER); PTHR12910:SF2 (PANTHER),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_09724,899,1215,848,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,198.423419,0,0.924729218,0.371897124,2.486518875,0.012899973,0.046544881,22.68545343,0,-1.038156507,1.210234784,-0.857814137,0.390995102,0.555382041,446.5934664,0,2.765133441,0.589244585,4.692675186,2.70E-06,6.20E-05,190.4123836,1,0.809170599,0.42874911,1.887282284,0.059122368,0.135709358,153.6496487,1,0.805692341,0.704673435,1.143355632,0.252890966,0.383943774,Y,-,,NAD(P) transhydrogenase,F:NADP binding; P:proton transport; C:integral component of membrane; P:oxidation-reduction process; F:NAD(P)+ transhydrogenase (AB-specific) activity,IPR007886 (SMART); IPR007698 (SMART); IPR029035 (G3DSA:3.40.50.GENE3D); IPR007698 (PFAM); IPR007886 (PFAM); G3DSA:3.40.50.1770 (GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR024605 (PFAM); IPR026255 (TIGRFAM); G3DSA:3.40.50.1770 (GENE3D); IPR012136 (PFAM); PTHR10160:SF19 (PANTHER); PTHR10160 (PANTHER); IPR016040 (SUPERFAMILY); IPR029035 (SUPERFAMILY); SSF52283 (SUPERFAMILY),3.D.2.3.1, the proton-translocating transhydrogenase (pth) family.
RL4_JR_09725,2717,2204,3367,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,340.1077858,0,-4.089901068,0.873411655,-4.68267288,2.83E-06,3.78E-05,124.7607103,0,-2.28606858,1.128211922,-2.026275859,0.042736524,0.104261049,321.0014889,0,-2.060926389,0.593967849,-3.469760853,0.000520922,0.003483365,412.8349617,0,-1.538016054,0.442635223,-3.474680668,0.000511462,0.004265693,311.7865828,0,-2.131781131,0.565465628,-3.76995705,0.000163276,0.001051632,N,-,,fungal specific transcription factor domain-containing,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR007219 (SMART); IPR007219 (PFAM); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31001 (PANTHER); PTHR31001:SF41 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09726,267,371,375,0,0,2,0,0,0,0,0,1,0,1,0,0,0,0,65.06458212,1,-2.267385668,1.136328385,-1.995361287,0.04600349,0.124849126,55.51841281,0,1.810486242,0.877766575,2.062605588,0.039150116,0.097365474,47.34983004,1,-3.376331207,1.254000725,-2.692447573,0.007092969,0.024821713,74.72280727,1,-0.880458641,0.848392183,-1.037796739,0.299364695,0.444568428,47.40672352,0,-3.480799697,1.273761081,-2.73269434,0.00628186,0.02161925,N,-,,tRNA isopentenyltransferase,F:organic cyclic compound binding; F:heterocyclic compound binding; P:tRNA processing; C:intracellular membrane-bounded organelle; C:cytoplasmic part; F:transferase activity,IPR030666 (PIRSF); G3DSA:1.10.287.890 (GENE3D); IPR018022 (TIGRFAM); IPR018022 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR11088:SF25 (PANTHER); PTHR11088 (PANTHER); IPR018022 (HAMAP); IPR027417 (SUPERFAMILY); SSF57667 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_09727,842,468,598,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,304.9365589,0,0.159718236,0.922415938,0.173152077,0.862531892,0.932361888,47.23270753,0,-2.096216245,1.193891935,-1.755783906,0.079125313,0.168835103,258.2261617,0,0.266365131,0.461047068,0.577739563,0.563439964,0.688492478,219.662409,0,-0.533329993,0.621541888,-0.858075704,0.390850662,0.535574903,198.4109292,1,-0.27169661,0.67637142,-0.401697355,0.687906772,0.778740615,N,-,,transport sec61 alpha subunit,C:endoplasmic reticulum membrane; P:protein transport; C:integral component of membrane; C:Golgi apparatus,IPR002208 (PIRSF); IPR019561 (PFAM); IPR002208 (TIGRFAM); IPR002208 (PFAM); IPR023201 (G3DSA:1.10.3370.GENE3D); IPR002208 (PANTHER); IPR023201 (SUPERFAMILY),3.A.5.9.2, the general secretory pathway (sec) family.
RL4_JR_09728,90,47,92,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,520.0786465,0,-1.254527804,0.44938829,-2.791634384,0.005244258,0.022612396,192.9010266,0,-0.51551342,0.727443723,-0.708664332,0.478532804,0.635907712,529.7514131,0,-0.404940882,0.419847057,-0.964496179,0.334797223,0.477998461,522.4210835,0,-1.124036189,0.394185969,-2.851537794,0.004350831,0.02518706,348.1440983,0,-2.390051908,0.568827978,-4.201712994,2.65E-05,0.000227493,N,-,,atp-dependent bile acid permease,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011527 (PFAM); G3DSA:1.20.1560.10 (GENE3D); IPR003439 (PFAM); PTHR24223 (PANTHER); PTHR24223 (PANTHER); PTHR24223:SF79 (PANTHER); PTHR24223:SF79 (PANTHER); PTHR24223:SF79 (PANTHER); PTHR24223 (PANTHER); PTHR24223:SF79 (PANTHER); PTHR24223 (PANTHER); IPR011527 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR011527 (SUPERFAMILY); IPR011527 (SUPERFAMILY),3.A.1.208.12, the atp-binding cassette (abc) superfamily.
RL4_JR_09729,10512,7391,6743,5,12,23,0,0,1,3,7,7,2,7,7,0,0,4,54.39291849,1,-0.02565932,0.676287694,-0.037941427,0.969734383,0.984504494,9.894325557,1,0.158888722,1.212505119,0.131041692,0.895742326,0.941995203,33.56641193,1,-1.534271415,1.190840588,-1.28839362,0.197608979,0.322676338,72.37313133,1,0.79645747,0.545305989,1.46056982,0.144133534,0.258228515,25.41223109,1,-2.581211974,1.197483922,-2.155529546,0.031120419,0.077456795,N,-,,alpha and gamma adaptin binding p34,,no IPS match,,
RL4_JR_09730,8984,11755,14732,0,2,8,0,0,1,0,0,0,0,4,2,0,10,0,15.99099792,1,-0.149747046,1.140305336,-0.131321885,0.89552068,0.94860497,2.549370284,1,2.115363474,1.285518438,1.645533359,0.099859869,0.202318174,6.612543795,0,-0.536352934,1.196319496,-0.448335863,0.653910822,0.760145835,7.628051205,1,-0.958651472,1.193950691,-0.802923839,0.422018757,0.565007512,6.520240702,1,-0.618747077,1.198545632,-0.516248243,0.60568104,0.713951967,N,-, Effector probability:0.578,dimeric alpha-beta barrel doman containing,,IPR009799 (PFAM); G3DSA:3.30.70.900 (GENE3D); IPR011008 (SUPERFAMILY),,
RL4_JR_09731,1094,914,1069,5,10,0,0,0,0,0,0,4,0,2,0,0,0,0,1.129192606,1,1.722503076,1.441068946,1.195295396,0.231971638,NA,19.11991526,0,6.558436412,1.026433125,6.389540881,1.66E-10,3.12E-08,0.936083093,1,2.284856444,1.250283833,1.827470198,0.067629103,0.142849372,1.079562908,1,1.862708883,1.293565363,1.439980488,0.14987292,0.265947456,0.916846197,0,2.211425227,1.222441807,1.809022904,0.070447445,0.145567425,N,-,,alpha beta,F:hydrolase activity,no IPS match,,
RL4_JR_09732,9153,10569,12315,0,5,30,0,0,0,0,1,1,1,9,0,1,6,7,3.957418527,1,-0.086869049,1.281805637,-0.067770843,0.945968054,0.973534425,1.246983829,0,3.14695775,1.410716004,2.230752144,0.025697552,0.069922209,3.261215344,1,0.483428027,1.245203553,0.388232129,0.697844258,0.794121078,3.764165528,1,0.060375144,1.255197684,0.048100108,0.96163646,0.978355082,7.100970443,1,1.316353803,1.177824902,1.117614172,0.263731813,0.396008395,N,-,,maleylacetoacetate isomerase,F:catalytic activity,IPR010987 (G3DSA:1.20.1050.GENE3D); IPR012336 (G3DSA:3.40.30.GENE3D); IPR005955 (TIGRFAM); IPR004045 (PFAM); PTHR11260:SF289 (PANTHER); PTHR11260 (PANTHER); IPR010987 (PROSITE_PROFILES); IPR004045 (PROSITE_PROFILES); IPR010987 (SUPERFAMILY); IPR012336 (SUPERFAMILY),1.A.12.3.1, the intracellular chloride channel (clic) family.
RL4_JR_09733,761,983,1274,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.27182589,0,0.909810534,0.843388529,1.078756116,0.280696463,0.463828589,3.138067498,0,1.81564851,1.268125012,1.431758299,0.152213005,0.279720414,8.133339637,0,-0.834921459,1.192518934,-0.700132665,0.483844458,0.619820485,13.39365907,0,-0.309812365,1.140732923,-0.271590623,0.785936811,0.861586207,8.01181133,0,-0.915944341,1.193409282,-0.767502277,0.44278294,0.576169807,N,-,,palmitoyltransferase akr1,F:zinc ion binding; F:protein-cysteine S-palmitoyltransferase activity; C:endosome; C:bounding membrane of organelle; C:integral component of membrane; C:Golgi apparatus; C:intracellular organelle part,IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR001594 (PFAM); PTHR24161 (PANTHER); PTHR24161 (PANTHER); PTHR24161 (PANTHER); PTHR24161:SF17 (PANTHER); PTHR24161:SF17 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR001594 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),8.A.114.1.1, the huntington-interacting protein 14 (hip14) family.
RL4_JR_09734,479,774,886,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_09735,6302,6857,5295,0,2,2,0,0,0,0,1,0,0,0,0,0,3,0,62.95471295,1,0.402256554,0.592609224,0.678788884,0.497271638,0.684284288,10.20439071,0,0.114359215,1.217103847,0.093960113,0.925140842,0.958737823,84.42921722,1,1.272292826,0.551378432,2.307476594,0.021028266,0.057756419,38.62400807,0,-1.239050808,1.021576199,-1.212881437,0.225175154,0.360743422,56.38980036,1,0.572036799,0.63867948,0.895655515,0.370436776,0.506573792,N,-,,signal recognition particle receptor beta subunit,C:endoplasmic reticulum membrane; F:purine ribonucleoside triphosphate binding; F:purine ribonucleoside binding; C:integral component of membrane; F:purine ribonucleotide binding,IPR027417 (G3DSA:3.40.50.GENE3D); IPR019009 (PFAM); PTHR11485 (PANTHER); IPR027417 (SUPERFAMILY),3.A.5.8.1, the general secretory pathway (sec) family.
RL4_JR_09736,1590,2232,1630,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,164.4010367,1,-1.949616575,0.60916481,-3.200474719,0.001372014,0.007624585,82.71890613,0,0.565978349,0.743388313,0.761349538,0.446448319,0.607549057,185.6007399,0,-0.692478936,0.501769264,-1.380074441,0.167563726,0.28468939,148.4791597,0,-3.371639781,1.007157626,-3.347678352,0.000814915,0.006246039,123.0948251,0,-3.092698444,0.968143967,-3.194461309,0.001400921,0.006298544,N,-,,cystathionine beta-synthase,P:hydrogen sulfide biosynthetic process; C:mitochondrion; P:cysteine biosynthetic process via cystathionine; F:cystathionine beta-synthase activity; P:traversing start control point of mitotic cell cycle; P:cellular amino acid biosynthetic process; P:transsulfuration; P:cysteine biosynthetic process from serine,IPR000644 (SMART); G3DSA:3.40.50.1100 (GENE3D); IPR005857 (TIGRFAM); G3DSA:3.10.580.10 (GENE3D); G3DSA:3.40.50.1100 (GENE3D); IPR001926 (PFAM); IPR000644 (PFAM); PTHR10314:SF8 (PANTHER); PTHR10314 (PANTHER); IPR000644 (PROSITE_PROFILES); IPR000644 (PROSITE_PROFILES); SSF54631 (SUPERFAMILY); IPR001926 (SUPERFAMILY),,
RL4_JR_09737,45581,63770,69466,23,23,58,0,0,2,1,1,3,2,3,3,0,11,3,62.53221324,1,-1.028502273,0.867686811,-1.185338142,0.235883778,0.410044718,12.25198051,1,-0.149412993,1.218638089,-0.122606535,0.90241868,0.944990883,91.77350122,1,0.628206713,0.628285399,0.99987476,0.317371121,0.460060886,202.2106031,1,2.155723763,0.361199542,5.968235032,2.40E-09,7.45E-08,42.92778383,1,-0.687169684,0.85957439,-0.79943015,0.424041034,0.559402667,N,-,,nucleoside-diphosphate-sugar epimerase,,IPR016040 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR14194 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09738,9062,11148,14168,0,0,3,0,0,0,1,0,1,0,6,0,0,0,3,0.514506993,1,2.856330524,1.998835712,1.428997144,0.153005054,NA,0.162356327,0,6.087984905,1.919089835,3.172329296,0.001512214,0.015023052,0.424612452,1,3.423848521,1.310870445,2.611889324,0.00900434,0.030115605,0.490072019,1,3.00135791,1.462375387,2.052385411,0.040132221,0.107667923,0.422280494,1,3.330501306,1.270858029,2.620671412,0.00877568,0.028279364,N,-,,serine threonine kinase,F:nucleotide binding; F:ATP binding; F:protein kinase activity; P:phosphorylation; F:protein serine/threonine kinase activity; P:protein phosphorylation; F:kinase activity,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),,
RL4_JR_09739,318,343,391,0,3,0,0,0,0,0,0,0,0,0,3,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_09740,2023,2624,2826,0,0,1,0,0,0,0,4,1,1,5,0,0,4,1,378.1743346,1,-2.778879597,0.575234982,-4.830859884,1.36E-06,1.99E-05,179.14584,0,-0.335749755,0.682330279,-0.492063396,0.622674527,0.751754719,283.4477467,1,-4.962696469,1.197779467,-4.14324724,3.42E-05,0.000528458,367.8777076,1,-2.625109372,0.557324484,-4.710199257,2.47E-06,4.09E-05,343.5041221,1,-1.65494952,0.88669822,-1.866418003,0.061982906,0.132121458,N,-,,arginyl-tRNA synthetase,F:ATP binding; F:arginine-tRNA ligase activity; C:cytoplasm; P:arginyl-tRNA aminoacylation,IPR001278 (PRINTS); IPR008909 (SMART); IPR005148 (SMART); IPR001278 (PFAM); IPR005148 (G3DSA:3.30.1360.GENE3D); IPR008909 (PFAM); IPR014729 (G3DSA:3.40.50.GENE3D); IPR001278 (TIGRFAM); IPR009080 (G3DSA:1.10.730.GENE3D); IPR001278 (PANTHER); IPR001278 (PANTHER); PTHR11956:SF1 (PANTHER); PTHR11956:SF1 (PANTHER); SSF52374 (SUPERFAMILY); IPR005148 (SUPERFAMILY); IPR009080 (SUPERFAMILY),,
RL4_JR_09741,403,371,641,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.96403857,0,3.29379305,0.75678593,4.352344461,1.35E-05,0.000150934,0.79397498,0,3.798324957,1.44353939,2.631258269,0.008506936,0.029781496,8.562993717,0,2.105122221,1.200487516,1.753556111,0.079506597,0.161924117,2.381757544,0,0.720785585,1.227387148,0.587252022,0.557034458,0.68587789,2.038476595,0,1.058985919,1.215221066,0.871434794,0.383516795,0.519590991,N,-,,ferric-chelate reductase,C:membrane,IPR013130 (PFAM); G3DSA:2.40.30.10 (GENE3D); G3DSA:3.40.50.80 (GENE3D); IPR013121 (PFAM); IPR013112 (PFAM); PTHR11972 (PANTHER); IPR017927 (PROSITE_PROFILES); SSF52343 (SUPERFAMILY); IPR017938 (SUPERFAMILY),5.B.1.5.4, the phagocyte (gp91(phox)) nadph oxidase family.
RL4_JR_09742,1354,1871,1357,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,42.93703064,0,3.517631545,0.628600463,5.59597352,2.19E-08,4.93E-07,1.193610971,0,3.210316765,1.416827421,2.265848838,0.02346064,0.065310396,9.576078616,0,1.529568588,1.216295918,1.257562872,0.208549888,0.335760601,21.20740831,0,2.453247861,0.886726326,2.766634742,0.005663817,0.03088964,10.73128205,1,2.155812372,1.003474807,2.14834728,0.031686178,0.078594451,Y,-,,GPI anchored cell wall,C:membrane,PTHR34992:SF1 (PANTHER); PTHR34992 (PANTHER),,
RL4_JR_09743,69,67,65,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,106.4269017,0,-2.304240666,0.884894273,-2.603972853,0.009215006,0.035544215,29.29870535,0,-1.40722479,1.224113527,-1.149586831,0.250314085,0.404353469,86.51895726,0,-3.086636176,1.207761653,-2.555666649,0.01059846,0.034226095,186.2116056,0,0.098222584,0.479093339,0.205017636,0.837558346,0.898239408,92.40830218,0,-1.894383718,0.859830776,-2.203205293,0.027580282,0.070499965,N,-,,het-s domain containing,,IPR029498 (PFAM); PTHR37542:SF2 (PANTHER); PTHR37542 (PANTHER); PTHR37542 (PANTHER); PTHR37542:SF2 (PANTHER); PTHR37542:SF2 (PANTHER); PTHR37542 (PANTHER),1.C.104.2.2, the heterokaryon incompatibility prion/amyloid protein (het-s) family
RL4_JR_09744,12,12,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.951577961,0,2.378798842,1.104413254,2.153902838,0.031247792,0.093548437,0.731553615,0,3.916475648,1.524113051,2.569675291,0.010179388,0.033982772,1.905717429,0,1.258815851,1.268864037,0.992080959,0.321158034,0.463757515,2.199295468,0,0.835916449,1.294094686,0.645946899,0.518313745,0.652970844,40.00419002,0,3.905225399,0.823503827,4.742206739,2.11E-06,2.71E-05,N,-,,fad binding domain,F:FAD binding; F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process,PR00420 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR002938 (PFAM); PTHR13789 (PANTHER); PTHR13789:SF251 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_09745,7,15,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30.56019158,0,-0.913117971,1.060430918,-0.861081996,0.389192884,0.581934669,7.236999871,0,0.610071487,1.252841032,0.486950436,0.626293456,0.754055235,18.90135246,0,-2.051467209,1.216720223,-1.686063214,0.091783624,0.181645631,43.48463447,0,0.234547311,0.792723054,0.295875476,0.76732518,0.848718314,33.4852525,0,-0.4355709,1.010238404,-0.431156545,0.666354548,0.762785732,N,-,,D-isomer specific 2-hydroxyacid dehydrogenase,F:NAD binding; P:oxidation-reduction process,IPR016040 (G3DSA:3.40.50.GENE3D); IPR006140 (PFAM); PTHR10996 (PANTHER); PTHR10996:SF130 (PANTHER); PTHR10996:SF130 (PANTHER); PTHR10996 (PANTHER); PTHR10996:SF130 (PANTHER); PTHR10996 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09746,19,40,16,0,0,3,0,0,0,0,0,0,0,0,0,0,3,0,17.66179606,1,-2.244796271,1.24277784,-1.806273171,0.07087568,0.172511962,5.671601229,0,0.961829942,1.302559065,0.738415606,0.460261934,0.618867989,14.61634375,0,-1.680423721,1.233539158,-1.362278375,0.173110049,0.292033358,16.85676732,0,-2.102344674,1.236457858,-1.700296262,0.089075213,0.179722188,14.27782867,1,-1.749469304,1.233520273,-1.418273654,0.156110885,0.266367158,N,-,,glycoside hydrolase family 3,P:glucan catabolic process; F:beta-glucosidase activity,IPR001764 (PRINTS); IPR026891 (SMART); IPR001764 (G3DSA:3.20.20.GENE3D); IPR002772 (G3DSA:3.40.50.GENE3D); IPR026891 (PFAM); IPR001764 (PFAM); IPR002772 (PFAM); PTHR30620:SF18 (PANTHER); IPR026892 (PANTHER); SSF56988 (SUPERFAMILY); IPR017853 (SUPERFAMILY); IPR002772 (SUPERFAMILY),,
RL4_JR_09747,10,22,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.56559571,0,-1.633959287,1.229970369,-1.328454187,0.184028109,0.341748534,3.715696529,0,1.571971829,1.310724717,1.199315011,0.23040548,0.380450942,9.578554801,0,-1.070671968,1.224419408,-0.874432373,0.381882834,0.525725022,29.67116312,0,0.273726628,1.049400888,0.260840858,0.794215235,0.867280981,9.364681846,0,-1.140994011,1.221729142,-0.933917325,0.350346541,0.487528688,N,-,,maltose permease,F:transmembrane transporter activity; C:membrane; P:transport,IPR003663 (TIGRFAM); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF87 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.11, the major facilitator superfamily (mfs).
RL4_JR_09748,12,10,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.315555582,0,-0.973124903,1.226319965,-0.793532627,0.427467568,0.618312131,24.66431701,0,3.16287269,1.145463282,2.761217003,0.00575864,0.022610145,6.063724257,0,-0.41101078,1.221506139,-0.336478686,0.736509922,0.82255118,6.992863411,0,-0.832872342,1.222607478,-0.681226278,0.495728323,0.634304217,5.930641069,0,-0.481970934,1.216000351,-0.396357562,0.691841269,0.781558543,N,-,,zn 2cys6 transcription factor,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_09749,17,23,28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26.3446578,0,0.267921315,1.001778062,0.26744578,0.789125955,0.891276415,181.7987122,0,5.755762137,1.697926366,3.389877355,0.000699239,0.015023052,8.554032208,0,-0.907570841,1.191948859,-0.761417601,0.446407678,0.585873908,66.06653862,0,2.221315971,0.565127148,3.930648136,8.47E-05,0.000925309,16.13622586,0,0.684250812,0.969138472,0.706040294,0.48016308,0.609305825,N,-,,xylitol dehydrogenase,F:zinc ion binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR020843 (SMART); IPR013154 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); IPR013149 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002085 (PANTHER); PTHR11695:SF521 (PANTHER); PTHR11695:SF521 (PANTHER); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY),,
RL4_JR_09750,13463,14803,20402,1,2,5,0,0,0,0,0,2,1,2,1,0,0,2,11.91040188,1,5.324152988,0.891640142,5.971190324,2.36E-09,6.04E-08,0.145893576,0,6.242742025,1.955358323,3.192633264,0.001409819,0.015023052,0.376667396,1,3.598559325,1.29911888,2.770000021,0.005605629,0.020659406,9.746692425,1,4.129868384,1.166414061,3.540653806,0.000399137,0.003459984,22.46550354,1,5.764412126,0.863625075,6.674669707,2.48E-11,2.00E-09,Y,-,,FAD dependent oxidoreductase,F:oxidoreductase activity; F:isomerase activity,IPR023753 (G3DSA:3.50.50.GENE3D); IPR003953 (PFAM); PTHR10742 (PANTHER); PTHR10742 (PANTHER); PTHR10742:SF282 (PANTHER); SSF51971 (SUPERFAMILY),,
RL4_JR_09751,28,11,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.004235441,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001340044,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003452355,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003983613,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003339785,0,10.24113992,1.835951848,5.578109216,2.43E-08,8.07E-07,N,-,,methyltransferase type 12,F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108:SF852 (PANTHER); PTHR10108:SF852 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_09752,76,64,74,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.62788218,0,0.454231916,0.901210901,0.504023992,0.614244517,0.778832262,4.164900797,0,1.407145742,1.270745509,1.107338749,0.268147497,0.425680372,10.8754888,0,-1.254136006,1.213816244,-1.033217352,0.301502194,0.442698798,22.18629797,0,-0.724950808,1.164625916,-0.62247525,0.533629413,0.666418761,10.79637952,0,-1.346222075,1.225694581,-1.098334036,0.272058655,0.404611322,N,-,,Aminoglycoside phosphotransferase,F:transferase activity,no IPS match,,
RL4_JR_09753,4161,5591,5261,3,6,13,0,0,3,3,0,2,0,2,0,0,5,0,0.027290181,1,7.091350195,3.945632481,1.797265769,0.072293438,NA,0.009012214,1,10.25971965,3.9444458,2.601054791,0.009293761,0.031888626,0.022996744,1,7.629964171,2.64422221,2.885523063,0.003907638,0.016192218,0.026493032,1,7.210264675,3.945038372,1.827679225,0.067597708,0.147505774,0.022405406,1,7.555360148,1.62483867,4.649914042,3.32E-06,4.02E-05,N,-,,luciferase-like monooxygenase,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity",IPR011251 (PFAM); IPR011251 (G3DSA:3.20.20.GENE3D); PTHR30011 (PANTHER); PTHR30011:SF21 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_09754,42,52,27,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0.027923072,1,7.059740123,3.944794241,1.789634565,0.073512678,NA,0.008853032,0,10.28426816,3.352162312,3.067950536,0.002155323,0.015045494,0.023080771,0,7.624423634,1.916489159,3.978328601,6.94E-05,0.000910129,0.026633728,0,7.202981497,3.888516563,1.85237259,0.063972338,0.142168553,0.022880937,0,7.537421664,1.41260086,5.335846719,9.51E-08,2.14E-06,N,-,,major facilitator superfamily transporter,,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF6 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.37, the major facilitator superfamily (mfs).
RL4_JR_09755,202,181,217,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,11.68304112,0,-1.64877373,1.215906473,-1.356003744,0.175097977,0.329972117,3.701697929,0,1.577234779,1.275172529,1.236879515,0.216131816,0.362920925,9.657243236,0,-1.082782728,1.21200927,-0.893378256,0.371654643,0.515994461,11.14416988,1,-1.505547331,1.212402804,-1.241788063,0.214314768,0.348814049,25.02444376,0,1.401958712,0.808653351,1.733695546,0.082972117,0.166059041,N,-,,mitochondrial carrier,,IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); IPR023395 (SUPERFAMILY),2.A.29.20.1, the mitochondrial carrier (mc) family.
RL4_JR_09756,900,1072,1035,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.729272989,0,2.35303166,1.681084826,1.399710249,0.161600103,NA,0.231673542,0,5.575189987,1.775832059,3.139480425,0.001692477,0.015023052,0.603346747,0,2.917173862,1.267141101,2.30216971,0.021325603,0.058462066,0.696167701,0,2.494935256,1.35105422,1.846658128,0.064796704,0.143371204,0.597593703,0,2.829090191,1.240500049,2.280604659,0.022571851,0.06013802,N,-,,kinase-like domain,,no IPS match,,
RL4_JR_09757,155,144,179,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0.42171514,0,3.143376319,2.133646849,1.473241141,0.140686025,NA,0.134345666,0,6.361527088,1.970583149,3.228245958,0.001245518,0.015023052,6.847350375,0,4.672116466,1.210936833,3.858266047,0.000114194,0.001252549,0.40219557,0,3.286973842,1.470452273,2.235348881,0.025394453,0.085851084,0.343482278,1,3.628737321,1.236826741,2.933909172,0.003347221,0.01293535,N,-,,methyltransferase type 12,F:methyltransferase activity; F:transferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_09758,1207,936,1431,0,2,0,0,0,0,2,0,0,0,0,0,0,2,3,1.410727736,1,1.401505015,1.417062499,0.989021314,0.322652714,NA,0.450298822,0,4.616695933,1.612687548,2.862734284,0.004200026,0.018413607,1.165310719,1,1.968869952,1.26191339,1.560225898,0.118706508,0.219986213,1.344274217,0,1.546396154,1.300069032,1.18947234,0.234253849,0.371525724,1.143442372,1,1.893243561,1.241922014,1.524446414,0.127397233,0.228867457,Y,-,,carbohydrate esterase family 3,C:membrane; P:lipid metabolic process; C:integral component of membrane; F:phosphoric diester hydrolase activity; F:hydrolase activity,IPR013830 (G3DSA:3.40.50.GENE3D); PF13517 (PFAM); G3DSA:2.130.10.130 (GENE3D); IPR013830 (PFAM); PTHR30383:SF4 (PANTHER); PTHR30383 (PANTHER); PTHR30383 (PANTHER); IPR013830 (SUPERFAMILY); SSF69318 (SUPERFAMILY),,
RL4_JR_09759,91,65,65,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.07755022,0,-1.061047032,1.186264369,-0.894443987,0.371084386,0.563312337,4.826024314,0,1.194646038,1.300044501,0.918927035,0.358133738,0.522263319,12.51803851,0,-1.457042377,1.231491132,-1.183152959,0.236748532,0.369256223,37.07523763,0,0.458876272,0.90514052,0.506966888,0.612178052,0.731881192,27.8058953,0,1.014293653,0.843748601,1.202127804,0.229314016,0.356871258,N,-,,phosphotransferase enzyme family,P:phosphorylation; F:transferase activity; F:kinase activity,G3DSA:3.90.1200.10 (GENE3D); IPR002575 (PFAM); PTHR21310 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_09760,83,107,109,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46.63965052,0,-3.645835763,1.267202295,-2.87707478,0.004013805,0.018090949,14.64009647,0,-0.406395588,1.265704191,-0.321082596,0.748147799,0.845834024,38.45856342,0,-3.076284802,1.24478671,-2.471334871,0.01346097,0.040814275,76.34597346,0,-0.707387568,0.846567108,-0.835595385,0.403382566,0.546826681,65.47360925,0,0.078124418,0.796896967,0.098035783,0.921903879,0.94986026,N,-,,3 -5 exoribonuclease csl4,"C:cytoplasmic exosome (RNase complex); P:nuclear-transcribed mRNA catabolic process, non-stop decay; C:nuclear exosome (RNase complex); F:RNA binding; P:nuclear polyadenylation-dependent rRNA catabolic process; C:cytosol; P:nuclear polyadenylation-dependent tRNA catabolic process; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:pathogenesis; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'",IPR025721 (PFAM); G3DSA:2.40.50.140 (GENE3D); IPR019495 (PFAM); PTHR12686 (PANTHER); PTHR12686:SF8 (PANTHER); SSF110324 (SUPERFAMILY); IPR012340 (SUPERFAMILY),,
RL4_JR_09761,71,105,85,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.345975315,0,-0.22194366,1.214706403,-0.18271383,0.855022563,0.92758379,1.381698356,0,2.999041918,1.351094254,2.219713324,0.026438234,0.071572025,25.77701688,0,2.750650721,0.855235416,3.216249784,0.001298777,0.007073062,4.144833659,0,-0.078560721,1.207347122,-0.065068877,0.948119161,0.96976528,3.548378756,0,0.259202474,1.208650535,0.214456095,0.830191402,0.885461702,N,-,,ribosomal l32,C:ribosome,IPR009449 (PFAM); PTHR14430:SF4 (PANTHER); PTHR14430 (PANTHER); PTHR14430 (PANTHER); SSF144284 (SUPERFAMILY),,
RL4_JR_09762,0,4,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.704548407,0,2.402897484,1.680621616,1.429767094,0.152783876,NA,0.224375214,0,5.621495009,1.77706011,3.163367957,0.001559551,0.015023052,0.582793406,0,2.967778164,1.25528947,2.364218163,0.018068169,0.051789962,20.73031648,0,5.573234694,0.688281959,8.097313348,5.62E-16,3.77E-14,0.575155905,0,2.884555027,1.224526808,2.355648736,0.018490393,0.051362203,N,-,,---NA---,,no IPS match,,
RL4_JR_09763,6842,6169,3872,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,51.12280335,1,-3.778228201,1.250395532,-3.021626442,0.002514206,0.012567949,16.07249544,0,-0.541048596,1.247510072,-0.433702788,0.664504282,0.785118751,42.10851585,0,-3.207074839,1.231318751,-2.604585397,0.009198549,0.030616845,82.31207084,0,-0.177144656,0.696703413,-0.254261214,0.799293762,0.870960377,57.3670243,0,-0.758321233,0.863406869,-0.878289553,0.379786604,0.515599271,N,-,,trna pseudouridine synthase b,P:pseudouridine synthesis; F:RNA binding; C:intracellular membrane-bounded organelle; P:RNA processing; F:pseudouridine synthase activity,IPR002501 (PFAM); IPR032819 (PFAM); IPR014780 (PANTHER); PTHR13767:SF2 (PANTHER); IPR014780 (HAMAP); IPR020103 (SUPERFAMILY),,
RL4_JR_09764,750,1122,690,0,0,1,0,0,0,0,0,0,0,3,0,0,0,0,65.60221172,1,-0.265295831,0.668611394,-0.396786285,0.691525066,0.832196708,13.53814508,0,-0.293474433,1.21296308,-0.241948365,0.808820174,0.883777832,41.75606761,0,-1.989091699,1.198282424,-1.659952328,0.096924043,0.189615268,52.71871318,1,-1.079639664,0.872555057,-1.237331279,0.21596412,0.35075982,34.8845031,0,-3.03827728,1.206123614,-2.519043027,0.011767428,0.035833144,N,-,,defective in methylation-7,,no IPS match,,
RL4_JR_09765,2084,2627,1359,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,133.6003678,1,0.599925916,0.591436688,1.01435357,0.310414071,0.498397557,19.14802135,0,-0.793634801,1.202088279,-0.66021341,0.509116888,0.661016052,49.83034602,0,-3.449984739,1.194688319,-2.887769708,0.003879838,0.016117965,106.9250322,1,0.252190412,0.512590286,0.491992179,0.622724873,0.739947111,49.27225403,0,-3.536473246,1.200810637,-2.945071552,0.0032288,0.012548256,N,-,,xpg i-region,P:DNA repair; P:nucleic acid phosphodiester bond hydrolysis; F:nuclease activity,IPR022039 (PFAM); IPR029060 (G3DSA:3.40.50.GENE3D); IPR022040 (PFAM); IPR006084 (PANTHER); PTHR11081:SF32 (PANTHER); IPR029060 (SUPERFAMILY),,
RL4_JR_09766,1,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,127.0635965,0,-0.338143014,0.529930502,-0.638089358,0.523415513,0.707239648,29.60842351,0,0.044162887,1.115705485,0.039582926,0.96842564,0.983587184,52.34884666,0,-3.521092189,1.1884719,-2.962705462,0.003049482,0.013727415,60.38053965,0,-3.94318779,1.187475429,-3.320647899,0.000898088,0.006735657,59.19519699,0,-1.927641692,0.966249017,-1.994974027,0.046045713,0.105233074,N,-,,ATP-dependent RNA helicase ded1,F:translation initiation factor activity; F:ATP binding; P:cytoplasmic translational initiation; C:cytosol; F:helicase activity,IPR001650 (SMART); IPR014001 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011545 (PFAM); IPR001650 (PFAM); PTHR24031:SF243 (PANTHER); PTHR24031 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_09767,1480,2476,1338,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,194.2491204,1,2.665137887,0.46479437,5.734014992,9.81E-09,2.31E-07,8.912387531,0,0.309709886,1.214431227,0.25502464,0.798704068,0.877976962,29.62728752,0,-1.380819481,1.187452174,-1.162842185,0.244893538,0.379040235,44.01786912,0,-0.451304741,0.84593104,-0.533500628,0.593687076,0.716609653,22.80135544,0,-2.424801509,1.191209485,-2.035579417,0.041792606,0.097387834,N,-, Effector probability:0.724,proteasome subunit beta type-2,"C:nuclear envelope; C:endoplasmic reticulum membrane; F:endopeptidase activator activity; P:proteasome-mediated ubiquitin-dependent protein catabolic process; C:cytosol; F:threonine-type endopeptidase activity; C:proteasome core complex, beta-subunit complex; P:proteasomal ubiquitin-independent protein catabolic process; P:positive regulation of endopeptidase activity",IPR029055 (G3DSA:3.60.20.GENE3D); IPR001353 (PFAM); PTHR11599 (PANTHER); PTHR11599:SF6 (PANTHER); IPR023333 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY),,
RL4_JR_09768,15,7,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,217.5420553,0,-2.481440632,0.707353793,-3.508061531,0.000451385,0.00309445,61.86345545,0,-2.485495172,1.203767728,-2.064763089,0.038945422,0.096951687,160.6885646,0,-5.139129679,1.204152643,-4.267839055,1.97E-05,0.000335274,193.4241525,0,-3.844509946,1.036497663,-3.709135181,0.000207968,0.00198649,158.4063418,0,-5.221263874,1.210362022,-4.313803456,1.60E-05,0.000149334,N,-,,WD repeat domain-containing,C:nucleus; C:intracellular ribonucleoprotein complex,IPR020472 (PRINTS); IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); PTHR19865:SF0 (PANTHER); PTHR19865 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),8.A.92.1.4,The G-Protein αβγ Complex (GPC) Family
RL4_JR_09769,1021,898,1405,0,1,4,0,0,0,0,1,0,0,1,3,0,0,1,195.4766717,1,-0.596178978,0.427953924,-1.393091512,0.163592119,0.314374876,38.52776333,0,-1.80231341,1.19035438,-1.514098188,0.130000938,0.247250939,151.9729129,1,-0.835029656,1.252952126,-0.66644977,0.50512366,0.637083833,195.609657,1,-0.558435506,0.440078374,-1.268945577,0.204460475,0.336126996,109.8327014,1,-2.860251342,0.971089081,-2.945405727,0.003225314,0.012541838,N,-,,ser thr phosphatase family,P:metabolic process; C:integral component of membrane; F:hydrolase activity,IPR004843 (PFAM); IPR003653 (PFAM); G3DSA:3.30.310.130 (GENE3D); IPR029052 (G3DSA:3.60.21.GENE3D); PTHR10340:SF27 (PANTHER); PTHR10340 (PANTHER); IPR003653 (PROSITE_PROFILES); IPR029052 (SUPERFAMILY); SSF54001 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_09770,1226,1225,1334,1,2,20,0,0,0,0,5,1,2,1,7,0,0,0,148.5117139,1,-0.572152822,0.612116509,-0.934712286,0.349936594,0.540064837,27.5041672,0,-1.316035796,1.243145204,-1.058634013,0.28976649,0.449160248,83.64882202,1,-2.143159888,1.072683034,-1.997943306,0.045722807,0.105660282,138.762257,1,-0.47985778,0.602845254,-0.795988318,0.426038825,0.568632099,124.3287784,0,-0.297477742,0.676677646,-0.439615145,0.660215869,0.75772905,N,-,,Chromo domain partial,P:histone deacetylation; C:HDA1 complex,G3DSA:2.40.50.40 (GENE3D); IPR016197 (SUPERFAMILY),,
RL4_JR_09771,7999,8108,4770,0,3,8,0,0,0,0,0,2,0,4,0,0,0,0,909.6267652,1,-0.12622315,0.333517751,-0.378460066,0.705088854,0.840460969,194.4833254,0,-0.845356011,0.701281518,-1.205444589,0.228031717,0.377702019,664.2130345,1,-0.400104029,0.368620094,-1.085410251,0.277739994,0.416789607,663.1406311,1,-1.034404503,0.339540891,-3.046479913,0.002315379,0.014894039,557.2208756,0,-0.881511214,0.512174166,-1.721116121,0.085229755,0.169438693,N,-,,cytochrome c oxidase subunit Va,"F:cytochrome-c oxidase activity; P:mitochondrial electron transport, cytochrome c to oxygen; P:hydrogen ion transmembrane transport; C:mitochondrial respiratory chain complex IV",IPR003204 (G3DSA:1.25.40.GENE3D); IPR003204 (PFAM); IPR003204 (PANTHER); IPR003204 (SUPERFAMILY),3.D.4.8.1, the proton-translocating cytochrome oxidase (cox) superfamily.
RL4_JR_09772,4692,4875,5810,4,0,12,0,0,0,0,0,2,0,2,0,0,7,2,354.5843433,1,0.349191644,0.435225589,0.802323329,0.422365951,0.6143094,62.56644313,0,-1.350655819,1.118232974,-1.20784832,0.227105611,0.376908181,249.6373334,1,-0.196752977,0.464526242,-0.423556214,0.671889494,0.77421002,406.0708509,1,0.759981767,0.582610705,1.304441817,0.192082985,0.321142705,328.0606193,1,0.611108658,0.671848612,0.909592797,0.363037299,0.499771099,N,-,,fatty acid elongase,C:integral component of membrane; C:endoplasmic reticulum; P:fatty acid elongation; P:post-Golgi vesicle-mediated transport; F:fatty acid elongase activity; P:sphingolipid biosynthetic process,IPR002076 (PFAM); PTHR11157:SF13 (PANTHER); IPR002076 (PANTHER),,
RL4_JR_09773,445,465,449,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4.625691616,1,-0.311825587,1.312294173,-0.237618663,0.812176874,0.904593187,1.4607277,0,2.918831952,1.434808143,2.034301218,0.041921235,0.102867087,23.30211496,0,2.639950423,0.936051892,2.820303495,0.004797825,0.018378047,13.70463912,0,0.795103869,1.20853645,0.657906403,0.510598276,0.64566099,3.759474953,0,0.175848545,1.273469264,0.138086211,0.890172284,0.928122168,N,-,,endonuclease exonuclease phosphatase family,,no IPS match,,
RL4_JR_09774,10951,16862,14889,0,3,18,3,0,0,2,0,6,2,18,0,0,11,8,102.7329669,1,-3.714146528,1.177778078,-3.153519833,0.001613143,0.008726802,29.94541179,1,-1.438768866,1.213131774,-1.185995534,0.235624063,0.38608066,106.7692223,1,-1.679118441,0.875601336,-1.9176746,0.055152284,0.121833237,128.849899,1,-1.012236593,0.628076476,-1.611645446,0.107039115,0.206353969,85.15504729,1,-2.532989786,1.013510966,-2.49922287,0.012446601,0.037473039,N,-,,hypothetical protein CMQ_2894,,no IPS match,,
RL4_JR_09775,17,5,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.01618246,0,-1.689202073,1.222818619,-1.381400354,0.167155897,0.318915354,3.799330877,0,1.539714779,1.279365658,1.2034986,0.228783433,0.378605545,9.911676918,0,-1.120190402,1.215370412,-0.921686418,0.356692167,0.50018377,21.0738961,0,-0.590861977,1.16572092,-0.506864008,0.612250241,0.731881192,21.40361622,0,0.969125701,0.896291734,1.081261451,0.27958083,0.413249037,N,-,,f-box domain-containing,C:cellular_component,IPR001810 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR24006:SF471 (PANTHER); PTHR24006:SF471 (PANTHER); PTHR24006 (PANTHER); PTHR24006:SF471 (PANTHER); PTHR24006 (PANTHER); PTHR24006 (PANTHER); SSF52047 (SUPERFAMILY); IPR001810 (SUPERFAMILY),,
RL4_JR_09776,32,25,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.40132052,0,1.548881445,1.012097887,1.530367235,0.125925854,0.261200895,1.369019517,0,3.012458376,1.365419335,2.206251442,0.027366399,0.073530836,3.538480246,0,0.366104501,1.208660804,0.302900946,0.76196535,0.839862516,4.081238928,0,-0.055959194,1.209313594,-0.046273518,0.963092247,0.978772417,3.472753289,0,0.29014434,1.200776925,0.241630509,0.80906648,0.870911982,N,-, Effector probability:0.56,cytidine deaminase,P:cytidine catabolic process; F:hydrolase activity,IPR002125 (PFAM); IPR006262 (TIGRFAM); G3DSA:3.40.140.10 (GENE3D); PTHR11644 (PANTHER); IPR002125 (PROSITE_PROFILES); IPR016193 (SUPERFAMILY),,
RL4_JR_09777,341,723,363,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37.75762377,0,0.078665898,0.81254962,0.096813655,0.92287438,0.962640224,7.198228644,0,0.617932041,1.265857167,0.488153053,0.625441435,0.753656929,31.59241769,0,-0.214669913,1.061578176,-0.202217715,0.839746525,0.896414363,45.5175556,0,0.784975597,0.696750251,1.126624061,0.259901462,0.400106781,32.94698461,0,-0.401423338,0.995631933,-0.403184474,0.68681252,0.778023805,N,-,,ncs1 nucleoside transporter family,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR001248 (PFAM); PTHR30618 (PANTHER); PTHR30618:SF11 (PANTHER),2.A.39.4.1, the nucleobase:cation symporter-1 (ncs1) family.
RL4_JR_09778,9556,7363,7616,2,1,10,0,0,0,2,0,5,7,2,0,0,4,3,8.451036629,1,-1.181226467,1.20017027,-0.984215738,0.325009449,0.514258666,2.704250268,0,2.030355222,1.292559021,1.570802717,0.116228481,0.227820427,6.996011637,1,-0.617363423,1.201389624,-0.513874442,0.607339777,0.723973614,8.06969992,1,-1.039505477,1.199743195,-0.866439986,0.386248924,0.531426873,6.870785309,1,-0.694198205,1.198079857,-0.579425655,0.562301998,0.679879117,N,-,,hydantoinase,F:hydrolase activity,IPR010318 (PFAM); IPR027479 (G3DSA:3.40.1610.GENE3D); IPR024071 (G3DSA:2.40.390.GENE3D); IPR008040 (PFAM); PTHR40138 (PANTHER); PTHR40138 (PANTHER); PTHR40138:SF1 (PANTHER); SSF160991 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_09779,210959,85257,86430,7,21,16,0,0,5,4,32,58,11,18,19,2,30,23,21.83880333,1,-1.327729423,1.162560301,-1.142073595,0.25342343,0.43102666,5.780861216,1,0.934221784,1.26462668,0.738733256,0.460068988,0.618846285,14.96777233,1,-1.714871259,1.211394296,-1.415617742,0.156887454,0.271092095,26.5757936,1,-1.185013701,1.163053226,-1.018881745,0.308259111,0.453915576,14.74581523,1,-1.796072273,1.215851635,-1.477213355,0.139618455,0.245465681,N,-,,basic proline-rich,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_09780,9553,2793,5207,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,115.2459763,0,-0.168339665,1.046052934,-0.160928438,0.872149764,0.938943648,18.8248381,0,-0.76908935,1.212287508,-0.634411676,0.525812192,0.674538485,82.20457139,0,-0.997104504,0.864986426,-1.152740059,0.249017094,0.383546182,64.55217078,1,-2.130092614,1.034511884,-2.059031555,0.039491216,0.106627584,82.89848497,0,0.049968746,0.608256183,0.082150823,0.934526779,0.957216352,N,-,,serine threonine- phosphatase 2A activator 2,F:phosphatase regulator activity; P:regulation of catalytic activity; C:intracellular part,IPR004327 (PFAM); PTHR10012:SF0 (PANTHER); IPR004327 (PANTHER); IPR004327 (PANTHER); IPR004327 (PANTHER); PTHR10012:SF0 (PANTHER); SSF140984 (SUPERFAMILY); SSF140984 (SUPERFAMILY),,
RL4_JR_09781,470,627,585,0,0,1,0,0,0,0,0,0,0,2,0,0,5,3,81.93264816,1,-1.305436941,0.772770454,-1.689294581,0.091162991,0.206815262,19.16331028,0,-0.794805058,1.207015404,-0.658487916,0.51022466,0.661520943,49.93838467,0,-3.453126198,1.199729033,-2.878255092,0.003998816,0.01637703,57.62440345,1,-3.875821053,1.201070855,-3.226971195,0.001251081,0.008958409,68.78132716,1,-0.64360156,0.721603548,-0.89190465,0.372444042,0.508718409,N,-,,exosome complex component RRP46,"C:cytoplasmic exosome (RNase complex); C:nuclear exosome (RNase complex); P:polyadenylation-dependent snoRNA 3'-end processing; P:U4 snRNA 3'-end processing; P:rRNA catabolic process; P:nuclear mRNA surveillance; C:nucleolus; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:rRNA 3'-end processing",IPR001247 (PFAM); PTHR11953:SF1 (PANTHER); PTHR11953 (PANTHER); PTHR11953:SF1 (PANTHER); PTHR11953 (PANTHER); IPR015847 (SUPERFAMILY); IPR020568 (SUPERFAMILY),,
RL4_JR_09782,873,680,910,0,0,0,0,3,0,0,0,0,0,2,1,0,2,0,30.47070936,0,-0.205160835,1.020893284,-0.200962077,0.840728227,0.919624667,4.625940562,1,1.255750265,1.264521729,0.993063414,0.320679052,0.48273548,37.98607498,0,1.413651772,0.765481424,1.846748633,0.06478358,0.138341077,13.83152411,1,-1.8171764,1.204991863,-1.508040391,0.13154419,0.240928063,11.82454163,1,-1.477552733,1.210144944,-1.220971702,0.222096734,0.348694283,N,-,,---NA---,,no IPS match,,
RL4_JR_09783,903,725,1194,5,0,1,0,0,0,0,0,1,0,0,0,0,0,1,446.7410842,1,0.73833292,0.626761335,1.178012872,0.238791475,0.413250074,64.88741037,0,-1.412451226,1.120393432,-1.260674317,0.207426211,0.352686826,149.9652143,1,-4.013788827,1.198157386,-3.349967936,0.000808209,0.004858854,198.841587,0,-1.892871859,0.600722218,-3.150993592,0.001627161,0.011154368,144.8341758,1,-4.123413224,1.129719392,-3.649944627,0.000262297,0.001571453,N,-,,atp-nad kinase,F:NAD+ kinase activity; P:NAD metabolic process; P:phosphorylation; P:NADP biosynthetic process,IPR017438 (G3DSA:3.40.50.GENE3D); IPR017437 (G3DSA:2.60.200.GENE3D); IPR002504 (PFAM); PTHR20275:SF0 (PANTHER); IPR002504 (PANTHER); IPR016064 (SUPERFAMILY),,
RL4_JR_09784,9957,9644,12176,0,0,1,0,0,0,0,0,0,0,3,2,0,2,0,64.66930717,1,2.10037093,0.777241546,2.702340013,0.006885331,0.028226398,4.7984422,0,1.202915286,1.253734972,0.959465368,0.337324358,0.500351283,12.45703616,0,-1.45002389,1.201125761,-1.207220707,0.227347158,0.358235428,92.24009274,1,2.334897153,0.50021232,4.667812164,3.04E-06,4.93E-05,16.16120302,1,-0.605331232,1.136579828,-0.53259016,0.594317315,0.705612432,N,-,,homeobox domain-containing,"F:DNA binding; C:nucleus; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR001356 (SMART); IPR009057 (G3DSA:1.10.10.GENE3D); IPR001356 (PFAM); IPR001356 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_09785,6954,5390,4389,1,4,4,0,0,2,0,2,4,2,11,0,0,1,4,1041.45969,1,-0.042947552,0.435257486,-0.098671599,0.921399019,0.961964073,199.9286368,1,-1.774596207,0.852086017,-2.082649137,0.037283217,0.093875801,568.8074464,1,-1.693378581,0.492119951,-3.440987461,0.000579595,0.003771709,696.0112214,1,-1.422802029,0.331950263,-4.286190394,1.82E-05,0.000239942,622.60514,1,-1.049964238,0.544829185,-1.927143895,0.0539617,0.118696982,N,-, Effector probability:0.839,GTP-binding nuclear GSP1 Ran,F:GTP binding; C:nucleus; P:small GTPase mediated signal transduction; F:GTPase activity; C:cytosol; P:intracellular protein transport; P:negative regulation of G2/M transition of mitotic cell cycle; P:poly(A)+ mRNA export from nucleus,IPR002041 (PRINTS); SM00175 (SMART); SM00174 (SMART); SM00173 (SMART); SM00176 (SMART); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); PTHR24071 (PANTHER); IPR002041 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.50.1.1, the nuclear t-rna exporter (t-exporter) family.
RL4_JR_09786,5,0,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42.93941791,0,0.991388651,0.679211364,1.459617291,0.144395284,0.288932237,4.913533194,0,1.168722843,1.242141808,0.94089325,0.346759567,0.509591976,12.78069131,0,-1.486960352,1.196287646,-1.242978941,0.213875594,0.34244449,28.07047075,0,-0.175048462,1.018083376,-0.171939221,0.863485312,0.915373674,19.99640414,0,-0.636602117,1.130857014,-0.562937762,0.573477265,0.688703275,N,-, Effector probability:0.674,26S proteasome non-ATPase regulatory subunit 9,,IPR001478 (G3DSA:2.30.42.GENE3D); IPR001478 (PFAM); PTHR12651:SF1 (PANTHER); PTHR12651 (PANTHER); IPR001478 (SUPERFAMILY),,
RL4_JR_09787,3,8,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.949183076,0,1.97282586,1.598348209,1.234290406,0.21709471,NA,0.308218638,0,5.163678389,1.752529117,2.946415177,0.003214806,0.016157033,0.791105681,0,2.527253232,1.298700709,1.945985872,0.051656437,0.116067303,0.911973167,0,2.105843489,1.372456351,1.534360993,0.124940868,0.231520185,0.771847711,0,2.459089141,1.262727247,1.947442843,0.051481666,0.114636434,N,-,,Round spore,P:regulation of Rho protein signal transduction; F:Rho guanyl-nucleotide exchange factor activity; P:positive regulation of GTPase activity,IPR000219 (PFAM); IPR000219 (G3DSA:1.20.900.GENE3D); PTHR22826 (PANTHER); PTHR22826 (PANTHER); PTHR22826:SF98 (PANTHER); PTHR22826:SF98 (PANTHER); IPR000219 (PROSITE_PROFILES); IPR000219 (SUPERFAMILY),,
RL4_JR_09788,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,111.2444026,0,1.741602693,0.751502661,2.317493713,0.020476853,0.066873565,7.320325987,0,0.593647072,1.230381845,0.48249011,0.629457823,0.756515326,137.4632673,0,2.75366022,0.409967381,6.716778814,1.86E-11,1.23E-09,100.7121192,0,1.601890662,0.495357709,3.233805862,0.001221525,0.008771586,64.26748655,0,1.787619246,0.500312265,3.57300704,0.000352905,0.002007397,N,-, Effector probability:0.87,shwachman-bodian-diamond syndrome,,IPR019783 (G3DSA:3.30.1250.GENE3D); IPR019783 (PFAM); PTHR10927 (PANTHER); PTHR10927:SF2 (PANTHER); IPR019783 (SUPERFAMILY),,
RL4_JR_09789,53,95,111,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,40.05910609,0,3.879631052,0.574085382,6.757933875,1.40E-11,5.73E-10,1.050167754,0,3.395009295,1.418800297,2.392873263,0.016717014,0.050180789,2.708402979,0,0.751800478,1.221452831,0.615496939,0.53822659,0.66671064,16.44721642,0,2.065112769,1.029493074,2.005951104,0.044861465,0.11505125,28.96523514,0,3.62162026,0.685039627,5.286731041,1.25E-07,2.73E-06,N,-,,PRO41,C:integral component of membrane,PTHR40629 (PANTHER),,
RL4_JR_09790,702,468,466,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.46683634,0,2.996607028,2.031227223,1.475269233,0.140140175,NA,0.149676443,0,6.205624576,1.93272654,3.210813556,0.001323598,0.015023052,0.387341298,0,3.557088045,1.285367031,2.767371466,0.005651032,0.02078353,0.446757957,0,3.135141558,1.438671414,2.179192224,0.029317391,0.091053282,0.38108875,0,3.477358746,1.233417566,2.819287516,0.004813039,0.017367076,N,-,,hypothetical protein SPI_03108,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_09791,369,471,528,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,36.69281914,0,0.137292567,0.839761726,0.163489908,0.870132718,0.937472625,5.384599009,0,1.0366963,1.234730973,0.8396131,0.401125352,0.564699695,20.45528193,0,-0.652074744,1.186954848,-0.549367775,0.582753084,0.704200552,24.1228657,1,-0.306510285,1.008377446,-0.303963844,0.761155437,0.844107207,29.18612746,0,0.920989792,0.741874038,1.241436882,0.214444402,0.339204744,N,-,,opa3 domain containing,C:mitochondrion; C:membrane; P:regulation of lipid metabolic process,IPR010754 (PFAM); PTHR12499:SF0 (PANTHER); IPR010754 (PANTHER); PTHR12499:SF0 (PANTHER); IPR010754 (PANTHER),,
RL4_JR_09792,249,421,374,0,0,0,0,0,0,0,0,1,0,3,0,0,0,0,57.99054931,0,2.34113073,0.722185458,3.241730644,0.001188063,0.006768306,3.90979515,0,1.498500134,1.277853678,1.172669578,0.240928336,0.392764795,10.08965998,1,-1.145689329,1.204333457,-0.951305739,0.341449194,0.484761134,23.67090524,1,0.726062568,0.873394622,0.831311013,0.405797955,0.54951241,9.885822881,0,-1.219170654,1.199806833,-1.016139115,0.309563145,0.445280131,N,-,,serine threonine kinase,F:nucleotide binding; P:biological regulation; C:intracellular organelle; P:cellular macromolecule metabolic process; P:single-organism organelle organization; F:protein kinase activity; P:phosphorylation; P:primary metabolic process; P:meiotic nuclear division,IPR000719 (SMART); IPR000959 (G3DSA:3.30.1120.GENE3D); IPR000959 (G3DSA:3.30.1120.GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); PTHR24345:SF0 (PANTHER); PTHR24345 (PANTHER); PTHR24345:SF0 (PANTHER); PTHR24345 (PANTHER); PTHR24345 (PANTHER); PTHR24345:SF0 (PANTHER); IPR000719 (PROSITE_PROFILES); SSF82615 (SUPERFAMILY); SSF82615 (SUPERFAMILY); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_09793,605,1009,1165,0,0,0,0,0,0,0,0,2,1,3,0,0,0,0,277.8300994,0,-0.910905228,0.584270701,-1.559046564,0.11898536,0.250639555,62.09682249,0,-2.49091722,1.210894471,-2.057088607,0.039677703,0.098405557,160.0733734,1,-5.133596384,1.204006694,-4.263760667,2.01E-05,0.000340883,196.6225922,1,-3.26646841,0.881733539,-3.70459812,0.000211726,0.002012889,186.2385132,0,-2.542765017,0.767630328,-3.312486393,0.000924706,0.004477595,N,-,,WD repeat,C:intracellular part,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22847:SF359 (PANTHER); PTHR22847 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_09794,36,47,53,0,0,2,0,0,0,0,0,0,0,0,0,0,2,0,25.31071648,1,-2.764024685,1.202423793,-2.298710905,0.021521361,0.069920853,36.29620333,0,2.596508862,0.897539372,2.892919177,0.003816795,0.017632861,21.03189078,0,-2.205491473,1.20579847,-1.829071381,0.067388916,0.142502396,24.25231656,0,-2.627209087,1.205651898,-2.179077635,0.029325901,0.091053282,32.1787134,1,-0.08248985,0.861796166,-0.095718516,0.923744134,0.950649376,N,-,,chitin synthase activator,C:incipient cellular bud site; C:cellular bud neck; P:fungal-type cell wall chitin biosynthetic process; P:positive regulation of catalytic activity; F:enzyme activator activity,IPR006597 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR006597 (PFAM); PTHR11102:SF46 (PANTHER); PTHR11102 (PANTHER); SSF81901 (SUPERFAMILY),3.A.16.1.4, the endoplasmic reticular retrotranslocon (er-rt) family.
RL4_JR_09795,0,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,179.1322667,0,0.263956061,0.442946188,0.595909995,0.551235355,0.730740661,27.33025438,0,-1.306879861,1.213063093,-1.077338737,0.281328962,0.440465856,90.02425563,0,-1.552360373,0.86602723,-1.792507577,0.073051697,0.151988363,93.37231447,0,-2.079299675,0.872925667,-2.381989388,0.017219394,0.071394906,84.5528462,0,-1.419441511,0.758684184,-1.8709254,0.061355422,0.131059841,N,-,,chitin synthase 4,C:incipient cellular bud site; C:prospore membrane; C:cellular bud neck; C:integral component of membrane; C:mating projection tip; F:chitin synthase activity; C:chitosome; P:ascospore wall assembly,IPR001199 (SMART); PF03142 (PFAM); IPR029044 (G3DSA:3.90.550.GENE3D); PTHR22914:SF10 (PANTHER); IPR004835 (PANTHER); PTHR22914:SF10 (PANTHER); IPR029044 (SUPERFAMILY),4.D.1.1.12, the putative vectorial glycosyl polymerization (vgp) family.
RL4_JR_09796,154,187,120,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,20.18392426,1,2.283512122,0.79635472,2.867456001,0.004137863,0.018578255,1.576289793,0,2.808970056,1.375574382,2.04203429,0.04114813,0.101412557,4.079686834,1,0.160355351,1.228388789,0.130541203,0.896138257,0.935406095,4.705276979,0,-0.261631025,1.232122331,-0.21234176,0.831840418,0.89463052,4.018006205,0,0.079576546,1.228695869,0.064765048,0.948361071,0.96649782,Y,-,,brucei -specific,,no IPS match,,
RL4_JR_09797,5006,6487,11627,1,0,27,0,0,4,0,0,0,0,4,0,0,6,0,596.2170982,1,-0.320781809,0.839416076,-0.382148756,0.702351029,0.839159299,134.9133774,1,-1.095735421,0.865013002,-1.26672711,0.205252883,0.350053863,338.3822632,0,-2.290856933,0.601598507,-3.807949833,0.000140124,0.001415819,456.5444157,1,-1.140685587,0.408240044,-2.794154084,0.005203568,0.028884937,399.4317208,1,-1.089671644,1.805889825,-0.603398739,0.546243461,0.667155011,N,-,,60s ribosomal l36,F:structural constituent of ribosome; C:ribosome; P:translation,IPR000509 (PFAM); IPR000509 (PANTHER),,
RL4_JR_09798,1559,1634,2431,0,2,4,0,0,0,0,3,4,0,0,0,0,2,1,210.6655488,1,0.061651261,0.923741238,0.066740834,0.946788026,0.973563316,69.81896931,0,-0.586740882,1.115873804,-0.525812937,0.599018185,0.734261144,87.92235334,1,-3.196598862,1.19498754,-2.675006018,0.007472791,0.025882496,101.9331533,0,-2.857446733,1.023212183,-2.792623836,0.005228245,0.028974265,87.77999665,1,-2.56924178,0.978757843,-2.625002495,0.008664833,0.027993439,N,-,,ubx domain-containing,,IPR021569 (PFAM); PTHR23153:SF35 (PANTHER); PTHR23153 (PANTHER); IPR029071 (SUPERFAMILY),,
RL4_JR_09799,42563,26287,37626,2,15,0,0,0,2,1,4,0,0,7,0,0,2,0,123.3460669,1,1.405208855,0.652286077,2.154283074,0.031217979,0.093493493,12.28118993,1,-0.152880979,1.206036246,-0.126763171,0.899127846,0.944130759,69.74168479,1,0.022807991,0.739739485,0.030832464,0.97540315,0.985920676,80.95024153,1,0.877072496,0.517247606,1.695653079,0.089951599,0.18084987,77.4860142,1,1.134493344,0.509093831,2.228456277,0.025850104,0.067128059,N,-, Effector probability:0.615,proteasome component pup3,"C:endoplasmic reticulum membrane; F:endopeptidase activator activity; C:nucleus; P:proteasome-mediated ubiquitin-dependent protein catabolic process; F:threonine-type endopeptidase activity; C:proteasome core complex, beta-subunit complex; C:proteasome storage granule; P:proteasomal ubiquitin-independent protein catabolic process; P:positive regulation of endopeptidase activity",IPR029055 (G3DSA:3.60.20.GENE3D); IPR001353 (PFAM); PTHR11599:SF62 (PANTHER); PTHR11599 (PANTHER); IPR023333 (PROSITE_PROFILES); IPR029055 (SUPERFAMILY),,
RL4_JR_09800,18,20,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,263.3279641,0,-0.077323639,0.4323545,-0.178843146,0.858060866,0.928759525,52.86062247,0,-1.0606151,1.126491294,-0.941520903,0.346437983,0.509456699,157.9959482,0,-1.464179891,0.687082145,-2.131011411,0.033088202,0.082896973,155.2234807,0,-2.013371071,0.696403138,-2.891099941,0.00383896,0.022757302,151.3752436,0,-1.259493953,0.602847948,-2.089239845,0.036686138,0.087973856,N,-,,calcium P-type ATPase,C:nuclear envelope; C:integral component of plasma membrane; F:ATP binding; F:metal ion binding; P:calcium ion transmembrane transport; F:calcium-transporting ATPase activity; C:sarcoplasmic reticulum membrane; P:cellular calcium ion homeostasis,PR00119 (PRINTS); IPR004014 (SMART); IPR023298 (G3DSA:1.20.1110.GENE3D); IPR023299 (G3DSA:3.40.1110.GENE3D); IPR005782 (TIGRFAM); IPR001757 (TIGRFAM); IPR004014 (PFAM); IPR006068 (PFAM); PF00702 (PFAM); IPR008250 (PFAM); IPR008250 (G3DSA:2.70.150.GENE3D); PTHR24093 (PANTHER); PTHR24093:SF353 (PANTHER); PTHR24093 (PANTHER); PTHR24093:SF353 (PANTHER); SSF81665 (SUPERFAMILY); IPR023299 (SUPERFAMILY); SSF81653 (SUPERFAMILY); IPR023214 (SUPERFAMILY),3.A.3.2.19, the p-type atpase (p-atpase) superfamily.
RL4_JR_09801,451,536,567,0,0,3,0,0,0,0,2,0,0,3,0,0,6,0,8.34106501,1,-1.162461275,1.226394857,-0.947868681,0.343196311,0.533294382,2.641102578,0,2.064343769,1.306081356,1.580562926,0.113978008,0.22462722,6.880327609,1,-0.593490978,1.217226845,-0.487576314,0.625849976,0.738129678,11.95134602,1,-0.070679338,1.167855012,-0.060520644,0.951740974,0.971311094,6.80539444,1,-0.680356073,1.224484654,-0.555626459,0.578466239,0.691507521,N,-,,ankyrin repeat,,IPR002110 (SMART); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24198 (PANTHER); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_09802,9030,7352,7833,10,0,21,0,0,0,9,3,2,2,30,11,5,16,15,26.88026948,1,7.863606319,1.061315354,7.409302326,1.27E-13,7.00E-12,0.046976896,0,7.877220312,2.616663063,3.010406813,0.00260898,0.015349618,0.123159884,1,5.210915468,1.646531077,3.164784157,0.00155198,0.008099097,0.14220092,1,4.787009224,2.299707027,2.081573508,0.037381443,0.102865591,0.122308719,1,5.120168481,1.457200766,3.513701476,0.000441909,0.002447664,N,-,,FAD FMN-dependent partial,F:oxidoreductase activity,IPR006094 (PFAM); IPR016167 (G3DSA:3.30.43.GENE3D); IPR016169 (G3DSA:3.30.465.GENE3D); PTHR11748 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR016166 (SUPERFAMILY),,
RL4_JR_09803,924,468,619,0,0,1,0,0,0,0,0,0,0,0,1,0,0,5,0.50955096,1,2.870257143,1.999920755,1.435185437,0.151234262,NA,0.164867348,0,6.066287143,1.936902363,3.131952987,0.001736477,0.015023052,0.424335414,0,3.425706522,1.316660648,2.601814314,0.009273205,0.030801156,0.489242716,1,3.004153682,1.46951478,2.044316752,0.040922265,0.109065,0.415350255,1,3.35257007,1.259617047,2.661578833,0.007777513,0.025657235,N,-,,---NA---,,no IPS match,,
RL4_JR_09804,254,283,323,0,2,0,0,0,0,1,2,1,0,0,0,0,0,0,125.8004765,1,0.937454757,0.53951486,1.737588388,0.082283367,0.192561019,24.60769411,0,0.452179061,1.137178271,0.39763252,0.690901086,0.804312801,39.55795464,1,-3.116884627,1.208529176,-2.579072718,0.009906593,0.032415756,77.59081419,0,-0.779420393,0.777086832,-1.00300296,0.315859433,0.46201629,38.98554336,0,-3.198626739,1.212548493,-2.63793717,0.008341203,0.027182068,N,-,,HD family hydrolase,C:intracellular part,IPR003607 (SMART); IPR006674 (G3DSA:1.10.3210.GENE3D); IPR006674 (PFAM); PTHR11845 (PANTHER); SSF109604 (SUPERFAMILY),,
RL4_JR_09805,41,29,33,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.659,hypothetical protein CMQ_7275,,no IPS match,,
RL4_JR_09806,7365,5321,7636,0,0,4,0,0,0,0,0,0,0,1,2,0,5,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,Y,-,,subtilisin-like serine protease,P:proteolysis; C:integral component of membrane; F:peptidase activity,no IPS match,,
RL4_JR_09807,2341,3280,3205,0,1,2,0,0,3,2,0,1,7,0,4,0,0,0,12.75555126,1,-1.775295901,1.189073952,-1.49300714,0.135435318,0.274709429,4.089988272,1,1.433473935,1.259903521,1.137764846,0.255218688,0.410181575,74.35032439,1,2.424906481,0.573989857,4.224650408,2.39E-05,0.000389517,16.20765647,1,-0.688288371,1.144142714,-0.601575628,0.547456656,0.677379768,10.38469625,0,-1.290209838,1.191143265,-1.083169319,0.278733275,0.412357454,N,-,,hypothetical protein BN1723_003026,,no IPS match,,
RL4_JR_09808,365,382,393,0,0,4,0,0,0,0,0,0,3,6,2,0,1,0,0.950849776,1,1.970601281,1.617747253,1.218114435,0.223180489,NA,0.3057387,0,5.175399343,1.754353117,2.95003286,0.003177401,0.016079667,0.787251829,0,2.534935253,1.301346262,1.947932942,0.051422987,0.115818982,0.907873629,1,2.112749497,1.377373601,1.53389719,0.125054947,0.231646788,4.628880248,1,3.393022182,1.177923634,2.880511168,0.003970309,0.014822779,N,-,,oligopeptide transporter 2,P:transmembrane transport; P:mycelium development; C:integral component of membrane,IPR004648 (TIGRFAM); IPR004813 (TIGRFAM); IPR004813 (PFAM); PTHR22601:SF20 (PANTHER); PTHR22601 (PANTHER); PTHR22601 (PANTHER); PTHR22601:SF20 (PANTHER); PTHR22601:SF20 (PANTHER),2.A.67.1.4, the oligopeptide transporter (opt) family.
RL4_JR_09809,114,95,93,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.679,STIP1 likey and U-box containing 1,F:ubiquitin-protein transferase activity; P:protein ubiquitination,IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR22904:SF345 (PANTHER); PTHR22904 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_09810,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,U-box domain-containing,F:ubiquitin-protein transferase activity; F:ligase activity; P:protein ubiquitination,IPR003613 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR003613 (PFAM); PTHR22904 (PANTHER); PTHR22904:SF345 (PANTHER); IPR003613 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY),1.A.87.4.2, the mechanosensitive calcium channel (mca) family.
RL4_JR_09811,631,162,795,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.107682774,0,-1.289338407,1.210728389,-1.064927871,0.286908571,0.4709921,2.888839512,0,1.934990511,1.284502578,1.506412322,0.131961359,0.25003985,7.520275508,0,-0.721831571,1.206445442,-0.598312652,0.549631336,0.67677787,27.9482235,0,0.60610675,1.025549553,0.591006791,0.554515871,0.683524859,7.435768034,0,-0.808171033,1.213065532,-0.666222072,0.505269167,0.632400404,N,-,,hypothetical protein F503_06075,,PTHR42051 (PANTHER),,
RL4_JR_09812,3205,2670,3900,0,0,7,0,0,0,0,0,8,0,6,0,1,6,0,25.46492353,1,-2.772695818,1.245912495,-2.225433832,0.026052128,0.081274671,8.128812943,0,0.442516205,1.283730156,0.344711233,0.730311473,0.831707102,21.02062546,1,-2.204679047,1.233201614,-1.787768538,0.073813359,0.153163854,24.24864468,1,-2.626950227,1.237083396,-2.123502938,0.03371173,0.098366358,20.59713816,1,-2.278126219,1.23649616,-1.842404604,0.065415989,0.138015605,N,-,,amino acid transporter,C:integral component of membrane,IPR013057 (PFAM); PTHR22950 (PANTHER); PTHR22950:SF8 (PANTHER),2.A.18.4.2, the amino acid/auxin permease (aaap) family.
RL4_JR_09813,13597,10880,13584,0,0,7,1,0,3,0,4,18,1,8,0,0,1,0,17.59762586,1,0.288521724,1.062323934,0.271594863,0.78593355,0.889847237,3.168083548,1,1.801819091,1.309577946,1.375877699,0.168859501,0.303102654,8.252656763,1,-0.856048497,1.226547777,-0.697933267,0.485218929,0.620879873,9.521892213,1,-1.278595809,1.228708624,-1.040601314,0.298060621,0.443151804,8.183742052,1,-0.94657309,1.237482325,-0.764918473,0.444320093,0.577214531,N,-,,sugar porter family MFS transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR005828 (PFAM); IPR003663 (TIGRFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF162 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.10, the major facilitator superfamily (mfs).
RL4_JR_09814,88,81,57,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0.081588216,1,5.513468456,3.919827769,1.406558854,0.159558241,NA,0.02575085,0,8.745059896,2.82620528,3.094276257,0.001972937,0.015023052,0.066997286,0,6.090868269,1.670636175,3.645837651,0.000266522,0.002119616,0.077321288,0,5.666332099,2.669293114,2.122783769,0.033771976,0.098485384,0.065975509,0,6.013099212,1.387557994,4.333584065,1.47E-05,0.000138583,N,-, Effector probability:0.694,hydantoinase,F:hydrolase activity,G3DSA:3.30.420.40 (GENE3D); IPR008040 (PFAM); PTHR11365 (PANTHER); PTHR11365:SF10 (PANTHER); SSF53067 (SUPERFAMILY),,
RL4_JR_09815,477,585,725,0,0,4,0,0,0,0,0,2,0,1,0,0,0,0,2.868355483,1,0.37745952,1.38112622,0.273298352,0.784623882,0.889119538,0.898632066,0,3.619554757,1.51813952,2.384204291,0.017116098,0.05109087,2.359040442,1,0.950611452,1.291151854,0.736250697,0.461578145,0.599026203,2.723506361,1,0.5272296,1.317619489,0.400137979,0.689054892,0.789842724,2.352761651,0,0.852036218,1.299771027,0.655527936,0.512127906,0.638268716,N,-,,Ankyrin repeat-containing,F:lysophospholipase activity; F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:hydrolase activity,no IPS match,,
RL4_JR_09816,9,21,15,0,0,3,0,0,0,0,0,0,0,0,0,2,0,0,0.141947304,1,4.714368776,3.577052159,1.31794801,0.187521052,NA,0.044465032,0,7.956507837,2.57803763,3.086265206,0.00202688,0.015023052,0.116414383,0,5.292191687,1.584701611,3.339550897,0.00083914,0.005006753,0.134397298,0,4.868421378,2.252362611,2.161473181,0.030658806,0.093673189,0.115503463,1,5.203190615,1.397859482,3.722255837,0.000197451,0.001231028,N,-,,glycoside hydrolase,C:membrane; C:integral component of membrane; F:hydrolase activity,no IPS match,,
RL4_JR_09817,293,555,514,0,0,1,0,0,0,0,0,0,0,0,1,0,4,0,2.84703521,1,0.388490338,1.321408462,0.293997162,0.768760072,0.878736817,0.912394312,0,3.597937728,1.492169731,2.411212111,0.015899599,0.048274668,2.353997245,0,0.954289799,1.260799895,0.756892353,0.449114357,0.588586893,2.715048301,1,0.532174742,1.278521363,0.416242354,0.67723267,0.780000089,2.301737265,1,0.88364268,1.250117296,0.706847815,0.479661057,0.608897718,N,-,,N-glycosylation EOS1,C:endoplasmic reticulum membrane; C:integral component of membrane; P:cellular response to oxidative stress,no IPS match,,
RL4_JR_09818,6,6,10,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,1035.453627,1,0.162870821,0.357492667,0.455592062,0.648683352,0.800356743,167.8130897,0,-2.925102988,1.114361864,-2.62491304,0.00866711,0.030230354,441.1580621,0,-3.68216745,0.76118066,-4.837442203,1.32E-06,3.41E-05,625.6466967,0,-1.550933859,0.972411956,-1.594934995,0.110726773,0.211713865,502.6746495,0,-1.799930674,0.496934363,-3.622069247,0.000292256,0.001712437,N,-,,60S ribosomal L28,C:nucleus; F:RNA binding; F:structural constituent of ribosome; C:cytosolic large ribosomal subunit; P:translation,G3DSA:3.100.10.10 (GENE3D); IPR021131 (PFAM); PTHR11721 (PANTHER); IPR021131 (SUPERFAMILY),,
RL4_JR_09819,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,189.8022902,0,0.205322307,0.912331754,0.225052243,0.821938633,0.909928731,29.83315058,0,-1.433363872,1.201002468,-1.193472878,0.232684228,0.382964188,130.4125348,0,-0.676294316,0.630766328,-1.07217885,0.283639708,0.423010284,153.8857614,0,-0.596870208,0.540934143,-1.103406425,0.269850708,0.411172072,107.4899052,0,-0.79412083,0.628976495,-1.262560424,0.206747198,0.329500296,N,-,,mitochondrial fusion,C:integral component of membrane,IPR023395 (G3DSA:1.50.40.GENE3D); PTHR24089:SF318 (PANTHER); PTHR24089 (PANTHER); IPR023395 (SUPERFAMILY),1.N.6.1.1, the mitochondrial inner/outer membrane fusion (mmf) family.
RL4_JR_09820,18,12,46,0,0,4,0,0,0,0,0,1,0,0,0,0,0,0,59.09041745,1,-3.98719596,1.199454394,-3.324174709,0.000886806,0.005423212,18.76057151,0,-0.764155986,1.20316577,-0.635121116,0.525349426,0.674386325,80.75783432,1,-0.598428078,0.750442205,-0.797433931,0.42519906,0.566173257,56.36332175,0,-3.843895276,1.196516775,-3.212571154,0.001315526,0.009325443,48.344248,0,-3.509047209,1.202962682,-2.917004211,0.00353411,0.013497874,N,-, Effector probability:0.629,2fe-2s iron-sulfur cluster binding domain-containing,"C:mitochondrial matrix; F:metal ion binding; F:electron carrier activity; P:heme a biosynthetic process; P:oxidation-reduction process; F:oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor; F:2 iron, 2 sulfur cluster binding; P:ubiquinone biosynthetic process; P:iron-sulfur cluster assembly",IPR001055 (PRINTS); IPR012675 (G3DSA:3.10.20.GENE3D); IPR001041 (PFAM); PTHR23426 (PANTHER); IPR001041 (PROSITE_PROFILES); IPR001041 (SUPERFAMILY),,
RL4_JR_09821,299,308,313,0,0,4,0,0,0,0,0,0,0,2,0,0,0,2,209.25933,1,0.229445132,0.69150456,0.331805668,0.740036004,0.863569407,56.78929794,0,0.749541021,0.964198224,0.777372331,0.436939132,0.598429933,75.20184806,0,-4.04371427,1.259571568,-3.210388654,0.001325556,0.007191817,108.4911084,1,-1.782515967,0.878743973,-2.028481585,0.042511121,0.11204724,97.76182523,1,-1.273563462,0.841326225,-1.513756999,0.130087482,0.232381045,N,-,,duf1665 domain containing,P:biological_process; P:rRNA processing; C:cellular_component; F:molecular_function,IPR012459 (PFAM); IPR025340 (PFAM); PTHR33119:SF1 (PANTHER); PTHR33119 (PANTHER),,
RL4_JR_09822,33,84,41,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,419.4343318,0,-0.120501225,0.386096884,-0.312101003,0.754963764,0.87163804,66.98235274,0,-2.600195915,1.196526707,-2.17311983,0.0297713,0.078598095,213.1863254,0,-1.870219321,0.645261183,-2.898391177,0.003750824,0.015764501,256.0442174,0,-1.536807289,0.509742153,-3.014871893,0.002570878,0.016330076,191.3245212,0,-2.441837586,0.722344583,-3.380433165,0.000723717,0.003693363,N,-,,glutamyl-tRNA synthetase,C:nucleus; F:ATP binding; C:mitochondrion; F:glutamate-tRNA ligase activity; C:cytosol; C:methionyl glutamyl tRNA synthetase complex; P:glutamyl-tRNA aminoacylation,IPR000924 (PRINTS); IPR004526 (TIGRFAM); IPR014729 (G3DSA:3.40.50.GENE3D); IPR020056 (G3DSA:2.40.240.GENE3D); IPR020056 (G3DSA:2.40.240.GENE3D); IPR020059 (PFAM); IPR020058 (PFAM); G3DSA:3.90.800.10 (GENE3D); IPR020061 (G3DSA:1.10.1160.GENE3D); PTHR11451:SF37 (PANTHER); PTHR11451:SF37 (PANTHER); PTHR11451 (PANTHER); PTHR11451 (PANTHER); IPR011035 (SUPERFAMILY); SSF52374 (SUPERFAMILY); IPR010987 (SUPERFAMILY),,
RL4_JR_09823,6,36,20,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,72.52956245,1,-2.431239525,1.103418862,-2.203369554,0.027568712,0.08461458,87.32412197,0,1.387634699,0.896194764,1.548362872,0.121534955,0.236007584,53.47364585,0,-3.551791894,1.234213461,-2.877777635,0.004004873,0.016395203,71.36372758,0,-3.019346554,1.195545431,-2.525497129,0.011553473,0.054358229,60.69491163,0,-2.705294939,1.179985784,-2.29265045,0.021868137,0.05873074,N,-,,50s ribosomal l1,F:RNA binding; F:structural constituent of ribosome; C:large ribosomal subunit; C:nucleolus; P:translation,IPR016095 (G3DSA:3.40.50.GENE3D); IPR028364 (PFAM); IPR016094 (G3DSA:3.30.190.GENE3D); PTHR23105 (PANTHER); PTHR23105:SF5 (PANTHER); IPR023674 (SUPERFAMILY),1.C.82.1.1, the pore-forming amphipathic helical peptide hp(2-20) (hp2-20) family.
RL4_JR_09824,9,9,5,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,28.48525506,0,-1.782192771,1.187355346,-1.500976752,0.133361575,0.272032989,7.811147636,0,0.499906422,1.26306563,0.39578816,0.692261312,0.804999435,36.09148277,0,-0.336842367,1.069135573,-0.31506048,0.752715734,0.834117129,35.5829388,1,-0.317227519,0.921535329,-0.344238044,0.730667274,0.820359963,20.29229502,0,-2.256647341,1.239995797,-1.819883057,0.068776816,0.14304956,N,-,,oligomeric golgi complex subunit 2,P:Golgi organization; C:membrane; P:protein transport; F:molecular_function,IPR024602 (PFAM); IPR009316 (PANTHER),,
RL4_JR_09825,32,81,27,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,122.7627806,1,-2.387680646,0.866940306,-2.754146542,0.005884541,0.024770943,69.08662427,0,1.065001942,0.772441236,1.378748172,0.167972411,0.301992317,172.3774065,0,-0.12474441,0.559581323,-0.222924541,0.823594236,0.886085871,194.0022694,0,0.052903366,0.457841132,0.115549613,0.908009498,0.943804144,107.8182004,0,-0.885709292,0.636643112,-1.391217899,0.164159361,0.276880482,N,-,,bzip transcription factor,F:DNA binding,IPR004827 (SMART); G3DSA:1.20.5.170 (GENE3D); IPR018287 (PFAM); PTHR10623:SF17 (PANTHER); IPR027328 (PANTHER); SSF57959 (SUPERFAMILY),,
RL4_JR_09826,3,10,4,0,0,2,0,0,0,0,0,0,0,0,0,0,2,0,120.398304,1,1.521594803,0.61739872,2.464525361,0.013719485,0.048874918,11.39931372,0,-0.045311508,1.254821743,-0.036109916,0.971194716,0.98529141,35.81491202,0,-1.722806861,1.21465843,-1.41834677,0.156089548,0.270275895,116.4700839,0,1.460316395,0.519345702,2.811838799,0.004925918,0.027708291,28.63145694,1,-2.753341075,1.212360483,-2.271058083,0.023143462,0.061158184,N,-,,hypothetical protein SPI_08211,,PTHR42064 (PANTHER); PTHR42064:SF1 (PANTHER),,
RL4_JR_09827,86,113,58,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.155221529,0,4.585116609,3.586323356,1.278500613,0.201072969,NA,0.051621419,0,7.742224457,2.66698354,2.902989216,0.003696194,0.017320774,0.130515682,0,5.127518355,1.720853865,2.979636133,0.00288591,0.013232314,0.150305602,0,4.707079667,2.352706008,2.000708822,0.045423778,0.115440701,0.125380989,0,5.079410837,1.516774576,3.348823824,0.000811554,0.004045782,Y,-,,lipase 3 precursor,F:hydrolase activity,IPR002018 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR11559 (PANTHER); PTHR11559:SF162 (PANTHER); PTHR11559:SF162 (PANTHER); IPR029058 (SUPERFAMILY),8.A.117.1.3, the neuroligin (nlg) family.
RL4_JR_09828,1311,915,1512,0,0,4,0,0,0,0,3,0,0,0,1,0,1,0,7.481193784,1,0.970479784,1.174044336,0.826612551,0.408456701,0.599940138,1.159995031,0,3.251326669,1.38986242,2.339315477,0.019319112,0.055982838,3.02324737,1,0.592770222,1.222472179,0.484894652,0.627751076,0.739510344,3.488753741,1,0.170018692,1.228162214,0.138433417,0.889897888,0.932252056,2.993288071,1,0.504668285,1.226165026,0.411582678,0.68064533,0.773200266,N,-,,siderophore iron transporter mirb,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501 (PANTHER); PTHR23501 (PANTHER); PTHR23501:SF50 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.16.7, the major facilitator superfamily (mfs).
RL4_JR_09829,182,169,280,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,50.40901145,0,1.67054766,0.619327506,2.697357445,0.00698922,0.028609162,5.172590264,0,1.094693109,1.272284683,0.860415223,0.389560198,0.553965766,13.32702914,0,-1.547237218,1.208760661,-1.280019501,0.200538278,0.326044934,15.36758255,1,-1.968947415,1.208163552,-1.62970271,0.103164344,0.200487329,13.04422791,0,-1.619190344,1.205066347,-1.343652445,0.179060802,0.296434045,N,-,,c6 zinc finger domain-containing,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR007219 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31944 (PANTHER); PTHR31944 (PANTHER); PTHR31944:SF80 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09830,16,5,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.806280252,0,1.044659685,1.407532139,0.74219242,0.45797076,NA,0.587154386,0,4.233898412,1.606338433,2.635744949,0.008395281,0.029526418,1.504588188,0,1.599914872,1.286974467,1.243159762,0.213808967,0.342391962,1.734368527,0,1.178599927,1.323295239,0.890655306,0.373114119,0.518794813,1.464181266,0,1.535799531,1.265315234,1.213768309,0.224836211,0.351577859,N,-,,hypothetical protein F503_01636,,no IPS match,,
RL4_JR_09831,92,132,149,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,87.09390337,0,1.227681171,0.901268833,1.362169784,0.173144309,0.327208051,18.94720626,0,1.122438759,1.140651804,0.984032774,0.325099399,0.487215889,31.20027357,0,-1.475673822,1.202309635,-1.227365879,0.219685105,0.348877177,44.53531734,0,-0.162612359,0.775061982,-0.209805619,0.833819388,0.895842668,46.29754722,0,-0.273444675,0.849513963,-0.321883674,0.747540822,0.823929125,Y,-,,fasciclin domain family,,IPR000782 (SMART); IPR000782 (PFAM); IPR000782 (G3DSA:2.30.180.GENE3D); IPR000782 (G3DSA:2.30.180.GENE3D); PTHR10900 (PANTHER); PTHR10900:SF83 (PANTHER); PTHR10900 (PANTHER); IPR000782 (PROSITE_PROFILES); IPR000782 (PROSITE_PROFILES); IPR000782 (SUPERFAMILY); IPR000782 (SUPERFAMILY),,
RL4_JR_09832,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,186.6724014,0,-0.198492397,0.537417639,-0.369344774,0.711870756,0.844759376,57.25917694,0,-0.735729278,1.122602286,-0.65537839,0.512224162,0.66300933,109.8561573,0,-1.910475098,0.868142172,-2.200647728,0.027760972,0.07211504,182.4156685,0,-0.637781928,0.516047425,-1.235897897,0.216496519,0.351173863,88.66216106,0,-4.384024502,1.198360669,-3.658351459,0.000253843,0.001529856,N,-,,vacuolar aminopeptidase 1,F:zinc ion binding; P:proteolysis; F:aminopeptidase activity,IPR001948 (PRINTS); G3DSA:3.40.630.10 (GENE3D); IPR023358 (G3DSA:2.30.250.GENE3D); IPR001948 (PFAM); PTHR28570 (PANTHER); PTHR28570:SF4 (PANTHER); SSF53187 (SUPERFAMILY); SSF101821 (SUPERFAMILY),,
RL4_JR_09833,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,145.8450536,0,2.142001319,0.352130685,6.082972626,1.18E-09,3.15E-08,46.4073827,0,2.904073753,0.755331412,3.844767618,0.000120667,0.005734219,54.40842902,0,0.487263198,0.736480264,0.661610666,0.50822077,0.639945106,93.19198544,0,1.295957503,0.478501164,2.708368549,0.006761489,0.035619187,26.53660534,0,-1.486233968,1.116829427,-1.330761827,0.183267392,0.301720706,N,-,,histone-lysine n-methyltransferase set9,P:regulation of cellular process; F:transferase activity; C:intracellular part; P:cellular process,IPR001214 (SMART); IPR001214 (PFAM); G3DSA:2.170.270.10 (GENE3D); PTHR12977:SF4 (PANTHER); PTHR12977 (PANTHER); IPR025783 (PROSITE_PROFILES); IPR001214 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY),,
RL4_JR_09834,214,225,237,0,0,23,4,0,0,30,31,9,10,65,13,0,8,4,77.6861865,1,-0.790879201,0.718203062,-1.101191632,0.270813263,0.452353522,16.57330529,1,-0.585324089,1.214474402,-0.481956712,0.629836698,0.756782577,114.3199846,1,0.594546836,0.568685926,1.045474855,0.295803556,0.436802101,86.50436404,1,-0.600676954,0.696819335,-0.862026817,0.388672761,0.533384617,66.05153559,1,-0.197357895,0.691997098,-0.285200467,0.775490563,0.84464737,N,-, Effector probability:0.772,50S ribosomal l14,F:structural constituent of ribosome; P:mitochondrial translation; C:mitochondrial large ribosomal subunit,IPR000218 (SMART); IPR000218 (PFAM); IPR000218 (G3DSA:2.40.150.GENE3D); IPR005745 (TIGRFAM); PTHR11761:SF3 (PANTHER); IPR000218 (PANTHER); IPR000218 (SUPERFAMILY),,
RL4_JR_09835,1020,1339,1194,0,0,0,0,0,0,0,0,2,5,2,0,0,7,0,154.6145444,0,-2.156408496,0.675721532,-3.191267991,0.001416498,0.007834436,52.57259518,0,-1.049421814,1.105262641,-0.949477324,0.3423779,0.505624322,112.1754193,1,-4.620639166,1.188388397,-3.888155741,0.000101009,0.001168701,180.6332273,1,-1.709148144,0.608780886,-2.807493113,0.004992875,0.02805375,122.3081548,1,-2.503029906,0.849929622,-2.944984904,0.003229704,0.012548256,N,-,,dna-directed rna polymerase ii subunit rpb9,"F:DNA-directed RNA polymerase activity; P:transcription, RNA-templated; P:maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair; C:cytosol; P:transcription initiation from RNA polymerase II promoter; C:DNA-directed RNA polymerase II, core complex",IPR001529 (SMART); G3DSA:2.20.25.10 (GENE3D); IPR001529 (PFAM); PTHR11239 (PANTHER); PTHR11239:SF1 (PANTHER); SSF57783 (SUPERFAMILY),,
RL4_JR_09836,3,1,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,69.89584109,0,1.641004182,0.830462832,1.976011591,0.048153464,0.129264878,6.412914379,1,0.784456951,1.246234656,0.629461673,0.529046853,0.677544297,23.23480684,0,-0.914209457,1.207375178,-0.757187553,0.448937506,0.588507486,23.32507157,0,-1.352910772,1.162764835,-1.163529143,0.244614881,0.383038304,32.05184768,0,0.608811856,0.807699809,0.75376006,0.450993311,0.583106534,N,-,,peptidyl-prolyl cis-trans isomerase ssp-1,C:nucleus; P:histone H3-K4 trimethylation; P:regulation of phosphorylation of RNA polymerase II C-terminal domain; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:protein peptidyl-prolyl isomerization,IPR001202 (SMART); G3DSA:3.10.50.40 (GENE3D); G3DSA:2.20.70.10 (GENE3D); IPR001202 (PFAM); IPR000297 (PFAM); PTHR10657:SF4 (PANTHER); PTHR10657:SF4 (PANTHER); PTHR10657 (PANTHER); IPR000297 (PROSITE_PROFILES); IPR001202 (PROSITE_PROFILES); SSF54534 (SUPERFAMILY); IPR001202 (SUPERFAMILY),,
RL4_JR_09837,1329,1680,2230,0,0,0,0,0,0,0,1,0,3,0,2,0,1,0,0.159752362,0,4.543666258,3.274239144,1.387701404,0.165227988,NA,0.050615371,0,7.769471305,2.395743407,3.243031487,0.001182651,0.015023052,0.131982358,1,5.109555899,1.411285191,3.620498487,0.000294036,0.002289862,0.152303048,1,4.687540715,1.984112631,2.36253761,0.0181503,0.073563223,0.130830215,1,5.02153518,1.278924008,3.926374945,8.62E-05,0.000612298,N,-,,hypothetical protein SPBR_02416,C:membrane; C:integral component of membrane,IPR007300 (PFAM); PTHR30249 (PANTHER); PTHR30249:SF0 (PANTHER),,
RL4_JR_09838,316,306,152,0,3,1,0,0,0,0,4,0,2,0,0,0,7,0,0.510988829,1,2.866517234,2.044672746,1.401944267,0.16093189,NA,0.162491114,0,6.087253819,1.953545982,3.116002324,0.001833208,0.015023052,0.421238434,1,3.43726567,1.336764619,2.571332021,0.010130815,0.03301074,0.486003603,1,3.014244488,1.501441622,2.00756689,0.044689336,0.114728762,0.413792691,1,3.360320027,1.28160902,2.621954103,0.00874272,0.028191097,N,-,,---NA---,,no IPS match,,
RL4_JR_09839,810,890,1075,0,5,6,0,0,1,0,0,3,0,4,0,0,4,1,4.358031031,1,-0.225901297,1.239867656,-0.182197911,0.855427412,0.92758379,1.380459843,1,3.000317833,1.368503883,2.192407249,0.028350114,0.075754976,10.09503523,1,1.304212282,1.209308336,1.078477873,0.280820551,0.419959308,8.161591494,1,0.865351973,1.166848791,0.741614491,0.458320941,0.600401026,3.558102583,1,0.255284403,1.225505999,0.208309387,0.834987403,0.888417281,N,-,,vacuolar H+ Ca2+ exchanger,,no IPS match,,
RL4_JR_09840,1374,1245,2306,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0.01164016,1,8.317974459,3.997123045,2.080990344,0.03743479,NA,0.003501898,0,11.6103591,4.002138943,2.901038485,0.003719282,0.017380689,0.009514587,0,8.898423346,3.998182413,2.22561715,0.026039836,0.068649449,0.011003575,1,8.472850999,3.997973129,2.11928663,0.034066251,0.0989162,0.009871642,0,8.75387984,1.939189559,4.514195015,6.36E-06,6.91E-05,N,-,,---NA---,,no IPS match,,
RL4_JR_09841,19,18,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,102.314333,0,1.499903661,0.539892249,2.778153721,0.005466875,0.023386872,26.63554329,0,2.116943496,1.019242792,2.076976666,0.037803713,0.094950169,20.53375237,0,-2.171027867,1.213474877,-1.789099971,0.073598717,0.152906507,23.69303877,0,-2.593656237,1.214878388,-2.134910179,0.032768348,0.096983198,28.08773983,0,-0.607668065,1.017874943,-0.596996781,0.55050953,0.67079882,N,-,,hypothetical protein CMQ_7709,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_09842,1991,2437,2158,0,0,3,0,0,0,0,0,0,0,4,0,0,0,1,20.21388067,1,4.729918797,0.724138462,6.531787834,6.50E-11,2.34E-09,0.356742603,0,4.952412714,1.651927402,2.997960267,0.002717931,0.015349618,0.928554509,0,2.295223738,1.257167664,1.825710129,0.067893937,0.143251111,1.071338402,1,1.872970144,1.304513822,1.435761056,0.151070345,0.267316889,8.640714432,1,3.862864291,1.01633418,3.800781641,0.00014424,0.000945877,Y,-,,hypothetical protein F503_08368,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09843,1876,2970,3437,0,0,8,0,0,0,3,0,1,0,4,2,0,0,0,48.98330451,1,3.092302224,0.645029768,4.794045757,1.63E-06,2.34E-05,2.2159988,0,2.31749444,1.300461322,1.782055646,0.074740158,0.161615013,5.769095569,1,-0.339521306,1.204647345,-0.281842904,0.778063971,0.85268669,6.656729497,1,-0.762150433,1.203943394,-0.633045073,0.52670421,0.660583798,5.708489687,0,-0.426823501,1.211359115,-0.352350922,0.724575103,0.806275914,N,-, Effector probability:0.872,plac8 family,,IPR006461 (PFAM); IPR006461 (TIGRFAM); PTHR15907 (PANTHER); PTHR15907:SF21 (PANTHER),1.A.87.3.2, the mechanosensitive calcium channel (mca) family.
RL4_JR_09844,4,1,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.303429504,0,3.618167275,2.468589274,1.465682166,0.142734895,NA,0.097225398,0,6.828069065,2.102907474,3.246965998,0.001166423,0.015023052,0.251672197,0,4.179172692,1.318885777,3.168714657,0.001531146,0.00799862,0.290284781,0,3.75719119,1.594010839,2.357067529,0.018419897,0.074086903,0.247645652,0,4.099210183,1.242788857,3.298396311,0.000972388,0.004672723,N,-,,---NA---,,no IPS match,,
RL4_JR_09845,208,204,457,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34.11774822,0,0.368729461,0.754548404,0.488675688,0.625071318,0.785211598,5.992780474,0,0.882243833,1.232323183,0.715919205,0.474041239,0.63151427,26.65779949,0,-0.811674622,1.193298179,-0.680194302,0.49638144,0.62934649,17.98497764,0,-2.196003587,1.193773107,-1.83954855,0.065834544,0.145160008,15.41296809,0,-1.859839858,1.202540809,-1.546591886,0.121961688,0.221897949,N,-,,hypothetical protein SAPIO_CDS2783,,IPR003615 (PFAM),,
RL4_JR_09846,2,3,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28.79880616,0,1.641389686,0.684600274,2.397588416,0.016503398,0.056342646,3.085691599,0,1.839896334,1.270148873,1.448567466,0.147458412,0.273114451,8.022724354,0,-0.81515507,1.198027119,-0.680414539,0.496242018,0.62934649,46.50563546,0,1.519324868,0.744805112,2.039895864,0.041360699,0.109918914,7.924451135,0,-0.900015045,1.203320923,-0.747942654,0.454494748,0.58636077,N,-,,Btb poz,,IPR000210 (PFAM); G3DSA:3.30.710.10 (GENE3D); PTHR26379 (PANTHER); PTHR26379:SF175 (PANTHER); PTHR26379:SF175 (PANTHER); IPR000210 (PROSITE_PROFILES); IPR011333 (SUPERFAMILY),,
RL4_JR_09847,2,3,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.208219748,0,4.161456134,2.911741289,1.429198449,0.152947203,NA,0.066327806,0,7.379706682,2.264031616,3.259542239,0.001115922,0.015023052,0.172240874,0,4.726349339,1.358789398,3.478353118,0.000504505,0.003404705,0.198714148,0,4.304002434,1.791568841,2.402365086,0.016289442,0.06909535,0.169934547,0,4.643846542,1.255689511,3.698244271,0.000217096,0.001333796,N,-,,---NA---,,no IPS match,,
RL4_JR_09848,1509,1081,1272,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,81.33518951,0,1.554045497,0.863264771,1.800195663,0.071829748,0.174141779,7.71252295,0,0.518343131,1.228584516,0.421902705,0.673096035,0.791390181,32.94896442,0,-0.309340399,1.03212995,-0.299710709,0.764397829,0.841718906,88.34213244,0,1.629612394,0.47112903,3.458951346,0.000542283,0.004467546,26.97994172,0,-1.274008681,1.118499096,-1.139034162,0.254688906,0.385632596,N,-,,homeobox domain-containing,"C:nucleus; P:mycelium development; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR001356 (SMART); IPR009057 (G3DSA:1.10.10.GENE3D); IPR001356 (PFAM); PTHR24326 (PANTHER); PTHR24326:SF278 (PANTHER); PTHR24326:SF278 (PANTHER); PTHR24326 (PANTHER); PTHR24326:SF278 (PANTHER); IPR001356 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY),8.A.39.1.2,The Homeobox; Penetratin (Penetratin) Family
RL4_JR_09849,199873,134394,125037,5,10,25,0,2,0,6,14,6,8,43,4,2,49,12,254.9361514,1,0.728924526,0.677528995,1.075857316,0.281991074,0.465119931,48.34934719,1,0.198071246,1.045282829,0.189490576,0.84970834,0.910324706,106.0430514,1,-1.240979439,0.794829088,-1.561316084,0.118449191,0.219782494,91.65068999,1,-3.536006087,1.181833835,-2.991965521,0.002771876,0.017421006,85.73120612,1,-1.946315125,0.893902931,-2.17732268,0.0294565,0.074061848,N,-,,p-type ATPase,F:magnesium ion binding; F:ATP binding; P:phospholipid translocation; C:integral component of membrane; F:phospholipid-translocating ATPase activity; C:plasma membrane,IPR032631 (PFAM); IPR001757 (TIGRFAM); PF13246 (PFAM); IPR023299 (G3DSA:3.40.1110.GENE3D); IPR006539 (TIGRFAM); IPR032630 (PFAM); IPR008250 (G3DSA:2.70.150.GENE3D); IPR008250 (PFAM); IPR023214 (G3DSA:3.40.50.GENE3D); PTHR24092:SF8 (PANTHER); PTHR24092:SF8 (PANTHER); IPR006539 (PANTHER); IPR006539 (PANTHER); IPR006539 (PANTHER); SSF81653 (SUPERFAMILY); SSF81665 (SUPERFAMILY); IPR023299 (SUPERFAMILY); IPR023214 (SUPERFAMILY),3.A.3.8.20, the p-type atpase (p-atpase) superfamily.
RL4_JR_09850,20325,25895,29976,0,3,11,0,0,0,4,4,2,2,14,1,0,5,9,216.9913366,1,-0.479001682,0.571012791,-0.838863314,0.401546017,0.593336787,216.9742318,0,2.214123116,1.7269317,1.282113888,0.199802698,0.343420429,147.2826508,1,-0.834403237,0.620295718,-1.345170073,0.178570318,0.298580295,169.3316316,1,-0.744816911,0.547981479,-1.359200883,0.174082942,0.297402289,143.2096651,1,-0.525475005,0.672317066,-0.78158808,0.434456694,0.569138832,N,-,,cullin-associated nedd8-dissociated 2,C:cellular_component,IPR011989 (G3DSA:1.25.10.GENE3D); IPR013932 (PFAM); PTHR12696:SF0 (PANTHER); PTHR12696:SF0 (PANTHER); PTHR12696 (PANTHER); PTHR12696 (PANTHER); IPR016024 (SUPERFAMILY),,
RL4_JR_09851,2374,4499,6127,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,19.2935866,0,0.078775476,1.021126157,0.077145684,0.938507651,0.969777845,3.747114997,0,1.559807997,1.277783095,1.220714222,0.222194241,0.370580015,9.670336158,0,-1.084470026,1.202605079,-0.901767376,0.367180454,0.511466003,19.17555611,1,0.215026297,1.027136432,0.20934541,0.834178605,0.896099043,9.478418915,1,-1.15848707,1.197941037,-0.967065185,0.333511448,0.470175914,N,-,,septum-promoting gtp-binding 1,F:GTP binding; F:GTPase activity; P:positive regulation of barrier septum assembly; P:septation initiation signaling; C:mitotic spindle pole body; P:cellular protein localization,PR00449 (PRINTS); SM00173 (SMART); SM00174 (SMART); SM00175 (SMART); IPR005225 (TIGRFAM); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24073 (PANTHER); PTHR24073:SF420 (PANTHER); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF81995 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_09852,5394,7847,7373,1,12,14,0,0,3,0,1,28,5,11,0,0,4,2,242.99886,1,1.215764918,0.365635288,3.325075446,0.000883946,0.005413261,25.03147519,1,-1.180161454,1.196433588,-0.986399467,0.323937126,0.486251334,149.9251254,1,0.321777682,0.503398693,0.639210405,0.522686064,0.65264846,188.5486247,1,0.488995061,0.402584774,1.214638737,0.224503908,0.360066856,110.5237856,1,0.121330183,0.602234008,0.20146684,0.840333555,0.892331122,N,-,,glycine cleavage system h,C:mitochondrion; P:glycine decarboxylation via glycine cleavage system; P:oxidation-reduction process; C:glycine cleavage complex; P:one-carbon metabolic process; P:protein lipoylation,G3DSA:2.40.50.100 (GENE3D); IPR017453 (TIGRFAM); IPR033753 (PFAM); PTHR11715:SF3 (PANTHER); IPR002930 (PANTHER); IPR000089 (PROSITE_PROFILES); IPR011053 (SUPERFAMILY),,
RL4_JR_09853,3444,3539,3462,0,0,1,0,0,0,6,0,6,2,0,0,0,0,2,34.48540285,1,0.293345622,0.833168363,0.352084447,0.724774932,0.854549559,44.39964157,0,1.794545085,1.138004103,1.576923212,0.114813195,0.225745757,46.43060611,1,1.01628545,0.7912324,1.284433563,0.198990296,0.324340664,26.3332045,1,-0.515368839,1.062048016,-0.485259453,0.627492314,0.743673807,19.65105671,1,-0.968120628,1.170375276,-0.827188208,0.408130394,0.544084298,N,-,,porphobilinogen deaminase,P:peptidyl-pyrromethane cofactor linkage; F:hydroxymethylbilane synthase activity; P:heme biosynthetic process,IPR000860 (PRINTS); IPR000860 (PIRSF); IPR022417 (PFAM); IPR000860 (TIGRFAM); IPR022418 (G3DSA:3.30.160.GENE3D); G3DSA:3.40.190.10 (GENE3D); G3DSA:3.40.190.10 (GENE3D); IPR022418 (PFAM); PTHR11557:SF0 (PANTHER); IPR000860 (PANTHER); IPR022418 (SUPERFAMILY); SSF53850 (SUPERFAMILY),,
RL4_JR_09854,7561,13229,16095,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,54.44394362,0,0.037294642,0.779908016,0.047819283,0.961860268,0.980643887,7.781615059,0,0.505373708,1.243791536,0.40631705,0.684509659,0.799648263,20.29811282,0,-2.154377905,1.211285583,-1.77858792,0.075307346,0.155530716,27.43429811,0,-1.631402985,1.165788831,-1.399398367,0.161693556,0.281345121,20.14450596,0,-2.246097626,1.223159682,-1.836307769,0.066312151,0.13927577,N,-,,micro-fibrillar-associated 1,C:microfibril,IPR009730 (PFAM); IPR033194 (PTHR15327:PANTHER); PTHR15327 (PANTHER),,
RL4_JR_09855,2849,3119,4668,4,4,0,0,0,0,0,2,2,0,2,0,0,2,0,140.2417319,1,-0.943611253,0.981815105,-0.961088548,0.336507648,0.526612198,72.2440074,0,0.433898392,1.095261426,0.396159658,0.69198725,0.804948636,72.25393237,1,-3.986011865,1.296880217,-3.073538953,0.002115361,0.010291164,99.45751125,1,-1.830826956,0.985195247,-1.85833921,0.063120859,0.140894775,148.1265482,1,0.388700128,0.812562798,0.478363185,0.632391732,0.735465918,N,-,,cipC-like antibiotic response,C:integral component of membrane,IPR022234 (PFAM); PTHR37450 (PANTHER); PTHR37450:SF1 (PANTHER),,
RL4_JR_09856,623,519,964,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,84.83876774,0,-1.000361193,0.788264205,-1.2690684,0.20441667,0.369353531,18.71379411,0,-0.760562189,1.241095431,-0.612815235,0.539998516,0.686839027,49.05236195,0,-3.427290893,1.229756984,-2.786965993,0.005320406,0.019817437,79.58134085,0,-1.509444617,0.911158129,-1.656622016,0.097595918,0.192435964,94.15553956,0,0.214384246,0.646525344,0.331594496,0.740195476,0.81813866,N,-,,tRNA methyltransferase complex GCD14 subunit,C:nucleus; C:tRNA (m1A) methyltransferase complex; F:tRNA (adenine-N1-)-methyltransferase activity; P:tRNA methylation,IPR014816 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR12133 (PANTHER); PTHR12133:SF2 (PANTHER); PTHR12133 (PANTHER); IPR014816 (PROSITE_PROFILES); IPR029063 (SUPERFAMILY),,
RL4_JR_09857,269,203,249,0,0,9,0,0,0,0,0,0,0,0,0,0,0,1,840.4529851,1,-0.322508247,0.715044007,-0.451032725,0.651965963,0.803227081,400.1571671,0,0.737589879,0.668315164,1.103655759,0.269742494,0.426948166,627.1573885,0,-0.586042939,0.50091896,-1.169935631,0.242026874,0.375406783,741.2608482,0,-0.501367626,0.335023048,-1.496516817,0.134519029,0.245097205,584.1631579,1,-0.669790001,0.503102943,-1.331317995,0.1830844,0.301615611,N,-,,nitrogen starvation-induced glutamine rich,,no IPS match,9.B.119.1.1," the glycan synthase, fks1 (fks1) family."
RL4_JR_09858,6533,4684,7605,1,6,0,0,0,0,2,7,0,1,3,0,0,4,0,7.105560876,1,-0.931035037,1.210204679,-0.769320309,0.441703184,0.631513245,2.265529674,0,2.285714452,1.309277658,1.745782829,0.080848696,0.171571687,5.873265743,1,-0.365010544,1.206716986,-0.302482312,0.762284415,0.840070998,6.775647043,1,-0.787368454,1.206049227,-0.65284935,0.513853405,0.648860933,5.778986011,1,-0.444472251,1.206177567,-0.368496532,0.71250303,0.797225459,N,-,,hypothetical protein K432DRAFT_297905,,no IPS match,,
RL4_JR_09859,524,478,526,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0.96841468,0,1.943967049,1.472802578,1.319910135,0.186865023,NA,0.309245683,0,5.158699225,1.672975127,3.083548071,0.002045481,0.015023052,11.87185527,1,3.46923523,1.196582075,2.899287315,0.00374012,0.015764501,0.925023248,0,2.085226198,1.284919724,1.622845505,0.104622435,0.202698461,0.790048977,0,2.426287897,1.214881376,1.997139758,0.045810003,0.104843192,N,-, Effector probability:0.581,hypothetical protein FVEG_10690,,SSF81301 (SUPERFAMILY),,
RL4_JR_09860,4,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,59.44021168,0,1.26977251,0.693179,1.831810412,0.066979672,0.165531706,51.37572093,0,2.427285748,1.041613182,2.330313968,0.019789563,0.057035865,17.40307444,0,-1.932314373,1.239982281,-1.55834031,0.119152598,0.220610992,20.06585755,0,-2.35388491,1.243880275,-1.892372567,0.058441358,0.134982775,17.07558327,0,-2.007699716,1.245362272,-1.612141111,0.106931237,0.200879177,N,-,,alpha beta hydrolase fold,P:lipid catabolic process; F:phospholipase activity,IPR000639 (PRINTS); IPR029058 (G3DSA:3.40.50.GENE3D); IPR022742 (PFAM); PTHR10992 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_09861,5125,4939,6248,3,1,1,0,0,0,2,0,0,4,3,0,0,4,0,12.40904423,1,-1.735761956,1.229729251,-1.411499283,0.158097447,0.307451483,4.010622126,0,1.461720166,1.313515018,1.112830951,0.26578104,0.422872105,10.33350068,1,-1.180298469,1.228853385,-0.960487625,0.336809856,0.48005955,11.91472621,1,-1.601889927,1.230660942,-1.30165009,0.193036028,0.322257178,10.12902946,1,-1.254302748,1.229917053,-1.019827105,0.307810466,0.443136779,N,-,,MFS transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23514 (PANTHER); PTHR23514:SF3 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.7.13, the major facilitator superfamily (mfs).
RL4_JR_09862,1441,1469,1149,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,35.80477988,0,1.50011009,0.61803187,2.427237435,0.015214295,0.052996678,4.122173903,0,1.422157197,1.25525039,1.132966943,0.257228136,0.412559529,10.67373528,0,-1.226893394,1.193475494,-1.028000491,0.303949597,0.445339871,59.19669074,1,1.429892647,0.665894488,2.147326149,0.031767325,0.095284166,17.86075975,0,-0.371541248,1.119601966,-0.331851193,0.740001626,0.81813866,N,-,,hypothetical protein Ao3042_09662,P:biological_process; F:molecular_function,PTHR40081 (PANTHER),,
RL4_JR_09863,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,56.70839499,0,-1.152168668,0.848527056,-1.357845527,0.174512705,0.329325619,41.23183564,0,1.939454258,0.851203254,2.278485485,0.022697668,0.06365913,46.96872785,0,-1.076339321,1.028740807,-1.046268714,0.295436986,0.436388101,67.12727347,0,-0.991931466,0.844745104,-1.174237603,0.240299868,0.378682672,41.19200808,0,-1.308180163,0.970614843,-1.347785038,0.177727532,0.294805252,N,-,,MFS multidrug transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); PTHR23502:SF40 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.85, the major facilitator superfamily (mfs).
RL4_JR_09864,40,49,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,79.20349724,0,-2.537913141,1.017154575,-2.495110579,0.012591788,0.045655026,22.77295064,0,-1.043742861,1.196214217,-0.872538419,0.382914719,0.54738017,104.6646779,0,-0.24210496,1.140413319,-0.212295802,0.83187627,0.891207975,147.3928268,0,0.603233616,0.450612051,1.338698365,0.180668889,0.306256906,73.14423194,0,-2.094652726,0.973679806,-2.151274692,0.031454525,0.078115541,N,-,,exs family,C:membrane,IPR004331 (PFAM); IPR004342 (PFAM); PTHR10783 (PANTHER); PTHR10783 (PANTHER); PTHR10783:SF41 (PANTHER); PTHR10783:SF41 (PANTHER); PTHR10783 (PANTHER); PTHR10783:SF41 (PANTHER); IPR004342 (PROSITE_PROFILES); IPR004331 (PROSITE_PROFILES),2.A.94.1.1, the phosphate permease (pho1) family.
RL4_JR_09865,196,265,86,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.947110506,0,0.230028072,1.139669367,0.201837549,0.840043725,0.919624667,20.71571805,0,4.136120867,0.991648686,4.170953811,3.03E-05,0.001677748,5.075610103,0,-0.154573373,1.19575595,-0.129268328,0.897145332,0.93607125,36.51423269,0,2.47451416,0.660413936,3.746913903,0.000179023,0.001747939,12.71852232,0,1.435222807,0.971891909,1.476730894,0.139747787,0.245607767,N,-,,chromatin assembly factor 1 subunit a,C:intracellular organelle; P:cellular process,IPR022043 (PFAM),1.F.2.1.1, the octameric exocyst (exocyst) family.
RL4_JR_09866,601,594,649,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,129.7027802,0,0.591307314,0.503690223,1.173950352,0.240414913,0.415146409,18.60512995,0,-0.75209995,1.226575034,-0.613170764,0.539763434,0.686626301,62.38281812,0,-1.577152716,1.050225214,-1.501728101,0.133167343,0.239933473,123.3096819,0,0.127592799,0.572710233,0.222787706,0.823700737,0.889312216,61.90861405,0,-1.779161356,0.986801868,-1.802957021,0.071394965,0.147045162,N,-,,hypothetical protein CMQ_7308,,PTHR42065 (PANTHER); PTHR42065:SF1 (PANTHER),,
RL4_JR_09867,21,31,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,252.7501317,0,-1.275206104,0.533949381,-2.388252798,0.016928693,0.057471609,69.32198931,0,-1.524383887,1.134192096,-1.344026195,0.178939916,0.316648572,161.4177506,0,-4.124591658,1.212301065,-3.402283292,0.000668253,0.004173594,226.5131995,0,-2.357234872,0.724344475,-3.254300895,0.001136718,0.008220908,179.3521637,0,-1.833887232,0.683026849,-2.684941646,0.007254247,0.024306274,N,-,,FAD synthetase,C:cytoplasm; F:catalytic activity; P:metabolic process,IPR002500 (PFAM); IPR014729 (G3DSA:3.40.50.GENE3D); PTHR23293 (PANTHER); PTHR23293 (PANTHER); PTHR23293:SF9 (PANTHER); PTHR23293:SF9 (PANTHER); SSF52402 (SUPERFAMILY),,
RL4_JR_09868,170,215,287,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.222310635,0,1.60798452,1.376596435,1.168087087,0.242771638,NA,0.390240411,0,4.823058158,1.60611338,3.002937538,0.002673873,0.015349618,1.012441448,0,2.170893255,1.231169454,1.763277386,0.077853718,0.159488271,10.80323422,0,2.697951372,1.14814462,2.349835836,0.018781693,0.074464508,0.998442584,0,2.088418523,1.214638021,1.719375228,0.08554607,0.169900737,N,-,,glutaminyl-tRNA synthetase,F:ATP binding; C:cytoplasm; F:glutamine-tRNA ligase activity; P:glutaminyl-tRNA aminoacylation,IPR000924 (PRINTS); IPR020059 (PFAM); IPR020056 (G3DSA:2.40.240.GENE3D); IPR004514 (TIGRFAM); IPR014729 (G3DSA:3.40.50.GENE3D); G3DSA:3.90.800.10 (GENE3D); IPR020058 (PFAM); IPR020061 (G3DSA:1.10.1160.GENE3D); IPR020056 (G3DSA:2.40.240.GENE3D); PTHR11451 (PANTHER); PTHR11451 (PANTHER); PTHR11451 (PANTHER); PTHR11451:SF29 (PANTHER); PTHR11451:SF29 (PANTHER); IPR011035 (SUPERFAMILY); SSF52374 (SUPERFAMILY),,
RL4_JR_09869,505,711,520,1,0,0,0,0,0,1,0,0,1,3,0,0,0,0,0.20180813,1,4.206387531,3.043798674,1.38195327,0.16698605,NA,0.065797234,0,7.391583815,2.369496,3.119475119,0.001811736,0.015023052,0.168733239,1,4.755862466,1.478002568,3.217763331,0.001291944,0.007047219,0.194483506,1,4.334932198,1.950429334,2.22255281,0.026245969,0.086335425,0.164741874,0,4.685230813,1.339868271,3.496784657,0.000470902,0.00257445,N,-,,serine threonine kinase,F:ATP binding; F:protein serine/threonine kinase activity; P:protein phosphorylation,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR37542:SF1 (PANTHER); PTHR37542 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); IPR011009 (SUPERFAMILY),1.C.104.2.4, the heterokaryon incompatibility prion/amyloid protein (het-s) family
RL4_JR_09870,1221,942,850,0,6,0,0,0,0,0,0,0,0,0,0,0,5,0,11.80448989,1,5.681713955,0.927627777,6.124993342,9.07E-10,2.51E-08,0.112224248,0,6.621014302,2.084598443,3.176158134,0.001492396,0.015023052,0.290199325,0,3.973097315,1.352024464,2.938628274,0.003296682,0.014523764,0.334672109,0,3.551670363,1.602602585,2.21618909,0.026678555,0.086855423,0.285678418,1,3.89239536,1.277054941,3.047946675,0.002304108,0.009568948,N,-,,serine threonine kinase,F:kinase activity,IPR000719 (SMART); IPR000719 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR23257 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011009 (SUPERFAMILY),8.A.23.1.12, the basigin (basigin) family.
RL4_JR_09871,542,586,510,0,0,24,0,0,3,3,1,0,0,3,5,0,5,9,0.413318891,1,3.172198755,2.173356339,1.459585204,0.144404108,NA,0.131605579,1,6.391015932,1.991864252,3.208559984,0.001334015,0.015023052,0.342431944,1,3.734012569,1.312259465,2.845483435,0.004434407,0.017373813,0.395077314,1,3.312179584,1.504803018,2.201071864,0.027730937,0.088461164,0.339048898,1,3.646353894,1.257662629,2.899310046,0.003739849,0.014134367,N,-,,CMGC SRPK kinase,F:ATP binding; F:protein serine/threonine kinase activity; P:protein phosphorylation,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24055:SF229 (PANTHER); PTHR24055 (PANTHER); PTHR24055 (PANTHER); PTHR24055:SF229 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.A.15.3.1, the autophagy-related phagophore-formation transporter (apt) family.
RL4_JR_09872,172,150,124,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.015953485,1,7.867140353,3.973076766,1.980112848,0.04769085,NA,0.005346613,0,11.01668392,3.970228347,2.774823752,0.005523163,0.021974647,0.013444566,0,8.408299533,2.921098072,2.878472179,0.003996065,0.01637703,0.015478003,0,7.987409939,3.972128364,2.010864002,0.044339824,0.114176173,0.012834372,0,8.355328124,1.611812863,5.183807821,2.17E-07,4.29E-06,N,-,,immunoglobulin variable region used by the itc63b heavy chain,,no IPS match,,
RL4_JR_09873,91,105,90,0,0,0,0,0,0,0,0,0,3,2,0,0,0,0,0.020821818,0,7.486458809,3.957797453,1.891571991,0.058548031,NA,0.006527476,0,10.72632783,3.958737066,2.709532775,0.006737805,0.025230672,0.016980947,0,8.072889215,2.849937382,2.832654944,0.004616319,0.017851647,0.019602312,1,7.647512339,3.958498577,1.931922468,0.053369076,0.127203836,0.016649689,0,8.007475228,1.678033554,4.771939874,1.82E-06,2.40E-05,N,-, Effector probability:0.801,catabolic 3-dehydroquinase,F:methyltransferase activity,IPR009959 (PFAM); PTHR41551 (PANTHER); IPR032710 (SUPERFAMILY),,
RL4_JR_09874,1869,1715,1896,0,1,17,0,0,0,8,20,23,10,40,6,0,31,11,0.293384553,1,3.666847385,2.514531427,1.458262699,0.144768148,NA,0.093409658,0,6.885837644,2.120413486,3.24740325,0.001164633,0.015023052,0.24244728,1,4.233673429,1.326857001,3.190753357,0.001419024,0.007577107,0.279714748,1,3.810921228,1.617684464,2.35578774,0.018483476,0.074146273,0.238899995,1,4.152875418,1.248380085,3.326611396,0.000879089,0.004308593,N,-,,pyridine nucleotide-disulfide oxidoreductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR008979 (G3DSA:2.60.120.GENE3D); IPR023753 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR10668 (PANTHER); PTHR10668:SF4 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_09875,2149,3104,4304,0,1,6,0,0,0,0,4,4,7,11,1,0,12,4,226.3248492,1,7.401034935,1.08791712,6.802940039,1.03E-11,4.31E-10,0.438954362,0,4.653231317,1.586221117,2.933532574,0.003351285,0.016419025,183.1081591,1,7.328984604,2.03500361,3.601460248,0.000316435,0.002423287,59.13131367,1,5.379271154,1.681103202,3.19984588,0.001375011,0.009681492,30.59519294,1,4.577299542,0.782602204,5.848820153,4.95E-09,2.45E-07,Y,-,,beta-glucosidase G,C:extracellular space; F:beta-glucosidase activity; P:cellulose catabolic process; F:scopolin beta-glucosidase activity,IPR001764 (PRINTS); IPR026891 (SMART); IPR001764 (G3DSA:3.20.20.GENE3D); IPR002772 (PFAM); IPR001764 (PFAM); IPR002772 (G3DSA:3.40.50.GENE3D); IPR026891 (PFAM); IPR026892 (PANTHER); IPR026892 (PANTHER); PTHR30620:SF53 (PANTHER); IPR017853 (SUPERFAMILY); IPR002772 (SUPERFAMILY),,
RL4_JR_09876,152,233,249,0,0,10,0,0,0,1,0,1,1,0,0,0,0,0,5.523008567,1,2.074641091,1.164513657,1.781551533,0.074822394,0.179269154,0.541622541,0,4.35009253,1.522929567,2.856397711,0.00428478,0.018621961,1.409005453,1,1.694073848,1.226322059,1.381426547,0.167147848,0.284308604,1.625737346,1,1.271567398,1.245426468,1.020989541,0.307259394,0.452994097,1.392884591,0,1.608385262,1.219243658,1.319166396,0.18711349,0.306111502,N,-,,Aminopeptidase 2,P:peptide catabolic process; P:proteolysis; F:metalloaminopeptidase activity,IPR014782 (PRINTS); IPR014782 (PFAM); G3DSA:1.10.390.10 (GENE3D); IPR024571 (PFAM); PTHR11533:SF190 (PANTHER); IPR001930 (PANTHER); SSF55486 (SUPERFAMILY),3.A.1.145.1, the atp-binding cassette (abc) superfamily.
RL4_JR_09877,3302,3086,4940,0,2,1,0,0,0,0,3,0,0,2,0,0,3,0,0.505385331,1,2.88208879,1.971632875,1.461777609,0.143802162,NA,0.161849586,0,6.092740585,1.910159973,3.189649386,0.001424455,0.015023052,0.419412596,1,3.441942495,1.289172127,2.669885909,0.007587702,0.026235621,0.483775204,1,3.020133456,1.4311936,2.110220068,0.034839405,0.099498352,0.413442246,1,3.359767552,1.24168771,2.705807205,0.006813859,0.023096861,N,-,,tetratricopeptide repeat-containing,F:organic cyclic compound binding; F:heterocyclic compound binding,IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (SUPERFAMILY),,
RL4_JR_09878,411,592,616,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0.892504595,1,2.061856244,1.548900074,1.331174476,0.183131608,NA,0.284076361,0,5.281196075,1.709509891,3.089304194,0.002006259,0.015023052,0.737418078,0,2.628748532,1.253267793,2.097515429,0.035947973,0.087886326,0.85077933,0,2.206141288,1.313293347,1.679854156,0.092985695,0.185373294,0.726670104,1,2.547464954,1.227263081,2.0757285,0.037919069,0.090251662,N,-,,---NA---,,IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (SUPERFAMILY),,
RL4_JR_09879,5466,3641,3753,10,1,1,0,0,0,0,7,17,3,4,9,0,7,6,0.141851531,1,4.715337132,3.535022394,1.333891729,0.182239343,NA,0.045974526,0,7.909368805,2.546219529,3.106318491,0.001894326,0.015023052,0.117725638,1,5.277784095,1.546726661,3.412228047,0.000644342,0.004059314,0.135717592,1,4.854774937,2.200795446,2.205918295,0.027389721,0.088070176,0.114197372,1,5.21656214,1.351537921,3.859723104,0.000113516,0.000770855,N,-,,aminotransferase,F:pyridoxal phosphate binding; F:transaminase activity,IPR005814 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR015421 (G3DSA:3.40.640.GENE3D); PTHR11986:SF78 (PANTHER); IPR005814 (PANTHER); IPR015424 (SUPERFAMILY),9.B.313.1.2, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_09880,2369,2397,3066,5,1,9,0,0,0,0,10,1,1,9,7,0,3,0,0.103047747,1,5.176016926,3.917106935,1.321387701,0.186372125,NA,0.033736863,0,8.355588683,2.687634651,3.10890049,0.00187785,0.015023052,0.086252005,1,5.724369432,1.600462612,3.576696756,0.000347963,0.002609468,0.099397165,1,5.303402198,2.429319378,2.183081503,0.029029808,0.090493422,0.083915144,1,5.656510736,1.364641306,4.145053144,3.40E-05,0.000279433,N,-,,CMGC kinase,F:kinase activity,IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24362 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.2, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_09881,13879,14378,16934,0,3,20,0,0,2,2,2,4,3,9,2,0,4,0,0.007786068,1,8.896911713,4.040984052,2.201669593,0.027688656,NA,0.002502822,1,12.10389348,4.040376809,2.995733828,0.002737853,0.015349618,0.006502266,1,9.448056946,3.305547956,2.858242286,0.00425995,0.016940088,0.007499321,1,9.02784755,4.040049892,2.234588134,0.025444401,0.085851084,0.00645541,1,9.348501478,1.703823852,5.486776974,4.09E-08,1.17E-06,N,-,,Short-chain dehydrogenase reductase SDR,C:membrane,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24322:SF583 (PANTHER); PTHR24322:SF583 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09882,2530,2781,2859,0,2,4,0,0,0,1,0,1,1,3,0,0,0,3,8.014746178,1,-1.104882289,1.219516855,-0.906000015,0.364935844,0.55668411,2.54044979,0,2.120402394,1.301946375,1.628640346,0.103389178,0.207722362,22.30037287,1,1.288021099,1.047763101,1.229305649,0.21895723,0.348103486,7.63261105,1,-0.95935251,1.212780837,-0.791035347,0.428923365,0.571502707,18.12116493,1,1.562805578,0.882521838,1.770840687,0.076587198,0.155618178,N,-,,monocarboxylate permease,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11360:SF97 (PANTHER); PTHR11360 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.13.26, the major facilitator superfamily (mfs).
RL4_JR_09883,2202,1662,1349,0,3,8,0,0,0,2,0,1,0,8,0,0,0,2,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,C6 finger domain-containing,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR021858 (PFAM),,
RL4_JR_09884,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.020162965,0,7.530309459,3.959361818,1.901899802,0.057184255,NA,0.006518434,0,10.72863192,3.595247881,2.984114664,0.002844002,0.015349618,0.016737713,0,8.093068843,2.110155252,3.835295453,0.000125413,0.001330907,0.019298012,0,7.668814375,3.959262975,1.936929783,0.052753927,0.126422133,0.016299842,0,8.024147024,1.467629563,5.467419861,4.57E-08,1.23E-06,N,-,,alcohol dehydrogenase,"F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:NAD binding; P:oxidation-reduction process",IPR016040 (G3DSA:3.40.50.GENE3D); IPR006139 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR006140 (PFAM); PTHR10996 (PANTHER); PTHR10996:SF138 (PANTHER); SSF52283 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_09885,4764,3827,4346,0,1,7,0,0,1,0,1,1,1,5,0,0,0,0,0.097945762,1,5.249056621,3.917643264,1.339850586,0.180293926,NA,0.031041986,1,8.474078189,2.807588637,3.018276281,0.00254217,0.015349618,0.081282751,1,5.806981486,1.714290413,3.387396582,0.000705593,0.004350944,0.093800412,1,5.386177032,2.599711863,2.071836155,0.038280724,0.104359808,0.081230995,0,5.706702462,1.454081824,3.924608897,8.69E-05,0.000615943,N,-,,tartrate transporter,P:transmembrane transport; C:integral component of membrane; P:antibiotic transport,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662:SF165 (PANTHER); PTHR11662 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_09886,2351,1764,3178,0,0,0,0,0,0,0,0,2,0,0,0,0,8,0,38.27410073,0,-2.069496986,1.165774371,-1.775212286,0.075862842,0.18111077,9.603185758,0,0.201938494,1.234269787,0.163609687,0.870038418,0.924958394,25.03786971,1,-2.457129801,1.208654897,-2.03294572,0.042058007,0.09936879,36.91444665,0,-1.165012451,1.042138888,-1.11790517,0.263607497,0.404275356,24.83598391,1,-2.548144572,1.219562418,-2.089392501,0.036672406,0.087966858,N,-,,Zn(2)-C6 fungal-type DNA-binding domain,F:binding,IPR001138 (SMART); IPR007219 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR007219 (PFAM); PTHR31944 (PANTHER); PTHR31944:SF81 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09887,640,789,652,1,0,3,0,0,0,0,0,0,0,4,0,0,0,0,1.188062075,1,1.64914104,1.449641426,1.137619973,0.255279203,NA,0.376111876,0,4.876204293,1.635411184,2.981638099,0.002867107,0.015349618,0.980162296,0,2.217809908,1.255237659,1.766844622,0.077254253,0.158677635,1.131099263,1,1.795057929,1.299339465,1.381515745,0.16712044,0.288097136,0.970046234,0,2.130602863,1.241302153,1.716425657,0.086084164,0.170734997,N,-,,hydrolase of the alpha beta superfamily,P:transmembrane transport; C:membrane; C:integral component of membrane; F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR000801 (PFAM); PTHR40841:SF1 (PANTHER); PTHR40841 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_09888,613,624,910,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,17.47247463,1,-2.229410813,1.183908349,-1.883094088,0.059687618,0.151881344,5.594500404,0,0.981532208,1.237696922,0.793031146,0.427759677,0.590612938,14.48377519,0,-1.667382588,1.190404574,-1.400685635,0.1613081,0.276793764,73.22602012,1,1.254359852,0.609020145,2.05963606,0.039433346,0.106530148,14.24997914,0,-1.74671387,1.189933017,-1.467909408,0.142128832,0.248756167,N,-,,transcription activator,"F:metal ion binding; C:membrane; P:regulation of transcription, DNA-templated",IPR007219 (SMART); IPR007219 (PFAM),,
RL4_JR_09889,6569,6002,7710,0,2,5,0,0,0,0,1,2,0,4,0,0,0,0,325.0066065,1,4.906106092,1.210789634,4.051988848,5.08E-05,0.000474024,3.465784753,0,1.672400893,1.287076146,1.299379915,0.193813581,0.336266895,188.8821584,1,4.199294922,0.508290067,8.261611215,1.44E-16,1.73E-14,452.6562963,1,5.494572927,0.507839993,10.8194963,2.78E-27,4.03E-25,52.95432947,0,2.380582071,1.380086297,1.724951603,0.084536195,0.168258103,N,-,,amino acid permease,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR004841 (PFAM); IPR002293 (PIRSF); IPR002293 (PANTHER); PTHR11785:SF336 (PANTHER),2.A.3.10.13, the amino acid-polyamine-organocation (apc) family.
RL4_JR_09890,1638,1592,2682,3,0,4,0,0,0,0,0,0,0,3,0,0,0,0,86.42380041,1,-1.541041566,0.743313966,-2.073204105,0.038153289,0.108830254,22.8093785,0,-1.046008902,1.2038307,-0.868900338,0.384901645,0.549502743,58.98113444,0,-3.693175338,1.19016362,-3.103082028,0.001915165,0.009556057,80.06307734,1,-1.811358636,0.854588655,-2.119567848,0.034042506,0.0989162,111.1449079,0,-0.322071111,0.567817511,-0.567208839,0.570572304,0.686435905,N,-,,vegetative incompatibility het-e-1,C:membrane,IPR020472 (PRINTS); IPR001680 (SMART); IPR001680 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PF05729 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22847:SF50 (PANTHER); PTHR22847:SF50 (PANTHER); PTHR22847 (PANTHER); PTHR22847 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR007111 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR027417 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_09891,1209,1301,1875,0,1,9,0,0,1,0,2,0,4,1,2,0,0,0,91.38274928,1,-0.715608039,0.649325652,-1.102078805,0.270427413,0.452079269,19.32922691,1,-0.807185154,1.22332357,-0.659829642,0.509363159,0.661166011,49.93429377,1,-3.452983212,1.204421134,-2.866923466,0.004144832,0.016732832,61.59790037,1,-2.928743402,1.159505731,-2.525855047,0.011541709,0.054328129,64.50192559,0,-0.93733278,0.779338178,-1.202729195,0.229081132,0.35661846,N,-,,kinase-like domain,P:protein metabolic process; F:organic cyclic compound binding; F:heterocyclic compound binding; F:peptidase activity,no IPS match,,
RL4_JR_09892,61277,69272,99483,4,9,20,0,0,2,2,6,0,0,7,0,0,15,0,0.100736941,1,5.209024035,3.917345955,1.329732961,0.183606271,NA,0.032087497,1,8.427538549,2.623460263,3.212375147,0.001316424,0.015023052,0.083210938,1,5.777159836,1.497072649,3.858970931,0.000113865,0.001251467,0.095999243,1,5.353861635,2.349939722,2.278297432,0.022708863,0.081131698,0.081876268,1,5.698876699,1.296217923,4.396542123,1.10E-05,0.000109287,N,-,,hypothetical protein SPI_06398,,no IPS match,,
RL4_JR_09893,1585,1875,1702,0,3,2,0,0,0,4,0,2,1,5,0,0,2,0,1.9152823,1,0.960286266,1.335724574,0.718925357,0.472186912,NA,0.606765244,0,4.186281546,1.523749493,2.747355497,0.006007798,0.023329322,1.579628655,1,1.529502269,1.245340871,1.228179613,0.21937955,0.348610668,1.822814066,1,1.106741077,1.268156064,0.87271678,0.382817469,0.528205758,1.560906547,1,1.444216598,1.238997105,1.165633553,0.243762636,0.373331824,Y,-,,---NA---,,no IPS match,,
RL4_JR_09894,21234,16407,23734,2,0,10,0,0,0,0,5,2,0,0,0,0,0,0,8.415832558,1,4.152191993,1.19694774,3.468983528,0.000522431,0.003490789,0.128097934,0,6.429826079,2.01401927,3.192534538,0.001410301,0.015023052,97.8160911,1,8.219498171,1.779469306,4.619072744,3.85E-06,8.39E-05,403.0469127,0,9.958770735,0.454170701,21.92737383,1.42E-106,4.81E-103,183.1501335,0,9.304390457,0.670316768,13.88058736,8.31E-44,1.40E-40,Y,-,,Hydroxyneurosporene synthase,,SSF159245 (SUPERFAMILY),,
RL4_JR_09895,6240,5459,6575,0,3,22,0,1,0,7,8,2,0,24,6,4,6,2,2.847111371,1,0.387951345,1.233709755,0.314459169,0.753172323,0.870775614,0.909038218,1,3.603065385,1.419786953,2.537750737,0.011156742,0.036511005,2.359240393,1,0.950372146,1.214182408,0.782726005,0.433788028,0.574299724,2.721617153,1,0.528099034,1.219818108,0.432932607,0.66506373,0.771513551,2.328281404,1,0.866862189,1.211456874,0.715553486,0.474267104,0.604551734,N,-,,het-domain-containing,,IPR010730 (PFAM); PTHR33112:SF6 (PANTHER); PTHR33112 (PANTHER); PTHR33112 (PANTHER),,
RL4_JR_09896,206,276,234,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,114.3992806,0,-0.119267787,0.647841106,-0.18410037,0.853934716,0.927316971,20.23130091,0,-0.872983877,1.249466539,-0.698685279,0.484748736,0.641221472,78.45955226,0,-0.733190809,0.819510343,-0.894669378,0.370963853,0.515263792,92.48019591,0,-1.166806537,0.818933396,-1.424788075,0.15421847,0.271322678,63.14367411,0,-1.433603602,0.91786016,-1.561897623,0.118312109,0.216698643,N,-,,bleomycin hydrolase,P:proteolysis; F:double-stranded DNA binding; F:cysteine-type endopeptidase activity,IPR004134 (PFAM); G3DSA:3.90.70.10 (GENE3D); IPR004134 (PIRSF); PTHR10363:SF2 (PANTHER); IPR004134 (PANTHER); IPR004134 (PANTHER); PTHR10363:SF2 (PANTHER); SSF54001 (SUPERFAMILY),,
RL4_JR_09897,529,538,384,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,63.94224452,1,-0.98955973,0.737590748,-1.341610821,0.179722216,0.336710446,15.58657475,0,-0.496700392,1.207130189,-0.411472099,0.680726396,0.797213072,53.35121387,0,-1.325269771,1.030831744,-1.285631509,0.198571695,0.323830515,65.17041156,0,-1.826074003,1.01157336,-1.805181982,0.071046209,0.152694305,50.93611684,0,-1.548277471,0.96797659,-1.59949888,0.109709797,0.204682458,N,-,,5 -nucleotidase,"F:nucleotide binding; F:hydrolase activity, acting on ester bonds; F:metal ion binding; P:nucleotide catabolic process; C:integral component of membrane",IPR006179 (PRINTS); IPR008334 (G3DSA:3.90.780.GENE3D); IPR029052 (G3DSA:3.60.21.GENE3D); IPR008334 (PFAM); IPR004843 (PFAM); PTHR11575:SF7 (PANTHER); IPR006179 (PANTHER); IPR008334 (SUPERFAMILY); IPR029052 (SUPERFAMILY),,
RL4_JR_09898,1132,1079,950,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,255.5551934,0,0.446927102,0.963165978,0.464018779,0.642634291,0.796362353,43.19227396,0,-0.698100484,1.130641117,-0.61743773,0.536946042,0.68390183,243.9242119,0,0.951089684,0.625668809,1.520116827,0.128481616,0.233947461,217.9262544,0,0.009791347,0.544579616,0.017979643,0.985655093,0.991333845,211.3880728,0,0.101667202,0.658973745,0.154281111,0.87738809,0.918291752,Y,-,,hemerythrin hhe cation binding domain-containing,,IPR012312 (PFAM); G3DSA:1.20.120.520 (GENE3D); PTHR38048 (PANTHER); PTHR38048:SF2 (PANTHER),,
RL4_JR_09899,23323,21444,20195,10,6,12,3,4,4,0,1,2,4,7,2,0,5,0,2609.709272,1,-1.890181188,0.472443118,-4.000865109,6.31E-05,0.000569245,709.4334422,1,-3.077206569,0.797347206,-3.859305641,0.00011371,0.00545483,1894.34917,1,-3.159488621,0.67274552,-4.696409752,2.65E-06,6.12E-05,2091.272933,1,-4.04814181,0.499254178,-8.108378428,5.13E-16,3.46E-14,1792.213855,1,-3.605390256,0.842025618,-4.281805897,1.85E-05,0.000168643,N,-,,heat shock sti1,C:nucleus; P:negative regulation of catalytic activity; F:ATPase inhibitor activity; C:cytosol; F:mRNA binding; F:Hsp90 protein binding; P:protein folding; F:Hsp70 protein binding,IPR006636 (SMART); IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); PF13424 (PFAM); IPR013105 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR22904 (PANTHER); PTHR22904:SF389 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR013026 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY),3.A.21.1.1, the c-terminal tail-anchored membrane protein biogenesis/ insertion complex (tamp-b) family.
RL4_JR_09900,4139,5031,6468,3,0,4,0,0,0,1,0,3,0,15,0,0,1,0,488.8290351,1,-1.311178763,0.497906896,-2.633381409,0.008453935,0.033189222,114.0944624,0,-3.368575722,1.200764852,-2.805358365,0.005026066,0.020714106,332.5382887,1,-3.198089997,0.767740734,-4.165585925,3.11E-05,0.000485193,385.4247799,1,-3.357511844,0.698943072,-4.80369858,1.56E-06,2.71E-05,336.9792594,1,-2.283910436,0.745923061,-3.061857924,0.002199678,0.009184224,N,-,,3-hydroxy-3-methylglutaryl-coenzyme a reductase,C:peroxisomal membrane; C:endoplasmic reticulum membrane; F:NADP binding; C:integral component of membrane; P:ergosterol biosynthetic process; P:coenzyme A metabolic process; P:oxidation-reduction process; P:isoprenoid biosynthetic process; F:hydroxymethylglutaryl-CoA reductase (NADPH) activity,IPR002202 (PRINTS); IPR009023 (G3DSA:3.30.70.GENE3D); IPR004554 (TIGRFAM); IPR000731 (PFAM); IPR025583 (PFAM); IPR002202 (PFAM); IPR023074 (G3DSA:3.90.770.GENE3D); IPR023282 (G3DSA:1.10.3270.GENE3D); PTHR10572:SF2 (PANTHER); IPR002202 (PANTHER); PTHR10572:SF2 (PANTHER); IPR002202 (PANTHER); IPR000731 (PROSITE_PROFILES); IPR002202 (PROSITE_PROFILES); IPR009023 (SUPERFAMILY); IPR009029 (SUPERFAMILY),2.A.6.6.5, the resistance-nodulation-cell division (rnd) superfamily.
RL4_JR_09901,6084,6774,6430,0,3,35,0,0,0,3,4,2,5,22,5,0,0,4,91.87368093,1,1.055452357,0.587982117,1.795041595,0.072647073,0.175617847,10.55918893,0,0.065034605,1.241702084,0.052375369,0.9582296,0.977939102,38.67439181,1,-1.636082066,1.21623394,-1.345203429,0.178559549,0.298580295,31.86033754,1,-3.020901093,1.220667884,-2.47479362,0.013331319,0.06085792,42.15564124,1,-0.982000226,1.013659192,-0.968767643,0.332661134,0.469369284,N,-,,pyrazinamidase nicotinamidase,F:catalytic activity; P:metabolic process,IPR000868 (PFAM); IPR000868 (G3DSA:3.40.50.GENE3D); PTHR11080:SF2 (PANTHER); PTHR11080 (PANTHER); IPR000868 (SUPERFAMILY),,
RL4_JR_09902,2696,1951,2634,2,0,0,0,0,0,0,2,3,1,3,5,0,0,0,130.0740111,1,0.010087504,0.491814068,0.020510809,0.98363589,0.991605119,21.35227034,0,-0.95083584,1.199751666,-0.792527209,0.428053333,0.590857198,161.7511135,1,0.815106406,0.459938786,1.772206283,0.076360321,0.157224302,148.673028,1,0.402751837,0.446124488,0.902779039,0.366643178,0.513097744,58.77233278,0,-2.763182555,1.129972116,-2.445354639,0.014470977,0.042297529,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,PR01036 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501:SF73 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_09903,3496,4421,7543,0,0,3,0,0,0,1,1,1,0,5,1,0,0,0,5.522729734,1,-0.567614044,1.195431255,-0.474819478,0.634915649,0.791837971,1.762309518,0,2.648060365,1.318325135,2.008654993,0.044573735,0.107781974,4.57100089,1,-0.003513624,1.19733181,-0.002934545,0.997658575,0.999239715,5.2731749,1,-0.425840782,1.19510703,-0.356320205,0.72160078,0.814152874,4.504241876,0,-0.084993374,1.196832062,-0.071015289,0.943385588,0.964144451,N,-,,C6 zink-finger PRO1A,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR021858 (PFAM),,
RL4_JR_09904,2763,2327,2376,0,1,6,0,0,0,0,0,3,0,7,2,0,5,0,1.110529076,1,1.746567141,1.476212354,1.183140851,0.23675333,NA,0.357467118,0,4.949832312,1.673243664,2.958225642,0.003094155,0.015857742,0.920946307,1,2.308451782,1.263971212,1.826348385,0.067797801,0.143116126,1.062018732,1,1.88639501,1.313851347,1.435775071,0.151066356,0.267316889,0.90036625,1,2.237572012,1.233773566,1.813600221,0.069739296,0.144487492,N,-,,hypothetical protein CMQ_1302,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09905,2853,4113,4083,0,0,1,0,0,0,0,0,0,1,1,0,0,2,0,2.464071824,1,0.596856533,1.283046858,0.465186856,0.641797651,0.796196052,0.791491286,0,3.803014752,1.479349336,2.570734755,0.010148302,0.033934956,2.041639552,0,1.159692079,1.235924641,0.93831941,0.348080288,0.491555982,2.354586156,1,0.737680751,1.249402302,0.590426918,0.554904468,0.683754137,1.998287155,1,1.087495624,1.221594921,0.890226052,0.373344519,0.50958658,N,-,,hypothetical protein CMQ_392,C:membrane,no IPS match,,
RL4_JR_09906,139,151,146,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,151.9483933,1,0.397825275,0.834959949,0.476460308,0.633746479,0.791550676,39.25715001,0,0.750475157,0.985212002,0.761739763,0.446215338,0.607477021,91.00610921,0,-0.398133358,0.664913369,-0.598774783,0.54932308,0.676480582,122.9380058,0,0.083960613,0.482573527,0.173985119,0.861877157,0.914632241,85.62852353,0,-0.66273212,0.666252769,-0.994715745,0.319874534,0.455197422,N,-,,golgi to endosome transport,P:vesicle-mediated transport; C:intracellular membrane-bounded organelle; P:endosomal transport; C:cytoplasmic part; F:binding,IPR013809 (SMART); IPR008942 (G3DSA:1.25.40.GENE3D); IPR013809 (PFAM); PTHR12276:SF45 (PANTHER); PTHR12276:SF45 (PANTHER); PTHR12276 (PANTHER); PTHR12276 (PANTHER); IPR013809 (PROSITE_PROFILES); IPR008942 (SUPERFAMILY),,
RL4_JR_09907,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1665.975355,0,0.798998399,0.421139123,1.897231475,0.057797394,0.148087671,344.1131675,0,0.003069256,0.628786656,0.004881236,0.996105353,0.997937453,1016.392097,0,-0.00332822,0.498292279,-0.006679253,0.994670767,0.99792358,1658.102941,0,0.872339916,0.373449883,2.335895542,0.019496686,0.075837092,950.2036455,0,-0.144607867,0.604440696,-0.23924244,0.810917596,0.87207017,N,-, Effector probability:0.936,peptidyl-prolyl cis-trans isomerase,F:peptidyl-prolyl cis-trans isomerase activity; C:mitochondrion; P:apoptotic process; F:peptide binding; P:protein peptidyl-prolyl isomerization; P:protein folding,IPR002130 (PRINTS); IPR029000 (G3DSA:2.40.100.GENE3D); IPR024936 (PIRSF); IPR002130 (PFAM); IPR024936 (PANTHER); IPR002130 (PROSITE_PROFILES); IPR029000 (SUPERFAMILY),3.D.1.8.1, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_09908,701,715,602,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,48.43851203,0,-3.700414053,1.272695871,-2.907539922,0.003642838,0.016771036,15.18554658,0,-0.459150832,1.268385861,-0.361996177,0.717354888,0.823038735,47.69615999,0,-2.165860673,1.245694747,-1.738676894,0.082091613,0.166252348,63.66767089,0,-1.253520469,0.94847427,-1.32161779,0.186295456,0.314059523,65.69900731,0,-0.557944647,0.862208173,-0.647111295,0.517559916,0.643121685,N,-,,DNA-directed RNA polymerase III subunit RPC6,C:nucleus; P:RNA biosynthetic process; C:cytoplasmic part,IPR011991 (G3DSA:1.10.10.GENE3D); IPR007832 (PFAM); PTHR12780:SF1 (PANTHER); IPR016049 (PANTHER); PTHR12780:SF1 (PANTHER); IPR016049 (PANTHER); PTHR12780:SF1 (PANTHER); IPR011991 (SUPERFAMILY),,
RL4_JR_09909,964,1275,1116,0,1,5,0,0,0,1,1,4,1,0,0,0,6,0,87.64155273,1,-0.034690732,0.628442956,-0.055201083,0.955978266,0.977792213,15.38673153,0,-0.47814047,1.224769418,-0.390392235,0.696246529,0.807389704,53.17761731,1,-1.325618674,1.058320832,-1.252567873,0.210363013,0.338050022,46.37206482,1,-3.562384176,1.214277971,-2.933746853,0.003348972,0.020304398,39.86870346,1,-3.230953066,1.221780249,-2.644463331,0.008182057,0.026732278,N,-,,homodimeric type,C:nucleus; P:'de novo' pyrimidine nucleobase biosynthetic process; C:cytoplasm; F:dihydroorotase activity; P:pyrimidine nucleotide biosynthetic process,G3DSA:3.20.20.140 (GENE3D); IPR006680 (PFAM); IPR004721 (PTHR11647:PANTHER); PTHR11647 (PANTHER); IPR032466 (SUPERFAMILY),,
RL4_JR_09910,30116,33827,49708,7,8,69,0,1,0,0,1,1,3,30,0,0,29,4,2.007421759,1,0.892140671,1.405347037,0.634818765,0.525546623,NA,0.631547061,1,4.128295952,1.5628773,2.641471569,0.008254674,0.029217138,8.155722655,1,2.421404118,1.249315607,1.938184479,0.05260072,0.117674862,1.912698757,1,1.036822988,1.320016192,0.785462326,0.432182551,0.574484486,1.654968711,1,1.359491251,1.2899863,1.053880379,0.291937687,0.426597626,N,-,,Aldo keto reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR023210 (G3DSA:3.20.20.GENE3D); IPR023210 (G3DSA:3.20.20.GENE3D); IPR023210 (PFAM); IPR001395 (PANTHER); PTHR11732:SF245 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.6, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_09911,2986,3026,3515,8,0,7,0,2,0,0,0,0,2,1,3,0,0,0,23.01887854,1,-1.417949552,1.142486207,-1.241108683,0.214565602,0.383025423,6.143738978,1,0.846396184,1.237409375,0.684006604,0.493970996,0.649100136,28.91881601,0,0.015366499,1.035246289,0.014843327,0.988157174,0.994620753,18.36517004,1,-2.226163325,1.192869258,-1.866225749,0.062009788,0.139336241,38.85124515,0,1.292122617,0.637096496,2.028142716,0.042545684,0.098688443,Y,-,,eukaryotic aspartyl protease,P:protein metabolic process; F:peptidase activity,IPR001461 (PRINTS); IPR021109 (G3DSA:2.40.70.GENE3D); IPR033121 (PFAM); IPR021109 (G3DSA:2.40.70.GENE3D); PTHR13683:SF318 (PANTHER); IPR001461 (PANTHER); IPR033121 (PROSITE_PROFILES); IPR021109 (SUPERFAMILY),8.A.32.1.4,The β-Amyloid Cleaving Enzyme (BACE1) Family
RL4_JR_09912,1894,1538,1931,0,0,2,1,0,0,2,0,2,1,6,1,0,1,1,2.123857437,1,0.811160054,1.31127036,0.61860626,0.536175777,NA,0.673265794,1,4.036248721,1.497036325,2.696159508,0.007014407,0.025989957,1.752150355,1,1.37995843,1.239047209,1.113725466,0.265396981,0.403193132,2.021843969,1,0.957236397,1.257315905,0.761333244,0.446458049,0.588515525,1.730890331,1,1.295055912,1.233989611,1.049486884,0.293954089,0.428921336,N,-,,flavin-binding monooxygenase,F:nucleotide binding; F:coenzyme binding; F:monooxygenase activity,IPR023753 (G3DSA:3.50.50.GENE3D); IPR020946 (PFAM); PTHR23023:SF30 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_09913,5185,4391,4645,7,1,9,0,0,1,1,0,0,6,2,0,0,6,0,7.777695628,1,0.859210528,1.162322774,0.739218526,0.459774313,0.648037119,1.259780618,1,3.132362894,1.373356487,2.280808315,0.022559792,0.063360215,3.270998108,1,0.479394116,1.213324873,0.395107796,0.692763336,0.789812614,3.773888979,1,0.056902674,1.216014233,0.046794414,0.962677081,0.978772417,3.224269791,1,0.397455967,1.211899335,0.327961206,0.742940995,0.820403269,N,-,,methyltransferase type 12,C:cytoplasm; C:integral component of membrane; F:S-adenosylmethionine-dependent methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PF13649 (PFAM); PTHR10108:SF919 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_09914,3203,2762,3837,3,0,3,4,0,0,0,1,0,0,8,0,0,0,0,123.9749455,1,2.149424557,0.410145391,5.240640521,1.60E-07,3.03E-06,8.485464732,1,0.380513528,1.216007589,0.312920356,0.754341172,0.850190701,35.03661486,1,-0.452421141,1.029972051,-0.439255746,0.660476236,0.765502166,44.05139399,1,-0.954466628,1.010595712,-0.944459409,0.344934935,0.491758127,45.13807977,0,-0.668761658,0.970788362,-0.68888512,0.490895564,0.619431404,N,-,,hypothetical protein CMQ_735,C:integral component of membrane,no IPS match,,
RL4_JR_09915,6837,8712,12191,2,6,26,0,0,1,1,0,0,0,5,0,0,0,0,52.67839401,1,-0.150828047,0.685957958,-0.219879433,0.825965054,0.912420164,10.67554152,1,0.049246529,1.211576589,0.040646649,0.967577594,0.983216586,35.61023967,1,-1.644574971,1.192143812,-1.379510555,0.167737394,0.284880621,62.69733143,1,0.020722288,0.673838362,0.030752609,0.975466835,0.98517231,34.81098156,0,-1.756744383,1.128109415,-1.557246452,0.119411984,0.218436555,Y,-,,arsenate reductase,C:membrane; C:integral component of membrane; C:endoplasmic reticulum,IPR024382 (PFAM); PTHR36853:SF1 (PANTHER); PTHR36853 (PANTHER); PTHR36853 (PANTHER); PTHR36853:SF1 (PANTHER),8.A.80.3.1,The (Pro)Renin Receptor (PRR) Family
RL4_JR_09916,1442,1773,1792,4,0,0,0,0,0,0,0,3,0,0,1,0,6,1,76.69740466,1,0.176434209,0.649292828,0.271732878,0.785827419,0.889847237,11.84133606,0,-0.100306883,1.231148978,-0.081474204,0.935064839,0.964115952,30.93965587,1,-2.762448709,1.212089697,-2.279079441,0.022662343,0.061427996,71.02428514,1,0.11276134,0.667884194,0.168833671,0.865927473,0.916624743,30.73960231,1,-2.855798723,1.224236077,-2.332718972,0.0196629,0.053953079,N,-,,hypothetical protein CMQ_640,P:spliceosomal complex disassembly; C:U2-type post-mRNA release spliceosomal complex,IPR028211 (PFAM),,
RL4_JR_09917,1851,1852,3591,0,0,0,0,0,0,0,0,6,0,0,1,0,0,0,45.38019689,0,-3.606324911,1.212390655,-2.974556836,0.002934121,0.014138546,14.35848895,0,-0.378360854,1.218881884,-0.310416341,0.756244369,0.851847931,45.30251884,1,-2.076509802,1.204895891,-1.723393546,0.084817381,0.170206376,62.17686375,1,-1.705238854,1.033264521,-1.650341049,0.098873201,0.194198091,37.13836359,0,-3.128606106,1.214883673,-2.575231009,0.010017316,0.031449712,N,-,,LSM domain-containing,"F:RNA binding; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP; C:cytosol; C:viral nucleocapsid; C:U2-type prespliceosome; C:U2 snRNP; C:U1 snRNP; C:small nucleolar ribonucleoprotein complex; P:mRNA splicing, via spliceosome",IPR001163 (SMART); IPR001163 (PFAM); G3DSA:2.30.30.100 (GENE3D); PTHR10553 (PANTHER); IPR010920 (SUPERFAMILY),,
RL4_JR_09918,2613,2362,2883,1,0,11,0,0,0,0,0,5,0,0,2,0,1,0,118.7109813,1,1.241208444,0.648510818,1.913936377,0.055628286,0.143864074,9.664002203,0,0.192852297,1.220515244,0.158008921,0.874449769,0.928082695,25.17079305,1,-2.464733357,1.198648346,-2.056260591,0.039757405,0.095199613,29.04482924,1,-2.887427807,1.198724755,-2.408749628,0.016007275,0.068184123,40.35436565,1,0.039206704,0.781462447,0.050170937,0.959986171,0.973935166,N,-,,Thioredoxin 4A,C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP; C:spliceosomal complex; P:spliceosomal complex assembly,IPR004123 (SMART); IPR004123 (PFAM); IPR004123 (PIRSF); IPR012336 (G3DSA:3.40.30.GENE3D); IPR004123 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_09919,220,189,332,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.034169871,0,0.87345118,1.278577812,0.683142764,0.494516635,NA,0.649372379,0,4.088464853,1.490522512,2.742974238,0.006088546,0.023504296,1.682425362,0,1.438778139,1.223249013,1.176193991,0.239517365,0.372427247,9.963996917,0,2.738432974,1.028272292,2.663139905,0.007741522,0.039567345,9.375738192,0,3.025767296,0.986192308,3.068131105,0.002154021,0.0090159,N,-,,endonuclease exonuclease phosphatase family,P:nucleic acid phosphodiester bond hydrolysis; F:exonuclease activity; F:endonuclease activity; C:integral component of membrane,IPR005135 (G3DSA:3.60.10.GENE3D); PTHR15822 (PANTHER); PTHR15822:SF4 (PANTHER); IPR005135 (SUPERFAMILY),,
RL4_JR_09920,6,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.495322491,0,2.911178191,2.00680419,1.450653833,0.146876277,NA,0.160048011,0,6.109134169,1.93511834,3.156982208,0.001594111,0.015023052,0.411976559,0,3.468673629,1.30527916,2.657418991,0.007874151,0.027013862,0.475016279,0,3.04687109,1.45752434,2.090442681,0.036578052,0.101605701,0.403013443,0,3.396242317,1.247178411,2.723140721,0.006466451,0.022171627,N,-,,hypothetical protein SPI_03136,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09921,1172,1969,1636,0,0,3,0,0,0,0,0,4,0,3,0,0,1,0,0.003880053,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,1,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,hypothetical protein K432DRAFT_430554,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09922,4306,2964,2241,0,5,7,0,0,0,0,0,0,3,2,4,0,5,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,hypothetical protein K432DRAFT_430554,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09923,1008,896,1490,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0.007786068,1,8.896911713,4.040984052,2.201669593,0.027688656,NA,0.002502822,0,12.10389348,4.040376809,2.995733828,0.002737853,0.015349618,0.006502266,0,9.448056946,3.305547956,2.858242286,0.00425995,0.016940088,0.007499321,1,9.02784755,4.040049892,2.234588134,0.025444401,0.085851084,0.00645541,0,9.348501478,1.703823852,5.486776974,4.09E-08,1.17E-06,Y,-,,hypothetical protein K432DRAFT_447799,,no IPS match,,
RL4_JR_09924,3234,2523,2831,0,0,0,0,0,0,0,0,0,0,0,0,0,2,5,1.837278637,0,1.019850378,1.312869199,0.776810347,0.437270671,NA,0.58606921,0,4.236282373,1.522656372,2.782165728,0.005399746,0.02171483,1.522893039,0,1.581682921,1.237338422,1.278294517,0.2011456,0.326555173,1.756887011,0,1.159434054,1.258027199,0.921628765,0.356722249,0.502827895,1.505610713,1,1.49571916,1.231143015,1.214902852,0.224403146,0.351009092,Y,-, Effector probability:0.86,---NA---,,no IPS match,,
RL4_JR_09925,130,121,99,0,0,176,0,0,0,0,0,3,1,1,0,0,1,0,17.30059887,1,0.339944593,1.04381496,0.325675149,0.744670148,0.866004143,3.060446161,0,1.851729546,1.287387964,1.438361704,0.150331453,0.277218977,49.65544953,1,2.587347138,0.643369961,4.021554156,5.78E-05,0.000809576,21.23723572,1,1.057939576,0.885320825,1.194978753,0.232095332,0.36914314,23.33431013,1,1.686952761,0.800137094,2.108329652,0.035002485,0.084800872,N,-,,alpha-l-arabinofuranosidase ii,"P:carbohydrate metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR006710 (PFAM); IPR023296 (G3DSA:2.115.10.GENE3D); IPR006710 (PANTHER); PTHR22925:SF12 (PANTHER); IPR023296 (SUPERFAMILY),,
RL4_JR_09926,136,124,105,0,0,12,0,0,0,0,0,0,0,3,0,0,7,0,7.725745334,1,7.083568828,1.160105129,6.105971475,1.02E-09,2.80E-08,0.027739959,0,8.636837625,2.77003587,3.117951546,0.001821127,0.015023052,0.072778693,0,5.968995679,1.63099959,3.659716234,0.000252495,0.002044019,0.084025494,1,5.545760797,2.577275453,2.151792037,0.031413737,0.094803008,0.072458129,1,5.877083083,1.372208074,4.282938715,1.84E-05,0.000167937,N,-,,hypothetical protein CMQ_6888,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09927,446,495,462,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,143.0596451,0,-0.883559375,0.536406329,-1.64718298,0.099520441,0.220629553,31.91962387,0,-1.530856886,1.195274278,-1.280757826,0.200278742,0.344004993,93.98917208,0,-3.222850175,1.191363192,-2.70517857,0.006826768,0.024106801,107.7024487,1,-2.305396733,0.858388017,-2.685728002,0.007237198,0.037488272,89.53516307,0,-2.60091853,0.979952461,-2.654127249,0.007951384,0.026088062,N,-,,major facilitator superfamily transporter,F:zinc ion binding; P:transmembrane transport; F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF241 (PANTHER); PTHR11662 (PANTHER); PTHR11662:SF241 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.4, the major facilitator superfamily (mfs).
RL4_JR_09928,924,824,767,0,0,22,0,0,0,0,0,1,0,7,0,0,2,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-, Effector probability:0.604,similar to An04g03150,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_09929,555,428,518,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0.008115494,0,8.845278576,4.03634189,2.191409652,0.028422161,NA,0.002507343,0,12.10167175,4.040174693,2.995333784,0.002741447,0.015349618,0.006623884,0,9.426891884,3.299070491,2.857438757,0.00427075,0.016940088,0.007651472,1,9.002876608,4.037800151,2.229648886,0.025770762,0.085851084,0.006630333,0,9.341240721,1.70468121,5.479758129,4.26E-08,1.17E-06,N,-,,predicted protein,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_09930,307,226,300,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.076086993,0,5.61378129,3.920766692,1.431807024,0.152199057,NA,0.02472917,0,8.803971975,2.798411657,3.146060357,0.001654859,0.015023052,0.063376878,0,6.170359081,1.60683736,3.840064486,0.000123002,0.001314965,9.385322656,0,6.706145376,1.216823841,5.511188348,3.56E-08,8.93E-07,0.061684661,0,6.101864004,1.33139634,4.583056015,4.58E-06,5.28E-05,N,-,,hypothetical protein FOYG_15868,F:GTP binding; C:membrane; C:integral component of membrane,IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (SUPERFAMILY),,
RL4_JR_09931,467,632,521,0,0,29,0,0,0,2,2,5,8,18,2,6,5,1,0.656423342,1,2.504839851,1.804188306,1.388347238,0.165031335,NA,0.212467409,0,5.700332228,1.853292364,3.07578682,0.002099479,0.015023052,0.54679434,1,3.059870991,1.305621647,2.34361233,0.01909801,0.053917528,0.630424402,1,2.638360625,1.417614901,1.861126475,0.062726318,0.140292461,0.535232079,1,2.986938576,1.259835549,2.370895614,0.017745042,0.049618489,N,-,,50S ribosome-binding GTPase domain-containing,F:GTP binding; P:biological_process; C:cellular_component,IPR027417 (G3DSA:3.40.50.GENE3D); IPR006703 (PFAM); SSF158634 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_09932,451,361,482,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.03486423,0,-1.42937447,1.209032288,-1.182246731,0.237107815,0.411208664,3.183296388,0,1.79491208,1.276821067,1.405766342,0.15979352,0.290278178,8.295738369,0,-0.863550619,1.206618077,-0.715678503,0.474189887,0.610853597,13.58411502,0,-0.339983584,1.157199916,-0.293798486,0.768911892,0.849994059,8.220051111,0,-0.952899157,1.215878737,-0.783712329,0.433208927,0.567887447,N,-,,c6 zinc finger domain containing,P:metabolic process; F:binding,PTHR31845 (PANTHER),,
RL4_JR_09933,457,409,414,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.176674963,0,1.663126504,1.479969158,1.123757543,0.261115898,NA,0.379053443,0,4.865261004,1.671949588,2.909932834,0.003615064,0.017053643,0.975735101,0,2.225100192,1.273565095,1.747142883,0.080612556,0.16378116,1.125159401,0,1.803101713,1.324263013,1.361588819,0.173327686,0.296443043,0.952802514,0,2.155948652,1.243879871,1.733245068,0.08305212,0.166186307,N,-,,multidrug resistance,,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); PTHR23502:SF48 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.77, the major facilitator superfamily (mfs).
RL4_JR_09934,230,393,431,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0.008470882,0,8.791019641,4.031633903,2.180510397,0.029219649,NA,0.002680088,0,12.01721297,4.032710343,2.979934573,0.0028831,0.015349618,0.006904709,0,9.374372631,4.033343739,2.324218623,0.02011378,0.055743746,0.007967227,1,8.951770626,4.033311655,2.219459191,0.026455501,0.08636862,0.006679571,0,9.335361424,1.822923296,5.121093929,3.04E-07,5.22E-06,N,-,,nitrilotriacetate monooxygenase,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity",IPR016215 (PIRSF); IPR011251 (PFAM); IPR016215 (TIGRFAM); IPR011251 (G3DSA:3.20.20.GENE3D); PTHR30011 (PANTHER); PTHR30011:SF18 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_09935,947,1107,990,1,0,17,0,0,0,2,0,0,2,0,0,0,2,0,0.015953485,1,7.867140353,3.973076766,1.980112848,0.04769085,NA,0.005346613,0,11.01668392,3.970228347,2.774823752,0.005523163,0.021974647,0.013444566,1,8.408299533,2.921098072,2.878472179,0.003996065,0.01637703,0.015478003,1,7.987409939,3.972128364,2.010864002,0.044339824,0.114176173,0.012834372,1,8.355328124,1.611812863,5.183807821,2.17E-07,4.29E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_09936,4584,7044,6245,5,0,6,0,0,0,0,1,1,1,5,0,0,0,0,0.031118311,1,6.902049499,3.940873852,1.75140077,0.0798769,NA,0.009843066,0,10.13007798,3.941222014,2.570288591,0.010161383,0.033945054,0.025849857,1,7.458988742,2.558827109,2.915003017,0.003556851,0.015355889,0.029833681,1,7.03823786,3.9407549,1.786012589,0.07409722,0.157153744,0.025947324,0,7.35121082,1.604102053,4.582757566,4.59E-06,5.28E-05,N,-,,general amidase,"F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (PFAM); IPR023631 (G3DSA:3.90.1300.GENE3D); PTHR11895:SF45 (PANTHER); IPR000120 (PANTHER); IPR023631 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_09937,2639,3507,6436,0,0,7,0,0,0,0,0,0,0,1,0,0,2,2,27.53728813,1,-2.885690735,1.210907217,-2.383081621,0.017168387,0.058043806,8.722918777,0,0.340635118,1.233462402,0.276161736,0.782423845,0.868577996,22.75845075,0,-2.319420397,1.206971207,-1.921686601,0.054645204,0.12100351,49.54496751,1,-0.412053258,0.874263506,-0.471314718,0.637416007,0.751755708,22.58145408,1,-2.410839984,1.218262089,-1.978917348,0.047825313,0.1082807,N,-,,major facilitator superfamily transporter,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); PTHR23502:SF30 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.2.33, the major facilitator superfamily (mfs).
RL4_JR_09938,6660,6259,8391,2,3,5,0,0,0,0,1,1,2,3,0,0,14,2,1.287932299,1,1.532480196,1.3853386,1.106213452,0.268634142,NA,0.414276532,0,4.736910075,1.61353803,2.935728806,0.003327651,0.016374567,1.069972793,1,2.091337002,1.244809058,1.68004642,0.092948284,0.183325235,1.233936926,1,1.66947384,1.279407395,1.304880562,0.191933521,0.320998828,1.050714989,1,2.014322981,1.223445892,1.646434055,0.099674427,0.190631577,N,-,,kinesin light chain 1,F:catalytic activity; P:lipid metabolic process; P:nucleoside metabolic process; F:ADP binding,IPR011990 (G3DSA:1.25.40.GENE3D); PF13424 (PFAM); PTHR19959 (PANTHER); PTHR19959:SF128 (PANTHER); IPR011990 (SUPERFAMILY),,
RL4_JR_09939,7548,5572,7568,0,0,1,0,0,0,0,0,1,0,3,0,0,5,0,6.097066553,1,-0.710709022,1.216684734,-0.584135727,0.559129,0.736695452,1.947294954,0,2.503992996,1.330481725,1.882019835,0.059833323,0.135804385,5.055792168,1,-0.149175986,1.214492013,-0.122829944,0.902241762,0.939645674,5.832317067,1,-0.571472977,1.215183552,-0.470277084,0.638157068,0.752251287,4.994069189,1,-0.234077028,1.218699567,-0.19207115,0.847686473,0.898348915,N,-,,hypothetical protein TCE0_033r09438,P:biological_process; C:cellular_component; F:molecular_function,IPR025340 (PFAM),,
RL4_JR_09940,9602,6961,8993,3,0,2,0,0,0,0,0,0,3,5,0,0,0,0,7.861680258,1,5.711989472,1.207199175,4.731604851,2.23E-06,3.07E-05,0.070001222,0,7.301428706,2.356178666,3.098843399,0.001942777,0.015023052,0.184336594,0,4.627783584,1.501914825,3.08125568,0.002061296,0.010086301,8.236036685,1,5.877486907,1.160531774,5.064477372,4.10E-07,8.11E-06,0.184375618,0,4.527100562,1.385652059,3.2671265,0.001086451,0.005099823,Y,-,,gpi anchored,C:membrane,PTHR34992 (PANTHER); PTHR34992:SF1 (PANTHER),,
RL4_JR_09941,2502,2272,2613,0,1,1,0,0,2,0,4,0,0,4,9,0,3,0,5.267660691,1,-0.499401577,1.217388278,-0.410223744,0.681641825,0.82563009,1.672126996,1,2.72379437,1.333105996,2.043194149,0.041033223,0.101203285,4.351075576,1,0.067562427,1.20939489,0.055864654,0.955449629,0.97422732,5.020553396,1,-0.35506628,1.209972927,-0.293449772,0.769178386,0.85002523,4.300689693,1,-0.018207834,1.213454993,-0.015004952,0.98802823,0.991947033,Y,-,,dynactin arp1 p25 subunit,P:biological_process; C:membrane; C:integral component of membrane; P:isoprenoid biosynthetic process; F:transferase activity; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_09942,2687,2492,2394,0,0,30,0,0,0,12,6,11,15,34,8,0,11,11,0.003880053,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,1,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,amino acid permease,F:oxidoreductase activity; C:integral component of membrane; F:amino acid transmembrane transporter activity; P:oxidation-reduction process; P:amino acid transmembrane transport; P:sulfur amino acid transport,IPR002293 (PFAM); PTHR11785:SF203 (PANTHER); IPR002293 (PANTHER),2.A.3.8.4, the amino acid-polyamine-organocation (apc) family.
RL4_JR_09943,45467,40505,23462,0,0,1,0,0,0,2,3,0,1,2,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,high affinity methionine permease,C:membrane,no IPS match,2.A.3.8.4, the amino acid-polyamine-organocation (apc) family.
RL4_JR_09944,30954,27858,39291,1,1,8,0,0,0,2,5,0,5,10,0,0,3,8,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,amino acid permease family,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,no IPS match,2.A.3.4.1, the amino acid-polyamine-organocation (apc) family.
RL4_JR_09945,18,26,27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,ubiquitin carboxyl-terminal hydrolase,P:proteolysis; F:thiol-dependent ubiquitinyl hydrolase activity,IPR001578 (PRINTS); IPR001578 (PFAM); IPR001578 (G3DSA:3.40.532.GENE3D); IPR001578 (PANTHER); PTHR10589:SF26 (PANTHER); SSF54001 (SUPERFAMILY),,
RL4_JR_09946,3774,2921,3107,0,3,12,2,0,0,0,0,1,0,0,2,0,3,0,0.092950873,1,5.325139423,3.91823149,1.359067078,0.174125334,NA,0.029584675,1,8.544795921,2.67566189,3.19352604,0.001405467,0.015023052,0.076708672,1,5.895016419,1.530663497,3.851281769,0.000117501,0.00128326,0.088499922,1,5.471316196,2.437954463,2.244224115,0.024817985,0.085296029,0.075420858,1,5.818095708,1.309117341,4.44428893,8.82E-06,8.99E-05,N,-, Effector probability:0.602,dienelactone hydrolase family,F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); PTHR17630 (PANTHER); PTHR17630:SF43 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_09947,2461,2400,4632,0,5,7,0,0,0,0,3,2,2,1,0,0,1,0,18.99983498,1,-2.350148149,1.23419326,-1.904197847,0.056884422,0.146253739,6.091998419,0,0.858666124,1.288482287,0.666416708,0.505144786,0.65856202,15.7171186,1,-1.785180744,1.226661467,-1.455316558,0.145581645,0.256191304,18.12744983,1,-2.207194103,1.228796227,-1.796224675,0.072458792,0.155071923,15.37219459,1,-1.856010739,1.226621185,-1.513108335,0.130252143,0.232511097,N,-,,N-glycosylation EOS1,,IPR021100 (PFAM); IPR013883 (PFAM); PTHR28147 (PANTHER),,
RL4_JR_09948,1605,2141,2615,0,1,2,0,0,0,0,0,4,3,1,0,0,0,0,0.032539862,1,6.840036638,3.939444787,1.736294581,0.082511761,NA,0.010534045,0,10.03632332,3.358510283,2.988325917,0.002805102,0.015349618,0.026973159,1,7.405836772,1.971279196,3.756868529,0.000172053,0.001606614,0.031096702,1,6.980706675,3.766315036,1.853457985,0.063816743,0.14210348,0.026144275,0,7.344760522,1.428461464,5.14172815,2.72E-07,4.92E-06,N,-,,glycoside hydrolase,C:membrane; C:integral component of membrane; F:hydrolase activity,no IPS match,,
RL4_JR_09949,740,748,1623,2,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0.122196472,1,4.930068439,3.795334738,1.298981191,0.193950384,NA,0.04007351,0,8.107068453,2.655819622,3.052567421,0.002268928,0.0150814,0.102465657,0,5.475297842,1.629062156,3.361012238,0.000776574,0.004702173,0.118075121,1,5.054808294,2.362599797,2.139511017,0.032394305,0.096326677,0.099815903,0,5.406872765,1.410648432,3.832898859,0.000126642,0.000844875,N,-,,C2H2 finger domain,,PTHR23225 (PANTHER); PTHR23225:SF2 (PANTHER),,
RL4_JR_09950,5636,5048,5026,0,0,0,0,1,0,1,3,0,2,6,1,0,0,1,0.078874921,0,5.561523865,3.920269452,1.418658572,0.155998581,NA,0.02521001,1,8.774750503,2.804254368,3.12908508,0.001753515,0.015023052,0.065546723,1,6.117789267,1.628376084,3.756987915,0.000171971,0.001606614,0.075613271,1,5.697377298,2.647425603,2.152044345,0.031393862,0.094771274,0.064953181,1,6.027988359,1.35370737,4.452947878,8.47E-06,8.72E-05,Y,-,,domain-containing,C:cellular_component; F:molecular_function,IPR018392 (SMART); IPR018392 (G3DSA:3.10.350.GENE3D); IPR018392 (G3DSA:3.10.350.GENE3D); IPR018392 (PFAM); PTHR21666:SF212 (PANTHER); PTHR21666 (PANTHER); PTHR21666:SF212 (PANTHER); IPR018392 (SUPERFAMILY); IPR018392 (SUPERFAMILY),,
RL4_JR_09951,2163,1638,2448,0,2,2,0,0,0,0,0,2,0,5,0,0,0,0,0.495733116,1,2.909779357,2.235558111,1.301589676,0.193056691,NA,0.155231307,0,6.152415246,2.071603469,2.969880741,0.002979154,0.015543812,0.409322147,1,3.476339598,1.450461208,2.396713252,0.016542864,0.048154099,0.472589736,1,3.053483288,1.668578376,1.829990926,0.067251296,0.147035061,0.411549781,0,3.367119734,1.403800292,2.398574608,0.016459023,0.046758588,Y,-,,necrosis-inducing factor domain-containing,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_09952,406,562,785,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0.074058512,0,5.652116747,3.921143044,1.441446201,0.149458666,NA,0.024365596,0,8.82446383,3.92074195,2.250712733,0.024403738,0.067251466,0.062328758,1,6.19209205,2.361352504,2.622265011,0.008734748,0.029378933,0.071816171,0,5.771976372,3.920931666,1.47209308,0.140995744,0.254075015,0.060886493,0,6.120916635,1.795699172,3.408653704,0.000652843,0.003386288,Y,-,,glycoside hydrolase family 18,F:chitinase activity; F:chitin binding; P:chitin catabolic process; C:extracellular region,IPR018392 (SMART); IPR011583 (SMART); IPR018392 (G3DSA:3.10.350.GENE3D); IPR013781 (G3DSA:3.20.20.GENE3D); IPR001223 (PFAM); IPR029070 (G3DSA:3.10.50.GENE3D); IPR018392 (PFAM); IPR001002 (G3DSA:3.30.60.GENE3D); IPR029226 (PFAM); PTHR11177:SF218 (PANTHER); PTHR11177:SF218 (PANTHER); PTHR11177:SF218 (PANTHER); PTHR11177 (PANTHER); PTHR11177 (PANTHER); IPR001002 (PRODOM); IPR017853 (SUPERFAMILY); IPR001002 (SUPERFAMILY); IPR029070 (SUPERFAMILY); IPR018392 (SUPERFAMILY),9.B.29.2.7, the small 4-5 tms putative permease (4-5pp) family.
RL4_JR_09953,499,342,634,0,0,0,2,0,0,0,0,0,0,2,0,0,0,1,4.430108055,0,-0.249749537,1.227897878,-0.203396017,0.838825513,0.919282447,1.404722019,1,2.975139137,1.356836085,2.192703429,0.028328754,0.075717888,3.660815991,0,0.316582179,1.215242279,0.260509517,0.794470775,0.864583696,4.22431396,1,-0.106107845,1.217807669,-0.087130216,0.930568008,0.958787125,3.626623693,1,0.227684336,1.221063919,0.186463896,0.852080989,0.901684784,N,-,,monocarboxylate transporter,"F:transferase activity, transferring acyl groups other than amino-acyl groups; P:transmembrane transport; C:integral component of membrane; F:lyase activity; C:periplasmic space",G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11360:SF156 (PANTHER); PTHR11360 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.13.14, the major facilitator superfamily (mfs).
RL4_JR_09954,6291,4478,2622,0,5,15,0,0,0,0,31,47,8,4,8,0,63,18,0.055620563,1,6.065557682,3.92590287,1.545009615,0.122343938,NA,0.018374439,0,9.232935565,3.064726346,3.012645999,0.002589808,0.015349618,0.046676756,1,6.611222421,1.825894238,3.620813453,0.000293678,0.002288836,0.053769726,1,6.19000785,3.092172634,2.001831263,0.045302882,0.115278131,0.045084211,1,6.550498309,1.436203781,4.560981106,5.09E-06,5.76E-05,N,-,,urea active,P:transmembrane transport; C:integral component of membrane; F:transporter activity,IPR001734 (TIGRFAM); IPR001734 (PFAM); PTHR11819:SF131 (PANTHER); IPR001734 (PANTHER); IPR001734 (PANTHER); IPR001734 (PROSITE_PROFILES),2.A.21.6.1, the solute:sodium symporter (sss) family.
RL4_JR_09955,14332,22529,22381,2,1,12,0,2,0,0,0,0,5,3,0,0,8,3,3.395519718,1,0.134102295,1.210902041,0.110745783,0.91181794,0.956734502,1.0859913,1,3.346541074,1.386138005,2.414291406,0.015765847,0.047994559,2.812694798,0,0.697111022,1.204492407,0.578759167,0.562751687,0.687913315,3.244458323,1,0.274905936,1.205685756,0.228007948,0.819640061,0.886440464,2.767601608,1,0.617583392,1.198290405,0.51538708,0.606282559,0.714539741,N,-,,TAM domain methyltransferase,F:methyltransferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108 (PANTHER); PTHR10108:SF905 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_09956,10515,9900,12220,7,0,2,0,0,3,0,2,1,0,2,7,0,0,0,13.53335267,1,0.385063044,1.168460109,0.329547445,0.741741939,0.864200334,1.751206458,1,2.657148382,1.34235545,1.979467049,0.047763446,0.113782443,4.55755127,1,0.00076458,1.218763499,0.000627341,0.999499454,0.99959819,5.259022118,1,-0.42193012,1.220834898,-0.345607846,0.729637448,0.819840103,4.502956907,0,-0.084497569,1.222835676,-0.069099692,0.944910266,0.964923494,N,-,,Alpha beta hydrolase fold,,IPR000073 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); IPR029058 (SUPERFAMILY),,
RL4_JR_09957,8208,8496,11392,0,0,3,0,0,7,0,1,3,5,4,0,0,9,0,0.306920136,1,3.601644327,2.585010716,1.393280231,0.163535066,NA,0.095869339,1,6.84771067,2.187594262,3.130247135,0.001746593,0.015023052,0.252455604,1,4.173646138,1.427989755,2.922742354,0.003469635,0.015075787,0.291498567,1,3.750790158,1.747771603,2.146041366,0.031869679,0.095422077,0.252821479,1,4.071008931,1.349961503,3.015648166,0.002564306,0.010439727,N,-,,retrograde regulation 2,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662 (PANTHER); PTHR11662:SF191 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.3, the major facilitator superfamily (mfs).
RL4_JR_09958,10037,11408,14664,0,1,6,0,0,0,0,0,0,0,0,0,0,0,1,8.935198107,1,-1.261632022,1.218813651,-1.035131187,0.30060765,0.4863858,2.844275495,0,1.957494767,1.300871059,1.50475695,0.132386575,0.250597551,7.37869641,0,-0.694246501,1.212800437,-0.572432594,0.567028939,0.691388773,8.512919392,0,-1.116700209,1.213043589,-0.920577149,0.357271237,0.503251429,7.262822143,1,-0.774204128,1.214510953,-0.637461627,0.523824197,0.647980452,Y,-,,Piso0_004744 partial,,PTHR35204:SF1 (PANTHER); PTHR35204 (PANTHER),,
RL4_JR_09959,8139,7645,9026,0,1,3,0,0,0,2,0,1,0,3,4,0,4,1,0.525032318,1,2.827204194,1.990302767,1.420489506,0.155465222,NA,0.165568213,0,6.05980948,1.916759074,3.161487305,0.001569657,0.015023052,0.432724489,1,3.3970458,1.313222059,2.586802267,0.009687116,0.03191421,0.499442962,1,2.974256077,1.463340384,2.032511444,0.042101906,0.111358883,0.429632547,1,3.305932976,1.271790974,2.599431072,0.009337843,0.02973134,Y,-,,amidohydrolase family,F:hydrolase activity,G3DSA:3.20.20.140 (GENE3D); IPR006680 (PFAM); PTHR35563:SF1 (PANTHER); PTHR35563 (PANTHER); IPR032466 (SUPERFAMILY),,
RL4_JR_09960,9344,6337,8525,0,7,7,0,0,2,0,0,1,1,2,1,0,10,1,31.79728521,1,-0.32496118,1.031922844,-0.314908408,0.752831198,0.870775614,5.024724,1,1.13640984,1.263967783,0.899081334,0.36860934,0.532932972,20.91525551,1,-0.55779641,1.208630505,-0.461511113,0.64443195,0.752419452,90.55204953,1,2.080641527,0.633106301,3.286401546,0.001014762,0.00747778,12.94142685,1,-1.607730658,1.220751426,-1.317000844,0.187838342,0.307148451,N,-,,DUF453 domain,P:biological_process; C:cellular_component; F:molecular_function; F:hydrolase activity,IPR007400 (PFAM); G3DSA:3.10.310.10 (GENE3D); G3DSA:3.10.310.10 (GENE3D); PTHR30349:SF18 (PANTHER); PTHR30349:SF18 (PANTHER); PTHR30349 (PANTHER); PTHR30349 (PANTHER); SSF54506 (SUPERFAMILY); SSF54506 (SUPERFAMILY),,
RL4_JR_09961,6458,4857,5924,0,5,3,0,0,0,0,0,2,1,3,1,0,5,0,75.42773466,1,1.534357798,1.02474314,1.497309656,0.134312703,0.27324764,6.935947417,0,0.671431222,1.326146084,0.506302609,0.612644232,0.745155601,74.62191626,1,1.778276613,0.72177034,2.463770696,0.013748404,0.041437582,24.8553994,1,-1.466678379,1.225095466,-1.197195173,0.231230491,0.368172467,17.81804686,1,-2.069014719,1.276774617,-1.620501136,0.10512467,0.198283772,N,-,,Lactam utilization lamB,P:carbohydrate metabolic process; F:catalytic activity,IPR005501 (PFAM); PTHR30292 (PANTHER); PTHR30292:SF0 (PANTHER); IPR011330 (SUPERFAMILY),,
RL4_JR_09962,28205,25584,29678,9,2,4,0,0,3,5,2,1,1,11,1,0,5,0,41.6365252,1,2.418898194,1.614344615,1.498377838,0.134035111,0.272887057,2.278355983,1,2.277527899,1.584605701,1.437283671,0.150637407,0.277530366,18.94890329,1,1.349698765,1.508798412,0.894552085,0.371026575,0.515263792,16.18276728,1,0.16570231,1.351447693,0.122610968,0.902415169,0.940247153,5.880985503,1,-0.469775104,1.422095302,-0.3303401,0.741142997,0.818757771,N,-,,flavin-containing amine oxidase,"P:regulation of transcription, DNA-templated",IPR001613 (PRINTS); G3DSA:1.10.405.10 (GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR002937 (PFAM); PTHR10742:SF281 (PANTHER); PTHR10742 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_09963,126,118,134,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51.42523492,0,-0.212210349,0.871602014,-0.243471614,0.807640072,0.902441818,10.27332274,0,0.104711514,1.295944137,0.080799404,0.935601482,0.964339006,227.2351739,0,2.883816779,0.496549099,5.807717278,6.33E-09,2.79E-07,201.3573222,0,2.503450524,0.667363973,3.751252126,0.000175954,0.001724618,44.73427137,0,-0.384942527,0.928799081,-0.414451882,0.6785432,0.771461954,N,-,,sodium proline,P:urea transmembrane transport; C:integral component of membrane; F:urea transmembrane transporter activity,IPR001734 (PFAM); IPR031155 (PTHR11819:PANTHER); IPR001734 (PANTHER); IPR001734 (PANTHER); IPR031155 (PTHR11819:PANTHER); IPR001734 (PROSITE_PROFILES),2.A.21.6.6, the solute:sodium symporter (sss) family.
RL4_JR_09964,17160,16721,18093,10,4,9,3,0,0,3,9,10,6,8,8,0,12,14,199.3562284,1,-0.752031339,1.155909548,-0.650597048,0.515306637,0.700528502,41.47593115,1,-1.908677198,1.271417548,-1.501219801,0.13329872,0.25172568,243.4087269,1,0.379221719,1.198474805,0.316420268,0.751683535,0.833520713,248.7725314,1,0.128347136,0.588871004,0.217954585,0.827464496,0.892329111,147.6292797,1,-0.879972824,0.745945824,-1.179673905,0.238129936,0.366981066,N,-,,urea carboxylase,"C:nucleus; F:DNA binding; F:ATP binding; F:zinc ion binding; P:transcription, DNA-templated; C:integral component of membrane; F:lyase activity; F:biotin carboxylase activity; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR003778 (SMART); IPR003833 (SMART); IPR005482 (SMART); IPR013815 (G3DSA:3.30.1490.GENE3D); IPR016185 (G3DSA:3.40.50.GENE3D); IPR024946 (G3DSA:3.30.1360.GENE3D); IPR003778 (PFAM); IPR005481 (PFAM); IPR005482 (PFAM); IPR013816 (G3DSA:3.30.470.GENE3D); IPR005479 (PFAM); IPR003833 (PFAM); IPR000089 (PFAM); G3DSA:2.40.50.100 (GENE3D); IPR029000 (G3DSA:2.40.100.GENE3D); PTHR18866 (PANTHER); PTHR18866:SF91 (PANTHER); IPR011761 (PROSITE_PROFILES); IPR011764 (PROSITE_PROFILES); IPR000089 (PROSITE_PROFILES); IPR029000 (SUPERFAMILY); SSF56059 (SUPERFAMILY); IPR011053 (SUPERFAMILY); IPR016185 (SUPERFAMILY); IPR011054 (SUPERFAMILY); IPR029000 (SUPERFAMILY); SSF160467 (SUPERFAMILY),3.B.1.1.5, the na(+)-transporting carboxylic acid decarboxylase (nat-dc) family.
RL4_JR_09965,5527,4565,7322,0,0,6,0,0,0,0,0,0,0,5,5,0,5,2,8.921652017,1,-1.259542053,1.220802154,-1.031733151,0.302197143,0.488279717,2.875740338,0,1.941679962,1.320653649,1.470241621,0.141496326,0.263956102,7.404890889,0,-0.69934022,1.219312588,-0.573552859,0.56627042,0.690713462,12.55031577,1,-0.175590204,1.169842634,-0.150097286,0.880687861,0.92661179,7.237956085,1,-0.769414127,1.213982295,-0.633793532,0.526215575,0.650153053,N,-,,acetamidase regulatory,"F:organic cyclic compound binding; F:heterocyclic compound binding; F:catalytic activity; F:metal ion binding; P:regulation of transcription, DNA-templated",IPR007219 (SMART); IPR001138 (SMART); IPR001138 (PFAM); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR19444 (PANTHER); PTHR19444:SF31 (PANTHER); PTHR19444 (PANTHER); PTHR19444:SF31 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09966,5162,5002,8702,2,2,4,2,0,0,0,0,0,3,1,5,0,0,0,29.34361299,1,1.552124983,0.699872491,2.217725375,0.026573563,0.082536643,3.29473419,1,1.74543746,1.291548052,1.351430523,0.176557562,0.313254275,8.500510741,0,-0.898414893,1.206877493,-0.744412667,0.456626858,0.595167213,9.803296416,1,-1.320304527,1.20584548,-1.094920161,0.273551616,0.415685143,12.18706898,0,-0.04192534,1.130781718,-0.037076422,0.970424072,0.980201888,N,-,,thiosulfate sulfurtransferase,F:transferase activity,IPR001763 (SMART); IPR001763 (G3DSA:3.40.250.GENE3D); IPR001763 (G3DSA:3.40.250.GENE3D); IPR001763 (G3DSA:3.40.250.GENE3D); IPR001763 (PFAM); PTHR12231:SF83 (PANTHER); PTHR12231 (PANTHER); IPR001763 (PROSITE_PROFILES); IPR001763 (PROSITE_PROFILES); IPR001763 (PROSITE_PROFILES); IPR001763 (SUPERFAMILY); IPR001763 (SUPERFAMILY); IPR001763 (SUPERFAMILY); IPR001763 (SUPERFAMILY),,
RL4_JR_09967,9774,9887,11626,11,47,19,0,0,3,4,4,30,2,7,7,0,9,1,71.76721105,1,-0.529106362,0.693414063,-0.763045329,0.445436363,0.634072561,14.0648026,1,-0.348513857,1.211524713,-0.287665495,0.773602805,0.862854831,36.58228723,1,-3.004088362,1.19682024,-2.51005812,0.012071129,0.037429743,46.22186009,1,-2.480009154,1.150561221,-2.155477786,0.031124465,0.094380117,47.71798056,1,-0.893907135,0.862688452,-1.036187668,0.300114599,0.435193385,N,-,,methyltransferase domain containing,F:transferase activity,IPR029063 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); PTHR10108 (PANTHER); PTHR10108:SF896 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_09968,201,197,369,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.613700648,0,2.601961528,1.80732975,1.439671719,0.149960298,NA,0.195094114,0,5.823115411,1.834226241,3.174698562,0.001499922,0.015023052,0.507852136,0,3.165723405,1.274808102,2.483294073,0.013017357,0.03972128,0.58596493,0,2.743570642,1.381889622,1.98537611,0.047102642,0.118473832,0.502779406,0,3.078297321,1.241182568,2.480132576,0.013133354,0.039072286,N,-,,sugar transporter stl1,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,IPR003663 (PRINTS); IPR003663 (TIGRFAM); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500 (PANTHER); PTHR23500:SF153 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.125, the major facilitator superfamily (mfs).
RL4_JR_09969,1282,1352,820,4,0,4,2,0,0,1,0,0,0,0,3,0,2,2,0.275936454,1,3.754994262,2.686165448,1.397901334,0.162142698,NA,0.088485112,1,6.963681266,2.233833713,3.11736779,0.001824738,0.015023052,0.229591533,1,4.31052753,1.435971982,3.001818687,0.00268372,0.012509198,0.264815779,1,3.889230327,1.789148513,2.173788424,0.029721028,0.09171759,0.227060143,1,4.223841383,1.337729799,3.157469756,0.001591447,0.007021092,N,-,,hypothetical protein NECHADRAFT_86736,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",no IPS match,,
RL4_JR_09970,2515,2969,2558,1,2,9,0,0,0,0,0,6,0,7,3,0,2,0,0.180929568,1,4.364193073,3.113524091,1.401689194,0.161008079,NA,0.057315592,0,7.590343643,2.344957937,3.236878378,0.001208449,0.015023052,0.14924413,1,4.933403563,1.400490719,3.522624961,0.000427296,0.003016735,0.172221115,1,4.510525853,1.910372037,2.361071962,0.018222194,0.073711433,0.147529141,1,4.849219746,1.277048177,3.797209717,0.000146334,0.000955891,N,-,,Demethylmenaquinone methyltransferase,F:methyltransferase activity; F:transferase activity; P:methylation,IPR027417 (G3DSA:3.40.50.GENE3D); PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF818 (PANTHER); PTHR10108 (PANTHER); IPR027417 (SUPERFAMILY); IPR029063 (SUPERFAMILY),,
RL4_JR_09971,4016,3905,2475,0,0,8,0,0,0,0,0,0,1,3,0,0,6,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,Y,-,,UPF0047 domain partial,,IPR008701 (PFAM),,
RL4_JR_09972,1203,958,1438,2,1,3,0,0,0,0,0,1,0,1,0,0,5,1,0.189382561,1,4.298336414,3.208884837,1.339510962,0.180404388,NA,0.062009845,0,7.477640363,2.47259421,3.024208475,0.002492846,0.015349618,0.157937719,1,4.853064643,1.566808576,3.09742027,0.001952129,0.009646518,0.18199945,1,4.43129954,2.091595397,2.118621768,0.034122445,0.098985751,0.152525565,1,4.797938965,1.39943423,3.428484784,0.000606961,0.003184184,N,-,,MFS drug efflux transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR002347 (PFAM); IPR011701 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501:SF12 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR016040 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_09973,12054,7727,9400,2,6,1,0,0,0,3,5,0,0,6,0,0,6,0,6.217836889,1,-0.738930402,1.23532322,-0.598167662,0.549728067,0.729379601,1.971737205,0,2.485929563,1.337870712,1.858123914,0.06315142,0.141765063,5.143816323,1,-0.174115794,1.225063452,-0.14212798,0.886978918,0.929968368,43.18469888,1,2.495370772,1.346712894,1.852934492,0.063891749,0.142111804,5.106098593,1,-0.266002788,1.235067923,-0.215375028,0.829474938,0.885461702,N,-,,hypothetical protein T310_6745,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09974,4204,3065,2744,1,0,0,0,0,0,1,3,2,0,8,1,0,2,0,39.14508302,1,-0.056766974,0.848369978,-0.066912992,0.94665097,0.973563316,6.198559963,0,0.833625,1.242368301,0.670996676,0.502222647,0.656111167,16.01847805,1,-1.812651558,1.19510923,-1.516724591,0.129336233,0.234996414,26.49765633,1,-0.509781625,1.019088131,-0.50023311,0.616910947,0.735628706,15.73013383,1,-1.889304443,1.192672561,-1.584093158,0.113172521,0.209521261,N,-,,#NAME?,C:integral component of membrane,IPR008030 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR14194 (PANTHER); PTHR14194:SF49 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09975,4275,5647,6657,1,0,9,0,0,0,0,0,0,0,0,0,0,3,0,104.5939691,1,-1.872512714,0.748549696,-2.501520905,0.012366114,0.045016849,28.65514197,0,-1.375190706,1.203630902,-1.142535227,0.253231612,0.407829813,100.1036984,0,-1.208371103,0.748775767,-1.613795687,0.10657175,0.203303637,131.3926456,0,-1.115535751,0.617145437,-1.807573523,0.070672902,0.151956495,72.85036331,1,-4.100665271,1.191018025,-3.44299178,0.000575317,0.003043408,N,-,,deoxyribodipyrimidine photo-lyase,F:lyase activity,IPR002081 (PRINTS); G3DSA:1.25.40.80 (GENE3D); IPR014729 (G3DSA:3.40.50.GENE3D); IPR005101 (PFAM); IPR006050 (PFAM); G3DSA:1.10.579.10 (GENE3D); PTHR11455 (PANTHER); PTHR11455:SF18 (PANTHER); IPR006050 (PROSITE_PROFILES); IPR006050 (SUPERFAMILY); IPR005101 (SUPERFAMILY),,
RL4_JR_09976,605,627,507,1,0,6,0,0,0,0,0,0,0,0,3,0,0,0,1.286153961,1,1.534747913,1.53299699,1.001142157,0.316758087,NA,0.404927768,0,4.769698176,1.67620246,2.845538227,0.004433644,0.019050679,1.058020805,0,2.107668515,1.302628527,1.618011944,0.105660024,0.201983021,1.221215566,1,1.684552667,1.361572522,1.237211121,0.216008714,0.350775979,1.048894288,0,2.017823926,1.290362781,1.563764824,0.117872808,0.216246092,N,-,,inositol monophosphatase,P:phosphatidylinositol phosphorylation,IPR000760 (PRINTS); IPR000760 (PFAM); G3DSA:3.30.540.10 (GENE3D); G3DSA:3.40.190.80 (GENE3D); PTHR20854:SF39 (PANTHER); IPR000760 (PANTHER); SSF56655 (SUPERFAMILY),,
RL4_JR_09977,2838,2776,3622,4,0,7,0,0,1,0,0,4,1,10,3,0,0,1,1.206826308,1,1.62667001,1.65839226,0.980871685,0.326656022,NA,0.380001458,1,4.861452677,1.762069879,2.758944316,0.005798842,0.022724546,0.99107311,1,2.202224446,1.356312706,1.623684889,0.104443078,0.200185861,1.143915808,1,1.77905074,1.438392344,1.236832737,0.216149186,0.350835284,0.979148118,1,2.117095248,1.338599315,1.581575027,0.113746619,0.210353336,N,-, Effector probability:0.82,catabolic 3-dehydroquinase,"F:3-dehydroquinate dehydratase activity; C:membrane; P:quinate metabolic process; P:3,4-dihydroxybenzoate biosynthetic process",IPR001874 (TIGRFAM); IPR001874 (G3DSA:3.40.50.GENE3D); IPR001874 (PFAM); IPR001874 (PIRSF); IPR001874 (PANTHER); IPR001874 (PRODOM); IPR001874 (SUPERFAMILY),,
RL4_JR_09978,1861,2076,3071,0,4,0,0,0,0,0,0,0,4,11,0,0,2,0,0.046794293,1,6.314093606,3.929490343,1.606847977,0.108087721,NA,0.015521606,0,9.47536007,3.928688065,2.41183823,0.015872322,0.048231656,0.039491222,0,6.850475142,2.495286538,2.745366129,0.006044342,0.021901546,0.045486743,1,6.430766881,3.929107442,1.636699168,0.101693343,0.198275582,0.038355402,1,6.784885588,1.749038277,3.879209322,0.000104797,0.000719854,N,-,,3-dehydroshikimate dehydratase,F:catalytic activity; P:monocarboxylic acid metabolic process,IPR013022 (G3DSA:3.20.20.GENE3D); IPR013022 (PFAM); PTHR12110 (PANTHER); PTHR12110:SF14 (PANTHER); PTHR12110:SF14 (PANTHER); IPR013022 (SUPERFAMILY),,
RL4_JR_09979,3955,4926,7096,0,0,1,0,0,0,0,0,0,2,1,0,0,0,0,46.47284947,1,2.460821508,0.637426295,3.860558513,0.000113128,0.000948509,2.173490209,0,2.345469568,1.319180913,1.777974155,0.0754081,0.162850605,31.63211725,0,2.502489742,0.765747213,3.26803637,0.001082964,0.00613882,14.5257768,1,0.989588579,1.035076131,0.956053907,0.339045,0.486236633,24.50919035,0,2.219681629,0.777252528,2.855804967,0.004292787,0.015816766,N,-,,quinate dehydrogenase,"F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; P:monocarboxylic acid metabolic process",IPR016040 (G3DSA:3.40.50.GENE3D); IPR013708 (PFAM); G3DSA:3.40.192.10 (GENE3D); PTHR21089:SF1 (PANTHER); PTHR21089 (PANTHER); SSF53223 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_09980,2094,2043,3748,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,70.994248,0,2.905382734,0.887596667,3.273314156,0.001062943,0.006225044,3.160898543,1,1.805176858,1.266535882,1.425286788,0.154074318,0.282218647,8.198349666,1,-0.846442357,1.192750219,-0.709656006,0.47791748,0.614326634,9.457459904,0,-1.268751602,1.190042085,-1.066140112,0.286360309,0.430625001,8.08216968,0,-0.928542855,1.195067391,-0.776979493,0.437170869,0.571916104,N,-,,quinate permease,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:quinate metabolic process,IPR003663 (PRINTS); IPR003663 (TIGRFAM); G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR23500 (PANTHER); PTHR23500:SF136 (PANTHER); IPR020846 (PROSITE_PROFILES); PS51257 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.7, the major facilitator superfamily (mfs).
RL4_JR_09981,14497,21927,29729,3,2,3,0,0,0,0,0,1,0,3,0,0,0,1,7.844172384,1,0.832906202,1.197802308,0.695361995,0.486828472,0.674542392,1.294205647,0,3.093589435,1.426361324,2.168868002,0.030092707,0.079260572,3.334363916,1,0.451897334,1.244378087,0.36315115,0.716491976,0.808128874,3.845295527,1,0.029998681,1.252974708,0.023941969,0.980898898,0.988219039,3.257595202,1,0.382454706,1.235684271,0.309508436,0.756934796,0.830721105,N,-,,quinic acid utilization activator,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; P:quinate metabolic process; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); IPR001138 (PFAM); PTHR31001:SF53 (PANTHER); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09982,2388,3866,3876,0,0,7,0,0,0,2,0,1,1,1,0,0,0,0,52.38397895,1,1.043674075,0.673242317,1.55022055,0.121088589,0.254074256,7.002772569,0,0.657652838,1.263624998,0.520449373,0.602750405,0.736840531,84.49523997,1,1.795653904,1.661827219,1.080529843,0.279906305,0.419258978,67.41156528,1,0.942178915,0.66445522,1.417972027,0.156198932,0.274140091,25.41823429,0,-0.398829332,0.999741548,-0.398932436,0.689942988,0.779999191,N,-,,shikimate dehydrogenase substrate binding domain-containing,F:catalytic activity,G3DSA:3.40.192.10 (GENE3D); IPR013785 (G3DSA:3.20.20.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR006151 (PFAM); IPR013708 (PFAM); IPR031322 (PFAM); IPR001381 (PFAM); PTHR21090:SF20 (PANTHER); PTHR21090 (PANTHER); IPR016040 (SUPERFAMILY); SSF51569 (SUPERFAMILY); IPR027417 (SUPERFAMILY); SSF53223 (SUPERFAMILY),,
RL4_JR_09983,11517,12895,16783,3,1,1,0,0,1,0,0,0,0,2,0,0,3,0,0.193869544,1,4.264602231,3.086582182,1.38165841,0.16707661,NA,0.062849739,1,7.458110582,2.378572502,3.135540571,0.001715377,0.015023052,0.161034067,0,4.825360923,1.467854696,3.287355986,0.001011329,0.005804249,0.185644399,1,4.402740712,1.959572172,2.24678671,0.024653662,0.084922906,0.156417329,1,4.762301014,1.320111997,3.607497716,0.000309164,0.001791808,N,-,,Proline iminopeptidase,F:hydrolase activity,IPR002410 (PRINTS); IPR000073 (PRINTS); IPR000073 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR10992 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_09984,21804,17570,14793,0,10,4,0,0,3,0,21,6,3,6,8,0,8,3,27.79956374,1,0.725757766,1.042651554,0.696069327,0.486385415,0.674359655,2.44084026,1,2.178187083,1.324329615,1.644746941,0.100022008,0.202525059,19.32802926,1,1.340478186,1.059619962,1.265055618,0.205851391,0.332329689,15.32686376,1,0.816254402,1.049432511,0.777805522,0.436683672,0.578417344,13.94880658,1,1.104602893,1.010210759,1.09343806,0.274201511,0.406961345,N,-,,amino acid permease,C:membrane; C:integral component of membrane,IPR003615 (PFAM); IPR025442 (PFAM),,
RL4_JR_09985,5113,6815,6742,2,2,10,0,0,0,2,4,13,1,7,2,0,3,1,145.8997857,1,0.307056975,0.529350712,0.580063402,0.561871863,0.738837953,21.00626417,0,-0.92719851,1.246126131,-0.744064736,0.456837312,0.616301116,262.0654829,1,1.886423928,0.600734521,3.140195645,0.00168835,0.008663744,98.19455363,1,-0.911666869,0.733749207,-1.242477485,0.214060443,0.348562557,131.5960981,1,0.859292647,0.508794157,1.68888073,0.091242289,0.178104525,N,-,,choline dehydrogenase,F:flavin adenine dinucleotide binding; P:oxidation-reduction process; F:choline dehydrogenase activity; F:choline:oxygen 1-oxidoreductase activity,IPR012132 (PIRSF); IPR000172 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); IPR007867 (PFAM); PTHR11552 (PANTHER); PTHR11552:SF135 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_09986,18736,10433,8121,4,5,17,0,0,0,8,1,2,6,15,10,0,7,0,172.7610399,1,-0.318235902,0.784891831,-0.405451923,0.685145351,0.828896683,33.52251504,0,-1.601527527,1.23232527,-1.299598057,0.193738766,0.336194718,182.0562891,1,0.256624993,0.508844675,0.50432874,0.614030385,0.729030564,179.9273927,1,-0.596016601,0.634583778,-0.939224452,0.347615517,0.494743761,262.3200297,1,1.31192819,0.52848228,2.482444994,0.013048421,0.038868863,N,-,,Betaine aldehyde dehydrogenase,"P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",IPR016162 (G3DSA:3.40.605.GENE3D); IPR016163 (G3DSA:3.40.309.GENE3D); IPR015590 (PFAM); PTHR11699 (PANTHER); PTHR11699:SF115 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_09987,8018,7472,7385,2,9,16,0,0,0,0,0,0,6,1,0,0,2,0,14.19306102,1,-1.929354724,1.221406301,-1.579617464,0.114194497,0.243874008,4.572244161,0,1.272695945,1.293922837,0.983594932,0.325314718,0.487466406,11.773063,0,-1.368316531,1.219467944,-1.12206027,0.261836815,0.398921883,13.57602545,1,-1.790064139,1.220169699,-1.467061624,0.142359293,0.256246727,11.50317879,1,-1.43776005,1.215945079,-1.182421867,0.237038351,0.365942236,N,-, Effector probability:0.631,alcohol dehydrogenase,,IPR002347 (PRINTS); IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); PF13561 (PFAM); PTHR24322:SF456 (PANTHER); IPR002347 (PANTHER); PTHR24322:SF456 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_09988,1947,1924,2713,0,0,3,0,0,0,0,0,0,0,2,0,0,3,0,32.79217516,1,1.121809593,0.755620227,1.484620916,0.137644272,0.278290451,3.592392092,0,1.620603552,1.267899824,1.278179491,0.201186146,0.345329179,15.81602335,0,-0.069008289,1.196807877,-0.057660289,0.954019225,0.97354003,42.84170939,1,2.22322904,0.572064446,3.886326194,0.000101773,0.001083543,9.173758574,1,-1.111206001,1.200915099,-0.925299384,0.354810199,0.492184309,N,-,,c6 zinc finger domain containing,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR021858 (PFAM); PTHR31263 (PANTHER); PTHR31263 (PANTHER); PTHR31263:SF4 (PANTHER); PTHR31263:SF4 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_09989,2033,2210,3036,0,0,9,0,0,0,1,1,0,3,0,0,0,2,0,0.180504368,1,4.367543782,3.170899235,1.377383341,0.168393761,NA,0.058820564,0,7.553672127,2.405767939,3.139817438,0.001690531,0.015023052,0.150433769,1,4.923098506,1.474076937,3.339783956,0.000838436,0.005006753,0.173389258,1,4.501080602,1.995641489,2.255455515,0.024104752,0.083898456,0.146048127,1,4.859875659,1.319729504,3.682478602,0.000230977,0.001406281,N,-,,RTA1 domain,C:membrane,IPR007568 (PFAM); PTHR31465 (PANTHER); PTHR31465:SF15 (PANTHER),9.A.26.1.3, the lipid-translocating exporter (lte) family.
RL4_JR_09990,9839,9013,11522,0,5,6,0,0,1,0,0,0,0,0,0,0,2,0,43.13178117,1,5.692621014,0.69083415,8.240213683,1.72E-16,1.36E-14,0.359976531,1,4.939641323,1.647136551,2.998926421,0.002709327,0.015349618,0.932292422,0,2.290679266,1.248741476,1.834390313,0.066596077,0.141168065,9.098652486,0,3.586427293,1.039660118,3.449615151,0.000561386,0.004603085,0.916211888,1,2.212925819,1.225291983,1.80603958,0.070912157,0.146288833,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662 (PANTHER); PTHR11662:SF6 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.37, the major facilitator superfamily (mfs).
RL4_JR_09991,3578285,1842341,1800370,229,326,74,0,20,42,62,76,174,33,31,194,2,134,70,31.73496051,1,2.03116362,0.639528506,3.176032969,0.00149304,0.008180134,2.80640839,1,1.976787427,1.280579054,1.543666844,0.122669062,0.237410373,21.63338979,1,1.144420907,1.036451627,1.10417204,0.269518516,0.407924272,12.42451052,1,-0.152941483,1.149195196,-0.133085731,0.89412558,0.93474667,7.194967916,1,-0.760666802,1.203856556,-0.631858338,0.527479449,0.65114965,N,-,,facilitated glucose transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,IPR003663 (PRINTS); IPR003663 (TIGRFAM); IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23500:SF135 (PANTHER); PTHR23500 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.69, the major facilitator superfamily (mfs).
RL4_JR_09992,146644,41135,60537,11,18,4,0,0,2,9,9,5,1,5,5,3,1,2,40.49330087,1,-0.043952857,0.742286146,-0.059212821,0.952782598,0.977080803,8.033066508,1,0.459555023,1.217312699,0.377516001,0.705790175,0.814874889,20.862456,1,-2.193881058,1.189133797,-1.844940462,0.0650462,0.138754262,40.1154168,1,0.101943955,0.741253926,0.137529059,0.890612625,0.932614834,39.88914197,1,0.64809751,0.681227889,0.951366673,0.341418272,0.478582558,N,-,,amid-like NADH oxidoreductase,C:membrane,PR00368 (PRINTS); PR00411 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (G3DSA:3.50.50.GENE3D); IPR023753 (PFAM); PTHR22912 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_09993,3193,1678,1828,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,80.09810779,1,0.373931026,0.668200712,0.55960884,0.575746274,0.750840654,13.49304787,0,-0.288608162,1.231358067,-0.234381996,0.814688434,0.888128846,92.1100309,0,0.494038045,0.640914625,0.770832847,0.440806015,0.580876378,60.22697295,0,-0.34961336,0.712296449,-0.49082564,0.623549774,0.740713636,49.2780834,0,-0.799444929,0.858707147,-0.930986696,0.351860446,0.489030476,N,-,,Alcohol dehydrogenase zinc- partial,F:zinc ion binding; F:metal ion binding; F:oxidoreductase activity; C:membrane; C:integral component of membrane; P:oxidation-reduction process,IPR020843 (SMART); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013154 (PFAM); IPR013149 (PFAM); IPR011032 (G3DSA:3.90.180.GENE3D); PTHR11695:SF571 (PANTHER); IPR002085 (PANTHER); IPR011032 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_09994,11860,11439,10901,6,16,19,0,0,2,7,0,6,7,21,7,0,12,10,59.89717337,1,-4.006761901,1.208218642,-3.316255652,0.000912323,0.00552952,19.3299446,1,-0.807223438,1.229983984,-0.656287763,0.511638989,0.66297924,62.80076385,1,-1.634385225,1.054213484,-1.550336104,0.121060866,0.223327297,109.4334738,1,0.00552796,0.56492246,0.009785343,0.99219255,0.995065735,48.77228226,1,-3.521799941,1.204712923,-2.923352007,0.003462848,0.013285841,N,-,,MFS transporter,P:transmembrane transport; C:integral component of membrane; P:phosphorylation; F:kinase activity,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.33, the major facilitator superfamily (mfs).
RL4_JR_09995,3385,2557,2068,3,10,0,0,0,2,0,1,3,0,0,0,0,0,0,57.19042252,1,1.171887386,0.606635867,1.931780579,0.053386594,0.139816319,7.344776885,1,0.588822591,1.250025736,0.471048374,0.63760619,0.763317547,31.96304441,1,-0.240070947,1.048070214,-0.229059985,0.818822294,0.883016287,59.58788889,0,1.201744069,0.587249018,2.046396048,0.040717421,0.108690715,62.81438052,0,1.292876245,1.39135936,0.92921806,0.35277609,0.490138268,N,-,,ester hydrolase c11orf54,C:nucleus; F:hydrolase activity,IPR015021 (SMART); IPR015021 (PFAM); PTHR13204 (PANTHER); SSF117856 (SUPERFAMILY),,
RL4_JR_09996,19093,21672,23145,4,0,56,0,0,0,21,2,6,9,33,16,0,17,7,116.6172621,1,-1.457960064,0.661776375,-2.203100805,0.027587644,0.084640844,27.20972001,0,-1.300508205,1.199517197,-1.084193047,0.278279214,0.437314424,134.8051337,1,0.035628067,0.511058481,0.069714266,0.944421086,0.966961881,111.8622249,1,-1.319930952,0.664684341,-1.985801186,0.047055404,0.11842803,91.29392344,1,-1.801182028,0.831335783,-2.166611934,0.030264457,0.075639823,N,-,,fungal specific transcription factor,P:nitrogen compound metabolic process; F:binding; P:cellular metabolic process; P:organic substance metabolic process,IPR007219 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); PTHR31944 (PANTHER),,
RL4_JR_09997,183,257,294,3,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0.39163378,1,3.250046878,2.212594628,1.468884918,0.141864006,NA,0.124287941,0,6.473592611,2.001157372,3.2349243,0.00121675,0.015023052,0.32369244,0,3.815663061,1.302902374,2.928587081,0.003405064,0.014871817,0.373503706,1,3.393397495,1.503101964,2.257596341,0.023970837,0.083576007,0.320431599,0,3.728723898,1.247353164,2.989308886,0.002796093,0.011194323,Y,-,,---NA---,,no IPS match,,
RL4_JR_09998,6588,5908,5217,1,0,5,0,0,0,0,3,0,0,1,0,0,5,0,6.413052981,1,1.46852294,1.157899696,1.26826438,0.204703553,0.369615521,0.82571096,0,3.74173863,1.434017421,2.609269995,0.009073562,0.031356297,17.83297547,1,2.910334138,1.03751812,2.805092347,0.005030217,0.019002206,2.47716102,1,0.663862705,1.223862285,0.542432522,0.587520581,0.71249801,2.122522007,1,1.000486056,1.214975897,0.823461649,0.410245517,0.546243816,N,-,,F-box cyclin,,no IPS match,,
RL4_JR_09999,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47.81457536,0,0.807535206,0.646355958,1.249366074,0.211531211,0.378852167,6.675583498,0,0.726675812,1.257070501,0.578070849,0.563216287,0.706078184,32.89238155,0,-0.091211457,1.046527512,-0.087156291,0.930547282,0.958632251,19.84136765,0,-2.337586763,1.205139369,-1.939681686,0.052418387,0.126072273,16.85063998,0,-1.988574395,1.202590154,-1.653576148,0.098213662,0.188405653,N,-,,O-glycosyl hydrolase,C:membrane,IPR000490 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR16631:SF11 (PANTHER); PTHR16631 (PANTHER); IPR017853 (SUPERFAMILY),4.D.3.1.11, the glycan glucosyl transferase (opgh) family.
RL4_JR_10000,4883,4272,7351,0,0,3,2,0,1,0,2,2,0,5,1,0,0,0,203.8062071,1,0.596999358,0.680061154,0.877861284,0.380019002,0.572202846,24.47291828,1,-1.147565436,1.218495556,-0.941788774,0.346300794,0.509410934,86.63420294,1,-1.381210073,0.868005971,-1.591244898,0.111554472,0.210312379,153.8297856,1,0.431234504,0.481797479,0.895053466,0.370758508,0.516572161,119.3435406,0,0.430161994,0.543268836,0.791803182,0.428475446,0.563197961,N,-,,viral a-type inclusion repeat,P:vesicle-mediated transport; P:protein transport; C:cytoplasmic part; P:cellular process; P:cellular protein localization,IPR000237 (SMART); IPR000237 (PFAM); PTHR13140 (PANTHER); IPR000237 (PROSITE_PROFILES),,
RL4_JR_10001,347,807,601,0,0,5,0,0,0,0,2,0,0,0,0,0,0,0,93.89135177,1,1.031722641,0.467190791,2.208353976,0.027219607,0.083890275,11.39573592,0,-0.044863042,1.2222839,-0.036704273,0.970720802,0.985026161,108.3623277,1,1.313080966,0.518585996,2.532040928,0.011340075,0.035707308,71.34574219,0,0.586717496,0.556545293,1.054213383,0.291785234,0.436272336,52.05222043,0,0.422524006,0.621457687,0.679891833,0.496572953,0.624726783,N,-,,hypothetical protein UCRPA7_6275,C:membrane; C:integral component of membrane,IPR019273 (PFAM); PTHR22166:SF12 (PANTHER); PTHR22166 (PANTHER),1.A.1.10.3, the voltage-gated ion channel (vic) superfamily.
RL4_JR_10002,4261,4624,3466,2,0,30,0,0,0,0,0,2,1,6,0,0,6,4,1560.957463,1,-3.854953705,0.908804161,-4.241787031,2.22E-05,0.000228699,520.0358467,0,-4.369436905,1.909784487,-2.287921457,0.022142096,0.062439583,1551.154777,1,-1.861694599,1.056087626,-1.762822092,0.0779305,0.159516454,1557.998242,1,-3.255692787,1.200401799,-2.712169199,0.006684446,0.035323601,1351.452992,1,-2.622789451,1.050692666,-2.496247986,0.012551482,0.037732706,N,-,,sterol regulatory element-binding sre1,F:DNA binding; F:protein dimerization activity,IPR011598 (SMART); IPR011598 (PFAM); IPR011598 (G3DSA:4.10.280.GENE3D); PTHR12565 (PANTHER); PTHR12565:SF142 (PANTHER); PTHR12565:SF142 (PANTHER); IPR011598 (PROSITE_PROFILES); IPR011598 (SUPERFAMILY),,
RL4_JR_10003,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,54.12976407,0,-2.669564515,1.23263692,-2.165734672,0.030331468,0.091206825,24.45311796,0,0.461545838,1.212769782,0.380571684,0.703521096,0.813089808,65.87698724,0,-0.288835353,0.857479647,-0.336842226,0.736235839,0.82249578,81.66269839,0,-0.3759427,1.508634016,-0.249194103,0.803210641,0.874087246,45.17435282,0,-1.503219296,1.069120304,-1.406033812,0.159714085,0.271291648,N,-,,Phospholipase carboxylesterase,F:hydrolase activity,IPR003140 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR10655 (PANTHER); PTHR10655:SF17 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_10004,603,473,708,7,8,2,0,0,1,0,6,10,0,1,4,1,0,0,12.54518674,1,-1.751505979,1.239422365,-1.413163122,0.157607767,0.306762878,48.67955921,1,3.156315702,1.03347885,3.054068985,0.002257602,0.015081,10.4514367,1,-1.196681888,1.236185326,-0.968044081,0.333022355,0.476456444,12.05061016,1,-1.618259721,1.238989975,-1.306112038,0.19151446,0.320668746,10.24944004,1,-1.271345308,1.23890646,-1.026183452,0.30480512,0.439987513,N,-,,sugar porter family MFS transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,IPR005828 (PFAM); G3DSA:1.20.1250.20 (GENE3D); IPR003663 (TIGRFAM); PTHR23500 (PANTHER); PTHR23500 (PANTHER); PTHR23500:SF87 (PANTHER); PTHR23500:SF87 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.11, the major facilitator superfamily (mfs).
RL4_JR_10005,722,481,573,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,10.29999289,0,1.660719756,1.218273358,1.363174976,0.172827372,0.326825614,10.12377267,0,4.800045782,1.221351202,3.930110991,8.49E-05,0.004192318,1.908361416,0,1.256888264,1.286490842,0.976989671,0.328574266,0.471440741,2.199701524,0,0.835670534,1.3153298,0.63533156,0.525212194,0.659364348,1.856016976,1,1.193735566,1.269307287,0.940462233,0.346980513,0.484375803,N,-,,plasma membrane ammonium transporter,C:integral component of membrane,IPR000791 (PFAM); IPR030186 (PTHR31123:PANTHER); PTHR31123 (PANTHER); IPR030186 (PTHR31123:PANTHER),2.A.96.2.1, the acetate uptake transporter (acetr) family.
RL4_JR_10006,8450,8016,5298,4,5,15,0,0,0,0,0,0,1,15,0,0,4,1,148.595365,1,1.722993865,0.939887605,1.83319139,0.066774114,0.165173809,10.55202992,0,0.066096764,1.321665186,0.050010218,0.960114246,0.978544397,62.17774448,0,0.548695296,0.79038123,0.694216,0.48754676,0.622368828,31.11223341,1,-2.986589337,1.271506832,-2.348858271,0.018831073,0.074566719,26.26788715,1,-2.629047797,1.265814385,-2.076961543,0.037805109,0.090051655,N,-,,swirm domain-containing,F:DNA binding,IPR007526 (PFAM); PTHR12374:SF21 (PANTHER); PTHR12374 (PANTHER); PTHR12374 (PANTHER); IPR007526 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY),,
RL4_JR_10007,6119,5371,6184,0,2,13,0,0,0,2,3,1,1,8,0,0,2,1,18.15320205,1,-0.995915426,1.138612274,-0.874674767,0.381750893,0.573857341,4.594439309,0,1.26566683,1.2505014,1.01212748,0.311477105,0.473175935,19.7281313,1,-0.42026764,1.190618553,-0.352982606,0.724101481,0.813268625,45.97981457,1,0.935669006,0.737565969,1.268590262,0.204587239,0.336273668,19.40333397,1,0.21058043,0.970072248,0.217077059,0.828148292,0.884680466,N,-,,f-box domain-containing,C:membrane; C:integral component of membrane,IPR001810 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001810 (PFAM); G3DSA:1.20.1280.50 (GENE3D); PTHR22844:SF146 (PANTHER); PTHR22844:SF146 (PANTHER); PTHR22844 (PANTHER); PTHR22844 (PANTHER); PTHR22844:SF146 (PANTHER); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY),,
RL4_JR_10008,7351,6777,4722,0,0,6,4,0,0,0,0,5,1,13,0,0,2,0,109.8252868,1,-0.252500989,0.624031891,-0.404628341,0.685750723,0.828896683,40.08577746,1,0.685729581,1.004591604,0.682595374,0.494862558,0.649885989,115.510401,1,0.342511389,0.575745323,0.594900862,0.551909741,0.679005252,127.653105,1,0.301226535,0.534264872,0.563814974,0.57288006,0.69977206,216.1839466,1,1.200714956,0.591462791,2.030076911,0.042348722,0.098366784,N,-, Effector probability:0.847,NADH-ubiquinone oxidoreductase 21 kDa subunit,C:integral component of membrane; F:NADH dehydrogenase (ubiquinone) activity; P:oxidation-reduction process,IPR024549 (PFAM); IPR019721 (PFAM); PTHR34062 (PANTHER),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_10009,224,231,283,0,0,7,3,0,0,0,0,0,0,0,1,0,0,0,26.10278964,1,-0.579618229,1.007838952,-0.57510997,0.565216926,0.742040502,5.917287066,1,0.900599873,1.239126692,0.726802093,0.467347201,0.626140088,26.38550285,0,-0.786170964,1.191384098,-0.659880357,0.50933061,0.640774685,45.60201665,1,0.161317021,0.848667539,0.190082704,0.849244323,0.905592288,15.06809545,0,-1.8272652,1.193273254,-1.531304916,0.125694051,0.226611871,N,-,,replication fork protection complex subunit Csm3 Swi3,F:nucleic acid binding; P:regulation of macromolecule metabolic process; P:regulation of cellular process; P:nuclear-transcribed mRNA catabolic process; C:cytoplasmic part; P:DNA metabolic process; P:cell cycle; P:single organism reproductive process; F:hydrolase activity,IPR012923 (PFAM); PTHR13220 (PANTHER); IPR012923 (PRODOM),,
RL4_JR_10010,1735,1409,1952,1,0,0,0,0,0,0,0,2,0,1,0,0,0,0,59.37933831,1,-0.691761324,0.893357346,-0.774338878,0.438730419,0.628805825,10.11232315,0,0.127505614,1.26535208,0.100766906,0.919735498,0.955670261,33.85633194,1,-1.550394606,1.219740705,-1.271085403,0.203698268,0.329694846,39.30401124,1,-1.980180223,1.176557663,-1.683028622,0.092369551,0.184465819,25.44385934,0,-2.58307433,1.220595641,-2.116240827,0.034324331,0.083521713,N,-,,DSHCT domain-containing,"P:nuclear-transcribed mRNA catabolic process, non-stop decay; F:ATP binding; F:RNA binding; F:RNA helicase activity; C:Ski complex; P:nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay; C:cytosol",IPR014001 (SMART); IPR012961 (SMART); IPR001650 (SMART); IPR016438 (PIRSF); IPR001650 (PFAM); IPR011545 (PFAM); IPR025696 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR012961 (PFAM); IPR001650 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_10011,43541,40271,57578,4,7,11,7,0,0,0,0,12,5,3,1,0,5,3,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,hypothetical protein OJAG_04830,,no IPS match,,
RL4_JR_10012,493,416,553,0,0,0,0,0,0,0,0,1,1,0,3,0,0,0,82.62345878,0,-1.446273115,0.878993881,-1.645373359,0.09989284,0.221326939,54.14235224,0,1.989817497,0.772744584,2.575000249,0.010024001,0.033619265,93.63101223,1,0.167563661,0.641330214,0.26127517,0.793880313,0.864219816,85.3349794,1,-0.368801273,0.64635643,-0.570584983,0.568281,0.695412754,58.41282061,0,-0.754451645,0.793604628,-0.950664372,0.34177478,0.478705763,N,-,,Vacuolar -sorting-associated 46,C:late endosome; P:protein targeting to vacuole; P:late endosome to vacuole transport via multivesicular body sorting pathway,PTHR10476:SF2 (PANTHER); PTHR10476 (PANTHER),3.A.31.1.1, the endosomal sorting complexes required for transport iii (escrt-iii) family.
RL4_JR_10013,740,559,693,1,0,0,0,0,0,0,9,0,4,0,0,0,0,0,116.9692768,1,0.724816913,1.010292732,0.717432571,0.473107228,0.662480049,52.99849915,0,2.079010373,0.79433437,2.617298775,0.008862873,0.030785861,66.05824842,1,-0.328378642,0.770628034,-0.426118215,0.670021708,0.772849467,109.4605085,1,0.358966821,0.544997498,0.658657741,0.510115575,0.645211768,61.52751032,0,-0.970950033,0.859984633,-1.129031841,0.258884402,0.390641516,N,-,,peroxisomal membrane pex16,C:peroxisomal membrane; P:peroxisome organization,IPR013919 (PFAM); PTHR13299:SF0 (PANTHER); PTHR13299 (PANTHER); PTHR13299:SF0 (PANTHER),9.A.17.1.1, the integral membrane peroxisomal protein importer-2 (ppi2) family.
RL4_JR_10014,5683,4703,6331,5,3,2,0,0,0,0,0,10,2,15,2,0,8,2,107.6473655,1,-0.564925811,0.583935422,-0.967445697,0.333321275,0.522929801,77.5015212,0,1.313967858,0.841475555,1.561504491,0.118404765,0.231146197,53.068063,1,-3.540816924,1.191481583,-2.971776462,0.002960822,0.013479228,73.26297575,1,-1.661596348,0.858421423,-1.935641752,0.052911593,0.12665009,75.61467613,1,-0.455824448,0.646173158,-0.705421515,0.480547959,0.609641409,N,-,,---NA---,,no IPS match,,
RL4_JR_10015,7783,7260,4544,0,5,11,0,0,2,0,0,2,0,1,0,0,0,0,317.3337803,1,-1.149158134,0.416758999,-2.757368496,0.005826865,0.024578884,117.3946616,1,-1.002465455,0.980000908,-1.022922985,0.306344261,0.467906535,252.1857496,1,-1.317765939,0.523186905,-2.518728828,0.011777932,0.036653843,399.762937,1,-0.069919807,0.336633553,-0.207703025,0.835460855,0.896749831,244.1601768,0,-1.004524822,0.627639697,-1.600480064,0.109492126,0.204389339,N,-,,transcriptional activator hac1,"P:regulation of transcription, DNA-templated; P:cellular process",IPR004827 (PFAM); G3DSA:1.20.5.170 (GENE3D); IPR004827 (PROSITE_PROFILES); SSF57959 (SUPERFAMILY),,
RL4_JR_10016,169,129,81,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,101.280117,0,-0.12834372,0.558215694,-0.229917792,0.81815565,0.907531826,20.18807529,0,-0.869914735,1.203540655,-0.722796302,0.469805039,0.628100222,60.15679048,0,-2.558361703,1.191215153,-2.147690696,0.031738335,0.080229439,89.24956735,0,-1.608215004,0.850189323,-1.89159633,0.058544785,0.135014457,137.1318665,0,0.853097687,0.457561029,1.864445688,0.062259142,0.132514991,N,-,,transcription factor spt8,P:negative regulation of transcription from RNA polymerase II promoter; F:transcription cofactor activity; C:cytosol; P:histone acetylation; F:TBP-class protein binding; P:positive regulation of transcription from RNA polymerase II promoter; C:SAGA complex,IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR22847:SF361 (PANTHER); PTHR22847 (PANTHER); PTHR22847:SF361 (PANTHER); PTHR22847 (PANTHER); PTHR22847 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_10017,13,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,112.85239,0,0.275620763,0.594126245,0.463909423,0.642712642,0.796362353,14.96760991,0,-0.438312176,1.218287289,-0.359777353,0.719013641,0.824074798,95.83443866,0,0.536558111,0.606202496,0.88511366,0.376095333,0.519915962,53.08716668,0,-1.805190357,1.039439347,-1.736696193,0.08244081,0.169657155,60.84313731,0,-0.936372381,0.874898288,-1.070264274,0.28450037,0.418869602,N,-,,WD domain-containing,P:phosphorylation; F:kinase activity,IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR19877 (PANTHER); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),8.A.92.1.4,The G-Protein αβγ Complex (GPC) Family
RL4_JR_10018,625,466,366,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,93.2758871,0,-0.810916938,0.627254323,-1.292804064,0.196078835,0.358175354,20.45105269,0,-0.888566691,1.201818822,-0.739351618,0.459693513,0.618587841,72.52678318,0,-1.137296968,0.853633378,-1.332301427,0.182761159,0.304171292,92.4829784,0,-0.911615726,0.670711009,-1.359178116,0.174090154,0.297402289,59.58024972,0,-2.686064911,1.120567401,-2.397057872,0.016527313,0.046913105,N,-,,phospholipase A-2-activating,F:ubiquitin binding; C:cytoplasm; P:double-strand break repair via nonhomologous end joining; P:ubiquitin-dependent protein catabolic process,IPR001680 (SMART); IPR013535 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); IPR033510 (PTHR19849:PANTHER); PTHR19849 (PANTHER); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR013535 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY),8.A.92.1.3,The G-Protein αβγ Complex (GPC) Family
RL4_JR_10019,181,136,125,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,55.64604105,0,1.684673019,0.606506256,2.777668001,0.005475053,0.023397318,5.560976476,0,0.99012598,1.243668466,0.79613338,0.425954514,0.58884343,22.30228421,0,-0.703278716,1.198410928,-0.58684271,0.557309349,0.683654411,72.05689357,0,2.05613428,0.507113413,4.05458469,5.02E-05,0.000595448,45.18364988,0,1.795388818,0.608425797,2.950875565,0.003168745,0.012368369,Y,-,,gpi anchored,C:integral component of membrane,PTHR34992:SF3 (PANTHER); PTHR34992 (PANTHER),,
RL4_JR_10020,31,31,29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20.57291641,0,2.200454609,0.752527123,2.924086777,0.003454684,0.016086366,1.690438807,0,2.708075252,1.330406771,2.035524256,0.04179815,0.102689534,10.88840173,0,1.016343674,1.197554546,0.848682574,0.396057946,0.538666083,5.064088029,0,-0.367722025,1.205011692,-0.305160545,0.760243881,0.843292408,8.195185176,0,0.899562759,1.134964264,0.792591262,0.428016001,0.562667101,N,-,,sensitivity to red light reduced- srr1,,IPR012942 (PFAM); PTHR42080 (PANTHER),,
RL4_JR_10021,862,918,1170,0,3,1,0,0,0,0,0,0,2,1,0,0,1,0,47.72515675,1,-2.611712401,1.151259164,-2.268570348,0.023294467,0.074290953,14.13400963,0,-0.355552561,1.226351879,-0.289927033,0.77187206,0.861779064,69.68229096,0,-0.572802544,0.862447909,-0.664159004,0.506588549,0.638454185,42.05986753,1,-3.421549391,1.200542275,-2.850003254,0.004371878,0.025279992,35.77104773,1,-3.074540773,1.197737973,-2.566956081,0.010259561,0.032071025,N,-,,DNA-directed RNA polymerase III subunit RPC1,"F:nucleotidyltransferase activity; P:transcription, DNA-templated; C:intracellular part",IPR006592 (SMART); IPR007081 (PFAM); IPR007066 (PFAM); G3DSA:3.30.1490.180 (GENE3D); IPR007083 (PFAM); G3DSA:2.40.40.20 (GENE3D); IPR000722 (PFAM); IPR007080 (PFAM); PTHR19376:SF32 (PANTHER); PTHR19376 (PANTHER); SSF64484 (SUPERFAMILY),,
RL4_JR_10022,8843,10604,11845,0,1,4,0,0,0,0,2,5,0,1,0,0,0,0,80.15396563,1,0.088285666,0.557073669,0.158481133,0.874077687,0.939103212,14.55203006,0,-0.39759021,1.214431093,-0.327388036,0.743374414,0.841753644,55.19194142,1,-1.219397071,1.033472614,-1.179902646,0.238038937,0.370868914,95.54558785,1,0.433786415,1.390917712,0.311870653,0.755138826,0.839457687,63.95926234,0,0.28524845,0.581962251,0.490149403,0.624028182,0.729257311,N,-,,Acyl-coenzyme A thioesterase mitochondrial,F:hydrolase activity,IPR029069 (G3DSA:3.10.129.GENE3D); IPR029069 (G3DSA:3.10.129.GENE3D); PTHR12655 (PANTHER); IPR033120 (PROSITE_PROFILES); IPR033120 (PROSITE_PROFILES); IPR029069 (SUPERFAMILY); IPR029069 (SUPERFAMILY),,
RL4_JR_10023,4226,3856,5644,0,3,14,0,0,0,1,1,0,0,4,1,0,4,0,0.609591764,1,2.61153788,1.887595882,1.383525947,0.166503657,NA,0.194030519,0,5.830913895,1.881419775,3.099209424,0.001940378,0.015023052,0.505437479,1,3.172324425,1.320036304,2.403209984,0.016251852,0.047416067,0.583157497,1,2.750326503,1.450464457,1.896169526,0.057937631,0.134453018,0.50143444,1,3.081741614,1.283450091,2.401138647,0.016344143,0.046549773,N,-,,Isotrichodermin C-15 hydroxylase,F:oxidoreductase activity; F:metal ion binding,IPR002401 (PRINTS); IPR001128 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305:SF94 (PANTHER); PTHR24305 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_10024,8898,9410,10242,3,0,2,0,0,0,0,0,2,2,3,1,0,0,0,11.15114221,1,1.790452405,1.066634715,1.678599412,0.093230141,0.210276885,1.109685304,0,3.315265485,1.41308768,2.346114493,0.018970279,0.05515359,25.08241476,1,3.05791801,0.8842336,3.45826941,0.000543657,0.003597378,11.36752206,1,1.93993356,1.056870878,1.83554453,0.066425047,0.145985154,2.874717519,0,0.562976004,1.241847243,0.453337564,0.650305688,0.750609335,N,-,,fungal specific transcription factor domain containing,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; C:cytosol; P:regulation of transcription, DNA-templated; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR007219 (PFAM); PTHR31944 (PANTHER),,
RL4_JR_10025,9000,16348,19438,0,0,0,0,0,0,0,0,0,2,2,2,0,5,0,3.256008313,0,0.194859362,1.250759134,0.155792875,0.876196287,0.939923479,1.04085761,0,3.40784096,1.418991125,2.401594273,0.016323802,0.049248855,2.692823316,0,0.760220177,1.224508293,0.620837099,0.534706811,0.663897013,3.106203895,1,0.33796971,1.231270325,0.274488634,0.783709137,0.86067336,2.643195611,1,0.684113809,1.216376161,0.562419613,0.57383016,0.688963639,N,-,,ABC transporter,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR010929 (PFAM); IPR013525 (PFAM); IPR029481 (PFAM); PTHR19241:SF179 (PANTHER); PTHR19241:SF179 (PANTHER); PTHR19241 (PANTHER); PTHR19241:SF179 (PANTHER); PTHR19241 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.205.4, the atp-binding cassette (abc) superfamily.
RL4_JR_10026,7613,17584,14802,10,8,169,2,0,4,1,4,2,10,28,9,0,15,9,6.290966856,1,1.538941613,1.15406236,1.333499528,0.18236793,0.33990349,0.787439688,1,3.810267814,1.44034533,2.645384919,0.008159804,0.029019308,56.72306136,1,4.969673942,0.543618481,9.141841407,6.14E-20,9.71E-18,2.359024007,1,0.734627198,1.220121847,0.602093307,0.547112029,0.677036091,2.01695687,1,1.074244564,1.207966161,0.889300213,0.373841757,0.510088619,N,-,,Sugar transporter,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane; P:carbohydrate transport,G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR23500 (PANTHER); PTHR23500:SF174 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.83, the major facilitator superfamily (mfs).
RL4_JR_10027,103,284,150,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,25.60949809,1,3.744523188,0.634715943,5.899525964,3.65E-09,9.04E-08,0.865102915,0,3.674580422,1.439295625,2.553040777,0.010678699,0.035323462,34.73297613,0,4.156035729,0.686992465,6.049608902,1.45E-09,7.39E-08,79.66509403,0,4.852941476,1.831817665,2.649249196,0.008067082,0.040839605,2.204235119,0,0.945695242,1.213236848,0.779481141,0.435696343,0.570467538,N,-,,beta-glucosidase precursor,F:beta-glucosidase activity; P:cellulose catabolic process; F:scopolin beta-glucosidase activity,IPR001764 (PRINTS); IPR011658 (SMART); IPR026891 (SMART); IPR001764 (G3DSA:3.20.20.GENE3D); IPR011658 (PFAM); IPR002772 (PFAM); IPR001764 (PFAM); IPR026891 (PFAM); IPR002772 (G3DSA:3.40.50.GENE3D); IPR026892 (PANTHER); PTHR30620:SF18 (PANTHER); IPR017853 (SUPERFAMILY); IPR002772 (SUPERFAMILY),,
RL4_JR_10028,1573,1443,1718,0,0,0,0,0,0,0,0,1,3,3,0,0,0,0,20.61992659,0,-2.468370537,1.205185394,-2.048125167,0.040547737,0.113673002,6.543860547,0,0.755303915,1.239159045,0.609529437,0.542173567,0.688826515,24.89552912,1,-0.941245757,1.202009554,-0.78306013,0.433591803,0.574190113,33.32368285,1,-0.590700256,1.029325212,-0.573871357,0.566054857,0.693381681,16.89953449,0,-1.992686692,1.213885923,-1.641576571,0.100677786,0.192042688,N,-,,quinate utilization pathway activator,F:binding,IPR001138 (SMART); IPR001138 (PFAM); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31001 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_10029,558,186,384,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,184.2882237,0,2.274285345,0.753572477,3.018004791,0.002544449,0.012672536,37.91356914,0,2.316110499,0.934388152,2.478745576,0.013184532,0.041595203,1648.72029,0,6.014222526,0.959363886,6.268969067,3.63E-10,1.98E-08,228.3461275,0,2.657174275,0.507096724,5.239975237,1.61E-07,3.47E-06,132.0467499,0,2.418342487,0.708279124,3.414391875,0.000639246,0.00333455,N,-,,aldo keto reductase,F:oxidoreductase activity; P:oxidation-reduction process,IPR020471 (PRINTS); IPR023210 (G3DSA:3.20.20.GENE3D); IPR020471 (PIRSF); IPR023210 (PFAM); IPR001395 (PANTHER); IPR001395 (PANTHER); PTHR11732:SF218 (PANTHER); PTHR11732:SF218 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.4, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_10030,63,152,117,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0.06079236,1,5.937882602,3.924285622,1.513111729,0.130251281,NA,0.019391598,0,9.154538322,2.911808475,3.143935599,0.001666921,0.015023052,0.050175547,0,6.508307234,1.656073422,3.929962976,8.50E-05,0.001054074,0.05788258,0,6.084004288,2.876006949,2.115434488,0.034392933,0.099376683,0.049200136,0,6.435039419,1.343285389,4.790522901,1.66E-06,2.20E-05,N,-,,FMN-dependent dehydrogenase family,F:FMN binding; F:oxidoreductase activity; C:integral component of membrane; P:oxidation-reduction process,IPR000262 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR10578 (PANTHER); SSF51395 (SUPERFAMILY),,
RL4_JR_10031,582,679,801,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0.8073154,0,2.206301502,1.615285124,1.365889817,0.171973549,NA,0.257879333,0,5.420653566,1.748638211,3.099928579,0.001935673,0.015023052,0.669483867,0,2.767198484,1.265621438,2.186434586,0.028783826,0.074206124,0.77230615,0,2.345206138,1.339091855,1.751340753,0.079887232,0.166294865,0.661268002,1,2.682551884,1.238822366,2.165404789,0.0303567,0.075798171,N,-, Effector probability:0.564,FMN-dependent dehydrogenase family,F:catalytic activity,IPR000262 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR10578 (PANTHER); PTHR10578:SF65 (PANTHER); IPR012133 (PROSITE_PROFILES); SSF51395 (SUPERFAMILY),,
RL4_JR_10032,2279,2764,3705,0,0,9,0,0,1,0,0,0,1,0,0,0,0,0,103.3415021,1,-1.196745752,0.693318567,-1.726112365,0.0843272,0.195493406,25.96101702,1,-1.232738685,1.226207339,-1.005326461,0.314739677,0.476772675,100.7247979,0,-0.747469434,0.706001977,-1.05873561,0.289720205,0.42932192,104.0961207,1,-1.561484304,0.775938811,-2.012380721,0.044179819,0.114079079,76.73296023,0,-2.269171468,0.990233532,-2.291551835,0.021931518,0.058830105,N,-,,metallo-beta-lactamase superfamily,,IPR001279 (SMART); IPR001279 (PFAM); IPR001279 (G3DSA:3.60.15.GENE3D); PTHR23200:SF37 (PANTHER); PTHR23200 (PANTHER); IPR001279 (SUPERFAMILY),,
RL4_JR_10033,42944,40420,58084,3,13,50,0,2,0,0,1,1,0,22,3,0,28,11,75.85916772,1,-0.238588329,0.610131398,-0.391044175,0.695764584,0.835696036,15.61251687,1,-0.499143159,1.203459242,-0.414757012,0.678319792,0.794946502,90.09078428,1,0.254449587,0.617934922,0.411774084,0.680505018,0.780230216,73.50608492,1,-0.844841045,0.747643232,-1.130005608,0.258473861,0.398333005,47.86245042,1,-1.57491774,0.983643348,-1.601106481,0.109353337,0.204167903,N,-,,Peptidase serine carboxypeptidase,F:carboxypeptidase activity,IPR001563 (PRINTS); IPR029058 (G3DSA:3.40.50.GENE3D); G3DSA:1.10.287.410 (GENE3D); IPR001563 (PFAM); IPR001563 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_10034,16365,21285,27685,0,3,3,0,0,1,0,1,2,0,4,0,0,1,1,214.8412779,1,1.958241566,0.915382816,2.139259698,0.032414642,0.096207691,32.6494554,1,1.258301232,1.132095947,1.111479319,0.266362087,0.423518229,630.2281089,1,4.082208388,0.510324036,7.999247736,1.25E-15,1.36E-13,605.4784787,1,3.774025712,0.508114086,7.427516405,1.11E-13,5.87E-12,202.1109628,1,2.470931212,0.749988367,3.294626051,0.000985527,0.00472689,N,-,,ABC-2 type transporter,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR010929 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003439 (PFAM); IPR013525 (PFAM); PTHR19241:SF279 (PANTHER); PTHR19241 (PANTHER); PTHR19241:SF279 (PANTHER); PTHR19241 (PANTHER); PTHR19241:SF279 (PANTHER); PTHR19241 (PANTHER); PTHR19241:SF279 (PANTHER); PTHR19241:SF279 (PANTHER); PTHR19241 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.205.7, the atp-binding cassette (abc) superfamily.
RL4_JR_10035,76249,54162,52133,5,13,20,0,0,3,0,6,9,6,9,2,0,10,6,442.9010339,1,-0.261202046,0.840837755,-0.310645002,0.756070512,0.87221091,79.07466126,1,-2.839639547,1.191567621,-2.383112379,0.017166953,0.051167225,253.6546359,1,-1.876026025,0.586385268,-3.199306201,0.001377588,0.007402706,290.4943021,1,-1.677537588,0.503195679,-3.333767873,0.000856781,0.006516038,244.4253744,1,-1.969641233,0.577683476,-3.409550931,0.000650699,0.003378203,N,-,,MFS AGZA xanthine uracil permease,C:integral component of membrane; P:purine nucleobase transmembrane transport; F:purine nucleobase transmembrane transporter activity,IPR006043 (PFAM); IPR006043 (PANTHER); IPR029940 (PTHR11119:PANTHER),2.A.40.7.1, the nucleobase/ascorbate transporter (nat) or nucleobase:cation symporter-2 (ncs2) family.
RL4_JR_10036,1903,1737,1559,0,0,4,0,0,3,1,4,4,2,2,3,0,8,0,18.32519998,1,-2.298133639,1.316462385,-1.745688799,0.080865043,0.189895514,6.007549029,1,0.878771422,1.390821504,0.631836234,0.527493894,0.676116651,15.34955613,1,-1.751140698,1.294573272,-1.352677933,0.176158543,0.295416447,17.68794586,1,-2.171882388,1.305932527,-1.663089282,0.096294565,0.190537907,14.92768503,1,-1.81375658,1.302490486,-1.392529618,0.163762079,0.276540644,N,-,,fusarin C cluster-transporter,C:membrane,PR01036 (PRINTS); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF83 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_10037,6709,6810,7722,2,9,4,0,0,0,1,4,2,0,7,0,0,0,2,108.9407149,1,-4.869738079,1.343006313,-3.625997907,0.000287848,0.002106064,35.06008196,0,-1.666247791,1.311807161,-1.270192632,0.204016022,0.348884975,90.80180326,1,-4.315668801,1.295060141,-3.332408022,0.000860979,0.005106358,104.7175811,1,-4.737545987,1.314111733,-3.605131791,0.000311995,0.002802968,89.67273339,1,-4.400385543,1.313161125,-3.350986759,0.000805242,0.00401827,N,-,,l-serine ammonia-lyase,"F:L-serine ammonia-lyase activity; P:gluconeogenesis; F:4 iron, 4 sulfur cluster binding",IPR005130 (PFAM); IPR005131 (PFAM); IPR029009 (G3DSA:3.30.1330.GENE3D); PTHR30182:SF1 (PANTHER); PTHR30182:SF1 (PANTHER); PTHR30182 (PANTHER); PTHR30182 (PANTHER); IPR029009 (SUPERFAMILY),,
RL4_JR_10038,202,131,248,0,0,0,0,0,0,0,0,1,0,0,2,0,5,1,0.025412647,0,7.19954747,3.948643277,1.823296501,0.068258496,NA,0.008040265,0,10.42689626,3.949049696,2.640355798,0.008281903,0.029239421,0.020714127,1,7.784870839,3.871110403,2.011017519,0.044323606,0.103180545,0.023901681,1,7.362109553,3.949263291,1.864172887,0.06229743,0.139827416,0.020038712,1,7.732621795,2.284507304,3.384809399,0.000712277,0.003640876,N,-,,cytochrome P450,F:oxidoreductase activity; F:binding,IPR002401 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305 (PANTHER); PTHR24305:SF72 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_10039,1048,794,1689,3,0,8,0,0,0,0,0,0,0,5,0,0,1,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,Cytochrome P450,F:oxidoreductase activity; F:metal ion binding; P:metabolic process,IPR002403 (PRINTS); IPR001128 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_10040,46380,51239,66855,6,9,78,0,0,0,3,7,9,8,53,5,0,31,3,0.49329401,1,2.917024681,2.034902858,1.43349579,0.151716201,NA,0.159684437,0,6.112365733,1.953235464,3.129354266,0.00175191,0.015023052,0.410928439,1,3.471977481,1.323619197,2.623093931,0.008713525,0.029327036,0.473776167,1,3.050476478,1.485261779,2.05383086,0.039992065,0.107518064,0.402215275,1,3.39888108,1.264597899,2.68771685,0.007194237,0.024151741,N,-,,translation elongation factor eEF-1B gamma,F:glutathione binding,IPR010987 (G3DSA:1.20.1050.GENE3D); PF13410 (PFAM); IPR004045 (PFAM); IPR012336 (G3DSA:3.40.30.GENE3D); PTHR11260:SF143 (PANTHER); PTHR11260 (PANTHER); IPR010987 (PROSITE_PROFILES); IPR012336 (SUPERFAMILY); IPR010987 (SUPERFAMILY),,
RL4_JR_10041,1328,883,1821,6,3,4,0,0,0,0,1,1,1,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.556,alpha beta hydrolase,F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR029058 (SUPERFAMILY),,
RL4_JR_10042,4221,3755,2921,1,2,2,0,0,0,0,0,0,0,1,0,0,2,7,0.51477143,1,2.85546108,2.021410202,1.412608424,0.157770891,NA,0.165656284,0,6.05919973,1.948120529,3.110279698,0.001869103,0.015023052,11.4983793,0,4.371950291,1.233571747,3.54413945,0.000393897,0.002850844,0.494040937,1,2.989767001,1.494208131,2.000903984,0.045402738,0.115440701,0.421838056,1,3.330464187,1.281046277,2.599800059,0.009327809,0.029708734,N,PKS,,polyketide synthase,F:catalytic activity; P:metabolic process; F:phosphopantetheine binding; F:transferase activity,IPR020806 (SMART); IPR020801 (SMART); SM00822 (SMART); IPR020807 (SMART); IPR020841 (SMART); IPR029063 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.300.30 (GENE3D); IPR032821 (PFAM); G3DSA:3.30.70.250 (GENE3D); IPR010071 (TIGRFAM); IPR009081 (PFAM); IPR001242 (PFAM); IPR020807 (PFAM); IPR013120 (PFAM); IPR000873 (PFAM); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR001227 (G3DSA:3.40.366.GENE3D); IPR014030 (PFAM); G3DSA:3.40.50.980 (GENE3D); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR014043 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013968 (PFAM); G3DSA:2.30.38.10 (GENE3D); IPR013217 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); G3DSA:3.40.50.980 (GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR014031 (PFAM); PTHR11712:SF258 (PANTHER); PTHR11712:SF258 (PANTHER); PTHR11712 (PANTHER); PTHR11712 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR009081 (PROSITE_PROFILES); IPR009081 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016035 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR029063 (SUPERFAMILY); IPR016036 (SUPERFAMILY); SSF56801 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF52777 (SUPERFAMILY),4.C.1.1.4, the fatty acid transporter (fat) family.
RL4_JR_10043,1961,1242,1231,0,1,0,0,0,1,0,0,5,2,0,0,0,0,0,0.842586273,1,2.144564108,1.763810594,1.215869842,0.224034508,NA,0.274372045,1,5.331412489,1.847393443,2.885910692,0.003902829,0.01779479,0.704235167,1,2.69467844,1.356340558,1.986727024,0.046952655,0.107886673,0.81175132,1,2.273565868,1.463859901,1.553130778,0.120391894,0.224984852,0.688254604,0,2.624408307,1.317795761,1.991513696,0.046424441,0.105842708,N,-,,3-octaprenyl-4-hydroxybenzoate carboxy-,F:FMN binding; C:cytoplasm; F:oxidoreductase activity; F:metal ion binding; P:ferulate metabolic process; P:oxidation-reduction process; P:cinnamic acid catabolic process; F:carboxy-lyase activity,G3DSA:3.40.1670.10 (GENE3D); IPR002830 (PFAM); PTHR30108:SF1 (PANTHER); PTHR30108 (PANTHER); IPR032903 (HAMAP); IPR012349 (SUPERFAMILY); SSF143968 (SUPERFAMILY),,
RL4_JR_10044,65172,27107,24299,2,0,2,0,0,0,0,3,1,0,7,1,0,4,0,0.019504112,1,7.575372061,3.961019049,1.912480593,0.055814579,NA,0.006509392,0,10.7300969,3.9588721,2.710392412,0.006720365,0.025175252,0.016494478,1,8.109867811,2.851793459,2.843778109,0.004458208,0.017386326,0.018993711,1,7.690398192,3.960048927,1.941995752,0.052137615,0.125807414,0.015949996,1,8.040879118,1.654939983,4.858713428,1.18E-06,1.67E-05,N,-, Effector probability:0.597,multicopper oxidase,F:copper ion binding; F:oxidoreductase activity; F:metal ion binding; P:oxidation-reduction process,IPR011707 (PFAM); IPR008972 (G3DSA:2.60.40.GENE3D); PTHR11709 (PANTHER); PTHR11709:SF87 (PANTHER); IPR008972 (SUPERFAMILY),,
RL4_JR_10045,1757,1201,1152,3,2,1,0,0,3,0,0,1,5,2,0,0,0,0,123.3633382,1,0.31315982,0.476896644,0.656661824,0.511398386,0.697307043,56.17138528,1,1.836356334,0.753131883,2.438293181,0.0147568,0.045469812,62.88606119,1,-1.590513392,1.035103806,-1.536573804,0.124397712,0.228069981,110.74055,1,0.317237764,0.492152702,0.644592141,0.519191529,0.65358874,51.86299237,0,-2.569159361,1.129901266,-2.273791029,0.022978554,0.060844552,N,-,,glc8,P:regulation of cellular process; P:regulation of catalytic activity; C:intracellular part; F:enzyme regulator activity,IPR007062 (PFAM); PTHR12398 (PANTHER),,
RL4_JR_10046,13009,13050,15051,4,6,0,0,0,0,7,5,7,2,4,0,0,10,0,31.11262947,1,1.375387409,0.845581409,1.626558241,0.103830954,0.227947504,2.297317661,0,2.265624542,1.302906358,1.738900519,0.082052263,0.173425142,5.939387071,1,-0.381223803,1.199080352,-0.317930156,0.750537918,0.832888949,6.850332409,1,-0.803252986,1.196789081,-0.671173391,0.502110078,0.639640732,5.833504212,1,-0.458220039,1.194345915,-0.383657727,0.701232148,0.788398531,N,-,,poly [ADP-ribose] polymerase,P:protein ADP-ribosylation; F:NAD+ ADP-ribosyltransferase activity,IPR008893 (SMART); IPR001357 (PFAM); IPR001357 (G3DSA:3.40.50.GENE3D); IPR012317 (PFAM); IPR004102 (PFAM); IPR004102 (G3DSA:1.20.142.GENE3D); IPR008893 (PFAM); IPR012317 (G3DSA:3.90.228.GENE3D); IPR008893 (G3DSA:2.20.140.GENE3D); PTHR10459 (PANTHER); PTHR10459:SF60 (PANTHER); IPR012317 (PROSITE_PROFILES); IPR004102 (PROSITE_PROFILES); IPR001357 (PROSITE_PROFILES); IPR001357 (SUPERFAMILY); SSF56399 (SUPERFAMILY); IPR008893 (SUPERFAMILY); IPR004102 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_10047,12041,12155,12860,8,9,4,4,0,0,0,8,9,2,39,5,0,7,2,7.649155257,1,9.969614609,1.3802678,7.222956741,5.09E-13,2.53E-11,0.00401109,1,11.43263965,3.991205167,2.86445802,0.004177235,0.018371529,11.08009885,1,9.801424686,1.471707251,6.659901065,2.74E-11,1.78E-09,9.646931097,1,9.370547938,1.440372841,6.505640531,7.74E-11,2.98E-09,0.00966951,1,8.76562085,1.6165792,5.422326879,5.88E-08,1.50E-06,Y,-,,hypothetical protein F503_01561,,no IPS match,,
RL4_JR_10048,544,376,352,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,20.85639232,0,2.134703814,0.737826933,2.89323108,0.003813007,0.017397375,1.782003186,0,2.632005719,1.317912285,1.997102348,0.045814066,0.109992878,26.76317387,0,1.808833255,1.028334288,1.758993428,0.078578625,0.160486181,5.333334456,1,-0.442365409,1.196295912,-0.369779253,0.711546975,0.807209278,4.558928912,0,-0.102488323,1.199167606,-0.08546622,0.931890749,0.95548292,N,-,,d-isomer specific 2-hydroxyacid dehydrogenase,"F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:NAD binding; P:oxidation-reduction process",IPR016040 (G3DSA:3.40.50.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR006140 (PFAM); IPR006139 (PFAM); PTHR10996:SF138 (PANTHER); PTHR10996 (PANTHER); IPR016040 (SUPERFAMILY); SSF52283 (SUPERFAMILY),,
RL4_JR_10049,224,324,172,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,63.68693767,0,-1.917271489,1.036237454,-1.850224078,0.06428126,0.160270941,15.18207885,0,-0.45882002,1.225331185,-0.374445722,0.708072732,0.816578807,58.99395324,0,-0.720497642,0.881416318,-0.817431704,0.413681764,0.555747635,53.59277162,0,-1.82297716,1.043391761,-1.74716461,0.080608789,0.167178202,39.10420784,0,-3.203045346,1.216606969,-2.632769191,0.008469188,0.027510596,N,-,,transcription initiation factor TFIID subunit 11,"C:nucleus; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:protein heterodimerization activity; F:NAD binding; C:cytosol; P:oxidation-reduction process; P:transcription initiation from RNA polymerase II promoter",IPR006809 (PFAM); IPR009072 (G3DSA:1.10.20.GENE3D); IPR006809 (PANTHER); PTHR13218:SF8 (PANTHER); IPR009072 (SUPERFAMILY),,
RL4_JR_10050,1240,1412,981,0,2,0,0,0,0,1,3,0,0,1,0,0,1,1,13.62323464,1,-1.870280289,1.199322056,-1.559447922,0.118890402,0.250557452,4.327255072,0,1.352034684,1.25088471,1.080862748,0.279758172,0.438821046,11.2565445,1,-1.303744123,1.198327331,-1.087969947,0.276608375,0.415733846,31.61272901,1,0.01991641,1.018750398,0.019549843,0.984402476,0.990270747,18.4893448,1,-0.452980707,1.132491049,-0.399986126,0.689166736,0.779643933,N,-,,thymidylate kinase,C:nucleus; F:thymidylate kinase activity; F:ATP binding; F:uridylate kinase activity; P:nucleotide phosphorylation; P:mycelium development; C:mitochondrion; P:dTDP biosynthetic process; C:cytosol; P:dUDP biosynthetic process; P:dTTP biosynthetic process,IPR027417 (G3DSA:3.40.50.GENE3D); PF02223 (PFAM); IPR018094 (TIGRFAM); PTHR10344 (PANTHER); IPR018094 (HAMAP); IPR027417 (SUPERFAMILY),,
RL4_JR_10051,1085,1129,1495,0,0,3,0,0,1,1,0,1,1,2,1,1,4,2,79.75187631,1,-0.139390021,0.588348337,-0.236917507,0.812720788,0.904772951,37.26367154,1,0.487581822,1.115990825,0.436904866,0.662180343,0.783564396,84.42518196,1,0.321464735,0.619647683,0.51878631,0.603909766,0.721182454,103.2538665,1,0.392329092,0.518417266,0.756782455,0.449180206,0.591103403,79.80786558,1,0.612678274,0.519678356,1.178956689,0.238415422,0.367309214,N,-,,thymidylate kinase,P:biological_process; P:phosphorylation; C:cellular_component; F:kinase activity; F:molecular_function,no IPS match,,
RL4_JR_10052,40,37,57,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,158.1946108,0,-1.082962617,0.828803305,-1.306658179,0.191328828,0.351466017,64.84884709,0,0.436141971,0.880201367,0.495502492,0.620245463,0.750106518,108.936388,0,-2.58164819,1.059994704,-2.435529329,0.014870019,0.044170556,182.7874208,0,-0.368706812,0.53011806,-0.695518299,0.486730547,0.626910926,132.5233184,0,-1.253173088,0.693689324,-1.806533625,0.070835027,0.146159496,N,-,,50S ribosomal,P:biological regulation; F:structural constituent of ribosome; C:ribosome; P:translation,IPR001684 (PRINTS); IPR032675 (G3DSA:3.80.10.GENE3D); IPR001684 (PFAM); G3DSA:2.40.50.100 (GENE3D); PTHR15893:SF0 (PANTHER); IPR001684 (PANTHER); IPR001684 (PRODOM); IPR001810 (PROSITE_PROFILES); SSF110324 (SUPERFAMILY); IPR001810 (SUPERFAMILY),,
RL4_JR_10053,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.87225659,0,-1.163038797,1.195953484,-0.972478289,0.330812661,0.520596005,5.054190593,0,1.12793837,1.285922406,0.877143414,0.380408746,0.544701843,52.23298541,0,1.822807495,0.71037429,2.565981795,0.010288423,0.0334382,15.28328711,0,-1.961149569,1.234717989,-1.588338055,0.112209917,0.213356884,28.63419187,0,0.912786394,0.858229347,1.06356931,0.287523851,0.421909999,Y,-, Effector probability:0.661,long chronological lifespan 2,P:biological_process; P:ER-associated ubiquitin-dependent protein catabolic process; C:cellular_component; F:molecular_function,PTHR38425:SF1 (PANTHER); PTHR38425 (PANTHER),,
RL4_JR_10054,358,318,338,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.74626754,0,-2.405890342,1.208198397,-1.991304035,0.046447472,0.125886538,6.257311119,0,0.819899577,1.242288821,0.65999111,0.509259535,0.661116456,95.73555396,0,2.021010557,0.578340145,3.494501589,0.000474948,0.003252373,18.83052846,0,-2.2622736,1.20556226,-1.876529877,0.060582556,0.137522773,16.18082911,0,-1.929978567,1.21625425,-1.586821643,0.112553045,0.20867278,N,-,,s-adenosylmethionine decarboxylase proenzyme,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_10055,313,450,535,0,2,1,0,0,0,0,0,0,0,0,2,0,0,0,56.57914998,1,-3.924573917,1.194852877,-3.284566654,0.001021393,0.006010225,46.17575462,0,1.472104956,0.860518758,1.710718033,0.087133177,0.181994368,88.50329683,0,-0.215347308,0.676354318,-0.318394224,0.750185919,0.832887364,124.8815718,1,0.004319207,0.559538853,0.007719226,0.99384101,0.99563127,46.30450124,0,-3.446871304,1.200066919,-2.872232581,0.004075829,0.01512748,N,-,,Fungal transcriptional regulatory partial,F:metal ion binding; F:transferase activity; P:primary metabolic process; P:cellular macromolecule biosynthetic process,IPR007219 (SMART); IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR31313 (PANTHER); PTHR31313:SF25 (PANTHER); PTHR31313 (PANTHER); PTHR31313:SF25 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY); IPR001138 (SUPERFAMILY),,
RL4_JR_10056,4383,6259,4143,0,0,5,0,0,0,0,0,2,7,1,0,0,4,1,21.12213111,1,2.028214957,0.802224795,2.528237682,0.011463672,0.042202452,1.883899588,0,2.551911533,1.363748088,1.871248478,0.061310648,0.138492832,4.85140952,1,-0.089195066,1.226789211,-0.072706105,0.94203999,0.965598143,32.88811987,1,2.22497104,0.7816821,2.846388629,0.004421819,0.025466395,4.741289109,1,-0.159100201,1.219554918,-0.130457594,0.896204402,0.932461903,N,-,,Transcription fungi,"F:DNA binding; C:nucleus; F:zinc ion binding; P:transcription, DNA-templated; F:metal ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR007219 (SMART); IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR007219 (PFAM); PTHR31313:SF6 (PANTHER); PTHR31313 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_10057,10227,16290,20147,1,3,4,0,0,0,0,0,0,1,3,0,0,4,0,34.77351099,1,1.527355085,0.877060056,1.741448689,0.08160496,0.191192781,2.125582527,0,2.377756723,1.339761045,1.774761799,0.075937226,0.163609324,5.4894466,0,-0.267437881,1.220177405,-0.219179506,0.826510219,0.888184848,10.34305951,1,0.256077329,1.168806262,0.21909305,0.826577565,0.891657558,12.74338552,1,0.597018137,1.140383054,0.52352421,0.600609508,0.710067867,N,-,,"glutamate-1-semialdehyde 2,1-aminomutase",F:catalytic activity,IPR015422 (G3DSA:3.90.1150.GENE3D); IPR015421 (G3DSA:3.40.640.GENE3D); IPR005814 (PFAM); PTHR11986:SF5 (PANTHER); IPR005814 (PANTHER); IPR015424 (SUPERFAMILY),9.B.313.1.2, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_10058,2830,3016,3990,0,0,2,0,0,0,2,5,4,3,6,3,0,0,0,52.44707739,1,0.922581611,0.694766683,1.327901341,0.184210702,0.341776417,5.287262361,0,1.062943592,1.252833601,0.84843158,0.396197662,0.56033432,37.27314494,1,0.817546155,0.867187574,0.942755845,0.345805801,0.489504745,15.85656684,1,-2.014313297,1.204310304,-1.672586617,0.094408703,0.187576162,40.61594129,0,1.680089804,0.644682414,2.606073577,0.009158679,0.029271345,N,-,,hypothetical protein HMPREF1624_02163,C:membrane,no IPS match,,
RL4_JR_10059,389,380,394,0,0,3,0,0,0,0,0,2,0,1,0,0,0,1,0.425929441,1,3.128867125,2.13926466,1.462590012,0.143579598,NA,0.137135205,0,6.331908738,1.984657064,3.190429648,0.001420614,0.015023052,0.354100263,1,3.68648613,1.310286329,2.813496598,0.00490059,0.018693888,12.44311287,1,5.550488607,0.896932283,6.188302853,6.08E-10,2.04E-08,0.347762163,1,3.608840494,1.249051538,2.889264682,0.003861439,0.014518036,N,-,,ZIP Zinc transporter,F:zinc ion transmembrane transporter activity; P:zinc II ion transmembrane transport; C:plasma membrane,IPR003689 (PFAM); PTHR11040:SF24 (PANTHER); PTHR11040 (PANTHER),2.A.5.1.14, the zinc (zn(2+))-iron (fe(2+)) permease (zip) family.
RL4_JR_10060,129511,139346,128438,18,67,13,0,0,5,5,5,19,14,84,12,0,31,21,137.5589383,1,-0.247758421,0.53970802,-0.459060106,0.646191004,0.798489277,21.6798661,1,-0.972776702,1.208271624,-0.805097697,0.420763305,0.584300476,75.70260049,1,-1.224082992,0.863128695,-1.418192905,0.156134453,0.270298427,112.8291545,1,-0.324531539,0.559041594,-0.580514121,0.561567967,0.689698649,70.50791219,1,-1.495504362,0.854741617,-1.749656659,0.080177577,0.16148756,N,-,,cytochrome P450,,no IPS match,,
RL4_JR_10061,3584,2399,3127,2,0,0,0,0,0,0,0,4,0,2,0,0,1,2,113.8085769,1,-0.130809852,0.541961534,-0.241363721,0.809273228,0.902858546,19.26815948,0,-0.802673195,1.206258182,-0.665424042,0.505779312,0.659049716,50.15847015,1,-3.459475069,1.198140869,-2.887369222,0.003884781,0.016131878,69.90842693,1,-1.58807899,0.872473659,-1.820202792,0.068728128,0.148866758,57.37657606,1,-1.885209621,0.993539058,-1.897469059,0.057766059,0.124867921,N,-,,cytosolic Fe-S cluster assembly factor CFD1,"C:nucleus; F:ATP binding; F:metal ion binding; C:cytosol; F:4 iron, 4 sulfur cluster binding; P:tRNA wobble uridine modification; F:hydrolase activity; P:iron-sulfur cluster assembly",IPR027417 (G3DSA:3.40.50.GENE3D); IPR033756 (PFAM); IPR019591 (PANTHER); PTHR23264:SF32 (PANTHER); IPR019591 (HAMAP); IPR028600 (HAMAP); IPR027417 (SUPERFAMILY),3.A.1.132.3, the atp-binding cassette (abc) superfamily.
RL4_JR_10062,149,122,150,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,609.3003495,0,-1.340403738,0.367775003,-3.644629802,0.000267777,0.001977999,178.2027485,0,-1.080027063,0.755707044,-1.429161038,0.152957953,0.28063085,432.3738067,0,-2.339879748,0.528369875,-4.42848818,9.49E-06,0.000180588,468.7774885,1,-2.873032206,0.528451841,-5.436696373,5.43E-08,1.30E-06,388.2045762,0,-3.237596163,0.663104895,-4.882479662,1.05E-06,1.51E-05,N,-,,adenosylmethionine decarboxylase,P:polyamine biosynthetic process,IPR016067 (G3DSA:3.60.90.GENE3D); IPR018167 (TIGRFAM); IPR001985 (PFAM); IPR001985 (PANTHER); IPR001985 (PANTHER); PTHR11570:SF0 (PANTHER); PTHR11570:SF0 (PANTHER); IPR016067 (SUPERFAMILY),,
RL4_JR_10063,34895,30697,36418,2,8,0,0,0,0,0,0,0,3,2,0,0,14,0,324.969617,1,-1.584381416,0.640217682,-2.474754228,0.013332789,0.047684741,82.1013047,0,-2.89381659,1.212852026,-2.385960139,0.017034597,0.050877602,267.7269107,0,-2.111892278,0.654397042,-3.227233841,0.001249933,0.006888578,301.5461155,1,-1.944611337,0.550655204,-3.531450031,0.000413288,0.00357653,273.4959792,1,-1.290830156,0.54782489,-2.356282419,0.018458878,0.051288732,N,-,,adaptor complexes medium subunit family,C:clathrin adaptor complex; P:intracellular protein transport; P:Golgi to vacuole transport,IPR001392 (PRINTS); IPR028565 (PFAM); IPR022775 (PFAM); G3DSA:3.30.450.60 (GENE3D); G3DSA:2.60.40.1170 (GENE3D); IPR001392 (PIRSF); PTHR10529 (PANTHER); IPR028565 (PROSITE_PROFILES); IPR011012 (SUPERFAMILY); IPR028565 (SUPERFAMILY),9.B.278.1.1, the organellar-targeting adaptor protein complex (o-apc) family.
RL4_JR_10064,2264,2175,2753,0,2,3,0,0,0,0,0,2,2,0,0,0,2,0,690.2536256,1,-3.602371787,0.667375999,-5.397814417,6.75E-08,1.38E-06,223.2641227,0,-2.596844588,1.061731907,-2.44585716,0.014450824,0.04474495,574.4241944,1,-3.246512814,0.671935345,-4.831585122,1.35E-06,3.48E-05,672.5301934,1,-2.905135221,0.642641285,-4.520617162,6.17E-06,9.30E-05,541.9222299,1,-3.740937382,0.729240442,-5.12990938,2.90E-07,5.10E-06,N,-,,clock controlled,C:nuclear part; P:regulation of cellular process; C:endomembrane system,IPR013927 (PFAM); PTHR38406 (PANTHER),,
RL4_JR_10065,646,565,967,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,97.61154166,0,-0.50589088,0.583891654,-0.866412248,0.38626413,0.579254186,21.37448749,0,-0.952286448,1.201115647,-0.792834937,0.427873999,0.590690209,61.95138006,0,-2.64238421,1.191362708,-2.217951083,0.026558168,0.069801374,71.99699127,0,-2.301153727,1.017621052,-2.261307117,0.023740246,0.083115487,58.4880249,0,-2.755107059,1.122584213,-2.454254236,0.014117713,0.041372458,N,-,,peptidase family m20 m25 m40,F:metallocarboxypeptidase activity; P:proteolysis,IPR011650 (G3DSA:3.30.70.GENE3D); IPR017141 (PIRSF); IPR011650 (PFAM); IPR002933 (PFAM); G3DSA:3.40.630.10 (GENE3D); PTHR11014 (PANTHER); PTHR11014:SF94 (PANTHER); PTHR11014 (PANTHER); PTHR11014:SF94 (PANTHER); IPR011650 (SUPERFAMILY); SSF53187 (SUPERFAMILY),,
RL4_JR_10066,6495,3124,2639,0,6,3,0,0,0,0,5,3,2,2,3,0,4,1,85.67807147,1,-1.214397999,0.803001918,-1.512322664,0.130451798,0.267797124,20.98093426,0,-0.92553765,1.230794913,-0.751983649,0.452060892,0.6117842,84.91499282,1,-1.159010939,0.891277736,-1.300392563,0.193466457,0.317479682,101.9456142,1,-0.873335226,1.424654697,-0.61301537,0.539866177,0.670935698,58.55799831,1,-2.760421706,1.168573904,-2.362214059,0.018166149,0.050586431,N,-,,rnase iii domain-containing,"P:RNA phosphodiester bond hydrolysis, endonucleolytic; F:RNA binding; F:ribonuclease III activity; F:structural constituent of ribosome; P:RNA processing; C:mitochondrial large ribosomal subunit",IPR000999 (PFAM); IPR000999 (G3DSA:1.10.1520.GENE3D); PTHR28160 (PANTHER); IPR000999 (SUPERFAMILY),,
RL4_JR_10067,2716,3544,3630,0,0,3,0,0,0,1,3,19,0,8,8,0,0,10,25.58869206,1,-1.106535055,1.16474132,-0.950026445,0.342098816,0.532197204,4.933278291,0,1.162894149,1.262853432,0.920846489,0.35713058,0.521326179,12.85098178,1,-1.494954198,1.211458159,-1.234012241,0.217198343,0.346002993,22.85103907,1,-0.202799868,1.042369854,-0.194556536,0.845740132,0.903377871,12.73750858,1,-1.584804308,1.221920283,-1.296978478,0.194638592,0.315544764,N,-,,H3 K56 histone acetylation KAT11,"F:histone acetyltransferase activity; P:regulation of transcription, DNA-templated; P:cellular response to stress; P:histone acetylation",IPR013178 (SMART); IPR013178 (PFAM); IPR016849 (PTHR31571:PANTHER); IPR016849 (PTHR31571:PANTHER); PTHR31571 (PANTHER); PTHR31571 (PANTHER); IPR016849 (PROSITE_PROFILES),,
RL4_JR_10068,3639,2510,1448,0,4,5,0,0,0,3,7,47,5,3,4,0,2,8,28.83560188,1,0.035221053,0.937620796,0.037564283,0.970035086,0.984504494,14.86650976,0,1.922678778,1.162142742,1.654425665,0.098041055,0.199391513,14.36024896,1,-1.65513402,1.229839528,-1.345812996,0.178362833,0.298420975,20.58536342,1,-1.13368323,1.185680883,-0.956145323,0.33899882,0.486236633,14.30125251,1,-1.751847086,1.245965241,-1.406016017,0.159719369,0.271291648,N,-,,SET domain-containing,P:peptidyl-lysine monomethylation; F:protein-lysine N-methyltransferase activity,IPR015353 (PFAM); G3DSA:3.90.1410.10 (GENE3D); IPR011383 (PIRSF); IPR015353 (G3DSA:3.90.1420.GENE3D); IPR001214 (PFAM); PTHR13271 (PANTHER); PTHR13271:SF46 (PANTHER); PTHR13271 (PANTHER); PTHR13271:SF46 (PANTHER); IPR001214 (PROSITE_PROFILES); IPR015353 (SUPERFAMILY); SSF82199 (SUPERFAMILY),,
RL4_JR_10069,196,95,75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.30281668,0,-0.638580937,1.180530893,-0.540926918,0.588557957,0.760205163,3.552206469,0,1.636689041,1.294633921,1.264209916,0.206154693,0.351000471,9.285112652,0,-1.026094304,1.224361712,-0.838064678,0.401994379,0.544162468,51.65644386,0,1.87522174,0.674821871,2.778839602,0.005455346,0.030002919,23.96511314,0,0.590638542,1.018117161,0.580128265,0.561828124,0.679712003,N,-,,udp-glucuronosyl udp-glucosyltransferase,"P:DNA repair; F:transferase activity, transferring hexosyl groups",G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); IPR002213 (PANTHER); PTHR11926:SF240 (PANTHER); SSF53756 (SUPERFAMILY),,
RL4_JR_10070,779,583,730,1,0,0,0,0,0,0,0,6,0,0,0,0,0,0,14.88219121,1,2.400464217,0.896229436,2.678403676,0.007397401,0.029810177,1.086111759,0,3.346310549,1.404087774,2.383263078,0.017159926,0.051167225,28.82253363,1,3.496574114,0.771295498,4.533378091,5.80E-06,0.000118653,88.50964112,0,4.699333092,0.477438453,9.842803944,7.36E-23,8.19E-21,14.37670746,0,2.788203812,0.885482971,3.148794392,0.001639455,0.007185923,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.78, the major facilitator superfamily (mfs).
RL4_JR_10071,3381,2335,4327,0,2,0,0,0,0,0,0,1,1,1,0,0,0,0,3.204929626,1,0.217369946,1.24515978,0.17457193,0.861416006,0.931525952,1.0331976,0,3.418507248,1.428533928,2.393017892,0.016710426,0.050175893,2.662540586,1,0.776353285,1.226247553,0.633113015,0.526659844,0.656072876,3.070239937,1,0.354593052,1.233084195,0.287565969,0.773678998,0.853322424,2.606763968,0,0.703721938,1.214739653,0.579319145,0.56237385,0.679884803,Y,-,,hypothetical protein SPBR_03321,F:ATP binding; P:chromosome organization; C:chromosome,IPR011058 (PFAM); IPR011058 (G3DSA:2.30.60.GENE3D); IPR011058 (G3DSA:2.30.60.GENE3D); IPR011058 (SUPERFAMILY); IPR011058 (SUPERFAMILY); IPR011058 (SUPERFAMILY),,
RL4_JR_10072,13406,10328,12731,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,98.46162592,0,-1.118881713,0.711270155,-1.573075582,0.115701318,0.246088742,141.2885603,0,2.325089939,0.609422188,3.815236766,0.000136052,0.006375568,70.24469212,0,-2.812757789,1.207046728,-2.330280777,0.019791316,0.055167204,118.5748892,1,-0.723468662,1.530208611,-0.472790871,0.636362388,0.751039652,126.8537166,0,0.508907942,0.57427146,0.886180103,0.375520484,0.511607589,N,-,,signal recognition particle srp54,"F:GTP binding; P:SRP-dependent cotranslational protein targeting to membrane; F:GTPase activity; F:7S RNA binding; C:signal recognition particle, endoplasmic reticulum targeting",IPR000897 (SMART); IPR003593 (SMART); IPR013822 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:1.20.120.140 (GENE3D); IPR013822 (PFAM); IPR004125 (G3DSA:1.10.260.GENE3D); IPR000897 (PFAM); IPR006325 (TIGRFAM); IPR004125 (PFAM); PTHR11564 (PANTHER); PTHR11564:SF5 (PANTHER); IPR022941 (HAMAP); IPR027417 (SUPERFAMILY); IPR004125 (SUPERFAMILY),3.A.5.9.1, the general secretory pathway (sec) family.
RL4_JR_10073,686,927,808,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,30.99778942,0,-0.242515947,1.043914751,-0.232313938,0.816294188,0.906524365,4.730402244,1,1.223473018,1.268441975,0.96454788,0.334771316,0.498097201,12.35819503,0,-1.438495009,1.216469013,-1.182516772,0.237000715,0.36953569,44.92208077,0,1.183697396,0.714463826,1.656763229,0.097567354,0.192417113,19.63704608,0,-0.590106468,1.156493636,-0.510254833,0.609872941,0.717768631,N,-,,nucleoside-diphosphate-sugar epimerase,F:coenzyme binding; F:catalytic activity,IPR016040 (G3DSA:3.40.50.GENE3D); IPR001509 (PFAM); G3DSA:3.90.25.10 (GENE3D); PTHR10366 (PANTHER); PTHR10366:SF228 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_10074,51,69,84,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.183522699,0,4.343281924,3.622936176,1.198829268,0.230594339,NA,0.060250749,0,7.518408836,2.790974951,2.693828848,0.007063643,0.026103757,0.154278143,0,4.884740649,1.864784079,2.619467156,0.008806725,0.029611188,0.177776846,0,4.464339241,2.488354246,1.794093123,0.072798306,0.155447875,0.150808725,0,4.813884741,1.670275077,2.882090984,0.003950456,0.014770447,N,-,,Dehydrogenase reductase SDR family member 7B,F:oxidoreductase activity; P:oxidation-reduction process,no IPS match,,
RL4_JR_10075,14148,9595,9062,2,0,14,0,1,0,0,0,3,0,3,2,0,6,4,0.007760107,1,8.901087564,4.041366561,2.202494486,0.027630398,NA,0.002334598,1,12.18995876,4.048442383,3.01102439,0.002603679,0.015349618,0.006343058,1,9.480780804,4.042868098,2.345063102,0.01902386,0.053738157,0.007335717,1,9.055356819,4.042572319,2.23999872,0.025091006,0.08557795,0.006581095,1,9.341867313,1.819064456,5.135533973,2.81E-07,4.95E-06,,,,,,,,
RL4_JR_10076,23611,14452,16188,4,1,6,0,0,0,0,0,3,0,5,0,0,1,0,61.03231742,1,-1.475197772,0.934049898,-1.579356494,0.11425431,0.243908253,15.62578569,0,-0.500388937,1.233941827,-0.405520687,0.685094816,0.799922681,81.97627604,1,-0.01392835,0.717758282,-0.019405349,0.984517743,0.992458193,87.80034762,1,-0.263653005,0.678226267,-0.388739006,0.697469225,0.796078878,59.24046025,1,-1.026747283,0.89798189,-1.143394198,0.25287496,0.383943774,N,-,,periplasmic binding ii,,PTHR30024 (PANTHER); PTHR30024:SF1 (PANTHER); SSF53850 (SUPERFAMILY),,
RL4_JR_10077,39,13,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18.27871651,0,3.024481363,0.745819423,4.055246174,5.01E-05,0.000469076,0.963558343,0,3.519147389,1.414618405,2.487700835,0.012857184,0.04080916,155.3174547,0,5.958394869,1.175688076,5.068006552,4.02E-07,1.20E-05,2.872906421,0,0.450460219,1.215361858,0.370638765,0.710906605,0.806671453,25.60917649,0,3.982745132,0.625833715,6.363903126,1.97E-10,1.30E-08,Y,-,,"endo-1,4-beta-xylanase",,IPR001000 (PRINTS); IPR001000 (SMART); IPR001000 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR31490:SF11 (PANTHER); PTHR31490 (PANTHER); IPR001000 (PROSITE_PROFILES); IPR017853 (SUPERFAMILY),,
RL4_JR_10078,174,108,139,4,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0.027645568,1,7.073514936,3.945157288,1.792961451,0.072979088,NA,0.009184959,0,10.23380518,3.539552713,2.891270736,0.003836874,0.017677215,0.02327757,0,7.614533777,2.14554248,3.549001638,0.000386695,0.0028185,0.026808788,1,7.193883725,3.944608344,1.823725729,0.068193547,0.148230929,0.022454644,0,7.550675179,1.512512957,4.992139171,5.97E-07,9.23E-06,N,-,,POT family,P:oligopeptide transport; C:integral component of membrane; F:transporter activity,G3DSA:1.20.1250.20 (GENE3D); IPR000109 (PFAM); PTHR11654:SF127 (PANTHER); IPR000109 (PANTHER); IPR020846 (SUPERFAMILY),2.A.17.2.4, the proton-dependent oligopeptide transporter (pot/ptr) family.
RL4_JR_10079,229,234,240,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.023687631,0,7.296282206,3.951530923,1.846444416,0.064827703,NA,0.007512988,0,10.52011027,3.508613538,2.998366778,0.002714308,0.015349618,0.019628416,0,7.855683688,2.049267543,3.833410486,0.000126379,0.00133277,0.022650115,0,7.436112476,3.951487371,1.88185151,0.05985618,0.136569486,0.019541152,0,7.761609809,1.449154076,5.355958994,8.51E-08,1.99E-06,N,-,,pap2 superfamily,C:integral component of membrane,IPR000326 (SMART); IPR000326 (G3DSA:1.20.144.GENE3D); IPR000326 (PFAM); PTHR10165:SF84 (PANTHER); PTHR10165 (PANTHER); IPR000326 (SUPERFAMILY),9.B.105.3.2, the lead resistance fusion protein (pbrbc) family.
RL4_JR_10080,6453,3958,8486,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.29588317,0,-1.722262309,1.213510275,-1.419239988,0.155829061,0.30514966,3.934229298,0,1.489506546,1.284064064,1.15999395,0.246051269,0.399123549,10.17129715,0,-1.157296616,1.210918904,-0.955717689,0.339214883,0.482604199,15.74384336,0,-0.633502819,1.162438453,-0.544977514,0.585768983,0.71079949,9.9758995,0,-1.232177534,1.209299865,-1.018918111,0.308241845,0.443568601,N,-,,hypothetical protein PDE_09284,P:biological_process; C:cellular_component; F:molecular_function; F:deaminase activity,IPR022085 (PFAM),,
RL4_JR_10081,538,857,555,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,45.69652978,1,-1.658149218,1.094985445,-1.514311652,0.129946815,0.267029248,12.03362962,0,-0.123483338,1.26315278,-0.097758039,0.922124428,0.957208846,45.67890531,0,-0.963921318,1.079390516,-0.893023706,0.371844478,0.516150846,59.44636729,0,-0.859729842,0.916471968,-0.938086349,0.348200036,0.495227612,56.90399401,0,-0.205912317,0.824719433,-0.249675597,0.802838232,0.86706529,N,-, Effector probability:0.684,short chain dehydrogenase reductase SDR,C:integral component of membrane; P:single-organism process,IPR002347 (PRINTS); IPR016040 (G3DSA:3.40.50.GENE3D); IPR002347 (PFAM); PTHR24322:SF583 (PANTHER); IPR002347 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_10082,29327,27297,24208,9,12,27,0,0,1,0,0,13,7,17,10,0,12,8,49.73742461,1,9.339161249,0.919835648,10.15307601,3.21E-24,7.48E-22,9.40964206,1,9.39637153,1.21095131,7.759495742,8.53E-15,2.78E-12,0.079955383,1,5.834881667,1.518053494,3.843660114,0.000121213,0.001301133,169.1179762,1,10.9648755,0.570903689,19.20617384,3.29E-82,2.77E-79,15.52025292,1,8.348277156,0.843563878,9.89643745,4.31E-23,1.32E-20,N,-,,alternative sulfate transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF217 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.38, the major facilitator superfamily (mfs).
RL4_JR_10083,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.198397127,0,4.231034641,3.212549832,1.317033155,0.187827511,NA,0.06127902,0,7.492911738,2.490513756,3.008580747,0.00262471,0.015349618,0.1627424,0,4.806570717,1.611996763,2.981749608,0.002866063,0.013159194,0.188000002,0,4.38335793,2.131999439,2.055984561,0.039784004,0.107074175,0.164489801,0,4.691236865,1.47824458,3.173518733,0.001506032,0.006693842,N,-,,cytochrome P450,F:oxidoreductase activity; F:metal ion binding; C:membrane,IPR001128 (PRINTS); IPR002401 (PRINTS); IPR001128 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24305 (PANTHER); PTHR24305:SF90 (PANTHER); IPR001128 (SUPERFAMILY),,
RL4_JR_10084,1058,685,960,0,0,0,0,0,0,0,11,1,1,0,1,0,8,0,0.371800241,0,3.325030454,2.273039835,1.462812223,0.143518767,NA,0.117774028,0,6.551220881,2.026844328,3.232226961,0.001228295,0.015023052,0.307076345,1,3.891653,1.313441413,2.962943731,0.003047123,0.013722896,0.354357844,1,3.469306221,1.531723607,2.264968827,0.023514593,0.082950519,0.30430668,1,3.803410328,1.254639641,3.031476293,0.00243361,0.009987963,N,-,,pth11-like integral membrane,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,PTHR33048 (PANTHER),9.B.313.1.1, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_10085,263,155,332,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,38.81990171,1,-3.381092055,1.224328827,-2.761588211,0.005752098,0.024401389,12.27829408,0,-0.152586811,1.23601024,-0.123451089,0.901749903,0.944583723,32.08265284,0,-2.814791726,1.21607853,-2.314646347,0.020632294,0.056915898,37.02527574,0,-3.237670125,1.219169325,-2.655636145,0.007915897,0.040295857,31.89566653,1,-2.90906889,1.228937175,-2.367142071,0.01792605,0.05002791,N,-,,L-asparaginase 3,P:asparagine metabolic process; P:cellular amino acid metabolic process; F:asparaginase activity,IPR023213 (G3DSA:3.30.559.GENE3D); IPR023213 (G3DSA:3.30.559.GENE3D); PTHR40788:SF1 (PANTHER); PTHR40788 (PANTHER),,
RL4_JR_10086,36,30,43,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.019109361,0,0.303794056,1.257251838,0.241633415,0.809064227,0.902858546,0.960233608,0,3.524089965,1.424357377,2.474161346,0.013354937,0.041979769,2.493126292,0,0.871238944,1.224444693,0.711538013,0.476750904,0.613294301,2.876469634,0,0.448704305,1.232424946,0.364082459,0.715796435,0.809679243,2.456648247,0,0.78979602,1.22048558,0.647116224,0.517556726,0.643121685,N,-,,heterokaryon incompatibility OR allele,C:membrane; C:integral component of membrane,IPR010730 (PFAM); PTHR24148 (PANTHER),,
RL4_JR_10087,4,14,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.44002816,0,-0.11538907,0.842789393,-0.136913292,0.891099332,0.946437749,6.397010151,0,0.788153853,1.231399139,0.640047429,0.522141765,0.671561274,16.55901999,0,-1.86051584,1.189232603,-1.56446757,0.117707803,0.218784956,27.12341974,0,-0.554010155,1.01052445,-0.548240228,0.583526964,0.709098717,16.28445185,0,-1.93922182,1.187726057,-1.632718091,0.102528301,0.194582764,N,-, Effector probability:0.58,Fsh1p,C:nucleus; C:cytoplasm,IPR029058 (G3DSA:3.40.50.GENE3D); IPR005645 (PFAM); PTHR22778:SF9 (PANTHER); PTHR22778 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_10088,9,20,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.75018156,0,-0.10552051,1.140197182,-0.092545843,0.92626437,0.964696123,2.470554267,0,2.160664977,1.286532206,1.679448806,0.093064608,0.19154127,6.410821601,0,-0.491662151,1.195918216,-0.411116868,0.680986842,0.780605841,7.395580277,0,-0.914004979,1.193499701,-0.765819194,0.443783892,0.585982252,6.323598836,0,-0.574546157,1.198607906,-0.479344541,0.63169354,0.734822736,N,-,,metalloprotease m41,F:catalytic activity,no IPS match,,
RL4_JR_10089,15,16,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,80.46485586,0,8.345024377,1.154084779,7.230859055,4.80E-13,2.42E-11,0.087086574,0,6.986975513,2.195123553,3.182953189,0.001457812,0.015023052,6.725331483,0,5.295165926,1.243223441,4.25922304,2.05E-05,0.000343873,36.36578651,0,7.620225135,0.730460792,10.43207961,1.77E-25,2.24E-23,0.223524006,0,4.249633542,1.297278938,3.275805547,0.001053611,0.004987288,N,-,,choline dehydrogenase,"F:oxidoreductase activity, acting on CH-OH group of donors; F:flavin adenine dinucleotide binding; P:oxidation-reduction process",IPR007867 (PFAM); IPR000172 (PFAM); IPR012132 (PIRSF); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR11552:SF107 (PANTHER); PTHR11552:SF107 (PANTHER); PTHR11552 (PANTHER); PTHR11552 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_10090,34,19,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.46377717,0,11.12587456,1.376152761,8.084767095,6.23E-16,4.62E-14,0.002507343,0,12.10167175,4.040174693,2.995333784,0.002741447,0.015349618,0.006623884,0,9.426891884,3.299070491,2.857438757,0.00427075,0.016940088,20.06559218,0,11.61556275,1.96856997,5.900507944,3.62E-09,1.10E-07,0.006630333,0,9.341240721,1.70468121,5.479758129,4.26E-08,1.17E-06,Y,-,,CFEM domain-containing,C:membrane; C:integral component of membrane,IPR008427 (PFAM); PTHR33048 (PANTHER); PTHR33048:SF37 (PANTHER); PS51257 (PROSITE_PROFILES),9.B.313.1.4, The 7 TMS Domain-containing Protein (7DCP) Family
RL4_JR_10091,1,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22.93495907,0,10.05346145,2.4153676,4.162290433,3.15E-05,0.000312197,0.00717654,0,10.58314818,3.953856896,2.676664447,0.007435906,0.027132749,0.01931,0,7.879034022,2.805765386,2.808158537,0.004982569,0.018871504,26.67003193,0,10.20034127,1.576288963,6.471111266,9.73E-11,3.72E-09,15.46193526,0,9.91799853,2.303950135,4.30478003,1.67E-05,0.000154109,Y,-,,oxidase,F:peroxidase activity; P:cellular oxidant detoxification,IPR000028 (G3DSA:1.10.489.GENE3D); IPR000028 (PFAM); PTHR33577 (PANTHER); PTHR33577:SF1 (PANTHER); IPR000028 (PROSITE_PROFILES); IPR000028 (SUPERFAMILY),,
RL4_JR_10092,5,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42.56128058,0,0.880598577,0.632828709,1.391527541,0.164065514,0.315002698,6.248648373,0,0.821927923,1.229970823,0.668249935,0.503974065,0.657459143,16.25294917,0,-1.833732599,1.194507495,-1.535136956,0.12475019,0.228619902,30.78722228,0,0.044996842,0.859416862,0.052357411,0.958243909,0.976274862,16.06895651,0,-1.919968111,1.201838696,-1.597525622,0.110148591,0.205198617,N,-,,Glutathione S- C-terminal,C:cytoplasm; P:glutathione metabolic process; F:glutathione transferase activity,IPR012336 (G3DSA:3.40.30.GENE3D); IPR004045 (PFAM); PTHR11260 (PANTHER); PTHR11260:SF192 (PANTHER); IPR012336 (SUPERFAMILY),,
RL4_JR_10093,421,342,549,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,43.21333367,1,5.602545482,0.674413677,8.307283303,9.79E-17,8.07E-15,0.383865145,0,4.84671864,1.617220118,2.996944316,0.002727005,0.015349618,0.999855471,0,2.188670767,1.243339279,1.760316596,0.078354142,0.160189284,25.2232372,0,5.036682818,0.651825168,7.727045637,1.10E-14,6.67E-13,0.990182822,0,2.100633318,1.231446734,1.705825562,0.088040562,0.173527486,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF6 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.37, the major facilitator superfamily (mfs).
RL4_JR_10094,1793,1874,2106,0,0,1,1,0,0,0,1,0,0,1,0,0,0,0,392.2052059,1,0.545403044,1.280658467,0.425877045,0.670197443,0.817382379,51.6661112,1,-2.225650956,1.193915606,-1.864161039,0.062299093,0.1403686,274.3350487,1,0.088141482,0.479073469,0.183983225,0.854026615,0.907448095,398.0737947,1,0.691419271,0.321162938,2.152861335,0.031329578,0.094723687,252.0451341,0,0.105436531,0.73650613,0.14315771,0.886165629,0.925278642,N,-,,h+ nucleoside cotransporter,F:nucleoside transmembrane transporter activity; C:integral component of membrane; P:nucleoside transmembrane transport,IPR002668 (PFAM); IPR011657 (PFAM); PTHR10590:SF4 (PANTHER); IPR008276 (PANTHER),2.A.41.2.7, the concentrative nucleoside transporter (cnt) family.
RL4_JR_10095,80,55,101,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29.19839635,0,0.476349498,1.031622183,0.461748018,0.644262032,0.797479603,2.895004656,0,1.932016161,1.302351916,1.483482411,0.137946286,0.258956289,7.495073511,0,-0.716783506,1.21246399,-0.591179212,0.55440035,0.681241551,8.646106497,0,-1.13906025,1.212511532,-0.939422199,0.34751402,0.494668839,7.361514063,0,-0.793694563,1.211629894,-0.655063537,0.512426847,0.638562687,N,-,,nadph dehydrogenase,F:pentaerythritol trinitrate reductase activity; F:FMN binding; F:NADPH dehydrogenase activity; F:trichloro-p-hydroquinone reductive dehalogenase activity; P:oxidation-reduction process,IPR001155 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); PTHR22893:SF14 (PANTHER); PTHR22893 (PANTHER); SSF51395 (SUPERFAMILY),,
RL4_JR_10096,5056,4643,5004,2,1,7,0,0,0,3,0,2,2,3,4,0,1,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-, Effector probability:0.887,phytanoyl- dioxygenase family,F:dioxygenase activity; P:oxidation-reduction process,IPR008775 (PFAM); G3DSA:2.60.120.620 (GENE3D); SSF51197 (SUPERFAMILY),,
RL4_JR_10097,307,379,333,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0.094828407,1,5.295865508,3.918001493,1.351675214,0.176479237,NA,0.030556624,0,8.497726466,2.698270897,3.149322952,0.001636492,0.015023052,0.078991289,0,5.849595606,1.572238131,3.720553197,0.000198787,0.001748495,0.091091274,0,5.428917346,2.461745615,2.205312081,0.027432203,0.088070176,0.077787553,0,5.766956969,1.335488547,4.318237685,1.57E-05,0.000147072,N,-,,quinate permease,F:substrate-specific transmembrane transporter activity; P:transmembrane transport; C:integral component of membrane,IPR003663 (PRINTS); IPR003663 (TIGRFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR23500 (PANTHER); PTHR23500:SF35 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.119, the major facilitator superfamily (mfs).
RL4_JR_10098,5034,4240,3231,0,0,1,0,0,0,0,0,2,5,0,3,0,5,6,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,glycosyl hydrolase,F:hydrolase activity,IPR011040 (PFAM); IPR011040 (G3DSA:2.120.10.GENE3D); PTHR33307:SF3 (PANTHER); PTHR33307 (PANTHER); IPR011040 (SUPERFAMILY),,
RL4_JR_10099,163,231,142,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.031395814,0,6.889759465,3.940585773,1.748409973,0.080393062,NA,0.009511139,0,10.17757984,3.942370063,2.581589166,0.009834658,0.033197402,0.025653058,0,7.469679184,2.74714537,2.719069499,0.006546585,0.023311485,0.029658622,0,7.046430285,3.940947618,1.788004046,0.073775355,0.156828778,0.026373618,0,7.334130557,1.84941031,3.965658955,7.32E-05,0.000535852,N,-,,cytochrome b2,F:FMN binding; F:oxidoreductase activity; F:metal ion binding; P:oxidation-reduction process; F:heme binding,IPR001199 (PRINTS); IPR001199 (SMART); IPR013785 (G3DSA:3.20.20.GENE3D); IPR000262 (PFAM); IPR001199 (G3DSA:3.10.120.GENE3D); IPR001199 (PFAM); PTHR10578 (PANTHER); PTHR10578:SF64 (PANTHER); IPR012133 (PROSITE_PROFILES); IPR001199 (PROSITE_PROFILES); SSF51395 (SUPERFAMILY); IPR001199 (SUPERFAMILY),,
RL4_JR_10100,3544,3052,4023,0,0,3,0,0,0,3,5,1,0,5,0,0,0,0,0.104235645,1,5.159680319,3.916990637,1.31725623,0.187752751,NA,0.032913827,0,8.390294585,2.615694788,3.207673396,0.001338134,0.015023052,0.085942434,1,5.728849429,1.50390975,3.809304002,0.000139359,0.001412278,0.099187742,1,5.306359169,2.336046819,2.271512337,0.023115981,0.082093759,0.085243263,0,5.641118446,1.306361317,4.318191585,1.57E-05,0.000147072,N,-,,2-ketogluconate reductase,"F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:NAD binding; P:oxidation-reduction process",IPR006139 (PFAM); IPR006140 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR10996:SF138 (PANTHER); PTHR10996 (PANTHER); SSF52283 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_10101,9309,8626,13835,0,4,1,0,0,0,0,1,0,0,2,0,0,0,0,0.217284493,1,4.09978604,3.144878627,1.303638876,0.192356739,NA,0.072312372,0,7.255685114,2.503124567,2.898651233,0.003747715,0.017473407,0.183049027,1,4.638942352,1.653038176,2.806312896,0.005011201,0.018944509,0.210802443,1,4.218888882,2.134759769,1.976282738,0.048122764,0.119965942,0.176346602,0,4.587554235,1.500817132,3.056704335,0.002237849,0.009328209,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane; F:hydrolase activity,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR11662 (PANTHER); PTHR11662:SF319 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_10102,1747,2561,1697,1,0,3,0,0,1,0,0,0,0,0,0,0,0,0,204.0267897,1,-4.001844627,1.035293472,-3.865420515,0.000110898,0.000933649,63.14758173,1,-2.515134266,1.20830233,-2.081543835,0.037384156,0.094036389,163.1653201,0,-5.161205315,1.20381811,-4.287363076,1.81E-05,0.000312904,192.1838688,0,-4.636891377,1.157963939,-4.004348684,6.22E-05,0.000715522,160.3286202,0,-5.238678086,1.206170426,-4.343232078,1.40E-05,0.00013348,N,-,,general amidase,"C:nucleus; C:cytosol; F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (G3DSA:3.90.1300.GENE3D); PIRSF001221 (PIRSF); IPR023631 (PFAM); IPR000120 (PANTHER); PTHR11895:SF45 (PANTHER); IPR023631 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_10103,2249,2135,3339,2,0,17,0,0,0,0,0,0,0,2,0,1,0,0,11.52183672,1,-1.628778252,1.230186175,-1.324009556,0.185499871,0.34315373,3.707573197,0,1.575037808,1.313115799,1.19946604,0.230346782,0.380450942,9.584047232,0,-1.071727379,1.228252235,-0.872562938,0.382901349,0.526554368,11.05267062,1,-1.493586049,1.23013943,-1.214159967,0.224686644,0.360224871,9.429619028,1,-1.151067641,1.232490019,-0.933936684,0.350336555,0.487528688,N,-,,dihydrodipicolinate synthase,P:metabolic process; F:lyase activity,IPR002220 (PRINTS); IPR002220 (SMART); IPR013785 (G3DSA:3.20.20.GENE3D); IPR002220 (PIRSF); IPR002220 (PFAM); PTHR12128:SF23 (PANTHER); IPR002220 (PANTHER); SSF51569 (SUPERFAMILY),,
RL4_JR_10104,21074,20976,28884,1,2,13,0,0,0,1,5,1,0,4,0,0,2,0,0.055265175,1,6.074600055,3.9260229,1.547265569,0.121799221,NA,0.018201694,0,9.246116499,3.064060826,3.017602138,0.002547832,0.015349618,0.046395931,1,6.618703438,1.823187334,3.630292572,0.0002831,0.002221787,0.05345397,1,6.19820231,3.094694207,2.002848067,0.045193599,0.115278131,0.045034973,1,6.551465597,1.43560452,4.56355877,5.03E-06,5.71E-05,N,-,,MFS sugar transporter,P:transport; F:transporter activity,G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR23500 (PANTHER); PTHR23500:SF21 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.83, the major facilitator superfamily (mfs).
RL4_JR_10105,197,251,218,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0.640995759,1,2.53957363,1.96924405,1.289618537,0.197183136,NA,0.204182622,0,5.75784502,1.939787958,2.968285784,0.002994658,0.01558642,0.527934163,0,3.111577218,1.380669938,2.253672027,0.024216808,0.064808609,0.609050625,0,2.688740318,1.531021448,1.756174168,0.079058674,0.164992426,0.516500657,0,3.040131464,1.330568295,2.284836845,0.022322396,0.059665327,N,-,,hypothetical protein A1O1_02308,,IPR010856 (PFAM); IPR027443 (G3DSA:2.60.120.GENE3D); PTHR30613:SF1 (PANTHER); PTHR30613 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_10106,2264,1953,2129,0,0,1,0,0,0,2,0,0,2,5,0,0,0,0,45.58001965,1,-2.54275557,1.204601689,-2.110868342,0.03478363,0.101562224,13.34710737,0,-0.272903598,1.268652105,-0.21511303,0.829679195,0.897895161,34.48446307,1,-2.91884387,1.233852582,-2.365634204,0.017999218,0.051680116,39.77799055,1,-3.341040107,1.23955108,-2.695362992,0.007031199,0.036658541,33.75653258,0,-2.990861872,1.235948545,-2.419891899,0.015525122,0.044670948,N,-,,guanine deaminase,"F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:DNA binding; C:nucleus; F:zinc ion binding; F:guanine deaminase activity; P:transcription, DNA-templated; C:cytosol; P:regulation of transcription, DNA-templated; P:guanine catabolic process; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter; F:hydrolase activity",IPR007219 (SMART); IPR006680 (PFAM); G3DSA:3.20.20.140 (GENE3D); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR11271 (PANTHER); IPR014311 (PTHR11271:PANTHER); IPR011059 (SUPERFAMILY); IPR011059 (SUPERFAMILY); IPR032466 (SUPERFAMILY),,
RL4_JR_10107,1680,1273,978,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,0.606242435,1,2.619863914,1.916974199,1.366666237,0.171729945,NA,0.191542765,0,5.849768147,1.89329532,3.089728309,0.002003397,0.015023052,0.499040084,1,3.192159714,1.328109991,2.403535653,0.016237384,0.047395456,0.575926734,0,2.769078723,1.464235005,1.891143643,0.058605172,0.135014457,0.493061258,0,3.107375808,1.286401332,2.415557051,0.015711161,0.04505112,N,-,,alpha-ketoglutarate dependent xanthine dioxygenase,F:oxidoreductase activity,G3DSA:3.60.130.10 (GENE3D); IPR003819 (PFAM); PTHR37995 (PANTHER); SSF51197 (SUPERFAMILY),,
RL4_JR_10108,9195,6477,5206,0,6,2,0,0,0,0,0,7,0,1,0,0,3,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,epoxide hydrolase,F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D),,
RL4_JR_10109,4293,2955,2679,0,1,3,0,0,0,1,0,0,0,5,0,0,5,0,0.011718044,1,8.30924678,3.99658426,2.0790871,0.037609346,NA,0.004006569,0,11.4341231,3.991291091,2.864768027,0.004173148,0.018371529,0.009992212,1,8.834284459,3.994251091,2.211749902,0.02698395,0.070608817,0.011494389,1,8.415706565,3.9944702,2.106839241,0.035131517,0.099498352,0.009494587,1,8.783878684,1.912952289,4.591791826,4.39E-06,5.09E-05,N,-,,alcohol dehydrogenase,,IPR023210 (PFAM); IPR023210 (G3DSA:3.20.20.GENE3D); PTHR11732:SF244 (PANTHER); IPR001395 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.6, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_10110,21574,20799,29891,4,6,64,0,0,0,2,1,4,5,16,3,0,19,7,0.023765515,1,7.291767558,3.951391854,1.845366855,0.064984191,NA,0.00801766,0,10.43077191,3.949162813,2.641261555,0.008259793,0.029217138,0.02010604,1,7.826608423,2.804730448,2.790502891,0.005262623,0.019647061,0.023140929,1,7.406611064,3.950587192,1.874812706,0.060818495,0.137784371,0.019164096,1,7.780288866,1.717906591,4.528935918,5.93E-06,6.54E-05,N,-,,nad-dependent epimerase dehydratase,F:coenzyme binding; F:catalytic activity,IPR016040 (G3DSA:3.40.50.GENE3D); IPR001509 (PFAM); G3DSA:3.90.25.10 (GENE3D); PTHR10366:SF328 (PANTHER); PTHR10366 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_10111,4349,4623,6005,0,0,0,0,0,3,0,3,1,0,1,1,0,1,0,1.957968935,0,0.928116297,1.42515561,0.651238567,0.514892498,NA,0.637140286,1,4.115919853,1.61340282,2.551080116,0.010738964,0.035488015,1.63536954,1,1.479305454,1.304008293,1.134429483,0.256614438,0.392797788,1.88508752,1,1.058113677,1.342733685,0.788029442,0.430679484,0.57302466,1.597628346,1,1.409878846,1.288992507,1.093783585,0.274049905,0.406961345,N,-,,C6 transcription factor,F:binding,no IPS match,,
RL4_JR_10112,3122,2664,3894,0,0,5,0,0,0,0,0,1,1,0,2,0,8,0,0.51970783,1,2.841757678,2.21209861,1.284643309,0.198916957,NA,0.171538373,0,6.009246587,2.090218968,2.874936396,0.004041089,0.018171436,0.436145252,1,3.386327502,1.467065936,2.308231292,0.020986276,0.057672382,0.502441881,1,2.965858844,1.677980519,1.767516852,0.077141709,0.162223717,0.421784338,1,3.330548431,1.395830536,2.386069329,0.01702954,0.04808257,N,-, Effector probability:0.891,transcription factor,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); PTHR30304 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_10113,12125,5754,9732,12,2,10,0,0,3,5,19,40,6,6,17,3,25,7,23.32306483,1,2.801000272,0.741932775,3.775275021,0.000159831,0.001277084,20.1233027,1,4.63480884,1.047532613,4.424500757,9.67E-06,0.000636677,3.520816351,1,0.373037732,1.236164535,0.301770292,0.762827179,0.840446443,36.33109475,1,2.714546381,0.782863259,3.467459162,0.000525404,0.004354344,7.311636683,1,1.22662563,1.156057512,1.061042048,0.288670793,0.423163715,Y,-,,cellobiose dehydrogenase,F:oxidoreductase activity,G3DSA:3.30.410.10 (GENE3D); IPR016040 (G3DSA:3.40.50.GENE3D); IPR007867 (PFAM); IPR012132 (PIRSF); IPR000172 (PFAM); PTHR11552 (PANTHER); PTHR11552:SF57 (PANTHER); IPR023753 (SUPERFAMILY); SSF54373 (SUPERFAMILY),,
RL4_JR_10114,166,76,50,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0.903841182,1,2.043261727,1.82913963,1.117061646,0.263967968,NA,0.289283387,1,5.254767073,1.880169292,2.794837196,0.005192586,0.021136506,0.752074718,0,2.59940941,1.401327453,1.854962167,0.063601629,0.136535813,0.867534567,0,2.177424962,1.521847935,1.430776959,0.152494149,0.26943072,0.745739707,0,2.509126621,1.375796397,1.823763041,0.068187904,0.14212747,N,-, Effector probability:0.592,hypothetical protein CMQ_6329,,IPR010634 (PFAM); PTHR36057 (PANTHER); PTHR36057:SF1 (PANTHER); IPR012336 (SUPERFAMILY); IPR012336 (SUPERFAMILY),,
RL4_JR_10115,887,702,563,2,8,4,0,0,0,0,0,4,2,1,0,0,0,1,1.54112723,1,1.273780363,1.356868132,0.938765038,0.347851393,NA,0.496619784,0,4.475466101,1.581226628,2.830376129,0.004649331,0.019707089,1.279257374,1,1.834122266,1.247560108,1.470167453,0.141516407,0.250868869,1.475157362,1,1.412234544,1.276321517,1.106488079,0.268515321,0.409692228,1.25114038,1,1.76275633,1.22482777,1.439187103,0.150097518,0.258899042,N,-,,c6 zinc finger domain containing,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",PTHR31944 (PANTHER); PTHR31944:SF80 (PANTHER); PTHR31944:SF80 (PANTHER),,
RL4_JR_10116,634,162,250,1,6,3,0,0,0,2,0,0,0,0,0,0,0,0,0.008141456,1,8.841220392,4.035983802,2.190598582,0.028480854,NA,0.002675567,0,12.01934062,4.032893235,2.980327006,0.002879408,0.015349618,0.006783092,1,9.399044527,3.291065204,2.855927776,0.004291127,0.016940088,0.007815077,0,8.97609272,4.035428601,2.224322026,0.026126786,0.086108719,0.006504647,0,9.346543544,1.704039324,5.484934187,4.14E-08,1.17E-06,N,-,,trichothecene 3-o-acetyltransferase,"F:transferase activity, transferring acyl groups other than amino-acyl groups",IPR023213 (G3DSA:3.30.559.GENE3D); IPR023213 (G3DSA:3.30.559.GENE3D); IPR003480 (PFAM); PTHR31642 (PANTHER); PTHR31642:SF31 (PANTHER),,
RL4_JR_10117,12469,10414,13160,1,3,9,0,0,0,2,0,1,0,9,0,0,3,0,52.96458656,1,4.261590964,0.807160114,5.279734329,1.29E-07,2.52E-06,95.66699239,0,6.762751105,0.62523475,10.81633915,2.88E-27,2.65E-24,575.4291048,1,7.743415388,0.371418924,20.84819832,1.58E-96,4.01E-93,459.8072941,1,7.243144013,0.489203945,14.80598038,1.34E-49,5.90E-47,131.1332049,1,5.66989659,0.454060133,12.48710507,8.78E-36,6.84E-33,Y,-,,5 -nucleotidase,"F:nucleotide binding; F:hydrolase activity, acting on ester bonds; F:metal ion binding; P:nucleotide catabolic process; C:integral component of membrane",IPR006179 (PRINTS); IPR008334 (G3DSA:3.90.780.GENE3D); IPR029052 (G3DSA:3.60.21.GENE3D); IPR008334 (PFAM); IPR004843 (PFAM); PTHR11575:SF7 (PANTHER); IPR006179 (PANTHER); IPR029052 (SUPERFAMILY); IPR008334 (SUPERFAMILY),,
RL4_JR_10118,47,44,38,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.735024002,0,3.312850123,1.17117442,2.82865649,0.004674384,0.020612771,0.233688934,0,5.562939792,1.79754748,3.094738722,0.001969863,0.015023052,0.60283532,0,2.919047013,1.279421387,2.281536827,0.0225167,0.06114782,28.63195101,0,4.850929056,0.878465022,5.522051457,3.35E-08,8.44E-07,8.312461732,0,4.501859933,1.008764924,4.462744319,8.09E-06,8.41E-05,N,-,,fungal zn(2)-Cys(6) binuclear cluster domain-containing,"C:nucleus; F:transcription factor activity, sequence-specific DNA binding; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_10119,324,412,558,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0.860180497,1,2.115057564,1.59662374,1.324706323,0.185268575,NA,0.277070497,0,5.317402191,1.746721452,3.044218748,0.002332854,0.015159195,20.20986568,0,5.072249384,0.885238597,5.729810475,1.01E-08,4.22E-07,0.82296618,1,2.254277139,1.34355619,1.677843588,0.093377638,0.186002081,0.697711515,0,2.605332951,1.235298904,2.109070883,0.034938464,0.084690434,N,-,,Fungal specific transcription factor domain,F:binding,IPR007219 (SMART); IPR007219 (PFAM); PTHR31001 (PANTHER); PTHR31001:SF35 (PANTHER),,
RL4_JR_10120,87,185,106,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.008115494,0,8.845278576,4.03634189,2.191409652,0.028422161,NA,0.002507343,0,12.10167175,4.040174693,2.995333784,0.002741447,0.015349618,0.006623884,0,9.426891884,3.299070491,2.857438757,0.00427075,0.016940088,0.007651472,0,9.002876608,4.037800151,2.229648886,0.025770762,0.085851084,0.006630333,0,9.341240721,1.70468121,5.479758129,4.26E-08,1.17E-06,N,-,,Major facilitator superfamily general substrate transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502 (PANTHER); PTHR23502 (PANTHER); PTHR23502:SF1 (PANTHER); PTHR23502:SF1 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.86, the major facilitator superfamily (mfs).
RL4_JR_10121,5,9,7,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0.30335162,0,3.618533591,2.470335924,1.464794142,0.142977091,NA,0.096720727,1,6.835448436,2.101205002,3.253108779,0.001141498,0.015023052,0.251194572,0,4.181527296,1.318434705,3.171584667,0.001516097,0.007948712,0.289793967,0,3.759523114,1.594231282,2.358204331,0.018363582,0.074009818,0.248022708,0,4.097657938,1.245600053,3.289705976,0.001002921,0.004796683,N,-, Effector probability:0.69,cuticle-degrading protease,P:proteolysis; F:peptidase activity,no IPS match,,
RL4_JR_10122,17,4,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.56324854,0,5.157544414,0.890385748,5.792483115,6.94E-09,1.66E-07,0.168407483,0,6.035313533,1.898982164,3.17818337,0.00148201,0.015023052,11.5095302,0,4.335523493,1.215404494,3.567144531,0.000360892,0.002666916,4.518857635,0,3.895951527,1.188413683,3.27827892,0.001044421,0.007668431,7.801321979,0,4.225788014,1.158790692,3.646722435,0.000265607,0.001588462,N,-,,alkanesulfonate monooxygenase,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity",IPR011251 (PFAM); IPR016215 (PIRSF); IPR016215 (TIGRFAM); IPR011251 (G3DSA:3.20.20.GENE3D); PTHR30011 (PANTHER); PTHR30011:SF30 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_10123,5107,4578,5288,0,7,23,0,0,0,3,3,4,1,15,5,0,2,0,5.748566003,1,1.896088172,1.164673323,1.628000002,0.103524885,0.227459201,0.616963224,0,4.162347047,1.504561023,2.766486027,0.005666401,0.022301624,1.596960553,1,1.514053847,1.225683394,1.235273199,0.216728845,0.345483046,11.15439008,1,2.042758034,1.152598385,1.772306868,0.076343632,0.160903262,1.569046506,1,1.436563017,1.211821891,1.185457225,0.235836717,0.364556758,N,-,,hydantoinase oxoprolinase,P:transmembrane transport; C:integral component of membrane,G3DSA:3.30.420.40 (GENE3D); IPR024071 (G3DSA:2.40.390.GENE3D); IPR010318 (PFAM); IPR002821 (PFAM); G3DSA:1.20.1250.20 (GENE3D); IPR008040 (PFAM); G3DSA:3.30.420.40 (GENE3D); IPR027479 (G3DSA:3.40.1610.GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11365 (PANTHER); PTHR11365:SF10 (PANTHER); IPR020846 (PROSITE_PROFILES); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY); IPR020846 (SUPERFAMILY); SSF160991 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_10124,162,326,257,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.803604182,0,2.21308274,1.64379467,1.346325536,0.178197554,NA,0.254089493,0,5.441928943,1.75313301,3.104116408,0.001908482,0.015023052,0.663288961,0,2.780750992,1.272995135,2.18441604,0.028931691,0.07445461,0.765475944,0,2.358124898,1.351294947,1.745085264,0.080970028,0.167667851,0.658092075,0,2.690352939,1.250550952,2.151334125,0.031449837,0.078115541,N,-,,Aromatic amino acid aminotransferase,F:pyridoxal phosphate binding; P:biosynthetic process; F:transferase activity,IPR015421 (G3DSA:3.40.640.GENE3D); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR004839 (PFAM); PTHR11751:SF377 (PANTHER); PTHR11751 (PANTHER); PTHR11751 (PANTHER); PTHR11751 (PANTHER); PTHR11751:SF377 (PANTHER); PTHR11751:SF377 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_10125,212,264,169,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.142474242,0,-0.153099382,1.253299634,-0.122157047,0.902774643,0.952760096,1.327186253,0,3.057100691,1.40233478,2.180007752,0.029256887,0.077715924,3.440539089,0,0.406110319,1.235803656,0.328620422,0.74244261,0.827028026,3.968477852,0,-0.01598971,1.242484624,-0.012869141,0.989732194,0.993657756,3.394901134,0,0.322696606,1.237186549,0.260831001,0.794222837,0.860514309,N,-,,pyruvate decarboxylase,F:magnesium ion binding; F:thiamine pyrophosphate binding; F:carboxy-lyase activity,IPR029035 (G3DSA:3.40.50.GENE3D); IPR012110 (PIRSF); IPR011766 (PFAM); IPR029061 (G3DSA:3.40.50.GENE3D); IPR012001 (PFAM); IPR029061 (G3DSA:3.40.50.GENE3D); IPR012000 (PFAM); PTHR18968 (PANTHER); IPR012110 (PTHR18968:PANTHER); IPR029061 (SUPERFAMILY); IPR029035 (SUPERFAMILY); IPR029061 (SUPERFAMILY),,
RL4_JR_10126,66,94,106,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.48091611,0,-2.655718069,1.191288118,-2.229282764,0.025795097,0.080657876,7.47066908,0,0.564261936,1.221657905,0.461882114,0.644165861,0.768853113,32.41215789,0,-0.270086453,1.032375897,-0.261616388,0.793617208,0.864026306,42.45778479,0,0.519218546,0.674747911,0.769500042,0.441596519,0.583550608,26.53432384,0,-1.239416961,1.125557616,-1.101158167,0.270827825,0.403066175,N,-,,Fungal transcriptional regulatory,"F:DNA binding; C:nucleus; F:zinc ion binding; F:metal ion binding; P:transcription, DNA-templated; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:N-acetyltransferase activity; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_10127,2842,2134,3758,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1.653619565,0,1.171947999,1.295740407,0.90446203,0.365750459,NA,0.529738567,0,4.382191399,1.532814466,2.858918347,0.004250882,0.018562306,1.371314166,1,1.733342079,1.223843293,1.416310478,0.156684621,0.270834063,10.89398618,0,2.260984951,1.148127301,1.969280713,0.048920865,0.121283975,1.349315189,0,1.653748447,1.20958802,1.367199756,0.171562702,0.28669482,Y,-,,glycosyl hydrolase family 16,"P:carbohydrate metabolic process; C:cell wall; P:cell wall organization; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR013320 (G3DSA:2.60.120.GENE3D); IPR017168 (PIRSF); IPR000757 (PFAM); PTHR10963 (PANTHER); PTHR10963:SF27 (PANTHER); IPR000757 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),,
RL4_JR_10128,2562,2636,5155,0,0,0,0,0,0,0,3,0,0,1,2,0,0,1,0.012047471,0,8.273092713,3.994385999,2.07118008,0.03834197,NA,0.00401109,0,11.43263965,3.991205167,2.86445802,0.004177235,0.018371529,0.010113829,1,8.82019535,3.041025661,2.900401487,0.00372685,0.01574077,0.01164654,1,8.398490877,3.993441208,2.103071121,0.035459553,0.099858856,0.00966951,1,8.76562085,1.6165792,5.422326879,5.88E-08,1.50E-06,Y,-,,glycoside hydrolase family 18,P:metabolic process; F:hydrolase activity,IPR011583 (SMART); IPR001223 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); IPR029226 (PFAM); PTHR11177:SF218 (PANTHER); PTHR11177:SF218 (PANTHER); PTHR11177 (PANTHER); PTHR11177:SF218 (PANTHER); PTHR11177 (PANTHER); IPR029070 (SUPERFAMILY); IPR017853 (SUPERFAMILY),9.B.29.2.7, the small 4-5 tms putative permease (4-5pp) family.
RL4_JR_10129,2863,2131,3168,0,0,1,0,2,0,0,3,0,1,3,0,0,0,0,0.007786068,1,8.896911713,4.040984052,2.201669593,0.027688656,NA,0.002502822,1,12.10389348,4.040376809,2.995733828,0.002737853,0.015349618,0.006502266,1,9.448056946,3.305547956,2.858242286,0.00425995,0.016940088,0.007499321,1,9.02784755,4.040049892,2.234588134,0.025444401,0.085851084,0.00645541,0,9.348501478,1.703823852,5.486776974,4.09E-08,1.17E-06,Y,-,,glycoside hydrolase family 11,"P:xylan catabolic process; F:endo-1,4-beta-xylanase activity",IPR001137 (PRINTS); IPR013319 (G3DSA:2.60.120.GENE3D); IPR033123 (PFAM); PTHR10587 (PANTHER); IPR033123 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),,
RL4_JR_10130,22091,13545,15014,2,12,7,0,0,0,2,0,0,0,8,0,0,4,0,0.023358204,1,7.315437055,3.952125779,1.851013218,0.064167652,NA,0.007508467,0,10.52125751,3.951891025,2.662334929,0.007760062,0.027959129,0.019506799,1,7.865462077,2.651210638,2.966743557,0.003009719,0.01361501,0.022497964,1,7.445332924,3.951772468,1.884048989,0.059558349,0.136354635,0.019366229,1,7.768283252,1.545930068,5.024990078,5.03E-07,7.99E-06,N,-, Effector probability:0.577,vesicular-fusion SEC18,P:transport,PTHR23078:SF3 (PANTHER); PTHR23078 (PANTHER),1.F.1.1.2, the synaptosomal vesicle fusion pore (svf-pore) family.
RL4_JR_10131,4792,2864,2059,0,11,1,0,0,0,0,0,3,1,5,0,0,1,0,52.45784439,1,0.672369081,0.638947425,1.052307365,0.292658554,0.477763039,30.50559252,0,1.357102735,1.124227988,1.207141922,0.227377492,0.377050291,21.31187593,1,-2.224686457,1.204102725,-1.84758859,0.064661882,0.138167347,47.87025292,1,-0.318740653,0.869121892,-0.366738723,0.71381392,0.808452969,21.08904855,1,-2.312218778,1.21263933,-1.906765451,0.056550967,0.123002909,N,-,,hypothetical protein SPI_05576,,no IPS match,,
RL4_JR_10132,2752,3134,4693,0,2,17,0,0,0,0,0,2,1,5,1,0,10,2,0.357398114,1,3.382103323,2.297776603,1.471902586,0.141047185,NA,0.113959513,0,6.598973964,2.035650698,3.241702504,0.00118818,0.015023052,0.295551121,1,3.947898731,1.304408634,3.026581264,0.002473363,0.011733988,0.340960886,1,3.52526878,1.527311163,2.308153613,0.020990594,0.078455086,0.291040832,1,3.867712272,1.23929533,3.120896351,0.001803015,0.007751815,N,-, Effector probability:0.617,hypothetical protein SPSK_03547,,no IPS match,,
RL4_JR_10133,27471,31423,40763,0,0,4,0,0,0,0,1,0,3,14,0,0,14,0,0.91627179,1,2.024112129,1.713486627,1.181282712,0.237490433,NA,0.291605644,0,5.243615393,1.801934571,2.909992115,0.003614379,0.017053643,0.754851059,1,2.595501436,1.337426767,1.940668079,0.052298551,0.117264803,4.882459219,1,3.11443447,1.245964786,2.499616767,0.012432772,0.057638194,0.739773293,1,2.521660703,1.304198266,1.933494905,0.05317526,0.117323929,N,-,,snf2 family atp-dependent chromatin-remodeling factor snf21,F:ATP binding; F:helicase activity,IPR001650 (SMART); IPR001650 (PFAM); IPR000330 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR10799:SF752 (PANTHER); PTHR10799:SF752 (PANTHER); PTHR10799 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_10134,3847,3711,5888,0,3,4,0,4,0,3,0,0,1,6,2,0,6,0,182.724289,1,-5.615845019,1.220598092,-4.600896115,4.21E-06,5.39E-05,95.70095886,1,0.172650916,0.788693902,0.218907381,0.826722197,0.8960362,173.033953,1,-3.209468858,1.048930922,-3.059752353,0.002215201,0.010699758,174.0858801,1,-5.470826581,1.209552083,-4.523018611,6.10E-06,9.24E-05,148.4514617,1,-5.127625054,1.212034944,-4.230591767,2.33E-05,0.000203968,N,-,,FAD dependent oxidoreductase,F:FAD binding; P:oxidation-reduction process; F:D-amino-acid oxidase activity; P:D-amino acid metabolic process,G3DSA:3.30.9.10 (GENE3D); IPR023209 (PIRSF); IPR006076 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR023209 (PANTHER); PTHR11530:SF8 (PANTHER); SSF54373 (SUPERFAMILY); SSF51971 (SUPERFAMILY),,
RL4_JR_10135,8,13,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,350.5670652,0,-6.555881582,1.192689057,-5.496723178,3.87E-08,8.49E-07,112.3435951,0,-3.346254461,1.196793676,-2.796016162,0.005173681,0.021131457,290.7995402,0,-5.99489388,1.194665982,-5.018050208,5.22E-07,1.51E-05,339.425217,0,-5.469996446,1.146131837,-4.772571767,1.82E-06,3.12E-05,300.8868827,0,-4.383998444,0.979138463,-4.477403974,7.56E-06,7.95E-05,N,-,,transcription factor,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated",IPR000818 (SMART); IPR000818 (PFAM); PTHR11795 (PANTHER); PTHR11795:SF383 (PANTHER); IPR000818 (PROSITE_PROFILES),,
RL4_JR_10136,738,1676,1461,2,0,16,6,0,0,0,0,0,1,17,0,0,9,6,18.3676459,1,-2.30148246,1.187340612,-1.938350661,0.052580455,0.138326784,5.853753756,1,0.916133829,1.229795999,0.744947804,0.456303275,0.615809103,15.20225825,0,-1.737306235,1.190341157,-1.459502785,0.144426775,0.254823399,17.5385527,1,-2.159730245,1.188262505,-1.817553138,0.06913246,0.149437693,15.00518709,1,-1.821158784,1.195469117,-1.523384216,0.127662609,0.229180092,N,-,,carbohydrate-binding module family 21,,IPR005036 (PFAM); PTHR12307:SF18 (PANTHER); PTHR12307 (PANTHER); IPR005036 (PROSITE_PROFILES),,
RL4_JR_10137,409,252,233,0,0,1,0,0,0,0,0,0,0,1,2,0,0,0,0.086790797,1,5.423584766,3.919039986,1.383906463,0.166387098,NA,0.028553952,0,8.596248398,2.828089284,3.039595831,0.002368958,0.015214845,0.07284503,0,5.967751394,1.70782125,3.494365347,0.00047519,0.003252373,0.083930616,1,5.547296962,2.647682445,2.095151921,0.03615749,0.101019477,0.070780164,0,5.901413125,1.425169196,4.140850885,3.46E-05,0.00028368,,,,,,,,
RL4_JR_10138,85,69,68,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.008115494,0,8.845278576,4.03634189,2.191409652,0.028422161,NA,0.002507343,0,12.10167175,4.040174693,2.995333784,0.002741447,0.015349618,0.006623884,0,9.426891884,3.299070491,2.857438757,0.00427075,0.016940088,0.007651472,0,9.002876608,4.037800151,2.229648886,0.025770762,0.085851084,0.006630333,0,9.341240721,1.70468121,5.479758129,4.26E-08,1.17E-06,N,-,,subtilisin-like serine protease pr1c,F:hydrolase activity,IPR010435 (PFAM),,
RL4_JR_10139,69,49,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,subtilisin-like serine protease pr1c,F:peptidase activity,IPR000209 (G3DSA:3.40.50.GENE3D); IPR000209 (SUPERFAMILY),2.A.7.3.49, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_10140,280,511,323,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0.007786068,0,8.896911713,4.040984052,2.201669593,0.027688656,NA,0.002502822,0,12.10389348,4.040376809,2.995733828,0.002737853,0.015349618,0.006502266,0,9.448056946,3.305547956,2.858242286,0.00425995,0.016940088,0.007499321,1,9.02784755,4.040049892,2.234588134,0.025444401,0.085851084,19.30913383,0,11.86493431,1.959918617,6.053789278,1.41E-09,8.09E-08,Y,-,,subtilisin-like protease,F:hydrolase activity,IPR015500 (PRINTS); IPR000209 (PFAM); IPR000209 (G3DSA:3.40.50.GENE3D); PTHR10795:SF363 (PANTHER); PTHR10795:SF363 (PANTHER); IPR015500 (PANTHER); IPR000209 (SUPERFAMILY),1.I.3.1.1,The Bacterial (Planctomycetes) Nuclear Pore-like Complex (B-NPC) Family
RL4_JR_10141,15,23,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.047297377,0,6.299088251,3.92925588,1.603124979,0.108907064,NA,0.014521304,0,9.568213228,3.285606369,2.912160543,0.003589381,0.016988757,0.038779208,0,6.873004972,2.01258714,3.415009882,0.000637797,0.004031389,0.044809415,0,6.451640693,3.439504035,1.875747383,0.060689976,0.137622846,0.03945936,0,6.752619719,1.568707142,4.304576386,1.67E-05,0.000154109,,,,,,,,
RL4_JR_10142,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.08454194,0,0.195379064,1.183848305,0.165037246,0.868914666,0.936747787,1.996860663,0,2.467850517,1.350280623,1.827657508,0.067600969,0.149407095,5.173697203,0,-0.182004073,1.227031444,-0.148328777,0.882083306,0.926466582,25.23923091,0,1.158753239,1.044796029,1.109071251,0.267399446,0.408605402,5.083315873,0,-0.259421086,1.226413595,-0.211528221,0.832475113,0.886798924,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23502:SF30 (PANTHER); PTHR23502 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.2.33, the major facilitator superfamily (mfs).
RL4_JR_10143,124,142,121,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.19616851,0,-1.452136299,1.271374629,-1.142178132,0.253379984,0.43102666,3.242325587,0,1.76854146,1.352014291,1.308078969,0.190846526,0.332308424,8.402944828,0,-0.881782538,1.25083415,-0.704955599,0.480837868,0.617218534,9.694863581,0,-1.304283757,1.256410787,-1.03810296,0.299222124,0.444565972,8.249874713,0,-0.958078148,1.255700719,-0.762982878,0.445473607,0.578184883,N,-,,general amidase,"F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (G3DSA:3.90.1300.GENE3D); IPR023631 (PFAM); PIRSF001221 (PIRSF); IPR000120 (PANTHER); PTHR11895:SF45 (PANTHER); IPR023631 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_10144,240,229,254,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,1.035625159,1,1.847418247,1.542174753,1.197930548,0.230944056,NA,0.330297194,0,5.063825004,1.70227432,2.974740878,0.002932361,0.0154422,0.855070113,0,2.415578266,1.278414179,1.889511479,0.058823326,0.128109434,0.986420157,0,1.992976271,1.339257005,1.488120849,0.136719026,0.248239594,0.839195293,0,2.339691347,1.250997535,1.870260557,0.061447644,0.131146163,Y,-, Effector probability:0.771,---NA---,,no IPS match,,
RL4_JR_10145,2073,1173,1266,0,0,3,0,0,0,2,4,3,0,3,3,0,1,0,8.585850084,1,-1.20448337,1.22566254,-0.982720228,0.325745153,0.515005611,2.73204475,0,2.015449177,1.310714882,1.537671697,0.124128907,0.239229398,7.112927696,1,-0.64165933,1.220971708,-0.525531694,0.599213627,0.717921747,8.206705076,1,-1.064177107,1.222418294,-0.870550705,0.383999522,0.52926697,7.048010563,1,-0.73103063,1.230390457,-0.594145237,0.552414977,0.672295324,N,-,,metalloprotease m41,C:membrane; P:proteolysis; C:integral component of membrane; F:peptidase activity; F:metallopeptidase activity,no IPS match,,
RL4_JR_10146,12885,12534,8707,2,0,10,0,0,0,1,7,2,2,7,0,2,3,3,200.8528014,1,6.535299415,0.870881062,7.504238754,6.18E-14,3.55E-12,10.09547499,0,4.858623351,1.170437689,4.151116625,3.31E-05,0.001820074,1.868376784,1,1.287279181,1.253377378,1.02704836,0.304397693,0.445786524,55.13156651,1,4.736710267,0.592093008,7.999942918,1.24E-15,8.13E-14,16.57886762,1,2.911023802,1.017419696,2.861182867,0.004220635,0.015579268,N,-, Effector probability:0.73,helix-turn-helix-domain containing type,,IPR018531 (PFAM); IPR027369 (G3DSA:1.20.120.GENE3D); PTHR36922 (PANTHER); SSF109854 (SUPERFAMILY),,
RL4_JR_10147,1579,1365,1368,0,4,4,0,0,0,0,0,2,0,1,0,0,0,2,0.156635007,1,4.572187806,3.292217007,1.388786886,0.164897564,NA,0.050130009,0,7.783891232,2.399315073,3.244213867,0.001177753,0.015023052,0.129690896,1,5.136632818,1.403559546,3.659718487,0.000252492,0.002044019,0.14959391,1,4.713859062,1.984123451,2.375789198,0.017511464,0.072103933,0.127386772,1,5.059428232,1.266608848,3.994467781,6.48E-05,0.000483789,N,-, Effector probability:0.73,---NA---,,no IPS match,,
RL4_JR_10148,3185,2655,3866,1,0,18,0,0,0,1,0,2,2,3,0,0,2,1,10.51138121,1,2.102714573,1.012662392,2.076422103,0.037854929,0.108244132,0.916720936,0,3.590960702,1.4107964,2.545342972,0.010917045,0.035959106,2.378768037,1,0.938727318,1.207460615,0.777439286,0.436899642,0.577060923,2.744242979,1,0.516372448,1.211136302,0.426353703,0.669850131,0.775200889,2.345254328,1,0.856580982,1.203254354,0.711886875,0.47653483,0.606373653,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF248 (PANTHER); PTHR11662 (PANTHER); PTHR11662:SF248 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_10149,2643,781,1696,1,0,12,0,0,0,0,3,0,0,9,0,0,0,0,7.66084734,1,8.971004029,1.254991139,7.148260854,8.79E-13,4.32E-11,0.007849436,0,10.46050377,3.590523679,2.913364373,0.003575571,0.016958421,0.019946832,1,7.837352665,2.157725522,3.632228744,0.000280984,0.002210804,0.022977324,1,7.416384117,3.950883384,1.877145791,0.060498115,0.137403188,0.019289782,0,7.769566241,1.492133271,5.207018966,1.92E-07,3.89E-06,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:membrane; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF254 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.17, the major facilitator superfamily (mfs).
RL4_JR_10150,19,8,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.039363613,1,6.563799275,3.933769771,1.668577384,0.095201164,NA,0.013191528,0,9.71133654,3.437961716,2.824736673,0.004731949,0.019923787,0.033269781,0,7.099132242,2.140770177,3.316158043,0.000912642,0.005337717,0.038303177,0,6.67913942,3.709693572,1.80045583,0.071788692,0.153963251,0.03194923,0,7.045093639,1.607103538,4.383721069,1.17E-05,0.00011491,Y,-,,hydrolase or acyltransferase (alpha beta hydrolase superfamily),P:proteolysis; F:aminopeptidase activity,IPR000073 (PFAM); G3DSA:1.20.1440.110 (GENE3D); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR17630:SF54 (PANTHER); PTHR17630 (PANTHER); PTHR17630 (PANTHER); IPR029058 (SUPERFAMILY),,
RL4_JR_10151,2715,3244,2746,0,0,0,0,0,0,1,0,0,0,0,2,0,1,0,0.167105158,0,4.478689939,3.261061695,1.373383995,0.169633003,NA,0.052440777,0,7.717951128,2.417712833,3.192253035,0.001411676,0.015023052,0.137726174,1,5.047220663,1.46402862,3.447487703,0.000565826,0.003710119,0.1589958,1,4.625219591,2.023941846,2.285253205,0.022297985,0.080484515,0.137613442,1,4.948811771,1.328076744,3.726299547,0.000194311,0.001213697,N,-,,catechol dioxygenase,"F:ferric iron binding; F:catechol 1,2-dioxygenase activity; P:oxidation-reduction process; P:catechol-containing compound metabolic process",IPR007535 (PFAM); IPR015889 (G3DSA:2.60.130.GENE3D); IPR000627 (PFAM); PTHR33711:SF4 (PANTHER); PTHR33711 (PANTHER); PTHR33711 (PANTHER); PTHR33711:SF4 (PANTHER); IPR015889 (SUPERFAMILY),,
RL4_JR_10152,189,293,196,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0.011666121,1,8.315060612,3.996942811,2.080355163,0.037492969,NA,0.003670122,0,11.54963874,3.998254364,2.888670325,0.003868744,0.017716233,0.009673795,0,8.874006407,3.050060812,2.909452288,0.003620626,0.015525295,0.01116718,0,8.453598072,3.996777749,2.115103366,0.034421138,0.099376683,0.009745957,0,8.762396083,1.617624164,5.416830608,6.07E-08,1.53E-06,N,-,,CAIB BAIF family enzyme,F:transferase activity,IPR003673 (PFAM); IPR023606 (G3DSA:3.40.50.GENE3D); IPR023606 (SUPERFAMILY); IPR023606 (SUPERFAMILY),,
RL4_JR_10153,17,9,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.57,3-oxoadipate enol-lactonase 2,F:binding,IPR029058 (G3DSA:3.40.50.GENE3D); IPR000073 (PFAM); PTHR10992 (PANTHER); PTHR10992:SF856 (PANTHER); IPR029058 (SUPERFAMILY),1.C.57.3.4, the clostridial cytotoxin (cct) family.
RL4_JR_10154,56,85,51,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.225468228,0,4.046973263,2.983672316,1.356373232,0.174980446,NA,0.07208895,0,7.260178032,2.377808623,3.053306293,0.002263348,0.015081,0.185771045,0,4.619448274,1.525510983,3.02813177,0.002460708,0.011679421,0.214278991,0,4.196025616,1.972767529,2.126974189,0.033422228,0.098001754,0.18097105,0,4.553899157,1.390514685,3.274973797,0.001056718,0.004994989,N,-, Effector probability:0.765,fungal specific transcription factor,,PTHR39401 (PANTHER); PTHR39401:SF1 (PANTHER); IPR032710 (SUPERFAMILY),,
RL4_JR_10155,5,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.407502615,0,2.173579229,1.187517084,1.830356175,0.067196696,0.165967499,0.510232717,0,4.436270898,1.575566314,2.815667522,0.004867601,0.02028401,1.320398493,0,1.787672123,1.252620307,1.42714605,0.153537801,0.26717372,1.522860392,0,1.365775525,1.282506794,1.064926542,0.286909173,0.431135732,1.300262167,0,1.707018534,1.23909707,1.377630998,0.168317245,0.282662339,N,-,,transcriptional activator Mut3p,"F:metal ion binding; P:regulation of transcription, DNA-templated",IPR001138 (SMART); IPR007219 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR31944:SF58 (PANTHER); PTHR31944 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_10156,1119,2366,1626,0,0,5,0,0,0,0,0,0,1,1,0,0,0,1,17.56787885,1,-0.404509336,1.182124489,-0.342188441,0.732209084,0.858724992,3.040360864,0,1.861319527,1.316189713,1.414172675,0.157311209,0.286695005,7.886115768,0,-0.790196903,1.22544928,-0.644822202,0.519042412,0.64930006,17.1217178,1,0.495589524,1.057943951,0.468445916,0.639465739,0.752946925,7.756645195,1,-0.869119931,1.22823886,-0.707614747,0.479184532,0.608598017,N,-,,Bacterial alpha-L-rhamnosidase,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transcription, DNA-templated; F:hydrolase activity",IPR008902 (PFAM); PTHR34987:SF2 (PANTHER); PTHR34987 (PANTHER); IPR008979 (SUPERFAMILY); IPR008928 (SUPERFAMILY),,
RL4_JR_10157,4373,2902,2905,1,3,2,0,0,0,2,0,0,0,5,0,0,1,1,26.7337573,1,12.66088291,3.635442929,3.482624581,0.000496524,0.0033497,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,1,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); PTHR11662:SF278 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.38, the major facilitator superfamily (mfs).
RL4_JR_10158,1650,1367,2292,0,0,0,0,0,0,0,0,0,1,4,0,0,0,0,3.818553893,0,11.6457219,1.964117141,5.929239992,3.04E-09,7.66E-08,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,Allantoate permease,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF278 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.38, the major facilitator superfamily (mfs).
RL4_JR_10159,11463,13085,15298,1,0,0,2,0,0,0,0,1,1,8,2,0,7,0,0.007786068,1,8.896911713,4.040984052,2.201669593,0.027688656,NA,0.002502822,1,12.10389348,4.040376809,2.995733828,0.002737853,0.015349618,0.006502266,1,9.448056946,3.305547956,2.858242286,0.00425995,0.016940088,0.007499321,1,9.02784755,4.040049892,2.234588134,0.025444401,0.085851084,0.00645541,1,9.348501478,1.703823852,5.486776974,4.09E-08,1.17E-06,N,-,,hypothetical protein UCRPA7_2112,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_10160,2494,3218,3483,0,0,0,0,0,0,0,1,0,2,1,0,0,0,2,0.421056287,0,3.145603691,2.127798055,1.478337516,0.139317461,NA,0.134336624,0,6.361622955,1.967298224,3.233685101,0.001222041,0.015023052,0.348374137,1,3.710486096,1.287654889,2.881584287,0.003956814,0.016305678,0.401891269,1,3.288011616,1.463271607,2.247027552,0.024638266,0.084922906,0.343132432,1,3.629883775,1.23271159,2.944633443,0.003233375,0.012557698,N,-,,Chitinase 1,F:chitinase activity; P:polysaccharide catabolic process; P:chitin catabolic process; C:extracellular region,IPR011583 (SMART); IPR029070 (G3DSA:3.10.50.GENE3D); IPR001223 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR11177:SF222 (PANTHER); PTHR11177 (PANTHER); PTHR11177:SF222 (PANTHER); IPR029070 (SUPERFAMILY); IPR017853 (SUPERFAMILY),9.B.29.2.7, the small 4-5 tms putative permease (4-5pp) family.
RL4_JR_10161,4577,5318,8177,2,3,10,0,0,0,5,0,1,0,1,2,0,2,1,2.194924805,1,0.763370007,1.343211278,0.568317151,0.569819635,0.745983002,0.712286462,0,3.95510718,1.544958336,2.560008957,0.010466947,0.034782151,1.829458266,1,1.317637928,1.267869064,1.039253947,0.298686647,0.439584767,39.03806025,1,3.976726436,0.744964833,5.338139815,9.39E-08,2.13E-06,1.786601904,1,1.248609665,1.252254722,0.997089205,0.318721212,0.454130633,N,-,,dimethylaniline monooxygenase,F:nucleotide binding; F:coenzyme binding; F:monooxygenase activity,IPR000960 (PRINTS); IPR023753 (G3DSA:3.50.50.GENE3D); IPR012143 (PIRSF); IPR020946 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY); IPR023753 (SUPERFAMILY),,
RL4_JR_10162,1239,1188,2427,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,81.92421702,0,0.452429949,0.501278871,0.902551404,0.366764028,0.558513285,14.00818405,0,-0.342662105,1.208796288,-0.283473823,0.776813645,0.864816071,55.75913789,1,-0.587918534,0.850074065,-0.691608601,0.489183159,0.623425265,91.11109686,1,0.130506165,0.568702475,0.229480564,0.818495425,0.885580913,74.28207051,0,0.830439077,0.507908398,1.635017417,0.102045397,0.193953693,Y,-,,hypothetical protein CTHT_0010660,,IPR025676 (PFAM); PTHR38788 (PANTHER); PTHR38788:SF1 (PANTHER),,
RL4_JR_10163,2937,3203,5318,0,5,1,0,0,2,0,0,0,3,8,3,0,0,0,51.91862194,1,-1.144265166,0.862814308,-1.326200963,0.18477314,0.342197339,12.8672045,1,-0.220122893,1.207787283,-0.182253031,0.855384157,0.914566224,46.44220701,0,-1.055117745,1.034045013,-1.02037893,0.307548782,0.448713629,48.22314594,1,-2.34754665,1.144422002,-2.05129458,0.040238268,0.107752569,36.88246988,0,-2.02924207,1.12708224,-1.800438334,0.071791452,0.147681523,N,-,,NADH-ubiquinone oxidoreductase B18 subunit,C:mitochondrion; F:NADH dehydrogenase (ubiquinone) activity; P:oxidation-reduction process,IPR008698 (PFAM); PTHR20900:SF0 (PANTHER); IPR008698 (PANTHER),3.D.1.6.2, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_10164,1840,1810,3481,3,0,0,0,0,0,0,0,0,0,2,1,0,0,0,62.78232314,1,2.134061359,0.620345243,3.44011884,0.000581459,0.003807015,2.750601071,0,2.005736189,1.276180574,1.571671149,0.116026836,0.22760148,42.28439828,0,2.177314473,0.74014129,2.941755181,0.003263578,0.014409275,8.245564316,1,-1.070947475,1.193833457,-0.89706606,0.369683668,0.515358273,14.77922679,0,0.93334911,0.982562399,0.94991332,0.342156298,0.479094526,N,-,,5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase,P:methionine biosynthetic process; F:zinc ion binding; F:5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity; P:methylation,IPR002629 (PFAM); G3DSA:3.20.20.210 (GENE3D); PTHR30519 (PANTHER); PTHR30519:SF8 (PANTHER); SSF51726 (SUPERFAMILY),,
RL4_JR_10165,3431,2962,3293,0,0,8,0,0,0,0,2,1,0,6,0,0,1,1,42.19415051,1,1.396413631,0.652866871,2.138894917,0.03244418,0.096247134,71.83643853,0,3.404762649,0.855657532,3.979118425,6.92E-05,0.003572203,23.85224602,1,-0.525427845,1.205154195,-0.435983915,0.6628484,0.767460796,28.07405952,1,-0.174773914,1.033605924,-0.16909144,0.865724718,0.916519181,35.48622978,1,1.337713998,0.72343979,1.84910205,0.064443078,0.136332254,N,-,,duf6 domain-containing,P:biological regulation; C:integral component of membrane,IPR031581 (PFAM); IPR026505 (PANTHER); PTHR19346:SF4 (PANTHER); SSF103481 (SUPERFAMILY); SSF103481 (SUPERFAMILY),2.A.7.24.7, the drug/metabolite transporter (dmt) superfamily.
RL4_JR_10166,3564,3461,3202,0,2,11,0,0,0,0,12,2,0,6,0,0,3,2,532.0544191,1,-0.362342406,0.56023069,-0.646773575,0.517778497,0.702484114,108.050038,0,-2.242643553,1.123927322,-1.995363498,0.046003249,0.11034239,364.6484898,1,-1.110589522,0.479636144,-2.315483387,0.020586493,0.056820516,422.9005056,1,-1.011103468,0.443252006,-2.281102973,0.022542354,0.080907954,304.3018862,1,-1.852652733,0.540248323,-3.429261423,0.000605226,0.00317838,N,-,,hypothetical protein CMQ_5479,,no IPS match,,
RL4_JR_10167,2661,3141,4014,4,1,10,0,0,0,0,0,1,2,10,0,0,2,0,1.887892988,1,0.980650776,1.325306701,0.739942517,0.459334875,NA,0.600239277,0,4.20176682,1.522966812,2.758935248,0.005799002,0.022724546,9.406252841,1,2.505221787,1.214482557,2.062789436,0.039132638,0.094029361,1.80373969,1,1.121424858,1.266207434,0.885656511,0.37580265,0.52137597,1.549316865,1,1.454528248,1.240696948,1.172347728,0.241057477,0.370365243,N,-,,hypothetical protein CFIO01_03591,C:membrane; C:integral component of membrane,no IPS match,,
RL4_JR_10168,16031,20898,29708,2,2,11,0,0,0,0,0,0,0,12,0,0,18,3,33.81839433,1,-3.182090798,1.215573283,-2.61776961,0.008850654,0.034301014,10.6945629,0,0.046646532,1.230245722,0.037916435,0.969754309,0.984457153,51.99371116,0,-0.207759198,0.876303852,-0.237085798,0.81259023,0.87816647,32.22853642,1,-3.03749663,1.211016041,-2.508221632,0.012134053,0.056590184,39.30786576,1,-0.52668566,0.893126145,-0.58971027,0.555384909,0.674819657,N,-,,transcription factor mbp1,F:DNA binding; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; C:MBF transcription complex,IPR002110 (SMART); IPR018004 (SMART); IPR003163 (G3DSA:3.10.260.GENE3D); IPR018004 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR002110 (PFAM); PTHR11707 (PANTHER); IPR029793 (PTHR11707:PANTHER); IPR020683 (PROSITE_PROFILES); IPR003163 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY); IPR003163 (SUPERFAMILY),3.A.23.6.1, the type vi symbiosis/virulence secretory system (t6ss) family.
RL4_JR_10169,1676,2231,2064,2,0,6,0,1,0,0,0,0,2,1,1,0,0,0,145.7151383,1,1.048253168,0.435843161,2.405115556,0.016167353,0.055394062,43.90046943,1,1.671748344,0.851338854,1.963669738,0.049568404,0.117008253,85.25619405,0,-0.110983309,1.178865859,-0.094144137,0.92499466,0.955956798,68.94731066,1,-0.86714646,0.746344884,-1.161857578,0.245293321,0.383922535,40.46283949,0,-3.252290191,1.195896721,-2.719541022,0.006537259,0.022391659,N,-,,mannose-6-phosphate isomerase,C:nucleus; P:carbohydrate metabolic process; F:zinc ion binding; P:cell wall mannoprotein biosynthetic process; P:GDP-mannose biosynthetic process; P:protein glycosylation; C:cytosol; F:mannose-6-phosphate isomerase activity,IPR016305 (PRINTS); IPR014710 (G3DSA:2.60.120.GENE3D); IPR001250 (TIGRFAM); IPR001250 (PFAM); IPR014710 (G3DSA:2.60.120.GENE3D); G3DSA:1.10.441.10 (GENE3D); IPR016305 (PIRSF); PTHR10309:SF0 (PANTHER); IPR016305 (PANTHER); IPR011051 (SUPERFAMILY),,
RL4_JR_10170,5099,4931,4572,0,5,8,0,0,1,2,0,2,0,10,5,0,6,1,27.6490958,1,2.365901518,0.847559353,2.791428717,0.005247591,0.022614818,1.161452264,1,3.249645432,1.386618185,2.34357624,0.019099858,0.05544272,3.00215322,1,0.603055182,1.209576327,0.498567282,0.618084259,0.731869595,32.36835528,1,2.515589287,0.851813624,2.953215606,0.003144822,0.019321193,2.948851341,1,0.525883072,1.201639595,0.437637936,0.661648767,0.75868559,N,-, Effector probability:0.714,phenylacrylic acid decarboxylase,F:prenyltransferase activity; P:cofactor biosynthetic process; C:mitochondrion; C:integral component of membrane; F:mRNA binding; P:cinnamic acid catabolic process; F:carboxy-lyase activity,IPR004507 (TIGRFAM); IPR003382 (G3DSA:3.40.50.GENE3D); IPR003382 (PFAM); PTHR30108 (PANTHER); PTHR30108:SF2 (PANTHER); IPR004507 (HAMAP); IPR003382 (SUPERFAMILY),,
RL4_JR_10171,716,696,1158,0,1,6,0,0,0,0,0,0,0,3,0,0,0,1,1.517549838,1,1.295797569,1.418502797,0.913496661,0.360981389,NA,0.492450458,0,4.487602217,1.625484316,2.76077854,0.005766376,0.022622969,1.264886938,0,1.850059865,1.278935647,1.446562123,0.148019601,0.259669111,1.458185562,1,1.428670003,1.319012196,1.08313631,0.278747924,0.422250558,1.235348563,1,1.780771262,1.256393398,1.417367574,0.156375488,0.266638905,N,-,,ferulic acid decarboxylase 1,F:FMN binding; C:cytoplasm; F:oxidoreductase activity; F:metal ion binding; P:ferulate metabolic process; P:oxidation-reduction process; P:ubiquinone biosynthetic process; P:cinnamic acid catabolic process; C:plasma membrane; F:carboxy-lyase activity,IPR002830 (TIGRFAM); G3DSA:3.40.1670.10 (GENE3D); IPR002830 (PFAM); PTHR30108 (PANTHER); PTHR30108:SF1 (PANTHER); IPR032903 (HAMAP); IPR012349 (SUPERFAMILY); SSF143968 (SUPERFAMILY),,
RL4_JR_10172,2002,2580,3292,0,5,6,0,0,0,0,0,2,0,2,0,0,0,0,0.035631255,1,6.707741519,3.936592289,1.703946212,0.088391136,NA,0.010851183,0,9.988588905,3.938016273,2.536451912,0.011198212,0.036599388,0.029105413,1,7.288536998,2.596821893,2.806714245,0.005004962,0.018936713,0.033642235,1,6.865203136,3.936927976,1.743796985,0.081194496,0.167944123,0.029713403,0,7.162890713,1.744343232,4.106353946,4.02E-05,0.000321976,,,,,,,,
RL4_JR_10173,1492,849,1445,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,66.33704619,0,0.276117837,0.752957409,0.366711097,0.713834528,0.846310432,11.35482124,0,-0.039703604,1.252362511,-0.031702964,0.974708931,0.986927705,37.34600663,0,-1.731976802,1.220514212,-1.419055005,0.15588298,0.27000159,46.07737796,0,-0.846904263,0.917804416,-0.92275026,0.356137367,0.502283165,52.23308278,1,0.342445665,0.723880267,0.473069485,0.636163607,0.738749457,N,-,,APC amino acid permease,C:integral component of plasma membrane; F:L-amino acid transmembrane transporter activity; P:L-alpha-amino acid transmembrane transport; F:antiporter activity; P:L-amino acid transport,IPR002293 (PFAM); PTHR11785:SF286 (PANTHER); PTHR11785:SF286 (PANTHER); IPR002293 (PANTHER); IPR002293 (PANTHER),2.A.3.4.7, the amino acid-polyamine-organocation (apc) family.
RL4_JR_10174,351,132,173,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,211.2181786,0,-3.469447451,0.902787956,-3.843036926,0.000121521,0.001005446,63.26923822,0,-2.517928915,1.200049724,-2.098187155,0.035888616,0.091089411,164.8902818,0,-5.176377843,1.204270291,-4.298352192,1.72E-05,0.00029881,203.6028957,0,-3.863972072,1.033004959,-3.74051648,0.000183643,0.001786148,167.1096799,0,-4.336347547,1.146815922,-3.781206263,0.00015607,0.001009075,N,-,,dna-dependent rna polymerase i subunit a43,F:DNA-directed RNA polymerase activity; P:transcription from RNA polymerase I promoter; C:nucleolus,IPR005576 (PFAM),,
RL4_JR_10175,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35.57274142,0,-0.935206059,1.052311404,-0.888716073,0.374155691,0.56638423,7.496073909,0,0.559331001,1.252163494,0.446691669,0.655097698,0.777823852,37.14549592,0,-0.275160657,1.057918791,-0.2600962,0.794789569,0.864744718,49.56483865,0,0.210395761,0.785852041,0.267729484,0.788907553,0.863440599,19.42196745,0,-2.193368441,1.228972129,-1.784717805,0.074307101,0.151654788,N,-, Effector probability:0.58,isoflavone reductase family,F:transmembrane transporter activity; C:membrane,IPR008030 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); PTHR15020:SF31 (PANTHER); PTHR15020 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_10176,682,750,596,0,0,0,0,0,0,0,0,2,0,0,0,0,0,3,41.22432212,0,-2.380896817,1.157979424,-2.056078689,0.039774932,0.112317029,11.89341475,0,-0.106565625,1.221237123,-0.087260388,0.93046454,0.960826785,30.89236298,1,-2.760165825,1.199780354,-2.300559278,0.021416555,0.058695507,74.64839011,0,0.336870865,0.599319611,0.56208884,0.574055491,0.700739284,61.57030611,1,-0.206494251,0.762590876,-0.270779861,0.78656035,0.85422327,N,-,,L-fuculose-phosphate aldolase,,IPR001303 (SMART); IPR001303 (PFAM); IPR001303 (G3DSA:3.40.225.GENE3D); PTHR10672 (PANTHER); PTHR10672:SF17 (PANTHER); IPR001303 (SUPERFAMILY),,
RL4_JR_10177,1577,1688,1518,0,0,19,0,0,0,0,0,0,0,1,0,0,3,0,86.14559958,1,1.930122356,0.765081962,2.522765472,0.011643603,0.042787617,34.72652772,0,2.900886292,0.904219997,3.208164276,0.001335852,0.015023052,17.23358726,0,-1.918261304,1.222634765,-1.568956943,0.116657972,0.217575022,29.20162035,1,-1.387670284,1.176891139,-1.179098251,0.238359055,0.376327059,35.73806381,1,0.218788021,0.899521618,0.243227085,0.807829486,0.870395546,N,-,,major facilitator superfamily transporter glucose,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR003663 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR005828 (PFAM); PTHR23503 (PANTHER); PTHR23503:SF8 (PANTHER); PTHR23503 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.1.96, the major facilitator superfamily (mfs).
RL4_JR_10178,4238,3800,4538,1,2,0,0,0,0,1,0,0,4,11,0,0,8,0,23.26876629,1,-1.439638455,1.191353895,-1.208405379,0.226891372,0.398317153,6.129467369,0,0.849662871,1.272343892,0.667793414,0.504265471,0.657754523,16.05005445,1,-1.815609139,1.227536418,-1.479067433,0.139122293,0.247927142,65.08978471,1,1.126009488,0.696997683,1.615513961,0.10619944,0.205266262,15.98633661,1,-1.912533666,1.243708524,-1.537766792,0.124105646,0.224628113,N,-,,peptidyl-prolyl cis-trans isomerase-like 4,F:nucleotide binding; F:nucleic acid binding; F:peptidyl-prolyl cis-trans isomerase activity; P:mycelium development; P:protein peptidyl-prolyl isomerization; P:protein folding,IPR002130 (PRINTS); IPR000504 (SMART); IPR000504 (PFAM); IPR002130 (PFAM); IPR029000 (G3DSA:2.40.100.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); PTHR11071:SF273 (PANTHER); IPR024936 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); IPR029000 (SUPERFAMILY); IPR012677 (SUPERFAMILY),3.D.1.8.1, the h(+) or na(+)-translocating nadh dehydrogenase (ndh) family.
RL4_JR_10179,3636,3333,3990,0,0,15,3,0,0,0,0,1,0,8,1,0,3,6,0.274717773,1,3.761528994,2.590433426,1.452084797,0.146478029,NA,0.087522205,1,6.979534172,2.150180495,3.246022456,0.001170296,0.015023052,0.227552151,1,4.323705574,1.338072145,3.231294806,0.001232308,0.00682115,0.262528728,1,3.901944981,1.654910347,2.357798407,0.018383673,0.074009818,0.225043295,1,4.23768928,1.256995533,3.37128428,0.000748186,0.003785799,N,-,,n-terminal fungal transcription factor-containing,"C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_10180,1889,2054,2795,0,2,0,0,0,0,2,8,1,0,2,0,0,2,0,55.6307176,1,-0.099904454,0.717143209,-0.139308931,0.889206033,0.945660475,19.61629289,0,1.02552566,1.130382473,0.907237757,0.364281081,0.528638438,44.28331318,1,-0.724474792,1.047211897,-0.691812988,0.489054779,0.623418608,46.87542488,1,-0.281811659,0.78342139,-0.359719128,0.719057186,0.812278702,26.50110465,1,-2.641748449,1.216652387,-2.17132558,0.02990657,0.075007189,N,-,,SAGA-associated factor 29,"F:methylated histone binding; C:Ada2/Gcn5/Ada3 transcription activator complex; P:histone H3-K9 acetylation; P:transcription from RNA polymerase II promoter; P:histone H3-K18 acetylation; P:positive regulation of transcription from RNA polymerase II promoter; C:SAGA complex; F:transcription factor activity, RNA polymerase II transcription factor recruiting; P:cellular protein complex localization; P:histone H3-K14 acetylation; C:integral component of membrane; C:cytosol; P:heterochromatin organization involved in chromatin silencing",G3DSA:2.30.30.140 (GENE3D); IPR010750 (PFAM); PTHR21539:SF0 (PANTHER); PTHR21539 (PANTHER); IPR010750 (PROSITE_PROFILES),,
RL4_JR_10181,3214,3746,5493,0,0,6,0,0,0,0,0,0,1,1,0,0,1,0,145.1952224,1,1.340740913,0.787730823,1.702029265,0.088749882,0.202807154,81.25652482,0,1.858313984,0.855867519,2.171263592,0.029911253,0.078844193,51.68704273,0,-1.213639954,1.048315299,-1.157705087,0.246984407,0.381285474,74.39950442,1,-0.409068117,0.701689918,-0.582975624,0.55990971,0.68857787,71.43018831,1,0.43291843,0.618408472,0.700052553,0.483894485,0.612275889,N,-, Effector probability:0.654,ADP-ribosylation factor 6,F:GTP binding; P:small GTPase mediated signal transduction; C:intracellular,IPR006689 (PRINTS); SM00175 (SMART); SM00178 (SMART); SM00177 (SMART); IPR005225 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR006689 (PFAM); PTHR11711 (PANTHER); PTHR11711:SF167 (PANTHER); IPR024156 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_10182,2491,2883,2413,2,1,1,0,0,0,2,5,3,2,9,1,0,4,1,310.3418454,1,1.073207213,0.359874425,2.982171387,0.002862117,0.013865292,32.22826988,0,-1.544772129,1.204601742,-1.282392408,0.199705026,0.343310848,175.8819218,1,0.087830339,0.497342704,0.176599232,0.859823197,0.9107397,215.1849597,1,0.395932631,0.41250663,0.959821253,0.337145184,0.484121289,133.0282621,1,-0.219674961,0.588841788,-0.373062792,0.709101711,0.79456118,N,-,,actin 2,F:ATPase activity; P:mitochondrion inheritance; F:ATP binding; P:establishment of mitochondrion localization; C:mitochondrion; P:Arp2/3 complex-mediated actin nucleation; P:regulation of endocytosis; P:ascospore wall assembly; C:actin cortical patch; P:CVT pathway; C:Arp2/3 protein complex,IPR004000 (PRINTS); IPR000719 (SMART); IPR004000 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.90.640.10 (GENE3D); IPR000719 (PFAM); G3DSA:3.30.420.40 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR004000 (PFAM); G3DSA:3.30.200.20 (GENE3D); IPR027306 (PTHR11937:PANTHER); IPR004000 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY); SSF53067 (SUPERFAMILY); SSF53067 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_10183,345,416,439,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,11.18909635,0,-1.586461826,1.247426641,-1.271787673,0.20344857,0.368011848,3.533947129,0,1.644118269,1.311813517,1.253317067,0.21009034,0.355905342,9.247100118,1,-1.020175918,1.235620263,-0.825638708,0.40900907,0.55115238,29.29691437,0,0.332661416,1.063990511,0.312654495,0.754543171,0.83897975,13.07068476,0,-0.191159472,1.181522545,-0.161790795,0.871470602,0.914876165,N,-,,hydantoin racemase,,PTHR28047 (PANTHER); PTHR28047:SF1 (PANTHER),,
RL4_JR_10184,62,52,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.19595987,0,-0.479931891,1.22418375,-0.392042363,0.695026913,0.835301938,1.651212345,0,2.741892899,1.342983159,2.041643546,0.041186903,0.101478281,4.30012548,0,0.084317202,1.216312882,0.069321967,0.94473334,0.967183774,4.961609901,0,-0.338259112,1.218118244,-0.277689882,0.781250428,0.859146365,8.120309112,0,0.923652106,1.14953255,0.803502351,0.421684439,0.557573336,N,-,,FAM86A protein,,IPR029063 (G3DSA:3.40.50.GENE3D); IPR019410 (PFAM); PTHR14614:SF29 (PANTHER); PTHR14614 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_10185,316,340,233,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,699.1866306,0,-0.451002055,0.983689908,-0.458479905,0.646607696,0.79868454,129.8500662,0,-3.555195915,1.198690777,-2.965899116,0.003017995,0.015636999,401.1736019,0,-2.411527722,1.51774974,-1.588883634,0.112086667,0.210923711,570.3300665,0,-1.114290054,0.574899535,-1.938234398,0.052594632,0.126308286,483.4344513,0,-0.924161359,0.57931335,-1.595270262,0.110651813,0.20587093,N,-,,40S ribosomal S24,"F:nucleotide binding; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:structural constituent of ribosome; C:cytosolic small ribosomal subunit; P:translation",IPR001976 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR001976 (PANTHER); IPR001976 (PRODOM); IPR012678 (SUPERFAMILY),,
RL4_JR_10186,787,456,651,0,0,0,0,0,3,0,1,1,0,2,0,0,0,3,15.27914265,0,-2.035774043,1.207691527,-1.685673864,0.091858634,0.207988547,4.844175467,1,1.189230562,1.252972317,0.949127563,0.342555737,0.505739377,12.61426596,1,-1.468024005,1.204279428,-1.219006129,0.222841866,0.352893955,14.55588911,1,-1.890732251,1.203890842,-1.570518012,0.116294647,0.218985179,12.47644221,1,-1.554859305,1.212117521,-1.282762833,0.199575179,0.321357934,Y,-,,hypothetical protein SPSK_09906,,no IPS match,,
RL4_JR_10187,1411,654,1201,1,2,2,0,0,0,0,1,0,0,1,4,0,0,0,20.05339993,1,-2.428130549,1.191473408,-2.03792257,0.041557677,0.11606557,95.62728345,0,3.427061821,0.738537735,4.64033408,3.48E-06,0.000266735,16.58614481,1,-1.86299269,1.192637267,-1.562078212,0.118269565,0.219618686,23.14810229,1,-1.338354686,1.143621672,-1.170277478,0.241889322,0.380299594,16.38801265,0,-1.94832703,1.199183975,-1.624710695,0.104224217,0.197032044,N,-,,gtp cyclohydrolase-2,F:identical protein binding; C:cytosol; F:cyclohydrolase activity; F:hydrolase activity,no IPS match,,
RL4_JR_10188,11228,13468,14303,4,1,0,0,0,0,0,0,0,1,0,0,0,0,0,10.4871346,1,-1.492965464,1.209176966,-1.234695588,0.216943819,0.384996487,3.325966584,0,1.731660098,1.274095378,1.359129095,0.174105685,0.310045345,8.668651107,0,-0.926979697,1.206658529,-0.768220399,0.442356256,0.582000324,10.00293154,1,-1.349684287,1.206318851,-1.118845391,0.263206103,0.403843279,8.590436957,0,-1.016482073,1.216109528,-0.83584747,0.403240717,0.540210242,N,-,,transcription factor atf21,,no IPS match,,
RL4_JR_10189,5004,6672,10055,1,1,10,0,0,0,2,1,0,0,1,0,0,1,0,86.85980985,1,-0.566232182,0.697189524,-0.812163928,0.416697575,0.608125012,14.88621199,0,-0.430440624,1.213988689,-0.354567244,0.722913819,0.826338946,72.62244778,1,0.042958642,0.691685001,0.062107234,0.950477437,0.971590627,90.3477823,1,-0.173094471,0.638596232,-0.271054638,0.786349009,0.861704567,38.43090113,1,-3.177976287,1.209996665,-2.626433922,0.008628474,0.027902684,N,-,,GTP cyclohydrolase-2,F:identical protein binding; F:GTP cyclohydrolase II activity; P:riboflavin biosynthetic process; C:cytosol,IPR000926 (TIGRFAM); IPR032677 (PFAM); PTHR21327 (PANTHER); PTHR21327:SF13 (PANTHER); IPR032677 (SUPERFAMILY),,
RL4_JR_10190,59,79,97,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.446087584,0,3.062331684,2.083602938,1.46972901,0.141635162,NA,0.14203592,0,6.281222519,1.950993003,3.219500279,0.001284142,0.015023052,0.36864823,0,3.629049428,1.290787315,2.811500692,0.004931098,0.018765519,0.42531359,0,3.206367537,1.456914441,2.200793298,0.02775066,0.0884962,0.363247591,0,3.548092359,1.237773025,2.866512912,0.004150212,0.015352904,N,-,,---NA---,,no IPS match,,
RL4_JR_10191,5226,4312,4714,6,12,65,0,0,2,1,4,4,13,48,8,0,15,2,0.037434156,1,6.638791936,3.935205378,1.687025529,0.091598443,NA,0.011883131,1,9.862248328,3.465670281,2.845697233,0.004431431,0.019050679,0.030668748,1,7.221280355,2.145018137,3.366535803,0.000761187,0.004631164,0.035384616,1,6.794795544,3.790399449,1.792633108,0.073031609,0.155726644,0.029833907,1,7.160544554,1.593450809,4.493734298,7.00E-06,7.48E-05,N,-,,mfs transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11662 (PANTHER); PTHR11662:SF191 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.14.11, the major facilitator superfamily (mfs).
RL4_JR_10192,780,557,1193,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.779249454,0,2.257283817,1.756882085,1.284823743,0.198853883,NA,0.251817065,0,5.455072034,1.834770278,2.973163506,0.002947474,0.0154422,0.649585681,0,2.810970915,1.331274565,2.111488485,0.034730347,0.085863255,0.748998375,0,2.389512648,1.436973636,1.662878558,0.096336747,0.190546897,0.638146759,0,2.733485114,1.294499807,2.111614926,0.034719491,0.084321144,N,-,,glycoside hydrolase family 18,F:chitinase activity; P:carbohydrate metabolic process; F:chitin binding; P:chitin catabolic process,IPR018392 (SMART); IPR018392 (PFAM); IPR001223 (PFAM); IPR001002 (PFAM); IPR018392 (G3DSA:3.10.350.GENE3D); IPR001002 (G3DSA:3.30.60.GENE3D); IPR018392 (G3DSA:3.10.350.GENE3D); IPR013781 (G3DSA:3.20.20.GENE3D); PTHR11177:SF185 (PANTHER); PTHR11177 (PANTHER); IPR001002 (PRODOM); IPR017853 (SUPERFAMILY); IPR018392 (SUPERFAMILY); IPR018392 (SUPERFAMILY); IPR001002 (SUPERFAMILY),9.B.29.2.7, the small 4-5 tms putative permease (4-5pp) family.
RL4_JR_10193,2533,2639,2754,0,4,6,0,0,2,0,2,3,0,3,2,0,9,4,0.1835698,1,4.343170078,3.077331208,1.411343071,0.15814348,NA,0.058969478,1,7.549500246,2.327695445,3.243336779,0.001181385,0.015023052,0.152406814,1,4.902881812,1.383528002,3.543753219,0.000394474,0.002852613,0.175771187,1,4.480984058,1.87875742,2.385078569,0.017075474,0.070957003,0.14974294,1,4.824353995,1.262473694,3.821350113,0.000132723,0.000879464,N,-,,kinase-like domain,F:ATP binding; F:protein kinase activity; P:protein phosphorylation,IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.3, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_10194,213,223,216,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.866284542,0,7.223812332,1.292878653,5.58738619,2.31E-08,5.15E-07,0.015198721,0,9.504869849,3.025740879,3.141336363,0.001681788,0.015023052,0.039537658,0,6.847835041,1.702770325,4.021584673,5.78E-05,0.000809576,0.045615985,0,6.426711941,3.129471991,2.05360903,0.040013547,0.10752048,0.039131542,0,6.761097214,1.352003231,5.000799598,5.71E-07,8.88E-06,Y,-,,hypothetical protein SPI_08829,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_10195,804,1167,1756,0,0,1,0,0,1,0,0,0,0,2,0,0,0,0,98.63771701,1,-2.732078718,1.002172777,-2.72615539,0.006407682,0.026629584,26.39659741,1,-1.256749875,1.194142561,-1.052428677,0.292602917,0.451620422,99.79110296,0,-1.083256687,0.734527185,-1.474767317,0.140275111,0.249367027,78.92542041,1,-4.329599016,1.184327286,-3.65574539,0.000256436,0.00237332,67.38132052,0,-3.988058882,1.186082198,-3.362379848,0.000772737,0.003881459,N,-, Effector probability:0.625,and NB-ARC domain partial,,no IPS match,,
RL4_JR_10196,1460,1432,1957,0,2,6,0,0,0,0,0,2,7,1,1,0,0,0,219.8171717,1,-0.773468098,0.431256466,-1.793522321,0.072889445,0.175978719,46.37362827,0,-2.069711184,1.190652523,-1.73829992,0.082157981,0.173601454,136.0319066,1,-2.897869134,1.028571956,-2.817371324,0.004841851,0.018518663,220.7200976,1,-0.824088236,0.447614018,-1.841068873,0.065611466,0.144768461,149.1633648,0,-1.394209642,0.5871367,-2.374591203,0.017568395,0.049219702,N,-,,Tetratricopeptide-like helical,F:identical protein binding,IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (SUPERFAMILY),,
RL4_JR_10197,23081,27458,29369,3,0,0,0,0,0,1,4,7,4,8,2,0,10,1,0.162747982,1,4.516763689,3.262832154,1.384307704,0.166264256,NA,0.052442003,0,7.718674266,2.405998358,3.208096232,0.001336168,0.015023052,0.135425867,1,5.072670082,1.432320332,3.541575141,0.000397746,0.002872165,0.156168875,1,4.651394033,1.99579182,2.33060081,0.019774419,0.076494698,0.133093252,1,4.993285259,1.288034552,3.876670274,0.000105896,0.000724945,Y,-, Effector probability:0.677,hypothetical protein CMQ_7356,P:protein-FAD linkage; C:mitochondrial matrix; C:mitochondrion,no IPS match,,
RL4_JR_10198,11375,9377,10726,5,7,7,0,0,0,0,0,3,0,2,1,0,1,0,14.16888759,1,-1.92692478,1.20134526,-1.603972517,0.108720111,0.235324665,4.499134311,0,1.295843125,1.25095048,1.035886828,0.300254943,0.460406143,11.70449296,1,-1.360026811,1.199699738,-1.133639333,0.256945867,0.393245648,13.50521639,1,-1.782643077,1.198648159,-1.487211292,0.136959015,0.248469812,11.56590064,1,-1.445524956,1.206172533,-1.198439623,0.230745915,0.358328587,N,-,,hypothetical protein CMQ_7375,,no IPS match,,
RL4_JR_10199,27848,16161,15497,3,5,2,0,0,0,0,1,5,1,2,2,0,3,0,0.024701871,1,7.238701169,3.949789044,1.832680452,0.066850106,NA,0.007694775,0,10.48756637,3.950855392,2.654505246,0.00794248,0.02841517,0.020152476,1,7.824018738,2.683596837,2.915497078,0.003551224,0.015351236,0.023270171,1,7.399037905,3.950359032,1.873003908,0.061067845,0.137947378,0.019940236,1,7.746134954,1.600920209,4.838551548,1.31E-06,1.80E-05,N,-,,FMN-dependent dehydrogenase,F:FMN binding; F:oxidoreductase activity; P:oxidation-reduction process,IPR012133 (PIRSF); IPR013785 (G3DSA:3.20.20.GENE3D); IPR000262 (PFAM); PTHR10578 (PANTHER); IPR012133 (PROSITE_PROFILES); SSF51395 (SUPERFAMILY),,
RL4_JR_10200,4840,4699,3909,2,0,7,0,0,2,5,1,0,2,4,1,0,0,2,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-, Effector probability:0.579,kinase-like domain,F:ATP binding; F:protein kinase activity; P:protein phosphorylation,no IPS match,,
RL4_JR_10201,2497,2594,3580,0,0,1,0,0,0,2,0,2,0,6,0,0,5,4,13.35905769,1,1.093447721,1.050537748,1.040845722,0.297947156,0.483759717,1.811925328,0,2.607950769,1.339470619,1.947001101,0.051534603,0.120692561,4.720656944,1,-0.050019103,1.220057792,-0.040997323,0.96729803,0.980861905,5.447532427,1,-0.472789354,1.222281721,-0.386808823,0.698897745,0.797154406,4.670244878,1,-0.137138366,1.225869202,-0.111870308,0.910926239,0.942963723,N,-,,hypothetical protein SPBR_08008,,no IPS match,,
RL4_JR_10202,189,233,262,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,168.7698862,0,-1.39747181,0.742875042,-1.881166724,0.059949243,0.152356985,40.92314762,0,-1.889356867,1.236496776,-1.527991745,0.126514587,0.242651626,142.556747,0,-1.435308003,0.751420851,-1.910125331,0.056117078,0.123345484,210.8052748,0,-0.664077763,0.641863368,-1.034609228,0.300851443,0.446448902,133.1438431,1,-1.991081118,0.854327438,-2.330583135,0.019775352,0.05414425,N,-,,kinase-like domain,F:ATP binding; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR23257 (PANTHER); PTHR23257:SF503 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_10203,6976,6720,11857,0,4,0,0,0,0,2,0,0,0,0,0,0,1,0,0.008470882,1,8.791019641,4.031633903,2.180510397,0.029219649,NA,0.002680088,0,12.01721297,4.032710343,2.979934573,0.0028831,0.015349618,0.006904709,1,9.374372631,4.033343739,2.324218623,0.02011378,0.055743746,0.007967227,0,8.951770626,4.033311655,2.219459191,0.026455501,0.08636862,0.006679571,1,9.335361424,1.822923296,5.121093929,3.04E-07,5.22E-06,N,-, Effector probability:0.65,polysaccharide export,"F:transferase activity, transferring glycosyl groups; C:membrane; C:integral component of membrane; F:transferase activity",IPR021047 (PFAM),,
RL4_JR_10204,601,409,838,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,78.34466898,0,-2.59170207,1.205436716,-2.150010892,0.031554353,0.094258665,22.44223487,0,-1.022614053,1.317826034,-0.775985621,0.437757476,0.59910508,58.13275291,0,-3.672273214,1.29118656,-2.844107373,0.004453604,0.017386326,67.07453847,0,-4.094857065,1.308676813,-3.129005591,0.00175399,0.011879027,56.95240602,0,-3.745457922,1.300488227,-2.880039852,0.003976249,0.014834017,N,-,,major facilitator superfamily transporter,C:membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501 (PANTHER); PTHR23501 (PANTHER); PTHR23501:SF43 (PANTHER); PTHR23501:SF43 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_10205,61,41,60,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1305.426495,0,-8.452626265,1.354781236,-6.239107864,4.40E-10,1.32E-08,413.4620307,0,-5.226089133,1.30362226,-4.008898353,6.10E-05,0.003249837,1073.10895,0,-7.87858435,1.31241992,-6.003097202,1.94E-09,9.61E-08,1238.28771,0,-8.301301743,1.324334801,-6.2682803,3.65E-10,1.27E-08,1090.824244,0,-4.809635139,1.123628864,-4.280448193,1.87E-05,0.000169523,N,PKS,,lovastatin nonaketide synthase,F:catalytic activity,IPR020801 (SMART); IPR020807 (SMART); IPR020806 (SMART); IPR020841 (SMART); SM00822 (SMART); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR013217 (PFAM); G3DSA:3.40.50.980 (GENE3D); IPR013968 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR013120 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR014031 (PFAM); IPR016039 (G3DSA:3.40.47.GENE3D); IPR014030 (PFAM); IPR009081 (PFAM); G3DSA:2.30.38.10 (GENE3D); IPR001242 (PFAM); IPR014043 (PFAM); IPR001227 (G3DSA:3.40.366.GENE3D); IPR020807 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR029063 (G3DSA:3.40.50.GENE3D); IPR000873 (PFAM); IPR032821 (PFAM); G3DSA:3.40.50.980 (GENE3D); G3DSA:3.30.300.30 (GENE3D); PTHR11712 (PANTHER); PTHR11712:SF258 (PANTHER); PTHR11712 (PANTHER); PTHR11712:SF258 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR009081 (PROSITE_PROFILES); IPR016035 (SUPERFAMILY); IPR016040 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF56801 (SUPERFAMILY); IPR016036 (SUPERFAMILY); SSF52777 (SUPERFAMILY); IPR016040 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR029063 (SUPERFAMILY); IPR016039 (SUPERFAMILY),4.C.1.1.4, the fatty acid transporter (fat) family.
RL4_JR_10206,242,176,212,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,144.4358583,1,-0.193731796,0.534238923,-0.362631377,0.716880268,0.848021123,23.38038533,0,-1.081708161,1.218576142,-0.887682045,0.374711807,0.539290901,73.47094364,0,-1.913402412,1.049692616,-1.822821635,0.06833041,0.143970254,85.79170181,0,-1.458878276,0.782187281,-1.865126565,0.062163666,0.139620035,59.49760942,0,-3.808562602,1.205335597,-3.159752861,0.00157903,0.006975428,N,-,,hypothetical protein CMQ_3433,,no IPS match,,
RL4_JR_10207,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51.04907674,0,-1.81776384,1.019513865,-1.782971182,0.074590995,0.179022611,13.92757901,0,-0.334348864,1.219859898,-0.274087922,0.784017055,0.869393146,59.5653148,0,-0.573077925,0.861578822,-0.665148575,0.505955469,0.637894541,41.56327019,0,-3.404444403,1.197415937,-2.843159422,0.004466872,0.025653477,50.18749973,0,-1.372409479,0.977338482,-1.404231497,0.160249926,0.271917295,N,-,,nrm1,P:phosphorylation; F:kinase activity,IPR013734 (PFAM); PTHR40468 (PANTHER),,
RL4_JR_10208,9,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27.56290989,0,-2.887085882,1.188782715,-2.428606882,0.015156957,0.052904287,8.833559415,0,0.3225326,1.226308914,0.263010891,0.792542185,0.874344631,35.86367854,0,-0.506883947,1.035344792,-0.489579849,0.624431239,0.73700231,63.76763791,0,0.952184772,0.554871393,1.716045888,0.086153644,0.175157646,22.50342684,0,-2.405899264,1.194850739,-2.013556326,0.044056136,0.101586967,N,-, Effector probability:0.555,nrm1,,PTHR40468 (PANTHER),,
RL4_JR_10209,489,364,714,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,264.348618,1,0.034069249,0.374093518,0.091071476,0.927435797,0.96537932,40.79522658,0,-1.884823793,1.197619499,-1.573808539,0.115531719,0.226894075,184.8542162,0,-0.391690927,0.503526168,-0.77789587,0.436630403,0.576918968,198.0847904,0,-0.64869141,0.463317629,-1.400100859,0.161483118,0.281027255,104.5124366,0,-4.62131894,1.199279898,-3.853411491,0.000116483,0.000786787,N,-,,metalloprotease m41,C:membrane; P:proteolysis; C:integral component of membrane; F:peptidase activity; F:metallopeptidase activity,no IPS match,,
RL4_JR_10210,3,21,39,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.049769496,0,0.86195283,1.455651398,0.592142344,0.553755274,NA,0.651250153,0,4.084043023,1.610874806,2.535295113,0.011235263,0.036684946,1.70011297,0,1.422892527,1.317412944,1.080065695,0.280112927,0.419444353,1.961702764,0,1.000364921,1.35992906,0.735600813,0.461973668,0.604169618,1.691749908,0,1.327587383,1.318967625,1.006535231,0.314158173,0.449673998,N,-, Effector probability:0.811,telomere-associated recq partial,F:nucleic acid binding; F:DNA binding; F:ATP binding; P:DNA integration; P:DNA recombination; F:helicase activity; F:hydrolase activity,no IPS match,,
RL4_JR_10211,61,34,50,0,3,0,0,0,0,0,0,1,0,0,1,0,0,0,19.71183956,1,-0.417872648,1.184217043,-0.352868294,0.724187181,0.854201491,3.128489153,0,1.82012159,1.341396965,1.356885126,0.174817714,0.310875773,8.03588017,1,-0.817429591,1.235338607,-0.661704886,0.508160373,0.639945106,9.264105099,1,-1.238806003,1.237991271,-1.000658108,0.316992127,0.463204688,7.84580876,0,-0.885819002,1.232538885,-0.718694569,0.472329131,0.603359021,N,-,,c2h2 finger domain containing,F:nucleic acid binding; F:metal ion binding,no IPS match,,
RL4_JR_10212,1676,2112,2138,0,2,0,0,0,0,3,8,2,4,8,8,0,12,5,7.996969224,1,5.059352344,1.115153346,4.536911771,5.71E-06,7.10E-05,0.116053552,0,6.572608613,2.099906203,3.129953426,0.00174834,0.015023052,0.299789093,1,3.926186584,1.37919458,2.846724198,0.004417161,0.017319652,42.89842496,1,6.640972804,0.780938533,8.503835481,1.83E-17,1.41E-15,0.294948843,1,3.84630001,1.302327433,2.953404737,0.003142896,0.012291163,N,-,,high affinity methionine permease,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PFAM); IPR002293 (PIRSF); IPR002293 (PANTHER); PTHR11785:SF203 (PANTHER),2.A.3.8.4, the amino acid-polyamine-organocation (apc) family.
RL4_JR_10213,335,370,329,0,1,5,0,0,0,0,0,0,0,0,0,0,0,0,18.95066007,1,-2.346538674,1.357727791,-1.7282836,0.083937392,0.194700382,6.251150395,0,0.821430865,1.431263082,0.57392025,0.566021769,0.708104357,15.90484123,0,-1.802400174,1.324792766,-1.360514806,0.173667071,0.292644045,18.32300694,0,-2.222763082,1.340755731,-1.657843431,0.097349073,0.192101252,15.39654108,0,-1.858365557,1.335206854,-1.391818468,0.163977376,0.276665711,N,-,,aat family amino acid transporter,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR004841 (PFAM); PTHR11785:SF204 (PANTHER); IPR002293 (PANTHER),2.A.3.1.2, the amino acid-polyamine-organocation (apc) family.
RL4_JR_10214,908,725,728,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,30.29287394,0,-0.044699526,0.869223577,-0.051424659,0.958987136,0.978906038,5.980149273,0,0.885287923,1.234885693,0.71689868,0.473436617,0.63104101,48.06124993,0,1.359714358,0.682870182,1.991175475,0.046461599,0.106919417,25.98607835,0,-0.471390416,1.023707166,-0.460473885,0.645176112,0.756854146,26.98223872,1,0.335192041,0.865593208,0.387239685,0.698578773,0.786687808,N,-,,Six-bladed beta-,,no IPS match,,
RL4_JR_10215,742,668,680,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,95.75353625,0,2.709373591,0.987976591,2.742345937,0.006100206,0.025520759,3.646060837,0,1.599188767,1.256210378,1.273026234,0.203008733,0.347338471,9.451989363,0,-1.051661725,1.190422546,-0.883435658,0.377000932,0.520703607,10.90342979,0,-1.473933615,1.187438915,-1.241271105,0.214505615,0.348950732,13.17177912,0,-0.202345579,1.12027737,-0.180620964,0.8566651,0.904644778,N,-,,hypothetical protein SPI_05323,,no IPS match,,
RL4_JR_10216,974,688,966,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2456.661945,0,-2.234403381,0.448633738,-4.980462218,6.34E-07,1.02E-05,782.5991656,0,-2.649831601,0.706403629,-3.751157968,0.00017602,0.007814351,1821.127375,0,-3.617222472,0.572286584,-6.320648734,2.60E-10,1.43E-08,2227.722501,0,-2.869423173,0.554267812,-5.176961589,2.26E-07,4.69E-06,1850.091015,0,-3.006977758,0.727155289,-4.135262171,3.55E-05,0.000289035,N,-,,glycosyltransferase family 20,P:trehalose biosynthetic process; F:transferase activity,IPR023214 (G3DSA:3.40.50.GENE3D); G3DSA:3.20.10.10 (GENE3D); IPR003337 (PFAM); PTHR10788 (PANTHER); PTHR10788:SF15 (PANTHER); IPR001544 (SUPERFAMILY); IPR023214 (SUPERFAMILY),,
RL4_JR_10217,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.258481962,0,3.84962998,2.810772714,1.36959846,0.170812281,NA,0.080889799,0,7.093152095,2.295732157,3.089712392,0.002003504,0.015023052,0.212114638,0,4.426094792,1.481237718,2.988105648,0.002807125,0.012935518,0.244892916,0,4.002624308,1.875859307,2.133755071,0.032862835,0.097092562,0.210968215,0,4.332817012,1.37552649,3.14993353,0.001633076,0.007161064,N,-,,mitochondrial chaperone BCS1,F:nucleotide binding; C:membrane,IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23070 (PANTHER); PTHR23070:SF33 (PANTHER); IPR027417 (SUPERFAMILY),3.A.28.1.2," the aaa-atpase, bcs1 (bcs1) family."
RL4_JR_10218,8,6,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.114913488,0,5.01879517,3.78383034,1.326379547,0.18471401,NA,0.036570386,0,8.238186038,2.574664719,3.199712171,0.001375649,0.015023052,0.095251377,0,5.579043657,1.496257321,3.728665905,0.000192496,0.00171552,0.109898471,0,5.158049345,2.263451867,2.278842073,0.022676455,0.081131698,0.094464451,0,5.489309658,1.309504443,4.19189846,2.77E-05,0.000236436,N,-,,neutral amino acid permease,F:nucleotide binding; P:biological_process; F:ATP binding; F:metal ion binding; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function; F:hydrolase activity,no IPS match,,
RL4_JR_10219,26,18,27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,het-s domain containing,F:ATP binding; C:membrane; C:integral component of membrane; F:protein kinase activity; P:phosphorylation; F:transferase activity; P:protein phosphorylation; C:cellular_component; F:kinase activity,G3DSA:1.10.510.10 (GENE3D); PTHR37542 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.C.104.2.2, the heterokaryon incompatibility prion/amyloid protein (het-s) family
RL4_JR_10220,606,442,871,0,0,0,0,0,0,0,0,0,0,0,0,0,3,1,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),,
RL4_JR_10221,159,78,130,0,0,8,0,0,0,0,0,0,0,3,1,0,0,0,27.16513968,1,-2.865980036,1.2697795,-2.25706907,0.024003759,0.07613634,8.558089524,0,0.36821485,1.293874356,0.284583158,0.775963516,0.864249858,48.33709012,0,0.490118494,0.846419544,0.579049122,0.562556029,0.687757183,78.76291384,1,1.14006026,0.663922945,1.717157493,0.0859504,0.174887515,64.58791887,0,1.209439611,1.31425545,0.920246981,0.357443708,0.494888219,Y,-,,acid ase,F:aspartic-type endopeptidase activity; P:proteolysis,IPR000250 (PRINTS); IPR000250 (PFAM); PTHR37536:SF1 (PANTHER); PTHR37536 (PANTHER); IPR013320 (SUPERFAMILY),,
RL4_JR_10222,221,94,204,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0.099948281,0,5.220227314,3.91742833,1.332564855,0.182674645,NA,0.031237336,0,8.465193831,2.691868145,3.144728262,0.001662412,0.015023052,0.082171663,1,5.792580306,1.586999037,3.650021312,0.000262219,0.002098319,0.094876919,0,5.37020481,2.44983316,2.192069606,0.028374481,0.089498947,0.082154848,0,5.694666434,1.36270282,4.178949622,2.93E-05,0.000248133,N,-,,transporter SEO1,C:membrane,PTHR11662:SF6 (PANTHER); PTHR11662 (PANTHER); IPR020846 (SUPERFAMILY),2.A.1.14.37, the major facilitator superfamily (mfs).
RL4_JR_10223,5319,4593,4767,1,0,4,0,0,0,1,1,0,0,1,1,0,1,1,0.264491091,1,3.816363039,2.771023667,1.377239424,0.168438237,NA,0.082528897,0,7.063955282,2.272603607,3.108309456,0.001881609,0.015023052,0.217212777,1,4.391021104,1.466934477,2.993331449,0.002759499,0.012770603,0.250813461,1,3.967855058,1.848160181,2.146921625,0.031799522,0.095311207,0.217177435,1,4.29066289,1.369906651,3.132084137,0.001735701,0.007523106,N,-,,xenobiotic compound family,F:oxidoreductase activity,IPR016215 (TIGRFAM); IPR011251 (PFAM); IPR016215 (PIRSF); IPR011251 (G3DSA:3.20.20.GENE3D); PTHR30011:SF30 (PANTHER); PTHR30011 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_10224,157,126,128,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.048531815,0,4.961974494,1.25952656,3.939555269,8.16E-05,0.000713784,0.072532397,0,7.250633628,2.270660218,3.19318301,0.001407137,0.015023052,0.189268257,0,4.590813524,1.410684534,3.254316193,0.001136657,0.006393064,0.218445701,0,4.167589066,1.821848959,2.287560143,0.022163149,0.080442001,14.91833116,0,6.216668816,1.03410515,6.011640899,1.84E-09,1.03E-07,N,-,,flavin-binding monooxygenase,P:oxidation-reduction process; F:monooxygenase activity,IPR023753 (G3DSA:3.50.50.GENE3D); PF13450 (PFAM); PTHR23023:SF76 (PANTHER); PTHR23023 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_10225,557,479,678,0,1,0,0,0,0,3,0,0,0,0,0,0,3,0,25.42361009,1,-2.770325687,1.201670881,-2.305394705,0.021144478,0.06883346,8.123256391,0,0.443504278,1.237604638,0.358356994,0.720076171,0.824790853,27.52577329,1,-1.243308959,1.199508377,-1.036515445,0.299961738,0.44082053,24.25549354,0,-2.62734108,1.200088783,-2.189288923,0.028575847,0.089798402,20.65480164,1,-2.282153535,1.200238143,-1.901417272,0.057247379,0.124078014,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501:SF8 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.52, the major facilitator superfamily (mfs).
RL4_JR_10226,1930,2484,2629,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.09470185,0,5.298552244,3.918022409,1.352353737,0.176262182,NA,0.030280175,0,8.512049228,2.821694322,3.016644703,0.002555892,0.015349618,0.077953591,0,5.873585326,1.727947468,3.399168918,0.00067591,0.004214081,0.089915093,0,5.449075457,2.624775664,2.076015688,0.0378925,0.103636295,0.075792732,0,5.811072079,1.455039844,3.993754605,6.50E-05,0.000484534,N,-, Effector probability:0.732,luciferase-like monooxygenase,"F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity",IPR011251 (PFAM); IPR011251 (G3DSA:3.20.20.GENE3D); PTHR30011:SF21 (PANTHER); PTHR30011 (PANTHER); IPR011251 (SUPERFAMILY),,
RL4_JR_10227,706,845,696,0,0,7,0,0,0,0,2,3,0,3,0,0,0,0,7.149500635,1,-0.940040327,1.195059861,-0.786605221,0.431513002,0.622464487,2.278463685,0,2.277459153,1.292932344,1.761468157,0.078159198,0.167398942,5.913908392,1,-0.37511049,1.196404987,-0.313531366,0.753876994,0.834947018,6.822731396,1,-0.79750828,1.19410473,-0.667871301,0.504215748,0.641193727,9.691413842,0,0.472621588,1.125732182,0.419834838,0.674606113,0.76852099,N,-,,hypothetical protein HMPREF1624_00758,,no IPS match,,
RL4_JR_10228,1022,822,1015,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.015572136,0,7.899458556,3.974566037,1.987502153,0.046866778,NA,0.005005645,0,11.10559461,3.974227246,2.79440352,0.005199555,0.021136506,0.013004533,0,8.449602389,2.844306081,2.970707845,0.002971143,0.013488722,0.014998643,0,8.029635455,3.97405316,2.020515361,0.043329958,0.113246213,0.012910819,0,8.3508871,1.560789616,5.350424565,8.77E-08,2.01E-06,N,-,,chitinase class V,F:hydrolase activity,no IPS match,,
RL4_JR_10229,2071,2087,4409,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,23.52113906,0,-0.89915836,1.174396105,-0.765634658,0.443893717,0.632870489,4.253673752,0,1.376707569,1.275492207,1.079353963,0.280429965,0.439310715,34.64291605,1,1.124277326,0.883436299,1.272618442,0.203153471,0.329023475,24.86123496,1,0.570139327,0.901207424,0.632639403,0.526969149,0.660668974,14.90511552,0,-0.451721383,1.161327793,-0.388969751,0.697298523,0.785728517,N,-,,capsule polysaccharide biosynthesis,"P:biological_process; F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; P:oxidation-reduction process; F:monooxygenase activity; C:cellular_component; F:molecular_function; F:heme binding",IPR007577 (PFAM); IPR029044 (SUPERFAMILY),,
RL4_JR_10230,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41.83735393,0,-3.488992242,1.195665488,-2.918033745,0.003522462,0.016364605,13.33485903,0,-0.27159264,1.212894474,-0.223921079,0.822818713,0.893431776,34.5871838,0,-2.923143695,1.19384896,-2.448503782,0.014345092,0.04287857,39.90191291,0,-3.345530717,1.19363447,-2.802810075,0.005065949,0.028291636,49.50009287,0,-0.398405435,0.758616913,-0.525173415,0.599462644,0.709475076,N,-,,integral membrane,C:membrane; C:integral component of membrane,PTHR42109 (PANTHER); PTHR42109:SF1 (PANTHER),,
RL4_JR_10231,182,202,234,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,27.72189133,0,-1.735658828,1.168987985,-1.484753351,0.137609173,0.278290451,7.565591394,0,0.545986604,1.242261223,0.4395103,0.66029182,0.781875737,19.7508061,0,-2.11493805,1.210458067,-1.747221244,0.080598968,0.16378116,22.79283924,1,-2.537768168,1.211527161,-2.094685328,0.036198974,0.101052846,19.61013395,0,-2.207299213,1.222725395,-1.805228893,0.071038871,0.146520386,N,-,,glycosyltransferase family 2,C:integral component of membrane; F:transferase activity,PTHR10587:SF1 (PANTHER); PTHR10587 (PANTHER),,
RL4_JR_10232,122054,102487,89917,252,478,128,3,1,61,37,70,108,55,75,98,1,86,39,117.7301524,1,0.204496131,0.570233709,0.358618103,0.719880802,0.850635514,18.03053702,1,-0.706876078,1.219750685,-0.579525051,0.562234949,0.70542458,47.00372617,1,-3.36572225,1.208615693,-2.784774573,0.005356495,0.019915224,54.24312227,1,-3.788553005,1.211337685,-3.127577927,0.001762531,0.011928894,54.25396383,1,-1.796613451,1.008625107,-1.78124998,0.074871622,0.152530216,N,-,,serine threonine kinase,F:kinase activity,G3DSA:3.30.200.20 (GENE3D); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24362 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.2, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_10233,40647,20078,26072,4,30,15,0,2,2,0,1,10,1,13,0,0,7,7,111.0466754,1,-2.06230037,0.900671549,-2.289736332,0.022036606,0.071254313,30.37457168,1,-1.459267457,1.248057734,-1.169230731,0.242310683,0.394573477,78.88620387,1,-4.112700391,1.236875581,-3.325072022,0.000883957,0.005209069,167.2826051,1,-0.234546163,0.601812735,-0.389732802,0.696734138,0.795699764,85.36348209,1,-2.547522165,1.045861841,-2.435811371,0.014858431,0.043255207,N,-, Effector probability:0.886,---NA---,,no IPS match,,
RL4_JR_10234,4914,4999,8381,1,0,2,0,0,0,0,0,0,1,4,1,0,1,0,24.32909773,1,-2.706901852,1.330890186,-2.033903233,0.041961353,0.116833009,7.65292629,0,0.529504941,1.360309203,0.389253369,0.697088727,0.807684535,19.9694314,0,-2.130710825,1.292766062,-1.648179734,0.099315794,0.192915023,46.33219736,1,-0.185155603,0.99954358,-0.18524015,0.853040679,0.90801481,50.62045085,1,0.974662557,1.316299197,0.740456698,0.459022927,0.590622914,N,-,,hypothetical protein AOR_1_446024,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_10235,3097,1913,1719,1,2,2,0,0,0,0,6,1,2,3,5,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-, Effector probability:0.659,hypothetical protein CMQ_7275,,no IPS match,,
RL4_JR_10236,1268,1548,1801,0,0,0,0,0,0,0,0,2,1,1,0,0,1,1,5.465530171,0,-0.552824891,1.19831113,-0.46133669,0.644557065,0.79767848,1.742723134,0,2.664146662,1.320123103,2.018104717,0.043580357,0.105809635,4.524918643,1,0.01092698,1.199656631,0.009108423,0.99273263,0.997097309,9.231797847,1,0.535551267,1.145230421,0.467636257,0.640044732,0.753278265,4.465775734,1,-0.072679609,1.201780493,-0.060476609,0.951776045,0.968710541,N,-,,Ribonuclease H partial,F:nucleic acid binding; F:protein dimerization activity,IPR008906 (PFAM); PTHR23272 (PANTHER); IPR012337 (SUPERFAMILY),,
RL4_JR_10237,4112,4830,7621,0,3,4,0,0,0,2,2,0,0,0,0,0,0,0,0.012706323,1,8.20293094,3.990270723,2.055732934,0.039808266,NA,0.004020132,0,11.42967648,3.991033794,2.863838561,0.004185413,0.018371529,0.010357064,1,8.787173804,3.991470463,2.201487869,0.027701505,0.072039566,0.01195084,0,8.36455496,3.991447685,2.095619339,0.036115972,0.100959199,0.010019356,0,8.741909568,1.949319774,4.484594926,7.31E-06,7.74E-05,N,-,,squalene cyclase,F:intramolecular transferase activity; F:transferase activity; C:cellular_component; P:hopanoid biosynthetic process; F:isomerase activity,IPR008930 (G3DSA:1.50.10.GENE3D); IPR032696 (PFAM); IPR032697 (PFAM); IPR008930 (G3DSA:1.50.10.GENE3D); IPR018333 (TIGRFAM); IPR006400 (TIGRFAM); PTHR11764:SF12 (PANTHER); PTHR11764 (PANTHER); IPR008930 (SUPERFAMILY); IPR008930 (SUPERFAMILY),,
RL4_JR_10238,5339,5563,5065,0,8,9,0,0,1,1,0,1,3,4,0,0,1,2,6.749756484,1,-0.857204737,1.230273988,-0.696759214,0.485953495,0.673875337,2.134072992,1,2.371805741,1.321917472,1.794216198,0.072778668,0.158252562,12.07037437,1,0.672478487,1.212090786,0.554808678,0.57902553,0.701142845,6.430034825,1,-0.712153151,1.221632576,-0.582951998,0.559925615,0.68857787,5.529217227,1,-0.380780188,1.229772706,-0.309634606,0.756838837,0.830721105,N,-,,hypothetical protein F503_06075,,PTHR42051 (PANTHER),,
RL4_JR_10239,2038,1597,3975,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,34.99459994,0,0.762304643,0.841215429,0.90619432,0.364833009,0.556631324,3.498964638,0,1.658583518,1.257864064,1.31857135,0.187312457,0.327626869,9.078200037,1,-0.99349378,1.191241656,-0.833998521,0.404281817,0.54657061,10.47275161,0,-1.415841755,1.188462773,-1.191321922,0.233527231,0.370721733,8.951241634,0,-1.075859983,1.194069991,-0.901002446,0.367587019,0.504017117,N,-,,HAT dimerisation,F:binding,IPR008906 (PFAM); PTHR23272 (PANTHER); IPR012337 (SUPERFAMILY),,
RL4_JR_10240,3683,2670,3454,0,1,0,0,0,0,2,0,0,0,3,0,0,0,0,25.34432561,1,3.908371948,0.616946298,6.335027802,2.37E-10,7.53E-09,0.77552943,0,3.832248139,1.44163572,2.658263864,0.007854437,0.02822244,15.01080378,1,2.999120207,1.034217332,2.899893586,0.003732894,0.015759723,10.34590277,1,2.482642439,1.018258693,2.438125456,0.014763649,0.065631958,1.986073425,0,1.096419473,1.206371518,0.908857227,0.363425494,0.499956947,N,-,,telomere-associated recq partial,F:nucleic acid binding; F:DNA binding; F:ATP binding; P:DNA integration; P:DNA recombination; F:helicase activity; F:hydrolase activity,no IPS match,,
RL4_JR_10241,20503,15730,18654,0,5,3,0,0,0,1,0,0,7,6,0,0,12,10,0.233984532,1,3.992999214,2.816729813,1.417601076,0.156307266,NA,0.073976144,0,7.221798332,2.250624769,3.208797145,0.001332915,0.015023052,0.193477484,1,4.556934788,1.398023482,3.259555255,0.00111587,0.006293634,0.22328974,1,4.135250503,1.795191862,2.30351451,0.021249912,0.079072163,0.192645743,1,4.46232028,1.300489394,3.431262339,0.000600779,0.003158302,N,-,,---NA---,,no IPS match,,
RL4_JR_10242,3349,3904,4598,2,0,8,0,0,1,3,5,2,5,8,0,0,0,3,58.48144425,1,-1.422770009,0.9811177,-1.450152218,0.147016076,0.292883309,24.13569782,1,0.495292248,1.167731313,0.424149154,0.67145704,0.790197437,38.72607897,1,-3.086274212,1.239595211,-2.489743575,0.012783529,0.039158986,60.75276686,1,-0.866694065,0.865266486,-1.001649872,0.316512725,0.462771313,38.63535486,1,-3.185622334,1.256572305,-2.535168348,0.01123933,0.034474125,N,-,,bah domain-containing,F:chromatin binding,IPR013083 (G3DSA:3.30.40.GENE3D); IPR011011 (SUPERFAMILY),,
RL4_JR_10243,3154,2619,5462,0,1,7,0,0,0,0,0,8,2,1,2,0,0,0,3.280005802,1,0.184181803,1.226010675,0.150228548,0.880584304,0.94187837,1.050877661,0,3.394008428,1.403026992,2.419061392,0.015560614,0.047512679,2.717035288,1,0.747240612,1.212357937,0.616353132,0.537661479,0.666334289,3.133866449,1,0.325123389,1.215798441,0.267415534,0.789149241,0.863611766,2.667289448,0,0.670883609,1.202853544,0.557743386,0.577019627,0.690771032,N,-, Effector probability:0.809,BAF1 ABF1 chromatin reorganising factor,,no IPS match,,
RL4_JR_10244,3372,3006,3726,0,1,5,0,0,0,3,1,4,1,8,1,0,6,0,3.899808038,1,-0.065525325,1.223644975,-0.053549295,0.957294255,0.978157131,1.251427276,0,3.14204311,1.384782883,2.268978876,0.02326961,0.064885674,3.231927961,1,0.496876631,1.214400561,0.409153822,0.68242678,0.7819023,3.72750114,1,0.074862327,1.216859465,0.061520931,0.950944346,0.971281297,3.168845693,1,0.422255342,1.205191356,0.350363733,0.726065741,0.807492929,N,-, Effector probability:0.686,BAF1 ABF1 chromatin reorganising factor,,no IPS match,,
RL4_JR_10245,344,438,546,0,3,0,0,0,0,0,0,0,0,2,0,0,0,1,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,tkl kinase,F:kinase activity,G3DSA:3.30.200.20 (GENE3D); IPR001245 (PFAM); G3DSA:1.10.510.10 (GENE3D); PIRSF000654 (PIRSF); PTHR23257 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.23.1.17, the basigin (basigin) family.
RL4_JR_10246,18249,13189,20067,1,2,4,0,0,0,0,0,1,2,6,0,0,15,4,4.214689406,1,-0.177582361,1.232982802,-0.144026633,0.885479439,0.944154115,1.355738231,0,3.026556219,1.388355158,2.179958206,0.02926056,0.077715924,3.495495599,1,0.383763957,1.222085686,0.314023772,0.753502984,0.834770123,4.031071926,1,-0.038106295,1.225509943,-0.031094236,0.975194387,0.98517231,3.42112756,1,0.311695991,1.21257389,0.257053193,0.79713771,0.862749258,N,-, Effector probability:0.816,---NA---,,no IPS match,,
RL4_JR_10247,4289,3107,5054,0,0,7,0,0,0,0,0,1,0,10,4,0,3,1,0.516994708,1,2.849461318,1.973571618,1.443809433,0.148792588,NA,0.163565541,0,6.07742534,1.905739336,3.189011858,0.0014276,0.015023052,0.42657823,1,3.417774092,1.295675766,2.637831302,0.008343808,0.028289588,0.492282305,1,2.995132064,1.439091844,2.081265401,0.03740962,0.102865591,0.422625159,1,3.329642439,1.253649151,2.655960351,0.007908291,0.025971926,N,-,,transcription factor bzip,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR004827 (PFAM); G3DSA:1.20.5.170 (GENE3D); IPR004827 (PROSITE_PROFILES); SSF57959 (SUPERFAMILY),,
RL4_JR_10248,1998,1581,1835,0,3,12,0,0,1,0,0,1,0,0,0,0,0,0,2.404287484,1,0.632325704,1.393414968,0.453795688,0.649975887,0.801326603,0.762178716,1,3.857387764,1.550780365,2.487384965,0.012868606,0.040829727,1.97925046,1,1.204347527,1.288944555,0.93436721,0.350114506,0.49357513,21.55441729,0,2.575476747,1.092715133,2.35695166,0.018425645,0.074086903,1.947097176,0,1.125179658,1.283047461,0.876958719,0.38050906,0.516095678,N,-,,homeobox domain-containing,"F:DNA binding; C:nucleus; P:regulation of transcription, DNA-templated",IPR001356 (SMART); IPR009057 (G3DSA:1.10.10.GENE3D); IPR008422 (PFAM); PTHR11850:SF57 (PANTHER); PTHR11850 (PANTHER); IPR001356 (PROSITE_PROFILES); IPR009057 (SUPERFAMILY),,
RL4_JR_10249,9479,11021,14564,0,0,2,0,0,0,0,0,3,2,12,3,0,8,0,0.919592014,1,2.018901565,1.787759941,1.129291197,0.258775013,NA,0.291819078,0,5.242550409,1.847777073,2.837220185,0.004550822,0.019403293,0.756226441,1,2.592807525,1.376246678,1.883970052,0.059569027,0.129433916,0.872556186,1,2.169943344,1.485739623,1.460513881,0.144148895,0.258228515,0.741396838,1,2.51848298,1.343103358,1.875122241,0.060775908,0.13001396,N,-,,acetamidase,"F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (G3DSA:3.90.1300.GENE3D); PIRSF001221 (PIRSF); IPR023631 (PFAM); IPR000120 (PANTHER); PTHR11895:SF45 (PANTHER); IPR023631 (SUPERFAMILY),3.A.9.1.1, the chloroplast envelope protein translocase (cept or tic-toc) family.
RL4_JR_10250,19995,25098,30685,5,24,11,0,0,1,1,0,3,2,13,3,0,6,2,8.485958463,1,-1.187553479,1.189970876,-0.997968524,0.318294622,0.506959689,2.718891859,1,2.022523872,1.28524848,1.573644244,0.115569719,0.226924673,29.17716577,1,1.203873548,1.030138579,1.168652036,0.242543854,0.376093426,37.02273576,1,1.282640493,0.847504244,1.513432532,0.130169827,0.239022397,6.922835036,1,-0.705237246,1.195183172,-0.590066244,0.555146238,0.674624023,N,-,,Alkaline-phosphatase- core domain,,IPR000917 (PFAM); G3DSA:3.30.1120.10 (GENE3D); IPR017849 (G3DSA:3.40.720.GENE3D); PTHR10342 (PANTHER); PTHR10342:SF198 (PANTHER); PTHR10342 (PANTHER); PTHR10342:SF198 (PANTHER); IPR017850 (SUPERFAMILY),,
RL4_JR_10251,26,57,47,0,0,2,0,0,0,0,0,0,0,5,0,0,0,0,2.727561742,1,0.450343888,1.264211919,0.356224998,0.721672073,0.851888405,0.870206512,0,3.66616467,1.445121988,2.536924011,0.011183123,0.036573689,2.254349644,0,1.016620206,1.226385569,0.828956433,0.407129061,0.549203812,10.62381187,1,2.311340099,1.038787397,2.225036717,0.026078773,0.086108719,2.215934238,0,0.938557154,1.218151114,0.770476785,0.441017121,0.574980472,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,PTHR23502 (PANTHER); PTHR23502:SF30 (PANTHER),2.A.1.2.33, the major facilitator superfamily (mfs).
RL4_JR_10252,28,13,26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.039511309,0,6.558582448,3.933672633,1.667292391,0.095456279,NA,0.012018482,0,9.841303846,3.934994458,2.500970192,0.01238536,0.039584659,0.032276942,0,7.139342944,2.581745913,2.76531587,0.00568677,0.020890007,0.037310093,0,6.715932509,3.933973437,1.707162648,0.087791826,0.177636338,0.03300395,0,7.010642114,1.78617445,3.924948155,8.67E-05,0.000615506,N,-,,high affinity methionine permease,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR002293 (PFAM); PTHR11785:SF203 (PANTHER); IPR002293 (PANTHER); PTHR11785:SF203 (PANTHER); IPR002293 (PANTHER); PTHR11785:SF203 (PANTHER),2.A.3.8.4, the amino acid-polyamine-organocation (apc) family.
RL4_JR_10253,221,227,224,0,0,0,0,0,0,0,0,0,0,1,3,0,0,2,0.074942945,0,5.635284287,3.920976567,1.437214477,0.150657061,NA,0.023706263,0,8.862982742,2.835890308,3.125291101,0.001776292,0.015023052,0.062056777,0,6.195984633,1.649457533,3.756377179,0.000172391,0.001606614,0.071618203,1,5.775533938,2.705136707,2.135024793,0.032758985,0.096983198,0.061914004,1,6.09897449,1.36804217,4.458177259,8.27E-06,8.54E-05,N,-,,ubiquitination network signaling,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_10254,1006,2321,2231,0,0,0,0,0,0,0,0,2,0,2,0,0,0,0,2.457869705,0,0.600279205,1.262845592,0.47533856,0.634545679,0.791774801,0.780036994,0,3.823833892,1.447955411,2.640850584,0.008269818,0.029217138,2.030708529,1,1.166815725,1.221492847,0.95523746,0.339457626,0.482813853,2.343192468,1,0.744206101,1.231636454,0.604241697,0.545682963,0.675763209,2.008751528,0,1.080135857,1.220277518,0.88515591,0.376072548,0.512165996,Y,-,,hypothetical protein AOR_1_446024,,no IPS match,,
RL4_JR_10255,1,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.623406955,0,1.198467608,1.598531371,0.749730427,0.453417078,NA,0.506005539,0,4.4479321,1.710197998,2.600828738,0.009299887,0.031898833,1.337137798,0,1.76926792,1.367518405,1.293779969,0.195741433,0.32049221,1.544096188,0,1.345665402,1.4357314,0.937268212,0.34862061,0.495547336,1.346178712,0,1.6574364,1.372234894,1.207837234,0.227109876,0.354257818,N,-,,ornithine aminotransferase,F:pyridoxal phosphate binding; F:ornithine-oxo-acid transaminase activity,IPR015422 (G3DSA:3.90.1150.GENE3D); IPR005814 (PFAM); IPR010164 (PTHR11986:PANTHER); IPR005814 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_10256,12,18,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.444232761,0,3.068265408,2.101886245,1.459767585,0.14435396,NA,0.140667524,0,6.294982883,1.958081969,3.214871994,0.001305027,0.015023052,0.366766479,0,3.635552976,1.300896261,2.794652491,0.005195553,0.019474187,0.423244,0,3.213068924,1.473768764,2.180171682,0.029244738,0.090912794,0.363378458,0,3.547497308,1.251939381,2.8336015,0.004602669,0.016690216,N,-,,---NA---,,no IPS match,,
RL4_JR_10257,1813,2076,1741,0,0,16,0,0,0,0,0,1,0,0,0,0,2,0,1.621566642,1,1.200209175,1.341211517,0.894869422,0.370856894,NA,0.513839442,0,4.425997469,1.544930933,2.86485135,0.00417205,0.018371529,1.339732817,1,1.766616382,1.238593645,1.426308288,0.153779373,0.267456172,1.545996349,0,1.343998979,1.263692353,1.063549191,0.28753297,0.431804187,1.327892536,1,1.67729735,1.233411442,1.359884701,0.173866413,0.289586681,N,-,,basic leucine zipper transcription factor domain-containing partial,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",G3DSA:1.20.5.170 (GENE3D); PTHR39607:SF2 (PANTHER); PTHR39607 (PANTHER),,
RL4_JR_10258,10,18,7,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,111.4620014,1,-4.902743645,1.207782932,-4.059292043,4.92E-05,0.000462616,35.94475379,0,-1.702174263,1.218575207,-1.396856142,0.162456835,0.29421866,92.6320566,0,-4.344445892,1.205238009,-3.60463731,0.000312589,0.002398921,106.8150645,0,-4.766147211,1.207204371,-3.948086442,7.88E-05,0.000871728,90.71486272,0,-4.417063967,1.202508908,-3.673206859,0.000239525,0.001453083,N,-,,hypothetical protein CMQ_7275,P:biological_process; C:cellular_component,no IPS match,,
RL4_JR_10259,210,161,338,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.173151564,0,5.461742294,1.186533944,4.603106655,4.16E-06,5.34E-05,0.052110076,0,7.727632854,2.387770779,3.23633781,0.00121074,0.015023052,0.135229068,0,5.074390313,1.409306006,3.600630589,0.000317446,0.002428778,0.155993815,0,4.652945318,1.969574741,2.362411145,0.018156493,0.073563223,0.133519545,0,4.990015531,1.275689746,3.911621573,9.17E-05,0.000645511,N,-,,---NA---,,,,
RL4_JR_10260,206,132,306,0,0,3,0,0,0,0,0,0,3,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_10261,230,265,246,0,0,58,0,0,0,0,4,6,3,1,3,0,0,1,0.088308121,1,5.39893678,3.918832371,1.377690156,0.168298972,NA,0.027735438,0,8.637049355,2.729147452,3.164742656,0.001552202,0.015023052,0.072657076,1,5.970967948,1.578823178,3.781910496,0.000155629,0.001520332,0.083873344,1,5.548273457,2.524154879,2.19807172,0.027943995,0.088851717,0.072283206,1,5.88004925,1.338295952,4.393683803,1.11E-05,0.000110626,N,-,,---NA---,,no IPS match,,
RL4_JR_10262,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_10263,503,1262,619,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_10264,6,14,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_10265,4,6,12,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0.012376897,0,8.237661038,3.992283311,2.063395906,0.039075029,NA,0.004015611,0,11.43115744,3.991119401,2.864148198,0.004181323,0.018371529,0.010235446,0,8.805715205,3.038577053,2.897973312,0.003755825,0.015764501,0.01179869,0,8.381441139,3.992433907,2.099331219,0.035787713,0.10034633,0.009844433,1,8.758432769,1.618956569,5.409924478,6.31E-08,1.56E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_10266,2327,2125,3815,0,1,1,0,0,0,0,0,1,2,0,0,0,2,0,0.039996504,1,6.54149921,3.933356973,1.663083024,0.096295817,NA,0.013032346,0,9.728499922,3.165701449,3.073094567,0.002118513,0.015045494,0.033353808,1,7.096674078,1.817984811,3.903593712,9.48E-05,0.001128758,0.038443873,1,6.67411915,3.394815131,1.965974256,0.049301585,0.121802535,0.032424762,1,7.027757183,1.385158265,5.073613145,3.90E-07,6.47E-06,,,,,,,,
RL4_JR_10267,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.027238258,0,7.093982006,3.945703095,1.797900611,0.072192759,NA,0.008675766,0,10.31238283,3.945839548,2.613482556,0.008962466,0.031046571,0.022678328,0,7.647888047,2.595472134,2.946626914,0.003212606,0.014227655,0.026165823,0,7.227450403,3.945494755,1.831823599,0.066977706,0.146670023,0.022656777,0,7.544876423,1.566871272,4.815249699,1.47E-06,1.98E-05,,,,,,,,
RL4_JR_10268,9,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.06360625,0,5.872062506,3.923505909,1.49663659,0.134487844,NA,0.020040663,0,9.105387122,2.88742953,3.153457782,0.001613486,0.015023052,0.052504599,0,6.437814418,1.645089667,3.913351683,9.10E-05,0.001103623,0.060603173,0,6.016696324,2.828648472,2.127056926,0.033415354,0.098001754,0.05234297,0,6.343659746,1.34855425,4.704044903,2.55E-06,3.20E-05,,,,,,,,
RL4_JR_10269,0,5,9,0,0,2,0,0,0,0,0,0,0,8,0,0,0,0,0.051281276,1,6.182483646,3.927514234,1.574146719,0.115453534,NA,0.016361499,0,9.398187881,3.035665052,3.095923866,0.001962007,0.015023052,0.042587569,0,6.739375554,1.74447559,3.863267329,0.00011188,0.001243128,0.049131693,1,6.319287853,3.101872553,2.037249354,0.04162506,0.110530746,0.042247166,0,6.648241686,1.373334609,4.840948186,1.29E-06,1.80E-05,,,,,,,,
RL4_JR_10270,12,6,6,2,0,0,0,0,0,0,0,11,0,0,10,0,0,0,0.047045835,1,6.3065725,3.92937252,1.604982085,0.108497747,NA,0.015021455,0,9.52117425,3.187070481,2.987437619,0.002813267,0.015349618,0.039135215,1,6.860806128,1.884520736,3.64061058,0.000271992,0.002152971,0.045148079,1,6.441071201,3.324035121,1.937726578,0.05265659,0.126338381,0.038907381,0,6.766098536,1.432899259,4.721963874,2.34E-06,2.96E-05,,,,,,,,
RL4_JR_10271,137,159,113,1,2,0,0,0,0,4,0,6,0,0,0,0,0,0,0.229220046,1,4.022623173,2.85717061,1.407904435,0.15915937,NA,0.073468178,0,7.232018226,2.278971634,3.173369127,0.001506808,0.015023052,0.190577935,1,4.579144386,1.419651304,3.225541634,0.001257345,0.006918133,0.21981985,0,4.157937938,1.831214494,2.270590339,0.023171789,0.082218611,0.188327685,0,4.493430467,1.308609264,3.433744962,0.000595304,0.003134401,,,,,,,,
RL4_JR_10272,109,222,279,6,4,2,0,0,0,0,3,49,2,0,0,0,13,0,0.046664486,1,6.318000818,3.929551793,1.607817164,0.107875228,NA,0.014680486,0,9.553777746,3.929908974,2.431043011,0.015055427,0.046263216,0.038695181,1,6.877670091,2.450988705,2.80607988,0.005014826,0.018951137,0.044668719,1,6.456300582,3.929505236,1.643031424,0.100376432,0.196350729,0.038983829,1,6.765781161,1.704190089,3.970085969,7.18E-05,0.000529438,,,,,,,,
RL4_JR_10273,108,74,111,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.039892658,0,6.545145995,3.933424046,1.663981793,0.096116068,NA,0.012359451,0,9.801634471,3.283108473,2.985473843,0.002831394,0.015349618,0.032716975,0,7.119823504,1.94373759,3.662955093,0.000249322,0.002031818,0.037789453,0,6.697972163,3.539346367,1.892431955,0.058433452,0.134982775,0.032927503,0,7.01635456,1.456270669,4.818029168,1.45E-06,1.96E-05,,,,,,,,
RL4_JR_10274,22,9,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.080348395,0,5.535232001,3.920025985,1.41203962,0.157938296,NA,0.026237438,0,8.718822369,2.815533522,3.09668569,0.001956973,0.015023052,0.066988441,0,6.09101642,1.652047101,3.686950824,0.000226957,0.001909987,0.077203501,0,5.668434187,2.652945743,2.136656659,0.032625928,0.096759671,0.064898761,0,6.028902428,1.360899135,4.430087632,9.42E-06,9.52E-05,,,,,,,,
RL4_JR_10275,9,7,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.012376897,0,8.237661038,3.992283311,2.063395906,0.039075029,NA,0.004015611,0,11.43115744,3.991119401,2.864148198,0.004181323,0.018371529,0.010235446,0,8.805715205,3.038577053,2.897973312,0.003755825,0.015764501,0.01179869,0,8.381441139,3.992433907,2.099331219,0.035787713,0.10034633,0.009844433,0,8.758432769,1.618956569,5.409924478,6.31E-08,1.56E-06,,,,,,,,
RL4_JR_10276,37,49,35,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003906015,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,0,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,,,,,,,,
RL4_JR_10277,8,5,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_10278,448,251,481,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003906015,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,0,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,,,,,,,,
RL4_JR_10279,166,84,128,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0.011995548,0,8.278788502,3.994728753,2.072428196,0.038225526,NA,0.003674643,0,11.54805534,3.998155187,2.888345949,0.003872737,0.017716233,0.009795413,0,8.859139625,3.047426446,2.90708891,0.003648095,0.015596838,0.01131933,1,8.43600951,3.995699254,2.111272389,0.034748906,0.099426657,0.00992088,0,8.755100215,1.62018887,5.403752846,6.53E-08,1.59E-06,,,,,,,,
RL4_JR_10280,45,39,59,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_10281,221,108,313,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0.016941764,0,7.786237146,3.969489371,1.961521097,0.049818266,NA,0.005360177,0,11.01327471,3.970079784,2.774068863,0.005535996,0.021974647,0.013809418,0,8.370946466,3.970412799,2.108331524,0.035002323,0.086240817,0.015934454,0,7.948319201,3.970395183,2.001896243,0.045295892,0.115278131,0.013359141,1,8.321812604,2.097869539,3.966792239,7.28E-05,0.000534084,,,,,,,,
RL4_JR_10282,10,3,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003906015,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,0,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,,,,,,,,
RL4_JR_10283,26,12,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_10284,12943,13675,5982,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_10285,70,80,70,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_10286,19,17,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.075272372,0,5.629061857,3.920915514,1.435649872,0.151101996,NA,0.023710784,0,8.862697659,2.810768185,3.153122945,0.001615338,0.015023052,0.062178395,0,6.19341987,1.619741642,3.82370849,0.000131459,0.001363621,0.071770353,0,5.772574597,2.672887492,2.159677358,0.030797655,0.093949923,0.062088927,0,6.096455381,1.352351132,4.508041764,6.54E-06,7.06E-05,,,,,,,,
RL4_JR_10287,28,77,41,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.020492391,0,7.508236164,3.958568492,1.896704877,0.0578669,NA,0.006522955,0,10.72761776,3.659062241,2.931794282,0.003370099,0.016450773,0.01685933,0,8.084625991,2.186120476,3.698161231,0.000217167,0.001850672,0.019450162,0,7.658128527,3.958878134,1.93441886,0.053061649,0.126799434,0.016474765,0,8.018942055,1.493133366,5.370546422,7.85E-08,1.87E-06,,,,,,,,
RL4_JR_10288,233,410,244,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.847904665,0,1.011947104,1.299907574,0.778476197,0.436288334,NA,0.587847896,0,4.232011238,1.51034004,2.802025455,0.005078287,0.020840615,1.526779104,0,1.578650695,1.227295829,1.286283761,0.198344048,0.323612064,1.761530323,0,1.156112716,1.244619432,0.928888531,0.352946857,0.499270799,1.505584703,0,1.496259351,1.218007962,1.228447923,0.219278867,0.34518012,N,-,,glycoside hydrolase family 3,"P:polysaccharide catabolic process; C:membrane; F:hydrolase activity, hydrolyzing O-glycosyl compounds",IPR026891 (SMART); IPR001764 (G3DSA:3.20.20.GENE3D); IPR026891 (PFAM); IPR002772 (G3DSA:3.40.50.GENE3D); IPR002772 (PFAM); PTHR30620:SF32 (PANTHER); IPR026892 (PANTHER); IPR017853 (SUPERFAMILY); IPR002772 (SUPERFAMILY),,
RL4_JR_10289,455,996,429,0,0,3,0,0,0,0,0,0,0,1,0,0,0,0,33.75736188,1,-2.061801354,1.19054088,-1.731819032,0.083305788,0.193861505,9.431906719,0,0.227894604,1.25339039,0.181822524,0.855722008,0.914830816,53.33546758,0,-0.013251831,0.892902064,-0.014841305,0.988158787,0.994620753,92.72586263,1,0.954829665,0.636501286,1.500122132,0.133582769,0.243830095,24.59280158,0,-2.533933911,1.239951072,-2.043575724,0.04099548,0.095949891,N,-,,ectomycorrhiza-induced ankyrin-domain nacht-domain containing,,IPR002110 (PRINTS); IPR002110 (SMART); PF13637 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); IPR001810 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),8.A.28.1.1, the ankyrin (ankyrin) family.
RL4_JR_10290,20,17,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.400077787,0,0.634473324,1.249999307,0.507578941,0.611748662,0.776912733,0.764089746,0,3.853642891,1.447332422,2.662583131,0.007754341,0.027959129,1.986166237,0,1.19869455,1.216104107,0.985684156,0.324288127,0.467277682,2.291508583,0,0.776278307,1.224743843,0.633829116,0.52619235,0.660267386,1.962628844,0,1.113492256,1.21338021,0.917677943,0.358787498,0.496134819,N,-,,hypothetical protein FPOA_06481,,no IPS match,,
RL4_JR_10291,3,11,12,0,0,14,0,0,0,0,0,0,0,0,0,0,8,0,78.61609455,1,-4.399115718,1.192518877,-3.688927533,0.000225201,0.00170843,43.9493094,0,0.449123803,0.995431885,0.451184868,0.651856315,0.77533368,76.29504104,0,-2.876586979,1.194295648,-2.408605426,0.0160136,0.046937374,75.23212548,0,-4.260473827,1.194580948,-3.566500735,0.00036178,0.003174194,64.211029,1,-3.918549699,1.194945867,-3.279269636,0.001040761,0.004935695,N,-,,perilipin mpl1,P:mycelium development,PTHR11736:SF79 (PANTHER); PTHR11736 (PANTHER),,
RL4_JR_10292,4,9,11,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,5.501106189,1,-0.562060872,1.192906457,-0.471169276,0.637519857,0.79330186,1.758563765,0,2.651138775,1.320216905,2.00810849,0.044631764,0.107870754,4.556959293,0,0.000906379,1.197192832,0.000757087,0.999395932,0.999593402,5.25659424,0,-0.421325857,1.194786364,-0.352636982,0.724360609,0.816208485,4.487002036,0,-0.079547655,1.195243794,-0.066553498,0.946937167,0.965921702,Y,-,,Pre-mRNA-splicing regulator WTAP,P:cell adhesion,no IPS match,,
RL4_JR_10293,5,6,2,0,7,2,0,0,0,0,0,0,0,1,0,0,0,1,0.00781203,1,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,0,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,0,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,0.007662926,1,9.0007212,4.037607722,2.229221316,0.025799183,0.085851084,0.006329724,1,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,N,-,,mitochondrial chaperone bcs1,F:nucleotide binding; P:cell division; F:ATP binding; C:membrane; P:proteolysis; C:integral component of membrane; F:peptidase activity,no IPS match,,
RL4_JR_10294,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.076639046,0,1.791012673,1.442032755,1.242005541,0.214234517,NA,0.345617423,0,4.998301906,1.65621069,3.017914288,0.002545209,0.015349618,0.893810785,0,2.350776195,1.245904961,1.886802178,0.059186938,0.128778973,1.030866137,0,1.928836295,1.289814192,1.495437333,0.134800344,0.245433102,0.878894461,0,2.271951295,1.222181785,1.858930745,0.063036955,0.133945262,N,-,,fad binding domain-containing,F:FAD binding; F:oxidoreductase activity; P:oxidation-reduction process; C:cellular_component,PR00420 (PRINTS); IPR002938 (PFAM); IPR023753 (G3DSA:3.50.50.GENE3D); PTHR13789 (PANTHER); PTHR13789:SF213 (PANTHER); IPR023753 (SUPERFAMILY),,
RL4_JR_10295,44,27,52,4,1,1,0,0,0,0,0,0,0,0,0,0,0,0,75.00009311,1,-2.448811725,1.012842526,-2.41776156,0.015616306,0.05393642,21.60795908,0,-0.967959023,1.206823212,-0.80207193,0.422511351,0.58568336,55.89238622,0,-3.615598891,1.192778391,-3.031241107,0.002435507,0.01157609,92.54580847,0,-0.540055338,0.593920712,-0.909305447,0.363188916,0.509390189,54.95619168,0,-3.694016745,1.191404783,-3.100555578,0.00193158,0.008238098,N,-,,kinase domain-containing,F:ATP binding; F:protein kinase activity; P:phosphorylation; F:protein serine/threonine kinase activity; P:protein phosphorylation; F:kinase activity,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); PTHR24363 (PANTHER); PTHR24363:SF0 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.E.43.3.3, the putative transglycosylase-associated holin (t-a hol) family.
RL4_JR_10296,299,517,564,0,2,1,0,0,0,0,0,0,1,0,0,0,3,0,27.93974904,1,-2.906530649,1.190586275,-2.441259999,0.014636113,0.051541352,8.968341384,0,0.300724492,1.229850482,0.244521181,0.8068272,0.883358844,23.16786342,0,-2.345010352,1.194551008,-1.963089342,0.049635794,0.112393821,26.72014996,1,-2.766982064,1.193301751,-2.318761421,0.020407976,0.077534994,22.73165997,1,-2.420439893,1.190987392,-2.032296824,0.042123616,0.097956272,N,-, Effector probability:0.552,---NA---,,no IPS match,,
RL4_JR_10297,880,930,1189,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.159685244,0,-0.158796371,1.266299118,-0.125401944,0.900205349,0.951329264,1.347703816,0,3.035139435,1.427767135,2.125794439,0.033520379,0.086268314,3.46123961,0,0.397861826,1.245637938,0.319404069,0.749420126,0.832469756,3.990396589,0,-0.023586587,1.253733872,-0.018813073,0.984990225,0.990763563,3.376410246,0,0.330548735,1.235959863,0.267442937,0.789128144,0.85627719,N,-,,cupin,F:manganese ion binding; F:nutrient reservoir activity,no IPS match,,
RL4_JR_10298,403,570,515,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0.023661669,1,7.297789941,3.951577463,1.846804222,0.06477552,NA,0.007344764,0,10.550876,3.599127215,2.931509606,0.003373189,0.016454661,90.50683038,0,12.1131298,1.532369668,7.904835268,2.68E-15,2.74E-13,33.40428173,0,10.90861073,0.864346859,12.62064022,1.62E-36,3.74E-34,0.019666837,0,7.757859709,1.497854666,5.179314045,2.23E-07,4.39E-06,N,-,,gpi anchored,C:membrane,PTHR34992 (PANTHER),8.A.23.1.4, the basigin (basigin) family.
RL4_JR_10299,157,212,191,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,50.91411467,0,0.975607088,0.735399245,1.326635966,0.184629132,0.342085955,4.050190528,0,1.447505452,1.248684861,1.159223994,0.246364893,0.399440245,10.5179728,1,-1.205896223,1.191944123,-1.01170533,0.311678966,0.453497823,16.14594569,0,-0.681012332,1.141368271,-0.5966631,0.550732333,0.679937187,10.38113596,0,-1.289655791,1.196618534,-1.077750139,0.281145276,0.414895194,N,-,,kinase-like domain partial,F:protein kinase activity; P:phosphorylation,IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24362 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),1.E.43.3.3, the putative transglycosylase-associated holin (t-a hol) family.
RL4_JR_10300,7,16,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.283531298,0,-0.503741548,1.20163708,-0.41921272,0.675060677,0.820981664,1.682783212,0,2.714658235,1.324013338,2.050325444,0.040332683,0.099718471,4.369969232,0,0.061333204,1.200224919,0.051101425,0.9592447,0.976117534,5.041659275,0,-0.361104532,1.198836468,-0.301212502,0.763252457,0.84522926,4.311223557,0,-0.021766839,1.201571711,-0.018115306,0.985546867,0.990240563,N,-,,neutral trehalase,"P:ascospore formation; C:cytoplasm; F:calcium ion binding; P:conidium formation; P:trehalose catabolic process; P:pathogenesis; F:alpha,alpha-trehalase activity",IPR001661 (PRINTS); IPR001661 (PFAM); IPR011120 (PFAM); PTHR23403:SF6 (PANTHER); PTHR23403:SF6 (PANTHER); PTHR23403:SF6 (PANTHER); IPR001661 (PANTHER); IPR001661 (PANTHER); IPR001661 (PANTHER); IPR008928 (SUPERFAMILY),,
RL4_JR_10301,234,238,227,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0.363217441,0,3.358703223,2.623202226,1.280382881,0.200410512,NA,0.112238655,0,6.620244479,2.277389627,2.906944161,0.003649783,0.017182841,0.297586715,1,3.936784364,1.563395613,2.518098638,0.011799027,0.036698419,0.343761485,0,3.512965486,1.889081405,1.859615725,0.062939913,0.14064591,0.299938682,0,3.824207465,1.487216726,2.571385459,0.010129252,0.031711292,N,-,,aat family amino acid transporter,C:integral component of membrane; F:amino acid transmembrane transporter activity; P:amino acid transmembrane transport,IPR004841 (PFAM); PTHR11785:SF204 (PANTHER); IPR002293 (PANTHER),2.A.3.1.2, the amino acid-polyamine-organocation (apc) family.
RL4_JR_10302,14,26,45,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,72.98893359,0,2.046619777,1.132414264,1.807306603,0.070714487,0.172257028,4.04144688,0,1.450617639,1.310642367,1.106798983,0.268380848,0.425791684,10.47050665,0,-1.199369924,1.231614581,-0.973819198,0.330146319,0.473226863,12.07650433,0,-1.621408255,1.234066133,-1.313874688,0.188888378,0.317426527,10.32811612,0,-1.282351995,1.238929924,-1.035048045,0.300646474,0.435797502,Y,-,,---NA---,,no IPS match,,
RL4_JR_10303,4,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.45450586,0,-1.740792814,1.185346844,-1.468593621,0.141943046,0.285059925,3.979976633,0,1.472784446,1.252054927,1.176293799,0.239477493,0.391296424,18.15567713,0,-0.21550694,1.188005329,-0.181402334,0.856051787,0.908688308,11.89617651,0,-1.599543993,1.187338988,-1.347167076,0.177926429,0.302621383,10.15112288,0,-1.257323633,1.190023462,-1.056553651,0.290715343,0.42538242,Y,-,,GPI anchored serine-rich,C:membrane,no IPS match,,
RL4_JR_10304,3,4,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.007786068,0,8.896911713,4.040984052,2.201669593,0.027688656,NA,0.002502822,0,12.10389348,4.040376809,2.995733828,0.002737853,0.015349618,0.006502266,0,9.448056946,3.305547956,2.858242286,0.00425995,0.016940088,0.007499321,0,9.02784755,4.040049892,2.234588134,0.025444401,0.085851084,0.00645541,0,9.348501478,1.703823852,5.486776974,4.09E-08,1.17E-06,N,-,,transcriptional regulator,"C:nucleus; F:zinc ion binding; P:proteolysis; F:serine-type peptidase activity; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter; F:hydrolase activity",IPR001138 (SMART); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_10305,128,35,33,8,28,4,0,0,6,3,2,1,0,0,0,0,3,0,100.2313829,1,1.016992897,0.530776261,1.916048194,0.055358961,0.143370923,10.55945604,1,0.064994942,1.225688259,0.053027302,0.957710154,0.977885375,104.9960297,1,1.429991846,1.745005246,0.819477104,0.41251426,0.55456845,75.86533179,0,1.00045367,0.621462439,1.609837711,0.10743329,0.206956253,65.50510902,1,1.037315622,0.592169906,1.751719583,0.079822038,0.161091914,N,-,,"3 ,5 -bisphosphate nucleotidase",,no IPS match,,
RL4_JR_10306,15,15,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.008115494,0,8.845278576,4.03634189,2.191409652,0.028422161,NA,0.002507343,0,12.10167175,4.040174693,2.995333784,0.002741447,0.015349618,0.006623884,0,9.426891884,3.299070491,2.857438757,0.00427075,0.016940088,0.007651472,0,9.002876608,4.037800151,2.229648886,0.025770762,0.085851084,0.006630333,0,9.341240721,1.70468121,5.479758129,4.26E-08,1.17E-06,N,-,,---NA---,,no IPS match,,
RL4_JR_10307,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.090948354,0,5.356141148,3.918480188,1.366892492,0.171659006,NA,0.029389325,0,8.554064358,2.717826095,3.147392092,0.001647339,0.015023052,0.07581976,0,5.90902852,1.580079032,3.739704408,0.000184237,0.00167886,0.087423415,0,5.488283221,2.496116976,2.198728374,0.027897242,0.088795843,0.074497005,0,5.82884298,1.335843935,4.363416136,1.28E-05,0.000124037,N,-,,telomerase-binding EST1A,,IPR018834 (PFAM); PTHR15696:SF6 (PANTHER); PTHR15696 (PANTHER); PTHR15696 (PANTHER); PTHR15696:SF6 (PANTHER); IPR011990 (SUPERFAMILY),,
RL4_JR_10308,806,934,1080,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.237994862,0,1.589766189,1.483904116,1.071340238,0.284016473,NA,0.390669349,0,4.821397384,1.649013551,2.923807012,0.003457791,0.01666655,1.019914443,0,2.160477614,1.275164127,1.694274147,0.090213201,0.179363403,5.188714021,0,2.681332435,1.198200429,2.237799596,0.025234127,0.085851084,1.010904979,0,2.071069553,1.262736106,1.6401444,0.100975147,0.192392427,N,-, Effector probability:0.837,"hypothetical protein CNYM01_13006, partial",,no IPS match,,
RL4_JR_10309,2207,3791,2084,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,12.23148718,1,-1.714928722,1.251997535,-1.369754073,0.170763683,0.324351601,3.850572032,0,1.520326297,1.308943258,1.161491369,0.245442131,0.398308512,66.11495452,0,2.643887219,0.628545021,4.206360933,2.60E-05,0.000417701,59.64423407,1,2.13706409,0.642795895,3.32463867,0.000885332,0.006684553,25.50651622,0,1.297108697,0.869441923,1.491886534,0.135728893,0.240338413,N,-,,kinase-like domain,F:nucleotide binding; P:phosphorylation; F:kinase activity,IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); PTHR24362 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.2.2, the pock size-determining protein (psdp) family.
RL4_JR_10310,189,356,193,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,100.7836857,0,0.439037758,0.674769764,0.650648238,0.515273584,0.700528502,13.19580261,0,-0.256462731,1.266396067,-0.20251384,0.839515039,0.90380464,34.16991313,0,-2.905627947,1.233373023,-2.35583874,0.018480939,0.052763966,123.5198353,0,1.318440832,0.607055913,2.171860621,0.029866178,0.092062527,60.54913485,0,0.319911731,0.727382248,0.439812398,0.660072988,0.757650946,N,-,,stomatin family,C:membrane,IPR001972 (PRINTS); IPR001107 (SMART); IPR001107 (PFAM); PTHR10264:SF19 (PANTHER); IPR001972 (PANTHER); IPR001107 (SUPERFAMILY),8.A.21.1.3, the stomatin/podocin/band 7/nephrosis.2/spfh (stomatin) family.
RL4_JR_10311,98,240,110,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.286287143,0,0.704765576,1.274901152,0.552800172,0.580400251,0.754566573,0.735882328,0,3.908099741,1.485294819,2.631194622,0.00850853,0.029781496,8.396010498,0,2.227414166,1.208915012,1.842490285,0.065403466,0.139252301,2.187928809,0,0.843493809,1.243812273,0.678152023,0.497675309,0.636072015,25.02072753,0,4.360315893,0.653310095,6.674190286,2.49E-11,2.00E-09,N,-,,hlh transcription factor,F:protein dimerization activity,IPR011598 (SMART); IPR011598 (PFAM); IPR011598 (G3DSA:4.10.280.GENE3D); PTHR12565:SF83 (PANTHER); PTHR12565:SF83 (PANTHER); PTHR12565 (PANTHER); PTHR12565 (PANTHER); PTHR12565:SF83 (PANTHER); IPR011598 (PROSITE_PROFILES); IPR011598 (SUPERFAMILY),,
RL4_JR_10312,1613,1239,1690,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0.044587333,0,6.385260388,3.930635959,1.624485314,0.104272272,NA,0.014545135,0,9.57066022,3.218790097,2.97337196,0.002945473,0.0154422,0.037086988,0,6.945606159,1.907307045,3.641577363,0.000270973,0.002149247,0.042743242,1,6.52170665,3.39180641,1.922782689,0.054507347,0.12903598,0.035813785,0,6.888068993,1.426649215,4.828144803,1.38E-06,1.88E-05,Y,-,,alpha beta-Hydrolase,F:hydrolase activity,IPR029058 (G3DSA:3.40.50.GENE3D); IPR000073 (PFAM); IPR029058 (SUPERFAMILY),,
RL4_JR_10313,2167,2071,2868,0,0,2,0,0,0,0,0,0,0,2,0,0,0,0,0.039970542,1,6.542410055,3.93337371,1.663307516,0.096250895,NA,0.012864123,0,9.746451341,3.124569951,3.119293693,0.001812852,0.015023052,0.0331946,0,7.102326488,1.761343441,4.032334821,5.52E-05,0.000782296,0.038280268,1,6.680040476,3.350576108,1.993699071,0.046184951,0.11664321,0.032550447,0,7.025142538,1.365856389,5.143397649,2.70E-07,4.90E-06,N,-,,rhamnogalacturonate lyase,P:biological_process; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_10314,1,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.190211821,0,4.29178092,3.064640696,1.400418955,0.161387897,NA,0.060449394,0,7.513208427,2.337870148,3.213697919,0.001310375,0.015023052,0.15758898,0,4.852933917,1.416590679,3.425784166,0.000613027,0.003922224,0.181832428,0,4.431600621,1.905000118,2.326299394,0.020002584,0.076714457,0.156427692,0,4.762102072,1.296078392,3.674239229,0.000238559,0.001448088,N,-,,aaa family ATPase,F:ATP binding,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003959 (PFAM); PTHR23077:SF87 (PANTHER); PTHR23077 (PANTHER); PTHR23077:SF87 (PANTHER); PTHR23077 (PANTHER); IPR027417 (SUPERFAMILY),3.A.25.2.1, the symbiont-specific erad-like machinery (selma) family.
RL4_JR_10315,44,44,93,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.499953919,0,2.897629195,2.01433367,1.438505069,0.1502908,NA,0.159150188,0,6.116829276,1.930350912,3.168765451,0.001530879,0.015023052,0.414321725,0,3.459059848,1.310563831,2.639367702,0.008306084,0.02818056,20.53596701,0,6.028247216,0.741194065,8.133156354,4.18E-16,2.89E-14,0.410583173,0,3.37014349,1.265612011,2.662856752,0.007748039,0.025603425,N,-,,"endo-beta-1,4-glucanase D","P:biological_process; P:carbohydrate metabolic process; C:extracellular region; F:hydrolase activity, hydrolyzing O-glycosyl compounds; C:cellular_component; F:molecular_function; F:cellulose binding; F:hydrolase activity",IPR005103 (PFAM); PTHR33353 (PANTHER); PTHR33353:SF2 (PANTHER),,
RL4_JR_10316,4682,5029,3972,4,0,3,0,0,0,0,0,0,13,16,8,0,6,2,2.387863225,1,0.64180551,1.28851733,0.498096141,0.61841628,0.780965947,0.756322252,0,3.868298917,1.466850784,2.637145482,0.008360697,0.029435468,1.973390728,0,1.207879099,1.234653404,0.978314314,0.327918892,0.470900832,2.277263858,1,0.785190955,1.249225814,0.628542051,0.529648909,0.663077172,1.958145524,1,1.11683314,1.236376916,0.903311219,0.366360744,0.502833473,N,-,,hypothetical protein SPI_03434,,no IPS match,,
RL4_JR_10317,10169,11809,18260,2,5,24,0,0,0,3,1,0,0,10,3,0,5,1,23.02899774,1,1.63477759,0.778606399,2.099620028,0.03576228,0.103640738,2.468406441,0,2.16185873,1.304346699,1.657426459,0.097433286,0.198552529,6.422371161,1,-0.494341397,1.211871792,-0.40791559,0.683335647,0.782587555,19.44458979,1,1.372142969,0.882028946,1.555666597,0.119787393,0.224144771,10.21762116,1,0.346157812,1.14767655,0.301616176,0.762944675,0.834717428,Y,-,,rare lipo A,C:spore wall; P:defense response to fungus; P:defense response to bacterium,IPR009009 (G3DSA:2.40.40.GENE3D); IPR009009 (PFAM); IPR007117 (G3DSA:2.60.40.GENE3D); PTHR31836:SF17 (PANTHER); PTHR31836 (PANTHER); IPR007117 (SUPERFAMILY); IPR009009 (SUPERFAMILY),,
RL4_JR_10318,4653,4403,5059,5,3,10,0,0,0,2,0,3,3,9,0,0,4,0,0.695371571,1,2.421645865,1.728179492,1.401269878,0.161133385,NA,0.222967355,0,5.630564572,1.807704144,3.114760006,0.001840946,0.015023052,0.577516791,1,2.980473472,1.280865065,2.326922292,0.019969402,0.0555446,0.666109902,1,2.558671533,1.375815025,1.859749665,0.062920952,0.140634578,0.569192274,1,2.898563324,1.245661575,2.326926817,0.019969161,0.05451274,Y,-,,cell wall,P:developmental process involved in reproduction; P:anatomical structure development; P:single-organism developmental process,no IPS match,,
RL4_JR_10319,2186,1750,2906,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,6.607647963,0,-0.826710086,1.227159306,-0.673677886,0.500516124,0.687293476,2.1108183,0,2.38765476,1.335553092,1.787764765,0.073813968,0.160056766,5.481535822,0,-0.265804515,1.222493651,-0.217428136,0.827874707,0.888802071,6.323417912,0,-0.688090019,1.224267149,-0.562042378,0.574087146,0.700739284,5.417562582,1,-0.351505194,1.228163003,-0.286204025,0.774721861,0.844173358,N,-,,aryl-alcohol dehydrogenase AAD14,,IPR023210 (G3DSA:3.20.20.GENE3D); IPR023210 (PFAM); IPR001395 (PANTHER); PTHR11732:SF259 (PANTHER); IPR023210 (SUPERFAMILY),8.A.5.1.6, the voltage-gated k(+) channel -subunit (kv) family.
RL4_JR_10320,5044,3711,6115,0,0,4,0,0,0,0,0,0,2,1,0,0,1,2,8.449537451,1,-1.181262575,1.210432798,-0.975900998,0.329113527,0.518283347,2.679492347,0,2.043478516,1.288414315,1.586041456,0.112729906,0.222427311,6.982362723,0,-0.614887836,1.206988379,-0.509439732,0.610444033,0.726391089,12.06868882,1,-0.091300575,1.156684683,-0.078932985,0.937085927,0.963171625,6.916412287,1,-0.703751751,1.215561682,-0.578951905,0.562621626,0.680103147,N,-,,hypothetical protein AOL_s00110g47,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR021833 (PFAM); PTHR38116 (PANTHER),,
RL4_JR_10321,4579,3388,5903,0,4,1,0,0,2,0,0,7,0,0,0,0,0,1,1.986169855,1,0.907619226,1.285281526,0.706163753,0.480086308,NA,0.630797407,1,4.130182144,1.48999023,2.771952501,0.005572117,0.022057476,1.642020594,1,1.473189432,1.224859362,1.202741701,0.229076291,0.36003166,1.894643071,0,1.050659408,1.239841719,0.847414143,0.396764324,0.540823745,1.624661876,1,1.386250955,1.221227372,1.135129287,0.256321152,0.387582387,N,-,,hypothetical protein TCE0_033r09154,F:catalytic activity,IPR008928 (SUPERFAMILY),,
RL4_JR_10322,1044,2033,1340,0,0,0,0,0,0,0,0,1,2,0,0,0,8,0,29.38047555,0,0.016672239,0.888091497,0.01877311,0.985022105,0.992332803,5.685773868,0,0.958081281,1.249525416,0.766756137,0.44322652,0.604302106,34.31978463,1,0.695241817,0.87491817,0.794636391,0.426825043,0.567604983,21.11677236,1,-1.177602678,1.160370758,-1.014850357,0.310177165,0.45614289,14.69975428,1,-1.791496384,1.218428387,-1.470333754,0.141471384,0.247987978,N,-,,ankyrin repeat-containing,F:catalytic activity; C:membrane; C:integral component of membrane; P:nucleoside metabolic process,IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR020683 (G3DSA:1.25.40.GENE3D); PTHR24198 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_10323,2,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.291184834,0,-0.968633499,1.315834407,-0.736136321,0.461647741,0.649891677,2.309175804,0,2.258017941,1.41541574,1.595303682,0.110644343,0.219166739,6.040354207,0,-0.405834121,1.283518109,-0.316188855,0.751859166,0.83362416,6.970677575,0,-0.828645125,1.295143892,-0.639809314,0.522296577,0.657007434,6.022341151,0,-0.504136199,1.301848251,-0.387246516,0.698573717,0.786687808,N,-,,multidrug resistance fnx1,P:transmembrane transport; C:integral component of membrane,PR01036 (PRINTS); G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); PTHR23501 (PANTHER); PTHR23501:SF73 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY); IPR020846 (SUPERFAMILY),2.A.1.3.65, the major facilitator superfamily (mfs).
RL4_JR_10324,48,23,94,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47.43766894,0,-3.670337959,1.211149815,-3.030457432,0.002441836,0.012289018,15.25110243,0,-0.465323722,1.234776572,-0.376848519,0.706286182,0.815219329,39.43052404,0,-3.112276729,1.21029663,-2.571499128,0.010125927,0.033005436,61.52056674,0,-0.850247033,0.795877204,-1.068314344,0.28537874,0.429467858,38.78682376,0,-3.191306176,1.212724431,-2.631518006,0.008500436,0.027576712,N,-,,ankyrin repeat,,IPR031359 (PFAM); PTHR10039 (PANTHER),,
RL4_JR_10325,11,13,26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,65.4494446,0,-1.054156159,0.770440756,-1.368250772,0.171233594,0.324980845,16.11434969,0,-0.54475079,1.222028891,-0.445775705,0.655759273,0.778238406,41.67254008,0,-3.192057445,1.201151316,-2.657498187,0.007872301,0.027013862,74.7094623,0,-0.880519721,0.763287612,-1.153588382,0.248668964,0.387767327,40.98593688,0,-3.270869429,1.201995461,-2.721199484,0.00650455,0.022289391,N,-,,ankyrin repeat-containing,F:catalytic activity; P:cellular metabolic process,IPR002110 (SMART); IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); PTHR24123 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),9.A.3.1.1, the sorting nexin27 (snx27)-retromer assembly apparatus for recycling integral membrane proteins (snx27-retromeraa) family.
RL4_JR_10326,2518,2576,3419,0,1,8,0,0,0,0,0,7,3,2,3,0,9,0,5.776009549,1,-0.632199217,1.305538869,-0.484243887,0.628212794,0.787849342,1.834230517,0,2.590405966,1.420515824,1.823567131,0.06821754,0.150474658,4.756849938,1,-0.060836626,1.269021577,-0.047939788,0.961764229,0.97753626,5.488497659,1,-0.483425938,1.279386647,-0.377857577,0.705536399,0.802352684,4.67241116,1,-0.137823076,1.272217581,-0.108332944,0.913731591,0.94451581,Y,-,,cytidine and deoxycytidylate deaminase zinc-binding region,P:nucleocytoplasmic transport; F:zinc ion binding; F:catalytic activity; F:structural constituent of nuclear pore; C:nuclear pore,IPR002125 (PFAM); G3DSA:3.40.140.10 (GENE3D); PTHR11079:SF9 (PANTHER); PTHR11079 (PANTHER); IPR002125 (PROSITE_PROFILES); IPR016193 (SUPERFAMILY),,
RL4_JR_10327,19083,19373,29182,6,12,17,0,0,0,0,5,4,2,14,1,0,5,0,0.203099874,1,4.197280817,2.966047715,1.415109001,0.15703654,NA,0.065647094,0,7.394843407,2.301954425,3.212419554,0.00131622,0.015023052,0.1690605,1,4.753365622,1.396067234,3.404825717,0.000662063,0.004144811,0.194928503,1,4.331750202,1.846717881,2.345648053,0.018994033,0.074947228,0.165567251,1,4.678517238,1.275037017,3.669318753,0.000243198,0.001470954,N,-,,ADP-ribosylation factor 5B,F:nucleotide binding,IPR027417 (G3DSA:3.40.50.GENE3D); IPR006689 (PFAM); IPR027417 (SUPERFAMILY),3.A.30.1.1, the endoplasmic reticulum surface retrieval pathway (er-surf).
RL4_JR_10328,3082,3105,4114,0,1,3,0,0,0,0,0,1,1,1,0,0,6,0,13.51957031,1,3.129958563,0.898545252,3.483362196,0.000495158,0.003343956,0.664598893,0,4.054990689,1.519220472,2.669125886,0.007604894,0.02755073,1.716311763,1,1.409504386,1.245325964,1.131835702,0.257703515,0.394126059,1.979244533,1,0.987716071,1.265080671,0.780753428,0.43494753,0.577023551,13.26777947,1,3.514925891,0.889665432,3.95084013,7.79E-05,0.000563623,N,-,,ADP-ribosylation factor 6,F:GTP binding; F:nucleotide binding; P:small GTPase mediated signal transduction; C:intracellular,IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (SUPERFAMILY),,
RL4_JR_10329,3972,4642,6744,0,0,5,0,0,0,0,0,1,4,3,1,0,0,0,0.003880053,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,0,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,"hypothetical protein MMYC01_210518, partial",F:DNA binding; P:DNA integration; P:DNA recombination,no IPS match,,
RL4_JR_10330,8068,9166,9656,1,4,21,0,0,2,7,17,9,6,18,18,0,4,1,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,"hypothetical protein MMYC01_210518, partial",F:DNA binding; F:metal ion binding; P:DNA integration; P:DNA recombination,IPR021842 (PFAM),,
RL4_JR_10331,371,145,441,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,29.48261079,0,1.523658906,0.713255263,2.136204224,0.032662771,0.096719742,3.306851727,0,1.740087542,1.282294789,1.357010538,0.174777862,0.310875773,8.581817511,0,-0.912191157,1.207020363,-0.755738001,0.449806295,0.589112411,9.901065175,1,-1.334654069,1.206513973,-1.106206889,0.268636982,0.409816098,8.45222144,0,-0.993014722,1.209284681,-0.821158771,0.411555837,0.547437951,N,-,,methyltransferase type 12,F:methyltransferase activity; P:methylation,PF13489 (PFAM); IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF905 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_10332,26205,26604,29296,0,25,80,0,0,0,4,7,10,1,28,5,0,21,16,0.109892637,1,5.083678995,3.890815321,1.306584501,0.191353863,NA,0.034944851,0,8.304759798,2.632295315,3.154949884,0.001605257,0.015023052,0.09051809,1,5.656943632,1.551336076,3.646497829,0.000265839,0.002115842,0.104434376,1,5.232722346,2.349567349,2.227100385,0.025940566,0.086008637,0.088779999,1,5.583298979,1.337819199,4.173433138,3.00E-05,0.000253585,Y,-,,H+ K+-exchanging ATPase,F:ATP binding; F:metal ion binding; C:integral component of membrane; F:hydrolase activity,IPR006068 (PFAM); IPR023298 (G3DSA:1.20.1110.GENE3D); PTHR24093:SF263 (PANTHER); PTHR24093 (PANTHER); SSF81665 (SUPERFAMILY),3.A.3.1.7, the p-type atpase (p-atpase) superfamily.
RL4_JR_10333,854,726,1630,0,0,0,0,0,0,2,0,0,0,0,6,0,0,0,0.398561376,0,3.224701181,2.186847013,1.474589289,0.140322996,NA,28.26330636,0,8.6067358,0.888251419,9.689526655,3.34E-22,1.61E-19,0.330625895,1,3.785241977,1.299068675,2.913812064,0.003570448,0.015394895,28.31816372,1,5.700634636,0.868163015,6.566318233,5.16E-11,2.04E-09,0.325733813,0,3.703782644,1.239971678,2.986989712,0.002817392,0.011261782,N,-,,Na+ H+ K+ antiporter P-type ATPase,F:ATP binding; F:metal ion binding; C:integral component of membrane; F:hydrolase activity,IPR001757 (PRINTS); PR00119 (PRINTS); PF00702 (PFAM); IPR006068 (PFAM); IPR023298 (G3DSA:1.20.1110.GENE3D); IPR001757 (TIGRFAM); PTHR24093:SF263 (PANTHER); PTHR24093:SF263 (PANTHER); PTHR24093 (PANTHER); PTHR24093 (PANTHER); SSF81665 (SUPERFAMILY); IPR023214 (SUPERFAMILY),3.A.3.1.7, the p-type atpase (p-atpase) superfamily.
RL4_JR_10334,3163,3518,5530,0,0,2,0,0,0,0,0,0,0,3,1,0,5,0,255.2253523,1,-1.862484232,0.902306771,-2.064136381,0.039004787,0.110773507,67.29276445,0,-2.60684881,1.226713026,-2.125068174,0.033580925,0.086358262,195.6101324,0,-2.846270972,0.89600291,-3.176631394,0.001489963,0.00785236,235.3203817,1,-2.376905855,0.686778832,-3.460948044,0.000538277,0.004438595,169.492036,1,-5.318855549,1.222958305,-4.349171616,1.37E-05,0.000130652,N,-,,recQ family helicase,F:nucleic acid binding; F:ATP binding; F:helicase activity; F:hydrolase activity,IPR014001 (SMART); IPR022698 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR13710 (PANTHER); IPR027417 (SUPERFAMILY),2.A.16.2.2, the telurite-resistance/dicarboxylate transporter (tdt) family.
RL4_JR_10335,9526,7237,8465,0,1,5,0,0,0,0,0,3,3,4,0,0,10,1,50.66237899,1,-3.765172952,1.199606686,-3.138672864,0.001697148,0.009102783,16.07943582,0,-0.541661838,1.206142863,-0.44908597,0.653369641,0.77645796,52.93005949,1,-2.236745763,1.195832863,-1.870450154,0.061421333,0.132699439,98.87427576,1,-0.266071119,0.634842792,-0.419113397,0.67513326,0.778556294,63.5049803,1,-1.044287004,0.855625295,-1.220495713,0.222277014,0.348907197,N,-,,Vegetative incompatibility HET-E-1,F:GTP binding; F:nucleotide binding; F:catalytic activity,IPR001680 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR010730 (PFAM); PF05729 (PFAM); IPR001680 (PFAM); PTHR10622 (PANTHER); PTHR10622:SF11 (PANTHER); IPR007111 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (SUPERFAMILY); IPR027417 (SUPERFAMILY),9.A.61.2.1, the domain of unknown function 3339 (duf3339) family.
RL4_JR_10336,4887,4674,5553,0,1,6,0,0,0,0,0,0,0,6,0,0,4,0,2989.452866,1,2.676965724,0.27892385,9.597478744,8.19E-22,1.31E-19,904.1892598,0,2.688368381,0.482325606,5.573762509,2.49E-08,3.41E-06,1024.320564,0,1.027672379,0.866700435,1.185729622,0.235729093,0.368210824,666.1192977,1,-0.435825132,0.27865436,-1.564034857,0.117809383,0.221179306,498.1247327,1,-0.78798056,0.831918982,-0.947184254,0.343544898,0.480440896,,,,,,,,
RL4_JR_10337,4597,3117,3536,6,10,10,0,0,4,2,6,37,4,4,25,0,18,0,0.13700591,1,4.76495839,3.751551987,1.270129911,0.204038359,NA,0.044397217,1,7.958669519,2.710146044,2.936620163,0.003318102,0.016335522,0.114590123,1,5.313058417,1.716337244,3.095579517,0.001964287,0.009681812,0.132115043,1,4.892405471,2.420813095,2.020976126,0.043282237,0.113246213,0.112879617,1,5.23110976,1.49873499,3.490350059,0.000482388,0.002627316,N,-,,DNA helicase,F:ATP binding; F:helicase activity; F:hydrolase activity,IPR027417 (G3DSA:3.40.50.GENE3D); IPR000330 (PFAM); PTHR10799:SF711 (PANTHER); PTHR10799 (PANTHER); PTHR10799 (PANTHER); PTHR10799:SF711 (PANTHER); IPR014001 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),,
RL4_JR_10338,3656,4901,6060,0,1,2,0,0,1,3,0,16,7,11,12,0,8,4,0.42896409,1,3.11875353,2.155485715,1.4468913,0.14792737,NA,67.07118109,1,8.583258894,0.872036746,9.842772036,7.37E-23,4.14E-20,63.54661303,1,7.14093598,0.668856834,10.67632955,1.31E-26,3.17E-24,921.388005,1,11.17115834,0.556375478,20.078452,1.14E-89,1.28E-86,511.2620023,1,10.55993451,0.954377751,11.06473249,1.86E-28,8.19E-26,Y,-, Effector probability:0.911,glycosyltransferase family 90,C:membrane; C:integral component of membrane; F:transferase activity,no IPS match,,
RL4_JR_10339,78,51,78,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.429168531,0,3.117908887,2.145814399,1.453018904,0.146218505,NA,0.136279297,0,6.340613422,1.98115982,3.200455287,0.001372107,0.015023052,0.355239677,0,3.680941229,1.315039422,2.799110937,0.005124353,0.019257219,0.409900897,0,3.258994189,1.501304661,2.170774709,0.029948207,0.092137828,0.352386011,0,3.590919684,1.263783722,2.841403653,0.004491542,0.016405795,N,-,,ubiquitination network signaling,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,no IPS match,,
RL4_JR_10340,107,110,139,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,22.77373732,1,-0.292973638,1.008751255,-0.290431994,0.77148577,0.880495372,4.85351194,0,1.186538193,1.250134515,0.949128417,0.342555303,0.505739377,12.54858843,0,-1.460391934,1.19367736,-1.223439418,0.221163773,0.350840181,22.49648453,0,-0.156119646,1.015848149,-0.153684039,0.877858871,0.92447541,16.18509069,0,-0.606809755,1.119355709,-0.542106276,0.587745295,0.700355551,N,-,,short-chain dehydrogenase reductase family,,no IPS match,,
RL4_JR_10341,591,824,410,0,0,1,1,0,0,2,0,0,0,3,0,0,0,0,106.7463958,1,-1.953101254,0.824618218,-2.368491518,0.01786079,0.059839148,29.40552672,1,-1.412471308,1.230633078,-1.147759908,0.251067692,0.405376803,75.78988206,1,-4.054923854,1.215114536,-3.337071307,0.000846662,0.005036198,123.5082051,1,-0.73033215,0.659455427,-1.107477655,0.268087468,0.409462697,149.0481015,0,-0.092709009,0.763012368,-0.12150394,0.903291894,0.937937691,N,-,,ABC multidrug transporter,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",G3DSA:1.20.1560.10 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011527 (PFAM); IPR003439 (PFAM); PTHR24223:SF257 (PANTHER); PTHR24223:SF257 (PANTHER); PTHR24223 (PANTHER); PTHR24223 (PANTHER); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.208.41, the atp-binding cassette (abc) superfamily.
RL4_JR_10342,570,692,475,0,0,2,0,0,0,0,0,0,0,2,0,0,0,0,78.5416766,1,-2.302475196,1.046278894,-2.200632364,0.027762061,0.085088266,20.04506981,0,-0.859624232,1.232575686,-0.697421052,0.485539331,0.641847865,51.7437658,0,-3.504291898,1.212368735,-2.890450569,0.0038469,0.016036854,142.8468758,1,0.231222558,0.573910672,0.402889456,0.687029549,0.78796717,50.6600386,0,-3.576552651,1.209816664,-2.956276565,0.003113777,0.01219613,N,-,,ABC multidrug transporter,"F:ATP binding; F:ATPase activity, coupled to transmembrane movement of substances; P:transmembrane transport; C:integral component of membrane",IPR003439 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR011527 (PFAM); G3DSA:1.20.1560.10 (GENE3D); PTHR24223 (PANTHER); PTHR24223:SF256 (PANTHER); IPR011527 (PROSITE_PROFILES); IPR011527 (SUPERFAMILY); IPR027417 (SUPERFAMILY),3.A.1.208.41, the atp-binding cassette (abc) superfamily.
RL4_JR_10343,10170,6892,4881,1,2,5,0,0,0,0,0,1,3,0,0,0,1,0,0.062566048,1,5.895380872,3.9237781,1.502475605,0.132974324,NA,0.019690652,0,9.130113206,3.10040789,2.944810338,0.003231527,0.016192829,0.051821331,1,6.455391609,1.882869124,3.428486626,0.000606956,0.00389406,0.059819512,1,6.034937464,3.090316907,1.952853913,0.050836908,0.124389486,0.052069571,1,6.348524227,1.503126389,4.223546519,2.40E-05,0.000209547,N,-,,Major facilitator superfamily general substrate transporter,"P:ATP hydrolysis coupled proton transport; F:hydrogen ion transmembrane transporter activity; C:membrane; C:integral component of membrane; C:proton-transporting V-type ATPase, V0 domain",G3DSA:1.20.1250.20 (GENE3D); PF13347 (PFAM); PTHR19432 (PANTHER); PTHR19432:SF30 (PANTHER); PTHR19432 (PANTHER); IPR020846 (SUPERFAMILY),2.A.2.6.1, the glycoside-pentoside-hexuronide (gph):cation symporter family.
RL4_JR_10344,33,11,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003880053,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,0,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,2OG-Fe(II) oxygenase,C:membrane; C:integral component of membrane,IPR021765 (PFAM); PTHR33365 (PANTHER),,
RL4_JR_10345,4204,2926,5512,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0.176439334,1,4.400066442,3.322347557,1.324384751,0.185375296,NA,0.055911027,0,7.625472043,2.516218044,3.030529115,0.002441256,0.015349618,0.14638944,0,4.958967966,1.595186058,3.108708192,0.001879072,0.009441055,0.168934322,1,4.537499345,2.160157715,2.100540768,0.035681298,0.100339377,0.146260623,0,4.858828031,1.439842656,3.37455486,0.000739352,0.003750469,N,-,,hypothetical protein VHEMI07077,P:transmembrane transport; C:membrane; C:integral component of membrane,IPR021765 (PFAM); PTHR33365 (PANTHER),,
RL4_JR_10346,4708,5484,7525,0,1,6,0,0,0,0,4,0,6,2,0,0,0,1,0.185950418,1,4.324444219,3.111276312,1.389926122,0.164551312,NA,0.058941126,0,7.549536028,2.363497458,3.194222191,0.001402082,0.015023052,0.153977417,1,4.886135755,1.440065895,3.392994564,0.00069133,0.004285993,0.17768521,1,4.464799717,1.944404529,2.296229848,0.021662743,0.079874461,0.153213592,1,4.792203001,1.31460379,3.645359184,0.000267019,0.001594082,N,-,,hypothetical protein PV08_05687,P:biological_process; C:membrane; C:integral component of membrane; C:cellular_component; F:molecular_function,PTHR35896 (PANTHER),,
RL4_JR_10347,8887,6255,2862,0,3,2,0,0,0,0,0,4,2,0,0,0,0,0,0.025057259,1,7.219003491,3.94920878,1.827961978,0.067555258,NA,0.00786752,0,10.45694023,3.949934497,2.647370541,0.008112041,0.028922185,7.863396857,1,8.770471963,2.229293463,3.93419355,8.35E-05,0.001042067,4.035174067,1,8.335897708,1.476093744,5.647268504,1.63E-08,4.38E-07,0.019989474,0,7.740939699,1.74385697,4.438976265,9.04E-06,9.18E-05,N,-,,---NA---,,no IPS match,,
RL4_JR_10348,119231,113096,95778,0,5,0,0,0,0,0,1,0,0,0,1,0,0,0,0.003906015,1,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001335523,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003330737,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003831463,1,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003164862,0,10.24113997,1.835086583,5.580739383,2.39E-08,8.07E-07,N,-,,amino acid transporter,C:integral component of membrane,no IPS match,2.A.18.4.1, the amino acid/auxin permease (aaap) family.
RL4_JR_10349,9616,7551,6897,0,0,6,0,0,0,0,0,0,2,1,0,0,8,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,casein kinase I isoform delta,C:nucleus; F:ATP binding; F:protein tyrosine kinase activity; P:peptidyl-serine autophosphorylation; P:peptidyl-threonine autophosphorylation; C:cell division site; P:regulation of DNA repair; P:homologous chromosome segregation; C:cytosol; P:peptidyl-tyrosine autophosphorylation; F:protein serine/threonine kinase activity,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); PTHR11909 (PANTHER); PTHR11909:SF18 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.3, the pock size-determining protein (psdp) family.
RL4_JR_10350,26199,19690,23146,3,5,41,0,0,0,2,0,12,3,9,9,2,36,2,7.749337191,1,6.729496885,1.176938886,5.717796367,1.08E-08,2.52E-07,0.036762441,0,8.23204606,2.664297114,3.089762781,0.002003164,0.015023052,0.093718365,1,5.606104448,1.60106416,3.501486441,0.000462671,0.003197322,0.107995902,1,5.184138358,2.383953031,2.174597524,0.02966029,0.091669852,0.09069319,1,5.546202614,1.367694288,4.055147896,5.01E-05,0.000390823,N,-, Effector probability:0.731,extracellular scp domain containing,,no IPS match,,
RL4_JR_10351,80116,38019,58970,0,0,0,0,3,2,0,8,5,4,0,3,0,8,1,7.301888356,0,1.043119594,1.161135247,0.898361837,0.368992675,0.560984391,1.112071909,1,3.312210377,1.39520365,2.373997787,0.017596656,0.052019086,2.887431381,1,0.65888677,1.217812447,0.541041251,0.58847915,0.708221618,3.330963382,1,0.236596581,1.222373463,0.19355507,0.846524282,0.903738755,2.851771404,1,0.574257206,1.218071279,0.471447949,0.637320882,0.739245495,N,-,,kinase-like domain,F:ATP binding; F:protein kinase activity; P:phosphorylation; P:protein phosphorylation; F:kinase activity,IPR000719 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),9.B.106.3.1, the pock size-determining protein (psdp) family.
RL4_JR_10352,39424,13270,25138,1,2,0,0,0,1,0,0,0,0,0,0,0,0,0,114.1360617,1,1.433101006,0.503733838,2.844956794,0.004441745,0.019693344,20.36402767,1,0.923717838,1.132829065,0.815407961,0.414838829,0.578613563,84.48701285,0,1.165338011,0.564915814,2.062852521,0.039126642,0.094029361,79.07370823,0,0.273847568,0.636479106,0.430253822,0.667011014,0.773044031,55.07931435,0,0.645851815,0.629199407,1.026466026,0.30467197,0.43988857,N,-,,metalloprotease m41,C:membrane; P:proteolysis; C:integral component of membrane; F:peptidase activity; F:metallopeptidase activity,no IPS match,,
RL4_JR_10353,13478,3765,8824,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2.241404483,1,0.733075511,1.255392347,0.583941357,0.559259767,0.736695452,0.717792718,0,3.943878876,1.468835798,2.68503728,0.007252172,0.026625492,1.859164189,0,1.294129675,1.219797894,1.060937784,0.288718177,0.428150406,2.144460383,0,0.872028143,1.230189242,0.708856908,0.478413279,0.619033156,1.830951925,0,1.213397359,1.211319797,1.001715123,0.316481201,0.451892844,N,-,,methyltransferase domain-containing,F:methyltransferase activity; F:transferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); IPR029063 (SUPERFAMILY),,
RL4_JR_10354,9749,5888,5532,0,6,5,0,0,0,0,0,0,3,2,2,0,1,0,12.02080301,1,-0.190385667,1.14095449,-0.166865259,0.867476069,0.935722566,2.622730615,0,2.074489582,1.284421721,1.615115619,0.106285659,0.212152128,6.792018838,0,-0.574740815,1.194609381,-0.481111922,0.630436955,0.741390235,15.85785908,1,0.73069439,1.013204433,0.721171726,0.470803866,0.611767087,14.04617504,1,0.279960742,1.118895875,0.250211613,0.802423705,0.866751994,N,-,,8-amino-7-oxononanoate synthase,F:pyridoxal phosphate binding; F:catalytic activity; P:biosynthetic process,IPR015421 (G3DSA:3.40.640.GENE3D); IPR004839 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); PTHR13693 (PANTHER); PTHR13693:SF53 (PANTHER); PTHR13693:SF53 (PANTHER); PTHR13693 (PANTHER); IPR015424 (SUPERFAMILY),,
RL4_JR_10355,3177,1842,2195,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,2.134359986,1,0.804163573,1.382557505,0.581649277,0.560802944,0.737670174,0.682764695,0,4.016218112,1.55978991,2.574845552,0.010028486,0.033623164,1.762873524,0,1.371552987,1.278384409,1.07287994,0.283324988,0.422815769,2.033404503,0,0.949296331,1.307744265,0.725903647,0.467897841,0.609320339,1.724383105,0,1.300367301,1.264484837,1.028377141,0.303772457,0.439071539,N,-,,class I glutamine amidotransferase,P:glutamine metabolic process; F:transferase activity,IPR017926 (PFAM); IPR029062 (G3DSA:3.40.50.GENE3D); PTHR11922:SF34 (PANTHER); PTHR11922 (PANTHER); IPR017926 (PROSITE_PROFILES); IPR029062 (SUPERFAMILY),,
RL4_JR_10356,1783,1382,1260,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0.007786068,0,8.896911713,4.040984052,2.201669593,0.027688656,NA,0.002502822,0,12.10389348,4.040376809,2.995733828,0.002737853,0.015349618,0.006502266,0,9.448056946,3.305547956,2.858242286,0.00425995,0.016940088,0.007499321,0,9.02784755,4.040049892,2.234588134,0.025444401,0.085851084,0.00645541,1,9.348501478,1.703823852,5.486776974,4.09E-08,1.17E-06,N,-,,nonribosomal peptide synthase,F:catalytic activity; P:metabolic process,IPR001242 (PFAM); IPR000873 (PFAM); IPR009081 (G3DSA:1.10.1200.GENE3D); G3DSA:2.30.38.10 (GENE3D); G3DSA:3.40.50.980 (GENE3D); G3DSA:3.30.300.30 (GENE3D); PTHR24095 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR009081 (SUPERFAMILY); SSF52777 (SUPERFAMILY); SSF56801 (SUPERFAMILY),4.C.1.1.16, the fatty acid transporter (fat) family.
RL4_JR_10357,29298,17418,18519,1,1,15,0,0,1,1,10,5,6,7,4,0,3,4,8.183870688,1,-1.135053031,1.235628415,-0.918603859,0.358302813,0.549649181,2.645903416,1,2.061858216,1.345268546,1.532674069,0.125356181,0.240952387,6.800890252,1,-0.576600844,1.230769631,-0.468488034,0.639435626,0.748917895,7.841264098,1,-0.998148482,1.232967526,-0.809549693,0.418199031,0.561424714,6.636377426,1,-0.644252839,1.225452667,-0.525726417,0.599078307,0.709154325,N,-,,NAD dependent epimerase dehydratase,,IPR016040 (G3DSA:3.40.50.GENE3D); IPR001509 (PFAM); PTHR10366 (PANTHER); PTHR10366:SF267 (PANTHER); IPR016040 (SUPERFAMILY),,
RL4_JR_10358,1617,1314,1386,0,0,2,8,0,0,0,0,0,0,2,0,0,0,0,84.00372191,1,-4.494692229,1.208774541,-3.718387572,0.000200498,0.001543082,26.97178749,1,-1.28783156,1.218541127,-1.056863434,0.290573919,0.44972312,69.60506961,0,-3.932107908,1.204013197,-3.265834559,0.00109142,0.00617983,80.27583707,1,-4.354051902,1.205718098,-3.61116907,0.00030482,0.002763027,68.17058118,0,-4.004860748,1.199901355,-3.337658326,0.000844876,0.004170827,N,-,,efflux pump antibiotic resistance,P:transmembrane transport; C:integral component of membrane,G3DSA:1.20.1250.20 (GENE3D); IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR23501:SF32 (PANTHER); PTHR23501 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.3.73, the major facilitator superfamily (mfs).
RL4_JR_10359,5158,4653,4936,4,6,22,0,0,4,11,6,7,2,10,1,0,10,1,763.2879672,1,-7.67840943,1.21029903,-6.344225055,2.24E-10,7.12E-09,243.1254878,1,-4.460037837,1.205064074,-3.701079415,0.000214684,0.009092193,650.2527582,1,-4.716387107,0.876853897,-5.378760502,7.50E-08,2.67E-06,735.7213042,1,-5.816362193,1.03452847,-5.62223502,1.89E-08,5.00E-07,621.1517664,1,-7.192581623,1.217226781,-5.908990612,3.44E-09,1.79E-07,N,PKS,,polyketide synthase,,SM00822 (SMART); IPR020843 (SMART); IPR020806 (SMART); IPR020841 (SMART); IPR020807 (SMART); IPR020801 (SMART); IPR016039 (G3DSA:3.40.47.GENE3D); IPR013154 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR032821 (PFAM); IPR009081 (G3DSA:1.10.1200.GENE3D); IPR013968 (PFAM); IPR009081 (PFAM); IPR013217 (PFAM); PF13602 (PFAM); IPR020807 (PFAM); IPR014031 (PFAM); IPR001227 (G3DSA:3.40.366.GENE3D); IPR029063 (G3DSA:3.40.50.GENE3D); IPR011032 (G3DSA:3.90.180.GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR014030 (PFAM); IPR016040 (G3DSA:3.40.50.GENE3D); IPR014043 (PFAM); PTHR11712:SF262 (PANTHER); PTHR11712:SF262 (PANTHER); PTHR11712 (PANTHER); IPR009081 (PROSITE_PROFILES); IPR016040 (SUPERFAMILY); IPR011032 (SUPERFAMILY); IPR016039 (SUPERFAMILY); IPR016035 (SUPERFAMILY); IPR016036 (SUPERFAMILY); IPR009081 (SUPERFAMILY); IPR029063 (SUPERFAMILY); IPR016040 (SUPERFAMILY),,
RL4_JR_10360,947,978,2711,2,0,10,0,0,0,0,0,0,0,1,0,0,0,1,12.18805837,1,-1.709582528,1.249526242,-1.368184574,0.171254309,0.324980845,3.891560086,0,1.505234888,1.322378751,1.138278187,0.255004339,0.409967268,10.06269438,0,-1.141827395,1.236597902,-0.923361906,0.355818637,0.499274267,20.92012634,1,-0.609218595,1.188400064,-0.512637633,0.608204824,0.72842132,9.860165009,1,-1.215336561,1.238488356,-0.981306409,0.326441663,0.462721803,N,-,,ankyrin repeat containing,,IPR020683 (G3DSA:1.25.40.GENE3D); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (SUPERFAMILY),,
RL4_JR_10361,4966,6941,8158,0,3,36,0,0,0,0,1,1,4,5,2,0,10,1,0.095435337,1,5.286782925,3.917931075,1.3493813,0.177214524,NA,0.030229218,0,8.512810514,2.65782857,3.202919334,0.001360421,0.015023052,0.078916107,1,5.850556787,1.521421522,3.845454203,0.000120329,0.001297917,0.091068364,1,5.42926052,2.409551074,2.253224917,0.024244971,0.084186358,0.078388769,1,5.759892734,1.311559679,4.391636023,1.13E-05,0.000111455,N,-,,major facilitator superfamily transporter,P:transmembrane transport; C:integral component of membrane,IPR011701 (PFAM); G3DSA:1.20.1250.20 (GENE3D); PTHR11360 (PANTHER); PTHR11360:SF97 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (SUPERFAMILY),2.A.1.13.19, the major facilitator superfamily (mfs).
RL4_JR_10362,3532,2484,2592,0,7,2,0,0,0,0,0,0,1,4,0,0,4,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,hypothetical protein SPI_03519,,no IPS match,,
RL4_JR_10363,1280,1698,945,0,0,5,0,0,0,0,0,0,0,2,0,0,0,0,0.65889166,1,2.499382473,1.807842658,1.382522125,0.166811442,NA,0.208747173,0,5.72540712,1.837578822,3.115734167,0.001834876,0.015023052,0.545105599,0,3.063314521,1.301304327,2.354033916,0.018570917,0.052931295,0.629043419,1,2.641053536,1.413011355,1.869095762,0.061609493,0.138739576,0.541817654,0,2.970339566,1.271533094,2.336030089,0.019489673,0.053608515,N,-,,hypothetical protein K441DRAFT_671458,,no IPS match,,
RL4_JR_10364,1555,1226,1943,0,0,4,0,0,0,0,0,0,0,1,0,0,1,0,77.10083604,1,6.900372221,1.03875032,6.642955568,3.07E-11,1.16E-09,0.232687407,0,5.568968107,1.769335602,3.147491127,0.001646781,0.015023052,0.604423613,0,2.914799626,1.258333692,2.316396394,0.020536635,0.056713829,0.697301481,1,2.492682715,1.337436539,1.863776443,0.062353105,0.139855449,4.457550197,1,3.759191189,1.144122306,3.285655013,0.001017455,0.00485473,Y,-,,CFEM domain-containing,F:chitin binding; C:membrane; C:integral component of membrane,IPR008427 (SMART); IPR001002 (G3DSA:3.30.60.GENE3D); IPR008427 (PFAM); PTHR37928 (PANTHER); IPR001002 (PROSITE_PROFILES),9.B.87.1.15, the selenoprotein p receptor (selp-receptor) family.
RL4_JR_10365,5832,5551,9688,0,0,4,0,0,0,0,1,0,0,0,0,0,1,1,38.42185541,1,7.738109137,0.858247229,9.016177245,1.95E-19,2.27E-17,0.074176016,0,7.217987172,2.26372828,3.188539559,0.001429934,0.015023052,0.194488014,1,4.550410777,1.416101298,3.213337056,0.001312022,0.007126084,0.224518397,0,4.127658057,1.818425232,2.269908041,0.023213163,0.082294565,11.77535157,1,6.618232975,0.951085256,6.958611685,3.44E-12,3.19E-10,N,-,,Pectin lyase fold virulence factor,F:catalytic activity,IPR024535 (PFAM); IPR012334 (G3DSA:2.160.20.GENE3D); PTHR31375 (PANTHER); PTHR31375:SF15 (PANTHER); IPR011050 (SUPERFAMILY); IPR011050 (SUPERFAMILY),,
RL4_JR_10366,25294,35202,29051,14,17,35,0,0,1,0,5,2,1,15,6,0,14,4,371.8578981,1,-3.267220382,0.680738946,-4.799520286,1.59E-06,2.29E-05,109.3147833,1,-3.30684074,1.200202679,-2.755235258,0.005864995,0.022929887,329.3456565,1,-2.810139602,0.694882265,-4.04405141,5.25E-05,0.000753355,457.1590967,1,-1.290490151,0.415819767,-3.10348438,0.001912563,0.012779506,297.7046945,1,-3.852119862,0.889254694,-4.331852154,1.48E-05,0.000139393,N,-,,mitochondrial carrier,C:membrane; P:transport,IPR002067 (PRINTS); IPR018108 (PFAM); IPR023395 (G3DSA:1.50.40.GENE3D); PTHR24089:SF88 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),2.A.29.10.4, the mitochondrial carrier (mc) family.
RL4_JR_10367,3660,2969,2849,0,0,0,0,0,0,0,2,0,3,4,3,0,0,0,41.57652925,0,0.087383404,0.871474684,0.100270732,0.920129393,0.961623962,5.599357277,0,0.980182997,1.248986574,0.784782652,0.432581013,0.594109228,21.08461221,1,-0.715849943,1.20396882,-0.594575151,0.552127494,0.679016134,43.4776155,1,0.633345028,0.765452737,0.827412324,0.408003398,0.551760972,26.03438378,0,0.418515238,0.882362581,0.474312088,0.635277373,0.738133087,N,-,,glyoxylate reductase,,no IPS match,,
RL4_JR_10368,18648,14996,14248,2,1,3,0,0,0,0,0,1,0,9,0,1,2,0,0.275123512,1,3.759829384,2.812841264,1.336666036,0.181331673,NA,0.086978349,0,6.989029657,2.331253578,2.997970586,0.002717839,0.015349618,0.22571999,1,4.337805867,1.539266944,2.818098502,0.004830899,0.018490744,0.260480668,1,3.914180973,1.926705373,2.031541007,0.042200144,0.111531313,0.221403501,1,4.263078583,1.425678148,2.990211073,0.002787847,0.011171308,N,-,,glycoside hydrolase family 18,F:chitinase activity; P:carbohydrate metabolic process; F:chitin binding; P:chitin catabolic process,IPR001002 (SMART); IPR018392 (SMART); IPR018392 (PFAM); IPR018392 (G3DSA:3.10.350.GENE3D); IPR001223 (PFAM); IPR001002 (PFAM); IPR013781 (G3DSA:3.20.20.GENE3D); IPR001002 (G3DSA:3.30.60.GENE3D); PTHR11177 (PANTHER); PTHR11177:SF218 (PANTHER); IPR001002 (PRODOM); IPR017853 (SUPERFAMILY); IPR018392 (SUPERFAMILY); IPR018392 (SUPERFAMILY); IPR001002 (SUPERFAMILY),,
RL4_JR_10369,2387,2036,1873,0,0,0,0,0,0,0,0,1,0,0,2,0,0,0,0.705431269,0,2.401296723,1.86193659,1.289676961,0.197162842,NA,0.222662834,0,5.632606428,1.874143518,3.005429613,0.00265206,0.015349618,0.580090023,1,2.975105186,1.347379475,2.208067765,0.02723955,0.071148917,0.669486776,1,2.551962946,1.473246767,1.732203323,0.083237368,0.170775754,0.572745754,0,2.891092766,1.310125153,2.20673022,0.027332913,0.070062213,N,-,,class V chitinase Chi100,"F:chitinase activity; P:carbohydrate metabolic process; F:chitin binding; P:chitin catabolic process; P:metabolic process; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:hydrolase activity, acting on glycosyl bonds; F:hydrolase activity",no IPS match,,
RL4_JR_10370,21895,30116,36877,1,0,4,2,0,0,1,3,0,1,12,0,0,9,0,0.052295516,1,6.154894042,3.927122226,1.567278452,0.11704962,NA,0.016543286,1,9.382878827,2.984235773,3.144147963,0.001665712,0.015023052,0.04311163,1,6.724957903,1.684831332,3.991472484,6.57E-05,0.000886381,0.049751748,1,6.301915963,3.034418018,2.07681207,0.037818908,0.103518908,0.04264625,1,6.641677473,1.34861938,4.92479759,8.44E-07,1.26E-05,N,-,,ankyrin repeat containing,,no IPS match,,
RL4_JR_10371,19255,19293,23321,6,1,1,0,0,0,0,0,2,1,0,3,0,5,1,0.221307421,1,4.073594331,2.843703283,1.432496265,0.152001846,NA,0.070688907,0,7.288051923,2.244850236,3.246564874,0.001168068,0.015023052,0.183037971,1,4.639662125,1.360141794,3.411160619,0.00064687,0.004072705,0.211144348,1,4.216749153,1.767137841,2.386202737,0.017023364,0.070814115,0.179877455,1,4.562150078,1.256450399,3.630983032,0.000282344,0.001665927,N,-,,ankyrin repeat containing,,no IPS match,,
RL4_JR_10372,453,468,484,0,0,7,0,0,0,0,5,1,0,1,0,0,4,0,291.9670447,1,-0.241422004,1.052220416,-0.229440524,0.818526542,0.907767745,84.12977032,0,-0.591416332,0.989352883,-0.597780976,0.549986086,0.696305086,168.7053893,1,-2.46938739,0.85710893,-2.881065993,0.003963326,0.016317494,211.0051827,1,-1.16737696,0.498895668,-2.339922021,0.019287767,0.075572463,163.4514382,1,-1.561134526,0.591969688,-2.637186593,0.008359683,0.027207263,N,-,,3-hydroxy-3-methylglutaryl-coenzyme a reductase,C:peroxisomal membrane; C:endoplasmic reticulum membrane; F:NADP binding; C:integral component of membrane; P:ergosterol biosynthetic process; P:coenzyme A metabolic process; P:oxidation-reduction process; P:isoprenoid biosynthetic process; F:hydroxymethylglutaryl-CoA reductase (NADPH) activity,IPR002202 (PRINTS); IPR023074 (G3DSA:3.90.770.GENE3D); IPR004554 (TIGRFAM); IPR023282 (G3DSA:1.10.3270.GENE3D); IPR002202 (PFAM); IPR000731 (PFAM); IPR025583 (PFAM); IPR009023 (G3DSA:3.30.70.GENE3D); IPR002202 (PANTHER); PTHR10572:SF2 (PANTHER); IPR002202 (PANTHER); PTHR10572:SF2 (PANTHER); PTHR10572:SF2 (PANTHER); IPR000731 (PROSITE_PROFILES); IPR002202 (PROSITE_PROFILES); IPR009029 (SUPERFAMILY); IPR009023 (SUPERFAMILY),2.A.6.6.5, the resistance-nodulation-cell division (rnd) superfamily.
RL4_JR_10373,150,186,187,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003880053,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,0,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,0,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-, Effector probability:0.601,cupin,F:manganese ion binding; F:nutrient reservoir activity,IPR006045 (SMART); IPR014710 (G3DSA:2.60.120.GENE3D); IPR006045 (PFAM); PTHR31238:SF29 (PANTHER); PTHR31238 (PANTHER); IPR011051 (SUPERFAMILY),,
RL4_JR_10374,354,320,322,0,0,0,0,0,0,0,1,0,0,1,0,0,3,1,225.692411,0,-1.034916964,0.813479723,-1.272209909,0.203298548,0.367870166,51.0176523,0,-2.207424799,1.230019169,-1.794626339,0.072713254,0.158178284,172.6574968,1,-2.010723909,0.802420813,-2.505822228,0.012216703,0.037765465,188.7135981,1,-1.997672967,0.704043101,-2.837429929,0.004547833,0.026040784,251.5806726,1,-0.212606334,0.530674311,-0.400634305,0.688689385,0.779365153,N,-,,Metallophosphoesterase domain,F:pyridoxal phosphate binding; F:transaminase activity; F:hydrolase activity,IPR004843 (PFAM); IPR029052 (G3DSA:3.60.21.GENE3D); PTHR32440:SF0 (PANTHER); PTHR32440 (PANTHER); IPR029052 (SUPERFAMILY),,
RL4_JR_10375,1317,2789,2561,0,2,0,0,0,0,0,0,0,0,2,0,0,0,5,56.58679636,1,-3.924770753,1.19326691,-3.289097117,0.001005093,0.005941704,18.0518154,0,-0.70857978,1.205139809,-0.587964794,0.556555924,0.701202273,46.87958296,0,-3.36194239,1.193761905,-2.816258733,0.004858652,0.018561884,102.2586294,1,-0.272435071,1.54113056,-0.176776114,0.859684252,0.912687748,54.01780275,1,-1.780761542,0.98362888,-1.810399814,0.070233808,0.145262449,N,-,,Velvet factor,,PF05729 (PFAM); PTHR10039 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_10376,15525,22896,24737,0,0,1,0,0,2,1,0,0,0,10,0,0,5,0,62.45357318,1,1.555119857,0.601080456,2.58720749,0.009675731,0.036954406,4.788125971,1,1.206107412,1.276815343,0.944621647,0.344852072,0.508149809,12.34138902,1,-1.43642084,1.209833212,-1.187288318,0.235113914,0.367499347,14.23099683,1,-1.858129204,1.209292997,-1.536541772,0.124405561,0.230697126,15.95077818,1,-0.580521963,1.13697337,-0.510585365,0.609641426,0.717607421,N,-,,hypothetical protein CMQ_3433,,IPR025676 (PFAM); PTHR38788:SF3 (PANTHER); PTHR38788 (PANTHER),,
RL4_JR_10377,962,1684,1438,0,4,38,0,0,1,1,2,20,0,0,3,0,1,0,0.109866676,1,5.084013966,3.903153387,1.302540142,0.192731805,NA,0.034776627,1,8.311540419,2.643332058,3.144342155,0.001664607,0.015023052,0.090358882,1,5.659073312,1.564891797,3.616271311,0.000298877,0.00231687,0.104270771,1,5.234897026,2.365787239,2.212750555,0.026914848,0.087153604,0.088905685,1,5.581655722,1.348734265,4.138439918,3.50E-05,0.000285752,N,-,,glycogen synthase,P:glycogen biosynthetic process; F:glycogen (starch) synthase activity,IPR008631 (PFAM); PTHR10176:SF3 (PANTHER); IPR008631 (PANTHER),,
RL4_JR_10378,606,607,538,4,2,4,0,0,0,0,0,0,0,1,0,0,0,0,4.267296525,1,-0.195540246,1.206993594,-0.162006035,0.871301102,0.938483547,1.368409636,0,3.013087532,1.361670401,2.212787712,0.026912285,0.072564237,3.537505729,0,0.36642664,1.205820018,0.303881703,0.761218018,0.839495775,4.080075581,1,-0.05562049,1.205802201,-0.046127375,0.963208727,0.978772417,3.473627305,0,0.289705807,1.198246234,0.241774853,0.808954625,0.870911982,N,-, Effector probability:0.581,ubiquitin family,C:intracellular organelle; P:single-organism process; P:organic substance metabolic process; P:cellular process,G3DSA:3.10.20.90 (GENE3D),,
RL4_JR_10379,378,312,351,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,70.28337414,0,-2.368933764,1.073800429,-2.206121081,0.027375523,0.084275289,19.79085117,0,-0.841295996,1.229780487,-0.684102574,0.493910397,0.649100136,58.25670012,0,-2.542961567,1.219915604,-2.08453893,0.037111173,0.090034391,95.83904236,1,-0.201185409,0.68661258,-0.293011539,0.769513332,0.85018255,51.5059578,0,-3.600448803,1.232985259,-2.920106933,0.003499113,0.013384405,N,-,,phosphotransferase enzyme family,F:transferase activity,G3DSA:3.90.1200.10 (GENE3D); IPR002575 (PFAM); PTHR21310 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_10380,1928,1401,1841,0,0,3,0,0,0,0,3,1,0,0,0,0,2,0,0.777542435,1,2.260907296,1.713371096,1.319566614,0.186979756,NA,0.247734198,0,5.478809069,1.797877903,3.047375498,0.002308491,0.015159195,0.641606628,1,2.830045618,1.299213821,2.178275486,0.029385533,0.075373483,0.740195494,0,2.407293405,1.391989947,1.729389935,0.08373933,0.171458184,0.629833778,1,2.753902088,1.262594514,2.181145298,0.029172671,0.073530818,N,-, Effector probability:0.878,glycoside hydrolase family 3,F:beta-glucosidase activity; P:cellulose catabolic process; F:scopolin beta-glucosidase activity,IPR001764 (PRINTS); IPR001764 (PFAM); IPR001764 (G3DSA:3.20.20.GENE3D); PTHR30620:SF32 (PANTHER); IPR026892 (PANTHER); IPR017853 (SUPERFAMILY),,
RL4_JR_10381,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.28144454,0,1.539720306,1.412268719,1.090245989,0.2756048,NA,0.406862344,0,4.762742863,1.612062595,2.954440402,0.003132366,0.015941545,1.060302477,0,2.103848219,1.251225687,1.68142985,0.092679452,0.182973239,30.12930861,0,4.034452191,0.873285218,4.619856274,3.84E-06,6.04E-05,1.051200182,0,2.014204369,1.241266032,1.622701595,0.10465321,0.197652258,N,-,,fad dependent oxidoreductase superfamily,,no IPS match,,
RL4_JR_10382,810,770,614,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.980109208,0,0.322578033,1.255748903,0.256880999,0.797270639,0.896831455,0.949397215,0,3.540488025,1.426992495,2.481083844,0.013098356,0.041380012,2.462085425,0,0.889382204,1.223770807,0.726755532,0.467375729,0.604254959,2.840456925,0,0.466934932,1.231612018,0.379125021,0.704595027,0.801936224,2.422939423,0,0.809719225,1.2179625,0.664814578,0.506169098,0.633051148,,,,,,,,
RL4_JR_10383,10949,19136,16922,8,4,54,0,0,0,5,2,0,6,99,3,0,39,4,273.3678881,1,-5.201916648,1.16384916,-4.469579759,7.84E-06,9.39E-05,195.7762173,0,0.383985556,1.453042638,0.264263103,0.791577189,0.873795221,252.6371667,1,-3.159651328,0.865693465,-3.649850038,0.000262393,0.002098319,265.2291774,1,-3.720419725,0.878070893,-4.237037982,2.26E-05,0.000292499,236.3499754,1,-3.07408198,0.792412565,-3.879395806,0.000104716,0.000719791,N,-, Effector probability:0.586,perilipin mpl1,,PTHR11736 (PANTHER); PTHR11736:SF79 (PANTHER),,
RL4_JR_10384,712,673,870,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,151.3528498,1,-2.946629923,0.886062757,-3.325531855,0.0008825,0.005409043,44.59004044,0,-2.013151304,1.20371679,-1.672445978,0.094436412,0.193616642,115.9104174,0,-4.667895144,1.201347032,-3.885550985,0.000102098,0.001175928,235.6262103,0,-0.172294917,0.766103238,-0.224897779,0.822058797,0.888202467,129.3549129,0,-3.056617448,0.992669221,-3.079190312,0.00207564,0.008738403,N,-,,---NA---,,no IPS match,,
RL4_JR_10385,52342,32073,31801,2,0,3,0,0,0,1,21,32,6,11,23,0,36,15,548.5125909,1,-4.145434177,0.814875369,-5.087200247,3.63E-07,6.19E-06,168.8931263,0,-3.934448687,1.253507996,-3.13875037,0.001696699,0.015023052,435.8868912,1,-6.578819828,1.249802529,-5.263887434,1.41E-07,4.73E-06,516.2623955,1,-5.262819738,1.09005022,-4.828052545,1.38E-06,2.47E-05,428.353781,1,-6.656440361,1.268540492,-5.247321943,1.54E-07,3.25E-06,N,-,,F-box domain-containing,,IPR021894 (PFAM); G3DSA:1.20.1280.50 (GENE3D); PTHR22990 (PANTHER); PTHR22990:SF15 (PANTHER); IPR001810 (PROSITE_PROFILES); IPR001810 (SUPERFAMILY),,
RL4_JR_10386,2960,2628,1428,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0.096605346,0,5.269425083,3.917797721,1.34499672,0.178626294,NA,0.031420348,0,8.458592806,2.703070128,3.129253924,0.001752508,0.015023052,0.080395416,0,5.827841325,1.585177042,3.676460844,0.000236492,0.001964107,0.092670049,0,5.405027512,2.46242685,2.195000234,0.028163581,0.089278728,0.078033741,1,5.764104952,1.337557515,4.309425864,1.64E-05,0.000151902,N,-,,transcription factor bzip,"F:transcription factor activity, sequence-specific DNA binding; P:regulation of transcription, DNA-templated; F:sequence-specific DNA binding",IPR004827 (PFAM); G3DSA:1.20.5.170 (GENE3D); IPR004827 (PROSITE_PROFILES); SSF57959 (SUPERFAMILY),,
RL4_JR_10387,1039,907,1099,0,0,1,0,2,0,0,0,2,0,4,0,0,0,1,37.36359274,1,-3.325875814,1.189378245,-2.796314653,0.005168905,0.022322883,11.99575461,1,-0.118894772,1.22052854,-0.097412529,0.922398795,0.957297304,30.99090969,1,-2.764752774,1.193342234,-2.316814653,0.02051383,0.056681774,35.74246137,1,-3.186716831,1.192435921,-2.672442833,0.00753012,0.038623338,30.41565158,1,-2.840555312,1.189816828,-2.387388753,0.016968537,0.047990626,N,-,,N-glycosylation EOS1,C:endoplasmic reticulum membrane; C:integral component of membrane; P:cellular response to oxidative stress,IPR021100 (PFAM); PTHR28147 (PANTHER),,
RL4_JR_10388,193,161,186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.086230968,0,5.433732393,3.919126495,1.386465173,0.165604908,NA,0.027600087,0,8.645773106,2.838603238,3.045784276,0.002320743,0.015159195,0.071048882,0,6.007518554,1.712228198,3.508596905,0.000450477,0.003130151,0.081947866,0,5.582895588,2.668294537,2.092308592,0.03641092,0.101308206,0.069113162,0,5.944329419,1.425479097,4.170057232,3.05E-05,0.000255875,N,-, Effector probability:0.58,glycogen synthase,P:glycogen biosynthetic process; F:glycogen (starch) synthase activity,IPR008631 (PFAM); PTHR10176:SF3 (PANTHER); IPR008631 (PANTHER),,
RL4_JR_10389,5387,5293,6058,5,2,8,0,2,3,4,7,2,13,33,16,0,10,3,9.979227021,1,0.221849544,1.152379492,0.192514311,0.847339359,0.923402951,1.962711342,1,2.492691533,1.314310117,1.896577908,0.057883669,0.132646252,5.092983383,1,-0.159412894,1.202884592,-0.13252551,0.894568647,0.934332417,25.14626873,1,1.162992042,1.016798459,1.143778329,0.252715579,0.39250579,5.017916452,1,-0.240730206,1.203111068,-0.200089761,0.841410381,0.893287208,N,-,,C6 transcription factor,F:binding,IPR001138 (SMART); IPR007219 (SMART); IPR007219 (PFAM); IPR001138 (G3DSA:4.10.240.GENE3D); IPR001138 (PFAM); PTHR19444 (PANTHER); PTHR19444:SF23 (PANTHER); IPR001138 (PROSITE_PROFILES); IPR001138 (SUPERFAMILY),,
RL4_JR_10390,10028,15566,20235,0,0,0,0,0,0,0,3,3,3,2,3,0,3,0,19.39736091,0,6.605117961,0.748406691,8.825573101,1.09E-18,1.20E-16,0.096234139,0,6.842602503,2.11978074,3.227976543,0.001246692,0.015023052,0.251203417,1,4.181596246,1.344655948,3.109788977,0.00187221,0.009420606,0.289911754,1,3.758987388,1.633060645,2.301805141,0.021346164,0.079255558,0.249099456,1,4.092741271,1.270055791,3.222489358,0.001270819,0.00583804,N,-,,hypothetical protein SBOR_0639,"P:RNA phosphodiester bond hydrolysis, endonucleolytic; F:nucleic acid binding; F:RNA-DNA hybrid ribonuclease activity",no IPS match,,
RL4_JR_10391,696,855,1512,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,67.23426646,0,-3.141185165,1.137832418,-2.760674696,0.00576821,0.024445224,20.30846424,0,-0.878464832,1.202105573,-0.730771782,0.464918562,0.623877196,63.62439792,0,-2.564940507,1.188008597,-2.159025207,0.030848211,0.078449458,72.65329116,0,-1.642312125,0.849814338,-1.932554031,0.05329116,0.127058254,51.66787434,0,-3.604989709,1.185115684,-3.041888448,0.00235099,0.009715826,Y,-,,pre-mrna-splicing regulator wtap,,no IPS match,,
RL4_JR_10392,518,384,622,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,---NA---,,no IPS match,,
RL4_JR_10393,602,589,870,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,50.91087208,0,0.399008342,0.733813582,0.543746194,0.58661614,0.75886158,6.036641879,0,0.871774867,1.234212362,0.706341059,0.479976065,0.637235225,44.28115972,0,0.634112396,0.848135835,0.747654291,0.454668709,0.593867373,18.04361074,1,-2.200668356,1.189262324,-1.850448225,0.064248974,0.142533054,23.1293999,1,-0.190376692,0.974530501,-0.195352215,0.845117223,0.89637669,Y,-,,---NA---,,no IPS match,,
RL4_JR_10394,2836,2183,1702,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,69.76148399,0,-1.208514587,0.829515391,-1.456892301,0.145146112,0.290078878,17.48965752,0,-0.662875736,1.242812796,-0.533367325,0.593779332,0.730194921,45.10607091,0,-3.306224781,1.217643575,-2.715264834,0.006622279,0.023507697,52.02120472,0,-3.728175079,1.221181326,-3.052925066,0.002266225,0.014633629,44.11376087,0,-3.37693444,1.215453658,-2.778332533,0.005463867,0.019262414,N,-,,recQ family helicase,F:nucleic acid binding; F:ATP binding; C:membrane; C:integral component of membrane; F:helicase activity; F:hydrolase activity,no IPS match,,
RL4_JR_10395,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,99.24228415,0,-4.73519723,1.226755803,-3.859934649,0.000113417,0.000949061,31.85813414,0,-1.528048099,1.229120463,-1.243204507,0.213792482,0.360487674,82.17155715,0,-4.17155869,1.215062142,-3.433206043,0.000596489,0.003843953,94.76896113,0,-4.59350469,1.21890968,-3.768535738,0.000164208,0.001625526,80.38516867,0,-4.242638196,1.212743006,-3.498381911,0.00046809,0.002563231,N,-, Effector probability:0.64,restless-like transposase,F:nucleic acid binding; F:ATP binding; F:metal ion binding; F:protein dimerization activity; F:helicase activity; F:hydrolase activity,no IPS match,,
RL4_JR_10396,1124,813,653,0,0,0,0,0,0,0,0,2,0,2,0,0,0,0,12.06277365,0,0.83083074,1.165096006,0.713100668,0.475783466,0.665177069,1.284352297,0,3.104360325,1.374361293,2.258765829,0.023897955,0.066272631,3.349405647,1,0.444780801,1.221095938,0.36424722,0.715673409,0.807655511,11.88824392,1,1.737898683,1.040256587,1.670644248,0.094791967,0.188153042,7.181939207,0,1.282498281,1.152721111,1.11258332,0.265887427,0.398182251,N,-,,S-adenosyl-L-methionine-dependent partial,F:methyltransferase activity; F:transferase activity; P:methylation,IPR029063 (G3DSA:3.40.50.GENE3D); PTHR10108:SF923 (PANTHER); PTHR10108 (PANTHER); IPR029063 (SUPERFAMILY),,
RL4_JR_10397,215,410,269,2,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12.46419344,1,1.34782042,1.028901701,1.309960338,0.190209253,0.350118928,1.533859817,0,2.848333695,1.343032139,2.120823183,0.033936685,0.087140316,3.987754185,1,0.193422328,1.209068528,0.159976315,0.872899731,0.919683305,4.601121368,0,-0.229143898,1.209839202,-0.189400291,0.849779096,0.905962809,7.797836555,0,1.038330753,1.137502547,0.912816201,0.361339216,0.498645163,N,-,,hydantoinase,F:hydrolase activity,IPR002821 (PFAM); IPR008040 (PFAM); G3DSA:3.30.420.40 (GENE3D); IPR024071 (G3DSA:2.40.390.GENE3D); IPR010318 (PFAM); IPR027479 (G3DSA:3.40.1610.GENE3D); PTHR11365 (PANTHER); PTHR11365:SF10 (PANTHER); PTHR11365:SF10 (PANTHER); SSF160991 (SUPERFAMILY); SSF53067 (SUPERFAMILY),,
RL4_JR_10398,154,348,232,0,0,57,0,0,0,0,13,1,3,14,3,0,13,0,13.89946344,1,2.900621986,0.874347026,3.31747224,0.000908359,0.005517793,0.783735286,0,3.817192905,1.463538261,2.608194816,0.009102113,0.031419274,2.024506664,1,1.17180774,1.224136847,0.957252241,0.338439955,0.481637068,186.0806748,1,6.348453713,1.357296782,4.677277511,2.91E-06,4.72E-05,21.28779172,1,4.014516809,0.695554586,5.771677583,7.85E-09,3.80E-07,N,-,,thiamine transporter,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transmembrane transport; P:transcription, DNA-templated; C:integral component of membrane; F:transporter activity",IPR001248 (PFAM); PTHR30618 (PANTHER); PTHR30618:SF4 (PANTHER),2.A.39.3.1, the nucleobase:cation symporter-1 (ncs1) family.
RL4_JR_10399,977,806,846,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.118505011,0,1.735919781,1.436086637,1.208784858,0.226745511,NA,0.35743933,0,4.949681776,1.644546484,3.009754862,0.002614586,0.015349618,0.927499121,0,2.29705444,1.24713202,1.841869508,0.06549424,0.13941625,1.069926648,0,1.874981796,1.290056075,1.453411083,0.146109651,0.260864084,0.915494749,0,2.21330729,1.229143116,1.800691279,0.071751553,0.14762944,N,-,,---NA---,,IPR022198 (PFAM),,
RL4_JR_10400,5711,15640,8497,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,552.313248,0,-2.12059083,0.387399559,-5.473911314,4.40E-08,9.46E-07,145.2586992,0,-3.71696216,1.194589327,-3.11149788,0.001861408,0.015023052,384.14983,0,-5.404982469,1.192343499,-4.533074969,5.81E-06,0.000118653,483.8166002,0,-2.649887546,0.495140717,-5.351786781,8.71E-08,1.99E-06,381.7823749,0,-4.769678658,0.980147931,-4.866284475,1.14E-06,1.61E-05,N,-, Effector probability:0.556,arginine deiminase type-3,,no IPS match,,
RL4_JR_10401,296,615,374,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,294.4284861,1,-1.794593161,0.545463176,-3.290035405,0.001001748,0.005930521,96.91871029,0,-1.826651031,1.136229155,-1.607643161,0.107913354,0.214563882,199.1036901,0,-4.438719708,1.215841706,-3.650738155,0.000261488,0.002096042,246.1752657,0,-2.59207245,0.703095401,-3.686658235,0.000227218,0.002140078,203.8989778,0,-3.772136741,1.006040685,-3.749487268,0.000177196,0.001122725,Y,-,,cupin,F:manganese ion binding; F:nutrient reservoir activity,IPR006045 (SMART); IPR006045 (PFAM); IPR014710 (G3DSA:2.60.120.GENE3D); PTHR35392:SF3 (PANTHER); PTHR35392 (PANTHER); IPR011051 (SUPERFAMILY),,
RL4_JR_10402,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.159778324,0,4.543434401,3.266423648,1.390950743,0.164240364,NA,0.050783595,0,7.764794066,2.38935577,3.249743786,0.00115509,0.015023052,0.132141566,0,5.108055584,1.401937737,3.643568077,0.000268884,0.002135048,0.152466653,0,4.686049182,1.972572329,2.375603223,0.017520291,0.072110955,0.130704529,0,5.022493468,1.271377299,3.95043507,7.80E-05,0.000564174,N,-,,h k atpase alpha,F:ATP binding; F:sodium:potassium-exchanging ATPase activity; F:metal ion binding; P:ATP hydrolysis coupled transmembrane transport; C:integral component of membrane; P:establishment or maintenance of transmembrane electrochemical gradient,IPR006068 (PFAM); G3DSA:3.30.200.20 (GENE3D); IPR023298 (G3DSA:1.20.1110.GENE3D); PTHR24093:SF263 (PANTHER); PTHR24093 (PANTHER); IPR011009 (SUPERFAMILY); SSF81665 (SUPERFAMILY),3.A.3.1.7, the p-type atpase (p-atpase) superfamily.
RL4_JR_10403,3,11,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,81.57885373,0,0.188446481,0.592275259,0.318173819,0.750353091,0.870005683,12.10895766,0,-0.132532608,1.211755986,-0.109372357,0.912907158,0.951348323,51.00361096,0,-0.388145044,0.860051732,-0.451304298,0.651770247,0.758276486,87.07038086,0,0.806749771,0.51421786,1.568887107,0.116674247,0.219536656,62.05511575,0,0.677171356,0.600506104,1.12766773,0.259460271,0.391335504,N,-,,"hypothetical protein MYCTH_2071098, partial",,no IPS match,,
RL4_JR_10404,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3.718132154,0,0.003258221,1.217029816,0.00267719,0.997863914,0.999396344,1.184471966,0,3.221281226,1.372869725,2.346385215,0.018956504,0.05515359,3.074571485,1,0.568667791,1.206574952,0.471307473,0.63742118,0.747077104,7.55869596,0,1.093131471,1.149289075,0.951137094,0.341534787,0.488423688,10.39656204,0,1.421808949,1.127211984,1.261350101,0.207182738,0.329908179,N,-,,hypothetical protein SPBR_06064,,no IPS match,,
RL4_JR_10405,11,5,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.959725897,0,-0.677737536,1.35185348,-0.501339491,0.616132217,0.77932821,1.913331764,0,2.529372837,1.475963319,1.713709822,0.086582032,0.181074789,4.962320527,0,-0.122173673,1.308052186,-0.093401222,0.925584819,0.956010343,5.723389184,0,-0.544182064,1.324724824,-0.410788757,0.681227438,0.783175634,4.906832792,0,-0.20866005,1.320810373,-0.15797881,0.874473496,0.916489325,N,-,,hypothetical protein S40293_11523,,no IPS match,,
RL4_JR_10406,81,57,82,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.180322638,0,4.368986209,3.096290194,1.411038996,0.158233116,NA,0.057642997,0,7.58230286,2.329507846,3.254894751,0.001134344,0.015023052,0.149319312,0,4.932786703,1.377263589,3.581585066,0.000341516,0.002572884,0.172244024,0,4.510337265,1.881110124,2.397699745,0.016498383,0.069610783,0.146927924,0,4.853300452,1.258716335,3.855753927,0.000115373,0.000781899,N,-,,---NA---,,no IPS match,,
RL4_JR_10407,2,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.019781616,0,7.556258757,3.960309894,1.907996838,0.056391625,NA,0.006177465,0,10.80099648,3.666590793,2.94578727,0.003221339,0.016157775,0.016297679,0,8.122821537,2.181397604,3.723677664,0.000196342,0.001734522,0.018818652,0,7.703057059,3.960515312,1.944963332,0.051779392,0.125559168,0.01637629,0,8.021846978,1.492011636,5.376531112,7.59E-08,1.81E-06,Y,-,,Aminoglycoside phosphotransferase,F:transferase activity,no IPS match,,
RL4_JR_10408,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.00781203,0,8.892744797,4.040603428,2.200845729,0.027746947,NA,0.002671046,0,12.02147059,4.033076589,2.980719638,0.002875719,0.015349618,0.006661474,0,9.419457567,4.037296344,2.333110271,0.019642359,0.054842592,0.007662926,0,9.0007212,4.037607722,2.229221316,0.025799183,0.085851084,0.006329724,0,9.358205403,1.810346289,5.16929024,2.35E-07,4.41E-06,N,-,,c6 transcription factor,"C:nucleus; F:zinc ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_10409,87,45,88,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.05336168,0,6.126422091,3.926725426,1.560186014,0.11871593,NA,0.017061521,0,9.339978716,3.083309107,3.029206087,0.002451974,0.015349618,0.043954106,0,6.70110955,1.826162711,3.669503001,0.000243022,0.001993808,0.050699014,0,6.275673096,3.142576026,1.996983699,0.045826954,0.116156628,0.042793964,0,6.637540837,1.429286936,4.643952637,3.42E-06,4.12E-05,N,-,,cytidylate kinase,F:ATP binding; P:phosphorylation; F:transferase activity; F:nucleobase-containing compound kinase activity; P:nucleobase-containing compound metabolic process; F:kinase activity,IPR000850 (PRINTS); IPR003607 (SMART); IPR006674 (PFAM); PF00406 (PFAM); IPR006674 (G3DSA:1.10.3210.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR23359:SF107 (PANTHER); IPR000850 (PANTHER); IPR000850 (HAMAP); IPR027417 (SUPERFAMILY); SSF109604 (SUPERFAMILY),,
RL4_JR_10410,4212,2582,4630,2,0,77,0,0,2,3,8,8,20,71,10,2,43,11,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,N,-,,delta-1-pyrroline-5-carboxylate dehydrogenase,"F:1-pyrroline-5-carboxylate dehydrogenase activity; P:glutamate biosynthetic process; P:proline biosynthetic process; P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",IPR015590 (PFAM); IPR016162 (G3DSA:3.40.605.GENE3D); PTHR11699:SF18 (PANTHER); PTHR11699 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_10411,1,7,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.39320554,0,-0.89533067,1.139454348,-0.785753876,0.432011693,0.622897029,42.62790464,0,2.288226051,1.11595363,2.050466963,0.040318885,0.09970871,11.09841818,0,-1.283251353,1.194164058,-1.074602224,0.282552856,0.421974496,12.80064063,0,-1.705283449,1.191744375,-1.43091378,0.152454927,0.26943072,10.90426668,0,-1.360669445,1.191410581,-1.142065939,0.253426612,0.384353572,N,-,,telomerase-binding EST1A partial,,IPR018834 (PFAM); PTHR15696 (PANTHER); PTHR15696:SF6 (PANTHER); IPR011990 (SUPERFAMILY),,
RL4_JR_10412,1,18,10,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,28.39674586,1,0.041128651,1.057984081,0.038874546,0.968990411,0.984068688,3.909911783,0,1.498349847,1.296459213,1.155724632,0.24779381,0.401114496,10.19779526,0,-1.161194363,1.226729715,-0.946577187,0.343854273,0.487409236,19.79231044,0,0.122208921,1.062530726,0.115016835,0.908431778,0.943952356,10.09587854,0,-1.249407364,1.236771497,-1.010216816,0.312391424,0.447821488,N,-,,ubiquitin-like modifier,F:identical protein binding; P:protein sumoylation; P:mitotic sister chromatid segregation; F:protein tag; C:condensed nuclear chromosome; C:septin ring,IPR000626 (SMART); G3DSA:3.10.20.90 (GENE3D); IPR022617 (PFAM); PTHR10562 (PANTHER); IPR000626 (PROSITE_PROFILES); IPR029071 (SUPERFAMILY),,
RL4_JR_10413,1628,1301,1467,0,4,2,0,0,0,0,0,2,0,1,3,0,2,0,195.0787898,1,-1.122875648,0.507797506,-2.211266566,0.027017383,0.083489886,42.61615577,0,-1.947815304,1.193654212,-1.63180868,0.102719796,0.206746824,216.1418245,1,-0.182905345,0.467360045,-0.391358541,0.695532233,0.792255662,391.6601362,1,1.131969558,0.29499963,3.837189762,0.00012445,0.001288404,211.3811097,1,0.262823575,0.425778027,0.617278389,0.537051119,0.659667909,N,-, Effector probability:0.759,Pterin-4-alpha-carbinolamine dehydratase,C:cell part,IPR001533 (G3DSA:3.30.1360.GENE3D); IPR001533 (PFAM); IPR001533 (SUPERFAMILY),,
RL4_JR_10414,172,207,201,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.60448161,0,0.68146616,0.621558907,1.096382261,0.272911524,0.45511288,7.226579202,0,0.612198737,1.222329335,0.500845983,0.616479521,0.747987748,29.83744933,0,-1.079389858,1.189233628,-0.907634826,0.364071188,0.508178796,88.2715338,0,1.592184029,0.487432462,3.266471059,0.001088969,0.007926538,25.88083041,0,-1.189843155,1.123092995,-1.059434224,0.28940207,0.423928814,N,-,,---NA---,,no IPS match,,
RL4_JR_10415,65,52,63,0,1,103,0,0,1,0,0,0,0,0,0,0,0,0,13.40998392,1,-1.847570235,1.254755843,-1.47245398,0.140898326,0.283604377,4.360892103,1,1.34096625,1.341388291,0.99968537,0.317462794,0.479105174,11.17384683,0,-1.293010038,1.247346535,-1.036608514,0.299918344,0.44082053,12.88011566,0,-1.714208522,1.251535653,-1.36968413,0.170785525,0.29318719,10.87460916,0,-1.356741044,1.245697215,-1.08914191,0.276091311,0.408986762,N,-,,cupin,F:manganese ion binding; F:nutrient reservoir activity,no IPS match,,
RL4_JR_10416,22,26,34,0,0,21,0,0,0,0,0,0,0,0,0,0,0,0,65.05176298,1,0.068712617,0.677820397,0.101372896,0.919254452,0.961445874,12.12670869,0,-0.134660649,1.224479598,-0.10997378,0.91243017,0.951145023,31.65338192,0,-2.795352179,1.207081135,-2.315794769,0.020569477,0.056789033,84.52360421,0,0.497953501,0.58716762,0.84806022,0.396404434,0.54047871,62.88218632,0,0.041339196,0.725424105,0.056986245,0.954556152,0.970227926,N,-,,Aminoglycoside phosphotransferase,F:transferase activity,G3DSA:3.90.1200.10 (GENE3D); IPR011009 (SUPERFAMILY),,
RL4_JR_10417,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,76.89326381,0,0.464390203,0.702739648,0.660828238,0.508722472,0.695052407,12.2574481,0,-0.150114965,1.219648984,-0.123080465,0.90204338,0.944793366,67.09580878,0,0.019209102,0.760948308,0.025243636,0.979860631,0.98914239,146.0485182,0,1.448382416,0.630425821,2.297466836,0.021592153,0.079759412,72.70597487,0,0.542470066,0.620572768,0.874144167,0.382039747,0.517894289,N,-,,mitochondrial dna helicase,P:DNA repair; P:G-quadruplex DNA unwinding; P:DNA replication; P:DNA recombination; P:telomere maintenance; P:mitochondrial genome maintenance; C:replication fork; C:nucleus; F:DNA binding; F:ATP binding; F:ATP-dependent 5'-3' DNA helicase activity; P:DNA duplex unwinding; C:mitochondrion; P:negative regulation of telomere maintenance via telomerase; F:telomerase inhibitor activity; P:negative regulation of telomerase activity,IPR003593 (SMART); IPR000719 (SMART); G3DSA:1.10.510.10 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR010285 (PFAM); IPR000719 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR003840 (PANTHER); IPR000719 (PROSITE_PROFILES); IPR010285 (HAMAP); IPR027417 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_10418,495,480,357,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0.204703155,0,4.186048897,3.194714249,1.310304638,0.190092799,NA,0.067515641,0,7.354892746,2.50854705,2.931933346,0.00336859,0.016450773,0.171298259,0,4.735521654,1.630680451,2.904015715,0.003684097,0.015684377,0.197336757,0,4.314472164,2.13948764,2.016591301,0.043738182,0.113580171,0.164884405,1,4.685307698,1.465327892,3.197446607,0.001386501,0.006236482,N,-,,ornithine aminotransferase,F:pyridoxal phosphate binding; F:ornithine-oxo-acid transaminase activity,IPR015422 (G3DSA:3.90.1150.GENE3D),,
RL4_JR_10419,1480,1239,2738,0,1,9,0,0,0,0,0,0,2,2,0,0,0,0,0.946280151,1,1.977358303,1.67199023,1.182637474,0.236952854,NA,0.296885849,0,5.217313613,1.764733395,2.956431622,0.003112212,0.015916638,0.778476115,0,2.549940572,1.320847142,1.930534194,0.053540683,0.119183349,0.898693645,1,2.126747333,1.407438058,1.511077039,0.130768824,0.239774419,0.77537716,0,2.453756207,1.303383874,1.882604393,0.059754001,0.128269304,N,-, Effector probability:0.664,spherulin-1b,F:manganese ion binding; F:nutrient reservoir activity,IPR014710 (G3DSA:2.60.120.GENE3D); IPR011051 (SUPERFAMILY),,
RL4_JR_10420,237,147,369,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,91.10949007,0,-0.990376011,0.739791958,-1.338722327,0.180661085,0.337725282,21.57857351,0,-0.966058752,1.22245263,-0.790262729,0.429374348,0.591725227,69.36770464,0,-1.815194867,1.063071543,-1.707500195,0.087729122,0.175215945,73.07672962,0,-2.341378373,1.054883994,-2.219560052,0.026448647,0.08636862,63.7496936,0,-2.069235969,1.022645993,-2.023413756,0.043030507,0.099539384,N,-, Effector probability:0.795,hypothetical protein FOCG_17844,,no IPS match,,
RL4_JR_10421,818,1035,949,0,0,2,0,0,1,0,0,1,1,1,0,0,0,0,0.241704039,1,3.946414023,2.845504457,1.386894339,0.165473984,NA,0.078721355,1,7.133222322,2.305309168,3.094258428,0.001973055,0.015023052,0.201208557,1,4.503642421,1.464462659,3.075286619,0.002103003,0.010255688,0.231914804,1,4.081621751,1.86920879,2.183609328,0.028990968,0.090479045,0.19504613,0,4.443435581,1.335698199,3.326676329,0.000878884,0.004308593,N,-,,snf2 family atp-dependent chromatin-remodeling factor snf21,F:ATP binding; F:helicase activity; C:cellular_component,IPR001650 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001650 (PFAM); IPR000330 (PFAM); PTHR10799:SF752 (PANTHER); PTHR10799 (PANTHER); IPR001650 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),1.I.1.1.3, the eukaryotic nuclear pore complex (e-npc) family.
RL4_JR_10422,94,44,32,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,Delta-1-pyrroline-5-carboxylate dehydrogenase,"F:1-pyrroline-5-carboxylate dehydrogenase activity; P:glutamate biosynthetic process; P:proline biosynthetic process; P:oxidation-reduction process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",IPR015590 (PFAM); IPR016162 (G3DSA:3.40.605.GENE3D); PTHR11699:SF18 (PANTHER); PTHR11699 (PANTHER); IPR016161 (SUPERFAMILY),,
RL4_JR_10423,63,36,28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.031395814,0,6.889759465,3.940585773,1.748409973,0.080393062,NA,0.009511139,0,10.17757984,3.942370063,2.581589166,0.009834658,0.033197402,0.025653058,0,7.469679184,2.74714537,2.719069499,0.006546585,0.023311485,0.029658622,0,7.046430285,3.940947618,1.788004046,0.073775355,0.156828778,0.026373618,0,7.334130557,1.84941031,3.965658955,7.32E-05,0.000535852,N,-,,Uridylate kinase,F:kinase activity; P:nucleobase-containing compound metabolic process,IPR000850 (PRINTS); IPR027417 (G3DSA:3.40.50.GENE3D); IPR006674 (PFAM); PF00406 (PFAM); IPR006674 (G3DSA:1.10.3210.GENE3D); PTHR23359:SF107 (PANTHER); IPR000850 (PANTHER); IPR000850 (HAMAP); SSF109604 (SUPERFAMILY); IPR027417 (SUPERFAMILY),,
RL4_JR_10424,295,214,208,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,N,-,,c6 transcription factor,"C:nucleus; F:zinc ion binding; C:membrane; C:integral component of membrane; P:regulation of transcription, DNA-templated; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_10425,51,43,46,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,0.003880053,0,9.757732186,4.080472857,2.39132388,0.016787736,NA,0.001167299,0,12.97265741,4.080472857,3.179204438,0.001476799,0.015023052,0.003171529,1,10.3209357,4.080472857,2.529347961,0.011427467,0.035707308,0.003667858,0,9.898672466,4.080472857,2.425864064,0.015271989,0.065631958,0.003290547,0,10.24113993,1.835716385,5.578824711,2.42E-08,8.07E-07,N,-,,Aminoglycoside phosphotransferase,F:transferase activity,no IPS match,,
RL4_JR_10426,15917,1115,6991,2,0,4,0,0,0,0,0,0,0,6,1,0,3,4,42.07960517,1,-3.497338449,1.196025386,-2.924133961,0.003454161,0.016086366,22.76573455,0,0.639567954,1.118433136,0.571842816,0.567428468,0.708900389,41.27273569,0,-1.969142038,1.193349854,-1.650096182,0.098923266,0.192410978,116.3752146,1,0.847351789,0.480377283,1.763929768,0.077743804,0.16312647,45.8827116,1,-0.814268286,0.853854215,-0.953638539,0.340266641,0.477583106,N,-, Effector probability:0.799,---NA---,,no IPS match,,
RL4_JR_10427,17927,7954,9922,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,25.69750915,1,-2.785801054,1.189605098,-2.341786412,0.019191694,0.063310086,8.236115791,0,0.423602192,1.229433911,0.344550601,0.730432249,0.831751066,21.29329837,0,-2.2232691,1.19309167,-1.863452035,0.062398695,0.134380852,24.55966979,0,-2.645325388,1.191571064,-2.220031577,0.026416624,0.08636862,20.90577871,0,-2.299617002,1.190042331,-1.932382524,0.053312309,0.117524817,N,-,,transcription factor,"F:nucleic acid binding; F:DNA binding; C:nucleus; F:microtubule motor activity; F:zinc ion binding; F:metal ion binding; P:regulation of transcription, DNA-templated; C:kinesin complex; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; P:regulation of transcription from RNA polymerase II promoter",no IPS match,,
RL4_JR_10428,2149,1552,1172,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20.41544669,0,-1.207158945,1.138445114,-1.060357614,0.288981937,0.473681866,5.300339927,0,1.059457233,1.236603472,0.856747742,0.391584312,0.555984907,29.42411374,0,0.233081462,1.02750306,0.226842597,0.820546139,0.884215978,15.84801739,0,-2.013347555,1.186796211,-1.696456002,0.089799556,0.180687699,13.5257751,0,-1.671384561,1.189994259,-1.404531618,0.160160603,0.271818259,Y,-,,hypothetical protein FAVG1_11529,,PTHR35186 (PANTHER); PTHR35186:SF4 (PANTHER),,
RL4_JR_10429,5286,3731,5247,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.016230989,1,7.844051975,3.972032729,1.974820579,0.048288513,NA,0.005014687,0,11.10319729,3.974116214,2.793878359,0.005208006,0.021136905,0.013247767,0,8.426962998,2.842504877,2.964625696,0.003030514,0.013672426,0.015302944,0,8.002812168,3.972824045,2.014388777,0.043968732,0.113902079,0.013260666,0,8.337600113,1.56708315,5.32045802,1.04E-07,2.30E-06,N,-, Effector probability:0.939,zinc-binding domain-domain-containing,F:metal ion binding,IPR027377 (SMART); IPR027377 (PFAM),,
RL4_JR_10430,1,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,188.4405752,0,-4.646627733,1.153530453,-4.028179509,5.62E-05,0.000519044,57.52474697,0,-2.380608786,1.196537009,-1.989582243,0.046636974,0.111545238,149.4642937,0,-5.034681557,1.196763979,-4.206912677,2.59E-05,0.000417346,172.4326519,0,-5.457081254,1.197107807,-4.558554561,5.15E-06,7.88E-05,147.6969115,0,-5.120281112,1.204883604,-4.24960643,2.14E-05,0.000190029,N,-,,bZIP transcription factor,,IPR019357 (PFAM); PTHR21614 (PANTHER),,
RL4_JR_10431,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,70.59054378,0,-4.243737049,1.197516215,-3.543782535,0.00039443,0.00274217,22.71513007,0,-1.04003663,1.215520108,-0.855630954,0.392201942,0.556591725,58.6087928,0,-3.684045006,1.198758935,-3.073215889,0.002117652,0.010297364,67.58843385,0,-4.105874796,1.199333967,-3.423462446,0.000618288,0.004971948,57.45556136,0,-3.758179671,1.194519467,-3.146185371,0.001654151,0.007237805,N,-, Effector probability:0.804,GTP-binding rhb1,F:catalytic activity; F:purine ribonucleoside binding; P:single-organism cellular process; C:intracellular part; P:regulation of biological process; F:purine ribonucleotide binding,SM00173 (SMART); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24070:SF264 (PANTHER); IPR020849 (PANTHER); IPR027417 (SUPERFAMILY),,
RL4_JR_10432,1113,1486,1426,2,0,2,0,0,0,0,0,2,0,1,0,0,3,0,0.289626235,1,3.68545354,2.622444993,1.405350179,0.159917174,NA,0.090901089,0,6.924789029,2.194309021,3.155794815,0.001600614,0.015023052,0.238123703,1,4.258947291,1.410909484,3.018582936,0.002539599,0.011980847,0.274890202,1,3.835815686,1.74339967,2.200192964,0.027793207,0.088524638,0.236789853,1,4.166121618,1.324021924,3.146565432,0.001652003,0.00723153,N,-,,peroxisomal dehydratase,F:catalytic activity; P:metabolic process,IPR029069 (G3DSA:3.10.129.GENE3D),,
RL4_JR_10433,2149,1795,2206,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_10434,21,10,70,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.214402535,0,4.119109927,2.98514397,1.379869771,0.167626745,NA,0.066962081,0,7.3652132,2.341188348,3.145929376,0.0016556,0.015023052,0.176505382,0,4.689317925,1.473964812,3.181431393,0.001465492,0.007751643,0.203805215,0,4.266924381,1.927841198,2.213317354,0.026875774,0.087153604,0.177072802,0,4.584799118,1.362787821,3.364279491,0.000767438,0.003861982,N,-,,serine threonine kinase,F:kinase activity,IPR000719 (SMART); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR000719 (PFAM); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY),8.A.104.1.1, the 5'-amp-activated protein kinase (ampk) family.
RL4_JR_10435,29,21,65,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.434522058,0,3.1000782,2.104313189,1.473201905,0.140696601,NA,0.138474023,0,6.317707367,1.958899577,3.225130804,0.001259151,0.015023052,0.359852925,0,3.66278499,1.292007179,2.834957151,0.004583183,0.017771025,0.415158986,0,3.240797186,1.463550513,2.214339141,0.026805458,0.087153604,0.355622139,0,3.577698369,1.240972026,2.882980675,0.003939316,0.014750583,N,-,,thiamine transporter,"C:nucleus; F:DNA binding; F:zinc ion binding; P:transmembrane transport; P:transcription, DNA-templated; C:integral component of membrane; F:transporter activity",IPR001248 (PFAM); PTHR30618:SF4 (PANTHER); PTHR30618 (PANTHER),2.A.39.3.2, the nucleobase:cation symporter-1 (ncs1) family.
RL4_JR_10436,14,2,16,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,3.095919851,1,0.267404071,1.245223343,0.214743863,0.829967022,0.915106226,0.996540369,0,3.470635045,1.430263527,2.426570334,0.015242296,0.046738114,2.569319113,0,0.827870717,1.224302095,0.676198073,0.498914896,0.631771658,2.962916568,0,0.406014857,1.231126688,0.329791289,0.74155767,0.828179066,24.61202999,0,2.99290435,0.851614889,3.514387065,0.00044077,0.002442691,N,-,,AAA family partial,F:nucleotide binding; F:ATP binding,no IPS match,,
RL4_JR_10437,1969,3481,3508,2,1,10,0,0,0,1,1,0,3,5,1,0,7,0,0.342371168,1,3.444086654,2.641250526,1.303960613,0.192247012,NA,0.11248657,0,6.618251846,2.292585469,2.886807029,0.003891728,0.017776207,0.285889959,1,3.996384391,1.55342444,2.57262876,0.01009294,0.032908512,0.329397945,1,3.575311374,1.884861018,1.896856766,0.057846845,0.134334703,0.275490622,1,3.945465723,1.444393231,2.731573119,0.006303275,0.02168558,N,-, Effector probability:0.652,---NA---,,no IPS match,,
RL4_JR_10438,2727,2303,2440,0,2,0,0,0,0,0,0,1,3,0,0,0,2,1,4.618859319,1,-0.309639465,1.299923518,-0.238198218,0.811727359,0.904486774,1.482532948,0,2.897584834,1.44039738,2.011656557,0.044256153,0.107207936,3.819928154,1,0.255725083,1.26391344,0.202328004,0.839660309,0.896414363,8.417105522,1,0.776664066,1.211874973,0.640878047,0.52160192,0.656378255,3.729029095,1,0.187494745,1.258705863,0.148958347,0.8815865,0.921637926,N,-,,---NA---,,no IPS match,,
RL4_JR_10439,10299,5909,3405,11,14,3,0,0,1,0,2,0,1,2,0,0,1,0,0.624438486,1,2.576898681,1.81677189,1.418394183,0.156075713,NA,0.20126951,1,5.778375306,1.853013498,3.118366548,0.001818565,0.015023052,0.519427583,1,3.133736809,1.293047376,2.423528223,0.015370559,0.045394264,0.598977582,1,2.712086084,1.405654595,1.92941146,0.053679802,0.127664111,0.509940391,1,3.056831555,1.24894292,2.447535036,0.014383714,0.042078909,N,-,,Na+ H+ K+ antiporter P-type ATPase,F:ATP binding; F:metal ion binding; C:integral component of membrane; F:hydrolase activity,PR00119 (PRINTS); PR00121 (PRINTS); IPR004014 (SMART); IPR023299 (G3DSA:3.40.1110.GENE3D); G3DSA:4.10.6.10 (GENE3D); IPR008250 (PFAM); IPR004014 (PFAM); PF13246 (PFAM); IPR008250 (G3DSA:2.70.150.GENE3D); IPR001757 (TIGRFAM); IPR023214 (G3DSA:3.40.50.GENE3D); PTHR24093:SF263 (PANTHER); PTHR24093:SF263 (PANTHER); PTHR24093 (PANTHER); PTHR24093 (PANTHER); SSF81665 (SUPERFAMILY); IPR023299 (SUPERFAMILY); IPR023214 (SUPERFAMILY); SSF81653 (SUPERFAMILY),3.A.3.1.7, the p-type atpase (p-atpase) superfamily.
RL4_JR_10440,1404,1742,1799,0,2,24,0,0,0,5,0,4,1,8,1,0,7,0,92.23679531,1,1.493919617,0.599749195,2.490907249,0.012741738,0.046116724,47.49088896,0,1.192555846,1.104950497,1.079284411,0.28046096,0.439310715,23.76351643,1,-2.381726544,1.187470042,-2.005715058,0.044886658,0.104227643,27.41487771,1,-2.804111235,1.185703138,-2.364935325,0.01803322,0.073357312,30.80482053,1,-1.530656706,1.120039299,-1.366609822,0.171747637,0.286907247,N,-,,kinase-like (PK-like),F:ubiquitin protein ligase activity; F:zinc ion binding; C:Hrd1p ubiquitin ligase complex; F:protein kinase activity; P:protein phosphorylation; C:cellular_component; F:metal ion binding; C:membrane; C:integral component of membrane; P:phosphorylation; P:ER-associated ubiquitin-dependent protein catabolic process; F:kinase activity; P:protein ubiquitination,IPR002575 (PFAM); G3DSA:3.90.1200.10 (GENE3D); PTHR21310 (PANTHER); IPR011009 (SUPERFAMILY),,
RL4_JR_10441,3907,5486,4119,0,0,14,0,0,0,0,0,0,0,0,0,0,0,0,67.88996597,1,-1.503622031,0.867911353,-1.732460379,0.083191626,0.193686439,16.6138599,0,-0.588796569,1.207934639,-0.487440753,0.62594602,0.753905951,56.15987317,0,-1.424170439,1.038492779,-1.37138213,0.170255865,0.288335627,49.79959063,0,-3.66523013,1.195651722,-3.065466358,0.002173308,0.014132785,42.57838784,0,-3.325809473,1.198879649,-2.774097865,0.005535502,0.019481043,N,-,,---NA---,,no IPS match,,
RL4_JR_10442,3,5,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.218038206,0,0.748208163,1.255503337,0.595942791,0.551213445,0.730740661,0.708101861,0,3.963450876,1.465554641,2.704403346,0.006842717,0.02551086,1.837709302,0,1.310773224,1.217848917,1.076301999,0.281792215,0.421086994,2.119987706,0,0.888516626,1.228061234,0.723511663,0.469365591,0.610289792,1.813394528,0,1.22743804,1.212121235,1.012636364,0.311233884,0.44665601,N,-,,Kinesin light chain,F:catalytic activity; P:lipid metabolic process; P:nucleoside metabolic process; F:ADP binding,PF13424 (PFAM); IPR011990 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR19959 (PANTHER); PTHR19959:SF128 (PANTHER); IPR013026 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY),,
RL4_JR_10443,3415,5457,3898,0,1,4,0,0,0,0,0,2,0,0,0,0,9,0,17.87375987,1,-2.262142479,1.202369191,-1.881404227,0.059916952,0.152322374,5.76102516,0,0.939240406,1.263877136,0.743142177,0.457395607,0.616486404,14.85303591,1,-1.703672695,1.206699627,-1.411844884,0.157995639,0.272448961,17.12759227,0,-2.125412302,1.205990421,-1.762379091,0.078005269,0.163385053,14.55348889,1,-1.777150284,1.204120155,-1.475891153,0.139973115,0.245961088,N,-,,N-glycosylation EOS1,C:endoplasmic reticulum membrane; C:integral component of membrane; P:cellular response to oxidative stress,IPR021100 (PFAM); PTHR28147 (PANTHER),,
RL4_JR_10444,2298,4057,2867,7,0,7,0,0,0,0,0,0,0,2,1,0,0,0,388.8311903,1,2.50975472,0.744151306,3.372640348,0.000744511,0.004682902,27.66466927,0,0.186858362,1.156677159,0.161547551,0.871662163,0.925906644,47.05366958,0,-3.367216802,1.218395352,-2.763648759,0.005715903,0.020978829,104.8333784,1,-0.224223675,0.645617901,-0.347300895,0.728365279,0.819065026,53.30642478,0,-2.496861987,1.144470527,-2.181674343,0.029133576,0.073505471,N,-,,cellular morphogenesis regulator,P:cellular component organization; C:Golgi apparatus part,PTHR14042:SF24 (PANTHER); PTHR14042:SF24 (PANTHER); PTHR14042 (PANTHER); PTHR14042 (PANTHER),,
RL4_JR_10445,118,148,192,0,0,0,0,0,0,1,1,0,0,0,1,0,0,0,2.659705196,0,0.486138654,1.271200202,0.382424934,0.702146198,0.839159299,0.854487491,0,3.69238552,1.462946461,2.523937559,0.011604854,0.037672974,2.210148836,1,1.044625918,1.23561728,0.845428382,0.397871703,0.539808781,2.548982163,1,0.622702825,1.247711659,0.499075905,0.617725912,0.735846679,6.035477911,0,1.892965362,1.15214359,1.64299431,0.100384111,0.191699193,N,-,,small s,,IPR029498 (PFAM),1.C.104.2.5, the heterokaryon incompatibility prion/amyloid protein (het-s) family
RL4_JR_10446,2,4,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.019478151,0,7.57718263,3.961086708,1.912905015,0.055760213,NA,0.006341168,0,10.76585697,3.960170739,2.718533538,0.006557201,0.024747198,0.01633527,0,8.122024615,2.743094565,2.960898512,0.00306743,0.013767301,0.018830106,0,7.702177146,3.960482763,1.944757144,0.051804214,0.125559168,0.016075682,0,8.032689633,1.553673371,5.170127636,2.34E-07,4.41E-06,N,-, Effector probability:0.85,rheb small monomeric GTPase,F:GTP binding; C:nucleus; P:tRNA aminoacylation for protein translation; F:aminoacyl-tRNA ligase activity; P:small GTPase mediated signal transduction; F:GTPase activity; C:membrane; F:GDP binding; P:regulation of L-arginine import; C:cytosol,PR00449 (PRINTS); SM00175 (SMART); SM00173 (SMART); SM00174 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR005225 (TIGRFAM); IPR001806 (PFAM); IPR020849 (PANTHER); IPR020849 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),9.A.63.1.1, the retromer-dependent vacuolar protein sorting (r-vps) family.
RL4_JR_10447,2784,3794,2924,0,2,9,0,0,0,1,0,2,0,0,0,0,2,0,34.31969717,1,-3.203301779,1.215996742,-2.634301284,0.008431064,0.033147286,55.47314002,0,1.704625696,0.99321772,1.716265891,0.086113388,0.180277087,45.89171745,1,-0.808535064,1.050764786,-0.769472934,0.441612606,0.5813896,77.95894874,0,0.288408027,0.660352557,0.436748558,0.66229371,0.770034001,80.36980572,1,1.075430488,0.584246124,1.8407148,0.065663364,0.13837907,N,-,,---NA---,,no IPS match,,
RL4_JR_10448,1294,2226,1294,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0.188666964,1,4.304059761,3.194205483,1.347458635,0.177832567,NA,0.060046637,0,7.523831733,2.450655939,3.070129761,0.002139658,0.015045494,0.155186323,0,4.879072195,1.546876046,3.15414555,0.001609688,0.008340061,0.179035071,0,4.455259364,2.068017807,2.154362186,0.03121178,0.094531639,0.151612675,0,4.80986532,1.394151839,3.45002975,0.000560525,0.002979167,N,-,,acetamidase,"F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor",IPR023631 (G3DSA:3.90.1300.GENE3D); IPR023631 (SUPERFAMILY),,
RL4_JR_10449,121,102,162,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.019426228,0,7.580809812,3.961222504,1.913755111,0.055651454,NA,0.00600472,0,10.83982954,3.962959958,2.735286163,0.006232607,0.023876729,0.016016853,0,8.147263859,2.853492395,2.855190318,0.004301105,0.016956535,0.018502896,0,7.725994189,3.961370727,1.950333539,0.051136378,0.124880807,0.016327052,0,8.023085814,1.667298077,4.81202847,1.49E-06,2.01E-05,N,-, Effector probability:0.655,---NA---,,no IPS match,,
RL4_JR_10450,22,33,12,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0.282044607,1,3.723522027,2.593182415,1.43588897,0.151033937,NA,0.089179387,0,6.952231097,2.161778147,3.215978063,0.001300008,0.015023052,0.233136759,0,4.28818216,1.366538366,3.137988853,0.001701113,0.008715624,0.269057875,0,3.866305672,1.686672453,2.292268227,0.02189017,0.080273303,0.231952208,0,4.194588173,1.286967583,3.259280364,0.001116952,0.005218801,N,-,,Telomerase-binding EST1A,F:metal ion binding,IPR011990 (SUPERFAMILY),,
RL4_JR_10451,2,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,334.5929105,0,-1.107844947,0.508823973,-2.177265626,0.029460754,0.089147194,76.92140619,0,-2.799810404,1.191696087,-2.349433244,0.018802015,0.054861343,255.9447182,0,-1.643661174,0.553727378,-2.968358145,0.002993953,0.013561869,293.9051006,0,-1.965897291,0.521411604,-3.770336675,0.000163027,0.001616702,278.9576813,0,-1.214869277,0.680830558,-1.784392992,0.074359829,0.151692525,N,-,,metalloprotease m41,F:catalytic activity,no IPS match,,
RL4_JR_10452,9,4,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.735726713,0,2.34039776,1.6614004,1.408689778,0.158926919,NA,0.236737117,0,5.544281856,1.778561087,3.117285033,0.00182525,0.015023052,0.610909767,0,2.900192119,1.264387661,2.293752311,0.02180473,0.059533735,0.704511373,0,2.478214579,1.344747154,1.842885163,0.065345779,0.144333772,0.599043027,0,2.824871304,1.226192904,2.303773978,0.021235335,0.057335403,N,-,,C2H2 finger domain,,IPR015880 (SMART); PTHR23225:SF2 (PANTHER); PTHR23225 (PANTHER),,
RL4_JR_10453,1,4,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.086964454,0,5.420745771,3.919015892,1.383190556,0.166606445,NA,0.02754913,0,8.646474916,2.737072111,3.159023425,0.001582988,0.015023052,0.072011398,0,5.981785273,1.58576214,3.772183181,0.000161825,0.001551228,0.083101138,0,5.561104988,2.536326623,2.192582351,0.028337484,0.089465864,0.071709199,0,5.88722985,1.343318986,4.382600046,1.17E-05,0.000115391,N,-,,telomerase-binding EST1A,F:metal ion binding,IPR011990 (SUPERFAMILY),,
RL4_JR_10454,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.141418259,0,4.719714482,3.46114294,1.363628883,0.172684397,NA,0.045297109,0,7.930379817,2.469739676,3.211018511,0.001322654,0.015023052,0.116967189,0,5.286624014,1.449648839,3.646830786,0.000265495,0.002114766,0.134911022,0,4.863162828,2.092278813,2.324337845,0.020107394,0.076941559,0.114525191,0,5.213865259,1.287308869,4.050205341,5.12E-05,0.000398557,N,-,,---NA---,,no IPS match,,
RL4_JR_10455,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_10456,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_10457,299,261,212,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_10458,46,32,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_10459,360,535,244,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_10460,68,38,51,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,,,,,,,,
RL4_JR_10461,2295,2265,2617,1,0,14,0,1,0,0,0,0,0,0,0,0,0,1,0,1,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,,,,,,,,